CDMCnumber Block Column Rown OligoID SampleID ORF Flag? sequence length FBan_Number FBgn_Number Gene_Symbol Chromosome_arm Chromosome_arm GO_Biological_process GO_Molecular_function GO_Cellular_component Gene_Symbol Full_name Synonyms CDMC20001 1 1 1 DAC01-A12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20001 1 2 1 DAC01-A12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20002 1 3 1 DAC01-A24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20002 1 4 1 DAC01-A24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20003 1 5 1 DAC01-E12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20003 1 6 1 DAC01-E12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20004 1 7 1 DAC01-E24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20004 1 8 1 DAC01-E24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20005 1 9 1 DAC01-I12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20005 1 10 1 DAC01-I12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20006 1 11 1 DAC01-I24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20006 1 12 1 DAC01-I24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20007 1 13 1 DAC01-M12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20007 1 14 1 DAC01-M12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20008 1 15 1 DAC01-M24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20008 1 16 1 DAC01-M24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20009 1 17 1 DAC02-A12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20009 1 18 1 DAC02-A12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20010 1 19 1 DAC02-A24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20010 1 20 1 DAC02-A24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20011 1 21 1 DAC02-E12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20011 1 22 1 DAC02-E12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20012 1 23 1 DAC02-E24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20012 1 24 1 DAC02-E24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20013 1 25 1 DAC02-I12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20013 1 26 1 DAC02-I12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20014 1 1 2 DAC02-I24 N/A CG9075 (01674-01910) CDMC20014 1 2 2 DAC02-I24 N/A CG9075 (01674-01910) CDMC20015 1 3 2 DAC02-M12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20015 1 4 2 DAC02-M12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20016 1 5 2 DAC02-M24 AutoBlank AutoBlank CDMC20016 1 6 2 DAC02-M24 AutoBlank AutoBlank CDMC20017 1 7 2 DAC03-A12 23-CG32207-RA_1 CG32207 CGACTGATGCATTTCTCAATCACAGCCATTTCTAAATCAATCGTCAAATCTAAACTAACTGCAAATTTT 69 FBan0032207 FBgn0052207 CG32207 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32207 CG32207 BcDNA:LD41276 CDMC20017 1 8 2 DAC03-A12 23-CG32207-RA_1 CG32207 CGACTGATGCATTTCTCAATCACAGCCATTTCTAAATCAATCGTCAAATCTAAACTAACTGCAAATTTT 69 FBan0032207 FBgn0052207 CG32207 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32207 CG32207 BcDNA:LD41276 CDMC20018 1 9 2 DAC03-A24 11-CG3221-RA_2 CG3221 GCCACGCAGTGTCTTATTGACCAGTTGGATCTTGGCAAGATTCACTGCCTCAGTTTAACGGACATGGCG 69 FBan0003221 FBgn0034569 CG3221 2 2R CG3221 CG3221 CDMC20018 1 10 2 DAC03-A24 11-CG3221-RA_2 CG3221 GCCACGCAGTGTCTTATTGACCAGTTGGATCTTGGCAAGATTCACTGCCTCAGTTTAACGGACATGGCG 69 FBan0003221 FBgn0034569 CG3221 2 2R CG3221 CG3221 CDMC20019 1 11 2 DAC03-E12 16-CG32248-RA_1 CG32248 TCAGCACTTCCGTTTGGATCCGCAGATTCTCCGACTTGTATAAAAGTACAGGAGTCGCCGGTCTAAGAT 69 FBan0032248 FBgn0052248 CG32248 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32248 CG32248 CDMC20019 1 12 2 DAC03-E12 16-CG32248-RA_1 CG32248 TCAGCACTTCCGTTTGGATCCGCAGATTCTCCGACTTGTATAAAAGTACAGGAGTCGCCGGTCTAAGAT 69 FBan0032248 FBgn0052248 CG32248 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32248 CG32248 CDMC20020 1 13 2 DAC03-E24 6-CG32254-RA_1 CG32254 GCATGCAACCAACTACCACCTAGCCTGGCTTCTTTCTCAAAAGCCCCCACCAAATGCTAAGGCGTATTT 69 FBan0032254 FBgn0052254 CG32254 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32254 CG32254 BcDNA:RH01388 CDMC20020 1 14 2 DAC03-E24 6-CG32254-RA_1 CG32254 GCATGCAACCAACTACCACCTAGCCTGGCTTCTTTCTCAAAAGCCCCCACCAAATGCTAAGGCGTATTT 69 FBan0032254 FBgn0052254 CG32254 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32254 CG32254 BcDNA:RH01388 CDMC20021 1 15 2 DAC03-I12 3-CG32296-RA_2 CG32296 GACAGCTCCTCTGTGCAAACGCAAGACGGCAAGCATTAAGTCCGAACAAGTCAGCGATGTTCTGGACAT 69 FBan0032296 FBgn0052296 Mrtf 3 3L "actin cytoskeleton organization and biogenesis; GO:0030036; border follicle cell migration (sensu Insecta); GO:0007298; mesodermal cell migration; GO:0008078; positive regulation of transcription, DNA-dependent; GO:0045893; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003677 Mrtf Myocardin-related transcription factor "CG12188, CG32296, CG14951, CG12188, CG12188, CG12188, CG32296, mal-d, DMRTF" CDMC20021 1 16 2 DAC03-I12 3-CG32296-RA_2 CG32296 GACAGCTCCTCTGTGCAAACGCAAGACGGCAAGCATTAAGTCCGAACAAGTCAGCGATGTTCTGGACAT 69 FBan0032296 FBgn0052296 Mrtf 3 3L "actin cytoskeleton organization and biogenesis; GO:0030036; border follicle cell migration (sensu Insecta); GO:0007298; mesodermal cell migration; GO:0008078; positive regulation of transcription, DNA-dependent; GO:0045893; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003677 Mrtf Myocardin-related transcription factor "CG12188, CG32296, CG14951, CG12188, CG12188, CG12188, CG32296, mal-d, DMRTF" CDMC20022 1 17 2 DAC03-I24 23-CG32306-RA_1 CG32306 AGCTAACTAGTTGTCTCATAGTAATCCCAATAATGAAAACAAACTGAACGAAACGAAAATTCCACAGAT 69 FBan0032306 FBgn0052306 CG32306 3 3L CG32306 CG32306 "CG13797, CG16763, CG13798, CG12790, CG13799, CG13797, CG16763, CG13797, CG13798" CDMC20022 1 18 2 DAC03-I24 23-CG32306-RA_1 CG32306 AGCTAACTAGTTGTCTCATAGTAATCCCAATAATGAAAACAAACTGAACGAAACGAAAATTCCACAGAT 69 FBan0032306 FBgn0052306 CG32306 3 3L CG32306 CG32306 "CG13797, CG16763, CG13798, CG12790, CG13799, CG13797, CG16763, CG13797, CG13798" CDMC20023 1 19 2 DAC03-M12 16-CG32350-RA_1 CG32350 TCTTGCAACCCTATCAAAAATGTATTTCGCATGTACCCCGTCCAATCAGGTCCCAGTTGAAGAAGAGCA 69 FBan0032350 FBgn0052350 CG32350 3 3L protein transport; GO:0015031; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32350 CG32350 BcDNA:LD20292 CDMC20023 1 20 2 DAC03-M12 16-CG32350-RA_1 CG32350 TCTTGCAACCCTATCAAAAATGTATTTCGCATGTACCCCGTCCAATCAGGTCCCAGTTGAAGAAGAGCA 69 FBan0032350 FBgn0052350 CG32350 3 3L protein transport; GO:0015031; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32350 CG32350 BcDNA:LD20292 CDMC20024 1 21 2 DAC03-M24 15-CG32364-RA_7 CG32364 TTCGGGAAATTCTCGCGGCTACGCCTACTTGCAATATATCAATGTGGACCTCAAGGAATCGGCAATGCA 69 FBan0032364 FBgn0052364 CG32364 3 3L biological process unknown; GO:0000004 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 CG32364 CG32364 anon-WO0118547.705 CDMC20024 1 22 2 DAC03-M24 15-CG32364-RA_7 CG32364 TTCGGGAAATTCTCGCGGCTACGCCTACTTGCAATATATCAATGTGGACCTCAAGGAATCGGCAATGCA 69 FBan0032364 FBgn0052364 CG32364 3 3L biological process unknown; GO:0000004 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 CG32364 CG32364 anon-WO0118547.705 CDMC20025 1 23 2 DAC04-A12 16-CG2928-RA_1 CG2928 AGGCCTAGACCTAAGTCCTTGTGTGAATGTGATAGAGCAGATGAGGAGATCCTGCATCATAGAGTGCGA 69 FBan0002928 FBgn0015801 Reg-5 2 2R circadian rhythm; GO:0007623 Reg-5 Rhythmically expressed gene 5 "CG2928, Dreg, Dreg-5, Drosophila Rhythmically expressed gene 5, DREG-5, reg-5, dreg-5, Dreg5, Rhythmically expressed gene 5" CDMC20025 1 24 2 DAC04-A12 16-CG2928-RA_1 CG2928 AGGCCTAGACCTAAGTCCTTGTGTGAATGTGATAGAGCAGATGAGGAGATCCTGCATCATAGAGTGCGA 69 FBan0002928 FBgn0015801 Reg-5 2 2R circadian rhythm; GO:0007623 Reg-5 Rhythmically expressed gene 5 "CG2928, Dreg, Dreg-5, Drosophila Rhythmically expressed gene 5, DREG-5, reg-5, dreg-5, Dreg5, Rhythmically expressed gene 5" CDMC20026 1 25 2 DAC04-A24 3-CG2943-RA_3 CG2943 GGCGATCGATCGGTGCTGTACAAGTACATCAACCCTAATCTAGTGGCTTTCGTCACACAGGCACCGGAT 69 FBan0002943 FBgn0037530 CG2943 3 3R CG2943 CG2943 NEST:bs09f06 CDMC20026 1 26 2 DAC04-A24 3-CG2943-RA_3 CG2943 GGCGATCGATCGGTGCTGTACAAGTACATCAACCCTAATCTAGTGGCTTTCGTCACACAGGCACCGGAT 69 FBan0002943 FBgn0037530 CG2943 3 3R CG2943 CG2943 NEST:bs09f06 CDMC20027 1 1 3 DAC04-E12 14-CG2983-RA_2 CG2983 CCGGGAGTCGTGGCTAAAAACGAAGATGGCCTTGAAGTACCTTCATGATCATCACCTAAACGATGCCGA 69 FBan0002983 FBgn0031472 CG2983 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG2983 CG2983 CDMC20027 1 2 3 DAC04-E12 14-CG2983-RA_2 CG2983 CCGGGAGTCGTGGCTAAAAACGAAGATGGCCTTGAAGTACCTTCATGATCATCACCTAAACGATGCCGA 69 FBan0002983 FBgn0031472 CG2983 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG2983 CG2983 CDMC20028 1 3 3 DAC04-E24 2-CG2991-RA_2 CG2991 AGGGCTTCACCATTCAGCATTGGTCCAAGACGGTTATATTGATCACCTTGATGTGCGTAACCGGTGCCA 69 FBan0002991 FBgn0031474 CG2991 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2991 CG2991 "CT10107, CT42388" CDMC20028 1 4 3 DAC04-E24 2-CG2991-RA_2 CG2991 AGGGCTTCACCATTCAGCATTGGTCCAAGACGGTTATATTGATCACCTTGATGTGCGTAACCGGTGCCA 69 FBan0002991 FBgn0031474 CG2991 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2991 CG2991 "CT10107, CT42388" CDMC20029 1 5 3 DAC04-I12 3-CG30019-RA_4 CG30019 TGCTGGCACCTAATCTTAGTGGGTTCAGTGCGAGTCTGGGAGGTGCGTCAAGAGGTGTTGTCAAACATT 69 FBgn0050019 CDMC20029 1 6 3 DAC04-I12 3-CG30019-RA_4 CG30019 TGCTGGCACCTAATCTTAGTGGGTTCAGTGCGAGTCTGGGAGGTGCGTCAAGAGGTGTTGTCAAACATT 69 FBgn0050019 CDMC20030 1 7 3 DAC04-I24 1-CG30029-RA_1 CG30029 GCTCGTGGTTAAGGTCATGGCAACTACGGACATGGCAACTACGGACATGGCAACTACGGACATGGTCAT 69 FBan0030029 FBgn0050029 CG30029 2 2R CG30029 CG30029 "CG18337, CG18337, BcDNA:LP05669" CDMC20030 1 8 3 DAC04-I24 1-CG30029-RA_1 CG30029 GCTCGTGGTTAAGGTCATGGCAACTACGGACATGGCAACTACGGACATGGCAACTACGGACATGGTCAT 69 FBan0030029 FBgn0050029 CG30029 2 2R CG30029 CG30029 "CG18337, CG18337, BcDNA:LP05669" CDMC20031 1 9 3 DAC04-M12 22-CG30058-RA_1 CG30058 AGGCTCAGCGGACATATAGATCACTCAGACGACAACATTACCCATACGAAAATGATCCCGAGACACCAA 69 FBan0030058 FBgn0050058 CG30058 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30058 CG30058 CDMC20031 1 10 3 DAC04-M12 22-CG30058-RA_1 CG30058 AGGCTCAGCGGACATATAGATCACTCAGACGACAACATTACCCATACGAAAATGATCCCGAGACACCAA 69 FBan0030058 FBgn0050058 CG30058 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30058 CG30058 CDMC20032 1 11 3 DAC04-M24 18-CG30071-RA_1 CG30071 TGCTCCCTCGATCTCCTTCACCTCGATTTGTTACCGTTTGAATTTATTGCTGCCCACTACACTTTTGGT 69 FBan0030071 FBgn0050071 CG30071 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30071 CG30071 CDMC20032 1 12 3 DAC04-M24 18-CG30071-RA_1 CG30071 TGCTCCCTCGATCTCCTTCACCTCGATTTGTTACCGTTTGAATTTATTGCTGCCCACTACACTTTTGGT 69 FBan0030071 FBgn0050071 CG30071 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30071 CG30071 CDMC20033 1 13 3 DAC05-A12 3-CG17820-RA_2 CG17820 GCACTCTGTCAACTGGCCCTGTGATGTGGGTCACTTCCCAGAGGCATTCATTCTAATGCACAAGGTGG 68 FBan0017820 FBgn0038914 fit 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fit female-specific independent of transformer "CG17820, CG17820, CG17820, CG17820, female-specific independent of transformer" CDMC20033 1 14 3 DAC05-A12 3-CG17820-RA_2 CG17820 GCACTCTGTCAACTGGCCCTGTGATGTGGGTCACTTCCCAGAGGCATTCATTCTAATGCACAAGGTGG 68 FBan0017820 FBgn0038914 fit 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fit female-specific independent of transformer "CG17820, CG17820, CG17820, CG17820, female-specific independent of transformer" CDMC20034 1 15 3 DAC05-A24 3-CG18112-RA_1 CG18112 ACTGCGAGAATGCGCTGAAAAGCCTCCAGAGCAAGCGATGGACTACGGACAACATCAAGCTCAAGTTG 68 FBan0018112 FBgn0039702 Vps16B 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps16B Vps16B "CG18112, CG18112" CDMC20034 1 16 3 DAC05-A24 3-CG18112-RA_1 CG18112 ACTGCGAGAATGCGCTGAAAAGCCTCCAGAGCAAGCGATGGACTACGGACAACATCAAGCTCAAGTTG 68 FBan0018112 FBgn0039702 Vps16B 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps16B Vps16B "CG18112, CG18112" CDMC20035 1 17 3 DAC05-E12 3-CG2102-RA_5 CG2102 ACGCGCTTTAAGCAGGTTTAGGTGGGTTTTTTTGTGGGTTCAGGCAGATCCAGGACAAGGCATCCTTC 68 FBan0002102 FBgn0004878 cas 3 3R "central nervous system development; GO:0007417; ganglion mother cell fate determination; GO:0007402; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; post-embryonic development; GO:0009791; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 cas castor "CG2102, l(3)neo33, ming, Cas, Castor, l(3)j1C2, castor" CDMC20035 1 18 3 DAC05-E12 3-CG2102-RA_5 CG2102 ACGCGCTTTAAGCAGGTTTAGGTGGGTTTTTTTGTGGGTTCAGGCAGATCCAGGACAAGGCATCCTTC 68 FBan0002102 FBgn0004878 cas 3 3R "central nervous system development; GO:0007417; ganglion mother cell fate determination; GO:0007402; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; post-embryonic development; GO:0009791; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 cas castor "CG2102, l(3)neo33, ming, Cas, Castor, l(3)j1C2, castor" CDMC20036 1 19 3 DAC05-E24 15-CG2225-RC_1 CG2225 CCTGGAGTATCGACTCGCAATACCGCAAGAAATCGCCAAAGCTATTTGGTCATTATAGCAGCGGTGGC 68 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC20036 1 20 3 DAC05-E24 15-CG2225-RC_1 CG2225 CCTGGAGTATCGACTCGCAATACCGCAAGAAATCGCCAAAGCTATTTGGTCATTATAGCAGCGGTGGC 68 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC20037 1 21 3 DAC05-I12 3-CG30165-RA_1 CG30165 TGCCGCAACATGGTGGATTTCATCAACGGCCTCACCTTCTTCATCTTCCTTACACTGCTTCTCTGGGC 68 FBan0030165 FBgn0050165 CG30165 2 2R CG30165 CG30165 CG4556 CDMC20037 1 22 3 DAC05-I12 3-CG30165-RA_1 CG30165 TGCCGCAACATGGTGGATTTCATCAACGGCCTCACCTTCTTCATCTTCCTTACACTGCTTCTCTGGGC 68 FBan0030165 FBgn0050165 CG30165 2 2R CG30165 CG30165 CG4556 CDMC20038 1 23 3 DAC05-I24 2-CG30386-RA_2 CG30386 CCTGGCTATGTTGGTGTTGTAACCTTGTTGCTCTACCGCTTGTTGGATCCTAACCCCCGAGATTGGCC 68 FBan0030386 FBgn0050386 CG30386 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30386 CG30386 CDMC20038 1 24 3 DAC05-I24 2-CG30386-RA_2 CG30386 CCTGGCTATGTTGGTGTTGTAACCTTGTTGCTCTACCGCTTGTTGGATCCTAACCCCCGAGATTGGCC 68 FBan0030386 FBgn0050386 CG30386 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30386 CG30386 CDMC20039 1 25 3 DAC05-M12 3-CG31266-RA_2 CG31266 TGGACTGGTGGGATCTGTATGCTCCGTACTACACTGTGAGCCAGATCCATGTGCACTGCAACTTCGAC 68 FBan0031266 FBgn0051266 CG31266 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31266 CG31266 "CG5240, SPH146" CDMC20039 1 26 3 DAC05-M12 3-CG31266-RA_2 CG31266 TGGACTGGTGGGATCTGTATGCTCCGTACTACACTGTGAGCCAGATCCATGTGCACTGCAACTTCGAC 68 FBan0031266 FBgn0051266 CG31266 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31266 CG31266 "CG5240, SPH146" CDMC20040 1 1 4 DAC05-M24 2-CG31363-RB_1 CG31363 GCTGTCAAACTCGGCGAGACTCTGGAAATAATCCCGAACAGCCATACTCGCTGAACAAGATGGCAGGC 68 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC20040 1 2 4 DAC05-M24 2-CG31363-RB_1 CG31363 GCTGTCAAACTCGGCGAGACTCTGGAAATAATCCCGAACAGCCATACTCGCTGAACAAGATGGCAGGC 68 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC20041 1 3 4 DAC06-A12 23-CG5227-RC_10 CG5227 CCTGTGATAAAACGATTTCCTTGTGCCCTAATAAGTTTTTCCAATGATTTCCAAGTGTGTTCAGCGCGT 69 FBan0005227 FBgn0021764 sdk X X cell adhesion; GO:0007155; cone cell differentiation (sensu Endopterygota); GO:0042674; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; pigment cell differentiation; GO:0050931 integral to plasma membrane; GO:0005887 sdk sidekick "CG5227, CG5227, CG5227, CT16627, EG:BACR19J1.1, BcDNA:RE63453, BcDNA:LD22322, sidekick" CDMC20041 1 4 4 DAC06-A12 23-CG5227-RC_10 CG5227 CCTGTGATAAAACGATTTCCTTGTGCCCTAATAAGTTTTTCCAATGATTTCCAAGTGTGTTCAGCGCGT 69 FBan0005227 FBgn0021764 sdk X X cell adhesion; GO:0007155; cone cell differentiation (sensu Endopterygota); GO:0042674; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; pigment cell differentiation; GO:0050931 integral to plasma membrane; GO:0005887 sdk sidekick "CG5227, CG5227, CG5227, CT16627, EG:BACR19J1.1, BcDNA:RE63453, BcDNA:LD22322, sidekick" CDMC20042 1 5 4 DAC06-A24 3-CG5245-RA_2 CG5245 GCCATGAGGTCACTTTATCGAGTCCACGTGCGTTTGCATACAAGAGAGCGACAGTACAAGTGCGCCGAA 69 FBan0005245 FBgn0038047 CG5245 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5245 CG5245 anon-WO0118547.611 CDMC20042 1 6 4 DAC06-A24 3-CG5245-RA_2 CG5245 GCCATGAGGTCACTTTATCGAGTCCACGTGCGTTTGCATACAAGAGAGCGACAGTACAAGTGCGCCGAA 69 FBan0005245 FBgn0038047 CG5245 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5245 CG5245 anon-WO0118547.611 CDMC20043 1 7 4 DAC06-E12 1-CG5279-RA_1 CG5279 CGTGTGGTCCTACGTGATACCGATGACCATGATCCTGGTGTCCTACTACAAGCTCTTCACCCACGTCCG 69 FBan0005279 FBgn0014019 Rh5 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; absorption of visible light; GO:0016038; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601" G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh5 Rhodopsin 5 "CG5279, rh5, Dm Rh5, rhodopsin, Rh, DMELRH5, RH5, Rhodopsin, Rhodopsin5, Rhodopsin 5" CDMC20043 1 8 4 DAC06-E12 1-CG5279-RA_1 CG5279 CGTGTGGTCCTACGTGATACCGATGACCATGATCCTGGTGTCCTACTACAAGCTCTTCACCCACGTCCG 69 FBan0005279 FBgn0014019 Rh5 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; absorption of visible light; GO:0016038; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601" G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh5 Rhodopsin 5 "CG5279, rh5, Dm Rh5, rhodopsin, Rh, DMELRH5, RH5, Rhodopsin, Rhodopsin5, Rhodopsin 5" CDMC20044 1 9 4 DAC06-E24 15-CG5302-RA_8 CG5302 TGCTGAGATCACTTCCCATCCCTGGATGGCCTATCTGTACAACGAGTTTCATTATTTCTGCGCTGGCAC 69 FBan0005302 FBgn0038351 CG5302 3 3R metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5302 CG5302 SPH73 CDMC20044 1 10 4 DAC06-E24 15-CG5302-RA_8 CG5302 TGCTGAGATCACTTCCCATCCCTGGATGGCCTATCTGTACAACGAGTTTCATTATTTCTGCGCTGGCAC 69 FBan0005302 FBgn0038351 CG5302 3 3R metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5302 CG5302 SPH73 CDMC20045 1 11 4 DAC06-I12 23-CG5338-RB_5 CG5338 CACAGTAAAGGAAATCGATCAGCACGTTCTGACCAAAAACATGGCTGCTTTTCTCAAAAAATCCGGAAA 69 FBan0005338 FBgn0039129 RpS19b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS19b Ribosomal protein S19b "CG5338, BcDNA:SD22440, Ribosomal protein S19b" CDMC20045 1 12 4 DAC06-I12 23-CG5338-RB_5 CG5338 CACAGTAAAGGAAATCGATCAGCACGTTCTGACCAAAAACATGGCTGCTTTTCTCAAAAAATCCGGAAA 69 FBan0005338 FBgn0039129 RpS19b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS19b Ribosomal protein S19b "CG5338, BcDNA:SD22440, Ribosomal protein S19b" CDMC20046 1 13 4 DAC06-I24 1-CG5354-RA_2 CG5354 ACCTCCGGATATTACTTGCGTTGCATTTGGTGTCGTTCGGAACGTTTCAGGGATTCCATACGCCTGCAG 69 FBan0005354 FBgn0005683 pie 2 2L "electron transport; GO:0006118; eye development (sensu Endopterygota); GO:0007456; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 pie pineapple eye "CG5354, l(2)54, mat(2)earlyQM47, l(2)31Ek, mat(2)QM47, mat(2)ea-E: maternal effect early arrest E, rumpled, lethal(2)54, maternal effect early arrest E" CDMC20046 1 14 4 DAC06-I24 1-CG5354-RA_2 CG5354 ACCTCCGGATATTACTTGCGTTGCATTTGGTGTCGTTCGGAACGTTTCAGGGATTCCATACGCCTGCAG 69 FBan0005354 FBgn0005683 pie 2 2L "electron transport; GO:0006118; eye development (sensu Endopterygota); GO:0007456; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 pie pineapple eye "CG5354, l(2)54, mat(2)earlyQM47, l(2)31Ek, mat(2)QM47, mat(2)ea-E: maternal effect early arrest E, rumpled, lethal(2)54, maternal effect early arrest E" CDMC20047 1 15 4 DAC06-M12 1-CG5392-RA_1 CG5392 TCCTCAGGGTCAAGTTGCCTATTGGTCCGCCTGTCAATCCAGTCGCTTTAATACCTCACCTTCACCAGT 69 FBan0005392 FBgn0036463 CG5392 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5392 CG5392 CDMC20047 1 16 4 DAC06-M12 1-CG5392-RA_1 CG5392 TCCTCAGGGTCAAGTTGCCTATTGGTCCGCCTGTCAATCCAGTCGCTTTAATACCTCACCTTCACCAGT 69 FBan0005392 FBgn0036463 CG5392 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5392 CG5392 CDMC20048 1 17 4 DAC06-M24 3-CG5400-RA_3 CG5400 GCGGTGTGTGCTTTTATGGCCTGTGACTCAGGTGTGGATTTGGGTCAATGTGATGCTCAACACGATGCT 69 FBan0005400 FBgn0000564 Eh 3 3R adult behavior; GO:0030534; ecdysis (sensu Insecta); GO:0018990; eclosion; GO:0007562; neuropeptide signaling pathway; GO:0007218; regulation of eclosion; GO:0007563 neuropeptide hormone activity; GO:0005184; ; GO:0005184; eclosion hormone activity; GO:0008031; ; GO:0008031; ; GO:0005184; ; GO:0008031; ; GO:0008031; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255 Eh Eclosion hormone "CG5400, EH, DMEHAB, EHAB, eh, Drm-EH" CDMC20048 1 18 4 DAC06-M24 3-CG5400-RA_3 CG5400 GCGGTGTGTGCTTTTATGGCCTGTGACTCAGGTGTGGATTTGGGTCAATGTGATGCTCAACACGATGCT 69 FBan0005400 FBgn0000564 Eh 3 3R adult behavior; GO:0030534; ecdysis (sensu Insecta); GO:0018990; eclosion; GO:0007562; neuropeptide signaling pathway; GO:0007218; regulation of eclosion; GO:0007563 neuropeptide hormone activity; GO:0005184; ; GO:0005184; eclosion hormone activity; GO:0008031; ; GO:0008031; ; GO:0005184; ; GO:0008031; ; GO:0008031; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255 Eh Eclosion hormone "CG5400, EH, DMEHAB, EHAB, eh, Drm-EH" CDMC20049 1 19 4 DAC07-A12 17-CG9757-RA_1 CG9757 ACTTTGCCGGTGATTAGTAGCAGAAGTTTCCTCGAAAATGCGCACATTTGTTTGCCTTGCCCTGG 65 FBan0009757 FBgn0003060 CG9757 3 3R CG9757 CG9757 "GCR-20, GCR 20, GCR20, Pen50DE, anon-Pen50DE, pen50DE" CDMC20049 1 20 4 DAC07-A12 17-CG9757-RA_1 CG9757 ACTTTGCCGGTGATTAGTAGCAGAAGTTTCCTCGAAAATGCGCACATTTGTTTGCCTTGCCCTGG 65 FBan0009757 FBgn0003060 CG9757 3 3R CG9757 CG9757 "GCR-20, GCR 20, GCR20, Pen50DE, anon-Pen50DE, pen50DE" CDMC20050 1 21 4 DAC07-A24 8-CG9783-RA_1 CG9783 CCGTCCAGGACTTTGAACGGGATCTATGCCCACAACAGCAATAGTACCAGTTCCCATGGTGCAGC 65 FBan0009783 FBgn0037256 CG9783 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; visual perception; GO:0007601 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 CG9783 CG9783 GYC CDMC20050 1 22 4 DAC07-A24 8-CG9783-RA_1 CG9783 CCGTCCAGGACTTTGAACGGGATCTATGCCCACAACAGCAATAGTACCAGTTCCCATGGTGCAGC 65 FBan0009783 FBgn0037256 CG9783 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; visual perception; GO:0007601 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 CG9783 CG9783 GYC CDMC20051 1 23 4 DAC07-E12 15-CG9904-RA_4 CG9904 ATGAGGGACTACGACTCGATGCTGAGGGGTCACTCCTGTCGGTCTGCCATGATGCGCTATCGTTC 65 FBan0009904 FBgn0040336 CG9904 X X CG9904 CG9904 EG:BACR7C10.1 CDMC20051 1 24 4 DAC07-E12 15-CG9904-RA_4 CG9904 ATGAGGGACTACGACTCGATGCTGAGGGGTCACTCCTGTCGGTCTGCCATGATGCGCTATCGTTC 65 FBan0009904 FBgn0040336 CG9904 X X CG9904 CG9904 EG:BACR7C10.1 CDMC20052 1 25 4 DAC07-E24 17-CG9964-RA_8 CG9964 TTCGTGCGAAAGCTTTTCTCCATGCGATTCTTCACCAAAGCAACGGATGAGTTCTTCCTGCGACT 65 FBan0009964 FBgn0031432 Cyp309a1 2 2L DNA methylation; GO:0006306; electron transport; GO:0006118; steroid metabolism; GO:0008202 DNA binding; GO:0003677; electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0003677; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a1 Cyp309a1 "CG9964, 309a1" CDMC20052 1 26 4 DAC07-E24 17-CG9964-RA_8 CG9964 TTCGTGCGAAAGCTTTTCTCCATGCGATTCTTCACCAAAGCAACGGATGAGTTCTTCCTGCGACT 65 FBan0009964 FBgn0031432 Cyp309a1 2 2L DNA methylation; GO:0006306; electron transport; GO:0006118; steroid metabolism; GO:0008202 DNA binding; GO:0003677; electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0003677; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a1 Cyp309a1 "CG9964, 309a1" CDMC20053 1 1 5 DAC07-I12 2-CR31356-RA_1 CR31356 TTAGCTCAGTGGCAGAGCACTGGTCTTGTAAACCAGGGGCCGTGAGTTCAATTCTCACAAGAGGC 65 FBan0031356 FBgn0051356 CR31356 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31356 CR31356 "tRNA[Thr][[3]], AE002708.trna4-ThrTGT, tRNA:T:TGT:AE002708-a, tRNA:T3:87BC, tRNA:thr3:87BC, transfer RNA:thr3:87BC" CDMC20053 1 2 5 DAC07-I12 2-CR31356-RA_1 CR31356 TTAGCTCAGTGGCAGAGCACTGGTCTTGTAAACCAGGGGCCGTGAGTTCAATTCTCACAAGAGGC 65 FBan0031356 FBgn0051356 CR31356 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31356 CR31356 "tRNA[Thr][[3]], AE002708.trna4-ThrTGT, tRNA:T:TGT:AE002708-a, tRNA:T3:87BC, tRNA:thr3:87BC, transfer RNA:thr3:87BC" CDMC20054 1 3 5 DAC07-I24 2-CR31541-RA_1 CR31541 CTCGGAGCGTCGTCTGGGAATGATCTGGGAAAACTAGGCACCCACAATTGGTTTACCGATGCCAC 65 FBan0031541 FBgn0037309 CR31541 3 3R CR31541 CR31541 CG2676 CDMC20054 1 4 5 DAC07-I24 2-CR31541-RA_1 CR31541 CTCGGAGCGTCGTCTGGGAATGATCTGGGAAAACTAGGCACCCACAATTGGTTTACCGATGCCAC 65 FBan0031541 FBgn0037309 CR31541 3 3R CR31541 CR31541 CG2676 CDMC20055 1 5 5 DAC07-M12 23-CR32894-RA_1 CR32894 AGCTCGCTTTGATTTCTATGAAGAAAACTGTTCCATATCCAACGCAAAAAATTATCTTGCTGACT 65 FBan0032894 FBgn0063383 snoRNA:U29:54Ec 2 2R snoRNA:U29:54Ec snoRNA:U29:54Ec "U29snoRNA, CR32894" CDMC20055 1 6 5 DAC07-M12 23-CR32894-RA_1 CR32894 AGCTCGCTTTGATTTCTATGAAGAAAACTGTTCCATATCCAACGCAAAAAATTATCTTGCTGACT 65 FBan0032894 FBgn0063383 snoRNA:U29:54Ec 2 2R snoRNA:U29:54Ec snoRNA:U29:54Ec "U29snoRNA, CR32894" CDMC20056 1 7 5 DAC07-M24 23-CR32905-RA_1 CR32905 TGATGATTTTTCAGTTCTGCTACTGAAGACAGTTGACGAAAGCAAAAATACCAAAATCACTGAAA 65 FBan0032905 FBgn0015543 snoRNA:Z1 2 2R RNA modification guide activity; GO:0030555; ; GO:0030555 nucleolus; GO:0005730 snoRNA:Z1 snoRNA:Z1 "snoRNA Z1, Z1, snoR797, Dm-797, CR32905" CDMC20056 1 8 5 DAC07-M24 23-CR32905-RA_1 CR32905 TGATGATTTTTCAGTTCTGCTACTGAAGACAGTTGACGAAAGCAAAAATACCAAAATCACTGAAA 65 FBan0032905 FBgn0015543 snoRNA:Z1 2 2R RNA modification guide activity; GO:0030555; ; GO:0030555 nucleolus; GO:0005730 snoRNA:Z1 snoRNA:Z1 "snoRNA Z1, Z1, snoR797, Dm-797, CR32905" CDMC20057 1 9 5 DAC08-A12 23-CG5603-RC_3 CG5603 TGGATACAATATACCTGAAATTACGTGTGTTCCAGAATTAACACAGTGGCTCTCGGAAGAAGGCGCACG 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC20057 1 10 5 DAC08-A12 23-CG5603-RC_3 CG5603 TGGATACAATATACCTGAAATTACGTGTGTTCCAGAATTAACACAGTGGCTCTCGGAAGAAGGCGCACG 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC20058 1 11 5 DAC08-A24 2-CG5612-RA_2 CG5612 GCTGCCCGGAGTGACGTTCACCTACGAGATTTTGGAGCCAATCACTTGCGTGGAAATTCTATCGGAGGA 69 FBan0005612 FBgn0039529 CG5612 3 3R CG5612 CG5612 CDMC20058 1 12 5 DAC08-A24 2-CG5612-RA_2 CG5612 GCTGCCCGGAGTGACGTTCACCTACGAGATTTTGGAGCCAATCACTTGCGTGGAAATTCTATCGGAGGA 69 FBan0005612 FBgn0039529 CG5612 3 3R CG5612 CG5612 CDMC20059 1 13 5 DAC08-E12 23-CG5650-RA_6 CG5650 CAGCGCTTTTATAGGTTTTGTCCAAAATTTAAACACTAGGTTAATCAACTGACCGTTCGAGCAGAGCAC 69 FBan0005650 FBgn0004103 Pp1-87B 3 3R adult locomotory behavior; GO:0008344; chromosome condensation; GO:0030261; learning and/or memory; GO:0007611; locomotion; GO:0040011; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; nervous system development; GO:0007399; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; visual learning; GO:0008542 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 cytoplasm; GO:0005737; protein phosphatase type 1 complex; GO:0000164 Pp1-87B Protein phosphatase 1 at 87B "CG5650, CG5650, CG5650, l(3)ck19, Su-var(3)6, Su(var)3-6: Suppressor of variegation, PP-1alpha, ck19, PP1 87B, PP1alpha87B, PP1alpha[[2]], Protein phosphatase 1, PP1A87B, l(3)j6E7, PP187B, Su(var)(3)6, su-var(3)6, Suvar(3)6, Pp1, PP1, PP1-87B, Su(Var)3-6, Pp1-87Bb, PP1c, Pp-1alpha, l(3)87Bg, Suppressor of variegation, Su(var)3-6" CDMC20059 1 14 5 DAC08-E12 23-CG5650-RA_6 CG5650 CAGCGCTTTTATAGGTTTTGTCCAAAATTTAAACACTAGGTTAATCAACTGACCGTTCGAGCAGAGCAC 69 FBan0005650 FBgn0004103 Pp1-87B 3 3R adult locomotory behavior; GO:0008344; chromosome condensation; GO:0030261; learning and/or memory; GO:0007611; locomotion; GO:0040011; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; nervous system development; GO:0007399; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; visual learning; GO:0008542 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 cytoplasm; GO:0005737; protein phosphatase type 1 complex; GO:0000164 Pp1-87B Protein phosphatase 1 at 87B "CG5650, CG5650, CG5650, l(3)ck19, Su-var(3)6, Su(var)3-6: Suppressor of variegation, PP-1alpha, ck19, PP1 87B, PP1alpha87B, PP1alpha[[2]], Protein phosphatase 1, PP1A87B, l(3)j6E7, PP187B, Su(var)(3)6, su-var(3)6, Suvar(3)6, Pp1, PP1, PP1-87B, Su(Var)3-6, Pp1-87Bb, PP1c, Pp-1alpha, l(3)87Bg, Suppressor of variegation, Su(var)3-6" CDMC20060 1 15 5 DAC08-E24 23-CG5661-RA_11 CG5661 ATCCAAAAGTGCCATCTAATGACTATGGAAATGTTACAACGAGAGAGACAAGTTTTATTTTTGCGCCAA 69 FBan0005661 FBgn0028679 Sema-5c 3 3L aromatic compound metabolism; GO:0006725; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 ferric iron binding; GO:0008199; receptor binding; GO:0005102; receptor activity; GO:0004872; catalytic activity; GO:0003824; ; GO:0005102; ; GO:0004872; ; GO:0003824; ; GO:0008199 plasma membrane; GO:0005886 Sema-5c Sema-5c "CG5661, CG5661, CG5661, CK02567, sema 5c, semaphorin 5C, CT17880, sema-5c, Sema 5c, semaphorin, semiphorin, BEST:CK02567" CDMC20060 1 16 5 DAC08-E24 23-CG5661-RA_11 CG5661 ATCCAAAAGTGCCATCTAATGACTATGGAAATGTTACAACGAGAGAGACAAGTTTTATTTTTGCGCCAA 69 FBan0005661 FBgn0028679 Sema-5c 3 3L aromatic compound metabolism; GO:0006725; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 ferric iron binding; GO:0008199; receptor binding; GO:0005102; receptor activity; GO:0004872; catalytic activity; GO:0003824; ; GO:0005102; ; GO:0004872; ; GO:0003824; ; GO:0008199 plasma membrane; GO:0005886 Sema-5c Sema-5c "CG5661, CG5661, CG5661, CK02567, sema 5c, semaphorin 5C, CT17880, sema-5c, Sema 5c, semaphorin, semiphorin, BEST:CK02567" CDMC20061 1 17 5 DAC08-I12 12-CG5691-RA_4 CG5691 CGCCCTGCAATGGACCCTGAACTTCGAGCTCCTAAAGACCAGTCAGTTGTTTTACAACGAGTTTGCCAA 69 FBan0005691 FBgn0035297 CG5691 3 3L lysosome organization and biogenesis; GO:0007040 CG5691 CG5691 CDMC20061 1 18 5 DAC08-I12 12-CG5691-RA_4 CG5691 CGCCCTGCAATGGACCCTGAACTTCGAGCTCCTAAAGACCAGTCAGTTGTTTTACAACGAGTTTGCCAA 69 FBan0005691 FBgn0035297 CG5691 3 3L lysosome organization and biogenesis; GO:0007040 CG5691 CG5691 CDMC20062 1 19 5 DAC08-I24 14-CG5706-RA_1 CG5706 GCCCATCATCAACGGTGATCATTCCAAGATTACGCTGAAGACCAAGAACGTATTCATCGAGTGCACGGC 69 FBan0005706 FBgn0039175 CG5706 3 3R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG5706 CG5706 CDMC20062 1 20 5 DAC08-I24 14-CG5706-RA_1 CG5706 GCCCATCATCAACGGTGATCATTCCAAGATTACGCTGAAGACCAAGAACGTATTCATCGAGTGCACGGC 69 FBan0005706 FBgn0039175 CG5706 3 3R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG5706 CG5706 CDMC20063 1 21 5 DAC08-M12 6-CG5730-RD_3 CG5730 GTCGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC20063 1 22 5 DAC08-M12 6-CG5730-RD_3 CG5730 GTCGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC20064 1 23 5 DAC08-M24 18-CG5746-RA_2 CG5746 GCGCGTGCTTCGATAGGCCAAAAAACCAAATAAGAAGGGACTAGGGCAGAGTAACATGGAAGGGAATAT 69 FBan0005746 FBgn0039186 CG5746 3 3R CG5746 CG5746 CDMC20064 1 24 5 DAC08-M24 18-CG5746-RA_2 CG5746 GCGCGTGCTTCGATAGGCCAAAAAACCAAATAAGAAGGGACTAGGGCAGAGTAACATGGAAGGGAATAT 69 FBan0005746 FBgn0039186 CG5746 3 3R CG5746 CG5746 CDMC20065 1 25 5 DAC09-A13 3-CG31231-RA_4 CG31231 AGTGCAAGGATGTTGCGGTCATGCAGTCGAACTACAAGAAGTCCATGATAGAGGAGACGTGCGTGCG 67 FBan0031231 FBgn0051231 CG31231 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31231 CG31231 "anon-WO0140519.92, BcDNA:AT20662, BcDNA:GH08511" CDMC20065 1 26 5 DAC09-A13 3-CG31231-RA_4 CG31231 AGTGCAAGGATGTTGCGGTCATGCAGTCGAACTACAAGAAGTCCATGATAGAGGAGACGTGCGTGCG 67 FBan0031231 FBgn0051231 CG31231 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31231 CG31231 "anon-WO0140519.92, BcDNA:AT20662, BcDNA:GH08511" CDMC20066 1 1 6 DAC09-B01 3-CG31465-RA_3 CG31465 GGCTCAAAGGATTGTGGGAACCGGTCAAAATGCAGCCGATGGTGGATTGAGATATGCACCCAATCGC 67 FBan0031465 FBgn0051465 CG31465 3 3R CG31465 CG31465 CG6670 CDMC20066 1 2 6 DAC09-B01 3-CG31465-RA_3 CG31465 GGCTCAAAGGATTGTGGGAACCGGTCAAAATGCAGCCGATGGTGGATTGAGATATGCACCCAATCGC 67 FBan0031465 FBgn0051465 CG31465 3 3R CG31465 CG31465 CG6670 CDMC20067 1 3 6 DAC09-E13 6-CG32040-RA_4 CG32040 GGAAGAACCTCCGGTGGAGAACACAACCCGAAAACCTCCTCCGATAACCTTCGATTCCGGGCAAATG 67 FBan0032040 FBgn0052040 CG32040 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32040 CG32040 CDMC20067 1 4 6 DAC09-E13 6-CG32040-RA_4 CG32040 GGAAGAACCTCCGGTGGAGAACACAACCCGAAAACCTCCTCCGATAACCTTCGATTCCGGGCAAATG 67 FBan0032040 FBgn0052040 CG32040 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32040 CG32040 CDMC20068 1 5 6 DAC09-F01 2-CG32100-RA_1 CG32100 GGGCGAGAAACCTCTGCCAAATCAAAGAGCAGCGTACAAGAACCACCGAAATGCAAGGGTCGCAAAC 67 FBan0032100 FBgn0052100 CG32100 3 3L CG32100 CG32100 "CG10429, CG18638" CDMC20068 1 6 6 DAC09-F01 2-CG32100-RA_1 CG32100 GGGCGAGAAACCTCTGCCAAATCAAAGAGCAGCGTACAAGAACCACCGAAATGCAAGGGTCGCAAAC 67 FBan0032100 FBgn0052100 CG32100 3 3L CG32100 CG32100 "CG10429, CG18638" CDMC20069 1 7 6 DAC09-I13 3-CG3253-RA_1 CG3253 TGCTGGCTATCAGTTCTACGTCCTTTCCCCTGTGTTTACCGGTCATTGGGGATTGCAGAGGAAGCAG 67 FBan0003253 FBgn0041706 CG3253 2 2R "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG3253 CG3253 "L-gene, BEST:GH04269" CDMC20069 1 8 6 DAC09-I13 3-CG3253-RA_1 CG3253 TGCTGGCTATCAGTTCTACGTCCTTTCCCCTGTGTTTACCGGTCATTGGGGATTGCAGAGGAAGCAG 67 FBan0003253 FBgn0041706 CG3253 2 2R "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG3253 CG3253 "L-gene, BEST:GH04269" CDMC20070 1 9 6 DAC09-J01 22-CG32691-RA_1 CG32691 CGCGTACACGCTTCAAAAATTCAACGGTCCGCCTATGAAAACGAACCTGCAAGAGGAAAAGCCACAG 67 FBan0032691 FBgn0052691 CG32691 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32691 CG32691 CDMC20070 1 10 6 DAC09-J01 22-CG32691-RA_1 CG32691 CGCGTACACGCTTCAAAAATTCAACGGTCCGCCTATGAAAACGAACCTGCAAGAGGAAAAGCCACAG 67 FBan0032691 FBgn0052691 CG32691 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32691 CG32691 CDMC20071 1 11 6 DAC09-M13 2-CG3333-RA_1 CG3333 GCTGTACGAAAACCACAAGGACGAGTCTATGCTGCGACGTGTGATCAAGCCGCTAGAAGGTCTGCTG 67 FBan0003333 FBgn0023184 Nop60B 2 2R chromosome segregation; GO:0007059; germ cell development; GO:0007281; mitosis; GO:0007067; pseudouridine synthesis; GO:0001522; rRNA metabolism; GO:0016072; rRNA processing; GO:0006364; ribosome biogenesis; GO:0007046 mRNA binding; GO:0003729; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; centromeric DNA binding; GO:0019237; ; GO:0003729; ; GO:0019237; ; GO:0004730 ; EC:4.2.1.70 nucleolus; GO:0005730; nucleus; GO:0005634 Nop60B Nucleolar protein at 60B "CG3333, mfl: minifly, minifly, nop60B, FBgn0023184, l(2)k05318, mfl" CDMC20071 1 12 6 DAC09-M13 2-CG3333-RA_1 CG3333 GCTGTACGAAAACCACAAGGACGAGTCTATGCTGCGACGTGTGATCAAGCCGCTAGAAGGTCTGCTG 67 FBan0003333 FBgn0023184 Nop60B 2 2R chromosome segregation; GO:0007059; germ cell development; GO:0007281; mitosis; GO:0007067; pseudouridine synthesis; GO:0001522; rRNA metabolism; GO:0016072; rRNA processing; GO:0006364; ribosome biogenesis; GO:0007046 mRNA binding; GO:0003729; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; centromeric DNA binding; GO:0019237; ; GO:0003729; ; GO:0019237; ; GO:0004730 ; EC:4.2.1.70 nucleolus; GO:0005730; nucleus; GO:0005634 Nop60B Nucleolar protein at 60B "CG3333, mfl: minifly, minifly, nop60B, FBgn0023184, l(2)k05318, mfl" CDMC20072 1 13 6 DAC09-N01 2-CG3395-RB_1 CG3395 GGCGCCAATGCTTGTACCGACTCTCAACGTCTGTAGATTGCGCATGTGACTCCGTTCACACCAATCG 67 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC20072 1 14 6 DAC09-N01 2-CG3395-RB_1 CG3395 GGCGCCAATGCTTGTACCGACTCTCAACGTCTGTAGATTGCGCATGTGACTCCGTTCACACCAATCG 67 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC20073 1 15 6 DAC10-A12 23-CG18317-RA_1 CG18317 CGAGCGCAAATTCTTAGTTAACTAGCTTCTAAGTCAGATATGAAACGAACTCGATAGACTTAAGACGTT 69 FBan0018317 FBgn0031359 CG18317 2 2L mitochondrial transport; GO:0006839; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18317 CG18317 CDMC20073 1 16 6 DAC10-A12 23-CG18317-RA_1 CG18317 CGAGCGCAAATTCTTAGTTAACTAGCTTCTAAGTCAGATATGAAACGAACTCGATAGACTTAAGACGTT 69 FBan0018317 FBgn0031359 CG18317 2 2L mitochondrial transport; GO:0006839; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18317 CG18317 CDMC20074 1 17 6 DAC10-A24 3-CG18331-RA_2 CG18331 TCTCCGGACATTCGCATTCGATTGGGCCGAGAACAGTCAGGAAACGATGCTCAGTCCCAAAACTCGAAT 69 FBan0018331 FBgn0036181 CG18331 3 3L CG18331 CG18331 CDMC20074 1 18 6 DAC10-A24 3-CG18331-RA_2 CG18331 TCTCCGGACATTCGCATTCGATTGGGCCGAGAACAGTCAGGAAACGATGCTCAGTCCCAAAACTCGAAT 69 FBan0018331 FBgn0036181 CG18331 3 3L CG18331 CG18331 CDMC20075 1 19 6 DAC10-E12 3-CG18398-RA_6 CG18398 TGCCCGGTCTACTCACATCAAGCTCTCATCATTCCCTCACCTGCAAAGTTTTCCTCTCTCTTCTGGGCT 69 FBan0018398 FBgn0032728 CG18398 2 2L CG18398 CG18398 CDMC20075 1 20 6 DAC10-E12 3-CG18398-RA_6 CG18398 TGCCCGGTCTACTCACATCAAGCTCTCATCATTCCCTCACCTGCAAAGTTTTCCTCTCTCTTCTGGGCT 69 FBan0018398 FBgn0032728 CG18398 2 2L CG18398 CG18398 CDMC20076 1 21 6 DAC10-E24 12-CG18417-RA_5 CG18417 AGGTCTCTAGTGAAGCGCGTTCTGTAGCCTTTTCAGAAGCTCTGTCCGAACTGGTCAAGAATGCGTCAT 69 FBan0018417 FBgn0035780 CG18417 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG18417 CG18417 CDMC20076 1 22 6 DAC10-E24 12-CG18417-RA_5 CG18417 AGGTCTCTAGTGAAGCGCGTTCTGTAGCCTTTTCAGAAGCTCTGTCCGAACTGGTCAAGAATGCGTCAT 69 FBan0018417 FBgn0035780 CG18417 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG18417 CG18417 CDMC20077 1 23 6 DAC10-I12 22-CG18482-RA_1 CG18482 TGCTGTTTTCGTCTGGTTAAACAGGTACTACGGACTTCCAACTACACTTGTTAACATGCCTCCAGAGCA 69 FBan0018482 FBgn0028891 CG18482 2 2L CG18482 CG18482 "BG:DS03023.4, DS03023.4" CDMC20077 1 24 6 DAC10-I12 22-CG18482-RA_1 CG18482 TGCTGTTTTCGTCTGGTTAAACAGGTACTACGGACTTCCAACTACACTTGTTAACATGCCTCCAGAGCA 69 FBan0018482 FBgn0028891 CG18482 2 2L CG18482 CG18482 "BG:DS03023.4, DS03023.4" CDMC20078 1 25 6 DAC10-I24 16-CG18496-RA_1 CG18496 CAACATATCCAGCTGCTCCACGCTAGACATTGTCAACAAAGTGAGTAATGATGCCCGCACTGAGAGAAA 69 FBan0018496 FBgn0038329 CG18496 3 3R CG18496 CG18496 CDMC20078 1 26 6 DAC10-I24 16-CG18496-RA_1 CG18496 CAACATATCCAGCTGCTCCACGCTAGACATTGTCAACAAAGTGAGTAATGATGCCCGCACTGAGAGAAA 69 FBan0018496 FBgn0038329 CG18496 3 3R CG18496 CG18496 CDMC20079 1 1 7 DAC10-M12 2-CG1854-RA_2 CG1854 CGGCTTAGCTCTACCAGGAGTGAGCATGACCAGTTCACCCGTCTACGAGGTTATCTACTTGGCCCAACT 69 FBan0001854 FBgn0026389 Or43a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Or43a Odorant receptor 43a "CG1854, CG1854, DOR43B.1, Olfactory receptor 43B.1, dor87, AN14, Dor87, 43B.1, DOR87, Or, 43a, Or43A, or43a, 43B1, Or43B.1, Or87: Odorant receptor 87, Odorant receptor 87" CDMC20079 1 2 7 DAC10-M12 2-CG1854-RA_2 CG1854 CGGCTTAGCTCTACCAGGAGTGAGCATGACCAGTTCACCCGTCTACGAGGTTATCTACTTGGCCCAACT 69 FBan0001854 FBgn0026389 Or43a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Or43a Odorant receptor 43a "CG1854, CG1854, DOR43B.1, Olfactory receptor 43B.1, dor87, AN14, Dor87, 43B.1, DOR87, Or, 43a, Or43A, or43a, 43B1, Or43B.1, Or87: Odorant receptor 87, Odorant receptor 87" CDMC20080 1 3 7 DAC10-M24 8-CG18577-RA_1 CG18577 ACGGCTGATGACAGAGCGTTTAAACGAACCCATCAACATCTCCATTCGCATGGGACCTGCCTATGACTA 69 FBan0018577 FBgn0037870 CG18577 3 3R CG18577 CG18577 CDMC20080 1 4 7 DAC10-M24 8-CG18577-RA_1 CG18577 ACGGCTGATGACAGAGCGTTTAAACGAACCCATCAACATCTCCATTCGCATGGGACCTGCCTATGACTA 69 FBan0018577 FBgn0037870 CG18577 3 3R CG18577 CG18577 CDMC20081 1 5 7 DAC11-A12 6-CG1017-RA_1 CG1017 TGCAGAAGTACTATCATCGTGGTGCCTTCTACCTGGATGAGGAGAACGACGTCCTCAAGCGCGACTT 67 FBan0001017 FBgn0035294 CG1017 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198 microfibril; GO:0001527 CG1017 CG1017 CDMC20081 1 6 7 DAC11-A12 6-CG1017-RA_1 CG1017 TGCAGAAGTACTATCATCGTGGTGCCTTCTACCTGGATGAGGAGAACGACGTCCTCAAGCGCGACTT 67 FBan0001017 FBgn0035294 CG1017 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198 microfibril; GO:0001527 CG1017 CG1017 CDMC20082 1 7 7 DAC11-A24 1-CG10340-RA_1 CG10340 ACGCTCCGGAGTGTCTCACAGTGGTTCACTATACCGAGGTCCAAGACAAGGGTGTAGTTCTCATGCG 67 FBan0010340 FBgn0022344 CG10340 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10340 CG10340 "anon2A5, anon-EST:fe2A5: anon-fast-evolving-2A5, anon-fast-evolving-2A5" CDMC20082 1 8 7 DAC11-A24 1-CG10340-RA_1 CG10340 ACGCTCCGGAGTGTCTCACAGTGGTTCACTATACCGAGGTCCAAGACAAGGGTGTAGTTCTCATGCG 67 FBan0010340 FBgn0022344 CG10340 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10340 CG10340 "anon2A5, anon-EST:fe2A5: anon-fast-evolving-2A5, anon-fast-evolving-2A5" CDMC20083 1 9 7 DAC11-E12 1-CG10754-RA_1 CG10754 TGGAACCGTGACACCAAGCAGTTCTTCCTTCAGTTCGCCTTCAAGTTCGAACCTAAGATCCTGCCGC 67 FBan0010754 FBgn0036314 CG10754 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "zinc ion binding; GO:0008270; ; GO:0008270; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG10754 CG10754 CDMC20083 1 10 7 DAC11-E12 1-CG10754-RA_1 CG10754 TGGAACCGTGACACCAAGCAGTTCTTCCTTCAGTTCGCCTTCAAGTTCGAACCTAAGATCCTGCCGC 67 FBan0010754 FBgn0036314 CG10754 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "zinc ion binding; GO:0008270; ; GO:0008270; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG10754 CG10754 CDMC20084 1 11 7 DAC11-E24 3-CG10880-RA_5 CG10880 TGGATTTGGCCTCTCTCACCGACGAAGATTTGGAACTCTTCGGGTTCAAGTGTCGAAAGCAACGGCA 67 FBan0010880 FBgn0031398 CG10880 2 2L CG10880 CG10880 CDMC20084 1 12 7 DAC11-E24 3-CG10880-RA_5 CG10880 TGGATTTGGCCTCTCTCACCGACGAAGATTTGGAACTCTTCGGGTTCAAGTGTCGAAAGCAACGGCA 67 FBan0010880 FBgn0031398 CG10880 2 2L CG10880 CG10880 CDMC20085 1 13 7 DAC11-I12 13-CG11227-RC_1 CG11227 GGGCATTCTGAAAAACCTTGCCAACGGTTATTTGAAGTTGGTCCACGAAATCGAGACCCACCTCTGC 67 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC20085 1 14 7 DAC11-I12 13-CG11227-RC_1 CG11227 GGGCATTCTGAAAAACCTTGCCAACGGTTATTTGAAGTTGGTCCACGAAATCGAGACCCACCTCTGC 67 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC20086 1 15 7 DAC11-I24 19-CG11293-RA_2 CG11293 CGTGAAGTGTTCACTGTACTTTGGGAGCGGAGGATAAGTCAAGACGTCAACAGAGGAAGCTGTACGA 67 FBan0011293 FBgn0034889 CG11293 2 2R CG11293 CG11293 CDMC20086 1 16 7 DAC11-I24 19-CG11293-RA_2 CG11293 CGTGAAGTGTTCACTGTACTTTGGGAGCGGAGGATAAGTCAAGACGTCAACAGAGGAAGCTGTACGA 67 FBan0011293 FBgn0034889 CG11293 2 2R CG11293 CG11293 CDMC20087 1 17 7 DAC11-M12 2-CG11980-RB_1 CG11980 GGATACTGCAGGTCGTGAGTTTGTGGACAACGTTGTGGAGGTATCATGTTCCTGGATTCCAGCCCGG 67 FBan0011980 FBgn0037652 CG11980 3 3R CG11980 CG11980 anon-WO0118547.327 CDMC20087 1 18 7 DAC11-M12 2-CG11980-RB_1 CG11980 GGATACTGCAGGTCGTGAGTTTGTGGACAACGTTGTGGAGGTATCATGTTCCTGGATTCCAGCCCGG 67 FBan0011980 FBgn0037652 CG11980 3 3R CG11980 CG11980 anon-WO0118547.327 CDMC20088 1 19 7 DAC11-M24 1-CG12081-RA_1 CG12081 TTGGAGCTCGAATAACACTTTCGGGAGAGATGACGAATGGAGGACCTGAGCGAACGAGGGAGAAGCC 67 FBan0012081 FBgn0030053 CG12081 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG12081 CG12081 CDMC20088 1 20 7 DAC11-M24 1-CG12081-RA_1 CG12081 TTGGAGCTCGAATAACACTTTCGGGAGAGATGACGAATGGAGGACCTGAGCGAACGAGGGAGAAGCC 67 FBan0012081 FBgn0030053 CG12081 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG12081 CG12081 CDMC20089 1 21 7 DAC12-A12 6-CG10125-RA_4 CG10125 CGGTCGGCTGAAGCATTTGTGCGATGATTTCCACAAGATGGCCGTTTGCAAGGACAAGAGCAGGAC 66 FBan0010125 FBgn0024177 zpg 3 3L germ cell development; GO:0007281; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 zpg zero population growth "CG10125, CG10125, Dm-inx4, inx4, zero population growth" CDMC20089 1 22 7 DAC12-A12 6-CG10125-RA_4 CG10125 CGGTCGGCTGAAGCATTTGTGCGATGATTTCCACAAGATGGCCGTTTGCAAGGACAAGAGCAGGAC 66 FBan0010125 FBgn0024177 zpg 3 3L germ cell development; GO:0007281; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 zpg zero population growth "CG10125, CG10125, Dm-inx4, inx4, zero population growth" CDMC20090 1 23 7 DAC12-A24 2-CG10211-RA_1 CG10211 GCTGCCTTCCGTATCGGTCACTCTCTGCTACGTCCCCATATTCCTCGTCTAAGTGTCCAGCACCAG 66 FBan0010211 FBgn0032685 CG10211 2 2L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 DNA binding; GO:0003677; peroxidase activity; GO:0004601 ; EC:1.11.1.7; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004601 ; EC:1.11.1.7; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG10211 CG10211 CDMC20090 1 24 7 DAC12-A24 2-CG10211-RA_1 CG10211 GCTGCCTTCCGTATCGGTCACTCTCTGCTACGTCCCCATATTCCTCGTCTAAGTGTCCAGCACCAG 66 FBan0010211 FBgn0032685 CG10211 2 2L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 DNA binding; GO:0003677; peroxidase activity; GO:0004601 ; EC:1.11.1.7; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004601 ; EC:1.11.1.7; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG10211 CG10211 CDMC20091 1 25 7 DAC12-E12 14-CG10638-RA_1 CG10638 ACTGAGCGATGTCGACTATCTGGATACGTACAAAGCCATGGAAAAGCTGGTAAAACTGGGCCTGGT 66 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC20091 1 26 7 DAC12-E12 14-CG10638-RA_1 CG10638 ACTGAGCGATGTCGACTATCTGGATACGTACAAAGCCATGGAAAAGCTGGTAAAACTGGGCCTGGT 66 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC20092 1 1 8 DAC12-E24 2-CG10776-RA_2 CG10776 TCAACGGGACCACCAACAATAACTCCATCCAGAGTCATGGTAGCGAATTGCAGACCCTCACCCGTC 66 FBan0010776 FBgn0024179 wit 3 3L dendrite morphogenesis; GO:0016358; neuromuscular junction development; GO:0007528; neuromuscular synaptic transmission; GO:0007274; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; ; GO:0005026" plasma membrane; GO:0005886 wit wishful thinking "CG10776, CG10776, CG10776, l(3)64Aa, l(3)SH12, STK-D, SE20, 1262/15, ALK3/BMPRII, Stk-D, l(3)S126215, Serine/threonine kinase-D, wishful thinking" CDMC20092 1 2 8 DAC12-E24 2-CG10776-RA_2 CG10776 TCAACGGGACCACCAACAATAACTCCATCCAGAGTCATGGTAGCGAATTGCAGACCCTCACCCGTC 66 FBan0010776 FBgn0024179 wit 3 3L dendrite morphogenesis; GO:0016358; neuromuscular junction development; GO:0007528; neuromuscular synaptic transmission; GO:0007274; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; ; GO:0005026" plasma membrane; GO:0005886 wit wishful thinking "CG10776, CG10776, CG10776, l(3)64Aa, l(3)SH12, STK-D, SE20, 1262/15, ALK3/BMPRII, Stk-D, l(3)S126215, Serine/threonine kinase-D, wishful thinking" CDMC20093 1 3 8 DAC12-I12 3-CG11132-RA_4 CG11132 CGCTTCATTGTGATGGCAGATCGTTGGAACCGTCAGCAGCATGGAACCAAAACTGTGGAGGAGCTC 66 FBan0011132 FBgn0034537 DMAP1 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 DMAP1 DMAP1 "CG11132, CG11132, CG11132, dDMAP1" CDMC20093 1 4 8 DAC12-I12 3-CG11132-RA_4 CG11132 CGCTTCATTGTGATGGCAGATCGTTGGAACCGTCAGCAGCATGGAACCAAAACTGTGGAGGAGCTC 66 FBan0011132 FBgn0034537 DMAP1 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 DMAP1 DMAP1 "CG11132, CG11132, CG11132, dDMAP1" CDMC20094 1 5 8 DAC12-I24 9-CG11178-RA_1 CG11178 TGAGCACCGAGGATCTGCGCTACATGGACTACATCATGAAGCATGTGCAATCGCCAAAGGAGGATG 66 FBan0011178 FBgn0030499 CG11178 X X CG11178 CG11178 CDMC20094 1 6 8 DAC12-I24 9-CG11178-RA_1 CG11178 TGAGCACCGAGGATCTGCGCTACATGGACTACATCATGAAGCATGTGCAATCGCCAAAGGAGGATG 66 FBan0011178 FBgn0030499 CG11178 X X CG11178 CG11178 CDMC20095 1 7 8 DAC12-M12 1-CG11928-RA_1 CG11928 CGACTTCAACGAGGAGGAATTATGCAGCATCACCAAGGATTCGCAGGACATTGCCGTGCTTCTGGC 66 FBan0011928 FBgn0031625 CG11928 2 2L CG11928 CG11928 CDMC20095 1 8 8 DAC12-M12 1-CG11928-RA_1 CG11928 CGACTTCAACGAGGAGGAATTATGCAGCATCACCAAGGATTCGCAGGACATTGCCGTGCTTCTGGC 66 FBan0011928 FBgn0031625 CG11928 2 2L CG11928 CG11928 CDMC20096 1 9 8 DAC12-M24 1-CG12045-RA_1 CG12045 TACGGAGATGATGGTTCCTACGATCCCCGCTACAACGATCCCTCTTTCGGACAGAACCAGCAGAGC 66 FBan0012045 FBgn0039805 CG12045 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12045 CG12045 CDMC20096 1 10 8 DAC12-M24 1-CG12045-RA_1 CG12045 TACGGAGATGATGGTTCCTACGATCCCCGCTACAACGATCCCTCTTTCGGACAGAACCAGCAGAGC 66 FBan0012045 FBgn0039805 CG12045 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12045 CG12045 CDMC20097 1 11 8 DAC13-A12 1-CG14529-RA_1 CG14529 CCATGCTGTCCAACATGAGCGATGCTTACGGACCGATTCTTAACGTGACTCGCTTTGTGACCTCCTGGT 69 FBan0014529 FBgn0039609 CG14529 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14529 CG14529 CDMC20097 1 12 8 DAC13-A12 1-CG14529-RA_1 CG14529 CCATGCTGTCCAACATGAGCGATGCTTACGGACCGATTCTTAACGTGACTCGCTTTGTGACCTCCTGGT 69 FBan0014529 FBgn0039609 CG14529 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14529 CG14529 CDMC20098 1 13 8 DAC13-A24 3-CG14543-RA_2 CG14543 CAGTTTCCGCAAATAGAGGCTGAATTGAGTAAACTTCCTGCTGGCAAGGAGTGGCTGCGTCCGGATGTT 69 FBan0014543 FBgn0039404 CG14543 3 3R CG14543 CG14543 CDMC20098 1 14 8 DAC13-A24 3-CG14543-RA_2 CG14543 CAGTTTCCGCAAATAGAGGCTGAATTGAGTAAACTTCCTGCTGGCAAGGAGTGGCTGCGTCCGGATGTT 69 FBan0014543 FBgn0039404 CG14543 3 3R CG14543 CG14543 CDMC20099 1 15 8 DAC13-E12 14-CG14581-RA_1 CG14581 CGCAGCCTGCCTTCAATCGAAACCGATATTCAAACGATCGCACGGCTTAATCAACTGAAGTTGGAGGAA 69 FBan0014581 FBgn0040645 CG14581 X X CG14581 CG14581 CDMC20099 1 16 8 DAC13-E12 14-CG14581-RA_1 CG14581 CGCAGCCTGCCTTCAATCGAAACCGATATTCAAACGATCGCACGGCTTAATCAACTGAAGTTGGAGGAA 69 FBan0014581 FBgn0040645 CG14581 X X CG14581 CG14581 CDMC20100 1 17 8 DAC13-E24 8-CG14591-RB_1 CG14591 GGGCTTCAAACTCTCCGGACAGTCAATGATTTTCGCCTTGAATCCATGTCATGTCCAGTCATGCCTGCA 69 FBan0014591 FBgn0033054 CG14591 2 2R CG14591 CG14591 CDMC20100 1 18 8 DAC13-E24 8-CG14591-RB_1 CG14591 GGGCTTCAAACTCTCCGGACAGTCAATGATTTTCGCCTTGAATCCATGTCATGTCCAGTCATGCCTGCA 69 FBan0014591 FBgn0033054 CG14591 2 2R CG14591 CG14591 CDMC20101 1 19 8 DAC13-I12 3-CG14637-RA_2 CG14637 CCCCTGGTCGTCTAATGGATATGCTGGACAAGAAGATCCTTACGCTGGACATGTGCCGGTACTTGTGCA 69 FBan0014637 FBgn0015331 abs 3 3R "apoptosis; GO:0006915; establishment of cell polarity; GO:0030010; morphogenesis; GO:0009653; nervous system development; GO:0007399; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0008026 nucleus; GO:0005634 abs abstrakt "CG14637, abstract, DmRH23, ABS, anon-WO0118547.315, l(3)00620, l(3)04505, l(3)06862, l(3)06863" CDMC20101 1 20 8 DAC13-I12 3-CG14637-RA_2 CG14637 CCCCTGGTCGTCTAATGGATATGCTGGACAAGAAGATCCTTACGCTGGACATGTGCCGGTACTTGTGCA 69 FBan0014637 FBgn0015331 abs 3 3R "apoptosis; GO:0006915; establishment of cell polarity; GO:0030010; morphogenesis; GO:0009653; nervous system development; GO:0007399; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0008026 nucleus; GO:0005634 abs abstrakt "CG14637, abstract, DmRH23, ABS, anon-WO0118547.315, l(3)00620, l(3)04505, l(3)06862, l(3)06863" CDMC20102 1 21 8 DAC13-I24 1-CG1464-RA_1 CG1464 CCTGTTTCTACTCACCGTGGGTCTAGGAACAGACTGGCGATTTGAGCAGAGAAGCACTGCGAAAGGACT 69 FBan0001464 FBgn0005558 ey 4 4 "DNA methylation; GO:0006306; adult walking behavior; GO:0007628; brain development; GO:0007420; cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 ey eyeless "CG1464, CG1464, l(4)33, pax6, EYEL, eye, DPax-6, Pax6, Ey, Ey/Pax6, Pax-6, l(4)102CDh, l(4)102CDr, tumor-head-63, eyeless" CDMC20102 1 22 8 DAC13-I24 1-CG1464-RA_1 CG1464 CCTGTTTCTACTCACCGTGGGTCTAGGAACAGACTGGCGATTTGAGCAGAGAAGCACTGCGAAAGGACT 69 FBan0001464 FBgn0005558 ey 4 4 "DNA methylation; GO:0006306; adult walking behavior; GO:0007628; brain development; GO:0007420; cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 ey eyeless "CG1464, CG1464, l(4)33, pax6, EYEL, eye, DPax-6, Pax6, Ey, Ey/Pax6, Pax-6, l(4)102CDh, l(4)102CDr, tumor-head-63, eyeless" CDMC20103 1 23 8 DAC13-M12 2-CG14685-RB_1 CG14685 CCCATCCCAAAGATGTGGCCTACTCCTTCTGATGCCGACTCGGGGATATCTTCGATGGGCTCATCATTG 69 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC20103 1 24 8 DAC13-M12 2-CG14685-RB_1 CG14685 CCCATCCCAAAGATGTGGCCTACTCCTTCTGATGCCGACTCGGGGATATCTTCGATGGGCTCATCATTG 69 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC20104 1 25 8 DAC13-M24 23-CG14691-RB_1 CG14691 GATGGTTTTACTGCTGATCATGACCTTTGGGAGACTTGGATCTGTAAGTGGCAATATGTTACTGCCGGT 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC20104 1 26 8 DAC13-M24 23-CG14691-RB_1 CG14691 GATGGTTTTACTGCTGATCATGACCTTTGGGAGACTTGGATCTGTAAGTGGCAATATGTTACTGCCGGT 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC20105 1 1 9 DAC14-A12 3-CG17248-RC_2 CG17248 CATGGGCGTGATTGGCCTGGTTGTCGTGGGCATTATTGCAAATAAACTTGGACTCATAGGCGGGG 65 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC20105 1 2 9 DAC14-A12 3-CG17248-RC_2 CG17248 CATGGGCGTGATTGGCCTGGTTGTCGTGGGCATTATTGCAAATAAACTTGGACTCATAGGCGGGG 65 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC20106 1 3 9 DAC14-A24 2-CG17268-RA_1 CG17268 GATGGCTCTGCACGTCTCTTTCATACCGAACCATCCGGGATATTCCACGAGTACAAGGCGACCGC 65 FBan0017268 FBgn0017557 Pros28.1A 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1A Pros28.1A "CG17268, alpha4t1_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t1, 20s proteasome, alpha4t1" CDMC20106 1 4 9 DAC14-A24 2-CG17268-RA_1 CG17268 GATGGCTCTGCACGTCTCTTTCATACCGAACCATCCGGGATATTCCACGAGTACAAGGCGACCGC 65 FBan0017268 FBgn0017557 Pros28.1A 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1A Pros28.1A "CG17268, alpha4t1_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t1, 20s proteasome, alpha4t1" CDMC20107 1 5 9 DAC14-E12 3-CG17429-RA_1 CG17429 GTGCACCTAAGCGAGAATCAAGGACCAAGCCAAGAGTGTTGCACGTGAATTGTGCTCGCGAGGAG 65 FBgn0039954 CG17429 CG17429 CG17429 CG40065 CDMC20107 1 6 9 DAC14-E12 3-CG17429-RA_1 CG17429 GTGCACCTAAGCGAGAATCAAGGACCAAGCCAAGAGTGTTGCACGTGAATTGTGCTCGCGAGGAG 65 FBgn0039954 CG17429 CG17429 CG17429 CG40065 CDMC20108 1 7 9 DAC14-E24 3-CG17525-RA_1 CG17525 GACCAATTGATGCACTTCGAGTCGGGTGTCATCTTCGAGTCTGCCCTAAGGAGACTCACCCGTCC 65 FBgn0034338 CDMC20108 1 8 9 DAC14-E24 3-CG17525-RA_1 CG17525 GACCAATTGATGCACTTCGAGTCGGGTGTCATCTTCGAGTCTGCCCTAAGGAGACTCACCCGTCC 65 FBgn0034338 CDMC20109 1 9 9 DAC14-I12 2-CG17652-RA_3 CG17652 TCTGCTGCAGGAGAGTCTTCGCAAGATTCCCGGACGTTGTCTGCTCTATCTGCACAAAGCCACTC 65 FBan0017652 FBgn0031361 CG17652 2 2L CG17652 CG17652 CDMC20109 1 10 9 DAC14-I12 2-CG17652-RA_3 CG17652 TCTGCTGCAGGAGAGTCTTCGCAAGATTCCCGGACGTTGTCTGCTCTATCTGCACAAAGCCACTC 65 FBan0017652 FBgn0031361 CG17652 2 2L CG17652 CG17652 CDMC20110 1 11 9 DAC14-I24 2-CG17689-RA_1 CG17689 GAAAACCATCGTTCACTCTCCCGCCACATCTTCGATACACTCGCCCATGTCTAGTCCGCATCCGC 65 FBan0017689 FBgn0036374 CG17689 3 3L CG17689 CG17689 CDMC20110 1 12 9 DAC14-I24 2-CG17689-RA_1 CG17689 GAAAACCATCGTTCACTCTCCCGCCACATCTTCGATACACTCGCCCATGTCTAGTCCGCATCCGC 65 FBan0017689 FBgn0036374 CG17689 3 3L CG17689 CG17689 CDMC20111 1 13 9 DAC14-M12 24-CG17826-RA_1 CG17826 ATTGGCCCGATAATGTTAAGTGCTAAGTGGTTTCAATAAACAATATTTAAAGCAGAGTATTAAAC 65 FBan0017826 FBgn0036227 CG17826 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG17826 CG17826 CDMC20111 1 14 9 DAC14-M12 24-CG17826-RA_1 CG17826 ATTGGCCCGATAATGTTAAGTGCTAAGTGGTTTCAATAAACAATATTTAAAGCAGAGTATTAAAC 65 FBan0017826 FBgn0036227 CG17826 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG17826 CG17826 CDMC20112 1 15 9 DAC14-M24 2-CG1785-RA_1 CG1785 ATTTTCGCGACGAGATTCCTGGACTCAAGGACGAGAAGGGTTGGATCAGTCGCGAACTGGCACTG 65 FBan0001785 FBgn0030061 CG1785 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1785 CG1785 CDMC20112 1 16 9 DAC14-M24 2-CG1785-RA_1 CG1785 ATTTTCGCGACGAGATTCCTGGACTCAAGGACGAGAAGGGTTGGATCAGTCGCGAACTGGCACTG 65 FBan0001785 FBgn0030061 CG1785 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1785 CG1785 CDMC20113 1 17 9 DAC15-A12 3-CG12538-RA_1 CG12538 CCCGCCGTCGTTTCTCAGACGTTGTTGTACAGAATTTGCATGTCCTGCCAGTCCGACGCTCTCAAAAC 68 FBan0012538 FBgn0038157 CG12538 3 3R CG12538 CG12538 CDMC20113 1 18 9 DAC15-A12 3-CG12538-RA_1 CG12538 CCCGCCGTCGTTTCTCAGACGTTGTTGTACAGAATTTGCATGTCCTGCCAGTCCGACGCTCTCAAAAC 68 FBan0012538 FBgn0038157 CG12538 3 3R CG12538 CG12538 CDMC20114 1 19 9 DAC15-A24 3-CG12736-RA_1 CG12736 GGCTTCAATCAGAACCTGAAGACAAGCATCAGCGACATCCAGATATTCCGGAAGAGCGTGCCTCAGGC 68 FBan0012736 FBgn0033184 CG12736 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; GTPase activity; GO:0003924; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003924; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG12736 CG12736 CDMC20114 1 20 9 DAC15-A24 3-CG12736-RA_1 CG12736 GGCTTCAATCAGAACCTGAAGACAAGCATCAGCGACATCCAGATATTCCGGAAGAGCGTGCCTCAGGC 68 FBan0012736 FBgn0033184 CG12736 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; GTPase activity; GO:0003924; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003924; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG12736 CG12736 CDMC20115 1 21 9 DAC15-E12 12-CG13353-RA_8 CG13353 ACGTTGGGGAGCTGATAACGCATTCGGATGACACCATTTTCATCAAGCAAGTGTCCCACAAATGGTGG 68 FBan0013353 FBgn0033896 CG13353 2 2R CG13353 CG13353 CDMC20115 1 22 9 DAC15-E12 12-CG13353-RA_8 CG13353 ACGTTGGGGAGCTGATAACGCATTCGGATGACACCATTTTCATCAAGCAAGTGTCCCACAAATGGTGG 68 FBan0013353 FBgn0033896 CG13353 2 2R CG13353 CG13353 CDMC20116 1 23 9 DAC15-E24 2-CG13434-RA_1 CG13434 GCAATGCCAATCGCGAGCGACTCCAACATGTCCATGACAAGCGCCTGAAATTGACTGTCCAAATGGAG 68 FBan0013434 FBgn0034523 CG13434 2 2R CG13434 CG13434 CDMC20116 1 24 9 DAC15-E24 2-CG13434-RA_1 CG13434 GCAATGCCAATCGCGAGCGACTCCAACATGTCCATGACAAGCGCCTGAAATTGACTGTCCAAATGGAG 68 FBan0013434 FBgn0034523 CG13434 2 2R CG13434 CG13434 CDMC20117 1 25 9 DAC15-I12 4-CG13813-RA_1 CG13813 CGCCGTTACCCGAGTCCTTTTGGAGCTGTATCAACGCCATGGTATACCTATGGTCTCGCAACCAATGG 68 FBan0013813 FBgn0036956 CG13813 3 3L CG13813 CG13813 CDMC20117 1 26 9 DAC15-I12 4-CG13813-RA_1 CG13813 CGCCGTTACCCGAGTCCTTTTGGAGCTGTATCAACGCCATGGTATACCTATGGTCTCGCAACCAATGG 68 FBan0013813 FBgn0036956 CG13813 3 3L CG13813 CG13813 CDMC20118 1 1 10 DAC15-I24 16-CG13876-RA_3 CG13876 TCCGGAGACCAGACTTCCAGCTCACTTCATATTCAGAGCGAAGAGGATTATCCCATTCACACGATTGC 68 FBan0013876 FBgn0035109 CG13876 3 3L CG13876 CG13876 CDMC20118 1 2 10 DAC15-I24 16-CG13876-RA_3 CG13876 TCCGGAGACCAGACTTCCAGCTCACTTCATATTCAGAGCGAAGAGGATTATCCCATTCACACGATTGC 68 FBan0013876 FBgn0035109 CG13876 3 3L CG13876 CG13876 CDMC20119 1 3 10 DAC15-M12 23-CG14292-RA_1 CG14292 ACCCAACGACTGAGAACCAAGTGAACTCAGATAAATTAAAAGAAATGAAATTCGCAATTGTTCTACTG 68 FBan0014292 FBgn0038658 CG14292 3 3R CG14292 CG14292 CDMC20119 1 4 10 DAC15-M12 23-CG14292-RA_1 CG14292 ACCCAACGACTGAGAACCAAGTGAACTCAGATAAATTAAAAGAAATGAAATTCGCAATTGTTCTACTG 68 FBan0014292 FBgn0038658 CG14292 3 3R CG14292 CG14292 CDMC20120 1 5 10 DAC15-M24 2-CG14376-RA_1 CG14376 TGGCTGGCTCAACGCGTATCAGGCTTCCAATTGCGGAATCTCAATGGATATTTCCCCACCTGCTTGAG 68 FBan0014376 FBgn0038153 CG14376 3 3R transport; GO:0006810 transporter activity; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005215; ; GO:0004867 CG14376 CG14376 CDMC20120 1 6 10 DAC15-M24 2-CG14376-RA_1 CG14376 TGGCTGGCTCAACGCGTATCAGGCTTCCAATTGCGGAATCTCAATGGATATTTCCCCACCTGCTTGAG 68 FBan0014376 FBgn0038153 CG14376 3 3R transport; GO:0006810 transporter activity; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005215; ; GO:0004867 CG14376 CG14376 CDMC20121 1 7 10 DAC16-A12 2-CG31049-RA_1 CG31049 AGGAGGAAGAACAGCAAGTACGCACGCTCAATGCACGAGTATCTGTACAGCGATGACCCTGGACA 65 FBgn0051049 CDMC20121 1 8 10 DAC16-A12 2-CG31049-RA_1 CG31049 AGGAGGAAGAACAGCAAGTACGCACGCTCAATGCACGAGTATCTGTACAGCGATGACCCTGGACA 65 FBgn0051049 CDMC20122 1 9 10 DAC16-A24 3-CG31078-RA_1 CG31078 ATGATGACCATTTTGGCTTGGGAGGTTCTATTGGGAAAGTCGATGGCTTGCACGCTCCGGCAATG 65 FBan0031078 FBgn0051078 CG31078 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31078 CG31078 CDMC20122 1 10 10 DAC16-A24 3-CG31078-RA_1 CG31078 ATGATGACCATTTTGGCTTGGGAGGTTCTATTGGGAAAGTCGATGGCTTGCACGCTCCGGCAATG 65 FBan0031078 FBgn0051078 CG31078 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31078 CG31078 CDMC20123 1 11 10 DAC16-E12 24-CG3119-RB_1 CG3119 TAGAGTTTATCTGACGGATTGATTATTCCTAATGCATCATAAATGTTTAATGATTTGTGATTGAT 65 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC20123 1 12 10 DAC16-E12 24-CG3119-RB_1 CG3119 TAGAGTTTATCTGACGGATTGATTATTCCTAATGCATCATAAATGTTTAATGATTTGTGATTGAT 65 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC20124 1 13 10 DAC16-E24 3-CG31229-RA_1 CG31229 TTTGTTTAGCGCCTCCGTTAATCCCAACATGGCCGATCCGTTCGCGAATGAGAAGAAGCAGACGG 65 FBan0031229 FBgn0051229 CG31229 3 3R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG31229 CG31229 CDMC20124 1 14 10 DAC16-E24 3-CG31229-RA_1 CG31229 TTTGTTTAGCGCCTCCGTTAATCCCAACATGGCCGATCCGTTCGCGAATGAGAAGAAGCAGACGG 65 FBan0031229 FBgn0051229 CG31229 3 3R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG31229 CG31229 CDMC20125 1 15 10 DAC16-I12 23-CG31315-RA_1 CG31315 GCCCCATTTTGCAACTCAATTCCAACATACATTTGCATGTCAGGACACCTAATCACAAACGGATA 65 FBan0031315 FBgn0051315 CG31315 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31315 CG31315 CDMC20125 1 16 10 DAC16-I12 23-CG31315-RA_1 CG31315 GCCCCATTTTGCAACTCAATTCCAACATACATTTGCATGTCAGGACACCTAATCACAAACGGATA 65 FBan0031315 FBgn0051315 CG31315 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31315 CG31315 CDMC20126 1 17 10 DAC16-I24 1-CG31349-RA_1 CG31349 GAGTTCCCCAATCGGTGACAGCTGTACCTCCATCGAAACCCAGTACACATCACAAGCCAGCTTGC 65 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC20126 1 18 10 DAC16-I24 1-CG31349-RA_1 CG31349 GAGTTCCCCAATCGGTGACAGCTGTACCTCCATCGAAACCCAGTACACATCACAAGCCAGCTTGC 65 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC20127 1 19 10 DAC16-M12 2-CG31468-RA_1 CG31468 TGCCTACAATCTGCCCAGCACCTTTGGGTTTAAGAACTGCGACAAGAGGATGCAGCGAAGTCCAC 65 FBan0031468 FBgn0047351 CG31468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31468 CG31468 "BcDNA:AT08725, NEST:bs12h04, NEST:bs34b06, NEST:bs21c04, NEST:bs18e02" CDMC20127 1 20 10 DAC16-M12 2-CG31468-RA_1 CG31468 TGCCTACAATCTGCCCAGCACCTTTGGGTTTAAGAACTGCGACAAGAGGATGCAGCGAAGTCCAC 65 FBan0031468 FBgn0047351 CG31468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31468 CG31468 "BcDNA:AT08725, NEST:bs12h04, NEST:bs34b06, NEST:bs21c04, NEST:bs18e02" CDMC20128 1 21 10 DAC16-M24 23-CG31516-RA_1 CG31516 CGCGTGGAGATTTGTCGAATGCAAAATACACAACCTTATCAGTGTACTAATTACCACCGCCCTAC 65 FBan0031516 FBgn0051516 CG31516 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31516 CG31516 BcDNA:RE68446 CDMC20128 1 22 10 DAC16-M24 23-CG31516-RA_1 CG31516 CGCGTGGAGATTTGTCGAATGCAAAATACACAACCTTATCAGTGTACTAATTACCACCGCCCTAC 65 FBan0031516 FBgn0051516 CG31516 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31516 CG31516 BcDNA:RE68446 CDMC20129 1 23 10 DAC17-A12 26-CG32668-RA_2 CG32668 CTCTAATGCCTCCCGCTCTATCGGCCATATCGACTTCGCTGTGTCCCAGGAAATTGACGGGTCAG 65 FBan0032668 FBgn0052668 CG32668 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32668 CG32668 CDMC20129 1 24 10 DAC17-A12 26-CG32668-RA_2 CG32668 CTCTAATGCCTCCCGCTCTATCGGCCATATCGACTTCGCTGTGTCCCAGGAAATTGACGGGTCAG 65 FBan0032668 FBgn0052668 CG32668 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32668 CG32668 CDMC20130 1 25 10 DAC17-A24 2-CG32693-RA_1 CG32693 GCTGTGGCTGGAACACTTTCTAACTGGCTACTTTCAGCTATGCGGACTGGTCTGTGGCTGGAGTG 65 FBan0032693 FBgn0052693 Gr9a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr9a Gr9a "CG32693, CG32693" CDMC20130 1 26 10 DAC17-A24 2-CG32693-RA_1 CG32693 GCTGTGGCTGGAACACTTTCTAACTGGCTACTTTCAGCTATGCGGACTGGTCTGTGGCTGGAGTG 65 FBan0032693 FBgn0052693 Gr9a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr9a Gr9a "CG32693, CG32693" CDMC20131 1 1 11 DAC17-E12 21-CG32821-RA_1 CG32821 ACTGTCCAATGCACACCCAAACAGCCTGGCCAGGACGCTAGGAACCGCAGCTGCAGCCAATGCTG 65 FBan0032821 FBgn0052821 CG32821 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32821 CG32821 CDMC20131 1 2 11 DAC17-E12 21-CG32821-RA_1 CG32821 ACTGTCCAATGCACACCCAAACAGCCTGGCCAGGACGCTAGGAACCGCAGCTGCAGCCAATGCTG 65 FBan0032821 FBgn0052821 CG32821 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32821 CG32821 CDMC20132 1 3 11 DAC17-E24 18-CG32836-RA_10 CG32836 CACAAGGAAGGCAGTCAAATGGAGGAGGCTCTAGCAGGCGCTCATACCACGGATCAAGCGGCACC 65 FBan0032836 FBgn0052836 CG32836 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32836 CG32836 CDMC20132 1 4 11 DAC17-E24 18-CG32836-RA_10 CG32836 CACAAGGAAGGCAGTCAAATGGAGGAGGCTCTAGCAGGCGCTCATACCACGGATCAAGCGGCACC 65 FBan0032836 FBgn0052836 CG32836 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32836 CG32836 CDMC20133 1 5 11 DAC17-I12 24-CG33075-RA_2 CG33075 GCCCCATTCGAAATTGTTAAATTGTAGTGAAATAAAATTCTTGTTTTTCTTGGTTCGAAAACAAA 65 FBgn0053075 CDMC20133 1 6 11 DAC17-I12 24-CG33075-RA_2 CG33075 GCCCCATTCGAAATTGTTAAATTGTAGTGAAATAAAATTCTTGTTTTTCTTGGTTCGAAAACAAA 65 FBgn0053075 CDMC20134 1 7 11 DAC17-I24 1-CG33114-RA_1 CG33114 CAGCAACCCGAGTTAACGCCGGATCTGATTAGCACCGTGGATACTTTGGACACCTACTGCTCCGG 65 FBan0033114 FBgn0010197 Gyc32E 2 2L cGMP biosynthesis; GO:0006182; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 Gyc32E Guanyl cyclase at 32E "CG6275, CG33114, CG6275, GC, DMRGC, GYC 32E, Cyg1, Gyc-r: Guanylate cyclase receptor-type, Guanylate cyclase receptor-type" CDMC20134 1 8 11 DAC17-I24 1-CG33114-RA_1 CG33114 CAGCAACCCGAGTTAACGCCGGATCTGATTAGCACCGTGGATACTTTGGACACCTACTGCTCCGG 65 FBan0033114 FBgn0010197 Gyc32E 2 2L cGMP biosynthesis; GO:0006182; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 Gyc32E Guanyl cyclase at 32E "CG6275, CG33114, CG6275, GC, DMRGC, GYC 32E, Cyg1, Gyc-r: Guanylate cyclase receptor-type, Guanylate cyclase receptor-type" CDMC20135 1 9 11 DAC17-M12 3-CG33207-RB_1 CG33207 CTATAGGCATCCGTACGGGGACTCCAGTTTTGGATCCGATTCGGGATACAGCCACCATACGCCTG 65 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC20135 1 10 11 DAC17-M12 3-CG33207-RB_1 CG33207 CTATAGGCATCCGTACGGGGACTCCAGTTTTGGATCCGATTCGGGATACAGCCACCATACGCCTG 65 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC20136 1 11 11 DAC17-M24 23-CG33252-RA_1 CG33252 GCATTACATGGTTCCCTTCGTTGTGCTTTCGTTGATCATCTTGATCATCTATGTGTTCGTCGTGG 65 FBan0033252 FBgn0053252 CG33252 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33252 CG33252 CDMC20136 1 12 11 DAC17-M24 23-CG33252-RA_1 CG33252 GCATTACATGGTTCCCTTCGTTGTGCTTTCGTTGATCATCTTGATCATCTATGTGTTCGTCGTGG 65 FBan0033252 FBgn0053252 CG33252 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33252 CG33252 CDMC20137 1 13 11 DAC18-A12 3-CG5864-RA_1 CG5864 CATGGCCTATCCGGATAAGGTGAAAAAGAAGATCACCCGGGAACTGGTCACTACGATACTGGCCCGCA 68 FBan0005864 FBgn0039132 AP-1sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1sigma AP-1sigma "CG5864, CG5864, sigma1, AP-1[sigma], cg5864, AP-1sigma" CDMC20137 1 14 11 DAC18-A12 3-CG5864-RA_1 CG5864 CATGGCCTATCCGGATAAGGTGAAAAAGAAGATCACCCGGGAACTGGTCACTACGATACTGGCCCGCA 68 FBan0005864 FBgn0039132 AP-1sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1sigma AP-1sigma "CG5864, CG5864, sigma1, AP-1[sigma], cg5864, AP-1sigma" CDMC20138 1 15 11 DAC18-A24 3-CG5946-RB_2 CG5946 CCCTCGGGTAGGCTACAATATCTCGGCAATGGCACCTTCTCCATCAAAAAGTTGCGCAAGGATCCTCC 68 FBan0005946 FBgn0036211 CG5946 3 3L cholesterol metabolism; GO:0008203; electron transport; GO:0006118; fatty acid desaturation; GO:0006636 cytochrome-b5 reductase activity; GO:0004128 ; EC:1.6.2.2; ; GO:0004128 ; EC:1.6.2.2 CG5946 CG5946 CDMC20138 1 16 11 DAC18-A24 3-CG5946-RB_2 CG5946 CCCTCGGGTAGGCTACAATATCTCGGCAATGGCACCTTCTCCATCAAAAAGTTGCGCAAGGATCCTCC 68 FBan0005946 FBgn0036211 CG5946 3 3L cholesterol metabolism; GO:0008203; electron transport; GO:0006118; fatty acid desaturation; GO:0006636 cytochrome-b5 reductase activity; GO:0004128 ; EC:1.6.2.2; ; GO:0004128 ; EC:1.6.2.2 CG5946 CG5946 CDMC20139 1 17 11 DAC18-E12 23-CG6283-RA_1 CG6283 GCACCCTTCGGCAAGATTGAGTAGAACCATGTTCTCTGAATAAAATACATTACTGAATACTCAAAAAA 68 FBan0006283 FBgn0039474 CG6283 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6283 CG6283 CDMC20139 1 18 11 DAC18-E12 23-CG6283-RA_1 CG6283 GCACCCTTCGGCAAGATTGAGTAGAACCATGTTCTCTGAATAAAATACATTACTGAATACTCAAAAAA 68 FBan0006283 FBgn0039474 CG6283 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6283 CG6283 CDMC20140 1 19 11 DAC18-E24 1-CG6420-RA_1 CG6420 CCGTCGCAGACTACATCGGGATACAACAGCAAGACTTCCAACAGCTCGAACAAGTCCTCCAACTCGGG 68 FBan0006420 FBgn0039451 CG6420 3 3R CG6420 CG6420 CDMC20140 1 20 11 DAC18-E24 1-CG6420-RA_1 CG6420 CCGTCGCAGACTACATCGGGATACAACAGCAAGACTTCCAACAGCTCGAACAAGTCCTCCAACTCGGG 68 FBan0006420 FBgn0039451 CG6420 3 3R CG6420 CG6420 CDMC20141 1 21 11 DAC18-I12 3-CG6811-RA_4 CG6811 TTCTAGACTGGCCCAAGGAAGAGCGTTCGAGGAACGTGACGCAACTGATACGCGAAAAACTGCCAGAG 68 FBan0006811 FBgn0036257 RhoGAP68F 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP68F RhoGAP68F "CG6811, CG6811, CG6811, CG 6811" CDMC20141 1 22 11 DAC18-I12 3-CG6811-RA_4 CG6811 TTCTAGACTGGCCCAAGGAAGAGCGTTCGAGGAACGTGACGCAACTGATACGCGAAAAACTGCCAGAG 68 FBan0006811 FBgn0036257 RhoGAP68F 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP68F RhoGAP68F "CG6811, CG6811, CG6811, CG 6811" CDMC20142 1 23 11 DAC18-I24 3-CG6976-RD_2 CG6976 TCCTGGCACCATTGATGTGGAGTCCTCCAAGCAAATGGTGGATGACGTGTTCCGCTTCCTAAACGATG 68 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC20142 1 24 11 DAC18-I24 3-CG6976-RD_2 CG6976 TCCTGGCACCATTGATGTGGAGTCCTCCAAGCAAATGGTGGATGACGTGTTCCGCTTCCTAAACGATG 68 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC20143 1 25 11 DAC18-M12 2-CG7399-RA_1 CG7399 CCCGACCCTTTGGTGTTCGCTACAATGCCTATACTCAGAGTGTTGAGGTTCTCGACTCGAAGCCCCAG 68 FBan0007399 FBgn0001208 Hn 3 3L L-phenylalanine catabolism; GO:0006559; eye pigment biosynthesis; GO:0006726; signal transduction; GO:0007165 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1 Hn Henna "CG7399, pah, phenylalanine hydroxylase, Pah: Phenylalanine-hydroxylase, DTPH, PAH, Tph, phenylalanine hydroxylase., TPH, bu, Phenylalanine-hydroxylase, Tryptophan hydrolase, brunette, Pah, Henna" CDMC20143 1 26 11 DAC18-M12 2-CG7399-RA_1 CG7399 CCCGACCCTTTGGTGTTCGCTACAATGCCTATACTCAGAGTGTTGAGGTTCTCGACTCGAAGCCCCAG 68 FBan0007399 FBgn0001208 Hn 3 3L L-phenylalanine catabolism; GO:0006559; eye pigment biosynthesis; GO:0006726; signal transduction; GO:0007165 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1 Hn Henna "CG7399, pah, phenylalanine hydroxylase, Pah: Phenylalanine-hydroxylase, DTPH, PAH, Tph, phenylalanine hydroxylase., TPH, bu, Phenylalanine-hydroxylase, Tryptophan hydrolase, brunette, Pah, Henna" CDMC20144 1 1 12 DAC18-M24 3-CG7452-RA_1 CG7452 GCAGGTGGAACCGGATAGCGAGTCAACTGAGAGACTGGAGCTAAAAGAGAAGCCAGAATGACCCGCAG 68 FBan0007452 FBgn0035540 Syx17 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx17 Syntaxin 17 "CG7452, Dm Syx17, DmSyx17, syntaxin, Syntaxin 17" CDMC20144 1 2 12 DAC18-M24 3-CG7452-RA_1 CG7452 GCAGGTGGAACCGGATAGCGAGTCAACTGAGAGACTGGAGCTAAAAGAGAAGCCAGAATGACCCGCAG 68 FBan0007452 FBgn0035540 Syx17 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx17 Syntaxin 17 "CG7452, Dm Syx17, DmSyx17, syntaxin, Syntaxin 17" CDMC20145 1 3 12 DAC19-A12 2-CG17778-RA_1 CG17778 CCTCCCTGGCGAATAGGTGCGGTAAATGTGTCAATGGGGACGCAAATGTAGGGACTAAATTGGCACCAA 69 FBan0017778 FBgn0023534 CG17778 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17778 CG17778 "EG:171D11.5, BcDNA:RH02374" CDMC20145 1 4 12 DAC19-A12 2-CG17778-RA_1 CG17778 CCTCCCTGGCGAATAGGTGCGGTAAATGTGTCAATGGGGACGCAAATGTAGGGACTAAATTGGCACCAA 69 FBan0017778 FBgn0023534 CG17778 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17778 CG17778 "EG:171D11.5, BcDNA:RH02374" CDMC20146 1 5 12 DAC19-A24 3-CG17797-RA_1 CG17797 TGGCGGCACATTCGTCTCCACCCTAACCGGACGAGAACCCTTCTTTGTCAAATGGAAGAGTAATCAGGA 69 FBan0017797 FBgn0015583 Acp29AB 2 2L physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321; spermatogenesis; GO:0007283 galactose binding; GO:0005534; sugar binding; GO:0005529; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005534; ; GO:0005529 extracellular region; GO:0005576 Acp29AB Accessory gland-specific peptide 29AB "CG17797, Acp29B, Accessory gland protein 29AB, AC 004423B, AC004423b, accessory gland protein, Acp29AB-II" CDMC20146 1 6 12 DAC19-A24 3-CG17797-RA_1 CG17797 TGGCGGCACATTCGTCTCCACCCTAACCGGACGAGAACCCTTCTTTGTCAAATGGAAGAGTAATCAGGA 69 FBan0017797 FBgn0015583 Acp29AB 2 2L physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321; spermatogenesis; GO:0007283 galactose binding; GO:0005534; sugar binding; GO:0005529; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005534; ; GO:0005529 extracellular region; GO:0005576 Acp29AB Accessory gland-specific peptide 29AB "CG17797, Acp29B, Accessory gland protein 29AB, AC 004423B, AC004423b, accessory gland protein, Acp29AB-II" CDMC20147 1 7 12 DAC19-E12 8-CG1783-RA_2 CG1783 ACGGTGAAAGTGCTGAGGAAATACCCATGGTATGGAAGGTTAAAAGGCGACCAGATGGAACGCGGTACA 69 FBgn0039919 CDMC20147 1 8 12 DAC19-E12 8-CG1783-RA_2 CG1783 ACGGTGAAAGTGCTGAGGAAATACCCATGGTATGGAAGGTTAAAAGGCGACCAGATGGAACGCGGTACA 69 FBgn0039919 CDMC20148 1 9 12 DAC19-E24 14-CG17868-RB_2 CG17868 TGCGATTTGGTTTGGTGCTAAGACAGTTGAGCTGCTTTCTTTAGGACAGATTGGTTCCGACTTGGCCTT 69 FBan0017868 FBgn0028946 Or35a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or35a Odorant receptor 35a "CG17868, CG17868, CG17868, BG:BACR44L22.5, BACR44L22.5, 36E.1, DOR91, 35a" CDMC20148 1 10 12 DAC19-E24 14-CG17868-RB_2 CG17868 TGCGATTTGGTTTGGTGCTAAGACAGTTGAGCTGCTTTCTTTAGGACAGATTGGTTCCGACTTGGCCTT 69 FBan0017868 FBgn0028946 Or35a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or35a Odorant receptor 35a "CG17868, CG17868, CG17868, BG:BACR44L22.5, BACR44L22.5, 36E.1, DOR91, 35a" CDMC20149 1 11 12 DAC19-I12 14-CG17921-RA_2 CG17921 GCCAGCCCAGTACATTTTGTTCAGTTTCAGTCTCAGTTCAGTTCGTGCAAGGCAATTTTCACAGGCAGC 69 FBan0017921 FBgn0010228 HmgZ 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 HmgZ HMG protein Z "CG17921, dHMG-Z, HMG-Z, clone 1.58, hmg-Z, BcDNA:RE28596, anon-EST:Liang-1.58" CDMC20149 1 12 12 DAC19-I12 14-CG17921-RA_2 CG17921 GCCAGCCCAGTACATTTTGTTCAGTTTCAGTCTCAGTTCAGTTCGTGCAAGGCAATTTTCACAGGCAGC 69 FBan0017921 FBgn0010228 HmgZ 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 HmgZ HMG protein Z "CG17921, dHMG-Z, HMG-Z, clone 1.58, hmg-Z, BcDNA:RE28596, anon-EST:Liang-1.58" CDMC20150 1 13 12 DAC19-I24 2-CG1792-RA_1 CG1792 CGCGGAATTGATCGAATCCTTCGCAGTTGGTGTGGAGAAGGAGATTCAGTACGCTGAAGAGGTCACCGA 69 FBan0001792 FBgn0039860 CG1792 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1792 CG1792 CDMC20150 1 14 12 DAC19-I24 2-CG1792-RA_1 CG1792 CGCGGAATTGATCGAATCCTTCGCAGTTGGTGTGGAGAAGGAGATTCAGTACGCTGAAGAGGTCACCGA 69 FBan0001792 FBgn0039860 CG1792 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1792 CG1792 CDMC20151 1 15 12 DAC19-M12 12-CG17970-RA_2 CG17970 ACCGCACTGGGAGTAAAACTTGATGACTTGTCGGAGGGTATTCGATATCGCCAGTCGATTCACGCCATT 69 FBan0017970 FBgn0031694 Cyp4ac2 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac2 Cyp4ac2 "CG17970, 4ac2" CDMC20151 1 16 12 DAC19-M12 12-CG17970-RA_2 CG17970 ACCGCACTGGGAGTAAAACTTGATGACTTGTCGGAGGGTATTCGATATCGCCAGTCGATTCACGCCATT 69 FBan0017970 FBgn0031694 Cyp4ac2 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac2 Cyp4ac2 "CG17970, 4ac2" CDMC20152 1 17 12 DAC19-M24 2-CG17991-RA_2 CG17991 TCAATGATGTGCCTAGGACGGAAATATGACCACCAGACCGAACCATACCCTTCTGCGCCAATGACCGAA 69 FBan0017991 FBgn0039498 CG17991 3 3R CG17991 CG17991 CDMC20152 1 18 12 DAC19-M24 2-CG17991-RA_2 CG17991 TCAATGATGTGCCTAGGACGGAAATATGACCACCAGACCGAACCATACCCTTCTGCGCCAATGACCGAA 69 FBan0017991 FBgn0039498 CG17991 3 3R CG17991 CG17991 CDMC20153 1 19 12 DAC20-A12 2-CG10602-RA_2 CG10602 AAGACTGCCACTGAGTTGTGTGGTCCGTATGTCTGGAAGCAGTACGATCTTCTGGTGATGCCCCC 65 FBan0010602 FBgn0032721 CG10602 2 2L cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0008237; leukotriene-A4 hydrolase activity; GO:0004463 ; EC:3.3.2.6; ; GO:0004463 ; EC:3.3.2.6; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG10602 CG10602 pepCG10602 CDMC20153 1 20 12 DAC20-A12 2-CG10602-RA_2 CG10602 AAGACTGCCACTGAGTTGTGTGGTCCGTATGTCTGGAAGCAGTACGATCTTCTGGTGATGCCCCC 65 FBan0010602 FBgn0032721 CG10602 2 2L cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0008237; leukotriene-A4 hydrolase activity; GO:0004463 ; EC:3.3.2.6; ; GO:0004463 ; EC:3.3.2.6; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG10602 CG10602 pepCG10602 CDMC20154 1 21 12 DAC20-A24 23-CG10659-RA_1 CG10659 TTTCGGCATCTCGAAACTGCTCTACTCCCACATTACCAGTGTCGAATCTTCGATGAGGGGCAAAG 65 FBan0010659 FBgn0032839 CG10659 2 2L CG10659 CG10659 CDMC20154 1 22 12 DAC20-A24 23-CG10659-RA_1 CG10659 TTTCGGCATCTCGAAACTGCTCTACTCCCACATTACCAGTGTCGAATCTTCGATGAGGGGCAAAG 65 FBan0010659 FBgn0032839 CG10659 2 2L CG10659 CG10659 CDMC20155 1 23 12 DAC20-E12 23-CG10742-RA_1 CG10742 TACAACCGCACCTGAACATACATACTCTCGGAATCAGTACTCATTTTTTTGTGCACCACTCACGT 65 FBan0010742 FBgn0040334 Tsp3A X X cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp3A Tetraspanin 3A "CG10742, CG10742, CG10742, CG10742, CG10742, CG10742, Dm.Tsp3A, EG:BACR7C10.6, BACR7C10.6, Tetraspanin 3A" CDMC20155 1 24 12 DAC20-E12 23-CG10742-RA_1 CG10742 TACAACCGCACCTGAACATACATACTCTCGGAATCAGTACTCATTTTTTTGTGCACCACTCACGT 65 FBan0010742 FBgn0040334 Tsp3A X X cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp3A Tetraspanin 3A "CG10742, CG10742, CG10742, CG10742, CG10742, CG10742, Dm.Tsp3A, EG:BACR7C10.6, BACR7C10.6, Tetraspanin 3A" CDMC20156 1 25 12 DAC20-E24 9-CG10795-RA_4 CG10795 AAACCGGAATCGAAAACGACAACAGATAGTACCCGCGAGAAAGAGCTCCCGCCAACAGAACACCA 65 FBan0010795 FBgn0034626 CG10795 2 2R CG10795 CG10795 LD27358 CDMC20156 1 26 12 DAC20-E24 9-CG10795-RA_4 CG10795 AAACCGGAATCGAAAACGACAACAGATAGTACCCGCGAGAAAGAGCTCCCGCCAACAGAACACCA 65 FBan0010795 FBgn0034626 CG10795 2 2R CG10795 CG10795 LD27358 CDMC20157 1 1 13 DAC20-I12 5-CG10911-RA_1 CG10911 CAAGACCCAGAGGGCCTATGGAGAGAGCTACGGTCAGCTGTACGCGGATTTGGGTGATTGCATTG 65 FBan0010911 FBgn0034295 CG10911 2 2R CG10911 CG10911 anon-WO0140519.211 CDMC20157 1 2 13 DAC20-I12 5-CG10911-RA_1 CG10911 CAAGACCCAGAGGGCCTATGGAGAGAGCTACGGTCAGCTGTACGCGGATTTGGGTGATTGCATTG 65 FBan0010911 FBgn0034295 CG10911 2 2R CG10911 CG10911 anon-WO0140519.211 CDMC20158 1 3 13 DAC20-I24 1-CG10936-RA_1 CG10936 AGCGCTTCACCAACTCAATGCACGGTAGCAACAGTTCCAACATCTACGACAGTTGGCGATCCACC 65 FBan0010936 FBgn0034253 CG10936 2 2R CG10936 CG10936 CDMC20158 1 4 13 DAC20-I24 1-CG10936-RA_1 CG10936 AGCGCTTCACCAACTCAATGCACGGTAGCAACAGTTCCAACATCTACGACAGTTGGCGATCCACC 65 FBan0010936 FBgn0034253 CG10936 2 2R CG10936 CG10936 CDMC20159 1 5 13 DAC20-M12 23-CG11079-RC_3 CG11079 CGTCCGTTTGCACAGTGTAATTACGGAAAACTAACTTTTGGCTTACATACAAAGTGGGAAGTAAA 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC20159 1 6 13 DAC20-M12 23-CG11079-RC_3 CG11079 CGTCCGTTTGCACAGTGTAATTACGGAAAACTAACTTTTGGCTTACATACAAAGTGGGAAGTAAA 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC20160 1 7 13 DAC20-M24 6-CG11103-RA_1 CG11103 GCAGCAGGAAAAGAAATACGGATGCCTGAAGTTCGGTGGTTCCACGTACGAAGAGGTGGAGCACG 65 FBan0011103 FBgn0030522 CG11103 X X CG11103 CG11103 BcDNA:LP03404 CDMC20160 1 8 13 DAC20-M24 6-CG11103-RA_1 CG11103 GCAGCAGGAAAAGAAATACGGATGCCTGAAGTTCGGTGGTTCCACGTACGAAGAGGTGGAGCACG 65 FBan0011103 FBgn0030522 CG11103 X X CG11103 CG11103 BcDNA:LP03404 CDMC20161 1 9 13 DAC21-A12 2-CG11183-RA_1 CG11183 ATTCAGCTCCTGAGCGACCTGAAGATCGGTAAAAGCTACGCTACGGCTCAATCTCCGACAGTCGC 65 FBan0011183 FBgn0034921 CG11183 2 2R "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tRNA aminoacylation for protein translation; GO:0006418; transcription from RNA polymerase II promoter; GO:0006366; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178" ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0030528; ; GO:0003712; ; GO:0004812 ; EC:6.1.1.- CG11183 CG11183 anon-WO0118547.163 CDMC20161 1 10 13 DAC21-A12 2-CG11183-RA_1 CG11183 ATTCAGCTCCTGAGCGACCTGAAGATCGGTAAAAGCTACGCTACGGCTCAATCTCCGACAGTCGC 65 FBan0011183 FBgn0034921 CG11183 2 2R "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tRNA aminoacylation for protein translation; GO:0006418; transcription from RNA polymerase II promoter; GO:0006366; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178" ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0030528; ; GO:0003712; ; GO:0004812 ; EC:6.1.1.- CG11183 CG11183 anon-WO0118547.163 CDMC20162 1 11 13 DAC21-A24 1-CG11213-RA_1 CG11213 TGAGCCCGTGTTCGTCAATGTGGTCAAGCCCCCAGCAGAGAAGTACTTTGTCAACGAGAACAAGC 65 FBan0011213 FBgn0000360 Cp38 X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp38 Chorion protein 38 "CG11213, E3, s38-1, s38, S38: Shell-38, Dms38, CP38, ACE1, Shell-38, S38" CDMC20162 1 12 13 DAC21-A24 1-CG11213-RA_1 CG11213 TGAGCCCGTGTTCGTCAATGTGGTCAAGCCCCCAGCAGAGAAGTACTTTGTCAACGAGAACAAGC 65 FBan0011213 FBgn0000360 Cp38 X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp38 Chorion protein 38 "CG11213, E3, s38-1, s38, S38: Shell-38, Dms38, CP38, ACE1, Shell-38, S38" CDMC20163 1 13 13 DAC21-E12 2-CG11337-RB_3 CG11337 CAAAGTTCGAGAACGACGACACTAAGCACCTGCAGGACTACCGCATTCTCACCGACATCCTGGGC 65 FBan0011337 FBgn0039846 CG11337 3 3R RNA catabolism; GO:0006401; RNA processing; GO:0006396 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; polyribonucleotide nucleotidyltransferase activity; GO:0004654 ; EC:2.7.7.8; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0004654 ; EC:2.7.7.8; ; GO:0000175 ; EC:3.1.13.- CG11337 CG11337 CDMC20163 1 14 13 DAC21-E12 2-CG11337-RB_3 CG11337 CAAAGTTCGAGAACGACGACACTAAGCACCTGCAGGACTACCGCATTCTCACCGACATCCTGGGC 65 FBan0011337 FBgn0039846 CG11337 3 3R RNA catabolism; GO:0006401; RNA processing; GO:0006396 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; polyribonucleotide nucleotidyltransferase activity; GO:0004654 ; EC:2.7.7.8; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0004654 ; EC:2.7.7.8; ; GO:0000175 ; EC:3.1.13.- CG11337 CG11337 CDMC20164 1 15 13 DAC21-E24 14-CG11401-RA_1 CG11401 CCAGCGTGCCTCATATATTTGCAGTTGGGGACATCATATATGGTCGACCAGAGCTAACGCCGGTG 65 FBan0011401 FBgn0037170 Trxr-2 3 3L sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0015036; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-2 thioredoxin reductase 2 "CG11401, DmTrxR-2, Trxr2, trxr-2, thioredoxin-reductase-2, thioredoxin reductase 2" CDMC20164 1 16 13 DAC21-E24 14-CG11401-RA_1 CG11401 CCAGCGTGCCTCATATATTTGCAGTTGGGGACATCATATATGGTCGACCAGAGCTAACGCCGGTG 65 FBan0011401 FBgn0037170 Trxr-2 3 3L sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0015036; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-2 thioredoxin reductase 2 "CG11401, DmTrxR-2, Trxr2, trxr-2, thioredoxin-reductase-2, thioredoxin reductase 2" CDMC20165 1 17 13 DAC21-I12 9-CG11527-RA_1 CG11527 CAGCAGCAAATTGAGGAGCTGGGATGGAACGAAAAGCTAGAGGACCTTGGACAGCAGACGCAAGT 65 FBan0011527 FBgn0011722 Tig 2 2L axon guidance; GO:0007411 binding; GO:0005488; ; GO:0005488 extracellular matrix (sensu Metazoa); GO:0005578 Tig Tiggrin "CG11527, tig, tiggrin, TIG, CT36389" CDMC20165 1 18 13 DAC21-I12 9-CG11527-RA_1 CG11527 CAGCAGCAAATTGAGGAGCTGGGATGGAACGAAAAGCTAGAGGACCTTGGACAGCAGACGCAAGT 65 FBan0011527 FBgn0011722 Tig 2 2L axon guidance; GO:0007411 binding; GO:0005488; ; GO:0005488 extracellular matrix (sensu Metazoa); GO:0005578 Tig Tiggrin "CG11527, tig, tiggrin, TIG, CT36389" CDMC20166 1 19 13 DAC21-I24 3-CG11560-RA_2 CG11560 TGGTCTTGGGTCGTCTGGAGCGACTGAGCATTTCCACGGTCACATCCTTGACCACAAACCTGTAG 65 FBan0011560 FBgn0036249 CG11560 3 3L CG11560 CG11560 CDMC20166 1 20 13 DAC21-I24 3-CG11560-RA_2 CG11560 TGGTCTTGGGTCGTCTGGAGCGACTGAGCATTTCCACGGTCACATCCTTGACCACAAACCTGTAG 65 FBan0011560 FBgn0036249 CG11560 3 3L CG11560 CG11560 CDMC20167 1 21 13 DAC21-M12 1-CG11659-RA_2 CG11659 AACTGCCCAGATTTCGAGACGTGCGATCTGTCGAGCCTACGGTGCTACATGTTTGGAGGATCTCG 65 FBan0011659 FBgn0038731 CG11659 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11659 CG11659 CDMC20167 1 22 13 DAC21-M12 1-CG11659-RA_2 CG11659 AACTGCCCAGATTTCGAGACGTGCGATCTGTCGAGCCTACGGTGCTACATGTTTGGAGGATCTCG 65 FBan0011659 FBgn0038731 CG11659 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11659 CG11659 CDMC20168 1 23 13 DAC21-M24 18-CG1168-RA_1 CG1168 ATGTCTTGATGACGGATCTGCTGAATCGCATGGACAAAGACATGCAGGTGGGCTATTACGACGTG 65 FBan0001168 FBgn0041707 7B2 3 3R neuropeptide signaling pathway; GO:0007218; peptide hormone processing; GO:0016486; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 proprotein convertase 2 activator activity; GO:0016484; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0016484 secretory granule; GO:0030141 7B2 7B2 "CG1168, CG1168, d7B2, FBgn0040073" CDMC20168 1 24 13 DAC21-M24 18-CG1168-RA_1 CG1168 ATGTCTTGATGACGGATCTGCTGAATCGCATGGACAAAGACATGCAGGTGGGCTATTACGACGTG 65 FBan0001168 FBgn0041707 7B2 3 3R neuropeptide signaling pathway; GO:0007218; peptide hormone processing; GO:0016486; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 proprotein convertase 2 activator activity; GO:0016484; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0016484 secretory granule; GO:0030141 7B2 7B2 "CG1168, CG1168, d7B2, FBgn0040073" CDMC20169 1 25 13 DAC22-A12 24-CG31619-RB_1 CG31619 ATTACGCTCATATCCATAACTTTAAGTCGAAACATATTGCTAATAAATAACGCCGCACTTAATAA 65 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC20169 1 26 13 DAC22-A12 24-CG31619-RB_1 CG31619 ATTACGCTCATATCCATAACTTTAAGTCGAAACATATTGCTAATAAATAACGCCGCACTTAATAA 65 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC20170 1 1 14 DAC22-A24 3-CG31657-RA_5 CG31657 AACTGGAACCGCATTTTGCTCATGACATTCCCGTGATACCCATGGATGACCTGACGGGGAATCCG 65 FBgn0051657 CDMC20170 1 2 14 DAC22-A24 3-CG31657-RA_5 CG31657 AACTGGAACCGCATTTTGCTCATGACATTCCCGTGATACCCATGGATGACCTGACGGGGAATCCG 65 FBgn0051657 CDMC20171 1 3 14 DAC22-E12 23-CG31737-RA_6 CG31737 TTCAATCAGTCGAAAGTGTGGTTACCATTTCCGATGTGAATGAAAGGCATACCACCAATCATTAC 65 FBan0031737 FBgn0051737 CG31737 2 2L CG31737 CG31737 "CG18115, BG:DS02740.19, DS02740.19" CDMC20171 1 4 14 DAC22-E12 23-CG31737-RA_6 CG31737 TTCAATCAGTCGAAAGTGTGGTTACCATTTCCGATGTGAATGAAAGGCATACCACCAATCATTAC 65 FBan0031737 FBgn0051737 CG31737 2 2L CG31737 CG31737 "CG18115, BG:DS02740.19, DS02740.19" CDMC20172 1 5 14 DAC22-E24 1-CG31773-RA_1 CG31773 ACGTGTGCCATCGTGGAGAGTATTCTTCGGTGTCATGGGGTGAAAACTGGTGTTCTCTCCTCGCC 65 FBan0031773 FBgn0051773 CG31773 2 2L folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 CG31773 CG31773 "CG3390, CG3390" CDMC20172 1 6 14 DAC22-E24 1-CG31773-RA_1 CG31773 ACGTGTGCCATCGTGGAGAGTATTCTTCGGTGTCATGGGGTGAAAACTGGTGTTCTCTCCTCGCC 65 FBan0031773 FBgn0051773 CG31773 2 2L folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 CG31773 CG31773 "CG3390, CG3390" CDMC20173 1 7 14 DAC22-I12 5-CG31913-RA_2 CG31913 CCTGGAGCTCGAAACGAGACAGAACCCGAACACACGCTACCTGCTTAAGAAGCCCCCGAACTACT 65 FBan0031913 FBgn0051913 CG31913 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31913 CG31913 "NEST:bs09g05, NEST:bs14h07, NEST:bs35c08, NEST:bs28e01, NEST:bs23g06" CDMC20173 1 8 14 DAC22-I12 5-CG31913-RA_2 CG31913 CCTGGAGCTCGAAACGAGACAGAACCCGAACACACGCTACCTGCTTAAGAAGCCCCCGAACTACT 65 FBan0031913 FBgn0051913 CG31913 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31913 CG31913 "NEST:bs09g05, NEST:bs14h07, NEST:bs35c08, NEST:bs28e01, NEST:bs23g06" CDMC20174 1 9 14 DAC22-I24 3-CG3193-RA_2 CG3193 TCGACTTCGAGGTAGCCCTAGGCGAAACAGAGCTAGCCAGACAGCTTTACGAGCGACTCCTTGAG 65 FBan0003193 FBgn0000377 crn X X "Malpighian tubule morphogenesis; GO:0007443; central nervous system development; GO:0007417; neuroblast proliferation; GO:0007405; neuron lineage restriction; GO:0042055; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 crn crooked neck "CG3193, CG18842, CG3193, CG3193, N5, l(1)2, l30, N10, l(1)CRN, RC63, yok: yolky, yolky, EG:30B8.1, 62D9.a, CDC16, l(1)2Fa, l(1)N7, l(1)crn, yok" CDMC20174 1 10 14 DAC22-I24 3-CG3193-RA_2 CG3193 TCGACTTCGAGGTAGCCCTAGGCGAAACAGAGCTAGCCAGACAGCTTTACGAGCGACTCCTTGAG 65 FBan0003193 FBgn0000377 crn X X "Malpighian tubule morphogenesis; GO:0007443; central nervous system development; GO:0007417; neuroblast proliferation; GO:0007405; neuron lineage restriction; GO:0042055; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 crn crooked neck "CG3193, CG18842, CG3193, CG3193, N5, l(1)2, l30, N10, l(1)CRN, RC63, yok: yolky, yolky, EG:30B8.1, 62D9.a, CDC16, l(1)2Fa, l(1)N7, l(1)crn, yok" CDMC20175 1 11 14 DAC22-M12 9-CG32082-RA_1 CG32082 GTTTGGCCGGAAACAAGAGCTACGGACCATGGTACGACTTCTGGGATCAGGAACAGCATGGCCAG 65 FBan0032082 FBgn0052082 CG32082 3 3L signal transduction; GO:0007165 signal transducer activity; GO:0004871; ; GO:0004871 CG32082 CG32082 "CG7624, anon-WO0118547.199" CDMC20175 1 12 14 DAC22-M12 9-CG32082-RA_1 CG32082 GTTTGGCCGGAAACAAGAGCTACGGACCATGGTACGACTTCTGGGATCAGGAACAGCATGGCCAG 65 FBan0032082 FBgn0052082 CG32082 3 3L signal transduction; GO:0007165 signal transducer activity; GO:0004871; ; GO:0004871 CG32082 CG32082 "CG7624, anon-WO0118547.199" CDMC20176 1 13 14 DAC22-M24 23-CG32118-RA_3 CG32118 TGATACAACTCGAGTGCAAAGAAAACAAAACACGAAACCCTAGTAGTCTTCTTGGTCTTGTGCCC 65 FBan0032118 FBgn0052118 CG32118 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32118 CG32118 CDMC20176 1 14 14 DAC22-M24 23-CG32118-RA_3 CG32118 TGATACAACTCGAGTGCAAAGAAAACAAAACACGAAACCCTAGTAGTCTTCTTGGTCTTGTGCCC 65 FBan0032118 FBgn0052118 CG32118 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32118 CG32118 CDMC20177 1 15 14 DAC23-A12 8-CG10737-RC_1 CG10737 CCACCGGAACCCTCAATGGTGATTCTTCCCGTTCATTATCTGTCGATCGTGCCACTCTGTCCAAAAGCA 69 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC20177 1 16 14 DAC23-A12 8-CG10737-RC_1 CG10737 CCACCGGAACCCTCAATGGTGATTCTTCCCGTTCATTATCTGTCGATCGTGCCACTCTGTCCAAAAGCA 69 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC20178 1 17 14 DAC23-A24 24-CG10750-RA_1 CG10750 GCTGGACGTATGTGCTAGTCGGAAAATATAATATTTTTCATGGAGCATAAATAAATAAATAAATGATTT 69 FBan0010750 FBgn0032769 CG10750 2 2L CG10750 CG10750 CDMC20178 1 18 14 DAC23-A24 24-CG10750-RA_1 CG10750 GCTGGACGTATGTGCTAGTCGGAAAATATAATATTTTTCATGGAGCATAAATAAATAAATAAATGATTT 69 FBan0010750 FBgn0032769 CG10750 2 2L CG10750 CG10750 CDMC20179 1 19 14 DAC23-E12 16-CG10793-RA_2 CG10793 TGGCCAGGATAATGCTTGTGAAATCGAACATGTCCATTTGGGTGGTGATGATGTTCTCTTCTCCTCCTT 69 FBan0010793 FBgn0029656 CG10793 X X response to oxidative stress; GO:0006979 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0005524; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016887; ; GO:0004601 ; EC:1.11.1.7 CG10793 CG10793 CDMC20179 1 20 14 DAC23-E12 16-CG10793-RA_2 CG10793 TGGCCAGGATAATGCTTGTGAAATCGAACATGTCCATTTGGGTGGTGATGATGTTCTCTTCTCCTCCTT 69 FBan0010793 FBgn0029656 CG10793 X X response to oxidative stress; GO:0006979 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0005524; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016887; ; GO:0004601 ; EC:1.11.1.7 CG10793 CG10793 CDMC20180 1 21 14 DAC23-E24 15-CG10803-RA_2 CG10803 TGTCCGCAATAAGTTCTACTAGACGGTGAGCTGCATTGCGAATATCGGACGACCCATTTCATCGCACAA 69 FBan0010803 FBgn0029666 CG10803 X X mRNA binding; GO:0003729; ; GO:0003729 ribonucleoprotein complex; GO:0030529 CG10803 CG10803 CDMC20180 1 22 14 DAC23-E24 15-CG10803-RA_2 CG10803 TGTCCGCAATAAGTTCTACTAGACGGTGAGCTGCATTGCGAATATCGGACGACCCATTTCATCGCACAA 69 FBan0010803 FBgn0029666 CG10803 X X mRNA binding; GO:0003729; ; GO:0003729 ribonucleoprotein complex; GO:0030529 CG10803 CG10803 CDMC20181 1 23 14 DAC23-I12 17-CG10834-RA_1 CG10834 GGCATAATTATTTTGGACCCGTTCGCTATACCAATCAAGACCACCATGGAGTACACCTTGACCGTGCAT 69 FBan0010834 FBgn0032972 CG10834 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG10834 CG10834 CDMC20181 1 24 14 DAC23-I12 17-CG10834-RA_1 CG10834 GGCATAATTATTTTGGACCCGTTCGCTATACCAATCAAGACCACCATGGAGTACACCTTGACCGTGCAT 69 FBan0010834 FBgn0032972 CG10834 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG10834 CG10834 CDMC20182 1 25 14 DAC23-I24 13-CG10843-RA_1 CG10843 ACTGCGGACCAAGAACCAGATTCACGTGAAGCTCGTGAGAAGAAAATGAGGCAGCTTTAACGGAATGGA 69 FBan0010843 FBgn0033397 Cyp4p3 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p3 Cyp4p3 "CG10843, 4p3" CDMC20182 1 26 14 DAC23-I24 13-CG10843-RA_1 CG10843 ACTGCGGACCAAGAACCAGATTCACGTGAAGCTCGTGAGAAGAAAATGAGGCAGCTTTAACGGAATGGA 69 FBan0010843 FBgn0033397 Cyp4p3 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p3 Cyp4p3 "CG10843, 4p3" CDMC20183 1 1 15 DAC23-M12 17-CG1088-RA_2 CG1088 CATGCACCAACGACGATGAAGTTTTGCCAAGTAGCTAAGTTTGTTGACCTGACCATCAAGTGCAGCTTT 69 FBan0001088 FBgn0015324 Vha26 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha26 Vacuolar H[+]-ATPase 26kD E subunit "CG1088, CG1088, vha26, E subunit, BcDNA.GH03683, V-ATPase, BcDNA:GH03683, VhaE, anon-83Bb" CDMC20183 1 2 15 DAC23-M12 17-CG1088-RA_2 CG1088 CATGCACCAACGACGATGAAGTTTTGCCAAGTAGCTAAGTTTGTTGACCTGACCATCAAGTGCAGCTTT 69 FBan0001088 FBgn0015324 Vha26 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha26 Vacuolar H[+]-ATPase 26kD E subunit "CG1088, CG1088, vha26, E subunit, BcDNA.GH03683, V-ATPase, BcDNA:GH03683, VhaE, anon-83Bb" CDMC20184 1 3 15 DAC23-M24 1-CG10904-RA_1 CG10904 TCGAGGAGTCTGGAGGAGATCGAGATTCGGAGAAGGCTTGTCGATGGGAGCACTTCAAGACGTTGATGT 69 FBan0010904 FBgn0034945 CG10904 2 2R CG10904 CG10904 CDMC20184 1 4 15 DAC23-M24 1-CG10904-RA_1 CG10904 TCGAGGAGTCTGGAGGAGATCGAGATTCGGAGAAGGCTTGTCGATGGGAGCACTTCAAGACGTTGATGT 69 FBan0010904 FBgn0034945 CG10904 2 2R CG10904 CG10904 CDMC20185 1 5 15 DAC24-A12 1-CG14926-RA_1 CG14926 GGCTGCACTCAAGTCAAGCGAACACCCAAAACTATTTGCATGGATCCAGTGGAATGGGATCGCACCAGA 69 FBan0014926 FBgn0032360 CG14926 2 2L CG14926 CG14926 bs34f02.y1 CDMC20185 1 6 15 DAC24-A12 1-CG14926-RA_1 CG14926 GGCTGCACTCAAGTCAAGCGAACACCCAAAACTATTTGCATGGATCCAGTGGAATGGGATCGCACCAGA 69 FBan0014926 FBgn0032360 CG14926 2 2L CG14926 CG14926 bs34f02.y1 CDMC20186 1 7 15 DAC24-A24 6-CG14934-RA_3 CG14934 GCCCCCAGTTTCCCTTCAACTTTGACTTCATCACCGAACTGAATGCCAATTCGACAGCTGCGGACTTTG 69 FBan0014934 FBgn0032381 CG14934 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG14934 CG14934 CDMC20186 1 8 15 DAC24-A24 6-CG14934-RA_3 CG14934 GCCCCCAGTTTCCCTTCAACTTTGACTTCATCACCGAACTGAATGCCAATTCGACAGCTGCGGACTTTG 69 FBan0014934 FBgn0032381 CG14934 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG14934 CG14934 CDMC20187 1 9 15 DAC24-E12 10-CG14963-RA_1 CG14963 GCCCAGTTCTGGTCGAGATTACAGGGGTTGCGAGTCATGTATGAACGTTGGCTGACTACAGTGGAAACT 69 FBan0014963 FBgn0035409 CG14963 3 3L CG14963 CG14963 CDMC20187 1 10 15 DAC24-E12 10-CG14963-RA_1 CG14963 GCCCAGTTCTGGTCGAGATTACAGGGGTTGCGAGTCATGTATGAACGTTGGCTGACTACAGTGGAAACT 69 FBan0014963 FBgn0035409 CG14963 3 3L CG14963 CG14963 CDMC20188 1 11 15 DAC24-E24 2-CG14973-RA_2 CG14973 GCGGCAAATCCTGGTGTGAACTCCCCCAAACACTCGGCTAATTCTAGTTCCATAAGCGATGCCATCGAC 69 FBan0014973 FBgn0035451 CG14973 3 3L CG14973 CG14973 CDMC20188 1 12 15 DAC24-E24 2-CG14973-RA_2 CG14973 GCGGCAAATCCTGGTGTGAACTCCCCCAAACACTCGGCTAATTCTAGTTCCATAAGCGATGCCATCGAC 69 FBan0014973 FBgn0035451 CG14973 3 3L CG14973 CG14973 CDMC20189 1 13 15 DAC24-I12 1-CG15000-RA_1 CG15000 CGCGCTACAATCTGTTCGCCATGTACCAAAAGTTTGCCAAGCCGCCATTTGATCTGTCGGAAATTGCCA 69 FBgn0035502 CDMC20189 1 14 15 DAC24-I12 1-CG15000-RA_1 CG15000 CGCGCTACAATCTGTTCGCCATGTACCAAAAGTTTGCCAAGCCGCCATTTGATCTGTCGGAAATTGCCA 69 FBgn0035502 CDMC20190 1 15 15 DAC24-I24 12-CG15010-RC_8 CG15010 ACGGAACGGAGGAAACAAAGCTAATGGTCCTCGACTTTGATGTTGAGGGTGCATGTGTGAAGTGCTCAT 69 FBan0015010 FBgn0041171 ago 3 3L DNA endoreduplication; GO:0042023; cyclin catabolism; GO:0008054; negative regulation of growth; GO:0045926; regulation of exit from mitosis; GO:0007096; regulation of mitosis; GO:0007088; regulation of proteolysis; GO:0030162 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; cyclin binding; GO:0030332; ; GO:0030332 SCF ubiquitin ligase complex; GO:0019005 ago archipelago "CG15010, CG15010, CG15010, CG15010, DmFbw7, cdc4, SCF[Ago], anon-WO0118547.345, archipelago" CDMC20190 1 16 15 DAC24-I24 12-CG15010-RC_8 CG15010 ACGGAACGGAGGAAACAAAGCTAATGGTCCTCGACTTTGATGTTGAGGGTGCATGTGTGAAGTGCTCAT 69 FBan0015010 FBgn0041171 ago 3 3L DNA endoreduplication; GO:0042023; cyclin catabolism; GO:0008054; negative regulation of growth; GO:0045926; regulation of exit from mitosis; GO:0007096; regulation of mitosis; GO:0007088; regulation of proteolysis; GO:0030162 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; cyclin binding; GO:0030332; ; GO:0030332 SCF ubiquitin ligase complex; GO:0019005 ago archipelago "CG15010, CG15010, CG15010, CG15010, DmFbw7, cdc4, SCF[Ago], anon-WO0118547.345, archipelago" CDMC20191 1 17 15 DAC24-M12 14-CG15043-RA_1 CG15043 TGCCGTGACTGGAGACCCTTAGTCCACACACTTCGTTTACCTCGAATTTCAATTCAACGCCCAAGATGT 69 FBan0015043 FBgn0030929 CG15043 X X CG15043 CG15043 BcDNA:RE41194 CDMC20191 1 18 15 DAC24-M12 14-CG15043-RA_1 CG15043 TGCCGTGACTGGAGACCCTTAGTCCACACACTTCGTTTACCTCGAATTTCAATTCAACGCCCAAGATGT 69 FBan0015043 FBgn0030929 CG15043 X X CG15043 CG15043 BcDNA:RE41194 CDMC20192 1 19 15 DAC24-M24 24-CG15064-RA_1 CG15064 CGCCTCTGCAAACCGACTTTATTTTTTTTCCTGTTAATAAATAGTTAAGTAATAAAGATTTTTTTTGAA 69 FBan0015064 FBgn0030900 Him X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Him Him "CG15064, CG15064, CG15064" CDMC20192 1 20 15 DAC24-M24 24-CG15064-RA_1 CG15064 CGCCTCTGCAAACCGACTTTATTTTTTTTCCTGTTAATAAATAGTTAAGTAATAAAGATTTTTTTTGAA 69 FBan0015064 FBgn0030900 Him X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Him Him "CG15064, CG15064, CG15064" CDMC20193 1 21 15 DAC25-A12 18-CG14307-RA_6 CG14307 ACGCTCGAGCGGACGGATAGTCGCGATGATCTATTGCAGCTGGATTATAGCAACAAGGATAACAACAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC20193 1 22 15 DAC25-A12 18-CG14307-RA_6 CG14307 ACGCTCGAGCGGACGGATAGTCGCGATGATCTATTGCAGCTGGATTATAGCAACAAGGATAACAACAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC20194 1 23 15 DAC25-A24 11-CG14316-RA_1 CG14316 GCCCGTTGGCATAACCTTTGCTCGATTCACCAACTGTCCAGATCTCACTGATGAACAGCTCTTGGACTT 69 FBan0014316 FBgn0038567 CG14316 3 3R CG14316 CG14316 CDMC20194 1 24 15 DAC25-A24 11-CG14316-RA_1 CG14316 GCCCGTTGGCATAACCTTTGCTCGATTCACCAACTGTCCAGATCTCACTGATGAACAGCTCTTGGACTT 69 FBan0014316 FBgn0038567 CG14316 3 3R CG14316 CG14316 CDMC20195 1 25 15 DAC25-E12 22-CG14357-RA_4 CG14357 CAATTGCTGAATACGGATAACGTGACCAATTACGGATTGATGAGGACAGGCAGATGCAAGGGAAATGCC 69 FBan0014357 FBgn0038204 CG14357 3 3R CG14357 CG14357 CDMC20195 1 26 15 DAC25-E12 22-CG14357-RA_4 CG14357 CAATTGCTGAATACGGATAACGTGACCAATTACGGATTGATGAGGACAGGCAGATGCAAGGGAAATGCC 69 FBan0014357 FBgn0038204 CG14357 3 3R CG14357 CG14357 CDMC20196 1 1 16 DAC25-E24 23-CG14375-RA_2 CG14375 AGAAATATCCACAACGTACATTAAAAACCGGAAATAAGCCTCAAAAACAAGAGCAACAACATCAAGAGA 69 FBan0014375 FBgn0038147 CG14375 3 3R CG14375 CG14375 BcDNA:RE10132 CDMC20196 1 2 16 DAC25-E24 23-CG14375-RA_2 CG14375 AGAAATATCCACAACGTACATTAAAAACCGGAAATAAGCCTCAAAAACAAGAGCAACAACATCAAGAGA 69 FBan0014375 FBgn0038147 CG14375 3 3R CG14375 CG14375 BcDNA:RE10132 CDMC20197 1 3 16 DAC25-I12 15-CG14423-RA_1 CG14423 TCACCGCCGTCTAAGGATCTAGGATTCAAGGTCAGGATCCAACGATCCGACACATTCCGGCAAGATAAT 69 FBan0014423 FBgn0029646 CG14423 X X CG14423 CG14423 CDMC20197 1 4 16 DAC25-I12 15-CG14423-RA_1 CG14423 TCACCGCCGTCTAAGGATCTAGGATTCAAGGTCAGGATCCAACGATCCGACACATTCCGGCAAGATAAT 69 FBan0014423 FBgn0029646 CG14423 X X CG14423 CG14423 CDMC20198 1 5 16 DAC25-I24 6-CG14434-RA_1 CG14434 ACCTGGACGAGGTAAAGGATCTGGGATACTTCATGGAACTGGAGGTGTGCCTGACAGAGGATCAAACCC 69 FBan0014434 FBgn0029915 CG14434 X X CG14434 CG14434 CDMC20198 1 6 16 DAC25-I24 6-CG14434-RA_1 CG14434 ACCTGGACGAGGTAAAGGATCTGGGATACTTCATGGAACTGGAGGTGTGCCTGACAGAGGATCAAACCC 69 FBan0014434 FBgn0029915 CG14434 X X CG14434 CG14434 CDMC20199 1 7 16 DAC25-M12 3-CG14481-RA_3 CG14481 GGAATCCGTGAGCCAGAATGAAGCCGGACATCTGCAGGTTAAAGGTGTGATTAACCAGCCCTTCGAGGA 69 FBan0014481 FBgn0034260 CG14481 2 2R CG14481 CG14481 CDMC20199 1 8 16 DAC25-M12 3-CG14481-RA_3 CG14481 GGAATCCGTGAGCCAGAATGAAGCCGGACATCTGCAGGTTAAAGGTGTGATTAACCAGCCCTTCGAGGA 69 FBan0014481 FBgn0034260 CG14481 2 2R CG14481 CG14481 CDMC20200 1 9 16 DAC25-M24 1-CG14499-RA_1 CG14499 CCACTGCAAATCTTCAAGACGCAGCTTTGTCTTAACACCACTGCTTTCTTCGAGGCCAAGGTACCCGCT 69 FBan0014499 FBgn0034317 CR14499 2 2R CR14499 CR14499 "CG14499, CG14499, CG14499" CDMC20200 1 10 16 DAC25-M24 1-CG14499-RA_1 CG14499 CCACTGCAAATCTTCAAGACGCAGCTTTGTCTTAACACCACTGCTTTCTTCGAGGCCAAGGTACCCGCT 69 FBan0014499 FBgn0034317 CR14499 2 2R CR14499 CR14499 "CG14499, CG14499, CG14499" CDMC20201 1 11 16 DAC26-A12 11-CG4714-RA_4 CG4714 AGGCGGTAGTCCGTGAACTACTGTACGACCTTTTCGAGGAGACGGCTAGTTTATCGGACATCCACAACA 69 FBan0004714 FBgn0033819 CG4714 2 2R CG4714 CG4714 anon-WO0140519.159 CDMC20201 1 12 16 DAC26-A12 11-CG4714-RA_4 CG4714 AGGCGGTAGTCCGTGAACTACTGTACGACCTTTTCGAGGAGACGGCTAGTTTATCGGACATCCACAACA 69 FBan0004714 FBgn0033819 CG4714 2 2R CG4714 CG4714 anon-WO0140519.159 CDMC20202 1 13 16 DAC26-A24 15-CG4725-RA_1 CG4725 GCGGCCAGAACCAGACTGTCACAATATCGAGTGTCTCTGCCGGATTACCAAAGTTTGGATCTAACCGAT 69 FBan0004725 FBgn0039022 CG4725 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4725 CG4725 CDMC20202 1 14 16 DAC26-A24 15-CG4725-RA_1 CG4725 GCGGCCAGAACCAGACTGTCACAATATCGAGTGTCTCTGCCGGATTACCAAAGTTTGGATCTAACCGAT 69 FBan0004725 FBgn0039022 CG4725 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4725 CG4725 CDMC20203 1 15 16 DAC26-E12 23-CG4753-RA_2 CG4753 TTATAAACTCTGCAACAGTTTTGGAATATACGACCTATGGACTAATAACTCAACTGCACTGACCATAGA 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC20203 1 16 16 DAC26-E12 23-CG4753-RA_2 CG4753 TTATAAACTCTGCAACAGTTTTGGAATATACGACCTATGGACTAATAACTCAACTGCACTGACCATAGA 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC20204 1 17 16 DAC26-E24 14-CG4759-RA_1 CG4759 ACTGACCGAAGTGGATCCTGTGCCTTCTTATTAAGTGTGCAAGTGGGACAAACGTGCCTATGGTGATGA 69 FBan0004759 FBgn0039359 RpL27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL27 Ribosomal protein L27 "CG4759, Ribosomal protein L27" CDMC20204 1 18 16 DAC26-E24 14-CG4759-RA_1 CG4759 ACTGACCGAAGTGGATCCTGTGCCTTCTTATTAAGTGTGCAAGTGGGACAAACGTGCCTATGGTGATGA 69 FBan0004759 FBgn0039359 RpL27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL27 Ribosomal protein L27 "CG4759, Ribosomal protein L27" CDMC20205 1 19 16 DAC26-I12 3-CG4787-RA_1 CG4787 GCCCTCTCTGGCTTCCTCAACGAGGAGATTCTGCAGAAGACCTTTTCGCCGTATGGCACAATACAGGAG 69 FBan0004787 FBgn0039572 CG4787 3 3R apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729 CG4787 CG4787 cg4787 CDMC20205 1 20 16 DAC26-I12 3-CG4787-RA_1 CG4787 GCCCTCTCTGGCTTCCTCAACGAGGAGATTCTGCAGAAGACCTTTTCGCCGTATGGCACAATACAGGAG 69 FBan0004787 FBgn0039572 CG4787 3 3R apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729 CG4787 CG4787 cg4787 CDMC20206 1 21 16 DAC26-I24 22-CG4797-RA_1 CG4797 CCCAATGGGCCACTCCGACAGGGAATCTTCAAATGTTAGGTTACCAATTCAAATTGTGATCGCTATGCT 69 FBan0004797 FBgn0034909 CG4797 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355 integral to membrane; GO:0016021; membrane; GO:0016020 CG4797 CG4797 CDMC20206 1 22 16 DAC26-I24 22-CG4797-RA_1 CG4797 CCCAATGGGCCACTCCGACAGGGAATCTTCAAATGTTAGGTTACCAATTCAAATTGTGATCGCTATGCT 69 FBan0004797 FBgn0034909 CG4797 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355 integral to membrane; GO:0016021; membrane; GO:0016020 CG4797 CG4797 CDMC20207 1 23 16 DAC26-M12 3-CG4836-RC_5 CG4836 GCTTCCAAGCAGTCGAGTTCGATAGCAACGCACTGTTCGGAGAGGTCCTTGAAGCCATCTACAGCAAGT 69 FBan0004836 FBgn0038762 CG4836 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG4836 CG4836 "bs15h04.y1, bs36e10.y1, DM_7300579, anon-WO0140519.105, anon-WO0140519.33" CDMC20207 1 24 16 DAC26-M12 3-CG4836-RC_5 CG4836 GCTTCCAAGCAGTCGAGTTCGATAGCAACGCACTGTTCGGAGAGGTCCTTGAAGCCATCTACAGCAAGT 69 FBan0004836 FBgn0038762 CG4836 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG4836 CG4836 "bs15h04.y1, bs36e10.y1, DM_7300579, anon-WO0140519.105, anon-WO0140519.33" CDMC20208 1 25 16 DAC26-M24 3-CG4847-RC_1 CG4847 AGCCGAACCACTCCATTCTGGTCGTCGGTTACGGATCGGAGAAAGGACAGGATTACTGGATCGTCAAGA 69 FBan0004847 FBgn0034229 CG4847 2 2R proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0004216 ; EC:3.4.22.38; ; GO:0008234 ; EC:3.4.-.- CG4847 CG4847 BEST:GH19547 CDMC20208 1 26 16 DAC26-M24 3-CG4847-RC_1 CG4847 AGCCGAACCACTCCATTCTGGTCGTCGGTTACGGATCGGAGAAAGGACAGGATTACTGGATCGTCAAGA 69 FBan0004847 FBgn0034229 CG4847 2 2R proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0004216 ; EC:3.4.22.38; ; GO:0008234 ; EC:3.4.-.- CG4847 CG4847 BEST:GH19547 CDMC20209 1 1 17 DAC27-A12 18-CG3461-RA_2 CG3461 GCTGCAAGGGCGGATATTAGTAAGCTAACTCTCACCGAAGTTTTGCGCAAGGATATGAAGGTCTTGCAA 69 FBan0003461 FBgn0003116 pn X X eye pigmentation (sensu Endopterygota); GO:0048072 pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.- cytoplasm; GO:0005737 pn prune "CG3461, CG3461, N4, TcD37, transcription unit II, EG:152A3.5, N3, se-like-62, prune" CDMC20209 1 2 17 DAC27-A12 18-CG3461-RA_2 CG3461 GCTGCAAGGGCGGATATTAGTAAGCTAACTCTCACCGAAGTTTTGCGCAAGGATATGAAGGTCTTGCAA 69 FBan0003461 FBgn0003116 pn X X eye pigmentation (sensu Endopterygota); GO:0048072 pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.- cytoplasm; GO:0005737 pn prune "CG3461, CG3461, N4, TcD37, transcription unit II, EG:152A3.5, N3, se-like-62, prune" CDMC20210 1 3 17 DAC27-A24 3-CG3485-RA_3 CG3485 GCCCCCCGAAATGAAAGTGTTGCACCTGATCATCAGCAAGGTGAGACTGACACCGAAATTGGCTTTGGA 69 FBan0003485 FBgn0031511 CG3485 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3485 CG3485 CDMC20210 1 4 17 DAC27-A24 3-CG3485-RA_3 CG3485 GCCCCCCGAAATGAAAGTGTTGCACCTGATCATCAGCAAGGTGAGACTGACACCGAAATTGGCTTTGGA 69 FBan0003485 FBgn0031511 CG3485 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3485 CG3485 CDMC20211 1 5 17 DAC27-E12 11-CG3525-RC_1 CG3525 TCGTGCCAGCCTTAGTGTATGTACAGTGCTCACTCGAAACAGTGGACTATTGAGAACCAAGGGTGTGCA 69 FBan0003525 FBgn0000536 eas X X associative learning; GO:0008306; brain development; GO:0007420; habituation; GO:0046959; long-term memory; GO:0007616; mechanosensory behavior; GO:0007638; mushroom body development; GO:0016319; neuroblast division; GO:0045034; phosphatidylethanolamine biosynthesis; GO:0006646; phosphorylation; GO:0016310; response to mechanical stimulus; GO:0009612 choline kinase activity; GO:0004103 ; EC:2.7.1.32; ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82 eas easily shocked "CG3525, CG3525, CG3525, CG3525, EtnK, Ethanolamine kinase, ala, alpha lobes absent, alpha-lobe absent, EP770, PC80, RH11, easily shocked" CDMC20211 1 6 17 DAC27-E12 11-CG3525-RC_1 CG3525 TCGTGCCAGCCTTAGTGTATGTACAGTGCTCACTCGAAACAGTGGACTATTGAGAACCAAGGGTGTGCA 69 FBan0003525 FBgn0000536 eas X X associative learning; GO:0008306; brain development; GO:0007420; habituation; GO:0046959; long-term memory; GO:0007616; mechanosensory behavior; GO:0007638; mushroom body development; GO:0016319; neuroblast division; GO:0045034; phosphatidylethanolamine biosynthesis; GO:0006646; phosphorylation; GO:0016310; response to mechanical stimulus; GO:0009612 choline kinase activity; GO:0004103 ; EC:2.7.1.32; ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82 eas easily shocked "CG3525, CG3525, CG3525, CG3525, EtnK, Ethanolamine kinase, ala, alpha lobes absent, alpha-lobe absent, EP770, PC80, RH11, easily shocked" CDMC20212 1 7 17 DAC27-E24 2-CG3534-RA_1 CG3534 TGGCTGAAGACCTTGGCTACAAATTCGGACCCGAGACACAAATCCTTGTCACAGGAGGCGCATCTGTTA 69 FBan0003534 FBgn0038463 CG3534 3 3R carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3534 CG3534 CDMC20212 1 8 17 DAC27-E24 2-CG3534-RA_1 CG3534 TGGCTGAAGACCTTGGCTACAAATTCGGACCCGAGACACAAATCCTTGTCACAGGAGGCGCATCTGTTA 69 FBan0003534 FBgn0038463 CG3534 3 3R carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3534 CG3534 CDMC20213 1 9 17 DAC27-I12 3-CG3582-RA_4 CG3582 GCTCTCGCATCCACAACAAACCCACTTTCTCGCAGACGGTGCTTCTCCAAAATCTATACGTGAACCCCC 69 FBan0003582 FBgn0017457 U2af38 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af38 U2 small nuclear riboprotein auxiliary factor 38 "CG3582, CG3582, dU2AF[38], U2AF, dU2AF38, DU2AF38, U2AF38, l(2)06751" CDMC20213 1 10 17 DAC27-I12 3-CG3582-RA_4 CG3582 GCTCTCGCATCCACAACAAACCCACTTTCTCGCAGACGGTGCTTCTCCAAAATCTATACGTGAACCCCC 69 FBan0003582 FBgn0017457 U2af38 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af38 U2 small nuclear riboprotein auxiliary factor 38 "CG3582, CG3582, dU2AF[38], U2AF, dU2AF38, DU2AF38, U2AF38, l(2)06751" CDMC20214 1 11 17 DAC27-I24 23-CG3590-RA_5 CG3590 CAATGTCTCGCTGTTGCTAAATGGATTATCACATTTAATTGACTGCATTCAGATCAGATCAGATTGCAA 69 FBan0003590 FBgn0038467 CG3590 3 3R purine base metabolism; GO:0006144; purine ribonucleotide biosynthesis; GO:0009152 adenylosuccinate lyase activity; GO:0004018 ; EC:4.3.2.2; ; GO:0004018 ; EC:4.3.2.2 CG3590 CG3590 CDMC20214 1 12 17 DAC27-I24 23-CG3590-RA_5 CG3590 CAATGTCTCGCTGTTGCTAAATGGATTATCACATTTAATTGACTGCATTCAGATCAGATCAGATTGCAA 69 FBan0003590 FBgn0038467 CG3590 3 3R purine base metabolism; GO:0006144; purine ribonucleotide biosynthesis; GO:0009152 adenylosuccinate lyase activity; GO:0004018 ; EC:4.3.2.2; ; GO:0004018 ; EC:4.3.2.2 CG3590 CG3590 CDMC20215 1 13 17 DAC27-M12 15-CG3631-RA_1 CG3631 ACATCGAGGGCGACAAAATGTTCAAAACTCTGTAGTTTCAGCTCAAGATTGGGGCTAATGGCCAGCACT 69 FBan0003631 FBgn0038268 CG3631 3 3R CG3631 CG3631 CDMC20215 1 14 17 DAC27-M12 15-CG3631-RA_1 CG3631 ACATCGAGGGCGACAAAATGTTCAAAACTCTGTAGTTTCAGCTCAAGATTGGGGCTAATGGCCAGCACT 69 FBan0003631 FBgn0038268 CG3631 3 3R CG3631 CG3631 CDMC20216 1 15 17 DAC27-M24 12-CG3644-RB_1 CG3644 TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC20216 1 16 17 DAC27-M24 12-CG3644-RB_1 CG3644 TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC20217 1 17 17 DAC28-A12 9-CG14731-RA_1 CG14731 TGGCCATTTTGATGCCACGGTCCTTTCCAAAAATGAAACCTCGCTGCAAGGACCTATCACAAGGACTGA 69 FBan0014731 FBgn0037964 CG14731 3 3R CG14731 CG14731 CDMC20217 1 18 17 DAC28-A12 9-CG14731-RA_1 CG14731 TGGCCATTTTGATGCCACGGTCCTTTCCAAAAATGAAACCTCGCTGCAAGGACCTATCACAAGGACTGA 69 FBan0014731 FBgn0037964 CG14731 3 3R CG14731 CG14731 CDMC20218 1 19 17 DAC28-A24 3-CG14749-RA_4 CG14749 TCCGCTGGCCCGAGACTATTGCATGCTACTTATGGCCAAGAAGTTTGTCAGTCAAACGGAGACTGCCAT 69 FBan0014749 FBgn0033316 CG14749 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 CG14749 CG14749 CDMC20218 1 20 17 DAC28-A24 3-CG14749-RA_4 CG14749 TCCGCTGGCCCGAGACTATTGCATGCTACTTATGGCCAAGAAGTTTGTCAGTCAAACGGAGACTGCCAT 69 FBan0014749 FBgn0033316 CG14749 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 CG14749 CG14749 CDMC20219 1 21 17 DAC28-E12 8-CG14801-RB_1 CG14801 GCCCGTGTGCGACATAATAGACTACAACACCCAGTATTCGGGCATTACGGAAACGGATCTGTGTTCCGG 69 FBan0014801 FBgn0024988 CG14801 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; exonuclease activity; GO:0004527; ; GO:0003676; exoribonuclease activity; GO:0004532; ; GO:0004527; ; GO:0004532 intracellular; GO:0005622 CG14801 CG14801 "CG17968, CG14800, CG17968, CG14800, CG17968, CG14800, EG:137E7.1, EG:131F2.2" CDMC20219 1 22 17 DAC28-E12 8-CG14801-RB_1 CG14801 GCCCGTGTGCGACATAATAGACTACAACACCCAGTATTCGGGCATTACGGAAACGGATCTGTGTTCCGG 69 FBan0014801 FBgn0024988 CG14801 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; exonuclease activity; GO:0004527; ; GO:0003676; exoribonuclease activity; GO:0004532; ; GO:0004527; ; GO:0004532 intracellular; GO:0005622 CG14801 CG14801 "CG17968, CG14800, CG17968, CG14800, CG17968, CG14800, EG:137E7.1, EG:131F2.2" CDMC20220 1 23 17 DAC28-E24 23-CG14812-RA_15 CG14812 GCCTGTTACATTTGTCGCTCATTCTAACCGATAGCCATTACCATAAGCATTGTTTTGTACGACTCGCAT 69 FBan0014812 FBgn0026090 CG14812 X X CG14812 CG14812 "EG:131F2.3, BcDNA:RE59545" CDMC20220 1 24 17 DAC28-E24 23-CG14812-RA_15 CG14812 GCCTGTTACATTTGTCGCTCATTCTAACCGATAGCCATTACCATAAGCATTGTTTTGTACGACTCGCAT 69 FBan0014812 FBgn0026090 CG14812 X X CG14812 CG14812 "EG:131F2.3, BcDNA:RE59545" CDMC20221 1 25 17 DAC28-I12 3-CG14843-RA_1 CG14843 GCCCACGAGACACAATTAACGCTATCGCACCCGGCTAATCCACATTTGGTCACCGATACGGACAACCTA 69 FBan0014843 FBgn0038230 CG14843 3 3R CG14843 CG14843 CDMC20221 1 26 17 DAC28-I12 3-CG14843-RA_1 CG14843 GCCCACGAGACACAATTAACGCTATCGCACCCGGCTAATCCACATTTGGTCACCGATACGGACAACCTA 69 FBan0014843 FBgn0038230 CG14843 3 3R CG14843 CG14843 CDMC20222 1 1 18 DAC28-I24 1-CG14864-RA_2 CG14864 CGCCTCCAGAGATTTGCGTTCAAGAGTCCGATCTGACCGAAAATGATGAGCGAGCTGTGTTCCCGGAAA 69 FBan0014864 FBgn0038311 CG14864 3 3R CG14864 CG14864 BcDNA:AT13896 CDMC20222 1 2 18 DAC28-I24 1-CG14864-RA_2 CG14864 CGCCTCCAGAGATTTGCGTTCAAGAGTCCGATCTGACCGAAAATGATGAGCGAGCTGTGTTCCCGGAAA 69 FBan0014864 FBgn0038311 CG14864 3 3R CG14864 CG14864 BcDNA:AT13896 CDMC20223 1 3 18 DAC28-M12 24-CG1488-RA_1 CG1488 AGCGAAACCATTTTAATATTAAGCCATACCAAAATTATAAATATTTCATTTTGACGTCCTTACTTTGCG 69 FBan0001488 FBgn0030367 Cyp311a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp311a1 Cyp311a1 "CG1488, 311a1" CDMC20223 1 4 18 DAC28-M12 24-CG1488-RA_1 CG1488 AGCGAAACCATTTTAATATTAAGCCATACCAAAATTATAAATATTTCATTTTGACGTCCTTACTTTGCG 69 FBan0001488 FBgn0030367 Cyp311a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp311a1 Cyp311a1 "CG1488, 311a1" CDMC20224 1 5 18 DAC28-M24 23-CG1489-RA_4 CG1489 GCAAATGCAGAGTCATACAATAAAGAGGAATTAATTCGACATCTTGCATTGTGGTCCTTCAGTTCGACA 69 FBan0001489 FBgn0020369 Pros45 X X ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros45 Pros45 "CG1489, DUG, pros45, p42C, Dm_Rpt6a, dRpt6, Dug, Ug, sug-1, sug1" CDMC20224 1 6 18 DAC28-M24 23-CG1489-RA_4 CG1489 GCAAATGCAGAGTCATACAATAAAGAGGAATTAATTCGACATCTTGCATTGTGGTCCTTCAGTTCGACA 69 FBan0001489 FBgn0020369 Pros45 X X ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros45 Pros45 "CG1489, DUG, pros45, p42C, Dm_Rpt6a, dRpt6, Dug, Ug, sug-1, sug1" CDMC20225 1 7 18 DAC29-A12 15-CG6382-RA_1 CG6382 CCGGTTTTGTTCTCTGCGATGCAGCCAATCCCATCAAGACGGGAAAAATCTTTGATGCTCAGGTCGTAA 69 FBan0006382 FBgn0020443 Elf 2 2L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; ; GO:0005525; translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003747; ; GO:0008079 cytosol; GO:0005829 Elf Ef1alpha-like factor "CG6382, CG6382, delf, dsup35, Dsup35, eRF3, DSUP35, eukaryotic release factor 3, Ef1alpha-like factor" CDMC20225 1 8 18 DAC29-A12 15-CG6382-RA_1 CG6382 CCGGTTTTGTTCTCTGCGATGCAGCCAATCCCATCAAGACGGGAAAAATCTTTGATGCTCAGGTCGTAA 69 FBan0006382 FBgn0020443 Elf 2 2L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; ; GO:0005525; translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003747; ; GO:0008079 cytosol; GO:0005829 Elf Ef1alpha-like factor "CG6382, CG6382, delf, dsup35, Dsup35, eRF3, DSUP35, eukaryotic release factor 3, Ef1alpha-like factor" CDMC20226 1 9 18 DAC29-A24 13-CG6393-RC_1 CG6393 CCGACAGGCACGCAAAATATGCAAATACCAGGAGTGCATCTCTATTGACCGGTCAAATACTCGGCTTGG 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC20226 1 10 18 DAC29-A24 13-CG6393-RC_1 CG6393 CCGACAGGCACGCAAAATATGCAAATACCAGGAGTGCATCTCTATTGACCGGTCAAATACTCGGCTTGG 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC20227 1 11 18 DAC29-E12 17-CG6428-RA_1 CG6428 CCGAACCATACATACCTCGTTCCTTGTTCCTGCAGCATGAAGAAAAAAACAAACACTGGAGGCTAGGGT 69 FBan0006428 FBgn0029689 CG6428 X X amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG6428 CG6428 CDMC20227 1 12 18 DAC29-E12 17-CG6428-RA_1 CG6428 CCGAACCATACATACCTCGTTCCTTGTTCCTGCAGCATGAAGAAAAAAACAAACACTGGAGGCTAGGGT 69 FBan0006428 FBgn0029689 CG6428 X X amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG6428 CG6428 CDMC20228 1 13 18 DAC29-E24 16-CG6445-RB_2 CG6445 TCGAACTGGGGAACTGAGAACTGGAGGTTCATTCGCGGATTATGTAGATGGTTACTTCTTAATGCGGGT 69 FBan0006445 FBgn0036715 Cad74A 3 3L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad74A Cad74A "CG6445, CG6445, CG6445, CT20086, Cad74B, DCad74B" CDMC20228 1 14 18 DAC29-E24 16-CG6445-RB_2 CG6445 TCGAACTGGGGAACTGAGAACTGGAGGTTCATTCGCGGATTATGTAGATGGTTACTTCTTAATGCGGGT 69 FBan0006445 FBgn0036715 Cad74A 3 3L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad74A Cad74A "CG6445, CG6445, CG6445, CT20086, Cad74B, DCad74B" CDMC20229 1 15 18 DAC29-I12 23-CG6478-RA_1 CG6478 GTCTGCGTTTCTAGGAAGGCTACATCTTGGACTCCATTAACTTAAGCAAATCTCGACTGAAGAACTCAT 69 FBan0006478 FBgn0039436 CG6478 3 3R CG6478 CG6478 CDMC20229 1 16 18 DAC29-I12 23-CG6478-RA_1 CG6478 GTCTGCGTTTCTAGGAAGGCTACATCTTGGACTCCATTAACTTAAGCAAATCTCGACTGAAGAACTCAT 69 FBan0006478 FBgn0039436 CG6478 3 3R CG6478 CG6478 CDMC20230 1 17 18 DAC29-I24 6-CG6486-RA_2 CG6486 GCAGCTGGGATTGTACACTGAAATTGTGGGACTGCAACAGACAGAACTCCATCACCACATTTGTGGGCC 69 FBan0006486 FBgn0035922 CG6486 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 peroxisome; GO:0005777 CG6486 CG6486 CDMC20230 1 18 18 DAC29-I24 6-CG6486-RA_2 CG6486 GCAGCTGGGATTGTACACTGAAATTGTGGGACTGCAACAGACAGAACTCCATCACCACATTTGTGGGCC 69 FBan0006486 FBgn0035922 CG6486 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 peroxisome; GO:0005777 CG6486 CG6486 CDMC20231 1 19 18 DAC29-M12 18-CG6523-RA_12 CG6523 GGCCAAGATTACTGGCGAAAAACTGCAGTTCATCAGCCTAAACGCTGAACAATTTCCCGAGATTTCCAT 69 FBan0006523 FBgn0032509 CG6523 2 2L electron transport; GO:0006118; regulation of signal transduction; GO:0009966; response to biotic stimulus; GO:0009607; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG6523 CG6523 CDMC20231 1 20 18 DAC29-M12 18-CG6523-RA_12 CG6523 GGCCAAGATTACTGGCGAAAAACTGCAGTTCATCAGCCTAAACGCTGAACAATTTCCCGAGATTTCCAT 69 FBan0006523 FBgn0032509 CG6523 2 2L electron transport; GO:0006118; regulation of signal transduction; GO:0009966; response to biotic stimulus; GO:0009607; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG6523 CG6523 CDMC20232 1 21 18 DAC29-M24 14-CG6539-RA_1 CG6539 ACGCTCAATCATTGTGGTTGCAGACTTTCAACATGCAGTACCAATTCATTGCATCCCATGTGGCCAAGA 69 FBan0006539 FBgn0011802 Dhh1 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dhh1 DEAD/DEAH RNA helicase 1 "CG6539, l(3)rL562, BcDNA.LD05563, DmRH22, DHH1, BcDNA:LD05563, DEAD/DEAH RNA helicase 1" CDMC20232 1 22 18 DAC29-M24 14-CG6539-RA_1 CG6539 ACGCTCAATCATTGTGGTTGCAGACTTTCAACATGCAGTACCAATTCATTGCATCCCATGTGGCCAAGA 69 FBan0006539 FBgn0011802 Dhh1 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dhh1 DEAD/DEAH RNA helicase 1 "CG6539, l(3)rL562, BcDNA.LD05563, DmRH22, DHH1, BcDNA:LD05563, DEAD/DEAH RNA helicase 1" CDMC20233 1 23 18 DAC30-A12 15-CG3770-RA_5 CG3770 GTGCGTGCCCAGACAAAGTAAGAGCGCTTAGAGTCTATTATCTATCCGGCAAGTGCTGACGCGTTGC 67 FBan0003770 FBgn0035085 CG3770 2 2R establishment and/or maintenance of cell polarity; GO:0007163 CG3770 CG3770 CT12588 CDMC20233 1 24 18 DAC30-A12 15-CG3770-RA_5 CG3770 GTGCGTGCCCAGACAAAGTAAGAGCGCTTAGAGTCTATTATCTATCCGGCAAGTGCTGACGCGTTGC 67 FBan0003770 FBgn0035085 CG3770 2 2R establishment and/or maintenance of cell polarity; GO:0007163 CG3770 CG3770 CT12588 CDMC20234 1 25 18 DAC30-A24 23-CG3931-RA_1 CG3931 TCTACCGTCAAATGAAAAATTAACATTTCAATGGGTTCGAAATTGGTGGATTTCAAAATTGCATCAG 67 FBan0003931 FBgn0034879 Rrp4 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp4 Rrp4 "CG3931, CG3931, CG3931, dRrp4, RRP4" CDMC20234 1 26 18 DAC30-A24 23-CG3931-RA_1 CG3931 TCTACCGTCAAATGAAAAATTAACATTTCAATGGGTTCGAAATTGGTGGATTTCAAAATTGCATCAG 67 FBan0003931 FBgn0034879 Rrp4 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp4 Rrp4 "CG3931, CG3931, CG3931, dRrp4, RRP4" CDMC20235 1 1 19 DAC30-E12 1-CG41117-RA_1 CG41117 AACCGTCAGAACAACCCCATCGTATGCTTCAGTGACCTCTTCGAACCGATTTGTGTTGCGTCCAGCG 67 FBgn0069934 CG41117 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41117 CG41117 CDMC20235 1 2 19 DAC30-E12 1-CG41117-RA_1 CG41117 AACCGTCAGAACAACCCCATCGTATGCTTCAGTGACCTCTTCGAACCGATTTGTGTTGCGTCCAGCG 67 FBgn0069934 CG41117 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41117 CG41117 CDMC20236 1 3 19 DAC30-E24 3-CG4165-RA_2 CG4165 CGTGCCTCAATAATTTCACCGCTGTCGAGCTGATGACGGGACAGAACAAGGTGGGATGCGATAGCTG 67 FBan0004165 FBgn0029763 CG4165 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG4165 CG4165 CDMC20236 1 4 19 DAC30-E24 3-CG4165-RA_2 CG4165 CGTGCCTCAATAATTTCACCGCTGTCGAGCTGATGACGGGACAGAACAAGGTGGGATGCGATAGCTG 67 FBan0004165 FBgn0029763 CG4165 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG4165 CG4165 CDMC20237 1 5 19 DAC30-I12 2-CG4658-RA_1 CG4658 CGGCGACAAATCATCACGCGAAGTGCAATTGGACATCAAGAAGTGGCAAATCAAGGAGGCCGAACGG 67 FBan0004658 FBgn0032170 CG4658 2 2L CG4658 CG4658 CDMC20237 1 6 19 DAC30-I12 2-CG4658-RA_1 CG4658 CGGCGACAAATCATCACGCGAAGTGCAATTGGACATCAAGAAGTGGCAAATCAAGGAGGCCGAACGG 67 FBan0004658 FBgn0032170 CG4658 2 2L CG4658 CG4658 CDMC20238 1 7 19 DAC30-I24 3-CG4872-RA_4 CG4872 GCCCTCCACATCCTTTGCCTTTCAACCGAAGAGGACTTTTATTCCATGCGGCAAGGAACCTGGCAAG 67 FBan0004872 FBgn0030799 CG4872 X X CG4872 CG4872 CDMC20238 1 8 19 DAC30-I24 3-CG4872-RA_4 CG4872 GCCCTCCACATCCTTTGCCTTTCAACCGAAGAGGACTTTTATTCCATGCGGCAAGGAACCTGGCAAG 67 FBan0004872 FBgn0030799 CG4872 X X CG4872 CG4872 CDMC20239 1 9 19 DAC30-M12 3-CG5254-RA_1 CG5254 CGGATTCCTGGAGGTCTGCATCATGCAACCACTCGATGTAGTCAAAACTCGCATCCAGATCCAGGCC 67 FBan0005254 FBgn0040383 CG5254 X X autophagic cell death; GO:0048102; lipid metabolism; GO:0006629; lipid transport; GO:0006869; salivary gland cell autophagic cell death; GO:0035071 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; tricarboxylate carrier activity; GO:0005371; ; GO:0005371; ; GO:0005371 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5254 CG5254 "EG:BACR19J1.2, CT16777" CDMC20239 1 10 19 DAC30-M12 3-CG5254-RA_1 CG5254 CGGATTCCTGGAGGTCTGCATCATGCAACCACTCGATGTAGTCAAAACTCGCATCCAGATCCAGGCC 67 FBan0005254 FBgn0040383 CG5254 X X autophagic cell death; GO:0048102; lipid metabolism; GO:0006629; lipid transport; GO:0006869; salivary gland cell autophagic cell death; GO:0035071 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; tricarboxylate carrier activity; GO:0005371; ; GO:0005371; ; GO:0005371 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5254 CG5254 "EG:BACR19J1.2, CT16777" CDMC20240 1 11 19 DAC30-M24 5-CG5388-RA_1 CG5388 TCCTGCAGGTCAATCACTCGGTGGTAATGGTGCTGAGCTACCGGTTTGATTCCTATATGGCGATGGC 67 FBan0005388 FBgn0038944 CG5388 3 3R CG5388 CG5388 CDMC20240 1 12 19 DAC30-M24 5-CG5388-RA_1 CG5388 TCCTGCAGGTCAATCACTCGGTGGTAATGGTGCTGAGCTACCGGTTTGATTCCTATATGGCGATGGC 67 FBan0005388 FBgn0038944 CG5388 3 3R CG5388 CG5388 CDMC20241 1 13 19 DAC31-A12 15-CG7466-RA_1 CG7466 GTGGTGGCTAGCATTTGCTCAATTAGTTCTTTAGCTCTCTACTGCGCACTCTTACGCACCGGTGTACCT 69 FBan0007466 FBgn0031981 CG7466 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; defense response; GO:0006952; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 membrane; GO:0016020 CG7466 CG7466 CDMC20241 1 14 19 DAC31-A12 15-CG7466-RA_1 CG7466 GTGGTGGCTAGCATTTGCTCAATTAGTTCTTTAGCTCTCTACTGCGCACTCTTACGCACCGGTGTACCT 69 FBan0007466 FBgn0031981 CG7466 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; defense response; GO:0006952; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 membrane; GO:0016020 CG7466 CG7466 CDMC20242 1 15 19 DAC31-A24 8-CG7485-RA_1 CG7485 TGGTCGTGTATGCGTTCAGCGGAGATCTCAGTCTATGTACAGTTGGACCCCCAGTTGATGAACTTCCGA 69 FBan0007485 FBgn0004514 TyrR 3 3L muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; octopamine/tyramine signaling pathway; GO:0007211; sensory perception of smell; GO:0007608 amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; tyramine receptor activity; GO:0008226; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0008227; ; GO:0004989; ; GO:0008226; ; GO:0008227 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 TyrR Tyramine receptor "CG7485, l(3)neo30, Tyr-dro: Tyramine-receptor, Tyramine receptor, OA-R, OctoR1, Octopamine receptor 1, OctyR99AB, TYR, honoka, Ocr: Octopamine receptor, hono, Dmoct/tyr, OcR, DmTyrR, TyR: Tyramine-receptor, Octopamine receptor, Tyramine-receptor, Ocr, Tyr-dro" CDMC20242 1 16 19 DAC31-A24 8-CG7485-RA_1 CG7485 TGGTCGTGTATGCGTTCAGCGGAGATCTCAGTCTATGTACAGTTGGACCCCCAGTTGATGAACTTCCGA 69 FBan0007485 FBgn0004514 TyrR 3 3L muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; octopamine/tyramine signaling pathway; GO:0007211; sensory perception of smell; GO:0007608 amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; tyramine receptor activity; GO:0008226; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0008227; ; GO:0004989; ; GO:0008226; ; GO:0008227 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 TyrR Tyramine receptor "CG7485, l(3)neo30, Tyr-dro: Tyramine-receptor, Tyramine receptor, OA-R, OctoR1, Octopamine receptor 1, OctyR99AB, TYR, honoka, Ocr: Octopamine receptor, hono, Dmoct/tyr, OcR, DmTyrR, TyR: Tyramine-receptor, Octopamine receptor, Tyramine-receptor, Ocr, Tyr-dro" CDMC20243 1 17 19 DAC31-E12 23-CG7525-RA_6 CG7525 GTTGAGACAACAAAATACGTTCTAGGCCTTACGATTAATGAATGGCGCTACCTATGCTTAGTTTAAAGT 69 FBan0007525 FBgn0014073 Tie 3 3L JAK-STAT cascade; GO:0007259; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Tie Tie-like receptor tyrosine kinase "CG7525, CG7525, DPR1, tie, tyrosine kinase, RTK" CDMC20243 1 18 19 DAC31-E12 23-CG7525-RA_6 CG7525 GTTGAGACAACAAAATACGTTCTAGGCCTTACGATTAATGAATGGCGCTACCTATGCTTAGTTTAAAGT 69 FBan0007525 FBgn0014073 Tie 3 3L JAK-STAT cascade; GO:0007259; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Tie Tie-like receptor tyrosine kinase "CG7525, CG7525, DPR1, tie, tyrosine kinase, RTK" CDMC20244 1 19 19 DAC31-E24 23-CG7533-RC_6 CG7533 AACCCCCGGATGGAAGTATAGAGTATTATCCCAATTTGTATGTATGGATGTGTGTACACCATCACCTTG 69 FBan0007533 FBgn0036165 chrb 3 3L negative regulation of growth; GO:0045926 chrb charybde "CG7533, clone 2.51, EP(3)1035, charybdis, char, BcDNA:GH09771, anon-EST:Liang-2.51, charybde" CDMC20244 1 20 19 DAC31-E24 23-CG7533-RC_6 CG7533 AACCCCCGGATGGAAGTATAGAGTATTATCCCAATTTGTATGTATGGATGTGTGTACACCATCACCTTG 69 FBan0007533 FBgn0036165 chrb 3 3L negative regulation of growth; GO:0045926 chrb charybde "CG7533, clone 2.51, EP(3)1035, charybdis, char, BcDNA:GH09771, anon-EST:Liang-2.51, charybde" CDMC20245 1 21 19 DAC31-I12 23-CG7571-RA_13 CG7571 TCCAAATCCCAGCACCATATTCTACATGAAGCCCATGGATTGCGATTTGAATCCTTGTAAATCTCAACG 69 FBan0007571 FBgn0036732 Oatp74D 3 3L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 membrane; GO:0016020 Oatp74D Organic anion transporting polypeptide 74D "CG7571, CG7571, oatp 74D, Organic anion transporting polypeptide 74D" CDMC20245 1 22 19 DAC31-I12 23-CG7571-RA_13 CG7571 TCCAAATCCCAGCACCATATTCTACATGAAGCCCATGGATTGCGATTTGAATCCTTGTAAATCTCAACG 69 FBan0007571 FBgn0036732 Oatp74D 3 3L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 membrane; GO:0016020 Oatp74D Organic anion transporting polypeptide 74D "CG7571, CG7571, oatp 74D, Organic anion transporting polypeptide 74D" CDMC20246 1 23 19 DAC31-I24 2-CG7579-RA_3 CG7579 GGCTTTCGATTGGCAGTTGGATCACATTTTTCTGCCCCTGGATCAGCACTCGTGGAATAGCCTTCCCAA 69 FBan0007579 FBgn0036528 CG7579 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7579 CG7579 CDMC20246 1 24 19 DAC31-I24 2-CG7579-RA_3 CG7579 GGCTTTCGATTGGCAGTTGGATCACATTTTTCTGCCCCTGGATCAGCACTCGTGGAATAGCCTTCCCAA 69 FBan0007579 FBgn0036528 CG7579 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7579 CG7579 CDMC20247 1 25 19 DAC31-M12 2-CG7611-RA_1 CG7611 ACGGGCAGCAAAGACTCCACTGTGATTATCTGGGATGTTGATCCGTACAAGCTGACCCTTAAGCACCGT 69 FBan0007611 FBgn0037094 CG7611 3 3L CG7611 CG7611 CDMC20247 1 26 19 DAC31-M12 2-CG7611-RA_1 CG7611 ACGGGCAGCAAAGACTCCACTGTGATTATCTGGGATGTTGATCCGTACAAGCTGACCCTTAAGCACCGT 69 FBan0007611 FBgn0037094 CG7611 3 3L CG7611 CG7611 CDMC20248 1 1 20 DAC31-M24 23-CG7622-RC_1 CG7622 TGTTATTCCGCGAAAATAAGTCTGAATTGTAGTGCAATCACTTGCGAAGTGTGTTAAATCAAGCGCTGA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC20248 1 2 20 DAC31-M24 23-CG7622-RC_1 CG7622 TGTTATTCCGCGAAAATAAGTCTGAATTGTAGTGCAATCACTTGCGAAGTGTGTTAAATCAAGCGCTGA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC20249 1 3 20 DAC32-A12 2-CG14744-RA_4 CG14744 TCTTGGGAAGAGCAGGATGACATTGGGATTAAGGACACCACAAAGTACCGTCGGTCCAGAGACACGGG 68 FBan0014744 FBgn0033324 CG14744 2 2R integral to membrane; GO:0016021 CG14744 CG14744 CDMC20249 1 4 20 DAC32-A12 2-CG14744-RA_4 CG14744 TCTTGGGAAGAGCAGGATGACATTGGGATTAAGGACACCACAAAGTACCGTCGGTCCAGAGACACGGG 68 FBan0014744 FBgn0033324 CG14744 2 2R integral to membrane; GO:0016021 CG14744 CG14744 CDMC20250 1 5 20 DAC32-A24 14-CG14856-RA_1 CG14856 AGTGTGGGCTTGAACTTGACAATGTGTGTTTTTTACGGCCTGGGAATGATATGTGCATCTTGGCAGGG 68 FBan0014856 FBgn0038261 CG14856 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14856 CG14856 CDMC20250 1 6 20 DAC32-A24 14-CG14856-RA_1 CG14856 AGTGTGGGCTTGAACTTGACAATGTGTGTTTTTTACGGCCTGGGAATGATATGTGCATCTTGGCAGGG 68 FBan0014856 FBgn0038261 CG14856 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14856 CG14856 CDMC20251 1 7 20 DAC32-E12 23-CG15312-RB_1 CG15312 ACATAGATATAGAAATGAGAGAGAGCTTATCGATCGATCGAATGTTTCGTTTTCATTTCGGTTTCCTG 68 FBan0015312 FBgn0030174 CG15312 X X CG15312 CG15312 CT35293 CDMC20251 1 8 20 DAC32-E12 23-CG15312-RB_1 CG15312 ACATAGATATAGAAATGAGAGAGAGCTTATCGATCGATCGAATGTTTCGTTTTCATTTCGGTTTCCTG 68 FBan0015312 FBgn0030174 CG15312 X X CG15312 CG15312 CT35293 CDMC20252 1 9 20 DAC32-E24 1-CG15357-RA_1 CG15357 CCCAGGGCTGGACACTCTACCTCATCGCCGCCTGCTTCGCATTACTCCTGCTCATGATCATCTATATG 68 FBan0015357 FBgn0040719 CG15357 2 2L CG15357 CG15357 CDMC20252 1 10 20 DAC32-E24 1-CG15357-RA_1 CG15357 CCCAGGGCTGGACACTCTACCTCATCGCCGCCTGCTTCGCATTACTCCTGCTCATGATCATCTATATG 68 FBan0015357 FBgn0040719 CG15357 2 2L CG15357 CG15357 CDMC20253 1 11 20 DAC32-I12 24-CG1577-RA_3 CG1577 TCAGCTGTTTGGTTATGTGAACTACGTTTTTTCACAACTACTTTTTAGTTTTCGATAAATAATGCTGA 68 FBan0001577 FBgn0033208 mRpL52 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL52 mitochondrial ribosomal protein L52 "CG1577, MRP-L52, BcDNA:RH01479, mitochondrial ribosomal protein L52" CDMC20253 1 12 20 DAC32-I12 24-CG1577-RA_3 CG1577 TCAGCTGTTTGGTTATGTGAACTACGTTTTTTCACAACTACTTTTTAGTTTTCGATAAATAATGCTGA 68 FBan0001577 FBgn0033208 mRpL52 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL52 mitochondrial ribosomal protein L52 "CG1577, MRP-L52, BcDNA:RH01479, mitochondrial ribosomal protein L52" CDMC20254 1 13 20 DAC32-I24 14-CG1663-RA_1 CG1663 CCGGCAATTTCGAGAGAATAGCACCTTGAAGAGTCACATCCGGAAAATTCACGACGGTAACAGTGCGC 68 FBan0001663 FBgn0033449 CG1663 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1663 CG1663 CDMC20254 1 14 20 DAC32-I24 14-CG1663-RA_1 CG1663 CCGGCAATTTCGAGAGAATAGCACCTTGAAGAGTCACATCCGGAAAATTCACGACGGTAACAGTGCGC 68 FBan0001663 FBgn0033449 CG1663 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1663 CG1663 CDMC20255 1 15 20 DAC32-M12 2-CG17075-RA_1 CG17075 GCCACGTCATCTGAGACCAGCGACTTATCTGCAGTACACCGAGCAATGTACTCTCTGCACATTCCGCC 68 FBan0017075 FBgn0031239 CG17075 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17075 CG17075 CDMC20255 1 16 20 DAC32-M12 2-CG17075-RA_1 CG17075 GCCACGTCATCTGAGACCAGCGACTTATCTGCAGTACACCGAGCAATGTACTCTCTGCACATTCCGCC 68 FBan0017075 FBgn0031239 CG17075 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17075 CG17075 CDMC20256 1 17 20 DAC32-M24 1-CG17237-RA_1 CG17237 ACCGATCCAATGATGTCCAGGAAAGGCAATCAACTCCACCCGTCATCAATCCGTCCATCATCGACCAC 68 FBan0017237 FBgn0031410 CG17237 2 2L "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG17237 CG17237 "DmAAF51272, BcDNA:AT15471" CDMC20256 1 18 20 DAC32-M24 1-CG17237-RA_1 CG17237 ACCGATCCAATGATGTCCAGGAAAGGCAATCAACTCCACCCGTCATCAATCCGTCCATCATCGACCAC 68 FBan0017237 FBgn0031410 CG17237 2 2L "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG17237 CG17237 "DmAAF51272, BcDNA:AT15471" CDMC20257 1 19 20 DAC33-A12 11-CG31439-RA_1 CG31439 CGGTCTGTCGTCCTCTAGTTCTGAGGCTCAGCTTAAGGTTTCGTGCTTGGGCAAACCTGACGGATT 66 FBan0031439 FBgn0051439 CG31439 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0008061 extracellular region; GO:0005576 CG31439 CG31439 CDMC20257 1 20 20 DAC33-A12 11-CG31439-RA_1 CG31439 CGGTCTGTCGTCCTCTAGTTCTGAGGCTCAGCTTAAGGTTTCGTGCTTGGGCAAACCTGACGGATT 66 FBan0031439 FBgn0051439 CG31439 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0008061 extracellular region; GO:0005576 CG31439 CG31439 CDMC20258 1 21 20 DAC33-A24 3-CG3158-RA_6 CG3158 TCACCACGATCATTTGATAGTGGCCCACGAAATCGCGGAGAGTAGAAACGGGCAGACACTGACAGC 66 FBan0003158 FBgn0003483 spn-E 3 3R "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; RNA localization; GO:0006403; chromatin silencing; GO:0006342; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; nuclear mRNA splicing, via spliceosome; GO:0000398; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oocyte localization during oogenesis; GO:0030720; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; RNA-dependent ATPase activity; GO:0008186; ; GO:0004004; ; GO:0008186; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 spn-E spindle E "CG3158 (homeless), fs(1)hls, hls: homeless, homeless, spn-E/hls, spnE, spn E, Homeless, Spindle E, spindle-E, Spn-E, Spindle-E (homeless), fs(1)hls (homeless), fs(3)hls (homeless), hls (homeless), female sterile(3)homeless (homeless), homeless (homeless), hls, Spindle-E" CDMC20258 1 22 20 DAC33-A24 3-CG3158-RA_6 CG3158 TCACCACGATCATTTGATAGTGGCCCACGAAATCGCGGAGAGTAGAAACGGGCAGACACTGACAGC 66 FBan0003158 FBgn0003483 spn-E 3 3R "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; RNA localization; GO:0006403; chromatin silencing; GO:0006342; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; nuclear mRNA splicing, via spliceosome; GO:0000398; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oocyte localization during oogenesis; GO:0030720; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; RNA-dependent ATPase activity; GO:0008186; ; GO:0004004; ; GO:0008186; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 spn-E spindle E "CG3158 (homeless), fs(1)hls, hls: homeless, homeless, spn-E/hls, spnE, spn E, Homeless, Spindle E, spindle-E, Spn-E, Spindle-E (homeless), fs(1)hls (homeless), fs(3)hls (homeless), hls (homeless), female sterile(3)homeless (homeless), homeless (homeless), hls, Spindle-E" CDMC20259 1 23 20 DAC33-E12 3-CG32158-RA_2 CG32158 GCGACTCGGTGTGCATTCTGTTCGCCAGCATACCTAACTTCTCCGAGTTCTACGTGGAACTGGAGG 66 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC20259 1 24 20 DAC33-E12 3-CG32158-RA_2 CG32158 GCGACTCGGTGTGCATTCTGTTCGCCAGCATACCTAACTTCTCCGAGTTCTACGTGGAACTGGAGG 66 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC20260 1 25 20 DAC33-E24 2-CG32238-RA_1 CG32238 GGTCGCACGTCGGTCGGTGCAAATCAATCCGTGACGAATGGCAACTCAAATAGTGGCGCAAATAGC 66 FBan0032238 FBgn0052238 CG32238 3 3L C-terminal protein-tyrosinylation; GO:0018166; protein metabolism; GO:0019538 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG32238 CG32238 "CG7474, CG7474, CG7474" CDMC20260 1 26 20 DAC33-E24 2-CG32238-RA_1 CG32238 GGTCGCACGTCGGTCGGTGCAAATCAATCCGTGACGAATGGCAACTCAAATAGTGGCGCAAATAGC 66 FBan0032238 FBgn0052238 CG32238 3 3L C-terminal protein-tyrosinylation; GO:0018166; protein metabolism; GO:0019538 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG32238 CG32238 "CG7474, CG7474, CG7474" CDMC20261 1 1 21 DAC33-I12 2-CG32663-RA_1 CG32663 TGAGCAGAGTCCCAAGTTGATGGATCGCTTCCGACATGGTCACTTGGATTCGGATTATGGCCACGG 66 FBan0032663 FBgn0052663 CG32663 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32663 CG32663 "CG1905, CG1905, CG1905" CDMC20261 1 2 21 DAC33-I12 2-CG32663-RA_1 CG32663 TGAGCAGAGTCCCAAGTTGATGGATCGCTTCCGACATGGTCACTTGGATTCGGATTATGGCCACGG 66 FBan0032663 FBgn0052663 CG32663 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32663 CG32663 "CG1905, CG1905, CG1905" CDMC20262 1 3 21 DAC33-I24 23-CG32796-RA_6 CG32796 TGTGACTAATACACAAAACCCAAGAGAGAAGCATCCTAAACTCGATTTAAGCTCATAGGCGGCAGT 66 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC20262 1 4 21 DAC33-I24 23-CG32796-RA_6 CG32796 TGTGACTAATACACAAAACCCAAGAGAGAAGCATCCTAAACTCGATTTAAGCTCATAGGCGGCAGT 66 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC20263 1 5 21 DAC33-M12 18-CG33281-RA_8 CG33281 CTGAGGGCAAGACTCGAAAGGCATTCCTAATCGGACTCGGACTGATAAGCTTCAATCAGCTGTGCG 66 FBan0033281 FBgn0053281 CG33281 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33281 CG33281 "CG15407, CG15407" CDMC20263 1 6 21 DAC33-M12 18-CG33281-RA_8 CG33281 CTGAGGGCAAGACTCGAAAGGCATTCCTAATCGGACTCGGACTGATAAGCTTCAATCAGCTGTGCG 66 FBan0033281 FBgn0053281 CG33281 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33281 CG33281 "CG15407, CG15407" CDMC20264 1 7 21 DAC33-M24 2-CG3429-RA_1 CG3429 ACTCGATGTCGATGTCGCATTTGGAGGCGCATGACCACTTTAGGAGTAAAAGGACGACACTGGGCA 66 FBan0003429 FBgn0003655 swa X X bicoid mRNA localization; GO:0045450; intracellular mRNA localization; GO:0008298; pole plasm mRNA localization; GO:0019094 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; dynein binding; GO:0045502; ; GO:0045502 swa swallow "CG3429, fs(1)1502, fs(1)1497, fs(1)m44, fs(1)M44, sww: swallow, anon-WO0140519.70, fs(1)M11-999, fs(1)M13C82, swallow, sww" CDMC20264 1 8 21 DAC33-M24 2-CG3429-RA_1 CG3429 ACTCGATGTCGATGTCGCATTTGGAGGCGCATGACCACTTTAGGAGTAAAAGGACGACACTGGGCA 66 FBan0003429 FBgn0003655 swa X X bicoid mRNA localization; GO:0045450; intracellular mRNA localization; GO:0008298; pole plasm mRNA localization; GO:0019094 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; dynein binding; GO:0045502; ; GO:0045502 swa swallow "CG3429, fs(1)1502, fs(1)1497, fs(1)m44, fs(1)M44, sww: swallow, anon-WO0140519.70, fs(1)M11-999, fs(1)M13C82, swallow, sww" CDMC20265 1 9 21 DAC34-A12 2-CG13437-RA_3 CG13437 GAGCGTACGATCGAGCGGACATATCCCACGGATGCGGTGATAAATCCTGCCTATATGCACGACGAGGAC 69 FBan0013437 FBgn0034541 CG13437 2 2R CG13437 CG13437 CDMC20265 1 10 21 DAC34-A12 2-CG13437-RA_3 CG13437 GAGCGTACGATCGAGCGGACATATCCCACGGATGCGGTGATAAATCCTGCCTATATGCACGACGAGGAC 69 FBan0013437 FBgn0034541 CG13437 2 2R CG13437 CG13437 CDMC20266 1 11 21 DAC34-A24 1-CG1344-RA_1 CG1344 ATGAGCTGTGTGCCGATCAGGGTTGGGGTCATGATGAACAGGATGATAAGGACGATATTGTCTGGGGCG 69 FBan0001344 FBgn0027507 CG1344 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1344 CG1344 BcDNA:LD22679 CDMC20266 1 12 21 DAC34-A24 1-CG1344-RA_1 CG1344 ATGAGCTGTGTGCCGATCAGGGTTGGGGTCATGATGAACAGGATGATAAGGACGATATTGTCTGGGGCG 69 FBan0001344 FBgn0027507 CG1344 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1344 CG1344 BcDNA:LD22679 CDMC20267 1 13 21 DAC34-E12 3-CG13493-RA_1 CG13493 CCCACGAAACGCCAAGCTAAACCCGTACATTCCAGTTCCAGCGAATGCGAAGATTTCAAGCCAGACGAA 69 FBan0013493 FBgn0034667 comr 2 2R positive regulation of transcription from RNA polymerase II promoter; GO:0045944; spermatogenesis; GO:0007283 transcriptional activator activity; GO:0016563; ; GO:0016563 chromatin; GO:0000785; nucleus; GO:0005634 comr cookie monster "CG13493, CG13493, CG13493, zab, zuker-aly-like b, Z2-1340, cookie monster" CDMC20267 1 14 21 DAC34-E12 3-CG13493-RA_1 CG13493 CCCACGAAACGCCAAGCTAAACCCGTACATTCCAGTTCCAGCGAATGCGAAGATTTCAAGCCAGACGAA 69 FBan0013493 FBgn0034667 comr 2 2R positive regulation of transcription from RNA polymerase II promoter; GO:0045944; spermatogenesis; GO:0007283 transcriptional activator activity; GO:0016563; ; GO:0016563 chromatin; GO:0000785; nucleus; GO:0005634 comr cookie monster "CG13493, CG13493, CG13493, zab, zuker-aly-like b, Z2-1340, cookie monster" CDMC20268 1 15 21 DAC34-E24 23-CG13503-RA_8 CG13503 GAGTGAAGTACTGGATAGACAAGACGGTGTACTCCTTTAAGAAGATACTCCATATAAATCGCCAAGGGA 69 FBan0013503 FBgn0034695 CG13503 2 2R actin filament organization; GO:0007015; regulation of cell shape; GO:0008360 CG13503 CG13503 Vrp1 CDMC20268 1 16 21 DAC34-E24 23-CG13503-RA_8 CG13503 GAGTGAAGTACTGGATAGACAAGACGGTGTACTCCTTTAAGAAGATACTCCATATAAATCGCCAAGGGA 69 FBan0013503 FBgn0034695 CG13503 2 2R actin filament organization; GO:0007015; regulation of cell shape; GO:0008360 CG13503 CG13503 Vrp1 CDMC20269 1 17 21 DAC34-I12 1-CG13565-RA_1 CG13565 AGCTTCAGCATCCTCAACCAGCTCGTCTAGTGATACCTTCGACAGCGCGTGAATGTAAATGCCCATGGA 69 FBan0013565 FBgn0034935 CG13565 2 2R CG13565 CG13565 BcDNA:RH09340 CDMC20269 1 18 21 DAC34-I12 1-CG13565-RA_1 CG13565 AGCTTCAGCATCCTCAACCAGCTCGTCTAGTGATACCTTCGACAGCGCGTGAATGTAAATGCCCATGGA 69 FBan0013565 FBgn0034935 CG13565 2 2R CG13565 CG13565 BcDNA:RH09340 CDMC20270 1 19 21 DAC34-I24 2-CG13577-RA_2 CG13577 TGGCCCATCTAAGCGGTCTAAATAGCAAGACTAAGCACACGAGGCTGATGAGTACTTCCAAGCGCTGCA 69 FBan0013577 FBgn0034998 CG13577 2 2R CG13577 CG13577 CDMC20270 1 20 21 DAC34-I24 2-CG13577-RA_2 CG13577 TGGCCCATCTAAGCGGTCTAAATAGCAAGACTAAGCACACGAGGCTGATGAGTACTTCCAAGCGCTGCA 69 FBan0013577 FBgn0034998 CG13577 2 2R CG13577 CG13577 CDMC20271 1 21 21 DAC34-M12 24-CG13607-RA_1 CG13607 CGTTTCTTTAGCGAGAGAGATTACACAGACTGATCAATAATGGAATATATAGAAATCTATATAGCATAT 69 FBan0013607 FBgn0039151 CG13607 3 3R CG13607 CG13607 CDMC20271 1 22 21 DAC34-M12 24-CG13607-RA_1 CG13607 CGTTTCTTTAGCGAGAGAGATTACACAGACTGATCAATAATGGAATATATAGAAATCTATATAGCATAT 69 FBan0013607 FBgn0039151 CG13607 3 3R CG13607 CG13607 CDMC20272 1 23 21 DAC34-M24 3-CG13618-RA_1 CG13618 TTGGCTGTGGCTCTTGGTCAATCGATTTCGTACATCCGATCCGATTTCGTACATCCCCCCGGACGAAAT 69 FBan0013618 FBgn0039203 CG13618 3 3R CG13618 CG13618 CDMC20272 1 24 21 DAC34-M24 3-CG13618-RA_1 CG13618 TTGGCTGTGGCTCTTGGTCAATCGATTTCGTACATCCGATCCGATTTCGTACATCCCCCCGGACGAAAT 69 FBan0013618 FBgn0039203 CG13618 3 3R CG13618 CG13618 CDMC20273 1 25 21 DAC35-A12 2-CG17446-RA_1 CG17446 TCCGAAGGTGAACGATACGGATGTGTGTGGTTCGCCCTTAGTGAACAACGTCTTCAATCCCACGGG 66 FBan0017446 FBgn0030121 CG17446 X X "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG17446 CG17446 CDMC20273 1 26 21 DAC35-A12 2-CG17446-RA_1 CG17446 TCCGAAGGTGAACGATACGGATGTGTGTGGTTCGCCCTTAGTGAACAACGTCTTCAATCCCACGGG 66 FBan0017446 FBgn0030121 CG17446 X X "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG17446 CG17446 CDMC20274 1 1 22 DAC35-A24 1-CG17807-RA_1 CG17807 GGACTACTTGCTGTAGGTCGTCGGAAGGGACAAAACGTGTTTCGATGCGACTGTCTTGTGGTGCCC 66 FBan0017807 FBgn0034748 CG17807 2 2R CG17807 CG17807 CDMC20274 1 2 22 DAC35-A24 1-CG17807-RA_1 CG17807 GGACTACTTGCTGTAGGTCGTCGGAAGGGACAAAACGTGTTTCGATGCGACTGTCTTGTGGTGCCC 66 FBan0017807 FBgn0034748 CG17807 2 2R CG17807 CG17807 CDMC20275 1 3 22 DAC35-E12 17-CG18549-RA_4 CG18549 GTGCAGCATGTTCATTGGGAATCTGTTCGTGTACTATCAGTTCCAGGACAAGACCCGCATCGACAA 66 FBan0018549 FBgn0038053 CG18549 3 3R CG18549 CG18549 CDMC20275 1 4 22 DAC35-E12 17-CG18549-RA_4 CG18549 GTGCAGCATGTTCATTGGGAATCTGTTCGTGTACTATCAGTTCCAGGACAAGACCCGCATCGACAA 66 FBan0018549 FBgn0038053 CG18549 3 3R CG18549 CG18549 CDMC20276 1 5 22 DAC35-E24 3-CG2097-RA_4 CG2097 AGTGCCCCGATTTAAGGCCAGCATTGTCGGAATACGCGGAGAGCATGCAGGATGAACCAATGAATG 66 FBan0002097 FBgn0037371 CG2097 3 3R mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848; tight junction; GO:0005923 CG2097 CG2097 CDMC20276 1 6 22 DAC35-E24 3-CG2097-RA_4 CG2097 AGTGCCCCGATTTAAGGCCAGCATTGTCGGAATACGCGGAGAGCATGCAGGATGAACCAATGAATG 66 FBan0002097 FBgn0037371 CG2097 3 3R mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848; tight junction; GO:0005923 CG2097 CG2097 CDMC20277 1 7 22 DAC35-I12 2-CG2972-RA_1 CG2972 TCTCTCGGGGATCGATCTGAAAGTGATCTCGCTCACCTACGAACTGGAAGCAGACAACGTGGGCAC 66 FBan0002972 FBgn0030177 CG2972 X X CG2972 CG2972 CDMC20277 1 8 22 DAC35-I12 2-CG2972-RA_1 CG2972 TCTCTCGGGGATCGATCTGAAAGTGATCTCGCTCACCTACGAACTGGAAGCAGACAACGTGGGCAC 66 FBan0002972 FBgn0030177 CG2972 X X CG2972 CG2972 CDMC20278 1 9 22 DAC35-I24 3-CG30104-RA_3 CG30104 GGAGCACATAGATGGACCGTATCCAACGATGGTCAAGCAGAACAGTGGCAAGGAGGTTCCCGTTGT 66 FBan0030104 FBgn0050104 CG30104 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG30104 CG30104 "CG4837, CG4837, CG4837" CDMC20278 1 10 22 DAC35-I24 3-CG30104-RA_3 CG30104 GGAGCACATAGATGGACCGTATCCAACGATGGTCAAGCAGAACAGTGGCAAGGAGGTTCCCGTTGT 66 FBan0030104 FBgn0050104 CG30104 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG30104 CG30104 "CG4837, CG4837, CG4837" CDMC20279 1 11 22 DAC35-M12 2-CG31112-RA_2 CG31112 GGTTTTGGGAGCCGAACTTGCTCAGAACACGTGGTAGCGATAGGTAGCTCATGATCGAACCCAGCC 66 FBan0031112 FBgn0051112 CG31112 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31112 CG31112 CDMC20279 1 12 22 DAC35-M12 2-CG31112-RA_2 CG31112 GGTTTTGGGAGCCGAACTTGCTCAGAACACGTGGTAGCGATAGGTAGCTCATGATCGAACCCAGCC 66 FBan0031112 FBgn0051112 CG31112 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31112 CG31112 CDMC20280 1 13 22 DAC35-M24 12-CG31187-RA_1 CG31187 CCACGGACGAGGTAATCTCCGAACGTGAATGCTACGTGCTCCTCAACTTCATCGAAGCCGTCAGCT 66 FBan0031187 FBgn0051187 CG31187 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31187 CG31187 "CG2667, CG9851, DGKd" CDMC20280 1 14 22 DAC35-M24 12-CG31187-RA_1 CG31187 CCACGGACGAGGTAATCTCCGAACGTGAATGCTACGTGCTCCTCAACTTCATCGAAGCCGTCAGCT 66 FBan0031187 FBgn0051187 CG31187 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31187 CG31187 "CG2667, CG9851, DGKd" CDMC20281 1 15 22 DAC36-A12 1-CG17540-RB_1 CG17540 ACCAAGCAAGGTTGTTCTTCTACGCAACATGGTAGGACCCGGGGACGTTGACGAAGAATTGGAACCC 67 FBgn0040024 CG17540 "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG17540 CG17540 CDMC20281 1 16 22 DAC36-A12 1-CG17540-RB_1 CG17540 ACCAAGCAAGGTTGTTCTTCTACGCAACATGGTAGGACCCGGGGACGTTGACGAAGAATTGGAACCC 67 FBgn0040024 CG17540 "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG17540 CG17540 CDMC20282 1 17 22 DAC36-A24 1-CG17829-RA_1 CG17829 GCATTTAGTCCTACCTAGAACCTAGTGCGATTGGATGAGATAGCACCCGGGGACGCGATACCCTGCC 67 FBan0017829 FBgn0025635 CG17829 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17829 CG17829 EG:115C2.6 CDMC20282 1 18 22 DAC36-A24 1-CG17829-RA_1 CG17829 GCATTTAGTCCTACCTAGAACCTAGTGCGATTGGATGAGATAGCACCCGGGGACGCGATACCCTGCC 67 FBan0017829 FBgn0025635 CG17829 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17829 CG17829 EG:115C2.6 CDMC20283 1 19 22 DAC36-E12 2-CG18557-RA_7 CG18557 GGCACAGTAGAAGAGGTTGTCGATCAGGCGAAACCCAATGAGTTCCCTTGGACTGTGGCTCTGATGC 67 FBan0018557 FBgn0031470 CG18557 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18557 CG18557 c-SPH125 CDMC20283 1 20 22 DAC36-E12 2-CG18557-RA_7 CG18557 GGCACAGTAGAAGAGGTTGTCGATCAGGCGAAACCCAATGAGTTCCCTTGGACTGTGGCTCTGATGC 67 FBan0018557 FBgn0031470 CG18557 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18557 CG18557 c-SPH125 CDMC20284 1 21 22 DAC36-E24 3-CG18678-RA_1 CG18678 GGCTTCTCCCTGACCTACGGAGCTCTGATGCTGAAGACCTGGCGGATATCGGTGATTTTCCGAGTTC 67 FBan0018678 FBgn0040664 CG18678 2 2R CG18678 CG18678 CDMC20284 1 22 22 DAC36-E24 3-CG18678-RA_1 CG18678 GGCTTCTCCCTGACCTACGGAGCTCTGATGCTGAAGACCTGGCGGATATCGGTGATTTTCCGAGTTC 67 FBan0018678 FBgn0040664 CG18678 2 2R CG18678 CG18678 CDMC20285 1 23 22 DAC36-I12 2-CG2750-RA_5 CG2750 CGCTTGGAGGACATTAGCATGCCCTCTGGAGTCTCAAATCGAACCCAGGACAGTGAATGCGTTGAGG 67 FBan0002750 FBgn0030376 CG2750 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG2750 CG2750 anon-WO0140519.124 CDMC20285 1 24 22 DAC36-I12 2-CG2750-RA_5 CG2750 CGCTTGGAGGACATTAGCATGCCCTCTGGAGTCTCAAATCGAACCCAGGACAGTGAATGCGTTGAGG 67 FBan0002750 FBgn0030376 CG2750 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG2750 CG2750 anon-WO0140519.124 CDMC20286 1 25 22 DAC36-I24 23-CG2932-RA_1 CG2932 GCGCTGCTAAATATAGTCAGTGTTGGGGAATTCGATAGCACCTATGTGGATACTAGCTTTTCCGGTG 67 FBan0002932 FBgn0025679 Bteb2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bteb2 Bteb2 CG2932 CDMC20286 1 26 22 DAC36-I24 23-CG2932-RA_1 CG2932 GCGCTGCTAAATATAGTCAGTGTTGGGGAATTCGATAGCACCTATGTGGATACTAGCTTTTCCGGTG 67 FBan0002932 FBgn0025679 Bteb2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bteb2 Bteb2 CG2932 CDMC20287 1 1 23 DAC36-M12 11-CG30359-RA_1 CG30359 ATGCAGTGCCCCATGTGTTCGAAATAGCGCCGGATAATCAGAATCAGTACCGTGATGAGCCGCGAAA 67 FBan0030359 FBgn0050359 CG30359 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30359 CG30359 "CG8689, CG8689, CG8689, CG8689, CG8689" CDMC20287 1 2 23 DAC36-M12 11-CG30359-RA_1 CG30359 ATGCAGTGCCCCATGTGTTCGAAATAGCGCCGGATAATCAGAATCAGTACCGTGATGAGCCGCGAAA 67 FBan0030359 FBgn0050359 CG30359 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30359 CG30359 "CG8689, CG8689, CG8689, CG8689, CG8689" CDMC20288 1 3 23 DAC36-M24 3-CG3040-RA_1 CG3040 GGCAAGCTGACGCTACTCAAGCACCTCAATCTAAGCGGAAATCGACTGGTGGAACTCAACGAGGTGG 67 FBan0003040 FBgn0029925 CG3040 X X CG3040 CG3040 CT9706 CDMC20288 1 4 23 DAC36-M24 3-CG3040-RA_1 CG3040 GGCAAGCTGACGCTACTCAAGCACCTCAATCTAAGCGGAAATCGACTGGTGGAACTCAACGAGGTGG 67 FBan0003040 FBgn0029925 CG3040 X X CG3040 CG3040 CT9706 CDMC20289 1 5 23 DAC37-A12 6-CG7567-RA_2 CG7567 CTCGGGATCCTGGCACTTCGGTACGCTGCTTCGACTACTACATACCCATCATCAACGGGCTGTCG 65 FBan0007567 FBgn0039670 CG7567 3 3R CG7567 CG7567 BcDNA:RE47447 CDMC20289 1 6 23 DAC37-A12 6-CG7567-RA_2 CG7567 CTCGGGATCCTGGCACTTCGGTACGCTGCTTCGACTACTACATACCCATCATCAACGGGCTGTCG 65 FBan0007567 FBgn0039670 CG7567 3 3R CG7567 CG7567 BcDNA:RE47447 CDMC20290 1 7 23 DAC37-A24 3-CG7600-RA_3 CG7600 TGCGTATGTGCTCAATTCCGAGAATTTCCGCAGCCTGAACTCTCAGCTCAAGAACGGCTGTGTGC 65 FBgn0027531 CDMC20290 1 8 23 DAC37-A24 3-CG7600-RA_3 CG7600 TGCGTATGTGCTCAATTCCGAGAATTTCCGCAGCCTGAACTCTCAGCTCAAGAACGGCTGTGTGC 65 FBgn0027531 CDMC20291 1 9 23 DAC37-E12 6-CG7717-RA_2 CG7717 CGGAGAGCCTATCCCAGGAGGGTCACGACTTCATCGATCATTGTCTGCAGCACGATCCCAAGAGG 65 FBan0007717 FBgn0024329 Mekk1 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.- Mekk1 Mekk1 "CG7717, DmMEKK1, MEKK, MEKK4, mekk1a, mekk1b, D-MEKK1, dMEKK, dMEKK4, D-Mekk1, mekk1" CDMC20291 1 10 23 DAC37-E12 6-CG7717-RA_2 CG7717 CGGAGAGCCTATCCCAGGAGGGTCACGACTTCATCGATCATTGTCTGCAGCACGATCCCAAGAGG 65 FBan0007717 FBgn0024329 Mekk1 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.- Mekk1 Mekk1 "CG7717, DmMEKK1, MEKK, MEKK4, mekk1a, mekk1b, D-MEKK1, dMEKK, dMEKK4, D-Mekk1, mekk1" CDMC20292 1 11 23 DAC37-E24 15-CG7766-RB_5 CG7766 GGTGGCGTCATCTACGTGGAGCATCTGGTGCACAAGGCCAATCAGTTGTTCCTCGAGGATCAGCG 65 FBan0007766 FBgn0030087 CG7766 X X glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG7766 CG7766 CDMC20292 1 12 23 DAC37-E24 15-CG7766-RB_5 CG7766 GGTGGCGTCATCTACGTGGAGCATCTGGTGCACAAGGCCAATCAGTTGTTCCTCGAGGATCAGCG 65 FBan0007766 FBgn0030087 CG7766 X X glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG7766 CG7766 CDMC20293 1 13 23 DAC37-I12 6-CG7915-RA_1 CG7915 GAGTAGCGAACTCGCAGATGGAACGCAAAGTATGCAAAACCTGGCCATTCCAATGACCCCGCAGC 65 FBan0007915 FBgn0035835 Ect4 3 3L biological process unknown; GO:0000004 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 Ect4 Ect4 "CG7915, CG7905, CG7915, CG7915, anon-WO0118547.272" CDMC20293 1 14 23 DAC37-I12 6-CG7915-RA_1 CG7915 GAGTAGCGAACTCGCAGATGGAACGCAAAGTATGCAAAACCTGGCCATTCCAATGACCCCGCAGC 65 FBan0007915 FBgn0035835 Ect4 3 3L biological process unknown; GO:0000004 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 Ect4 Ect4 "CG7915, CG7905, CG7915, CG7915, anon-WO0118547.272" CDMC20294 1 15 23 DAC37-I24 23-CG7938-RA_1 CG7938 GTGCCAGGAACCTTTAAGCCCATCAAGGATATACTGAAATACTTCGAGAAGATCATAAACCAGCG 65 FBan0007938 FBgn0003511 Sry-beta 3 3R DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sry-beta Serendipity beta "CG7938, sry beta, Srybeta, srybeta, sry-b, sryb, Sry-beta, sry, serendipity beta, sry beta, sry-beta" CDMC20294 1 16 23 DAC37-I24 23-CG7938-RA_1 CG7938 GTGCCAGGAACCTTTAAGCCCATCAAGGATATACTGAAATACTTCGAGAAGATCATAAACCAGCG 65 FBan0007938 FBgn0003511 Sry-beta 3 3R DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sry-beta Serendipity beta "CG7938, sry beta, Srybeta, srybeta, sry-b, sryb, Sry-beta, sry, serendipity beta, sry beta, sry-beta" CDMC20295 1 17 23 DAC37-M12 3-CG8019-RA_1 CG8019 GTGGCAGACACCAGTTTCGATTTGCCCGAGGCTAATGTGCTTATCCAGATCTCTTCGCATGGCGG 65 FBan0008019 FBgn0001179 hay 3 3L "nucleotide-excision repair; GO:0006289; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; ; GO:0004386; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIIH complex; GO:0005675 hay haywire "CG8019, CG8019, CG8019, ERCC3, nc2, DmXPB, DhR25, DhXPB, hwr, TFIIH, Xpb/hay, i50, ms(3)nc2, haywire" CDMC20295 1 18 23 DAC37-M12 3-CG8019-RA_1 CG8019 GTGGCAGACACCAGTTTCGATTTGCCCGAGGCTAATGTGCTTATCCAGATCTCTTCGCATGGCGG 65 FBan0008019 FBgn0001179 hay 3 3L "nucleotide-excision repair; GO:0006289; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; ; GO:0004386; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIIH complex; GO:0005675 hay haywire "CG8019, CG8019, CG8019, ERCC3, nc2, DmXPB, DhR25, DhXPB, hwr, TFIIH, Xpb/hay, i50, ms(3)nc2, haywire" CDMC20296 1 19 23 DAC37-M24 5-CG8043-RA_1 CG8043 CTTCGGAGGCTGTACCCAATCCACATCCAGACTTATTTGTGTCTCCCGACCCGAGGCTGCATGTC 65 FBan0008043 FBgn0037610 CG8043 3 3R aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 CG8043 CG8043 CDMC20296 1 20 23 DAC37-M24 5-CG8043-RA_1 CG8043 CTTCGGAGGCTGTACCCAATCCACATCCAGACTTATTTGTGTCTCCCGACCCGAGGCTGCATGTC 65 FBan0008043 FBgn0037610 CG8043 3 3R aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 CG8043 CG8043 CDMC20297 1 21 23 DAC38-A12 3-CG4148-RA_5 CG4148 CCTGCAAGCAGGACCTCGAGTTCCTGGACATAGACGATACGGAGGATAGGTGTTCCTTGGTAGAGGAGC 69 FBan0004148 FBgn0001990 wek 2 2L "cell proliferation; GO:0008283; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded (sensu Insecta); GO:0048124; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wek weckle "CG4148, CG4148, l(2)35Ea: lethal(2)35Ea, l(2)br47, l35Ea, BG:DS09217.5, lethal(2)35Ea, l(2)35Ea, weckle" CDMC20297 1 22 23 DAC38-A12 3-CG4148-RA_5 CG4148 CCTGCAAGCAGGACCTCGAGTTCCTGGACATAGACGATACGGAGGATAGGTGTTCCTTGGTAGAGGAGC 69 FBan0004148 FBgn0001990 wek 2 2L "cell proliferation; GO:0008283; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded (sensu Insecta); GO:0048124; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wek weckle "CG4148, CG4148, l(2)35Ea: lethal(2)35Ea, l(2)br47, l35Ea, BG:DS09217.5, lethal(2)35Ea, l(2)35Ea, weckle" CDMC20298 1 23 23 DAC38-A24 12-CG4161-RA_3 CG4161 ACGATGCATTTAGCAAGCTTTTGCGGATTAACCTGTGGGGAAATCACTTTGAAATGCAGATCGGCGCCT 69 FBan0004161 FBgn0028892 CG4161 2 2L CG4161 CG4161 BG:DS03023.2 CDMC20298 1 24 23 DAC38-A24 12-CG4161-RA_3 CG4161 ACGATGCATTTAGCAAGCTTTTGCGGATTAACCTGTGGGGAAATCACTTTGAAATGCAGATCGGCGCCT 69 FBan0004161 FBgn0028892 CG4161 2 2L CG4161 CG4161 BG:DS03023.2 CDMC20299 1 25 23 DAC38-E12 14-CG4201-RA_1 CG4201 GCGGTCTCTGCGGAGATGACTATGAAGGATCTAATTGCGTTGATTGTCCTGGACACTGGAATGGACGAA 69 FBan0004201 FBgn0024222 ird5 3 3R Toll signaling pathway; GO:0008063; antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; cytokine and chemokine mediated signaling pathway; GO:0019221; dorsal/ventral axis specification; GO:0009950; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0005515 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737 ird5 immune response deficient 5 "CG4201, CG4201, CG4201, DIK, IKK-like protein, DLAK, Lipopolysaccharide activated kinase, LRK, LPS-responsive kinase, DmIKK, ikk, DmIKKbeta, Ik, Ird-5, dLak, ird, DmIKKBeta, Dmikkbeta, IKK, IKKB, dIKK, ird5/DmIkk[beta], dmIKKbeta, DmIkkbeta, DmIKKb, IKK-beta, dIKK-beta, IK, Lak, anon-89Bd, cactus kinase, LPS-responsive-kinase, immune response deficient 5" CDMC20299 1 26 23 DAC38-E12 14-CG4201-RA_1 CG4201 GCGGTCTCTGCGGAGATGACTATGAAGGATCTAATTGCGTTGATTGTCCTGGACACTGGAATGGACGAA 69 FBan0004201 FBgn0024222 ird5 3 3R Toll signaling pathway; GO:0008063; antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; cytokine and chemokine mediated signaling pathway; GO:0019221; dorsal/ventral axis specification; GO:0009950; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0005515 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737 ird5 immune response deficient 5 "CG4201, CG4201, CG4201, DIK, IKK-like protein, DLAK, Lipopolysaccharide activated kinase, LRK, LPS-responsive kinase, DmIKK, ikk, DmIKKbeta, Ik, Ird-5, dLak, ird, DmIKKBeta, Dmikkbeta, IKK, IKKB, dIKK, ird5/DmIkk[beta], dmIKKbeta, DmIkkbeta, DmIKKb, IKK-beta, dIKK-beta, IK, Lak, anon-89Bd, cactus kinase, LPS-responsive-kinase, immune response deficient 5" CDMC20300 1 1 24 DAC38-E24 2-CG4207-RA_1 CG4207 TCCGCGCGACAAGATGATCAAGGTGCGTCTCAAGGAGCTCATCGACAAACGCAAGAAGTTCCTCAAGTA 69 FBan0004207 FBgn0026261 bonsai 2 2R protein biosynthesis; GO:0006412; regulation of growth; GO:0040008 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763; mitochondrion; GO:0005739 bonsai bonsai "CG4207, CG4207, MRP-S15, DmMRPS15, mRpS15" CDMC20300 1 2 24 DAC38-E24 2-CG4207-RA_1 CG4207 TCCGCGCGACAAGATGATCAAGGTGCGTCTCAAGGAGCTCATCGACAAACGCAAGAAGTTCCTCAAGTA 69 FBan0004207 FBgn0026261 bonsai 2 2R protein biosynthesis; GO:0006412; regulation of growth; GO:0040008 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763; mitochondrion; GO:0005739 bonsai bonsai "CG4207, CG4207, MRP-S15, DmMRPS15, mRpS15" CDMC20301 1 3 24 DAC38-I12 3-CG4238-RA_2 CG4238 GCTGGAGCTGTACTTCGTGGAGGAGATGTACGACTCCAGTAGTGGACAGCTGAGCAAGACCATCGAACT 69 FBan0004238 FBgn0031384 CG4238 2 2L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG4238 CG4238 CDMC20301 1 4 24 DAC38-I12 3-CG4238-RA_2 CG4238 GCTGGAGCTGTACTTCGTGGAGGAGATGTACGACTCCAGTAGTGGACAGCTGAGCAAGACCATCGAACT 69 FBan0004238 FBgn0031384 CG4238 2 2L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG4238 CG4238 CDMC20302 1 5 24 DAC38-I24 23-CG4250-RA_3 CG4250 TGTATCTCCACACCTATTGATGGGATCAGATTTGGCACGAATATTCACGAAATACAACTCTGGTTCAAA 69 FBan0004250 FBgn0034761 CG4250 2 2R CG4250 CG4250 "CT13934, BcDNA:RH52355" CDMC20302 1 6 24 DAC38-I24 23-CG4250-RA_3 CG4250 TGTATCTCCACACCTATTGATGGGATCAGATTTGGCACGAATATTCACGAAATACAACTCTGGTTCAAA 69 FBan0004250 FBgn0034761 CG4250 2 2R CG4250 CG4250 "CT13934, BcDNA:RH52355" CDMC20303 1 7 24 DAC38-M12 4-CG4293-RB_1 CG4293 GCCCACAGAGATCCACCAGACTTTCACCACCATATACGCTTTTCAGTATGCCGTCACCGAAAACGTGCG 69 FBan0004293 FBgn0024983 CG4293 X X arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 CG4293 CG4293 EG:65F1.1 CDMC20303 1 8 24 DAC38-M12 4-CG4293-RB_1 CG4293 GCCCACAGAGATCCACCAGACTTTCACCACCATATACGCTTTTCAGTATGCCGTCACCGAAAACGTGCG 69 FBan0004293 FBgn0024983 CG4293 X X arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 CG4293 CG4293 EG:65F1.1 CDMC20304 1 9 24 DAC38-M24 12-CG4314-RA_1 CG4314 ACACGGGTCAGGATGTCCTGGACAAGTACAGCTTCAACGAGAGCAATGTCTATCGGAATTTACTGGCCA 69 FBan0004314 FBgn0003515 st 3 3L eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 st scarlet "CG4314, CG4314, CG4314, scarlet" CDMC20304 1 10 24 DAC38-M24 12-CG4314-RA_1 CG4314 ACACGGGTCAGGATGTCCTGGACAAGTACAGCTTCAACGAGAGCAATGTCTATCGGAATTTACTGGCCA 69 FBan0004314 FBgn0003515 st 3 3L eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 st scarlet "CG4314, CG4314, CG4314, scarlet" CDMC20305 1 11 24 DAC39-A12 12-CG6921-RB_1 CG6921 CGTGGGCAACACGGTCATCTTCCTTTACCTGTTCGGCAATTTCTATCGCAAGACCTACAAGAAGGCCAA 69 FBan0006921 FBgn0038985 CG6921 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6921 CG6921 CDMC20305 1 12 24 DAC39-A12 12-CG6921-RB_1 CG6921 CGTGGGCAACACGGTCATCTTCCTTTACCTGTTCGGCAATTTCTATCGCAAGACCTACAAGAAGGCCAA 69 FBan0006921 FBgn0038985 CG6921 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6921 CG6921 CDMC20306 1 13 24 DAC39-A24 24-CG6937-RA_1 CG6937 TGCGGCGATTTTTATTCATTTACTACTTTAATAATCAATTTTAGTGAATTGACACTAATTAAAATGCCG 69 FBan0006937 FBgn0038989 CG6937 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6937 CG6937 cg6937 CDMC20306 1 14 24 DAC39-A24 24-CG6937-RA_1 CG6937 TGCGGCGATTTTTATTCATTTACTACTTTAATAATCAATTTTAGTGAATTGACACTAATTAAAATGCCG 69 FBan0006937 FBgn0038989 CG6937 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6937 CG6937 cg6937 CDMC20307 1 15 24 DAC39-E12 3-CG6969-RA_12 CG6969 TGCCCATTTCCTCGAATCCGGCAGATGGCTGCAATCGTGTCCAGATGACTCGACTGGGTAAATACTGTT 69 FBan0006969 FBgn0039005 CG6969 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6969 CG6969 CDMC20307 1 16 24 DAC39-E12 3-CG6969-RA_12 CG6969 TGCCCATTTCCTCGAATCCGGCAGATGGCTGCAATCGTGTCCAGATGACTCGACTGGGTAAATACTGTT 69 FBan0006969 FBgn0039005 CG6969 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6969 CG6969 CDMC20308 1 17 24 DAC39-E24 18-CG6978-RA_2 CG6978 GGCCATCGATCTTCTATATCTTCGGGCTGTTCAGCACCATCTGGTGTATCATCTTTATTTGCCTGGTGC 69 FBan0006978 FBgn0029727 CG6978 X X carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021; membrane; GO:0016020 CG6978 CG6978 CDMC20308 1 18 24 DAC39-E24 18-CG6978-RA_2 CG6978 GGCCATCGATCTTCTATATCTTCGGGCTGTTCAGCACCATCTGGTGTATCATCTTTATTTGCCTGGTGC 69 FBan0006978 FBgn0029727 CG6978 X X carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021; membrane; GO:0016020 CG6978 CG6978 CDMC20309 1 19 24 DAC39-I12 23-CG7006-RA_4 CG7006 CCTACTCAACACTGAAACATTTCTCACGTGTAAAGTTGAGCAGTTTGTTTTCCTCTTTTTTCCGCTTAA 69 FBan0007006 FBgn0039233 CG7006 3 3R CG7006 CG7006 "anon-WO0118547.410, BcDNA:GM12126" CDMC20309 1 20 24 DAC39-I12 23-CG7006-RA_4 CG7006 CCTACTCAACACTGAAACATTTCTCACGTGTAAAGTTGAGCAGTTTGTTTTCCTCTTTTTTCCGCTTAA 69 FBan0007006 FBgn0039233 CG7006 3 3R CG7006 CG7006 "anon-WO0118547.410, BcDNA:GM12126" CDMC20310 1 21 24 DAC39-I24 11-CG7015-RA_1 CG7015 GGGTCAGGAGGTGGAGTACACTCTTGCTCGTAATGGGAATACATCCGTTTCTGGAAACTGTCTGCCTGC 69 FBan0007015 FBgn0035895 CG7015 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 CG7015 CG7015 CDMC20310 1 22 24 DAC39-I24 11-CG7015-RA_1 CG7015 GGGTCAGGAGGTGGAGTACACTCTTGCTCGTAATGGGAATACATCCGTTTCTGGAAACTGTCTGCCTGC 69 FBan0007015 FBgn0035895 CG7015 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 CG7015 CG7015 CDMC20311 1 23 24 DAC39-M12 23-CG7045-RA_1 CG7045 ACCAGGTGCCTTCACTAAGCGTTTACTACATTTGTTAATTTATTGTTGTACTAAAATCCACAAGCTAAT 69 FBan0007045 FBgn0038978 CG7045 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7045 CG7045 CDMC20311 1 24 24 DAC39-M12 23-CG7045-RA_1 CG7045 ACCAGGTGCCTTCACTAAGCGTTTACTACATTTGTTAATTTATTGTTGTACTAAAATCCACAAGCTAAT 69 FBan0007045 FBgn0038978 CG7045 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7045 CG7045 CDMC20312 1 25 24 DAC39-M24 22-CG7055-RA_1 CG7055 AGTTGTGGTCCCTAACTTATATATGAATCGATCCCTGGTGTTGTAACATAGCTGTCCCCTCCCGGAACT 69 FBan0007055 FBgn0030093 dalao X X "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dalao dalao "CG7055, CG7055, CG7055, BAP111, BRM-associated protein 111, clone 1.83, Bap111, Brahma associated protein 111kD, BAF57, anon-EST:Liang-1.83" CDMC20312 1 26 24 DAC39-M24 22-CG7055-RA_1 CG7055 AGTTGTGGTCCCTAACTTATATATGAATCGATCCCTGGTGTTGTAACATAGCTGTCCCCTCCCGGAACT 69 FBan0007055 FBgn0030093 dalao X X "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dalao dalao "CG7055, CG7055, CG7055, BAP111, BRM-associated protein 111, clone 1.83, Bap111, Brahma associated protein 111kD, BAF57, anon-EST:Liang-1.83" CDMC20313 1 1 25 DAC40-A12 23-CG33300-RA_2 CG33300 AACATCCGTAGAAACTACTACCAATTCATCGAATCAGAGCAATACGACCACGGAATCAACCACCA 65 FBan0033300 FBgn0053300 CG33300 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33300 CG33300 CDMC20313 1 2 25 DAC40-A12 23-CG33300-RA_2 CG33300 AACATCCGTAGAAACTACTACCAATTCATCGAATCAGAGCAATACGACCACGGAATCAACCACCA 65 FBan0033300 FBgn0053300 CG33300 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33300 CG33300 CDMC20314 1 3 25 DAC40-A24 3-CG3331-RA_3 CG3331 TGACTACTCGCAGGTTCCTGAGGATCTAAAGCTAACGGCACGGGATCTCTTCGAGACAGTGGGCG 65 FBan0003331 FBgn0000527 e 3 3R amino acid adenylylation by nonribosomal peptide synthase; GO:0043042; circadian rhythm; GO:0007623; cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; defense response; GO:0006952; dopamine metabolism; GO:0042417; histamine metabolism; GO:0001692; locomotor rhythm; GO:0045475; melanin biosynthesis from tyrosine; GO:0006583; negative regulation of melanin biosynthesis; GO:0048022; pigment metabolism; GO:0042440; pigmentation during development; GO:0048066 beta-alanyl-dopamine synthase activity; GO:0003833; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0003833; cofactor binding; GO:0048037; ; GO:0048037 e ebony "CG3331, CG3331, ebony" CDMC20314 1 4 25 DAC40-A24 3-CG3331-RA_3 CG3331 TGACTACTCGCAGGTTCCTGAGGATCTAAAGCTAACGGCACGGGATCTCTTCGAGACAGTGGGCG 65 FBan0003331 FBgn0000527 e 3 3R amino acid adenylylation by nonribosomal peptide synthase; GO:0043042; circadian rhythm; GO:0007623; cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; defense response; GO:0006952; dopamine metabolism; GO:0042417; histamine metabolism; GO:0001692; locomotor rhythm; GO:0045475; melanin biosynthesis from tyrosine; GO:0006583; negative regulation of melanin biosynthesis; GO:0048022; pigment metabolism; GO:0042440; pigmentation during development; GO:0048066 beta-alanyl-dopamine synthase activity; GO:0003833; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0003833; cofactor binding; GO:0048037; ; GO:0048037 e ebony "CG3331, CG3331, ebony" CDMC20315 1 5 25 DAC40-E12 9-CG3362-RA_7 CG3362 CGGCTTCCCCTTCGACCAGTCGGAAATAGATCAGATAGCCAGCAAGTACACGCATGCGCTACGTG 65 FBan0003362 FBgn0034988 CG3362 2 2R CG3362 CG3362 CDMC20315 1 6 25 DAC40-E12 9-CG3362-RA_7 CG3362 CGGCTTCCCCTTCGACCAGTCGGAAATAGATCAGATAGCCAGCAAGTACACGCATGCGCTACGTG 65 FBan0003362 FBgn0034988 CG3362 2 2R CG3362 CG3362 CDMC20316 1 7 25 DAC40-E24 6-CG3416-RA_1 CG3416 GTGGGATGGTATCACACAGGTCCCAAGCTCCACCAAAACGACATAGCCATCAACGAGCTGGTCCG 65 FBan0003416 FBgn0002787 Mov34 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Mov34 Mov34 "CG3416, l(2)k08003, PRSC_DROME, p39B" CDMC20316 1 8 25 DAC40-E24 6-CG3416-RA_1 CG3416 GTGGGATGGTATCACACAGGTCCCAAGCTCCACCAAAACGACATAGCCATCAACGAGCTGGTCCG 65 FBan0003416 FBgn0002787 Mov34 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Mov34 Mov34 "CG3416, l(2)k08003, PRSC_DROME, p39B" CDMC20317 1 9 25 DAC40-I12 24-CG3566-RB_1 CG3566 GGGAACATCAATTTCCTCACACATTTGACACGAAATAAATTGTACAAATTGCTTAAATTACACAA 65 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC20317 1 10 25 DAC40-I12 24-CG3566-RB_1 CG3566 GGGAACATCAATTTCCTCACACATTTGACACGAAATAAATTGTACAAATTGCTTAAATTACACAA 65 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC20318 1 11 25 DAC40-I24 2-CG3609-RA_1 CG3609 CAAGGATGTGGAGGTCAACTTTGGCTTCCCTATGCCTCATGTCGACCGCTTGCAGAAACGCGAAC 65 FBan0003609 FBgn0031418 CG3609 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3609 CG3609 CT12127 CDMC20318 1 12 25 DAC40-I24 2-CG3609-RA_1 CG3609 CAAGGATGTGGAGGTCAACTTTGGCTTCCCTATGCCTCATGTCGACCGCTTGCAGAAACGCGAAC 65 FBan0003609 FBgn0031418 CG3609 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3609 CG3609 CT12127 CDMC20319 1 13 25 DAC40-M12 3-CG3695-RA_4 CG3695 CCGCCCAACTGGAGTGTTAGTGAGCCGTACAAGGTGTATTTGCAAAGCCAAGACTCGCTGTGGAC 65 FBan0003695 FBgn0034795 MED23 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED23 Mediator complex subunit 23 "CG3695, CG3695, dTRAP150beta, dSUR2, Gal11/SUR2, Trap150beta, Med23, Mediator complex subunit 23" CDMC20319 1 14 25 DAC40-M12 3-CG3695-RA_4 CG3695 CCGCCCAACTGGAGTGTTAGTGAGCCGTACAAGGTGTATTTGCAAAGCCAAGACTCGCTGTGGAC 65 FBan0003695 FBgn0034795 MED23 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED23 Mediator complex subunit 23 "CG3695, CG3695, dTRAP150beta, dSUR2, Gal11/SUR2, Trap150beta, Med23, Mediator complex subunit 23" CDMC20320 1 15 25 DAC40-M24 6-CG3713-RA_1 CG3713 GAGCACCGCATAATCAGAGGTGGGGATGTTTCTGGGCTTCTTGGTGGATCTGCTGTACTGCCGAC 65 FBan0003713 FBgn0040343 CG3713 X X CG3713 CG3713 "EG:BACR7A4.2, BcDNA:GH13231" CDMC20320 1 16 25 DAC40-M24 6-CG3713-RA_1 CG3713 GAGCACCGCATAATCAGAGGTGGGGATGTTTCTGGGCTTCTTGGTGGATCTGCTGTACTGCCGAC 65 FBan0003713 FBgn0040343 CG3713 X X CG3713 CG3713 "EG:BACR7A4.2, BcDNA:GH13231" CDMC20321 1 17 25 DAC41-A12 AutoBlank AutoBlank CDMC20321 1 18 25 DAC41-A12 AutoBlank AutoBlank CDMC20322 1 19 25 DAC41-A24 AutoBlank AutoBlank CDMC20322 1 20 25 DAC41-A24 AutoBlank AutoBlank CDMC20323 1 21 25 DAC41-E12 AutoBlank AutoBlank CDMC20323 1 22 25 DAC41-E12 AutoBlank AutoBlank CDMC20324 1 23 25 DAC41-E24 AutoBlank AutoBlank CDMC20324 1 24 25 DAC41-E24 AutoBlank AutoBlank CDMC20325 1 25 25 DAC41-I12 AutoBlank AutoBlank CDMC20325 1 26 25 DAC41-I12 AutoBlank AutoBlank CDMC20326 1 1 26 DAC41-I24 AutoBlank AutoBlank CDMC20326 1 2 26 DAC41-I24 AutoBlank AutoBlank CDMC20327 1 3 26 DAC41-M12 AutoBlank AutoBlank CDMC20327 1 4 26 DAC41-M12 AutoBlank AutoBlank CDMC20328 1 5 26 DAC41-M24 AutoBlank AutoBlank CDMC20328 1 6 26 DAC41-M24 AutoBlank AutoBlank CDMC20329 1 7 26 DAC42-A12 150mM NaPO4 Blank CDMC20329 1 8 26 DAC42-A12 150mM NaPO4 Blank CDMC20330 1 9 26 DAC42A24 Ambion control 1 Ambion control spot1 CDMC20330 1 10 26 DAC42A24 Ambion control 1 Ambion control spot1 CDMC20331 1 11 26 DAC42E12 Ambion control 3 Ambion control spot3 CDMC20331 1 12 26 DAC42E12 Ambion control 3 Ambion control spot3 CDMC20332 1 13 26 DAC42E24 Ambion control 5 Ambion control spot5 CDMC20332 1 14 26 DAC42E24 Ambion control 5 Ambion control spot5 CDMC20333 1 15 26 DAC42I12 Ambion control 7 Ambion control spot7 CDMC20333 1 16 26 DAC42I12 Ambion control 7 Ambion control spot7 CDMC20334 1 17 26 DAC42-I24 5uM MSP 5uM MSP CDMC20334 1 18 26 DAC42-I24 5uM MSP 5uM MSP CDMC20335 1 19 26 DAC42-M12 10uM MSP 10uM MSP CDMC20335 1 20 26 DAC42-M12 10uM MSP 10uM MSP CDMC20336 1 21 26 DAC42-M24 20uM MSP 20uM MSP CDMC20336 1 22 26 DAC42-M24 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC20337 2 1 1 DAC01-B12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20337 2 2 1 DAC01-B12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20338 2 3 1 DAC01-B24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20338 2 4 1 DAC01-B24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20339 2 5 1 DAC01-F12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20339 2 6 1 DAC01-F12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20340 2 7 1 DAC01-F24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20340 2 8 1 DAC01-F24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20341 2 9 1 DAC01-J12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20341 2 10 1 DAC01-J12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20342 2 11 1 DAC01-J24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20342 2 12 1 DAC01-J24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20343 2 13 1 DAC01-N12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20343 2 14 1 DAC01-N12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20344 2 15 1 DAC01-N24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20344 2 16 1 DAC01-N24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20345 2 17 1 DAC02-B12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20345 2 18 1 DAC02-B12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20346 2 19 1 DAC02-B24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20346 2 20 1 DAC02-B24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20347 2 21 1 DAC02-F12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20347 2 22 1 DAC02-F12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20348 2 23 1 DAC02-F24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20348 2 24 1 DAC02-F24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20349 2 25 1 DAC02-J12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20349 2 26 1 DAC02-J12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20350 2 1 2 DAC02-J24 N/A CG9075 (00240-00478) CDMC20350 2 2 2 DAC02-J24 N/A CG9075 (00240-00478) CDMC20351 2 3 2 DAC02-N12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20351 2 4 2 DAC02-N12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20352 2 5 2 DAC02-N24 AutoBlank AutoBlank CDMC20352 2 6 2 DAC02-N24 AutoBlank AutoBlank CDMC20353 2 7 2 DAC03-B12 23-CG5435-RA_1 CG5435 TCTTCCGCTATTAGTTCCACAAATCTGTGTTTGCTTTCCCAGAAAGAATACCATTTTGCGTTTTGGGTT 69 FBan0005435 FBgn0032431 CG5435 2 2L CG5435 CG5435 BcDNA:AT11334 CDMC20353 2 8 2 DAC03-B12 23-CG5435-RA_1 CG5435 TCTTCCGCTATTAGTTCCACAAATCTGTGTTTGCTTTCCCAGAAAGAATACCATTTTGCGTTTTGGGTT 69 FBan0005435 FBgn0032431 CG5435 2 2L CG5435 CG5435 BcDNA:AT11334 CDMC20354 2 9 2 DAC03-B24 13-CG5445-RC_1 CG5445 AGGACCCCCCTTTCGTTACTCCTCCCACTATTCCCACTCCTTAATTTCGGTGTCAGACAGATCAGCTTT 69 FBan0005445 FBgn0030838 CG5445 X X CG5445 CG5445 CDMC20354 2 10 2 DAC03-B24 13-CG5445-RC_1 CG5445 AGGACCCCCCTTTCGTTACTCCTCCCACTATTCCCACTCCTTAATTTCGGTGTCAGACAGATCAGCTTT 69 FBan0005445 FBgn0030838 CG5445 X X CG5445 CG5445 CDMC20355 2 11 2 DAC03-F12 23-CG5472-RA_6 CG5472 AATTGCTTGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAA 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC20355 2 12 2 DAC03-F12 23-CG5472-RA_6 CG5472 AATTGCTTGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAA 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC20356 2 13 2 DAC03-F24 16-CG5475-RB_1 CG5475 GTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCATCGGAATGGAGT 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC20356 2 14 2 DAC03-F24 16-CG5475-RB_1 CG5475 GTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCATCGGAATGGAGT 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC20357 2 15 2 DAC03-J12 23-CG5501-RD_1 CG5501 ATTGATAGTTCAGGCATCTACGTAATTAAAGCTGGAGTTGAGTTCTAGAGCTTCAGCGATGTCACATGC 69 FBgn0051134 CDMC20357 2 16 2 DAC03-J12 23-CG5501-RD_1 CG5501 ATTGATAGTTCAGGCATCTACGTAATTAAAGCTGGAGTTGAGTTCTAGAGCTTCAGCGATGTCACATGC 69 FBgn0051134 CDMC20358 2 17 2 DAC03-J24 23-CG5516-RA_2 CG5516 ACCGATTTGTGGTCTGTAGTATGTAGCTTTACTAGTTTAGTTTTCCCACACTTACACCGAAAATGAACA 69 FBan0005516 FBgn0038389 CG5516 3 3R CG5516 CG5516 CDMC20358 2 18 2 DAC03-J24 23-CG5516-RA_2 CG5516 ACCGATTTGTGGTCTGTAGTATGTAGCTTTACTAGTTTAGTTTTCCCACACTTACACCGAAAATGAACA 69 FBan0005516 FBgn0038389 CG5516 3 3R CG5516 CG5516 CDMC20359 2 19 2 DAC03-N12 23-CG5557-RA_1 CG5557 ATCCTTCCAACTTCCAAATTCATCATGAAACTTGTATACGATTCGGCCAAAATCAACTCCATCACTGCC 69 FBan0005557 FBgn0010768 sqz 3 3R cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sqz squeeze "CG5557, CG5557, CG5557, CG5557, CG5557, l(3)02102, anon-WO0118547.697, squeeze" CDMC20359 2 20 2 DAC03-N12 23-CG5557-RA_1 CG5557 ATCCTTCCAACTTCCAAATTCATCATGAAACTTGTATACGATTCGGCCAAAATCAACTCCATCACTGCC 69 FBan0005557 FBgn0010768 sqz 3 3R cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sqz squeeze "CG5557, CG5557, CG5557, CG5557, CG5557, l(3)02102, anon-WO0118547.697, squeeze" CDMC20360 2 21 2 DAC03-N24 1-CG5565-RA_1 CG5565 AGGGGTCAGGGATCTGATTCTCCACTTGCACGAATACCGCATACCCTTCTGCATAGCCACAAGTTCGTT 69 FBan0005565 FBgn0031335 CG5565 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5565 CG5565 CDMC20360 2 22 2 DAC03-N24 1-CG5565-RA_1 CG5565 AGGGGTCAGGGATCTGATTCTCCACTTGCACGAATACCGCATACCCTTCTGCATAGCCACAAGTTCGTT 69 FBan0005565 FBgn0031335 CG5565 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5565 CG5565 CDMC20361 2 23 2 DAC04-B12 3-CG12362-RB_2 CG12362 GCCAAAATGGATGACATGCAGGAGGAGATGAGCTGGATTGAGGTTCAGTTTCTGCGTGATGCCGTCGAT 69 FBan0012362 FBgn0036082 CG12362 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG12362 CG12362 CDMC20361 2 24 2 DAC04-B12 3-CG12362-RB_2 CG12362 GCCAAAATGGATGACATGCAGGAGGAGATGAGCTGGATTGAGGTTCAGTTTCTGCGTGATGCCGTCGAT 69 FBan0012362 FBgn0036082 CG12362 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG12362 CG12362 CDMC20362 2 25 2 DAC04-B24 11-CG12373-RA_1 CG12373 CGCAAGCCAGCACTGAATACGTGATCAACCGGAATCCACGGAACTTGGAAAGATTACGCATTGCCTACA 69 FBan0012373 FBgn0026741 mRpL18 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL18 mitochondrial ribosomal protein L18 "CG12373, HL, MRP-L18, anon-49Ca, mitochondrial ribosomal protein L18" CDMC20362 2 26 2 DAC04-B24 11-CG12373-RA_1 CG12373 CGCAAGCCAGCACTGAATACGTGATCAACCGGAATCCACGGAACTTGGAAAGATTACGCATTGCCTACA 69 FBan0012373 FBgn0026741 mRpL18 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL18 mitochondrial ribosomal protein L18 "CG12373, HL, MRP-L18, anon-49Ca, mitochondrial ribosomal protein L18" CDMC20363 2 1 3 DAC04-F12 23-CG1240-RA_3 CG1240 TGTTCCACAACCTTTGATTAAGATTTAGTTGACGCATGTGTTTAGCATTACCCTAATTAGGACGGGTTT 69 FBan0001240 FBgn0035370 CG1240 3 3L CG1240 CG1240 CDMC20363 2 2 3 DAC04-F12 23-CG1240-RA_3 CG1240 TGTTCCACAACCTTTGATTAAGATTTAGTTGACGCATGTGTTTAGCATTACCCTAATTAGGACGGGTTT 69 FBan0001240 FBgn0035370 CG1240 3 3L CG1240 CG1240 CDMC20364 2 3 3 DAC04-F24 15-CG12420-RA_2 CG12420 AGGCGGAGATCACATGATCATCGCTATCACCACACTGTTGGTTTTGATCTGTTCCCTACATCTCGCCAA 69 FBan0012420 FBgn0037797 CG12420 3 3R CG12420 CG12420 CDMC20364 2 4 3 DAC04-F24 15-CG12420-RA_2 CG12420 AGGCGGAGATCACATGATCATCGCTATCACCACACTGTTGGTTTTGATCTGTTCCCTACATCTCGCCAA 69 FBan0012420 FBgn0037797 CG12420 3 3R CG12420 CG12420 CDMC20365 2 5 3 DAC04-J12 1-CG12460-RA_8 CG12460 GGTGGACCAGAATATCAAGGAGGTGCAGGCAATTAAGGAGGCCAAGGAAATCAAGGAGGAGCCGGAAAT 69 FBgn0040045 CG12460 "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 CG12460 CG12460 "CG40051, CG40051" CDMC20365 2 6 3 DAC04-J12 1-CG12460-RA_8 CG12460 GGTGGACCAGAATATCAAGGAGGTGCAGGCAATTAAGGAGGCCAAGGAAATCAAGGAGGAGCCGGAAAT 69 FBgn0040045 CG12460 "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 CG12460 CG12460 "CG40051, CG40051" CDMC20366 2 7 3 DAC04-J24 13-CG12486-RA_1 CG12486 GCGATGCATTCGAGAATGTGGAAGCTACAGTGAGTAAAGGACACACCAGAATACCACAATCGCTCCCGA 69 FBan0012486 FBgn0036541 CG12486 3 3L CG12486 CG12486 CDMC20366 2 8 3 DAC04-J24 13-CG12486-RA_1 CG12486 GCGATGCATTCGAGAATGTGGAAGCTACAGTGAGTAAAGGACACACCAGAATACCACAATCGCTCCCGA 69 FBan0012486 FBgn0036541 CG12486 3 3L CG12486 CG12486 CDMC20367 2 9 3 DAC04-N12 3-CG12525-RA_1 CG12525 GGGTTCAGAGTGCCGGTATTGTGGAATATTGGAAGCATCAAACTCTGCGCGAGATGATCACCATGGGCA 69 FBan0012525 FBgn0036010 CG12525 3 3L CG12525 CG12525 CDMC20367 2 10 3 DAC04-N12 3-CG12525-RA_1 CG12525 GGGTTCAGAGTGCCGGTATTGTGGAATATTGGAAGCATCAAACTCTGCGCGAGATGATCACCATGGGCA 69 FBan0012525 FBgn0036010 CG12525 3 3L CG12525 CG12525 CDMC20368 2 11 3 DAC04-N24 15-CG12535-RB_5 CG12535 GTTCGAACTGCAGCATATTACCACTCGGATTCGCACACTTTTGCGTAGAACCTTTCACCTGTCCAGCAA 69 FBan0012535 FBgn0029657 CG12535 X X CG12535 CG12535 CDMC20368 2 12 3 DAC04-N24 15-CG12535-RB_5 CG12535 GTTCGAACTGCAGCATATTACCACTCGGATTCGCACACTTTTGCGTAGAACCTTTCACCTGTCCAGCAA 69 FBan0012535 FBgn0029657 CG12535 X X CG12535 CG12535 CDMC20369 2 13 3 DAC05-B12 7-CG5043-RA_1 CG5043 GCTGCTTCAGGACAATGCACTAATTGAAGGTGAGATGAGCTTTGTGGTTGGTCCAGATCAGGATGCCCG 69 FBan0005043 FBgn0032636 CG5043 2 2L CG5043 CG5043 CDMC20369 2 14 3 DAC05-B12 7-CG5043-RA_1 CG5043 GCTGCTTCAGGACAATGCACTAATTGAAGGTGAGATGAGCTTTGTGGTTGGTCCAGATCAGGATGCCCG 69 FBan0005043 FBgn0032636 CG5043 2 2L CG5043 CG5043 CDMC20370 2 15 3 DAC05-B24 14-CG5053-RA_1 CG5053 GGCCAATTGCGAAACAGAGCTGCTACAATGCAAGAACAAAATGCGCTTGCTGATGGATGACATTGAGCT 69 FBan0005053 FBgn0039352 CG5053 3 3R signal transduction; GO:0007165 CG5053 CG5053 CDMC20370 2 16 3 DAC05-B24 14-CG5053-RA_1 CG5053 GGCCAATTGCGAAACAGAGCTGCTACAATGCAAGAACAAAATGCGCTTGCTGATGGATGACATTGAGCT 69 FBan0005053 FBgn0039352 CG5053 3 3R signal transduction; GO:0007165 CG5053 CG5053 CDMC20371 2 17 3 DAC05-F12 2-CG5083-RA_1 CG5083 ACAAGCTCGTCACCTTCGCATAGGAAGCTGTCCACCCATGATCTACCAGCAAGTCTTCCCCTAAGCATT 69 FBan0005083 FBgn0038390 Rbf2 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634 Rbf2 Retinoblastoma-family protein 2 "CG5083, rbf2, RBF2, Retinoblastoma-family protein 2" CDMC20371 2 18 3 DAC05-F12 2-CG5083-RA_1 CG5083 ACAAGCTCGTCACCTTCGCATAGGAAGCTGTCCACCCATGATCTACCAGCAAGTCTTCCCCTAAGCATT 69 FBan0005083 FBgn0038390 Rbf2 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634 Rbf2 Retinoblastoma-family protein 2 "CG5083, rbf2, RBF2, Retinoblastoma-family protein 2" CDMC20372 2 19 3 DAC05-F24 9-CG5096-RA_1 CG5096 GTTCTGGCCAAAGATGTCAAATGTGGCGGTCCGAACAAGTTAAACGATGTTACGCTGCTCAGAGTGGCG 69 FBan0005096 FBgn0032235 CG5096 2 2L cell adhesion; GO:0007155; development; GO:0007275; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG5096 CG5096 CT16355 CDMC20372 2 20 3 DAC05-F24 9-CG5096-RA_1 CG5096 GTTCTGGCCAAAGATGTCAAATGTGGCGGTCCGAACAAGTTAAACGATGTTACGCTGCTCAGAGTGGCG 69 FBan0005096 FBgn0032235 CG5096 2 2L cell adhesion; GO:0007155; development; GO:0007275; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG5096 CG5096 CT16355 CDMC20373 2 21 3 DAC05-J12 3-CG5130-RB_10 CG5130 CGACTTGGAGATCTTTGAGCGAACCTTGGTCACCAAGTTCCCGGAGATCATCAGTTACCACGACCTGCA 69 FBan0005130 FBgn0037000 CG5130 3 3L cation transport; GO:0006812 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG5130 CG5130 anon-WO0118547.435 CDMC20373 2 22 3 DAC05-J12 3-CG5130-RB_10 CG5130 CGACTTGGAGATCTTTGAGCGAACCTTGGTCACCAAGTTCCCGGAGATCATCAGTTACCACGACCTGCA 69 FBan0005130 FBgn0037000 CG5130 3 3L cation transport; GO:0006812 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG5130 CG5130 anon-WO0118547.435 CDMC20374 2 23 3 DAC05-J24 7-CG5142-RA_1 CG5142 AGCCCAGGCATTGGATTACACATCCGAGATTGTAGAGCGAGGAATGCGCAATCATCCAGAGCTTGGAAT 69 FBan0005142 FBgn0032470 CG5142 2 2L CG5142 CG5142 CDMC20374 2 24 3 DAC05-J24 7-CG5142-RA_1 CG5142 AGCCCAGGCATTGGATTACACATCCGAGATTGTAGAGCGAGGAATGCGCAATCATCCAGAGCTTGGAAT 69 FBan0005142 FBgn0032470 CG5142 2 2L CG5142 CG5142 CDMC20375 2 25 3 DAC05-N12 2-CG5175-RB_1 CG5175 CGTCGGGTCGTTTTTCGTCAGGAAAATCACCGTTCTGTCACAGATTCCTTGCTGGTTGTCTCCTCGCGA 69 FBan0005175 FBgn0038476 kuk 3 3R kuk kugelkern "CG5175, CG5175, CG5175, kugelkern" CDMC20375 2 26 3 DAC05-N12 2-CG5175-RB_1 CG5175 CGTCGGGTCGTTTTTCGTCAGGAAAATCACCGTTCTGTCACAGATTCCTTGCTGGTTGTCTCCTCGCGA 69 FBan0005175 FBgn0038476 kuk 3 3R kuk kugelkern "CG5175, CG5175, CG5175, kugelkern" CDMC20376 2 1 4 DAC05-N24 3-CG5187-RA_1 CG5187 CTTGTGGATTTGGCATGTACCTACTTTGGGAGACCCCATGAGTATGGAGGAGCGATTCAGGCCTCACCT 69 FBan0005187 FBgn0035956 Doc2 3 3L mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc2 Dorsocross2 "CG5187, CG5187, Dm-DOC2, Dorsocross2" CDMC20376 2 2 4 DAC05-N24 3-CG5187-RA_1 CG5187 CTTGTGGATTTGGCATGTACCTACTTTGGGAGACCCCATGAGTATGGAGGAGCGATTCAGGCCTCACCT 69 FBan0005187 FBgn0035956 Doc2 3 3L mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc2 Dorsocross2 "CG5187, CG5187, Dm-DOC2, Dorsocross2" CDMC20377 2 3 4 DAC06-B12 17-CG9372-RA_7 CG9372 TGAAGGCATTTCTTTGGGCATTGGTGATTTTACTGGGCTATATCCCGCAGAGTACAATCGCCAAGACTG 69 FBan0009372 FBgn0036891 CG9372 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9372 CG9372 "SP34, c-SP34" CDMC20377 2 4 4 DAC06-B12 17-CG9372-RA_7 CG9372 TGAAGGCATTTCTTTGGGCATTGGTGATTTTACTGGGCTATATCCCGCAGAGTACAATCGCCAAGACTG 69 FBan0009372 FBgn0036891 CG9372 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9372 CG9372 "SP34, c-SP34" CDMC20378 2 5 4 DAC06-B24 23-CG9384-RA_2 CG9384 GCTCTCCCCGACACACTCATTTTGCCAAATTGAAAACAATTAGCAAGCAACAATAATAGTGGATAGTGA 69 FBan0009384 FBgn0036446 CG9384 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG9384 CG9384 CDMC20378 2 6 4 DAC06-B24 23-CG9384-RA_2 CG9384 GCTCTCCCCGACACACTCATTTTGCCAAATTGAAAACAATTAGCAAGCAACAATAATAGTGGATAGTGA 69 FBan0009384 FBgn0036446 CG9384 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG9384 CG9384 CDMC20379 2 7 4 DAC06-F12 15-CG9427-RA_1 CG9427 ACCCGTTTACGAGGAGTTCGGGGACTACATTGATATACTCTTAGTGCCCTTCGGAAAATCGCAGTCGGA 69 FBan0009427 FBgn0037721 CG9427 3 3R CG9427 CG9427 CDMC20379 2 8 4 DAC06-F12 15-CG9427-RA_1 CG9427 ACCCGTTTACGAGGAGTTCGGGGACTACATTGATATACTCTTAGTGCCCTTCGGAAAATCGCAGTCGGA 69 FBan0009427 FBgn0037721 CG9427 3 3R CG9427 CG9427 CDMC20380 2 9 4 DAC06-F24 9-CG9432-RB_3 CG9432 GGGCTTGGAACTGATCGATGACGAATGCGACGTGTTCGGAATTCATATGGTCAAGATCCAGGATCCGCA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC20380 2 10 4 DAC06-F24 9-CG9432-RB_3 CG9432 GGGCTTGGAACTGATCGATGACGAATGCGACGTGTTCGGAATTCATATGGTCAAGATCCAGGATCCGCA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC20381 2 11 4 DAC06-J12 14-CG9465-RA_1 CG9465 ACGTGAATTGATGAAACGTGTGAAGGATAAACGCGAGGACTTCGTTTCCGACTTAAGCCGACAGCCTGT 69 FBan0009465 FBgn0032067 CG9465 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9465 CG9465 CDMC20381 2 12 4 DAC06-J12 14-CG9465-RA_1 CG9465 ACGTGAATTGATGAAACGTGTGAAGGATAAACGCGAGGACTTCGTTTCCGACTTAAGCCGACAGCCTGT 69 FBan0009465 FBgn0032067 CG9465 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9465 CG9465 CDMC20382 2 13 4 DAC06-J24 3-CG9475-RA_1 CG9475 CCACCAATCGTGCAGATACCTTAGATCCGGCTCTGTTACGACCCGGCCGTTTGGATCGGAAAATTGAGT 69 FBan0009475 FBgn0037742 Rpt3R 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3R Rpt3R "CG9475, CG9475, DmCG9475, Dm_Rpt3b" CDMC20382 2 14 4 DAC06-J24 3-CG9475-RA_1 CG9475 CCACCAATCGTGCAGATACCTTAGATCCGGCTCTGTTACGACCCGGCCGTTTGGATCGGAAAATTGAGT 69 FBan0009475 FBgn0037742 Rpt3R 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3R Rpt3R "CG9475, CG9475, DmCG9475, Dm_Rpt3b" CDMC20383 2 15 4 DAC06-N12 3-CG9511-RA_1 CG9511 GGCTTGGCATATCAGACGAACTAACCGCATCACCGACTTGACTACTGACCCCAATCTAAGCCCCTTCGT 69 FBan0009511 FBgn0031810 CG9511 2 2L CG9511 CG9511 CT26922 CDMC20383 2 16 4 DAC06-N12 3-CG9511-RA_1 CG9511 GGCTTGGCATATCAGACGAACTAACCGCATCACCGACTTGACTACTGACCCCAATCTAAGCCCCTTCGT 69 FBan0009511 FBgn0031810 CG9511 2 2L CG9511 CG9511 CT26922 CDMC20384 2 17 4 DAC06-N24 23-CG9520-RB_10 CG9520 AAGAGATCCGCCGAGACAAAGACGCAATAATAGAGACACACGGGTAGACACCTAATGTACATATAGCTT 69 FBan0009520 FBgn0032078 CG9520 2 2L glycolipid biosynthesis; GO:0009247; protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG9520 CG9520 anon-WO0144478.18 CDMC20384 2 18 4 DAC06-N24 23-CG9520-RB_10 CG9520 AAGAGATCCGCCGAGACAAAGACGCAATAATAGAGACACACGGGTAGACACCTAATGTACATATAGCTT 69 FBan0009520 FBgn0032078 CG9520 2 2L glycolipid biosynthesis; GO:0009247; protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG9520 CG9520 anon-WO0144478.18 CDMC20385 2 19 4 DAC07-B12 23-CG6571-RA_2 CG6571 ATAAGAAGCACCTGTACCCTATTTGTATTTTGAGCCACATTTCATCGATAGACGGACTATTTTCCTGGA 69 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC20385 2 20 4 DAC07-B12 23-CG6571-RA_2 CG6571 ATAAGAAGCACCTGTACCCTATTTGTATTTTGAGCCACATTTCATCGATAGACGGACTATTTTCCTGGA 69 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC20386 2 21 4 DAC07-B24 8-CG6582-RA_1 CG6582 ACGGAGGAGAACCAACTGAAGCAGACGGCACTGAAGACGACATCAAACATCAACATTCTGATCCGGGAT 69 FBan0006582 FBgn0027885 Aac11 2 2L anti-apoptosis; GO:0006916 Aac11 Aac11 "CG6582, BcDNA.LD09852, l(2)k06710, BcDNA:LD09852" CDMC20386 2 22 4 DAC07-B24 8-CG6582-RA_1 CG6582 ACGGAGGAGAACCAACTGAAGCAGACGGCACTGAAGACGACATCAAACATCAACATTCTGATCCGGGAT 69 FBan0006582 FBgn0027885 Aac11 2 2L anti-apoptosis; GO:0006916 Aac11 Aac11 "CG6582, BcDNA.LD09852, l(2)k06710, BcDNA:LD09852" CDMC20387 2 23 4 DAC07-F12 2-CG6608-RA_1 CG6608 GGCCCCCACACTCCTTAAGTCAAGCATGACGACGGCCCTGTACTTCAGCATTTACGATAAGCTCAAGCA 69 FBan0006608 FBgn0037852 CG6608 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6608 CG6608 CDMC20387 2 24 4 DAC07-F12 2-CG6608-RA_1 CG6608 GGCCCCCACACTCCTTAAGTCAAGCATGACGACGGCCCTGTACTTCAGCATTTACGATAAGCTCAAGCA 69 FBan0006608 FBgn0037852 CG6608 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6608 CG6608 CDMC20388 2 25 4 DAC07-F24 17-CG6621-RA_1 CG6621 CGCCACCAATGAAAAAAACAGCAGTCTCATCTAGAAAGTCAAGCTTTGACAATGTGGGACCCAGCACAT 69 FBan0006621 FBgn0037855 CG6621 3 3R CG6621 CG6621 CDMC20388 2 26 4 DAC07-F24 17-CG6621-RA_1 CG6621 CGCCACCAATGAAAAAAACAGCAGTCTCATCTAGAAAGTCAAGCTTTGACAATGTGGGACCCAGCACAT 69 FBan0006621 FBgn0037855 CG6621 3 3R CG6621 CG6621 CDMC20389 2 1 5 DAC07-J12 17-CG6656-RA_1 CG6656 CCGACCGATTGCAAAACATAAGATGCCTTCCAGACTTTGTTGAAAGTGTGTGTCGTTCTGGGTTGTTGT 69 FBan0006656 FBgn0038912 CG6656 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG6656 CG6656 CDMC20389 2 2 5 DAC07-J12 17-CG6656-RA_1 CG6656 CCGACCGATTGCAAAACATAAGATGCCTTCCAGACTTTGTTGAAAGTGTGTGTCGTTCTGGGTTGTTGT 69 FBan0006656 FBgn0038912 CG6656 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG6656 CG6656 CDMC20390 2 3 5 DAC07-J24 23-CG6664-RA_8 CG6664 CTCTCGCACAGGGATACAGAAAAATCATGACTTATTCACACACTTTCACACGAAAACACACTATATTCA 69 FBan0006664 FBgn0036685 CG6664 3 3L CG6664 CG6664 CDMC20390 2 4 5 DAC07-J24 23-CG6664-RA_8 CG6664 CTCTCGCACAGGGATACAGAAAAATCATGACTTATTCACACACTTTCACACGAAAACACACTATATTCA 69 FBan0006664 FBgn0036685 CG6664 3 3L CG6664 CG6664 CDMC20391 2 5 5 DAC07-N12 2-CG6691-RA_2 CG6691 GGGGTCCCATAGAAGATGAGTTCAGTCAGCTTCCCTGGTTCCGCCAGTACATAATGAGGATGTGGCACA 69 FBan0006691 FBgn0032971 CG6691 2 2L CG6691 CG6691 CDMC20391 2 6 5 DAC07-N12 2-CG6691-RA_2 CG6691 GGGGTCCCATAGAAGATGAGTTCAGTCAGCTTCCCTGGTTCCGCCAGTACATAATGAGGATGTGGCACA 69 FBan0006691 FBgn0032971 CG6691 2 2L CG6691 CG6691 CDMC20392 2 7 5 DAC07-N24 3-CG6701-RA_4 CG6701 AGTCCAGGACGCCAAGATCTTCTACAGCAAGAATGAGCTGCTTAACCTCGGGAATGAGTGTCAGCGGAA 69 FBan0006701 FBgn0033889 CG6701 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; ; GO:0008270 nucleus; GO:0005634 CG6701 CG6701 "EP(2)2054, EP2054" CDMC20392 2 8 5 DAC07-N24 3-CG6701-RA_4 CG6701 AGTCCAGGACGCCAAGATCTTCTACAGCAAGAATGAGCTGCTTAACCTCGGGAATGAGTGTCAGCGGAA 69 FBan0006701 FBgn0033889 CG6701 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; ; GO:0008270 nucleus; GO:0005634 CG6701 CG6701 "EP(2)2054, EP2054" CDMC20393 2 9 5 DAC08-B12 16-CG31861-RA_1 CG31861 TGAGCGTCGAAGAAAAGCAAGCCTTTCAAAGAATCGGCACAATTCAAGAAACTCCAACACACGTGCATT 69 FBan0031861 FBgn0051861 CG31861 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31861 CG31861 "CG17215, CG17215" CDMC20393 2 10 5 DAC08-B12 16-CG31861-RA_1 CG31861 TGAGCGTCGAAGAAAAGCAAGCCTTTCAAAGAATCGGCACAATTCAAGAAACTCCAACACACGTGCATT 69 FBan0031861 FBgn0051861 CG31861 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31861 CG31861 "CG17215, CG17215" CDMC20394 2 11 5 DAC08-B24 6-CG3186-RA_3 CG3186 CGCGGCCATGCAAGATTGTCGAGATGTCTACTTCAAAGACTGGAAAGCACGGACACGCCAAGGTTCATA 69 FBan0003186 FBgn0034967 eIF-5A 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; translation regulator activity; GO:0045182; ; GO:0003743; ; GO:0045182 cytosol; GO:0005829 eIF-5A eIF-5A "CG3186, CG3186, CG3186, l(2)01296, 1296, anon-EST:fe2H10, anon-fast-evolving-2H10" CDMC20394 2 12 5 DAC08-B24 6-CG3186-RA_3 CG3186 CGCGGCCATGCAAGATTGTCGAGATGTCTACTTCAAAGACTGGAAAGCACGGACACGCCAAGGTTCATA 69 FBan0003186 FBgn0034967 eIF-5A 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; translation regulator activity; GO:0045182; ; GO:0003743; ; GO:0045182 cytosol; GO:0005829 eIF-5A eIF-5A "CG3186, CG3186, CG3186, l(2)01296, 1296, anon-EST:fe2H10, anon-fast-evolving-2H10" CDMC20395 2 13 5 DAC08-F12 12-CG31901-RA_1 CG31901 TCCTCCACCACAAATGCAGGTTCAACCGCCAGTTCTACAACTTCTTCGCCATCCATAAGCACTTCAACT 69 FBan0031901 FBgn0051901 CG31901 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31901 CG31901 BcDNA:LP08232 CDMC20395 2 14 5 DAC08-F12 12-CG31901-RA_1 CG31901 TCCTCCACCACAAATGCAGGTTCAACCGCCAGTTCTACAACTTCTTCGCCATCCATAAGCACTTCAACT 69 FBan0031901 FBgn0051901 CG31901 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31901 CG31901 BcDNA:LP08232 CDMC20396 2 15 5 DAC08-F24 3-CG31908-RA_3 CG31908 TCCCAAGTGACGCCGATGTATAATAACTACAACAGCTACTTCCCGGGACTGCACAATCAGCCTGGCCTT 69 FBan0031908 FBgn0051908 CG31908 2 2L CG31908 CG31908 "CG8761, CG8761" CDMC20396 2 16 5 DAC08-F24 3-CG31908-RA_3 CG31908 TCCCAAGTGACGCCGATGTATAATAACTACAACAGCTACTTCCCGGGACTGCACAATCAGCCTGGCCTT 69 FBan0031908 FBgn0051908 CG31908 2 2L CG31908 CG31908 "CG8761, CG8761" CDMC20397 2 17 5 DAC08-J12 12-CG31937-RA_1 CG31937 GCTCGATCTCGACGAGCATAAGACGCATCTCAACACGGTGCTCAATCACTTTCATCGACTGGATGTCCT 69 FBgn0051937 CDMC20397 2 18 5 DAC08-J12 12-CG31937-RA_1 CG31937 GCTCGATCTCGACGAGCATAAGACGCATCTCAACACGGTGCTCAATCACTTTCATCGACTGGATGTCCT 69 FBgn0051937 CDMC20398 2 19 5 DAC08-J24 3-CG31960-RA_1 CG31960 TGCCATCACCTCGAAGGAATTGGGAATGGTAATCCGAGCATTAGGTCGACAGCCCAATGAATCGGAGGT 69 FBan0031960 FBgn0051960 CG31960 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31960 CG31960 CG10022 CDMC20398 2 20 5 DAC08-J24 3-CG31960-RA_1 CG31960 TGCCATCACCTCGAAGGAATTGGGAATGGTAATCCGAGCATTAGGTCGACAGCCCAATGAATCGGAGGT 69 FBan0031960 FBgn0051960 CG31960 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31960 CG31960 CG10022 CDMC20399 2 21 5 DAC08-N12 23-CG32006-RA_7 CG32006 ATGATAGCGCTGGGTATGATCGAAACGACGATATCTTAGAAAACCTTCTTGATGTTTGTGTTACGCCTT 69 FBan0032006 FBgn0052006 CG32006 4 4 "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32006 CG32006 "DmCg32006, BcDNA:RE51913" CDMC20399 2 22 5 DAC08-N12 23-CG32006-RA_7 CG32006 ATGATAGCGCTGGGTATGATCGAAACGACGATATCTTAGAAAACCTTCTTGATGTTTGTGTTACGCCTT 69 FBan0032006 FBgn0052006 CG32006 4 4 "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32006 CG32006 "DmCg32006, BcDNA:RE51913" CDMC20400 2 23 5 DAC08-N24 23-CG3201-RA_1 CG3201 CAATGGAAGGAAGGAAAGCCAGAGTATCACGAAAAAGTATTTCTAAATTAAAGCTGATATGCGTCGGTG 69 FBan0003201 FBgn0004687 Mlc-c X X muscle contraction; GO:0006936 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0005509" myosin; GO:0016459; unconventional myosin; GO:0016461 Mlc-c Myosin light chain cytoplasmic "CG3201, CG3201, alkali light chain of non-muscle myosin-II, DmMLC_C, nmELC" CDMC20400 2 24 5 DAC08-N24 23-CG3201-RA_1 CG3201 CAATGGAAGGAAGGAAAGCCAGAGTATCACGAAAAAGTATTTCTAAATTAAAGCTGATATGCGTCGGTG 69 FBan0003201 FBgn0004687 Mlc-c X X muscle contraction; GO:0006936 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0005509" myosin; GO:0016459; unconventional myosin; GO:0016461 Mlc-c Myosin light chain cytoplasmic "CG3201, CG3201, alkali light chain of non-muscle myosin-II, DmMLC_C, nmELC" CDMC20401 2 25 5 DAC09-B13 3-CG5389-RA_1 CG5389 TAGGCGAGGAGCACTACAATGTGGCTCGAGCAGTTCAGAAGACTCTGCAGGCTTACAAGTCGCTG 65 FBan0005389 FBgn0036568 CG5389 3 3L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" CG5389 CG5389 CDMC20401 2 26 5 DAC09-B13 3-CG5389-RA_1 CG5389 TAGGCGAGGAGCACTACAATGTGGCTCGAGCAGTTCAGAAGACTCTGCAGGCTTACAAGTCGCTG 65 FBan0005389 FBgn0036568 CG5389 3 3L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" CG5389 CG5389 CDMC20402 2 1 6 DAC09-C01 6-CG5423-RA_3 CG5423 GGCAGCAATAACAACAATCACCAGGGCAATGACTACCAGTCGACCGGGATGTACTCCGCTCCACC 65 FBan0005423 FBgn0041097 robo3 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron recognition; GO:0008038; signal transduction; GO:0007165; ventral cord development; GO:0007419 axon guidance receptor activity; GO:0008046; ; GO:0008046 plasma membrane; GO:0005886 robo3 robo3 "CG5423, CG14345, dRobo-3, Robo3, CT17158, Robo-3" CDMC20402 2 2 6 DAC09-C01 6-CG5423-RA_3 CG5423 GGCAGCAATAACAACAATCACCAGGGCAATGACTACCAGTCGACCGGGATGTACTCCGCTCCACC 65 FBan0005423 FBgn0041097 robo3 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron recognition; GO:0008038; signal transduction; GO:0007165; ventral cord development; GO:0007419 axon guidance receptor activity; GO:0008046; ; GO:0008046 plasma membrane; GO:0005886 robo3 robo3 "CG5423, CG14345, dRobo-3, Robo3, CT17158, Robo-3" CDMC20403 2 3 6 DAC09-F13 3-CG5569-RA_3 CG5569 TTCAGCAAGGCCTACGACCACGACGGGAAGACCAAAGTCACCATCTTCAACACCGAAACGGATCT 65 FBan0005569 FBgn0034919 CG5569 2 2R CG5569 CG5569 BcDNA:SD18780 CDMC20403 2 4 6 DAC09-F13 3-CG5569-RA_3 CG5569 TTCAGCAAGGCCTACGACCACGACGGGAAGACCAAAGTCACCATCTTCAACACCGAAACGGATCT 65 FBan0005569 FBgn0034919 CG5569 2 2R CG5569 CG5569 BcDNA:SD18780 CDMC20404 2 5 6 DAC09-G01 3-CG5599-RA_1 CG5599 TTCCTCCCGGTACTAACGTTCCACATCCCACACTATTGGCGAAAACGCCTAGTGCTGCTCCAAGT 65 FBan0005599 FBgn0030612 CG5599 X X tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoamide branched chain acyltransferase activity; GO:0004147 ; EC:2.3.1.-; ; GO:0004147 ; EC:2.3.1.-; ; GO:0005515 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5599 CG5599 CDMC20404 2 6 6 DAC09-G01 3-CG5599-RA_1 CG5599 TTCCTCCCGGTACTAACGTTCCACATCCCACACTATTGGCGAAAACGCCTAGTGCTGCTCCAAGT 65 FBan0005599 FBgn0030612 CG5599 X X tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoamide branched chain acyltransferase activity; GO:0004147 ; EC:2.3.1.-; ; GO:0004147 ; EC:2.3.1.-; ; GO:0005515 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5599 CG5599 CDMC20405 2 7 6 DAC09-J13 23-CG5725-RC_1 CG5725 TTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC20405 2 8 6 DAC09-J13 23-CG5725-RC_1 CG5725 TTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC20406 2 9 6 DAC09-K01 3-CG5747-RA_3 CG5747 CTCTTCAAGCGCAAGGTCATCAACGGCTGGTTTCCGCTGCAAAGTAATGCACATCCATCGCAACG 65 FBan0005747 FBgn0035935 mfr 3 3L development; GO:0007275; mesoderm development; GO:0007498; spermatogenesis; GO:0007283 mfr misfire "CG5747, CG5747" CDMC20406 2 10 6 DAC09-K01 3-CG5747-RA_3 CG5747 CTCTTCAAGCGCAAGGTCATCAACGGCTGGTTTCCGCTGCAAAGTAATGCACATCCATCGCAACG 65 FBan0005747 FBgn0035935 mfr 3 3L development; GO:0007275; mesoderm development; GO:0007498; spermatogenesis; GO:0007283 mfr misfire "CG5747, CG5747" CDMC20407 2 11 6 DAC09-N13 3-CG5905-RB_1 CG5905 GAACATGACCCACGATCAGCTGTTCTTTCTCAACTACGCCCAAATCTGGTGCGGATCCATGCGGC 65 FBan0005905 FBgn0029843 Nep1 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004222 ; EC:3.4.24.-; sugar binding; GO:0005529; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0005529; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep1 Neprilysin 1 "CG5894, CG5905, CG5914, CG5894, NEP, dNEP1, Neprilysin 1" CDMC20407 2 12 6 DAC09-N13 3-CG5905-RB_1 CG5905 GAACATGACCCACGATCAGCTGTTCTTTCTCAACTACGCCCAAATCTGGTGCGGATCCATGCGGC 65 FBan0005905 FBgn0029843 Nep1 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004222 ; EC:3.4.24.-; sugar binding; GO:0005529; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0005529; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep1 Neprilysin 1 "CG5894, CG5905, CG5914, CG5894, NEP, dNEP1, Neprilysin 1" CDMC20408 2 13 6 DAC09-O01 14-CG5925-RA_1 CG5925 CTACAAGACGGCCGAATGGGGTTGCTACTCCCTGAATATAACGACGGCCTTCATCGACTTGTTCG 65 FBan0005925 FBgn0043043 desat2 3 3R cuticle hydrocarbon biosynthesis; GO:0006723; fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat2 desat2 "CG5925, CG5925, desat, desaturase, 7-11HD, 7,11-heptacosadiene modifier, ds2, desaturase2, desat2/Fad, Fad, Fatty acid desaturase" CDMC20408 2 14 6 DAC09-O01 14-CG5925-RA_1 CG5925 CTACAAGACGGCCGAATGGGGTTGCTACTCCCTGAATATAACGACGGCCTTCATCGACTTGTTCG 65 FBan0005925 FBgn0043043 desat2 3 3R cuticle hydrocarbon biosynthesis; GO:0006723; fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat2 desat2 "CG5925, CG5925, desat, desaturase, 7-11HD, 7,11-heptacosadiene modifier, ds2, desaturase2, desat2/Fad, Fad, Fatty acid desaturase" CDMC20409 2 15 6 DAC10-B12 15-CG6499-RA_3 CG6499 GCCGATCTAACGGAGCATCGGATTCGGCACTCACAAATCGGTTTATCGCGAGCCATCTCAGCGTT 65 FBan0006499 FBgn0038309 CG6499 3 3R cation transport; GO:0006812 ammonium transporter activity; GO:0008519; ; GO:0008519 CG6499 CG6499 CDMC20409 2 16 6 DAC10-B12 15-CG6499-RA_3 CG6499 GCCGATCTAACGGAGCATCGGATTCGGCACTCACAAATCGGTTTATCGCGAGCCATCTCAGCGTT 65 FBan0006499 FBgn0038309 CG6499 3 3R cation transport; GO:0006812 ammonium transporter activity; GO:0008519; ; GO:0008519 CG6499 CG6499 CDMC20410 2 17 6 DAC10-B24 16-CG6519-RA_1 CG6519 TTCCGCCGCTGCCGTGAATCCCGGAACCTACAAGCAGTACGCCATTCCCTCCTACGAGTTGGATG 65 FBan0006519 FBgn0000355 Cp15 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp15 Chorion protein 15 "CG6519, E6, s15-1, s15, Cs15, s15 chorion gene, C.s15, s-15, cp15, S15: Shell-15, Dms15, Shell-15, S15" CDMC20410 2 18 6 DAC10-B24 16-CG6519-RA_1 CG6519 TTCCGCCGCTGCCGTGAATCCCGGAACCTACAAGCAGTACGCCATTCCCTCCTACGAGTTGGATG 65 FBan0006519 FBgn0000355 Cp15 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp15 Chorion protein 15 "CG6519, E6, s15-1, s15, Cs15, s15 chorion gene, C.s15, s-15, cp15, S15: Shell-15, Dms15, Shell-15, S15" CDMC20411 2 19 6 DAC10-F12 3-CG6652-RA_2 CG6652 AAGGACAGTGCCGAAGACAAGAGTGGACCCAACACTCCACCTAGTCAAATCGAACGACAGGTGGG 65 FBan0006652 FBgn0036687 CG6652 3 3L CG6652 CG6652 CDMC20411 2 20 6 DAC10-F12 3-CG6652-RA_2 CG6652 AAGGACAGTGCCGAAGACAAGAGTGGACCCAACACTCCACCTAGTCAAATCGAACGACAGGTGGG 65 FBan0006652 FBgn0036687 CG6652 3 3L CG6652 CG6652 CDMC20412 2 21 6 DAC10-F24 3-CG6698-RA_1 CG6698 ATCCTATGAGCTGATGGTCTACGCCAACGGAAGCATCACCCTGTACGCTCAAAACCTCCAGCTGG 65 FBan0006698 FBgn0029147 NtR 2 2R transport; GO:0006810 excitatory extracellular ligand-gated ion channel activity; GO:0005231; ; GO:0005231 membrane; GO:0016020 NtR NtR "CG6698, DNtR, anon-WO0138359.3" CDMC20412 2 22 6 DAC10-F24 3-CG6698-RA_1 CG6698 ATCCTATGAGCTGATGGTCTACGCCAACGGAAGCATCACCCTGTACGCTCAAAACCTCCAGCTGG 65 FBan0006698 FBgn0029147 NtR 2 2R transport; GO:0006810 excitatory extracellular ligand-gated ion channel activity; GO:0005231; ; GO:0005231 membrane; GO:0016020 NtR NtR "CG6698, DNtR, anon-WO0138359.3" CDMC20413 2 23 6 DAC10-J12 3-CG6789-RA_4 CG6789 ATTTTGTCAGCGGGTCAATGAATTGATTGCCAGTGGTGAACGCCAAAGGGATGAGATTGCGGCGG 65 FBan0006789 FBgn0029745 CG6789 X X CG6789 CG6789 CDMC20413 2 24 6 DAC10-J12 3-CG6789-RA_4 CG6789 ATTTTGTCAGCGGGTCAATGAATTGATTGCCAGTGGTGAACGCCAAAGGGATGAGATTGCGGCGG 65 FBan0006789 FBgn0029745 CG6789 X X CG6789 CG6789 CDMC20414 2 25 6 DAC10-J24 1-CG6835-RA_4 CG6835 TATCGCAAGGTGCTGGCGCACGGATTCACCCAGATTGTTGCCTAGAGTTTTCATTTGCTGACGCT 65 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC20414 2 26 6 DAC10-J24 1-CG6835-RA_4 CG6835 TATCGCAAGGTGCTGGCGCACGGATTCACCCAGATTGTTGCCTAGAGTTTTCATTTGCTGACGCT 65 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC20415 2 1 7 DAC10-N12 2-CG6906-RA_2 CG6906 CGCCTTGCAGTGAGGAGGTCACCTGGATTGATTTCACAACGCCCATTGACATCACGGAGAAGCAG 65 FBgn0036261 CDMC20415 2 2 7 DAC10-N12 2-CG6906-RA_2 CG6906 CGCCTTGCAGTGAGGAGGTCACCTGGATTGATTTCACAACGCCCATTGACATCACGGAGAAGCAG 65 FBgn0036261 CDMC20416 2 3 7 DAC10-N24 3-CG6946-RA_9 CG6946 TTGTTCAGTTCGAAAGCCAGGACGACACTGAGCAAGCCTTGGGCCGAAATCGGGAAAAAATTGGG 65 FBan0006946 FBgn0037954 CG6946 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG6946 CG6946 "0110/46, 110/46, l(3)S011046, cg6946, l(3)S11046, anon-WO0118547.328" CDMC20416 2 4 7 DAC10-N24 3-CG6946-RA_9 CG6946 TTGTTCAGTTCGAAAGCCAGGACGACACTGAGCAAGCCTTGGGCCGAAATCGGGAAAAAATTGGG 65 FBan0006946 FBgn0037954 CG6946 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG6946 CG6946 "0110/46, 110/46, l(3)S011046, cg6946, l(3)S11046, anon-WO0118547.328" CDMC20417 2 5 7 DAC11-B12 15-CG10000-RA_1 CG10000 AGACAGTGGCAGTTAGAGCAACAGTAGCAGAAAATGCCAGCAGAAAACAGAAGTTCATGGTGTGGCTGC 69 FBan0010000 FBgn0039596 CG10000 3 3R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG10000 CG10000 CDMC20417 2 6 7 DAC11-B12 15-CG10000-RA_1 CG10000 AGACAGTGGCAGTTAGAGCAACAGTAGCAGAAAATGCCAGCAGAAAACAGAAGTTCATGGTGTGGCTGC 69 FBan0010000 FBgn0039596 CG10000 3 3R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG10000 CG10000 CDMC20418 2 7 7 DAC11-B24 1-CG10013-RA_1 CG10013 GCAACTCCATGCCCCAAACAGGAGATGAAGAATTAGCTCCAACACCCAGATCCACTACCCCCAGAGGAA 69 FBan0010013 FBgn0038012 CG10013 3 3R CG10013 CG10013 CDMC20418 2 8 7 DAC11-B24 1-CG10013-RA_1 CG10013 GCAACTCCATGCCCCAAACAGGAGATGAAGAATTAGCTCCAACACCCAGATCCACTACCCCCAGAGGAA 69 FBan0010013 FBgn0038012 CG10013 3 3R CG10013 CG10013 CDMC20419 2 9 7 DAC11-F12 14-CG10050-RA_1 CG10050 CTGCGACAGGTGAAACTCATCGCCGTGGGTATAAGTGACTACATCATCCGTACACAGCCTACTGAAGGA 69 FBan0010050 FBgn0037492 CG10050 3 3R CG10050 CG10050 CDMC20419 2 10 7 DAC11-F12 14-CG10050-RA_1 CG10050 CTGCGACAGGTGAAACTCATCGCCGTGGGTATAAGTGACTACATCATCCGTACACAGCCTACTGAAGGA 69 FBan0010050 FBgn0037492 CG10050 3 3R CG10050 CG10050 CDMC20420 2 11 7 DAC11-F24 2-CG10062-RA_1 CG10062 CGGTGTTGATCGTTCGATGTCCTGGTTCACCTCATCATGGACTATCTTTGGCCTGTACTTGGCGCCCAT 69 FBan0010062 FBgn0034439 CG10062 2 2R CG10062 CG10062 anon-WO0140519.226 CDMC20420 2 12 7 DAC11-F24 2-CG10062-RA_1 CG10062 CGGTGTTGATCGTTCGATGTCCTGGTTCACCTCATCATGGACTATCTTTGGCCTGTACTTGGCGCCCAT 69 FBan0010062 FBgn0034439 CG10062 2 2R CG10062 CG10062 anon-WO0140519.226 CDMC20421 2 13 7 DAC11-J12 5-CG10090-RA_1 CG10090 CAGTGGGAGGCCATACTGGAGACTATTGATCCGAAGAGAGCGTCATCCACTCAAGATTTCGCACTGGCG 69 FBan0010090 FBgn0038018 Tim17a1 3 3R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a1 Tim17a1 CG10090 CDMC20421 2 14 7 DAC11-J12 5-CG10090-RA_1 CG10090 CAGTGGGAGGCCATACTGGAGACTATTGATCCGAAGAGAGCGTCATCCACTCAAGATTTCGCACTGGCG 69 FBan0010090 FBgn0038018 Tim17a1 3 3R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a1 Tim17a1 CG10090 CDMC20422 2 15 7 DAC11-J24 2-CG10098-RA_1 CG10098 CGCGAGAAAAGCACGGATAAAAATGACCAACGGTGACTGCTTTGTTGTTCTGCCCGAGAACTGTGCCGA 69 FBan0010098 FBgn0037472 CG10098 3 3R CG10098 CG10098 CDMC20422 2 16 7 DAC11-J24 2-CG10098-RA_1 CG10098 CGCGAGAAAAGCACGGATAAAAATGACCAACGGTGACTGCTTTGTTGTTCTGCCCGAGAACTGTGCCGA 69 FBan0010098 FBgn0037472 CG10098 3 3R CG10098 CG10098 CDMC20423 2 17 7 DAC11-N12 23-CG10130-RA_2 CG10130 CGTTCTTAAGCCATGCATTTCGTAGCCAATAAAATACTTTCACCTCAACGAGCGTGAACAATGTCGACG 69 FBan0010130 FBgn0010638 Sec61beta 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616" protein transporter activity; GO:0008565; ; GO:0008565 translocon complex; GO:0005784 Sec61beta Sec61beta "CG10130, l(2)07214, DSec61beta, Sec61beta, Sec61" CDMC20423 2 18 7 DAC11-N12 23-CG10130-RA_2 CG10130 CGTTCTTAAGCCATGCATTTCGTAGCCAATAAAATACTTTCACCTCAACGAGCGTGAACAATGTCGACG 69 FBan0010130 FBgn0010638 Sec61beta 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616" protein transporter activity; GO:0008565; ; GO:0008565 translocon complex; GO:0005784 Sec61beta Sec61beta "CG10130, l(2)07214, DSec61beta, Sec61beta, Sec61" CDMC20424 2 19 7 DAC11-N24 8-CG10139-RA_1 CG10139 TGCATCGGATCAGTCCGTCGACTACGAGGAAATCATTGAGAACCTGGCACTTTACGAACCAGAGCAGGT 69 FBan0010139 FBgn0033951 CG10139 2 2R CG10139 CG10139 CDMC20424 2 20 7 DAC11-N24 8-CG10139-RA_1 CG10139 TGCATCGGATCAGTCCGTCGACTACGAGGAAATCATTGAGAACCTGGCACTTTACGAACCAGAGCAGGT 69 FBan0010139 FBgn0033951 CG10139 2 2R CG10139 CG10139 CDMC20425 2 21 7 DAC12-B12 18-CG30096-RA_2 CG30096 CGCCCACATCAAGAAGTGCTTCAGCATCAAGAGACGAGGTCCTTTGTACAGGATTTATGGATATGCGGA 69 FBan0030096 FBgn0050096 CG30096 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30096 CG30096 CDMC20425 2 22 7 DAC12-B12 18-CG30096-RA_2 CG30096 CGCCCACATCAAGAAGTGCTTCAGCATCAAGAGACGAGGTCCTTTGTACAGGATTTATGGATATGCGGA 69 FBan0030096 FBgn0050096 CG30096 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30096 CG30096 CDMC20426 2 23 7 DAC12-B24 14-CG30103-RA_1 CG30103 TGTACTTTTGTCACCGATTTCTCGTTGTCTAGTCTTTCCACGTACGGATTGCGTCTCCATGGGGCATCA 69 FBan0030103 FBgn0050103 CG30103 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" hydrolase activity; GO:0016787 ; EC:3.-.-.-; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0008081 ; EC:3.1.4.- CG30103 CG30103 "CG4837, CG4837, BcDNA:AT08275" CDMC20426 2 24 7 DAC12-B24 14-CG30103-RA_1 CG30103 TGTACTTTTGTCACCGATTTCTCGTTGTCTAGTCTTTCCACGTACGGATTGCGTCTCCATGGGGCATCA 69 FBan0030103 FBgn0050103 CG30103 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" hydrolase activity; GO:0016787 ; EC:3.-.-.-; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0008081 ; EC:3.1.4.- CG30103 CG30103 "CG4837, CG4837, BcDNA:AT08275" CDMC20427 2 25 7 DAC12-F12 18-CG30147-RB_5 CG30147 ACGAATACGACGATCACTACTTTCTCACGGATCCTCGGGAGTTCATATACGAGTTCTATCCGCTGCAGG 69 FBan0030147 FBgn0050147 Hil 2 2R zinc ion binding; GO:0008270; ; GO:0008270 Hil Hillarin "CG13435, CG30147, CG10439, CG13435, CG13435, CG30147, CG30147, D-hillarin, Hillarin" CDMC20427 2 26 7 DAC12-F12 18-CG30147-RB_5 CG30147 ACGAATACGACGATCACTACTTTCTCACGGATCCTCGGGAGTTCATATACGAGTTCTATCCGCTGCAGG 69 FBan0030147 FBgn0050147 Hil 2 2R zinc ion binding; GO:0008270; ; GO:0008270 Hil Hillarin "CG13435, CG30147, CG10439, CG13435, CG13435, CG30147, CG30147, D-hillarin, Hillarin" CDMC20428 2 1 8 DAC12-F24 23-CG30153-RA_7 CG30153 TCGTGTTTCGTGCTTAAATATAGCCTTAGCCCATCTATAGATCTCTCTGTATGTCCTGTATGCGCTAGC 69 FBan0030153 FBgn0050153 CG30153 2 2R CG30153 CG30153 CDMC20428 2 2 8 DAC12-F24 23-CG30153-RA_7 CG30153 TCGTGTTTCGTGCTTAAATATAGCCTTAGCCCATCTATAGATCTCTCTGTATGTCCTGTATGCGCTAGC 69 FBan0030153 FBgn0050153 CG30153 2 2R CG30153 CG30153 CDMC20429 2 3 8 DAC12-J12 1-CG30184-RA_1 CG30184 GCTCGGTGATCATATGCTTCATATCACTGATTGGAGCTTTCTACGCCGAGCGGCCGACGATGAAGCACG 69 FBan0030184 FBgn0050184 CG30184 2 2R carbohydrate metabolism; GO:0005975; lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG30184 CG30184 CDMC20429 2 4 8 DAC12-J12 1-CG30184-RA_1 CG30184 GCTCGGTGATCATATGCTTCATATCACTGATTGGAGCTTTCTACGCCGAGCGGCCGACGATGAAGCACG 69 FBan0030184 FBgn0050184 CG30184 2 2R carbohydrate metabolism; GO:0005975; lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG30184 CG30184 CDMC20430 2 5 8 DAC12-J24 23-CG30193-RB_5 CG30193 TCAGCGAACAATCGGATTTTACACACTCAGCGAAACACTTACACTTCATCACATTAACACTGTCGCCCA 69 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20430 2 6 8 DAC12-J24 23-CG30193-RB_5 CG30193 TCAGCGAACAATCGGATTTTACACACTCAGCGAAACACTTACACTTCATCACATTAACACTGTCGCCCA 69 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20431 2 7 8 DAC12-N12 15-CG30281-RA_5 CG30281 AGCTGCCGGAATCAACAGTAATGGCATCCATGTTATTGAAGTTCCGGGTCTGGAACCTTTTCCGGTTTA 69 FBan0030281 FBgn0050281 CG30281 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30281 CG30281 "CG6676, CG6676" CDMC20431 2 8 8 DAC12-N12 15-CG30281-RA_5 CG30281 AGCTGCCGGAATCAACAGTAATGGCATCCATGTTATTGAAGTTCCGGGTCTGGAACCTTTTCCGGTTTA 69 FBan0030281 FBgn0050281 CG30281 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30281 CG30281 "CG6676, CG6676" CDMC20432 2 9 8 DAC12-N24 7-CG30289-RA_1 CG30289 GGAGGCCCATTGAGCTCGAAATTTCATTATGGCAACAGGCTTCTGAGTTTCCAGTACGGCTTGGTCAGC 69 FBan0030289 FBgn0050289 CG30289 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30289 CG30289 CDMC20432 2 10 8 DAC12-N24 7-CG30289-RA_1 CG30289 GGAGGCCCATTGAGCTCGAAATTTCATTATGGCAACAGGCTTCTGAGTTTCCAGTACGGCTTGGTCAGC 69 FBan0030289 FBgn0050289 CG30289 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30289 CG30289 CDMC20433 2 11 8 DAC13-B12 3-CG1322-RB_1 CG1322 TTTCGGTTAAGCCAGGCTGGGTTGACATTGCACAACCGCTCGAAAGGAATTTTCCACCCACAACC 65 FBan0001322 FBgn0004606 zfh1 3 3R central nervous system development; GO:0007417; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh1 Zn finger homeodomain 1 "CG1322, zfh-1, Zfh-1, Zfh1, l(3)00865, ZFH-1, zfl-1" CDMC20433 2 12 8 DAC13-B12 3-CG1322-RB_1 CG1322 TTTCGGTTAAGCCAGGCTGGGTTGACATTGCACAACCGCTCGAAAGGAATTTTCCACCCACAACC 65 FBan0001322 FBgn0004606 zfh1 3 3R central nervous system development; GO:0007417; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh1 Zn finger homeodomain 1 "CG1322, zfh-1, Zfh-1, Zfh1, l(3)00865, ZFH-1, zfl-1" CDMC20434 2 13 8 DAC13-B24 2-CG13243-RA_2 CG13243 TATCATTTCGGCGCTATTGAGACCGATTGAGCCCTCGGACGATCAGTACAAGGTGTGCGACTGGG 65 FBan0013243 FBgn0028903 CG13243 2 2L CG13243 CG13243 BG:DS02252.1 CDMC20434 2 14 8 DAC13-B24 2-CG13243-RA_2 CG13243 TATCATTTCGGCGCTATTGAGACCGATTGAGCCCTCGGACGATCAGTACAAGGTGTGCGACTGGG 65 FBan0013243 FBgn0028903 CG13243 2 2L CG13243 CG13243 BG:DS02252.1 CDMC20435 2 15 8 DAC13-F12 15-CG1341-RA_3 CG1341 CGCTGCCTCCCAAGATTGATCCTACGGTTACCATGATGCAGGTTGAGGACAAGCCGGACGTCACC 65 FBan0001341 FBgn0028687 Rpt1 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt1 Rpt1 "CG1341, CG1341, CG1341, CG1341, l(2)43Ed, l(2)05643, p48B, AAA ATPase, Dmp48B, Dm_Rpt1, dRpt1, anon-WO0118547.90, lethal(2)43Ed" CDMC20435 2 16 8 DAC13-F12 15-CG1341-RA_3 CG1341 CGCTGCCTCCCAAGATTGATCCTACGGTTACCATGATGCAGGTTGAGGACAAGCCGGACGTCACC 65 FBan0001341 FBgn0028687 Rpt1 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt1 Rpt1 "CG1341, CG1341, CG1341, CG1341, l(2)43Ed, l(2)05643, p48B, AAA ATPase, Dmp48B, Dm_Rpt1, dRpt1, anon-WO0118547.90, lethal(2)43Ed" CDMC20436 2 17 8 DAC13-F24 5-CG13455-RA_1 CG13455 GTGGGAAAGGACCAAGGATGAACCTGAGCACCCTTCTGAGGAGTGTGAGCAACGGTCTTGGCTTC 65 FBan0013455 FBgn0036498 CG13455 3 3L CG13455 CG13455 CDMC20436 2 18 8 DAC13-F24 5-CG13455-RA_1 CG13455 GTGGGAAAGGACCAAGGATGAACCTGAGCACCCTTCTGAGGAGTGTGAGCAACGGTCTTGGCTTC 65 FBan0013455 FBgn0036498 CG13455 3 3L CG13455 CG13455 CDMC20437 2 19 8 DAC13-J12 4-CG13542-RA_1 CG13542 GATGAGGATGAAGTGGAGGCTGGGCATGCTACAGTCCATCTGGGAGCGGGATCCACATTCGAATG 65 FBan0013542 FBgn0034809 CG13542 2 2R CG13542 CG13542 CDMC20437 2 20 8 DAC13-J12 4-CG13542-RA_1 CG13542 GATGAGGATGAAGTGGAGGCTGGGCATGCTACAGTCCATCTGGGAGCGGGATCCACATTCGAATG 65 FBan0013542 FBgn0034809 CG13542 2 2R CG13542 CG13542 CDMC20438 2 21 8 DAC13-J24 3-CG13576-RA_4 CG13576 TATACGCCTTTCCCAACAACGTTTTCAGCAGTCCGGTGCAGATGATCATGAAGGCGGGATTCCCC 65 FBan0013576 FBgn0034994 CG13576 2 2R CG13576 CG13576 CDMC20438 2 22 8 DAC13-J24 3-CG13576-RA_4 CG13576 TATACGCCTTTCCCAACAACGTTTTCAGCAGTCCGGTGCAGATGATCATGAAGGCGGGATTCCCC 65 FBan0013576 FBgn0034994 CG13576 2 2R CG13576 CG13576 CDMC20439 2 23 8 DAC13-N12 15-CG13672-RA_1 CG13672 GAGACCAGCCAGTTTGTAAATGGACTGGATCTACAGGGACCGATTTTTCTCCATGAGCCACCGCA 65 FBan0013672 FBgn0035862 CG13672 3 3L CG13672 CG13672 CDMC20439 2 24 8 DAC13-N12 15-CG13672-RA_1 CG13672 GAGACCAGCCAGTTTGTAAATGGACTGGATCTACAGGGACCGATTTTTCTCCATGAGCCACCGCA 65 FBan0013672 FBgn0035862 CG13672 3 3L CG13672 CG13672 CDMC20440 2 25 8 DAC13-N24 6-CG13687-RA_1 CG13687 CAGCAGCCCGATCGCAGTACATCGAAAATGCTCAGTGCCCTATTCGGATTCAGTCCCAGCACTCC 65 FBgn0031269 CDMC20440 2 26 8 DAC13-N24 6-CG13687-RA_1 CG13687 CAGCAGCCCGATCGCAGTACATCGAAAATGCTCAGTGCCCTATTCGGATTCAGTCCCAGCACTCC 65 FBgn0031269 CDMC20441 2 1 9 DAC14-B12 23-CG1656-RA_1 CG1656 CCAATGGACATTTAGGGAACCGAGGAATATTTGAGCTTTCACCAAATAAATTTGAGTTTTAACAACATG 69 FBan0001656 FBgn0040093 lectin-46Ca 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Ca lectin-46Ca "CG1656, CG1656, AC 007330A, AC007330a, lectin-44Ca" CDMC20441 2 2 9 DAC14-B12 23-CG1656-RA_1 CG1656 CCAATGGACATTTAGGGAACCGAGGAATATTTGAGCTTTCACCAAATAAATTTGAGTTTTAACAACATG 69 FBan0001656 FBgn0040093 lectin-46Ca 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Ca lectin-46Ca "CG1656, CG1656, AC 007330A, AC007330a, lectin-44Ca" CDMC20442 2 3 9 DAC14-B24 11-CG1664-RA_2 CG1664 ATGATGGTTTTCACCGTGACGGGATTATTCAAAGAGCTGAACGACGAGACCAACAATCCCGCCTCCATG 69 FBan0001664 FBgn0003321 sbr X X adult behavior; GO:0030534; long-term memory; GO:0007616; mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein import into nucleus; GO:0006606 mRNA binding; GO:0003729; ; GO:0003729; protein transporter activity; GO:0008565; ; GO:0008565 nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 sbr small bristles "CG1664, CG17335, CG1664, CG1664, CG1664, locus 1, l(1)ts403, sbt: shorter bristles, shorter-bristles, l(1)ts, CT4634, nxf1, nuclear export factor 1, NXF1, DmNXF1, PABPr, dTap, l(1)9Fd, l(1)G1, sbt" CDMC20442 2 4 9 DAC14-B24 11-CG1664-RA_2 CG1664 ATGATGGTTTTCACCGTGACGGGATTATTCAAAGAGCTGAACGACGAGACCAACAATCCCGCCTCCATG 69 FBan0001664 FBgn0003321 sbr X X adult behavior; GO:0030534; long-term memory; GO:0007616; mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein import into nucleus; GO:0006606 mRNA binding; GO:0003729; ; GO:0003729; protein transporter activity; GO:0008565; ; GO:0008565 nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 sbr small bristles "CG1664, CG17335, CG1664, CG1664, CG1664, locus 1, l(1)ts403, sbt: shorter bristles, shorter-bristles, l(1)ts, CT4634, nxf1, nuclear export factor 1, NXF1, DmNXF1, PABPr, dTap, l(1)9Fd, l(1)G1, sbt" CDMC20443 2 5 9 DAC14-F12 8-CG16732-RA_2 CG16732 ACATCCTGGGTATATTTCCCTACCGCCACATTTCACCCTTTTTTGTGATGCAGCCTTTGGTGCGGACTT 69 FBan0016732 FBgn0039086 CG16732 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG16732 CG16732 CDMC20443 2 6 9 DAC14-F12 8-CG16732-RA_2 CG16732 ACATCCTGGGTATATTTCCCTACCGCCACATTTCACCCTTTTTTGTGATGCAGCCTTTGGTGCGGACTT 69 FBan0016732 FBgn0039086 CG16732 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG16732 CG16732 CDMC20444 2 7 9 DAC14-F24 3-CG16739-RA_3 CG16739 GCCGCCATGAAGTTCTATCCGAATGCAGATGTCTGGTTCTGTGTGGACAAGACCAGCTGCTTGAACAGC 69 FBan0016739 FBgn0034505 CG16739 2 2R CG16739 CG16739 CDMC20444 2 8 9 DAC14-F24 3-CG16739-RA_3 CG16739 GCCGCCATGAAGTTCTATCCGAATGCAGATGTCTGGTTCTGTGTGGACAAGACCAGCTGCTTGAACAGC 69 FBan0016739 FBgn0034505 CG16739 2 2R CG16739 CG16739 CDMC20445 2 9 9 DAC14-J12 3-CG16781-RA_2 CG16781 TGCCCTTACATACGGAGCATTCACTATCATCCAGGTGGTGGGTCAAGATCGCGCAATGCAGTTGATGGA 69 FBan0016781 FBgn0029661 CG16781 X X CG16781 CG16781 CDMC20445 2 10 9 DAC14-J12 3-CG16781-RA_2 CG16781 TGCCCTTACATACGGAGCATTCACTATCATCCAGGTGGTGGGTCAAGATCGCGCAATGCAGTTGATGGA 69 FBan0016781 FBgn0029661 CG16781 X X CG16781 CG16781 CDMC20446 2 11 9 DAC14-J24 2-CG16788-RA_2 CG16788 TGCGCATTCATGTCGGTCGGCTTACCCGCAACGTTACCAAGGACCATGTGTTCGAGATATTTAGCAGCT 69 FBan0016788 FBgn0037707 RnpS1 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184; nuclear mRNA splicing, via spliceosome; GO:0000398; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 RnpS1 RNA-binding protein S1 "CG16788, CG16788, CG16788, cg16788, RRM-domain protein, DEK" CDMC20446 2 12 9 DAC14-J24 2-CG16788-RA_2 CG16788 TGCGCATTCATGTCGGTCGGCTTACCCGCAACGTTACCAAGGACCATGTGTTCGAGATATTTAGCAGCT 69 FBan0016788 FBgn0037707 RnpS1 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184; nuclear mRNA splicing, via spliceosome; GO:0000398; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 RnpS1 RNA-binding protein S1 "CG16788, CG16788, CG16788, cg16788, RRM-domain protein, DEK" CDMC20447 2 13 9 DAC14-N12 17-CG16837-RA_3 CG16837 TCCAGAAGTTCGAGGTTATCAGTAACTGAAACTCAGCGCAAAAGCACTCCAGTGGTAAAGAAGGCGGTT 69 FBan0016837 FBgn0035009 CG16837 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG16837 CG16837 CDMC20447 2 14 9 DAC14-N12 17-CG16837-RA_3 CG16837 TCCAGAAGTTCGAGGTTATCAGTAACTGAAACTCAGCGCAAAAGCACTCCAGTGGTAAAGAAGGCGGTT 69 FBan0016837 FBgn0035009 CG16837 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG16837 CG16837 CDMC20448 2 15 9 DAC14-N24 1-CG16852-RA_1 CG16852 TGGCTGGAATGCTGAGCACAAAGATGTTCAGATTCCAAGGGACCAACTAACCCACAGGCAGATCAGCAA 69 FBan0016852 FBgn0028942 CG16852 2 2L CG16852 CG16852 "BG:BACR48E02.2, BcDNA:AT28681" CDMC20448 2 16 9 DAC14-N24 1-CG16852-RA_1 CG16852 TGGCTGGAATGCTGAGCACAAAGATGTTCAGATTCCAAGGGACCAACTAACCCACAGGCAGATCAGCAA 69 FBan0016852 FBgn0028942 CG16852 2 2L CG16852 CG16852 "BG:BACR48E02.2, BcDNA:AT28681" CDMC20449 2 17 9 DAC15-B12 23-CG18628-RA_1 CG18628 TGACGGCAACTTCATCGATCTTAAACCGCCTTTAACTTTTAATAAAGAGCAATATTGAACAAAGAACAT 69 FBan0018628 FBgn0036091 CG18628 3 3L CG18628 CG18628 BcDNA:GH08251 CDMC20449 2 18 9 DAC15-B12 23-CG18628-RA_1 CG18628 TGACGGCAACTTCATCGATCTTAAACCGCCTTTAACTTTTAATAAAGAGCAATATTGAACAAAGAACAT 69 FBan0018628 FBgn0036091 CG18628 3 3L CG18628 CG18628 BcDNA:GH08251 CDMC20450 2 19 9 DAC15-B24 16-CG18646-RA_1 CG18646 GGCGGCGCTACTAATTGGATGGATGTGTTCCCGTATGACTGGTCCTAAGACTTATGGCTAACACACATA 69 FBan0018646 FBgn0030444 CG18646 X X cell adhesion; GO:0007155 protein binding; GO:0005515; GTPase activator activity; GO:0005096; ; GO:0005515; ; GO:0005096 CG18646 CG18646 CG4368 CDMC20450 2 20 9 DAC15-B24 16-CG18646-RA_1 CG18646 GGCGGCGCTACTAATTGGATGGATGTGTTCCCGTATGACTGGTCCTAAGACTTATGGCTAACACACATA 69 FBan0018646 FBgn0030444 CG18646 X X cell adhesion; GO:0007155 protein binding; GO:0005515; GTPase activator activity; GO:0005096; ; GO:0005515; ; GO:0005096 CG18646 CG18646 CG4368 CDMC20451 2 21 9 DAC15-F12 8-CG18741-RA_1 CG18741 ATGGATGGTCCAAGGGATGGTTAGGTGGGGAGGGAACAGAGATGGGGGAATTTCAAACAAATGGCAATT 69 FBan0018741 FBgn0015129 DopR2 3 3R dopamine receptor signaling pathway; GO:0007212; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; amine receptor activity; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0004952; kinase activity; GO:0016301; ; GO:0016301; ; GO:0008227; ; GO:0004952; dopamine D1 receptor activity; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 DopR2 Dopamine receptor 2 "CG7569, CG18741, CG7569, Dar2, DopR99B, DAMB, dopamine receptor in mushroom bodies, DOPR99B, DopRII, DopD1" CDMC20451 2 22 9 DAC15-F12 8-CG18741-RA_1 CG18741 ATGGATGGTCCAAGGGATGGTTAGGTGGGGAGGGAACAGAGATGGGGGAATTTCAAACAAATGGCAATT 69 FBan0018741 FBgn0015129 DopR2 3 3R dopamine receptor signaling pathway; GO:0007212; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; amine receptor activity; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0004952; kinase activity; GO:0016301; ; GO:0016301; ; GO:0008227; ; GO:0004952; dopamine D1 receptor activity; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 DopR2 Dopamine receptor 2 "CG7569, CG18741, CG7569, Dar2, DopR99B, DAMB, dopamine receptor in mushroom bodies, DOPR99B, DopRII, DopD1" CDMC20452 2 23 9 DAC15-F24 3-CG18765-RA_1 CG18765 CGGATAGGATCGTGCACTTTGGACCACCAGTCATCCAGGCAAAGCTGAAATCCAGCCACATATATGGCG 69 FBan0018765 FBgn0042110 CG18765 3 3R CG18765 CG18765 CDMC20452 2 24 9 DAC15-F24 3-CG18765-RA_1 CG18765 CGGATAGGATCGTGCACTTTGGACCACCAGTCATCCAGGCAAAGCTGAAATCCAGCCACATATATGGCG 69 FBan0018765 FBgn0042110 CG18765 3 3R CG18765 CG18765 CDMC20453 2 25 9 DAC15-J12 17-CG18814-RA_1 CG18814 TCCACGAATTGGATATACCGAACCTGTGGAATCCCCAGTTAGATGATTGCGTATTCGTCTGCTTGAGCT 69 FBan0018814 FBgn0042137 CG18814 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18814 CG18814 CDMC20453 2 26 9 DAC15-J12 17-CG18814-RA_1 CG18814 TCCACGAATTGGATATACCGAACCTGTGGAATCCCCAGTTAGATGATTGCGTATTCGTCTGCTTGAGCT 69 FBan0018814 FBgn0042137 CG18814 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18814 CG18814 CDMC20454 2 1 10 DAC15-J24 23-CG1883-RC_2 CG1883 GTGCAGCGAAATAATAAGAGAAAAGGCCGCAATGATAATGGCAAATTACGATTTTCTTGTGAATCCAGA 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC20454 2 2 10 DAC15-J24 23-CG1883-RC_2 CG1883 GTGCAGCGAAATAATAAGAGAAAAGGCCGCAATGATAATGGCAAATTACGATTTTCTTGTGAATCCAGA 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC20455 2 3 10 DAC15-N12 47-CG1906-RE_4 CG1906 TAGTAGGCGATGAAAATCAAGTGGAAAACGATCGTTTTTTCTTCTTAAACTTTTACTTACGGCAGACAC 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC20455 2 4 10 DAC15-N12 47-CG1906-RE_4 CG1906 TAGTAGGCGATGAAAATCAAGTGGAAAACGATCGTTTTTTCTTCTTAAACTTTTACTTACGGCAGACAC 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC20456 2 5 10 DAC15-N24 13-CG1919-RA_1 CG1919 CGTTGACGACCTCACAAAACGGCTGATCGATCCACTGACGAAGCCTGCTAAAATACTCAGTACCACAGT 69 FBan0001919 FBgn0035281 CG1919 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG1919 CG1919 CDMC20456 2 6 10 DAC15-N24 13-CG1919-RA_1 CG1919 CGTTGACGACCTCACAAAACGGCTGATCGATCCACTGACGAAGCCTGCTAAAATACTCAGTACCACAGT 69 FBan0001919 FBgn0035281 CG1919 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG1919 CG1919 CDMC20457 2 7 10 DAC16-B12 23-CG32743-RA_4 CG32743 GGGCTTTTGACATACACCACACATCAAAAATTTGGAGCGGAGAAAGACTACTACATTCAACATTGGGGC 69 FBan0032743 FBgn0052743 Smg1 X X "intracellular signaling cascade; GO:0007242; mRNA catabolism, nonsense-mediated decay; GO:0000184; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Smg1 Smg1 "CG4549, CG32743, CG4555, CG4549, CG4549, CG4549, CG32743, CG32743, CG4549, CG4555, clone 1.24, FRAP-related, SMG1, anon-WO0170980.133, anon-EST:Liang-1.24" CDMC20457 2 8 10 DAC16-B12 23-CG32743-RA_4 CG32743 GGGCTTTTGACATACACCACACATCAAAAATTTGGAGCGGAGAAAGACTACTACATTCAACATTGGGGC 69 FBan0032743 FBgn0052743 Smg1 X X "intracellular signaling cascade; GO:0007242; mRNA catabolism, nonsense-mediated decay; GO:0000184; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Smg1 Smg1 "CG4549, CG32743, CG4555, CG4549, CG4549, CG4549, CG32743, CG32743, CG4549, CG4555, clone 1.24, FRAP-related, SMG1, anon-WO0170980.133, anon-EST:Liang-1.24" CDMC20458 2 9 10 DAC16-B24 3-CG32754-RA_6 CG32754 TCCTTGGGTACAGCGACGGAGAATGGTAGCTACTATAGCTATCGATTGGGAACCTACGATGGCTGGCGC 69 FBan0032754 FBgn0040069 vanin-like X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.- extrinsic to membrane; GO:0019898 vanin-like vanin-like "CG3648, CG32754, CG3648, CG3648" CDMC20458 2 10 10 DAC16-B24 3-CG32754-RA_6 CG32754 TCCTTGGGTACAGCGACGGAGAATGGTAGCTACTATAGCTATCGATTGGGAACCTACGATGGCTGGCGC 69 FBan0032754 FBgn0040069 vanin-like X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.- extrinsic to membrane; GO:0019898 vanin-like vanin-like "CG3648, CG32754, CG3648, CG3648" CDMC20459 2 11 10 DAC16-F12 3-CG32793-RA_6 CG32793 GGGCCTGAACTCTCCCTATCCCTACGCTTATGTCCAGGGTCAGACGAAGAAACAAAGGGTTCCCATCAA 69 FBan0032793 FBgn0052793 CG32793 X X CG32793 CG32793 "CG18089, CG18852, CG3591, EG:100G7.1, EG:100G7.2, anon-3Ca, anon-3Cb" CDMC20459 2 12 10 DAC16-F12 3-CG32793-RA_6 CG32793 GGGCCTGAACTCTCCCTATCCCTACGCTTATGTCCAGGGTCAGACGAAGAAACAAAGGGTTCCCATCAA 69 FBan0032793 FBgn0052793 CG32793 X X CG32793 CG32793 "CG18089, CG18852, CG3591, EG:100G7.1, EG:100G7.2, anon-3Ca, anon-3Cb" CDMC20460 2 13 10 DAC16-F24 23-CG32800-RA_1 CG32800 GCCCTTTGTTGCTATTTTATTCGTAGTCACTTAAGAATCCAATAAACACCGAATCCTTTCGAACTATAT 69 FBgn0023548 CDMC20460 2 14 10 DAC16-F24 23-CG32800-RA_1 CG32800 GCCCTTTGTTGCTATTTTATTCGTAGTCACTTAAGAATCCAATAAACACCGAATCCTTTCGAACTATAT 69 FBgn0023548 CDMC20461 2 15 10 DAC16-J12 1-CG32834-RA_1 CG32834 ACGCCAATGTACCTTGGTTCACAGGTTGGATTGCCGAGAACACCGAAGATGAGGATACAACCGCTTCGA 69 FBan0032834 FBgn0052834 CG32834 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32834 CG32834 "CG9898, CG30331, CG9898, SPH196" CDMC20461 2 16 10 DAC16-J12 1-CG32834-RA_1 CG32834 ACGCCAATGTACCTTGGTTCACAGGTTGGATTGCCGAGAACACCGAAGATGAGGATACAACCGCTTCGA 69 FBan0032834 FBgn0052834 CG32834 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32834 CG32834 "CG9898, CG30331, CG9898, SPH196" CDMC20462 2 17 10 DAC16-J24 14-CG32847-RB_1 CG32847 TGCTGATCACGGCATAAGGGATGGGCAGAACGAAACACTCCTTTCTAAGTTCTTTCTCTACGTGGCCAT 69 FBan0032847 FBgn0052847 CG32847 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32847 CG32847 CDMC20462 2 18 10 DAC16-J24 14-CG32847-RB_1 CG32847 TGCTGATCACGGCATAAGGGATGGGCAGAACGAAACACTCCTTTCTAAGTTCTTTCTCTACGTGGCCAT 69 FBan0032847 FBgn0052847 CG32847 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32847 CG32847 CDMC20463 2 19 10 DAC16-N12 1-CG32922-RA_1 CG32922 GCGTTCGGTCGCGAGATACCTGGCTAAGTGGAACCCCAAAAAAAGATCCCTGGATCGGTACAAACTCGA 69 FBgn0052922 CDMC20463 2 20 10 DAC16-N12 1-CG32922-RA_1 CG32922 GCGTTCGGTCGCGAGATACCTGGCTAAGTGGAACCCCAAAAAAAGATCCCTGGATCGGTACAAACTCGA 69 FBgn0052922 CDMC20464 2 21 10 DAC16-N24 8-CG32944-RB_1 CG32944 CCTCCCGAAGACCACCTCAACTGTGATCCTTGCCTAGAACTGGAGGAAATGATTGTAGAATCGCGGCCC 69 FBan0032944 FBgn0052944 CG32944 3 3R actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 CG32944 CG32944 "CG10532, CG9818" CDMC20464 2 22 10 DAC16-N24 8-CG32944-RB_1 CG32944 CCTCCCGAAGACCACCTCAACTGTGATCCTTGCCTAGAACTGGAGGAAATGATTGTAGAATCGCGGCCC 69 FBan0032944 FBgn0052944 CG32944 3 3R actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 CG32944 CG32944 "CG10532, CG9818" CDMC20465 2 23 10 DAC17-B12 3-CG12286-RA_2 CG12286 ATTGCCGATATGCCGGGTGTGAACCGTATGTACCTGCAACAATTGTCCTTGGTGTCCATTGGCCT 65 FBan0012286 FBgn0001296 kar 3 3R cation transport; GO:0006812; ommochrome biosynthesis; GO:0006727 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 plasma membrane; GO:0005886 kar karmoisin CG12286 CDMC20465 2 24 10 DAC17-B12 3-CG12286-RA_2 CG12286 ATTGCCGATATGCCGGGTGTGAACCGTATGTACCTGCAACAATTGTCCTTGGTGTCCATTGGCCT 65 FBan0012286 FBgn0001296 kar 3 3R cation transport; GO:0006812; ommochrome biosynthesis; GO:0006727 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 plasma membrane; GO:0005886 kar karmoisin CG12286 CDMC20466 2 25 10 DAC17-B24 6-CG12363-RA_1 CG12363 GACACCGACGGATCGTGCACAGTACGCTGGGAGAACAAGACCATGTACTGCATCGTTTCGGTCTT 65 FBan0012363 FBgn0024432 Dlc90F 3 3R RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlc90F Dynein light chain 90F "CG12363, CG12363, CG12363, Tctex, tctex-1, tctex, dynein light chain; tctex-1, dynein light chain; tctex-1., bs35g12.y1, dtctex-1, Tctex-1, l(3)04091, Dynein light chain 90F" CDMC20466 2 26 10 DAC17-B24 6-CG12363-RA_1 CG12363 GACACCGACGGATCGTGCACAGTACGCTGGGAGAACAAGACCATGTACTGCATCGTTTCGGTCTT 65 FBan0012363 FBgn0024432 Dlc90F 3 3R RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlc90F Dynein light chain 90F "CG12363, CG12363, CG12363, Tctex, tctex-1, tctex, dynein light chain; tctex-1, dynein light chain; tctex-1., bs35g12.y1, dtctex-1, Tctex-1, l(3)04091, Dynein light chain 90F" CDMC20467 2 1 11 DAC17-F12 1-CG12490-RA_2 CG12490 GTTTTGGGGTGTCTTTGTATCTGGTGTCTGCAGTGCATTGACCCCGCTCTTCATCGGTTTTGGCG 65 FBan0012490 FBgn0034782 CG12490 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12490 CG12490 CDMC20467 2 2 11 DAC17-F12 1-CG12490-RA_2 CG12490 GTTTTGGGGTGTCTTTGTATCTGGTGTCTGCAGTGCATTGACCCCGCTCTTCATCGGTTTTGGCG 65 FBan0012490 FBgn0034782 CG12490 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12490 CG12490 CDMC20468 2 3 11 DAC17-F24 1-CG12511-RA_1 CG12511 CAGGATCAGTCCCGGGGGCAGCTAGAGGTCAGAGAAATATCCCTGGAGCCAGTGAATCTTAACCG 65 FBan0012511 FBgn0031729 CG12511 2 2L CG12511 CG12511 CDMC20468 2 4 11 DAC17-F24 1-CG12511-RA_1 CG12511 CAGGATCAGTCCCGGGGGCAGCTAGAGGTCAGAGAAATATCCCTGGAGCCAGTGAATCTTAACCG 65 FBan0012511 FBgn0031729 CG12511 2 2L CG12511 CG12511 CDMC20469 2 5 11 DAC17-J12 12-CG12626-RA_1 CG12626 TCCAGAAGGCTCCCATCAATGCCATCATCGAGGATCTCAGCGACAAGCCCTGCTACTGTGACCAC 65 FBan0012626 FBgn0040851 CG12626 X X CG12626 CG12626 CDMC20469 2 6 11 DAC17-J12 12-CG12626-RA_1 CG12626 TCCAGAAGGCTCCCATCAATGCCATCATCGAGGATCTCAGCGACAAGCCCTGCTACTGTGACCAC 65 FBan0012626 FBgn0040851 CG12626 X X CG12626 CG12626 CDMC20470 2 7 11 DAC17-J24 17-CG1265-RB_6 CG1265 CTCAGAAGCTGCAAATTTCGAATTTCGACGGTCGCTATGAGTGGAGCTCTCGGAGATGTGGTGTC 65 FBan0001265 FBgn0035517 CG1265 3 3L CG1265 CG1265 BcDNA:RE09466 CDMC20470 2 8 11 DAC17-J24 17-CG1265-RB_6 CG1265 CTCAGAAGCTGCAAATTTCGAATTTCGACGGTCGCTATGAGTGGAGCTCTCGGAGATGTGGTGTC 65 FBan0001265 FBgn0035517 CG1265 3 3L CG1265 CG1265 BcDNA:RE09466 CDMC20471 2 9 11 DAC17-N12 11-CG12768-RA_1 CG12768 GCTGCAGCCCGAACCAAAGAGTAGTCTGCCAGTGACTATTCCCAGTCTAAGTCTCACCCTCAGCC 65 FBan0012768 FBgn0037206 CG12768 3 3L CG12768 CG12768 CDMC20471 2 10 11 DAC17-N12 11-CG12768-RA_1 CG12768 GCTGCAGCCCGAACCAAAGAGTAGTCTGCCAGTGACTATTCCCAGTCTAAGTCTCACCCTCAGCC 65 FBan0012768 FBgn0037206 CG12768 3 3L CG12768 CG12768 CDMC20472 2 11 11 DAC17-N24 3-CG12811-RA_1 CG12811 AACTTGATGGTGGACTGTGTGAAGCTGTCCGTTCAACTGGAGACGCGTATTTCGGACACGGAGCA 65 FBan0012811 FBgn0037779 CG12811 3 3R CG12811 CG12811 CDMC20472 2 12 11 DAC17-N24 3-CG12811-RA_1 CG12811 AACTTGATGGTGGACTGTGTGAAGCTGTCCGTTCAACTGGAGACGCGTATTTCGGACACGGAGCA 65 FBan0012811 FBgn0037779 CG12811 3 3R CG12811 CG12811 CDMC20473 2 13 11 DAC18-B12 14-CG5738-RB_1 CG5738 TCCGCTGCGAATTAAGACCATCTAACGGTGAACCTTTCGGTCACTAGTCCAAATTAAGCCTCCTGCC 67 FBan0005738 FBgn0022238 lolal 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 lolal lola like "CG5738, CG5738, CG5738, l(2)k02512, 25/12, batman, EP647, l(2)kO2512, Batman, Ban, anon-WO0172774.186, EP0647, anon-EST:fe3D3, anon-fast-evolving-3D3, lola like" CDMC20473 2 14 11 DAC18-B12 14-CG5738-RB_1 CG5738 TCCGCTGCGAATTAAGACCATCTAACGGTGAACCTTTCGGTCACTAGTCCAAATTAAGCCTCCTGCC 67 FBan0005738 FBgn0022238 lolal 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 lolal lola like "CG5738, CG5738, CG5738, l(2)k02512, 25/12, batman, EP647, l(2)kO2512, Batman, Ban, anon-WO0172774.186, EP0647, anon-EST:fe3D3, anon-fast-evolving-3D3, lola like" CDMC20474 2 15 11 DAC18-B24 2-CG5948-RA_3 CG5948 CCCTACAACTCGGACATTAGGGTGACGATCAATGTGACTGGATTGCCACCCGGTAAACATGCCCTGC 67 FBan0005948 FBgn0039386 CG5948 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG5948 CG5948 CDMC20474 2 16 11 DAC18-B24 2-CG5948-RA_3 CG5948 CCCTACAACTCGGACATTAGGGTGACGATCAATGTGACTGGATTGCCACCCGGTAAACATGCCCTGC 67 FBan0005948 FBgn0039386 CG5948 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG5948 CG5948 CDMC20475 2 17 11 DAC18-F12 2-CG6527-RA_3 CG6527 GATGCGGCATTTTCACCCTTCAGACCAACAGACTGGAGTGTCAATTATCCCGCCCGAGCATTTTGCC 67 FBan0006527 FBgn0036085 CG6527 3 3L CG6527 CG6527 BcDNA:AT13283 CDMC20475 2 18 11 DAC18-F12 2-CG6527-RA_3 CG6527 GATGCGGCATTTTCACCCTTCAGACCAACAGACTGGAGTGTCAATTATCCCGCCCGAGCATTTTGCC 67 FBan0006527 FBgn0036085 CG6527 3 3L CG6527 CG6527 BcDNA:AT13283 CDMC20476 2 19 11 DAC18-F24 2-CG6612-RB_3 CG6612 CGGCAGGGTGTACAATATTGGCTTCAAGAATCCCAAAGTGCCTGGCAAAGATGATGTGACGGGGGAG 67 FBan0006612 FBgn0042094 Adk3 3 3R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; nucleoside triphosphate adenylate kinase activity; GO:0046899 ; EC:2.7.4.10; ; GO:0046899 ; EC:2.7.4.10 mitochondrial matrix; GO:0005759 Adk3 Adenylate kinase-3 "CG6612, AK3, bs12h03.y1, DAK3, Adenylate kinase-3" CDMC20476 2 20 11 DAC18-F24 2-CG6612-RB_3 CG6612 CGGCAGGGTGTACAATATTGGCTTCAAGAATCCCAAAGTGCCTGGCAAAGATGATGTGACGGGGGAG 67 FBan0006612 FBgn0042094 Adk3 3 3R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; nucleoside triphosphate adenylate kinase activity; GO:0046899 ; EC:2.7.4.10; ; GO:0046899 ; EC:2.7.4.10 mitochondrial matrix; GO:0005759 Adk3 Adenylate kinase-3 "CG6612, AK3, bs12h03.y1, DAK3, Adenylate kinase-3" CDMC20477 2 21 11 DAC18-J12 3-CG7158-RA_1 CG7158 GCTACACTACACTGAAGGCCGCATATGAGCACGTGACGTCGAGAGCTCTGCAAAAAATCCCCTGAGC 67 FBan0007158 FBgn0037116 CG7158 3 3L CG7158 CG7158 CDMC20477 2 22 11 DAC18-J12 3-CG7158-RA_1 CG7158 GCTACACTACACTGAAGGCCGCATATGAGCACGTGACGTCGAGAGCTCTGCAAAAAATCCCCTGAGC 67 FBan0007158 FBgn0037116 CG7158 3 3L CG7158 CG7158 CDMC20478 2 23 11 DAC18-J24 3-CG7275-RA_1 CG7275 AGCACACCAAGAAGAGCAAGAAGGTGCCCTACGTCAGCGAGAAAAAGAAGCATGTGCTGAAGGAGGA 67 FBan0007275 FBgn0036500 CG7275 3 3L CG7275 CG7275 CDMC20478 2 24 11 DAC18-J24 3-CG7275-RA_1 CG7275 AGCACACCAAGAAGAGCAAGAAGGTGCCCTACGTCAGCGAGAAAAAGAAGCATGTGCTGAAGGAGGA 67 FBan0007275 FBgn0036500 CG7275 3 3L CG7275 CG7275 CDMC20479 2 25 11 DAC18-N12 3-CG7886-RA_3 CG7886 GACATGCACATGGAGTCGTCGTATATGTCCCGCTCCGAAGAACTCTCCTCAACGGACGTTACGCTGG 67 FBan0007886 FBgn0038248 CG7886 3 3R CG7886 CG7886 anon-WO0140519.200 CDMC20479 2 26 11 DAC18-N12 3-CG7886-RA_3 CG7886 GACATGCACATGGAGTCGTCGTATATGTCCCGCTCCGAAGAACTCTCCTCAACGGACGTTACGCTGG 67 FBan0007886 FBgn0038248 CG7886 3 3R CG7886 CG7886 anon-WO0140519.200 CDMC20480 2 1 12 DAC18-N24 17-CG7992-RA_2 CG7992 TCATATGCATCTCGTATGTGCTCAAGTTGATCTGCACCAGCATCGTGTACTTCTACTTTGTGGCGGA 67 FBan0007992 FBgn0031004 CG7992 X X CG7992 CG7992 CDMC20480 2 2 12 DAC18-N24 17-CG7992-RA_2 CG7992 TCATATGCATCTCGTATGTGCTCAAGTTGATCTGCACCAGCATCGTGTACTTCTACTTTGTGGCGGA 67 FBan0007992 FBgn0031004 CG7992 X X CG7992 CG7992 CDMC20481 2 3 12 DAC19-B12 1-CG7896-RA_1 CG7896 GCTGAAGCATCCACGACTCAAGAGCCTGGGAATCAGAGGTGATCGACTGAAGTCCATATCCTCTGGCA 68 FBan0007896 FBgn0039728 CG7896 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7896 CG7896 "CT23878, tartan/capricious-like" CDMC20481 2 4 12 DAC19-B12 1-CG7896-RA_1 CG7896 GCTGAAGCATCCACGACTCAAGAGCCTGGGAATCAGAGGTGATCGACTGAAGTCCATATCCTCTGGCA 68 FBan0007896 FBgn0039728 CG7896 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7896 CG7896 "CT23878, tartan/capricious-like" CDMC20482 2 5 12 DAC19-B24 1-CG8032-RA_1 CG8032 GTCGAGTGTTCCATGCAGCCCATGTGATATGCACCATACCGCTAGGCGTACTGAAAAACACCCATCGC 68 FBan0008032 FBgn0037606 CG8032 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8032 CG8032 CDMC20482 2 6 12 DAC19-B24 1-CG8032-RA_1 CG8032 GTCGAGTGTTCCATGCAGCCCATGTGATATGCACCATACCGCTAGGCGTACTGAAAAACACCCATCGC 68 FBan0008032 FBgn0037606 CG8032 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8032 CG8032 CDMC20483 2 7 12 DAC19-F12 3-CG8602-RA_1 CG8602 GCTTACGTTCACCCAGCTGACACCCTATGTGGGCATGATCATCATGGGACTGTCGTATTCCATGCTGG 68 FBan0008602 FBgn0035763 CG8602 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8602 CG8602 "anon-WO0118547.349, anon-WO0118547.382" CDMC20483 2 8 12 DAC19-F12 3-CG8602-RA_1 CG8602 GCTTACGTTCACCCAGCTGACACCCTATGTGGGCATGATCATCATGGGACTGTCGTATTCCATGCTGG 68 FBan0008602 FBgn0035763 CG8602 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8602 CG8602 "anon-WO0118547.349, anon-WO0118547.382" CDMC20484 2 9 12 DAC19-F24 2-CG8771-RA_1 CG8771 GGTCGCTTCGCAAGCCATCTGTATAATTCGCTCACCGAACCTCGAAACGCTCTGGAAGCAAATCGTGC 68 FBan0008771 FBgn0033766 CG8771 2 2R CG8771 CG8771 CDMC20484 2 10 12 DAC19-F24 2-CG8771-RA_1 CG8771 GGTCGCTTCGCAAGCCATCTGTATAATTCGCTCACCGAACCTCGAAACGCTCTGGAAGCAAATCGTGC 68 FBan0008771 FBgn0033766 CG8771 2 2R CG8771 CG8771 CDMC20485 2 11 12 DAC19-J12 6-CG9201-RB_4 CG9201 TGGAGATTGTGCGCTTCTGGTTAATTTTCCTCATCAACAACCTGCACGCGCACATTATGGAGGCCGTG 68 FBan0009201 FBgn0026433 Grip128 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip128 Grip128 "CG9201, CG9201, Dgrip128, grip128, Dgrips128" CDMC20485 2 12 12 DAC19-J12 6-CG9201-RB_4 CG9201 TGGAGATTGTGCGCTTCTGGTTAATTTTCCTCATCAACAACCTGCACGCGCACATTATGGAGGCCGTG 68 FBan0009201 FBgn0026433 Grip128 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip128 Grip128 "CG9201, CG9201, Dgrip128, grip128, Dgrips128" CDMC20486 2 13 12 DAC19-J24 12-CG9336-RA_1 CG9336 TCGAAAAGCAATTCCCACACTCGAAGTATTCGCGAAAATGGTGTCCGCTCTGAAATGCAGTTTGGCCG 68 FBan0009336 FBgn0032897 CG9336 2 2L CG9336 CG9336 BcDNA:RE71975 CDMC20486 2 14 12 DAC19-J24 12-CG9336-RA_1 CG9336 TCGAAAAGCAATTCCCACACTCGAAGTATTCGCGAAAATGGTGTCCGCTCTGAAATGCAGTTTGGCCG 68 FBan0009336 FBgn0032897 CG9336 2 2L CG9336 CG9336 BcDNA:RE71975 CDMC20487 2 15 12 DAC19-N12 3-CG9890-RA_1 CG9890 CCTGGAGGAGAACTTGAATCGGTTAATGTGCCTCTACTGCGAGAAGATCTTCAGGGATCGGCCCACGC 68 FBan0009890 FBgn0034814 CG9890 2 2R cell proliferation; GO:0008283 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9890 CG9890 "ld46465, anon-EST:Posey169" CDMC20487 2 16 12 DAC19-N12 3-CG9890-RA_1 CG9890 CCTGGAGGAGAACTTGAATCGGTTAATGTGCCTCTACTGCGAGAAGATCTTCAGGGATCGGCCCACGC 68 FBan0009890 FBgn0034814 CG9890 2 2R cell proliferation; GO:0008283 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9890 CG9890 "ld46465, anon-EST:Posey169" CDMC20488 2 17 12 DAC19-N24 2-CG9926-RA_3 CG9926 CCAAAGTGGCTCGCAAAGAGGTCGTCGACTACGAGAAGAATCTGCATCGACTTGGAGTGGTCCAGCAA 68 FBan0009926 FBgn0038190 CG9926 3 3R CG9926 CG9926 CDMC20488 2 18 12 DAC19-N24 2-CG9926-RA_3 CG9926 CCAAAGTGGCTCGCAAAGAGGTCGTCGACTACGAGAAGAATCTGCATCGACTTGGAGTGGTCCAGCAA 68 FBan0009926 FBgn0038190 CG9926 3 3R CG9926 CG9926 CDMC20489 2 19 12 DAC20-B12 22-CG18041-RA_1 CG18041 ACGAAAATGTCAGTTGGTTTTGTACTCAGCCATTGTAGTTTTTGGTGCATTCGGGTGTAAGGAACCCCT 69 FBan0018041 FBgn0039710 CG18041 3 3R CG18041 CG18041 CDMC20489 2 20 12 DAC20-B12 22-CG18041-RA_1 CG18041 ACGAAAATGTCAGTTGGTTTTGTACTCAGCCATTGTAGTTTTTGGTGCATTCGGGTGTAAGGAACCCCT 69 FBan0018041 FBgn0039710 CG18041 3 3R CG18041 CG18041 CDMC20490 2 21 12 DAC20-B24 12-CG18067-RA_1 CG18067 CCGGCTCAGGTGGAGTACTCCAATGGTGATATAGTCATCGAACTGGCCGATCATACGGTGATTGCCAAG 69 FBan0018067 FBgn0034512 CG18067 2 2R CG18067 CG18067 CT40493 CDMC20490 2 22 12 DAC20-B24 12-CG18067-RA_1 CG18067 CCGGCTCAGGTGGAGTACTCCAATGGTGATATAGTCATCGAACTGGCCGATCATACGGTGATTGCCAAG 69 FBan0018067 FBgn0034512 CG18067 2 2R CG18067 CG18067 CT40493 CDMC20491 2 23 12 DAC20-F12 14-CG18110-RA_6 CG18110 TCTACTACTGGGTGCAGACCTCCATCGAAAGGACTGACATGCATGTATCCGAGATCGATTTCCCAGCCG 69 FBan0018110 FBgn0039677 CG18110 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG18110 CG18110 CDMC20491 2 24 12 DAC20-F12 14-CG18110-RA_6 CG18110 TCTACTACTGGGTGCAGACCTCCATCGAAAGGACTGACATGCATGTATCCGAGATCGATTTCCCAGCCG 69 FBan0018110 FBgn0039677 CG18110 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG18110 CG18110 CDMC20492 2 25 12 DAC20-F24 1-CG18140-RA_1 CG18140 GCGGCAAGCACCCATTACTCAGGACTCTTAGTCAGGAGCTCCTAGGCATTCCTGGACAAAAGGCTAAGG 69 CDMC20492 2 26 12 DAC20-F24 1-CG18140-RA_1 CG18140 GCGGCAAGCACCCATTACTCAGGACTCTTAGTCAGGAGCTCCTAGGCATTCCTGGACAAAAGGCTAAGG 69 CDMC20493 2 1 13 DAC20-J12 27-CG18208-RA_1 CG18208 GGGATGGCCGGTATCCCAGTGGATATACGCTTACGCACATCGTGATCGCCTCCATTATTGTGACGATCC 69 FBan0018208 FBgn0038653 CG18208 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG18208 CG18208 CDMC20493 2 2 13 DAC20-J12 27-CG18208-RA_1 CG18208 GGGATGGCCGGTATCCCAGTGGATATACGCTTACGCACATCGTGATCGCCTCCATTATTGTGACGATCC 69 FBan0018208 FBgn0038653 CG18208 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG18208 CG18208 CDMC20494 2 3 13 DAC20-J24 23-CG18214-RF_12 CG18214 TTGGCGAAAGAATTCCAAATGATAAGGCAGGAAGCTTAAAGGCAAGCAAGAACAACAAACGAAAGTATG 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC20494 2 4 13 DAC20-J24 23-CG18214-RF_12 CG18214 TTGGCGAAAGAATTCCAAATGATAAGGCAGGAAGCTTAAAGGCAAGCAAGAACAACAAACGAAAGTATG 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC20495 2 5 13 DAC20-N12 17-CG18265-RA_1 CG18265 AGAATTTGTTCTTTGGCGAGAAGAGTTGCCCAAAATGAGTTGATCGCTCCGAGAAGAATTGGGATCGGC 69 FBan0018265 FBgn0036725 CG18265 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18265 CG18265 CDMC20495 2 6 13 DAC20-N12 17-CG18265-RA_1 CG18265 AGAATTTGTTCTTTGGCGAGAAGAGTTGCCCAAAATGAGTTGATCGCTCCGAGAAGAATTGGGATCGGC 69 FBan0018265 FBgn0036725 CG18265 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18265 CG18265 CDMC20496 2 7 13 DAC20-N24 14-CG18273-RA_1 CG18273 CGCCAGGATGTACGAAGGATTGGTGAAGGATCACGAGAAGTACCACAAATTTAGGGGCAAGGTGTAGGT 69 FBan0018273 FBgn0029525 CG18273 X X CG18273 CG18273 "CG13372, CG13372, EG:171D11.6" CDMC20496 2 8 13 DAC20-N24 14-CG18273-RA_1 CG18273 CGCCAGGATGTACGAAGGATTGGTGAAGGATCACGAGAAGTACCACAAATTTAGGGGCAAGGTGTAGGT 69 FBan0018273 FBgn0029525 CG18273 X X CG18273 CG18273 "CG13372, CG13372, EG:171D11.6" CDMC20497 2 9 13 DAC21-B12 23-CG3902-RA_1 CG3902 CCGTTATCGGTTCTCACCATGTTAACGTAGCATTTACCACTTAGTTGATTCTGTTATGCATATTGTATA 69 FBan0003902 FBgn0036824 CG3902 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- CG3902 CG3902 "CG18168, CT12987" CDMC20497 2 10 13 DAC21-B12 23-CG3902-RA_1 CG3902 CCGTTATCGGTTCTCACCATGTTAACGTAGCATTTACCACTTAGTTGATTCTGTTATGCATATTGTATA 69 FBan0003902 FBgn0036824 CG3902 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- CG3902 CG3902 "CG18168, CT12987" CDMC20498 2 11 13 DAC21-B24 3-CG3918-RA_1 CG3918 GGCCCCAAAACAACTTCTCCATGAACTCTTCCCACGGATTATGAGACGCGCAAACCGTAGACTTGTCCC 69 FBan0003918 FBgn0029873 CG3918 X X CG3918 CG3918 CDMC20498 2 12 13 DAC21-B24 3-CG3918-RA_1 CG3918 GGCCCCAAAACAACTTCTCCATGAACTCTTCCCACGGATTATGAGACGCGCAAACCGTAGACTTGTCCC 69 FBan0003918 FBgn0029873 CG3918 X X CG3918 CG3918 CDMC20499 2 13 13 DAC21-F12 12-CG3948-RA_1 CG3948 CAGGTTCTGCAATCGGCACGTGAACAACTCAAATGGTCCATTCTGAAGTGATGTGAAATGGGGTGGCGG 69 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC20499 2 14 13 DAC21-F12 12-CG3948-RA_1 CG3948 CAGGTTCTGCAATCGGCACGTGAACAACTCAAATGGTCCATTCTGAAGTGATGTGAAATGGGGTGGCGG 69 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC20500 2 15 13 DAC21-F24 23-CG3959-RA_12 CG3959 TAGGAACTTAACTAGCGAGCGATATACAAGTAGACTAATAGGAACCACGACAGACTTGGACGTCAGGGC 69 FBan0003959 FBgn0011207 pelo 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye development (sensu Endopterygota); GO:0007456; male meiosis; GO:0007140; male meiosis I; GO:0007141; male meiosis I spindle assembly (sensu Metazoa); GO:0007054; meiosis; GO:0007126; meiotic G2/MI transition; GO:0008315; meiotic nuclear envelope disassembly; GO:0051078; meiotic spindle organization and biogenesis; GO:0000212; mitosis; GO:0007067; protein biosynthesis; GO:0006412; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 nucleus; GO:0005634 pelo pelota "CG3959, ms(2)01559" CDMC20500 2 16 13 DAC21-F24 23-CG3959-RA_12 CG3959 TAGGAACTTAACTAGCGAGCGATATACAAGTAGACTAATAGGAACCACGACAGACTTGGACGTCAGGGC 69 FBan0003959 FBgn0011207 pelo 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye development (sensu Endopterygota); GO:0007456; male meiosis; GO:0007140; male meiosis I; GO:0007141; male meiosis I spindle assembly (sensu Metazoa); GO:0007054; meiosis; GO:0007126; meiotic G2/MI transition; GO:0008315; meiotic nuclear envelope disassembly; GO:0051078; meiotic spindle organization and biogenesis; GO:0000212; mitosis; GO:0007067; protein biosynthesis; GO:0006412; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 nucleus; GO:0005634 pelo pelota "CG3959, ms(2)01559" CDMC20501 2 17 13 DAC21-J12 6-CG3996-RA_3 CG3996 AGCAGGGGAAGGAGTATTCATAGATCTGGAGACTATGCACCTTCGATTAGGGTCACCTCCGAGCACCGA 69 FBan0003996 FBgn0037800 CG3996 3 3R cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3996 CG3996 CDMC20501 2 18 13 DAC21-J12 6-CG3996-RA_3 CG3996 AGCAGGGGAAGGAGTATTCATAGATCTGGAGACTATGCACCTTCGATTAGGGTCACCTCCGAGCACCGA 69 FBan0003996 FBgn0037800 CG3996 3 3R cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3996 CG3996 CDMC20502 2 19 13 DAC21-J24 17-CG40044-RA_1 CG40044 GCCAGAAGATACACGAGCTGAACGCAATGAAGTCAGAAGATTAGAACAACGACAGTCACGCCGTTTCAC 69 FBgn0058044 CG40044 CG40044 CG40044 CDMC20502 2 20 13 DAC21-J24 17-CG40044-RA_1 CG40044 GCCAGAAGATACACGAGCTGAACGCAATGAAGTCAGAAGATTAGAACAACGACAGTCACGCCGTTTCAC 69 FBgn0058044 CG40044 CG40044 CG40044 CDMC20503 2 21 13 DAC21-N12 1-CG4009-RA_1 CG4009 TGGCAACTGCTTACCTGGATCTCTCCTCCATCTATGGCAACAATCCCTCGCAAAACAGAAAGGTCCGCT 69 FBan0004009 FBgn0038469 CG4009 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG4009 CG4009 CDMC20503 2 22 13 DAC21-N12 1-CG4009-RA_1 CG4009 TGGCAACTGCTTACCTGGATCTCTCCTCCATCTATGGCAACAATCCCTCGCAAAACAGAAAGGTCCGCT 69 FBan0004009 FBgn0038469 CG4009 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG4009 CG4009 CDMC20504 2 23 13 DAC21-N24 15-CG40115-RA_1 CG40115 CGCGTCGAGTTGCGAAAGTGCGTCGAAAAATTTTAACTTGCGGTCATACGGAATTTTTTTGTCGCGCGA 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC20504 2 24 13 DAC21-N24 15-CG40115-RA_1 CG40115 CGCGTCGAGTTGCGAAAGTGCGTCGAAAAATTTTAACTTGCGGTCATACGGAATTTTTTTGTCGCGCGA 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC20505 2 25 13 DAC22-B12 18-CG13744-RA_6 CG13744 GCGGACATAACCGTGTACCTGGGAGAGCTGGACACGCAGGATCTGGGTCACATACACGAACCGCT 65 FBan0013744 FBgn0033363 CG13744 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG13744 CG13744 "SP67, c-SP67" CDMC20505 2 26 13 DAC22-B12 18-CG13744-RA_6 CG13744 GCGGACATAACCGTGTACCTGGGAGAGCTGGACACGCAGGATCTGGGTCACATACACGAACCGCT 65 FBan0013744 FBgn0033363 CG13744 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG13744 CG13744 "SP67, c-SP67" CDMC20506 2 1 14 DAC22-B24 3-CG13784-RA_3 CG13784 AGCATAAACGCGGATCTTCACCAGTGGACAACTCCTTATGACGAAGTGTCTCGCTGGTCGCCTGG 65 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC20506 2 2 14 DAC22-B24 3-CG13784-RA_3 CG13784 AGCATAAACGCGGATCTTCACCAGTGGACAACTCCTTATGACGAAGTGTCTCGCTGGTCGCCTGG 65 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC20507 2 3 14 DAC22-F12 2-CG13847-RA_1 CG13847 CTCTACAGAAATCGAACGAAAGCCCCCAGGTTCAGCCCTCCAATCAGTTCAACTTTGCACCGGCC 65 FBan0013847 FBgn0038967 CG13847 3 3R CG13847 CG13847 CDMC20507 2 4 14 DAC22-F12 2-CG13847-RA_1 CG13847 CTCTACAGAAATCGAACGAAAGCCCCCAGGTTCAGCCCTCCAATCAGTTCAACTTTGCACCGGCC 65 FBan0013847 FBgn0038967 CG13847 3 3R CG13847 CG13847 CDMC20508 2 5 14 DAC22-F24 3-CG13870-RA_3 CG13870 GACATCCCATTTCCATTCGGGCGTATCCGGTTCCTCCGTACGTGCCCAAGATCACCTACAACTGT 65 FBan0013870 FBgn0034506 CG13870 2 2R CG13870 CG13870 CDMC20508 2 6 14 DAC22-F24 3-CG13870-RA_3 CG13870 GACATCCCATTTCCATTCGGGCGTATCCGGTTCCTCCGTACGTGCCCAAGATCACCTACAACTGT 65 FBan0013870 FBgn0034506 CG13870 2 2R CG13870 CG13870 CDMC20509 2 7 14 DAC22-J12 6-CG13942-RA_2 CG13942 CAGTACACCCAATATGGGGGAGCAGAGTCCCACGAACAGCATCGATTCCTACCGCAGCAACCATC 65 FBan0013942 FBgn0033922 CG13942 2 2R CG13942 CG13942 CDMC20509 2 8 14 DAC22-J12 6-CG13942-RA_2 CG13942 CAGTACACCCAATATGGGGGAGCAGAGTCCCACGAACAGCATCGATTCCTACCGCAGCAACCATC 65 FBan0013942 FBgn0033922 CG13942 2 2R CG13942 CG13942 CDMC20510 2 9 14 DAC22-J24 15-CG13953-RA_1 CG13953 CGCCTATGCTCACCACCAATCGATGACGGCTATGTCGAACAACGGTATTATCTATCAGTCGGCGG 65 FBan0013953 FBgn0033416 CG13953 2 2R CG13953 CG13953 CDMC20510 2 10 14 DAC22-J24 15-CG13953-RA_1 CG13953 CGCCTATGCTCACCACCAATCGATGACGGCTATGTCGAACAACGGTATTATCTATCAGTCGGCGG 65 FBan0013953 FBgn0033416 CG13953 2 2R CG13953 CG13953 CDMC20511 2 11 14 DAC22-N12 3-CG14031-RA_1 CG14031 CATCATGAGAGACGCACGGCATTTCCCGAAACCAAATCAATTCCTGCCCGAACGTTTTCTGCCCG 65 FBan0014031 FBgn0031695 Cyp4ac3 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac3 Cyp4ac3 "CG14031, CG14031, 4ac3" CDMC20511 2 12 14 DAC22-N12 3-CG14031-RA_1 CG14031 CATCATGAGAGACGCACGGCATTTCCCGAAACCAAATCAATTCCTGCCCGAACGTTTTCTGCCCG 65 FBan0014031 FBgn0031695 Cyp4ac3 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac3 Cyp4ac3 "CG14031, CG14031, 4ac3" CDMC20512 2 13 14 DAC22-N24 22-CG14069-RA_1 CG14069 TGAACACAGCGACCACAATTGCCATCGGATTGTTAATGTTCATCCCACTGATCCTGATGCAGCTG 65 FBan0014069 FBgn0032315 CG14069 2 2L CG14069 CG14069 CDMC20512 2 14 14 DAC22-N24 22-CG14069-RA_1 CG14069 TGAACACAGCGACCACAATTGCCATCGGATTGTTAATGTTCATCCCACTGATCCTGATGCAGCTG 65 FBan0014069 FBgn0032315 CG14069 2 2L CG14069 CG14069 CDMC20513 2 15 14 DAC23-B12 1-CG4653-RA_1 CG4653 GAACTACTCCAGTTCGGATGCAGTTGGCTCTAATGACTTGGCCTTGCTGGAGCTGGAAACGTCGG 65 FBan0004653 FBgn0030776 CG4653 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4653 CG4653 SPH179 CDMC20513 2 16 14 DAC23-B12 1-CG4653-RA_1 CG4653 GAACTACTCCAGTTCGGATGCAGTTGGCTCTAATGACTTGGCCTTGCTGGAGCTGGAAACGTCGG 65 FBan0004653 FBgn0030776 CG4653 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4653 CG4653 SPH179 CDMC20514 2 17 14 DAC23-B24 3-CG4711-RA_1 CG4711 GAGCTAGAGGCGTTAGCCATGATGCGTCACTTCGGAATGATGTCCATGGCAACAGATTCGCTGCC 65 FBgn0032594 CDMC20514 2 18 14 DAC23-B24 3-CG4711-RA_1 CG4711 GAGCTAGAGGCGTTAGCCATGATGCGTCACTTCGGAATGATGTCCATGGCAACAGATTCGCTGCC 65 FBgn0032594 CDMC20515 2 19 14 DAC23-F12 2-CG4882-RA_2 CG4882 GATATCGGTGCTCCGTAATCCCATCCAGTACGGGCTCTTTGTGGACCAGTTCTCTGGCTGCTTCC 65 FBan0004882 FBgn0025336 CG4882 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG4882 CG4882 "UD1, undefined 1, LD24471, GM14313, anon-60Aa" CDMC20515 2 20 14 DAC23-F12 2-CG4882-RA_2 CG4882 GATATCGGTGCTCCGTAATCCCATCCAGTACGGGCTCTTTGTGGACCAGTTCTCTGGCTGCTTCC 65 FBan0004882 FBgn0025336 CG4882 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG4882 CG4882 "UD1, undefined 1, LD24471, GM14313, anon-60Aa" CDMC20516 2 21 14 DAC23-F24 2-CG4913-RA_2 CG4913 AAACAGCATGTGACCGGTTCAGAGAAGTCATCAACGGTCGACCCATCGCCTAAACTAGAGGGGGC 65 FBan0004913 FBgn0026441 ear 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669; transcription factor TFIIF complex; GO:0005674 ear ENL/AF9-related "CG4913, CG4913, dENL/AF9, ENL/AF9, ENL/AF-9, ENL/AF9-related" CDMC20516 2 22 14 DAC23-F24 2-CG4913-RA_2 CG4913 AAACAGCATGTGACCGGTTCAGAGAAGTCATCAACGGTCGACCCATCGCCTAAACTAGAGGGGGC 65 FBan0004913 FBgn0026441 ear 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669; transcription factor TFIIF complex; GO:0005674 ear ENL/AF9-related "CG4913, CG4913, dENL/AF9, ENL/AF9, ENL/AF-9, ENL/AF9-related" CDMC20517 2 23 14 DAC23-J12 3-CG5122-RA_1 CG5122 GAATTCTTTCGGTCCAAGGGTTACGTCCGATCGGTGACCTTCCAGCTCTTCACCTCCCAGGTAGC 65 FBan0005122 FBgn0032471 CG5122 2 2L amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 CG5122 CG5122 CDMC20517 2 24 14 DAC23-J12 3-CG5122-RA_1 CG5122 GAATTCTTTCGGTCCAAGGGTTACGTCCGATCGGTGACCTTCCAGCTCTTCACCTCCCAGGTAGC 65 FBan0005122 FBgn0032471 CG5122 2 2L amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 CG5122 CG5122 CDMC20518 2 25 14 DAC23-J24 2-CG5165-RA_2 CG5165 GGTTCCCACTGGATGGAAGTACTTCGGTAATCTCATGGACGCCGGAAGGTTGTGTCTGTGCGGAG 65 FBan0005165 FBgn0003076 Pgm 3 3L detection of light stimulus during visual perception; GO:0050908; monosaccharide metabolism; GO:0005996 protein binding; GO:0005515; phosphoglucomutase activity; GO:0004614 ; EC:5.4.2.2; ; GO:0004614 ; EC:5.4.2.2; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 Pgm Phosphogluconate mutase "CG5165, CG5165, PGM, PGM-1, pgm" CDMC20518 2 26 14 DAC23-J24 2-CG5165-RA_2 CG5165 GGTTCCCACTGGATGGAAGTACTTCGGTAATCTCATGGACGCCGGAAGGTTGTGTCTGTGCGGAG 65 FBan0005165 FBgn0003076 Pgm 3 3L detection of light stimulus during visual perception; GO:0050908; monosaccharide metabolism; GO:0005996 protein binding; GO:0005515; phosphoglucomutase activity; GO:0004614 ; EC:5.4.2.2; ; GO:0004614 ; EC:5.4.2.2; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 Pgm Phosphogluconate mutase "CG5165, CG5165, PGM, PGM-1, pgm" CDMC20519 2 1 15 DAC23-N12 3-CG5263-RA_1 CG5263 GGGAGTGCTCACCAACAACGGATCTAACGACAACCTGGTATTGGAACGCAATCAGCAGTCGCAGC 65 FBan0005263 FBgn0016070 smg 3 3L negative regulation of translation; GO:0016478 "mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation repressor activity; GO:0030371; ; GO:0030371; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0030371; ; GO:0000900; ; GO:0030371" cytoplasm; GO:0005737 smg smaug "CG5263, D69, Smg, anon-D69, anonD69" CDMC20519 2 2 15 DAC23-N12 3-CG5263-RA_1 CG5263 GGGAGTGCTCACCAACAACGGATCTAACGACAACCTGGTATTGGAACGCAATCAGCAGTCGCAGC 65 FBan0005263 FBgn0016070 smg 3 3L negative regulation of translation; GO:0016478 "mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation repressor activity; GO:0030371; ; GO:0030371; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0030371; ; GO:0000900; ; GO:0030371" cytoplasm; GO:0005737 smg smaug "CG5263, D69, Smg, anon-D69, anonD69" CDMC20520 2 3 15 DAC23-N24 2-CG5292-RA_3 CG5292 TGCACACTCTGGGCGTCAAGGAGATCATCTACGGCTGTGAGAACGATCGTTTCGGAGGAAAGACG 65 FBan0005292 FBgn0038491 CG5292 3 3R pyrimidine base metabolism; GO:0006206 cytosine deaminase activity; GO:0004131 ; EC:3.5.4.1; zinc ion binding; GO:0008270; ; GO:0004131 ; EC:3.5.4.1; ; GO:0008270 CG5292 CG5292 BcDNA:RE41712 CDMC20520 2 4 15 DAC23-N24 2-CG5292-RA_3 CG5292 TGCACACTCTGGGCGTCAAGGAGATCATCTACGGCTGTGAGAACGATCGTTTCGGAGGAAAGACG 65 FBan0005292 FBgn0038491 CG5292 3 3R pyrimidine base metabolism; GO:0006206 cytosine deaminase activity; GO:0004131 ; EC:3.5.4.1; zinc ion binding; GO:0008270; ; GO:0004131 ; EC:3.5.4.1; ; GO:0008270 CG5292 CG5292 BcDNA:RE41712 CDMC20521 2 5 15 DAC24-B12 2-CG9188-RB_2 CG9188 AGCGTCGCCAAAATCAGATAAAGCAGCCATACGCCAACATAGTCAGTCCCATACGCACCTACACCCAGA 69 FBan0009188 FBgn0031878 sip2 2 2L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 sip2 septin interacting protein 2 "CG9188, CG9188, CG9188, CG9188, CG9188, septin interacting protein 2" CDMC20521 2 6 15 DAC24-B12 2-CG9188-RB_2 CG9188 AGCGTCGCCAAAATCAGATAAAGCAGCCATACGCCAACATAGTCAGTCCCATACGCACCTACACCCAGA 69 FBan0009188 FBgn0031878 sip2 2 2L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 sip2 septin interacting protein 2 "CG9188, CG9188, CG9188, CG9188, CG9188, septin interacting protein 2" CDMC20522 2 7 15 DAC24-B24 3-CG9204-RB_3 CG9204 GCTGGGAGACTCGGCCTCCTACTCAACGAAATCCCTTACCCAGGAAAAGACACTTCGCGACTTCTTGAA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC20522 2 8 15 DAC24-B24 3-CG9204-RB_3 CG9204 GCTGGGAGACTCGGCCTCCTACTCAACGAAATCCCTTACCCAGGAAAAGACACTTCGCGACTTCTTGAA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC20523 2 9 15 DAC24-F12 3-CG9243-RA_1 CG9243 TGACGCAACGCAAGGAACTAGGTGTGCTGGCCAGAAATTGTCCCCATCTTGCTCTAGATCTGGGAAAGA 69 FBan0009243 FBgn0032926 CG9243 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9243 CG9243 CDMC20523 2 10 15 DAC24-F12 3-CG9243-RA_1 CG9243 TGACGCAACGCAAGGAACTAGGTGTGCTGGCCAGAAATTGTCCCCATCTTGCTCTAGATCTGGGAAAGA 69 FBan0009243 FBgn0032926 CG9243 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9243 CG9243 CDMC20524 2 11 15 DAC24-F24 16-CG9249-RA_1 CG9249 TGCGAATGCTATGATGCGGTGATAGTGTCTGAAGTTCTGGAGCACGTCAAAGATAAAGTGTCCCTGCTG 69 FBan0009249 FBgn0032922 CG9249 2 2L ubiquinone metabolism; GO:0006743 hexaprenyldihydroxybenzoate methyltransferase activity; GO:0004395 ; EC:2.1.1.114; ; GO:0004395 ; EC:2.1.1.114 CG9249 CG9249 CDMC20524 2 12 15 DAC24-F24 16-CG9249-RA_1 CG9249 TGCGAATGCTATGATGCGGTGATAGTGTCTGAAGTTCTGGAGCACGTCAAAGATAAAGTGTCCCTGCTG 69 FBan0009249 FBgn0032922 CG9249 2 2L ubiquinone metabolism; GO:0006743 hexaprenyldihydroxybenzoate methyltransferase activity; GO:0004395 ; EC:2.1.1.114; ; GO:0004395 ; EC:2.1.1.114 CG9249 CG9249 CDMC20525 2 13 15 DAC24-J12 1-CG9289-RA_1 CG9289 AGACGGGACCCTACATGAAGATCGATCGGACTGTCAGTTTCGGGGACAATTACCTGGATGAGTACCGCA 69 FBan0009289 FBgn0032058 CG9289 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9289 CG9289 "CT26467, glutactin-like" CDMC20525 2 14 15 DAC24-J12 1-CG9289-RA_1 CG9289 AGACGGGACCCTACATGAAGATCGATCGGACTGTCAGTTTCGGGGACAATTACCTGGATGAGTACCGCA 69 FBan0009289 FBgn0032058 CG9289 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9289 CG9289 "CT26467, glutactin-like" CDMC20526 2 15 15 DAC24-J24 15-CG9302-RA_1 CG9302 GGACCGCACAGAGCTGTGATACGCTGTTGCAAAGTATAACGATGCTTCTCCCACAACACTTTGCAATCT 69 FBan0009302 FBgn0032514 CG9302 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9302 CG9302 anon-WO0118547.80 CDMC20526 2 16 15 DAC24-J24 15-CG9302-RA_1 CG9302 GGACCGCACAGAGCTGTGATACGCTGTTGCAAAGTATAACGATGCTTCTCCCACAACACTTTGCAATCT 69 FBan0009302 FBgn0032514 CG9302 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9302 CG9302 anon-WO0118547.80 CDMC20527 2 17 15 DAC24-N12 15-CG9327-RA_2 CG9327 AGCGTGTGGACAATAAGACCGTATACAGTGTCCTGGAGAAACCCGATGTGGAGAAGCTGATCGAGAAGT 69 FBan0009327 FBgn0003150 Pros29 2 2R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros29 Proteasome 29kD subunit "CG9327, PROS-29, alpha3_dm, 20S proteasome, 20s proteasome, pros29, Proteasome subunit alpha-type 4" CDMC20527 2 18 15 DAC24-N12 15-CG9327-RA_2 CG9327 AGCGTGTGGACAATAAGACCGTATACAGTGTCCTGGAGAAACCCGATGTGGAGAAGCTGATCGAGAAGT 69 FBan0009327 FBgn0003150 Pros29 2 2R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros29 Proteasome 29kD subunit "CG9327, PROS-29, alpha3_dm, 20S proteasome, 20s proteasome, pros29, Proteasome subunit alpha-type 4" CDMC20528 2 19 15 DAC24-N24 2-CG9338-RA_4 CG9338 TCCGAGTGTGGAAAGGACATCAAGTCAGACAGTAGCCTCGTTTTGGATTGCACCAAGATGGCTCCACCT 69 FBan0009338 FBgn0032899 CG9338 2 2L CG9338 CG9338 BcDNA:GH07967 CDMC20528 2 20 15 DAC24-N24 2-CG9338-RA_4 CG9338 TCCGAGTGTGGAAAGGACATCAAGTCAGACAGTAGCCTCGTTTTGGATTGCACCAAGATGGCTCCACCT 69 FBan0009338 FBgn0032899 CG9338 2 2L CG9338 CG9338 BcDNA:GH07967 CDMC20529 2 21 15 DAC25-B12 12-CG10572-RA_1 CG10572 GCCGCCAGGAGGACATAAAGACCAGTAATCCGTACCATCACGATCAGCTAGACCGCATCTTCAATGTGA 69 FBan0010572 FBgn0015618 Cdk8 3 3L G1/S transition of mitotic cell cycle; GO:0000082; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription mediator activity; GO:0016455; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016455; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- mediator complex; GO:0000119; nucleus; GO:0005634 Cdk8 Cyclin-dependent kinase 8 "CG10572, CG10572, CG10572, DmCdk8, CDK8, dTRAP56, p58, cdk8, Cyclin-dependent kinase 8" CDMC20529 2 22 15 DAC25-B12 12-CG10572-RA_1 CG10572 GCCGCCAGGAGGACATAAAGACCAGTAATCCGTACCATCACGATCAGCTAGACCGCATCTTCAATGTGA 69 FBan0010572 FBgn0015618 Cdk8 3 3L G1/S transition of mitotic cell cycle; GO:0000082; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription mediator activity; GO:0016455; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016455; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- mediator complex; GO:0000119; nucleus; GO:0005634 Cdk8 Cyclin-dependent kinase 8 "CG10572, CG10572, CG10572, DmCdk8, CDK8, dTRAP56, p58, cdk8, Cyclin-dependent kinase 8" CDMC20530 2 23 15 DAC25-B24 3-CG10580-RA_3 CG10580 GCCGGTCACCGAGTTGGATGACATTTTCATCAGCGTAAAGACGACGAAGAACTATCACGACACCCGGCT 69 FBan0010580 FBgn0011591 fng 3 3L "Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; eye development (sensu Endopterygota); GO:0007456; fucose metabolism; GO:0006004; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; positive regulation of Notch signaling pathway; GO:0045747; regulation of Notch signaling pathway; GO:0008593; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008375 ; EC:2.4.1.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008194" Golgi apparatus; GO:0005794; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 fng fringe "CG10580, CG10580, l(3)rG554, D-fng, Frg, fg: flag, frg, D-Fng, Dfng, fringe, fg" CDMC20530 2 24 15 DAC25-B24 3-CG10580-RA_3 CG10580 GCCGGTCACCGAGTTGGATGACATTTTCATCAGCGTAAAGACGACGAAGAACTATCACGACACCCGGCT 69 FBan0010580 FBgn0011591 fng 3 3L "Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; eye development (sensu Endopterygota); GO:0007456; fucose metabolism; GO:0006004; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; positive regulation of Notch signaling pathway; GO:0045747; regulation of Notch signaling pathway; GO:0008593; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008375 ; EC:2.4.1.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008194" Golgi apparatus; GO:0005794; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 fng fringe "CG10580, CG10580, l(3)rG554, D-fng, Frg, fg: flag, frg, D-Fng, Dfng, fringe, fg" CDMC20531 2 25 15 DAC25-F12 9-CG10616-RA_1 CG10616 AGGGACTCCCGGATGATACGCACTTCAACAATTGCAAGATGGACGCTGATTGCATAGACGATTCTGGGA 69 FBan0010616 FBgn0036286 CG10616 3 3L CG10616 CG10616 CDMC20531 2 26 15 DAC25-F12 9-CG10616-RA_1 CG10616 AGGGACTCCCGGATGATACGCACTTCAACAATTGCAAGATGGACGCTGATTGCATAGACGATTCTGGGA 69 FBan0010616 FBgn0036286 CG10616 3 3L CG10616 CG10616 CDMC20532 2 1 16 DAC25-F24 2-CG10623-RA_1 CG10623 CGTCGATGGCCTCAACATAAAGCCGTAATCGGGAGAGAACTCCGGTCACTGATAGCAGCCTTGTCGCTA 69 FBan0010623 FBgn0032727 CG10623 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10623 CG10623 selenocysteine methyltransferase CDMC20532 2 2 16 DAC25-F24 2-CG10623-RA_1 CG10623 CGTCGATGGCCTCAACATAAAGCCGTAATCGGGAGAGAACTCCGGTCACTGATAGCAGCCTTGTCGCTA 69 FBan0010623 FBgn0032727 CG10623 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10623 CG10623 selenocysteine methyltransferase CDMC20533 2 3 16 DAC25-J12 3-CG1064-RA_1 CG1064 CCGAGGAGTTTGCCATTAAACTCTGTGCGGAATTGGGATTGGGAGGAGAGTTTGTTACGGCCATTGCCT 69 FBan0001064 FBgn0011715 Snr1 3 3R "chromatin remodeling; GO:0006338; embryonic development (sensu Insecta); GO:0001700; larval or pupal development (sensu Insecta); GO:0002165; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; wing vein specification; GO:0007474" RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nuclear chromosome; GO:0000228; nucleus; GO:0005634 Snr1 Snf5-related 1 "CG1064, snr1, snf5-related 1, BAP45, snr, SNR1, l(3)01319" CDMC20533 2 4 16 DAC25-J12 3-CG1064-RA_1 CG1064 CCGAGGAGTTTGCCATTAAACTCTGTGCGGAATTGGGATTGGGAGGAGAGTTTGTTACGGCCATTGCCT 69 FBan0001064 FBgn0011715 Snr1 3 3R "chromatin remodeling; GO:0006338; embryonic development (sensu Insecta); GO:0001700; larval or pupal development (sensu Insecta); GO:0002165; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; wing vein specification; GO:0007474" RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nuclear chromosome; GO:0000228; nucleus; GO:0005634 Snr1 Snf5-related 1 "CG1064, snr1, snf5-related 1, BAP45, snr, SNR1, l(3)01319" CDMC20534 2 5 16 DAC25-J24 2-CG10658-RA_1 CG10658 GCCTGGATAAACAGCGACCTCATGTACCATAAGACTCCCGATAAGTTGCTCGTCGAGGTTCTTCCCGGC 69 FBan0010658 FBgn0014000 Os9 2 2L nucleus; GO:0005634 Os9 Olfactory-specific 9 "CG10658, OS9" CDMC20534 2 6 16 DAC25-J24 2-CG10658-RA_1 CG10658 GCCTGGATAAACAGCGACCTCATGTACCATAAGACTCCCGATAAGTTGCTCGTCGAGGTTCTTCCCGGC 69 FBan0010658 FBgn0014000 Os9 2 2L nucleus; GO:0005634 Os9 Olfactory-specific 9 "CG10658, OS9" CDMC20535 2 7 16 DAC25-N12 23-CG10691-RB_5 CG10691 TCGCGCAGTAGCTGGGTGCATCTAGTTCCGTTAAGTTGTAACTACCTATAGCATTTACTAAGTACTTTT 69 FBan0010691 FBgn0002031 l(2)37Cc 2 2L DNA replication; GO:0006260; larval or pupal development (sensu Insecta); GO:0002165; regulation of progression through cell cycle; GO:0000074 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 l(2)37Cc lethal (2) 37Cc "CG10691, transcription unit No. 4, l(2)Cc, Cc, fs(2)HH32" CDMC20535 2 8 16 DAC25-N12 23-CG10691-RB_5 CG10691 TCGCGCAGTAGCTGGGTGCATCTAGTTCCGTTAAGTTGTAACTACCTATAGCATTTACTAAGTACTTTT 69 FBan0010691 FBgn0002031 l(2)37Cc 2 2L DNA replication; GO:0006260; larval or pupal development (sensu Insecta); GO:0002165; regulation of progression through cell cycle; GO:0000074 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 l(2)37Cc lethal (2) 37Cc "CG10691, transcription unit No. 4, l(2)Cc, Cc, fs(2)HH32" CDMC20536 2 9 16 DAC25-N24 11-CG10699-RA_1 CG10699 ACTTCGGTTTGCCAAAAGGTGGGCTTAGCTTGAAGATACACCTGACACGGCTTGAATGTTACTAGGCGT 69 FBan0010699 FBgn0002023 Lim3 2 2L "ectoderm development; GO:0007398; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 Lim3 Lim3 "CG10699, CG15174, CG10699, l(2)37Bd: lethal(2)37Bd, l(2)Bd, lim3, lethal(2)37Bd, l(2)37Bd" CDMC20536 2 10 16 DAC25-N24 11-CG10699-RA_1 CG10699 ACTTCGGTTTGCCAAAAGGTGGGCTTAGCTTGAAGATACACCTGACACGGCTTGAATGTTACTAGGCGT 69 FBan0010699 FBgn0002023 Lim3 2 2L "ectoderm development; GO:0007398; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 Lim3 Lim3 "CG10699, CG15174, CG10699, l(2)37Bd: lethal(2)37Bd, l(2)Bd, lim3, lethal(2)37Bd, l(2)37Bd" CDMC20537 2 11 16 DAC26-B12 9-CG8028-RA_1 CG8028 TCCTTGGGTCCTCGAAGTGCTGATCGTCAAGTTTCGGAGGCGTAACAAAATCGAACGCAACAACGTTGA 69 FBan0008028 FBgn0031010 CG8028 X X monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG8028 CG8028 CDMC20537 2 12 16 DAC26-B12 9-CG8028-RA_1 CG8028 TCCTTGGGTCCTCGAAGTGCTGATCGTCAAGTTTCGGAGGCGTAACAAAATCGAACGCAACAACGTTGA 69 FBan0008028 FBgn0031010 CG8028 X X monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG8028 CG8028 CDMC20538 2 13 16 DAC26-B24 2-CG8046-RB_2 CG8046 TGGTGTCTTGCAAGCACTTTCCCCCCTCATATCTTCCACCTTGTACGTTGCGATCTACACCCGTACACT 69 FBan0008046 FBgn0033388 CG8046 2 2R glycerol-3-phosphate metabolism; GO:0006072; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; membrane; GO:0016020 CG8046 CG8046 CDMC20538 2 14 16 DAC26-B24 2-CG8046-RB_2 CG8046 TGGTGTCTTGCAAGCACTTTCCCCCCTCATATCTTCCACCTTGTACGTTGCGATCTACACCCGTACACT 69 FBan0008046 FBgn0033388 CG8046 2 2R glycerol-3-phosphate metabolism; GO:0006072; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; membrane; GO:0016020 CG8046 CG8046 CDMC20539 2 15 16 DAC26-F12 23-CG8083-RA_1 CG8083 AGTTGGGTCGAAAGAATGTTACTCAGTTTTAGTTCCTTAAAGTTGTAGTTCGTGATAATTAGCTGATCA 69 FBan0008083 FBgn0025709 CG8083 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005415 membrane; GO:0016020 CG8083 CG8083 "CK00459, BEST:CK00459" CDMC20539 2 16 16 DAC26-F12 23-CG8083-RA_1 CG8083 AGTTGGGTCGAAAGAATGTTACTCAGTTTTAGTTCCTTAAAGTTGTAGTTCGTGATAATTAGCTGATCA 69 FBan0008083 FBgn0025709 CG8083 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005415 membrane; GO:0016020 CG8083 CG8083 "CK00459, BEST:CK00459" CDMC20540 2 17 16 DAC26-F24 10-CG8089-RA_1 CG8089 CCTCACTGCACATGGAGATTCCAACTGAAGTCTGCCCTCGATTCACATGTACTGCGAATCCATGAACGC 69 FBan0008089 FBgn0033993 CG8089 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8089 CG8089 CDMC20540 2 18 16 DAC26-F24 10-CG8089-RA_1 CG8089 CCTCACTGCACATGGAGATTCCAACTGAAGTCTGCCCTCGATTCACATGTACTGCGAATCCATGAACGC 69 FBan0008089 FBgn0033993 CG8089 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8089 CG8089 CDMC20541 2 19 16 DAC26-J12 23-CG8127-RB_2 CG8127 GGCGGGAGTTGAATTAAATTATTTTACCATTTAATTGAGACGTGTACAAAGTTTGAAAGCAAAACCAAC 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC20541 2 20 16 DAC26-J12 23-CG8127-RB_2 CG8127 GGCGGGAGTTGAATTAAATTATTTTACCATTTAATTGAGACGTGTACAAAGTTTGAAAGCAAAACCAAC 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC20542 2 21 16 DAC26-J24 15-CG8136-RB_4 CG8136 TGCACAGCGAGGTTCTGTTTCACAAGGAACTGCAGATCAAGGAGAACATGATCAAGGTGTACGAGGACA 69 FBan0008136 FBgn0037616 CG8136 3 3R CG8136 CG8136 "anon-WO0140519.254, anon-WO0140519.56" CDMC20542 2 22 16 DAC26-J24 15-CG8136-RB_4 CG8136 TGCACAGCGAGGTTCTGTTTCACAAGGAACTGCAGATCAAGGAGAACATGATCAAGGTGTACGAGGACA 69 FBan0008136 FBgn0037616 CG8136 3 3R CG8136 CG8136 "anon-WO0140519.254, anon-WO0140519.56" CDMC20543 2 23 16 DAC26-N12 16-CG8178-RC_1 CG8178 AACCTGTGAACACATTGATTACGACGTACAGTTGACGAATTTTCCCCTGGAACTGAATATGCCGGTGGC 69 FBan0008178 FBgn0024319 Nach 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814; tracheal liquid clearance; GO:0035002 sodium channel activity; GO:0005272; ; GO:0005272 integral to membrane; GO:0016021 Nach Nach "CG8178, PPK4, pickpocket 4, ppk4" CDMC20543 2 24 16 DAC26-N12 16-CG8178-RC_1 CG8178 AACCTGTGAACACATTGATTACGACGTACAGTTGACGAATTTTCCCCTGGAACTGAATATGCCGGTGGC 69 FBan0008178 FBgn0024319 Nach 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814; tracheal liquid clearance; GO:0035002 sodium channel activity; GO:0005272; ; GO:0005272 integral to membrane; GO:0016021 Nach Nach "CG8178, PPK4, pickpocket 4, ppk4" CDMC20544 2 25 16 DAC26-N24 23-CG8186-RA_8 CG8186 TTAGTCCAGCCAATTACCATCCGAAAAAAACAGCAAAATGTCCGGAAAAGATAGGCTACCGATTTTCCC 69 FBan0008186 FBgn0022097 Vha36 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha36 Vha36 "CG8186, l(2)k07207, vha36, VhaD, Vacuolar H-ATPase subunit D, V-ATPase, anon-WO0153538.20, anon-WO0153538.21, anon-WO0153538.28, anon-WO02059370.27" CDMC20544 2 26 16 DAC26-N24 23-CG8186-RA_8 CG8186 TTAGTCCAGCCAATTACCATCCGAAAAAAACAGCAAAATGTCCGGAAAAGATAGGCTACCGATTTTCCC 69 FBan0008186 FBgn0022097 Vha36 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha36 Vha36 "CG8186, l(2)k07207, vha36, VhaD, Vacuolar H-ATPase subunit D, V-ATPase, anon-WO0153538.20, anon-WO0153538.21, anon-WO0153538.28, anon-WO02059370.27" CDMC20545 2 1 17 DAC27-B12 2-CG8421-RA_1 CG8421 TGGCTGTGGAGACCCTGAAACTTTGGCCCAACAATGCAGTGGCTCAACTTCATTATGGACTAGCACTCA 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC20545 2 2 17 DAC27-B12 2-CG8421-RA_1 CG8421 TGGCTGTGGAGACCCTGAAACTTTGGCCCAACAATGCAGTGGCTCAACTTCATTATGGACTAGCACTCA 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC20546 2 3 17 DAC27-B24 23-CG8434-RA_3 CG8434 GCCTTTGCTATGGAAATAGGACAGCTAGAGAAACATACCAGTGTCTTCGTAATTTATGAAATTAATCGT 69 FBan0008434 FBgn0034083 lbk 2 2R bristle morphogenesis; GO:0008407; cell adhesion; GO:0007155; oogenesis (sensu Insecta); GO:0009993; transmission of nerve impulse; GO:0019226 lbk lambik "CG8434, CG8434, CG8434, kekkon-like, Lbk, lambik" CDMC20546 2 4 17 DAC27-B24 23-CG8434-RA_3 CG8434 GCCTTTGCTATGGAAATAGGACAGCTAGAGAAACATACCAGTGTCTTCGTAATTTATGAAATTAATCGT 69 FBan0008434 FBgn0034083 lbk 2 2R bristle morphogenesis; GO:0008407; cell adhesion; GO:0007155; oogenesis (sensu Insecta); GO:0009993; transmission of nerve impulse; GO:0019226 lbk lambik "CG8434, CG8434, CG8434, kekkon-like, Lbk, lambik" CDMC20547 2 5 17 DAC27-F12 2-CG8475-RA_1 CG8475 GGTCCTCATTTTGAGGTAAACGGTCTGAACGTAAACACGGCCTTGACGCAGCTATACCATCGCGCTGGT 69 FBan0008475 FBgn0031995 CG8475 2 2L glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG8475 CG8475 CDMC20547 2 6 17 DAC27-F12 2-CG8475-RA_1 CG8475 GGTCCTCATTTTGAGGTAAACGGTCTGAACGTAAACACGGCCTTGACGCAGCTATACCATCGCGCTGGT 69 FBan0008475 FBgn0031995 CG8475 2 2L glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG8475 CG8475 CDMC20548 2 7 17 DAC27-F24 12-CG8487-RB_1 CG8487 GCAGCAGCGGACATCTATCAGGAGTATGTGCAAAATCCGTACAACCTTACGTTGCAACAGCATCCCCAA 69 FBan0008487 FBgn0033714 garz 2 2R ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085; ; GO:0005085 Golgi vesicle; GO:0005798 garz gartenzwerg "CG8487, CG8487, CG8487, CG 8487, sec7-family GEF, Gartenzwerg, GBF1, gartenzwerg" CDMC20548 2 8 17 DAC27-F24 12-CG8487-RB_1 CG8487 GCAGCAGCGGACATCTATCAGGAGTATGTGCAAAATCCGTACAACCTTACGTTGCAACAGCATCCCCAA 69 FBan0008487 FBgn0033714 garz 2 2R ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085; ; GO:0005085 Golgi vesicle; GO:0005798 garz gartenzwerg "CG8487, CG8487, CG8487, CG 8487, sec7-family GEF, Gartenzwerg, GBF1, gartenzwerg" CDMC20549 2 9 17 DAC27-J12 2-CG8531-RA_2 CG8531 GCCGCACTCTTAGCCAAAAGCTGACGTTGAATGGAGGCACCAATCTGAACTTTCGTGACCAAGGTGTCA 69 FBan0008531 FBgn0033918 CG8531 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 CG8531 CG8531 CDMC20549 2 10 17 DAC27-J12 2-CG8531-RA_2 CG8531 GCCGCACTCTTAGCCAAAAGCTGACGTTGAATGGAGGCACCAATCTGAACTTTCGTGACCAAGGTGTCA 69 FBan0008531 FBgn0033918 CG8531 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 CG8531 CG8531 CDMC20550 2 11 17 DAC27-J24 1-CG8541-RA_1 CG8541 GTGGACACCCCCTACTCCAGTGTGAGGAAGAGCGACACGAGGATCCAGAACAATGTATACACTCCTGCT 69 FBan0008541 FBgn0035788 CG8541 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8541 CG8541 CDMC20550 2 12 17 DAC27-J24 1-CG8541-RA_1 CG8541 GTGGACACCCCCTACTCCAGTGTGAGGAAGAGCGACACGAGGATCCAGAACAATGTATACACTCCTGCT 69 FBan0008541 FBgn0035788 CG8541 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8541 CG8541 CDMC20551 2 13 17 DAC27-N12 1-CG8573-RB_1 CG8573 GCCGCATGCGAGAGTACTGCAAACTGCTCTTTACCGTGGTCATTCACAACGATTCCATCAAGTCGCTGC 69 FBan0008573 FBgn0003567 su(Hw) 3 3R cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 su(Hw) suppressor of Hairy wing "CG8573, Su(Hw), Su[Hw], su(hw), Su(hw), suppressor of hairy-wing, Su(HW)" CDMC20551 2 14 17 DAC27-N12 1-CG8573-RB_1 CG8573 GCCGCATGCGAGAGTACTGCAAACTGCTCTTTACCGTGGTCATTCACAACGATTCCATCAAGTCGCTGC 69 FBan0008573 FBgn0003567 su(Hw) 3 3R cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 su(Hw) suppressor of Hairy wing "CG8573, Su(Hw), Su[Hw], su(hw), Su(hw), suppressor of hairy-wing, Su(HW)" CDMC20552 2 15 17 DAC27-N24 14-CG8584-RA_4 CG8584 GGACGGGATATAATGTAAGACAGCGAGCCGACTCCACTAGCCTGTGCATTGAAAAAGAAAGGACTCGGG 69 FBan0008584 FBgn0033322 CG8584 2 2R development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG8584 CG8584 BEST:LP01468 CDMC20552 2 16 17 DAC27-N24 14-CG8584-RA_4 CG8584 GGACGGGATATAATGTAAGACAGCGAGCCGACTCCACTAGCCTGTGCATTGAAAAAGAAAGGACTCGGG 69 FBan0008584 FBgn0033322 CG8584 2 2R development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG8584 CG8584 BEST:LP01468 CDMC20553 2 17 17 DAC28-B12 16-CG30342-RA_1 CG30342 CGGAAAAGGACATCGTAGTGGAGTTTATCAAGAACGAGGAGTTCAAGTACGTTCGAGCATTGGGAGCCT 69 FBan0030342 FBgn0050342 CG30342 2 2R CG30342 CG30342 CG8054 CDMC20553 2 18 17 DAC28-B12 16-CG30342-RA_1 CG30342 CGGAAAAGGACATCGTAGTGGAGTTTATCAAGAACGAGGAGTTCAAGTACGTTCGAGCATTGGGAGCCT 69 FBan0030342 FBgn0050342 CG30342 2 2R CG30342 CG30342 CG8054 CDMC20554 2 19 17 DAC28-B24 12-CG30355-RA_2 CG30355 ACCCTAACGCCCTTGACTTGTGTGCAACAATGCAATGCTTTACTAGGCTCAACATCAGGAAAGCCGAGA 69 FBan0030355 FBgn0050355 CG30355 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30355 CG30355 "NEST:bs10b08, BcDNA:AT24812, NEST:bs04f07, NEST:bs06e10, NEST:bs23e07, NEST:bs23a07" CDMC20554 2 20 17 DAC28-B24 12-CG30355-RA_2 CG30355 ACCCTAACGCCCTTGACTTGTGTGCAACAATGCAATGCTTTACTAGGCTCAACATCAGGAAAGCCGAGA 69 FBan0030355 FBgn0050355 CG30355 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30355 CG30355 "NEST:bs10b08, BcDNA:AT24812, NEST:bs04f07, NEST:bs06e10, NEST:bs23e07, NEST:bs23a07" CDMC20555 2 21 17 DAC28-F12 18-CG30387-RC_1 CG30387 TGGAACAGCAGGAGGAAGAGGAATCAGCCCCTTTCGTCTTTACAGTGCGAAAATGACACAATCTTCTCT 69 FBan0030387 FBgn0050387 CG30387 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG30387 CG30387 "CG15665, CG10074, CG15665" CDMC20555 2 22 17 DAC28-F12 18-CG30387-RC_1 CG30387 TGGAACAGCAGGAGGAAGAGGAATCAGCCCCTTTCGTCTTTACAGTGCGAAAATGACACAATCTTCTCT 69 FBan0030387 FBgn0050387 CG30387 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG30387 CG30387 "CG15665, CG10074, CG15665" CDMC20556 2 23 17 DAC28-F24 18-CG30395-RA_7 CG30395 CCCAAATTTCTTTGCATTCCACCATTTGTGGCCATTAATGGAAGCTGCCTTATTCCAACCCCCAAAGAA 69 FBan0030395 FBgn0050395 CG30395 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30395 CG30395 CDMC20556 2 24 17 DAC28-F24 18-CG30395-RA_7 CG30395 CCCAAATTTCTTTGCATTCCACCATTTGTGGCCATTAATGGAAGCTGCCTTATTCCAACCCCCAAAGAA 69 FBan0030395 FBgn0050395 CG30395 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30395 CG30395 CDMC20557 2 25 17 DAC28-J12 22-CG30440-RA_4 CG30440 GCGCCAGGAAGTTTATACGTTGCAAGCATCGACAATCGGTGTAAAAGAAATGTGGGTTGCCGAGATTAA 69 FBan0030440 FBgn0050440 CG30440 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30440 CG30440 "CG10412, CG10416, CG12183, CG10412" CDMC20557 2 26 17 DAC28-J12 22-CG30440-RA_4 CG30440 GCGCCAGGAAGTTTATACGTTGCAAGCATCGACAATCGGTGTAAAAGAAATGTGGGTTGCCGAGATTAA 69 FBan0030440 FBgn0050440 CG30440 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30440 CG30440 "CG10412, CG10416, CG12183, CG10412" CDMC20558 2 1 18 DAC28-J24 6-CG3044-RA_1 CG3044 CCGCCACTTTGGATAATGCCACCATAGTCCTTCCCGATACCCTCAGACAGGTACTACAGAACGACACCC 69 FBan0003044 FBgn0029913 CG3044 X X polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG3044 CG3044 CDMC20558 2 2 18 DAC28-J24 6-CG3044-RA_1 CG3044 CCGCCACTTTGGATAATGCCACCATAGTCCTTCCCGATACCCTCAGACAGGTACTACAGAACGACACCC 69 FBan0003044 FBgn0029913 CG3044 X X polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG3044 CG3044 CDMC20559 2 3 18 DAC28-N12 3-CG30487-RA_1 CG30487 TGACGGTCCCAAGGGTGGACAAACTACAGGATCTGGCTAAATCGATCCCAACGGATCCCGATACAGTCT 69 FBan0030487 FBgn0050487 CG30487 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30487 CG30487 "bs33e02.y1, NEST:bs16h04" CDMC20559 2 4 18 DAC28-N12 3-CG30487-RA_1 CG30487 TGACGGTCCCAAGGGTGGACAAACTACAGGATCTGGCTAAATCGATCCCAACGGATCCCGATACAGTCT 69 FBan0030487 FBgn0050487 CG30487 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30487 CG30487 "bs33e02.y1, NEST:bs16h04" CDMC20560 2 5 18 DAC28-N24 22-CG30493-RB_1 CG30493 TAACGTTGCCAATTTTCTGAATAGTTGGCTCTGTCCAATCGCTGACTAATCAAGCGCATGACCTTCGTG 69 FBan0030493 FBgn0050493 CG30493 2 2R CG30493 CG30493 "CG1952, CG1952, CG1952" CDMC20560 2 6 18 DAC28-N24 22-CG30493-RB_1 CG30493 TAACGTTGCCAATTTTCTGAATAGTTGGCTCTGTCCAATCGCTGACTAATCAAGCGCATGACCTTCGTG 69 FBan0030493 FBgn0050493 CG30493 2 2R CG30493 CG30493 "CG1952, CG1952, CG1952" CDMC20561 2 7 18 DAC29-B12 14-CG9973-RA_1 CG9973 CGAGAAGCTCACCGAGAAGAAGGTAAGTCTGCTCACTGGTTTTCCATTCTCAGATCCTGTCCCACCGAA 69 FBan0009973 FBgn0035378 CG9973 3 3L DNA binding; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9973 CG9973 CDMC20561 2 8 18 DAC29-B12 14-CG9973-RA_1 CG9973 CGAGAAGCTCACCGAGAAGAAGGTAAGTCTGCTCACTGGTTTTCCATTCTCAGATCCTGTCCCACCGAA 69 FBan0009973 FBgn0035378 CG9973 3 3L DNA binding; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9973 CG9973 CDMC20562 2 9 18 DAC29-B24 2-CG9988-RA_3 CG9988 CACCACCCAAAGGACTCTCGCTGAAACCGTCCAAGAGGAAGCCAAGTGTCCTTATGTTCGGCATAGACA 69 FBan0009988 FBgn0039591 CG9988 3 3R CG9988 CG9988 CDMC20562 2 10 18 DAC29-B24 2-CG9988-RA_3 CG9988 CACCACCCAAAGGACTCTCGCTGAAACCGTCCAAGAGGAAGCCAAGTGTCCTTATGTTCGGCATAGACA 69 FBan0009988 FBgn0039591 CG9988 3 3R CG9988 CG9988 CDMC20563 2 11 18 DAC29-F12 3-CR30298-RA_1 CR30298 CGTGGCTTAGTTGGTTAAAGCGCCTGTCTAGTAAACAGGAGATCGTGAGTTCGAATTTCGCCGGGGCCT 69 FBan0030298 FBgn0050298 CR30298 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30298 CR30298 "tRNA[Thr][[3]], AE002787.trna28-ThrAGT, tRNA:T:AGT:AE002787-b, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC20563 2 12 18 DAC29-F12 3-CR30298-RA_1 CR30298 CGTGGCTTAGTTGGTTAAAGCGCCTGTCTAGTAAACAGGAGATCGTGAGTTCGAATTTCGCCGGGGCCT 69 FBan0030298 FBgn0050298 CR30298 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30298 CR30298 "tRNA[Thr][[3]], AE002787.trna28-ThrAGT, tRNA:T:AGT:AE002787-b, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC20564 2 13 18 DAC29-F24 23-CR31273-RA_9 CR31273 TGCAACGAAATGGGTCCATGTGTTAAAGATGTGCTTGCCAAGTAAAAAAAACCGAAAAGTAGAGGGGGT 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC20564 2 14 18 DAC29-F24 23-CR31273-RA_9 CR31273 TGCAACGAAATGGGTCCATGTGTTAAAGATGTGCTTGCCAAGTAAAAAAAACCGAAAAGTAGAGGGGGT 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC20565 2 15 18 DAC29-J12 14-CR32028-RA_1 CR32028 GGGAAGTGGGAGACAGAGCGATAAATGGAGGAGAAGCGAGGAGAGCTGAATAAAACCGATCAAGCAACA 69 FBan0032028 FBgn0062463 CR32028 3 3L CR32028 CR32028 BcDNA:LD13080 CDMC20565 2 16 18 DAC29-J12 14-CR32028-RA_1 CR32028 GGGAAGTGGGAGACAGAGCGATAAATGGAGGAGAAGCGAGGAGAGCTGAATAAAACCGATCAAGCAACA 69 FBan0032028 FBgn0062463 CR32028 3 3L CR32028 CR32028 BcDNA:LD13080 CDMC20566 2 17 18 DAC29-J24 17-CR32646-RA_1 CR32646 TCGTACGTGTTCGTTCGTTGCTTTCGTTCGGTTTGATTCCATTCGGTTGTGTTTCTCGTTCGAGAACAT 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC20566 2 18 18 DAC29-J24 17-CR32646-RA_1 CR32646 TCGTACGTGTTCGTTCGTTGCTTTCGTTCGGTTTGATTCCATTCGGTTGTGTTTCTCGTTCGAGAACAT 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC20567 2 19 18 DAC29-N12 23-CR32957-RA_2 CR32957 CTCTTTCTTTTTAGATAATGCTGAAACCCGAATTTCTCTGACAGAAACCCTACGTAAGAAGGATTTCCA 69 FBan0032957 FBgn0047311 pncr012:2L 2 2L pncr012:2L putative noncoding RNA 012:2L "CR32957, BcDNA:GH14469, putative noncoding RNA 012:2L" CDMC20567 2 20 18 DAC29-N12 23-CR32957-RA_2 CR32957 CTCTTTCTTTTTAGATAATGCTGAAACCCGAATTTCTCTGACAGAAACCCTACGTAAGAAGGATTTCCA 69 FBan0032957 FBgn0047311 pncr012:2L 2 2L pncr012:2L putative noncoding RNA 012:2L "CR32957, BcDNA:GH14469, putative noncoding RNA 012:2L" CDMC20568 2 21 18 DAC29-N24 15-CR33328-RA_1 CR33328 CCGAGGGTCCTTGGTGAGAACAACACCAGTAGAGCCACTATATCCATCTACTATCCACCGACATCCGAA 69 FBan0033328 FBgn0053328 CR33328 3 3R CR33328 CR33328 BcDNA:GM03761 CDMC20568 2 22 18 DAC29-N24 15-CR33328-RA_1 CR33328 CCGAGGGTCCTTGGTGAGAACAACACCAGTAGAGCCACTATATCCATCTACTATCCACCGACATCCGAA 69 FBan0033328 FBgn0053328 CR33328 3 3R CR33328 CR33328 BcDNA:GM03761 CDMC20569 2 23 18 DAC30-B12 17-CG11987-RA_2 CG11987 TCCCGCGAACAACATTGACACCATTTCCCATTAATTTTCGCTCATTTTTCGCCAAGGCAATCAGACGTA 69 FBan0011987 FBgn0015014 tgo 3 3R ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 tgo tango "CG11987, PRD gene 7, ARNT, darnt, DARNT, dARNT, Arnt, Tango, arnt, TGO, Hif1, HIF-1beta, HIF1b, prd7, paired-like 7" CDMC20569 2 24 18 DAC30-B12 17-CG11987-RA_2 CG11987 TCCCGCGAACAACATTGACACCATTTCCCATTAATTTTCGCTCATTTTTCGCCAAGGCAATCAGACGTA 69 FBan0011987 FBgn0015014 tgo 3 3R ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 tgo tango "CG11987, PRD gene 7, ARNT, darnt, DARNT, dARNT, Arnt, Tango, arnt, TGO, Hif1, HIF-1beta, HIF1b, prd7, paired-like 7" CDMC20570 2 25 18 DAC30-B24 17-CG11997-RA_1 CG11997 CCCACTGCCAATTCCTTTAACAATTCCTCAAAAGGGCCAAAATCAAGACCTGCAATATCAAGGGGTCGA 69 FBan0011997 FBgn0037662 CG11997 3 3R CG11997 CG11997 CDMC20570 2 26 18 DAC30-B24 17-CG11997-RA_1 CG11997 CCCACTGCCAATTCCTTTAACAATTCCTCAAAAGGGCCAAAATCAAGACCTGCAATATCAAGGGGTCGA 69 FBan0011997 FBgn0037662 CG11997 3 3R CG11997 CG11997 CDMC20571 2 1 19 DAC30-F12 16-CG12024-RA_1 CG12024 AGTTCCCCAGTCCAAAGTAATCTCCGGGCAAGAACGAAATCTGAAATCTCCTATCCCAATCTCGACACA 69 FBan0012024 FBgn0035283 CG12024 3 3L CG12024 CG12024 CDMC20571 2 2 19 DAC30-F12 16-CG12024-RA_1 CG12024 AGTTCCCCAGTCCAAAGTAATCTCCGGGCAAGAACGAAATCTGAAATCTCCTATCCCAATCTCGACACA 69 FBan0012024 FBgn0035283 CG12024 3 3L CG12024 CG12024 CDMC20572 2 3 19 DAC30-F24 13-CG12030-RA_2 CG12030 CGGGTTAGCACACGATAGCACTCAACGGTCAGCGATCTTTGGCATCTTCATCTACACCATCATCTGCAA 69 FBan0012030 FBgn0035147 CG12030 3 3L galactose metabolism; GO:0006012; nucleotide-sugar metabolism; GO:0009225 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG12030 CG12030 CDMC20572 2 4 19 DAC30-F24 13-CG12030-RA_2 CG12030 CGGGTTAGCACACGATAGCACTCAACGGTCAGCGATCTTTGGCATCTTCATCTACACCATCATCTGCAA 69 FBan0012030 FBgn0035147 CG12030 3 3L galactose metabolism; GO:0006012; nucleotide-sugar metabolism; GO:0009225 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG12030 CG12030 CDMC20573 2 5 19 DAC30-J12 23-CG12065-RA_1 CG12065 GGGGACCACTATTCGTAAACCAAAATGTGCATAGATTGCATCATATATAATGTATGTTCGCGTAATATT 69 FBan0012065 FBgn0030052 CG12065 X X CG12065 CG12065 CDMC20573 2 6 19 DAC30-J12 23-CG12065-RA_1 CG12065 GGGGACCACTATTCGTAAACCAAAATGTGCATAGATTGCATCATATATAATGTATGTTCGCGTAATATT 69 FBan0012065 FBgn0030052 CG12065 X X CG12065 CG12065 CDMC20574 2 7 19 DAC30-J24 13-CG12073-RA_1 CG12073 AGTGCGTATCTCTGTATATGTGCACCCCCTGAAACTTGCAGCAATGTGCGAATTGTAGACGACTCCTCT 69 FBan0012073 FBgn0004573 5-HT7 3 3R "nerve-nerve synaptic transmission; GO:0007270; serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase activating pathway; GO:0007192" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0016609; ; GO:0004993; ; GO:0004993; ; GO:0004952 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 5-HT7 Serotonin receptor 7 "CG12073, 5HT-dro, 5HT-dro1, 5-HT7Dro, 5-HT[[dro1]], 5htdror, DRO1, Serotonin receptor, 5-HT-dro1, 5-HT[[7Dro]], 5-HT-dro, 5-HTdro1, 5-HT[[7]], Dm5HTdro1, 5HT[[7Dro]], 5HT-R1: Serotonin receptor 1, Serotonin receptor 1" CDMC20574 2 8 19 DAC30-J24 13-CG12073-RA_1 CG12073 AGTGCGTATCTCTGTATATGTGCACCCCCTGAAACTTGCAGCAATGTGCGAATTGTAGACGACTCCTCT 69 FBan0012073 FBgn0004573 5-HT7 3 3R "nerve-nerve synaptic transmission; GO:0007270; serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase activating pathway; GO:0007192" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0016609; ; GO:0004993; ; GO:0004993; ; GO:0004952 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 5-HT7 Serotonin receptor 7 "CG12073, 5HT-dro, 5HT-dro1, 5-HT7Dro, 5-HT[[dro1]], 5htdror, DRO1, Serotonin receptor, 5-HT-dro1, 5-HT[[7Dro]], 5-HT-dro, 5-HTdro1, 5-HT[[7]], Dm5HTdro1, 5HT[[7Dro]], 5HT-R1: Serotonin receptor 1, Serotonin receptor 1" CDMC20575 2 9 19 DAC30-N12 6-CG12113-RA_4 CG12113 CGGCGGAGTACCTGCAGATGATTCTCAGTCACATCGAAGAGATCTTCACCATGACTGACGAGCGCTTGG 69 FBgn0030047 CDMC20575 2 10 19 DAC30-N12 6-CG12113-RA_4 CG12113 CGGCGGAGTACCTGCAGATGATTCTCAGTCACATCGAAGAGATCTTCACCATGACTGACGAGCGCTTGG 69 FBgn0030047 CDMC20576 2 11 19 DAC30-N24 16-CG12124-RA_1 CG12124 GCTCCGGAAGATCTCTCCAAATCCACTGAAGGAGCAAAGACGAAGACCCAAATCAAGGCAAATACCAAG 69 FBan0012124 FBgn0030112 CG12124 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12124 CG12124 CDMC20576 2 12 19 DAC30-N24 16-CG12124-RA_1 CG12124 GCTCCGGAAGATCTCTCCAAATCCACTGAAGGAGCAAAGACGAAGACCCAAATCAAGGCAAATACCAAG 69 FBan0012124 FBgn0030112 CG12124 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12124 CG12124 CDMC20577 2 13 19 DAC31-B12 8-CG3680-RA_1 CG3680 GGGGCGGTGAAGATACCTCCTCGCATACGCTGGCTAACGATATGAAGGCGAACAACGGTAGCGAAC 66 FBan0003680 FBgn0037027 CG3680 3 3L CG3680 CG3680 CDMC20577 2 14 19 DAC31-B12 8-CG3680-RA_1 CG3680 GGGGCGGTGAAGATACCTCCTCGCATACGCTGGCTAACGATATGAAGGCGAACAACGGTAGCGAAC 66 FBan0003680 FBgn0037027 CG3680 3 3L CG3680 CG3680 CDMC20578 2 15 19 DAC31-B24 2-CG3861-RB_1 CG3861 GCTGCTGCAGTACTACGGCATGAAGGAGATGAACTACTACACCGTGTTGTTCGGCGTTTCCCGTGC 66 FBgn0029869 CDMC20578 2 16 19 DAC31-B24 2-CG3861-RB_1 CG3861 GCTGCTGCAGTACTACGGCATGAAGGAGATGAACTACTACACCGTGTTGTTCGGCGTTTCCCGTGC 66 FBgn0029869 CDMC20579 2 17 19 DAC31-F12 3-CG4076-RA_3 CG4076 CCTCCGACGAAGGACCGGATGAAGAGCCCTTCCAGCGAGTGACCGAAACTATAACAGCGTCAGATC 66 FBan0004076 FBgn0036812 Nufip 3 3L mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Nufip Nufip "CG4076, CG4076, NUFIP" CDMC20579 2 18 19 DAC31-F12 3-CG4076-RA_3 CG4076 CCTCCGACGAAGGACCGGATGAAGAGCCCTTCCAGCGAGTGACCGAAACTATAACAGCGTCAGATC 66 FBan0004076 FBgn0036812 Nufip 3 3L mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Nufip Nufip "CG4076, CG4076, NUFIP" CDMC20580 2 19 19 DAC31-F24 2-CG4324-RA_1 CG4324 AACAAGGAGAGCCATCCCAATGAGTGCGTCACCTTCATGACCTCCGACTTTATGGACCTGCTGTGG 66 FBan0004324 FBgn0034956 CG4324 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG4324 CG4324 CDMC20580 2 20 19 DAC31-F24 2-CG4324-RA_1 CG4324 AACAAGGAGAGCCATCCCAATGAGTGCGTCACCTTCATGACCTCCGACTTTATGGACCTGCTGTGG 66 FBan0004324 FBgn0034956 CG4324 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG4324 CG4324 CDMC20581 2 21 19 DAC31-J12 6-CG4818-RA_3 CG4818 GCCACTAATCTGCCAAAGGCTAAAGTTCCCCAGGAGTCGCTAGAATTTAGTCCCAGGAGCGCGTCG 66 FBan0004818 FBgn0036617 CG4818 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG4818 CG4818 CDMC20581 2 22 19 DAC31-J12 6-CG4818-RA_3 CG4818 GCCACTAATCTGCCAAAGGCTAAAGTTCCCCAGGAGTCGCTAGAATTTAGTCCCAGGAGCGCGTCG 66 FBan0004818 FBgn0036617 CG4818 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG4818 CG4818 CDMC20582 2 23 19 DAC31-J24 12-CG4875-RA_4 CG4875 GCACCCACTTCAATGGAAACCAAGTCCAATCCGACACCAGATGGAGAAAACCTCGGGTAGCAGCCG 66 FBan0004875 FBgn0030801 CG4875 X X G-protein coupled receptor activity; GO:0004930; ; GO:0004930 CG4875 CG4875 CDMC20582 2 24 19 DAC31-J24 12-CG4875-RA_4 CG4875 GCACCCACTTCAATGGAAACCAAGTCCAATCCGACACCAGATGGAGAAAACCTCGGGTAGCAGCCG 66 FBan0004875 FBgn0030801 CG4875 X X G-protein coupled receptor activity; GO:0004930; ; GO:0004930 CG4875 CG4875 CDMC20583 2 25 19 DAC31-N12 24-CG5210-RA_2 CG5210 AGAAAATGCTTGATCAAGAAATATATTTGTCCCATTTATATTTGTAATGTCATAAAGTGCCTCAGA 66 FBan0005210 FBgn0013763 Chit 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Chit Chitinase-like "CG5210, CG5210, DS47, chitinase-related, ds47, chitinase-like, chit" CDMC20583 2 26 19 DAC31-N12 24-CG5210-RA_2 CG5210 AGAAAATGCTTGATCAAGAAATATATTTGTCCCATTTATATTTGTAATGTCATAAAGTGCCTCAGA 66 FBan0005210 FBgn0013763 Chit 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Chit Chitinase-like "CG5210, CG5210, DS47, chitinase-related, ds47, chitinase-like, chit" CDMC20584 2 1 20 DAC31-N24 9-CG5362-RA_1 CG5362 AAGGTGACCGCCAATGGTACCGTTAAGTCCGTGGTGGATGCGATCAACGATAATGGCTACCTGCAG 66 FBan0005362 FBgn0032237 CG5362 2 2L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 cytosol; GO:0005829 CG5362 CG5362 CT17038 CDMC20584 2 2 20 DAC31-N24 9-CG5362-RA_1 CG5362 AAGGTGACCGCCAATGGTACCGTTAAGTCCGTGGTGGATGCGATCAACGATAATGGCTACCTGCAG 66 FBan0005362 FBgn0032237 CG5362 2 2L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 cytosol; GO:0005829 CG5362 CG5362 CT17038 CDMC20585 2 3 20 DAC32-B12 15-CG11138-RB_1 CG11138 GGCGACAACACACTCCCCGGATAATATCTGGCATCTAAAAACTCTCGACACTTCTCTGTTGGGGTCACA 69 FBan0011138 FBgn0030400 CG11138 X X CG11138 CG11138 "CG1855, CG1855, EP(X)1313, RE18684, BcDNA:RE48052, BEST:RE18684" CDMC20585 2 4 20 DAC32-B12 15-CG11138-RB_1 CG11138 GGCGACAACACACTCCCCGGATAATATCTGGCATCTAAAAACTCTCGACACTTCTCTGTTGGGGTCACA 69 FBan0011138 FBgn0030400 CG11138 X X CG11138 CG11138 "CG1855, CG1855, EP(X)1313, RE18684, BcDNA:RE48052, BEST:RE18684" CDMC20586 2 5 20 DAC32-B24 2-CG11147-RB_3 CG11147 GGCCACAACCGTTGGCTATTTGCACTTTGCCCAGAACTTCAGCGATTCGATTCTCTCGGTAATGGAGGA 69 FBan0011147 FBgn0031734 CG11147 2 2L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG11147 CG11147 CDMC20586 2 6 20 DAC32-B24 2-CG11147-RB_3 CG11147 GGCCACAACCGTTGGCTATTTGCACTTTGCCCAGAACTTCAGCGATTCGATTCTCTCGGTAATGGAGGA 69 FBan0011147 FBgn0031734 CG11147 2 2L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG11147 CG11147 CDMC20587 2 7 20 DAC32-F12 3-CG11182-RA_2 CG11182 CGCAATCCGGGGTTCCCTCAACCAGGAGTCGAGCTTATTGTTCTCCAAAATCACCACTGTCTCCGAGTT 69 FBan0011182 FBgn0025334 PHDP 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 PHDP Putative homeodomain protein "CG11182, anon-60Ac, Putative homeodomain protein" CDMC20587 2 8 20 DAC32-F12 3-CG11182-RA_2 CG11182 CGCAATCCGGGGTTCCCTCAACCAGGAGTCGAGCTTATTGTTCTCCAAAATCACCACTGTCTCCGAGTT 69 FBan0011182 FBgn0025334 PHDP 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 PHDP Putative homeodomain protein "CG11182, anon-60Ac, Putative homeodomain protein" CDMC20588 2 9 20 DAC32-F24 2-CG1119-RA_1 CG1119 ACGGCAGATGCCCTAAGCTTGGGTGACCTTGTTGAAAAGCGTATTCGTGCGAATTCTGCTTGGAGTCTT 69 FBan0001119 FBgn0004913 Gnf1 3 3R DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA polymerase processivity factor activity; GO:0030337; DNA ligase activity; GO:0003909 ; EC:6.5.1.-; ; GO:0030337; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003909 ; EC:6.5.1.-; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Gnf1 Germ line transcription factor 1 "CG1119, GTF-1, ONF-CAACAA, RF-C 140, RFC, dRF-Cp140, germline transcription factor, Gnf-1, Gtf1: Germ line transcription factor 1, RfC140, gtf1, Germ line transcription factor 1, Replication-factor-C 140kD subunit" CDMC20588 2 10 20 DAC32-F24 2-CG1119-RA_1 CG1119 ACGGCAGATGCCCTAAGCTTGGGTGACCTTGTTGAAAAGCGTATTCGTGCGAATTCTGCTTGGAGTCTT 69 FBan0001119 FBgn0004913 Gnf1 3 3R DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA polymerase processivity factor activity; GO:0030337; DNA ligase activity; GO:0003909 ; EC:6.5.1.-; ; GO:0030337; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003909 ; EC:6.5.1.-; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Gnf1 Germ line transcription factor 1 "CG1119, GTF-1, ONF-CAACAA, RF-C 140, RFC, dRF-Cp140, germline transcription factor, Gnf-1, Gtf1: Germ line transcription factor 1, RfC140, gtf1, Germ line transcription factor 1, Replication-factor-C 140kD subunit" CDMC20589 2 11 20 DAC32-J12 8-CG11257-RA_1 CG11257 GCAGCCTCCGGAAATAGTGCCACGCTTTGATTGGATTCAGCAGAGGAGCGAACTTACCCTGATCTTCTA 69 FBan0011257 FBgn0034442 CG11257 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG11257 CG11257 CDMC20589 2 12 20 DAC32-J12 8-CG11257-RA_1 CG11257 GCAGCCTCCGGAAATAGTGCCACGCTTTGATTGGATTCAGCAGAGGAGCGAACTTACCCTGATCTTCTA 69 FBan0011257 FBgn0034442 CG11257 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG11257 CG11257 CDMC20590 2 13 20 DAC32-J24 17-CG11265-RA_1 CG11265 GGAGAGCGACGCAGACCTACTAAGCCTAGTGTTAGGAACTTTGCCTCTGATCGCGCTAAATGTATTTCA 69 FBan0011265 FBgn0030049 CG11265 X X DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003676; sigma DNA polymerase activity; GO:0019984; ; GO:0003916 ; EC:5.99.1.-; ; GO:0019984 CG11265 CG11265 AAF46390 CDMC20590 2 14 20 DAC32-J24 17-CG11265-RA_1 CG11265 GGAGAGCGACGCAGACCTACTAAGCCTAGTGTTAGGAACTTTGCCTCTGATCGCGCTAAATGTATTTCA 69 FBan0011265 FBgn0030049 CG11265 X X DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003676; sigma DNA polymerase activity; GO:0019984; ; GO:0003916 ; EC:5.99.1.-; ; GO:0019984 CG11265 CG11265 AAF46390 CDMC20591 2 15 20 DAC32-N12 16-CG11301-RA_1 CG11301 GCTGTGGACAGTTTGCTATTCCTTGATGGAGCCATGAACTTTTGAACACCCCCACAAATGAAACTGGAT 69 FBan0011301 FBgn0034726 Mes4 2 2R DNA replication; GO:0006260 epsilon DNA polymerase activity; GO:0003893; ; GO:0003893 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 Mes4 Mes4 "CG11301, CG11301, CG11301, CG11301, NF-YC-like, BcDNA:GM21739" CDMC20591 2 16 20 DAC32-N12 16-CG11301-RA_1 CG11301 GCTGTGGACAGTTTGCTATTCCTTGATGGAGCCATGAACTTTTGAACACCCCCACAAATGAAACTGGAT 69 FBan0011301 FBgn0034726 Mes4 2 2R DNA replication; GO:0006260 epsilon DNA polymerase activity; GO:0003893; ; GO:0003893 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 Mes4 Mes4 "CG11301, CG11301, CG11301, CG11301, NF-YC-like, BcDNA:GM21739" CDMC20592 2 17 20 DAC32-N24 2-CG11312-RA_1 CG11312 CGTGACCCGTTTGGACTCGCTCCCTTAGTCGCTTATCCTTGCTGTATCCTTGCTGCTGGATGTAAACGA 69 FBan0011312 FBgn0011674 insc 2 2R RNA localization; GO:0006403; apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cytoskeleton organization and biogenesis; GO:0007010; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; sensory organ development; GO:0007423; somatic muscle development; GO:0007525 cytoskeletal adaptor activity; GO:0008093; ; GO:0008093; ; GO:0008093; protein binding; GO:0005515; ; GO:0008093; ; GO:0005515 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 insc inscuteable "CG11312, fam, nem, inscrutable, 25/17, l(2)05475, l(2)k12405, Inscuteable, Ins, Inscutable, fata morgana, not enough muscles, inscuteable" CDMC20592 2 18 20 DAC32-N24 2-CG11312-RA_1 CG11312 CGTGACCCGTTTGGACTCGCTCCCTTAGTCGCTTATCCTTGCTGTATCCTTGCTGCTGGATGTAAACGA 69 FBan0011312 FBgn0011674 insc 2 2R RNA localization; GO:0006403; apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cytoskeleton organization and biogenesis; GO:0007010; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; sensory organ development; GO:0007423; somatic muscle development; GO:0007525 cytoskeletal adaptor activity; GO:0008093; ; GO:0008093; ; GO:0008093; protein binding; GO:0005515; ; GO:0008093; ; GO:0005515 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 insc inscuteable "CG11312, fam, nem, inscrutable, 25/17, l(2)05475, l(2)k12405, Inscuteable, Ins, Inscutable, fata morgana, not enough muscles, inscuteable" CDMC20593 2 19 20 DAC33-B12 1-CG12585-RA_1 CG12585 GCCCTCGATTTCAATAAGACCGTCGTCCTGTGGCCCTGTCCGCGAATGAAAGTGAGTACGTCCTTAGTT 69 FBan0012585 FBgn0037258 CG12585 3 3R CG12585 CG12585 CDMC20593 2 20 20 DAC33-B12 1-CG12585-RA_1 CG12585 GCCCTCGATTTCAATAAGACCGTCGTCCTGTGGCCCTGTCCGCGAATGAAAGTGAGTACGTCCTTAGTT 69 FBan0012585 FBgn0037258 CG12585 3 3R CG12585 CG12585 CDMC20594 2 21 20 DAC33-B24 3-CG12594-RA_1 CG12594 GCTGGCATCAAGTGGCCATCAGCATACAGAACGGCGATTTCATATCGATTTACGTCGATTGCGCGTGGA 69 FBan0012594 FBgn0037941 CG12594 3 3R cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG12594 CG12594 CDMC20594 2 22 20 DAC33-B24 3-CG12594-RA_1 CG12594 GCTGGCATCAAGTGGCCATCAGCATACAGAACGGCGATTTCATATCGATTTACGTCGATTGCGCGTGGA 69 FBan0012594 FBgn0037941 CG12594 3 3R cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG12594 CG12594 CDMC20595 2 23 20 DAC33-F12 7-CG12643-RA_1 CG12643 TGGAGGTGACCCATCAATCCACACAATCAGCCATCACCTGTAATCAGCCACTTCAATAGAGGACGCACT 69 FBan0012643 FBgn0040942 CG12643 X X CG12643 CG12643 CDMC20595 2 24 20 DAC33-F12 7-CG12643-RA_1 CG12643 TGGAGGTGACCCATCAATCCACACAATCAGCCATCACCTGTAATCAGCCACTTCAATAGAGGACGCACT 69 FBan0012643 FBgn0040942 CG12643 X X CG12643 CG12643 CDMC20596 2 25 20 DAC33-F24 6-CG12661-RA_1 CG12661 TTGTGACAATTCGAGTTTGGAGGAGAAGCGAGAACGCGTTGACAATGCAATCCTAACCGCCATGGAGGA 69 FBan0012661 FBgn0030071 CG12661 X X CG12661 CG12661 CDMC20596 2 26 20 DAC33-F24 6-CG12661-RA_1 CG12661 TTGTGACAATTCGAGTTTGGAGGAGAAGCGAGAACGCGTTGACAATGCAATCCTAACCGCCATGGAGGA 69 FBan0012661 FBgn0030071 CG12661 X X CG12661 CG12661 CDMC20597 2 1 21 DAC33-J12 9-CG12698-RA_3 CG12698 AGCGACTCTGCGACGAAATAAAGAAACCAGTATCTAGGAGATCCACCAAGGAATCAGCACGCCAACGGC 69 FBan0012698 FBgn0030721 CG12698 X X CG12698 CG12698 CDMC20597 2 2 21 DAC33-J12 9-CG12698-RA_3 CG12698 AGCGACTCTGCGACGAAATAAAGAAACCAGTATCTAGGAGATCCACCAAGGAATCAGCACGCCAACGGC 69 FBan0012698 FBgn0030721 CG12698 X X CG12698 CG12698 CDMC20598 2 3 21 DAC33-J24 23-CG12721-RA_3 CG12721 CCTTTGTCATCAAACGGGGACTATTGAATAAGCACATTAACTGGCAGATTCTCGACAAGATCATGGCAG 69 FBan0012721 FBgn0030373 CG12721 X X CG12721 CG12721 BcDNA:RE60404 CDMC20598 2 4 21 DAC33-J24 23-CG12721-RA_3 CG12721 CCTTTGTCATCAAACGGGGACTATTGAATAAGCACATTAACTGGCAGATTCTCGACAAGATCATGGCAG 69 FBan0012721 FBgn0030373 CG12721 X X CG12721 CG12721 BcDNA:RE60404 CDMC20599 2 5 21 DAC33-N12 2-CG12763-RA_2 CG12763 GCCACGAGATTGGACTGAATGGAGGATATGGACAGCACTTGGGAGGACCATATGGCAACTCAGAACCGA 69 FBan0012763 FBgn0004240 Dpt 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; innate immune response; GO:0045087 extracellular region; GO:0005576 Dpt Diptericin "CG12763, CG12763, CG12763, diptericin, Dipt, dip, Dip, dipt, DptA, DIPT, dpt, DPT, Diptericin" CDMC20599 2 6 21 DAC33-N12 2-CG12763-RA_2 CG12763 GCCACGAGATTGGACTGAATGGAGGATATGGACAGCACTTGGGAGGACCATATGGCAACTCAGAACCGA 69 FBan0012763 FBgn0004240 Dpt 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; innate immune response; GO:0045087 extracellular region; GO:0005576 Dpt Diptericin "CG12763, CG12763, CG12763, diptericin, Dipt, dip, Dip, dipt, DptA, DIPT, dpt, DPT, Diptericin" CDMC20600 2 7 21 DAC33-N24 3-CG12773-RA_1 CG12773 CCAACTACCACCACTCGTCCGTTATCGAGGGTCGCCTCATAGATGACATCTAGACCGAGTCCAGGGTCT 69 FBan0012773 FBgn0024365 CG12773 X X amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12773 CG12773 EG:8D8.3 CDMC20600 2 8 21 DAC33-N24 3-CG12773-RA_1 CG12773 CCAACTACCACCACTCGTCCGTTATCGAGGGTCGCCTCATAGATGACATCTAGACCGAGTCCAGGGTCT 69 FBan0012773 FBgn0024365 CG12773 X X amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12773 CG12773 EG:8D8.3 CDMC20601 2 9 21 DAC34-B12 23-CG4347-RA_8 CG4347 GCATCTTGGACCACTAAATCAAATCCTGTACAATTGGATATCGTCTCACTAACTGTAGTCTAATTGTCT 69 FBan0004347 FBgn0035978 UGP 3 3L polysaccharide metabolism; GO:0005976 UTP:glucose-1-phosphate uridylyltransferase activity; GO:0003983 ; EC:2.7.7.9; ; GO:0003983 ; EC:2.7.7.9 UGP UGP "CG4347, CG4347, CG4347, UTP-G-1-P uridyiyltransferase, UDPGPP, UDP-glucose pyrophosphorylase, UGPase" CDMC20601 2 10 21 DAC34-B12 23-CG4347-RA_8 CG4347 GCATCTTGGACCACTAAATCAAATCCTGTACAATTGGATATCGTCTCACTAACTGTAGTCTAATTGTCT 69 FBan0004347 FBgn0035978 UGP 3 3L polysaccharide metabolism; GO:0005976 UTP:glucose-1-phosphate uridylyltransferase activity; GO:0003983 ; EC:2.7.7.9; ; GO:0003983 ; EC:2.7.7.9 UGP UGP "CG4347, CG4347, CG4347, UTP-G-1-P uridyiyltransferase, UDPGPP, UDP-glucose pyrophosphorylase, UGPase" CDMC20602 2 11 21 DAC34-B24 18-CG4356-RB_3 CG4356 GGGCCTGGTGCGAATCAAGCCGAAATCAAAGCGACATTTGTAGTGTCTGTGACACAGTACGCATATTTA 69 FBan0004356 FBgn0000037 mAcR-60C 2 2R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213; neuromuscular synaptic transmission; GO:0007274" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981; amine receptor activity; GO:0008227; ligand-gated ion channel activity; GO:0015276; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0015276; ; GO:0008227; ; GO:0004981 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 mAcR-60C muscarinic Acetylcholine Receptor 60C "CG4356, muscarinic receptor, mAChR-1, mAChR, Acr60C, Dm1, DM1, AcrC" CDMC20602 2 12 21 DAC34-B24 18-CG4356-RB_3 CG4356 GGGCCTGGTGCGAATCAAGCCGAAATCAAAGCGACATTTGTAGTGTCTGTGACACAGTACGCATATTTA 69 FBan0004356 FBgn0000037 mAcR-60C 2 2R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213; neuromuscular synaptic transmission; GO:0007274" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981; amine receptor activity; GO:0008227; ligand-gated ion channel activity; GO:0015276; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0015276; ; GO:0008227; ; GO:0004981 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 mAcR-60C muscarinic Acetylcholine Receptor 60C "CG4356, muscarinic receptor, mAChR-1, mAChR, Acr60C, Dm1, DM1, AcrC" CDMC20603 2 13 21 DAC34-F12 2-CG4389-RB_1 CG4389 ACATGGCTAAGGACCCGTCGAAGAAGTTCTACCCCAAGACTGGCTCCTCGAAGTTGTAGATCCGATCCA 69 FBan0004389 FBgn0028479 CG4389 2 2L fatty acid beta-oxidation; GO:0006635 long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; long-chain-enoyl-CoA hydratase activity; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211; ; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 CG4389 CG4389 BcDNA:GH12558 CDMC20603 2 14 21 DAC34-F12 2-CG4389-RB_1 CG4389 ACATGGCTAAGGACCCGTCGAAGAAGTTCTACCCCAAGACTGGCTCCTCGAAGTTGTAGATCCGATCCA 69 FBan0004389 FBgn0028479 CG4389 2 2L fatty acid beta-oxidation; GO:0006635 long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; long-chain-enoyl-CoA hydratase activity; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211; ; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 CG4389 CG4389 BcDNA:GH12558 CDMC20604 2 15 21 DAC34-F24 3-CG4413-RA_2 CG4413 AGCCGGTGCCAAATGAGATCGAGGAGGCTGAAACCTATGCTGAATACGAGGAATACGAACTGCTCACCA 69 FBan0004413 FBgn0038767 CG4413 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4413 CG4413 CDMC20604 2 16 21 DAC34-F24 3-CG4413-RA_2 CG4413 AGCCGGTGCCAAATGAGATCGAGGAGGCTGAAACCTATGCTGAATACGAGGAATACGAACTGCTCACCA 69 FBan0004413 FBgn0038767 CG4413 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4413 CG4413 CDMC20605 2 17 21 DAC34-J12 23-CG4440-RA_3 CG4440 GCAGTTTTATCCTCAAAGACGATTCATCATATACTCTTACTCCAGTATCGCTAAAGAAGCTAAAAGTGT 69 FBan0004440 FBgn0040984 CG4440 2 2L CG4440 CG4440 BcDNA:RE16123 CDMC20605 2 18 21 DAC34-J12 23-CG4440-RA_3 CG4440 GCAGTTTTATCCTCAAAGACGATTCATCATATACTCTTACTCCAGTATCGCTAAAGAAGCTAAAAGTGT 69 FBan0004440 FBgn0040984 CG4440 2 2L CG4440 CG4440 BcDNA:RE16123 CDMC20606 2 19 21 DAC34-J24 23-CG4452-RA_2 CG4452 CTGTTCCAACTCCCTCCTTCCAAATGTAACCCAATCATCAGTTAGAAAATGTAATTCGAATTCAACTTA 69 FBan0004452 FBgn0035981 CG4452 3 3L CG4452 CG4452 "cg4452, anon-WO0172774.118" CDMC20606 2 20 21 DAC34-J24 23-CG4452-RA_2 CG4452 CTGTTCCAACTCCCTCCTTCCAAATGTAACCCAATCATCAGTTAGAAAATGTAATTCGAATTCAACTTA 69 FBan0004452 FBgn0035981 CG4452 3 3L CG4452 CG4452 "cg4452, anon-WO0172774.118" CDMC20607 2 21 21 DAC34-N12 6-CG4488-RA_2 CG4488 TGGCATGGACAGCGTCTATGAAGAACTGCGCCATTCAGAGAATCTGGTTACGTACAAGATCGGCGACCT 69 FBan0004488 FBgn0011737 wee 2 2L "cell cycle; GO:0007049; embryonic development (sensu Insecta); GO:0001700; mitotic cell cycle, embryonic; GO:0045448; mitotic checkpoint; GO:0007093; negative regulation of cyclin dependent protein kinase activity; GO:0045736; nuclear division; GO:0000280; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.- nucleus; GO:0005634 wee wee "CG4488, CG4488, Dwee1, Wee1, Wee, WEE1, wee1, Dwee, dwee1, Wee 1, dWee1" CDMC20607 2 22 21 DAC34-N12 6-CG4488-RA_2 CG4488 TGGCATGGACAGCGTCTATGAAGAACTGCGCCATTCAGAGAATCTGGTTACGTACAAGATCGGCGACCT 69 FBan0004488 FBgn0011737 wee 2 2L "cell cycle; GO:0007049; embryonic development (sensu Insecta); GO:0001700; mitotic cell cycle, embryonic; GO:0045448; mitotic checkpoint; GO:0007093; negative regulation of cyclin dependent protein kinase activity; GO:0045736; nuclear division; GO:0000280; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.- nucleus; GO:0005634 wee wee "CG4488, CG4488, Dwee1, Wee1, Wee, WEE1, wee1, Dwee, dwee1, Wee 1, dWee1" CDMC20608 2 23 21 DAC34-N24 13-CG4511-RA_1 CG4511 GGCCGACGAAAAAGAGTTCTTCGAGATGTCGAAAAAGTCGCCCAACATTGTTTGCCACTTTTACCGCGA 69 FBan0004511 FBgn0037843 CG4511 3 3R electron transport; GO:0006118 ATP binding; GO:0005524; ; GO:0005524; electron transporter activity; GO:0005489; ; GO:0005489 CG4511 CG4511 CDMC20608 2 24 21 DAC34-N24 13-CG4511-RA_1 CG4511 GGCCGACGAAAAAGAGTTCTTCGAGATGTCGAAAAAGTCGCCCAACATTGTTTGCCACTTTTACCGCGA 69 FBan0004511 FBgn0037843 CG4511 3 3R electron transport; GO:0006118 ATP binding; GO:0005524; ; GO:0005524; electron transporter activity; GO:0005489; ; GO:0005489 CG4511 CG4511 CDMC20609 2 25 21 DAC35-B12 8-CG8807-RA_2 CG8807 AACTTCCGCATCTGGTTCCCCCGGAAATGATGGAGATGTCCAGGAAATCCGTTGAAGCTTGTCGGGATA 69 FBan0008807 FBgn0020277 lush 3 3L NOT response to ethanol; GO:0045471; olfactory behavior; GO:0042048; response to ethanol; GO:0045471; response to pheromone; GO:0019236; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; NOT ethanol binding; GO:0035276; dibutyl phthalate binding; GO:0035275; diphenyl phthalate binding; GO:0035274; ; GO:0035276; ; GO:0035275; ; GO:0035274 extracellular region; GO:0005576 lush lush "CG8807, LUSH, 76c, 76c(LUSH), 76a, Obp76a" CDMC20609 2 26 21 DAC35-B12 8-CG8807-RA_2 CG8807 AACTTCCGCATCTGGTTCCCCCGGAAATGATGGAGATGTCCAGGAAATCCGTTGAAGCTTGTCGGGATA 69 FBan0008807 FBgn0020277 lush 3 3L NOT response to ethanol; GO:0045471; olfactory behavior; GO:0042048; response to ethanol; GO:0045471; response to pheromone; GO:0019236; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; NOT ethanol binding; GO:0035276; dibutyl phthalate binding; GO:0035275; diphenyl phthalate binding; GO:0035274; ; GO:0035276; ; GO:0035275; ; GO:0035274 extracellular region; GO:0005576 lush lush "CG8807, LUSH, 76c, 76c(LUSH), 76a, Obp76a" CDMC20610 2 1 22 DAC35-B24 13-CG8816-RA_1 CG8816 CCTGGAGCGGGGAAATCGTATTTATGCGAACGTATAGCCTCCGAACTAAAGTTTGAGTGGCTGGACTGC 69 FBan0008816 FBgn0033754 CG8816 2 2R CG8816 CG8816 CDMC20610 2 2 22 DAC35-B24 13-CG8816-RA_1 CG8816 CCTGGAGCGGGGAAATCGTATTTATGCGAACGTATAGCCTCCGAACTAAAGTTTGAGTGGCTGGACTGC 69 FBan0008816 FBgn0033754 CG8816 2 2R CG8816 CG8816 CDMC20611 2 3 22 DAC35-F12 1-CG8850-RB_1 CG8850 GGCACCTGGTCTGATGTTCCTGGTCCTCGTCTATATGCTCTTCAGCTACGAACCTCTGACGTACCGAGG 69 FBan0008850 FBgn0033708 CG8850 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8850 CG8850 CDMC20611 2 4 22 DAC35-F12 1-CG8850-RB_1 CG8850 GGCACCTGGTCTGATGTTCCTGGTCCTCGTCTATATGCTCTTCAGCTACGAACCTCTGACGTACCGAGG 69 FBan0008850 FBgn0033708 CG8850 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8850 CG8850 CDMC20612 2 5 22 DAC35-F24 3-CG8859-RA_4 CG8859 GGAGGAGATCAAGGATGCACTGGTCGAAAGTGGAGGTCAGGTGACGCTGAAGATGATCGAGTCACTGGA 69 FBan0008859 FBgn0033696 Cyp6g2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g2 Cyp6g2 "CG8859, 6g2" CDMC20612 2 6 22 DAC35-F24 3-CG8859-RA_4 CG8859 GGAGGAGATCAAGGATGCACTGGTCGAAAGTGGAGGTCAGGTGACGCTGAAGATGATCGAGTCACTGGA 69 FBan0008859 FBgn0033696 Cyp6g2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g2 Cyp6g2 "CG8859, 6g2" CDMC20613 2 7 22 DAC35-J12 2-CG8907-RA_1 CG8907 CCTGGCTGAGTAGATTGGAGAGCCGAAATGTCAAGATCGCCGAGGTTACCTTCAATAAGTCGGCCACCA 69 FBan0008907 FBgn0038466 CG8907 3 3R development; GO:0007275 CG8907 CG8907 LP01469p CDMC20613 2 8 22 DAC35-J12 2-CG8907-RA_1 CG8907 CCTGGCTGAGTAGATTGGAGAGCCGAAATGTCAAGATCGCCGAGGTTACCTTCAATAAGTCGGCCACCA 69 FBan0008907 FBgn0038466 CG8907 3 3R development; GO:0007275 CG8907 CG8907 LP01469p CDMC20614 2 9 22 DAC35-J24 3-CG8916-RA_2 CG8916 CGCGATTGCATCAGATGTGGATGTGCCTGAAGAGCGACAACAGTTTCCGGAAACAACGAGAACGCAACG 69 FBan0008916 FBgn0030707 CG8916 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG8916 CG8916 CDMC20614 2 10 22 DAC35-J24 3-CG8916-RA_2 CG8916 CGCGATTGCATCAGATGTGGATGTGCCTGAAGAGCGACAACAGTTTCCGGAAACAACGAGAACGCAACG 69 FBan0008916 FBgn0030707 CG8916 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG8916 CG8916 CDMC20615 2 11 22 DAC35-N12 5-CG8954-RA_3 CG8954 CCCCATTTGTGGTGGTCGATTCGAAGGCATTGACCGAATACAATGGCATAGTCAAGTCGCTGGTGAGGA 69 FBan0008954 FBgn0019890 Smg5 2 2L "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg5 Smg5 "CG8954, CG8954, CG8954, CG8954, BG:DS08220.2, anon-34Ea, SMG5" CDMC20615 2 12 22 DAC35-N12 5-CG8954-RA_3 CG8954 CCCCATTTGTGGTGGTCGATTCGAAGGCATTGACCGAATACAATGGCATAGTCAAGTCGCTGGTGAGGA 69 FBan0008954 FBgn0019890 Smg5 2 2L "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg5 Smg5 "CG8954, CG8954, CG8954, CG8954, BG:DS08220.2, anon-34Ea, SMG5" CDMC20616 2 13 22 DAC35-N24 10-CG8964-RA_2 CG8964 TCCGAAATCCTCGATTACCATCAAGGAACAAAGTTCGTTGCAATTGCCCTGTGACTACCAACTGCCGGA 69 FBan0008964 FBgn0033674 CG8964 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004888; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG8964 CG8964 CT25760 CDMC20616 2 14 22 DAC35-N24 10-CG8964-RA_2 CG8964 TCCGAAATCCTCGATTACCATCAAGGAACAAAGTTCGTTGCAATTGCCCTGTGACTACCAACTGCCGGA 69 FBan0008964 FBgn0033674 CG8964 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004888; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG8964 CG8964 CT25760 CDMC20617 2 15 22 DAC36-B12 18-CG7056-RA_1 CG7056 AAAGGCGGCCAGATCAGATTCACCTCCCAGCAGACCAAAAATCTCGAGGCTCGCTTCGCCAGCTC 65 FBan0007056 FBgn0038852 CG7056 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7056 CG7056 CDMC20617 2 16 22 DAC36-B12 18-CG7056-RA_1 CG7056 AAAGGCGGCCAGATCAGATTCACCTCCCAGCAGACCAAAAATCTCGAGGCTCGCTTCGCCAGCTC 65 FBan0007056 FBgn0038852 CG7056 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7056 CG7056 CDMC20618 2 17 22 DAC36-B24 1-CG7076-RA_3 CG7076 CTATCCGTTGGAGCACCAGTACTACGAGGAGAGCCATGGATATGAGCACCTGGCCCATCACGAAC 65 FBan0007076 FBgn0035875 CG7076 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7076 CG7076 CDMC20618 2 18 22 DAC36-B24 1-CG7076-RA_3 CG7076 CTATCCGTTGGAGCACCAGTACTACGAGGAGAGCCATGGATATGAGCACCTGGCCCATCACGAAC 65 FBan0007076 FBgn0035875 CG7076 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7076 CG7076 CDMC20619 2 19 22 DAC36-F12 2-CG7216-RA_1 CG7216 AGAACAAGAGTTCAACCAGAGCGCAACCCAAAACCCACAAACAGCACCATGAAATTCGCCGTCGC 65 FBan0007216 FBgn0014454 Acp1 2 2L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 Acp1 Adult cuticle protein 1 "CG7216, Dacp-1" CDMC20619 2 20 22 DAC36-F12 2-CG7216-RA_1 CG7216 AGAACAAGAGTTCAACCAGAGCGCAACCCAAAACCCACAAACAGCACCATGAAATTCGCCGTCGC 65 FBan0007216 FBgn0014454 Acp1 2 2L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 Acp1 Adult cuticle protein 1 "CG7216, Dacp-1" CDMC20620 2 21 22 DAC36-F24 3-CG7242-RA_1 CG7242 TCCGTGGCGATAAACGCGACCAGTTGATACCCTTTGATCTGAAGGCGACCGATGTGGAAGGACTG 65 FBan0007242 FBgn0040494 CG7242 3 3R CG7242 CG7242 "BcDNA:LD37196, l(3)c00064, lethal (3) c00064" CDMC20620 2 22 22 DAC36-F24 3-CG7242-RA_1 CG7242 TCCGTGGCGATAAACGCGACCAGTTGATACCCTTTGATCTGAAGGCGACCGATGTGGAAGGACTG 65 FBan0007242 FBgn0040494 CG7242 3 3R CG7242 CG7242 "BcDNA:LD37196, l(3)c00064, lethal (3) c00064" CDMC20621 2 23 22 DAC36-J12 1-CG7345-RA_1 CG7345 GTACCGGCATCTCATCCTACGGATGCGTCAAGTCAGAGAAGTCCTCACCAAATGCGGTAGTGGCC 65 FBan0007345 FBgn0036411 Sox21a 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox21a Sox21a "CG7345, CG7345, SOXB2.3, Sox B2-3, SoxB2.3" CDMC20621 2 24 22 DAC36-J12 1-CG7345-RA_1 CG7345 GTACCGGCATCTCATCCTACGGATGCGTCAAGTCAGAGAAGTCCTCACCAAATGCGGTAGTGGCC 65 FBan0007345 FBgn0036411 Sox21a 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox21a Sox21a "CG7345, CG7345, SOXB2.3, Sox B2-3, SoxB2.3" CDMC20622 2 25 22 DAC36-J24 1-CG7377-RA_1 CG7377 GAAGTACTCCTGTGTTTTGCTCCTTTTGGCCACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTG 65 FBan0007377 FBgn0036176 CG7377 3 3L CG7377 CG7377 HDC09644 CDMC20622 2 26 22 DAC36-J24 1-CG7377-RA_1 CG7377 GAAGTACTCCTGTGTTTTGCTCCTTTTGGCCACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTG 65 FBan0007377 FBgn0036176 CG7377 3 3L CG7377 CG7377 HDC09644 CDMC20623 2 1 23 DAC36-N12 3-CG7439-RC_2 CG7439 GAACCGTGGTCGATCGCACCATTGTGCATCCTAACGAGATGCAGTTCTTCATGGTCAGCCACCAG 65 FBan0007439 FBgn0046812 AGO2 3 3L "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413" protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; translation initiation factor activity; GO:0003743; ; GO:0003743 RNA-induced silencing complex; GO:0016442 AGO2 Argonaute 2 "CG7439, CG13452, CG7439, CG7439, CG7439, CG7439, CG7439, Ago-2, ago2, Dm Ago2, dAgo2, Ago2, Argonaute2, AGO 2, Argonaute 2" CDMC20623 2 2 23 DAC36-N12 3-CG7439-RC_2 CG7439 GAACCGTGGTCGATCGCACCATTGTGCATCCTAACGAGATGCAGTTCTTCATGGTCAGCCACCAG 65 FBan0007439 FBgn0046812 AGO2 3 3L "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413" protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; translation initiation factor activity; GO:0003743; ; GO:0003743 RNA-induced silencing complex; GO:0016442 AGO2 Argonaute 2 "CG7439, CG13452, CG7439, CG7439, CG7439, CG7439, CG7439, Ago-2, ago2, Dm Ago2, dAgo2, Ago2, Argonaute2, AGO 2, Argonaute 2" CDMC20624 2 3 23 DAC36-N24 1-CG7476-RA_1 CG7476 CAGTTTGGGGACGGTTCGATTACGCCGATTGAAAAGCATTTAAGGGCCTGTGTTTGCAGCGTGCG 65 FBan0007476 FBgn0035847 mthl7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl7 methuselah-like 7 "CG7476, CG7476, mth-like 7, Mth-like 7, anon-WO0170980.86, anon-WO0170980.85" CDMC20624 2 4 23 DAC36-N24 1-CG7476-RA_1 CG7476 CAGTTTGGGGACGGTTCGATTACGCCGATTGAAAAGCATTTAAGGGCCTGTGTTTGCAGCGTGCG 65 FBan0007476 FBgn0035847 mthl7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl7 methuselah-like 7 "CG7476, CG7476, mth-like 7, Mth-like 7, anon-WO0170980.86, anon-WO0170980.85" CDMC20625 2 5 23 DAC37-B12 2-CG12892-RA_2 CG12892 AGCAAGCTACTCCCATTGCAGTGAGGAGAACTCCACGCGTACTCATCGAAATGCCGGTGAACTCG 65 FBan0012892 FBgn0033526 Caf1-105 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-105 Caf1-105 "CG12892, CG12892, Caf1-10" CDMC20625 2 6 23 DAC37-B12 2-CG12892-RA_2 CG12892 AGCAAGCTACTCCCATTGCAGTGAGGAGAACTCCACGCGTACTCATCGAAATGCCGGTGAACTCG 65 FBan0012892 FBgn0033526 Caf1-105 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-105 Caf1-105 "CG12892, CG12892, Caf1-10" CDMC20626 2 7 23 DAC37-B24 2-CG12923-RA_1 CG12923 ACACTCGCACCTGGATAGTCACATCCCGTTGGTGGTGCTAATTTCCCAGACATTGCCCAATACGG 65 FBan0012923 FBgn0033461 CG12923 2 2R CG12923 CG12923 CDMC20626 2 8 23 DAC37-B24 2-CG12923-RA_1 CG12923 ACACTCGCACCTGGATAGTCACATCCCGTTGGTGGTGCTAATTTCCCAGACATTGCCCAATACGG 65 FBan0012923 FBgn0033461 CG12923 2 2R CG12923 CG12923 CDMC20627 2 9 23 DAC37-F12 12-CG13005-RA_3 CG13005 GCACGAATTGCACGAGTTTTGGGCATACCCGAGGGTCAGTATGCGTTGGATATGTCCGCCATGGA 65 FBan0013005 FBgn0030794 CG13005 X X CG13005 CG13005 CDMC20627 2 10 23 DAC37-F12 12-CG13005-RA_3 CG13005 GCACGAATTGCACGAGTTTTGGGCATACCCGAGGGTCAGTATGCGTTGGATATGTCCGCCATGGA 65 FBan0013005 FBgn0030794 CG13005 X X CG13005 CG13005 CDMC20628 2 11 23 DAC37-F24 12-CG13031-RA_1 CG13031 CAGCTGTGGATCCAGCACTGTTTCCTTCGGCCTCTACTTTCGGACTCTATCCAGGATCAGGTGGA 65 FBan0013031 FBgn0036655 CG13031 3 3L CG13031 CG13031 CDMC20628 2 12 23 DAC37-F24 12-CG13031-RA_1 CG13031 CAGCTGTGGATCCAGCACTGTTTCCTTCGGCCTCTACTTTCGGACTCTATCCAGGATCAGGTGGA 65 FBan0013031 FBgn0036655 CG13031 3 3L CG13031 CG13031 CDMC20629 2 13 23 DAC37-J12 1-CG13063-RA_1 CG13063 TCTGCTCTCCTCGCCGTAGCTGTCGCTCGTCCCGGTCATCTTTATGAGTCTCCTCTGGTTTATGC 65 FBan0013063 FBgn0036601 CG13063 3 3L CG13063 CG13063 CDMC20629 2 14 23 DAC37-J12 1-CG13063-RA_1 CG13063 TCTGCTCTCCTCGCCGTAGCTGTCGCTCGTCCCGGTCATCTTTATGAGTCTCCTCTGGTTTATGC 65 FBan0013063 FBgn0036601 CG13063 3 3L CG13063 CG13063 CDMC20630 2 15 23 DAC37-J24 12-CG13087-RA_1 CG13087 CGAACAGGACGAGCGCAGTGGTGGAAAGGTTCGCCAAATTCTCAGCCATTTACACGCTCCCAGTG 65 FBan0013087 FBgn0032045 CG13087 2 2L CG13087 CG13087 CDMC20630 2 16 23 DAC37-J24 12-CG13087-RA_1 CG13087 CGAACAGGACGAGCGCAGTGGTGGAAAGGTTCGCCAAATTCTCAGCCATTTACACGCTCCCAGTG 65 FBan0013087 FBgn0032045 CG13087 2 2L CG13087 CG13087 CDMC20631 2 17 23 DAC37-N12 3-CG13162-RA_3 CG13162 CACAAGCGGATCCTGTGCCTTCGAATACTCCGCAACATGTGCTTCTTCAATGGTAATCGCCCCCG 65 FBan0013162 FBgn0033718 CG13162 2 2R CG13162 CG13162 CDMC20631 2 18 23 DAC37-N12 3-CG13162-RA_3 CG13162 CACAAGCGGATCCTGTGCCTTCGAATACTCCGCAACATGTGCTTCTTCAATGGTAATCGCCCCCG 65 FBan0013162 FBgn0033718 CG13162 2 2R CG13162 CG13162 CDMC20632 2 19 23 DAC37-N24 23-CG13176-RA_2 CG13176 CAACCTAGGTTCTCTAGCTTAAAGCATACAAATTTCTAAAACGAATTCCAAATTCTGTGCCCAAG 65 FBan0013176 FBgn0033692 CG13176 2 2R transcription factor complex; GO:0005667 CG13176 CG13176 "p65, p63" CDMC20632 2 20 23 DAC37-N24 23-CG13176-RA_2 CG13176 CAACCTAGGTTCTCTAGCTTAAAGCATACAAATTTCTAAAACGAATTCCAAATTCTGTGCCCAAG 65 FBan0013176 FBgn0033692 CG13176 2 2R transcription factor complex; GO:0005667 CG13176 CG13176 "p65, p63" CDMC20633 2 21 23 DAC38-B12 23-CG32572-RA_4 CG32572 ACATTGTAGGCCACAAAGTGAACTAATTATTGCAACATCCTGCGATTCTTATCTCTACTGCCAATCTTT 69 FBan0032572 FBgn0052572 CG32572 X X CG32572 CG32572 "CG13006, CG13007" CDMC20633 2 22 23 DAC38-B12 23-CG32572-RA_4 CG32572 ACATTGTAGGCCACAAAGTGAACTAATTATTGCAACATCCTGCGATTCTTATCTCTACTGCCAATCTTT 69 FBan0032572 FBgn0052572 CG32572 X X CG32572 CG32572 "CG13006, CG13007" CDMC20634 2 23 23 DAC38-B24 1-CG32581-RA_1 CG32581 CGCGTCCCAATCGCAAACTCTGTCCCGTTTGTAAGGCTGCCGTTGATAAGGATAAGGTCATACCGCTGT 69 FBan0032581 FBgn0052581 CG32581 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32581 CG32581 CDMC20634 2 24 23 DAC38-B24 1-CG32581-RA_1 CG32581 CGCGTCCCAATCGCAAACTCTGTCCCGTTTGTAAGGCTGCCGTTGATAAGGATAAGGTCATACCGCTGT 69 FBan0032581 FBgn0052581 CG32581 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32581 CG32581 CDMC20635 2 25 23 DAC38-F12 1-CG32606-RA_1 CG32606 GCGGGGGATGACAATTTGCTGTTGCTTTGGCCGTTGCTGACTCAAAACAGTTGCAAAGTTGTTGCTGAA 69 FBan0032606 FBgn0052606 CG32606 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32606 CG32606 CDMC20635 2 26 23 DAC38-F12 1-CG32606-RA_1 CG32606 GCGGGGGATGACAATTTGCTGTTGCTTTGGCCGTTGCTGACTCAAAACAGTTGCAAAGTTGTTGCTGAA 69 FBan0032606 FBgn0052606 CG32606 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32606 CG32606 CDMC20636 2 1 24 DAC38-F24 23-CG32631-RA_1 CG32631 ATTTAAAAAATACAATTGAGCAACCAAACATGGCCAACATTCTAAGTTTTACCATCTTTATGGCTGCCA 69 FBan0032631 FBgn0052631 CG32631 X X CG32631 CG32631 "CG1733, CG1733, CG1733" CDMC20636 2 2 24 DAC38-F24 23-CG32631-RA_1 CG32631 ATTTAAAAAATACAATTGAGCAACCAAACATGGCCAACATTCTAAGTTTTACCATCTTTATGGCTGCCA 69 FBan0032631 FBgn0052631 CG32631 X X CG32631 CG32631 "CG1733, CG1733, CG1733" CDMC20637 2 3 24 DAC38-J12 23-CG32654-RC_7 CG32654 GCAGGGGAAAAGTTGGTCCTACGATATTTTCAAGATTCTACAGTTTGTTCAACTTCTGTCTGTCTGTGC 69 FBan0032654 FBgn0052654 CG32654 X X CG32654 CG32654 "CG18079, CG2551, BcDNA:RE70141" CDMC20637 2 4 24 DAC38-J12 23-CG32654-RC_7 CG32654 GCAGGGGAAAAGTTGGTCCTACGATATTTTCAAGATTCTACAGTTTGTTCAACTTCTGTCTGTCTGTGC 69 FBan0032654 FBgn0052654 CG32654 X X CG32654 CG32654 "CG18079, CG2551, BcDNA:RE70141" CDMC20638 2 5 24 DAC38-J24 22-CG32670-RA_1 CG32670 TCAACATGTTGTCAGTTGGCATATACAATCGTCTTGTGATTCATACCCCAAATCGCTTGTCAGGTGGGC 69 FBan0032670 FBgn0052670 CG32670 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG32670 CG32670 "CG2532, CG2532, CG2532, DmRabX3" CDMC20638 2 6 24 DAC38-J24 22-CG32670-RA_1 CG32670 TCAACATGTTGTCAGTTGGCATATACAATCGTCTTGTGATTCATACCCCAAATCGCTTGTCAGGTGGGC 69 FBan0032670 FBgn0052670 CG32670 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG32670 CG32670 "CG2532, CG2532, CG2532, DmRabX3" CDMC20639 2 7 24 DAC38-N12 9-CG32700-RB_1 CG32700 ACGGATGAATTCGGTTGGACACTGGGCAATACAAACAACCAAATGCCTGGAAACTCCGAACCAACTCGA 69 FBan0032700 FBgn0052700 CG32700 X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG32700 CG32700 "CG12651, CG12652, CG2994, CG18429, CG12651, CG12652, CG2994, CG2994, BcDNA:GH19985" CDMC20639 2 8 24 DAC38-N12 9-CG32700-RB_1 CG32700 ACGGATGAATTCGGTTGGACACTGGGCAATACAAACAACCAAATGCCTGGAAACTCCGAACCAACTCGA 69 FBan0032700 FBgn0052700 CG32700 X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG32700 CG32700 "CG12651, CG12652, CG2994, CG18429, CG12651, CG12652, CG2994, CG2994, BcDNA:GH19985" CDMC20640 2 9 24 DAC38-N24 1-CG32708-RA_7 CG32708 AGACCACCTTCTTCCAGAACAATCTCGACAAGAGCGAGTTCATCAGGAAGCAGGCGAAGAAGGCCAAGA 69 FBan0032708 FBgn0052708 CG32708 X X CG32708 CG32708 CG6997 CDMC20640 2 10 24 DAC38-N24 1-CG32708-RA_7 CG32708 AGACCACCTTCTTCCAGAACAATCTCGACAAGAGCGAGTTCATCAGGAAGCAGGCGAAGAAGGCCAAGA 69 FBan0032708 FBgn0052708 CG32708 X X CG32708 CG32708 CG6997 CDMC20641 2 11 24 DAC39-B12 1-CG13661-RA_1 CG13661 TGCAACAGCGTCTGACTCTGACCCATGAGGAGTCCCAGAAGAAATACGAAGTGGTCAAGAACTCCCTGC 69 FBan0013661 FBgn0039285 CG13661 3 3R CG13661 CG13661 CDMC20641 2 12 24 DAC39-B12 1-CG13661-RA_1 CG13661 TGCAACAGCGTCTGACTCTGACCCATGAGGAGTCCCAGAAGAAATACGAAGTGGTCAAGAACTCCCTGC 69 FBan0013661 FBgn0039285 CG13661 3 3R CG13661 CG13661 CDMC20642 2 13 24 DAC39-B24 8-CG13676-RA_1 CG13676 GCAGCGGCAATATGCTAGCGCCTATAATCCATTTGCCTATCAGCCAGCGTATCAATCACCAACATCCGC 69 FBan0013676 FBgn0035844 CG13676 3 3L CG13676 CG13676 CDMC20642 2 14 24 DAC39-B24 8-CG13676-RA_1 CG13676 GCAGCGGCAATATGCTAGCGCCTATAATCCATTTGCCTATCAGCCAGCGTATCAATCACCAACATCCGC 69 FBan0013676 FBgn0035844 CG13676 3 3L CG13676 CG13676 CDMC20643 2 15 24 DAC39-F12 14-CG13724-RA_1 CG13724 AGGTTCAGACTATACCCACAGCATTATTGTCCGCCTTGACTACCAAGAAACCACATACGGTGACCACCA 69 FBan0013724 FBgn0036707 CG13724 3 3L CG13724 CG13724 CDMC20643 2 16 24 DAC39-F12 14-CG13724-RA_1 CG13724 AGGTTCAGACTATACCCACAGCATTATTGTCCGCCTTGACTACCAAGAAACCACATACGGTGACCACCA 69 FBan0013724 FBgn0036707 CG13724 3 3L CG13724 CG13724 CDMC20644 2 17 24 DAC39-F24 23-CG1373-RA_2 CG1373 TGTCCATCAAAGGACTCTACCAGGATAACGCGCGTTTAATTATACACACTTATTTATTTACCAGCCATA 69 FBan0001373 FBgn0000279 CecC 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecC Cecropin C "CG1373, CG1373, CG1373, Cecropin, cecropin, cecropin C, Cec-C, cec, cecC, Cec, BcDNA:RH33561" CDMC20644 2 18 24 DAC39-F24 23-CG1373-RA_2 CG1373 TGTCCATCAAAGGACTCTACCAGGATAACGCGCGTTTAATTATACACACTTATTTATTTACCAGCCATA 69 FBan0001373 FBgn0000279 CecC 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecC Cecropin C "CG1373, CG1373, CG1373, Cecropin, cecropin, cecropin C, Cec-C, cec, cecC, Cec, BcDNA:RH33561" CDMC20645 2 19 24 DAC39-J12 23-CG13779-RA_3 CG13779 AATAGCGTCAAAAACATTGTTTTATCGCCGTTGGAATTAATAAAAGCACACAAAATGTCTGCCCCAGAT 69 FBan0013779 FBgn0040954 CG13779 2 2L proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- proteasome complex (sensu Eukaryota); GO:0000502 CG13779 CG13779 BcDNA:RH34416 CDMC20645 2 20 24 DAC39-J12 23-CG13779-RA_3 CG13779 AATAGCGTCAAAAACATTGTTTTATCGCCGTTGGAATTAATAAAAGCACACAAAATGTCTGCCCCAGAT 69 FBan0013779 FBgn0040954 CG13779 2 2L proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- proteasome complex (sensu Eukaryota); GO:0000502 CG13779 CG13779 BcDNA:RH34416 CDMC20646 2 21 24 DAC39-J24 9-CG13788-RA_2 CG13788 CAGGTGGTCCTGGTCATATTGGCGGTAGTTCTCCTGGATACCGTCCTTCTGACAACTGGCTTAGTTTGC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC20646 2 22 24 DAC39-J24 9-CG13788-RA_2 CG13788 CAGGTGGTCCTGGTCATATTGGCGGTAGTTCTCCTGGATACCGTCCTTCTGACAACTGGCTTAGTTTGC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC20647 2 23 24 DAC39-N12 3-CG13830-RA_3 CG13830 TTGCAGGACAAAGAGGACAATAACCGGCACAACAACCACATCAATGCCCAGTACACTTTCACGCCCGAG 69 FBan0013830 FBgn0039054 CG13830 3 3R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG13830 CG13830 CDMC20647 2 24 24 DAC39-N12 3-CG13830-RA_3 CG13830 TTGCAGGACAAAGAGGACAATAACCGGCACAACAACCACATCAATGCCCAGTACACTTTCACGCCCGAG 69 FBan0013830 FBgn0039054 CG13830 3 3R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG13830 CG13830 CDMC20648 2 25 24 DAC39-N24 9-CG13852-RA_1 CG13852 GCCCATCTCAACACGTCCTTCAAGCACTTCATCTTCTTCGTGCAGGAGTTCAATCTGATTGAGCGGCGC 69 FBan0013852 FBgn0038965 mats 3 3R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 mats mob as tumor suppressor "CG13852, CG13852, CG13852, CG13852, anon-WO0118547.303, mob as tumor suppressor" CDMC20648 2 26 24 DAC39-N24 9-CG13852-RA_1 CG13852 GCCCATCTCAACACGTCCTTCAAGCACTTCATCTTCTTCGTGCAGGAGTTCAATCTGATTGAGCGGCGC 69 FBan0013852 FBgn0038965 mats 3 3R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 mats mob as tumor suppressor "CG13852, CG13852, CG13852, CG13852, anon-WO0118547.303, mob as tumor suppressor" CDMC20649 2 1 25 DAC40-B12 17-CG14133-RA_1 CG14133 TCAAGAAGGAAATGCAGGGCGTCTATCAGCGCACCAAAGAGTTAAAGAAACGAGCCGCTAACGTG 65 FBan0014133 FBgn0036192 CG14133 3 3L CG14133 CG14133 CDMC20649 2 2 25 DAC40-B12 17-CG14133-RA_1 CG14133 TCAAGAAGGAAATGCAGGGCGTCTATCAGCGCACCAAAGAGTTAAAGAAACGAGCCGCTAACGTG 65 FBan0014133 FBgn0036192 CG14133 3 3L CG14133 CG14133 CDMC20650 2 3 25 DAC40-B24 23-CG14157-RA_3 CG14157 GGCGCCTTTGTCGATGAACACAGCTTTGCAATTGACGAAAGGCATATATAGTTTCAGCATGATGT 65 FBan0014157 FBgn0036080 Or67d 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67d Or67d "CG14157, CG14157, 67d" CDMC20650 2 4 25 DAC40-B24 23-CG14157-RA_3 CG14157 GGCGCCTTTGTCGATGAACACAGCTTTGCAATTGACGAAAGGCATATATAGTTTCAGCATGATGT 65 FBan0014157 FBgn0036080 Or67d 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67d Or67d "CG14157, CG14157, 67d" CDMC20651 2 5 25 DAC40-F12 6-CG1422-RA_3 CG1422 TGGTGGCCAAAAGCCTATCACGCTACTCGAGCAGTGCACTAATCTCATGCAGCAGGAACGCTACC 65 FBan0001422 FBgn0040087 p115 X X Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; membrane; GO:0016020 p115 p115 "CG1422, CG1422, CG1422, CG1422, CG1422, l(1)G0306, dp115" CDMC20651 2 6 25 DAC40-F12 6-CG1422-RA_3 CG1422 TGGTGGCCAAAAGCCTATCACGCTACTCGAGCAGTGCACTAATCTCATGCAGCAGGAACGCTACC 65 FBan0001422 FBgn0040087 p115 X X Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; membrane; GO:0016020 p115 p115 "CG1422, CG1422, CG1422, CG1422, CG1422, l(1)G0306, dp115" CDMC20652 2 7 25 DAC40-F24 14-CG14249-RB_1 CG14249 CAGCAGGTGACACTGAAGGATGTCCAGTTCGATCTATCCGGCCAATTCTACTGCGAGGTCTCCAC 65 FBan0014249 FBgn0039447 beat-VII 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 beat-VII beat-VII "CG14249, beat VII" CDMC20652 2 8 25 DAC40-F24 14-CG14249-RB_1 CG14249 CAGCAGGTGACACTGAAGGATGTCCAGTTCGATCTATCCGGCCAATTCTACTGCGAGGTCTCCAC 65 FBan0014249 FBgn0039447 beat-VII 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 beat-VII beat-VII "CG14249, beat VII" CDMC20653 2 9 25 DAC40-J12 2-CG14325-RA_1 CG14325 CTGAGGCATGTTCCCCTCGAGAAACTGGTGCTTCGCTTGAATCCCATTCAAAGTGACGGAGCTGC 65 FBan0014325 FBgn0038531 CG14325 3 3R amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG14325 CG14325 CDMC20653 2 10 25 DAC40-J12 2-CG14325-RA_1 CG14325 CTGAGGCATGTTCCCCTCGAGAAACTGGTGCTTCGCTTGAATCCCATTCAAAGTGACGGAGCTGC 65 FBan0014325 FBgn0038531 CG14325 3 3R amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG14325 CG14325 CDMC20654 2 11 25 DAC40-J24 23-CG14363-RA_1 CG14363 CGACTGGAGTTCATAATTTAGCGTTTATTTATGAGTTGTCAAGTTGCTTGGTACGTGACTGGTCG 65 FBan0014363 FBgn0038185 CG14363 3 3R CG14363 CG14363 CDMC20654 2 12 25 DAC40-J24 23-CG14363-RA_1 CG14363 CGACTGGAGTTCATAATTTAGCGTTTATTTATGAGTTGTCAAGTTGCTTGGTACGTGACTGGTCG 65 FBan0014363 FBgn0038185 CG14363 3 3R CG14363 CG14363 CDMC20655 2 13 25 DAC40-N12 2-CG14430-RA_1 CG14430 AGTGGTTCGAGCGATACGACATACCGGACATTCAACCCCAAAATTGTTCCAGTGTCCATGGCGCC 65 FBan0014430 FBgn0029927 CG14430 X X CG14430 CG14430 BcDNA:RE28342 CDMC20655 2 14 25 DAC40-N12 2-CG14430-RA_1 CG14430 AGTGGTTCGAGCGATACGACATACCGGACATTCAACCCCAAAATTGTTCCAGTGTCCATGGCGCC 65 FBan0014430 FBgn0029927 CG14430 X X CG14430 CG14430 BcDNA:RE28342 CDMC20656 2 15 25 DAC40-N24 3-CG14462-RA_1 CG14462 TGCCTGTAGTTCCGGTAGCATTTCCCCGGTGCCCATCATACCCATCATCTCCATCAGTCACGATG 65 FBan0014462 FBgn0040523 CG14462 3 3R CG14462 CG14462 CDMC20656 2 16 25 DAC40-N24 3-CG14462-RA_1 CG14462 TGCCTGTAGTTCCGGTAGCATTTCCCCGGTGCCCATCATACCCATCATCTCCATCAGTCACGATG 65 FBan0014462 FBgn0040523 CG14462 3 3R CG14462 CG14462 CDMC20657 2 17 25 DAC41-B12 AutoBlank AutoBlank CDMC20657 2 18 25 DAC41-B12 AutoBlank AutoBlank CDMC20658 2 19 25 DAC41-B24 AutoBlank AutoBlank CDMC20658 2 20 25 DAC41-B24 AutoBlank AutoBlank CDMC20659 2 21 25 DAC41-F12 AutoBlank AutoBlank CDMC20659 2 22 25 DAC41-F12 AutoBlank AutoBlank CDMC20660 2 23 25 DAC41-F24 AutoBlank AutoBlank CDMC20660 2 24 25 DAC41-F24 AutoBlank AutoBlank CDMC20661 2 25 25 DAC41-J12 AutoBlank AutoBlank CDMC20661 2 26 25 DAC41-J12 AutoBlank AutoBlank CDMC20662 2 1 26 DAC41-J24 AutoBlank AutoBlank CDMC20662 2 2 26 DAC41-J24 AutoBlank AutoBlank CDMC20663 2 3 26 DAC41-N12 AutoBlank AutoBlank CDMC20663 2 4 26 DAC41-N12 AutoBlank AutoBlank CDMC20664 2 5 26 DAC41-N24 AutoBlank AutoBlank CDMC20664 2 6 26 DAC41-N24 AutoBlank AutoBlank CDMC20665 2 7 26 DAC42-B12 150mM NaPO4 Blank CDMC20665 2 8 26 DAC42-B12 150mM NaPO4 Blank CDMC20666 2 9 26 DAC42B24 Ambion control 2 Ambion control spot2 CDMC20666 2 10 26 DAC42B24 Ambion control 2 Ambion control spot2 CDMC20667 2 11 26 DAC42F12 Ambion control 4 Ambion control spot4 CDMC20667 2 12 26 DAC42F12 Ambion control 4 Ambion control spot4 CDMC20668 2 13 26 DAC42F24 Ambion control 6 Ambion control spot6 CDMC20668 2 14 26 DAC42F24 Ambion control 6 Ambion control spot6 CDMC20669 2 15 26 DAC42J12 Ambion control 8 Ambion control spot8 CDMC20669 2 16 26 DAC42J12 Ambion control 8 Ambion control spot8 CDMC20670 2 17 26 DAC42-J24 5uM MSP 5uM MSP CDMC20670 2 18 26 DAC42-J24 5uM MSP 5uM MSP CDMC20671 2 19 26 DAC42-N12 10uM MSP 10uM MSP CDMC20671 2 20 26 DAC42-N12 10uM MSP 10uM MSP CDMC20672 2 21 26 DAC42-N24 20uM MSP 20uM MSP CDMC20672 2 22 26 DAC42-N24 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC20673 3 1 1 DAC01-C12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20673 3 2 1 DAC01-C12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20674 3 3 1 DAC01-C24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20674 3 4 1 DAC01-C24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20675 3 5 1 DAC01-G12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20675 3 6 1 DAC01-G12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20676 3 7 1 DAC01-G24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20676 3 8 1 DAC01-G24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20677 3 9 1 DAC01-K12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20677 3 10 1 DAC01-K12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20678 3 11 1 DAC01-K24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20678 3 12 1 DAC01-K24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20679 3 13 1 DAC01-O12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20679 3 14 1 DAC01-O12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20680 3 15 1 DAC01-O24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20680 3 16 1 DAC01-O24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20681 3 17 1 DAC02-C12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20681 3 18 1 DAC02-C12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20682 3 19 1 DAC02-C24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20682 3 20 1 DAC02-C24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20683 3 21 1 DAC02-G12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20683 3 22 1 DAC02-G12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20684 3 23 1 DAC02-G24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20684 3 24 1 DAC02-G24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20685 3 25 1 DAC02-K12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20685 3 26 1 DAC02-K12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20686 3 1 2 DAC02-K24 N/A CG9075 (00240-00478) CDMC20686 3 2 2 DAC02-K24 N/A CG9075 (00240-00478) CDMC20687 3 3 2 DAC02-O12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20687 3 4 2 DAC02-O12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20688 3 5 2 DAC02-O24 AutoBlank AutoBlank CDMC20688 3 6 2 DAC02-O24 AutoBlank AutoBlank CDMC20689 3 7 2 DAC03-C12 23-CG32230-RA_2 CG32230 CACTTGGAATCGCACATCAAATCCCGAACCATGGCAAGAGTACAAAGAAAAGCAATACAAGTTTTATTC 69 FBan0032230 FBgn0052230 CG32230 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG32230 CG32230 "BcDNA:RE56733, BEST:GH04411" CDMC20689 3 8 2 DAC03-C12 23-CG32230-RA_2 CG32230 CACTTGGAATCGCACATCAAATCCCGAACCATGGCAAGAGTACAAAGAAAAGCAATACAAGTTTTATTC 69 FBan0032230 FBgn0052230 CG32230 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG32230 CG32230 "BcDNA:RE56733, BEST:GH04411" CDMC20690 3 9 2 DAC03-C24 16-CG32240-RA_1 CG32240 CCGGATGGTATTCGACCCTTTATAGAACACATGGAGCAGCTATATCCACTCAGGCATAACTTGGCCGAT 69 FBan0032240 FBgn0052240 CG32240 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32240 CG32240 "BcDNA:GH04494, BEST:GH04494" CDMC20690 3 10 2 DAC03-C24 16-CG32240-RA_1 CG32240 CCGGATGGTATTCGACCCTTTATAGAACACATGGAGCAGCTATATCCACTCAGGCATAACTTGGCCGAT 69 FBan0032240 FBgn0052240 CG32240 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32240 CG32240 "BcDNA:GH04494, BEST:GH04494" CDMC20691 3 11 2 DAC03-G12 23-CG32264-RA_1 CG32264 GCAGCAATTGTATTTCATGCAGCATAAAATTGTCAACAAATGTTTAAAAGCAAAAAATTAAGCCAGCAA 69 FBan0032264 FBgn0052264 CG32264 3 3L CG32264 CG32264 "CG10860, CG14978, CG10857, CG12604, CG10860, CG14978" CDMC20691 3 12 2 DAC03-G12 23-CG32264-RA_1 CG32264 GCAGCAATTGTATTTCATGCAGCATAAAATTGTCAACAAATGTTTAAAAGCAAAAAATTAAGCCAGCAA 69 FBan0032264 FBgn0052264 CG32264 3 3L CG32264 CG32264 "CG10860, CG14978, CG10857, CG12604, CG10860, CG14978" CDMC20692 3 13 2 DAC03-G24 9-CG32277-RA_1 CG32277 GCGTCTACACCCGCCTCAGTAGTCCATCGATTACGTACTGGCTGAAGGACTTTATCGAGCGACATTGCT 69 FBan0032277 FBgn0052277 CG32277 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32277 CG32277 "CG11531, CG11531, SP183" CDMC20692 3 14 2 DAC03-G24 9-CG32277-RA_1 CG32277 GCGTCTACACCCGCCTCAGTAGTCCATCGATTACGTACTGGCTGAAGGACTTTATCGAGCGACATTGCT 69 FBan0032277 FBgn0052277 CG32277 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32277 CG32277 "CG11531, CG11531, SP183" CDMC20693 3 15 2 DAC03-K12 1-CG32318-RA_1 CG32318 CCCCAAAAGAAGTCCAACCAAAACATCCAGGTGTATGTGCGCGTCAGACCCCTTAATTCTCGGGAACGT 69 FBan0032318 FBgn0052318 CG32318 3 3L CG32318 CG32318 CR32318 CDMC20693 3 16 2 DAC03-K12 1-CG32318-RA_1 CG32318 CCCCAAAAGAAGTCCAACCAAAACATCCAGGTGTATGTGCGCGTCAGACCCCTTAATTCTCGGGAACGT 69 FBan0032318 FBgn0052318 CG32318 3 3L CG32318 CG32318 CR32318 CDMC20694 3 17 2 DAC03-K24 6-CG32336-RA_1 CG32336 CCCACCACATCCCCTCATCGTCAAAGTACCGCGCATAACACCAGCGAGTTTATTATGTCTGCACTTGGG 69 FBan0032336 FBgn0052336 CG32336 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32336 CG32336 CDMC20694 3 18 2 DAC03-K24 6-CG32336-RA_1 CG32336 CCCACCACATCCCCTCATCGTCAAAGTACCGCGCATAACACCAGCGAGTTTATTATGTCTGCACTTGGG 69 FBan0032336 FBgn0052336 CG32336 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32336 CG32336 CDMC20695 3 19 2 DAC03-O12 23-CG32381-RA_20 CG32381 TTAGCAAGGAATCGAAATTCAAATGGTGCAAATGTGACGAGTGACTAAAAATCGGGGAATTCAGATTCC 69 FBan0032381 FBgn0035756 unc-13-4A 3 3L neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 synaptic vesicle; GO:0008021 unc-13-4A unc-13-4A "CG8608, CG14833, CG32381, CG14831, CG14832, CG8608, CG14833, dunc-13-4A" CDMC20695 3 20 2 DAC03-O12 23-CG32381-RA_20 CG32381 TTAGCAAGGAATCGAAATTCAAATGGTGCAAATGTGACGAGTGACTAAAAATCGGGGAATTCAGATTCC 69 FBan0032381 FBgn0035756 unc-13-4A 3 3L neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 synaptic vesicle; GO:0008021 unc-13-4A unc-13-4A "CG8608, CG14833, CG32381, CG14831, CG14832, CG8608, CG14833, dunc-13-4A" CDMC20696 3 21 2 DAC03-O24 16-CG32390-RA_2 CG32390 ACGGGTGCGTGGATATCTCGAAATAGCCAATGGTACTCAGGTCCAATCTCCTCATCAGCATAACAACAA 69 FBan0032390 FBgn0052390 CG32390 3 3L CG32390 CG32390 CG8621 CDMC20696 3 22 2 DAC03-O24 16-CG32390-RA_2 CG32390 ACGGGTGCGTGGATATCTCGAAATAGCCAATGGTACTCAGGTCCAATCTCCTCATCAGCATAACAACAA 69 FBan0032390 FBgn0052390 CG32390 3 3L CG32390 CG32390 CG8621 CDMC20697 3 23 2 DAC04-C12 22-CG2957-RA_1 CG2957 TGCCCAAGGACCAGTTGGAACTTTTGCTAGTTGAGAGCATTGCCGATATCGAATACTCCAACTTTACCA 69 FBan0002957 FBgn0037529 mRpS9 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS9 mitochondrial ribosomal protein S9 "CG2957, CG2957, MRP-S9, mitochondrial ribosomal protein S9" CDMC20697 3 24 2 DAC04-C12 22-CG2957-RA_1 CG2957 TGCCCAAGGACCAGTTGGAACTTTTGCTAGTTGAGAGCATTGCCGATATCGAATACTCCAACTTTACCA 69 FBan0002957 FBgn0037529 mRpS9 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS9 mitochondrial ribosomal protein S9 "CG2957, CG2957, MRP-S9, mitochondrial ribosomal protein S9" CDMC20698 3 25 2 DAC04-C24 24-CG2973-RA_2 CG2973 TACGCACTCCTTGTATATTCCTTCATTGTGCTTCATCTATTGCTAGTTTTTTAAAAAATAAATACAAAT 69 FBan0002973 FBgn0031467 CG2973 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG2973 CG2973 CDMC20698 3 26 2 DAC04-C24 24-CG2973-RA_2 CG2973 TACGCACTCCTTGTATATTCCTTCATTGTGCTTCATCTATTGCTAGTTTTTTAAAAAATAAATACAAAT 69 FBan0002973 FBgn0031467 CG2973 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG2973 CG2973 CDMC20699 3 1 3 DAC04-G12 8-CG30001-RA_1 CG30001 TGCTGAATCTGCGTTGAAGCTAACCTTGATACTGACAAGCGCTTTGGGGAATCTCTATTCCGGCCTCGT 69 FBan0030001 FBgn0050001 CG30001 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30001 CG30001 CDMC20699 3 2 3 DAC04-G12 8-CG30001-RA_1 CG30001 TGCTGAATCTGCGTTGAAGCTAACCTTGATACTGACAAGCGCTTTGGGGAATCTCTATTCCGGCCTCGT 69 FBan0030001 FBgn0050001 CG30001 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30001 CG30001 CDMC20700 3 3 3 DAC04-G24 23-CG30010-RA_5 CG30010 TCTCCAAGCATATCTTGCCGTTACGTACAATATAACCAAGGTCAATCTCCGGAGCCAAAAATTCGCGAA 69 FBan0030010 FBgn0050010 CG30010 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30010 CG30010 BcDNA:SD18306 CDMC20700 3 4 3 DAC04-G24 23-CG30010-RA_5 CG30010 TCTCCAAGCATATCTTGCCGTTACGTACAATATAACCAAGGTCAATCTCCGGAGCCAAAAATTCGCGAA 69 FBan0030010 FBgn0050010 CG30010 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30010 CG30010 BcDNA:SD18306 CDMC20701 3 5 3 DAC04-K12 14-CG30039-RA_1 CG30039 AGCCGCAACTGATGAAGGAGGTCCTCCATTACCGCAATCACCTGAAAACGTTGAGGAAAATGTGAAAGA 69 FBan0030039 FBgn0050039 CG30039 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30039 CG30039 "BcDNA:AT09538, NEST:bs15e10, NEST:bs25c07" CDMC20701 3 6 3 DAC04-K12 14-CG30039-RA_1 CG30039 AGCCGCAACTGATGAAGGAGGTCCTCCATTACCGCAATCACCTGAAAACGTTGAGGAAAATGTGAAAGA 69 FBan0030039 FBgn0050039 CG30039 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30039 CG30039 "BcDNA:AT09538, NEST:bs15e10, NEST:bs25c07" CDMC20702 3 7 3 DAC04-K24 2-CG30049-RA_1 CG30049 TCCGTCCGCTCAAGGATTACGCCGTAAACCTGACCGGACTAACATCAGTGGATGGATACTGCGATAGGT 69 FBan0030049 FBgn0050049 CG30049 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30049 CG30049 CDMC20702 3 8 3 DAC04-K24 2-CG30049-RA_1 CG30049 TCCGTCCGCTCAAGGATTACGCCGTAAACCTGACCGGACTAACATCAGTGGATGGATACTGCGATAGGT 69 FBan0030049 FBgn0050049 CG30049 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30049 CG30049 CDMC20703 3 9 3 DAC04-O12 5-CG30079-RA_2 CG30079 CGGCGCATCCGTACCGATTCATTAAGCAGAGCTCCAACGAGACGAACACTTCACTGACGGGCTCTTATA 69 FBan0030079 FBgn0050079 CG30079 2 2R CG30079 CG30079 "CG16805, BcDNA:GH04950" CDMC20703 3 10 3 DAC04-O12 5-CG30079-RA_2 CG30079 CGGCGCATCCGTACCGATTCATTAAGCAGAGCTCCAACGAGACGAACACTTCACTGACGGGCTCTTATA 69 FBan0030079 FBgn0050079 CG30079 2 2R CG30079 CG30079 "CG16805, BcDNA:GH04950" CDMC20704 3 11 3 DAC04-O24 AutoBlank AutoBlank CDMC20704 3 12 3 DAC04-O24 AutoBlank AutoBlank CDMC20705 3 13 3 DAC05-C12 8-CG1856-RA_1 CG1856 AGCCGCCATGTTGAGCCTGCAACAAGACGTAATCATCAAGGATGAGATACAGATCTCTCCGTCGCCCT 68 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC20705 3 14 3 DAC05-C12 8-CG1856-RA_1 CG1856 AGCCGCCATGTTGAGCCTGCAACAAGACGTAATCATCAAGGATGAGATACAGATCTCTCCGTCGCCCT 68 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC20706 3 15 3 DAC05-C24 5-CG1946-RA_2 CG1946 TGGAACTTGCATTAACATGAGCCTGGACATCGACAATTGGCTATCCCTTTACCCGCACGTTCGACCCA 68 FBan0001946 FBgn0033216 CG1946 2 2R CG1946 CG1946 CDMC20706 3 16 3 DAC05-C24 5-CG1946-RA_2 CG1946 TGGAACTTGCATTAACATGAGCCTGGACATCGACAATTGGCTATCCCTTTACCCGCACGTTCGACCCA 68 FBan0001946 FBgn0033216 CG1946 2 2R CG1946 CG1946 CDMC20707 3 17 3 DAC05-G12 3-CG2816-RA_1 CG2816 GCAGCCCATGATCAGTGGTCGGTGCTTTGGATACGTTGAGAGCTATGCCTACAATCCCATTAAGCGCC 68 FBan0002816 FBgn0031564 CG2816 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG2816 CG2816 CDMC20707 3 18 3 DAC05-G12 3-CG2816-RA_1 CG2816 GCAGCCCATGATCAGTGGTCGGTGCTTTGGATACGTTGAGAGCTATGCCTACAATCCCATTAAGCGCC 68 FBan0002816 FBgn0031564 CG2816 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG2816 CG2816 CDMC20708 3 19 3 DAC05-G24 3-CG2976-RA_4 CG2976 TGGCCACCAAACACGATGTGATTCGTCGCAAGTACTGGCAGTATGTGGCCAACCATCTGAAGAACCAG 68 FBan0002976 FBgn0031633 CG2976 2 2L protein amino acid prenylation; GO:0018346; protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; protein farnesyltransferase activity; GO:0004660 ; EC:2.5.1.58; ; GO:0004660 ; EC:2.5.1.58 protein farnesyltransferase complex; GO:0005965 CG2976 CG2976 CDMC20708 3 20 3 DAC05-G24 3-CG2976-RA_4 CG2976 TGGCCACCAAACACGATGTGATTCGTCGCAAGTACTGGCAGTATGTGGCCAACCATCTGAAGAACCAG 68 FBan0002976 FBgn0031633 CG2976 2 2L protein amino acid prenylation; GO:0018346; protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; protein farnesyltransferase activity; GO:0004660 ; EC:2.5.1.58; ; GO:0004660 ; EC:2.5.1.58 protein farnesyltransferase complex; GO:0005965 CG2976 CG2976 CDMC20709 3 21 3 DAC05-K12 3-CG3058-RA_1 CG3058 GCCGTGGTCTGGTAGTCTCGCCCAAGGACTACTCTACCAAGTACAGATACTAAGGTGGGTCGCGTACC 68 FBan0003058 FBgn0031601 CG3058 2 2L "chromosome segregation; GO:0007059; electron transport; GO:0006118; mitosis; GO:0007067; nuclear mRNA splicing, via spliceosome; GO:0000398" electron transporter activity; GO:0005489; ; GO:0005489 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3058 CG3058 BcDNA:RE13747 CDMC20709 3 22 3 DAC05-K12 3-CG3058-RA_1 CG3058 GCCGTGGTCTGGTAGTCTCGCCCAAGGACTACTCTACCAAGTACAGATACTAAGGTGGGTCGCGTACC 68 FBan0003058 FBgn0031601 CG3058 2 2L "chromosome segregation; GO:0007059; electron transport; GO:0006118; mitosis; GO:0007067; nuclear mRNA splicing, via spliceosome; GO:0000398" electron transporter activity; GO:0005489; ; GO:0005489 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3058 CG3058 BcDNA:RE13747 CDMC20710 3 23 3 DAC05-K24 3-CG31160-RA_2 CG31160 GCGCCGAGTACCCCAACGAACTGTATATGCCCAACGATTACTCCAAGAGCTTTGCCAACCACATGGAC 68 FBan0031160 FBgn0051160 CG31160 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 CG31160 CG31160 "CG13846, CG13851" CDMC20710 3 24 3 DAC05-K24 3-CG31160-RA_2 CG31160 GCGCCGAGTACCCCAACGAACTGTATATGCCCAACGATTACTCCAAGAGCTTTGCCAACCACATGGAC 68 FBan0031160 FBgn0051160 CG31160 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 CG31160 CG31160 "CG13846, CG13851" CDMC20711 3 25 3 DAC05-O12 12-CG31561-RA_7 CG31561 GGAAAAGCTTGCCGAACAGGAGGAACTAAACGTTTTGCCAGGAATCAGCGTGGTCAAGGATGAGAACG 68 FBan0031561 FBgn0051561 Osi16 3 3R Osi16 Osiris 16 "CG31561, CG10314, CG31561, Osiris, Osiris 16" CDMC20711 3 26 3 DAC05-O12 12-CG31561-RA_7 CG31561 GGAAAAGCTTGCCGAACAGGAGGAACTAAACGTTTTGCCAGGAATCAGCGTGGTCAAGGATGAGAACG 68 FBan0031561 FBgn0051561 Osi16 3 3R Osi16 Osiris 16 "CG31561, CG10314, CG31561, Osiris, Osiris 16" CDMC20712 3 1 4 DAC05-O24 AutoBlank AutoBlank CDMC20712 3 2 4 DAC05-O24 AutoBlank AutoBlank CDMC20713 3 3 4 DAC06-C12 13-CG5262-RA_1 CG5262 TGTCGCAATATGAATCCTATAGCGTTATCCTACGCCTGTGCTTCCCTTTGCTCGCCATAATTCCGCCTT 69 FBan0005262 FBgn0036988 CG5262 3 3L CG5262 CG5262 anon-WO0118547.347 CDMC20713 3 4 4 DAC06-C12 13-CG5262-RA_1 CG5262 TGTCGCAATATGAATCCTATAGCGTTATCCTACGCCTGTGCTTCCCTTTGCTCGCCATAATTCCGCCTT 69 FBan0005262 FBgn0036988 CG5262 3 3L CG5262 CG5262 anon-WO0118547.347 CDMC20714 3 5 4 DAC06-C24 22-CG5269-RA_2 CG5269 AGATCTACCATCTGCAATCAAAAGTTCCAGCCTACATAAGACTATTGGCACCCAAGGGCTCATTGGAGA 69 FBan0005269 FBgn0026158 vib 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 phospholipid transporter activity; GO:0005548; ; GO:0005548; carrier activity; GO:0005386; ; GO:0005386; phosphoinositide binding; GO:0035091; ; GO:0005548; ; GO:0035091 intracellular; GO:0005622 vib vibrator "CG5269, anon-WO0142479.3, anon-WO0172774.12, anon-WO0172774.16, anon-WO0172774.28, vibrator" CDMC20714 3 6 4 DAC06-C24 22-CG5269-RA_2 CG5269 AGATCTACCATCTGCAATCAAAAGTTCCAGCCTACATAAGACTATTGGCACCCAAGGGCTCATTGGAGA 69 FBan0005269 FBgn0026158 vib 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 phospholipid transporter activity; GO:0005548; ; GO:0005548; carrier activity; GO:0005386; ; GO:0005386; phosphoinositide binding; GO:0035091; ; GO:0005548; ; GO:0035091 intracellular; GO:0005622 vib vibrator "CG5269, anon-WO0142479.3, anon-WO0172774.12, anon-WO0172774.16, anon-WO0172774.28, vibrator" CDMC20715 3 7 4 DAC06-G12 2-CG5316-RB_1 CG5316 CCGTGTCATCAACAGCAGAACAGATTCAGGCCTCCAGGATTTAACGCATGTCGGCAACCTTATCCACCC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC20715 3 8 4 DAC06-G12 2-CG5316-RB_1 CG5316 CCGTGTCATCAACAGCAGAACAGATTCAGGCCTCCAGGATTTAACGCATGTCGGCAACCTTATCCACCC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC20716 3 9 4 DAC06-G24 1-CG5326-RB_1 CG5326 GAGCTGGAGATCTCGAGATCAGCCTCCTCGTGTGTTCTGTGTGTTCTGATCTGATCGACAACGACGCGT 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC20716 3 10 4 DAC06-G24 1-CG5326-RB_1 CG5326 GAGCTGGAGATCTCGAGATCAGCCTCCTCGTGTGTTCTGTGTGTTCTGATCTGATCGACAACGACGCGT 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC20717 3 11 4 DAC06-K12 13-CG5367-RA_1 CG5367 TTCAAGCGAACCGGGAAAATATTGAGCCTGAGTAAGCAACAAATCGTGGACTGCAGTGTGTCCCATGGA 69 FBan0005367 FBgn0032228 CG5367 2 2L proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG5367 CG5367 CDMC20717 3 12 4 DAC06-K12 13-CG5367-RA_1 CG5367 TTCAAGCGAACCGGGAAAATATTGAGCCTGAGTAAGCAACAAATCGTGGACTGCAGTGTGTCCCATGGA 69 FBan0005367 FBgn0032228 CG5367 2 2L proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG5367 CG5367 CDMC20718 3 13 4 DAC06-K24 11-CG5378-RA_1 CG5378 TCCGCTTGGGACTGTTTTACCTTGACCACGATCTCATCACTCGCAACATCGACAAGGCCAAGTATCTGA 69 FBan0005378 FBgn0028688 Rpn7 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn7 Rpn7 "CG5378, p42A, anon-WO0172774.103, anon-WO0172774.106" CDMC20718 3 14 4 DAC06-K24 11-CG5378-RA_1 CG5378 TCCGCTTGGGACTGTTTTACCTTGACCACGATCTCATCACTCGCAACATCGACAAGGCCAAGTATCTGA 69 FBan0005378 FBgn0028688 Rpn7 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn7 Rpn7 "CG5378, p42A, anon-WO0172774.103, anon-WO0172774.106" CDMC20719 3 15 4 DAC06-O12 24-CG5408-RA_4 CG5408 TACAATACATTTAACATTTTAATTTTTTTGCAAACTGTTGATCTTATCAAAGGACAGTCGCCCTGATTT 69 FBan0005408 FBgn0028978 trbl 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; NOT protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674 trbl tribbles "CG5408, CG5408, CG5408, CG5408, CG5408, tribbles" CDMC20719 3 16 4 DAC06-O12 24-CG5408-RA_4 CG5408 TACAATACATTTAACATTTTAATTTTTTTGCAAACTGTTGATCTTATCAAAGGACAGTCGCCCTGATTT 69 FBan0005408 FBgn0028978 trbl 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; NOT protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674 trbl tribbles "CG5408, CG5408, CG5408, CG5408, CG5408, tribbles" CDMC20720 3 17 4 DAC06-O24 23-CG5424-RA_5 CG5424 TTTTTTTTCGCCAAAACGAATATTGTTATTCCTAGTGGGCAGTACAGTATCTCAAGGCGAATCAAACGT 69 FBan0005424 FBgn0000630 f X X actin filament bundle formation; GO:0051017; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 f forked "CG5424, CG5424, X1, forked" CDMC20720 3 18 4 DAC06-O24 23-CG5424-RA_5 CG5424 TTTTTTTTCGCCAAAACGAATATTGTTATTCCTAGTGGGCAGTACAGTATCTCAAGGCGAATCAAACGT 69 FBan0005424 FBgn0000630 f X X actin filament bundle formation; GO:0051017; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 f forked "CG5424, CG5424, X1, forked" CDMC20721 3 19 4 DAC07-C12 3-CG9826-RB_1 CG9826 TACGGTGGCGAACGTTATTCCCATCCTCACACCACTGATTGCGGGTGAGATCGTGGCTGATAAGG 65 FBan0009826 FBgn0034784 CG9826 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9826 CG9826 CDMC20721 3 20 4 DAC07-C12 3-CG9826-RB_1 CG9826 TACGGTGGCGAACGTTATTCCCATCCTCACACCACTGATTGCGGGTGAGATCGTGGCTGATAAGG 65 FBan0009826 FBgn0034784 CG9826 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9826 CG9826 CDMC20722 3 21 4 DAC07-C24 3-CG9871-RA_3 CG9871 GTTGGTCTCGAAGGCGAAGAAAGGCCAGAATGCTTCACGCAAGAACTTGATGCAAGTGCCGGAAC 65 FBan0009871 FBgn0034837 CG9871 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG9871 CG9871 CDMC20722 3 22 4 DAC07-C24 3-CG9871-RA_3 CG9871 GTTGGTCTCGAAGGCGAAGAAAGGCCAGAATGCTTCACGCAAGAACTTGATGCAAGTGCCGGAAC 65 FBan0009871 FBgn0034837 CG9871 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG9871 CG9871 CDMC20723 3 23 4 DAC07-G12 2-CG9984-RA_1 CG9984 CCATCGACTTGATACGAAACCCCCAGTTTCTGGAGCTACTGGTAGACGCGCTCTTTCGTTCCGGC 65 FBan0009984 FBgn0010416 TH1 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 TH1 TH1 "CG9984, CG9984, CG9984, NELF-D, NELF" CDMC20723 3 24 4 DAC07-G12 2-CG9984-RA_1 CG9984 CCATCGACTTGATACGAAACCCCCAGTTTCTGGAGCTACTGGTAGACGCGCTCTTTCGTTCCGGC 65 FBan0009984 FBgn0010416 TH1 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 TH1 TH1 "CG9984, CG9984, CG9984, NELF-D, NELF" CDMC20724 3 25 4 DAC07-G24 20-CR30241-RA_1 CR30241 GTCTAAGGCGCTGGTTTAAGGCACCAGTCTCCTCGGAGGCGTGGGTTCGAATCCCACCGCTGCCA 65 FBan0030241 FBgn0050241 CR30241 2 2R CR30241 CR30241 "AE002787.trna15-LeuAAG, tRNA:L:AAG:AE002787-b" CDMC20724 3 26 4 DAC07-G24 20-CR30241-RA_1 CR30241 GTCTAAGGCGCTGGTTTAAGGCACCAGTCTCCTCGGAGGCGTGGGTTCGAATCCCACCGCTGCCA 65 FBan0030241 FBgn0050241 CR30241 2 2R CR30241 CR30241 "AE002787.trna15-LeuAAG, tRNA:L:AAG:AE002787-b" CDMC20725 3 1 5 DAC07-K12 3-CR32525-RA_1 CR32525 TAGCTCAGTTGGTAGAGCGGTGGACTGTAGATCCATAGGTCGCTGGTTCAAGTCCGGCTCGAAGG 65 FBan0032525 FBgn0052525 CR32525 X X protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR32525 CR32525 "tRNA[Tyr][[1gamma]], AE002620.trna4-TyrGTA, tRNA:Y:GTA:AE002620-b, tRNA:Y1:19F, tRNA:tyr1:19F, transfer RNA:tyr1:19F" CDMC20725 3 2 5 DAC07-K12 3-CR32525-RA_1 CR32525 TAGCTCAGTTGGTAGAGCGGTGGACTGTAGATCCATAGGTCGCTGGTTCAAGTCCGGCTCGAAGG 65 FBan0032525 FBgn0052525 CR32525 X X protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR32525 CR32525 "tRNA[Tyr][[1gamma]], AE002620.trna4-TyrGTA, tRNA:Y:GTA:AE002620-b, tRNA:Y1:19F, tRNA:tyr1:19F, transfer RNA:tyr1:19F" CDMC20726 3 3 5 DAC07-K24 1-CR32868-RA_1 CR32868 TTCCCAGCAGGAAACCTGTGTGATTGCAGGGCGAAAGTACCAGAAATCCTGCTACCAGGTGTTGC 65 FBan0032868 FBgn0046696 RNaseP:RNA 3 3R ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 RNaseP:RNA Ribonuclease P RNA "RNase P RNA, CR32868, Ribonuclease P RNA" CDMC20726 3 4 5 DAC07-K24 1-CR32868-RA_1 CR32868 TTCCCAGCAGGAAACCTGTGTGATTGCAGGGCGAAAGTACCAGAAATCCTGCTACCAGGTGTTGC 65 FBan0032868 FBgn0046696 RNaseP:RNA 3 3R ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 RNaseP:RNA Ribonuclease P RNA "RNase P RNA, CR32868, Ribonuclease P RNA" CDMC20727 3 5 5 DAC07-O12 1-CR33315-RA_2 CR33315 AGTCTGGATCTGTCTGGACCAGTCTGGATCAGCTCGGAGTCACTAGATCAGCATCGGGATGGACC 65 FBan0033315 FBgn0053315 CR33315 2 2L CR33315 CR33315 CDMC20727 3 6 5 DAC07-O12 1-CR33315-RA_2 CR33315 AGTCTGGATCTGTCTGGACCAGTCTGGATCAGCTCGGAGTCACTAGATCAGCATCGGGATGGACC 65 FBan0033315 FBgn0053315 CR33315 2 2L CR33315 CR33315 CDMC20728 3 7 5 DAC07-O24 12-CR7249-RA_1 CR7249 CGCAAGTACCCGGCTCTTAGTTCACTTACACGTCTCGCCTCCGAGGACTATGAGATCCCCTCGCC 65 FBan0007249 FBgn0031726 Cyp6a16Psi 2 2L electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489 membrane; GO:0016020 Cyp6a16Psi Cyp6a16Psi "CG7249, Cyp6a16p, 6a16, CR7249, Cyp6a16" CDMC20728 3 8 5 DAC07-O24 12-CR7249-RA_1 CR7249 CGCAAGTACCCGGCTCTTAGTTCACTTACACGTCTCGCCTCCGAGGACTATGAGATCCCCTCGCC 65 FBan0007249 FBgn0031726 Cyp6a16Psi 2 2L electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489 membrane; GO:0016020 Cyp6a16Psi Cyp6a16Psi "CG7249, Cyp6a16p, 6a16, CR7249, Cyp6a16" CDMC20729 3 9 5 DAC08-C12 3-CG5623-RA_1 CG5623 AGCGAGGTTATCACTACGAGACCCTGGAACTTGACCAGCAGTGGAAGATCATCGTGTTCCCCTACAGCA 69 FBan0005623 FBgn0038357 CG5623 3 3R CG5623 CG5623 BcDNA:AT10995 CDMC20729 3 10 5 DAC08-C12 3-CG5623-RA_1 CG5623 AGCGAGGTTATCACTACGAGACCCTGGAACTTGACCAGCAGTGGAAGATCATCGTGTTCCCCTACAGCA 69 FBan0005623 FBgn0038357 CG5623 3 3R CG5623 CG5623 BcDNA:AT10995 CDMC20730 3 11 5 DAC08-C24 23-CG5638-RA_16 CG5638 TAATGAGCTTATGTGATGTTTAGACAGGGGGAGTAGGCGATCAGAGCAGGGAATGGATTAGTTAGCCTA 69 FBan0005638 FBgn0036260 Rh7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh7 Rhodopsin 7 "CG5638, CG5638, CG5638, Rh, DMELRH7, rh7, rhodopsin, Rhodopsin, anon-WO0170980.34, anon-WO0170980.35, Rhodopsin 7" CDMC20730 3 12 5 DAC08-C24 23-CG5638-RA_16 CG5638 TAATGAGCTTATGTGATGTTTAGACAGGGGGAGTAGGCGATCAGAGCAGGGAATGGATTAGTTAGCCTA 69 FBan0005638 FBgn0036260 Rh7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh7 Rhodopsin 7 "CG5638, CG5638, CG5638, Rh, DMELRH7, rh7, rhodopsin, Rhodopsin, anon-WO0170980.34, anon-WO0170980.35, Rhodopsin 7" CDMC20731 3 13 5 DAC08-G12 9-CG5671-RA_3 CG5671 GCCGACGAGGCATTAGCGTGGTATGATGAGAAGCGTACAAAGGACCGAAAAGGTGTGACAATCCCATCT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC20731 3 14 5 DAC08-G12 9-CG5671-RA_3 CG5671 GCCGACGAGGCATTAGCGTGGTATGATGAGAAGCGTACAAAGGACCGAAAAGGTGTGACAATCCCATCT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC20732 3 15 5 DAC08-G24 23-CG5681-RA_8 CG5681 ACGAGTGGAGGTATGAAAGCTGCACCAGAAAAAATGATGAAACATAATGAATCCTCTGAACGGATGTCC 69 FBan0005681 FBgn0032658 CG5681 2 2L CG5681 CG5681 CDMC20732 3 16 5 DAC08-G24 23-CG5681-RA_8 CG5681 ACGAGTGGAGGTATGAAAGCTGCACCAGAAAAAATGATGAAACATAATGAATCCTCTGAACGGATGTCC 69 FBan0005681 FBgn0032658 CG5681 2 2L CG5681 CG5681 CDMC20733 3 17 5 DAC08-K12 23-CG5714-RA_4 CG5714 AGGACAAGGAACAAAAGGATATATCTGAGTCGGCCGTTTAAGCGGGATTACAGGAATTAGTATAGTCTT 69 FBgn0035324 CDMC20733 3 18 5 DAC08-K12 23-CG5714-RA_4 CG5714 AGGACAAGGAACAAAAGGATATATCTGAGTCGGCCGTTTAAGCGGGATTACAGGAATTAGTATAGTCTT 69 FBgn0035324 CDMC20734 3 19 5 DAC08-K24 23-CG5723-RB_3 CG5723 CCGAGAGAAGTGCAGAGGGTATAGGCTATAAATTACAAATCGAATGCAGACAACAAAGACAATTGTACA 69 FBan0005723 FBgn0004449 Ten-m 3 3L cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; integral to plasma membrane; GO:0005887 Ten-m Tenascin major "CG5723, CG11452, ten[m], Ten[m], odz: odd-Oz, odd(Oz), l(3)00844, l(3)05309, odd Oz, odd-Oz, 2017, 5301, ten-m, ten(m), tenascin major, CT16449, odz/ten-m, Ten-mc, BcDNA:AT25108, Ten79E, l(3)05301, l(3)rJ307, l(3)rL201, l(3)rP126, odz" CDMC20734 3 20 5 DAC08-K24 23-CG5723-RB_3 CG5723 CCGAGAGAAGTGCAGAGGGTATAGGCTATAAATTACAAATCGAATGCAGACAACAAAGACAATTGTACA 69 FBan0005723 FBgn0004449 Ten-m 3 3L cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; integral to plasma membrane; GO:0005887 Ten-m Tenascin major "CG5723, CG11452, ten[m], Ten[m], odz: odd-Oz, odd(Oz), l(3)00844, l(3)05309, odd Oz, odd-Oz, 2017, 5301, ten-m, ten(m), tenascin major, CT16449, odz/ten-m, Ten-mc, BcDNA:AT25108, Ten79E, l(3)05301, l(3)rJ307, l(3)rL201, l(3)rP126, odz" CDMC20735 3 21 5 DAC08-O12 2-CG5758-RB_1 CG5758 ACGCGGCGTAAAAATGCTGCTGAACCACTTCGTTAAGGGACGACTGTATAACCGTGATCTGCGCGACAA 69 FBan0005758 FBgn0032666 CG5758 2 2L CG5758 CG5758 CDMC20735 3 22 5 DAC08-O12 2-CG5758-RB_1 CG5758 ACGCGGCGTAAAAATGCTGCTGAACCACTTCGTTAAGGGACGACTGTATAACCGTGATCTGCGCGACAA 69 FBan0005758 FBgn0032666 CG5758 2 2L CG5758 CG5758 CDMC20736 3 23 5 DAC08-O24 10-CG5772-RA_1 CG5772 GGATGTGCATTTGTTCAACGCGACCATACGTGAAAATCTCGATCCACACGGTTACTTCCAGGACCTGCA 69 FBan0005772 FBgn0028675 Sur 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; heart development; GO:0007507; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; sulfonylurea receptor activity; GO:0008281; ; GO:0008281; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008281; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626" ATP-sensitive potassium channel complex; GO:0008282 Sur Sulfonylurea receptor "CG5772, CG5772, CK00325, Dsur, SUR, sulfonyl urea receptor, sur, dSUR, BEST:CK00325, Sulfonylurea receptor" CDMC20736 3 24 5 DAC08-O24 10-CG5772-RA_1 CG5772 GGATGTGCATTTGTTCAACGCGACCATACGTGAAAATCTCGATCCACACGGTTACTTCCAGGACCTGCA 69 FBan0005772 FBgn0028675 Sur 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; heart development; GO:0007507; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; sulfonylurea receptor activity; GO:0008281; ; GO:0008281; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008281; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626" ATP-sensitive potassium channel complex; GO:0008282 Sur Sulfonylurea receptor "CG5772, CG5772, CK00325, Dsur, SUR, sulfonyl urea receptor, sur, dSUR, BEST:CK00325, Sulfonylurea receptor" CDMC20737 3 25 5 DAC09-C13 2-CG31671-RA_4 CG31671 GCCACCAGATCCGATAAGTTGTCACCCACCTCTCCATCTGGGAATACACAAGGAACAAGGGCTCCAG 67 FBgn0051671 CDMC20737 3 26 5 DAC09-C13 2-CG31671-RA_4 CG31671 GCCACCAGATCCGATAAGTTGTCACCCACCTCTCCATCTGGGAATACACAAGGAACAAGGGCTCCAG 67 FBgn0051671 CDMC20738 3 1 6 DAC09-D01 24-CG31842-RA_1 CG31842 TTAAAAAACACATTTAATTAATTAAAACTTTACCAAAATGGCACAAAGTAGGCTTGAAAAGATTGGC 67 FBan0031842 FBgn0051842 mRpS23 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761 mRpS23 mRpS23 CG31842 CDMC20738 3 2 6 DAC09-D01 24-CG31842-RA_1 CG31842 TTAAAAAACACATTTAATTAATTAAAACTTTACCAAAATGGCACAAAGTAGGCTTGAAAAGATTGGC 67 FBan0031842 FBgn0051842 mRpS23 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761 mRpS23 mRpS23 CG31842 CDMC20739 3 3 6 DAC09-G13 2-CG32283-RA_1 CG32283 CCTAATGGAGGCCAACACTGTTTTGGCACGTGATTGCCTATCTGGAACTTTCGGAGGTCCTTGCTGG 67 FBan0032283 FBgn0052283 dro3 3 3L defense response; GO:0006952 dro3 drosomycin-3 "CG10813, CG32283, CG10813, CG10813, CT30310, Dro-3, drosomycin-E" CDMC20739 3 4 6 DAC09-G13 2-CG32283-RA_1 CG32283 CCTAATGGAGGCCAACACTGTTTTGGCACGTGATTGCCTATCTGGAACTTTCGGAGGTCCTTGCTGG 67 FBan0032283 FBgn0052283 dro3 3 3L defense response; GO:0006952 dro3 drosomycin-3 "CG10813, CG32283, CG10813, CG10813, CT30310, Dro-3, drosomycin-E" CDMC20740 3 5 6 DAC09-H01 3-CG32491-RD_3 CG32491 CCTGTGGCTCGATGGGATGAAGTTCTTCCGCAACAACATAAACCGCACGAATTTGTACTGGCGCTGC 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC20740 3 6 6 DAC09-H01 3-CG32491-RD_3 CG32491 CCTGTGGCTCGATGGGATGAAGTTCTTCCGCAACAACATAAACCGCACGAATTTGTACTGGCGCTGC 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC20741 3 7 6 DAC09-K13 11-CG33087-RC_2 CG33087 GCAATGCGAGCACTGTAGGAATCTAACCTGTGAAAATGGCGGTATTTGCAGGGAAACGCTAACGGGC 67 FBan0033087 FBgn0053087 CG33087 2 2R cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0016887 membrane; GO:0016020 CG33087 CG33087 "CG8706, CG30368, CG8706, CG8706, CT9297, LDLR-like" CDMC20741 3 8 6 DAC09-K13 11-CG33087-RC_2 CG33087 GCAATGCGAGCACTGTAGGAATCTAACCTGTGAAAATGGCGGTATTTGCAGGGAAACGCTAACGGGC 67 FBan0033087 FBgn0053087 CG33087 2 2R cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0016887 membrane; GO:0016020 CG33087 CG33087 "CG8706, CG30368, CG8706, CG8706, CT9297, LDLR-like" CDMC20742 3 9 6 DAC09-L01 14-CG33269-RA_1 CG33269 GCGGAAGTGCAAGAACCCAAAGAGGTGCCACAAGACCATCGTGATTGTGACCCACAGGAAAAATTAA 67 FBan0033269 FBgn0053269 CG33269 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33269 CG33269 "CG14139, CG6100, CG32084, CG14139, CG6100, CG32084" CDMC20742 3 10 6 DAC09-L01 14-CG33269-RA_1 CG33269 GCGGAAGTGCAAGAACCCAAAGAGGTGCCACAAGACCATCGTGATTGTGACCCACAGGAAAAATTAA 67 FBan0033269 FBgn0053269 CG33269 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33269 CG33269 "CG14139, CG6100, CG32084, CG14139, CG6100, CG32084" CDMC20743 3 11 6 DAC09-O13 14-CG3600-RA_1 CG3600 CCAACAAGCTGACCATTATCAAGACGCCGTTGAACAAGACTCTGCTGAAGAAGTGCAACAGCAACGG 67 FBan0003600 FBgn0026087 CG3600 X X CG3600 CG3600 EG:BACH61I5.1 CDMC20743 3 12 6 DAC09-O13 14-CG3600-RA_1 CG3600 CCAACAAGCTGACCATTATCAAGACGCCGTTGAACAAGACTCTGCTGAAGAAGTGCAACAGCAACGG 67 FBan0003600 FBgn0026087 CG3600 X X CG3600 CG3600 EG:BACH61I5.1 CDMC20744 3 13 6 DAC09-P01 AutoBlank AutoBlank CDMC20744 3 14 6 DAC09-P01 AutoBlank AutoBlank CDMC20745 3 15 6 DAC10-C12 18-CG18361-RA_2 CG18361 GCGCAGCAATTACATCAAGCATACGGTCAATAAGTTGACCTTCTCGGAGCAGTGCTACTACGTGGTGAA 69 FBan0018361 FBgn0000499 dsh X X "R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment of body bristle orientation; GO:0048106; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; female gonad development; GO:0008585; filopodium formation; GO:0046847; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; lamellipodium biogenesis; GO:0030032; mesoderm development; GO:0007498; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; segment specification; GO:0007379; sensory organ development; GO:0007423; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476" Notch binding; GO:0005112; protein binding; GO:0005515; ; GO:0005112; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737 dsh dishevelled "CG18361, CG1720, l(1)dsh, l(1)10Bd, l(1)G0267, DSH, disshevelled, Dsh, l(1)G17" CDMC20745 3 16 6 DAC10-C12 18-CG18361-RA_2 CG18361 GCGCAGCAATTACATCAAGCATACGGTCAATAAGTTGACCTTCTCGGAGCAGTGCTACTACGTGGTGAA 69 FBan0018361 FBgn0000499 dsh X X "R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment of body bristle orientation; GO:0048106; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; female gonad development; GO:0008585; filopodium formation; GO:0046847; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; lamellipodium biogenesis; GO:0030032; mesoderm development; GO:0007498; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; segment specification; GO:0007379; sensory organ development; GO:0007423; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476" Notch binding; GO:0005112; protein binding; GO:0005515; ; GO:0005112; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737 dsh dishevelled "CG18361, CG1720, l(1)dsh, l(1)10Bd, l(1)G0267, DSH, disshevelled, Dsh, l(1)G17" CDMC20746 3 17 6 DAC10-C24 9-CG18375-RA_1 CG18375 CCGCTCGCCACAAAAACTTCACCTTCAAGTCGCTGCAGAAAAAGTTCTGATTGCAATTTGCAGCCAGGA 69 FBan0018375 FBgn0034606 CG18375 2 2R apoptosis; GO:0006915; cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG18375 CG18375 CDMC20746 3 18 6 DAC10-C24 9-CG18375-RA_1 CG18375 CCGCTCGCCACAAAAACTTCACCTTCAAGTCGCTGCAGAAAAAGTTCTGATTGCAATTTGCAGCCAGGA 69 FBan0018375 FBgn0034606 CG18375 2 2R apoptosis; GO:0006915; cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG18375 CG18375 CDMC20747 3 19 6 DAC10-G12 2-CG18445-RA_1 CG18445 AGTGCGTAAGAGTGTCTGGACAGGAGTACCGGCATGCTCCACATTTGTATATCCTTTCCAAACCGGCCT 69 FBan0018445 FBgn0033476 CG18445 2 2R CG18445 CG18445 O-acyl transferase CDMC20747 3 20 6 DAC10-G12 2-CG18445-RA_1 CG18445 AGTGCGTAAGAGTGTCTGGACAGGAGTACCGGCATGCTCCACATTTGTATATCCTTTCCAAACCGGCCT 69 FBan0018445 FBgn0033476 CG18445 2 2R CG18445 CG18445 O-acyl transferase CDMC20748 3 21 6 DAC10-G24 23-CG18469-RA_3 CG18469 AGGAAGGCGATTCTGACGAGTCTACAGATACAGATGTGAATCGTAATAGAATTGAAGCTACTGATAATG 69 FBan0018469 FBgn0034206 CG18469 2 2R CG18469 CG18469 BcDNA:AT30190 CDMC20748 3 22 6 DAC10-G24 23-CG18469-RA_3 CG18469 AGGAAGGCGATTCTGACGAGTCTACAGATACAGATGTGAATCGTAATAGAATTGAAGCTACTGATAATG 69 FBan0018469 FBgn0034206 CG18469 2 2R CG18469 CG18469 BcDNA:AT30190 CDMC20749 3 23 6 DAC10-K12 10-CG18516-RA_1 CG18516 GCCAACTGCTATGAATTCACCGATAGCAACTTCAAGCTGAGTGGTCATGCTGTTCTTACGGATGCCCCA 69 FBan0018516 FBgn0038350 CG18516 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18516 CG18516 DmAO4 CDMC20749 3 24 6 DAC10-K12 10-CG18516-RA_1 CG18516 GCCAACTGCTATGAATTCACCGATAGCAACTTCAAGCTGAGTGGTCATGCTGTTCTTACGGATGCCCCA 69 FBan0018516 FBgn0038350 CG18516 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18516 CG18516 DmAO4 CDMC20750 3 25 6 DAC10-K24 16-CG18538-RA_1 CG18538 TGCCGGTTTTTATCTGATTGTGATCAAATGCTATGGACCAGGTCAACCCACATGGAACACTACGTCAGT 69 FBan0018538 FBgn0034324 CG18538 2 2R CG18538 CG18538 CDMC20750 3 26 6 DAC10-K24 16-CG18538-RA_1 CG18538 TGCCGGTTTTTATCTGATTGTGATCAAATGCTATGGACCAGGTCAACCCACATGGAACACTACGTCAGT 69 FBan0018538 FBgn0034324 CG18538 2 2R CG18538 CG18538 CDMC20751 3 1 7 DAC10-O12 3-CG18594-RA_3 CG18594 GCCGGCAACTTCTTCCAGGCCCAATACGATGACTACGTGAAGACCCTCATCGAGACGGTCCAGTAATCT 69 FBan0018594 FBgn0038973 CG18594 3 3R signal transduction; GO:0007165 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18594 CG18594 "T2, BcDNA:LP12095" CDMC20751 3 2 7 DAC10-O12 3-CG18594-RA_3 CG18594 GCCGGCAACTTCTTCCAGGCCCAATACGATGACTACGTGAAGACCCTCATCGAGACGGTCCAGTAATCT 69 FBan0018594 FBgn0038973 CG18594 3 3R signal transduction; GO:0007165 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18594 CG18594 "T2, BcDNA:LP12095" CDMC20752 3 3 7 DAC10-O24 AutoBlank AutoBlank CDMC20752 3 4 7 DAC10-O24 AutoBlank AutoBlank CDMC20753 3 5 7 DAC11-C12 1-CG10546-RA_1 CG10546 GCGCACTTCCTCACCTACGAGTGCTTGATGGAGGATCAGGAAACACAGATCACTGGGCTAACGCATG 67 FBan0010546 FBgn0035636 Cralbp 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; ; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 Cralbp Cellular retinaldehyde binding protein "CG10546, CG10546, CRALBP, Cellular retinaldehyde binding protein" CDMC20753 3 6 7 DAC11-C12 1-CG10546-RA_1 CG10546 GCGCACTTCCTCACCTACGAGTGCTTGATGGAGGATCAGGAAACACAGATCACTGGGCTAACGCATG 67 FBan0010546 FBgn0035636 Cralbp 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; ; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 Cralbp Cellular retinaldehyde binding protein "CG10546, CG10546, CRALBP, Cellular retinaldehyde binding protein" CDMC20754 3 7 7 DAC11-C24 3-CG10651-RA_1 CG10651 TGTGAGCCAATCCGAGATCAGTGCGCCATAACCCCAAATTACGGTCATGCGGAAGTCAGCTATTCGC 67 FBan0010651 FBgn0032853 CG10651 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG10651 CG10651 38C.2 CDMC20754 3 8 7 DAC11-C24 3-CG10651-RA_1 CG10651 TGTGAGCCAATCCGAGATCAGTGCGCCATAACCCCAAATTACGGTCATGCGGAAGTCAGCTATTCGC 67 FBan0010651 FBgn0032853 CG10651 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG10651 CG10651 38C.2 CDMC20755 3 9 7 DAC11-G12 18-CG10962-RB_1 CG10962 ACCAAGGACATCAACAACATACTACAGACGAATCTCATGGGCAGCATTTACTGCACCAAATTGGCCG 67 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC20755 3 10 7 DAC11-G12 18-CG10962-RB_1 CG10962 ACCAAGGACATCAACAACATACTACAGACGAATCTCATGGGCAGCATTTACTGCACCAAATTGGCCG 67 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC20756 3 11 7 DAC11-G24 18-CG11105-RA_1 CG11105 TCAATGGCGACGGCTTCATTACGAGGGAGGAAATGACTGACATTGTAACTGCCATATACGAGCTGAT 67 FBan0011105 FBgn0030281 CG11105 X X calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG11105 CG11105 CDMC20756 3 12 7 DAC11-G24 18-CG11105-RA_1 CG11105 TCAATGGCGACGGCTTCATTACGAGGGAGGAAATGACTGACATTGTAACTGCCATATACGAGCTGAT 67 FBan0011105 FBgn0030281 CG11105 X X calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG11105 CG11105 CDMC20757 3 13 7 DAC11-K12 2-CG11404-RA_2 CG11404 CGCCTTTAAGTGGGTCACCATCAGTCAGGGGCTTAACCTTGCCGCATCTACAAATACACTGGGTCGG 67 FBan0011404 FBgn0037169 CG11404 3 3L CG11404 CG11404 BcDNA:GH11730 CDMC20757 3 14 7 DAC11-K12 2-CG11404-RA_2 CG11404 CGCCTTTAAGTGGGTCACCATCAGTCAGGGGCTTAACCTTGCCGCATCTACAAATACACTGGGTCGG 67 FBan0011404 FBgn0037169 CG11404 3 3L CG11404 CG11404 BcDNA:GH11730 CDMC20758 3 15 7 DAC11-K24 3-CG11619-RA_3 CG11619 CCCAAAACACTGGGACTTCTGGTGGAGATAAAGTGGCCGCAAATAATGGCTTCTGGTGTGCCGGAAT 67 FBan0011619 FBgn0036836 CG11619 3 3L CG11619 CG11619 CDMC20758 3 16 7 DAC11-K24 3-CG11619-RA_3 CG11619 CCCAAAACACTGGGACTTCTGGTGGAGATAAAGTGGCCGCAAATAATGGCTTCTGGTGTGCCGGAAT 67 FBan0011619 FBgn0036836 CG11619 3 3L CG11619 CG11619 CDMC20759 3 17 7 DAC11-O12 3-CG12204-RA_1 CG12204 GGTAGCCACAGACCACAGGACAAAAACGGCGCAACTAAATCGGAGGTGTTAGAGCCATTGCCATTGC 67 FBan0012204 FBgn0031022 CG12204 X X CG12204 CG12204 CDMC20759 3 18 7 DAC11-O12 3-CG12204-RA_1 CG12204 GGTAGCCACAGACCACAGGACAAAAACGGCGCAACTAAATCGGAGGTGTTAGAGCCATTGCCATTGC 67 FBan0012204 FBgn0031022 CG12204 X X CG12204 CG12204 CDMC20760 3 19 7 DAC11-O24 AutoBlank AutoBlank CDMC20760 3 20 7 DAC11-O24 AutoBlank AutoBlank CDMC20761 3 21 7 DAC12-C12 2-CG10308-RA_2 CG10308 CACTGGCTCACCGACTATGCCCGGGATATATTTTTGACCATGAGGGAGCAAGAACTCAGCCGTCGG 66 FBan0010308 FBgn0010317 CycJ 3 3L "mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; transcription factor activity; GO:0003700; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0003700 intracellular; GO:0005622; nucleus; GO:0005634 CycJ Cyclin J "CG10308, CDI5, Cdi5: Cyclin-dependent kinase interactor 5, cycJ, cyclinJ, cdi5, Cyclin-dependent kinase interactor 5, Cdi5" CDMC20761 3 22 7 DAC12-C12 2-CG10308-RA_2 CG10308 CACTGGCTCACCGACTATGCCCGGGATATATTTTTGACCATGAGGGAGCAAGAACTCAGCCGTCGG 66 FBan0010308 FBgn0010317 CycJ 3 3L "mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; transcription factor activity; GO:0003700; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0003700 intracellular; GO:0005622; nucleus; GO:0005634 CycJ Cyclin J "CG10308, CDI5, Cdi5: Cyclin-dependent kinase interactor 5, cycJ, cyclinJ, cdi5, Cyclin-dependent kinase interactor 5, Cdi5" CDMC20762 3 23 7 DAC12-C24 42-CG10494-RB_4 CG10494 GAAGAGGTTGATTCGTTTCTACTCATCATTCGGGACAATGGTTTCTTTCGCGCCTTGGATGGCTCA 66 FBan0010494 FBgn0034634 CG10494 2 2R CG10494 CG10494 CDMC20762 3 24 7 DAC12-C24 42-CG10494-RB_4 CG10494 GAAGAGGTTGATTCGTTTCTACTCATCATTCGGGACAATGGTTTCTTTCGCGCCTTGGATGGCTCA 66 FBan0010494 FBgn0034634 CG10494 2 2R CG10494 CG10494 CDMC20763 3 25 7 DAC12-G12 17-CG10997-RA_1 CG10997 CCAGGAGTACTTCATGGACCTATATCTACTGGCCGAACTGAAGACGATCAGCCTGAAGGTGACGAC 66 FBan0010997 FBgn0030529 Clic X X determination of adult life span; GO:0008340; response to oxidative stress; GO:0006979 chloride channel activity; GO:0005254; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0005254 Clic Chloride intracellular channel "CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, l(1)G0472, l(1)G0053, DCLIC, Chloride intracellular channel" CDMC20763 3 26 7 DAC12-G12 17-CG10997-RA_1 CG10997 CCAGGAGTACTTCATGGACCTATATCTACTGGCCGAACTGAAGACGATCAGCCTGAAGGTGACGAC 66 FBan0010997 FBgn0030529 Clic X X determination of adult life span; GO:0008340; response to oxidative stress; GO:0006979 chloride channel activity; GO:0005254; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0005254 Clic Chloride intracellular channel "CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, l(1)G0472, l(1)G0053, DCLIC, Chloride intracellular channel" CDMC20764 3 1 8 DAC12-G24 2-CG11066-RA_1 CG11066 TGACTGGAGTCAAGACCGTCGATGTCCATCCCGATTACGATCCGTCGACAAACTCCCACGACTTGG 66 FBan0011066 FBgn0033033 scarface 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- scarface scarface "CG15900, CG11066, CG15900, CG11066, CG11066, CG11066, SPH142, scarface" CDMC20764 3 2 8 DAC12-G24 2-CG11066-RA_1 CG11066 TGACTGGAGTCAAGACCGTCGATGTCCATCCCGATTACGATCCGTCGACAAACTCCCACGACTTGG 66 FBan0011066 FBgn0033033 scarface 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- scarface scarface "CG15900, CG11066, CG15900, CG11066, CG11066, CG11066, SPH142, scarface" CDMC20765 3 3 8 DAC12-K12 1-CG11299-RA_1 CG11299 ACCGAGAGCATCAACACGTTTCGCATCCAGGACTACTCTTGGGAGGATCACGGCTACTCGCTAGTG 66 FBan0011299 FBgn0034897 CG11299 2 2R cell cycle arrest; GO:0007050; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 CG11299 CG11299 "BcDNA:GH20113, BEST:GH20113" CDMC20765 3 4 8 DAC12-K12 1-CG11299-RA_1 CG11299 ACCGAGAGCATCAACACGTTTCGCATCCAGGACTACTCTTGGGAGGATCACGGCTACTCGCTAGTG 66 FBan0011299 FBgn0034897 CG11299 2 2R cell cycle arrest; GO:0007050; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 CG11299 CG11299 "BcDNA:GH20113, BEST:GH20113" CDMC20766 3 5 8 DAC12-K24 2-CG11475-RA_2 CG11475 ACTGACAGCTGGAACTCGTTCCTCAAGGGTCTTGGAGAGGACAGAAGGCAGTGGTTTTCGGCAATT 66 FBan0011475 FBgn0034687 CG11475 2 2R CG11475 CG11475 CDMC20766 3 6 8 DAC12-K24 2-CG11475-RA_2 CG11475 ACTGACAGCTGGAACTCGTTCCTCAAGGGTCTTGGAGAGGACAGAAGGCAGTGGTTTTCGGCAATT 66 FBan0011475 FBgn0034687 CG11475 2 2R CG11475 CG11475 CDMC20767 3 7 8 DAC12-O12 AutoBlank AutoBlank CDMC20767 3 8 8 DAC12-O12 AutoBlank AutoBlank CDMC20768 3 9 8 DAC12-O24 AutoBlank AutoBlank CDMC20768 3 10 8 DAC12-O24 AutoBlank AutoBlank CDMC20769 3 11 8 DAC13-C12 16-CG14556-RA_1 CG14556 CCTTGACTGTGACGGTTAGACTATCCGATGAGTTCCGGAAGTCACAAATGAAACTTGAAGACAGCGCCA 69 FBan0014556 FBgn0039413 CG14556 3 3R CG14556 CG14556 CDMC20769 3 12 8 DAC13-C12 16-CG14556-RA_1 CG14556 CCTTGACTGTGACGGTTAGACTATCCGATGAGTTCCGGAAGTCACAAATGAAACTTGAAGACAGCGCCA 69 FBan0014556 FBgn0039413 CG14556 3 3R CG14556 CG14556 CDMC20770 3 13 8 DAC13-C24 23-CG14568-RA_4 CG14568 GATCAGTTCTGGTGTACACCATCTGAAATGGGTCAACCCTAATTTGCTAGAAATCAAATGGAATCGACT 69 FBan0014568 FBgn0037124 CG14568 3 3L CG14568 CG14568 BcDNA:RE21944 CDMC20770 3 14 8 DAC13-C24 23-CG14568-RA_4 CG14568 GATCAGTTCTGGTGTACACCATCTGAAATGGGTCAACCCTAATTTGCTAGAAATCAAATGGAATCGACT 69 FBan0014568 FBgn0037124 CG14568 3 3L CG14568 CG14568 BcDNA:RE21944 CDMC20771 3 15 8 DAC13-G12 17-CG14610-RA_1 CG14610 TGCCCTCCCATCTGAAGCAGCGTCTATTTTATCGATTAAACAATGCTGATCCCATTTCCATCTGCCTCT 69 FBan0014610 FBgn0037477 CG14610 3 3R CG14610 CG14610 CDMC20771 3 16 8 DAC13-G12 17-CG14610-RA_1 CG14610 TGCCCTCCCATCTGAAGCAGCGTCTATTTTATCGATTAAACAATGCTGATCCCATTTCCATCTGCCTCT 69 FBan0014610 FBgn0037477 CG14610 3 3R CG14610 CG14610 CDMC20772 3 17 8 DAC13-G24 3-CG14620-RA_1 CG14620 CGGAGGAAGCGTTTCACGGAGGAGTAGTGGACATCAGCAACATTTGTGCACCCGAAGATCTTCCCGATT 69 FBgn0031185 CDMC20772 3 18 8 DAC13-G24 3-CG14620-RA_1 CG14620 CGGAGGAAGCGTTTCACGGAGGAGTAGTGGACATCAGCAACATTTGTGCACCCGAAGATCTTCCCGATT 69 FBgn0031185 CDMC20773 3 19 8 DAC13-K12 1-CG14660-RA_1 CG14660 CGCGGATTGGACTGATTGGACTCCAGATACAACACAGGGTGACCGACAGTTCAAAGGTCATGATGGCGA 69 FBgn0037285 CDMC20773 3 20 8 DAC13-K12 1-CG14660-RA_1 CG14660 CGCGGATTGGACTGATTGGACTCCAGATACAACACAGGGTGACCGACAGTTCAAAGGTCATGATGGCGA 69 FBgn0037285 CDMC20774 3 21 8 DAC13-K24 22-CG14669-RA_1 CG14669 GCCGCTCGATGAGAGATCAGATCTTGGACAGTTTCAGTCATCGTGATTTTAGCATAATTGTGGTCGGCA 69 FBan0014669 FBgn0037326 CG14669 3 3R CG14669 CG14669 CDMC20774 3 22 8 DAC13-K24 22-CG14669-RA_1 CG14669 GCCGCTCGATGAGAGATCAGATCTTGGACAGTTTCAGTCATCGTGATTTTAGCATAATTGTGGTCGGCA 69 FBan0014669 FBgn0037326 CG14669 3 3R CG14669 CG14669 CDMC20775 3 23 8 DAC13-O12 14-CG14709-RA_1 CG14709 CGAGGGCATCATTACCATCGATGAAAGGGATACGGCTGACATGGGACTCTTTGATCTACGCAGCAAGAT 69 FBan0014709 FBgn0025701 CG14709 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; organic anion transporter activity; GO:0008514; ; GO:0042626; ; GO:0008514; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG14709 CG14709 "CK01227, BEST:CK01227, BEST:CK02472" CDMC20775 3 24 8 DAC13-O12 14-CG14709-RA_1 CG14709 CGAGGGCATCATTACCATCGATGAAAGGGATACGGCTGACATGGGACTCTTTGATCTACGCAGCAAGAT 69 FBan0014709 FBgn0025701 CG14709 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; organic anion transporter activity; GO:0008514; ; GO:0042626; ; GO:0008514; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG14709 CG14709 "CK01227, BEST:CK01227, BEST:CK02472" CDMC20776 3 25 8 DAC13-O24 AutoBlank AutoBlank CDMC20776 3 26 8 DAC13-O24 AutoBlank AutoBlank CDMC20777 3 1 9 DAC14-C12 5-CG17333-RA_1 CG17333 GCCGCAAAAGCCAGTGTCGTCAAGAGTGTGTTTGTCGATCTGGACAAGAAGTTTCCCGCTGCGTG 65 FBan0017333 FBgn0030239 CG17333 X X pentose-phosphate shunt; GO:0006098 6-phosphogluconolactonase activity; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31 cellular component unknown; GO:0008372 CG17333 CG17333 CDMC20777 3 2 9 DAC14-C12 5-CG17333-RA_1 CG17333 GCCGCAAAAGCCAGTGTCGTCAAGAGTGTGTTTGTCGATCTGGACAAGAAGTTTCCCGCTGCGTG 65 FBan0017333 FBgn0030239 CG17333 X X pentose-phosphate shunt; GO:0006098 6-phosphogluconolactonase activity; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31 cellular component unknown; GO:0008372 CG17333 CG17333 CDMC20778 3 3 9 DAC14-C24 3-CG17369-RB_1 CG17369 TACCGAGGGCCAGATCTACGTCGATCGTCAGCTGCACAACAGACAGATCTACCCACCAGTCAACG 65 FBan0017369 FBgn0005671 Vha55 3 3R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; energy coupled proton transport, against electrochemical gradient; GO:0015988; proton transport; GO:0015992; purine base metabolism; GO:0006144" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha55 Vacuolar H[+]-ATPase 55kD B subunit "CG17369, CG17369, l(3)SzA, vha55, B subunit, 1208/13, l(3)87Ca, VAT-2, l(3)j2E9, SzA, vacuolar ATPase B subunit, V-ATPase" CDMC20778 3 4 9 DAC14-C24 3-CG17369-RB_1 CG17369 TACCGAGGGCCAGATCTACGTCGATCGTCAGCTGCACAACAGACAGATCTACCCACCAGTCAACG 65 FBan0017369 FBgn0005671 Vha55 3 3R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; energy coupled proton transport, against electrochemical gradient; GO:0015988; proton transport; GO:0015992; purine base metabolism; GO:0006144" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha55 Vacuolar H[+]-ATPase 55kD B subunit "CG17369, CG17369, l(3)SzA, vha55, B subunit, 1208/13, l(3)87Ca, VAT-2, l(3)j2E9, SzA, vacuolar ATPase B subunit, V-ATPase" CDMC20779 3 5 9 DAC14-G12 3-CG17568-RA_3 CG17568 CTTGACAGCTGTGAAGGAGACGACGATTTCCTGCCCGTAGATGGCCAGCTAATGGATCTCGTCGC 65 FBan0017568 FBgn0032763 CG17568 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17568 CG17568 CDMC20779 3 6 9 DAC14-G12 3-CG17568-RA_3 CG17568 CTTGACAGCTGTGAAGGAGACGACGATTTCCTGCCCGTAGATGGCCAGCTAATGGATCTCGTCGC 65 FBan0017568 FBgn0032763 CG17568 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17568 CG17568 CDMC20780 3 7 9 DAC14-G24 23-CG17626-RA_1 CG17626 CATGACTGCATATTGAACCGAAGAATGTGTCTTACTATATCCGACGTATATCCGATGGATCCACG 65 FBgn0040032 CG17626 CG17626 CG17626 CDMC20780 3 8 9 DAC14-G24 23-CG17626-RA_1 CG17626 CATGACTGCATATTGAACCGAAGAATGTGTCTTACTATATCCGACGTATATCCGATGGATCCACG 65 FBgn0040032 CG17626 CG17626 CG17626 CDMC20781 3 9 9 DAC14-K12 18-CG17738-RA_1 CG17738 CCCTGGAGGAGTCCATCAATCAATCCAATGATCTGTCGTCGGTGGAAAAGGATATTGGCCAGGCT 65 FBan0017738 FBgn0038009 CG17738 3 3R CG17738 CG17738 CDMC20781 3 10 9 DAC14-K12 18-CG17738-RA_1 CG17738 CCCTGGAGGAGTCCATCAATCAATCCAATGATCTGTCGTCGGTGGAAAAGGATATTGGCCAGGCT 65 FBan0017738 FBgn0038009 CG17738 3 3R CG17738 CG17738 CDMC20782 3 11 9 DAC14-K24 8-CG17781-RA_1 CG17781 TAGTGCACCAAGTGGTAATGGTCACTCGAATGTCTCGCACACAGTGGTCATCACACCTGCTCCTG 65 FBan0017781 FBgn0039196 CG17781 3 3R CG17781 CG17781 CDMC20782 3 12 9 DAC14-K24 8-CG17781-RA_1 CG17781 TAGTGCACCAAGTGGTAATGGTCACTCGAATGTCTCGCACACAGTGGTCATCACACCTGCTCCTG 65 FBan0017781 FBgn0039196 CG17781 3 3R CG17781 CG17781 CDMC20783 3 13 9 DAC14-O12 2-CG17957-RA_1 CG17957 ATATGCAGGGATAATCTGGAGCCCGATTCCTCAGTTGCTTCCGAAGCTCAAGTGCCCTCAAGTGC 65 FBan0017957 FBgn0003510 Sry-alpha 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; cytoskeleton organization and biogenesis; GO:0007010" actin binding; GO:0003779; ; GO:0003779 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; plasma membrane; GO:0005886 Sry-alpha Serendipity alpha "CG17957, CG17957, sry alpha, Sry alpha, Sryalpha, sryalpha, sry-alpha, serendipity-alpha, srya, Sry-alpha, sry, serendipity alpha, serendipity alpha" CDMC20783 3 14 9 DAC14-O12 2-CG17957-RA_1 CG17957 ATATGCAGGGATAATCTGGAGCCCGATTCCTCAGTTGCTTCCGAAGCTCAAGTGCCCTCAAGTGC 65 FBan0017957 FBgn0003510 Sry-alpha 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; cytoskeleton organization and biogenesis; GO:0007010" actin binding; GO:0003779; ; GO:0003779 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; plasma membrane; GO:0005886 Sry-alpha Serendipity alpha "CG17957, CG17957, sry alpha, Sry alpha, Sryalpha, sryalpha, sry-alpha, serendipity-alpha, srya, Sry-alpha, sry, serendipity alpha, serendipity alpha" CDMC20784 3 15 9 DAC14-O24 AutoBlank AutoBlank CDMC20784 3 16 9 DAC14-O24 AutoBlank AutoBlank CDMC20785 3 17 9 DAC15-C12 13-CG12946-RA_1 CG12946 CCAAAGCCAACAATAGTGCCTCATACGAACTCGACGATTTCCAACGGATCACTGTATGCTGTGTCCCC 68 FBan0012946 FBgn0037750 CG12946 3 3R CG12946 CG12946 CDMC20785 3 18 9 DAC15-C12 13-CG12946-RA_1 CG12946 CCAAAGCCAACAATAGTGCCTCATACGAACTCGACGATTTCCAACGGATCACTGTATGCTGTGTCCCC 68 FBan0012946 FBgn0037750 CG12946 3 3R CG12946 CG12946 CDMC20786 3 19 9 DAC15-C24 2-CG1314-RA_1 CG1314 ATGGCTTGTCCGCTGAGCAATTGCGACTTGATGTTCAATCCTGAGCAGCTCCTAAGTCACTGCCTGAT 68 FBan0001314 FBgn0031134 CG1314 X X CG1314 CG1314 anon-WO0140519.251 CDMC20786 3 20 9 DAC15-C24 2-CG1314-RA_1 CG1314 ATGGCTTGTCCGCTGAGCAATTGCGACTTGATGTTCAATCCTGAGCAGCTCCTAAGTCACTGCCTGAT 68 FBan0001314 FBgn0031134 CG1314 X X CG1314 CG1314 anon-WO0140519.251 CDMC20787 3 21 9 DAC15-G12 6-CG1354-RB_1 CG1354 TACGAGACGGAGACCAAGTGCAAAAGTATGCTGGAGAAGATCGTTGTGACCGGCTACAAGGGACTGCA 68 FBan0001354 FBgn0030151 CG1354 X X "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG1354 CG1354 CDMC20787 3 22 9 DAC15-G12 6-CG1354-RB_1 CG1354 TACGAGACGGAGACCAAGTGCAAAAGTATGCTGGAGAAGATCGTTGTGACCGGCTACAAGGGACTGCA 68 FBan0001354 FBgn0030151 CG1354 X X "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG1354 CG1354 CDMC20788 3 23 9 DAC15-G24 3-CG13702-RB_6 CG13702 CCTGAAGCTCATCACGATGATCCTGTACGCACTGGTCTGCATCATTGGACTCTTTGGCAACACCCTGG 68 FBan0013702 FBgn0036789 AlCR2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; G-protein coupled receptor activity; GO:0004930; ; GO:0004994; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994; ; GO:0004930 integral to membrane; GO:0016021 AlCR2 allatostatin C receptor 2 "CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, Drostar2, Drosophila allatostatin C receptor 2, anon-WO0170980.154, anon-WO0170980.155" CDMC20788 3 24 9 DAC15-G24 3-CG13702-RB_6 CG13702 CCTGAAGCTCATCACGATGATCCTGTACGCACTGGTCTGCATCATTGGACTCTTTGGCAACACCCTGG 68 FBan0013702 FBgn0036789 AlCR2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; G-protein coupled receptor activity; GO:0004930; ; GO:0004994; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994; ; GO:0004930 integral to membrane; GO:0016021 AlCR2 allatostatin C receptor 2 "CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, Drostar2, Drosophila allatostatin C receptor 2, anon-WO0170980.154, anon-WO0170980.155" CDMC20789 3 25 9 DAC15-K12 6-CG13921-RA_2 CG13921 TTCGCCGACGTGAGTAGTTGCTGCAACATGTCTGTGAAGAATGACAGCTACTATGACAACGCCCAGCG 68 FBan0013921 FBgn0035267 CG13921 3 3L CG13921 CG13921 CDMC20789 3 26 9 DAC15-K12 6-CG13921-RA_2 CG13921 TTCGCCGACGTGAGTAGTTGCTGCAACATGTCTGTGAAGAATGACAGCTACTATGACAACGCCCAGCG 68 FBan0013921 FBgn0035267 CG13921 3 3L CG13921 CG13921 CDMC20790 3 1 10 DAC15-K24 18-CG14112-RA_4 CG14112 GGGAAAGAAACATTCCGACAAACCACACAAGGTGAAGACCCACGATCCGCTCAAGAAACAAAAGAAGC 68 FBan0014112 FBgn0036349 SNCF 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944 protein binding; GO:0005515; ; GO:0005515 colocalizes_with nucleolus; GO:0005730; nucleus; GO:0005634 SNCF SoxNeuro Co-Factor "CG14112, HL6, BcDNA:RE54375, SoxNeuro Co-Factor" CDMC20790 3 2 10 DAC15-K24 18-CG14112-RA_4 CG14112 GGGAAAGAAACATTCCGACAAACCACACAAGGTGAAGACCCACGATCCGCTCAAGAAACAAAAGAAGC 68 FBan0014112 FBgn0036349 SNCF 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944 protein binding; GO:0005515; ; GO:0005515 colocalizes_with nucleolus; GO:0005730; nucleus; GO:0005634 SNCF SoxNeuro Co-Factor "CG14112, HL6, BcDNA:RE54375, SoxNeuro Co-Factor" CDMC20791 3 3 10 DAC15-O12 8-CG14527-RA_1 CG14527 TCCACCTTTAAGGAGACCTTGCTATCCAGTCCGGCTCTAGATTGGATCGAGCCATCCACTCGAAGTCT 68 FBan0014527 FBgn0039613 CG14527 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14527 CG14527 CDMC20791 3 4 10 DAC15-O12 8-CG14527-RA_1 CG14527 TCCACCTTTAAGGAGACCTTGCTATCCAGTCCGGCTCTAGATTGGATCGAGCCATCCACTCGAAGTCT 68 FBan0014527 FBgn0039613 CG14527 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14527 CG14527 CDMC20792 3 5 10 DAC15-O24 AutoBlank AutoBlank CDMC20792 3 6 10 DAC15-O24 AutoBlank AutoBlank CDMC20793 3 7 10 DAC16-C12 23-CG3109-RA_3 CG3109 TATATTTTGACATAAACTCACCATGCTCTCATTAAAGTTAGTCTCCCAGCTCTTTAAGCAAAGCC 65 FBan0003109 FBgn0023519 mRpL16 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL16 mitochondrial ribosomal protein L16 "CG3109, CG3109, D-15, EG:63B12.2, anon-2Bd, L16, mitochondrial ribosomal protein L16" CDMC20793 3 8 10 DAC16-C12 23-CG3109-RA_3 CG3109 TATATTTTGACATAAACTCACCATGCTCTCATTAAAGTTAGTCTCCCAGCTCTTTAAGCAAAGCC 65 FBan0003109 FBgn0023519 mRpL16 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL16 mitochondrial ribosomal protein L16 "CG3109, CG3109, D-15, EG:63B12.2, anon-2Bd, L16, mitochondrial ribosomal protein L16" CDMC20794 3 9 10 DAC16-C24 18-CG31146-RD_10 CG31146 AGGACGAGGACCTTAAGGAGCCCCAAATCACACAGAACACTCTCATTGTTGGACCCATTGTGCCC 65 FBan0031146 FBgn0051146 CG31146 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 neurexin binding; GO:0042043; NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG31146 CG31146 "CG12148, CG14596, anon-WO0118547.256" CDMC20794 3 10 10 DAC16-C24 18-CG31146-RD_10 CG31146 AGGACGAGGACCTTAAGGAGCCCCAAATCACACAGAACACTCTCATTGTTGGACCCATTGTGCCC 65 FBan0031146 FBgn0051146 CG31146 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 neurexin binding; GO:0042043; NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG31146 CG31146 "CG12148, CG14596, anon-WO0118547.256" CDMC20795 3 11 10 DAC16-G12 6-CG31259-RA_6 CG31259 CTCGCCAGGCTCCCCTCAACTTCCAAAGCATTTCAGCCTACGTACAGCTCTATGACCGCATGCTG 65 FBan0031259 FBgn0051259 CG31259 3 3R CG31259 CG31259 CG11740 CDMC20795 3 12 10 DAC16-G12 6-CG31259-RA_6 CG31259 CTCGCCAGGCTCCCCTCAACTTCCAAAGCATTTCAGCCTACGTACAGCTCTATGACCGCATGCTG 65 FBan0031259 FBgn0051259 CG31259 3 3R CG31259 CG31259 CG11740 CDMC20796 3 13 10 DAC16-G24 23-CG31289-RA_4 CG31289 ACGACTACAACCACTAATTCCGCTGCGAAATTACCTAATTTAGTGTCTAGGAAATGTTGTCTGTG 65 FBan0031289 FBgn0024558 Dph5 3 3R amino acid metabolism; GO:0006520; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 diphthine synthase activity; GO:0004164 ; EC:2.1.1.98; ; GO:0004164 ; EC:2.1.1.98; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004164 ; EC:2.1.1.98 Dph5 Diphthamide methyltransferase "CG5275, CG31289, CG5275, l(3)L4910, BcDNA.LD12153, BcDNA:LD12153, Diphthamide methyltransferase" CDMC20796 3 14 10 DAC16-G24 23-CG31289-RA_4 CG31289 ACGACTACAACCACTAATTCCGCTGCGAAATTACCTAATTTAGTGTCTAGGAAATGTTGTCTGTG 65 FBan0031289 FBgn0024558 Dph5 3 3R amino acid metabolism; GO:0006520; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 diphthine synthase activity; GO:0004164 ; EC:2.1.1.98; ; GO:0004164 ; EC:2.1.1.98; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004164 ; EC:2.1.1.98 Dph5 Diphthamide methyltransferase "CG5275, CG31289, CG5275, l(3)L4910, BcDNA.LD12153, BcDNA:LD12153, Diphthamide methyltransferase" CDMC20797 3 15 10 DAC16-K12 2-CG31392-RA_1 CG31392 ATCTGCGATCCATGCACCCTGGTTGTGCGTTTGCCAGTACTGTTGAAATGGTTACACCGAGGTCC 65 FBan0031392 FBgn0051392 CG31392 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG31392 CG31392 "CG12258, CG12258, CG12258" CDMC20797 3 16 10 DAC16-K12 2-CG31392-RA_1 CG31392 ATCTGCGATCCATGCACCCTGGTTGTGCGTTTGCCAGTACTGTTGAAATGGTTACACCGAGGTCC 65 FBan0031392 FBgn0051392 CG31392 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG31392 CG31392 "CG12258, CG12258, CG12258" CDMC20798 3 17 10 DAC16-K24 1-CG31447-RA_2 CG31447 ATGTCTGGAACATCGACCTCTGAACGCTCCAACTCCGAAGACAGCCCGTTGAATCCCTGCCTAAC 65 FBan0031447 FBgn0043069 MESK4 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK4 Misexpression suppressor of KSR 4 "CG31447, BcDNA:LD15753, Misexpression suppressor of KSR 4" CDMC20798 3 18 10 DAC16-K24 1-CG31447-RA_2 CG31447 ATGTCTGGAACATCGACCTCTGAACGCTCCAACTCCGAAGACAGCCCGTTGAATCCCTGCCTAAC 65 FBan0031447 FBgn0043069 MESK4 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK4 Misexpression suppressor of KSR 4 "CG31447, BcDNA:LD15753, Misexpression suppressor of KSR 4" CDMC20799 3 19 10 DAC16-O12 15-CG31547-RB_6 CG31547 AGCATGGCTAGCTTGTTGACCAAGTTCCGCATCAAGTACTCTGAGCTCATTATGCTGAAGGGCGT 65 FBan0031547 FBgn0051547 CG31547 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 CG31547 CG31547 "CG10544, CG2509" CDMC20799 3 20 10 DAC16-O12 15-CG31547-RB_6 CG31547 AGCATGGCTAGCTTGTTGACCAAGTTCCGCATCAAGTACTCTGAGCTCATTATGCTGAAGGGCGT 65 FBan0031547 FBgn0051547 CG31547 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 CG31547 CG31547 "CG10544, CG2509" CDMC20800 3 21 10 DAC16-O24 AutoBlank AutoBlank CDMC20800 3 22 10 DAC16-O24 AutoBlank AutoBlank CDMC20801 3 23 10 DAC17-C12 5-CG32742-RA_1 CG32742 ACCCAGAGCCAGAAGAAACTCGTCCAATGCCCCACTAGGCCACATTTACTTACCTCAAGCCGCAG 65 FBgn0052742 CDMC20801 3 24 10 DAC17-C12 5-CG32742-RA_1 CG32742 ACCCAGAGCCAGAAGAAACTCGTCCAATGCCCCACTAGGCCACATTTACTTACCTCAAGCCGCAG 65 FBgn0052742 CDMC20802 3 25 10 DAC17-C24 2-CG32795-RC_1 CG32795 TATTCCTGTTGGTCTGGTACTACTGCACCCTGACCATTCGCGAGTCCATCCTCAAGGTGAACGGC 65 FBan0032795 FBgn0040384 CG32795 X X carbon utilization by fixation of carbon dioxide; GO:0015977 ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG32795 CG32795 "CG2766, CG2716, CG2766, CG2766, CG2766, EG:BACN33B1.2" CDMC20802 3 26 10 DAC17-C24 2-CG32795-RC_1 CG32795 TATTCCTGTTGGTCTGGTACTACTGCACCCTGACCATTCGCGAGTCCATCCTCAAGGTGAACGGC 65 FBan0032795 FBgn0040384 CG32795 X X carbon utilization by fixation of carbon dioxide; GO:0015977 ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG32795 CG32795 "CG2766, CG2716, CG2766, CG2766, CG2766, EG:BACN33B1.2" CDMC20803 3 1 11 DAC17-G12 23-CG3294-RB_1 CG3294 GGTATTTTTCATAGACCCTGTACACGGTATTAATCAGCTGTGTTCTCACAAATGCGTTTCAGCTG 65 FBan0003294 FBgn0031628 CG3294 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG3294 CG3294 cg3294 CDMC20803 3 2 11 DAC17-G12 23-CG3294-RB_1 CG3294 GGTATTTTTCATAGACCCTGTACACGGTATTAATCAGCTGTGTTCTCACAAATGCGTTTCAGCTG 65 FBan0003294 FBgn0031628 CG3294 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG3294 CG3294 cg3294 CDMC20804 3 3 11 DAC17-G24 3-CG33012-RB_2 CG33012 CAGCCTCGGGATGGAGTAAGGATGCTCAGCTGGTCGTTCCTCAAGGGTATGCTGGACAATCCATC 65 FBan0033012 FBgn0053012 CG33012 2 2R CG33012 CG33012 "CG13161, CG30041" CDMC20804 3 4 11 DAC17-G24 3-CG33012-RB_2 CG33012 CAGCCTCGGGATGGAGTAAGGATGCTCAGCTGGTCGTTCCTCAAGGGTATGCTGGACAATCCATC 65 FBan0033012 FBgn0053012 CG33012 2 2R CG33012 CG33012 "CG13161, CG30041" CDMC20805 3 5 11 DAC17-K12 3-CG33140-RA_1 CG33140 CTCACTGAATGCCTCTTCCCAGCAGGATGTCCAAAAGCAACGGTCGCGGTTCATATATGTGCGCG 65 FBan0033140 FBgn0053140 CG33140 2 2R CG33140 CG33140 "CG11074, BcDNA:AT21895" CDMC20805 3 6 11 DAC17-K12 3-CG33140-RA_1 CG33140 CTCACTGAATGCCTCTTCCCAGCAGGATGTCCAAAAGCAACGGTCGCGGTTCATATATGTGCGCG 65 FBan0033140 FBgn0053140 CG33140 2 2R CG33140 CG33140 "CG11074, BcDNA:AT21895" CDMC20806 3 7 11 DAC17-K24 2-CG33161-RA_1 CG33161 CAACGGGAGTGTAGGGATCTGTATCGTGGCTACCGGAACATCACGTCCAGCATGTTCTGTGCCTC 65 FBgn0053161 CDMC20806 3 8 11 DAC17-K24 2-CG33161-RA_1 CG33161 CAACGGGAGTGTAGGGATCTGTATCGTGGCTACCGGAACATCACGTCCAGCATGTTCTGTGCCTC 65 FBgn0053161 CDMC20807 3 9 11 DAC17-O12 1-CG33267-RA_2 CG33267 CACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTGCCAGTACCACAACCACAACTACAGATGATG 65 FBan0033267 FBgn0053267 CG33267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33267 CG33267 CDMC20807 3 10 11 DAC17-O12 1-CG33267-RA_2 CG33267 CACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTGCCAGTACCACAACCACAACTACAGATGATG 65 FBan0033267 FBgn0053267 CG33267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33267 CG33267 CDMC20808 3 11 11 DAC17-O24 AutoBlank AutoBlank CDMC20808 3 12 11 DAC17-O24 AutoBlank AutoBlank CDMC20809 3 13 11 DAC18-C12 2-CG6012-RA_1 CG6012 CGCATCTTCTTCCAGCGCATGAAGGCGTCTAAATTGAAGGGAGCCATTGTGAATGTTGGTTCCGGCAC 68 FBan0006012 FBgn0032615 CG6012 2 2L steroid metabolism; GO:0008202 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG6012 CG6012 CDMC20809 3 14 11 DAC18-C12 2-CG6012-RA_1 CG6012 CGCATCTTCTTCCAGCGCATGAAGGCGTCTAAATTGAAGGGAGCCATTGTGAATGTTGGTTCCGGCAC 68 FBan0006012 FBgn0032615 CG6012 2 2L steroid metabolism; GO:0008202 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG6012 CG6012 CDMC20810 3 15 11 DAC18-C24 3-CG6171-RA_4 CG6171 GCTGAGCCAGTGGAGAATGCAGATGAGCCCACAAGCACTACTCCTGCGATCAAGATTAAAGCCGAACC 68 FBan0006171 FBgn0026737 CG6171 3 3R CG6171 CG6171 "Anon-becker2, anon-Becker2" CDMC20810 3 16 11 DAC18-C24 3-CG6171-RA_4 CG6171 GCTGAGCCAGTGGAGAATGCAGATGAGCCCACAAGCACTACTCCTGCGATCAAGATTAAAGCCGAACC 68 FBan0006171 FBgn0026737 CG6171 3 3R CG6171 CG6171 "Anon-becker2, anon-Becker2" CDMC20811 3 17 11 DAC18-G12 1-CG6613-RA_1 CG6613 GTCTGCGTTCTCCAACTACGGACAGATGCAGCTACAATGCTCTGTTGCGGAAACACGAAAGCAACCGG 68 FBan0006613 FBgn0034694 CG6613 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567 diacylglycerol binding; GO:0019992; ; GO:0019992; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6613 CG6613 CDMC20811 3 18 11 DAC18-G12 1-CG6613-RA_1 CG6613 GTCTGCGTTCTCCAACTACGGACAGATGCAGCTACAATGCTCTGTTGCGGAAACACGAAAGCAACCGG 68 FBan0006613 FBgn0034694 CG6613 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567 diacylglycerol binding; GO:0019992; ; GO:0019992; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6613 CG6613 CDMC20812 3 19 11 DAC18-G24 1-CG6706-RB_1 CG6706 TCCACCAACATCTCCACATCGCAATCGGAGTTGAGCAACATGTGTCCACACTCAAAGCCCAGTACTCC 68 FBan0006706 FBgn0027575 GABA-B-R2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R2 metabotropic GABA-B receptor subtype 2 "CG6706, CG6706, D-GABA[[B]]R2, D-Gaba2, GH07312, GABA[[B]]R2, GB2, anon-WO0170980.58, anon-WO0170980.59, BcDNA:GH07312, metabotropic GABA-B receptor subtype 2" CDMC20812 3 20 11 DAC18-G24 1-CG6706-RB_1 CG6706 TCCACCAACATCTCCACATCGCAATCGGAGTTGAGCAACATGTGTCCACACTCAAAGCCCAGTACTCC 68 FBan0006706 FBgn0027575 GABA-B-R2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R2 metabotropic GABA-B receptor subtype 2 "CG6706, CG6706, D-GABA[[B]]R2, D-Gaba2, GH07312, GABA[[B]]R2, GB2, anon-WO0170980.58, anon-WO0170980.59, BcDNA:GH07312, metabotropic GABA-B receptor subtype 2" CDMC20813 3 21 11 DAC18-K12 3-CG7128-RA_2 CG7128 GCAAACCGGCCTTTCCTCCCTATGCAGCCGCTTTAAATCCCACAGATCAGGTGTTTGACTTCGAGGAG 68 FBan0007128 FBgn0022724 Taf8 X X cellular physiological process; GO:0050875; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein binding; GO:0005515; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf8 TBP-associated factor 8 "CG7128, CG7128, pds: prodos, prodos, HL-VIII, pro, prod, TAF8, TFIID, TAF[[II]], TAF, l(1)16Fg, pds" CDMC20813 3 22 11 DAC18-K12 3-CG7128-RA_2 CG7128 GCAAACCGGCCTTTCCTCCCTATGCAGCCGCTTTAAATCCCACAGATCAGGTGTTTGACTTCGAGGAG 68 FBan0007128 FBgn0022724 Taf8 X X cellular physiological process; GO:0050875; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein binding; GO:0005515; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf8 TBP-associated factor 8 "CG7128, CG7128, pds: prodos, prodos, HL-VIII, pro, prod, TAF8, TFIID, TAF[[II]], TAF, l(1)16Fg, pds" CDMC20814 3 23 11 DAC18-K24 3-CG7274-RA_4 CG7274 GCCCTGCACTGTGAGTGTGATGAATCTGGTGAAGCAGGCGTACAAGAAGTTTCTGCAACCATACGGCG 68 FBan0007274 FBgn0030965 CG7274 X X "cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712; ; GO:0003677 intracellular; GO:0005622 CG7274 CG7274 CDMC20814 3 24 11 DAC18-K24 3-CG7274-RA_4 CG7274 GCCCTGCACTGTGAGTGTGATGAATCTGGTGAAGCAGGCGTACAAGAAGTTTCTGCAACCATACGGCG 68 FBan0007274 FBgn0030965 CG7274 X X "cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712; ; GO:0003677 intracellular; GO:0005622 CG7274 CG7274 CDMC20815 3 25 11 DAC18-O12 3-CG7503-RA_2 CG7503 CTTGGGTCATGGCCTAGACCTGGATGACAATCTTAGCTTGCACAAGCAGGGATTCTATGGTGCCGGTT 68 FBan0007503 FBgn0005775 Con 3 3L axonal fasciculation; GO:0007413; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; synaptic target attraction; GO:0016200 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 Con Connectin "CG7503, connectin, conn, con, CT1840, CON, Ubx-t35, anon-64C, transcript-35" CDMC20815 3 26 11 DAC18-O12 3-CG7503-RA_2 CG7503 CTTGGGTCATGGCCTAGACCTGGATGACAATCTTAGCTTGCACAAGCAGGGATTCTATGGTGCCGGTT 68 FBan0007503 FBgn0005775 Con 3 3L axonal fasciculation; GO:0007413; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; synaptic target attraction; GO:0016200 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 Con Connectin "CG7503, connectin, conn, con, CT1840, CON, Ubx-t35, anon-64C, transcript-35" CDMC20816 3 1 12 DAC18-O24 AutoBlank AutoBlank CDMC20816 3 2 12 DAC18-O24 AutoBlank AutoBlank CDMC20817 3 3 12 DAC19-C12 16-CG1780-RB_1 CG1780 GCGCCAGGTTAAGAGCAAGTTGTAGAGCTCCTCATCCTTCTGATTCTTTTCCCGAACGAAAGAACAACG 69 FBan0001780 FBgn0026415 Idgf4 X X cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 imaginal disc growth factor activity; GO:0008084; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008084 extracellular region; GO:0005576 Idgf4 Imaginal disc growth factor 4 "CG1780, CG1780, IDGF, IDGF4, IDGF-4" CDMC20817 3 4 12 DAC19-C12 16-CG1780-RB_1 CG1780 GCGCCAGGTTAAGAGCAAGTTGTAGAGCTCCTCATCCTTCTGATTCTTTTCCCGAACGAAAGAACAACG 69 FBan0001780 FBgn0026415 Idgf4 X X cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 imaginal disc growth factor activity; GO:0008084; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008084 extracellular region; GO:0005576 Idgf4 Imaginal disc growth factor 4 "CG1780, CG1780, IDGF, IDGF4, IDGF-4" CDMC20818 3 5 12 DAC19-C24 23-CG17834-RB_4 CG17834 CTCGCAATGCGGATATAATCAATTGGAGAGTGACCAATATCGCCAAAATGTGACTTAATATTATTAACT 69 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC20818 3 6 12 DAC19-C24 23-CG17834-RB_4 CG17834 CTCGCAATGCGGATATAATCAATTGGAGAGTGACCAATATCGCCAAAATGTGACTTAATATTATTAACT 69 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC20819 3 7 12 DAC19-G12 15-CG17883-RB_1 CG17883 CCCTGGCGCCTTACGGATTGGTTAATGACGATTTTAGAAGGATTTTATGGCCTCAGTTGGCAGGAGTCG 69 FBgn0040005 CG17883 CG17883 CG17883 "CG40289, CG40289" CDMC20819 3 8 12 DAC19-G12 15-CG17883-RB_1 CG17883 CCCTGGCGCCTTACGGATTGGTTAATGACGATTTTAGAAGGATTTTATGGCCTCAGTTGGCAGGAGTCG 69 FBgn0040005 CG17883 CG17883 CG17883 "CG40289, CG40289" CDMC20820 3 9 12 DAC19-G24 2-CG17904-RA_1 CG17904 CCCGCTATCTGGCCAGAAGTAATCCGGACAGTAACTTCGGCGTGCTTGATATCGACATTTGCGGTCCAT 69 FBan0017904 FBgn0032597 CG17904 2 2L nucleotide binding; GO:0000166; ; GO:0000166 CG17904 CG17904 CDMC20820 3 10 12 DAC19-G24 2-CG17904-RA_1 CG17904 CCCGCTATCTGGCCAGAAGTAATCCGGACAGTAACTTCGGCGTGCTTGATATCGACATTTGCGGTCCAT 69 FBan0017904 FBgn0032597 CG17904 2 2L nucleotide binding; GO:0000166; ; GO:0000166 CG17904 CG17904 CDMC20821 3 11 12 DAC19-K12 6-CG17941-RA_7 CG17941 GCGCATGTGTTTTCCGAAATAGCGAGACTGAAAGATGACACCTTATCGGAGCACAGTGGAAGTGGGGCT 69 FBan0017941 FBgn0000497 ds 2 2L calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; signal transduction; GO:0007165; wing disc pattern formation; GO:0035222 signal transducer activity; GO:0004871; receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; ; GO:0004871; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ds dachsous "CG17941, l(2)05142, CT39575, Ds, cad2: cadherin-2, cadherin-2, dachsous" CDMC20821 3 12 12 DAC19-K12 6-CG17941-RA_7 CG17941 GCGCATGTGTTTTCCGAAATAGCGAGACTGAAAGATGACACCTTATCGGAGCACAGTGGAAGTGGGGCT 69 FBan0017941 FBgn0000497 ds 2 2L calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; signal transduction; GO:0007165; wing disc pattern formation; GO:0035222 signal transducer activity; GO:0004871; receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; ; GO:0004871; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ds dachsous "CG17941, l(2)05142, CT39575, Ds, cad2: cadherin-2, cadherin-2, dachsous" CDMC20822 3 13 12 DAC19-K24 23-CG17950-RA_3 CG17950 GACAAAATACACGAAAAACAATACACACACCGCAAATGAATCGAACGAAATTTCGCTCAGGTCTTTTCG 69 FBan0017950 FBgn0004362 HmgD 2 2R "establishment and/or maintenance of chromatin architecture; GO:0006325; regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; ; GO:0003680; DNA bending activity; GO:0008301; ; GO:0008301; ; GO:0008301 colocalizes_with nuclear chromatin; GO:0000790 HmgD High mobility group protein D "CG17950, HMG D, dHMG-D, HMG-D, clone 1.9, hmg-D, anon-EST:Liang-1.9" CDMC20822 3 14 12 DAC19-K24 23-CG17950-RA_3 CG17950 GACAAAATACACGAAAAACAATACACACACCGCAAATGAATCGAACGAAATTTCGCTCAGGTCTTTTCG 69 FBan0017950 FBgn0004362 HmgD 2 2R "establishment and/or maintenance of chromatin architecture; GO:0006325; regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; ; GO:0003680; DNA bending activity; GO:0008301; ; GO:0008301; ; GO:0008301 colocalizes_with nuclear chromatin; GO:0000790 HmgD High mobility group protein D "CG17950, HMG D, dHMG-D, HMG-D, clone 1.9, hmg-D, anon-EST:Liang-1.9" CDMC20823 3 15 12 DAC19-O12 14-CG18004-RC_1 CG18004 CCCACAACGATGCTCAGCGATGAAAGCCCCTCTAAGTGGTAATAAGTTGTGCAATTCCCACGTTGCAGC 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC20823 3 16 12 DAC19-O12 14-CG18004-RC_1 CG18004 CCCACAACGATGCTCAGCGATGAAAGCCCCTCTAAGTGGTAATAAGTTGTGCAATTCCCACGTTGCAGC 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC20824 3 17 12 DAC19-O24 AutoBlank AutoBlank CDMC20824 3 18 12 DAC19-O24 AutoBlank AutoBlank CDMC20825 3 19 12 DAC20-C12 2-CG10688-RA_1 CG10688 TCAGATCAGCTTCGATGTCTTCCCGCATGGTTGGGACAAGACCTACTGCCTGCGACACATCGAAG 65 FBan0010688 FBgn0036300 CG10688 3 3L GDP-mannose biosynthesis; GO:0009298 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 cytoplasm; GO:0005737 CG10688 CG10688 CDMC20825 3 20 12 DAC20-C12 2-CG10688-RA_1 CG10688 TCAGATCAGCTTCGATGTCTTCCCGCATGGTTGGGACAAGACCTACTGCCTGCGACACATCGAAG 65 FBan0010688 FBgn0036300 CG10688 3 3L GDP-mannose biosynthesis; GO:0009298 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 cytoplasm; GO:0005737 CG10688 CG10688 CDMC20826 3 21 12 DAC20-C24 3-CG10723-RA_3 CG10723 AGAGCGATATGGATATTCTGGCCAACTCCATGTACGAGGACGATCCCAATGGCAACCTAGCGCCC 65 FBan0010723 FBgn0032850 Kua 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Kua Kua "CG10723, CG10723, CG10723, 38B.18" CDMC20826 3 22 12 DAC20-C24 3-CG10723-RA_3 CG10723 AGAGCGATATGGATATTCTGGCCAACTCCATGTACGAGGACGATCCCAATGGCAACCTAGCGCCC 65 FBan0010723 FBgn0032850 Kua 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Kua Kua "CG10723, CG10723, CG10723, 38B.18" CDMC20827 3 23 12 DAC20-G12 23-CG10851-RD_1 CG10851 GAAAGAGAATCAAATCTAATTGAATCGCTGTGAGAAAGACAAGCTAGTCTAGTGACCGACCGACC 65 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20827 3 24 12 DAC20-G12 23-CG10851-RD_1 CG10851 GAAAGAGAATCAAATCTAATTGAATCGCTGTGAGAAAGACAAGCTAGTCTAGTGACCGACCGACC 65 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20828 3 25 12 DAC20-G24 17-CG10883-RA_1 CG10883 CAACTCACGATCATGCGATGCTGCTGATTGCCGTTGGCCAGGCCATCGCCGTTCCCAGTTGTTTC 65 FBan0010883 FBgn0038781 CG10883 3 3R CG10883 CG10883 CDMC20828 3 26 12 DAC20-G24 17-CG10883-RA_1 CG10883 CAACTCACGATCATGCGATGCTGCTGATTGCCGTTGGCCAGGCCATCGCCGTTCCCAGTTGTTTC 65 FBan0010883 FBgn0038781 CG10883 3 3R CG10883 CG10883 CDMC20829 3 1 13 DAC20-K12 15-CG10966-RA_6 CG10966 CCTCCAAGCCATCGATTGATGACGGACTAATGGAGGTTGTTGGCCTGACCACCTACCAGCTGCCC 65 FBan0010966 FBgn0003217 rdgA X X actin filament organization; GO:0007015; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphatidic acid biosynthesis; GO:0006654; phosphoinositide biosynthesis; GO:0046489; phosphorylation; GO:0016310; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein kinase C activation; GO:0007205; rhodopsin mediated signaling; GO:0016056; visual perception; GO:0007601 diacylglycerol binding; GO:0019992; ; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 membrane; GO:0016020 rdgA retinal degeneration A "CG10966, CG10966, receptor-degeneration-I, DGK2, dDGK2, x35" CDMC20829 3 2 13 DAC20-K12 15-CG10966-RA_6 CG10966 CCTCCAAGCCATCGATTGATGACGGACTAATGGAGGTTGTTGGCCTGACCACCTACCAGCTGCCC 65 FBan0010966 FBgn0003217 rdgA X X actin filament organization; GO:0007015; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphatidic acid biosynthesis; GO:0006654; phosphoinositide biosynthesis; GO:0046489; phosphorylation; GO:0016310; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein kinase C activation; GO:0007205; rhodopsin mediated signaling; GO:0016056; visual perception; GO:0007601 diacylglycerol binding; GO:0019992; ; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 membrane; GO:0016020 rdgA retinal degeneration A "CG10966, CG10966, receptor-degeneration-I, DGK2, dDGK2, x35" CDMC20830 3 3 13 DAC20-K24 12-CG11000-RA_1 CG11000 GTCTACTGGATGCTGGCCAAGTCGGAGCAGGAGGTGAGCGACTGGATCGATGCGATTACCAAGAC 65 FBan0011000 FBgn0037380 CG11000 3 3R CG11000 CG11000 CDMC20830 3 4 13 DAC20-K24 12-CG11000-RA_1 CG11000 GTCTACTGGATGCTGGCCAAGTCGGAGCAGGAGGTGAGCGACTGGATCGATGCGATTACCAAGAC 65 FBan0011000 FBgn0037380 CG11000 3 3R CG11000 CG11000 CDMC20831 3 5 13 DAC20-O12 12-CG11126-RA_1 CG11126 CATGTGCCCATGGCAGAATAGACTGGTGACCCTCAGTCTGCGTGGTAAGCACATTGTGGAGCTGC 65 FBan0011126 FBgn0030265 CG11126 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG11126 CG11126 CDMC20831 3 6 13 DAC20-O12 12-CG11126-RA_1 CG11126 CATGTGCCCATGGCAGAATAGACTGGTGACCCTCAGTCTGCGTGGTAAGCACATTGTGGAGCTGC 65 FBan0011126 FBgn0030265 CG11126 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG11126 CG11126 CDMC20832 3 7 13 DAC20-O24 AutoBlank AutoBlank CDMC20832 3 8 13 DAC20-O24 AutoBlank AutoBlank CDMC20833 3 9 13 DAC21-C12 1-CG11269-RA_1 CG11269 CATTGCGATAGTGGCCATTCGTCGGGATAACAAGAGAAGGAAGCGACTCTACAAGCGGGGTCCCG 65 FBan0011269 FBgn0034700 CG11269 2 2R CG11269 CG11269 CDMC20833 3 10 13 DAC21-C12 1-CG11269-RA_1 CG11269 CATTGCGATAGTGGCCATTCGTCGGGATAACAAGAGAAGGAAGCGACTCTACAAGCGGGGTCCCG 65 FBan0011269 FBgn0034700 CG11269 2 2R CG11269 CG11269 CDMC20834 3 11 13 DAC21-C24 23-CG11295-RA_1 CG11295 CGCCCTCTGTACAGAGCCAAAAGATACGAAAGACTAACGTACCCGAATAAAAGTAACTCCATTTT 65 FBan0011295 FBgn0013548 l(2)dtl 2 2R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cytoplasm; GO:0005737 l(2)dtl lethal-(2)-denticleless "CG11295, DTL83" CDMC20834 3 12 13 DAC21-C24 23-CG11295-RA_1 CG11295 CGCCCTCTGTACAGAGCCAAAAGATACGAAAGACTAACGTACCCGAATAAAAGTAACTCCATTTT 65 FBan0011295 FBgn0013548 l(2)dtl 2 2R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cytoplasm; GO:0005737 l(2)dtl lethal-(2)-denticleless "CG11295, DTL83" CDMC20835 3 13 13 DAC21-G12 3-CG11437-RA_1 CG11437 GCCGTCCCATGCCAAGAAATGAACAGATCTACGGCTACGCGGGATACTACACCAGAGCCACCTAC 65 FBan0011437 FBgn0037165 CG11437 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11437 CG11437 WUN-like CDMC20835 3 14 13 DAC21-G12 3-CG11437-RA_1 CG11437 GCCGTCCCATGCCAAGAAATGAACAGATCTACGGCTACGCGGGATACTACACCAGAGCCACCTAC 65 FBan0011437 FBgn0037165 CG11437 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11437 CG11437 WUN-like CDMC20836 3 15 13 DAC21-G24 23-CG11491-RD_1 CG11491 CAACTCACGCCTATGGACCAGTATATAGAATACGGATATACACTGTTTACACTCTGTGGCCTTCT 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC20836 3 16 13 DAC21-G24 23-CG11491-RD_1 CG11491 CAACTCACGCCTATGGACCAGTATATAGAATACGGATATACACTGTTTACACTCTGTGGCCTTCT 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC20837 3 17 13 DAC21-K12 2-CG11589-RA_2 CG11589 GCGGTTGCTTCTTCCGCGTATTTCCGGATCTTAAGCCACATCACACACAGTCGGTGAAACCACGG 65 FBan0011589 FBgn0028664 VhaM9.7-1 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-1 VhaM9.7-1 "CG11589, vhaM9.2-1, vhaM9.7-1, V-ATPase" CDMC20837 3 18 13 DAC21-K12 2-CG11589-RA_2 CG11589 GCGGTTGCTTCTTCCGCGTATTTCCGGATCTTAAGCCACATCACACACAGTCGGTGAAACCACGG 65 FBan0011589 FBgn0028664 VhaM9.7-1 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-1 VhaM9.7-1 "CG11589, vhaM9.2-1, vhaM9.7-1, V-ATPase" CDMC20838 3 19 13 DAC21-K24 2-CG11608-RA_2 CG11608 GGGACCCGGTACTCCAGGAAGCATCTCAAACTCAAGGCCTGGCTCTTGCAGTTTTGGCGTTTTAG 65 FBan0011608 FBgn0038069 CG11608 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11608 CG11608 CDMC20838 3 20 13 DAC21-K24 2-CG11608-RA_2 CG11608 GGGACCCGGTACTCCAGGAAGCATCTCAAACTCAAGGCCTGGCTCTTGCAGTTTTGGCGTTTTAG 65 FBan0011608 FBgn0038069 CG11608 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11608 CG11608 CDMC20839 3 21 13 DAC21-O12 1-CG11700-RA_4 CG11700 ACGTCAAAGCCAAGATACAGGACAAGGAGGAAAACCCCCCAGAGCATCAGCGTTTGATCTTCGGC 65 FBan0011700 FBgn0029856 CG11700 X X cellular physiological process; GO:0050875; protein metabolism; GO:0019538; proteolysis; GO:0006508 CG11700 CG11700 CDMC20839 3 22 13 DAC21-O12 1-CG11700-RA_4 CG11700 ACGTCAAAGCCAAGATACAGGACAAGGAGGAAAACCCCCCAGAGCATCAGCGTTTGATCTTCGGC 65 FBan0011700 FBgn0029856 CG11700 X X cellular physiological process; GO:0050875; protein metabolism; GO:0019538; proteolysis; GO:0006508 CG11700 CG11700 CDMC20840 3 23 13 DAC21-O24 AutoBlank AutoBlank CDMC20840 3 24 13 DAC21-O24 AutoBlank AutoBlank CDMC20841 3 25 13 DAC22-C12 3-CG3168-RA_2 CG3168 TATGGCCTGTTGATGTGGTTCCCGGAGCTCTTCAATCGCTTCGAGGAGTACGAGAAGGCATTCCC 65 FBan0003168 FBgn0029896 CG3168 X X DNA metabolism; GO:0006259; DNA topological change; GO:0006265; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0015144; ; GO:0003677; ; GO:0003918 ; EC:5.99.1.3 integral to membrane; GO:0016021; membrane; GO:0016020 CG3168 CG3168 "LP06294.5prime, BEST:LP06294" CDMC20841 3 26 13 DAC22-C12 3-CG3168-RA_2 CG3168 TATGGCCTGTTGATGTGGTTCCCGGAGCTCTTCAATCGCTTCGAGGAGTACGAGAAGGCATTCCC 65 FBan0003168 FBgn0029896 CG3168 X X DNA metabolism; GO:0006259; DNA topological change; GO:0006265; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0015144; ; GO:0003677; ; GO:0003918 ; EC:5.99.1.3 integral to membrane; GO:0016021; membrane; GO:0016020 CG3168 CG3168 "LP06294.5prime, BEST:LP06294" CDMC20842 3 1 14 DAC22-C24 2-CG31710-RA_1 CG31710 ATCGAGTCAAATCAGGCGGATCCAAGATGCTCACCAGACAACCCGACTACACCATCTCCGAGCTG 65 FBan0031710 FBgn0051710 CG31710 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31710 CG31710 CDMC20842 3 2 14 DAC22-C24 2-CG31710-RA_1 CG31710 ATCGAGTCAAATCAGGCGGATCCAAGATGCTCACCAGACAACCCGACTACACCATCTCCGAGCTG 65 FBan0031710 FBgn0051710 CG31710 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31710 CG31710 CDMC20843 3 3 14 DAC22-G12 3-CG31805-RA_3 CG31805 CTTGCCCGACTACCAAGCGTTGCTCAAGGAAAAGCACTTGTGTGCCGAAAACCACTCGAATGTGC 65 FBan0031805 FBgn0051805 CG31805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31805 CG31805 CDMC20843 3 4 14 DAC22-G12 3-CG31805-RA_3 CG31805 CTTGCCCGACTACCAAGCGTTGCTCAAGGAAAAGCACTTGTGTGCCGAAAACCACTCGAATGTGC 65 FBan0031805 FBgn0051805 CG31805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31805 CG31805 CDMC20844 3 5 14 DAC22-G24 3-CG31869-RA_1 CG31869 GGTGGTGGCGACATCGATCTCTACCAGGATAAGTCTTCTACCACCGAGGAAATGATGGCGTCCGG 65 FBan0031869 FBgn0051869 CG31869 2 2L CG31869 CG31869 "CG17130, CG18499" CDMC20844 3 6 14 DAC22-G24 3-CG31869-RA_1 CG31869 GGTGGTGGCGACATCGATCTCTACCAGGATAAGTCTTCTACCACCGAGGAAATGATGGCGTCCGG 65 FBan0031869 FBgn0051869 CG31869 2 2L CG31869 CG31869 "CG17130, CG18499" CDMC20845 3 7 14 DAC22-K12 2-CG31961-RB_1 CG31961 CACTGCGCATATGATACGTGCCCAGTAAGAAAGCCGCGTTTTCCATGCATTTCTCTGCAGCTGCG 65 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC20845 3 8 14 DAC22-K12 2-CG31961-RB_1 CG31961 CACTGCGCATATGATACGTGCCCAGTAAGAAAGCCGCGTTTTCCATGCATTTCTCTGCAGCTGCG 65 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC20846 3 9 14 DAC22-K24 18-CG32031-RA_1 CG32031 GAGGCTGAGGGTGGTGTCTACGACATCTCCAACAAGCGTCGCATGGGTCTGACCGAGTTCGAGGC 65 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC20846 3 10 14 DAC22-K24 18-CG32031-RA_1 CG32031 GAGGCTGAGGGTGGTGTCTACGACATCTCCAACAAGCGTCGCATGGGTCTGACCGAGTTCGAGGC 65 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC20847 3 11 14 DAC22-O12 23-CG32143-RB_1 CG32143 CATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTCCG 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC20847 3 12 14 DAC22-O12 23-CG32143-RB_1 CG32143 CATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTCCG 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC20848 3 13 14 DAC22-O24 AutoBlank AutoBlank CDMC20848 3 14 14 DAC22-O24 AutoBlank AutoBlank CDMC20849 3 15 14 DAC23-C12 23-CG10757-RB_1 CG10757 ACGTCGCCTCTGAATTTTTTGAAGTAACTTCAGGTTTTATTCAATTAAAATGTTGCCGATTGCACGTGG 69 FBan0010757 FBgn0032849 mRpS18B 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18B mitochondrial ribosomal protein S18B "CG10757, CG10757, CG10757, CG10757, MRP-S18-(2), mitochondrial ribosomal protein S18b, 38B.17, mRpS18b, mitochondrial ribosomal protein S18B" CDMC20849 3 16 14 DAC23-C12 23-CG10757-RB_1 CG10757 ACGTCGCCTCTGAATTTTTTGAAGTAACTTCAGGTTTTATTCAATTAAAATGTTGCCGATTGCACGTGG 69 FBan0010757 FBgn0032849 mRpS18B 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18B mitochondrial ribosomal protein S18B "CG10757, CG10757, CG10757, CG10757, MRP-S18-(2), mitochondrial ribosomal protein S18b, 38B.17, mRpS18b, mitochondrial ribosomal protein S18B" CDMC20850 3 17 14 DAC23-C24 23-CG10778-RA_6 CG10778 GTGTAAATAGCGTATACCTGTACGTACAGATGCTACTGTTTTCCGGCCTATGCAATAAGGCTATCCGCC 69 FBan0010778 FBgn0029980 CG10778 X X metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- CG10778 CG10778 CDMC20850 3 18 14 DAC23-C24 23-CG10778-RA_6 CG10778 GTGTAAATAGCGTATACCTGTACGTACAGATGCTACTGTTTTCCGGCCTATGCAATAAGGCTATCCGCC 69 FBan0010778 FBgn0029980 CG10778 X X metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- CG10778 CG10778 CDMC20851 3 19 14 DAC23-G12 23-CG10811-RA_1 CG10811 TATGATGCCTTTGTAATACAGAAGGAATCGCTTTGTAAGTGGCGAGATTCAAAGGATCAGTCTGCTGGC 69 FBan0010811 FBgn0023213 eIF-4G 4 4 regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4G Eukaryotic-initiation-factor-4G "CG10811, CG10811, CG10811, eIF4G, translation initiation factor eIF4G, eIF4g, Eif4G" CDMC20851 3 20 14 DAC23-G12 23-CG10811-RA_1 CG10811 TATGATGCCTTTGTAATACAGAAGGAATCGCTTTGTAAGTGGCGAGATTCAAAGGATCAGTCTGCTGGC 69 FBan0010811 FBgn0023213 eIF-4G 4 4 regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4G Eukaryotic-initiation-factor-4G "CG10811, CG10811, CG10811, eIF4G, translation initiation factor eIF4G, eIF4g, Eif4G" CDMC20852 3 21 14 DAC23-G24 16-CG10823-RA_1 CG10823 AGAACAGGACGAAGGAGTAGGTTGTCCGCTAAGTGAGCACAAAGCAGTCAAAGATTTCGCACTAAACGT 69 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC20852 3 22 14 DAC23-G24 16-CG10823-RA_1 CG10823 AGAACAGGACGAAGGAGTAGGTTGTCCGCTAAGTGAGCACAAAGCAGTCAAAGATTTCGCACTAAACGT 69 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC20853 3 23 14 DAC23-K12 17-CG10851-RB_1 CG10851 GGCTGAATGTGCCGATTTGGATTCAAGGAGTACATATAGGCCACGAAATTACTGCGACTTGTACACCGG 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20853 3 24 14 DAC23-K12 17-CG10851-RB_1 CG10851 GGCTGAATGTGCCGATTTGGATTCAAGGAGTACATATAGGCCACGAAATTACTGCGACTTGTACACCGG 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20854 3 25 14 DAC23-K24 2-CG10862-RA_2 CG10862 GATCCCCTCACCATCACTAGGCTCCGTCGAGAGATCTCAGAGTTCTCAACCGATCAAACGGAAGGGTGT 69 FBan0010862 FBgn0035455 CG10862 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG10862 CG10862 CDMC20854 3 26 14 DAC23-K24 2-CG10862-RA_2 CG10862 GATCCCCTCACCATCACTAGGCTCCGTCGAGAGATCTCAGAGTTCTCAACCGATCAAACGGAAGGGTGT 69 FBan0010862 FBgn0035455 CG10862 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG10862 CG10862 CDMC20855 3 1 15 DAC23-O12 6-CG10914-RA_2 CG10914 GCGGTTTGGCCAGATTGGATCTGCTGGAAATAACAAGCCCAAGGAAACACTTTGACTGGCTGAAGGTGT 69 FBan0010914 FBgn0034307 CG10914 2 2R CG10914 CG10914 CDMC20855 3 2 15 DAC23-O12 6-CG10914-RA_2 CG10914 GCGGTTTGGCCAGATTGGATCTGCTGGAAATAACAAGCCCAAGGAAACACTTTGACTGGCTGAAGGTGT 69 FBan0010914 FBgn0034307 CG10914 2 2R CG10914 CG10914 CDMC20856 3 3 15 DAC23-O24 AutoBlank AutoBlank CDMC20856 3 4 15 DAC23-O24 AutoBlank AutoBlank CDMC20857 3 5 15 DAC24-C12 1-CG14944-RA_1 CG14944 TCCGCCGGGTATCGTCGAGCTTGAAAAAATCAGCTCTGGACTTCGCATCGCGTTTCTTCAACAAATGCA 69 FBan0014944 FBgn0032384 CG14944 2 2L CG14944 CG14944 CDMC20857 3 6 15 DAC24-C12 1-CG14944-RA_1 CG14944 TCCGCCGGGTATCGTCGAGCTTGAAAAAATCAGCTCTGGACTTCGCATCGCGTTTCTTCAACAAATGCA 69 FBan0014944 FBgn0032384 CG14944 2 2L CG14944 CG14944 CDMC20858 3 7 15 DAC24-C24 14-CG14957-RA_1 CG14957 TGCGGATGAGGCGTGTCAGAATGTGGATAAATCGGTCATAATAGCGAACCAGAATGACTCCACATGCGT 69 FBan0014957 FBgn0035412 CG14957 3 3L CG14957 CG14957 CDMC20858 3 8 15 DAC24-C24 14-CG14957-RA_1 CG14957 TGCGGATGAGGCGTGTCAGAATGTGGATAAATCGGTCATAATAGCGAACCAGAATGACTCCACATGCGT 69 FBan0014957 FBgn0035412 CG14957 3 3L CG14957 CG14957 CDMC20859 3 9 15 DAC24-G12 3-CG14982-RB_2 CG14982 TCCCCAAAGGTTTCTCCTCGGAGGTGTACCACAATAGCTTGGATATGGAAAGGGAGGCTCTGAATGCCA 69 FBan0014982 FBgn0035477 CG14982 3 3L CG14982 CG14982 CDMC20859 3 10 15 DAC24-G12 3-CG14982-RB_2 CG14982 TCCCCAAAGGTTTCTCCTCGGAGGTGTACCACAATAGCTTGGATATGGAAAGGGAGGCTCTGAATGCCA 69 FBan0014982 FBgn0035477 CG14982 3 3L CG14982 CG14982 CDMC20860 3 11 15 DAC24-G24 18-CG14995-RA_1 CG14995 AGCGGCGTTGCAAAATACAAATGACCAGGAAAACTGAACACACATAAAAGACAAGACACGAGCAGCTGT 69 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC20860 3 12 15 DAC24-G24 18-CG14995-RA_1 CG14995 AGCGGCGTTGCAAAATACAAATGACCAGGAAAACTGAACACACATAAAAGACAAGACACGAGCAGCTGT 69 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC20861 3 13 15 DAC24-K12 11-CG15018-RA_1 CG15018 AGCAGCTGTTCAACATGTTCAAGCCAATGATGTCCAAGAAAATGCAGTCTCGCCTATTTGTGCACGGCA 69 FBgn0035536 CDMC20861 3 14 15 DAC24-K12 11-CG15018-RA_1 CG15018 AGCAGCTGTTCAACATGTTCAAGCCAATGATGTCCAAGAAAATGCAGTCTCGCCTATTTGTGCACGGCA 69 FBgn0035536 CDMC20862 3 15 15 DAC24-K24 3-CG15031-RA_2 CG15031 ACCACTCGTAGCCCTCACCAAGGATCCCAAGATGAAGAAGTCACAGAAGAAGTCATCAATGGTGGCCGT 69 FBan0015031 FBgn0030623 CG15031 X X CG15031 CG15031 BcDNA:AT19571 CDMC20862 3 16 15 DAC24-K24 3-CG15031-RA_2 CG15031 ACCACTCGTAGCCCTCACCAAGGATCCCAAGATGAAGAAGTCACAGAAGAAGTCATCAATGGTGGCCGT 69 FBan0015031 FBgn0030623 CG15031 X X CG15031 CG15031 BcDNA:AT19571 CDMC20863 3 17 15 DAC24-O12 3-CG15072-RA_1 CG15072 CCAGAGGTTTTCCAAGGCTTGGAATACGATGGACCCAAGTCGGATATCTGGAGTTTGGGCGTTGTGCTG 69 FBan0015072 FBgn0034376 CG15072 2 2R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG15072 CG15072 EMK/KIAA0999 CDMC20863 3 18 15 DAC24-O12 3-CG15072-RA_1 CG15072 CCAGAGGTTTTCCAAGGCTTGGAATACGATGGACCCAAGTCGGATATCTGGAGTTTGGGCGTTGTGCTG 69 FBan0015072 FBgn0034376 CG15072 2 2R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG15072 CG15072 EMK/KIAA0999 CDMC20864 3 19 15 DAC24-O24 AutoBlank AutoBlank CDMC20864 3 20 15 DAC24-O24 AutoBlank AutoBlank CDMC20865 3 21 15 DAC25-C12 1-CG14330-RA_1 CG14330 TGCCAGCCAGTGACGTTTTTTGGGGCCAAACTGACTAATTACACCGCGACGTAATCAAGTGACACGGAT 69 FBan0014330 FBgn0038512 CG14330 3 3R CG14330 CG14330 CDMC20865 3 22 15 DAC25-C12 1-CG14330-RA_1 CG14330 TGCCAGCCAGTGACGTTTTTTGGGGCCAAACTGACTAATTACACCGCGACGTAATCAAGTGACACGGAT 69 FBan0014330 FBgn0038512 CG14330 3 3R CG14330 CG14330 CDMC20866 3 23 15 DAC25-C24 3-CG14346-RA_1 CG14346 CCCACAAGACCAAGTAGTCGCACTGAAACTCAACCTCCTCCCACGGAACTGTGTGCCTCCAAAACATTG 69 FBan0014346 FBgn0031337 CG14346 2 2L CG14346 CG14346 CDMC20866 3 24 15 DAC25-C24 3-CG14346-RA_1 CG14346 CCCACAAGACCAAGTAGTCGCACTGAAACTCAACCTCCTCCCACGGAACTGTGTGCCTCCAAAACATTG 69 FBan0014346 FBgn0031337 CG14346 2 2L CG14346 CG14346 CDMC20867 3 25 15 DAC25-G12 1-CG14391-RA_1 CG14391 TCCCCTGATTCCGAACAAGAGCATGTTTTTGGGTGGTAGCATTCCCATGGGGTCACAAACATCCCAAGT 69 FBan0014391 FBgn0038078 CG14391 3 3R CG14391 CG14391 BcDNA:AT22529 CDMC20867 3 26 15 DAC25-G12 1-CG14391-RA_1 CG14391 TCCCCTGATTCCGAACAAGAGCATGTTTTTGGGTGGTAGCATTCCCATGGGGTCACAAACATCCCAAGT 69 FBan0014391 FBgn0038078 CG14391 3 3R CG14391 CG14391 BcDNA:AT22529 CDMC20868 3 1 16 DAC25-G24 13-CG14406-RA_1 CG14406 GCTGCAAGCAGAACCGTATTTGGTGATGATCAATTGCCCATCAACGATCCATCGGATCTAAGTGCTGGT 69 FBan0014406 FBgn0030595 CG14406 X X CG14406 CG14406 CDMC20868 3 2 16 DAC25-G24 13-CG14406-RA_1 CG14406 GCTGCAAGCAGAACCGTATTTGGTGATGATCAATTGCCCATCAACGATCCATCGGATCTAAGTGCTGGT 69 FBan0014406 FBgn0030595 CG14406 X X CG14406 CG14406 CDMC20869 3 3 16 DAC25-K12 2-CG14444-RA_4 CG14444 GCCTCTACTACAACGGCGATTACTTTCAAGCGGAGGATATCTTCTCGTCGACGCTGTGTGCCAATCCGG 69 FBan0014444 FBgn0029879 APC7 X X cell cycle; GO:0007049; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC7 Anaphase Promoting Complex 7 "CG14444, CG14444, Anaphase Promoting Complex 7" CDMC20869 3 4 16 DAC25-K12 2-CG14444-RA_4 CG14444 GCCTCTACTACAACGGCGATTACTTTCAAGCGGAGGATATCTTCTCGTCGACGCTGTGTGCCAATCCGG 69 FBan0014444 FBgn0029879 APC7 X X cell cycle; GO:0007049; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC7 Anaphase Promoting Complex 7 "CG14444, CG14444, Anaphase Promoting Complex 7" CDMC20870 3 5 16 DAC25-K24 3-CG14458-RA_3 CG14458 AGGAGTCGATATATCGACGGTGGTTTACGTCCATGCTGAAGGTGGGAAACTTCGCTACGAGCTGTCCCA 69 FBgn0037173 CDMC20870 3 6 16 DAC25-K24 3-CG14458-RA_3 CG14458 AGGAGTCGATATATCGACGGTGGTTTACGTCCATGCTGAAGGTGGGAAACTTCGCTACGAGCTGTCCCA 69 FBgn0037173 CDMC20871 3 7 16 DAC25-O12 8-CG14508-RA_1 CG14508 AACATATTTCCCCAAGTGGTGACAACCCCAGTCGACAGAGCTTTCCAACACTGGTTGCGTTGACATTGT 69 FBan0014508 FBgn0039651 CG14508 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14508 CG14508 CDMC20871 3 8 16 DAC25-O12 8-CG14508-RA_1 CG14508 AACATATTTCCCCAAGTGGTGACAACCCCAGTCGACAGAGCTTTCCAACACTGGTTGCGTTGACATTGT 69 FBan0014508 FBgn0039651 CG14508 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14508 CG14508 CDMC20872 3 9 16 DAC25-O24 AutoBlank AutoBlank CDMC20872 3 10 16 DAC25-O24 AutoBlank AutoBlank CDMC20873 3 11 16 DAC26-C12 3-CG4734-RA_2 CG4734 AGCACGCCACCTACTTCTGTGGCTCCATTAAGAAGGATGTGGTCATATCGAGCAACAATCCCGGTCCTT 69 FBan0004734 FBgn0033826 CG4734 2 2R CG4734 CG4734 CDMC20873 3 12 16 DAC26-C12 3-CG4734-RA_2 CG4734 AGCACGCCACCTACTTCTGTGGCTCCATTAAGAAGGATGTGGTCATATCGAGCAACAATCCCGGTCCTT 69 FBan0004734 FBgn0033826 CG4734 2 2R CG4734 CG4734 CDMC20874 3 13 16 DAC26-C24 12-CG4744-RA_2 CG4744 TCCTTGCCGAGGATTTCAGTCAGGATGTGCGATTGCTCGATCCGAGTAAGATCAGCCAAAAGTCGAGAA 69 FBan0004744 FBgn0033834 CG4744 2 2R CG4744 CG4744 CDMC20874 3 14 16 DAC26-C24 12-CG4744-RA_2 CG4744 TCCTTGCCGAGGATTTCAGTCAGGATGTGCGATTGCTCGATCCGAGTAAGATCAGCCAAAAGTCGAGAA 69 FBan0004744 FBgn0033834 CG4744 2 2R CG4744 CG4744 CDMC20875 3 15 16 DAC26-G12 23-CG4769-RA_2 CG4769 CGCAACCACCAAGTCAATGTTCTCTCCGCTGAAAAATATAAACACAAATACTATCCCAATATGCGAGAG 69 FBan0004769 FBgn0035600 CG4769 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4769 CG4769 anon-EST:Posey141 CDMC20875 3 16 16 DAC26-G12 23-CG4769-RA_2 CG4769 CGCAACCACCAAGTCAATGTTCTCTCCGCTGAAAAATATAAACACAAATACTATCCCAATATGCGAGAG 69 FBan0004769 FBgn0035600 CG4769 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4769 CG4769 anon-EST:Posey141 CDMC20876 3 17 16 DAC26-G24 10-CG4779-RA_1 CG4779 TGGTGATTAACTCGGTTAGCTTTGACCATTGTGACCCCAGCATTTTTACCGTGCTCACTTGTCCCAGCT 69 FBan0004779 FBgn0040211 hgo 2 2L L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 "homogentisate 1,2-dioxygenase activity; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5" hgo "homogentisate 1,2-dioxygenase" "CG4779, homogentisate 1,2-dioxygenase" CDMC20876 3 18 16 DAC26-G24 10-CG4779-RA_1 CG4779 TGGTGATTAACTCGGTTAGCTTTGACCATTGTGACCCCAGCATTTTTACCGTGCTCACTTGTCCCAGCT 69 FBan0004779 FBgn0040211 hgo 2 2L L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 "homogentisate 1,2-dioxygenase activity; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5" hgo "homogentisate 1,2-dioxygenase" "CG4779, homogentisate 1,2-dioxygenase" CDMC20877 3 19 16 DAC26-K12 9-CG4807-RA_2 CG4807 CCCCGAAACGAACCTCAGACTTCCATGAGTTGTGACTGGTCCTGCACTCCATCTTCATGAAACTTGCCA 69 FBan0004807 FBgn0000011 ab 2 2L axon choice point recognition; GO:0016198; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ab abrupt "CG4807, CG4807, clu: clueless, clueless, l(2)k02807, ptd, parted, clu" CDMC20877 3 20 16 DAC26-K12 9-CG4807-RA_2 CG4807 CCCCGAAACGAACCTCAGACTTCCATGAGTTGTGACTGGTCCTGCACTCCATCTTCATGAAACTTGCCA 69 FBan0004807 FBgn0000011 ab 2 2L axon choice point recognition; GO:0016198; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ab abrupt "CG4807, CG4807, clu: clueless, clueless, l(2)k02807, ptd, parted, clu" CDMC20878 3 21 16 DAC26-K24 3-CG4817-RA_1 CG4817 GCGGATCCACGCGATCTTTCGACTTCGAAGTGACGCTCAAGAACGGAACTGTTCACATCTTCTCCTCCA 69 FBan0004817 FBgn0010278 Ssrp 2 2R regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; single-stranded RNA binding; GO:0003727; ; GO:0003697; ; GO:0003727; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; DNA secondary structure binding; GO:0000217; ; GO:0000217; ; GO:0003697; ; GO:0005515 FACT complex; GO:0035101; nucleolus; GO:0005730; nucleus; GO:0005634 Ssrp Structure specific recognition protein "CG4817, DssRP, SSRP1, dSSRP, SSRP, dSSRP1, Cf5: Chorion factor, Chorion factor" CDMC20878 3 22 16 DAC26-K24 3-CG4817-RA_1 CG4817 GCGGATCCACGCGATCTTTCGACTTCGAAGTGACGCTCAAGAACGGAACTGTTCACATCTTCTCCTCCA 69 FBan0004817 FBgn0010278 Ssrp 2 2R regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; single-stranded RNA binding; GO:0003727; ; GO:0003697; ; GO:0003727; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; DNA secondary structure binding; GO:0000217; ; GO:0000217; ; GO:0003697; ; GO:0005515 FACT complex; GO:0035101; nucleolus; GO:0005730; nucleus; GO:0005634 Ssrp Structure specific recognition protein "CG4817, DssRP, SSRP1, dSSRP, SSRP, dSSRP1, Cf5: Chorion factor, Chorion factor" CDMC20879 3 23 16 DAC26-O12 11-CG4857-RB_1 CG4857 TCGGCAGCAATCTAACGAGAGCATCCAACGTCGGCTGAAATCAGGAGAGCAGATTGGTTGGAATAGAGT 69 FBan0004857 FBgn0026083 CG4857 X X CG4857 CG4857 "EG:EG0007.12, EG:EG0007.4" CDMC20879 3 24 16 DAC26-O12 11-CG4857-RB_1 CG4857 TCGGCAGCAATCTAACGAGAGCATCCAACGTCGGCTGAAATCAGGAGAGCAGATTGGTTGGAATAGAGT 69 FBan0004857 FBgn0026083 CG4857 X X CG4857 CG4857 "EG:EG0007.12, EG:EG0007.4" CDMC20880 3 25 16 DAC26-O24 1-CG4863-RC_1 CG4863 CGCGGCTAAGAAGTTGGAGTTGTTGCGACACCCCAATGGATTGCTACATTACGCTCGTTTCTGACCACT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC20880 3 26 16 DAC26-O24 1-CG4863-RC_1 CG4863 CGCGGCTAAGAAGTTGGAGTTGTTGCGACACCCCAATGGATTGCTACATTACGCTCGTTTCTGACCACT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC20881 3 1 17 DAC27-C12 6-CG3499-RB_1 CG3499 AGGCGCTTCTCAAGTACGAGACTCTTGACGCCGACGACATCAAGGCAATACTGAATGAAAGCCAGACGT 69 FBan0003499 FBgn0034792 CG3499 2 2R mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATP-dependent peptidase activity; GO:0004176; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004176; ; GO:0004222 ; EC:3.4.24.- mitochondrial inner membrane; GO:0005743 CG3499 CG3499 DmCG3499 CDMC20881 3 2 17 DAC27-C12 6-CG3499-RB_1 CG3499 AGGCGCTTCTCAAGTACGAGACTCTTGACGCCGACGACATCAAGGCAATACTGAATGAAAGCCAGACGT 69 FBan0003499 FBgn0034792 CG3499 2 2R mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATP-dependent peptidase activity; GO:0004176; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004176; ; GO:0004222 ; EC:3.4.24.- mitochondrial inner membrane; GO:0005743 CG3499 CG3499 DmCG3499 CDMC20882 3 3 17 DAC27-C24 2-CG3510-RA_1 CG3510 ACCTGCATCACCCATCCCTAAGATATCGTAATCTGCTGGAGTCCCTTGAGCAGTTTTCGGCTACTGCCA 69 FBan0003510 FBgn0000405 CycB 2 2R G2/M transition of mitotic cell cycle; GO:0000086; attachment of spindle microtubules to kinetochore; GO:0008608; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; cytokinesis after mitosis; GO:0000281; embryonic development (sensu Insecta); GO:0001700; mitotic anaphase B; GO:0000092; mitotic chromosome movement towards spindle pole; GO:0007079; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- "chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; pole plasm; GO:0045495; spindle; GO:0005819" CycB Cyclin B "CG3510, CG3510, CG3510, cycB, cyclinB, cyc-B, cyclin B, Cyclin-B, 2g, CyclinB, cyc B, mAbF2F4, DmcycB, Cyclin B" CDMC20882 3 4 17 DAC27-C24 2-CG3510-RA_1 CG3510 ACCTGCATCACCCATCCCTAAGATATCGTAATCTGCTGGAGTCCCTTGAGCAGTTTTCGGCTACTGCCA 69 FBan0003510 FBgn0000405 CycB 2 2R G2/M transition of mitotic cell cycle; GO:0000086; attachment of spindle microtubules to kinetochore; GO:0008608; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; cytokinesis after mitosis; GO:0000281; embryonic development (sensu Insecta); GO:0001700; mitotic anaphase B; GO:0000092; mitotic chromosome movement towards spindle pole; GO:0007079; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- "chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; pole plasm; GO:0045495; spindle; GO:0005819" CycB Cyclin B "CG3510, CG3510, CG3510, cycB, cyclinB, cyc-B, cyclin B, Cyclin-B, 2g, CyclinB, cyc B, mAbF2F4, DmcycB, Cyclin B" CDMC20883 3 5 17 DAC27-G12 14-CG3548-RA_1 CG3548 GCCGGACGCGCATACAATACTCATCGACACACTCAAGTTGCCACTCGGACGAATGGACTGTTGTTTATT 69 FBan0003548 FBgn0035033 CG3548 2 2R CG3548 CG3548 CDMC20883 3 6 17 DAC27-G12 14-CG3548-RA_1 CG3548 GCCGGACGCGCATACAATACTCATCGACACACTCAAGTTGCCACTCGGACGAATGGACTGTTGTTTATT 69 FBan0003548 FBgn0035033 CG3548 2 2R CG3548 CG3548 CDMC20884 3 7 17 DAC27-G24 9-CG3568-RA_7 CG3568 CGCTAACGACTATTACCGTACAATGCAGGGAAATATTGGTAACGAGGGCTTCGAGGCAGTGGGTACGCC 69 FBan0003568 FBgn0029710 CG3568 X X CG3568 CG3568 CDMC20884 3 8 17 DAC27-G24 9-CG3568-RA_7 CG3568 CGCTAACGACTATTACCGTACAATGCAGGGAAATATTGGTAACGAGGGCTTCGAGGCAGTGGGTACGCC 69 FBan0003568 FBgn0029710 CG3568 X X CG3568 CG3568 CDMC20885 3 9 17 DAC27-K12 3-CG3606-RA_1 CG3606 TCGACCACCGAGCAGGACATTGAGACACACTTTGGAGCAATTGGCATCATCAAGGCAAACAAGCGTACA 69 FBan0003606 FBgn0011571 caz X X transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; ; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 caz cabeza "CG3606, CG3606, p19, P19, SARFH, Sarcoma-associated RNA-binding fly homolog, cas, TFIID, BcDNA:GM09207, Pen19, Sarfh: Sarcoma-associated RNA-binding fly homolog, anon-Pen19, pen19, cabeza" CDMC20885 3 10 17 DAC27-K12 3-CG3606-RA_1 CG3606 TCGACCACCGAGCAGGACATTGAGACACACTTTGGAGCAATTGGCATCATCAAGGCAAACAAGCGTACA 69 FBan0003606 FBgn0011571 caz X X transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; ; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 caz cabeza "CG3606, CG3606, p19, P19, SARFH, Sarcoma-associated RNA-binding fly homolog, cas, TFIID, BcDNA:GM09207, Pen19, Sarfh: Sarcoma-associated RNA-binding fly homolog, anon-Pen19, pen19, cabeza" CDMC20886 3 11 17 DAC27-K24 2-CG3618-RA_1 CG3618 TGGATCTGGTGGCATAAGGAGCGATCAGCCCGAAAAGTTGATGCCTATGACTTCCCAGTTATCCTGCCT 69 FBan0003618 FBgn0037028 CG3618 3 3L actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 CG3618 CG3618 GYCb100B CDMC20886 3 12 17 DAC27-K24 2-CG3618-RA_1 CG3618 TGGATCTGGTGGCATAAGGAGCGATCAGCCCGAAAAGTTGATGCCTATGACTTCCCAGTTATCCTGCCT 69 FBan0003618 FBgn0037028 CG3618 3 3L actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 CG3618 CG3618 GYCb100B CDMC20887 3 13 17 DAC27-O12 3-CG3664-RB_1 CG3664 AGCATAAGGCCGACTGGAACCGAAACAAATCGACCGACGAACAACTGCTGCAAGTGATGTCCCTTCGTA 69 FBan0003664 FBgn0014010 Rab5 2 2L cellularization (sensu Metazoa); GO:0009796; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; regulation of synapse structure and function; GO:0050803; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle to endosome fusion; GO:0016189 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 early endosome; GO:0005769; plasma membrane; GO:0005886 Rab5 Rab-protein 5 "CG3664, CG3664, CG3664, l(2)k08232, Drab5, DRab5, rab5, DmRab5, AAF51265, BAA88244, Rab, Dm Rab5" CDMC20887 3 14 17 DAC27-O12 3-CG3664-RB_1 CG3664 AGCATAAGGCCGACTGGAACCGAAACAAATCGACCGACGAACAACTGCTGCAAGTGATGTCCCTTCGTA 69 FBan0003664 FBgn0014010 Rab5 2 2L cellularization (sensu Metazoa); GO:0009796; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; regulation of synapse structure and function; GO:0050803; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle to endosome fusion; GO:0016189 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 early endosome; GO:0005769; plasma membrane; GO:0005886 Rab5 Rab-protein 5 "CG3664, CG3664, CG3664, l(2)k08232, Drab5, DRab5, rab5, DmRab5, AAF51265, BAA88244, Rab, Dm Rab5" CDMC20888 3 15 17 DAC27-O24 2-CG3671-RC_1 CG3671 CGTTCACGTTCCTGTTTCTGGACAAGTACGGTCTACGCAAGCTGGAGTTCCTATTCGGCACCCTCATCA 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC20888 3 16 17 DAC27-O24 2-CG3671-RC_1 CG3671 CGTTCACGTTCCTGTTTCTGGACAAGTACGGTCTACGCAAGCTGGAGTTCCTATTCGGCACCCTCATCA 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC20889 3 17 17 DAC28-C12 16-CG14763-RA_1 CG14763 AGCGAGGAAATCAAGAACCGCATCAAACTCGACAACTACGACAGATATCGCTACATAGTGCTGGTCACT 69 FBan0014763 FBgn0033243 CG14763 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG14763 CG14763 CDMC20889 3 18 17 DAC28-C12 16-CG14763-RA_1 CG14763 AGCGAGGAAATCAAGAACCGCATCAAACTCGACAACTACGACAGATATCGCTACATAGTGCTGGTCACT 69 FBan0014763 FBgn0033243 CG14763 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG14763 CG14763 CDMC20890 3 19 17 DAC28-C24 5-CG14789-RA_1 CG14789 CGACAGCGAGGAAGATTCCGACCCGTACTGATCCATCTGTAGCTCCCACCTGACATCTCAAGACCTAGT 69 FBan0014789 FBgn0027791 O-fut2 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0004812 ; EC:6.1.1.- O-fut2 O-fucosyltransferase 2 "CG14789, CG14789, CG14789, EG:BACN32G11.6, O-FUT2, O-fucosyltransferase 2" CDMC20890 3 20 17 DAC28-C24 5-CG14789-RA_1 CG14789 CGACAGCGAGGAAGATTCCGACCCGTACTGATCCATCTGTAGCTCCCACCTGACATCTCAAGACCTAGT 69 FBan0014789 FBgn0027791 O-fut2 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0004812 ; EC:6.1.1.- O-fut2 O-fucosyltransferase 2 "CG14789, CG14789, CG14789, EG:BACN32G11.6, O-FUT2, O-fucosyltransferase 2" CDMC20891 3 21 17 DAC28-G12 23-CG14823-RC_1 CG14823 GCTGACTGATTAGAATTGCCATTAGATGAACCAGCAGATTTCAACGTTTCGAAATTATAGCGATAATAA 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC20891 3 22 17 DAC28-G12 23-CG14823-RC_1 CG14823 GCTGACTGATTAGAATTGCCATTAGATGAACCAGCAGATTTCAACGTTTCGAAATTATAGCGATAATAA 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC20892 3 23 17 DAC28-G24 5-CG14835-RA_1 CG14835 GCGAAGTCCAGGGATTGGAAGTACCAGGTGTACCAGGTATACATCCCAATTTCACTGGGAAAACCCGCC 69 FBan0014835 FBgn0035782 CG14835 3 3L CG14835 CG14835 CDMC20892 3 24 17 DAC28-G24 5-CG14835-RA_1 CG14835 GCGAAGTCCAGGGATTGGAAGTACCAGGTGTACCAGGTATACATCCCAATTTCACTGGGAAAACCCGCC 69 FBan0014835 FBgn0035782 CG14835 3 3L CG14835 CG14835 CDMC20893 3 25 17 DAC28-K12 6-CG14876-RA_1 CG14876 TGTTGGCTCTTTCCACGATTCCACTGCGCATGGACCAACAAATCCAGTGCATCAAGACAATTCAGCAGG 69 FBan0014876 FBgn0038368 CG14876 3 3R CG14876 CG14876 CDMC20893 3 26 17 DAC28-K12 6-CG14876-RA_1 CG14876 TGTTGGCTCTTTCCACGATTCCACTGCGCATGGACCAACAAATCCAGTGCATCAAGACAATTCAGCAGG 69 FBan0014876 FBgn0038368 CG14876 3 3R CG14876 CG14876 CDMC20894 3 1 18 DAC28-K24 23-CG14883-RA_15 CG14883 CTCACCCAACGAGAAAAGATACTTCCAAAAGACCATGAAGATCCAGTACCTTACAGACTCGTTGCGGTC 69 FBan0014883 FBgn0038432 CG14883 3 3R CG14883 CG14883 CDMC20894 3 2 18 DAC28-K24 23-CG14883-RA_15 CG14883 CTCACCCAACGAGAAAAGATACTTCCAAAAGACCATGAAGATCCAGTACCTTACAGACTCGTTGCGGTC 69 FBan0014883 FBgn0038432 CG14883 3 3R CG14883 CG14883 CDMC20895 3 3 18 DAC28-O12 9-CG14905-RA_1 CG14905 ACGCCGGGTCAACCTGATCATCAGCGCCATCAATATCGAGGATAACTCCAACAAAATACTGGCCCGAAA 69 FBan0014905 FBgn0038452 CG14905 3 3R CG14905 CG14905 CDMC20895 3 4 18 DAC28-O12 9-CG14905-RA_1 CG14905 ACGCCGGGTCAACCTGATCATCAGCGCCATCAATATCGAGGATAACTCCAACAAAATACTGGCCCGAAA 69 FBan0014905 FBgn0038452 CG14905 3 3R CG14905 CG14905 CDMC20896 3 5 18 DAC28-O24 AutoBlank AutoBlank CDMC20896 3 6 18 DAC28-O24 AutoBlank AutoBlank CDMC20897 3 7 18 DAC29-C12 16-CG6405-RA_1 CG6405 ACGAGCGCATAAACATAACAGAAAGGCATCTAATGGAGATGTGCTCTTCGTTTGCTTTGGTAACGCGGA 69 FBan0006405 FBgn0032428 CG6405 2 2L CG6405 CG6405 CDMC20897 3 8 18 DAC29-C12 16-CG6405-RA_1 CG6405 ACGAGCGCATAAACATAACAGAAAGGCATCTAATGGAGATGTGCTCTTCGTTTGCTTTGGTAACGCGGA 69 FBan0006405 FBgn0032428 CG6405 2 2L CG6405 CG6405 CDMC20898 3 9 18 DAC29-C24 23-CG6416-RH_2 CG6416 AACACACACATTGCAAAAATGGAGTACGTTCAGTTCAAAAACGGATCCCCAGTCTACTACAAGGAGCAG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC20898 3 10 18 DAC29-C24 23-CG6416-RH_2 CG6416 AACACACACATTGCAAAAATGGAGTACGTTCAGTTCAAAAACGGATCCCCAGTCTACTACAAGGAGCAG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC20899 3 11 18 DAC29-G12 3-CG6451-RA_2 CG6451 CGTGGGAGTCACTCCGTCCGCTACTCTCAACGAGTCGTCTGTTCATCTGCTAAACGATCTCTGCTGGTT 69 FBan0006451 FBgn0041161 blue 3 3L oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 blue bluestreak "CG6451, CG6451, bls, bluestreak" CDMC20899 3 12 18 DAC29-G12 3-CG6451-RA_2 CG6451 CGTGGGAGTCACTCCGTCCGCTACTCTCAACGAGTCGTCTGTTCATCTGCTAAACGATCTCTGCTGGTT 69 FBan0006451 FBgn0041161 blue 3 3L oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 blue bluestreak "CG6451, CG6451, bls, bluestreak" CDMC20900 3 13 18 DAC29-G24 2-CG6461-RA_1 CG6461 TGGAGAGCGTAAGGAAGCTGATCCACGACAATAGCACTTCGGAGGACTACCTCTACTATGGCGCCAACT 69 FBan0006461 FBgn0030932 CG6461 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG6461 CG6461 CDMC20900 3 14 18 DAC29-G24 2-CG6461-RA_1 CG6461 TGGAGAGCGTAAGGAAGCTGATCCACGACAATAGCACTTCGGAGGACTACCTCTACTATGGCGCCAACT 69 FBan0006461 FBgn0030932 CG6461 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG6461 CG6461 CDMC20901 3 15 18 DAC29-K12 3-CG6502-RA_1 CG6502 CCGAGAGCGTTTCCCGGGAAAGGACTATGCACTCCTTTCACACGCTCTTCTGTCGTCGTTGCTTCAAAT 69 FBan0006502 FBgn0000629 E(z) 3 3L chromatin silencing; GO:0006342; histone methylation; GO:0016571; pheromone metabolism; GO:0042810; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ; GO:0046976; protein binding; GO:0005515; ; GO:0042054; ; GO:0003712; ; GO:0005515; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0046976 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 E(z) Enhancer of zeste "CG6502, l(3)1902, Su(z)301, pco: polycombeotic, l(3)67Fa, polycombeotic, E(z)1, E[z], Ez, E(Z), EZ, enhancer of zeste, Enhancer-of-zeste, l(3)B12, l(3)SG17, l(3)ds12, pco/E(z), pco" CDMC20901 3 16 18 DAC29-K12 3-CG6502-RA_1 CG6502 CCGAGAGCGTTTCCCGGGAAAGGACTATGCACTCCTTTCACACGCTCTTCTGTCGTCGTTGCTTCAAAT 69 FBan0006502 FBgn0000629 E(z) 3 3L chromatin silencing; GO:0006342; histone methylation; GO:0016571; pheromone metabolism; GO:0042810; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ; GO:0046976; protein binding; GO:0005515; ; GO:0042054; ; GO:0003712; ; GO:0005515; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0046976 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 E(z) Enhancer of zeste "CG6502, l(3)1902, Su(z)301, pco: polycombeotic, l(3)67Fa, polycombeotic, E(z)1, E[z], Ez, E(Z), EZ, enhancer of zeste, Enhancer-of-zeste, l(3)B12, l(3)SG17, l(3)ds12, pco/E(z), pco" CDMC20902 3 17 18 DAC29-K24 3-CG6513-RA_1 CG6513 AGTCGGCACGCTAATTGGCAAAACCGATTCGATTCCAGGGAAGGAGACACACTGATAGACGGGTGAAGA 69 FBgn0036401 CDMC20902 3 18 18 DAC29-K24 3-CG6513-RA_1 CG6513 AGTCGGCACGCTAATTGGCAAAACCGATTCGATTCCAGGGAAGGAGACACACTGATAGACGGGTGAAGA 69 FBgn0036401 CDMC20903 3 19 18 DAC29-O12 3-CG6549-RC_8 CG6549 ACGGCTCTCGAGCAGATCAACCAGTTTGGCTATACATCAGAATCATCGGATCAGTGCATTCCGCAGCGT 69 FBan0006549 FBgn0024689 fws 2 2L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; intracellular protein transport; GO:0006886; meiotic spindle stabilization; GO:0043147; membrane organization and biogenesis; GO:0016044; protein biosynthesis; GO:0006412; vesicle-mediated transport; GO:0016192" structural constituent of ribosome; GO:0003735; ; GO:0003735 Golgi transport complex; GO:0017119; ribosome; GO:0005840 fws four way stop "CG6549, CG6549, CG6549, Drosophila Cog5, dCOG5, anon-EST:Posey162, anon-EST:Posey186, four way stop" CDMC20903 3 20 18 DAC29-O12 3-CG6549-RC_8 CG6549 ACGGCTCTCGAGCAGATCAACCAGTTTGGCTATACATCAGAATCATCGGATCAGTGCATTCCGCAGCGT 69 FBan0006549 FBgn0024689 fws 2 2L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; intracellular protein transport; GO:0006886; meiotic spindle stabilization; GO:0043147; membrane organization and biogenesis; GO:0016044; protein biosynthesis; GO:0006412; vesicle-mediated transport; GO:0016192" structural constituent of ribosome; GO:0003735; ; GO:0003735 Golgi transport complex; GO:0017119; ribosome; GO:0005840 fws four way stop "CG6549, CG6549, CG6549, Drosophila Cog5, dCOG5, anon-EST:Posey162, anon-EST:Posey186, four way stop" CDMC20904 3 21 18 DAC29-O24 6-CG6560-RA_1 CG6560 CCCGAGGCGGGTAGTGAACTATTCGAAATGCTCATGGACAATCGGTTGAAGCAAGTTCCCGTGCTGATT 69 FBan0006560 FBgn0038916 CG6560 3 3R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG6560 CG6560 CDMC20904 3 22 18 DAC29-O24 6-CG6560-RA_1 CG6560 CCCGAGGCGGGTAGTGAACTATTCGAAATGCTCATGGACAATCGGTTGAAGCAAGTTCCCGTGCTGATT 69 FBan0006560 FBgn0038916 CG6560 3 3R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG6560 CG6560 CDMC20905 3 23 18 DAC30-C12 2-CG4016-RB_1 CG4016 TGGCCTTGCGTCAGAAGTACAAGCTGCGTTTGTTCATCGACGAAAGCATCTCCTTTGGCACATTGGG 67 FBan0004016 FBgn0033800 Spt-I 2 2R lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50 serine C-palmitoyltransferase complex; GO:0017059 Spt-I Serine palmitoyltransferase subunit I "CG4016, CG4016, SPT-I, lcb1, Serine palmitoyltransferase subunit I" CDMC20905 3 24 18 DAC30-C12 2-CG4016-RB_1 CG4016 TGGCCTTGCGTCAGAAGTACAAGCTGCGTTTGTTCATCGACGAAAGCATCTCCTTTGGCACATTGGG 67 FBan0004016 FBgn0033800 Spt-I 2 2R lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50 serine C-palmitoyltransferase complex; GO:0017059 Spt-I Serine palmitoyltransferase subunit I "CG4016, CG4016, SPT-I, lcb1, Serine palmitoyltransferase subunit I" CDMC20906 3 25 18 DAC30-C24 1-CG40354-RA_1 CG40354 CGTCTACTCCACCAATGTGACTCGCAATACTCAAAAATCGAGGAGCTCTGCACAGGTGCCGCCAACT 67 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC20906 3 26 18 DAC30-C24 1-CG40354-RA_1 CG40354 CGTCTACTCCACCAATGTGACTCGCAATACTCAAAAATCGAGGAGCTCTGCACAGGTGCCGCCAACT 67 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC20907 3 1 19 DAC30-G12 8-CG4338-RA_3 CG4338 GCCATAGCCGCCACTCTATACATCTGTGGATTCACGGAAGAGGCTCGCTGGTTTCTGGGCAAGTTCT 67 FBan0004338 FBgn0038313 CG4338 3 3R CG4338 CG4338 CDMC20907 3 2 19 DAC30-G12 8-CG4338-RA_3 CG4338 GCCATAGCCGCCACTCTATACATCTGTGGATTCACGGAAGAGGCTCGCTGGTTTCTGGGCAAGTTCT 67 FBan0004338 FBgn0038313 CG4338 3 3R CG4338 CG4338 CDMC20908 3 3 19 DAC30-G24 2-CG4509-RB_8 CG4509 GTGTCCATCTCGAAGTACGAGTCCACGGTGACAGAGAATGGCAGGAAGCTCATGTCCACCTCAACGG 67 FBan0004509 FBgn0037840 CG4509 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; transport; GO:0006810 transporter activity; GO:0005215; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005215 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG4509 CG4509 "CG33112, CG31393, CG31425, CT14654, DCad86C" CDMC20908 3 4 19 DAC30-G24 2-CG4509-RB_8 CG4509 GTGTCCATCTCGAAGTACGAGTCCACGGTGACAGAGAATGGCAGGAAGCTCATGTCCACCTCAACGG 67 FBan0004509 FBgn0037840 CG4509 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; transport; GO:0006810 transporter activity; GO:0005215; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005215 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG4509 CG4509 "CG33112, CG31393, CG31425, CT14654, DCad86C" CDMC20909 3 5 19 DAC30-K12 2-CG5003-RA_2 CG5003 CCGCGTCCGAACTACGATCAGGTTGTTCAGCATCCGATGTTTTGGAACATGCTCGAGCCACTGGATC 67 FBan0005003 FBgn0039554 CG5003 3 3R CG5003 CG5003 CDMC20909 3 6 19 DAC30-K12 2-CG5003-RA_2 CG5003 CCGCGTCCGAACTACGATCAGGTTGTTCAGCATCCGATGTTTTGGAACATGCTCGAGCCACTGGATC 67 FBan0005003 FBgn0039554 CG5003 3 3R CG5003 CG5003 CDMC20910 3 7 19 DAC30-K24 3-CG5155-RA_4 CG5155 ACCGAGGGCATGATTCCCGACATTGTGAGCCATCTGAGTTCCGAAAATACCGAGCTGAAGATGGAGG 67 FBan0005155 FBgn0031905 CG5155 2 2L CG5155 CG5155 CDMC20910 3 8 19 DAC30-K24 3-CG5155-RA_4 CG5155 ACCGAGGGCATGATTCCCGACATTGTGAGCCATCTGAGTTCCGAAAATACCGAGCTGAAGATGGAGG 67 FBan0005155 FBgn0031905 CG5155 2 2L CG5155 CG5155 CDMC20911 3 9 19 DAC30-O12 23-CG5626-RA_11 CG5626 ACGTATGGCTGTGGAAAAACCAATCGAAGAACCTGCTAGTAAAAAAGAAAAATTCTCCACAACGGGC 67 FBan0005626 FBgn0036266 CG5626 3 3L tRNA splicing; GO:0006388 adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG5626 CG5626 CDMC20911 3 10 19 DAC30-O12 23-CG5626-RA_11 CG5626 ACGTATGGCTGTGGAAAAACCAATCGAAGAACCTGCTAGTAAAAAAGAAAAATTCTCCACAACGGGC 67 FBan0005626 FBgn0036266 CG5626 3 3L tRNA splicing; GO:0006388 adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG5626 CG5626 CDMC20912 3 11 19 DAC30-O24 AutoBlank AutoBlank CDMC20912 3 12 19 DAC30-O24 AutoBlank AutoBlank CDMC20913 3 13 19 DAC31-C12 12-CG7499-RA_1 CG7499 GGTGCCGTTTTGAAGTACACCAACTTCCGGAACCTGAAGAAGGACGAACATCACCAGGACGAGCACTAC 69 FBan0007499 FBgn0028699 Rh50 3 3L Rh50 Rh50 "CG7499, BcDNA:GH03016, Rh-like" CDMC20913 3 14 19 DAC31-C12 12-CG7499-RA_1 CG7499 GGTGCCGTTTTGAAGTACACCAACTTCCGGAACCTGAAGAAGGACGAACATCACCAGGACGAGCACTAC 69 FBan0007499 FBgn0028699 Rh50 3 3L Rh50 Rh50 "CG7499, BcDNA:GH03016, Rh-like" CDMC20914 3 15 19 DAC31-C24 9-CG7514-RA_1 CG7514 GGCCATGGCGTACAGCATCGAAAAGAAATCCATACCCGGCTACATGATGTACATTAATGGCGGTCTGGC 69 FBan0007514 FBgn0035567 CG7514 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG7514 CG7514 CDMC20914 3 16 19 DAC31-C24 9-CG7514-RA_1 CG7514 GGCCATGGCGTACAGCATCGAAAAGAAATCCATACCCGGCTACATGATGTACATTAATGGCGGTCTGGC 69 FBan0007514 FBgn0035567 CG7514 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG7514 CG7514 CDMC20915 3 17 19 DAC31-G12 3-CG7548-RA_1 CG7548 CCAGCTCCGGTTTACACGCACCAGGCTCATCAGGAACCAAAAAATCTGTTTACTCAGGCATCGCCAGTT 69 FBan0007548 FBgn0035792 CG7548 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7548 CG7548 CDMC20915 3 18 19 DAC31-G12 3-CG7548-RA_1 CG7548 CCAGCTCCGGTTTACACGCACCAGGCTCATCAGGAACCAAAAAATCTGTTTACTCAGGCATCGCCAGTT 69 FBan0007548 FBgn0035792 CG7548 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7548 CG7548 CDMC20916 3 19 19 DAC31-G24 1-CG7557-RA_1 CG7557 CCCTGGCCAAGAAATGCTCACTCCTACTCCTGGAGCACACAAGTGTCGGATGAAGCGAGTAAATTCCGA 69 FBan0007557 FBgn0036159 CG7557 3 3L CG7557 CG7557 anon-WO0140519.44 CDMC20916 3 20 19 DAC31-G24 1-CG7557-RA_1 CG7557 CCCTGGCCAAGAAATGCTCACTCCTACTCCTGGAGCACACAAGTGTCGGATGAAGCGAGTAAATTCCGA 69 FBan0007557 FBgn0036159 CG7557 3 3L CG7557 CG7557 anon-WO0140519.44 CDMC20917 3 21 19 DAC31-K12 17-CG7589-RA_1 CG7589 CGCTGAGCTTTACGGTCAATCTGAAGCGAGAAATTGGCTTCTATTTGCTCGACTATTACCTGCCCTCCA 69 FBan0007589 FBgn0036727 CG7589 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG7589 CG7589 CDMC20917 3 22 19 DAC31-K12 17-CG7589-RA_1 CG7589 CGCTGAGCTTTACGGTCAATCTGAAGCGAGAAATTGGCTTCTATTTGCTCGACTATTACCTGCCCTCCA 69 FBan0007589 FBgn0036727 CG7589 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG7589 CG7589 CDMC20918 3 23 19 DAC31-K24 1-CG7599-RA_1 CG7599 GTTCATGAACGAGGGATGCCGTGAGAAAGTCCGTGGCAGATACATCTGGAAGAATCAGACTCGCTGCGA 69 FBan0007599 FBgn0004593 Eig71Ef 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ef Ecdysone-induced gene 71Ef "CG7599, gene V, V: transcript group V, Gene V, 71E-Gene-V, L71-5, L71, gene-V" CDMC20918 3 24 19 DAC31-K24 1-CG7599-RA_1 CG7599 GTTCATGAACGAGGGATGCCGTGAGAAAGTCCGTGGCAGATACATCTGGAAGAATCAGACTCGCTGCGA 69 FBan0007599 FBgn0004593 Eig71Ef 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ef Ecdysone-induced gene 71Ef "CG7599, gene V, V: transcript group V, Gene V, 71E-Gene-V, L71-5, L71, gene-V" CDMC20919 3 25 19 DAC31-O12 2-CG7632-RA_1 CG7632 ACCTGGCACTTCCTACCACTCCATTGACCTCGTGCTGATCACTCGCCGACTAATGGAGGAGTACAACTG 69 FBan0007632 FBgn0037071 CG7632 3 3L calcium-dependent phospholipid binding; GO:0005544; calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509; ; GO:0005544 CG7632 CG7632 CDMC20919 3 26 19 DAC31-O12 2-CG7632-RA_1 CG7632 ACCTGGCACTTCCTACCACTCCATTGACCTCGTGCTGATCACTCGCCGACTAATGGAGGAGTACAACTG 69 FBan0007632 FBgn0037071 CG7632 3 3L calcium-dependent phospholipid binding; GO:0005544; calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509; ; GO:0005544 CG7632 CG7632 CDMC20920 3 1 20 DAC31-O24 14-CG7641-RA_1 CG7641 GCGGGGCAAACTCGAGCAGAAACTCAAATGGGCATTCTCAATGTACGATCTTGATGGGAACGGATACAT 69 FBan0007641 FBgn0013303 Nca 3 3L calcium-mediated signaling; GO:0019722; negative regulation of phosphorylation; GO:0042326; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Nca Neurocalcin "CG7641, nca, neurocalcin, Ncalc" CDMC20920 3 2 20 DAC31-O24 14-CG7641-RA_1 CG7641 GCGGGGCAAACTCGAGCAGAAACTCAAATGGGCATTCTCAATGTACGATCTTGATGGGAACGGATACAT 69 FBan0007641 FBgn0013303 Nca 3 3L calcium-mediated signaling; GO:0019722; negative regulation of phosphorylation; GO:0042326; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Nca Neurocalcin "CG7641, nca, neurocalcin, Ncalc" CDMC20921 3 3 20 DAC32-C12 14-CG15028-RB_1 CG15028 GGCGATGAGATTTTGGTAGTTGAGATCATCGACAGTGGTGCGGACAATAGTAGCTCGGAATCGGGTGG 68 FBan0015028 FBgn0030618 CG15028 X X CG15028 CG15028 CDMC20921 3 4 20 DAC32-C12 14-CG15028-RB_1 CG15028 GGCGATGAGATTTTGGTAGTTGAGATCATCGACAGTGGTGCGGACAATAGTAGCTCGGAATCGGGTGG 68 FBan0015028 FBgn0030618 CG15028 X X CG15028 CG15028 CDMC20922 3 5 20 DAC32-C24 2-CG15134-RA_1 CG15134 GGTGGCCCTACATGGAATGATGACTCGAAGCTCTAAGCAGTTGTCGTCCACTCTACAGGAGCTGCGTG 68 FBan0015134 FBgn0032621 CG15134 2 2L CG15134 CG15134 CDMC20922 3 6 20 DAC32-C24 2-CG15134-RA_1 CG15134 GGTGGCCCTACATGGAATGATGACTCGAAGCTCTAAGCAGTTGTCGTCCACTCTACAGGAGCTGCGTG 68 FBan0015134 FBgn0032621 CG15134 2 2L CG15134 CG15134 CDMC20923 3 7 20 DAC32-G12 3-CG15538-RA_5 CG15538 CGACCATGACCGCTAAAAGAAACCGTTAGGGATCCCAGAAGAGGGTTTCCACATCTGCCCCAATGACC 68 FBan0015538 FBgn0039771 Osi23 3 3R Osi23 Osiris 23 "CG15538, CG15538, Osiris, Osiris 23" CDMC20923 3 8 20 DAC32-G12 3-CG15538-RA_5 CG15538 CGACCATGACCGCTAAAAGAAACCGTTAGGGATCCCAGAAGAGGGTTTCCACATCTGCCCCAATGACC 68 FBan0015538 FBgn0039771 Osi23 3 3R Osi23 Osiris 23 "CG15538, CG15538, Osiris, Osiris 23" CDMC20924 3 9 20 DAC32-G24 1-CG15650-RA_1 CG15650 GCCCGGGGTCTTTGACTTCTCCAATGTGGATCTGGTGAACTTCCAGTACTTCAAGAACCTGGCATCGC 68 FBan0015650 FBgn0034565 CG15650 2 2R CG15650 CG15650 CDMC20924 3 10 20 DAC32-G24 1-CG15650-RA_1 CG15650 GCCCGGGGTCTTTGACTTCTCCAATGTGGATCTGGTGAACTTCCAGTACTTCAAGAACCTGGCATCGC 68 FBan0015650 FBgn0034565 CG15650 2 2R CG15650 CG15650 CDMC20925 3 11 20 DAC32-K12 1-CG16890-RA_1 CG16890 CCGAATGAGACGGAATCACGTCGGCACAAGCGAGACATCGATGTAATCCGAGAGAATCACCGCTTCCT 68 FBan0016890 FBgn0028932 CG16890 2 2L CG16890 CG16890 BG:DS00797.4 CDMC20925 3 12 20 DAC32-K12 1-CG16890-RA_1 CG16890 CCGAATGAGACGGAATCACGTCGGCACAAGCGAGACATCGATGTAATCCGAGAGAATCACCGCTTCCT 68 FBan0016890 FBgn0028932 CG16890 2 2L CG16890 CG16890 BG:DS00797.4 CDMC20926 3 13 20 DAC32-K24 3-CG17003-RA_1 CG17003 AGGCAGGACCAGAAAATCGTGGTAGGTACATCGATCTATCGACGTCGCTGGAAATCACCACGCACACT 68 FBan0017003 FBgn0031082 CG17003 X X CG17003 CG17003 CDMC20926 3 14 20 DAC32-K24 3-CG17003-RA_1 CG17003 AGGCAGGACCAGAAAATCGTGGTAGGTACATCGATCTATCGACGTCGCTGGAAATCACCACGCACACT 68 FBan0017003 FBgn0031082 CG17003 X X CG17003 CG17003 CDMC20927 3 15 20 DAC32-O12 8-CG17359-RA_1 CG17359 AGGGCGAGATCCTACTCGGACAATGACTCATGGAGCCCGGATAGTGAGCTTGAACACGAAGATGATGA 68 FBan0017359 FBgn0036396 CG17359 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17359 CG17359 CDMC20927 3 16 20 DAC32-O12 8-CG17359-RA_1 CG17359 AGGGCGAGATCCTACTCGGACAATGACTCATGGAGCCCGGATAGTGAGCTTGAACACGAAGATGATGA 68 FBan0017359 FBgn0036396 CG17359 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17359 CG17359 CDMC20928 3 17 20 DAC32-O24 AutoBlank AutoBlank CDMC20928 3 18 20 DAC32-O24 AutoBlank AutoBlank CDMC20929 3 19 20 DAC33-C12 11-CG31719-RB_2 CG31719 ACAAATGCAGTCAAGGAGTATCAAGTTGCGGCACAGAAGTCTTCCTCGGAAATTTGCCCAGCTCCA 66 FBan0031719 FBgn0051719 RluA-1 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072; riboflavin biosynthesis; GO:0009231 mRNA binding; GO:0003729; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity; GO:0008835 ; EC:3.5.4.26; ; GO:0008835 ; EC:3.5.4.26; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-1 RluA-1 "CG31719, CG13143, CG7475, CG31719, CG31719, CG31719, multiple" CDMC20929 3 20 20 DAC33-C12 11-CG31719-RB_2 CG31719 ACAAATGCAGTCAAGGAGTATCAAGTTGCGGCACAGAAGTCTTCCTCGGAAATTTGCCCAGCTCCA 66 FBan0031719 FBgn0051719 RluA-1 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072; riboflavin biosynthesis; GO:0009231 mRNA binding; GO:0003729; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity; GO:0008835 ; EC:3.5.4.26; ; GO:0008835 ; EC:3.5.4.26; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-1 RluA-1 "CG31719, CG13143, CG7475, CG31719, CG31719, CG31719, multiple" CDMC20930 3 21 20 DAC33-C24 23-CG31814-RA_1 CG31814 TGTGACATATTTGTATGTAAATGTACGCAAAAGTTTACAGCAAAAATAAAGCCCAAAAACAAGCCC 66 FBan0031814 FBgn0051814 CG31814 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31814 CG31814 BG:DS08249.1 CDMC20930 3 22 20 DAC33-C24 23-CG31814-RA_1 CG31814 TGTGACATATTTGTATGTAAATGTACGCAAAAGTTTACAGCAAAAATAAAGCCCAAAAACAAGCCC 66 FBan0031814 FBgn0051814 CG31814 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31814 CG31814 BG:DS08249.1 CDMC20931 3 23 20 DAC33-G12 2-CG32452-RA_1 CG32452 CGATCTGCGGCACCATATCCAGGGAATATACTCGCACCAACCCGCCTTTAATGCCTACACCGAGTG 66 FBan0032452 FBgn0052452 CG32452 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32452 CG32452 BcDNA:SD04526 CDMC20931 3 24 20 DAC33-G12 2-CG32452-RA_1 CG32452 CGATCTGCGGCACCATATCCAGGGAATATACTCGCACCAACCCGCCTTTAATGCCTACACCGAGTG 66 FBan0032452 FBgn0052452 CG32452 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32452 CG32452 BcDNA:SD04526 CDMC20932 3 25 20 DAC33-G24 3-CG32562-RA_1 CG32562 AGGTCACATAAGTCGAGGAAGAGGAGAGACGCATCGGACCACAAACATGCCAGTAAGCACAAGCGC 66 FBan0032562 FBgn0028974 xmas-2 X X embryonic development; GO:0009790; intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 xmas-2 xmas-2 "CG8919, CG32562, CG8919, CG8919" CDMC20932 3 26 20 DAC33-G24 3-CG32562-RA_1 CG32562 AGGTCACATAAGTCGAGGAAGAGGAGAGACGCATCGGACCACAAACATGCCAGTAAGCACAAGCGC 66 FBan0032562 FBgn0028974 xmas-2 X X embryonic development; GO:0009790; intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 xmas-2 xmas-2 "CG8919, CG32562, CG8919, CG8919" CDMC20933 3 1 21 DAC33-K12 1-CG32946-RA_1 CG32946 GAGCCCGAAGAAAGTGCCCATCATCTCGCTGAAGCCCGCGAAAAAGGTGTTAATGTACAGGTGGTC 66 FBan0032946 FBgn0052946 CG32946 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32946 CG32946 CDMC20933 3 2 21 DAC33-K12 1-CG32946-RA_1 CG32946 GAGCCCGAAGAAAGTGCCCATCATCTCGCTGAAGCCCGCGAAAAAGGTGTTAATGTACAGGTGGTC 66 FBan0032946 FBgn0052946 CG32946 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32946 CG32946 CDMC20934 3 3 21 DAC33-K24 3-CG33234-RA_1 CG33234 CGAATGAACAAGGGCAAGAAGGTTACTCTGAATAGTCTGGGAGTGGAGTCGCTAACCCAGCCGCGC 66 FBan0033234 FBgn0053234 CG33234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33234 CG33234 CG12036 CDMC20934 3 4 21 DAC33-K24 3-CG33234-RA_1 CG33234 CGAATGAACAAGGGCAAGAAGGTTACTCTGAATAGTCTGGGAGTGGAGTCGCTAACCCAGCCGCGC 66 FBan0033234 FBgn0053234 CG33234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33234 CG33234 CG12036 CDMC20935 3 5 21 DAC33-O12 AutoBlank AutoBlank CDMC20935 3 6 21 DAC33-O12 AutoBlank AutoBlank CDMC20936 3 7 21 DAC33-O24 AutoBlank AutoBlank CDMC20936 3 8 21 DAC33-O24 AutoBlank AutoBlank CDMC20937 3 9 21 DAC34-C12 2-CG13466-RA_3 CG13466 GGTCTCCTCCACGATCCTCGACAGTGATTCGGTGGACTATCCGTAGTGCTGAGTACGAGGGATATCGGA 69 FBan0013466 FBgn0036456 CG13466 3 3L intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008017 CG13466 CG13466 anon-71Aa CDMC20937 3 10 21 DAC34-C12 2-CG13466-RA_3 CG13466 GGTCTCCTCCACGATCCTCGACAGTGATTCGGTGGACTATCCGTAGTGCTGAGTACGAGGGATATCGGA 69 FBan0013466 FBgn0036456 CG13466 3 3L intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008017 CG13466 CG13466 anon-71Aa CDMC20938 3 11 21 DAC34-C24 15-CG13477-RA_2 CG13477 TCTCCGAGCAGGTATTCTCGAACATTCAGGAGCGTCTGAACCGAATCATTAATCGCATTAGCATGGCCA 69 FBan0013477 FBgn0036438 CG13477 3 3L CG13477 CG13477 CDMC20938 3 12 21 DAC34-C24 15-CG13477-RA_2 CG13477 TCTCCGAGCAGGTATTCTCGAACATTCAGGAGCGTCTGAACCGAATCATTAATCGCATTAGCATGGCCA 69 FBan0013477 FBgn0036438 CG13477 3 3L CG13477 CG13477 CDMC20939 3 13 21 DAC34-G12 3-CG13531-RB_3 CG13531 CGCTGCACTTCCTCATGTACAAAGAGTTGGCGGAGATGTGGACTACGGAGGCCCAAGAGATTGTTACCA 69 FBan0013531 FBgn0034786 CG13531 2 2R CG13531 CG13531 CDMC20939 3 14 21 DAC34-G12 3-CG13531-RB_3 CG13531 CGCTGCACTTCCTCATGTACAAAGAGTTGGCGGAGATGTGGACTACGGAGGCCCAAGAGATTGTTACCA 69 FBan0013531 FBgn0034786 CG13531 2 2R CG13531 CG13531 CDMC20940 3 15 21 DAC34-G24 23-CG13551-RA_1 CG13551 GACGGATGAACTCGAGACATTTACTAAAATGCATTTCACTCTCTTTTGTATGTTCCCAAGTGCTCACTA 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC20940 3 16 21 DAC34-G24 23-CG13551-RA_1 CG13551 GACGGATGAACTCGAGACATTTACTAAAATGCATTTCACTCTCTTTTGTATGTTCCCAAGTGCTCACTA 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC20941 3 17 21 DAC34-K12 13-CG1358-RA_1 CG1358 CGACCTTTAGGCCAAGTGACAAACGCAAGGAAGTTACAATCTTCCACCCAGAGTCAATTGAGATGGCCA 69 FBan0001358 FBgn0033196 CG1358 2 2R development; GO:0007275 transporter activity; GO:0005215; ; GO:0005215 CG1358 CG1358 CDMC20941 3 18 21 DAC34-K12 13-CG1358-RA_1 CG1358 CGACCTTTAGGCCAAGTGACAAACGCAAGGAAGTTACAATCTTCCACCCAGAGTCAATTGAGATGGCCA 69 FBan0001358 FBgn0033196 CG1358 2 2R development; GO:0007275 transporter activity; GO:0005215; ; GO:0005215 CG1358 CG1358 CDMC20942 3 19 21 DAC34-K24 18-CG1359-RA_5 CG1359 AGGGCTTCCTTTACTACAAGACCAATCGCTACGCCCTGCATTATCTGGAAACTCCCTCTGGATTAAAGT 69 FBan0001359 FBgn0039753 CG1359 3 3R CG1359 CG1359 CDMC20942 3 20 21 DAC34-K24 18-CG1359-RA_5 CG1359 AGGGCTTCCTTTACTACAAGACCAATCGCTACGCCCTGCATTATCTGGAAACTCCCTCTGGATTAAAGT 69 FBan0001359 FBgn0039753 CG1359 3 3R CG1359 CG1359 CDMC20943 3 21 21 DAC34-O12 9-CG13628-RA_1 CG13628 TGGGCCACGTGGATCTTATCGAAAAACTGCTCAACTATGCTCCTCTGGAGAAGTGAACGGCACAATGGA 69 FBan0013628 FBgn0039218 Rpb10 3 3R transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb10 Rpb10 "CG13628, CG13628, CG13628, RPB10, BcDNA:SD08670" CDMC20943 3 22 21 DAC34-O12 9-CG13628-RA_1 CG13628 TGGGCCACGTGGATCTTATCGAAAAACTGCTCAACTATGCTCCTCTGGAGAAGTGAACGGCACAATGGA 69 FBan0013628 FBgn0039218 Rpb10 3 3R transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb10 Rpb10 "CG13628, CG13628, CG13628, RPB10, BcDNA:SD08670" CDMC20944 3 23 21 DAC34-O24 AutoBlank AutoBlank CDMC20944 3 24 21 DAC34-O24 AutoBlank AutoBlank CDMC20945 3 25 21 DAC35-C12 3-CG18005-RA_4 CG18005 GGACGGATGGCCTATGTGATCGACCTGGATGACGAGCTAGGGGAGTCGGATATTCCAACCACACTG 66 FBan0018005 FBgn0037660 CG18005 3 3R cell communication; GO:0007154; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 CG18005 CG18005 CDMC20945 3 26 21 DAC35-C12 3-CG18005-RA_4 CG18005 GGACGGATGGCCTATGTGATCGACCTGGATGACGAGCTAGGGGAGTCGGATATTCCAACCACACTG 66 FBan0018005 FBgn0037660 CG18005 3 3R cell communication; GO:0007154; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 CG18005 CG18005 CDMC20946 3 1 22 DAC35-C24 1-CG18372-RA_3 CG18372 GCAGAAGACAAGCATCCTTATCTTGGCACTTTTCGCCATCGCAGAGGCAGTTCCCACAACAGGACC 66 FBan0018372 FBgn0041581 AttB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttB Attacin-B "CG18372, Attacin, attacin B, attacin, Attacin B, att, Attackin, Att, AttB1, Attacin B1, AttBn, AttB2, Attacin-B" CDMC20946 3 2 22 DAC35-C24 1-CG18372-RA_3 CG18372 GCAGAAGACAAGCATCCTTATCTTGGCACTTTTCGCCATCGCAGAGGCAGTTCCCACAACAGGACC 66 FBan0018372 FBgn0041581 AttB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttB Attacin-B "CG18372, Attacin, attacin B, attacin, Attacin B, att, Attackin, Att, AttB1, Attacin B1, AttBn, AttB2, Attacin-B" CDMC20947 3 3 22 DAC35-G12 8-CG2691-RA_1 CG2691 TGATGATATGCTAGCTGACTCCGATTCGGATCTGCCCGAAGATATGGACGCTAAGGATGAGGCCGG 66 FBan0002691 FBgn0030504 CG2691 X X CG2691 CG2691 CDMC20947 3 4 22 DAC35-G12 8-CG2691-RA_1 CG2691 TGATGATATGCTAGCTGACTCCGATTCGGATCTGCCCGAAGATATGGACGCTAAGGATGAGGCCGG 66 FBan0002691 FBgn0030504 CG2691 X X CG2691 CG2691 CDMC20948 3 5 22 DAC35-G24 2-CG2857-RA_1 CG2857 GCCAGGTTCTGAGCATTTCGTACGCTCTGGTACAGTTCTGGTCCTACGAACAGCTTCGCTCCATGG 66 FBan0002857 FBgn0035078 CG2857 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG2857 CG2857 CDMC20948 3 6 22 DAC35-G24 2-CG2857-RA_1 CG2857 GCCAGGTTCTGAGCATTTCGTACGCTCTGGTACAGTTCTGGTCCTACGAACAGCTTCGCTCCATGG 66 FBan0002857 FBgn0035078 CG2857 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG2857 CG2857 CDMC20949 3 7 22 DAC35-K12 2-CG3032-RA_1 CG3032 CGAAGCCCATGTGAGAGCAGTCCACTTAAAGCTGAAACCCTTTCCCTGTCACCACTGTCCGGAGAG 66 FBan0003032 FBgn0029928 CG3032 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG3032 CG3032 CDMC20949 3 8 22 DAC35-K12 2-CG3032-RA_1 CG3032 CGAAGCCCATGTGAGAGCAGTCCACTTAAAGCTGAAACCCTTTCCCTGTCACCACTGTCCGGAGAG 66 FBan0003032 FBgn0029928 CG3032 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG3032 CG3032 CDMC20950 3 9 22 DAC35-K24 6-CG3047-RA_1 CG3047 GATGCCCGGATATCCAAATCAGTGGCCACAATTACCAGGTTATCCCCAGCAATTACCACCGCCGTT 66 FBan0003047 FBgn0003372 Sgs1 2 2L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs1 Salivary gland secretion 1 "CG3047, Sgs-1, Sgs, sgs-1, sgs1" CDMC20950 3 10 22 DAC35-K24 6-CG3047-RA_1 CG3047 GATGCCCGGATATCCAAATCAGTGGCCACAATTACCAGGTTATCCCCAGCAATTACCACCGCCGTT 66 FBan0003047 FBgn0003372 Sgs1 2 2L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs1 Salivary gland secretion 1 "CG3047, Sgs-1, Sgs, sgs-1, sgs1" CDMC20951 3 11 22 DAC35-O12 AutoBlank AutoBlank CDMC20951 3 12 22 DAC35-O12 AutoBlank AutoBlank CDMC20952 3 13 22 DAC35-O24 AutoBlank AutoBlank CDMC20952 3 14 22 DAC35-O24 AutoBlank AutoBlank CDMC20953 3 15 22 DAC36-C12 3-CG1795-RA_2 CG1795 GCTGCCAAGTTCGGTTATCGGGCCAAGTTCATAGCACAAACGCTGCAAGAGATCCAGAAAAAGGGGG 67 FBan0001795 FBgn0027864 Ogg1 X X DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003677 nucleus; GO:0005634 Ogg1 Ogg1 "CG1795, CG1795, dOGG1, BcDNA:LD19945" CDMC20953 3 16 22 DAC36-C12 3-CG1795-RA_2 CG1795 GCTGCCAAGTTCGGTTATCGGGCCAAGTTCATAGCACAAACGCTGCAAGAGATCCAGAAAAAGGGGG 67 FBan0001795 FBgn0027864 Ogg1 X X DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003677 nucleus; GO:0005634 Ogg1 Ogg1 "CG1795, CG1795, dOGG1, BcDNA:LD19945" CDMC20954 3 17 22 DAC36-C24 2-CG18347-RA_1 CG18347 GGCCTGTGCCGAATGATTGTGATTGCTCCTCTGTTCGGAATCGCTCAAACGGTCTACTATCTGGGCG 67 FBan0018347 FBgn0037969 CG18347 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18347 CG18347 CDMC20954 3 18 22 DAC36-C24 2-CG18347-RA_1 CG18347 GGCCTGTGCCGAATGATTGTGATTGCTCCTCTGTTCGGAATCGCTCAAACGGTCTACTATCTGGGCG 67 FBan0018347 FBgn0037969 CG18347 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18347 CG18347 CDMC20955 3 19 22 DAC36-G12 2-CG2038-RA_1 CG2038 CCGGACTCCAAGCACTTCGAGACCCTGAACCTATTCGCATACGGCACATACAAGGAATACCGTGCAC 67 FBgn0033291 CDMC20955 3 20 22 DAC36-G12 2-CG2038-RA_1 CG2038 CCGGACTCCAAGCACTTCGAGACCCTGAACCTATTCGCATACGGCACATACAAGGAATACCGTGCAC 67 FBgn0033291 CDMC20956 3 21 22 DAC36-G24 23-CG2249-RB_2 CG2249 GCAGGCCATTACAGTGTGTTACAGCTTAAATTTAAGTAAAAAGTGGAAACGAAATAAAGTTACCCGT 67 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC20956 3 22 22 DAC36-G24 23-CG2249-RB_2 CG2249 GCAGGCCATTACAGTGTGTTACAGCTTAAATTTAAGTAAAAAGTGGAAACGAAATAAAGTTACCCGT 67 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC20957 3 23 22 DAC36-K12 2-CG30053-RA_3 CG30053 CACGGATATCTGGAGCCTAAGTTATGGTCTGGAGAAACCCCACGGAAAGCTGACCTCCCTGGCTAGC 67 FBan0030053 FBgn0050053 CG30053 2 2R CG30053 CG30053 "CG8769, CG8769" CDMC20957 3 24 22 DAC36-K12 2-CG30053-RA_3 CG30053 CACGGATATCTGGAGCCTAAGTTATGGTCTGGAGAAACCCCACGGAAAGCTGACCTCCCTGGCTAGC 67 FBan0030053 FBgn0050053 CG30053 2 2R CG30053 CG30053 "CG8769, CG8769" CDMC20958 3 25 22 DAC36-K24 9-CG30193-RD_1 CG30193 GCTCGAGGACCAGCCAGAGGACGTGATACCCGTGTATCCAAAGTTTATCTACGCCCCACAACAGCAG 67 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20958 3 26 22 DAC36-K24 9-CG30193-RD_1 CG30193 GCTCGAGGACCAGCCAGAGGACGTGATACCCGTGTATCCAAAGTTTATCTACGCCCCACAACAGCAG 67 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20959 3 1 23 DAC36-O12 3-CG31003-RA_1 CG31003 GGCCATAGATCTGGTCTCCAAGATGCTGATATACTCGCCCAATGCCAGGGTTTCTCCGTTGATGGGC 67 FBgn0051003 CDMC20959 3 2 23 DAC36-O12 3-CG31003-RA_1 CG31003 GGCCATAGATCTGGTCTCCAAGATGCTGATATACTCGCCCAATGCCAGGGTTTCTCCGTTGATGGGC 67 FBgn0051003 CDMC20960 3 3 23 DAC36-O24 AutoBlank AutoBlank CDMC20960 3 4 23 DAC36-O24 AutoBlank AutoBlank CDMC20961 3 5 23 DAC37-C12 3-CG7629-RA_1 CG7629 CCAGGCTTCTGGCACAGCAAATCTGTATACCTCTCCAAGTGGCAATCTCAACCTCAACGCCACCG 65 FBan0007629 FBgn0038530 AttD 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 AttD Attacin-D "CG7629, attacin, Attacin, att, Attackin, Att, Attacin D, Attacin-D" CDMC20961 3 6 23 DAC37-C12 3-CG7629-RA_1 CG7629 CCAGGCTTCTGGCACAGCAAATCTGTATACCTCTCCAAGTGGCAATCTCAACCTCAACGCCACCG 65 FBan0007629 FBgn0038530 AttD 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 AttD Attacin-D "CG7629, attacin, Attacin, att, Attackin, Att, Attacin D, Attacin-D" CDMC20962 3 7 23 DAC37-C24 12-CG7685-RA_1 CG7685 CAAGTTCCGGTGTCTGGACGGCTCCAAAGAGATCCCGTTCGACCACCTGAACGACAACTACTGCG 65 FBan0007685 FBgn0038619 CG7685 3 3R signal transduction; GO:0007165 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG7685 CG7685 CDMC20962 3 8 23 DAC37-C24 12-CG7685-RA_1 CG7685 CAAGTTCCGGTGTCTGGACGGCTCCAAAGAGATCCCGTTCGACCACCTGAACGACAACTACTGCG 65 FBan0007685 FBgn0038619 CG7685 3 3R signal transduction; GO:0007165 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG7685 CG7685 CDMC20963 3 9 23 DAC37-G12 18-CG7843-RD_2 CG7843 GCGTCCGCAACTTCCCGAACATCCAGGCACCTCTAAGCGTCCAGAATCGGAATCTGCTCGTGGAG 65 FBan0007843 FBgn0033062 CG7843 2 2R defense response; GO:0006952; response to arsenic; GO:0046685; response to toxin; GO:0009636 CG7843 CG7843 anon-WO0118547.166 CDMC20963 3 10 23 DAC37-G12 18-CG7843-RD_2 CG7843 GCGTCCGCAACTTCCCGAACATCCAGGCACCTCTAAGCGTCCAGAATCGGAATCTGCTCGTGGAG 65 FBan0007843 FBgn0033062 CG7843 2 2R defense response; GO:0006952; response to arsenic; GO:0046685; response to toxin; GO:0009636 CG7843 CG7843 anon-WO0118547.166 CDMC20964 3 11 23 DAC37-G24 2-CG7888-RA_2 CG7888 GCGAAGGCCCCAAATGTTTCCGGGTTTTTGCTCCCTACATTGGCACAGTGGTTAACACCTTCCTG 65 FBan0007888 FBgn0036116 CG7888 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG7888 CG7888 CDMC20964 3 12 23 DAC37-G24 2-CG7888-RA_2 CG7888 GCGAAGGCCCCAAATGTTTCCGGGTTTTTGCTCCCTACATTGGCACAGTGGTTAACACCTTCCTG 65 FBan0007888 FBgn0036116 CG7888 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG7888 CG7888 CDMC20965 3 13 23 DAC37-K12 3-CG7958-RA_5 CG7958 CACCGATACCCTGGAGATCGATCAGTACATCTGGGCCATACTCAACACGCTGGGCAACTCGGATG 65 FBgn0036103 CDMC20965 3 14 23 DAC37-K12 3-CG7958-RA_5 CG7958 CACCGATACCCTGGAGATCGATCAGTACATCTGGGCCATACTCAACACGCTGGGCAACTCGGATG 65 FBgn0036103 CDMC20966 3 15 23 DAC37-K24 18-CG7994-RA_5 CG7994 TGCGACCATCAGCGCGACCTTCGAGGACGTACCCTTCGATGCGAACAACTACTGGGCCCTATTGG 65 FBan0007994 FBgn0037599 CG7994 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 CG7994 CG7994 "anon-WO0170980.94, anon-WO0170980.95" CDMC20966 3 16 23 DAC37-K24 18-CG7994-RA_5 CG7994 TGCGACCATCAGCGCGACCTTCGAGGACGTACCCTTCGATGCGAACAACTACTGGGCCCTATTGG 65 FBan0007994 FBgn0037599 CG7994 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 CG7994 CG7994 "anon-WO0170980.94, anon-WO0170980.95" CDMC20967 3 17 23 DAC37-O12 23-CG8087-RA_1 CG8087 CGGGCCAATGGAAACGTTATTGTTGTCGGCTAAGTACGCGGAATTCAATAAAATGCTCAACAAGA 65 FBan0008087 FBgn0038241 CG8087 3 3R CG8087 CG8087 CDMC20967 3 18 23 DAC37-O12 23-CG8087-RA_1 CG8087 CGGGCCAATGGAAACGTTATTGTTGTCGGCTAAGTACGCGGAATTCAATAAAATGCTCAACAAGA 65 FBan0008087 FBgn0038241 CG8087 3 3R CG8087 CG8087 CDMC20968 3 19 23 DAC37-O24 AutoBlank AutoBlank CDMC20968 3 20 23 DAC37-O24 AutoBlank AutoBlank CDMC20969 3 21 23 DAC38-C12 23-CG4178-RA_1 CG4178 GGATGTTTTTAGAGTGTCTGATACCTAGCTAGTAAGGTGTGCAAAAAGTCTAATAAACTTTCGAAAACC 69 FBan0004178 FBgn0002563 Lsp1beta 2 2L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1beta Larval serum protein 1 beta "CG4178, CG4178, CG4178, LSP-1beta, LSP-1 beta, LSP-1, Lsp1-beta, LSP1beta, Lsp-1beta, LSP 1, Lsp1, DmeLSP1b, Lsp-1b, Lsp1b" CDMC20969 3 22 23 DAC38-C12 23-CG4178-RA_1 CG4178 GGATGTTTTTAGAGTGTCTGATACCTAGCTAGTAAGGTGTGCAAAAAGTCTAATAAACTTTCGAAAACC 69 FBan0004178 FBgn0002563 Lsp1beta 2 2L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1beta Larval serum protein 1 beta "CG4178, CG4178, CG4178, LSP-1beta, LSP-1 beta, LSP-1, Lsp1-beta, LSP1beta, Lsp-1beta, LSP 1, Lsp1, DmeLSP1b, Lsp-1b, Lsp1b" CDMC20970 3 23 23 DAC38-C24 2-CG4187-RA_2 CG4187 CGCCAGTGATTTCCTCATGGGCATTTACCTCACATTGATTGCCTGTGCGGATATCAGTTTTCGCGGCGA 69 FBan0004187 FBgn0030458 CG4187 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0016500 integral to membrane; GO:0016021 CG4187 CG4187 "anon-WO0170980.19, anon-WO0170980.20" CDMC20970 3 24 23 DAC38-C24 2-CG4187-RA_2 CG4187 CGCCAGTGATTTCCTCATGGGCATTTACCTCACATTGATTGCCTGTGCGGATATCAGTTTTCGCGGCGA 69 FBan0004187 FBgn0030458 CG4187 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0016500 integral to membrane; GO:0016021 CG4187 CG4187 "anon-WO0170980.19, anon-WO0170980.20" CDMC20971 3 25 23 DAC38-G12 3-CG4213-RA_3 CG4213 CGGCCCAAATCCTCAGCTGGATCAGGATCGAAGCTCCACTAGCATGTCGCAGACTTTAGAGCAACGATT 69 FBan0004213 FBgn0031251 CG4213 2 2L CG4213 CG4213 CDMC20971 3 26 23 DAC38-G12 3-CG4213-RA_3 CG4213 CGGCCCAAATCCTCAGCTGGATCAGGATCGAAGCTCCACTAGCATGTCGCAGACTTTAGAGCAACGATT 69 FBan0004213 FBgn0031251 CG4213 2 2L CG4213 CG4213 CDMC20972 3 1 24 DAC38-G24 23-CG4221-RA_5 CG4221 GCACAGATATAAAGGGAATTTATGGGCAAAGAAAACTCTTGAAAAACAAAATAGTTGATGAAGTGGCAG 69 FBan0004221 FBgn0038385 CG4221 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG4221 CG4221 CDMC20972 3 2 24 DAC38-G24 23-CG4221-RA_5 CG4221 GCACAGATATAAAGGGAATTTATGGGCAAAGAAAACTCTTGAAAAACAAAATAGTTGATGAAGTGGCAG 69 FBan0004221 FBgn0038385 CG4221 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG4221 CG4221 CDMC20973 3 3 24 DAC38-K12 8-CG4260-RA_1 CG4260 CGGGCAAGCAAGGAGACCGTAACTCGGGAAATCTGCGATCTGTTGACGGATCAATTCTAAGCCACAACA 69 FBan0004260 FBgn0015567 alpha-Adaptin 2 2L asymmetric cell division; GO:0008356; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; synaptic vesicle transport; GO:0048489; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 AP-2 adaptor complex; GO:0030122; clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 alpha-Adaptin alpha-Adaptin "CG4260, CG31654, CG4260, CG4260, CG4260, CG4260, dAP-2a, D-alphaAda, alpha-adaptin, D-Ada, alpha-adaptin, alpha-Ada, alpha adaptin, alpha adaptin, AP-2, alpha, cg4260, ada, alpha-Adaptin, AP2, l(2)06694, alpha-Adaptin" CDMC20973 3 4 24 DAC38-K12 8-CG4260-RA_1 CG4260 CGGGCAAGCAAGGAGACCGTAACTCGGGAAATCTGCGATCTGTTGACGGATCAATTCTAAGCCACAACA 69 FBan0004260 FBgn0015567 alpha-Adaptin 2 2L asymmetric cell division; GO:0008356; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; synaptic vesicle transport; GO:0048489; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 AP-2 adaptor complex; GO:0030122; clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 alpha-Adaptin alpha-Adaptin "CG4260, CG31654, CG4260, CG4260, CG4260, CG4260, dAP-2a, D-alphaAda, alpha-adaptin, D-Ada, alpha-adaptin, alpha-Ada, alpha adaptin, alpha adaptin, AP-2, alpha, cg4260, ada, alpha-Adaptin, AP2, l(2)06694, alpha-Adaptin" CDMC20974 3 5 24 DAC38-K24 15-CG4269-RA_1 CG4269 ACCTCGTCCGGGTACTTAGCGAATAGCGAATTGACCGTGGAGTGGATAAAGTGTTAGTGGAGCAACAGA 69 FBan0004269 FBgn0034741 CG4269 2 2R CG4269 CG4269 CDMC20974 3 6 24 DAC38-K24 15-CG4269-RA_1 CG4269 ACCTCGTCCGGGTACTTAGCGAATAGCGAATTGACCGTGGAGTGGATAAAGTGTTAGTGGAGCAACAGA 69 FBan0004269 FBgn0034741 CG4269 2 2R CG4269 CG4269 CDMC20975 3 7 24 DAC38-O12 9-CG4321-RA_2 CG4321 ATGATGCTGGCCAAGATTGTCAGGGAATACGAACTGCTTCCGATGGGTCAAAGGGTTGAGTGCATTGTT 69 FBan0004321 FBgn0015033 Cyp4d8 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d8 Cytochrome P450-4d8 "CG4321, P450, P-450, 4d8" CDMC20975 3 8 24 DAC38-O12 9-CG4321-RA_2 CG4321 ATGATGCTGGCCAAGATTGTCAGGGAATACGAACTGCTTCCGATGGGTCAAAGGGTTGAGTGCATTGTT 69 FBan0004321 FBgn0015033 Cyp4d8 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d8 Cytochrome P450-4d8 "CG4321, P450, P-450, 4d8" CDMC20976 3 9 24 DAC38-O24 23-CG4334-RA_1 CG4334 CTCTTGTGTAAGACTTGTTACTTGTGCATTTCCAACTAATCTTGTTTTAGGTACATTGTCGATCTGCCG 69 FBan0004334 FBgn0038312 CG4334 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG4334 CG4334 CDMC20976 3 10 24 DAC38-O24 23-CG4334-RA_1 CG4334 CTCTTGTGTAAGACTTGTTACTTGTGCATTTCCAACTAATCTTGTTTTAGGTACATTGTCGATCTGCCG 69 FBan0004334 FBgn0038312 CG4334 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG4334 CG4334 CDMC20977 3 11 24 DAC39-C12 3-CG6951-RA_1 CG6951 GCAGCGATGACGTGTTTCCGTGGTCAAAAGCTAAGAAAGGCTCGCAGGAATTTGATCCCCTGGAAGACA 69 FBan0006951 FBgn0036959 CG6951 3 3L pyrimidine base metabolism; GO:0006206 dCMP deaminase activity; GO:0004132 ; EC:3.5.4.12; zinc ion binding; GO:0008270; ; GO:0004132 ; EC:3.5.4.12; ; GO:0008270; ; GO:0004132 ; EC:3.5.4.12 CG6951 CG6951 anon-WO0118547.579 CDMC20977 3 12 24 DAC39-C12 3-CG6951-RA_1 CG6951 GCAGCGATGACGTGTTTCCGTGGTCAAAAGCTAAGAAAGGCTCGCAGGAATTTGATCCCCTGGAAGACA 69 FBan0006951 FBgn0036959 CG6951 3 3L pyrimidine base metabolism; GO:0006206 dCMP deaminase activity; GO:0004132 ; EC:3.5.4.12; zinc ion binding; GO:0008270; ; GO:0004132 ; EC:3.5.4.12; ; GO:0008270; ; GO:0004132 ; EC:3.5.4.12 CG6951 CG6951 anon-WO0118547.579 CDMC20978 3 13 24 DAC39-C24 18-CG6958-RA_9 CG6958 GGACAAGGAGCGACTGGAAGATTACACCCGCAAGTACGAGGAATATGACTTCTCACAGTTTGCCATCAA 69 FBan0006958 FBgn0039004 CG6958 3 3R RNA transport; GO:0050658; glycolysis; GO:0006096 transporter activity; GO:0005215; ; GO:0005215; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nuclear pore; GO:0005643 CG6958 CG6958 CDMC20978 3 14 24 DAC39-C24 18-CG6958-RA_9 CG6958 GGACAAGGAGCGACTGGAAGATTACACCCGCAAGTACGAGGAATATGACTTCTCACAGTTTGCCATCAA 69 FBan0006958 FBgn0039004 CG6958 3 3R RNA transport; GO:0050658; glycolysis; GO:0006096 transporter activity; GO:0005215; ; GO:0005215; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nuclear pore; GO:0005643 CG6958 CG6958 CDMC20979 3 15 24 DAC39-G12 23-CG6987-RA_11 CG6987 CTCTGAAAATCGAAATAGATCGAAGCGTCTGATTTAAACTGGAGAAAATGGGATCACGCAACGAGTGCC 69 FBan0006987 FBgn0040284 SF2 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF2 SF2 "CG6987, CG6987, CG6987, cg6987, ASF/SF2, dSF2/ASF, dASF, dmSF2/p28, ASF" CDMC20979 3 16 24 DAC39-G12 23-CG6987-RA_11 CG6987 CTCTGAAAATCGAAATAGATCGAAGCGTCTGATTTAAACTGGAGAAAATGGGATCACGCAACGAGTGCC 69 FBan0006987 FBgn0040284 SF2 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF2 SF2 "CG6987, CG6987, CG6987, cg6987, ASF/SF2, dSF2/ASF, dASF, dmSF2/p28, ASF" CDMC20980 3 17 24 DAC39-G24 7-CG6998-RB_1 CG6998 TCGGGAACACGTCACATAGGGCATTCTCTTTCACAATATGGAGAGAGAGGCTACACACGAGCACACCGT 69 FBan0006998 FBgn0011760 ctp X X RNA localization; GO:0006403; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatogenesis; GO:0007283; vesicle-mediated transport; GO:0016192; wing morphogenesis; GO:0007476 "microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003777" cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 ctp cut up "CG6998, CG6998, CG6998, CG6998, CG6998, dynein light chain, ddlc1, dynein light-chain 1, Cytoplasmic dynein 8kD light chain, Cdlc1, l(1)G0207, l(1)G0153, l(1)G0432, l(1)G0371, l(1)G0387, l(1)G0338, l(1)G0248, Ddlc1, 8kd dynein light chain, l(1)G0204, Ddlc-1, cytoplasmic dynein light chain 1, LC8, cytoplasmic dynein, dlc, Cytoplasmic dynein, dynein, anon-WO03040301.128, Dlc, l(1)G0244, l(1)G0445, Cytoplasmic dynein light chain 1, Dynein light chain" CDMC20980 3 18 24 DAC39-G24 7-CG6998-RB_1 CG6998 TCGGGAACACGTCACATAGGGCATTCTCTTTCACAATATGGAGAGAGAGGCTACACACGAGCACACCGT 69 FBan0006998 FBgn0011760 ctp X X RNA localization; GO:0006403; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatogenesis; GO:0007283; vesicle-mediated transport; GO:0016192; wing morphogenesis; GO:0007476 "microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003777" cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 ctp cut up "CG6998, CG6998, CG6998, CG6998, CG6998, dynein light chain, ddlc1, dynein light-chain 1, Cytoplasmic dynein 8kD light chain, Cdlc1, l(1)G0207, l(1)G0153, l(1)G0432, l(1)G0371, l(1)G0387, l(1)G0338, l(1)G0248, Ddlc1, 8kd dynein light chain, l(1)G0204, Ddlc-1, cytoplasmic dynein light chain 1, LC8, cytoplasmic dynein, dlc, Cytoplasmic dynein, dynein, anon-WO03040301.128, Dlc, l(1)G0244, l(1)G0445, Cytoplasmic dynein light chain 1, Dynein light chain" CDMC20981 3 19 24 DAC39-K12 12-CG7025-RA_4 CG7025 CCCGTCAACCCTCCGAAATTTCTAGTTGCATTGGAGCAGACCCCAATCGAAACTACGATTCGCATTGGA 69 FBan0007025 FBgn0031930 CG7025 2 2L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG7025 CG7025 CDMC20981 3 20 24 DAC39-K12 12-CG7025-RA_4 CG7025 CCCGTCAACCCTCCGAAATTTCTAGTTGCATTGGAGCAGACCCCAATCGAAACTACGATTCGCATTGGA 69 FBan0007025 FBgn0031930 CG7025 2 2L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG7025 CG7025 CDMC20982 3 21 24 DAC39-K24 23-CG7037-RB_5 CG7037 GCGAACCCATCGTTAAACGCTAGTGTTACTTAGCTAAACACATAAAACTAAGTTGGAGAAGTTCGACCG 69 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC20982 3 22 24 DAC39-K24 23-CG7037-RB_5 CG7037 GCGAACCCATCGTTAAACGCTAGTGTTACTTAGCTAAACACATAAAACTAAGTTGGAGAAGTTCGACCG 69 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC20983 3 23 24 DAC39-O12 11-CG7068-RA_1 CG7068 CTGGTGAGCAACAATCACCCTGGTATAATGCCACTCGTAGCGTCAACATTGAGATCTCCGCTTACGCCG 69 FBan0007068 FBgn0041181 TepIII 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepIII Thiolester containing protein III "CG7068, dTEPIII, Tep3, Thiolester containing protein III" CDMC20983 3 24 24 DAC39-O12 11-CG7068-RA_1 CG7068 CTGGTGAGCAACAATCACCCTGGTATAATGCCACTCGTAGCGTCAACATTGAGATCTCCGCTTACGCCG 69 FBan0007068 FBgn0041181 TepIII 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepIII Thiolester containing protein III "CG7068, dTEPIII, Tep3, Thiolester containing protein III" CDMC20984 3 25 24 DAC39-O24 18-CG7075-RA_2 CG7075 TTAGATGTCGAGTTTATGCTCGGAAAACGGCCAACTCTATATTGGAGAATCGTGTGGCAGGTCGTCACA 69 FBan0007075 FBgn0031934 CG7075 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 amino acid transporter activity; GO:0015171; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0005328; ; GO:0015187 Nebenkern; GO:0016006; integral to plasma membrane; GO:0005887; membrane; GO:0016020; mitochondrial derivative; GO:0016007; nucleus; GO:0005634 CG7075 CG7075 CDMC20984 3 26 24 DAC39-O24 18-CG7075-RA_2 CG7075 TTAGATGTCGAGTTTATGCTCGGAAAACGGCCAACTCTATATTGGAGAATCGTGTGGCAGGTCGTCACA 69 FBan0007075 FBgn0031934 CG7075 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 amino acid transporter activity; GO:0015171; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0005328; ; GO:0015187 Nebenkern; GO:0016006; integral to plasma membrane; GO:0005887; membrane; GO:0016020; mitochondrial derivative; GO:0016007; nucleus; GO:0005634 CG7075 CG7075 CDMC20985 3 1 25 DAC40-C12 3-CG33347-RA_2 CG33347 TTTGCGTAAAGAGGACCACATTTTGGACCGCCCACACAGTCGGGTTGAAGGTGTCATGGTATGGG 65 FBan0033347 FBgn0053347 CG33347 2 2R CG33347 CG33347 CDMC20985 3 2 25 DAC40-C12 3-CG33347-RA_2 CG33347 TTTGCGTAAAGAGGACCACATTTTGGACCGCCCACACAGTCGGGTTGAAGGTGTCATGGTATGGG 65 FBan0033347 FBgn0053347 CG33347 2 2R CG33347 CG33347 CDMC20986 3 3 25 DAC40-C24 3-CG33474-RA_3 CG33474 TAAACAATGTGGGTTCAGAAGACTCTGGGGAGCCACCTGTGCTTCGGTACACTGTGGACAGCGAA 65 FBan0033474 FBgn0053474 CG33474 2 2R CG33474 CG33474 CDMC20986 3 4 25 DAC40-C24 3-CG33474-RA_3 CG33474 TAAACAATGTGGGTTCAGAAGACTCTGGGGAGCCACCTGTGCTTCGGTACACTGTGGACAGCGAA 65 FBan0033474 FBgn0053474 CG33474 2 2R CG33474 CG33474 CDMC20987 3 5 25 DAC40-G12 23-CG3450-RA_1 CG3450 GGTACACAATCTTCAAGGACCCGATTCGCCTATCTGACTATGAAATTCACGATGGCATGAATCTG 65 FBgn0033105 CDMC20987 3 6 25 DAC40-G12 23-CG3450-RA_1 CG3450 GGTACACAATCTTCAAGGACCCGATTCGCCTATCTGACTATGAAATTCACGATGGCATGAATCTG 65 FBgn0033105 CDMC20988 3 7 25 DAC40-G24 2-CG3523-RA_2 CG3523 GAATGTGGCATAGGCCCACTACCCACACGATCATCACCCTCTCACCGTCACTCACCCAATACTCG 65 FBan0003523 FBgn0027571 CG3523 2 2L fatty acid biosynthesis; GO:0006633 "fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004312 ; EC:2.3.1.85; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" CG3523 CG3523 "Fatty acid synthase, Fatty acid synthetase, BcDNA:GH07626, DM_7295848, BcDNA:gh07626, anon-WO0138581.1, anon-EST:Posey235, anon-EST:Posey43" CDMC20988 3 8 25 DAC40-G24 2-CG3523-RA_2 CG3523 GAATGTGGCATAGGCCCACTACCCACACGATCATCACCCTCTCACCGTCACTCACCCAATACTCG 65 FBan0003523 FBgn0027571 CG3523 2 2L fatty acid biosynthesis; GO:0006633 "fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004312 ; EC:2.3.1.85; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" CG3523 CG3523 "Fatty acid synthase, Fatty acid synthetase, BcDNA:GH07626, DM_7295848, BcDNA:gh07626, anon-WO0138581.1, anon-EST:Posey235, anon-EST:Posey43" CDMC20989 3 9 25 DAC40-K12 18-CG3629-RA_2 CG3629 GCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 65 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC20989 3 10 25 DAC40-K12 18-CG3629-RA_2 CG3629 GCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 65 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC20990 3 11 25 DAC40-K24 2-CG3654-RD_1 CG3654 CTCCGAAGCCCTGCATCAAATGTTGCCAATGCTAAACGATGTTTGCGAGAAGGAATCCGCTGCCC 65 FBan0003654 FBgn0036004 CG3654 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 CG3654 CG3654 CDMC20990 3 12 25 DAC40-K24 2-CG3654-RD_1 CG3654 CTCCGAAGCCCTGCATCAAATGTTGCCAATGCTAAACGATGTTTGCGAGAAGGAATCCGCTGCCC 65 FBan0003654 FBgn0036004 CG3654 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 CG3654 CG3654 CDMC20991 3 13 25 DAC40-O12 15-CG3740-RA_2 CG3740 CGTTGCGAAATTCGGGCCAACTCCACGTAGCCTAAATATGCCCATAGATACGCGCGAGTTGATGG 65 FBan0003740 FBgn0023530 CG3740 X X CG3740 CG3740 EG:171E4.4 CDMC20991 3 14 25 DAC40-O12 15-CG3740-RA_2 CG3740 CGTTGCGAAATTCGGGCCAACTCCACGTAGCCTAAATATGCCCATAGATACGCGCGAGTTGATGG 65 FBan0003740 FBgn0023530 CG3740 X X CG3740 CG3740 EG:171E4.4 CDMC20992 3 15 25 DAC40-O24 AutoBlank AutoBlank CDMC20992 3 16 25 DAC40-O24 AutoBlank AutoBlank CDMC20993 3 17 25 DAC41-C12 AutoBlank AutoBlank CDMC20993 3 18 25 DAC41-C12 AutoBlank AutoBlank CDMC20994 3 19 25 DAC41-C24 AutoBlank AutoBlank CDMC20994 3 20 25 DAC41-C24 AutoBlank AutoBlank CDMC20995 3 21 25 DAC41-G12 AutoBlank AutoBlank CDMC20995 3 22 25 DAC41-G12 AutoBlank AutoBlank CDMC20996 3 23 25 DAC41-G24 AutoBlank AutoBlank CDMC20996 3 24 25 DAC41-G24 AutoBlank AutoBlank CDMC20997 3 25 25 DAC41-K12 AutoBlank AutoBlank CDMC20997 3 26 25 DAC41-K12 AutoBlank AutoBlank CDMC20998 3 1 26 DAC41-K24 AutoBlank AutoBlank CDMC20998 3 2 26 DAC41-K24 AutoBlank AutoBlank CDMC20999 3 3 26 DAC41-O12 AutoBlank AutoBlank CDMC20999 3 4 26 DAC41-O12 AutoBlank AutoBlank CDMC21000 3 5 26 DAC41-O24 AutoBlank AutoBlank CDMC21000 3 6 26 DAC41-O24 AutoBlank AutoBlank CDMC21001 3 7 26 DAC42-C12 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC21001 3 8 26 DAC42-C12 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC21002 3 9 26 DAC42-C24 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21002 3 10 26 DAC42-C24 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21003 3 11 26 DAC42-G12 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21003 3 12 26 DAC42-G12 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21004 3 13 26 DAC42-G24 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC21004 3 14 26 DAC42-G24 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC21005 3 15 26 DAC42-K12 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC21005 3 16 26 DAC42-K12 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC21006 3 17 26 DAC42-K24 5uM MSP 5uM MSP CDMC21006 3 18 26 DAC42-K24 5uM MSP 5uM MSP CDMC21007 3 19 26 DAC42-O12 10uM MSP 10uM MSP CDMC21007 3 20 26 DAC42-O12 10uM MSP 10uM MSP CDMC21008 3 21 26 DAC42-O24 20uM MSP 20uM MSP CDMC21008 3 22 26 DAC42-O24 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC21009 4 1 1 DAC01-D12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21009 4 2 1 DAC01-D12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21010 4 3 1 DAC01-D24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21010 4 4 1 DAC01-D24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21011 4 5 1 DAC01-H12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21011 4 6 1 DAC01-H12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21012 4 7 1 DAC01-H24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21012 4 8 1 DAC01-H24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21013 4 9 1 DAC01-L12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21013 4 10 1 DAC01-L12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21014 4 11 1 DAC01-L24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21014 4 12 1 DAC01-L24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21015 4 13 1 DAC01-P12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21015 4 14 1 DAC01-P12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21016 4 15 1 DAC01-P24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21016 4 16 1 DAC01-P24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21017 4 17 1 DAC02-D12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21017 4 18 1 DAC02-D12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21018 4 19 1 DAC02-D24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21018 4 20 1 DAC02-D24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21019 4 21 1 DAC02-H12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21019 4 22 1 DAC02-H12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21020 4 23 1 DAC02-H24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21020 4 24 1 DAC02-H24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21021 4 25 1 DAC02-L12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21021 4 26 1 DAC02-L12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21022 4 1 2 DAC02-L24 AutoBlank AutoBlank CDMC21022 4 2 2 DAC02-L24 AutoBlank AutoBlank CDMC21023 4 3 2 DAC02-P12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21023 4 4 2 DAC02-P12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21024 4 5 2 DAC02-P24 AutoBlank AutoBlank CDMC21024 4 6 2 DAC02-P24 AutoBlank AutoBlank CDMC21025 4 7 2 DAC03-D12 1-CG5455-RA_1 CG5455 CGGCGTGCGGGTTATTGCCTTAAACTACACCACTGATCAGTACCTTTGGAGACCGCTGTGGAAAAGCAA 69 FBan0005455 FBgn0039430 CG5455 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG5455 CG5455 CT17296 CDMC21025 4 8 2 DAC03-D12 1-CG5455-RA_1 CG5455 CGGCGTGCGGGTTATTGCCTTAAACTACACCACTGATCAGTACCTTTGGAGACCGCTGTGGAAAAGCAA 69 FBan0005455 FBgn0039430 CG5455 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG5455 CG5455 CT17296 CDMC21026 4 9 2 DAC03-D24 8-CG5465-RA_1 CG5465 GTGCTGGAGCCCAACTCGATGAAGCAGCTTAATCACACCCAGTTTGATAGGTTATCTGACGCCAGTGGA 69 FBan0005465 FBgn0034707 MED16 2 2R transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription cofactor activity; GO:0003712; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED16 Mediator complex subunit 16 "CG5465, CG5465, Trap95, dTRAP95, Sin4/TRAP95, Med16, Mediator complex subunit 16" CDMC21026 4 10 2 DAC03-D24 8-CG5465-RA_1 CG5465 GTGCTGGAGCCCAACTCGATGAAGCAGCTTAATCACACCCAGTTTGATAGGTTATCTGACGCCAGTGGA 69 FBan0005465 FBgn0034707 MED16 2 2R transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription cofactor activity; GO:0003712; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED16 Mediator complex subunit 16 "CG5465, CG5465, Trap95, dTRAP95, Sin4/TRAP95, Med16, Mediator complex subunit 16" CDMC21027 4 11 2 DAC03-H12 3-CG5484-RC_3 CG5484 CCATCGTGCAAGACATGGCTATGCAGTACGGTCAGAAACTAGCGGATCAGGGCAAGCAGATCATGGAGA 69 FBan0005484 FBgn0039450 CG5484 3 3R CG5484 CG5484 anon-WO0118547.366 CDMC21027 4 12 2 DAC03-H12 3-CG5484-RC_3 CG5484 CCATCGTGCAAGACATGGCTATGCAGTACGGTCAGAAACTAGCGGATCAGGGCAAGCAGATCATGGAGA 69 FBan0005484 FBgn0039450 CG5484 3 3R CG5484 CG5484 anon-WO0118547.366 CDMC21028 4 13 2 DAC03-H24 1-CG5493-RA_6 CG5493 GGGAGACACCAATCGCCGTCAATGATGTGGCCTACATAAATGACAATCTGGGTCTGCATCGCGTGGAGA 69 FBan0005493 FBgn0034364 CG5493 2 2R amino acid catabolism; GO:0009063 cysteine dioxygenase activity; GO:0017172 ; EC:1.13.11.20; ; GO:0017172 ; EC:1.13.11.20 CG5493 CG5493 CDMC21028 4 14 2 DAC03-H24 1-CG5493-RA_6 CG5493 GGGAGACACCAATCGCCGTCAATGATGTGGCCTACATAAATGACAATCTGGGTCTGCATCGCGTGGAGA 69 FBan0005493 FBgn0034364 CG5493 2 2R amino acid catabolism; GO:0009063 cysteine dioxygenase activity; GO:0017172 ; EC:1.13.11.20; ; GO:0017172 ; EC:1.13.11.20 CG5493 CG5493 CDMC21029 4 15 2 DAC03-L12 8-CG5528-RA_1 CG5528 CCAGTGCCGTCTACGATATCTTCATCAGCTACTGCCAGAATGATCGGACCTGGGTGCTCAATGAACTGC 69 FBan0005528 FBgn0036978 Toll-9 3 3L antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021 Toll-9 Toll-9 "CG5528, CG5528, Tl-9, CT17508, Tak/Toll-like, Tl-5, dTLR9, toll, dToll9, Toll 9" CDMC21029 4 16 2 DAC03-L12 8-CG5528-RA_1 CG5528 CCAGTGCCGTCTACGATATCTTCATCAGCTACTGCCAGAATGATCGGACCTGGGTGCTCAATGAACTGC 69 FBan0005528 FBgn0036978 Toll-9 3 3L antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021 Toll-9 Toll-9 "CG5528, CG5528, Tl-9, CT17508, Tak/Toll-like, Tl-5, dTLR9, toll, dToll9, Toll 9" CDMC21030 4 17 2 DAC03-L24 15-CG5546-RA_2 CG5546 GGCGTCGGTGGGAGTCTGCTTATGTCGCAGTTTTAGGCAGGATCCTTTAGCAAAATAGACTTGGCTCAT 69 FBan0005546 FBgn0036761 MED19 3 3L mediator complex; GO:0000119 MED19 Mediator complex subunit 19 "CG5546, CG5546, Mediator complex subunit 19" CDMC21030 4 18 2 DAC03-L24 15-CG5546-RA_2 CG5546 GGCGTCGGTGGGAGTCTGCTTATGTCGCAGTTTTAGGCAGGATCCTTTAGCAAAATAGACTTGGCTCAT 69 FBan0005546 FBgn0036761 MED19 3 3L mediator complex; GO:0000119 MED19 Mediator complex subunit 19 "CG5546, CG5546, Mediator complex subunit 19" CDMC21031 4 19 2 DAC03-P12 7-CG5581-RA_1 CG5581 AGCGACGACACTGATTCCAAGGAAGACCAGTACGAAAGCACATTTGCCAGGAATCTAGCTCGTTTGCGA 69 FBan0005581 FBgn0003022 Ote 2 2R nuclear envelope reassembly; GO:0031468 protein binding; GO:0005515; ; GO:0005515 nuclear inner membrane; GO:0005637 Ote Otefin "CG5581, otefin" CDMC21031 4 20 2 DAC03-P12 7-CG5581-RA_1 CG5581 AGCGACGACACTGATTCCAAGGAAGACCAGTACGAAAGCACATTTGCCAGGAATCTAGCTCGTTTGCGA 69 FBan0005581 FBgn0003022 Ote 2 2R nuclear envelope reassembly; GO:0031468 protein binding; GO:0005515; ; GO:0005515 nuclear inner membrane; GO:0005637 Ote Otefin "CG5581, otefin" CDMC21032 4 21 2 DAC03-P24 2-CG5592-RA_1 CG5592 GTCACATGGATGACTGTGGCCCTAGCATACGATGCCCATGTTCGCGTAGTCGAAATCCTGGACACAGAT 69 FBan0005592 FBgn0035645 CG5592 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG5592 CG5592 CDMC21032 4 22 2 DAC03-P24 2-CG5592-RA_1 CG5592 GTCACATGGATGACTGTGGCCCTAGCATACGATGCCCATGTTCGCGTAGTCGAAATCCTGGACACAGAT 69 FBan0005592 FBgn0035645 CG5592 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG5592 CG5592 CDMC21033 4 23 2 DAC04-D12 23-CG12385-RA_5 CG12385 GCATACTTTCGGGGATTATATAGCGATTCGAAATCAAAAAGCTTCCCATCTGCCCATCTAATTGTTAAT 69 FBan0012385 FBgn0011555 thetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 thetaTry thetaTrypsin "CG12385, CG12385, CG12385, DmThetaTry, thetaTrypsin, SP139" CDMC21033 4 24 2 DAC04-D12 23-CG12385-RA_5 CG12385 GCATACTTTCGGGGATTATATAGCGATTCGAAATCAAAAAGCTTCCCATCTGCCCATCTAATTGTTAAT 69 FBan0012385 FBgn0011555 thetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 thetaTry thetaTrypsin "CG12385, CG12385, CG12385, DmThetaTry, thetaTrypsin, SP139" CDMC21034 4 25 2 DAC04-D24 15-CG12395-RA_3 CG12395 TCCGCGCTTGGTGGATCTCTTCAATTATCCGAAGAAGAGTAGTGTTCAGCTGAAGTTGGCCAATTGGGA 69 FBan0012395 FBgn0030722 CG12395 X X CG12395 CG12395 CDMC21034 4 26 2 DAC04-D24 15-CG12395-RA_3 CG12395 TCCGCGCTTGGTGGATCTCTTCAATTATCCGAAGAAGAGTAGTGTTCAGCTGAAGTTGGCCAATTGGGA 69 FBan0012395 FBgn0030722 CG12395 X X CG12395 CG12395 CDMC21035 4 1 3 DAC04-H12 7-CG12433-RA_1 CG12433 GCCACAAGCTTTTACTGAGGATCGTCGAGTGATGGTTCCGCCTCTATTGCAACTCTTCCATGGTCCTGT 69 FBan0012433 FBgn0030811 CG12433 X X CG12433 CG12433 CDMC21035 4 2 3 DAC04-H12 7-CG12433-RA_1 CG12433 GCCACAAGCTTTTACTGAGGATCGTCGAGTGATGGTTCCGCCTCTATTGCAACTCTTCCATGGTCCTGT 69 FBan0012433 FBgn0030811 CG12433 X X CG12433 CG12433 CDMC21036 4 3 3 DAC04-H24 10-CG12444-RB_1 CG12444 CCCGTAACTTGATGGGTTATCCACTGCGTGTTTTAGTGACCAACGACCCACCTCATTGCTTTGTGGACA 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC21036 4 4 3 DAC04-H24 10-CG12444-RB_1 CG12444 CCCGTAACTTGATGGGTTATCCACTGCGTGTTTTAGTGACCAACGACCCACCTCATTGCTTTGTGGACA 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC21037 4 5 3 DAC04-L12 23-CG12496-RA_3 CG12496 CAGAGGTAATTTCAAACAGATCCTCGGAAAGCCACAAAAATGAGAAGAGAAACTAAATGCGAGATGGAG 69 FBan0012496 FBgn0040385 CG12496 X X CG12496 CG12496 EG:BACH7M4.4 CDMC21037 4 6 3 DAC04-L12 23-CG12496-RA_3 CG12496 CAGAGGTAATTTCAAACAGATCCTCGGAAAGCCACAAAAATGAGAAGAGAAACTAAATGCGAGATGGAG 69 FBan0012496 FBgn0040385 CG12496 X X CG12496 CG12496 EG:BACH7M4.4 CDMC21038 4 7 3 DAC04-L24 1-CG12505-RA_1 CG12505 CGGCGTGCCGGTAAGCCTCGACTAGCTTCTGAAATCCACAAATCCACGCTGTTTGTATTGCTATTCGCA 69 FBan0012505 FBgn0033926 CG12505 2 2R CG12505 CG12505 "anon-WO0153538.31, anon-WO0153538.40, anon-WO0153538.41, anon-WO0153538.43, anon-WO0153538.45" CDMC21038 4 8 3 DAC04-L24 1-CG12505-RA_1 CG12505 CGGCGTGCCGGTAAGCCTCGACTAGCTTCTGAAATCCACAAATCCACGCTGTTTGTATTGCTATTCGCA 69 FBan0012505 FBgn0033926 CG12505 2 2R CG12505 CG12505 "anon-WO0153538.31, anon-WO0153538.40, anon-WO0153538.41, anon-WO0153538.43, anon-WO0153538.45" CDMC21039 4 9 3 DAC04-P12 3-CG12548-RB_5 CG12548 GGGCGGCTCTTCAAGCCTACCTTCAGGTAGTTGGCATTTCTGCCTCTGACATCGATTCAAGGCTGTTTG 69 FBan0012548 FBgn0016919 nompB 2 2L NOT flagellum biogenesis; GO:0009296; intraflagellar transport; GO:0042073; sensory cilium biogenesis; GO:0035058; sensory perception of sound; GO:0007605 nompB no mechanoreceptor potential B "CG14465, CG12548, CG15190, CG4137, CG14465, CG12548, CG12548, nomp, osm-5, no mechanoreceptor potential B" CDMC21039 4 10 3 DAC04-P12 3-CG12548-RB_5 CG12548 GGGCGGCTCTTCAAGCCTACCTTCAGGTAGTTGGCATTTCTGCCTCTGACATCGATTCAAGGCTGTTTG 69 FBan0012548 FBgn0016919 nompB 2 2L NOT flagellum biogenesis; GO:0009296; intraflagellar transport; GO:0042073; sensory cilium biogenesis; GO:0035058; sensory perception of sound; GO:0007605 nompB no mechanoreceptor potential B "CG14465, CG12548, CG15190, CG4137, CG14465, CG12548, CG12548, nomp, osm-5, no mechanoreceptor potential B" CDMC21040 4 11 3 DAC04-P24 AutoBlank AutoBlank CDMC21040 4 12 3 DAC04-P24 AutoBlank AutoBlank CDMC21041 4 13 3 DAC05-D12 17-CG5060-RA_1 CG5060 CCGACTTGGGATTACTGTTATATACGGATGTGTTGCACCAGGGTCGTAACCATGTGATACTCGATGCCA 69 FBan0005060 FBgn0038780 CG5060 3 3R CG5060 CG5060 CDMC21041 4 14 3 DAC05-D12 17-CG5060-RA_1 CG5060 CCGACTTGGGATTACTGTTATATACGGATGTGTTGCACCAGGGTCGTAACCATGTGATACTCGATGCCA 69 FBan0005060 FBgn0038780 CG5060 3 3R CG5060 CG5060 CDMC21042 4 15 3 DAC05-D24 2-CG5074-RA_1 CG5074 GGCATCCGCAGTCGAGCCACGGAACTTACATAATGTGCTTGATTCGTACCTAGAGTGTTGAGCACCGGA 69 FBgn0031311 CDMC21042 4 16 3 DAC05-D24 2-CG5074-RA_1 CG5074 GGCATCCGCAGTCGAGCCACGGAACTTACATAATGTGCTTGATTCGTACCTAGAGTGTTGAGCACCGGA 69 FBgn0031311 CDMC21043 4 17 3 DAC05-H12 23-CG5108-RA_6 CG5108 TCGATTGATGTCGGTGTATCCCACACACTATGTCGAACCAATTGTACAAAAATATAAACAACTAGAGCA 69 FBan0005108 FBgn0032236 mRpS7 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS7 mitochondrial ribosomal protein S7 "CG5108, MRP-S7, RpS7, mRPS7, mitochondrial ribosomal protein S7" CDMC21043 4 18 3 DAC05-H12 23-CG5108-RA_6 CG5108 TCGATTGATGTCGGTGTATCCCACACACTATGTCGAACCAATTGTACAAAAATATAAACAACTAGAGCA 69 FBan0005108 FBgn0032236 mRpS7 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS7 mitochondrial ribosomal protein S7 "CG5108, MRP-S7, RpS7, mRPS7, mitochondrial ribosomal protein S7" CDMC21044 4 19 3 DAC05-H24 3-CG5121-RA_1 CG5121 GCTGAAGCCCTACATGCTGATCAAGGACGAGAATCAGGACCTGAGCATCGAGATTCAACGCAAGGAGGC 69 FBan0005121 FBgn0039337 MED28 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED28 Mediator complex subunit 28 "CG5121, Med23, dMED23, Med28, BcDNA:GM31575, Mediator complex subunit 28" CDMC21044 4 20 3 DAC05-H24 3-CG5121-RA_1 CG5121 GCTGAAGCCCTACATGCTGATCAAGGACGAGAATCAGGACCTGAGCATCGAGATTCAACGCAAGGAGGC 69 FBan0005121 FBgn0039337 MED28 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED28 Mediator complex subunit 28 "CG5121, Med23, dMED23, Med28, BcDNA:GM31575, Mediator complex subunit 28" CDMC21045 4 21 3 DAC05-L12 17-CG5160-RA_3 CG5160 TCATCGCTGGTCAAGTTGGGTCTGCATACCAATAAACAAAAGACTCTGAAGGTTATGGTCCTGGGCCAA 69 FBan0005160 FBgn0031906 CG5160 2 2L "regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG5160 CG5160 CDMC21045 4 22 3 DAC05-L12 17-CG5160-RA_3 CG5160 TCATCGCTGGTCAAGTTGGGTCTGCATACCAATAAACAAAAGACTCTGAAGGTTATGGTCCTGGGCCAA 69 FBan0005160 FBgn0031906 CG5160 2 2L "regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG5160 CG5160 CDMC21046 4 23 3 DAC05-L24 3-CG5169-RA_2 CG5169 CCGGGAGTGAGCGACCTATTTATGAAAGAGCTGATCCACATGCTCGTTCCTGGTTACTCGGAGACGCGA 69 FBan0005169 FBgn0038477 CG5169 3 3R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG5169 CG5169 STLK3 CDMC21046 4 24 3 DAC05-L24 3-CG5169-RA_2 CG5169 CCGGGAGTGAGCGACCTATTTATGAAAGAGCTGATCCACATGCTCGTTCCTGGTTACTCGGAGACGCGA 69 FBan0005169 FBgn0038477 CG5169 3 3R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG5169 CG5169 STLK3 CDMC21047 4 25 3 DAC05-P12 16-CG5198-RA_3 CG5198 GGCGAGCAAAAGAAAGCACCAAGCATCCCAGAAAGTGAAAGAGGAATCCTTCAAGAAACACACGCTTGA 69 FBan0005198 FBgn0032250 CG5198 2 2L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5198 CG5198 CDMC21047 4 26 3 DAC05-P12 16-CG5198-RA_3 CG5198 GGCGAGCAAAAGAAAGCACCAAGCATCCCAGAAAGTGAAAGAGGAATCCTTCAAGAAACACACGCTTGA 69 FBan0005198 FBgn0032250 CG5198 2 2L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5198 CG5198 CDMC21048 4 1 4 DAC05-P24 17-CG5213-RA_1 CG5213 GCGTCGCGAGAGGACGAACGATCATCATGTGTCTAAGCGTTCTCGAGATTCGGACTAATCATTATGCGT 69 FBan0005213 FBgn0038345 CG5213 3 3R "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG5213 CG5213 cg5213 CDMC21048 4 2 4 DAC05-P24 17-CG5213-RA_1 CG5213 GCGTCGCGAGAGGACGAACGATCATCATGTGTCTAAGCGTTCTCGAGATTCGGACTAATCATTATGCGT 69 FBan0005213 FBgn0038345 CG5213 3 3R "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG5213 CG5213 cg5213 CDMC21049 4 3 4 DAC06-D12 12-CG9399-RB_1 CG9399 GCGGAAATTGGCACACTCTCCTCAAGGTCAAGGATGTTGTGCGATAGCTAATGAACCTGTGATCGTGCA 69 FBan0009399 FBgn0037715 CG9399 3 3R CG9399 CG9399 CDMC21049 4 4 4 DAC06-D12 12-CG9399-RB_1 CG9399 GCGGAAATTGGCACACTCTCCTCAAGGTCAAGGATGTTGTGCGATAGCTAATGAACCTGTGATCGTGCA 69 FBan0009399 FBgn0037715 CG9399 3 3R CG9399 CG9399 CDMC21050 4 5 4 DAC06-D24 1-CG9414-RA_1 CG9414 GCAGGATACCCAGCAAGAGACTGAGGCAGGTGATTAGGGAGTACACCAAGGAAAACTGCATCCTCGACG 69 FBan0009414 FBgn0028406 Rep4 2 2L DNA fragmentation during apoptosis; GO:0006309 nucleic acid binding; GO:0003676; caspase-activated deoxyribonuclease activity; GO:0004537; ; GO:0003676; protein binding; GO:0005515; ; GO:0004537; ; GO:0004537; ; GO:0005515 intracellular; GO:0005622 Rep4 Rep4 "CG9414, CG9414, CG9414, drep4, dCAD, Caspase-activated DNase, CAD, Drep4" CDMC21050 4 6 4 DAC06-D24 1-CG9414-RA_1 CG9414 GCAGGATACCCAGCAAGAGACTGAGGCAGGTGATTAGGGAGTACACCAAGGAAAACTGCATCCTCGACG 69 FBan0009414 FBgn0028406 Rep4 2 2L DNA fragmentation during apoptosis; GO:0006309 nucleic acid binding; GO:0003676; caspase-activated deoxyribonuclease activity; GO:0004537; ; GO:0003676; protein binding; GO:0005515; ; GO:0004537; ; GO:0004537; ; GO:0005515 intracellular; GO:0005622 Rep4 Rep4 "CG9414, CG9414, CG9414, drep4, dCAD, Caspase-activated DNase, CAD, Drep4" CDMC21051 4 7 4 DAC06-H12 15-CG9441-RB_1 CG9441 AGTGGGCACTAGAGGACGCTACTGAAATCCGAGACCAACTAAACCCCTACAATATTTTTGGAGGCGCTT 69 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC21051 4 8 4 DAC06-H12 15-CG9441-RB_1 CG9441 AGTGGGCACTAGAGGACGCTACTGAAATCCGAGACCAACTAAACCCCTACAATATTTTTGGAGGCGCTT 69 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC21052 4 9 4 DAC06-H24 2-CG9453-RC_1 CG9453 ACGCAGTCGTTGTACGAAACAAAGGTAGCGCTCAAATTGCCCAGGTTCAAGGCAGAGTTCCAAGTGGAA 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC21052 4 10 4 DAC06-H24 2-CG9453-RC_1 CG9453 ACGCAGTCGTTGTACGAAACAAAGGTAGCGCTCAAATTGCCCAGGTTCAAGGCAGAGTTCCAAGTGGAA 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC21053 4 11 4 DAC06-L12 3-CG9491-RA_5 CG9491 AGGCACCCAAGTTCACCCACCCTTTCGACTACCAGCTCAACGAGTTCTACCAGCGATCATCAAAGAAGA 69 FBgn0031798 CDMC21053 4 12 4 DAC06-L12 3-CG9491-RA_5 CG9491 AGGCACCCAAGTTCACCCACCCTTTCGACTACCAGCTCAACGAGTTCTACCAGCGATCATCAAAGAAGA 69 FBgn0031798 CDMC21054 4 13 4 DAC06-L24 12-CG9500-RA_1 CG9500 TGGCGCACTGAGAGTTATTCCTACAAGGTGATGCAAATGATGGTTCGACCGAAATGCCATTGCTCAGGA 69 FBan0009500 FBgn0031804 CG9500 2 2L defense response to bacteria; GO:0042742; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215 extracellular region; GO:0005576 CG9500 CG9500 CDMC21054 4 14 4 DAC06-L24 12-CG9500-RA_1 CG9500 TGGCGCACTGAGAGTTATTCCTACAAGGTGATGCAAATGATGGTTCGACCGAAATGCCATTGCTCAGGA 69 FBan0009500 FBgn0031804 CG9500 2 2L defense response to bacteria; GO:0042742; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215 extracellular region; GO:0005576 CG9500 CG9500 CDMC21055 4 15 4 DAC06-P12 16-CG9531-RA_1 CG9531 GCGAGATTGCGCCATAGACAGGACGGAATGCTATGACTTTGACAATGCAATTAGCTATAACGTTGCCCA 69 FBan0009531 FBgn0031817 CG9531 2 2L DNA methylation; GO:0006306; porphyrin metabolism; GO:0006778; protein amino acid methylation; GO:0006479 DNA binding; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.-; ; GO:0008757; ; GO:0008276 ; EC:2.1.1.- CG9531 CG9531 CDMC21055 4 16 4 DAC06-P12 16-CG9531-RA_1 CG9531 GCGAGATTGCGCCATAGACAGGACGGAATGCTATGACTTTGACAATGCAATTAGCTATAACGTTGCCCA 69 FBan0009531 FBgn0031817 CG9531 2 2L DNA methylation; GO:0006306; porphyrin metabolism; GO:0006778; protein amino acid methylation; GO:0006479 DNA binding; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.-; ; GO:0008757; ; GO:0008276 ; EC:2.1.1.- CG9531 CG9531 CDMC21056 4 17 4 DAC06-P24 3-CG9547-RA_2 CG9547 GCGCCAAATGAGGGACATGCTGGGTGCAAACGGAATCAGCGACGAATATCATGTGATCCGCCATGTAAT 69 FBan0009547 FBgn0031824 CG9547 2 2L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; hydroxylysine catabolism; GO:0046948; lysine catabolism; GO:0006554; tryptophan metabolism; GO:0006568 glutaryl-CoA dehydrogenase activity; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7 mitochondrial matrix; GO:0005759 CG9547 CG9547 CDMC21056 4 18 4 DAC06-P24 3-CG9547-RA_2 CG9547 GCGCCAAATGAGGGACATGCTGGGTGCAAACGGAATCAGCGACGAATATCATGTGATCCGCCATGTAAT 69 FBan0009547 FBgn0031824 CG9547 2 2L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; hydroxylysine catabolism; GO:0046948; lysine catabolism; GO:0006554; tryptophan metabolism; GO:0006568 glutaryl-CoA dehydrogenase activity; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7 mitochondrial matrix; GO:0005759 CG9547 CG9547 CDMC21057 4 19 4 DAC07-D12 11-CG6589-RA_2 CG6589 TGGAGGGGAACCGAAGGGAGTAGGATCTGGAATGTGCAATAACCGGGATGTAAGTGCCTATGTGGATAC 69 FBan0006589 FBgn0032368 CG6589 2 2L CG6589 CG6589 CDMC21057 4 20 4 DAC07-D12 11-CG6589-RA_2 CG6589 TGGAGGGGAACCGAAGGGAGTAGGATCTGGAATGTGCAATAACCGGGATGTAAGTGCCTATGTGGATAC 69 FBan0006589 FBgn0032368 CG6589 2 2L CG6589 CG6589 CDMC21058 4 21 4 DAC07-D24 23-CG6601-RA_3 CG6601 ATTTCCGATACCCCCTAAACCCTCTAAACGAAAAAAAACCCAAGACCATGTACTTATGTCAGGCCAGGC 69 FBan0006601 FBgn0015797 Rab6 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab6 Rab-protein 6 "CG6601, CG6601, CG6601, l(2)08323, rab6, wrt, warthog, DRab6, 136/6, Drab6, dRab6, DmRab6, drab6, AAF53168, Dm Rab6" CDMC21058 4 22 4 DAC07-D24 23-CG6601-RA_3 CG6601 ATTTCCGATACCCCCTAAACCCTCTAAACGAAAAAAAACCCAAGACCATGTACTTATGTCAGGCCAGGC 69 FBan0006601 FBgn0015797 Rab6 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab6 Rab-protein 6 "CG6601, CG6601, CG6601, l(2)08323, rab6, wrt, warthog, DRab6, 136/6, Drab6, dRab6, DmRab6, drab6, AAF53168, Dm Rab6" CDMC21059 4 23 4 DAC07-H12 8-CG6630-RA_2 CG6630 TGCCTTGGAGAGCTCTACAAACTCATCCTGCCCATGTACGAAAGAGATCGTAGTTACCAGGACCTGGCA 69 FBan0006630 FBgn0031921 CG6630 2 2L CG6630 CG6630 CDMC21059 4 24 4 DAC07-H12 8-CG6630-RA_2 CG6630 TGCCTTGGAGAGCTCTACAAACTCATCCTGCCCATGTACGAAAGAGATCGTAGTTACCAGGACCTGGCA 69 FBan0006630 FBgn0031921 CG6630 2 2L CG6630 CG6630 CDMC21060 4 25 4 DAC07-H24 23-CG6642-RA_1 CG6642 AGGCCAATGAGGAGCCATAATCAATCTCTATTTTACGTCGTTTTTAACTTAAGTGATTTTATGTTGCTT 69 FBan0006642 FBgn0011293 a10 3 3L sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; pheromone binding; GO:0005550; ; GO:0005549; ; GO:0005550; carrier activity; GO:0005386; ; GO:0005386 a10 antennal protein 10 "CG6642, OS-D, A10, Phk-1, OS-D/A10, Pherokine 1, Os-D" CDMC21060 4 26 4 DAC07-H24 23-CG6642-RA_1 CG6642 AGGCCAATGAGGAGCCATAATCAATCTCTATTTTACGTCGTTTTTAACTTAAGTGATTTTATGTTGCTT 69 FBan0006642 FBgn0011293 a10 3 3L sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; pheromone binding; GO:0005550; ; GO:0005549; ; GO:0005550; carrier activity; GO:0005386; ; GO:0005386 a10 antennal protein 10 "CG6642, OS-D, A10, Phk-1, OS-D/A10, Pherokine 1, Os-D" CDMC21061 4 1 5 DAC07-L12 8-CG6673-RA_3 CG6673 TGACCCAGGATGAGGTTGTGCAGAAGACAGCTTTGGATGTCCAGTTGCATGCTGAGTTCCAGAAATCGA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC21061 4 2 5 DAC07-L12 8-CG6673-RA_3 CG6673 TGACCCAGGATGAGGTTGTGCAGAAGACAGCTTTGGATGTCCAGTTGCATGCTGAGTTCCAGAAATCGA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC21062 4 3 5 DAC07-L24 23-CG6684-RA_1 CG6684 GTTATACGGCTGGGAATGTAAAATATCATATAGCCCAAAAACTATTGTTCTTACAAATCGAACAGCTGA 69 FBan0006684 FBgn0010413 RpS25 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS25 Ribosomal protein S25 "CG6684, D25, RpS31, anon-EST:Posey260" CDMC21062 4 4 5 DAC07-L24 23-CG6684-RA_1 CG6684 GTTATACGGCTGGGAATGTAAAATATCATATAGCCCAAAAACTATTGTTCTTACAAATCGAACAGCTGA 69 FBan0006684 FBgn0010413 RpS25 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS25 Ribosomal protein S25 "CG6684, D25, RpS31, anon-EST:Posey260" CDMC21063 4 5 5 DAC07-P12 9-CG6713-RA_1 CG6713 GCACGACAAAATACCGCCGGATACTCTAAGGAATCTTCTGGCCCGATTCTTTGATCTGACCACTCCGCC 69 FBan0006713 FBgn0011676 Nos 2 2L defense response; GO:0006952; electron transport; GO:0006118; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; nitric oxide biosynthesis; GO:0006809; nitric oxide mediated signal transduction; GO:0007263; regulation of organ size; GO:0046620; synaptogenesis; GO:0007416 calmodulin binding; GO:0005516; ; GO:0005516; heme binding; GO:0020037; nitric-oxide synthase activity; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; electron transporter activity; GO:0005489; ; GO:0020037; ; GO:0004517 ; EC:1.14.13.39; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 cellular component unknown; GO:0008372 Nos Nitric oxide synthase "CG6713, dNOS, NOS, DNOS, DNOS1, nitric oxide synthase, nitric oixide synthase" CDMC21063 4 6 5 DAC07-P12 9-CG6713-RA_1 CG6713 GCACGACAAAATACCGCCGGATACTCTAAGGAATCTTCTGGCCCGATTCTTTGATCTGACCACTCCGCC 69 FBan0006713 FBgn0011676 Nos 2 2L defense response; GO:0006952; electron transport; GO:0006118; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; nitric oxide biosynthesis; GO:0006809; nitric oxide mediated signal transduction; GO:0007263; regulation of organ size; GO:0046620; synaptogenesis; GO:0007416 calmodulin binding; GO:0005516; ; GO:0005516; heme binding; GO:0020037; nitric-oxide synthase activity; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; electron transporter activity; GO:0005489; ; GO:0020037; ; GO:0004517 ; EC:1.14.13.39; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 cellular component unknown; GO:0008372 Nos Nitric oxide synthase "CG6713, dNOS, NOS, DNOS, DNOS1, nitric oxide synthase, nitric oixide synthase" CDMC21064 4 7 5 DAC07-P24 14-CG6727-RA_4 CG6727 GAAGGGAAGTGAAGAGCAAGTACCATGTCCCGATTTTTGATAGCTACCAAAGAGCGTCTCCAGAGGGGA 69 FBan0006727 FBgn0029084 gom 2 2R calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning; GO:0007612 calcium ion binding; GO:0005509; ; GO:0005509 gom gomdanji "CG6727, CG6727, CG6727" CDMC21064 4 8 5 DAC07-P24 14-CG6727-RA_4 CG6727 GAAGGGAAGTGAAGAGCAAGTACCATGTCCCGATTTTTGATAGCTACCAAAGAGCGTCTCCAGAGGGGA 69 FBan0006727 FBgn0029084 gom 2 2R calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning; GO:0007612 calcium ion binding; GO:0005509; ; GO:0005509 gom gomdanji "CG6727, CG6727, CG6727" CDMC21065 4 9 5 DAC08-D12 8-CG31875-RA_1 CG31875 TCCTCGGCGTTGGAGACAGATGACCAACAGGCCATCCATAGATGATGCTTTGAATCGGCATTCGTGAAT 69 FBan0031875 FBgn0051875 CG31875 2 2L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31875 CG31875 "CG5831, BcDNA:AT29184" CDMC21065 4 10 5 DAC08-D12 8-CG31875-RA_1 CG31875 TCCTCGGCGTTGGAGACAGATGACCAACAGGCCATCCATAGATGATGCTTTGAATCGGCATTCGTGAAT 69 FBan0031875 FBgn0051875 CG31875 2 2L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31875 CG31875 "CG5831, BcDNA:AT29184" CDMC21066 4 11 5 DAC08-D24 16-CG31886-RA_1 CG31886 CGCCTCACCGGGAACGTCTCAAAAGACACAATAGGGTAGCCCATAGGAATCAGAAGAGACAGGATCTTT 69 FBgn0051886 CDMC21066 4 12 5 DAC08-D24 16-CG31886-RA_1 CG31886 CGCCTCACCGGGAACGTCTCAAAAGACACAATAGGGTAGCCCATAGGAATCAGAAGAGACAGGATCTTT 69 FBgn0051886 CDMC21067 4 13 5 DAC08-H12 23-CG31919-RB_14 CG31919 GCAAAGGAGCCAACACTTAAGCTGGTCAAGGATAAAAAGGACAAAATTGCATTTGAGTACATCATGGAG 69 FBgn0051919 CDMC21067 4 14 5 DAC08-H12 23-CG31919-RB_14 CG31919 GCAAAGGAGCCAACACTTAAGCTGGTCAAGGATAAAAAGGACAAAATTGCATTTGAGTACATCATGGAG 69 FBgn0051919 CDMC21068 4 15 5 DAC08-H24 1-CG31928-RA_1 CG31928 TGGTCTGGGATTCTCCGAAATCGCCCTGAATGGAGTGGAGACCCCTCTGGACAATATTTTGGAACAGGG 69 FBan0031928 FBgn0051928 CG31928 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31928 CG31928 CG10872 CDMC21068 4 16 5 DAC08-H24 1-CG31928-RA_1 CG31928 TGGTCTGGGATTCTCCGAAATCGCCCTGAATGGAGTGGAGACCCCTCTGGACAATATTTTGGAACAGGG 69 FBan0031928 FBgn0051928 CG31928 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31928 CG31928 CG10872 CDMC21069 4 17 5 DAC08-L12 22-CG31988-RA_1 CG31988 ACATCGTCCCGGATAACCATGGTGCATCCTTGCTCTTCCTCCAAATTGTTCATTTGCTTGCTTACAATA 69 FBan0031988 FBgn0051988 CG31988 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31988 CG31988 "CG17401, CG17401, bs21c01.y1, anon-WO0140519.26" CDMC21069 4 18 5 DAC08-L12 22-CG31988-RA_1 CG31988 ACATCGTCCCGGATAACCATGGTGCATCCTTGCTCTTCCTCCAAATTGTTCATTTGCTTGCTTACAATA 69 FBan0031988 FBgn0051988 CG31988 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31988 CG31988 "CG17401, CG17401, bs21c01.y1, anon-WO0140519.26" CDMC21070 4 19 5 DAC08-L24 11-CG31998-RA_1 CG31998 GTCGAACCCTTGAGTCACCAATTGCTTCTGCTGAAACTCAACGAATAGTCGCCAATGGATCGCAGACGT 69 FBan0031998 FBgn0051998 CG31998 4 4 CG31998 CG31998 "CG11572, CG11578, CG11572" CDMC21070 4 20 5 DAC08-L24 11-CG31998-RA_1 CG31998 GTCGAACCCTTGAGTCACCAATTGCTTCTGCTGAAACTCAACGAATAGTCGCCAATGGATCGCAGACGT 69 FBan0031998 FBgn0051998 CG31998 4 4 CG31998 CG31998 "CG11572, CG11578, CG11572" CDMC21071 4 21 5 DAC08-P12 47-CG32031-RC_1 CG32031 CTGAAACGAGAATCAATCAATCAATCCCAATCACCGAAAATCAAAAGCAATAGCGTTAAGCCAAGCGTG 69 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC21071 4 22 5 DAC08-P12 47-CG32031-RC_1 CG32031 CTGAAACGAGAATCAATCAATCAATCCCAATCACCGAAAATCAAAAGCAATAGCGTTAAGCCAAGCGTG 69 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC21072 4 23 5 DAC08-P24 23-CG32039-RA_3 CG32039 TCAGAAAAGAACATCTTGGATTCAACACCATACAAACTTTTAGCTGGCGACCAAAATGTACAACCAAAA 69 FBan0032039 FBgn0052039 CG32039 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32039 CG32039 "BcDNA:RE03722, BEST:GH02734" CDMC21072 4 24 5 DAC08-P24 23-CG32039-RA_3 CG32039 TCAGAAAAGAACATCTTGGATTCAACACCATACAAACTTTTAGCTGGCGACCAAAATGTACAACCAAAA 69 FBan0032039 FBgn0052039 CG32039 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32039 CG32039 "BcDNA:RE03722, BEST:GH02734" CDMC21073 4 25 5 DAC09-D13 3-CG5458-RA_5 CG5458 ATCGGGGTGTACGTGTTCAAGGATGGTTCACGATACTACGGACAGTATCGCTGCGGGAAGCGTTG 65 FBan0005458 FBgn0032478 CG5458 2 2L CG5458 CG5458 CDMC21073 4 26 5 DAC09-D13 3-CG5458-RA_5 CG5458 ATCGGGGTGTACGTGTTCAAGGATGGTTCACGATACTACGGACAGTATCGCTGCGGGAAGCGTTG 65 FBan0005458 FBgn0032478 CG5458 2 2L CG5458 CG5458 CDMC21074 4 1 6 DAC09-E01 2-CG5515-RA_1 CG5515 CCCGAGAAAGGTCTTGCCTGCAAACTGGTCTTCACATTCACAGCTACCTATCCGGATGGAGCACC 65 FBan0005515 FBgn0039163 CG5515 3 3R CG5515 CG5515 CDMC21074 4 2 6 DAC09-E01 2-CG5515-RA_1 CG5515 CCCGAGAAAGGTCTTGCCTGCAAACTGGTCTTCACATTCACAGCTACCTATCCGGATGGAGCACC 65 FBan0005515 FBgn0039163 CG5515 3 3R CG5515 CG5515 CDMC21075 4 3 6 DAC09-H13 3-CG5643-RA_2 CG5643 ATGCCGATCATGTTCCCGGCCCTATACCGCATCAGCAAGGAACACTGGAATCAAACTATCGTGGC 65 FBan0005643 FBgn0027492 wdb 3 3R intracellular signaling cascade; GO:0007242 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 wdb widerborst "CG5643, CG5643, CG5643, CG5643, CG5643, CG5643, 0318/07, LD02456, EP3559, l(3)S031807, PP2A B subunit, BcDNA:LD34343, PP2-AB, PP2A, BEST:LD02456, widerborst" CDMC21075 4 4 6 DAC09-H13 3-CG5643-RA_2 CG5643 ATGCCGATCATGTTCCCGGCCCTATACCGCATCAGCAAGGAACACTGGAATCAAACTATCGTGGC 65 FBan0005643 FBgn0027492 wdb 3 3R intracellular signaling cascade; GO:0007242 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 wdb widerborst "CG5643, CG5643, CG5643, CG5643, CG5643, CG5643, 0318/07, LD02456, EP3559, l(3)S031807, PP2A B subunit, BcDNA:LD34343, PP2-AB, PP2A, BEST:LD02456, widerborst" CDMC21076 4 5 6 DAC09-I01 2-CG5684-RA_1 CG5684 CAACTTCCACGACAGCAACGGTGAGACGAACAGCGCTTCATGATTCGTACTGATGGGGAACGTGG 65 FBan0005684 FBgn0036239 CG5684 3 3L negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016564 cytoplasm; GO:0005737; nucleus; GO:0005634 CG5684 CG5684 CAF1 CDMC21076 4 6 6 DAC09-I01 2-CG5684-RA_1 CG5684 CAACTTCCACGACAGCAACGGTGAGACGAACAGCGCTTCATGATTCGTACTGATGGGGAACGTGG 65 FBan0005684 FBgn0036239 CG5684 3 3L negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016564 cytoplasm; GO:0005737; nucleus; GO:0005634 CG5684 CG5684 CAF1 CDMC21077 4 7 6 DAC09-L13 3-CG5819-RA_6 CG5819 ATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGCCCGCAA 65 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC21077 4 8 6 DAC09-L13 3-CG5819-RA_6 CG5819 ATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGCCCGCAA 65 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC21078 4 9 6 DAC09-M01 1-CG5837-RA_1 CG5837 CTGGACAAGCGCATACCCTTCCTGCTTAGCTCAGTGAAGGACTTTCAGGAACATTTGCCCGGAGG 65 FBan0005837 FBgn0011771 Hem 3 3L apoptosis; GO:0006915; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell projection biogenesis; GO:0030031; central nervous system development; GO:0007417; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; myoblast fusion; GO:0007520; neuromuscular junction development; GO:0007528; oocyte growth; GO:0001555; regulation of cell shape; GO:0008360 receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Hem HEM-protein "CG5837, dhem-2, kte, kette, dhem, Kette, l(3)03335" CDMC21078 4 10 6 DAC09-M01 1-CG5837-RA_1 CG5837 CTGGACAAGCGCATACCCTTCCTGCTTAGCTCAGTGAAGGACTTTCAGGAACATTTGCCCGGAGG 65 FBan0005837 FBgn0011771 Hem 3 3L apoptosis; GO:0006915; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell projection biogenesis; GO:0030031; central nervous system development; GO:0007417; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; myoblast fusion; GO:0007520; neuromuscular junction development; GO:0007528; oocyte growth; GO:0001555; regulation of cell shape; GO:0008360 receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Hem HEM-protein "CG5837, dhem-2, kte, kette, dhem, Kette, l(3)03335" CDMC21079 4 11 6 DAC09-P13 3-CG5964-RA_1 CG5964 ACCGGGACAGGTCCAGAGTGACATTGTGGATCGAATGCTGGACGAAAACATCGAAGCCTCCTACC 65 FBan0005964 FBgn0036206 CG5964 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0008017; ; GO:0005200; ; GO:0005198 CG5964 CG5964 CDMC21079 4 12 6 DAC09-P13 3-CG5964-RA_1 CG5964 ACCGGGACAGGTCCAGAGTGACATTGTGGATCGAATGCTGGACGAAAACATCGAAGCCTCCTACC 65 FBan0005964 FBgn0036206 CG5964 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0008017; ; GO:0005200; ; GO:0005198 CG5964 CG5964 CDMC21080 4 13 6 DAC08-P24 AutoBlank AutoBlank CDMC21080 4 14 6 DAC08-P24 AutoBlank AutoBlank CDMC21081 4 15 6 DAC10-D12 3-CG6553-RA_1 CG6553 GATGCAATCCTCACTGTAGGATCAAGGGTAGCCAATGGCACCCGTATCTACTACGACTGCCCGGC 65 FBan0006553 FBgn0033880 CG6553 2 2R CG6553 CG6553 CDMC21081 4 16 6 DAC10-D12 3-CG6553-RA_1 CG6553 GATGCAATCCTCACTGTAGGATCAAGGGTAGCCAATGGCACCCGTATCTACTACGACTGCCCGGC 65 FBan0006553 FBgn0033880 CG6553 2 2R CG6553 CG6553 CDMC21082 4 17 6 DAC10-D24 3-CG6619-RA_1 CG6619 CTTTGTTTTGGGATCCCACAAGTGAGACGGCTCAGTCCCGACAGCACTCCACAAAATCCAGGCAG 65 FBan0006619 FBgn0035676 CG6619 3 3L protein binding; GO:0005515; ; GO:0005515 CG6619 CG6619 CDMC21082 4 18 6 DAC10-D24 3-CG6619-RA_1 CG6619 CTTTGTTTTGGGATCCCACAAGTGAGACGGCTCAGTCCCGACAGCACTCCACAAAATCCAGGCAG 65 FBan0006619 FBgn0035676 CG6619 3 3L protein binding; GO:0005515; ; GO:0005515 CG6619 CG6619 CDMC21083 4 19 6 DAC10-H12 1-CG6729-RA_1 CG6729 GTGCGTTAAGGTCAAGCAGTACCAGTTCCCCATTTTCGAGCCATCGGTTAGTGATTACCGGGCGG 65 FBan0006729 FBgn0032296 CG6729 2 2L CG6729 CG6729 CDMC21083 4 20 6 DAC10-H12 1-CG6729-RA_1 CG6729 GTGCGTTAAGGTCAAGCAGTACCAGTTCCCCATTTTCGAGCCATCGGTTAGTGATTACCGGGCGG 65 FBan0006729 FBgn0032296 CG6729 2 2L CG6729 CG6729 CDMC21084 4 21 6 DAC10-H24 5-CG6760-RA_1 CG6760 GTTGAAGGACTGCAGGGAGTTACCGTGATAGCAGCTACCTCCAGACCGGAACTGCTAGATCCCGC 65 FBan0006760 FBgn0013563 l(3)70Da 3 3L mitosis; GO:0007067; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; nucleotide binding; GO:0000166; ; GO:0000166" peroxisome; GO:0005777 l(3)70Da lethal (3) 70Da "CG6760, 0848/07, l(3)S084807, l(3)s4868, l(3)02402, l(3)084807, DmCAB51031.1, anon-WO0172774.100, anon-WO0172774.101, anon-WO0172774.102, anon-WO0172774.96, anon-WO0172774.99, anon-WO0172774.98" CDMC21084 4 22 6 DAC10-H24 5-CG6760-RA_1 CG6760 GTTGAAGGACTGCAGGGAGTTACCGTGATAGCAGCTACCTCCAGACCGGAACTGCTAGATCCCGC 65 FBan0006760 FBgn0013563 l(3)70Da 3 3L mitosis; GO:0007067; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; nucleotide binding; GO:0000166; ; GO:0000166" peroxisome; GO:0005777 l(3)70Da lethal (3) 70Da "CG6760, 0848/07, l(3)S084807, l(3)s4868, l(3)02402, l(3)084807, DmCAB51031.1, anon-WO0172774.100, anon-WO0172774.101, anon-WO0172774.102, anon-WO0172774.96, anon-WO0172774.99, anon-WO0172774.98" CDMC21085 4 23 6 DAC10-L12 3-CG6854-RB_1 CG6854 TGAGCTCAGCGGTCATCCCTACTTTGTTGCCACCCAATATCATCCAGAGTACTTGTCGCGGCCTC 65 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC21085 4 24 6 DAC10-L12 3-CG6854-RB_1 CG6854 TGAGCTCAGCGGTCATCCCTACTTTGTTGCCACCCAATATCATCCAGAGTACTTGTCGCGGCCTC 65 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC21086 4 25 6 DAC10-L24 2-CG6898-RA_1 CG6898 GTCCATTCCCTTCTTGCTTAACCGTTGCTATCGCTGGACGGAAAACCAGACGAACGCACGATCCG 65 FBan0006898 FBgn0038412 Zip3 3 3R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 Zip3 Zinc/iron regulated transporter-related protein 3 "CG6898, ZIP3, Zinc/iron regulated transporter-related protein 3" CDMC21086 4 26 6 DAC10-L24 2-CG6898-RA_1 CG6898 GTCCATTCCCTTCTTGCTTAACCGTTGCTATCGCTGGACGGAAAACCAGACGAACGCACGATCCG 65 FBan0006898 FBgn0038412 Zip3 3 3R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 Zip3 Zinc/iron regulated transporter-related protein 3 "CG6898, ZIP3, Zinc/iron regulated transporter-related protein 3" CDMC21087 4 1 7 DAC10-P12 3-CG7003-RA_4 CG7003 TCACTACGACCAGTGGAAGCAATGCATTGACTGCGTCGCCAACCTGGATGTCCTAGGCTCACTAG 65 FBan0007003 FBgn0036486 CG7003 3 3L DNA repair; GO:0006281; mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7003 CG7003 Msh6 CDMC21087 4 2 7 DAC10-P12 3-CG7003-RA_4 CG7003 TCACTACGACCAGTGGAAGCAATGCATTGACTGCGTCGCCAACCTGGATGTCCTAGGCTCACTAG 65 FBan0007003 FBgn0036486 CG7003 3 3L DNA repair; GO:0006281; mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7003 CG7003 Msh6 CDMC21088 4 3 7 DAC10-P24 AutoBlank AutoBlank CDMC21088 4 4 7 DAC10-P24 AutoBlank AutoBlank CDMC21089 4 5 7 DAC11-D12 10-CG10031-RA_1 CG10031 TCGTTGGGGATTCCGACAAACTTGTGAGGAGGCTTGTATTCCCAAAAAGTGATCCATTGATGGCGGTCA 69 FBan0010031 FBgn0031563 CG10031 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; protease inhibitor activity; GO:0030414; ; GO:0030414 CG10031 CG10031 CDMC21089 4 6 7 DAC11-D12 10-CG10031-RA_1 CG10031 TCGTTGGGGATTCCGACAAACTTGTGAGGAGGCTTGTATTCCCAAAAAGTGATCCATTGATGGCGGTCA 69 FBan0010031 FBgn0031563 CG10031 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; protease inhibitor activity; GO:0030414; ; GO:0030414 CG10031 CG10031 CDMC21090 4 7 7 DAC11-D24 3-CG10041-RA_1 CG10041 TGCCTTCACTCGCATCAACGCATACTCCAGCTGGATTCAGGAATCCATGGACTCTATGGCTGCGAGATT 69 FBan0010041 FBgn0038014 CG10041 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10041 CG10041 SP178 CDMC21090 4 8 7 DAC11-D24 3-CG10041-RA_1 CG10041 TGCCTTCACTCGCATCAACGCATACTCCAGCTGGATTCAGGAATCCATGGACTCTATGGCTGCGAGATT 69 FBan0010041 FBgn0038014 CG10041 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10041 CG10041 SP178 CDMC21091 4 9 7 DAC11-H12 2-CG10073-RA_2 CG10073 ACCTTGTTGGCCATAAGCGCTGTGACCATTTACACGGCTAGCTCCACCCAAATTGGTTTTCCATACCGT 69 FBan0010073 FBgn0034440 CG10073 2 2R CG10073 CG10073 CDMC21091 4 10 7 DAC11-H12 2-CG10073-RA_2 CG10073 ACCTTGTTGGCCATAAGCGCTGTGACCATTTACACGGCTAGCTCCACCCAAATTGGTTTTCCATACCGT 69 FBan0010073 FBgn0034440 CG10073 2 2R CG10073 CG10073 CDMC21092 4 11 7 DAC11-H24 2-CG10079-RB_1 CG10079 ACCGACTGCACGGATGAGATACCCAAGCTGAACCGCTACTGCAAGGATCCTAGCAACAAGAATTCGAGT 69 FBan0010079 FBgn0003731 Egfr 2 2R "G2/M transition of mitotic cell cycle; GO:0000086; Malpighian tubule morphogenesis; GO:0007443; R7 cell differentiation; GO:0045466; antennal morphogenesis; GO:0007469; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal closure; GO:0007391; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; embryonic pattern specification; GO:0009880; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; eye development; GO:0001654; female germ-line cyst encapsulation; GO:0048139; gastrulation; GO:0007369; germ-band shortening; GO:0007390; gurken receptor signaling pathway; GO:0008314; imaginal disc development; GO:0007444; imaginal disc pattern formation; GO:0007447; leg disc proximal/distal pattern formation; GO:0007479; male germ-line cyst encapsulation; GO:0048140; maternal determination of dorsal/ventral axis, follicular epithelium, soma encoded (sensu Insecta); GO:0008071; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; muscle attachment; GO:0016203; muscle cell fate specification; GO:0042694; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; oenocyte differentiation; GO:0001742; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein amino acid phosphorylation; GO:0006468; regulation of R8 spacing; GO:0045468; regulation of hemocyte differentiation; GO:0045610; regulation of progression through mitotic cell cycle; GO:0007346; salivary gland development; GO:0007431; second mitotic wave (sensu Endopterygota); GO:0016330; stomatogastric nervous system development; GO:0007421; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; epidermal growth factor receptor activity; GO:0005006; ; GO:0005006; gurken receptor activity; GO:0008313; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004888; ; GO:0005006; ; GO:0008313; ; GO:0005006 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Egfr Epidermal growth factor receptor "CG10079, CG10079, CG10079, CG10079, c-erbB, flb: faint little ball, top: torpedo, DER, torpedo, l(2)57DEFa, Elp, top/flb, Ellipse, top/DER, l(2)05351, Egf-r, DER/top, EGFr, DER/faint little ball, torpedo/DER, EGF-R, EGF receptor, torpedo/Egfr, Ellipse torpedo, Torpedo/DER, EGFR, DER-Ellipse, Degfr, D-Egf, Torpedo/Egfr, Der: Drosophila epidermal growth factor receptor homologue, DmHD-33, DER flb, egfr, faint little ball, Elp-1, Elp-B1, Elp-B1RB1, epidermal growth factor receptor, DER/EGFR, EGF Receptor, EGF-receptor, EgfR, Torpedo, DER\torpedo, EK2-6, Egf, l(2)09261, dEGFR, dEGFR1, D-EGFR, torpedo/egfr, C-erb, El: Ellipse, HD-33, l(2)57EFa, l(2)57Ea, Drosophila epidermal growth factor receptor homologue, top, flb, Der" CDMC21092 4 12 7 DAC11-H24 2-CG10079-RB_1 CG10079 ACCGACTGCACGGATGAGATACCCAAGCTGAACCGCTACTGCAAGGATCCTAGCAACAAGAATTCGAGT 69 FBan0010079 FBgn0003731 Egfr 2 2R "G2/M transition of mitotic cell cycle; GO:0000086; Malpighian tubule morphogenesis; GO:0007443; R7 cell differentiation; GO:0045466; antennal morphogenesis; GO:0007469; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal closure; GO:0007391; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; embryonic pattern specification; GO:0009880; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; eye development; GO:0001654; female germ-line cyst encapsulation; GO:0048139; gastrulation; GO:0007369; germ-band shortening; GO:0007390; gurken receptor signaling pathway; GO:0008314; imaginal disc development; GO:0007444; imaginal disc pattern formation; GO:0007447; leg disc proximal/distal pattern formation; GO:0007479; male germ-line cyst encapsulation; GO:0048140; maternal determination of dorsal/ventral axis, follicular epithelium, soma encoded (sensu Insecta); GO:0008071; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; muscle attachment; GO:0016203; muscle cell fate specification; GO:0042694; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; oenocyte differentiation; GO:0001742; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein amino acid phosphorylation; GO:0006468; regulation of R8 spacing; GO:0045468; regulation of hemocyte differentiation; GO:0045610; regulation of progression through mitotic cell cycle; GO:0007346; salivary gland development; GO:0007431; second mitotic wave (sensu Endopterygota); GO:0016330; stomatogastric nervous system development; GO:0007421; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; epidermal growth factor receptor activity; GO:0005006; ; GO:0005006; gurken receptor activity; GO:0008313; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004888; ; GO:0005006; ; GO:0008313; ; GO:0005006 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Egfr Epidermal growth factor receptor "CG10079, CG10079, CG10079, CG10079, c-erbB, flb: faint little ball, top: torpedo, DER, torpedo, l(2)57DEFa, Elp, top/flb, Ellipse, top/DER, l(2)05351, Egf-r, DER/top, EGFr, DER/faint little ball, torpedo/DER, EGF-R, EGF receptor, torpedo/Egfr, Ellipse torpedo, Torpedo/DER, EGFR, DER-Ellipse, Degfr, D-Egf, Torpedo/Egfr, Der: Drosophila epidermal growth factor receptor homologue, DmHD-33, DER flb, egfr, faint little ball, Elp-1, Elp-B1, Elp-B1RB1, epidermal growth factor receptor, DER/EGFR, EGF Receptor, EGF-receptor, EgfR, Torpedo, DER\torpedo, EK2-6, Egf, l(2)09261, dEGFR, dEGFR1, D-EGFR, torpedo/egfr, C-erb, El: Ellipse, HD-33, l(2)57EFa, l(2)57Ea, Drosophila epidermal growth factor receptor homologue, top, flb, Der" CDMC21093 4 13 7 DAC11-L12 6-CG10112-RA_1 CG10112 GCCAACGTGGAGGGCTCTATGATCGGCAAATACTCCATCAAACTGGATAAGGCCGACGATGACAAGCAC 69 FBan0010112 FBgn0033942 CG10112 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG10112 CG10112 CDMC21093 4 14 7 DAC11-L12 6-CG10112-RA_1 CG10112 GCCAACGTGGAGGGCTCTATGATCGGCAAATACTCCATCAAACTGGATAAGGCCGACGATGACAAGCAC 69 FBan0010112 FBgn0033942 CG10112 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG10112 CG10112 CDMC21094 4 15 7 DAC11-L24 23-CG10120-RB_1 CG10120 CGCACATTTGTCGTCTAGCATAATATCCAAATTTGTATCGCGGCTAATTAACCACAACCACACACTATC 69 FBan0010120 FBgn0002719 Men 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 Men Malic enzyme "CG10120, CG10120, CG10120, CG10120, ME, Mdh-NADP, Me, NADP-malic enzyme, MDH, malic enzyme, anon-WO0118547.278" CDMC21094 4 16 7 DAC11-L24 23-CG10120-RB_1 CG10120 CGCACATTTGTCGTCTAGCATAATATCCAAATTTGTATCGCGGCTAATTAACCACAACCACACACTATC 69 FBan0010120 FBgn0002719 Men 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 Men Malic enzyme "CG10120, CG10120, CG10120, CG10120, ME, Mdh-NADP, Me, NADP-malic enzyme, MDH, malic enzyme, anon-WO0118547.278" CDMC21095 4 17 7 DAC11-P12 9-CG10153-RA_1 CG10153 CGCAGAGCCGAGTGTTTACAGTCCCAGAATTGCAAACAAGACTCCACGATCTGGGTCAAGATGTAGGCA 69 FBan0010153 FBgn0033962 CG10153 2 2R CG10153 CG10153 CDMC21095 4 18 7 DAC11-P12 9-CG10153-RA_1 CG10153 CGCAGAGCCGAGTGTTTACAGTCCCAGAATTGCAAACAAGACTCCACGATCTGGGTCAAGATGTAGGCA 69 FBan0010153 FBgn0033962 CG10153 2 2R CG10153 CG10153 CDMC21096 4 19 7 DAC11-P24 AutoBlank AutoBlank CDMC21096 4 20 7 DAC11-P24 AutoBlank AutoBlank CDMC21097 4 21 7 DAC12-D12 9-CG30118-RA_1 CG30118 TGCTCCTCAATGGTCAGTAGGCTTCCGAACTGTCCCTGAATCTCTTTTGCACACGCATATTACACGGCA 69 FBan0030118 FBgn0050118 CG30118 2 2R CG30118 CG30118 "CG16859, CG5544, CG16859" CDMC21097 4 22 7 DAC12-D12 9-CG30118-RA_1 CG30118 TGCTCCTCAATGGTCAGTAGGCTTCCGAACTGTCCCTGAATCTCTTTTGCACACGCATATTACACGGCA 69 FBan0030118 FBgn0050118 CG30118 2 2R CG30118 CG30118 "CG16859, CG5544, CG16859" CDMC21098 4 23 7 DAC12-D24 3-CG30127-RA_1 CG30127 CCTCGCCCAGCGATCACTCCTACGCCGAGCTAAACAAGTTCGAGGACATTGCTAGCAAATTTGAGCAGA 69 FBan0030127 FBgn0050127 CG30127 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30127 CG30127 CDMC21098 4 24 7 DAC12-D24 3-CG30127-RA_1 CG30127 CCTCGCCCAGCGATCACTCCTACGCCGAGCTAAACAAGTTCGAGGACATTGCTAGCAAATTTGAGCAGA 69 FBan0030127 FBgn0050127 CG30127 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30127 CG30127 CDMC21099 4 25 7 DAC12-H12 2-CG30164-RA_1 CG30164 CCTTGAGCTGGCGTATGATTCACTGACGACACTTAGCCTGGGTGAGTACGGATGGTTAAGTGCTCCCAT 69 FBan0030164 FBgn0050164 CG30164 2 2R intracellular protein transport; GO:0006886 CG30164 CG30164 CG4556 CDMC21099 4 26 7 DAC12-H12 2-CG30164-RA_1 CG30164 CCTTGAGCTGGCGTATGATTCACTGACGACACTTAGCCTGGGTGAGTACGGATGGTTAAGTGCTCCCAT 69 FBan0030164 FBgn0050164 CG30164 2 2R intracellular protein transport; GO:0006886 CG30164 CG30164 CG4556 CDMC21100 4 1 8 DAC12-H24 18-CG30174-RA_5 CG30174 TGCGTGCAATGCAACAAGACTCTAGACTCAACTCTTCACTGTGATGGTCCGGACAAGGACATTTACTGT 69 FBan0030174 FBgn0050174 CG30174 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30174 CG30174 "CG3220, CG3220, CG3220" CDMC21100 4 2 8 DAC12-H24 18-CG30174-RA_5 CG30174 TGCGTGCAATGCAACAAGACTCTAGACTCAACTCTTCACTGTGATGGTCCGGACAAGGACATTTACTGT 69 FBan0030174 FBgn0050174 CG30174 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30174 CG30174 "CG3220, CG3220, CG3220" CDMC21101 4 3 8 DAC12-L12 22-CG3022-RA_6 CG3022 TCGCGGTCGTTTAAGCTTAGTTTTTGACCAAATCGCATCTCTCTGTGTAGAACCTACTCCGCAATGTGA 69 FBan0003022 FBgn0031275 GABA-B-R3 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270; regulation of transcription, DNA-dependent; GO:0006355" GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965; transcription factor activity; GO:0003700; ; GO:0004965; ; GO:0003700 integral to membrane; GO:0016021; intracellular; GO:0005622 GABA-B-R3 metabotropic GABA-B receptor subtype 3 "CG3022, CG3022, D-GABA[[B]]R3, D-Gaba3, GB3, anon-WO0170980.13, anon-WO0170980.14, metabotropic GABA-B receptor subtype 3" CDMC21101 4 4 8 DAC12-L12 22-CG3022-RA_6 CG3022 TCGCGGTCGTTTAAGCTTAGTTTTTGACCAAATCGCATCTCTCTGTGTAGAACCTACTCCGCAATGTGA 69 FBan0003022 FBgn0031275 GABA-B-R3 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270; regulation of transcription, DNA-dependent; GO:0006355" GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965; transcription factor activity; GO:0003700; ; GO:0004965; ; GO:0003700 integral to membrane; GO:0016021; intracellular; GO:0005622 GABA-B-R3 metabotropic GABA-B receptor subtype 3 "CG3022, CG3022, D-GABA[[B]]R3, D-Gaba3, GB3, anon-WO0170980.13, anon-WO0170980.14, metabotropic GABA-B receptor subtype 3" CDMC21102 4 5 8 DAC12-L24 2-CG30270-RA_1 CG30270 TCGCCTTTCCCAACCATTGCATATGGGCGTTCAACAATCGGTACATGAGCGAAGGACATTTCCGCATCT 69 FBan0030270 FBgn0061435 CG30270 2 2R CG30270 CG30270 BcDNA:AT30770 CDMC21102 4 6 8 DAC12-L24 2-CG30270-RA_1 CG30270 TCGCCTTTCCCAACCATTGCATATGGGCGTTCAACAATCGGTACATGAGCGAAGGACATTTCCGCATCT 69 FBan0030270 FBgn0061435 CG30270 2 2R CG30270 CG30270 BcDNA:AT30770 CDMC21103 4 7 8 DAC12-P12 2-CG30321-RA_1 CG30321 ACGGGCCACGAGTGGAATAGAAAAAGTATGCCAAGCTGACCGCATAGCACAGGATAACACAGACCAGGA 69 FBan0030321 FBgn0050321 CG30321 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30321 CG30321 CDMC21103 4 8 8 DAC12-P12 2-CG30321-RA_1 CG30321 ACGGGCCACGAGTGGAATAGAAAAAGTATGCCAAGCTGACCGCATAGCACAGGATAACACAGACCAGGA 69 FBan0030321 FBgn0050321 CG30321 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30321 CG30321 CDMC21104 4 9 8 DAC12-P24 AutoBlank AutoBlank CDMC21104 4 10 8 DAC12-P24 AutoBlank AutoBlank CDMC21105 4 11 8 DAC13-D12 18-CG13290-RA_1 CG13290 GATCATGCAGGATATACGCCTACGCCTGGAACCACAGCACAGTAAAGCCACATTCATATCCTCCT 65 FBgn0035654 CDMC21105 4 12 8 DAC13-D12 18-CG13290-RA_1 CG13290 GATCATGCAGGATATACGCCTACGCCTGGAACCACAGCACAGTAAAGCCACATTCATATCCTCCT 65 FBgn0035654 CDMC21106 4 13 8 DAC13-D24 23-CG13365-RA_1 CG13365 TACATTTTGCATCTTTACATAACGAACTTAGTTATAGCAGCACATAAGCACACAATGGCACTGTT 65 FBan0013365 FBgn0029529 CG13365 X X CG13365 CG13365 BcDNA:LP07417 CDMC21106 4 14 8 DAC13-D24 23-CG13365-RA_1 CG13365 TACATTTTGCATCTTTACATAACGAACTTAGTTATAGCAGCACATAAGCACACAATGGCACTGTT 65 FBan0013365 FBgn0029529 CG13365 X X CG13365 CG13365 BcDNA:LP07417 CDMC21107 4 15 8 DAC13-H12 14-CG13490-RA_1 CG13490 GACGGTGCCCATCTACAGTTTTGGCCTCTGTCTCTCGGAGTGCAGGATGTTCTTTGCTCTGCGGG 65 FBan0013490 FBgn0034673 CG13490 2 2R CG13490 CG13490 CDMC21107 4 16 8 DAC13-H12 14-CG13490-RA_1 CG13490 GACGGTGCCCATCTACAGTTTTGGCCTCTGTCTCTCGGAGTGCAGGATGTTCTTTGCTCTGCGGG 65 FBan0013490 FBgn0034673 CG13490 2 2R CG13490 CG13490 CDMC21108 4 17 8 DAC13-H24 23-CG13517-RA_1 CG13517 GGAGATGAATATGGTAGGTGATCCAAGAGATTCCTTTCAAAGTCGAAATCCTTCAGAGAAGCAGG 65 FBan0013517 FBgn0034766 Obp59a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp59a Odorant-binding protein 59a "CG13517, CG13517, CG13517, CG13517, 59a, Obp58a, Odorant-binding protein 59a" CDMC21108 4 18 8 DAC13-H24 23-CG13517-RA_1 CG13517 GGAGATGAATATGGTAGGTGATCCAAGAGATTCCTTTCAAAGTCGAAATCCTTCAGAGAAGCAGG 65 FBan0013517 FBgn0034766 Obp59a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp59a Odorant-binding protein 59a "CG13517, CG13517, CG13517, CG13517, 59a, Obp58a, Odorant-binding protein 59a" CDMC21109 4 19 8 DAC13-L12 3-CG13617-RA_2 CG13617 TACGCCACTCGAAATCGCATCCGCAAGTTTGTCGAAAAACTGTGCTCCGCCAAGTTCTCGGAACG 65 FBan0013617 FBgn0039201 CG13617 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13617 CG13617 CDMC21109 4 20 8 DAC13-L12 3-CG13617-RA_2 CG13617 TACGCCACTCGAAATCGCATCCGCAAGTTTGTCGAAAAACTGTGCTCCGCCAAGTTCTCGGAACG 65 FBan0013617 FBgn0039201 CG13617 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13617 CG13617 CDMC21110 4 21 8 DAC13-L24 8-CG1363-RA_1 CG1363 AAGGCAGCGAAAAAGAGCTATTCGAATGGTAGTGAACCGGAGATGCTCTCTCCCCTGACCAGCCC 65 FBan0001363 FBgn0004133 blow 2 2R mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 cytoplasm; GO:0005737 blow blown fuse "CG1363, CG1363, l(2)43Eb" CDMC21110 4 22 8 DAC13-L24 8-CG1363-RA_1 CG1363 AAGGCAGCGAAAAAGAGCTATTCGAATGGTAGTGAACCGGAGATGCTCTCTCCCCTGACCAGCCC 65 FBan0001363 FBgn0004133 blow 2 2R mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 cytoplasm; GO:0005737 blow blown fuse "CG1363, CG1363, l(2)43Eb" CDMC21111 4 23 8 DAC13-P12 3-CG13713-RA_1 CG13713 GATGCTGAAGCCCACTGTCACCTATCATCTGTTCCTGTACCGTGTCGAGTTGGCCCGTCGGAATG 65 FBan0013713 FBgn0042199 CG13713 3 3L CG13713 CG13713 "CG18465, HL2" CDMC21111 4 24 8 DAC13-P12 3-CG13713-RA_1 CG13713 GATGCTGAAGCCCACTGTCACCTATCATCTGTTCCTGTACCGTGTCGAGTTGGCCCGTCGGAATG 65 FBan0013713 FBgn0042199 CG13713 3 3L CG13713 CG13713 "CG18465, HL2" CDMC21112 4 25 8 DAC13-P24 AutoBlank AutoBlank CDMC21112 4 26 8 DAC13-P24 AutoBlank AutoBlank CDMC21113 4 1 9 DAC14-D12 13-CG16707-RD_1 CG16707 ACCCCCTGAGCGGATTTAATACGGGCCCAGATAGTAGGAGCAGGCTCTACATTCTTGAATTACTTCCCT 69 FBan0016707 FBgn0045823 vsg 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 vsg visgun "CG16707, GH15083, FBgn0045823, anon-WO0118547.164, BEST:GH15083, visgun" CDMC21113 4 2 9 DAC14-D12 13-CG16707-RD_1 CG16707 ACCCCCTGAGCGGATTTAATACGGGCCCAGATAGTAGGAGCAGGCTCTACATTCTTGAATTACTTCCCT 69 FBan0016707 FBgn0045823 vsg 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 vsg visgun "CG16707, GH15083, FBgn0045823, anon-WO0118547.164, BEST:GH15083, visgun" CDMC21114 4 3 9 DAC14-D24 3-CG16718-RA_1 CG16718 TGGTGCATTCCGGACATGAGCGTTGAACTGCGTGACCAAATCCGACGCGAAGTTTATGTGACCAATGAA 69 FBan0016718 FBgn0038721 CG16718 3 3R CG16718 CG16718 CDMC21114 4 4 9 DAC14-D24 3-CG16718-RA_1 CG16718 TGGTGCATTCCGGACATGAGCGTTGAACTGCGTGACCAAATCCGACGCGAAGTTTATGTGACCAATGAA 69 FBan0016718 FBgn0038721 CG16718 3 3R CG16718 CG16718 CDMC21115 4 5 9 DAC14-H12 23-CG16747-RC_2 CG16747 AGAAAGGGAAACGCATATGCATAGAAGCTAATTACATAGATCAGCAAAAAGGATCCACATACACGCTAT 69 FBan0016747 FBgn0014184 Oda 2 2R cell differentiation; GO:0030154 ornithine decarboxylase inhibitor activity; GO:0008073; ; GO:0008073; ; GO:0008073 Oda Ornithine decarboxylase antizyme "CG16747, CG16747, guf: gut feeling, gut feeling, gutfeeling, ODA, Ornithine Deacarboxylase Antizyme, ornithine decarboxylase antizyme, AZ: Antizyme, antizyme, D-AZ, l(2)02833, l(2)k09037, Antizyme, guf, AZ" CDMC21115 4 6 9 DAC14-H12 23-CG16747-RC_2 CG16747 AGAAAGGGAAACGCATATGCATAGAAGCTAATTACATAGATCAGCAAAAAGGATCCACATACACGCTAT 69 FBan0016747 FBgn0014184 Oda 2 2R cell differentiation; GO:0030154 ornithine decarboxylase inhibitor activity; GO:0008073; ; GO:0008073; ; GO:0008073 Oda Ornithine decarboxylase antizyme "CG16747, CG16747, guf: gut feeling, gut feeling, gutfeeling, ODA, Ornithine Deacarboxylase Antizyme, ornithine decarboxylase antizyme, AZ: Antizyme, antizyme, D-AZ, l(2)02833, l(2)k09037, Antizyme, guf, AZ" CDMC21116 4 7 9 DAC14-H24 23-CG16756-RA_1 CG16756 CCGAAACGCCCAAAATCTGCCTAATCTTAAGGTTATCTGTGGGATCTAGATGTAATTAATTTAATGATT 69 FBan0016756 FBgn0029765 CG16756 X X antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16756 CG16756 BcDNA:RH17440 CDMC21116 4 8 9 DAC14-H24 23-CG16756-RA_1 CG16756 CCGAAACGCCCAAAATCTGCCTAATCTTAAGGTTATCTGTGGGATCTAGATGTAATTAATTTAATGATT 69 FBan0016756 FBgn0029765 CG16756 X X antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16756 CG16756 BcDNA:RH17440 CDMC21117 4 9 9 DAC14-L12 14-CG16801-RA_2 CG16801 TTGCTGCGCATGATCAGCTCCCACAAGATTGAGTCCATCTATTTTCAGCGCACTATTGGGAACACGCCC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC21117 4 10 9 DAC14-L12 14-CG16801-RA_2 CG16801 TTGCTGCGCATGATCAGCTCCCACAAGATTGAGTCCATCTATTTTCAGCGCACTATTGGGAACACGCCC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC21118 4 11 9 DAC14-L24 3-CG16825-RA_1 CG16825 AGCGTCTGTTTGGTTTTCTTCGGACCCTGGACCATGTACAACTCCCAGAAGTTGTTCCTGCACCACAAG 69 FBan0016825 FBgn0032503 CG16825 2 2L CG16825 CG16825 BcDNA:AT09390 CDMC21118 4 12 9 DAC14-L24 3-CG16825-RA_1 CG16825 AGCGTCTGTTTGGTTTTCTTCGGACCCTGGACCATGTACAACTCCCAGAAGTTGTTCCTGCACCACAAG 69 FBan0016825 FBgn0032503 CG16825 2 2L CG16825 CG16825 BcDNA:AT09390 CDMC21119 4 13 9 DAC14-P12 14-CG16876-RA_5 CG16876 AGTTGTGTACCGACTGCAGTTGCGAACGGACAAGTCAAACTGGAAAATGAAATTCATCTGGGCCCTGAT 69 FBan0016876 FBgn0028876 CG16876 2 2L CG16876 CG16876 "BG:DS05899.3, CT35247" CDMC21119 4 14 9 DAC14-P12 14-CG16876-RA_5 CG16876 AGTTGTGTACCGACTGCAGTTGCGAACGGACAAGTCAAACTGGAAAATGAAATTCATCTGGGCCCTGAT 69 FBan0016876 FBgn0028876 CG16876 2 2L CG16876 CG16876 "BG:DS05899.3, CT35247" CDMC21120 4 15 9 DAC14-P24 AutoBlank AutoBlank CDMC21120 4 16 9 DAC14-P24 AutoBlank AutoBlank CDMC21121 4 17 9 DAC15-D12 23-CG1865-RA_2 CG1865 TGTTCGCCATCAAGTACAAGGACTCAATCGCCTTTATCGGACACATTGCTAACTATGCTTATGTCTAAG 69 FBan0001865 FBgn0024293 Spn43Ab 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Ab Serine protease inhibitor 43Ab "CG1865, CG1865, SER2, Serine protease inhibitor 2, Ser2: Serine protease 2, anon-WO0118057.2, Ser2" CDMC21121 4 18 9 DAC15-D12 23-CG1865-RA_2 CG1865 TGTTCGCCATCAAGTACAAGGACTCAATCGCCTTTATCGGACACATTGCTAACTATGCTTATGTCTAAG 69 FBan0001865 FBgn0024293 Spn43Ab 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Ab Serine protease inhibitor 43Ab "CG1865, CG1865, SER2, Serine protease inhibitor 2, Ser2: Serine protease 2, anon-WO0118057.2, Ser2" CDMC21122 4 19 9 DAC15-D24 10-CG1867-RA_1 CG1867 CCGTTTGTGTGGACACACTGTTCTGTTCTCTGAGCCATAATCTCTGTGCCCTATTCCAGATTGCCAGGC 69 FBan0001867 FBgn0039582 Or98b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98b Odorant receptor 98b "CG1867, CG1867, 98C.1, DOR121, 98b" CDMC21122 4 20 9 DAC15-D24 10-CG1867-RA_1 CG1867 CCGTTTGTGTGGACACACTGTTCTGTTCTCTGAGCCATAATCTCTGTGCCCTATTCCAGATTGCCAGGC 69 FBan0001867 FBgn0039582 Or98b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98b Odorant receptor 98b "CG1867, CG1867, 98C.1, DOR121, 98b" CDMC21123 4 21 9 DAC15-H12 23-CG18779-RA_3 CG18779 TTGCTTTCACTGTAAGCAGCTTTAAACCCACCAATTCTGCAACACTCTTTGTTATCTTCCCCAACACTT 69 FBan0018779 FBgn0042120 CG18779 3 3L CG18779 CG18779 CDMC21123 4 22 9 DAC15-H12 23-CG18779-RA_3 CG18779 TTGCTTTCACTGTAAGCAGCTTTAAACCCACCAATTCTGCAACACTCTTTGTTATCTTCCCCAACACTT 69 FBan0018779 FBgn0042120 CG18779 3 3L CG18779 CG18779 CDMC21124 4 23 9 DAC15-H24 13-CG18801-RA_1 CG18801 GCCCCGCTTAGCAGACGATACCCATCCGGCTACTTTGTATATGCTGGAAGTTTCCTATACGTCTCAGCA 69 FBan0018801 FBgn0041627 Ku80 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116; ; GO:0003677 DNA-dependent protein kinase complex; GO:0005958; single-stranded DNA-dependent ATP-dependent DNA helicase complex; GO:0017117 Ku80 Ku80 "CG18801, BG:DS09217.6, DmKu80, KU80" CDMC21124 4 24 9 DAC15-H24 13-CG18801-RA_1 CG18801 GCCCCGCTTAGCAGACGATACCCATCCGGCTACTTTGTATATGCTGGAAGTTTCCTATACGTCTCAGCA 69 FBan0018801 FBgn0041627 Ku80 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116; ; GO:0003677 DNA-dependent protein kinase complex; GO:0005958; single-stranded DNA-dependent ATP-dependent DNA helicase complex; GO:0017117 Ku80 Ku80 "CG18801, BG:DS09217.6, DmKu80, KU80" CDMC21125 4 25 9 DAC15-L12 2-CG1889-RB_4 CG1889 ACCCCGCTCGAACGTGGAACCGTTCTTTGTTTTTTGCGATCAGAAGGTCAGAAACGGTGGTTGGACAAT 69 FBan0001889 FBgn0030164 CG1889 X X receptor binding; GO:0005102; ; GO:0005102 CG1889 CG1889 CDMC21125 4 26 9 DAC15-L12 2-CG1889-RB_4 CG1889 ACCCCGCTCGAACGTGGAACCGTTCTTTGTTTTTTGCGATCAGAAGGTCAGAAACGGTGGTTGGACAAT 69 FBan0001889 FBgn0030164 CG1889 X X receptor binding; GO:0005102; ; GO:0005102 CG1889 CG1889 CDMC21126 4 1 10 DAC15-L24 39-CG1898-RA_6 CG1898 GCCGCATCGTGGAGACATCCATGAAATTCGACTATGACATGCAGAAGATCCTGGACGAGATCCTCAACG 69 FBan0001898 FBgn0042712 HBS1 3 3L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; translation release factor activity; GO:0003747; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003747; ; GO:0005525 cytosol; GO:0005829 HBS1 HBS1 "CG1898, CG1898" CDMC21126 4 2 10 DAC15-L24 39-CG1898-RA_6 CG1898 GCCGCATCGTGGAGACATCCATGAAATTCGACTATGACATGCAGAAGATCCTGGACGAGATCCTCAACG 69 FBan0001898 FBgn0042712 HBS1 3 3L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; translation release factor activity; GO:0003747; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003747; ; GO:0005525 cytosol; GO:0005829 HBS1 HBS1 "CG1898, CG1898" CDMC21127 4 3 10 DAC15-P12 2-CG1927-RA_2 CG1927 CGAAACGGGTGAGTTGGAGTACTTCTACACAGACACCGTCCGCGTTAATAGACCGGCCTTCGATGAGGA 69 FBan0001927 FBgn0027547 CG1927 3 3L CG1927 CG1927 "cDNA A, BcDNA:GH11112, anon-WO0118547.340, anon-62BCb" CDMC21127 4 4 10 DAC15-P12 2-CG1927-RA_2 CG1927 CGAAACGGGTGAGTTGGAGTACTTCTACACAGACACCGTCCGCGTTAATAGACCGGCCTTCGATGAGGA 69 FBan0001927 FBgn0027547 CG1927 3 3L CG1927 CG1927 "cDNA A, BcDNA:GH11112, anon-WO0118547.340, anon-62BCb" CDMC21128 4 5 10 DAC15-P24 AutoBlank AutoBlank CDMC21128 4 6 10 DAC15-P24 AutoBlank AutoBlank CDMC21129 4 7 10 DAC16-D12 15-CG32770-RA_1 CG32770 GGCCCATTCTGGATGGCATATACTTTTGCTTTATGAGCCTGTCCACCATTGGTTTTGGCGATATGCTGC 69 FBan0032770 FBgn0052770 CG32770 X X potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG32770 CG32770 "CG6952, CG6952" CDMC21129 4 8 10 DAC16-D12 15-CG32770-RA_1 CG32770 GGCCCATTCTGGATGGCATATACTTTTGCTTTATGAGCCTGTCCACCATTGGTTTTGGCGATATGCTGC 69 FBan0032770 FBgn0052770 CG32770 X X potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG32770 CG32770 "CG6952, CG6952" CDMC21130 4 9 10 DAC16-D24 23-CG32782-RC_12 CG32782 AGCATCAACAAACAAAGCAAAAAACGCAAAAAAGGATTACAAAGACGCAGAGAATAGGGGACATTTGCA 69 FBgn0052782 CDMC21130 4 10 10 DAC16-D24 23-CG32782-RC_12 CG32782 AGCATCAACAAACAAAGCAAAAAACGCAAAAAAGGATTACAAAGACGCAGAGAATAGGGGACATTTGCA 69 FBgn0052782 CDMC21131 4 11 10 DAC16-H12 18-CG32811-RA_1 CG32811 GCCACACCAACCAGAGTATCCGGATTATGAGGCGATGAGAAGACCGGTAGAGTCGTTGCGCATGGTGAA 69 FBan0032811 FBgn0052811 CG32811 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32811 CG32811 CDMC21131 4 12 10 DAC16-H12 18-CG32811-RA_1 CG32811 GCCACACCAACCAGAGTATCCGGATTATGAGGCGATGAGAAGACCGGTAGAGTCGTTGCGCATGGTGAA 69 FBan0032811 FBgn0052811 CG32811 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32811 CG32811 CDMC21132 4 13 10 DAC16-H24 2-CG3281-RA_1 CG3281 TCCGCGTGTCTTTGCCAAAAGTGAATCTCTGACTCGTCATTTTTCCCAAGCCCACAAACTGACAGCGGA 69 FBan0003281 FBgn0037967 CG3281 3 3R "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleosome assembly; GO:0006334; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3281 CG3281 anon-WO0140519.243 CDMC21132 4 14 10 DAC16-H24 2-CG3281-RA_1 CG3281 TCCGCGTGTCTTTGCCAAAAGTGAATCTCTGACTCGTCATTTTTCCCAAGCCCACAAACTGACAGCGGA 69 FBan0003281 FBgn0037967 CG3281 3 3R "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleosome assembly; GO:0006334; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3281 CG3281 anon-WO0140519.243 CDMC21133 4 15 10 DAC16-L12 15-CG32853-RA_1 CG32853 GGCGCAAGTTGGCTACTTGACCAATTAACGCGATTGGCTGAGGATTCTCACCTTTTGCTGGACACTATA 69 FBgn0052853 CDMC21133 4 16 10 DAC16-L12 15-CG32853-RA_1 CG32853 GGCGCAAGTTGGCTACTTGACCAATTAACGCGATTGGCTGAGGATTCTCACCTTTTGCTGGACACTATA 69 FBgn0052853 CDMC21134 4 17 10 DAC16-L24 15-CG3288-RA_2 CG3288 TCGTCATCCTGTGCTTCGTGGTGGTCTATATCAGCCACAAGATCTATGTCTCCGTCTACGACAACCTGC 69 FBan0003288 FBgn0037030 CG3288 3 3L CG3288 CG3288 CDMC21134 4 18 10 DAC16-L24 15-CG3288-RA_2 CG3288 TCGTCATCCTGTGCTTCGTGGTGGTCTATATCAGCCACAAGATCTATGTCTCCGTCTACGACAACCTGC 69 FBan0003288 FBgn0037030 CG3288 3 3L CG3288 CG3288 CDMC21135 4 19 10 DAC16-P12 17-CG32954-RA_1 CG32954 AGAAGTACTTCGATGAGGTGATGGTCCAAATGGACTACATCGATGTCCTGATCAATGGTGCTACGCTGT 69 FBgn0052954 CDMC21135 4 20 10 DAC16-P12 17-CG32954-RA_1 CG32954 AGAAGTACTTCGATGAGGTGATGGTCCAAATGGACTACATCGATGTCCTGATCAATGGTGCTACGCTGT 69 FBgn0052954 CDMC21136 4 21 10 DAC16-P24 12-CG32971-RA_1 CG32971 AGAGGAGCTGTCCGAACTGGAGTACGAGTACTACGAAAAGAGCGGTGGACCTGACTTGGATTCAAAGGA 69 FBan0032971 FBgn0052971 CG32971 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32971 CG32971 CDMC21136 4 22 10 DAC16-P24 12-CG32971-RA_1 CG32971 AGAGGAGCTGTCCGAACTGGAGTACGAGTACTACGAAAAGAGCGGTGGACCTGACTTGGATTCAAAGGA 69 FBan0032971 FBgn0052971 CG32971 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32971 CG32971 CDMC21137 4 23 10 DAC17-D12 1-CG12426-RA_3 CG12426 AATCTTGCAGTGCAATGGGCGTGGTAACGTATCTGCCTTTGTCCATCAGGTCCTGGAGGTTGTGG 65 FBan0012426 FBgn0039552 CG12426 3 3R CG12426 CG12426 CDMC21137 4 24 10 DAC17-D12 1-CG12426-RA_3 CG12426 AATCTTGCAGTGCAATGGGCGTGGTAACGTATCTGCCTTTGTCCATCAGGTCCTGGAGGTTGTGG 65 FBan0012426 FBgn0039552 CG12426 3 3R CG12426 CG12426 CDMC21138 4 25 10 DAC17-D24 15-CG1245-RA_8 CG1245 AGTTAAATTCCACTCTAACTGCCGTCAAAAACCTGCGGTCCAACGTAAGGCTGTGCTTCGAGCAC 65 FBan0001245 FBgn0037359 MED27 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED27 Mediator complex subunit 27 "CG1245, dTRAP37, dCRSP34, CRSP34, Trap37, Med27, Mediator complex subunit 27" CDMC21138 4 26 10 DAC17-D24 15-CG1245-RA_8 CG1245 AGTTAAATTCCACTCTAACTGCCGTCAAAAACCTGCGGTCCAACGTAAGGCTGTGCTTCGAGCAC 65 FBan0001245 FBgn0037359 MED27 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED27 Mediator complex subunit 27 "CG1245, dTRAP37, dCRSP34, CRSP34, Trap37, Med27, Mediator complex subunit 27" CDMC21139 4 1 11 DAC17-H12 18-CG12534-RA_2 CG12534 CAACTACGGCTACGACTACATCAGCCCCACGCACATCGAACTCAGCCGGGAAGCAACTCGCCTGG 65 FBan0012534 FBgn0031068 CG12534 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971 mitochondrion; GO:0005739 CG12534 CG12534 CDMC21139 4 2 11 DAC17-H12 18-CG12534-RA_2 CG12534 CAACTACGGCTACGACTACATCAGCCCCACGCACATCGAACTCAGCCGGGAAGCAACTCGCCTGG 65 FBan0012534 FBgn0031068 CG12534 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971 mitochondrion; GO:0005739 CG12534 CG12534 CDMC21140 4 3 11 DAC17-H24 3-CG12581-RA_1 CG12581 CTATGGGTCCGAACACACTACAGCGGAAGCATGCCATGACAATGTCAAATGGCGGATTGCATGGC 65 FBan0012581 FBgn0037213 CG12581 3 3R CG12581 CG12581 CDMC21140 4 4 11 DAC17-H24 3-CG12581-RA_1 CG12581 CTATGGGTCCGAACACACTACAGCGGAAGCATGCCATGACAATGTCAAATGGCGGATTGCATGGC 65 FBan0012581 FBgn0037213 CG12581 3 3R CG12581 CG12581 CDMC21141 4 5 11 DAC17-L12 3-CG12688-RA_1 CG12688 CCCTTCGAGGACGCCTACCCACGCTATGCAGGACTTAGAGGACACTCCGATTATCACCATCGACG 65 FBan0012688 FBgn0029707 CG12688 X X CG12688 CG12688 CDMC21141 4 6 11 DAC17-L12 3-CG12688-RA_1 CG12688 CCCTTCGAGGACGCCTACCCACGCTATGCAGGACTTAGAGGACACTCCGATTATCACCATCGACG 65 FBan0012688 FBgn0029707 CG12688 X X CG12688 CG12688 CDMC21142 4 7 11 DAC17-L24 20-CG12724-RA_1 CG12724 CTACCGCAACTCCTACCGCTTCCGGCTCGGCCACGCCCACGCCCTCGCCAACATCACCCAATCCG 65 FBan0012724 FBgn0030470 CG12724 X X CG12724 CG12724 CDMC21142 4 8 11 DAC17-L24 20-CG12724-RA_1 CG12724 CTACCGCAACTCCTACCGCTTCCGGCTCGGCCACGCCCACGCCCTCGCCAACATCACCCAATCCG 65 FBan0012724 FBgn0030470 CG12724 X X CG12724 CG12724 CDMC21143 4 9 11 DAC17-P12 2-CG12841-RA_1 CG12841 CTGTACTGGGATGCTGTGGAATCTGCATGGAGAACGTGTGCATGACCGCAACGTACGGCTTCTTG 65 FBan0012841 FBgn0033133 Tsp42Ek 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Ek Tetraspanin 42Ek "CG12841, CG12841, CG12841, Dm.Tsp42Ek, tetraspanin 42E, Tetraspanin 42Ek" CDMC21143 4 10 11 DAC17-P12 2-CG12841-RA_1 CG12841 CTGTACTGGGATGCTGTGGAATCTGCATGGAGAACGTGTGCATGACCGCAACGTACGGCTTCTTG 65 FBan0012841 FBgn0033133 Tsp42Ek 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Ek Tetraspanin 42Ek "CG12841, CG12841, CG12841, Dm.Tsp42Ek, tetraspanin 42E, Tetraspanin 42Ek" CDMC21144 4 11 11 DAC17-P24 AutoBlank AutoBlank CDMC21144 4 12 11 DAC17-P24 AutoBlank AutoBlank CDMC21145 4 13 11 DAC18-D12 3-CG6141-RB_1 CG6141 ACGGTCATTGAGATCCGTAACTTCTTGGGTGAGAAGTACATCCGTCGTGTGGAGATGGCTCCTGGCG 67 FBan0006141 FBgn0015756 RpL9 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL9 Ribosomal protein L9 "CG6141, M(2)32D, rpL9, L9, anon-WO0153538.25, anon-WO0153538.26, anon-WO0153538.27, anon-EST:fe3A6, anon-fast-evolving-3A6" CDMC21145 4 14 11 DAC18-D12 3-CG6141-RB_1 CG6141 ACGGTCATTGAGATCCGTAACTTCTTGGGTGAGAAGTACATCCGTCGTGTGGAGATGGCTCCTGGCG 67 FBan0006141 FBgn0015756 RpL9 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL9 Ribosomal protein L9 "CG6141, M(2)32D, rpL9, L9, anon-WO0153538.25, anon-WO0153538.26, anon-WO0153538.27, anon-EST:fe3A6, anon-fast-evolving-3A6" CDMC21146 4 15 11 DAC18-D24 2-CG6349-RA_2 CG6349 GGCCTGGATATAGTACGTCGCGATTGGTCTCAGCTGGCTGTAATGGTGGGAAAAGCCGTTCTCGATG 67 FBan0006349 FBgn0004493 DNApol-alpha180 3 3R DNA recombination; GO:0006310; DNA strand elongation; GO:0006271 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003889; ; GO:0003889; ; GO:0003677; ; GO:0000166 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha180 DNA polymerase alpha 180kD "CG6349, CG6349, pol alpha, DNApol-alpha, 183 kDa pol alpha, DNA polymerase alpha, DNApolalpha, DNApola, POLA, DNA-polymerase alpha, Polalpha, polalpha, DNA polymerase-primase 180 kda subunit, DmPolalpha, polalphap180, AAB24152, DNA polymerase 180K, DNA polalpha, DNApol-alpha180" CDMC21146 4 16 11 DAC18-D24 2-CG6349-RA_2 CG6349 GGCCTGGATATAGTACGTCGCGATTGGTCTCAGCTGGCTGTAATGGTGGGAAAAGCCGTTCTCGATG 67 FBan0006349 FBgn0004493 DNApol-alpha180 3 3R DNA recombination; GO:0006310; DNA strand elongation; GO:0006271 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003889; ; GO:0003889; ; GO:0003677; ; GO:0000166 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha180 DNA polymerase alpha 180kD "CG6349, CG6349, pol alpha, DNApol-alpha, 183 kDa pol alpha, DNA polymerase alpha, DNApolalpha, DNApola, POLA, DNA-polymerase alpha, Polalpha, polalpha, DNA polymerase-primase 180 kda subunit, DmPolalpha, polalphap180, AAB24152, DNA polymerase 180K, DNA polalpha, DNApol-alpha180" CDMC21147 4 17 11 DAC18-H12 3-CG6761-RA_3 CG6761 GGAGCTCAAGTCTTGGCGCAAGGTGTACTGGAAGTTATGGGGTCACTGCCATTACCTGTACTGCTGC 67 FBan0006761 FBgn0036031 CG6761 3 3L CG6761 CG6761 CDMC21147 4 18 11 DAC18-H12 3-CG6761-RA_3 CG6761 GGAGCTCAAGTCTTGGCGCAAGGTGTACTGGAAGTTATGGGGTCACTGCCATTACCTGTACTGCTGC 67 FBan0006761 FBgn0036031 CG6761 3 3L CG6761 CG6761 CDMC21148 4 19 11 DAC18-H24 1-CG7009-RA_1 CG7009 CGCTCCCGATTCTACTGGAATGCACGACTTTGACTCGTACGTTCAGGGCGAACTACTTCTCTCCGCC 67 FBan0007009 FBgn0038861 CG7009 3 3R rRNA modification; GO:0000154 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG7009 CG7009 CDMC21148 4 20 11 DAC18-H24 1-CG7009-RA_1 CG7009 CGCTCCCGATTCTACTGGAATGCACGACTTTGACTCGTACGTTCAGGGCGAACTACTTCTCTCCGCC 67 FBan0007009 FBgn0038861 CG7009 3 3R rRNA modification; GO:0000154 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG7009 CG7009 CDMC21149 4 21 11 DAC18-L12 1-CG7562-RA_1 CG7562 CACGGGCAGTTTAGTTCCTACGAACCGGAGATGTTTCCAGGCCTAATCTATCGCATGGTCAAGCCGC 67 FBan0007562 FBgn0010287 Trf 2 2L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367; transcription initiation from RNA polymerase III promoter; GO:0006384 DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003704; ; GO:0008134; ; GO:0003709; ; GO:0008134 NOT transcription factor TFIID complex; GO:0005669; polytene chromosome; GO:0005700; transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf TBP-related factor "CG7562, CG7562, trf, TRF, TRF1, Trf1, dTRF1, X70838" CDMC21149 4 22 11 DAC18-L12 1-CG7562-RA_1 CG7562 CACGGGCAGTTTAGTTCCTACGAACCGGAGATGTTTCCAGGCCTAATCTATCGCATGGTCAAGCCGC 67 FBan0007562 FBgn0010287 Trf 2 2L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367; transcription initiation from RNA polymerase III promoter; GO:0006384 DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003704; ; GO:0008134; ; GO:0003709; ; GO:0008134 NOT transcription factor TFIID complex; GO:0005669; polytene chromosome; GO:0005700; transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf TBP-related factor "CG7562, CG7562, trf, TRF, TRF1, Trf1, dTRF1, X70838" CDMC21150 4 23 11 DAC18-L24 1-CG7747-RA_1 CG7747 ACCTGGAGCTCTTCTGCGATCAAACTCCTCGAGCCTGCGATAACTTCATCAAGCATTGCGCCAATGG 67 FBan0007747 FBgn0034109 CG7747 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7747 CG7747 CDMC21150 4 24 11 DAC18-L24 1-CG7747-RA_1 CG7747 ACCTGGAGCTCTTCTGCGATCAAACTCCTCGAGCCTGCGATAACTTCATCAAGCATTGCGCCAATGG 67 FBan0007747 FBgn0034109 CG7747 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7747 CG7747 CDMC21151 4 25 11 DAC18-P12 2-CG8100-RA_1 CG8100 TCCTGACGGCACAGGAAGTGACTTGGAACCAATTGAGCCCCATTAGGTTGGTGACACCGAAACGAAG 67 FBan0008100 FBgn0036410 CG8100 3 3L extracellular region; GO:0005576; larval serum protein complex; GO:0005616 CG8100 CG8100 CDMC21151 4 26 11 DAC18-P12 2-CG8100-RA_1 CG8100 TCCTGACGGCACAGGAAGTGACTTGGAACCAATTGAGCCCCATTAGGTTGGTGACACCGAAACGAAG 67 FBan0008100 FBgn0036410 CG8100 3 3L extracellular region; GO:0005576; larval serum protein complex; GO:0005616 CG8100 CG8100 CDMC21152 4 1 12 DAC18-P24 AutoBlank AutoBlank CDMC21152 4 2 12 DAC18-P24 AutoBlank AutoBlank CDMC21153 4 3 12 DAC19-D12 2-CG8194-RA_4 CG8194 TGCAAGACTCGTCGAGGGAGATGTCTGTGCAGGATCACAACTGGGATGTGCTGATTTTCACGCAACAA 68 FBan0008194 FBgn0010406 RNaseX25 3 3L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; endoribonuclease activity; GO:0004521; ribonuclease activity; GO:0004540; ; GO:0004521; ; GO:0004540 RNaseX25 Ribonuclease X25 "CG8194, CG8194, acid RNase, DmRNase-66B, DmRNase-X25" CDMC21153 4 4 12 DAC19-D12 2-CG8194-RA_4 CG8194 TGCAAGACTCGTCGAGGGAGATGTCTGTGCAGGATCACAACTGGGATGTGCTGATTTTCACGCAACAA 68 FBan0008194 FBgn0010406 RNaseX25 3 3L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; endoribonuclease activity; GO:0004521; ribonuclease activity; GO:0004540; ; GO:0004521; ; GO:0004540 RNaseX25 Ribonuclease X25 "CG8194, CG8194, acid RNase, DmRNase-66B, DmRNase-X25" CDMC21154 4 5 12 DAC19-D24 2-CG8427-RA_1 CG8427 ACAGACAGCAACACACCAAGCTAGCGAACATGTCTATCGGAGTGCCCATTAAAGTTCTGCACGAGGCC 68 FBan0008427 FBgn0023167 SmD3 2 2R "central nervous system development; GO:0007417; lymph gland development (sensu Arthropoda); GO:0048542; muscle development; GO:0007517; neuron differentiation; GO:0030182; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmD3 Small ribonucleoprotein Sm D3 "CG8427, CG8427, l(2)90/37, guf: gut feeling, gut feeling, gutfeeling, l(2)131/7, l(2)154/1, guf2, snRNP Sm D3, Sm D3, guf" CDMC21154 4 6 12 DAC19-D24 2-CG8427-RA_1 CG8427 ACAGACAGCAACACACCAAGCTAGCGAACATGTCTATCGGAGTGCCCATTAAAGTTCTGCACGAGGCC 68 FBan0008427 FBgn0023167 SmD3 2 2R "central nervous system development; GO:0007417; lymph gland development (sensu Arthropoda); GO:0048542; muscle development; GO:0007517; neuron differentiation; GO:0030182; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmD3 Small ribonucleoprotein Sm D3 "CG8427, CG8427, l(2)90/37, guf: gut feeling, gut feeling, gutfeeling, l(2)131/7, l(2)154/1, guf2, snRNP Sm D3, Sm D3, guf" CDMC21155 4 7 12 DAC19-H12 3-CG8931-RA_2 CG8931 CGGTCTATTCGATGTATTCCGGGAGGGAAGTCTGCGCTTGTTTTATTGGAGCTCTCCGCAAAAGGGCC 68 FBan0008931 FBgn0030717 CG8931 X X transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG8931 CG8931 CDMC21155 4 8 12 DAC19-H12 3-CG8931-RA_2 CG8931 CGGTCTATTCGATGTATTCCGGGAGGGAAGTCTGCGCTTGTTTTATTGGAGCTCTCCGCAAAAGGGCC 68 FBan0008931 FBgn0030717 CG8931 X X transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG8931 CG8931 CDMC21156 4 9 12 DAC19-H24 15-CG9022-RA_1 CG9022 CGCCTTCTCAATGATGATCGGCGTGTTTGTCTTCTCATTCGTGTTCCTTCACTTCAAGGATGAGCCCG 68 FBan0009022 FBgn0014868 Ost48 X X protein amino acid N-linked glycosylation; GO:0006487; protein amino acid N-linked glycosylation via asparagine; GO:0018279 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789 Ost48 Oligosaccharyltransferase 48kD subunit "CG9022, CG9022, DmOST50, OST48, clone 1.11, DrOST, OST48/WBP1, anon-EST:Liang-1.11" CDMC21156 4 10 12 DAC19-H24 15-CG9022-RA_1 CG9022 CGCCTTCTCAATGATGATCGGCGTGTTTGTCTTCTCATTCGTGTTCCTTCACTTCAAGGATGAGCCCG 68 FBan0009022 FBgn0014868 Ost48 X X protein amino acid N-linked glycosylation; GO:0006487; protein amino acid N-linked glycosylation via asparagine; GO:0018279 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789 Ost48 Oligosaccharyltransferase 48kD subunit "CG9022, CG9022, DmOST50, OST48, clone 1.11, DrOST, OST48/WBP1, anon-EST:Liang-1.11" CDMC21157 4 11 12 DAC19-L12 3-CG9460-RA_3 CG9460 AATCAAGGACCTCATTGCTCCGGAATCTCTGGACGCAGATACTTCGGCCATCCTGGTCAATGCCATCT 68 FBan0009460 FBgn0033115 CG9460 2 2R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9460 CG9460 CDMC21157 4 12 12 DAC19-L12 3-CG9460-RA_3 CG9460 AATCAAGGACCTCATTGCTCCGGAATCTCTGGACGCAGATACTTCGGCCATCCTGGTCAATGCCATCT 68 FBan0009460 FBgn0033115 CG9460 2 2R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9460 CG9460 CDMC21158 4 13 12 DAC19-L24 2-CG9626-RA_1 CG9626 GCAAATGCGAGCAACAAGATTGAGCACAAGATAGCCAAGACTAGCTCAGGACCCAGTTTCTCCCGGGT 68 FBan0009626 FBgn0037565 CG9626 3 3R CG9626 CG9626 CDMC21158 4 14 12 DAC19-L24 2-CG9626-RA_1 CG9626 GCAAATGCGAGCAACAAGATTGAGCACAAGATAGCCAAGACTAGCTCAGGACCCAGTTTCTCCCGGGT 68 FBan0009626 FBgn0037565 CG9626 3 3R CG9626 CG9626 CDMC21159 4 15 12 DAC19-P12 23-CR31850-RA_1 CR31850 TTATGGCTAAGATCAAAGTGTAGTATCTGTTCTTATCAGCTTAACATCTGATAGTTCCTCCATTGGAG 68 FBan0031850 FBgn0004191 snRNA:U2:34ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U2; GO:0005686 snRNA:U2:34ABa small nuclear RNA U2 at 34ABa "dU2, K6, Dm U2-131A, U2, U2 131A, 131A, D.U2-1, U2-131A, U2 snRNA, U2-34ABa, snRNA:U2, U2snRNA, CR31850, U2snRNA34ABa, snRNA-U2-131A, small nuclear RNA U2" CDMC21159 4 16 12 DAC19-P12 23-CR31850-RA_1 CR31850 TTATGGCTAAGATCAAAGTGTAGTATCTGTTCTTATCAGCTTAACATCTGATAGTTCCTCCATTGGAG 68 FBan0031850 FBgn0004191 snRNA:U2:34ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U2; GO:0005686 snRNA:U2:34ABa small nuclear RNA U2 at 34ABa "dU2, K6, Dm U2-131A, U2, U2 131A, 131A, D.U2-1, U2-131A, U2 snRNA, U2-34ABa, snRNA:U2, U2snRNA, CR31850, U2snRNA34ABa, snRNA-U2-131A, small nuclear RNA U2" CDMC21160 4 17 12 DAC19-P24 AutoBlank AutoBlank CDMC21160 4 18 12 DAC19-P24 AutoBlank AutoBlank CDMC21161 4 19 12 DAC20-D12 3-CG18088-RA_1 CG18088 GGTGCACCTGCGAACCCTACAAGATTATCTCGGGACAAGATTGGACGACTCCTATTGCCCACAGTGTGA 69 FBan0018088 FBgn0032082 CG18088 2 2L CG18088 CG18088 CDMC21161 4 20 12 DAC20-D12 3-CG18088-RA_1 CG18088 GGTGCACCTGCGAACCCTACAAGATTATCTCGGGACAAGATTGGACGACTCCTATTGCCCACAGTGTGA 69 FBan0018088 FBgn0032082 CG18088 2 2L CG18088 CG18088 CDMC21162 4 21 12 DAC20-D24 13-CG18103-RA_2 CG18103 AGGCTGAAAAGTGTGTTCGGTTTGCATCCCAGGAGAAAACAATCGCTCACTCATTTATCCCACTTGCCA 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC21162 4 22 12 DAC20-D24 13-CG18103-RA_2 CG18103 AGGCTGAAAAGTGTGTTCGGTTTGCATCCCAGGAGAAAACAATCGCTCACTCATTTATCCCACTTGCCA 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC21163 4 23 12 DAC20-H12 15-CG1815-RA_1 CG1815 AGCAGCATCAGAAGCAAGTACCAAAAGCTACTGGTCGCTCAGGTAAAAACAATAGCCGAATGCGCCAAA 69 FBan0001815 FBgn0039863 CG1815 3 3R "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; protein kinase C binding; GO:0005080; receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005080; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG1815 CG1815 CDMC21163 4 24 12 DAC20-H12 15-CG1815-RA_1 CG1815 AGCAGCATCAGAAGCAAGTACCAAAAGCTACTGGTCGCTCAGGTAAAAACAATAGCCGAATGCGCCAAA 69 FBan0001815 FBgn0039863 CG1815 3 3R "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; protein kinase C binding; GO:0005080; receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005080; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG1815 CG1815 CDMC21164 4 25 12 DAC20-H24 17-CG1817-RA_1 CG1817 AGGAGCTGTATATGCACGATGAGTTCGAGACCCACATCGATACCAAGTCGAATAATGCCAACGATGACA 69 FBan0001817 FBgn0004370 Ptp10D X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; receptor signaling protein tyrosine phosphatase activity; GO:0004728; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004896; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp10D Protein tyrosine phosphatase 10D "CG1817, CG1817, CG1817, CG1817, CG1817, DPTP[[10D]], DPTP10D, PTP10D, DPTP, R-PTP 10D, CT4920, Ptp10" CDMC21164 4 26 12 DAC20-H24 17-CG1817-RA_1 CG1817 AGGAGCTGTATATGCACGATGAGTTCGAGACCCACATCGATACCAAGTCGAATAATGCCAACGATGACA 69 FBan0001817 FBgn0004370 Ptp10D X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; receptor signaling protein tyrosine phosphatase activity; GO:0004728; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004896; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp10D Protein tyrosine phosphatase 10D "CG1817, CG1817, CG1817, CG1817, CG1817, DPTP[[10D]], DPTP10D, PTP10D, DPTP, R-PTP 10D, CT4920, Ptp10" CDMC21165 4 1 13 DAC20-L12 2-CG18233-RA_1 CG18233 ATTCAACGCCAGATCCACGATCCCTGCACTCTGTGTGTCCAGTTTTAGTGGGTTCACGATGGAGTGAGT 69 FBan0018233 FBgn0036795 CG18233 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18233 CG18233 CDMC21165 4 2 13 DAC20-L12 2-CG18233-RA_1 CG18233 ATTCAACGCCAGATCCACGATCCCTGCACTCTGTGTGTCCAGTTTTAGTGGGTTCACGATGGAGTGAGT 69 FBan0018233 FBgn0036795 CG18233 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18233 CG18233 CDMC21166 4 3 13 DAC20-L24 14-CG18251-RA_1 CG18251 CCCAGGAACGGTGGCTACGGTACAACTGTCAACTGCCGTCATTACTCTAATCAATGAAACATGACCCGT 69 FBgn0010070 CDMC21166 4 4 13 DAC20-L24 14-CG18251-RA_1 CG18251 CCCAGGAACGGTGGCTACGGTACAACTGTCAACTGCCGTCATTACTCTAATCAATGAAACATGACCCGT 69 FBgn0010070 CDMC21167 4 5 13 DAC20-P12 2-CG18287-RA_3 CG18287 GCCGAGACCAGGACTACTGCGCTTCAGGAACAATCCGCGTGGTATTAAGTTTCGGGAAAAACTGTGCAA 69 FBan0018287 FBgn0039679 ppk19 3 3R sensory perception of salty taste; GO:0050914; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk19 pickpocket 19 "CG18287, PPK19" CDMC21167 4 6 13 DAC20-P12 2-CG18287-RA_3 CG18287 GCCGAGACCAGGACTACTGCGCTTCAGGAACAATCCGCGTGGTATTAAGTTTCGGGAAAAACTGTGCAA 69 FBan0018287 FBgn0039679 ppk19 3 3R sensory perception of salty taste; GO:0050914; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk19 pickpocket 19 "CG18287, PPK19" CDMC21168 4 7 13 DAC20-P24 AutoBlank AutoBlank CDMC21168 4 8 13 DAC20-P24 AutoBlank AutoBlank CDMC21169 4 9 13 DAC21-D12 1-CG3927-RA_3 CG3927 GGAAACCCCAAGCGAGTTAACTGAGAAACAGAACCAAGACCAACCTACCTACCAGCCGCGACTGAACGA 69 FBan0003927 FBgn0034739 CG3927 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003729 CG3927 CG3927 "cg3927, BcDNA:AT29209" CDMC21169 4 10 13 DAC21-D12 1-CG3927-RA_3 CG3927 GGAAACCCCAAGCGAGTTAACTGAGAAACAGAACCAAGACCAACCTACCTACCAGCCGCGACTGAACGA 69 FBan0003927 FBgn0034739 CG3927 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003729 CG3927 CG3927 "cg3927, BcDNA:AT29209" CDMC21170 4 11 13 DAC21-D24 22-CG3938-RB_1 CG3938 ACACTATCCAGAATTCAGTGGTGTGACGCTCTCACAAACCAAGTTGGGTGCCTCAAAAATGAAACAACA 69 FBan0003938 FBgn0010382 CycE 2 2L G1/S transition of mitotic cell cycle; GO:0000082; JAK-STAT cascade; GO:0007259; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; regulation of protein amino acid phosphorylation; GO:0001932; sensory organ development; GO:0007423 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycE Cyclin E "CG3938, l(2)br37, br37, CDI7, cycE, DmcycE, l35Dd, l(2)35Dd, fond, DmcyclinE, cyclinE, DmCycE, cyclin E, l(2)k02602, l(2)k05007, BG:DS07108.3, CyeE, fondue, D-CycE, Cyc E, cycline E, Cdi7, cdi7, l(2)05206, l(2)k02514, Cyclin-dependent kinase interactor 7, Cyclin E" CDMC21170 4 12 13 DAC21-D24 22-CG3938-RB_1 CG3938 ACACTATCCAGAATTCAGTGGTGTGACGCTCTCACAAACCAAGTTGGGTGCCTCAAAAATGAAACAACA 69 FBan0003938 FBgn0010382 CycE 2 2L G1/S transition of mitotic cell cycle; GO:0000082; JAK-STAT cascade; GO:0007259; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; regulation of protein amino acid phosphorylation; GO:0001932; sensory organ development; GO:0007423 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycE Cyclin E "CG3938, l(2)br37, br37, CDI7, cycE, DmcycE, l35Dd, l(2)35Dd, fond, DmcyclinE, cyclinE, DmCycE, cyclin E, l(2)k02602, l(2)k05007, BG:DS07108.3, CyeE, fondue, D-CycE, Cyc E, cycline E, Cdi7, cdi7, l(2)05206, l(2)k02514, Cyclin-dependent kinase interactor 7, Cyclin E" CDMC21171 4 13 13 DAC21-H12 22-CG3973-RA_1 CG3973 TCAGAAGACAGGATCCCGGAGAATCAGAAAATGGAATGGGAAAGACGAAGATCGGCCATTGAAAACGAT 69 FBan0003973 FBgn0029881 CG3973 X X CG3973 CG3973 CDMC21171 4 14 13 DAC21-H12 22-CG3973-RA_1 CG3973 TCAGAAGACAGGATCCCGGAGAATCAGAAAATGGAATGGGAAAGACGAAGATCGGCCATTGAAAACGAT 69 FBan0003973 FBgn0029881 CG3973 X X CG3973 CG3973 CDMC21172 4 15 13 DAC21-H24 6-CG3984-RA_6 CG3984 TGCGGAGGTCAAACGGGGATTCAATGCAATCCTTCCAATCCTGTGACTACTGTTGTTCCTGGTACCCCC 69 FBan0003984 FBgn0038291 CG3984 3 3R CG3984 CG3984 CDMC21172 4 16 13 DAC21-H24 6-CG3984-RA_6 CG3984 TGCGGAGGTCAAACGGGGATTCAATGCAATCCTTCCAATCCTGTGACTACTGTTGTTCCTGGTACCCCC 69 FBan0003984 FBgn0038291 CG3984 3 3R CG3984 CG3984 CDMC21173 4 17 13 DAC21-L12 8-CG40057-RA_3 CG40057 GGGCCGACTGAAAGAGTCCCAGAGATACAACATAGAACCATCGTGCCAGAAAGCCCGATTAACGTACGC 69 FBgn0058057 CG40057 CG40057 CG40057 CDMC21173 4 18 13 DAC21-L12 8-CG40057-RA_3 CG40057 GGGCCGACTGAAAGAGTCCCAGAGATACAACATAGAACCATCGTGCCAGAAAGCCCGATTAACGTACGC 69 FBgn0058057 CG40057 CG40057 CG40057 CDMC21174 4 19 13 DAC21-L24 23-CG40081-RA_7 CG40081 GCAAGTTCAGAGGTGAAAATATACTCATACCACGAATTCCTGTTATACCTAGAGATGTGCCAATTCAAT 69 FBgn0058081 CG40081 CG40081 CG40081 CDMC21174 4 20 13 DAC21-L24 23-CG40081-RA_7 CG40081 GCAAGTTCAGAGGTGAAAATATACTCATACCACGAATTCCTGTTATACCTAGAGATGTGCCAATTCAAT 69 FBgn0058081 CG40081 CG40081 CG40081 CDMC21175 4 21 13 DAC21-P12 11-CG40128-RA_1 CG40128 CCCGCGACAAGAAAATCCTCAAGCCCGCAGGTTACGACTTTTTCGACACGCACTTTTCACAACTAGACT 69 FBgn0058128 CG40128 CG40128 CG40128 CDMC21175 4 22 13 DAC21-P12 11-CG40128-RA_1 CG40128 CCCGCGACAAGAAAATCCTCAAGCCCGCAGGTTACGACTTTTTCGACACGCACTTTTCACAACTAGACT 69 FBgn0058128 CG40128 CG40128 CG40128 CDMC21176 4 23 13 DAC21-P24 2-CG40143-RA_1 CG40143 GGCACCCAGTACCTCACACCCCAGGAATCGAAACTCAAAACAGAAGCCGAAATGGAAACTGCACGAGAT 69 FBgn0058143 CG40143 CG40143 CG40143 CDMC21176 4 24 13 DAC21-P24 2-CG40143-RA_1 CG40143 GGCACCCAGTACCTCACACCCCAGGAATCGAAACTCAAAACAGAAGCCGAAATGGAAACTGCACGAGAT 69 FBgn0058143 CG40143 CG40143 CG40143 CDMC21177 4 25 13 DAC22-D12 2-CG13802-RA_1 CG13802 ATGCTGCTGTTTCCACTAACGACATCAGCCTGGTCGAGAAGCTACATTTGCAGCCCAGTCCAAGG 65 FBan0013802 FBgn0035330 CG13802 3 3L CG13802 CG13802 CDMC21177 4 26 13 DAC22-D12 2-CG13802-RA_1 CG13802 ATGCTGCTGTTTCCACTAACGACATCAGCCTGGTCGAGAAGCTACATTTGCAGCCCAGTCCAAGG 65 FBan0013802 FBgn0035330 CG13802 3 3L CG13802 CG13802 CDMC21178 4 1 14 DAC22-D24 9-CG13811-RA_1 CG13811 CGGAGTACGCCTATCAGCACCTGAGCAGCGTTGCCACAACCAATTCGAGCACATCTTTGGAGAGC 65 FBan0013811 FBgn0036944 CG13811 3 3L CG13811 CG13811 CDMC21178 4 2 14 DAC22-D24 9-CG13811-RA_1 CG13811 CGGAGTACGCCTATCAGCACCTGAGCAGCGTTGCCACAACCAATTCGAGCACATCTTTGGAGAGC 65 FBan0013811 FBgn0036944 CG13811 3 3L CG13811 CG13811 CDMC21179 4 3 14 DAC22-H12 1-CG13905-RA_1 CG13905 AGAGCCATTAACTCCCTACCCGCCTATCGATTCTACCGCCAGTTGATCAACCAACCCGAAGTGCG 65 FBan0013905 FBgn0035176 CG13905 3 3L CG13905 CG13905 CDMC21179 4 4 14 DAC22-H12 1-CG13905-RA_1 CG13905 AGAGCCATTAACTCCCTACCCGCCTATCGATTCTACCGCCAGTTGATCAACCAACCCGAAGTGCG 65 FBan0013905 FBgn0035176 CG13905 3 3L CG13905 CG13905 CDMC21180 4 5 14 DAC22-H24 3-CG13928-RA_1 CG13928 CCAGTCAATCCAGGCACCGAGGTTCTCCCTTCATCTTCATTTTCCAACTCACTTCCGGGGTGTGG 65 FBan0013928 FBgn0035246 CG13928 3 3L CG13928 CG13928 CDMC21180 4 6 14 DAC22-H24 3-CG13928-RA_1 CG13928 CCAGTCAATCCAGGCACCGAGGTTCTCCCTTCATCTTCATTTTCCAACTCACTTCCGGGGTGTGG 65 FBan0013928 FBgn0035246 CG13928 3 3L CG13928 CG13928 CDMC21181 4 7 14 DAC22-L12 16-CG13988-RA_1 CG13988 CAGTGAAGCGACCTTCTCCAGCAACATCAGCATGTTCTCCCGCCAGTGCCTTTCCCACCTCACCC 65 FBan0013988 FBgn0040951 CG13988 2 2L CG13988 CG13988 CDMC21181 4 8 14 DAC22-L12 16-CG13988-RA_1 CG13988 CAGTGAAGCGACCTTCTCCAGCAACATCAGCATGTTCTCCCGCCAGTGCCTTTCCCACCTCACCC 65 FBan0013988 FBgn0040951 CG13988 2 2L CG13988 CG13988 CDMC21182 4 9 14 DAC22-L24 1-CG14004-RA_1 CG14004 AGACGGTAAGGGCATGGCAACAGGAATCGGATGTGGAGCACCGAAAACAACATAAGCAGCGATGG 65 FBan0014004 FBgn0031742 CG14004 2 2L CG14004 CG14004 CDMC21182 4 10 14 DAC22-L24 1-CG14004-RA_1 CG14004 AGACGGTAAGGGCATGGCAACAGGAATCGGATGTGGAGCACCGAAAACAACATAAGCAGCGATGG 65 FBan0014004 FBgn0031742 CG14004 2 2L CG14004 CG14004 CDMC21183 4 11 14 DAC22-P12 3-CG14100-RA_3 CG14100 CTGGAGTTTGTGCGTCTCACTCTGCAGGATCCACTTACCAGCACCCTACTAACCACAGTGCGCTC 65 FBan0014100 FBgn0036889 CG14100 3 3L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.- CG14100 CG14100 CDMC21183 4 12 14 DAC22-P12 3-CG14100-RA_3 CG14100 CTGGAGTTTGTGCGTCTCACTCTGCAGGATCCACTTACCAGCACCCTACTAACCACAGTGCGCTC 65 FBan0014100 FBgn0036889 CG14100 3 3L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.- CG14100 CG14100 CDMC21184 4 13 14 DAC22-P24 AutoBlank AutoBlank CDMC21184 4 14 14 DAC22-P24 AutoBlank AutoBlank CDMC21185 4 15 14 DAC23-D12 8-CG4747-RA_2 CG4747 GGCCGCTACATCGGTCAAGTCGACAAAGGGATCGGCAAAATCAGCACAGAAACGGCGTACCTCTG 65 FBan0004747 FBgn0043456 CG4747 2 2L pentose-phosphate shunt; GO:0006098 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 CG4747 CG4747 "LD29743, Dm_AI388468, BEST:LD22483, BEST:LD29743, BEST:GH19401" CDMC21185 4 16 14 DAC23-D12 8-CG4747-RA_2 CG4747 GGCCGCTACATCGGTCAAGTCGACAAAGGGATCGGCAAAATCAGCACAGAAACGGCGTACCTCTG 65 FBan0004747 FBgn0043456 CG4747 2 2L pentose-phosphate shunt; GO:0006098 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 CG4747 CG4747 "LD29743, Dm_AI388468, BEST:LD22483, BEST:LD29743, BEST:GH19401" CDMC21186 4 17 14 DAC23-D24 6-CG4824-RA_1 CG4824 CTCCAGTCAACCGACGGATGCAGCTAGCCAAGCACAAGGACATCCAGACTCTGCTCACCAGTTTG 65 FBan0004824 FBgn0000182 BicC 2 2L follicle cell migration (sensu Insecta); GO:0007297; negative regulation of oskar mRNA translation; GO:0007319; oogenesis (sensu Insecta); GO:0009993 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 integral to plasma membrane; GO:0005887 BicC Bicaudal C "CG4824, l(2)br34, br34, Bic-C, BG:DS00913.2, Bicaudal-C" CDMC21186 4 18 14 DAC23-D24 6-CG4824-RA_1 CG4824 CTCCAGTCAACCGACGGATGCAGCTAGCCAAGCACAAGGACATCCAGACTCTGCTCACCAGTTTG 65 FBan0004824 FBgn0000182 BicC 2 2L follicle cell migration (sensu Insecta); GO:0007297; negative regulation of oskar mRNA translation; GO:0007319; oogenesis (sensu Insecta); GO:0009993 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 integral to plasma membrane; GO:0005887 BicC Bicaudal C "CG4824, l(2)br34, br34, Bic-C, BG:DS00913.2, Bicaudal-C" CDMC21187 4 19 14 DAC23-H12 2-CG4999-RC_1 CG4999 GTGAAGAGCGACGATCCCTCCTAGAACTCCCCCAAAAAATACAACGCCCTACCGAACACCGCGAC 65 FBan0004999 FBgn0035936 Tsp66E 3 3L cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp66E Tetraspanin 66E "CG4999, CG4999, CG4999, CG4999, Dm.Tsp66E, Tetraspanin 66E" CDMC21187 4 20 14 DAC23-H12 2-CG4999-RC_1 CG4999 GTGAAGAGCGACGATCCCTCCTAGAACTCCCCCAAAAAATACAACGCCCTACCGAACACCGCGAC 65 FBan0004999 FBgn0035936 Tsp66E 3 3L cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp66E Tetraspanin 66E "CG4999, CG4999, CG4999, CG4999, Dm.Tsp66E, Tetraspanin 66E" CDMC21188 4 21 14 DAC23-H24 1-CG5070-RA_1 CG5070 GATCAGGATATGGCGCCGGCTATGGATACGCTCCCGAGAACGTGGTGAAGGTGATCAAGGTATCG 65 FBan0005070 FBgn0030824 CG5070 X X CG5070 CG5070 CDMC21188 4 22 14 DAC23-H24 1-CG5070-RA_1 CG5070 GATCAGGATATGGCGCCGGCTATGGATACGCTCCCGAGAACGTGGTGAAGGTGATCAAGGTATCG 65 FBan0005070 FBgn0030824 CG5070 X X CG5070 CG5070 CDMC21189 4 23 14 DAC23-L12 23-CG5192-RB_2 CG5192 TAGGGAACTGACAGCTCTAGATCTACAAAAGACTCAACTATTTTGCAAATGGCACCTCAAGGAAA 65 FBan0005192 FBgn0019940 Rh6 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh6 Rhodopsin 6 "CG5192, rh6, Dm Rh6, rhodopsin, Rh, DMELRH6, RH6, Rhodopsin" CDMC21189 4 24 14 DAC23-L12 23-CG5192-RB_2 CG5192 TAGGGAACTGACAGCTCTAGATCTACAAAAGACTCAACTATTTTGCAAATGGCACCTCAAGGAAA 65 FBan0005192 FBgn0019940 Rh6 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh6 Rhodopsin 6 "CG5192, rh6, Dm Rh6, rhodopsin, Rh, DMELRH6, RH6, Rhodopsin" CDMC21190 4 25 14 DAC23-L24 6-CG5219-RA_1 CG5219 CAGGACCGCCTAGTTCTGGCCCAGAAGTACGGCTATCAGCTGCCCAAAATTGAGGAAGATTCCGC 65 FBan0005219 FBgn0036990 mRpL15 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL15 mitochondrial ribosomal protein L15 "CG5219, CG5219, 50S ribosomal protein L15, l(3)77CDc, L15, mitochondrial ribosomal protein L15" CDMC21190 4 26 14 DAC23-L24 6-CG5219-RA_1 CG5219 CAGGACCGCCTAGTTCTGGCCCAGAAGTACGGCTATCAGCTGCCCAAAATTGAGGAAGATTCCGC 65 FBan0005219 FBgn0036990 mRpL15 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL15 mitochondrial ribosomal protein L15 "CG5219, CG5219, 50S ribosomal protein L15, l(3)77CDc, L15, mitochondrial ribosomal protein L15" CDMC21191 4 1 15 DAC23-P12 18-CG5344-RB_3 CG5344 CATCATCAACAATATGATGCGACTGAATCTGCGCGTAGAGGACTTCCAGATCGAGCACACACGCC 65 FBan0005344 FBgn0037917 wkd 3 3R "chromosome segregation; GO:0007059; mitosis; GO:0007067; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" hormone activity; GO:0005179; ; GO:0005179; Rab GTPase activator activity; GO:0005097; ; GO:0005097 extracellular region; GO:0005576 wkd whacked "CG5344, CG5344, CG5344, whacked" CDMC21191 4 2 15 DAC23-P12 18-CG5344-RB_3 CG5344 CATCATCAACAATATGATGCGACTGAATCTGCGCGTAGAGGACTTCCAGATCGAGCACACACGCC 65 FBan0005344 FBgn0037917 wkd 3 3R "chromosome segregation; GO:0007059; mitosis; GO:0007067; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" hormone activity; GO:0005179; ; GO:0005179; Rab GTPase activator activity; GO:0005097; ; GO:0005097 extracellular region; GO:0005576 wkd whacked "CG5344, CG5344, CG5344, whacked" CDMC21192 4 3 15 DAC23-P24 AutoBlank AutoBlank CDMC21192 4 4 15 DAC23-P24 AutoBlank AutoBlank CDMC21193 4 5 15 DAC24-D12 2-CG9210-RA_3 CG9210 ACCAGACCATCCGTCGTCGACAACCACAAGTGGCTAAGAGTATGGAGCTGTTGCCAGAAAACCAAACCA 69 FBan0009210 FBgn0022710 Ac13E X X G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac13E Adenylyl cyclase 35C "CG9210, CG9210, adenylyl cyclase, DAC9, AC 13E, Ac35C, Adenylyl cyclase 35C" CDMC21193 4 6 15 DAC24-D12 2-CG9210-RA_3 CG9210 ACCAGACCATCCGTCGTCGACAACCACAAGTGGCTAAGAGTATGGAGCTGTTGCCAGAAAACCAAACCA 69 FBan0009210 FBgn0022710 Ac13E X X G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac13E Adenylyl cyclase 35C "CG9210, CG9210, adenylyl cyclase, DAC9, AC 13E, Ac35C, Adenylyl cyclase 35C" CDMC21194 4 7 15 DAC24-D24 18-CG9224-RA_4 CG9224 GCGCACACAGACTTGTGCAAGGAGTTGCATAGATCGTTGTTGCTATCTTATCATGTGGCAGCAATGAGA 69 FBan0009224 FBgn0003463 sog X X "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; ectoderm development; GO:0007398; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; positive regulation of transforming growth factor beta receptor signaling pathway; GO:0030511; regulation of BMP signaling pathway; GO:0030510; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; wing vein morphogenesis; GO:0008586; zygotic determination of anterior/posterior axis, embryo; GO:0007354" growth factor activity; GO:0008083; ; GO:0008083 integral to membrane; GO:0016021; plasma membrane; GO:0005886 sog short gastrulation "CG9224, CG9224, CG9224, l(1)G0395, l(1)G0160, l(1)G0479, Sog" CDMC21194 4 8 15 DAC24-D24 18-CG9224-RA_4 CG9224 GCGCACACAGACTTGTGCAAGGAGTTGCATAGATCGTTGTTGCTATCTTATCATGTGGCAGCAATGAGA 69 FBan0009224 FBgn0003463 sog X X "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; ectoderm development; GO:0007398; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; positive regulation of transforming growth factor beta receptor signaling pathway; GO:0030511; regulation of BMP signaling pathway; GO:0030510; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; wing vein morphogenesis; GO:0008586; zygotic determination of anterior/posterior axis, embryo; GO:0007354" growth factor activity; GO:0008083; ; GO:0008083 integral to membrane; GO:0016021; plasma membrane; GO:0005886 sog short gastrulation "CG9224, CG9224, CG9224, l(1)G0395, l(1)G0160, l(1)G0479, Sog" CDMC21195 4 9 15 DAC24-H12 16-CG9261-RA_1 CG9261 TCAGAGGTGTGTGAGGACGATAAGTCTCGTCTAAGACAATCCTACCAGAGGCAAACCACCAGATGTTGT 69 FBan0009261 FBgn0015777 nrv2 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; sodium ion transport; GO:0006814; tracheal system development (sensu Insecta); GO:0007424 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv2 nervana 2 "CG9261, nervana, Nrv2: Nervana 2, 42kDa, l(2)k13315, l(2)k04223, ectatic, Nervana, Na[+]/K[+]-ATPase, nervana2, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, l(2)SH2 0329, Nrv: Nirvana, NEST:bs13c10, ecta, l(2)SH0329, Nervana 2, Nirvana, Nrv2" CDMC21195 4 10 15 DAC24-H12 16-CG9261-RA_1 CG9261 TCAGAGGTGTGTGAGGACGATAAGTCTCGTCTAAGACAATCCTACCAGAGGCAAACCACCAGATGTTGT 69 FBan0009261 FBgn0015777 nrv2 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; sodium ion transport; GO:0006814; tracheal system development (sensu Insecta); GO:0007424 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv2 nervana 2 "CG9261, nervana, Nrv2: Nervana 2, 42kDa, l(2)k13315, l(2)k04223, ectatic, Nervana, Na[+]/K[+]-ATPase, nervana2, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, l(2)SH2 0329, Nrv: Nirvana, NEST:bs13c10, ecta, l(2)SH0329, Nervana 2, Nirvana, Nrv2" CDMC21196 4 11 15 DAC24-H24 8-CG9279-RA_2 CG9279 ACGTGAAAAACCTCGAGCTGACTGTGGCTGAACGGGAGAAGGAAATCAAAAGCCTCAAGTACACAGCCA 69 FBan0009279 FBgn0036882 CG9279 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 dynactin complex; GO:0005869 CG9279 CG9279 CDMC21196 4 12 15 DAC24-H24 8-CG9279-RA_2 CG9279 ACGTGAAAAACCTCGAGCTGACTGTGGCTGAACGGGAGAAGGAAATCAAAAGCCTCAAGTACACAGCCA 69 FBan0009279 FBgn0036882 CG9279 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 dynactin complex; GO:0005869 CG9279 CG9279 CDMC21197 4 13 15 DAC24-L12 2-CG9310-RA_2 CG9310 TTGCAATAGGACACCCCTTAAGCACACAACCCATACACATACAGGCCCTCTCTTGCTGTACTCCCCACC 69 FBan0009310 FBgn0004914 Hnf4 2 2L endoderm development; GO:0007492; lipid biosynthesis; GO:0008610; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 nucleus; GO:0005634 Hnf4 Hepatocyte nuclear factor 4 "CG9310, Hnf-4h, Hepatocyte nuclear factor 4 homologue, HNF4, HNF-4(D), dHNF4, DmHNF4, NR2A4, hepatocyte nuclear factor 4, HNF-4" CDMC21197 4 14 15 DAC24-L12 2-CG9310-RA_2 CG9310 TTGCAATAGGACACCCCTTAAGCACACAACCCATACACATACAGGCCCTCTCTTGCTGTACTCCCCACC 69 FBan0009310 FBgn0004914 Hnf4 2 2L endoderm development; GO:0007492; lipid biosynthesis; GO:0008610; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 nucleus; GO:0005634 Hnf4 Hepatocyte nuclear factor 4 "CG9310, Hnf-4h, Hepatocyte nuclear factor 4 homologue, HNF4, HNF-4(D), dHNF4, DmHNF4, NR2A4, hepatocyte nuclear factor 4, HNF-4" CDMC21198 4 15 15 DAC24-L24 18-CG9324-RA_1 CG9324 CGCTGTGGTGGAGAAATCTCTGGGAATTTACCAATAAGTCCCTGCAAATGAAGTTGCTAAATGCCTGGC 69 FBan0009324 FBgn0032884 Pomp 2 2L proteolysis; GO:0006508 proteasome complex (sensu Eukaryota); GO:0000502 Pomp Pomp "CG9324, 38E.20, POMP, Pomp" CDMC21198 4 16 15 DAC24-L24 18-CG9324-RA_1 CG9324 CGCTGTGGTGGAGAAATCTCTGGGAATTTACCAATAAGTCCCTGCAAATGAAGTTGCTAAATGCCTGGC 69 FBan0009324 FBgn0032884 Pomp 2 2L proteolysis; GO:0006508 proteasome complex (sensu Eukaryota); GO:0000502 Pomp Pomp "CG9324, 38E.20, POMP, Pomp" CDMC21199 4 17 15 DAC24-P12 17-CG9354-RA_1 CG9354 GCAGCCCAAACTGCACCCACCCTAGTGTAACTCCAAACTAATAATGATTTTCACCGCTTTTGCACATGT 69 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC21199 4 18 15 DAC24-P12 17-CG9354-RA_1 CG9354 GCAGCCCAAACTGCACCCACCCTAGTGTAACTCCAAACTAATAATGATTTTCACCGCTTTTGCACATGT 69 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC21200 4 19 15 DAC24-P24 12-CG9361-RA_2 CG9361 TTGGTTTCGGCGATTATGTGGCATTGCAGAACGACCAAGCTCTAACTAATAAGCCTGGCTATGTGGCGC 69 FBan0009361 FBgn0037690 Task7 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 Task7 Task7 "CG9361, CG9361, K2P-TASK7, dTASK-7" CDMC21200 4 20 15 DAC24-P24 12-CG9361-RA_2 CG9361 TTGGTTTCGGCGATTATGTGGCATTGCAGAACGACCAAGCTCTAACTAATAAGCCTGGCTATGTGGCGC 69 FBan0009361 FBgn0037690 Task7 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 Task7 Task7 "CG9361, CG9361, K2P-TASK7, dTASK-7" CDMC21201 4 21 15 DAC25-D12 3-CG10595-RB_1 CG10595 TCCGCCGTCTCGTTCCTACACGATCACCGGGAATTCGAAAATAAGCTATCCCCAAAACCGGGTCATGAA 69 FBan0010595 FBgn0000410 d 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 d dachs "CG10595, CG31610, CG10595, clone 1.78, 29C3-D1, AAF52683, 29CD, Myo29D, unconventional myosin 29D, myosin 29D, anon-EST:Liang-1.78" CDMC21201 4 22 15 DAC25-D12 3-CG10595-RB_1 CG10595 TCCGCCGTCTCGTTCCTACACGATCACCGGGAATTCGAAAATAAGCTATCCCCAAAACCGGGTCATGAA 69 FBan0010595 FBgn0000410 d 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 d dachs "CG10595, CG31610, CG10595, clone 1.78, 29C3-D1, AAF52683, 29CD, Myo29D, unconventional myosin 29D, myosin 29D, anon-EST:Liang-1.78" CDMC21202 4 23 15 DAC25-D24 23-CG10601-RA_6 CG10601 ACGATTATATCATTGCTTTTTTGATCGATTTGAGTTCGAAAAAACTAGCGGTACCCCTTCAAGGTCCTG 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC21202 4 24 15 DAC25-D24 23-CG10601-RA_6 CG10601 ACGATTATATCATTGCTTTTTTGATCGATTTGAGTTCGAAAAAACTAGCGGTACCCCTTCAAGGTCCTG 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC21203 4 25 15 DAC25-H12 18-CG10629-RA_2 CG10629 AGTCATGGAAATGAAGCACTTGAAGATCTACCGCACATTTGACGATGAAACTCTGGAGAAGATGCGGCA 69 FBan0010629 FBgn0035609 CG10629 3 3L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10629 CG10629 CDMC21203 4 26 15 DAC25-H12 18-CG10629-RA_2 CG10629 AGTCATGGAAATGAAGCACTTGAAGATCTACCGCACATTTGACGATGAAACTCTGGAGAAGATGCGGCA 69 FBan0010629 FBgn0035609 CG10629 3 3L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10629 CG10629 CDMC21204 4 1 16 DAC25-H24 18-CG10638-RB_5 CG10638 GGGACATATACCACGAACCCAAGATGGTGAAATACGCCTGTGATATGCAATTAAAGCTACTGGGCGTGG 69 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC21204 4 2 16 DAC25-H24 18-CG10638-RB_5 CG10638 GGGACATATACCACGAACCCAAGATGGTGAAATACGCCTGTGATATGCAATTAAAGCTACTGGGCGTGG 69 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC21205 4 3 16 DAC25-L12 2-CG10670-RA_1 CG10670 GGTCACCAGCTTCATTACGAACCCATGGCGGAAGATTTGAGCTTACGTCTGGCGCAGATGAGTCTAGGA 69 FBan0010670 FBgn0027914 Gen 3 3L "DNA catabolism, endonucleolytic; GO:0000737; DNA catabolism, exonucleolytic; GO:0000738; DNA replication; GO:0006260; base-excision repair; GO:0006284" damaged DNA binding; GO:0003684; endodeoxyribonuclease activity; GO:0004520; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0004519; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0048256; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003684; ; GO:0000014; 5'-3' exodeoxyribonuclease activity; GO:0035312; ; GO:0035312; ; GO:0008311; ; GO:0008310 nucleus; GO:0005634 Gen XPG-like endonuclease "CG10670, CG10670, BcDNA:GM10765, DmGEN, XPG-like endonuclease" CDMC21205 4 4 16 DAC25-L12 2-CG10670-RA_1 CG10670 GGTCACCAGCTTCATTACGAACCCATGGCGGAAGATTTGAGCTTACGTCTGGCGCAGATGAGTCTAGGA 69 FBan0010670 FBgn0027914 Gen 3 3L "DNA catabolism, endonucleolytic; GO:0000737; DNA catabolism, exonucleolytic; GO:0000738; DNA replication; GO:0006260; base-excision repair; GO:0006284" damaged DNA binding; GO:0003684; endodeoxyribonuclease activity; GO:0004520; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0004519; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0048256; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003684; ; GO:0000014; 5'-3' exodeoxyribonuclease activity; GO:0035312; ; GO:0035312; ; GO:0008311; ; GO:0008310 nucleus; GO:0005634 Gen XPG-like endonuclease "CG10670, CG10670, BcDNA:GM10765, DmGEN, XPG-like endonuclease" CDMC21206 4 5 16 DAC25-L24 23-CG10681-RA_1 CG10681 AATGCCTGAGCGAAATGAAGAAGGATCTGGATTACATATTCCGCAAGATACGGATCATCAAGCAGAAGC 69 FBan0010681 FBgn0036291 CG10681 3 3L CG10681 CG10681 CDMC21206 4 6 16 DAC25-L24 23-CG10681-RA_1 CG10681 AATGCCTGAGCGAAATGAAGAAGGATCTGGATTACATATTCCGCAAGATACGGATCATCAAGCAGAAGC 69 FBan0010681 FBgn0036291 CG10681 3 3L CG10681 CG10681 CDMC21207 4 7 16 DAC25-P12 5-CG10718-RA_1 CG10718 GGCCCAACAACAGGAACACACTCCGCTAAGGCATGAAGATGCAGTATCAACTCCAGCACAGAAGTCGAC 69 FBan0010718 FBgn0004374 neb 2 2L "chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; meiosis; GO:0007126; microtubule-based movement; GO:0007018; mitotic cell cycle, embryonic; GO:0045448; mitotic chromosome condensation; GO:0007076; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074" chromatin binding; GO:0003682; protein phosphatase 1 binding; GO:0008157; ; GO:0003682; ATP binding; GO:0005524; ; GO:0008157; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 neb nebbish "CG10718, CG10718, CG10718, Mot, Mothra, KLP-38B, klp38B, Kinesin-like protein at 38B, KLP38B, tio, tiovivo, Klp38, KLP 38B, Klp38B, l(2)k00802, Dm0332, DmKlp38B, KIF14, Neb, 38B.10, 38B.12, l(2)03552, l(2)k07614, sl(2)ry, sl(2)ry3" CDMC21207 4 8 16 DAC25-P12 5-CG10718-RA_1 CG10718 GGCCCAACAACAGGAACACACTCCGCTAAGGCATGAAGATGCAGTATCAACTCCAGCACAGAAGTCGAC 69 FBan0010718 FBgn0004374 neb 2 2L "chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; meiosis; GO:0007126; microtubule-based movement; GO:0007018; mitotic cell cycle, embryonic; GO:0045448; mitotic chromosome condensation; GO:0007076; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074" chromatin binding; GO:0003682; protein phosphatase 1 binding; GO:0008157; ; GO:0003682; ATP binding; GO:0005524; ; GO:0008157; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 neb nebbish "CG10718, CG10718, CG10718, Mot, Mothra, KLP-38B, klp38B, Kinesin-like protein at 38B, KLP38B, tio, tiovivo, Klp38, KLP 38B, Klp38B, l(2)k00802, Dm0332, DmKlp38B, KIF14, Neb, 38B.10, 38B.12, l(2)03552, l(2)k07614, sl(2)ry, sl(2)ry3" CDMC21208 4 9 16 DAC25-P24 AutoBlank AutoBlank CDMC21208 4 10 16 DAC25-P24 AutoBlank AutoBlank CDMC21209 4 11 16 DAC26-D12 2-CG8058-RA_1 CG8058 GCGCTGCAAGACGATCAAAGAGTTCGACGCGCTTTTTACGGCTAAGCAGTTCGGATATGCCCATGTGAA 69 FBan0008058 FBgn0033382 CG8058 2 2R CG8058 CG8058 CDMC21209 4 12 16 DAC26-D12 2-CG8058-RA_1 CG8058 GCGCTGCAAGACGATCAAAGAGTTCGACGCGCTTTTTACGGCTAAGCAGTTCGGATATGCCCATGTGAA 69 FBan0008058 FBgn0033382 CG8058 2 2R CG8058 CG8058 CDMC21210 4 13 16 DAC26-D24 6-CG8067-RA_2 CG8067 GGTCATCGGCTATCCCAGCATGTTCGAACTGATGTGGGATCTCAAGGGTATGGCAGAGAACAATGCTGC 69 FBan0008067 FBgn0033891 CG8067 2 2R CG8067 CG8067 CDMC21210 4 14 16 DAC26-D24 6-CG8067-RA_2 CG8067 GGTCATCGGCTATCCCAGCATGTTCGAACTGATGTGGGATCTCAAGGGTATGGCAGAGAACAATGCTGC 69 FBan0008067 FBgn0033891 CG8067 2 2R CG8067 CG8067 CDMC21211 4 15 16 DAC26-H12 2-CG8102-RA_1 CG8102 GCCCGCTTTGTTAAGGGTCAGACACATCCCCACGAGATCGATTGGACGCTGGTCATTGCCGATAAAATG 69 FBan0008102 FBgn0034007 CG8102 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8102 CG8102 CDMC21211 4 16 16 DAC26-H12 2-CG8102-RA_1 CG8102 GCCCGCTTTGTTAAGGGTCAGACACATCCCCACGAGATCGATTGGACGCTGGTCATTGCCGATAAAATG 69 FBan0008102 FBgn0034007 CG8102 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8102 CG8102 CDMC21212 4 17 16 DAC26-H24 22-CG8116-RA_2 CG8116 TGTGCATGTGCGTTTGAGGTTCCTTTCCTTTTTATATAAGCCCCTCGTCTCTTGCCAACAAACCAACAA 69 FBan0008116 FBgn0037614 CG8116 3 3R CG8116 CG8116 "EP(3)3246, GH04517" CDMC21212 4 18 16 DAC26-H24 22-CG8116-RA_2 CG8116 TGTGCATGTGCGTTTGAGGTTCCTTTCCTTTTTATATAAGCCCCTCGTCTCTTGCCAACAAACCAACAA 69 FBan0008116 FBgn0037614 CG8116 3 3R CG8116 CG8116 "EP(3)3246, GH04517" CDMC21213 4 19 16 DAC26-L12 23-CG8147-RA_2 CG8147 CTAAGCGACAAACGTATTATTCTCGTTTAAGAGAGAAGCCACTAGAAGATAAGCAATCGTTTAAGGGGG 69 FBgn0037699 CDMC21213 4 20 16 DAC26-L12 23-CG8147-RA_2 CG8147 CTAAGCGACAAACGTATTATTCTCGTTTAAGAGAGAAGCCACTAGAAGATAAGCAATCGTTTAAGGGGG 69 FBgn0037699 CDMC21214 4 21 16 DAC26-L24 1-CG8167-RA_1 CG8167 GCTCCGTGGTCAGAAATTAGGCCTCCTAATGCGAAAATCATTGACCCCAACTGACCTGGTCGACGCGAT 69 FBan0008167 FBgn0036046 Ilp2 3 3L growth; GO:0040007; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; regulation of body size; GO:0040014; regulation of cell size; GO:0008361 insulin receptor binding; GO:0005158; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005158 extracellular region; GO:0005576 Ilp2 Insulin-related peptide "CG8167, CG8167, CG8167, dilp2, insulin-like peptide 2, DILP2, DILP, Drosophila insulin-like peptide 2, Dilp 2, dILP2, ILP2, Dilp, Dilp2, dilp-2, dilp, IRP, Insulin-related peptide" CDMC21214 4 22 16 DAC26-L24 1-CG8167-RA_1 CG8167 GCTCCGTGGTCAGAAATTAGGCCTCCTAATGCGAAAATCATTGACCCCAACTGACCTGGTCGACGCGAT 69 FBan0008167 FBgn0036046 Ilp2 3 3L growth; GO:0040007; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; regulation of body size; GO:0040014; regulation of cell size; GO:0008361 insulin receptor binding; GO:0005158; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005158 extracellular region; GO:0005576 Ilp2 Insulin-related peptide "CG8167, CG8167, CG8167, dilp2, insulin-like peptide 2, DILP2, DILP, Drosophila insulin-like peptide 2, Dilp 2, dILP2, ILP2, Dilp, Dilp2, dilp-2, dilp, IRP, Insulin-related peptide" CDMC21215 4 23 16 DAC26-P12 24-CG8198-RA_4 CG8198 TAAGCACTCATATTTTCGAATTTTTTTTGTGGAAATTCTCGAGTCAAACAAATTATATAAAGGGCACGA 69 FBgn0030677 CDMC21215 4 24 16 DAC26-P12 24-CG8198-RA_4 CG8198 TAAGCACTCATATTTTCGAATTTTTTTTGTGGAAATTCTCGAGTCAAACAAATTATATAAAGGGCACGA 69 FBgn0030677 CDMC21216 4 25 16 DAC26-P24 6-CG8208-RA_2 CG8208 CGGCGTACACGGCCAGAGTTCTACGAAGGCTGATTTGACCAAGAATGCCATGGCGTTTATGAATCCTGA 69 FBan0008208 FBgn0027950 MBD-like 3 3R "development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" methyl-CpG binding; GO:0008327; NOT methyl-CpG binding; GO:0008327; ; GO:0008327; histone deacetylase binding; GO:0042826; ; GO:0008327; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008327; ; GO:0042826 NuRD complex; GO:0016581; nucleus; GO:0005634; polytene chromosome; GO:0005700 MBD-like MBD-like "CG8208, CG8208, CG8208, dMBD2/3, dMBD-like, MBD2/3, DmMbd2/3, Dm Mbd2/3, dMbD2/3, MBD2-3, methyl-CpG-binding-domain-like-protein" CDMC21216 4 26 16 DAC26-P24 6-CG8208-RA_2 CG8208 CGGCGTACACGGCCAGAGTTCTACGAAGGCTGATTTGACCAAGAATGCCATGGCGTTTATGAATCCTGA 69 FBan0008208 FBgn0027950 MBD-like 3 3R "development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" methyl-CpG binding; GO:0008327; NOT methyl-CpG binding; GO:0008327; ; GO:0008327; histone deacetylase binding; GO:0042826; ; GO:0008327; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008327; ; GO:0042826 NuRD complex; GO:0016581; nucleus; GO:0005634; polytene chromosome; GO:0005700 MBD-like MBD-like "CG8208, CG8208, CG8208, dMBD2/3, dMBD-like, MBD2/3, DmMbd2/3, Dm Mbd2/3, dMbD2/3, MBD2-3, methyl-CpG-binding-domain-like-protein" CDMC21217 4 1 17 DAC27-D12 9-CG8445-RA_4 CG8445 CGGGTGAGGCGTTTCACTTCGTTAGCTTTGTGCCTATCAATGGACAACTGTTTGAGCTGGATGGCTTGA 69 FBan0008445 FBgn0034088 CG8445 2 2R ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8445 CG8445 CDMC21217 4 2 17 DAC27-D12 9-CG8445-RA_4 CG8445 CGGGTGAGGCGTTTCACTTCGTTAGCTTTGTGCCTATCAATGGACAACTGTTTGAGCTGGATGGCTTGA 69 FBan0008445 FBgn0034088 CG8445 2 2R ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8445 CG8445 CDMC21218 4 3 17 DAC27-D24 7-CG8457-RA_1 CG8457 CAAGGCTCCGGATATTCAAGAACGACTGAGGAGTGAGCTACGAGAAGCCTTCATCTCCACTGCTACCCT 69 FBan0008457 FBgn0033697 Cyp6t3 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t3 Cyp6t3 "CG8457, 6t3" CDMC21218 4 4 17 DAC27-D24 7-CG8457-RA_1 CG8457 CAAGGCTCCGGATATTCAAGAACGACTGAGGAGTGAGCTACGAGAAGCCTTCATCTCCACTGCTACCCT 69 FBan0008457 FBgn0033697 Cyp6t3 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t3 Cyp6t3 "CG8457, 6t3" CDMC21219 4 5 17 DAC27-H12 4-CG8501-RA_1 CG8501 GCACTGCGAGAAAACGCCCTCCAAAAGCAAGAGACTACACTGTCGTTTGGGATAAACTCGCATCTCGCT 69 FBan0008501 FBgn0033724 CG8501 2 2R CG8501 CG8501 CDMC21219 4 6 17 DAC27-H12 4-CG8501-RA_1 CG8501 GCACTGCGAGAAAACGCCCTCCAAAAGCAAGAGACTACACTGTCGTTTGGGATAAACTCGCATCTCGCT 69 FBan0008501 FBgn0033724 CG8501 2 2R CG8501 CG8501 CDMC21220 4 7 17 DAC27-H24 2-CG8515-RA_1 CG8515 GCCGGCTATTCCCGAGGAGATACAGAAGGGTTTGGATCAGATCTACGCTGGCATTAAACTGCAGCAGGA 69 FBan0008515 FBgn0033731 CG8515 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8515 CG8515 CDMC21220 4 8 17 DAC27-H24 2-CG8515-RA_1 CG8515 GCCGGCTATTCCCGAGGAGATACAGAAGGGTTTGGATCAGATCTACGCTGGCATTAAACTGCAGCAGGA 69 FBan0008515 FBgn0033731 CG8515 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8515 CG8515 CDMC21221 4 9 17 DAC27-L12 10-CG8548-RA_1 CG8548 TTGCTGGGCCATAGGCTACCTGTCAGATGGTCCCAATGATAAAATCCAGGCTGTAATTGATGCGGGTGT 69 FBan0008548 FBgn0024889 Kap-alpha1 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 Kap-alpha1 karyopherin alpha1 "CG8548, Kap alpha1, karyopherin-alpha1, importin alpha1, Kap-alpha1, imp alpha1, anon-WO0118547.276" CDMC21221 4 10 17 DAC27-L12 10-CG8548-RA_1 CG8548 TTGCTGGGCCATAGGCTACCTGTCAGATGGTCCCAATGATAAAATCCAGGCTGTAATTGATGCGGGTGT 69 FBan0008548 FBgn0024889 Kap-alpha1 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 Kap-alpha1 karyopherin alpha1 "CG8548, Kap alpha1, karyopherin-alpha1, importin alpha1, Kap-alpha1, imp alpha1, anon-WO0118547.276" CDMC21222 4 11 17 DAC27-L24 9-CG8557-RA_1 CG8557 GGAAACTGTCGAAGGAGCAGGACTTGTGGATGGAGTGCGACATGGTAATGCAAATGGTTATTTGGCCCA 69 FBan0008557 FBgn0030842 CG8557 X X CG8557 CG8557 CDMC21222 4 12 17 DAC27-L24 9-CG8557-RA_1 CG8557 GGAAACTGTCGAAGGAGCAGGACTTGTGGATGGAGTGCGACATGGTAATGCAAATGGTTATTTGGCCCA 69 FBan0008557 FBgn0030842 CG8557 X X CG8557 CG8557 CDMC21223 4 13 17 DAC27-P12 1-CG8595-RA_1 CG8595 GCACTGGAAGATAGCAGCTCGAATTCGGGATCCCTTGAGAAGAGAGAGCTGGACTTTAACGCCACAGGT 69 FBan0008595 FBgn0034476 Toll-7 2 2R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-7 Toll-7 "CG8595, CG8595, Tl-7, CT24947, Toll-like, dTLR7, toll, dToll7, Toll-7" CDMC21223 4 14 17 DAC27-P12 1-CG8595-RA_1 CG8595 GCACTGGAAGATAGCAGCTCGAATTCGGGATCCCTTGAGAAGAGAGAGCTGGACTTTAACGCCACAGGT 69 FBan0008595 FBgn0034476 Toll-7 2 2R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-7 Toll-7 "CG8595, CG8595, Tl-7, CT24947, Toll-like, dTLR7, toll, dToll7, Toll-7" CDMC21224 4 15 17 DAC27-P24 9-CG8605-RA_2 CG8605 GCGGTGGACATAGAACAGATTGCCCAGGACCAGATACTATTTGCCCATCTACTTGATGAGACGCTGGCC 69 FBan0008605 FBgn0035762 CG8605 3 3L CG8605 CG8605 CDMC21224 4 16 17 DAC27-P24 9-CG8605-RA_2 CG8605 GCGGTGGACATAGAACAGATTGCCCAGGACCAGATACTATTTGCCCATCTACTTGATGAGACGCTGGCC 69 FBan0008605 FBgn0035762 CG8605 3 3L CG8605 CG8605 CDMC21225 4 17 17 DAC28-D12 16-CG30362-RA_1 CG30362 GCAGCCACCCGAGTAACTTGCTTCAAATGACAACATTTGTGGAACGATCACATTCCGTTACAACGCTCA 69 FBan0030362 FBgn0050362 CG30362 2 2R CG30362 CG30362 "CG2149, CG2149, CG2149, NEST:bs34d07" CDMC21225 4 18 17 DAC28-D12 16-CG30362-RA_1 CG30362 GCAGCCACCCGAGTAACTTGCTTCAAATGACAACATTTGTGGAACGATCACATTCCGTTACAACGCTCA 69 FBan0030362 FBgn0050362 CG30362 2 2R CG30362 CG30362 "CG2149, CG2149, CG2149, NEST:bs34d07" CDMC21226 4 19 17 DAC28-D24 13-CG30375-RA_1 CG30375 ACCCCGGCGCTATACCAAGTGGTTCTAACTGTCGATTTCGCTTGAAGGCACCCAGTAATCATGTTATCT 69 FBan0030375 FBgn0050375 CG30375 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30375 CG30375 "CG2280, SP80" CDMC21226 4 20 17 DAC28-D24 13-CG30375-RA_1 CG30375 ACCCCGGCGCTATACCAAGTGGTTCTAACTGTCGATTTCGCTTGAAGGCACCCAGTAATCATGTTATCT 69 FBan0030375 FBgn0050375 CG30375 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30375 CG30375 "CG2280, SP80" CDMC21227 4 21 17 DAC28-H12 23-CG30418-RA_16 CG30418 CAAAGCTTCGCTGCATTTTCGAATACAAACACTGAACTATCCGTCGTTGTAAAGCTACCTTATCCACTA 69 FBan0030418 FBgn0050418 nord 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 nord nord "CG3372, CG30418, CG13574, CG3372, nord" CDMC21227 4 22 17 DAC28-H12 23-CG30418-RA_16 CG30418 CAAAGCTTCGCTGCATTTTCGAATACAAACACTGAACTATCCGTCGTTGTAAAGCTACCTTATCCACTA 69 FBan0030418 FBgn0050418 nord 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 nord nord "CG3372, CG30418, CG13574, CG3372, nord" CDMC21228 4 23 17 DAC28-H24 3-CG30429-RA_1 CG30429 GGCAGGGAGTCGGATCAATGCTACGCAAACGCGGAACTGAGGTACAGCTGATATATTCGGGAAGATGGT 69 FBan0030429 FBgn0050429 CG30429 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30429 CG30429 CDMC21228 4 24 17 DAC28-H24 3-CG30429-RA_1 CG30429 GGCAGGGAGTCGGATCAATGCTACGCAAACGCGGAACTGAGGTACAGCTGATATATTCGGGAAGATGGT 69 FBan0030429 FBgn0050429 CG30429 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30429 CG30429 CDMC21229 4 25 17 DAC28-L12 16-CG30464-RA_1 CG30464 CGATCGGAGCTTTTCGGATATGGTGAGACTAAAACTGGCAACCATGAACGATTTTAGTCCACCACGGTT 69 FBan0030464 FBgn0050464 CG30464 2 2R CG30464 CG30464 CG12961 CDMC21229 4 26 17 DAC28-L12 16-CG30464-RA_1 CG30464 CGATCGGAGCTTTTCGGATATGGTGAGACTAAAACTGGCAACCATGAACGATTTTAGTCCACCACGGTT 69 FBan0030464 FBgn0050464 CG30464 2 2R CG30464 CG30464 CG12961 CDMC21230 4 1 18 DAC28-L24 17-CG30477-RA_2 CG30477 TGTGAATAGTGTGGATGGGGCTAATTTCCGATTTGCACTCACTTCCTCTCGCGGGAAATGCAATCATAA 69 FBan0030477 FBgn0050477 CG30477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30477 CG30477 CDMC21230 4 2 18 DAC28-L24 17-CG30477-RA_2 CG30477 TGTGAATAGTGTGGATGGGGCTAATTTCCGATTTGCACTCACTTCCTCTCGCGGGAAATGCAATCATAA 69 FBan0030477 FBgn0050477 CG30477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30477 CG30477 CDMC21231 4 3 18 DAC28-P12 15-CG30501-RA_5 CG30501 ACTGGTTGAGCCGGGATGGGAAGGCAAAAAGCAAAAGATGGCAAGGAAAACTTAAGAAATTGACACCGT 69 FBan0030501 FBgn0050501 CG30501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30501 CG30501 CDMC21231 4 4 18 DAC28-P12 15-CG30501-RA_5 CG30501 ACTGGTTGAGCCGGGATGGGAAGGCAAAAAGCAAAAGATGGCAAGGAAAACTTAAGAAATTGACACCGT 69 FBan0030501 FBgn0050501 CG30501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30501 CG30501 CDMC21232 4 5 18 DAC28-P24 2-CG3064-RB_1 CG3064 ACAGGAGAAAGGAGGGGAAGTAGAACAAGCCGTCCCTACCACAACTGCAGTTACAGCAAGCACTACAGC 69 FBan0003064 FBgn0015390 futsch X X axonogenesis; GO:0007409; dendrite morphogenesis; GO:0016358; eye development (sensu Endopterygota); GO:0007456; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; nervous system development; GO:0007399; neuromuscular junction development; GO:0007528; regulation of synaptic growth at neuromuscular junction; GO:0008582 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0008017 microtubule associated complex; GO:0005875; microtubule cytoskeleton; GO:0015630 futsch futsch "CG3064, CG3064, CG3064, mAb22C10, MAb22C10, Mab22C10, mAb 22C10, 22C10, 22c10, EG:49E4.1, Mab 22C10, mAb-22C10, map1b, MAP1B, 22C10/FUTSCH, ssC10, Futsch, futsch" CDMC21232 4 6 18 DAC28-P24 2-CG3064-RB_1 CG3064 ACAGGAGAAAGGAGGGGAAGTAGAACAAGCCGTCCCTACCACAACTGCAGTTACAGCAAGCACTACAGC 69 FBan0003064 FBgn0015390 futsch X X axonogenesis; GO:0007409; dendrite morphogenesis; GO:0016358; eye development (sensu Endopterygota); GO:0007456; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; nervous system development; GO:0007399; neuromuscular junction development; GO:0007528; regulation of synaptic growth at neuromuscular junction; GO:0008582 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0008017 microtubule associated complex; GO:0005875; microtubule cytoskeleton; GO:0015630 futsch futsch "CG3064, CG3064, CG3064, mAb22C10, MAb22C10, Mab22C10, mAb 22C10, 22C10, 22c10, EG:49E4.1, Mab 22C10, mAb-22C10, map1b, MAP1B, 22C10/FUTSCH, ssC10, Futsch, futsch" CDMC21233 4 7 18 DAC29-D12 18-CG9995-RA_1 CG9995 CGAAGGACGCTAGTGGGCATTAGTATGCGCCTTAGCCAATTGCCGGCTAATTCCCAATCAAAATTACTT 69 FBan0009995 FBgn0027655 huntingtin 3 3R axon cargo transport; GO:0008088; proteolysis; GO:0006508 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 cytoplasm; GO:0005737 huntingtin huntingtin "CG9995, HD, Hsap\HD, Htt, dhtt, htt" CDMC21233 4 8 18 DAC29-D12 18-CG9995-RA_1 CG9995 CGAAGGACGCTAGTGGGCATTAGTATGCGCCTTAGCCAATTGCCGGCTAATTCCCAATCAAAATTACTT 69 FBan0009995 FBgn0027655 huntingtin 3 3R axon cargo transport; GO:0008088; proteolysis; GO:0006508 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 cytoplasm; GO:0005737 huntingtin huntingtin "CG9995, HD, Hsap\HD, Htt, dhtt, htt" CDMC21234 4 9 18 DAC29-D24 9-CR14753-RA_1 CR14753 ACCTGTGCACAGTGTTCACTACGATCCGCACTTATATCCACATCCAAAACTCTTCGATTCCAGCCGCCT 69 FBan0014753 FBgn0033303 Cyp6a15Psi 2 2R Cyp6a15Psi Cyp6a15Psi "CG14753, CG14753, Cyp6a15p, 6a15p, CR14753" CDMC21234 4 10 18 DAC29-D24 9-CR14753-RA_1 CR14753 ACCTGTGCACAGTGTTCACTACGATCCGCACTTATATCCACATCCAAAACTCTTCGATTCCAGCCGCCT 69 FBan0014753 FBgn0033303 Cyp6a15Psi 2 2R Cyp6a15Psi Cyp6a15Psi "CG14753, CG14753, Cyp6a15p, 6a15p, CR14753" CDMC21235 4 11 18 DAC29-H12 2-CR31511-RA_3 CR31511 GGAGCCACAAGATATTCAACCATGGAAAGGGACCCGAGATTGCTCACAGCCAGCTAGCAAGTGCGTAAA 69 FBgn0020769 CDMC21235 4 12 18 DAC29-H12 2-CR31511-RA_3 CR31511 GGAGCCACAAGATATTCAACCATGGAAAGGGACCCGAGATTGCTCACAGCCAGCTAGCAAGTGCGTAAA 69 FBgn0020769 CDMC21236 4 13 18 DAC29-H24 9-CR31863-RA_1 CR31863 CCAGCTACTGCCTCTCTCCGTTTTGGCCAAATTTGCATATTGAACGGCAGTTTGTCTTGAGCCTGAGCT 69 FBan0031863 FBgn0041606 bft 2 2L bristle morphogenesis; GO:0008407 bft bereft "CR31863, bereft" CDMC21236 4 14 18 DAC29-H24 9-CR31863-RA_1 CR31863 CCAGCTACTGCCTCTCTCCGTTTTGGCCAAATTTGCATATTGAACGGCAGTTTGTCTTGAGCCTGAGCT 69 FBan0031863 FBgn0041606 bft 2 2L bristle morphogenesis; GO:0008407 bft bereft "CR31863, bereft" CDMC21237 4 15 18 DAC29-L12 14-CR32665-RB_2 CR32665 CGACACGTTGCGCCTATGACAATCCTAATTCCATCCTCTTCTCTTTCGTTTAGGTAGCTCGGATGGCCA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC21237 4 16 18 DAC29-L12 14-CR32665-RB_2 CR32665 CGACACGTTGCGCCTATGACAATCCTAATTCCATCCTCTTCTCTTTCGTTTAGGTAGCTCGGATGGCCA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC21238 4 17 18 DAC29-L24 23-CR32881-RA_1 CR32881 TCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACT 69 FBan0032881 FBgn0043022 snRNA:U5:38ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABa snRNA:U5:38ABa "dU5, K2, U5, U5 small nuclear RNA, U5-38ABa, snRNA:U5, U5snRNA, CR32881, small nuclear RNA U5" CDMC21238 4 18 18 DAC29-L24 23-CR32881-RA_1 CR32881 TCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACT 69 FBan0032881 FBgn0043022 snRNA:U5:38ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABa snRNA:U5:38ABa "dU5, K2, U5, U5 small nuclear RNA, U5-38ABa, snRNA:U5, U5snRNA, CR32881, small nuclear RNA U5" CDMC21239 4 19 18 DAC29-P12 10-CR40454-RA_1 CR40454 TGTGCGTCATCGTGTGAACTGCAGGACACATGAACATCGACATTTTGAACGCATATCGCAGTCCATGCT 69 FBgn0058454 CDMC21239 4 20 18 DAC29-P12 10-CR40454-RA_1 CR40454 TGTGCGTCATCGTGTGAACTGCAGGACACATGAACATCGACATTTTGAACGCATATCGCAGTCCATGCT 69 FBgn0058454 CDMC21240 4 21 18 DAC29-P24 3-CR9700-RA_1 CR9700 AGTCCATATTGTCTGGTCAAGTCACTGCAGATCACCTTTCAGCTTTGCCTGCTGGTCTTTGTGGGCGTT 69 FBan0009700 FBgn0026399 Or85e 3 3R Or85e Odorant receptor 85e "CG9700, CG9700, CG9700, dor104, Odorant receptor 104, Dor104, 85B.1, DOR104, DOR85e, 85e, CR9700, Or104: Odorant receptor 104" CDMC21240 4 22 18 DAC29-P24 3-CR9700-RA_1 CR9700 AGTCCATATTGTCTGGTCAAGTCACTGCAGATCACCTTTCAGCTTTGCCTGCTGGTCTTTGTGGGCGTT 69 FBan0009700 FBgn0026399 Or85e 3 3R Or85e Odorant receptor 85e "CG9700, CG9700, CG9700, dor104, Odorant receptor 104, Dor104, 85B.1, DOR104, DOR85e, 85e, CR9700, Or104: Odorant receptor 104" CDMC21241 4 23 18 DAC30-D12 6-CG12006-RA_1 CG12006 GCCCGCCTGGTATCTGAGCACAGTGCATCAGAAGGGACCCATTGAACTGATGCCCAAGTTGAGAGAAAT 69 FBan0012006 FBgn0035464 CG12006 3 3L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG12006 CG12006 CDMC21241 4 24 18 DAC30-D12 6-CG12006-RA_1 CG12006 GCCCGCCTGGTATCTGAGCACAGTGCATCAGAAGGGACCCATTGAACTGATGCCCAAGTTGAGAGAAAT 69 FBan0012006 FBgn0035464 CG12006 3 3L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG12006 CG12006 CDMC21242 4 25 18 DAC30-D24 39-CG12017-RA_1 CG12017 CGGTCGGATACTTGATGCTTGGGATGGAGAGCTGAATATCCAATGGCAGAAACTAAAAGTCGAGGCCGA 69 FBan0012017 FBgn0035429 CG12017 3 3L CG12017 CG12017 CDMC21242 4 26 18 DAC30-D24 39-CG12017-RA_1 CG12017 CGGTCGGATACTTGATGCTTGGGATGGAGAGCTGAATATCCAATGGCAGAAACTAAAAGTCGAGGCCGA 69 FBan0012017 FBgn0035429 CG12017 3 3L CG12017 CG12017 CDMC21243 4 1 19 DAC30-H12 17-CG12052-RE_1 CG12052 TGATGAACGAGGAGTGGAACATGAAGCTGGGCCTACAGATCATATCGAATTCATTGCTCAAGGAGCGAT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21243 4 2 19 DAC30-H12 17-CG12052-RE_1 CG12052 TGATGAACGAGGAGTGGAACATGAAGCTGGGCCTACAGATCATATCGAATTCATTGCTCAAGGAGCGAT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21244 4 3 19 DAC30-H24 15-CG12052-RO_2 CG12052 ACCTCCAAAACCATAACCAACCCAAATGAACCCAATTGTTGTGGAAAAGCTGGTCCACATTCCTGCACA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21244 4 4 19 DAC30-H24 15-CG12052-RO_2 CG12052 ACCTCCAAAACCATAACCAACCCAAATGAACCCAATTGTTGTGGAAAAGCTGGTCCACATTCCTGCACA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21245 4 5 19 DAC30-L12 11-CG1208-RA_1 CG1208 TGCCGTAATCTTCTTCATGAACGAGATCTTCGAGTCTAGCAGCACGCTGAATCCCAACGTCTGCACCAT 69 FBan0001208 FBgn0037386 CG1208 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1208 CG1208 CDMC21245 4 6 19 DAC30-L12 11-CG1208-RA_1 CG1208 TGCCGTAATCTTCTTCATGAACGAGATCTTCGAGTCTAGCAGCACGCTGAATCCCAACGTCTGCACCAT 69 FBan0001208 FBgn0037386 CG1208 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1208 CG1208 CDMC21246 4 7 19 DAC30-L24 23-CG12106-RA_1 CG12106 TGCCAGGACAAACTGCAAAGGTAGTTGGCATTAGTTATGTATGTAGATATACTCGTTTAGATAATAGGT 69 FBan0012106 FBgn0030100 CG12106 X X CG12106 CG12106 BcDNA:GH03263 CDMC21246 4 8 19 DAC30-L24 23-CG12106-RA_1 CG12106 TGCCAGGACAAACTGCAAAGGTAGTTGGCATTAGTTATGTATGTAGATATACTCGTTTAGATAATAGGT 69 FBan0012106 FBgn0030100 CG12106 X X CG12106 CG12106 BcDNA:GH03263 CDMC21247 4 9 19 DAC30-P12 8-CG12133-RA_1 CG12133 GCCAAGGCACCATCAGTGGAATGAGTCCGGATGAATGCTTGAATCGGTATCCAACACTGCTCGTCGATA 69 FBan0012133 FBgn0033469 CG12133 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12133 CG12133 SP15 CDMC21247 4 10 19 DAC30-P12 8-CG12133-RA_1 CG12133 GCCAAGGCACCATCAGTGGAATGAGTCCGGATGAATGCTTGAATCGGTATCCAACACTGCTCGTCGATA 69 FBan0012133 FBgn0033469 CG12133 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12133 CG12133 SP15 CDMC21248 4 11 19 DAC30-P24 AutoBlank AutoBlank CDMC21248 4 12 19 DAC30-P24 AutoBlank AutoBlank CDMC21249 4 13 19 DAC31-D12 2-CG3999-RA_1 CG3999 GGTCGCATGGACAAGGCAGTCAATCCACTGAAGATGTCTCCTCACACCCAAGCTCAGGTGATCTCG 66 FBan0003999 FBgn0037801 CG3999 3 3R amino acid catabolism; GO:0009063; glycine metabolism; GO:0006544 glycine dehydrogenase (decarboxylating) activity; GO:0004375 ; EC:1.4.4.2; ; GO:0004375 ; EC:1.4.4.2 glycine dehydrogenase complex (decarboxylating); GO:0005961 CG3999 CG3999 CDMC21249 4 14 19 DAC31-D12 2-CG3999-RA_1 CG3999 GGTCGCATGGACAAGGCAGTCAATCCACTGAAGATGTCTCCTCACACCCAAGCTCAGGTGATCTCG 66 FBan0003999 FBgn0037801 CG3999 3 3R amino acid catabolism; GO:0009063; glycine metabolism; GO:0006544 glycine dehydrogenase (decarboxylating) activity; GO:0004375 ; EC:1.4.4.2; ; GO:0004375 ; EC:1.4.4.2 glycine dehydrogenase complex (decarboxylating); GO:0005961 CG3999 CG3999 CDMC21250 4 15 19 DAC31-D24 18-CG40384-RA_8 CG40384 AGTTTCAAAGGGTATTATTGGCTACTACAACCCCCGTTCCTTAGTGGGTAGCGAACGAGAGTTGGT 66 FBgn0058384 CG40384 CG40384 CG40384 CDMC21250 4 16 19 DAC31-D24 18-CG40384-RA_8 CG40384 AGTTTCAAAGGGTATTATTGGCTACTACAACCCCCGTTCCTTAGTGGGTAGCGAACGAGAGTTGGT 66 FBgn0058384 CG40384 CG40384 CG40384 CDMC21251 4 17 19 DAC31-H12 3-CG4501-RA_3 CG4501 GGAGAGCTGTGCATCCGAGGACGTCACGTTTTCATGGGCTACATCGACAACAAGGAGAAGACCGAG 66 FBan0004501 FBgn0027348 bgm 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 bgm bubblegum "CG4501, CG4501, BG:DS01514.2, BG:DS0514.2, 2a9hom, bubblegum" CDMC21251 4 18 19 DAC31-H12 3-CG4501-RA_3 CG4501 GGAGAGCTGTGCATCCGAGGACGTCACGTTTTCATGGGCTACATCGACAACAAGGAGAAGACCGAG 66 FBan0004501 FBgn0027348 bgm 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 bgm bubblegum "CG4501, CG4501, BG:DS01514.2, BG:DS0514.2, 2a9hom, bubblegum" CDMC21252 4 19 19 DAC31-H24 6-CG4636-RA_4 CG4636 TGAGCAATACTTTCCACAGCATCGGTATGACGGGCAATCAACTGAACTCCCTTAGCGACTTGCCGC 66 FBan0004636 FBgn0041781 SCAR 2 2L actin filament organization; GO:0007015; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779 SCAR SCAR "CG4636, CG4636, l(2)k13811, l(2)k03107, D-SCAR, Scar, WAVE, scar, wave, Wave, BEST:SD02991" CDMC21252 4 20 19 DAC31-H24 6-CG4636-RA_4 CG4636 TGAGCAATACTTTCCACAGCATCGGTATGACGGGCAATCAACTGAACTCCCTTAGCGACTTGCCGC 66 FBan0004636 FBgn0041781 SCAR 2 2L actin filament organization; GO:0007015; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779 SCAR SCAR "CG4636, CG4636, l(2)k13811, l(2)k03107, D-SCAR, Scar, WAVE, scar, wave, Wave, BEST:SD02991" CDMC21253 4 21 19 DAC31-L12 6-CG4988-RA_4 CG4988 GGGAGTTAACCCTTGTTGACAACACGGCTTATGATCTCAGGTCACCTGTGGTCCTGGGAGATCGCC 66 FBan0004988 FBgn0032372 CG4988 2 2L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG4988 CG4988 CDMC21253 4 22 19 DAC31-L12 6-CG4988-RA_4 CG4988 GGGAGTTAACCCTTGTTGACAACACGGCTTATGATCTCAGGTCACCTGTGGTCCTGGGAGATCGCC 66 FBan0004988 FBgn0032372 CG4988 2 2L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG4988 CG4988 CDMC21254 4 23 19 DAC31-L24 2-CG5068-RA_1 CG5068 GACCCCACAGCGAAGACAATCGGATCAATGTCGAGTTTACAGCGCACGATGTTGAAGGGCAAGCTG 66 FBan0005068 FBgn0035951 CG5068 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG5068 CG5068 CDMC21254 4 24 19 DAC31-L24 2-CG5068-RA_1 CG5068 GACCCCACAGCGAAGACAATCGGATCAATGTCGAGTTTACAGCGCACGATGTTGAAGGGCAAGCTG 66 FBan0005068 FBgn0035951 CG5068 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG5068 CG5068 CDMC21255 4 25 19 DAC31-P12 AutoBlank AutoBlank CDMC21255 4 26 19 DAC31-P12 AutoBlank AutoBlank CDMC21256 4 1 20 DAC31-P24 AutoBlank AutoBlank CDMC21256 4 2 20 DAC31-P24 AutoBlank AutoBlank CDMC21257 4 3 20 DAC32-D12 12-CG11158-RA_2 CG11158 GGCCGGAAAGTGGACGACATTCATGGCAAGAAGATAAATGTGCACATCATTAGGCGCCTCACTAGTGGA 69 FBan0011158 FBgn0030511 CG11158 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG11158 CG11158 CDMC21257 4 4 20 DAC32-D12 12-CG11158-RA_2 CG11158 GGCCGGAAAGTGGACGACATTCATGGCAAGAAGATAAATGTGCACATCATTAGGCGCCTCACTAGTGGA 69 FBan0011158 FBgn0030511 CG11158 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG11158 CG11158 CDMC21258 4 5 20 DAC32-D24 9-CG11169-RA_1 CG11169 CCACGGCCTTGACCTCCAGGAGATTGTCCACGAGCAGGTGAGTCGTGTCTATTCTATGTCTATTCAGCT 69 FBgn0034905 CDMC21258 4 6 20 DAC32-D24 9-CG11169-RA_1 CG11169 CCACGGCCTTGACCTCCAGGAGATTGTCCACGAGCAGGTGAGTCGTGTCTATTCTATGTCTATTCAGCT 69 FBgn0034905 CDMC21259 4 7 20 DAC32-H12 8-CG11226-RA_3 CG11226 CAGAGCGTTGGACTTGCCCGGGATAATACGATCATGACCTCTGCCAAAAATACGAACCCTTCCTGTCGT 69 FBan0011226 FBgn0037195 CG11226 3 3L CG11226 CG11226 BcDNA:AT16729 CDMC21259 4 8 20 DAC32-H12 8-CG11226-RA_3 CG11226 CAGAGCGTTGGACTTGCCCGGGATAATACGATCATGACCTCTGCCAAAAATACGAACCCTTCCTGTCGT 69 FBan0011226 FBgn0037195 CG11226 3 3L CG11226 CG11226 BcDNA:AT16729 CDMC21260 4 9 20 DAC32-H24 9-CG11245-RA_1 CG11245 ACGGTTGTGCGAACTTAAGCGCCAGCATGAAAAAGAAACTGCGCAAGGAGAAAAAGAAGCAAAAGGCGA 69 FBan0011245 FBgn0030388 CG11245 X X CG11245 CG11245 CDMC21260 4 10 20 DAC32-H24 9-CG11245-RA_1 CG11245 ACGGTTGTGCGAACTTAAGCGCCAGCATGAAAAAGAAACTGCGCAAGGAGAAAAAGAAGCAAAAGGCGA 69 FBan0011245 FBgn0030388 CG11245 X X CG11245 CG11245 CDMC21261 4 11 20 DAC32-L12 16-CG11271-RE_1 CG11271 TGGACGCGCGTTACCTCTACAAAGTGTTTCTGAAAATCCAGGCATCCAGTGAAATCAGCGTGTGATATT 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC21261 4 12 20 DAC32-L12 16-CG11271-RE_1 CG11271 TGGACGCGCGTTACCTCTACAAAGTGTTTCTGAAAATCCAGGCATCCAGTGAAATCAGCGTGTGATATT 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC21262 4 13 20 DAC32-L24 9-CG11289-RA_1 CG11289 TGCAGTCGAAAAACTGGGGTTTGACCTTATCCACCAACAATCTGACGCATTGGAAACTAGCGAAGGCCA 69 FBan0011289 FBgn0031887 CG11289 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ATP binding; GO:0005524; ; GO:0005524; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ATPase activity; GO:0016887; ; GO:0016887 membrane; GO:0016020 CG11289 CG11289 CDMC21262 4 14 20 DAC32-L24 9-CG11289-RA_1 CG11289 TGCAGTCGAAAAACTGGGGTTTGACCTTATCCACCAACAATCTGACGCATTGGAAACTAGCGAAGGCCA 69 FBan0011289 FBgn0031887 CG11289 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ATP binding; GO:0005524; ; GO:0005524; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ATPase activity; GO:0016887; ; GO:0016887 membrane; GO:0016020 CG11289 CG11289 CDMC21263 4 15 20 DAC32-P12 8-CG11321-RB_1 CG11321 AGGACCCTGGGACACCGATGAGATCTACAAGAACATGTGCTCCGAGGTAGGTGTTGGCTATCATCAGTT 69 FBan0011321 FBgn0031857 CG11321 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11321 CG11321 CDMC21263 4 16 20 DAC32-P12 8-CG11321-RB_1 CG11321 AGGACCCTGGGACACCGATGAGATCTACAAGAACATGTGCTCCGAGGTAGGTGTTGGCTATCATCAGTT 69 FBan0011321 FBgn0031857 CG11321 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11321 CG11321 CDMC21264 4 17 20 DAC32-P24 AutoBlank AutoBlank CDMC21264 4 18 20 DAC32-P24 AutoBlank AutoBlank CDMC21265 4 19 20 DAC33-D12 22-CG12610-RA_1 CG12610 TGGTGCTCAATGTGATCATCGTGGTGTACATAATGTACCATCGACTTTACAAGGATGTGACCCATGCGT 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC21265 4 20 20 DAC33-D12 22-CG12610-RA_1 CG12610 TGGTGCTCAATGTGATCATCGTGGTGTACATAATGTACCATCGACTTTACAAGGATGTGACCCATGCGT 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC21266 4 21 20 DAC33-D24 22-CG1262-RA_1 CG1262 CCTGTGTTCTGCGATCCGATTGCCCAAAAGATGTTGTTCGAAAGGAAGATATGCTACTGGGTGTATCGA 69 FBan0001262 FBgn0020509 Acp62F 3 3L determination of adult life span; GO:0008340; negative regulation of proteolysis; GO:0045861; physiological process; GO:0007582; post-mating behavior; GO:0045297; regulation of proteolysis; GO:0030162 protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0030414 Acp62F Accessory gland peptide 62F "CG1262, CG1262, Accessory gland protein 62F, CT2528, Acp62" CDMC21266 4 22 20 DAC33-D24 22-CG1262-RA_1 CG1262 CCTGTGTTCTGCGATCCGATTGCCCAAAAGATGTTGTTCGAAAGGAAGATATGCTACTGGGTGTATCGA 69 FBan0001262 FBgn0020509 Acp62F 3 3L determination of adult life span; GO:0008340; negative regulation of proteolysis; GO:0045861; physiological process; GO:0007582; post-mating behavior; GO:0045297; regulation of proteolysis; GO:0030162 protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0030414 Acp62F Accessory gland peptide 62F "CG1262, CG1262, Accessory gland protein 62F, CT2528, Acp62" CDMC21267 4 23 20 DAC33-H12 2-CG12674-RA_3 CG12674 AGCAACAAAAGGCGATGATTGATGCGAGCTTCAAGGATATTGGCAAACCCCTCTACCGACATCCCACCA 69 FBan0012674 FBgn0031388 CG12674 2 2L CG12674 CG12674 CDMC21267 4 24 20 DAC33-H12 2-CG12674-RA_3 CG12674 AGCAACAAAAGGCGATGATTGATGCGAGCTTCAAGGATATTGGCAAACCCCTCTACCGACATCCCACCA 69 FBan0012674 FBgn0031388 CG12674 2 2L CG12674 CG12674 CDMC21268 4 25 20 DAC33-H24 11-CG12684-RA_1 CG12684 GCTGCTGCCAACTATTCATGTCCGCACTCAAAAGCCAAGAACAGTACATGTCCAAAAGCCAGGACCAAT 69 FBan0012684 FBgn0029717 CG12684 X X CG12684 CG12684 CDMC21268 4 26 20 DAC33-H24 11-CG12684-RA_1 CG12684 GCTGCTGCCAACTATTCATGTCCGCACTCAAAAGCCAAGAACAGTACATGTCCAAAAGCCAGGACCAAT 69 FBan0012684 FBgn0029717 CG12684 X X CG12684 CG12684 CDMC21269 4 1 21 DAC33-L12 24-CG12740-RA_1 CG12740 CGACAAACTATATTATTGTTGATACAAAAGGTATCTTTAGATCAATCAATCTTTGTTTGCCTAAATGAT 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC21269 4 2 21 DAC33-L12 24-CG12740-RA_1 CG12740 CGACAAACTATATTATTGTTGATACAAAAGGTATCTTTAGATCAATCAATCTTTGTTTGCCTAAATGAT 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC21270 4 3 21 DAC33-L24 9-CG12750-RA_6 CG12750 CGGATGGAGAGTAGTCGCAGTGAAAAAGACAGTCGTCGTGGTGACCGTTCCTCCAGAAACGAGAGATCA 69 FBan0012750 FBgn0032678 CG12750 2 2L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG12750 CG12750 CDMC21270 4 4 21 DAC33-L24 9-CG12750-RA_6 CG12750 CGGATGGAGAGTAGTCGCAGTGAAAAAGACAGTCGTCGTGGTGACCGTTCCTCCAGAAACGAGAGATCA 69 FBan0012750 FBgn0032678 CG12750 2 2L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG12750 CG12750 CDMC21271 4 5 21 DAC33-P12 2-CG12787-RA_3 CG12787 TCTTCTTCGCAGCTCTGTTTATTCTCATGGAAGCCCTGACGGAACTGGGACTGATTGAGTGGATCGGCA 69 FBan0012787 FBgn0041150 hoe1 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; transport; GO:0006810 transporter activity; GO:0005215; L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137; arsenite transporter activity; GO:0015105; ; GO:0015105 integral to membrane; GO:0016021; membrane; GO:0016020 hoe1 hoepel1 "CG2831, CG12787, CG11918, CG2831, hoe, hoepel, BcDNA:GH02636" CDMC21271 4 6 21 DAC33-P12 2-CG12787-RA_3 CG12787 TCTTCTTCGCAGCTCTGTTTATTCTCATGGAAGCCCTGACGGAACTGGGACTGATTGAGTGGATCGGCA 69 FBan0012787 FBgn0041150 hoe1 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; transport; GO:0006810 transporter activity; GO:0005215; L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137; arsenite transporter activity; GO:0015105; ; GO:0015105 integral to membrane; GO:0016021; membrane; GO:0016020 hoe1 hoepel1 "CG2831, CG12787, CG11918, CG2831, hoe, hoepel, BcDNA:GH02636" CDMC21272 4 7 21 DAC33-P24 AutoBlank AutoBlank CDMC21272 4 8 21 DAC33-P24 AutoBlank AutoBlank CDMC21273 4 9 21 DAC34-D12 15-CG4371-RA_2 CG4371 CGTGGAGAGGTGGCTTAAGAATGCCCCAAAAGTAACTCCTGGATGGGAGCAAAATCTTGAGAGTCTGCA 69 FBan0004371 FBgn0010043 GstD7 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD7 Glutathione S transferase D7 "CG4371, CG4371, DmGST26, gstD26, Gst, DmGSTD7, GstD26: Glutathione S transferase D26, Glutathione S transferase D26, Glutathione S transferase D7" CDMC21273 4 10 21 DAC34-D12 15-CG4371-RA_2 CG4371 CGTGGAGAGGTGGCTTAAGAATGCCCCAAAAGTAACTCCTGGATGGGAGCAAAATCTTGAGAGTCTGCA 69 FBan0004371 FBgn0010043 GstD7 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD7 Glutathione S transferase D7 "CG4371, CG4371, DmGST26, gstD26, Gst, DmGSTD7, GstD26: Glutathione S transferase D26, Glutathione S transferase D26, Glutathione S transferase D7" CDMC21274 4 11 21 DAC34-D24 2-CG4380-RA_2 CG4380 AAAGCCGGTGTGTCAGCCATCTTCGACCGCATATTGTCGGAGCTGAGTGTAAAGATGAAGCGGCTGAAT 69 FBan0004380 FBgn0003964 usp X X "border follicle cell migration (sensu Insecta); GO:0007298; dendrite morphogenesis; GO:0016358; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; lipid metabolism; GO:0006629; metamorphosis; GO:0007552; negative regulation of cell differentiation; GO:0045596; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; positive regulation of transcription; GO:0045941; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165" DNA binding; GO:0003677; juvenile hormone binding; GO:0005500; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0005500; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0005515 ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 usp ultraspiracle "CG4380, CG4380, CG4380, l(1)usp, Cf1, XR2C, X receptor at 2C, 2C, CF1, Usp, CF1/USP, CF1/Usp, DmUsp, USP, DmUSP, NR2B4, chorion factor CF1, dmUSP, EG:22E5.1, Ultraspiracle, dUSP, cf1: Chorion factor 1, l(1)2Cf, Chorion factor 1" CDMC21274 4 12 21 DAC34-D24 2-CG4380-RA_2 CG4380 AAAGCCGGTGTGTCAGCCATCTTCGACCGCATATTGTCGGAGCTGAGTGTAAAGATGAAGCGGCTGAAT 69 FBan0004380 FBgn0003964 usp X X "border follicle cell migration (sensu Insecta); GO:0007298; dendrite morphogenesis; GO:0016358; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; lipid metabolism; GO:0006629; metamorphosis; GO:0007552; negative regulation of cell differentiation; GO:0045596; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; positive regulation of transcription; GO:0045941; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165" DNA binding; GO:0003677; juvenile hormone binding; GO:0005500; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0005500; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0005515 ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 usp ultraspiracle "CG4380, CG4380, CG4380, l(1)usp, Cf1, XR2C, X receptor at 2C, 2C, CF1, Usp, CF1/USP, CF1/Usp, DmUsp, USP, DmUSP, NR2B4, chorion factor CF1, dmUSP, EG:22E5.1, Ultraspiracle, dUSP, cf1: Chorion factor 1, l(1)2Cf, Chorion factor 1" CDMC21275 4 13 21 DAC34-H12 6-CG4424-RA_2 CG4424 ACCCATCGAAATGAGCGTCCTTATGCCTGCAAGACCTGCGGAAAGAAGTTCACATATGCCAGTGTCCTT 69 FBan0004424 FBgn0038765 CG4424 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4424 CG4424 CDMC21275 4 14 21 DAC34-H12 6-CG4424-RA_2 CG4424 ACCCATCGAAATGAGCGTCCTTATGCCTGCAAGACCTGCGGAAAGAAGTTCACATATGCCAGTGTCCTT 69 FBan0004424 FBgn0038765 CG4424 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4424 CG4424 CDMC21276 4 15 21 DAC34-H24 23-CG4433-RA_8 CG4433 CTCGCGCTACATGTTTATCAATTCGATGCGTCAGATAAATCTCTCGGATGTGGAGTTGGAAATGCAGAT 69 FBan0004433 FBgn0038763 CG4433 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG4433 CG4433 CDMC21276 4 16 21 DAC34-H24 23-CG4433-RA_8 CG4433 CTCGCGCTACATGTTTATCAATTCGATGCGTCAGATAAATCTCTCGGATGTGGAGTTGGAAATGCAGAT 69 FBan0004433 FBgn0038763 CG4433 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG4433 CG4433 CDMC21277 4 17 21 DAC34-L12 23-CG4467-RA_10 CG4467 GGTCCTGTCACAGTTCTCTCTTCACACACTCATTTGTAATTATGTTCCTCTCTCAGACACACGAATCTT 69 FBan0004467 FBgn0039064 CG4467 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0004179 ; EC:3.4.11.2 CG4467 CG4467 CDMC21277 4 18 21 DAC34-L12 23-CG4467-RA_10 CG4467 GGTCCTGTCACAGTTCTCTCTTCACACACTCATTTGTAATTATGTTCCTCTCTCAGACACACGAATCTT 69 FBan0004467 FBgn0039064 CG4467 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0004179 ; EC:3.4.11.2 CG4467 CG4467 CDMC21278 4 19 21 DAC34-L24 23-CG4479-RA_7 CG4479 GAGCCTGTGGAATGGCATAATTTCCATTTCTGCAAAAGATGAAAGTCCTAAAGGTCTCACTGAAATGTG 69 FBan0004479 FBgn0013300 Mst35Ba 2 2L DNA binding; GO:0003677; ; GO:0003677 Mst35Ba Male-specific-transcript-35Ba "CG4479 (mst35Ba), BG:DS03431.2, protamine (mst35Ba), mst35Bb (mst35Ba), BcDNA:AT31403 (mst35Ba), mst35b (mst35Ba), protamine, mst35Bb" CDMC21278 4 20 21 DAC34-L24 23-CG4479-RA_7 CG4479 GAGCCTGTGGAATGGCATAATTTCCATTTCTGCAAAAGATGAAAGTCCTAAAGGTCTCACTGAAATGTG 69 FBan0004479 FBgn0013300 Mst35Ba 2 2L DNA binding; GO:0003677; ; GO:0003677 Mst35Ba Male-specific-transcript-35Ba "CG4479 (mst35Ba), BG:DS03431.2, protamine (mst35Ba), mst35Bb (mst35Ba), BcDNA:AT31403 (mst35Ba), mst35b (mst35Ba), protamine, mst35Bb" CDMC21279 4 21 21 DAC34-P12 23-CG4531-RA_11 CG4531 AGTCTCGCCAAGTTACCAACTAATGAACTAATGAGAAGGGAAAAACGAACAGATACCAGCTAGGAACTT 69 FBan0004531 FBgn0004569 argos 3 3L axon guidance; GO:0007411; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; negative regulation of cell differentiation; GO:0045596; negative regulation of cell fate specification; GO:0009996; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476 receptor antagonist activity; GO:0048019; ; GO:0048019; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0048019 extracellular region; GO:0005576 argos argos "CG4531, CG4531, aos: argos, sty, gil, strawberry, rlt, roulette, arg, Argos, Aos, l(3)05845, l(3)05959, l(3)j5E11, l(3)rJ472, l(3)rJ812, l(3)rQ526, giant lens, aos" CDMC21279 4 22 21 DAC34-P12 23-CG4531-RA_11 CG4531 AGTCTCGCCAAGTTACCAACTAATGAACTAATGAGAAGGGAAAAACGAACAGATACCAGCTAGGAACTT 69 FBan0004531 FBgn0004569 argos 3 3L axon guidance; GO:0007411; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; negative regulation of cell differentiation; GO:0045596; negative regulation of cell fate specification; GO:0009996; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476 receptor antagonist activity; GO:0048019; ; GO:0048019; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0048019 extracellular region; GO:0005576 argos argos "CG4531, CG4531, aos: argos, sty, gil, strawberry, rlt, roulette, arg, Argos, Aos, l(3)05845, l(3)05959, l(3)j5E11, l(3)rJ472, l(3)rJ812, l(3)rQ526, giant lens, aos" CDMC21280 4 23 21 DAC34-P24 2-CG4538-RB_1 CG4538 GCTGCTGGATCCCATGTTCATAGTGCCTGGTTCAGACATTCGGGGTGTTCACATAACCGCCGACTATGT 69 FBan0004538 FBgn0038745 CG4538 3 3R ATP-dependent proteolysis; GO:0006510; protein folding; GO:0006457; protein transport; GO:0015031 ATP binding; GO:0005524; ; GO:0005524; endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; protein binding; GO:0005515; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92; ; GO:0000166; ; GO:0005515; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887 endopeptidase Clp complex; GO:0009368; mitochondrion; GO:0005739 CG4538 CG4538 CDMC21280 4 24 21 DAC34-P24 2-CG4538-RB_1 CG4538 GCTGCTGGATCCCATGTTCATAGTGCCTGGTTCAGACATTCGGGGTGTTCACATAACCGCCGACTATGT 69 FBan0004538 FBgn0038745 CG4538 3 3R ATP-dependent proteolysis; GO:0006510; protein folding; GO:0006457; protein transport; GO:0015031 ATP binding; GO:0005524; ; GO:0005524; endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; protein binding; GO:0005515; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92; ; GO:0000166; ; GO:0005515; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887 endopeptidase Clp complex; GO:0009368; mitochondrion; GO:0005739 CG4538 CG4538 CDMC21281 4 25 21 DAC35-D12 3-CG8822-RA_1 CG8822 CCGGCACCCATTCGAGTTGTGGGCGACATACACGGGCAGTTTTATGATCTGCTGAAGATCCTCGATCAA 69 FBan0008822 FBgn0005779 PpD6 2 2L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163 PpD6 Protein phosphatase D6 "CG8822, CG8822, CG8822, D6, protein phosphatase from PCR fragment D6, PP1-like" CDMC21281 4 26 21 DAC35-D12 3-CG8822-RA_1 CG8822 CCGGCACCCATTCGAGTTGTGGGCGACATACACGGGCAGTTTTATGATCTGCTGAAGATCCTCGATCAA 69 FBan0008822 FBgn0005779 PpD6 2 2L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163 PpD6 Protein phosphatase D6 "CG8822, CG8822, CG8822, D6, protein phosphatase from PCR fragment D6, PP1-like" CDMC21282 4 1 22 DAC35-D24 9-CG8831-RA_4 CG8831 TGCTCCCAACGAAAGCAAGCGTATACTTGCCACCGAACTCTCAAACTACCTTAATCAGGCGACGCTGAA 69 FBan0008831 FBgn0033737 CG8831 2 2R nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 CG8831 CG8831 CDMC21282 4 2 22 DAC35-D24 9-CG8831-RA_4 CG8831 TGCTCCCAACGAAAGCAAGCGTATACTTGCCACCGAACTCTCAAACTACCTTAATCAGGCGACGCTGAA 69 FBan0008831 FBgn0033737 CG8831 2 2R nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 CG8831 CG8831 CDMC21283 4 3 22 DAC35-H12 3-CG8870-RA_4 CG8870 TGCCCTCAAAACAGTGAGACTGGGCGAACATAACACGTCCACAAATCCCGATCGGGCTATTGTGAATGG 69 FBan0008870 FBgn0038144 CG8870 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG8870 CG8870 SP38 CDMC21283 4 4 22 DAC35-H12 3-CG8870-RA_4 CG8870 TGCCCTCAAAACAGTGAGACTGGGCGAACATAACACGTCCACAAATCCCGATCGGGCTATTGTGAATGG 69 FBan0008870 FBgn0038144 CG8870 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG8870 CG8870 SP38 CDMC21284 4 5 22 DAC35-H24 2-CG8889-RB_1 CG8889 CGGAGGACCCCTGTTGAGAGCCATCATCAGCGACTTGGATCCACATATCATTTTCTCAGGACACTGGCA 69 FBan0008889 FBgn0033675 CG8889 2 2R hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8889 CG8889 CDMC21284 4 6 22 DAC35-H24 2-CG8889-RB_1 CG8889 CGGAGGACCCCTGTTGAGAGCCATCATCAGCGACTTGGATCCACATATCATTTTCTCAGGACACTGGCA 69 FBan0008889 FBgn0033675 CG8889 2 2R hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8889 CG8889 CDMC21285 4 7 22 DAC35-L12 23-CG8929-RA_15 CG8929 GGAGGAGTGGTGGTATAAATATCAGGAATGGTTGAAACAGGAACGCTACTATGAGTACTGGGATCGCAG 69 FBan0008929 FBgn0034504 CG8929 2 2R CG8929 CG8929 anon-WO0118547.91 CDMC21285 4 8 22 DAC35-L12 23-CG8929-RA_15 CG8929 GGAGGAGTGGTGGTATAAATATCAGGAATGGTTGAAACAGGAACGCTACTATGAGTACTGGGATCGCAG 69 FBan0008929 FBgn0034504 CG8929 2 2R CG8929 CG8929 anon-WO0118547.91 CDMC21286 4 9 22 DAC35-L24 16-CG8944-RA_1 CG8944 CCGCGAACGACTGAATCTGTAATACTACACTTCGAGGCGAGTTAGGTTCTCGAAAATATCGCGCCACTT 69 FBan0008944 FBgn0030680 CG8944 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8944 CG8944 CDMC21286 4 10 22 DAC35-L24 16-CG8944-RA_1 CG8944 CCGCGAACGACTGAATCTGTAATACTACACTTCGAGGCGAGTTAGGTTCTCGAAAATATCGCGCCACTT 69 FBan0008944 FBgn0030680 CG8944 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8944 CG8944 CDMC21287 4 11 22 DAC35-P12 2-CG8975-RA_1 CG8975 TGCCCGTCAATTTGATTGGCATGAATTGCGACCTGATGTCCCAGTACATTGAGTTCGTAGCGGACCGTT 69 FBan0008975 FBgn0011704 RnrS 2 2R DNA replication; GO:0006260; deoxyribonucleoside diphosphate metabolism; GO:0009186; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrS Ribonucleoside diphosphate reductase small subunit "CG8975, RNR2, Ribonucleotide reductase small subunit, DmRNR2, Rnr2, ribonucleoside-diphosphate reductase small subunit, RNrS, dRNR2, rnr2, anon-WO0118547.148" CDMC21287 4 12 22 DAC35-P12 2-CG8975-RA_1 CG8975 TGCCCGTCAATTTGATTGGCATGAATTGCGACCTGATGTCCCAGTACATTGAGTTCGTAGCGGACCGTT 69 FBan0008975 FBgn0011704 RnrS 2 2R DNA replication; GO:0006260; deoxyribonucleoside diphosphate metabolism; GO:0009186; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrS Ribonucleoside diphosphate reductase small subunit "CG8975, RNR2, Ribonucleotide reductase small subunit, DmRNR2, Rnr2, ribonucleoside-diphosphate reductase small subunit, RNrS, dRNR2, rnr2, anon-WO0118547.148" CDMC21288 4 13 22 DAC35-P24 24-CG8989-RC_2 CG8989 AATCTATCATTCATATTTACATGTATACATTTATCATCCTTTTGTTGTTCAATCGAATCGTCAGCATGA 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC21288 4 14 22 DAC35-P24 24-CG8989-RC_2 CG8989 AATCTATCATTCATATTTACATGTATACATTTATCATCCTTTTGTTGTTCAATCGAATCGTCAGCATGA 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC21289 4 15 22 DAC36-D12 3-CG7111-RA_2 CG7111 CTGCTGTGGGACCTCAATGACGGCAAGAACCTGTACACTCTGGAGCACAACGACATCATCAACGC 65 FBan0007111 FBgn0020618 Rack1 2 2L protein targeting; GO:0006605; signal transduction; GO:0007165 protein kinase C binding; GO:0005080; ; GO:0005080 Rack1 Receptor of activated protein kinase C 1 "CG7111, CG7111, rack1, RACK1, i173, Guanine nucleotide-binding protein beta-subunit like protein" CDMC21289 4 16 22 DAC36-D12 3-CG7111-RA_2 CG7111 CTGCTGTGGGACCTCAATGACGGCAAGAACCTGTACACTCTGGAGCACAACGACATCATCAACGC 65 FBan0007111 FBgn0020618 Rack1 2 2L protein targeting; GO:0006605; signal transduction; GO:0007165 protein kinase C binding; GO:0005080; ; GO:0005080 Rack1 Receptor of activated protein kinase C 1 "CG7111, CG7111, rack1, RACK1, i173, Guanine nucleotide-binding protein beta-subunit like protein" CDMC21290 4 17 22 DAC36-D24 6-CG7191-RA_1 CG7191 CTGCACGAGAATCGCAAGGGCAATCACAGCAAGACGGTTAACTTCTGCAATCGAAAGCGTCCGGC 65 FBan0007191 FBgn0031945 CG7191 2 2L CG7191 CG7191 CDMC21290 4 18 22 DAC36-D24 6-CG7191-RA_1 CG7191 CTGCACGAGAATCGCAAGGGCAATCACAGCAAGACGGTTAACTTCTGCAATCGAAAGCGTCCGGC 65 FBan0007191 FBgn0031945 CG7191 2 2L CG7191 CG7191 CDMC21291 4 19 22 DAC36-H12 3-CG7262-RA_2 CG7262 AAAATCGGGCACATGCAGTTCACATGGCCATAGCGCTGTTTGAGCTAGGACTTCTAGGCAGTGCG 65 FBan0007262 FBgn0038274 CG7262 3 3R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG7262 CG7262 CDMC21291 4 20 22 DAC36-H12 3-CG7262-RA_2 CG7262 AAAATCGGGCACATGCAGTTCACATGGCCATAGCGCTGTTTGAGCTAGGACTTCTAGGCAGTGCG 65 FBan0007262 FBgn0038274 CG7262 3 3R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG7262 CG7262 CDMC21292 4 21 22 DAC36-H24 1-CG7299-RA_1 CG7299 ATTCGGTGGTAACTCCGAAGCTAACGCCAATGCCAATGCTGTCGCCAACTCTGACGGAGGATTTG 65 FBan0007299 FBgn0032282 CG7299 2 2L CG7299 CG7299 "CT22515, BcDNA:RE24635" CDMC21292 4 22 22 DAC36-H24 1-CG7299-RA_1 CG7299 ATTCGGTGGTAACTCCGAAGCTAACGCCAATGCCAATGCTGTCGCCAACTCTGACGGAGGATTTG 65 FBan0007299 FBgn0032282 CG7299 2 2L CG7299 CG7299 "CT22515, BcDNA:RE24635" CDMC21293 4 23 22 DAC36-L12 2-CG7407-RA_1 CG7407 ATGACGAGGCCTACGAAGAGAACTCCACCGAAAGCGAAGTTGAGCTAATCGAGGAACAGCTGCCC 65 FBan0007407 FBgn0037134 CG7407 3 3L CG7407 CG7407 BcDNA:LD29166 CDMC21293 4 24 22 DAC36-L12 2-CG7407-RA_1 CG7407 ATGACGAGGCCTACGAAGAGAACTCCACCGAAAGCGAAGTTGAGCTAATCGAGGAACAGCTGCCC 65 FBan0007407 FBgn0037134 CG7407 3 3L CG7407 CG7407 BcDNA:LD29166 CDMC21294 4 25 22 DAC36-L24 19-CG7423-RA_1 CG7423 GAGTTCTTTGTGCGGATCGGCGCGGAGGTGGACAGGAAGGACAAGTACGGCATCACACCGCTCCT 65 FBan0007423 FBgn0030982 CG7423 X X CG7423 CG7423 CDMC21294 4 26 22 DAC36-L24 19-CG7423-RA_1 CG7423 GAGTTCTTTGTGCGGATCGGCGCGGAGGTGGACAGGAAGGACAAGTACGGCATCACACCGCTCCT 65 FBan0007423 FBgn0030982 CG7423 X X CG7423 CG7423 CDMC21295 4 1 23 DAC36-P12 2-CG7528-RA_1 CG7528 AATCGGCTAAGAAGCGTTCTACCAACGGGGAAGGAGACTCAAAGGACGATGGACCCTCCACTTCG 65 FBan0007528 FBgn0029113 Uba2 3 3L SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein sumoylation; GO:0016925; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; SUMO activating enzyme activity; GO:0019948; ubiquitin-like activating enzyme activity; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ; GO:0004839; ; GO:0008642; ; GO:0005515; ; GO:0019948; ; GO:0005515 SUMO activating enzyme complex; GO:0031510; cytoplasm; GO:0005737; nucleus; GO:0005634 Uba2 Smt3 activating enzyme 2 "CG7528, CG7528 (E1), CG7528, CG7528, sip2, DmSAE2, SAE2, Dmuba2, DmUba2, DmSae2, dUba2, L36, Sae2, Ubc2, ubiquitin-activating enzyme (E1), SAE2 (E1), sip2 (E1), ubiquitin-activating enzyme, Smt3 activating enzyme 2" CDMC21295 4 2 23 DAC36-P12 2-CG7528-RA_1 CG7528 AATCGGCTAAGAAGCGTTCTACCAACGGGGAAGGAGACTCAAAGGACGATGGACCCTCCACTTCG 65 FBan0007528 FBgn0029113 Uba2 3 3L SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein sumoylation; GO:0016925; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; SUMO activating enzyme activity; GO:0019948; ubiquitin-like activating enzyme activity; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ; GO:0004839; ; GO:0008642; ; GO:0005515; ; GO:0019948; ; GO:0005515 SUMO activating enzyme complex; GO:0031510; cytoplasm; GO:0005737; nucleus; GO:0005634 Uba2 Smt3 activating enzyme 2 "CG7528, CG7528 (E1), CG7528, CG7528, sip2, DmSAE2, SAE2, Dmuba2, DmUba2, DmSae2, dUba2, L36, Sae2, Ubc2, ubiquitin-activating enzyme (E1), SAE2 (E1), sip2 (E1), ubiquitin-activating enzyme, Smt3 activating enzyme 2" CDMC21296 4 3 23 DAC36-P24 AutoBlank AutoBlank CDMC21296 4 4 23 DAC36-P24 AutoBlank AutoBlank CDMC21297 4 5 23 DAC37-D12 3-CG12936-RA_9 CG12936 AGATGAAGCCTGGAAATCGGAAAACCAAGTGGTCCAGTGGCTATCCGAAAGCAGCTTCCAACGGG 65 FBan0012936 FBgn0033549 CG12936 2 2R CG12936 CG12936 CDMC21297 4 6 23 DAC37-D12 3-CG12936-RA_9 CG12936 AGATGAAGCCTGGAAATCGGAAAACCAAGTGGTCCAGTGGCTATCCGAAAGCAGCTTCCAACGGG 65 FBan0012936 FBgn0033549 CG12936 2 2R CG12936 CG12936 CDMC21298 4 7 23 DAC37-D24 23-CG12971-RA_1 CG12971 TCTCCATTGAAGCTGTACTCGTATAAATATCATATCTTCGATCTGTTCCAACATCAGACGCTTCA 65 FBan0012971 FBgn0037078 CG12971 3 3L CG12971 CG12971 CDMC21298 4 8 23 DAC37-D24 23-CG12971-RA_1 CG12971 TCTCCATTGAAGCTGTACTCGTATAAATATCATATCTTCGATCTGTTCCAACATCAGACGCTTCA 65 FBan0012971 FBgn0037078 CG12971 3 3L CG12971 CG12971 CDMC21299 4 9 23 DAC37-H12 19-CG13044-RA_1 CG13044 CCGCCCCGGTGGCCTACTCCTCGTATGCCGCTCCTCTGACCTATTCCGCACCGGTGGCCTACTCG 65 FBan0013044 FBgn0036599 CG13044 3 3L CG13044 CG13044 CDMC21299 4 10 23 DAC37-H12 19-CG13044-RA_1 CG13044 CCGCCCCGGTGGCCTACTCCTCGTATGCCGCTCCTCTGACCTATTCCGCACCGGTGGCCTACTCG 65 FBan0013044 FBgn0036599 CG13044 3 3L CG13044 CG13044 CDMC21300 4 11 23 DAC37-H24 12-CG13055-RA_1 CG13055 CAATCGAAACGGAAGCCGATTAGCCGAGCCAGTTTCTCGCGTCTCCATCGTCGCTCCACATCCTC 65 FBan0013055 FBgn0036583 CG13055 3 3L CG13055 CG13055 CDMC21300 4 12 23 DAC37-H24 12-CG13055-RA_1 CG13055 CAATCGAAACGGAAGCCGATTAGCCGAGCCAGTTTCTCGCGTCTCCATCGTCGCTCCACATCCTC 65 FBan0013055 FBgn0036583 CG13055 3 3L CG13055 CG13055 CDMC21301 4 13 23 DAC37-L12 2-CG13114-RA_2 CG13114 CGGAGATCAAGCCATATGGTGGTCCCGATTCTGGACCCGATAAGCCATCGTCCACGTTCGATCTG 65 FBan0013114 FBgn0032127 CG13114 2 2L CG13114 CG13114 CDMC21301 4 14 23 DAC37-L12 2-CG13114-RA_2 CG13114 CGGAGATCAAGCCATATGGTGGTCCCGATTCTGGACCCGATAAGCCATCGTCCACGTTCGATCTG 65 FBan0013114 FBgn0032127 CG13114 2 2L CG13114 CG13114 CDMC21302 4 15 23 DAC37-L24 12-CG13135-RA_1 CG13135 GTGTGCCGATGATCCCACCGATACGGCTTGCATCGATTGCACAGATACCGCGAATGCAGCTGAAG 65 FBan0013135 FBgn0032184 CG13135 2 2L CG13135 CG13135 CDMC21302 4 16 23 DAC37-L24 12-CG13135-RA_1 CG13135 GTGTGCCGATGATCCCACCGATACGGCTTGCATCGATTGCACAGATACCGCGAATGCAGCTGAAG 65 FBan0013135 FBgn0032184 CG13135 2 2L CG13135 CG13135 CDMC21303 4 17 23 DAC37-P12 15-CG13203-RA_3 CG13203 CAAATCGGACAGCTATCCGCCCACCTTCCAACTGGCCTCCAAGGAGTACTCGCACATGATACGCC 65 FBan0013203 FBgn0033628 CG13203 2 2R CG13203 CG13203 anon-EST:Posey175 CDMC21303 4 18 23 DAC37-P12 15-CG13203-RA_3 CG13203 CAAATCGGACAGCTATCCGCCCACCTTCCAACTGGCCTCCAAGGAGTACTCGCACATGATACGCC 65 FBan0013203 FBgn0033628 CG13203 2 2R CG13203 CG13203 anon-EST:Posey175 CDMC21304 4 19 23 DAC37-P24 AutoBlank AutoBlank CDMC21304 4 20 23 DAC37-P24 AutoBlank AutoBlank CDMC21305 4 21 23 DAC38-D12 15-CG32590-RA_1 CG32590 CGCAAGGTTACCCCAGCGATTTTCGAGAAACGCGATGAAGTCTTTCAGCTGCAAAATAATCTCCAGGGA 69 FBan0032590 FBgn0052590 CG32590 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32590 CG32590 CDMC21305 4 22 23 DAC38-D12 15-CG32590-RA_1 CG32590 CGCAAGGTTACCCCAGCGATTTTCGAGAAACGCGATGAAGTCTTTCAGCTGCAAAATAATCTCCAGGGA 69 FBan0032590 FBgn0052590 CG32590 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32590 CG32590 CDMC21306 4 23 23 DAC38-D24 18-CG32598-RA_1 CG32598 CGGATGAGCAGCTCAATCCGAAGACTTATCGCGCTCAGGTCTCCGAGGACGAAGATTAGACATATTCAT 69 FBan0032598 FBgn0052598 CG32598 X X CG32598 CG32598 CDMC21306 4 24 23 DAC38-D24 18-CG32598-RA_1 CG32598 CGGATGAGCAGCTCAATCCGAAGACTTATCGCGCTCAGGTCTCCGAGGACGAAGATTAGACATATTCAT 69 FBan0032598 FBgn0052598 CG32598 X X CG32598 CG32598 CDMC21307 4 25 23 DAC38-H12 13-CG32640-RA_1 CG32640 ACATCCACGAACGACGGCTCAATTCCGGAAGATCAACGAAGCATTTAATGTCCTGTCAGATGCGTCGGC 69 FBan0032640 FBgn0052640 CG32640 X X protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG32640 CG32640 CDMC21307 4 26 23 DAC38-H12 13-CG32640-RA_1 CG32640 ACATCCACGAACGACGGCTCAATTCCGGAAGATCAACGAAGCATTTAATGTCCTGTCAGATGCGTCGGC 69 FBan0032640 FBgn0052640 CG32640 X X protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG32640 CG32640 CDMC21308 4 1 24 DAC38-H24 8-CG32649-RA_1 CG32649 GCATGAATTGCGTGCCCTTCTACAAGGACATCGTTCTGGGGAAGTTCAAGGACTAGTGAGCACAGCTCA 69 FBan0032649 FBgn0052649 CG32649 X X "coenzyme metabolism; GO:0006732; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; prosthetic group metabolism; GO:0051189" protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 mitochondrion; GO:0005739 CG32649 CG32649 "CG4410, CG4410" CDMC21308 4 2 24 DAC38-H24 8-CG32649-RA_1 CG32649 GCATGAATTGCGTGCCCTTCTACAAGGACATCGTTCTGGGGAAGTTCAAGGACTAGTGAGCACAGCTCA 69 FBan0032649 FBgn0052649 CG32649 X X "coenzyme metabolism; GO:0006732; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; prosthetic group metabolism; GO:0051189" protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 mitochondrion; GO:0005739 CG32649 CG32649 "CG4410, CG4410" CDMC21309 4 3 24 DAC38-L12 1-CG32683-RA_1 CG32683 AGGATTGCGCAAACATTTTGGTTCCCCTCCTATCCCATTCGATTCCGTTGTCCTTTCTGTCTCCGGAGC 69 FBan0032683 FBgn0052683 CG32683 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 CG32683 CG32683 "CG15303, CG2881, CG2883" CDMC21309 4 4 24 DAC38-L12 1-CG32683-RA_1 CG32683 AGGATTGCGCAAACATTTTGGTTCCCCTCCTATCCCATTCGATTCCGTTGTCCTTTCTGTCTCCGGAGC 69 FBan0032683 FBgn0052683 CG32683 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 CG32683 CG32683 "CG15303, CG2881, CG2883" CDMC21310 4 5 24 DAC38-L24 23-CG32695-RA_1 CG32695 AAACTGGACTCTCCCACTGAGCAAAGTTAAATTTAAATGCGTGTTTATTTTTAAGTCTGTTTGCCTTGC 69 FBan0032695 FBgn0052695 CG32695 X X CG32695 CG32695 "CG15246, BcDNA:RH68724" CDMC21310 4 6 24 DAC38-L24 23-CG32695-RA_1 CG32695 AAACTGGACTCTCCCACTGAGCAAAGTTAAATTTAAATGCGTGTTTATTTTTAAGTCTGTTTGCCTTGC 69 FBan0032695 FBgn0052695 CG32695 X X CG32695 CG32695 "CG15246, BcDNA:RH68724" CDMC21311 4 7 24 DAC38-P12 17-CG32718-RA_3 CG32718 TGAGGAAAATGCCTCTTGGACTACCCATTTGGACACCATTGTTCATCCTTTTCTTGCTTTTCCTGGCCG 69 FBan0032718 FBgn0052718 CG32718 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32718 CG32718 CDMC21311 4 8 24 DAC38-P12 17-CG32718-RA_3 CG32718 TGAGGAAAATGCCTCTTGGACTACCCATTTGGACACCATTGTTCATCCTTTTCTTGCTTTTCCTGGCCG 69 FBan0032718 FBgn0052718 CG32718 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32718 CG32718 CDMC21312 4 9 24 DAC38-P24 2-CG32732-RA_1 CG32732 TCTCGCCGGAGCTTTACAATACGCCCAAGAGCATCGCAAGGTCTAGGGATTTAAGCAGACAACCCACAA 69 FBan0032732 FBgn0052732 CG32732 X X CG32732 CG32732 "CG12542, CG3042" CDMC21312 4 10 24 DAC38-P24 2-CG32732-RA_1 CG32732 TCTCGCCGGAGCTTTACAATACGCCCAAGAGCATCGCAAGGTCTAGGGATTTAAGCAGACAACCCACAA 69 FBan0032732 FBgn0052732 CG32732 X X CG32732 CG32732 "CG12542, CG3042" CDMC21313 4 11 24 DAC39-D12 3-CG13692-RA_1 CG13692 AGTATGGCCCCCTTGTGGAGGCAGTATTTCGAGGATGTCAAGAAGCTGATCTACGTCGTGGACACCTCT 69 FBan0013692 FBgn0031254 CG13692 2 2L protein amino acid ADP-ribosylation; GO:0006471 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0005525 CG13692 CG13692 CDMC21313 4 12 24 DAC39-D12 3-CG13692-RA_1 CG13692 AGTATGGCCCCCTTGTGGAGGCAGTATTTCGAGGATGTCAAGAAGCTGATCTACGTCGTGGACACCTCT 69 FBan0013692 FBgn0031254 CG13692 2 2L protein amino acid ADP-ribosylation; GO:0006471 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0005525 CG13692 CG13692 CDMC21314 4 13 24 DAC39-D24 23-CG13704-RA_4 CG13704 CGTGCGCGTTACAAACTTGGCTAACAGCTAAAAGCGAACATAAGTTTTTCGAAAGAACCGACGAAAACG 69 FBan0013704 FBgn0035583 CG13704 3 3L CG13704 CG13704 BcDNA:RE40159 CDMC21314 4 14 24 DAC39-D24 23-CG13704-RA_4 CG13704 CGTGCGCGTTACAAACTTGGCTAACAGCTAAAAGCGAACATAAGTTTTTCGAAAGAACCGACGAAAACG 69 FBan0013704 FBgn0035583 CG13704 3 3L CG13704 CG13704 BcDNA:RE40159 CDMC21315 4 15 24 DAC39-H12 3-CG13746-RA_1 CG13746 AGCGCCGTCGCATATAGGTGACCCCCGCCCGAAACTGACGATTGTTGATCCGTTTTAGCTCATTAGTTT 69 FBan0013746 FBgn0033341 MrgBP 2 2R MrgBP MrgBP "CG13746, CG13746, dMrgBP" CDMC21315 4 16 24 DAC39-H12 3-CG13746-RA_1 CG13746 AGCGCCGTCGCATATAGGTGACCCCCGCCCGAAACTGACGATTGTTGATCCGTTTTAGCTCATTAGTTT 69 FBan0013746 FBgn0033341 MrgBP 2 2R MrgBP MrgBP "CG13746, CG13746, dMrgBP" CDMC21316 4 17 24 DAC39-H24 2-CG13771-RA_2 CG13771 GCGGATGCAGATGTGTCCCTCTCCGGTCACGTTTCATATACGGACAATAACTTCATGGAGGTCACGGCA 69 FBan0013771 FBgn0031844 CG13771 2 2L lipid metabolism; GO:0006629 "acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016291 ; EC:3.1.2.-" CG13771 CG13771 CDMC21316 4 18 24 DAC39-H24 2-CG13771-RA_2 CG13771 GCGGATGCAGATGTGTCCCTCTCCGGTCACGTTTCATATACGGACAATAACTTCATGGAGGTCACGGCA 69 FBan0013771 FBgn0031844 CG13771 2 2L lipid metabolism; GO:0006629 "acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016291 ; EC:3.1.2.-" CG13771 CG13771 CDMC21317 4 19 24 DAC39-L12 18-CG13794-RA_2 CG13794 ACAAACAAGTATTGACTCATTGGGCTCTGTATTTGTCCAGTGCTACCGCATTGTCTTCTCTGGGTTGGC 69 FBan0013794 FBgn0031936 CG13794 2 2L CG13794 CG13794 CDMC21317 4 20 24 DAC39-L12 18-CG13794-RA_2 CG13794 ACAAACAAGTATTGACTCATTGGGCTCTGTATTTGTCCAGTGCTACCGCATTGTCTTCTCTGGGTTGGC 69 FBan0013794 FBgn0031936 CG13794 2 2L CG13794 CG13794 CDMC21318 4 21 24 DAC39-L24 15-CG13809-RA_3 CG13809 GCGCCACCGATCGAAGCTCACTTTAATATATACACCAGGATAGCACTGGACTGTTTGGCTCTGAGGGAG 69 FBan0013809 FBgn0035317 osm-1 3 3L microtubule-based movement; GO:0007018; sensory cilium biogenesis; GO:0035058 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-1 osm-1 "CG13809, CG13809, CG13809, OSEG2" CDMC21318 4 22 24 DAC39-L24 15-CG13809-RA_3 CG13809 GCGCCACCGATCGAAGCTCACTTTAATATATACACCAGGATAGCACTGGACTGTTTGGCTCTGAGGGAG 69 FBan0013809 FBgn0035317 osm-1 3 3L microtubule-based movement; GO:0007018; sensory cilium biogenesis; GO:0035058 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-1 osm-1 "CG13809, CG13809, CG13809, OSEG2" CDMC21319 4 23 24 DAC39-P12 1-CG13869-RA_2 CG13869 CCAGTTGGGTCAAAATGGTAGTGCCTGTCTGGATCGTCTGATCTGCGAGAATGGTCAGGTGGATGAGCA 69 FBan0013869 FBgn0034486 CG13869 2 2R CG13869 CG13869 CDMC21319 4 24 24 DAC39-P12 1-CG13869-RA_2 CG13869 CCAGTTGGGTCAAAATGGTAGTGCCTGTCTGGATCGTCTGATCTGCGAGAATGGTCAGGTGGATGAGCA 69 FBan0013869 FBgn0034486 CG13869 2 2R CG13869 CG13869 CDMC21320 4 25 24 DAC39-P24 AutoBlank AutoBlank CDMC21320 4 26 24 DAC39-P24 AutoBlank AutoBlank CDMC21321 4 1 25 DAC40-D12 21-CG14177-RA_1 CG14177 ACGACCCAAGCCAGGTATCCTGCGACTGGACATCGGCAAACCGCGACGCTCATCAGGTGGTTCCG 65 FBan0014177 FBgn0036013 CG14177 3 3L CG14177 CG14177 CDMC21321 4 2 25 DAC40-D12 21-CG14177-RA_1 CG14177 ACGACCCAAGCCAGGTATCCTGCGACTGGACATCGGCAAACCGCGACGCTCATCAGGTGGTTCCG 65 FBan0014177 FBgn0036013 CG14177 3 3L CG14177 CG14177 CDMC21322 4 3 25 DAC40-D24 10-CG14199-RA_1 CG14199 CTCTTCCCCAGCTTGATAGACCGCAACAAGACCGGATTCATGGGCACCTTCTGGAAGCTGGCAAG 65 FBan0014199 FBgn0040890 CG14199 X X CG14199 CG14199 CDMC21322 4 4 25 DAC40-D24 10-CG14199-RA_1 CG14199 CTCTTCCCCAGCTTGATAGACCGCAACAAGACCGGATTCATGGGCACCTTCTGGAAGCTGGCAAG 65 FBan0014199 FBgn0040890 CG14199 X X CG14199 CG14199 CDMC21323 4 5 25 DAC40-H12 1-CG14266-RA_4 CG14266 GAAGGTCAGGAAAATCACAAGGAGAAGGGGTCTCAGGAGCCGCAATGGTCGCAGCAGTAGAAACC 65 FBan0014266 FBgn0010294 ng2 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng2 new glue 2 "CG14266, ng-2, ng, BcDNA:RE05239, EG:96G10.4" CDMC21323 4 6 25 DAC40-H12 1-CG14266-RA_4 CG14266 GAAGGTCAGGAAAATCACAAGGAGAAGGGGTCTCAGGAGCCGCAATGGTCGCAGCAGTAGAAACC 65 FBan0014266 FBgn0010294 ng2 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng2 new glue 2 "CG14266, ng-2, ng, BcDNA:RE05239, EG:96G10.4" CDMC21324 4 7 25 DAC40-H24 3-CG14291-RA_5 CG14291 CAACCAGATTGGCAGAAACATCACCCGGATGAAGGAGTATGCCAGGCAGTTTCTCAAGCAGGCCA 65 FBan0014291 FBgn0038660 CG14291 3 3R sulfur metabolism; GO:0006790 N-sulfoglucosamine sulfohydrolase activity; GO:0016250 ; EC:3.10.1.1; ; GO:0016250 ; EC:3.10.1.1; sulfuric ester hydrolase activity; GO:0008484 ; EC:3.1.6.-; ; GO:0008484 ; EC:3.1.6.- CG14291 CG14291 CDMC21324 4 8 25 DAC40-H24 3-CG14291-RA_5 CG14291 CAACCAGATTGGCAGAAACATCACCCGGATGAAGGAGTATGCCAGGCAGTTTCTCAAGCAGGCCA 65 FBan0014291 FBgn0038660 CG14291 3 3R sulfur metabolism; GO:0006790 N-sulfoglucosamine sulfohydrolase activity; GO:0016250 ; EC:3.10.1.1; ; GO:0016250 ; EC:3.10.1.1; sulfuric ester hydrolase activity; GO:0008484 ; EC:3.1.6.-; ; GO:0008484 ; EC:3.1.6.- CG14291 CG14291 CDMC21325 4 9 25 DAC40-L12 23-CG14394-RA_1 CG14394 GCTTCGCCATCAACCACTTCATAGATGCCTTCATATTCCTGTCCGTGTTTTGTGACATCATGAAG 65 FBan0014394 FBgn0038079 CG14394 3 3R CG14394 CG14394 CDMC21325 4 10 25 DAC40-L12 23-CG14394-RA_1 CG14394 GCTTCGCCATCAACCACTTCATAGATGCCTTCATATTCCTGTCCGTGTTTTGTGACATCATGAAG 65 FBan0014394 FBgn0038079 CG14394 3 3R CG14394 CG14394 CDMC21326 4 11 25 DAC40-L24 23-CG14414-RC_1 CG14414 TTTTAATTTTCATTTATTTTCGCACACAAAATGGCTAGCACTGTCCGTAAATCCGCGTAGAAACG 65 FBan0014414 FBgn0030571 CG14414 X X mRNA binding; GO:0003729; ; GO:0003729 CG14414 CG14414 "cg14414, BcDNA:AT01764" CDMC21326 4 12 25 DAC40-L24 23-CG14414-RC_1 CG14414 TTTTAATTTTCATTTATTTTCGCACACAAAATGGCTAGCACTGTCCGTAAATCCGCGTAGAAACG 65 FBan0014414 FBgn0030571 CG14414 X X mRNA binding; GO:0003729; ; GO:0003729 CG14414 CG14414 "cg14414, BcDNA:AT01764" CDMC21327 4 13 25 DAC40-P12 23-CG14482-RA_2 CG14482 TTTGGTGCGTGTGAAAAGTTATTAAATCAACAAAAATGGCTTTCCGCATACCTTTTGGCAAGAAG 65 FBan0014482 FBgn0034245 CG14482 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14482 CG14482 CDMC21327 4 14 25 DAC40-P12 23-CG14482-RA_2 CG14482 TTTGGTGCGTGTGAAAAGTTATTAAATCAACAAAAATGGCTTTCCGCATACCTTTTGGCAAGAAG 65 FBan0014482 FBgn0034245 CG14482 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14482 CG14482 CDMC21328 4 15 25 DAC40-P24 AutoBlank AutoBlank CDMC21328 4 16 25 DAC40-P24 AutoBlank AutoBlank CDMC21329 4 17 25 DAC41-D12 AutoBlank AutoBlank CDMC21329 4 18 25 DAC41-D12 AutoBlank AutoBlank CDMC21330 4 19 25 DAC41-D24 AutoBlank AutoBlank CDMC21330 4 20 25 DAC41-D24 AutoBlank AutoBlank CDMC21331 4 21 25 DAC41-H12 AutoBlank AutoBlank CDMC21331 4 22 25 DAC41-H12 AutoBlank AutoBlank CDMC21332 4 23 25 DAC41-H24 AutoBlank AutoBlank CDMC21332 4 24 25 DAC41-H24 AutoBlank AutoBlank CDMC21333 4 25 25 DAC41-L12 AutoBlank AutoBlank CDMC21333 4 26 25 DAC41-L12 AutoBlank AutoBlank CDMC21334 4 1 26 DAC41-L24 AutoBlank AutoBlank CDMC21334 4 2 26 DAC41-L24 AutoBlank AutoBlank CDMC21335 4 3 26 DAC41-P12 AutoBlank AutoBlank CDMC21335 4 4 26 DAC41-P12 AutoBlank AutoBlank CDMC21336 4 5 26 DAC41-P24 AutoBlank AutoBlank CDMC21336 4 6 26 DAC41-P24 AutoBlank AutoBlank CDMC21337 4 7 26 DAC42-D12 Oligo GFP control GFP CDMC21337 4 8 26 DAC42-D12 Oligo GFP control GFP CDMC21338 4 9 26 DAC42-D24 Oligo lacZ control lacZ CDMC21338 4 10 26 DAC42-D24 Oligo lacZ control lacZ CDMC21339 4 11 26 DAC42-H12 pBS vector pBS vector CDMC21339 4 12 26 DAC42-H12 pBS vector pBS vector CDMC21340 4 13 26 DAC42H24 pOT2A vector pOT2A vector CDMC21340 4 14 26 DAC42H24 pOT2A vector pOT2A vector CDMC21341 4 15 26 DAC42-L12 Oligo Tet control Tet CDMC21341 4 16 26 DAC42-L12 Oligo Tet control Tet CDMC21342 4 17 26 DAC42-L24 5uM MSP 5uM MSP CDMC21342 4 18 26 DAC42-L24 5uM MSP 5uM MSP CDMC21343 4 19 26 DAC42-P12 10uM MSP 10uM MSP CDMC21343 4 20 26 DAC42-P12 10uM MSP 10uM MSP CDMC21344 4 21 26 DAC42-P24 20uM MSP 20uM MSP CDMC21344 4 22 26 DAC42-P24 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC21345 1 1 1 DAC01-A11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21345 1 2 1 DAC01-A11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21346 1 3 1 DAC01-A23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21346 1 4 1 DAC01-A23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21347 1 5 1 DAC01-E11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21347 1 6 1 DAC01-E11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21348 1 7 1 DAC01-E23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21348 1 8 1 DAC01-E23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21349 1 9 1 DAC01-I11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21349 1 10 1 DAC01-I11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21350 1 11 1 DAC01-I23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21350 1 12 1 DAC01-I23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21351 1 13 1 DAC01-M11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21351 1 14 1 DAC01-M11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21352 1 15 1 DAC01-M23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21352 1 16 1 DAC01-M23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21353 1 17 1 DAC02-A11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21353 1 18 1 DAC02-A11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21354 1 19 1 DAC02-A23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21354 1 20 1 DAC02-A23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21355 1 21 1 DAC02-E11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21355 1 22 1 DAC02-E11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21356 1 23 1 DAC02-E23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21356 1 24 1 DAC02-E23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21357 1 25 1 DAC02-I11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21357 1 26 1 DAC02-I11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21358 1 1 2 DAC02-I23 N/A CG9075 (01196-01434) CDMC21358 1 2 2 DAC02-I23 N/A CG9075 (01196-01434) CDMC21359 1 3 2 DAC02-M11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21359 1 4 2 DAC02-M11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21360 1 5 2 DAC02-M23 AutoBlank AutoBlank CDMC21360 1 6 2 DAC02-M23 AutoBlank AutoBlank CDMC21361 1 7 2 DAC03-A11 9-CG17083-RA_3 CG17083 GCAACATCAGGCCTATGTAATGCGAGCACGGAAAAGGATGACCATTTTGGAGAATTCCCTGGAGGTGGG 69 FBan0017083 FBgn0039070 CG17083 3 3R CG17083 CG17083 CDMC21361 1 8 2 DAC03-A11 9-CG17083-RA_3 CG17083 GCAACATCAGGCCTATGTAATGCGAGCACGGAAAAGGATGACCATTTTGGAGAATTCCCTGGAGGTGGG 69 FBan0017083 FBgn0039070 CG17083 3 3R CG17083 CG17083 CDMC21362 1 9 2 DAC03-A23 15-CG1709-RC_5 CG1709 TCTTCGGTGTGGTGATGAGCTGGCACAATCATACGTATTTCAGGAACAGGATCTCCCTGCTCTACGAGT 69 FBan0001709 FBgn0028671 Vha100-1 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-1 Vha100-1 "CG1709, vha100-1, V-ATPase, BcDNA:LD21248" CDMC21362 1 10 2 DAC03-A23 15-CG1709-RC_5 CG1709 TCTTCGGTGTGGTGATGAGCTGGCACAATCATACGTATTTCAGGAACAGGATCTCCCTGCTCTACGAGT 69 FBan0001709 FBgn0028671 Vha100-1 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-1 Vha100-1 "CG1709, vha100-1, V-ATPase, BcDNA:LD21248" CDMC21363 1 11 2 DAC03-E11 2-CG17148-RA_2 CG17148 GCTGTCCGAAGCTTCCTTGTGTTTTCCTATGTACCCTTCAGTGCTTTTGGACCTGTTGTGGAGCCGTCA 69 FBan0017148 FBgn0000594 Est-P 3 3L neuromuscular synaptic transmission; GO:0007274; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 Est-P Esterase P "CG17148, est-P, EstP, ESTP, Est-5, PsiEst-6, yEst-6, EST-5, Est-7" CDMC21363 1 12 2 DAC03-E11 2-CG17148-RA_2 CG17148 GCTGTCCGAAGCTTCCTTGTGTTTTCCTATGTACCCTTCAGTGCTTTTGGACCTGTTGTGGAGCCGTCA 69 FBan0017148 FBgn0000594 Est-P 3 3L neuromuscular synaptic transmission; GO:0007274; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 Est-P Esterase P "CG17148, est-P, EstP, ESTP, Est-5, PsiEst-6, yEst-6, EST-5, Est-7" CDMC21364 1 13 2 DAC03-E23 23-CG17158-RA_4 CG17158 GGCAGTAAATTTGTTACATGAGAAAATTGTTACACCACGAGAAGCACATTAATGTAAATTTTGCCCGCC 69 FBan0017158 FBgn0011570 cpb 2 2L actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament length; GO:0030832 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 F-actin capping protein complex; GO:0008290 cpb capping protein beta "CG17158, CG17158, CP beta subunit, J, capping protein, CP-beta, capping protein beta, CapZ, CP, Ancpbeta, Capping-protein-beta, capping protein beta" CDMC21364 1 14 2 DAC03-E23 23-CG17158-RA_4 CG17158 GGCAGTAAATTTGTTACATGAGAAAATTGTTACACCACGAGAAGCACATTAATGTAAATTTTGCCCGCC 69 FBan0017158 FBgn0011570 cpb 2 2L actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament length; GO:0030832 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 F-actin capping protein complex; GO:0008290 cpb capping protein beta "CG17158, CG17158, CP beta subunit, J, capping protein, CP-beta, capping protein beta, CapZ, CP, Ancpbeta, Capping-protein-beta, capping protein beta" CDMC21365 1 15 2 DAC03-I11 14-CG17196-RA_1 CG17196 TGGTGCCGCGAATATGCCAATCTCTATCCTAAGAAGGCCGTGAGCATAGGACATCCTTTGTCAGTGATT 69 FBan0017196 FBgn0039368 CG17196 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17196 CG17196 CDMC21365 1 16 2 DAC03-I11 14-CG17196-RA_1 CG17196 TGGTGCCGCGAATATGCCAATCTCTATCCTAAGAAGGCCGTGAGCATAGGACATCCTTTGTCAGTGATT 69 FBan0017196 FBgn0039368 CG17196 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17196 CG17196 CDMC21366 1 17 2 DAC03-I23 23-CG17205-RA_4 CG17205 GCCCGAACAACCATATGAAAAAGCGCTGTGATCGTATCTTTAATATTGTTAATCACAATCCTTGCGTGG 69 FBan0017205 FBgn0038794 CG17205 3 3R CG17205 CG17205 BcDNA:GH26447 CDMC21366 1 18 2 DAC03-I23 23-CG17205-RA_4 CG17205 GCCCGAACAACCATATGAAAAAGCGCTGTGATCGTATCTTTAATATTGTTAATCACAATCCTTGCGTGG 69 FBan0017205 FBgn0038794 CG17205 3 3R CG17205 CG17205 BcDNA:GH26447 CDMC21367 1 19 2 DAC03-M11 23-CG17244-RA_1 CG17244 CTTCGTGACACGTGTTTACTGCATAATTATACCTGTGGAATTTTCGTTTTTATATACATGCCTGCTCCC 69 FBan0017244 FBgn0039031 CG17244 3 3R CG17244 CG17244 BcDNA:RH17470 CDMC21367 1 20 2 DAC03-M11 23-CG17244-RA_1 CG17244 CTTCGTGACACGTGTTTACTGCATAATTATACCTGTGGAATTTTCGTTTTTATATACATGCCTGCTCCC 69 FBan0017244 FBgn0039031 CG17244 3 3R CG17244 CG17244 BcDNA:RH17470 CDMC21368 1 21 2 DAC03-M23 2-CG17257-RA_1 CG17257 GGCTGAGGACAGTCGAGAGCGATCCCACATCCTAGGATGCTGTTGTAACTGCGTGGACTTCGACTTAGT 69 FBan0017257 FBgn0031495 CG17257 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17257 CG17257 CDMC21368 1 22 2 DAC03-M23 2-CG17257-RA_1 CG17257 GGCTGAGGACAGTCGAGAGCGATCCCACATCCTAGGATGCTGTTGTAACTGCGTGGACTTCGACTTAGT 69 FBan0017257 FBgn0031495 CG17257 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17257 CG17257 CDMC21369 1 23 2 DAC04-A11 9-CG15874-RA_1 CG15874 ACATTATCCTGGTGAGACATGGCGAGTACACGAGGACCCCGAATGGAAGCCACCTCACGGAACTG 65 FBan0015874 FBgn0035004 CG15874 2 2R CG15874 CG15874 CDMC21369 1 24 2 DAC04-A11 9-CG15874-RA_1 CG15874 ACATTATCCTGGTGAGACATGGCGAGTACACGAGGACCCCGAATGGAAGCCACCTCACGGAACTG 65 FBan0015874 FBgn0035004 CG15874 2 2R CG15874 CG15874 CDMC21370 1 25 2 DAC04-A23 2-CG15904-RA_2 CG15904 GGTGGACAAGCACATGCTGGACCTGCATCGTGATCCATTCAACACCTCCTTTGGCTACACGGTAA 65 FBan0015904 FBgn0034458 CG15904 2 2R CG15904 CG15904 CDMC21370 1 26 2 DAC04-A23 2-CG15904-RA_2 CG15904 GGTGGACAAGCACATGCTGGACCTGCATCGTGATCCATTCAACACCTCCTTTGGCTACACGGTAA 65 FBan0015904 FBgn0034458 CG15904 2 2R CG15904 CG15904 CDMC21371 1 1 3 DAC04-E11 1-CG1675-RA_1 CG1675 AGGGGTCGTCGAAGCAGAAGGATGATAGCAGTATAGCCGCAAGTTCAGATGCCAAGACAGCGTCC 65 FBan0001675 FBgn0033457 CG1675 2 2R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG1675 CG1675 CDMC21371 1 2 3 DAC04-E11 1-CG1675-RA_1 CG1675 AGGGGTCGTCGAAGCAGAAGGATGATAGCAGTATAGCCGCAAGTTCAGATGCCAAGACAGCGTCC 65 FBan0001675 FBgn0033457 CG1675 2 2R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG1675 CG1675 CDMC21372 1 3 3 DAC04-E23 3-CG1677-RA_1 CG1677 TATAAGAGACCAGCTGTGGACAAGCGTGGCGTTGGACACAGTCCGTCTTCCAAGCGTAAGAAGCT 65 FBan0001677 FBgn0029941 CG1677 X X nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG1677 CG1677 CDMC21372 1 4 3 DAC04-E23 3-CG1677-RA_1 CG1677 TATAAGAGACCAGCTGTGGACAAGCGTGGCGTTGGACACAGTCCGTCTTCCAAGCGTAAGAAGCT 65 FBan0001677 FBgn0029941 CG1677 X X nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG1677 CG1677 CDMC21373 1 5 3 DAC04-I11 2-CG16908-RA_2 CG16908 ATTGGTTTGAGGACCGTACTCCTGGCATCTATTCATCGGCGATTGAGGTACGCACCCAGGACTGC 65 FBan0016908 FBgn0037741 CG16908 3 3R CG16908 CG16908 CDMC21373 1 6 3 DAC04-I11 2-CG16908-RA_2 CG16908 ATTGGTTTGAGGACCGTACTCCTGGCATCTATTCATCGGCGATTGAGGTACGCACCCAGGACTGC 65 FBan0016908 FBgn0037741 CG16908 3 3R CG16908 CG16908 CDMC21374 1 7 3 DAC04-I23 23-CG16958-RA_2 CG16958 CTACATTTACATGCGGGAAAATATTCCACACATCAACATCGAATGTAGACACACTCGTACGTCTT 65 FBgn0030902 CDMC21374 1 8 3 DAC04-I23 23-CG16958-RA_2 CG16958 CTACATTTACATGCGGGAAAATATTCCACACATCAACATCGAATGTAGACACACTCGTACGTCTT 65 FBgn0030902 CDMC21375 1 9 3 DAC04-M11 19-CG17127-RA_1 CG17127 TGGGCGCGTACGAGCAGATACCCGGCAACCAGCGCATCAATCTCTTCGAGATCCTCGGCGACCAG 65 FBan0017127 FBgn0032299 CG17127 2 2L CG17127 CG17127 CDMC21375 1 10 3 DAC04-M11 19-CG17127-RA_1 CG17127 TGGGCGCGTACGAGCAGATACCCGGCAACCAGCGCATCAATCTCTTCGAGATCCTCGGCGACCAG 65 FBan0017127 FBgn0032299 CG17127 2 2L CG17127 CG17127 CDMC21376 1 11 3 DAC04-M23 3-CG17150-RC_3 CG17150 GCCCAAGCTGAAAGTCCTGTCCGAGGAAACGGATCGCATAATGGTGAACATCGAACGTGAGACGG 65 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC21376 1 12 3 DAC04-M23 3-CG17150-RC_3 CG17150 GCCCAAGCTGAAAGTCCTGTCCGAGGAAACGGATCGCATAATGGTGAACATCGAACGTGAGACGG 65 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC21377 1 13 3 DAC05-A11 5-CG10240-RA_1 CG10240 GGATCGGGGAATGTATCACAATGAGCGGGATGATCCTCTAACTGGGCATCTATTCCGCATTGACGGGC 68 FBan0010240 FBgn0013773 Cyp6a22 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a22 Cyp6a22 "CG10240, P-450, BF6-2, P450, 6a22, Cyt-P450-rBF6-2: Cytochrome P450 related BF6-2, Cytochrome P450 related BF6-2" CDMC21377 1 14 3 DAC05-A11 5-CG10240-RA_1 CG10240 GGATCGGGGAATGTATCACAATGAGCGGGATGATCCTCTAACTGGGCATCTATTCCGCATTGACGGGC 68 FBan0010240 FBgn0013773 Cyp6a22 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a22 Cyp6a22 "CG10240, P-450, BF6-2, P450, 6a22, Cyt-P450-rBF6-2: Cytochrome P450 related BF6-2, Cytochrome P450 related BF6-2" CDMC21378 1 15 3 DAC05-A23 3-CG10361-RA_6 CG10361 CCCGAATCGTTGAACTGGCTAGGAAATACAATGCCCTGGTGTTTGTGGACGAGTGTCATGCTACGGGC 68 FBan0010361 FBgn0036208 CG10361 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; glycine C-acetyltransferase activity; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29 mitochondrion; GO:0005739 CG10361 CG10361 CDMC21378 1 16 3 DAC05-A23 3-CG10361-RA_6 CG10361 CCCGAATCGTTGAACTGGCTAGGAAATACAATGCCCTGGTGTTTGTGGACGAGTGTCATGCTACGGGC 68 FBan0010361 FBgn0036208 CG10361 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; glycine C-acetyltransferase activity; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29 mitochondrion; GO:0005739 CG10361 CG10361 CDMC21379 1 17 3 DAC05-E11 1-CG10887-RA_2 CG10887 GCGCGCTTATGAAGAATCATCCTCCGAAACGTGACAGGCACTATCAAGGCTCCGATCACAATGTGGCC 68 FBan0010887 FBgn0038773 CG10887 3 3R CG10887 CG10887 CDMC21379 1 18 3 DAC05-E11 1-CG10887-RA_2 CG10887 GCGCGCTTATGAAGAATCATCCTCCGAAACGTGACAGGCACTATCAAGGCTCCGATCACAATGTGGCC 68 FBan0010887 FBgn0038773 CG10887 3 3R CG10887 CG10887 CDMC21380 1 19 3 DAC05-E23 2-CG11015-RA_1 CG11015 TCACCACTTAAGACCGACCGAAATTTTCGCAAAACGAACAATGGCATCGATCTGTGGACGCATGGCGC 68 FBan0011015 FBgn0031830 CG11015 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11015 CG11015 "Vb, anon-WO0118547.187, BcDNA:RH49324, anon-EST:Posey143" CDMC21380 1 20 3 DAC05-E23 2-CG11015-RA_1 CG11015 TCACCACTTAAGACCGACCGAAATTTTCGCAAAACGAACAATGGCATCGATCTGTGGACGCATGGCGC 68 FBan0011015 FBgn0031830 CG11015 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11015 CG11015 "Vb, anon-WO0118547.187, BcDNA:RH49324, anon-EST:Posey143" CDMC21381 1 21 3 DAC05-I11 3-CG11309-RB_5 CG11309 CGGGTCCCAGGAGCTGTGTGTGGAAATGGCCAATCGGATTACATGTCCTTACTTGTTCATCAAGGCCG 68 FBan0011309 FBgn0037070 CG11309 3 3L calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG11309 CG11309 CDMC21381 1 22 3 DAC05-I11 3-CG11309-RB_5 CG11309 CGGGTCCCAGGAGCTGTGTGTGGAAATGGCCAATCGGATTACATGTCCTTACTTGTTCATCAAGGCCG 68 FBan0011309 FBgn0037070 CG11309 3 3L calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG11309 CG11309 CDMC21382 1 23 3 DAC05-I23 3-CG11396-RA_1 CG11396 ACCGGCAACACAATGATCCTGAACAACATGGGAGTGTGCCTTCTCTACGCCGGAAAGCTAAAGGATGC 68 FBan0011396 FBgn0037022 CG11396 3 3L CG11396 CG11396 CDMC21382 1 24 3 DAC05-I23 3-CG11396-RA_1 CG11396 ACCGGCAACACAATGATCCTGAACAACATGGGAGTGTGCCTTCTCTACGCCGGAAAGCTAAAGGATGC 68 FBan0011396 FBgn0037022 CG11396 3 3L CG11396 CG11396 CDMC21383 1 25 3 DAC05-M11 5-CG11981-RA_1 CG11981 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC21383 1 26 3 DAC05-M11 5-CG11981-RA_1 CG11981 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC21384 1 1 4 DAC05-M23 2-CG12110-RB_2 CG12110 AGCGAAGGTTCCAGTCGGTCTGACCTGGACATTAACGATCCTGTTTGTGAGAAGTTTTGGCACGGCAC 68 FBan0012110 FBgn0033075 Pld 2 2R intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644; signal transduction; GO:0007165 phospholipase D activity; GO:0004630 ; EC:3.1.4.4; ; GO:0004630 ; EC:3.1.4.4 Pld Phospholipase D "CG12110, CG12110, dPLD, Phospholipase D" CDMC21384 1 2 4 DAC05-M23 2-CG12110-RB_2 CG12110 AGCGAAGGTTCCAGTCGGTCTGACCTGGACATTAACGATCCTGTTTGTGAGAAGTTTTGGCACGGCAC 68 FBan0012110 FBgn0033075 Pld 2 2R intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644; signal transduction; GO:0007165 phospholipase D activity; GO:0004630 ; EC:3.1.4.4; ; GO:0004630 ; EC:3.1.4.4 Pld Phospholipase D "CG12110, CG12110, dPLD, Phospholipase D" CDMC21385 1 3 4 DAC06-A11 15-CG32985-RA_1 CG32985 TGGTGGAGTGCAGGACAGCTGACGAAATGAGAGTCCTTCAAAGAGATGCCTTCGTGTTTGTGCAATACA 69 FBan0032985 FBgn0052985 CG32985 2 2L CG32985 CG32985 CG17789 CDMC21385 1 4 4 DAC06-A11 15-CG32985-RA_1 CG32985 TGGTGGAGTGCAGGACAGCTGACGAAATGAGAGTCCTTCAAAGAGATGCCTTCGTGTTTGTGCAATACA 69 FBan0032985 FBgn0052985 CG32985 2 2L CG32985 CG32985 CG17789 CDMC21386 1 5 4 DAC06-A23 2-CG33003-RA_1 CG33003 CCGCAAGCTCTGGTACATCCCGCTCTACTTTACGGTGTGGTTCAGCTTCTACATCCTGTGGCTGATCAT 69 FBan0033003 FBgn0053003 CG33003 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33003 CG33003 CDMC21386 1 6 4 DAC06-A23 2-CG33003-RA_1 CG33003 CCGCAAGCTCTGGTACATCCCGCTCTACTTTACGGTGTGGTTCAGCTTCTACATCCTGTGGCTGATCAT 69 FBan0033003 FBgn0053003 CG33003 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33003 CG33003 CDMC21387 1 7 4 DAC06-E11 22-CG33056-RA_1 CG33056 GCCGAGGATAGCGTGGACATAATTGCATTCTTCTACACACCGCCACAAATGGTTAAGGACACGTTGAAC 69 FBan0033056 FBgn0053056 CG33056 3 3L CG33056 CG33056 "CG10517, CG10517, CG10517" CDMC21387 1 8 4 DAC06-E11 22-CG33056-RA_1 CG33056 GCCGAGGATAGCGTGGACATAATTGCATTCTTCTACACACCGCCACAAATGGTTAAGGACACGTTGAAC 69 FBan0033056 FBgn0053056 CG33056 3 3L CG33056 CG33056 "CG10517, CG10517, CG10517" CDMC21388 1 9 4 DAC06-E23 8-CG3306-RA_1 CG3306 GCCCGTCGACTTTGAGATGAAGGATCATTACACGATGAGTTTCAAACCCTGGACGTATTGCACGCCGGA 69 FBan0003306 FBgn0036016 CG3306 3 3L CG3306 CG3306 CDMC21388 1 10 4 DAC06-E23 8-CG3306-RA_1 CG3306 GCCCGTCGACTTTGAGATGAAGGATCATTACACGATGAGTTTCAAACCCTGGACGTATTGCACGCCGGA 69 FBan0003306 FBgn0036016 CG3306 3 3L CG3306 CG3306 CDMC21389 1 11 4 DAC06-I11 3-CG3309-RA_1 CG3309 TGGCCTCCGTTAATGAAATCGAACTCTTCCGCTCCCTGGACTTTGTCATGGAGCAACTGTACACGCTGT 69 FBan0003309 FBgn0029756 CG3309 X X CG3309 CG3309 BEST:LD39762 CDMC21389 1 12 4 DAC06-I11 3-CG3309-RA_1 CG3309 TGGCCTCCGTTAATGAAATCGAACTCTTCCGCTCCCTGGACTTTGTCATGGAGCAACTGTACACGCTGT 69 FBan0003309 FBgn0029756 CG3309 X X CG3309 CG3309 BEST:LD39762 CDMC21390 1 13 4 DAC06-I23 2-CG33107-RA_1 CG33107 TGGAAGTGGATGAAATGCGCCTAGGCTATGACCACGAATCCATCATGTCCTTTCTCCGGAAGTCGTCCA 69 FBan0033107 FBgn0053107 CG33107 3 3R CG33107 CG33107 CG5275 CDMC21390 1 14 4 DAC06-I23 2-CG33107-RA_1 CG33107 TGGAAGTGGATGAAATGCGCCTAGGCTATGACCACGAATCCATCATGTCCTTTCTCCGGAAGTCGTCCA 69 FBan0033107 FBgn0053107 CG33107 3 3R CG33107 CG33107 CG5275 CDMC21391 1 15 4 DAC06-M11 12-CG33129-RE_1 CG33129 TGGACCACGTCTACCCATGAGTTGGCTACGTCGACTGTGTATCACTCTTTTCTGCAAGATGTGGCGAAT 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC21391 1 16 4 DAC06-M11 12-CG33129-RE_1 CG33129 TGGACCACGTCTACCCATGAGTTGGCTACGTCGACTGTGTATCACTCTTTTCTGCAAGATGTGGCGAAT 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC21392 1 17 4 DAC06-M23 15-CG33137-RA_3 CG33137 GCAACAAGTTTCAGCCGTTCCTCGTAGACGTCGTGATAAACATGTGCGATGCATTATCCAGGCGTAGCT 69 FBan0033137 FBgn0053137 CG33137 2 2R CG33137 CG33137 "CG4023, CG4023" CDMC21392 1 18 4 DAC06-M23 15-CG33137-RA_3 CG33137 GCAACAAGTTTCAGCCGTTCCTCGTAGACGTCGTGATAAACATGTGCGATGCATTATCCAGGCGTAGCT 69 FBan0033137 FBgn0053137 CG33137 2 2R CG33137 CG33137 "CG4023, CG4023" CDMC21393 1 19 4 DAC07-A11 14-CG5786-RA_12 CG5786 AGCAGCCACACTGATCCATACACGTGCGGGAGAAAAGTGAACAAAAACATTGAAACATGGGCGGTAAGA 69 FBan0005786 FBgn0010770 ppan 3 3R imaginal disc development; GO:0007444; larval development; GO:0002164; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ppan peter pan "CG5786, l(3)02231, Peter Pan, l(3)j6B6, peter pan" CDMC21393 1 20 4 DAC07-A11 14-CG5786-RA_12 CG5786 AGCAGCCACACTGATCCATACACGTGCGGGAGAAAAGTGAACAAAAACATTGAAACATGGGCGGTAAGA 69 FBan0005786 FBgn0010770 ppan 3 3R imaginal disc development; GO:0007444; larval development; GO:0002164; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ppan peter pan "CG5786, l(3)02231, Peter Pan, l(3)j6B6, peter pan" CDMC21394 1 21 4 DAC07-A23 12-CG5794-RD_1 CG5794 CGGAGAGCGAGAAAGAGACCTCAACGGAGAACGACAAACCATCAGATGTTTCCATGGAATCCAGCGGTA 69 FBan0005794 FBgn0039214 CG5794 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5794 CG5794 "BcDNA:AT28817, NEST:bs19d10" CDMC21394 1 22 4 DAC07-A23 12-CG5794-RD_1 CG5794 CGGAGAGCGAGAAAGAGACCTCAACGGAGAACGACAAACCATCAGATGTTTCCATGGAATCCAGCGGTA 69 FBan0005794 FBgn0039214 CG5794 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5794 CG5794 "BcDNA:AT28817, NEST:bs19d10" CDMC21395 1 23 4 DAC07-E11 15-CG5827-RB_3 CG5827 TTGAATGCTCCGCTATGCTAGCTCCCGTAGTTTTAATCTGACAACGCGATTTTCCTGTGGTTTGCGCCG 69 FBan0005827 FBgn0028696 RpL37A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL37A Ribosomal protein L37A "CG5827, DmL37a, Ribosomal protein L37a, RpL37a, L37A, BcDNA:RE23595, BcDNA:RH41593, Ribosomal protein L37A" CDMC21395 1 24 4 DAC07-E11 15-CG5827-RB_3 CG5827 TTGAATGCTCCGCTATGCTAGCTCCCGTAGTTTTAATCTGACAACGCGATTTTCCTGTGGTTTGCGCCG 69 FBan0005827 FBgn0028696 RpL37A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL37A Ribosomal protein L37A "CG5827, DmL37a, Ribosomal protein L37a, RpL37a, L37A, BcDNA:RE23595, BcDNA:RH41593, Ribosomal protein L37A" CDMC21396 1 25 4 DAC07-E23 9-CG5842-RA_2 CG5842 TGGAGCGATGGTGTCTACGCAGCACGAATACGAGGCGAAGATCCTCTTCTTTCTGTTCATGGTGATCGT 69 FBan0005842 FBgn0036414 nan 3 3L calcium ion transport; GO:0006816; sensory perception of pain; GO:0019233; sensory perception of sound; GO:0007605 calcium channel activity; GO:0005262; ion channel activity; GO:0005216; ; GO:0005262; ; GO:0005216 membrane; GO:0016020 nan nanchung "CG5842, CT18317, OCR, TRPV, nanchung" CDMC21396 1 26 4 DAC07-E23 9-CG5842-RA_2 CG5842 TGGAGCGATGGTGTCTACGCAGCACGAATACGAGGCGAAGATCCTCTTCTTTCTGTTCATGGTGATCGT 69 FBan0005842 FBgn0036414 nan 3 3L calcium ion transport; GO:0006816; sensory perception of pain; GO:0019233; sensory perception of sound; GO:0007605 calcium channel activity; GO:0005262; ion channel activity; GO:0005216; ; GO:0005262; ; GO:0005216 membrane; GO:0016020 nan nanchung "CG5842, CT18317, OCR, TRPV, nanchung" CDMC21397 1 1 5 DAC07-I11 8-CG5872-RA_1 CG5872 GCGGTGGGAAATAGTTGGACCCGCAAGACACCCAAGAATCAGGGAGTCCTTACAAAGCTATCACTCACA 69 FBan0005872 FBgn0036991 CG5872 3 3L CG5872 CG5872 CDMC21397 1 2 5 DAC07-I11 8-CG5872-RA_1 CG5872 GCGGTGGGAAATAGTTGGACCCGCAAGACACCCAAGAATCAGGGAGTCCTTACAAAGCTATCACTCACA 69 FBan0005872 FBgn0036991 CG5872 3 3L CG5872 CG5872 CDMC21398 1 3 5 DAC07-I23 22-CG5880-RA_1 CG5880 TCCTCTACATGACGTACACCACTCTGGGTTGTCTGTTTCTTATTTTGTTTGGCTTGGAGATTGGCCACA 69 FBan0005880 FBgn0039489 CG5880 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG5880 CG5880 CDMC21398 1 4 5 DAC07-I23 22-CG5880-RA_1 CG5880 TCCTCTACATGACGTACACCACTCTGGGTTGTCTGTTTCTTATTTTGTTTGGCTTGGAGATTGGCCACA 69 FBan0005880 FBgn0039489 CG5880 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG5880 CG5880 CDMC21399 1 5 5 DAC07-M11 6-CG5922-RA_3 CG5922 GGCTAGACCCTGTAGCGACAGTCAGCTACAGTTGGTTAATTGGTACGACGGCGATAACCTTGGTCTGCA 69 FBan0005922 FBgn0032983 CG5922 2 2L CG5922 CG5922 CDMC21399 1 6 5 DAC07-M11 6-CG5922-RA_3 CG5922 GGCTAGACCCTGTAGCGACAGTCAGCTACAGTTGGTTAATTGGTACGACGGCGATAACCTTGGTCTGCA 69 FBan0005922 FBgn0032983 CG5922 2 2L CG5922 CG5922 CDMC21400 1 7 5 DAC07-M23 1-CG5933-RA_1 CG5933 GCCGGATGAGATTTATGGTATTATCGAGCGTCTAAGCCCGGGTACTCGCAAGATCGAGCTCTTTGGGCG 69 FBan0005933 FBgn0039139 CG5933 3 3R RNA methylation; GO:0001510 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG5933 CG5933 CDMC21400 1 8 5 DAC07-M23 1-CG5933-RA_1 CG5933 GCCGGATGAGATTTATGGTATTATCGAGCGTCTAAGCCCGGGTACTCGCAAGATCGAGCTCTTTGGGCG 69 FBan0005933 FBgn0039139 CG5933 3 3R RNA methylation; GO:0001510 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG5933 CG5933 CDMC21401 1 9 5 DAC08-A11 2-CG8223-RA_2 CG8223 GCCGAGTTGCATTACAAGATCGGGCTGACCTATTTGATGCAGCAACTCAACAAGGAAGGAGCGACAGCA 69 FBan0008223 FBgn0037624 CG8223 3 3R CG8223 CG8223 CDMC21401 1 10 5 DAC08-A11 2-CG8223-RA_2 CG8223 GCCGAGTTGCATTACAAGATCGGGCTGACCTATTTGATGCAGCAACTCAACAAGGAAGGAGCGACAGCA 69 FBan0008223 FBgn0037624 CG8223 3 3R CG8223 CG8223 CDMC21402 1 11 5 DAC08-A23 2-CG8232-RA_1 CG8232 GCACACAAGCCAACCGAATGCTGTCAACAATTCTCCCAATGGACGCCAAAAGTCCTGGTTTCCCCTTAC 69 FBan0008232 FBgn0033352 CG8232 2 2R ubiquitin-dependent protein catabolism; GO:0006511 poly(A)-specific ribonuclease activity; GO:0004535 ; EC:3.1.13.4; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004535 ; EC:3.1.13.4; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8232 CG8232 CDMC21402 1 12 5 DAC08-A23 2-CG8232-RA_1 CG8232 GCACACAAGCCAACCGAATGCTGTCAACAATTCTCCCAATGGACGCCAAAAGTCCTGGTTTCCCCTTAC 69 FBan0008232 FBgn0033352 CG8232 2 2R ubiquitin-dependent protein catabolism; GO:0006511 poly(A)-specific ribonuclease activity; GO:0004535 ; EC:3.1.13.4; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004535 ; EC:3.1.13.4; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8232 CG8232 CDMC21403 1 13 5 DAC08-E11 12-CG8277-RA_2 CG8277 CGAGATTACCGAGATTGACAGTGTGGAGACCTTCTGGAGCTTGTACCATACCATCAAGACCCCAGCGGA 69 FBan0008277 FBgn0035823 CG8277 3 3L autophagic cell death; GO:0048102; protein biosynthesis; GO:0006412; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8277 CG8277 "eIF4E, CT24507" CDMC21403 1 14 5 DAC08-E11 12-CG8277-RA_2 CG8277 CGAGATTACCGAGATTGACAGTGTGGAGACCTTCTGGAGCTTGTACCATACCATCAAGACCCCAGCGGA 69 FBan0008277 FBgn0035823 CG8277 3 3L autophagic cell death; GO:0048102; protein biosynthesis; GO:0006412; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8277 CG8277 "eIF4E, CT24507" CDMC21404 1 15 5 DAC08-E23 16-CG8286-RA_1 CG8286 AAACCCATGGTCCGTTGTCAGAGAGTACCACAAACAAACACAAATCGCAACAAAACACACTGAGCACTT 69 FBan0008286 FBgn0037718 CG8286 3 3R cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 protein kinase inhibitor activity; GO:0004860; ; GO:0004860 CG8286 CG8286 "SD05682.5prime, BEST:SD05682" CDMC21404 1 16 5 DAC08-E23 16-CG8286-RA_1 CG8286 AAACCCATGGTCCGTTGTCAGAGAGTACCACAAACAAACACAAATCGCAACAAAACACACTGAGCACTT 69 FBan0008286 FBgn0037718 CG8286 3 3R cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 protein kinase inhibitor activity; GO:0004860; ; GO:0004860 CG8286 CG8286 "SD05682.5prime, BEST:SD05682" CDMC21405 1 17 5 DAC08-I11 15-CG8319-RA_8 CG8319 AGCAATTCACACGTATGCCAAAACTGCGAAGAGCGTTTTCTGTTCAAGGCCGATCTGGATAACCACCAA 69 FBan0008319 FBgn0037722 CG8319 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8319 CG8319 CDMC21405 1 18 5 DAC08-I11 15-CG8319-RA_8 CG8319 AGCAATTCACACGTATGCCAAAACTGCGAAGAGCGTTTTCTGTTCAAGGCCGATCTGGATAACCACCAA 69 FBan0008319 FBgn0037722 CG8319 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8319 CG8319 CDMC21406 1 19 5 DAC08-I23 3-CG8327-RB_1 CG8327 GCTTCGTCATGGGCTCCCTGAACAAAAACCAGGACTTCGCTACTCCCAAGCTTGGAAAGTCCGAAATCG 69 FBan0008327 FBgn0037723 SpdS 3 3R spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 SpdS Spermidine Synthase "CG8327, CG8327, CG8327, Spermidine Synthase" CDMC21406 1 20 5 DAC08-I23 3-CG8327-RB_1 CG8327 GCTTCGTCATGGGCTCCCTGAACAAAAACCAGGACTTCGCTACTCCCAAGCTTGGAAAGTCCGAAATCG 69 FBan0008327 FBgn0037723 SpdS 3 3R spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 SpdS Spermidine Synthase "CG8327, CG8327, CG8327, Spermidine Synthase" CDMC21407 1 21 5 DAC08-M11 23-CG8369-RA_1 CG8369 GCCTGTCCTAGAAGTCCAATTTCAACACTTTTGACGATTAAACATCTTTCACTGATTGTGCAATAATAT 69 FBan0008369 FBgn0040532 CG8369 3 3R CG8369 CG8369 "BcDNA:GH11984, anon-EST:Posey161" CDMC21407 1 22 5 DAC08-M11 23-CG8369-RA_1 CG8369 GCCTGTCCTAGAAGTCCAATTTCAACACTTTTGACGATTAAACATCTTTCACTGATTGTGCAATAATAT 69 FBan0008369 FBgn0040532 CG8369 3 3R CG8369 CG8369 "BcDNA:GH11984, anon-EST:Posey161" CDMC21408 1 23 5 DAC08-M23 23-CG8384-RE_5 CG8384 ACGATGCGAGTGCTTTTAGTTTGTTTTATGTGAGCGGTTTTTGTAATTTAGCTGAAAAGTCAGACAGCG 69 FBan0008384 FBgn0001139 gro 3 3R "actin filament organization; GO:0007015; ectoderm development; GO:0007398; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; sex determination, primary response to X:A ratio; GO:0007541" "NOT DNA binding; GO:0003677; ; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; GO:0016812 ; EC:3.5.2.-; ; GO:0005515; ; GO:0016812 ; EC:3.5.2.-" nucleus; GO:0005634 gro groucho "CG8384, m9/m10, m9,m10, m10, m9, E(spl)m9/m10, m9/10, E(spl)-WD, m9-m10, l(3)gro, E(spl)[2], BcDNA.LD33829, dAES2, dAES1, dGro, E(spl)gro, Groucho, Gro, Dgroucho, anon-WO0118547.385, BcDNA:LD33829, En-spl, BEST:GM01575, BEST:LD15161, groucho" CDMC21408 1 24 5 DAC08-M23 23-CG8384-RE_5 CG8384 ACGATGCGAGTGCTTTTAGTTTGTTTTATGTGAGCGGTTTTTGTAATTTAGCTGAAAAGTCAGACAGCG 69 FBan0008384 FBgn0001139 gro 3 3R "actin filament organization; GO:0007015; ectoderm development; GO:0007398; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; sex determination, primary response to X:A ratio; GO:0007541" "NOT DNA binding; GO:0003677; ; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; GO:0016812 ; EC:3.5.2.-; ; GO:0005515; ; GO:0016812 ; EC:3.5.2.-" nucleus; GO:0005634 gro groucho "CG8384, m9/m10, m9,m10, m10, m9, E(spl)m9/m10, m9/10, E(spl)-WD, m9-m10, l(3)gro, E(spl)[2], BcDNA.LD33829, dAES2, dAES1, dGro, E(spl)gro, Groucho, Gro, Dgroucho, anon-WO0118547.385, BcDNA:LD33829, En-spl, BEST:GM01575, BEST:LD15161, groucho" CDMC21409 1 25 5 DAC09-A12 3-CG12812-RA_6 CG12812 AGAGGAGGCCCTAAACCTCTTTCGCAAGCTTCTCGAGGATCTGCGTCCCTTCTACGACAACTTCATGGA 69 FBan0012812 FBgn0037781 CG12812 3 3R CG12812 CG12812 CDMC21409 1 26 5 DAC09-A12 3-CG12812-RA_6 CG12812 AGAGGAGGCCCTAAACCTCTTTCGCAAGCTTCTCGAGGATCTGCGTCCCTTCTACGACAACTTCATGGA 69 FBan0012812 FBgn0037781 CG12812 3 3R CG12812 CG12812 CDMC21410 1 1 6 DAC09-A24 24-CG12821-RA_1 CG12821 ACACAGATCAGGTATTTACATATTTTACAAAATCTCACTAGATGTGAAAATAAATCCACTTATCGTAGA 69 FBan0012821 FBgn0040780 CG12821 2 2R CG12821 CG12821 CDMC21410 1 2 6 DAC09-A24 24-CG12821-RA_1 CG12821 ACACAGATCAGGTATTTACATATTTTACAAAATCTCACTAGATGTGAAAATAAATCCACTTATCGTAGA 69 FBan0012821 FBgn0040780 CG12821 2 2R CG12821 CG12821 CDMC21411 1 3 6 DAC09-E12 9-CG12857-RA_5 CG12857 AGGACAATCCCGCCATGGATGTAGTTCGCAATTTGATGCTGACTAGGATCCGCAAGTTTCTGCTCACCT 69 FBan0012857 FBgn0033963 CG12857 2 2R CG12857 CG12857 CDMC21411 1 4 6 DAC09-E12 9-CG12857-RA_5 CG12857 AGGACAATCCCGCCATGGATGTAGTTCGCAATTTGATGCTGACTAGGATCCGCAAGTTTCTGCTCACCT 69 FBan0012857 FBgn0033963 CG12857 2 2R CG12857 CG12857 CDMC21412 1 5 6 DAC09-E24 1-CG12865-RA_1 CG12865 GGGTGGTGCATTAGGAGGTCTAACAAATCGCGGTGATGTTGGTCTGAATGCCGTATCGTTAGCCTTGGC 69 FBan0012865 FBgn0033957 CG12865 2 2R CG12865 CG12865 CDMC21412 1 6 6 DAC09-E24 1-CG12865-RA_1 CG12865 GGGTGGTGCATTAGGAGGTCTAACAAATCGCGGTGATGTTGGTCTGAATGCCGTATCGTTAGCCTTGGC 69 FBan0012865 FBgn0033957 CG12865 2 2R CG12865 CG12865 CDMC21413 1 7 6 DAC09-I12 13-CG12909-RA_1 CG12909 AGCTCGCCGATTCCTTGGAAGTCGAGGGTGAAATAGTTAAGATCGCTAGCTAGCCGAATATCCCACCTT 69 FBan0012909 FBgn0033507 CG12909 2 2R nucleolus; GO:0005730 CG12909 CG12909 CDMC21413 1 8 6 DAC09-I12 13-CG12909-RA_1 CG12909 AGCTCGCCGATTCCTTGGAAGTCGAGGGTGAAATAGTTAAGATCGCTAGCTAGCCGAATATCCCACCTT 69 FBan0012909 FBgn0033507 CG12909 2 2R nucleolus; GO:0005730 CG12909 CG12909 CDMC21414 1 9 6 DAC09-I24 15-CG12919-RA_4 CG12919 CGGACAGTGCATCCTCAGCCTCAAATGATGACAATGTGTTCGATGACTTTACCAGCTACAATGCCCACA 69 FBan0012919 FBgn0033483 egr 2 2R JNK cascade; GO:0007254; apoptosis; GO:0006915; immune response; GO:0006955; induction of apoptosis; GO:0006917; response to pathogenic bacteria; GO:0009618 tumor necrosis factor receptor binding; GO:0005164; protein binding; GO:0005515; ; GO:0005164; ; GO:0005164; ; GO:0005515; ; GO:0005164 membrane; GO:0016020 egr eiger "CG12919, CG12919, CG12919, regg1, Eiger, Ect1, dt1, tumor necrosis factor family member DT1, darth, Drosophila aspartate rich TNF homolog, BcDNA:RH51659, eiger" CDMC21414 1 10 6 DAC09-I24 15-CG12919-RA_4 CG12919 CGGACAGTGCATCCTCAGCCTCAAATGATGACAATGTGTTCGATGACTTTACCAGCTACAATGCCCACA 69 FBan0012919 FBgn0033483 egr 2 2R JNK cascade; GO:0007254; apoptosis; GO:0006915; immune response; GO:0006955; induction of apoptosis; GO:0006917; response to pathogenic bacteria; GO:0009618 tumor necrosis factor receptor binding; GO:0005164; protein binding; GO:0005515; ; GO:0005164; ; GO:0005164; ; GO:0005515; ; GO:0005164 membrane; GO:0016020 egr eiger "CG12919, CG12919, CG12919, regg1, Eiger, Ect1, dt1, tumor necrosis factor family member DT1, darth, Drosophila aspartate rich TNF homolog, BcDNA:RH51659, eiger" CDMC21415 1 11 6 DAC09-M12 23-CG12963-RB_2 CG12963 AGCAGTGTTTCCAATTTTAATTAATTAACGAATAACAAGGTTGTTGTGTGGGTTAATCAAACTGCACAT 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC21415 1 12 6 DAC09-M12 23-CG12963-RB_2 CG12963 AGCAGTGTTTCCAATTTTAATTAATTAACGAATAACAAGGTTGTTGTGTGGGTTAATCAAACTGCACAT 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC21416 1 13 6 DAC09-M24 23-CG12990-RA_11 CG12990 CGACTCAATGCCGTACGCAACGTTTTCTTCATCCAGAATTTGTTTCCCATTCAGTTTATGTGCGGATCG 69 FBan0012990 FBgn0030859 CG12990 X X CG12990 CG12990 CDMC21416 1 14 6 DAC09-M24 23-CG12990-RA_11 CG12990 CGACTCAATGCCGTACGCAACGTTTTCTTCATCCAGAATTTGTTTCCCATTCAGTTTATGTGCGGATCG 69 FBan0012990 FBgn0030859 CG12990 X X CG12990 CG12990 CDMC21417 1 15 6 DAC10-A11 17-CG10939-RA_1 CG10939 GCTCTGAGACGAAAAGGGTAGCCCAACCAACTACTTGTTATAATGTCAGGATGAGGAGCTAGAGCTGGT 69 FBan0010939 FBgn0010620 Sip1 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811 sodium:hydrogen antiporter regulator activity; GO:0017155; protein binding; GO:0005515; ; GO:0017155; ; GO:0005515 Sip1 SRY interacting protein 1 "CG10939, CG10939, l(2)06373, SRY interacting protein 1" CDMC21417 1 16 6 DAC10-A11 17-CG10939-RA_1 CG10939 GCTCTGAGACGAAAAGGGTAGCCCAACCAACTACTTGTTATAATGTCAGGATGAGGAGCTAGAGCTGGT 69 FBan0010939 FBgn0010620 Sip1 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811 sodium:hydrogen antiporter regulator activity; GO:0017155; protein binding; GO:0005515; ; GO:0017155; ; GO:0005515 Sip1 SRY interacting protein 1 "CG10939, CG10939, l(2)06373, SRY interacting protein 1" CDMC21418 1 17 6 DAC10-A23 6-CG10950-RA_3 CG10950 TGGCTGTTTGCGCGTCATGGACCAAATTTAGTATGCTTTCACCCGACCAAGTTCTGCAACGCAAACTGT 69 FBan0010950 FBgn0034205 CG10950 2 2R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 CG10950 CG10950 CDMC21418 1 18 6 DAC10-A23 6-CG10950-RA_3 CG10950 TGGCTGTTTGCGCGTCATGGACCAAATTTAGTATGCTTTCACCCGACCAAGTTCTGCAACGCAAACTGT 69 FBan0010950 FBgn0034205 CG10950 2 2R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 CG10950 CG10950 CDMC21419 1 19 6 DAC10-E11 14-CG10987-RA_2 CG10987 ATGTGAGCATTGACCCGATCTTGATGGCGTCTTGATGATGTCTTGACCTGATCACGATGGCGATACGAT 69 FBan0010987 FBgn0040647 CG10987 X X CG10987 CG10987 CDMC21419 1 20 6 DAC10-E11 14-CG10987-RA_2 CG10987 ATGTGAGCATTGACCCGATCTTGATGGCGTCTTGATGATGTCTTGACCTGATCACGATGGCGATACGAT 69 FBan0010987 FBgn0040647 CG10987 X X CG10987 CG10987 CDMC21420 1 21 6 DAC10-E23 2-CG10993-RA_1 CG10993 GGGCCCGTCTAAACGAACTCATGAACATCGTGCCGGTCACCAACTCTCAGAACCATCTCAAGTTCCTCA 69 FBan0010993 FBgn0030524 CG10993 X X mRNA binding; GO:0003729; ; GO:0003729 CG10993 CG10993 BcDNA:GH23064 CDMC21420 1 22 6 DAC10-E23 2-CG10993-RA_1 CG10993 GGGCCCGTCTAAACGAACTCATGAACATCGTGCCGGTCACCAACTCTCAGAACCATCTCAAGTTCCTCA 69 FBan0010993 FBgn0030524 CG10993 X X mRNA binding; GO:0003729; ; GO:0003729 CG10993 CG10993 BcDNA:GH23064 CDMC21421 1 23 6 DAC10-I11 2-CG11044-RA_1 CG11044 GGCGCCTTCTTAGCGATCGAGACTTCAAGCAGCTGACTGTGAATGTCAAGTCAGGAGCCTAGATGCCAA 69 FBan0011044 FBgn0034484 CG11044 2 2R CG11044 CG11044 CDMC21421 1 24 6 DAC10-I11 2-CG11044-RA_1 CG11044 GGCGCCTTCTTAGCGATCGAGACTTCAAGCAGCTGACTGTGAATGTCAAGTCAGGAGCCTAGATGCCAA 69 FBan0011044 FBgn0034484 CG11044 2 2R CG11044 CG11044 CDMC21422 1 25 6 DAC10-I23 18-CG11053-RA_1 CG11053 GACGTGATCTATGACAGTGAGATAGCTCAGTTGACGAATGTGACCCGAGAGGAGATGATTCTGGGCACC 69 FBan0011053 FBgn0031838 CG11053 2 2L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11053 CG11053 CDMC21422 1 26 6 DAC10-I23 18-CG11053-RA_1 CG11053 GACGTGATCTATGACAGTGAGATAGCTCAGTTGACGAATGTGACCCGAGAGGAGATGATTCTGGGCACC 69 FBan0011053 FBgn0031838 CG11053 2 2L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11053 CG11053 CDMC21423 1 1 7 DAC10-M11 1-CG11092-RA_1 CG11092 CCCTTCTGAGCTCCGACCCTGACGACCCAAAACCAATGAAACGACTCAATCTTGTGCGTCTGATCGTCA 69 FBan0011092 FBgn0027537 CG11092 X X protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG11092 CG11092 BcDNA:LD21129 CDMC21423 1 2 7 DAC10-M11 1-CG11092-RA_1 CG11092 CCCTTCTGAGCTCCGACCCTGACGACCCAAAACCAATGAAACGACTCAATCTTGTGCGTCTGATCGTCA 69 FBan0011092 FBgn0027537 CG11092 X X protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG11092 CG11092 BcDNA:LD21129 CDMC21424 1 3 7 DAC10-M23 9-CG11099-RA_1 CG11099 CGGCAGCTCTCTCCAAGTTCATGAACCATGTGCGCATCTTCCACAACACCGCTATCAACTACATACCCA 69 FBan0011099 FBgn0034485 CG11099 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG11099 CG11099 CT31033 CDMC21424 1 4 7 DAC10-M23 9-CG11099-RA_1 CG11099 CGGCAGCTCTCTCCAAGTTCATGAACCATGTGCGCATCTTCCACAACACCGCTATCAACTACATACCCA 69 FBan0011099 FBgn0034485 CG11099 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG11099 CG11099 CT31033 CDMC21425 1 5 7 DAC11-A11 24-CG12171-RA_1 CG12171 ATACTTTTCAAGGATGTGATTCTATGTAAATGTAATAGTTTGCTAGAAATAAATAAAATGAAAACCGCC 69 FBan0012171 FBgn0037354 CG12171 3 3R lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG12171 CG12171 anon-WO0118547.83 CDMC21425 1 6 7 DAC11-A11 24-CG12171-RA_1 CG12171 ATACTTTTCAAGGATGTGATTCTATGTAAATGTAATAGTTTGCTAGAAATAAATAAAATGAAAACCGCC 69 FBan0012171 FBgn0037354 CG12171 3 3R lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG12171 CG12171 anon-WO0118547.83 CDMC21426 1 7 7 DAC11-A23 13-CG12187-RA_1 CG12187 ACCCGAGACACCTATATCTGTATGGTACACGACTAAAGTCCGAGAGTTGTGCGCATTTGTAGACCCCGT 69 FBan0012187 FBgn0035367 CG12187 3 3L protein binding; GO:0005515; ; GO:0005515 CG12187 CG12187 anon-EST:Posey171 CDMC21426 1 8 7 DAC11-A23 13-CG12187-RA_1 CG12187 ACCCGAGACACCTATATCTGTATGGTACACGACTAAAGTCCGAGAGTTGTGCGCATTTGTAGACCCCGT 69 FBan0012187 FBgn0035367 CG12187 3 3L protein binding; GO:0005515; ; GO:0005515 CG12187 CG12187 anon-EST:Posey171 CDMC21427 1 9 7 DAC11-E11 3-CG12220-RA_2 CG12220 GCCGAACAGTCCACAGATGATCTGAAAAACAAGCGCATCGTGGAGATGAAGAAGCCTCGTCCCATGTGG 69 FBan0012220 FBgn0039835 mRpL32 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL32 mitochondrial ribosomal protein L32 "CG12220, CG12220, L32, BcDNA:LD41522, mitochondrial ribosomal protein L32" CDMC21427 1 10 7 DAC11-E11 3-CG12220-RA_2 CG12220 GCCGAACAGTCCACAGATGATCTGAAAAACAAGCGCATCGTGGAGATGAAGAAGCCTCGTCCCATGTGG 69 FBan0012220 FBgn0039835 mRpL32 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL32 mitochondrial ribosomal protein L32 "CG12220, CG12220, L32, BcDNA:LD41522, mitochondrial ribosomal protein L32" CDMC21428 1 11 7 DAC11-E23 2-CG12231-RA_2 CG12231 CGGCGACAGGGAGATCAGTACCGAAGACATTGAACAGAGGGAGCCGGTAATGCTGAACATCTACGACCT 69 FBan0012231 FBgn0031026 CG12231 X X CG12231 CG12231 CDMC21428 1 12 7 DAC11-E23 2-CG12231-RA_2 CG12231 CGGCGACAGGGAGATCAGTACCGAAGACATTGAACAGAGGGAGCCGGTAATGCTGAACATCTACGACCT 69 FBan0012231 FBgn0031026 CG12231 X X CG12231 CG12231 CDMC21429 1 13 7 DAC11-I11 18-CG12268-RA_2 CG12268 AGGCGCTGTCGGAAGATTTAATTTGCAGATACAACAATAAGCTGCCCATAATCATCACAAGGCCCTCGA 69 FBan0012268 FBgn0039131 CG12268 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12268 CG12268 CDMC21429 1 14 7 DAC11-I11 18-CG12268-RA_2 CG12268 AGGCGCTGTCGGAAGATTTAATTTGCAGATACAACAATAAGCTGCCCATAATCATCACAAGGCCCTCGA 69 FBan0012268 FBgn0039131 CG12268 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12268 CG12268 CDMC21430 1 15 7 DAC11-I23 2-CG12292-RA_2 CG12292 TGGGGAAGATCGGCTGCTTTCTGTGCATACTGGGATCCACCATCATTGTGATTCACTCGCCCAAAGAGA 69 FBan0012292 FBgn0032451 CG12292 2 2L CG12292 CG12292 CDMC21430 1 16 7 DAC11-I23 2-CG12292-RA_2 CG12292 TGGGGAAGATCGGCTGCTTTCTGTGCATACTGGGATCCACCATCATTGTGATTCACTCGCCCAAAGAGA 69 FBan0012292 FBgn0032451 CG12292 2 2L CG12292 CG12292 CDMC21431 1 17 7 DAC11-M11 23-CG1232-RA_1 CG1232 AGAAATCGTTTGTTTTTAACGACAGTTGGAAATAGTTAACGAGGGTCAAGCAATGGCAACAGAAGCGCA 69 FBan0001232 FBgn0003710 tipE 3 3L sodium ion transport; GO:0006814 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 tipE temperature-induced paralytic E "CG1232, tip-E, temperature-induced paralysis locus E, TipE" CDMC21431 1 18 7 DAC11-M11 23-CG1232-RA_1 CG1232 AGAAATCGTTTGTTTTTAACGACAGTTGGAAATAGTTAACGAGGGTCAAGCAATGGCAACAGAAGCGCA 69 FBan0001232 FBgn0003710 tipE 3 3L sodium ion transport; GO:0006814 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 tipE temperature-induced paralytic E "CG1232, tip-E, temperature-induced paralysis locus E, TipE" CDMC21432 1 19 7 DAC11-M23 3-CG12343-RA_1 CG12343 CGCCTTCTACGGTGGAGCACACACCACTTTGCATTCGAGGACGAAGGACACTCCAGGTGCTATTAACAA 69 FBan0012343 FBgn0033556 CG12343 2 2R CG12343 CG12343 CDMC21432 1 20 7 DAC11-M23 3-CG12343-RA_1 CG12343 CGCCTTCTACGGTGGAGCACACACCACTTTGCATTCGAGGACGAAGGACACTCCAGGTGCTATTAACAA 69 FBan0012343 FBgn0033556 CG12343 2 2R CG12343 CG12343 CDMC21433 1 21 7 DAC12-A11 23-CG7847-RA_5 CG7847 ACAATATGCTACAGTTAGCCTAGATAATATTTCACACATCCAAGAATGGTCAGGATAGGAAATCGAGAT 69 FBan0007847 FBgn0003499 sr 3 3R central nervous system development; GO:0007417; determination of muscle attachment site; GO:0016204; muscle development; GO:0007517; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal epithelial cell migration (sensu Insecta); GO:0007427 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sr stripe "CG7847, Stripe, l(3)06948, Sr, Striped, l(3)03999, l(3)06948b, stripe" CDMC21433 1 22 7 DAC12-A11 23-CG7847-RA_5 CG7847 ACAATATGCTACAGTTAGCCTAGATAATATTTCACACATCCAAGAATGGTCAGGATAGGAAATCGAGAT 69 FBan0007847 FBgn0003499 sr 3 3R central nervous system development; GO:0007417; determination of muscle attachment site; GO:0016204; muscle development; GO:0007517; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal epithelial cell migration (sensu Insecta); GO:0007427 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sr stripe "CG7847, Stripe, l(3)06948, Sr, Striped, l(3)03999, l(3)06948b, stripe" CDMC21434 1 23 7 DAC12-A23 1-CG7856-RA_1 CG7856 GCTGTCGTTGCATTGGATCACCCATGACCTTGACAGCGTAGACCACTTCGACGTTTTTGTGGACAACGT 69 FBan0007856 FBgn0033056 CG7856 2 2R CG7856 CG7856 CDMC21434 1 24 7 DAC12-A23 1-CG7856-RA_1 CG7856 GCTGTCGTTGCATTGGATCACCCATGACCTTGACAGCGTAGACCACTTCGACGTTTTTGTGGACAACGT 69 FBan0007856 FBgn0033056 CG7856 2 2R CG7856 CG7856 CDMC21435 1 25 7 DAC12-E11 22-CG7890-RA_1 CG7890 AGGCTAGGCACCTTCACTGATCTGCTCAATTTACATATCACATCCATCCCCATTGGAGTATGCTTGACT 69 FBan0007890 FBgn0031005 CG7890 X X defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG7890 CG7890 CDMC21435 1 26 7 DAC12-E11 22-CG7890-RA_1 CG7890 AGGCTAGGCACCTTCACTGATCTGCTCAATTTACATATCACATCCATCCCCATTGGAGTATGCTTGACT 69 FBan0007890 FBgn0031005 CG7890 X X defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG7890 CG7890 CDMC21436 1 1 8 DAC12-E23 3-CG7903-RA_1 CG7903 ACCCGGGCCAAATATGGGCGGCAATAGAAGATTTTAAGCAAGTGCAATGCAGCAACGATGTTTGCCAGT 69 FBan0007903 FBgn0039730 CG7903 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG7903 CG7903 cg7903 CDMC21436 1 2 8 DAC12-E23 3-CG7903-RA_1 CG7903 ACCCGGGCCAAATATGGGCGGCAATAGAAGATTTTAAGCAAGTGCAATGCAGCAACGATGTTTGCCAGT 69 FBan0007903 FBgn0039730 CG7903 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG7903 CG7903 cg7903 CDMC21437 1 3 8 DAC12-I11 16-CG7930-RB_1 CG7930 TGGACACACGTTTGTTTGCTCCTGTTTGCACACTTGTTTCGCTTTTTATTTGCATTTTGCCCCAACCAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC21437 1 4 8 DAC12-I11 16-CG7930-RB_1 CG7930 TGGACACACGTTTGTTTGCTCCTGTTTGCACACTTGTTTCGCTTTTTATTTGCATTTTGCCCCAACCAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC21438 1 5 8 DAC12-I23 8-CG7941-RA_1 CG7941 ACCATTCAGAGTCGTCTCTCAGTTTAGACAAACGCACTCCAAGCCAGCAAAGATGTTCCGCTACCTGCT 69 FBan0007941 FBgn0036108 CG7941 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7941 CG7941 BcDNA:RE57116 CDMC21438 1 6 8 DAC12-I23 8-CG7941-RA_1 CG7941 ACCATTCAGAGTCGTCTCTCAGTTTAGACAAACGCACTCCAAGCCAGCAAAGATGTTCCGCTACCTGCT 69 FBan0007941 FBgn0036108 CG7941 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7941 CG7941 BcDNA:RE57116 CDMC21439 1 7 8 DAC12-M11 8-CG7973-RB_1 CG7973 CGCTCTGGCTATTTGATGGTCCAGCAGTGTCCTTTCTTCTACGGATGGGACTACGAGAAGCGATCCTGT 69 FBgn0036507 CDMC21439 1 8 8 DAC12-M11 8-CG7973-RB_1 CG7973 CGCTCTGGCTATTTGATGGTCCAGCAGTGTCCTTTCTTCTACGGATGGGACTACGAGAAGCGATCCTGT 69 FBgn0036507 CDMC21440 1 9 8 DAC12-M23 3-CG7987-RB_3 CG7987 TCGCGACCTCGAATGATTCACACAGAGAAAGCCAAGGTGACAAAAGGAGTTGGCGGAGACTCCACTAGT 69 FBan0007987 FBgn0038244 CG7987 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7987 CG7987 anon-WO0118547.245 CDMC21440 1 10 8 DAC12-M23 3-CG7987-RB_3 CG7987 TCGCGACCTCGAATGATTCACACAGAGAAAGCCAAGGTGACAAAAGGAGTTGGCGGAGACTCCACTAGT 69 FBan0007987 FBgn0038244 CG7987 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7987 CG7987 anon-WO0118547.245 CDMC21441 1 11 8 DAC13-A11 9-CG13248-RA_1 CG13248 CCTCCTCACCGACCAGTGAGATGATAGAGGAAGTCTTAGCTGGAAGACTAAAGGCCCAGTTCAGGTGCT 69 FBan0013248 FBgn0036984 CG13248 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG13248 CG13248 CDMC21441 1 12 8 DAC13-A11 9-CG13248-RA_1 CG13248 CCTCCTCACCGACCAGTGAGATGATAGAGGAAGTCTTAGCTGGAAGACTAAAGGCCCAGTTCAGGTGCT 69 FBan0013248 FBgn0036984 CG13248 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG13248 CG13248 CDMC21442 1 13 8 DAC13-A23 3-CG13260-RA_1 CG13260 ACGACGACAACAACCACAGCTTTGGGCTATACCGCCTATGAGCAGACAACGGTCTACTATCAGCAGCAA 69 FBan0013260 FBgn0032589 CG13260 2 2L CG13260 CG13260 CDMC21442 1 14 8 DAC13-A23 3-CG13260-RA_1 CG13260 ACGACGACAACAACCACAGCTTTGGGCTATACCGCCTATGAGCAGACAACGGTCTACTATCAGCAGCAA 69 FBan0013260 FBgn0032589 CG13260 2 2L CG13260 CG13260 CDMC21443 1 15 8 DAC13-E11 1-CG13299-RA_2 CG13299 GGTTCAAGAAACCCATCCTCAGGTTCGATCGTCTTTTTGCCACCGAAGAATCACCGTCGGGAAGTCGGA 69 FBan0013299 FBgn0035694 CG13299 3 3L CG13299 CG13299 CDMC21443 1 16 8 DAC13-E11 1-CG13299-RA_2 CG13299 GGTTCAAGAAACCCATCCTCAGGTTCGATCGTCTTTTTGCCACCGAAGAATCACCGTCGGGAAGTCGGA 69 FBan0013299 FBgn0035694 CG13299 3 3L CG13299 CG13299 CDMC21444 1 17 8 DAC13-E23 15-CG13310-RA_11 CG13310 CCAATCACCCGGATGTCTACGATGGCACTGGTAGTTGTCAGGTAACCGTTCAAAAACTGCATCCGGACA 69 FBan0013310 FBgn0035928 CG13310 3 3L CG13310 CG13310 CDMC21444 1 18 8 DAC13-E23 15-CG13310-RA_11 CG13310 CCAATCACCCGGATGTCTACGATGGCACTGGTAGTTGTCAGGTAACCGTTCAAAAACTGCATCCGGACA 69 FBan0013310 FBgn0035928 CG13310 3 3L CG13310 CG13310 CDMC21445 1 19 8 DAC13-I11 9-CG13335-RA_1 CG13335 CGGCAAGTTCGTGTATCCGGATGGAGCTGTCAATAATGTGTCCAAGATACGTCGCCAGAACCAGAACGT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC21445 1 20 8 DAC13-I11 9-CG13335-RA_1 CG13335 CGGCAAGTTCGTGTATCCGGATGGAGCTGTCAATAATGTGTCCAAGATACGTCGCCAGAACCAGAACGT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC21446 1 21 8 DAC13-I23 23-CG13340-RA_3 CG13340 ATCAGTGCAGTGATCAGTGGCCGATTCACATTCGACCAAGTGTTATATTTCGTTTGATATTTTCAAGTA 69 FBan0013340 FBgn0033868 CG13340 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG13340 CG13340 CDMC21446 1 22 8 DAC13-I23 23-CG13340-RA_3 CG13340 ATCAGTGCAGTGATCAGTGGCCGATTCACATTCGACCAAGTGTTATATTTCGTTTGATATTTTCAAGTA 69 FBan0013340 FBgn0033868 CG13340 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG13340 CG13340 CDMC21447 1 23 8 DAC13-M11 3-CG13392-RA_1 CG13392 CCCGCTGCTACACGTACCGTATTCCCTCGATTACGGAAAATCCCAGAGAAGTGTTTCTGTTGTGGCGGA 69 FBan0013392 FBgn0032033 CG13392 2 2L CG13392 CG13392 CDMC21447 1 24 8 DAC13-M11 3-CG13392-RA_1 CG13392 CCCGCTGCTACACGTACCGTATTCCCTCGATTACGGAAAATCCCAGAGAAGTGTTTCTGTTGTGGCGGA 69 FBan0013392 FBgn0032033 CG13392 2 2L CG13392 CG13392 CDMC21448 1 25 8 DAC13-M23 2-CG13398-RA_2 CG13398 CCCATGCAGACCCAAAGCCTGAATAGCATCTCTGCTGATACGGGAGATACGCAGGCGAAGAAGGTAACA 69 FBan0013398 FBgn0032042 CG13398 2 2L CG13398 CG13398 CDMC21448 1 26 8 DAC13-M23 2-CG13398-RA_2 CG13398 CCCATGCAGACCCAAAGCCTGAATAGCATCTCTGCTGATACGGGAGATACGCAGGCGAAGAAGGTAACA 69 FBan0013398 FBgn0032042 CG13398 2 2L CG13398 CG13398 CDMC21449 1 1 9 DAC14-A11 5-CG8612-RA_1 CG8612 CAAGAGCTCCACCCTAGTCACCGGTCTCAAGTACCGTGGAAAGTACGAGGGACACGAAGCCAAGC 65 FBan0008612 FBgn0028648 mRpL50 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL50 mitochondrial ribosomal protein L50 "CG8612, ANON-65Eb, MRP-L50, BcDNA:RE06140, BcDNA:GM06185, anon-65Eb, mitochondrial ribosomal protein L50" CDMC21449 1 2 9 DAC14-A11 5-CG8612-RA_1 CG8612 CAAGAGCTCCACCCTAGTCACCGGTCTCAAGTACCGTGGAAAGTACGAGGGACACGAAGCCAAGC 65 FBan0008612 FBgn0028648 mRpL50 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL50 mitochondrial ribosomal protein L50 "CG8612, ANON-65Eb, MRP-L50, BcDNA:RE06140, BcDNA:GM06185, anon-65Eb, mitochondrial ribosomal protein L50" CDMC21450 1 3 9 DAC14-A23 3-CG8647-RA_1 CG8647 CGCTCCTGGTTCCAGTGCTAGGATCTTTTGAGCTGGTTGGACAGTCCATTAAAGATGCCCTGGCC 65 FBan0008647 FBgn0035729 CG8647 3 3L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG8647 CG8647 CDMC21450 1 4 9 DAC14-A23 3-CG8647-RA_1 CG8647 CGCTCCTGGTTCCAGTGCTAGGATCTTTTGAGCTGGTTGGACAGTCCATTAAAGATGCCCTGGCC 65 FBan0008647 FBgn0035729 CG8647 3 3L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG8647 CG8647 CDMC21451 1 5 9 DAC14-E11 3-CG8778-RA_1 CG8778 CATCCGGACTGCTGCTAGCGACACGAAGATGGGTCTGGTGGAGACAAGGTTAGCCATCATACCAG 65 FBan0008778 FBgn0033761 CG8778 2 2R fatty acid beta-oxidation; GO:0006635 AU-specific RNA binding; GO:0017091; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017091; ; GO:0004300 ; EC:4.2.1.17 CG8778 CG8778 CDMC21451 1 6 9 DAC14-E11 3-CG8778-RA_1 CG8778 CATCCGGACTGCTGCTAGCGACACGAAGATGGGTCTGGTGGAGACAAGGTTAGCCATCATACCAG 65 FBan0008778 FBgn0033761 CG8778 2 2R fatty acid beta-oxidation; GO:0006635 AU-specific RNA binding; GO:0017091; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017091; ; GO:0004300 ; EC:4.2.1.17 CG8778 CG8778 CDMC21452 1 7 9 DAC14-E23 3-CG8801-RA_1 CG8801 GTAATGCTCATGTCCACCGTACAGGAAACCGGTGTCATGGAGGTGAAAACCGAGGCATGTGAGCG 65 FBan0008801 FBgn0028473 CG8801 2 2R cell proliferation; GO:0008283 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 CG8801 CG8801 "CG30341, BcDNA:LD23830" CDMC21452 1 8 9 DAC14-E23 3-CG8801-RA_1 CG8801 GTAATGCTCATGTCCACCGTACAGGAAACCGGTGTCATGGAGGTGAAAACCGAGGCATGTGAGCG 65 FBan0008801 FBgn0028473 CG8801 2 2R cell proliferation; GO:0008283 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 CG8801 CG8801 "CG30341, BcDNA:LD23830" CDMC21453 1 9 9 DAC14-I11 1-CG8922-RA_6 CG8922 TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC21453 1 10 9 DAC14-I11 1-CG8922-RA_6 CG8922 TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC21454 1 11 9 DAC14-I23 3-CG8967-RA_3 CG8967 CAAGGGAGTAGTACGTCTGTTTGGCCTGTGTCGCGAAAAGGATCCGCACTACATGGTGCTGGAGT 65 FBan0008967 FBgn0004839 otk 2 2R axon guidance; GO:0007411; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; receptor activity; GO:0004872; ; GO:0004872; semaphorin receptor binding; GO:0030215; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; cell adhesion molecule binding; GO:0050839; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0050839; ; GO:0030215 plasma membrane; GO:0005886 otk off-track "CG8967, CG8967, Dtrk, DTrk, OFT/TRK, CT25769, dTrk, Otk, OTK, Off-track, anon-WO2004063362.81, Dtkr, IGGtyk, Tk48D: Tyrosine kinase at 48D, Trk48D, Tyrosine kinase at 48D" CDMC21454 1 12 9 DAC14-I23 3-CG8967-RA_3 CG8967 CAAGGGAGTAGTACGTCTGTTTGGCCTGTGTCGCGAAAAGGATCCGCACTACATGGTGCTGGAGT 65 FBan0008967 FBgn0004839 otk 2 2R axon guidance; GO:0007411; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; receptor activity; GO:0004872; ; GO:0004872; semaphorin receptor binding; GO:0030215; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; cell adhesion molecule binding; GO:0050839; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0050839; ; GO:0030215 plasma membrane; GO:0005886 otk off-track "CG8967, CG8967, Dtrk, DTrk, OFT/TRK, CT25769, dTrk, Otk, OTK, Off-track, anon-WO2004063362.81, Dtkr, IGGtyk, Tk48D: Tyrosine kinase at 48D, Trk48D, Tyrosine kinase at 48D" CDMC21455 1 13 9 DAC14-M11 2-CG9040-RA_1 CG9040 CTCCGCCGAAACGACCTCCAGTTCAACTCCAACCAAGGCAGAAAAAGCCAAGAAAACTGCTGCAC 65 FBan0009040 FBgn0036394 CG9040 3 3L CG9040 CG9040 BcDNA:LP10528 CDMC21455 1 14 9 DAC14-M11 2-CG9040-RA_1 CG9040 CTCCGCCGAAACGACCTCCAGTTCAACTCCAACCAAGGCAGAAAAAGCCAAGAAAACTGCTGCAC 65 FBan0009040 FBgn0036394 CG9040 3 3L CG9040 CG9040 BcDNA:LP10528 CDMC21456 1 15 9 DAC14-M23 23-CG9073-RA_3 CG9073 TGATTCAGTCGTTAGCGGTGATCGATCTGGTGAACAACTAGCACAGGATTTAAAATGGATAACAT 65 FBan0009073 FBgn0010423 TpnC47D 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC47D Troponin C at 47D "CG9073, CG9073, troponin C, TnC47D, TnC, DmTnC2, TNC, TpnC Ib, DmTpnC47D, DmTpnCIb, BcDNA:RE34610" CDMC21456 1 16 9 DAC14-M23 23-CG9073-RA_3 CG9073 TGATTCAGTCGTTAGCGGTGATCGATCTGGTGAACAACTAGCACAGGATTTAAAATGGATAACAT 65 FBan0009073 FBgn0010423 TpnC47D 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC47D Troponin C at 47D "CG9073, CG9073, troponin C, TnC47D, TnC, DmTnC2, TNC, TpnC Ib, DmTpnC47D, DmTpnCIb, BcDNA:RE34610" CDMC21457 1 17 9 DAC15-A11 11-CG8204-RA_1 CG8204 TGCGACAAGGGAGTCCGACTTGAAAAAGACTGAAGTTGGCTACCAGGAGGAACCTACGCTTCATGTG 67 FBan0008204 FBgn0034033 CG8204 2 2R CG8204 CG8204 BcDNA:AT23078 CDMC21457 1 18 9 DAC15-A11 11-CG8204-RA_1 CG8204 TGCGACAAGGGAGTCCGACTTGAAAAAGACTGAAGTTGGCTACCAGGAGGAACCTACGCTTCATGTG 67 FBan0008204 FBgn0034033 CG8204 2 2R CG8204 CG8204 BcDNA:AT23078 CDMC21458 1 19 9 DAC15-A23 3-CG8338-RA_1 CG8338 CCAGTGGCATTGGTCGTTTCTACGCCAAGTCGGCAAAAATCATACGTTTCGTACGCCTGGGATGCAC 67 FBan0008338 FBgn0033907 mRpS16 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS16 mitochondrial ribosomal protein S16 "CG8338, MRP-S16, BcDNA:SD15809, mitochondrial ribosomal protein S16" CDMC21458 1 20 9 DAC15-A23 3-CG8338-RA_1 CG8338 CCAGTGGCATTGGTCGTTTCTACGCCAAGTCGGCAAAAATCATACGTTTCGTACGCCTGGGATGCAC 67 FBan0008338 FBgn0033907 mRpS16 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS16 mitochondrial ribosomal protein S16 "CG8338, MRP-S16, BcDNA:SD15809, mitochondrial ribosomal protein S16" CDMC21459 1 21 9 DAC15-E11 3-CG8663-RC_2 CG8663 GGGTCTCGTGCGAGGGAGAAAATCCCGCTGATGTCGAGAACATAAAAGCACGCGACTACTATCCCCG 67 FBan0008663 FBgn0032946 nrv3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv3 nervana 3 "CG8663, CG8663, CG8663, CG8663, JYbeta1, Nrv3: Nervana 3, Nervana 3" CDMC21459 1 22 9 DAC15-E11 3-CG8663-RC_2 CG8663 GGGTCTCGTGCGAGGGAGAAAATCCCGCTGATGTCGAGAACATAAAAGCACGCGACTACTATCCCCG 67 FBan0008663 FBgn0032946 nrv3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv3 nervana 3 "CG8663, CG8663, CG8663, CG8663, JYbeta1, Nrv3: Nervana 3, Nervana 3" CDMC21460 1 23 9 DAC15-E23 6-CG8873-RA_2 CG8873 CGACTTCTATCCCAGCGATTTCCTTGTTTACTAGCCCACACTTCGTTCTCCCTCTTCCGCAGTGCCC 67 FBan0008873 FBgn0031652 CG8873 2 2L CG8873 CG8873 CDMC21460 1 24 9 DAC15-E23 6-CG8873-RA_2 CG8873 CGACTTCTATCCCAGCGATTTCCTTGTTTACTAGCCCACACTTCGTTCTCCCTCTTCCGCAGTGCCC 67 FBan0008873 FBgn0031652 CG8873 2 2L CG8873 CG8873 CDMC21461 1 25 9 DAC15-I11 2-CG9238-RB_1 CG9238 CCTATGATAAGGGTCAGAATCGCAACTCGAGCCAGCAAATAAGGTCCACCCTGACCGATGCCTTGGC 67 FBan0009238 FBgn0036428 CG9238 3 3L glycogen metabolism; GO:0005977 protein phosphatase 1 binding; GO:0008157; ; GO:0008157; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9238 CG9238 anon-WO0118547.400 CDMC21461 1 26 9 DAC15-I11 2-CG9238-RB_1 CG9238 CCTATGATAAGGGTCAGAATCGCAACTCGAGCCAGCAAATAAGGTCCACCCTGACCGATGCCTTGGC 67 FBan0009238 FBgn0036428 CG9238 3 3L glycogen metabolism; GO:0005977 protein phosphatase 1 binding; GO:0008157; ; GO:0008157; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9238 CG9238 anon-WO0118547.400 CDMC21462 1 1 10 DAC15-I23 2-CG9347-RA_1 CG9347 TGCAAACGAATCCCAATTATGCTACCCTCTTTCGTGGACGTCCCTTGAGATTCGTCCTGCCCTTGGG 67 FBgn0038171 CDMC21462 1 2 10 DAC15-I23 2-CG9347-RA_1 CG9347 TGCAAACGAATCCCAATTATGCTACCCTCTTTCGTGGACGTCCCTTGAGATTCGTCCTGCCCTTGGG 67 FBgn0038171 CDMC21463 1 3 10 DAC15-M11 2-CG9775-RA_1 CG9775 CGGAGCCGGAAATCAAGGAATGTCCGCGGTCAACTCTAGGCTGCTGAATGAATTCAAGAGGCTCCAC 67 FBan0009775 FBgn0037261 CG9775 3 3R CG9775 CG9775 CDMC21463 1 4 10 DAC15-M11 2-CG9775-RA_1 CG9775 CGGAGCCGGAAATCAAGGAATGTCCGCGGTCAACTCTAGGCTGCTGAATGAATTCAAGAGGCTCCAC 67 FBan0009775 FBgn0037261 CG9775 3 3R CG9775 CG9775 CDMC21464 1 5 10 DAC15-M23 16-CG9894-RA_1 CG9894 TCCGGAAAACCTCAAAGAAACCAATTCAAATATGTCGGCTGCTACGGAACAACAGAACAACGGCGAT 67 FBan0009894 FBgn0031453 CG9894 2 2L nucleus; GO:0005634 CG9894 CG9894 "clone 2.54, anon-EST:Liang-2.54" CDMC21464 1 6 10 DAC15-M23 16-CG9894-RA_1 CG9894 TCCGGAAAACCTCAAAGAAACCAATTCAAATATGTCGGCTGCTACGGAACAACAGAACAACGGCGAT 67 FBan0009894 FBgn0031453 CG9894 2 2L nucleus; GO:0005634 CG9894 CG9894 "clone 2.54, anon-EST:Liang-2.54" CDMC21465 1 7 10 DAC16-A11 18-CG4879-RA_4 CG4879 AGCATCCCACAGGAAAACGTCAAAGGAATCGTTATCGAACTTGAAGAAGGAAGGATCCGACTCCAGAGT 69 FBan0004879 FBgn0027375 RecQ5 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 GTP binding; GO:0005525; ; GO:0005525; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003676; GTPase activity; GO:0003924; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0003924; ; GO:0004003; ; GO:0017116 RecQ5 homolog of RecQ "CG4879, DQ1, Drosophila homolog of RecQ, Q1, Dq1, RECQE, RECQ5, RECQ5/QE, Dm RECQ5/QE, DmRECQ5, anon-EST:Posey293, homolog of RecQ" CDMC21465 1 8 10 DAC16-A11 18-CG4879-RA_4 CG4879 AGCATCCCACAGGAAAACGTCAAAGGAATCGTTATCGAACTTGAAGAAGGAAGGATCCGACTCCAGAGT 69 FBan0004879 FBgn0027375 RecQ5 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 GTP binding; GO:0005525; ; GO:0005525; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003676; GTPase activity; GO:0003924; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0003924; ; GO:0004003; ; GO:0017116 RecQ5 homolog of RecQ "CG4879, DQ1, Drosophila homolog of RecQ, Q1, Dq1, RECQE, RECQ5, RECQ5/QE, Dm RECQ5/QE, DmRECQ5, anon-EST:Posey293, homolog of RecQ" CDMC21466 1 9 10 DAC16-A23 17-CG4894-RC_1 CG4894 ACAATCGCCGCTAAGAGGACAGGGCAATCAGACTTACTCCTCATAGCACCCACATTGTAAGCTATACAT 69 FBan0004894 FBgn0001991 Ca-alpha1D 2 2L calcium ion transport; GO:0006816; embryonic development; GO:0009790; epithelial fluid transport; GO:0042045; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; proteolysis; GO:0006508; sodium ion transport; GO:0006814 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; voltage-gated sodium channel activity; GO:0005248; ; GO:0005245; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005248 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 Ca-alpha1D Ca[2+]-channel protein alpha[[1]] subunit D "CG4894, CG4894, l(2)35Fa, l35Fa, DroCa1, alpha1, Dmca1D, DmCa1alpha1, Ca-alpha1, Ca[2+]-channel alpha1 subunit, Drosophila melanogaster calcium channel alpha[[1]] subunit DHP-sensitive, BG:DS02795.1, Ca-alpha1, Ca-_1D, Ca-a1D, calcium channel alpha-1 subunit, alpha1D, DmCa1D" CDMC21466 1 10 10 DAC16-A23 17-CG4894-RC_1 CG4894 ACAATCGCCGCTAAGAGGACAGGGCAATCAGACTTACTCCTCATAGCACCCACATTGTAAGCTATACAT 69 FBan0004894 FBgn0001991 Ca-alpha1D 2 2L calcium ion transport; GO:0006816; embryonic development; GO:0009790; epithelial fluid transport; GO:0042045; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; proteolysis; GO:0006508; sodium ion transport; GO:0006814 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; voltage-gated sodium channel activity; GO:0005248; ; GO:0005245; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005248 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 Ca-alpha1D Ca[2+]-channel protein alpha[[1]] subunit D "CG4894, CG4894, l(2)35Fa, l35Fa, DroCa1, alpha1, Dmca1D, DmCa1alpha1, Ca-alpha1, Ca[2+]-channel alpha1 subunit, Drosophila melanogaster calcium channel alpha[[1]] subunit DHP-sensitive, BG:DS02795.1, Ca-alpha1, Ca-_1D, Ca-a1D, calcium channel alpha-1 subunit, alpha1D, DmCa1D" CDMC21467 1 11 10 DAC16-E11 2-CG4921-RA_1 CG4921 AGCGCCAAGACGGGGGAGAATGTTGAAGAGGCCTTTCTCAAGTGCTCAAAGACCATACTGGCCAAAATT 69 FBan0004921 FBgn0016701 Rab4 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab4 Rab-protein 4 "CG4921, CG4921, CG4921, DRAB4, DmRab4" CDMC21467 1 12 10 DAC16-E11 2-CG4921-RA_1 CG4921 AGCGCCAAGACGGGGGAGAATGTTGAAGAGGCCTTTCTCAAGTGCTCAAAGACCATACTGGCCAAAATT 69 FBan0004921 FBgn0016701 Rab4 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab4 Rab-protein 4 "CG4921, CG4921, CG4921, DRAB4, DmRab4" CDMC21468 1 13 10 DAC16-E23 10-CG4930-RA_2 CG4930 TCCGCTCGAGGAATACCGAACTCTAATGAAGCGCTTTGTTCTGACCAAAATCATCGTTCCGGACAGCGT 69 FBan0004930 FBgn0028515 CG4930 2 2L CG4930 CG4930 BG:DS07473.2 CDMC21468 1 14 10 DAC16-E23 10-CG4930-RA_2 CG4930 TCCGCTCGAGGAATACCGAACTCTAATGAAGCGCTTTGTTCTGACCAAAATCATCGTTCCGGACAGCGT 69 FBan0004930 FBgn0028515 CG4930 2 2L CG4930 CG4930 BG:DS07473.2 CDMC21469 1 15 10 DAC16-I11 17-CG4956-RA_4 CG4956 GGCTCGGCTGTATGACCAATACCTCAGTCGATAGCTTAGTTCTGGAAAGACAGTATCCTGTGGCAGGTG 69 FBan0004956 FBgn0039370 CG4956 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG4956 CG4956 CDMC21469 1 16 10 DAC16-I11 17-CG4956-RA_4 CG4956 GGCTCGGCTGTATGACCAATACCTCAGTCGATAGCTTAGTTCTGGAAAGACAGTATCCTGTGGCAGGTG 69 FBan0004956 FBgn0039370 CG4956 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG4956 CG4956 CDMC21470 1 17 10 DAC16-I23 2-CG4972-RA_1 CG4972 GGCCATACAATACTTCCCCCGGTTTTACGATGAAGTTTCCAAGCTAACGAAGGAGGATCCCGCGGGTCA 69 FBan0004972 FBgn0032217 CG4972 2 2L CG4972 CG4972 CDMC21470 1 18 10 DAC16-I23 2-CG4972-RA_1 CG4972 GGCCATACAATACTTCCCCCGGTTTTACGATGAAGTTTCCAAGCTAACGAAGGAGGATCCCGCGGGTCA 69 FBan0004972 FBgn0032217 CG4972 2 2L CG4972 CG4972 CDMC21471 1 19 10 DAC16-M11 23-CG5001-RA_4 CG5001 AAACCGATCCCATTCATTTTGTAACAACCCATCGAGATCTTGCTCCCATTTTGCTTGTTTTTGTGTTCA 69 FBan0005001 FBgn0031322 CG5001 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG5001 CG5001 CDMC21471 1 20 10 DAC16-M11 23-CG5001-RA_4 CG5001 AAACCGATCCCATTCATTTTGTAACAACCCATCGAGATCTTGCTCCCATTTTGCTTGTTTTTGTGTTCA 69 FBan0005001 FBgn0031322 CG5001 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG5001 CG5001 CDMC21472 1 21 10 DAC16-M23 23-CG5011-RA_2 CG5011 TAGAATGCAGATAAGATTACAGCCTACTGAAACTATGTTACTTTTGTATAAAAGGTCTGGCAGGAGTGA 69 FBan0005011 FBgn0040723 CG5011 2 2L CG5011 CG5011 CDMC21472 1 22 10 DAC16-M23 23-CG5011-RA_2 CG5011 TAGAATGCAGATAAGATTACAGCCTACTGAAACTATGTTACTTTTGTATAAAAGGTCTGGCAGGAGTGA 69 FBan0005011 FBgn0040723 CG5011 2 2L CG5011 CG5011 CDMC21473 1 23 10 DAC17-A11 3-CG7092-RA_2 CG7092 GCGCACCATTCTGACCATCTTTTCCTCGAAGCGAATCATCCAGCCCGACTACAAGTACTGTCGTGGTGA 69 FBan0007092 FBgn0013809 Dhc16F X X "cell motility; GO:0006928; microtubule-based movement; GO:0007018; regulation of transcription, DNA-dependent; GO:0006355; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0005509; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc16F Dynein heavy chain at 16F "CG7092, CG7092, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC21473 1 24 10 DAC17-A11 3-CG7092-RA_2 CG7092 GCGCACCATTCTGACCATCTTTTCCTCGAAGCGAATCATCCAGCCCGACTACAAGTACTGTCGTGGTGA 69 FBan0007092 FBgn0013809 Dhc16F X X "cell motility; GO:0006928; microtubule-based movement; GO:0007018; regulation of transcription, DNA-dependent; GO:0006355; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0005509; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc16F Dynein heavy chain at 16F "CG7092, CG7092, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC21474 1 25 10 DAC17-A23 23-CG7101-RA_1 CG7101 CCTGAGCGACATCTCACGTCCAGAACTACGATTAATATATACTTAAGCAATGGATAAATGTAACGTTTT 69 FBan0007101 FBgn0030963 CG7101 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7101 CG7101 CDMC21474 1 26 10 DAC17-A23 23-CG7101-RA_1 CG7101 CCTGAGCGACATCTCACGTCCAGAACTACGATTAATATATACTTAAGCAATGGATAAATGTAACGTTTT 69 FBan0007101 FBgn0030963 CG7101 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7101 CG7101 CDMC21475 1 1 11 DAC17-E11 3-CG7138-RA_3 CG7138 CGGCTTGATGAAGGATTCGACTGTGGGTGATCTGGATGAGGAACTGACTAACCTCAACCGGGACATGGT 69 FBan0007138 FBgn0031951 r2d2 2 2L "RNA interference, siRNA loading onto RISC; GO:0035087" double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 r2d2 r2d2 "CG7138, cg7138, R2D2" CDMC21475 1 2 11 DAC17-E11 3-CG7138-RA_3 CG7138 CGGCTTGATGAAGGATTCGACTGTGGGTGATCTGGATGAGGAACTGACTAACCTCAACCGGGACATGGT 69 FBan0007138 FBgn0031951 r2d2 2 2L "RNA interference, siRNA loading onto RISC; GO:0035087" double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 r2d2 r2d2 "CG7138, cg7138, R2D2" CDMC21476 1 3 11 DAC17-E23 2-CG7148-RA_1 CG7148 GGCCATTTGCAGCTGGACTCATTCGGCAGACTACCTAAAGCGCTATACCTGTATGACAGAGCTGCAGCT 69 FBan0007148 FBgn0046301 CG7148 3 3L CG7148 CG7148 BEST:GH10766 CDMC21476 1 4 11 DAC17-E23 2-CG7148-RA_1 CG7148 GGCCATTTGCAGCTGGACTCATTCGGCAGACTACCTAAAGCGCTATACCTGTATGACAGAGCTGCAGCT 69 FBan0007148 FBgn0046301 CG7148 3 3L CG7148 CG7148 BEST:GH10766 CDMC21477 1 5 11 DAC17-I11 23-CG7184-RA_17 CG7184 AGATTACTCGGATGAAGACTAAGCTTCTGAAGCAGAAGGAAACAAAAAAAAGAAACATCAGCCCAAAAG 69 FBan0007184 FBgn0029152 Mkrn1 3 3L Mkrn1 Makorin 1 "CG7184, MKRN1" CDMC21477 1 6 11 DAC17-I11 23-CG7184-RA_17 CG7184 AGATTACTCGGATGAAGACTAAGCTTCTGAAGCAGAAGGAAACAAAAAAAAGAAACATCAGCCCAAAAG 69 FBan0007184 FBgn0029152 Mkrn1 3 3L Mkrn1 Makorin 1 "CG7184, MKRN1" CDMC21478 1 7 11 DAC17-I23 8-CG7192-RA_1 CG7192 GCTCGCCCGAGCAATCAAACACCTCAGTTTCGTAGAACCCCTCATTGGAAAGCAACCGAATCAGAATCC 69 FBan0007192 FBgn0030894 CG7192 X X CG7192 CG7192 CDMC21478 1 8 11 DAC17-I23 8-CG7192-RA_1 CG7192 GCTCGCCCGAGCAATCAAACACCTCAGTTTCGTAGAACCCCTCATTGGAAAGCAACCGAATCAGAATCC 69 FBan0007192 FBgn0030894 CG7192 X X CG7192 CG7192 CDMC21479 1 9 11 DAC17-M11 23-CG7234-RI_4 CG7234 TGCGAAAAAGAAAAAAAAGACCAGGCGAATTGAAAAGTAGGGGAGTAAAAAGGCTTGCGAACATTCAGT 69 FBan0007234 FBgn0020429 GluRIIB 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 kainate selective glutamate receptor activity; GO:0015277; alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066; ; GO:0004971 plasma membrane; GO:0005886 GluRIIB Glutamate receptor IIB "CG7234, DGluIIB, DGluRIIB, dGluRIIB, GluRIIb, DGluR-IIB, glurIIB, dglurIIB, glutamate receptor, Glu-RIIB" CDMC21479 1 10 11 DAC17-M11 23-CG7234-RI_4 CG7234 TGCGAAAAAGAAAAAAAAGACCAGGCGAATTGAAAAGTAGGGGAGTAAAAAGGCTTGCGAACATTCAGT 69 FBan0007234 FBgn0020429 GluRIIB 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 kainate selective glutamate receptor activity; GO:0015277; alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066; ; GO:0004971 plasma membrane; GO:0005886 GluRIIB Glutamate receptor IIB "CG7234, DGluIIB, DGluRIIB, dGluRIIB, GluRIIb, DGluR-IIB, glurIIB, dglurIIB, glutamate receptor, Glu-RIIB" CDMC21480 1 11 11 DAC17-M23 2-CG7251-RA_1 CG7251 GGCATGGACTCACTGCGAGGCACCATATCTCAACTCTATGTGAATCCCACTCCATGGATGGGTCCAGTT 69 FBan0007251 FBgn0031723 CG7251 2 2L CG7251 CG7251 "bs11h10.y1, anon-WO0140519.103" CDMC21480 1 12 11 DAC17-M23 2-CG7251-RA_1 CG7251 GGCATGGACTCACTGCGAGGCACCATATCTCAACTCTATGTGAATCCCACTCCATGGATGGGTCCAGTT 69 FBan0007251 FBgn0031723 CG7251 2 2L CG7251 CG7251 "bs11h10.y1, anon-WO0140519.103" CDMC21481 1 13 11 DAC18-A11 3-CG32398-RA_1 CG32398 CGCAGTCTCAGCTCAACACAGGCAGCTCAAATATGCCAAAAGCTGTGGTTCTGCTCGCTGTAGTTGACA 69 FBan0032398 FBgn0052398 CG32398 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32398 CG32398 CDMC21481 1 14 11 DAC18-A11 3-CG32398-RA_1 CG32398 CGCAGTCTCAGCTCAACACAGGCAGCTCAAATATGCCAAAAGCTGTGGTTCTGCTCGCTGTAGTTGACA 69 FBan0032398 FBgn0052398 CG32398 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32398 CG32398 CDMC21482 1 15 11 DAC18-A23 22-CG32405-RA_1 CG32405 AGCCAGGACCTTTTGAAAAGTCTCTACCAGAATCCAATCCAACTAAACATGCAGTCCTCCAGCATCTGT 69 FBan0032405 FBgn0052405 CG32405 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32405 CG32405 "CG10461, CG10461, BcDNA:RE31218" CDMC21482 1 16 11 DAC18-A23 22-CG32405-RA_1 CG32405 AGCCAGGACCTTTTGAAAAGTCTCTACCAGAATCCAATCCAACTAAACATGCAGTCCTCCAGCATCTGT 69 FBan0032405 FBgn0052405 CG32405 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32405 CG32405 "CG10461, CG10461, BcDNA:RE31218" CDMC21483 1 17 11 DAC18-E11 17-CG32440-RA_2 CG32440 TCTCGGCCCTAAATTGTCCGTTCGACGAGGAATTTGCCTTTTTTTCGTTTCAATCCCAAGATCAGTGGG 69 FBan0032440 FBgn0052440 CG32440 3 3L CG32440 CG32440 "CG5051, CG5051, CG5051, bs36c07.y1" CDMC21483 1 18 11 DAC18-E11 17-CG32440-RA_2 CG32440 TCTCGGCCCTAAATTGTCCGTTCGACGAGGAATTTGCCTTTTTTTCGTTTCAATCCCAAGATCAGTGGG 69 FBan0032440 FBgn0052440 CG32440 3 3L CG32440 CG32440 "CG5051, CG5051, CG5051, bs36c07.y1" CDMC21484 1 19 11 DAC18-E23 2-CG3244-RA_1 CG3244 CGTCTGGTCTCGTCTGGTTGTCTGCTTGGACAATTCGGCGACTACAGTATAGAAACCGTGCTGTGCAGT 69 FBan0003244 FBgn0031629 CG3244 2 2L sugar binding; GO:0005529; ; GO:0005529 CG3244 CG3244 CDMC21484 1 20 11 DAC18-E23 2-CG3244-RA_1 CG3244 CGTCTGGTCTCGTCTGGTTGTCTGCTTGGACAATTCGGCGACTACAGTATAGAAACCGTGCTGTGCAGT 69 FBan0003244 FBgn0031629 CG3244 2 2L sugar binding; GO:0005529; ; GO:0005529 CG3244 CG3244 CDMC21485 1 21 11 DAC18-I11 3-CG32483-RA_2 CG32483 TCGAATGTCATCTGGGGATCGCAGAGTGGGACCACTTTTGACATCCACAGAACGGACTTCATGAAGCCA 69 FBan0032483 FBgn0052483 CG32483 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG32483 CG32483 CDMC21485 1 22 11 DAC18-I11 3-CG32483-RA_2 CG32483 TCGAATGTCATCTGGGGATCGCAGAGTGGGACCACTTTTGACATCCACAGAACGGACTTCATGAAGCCA 69 FBan0032483 FBgn0052483 CG32483 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG32483 CG32483 CDMC21486 1 23 11 DAC18-I23 3-CG32491-RB_1 CG32491 CCTAGCAACCTGGCTGACTTTGGTAACGAGAGCTTCTTGCCCAAAACCAAGGGTAAACGGCCACAGAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21486 1 24 11 DAC18-I23 3-CG32491-RB_1 CG32491 CCTAGCAACCTGGCTGACTTTGGTAACGAGAGCTTCTTGCCCAAAACCAAGGGTAAACGGCCACAGAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21487 1 25 11 DAC18-M11 16-CG3250-RA_1 CG3250 GCCGTCGAGAAGAACGAATAGCCGAGCCAAATTTAATGTGACTACCATTGAAGGAACTGGACCGGAATT 69 FBan0003250 FBgn0010401 Os-C 3 3R biological process unknown; GO:0000004 pheromone binding; GO:0005550; ; GO:0005550 cellular component unknown; GO:0008372 Os-C Os-C "CG3250, OS-C, Os-c" CDMC21487 1 26 11 DAC18-M11 16-CG3250-RA_1 CG3250 GCCGTCGAGAAGAACGAATAGCCGAGCCAAATTTAATGTGACTACCATTGAAGGAACTGGACCGGAATT 69 FBan0003250 FBgn0010401 Os-C 3 3R biological process unknown; GO:0000004 pheromone binding; GO:0005550; ; GO:0005550 cellular component unknown; GO:0008372 Os-C Os-C "CG3250, OS-C, Os-c" CDMC21488 1 1 12 DAC18-M23 23-CG32527-RA_8 CG32527 AGGTTTTACATGTTTTTCGGGCTATGTTGCACACATATCCAAAATATTCAGTTCATATCCGCACAACTG 69 FBgn0052527 CDMC21488 1 2 12 DAC18-M23 23-CG32527-RA_8 CG32527 AGGTTTTACATGTTTTTCGGGCTATGTTGCACACATATCCAAAATATTCAGTTCATATCCGCACAACTG 69 FBgn0052527 CDMC21489 1 3 12 DAC19-A11 5-CG8132-RA_3 CG8132 CAGCGATCCCGTGCCAATGACAACCAACTCTTTGTGGTCACAACATCACCAGCCCGTGACACAAG 65 FBan0008132 FBgn0037687 CG8132 3 3R nitrogen compound metabolism; GO:0006807 nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1 CG8132 CG8132 CDMC21489 1 4 12 DAC19-A11 5-CG8132-RA_3 CG8132 CAGCGATCCCGTGCCAATGACAACCAACTCTTTGTGGTCACAACATCACCAGCCCGTGACACAAG 65 FBan0008132 FBgn0037687 CG8132 3 3R nitrogen compound metabolism; GO:0006807 nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1 CG8132 CG8132 CDMC21490 1 5 12 DAC19-A23 3-CG8171-RA_3 CG8171 CAATCGGAGAAGCCACAACATTTCACCAAGATCAACGAAGACGATGTGCTCGCGTCGGCCCAGTC 65 FBan0008171 FBgn0000996 dup 2 2R DNA replication; GO:0006260; DNA replication checkpoint; GO:0000076; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304 DNA binding; GO:0003677; ; GO:0003677 cytoplasm; GO:0005737; nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634; replication fork; GO:0005657 dup double parked "CG8171, CG8171, CG8171, fs(2)51Fa: female sterile(2)51Fa, l(2)51Ec, fs(2)PA77, fs(2)ltoPA77, speckled, l(2)k03308, 19k, double parked, DUP/CDT1, Cdt1, Dup, cdt1/dup, DUP, Double-parked, CDT1/DUP, CDT1, anon-WO0257455.31, female sterile(2)51Fa, lethal(2)51Ec, fs(2)51Fa" CDMC21490 1 6 12 DAC19-A23 3-CG8171-RA_3 CG8171 CAATCGGAGAAGCCACAACATTTCACCAAGATCAACGAAGACGATGTGCTCGCGTCGGCCCAGTC 65 FBan0008171 FBgn0000996 dup 2 2R DNA replication; GO:0006260; DNA replication checkpoint; GO:0000076; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304 DNA binding; GO:0003677; ; GO:0003677 cytoplasm; GO:0005737; nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634; replication fork; GO:0005657 dup double parked "CG8171, CG8171, CG8171, fs(2)51Fa: female sterile(2)51Fa, l(2)51Ec, fs(2)PA77, fs(2)ltoPA77, speckled, l(2)k03308, 19k, double parked, DUP/CDT1, Cdt1, Dup, cdt1/dup, DUP, Double-parked, CDT1/DUP, CDT1, anon-WO0257455.31, female sterile(2)51Fa, lethal(2)51Ec, fs(2)51Fa" CDMC21491 1 7 12 DAC19-E11 8-CG8251-RA_4 CG8251 CCTGTTATCCTGGCGTTGCTAGGCGTTTGGTACTCCAACTTCTTCAAGGCGGAAACACATGCCCT 65 FBan0008251 FBgn0003074 Pgi 2 2R gluconeogenesis; GO:0006094; glycolysis; GO:0006096 phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; glucose-6-phosphate isomerase activity; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44; ; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44 cytoplasm; GO:0005737 Pgi Phosphoglucose isomerase "CG8251, CG8251, PGI, glucose phosphate isomerase, Gpi, pgi, GPI" CDMC21491 1 8 12 DAC19-E11 8-CG8251-RA_4 CG8251 CCTGTTATCCTGGCGTTGCTAGGCGTTTGGTACTCCAACTTCTTCAAGGCGGAAACACATGCCCT 65 FBan0008251 FBgn0003074 Pgi 2 2R gluconeogenesis; GO:0006094; glycolysis; GO:0006096 phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; glucose-6-phosphate isomerase activity; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44; ; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44 cytoplasm; GO:0005737 Pgi Phosphoglucose isomerase "CG8251, CG8251, PGI, glucose phosphate isomerase, Gpi, pgi, GPI" CDMC21492 1 9 12 DAC19-E23 2-CG8266-RB_1 CG8266 GTTTTGGACCCATCTGTAGCAGCTCCAACCAGTTCCTACGGAATGCCATACAATCCAGTGCCGGC 65 FBan0008266 FBgn0033339 sec31 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886 COPII-coated vesicle; GO:0030138; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; synaptic vesicle; GO:0008021 sec31 sec31 "CG8266, CG8266, dSec31p" CDMC21492 1 10 12 DAC19-E23 2-CG8266-RB_1 CG8266 GTTTTGGACCCATCTGTAGCAGCTCCAACCAGTTCCTACGGAATGCCATACAATCCAGTGCCGGC 65 FBan0008266 FBgn0033339 sec31 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886 COPII-coated vesicle; GO:0030138; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; synaptic vesicle; GO:0008021 sec31 sec31 "CG8266, CG8266, dSec31p" CDMC21493 1 11 12 DAC19-I11 3-CG8354-RA_2 CG8354 AGCGATTTGGCAAAAACAGCTCACAAGCCGACAGTCAGCGATACGATAGCCTGGAGGAGATTGCC 65 FBan0008354 FBgn0002632 m6 3 3R m6 E(spl) region transcript m6 "CG8354, CG8354, E(spl)m6, M6" CDMC21493 1 12 12 DAC19-I11 3-CG8354-RA_2 CG8354 AGCGATTTGGCAAAAACAGCTCACAAGCCGACAGTCAGCGATACGATAGCCTGGAGGAGATTGCC 65 FBan0008354 FBgn0002632 m6 3 3R m6 E(spl) region transcript m6 "CG8354, CG8354, E(spl)m6, M6" CDMC21494 1 13 12 DAC19-I23 6-CG8388-RA_2 CG8388 ATGCGCATGCATGAGATCAAATCTCGCGGACGACTATACCGCTGTGAACAGTGCTCCAAGGCCTT 65 FBan0008388 FBgn0034062 CG8388 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8388 CG8388 CDMC21494 1 14 12 DAC19-I23 6-CG8388-RA_2 CG8388 ATGCGCATGCATGAGATCAAATCTCGCGGACGACTATACCGCTGTGAACAGTGCTCCAAGGCCTT 65 FBan0008388 FBgn0034062 CG8388 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8388 CG8388 CDMC21495 1 15 12 DAC19-M11 1-CG8461-RA_1 CG8461 AAGCGGCTAAACAAAAACCGACCTCGTGAAATGACCACCAGACGACAGGTTCCATTTTTGGGCGC 65 FBan0008461 FBgn0038235 CG8461 3 3R CG8461 CG8461 CDMC21495 1 16 12 DAC19-M11 1-CG8461-RA_1 CG8461 AAGCGGCTAAACAAAAACCGACCTCGTGAAATGACCACCAGACGACAGGTTCCATTTTTGGGCGC 65 FBan0008461 FBgn0038235 CG8461 3 3R CG8461 CG8461 CDMC21496 1 17 12 DAC19-M23 1-CG8498-RA_1 CG8498 TGTCCGAATTGCAGGAATTCAACCAGGCGGCCGAAGATGTTAAGAACCTAAACACCACACCCGGG 65 FBan0008498 FBgn0031992 CG8498 2 2L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386 CG8498 CG8498 CDMC21496 1 18 12 DAC19-M23 1-CG8498-RA_1 CG8498 TGTCCGAATTGCAGGAATTCAACCAGGCGGCCGAAGATGTTAAGAACCTAAACACCACACCCGGG 65 FBan0008498 FBgn0031992 CG8498 2 2L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386 CG8498 CG8498 CDMC21497 1 19 12 DAC20-A11 2-CG7656-RA_2 CG7656 CCGCCATCCATACGCTTCCTGACGAAGGTCTGGCATCCGAATGTTTACGAGAACGGTGATCTGTGCATA 69 FBan0007656 FBgn0036516 CG7656 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG7656 CG7656 CDMC21497 1 20 12 DAC20-A11 2-CG7656-RA_2 CG7656 CCGCCATCCATACGCTTCCTGACGAAGGTCTGGCATCCGAATGTTTACGAGAACGGTGATCTGTGCATA 69 FBan0007656 FBgn0036516 CG7656 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG7656 CG7656 CDMC21498 1 21 12 DAC20-A23 1-CG7670-RA_2 CG7670 ACGTGATTTCCCCGAGGTTACAGCCGAACCACTGATAGAGAAATGCGTGGACTTGGGTCTTTGGTGCAA 69 FBan0007670 FBgn0038608 CG7670 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 CG7670 CG7670 CDMC21498 1 22 12 DAC20-A23 1-CG7670-RA_2 CG7670 ACGTGATTTCCCCGAGGTTACAGCCGAACCACTGATAGAGAAATGCGTGGACTTGGGTCTTTGGTGCAA 69 FBan0007670 FBgn0038608 CG7670 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 CG7670 CG7670 CDMC21499 1 23 12 DAC20-E11 23-CG7712-RA_2 CG7712 TGTTCTGCTTGGAGCAATTTGGTCGTAGGAAAAACAGAAAGAAATAAAAACAAATCAAATGGCCGGACG 69 FBan0007712 FBgn0033570 CG7712 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG7712 CG7712 BcDNA:RE25411 CDMC21499 1 24 12 DAC20-E11 23-CG7712-RA_2 CG7712 TGTTCTGCTTGGAGCAATTTGGTCGTAGGAAAAACAGAAAGAAATAAAAACAAATCAAATGGCCGGACG 69 FBan0007712 FBgn0033570 CG7712 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG7712 CG7712 BcDNA:RE25411 CDMC21500 1 25 12 DAC20-E23 16-CG7720-RB_1 CG7720 CCGACAAACAGCAGCTACGAATTCTGAAGTCGATCACTGTCGTCTGTGGACTGATTATTATGGGCGTGG 69 FBan0007720 FBgn0038652 CG7720 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG7720 CG7720 BcDNA:RH05973 CDMC21500 1 26 12 DAC20-E23 16-CG7720-RB_1 CG7720 CCGACAAACAGCAGCTACGAATTCTGAAGTCGATCACTGTCGTCTGTGGACTGATTATTATGGGCGTGG 69 FBan0007720 FBgn0038652 CG7720 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG7720 CG7720 BcDNA:RH05973 CDMC21501 1 1 13 DAC20-I11 2-CG7759-RA_1 CG7759 GCCAAGCGCGTTTAAAGGACCTCTACTGGTTCGAATGCTCTTGCGATGCCTGTATTGACAATTGGCCCA 69 FBan0007759 FBgn0033633 CG7759 2 2R CG7759 CG7759 CDMC21501 1 2 13 DAC20-I11 2-CG7759-RA_1 CG7759 GCCAAGCGCGTTTAAAGGACCTCTACTGGTTCGAATGCTCTTGCGATGCCTGTATTGACAATTGGCCCA 69 FBan0007759 FBgn0033633 CG7759 2 2R CG7759 CG7759 CDMC21502 1 3 13 DAC20-I23 11-CG7768-RB_1 CG7768 TGTTACGCATTTCAGACCAATTCGTTGAATAATCCGGTGCACCCTGAACAGCCCAGTTCCCTGACTCAT 69 FBan0007768 FBgn0036415 CG7768 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7768 CG7768 CDMC21502 1 4 13 DAC20-I23 11-CG7768-RB_1 CG7768 TGTTACGCATTTCAGACCAATTCGTTGAATAATCCGGTGCACCCTGAACAGCCCAGTTCCCTGACTCAT 69 FBan0007768 FBgn0036415 CG7768 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7768 CG7768 CDMC21503 1 5 13 DAC20-M11 23-CG7804-RA_2 CG7804 GCATGCATTCATTTAATCCACATGGTTACCAAATGAATCGCGTCATGAACTAGACCCACAAGACCAATG 69 FBan0007804 FBgn0036496 CG7804 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG7804 CG7804 cg7804 CDMC21503 1 6 13 DAC20-M11 23-CG7804-RA_2 CG7804 GCATGCATTCATTTAATCCACATGGTTACCAAATGAATCGCGTCATGAACTAGACCCACAAGACCAATG 69 FBan0007804 FBgn0036496 CG7804 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG7804 CG7804 cg7804 CDMC21504 1 7 13 DAC20-M23 12-CG7815-RA_1 CG7815 TTTACCGACGAGATGAGCCGTCAAGTGGAAAGCTTATTCAATGAGGCCAAATCCAAACCTCTGCCCACT 69 FBan0007815 FBgn0036497 ran-like 3 3L RNA localization; GO:0006403; cell cycle; GO:0007049; protein targeting; GO:0006605; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 ran-like ran-like "CG7815, CG7815, anon-WO0140519.150, BcDNA:GH25818, ran-like" CDMC21504 1 8 13 DAC20-M23 12-CG7815-RA_1 CG7815 TTTACCGACGAGATGAGCCGTCAAGTGGAAAGCTTATTCAATGAGGCCAAATCCAAACCTCTGCCCACT 69 FBan0007815 FBgn0036497 ran-like 3 3L RNA localization; GO:0006403; cell cycle; GO:0007049; protein targeting; GO:0006605; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 ran-like ran-like "CG7815, CG7815, anon-WO0140519.150, BcDNA:GH25818, ran-like" CDMC21505 1 9 13 DAC21-A11 1-CG2559-RA_8 CG2559 CGGCTTCCAGCAACGCATCCAGAACATCGTCGAATTGGGCTACTACCAGACGACCGATGGTCATATGAT 69 FBan0002559 FBgn0002562 Lsp1alpha X X transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1alpha Larval serum protein 1 alpha "CG2559, CG2559, LSP-1alpha, LSP-1 alpha, LSP1alpha, Lsp-1alpha, LSP1-alpha, LSP 1, Lsp1, DmeLSP1a, Lsp1alpha, LSP-1, Lsp1-alpha" CDMC21505 1 10 13 DAC21-A11 1-CG2559-RA_8 CG2559 CGGCTTCCAGCAACGCATCCAGAACATCGTCGAATTGGGCTACTACCAGACGACCGATGGTCATATGAT 69 FBan0002559 FBgn0002562 Lsp1alpha X X transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1alpha Larval serum protein 1 alpha "CG2559, CG2559, LSP-1alpha, LSP-1 alpha, LSP1alpha, Lsp-1alpha, LSP1-alpha, LSP 1, Lsp1, DmeLSP1a, Lsp1alpha, LSP-1, Lsp1-alpha" CDMC21506 1 11 13 DAC21-A23 1-CG2614-RA_1 CG2614 TCCAACATAGCTGGTCACAATGAGGTGATCATGGATCTGCACCGACCATCTGAGCAAACCCCTCGCTAT 69 FBan0002614 FBgn0032873 CG2614 2 2L CG2614 CG2614 38D.29 CDMC21506 1 12 13 DAC21-A23 1-CG2614-RA_1 CG2614 TCCAACATAGCTGGTCACAATGAGGTGATCATGGATCTGCACCGACCATCTGAGCAAACCCCTCGCTAT 69 FBan0002614 FBgn0032873 CG2614 2 2L CG2614 CG2614 38D.29 CDMC21507 1 13 13 DAC21-E11 23-CG2671-RA_5 CG2671 GATAACATGCCGATTAATTACTTCTGTTCGTCCGTATAAACACAAATACCGATAAATTGGTCCGTCCCC 69 FBan0002671 FBgn0002121 l(2)gl 2 2L asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell differentiation; GO:0030154; cell proliferation; GO:0008283; dorsal closure; GO:0007391; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; establishment of neuroblast polarity; GO:0045200; establishment of protein localization; GO:0045184; histolysis; GO:0007559; intracellular protein transport; GO:0006886; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of Notch signaling pathway; GO:0045746; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; regulation of cell proliferation; GO:0042127; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; sensory organ development; GO:0007423; septate junction assembly; GO:0019991; synaptic vesicle priming; GO:0016082; transforming growth factor beta receptor signaling pathway; GO:0007179; zonula adherens assembly; GO:0045186 myosin binding; GO:0017022; protein binding; GO:0005515; myosin II binding; GO:0045159; ; GO:0045159; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0045159; ; GO:0017022 apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; cytosol; GO:0005829; extracellular matrix (sensu Metazoa); GO:0005578; interstitial matrix; GO:0005614; plasma membrane; GO:0005886; septate junction; GO:0005918; synaptic vesicle; GO:0008021 l(2)gl lethal (2) giant larvae "CG2671, CG2671, l-gl, lgl: lethal-giant-larvae, l[[2]]gl, gl, l(2), p127, D-LGL, lethal(2)giant larvae, l(2)giant larvae, L(2)GL, lethal giant larvae, LGL, lethal giant larva, Lgl, l(2) giant larva, p127l(2)gl, dlgl, Lethal Giant Larvae, Complementation group 2.1, lethal giant larve, lethal-giant-larvae" CDMC21507 1 14 13 DAC21-E11 23-CG2671-RA_5 CG2671 GATAACATGCCGATTAATTACTTCTGTTCGTCCGTATAAACACAAATACCGATAAATTGGTCCGTCCCC 69 FBan0002671 FBgn0002121 l(2)gl 2 2L asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell differentiation; GO:0030154; cell proliferation; GO:0008283; dorsal closure; GO:0007391; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; establishment of neuroblast polarity; GO:0045200; establishment of protein localization; GO:0045184; histolysis; GO:0007559; intracellular protein transport; GO:0006886; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of Notch signaling pathway; GO:0045746; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; regulation of cell proliferation; GO:0042127; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; sensory organ development; GO:0007423; septate junction assembly; GO:0019991; synaptic vesicle priming; GO:0016082; transforming growth factor beta receptor signaling pathway; GO:0007179; zonula adherens assembly; GO:0045186 myosin binding; GO:0017022; protein binding; GO:0005515; myosin II binding; GO:0045159; ; GO:0045159; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0045159; ; GO:0017022 apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; cytosol; GO:0005829; extracellular matrix (sensu Metazoa); GO:0005578; interstitial matrix; GO:0005614; plasma membrane; GO:0005886; septate junction; GO:0005918; synaptic vesicle; GO:0008021 l(2)gl lethal (2) giant larvae "CG2671, CG2671, l-gl, lgl: lethal-giant-larvae, l[[2]]gl, gl, l(2), p127, D-LGL, lethal(2)giant larvae, l(2)giant larvae, L(2)GL, lethal giant larvae, LGL, lethal giant larva, Lgl, l(2) giant larva, p127l(2)gl, dlgl, Lethal Giant Larvae, Complementation group 2.1, lethal giant larve, lethal-giant-larvae" CDMC21508 1 15 13 DAC21-E23 23-CG2680-RA_1 CG2680 CGCAGGGAAATTACGAGAAACGTGCTACCTGAAATTAACTATATCAACCCAAGATAAAGTAGTAATGTT 69 FBan0002680 FBgn0024995 CG2680 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG2680 CG2680 EG:100G10.4 CDMC21508 1 16 13 DAC21-E23 23-CG2680-RA_1 CG2680 CGCAGGGAAATTACGAGAAACGTGCTACCTGAAATTAACTATATCAACCCAAGATAAAGTAGTAATGTT 69 FBan0002680 FBgn0024995 CG2680 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG2680 CG2680 EG:100G10.4 CDMC21509 1 17 13 DAC21-I11 1-CG2762-RA_1 CG2762 TTCCCCCGACACCAGAGATCAAGATGTGACTTCCAACCCCACTACCAACCAACACTCGAATTCCGATGT 69 FBan0002762 FBgn0003963 ush 2 2L "amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; germ-band shortening; GO:0007390; head involution; GO:0008258; heart development; GO:0007507; hemopoiesis; GO:0030097; negative regulation of cell fate specification; GO:0009996; negative regulation of crystal cell differentiation; GO:0042690; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" transcription factor binding; GO:0008134; ; GO:0008134; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0008134; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ush u-shaped "CG2762, u-sh, Ush, ushaped, FOG, dFOG, l(2)19, u-shaped" CDMC21509 1 18 13 DAC21-I11 1-CG2762-RA_1 CG2762 TTCCCCCGACACCAGAGATCAAGATGTGACTTCCAACCCCACTACCAACCAACACTCGAATTCCGATGT 69 FBan0002762 FBgn0003963 ush 2 2L "amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; germ-band shortening; GO:0007390; head involution; GO:0008258; heart development; GO:0007507; hemopoiesis; GO:0030097; negative regulation of cell fate specification; GO:0009996; negative regulation of crystal cell differentiation; GO:0042690; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" transcription factor binding; GO:0008134; ; GO:0008134; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0008134; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ush u-shaped "CG2762, u-sh, Ush, ushaped, FOG, dFOG, l(2)19, u-shaped" CDMC21510 1 19 13 DAC21-I23 9-CG2790-RA_1 CG2790 GGCGGAAGGCAGTGACGAACCAGATGAGCCAATAGAAAAGAAGGCAATCAAGAGCGAGTCAGAGGATGA 69 FBan0002790 FBgn0027599 CG2790 2 2R protein folding; GO:0006457 "nucleic acid binding; GO:0003676; ; GO:0003676; structural molecule activity; GO:0005198; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0008270" nucleus; GO:0005634 CG2790 CG2790 BcDNA:GH03108 CDMC21510 1 20 13 DAC21-I23 9-CG2790-RA_1 CG2790 GGCGGAAGGCAGTGACGAACCAGATGAGCCAATAGAAAAGAAGGCAATCAAGAGCGAGTCAGAGGATGA 69 FBan0002790 FBgn0027599 CG2790 2 2R protein folding; GO:0006457 "nucleic acid binding; GO:0003676; ; GO:0003676; structural molecule activity; GO:0005198; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0008270" nucleus; GO:0005634 CG2790 CG2790 BcDNA:GH03108 CDMC21511 1 21 13 DAC21-M11 23-CG2852-RA_6 CG2852 GAATAAACTGAAGCGCTGTGAATATTTAGAACGATGAAGCTGTTCTTATCCGTTTTCGTGGTAGCCCTG 69 FBan0002852 FBgn0034753 CG2852 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG2852 CG2852 CDMC21511 1 22 13 DAC21-M11 23-CG2852-RA_6 CG2852 GAATAAACTGAAGCGCTGTGAATATTTAGAACGATGAAGCTGTTCTTATCCGTTTTCGTGGTAGCCCTG 69 FBan0002852 FBgn0034753 CG2852 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG2852 CG2852 CDMC21512 1 23 13 DAC21-M23 23-CG2867-RA_4 CG2867 ATAGAGGGCTCGGAATTACTGTCACAAATTTTGCATTTAGTTTATCTAGCATTACAGCCCACCCATTCC 69 FBan0002867 FBgn0004901 Prat 3 3R 'de novo' IMP biosynthesis; GO:0006189; determination of adult life span; GO:0008340; embryonic cleavage; GO:0040016; monosaccharide metabolism; GO:0005996; nucleoside metabolism; GO:0009116; oogenesis (sensu Insecta); GO:0009993; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 amidophosphoribosyltransferase activity; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14 Prat Phosphoribosylamidotransferase "CG2867, transcript D" CDMC21512 1 24 13 DAC21-M23 23-CG2867-RA_4 CG2867 ATAGAGGGCTCGGAATTACTGTCACAAATTTTGCATTTAGTTTATCTAGCATTACAGCCCACCCATTCC 69 FBan0002867 FBgn0004901 Prat 3 3R 'de novo' IMP biosynthesis; GO:0006189; determination of adult life span; GO:0008340; embryonic cleavage; GO:0040016; monosaccharide metabolism; GO:0005996; nucleoside metabolism; GO:0009116; oogenesis (sensu Insecta); GO:0009993; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 amidophosphoribosyltransferase activity; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14 Prat Phosphoribosylamidotransferase "CG2867, transcript D" CDMC21513 1 25 13 DAC22-A11 2-CG14519-RA_1 CG14519 ATGGTCTCGTCTGCGAAAGGCTCCAAGTCACAGTCACACGCTCACTTTAATTGGTACAGTGCGCC 65 FBan0014519 FBgn0039619 CG14519 3 3R CG14519 CG14519 CDMC21513 1 26 13 DAC22-A11 2-CG14519-RA_1 CG14519 ATGGTCTCGTCTGCGAAAGGCTCCAAGTCACAGTCACACGCTCACTTTAATTGGTACAGTGCGCC 65 FBan0014519 FBgn0039619 CG14519 3 3R CG14519 CG14519 CDMC21514 1 1 14 DAC22-A23 3-CG14541-RA_1 CG14541 AACAAATGCGGCATCTAGCATAGGACAACCGGGTGATTTGGCCCCCACAGTTATATCCCCAACCG 65 FBan0014541 FBgn0039399 CG14541 3 3R CG14541 CG14541 CDMC21514 1 2 14 DAC22-A23 3-CG14541-RA_1 CG14541 AACAAATGCGGCATCTAGCATAGGACAACCGGGTGATTTGGCCCCCACAGTTATATCCCCAACCG 65 FBan0014541 FBgn0039399 CG14541 3 3R CG14541 CG14541 CDMC21515 1 3 14 DAC22-E11 18-CG14632-RA_1 CG14632 GCGGCTCGTGGATCACAATCGCTGCAGGGATCTCCGCTTTTGGCAAAGAGAGCCACCTCCTTCAG 65 FBan0014632 FBgn0029538 CG14632 X X CG14632 CG14632 CDMC21515 1 4 14 DAC22-E11 18-CG14632-RA_1 CG14632 GCGGCTCGTGGATCACAATCGCTGCAGGGATCTCCGCTTTTGGCAAAGAGAGCCACCTCCTTCAG 65 FBan0014632 FBgn0029538 CG14632 X X CG14632 CG14632 CDMC21516 1 5 14 DAC22-E23 8-CG14643-RA_2 CG14643 AGCTCAATATGACCAGCTTGGCGGAACATCACAGGTTTCTGACGAGGGAGTTGCACCCGTTACAT 65 FBan0014643 FBgn0037225 CG14643 3 3R CG14643 CG14643 CDMC21516 1 6 14 DAC22-E23 8-CG14643-RA_2 CG14643 AGCTCAATATGACCAGCTTGGCGGAACATCACAGGTTTCTGACGAGGGAGTTGCACCCGTTACAT 65 FBan0014643 FBgn0037225 CG14643 3 3R CG14643 CG14643 CDMC21517 1 7 14 DAC22-I11 5-CG14755-RA_1 CG14755 GAATCCACGACGTCACAGTCACAGTACACAACGCTAGACAAGATGCTGGGCACGGTGCTGCCATG 65 FBan0014755 FBgn0033282 CG14755 2 2R CG14755 CG14755 CDMC21517 1 8 14 DAC22-I11 5-CG14755-RA_1 CG14755 GAATCCACGACGTCACAGTCACAGTACACAACGCTAGACAAGATGCTGGGCACGGTGCTGCCATG 65 FBan0014755 FBgn0033282 CG14755 2 2R CG14755 CG14755 CDMC21518 1 9 14 DAC22-I23 3-CG14781-RA_6 CG14781 CTGATTAGTGCTGGGGATCTCAAGAAGGAGTCCCCCAAAGACACGACAGAGGCGTCCAAGGATGC 65 FBan0014781 FBgn0026871 CG14781 X X CG14781 CG14781 EG:80H7.11 CDMC21518 1 10 14 DAC22-I23 3-CG14781-RA_6 CG14781 CTGATTAGTGCTGGGGATCTCAAGAAGGAGTCCCCCAAAGACACGACAGAGGCGTCCAAGGATGC 65 FBan0014781 FBgn0026871 CG14781 X X CG14781 CG14781 EG:80H7.11 CDMC21519 1 11 14 DAC22-M11 1-CG14850-RA_2 CG14850 GCCGCTAATACCACTACGAAACCCGCAGATGGAACAGATACCACGACACCCACCACAGGAGGAAG 65 FBan0014850 FBgn0038239 CG14850 3 3R CG14850 CG14850 CDMC21519 1 12 14 DAC22-M11 1-CG14850-RA_2 CG14850 GCCGCTAATACCACTACGAAACCCGCAGATGGAACAGATACCACGACACCCACCACAGGAGGAAG 65 FBan0014850 FBgn0038239 CG14850 3 3R CG14850 CG14850 CDMC21520 1 13 14 DAC22-M23 2-CG1487-RA_1 CG1487 GCTCGCCACTTCTAAATGGTGACCTCGTAGCTGAGCTGCCATTCACACTAATGCACCCTAAGCCC 65 FBan0001487 FBgn0040206 krz 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 krz kurtz "CG1487, 0952/14, kurtz-arrestin, l(3)S095214, kurtz" CDMC21520 1 14 14 DAC22-M23 2-CG1487-RA_1 CG1487 GCTCGCCACTTCTAAATGGTGACCTCGTAGCTGAGCTGCCATTCACACTAATGCACCCTAAGCCC 65 FBan0001487 FBgn0040206 krz 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 krz kurtz "CG1487, 0952/14, kurtz-arrestin, l(3)S095214, kurtz" CDMC21521 1 15 14 DAC23-A11 15-CG6738-RA_1 CG6738 CCGCCGGTCATGGTTCTCTATTGTTGCCCGATACAGCCGGAGTTAAGTTGAACTATGTGTTGAACAAGC 69 FBan0006738 FBgn0039053 CG6738 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6738 CG6738 CDMC21521 1 16 14 DAC23-A11 15-CG6738-RA_1 CG6738 CCGCCGGTCATGGTTCTCTATTGTTGCCCGATACAGCCGGAGTTAAGTTGAACTATGTGTTGAACAAGC 69 FBan0006738 FBgn0039053 CG6738 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6738 CG6738 CDMC21522 1 17 14 DAC23-A23 1-CG6752-RA_1 CG6752 CCTGCGAGTGAAACAGACTCTGCTTTCCGACATTACACTGCCATCAGAGGACTCCCTGTGTCCGATCTG 69 FBan0006752 FBgn0038296 CG6752 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6752 CG6752 CDMC21522 1 18 14 DAC23-A23 1-CG6752-RA_1 CG6752 CCTGCGAGTGAAACAGACTCTGCTTTCCGACATTACACTGCCATCAGAGGACTCCCTGTGTCCGATCTG 69 FBan0006752 FBgn0038296 CG6752 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6752 CG6752 CDMC21523 1 19 14 DAC23-E11 12-CG6784-RB_1 CG6784 TGCGTGGAATTTTGTGGCAAATACGACTGGAAGAAGGTGCGAAAGACAGGACTTCGACGTTCAGCTGAT 69 FBan0006784 FBgn0039074 CG6784 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6784 CG6784 CDMC21523 1 20 14 DAC23-E11 12-CG6784-RB_1 CG6784 TGCGTGGAATTTTGTGGCAAATACGACTGGAAGAAGGTGCGAAAGACAGGACTTCGACGTTCAGCTGAT 69 FBan0006784 FBgn0039074 CG6784 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6784 CG6784 CDMC21524 1 21 14 DAC23-E23 18-CG6800-RA_4 CG6800 GGTGGCCCTTAAGAACAAGTTCGGAAACATAGCCCTAAATACTTTGAGGGAAATCAAGACCCTGCAGCT 69 FBan0006800 FBgn0038902 CG6800 3 3R protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- CG6800 CG6800 "AC014407, CDK7-like" CDMC21524 1 22 14 DAC23-E23 18-CG6800-RA_4 CG6800 GGTGGCCCTTAAGAACAAGTTCGGAAACATAGCCCTAAATACTTTGAGGGAAATCAAGACCCTGCAGCT 69 FBan0006800 FBgn0038902 CG6800 3 3R protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- CG6800 CG6800 "AC014407, CDK7-like" CDMC21525 1 23 14 DAC23-I11 23-CG6833-RA_6 CG6833 ACATTTGTTATTCGAGATTGTCTTAAGCTGGATATTTATTTGGAATATATAGATGCCCCGACGCCATGT 69 FBan0006833 FBgn0036405 CG6833 3 3L "RNA catabolism; GO:0006401; cell cycle; GO:0007049; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG6833 CG6833 CDMC21525 1 24 14 DAC23-I11 23-CG6833-RA_6 CG6833 ACATTTGTTATTCGAGATTGTCTTAAGCTGGATATTTATTTGGAATATATAGATGCCCCGACGCCATGT 69 FBan0006833 FBgn0036405 CG6833 3 3L "RNA catabolism; GO:0006401; cell cycle; GO:0007049; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG6833 CG6833 CDMC21526 1 25 14 DAC23-I23 14-CG6847-RA_2 CG6847 GGCGAAATCTGCAGGATTATGCCACCACTGACAGTCCAGAGATTATGGAACCTGTTTTAAAGGCCACCA 69 FBan0006847 FBgn0030884 CG6847 X X lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6847 CG6847 CDMC21526 1 26 14 DAC23-I23 14-CG6847-RA_2 CG6847 GGCGAAATCTGCAGGATTATGCCACCACTGACAGTCCAGAGATTATGGAACCTGTTTTAAAGGCCACCA 69 FBan0006847 FBgn0030884 CG6847 X X lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6847 CG6847 CDMC21527 1 1 15 DAC23-M11 16-CG6883-RA_1 CG6883 CCAGAAAGGGTAATCCGGGATAGAGGGGCCATGTCTTAGGGGACTGAAGGATGTTTTGAAAACCACTAA 69 FBan0006883 FBgn0003749 trh 3 3L "Malpighian tubule morphogenesis; GO:0007443; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; signal transduction; GO:0007165; spiracle morphogenesis; GO:0035277; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 trh trachealess "CG6883, l(3)10512, 3.1, DMU42699, TRH, trachealess" CDMC21527 1 2 15 DAC23-M11 16-CG6883-RA_1 CG6883 CCAGAAAGGGTAATCCGGGATAGAGGGGCCATGTCTTAGGGGACTGAAGGATGTTTTGAAAACCACTAA 69 FBan0006883 FBgn0003749 trh 3 3L "Malpighian tubule morphogenesis; GO:0007443; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; signal transduction; GO:0007165; spiracle morphogenesis; GO:0035277; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 trh trachealess "CG6883, l(3)10512, 3.1, DMU42699, TRH, trachealess" CDMC21528 1 3 15 DAC23-M23 16-CG6890-RA_1 CG6890 ATGAGAACAGAGCCGTACAGATTAGTTTGGTCTTGGCGATTAACATCTACCAGCTTGTGTGCTTCGCCC 69 FBan0006890 FBgn0029114 Tollo 3 3L cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor activity; GO:0004888; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004888; ; GO:0004675 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 Tollo Tollo "CG6890, CG6890, CG6890, CG6890, CG6890, tollo, Toll-8, Tl-8, CT21344, dTLR8, toll, dToll8" CDMC21528 1 4 15 DAC23-M23 16-CG6890-RA_1 CG6890 ATGAGAACAGAGCCGTACAGATTAGTTTGGTCTTGGCGATTAACATCTACCAGCTTGTGTGCTTCGCCC 69 FBan0006890 FBgn0029114 Tollo 3 3L cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor activity; GO:0004888; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004888; ; GO:0004675 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 Tollo Tollo "CG6890, CG6890, CG6890, CG6890, CG6890, tollo, Toll-8, Tl-8, CT21344, dTLR8, toll, dToll8" CDMC21529 1 5 15 DAC24-A11 9-CG2158-RA_7 CG2158 GCGTTGCTGACCTAAATCGGTCCGTCATAAAATTCCTGCAGGACCAAATGGGCAAAAGTCCCTACTGCA 69 FBan0002158 FBgn0033264 CG2158 2 2R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG2158 CG2158 CDMC21529 1 6 15 DAC24-A11 9-CG2158-RA_7 CG2158 GCGTTGCTGACCTAAATCGGTCCGTCATAAAATTCCTGCAGGACCAAATGGGCAAAAGTCCCTACTGCA 69 FBan0002158 FBgn0033264 CG2158 2 2R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG2158 CG2158 CDMC21530 1 7 15 DAC24-A23 7-CG2171-RA_1 CG2171 GCCGCCTGGAGTACTCAATGATCTGAACAGGAACGGTATCCAGTGCATTGCATCAGTAACGCTTCTCCA 69 FBan0002171 FBgn0003738 Tpi 3 3R gluconeogenesis; GO:0006094; glycolysis; GO:0006096; pentose-phosphate shunt; GO:0006098 triose-phosphate isomerase activity; GO:0004807 ; EC:5.3.1.1; intramolecular transferase activity; GO:0016866 ; EC:5.4.-.-; ; GO:0016866 ; EC:5.4.-.-; ; GO:0004807 ; EC:5.3.1.1; ; GO:0004807 ; EC:5.3.1.1 Tpi Triose phosphate isomerase "CG2171, TPI, TPIS" CDMC21530 1 8 15 DAC24-A23 7-CG2171-RA_1 CG2171 GCCGCCTGGAGTACTCAATGATCTGAACAGGAACGGTATCCAGTGCATTGCATCAGTAACGCTTCTCCA 69 FBan0002171 FBgn0003738 Tpi 3 3R gluconeogenesis; GO:0006094; glycolysis; GO:0006096; pentose-phosphate shunt; GO:0006098 triose-phosphate isomerase activity; GO:0004807 ; EC:5.3.1.1; intramolecular transferase activity; GO:0016866 ; EC:5.4.-.-; ; GO:0016866 ; EC:5.4.-.-; ; GO:0004807 ; EC:5.3.1.1; ; GO:0004807 ; EC:5.3.1.1 Tpi Triose phosphate isomerase "CG2171, TPI, TPIS" CDMC21531 1 9 15 DAC24-E11 23-CG2204-RA_4 CG2204 CTCATCCTTTACGCAAATATCCTCACTTGTGCTCTTGCTCTATAGTTGGACGGAAATCCATTTATGTTT 69 FBan0002204 FBgn0001122 G-oalpha47A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; establishment of wing hair orientation; GO:0001737; heart development; GO:0007507 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 G-oalpha47A G protein oalpha 47A "CG2204, DGalpha[[o]], dgo, Goalpha, DG[[o]], G[[oalpha]], dgoalpha, alpha(o), G[[o]]alpha, Go-alpha, Go, DROGPAD, Goa, bkh, brokenheart, Galpha47A, Galpha[[047A]], Drogpad, Galphao, Bkh, brokenhearted, Galpha[[o]], Galpha[[0]], Galphao47A, G-oalpha47A, Galpha47A, DGalpha0, G-alpha-47A" CDMC21531 1 10 15 DAC24-E11 23-CG2204-RA_4 CG2204 CTCATCCTTTACGCAAATATCCTCACTTGTGCTCTTGCTCTATAGTTGGACGGAAATCCATTTATGTTT 69 FBan0002204 FBgn0001122 G-oalpha47A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; establishment of wing hair orientation; GO:0001737; heart development; GO:0007507 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 G-oalpha47A G protein oalpha 47A "CG2204, DGalpha[[o]], dgo, Goalpha, DG[[o]], G[[oalpha]], dgoalpha, alpha(o), G[[o]]alpha, Go-alpha, Go, DROGPAD, Goa, bkh, brokenheart, Galpha47A, Galpha[[047A]], Drogpad, Galphao, Bkh, brokenhearted, Galpha[[o]], Galpha[[0]], Galphao47A, G-oalpha47A, Galpha47A, DGalpha0, G-alpha-47A" CDMC21532 1 11 15 DAC24-E23 17-CG2218-RA_2 CG2218 GCCAGTCAATCGCTTTAGCCCCTAGGCCTCGTCTACGTTAGTTTATAGTCATATCAGAGTCGGTCTGGT 69 FBan0002218 FBgn0039767 CG2218 3 3R CG2218 CG2218 CDMC21532 1 12 15 DAC24-E23 17-CG2218-RA_2 CG2218 GCCAGTCAATCGCTTTAGCCCCTAGGCCTCGTCTACGTTAGTTTATAGTCATATCAGAGTCGGTCTGGT 69 FBan0002218 FBgn0039767 CG2218 3 3R CG2218 CG2218 CDMC21533 1 13 15 DAC24-I11 3-CG2267-RA_2 CG2267 CCCAAGCCAACGGAGAATGTCCTGGAACCACTTCATCGGAGCTCTACCAGTCCTGATCTTTCGAAGCTT 69 FBan0002267 FBgn0039792 CG2267 3 3R CG2267 CG2267 anon-WO0140519.167 CDMC21533 1 14 15 DAC24-I11 3-CG2267-RA_2 CG2267 CCCAAGCCAACGGAGAATGTCCTGGAACCACTTCATCGGAGCTCTACCAGTCCTGATCTTTCGAAGCTT 69 FBan0002267 FBgn0039792 CG2267 3 3R CG2267 CG2267 anon-WO0140519.167 CDMC21534 1 15 15 DAC24-I23 9-CG2292-RA_1 CG2292 TCCGTCTGGCCTTCACCCTGCTATTGTACACCTTCTTTTCGCTCTTTGGATCCGGAAACATAGCGTCAA 69 FBan0002292 FBgn0033479 CG2292 2 2R CG2292 CG2292 CDMC21534 1 16 15 DAC24-I23 9-CG2292-RA_1 CG2292 TCCGTCTGGCCTTCACCCTGCTATTGTACACCTTCTTTTCGCTCTTTGGATCCGGAAACATAGCGTCAA 69 FBan0002292 FBgn0033479 CG2292 2 2R CG2292 CG2292 CDMC21535 1 17 15 DAC24-M11 23-CG2381-RF_4 CG2381 AGCATAAAAGGTGATAGGAACAAACCATTCAAAAACATGACTAAGTGCAATTTTTGCGTACTTTCTTTG 69 FBan0002381 FBgn0039900 Syt7 4 4 intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020; synaptic vesicle; GO:0008021 Syt7 Syt7 "CG2381, CG10322, CG2381, SYT7, Synaptotagmin VII" CDMC21535 1 18 15 DAC24-M11 23-CG2381-RF_4 CG2381 AGCATAAAAGGTGATAGGAACAAACCATTCAAAAACATGACTAAGTGCAATTTTTGCGTACTTTCTTTG 69 FBan0002381 FBgn0039900 Syt7 4 4 intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020; synaptic vesicle; GO:0008021 Syt7 Syt7 "CG2381, CG10322, CG2381, SYT7, Synaptotagmin VII" CDMC21536 1 19 15 DAC24-M23 15-CG2457-RA_4 CG2457 ACGGGACCCACTTCAGTAGAAAGTCACACGATATCAGCGATCACGGATCACGAATTACGGATCACGGAA 69 FBan0002457 FBgn0023077 inaF X X maintenance of rhodopsin mediated signaling; GO:0016058; response to light stimulus; GO:0009416; rhodopsin mediated signaling; GO:0016056 calcium channel regulator activity; GO:0005246; ; GO:0005246; ; GO:0005246 inaF inaF "CG2457, INAF, InaF, anon-WO0172774.148" CDMC21536 1 20 15 DAC24-M23 15-CG2457-RA_4 CG2457 ACGGGACCCACTTCAGTAGAAAGTCACACGATATCAGCGATCACGGATCACGAATTACGGATCACGGAA 69 FBan0002457 FBgn0023077 inaF X X maintenance of rhodopsin mediated signaling; GO:0016058; response to light stimulus; GO:0009416; rhodopsin mediated signaling; GO:0016056 calcium channel regulator activity; GO:0005246; ; GO:0005246; ; GO:0005246 inaF inaF "CG2457, INAF, InaF, anon-WO0172774.148" CDMC21537 1 21 15 DAC25-A11 1-CG10029-RA_1 CG10029 CGAGTCCAAGTTTAAGGACCTCAAGCCATCCAAGCACCGTTACACGTTGGTCAACCGCACAAGGG 65 FBan0010029 FBgn0037498 CG10029 3 3R electron transport; GO:0006118 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 CG10029 CG10029 CDMC21537 1 22 15 DAC25-A11 1-CG10029-RA_1 CG10029 CGAGTCCAAGTTTAAGGACCTCAAGCCATCCAAGCACCGTTACACGTTGGTCAACCGCACAAGGG 65 FBan0010029 FBgn0037498 CG10029 3 3R electron transport; GO:0006118 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 CG10029 CG10029 CDMC21538 1 23 15 DAC25-A23 1-CG10080-RA_1 CG10080 TAACTGCACCTTCTCCCCGATGCATGTAATCTACGGTGCTAGCTTGGGGGCTGATAGGGACCATG 65 FBan0010080 FBgn0034641 CG10080 2 2R CG10080 CG10080 "anon-WO0172774.151, BcDNA:SD08722" CDMC21538 1 24 15 DAC25-A23 1-CG10080-RA_1 CG10080 TAACTGCACCTTCTCCCCGATGCATGTAATCTACGGTGCTAGCTTGGGGGCTGATAGGGACCATG 65 FBan0010080 FBgn0034641 CG10080 2 2R CG10080 CG10080 "anon-WO0172774.151, BcDNA:SD08722" CDMC21539 1 25 15 DAC25-E11 23-CG10182-RA_1 CG10182 TCCCAGATAGATGACAACGGACACAATAACCTTGAGGAGCTCAAAGTAACGACTCCAACACCTGC 65 FBan0010182 FBgn0039091 CG10182 3 3R CG10182 CG10182 CDMC21539 1 26 15 DAC25-E11 23-CG10182-RA_1 CG10182 TCCCAGATAGATGACAACGGACACAATAACCTTGAGGAGCTCAAAGTAACGACTCCAACACCTGC 65 FBan0010182 FBgn0039091 CG10182 3 3R CG10182 CG10182 CDMC21540 1 1 16 DAC25-E23 2-CG10232-RA_1 CG10232 TACCGATTTGTGTGCCGAAAGATCCCATCCCCTTGCATAATCACCCATTGCAAATCGCCGGTTGG 65 FBan0010232 FBgn0039108 CG10232 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG10232 CG10232 SP14 CDMC21540 1 2 16 DAC25-E23 2-CG10232-RA_1 CG10232 TACCGATTTGTGTGCCGAAAGATCCCATCCCCTTGCATAATCACCCATTGCAAATCGCCGGTTGG 65 FBan0010232 FBgn0039108 CG10232 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG10232 CG10232 SP14 CDMC21541 1 3 16 DAC25-I11 1-CG10332-RA_1 CG10332 AATCCGTTCAGGTCTCCAAGCTCACAGCAACGACCACTGTACTACGACGCTCCGATTGGGAAACC 65 FBgn0034881 CG10332 CG10332 CG10332 "CG10332-ORFA, anon-WO0153538.56, anon-WO0153538.57, anon-WO0153538.58, BcDNA:AT19986" CDMC21541 1 4 16 DAC25-I11 1-CG10332-RA_1 CG10332 AATCCGTTCAGGTCTCCAAGCTCACAGCAACGACCACTGTACTACGACGCTCCGATTGGGAAACC 65 FBgn0034881 CG10332 CG10332 CG10332 "CG10332-ORFA, anon-WO0153538.56, anon-WO0153538.57, anon-WO0153538.58, BcDNA:AT19986" CDMC21542 1 5 16 DAC25-I23 2-CG10369-RA_2 CG10369 TGCCATGTCATCGATGAGACCAGCCCGTTGTCTCAGTTCACCACAGCGAAACTCTTCAATGCTGC 65 FBan0010369 FBgn0032706 Irk3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; ; GO:0005242; ; GO:0005242 membrane; GO:0016020 Irk3 Inwardly rectifying potassium channel 3 "CG10369, irk3, dKirIII" CDMC21542 1 6 16 DAC25-I23 2-CG10369-RA_2 CG10369 TGCCATGTCATCGATGAGACCAGCCCGTTGTCTCAGTTCACCACAGCGAAACTCTTCAATGCTGC 65 FBan0010369 FBgn0032706 Irk3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; ; GO:0005242; ; GO:0005242 membrane; GO:0016020 Irk3 Inwardly rectifying potassium channel 3 "CG10369, irk3, dKirIII" CDMC21543 1 7 16 DAC25-M11 1-CG10475-RA_4 CG10475 AGATTGGCGAAAACTCCGTGTGCGAGAACTACTACGGCAGCTTCTCCGGCGACCTAATCTGCATC 65 FBan0010475 FBgn0035667 Jon65Ai 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Ai Jonah 65Ai "CG10475, CG10475, CG10475, CG10475, CG10475, Jon65A, CT29408, SP145, Jonah 65A" CDMC21543 1 8 16 DAC25-M11 1-CG10475-RA_4 CG10475 AGATTGGCGAAAACTCCGTGTGCGAGAACTACTACGGCAGCTTCTCCGGCGACCTAATCTGCATC 65 FBan0010475 FBgn0035667 Jon65Ai 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Ai Jonah 65Ai "CG10475, CG10475, CG10475, CG10475, CG10475, Jon65A, CT29408, SP145, Jonah 65A" CDMC21544 1 9 16 DAC25-M23 2-CG10529-RA_1 CG10529 TTGCTGTCCAGGGATCCTTCCGCTTCGTTGCCGATGATGGCCAGACCTACGAAGTCAACTACATC 65 FBan0010529 FBgn0020640 Lcp65Ae 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ae Lcp65Ae "CG10529, CG10529, CG10529, Lcp-e, DMLCP65e, DCP6" CDMC21544 1 10 16 DAC25-M23 2-CG10529-RA_1 CG10529 TTGCTGTCCAGGGATCCTTCCGCTTCGTTGCCGATGATGGCCAGACCTACGAAGTCAACTACATC 65 FBan0010529 FBgn0020640 Lcp65Ae 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ae Lcp65Ae "CG10529, CG10529, CG10529, Lcp-e, DMLCP65e, DCP6" CDMC21545 1 11 16 DAC26-A11 13-CG6174-RA_1 CG6174 TGGGCGAGGAATGTGAGGGCATTCACGACGTTCTGATGTACTCCATCGAGAAGTCAGATATGGATCTCA 69 FBan0006174 FBgn0011745 Arp87C 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin cytoskeleton; GO:0015629; actin filament; GO:0005884; dynactin complex; GO:0005869 Arp87C Actin-related protein 87C "CG6174, CG6174, arp1, Arp, gdl, gridlock, ARP87C, grid, ARP1, Arp1, Arp-1, Actr87C, Actin-related protein 87C" CDMC21545 1 12 16 DAC26-A11 13-CG6174-RA_1 CG6174 TGGGCGAGGAATGTGAGGGCATTCACGACGTTCTGATGTACTCCATCGAGAAGTCAGATATGGATCTCA 69 FBan0006174 FBgn0011745 Arp87C 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin cytoskeleton; GO:0015629; actin filament; GO:0005884; dynactin complex; GO:0005869 Arp87C Actin-related protein 87C "CG6174, CG6174, arp1, Arp, gdl, gridlock, ARP87C, grid, ARP1, Arp1, Arp-1, Actr87C, Actin-related protein 87C" CDMC21546 1 13 16 DAC26-A23 14-CG6182-RA_5 CG6182 AGCCCTTCATGTGGCTGATAGACCATAAGAAGAAAGCACAGGTCATGCACACCATGTGGCTGATAGAGT 69 FBan0006182 FBgn0039158 CG6182 3 3R CG6182 CG6182 BcDNA:LD17019 CDMC21546 1 14 16 DAC26-A23 14-CG6182-RA_5 CG6182 AGCCCTTCATGTGGCTGATAGACCATAAGAAGAAAGCACAGGTCATGCACACCATGTGGCTGATAGAGT 69 FBan0006182 FBgn0039158 CG6182 3 3R CG6182 CG6182 BcDNA:LD17019 CDMC21547 1 15 16 DAC26-E11 5-CG6210-RB_2 CG6210 CCGGTGAACACATGCTCATTCAGGATGCTCCGAACAAGTCGACCATTCGCTCGCGTTACTGGAAACATC 69 FBan0006210 FBgn0036141 MRP 3 3L biological process unknown; GO:0000004 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0042626" cellular component unknown; GO:0008372 MRP Multidrug-Resistance like Protein 1 "CG6210, dMRP, Multidrug-Resistance like Protein 1" CDMC21547 1 16 16 DAC26-E11 5-CG6210-RB_2 CG6210 CCGGTGAACACATGCTCATTCAGGATGCTCCGAACAAGTCGACCATTCGCTCGCGTTACTGGAAACATC 69 FBan0006210 FBgn0036141 MRP 3 3L biological process unknown; GO:0000004 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0042626" cellular component unknown; GO:0008372 MRP Multidrug-Resistance like Protein 1 "CG6210, dMRP, Multidrug-Resistance like Protein 1" CDMC21548 1 17 16 DAC26-E23 1-CG6219-RD_1 CG6219 TATCAGCGGACGGTATCACGGCAAGATTTGTCCAAAATGCGTGCTTATTCGTCCAACTGAAGTCCGGCC 69 FBan0006219 FBgn0026257 cav 3 3R telomere capping; GO:0016233 satellite DNA binding; GO:0003696; ; GO:0003696 "chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; nuclear chromosome, telomeric region; GO:0000784; nucleus; GO:0005634" cav caravaggio "CG6219, Hoap, 1G5, anon1G5, Anon1G5, HOAP, HP1/ORC-associated protein, anon fe 1G5, p55, anonymous fast evolving gene IG5, anon-EST:fe1G5: anon-fast-evolving-1G5, anon-fast-evolving-1G5, caravaggio" CDMC21548 1 18 16 DAC26-E23 1-CG6219-RD_1 CG6219 TATCAGCGGACGGTATCACGGCAAGATTTGTCCAAAATGCGTGCTTATTCGTCCAACTGAAGTCCGGCC 69 FBan0006219 FBgn0026257 cav 3 3R telomere capping; GO:0016233 satellite DNA binding; GO:0003696; ; GO:0003696 "chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; nuclear chromosome, telomeric region; GO:0000784; nucleus; GO:0005634" cav caravaggio "CG6219, Hoap, 1G5, anon1G5, Anon1G5, HOAP, HP1/ORC-associated protein, anon fe 1G5, p55, anonymous fast evolving gene IG5, anon-EST:fe1G5: anon-fast-evolving-1G5, anon-fast-evolving-1G5, caravaggio" CDMC21549 1 19 16 DAC26-I11 15-CG6259-RA_6 CG6259 GCGGCCATGAAGGATGGAGTCAAGCAGATGAAGACCGAGTACAAGAAGATCAACATCGACCAGATCGAG 69 FBan0006259 FBgn0036740 CG6259 3 3L CG6259 CG6259 "bs36h07.y1, anon-74EFb" CDMC21549 1 20 16 DAC26-I11 15-CG6259-RA_6 CG6259 GCGGCCATGAAGGATGGAGTCAAGCAGATGAAGACCGAGTACAAGAAGATCAACATCGACCAGATCGAG 69 FBan0006259 FBgn0036740 CG6259 3 3L CG6259 CG6259 "bs36h07.y1, anon-74EFb" CDMC21550 1 21 16 DAC26-I23 15-CG6282-RB_1 CG6282 GCGCACCCCTAGATTGTTGCACTCCTTCAAAGTTTACGCTAGTCTCTGTTGAATCCACTGTTGCTCCCC 69 FBan0006282 FBgn0035914 CG6282 3 3L CG6282 CG6282 CDMC21550 1 22 16 DAC26-I23 15-CG6282-RB_1 CG6282 GCGCACCCCTAGATTGTTGCACTCCTTCAAAGTTTACGCTAGTCTCTGTTGAATCCACTGTTGCTCCCC 69 FBan0006282 FBgn0035914 CG6282 3 3L CG6282 CG6282 CDMC21551 1 23 16 DAC26-M11 2-CG6321-RA_1 CG6321 TGCCAACTTCGCAGGACATGTTATCTCCAATGGAAGTTTCTCCAAGATTCTGGGACCGGGAGTTCGCCT 69 FBan0006321 FBgn0036117 CG6321 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008483 ; EC:2.6.1.- CG6321 CG6321 CDMC21551 1 24 16 DAC26-M11 2-CG6321-RA_1 CG6321 TGCCAACTTCGCAGGACATGTTATCTCCAATGGAAGTTTCTCCAAGATTCTGGGACCGGGAGTTCGCCT 69 FBan0006321 FBgn0036117 CG6321 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008483 ; EC:2.6.1.- CG6321 CG6321 CDMC21552 1 25 16 DAC26-M23 8-CG6338-RA_2 CG6338 GGGCAAGGATGTCAAGCCAGTCTTGAATTGGGTCCTGGACAGCAAGTTTAAGCGAGAACAAATACGCCT 69 FBan0006338 FBgn0004510 Ets97D 3 3R pole plasm oskar mRNA localization; GO:0045451; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 Ets97D Ets at 97D "CG6338, tny, tiny, D-elg, D-Elg, DELG, elg, Ets, Elg, tne: tiny eggs, tiny eggs" CDMC21552 1 26 16 DAC26-M23 8-CG6338-RA_2 CG6338 GGGCAAGGATGTCAAGCCAGTCTTGAATTGGGTCCTGGACAGCAAGTTTAAGCGAGAACAAATACGCCT 69 FBan0006338 FBgn0004510 Ets97D 3 3R pole plasm oskar mRNA localization; GO:0045451; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 Ets97D Ets at 97D "CG6338, tny, tiny, D-elg, D-Elg, DELG, elg, Ets, Elg, tne: tiny eggs, tiny eggs" CDMC21553 1 1 17 DAC27-A11 10-CG3689-RB_1 CG3689 TGCTGCGCCATTATTCGAGCTATACGACAACTCGCAAGGATATGGACCCATTATCTCATCTCTGCCGCA 69 FBan0003689 FBgn0035987 CG3689 3 3L "mRNA cleavage; GO:0006379; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA cleavage factor complex; GO:0005849 CG3689 CG3689 CDMC21553 1 2 17 DAC27-A11 10-CG3689-RB_1 CG3689 TGCTGCGCCATTATTCGAGCTATACGACAACTCGCAAGGATATGGACCCATTATCTCATCTCTGCCGCA 69 FBan0003689 FBgn0035987 CG3689 3 3L "mRNA cleavage; GO:0006379; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA cleavage factor complex; GO:0005849 CG3689 CG3689 CDMC21554 1 3 17 DAC27-A23 23-CG3704-RA_6 CG3704 GTGTGTGTTCGTCACTTGCACCTCCGATATTTGGTTTGTATATATGGACTTAGTTTAGCTTTGCAAATT 69 FBan0003704 FBgn0040346 CG3704 X X ATP binding; GO:0005524; ; GO:0005524; purine nucleotide binding; GO:0017076; ; GO:0017076 CG3704 CG3704 EG:BACR7A4.17 CDMC21554 1 4 17 DAC27-A23 23-CG3704-RA_6 CG3704 GTGTGTGTTCGTCACTTGCACCTCCGATATTTGGTTTGTATATATGGACTTAGTTTAGCTTTGCAAATT 69 FBan0003704 FBgn0040346 CG3704 X X ATP binding; GO:0005524; ; GO:0005524; purine nucleotide binding; GO:0017076; ; GO:0017076 CG3704 CG3704 EG:BACR7A4.17 CDMC21555 1 5 17 DAC27-E11 22-CG3738-RA_3 CG3738 CCGAGAAACTCGTACCTAAAAAGCAGTTGCAGTGTTTGCCAATTGATTCAACACCACGGCTAAAGTTGC 69 FBan0003738 FBgn0010314 Cks30A 2 2L positive regulation of mitotic metaphase/anaphase transition; GO:0045842; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0004674; ; GO:0004693 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 Cks30A Cyclin-dependent kinase subunit 30A "CG3738, CDI2, Cks, Cdi2: Cyclin-dependent kinase interactor 2, U40077, cks30A, DmCks1, cdi2, Cyclin-dependent kinase interactor 2, Cdi2, Cyclin-dependent kinase subunit 30A" CDMC21555 1 6 17 DAC27-E11 22-CG3738-RA_3 CG3738 CCGAGAAACTCGTACCTAAAAAGCAGTTGCAGTGTTTGCCAATTGATTCAACACCACGGCTAAAGTTGC 69 FBan0003738 FBgn0010314 Cks30A 2 2L positive regulation of mitotic metaphase/anaphase transition; GO:0045842; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0004674; ; GO:0004693 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 Cks30A Cyclin-dependent kinase subunit 30A "CG3738, CDI2, Cks, Cdi2: Cyclin-dependent kinase interactor 2, U40077, cks30A, DmCks1, cdi2, Cyclin-dependent kinase interactor 2, Cdi2, Cyclin-dependent kinase subunit 30A" CDMC21556 1 7 17 DAC27-E23 23-CG3751-RA_2 CG3751 CAATCAACAACCGACAAAACAAAATCAGTGTTTACTTTTGGAGCGGCTTTTGTTTGTAAACTAAGGAAA 69 FBan0003751 FBgn0034751 RpS24 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS24 Ribosomal protein S24 "CG3751, S24, BcDNA:RE59324, Ribosomal protein S24" CDMC21556 1 8 17 DAC27-E23 23-CG3751-RA_2 CG3751 CAATCAACAACCGACAAAACAAAATCAGTGTTTACTTTTGGAGCGGCTTTTGTTTGTAAACTAAGGAAA 69 FBan0003751 FBgn0034751 RpS24 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS24 Ribosomal protein S24 "CG3751, S24, BcDNA:RE59324, Ribosomal protein S24" CDMC21557 1 9 17 DAC27-I11 16-CG3792-RA_5 CG3792 AGCGCCGCTTACTAATTAAGTACGACCACGACCTCCGAGATAAACAGAAGTCAATTGTTCGCAGCACAA 69 FBan0003792 FBgn0031662 CG3792 2 2L integral to membrane; GO:0016021 CG3792 CG3792 anon-EST:Posey8 CDMC21557 1 10 17 DAC27-I11 16-CG3792-RA_5 CG3792 AGCGCCGCTTACTAATTAAGTACGACCACGACCTCCGAGATAAACAGAAGTCAATTGTTCGCAGCACAA 69 FBan0003792 FBgn0031662 CG3792 2 2L integral to membrane; GO:0016021 CG3792 CG3792 anon-EST:Posey8 CDMC21558 1 11 17 DAC27-I23 2-CG3801-RA_1 CG3801 GCGGGCGAAAACATTGTAGCCATCAGCGGAATGACAGTCACTCCCCTTTGGGCATCTCATTTCCAATCA 69 FBan0003801 FBgn0015586 Acp76A 3 3L negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; hormone binding; GO:0042562; ; GO:0042562 Acp76A Accessory gland-specific peptide 76A "CG3801, CG3801, Accessory gland protein 76A, Acp76, Accessory gland-specific peptide 76A" CDMC21558 1 12 17 DAC27-I23 2-CG3801-RA_1 CG3801 GCGGGCGAAAACATTGTAGCCATCAGCGGAATGACAGTCACTCCCCTTTGGGCATCTCATTTCCAATCA 69 FBan0003801 FBgn0015586 Acp76A 3 3L negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; hormone binding; GO:0042562; ; GO:0042562 Acp76A Accessory gland-specific peptide 76A "CG3801, CG3801, Accessory gland protein 76A, Acp76, Accessory gland-specific peptide 76A" CDMC21559 1 13 17 DAC27-M11 23-CG3842-RB_3 CG3842 GGGAAATGAGCGAAATTGCCACCTGACTGACATCCCCCTAAAAAGTTGTTAGTTGTTATTACAGCATTC 69 FBan0003842 FBgn0029866 CG3842 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3842 CG3842 CDMC21559 1 14 17 DAC27-M11 23-CG3842-RB_3 CG3842 GGGAAATGAGCGAAATTGCCACCTGACTGACATCCCCCTAAAAAGTTGTTAGTTGTTATTACAGCATTC 69 FBan0003842 FBgn0029866 CG3842 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3842 CG3842 CDMC21560 1 15 17 DAC27-M23 23-CG3856-RA_2 CG3856 GCGCAAATAAAAACCATTACCCAGTGCTAAACTAGTAAAGAAGTGTTAATGTTGTACTCTTGGCCCGAG 69 FBan0003856 FBgn0024944 Oamb 3 3R "NOT G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; octopamine/tyramine signaling pathway; GO:0007211; ovulation; GO:0030728" amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0008227; ; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Oamb Octopamine receptor in mushroom bodies "CG3856, CG15698, OAMB, octopamine receptor, octopamine receptor OAMB, OAMB-1a, DmOCT1B, Oamb a, Oamb b, DmOAMB, oamb, Dmoa1, Dm-OAMB, Octopamine receptor in mushroom bodies" CDMC21560 1 16 17 DAC27-M23 23-CG3856-RA_2 CG3856 GCGCAAATAAAAACCATTACCCAGTGCTAAACTAGTAAAGAAGTGTTAATGTTGTACTCTTGGCCCGAG 69 FBan0003856 FBgn0024944 Oamb 3 3R "NOT G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; octopamine/tyramine signaling pathway; GO:0007211; ovulation; GO:0030728" amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0008227; ; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Oamb Octopamine receptor in mushroom bodies "CG3856, CG15698, OAMB, octopamine receptor, octopamine receptor OAMB, OAMB-1a, DmOCT1B, Oamb a, Oamb b, DmOAMB, oamb, Dmoa1, Dm-OAMB, Octopamine receptor in mushroom bodies" CDMC21561 1 17 17 DAC28-A11 1-CG10177-RA_1 CG10177 GGTGGACCCACGTATCCCAAGGATATGGAAAGTGTCATGAGTCCAGAGGCTACCCAGTTGATCGACGGA 69 FBan0010177 FBgn0039083 CG10177 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674 CG10177 CG10177 MLCK-like CDMC21561 1 18 17 DAC28-A11 1-CG10177-RA_1 CG10177 GGTGGACCCACGTATCCCAAGGATATGGAAAGTGTCATGAGTCCAGAGGCTACCCAGTTGATCGACGGA 69 FBan0010177 FBgn0039083 CG10177 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674 CG10177 CG10177 MLCK-like CDMC21562 1 19 17 DAC28-A23 3-CG10189-RA_1 CG10189 CCAGAGCAGTCCTCTTGTGTTCACTGTCGATCTACACTGGACTCCGAACTATCCGACACTCTGCTGGCT 69 FBan0010189 FBgn0032793 CG10189 2 2L CG10189 CG10189 "i199, i180" CDMC21562 1 20 17 DAC28-A23 3-CG10189-RA_1 CG10189 CCAGAGCAGTCCTCTTGTGTTCACTGTCGATCTACACTGGACTCCGAACTATCCGACACTCTGCTGGCT 69 FBan0010189 FBgn0032793 CG10189 2 2L CG10189 CG10189 "i199, i180" CDMC21563 1 21 17 DAC28-E11 5-CG10221-RA_1 CG10221 AGACTCCATCAAGGCATTATCCTATTTCACTCAGGCGGCTGATCAAGGTTGGGTTGATGGGCAACTGCA 69 FBan0010221 FBgn0028475 CG10221 3 3R plasma membrane; GO:0005886 CG10221 CG10221 BcDNA:LD23587 CDMC21563 1 22 17 DAC28-E11 5-CG10221-RA_1 CG10221 AGACTCCATCAAGGCATTATCCTATTTCACTCAGGCGGCTGATCAAGGTTGGGTTGATGGGCAACTGCA 69 FBan0010221 FBgn0028475 CG10221 3 3R plasma membrane; GO:0005886 CG10221 CG10221 BcDNA:LD23587 CDMC21564 1 23 17 DAC28-E23 23-CG10231-RA_9 CG10231 AACTTGTATTGGTCATAACTCTTCAAAAGGTTTTCTAGACAAGTCCGTTGTGGCGAGATTTCTGGATCA 69 FBan0010231 FBgn0032686 Pde11 2 2L cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35; ; GO:0004115 ; EC:3.1.4.-" Pde11 Phosphodiesterase 11 "CG10231, CG10231, CG10231, CG10231, PDE11, Phosphodiesterase 11" CDMC21564 1 24 17 DAC28-E23 23-CG10231-RA_9 CG10231 AACTTGTATTGGTCATAACTCTTCAAAAGGTTTTCTAGACAAGTCCGTTGTGGCGAGATTTCTGGATCA 69 FBan0010231 FBgn0032686 Pde11 2 2L cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35; ; GO:0004115 ; EC:3.1.4.-" Pde11 Phosphodiesterase 11 "CG10231, CG10231, CG10231, CG10231, PDE11, Phosphodiesterase 11" CDMC21565 1 25 17 DAC28-I11 3-CG10264-RA_1 CG10264 CGGCGATTGCTAAATTTCGAGCTGGAACTTCCAAGGCTTAGGATCCGGGCGAAGTACAACCTGAAGGGA 69 FBan0010264 FBgn0038394 CG10264 3 3R CG10264 CG10264 CDMC21565 1 26 17 DAC28-I11 3-CG10264-RA_1 CG10264 CGGCGATTGCTAAATTTCGAGCTGGAACTTCCAAGGCTTAGGATCCGGGCGAAGTACAACCTGAAGGGA 69 FBan0010264 FBgn0038394 CG10264 3 3R CG10264 CG10264 CDMC21566 1 1 18 DAC28-I23 23-CG10274-RA_3 CG10274 AGGAGAACACAGAATACCTATGTGAATTCGACTTAAGTTTAATGATTCTGGTCTGAATGGAGAGGTTGC 69 FBan0010274 FBgn0035690 CG10274 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG10274 CG10274 CDMC21566 1 2 18 DAC28-I23 23-CG10274-RA_3 CG10274 AGGAGAACACAGAATACCTATGTGAATTCGACTTAAGTTTAATGATTCTGGTCTGAATGGAGAGGTTGC 69 FBan0010274 FBgn0035690 CG10274 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG10274 CG10274 CDMC21567 1 3 18 DAC28-M11 23-CG1030-RA_8 CG1030 TCAATCTTAGTTTGTACATTTTCGATTGTGTGTTCAATGCAATTGGTCGGAACCATACTGATTTTCGCA 69 FBan0001030 FBgn0003339 Scr 3 3R "anterior/posterior axis specification; GO:0009948; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; segment specification; GO:0007379; sex comb development; GO:0045498; sex differentiation; GO:0007548; specification of segmental identity, labial segment; GO:0007381" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 Scr Sex combs reduced "CG1030, Msc, Multiple sex comb, scr, SCR, Multi sex combs, sex-combs reduced, BG:DS07876.2, l(3)84Af, Sex combs reduced" CDMC21567 1 4 18 DAC28-M11 23-CG1030-RA_8 CG1030 TCAATCTTAGTTTGTACATTTTCGATTGTGTGTTCAATGCAATTGGTCGGAACCATACTGATTTTCGCA 69 FBan0001030 FBgn0003339 Scr 3 3R "anterior/posterior axis specification; GO:0009948; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; segment specification; GO:0007379; sex comb development; GO:0045498; sex differentiation; GO:0007548; specification of segmental identity, labial segment; GO:0007381" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 Scr Sex combs reduced "CG1030, Msc, Multiple sex comb, scr, SCR, Multi sex combs, sex-combs reduced, BG:DS07876.2, l(3)84Af, Sex combs reduced" CDMC21568 1 5 18 DAC28-M23 18-CG10325-RA_1 CG10325 TGGGATCCCTACTATCCTACTGTCCTTTGTTTTTCAAGTCCCACTGGTCGAGTGATATTCCCGGGTGGC 69 FBan0010325 FBgn0000014 abd-A 3 3R "anterior/posterior axis specification; GO:0009948; apoptosis; GO:0006915; cellular physiological process; GO:0050875; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; heart proper cell fate commitment (sensu Insecta); GO:0035053; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; nervous system development; GO:0007399; oenocyte development; GO:0007438; peripheral nervous system development; GO:0007422; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, abdomen; GO:0007385" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 abd-A abdominal A "CG10325, CG10325, Hab: Hyperabdominal, iab-2, iab-5, abdA, AbdA, abd-a, iab-4, Cbxd: Contrabithoraxoid, iab2: infra-abdominal 2, iab3: infra-abdominal 3, iab4: infra-abdominal 4, Contrabithoraxoid, Hyperabdominal, infra-abdominal 2, infra-abdominal 3, infra-abdominal 4, abd A, Abd-A, abda, DmabdA, iab-3, Abda, Ultraabdominal, abdominal-A, iab: infraabdominal, l(3)89Ec, infraabdominal, iab4, Hab, Cbxd, iab2, iab3" CDMC21568 1 6 18 DAC28-M23 18-CG10325-RA_1 CG10325 TGGGATCCCTACTATCCTACTGTCCTTTGTTTTTCAAGTCCCACTGGTCGAGTGATATTCCCGGGTGGC 69 FBan0010325 FBgn0000014 abd-A 3 3R "anterior/posterior axis specification; GO:0009948; apoptosis; GO:0006915; cellular physiological process; GO:0050875; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; heart proper cell fate commitment (sensu Insecta); GO:0035053; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; nervous system development; GO:0007399; oenocyte development; GO:0007438; peripheral nervous system development; GO:0007422; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, abdomen; GO:0007385" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 abd-A abdominal A "CG10325, CG10325, Hab: Hyperabdominal, iab-2, iab-5, abdA, AbdA, abd-a, iab-4, Cbxd: Contrabithoraxoid, iab2: infra-abdominal 2, iab3: infra-abdominal 3, iab4: infra-abdominal 4, Contrabithoraxoid, Hyperabdominal, infra-abdominal 2, infra-abdominal 3, infra-abdominal 4, abd A, Abd-A, abda, DmabdA, iab-3, Abda, Ultraabdominal, abdominal-A, iab: infraabdominal, l(3)89Ec, infraabdominal, iab4, Hab, Cbxd, iab2, iab3" CDMC21569 1 7 18 DAC29-A11 23-CG13891-RA_1 CG13891 TCTGCCTAAAATGGTCTAGGGAACTTGCTACAAAATCAAGTGTGTATATAATAATGATCTAGAAACCGG 69 FBan0013891 FBgn0035139 CG13891 3 3L CG13891 CG13891 CDMC21569 1 8 18 DAC29-A11 23-CG13891-RA_1 CG13891 TCTGCCTAAAATGGTCTAGGGAACTTGCTACAAAATCAAGTGTGTATATAATAATGATCTAGAAACCGG 69 FBan0013891 FBgn0035139 CG13891 3 3L CG13891 CG13891 CDMC21570 1 9 18 DAC29-A23 6-CG13900-RA_3 CG13900 GCCTGCTGTCAGGTGCTTCACAGAAGTCGGAGAACATTTGCTCCTTCCATGTGGGCGAGATAATCATGT 69 FBan0013900 FBgn0035162 CG13900 3 3L "DNA repair; GO:0006281; mRNA polyadenylylation; GO:0006378; nuclear mRNA splicing, via spliceosome; GO:0000398" poly(A) binding; GO:0008143; damaged DNA binding; GO:0003684; ; GO:0003684; ; GO:0008143 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG13900 CG13900 CDMC21570 1 10 18 DAC29-A23 6-CG13900-RA_3 CG13900 GCCTGCTGTCAGGTGCTTCACAGAAGTCGGAGAACATTTGCTCCTTCCATGTGGGCGAGATAATCATGT 69 FBan0013900 FBgn0035162 CG13900 3 3L "DNA repair; GO:0006281; mRNA polyadenylylation; GO:0006378; nuclear mRNA splicing, via spliceosome; GO:0000398" poly(A) binding; GO:0008143; damaged DNA binding; GO:0003684; ; GO:0003684; ; GO:0008143 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG13900 CG13900 CDMC21571 1 11 18 DAC29-E11 23-CG1395-RA_4 CG1395 ACCAACGAACAAGCAAACGAAAAATGTGCATTATAATCTAAAAACGTGAGGAACCATGTCATTTAAATT 69 FBan0001395 FBgn0003525 stg 3 3R G2/M transition of mitotic cell cycle; GO:0000086; cell cycle; GO:0007049; cellular physiological process; GO:0050875; centriole replication; GO:0007099; gastrulation; GO:0007369; mesoderm development; GO:0007498; peripheral nervous system development; GO:0007422; protein amino acid dephosphorylation; GO:0006470; regulation of mitosis; GO:0007088; tracheal system development (sensu Insecta); GO:0007424 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726 chromosome; GO:0005694; nucleus; GO:0005634 stg string "CG1395, CG5462, CG1395, CG5462, cdc25, Cdc25, S(rux)3A, Suppressor of rux 3A, l(3)01235, Cdc25[String], Cdc25[string], 0224/06, 0245/03, 0439/22, 0730/13, 0896/05, 0967/05, 0980/06, 1083/13, 1089/08, 1143/02, Cdc25[stg], 5473, clone 2.21, SY3-4, cdc25[string], EP1213, String/Cdc25, CDC25[string], stg[cdc25], anon-EST:Liang-2.21, l(3)j10B9, l(3)j1D3, l(3)j1E3, l(3)j3D1, l(3)s2213, string" CDMC21571 1 12 18 DAC29-E11 23-CG1395-RA_4 CG1395 ACCAACGAACAAGCAAACGAAAAATGTGCATTATAATCTAAAAACGTGAGGAACCATGTCATTTAAATT 69 FBan0001395 FBgn0003525 stg 3 3R G2/M transition of mitotic cell cycle; GO:0000086; cell cycle; GO:0007049; cellular physiological process; GO:0050875; centriole replication; GO:0007099; gastrulation; GO:0007369; mesoderm development; GO:0007498; peripheral nervous system development; GO:0007422; protein amino acid dephosphorylation; GO:0006470; regulation of mitosis; GO:0007088; tracheal system development (sensu Insecta); GO:0007424 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726 chromosome; GO:0005694; nucleus; GO:0005634 stg string "CG1395, CG5462, CG1395, CG5462, cdc25, Cdc25, S(rux)3A, Suppressor of rux 3A, l(3)01235, Cdc25[String], Cdc25[string], 0224/06, 0245/03, 0439/22, 0730/13, 0896/05, 0967/05, 0980/06, 1083/13, 1089/08, 1143/02, Cdc25[stg], 5473, clone 2.21, SY3-4, cdc25[string], EP1213, String/Cdc25, CDC25[string], stg[cdc25], anon-EST:Liang-2.21, l(3)j10B9, l(3)j1D3, l(3)j1E3, l(3)j3D1, l(3)s2213, string" CDMC21572 1 13 18 DAC29-E23 2-CG13970-RA_1 CG13970 TCGCCATGTGGACAAAGGCCCGGGAGAGAGATGCCCAAAAGAAGAGAGATAAGCTCCAAAGGAACGTAA 69 FBan0013970 FBgn0032851 CG13970 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13970 CG13970 38B.19 CDMC21572 1 14 18 DAC29-E23 2-CG13970-RA_1 CG13970 TCGCCATGTGGACAAAGGCCCGGGAGAGAGATGCCCAAAAGAAGAGAGATAAGCTCCAAAGGAACGTAA 69 FBan0013970 FBgn0032851 CG13970 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13970 CG13970 38B.19 CDMC21573 1 15 18 DAC29-I11 2-CG14015-RA_3 CG14015 TTCTACAAGGTGTGGAGTCAGTCGAGAGGTGTCTCCCTGCCGGTTCTCTACGTGAGCAATGCCTACAAG 69 FBan0014015 FBgn0031716 CG14015 2 2L "mannan endo-1,6-alpha-mannosidase activity; GO:0008496 ; EC:3.2.1.101; ; GO:0008496 ; EC:3.2.1.101" CG14015 CG14015 CDMC21573 1 16 18 DAC29-I11 2-CG14015-RA_3 CG14015 TTCTACAAGGTGTGGAGTCAGTCGAGAGGTGTCTCCCTGCCGGTTCTCTACGTGAGCAATGCCTACAAG 69 FBan0014015 FBgn0031716 CG14015 2 2L "mannan endo-1,6-alpha-mannosidase activity; GO:0008496 ; EC:3.2.1.101; ; GO:0008496 ; EC:3.2.1.101" CG14015 CG14015 CDMC21574 1 17 18 DAC29-I23 15-CG14026-RB_1 CG14026 AGCAGTTTGAAGAGTTCAAACGGGCTGATATGTATTCAGTGGGTCTCGTTCTGTGGGAGATGACCCGTC 69 FBan0014026 FBgn0003716 tkv 2 2L "BMP signaling pathway; GO:0030509; anterior/posterior pattern formation, imaginal disc; GO:0007448; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; branching morphogenesis; GO:0001763; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; negative regulation of salivary gland determination; GO:0045705; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; protein amino acid phosphorylation; GO:0006468; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor complex assembly; GO:0007181; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing morphogenesis; GO:0007476" "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta binding; GO:0050431; ; GO:0050431; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025; ; GO:0005025" plasma membrane; GO:0005886 tkv thickveins "CG14026, CG14026, str, slater, Brk25D: BMP receptor kinase 25D, dtfr, l(2)04415, Atkv, TKV, thick veins, Brk25D1, Brk25D2, Tkv, thickvein, Atr25D: Activin-A-receptor-25D, Dtfr, STK-A, l(2)25Da, Activin-A-receptor-25D, BMP receptor kinase 25D, Brk25D" CDMC21574 1 18 18 DAC29-I23 15-CG14026-RB_1 CG14026 AGCAGTTTGAAGAGTTCAAACGGGCTGATATGTATTCAGTGGGTCTCGTTCTGTGGGAGATGACCCGTC 69 FBan0014026 FBgn0003716 tkv 2 2L "BMP signaling pathway; GO:0030509; anterior/posterior pattern formation, imaginal disc; GO:0007448; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; branching morphogenesis; GO:0001763; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; negative regulation of salivary gland determination; GO:0045705; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; protein amino acid phosphorylation; GO:0006468; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor complex assembly; GO:0007181; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing morphogenesis; GO:0007476" "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta binding; GO:0050431; ; GO:0050431; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025; ; GO:0005025" plasma membrane; GO:0005886 tkv thickveins "CG14026, CG14026, str, slater, Brk25D: BMP receptor kinase 25D, dtfr, l(2)04415, Atkv, TKV, thick veins, Brk25D1, Brk25D2, Tkv, thickvein, Atr25D: Activin-A-receptor-25D, Dtfr, STK-A, l(2)25Da, Activin-A-receptor-25D, BMP receptor kinase 25D, Brk25D" CDMC21575 1 19 18 DAC29-M11 2-CG14045-RA_3 CG14045 AAACCTCTGTGCTGTCCCTCTCCAGTTGCAAGTGCTTAACCGTCATTCCGGAGGTTACTAGTGAACCGC 69 FBan0014045 FBgn0040387 CG14045 X X protein binding; GO:0005515; ; GO:0005515 CG14045 CG14045 "EG:BACH7M4.1, EG:BACH7M4.2" CDMC21575 1 20 18 DAC29-M11 2-CG14045-RA_3 CG14045 AAACCTCTGTGCTGTCCCTCTCCAGTTGCAAGTGCTTAACCGTCATTCCGGAGGTTACTAGTGAACCGC 69 FBan0014045 FBgn0040387 CG14045 X X protein binding; GO:0005515; ; GO:0005515 CG14045 CG14045 "EG:BACH7M4.1, EG:BACH7M4.2" CDMC21576 1 21 18 DAC29-M23 8-CG14054-RA_1 CG14054 CCCGAGCTTTCGACATCAGTCAGGAACTGTTCGTAACCAGGATGAGGATTAACGACGTGGAGAACGCCT 69 FBan0014054 FBgn0029596 CG14054 X X CG14054 CG14054 BcDNA:AT13882 CDMC21576 1 22 18 DAC29-M23 8-CG14054-RA_1 CG14054 CCCGAGCTTTCGACATCAGTCAGGAACTGTTCGTAACCAGGATGAGGATTAACGACGTGGAGAACGCCT 69 FBan0014054 FBgn0029596 CG14054 X X CG14054 CG14054 BcDNA:AT13882 CDMC21577 1 23 18 DAC30-A11 22-CG15099-RA_4 CG15099 CGCTGTGGCCCATAATCATAGCGGAAATGGTACAGGTGTTTCTACAAATGGAACAAGAGCTCAAATCGG 69 FBan0015099 FBgn0034400 CG15099 2 2R CG15099 CG15099 CDMC21577 1 24 18 DAC30-A11 22-CG15099-RA_4 CG15099 CGCTGTGGCCCATAATCATAGCGGAAATGGTACAGGTGTTTCTACAAATGGAACAAGAGCTCAAATCGG 69 FBan0015099 FBgn0034400 CG15099 2 2R CG15099 CG15099 CDMC21578 1 25 18 DAC30-A23 23-CG15109-RB_1 CG15109 AGGCGATACTGCAAGTGATTATAATGAAACCACTACAATGGACAATACTGCTTCACTGAGCGGAAAAGC 69 FBan0015109 FBgn0034416 CG15109 2 2R CG15109 CG15109 CDMC21578 1 26 18 DAC30-A23 23-CG15109-RB_1 CG15109 AGGCGATACTGCAAGTGATTATAATGAAACCACTACAATGGACAATACTGCTTCACTGAGCGGAAAAGC 69 FBan0015109 FBgn0034416 CG15109 2 2R CG15109 CG15109 CDMC21579 1 1 19 DAC30-E11 12-CG15143-RA_2 CG15143 TGTTCAGTCTTAGAAGCACTCTCGATGTTTCGCATGCCTCAAAATTGGGATCATTTGTCGGCAGGGGCT 69 FBan0015143 FBgn0032647 CG15143 2 2L CG15143 CG15143 CDMC21579 1 2 19 DAC30-E11 12-CG15143-RA_2 CG15143 TGTTCAGTCTTAGAAGCACTCTCGATGTTTCGCATGCCTCAAAATTGGGATCATTTGTCGGCAGGGGCT 69 FBan0015143 FBgn0032647 CG15143 2 2L CG15143 CG15143 CDMC21580 1 3 19 DAC30-E23 14-CG15150-RA_1 CG15150 TCCCAACAAACGGATCAAATCAGATGACGAGGAGTCCAAGAAATCTGTCTTGCCCTACAACTGCCCTGT 69 FBan0015150 FBgn0032660 elfless 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 elfless elfless "CG15150, CG15150, BcDNA:AT24563" CDMC21580 1 4 19 DAC30-E23 14-CG15150-RA_1 CG15150 TCCCAACAAACGGATCAAATCAGATGACGAGGAGTCCAAGAAATCTGTCTTGCCCTACAACTGCCCTGT 69 FBan0015150 FBgn0032660 elfless 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 elfless elfless "CG15150, CG15150, BcDNA:AT24563" CDMC21581 1 5 19 DAC30-I11 3-CG15188-RA_2 CG15188 TCTCGACAATTGTGGATAAGTGCTTCCATGCCAATGCGATGCATTGCCTGAAGGAGAAGGTGCTCACCT 69 FBan0015188 FBgn0037430 Osi20 3 3R Osi20 Osiris 20 "CG15188, CG15188, Osiris, Osiris 20" CDMC21581 1 6 19 DAC30-I11 3-CG15188-RA_2 CG15188 TCTCGACAATTGTGGATAAGTGCTTCCATGCCAATGCGATGCATTGCCTGAAGGAGAAGGTGCTCACCT 69 FBan0015188 FBgn0037430 Osi20 3 3R Osi20 Osiris 20 "CG15188, CG15188, Osiris, Osiris 20" CDMC21582 1 7 19 DAC30-I23 9-CG15203-RA_1 CG15203 AGGATTAGCCACCGGGAGAAGAGGACCACCGAAGCCAAGGATGCAATGAATCTTTCTTAGTTGCAACGT 69 FBan0015203 FBgn0030261 CG15203 X X CG15203 CG15203 CDMC21582 1 8 19 DAC30-I23 9-CG15203-RA_1 CG15203 AGGATTAGCCACCGGGAGAAGAGGACCACCGAAGCCAAGGATGCAATGAATCTTTCTTAGTTGCAACGT 69 FBan0015203 FBgn0030261 CG15203 X X CG15203 CG15203 CDMC21583 1 9 19 DAC30-M11 8-CG15234-RA_1 CG15234 GGTGGTTGAATGGTTGGCTGTAGAGCTTGTGGGTGACGTACGCATGAGTTATGGCTAGTACCTGCATCT 69 FBan0015234 FBgn0040673 CG15234 2 2R CG15234 CG15234 BcDNA:LD10051 CDMC21583 1 10 19 DAC30-M11 8-CG15234-RA_1 CG15234 GGTGGTTGAATGGTTGGCTGTAGAGCTTGTGGGTGACGTACGCATGAGTTATGGCTAGTACCTGCATCT 69 FBan0015234 FBgn0040673 CG15234 2 2R CG15234 CG15234 BcDNA:LD10051 CDMC21584 1 11 19 DAC30-M23 15-CG15253-RA_3 CG15253 CCACATCGTGAGCGCTATTCAGAAAATCGAATCCATTTCATGCCTGACCTTCAAAGAGGCCACCACTGA 69 FBan0015253 FBgn0028948 CG15253 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15253 CG15253 "BG:BACR44L22.3, BACR44L22.3" CDMC21584 1 12 19 DAC30-M23 15-CG15253-RA_3 CG15253 CCACATCGTGAGCGCTATTCAGAAAATCGAATCCATTTCATGCCTGACCTTCAAAGAGGCCACCACTGA 69 FBan0015253 FBgn0028948 CG15253 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15253 CG15253 "BG:BACR44L22.3, BACR44L22.3" CDMC21585 1 13 19 DAC31-A11 18-CG12523-RA_2 CG12523 AGGTGGTGCTGAAGCTGTGAAGATCATCAAAATCATCTCGGAATCGAATTCTGGAGCTGGAGACTCC 67 FBan0012523 FBgn0036102 CG12523 3 3L CG12523 CG12523 BcDNA:RE74758 CDMC21585 1 14 19 DAC31-A11 18-CG12523-RA_2 CG12523 AGGTGGTGCTGAAGCTGTGAAGATCATCAAAATCATCTCGGAATCGAATTCTGGAGCTGGAGACTCC 67 FBan0012523 FBgn0036102 CG12523 3 3L CG12523 CG12523 BcDNA:RE74758 CDMC21586 1 15 19 DAC31-A23 1-CG12746-RA_1 CG12746 ATCGGGAAGCAGTCAAGTTGAAACCACGTCGGGATTAACGCCACCAGACTAACAACGAGTGGATGCC 67 FBan0012746 FBgn0037341 CG12746 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG12746 CG12746 WUN-like CDMC21586 1 16 19 DAC31-A23 1-CG12746-RA_1 CG12746 ATCGGGAAGCAGTCAAGTTGAAACCACGTCGGGATTAACGCCACCAGACTAACAACGAGTGGATGCC 67 FBan0012746 FBgn0037341 CG12746 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG12746 CG12746 WUN-like CDMC21587 1 17 19 DAC31-E11 11-CG13142-RA_4 CG13142 AGGAAATCATTCAGACAGCCAACGATATCAGCAAGGGACATGAAGACCGCCGTACAAACTCCACGGA 67 FBan0013142 FBgn0032251 CG13142 2 2L CG13142 CG13142 CDMC21587 1 18 19 DAC31-E11 11-CG13142-RA_4 CG13142 AGGAAATCATTCAGACAGCCAACGATATCAGCAAGGGACATGAAGACCGCCGTACAAACTCCACGGA 67 FBan0013142 FBgn0032251 CG13142 2 2L CG13142 CG13142 CDMC21588 1 19 19 DAC31-E23 13-CG13315-RA_1 CG13315 ACACACACAACAATATCCCCAAGATGTCTGCCACTAAGGTGAACCATTTGATCGGAGCGACTACGCG 67 FBan0013315 FBgn0040827 CG13315 3 3L CG13315 CG13315 BcDNA:RH39779 CDMC21588 1 20 19 DAC31-E23 13-CG13315-RA_1 CG13315 ACACACACAACAATATCCCCAAGATGTCTGCCACTAAGGTGAACCATTTGATCGGAGCGACTACGCG 67 FBan0013315 FBgn0040827 CG13315 3 3L CG13315 CG13315 BcDNA:RH39779 CDMC21589 1 21 19 DAC31-I11 17-CG13596-RA_1 CG13596 ACTGGAATTCCTGTTGCAAAACCTCTCATCCTCCCGACCAGAGTATGAATATTTCATGTCGCCCTCC 67 FBgn0035052 CDMC21589 1 22 19 DAC31-I11 17-CG13596-RA_1 CG13596 ACTGGAATTCCTGTTGCAAAACCTCTCATCCTCCCGACCAGAGTATGAATATTTCATGTCGCCCTCC 67 FBgn0035052 CDMC21590 1 23 19 DAC31-I23 1-CG13673-RA_1 CG13673 CGACAAGGATGACGAGGACATGGTCGTAGATATGGACTTGCTGGGAGGGTGGTCACAGAGTCGTTGA 67 FBan0013673 FBgn0040831 CG13673 3 3L CG13673 CG13673 CDMC21590 1 24 19 DAC31-I23 1-CG13673-RA_1 CG13673 CGACAAGGATGACGAGGACATGGTCGTAGATATGGACTTGCTGGGAGGGTGGTCACAGAGTCGTTGA 67 FBan0013673 FBgn0040831 CG13673 3 3L CG13673 CG13673 CDMC21591 1 25 19 DAC31-M11 1-CG14011-RA_2 CG14011 AGAGAGATGGGGGCTCGTGTACTGCTACCGCGAAGAAAGGGTTCCAGGACTTTCATCAAGACCTGTG 67 FBan0014011 FBgn0031722 CG14011 2 2L CG14011 CG14011 CDMC21591 1 26 19 DAC31-M11 1-CG14011-RA_2 CG14011 AGAGAGATGGGGGCTCGTGTACTGCTACCGCGAAGAAAGGGTTCCAGGACTTTCATCAAGACCTGTG 67 FBan0014011 FBgn0031722 CG14011 2 2L CG14011 CG14011 CDMC21592 1 1 20 DAC31-M23 15-CG14248-RA_1 CG14248 GCAGTACGCCGACTACAAGACTTACTCAGTGAAAGTTGAGGTGGAGCGACAATTGGCCTCCTCTACG 67 FBan0014248 FBgn0039445 CG14248 3 3R CG14248 CG14248 CDMC21592 1 2 20 DAC31-M23 15-CG14248-RA_1 CG14248 GCAGTACGCCGACTACAAGACTTACTCAGTGAAAGTTGAGGTGGAGCGACAATTGGCCTCCTCTACG 67 FBan0014248 FBgn0039445 CG14248 3 3R CG14248 CG14248 CDMC21593 1 3 20 DAC32-A11 2-CG31706-RA_2 CG31706 CCCATCATGCTAAACGAAACAGATCCCGAAAACTCGGAGGTGATGCGAGAAGTGGAACGGGTCGTTTGC 69 FBan0031706 FBgn0051706 CG31706 2 2L CG31706 CG31706 CG6528 CDMC21593 1 4 20 DAC32-A11 2-CG31706-RA_2 CG31706 CCCATCATGCTAAACGAAACAGATCCCGAAAACTCGGAGGTGATGCGAGAAGTGGAACGGGTCGTTTGC 69 FBan0031706 FBgn0051706 CG31706 2 2L CG31706 CG31706 CG6528 CDMC21594 1 5 20 DAC32-A23 7-CG31718-RA_1 CG31718 GGGCGGATTGCTTAGTTCTTCAGATCAGGGTCCCTCTACAGTCGACGAAATAACTGCAAGCCCCTTGAA 69 FBan0031718 FBgn0051718 CG31718 2 2L glutamate receptor activity; GO:0008066; ; GO:0008066 CG31718 CG31718 CDMC21594 1 6 20 DAC32-A23 7-CG31718-RA_1 CG31718 GGGCGGATTGCTTAGTTCTTCAGATCAGGGTCCCTCTACAGTCGACGAAATAACTGCAAGCCCCTTGAA 69 FBan0031718 FBgn0051718 CG31718 2 2L glutamate receptor activity; GO:0008066; ; GO:0008066 CG31718 CG31718 CDMC21595 1 7 20 DAC32-E11 5-CG31744-RA_1 CG31744 AGGTGAGGTTCAGAGCCAACTACAATCGATGGTGGGTCAACTTGATGAGGTATTTGGCATGCAAGGGCT 69 FBan0031744 FBgn0045486 Gr36b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36b Gustatory receptor 36b "CG15137, CG31744, CG15137, CG15137, Gr36B2, Gustatory receptor 36B2, Gr36B.2, Gustatory receptor 36b" CDMC21595 1 8 20 DAC32-E11 5-CG31744-RA_1 CG31744 AGGTGAGGTTCAGAGCCAACTACAATCGATGGTGGGTCAACTTGATGAGGTATTTGGCATGCAAGGGCT 69 FBan0031744 FBgn0045486 Gr36b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36b Gustatory receptor 36b "CG15137, CG31744, CG15137, CG15137, Gr36B2, Gustatory receptor 36B2, Gr36B.2, Gustatory receptor 36b" CDMC21596 1 9 20 DAC32-E23 16-CG31752-RA_1 CG31752 TCAGCGCATGTATCTGAACACTCTGAAAGACGAAATGTCCCTCATGGAGTATCTAGTTACGGTCCCGGA 69 FBan0031752 FBgn0051752 CG31752 2 2L CG31752 CG31752 CG10599 CDMC21596 1 10 20 DAC32-E23 16-CG31752-RA_1 CG31752 TCAGCGCATGTATCTGAACACTCTGAAAGACGAAATGTCCCTCATGGAGTATCTAGTTACGGTCCCGGA 69 FBan0031752 FBgn0051752 CG31752 2 2L CG31752 CG31752 CG10599 CDMC21597 1 11 20 DAC32-I11 10-CG31778-RA_1 CG31778 CCCTGGGCATATTTTTCGATCCGGAGACACAACGTTGTCGCTACATGGGATGCAGTAATCGAAAGCTGT 69 FBan0031778 FBgn0051778 CG31778 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31778 CG31778 BcDNA:HL03084 CDMC21597 1 12 20 DAC32-I11 10-CG31778-RA_1 CG31778 CCCTGGGCATATTTTTCGATCCGGAGACACAACGTTGTCGCTACATGGGATGCAGTAATCGAAAGCTGT 69 FBan0031778 FBgn0051778 CG31778 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31778 CG31778 BcDNA:HL03084 CDMC21598 1 13 20 DAC32-I23 23-CG31788-RA_3 CG31788 ATGGCAAGGATGATGCTTTCATTCGTTTCATGAAGCAGAACATTTAGCAAAGTTAACAAAATTGGAAAA 69 FBan0031788 FBgn0051788 CG31788 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31788 CG31788 CDMC21598 1 14 20 DAC32-I23 23-CG31788-RA_3 CG31788 ATGGCAAGGATGATGCTTTCATTCGTTTCATGAAGCAGAACATTTAGCAAAGTTAACAAAATTGGAAAA 69 FBan0031788 FBgn0051788 CG31788 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31788 CG31788 CDMC21599 1 15 20 DAC32-M11 15-CG31817-RA_2 CG31817 AGGCAGGCGCTTCAAAATCAAGGGAACTCGCATGTATTCAAGGAACGGAAAATTCCCAGGAAAAGTCCA 69 FBan0031817 FBgn0028899 CG31817 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31817 CG31817 "BG:DS02740.18, DS02740.18, anon-WO03042407.98, anon-WO03042407.99" CDMC21599 1 16 20 DAC32-M11 15-CG31817-RA_2 CG31817 AGGCAGGCGCTTCAAAATCAAGGGAACTCGCATGTATTCAAGGAACGGAAAATTCCCAGGAAAAGTCCA 69 FBan0031817 FBgn0028899 CG31817 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31817 CG31817 "BG:DS02740.18, DS02740.18, anon-WO03042407.98, anon-WO03042407.99" CDMC21600 1 17 20 DAC32-M23 7-CG31823-RA_1 CG31823 ACCAAATTGCTGGAAGAGACGCCGATACAGGTGGGTATTTATTCTGGCATTCTGGACCTACTGTGCGCA 69 FBan0031823 FBgn0051823 CG31823 2 2L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG31823 CG31823 "CG7647, BG:DS00365.3" CDMC21600 1 18 20 DAC32-M23 7-CG31823-RA_1 CG31823 ACCAAATTGCTGGAAGAGACGCCGATACAGGTGGGTATTTATTCTGGCATTCTGGACCTACTGTGCGCA 69 FBan0031823 FBgn0051823 CG31823 2 2L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG31823 CG31823 "CG7647, BG:DS00365.3" CDMC21601 1 19 20 DAC33-A11 9-CG15517-RA_1 CG15517 GCAGCTGCTGCCAGAGTGTTTCGGTTGATCTCCTTAGTCAAAATAGTACCGTCTGCCTCACTTTGGGCA 69 FBan0015517 FBgn0039718 CG15517 3 3R CG15517 CG15517 CDMC21601 1 20 20 DAC33-A11 9-CG15517-RA_1 CG15517 GCAGCTGCTGCCAGAGTGTTTCGGTTGATCTCCTTAGTCAAAATAGTACCGTCTGCCTCACTTTGGGCA 69 FBan0015517 FBgn0039718 CG15517 3 3R CG15517 CG15517 CDMC21602 1 21 20 DAC33-A23 23-CG15532-RA_1 CG15532 GGCCGTATACGAGCCAACTCTCCTGAAGCGAGTGTTTTAGTTTTTTAAAATCATTTGATTTTTTTTATA 69 FBan0015532 FBgn0010113 hdc 3 3R "cell differentiation; GO:0030154; negative regulation of terminal cell fate specification; GO:0035155; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424" cytoplasm; GO:0005737 hdc headcase "CG15532, l(3)B4-3-20, Fusion-6, Hdc" CDMC21602 1 22 20 DAC33-A23 23-CG15532-RA_1 CG15532 GGCCGTATACGAGCCAACTCTCCTGAAGCGAGTGTTTTAGTTTTTTAAAATCATTTGATTTTTTTTATA 69 FBan0015532 FBgn0010113 hdc 3 3R "cell differentiation; GO:0030154; negative regulation of terminal cell fate specification; GO:0035155; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424" cytoplasm; GO:0005737 hdc headcase "CG15532, l(3)B4-3-20, Fusion-6, Hdc" CDMC21603 1 23 20 DAC33-E11 3-CG15573-RB_8 CG15573 AGTCCGAGGAAGTCACTGAAAAACCCAGCCGAAAGACCTACGAACGCAAGAGCTACGACAGACGAACCT 69 FBan0015573 FBgn0041252 Femcoat X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 cytoplasm; GO:0005737 Femcoat Femcoat "CG15573, FEMCOAT, Femcoat" CDMC21603 1 24 20 DAC33-E11 3-CG15573-RB_8 CG15573 AGTCCGAGGAAGTCACTGAAAAACCCAGCCGAAAGACCTACGAACGCAAGAGCTACGACAGACGAACCT 69 FBan0015573 FBgn0041252 Femcoat X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 cytoplasm; GO:0005737 Femcoat Femcoat "CG15573, FEMCOAT, Femcoat" CDMC21604 1 25 20 DAC33-E23 3-CG15590-RA_1 CG15590 CGGTGCCACGCTATATTGTCGCGGTGAACGAGCTCTGCGAAATGTCTTGCGGAATTTAAATCGCAGTGA 69 FBan0015590 FBgn0037413 Osi5 3 3R Osi5 Osiris 5 "CG15590, CG15590, CG15590, Osiris, Osiris 5" CDMC21604 1 26 20 DAC33-E23 3-CG15590-RA_1 CG15590 CGGTGCCACGCTATATTGTCGCGGTGAACGAGCTCTGCGAAATGTCTTGCGGAATTTAAATCGCAGTGA 69 FBan0015590 FBgn0037413 Osi5 3 3R Osi5 Osiris 5 "CG15590, CG15590, CG15590, Osiris, Osiris 5" CDMC21605 1 1 21 DAC33-I11 12-CG15629-RA_1 CG15629 ACGAGAGTTTGCTCACCGATCTGAAGGCCCATGGCTATGATCAAATCCAAATGAGTTTGATCTGCCCGT 69 FBan0015629 FBgn0031630 CG15629 2 2L metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG15629 CG15629 CDMC21605 1 2 21 DAC33-I11 12-CG15629-RA_1 CG15629 ACGAGAGTTTGCTCACCGATCTGAAGGCCCATGGCTATGATCAAATCCAAATGAGTTTGATCTGCCCGT 69 FBan0015629 FBgn0031630 CG15629 2 2L metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG15629 CG15629 CDMC21606 1 3 21 DAC33-I23 3-CG15642-RA_1 CG15642 CCGTGTTCGCGCTAATAGTTCTCGAGGTGATCGTGTCTCTGGTGCACTTTGTTATCTGCAAGCCAGGCT 69 FBan0015642 FBgn0030642 CG15642 X X CG15642 CG15642 CDMC21606 1 4 21 DAC33-I23 3-CG15642-RA_1 CG15642 CCGTGTTCGCGCTAATAGTTCTCGAGGTGATCGTGTCTCTGGTGCACTTTGTTATCTGCAAGCCAGGCT 69 FBan0015642 FBgn0030642 CG15642 X X CG15642 CG15642 CDMC21607 1 5 21 DAC33-M11 22-CG15704-RA_1 CG15704 CGCCTGTGAACACGGTGAACTTAAGCATTAGAGGTTTAAGCTTATCAGGATATAGGAGTGCACCCAGCT 69 FBan0015704 FBgn0034103 CG15704 2 2R CG15704 CG15704 BcDNA:RH57845 CDMC21607 1 6 21 DAC33-M11 22-CG15704-RA_1 CG15704 CGCCTGTGAACACGGTGAACTTAAGCATTAGAGGTTTAAGCTTATCAGGATATAGGAGTGCACCCAGCT 69 FBan0015704 FBgn0034103 CG15704 2 2R CG15704 CG15704 BcDNA:RH57845 CDMC21608 1 7 21 DAC33-M23 23-CG15715-RA_6 CG15715 ATAATTTCGGGTAGCAAATCACTACTTACTTTACAACGAGTTTTGCTCAAATTCGAAGCTGCATCACCT 69 FBan0015715 FBgn0036538 CG15715 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15715 CG15715 BcDNA:RE26825 CDMC21608 1 8 21 DAC33-M23 23-CG15715-RA_6 CG15715 ATAATTTCGGGTAGCAAATCACTACTTACTTTACAACGAGTTTTGCTCAAATTCGAAGCTGCATCACCT 69 FBan0015715 FBgn0036538 CG15715 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15715 CG15715 BcDNA:RE26825 CDMC21609 1 9 21 DAC34-A11 3-CG31133-RA_4 CG31133 TGCGTTGCGTTCTCCTGGAAGCAAATGCGACACCCTTATCCGACTATCATCTGGTTCAGGAAGAGCACC 69 FBan0031133 FBgn0051133 CG31133 3 3R seryl-tRNA aminoacylation; GO:0006434 ATP binding; GO:0005524; ; GO:0005524; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 CG31133 CG31133 BcDNA:LD24627 CDMC21609 1 10 21 DAC34-A11 3-CG31133-RA_4 CG31133 TGCGTTGCGTTCTCCTGGAAGCAAATGCGACACCCTTATCCGACTATCATCTGGTTCAGGAAGAGCACC 69 FBan0031133 FBgn0051133 CG31133 3 3R seryl-tRNA aminoacylation; GO:0006434 ATP binding; GO:0005524; ; GO:0005524; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 CG31133 CG31133 BcDNA:LD24627 CDMC21610 1 11 21 DAC34-A23 5-CG31145-RB_1 CG31145 GGCGACCGGAGTGAGCCCACACAACATCCTAGAGCATTAGATTAAATCCCCTAGCTGTTAGTCGCGTGT 69 FBan0031145 FBgn0051145 CG31145 3 3R CG31145 CG31145 "CG13820, CG10187, CG13821, CG13820" CDMC21610 1 12 21 DAC34-A23 5-CG31145-RB_1 CG31145 GGCGACCGGAGTGAGCCCACACAACATCCTAGAGCATTAGATTAAATCCCCTAGCTGTTAGTCGCGTGT 69 FBan0031145 FBgn0051145 CG31145 3 3R CG31145 CG31145 "CG13820, CG10187, CG13821, CG13820" CDMC21611 1 13 21 DAC34-E11 23-CG31174-RA_15 CG31174 ATTCGATGAAGATTTTGTGATGCATATGGAACCTGAGATCAAGGTGGAATGCTCTGTTGATGATCCCAA 69 FBan0031174 FBgn0051174 CG31174 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31174 CG31174 BcDNA:SD11171 CDMC21611 1 14 21 DAC34-E11 23-CG31174-RA_15 CG31174 ATTCGATGAAGATTTTGTGATGCATATGGAACCTGAGATCAAGGTGGAATGCTCTGTTGATGATCCCAA 69 FBan0031174 FBgn0051174 CG31174 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31174 CG31174 BcDNA:SD11171 CDMC21612 1 15 21 DAC34-E23 23-CG31184-RA_2 CG31184 TTCAGTGGTGCAACTTATAAACAGCGTTTTGTGTTTCGCAAAATAATATACAATTTTCAGTCAGTAAGT 69 FBan0031184 FBgn0051184 CG31184 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688 CG31184 CG31184 "CG5926, CG5926, CG5926, BcDNA:RE11655" CDMC21612 1 16 21 DAC34-E23 23-CG31184-RA_2 CG31184 TTCAGTGGTGCAACTTATAAACAGCGTTTTGTGTTTCGCAAAATAATATACAATTTTCAGTCAGTAAGT 69 FBan0031184 FBgn0051184 CG31184 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688 CG31184 CG31184 "CG5926, CG5926, CG5926, BcDNA:RE11655" CDMC21613 1 17 21 DAC34-I11 23-CG31209-RA_1 CG31209 CTACTAGACTGCACCTAATCTCTGTTTAGTCATAGGCTAACCATTTTTTCCCCTCTCCTGCGAAACGGA 69 FBan0031209 FBgn0051209 CG31209 3 3R CG31209 CG31209 "CG5035, CG15682, CG15683, CG5035, BcDNA:AT13703" CDMC21613 1 18 21 DAC34-I11 23-CG31209-RA_1 CG31209 CTACTAGACTGCACCTAATCTCTGTTTAGTCATAGGCTAACCATTTTTTCCCCTCTCCTGCGAAACGGA 69 FBan0031209 FBgn0051209 CG31209 3 3R CG31209 CG31209 "CG5035, CG15682, CG15683, CG5035, BcDNA:AT13703" CDMC21614 1 19 21 DAC34-I23 23-CG31217-RA_1 CG31217 TCAAAGGGCAATTGTGTATTAGGTTATTTCAAGTCAGTTCTTTGTAAAGGACAATTGCCAATTGCCACA 69 FBan0031217 FBgn0051217 CG31217 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; proteolysis; GO:0006508; receptor mediated endocytosis; GO:0006898 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; low-density lipoprotein receptor activity; GO:0005041; scavenger receptor activity; GO:0005044; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0005044; ; GO:0005041; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31217 CG31217 "CG17557, CG10100, X, LDL, W, Serine protease-like, predicted gene X, low density lipoprotein receptor-like 'a' repeats, predicted gene W, CT28389, Ser89E, SP53, SP172, Ldlr, Serine protease like 89E" CDMC21614 1 20 21 DAC34-I23 23-CG31217-RA_1 CG31217 TCAAAGGGCAATTGTGTATTAGGTTATTTCAAGTCAGTTCTTTGTAAAGGACAATTGCCAATTGCCACA 69 FBan0031217 FBgn0051217 CG31217 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; proteolysis; GO:0006508; receptor mediated endocytosis; GO:0006898 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; low-density lipoprotein receptor activity; GO:0005041; scavenger receptor activity; GO:0005044; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0005044; ; GO:0005041; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31217 CG31217 "CG17557, CG10100, X, LDL, W, Serine protease-like, predicted gene X, low density lipoprotein receptor-like 'a' repeats, predicted gene W, CT28389, Ser89E, SP53, SP172, Ldlr, Serine protease like 89E" CDMC21615 1 21 21 DAC34-M11 15-CG31253-RA_2 CG31253 AGCCAAGGAATACATCAAGAACCACAAGCCTTACAAAGCCAAAATCTACACACCCTACAAGCCGCGCAT 69 FBan0031253 FBgn0051253 CG31253 3 3R CG31253 CG31253 BcDNA:RE50074 CDMC21615 1 22 21 DAC34-M11 15-CG31253-RA_2 CG31253 AGCCAAGGAATACATCAAGAACCACAAGCCTTACAAAGCCAAAATCTACACACCCTACAAGCCGCGCAT 69 FBan0031253 FBgn0051253 CG31253 3 3R CG31253 CG31253 BcDNA:RE50074 CDMC21616 1 23 21 DAC34-M23 11-CG31269-RA_1 CG31269 TGTTGGGTCTTTCGGGACTCGTATCCATAACAGCCATACGAATCAAGGGAAACTCAACGGATGGTCGGT 69 FBan0031269 FBgn0051269 CG31269 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31269 CG31269 "CG5233, SP126" CDMC21616 1 24 21 DAC34-M23 11-CG31269-RA_1 CG31269 TGTTGGGTCTTTCGGGACTCGTATCCATAACAGCCATACGAATCAAGGGAAACTCAACGGATGGTCGGT 69 FBan0031269 FBgn0051269 CG31269 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31269 CG31269 "CG5233, SP126" CDMC21617 1 25 21 DAC35-A11 3-CG7841-RA_2 CG7841 GGGGACGTCGCCTCTTCCAGAACATAACCAAAAGCCTGTAGGACCGATCGCATGGGATCGAATGAG 66 FBan0007841 FBgn0036502 CG7841 3 3L CG7841 CG7841 CDMC21617 1 26 21 DAC35-A11 3-CG7841-RA_2 CG7841 GGGGACGTCGCCTCTTCCAGAACATAACCAAAAGCCTGTAGGACCGATCGCATGGGATCGAATGAG 66 FBan0007841 FBgn0036502 CG7841 3 3L CG7841 CG7841 CDMC21618 1 1 22 DAC35-A23 2-CG7979-RA_1 CG7979 TGGGGACATGTAAACCCTATTGGACCGAGAGCCTGTTATGACGAGGGAAAGCGTGTCTCCGAGACG 66 FBan0007979 FBgn0035848 CG7979 3 3L RNA processing; GO:0006396; carbohydrate metabolism; GO:0005975; nucleotide-sugar metabolism; GO:0009225 "mRNA binding; GO:0003729; dTDP-glucose 4,6-dehydratase activity; GO:0008460 ; EC:4.2.1.46; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0008460 ; EC:4.2.1.46; ; GO:0000175 ; EC:3.1.13.-" CG7979 CG7979 CDMC21618 1 2 22 DAC35-A23 2-CG7979-RA_1 CG7979 TGGGGACATGTAAACCCTATTGGACCGAGAGCCTGTTATGACGAGGGAAAGCGTGTCTCCGAGACG 66 FBan0007979 FBgn0035848 CG7979 3 3L RNA processing; GO:0006396; carbohydrate metabolism; GO:0005975; nucleotide-sugar metabolism; GO:0009225 "mRNA binding; GO:0003729; dTDP-glucose 4,6-dehydratase activity; GO:0008460 ; EC:4.2.1.46; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0008460 ; EC:4.2.1.46; ; GO:0000175 ; EC:3.1.13.-" CG7979 CG7979 CDMC21619 1 3 22 DAC35-E11 2-CG8357-RA_2 CG8357 CAACCTCTGCAACGTGTCCGTGATGAACGATGCCGATCTGGACTCACTCTCCAACATGGATCCCAA 66 FBan0008357 FBgn0024732 Rep1 2 2R DNA fragmentation during apoptosis; GO:0006309; anti-apoptosis; GO:0006916; regulation of apoptosis; GO:0042981 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 Rep1 Rep1 "CG8357, DREP-1, drep1, DREP-1/dICAD, dICAD, ICAD, ICAD/DREP-1, Drep1" CDMC21619 1 4 22 DAC35-E11 2-CG8357-RA_2 CG8357 CAACCTCTGCAACGTGTCCGTGATGAACGATGCCGATCTGGACTCACTCTCCAACATGGATCCCAA 66 FBan0008357 FBgn0024732 Rep1 2 2R DNA fragmentation during apoptosis; GO:0006309; anti-apoptosis; GO:0006916; regulation of apoptosis; GO:0042981 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 Rep1 Rep1 "CG8357, DREP-1, drep1, DREP-1/dICAD, dICAD, ICAD, ICAD/DREP-1, Drep1" CDMC21620 1 5 22 DAC35-E23 17-CG8497-RA_1 CG8497 ACGAGGAGCACGATGGTGGATACAATCTGTACAAGGAGGAGTTTGAGAACTTTGGCTTCCATGTGC 66 FBan0008497 FBgn0026374 Rhp X X cytoskeleton organization and biogenesis; GO:0007010; signal transduction; GO:0007165 GTP-Rho binding; GO:0017049; ; GO:0017049; ; GO:0017049; ; GO:0017049; small GTPase regulator activity; GO:0005083; ; GO:0005083 intracellular; GO:0005622 Rhp Rhophilin "CG8497, CG8497, Rhophilin" CDMC21620 1 6 22 DAC35-E23 17-CG8497-RA_1 CG8497 ACGAGGAGCACGATGGTGGATACAATCTGTACAAGGAGGAGTTTGAGAACTTTGGCTTCCATGTGC 66 FBan0008497 FBgn0026374 Rhp X X cytoskeleton organization and biogenesis; GO:0007010; signal transduction; GO:0007165 GTP-Rho binding; GO:0017049; ; GO:0017049; ; GO:0017049; ; GO:0017049; small GTPase regulator activity; GO:0005083; ; GO:0005083 intracellular; GO:0005622 Rhp Rhophilin "CG8497, CG8497, Rhophilin" CDMC21621 1 7 22 DAC35-I11 17-CG9135-RB_4 CG9135 GTCGCCCAAAAAGGTCGTTTTGTACATAGAGAAGAGCAAGGAGGGTCATGTAACGCCAGTCGATGG 66 FBan0009135 FBgn0031769 CG9135 2 2L proteolysis; GO:0006508 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG9135 CG9135 CDMC21621 1 8 22 DAC35-I11 17-CG9135-RB_4 CG9135 GTCGCCCAAAAAGGTCGTTTTGTACATAGAGAAGAGCAAGGAGGGTCATGTAACGCCAGTCGATGG 66 FBan0009135 FBgn0031769 CG9135 2 2L proteolysis; GO:0006508 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG9135 CG9135 CDMC21622 1 9 22 DAC35-I23 15-CG9283-RA_1 CG9283 TGGAGCCACCACGAGGAACCCAAACACCATCCCAAATACGAATTCAATTACGGGGTGAAGGACACC 66 FBan0009283 FBgn0036878 CG9283 3 3L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 CG9283 CG9283 CDMC21622 1 10 22 DAC35-I23 15-CG9283-RA_1 CG9283 TGGAGCCACCACGAGGAACCCAAACACCATCCCAAATACGAATTCAATTACGGGGTGAAGGACACC 66 FBan0009283 FBgn0036878 CG9283 3 3L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 CG9283 CG9283 CDMC21623 1 11 22 DAC35-M11 9-CG9770-RA_1 CG9770 GGACGCCACTTCTTCTACAACTGGAACTGTTTCCTCAACATCGCTCTGGATCACATGTCCGCCGGG 66 FBan0009770 FBgn0037605 CG9770 3 3R CG9770 CG9770 CDMC21623 1 12 22 DAC35-M11 9-CG9770-RA_1 CG9770 GGACGCCACTTCTTCTACAACTGGAACTGTTTCCTCAACATCGCTCTGGATCACATGTCCGCCGGG 66 FBan0009770 FBgn0037605 CG9770 3 3R CG9770 CG9770 CDMC21624 1 13 22 DAC35-M23 2-CG9940-RA_2 CG9940 GGCGGTCTCTCCAAGAAGCCCAGTGGTTACTCAAAGGTGCACGTCAATGTGCTTGGCAAGATCAAG 66 FBan0009940 FBgn0030512 CG9940 X X NAD biosynthesis; GO:0009435; amino acid catabolism; GO:0009063; nitrogen compound metabolism; GO:0006807 "ATP binding; GO:0005524; ; GO:0005524; NAD+ synthase (glutamine-hydrolyzing) activity; GO:0003952 ; EC:6.3.5.1; ; GO:0003952 ; EC:6.3.5.1; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" CG9940 CG9940 Q9VYA0 CDMC21624 1 14 22 DAC35-M23 2-CG9940-RA_2 CG9940 GGCGGTCTCTCCAAGAAGCCCAGTGGTTACTCAAAGGTGCACGTCAATGTGCTTGGCAAGATCAAG 66 FBan0009940 FBgn0030512 CG9940 X X NAD biosynthesis; GO:0009435; amino acid catabolism; GO:0009063; nitrogen compound metabolism; GO:0006807 "ATP binding; GO:0005524; ; GO:0005524; NAD+ synthase (glutamine-hydrolyzing) activity; GO:0003952 ; EC:6.3.5.1; ; GO:0003952 ; EC:6.3.5.1; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" CG9940 CG9940 Q9VYA0 CDMC21625 1 15 22 DAC36-A11 3-CG18104-RA_2 CG18104 GTCAGGTGCTTCAGAGCAGTCATGATGGCCTGGTGATACGGGACTACGGAAATCTGCAGTACGCC 65 FBan0018104 FBgn0023535 arg X X arginine catabolism to ornithine; GO:0019547 arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 mitochondrion; GO:0005739 arg arginase "CG18104, CG18104, CG18104, EG:171D11.4, EG:65F1.3, arginase" CDMC21625 1 16 22 DAC36-A11 3-CG18104-RA_2 CG18104 GTCAGGTGCTTCAGAGCAGTCATGATGGCCTGGTGATACGGGACTACGGAAATCTGCAGTACGCC 65 FBan0018104 FBgn0023535 arg X X arginine catabolism to ornithine; GO:0019547 arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 mitochondrion; GO:0005739 arg arginase "CG18104, CG18104, CG18104, EG:171D11.4, EG:65F1.3, arginase" CDMC21626 1 17 22 DAC36-A23 3-CG18155-RA_1 CG18155 AACCTGCAAAAACGAACTCGGTGGATCCGTGGATAGTGGCCTAATACCGGTGGAGGATATCGGCG 65 FBan0018155 FBgn0029945 CG18155 X X metabolism; GO:0008152 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG18155 CG18155 FBgn0029945 CDMC21626 1 18 22 DAC36-A23 3-CG18155-RA_1 CG18155 AACCTGCAAAAACGAACTCGGTGGATCCGTGGATAGTGGCCTAATACCGGTGGAGGATATCGGCG 65 FBan0018155 FBgn0029945 CG18155 X X metabolism; GO:0008152 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG18155 CG18155 FBgn0029945 CDMC21627 1 19 22 DAC36-E11 3-CG18356-RA_1 CG18356 CGGCGGCTGTGATAAGTTTGAGCCACTTGAACTCGTTAACGTGCCATTCGAGACACATCGCAGCG 65 FBan0018356 FBgn0033771 CG18356 2 2R CG18356 CG18356 CG13486 CDMC21627 1 20 22 DAC36-E11 3-CG18356-RA_1 CG18356 CGGCGGCTGTGATAAGTTTGAGCCACTTGAACTCGTTAACGTGCCATTCGAGACACATCGCAGCG 65 FBan0018356 FBgn0033771 CG18356 2 2R CG18356 CG18356 CG13486 CDMC21628 1 21 22 DAC36-E23 2-CG18426-RA_1 CG18426 AGTGCATGTAATCCTCAAGCGAAAGTACCGCCAGTACATGAATCGCAAGGGTGGCTTCAACCGGC 65 FBan0018426 FBgn0021895 ytr 2 2R hemocyte differentiation (sensu Arthropoda); GO:0042386; hemopoiesis; GO:0030097 mRNA binding; GO:0003729; ; GO:0003729 ytr yantar "CG18426, CG18426, l(2)k13108, bgcn, b(2)gcn, l(2)60A-F, l(2)k13214, yantar" CDMC21628 1 22 22 DAC36-E23 2-CG18426-RA_1 CG18426 AGTGCATGTAATCCTCAAGCGAAAGTACCGCCAGTACATGAATCGCAAGGGTGGCTTCAACCGGC 65 FBan0018426 FBgn0021895 ytr 2 2R hemocyte differentiation (sensu Arthropoda); GO:0042386; hemopoiesis; GO:0030097 mRNA binding; GO:0003729; ; GO:0003729 ytr yantar "CG18426, CG18426, l(2)k13108, bgcn, b(2)gcn, l(2)60A-F, l(2)k13214, yantar" CDMC21629 1 23 22 DAC36-I11 14-CG18598-RA_1 CG18598 GGGCCAAGTTCTTGATTCTCTGCCTGATCGAGACCAAGTTGTGCCAATTCATGGTCAGCATCCGC 65 FBan0018598 FBgn0038589 CG18598 3 3R CG18598 CG18598 CT42539 CDMC21629 1 24 22 DAC36-I11 14-CG18598-RA_1 CG18598 GGGCCAAGTTCTTGATTCTCTGCCTGATCGAGACCAAGTTGTGCCAATTCATGGTCAGCATCCGC 65 FBan0018598 FBgn0038589 CG18598 3 3R CG18598 CG18598 CT42539 CDMC21630 1 25 22 DAC36-I23 23-CG18643-RA_7 CG18643 GCAGGAGTTGTACAATCAATTTTTGGATCGCCTAGGTCAATCCTACGATAGCACCAAGATTAAAG 65 FBan0018643 FBgn0037898 CG18643 3 3R CG18643 CG18643 CDMC21630 1 26 22 DAC36-I23 23-CG18643-RA_7 CG18643 GCAGGAGTTGTACAATCAATTTTTGGATCGCCTAGGTCAATCCTACGATAGCACCAAGATTAAAG 65 FBan0018643 FBgn0037898 CG18643 3 3R CG18643 CG18643 CDMC21631 1 1 23 DAC36-M11 2-CG18788-RA_1 CG18788 CACTTCTGATGCCCTATCTGGAACAACTGGAGACCGACTACAAGCTGGTGAGCAGTGTGAGGGCC 65 FBan0018788 FBgn0042126 CG18788 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG18788 CG18788 CDMC21631 1 2 23 DAC36-M11 2-CG18788-RA_1 CG18788 CACTTCTGATGCCCTATCTGGAACAACTGGAGACCGACTACAAGCTGGTGAGCAGTGTGAGGGCC 65 FBan0018788 FBgn0042126 CG18788 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG18788 CG18788 CDMC21632 1 3 23 DAC36-M23 3-CG1886-RA_1 CG1886 TCCAGCACATCACTGATTTCGCGCATTTTCATGCACGACTACGGGAACATCACTTCGCCGGATGC 65 FBan0001886 FBgn0030343 ATP7 X X cation transport; GO:0006812; copper ion transport; GO:0006825; metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; copper-exporting ATPase activity; GO:0004008 ; EC:3.6.3.4; metal ion binding; GO:0046872; copper ion binding; GO:0005507; ; GO:0004008 ; EC:3.6.3.4; ; GO:0005507; ; GO:0046872 integral to membrane; GO:0016021; membrane; GO:0016020 ATP7 ATP7 "CG1886, CG1886, CG1886, dmATP7, DmATP7" CDMC21632 1 4 23 DAC36-M23 3-CG1886-RA_1 CG1886 TCCAGCACATCACTGATTTCGCGCATTTTCATGCACGACTACGGGAACATCACTTCGCCGGATGC 65 FBan0001886 FBgn0030343 ATP7 X X cation transport; GO:0006812; copper ion transport; GO:0006825; metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; copper-exporting ATPase activity; GO:0004008 ; EC:3.6.3.4; metal ion binding; GO:0046872; copper ion binding; GO:0005507; ; GO:0004008 ; EC:3.6.3.4; ; GO:0005507; ; GO:0046872 integral to membrane; GO:0016021; membrane; GO:0016020 ATP7 ATP7 "CG1886, CG1886, CG1886, dmATP7, DmATP7" CDMC21633 1 5 23 DAC37-A11 23-CG1689-RA_4 CG1689 TGAGAGATTAGGCGCCCTAACTTCAAGAGCTCAGAACTAATGAAATAAAACCCAACTCCTATCTTAAAT 69 FBan0001689 FBgn0002576 lz X X antennal morphogenesis; GO:0007469; cell differentiation; GO:0030154; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; crystal cell differentiation; GO:0042688; defense response; GO:0006952; embryonic crystal cell differentiation; GO:0035165; embryonic hemopoiesis; GO:0035162; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; lymph gland crystal cell differentiation; GO:0035170; lymph gland hemocyte differentiation (sensu Arthropoda); GO:0035168; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; scab formation; GO:0035314; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; spermathecum morphogenesis; GO:0035211; wound healing; GO:0042060 "DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; RNA polymerase II transcription factor activity, enhancer binding; GO:0003705; ; GO:0003702; ; GO:0003700; ; GO:0003705" nucleus; GO:0005634 lz lozenge "CG1689, fs(1)M69, amx, Lz, fs(1)A1569, spe: spectacled, spectacled, lozenge" CDMC21633 1 6 23 DAC37-A11 23-CG1689-RA_4 CG1689 TGAGAGATTAGGCGCCCTAACTTCAAGAGCTCAGAACTAATGAAATAAAACCCAACTCCTATCTTAAAT 69 FBan0001689 FBgn0002576 lz X X antennal morphogenesis; GO:0007469; cell differentiation; GO:0030154; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; crystal cell differentiation; GO:0042688; defense response; GO:0006952; embryonic crystal cell differentiation; GO:0035165; embryonic hemopoiesis; GO:0035162; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; lymph gland crystal cell differentiation; GO:0035170; lymph gland hemocyte differentiation (sensu Arthropoda); GO:0035168; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; scab formation; GO:0035314; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; spermathecum morphogenesis; GO:0035211; wound healing; GO:0042060 "DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; RNA polymerase II transcription factor activity, enhancer binding; GO:0003705; ; GO:0003702; ; GO:0003700; ; GO:0003705" nucleus; GO:0005634 lz lozenge "CG1689, fs(1)M69, amx, Lz, fs(1)A1569, spe: spectacled, spectacled, lozenge" CDMC21634 1 7 23 DAC37-A23 18-CG16916-RA_1 CG16916 GGTGCGTGAGAATCGCTACATCGTTTTGGCCAAGGACTTCGAGAAGGGCTACAAGAACAATATCAAGAA 69 FBan0016916 FBgn0028686 Rpt3 X X proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3 Rpt3 "CG16916, l(1)G0052, p48A, Dmp48A, Dm_Rpt3a" CDMC21634 1 8 23 DAC37-A23 18-CG16916-RA_1 CG16916 GGTGCGTGAGAATCGCTACATCGTTTTGGCCAAGGACTTCGAGAAGGGCTACAAGAACAATATCAAGAA 69 FBan0016916 FBgn0028686 Rpt3 X X proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3 Rpt3 "CG16916, l(1)G0052, p48A, Dmp48A, Dm_Rpt3a" CDMC21635 1 9 23 DAC37-E11 10-CG16956-RA_1 CG16956 TCCTGGTGGATGAAGATGGAACCAGTACCACGACATCATTACCACCAAGTAAGGACCAAACGCAACCGA 69 FBan0016956 FBgn0032523 CG16956 2 2L CG16956 CG16956 CDMC21635 1 10 23 DAC37-E11 10-CG16956-RA_1 CG16956 TCCTGGTGGATGAAGATGGAACCAGTACCACGACATCATTACCACCAAGTAAGGACCAAACGCAACCGA 69 FBan0016956 FBgn0032523 CG16956 2 2L CG16956 CG16956 CDMC21636 1 11 23 DAC37-E23 23-CG16964-RA_4 CG16964 GCGTATCCAATATGAAGCTACCCTACTTTATAAGCCCAAGGTGTGTTCAAAATCAGGATCAACTGGTTG 69 FBan0016964 FBgn0032385 CG16964 2 2L CG16964 CG16964 BcDNA:GH05159 CDMC21636 1 12 23 DAC37-E23 23-CG16964-RA_4 CG16964 GCGTATCCAATATGAAGCTACCCTACTTTATAAGCCCAAGGTGTGTTCAAAATCAGGATCAACTGGTTG 69 FBan0016964 FBgn0032385 CG16964 2 2L CG16964 CG16964 BcDNA:GH05159 CDMC21637 1 13 23 DAC37-I11 23-CG16987-RA_9 CG16987 TACGTTACATCGGACAAATTAGACGTAGACTCCATTTCGCTCCATTTCAGCTAGCATCCAACCATCCAA 69 FBan0016987 FBgn0031461 Alp23B 2 2L cellular physiological process; GO:0050875; growth; GO:0040007; proteolysis; GO:0006508; transforming growth factor beta receptor signaling pathway; GO:0007179 metallopeptidase activity; GO:0008237; growth factor activity; GO:0008083; zinc ion binding; GO:0008270; ; GO:0008083; transforming growth factor beta receptor binding; GO:0005160; ; GO:0008237; ; GO:0008270; ; GO:0005160 Alp23B Activin Like Protein at 23B "CG16987, CG16987, ALP23B, Alp, Activin-Like Protein, dActivin2, Alp23b, Activin Like Protein at 23B" CDMC21637 1 14 23 DAC37-I11 23-CG16987-RA_9 CG16987 TACGTTACATCGGACAAATTAGACGTAGACTCCATTTCGCTCCATTTCAGCTAGCATCCAACCATCCAA 69 FBan0016987 FBgn0031461 Alp23B 2 2L cellular physiological process; GO:0050875; growth; GO:0040007; proteolysis; GO:0006508; transforming growth factor beta receptor signaling pathway; GO:0007179 metallopeptidase activity; GO:0008237; growth factor activity; GO:0008083; zinc ion binding; GO:0008270; ; GO:0008083; transforming growth factor beta receptor binding; GO:0005160; ; GO:0008237; ; GO:0008270; ; GO:0005160 Alp23B Activin Like Protein at 23B "CG16987, CG16987, ALP23B, Alp, Activin-Like Protein, dActivin2, Alp23b, Activin Like Protein at 23B" CDMC21638 1 15 23 DAC37-I23 16-CG17002-RB_1 CG17002 ACAACACTGACTACGCTTCCCACGTGAAGTCGGATAAACGAAATAAAGCACACAACTATGGCGTCCCTA 69 FBan0017002 FBgn0033122 CG17002 2 2R CG17002 CG17002 CDMC21638 1 16 23 DAC37-I23 16-CG17002-RB_1 CG17002 ACAACACTGACTACGCTTCCCACGTGAAGTCGGATAAACGAAATAAAGCACACAACTATGGCGTCCCTA 69 FBan0017002 FBgn0033122 CG17002 2 2R CG17002 CG17002 CDMC21639 1 17 23 DAC37-M11 3-CG17035-RB_4 CG17035 TGCGACCTGGACTTCAAGAGGTGCTTGTACAAGTACTGCGACAGCTACGAGAAGTCCATAGCCAGCGAT 69 FBan0017035 FBgn0036545 GXIVsPLA2 3 3L lipid catabolism; GO:0016042 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 GXIVsPLA2 GXIVsPLA2 CG17035 CDMC21639 1 18 23 DAC37-M11 3-CG17035-RB_4 CG17035 TGCGACCTGGACTTCAAGAGGTGCTTGTACAAGTACTGCGACAGCTACGAGAAGTCCATAGCCAGCGAT 69 FBan0017035 FBgn0036545 GXIVsPLA2 3 3L lipid catabolism; GO:0016042 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 GXIVsPLA2 GXIVsPLA2 CG17035 CDMC21640 1 19 23 DAC37-M23 16-CG17047-RA_2 CG17047 TGACCAGCAACTATATGCCTGACTTGAGTTACAACATCTGCATCAGATCAGCTACTTCCGCCAGCATGA 69 FBan0017047 FBgn0033827 CG17047 2 2R CG17047 CG17047 CDMC21640 1 20 23 DAC37-M23 16-CG17047-RA_2 CG17047 TGACCAGCAACTATATGCCTGACTTGAGTTACAACATCTGCATCAGATCAGCTACTTCCGCCAGCATGA 69 FBan0017047 FBgn0033827 CG17047 2 2R CG17047 CG17047 CDMC21641 1 21 23 DAC38-A11 3-CG17562-RA_1 CG17562 AGCATCTCAACTGCAGTTCCGATAAGGTGCTTGCAATGGCAGAGCTGATGAGTGACGAGCTACTGGACA 69 FBan0017562 FBgn0038449 CG17562 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17562 CG17562 CDMC21641 1 22 23 DAC38-A11 3-CG17562-RA_1 CG17562 AGCATCTCAACTGCAGTTCCGATAAGGTGCTTGCAATGGCAGAGCTGATGAGTGACGAGCTACTGGACA 69 FBan0017562 FBgn0038449 CG17562 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17562 CG17562 CDMC21642 1 23 23 DAC38-A23 2-CG17574-RA_7 CG17574 CCGCCGTATGACATGTCCATGGCTAATCCAGGACCTAGTGTTATGCCCGCTGGATATGAGAAGCAAGCT 69 FBan0017574 FBgn0033777 CG17574 2 2R CG17574 CG17574 BcDNA:RH03863 CDMC21642 1 24 23 DAC38-A23 2-CG17574-RA_7 CG17574 CCGCCGTATGACATGTCCATGGCTAATCCAGGACCTAGTGTTATGCCCGCTGGATATGAGAAGCAAGCT 69 FBan0017574 FBgn0033777 CG17574 2 2R CG17574 CG17574 BcDNA:RH03863 CDMC21643 1 25 23 DAC38-E11 1-CG17623-RA_1 CG17623 CGCCGCTCCAAGCTGACCAGAATCATAAACGGTGAGTGCGGGGTAAATCGGATGCGGAATCCAAAAATT 69 FBan0017623 FBgn0038999 CG17623 3 3R CG17623 CG17623 CDMC21643 1 26 23 DAC38-E11 1-CG17623-RA_1 CG17623 CGCCGCTCCAAGCTGACCAGAATCATAAACGGTGAGTGCGGGGTAAATCGGATGCGGAATCCAAAAATT 69 FBan0017623 FBgn0038999 CG17623 3 3R CG17623 CG17623 CDMC21644 1 1 24 DAC38-E23 3-CG17632-RB_1 CG17632 TGCGTTTGCCCAGACAGACAGACAGACGGACAGATTTAAGGTTTCCCCCGAAAGATCCCGAGCAGATAT 69 FBan0017632 FBgn0000241 bw 2 2R coenzyme metabolism; GO:0006732; eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 bw brown "CG17632, CG17632, Plum, Su(w[coJ]), Suppressor of white-coral J, Pm: Plum, Rosy, Su(w[co2]): Suppressor of white-coral-2, ptm: pteridine-modifier, Suppressor of white-coral-2, pteridine-modifier, brown" CDMC21644 1 2 24 DAC38-E23 3-CG17632-RB_1 CG17632 TGCGTTTGCCCAGACAGACAGACAGACGGACAGATTTAAGGTTTCCCCCGAAAGATCCCGAGCAGATAT 69 FBan0017632 FBgn0000241 bw 2 2R coenzyme metabolism; GO:0006732; eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 bw brown "CG17632, CG17632, Plum, Su(w[coJ]), Suppressor of white-coral J, Pm: Plum, Rosy, Su(w[co2]): Suppressor of white-coral-2, ptm: pteridine-modifier, Suppressor of white-coral-2, pteridine-modifier, brown" CDMC21645 1 3 24 DAC38-I11 3-CG17684-RA_1 CG17684 TGGCCTAGCAGATACCACAGCTCCCTTCGTCCATGGAGTGCAATTAGCAAAATCTTTGACAAGCGCCAA 69 CDMC21645 1 4 24 DAC38-I11 3-CG17684-RA_1 CG17684 TGGCCTAGCAGATACCACAGCTCCCTTCGTCCATGGAGTGCAATTAGCAAAATCTTTGACAAGCGCCAA 69 CDMC21646 1 5 24 DAC38-I23 16-CG17697-RB_1 CG17697 CCACGCTTCTTCGTCGCAGTCACTTTGAAAATTACGCAAATTGAAAGTTACATCGTTATGTGGCCGGCA 69 FBan0017697 FBgn0001085 fz 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; asymmetric protein localization; GO:0008105; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; establishment of cell polarity; GO:0030010; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; protein localization; GO:0008104; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; wing hair site selection; GO:0035320 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 cell cortex; GO:0005938; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 fz frizzled "CG3646, CG17697, CG3646, Dfz1, Fz1, DFZ1, Fz, frz, FZ, Frizzled 1, DFz, frizzled 1, Frizzled, fz1, DFz1, frizzled" CDMC21646 1 6 24 DAC38-I23 16-CG17697-RB_1 CG17697 CCACGCTTCTTCGTCGCAGTCACTTTGAAAATTACGCAAATTGAAAGTTACATCGTTATGTGGCCGGCA 69 FBan0017697 FBgn0001085 fz 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; asymmetric protein localization; GO:0008105; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; establishment of cell polarity; GO:0030010; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; protein localization; GO:0008104; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; wing hair site selection; GO:0035320 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 cell cortex; GO:0005938; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 fz frizzled "CG3646, CG17697, CG3646, Dfz1, Fz1, DFZ1, Fz, frz, FZ, Frizzled 1, DFz, frizzled 1, Frizzled, fz1, DFz1, frizzled" CDMC21647 1 7 24 DAC38-M11 15-CG17735-RA_9 CG17735 CAGTACATCTCCCTGGTCACATACTGGTTCCTTATCGAGGGTGTCCAGAAACAGTTTGAGGCTTTGCGT 69 FBan0017735 FBgn0037277 CG17735 3 3R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 intracellular; GO:0005622 CG17735 CG17735 CDMC21647 1 8 24 DAC38-M11 15-CG17735-RA_9 CG17735 CAGTACATCTCCCTGGTCACATACTGGTTCCTTATCGAGGGTGTCCAGAAACAGTTTGAGGCTTTGCGT 69 FBan0017735 FBgn0037277 CG17735 3 3R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 intracellular; GO:0005622 CG17735 CG17735 CDMC21648 1 9 24 DAC38-M23 15-CG17745-RA_2 CG17745 GGATGAGGAGATGAGCCTGGCTAAAAACCGAGCAGATGAGCAGGCGAAATGGACTTTTAAATGTTGCCA 69 FBan0017745 FBgn0032386 CG17745 2 2L CG17745 CG17745 CDMC21648 1 10 24 DAC38-M23 15-CG17745-RA_2 CG17745 GGATGAGGAGATGAGCCTGGCTAAAAACCGAGCAGATGAGCAGGCGAAATGGACTTTTAAATGTTGCCA 69 FBan0017745 FBgn0032386 CG17745 2 2L CG17745 CG17745 CDMC21649 1 11 24 DAC39-A11 23-CG32172-RA_5 CG32172 CATTGTGAAATCAGCGAGCTCATTGAGTGAATCGTTTTATGACTGAGTTGTTCGCAACCCATAAT 65 FBan0032172 FBgn0026197 noe 3 3L noe noe "CG32172, CG32172, anon-WO02059370.51, anon-EST:Posey151, anon-EST:Posey35, anon-EST:Posey292, anon-EST:Posey243, anon-EST:Posey101" CDMC21649 1 12 24 DAC39-A11 23-CG32172-RA_5 CG32172 CATTGTGAAATCAGCGAGCTCATTGAGTGAATCGTTTTATGACTGAGTTGTTCGCAACCCATAAT 65 FBan0032172 FBgn0026197 noe 3 3L noe noe "CG32172, CG32172, anon-WO02059370.51, anon-EST:Posey151, anon-EST:Posey35, anon-EST:Posey292, anon-EST:Posey243, anon-EST:Posey101" CDMC21650 1 13 24 DAC39-A23 3-CG32198-RB_1 CG32198 CTCTTTTCCTGGGGTTAGTGGCCCTCATTGCTGCTGTCTTTGCTCTTGATGATCCCACATCGCCG 65 FBan0032198 FBgn0052198 CG32198 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32198 CG32198 CDMC21650 1 14 24 DAC39-A23 3-CG32198-RB_1 CG32198 CTCTTTTCCTGGGGTTAGTGGCCCTCATTGCTGCTGTCTTTGCTCTTGATGATCCCACATCGCCG 65 FBan0032198 FBgn0052198 CG32198 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32198 CG32198 CDMC21651 1 15 24 DAC39-E11 17-CG32282-RA_1 CG32282 GGGAGGAAGGACGTGTCAGTGGACACTGCAGTGCCAGTCTGAAGTGCTGGTGCGAACAATGCTGA 65 FBan0032282 FBgn0052282 dro4 3 3L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 dro4 drosomycin-4 "CG32282, Dro-4, drosomycin-F" CDMC21651 1 16 24 DAC39-E11 17-CG32282-RA_1 CG32282 GGGAGGAAGGACGTGTCAGTGGACACTGCAGTGCCAGTCTGAAGTGCTGGTGCGAACAATGCTGA 65 FBan0032282 FBgn0052282 dro4 3 3L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 dro4 drosomycin-4 "CG32282, Dro-4, drosomycin-F" CDMC21652 1 17 24 DAC39-E23 2-CG32353-RA_1 CG32353 AGGAGCAGCTCTATGGGGTGGGCCGCATGACAAAGACGGTTAGTTTCCATTTTGACGAACGCAAA 65 FBan0032353 FBgn0052353 CG32353 3 3L CG32353 CG32353 "CG6239, CG6239" CDMC21652 1 18 24 DAC39-E23 2-CG32353-RA_1 CG32353 AGGAGCAGCTCTATGGGGTGGGCCGCATGACAAAGACGGTTAGTTTCCATTTTGACGAACGCAAA 65 FBan0032353 FBgn0052353 CG32353 3 3L CG32353 CG32353 "CG6239, CG6239" CDMC21653 1 19 24 DAC39-I11 5-CG32466-RA_1 CG32466 CAGCGGCCCTATCTCTACGATGCCATCAGCTTCCCGAACAAGAACGTGAACCAGAACAACGCGAA 65 FBan0032466 FBgn0003263 rn 3 3R cell proliferation; GO:0008283; eye development (sensu Endopterygota); GO:0007456; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 rn rotund "CG10040, CG32466, CG14600, CG14601, CG14603, CG10040, CG10040, roe, P5.3, 5.3, roughened eye, Dipr, Distal-into-proximal" CDMC21653 1 20 24 DAC39-I11 5-CG32466-RA_1 CG32466 CAGCGGCCCTATCTCTACGATGCCATCAGCTTCCCGAACAAGAACGTGAACCAGAACAACGCGAA 65 FBan0032466 FBgn0003263 rn 3 3R cell proliferation; GO:0008283; eye development (sensu Endopterygota); GO:0007456; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 rn rotund "CG10040, CG32466, CG14600, CG14601, CG14603, CG10040, CG10040, roe, P5.3, 5.3, roughened eye, Dipr, Distal-into-proximal" CDMC21654 1 21 24 DAC39-I23 11-CG32491-RK_1 CG32491 CATGCAGTACCGCACCTACTTCCATTGCTTGACCAGGAACTGCCCGACCTACTACGTCCTCGTGG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21654 1 22 24 DAC39-I23 11-CG32491-RK_1 CG32491 CATGCAGTACCGCACCTACTTCCATTGCTTGACCAGGAACTGCCCGACCTACTACGTCCTCGTGG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21655 1 23 24 DAC39-M11 1-CG32544-RA_1 CG32544 CTTGAGCAGGTGATCATCCATTGCTGACCCGCGAAGCCCACAAAGAAACAGGCGTTTGCTTCATG 65 FBan0032544 FBgn0052544 CG32544 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32544 CG32544 CDMC21655 1 24 24 DAC39-M11 1-CG32544-RA_1 CG32544 CTTGAGCAGGTGATCATCCATTGCTGACCCGCGAAGCCCACAAAGAAACAGGCGTTTGCTTCATG 65 FBan0032544 FBgn0052544 CG32544 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32544 CG32544 CDMC21656 1 25 24 DAC39-M23 41-CG32560-RA_1 CG32560 AATCCCAACTCGAATATGCCCAAGAACTTGGAGGATCTGGACGATCTGTTCAAGTACGCCGAGGA 65 FBan0032560 FBgn0052560 CG32560 X X G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; negative regulation of Ras protein signal transduction; GO:0046580 receptor binding; GO:0005102; ; GO:0005102; Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099 cytoplasm; GO:0005737 CG32560 CG32560 "CG5960, CG5898, CG5960, CG5960, CG5960" CDMC21656 1 26 24 DAC39-M23 41-CG32560-RA_1 CG32560 AATCCCAACTCGAATATGCCCAAGAACTTGGAGGATCTGGACGATCTGTTCAAGTACGCCGAGGA 65 FBan0032560 FBgn0052560 CG32560 X X G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; negative regulation of Ras protein signal transduction; GO:0046580 receptor binding; GO:0005102; ; GO:0005102; Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099 cytoplasm; GO:0005737 CG32560 CG32560 "CG5960, CG5898, CG5960, CG5960, CG5960" CDMC21657 1 1 25 DAC40-A11 1-CG41065-RA_1 CG41065 CACAATATGTGGACCTTGTACCCGAGCGGGCCGTGCGCAAAAAGGGGAAAAAAACCATGGGATTC 65 FBgn0069955 CG41065 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41065 CG41065 CDMC21657 1 2 25 DAC40-A11 1-CG41065-RA_1 CG41065 CACAATATGTGGACCTTGTACCCGAGCGGGCCGTGCGCAAAAAGGGGAAAAAAACCATGGGATTC 65 FBgn0069955 CG41065 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41065 CG41065 CDMC21658 1 3 25 DAC40-A23 3-CG41105-RC_4 CG41105 GGGTGAGGTAAACAAAGTGGCCTACAGAAACGGAAAGGACGCCTTCAAATTTCGCCAACCCGTGC 65 FBgn0069939 CG41105 biological process unknown; GO:0000004 cellular component unknown; GO:0008372 CG41105 CG41105 CDMC21658 1 4 25 DAC40-A23 3-CG41105-RC_4 CG41105 GGGTGAGGTAAACAAAGTGGCCTACAGAAACGGAAAGGACGCCTTCAAATTTCGCCAACCCGTGC 65 FBgn0069939 CG41105 biological process unknown; GO:0000004 cellular component unknown; GO:0008372 CG41105 CG41105 CDMC21659 1 5 25 DAC40-E11 23-CG4168-RA_3 CG4168 GAATGAGACAAAGTGGACAAATGAATTATGGCAAAACAAACAAACGAAAAAGCTGCTGGTATGCC 65 FBan0004168 FBgn0028888 CG4168 2 2L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; development; GO:0007275; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004930; ; GO:0004675 ; EC:2.7.1.- CG4168 CG4168 "BG:DS03192.2, chaoptic-like" CDMC21659 1 6 25 DAC40-E11 23-CG4168-RA_3 CG4168 GAATGAGACAAAGTGGACAAATGAATTATGGCAAAACAAACAAACGAAAAAGCTGCTGGTATGCC 65 FBan0004168 FBgn0028888 CG4168 2 2L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; development; GO:0007275; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004930; ; GO:0004675 ; EC:2.7.1.- CG4168 CG4168 "BG:DS03192.2, chaoptic-like" CDMC21660 1 7 25 DAC40-E23 2-CG4217-RA_1 CG4217 TCAAGCGGGACCAACAAATCTACGTGGAGGAGCGAACAAAGTACGATGCCACACTCACGGAGGAG 65 FBan0004217 FBgn0038805 TFAM 3 3R "mitochondrial DNA replication; GO:0006264; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700 mitochondrion; GO:0005739 TFAM mitochondrial transcription factor A "CG4217, d-TFAM, d-tfam, d-mttfa, mttfa, mitochondrial transcription factor A, D-mtTFA, Tfam" CDMC21660 1 8 25 DAC40-E23 2-CG4217-RA_1 CG4217 TCAAGCGGGACCAACAAATCTACGTGGAGGAGCGAACAAAGTACGATGCCACACTCACGGAGGAG 65 FBan0004217 FBgn0038805 TFAM 3 3R "mitochondrial DNA replication; GO:0006264; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700 mitochondrion; GO:0005739 TFAM mitochondrial transcription factor A "CG4217, d-TFAM, d-tfam, d-mttfa, mttfa, mitochondrial transcription factor A, D-mtTFA, Tfam" CDMC21661 1 9 25 DAC40-I11 1-CG4336-RA_1 CG4336 TGAAATCTGCCTGGCTGTCTACGATCGGGGTCTGACAAGCCTCAAACGATCCACTCTGATTCCGC 65 FBan0004336 FBgn0003302 rux X X eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; mitotic cell cycle; GO:0000278; regulation of exit from mitosis; GO:0007096; regulation of meiosis; GO:0040020; regulation of mitosis; GO:0007088; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 rux roughex "CG4336, Rux" CDMC21661 1 10 25 DAC40-I11 1-CG4336-RA_1 CG4336 TGAAATCTGCCTGGCTGTCTACGATCGGGGTCTGACAAGCCTCAAACGATCCACTCTGATTCCGC 65 FBan0004336 FBgn0003302 rux X X eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; mitotic cell cycle; GO:0000278; regulation of exit from mitosis; GO:0007096; regulation of meiosis; GO:0040020; regulation of mitosis; GO:0007088; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 rux roughex "CG4336, Rux" CDMC21662 1 11 25 DAC40-I23 6-CG4390-RA_1 CG4390 GTTCTTCCTCAGCGGACTGACCTGCACGCATGAGAACTTCATCCAGAAGAGCGGATTCCAGCAGC 65 FBan0004390 FBgn0038771 CG4390 3 3R "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG4390 CG4390 CDMC21662 1 12 25 DAC40-I23 6-CG4390-RA_1 CG4390 GTTCTTCCTCAGCGGACTGACCTGCACGCATGAGAACTTCATCCAGAAGAGCGGATTCCAGCAGC 65 FBan0004390 FBgn0038771 CG4390 3 3R "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG4390 CG4390 CDMC21663 1 13 25 DAC40-M11 2-CG4527-RD_1 CG4527 TAGTCCTTTGATCTATCCCCAGTGTGCTTCCCAGCCATTCGATACGACCCAGGGCCCTGAAACTG 65 FBan0004527 FBgn0035001 slik 2 2R MAPKKK cascade; GO:0000165; cell proliferation; GO:0008283; cytokinesis; GO:0000910; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; polo kinase kinase activity; GO:0042801; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042801 slik Sterile20-like kinase "CG4527, CG4527, CG4527, CG4527, CG4527, SLK, slk, DPlkk1, Polo kinase kinase 1, polo kinase kinase 1, Plkk1, Sterile20-like kinase" CDMC21663 1 14 25 DAC40-M11 2-CG4527-RD_1 CG4527 TAGTCCTTTGATCTATCCCCAGTGTGCTTCCCAGCCATTCGATACGACCCAGGGCCCTGAAACTG 65 FBan0004527 FBgn0035001 slik 2 2R MAPKKK cascade; GO:0000165; cell proliferation; GO:0008283; cytokinesis; GO:0000910; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; polo kinase kinase activity; GO:0042801; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042801 slik Sterile20-like kinase "CG4527, CG4527, CG4527, CG4527, CG4527, SLK, slk, DPlkk1, Polo kinase kinase 1, polo kinase kinase 1, Plkk1, Sterile20-like kinase" CDMC21664 1 15 25 DAC40-M23 1-CG4557-RA_1 CG4557 CGAAGATCTTCAGTCCAGACTAGCTGCCCTGCAAGCCAGTTTCGACGGCCTAAAGGGAGATCTGC 65 FBan0004557 FBgn0029912 CG4557 X X transcription factor activity; GO:0003700; ; GO:0003700 CG4557 CG4557 CDMC21664 1 16 25 DAC40-M23 1-CG4557-RA_1 CG4557 CGAAGATCTTCAGTCCAGACTAGCTGCCCTGCAAGCCAGTTTCGACGGCCTAAAGGGAGATCTGC 65 FBan0004557 FBgn0029912 CG4557 X X transcription factor activity; GO:0003700; ; GO:0003700 CG4557 CG4557 CDMC21665 1 17 25 DAC41-A11 22-CG4552-RA_1 CG4552 TCCGCCTTTCCGCATCAAGCTTTATTTCATGAACGGCCACTGATACAAAAATCAGAGACACAAAGTGCA 69 FBan0004552 FBgn0031304 CG4552 2 2L CG4552 CG4552 CDMC21665 1 18 25 DAC41-A11 22-CG4552-RA_1 CG4552 TCCGCCTTTCCGCATCAAGCTTTATTTCATGAACGGCCACTGATACAAAAATCAGAGACACAAAGTGCA 69 FBan0004552 FBgn0031304 CG4552 2 2L CG4552 CG4552 CDMC21666 1 19 25 DAC41-A23 15-CG4569-RA_1 CG4569 CCTCTCCGGCGTAGACGCGTACGCTCCTTTCAGGCCAACCAAGTTAAAAAGTTTTAAGTGAAAATGCGA 69 FBan0004569 FBgn0017556 Pros28.1B 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1B Pros28.1B "CG4569, alpha4t2_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t2, 20s proteasome, alpha4t2" CDMC21666 1 20 25 DAC41-A23 15-CG4569-RA_1 CG4569 CCTCTCCGGCGTAGACGCGTACGCTCCTTTCAGGCCAACCAAGTTAAAAAGTTTTAAGTGAAAATGCGA 69 FBan0004569 FBgn0017556 Pros28.1B 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1B Pros28.1B "CG4569, alpha4t2_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t2, 20s proteasome, alpha4t2" CDMC21667 1 21 25 DAC41-E11 23-CG4606-RA_1 CG4606 GGAGGTGTAAGGTGGCTGCAGTGTATTTAGCGGAAATAGTTATCATATTTATTTGTGGTTTAGTTCTAA 69 FBan0004606 FBgn0026616 alpha-Man-IIb 3 3R carbohydrate metabolism; GO:0005975; protein secretion; GO:0009306 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; GO:0004572 ; EC:3.2.1.114; ; GO:0004559 ; EC:3.2.1.24; ; GO:0004572 ; EC:3.2.1.114" Golgi membrane; GO:0000139 alpha-Man-IIb alpha-Man-IIb "CG4606, alpha-M-II, Man'ase, GTD#24/1, DM-GII.2, alpha-mannosidase, mannosidase II, alpha-D-mannosidase, alpha-mannosidase, alpha-mannosidase 2" CDMC21667 1 22 25 DAC41-E11 23-CG4606-RA_1 CG4606 GGAGGTGTAAGGTGGCTGCAGTGTATTTAGCGGAAATAGTTATCATATTTATTTGTGGTTTAGTTCTAA 69 FBan0004606 FBgn0026616 alpha-Man-IIb 3 3R carbohydrate metabolism; GO:0005975; protein secretion; GO:0009306 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; GO:0004572 ; EC:3.2.1.114; ; GO:0004559 ; EC:3.2.1.24; ; GO:0004572 ; EC:3.2.1.114" Golgi membrane; GO:0000139 alpha-Man-IIb alpha-Man-IIb "CG4606, alpha-M-II, Man'ase, GTD#24/1, DM-GII.2, alpha-mannosidase, mannosidase II, alpha-D-mannosidase, alpha-mannosidase, alpha-mannosidase 2" CDMC21668 1 23 25 DAC41-E23 2-CG4611-RA_1 CG4611 TTGCAGCGAGGTATTAGCCCGGACTACTACAGCTTCAATGCAATGCTGAGATGTGCAAGGGATTGTGGC 69 FBan0004611 FBgn0035591 CG4611 3 3L CG4611 CG4611 CDMC21668 1 24 25 DAC41-E23 2-CG4611-RA_1 CG4611 TTGCAGCGAGGTATTAGCCCGGACTACTACAGCTTCAATGCAATGCTGAGATGTGCAAGGGATTGTGGC 69 FBan0004611 FBgn0035591 CG4611 3 3L CG4611 CG4611 CDMC21669 1 25 25 DAC41-I11 3-CG4643-RA_1 CG4643 CGGATACGCGTCATTCTCGACTGCGAGGACAACACCTTGTCGTTCGAGAAGAACTACGAGTTCCTCGGT 69 FBgn0033811 CDMC21669 1 26 25 DAC41-I11 3-CG4643-RA_1 CG4643 CGGATACGCGTCATTCTCGACTGCGAGGACAACACCTTGTCGTTCGAGAAGAACTACGAGTTCCTCGGT 69 FBgn0033811 CDMC21670 1 1 26 DAC41-I23 15-CG4650-RA_1 CG4650 GCAGTCAGTTTTGTGCTGGAGACTCGGATTCCAAACTGTGCAATGTTGACTTTAGCAGTCCTCTGGGAG 69 FBan0004650 FBgn0032549 CG4650 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4650 CG4650 SPH197 CDMC21670 1 2 26 DAC41-I23 15-CG4650-RA_1 CG4650 GCAGTCAGTTTTGTGCTGGAGACTCGGATTCCAAACTGTGCAATGTTGACTTTAGCAGTCCTCTGGGAG 69 FBan0004650 FBgn0032549 CG4650 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4650 CG4650 SPH197 CDMC21671 1 3 26 DAC41-M11 9-CG4677-RA_2 CG4677 ACCAATTAAAGATGCCCCAACTGGAAAAGTCAGCGATTCAATGCCCAAAGATCTCAGTGCCTGAGCCCT 69 FBan0004677 FBgn0039039 lmd 3 3R "muscle development; GO:0007517; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; somatic muscle development; GO:0007525; striated muscle development; GO:0007519" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lmd lame duck "CG4677, CG4677, CG4677, CG4677, K, Lmd, gfl, gleeful, minc, myoblasts incompetent, anon-EST:CL2d4" CDMC21671 1 4 26 DAC41-M11 9-CG4677-RA_2 CG4677 ACCAATTAAAGATGCCCCAACTGGAAAAGTCAGCGATTCAATGCCCAAAGATCTCAGTGCCTGAGCCCT 69 FBan0004677 FBgn0039039 lmd 3 3R "muscle development; GO:0007517; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; somatic muscle development; GO:0007525; striated muscle development; GO:0007519" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lmd lame duck "CG4677, CG4677, CG4677, CG4677, K, Lmd, gfl, gleeful, minc, myoblasts incompetent, anon-EST:CL2d4" CDMC21672 1 5 26 DAC41-M23 23-CG4688-RA_4 CG4688 TGCCTTATGCTAATCAAATTGCTCGATATAGATGTGGAGCTCAGGTTTGTGAATCTCTTCAAGGGCGAG 69 FBan0004688 FBgn0033817 CG4688 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG4688 CG4688 CDMC21672 1 6 26 DAC41-M23 23-CG4688-RA_4 CG4688 TGCCTTATGCTAATCAAATTGCTCGATATAGATGTGGAGCTCAGGTTTGTGAATCTCTTCAAGGGCGAG 69 FBan0004688 FBgn0033817 CG4688 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG4688 CG4688 CDMC21673 1 7 26 DAC42-A11 150mM NaPO4 Blank CDMC21673 1 8 26 DAC42-A11 150mM NaPO4 Blank CDMC21674 1 9 26 DAC42-A23 150mM NaPO4 Blank CDMC21674 1 10 26 DAC42-A23 150mM NaPO4 Blank CDMC21675 1 11 26 DAC42-E11 150mM NaPO4 Blank CDMC21675 1 12 26 DAC42-E11 150mM NaPO4 Blank CDMC21676 1 13 26 DAC42-E23 150mM NaPO4 Blank CDMC21676 1 14 26 DAC42-E23 150mM NaPO4 Blank CDMC21677 1 15 26 DAC42-I11 150mM NaPO4 Blank CDMC21677 1 16 26 DAC42-I11 150mM NaPO4 Blank CDMC21678 1 17 26 DAC42-I23 5uM MSP 5uM MSP CDMC21678 1 18 26 DAC42-I23 5uM MSP 5uM MSP CDMC21679 1 19 26 DAC42-M11 10uM MSP 10uM MSP CDMC21679 1 20 26 DAC42-M11 10uM MSP 10uM MSP CDMC21680 1 21 26 DAC42-M23 20uM MSP 20uM MSP CDMC21680 1 22 26 DAC42-M23 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC21681 2 1 1 DAC01-B11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21681 2 2 1 DAC01-B11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21682 2 3 1 DAC01-B23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21682 2 4 1 DAC01-B23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21683 2 5 1 DAC01-F11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21683 2 6 1 DAC01-F11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21684 2 7 1 DAC01-F23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21684 2 8 1 DAC01-F23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21685 2 9 1 DAC01-J11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21685 2 10 1 DAC01-J11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21686 2 11 1 DAC01-J23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21686 2 12 1 DAC01-J23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21687 2 13 1 DAC01-N11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21687 2 14 1 DAC01-N11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21688 2 15 1 DAC01-N23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21688 2 16 1 DAC01-N23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21689 2 17 1 DAC02-B11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21689 2 18 1 DAC02-B11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21690 2 19 1 DAC02-B23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21690 2 20 1 DAC02-B23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21691 2 21 1 DAC02-F11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21691 2 22 1 DAC02-F11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21692 2 23 1 DAC02-F23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21692 2 24 1 DAC02-F23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21693 2 25 1 DAC02-J11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21693 2 26 1 DAC02-J11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21694 2 1 2 DAC02-J23 N/A CG9075 (01674-01910) CDMC21694 2 2 2 DAC02-J23 N/A CG9075 (01674-01910) CDMC21695 2 3 2 DAC02-N11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21695 2 4 2 DAC02-N11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21696 2 5 2 DAC02-N23 AutoBlank AutoBlank CDMC21696 2 6 2 DAC02-N23 AutoBlank AutoBlank CDMC21697 2 7 2 DAC03-B11 2-CG3803-RA_3 CG3803 GAGTAACCCGACTGACAGAGTCCGGACTGTCCATGGTCACTTGGAAGCTGACGGGTGAACGTATG 65 FBan0003803 FBgn0034938 CG3803 2 2R cytochrome c oxidase complex assembly; GO:0008535; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 mitochondrial inner membrane; GO:0005743 CG3803 CG3803 CDMC21697 2 8 2 DAC03-B11 2-CG3803-RA_3 CG3803 GAGTAACCCGACTGACAGAGTCCGGACTGTCCATGGTCACTTGGAAGCTGACGGGTGAACGTATG 65 FBan0003803 FBgn0034938 CG3803 2 2R cytochrome c oxidase complex assembly; GO:0008535; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 mitochondrial inner membrane; GO:0005743 CG3803 CG3803 CDMC21698 2 9 2 DAC03-B23 2-CG3838-RA_1 CG3838 TGAAGTCCAGCCGTAACTCTTTGGAGGGGAACAACAGTCTGGCCACTCTGTACCAGATGTCCCAG 65 FBan0003838 FBgn0032130 CG3838 2 2L DNA binding; GO:0003677; ; GO:0003677 CG3838 CG3838 "bs09e08.y1, anon-WO0118547.445, NEST:bs09e08" CDMC21698 2 10 2 DAC03-B23 2-CG3838-RA_1 CG3838 TGAAGTCCAGCCGTAACTCTTTGGAGGGGAACAACAGTCTGGCCACTCTGTACCAGATGTCCCAG 65 FBan0003838 FBgn0032130 CG3838 2 2L DNA binding; GO:0003677; ; GO:0003677 CG3838 CG3838 "bs09e08.y1, anon-WO0118547.445, NEST:bs09e08" CDMC21699 2 11 2 DAC03-F11 3-CG3966-RA_2 CG3966 GAGATACCCACGGAGCAGTTCGAGTTCTACCCGGACGACTTCAACATCCTCGGATGGATCAAGGC 65 FBan0003966 FBgn0002936 ninaA 2 2L "'de novo' protein folding; GO:0006458; defense response; GO:0006952; phototransduction; GO:0007602; phototransduction, visible light; GO:0007603; protein targeting; GO:0006605; rhodopsin biosynthesis; GO:0016063; transport; GO:0006810" cyclosporin A binding; GO:0016018; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0016018; ; GO:0003755 ; EC:5.2.1.8 NOT nuclear membrane; GO:0005635; NOT rhabdomere; GO:0016028; cytoplasmic membrane-bound vesicle; GO:0016023; endoplasmic reticulum cisterna; GO:0016022; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; membrane fraction; GO:0005624 ninaA neither inactivation nor afterpotential A "CG3966, ninA" CDMC21699 2 12 2 DAC03-F11 3-CG3966-RA_2 CG3966 GAGATACCCACGGAGCAGTTCGAGTTCTACCCGGACGACTTCAACATCCTCGGATGGATCAAGGC 65 FBan0003966 FBgn0002936 ninaA 2 2L "'de novo' protein folding; GO:0006458; defense response; GO:0006952; phototransduction; GO:0007602; phototransduction, visible light; GO:0007603; protein targeting; GO:0006605; rhodopsin biosynthesis; GO:0016063; transport; GO:0006810" cyclosporin A binding; GO:0016018; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0016018; ; GO:0003755 ; EC:5.2.1.8 NOT nuclear membrane; GO:0005635; NOT rhabdomere; GO:0016028; cytoplasmic membrane-bound vesicle; GO:0016023; endoplasmic reticulum cisterna; GO:0016022; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; membrane fraction; GO:0005624 ninaA neither inactivation nor afterpotential A "CG3966, ninA" CDMC21700 2 13 2 DAC03-F23 3-CG3986-RA_1 CG3986 AGTCCTATCCACTGCTGAAGACCATGAATCGTGCTCTTGGCAGGGAAGTGAGTGGAGGAAGTGGC 65 FBan0003986 FBgn0022700 Cht4 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 Cht4 Chitinase 4 "CG3986, DmCHT4, CHT4, BcDNA:RE62779" CDMC21700 2 14 2 DAC03-F23 3-CG3986-RA_1 CG3986 AGTCCTATCCACTGCTGAAGACCATGAATCGTGCTCTTGGCAGGGAAGTGAGTGGAGGAAGTGGC 65 FBan0003986 FBgn0022700 Cht4 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 Cht4 Chitinase 4 "CG3986, DmCHT4, CHT4, BcDNA:RE62779" CDMC21701 2 15 2 DAC03-J11 23-CG40169-RA_1 CG40169 GTAAGGACACTTCTTGTTTTATCGGACTGATGAGTGAAAGTCGGCTGAGATTAATTGCCCGGCAA 65 FBan0040169 FBgn0058169 CG40169 2 2L CG40169 CG40169 CDMC21701 2 16 2 DAC03-J11 23-CG40169-RA_1 CG40169 GTAAGGACACTTCTTGTTTTATCGGACTGATGAGTGAAAGTCGGCTGAGATTAATTGCCCGGCAA 65 FBan0040169 FBgn0058169 CG40169 2 2L CG40169 CG40169 CDMC21702 2 17 2 DAC03-J23 1-CG40212-RA_2 CG40212 ACAAGAGCACTGACGAAACTCAGAAACAGGAGCATGAGAAGGAGGAGCCCCAGGTGTTGGAGACG 65 FBgn0058212 CG40212 CG40212 CG40212 CDMC21702 2 18 2 DAC03-J23 1-CG40212-RA_2 CG40212 ACAAGAGCACTGACGAAACTCAGAAACAGGAGCATGAGAAGGAGGAGCCCCAGGTGTTGGAGACG 65 FBgn0058212 CG40212 CG40212 CG40212 CDMC21703 2 19 2 DAC03-N11 3-CG40374-RA_2 CG40374 GAGCTGTACACAGGCAGCGACCACGAGAATCCTCTAATCACGAGGTGTCCAAAGCAAGCCACTCG 65 FBgn0058374 CG40374 CG40374 CG40374 CDMC21703 2 20 2 DAC03-N11 3-CG40374-RA_2 CG40374 GAGCTGTACACAGGCAGCGACCACGAGAATCCTCTAATCACGAGGTGTCCAAAGCAAGCCACTCG 65 FBgn0058374 CG40374 CG40374 CG40374 CDMC21704 2 21 2 DAC03-N23 1-CG40450-RB_1 CG40450 TCCACCGGTGGGCCACTATCGATAGCTCCACTATCATACGCAGCACAAGGAATCACCAACAGCAG 65 FBgn0067319 CG40450 CG40450 CG40450 CDMC21704 2 22 2 DAC03-N23 1-CG40450-RB_1 CG40450 TCCACCGGTGGGCCACTATCGATAGCTCCACTATCATACGCAGCACAAGGAATCACCAACAGCAG 65 FBgn0067319 CG40450 CG40450 CG40450 CDMC21705 2 23 2 DAC04-B11 18-CG31517-RA_9 CG31517 GCGACATGCCCACACATTGACACCTACCAATAACCAACTATCAAGTACCGGCCATCCAATAAACGAACT 69 FBan0031517 FBgn0047199 CG31517 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31517 CG31517 BcDNA:LD34214 CDMC21705 2 24 2 DAC04-B11 18-CG31517-RA_9 CG31517 GCGACATGCCCACACATTGACACCTACCAATAACCAACTATCAAGTACCGGCCATCCAATAAACGAACT 69 FBan0031517 FBgn0047199 CG31517 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31517 CG31517 BcDNA:LD34214 CDMC21706 2 25 2 DAC04-B23 22-CG31524-RA_8 CG31524 TGGTGAATATGGATGACCTTCTGAACATGGAAGACGATCTGGTCTCCAAATTGGAAGGCTACGCTGAAA 69 FBan0031524 FBgn0051524 CG31524 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 CG31524 CG31524 CDMC21706 2 26 2 DAC04-B23 22-CG31524-RA_8 CG31524 TGGTGAATATGGATGACCTTCTGAACATGGAAGACGATCTGGTCTCCAAATTGGAAGGCTACGCTGAAA 69 FBan0031524 FBgn0051524 CG31524 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 CG31524 CG31524 CDMC21707 2 1 3 DAC04-F11 2-CG31555-RA_1 CG31555 ACCATCGACTCCCGACCTCTAGAGATCCCTCCAGTTTCCCCGAACAGAAACTAGCGAAGTAACCACGTT 69 FBan0031555 FBgn0051555 CG31555 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31555 CG31555 BcDNA:HL04389 CDMC21707 2 2 3 DAC04-F11 2-CG31555-RA_1 CG31555 ACCATCGACTCCCGACCTCTAGAGATCCCTCCAGTTTCCCCGAACAGAAACTAGCGAAGTAACCACGTT 69 FBan0031555 FBgn0051555 CG31555 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31555 CG31555 BcDNA:HL04389 CDMC21708 2 3 3 DAC04-F23 23-CG3159-RA_15 CG3159 AGCTGGCCTAGATTTAGTTTTAGTTGACCTCCTATTTTCCCGAAACTCACGTTTGGTTATACGCCCCTG 69 FBan0003159 FBgn0026438 Eaat2 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; dicarboxylic acid transport; GO:0006835; taurine transport; GO:0015734 cation transporter activity; GO:0008324; ; GO:0008324; sodium:dicarboxylate symporter activity; GO:0017153; glutamate:sodium symporter activity; GO:0015501; ; GO:0015501; ; GO:0017153; L-aspartate transporter activity; GO:0015183; taurine:sodium symporter activity; GO:0005369; ; GO:0015183; ; GO:0005369 plasma membrane; GO:0005886 Eaat2 Excitatory amino acid transporter 2 "CG3159, dEAAT2, sodium-dependent excitatory amino acid transporter 2, EAAT, Excitatory amino acid transporter 2" CDMC21708 2 4 3 DAC04-F23 23-CG3159-RA_15 CG3159 AGCTGGCCTAGATTTAGTTTTAGTTGACCTCCTATTTTCCCGAAACTCACGTTTGGTTATACGCCCCTG 69 FBan0003159 FBgn0026438 Eaat2 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; dicarboxylic acid transport; GO:0006835; taurine transport; GO:0015734 cation transporter activity; GO:0008324; ; GO:0008324; sodium:dicarboxylate symporter activity; GO:0017153; glutamate:sodium symporter activity; GO:0015501; ; GO:0015501; ; GO:0017153; L-aspartate transporter activity; GO:0015183; taurine:sodium symporter activity; GO:0005369; ; GO:0015183; ; GO:0005369 plasma membrane; GO:0005886 Eaat2 Excitatory amino acid transporter 2 "CG3159, dEAAT2, sodium-dependent excitatory amino acid transporter 2, EAAT, Excitatory amino acid transporter 2" CDMC21709 2 5 3 DAC04-J11 18-CG31632-RA_1 CG31632 TGGCAAACCAAAATCCAAATCCAAATCAACCGCAACCATTGTGCAATAGACGGAAGTGAAAGGCTTCGC 69 FBan0031632 FBgn0051632 CG31632 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31632 CG31632 "CG11243, CG17373" CDMC21709 2 6 3 DAC04-J11 18-CG31632-RA_1 CG31632 TGGCAAACCAAAATCCAAATCCAAATCAACCGCAACCATTGTGCAATAGACGGAAGTGAAAGGCTTCGC 69 FBan0031632 FBgn0051632 CG31632 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31632 CG31632 "CG11243, CG17373" CDMC21710 2 7 3 DAC04-J23 12-CG3163-RA_6 CG3163 CGCTGTGCATTTCGTCATCAGCTGAGGAAATACAACGAGGTCAAGAAAAAGGGCGAGAAGTACGAGCCC 69 FBan0003163 FBgn0034961 CG3163 2 2R CG3163 CG3163 CDMC21710 2 8 3 DAC04-J23 12-CG3163-RA_6 CG3163 CGCTGTGCATTTCGTCATCAGCTGAGGAAATACAACGAGGTCAAGAAAAAGGGCGAGAAGTACGAGCCC 69 FBan0003163 FBgn0034961 CG3163 2 2R CG3163 CG3163 CDMC21711 2 9 3 DAC04-N11 3-CG31664-RA_5 CG31664 TGCAGGGTTACGTGGAGAATGAGGTGGACCTTAACAGCGATGGAGCGTGCAATCAGGAATGTGGTTACT 69 FBan0031664 FBgn0051664 CG31664 2 2L CG31664 CG31664 CG15622 CDMC21711 2 10 3 DAC04-N11 3-CG31664-RA_5 CG31664 TGCAGGGTTACGTGGAGAATGAGGTGGACCTTAACAGCGATGGAGCGTGCAATCAGGAATGTGGTTACT 69 FBan0031664 FBgn0051664 CG31664 2 2L CG31664 CG31664 CG15622 CDMC21712 2 11 3 DAC04-N23 9-CG31674-RA_1 CG31674 CCTCCAAAAAATCGGCCTGAAATTCTAGAAAAGATCAGGGGGGCTCATGCCGTTATTTGGGGTGGTCGG 69 FBan0031674 FBgn0051674 CG31674 2 2L L-serine biosynthesis; GO:0006564; carbohydrate metabolism; GO:0005975 glyoxylate reductase (NADP) activity; GO:0030267 ; EC:1.1.1.79; ; GO:0030267 ; EC:1.1.1.79 CG31674 CG31674 "CG9332, CG9332" CDMC21712 2 12 3 DAC04-N23 9-CG31674-RA_1 CG31674 CCTCCAAAAAATCGGCCTGAAATTCTAGAAAAGATCAGGGGGGCTCATGCCGTTATTTGGGGTGGTCGG 69 FBan0031674 FBgn0051674 CG31674 2 2L L-serine biosynthesis; GO:0006564; carbohydrate metabolism; GO:0005975 glyoxylate reductase (NADP) activity; GO:0030267 ; EC:1.1.1.79; ; GO:0030267 ; EC:1.1.1.79 CG31674 CG31674 "CG9332, CG9332" CDMC21713 2 13 3 DAC05-B11 17-CG5972-RA_1 CG5972 TCCACACGGAGCAGATGTATAAGCACAAACTGGTGGACTTTGTCATTAGCTTCATGGAGGAGATCGACA 69 FBan0005972 FBgn0031781 Arc-p20 2 2L actin filament polymerization; GO:0030041; cell motility; GO:0006928; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arc-p20 Arc-p20 "CG5972, CG5972, CG5972, P-20 ARC, p20 subunit of Arp2/3, Arp-p20, BcDNA:RE43724, anon-EST:Posey49" CDMC21713 2 14 3 DAC05-B11 17-CG5972-RA_1 CG5972 TCCACACGGAGCAGATGTATAAGCACAAACTGGTGGACTTTGTCATTAGCTTCATGGAGGAGATCGACA 69 FBan0005972 FBgn0031781 Arc-p20 2 2L actin filament polymerization; GO:0030041; cell motility; GO:0006928; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arc-p20 Arc-p20 "CG5972, CG5972, CG5972, P-20 ARC, p20 subunit of Arp2/3, Arp-p20, BcDNA:RE43724, anon-EST:Posey49" CDMC21714 2 15 3 DAC05-B23 3-CG5989-RA_2 CG5989 GCGCTCCGAGTTCCAGAGCTACTACATGAAGCGGCGATTATGCAATAACAAGGACGTCTTTCGCTGCCT 69 FBan0005989 FBgn0017429 CG5989 3 3L CG5989 CG5989 "anon-66Db: anonymous-66Db, SAM methionine methyltransferase, anonymous-66Db" CDMC21714 2 16 3 DAC05-B23 3-CG5989-RA_2 CG5989 GCGCTCCGAGTTCCAGAGCTACTACATGAAGCGGCGATTATGCAATAACAAGGACGTCTTTCGCTGCCT 69 FBan0005989 FBgn0017429 CG5989 3 3L CG5989 CG5989 "anon-66Db: anonymous-66Db, SAM methionine methyltransferase, anonymous-66Db" CDMC21715 2 17 3 DAC05-F11 3-CG6028-RA_1 CG6028 TGTCGTGCAGTCGGAGATTGTTGGATTGGGCAAGCTGTGCAACAAGATTGTGGCTCCCTAAGATTGTCA 69 FBan0006028 FBgn0038924 CG6028 3 3R amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG6028 CG6028 CDMC21715 2 18 3 DAC05-F11 3-CG6028-RA_1 CG6028 TGTCGTGCAGTCGGAGATTGTTGGATTGGGCAAGCTGTGCAACAAGATTGTGGCTCCCTAAGATTGTCA 69 FBan0006028 FBgn0038924 CG6028 3 3R amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG6028 CG6028 CDMC21716 2 19 3 DAC05-F23 2-CG6042-RA_1 CG6042 TGAGAGATCCCGATACTCTTGAGGCTCCCGACGACTTCATAGACACCATCAACCGCTGGACCTTGGAAT 69 FBan0006042 FBgn0038681 Cyp12a4 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12a4 Cyp12a4 "CG6042, 12a4, cyp12a4" CDMC21716 2 20 3 DAC05-F23 2-CG6042-RA_1 CG6042 TGAGAGATCCCGATACTCTTGAGGCTCCCGACGACTTCATAGACACCATCAACCGCTGGACCTTGGAAT 69 FBan0006042 FBgn0038681 Cyp12a4 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12a4 Cyp12a4 "CG6042, 12a4, cyp12a4" CDMC21717 2 21 3 DAC05-J11 2-CG6071-RA_2 CG6071 TGGGCGCTTGACTCAAAAAAGGTTCCAAGAACGATGACAGCCAGTCTTCTGAGCGCCGTTTTGAGATCC 69 FBan0006071 FBgn0036186 CG6071 3 3L proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG6071 CG6071 CDMC21717 2 22 3 DAC05-J11 2-CG6071-RA_2 CG6071 TGGGCGCTTGACTCAAAAAAGGTTCCAAGAACGATGACAGCCAGTCTTCTGAGCGCCGTTTTGAGATCC 69 FBan0006071 FBgn0036186 CG6071 3 3L proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG6071 CG6071 CDMC21718 2 23 3 DAC05-J23 17-CG6090-RA_1 CG6090 AAGGGCGCTCCTAAAGGAGTCGTCAAGTCCAAGAAGTAACCATTTACCAGAAGGATTTGTTTGGAGCAA 69 FBan0006090 FBgn0039406 RpL34a 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34a Ribosomal protein L34a "CG6090, L34, RpL34, Ribosomal protein L34a" CDMC21718 2 24 3 DAC05-J23 17-CG6090-RA_1 CG6090 AAGGGCGCTCCTAAAGGAGTCGTCAAGTCCAAGAAGTAACCATTTACCAGAAGGATTTGTTTGGAGCAA 69 FBan0006090 FBgn0039406 RpL34a 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34a Ribosomal protein L34a "CG6090, L34, RpL34, Ribosomal protein L34a" CDMC21719 2 25 3 DAC05-N11 3-CG6131-RA_1 CG6131 ACGCGTGCTCTTTGTCGGTTGCCTCATAGTAGGCGTGGGTATGGTGAGATCACAGGACTACCAAGACTA 69 FBan0006131 FBgn0039480 CG6131 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG6131 CG6131 CDMC21719 2 26 3 DAC05-N11 3-CG6131-RA_1 CG6131 ACGCGTGCTCTTTGTCGGTTGCCTCATAGTAGGCGTGGGTATGGTGAGATCACAGGACTACCAAGACTA 69 FBan0006131 FBgn0039480 CG6131 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG6131 CG6131 CDMC21720 2 1 4 DAC05-N23 18-CG6140-RA_1 CG6140 TGCGTCCCGAGAAGATGCTGGGTCCTTCTTAGGTTTTCCTCCCTTGTTCCATGTGTTACACATTCATAA 69 FBan0006140 FBgn0036162 CG6140 3 3L fumarate metabolism; GO:0006106; tricarboxylic acid cycle; GO:0006099 fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2 cytoplasm; GO:0005737; mitochondrion; GO:0005739; tricarboxylic acid cycle enzyme complex; GO:0045239 CG6140 CG6140 CDMC21720 2 2 4 DAC05-N23 18-CG6140-RA_1 CG6140 TGCGTCCCGAGAAGATGCTGGGTCCTTCTTAGGTTTTCCTCCCTTGTTCCATGTGTTACACATTCATAA 69 FBan0006140 FBgn0036162 CG6140 3 3L fumarate metabolism; GO:0006106; tricarboxylic acid cycle; GO:0006099 fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2 cytoplasm; GO:0005737; mitochondrion; GO:0005739; tricarboxylic acid cycle enzyme complex; GO:0045239 CG6140 CG6140 CDMC21721 2 3 4 DAC06-B11 23-CG11525-RB_6 CG11525 GAGTGTAGTAGTGCTGGTTGAGGTAGAGTGTGTATATTTTGCTAAAGTGCATCATAATTCTTTTGGCAT 69 FBan0011525 FBgn0039858 CycG 3 3R DNA repair; GO:0006281 cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- CycG Cyclin G "CG11525, CG11525, CG11525, clone 1.25, clone 2.24, dCycG, CG 11525, cyclin G1, i261, i205, anon-EST:Liang-1.25, anon-EST:Liang-2.24, Cyclin G" CDMC21721 2 4 4 DAC06-B11 23-CG11525-RB_6 CG11525 GAGTGTAGTAGTGCTGGTTGAGGTAGAGTGTGTATATTTTGCTAAAGTGCATCATAATTCTTTTGGCAT 69 FBan0011525 FBgn0039858 CycG 3 3R DNA repair; GO:0006281 cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- CycG Cyclin G "CG11525, CG11525, CG11525, clone 1.25, clone 2.24, dCycG, CG 11525, cyclin G1, i261, i205, anon-EST:Liang-1.25, anon-EST:Liang-2.24, Cyclin G" CDMC21722 2 5 4 DAC06-B23 23-CG1154-RA_4 CG1154 CAACTCACTGTGCTTCAATTCTTATGGCTAACTGCACTTGCTATTTTCAATTACCTCTCGTACTTCCGC 69 FBan0001154 FBgn0037419 Osi12 3 3R Osi12 Osiris 12 "CG1154, CG1154, CG1154, Osiris, Osiris 12" CDMC21722 2 6 4 DAC06-B23 23-CG1154-RA_4 CG1154 CAACTCACTGTGCTTCAATTCTTATGGCTAACTGCACTTGCTATTTTCAATTACCTCTCGTACTTCCGC 69 FBan0001154 FBgn0037419 Osi12 3 3R Osi12 Osiris 12 "CG1154, CG1154, CG1154, Osiris, Osiris 12" CDMC21723 2 7 4 DAC06-F11 23-CG1158-RA_1 CG1158 GCGTGGATCGACGATTGCATACCAATTTATAAAAGATTGCTTTGATTGTTCGAATCTGATACTGGCGGC 69 FBan0001158 FBgn0037310 Tim17b1 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17b1 Tim17b1 "CG1158, BcDNA:AT16284" CDMC21723 2 8 4 DAC06-F11 23-CG1158-RA_1 CG1158 GCGTGGATCGACGATTGCATACCAATTTATAAAAGATTGCTTTGATTGTTCGAATCTGATACTGGCGGC 69 FBan0001158 FBgn0037310 Tim17b1 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17b1 Tim17b1 "CG1158, BcDNA:AT16284" CDMC21724 2 9 4 DAC06-F23 22-CG11600-RA_3 CG11600 CCCCGCCGTTTTCATGAAGCACGCAAGGAACAAGCTAATGAAAATGTTTGGGAACATCATTATGAGCAT 69 FBan0011600 FBgn0038068 CG11600 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11600 CG11600 CDMC21724 2 10 4 DAC06-F23 22-CG11600-RA_3 CG11600 CCCCGCCGTTTTCATGAAGCACGCAAGGAACAAGCTAATGAAAATGTTTGGGAACATCATTATGAGCAT 69 FBan0011600 FBgn0038068 CG11600 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11600 CG11600 CDMC21725 2 11 4 DAC06-J11 23-CG11641-RA_11 CG11641 TGTGCAGTTTTAGGCCAAATTTTATCACATTGATGTGCCATTCCAAAAAGAAAACAAAGCAAACCAGTT 69 FBan0011641 FBgn0033288 CG11641 2 2R carbohydrate metabolism; GO:0005975; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 "transcription factor activity; GO:0003700; ; GO:0003700; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" nucleus; GO:0005634 CG11641 CG11641 BcDNA:AT16994 CDMC21725 2 12 4 DAC06-J11 23-CG11641-RA_11 CG11641 TGTGCAGTTTTAGGCCAAATTTTATCACATTGATGTGCCATTCCAAAAAGAAAACAAAGCAAACCAGTT 69 FBan0011641 FBgn0033288 CG11641 2 2R carbohydrate metabolism; GO:0005975; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 "transcription factor activity; GO:0003700; ; GO:0003700; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" nucleus; GO:0005634 CG11641 CG11641 BcDNA:AT16994 CDMC21726 2 13 4 DAC06-J23 15-CG11658-RA_2 CG11658 GGACGTGGTTTCAGTTCAGTTGTTTGCCAACCAGTTGTATTACCACATCAGCAATCTGTGCAGGACCGA 69 FBan0011658 FBgn0036196 CG11658 3 3L CG11658 CG11658 anon-WO0118547.413 CDMC21726 2 14 4 DAC06-J23 15-CG11658-RA_2 CG11658 GGACGTGGTTTCAGTTCAGTTGTTTGCCAACCAGTTGTATTACCACATCAGCAATCTGTGCAGGACCGA 69 FBan0011658 FBgn0036196 CG11658 3 3L CG11658 CG11658 anon-WO0118547.413 CDMC21727 2 15 4 DAC06-N11 23-CG11710-RB_4 CG11710 CAAGGGTTAAGGTTGGGATTCAGTTTCAAAACACATTCTTATTAGTTTAATGCCTGTATGAAAACAGCC 69 FBan0011710 FBgn0031115 CG11710 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription cofactor activity; GO:0003712; ; GO:0003712; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 CG11710 CG11710 CDMC21727 2 16 4 DAC06-N11 23-CG11710-RB_4 CG11710 CAAGGGTTAAGGTTGGGATTCAGTTTCAAAACACATTCTTATTAGTTTAATGCCTGTATGAAAACAGCC 69 FBan0011710 FBgn0031115 CG11710 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription cofactor activity; GO:0003712; ; GO:0003712; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 CG11710 CG11710 CDMC21728 2 17 4 DAC06-N23 22-CG11722-RA_3 CG11722 TCCCAAGTTCGTGGACAAGCTCAATATGAAAGACTCCAGCTTGGACGGACGATTGAAAGACGTTTATGT 69 FBan0011722 FBgn0037777 CG11722 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG11722 CG11722 BcDNA:AT14909 CDMC21728 2 18 4 DAC06-N23 22-CG11722-RA_3 CG11722 TCCCAAGTTCGTGGACAAGCTCAATATGAAAGACTCCAGCTTGGACGGACGATTGAAAGACGTTTATGT 69 FBan0011722 FBgn0037777 CG11722 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG11722 CG11722 BcDNA:AT14909 CDMC21729 2 19 4 DAC07-B11 2-CG15002-RB_1 CG15002 TCTTGTGGCGATTTCCAGGACTGACGACTAGCCTGGTGTAGCCTACGATTGTTTCCAGGGGTTCC 65 FBan0015002 FBgn0011653 mas 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; proteolysis; GO:0006508; visual perception; GO:0007601 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; NOT peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; plasma membrane; GO:0005886 mas masquerade "CG15002, c-SPH79, SPH79" CDMC21729 2 20 4 DAC07-B11 2-CG15002-RB_1 CG15002 TCTTGTGGCGATTTCCAGGACTGACGACTAGCCTGGTGTAGCCTACGATTGTTTCCAGGGGTTCC 65 FBan0015002 FBgn0011653 mas 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; proteolysis; GO:0006508; visual perception; GO:0007601 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; NOT peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; plasma membrane; GO:0005886 mas masquerade "CG15002, c-SPH79, SPH79" CDMC21730 2 21 4 DAC07-B23 3-CG15027-RA_1 CG15027 GCACGTCGCCAAAACAACAAGCACAAGGTCCGTTTGGGTCATGCCATCAAAAGCAACATCACTGG 65 FBan0015027 FBgn0030611 CG15027 X X CG15027 CG15027 BcDNA:SD22530 CDMC21730 2 22 4 DAC07-B23 3-CG15027-RA_1 CG15027 GCACGTCGCCAAAACAACAAGCACAAGGTCCGTTTGGGTCATGCCATCAAAAGCAACATCACTGG 65 FBan0015027 FBgn0030611 CG15027 X X CG15027 CG15027 BcDNA:SD22530 CDMC21731 2 23 4 DAC07-F11 6-CG15106-RA_4 CG15106 CTATGCACTGGAGCAGTTTGTGGACTACTGGCGGGACAATTACCTGACCAAGTGGGATGAGCGCC 65 FBan0015106 FBgn0034406 Jheh3 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- microsome; GO:0005792 Jheh3 Juvenile hormone epoxide hydrolase 3 CG15106 CDMC21731 2 24 4 DAC07-F11 6-CG15106-RA_4 CG15106 CTATGCACTGGAGCAGTTTGTGGACTACTGGCGGGACAATTACCTGACCAAGTGGGATGAGCGCC 65 FBan0015106 FBgn0034406 Jheh3 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- microsome; GO:0005792 Jheh3 Juvenile hormone epoxide hydrolase 3 CG15106 CDMC21732 2 25 4 DAC07-F23 3-CG15136-RA_4 CG15136 GTTATCTACGTACACCCGGTGGAGTACGGCAACCTCGGAGGACATATGCTACGAGCCCCGTTACG 65 FBan0015136 FBgn0032625 CG15136 2 2L CG15136 CG15136 CDMC21732 2 26 4 DAC07-F23 3-CG15136-RA_4 CG15136 GTTATCTACGTACACCCGGTGGAGTACGGCAACCTCGGAGGACATATGCTACGAGCCCCGTTACG 65 FBan0015136 FBgn0032625 CG15136 2 2L CG15136 CG15136 CDMC21733 2 1 5 DAC07-J11 1-CG15210-RA_1 CG15210 GTTGCTCAAAGGATTTGGATGACAAACGCTCGTGGAGTCCCGAGGAGACCAAGAATGGCAGCACC 65 FBan0015210 FBgn0040850 CG15210 X X CG15210 CG15210 CDMC21733 2 2 5 DAC07-J11 1-CG15210-RA_1 CG15210 GTTGCTCAAAGGATTTGGATGACAAACGCTCGTGGAGTCCCGAGGAGACCAAGAATGGCAGCACC 65 FBan0015210 FBgn0040850 CG15210 X X CG15210 CG15210 CDMC21734 2 3 5 DAC07-J23 17-CG15247-RA_1 CG15247 TCTCGCAGCTGCAGTAATATTGCTCTGCCCAGGATCTTGTTATACGATCACACGGGCAATCTGCT 65 FBan0015247 FBgn0030156 CG15247 X X CG15247 CG15247 CDMC21734 2 4 5 DAC07-J23 17-CG15247-RA_1 CG15247 TCTCGCAGCTGCAGTAATATTGCTCTGCCCAGGATCTTGTTATACGATCACACGGGCAATCTGCT 65 FBan0015247 FBgn0030156 CG15247 X X CG15247 CG15247 CDMC21735 2 5 5 DAC07-N11 1-CG15344-RA_1 CG15344 ATTCCCGCTCCCAATTTTACTCCCACTTCTACTTCCACTCCGGCTACCGCATCTCCATCTCCAGC 65 FBan0015344 FBgn0030032 CG15344 X X CG15344 CG15344 CDMC21735 2 6 5 DAC07-N11 1-CG15344-RA_1 CG15344 ATTCCCGCTCCCAATTTTACTCCCACTTCTACTTCCACTCCGGCTACCGCATCTCCATCTCCAGC 65 FBan0015344 FBgn0030032 CG15344 X X CG15344 CG15344 CDMC21736 2 7 5 DAC07-N23 2-CG15364-RA_1 CG15364 AAGTCGATGCTCTAATGGGTAATGCACAGGTAAGCGGACCCAAAAACCCCGGAACTCAGCTCCAG 65 FBan0015364 FBgn0030075 CG15364 X X CG15364 CG15364 CDMC21736 2 8 5 DAC07-N23 2-CG15364-RA_1 CG15364 AAGTCGATGCTCTAATGGGTAATGCACAGGTAAGCGGACCCAAAAACCCCGGAACTCAGCTCCAG 65 FBan0015364 FBgn0030075 CG15364 X X CG15364 CG15364 CDMC21737 2 9 5 DAC08-B11 21-CG14456-RA_2 CG14456 TCCCTGGCCGAGAAAATGATGAGACCCAAGTTCAAGGACATCAAGTTCTGGAGCGACGAGAAGTTC 66 FBan0014456 FBgn0037176 CG14456 3 3L CG14456 CG14456 CDMC21737 2 10 5 DAC08-B11 21-CG14456-RA_2 CG14456 TCCCTGGCCGAGAAAATGATGAGACCCAAGTTCAAGGACATCAAGTTCTGGAGCGACGAGAAGTTC 66 FBan0014456 FBgn0037176 CG14456 3 3L CG14456 CG14456 CDMC21738 2 11 5 DAC08-B23 18-CG14536-RA_2 CG14536 CCACCAAATGCCAATAATTCTGTGATTTCCGTTGTGCGCACCTTTGTCATCACGTTCTTCACCTCG 66 FBan0014536 FBgn0031950 CG14536 2 2L CG14536 CG14536 CDMC21738 2 12 5 DAC08-B23 18-CG14536-RA_2 CG14536 CCACCAAATGCCAATAATTCTGTGATTTCCGTTGTGCGCACCTTTGTCATCACGTTCTTCACCTCG 66 FBan0014536 FBgn0031950 CG14536 2 2L CG14536 CG14536 CDMC21739 2 13 5 DAC08-F11 24-CG1475-RB_2 CG1475 GGGCAGAATTACATACGTTCAGATGCGTAGAAGTTTTTTAAAAGAGAATAAAACAACATCTAGTTT 66 FBan0001475 FBgn0037351 RpL13A 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL13A Ribosomal protein L13A "CG1475, bs25f04.y1, L13a2, cg1475, anon-EST:Posey125, anon-EST:fe1A5, anon-fast-evolving-1A5, Ribosomal protein L13A" CDMC21739 2 14 5 DAC08-F11 24-CG1475-RB_2 CG1475 GGGCAGAATTACATACGTTCAGATGCGTAGAAGTTTTTTAAAAGAGAATAAAACAACATCTAGTTT 66 FBan0001475 FBgn0037351 RpL13A 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL13A Ribosomal protein L13A "CG1475, bs25f04.y1, L13a2, cg1475, anon-EST:Posey125, anon-EST:fe1A5, anon-fast-evolving-1A5, Ribosomal protein L13A" CDMC21740 2 15 5 DAC08-F23 2-CG14817-RA_1 CG14817 GCAGGTAATGTTACTCCTCCGACACCCGTATCTCACCATGGAGCAGTCATTCGGTCATGCCAAGGA 66 FBan0014817 FBgn0026089 CG14817 X X CG14817 CG14817 EG:63B12.11 CDMC21740 2 16 5 DAC08-F23 2-CG14817-RA_1 CG14817 GCAGGTAATGTTACTCCTCCGACACCCGTATCTCACCATGGAGCAGTCATTCGGTCATGCCAAGGA 66 FBan0014817 FBgn0026089 CG14817 X X CG14817 CG14817 EG:63B12.11 CDMC21741 2 17 5 DAC08-J11 23-CG15283-RA_9 CG15283 AAAGGCAGCAAGTAATTTGAAAAAAGATGATGTCGAAGAAATGGAAACACCAGCGAATAGACAGAG 66 FBan0015283 FBgn0028844 CG15283 2 2L CG15283 CG15283 "BG:DS08340.1, DS08340.1" CDMC21741 2 18 5 DAC08-J11 23-CG15283-RA_9 CG15283 AAAGGCAGCAAGTAATTTGAAAAAAGATGATGTCGAAGAAATGGAAACACCAGCGAATAGACAGAG 66 FBan0015283 FBgn0028844 CG15283 2 2L CG15283 CG15283 "BG:DS08340.1, DS08340.1" CDMC21742 2 19 5 DAC08-J23 2-CG15393-RA_3 CG15393 GCAGGGGTACTCGCATTCTAGGCACCCATTAACACCAACTTGGCAACGCTTTGATGGACAGCTGAC 66 FBan0015393 FBgn0031429 CG15393 2 2L CG15393 CG15393 CDMC21742 2 20 5 DAC08-J23 2-CG15393-RA_3 CG15393 GCAGGGGTACTCGCATTCTAGGCACCCATTAACACCAACTTGGCAACGCTTTGATGGACAGCTGAC 66 FBan0015393 FBgn0031429 CG15393 2 2L CG15393 CG15393 CDMC21743 2 21 5 DAC08-N11 3-CG15911-RA_1 CG15911 GCCAAACAAACCGAGAGCACCATGAGCACCGACTGCCGGCACAAAATTGAATTGATAGCAGCATGA 66 FBan0015911 FBgn0040878 CG15911 X X CG15911 CG15911 CDMC21743 2 22 5 DAC08-N11 3-CG15911-RA_1 CG15911 GCCAAACAAACCGAGAGCACCATGAGCACCGACTGCCGGCACAAAATTGAATTGATAGCAGCATGA 66 FBan0015911 FBgn0040878 CG15911 X X CG15911 CG15911 CDMC21744 2 23 5 DAC08-N23 2-CG16978-RA_1 CG16978 GGCAGTGGATACAACAGTGCCGAAGAGTTCATGAATGCAATGGACGAGCTGATCAGACGCTGGCAG 66 FBan0016978 FBgn0040972 CG16978 2 2L CG16978 CG16978 CT35582 CDMC21744 2 24 5 DAC08-N23 2-CG16978-RA_1 CG16978 GGCAGTGGATACAACAGTGCCGAAGAGTTCATGAATGCAATGGACGAGCTGATCAGACGCTGGCAG 66 FBan0016978 FBgn0040972 CG16978 2 2L CG16978 CG16978 CT35582 CDMC21745 2 25 5 DAC09-B12 12-CG14088-RA_5 CG14088 TGTTGCGGTGCTCACAAGTCTACTGATTTTCTTATCGGGAACAGGATCGGCGCAATTCTTGGGGAACAT 69 FBan0014088 FBgn0036858 CG14088 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14088 CG14088 SPH199 CDMC21745 2 26 5 DAC09-B12 12-CG14088-RA_5 CG14088 TGTTGCGGTGCTCACAAGTCTACTGATTTTCTTATCGGGAACAGGATCGGCGCAATTCTTGGGGAACAT 69 FBan0014088 FBgn0036858 CG14088 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14088 CG14088 SPH199 CDMC21746 2 1 6 DAC09-B24 11-CG14103-RA_4 CG14103 GGGGCTGATTAACAAAAAGGACAAGCACCCCAGTGTATTTTTGTTCCTGCACCAGGATCCAAAGCTGGA 69 FBan0014103 FBgn0036908 CG14103 3 3L CG14103 CG14103 CDMC21746 2 2 6 DAC09-B24 11-CG14103-RA_4 CG14103 GGGGCTGATTAACAAAAAGGACAAGCACCCCAGTGTATTTTTGTTCCTGCACCAGGATCCAAAGCTGGA 69 FBan0014103 FBgn0036908 CG14103 3 3L CG14103 CG14103 CDMC21747 2 3 6 DAC09-F12 14-CG14149-RA_1 CG14149 CCCTGCCACGATCCAATCTCGTCGAGGAGGAATATCAGCCTGTGGAGATCTACAAATCCGACGATTACT 69 FBan0014149 FBgn0036105 CG14149 3 3L CG14149 CG14149 CDMC21747 2 4 6 DAC09-F12 14-CG14149-RA_1 CG14149 CCCTGCCACGATCCAATCTCGTCGAGGAGGAATATCAGCCTGTGGAGATCTACAAATCCGACGATTACT 69 FBan0014149 FBgn0036105 CG14149 3 3L CG14149 CG14149 CDMC21748 2 5 6 DAC09-F24 3-CG14164-RA_5 CG14164 CGCCCTTTGGTCAAGCTCTGTTCAGACTGTTAGTCAAGCGATTCGGTGATCCCGCTATCATCTGGCAGA 69 FBan0014164 FBgn0036057 CG14164 3 3L CG14164 CG14164 CDMC21748 2 6 6 DAC09-F24 3-CG14164-RA_5 CG14164 CGCCCTTTGGTCAAGCTCTGTTCAGACTGTTAGTCAAGCGATTCGGTGATCCCGCTATCATCTGGCAGA 69 FBan0014164 FBgn0036057 CG14164 3 3L CG14164 CG14164 CDMC21749 2 7 6 DAC09-J12 23-CG14210-RA_1 CG14210 GTATTTGTGTTGTTTGCATTTGATTTCATATTAGACTAAACCGAACGCAAAATGAGTGAATCCGCACCG 69 FBan0014210 FBgn0031040 CG14210 X X CG14210 CG14210 BcDNA:RE23450 CDMC21749 2 8 6 DAC09-J12 23-CG14210-RA_1 CG14210 GTATTTGTGTTGTTTGCATTTGATTTCATATTAGACTAAACCGAACGCAAAATGAGTGAATCCGCACCG 69 FBan0014210 FBgn0031040 CG14210 X X CG14210 CG14210 BcDNA:RE23450 CDMC21750 2 9 6 DAC09-J24 18-CG14216-RA_10 CG14216 TGTGTTCACTAAGGATTGGAATAAAAGTGCACGCCAATTTATGCCGGTTTCTTGTTGACGGCCTGTGTC 69 FBan0014216 FBgn0031054 CG14216 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG14216 CG14216 BEST:CK01830 CDMC21750 2 10 6 DAC09-J24 18-CG14216-RA_10 CG14216 TGTGTTCACTAAGGATTGGAATAAAAGTGCACGCCAATTTATGCCGGTTTCTTGTTGACGGCCTGTGTC 69 FBan0014216 FBgn0031054 CG14216 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG14216 CG14216 BEST:CK01830 CDMC21751 2 11 6 DAC09-N12 18-CG14258-RA_3 CG14258 GCTGGCCACCTCAGATGGTTATTTCGCTGATGTGCAAAGTGTAAAGGTAAATTTCCGCGAGATCAAGCA 69 FBan0014258 FBgn0039482 CG14258 3 3R CG14258 CG14258 CDMC21751 2 12 6 DAC09-N12 18-CG14258-RA_3 CG14258 GCTGGCCACCTCAGATGGTTATTTCGCTGATGTGCAAAGTGTAAAGGTAAATTTCCGCGAGATCAAGCA 69 FBan0014258 FBgn0039482 CG14258 3 3R CG14258 CG14258 CDMC21752 2 13 6 DAC09-N24 23-CG14275-RA_9 CG14275 ATCAGCGTTGGAGAAGTCTACTGGAAATCTAGTAACTGCAATCAAAAACCACAAAATGGCAATCACAAC 69 FBan0014275 FBgn0032022 CG14275 2 2L CG14275 CG14275 "CT33900, BcDNA:RE73208" CDMC21752 2 14 6 DAC09-N24 23-CG14275-RA_9 CG14275 ATCAGCGTTGGAGAAGTCTACTGGAAATCTAGTAACTGCAATCAAAAACCACAAAATGGCAATCACAAC 69 FBan0014275 FBgn0032022 CG14275 2 2L CG14275 CG14275 "CT33900, BcDNA:RE73208" CDMC21753 2 15 6 DAC10-B11 6-CG1958-RA_2 CG1958 CGCAGAAAATCACTGTAATGCCCATACATCGCGAGAGCCAGGTGAAAAGTACTCCCTCGTACGGCGACA 69 FBan0001958 FBgn0029940 CG1958 X X CG1958 CG1958 CDMC21753 2 16 6 DAC10-B11 6-CG1958-RA_2 CG1958 CGCAGAAAATCACTGTAATGCCCATACATCGCGAGAGCCAGGTGAAAAGTACTCCCTCGTACGGCGACA 69 FBan0001958 FBgn0029940 CG1958 X X CG1958 CG1958 CDMC21754 2 17 6 DAC10-B23 23-CG1969-RB_2 CG1969 GCACCTTCATCAAGTAGCCCTAAGATTGAAACACTCGCATAACTGTTAAACTGTTATTAACACTAATCA 69 FBan0001969 FBgn0039690 CG1969 3 3R glucosamine 6-phosphate N-acetyltransferase activity; GO:0004343 ; EC:2.3.1.4; ; GO:0004343 ; EC:2.3.1.4 CG1969 CG1969 CDMC21754 2 18 6 DAC10-B23 23-CG1969-RB_2 CG1969 GCACCTTCATCAAGTAGCCCTAAGATTGAAACACTCGCATAACTGTTAAACTGTTATTAACACTAATCA 69 FBan0001969 FBgn0039690 CG1969 3 3R glucosamine 6-phosphate N-acetyltransferase activity; GO:0004343 ; EC:2.3.1.4; ; GO:0004343 ; EC:2.3.1.4 CG1969 CG1969 CDMC21755 2 19 6 DAC10-F11 23-CG2009-RA_6 CG2009 GATGACAGATGCAGGGAAACTAAAGCAAACCACGATTTTGTCTTCAGAAAATAAGAAGCGTGAACGGGA 69 FBan0002009 FBgn0026262 bip2 4 4 regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 transcription factor TFIID complex; GO:0005669 bip2 bip2 "CG2009, CG2009, CG2009, bip-II, BIP2, TAFII155, TAF3, TAF[[II]]155, TFIID, dBIP2, dTAF[[II]]155, i163, i31" CDMC21755 2 20 6 DAC10-F11 23-CG2009-RA_6 CG2009 GATGACAGATGCAGGGAAACTAAAGCAAACCACGATTTTGTCTTCAGAAAATAAGAAGCGTGAACGGGA 69 FBan0002009 FBgn0026262 bip2 4 4 regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 transcription factor TFIID complex; GO:0005669 bip2 bip2 "CG2009, CG2009, CG2009, bip-II, BIP2, TAFII155, TAF3, TAF[[II]]155, TFIID, dBIP2, dTAF[[II]]155, i163, i31" CDMC21756 2 21 6 DAC10-F23 3-CG2028-RB_3 CG2028 GCGTACTGCCATGGCAAGGCATGAAGGCCAACACCAAGCAGCAGAAATACGAGAAGATCTCCGAAAAGA 69 FBan0002028 FBgn0015024 CkIalpha X X DNA repair; GO:0006281; Wnt receptor signaling pathway; GO:0016055; intracellular signaling cascade; GO:0007242; negative regulation of smoothened signaling pathway; GO:0045879; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163; regulation of proteolysis; GO:0030162; smoothened signaling pathway; GO:0007224 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- cytoplasm; GO:0005737; nucleus; GO:0005634 CkIalpha Casein kinase Ialpha "CG2028, CG2028, dmCK1, Casein kinase 1, dmckI, l(1)G0492, CK I, CKIa, CKIalpha, CK1, CKI, CK1alpha, CK1alpha, CkIalpha, CkIa, casein kinase I, CK1a, Casein Kinase 1, anon-WO03040301.93, anon-WO03040301.95, Casein kinase Ialpha" CDMC21756 2 22 6 DAC10-F23 3-CG2028-RB_3 CG2028 GCGTACTGCCATGGCAAGGCATGAAGGCCAACACCAAGCAGCAGAAATACGAGAAGATCTCCGAAAAGA 69 FBan0002028 FBgn0015024 CkIalpha X X DNA repair; GO:0006281; Wnt receptor signaling pathway; GO:0016055; intracellular signaling cascade; GO:0007242; negative regulation of smoothened signaling pathway; GO:0045879; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163; regulation of proteolysis; GO:0030162; smoothened signaling pathway; GO:0007224 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- cytoplasm; GO:0005737; nucleus; GO:0005634 CkIalpha Casein kinase Ialpha "CG2028, CG2028, dmCK1, Casein kinase 1, dmckI, l(1)G0492, CK I, CKIa, CKIalpha, CK1, CKI, CK1alpha, CK1alpha, CkIalpha, CkIa, casein kinase I, CK1a, Casein Kinase 1, anon-WO03040301.93, anon-WO03040301.95, Casein kinase Ialpha" CDMC21757 2 23 6 DAC10-J11 10-CG2060-RA_1 CG2060 ACCTGGGTCTCGTGATGCTGGGTTATAACGAAAAGGTGTTCAAAGATCCCCACAAGTTCCGACCTGAGC 69 FBan0002060 FBgn0014469 Cyp4e2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e2 Cytochrome P450-4e2 "CG2060, P450, P-450, CYP4E2, 4e2, Cyt-P450-4E2" CDMC21757 2 24 6 DAC10-J11 10-CG2060-RA_1 CG2060 ACCTGGGTCTCGTGATGCTGGGTTATAACGAAAAGGTGTTCAAAGATCCCCACAAGTTCCGACCTGAGC 69 FBan0002060 FBgn0014469 Cyp4e2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e2 Cytochrome P450-4e2 "CG2060, P450, P-450, CYP4E2, 4e2, Cyt-P450-4E2" CDMC21758 2 25 6 DAC10-J23 16-CG2075-RA_1 CG2075 GGACTTGGCCCGAATGAATGAGGATTTCGAGACATTCAAGGAGATTGGTTCTTCAAGTAGTCGTCGCGA 69 FBan0002075 FBgn0004372 aly 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325; male meiosis I; GO:0007141; meiosis; GO:0007126; spermatid development; GO:0007286; spermatogenesis; GO:0007283; transcription initiation; GO:0006352 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 aly always early "CG2075, CG2075, ms(3)2, ms(3)ry2" CDMC21758 2 26 6 DAC10-J23 16-CG2075-RA_1 CG2075 GGACTTGGCCCGAATGAATGAGGATTTCGAGACATTCAAGGAGATTGGTTCTTCAAGTAGTCGTCGCGA 69 FBan0002075 FBgn0004372 aly 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325; male meiosis I; GO:0007141; meiosis; GO:0007126; spermatid development; GO:0007286; spermatogenesis; GO:0007283; transcription initiation; GO:0006352 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 aly always early "CG2075, CG2075, ms(3)2, ms(3)ry2" CDMC21759 2 1 7 DAC10-N11 3-CG2105-RA_5 CG2105 TCAAGGTCAAGGCCGTAATTCCGCATCCGCAATACAACATGGCTATTGCCCACGACAATGACATAGCCC 69 FBan0002105 FBgn0033192 Corin 2 2R defense response; GO:0006952; development; GO:0007275; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; structural molecule activity; GO:0005198; transmembrane receptor activity; GO:0004888; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0005198; ; GO:0004888; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044 membrane; GO:0016020; microtubule; GO:0005874 Corin Corin "CG2105, CG2105, SP75, DCorin" CDMC21759 2 2 7 DAC10-N11 3-CG2105-RA_5 CG2105 TCAAGGTCAAGGCCGTAATTCCGCATCCGCAATACAACATGGCTATTGCCCACGACAATGACATAGCCC 69 FBan0002105 FBgn0033192 Corin 2 2R defense response; GO:0006952; development; GO:0007275; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; structural molecule activity; GO:0005198; transmembrane receptor activity; GO:0004888; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0005198; ; GO:0004888; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044 membrane; GO:0016020; microtubule; GO:0005874 Corin Corin "CG2105, CG2105, SP75, DCorin" CDMC21760 2 3 7 DAC10-N23 3-CG2120-RA_1 CG2120 AGCGACCATTTGCCTGTCCACTCTGTCCAGCACGATTTCTGCGCAAATCCAATCATAAGCAACACCTCA 69 FBan0002120 FBgn0030005 CG2120 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2120 CG2120 CDMC21760 2 4 7 DAC10-N23 3-CG2120-RA_1 CG2120 AGCGACCATTTGCCTGTCCACTCTGTCCAGCACGATTTCTGCGCAAATCCAATCATAAGCAACACCTCA 69 FBan0002120 FBgn0030005 CG2120 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2120 CG2120 CDMC21761 2 5 7 DAC11-B11 3-CG9194-RA_3 CG9194 AGTCTGGGCAGGCAATCATCTCGCTATGGCAACCATCTCGAACTTCCCGACTATGATGCTCCACC 65 FBan0009194 FBgn0035192 CG9194 3 3L cation transport; GO:0006812; potassium ion transport; GO:0006813 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG9194 CG9194 "anon-WO0109301.3, anon-WO0109301.19, anon-WO0109301.20, anon-WO0109301.21, anon-WO0109301.22, anon-WO0109301.23, anon-WO0109301.24, anon-WO0109301.25, anon-WO0109301.26, anon-WO0109301.27, anon-WO0109301.28, anon-WO0109301.29, anon-WO0109301.31, anon-WO0109301.32, anon-WO0109301.33, anon-WO0109301.34, anon-WO0109301.36, anon-WO0109301.37, anon-WO0109301.38" CDMC21761 2 6 7 DAC11-B11 3-CG9194-RA_3 CG9194 AGTCTGGGCAGGCAATCATCTCGCTATGGCAACCATCTCGAACTTCCCGACTATGATGCTCCACC 65 FBan0009194 FBgn0035192 CG9194 3 3L cation transport; GO:0006812; potassium ion transport; GO:0006813 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG9194 CG9194 "anon-WO0109301.3, anon-WO0109301.19, anon-WO0109301.20, anon-WO0109301.21, anon-WO0109301.22, anon-WO0109301.23, anon-WO0109301.24, anon-WO0109301.25, anon-WO0109301.26, anon-WO0109301.27, anon-WO0109301.28, anon-WO0109301.29, anon-WO0109301.31, anon-WO0109301.32, anon-WO0109301.33, anon-WO0109301.34, anon-WO0109301.36, anon-WO0109301.37, anon-WO0109301.38" CDMC21762 2 7 7 DAC11-B23 9-CG9254-RA_2 CG9254 CGGTGCCGATGCATTAATTGTCCTCCGCGTACTTATGGGACTCGGTGAAGGAACCACTTTCCCCG 65 FBan0009254 FBgn0028513 CG9254 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021 CG9254 CG9254 "BG:DS07660.1, DS07660.1" CDMC21762 2 8 7 DAC11-B23 9-CG9254-RA_2 CG9254 CGGTGCCGATGCATTAATTGTCCTCCGCGTACTTATGGGACTCGGTGAAGGAACCACTTTCCCCG 65 FBan0009254 FBgn0028513 CG9254 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021 CG9254 CG9254 "BG:DS07660.1, DS07660.1" CDMC21763 2 9 7 DAC11-F11 4-CG9346-RA_1 CG9346 ACGGCTAAGTTGCCTGGCTTCATACCCTCAAAGTGGGAGACAGTTGATCCCCAGCAAGTAGAAGC 65 FBan0009346 FBgn0034572 CG9346 2 2R RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729 CG9346 CG9346 cg9346 CDMC21763 2 10 7 DAC11-F11 4-CG9346-RA_1 CG9346 ACGGCTAAGTTGCCTGGCTTCATACCCTCAAAGTGGGAGACAGTTGATCCCCAGCAAGTAGAAGC 65 FBan0009346 FBgn0034572 CG9346 2 2R RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729 CG9346 CG9346 cg9346 CDMC21764 2 11 7 DAC11-F23 2-CG9376-RA_2 CG9376 TTTCCTCGGAGAGCTGCTAAAAGTTGTTTTGGCTCGCTTCTACGGGAAGGTTGAGGATGGCGTCC 65 FBan0009376 FBgn0036893 CG9376 3 3L GPI anchor biosynthesis; GO:0006506 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 CG9376 CG9376 CDMC21764 2 12 7 DAC11-F23 2-CG9376-RA_2 CG9376 TTTCCTCGGAGAGCTGCTAAAAGTTGTTTTGGCTCGCTTCTACGGGAAGGTTGAGGATGGCGTCC 65 FBan0009376 FBgn0036893 CG9376 3 3L GPI anchor biosynthesis; GO:0006506 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 CG9376 CG9376 CDMC21765 2 13 7 DAC11-J11 3-CG9498-RA_2 CG9498 GTGAAGACTCCGGTGCAAACGATCGTGTTCAGTGACCTCACGGTAGAGGGATTCAAGGTGGCCTC 65 FBan0009498 FBgn0031801 CG9498 2 2L CG9498 CG9498 CDMC21765 2 14 7 DAC11-J11 3-CG9498-RA_2 CG9498 GTGAAGACTCCGGTGCAAACGATCGTGTTCAGTGACCTCACGGTAGAGGGATTCAAGGTGGCCTC 65 FBan0009498 FBgn0031801 CG9498 2 2L CG9498 CG9498 CDMC21766 2 15 7 DAC11-J23 9-CG9541-RA_3 CG9541 AGTGTCGGTCGTCTTTTGCGCAATATCACGGACTCTGCACCACGTGCCAATACGGAAAGCTTCGC 65 FBan0009541 FBgn0032083 CG9541 2 2L ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3 CG9541 CG9541 CDMC21766 2 16 7 DAC11-J23 9-CG9541-RA_3 CG9541 AGTGTCGGTCGTCTTTTGCGCAATATCACGGACTCTGCACCACGTGCCAATACGGAAAGCTTCGC 65 FBan0009541 FBgn0032083 CG9541 2 2L ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3 CG9541 CG9541 CDMC21767 2 17 7 DAC11-N11 2-CG9614-RE_1 CG9614 TCTTCAGTATGCCGCCCTAAGTCATGGAAAGCGATTCGGGGAGGATGACTATCTTCTGGTGCCCG 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC21767 2 18 7 DAC11-N11 2-CG9614-RE_1 CG9614 TCTTCAGTATGCCGCCCTAAGTCATGGAAAGCGATTCGGGGAGGATGACTATCTTCTGGTGCCCG 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC21768 2 19 7 DAC11-N23 2-CG9637-RA_1 CG9637 ATTCACCGGTGCATTCTATTATGCAACCACGGTGCTAACCACCATTGGCTACGGACACTCGACGC 65 FBan0009637 FBgn0038165 Task6 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 Task6 Task6 "CG9637, K2P-TASK6, dTASK-6, anon-WO0109301.11, anon-WO0109301.53, anon-WO0109301.54, anon-WO0109301.55, anon-WO0109301.56, anon-WO0109301.57, anon-WO0109301.58, anon-WO0109301.59, anon-WO0109301.60" CDMC21768 2 20 7 DAC11-N23 2-CG9637-RA_1 CG9637 ATTCACCGGTGCATTCTATTATGCAACCACGGTGCTAACCACCATTGGCTACGGACACTCGACGC 65 FBan0009637 FBgn0038165 Task6 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 Task6 Task6 "CG9637, K2P-TASK6, dTASK-6, anon-WO0109301.11, anon-WO0109301.53, anon-WO0109301.54, anon-WO0109301.55, anon-WO0109301.56, anon-WO0109301.57, anon-WO0109301.58, anon-WO0109301.59, anon-WO0109301.60" CDMC21769 2 21 7 DAC12-B11 20-CG15431-RA_1 CG15431 GAGTCTGCCACACACACCCAGTACAGCAGCCTCAACACGGTAATCAGCATGGGTCGGTCCACGCC 65 FBan0015431 FBgn0031602 CG15431 2 2L CG15431 CG15431 CDMC21769 2 22 7 DAC12-B11 20-CG15431-RA_1 CG15431 GAGTCTGCCACACACACCCAGTACAGCAGCCTCAACACGGTAATCAGCATGGGTCGGTCCACGCC 65 FBan0015431 FBgn0031602 CG15431 2 2L CG15431 CG15431 CDMC21770 2 23 7 DAC12-B23 23-CG1543-RB_6 CG1543 AGTTTGACTGTAGTCGCTTTGTATTTTACCCTTTATCTGCATGGTCATTAGCATTATCAACGCGT 65 FBan0001543 FBgn0010329 Tbh X X behavioral response to ethanol; GO:0048149; catecholamine metabolism; GO:0006584; memory; GO:0007613; octopamine biosynthesis; GO:0006589; ovulation; GO:0030728 tyramine-beta hydroxylase activity; GO:0004836; dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1; ; GO:0004836; copper ion binding; GO:0005507; ; GO:0005507 Tbh Tyramine beta hydroxylase "CG1543, CG1543, Tbetah, Tyramine beta hydroxylase, TBH, TBetaH, tyramine-beta-hydroxylase, DBH, TbetaH, tyramine-beta-hydroxylase, T beta h, Dbh: Dopamine beta hydroxylase, Dopamine beta hydroxylase" CDMC21770 2 24 7 DAC12-B23 23-CG1543-RB_6 CG1543 AGTTTGACTGTAGTCGCTTTGTATTTTACCCTTTATCTGCATGGTCATTAGCATTATCAACGCGT 65 FBan0001543 FBgn0010329 Tbh X X behavioral response to ethanol; GO:0048149; catecholamine metabolism; GO:0006584; memory; GO:0007613; octopamine biosynthesis; GO:0006589; ovulation; GO:0030728 tyramine-beta hydroxylase activity; GO:0004836; dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1; ; GO:0004836; copper ion binding; GO:0005507; ; GO:0005507 Tbh Tyramine beta hydroxylase "CG1543, CG1543, Tbetah, Tyramine beta hydroxylase, TBH, TBetaH, tyramine-beta-hydroxylase, DBH, TbetaH, tyramine-beta-hydroxylase, T beta h, Dbh: Dopamine beta hydroxylase, Dopamine beta hydroxylase" CDMC21771 2 25 7 DAC12-F11 3-CG15522-RA_2 CG15522 ATAGCACCATGTTCCCACCCAGTTCTGAAGGACACATCCGAGTGTCTCGACGTGACTAGGCCAAG 65 FBan0015522 FBgn0039723 CG15522 3 3R CG15522 CG15522 CDMC21771 2 26 7 DAC12-F11 3-CG15522-RA_2 CG15522 ATAGCACCATGTTCCCACCCAGTTCTGAAGGACACATCCGAGTGTCTCGACGTGACTAGGCCAAG 65 FBan0015522 FBgn0039723 CG15522 3 3R CG15522 CG15522 CDMC21772 2 1 8 DAC12-F23 6-CG15537-RA_1 CG15537 TCCTTTGTGGCCAATGTGCGGTTCCACAAGATCACGCAACCCTGTAACGTTTTGGTCCAGGACAC 65 FBan0015537 FBgn0039770 CG15537 3 3R adrenocorticotropin-releasing hormone binding; GO:0017047; ; GO:0017047 CG15537 CG15537 CDMC21772 2 2 8 DAC12-F23 6-CG15537-RA_1 CG15537 TCCTTTGTGGCCAATGTGCGGTTCCACAAGATCACGCAACCCTGTAACGTTTTGGTCCAGGACAC 65 FBan0015537 FBgn0039770 CG15537 3 3R adrenocorticotropin-releasing hormone binding; GO:0017047; ; GO:0017047 CG15537 CG15537 CDMC21773 2 3 8 DAC12-J11 3-CG15634-RA_1 CG15634 CTGAACCGGAGGCCATGAATGATGACACTTGGATGCTGGTGCAATACAGTCCCGAACCGGAGATG 65 FBan0015634 FBgn0031621 CG15634 2 2L CG15634 CG15634 CDMC21773 2 4 8 DAC12-J11 3-CG15634-RA_1 CG15634 CTGAACCGGAGGCCATGAATGATGACACTTGGATGCTGGTGCAATACAGTCCCGAACCGGAGATG 65 FBan0015634 FBgn0031621 CG15634 2 2L CG15634 CG15634 CDMC21774 2 5 8 DAC12-J23 23-CG15663-RA_1 CG15663 GAAATCCAGAGAGCAAGGTAAATCATTTGTCAAGGGTCCTCAGCTTTTTCTATTTGTGTTTGTAA 65 FBan0033949 FBgn0034609 Rgk3 2 2R small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" Rgk3 Rgk3 "CG15663, CG33949, CG15664, CG15663" CDMC21774 2 6 8 DAC12-J23 23-CG15663-RA_1 CG15663 GAAATCCAGAGAGCAAGGTAAATCATTTGTCAAGGGTCCTCAGCTTTTTCTATTTGTGTTTGTAA 65 FBan0033949 FBgn0034609 Rgk3 2 2R small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" Rgk3 Rgk3 "CG15663, CG33949, CG15664, CG15663" CDMC21775 2 7 8 DAC12-N11 24-CG15760-RA_1 CG15760 CGATAGTAGATAAGTTCCGTTTGTAGTATTAACAAGTTCTGTAAGATTTCTATAGTGCGACACAC 65 FBan0015760 FBgn0030508 CG15760 X X CG15760 CG15760 CDMC21775 2 8 8 DAC12-N11 24-CG15760-RA_1 CG15760 CGATAGTAGATAAGTTCCGTTTGTAGTATTAACAAGTTCTGTAAGATTTCTATAGTGCGACACAC 65 FBan0015760 FBgn0030508 CG15760 X X CG15760 CG15760 CDMC21776 2 9 8 DAC12-N23 1-CG15777-RA_1 CG15777 GAAGCCAGAGCCACTGAAGCCACCAATAGCCACCGTCAGCTATCAGGATGAACAGAAGCCATCAC 65 FBan0015777 FBgn0029781 CG15777 X X CG15777 CG15777 CDMC21776 2 10 8 DAC12-N23 1-CG15777-RA_1 CG15777 GAAGCCAGAGCCACTGAAGCCACCAATAGCCACCGTCAGCTATCAGGATGAACAGAAGCCATCAC 65 FBan0015777 FBgn0029781 CG15777 X X CG15777 CG15777 CDMC21777 2 11 8 DAC13-B11 1-CG13026-RA_1 CG13026 GGCCCAGGTTACTTACCCTCATCATGAAGAGCCTTTTTGCTACCATGTTGGGCTACTTGCTCCTTGGGT 69 FBan0013026 FBgn0036656 CG13026 3 3L CG13026 CG13026 CDMC21777 2 12 8 DAC13-B11 1-CG13026-RA_1 CG13026 GGCCCAGGTTACTTACCCTCATCATGAAGAGCCTTTTTGCTACCATGTTGGGCTACTTGCTCCTTGGGT 69 FBan0013026 FBgn0036656 CG13026 3 3L CG13026 CG13026 CDMC21778 2 13 8 DAC13-B23 8-CG13037-RA_1 CG13037 CCCCAATCCCCAGATGAAGGTCCACTACAAACTGACCGACAACAAAATGGCCAGATTAGCCAAGGATGG 69 FBan0013037 FBgn0036613 mRpS34 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS34 mitochondrial ribosomal protein S34 "CG13037, MRP-S34, mitochondrial ribosomal protein S34" CDMC21778 2 14 8 DAC13-B23 8-CG13037-RA_1 CG13037 CCCCAATCCCCAGATGAAGGTCCACTACAAACTGACCGACAACAAAATGGCCAGATTAGCCAAGGATGG 69 FBan0013037 FBgn0036613 mRpS34 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS34 mitochondrial ribosomal protein S34 "CG13037, MRP-S34, mitochondrial ribosomal protein S34" CDMC21779 2 15 8 DAC13-F11 23-CG13076-RB_20 CG13076 GGAGACAACTCCAATTCCTAGAACACACCAAGAAGAAAAGACATGCGCATAGTACCCAGTAATTAAGCA 69 FBan0013076 FBgn0044028 Notum 3 3L Wnt receptor signaling pathway; GO:0016055; negative regulation of Wnt receptor signaling pathway; GO:0030178; proteoglycan metabolism; GO:0006029; wing disc dorsal/ventral pattern formation; GO:0048190 extracellular space; GO:0005615 Notum Notum "CG13076, CG13076, l(3)72CDf, lethal(3)72CDf, wf, wingful, Not, anon-WO0118547.482, anon-WO03062410.10, anon-WO03062410.8, l(3)72Da, lethal(3)72Da, Notum" CDMC21779 2 16 8 DAC13-F11 23-CG13076-RB_20 CG13076 GGAGACAACTCCAATTCCTAGAACACACCAAGAAGAAAAGACATGCGCATAGTACCCAGTAATTAAGCA 69 FBan0013076 FBgn0044028 Notum 3 3L Wnt receptor signaling pathway; GO:0016055; negative regulation of Wnt receptor signaling pathway; GO:0030178; proteoglycan metabolism; GO:0006029; wing disc dorsal/ventral pattern formation; GO:0048190 extracellular space; GO:0005615 Notum Notum "CG13076, CG13076, l(3)72CDf, lethal(3)72CDf, wf, wingful, Not, anon-WO0118547.482, anon-WO03062410.10, anon-WO03062410.8, l(3)72Da, lethal(3)72Da, Notum" CDMC21780 2 17 8 DAC13-F23 8-CG1308-RA_1 CG1308 TGCCTGATCTGCCGTCAACTTCCTCTGGTCCCGTCTTCTTCAATGATTTCCAAATGTACAGCACCAGCA 69 FBan0001308 FBgn0035507 CG1308 3 3L CG1308 CG1308 CDMC21780 2 18 8 DAC13-F23 8-CG1308-RA_1 CG1308 TGCCTGATCTGCCGTCAACTTCCTCTGGTCCCGTCTTCTTCAATGATTTCCAAATGTACAGCACCAGCA 69 FBan0001308 FBgn0035507 CG1308 3 3L CG1308 CG1308 CDMC21781 2 19 8 DAC13-J11 3-CG13126-RA_1 CG13126 ACCGTCACACCTCCCTCTACAGTTATGCCATCCTGAAGAAGGGTTCCCAATCCGATAGCTCAAGCTCCT 69 FBan0013126 FBgn0032168 CG13126 2 2L CG13126 CG13126 anon-WO0118547.208 CDMC21781 2 20 8 DAC13-J11 3-CG13126-RA_1 CG13126 ACCGTCACACCTCCCTCTACAGTTATGCCATCCTGAAGAAGGGTTCCCAATCCGATAGCTCAAGCTCCT 69 FBan0013126 FBgn0032168 CG13126 2 2L CG13126 CG13126 anon-WO0118547.208 CDMC21782 2 21 8 DAC13-J23 3-CG13140-RA_1 CG13140 GCCTATCTCCTGAATCCCTCGGTCAGTGTGCTTACTGTGAAGCAAGTCAATTTCCGTCATGCCGGCAAC 69 FBan0013140 FBgn0032233 dpr19 2 2L dpr19 dpr19 "CG13140, CG13140, Dpr-19, BcDNA:LP09705" CDMC21782 2 22 8 DAC13-J23 3-CG13140-RA_1 CG13140 GCCTATCTCCTGAATCCCTCGGTCAGTGTGCTTACTGTGAAGCAAGTCAATTTCCGTCATGCCGGCAAC 69 FBan0013140 FBgn0032233 dpr19 2 2L dpr19 dpr19 "CG13140, CG13140, Dpr-19, BcDNA:LP09705" CDMC21783 2 23 8 DAC13-N11 9-CG13192-RA_4 CG13192 TGTGATGGAATTGGCCCAAGATGCTACGTCTGTGGACTACGATCCAGTTACGAATCGTGGCATTGTGGG 69 FBan0013192 FBgn0033653 CG13192 2 2R CG13192 CG13192 CDMC21783 2 24 8 DAC13-N11 9-CG13192-RA_4 CG13192 TGTGATGGAATTGGCCCAAGATGCTACGTCTGTGGACTACGATCCAGTTACGAATCGTGGCATTGTGGG 69 FBan0013192 FBgn0033653 CG13192 2 2R CG13192 CG13192 CDMC21784 2 25 8 DAC13-N23 23-CG1319-RA_6 CG1319 TCAGTTATAGTAAGAGATTGCAAAGGAATCCTAACCAGAATGCTAGTCATAAACTCATGCAGAGCTGCC 69 FBan0001319 FBgn0035529 CG1319 3 3L ferredoxin metabolism; GO:0006124 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; electron carrier activity; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0009055 mitochondrial matrix; GO:0005759 CG1319 CG1319 "BcDNA:RE08888, BcDNA:RH09920" CDMC21784 2 26 8 DAC13-N23 23-CG1319-RA_6 CG1319 TCAGTTATAGTAAGAGATTGCAAAGGAATCCTAACCAGAATGCTAGTCATAAACTCATGCAGAGCTGCC 69 FBan0001319 FBgn0035529 CG1319 3 3L ferredoxin metabolism; GO:0006124 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; electron carrier activity; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0009055 mitochondrial matrix; GO:0005759 CG1319 CG1319 "BcDNA:RE08888, BcDNA:RH09920" CDMC21785 2 1 9 DAC14-B11 3-CG40158-RA_1 CG40158 GGCAATGGCGCTGATGTCCGAGGCAAAACTCGAGATTGGAAAATGGGTGTTCAGCAGCAACAAAATCGA 69 FBgn0058158 CG40158 CG40158 CG40158 CDMC21785 2 2 9 DAC14-B11 3-CG40158-RA_1 CG40158 GGCAATGGCGCTGATGTCCGAGGCAAAACTCGAGATTGGAAAATGGGTGTTCAGCAGCAACAAAATCGA 69 FBgn0058158 CG40158 CG40158 CG40158 CDMC21786 2 3 9 DAC14-B23 23-CG40169-RB_3 CG40169 TGCCTATATTTGGCCTAGTTAAACTCAATTATTATGCAAAGTCAACAATGTCTATTTGTGCCACCAAAA 69 FBan0040169 FBgn0058169 CG40169 2 2L CG40169 CG40169 CDMC21786 2 4 9 DAC14-B23 23-CG40169-RB_3 CG40169 TGCCTATATTTGGCCTAGTTAAACTCAATTATTATGCAAAGTCAACAATGTCTATTTGTGCCACCAAAA 69 FBan0040169 FBgn0058169 CG40169 2 2L CG40169 CG40169 CDMC21787 2 5 9 DAC14-F11 9-CG40211-RA_1 CG40211 AGCGGAACAAGGAAAGAGAGTCTTTCGTCTTGCGCAACTTACGAAGGGAGTCAAAGACCTCGGCAATGT 69 FBgn0058211 CG40211 CG40211 CG40211 CDMC21787 2 6 9 DAC14-F11 9-CG40211-RA_1 CG40211 AGCGGAACAAGGAAAGAGAGTCTTTCGTCTTGCGCAACTTACGAAGGGAGTCAAAGACCTCGGCAATGT 69 FBgn0058211 CG40211 CG40211 CG40211 CDMC21788 2 7 9 DAC14-F23 47-CG4022-RA_2 CG4022 CCCAGTGAACGAATGAGAAACAAAAGGATATCTTATTGAAACTGATTAAACTAAAGACTGCCGAATAGT 69 FBan0004022 FBgn0035986 CG4022 3 3L CG4022 CG4022 CDMC21788 2 8 9 DAC14-F23 47-CG4022-RA_2 CG4022 CCCAGTGAACGAATGAGAAACAAAAGGATATCTTATTGAAACTGATTAAACTAAAGACTGCCGAATAGT 69 FBan0004022 FBgn0035986 CG4022 3 3L CG4022 CG4022 CDMC21789 2 9 9 DAC14-J11 23-CG40295-RA_1 CG40295 TCATTCAAGAAGGTGCCATTCTAATAAGTGGAAATAATATTGTGAACGATTCGCATTTAAACTGGTCAT 69 FBgn0058295 CG40295 CG40295 CG40295 CDMC21789 2 10 9 DAC14-J11 23-CG40295-RA_1 CG40295 TCATTCAAGAAGGTGCCATTCTAATAAGTGGAAATAATATTGTGAACGATTCGCATTTAAACTGGTCAT 69 FBgn0058295 CG40295 CG40295 CG40295 CDMC21790 2 11 9 DAC14-J23 23-CG40306-RA_12 CG40306 GCTGGCTCCAGTTTTCCACTTCACATGATGTTAACATTAGCATTAACGTGTAAGTTTATGGCGAAGGCT 69 CDMC21790 2 12 9 DAC14-J23 23-CG40306-RA_12 CG40306 GCTGGCTCCAGTTTTCCACTTCACATGATGTTAACATTAGCATTAACGTGTAAGTTTATGGCGAAGGCT 69 CDMC21791 2 13 9 DAC14-N11 1-CG40367-RA_1 CG40367 CGTCTTGACGTGGTATCTTGATCCTTCACCTAAGCCTCTCCGAACTCCTCTCGTCAACCTGCGCCTTCT 69 FBgn0058367 CG40367 CG40367 CG40367 CDMC21791 2 14 9 DAC14-N11 1-CG40367-RA_1 CG40367 CGTCTTGACGTGGTATCTTGATCCTTCACCTAAGCCTCTCCGAACTCCTCTCGTCAACCTGCGCCTTCT 69 FBgn0058367 CG40367 CG40367 CG40367 CDMC21792 2 15 9 DAC14-N23 24-CG40383-RA_7 CG40383 CTAGTGTCTTTGGTTTTACTCTCAACACACTCTTTTTCAGTTTTTTTCCTTTTTCTAATAAAGAAACTT 69 FBgn0058383 CG40383 CG40383 CG40383 CDMC21792 2 16 9 DAC14-N23 24-CG40383-RA_7 CG40383 CTAGTGTCTTTGGTTTTACTCTCAACACACTCTTTTTCAGTTTTTTTCCTTTTTCTAATAAAGAAACTT 69 FBgn0058383 CG40383 CG40383 CG40383 CDMC21793 2 17 9 DAC15-B11 2-CG7289-RA_1 CG7289 CCAGGAGCACATTGACGTTTGGACTGATTTGTGGGCCACTGGATTTACGATAAGCACATCCAAGGCGGA 69 FBan0007289 FBgn0031379 CG7289 2 2L CG7289 CG7289 CDMC21793 2 18 9 DAC15-B11 2-CG7289-RA_1 CG7289 CCAGGAGCACATTGACGTTTGGACTGATTTGTGGGCCACTGGATTTACGATAAGCACATCCAAGGCGGA 69 FBan0007289 FBgn0031379 CG7289 2 2L CG7289 CG7289 CDMC21794 2 19 9 DAC15-B23 10-CG7297-RA_1 CG7297 TGGTCAACCCAAATTAGCTCCTTGTAGTTCGGACCACGTATTCCCAAGTCCAGAGCAGTATTGGAGCCT 69 FBan0007297 FBgn0036529 pgant8 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant8 polypeptide GalNAc transferase 8 "CG7297, CG7297, CG7297, polypeptide GalNAc transferase 8" CDMC21794 2 20 9 DAC15-B23 10-CG7297-RA_1 CG7297 TGGTCAACCCAAATTAGCTCCTTGTAGTTCGGACCACGTATTCCCAAGTCCAGAGCAGTATTGGAGCCT 69 FBan0007297 FBgn0036529 pgant8 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant8 polypeptide GalNAc transferase 8 "CG7297, CG7297, CG7297, polypeptide GalNAc transferase 8" CDMC21795 2 21 9 DAC15-F11 23-CG7331-RA_1 CG7331 ACTTAGTTGGCACTGTCAGGAAGTTGAAGAGAGCAGCTAGTGTTTTGTTTTGTCTTTAATCGTTGGTCG 69 FBan0007331 FBgn0037582 CG7331 3 3R CG7331 CG7331 BcDNA:HL01508 CDMC21795 2 22 9 DAC15-F11 23-CG7331-RA_1 CG7331 ACTTAGTTGGCACTGTCAGGAAGTTGAAGAGAGCAGCTAGTGTTTTGTTTTGTCTTTAATCGTTGGTCG 69 FBan0007331 FBgn0037582 CG7331 3 3R CG7331 CG7331 BcDNA:HL01508 CDMC21796 2 23 9 DAC15-F23 23-CG7339-RA_6 CG7339 GTCCTTCTTAACGTGGGATTATGCATTGCGCTGAAGGATATTGTTTCACTGAAGGATTCCATCATCCTG 69 FBan0007339 FBgn0036188 CG7339 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368; transcription from RNA polymerase III promoter; GO:0006383 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6 DNA-directed RNA polymerase III complex; GO:0005666 CG7339 CG7339 CDMC21796 2 24 9 DAC15-F23 23-CG7339-RA_6 CG7339 GTCCTTCTTAACGTGGGATTATGCATTGCGCTGAAGGATATTGTTTCACTGAAGGATTCCATCATCCTG 69 FBan0007339 FBgn0036188 CG7339 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368; transcription from RNA polymerase III promoter; GO:0006383 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6 DNA-directed RNA polymerase III complex; GO:0005666 CG7339 CG7339 CDMC21797 2 25 9 DAC15-J11 5-CG7366-RA_1 CG7366 CACGCCCGAGTTCGAGAGCATTAAGCGGTCTAACCAGGATCTGCTTAAGGAAATCGACTCGCTGCACTG 69 FBan0007366 FBgn0035855 CG7366 3 3L CG7366 CG7366 anon-WO0140519.185 CDMC21797 2 26 9 DAC15-J11 5-CG7366-RA_1 CG7366 CACGCCCGAGTTCGAGAGCATTAAGCGGTCTAACCAGGATCTGCTTAAGGAAATCGACTCGCTGCACTG 69 FBan0007366 FBgn0035855 CG7366 3 3L CG7366 CG7366 anon-WO0140519.185 CDMC21798 2 1 10 DAC15-J23 3-CG7379-RA_1 CG7379 TGTGCCCCATCGAGTGGTTCCATTTTTCGTGCGTCTCCCTGGTACTAAAACCAAAAGGCAAGTGGTTCT 69 FBan0007379 FBgn0038546 CG7379 3 3R "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 CG7379 CG7379 CDMC21798 2 2 10 DAC15-J23 3-CG7379-RA_1 CG7379 TGTGCCCCATCGAGTGGTTCCATTTTTCGTGCGTCTCCCTGGTACTAAAACCAAAAGGCAAGTGGTTCT 69 FBan0007379 FBgn0038546 CG7379 3 3R "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 CG7379 CG7379 CDMC21799 2 3 10 DAC15-N11 13-CG7420-RA_2 CG7420 ACTGTGCCGTCCTTACGCAAGACAACAAAATCTACGTTTTCGGACGATTGAGGATTATGGACCCTCCGC 69 FBan0007420 FBgn0031344 CG7420 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; transport; GO:0006810" guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7420 CG7420 CDMC21799 2 4 10 DAC15-N11 13-CG7420-RA_2 CG7420 ACTGTGCCGTCCTTACGCAAGACAACAAAATCTACGTTTTCGGACGATTGAGGATTATGGACCCTCCGC 69 FBan0007420 FBgn0031344 CG7420 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; transport; GO:0006810" guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7420 CG7420 CDMC21800 2 5 10 DAC15-N23 22-CG7437-RA_1 CG7437 CGCCCAGTGCAATTGTTAAAACACCCATTCACTAAATTCAACAATCAACCGCTAGCTAAGCAACAGCCA 69 FBan0007437 FBgn0014362 mub 3 3L "histone mRNA 3'-end processing; GO:0006398; induction of apoptosis; GO:0006917; mRNA polyadenylylation; GO:0006378; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of progression through cell cycle; GO:0000074; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" poly(rC) binding; GO:0017130; ; GO:0017130 nucleus; GO:0005634 mub mushroom-body expressed "CG7437, CG7437, l(3)04093, mushroom bodies, Mub, anon-WO0172774.33, anon-WO0172774.35, anon-WO0172774.36, anon-WO0172774.37, l(3)j6B10, l(3)j8B3, mushroom-body expressed" CDMC21800 2 6 10 DAC15-N23 22-CG7437-RA_1 CG7437 CGCCCAGTGCAATTGTTAAAACACCCATTCACTAAATTCAACAATCAACCGCTAGCTAAGCAACAGCCA 69 FBan0007437 FBgn0014362 mub 3 3L "histone mRNA 3'-end processing; GO:0006398; induction of apoptosis; GO:0006917; mRNA polyadenylylation; GO:0006378; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of progression through cell cycle; GO:0000074; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" poly(rC) binding; GO:0017130; ; GO:0017130 nucleus; GO:0005634 mub mushroom-body expressed "CG7437, CG7437, l(3)04093, mushroom bodies, Mub, anon-WO0172774.33, anon-WO0172774.35, anon-WO0172774.36, anon-WO0172774.37, l(3)j6B10, l(3)j8B3, mushroom-body expressed" CDMC21801 2 7 10 DAC16-B11 12-CG12269-RA_5 CG12269 ACATGAAGAGCGACGAGATCATCGAGAAGATACGCAACAAGTTGAAGGAATCGGATCCTGCCCGGC 66 FBan0012269 FBgn0038665 CG12269 3 3R CG12269 CG12269 CDMC21801 2 8 10 DAC16-B11 12-CG12269-RA_5 CG12269 ACATGAAGAGCGACGAGATCATCGAGAAGATACGCAACAAGTTGAAGGAATCGGATCCTGCCCGGC 66 FBan0012269 FBgn0038665 CG12269 3 3R CG12269 CG12269 CDMC21802 2 9 10 DAC16-B23 9-CG12366-RA_7 CG12366 GGAACGATATAGCCTTCAGCAGGAGAAGAACGATCCAGACAAGCCCAATTGCCACGCCAAGGATGG 66 FBan0012366 FBgn0033901 O-fut1 2 2R nervous system development; GO:0007399; protein amino acid O-linked glycosylation; GO:0006493; regulation of Notch signaling pathway; GO:0008593 fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.- NOT Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to Golgi membrane; GO:0030173 O-fut1 O-fucosyltransferase 1 "CG12366, CG12366, CG12366, CG12366, CG12366, O-FUT1, AAF58290.1, OFUT1, ntc, 4R6, neurotic, Ofut1, nti, l(2)SH2 2260, l(2)SH2260, O-fucosyltransferase 1" CDMC21802 2 10 10 DAC16-B23 9-CG12366-RA_7 CG12366 GGAACGATATAGCCTTCAGCAGGAGAAGAACGATCCAGACAAGCCCAATTGCCACGCCAAGGATGG 66 FBan0012366 FBgn0033901 O-fut1 2 2R nervous system development; GO:0007399; protein amino acid O-linked glycosylation; GO:0006493; regulation of Notch signaling pathway; GO:0008593 fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.- NOT Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to Golgi membrane; GO:0030173 O-fut1 O-fucosyltransferase 1 "CG12366, CG12366, CG12366, CG12366, CG12366, O-FUT1, AAF58290.1, OFUT1, ntc, 4R6, neurotic, Ofut1, nti, l(2)SH2 2260, l(2)SH2260, O-fucosyltransferase 1" CDMC21803 2 11 10 DAC16-F11 3-CG13021-RB_1 CG13021 GCTGAACAAAGGTTGGCTAGCGCACTTGAGGGCCAATTGAGTGTGGCATAATTTGATGGTGTGCGC 66 FBan0013021 FBgn0029669 CG13021 X X CG13021 CG13021 BcDNA:AT30881 CDMC21803 2 12 10 DAC16-F11 3-CG13021-RB_1 CG13021 GCTGAACAAAGGTTGGCTAGCGCACTTGAGGGCCAATTGAGTGTGGCATAATTTGATGGTGTGCGC 66 FBan0013021 FBgn0029669 CG13021 X X CG13021 CG13021 BcDNA:AT30881 CDMC21804 2 13 10 DAC16-F23 2-CG13196-RA_1 CG13196 GGTGGAGAGATCCTTAACACGGTTCAGTTGGTCAGTTCGAGGGGCTGTCTAAATCCCGCCATGCAG 66 FBan0013196 FBgn0033645 CG13196 2 2R CG13196 CG13196 CDMC21804 2 14 10 DAC16-F23 2-CG13196-RA_1 CG13196 GGTGGAGAGATCCTTAACACGGTTCAGTTGGTCAGTTCGAGGGGCTGTCTAAATCCCGCCATGCAG 66 FBan0013196 FBgn0033645 CG13196 2 2R CG13196 CG13196 CDMC21805 2 15 10 DAC16-J11 1-CG13489-RA_1 CG13489 GGTCCTGGATTGCTGATTTTTCCCGGCACCGGTCAAAGACATCAGCATAATCCAAATGGCAGCACG 66 FBan0013489 FBgn0034672 CG13489 2 2R CG13489 CG13489 CDMC21805 2 16 10 DAC16-J11 1-CG13489-RA_1 CG13489 GGTCCTGGATTGCTGATTTTTCCCGGCACCGGTCAAAGACATCAGCATAATCCAAATGGCAGCACG 66 FBan0013489 FBgn0034672 CG13489 2 2R CG13489 CG13489 CDMC21806 2 17 10 DAC16-J23 3-CG13646-RA_3 CG13646 GGTTTCCTTACCGTGCTCAACAGCTACAGCATATTGGCCTTCCAGTTTGACATCCACCCCGTCCTG 66 FBan0013646 FBgn0039255 CG13646 3 3R CG13646 CG13646 CDMC21806 2 18 10 DAC16-J23 3-CG13646-RA_3 CG13646 GGTTTCCTTACCGTGCTCAACAGCTACAGCATATTGGCCTTCCAGTTTGACATCCACCCCGTCCTG 66 FBan0013646 FBgn0039255 CG13646 3 3R CG13646 CG13646 CDMC21807 2 19 10 DAC16-N11 3-CG14129-RA_1 CG14129 CGAGCATACAGCATCCACAGCAAATGAATATCCTGTGCACCGGAACACTGGGACGCCAAAGGATGC 66 FBan0014129 FBgn0036216 CG14129 3 3L CG14129 CG14129 CDMC21807 2 20 10 DAC16-N11 3-CG14129-RA_1 CG14129 CGAGCATACAGCATCCACAGCAAATGAATATCCTGTGCACCGGAACACTGGGACGCCAAAGGATGC 66 FBan0014129 FBgn0036216 CG14129 3 3L CG14129 CG14129 CDMC21808 2 21 10 DAC16-N23 3-CG14223-RA_1 CG14223 ACCACCAACACCAACAAACGAACCATGCGCAAGCTCAAAGCCAGACACACAATCTTAGCCAGTTGC 66 FBan0014223 FBgn0031053 CG14223 X X CG14223 CG14223 CDMC21808 2 22 10 DAC16-N23 3-CG14223-RA_1 CG14223 ACCACCAACACCAACAAACGAACCATGCGCAAGCTCAAAGCCAGACACACAATCTTAGCCAGTTGC 66 FBan0014223 FBgn0031053 CG14223 X X CG14223 CG14223 CDMC21809 2 23 10 DAC17-B11 11-CG17285-RB_1 CG17285 ACCATTGACATGGACATCACTTCGGATCAGGATCAGGATGCTATTATTCGCATCTTCCTGGGACCCGCA 69 FBan0017285 FBgn0000639 Fbp1 3 3L storage protein import into fat body; GO:0015032 protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0008565 Fbp1 Fat body protein 1 "CG17285, CG17285, P1: Protein-1, fbp1, Fbp-1, DmeFBP1, fbp-1, Protein-1" CDMC21809 2 24 10 DAC17-B11 11-CG17285-RB_1 CG17285 ACCATTGACATGGACATCACTTCGGATCAGGATCAGGATGCTATTATTCGCATCTTCCTGGGACCCGCA 69 FBan0017285 FBgn0000639 Fbp1 3 3L storage protein import into fat body; GO:0015032 protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0008565 Fbp1 Fat body protein 1 "CG17285, CG17285, P1: Protein-1, fbp1, Fbp-1, DmeFBP1, fbp-1, Protein-1" CDMC21810 2 25 10 DAC17-B23 3-CG17294-RA_2 CG17294 AAGGAGCACTCATTGATCTCAGTGGCACCTTGCATGTGGAGGATGAACCTACTCCGAATGCTGTCGAGG 69 FBan0017294 FBgn0032032 CG17294 2 2L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG17294 CG17294 CDMC21810 2 26 10 DAC17-B23 3-CG17294-RA_2 CG17294 AAGGAGCACTCATTGATCTCAGTGGCACCTTGCATGTGGAGGATGAACCTACTCCGAATGCTGTCGAGG 69 FBan0017294 FBgn0032032 CG17294 2 2L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG17294 CG17294 CDMC21811 2 1 11 DAC17-F11 2-CG17337-RA_2 CG17337 GGGCTTCGCGGTTTGGCATACTTTCAAGTGGAGGTGGAATGCTCCAGCAAAGACTTGCATAGTGGAGTT 69 FBan0017337 FBgn0033035 CG17337 2 2R CG17337 CG17337 CDMC21811 2 2 11 DAC17-F11 2-CG17337-RA_2 CG17337 GGGCTTCGCGGTTTGGCATACTTTCAAGTGGAGGTGGAATGCTCCAGCAAAGACTTGCATAGTGGAGTT 69 FBan0017337 FBgn0033035 CG17337 2 2R CG17337 CG17337 CDMC21812 2 3 11 DAC17-F23 15-CG17360-RA_4 CG17360 GCAGGCGGATAACAATGCAGCCGTTCAGGGAAATAAAGAAACCATGCTTGAGGAGGATATGCTCAGTGT 69 FBan0017360 FBgn0037949 CG17360 3 3R CG17360 CG17360 BcDNA:RH29885 CDMC21812 2 4 11 DAC17-F23 15-CG17360-RA_4 CG17360 GCAGGCGGATAACAATGCAGCCGTTCAGGGAAATAAAGAAACCATGCTTGAGGAGGATATGCTCAGTGT 69 FBan0017360 FBgn0037949 CG17360 3 3R CG17360 CG17360 BcDNA:RH29885 CDMC21813 2 5 11 DAC17-J11 15-CG17397-RB_1 CG17397 GGCTCGAGATCGAAAACCAGGGAACTGCAAGAGACCTAGAGGAAGTAGTGCAAAAAGGCGAACTTTTGC 69 CDMC21813 2 6 11 DAC17-J11 15-CG17397-RB_1 CG17397 GGCTCGAGATCGAAAACCAGGGAACTGCAAGAGACCTAGAGGAAGTAGTGCAAAAAGGCGAACTTTTGC 69 CDMC21814 2 7 11 DAC17-J23 1-CG17438-RA_4 CG17438 GGCGGGACAACGACAGCAAGTATGCCGACTACTTTCTCAAATACACCCCCCCGAAGCAGAAGGAAAAAG 69 FBan0017438 FBgn0030116 CG17438 X X CG17438 CG17438 CDMC21814 2 8 11 DAC17-J23 1-CG17438-RA_4 CG17438 GGCGGGACAACGACAGCAAGTATGCCGACTACTTTCTCAAATACACCCCCCCGAAGCAGAAGGAAAAAG 69 FBan0017438 FBgn0030116 CG17438 X X CG17438 CG17438 CDMC21815 2 9 11 DAC17-N11 22-CG17490-RC_4 CG17490 GGCAGGTCAGCAGTCTTGGAAGTCAATTCACTTTTCCCAATATAGCGGATCTATTTTGCAATGCCGTCT 69 FBgn0040009 CG17490 CG17490 CG17490 CDMC21815 2 10 11 DAC17-N11 22-CG17490-RC_4 CG17490 GGCAGGTCAGCAGTCTTGGAAGTCAATTCACTTTTCCCAATATAGCGGATCTATTTTGCAATGCCGTCT 69 FBgn0040009 CG17490 CG17490 CG17490 CDMC21816 2 11 11 DAC17-N23 12-CG17509-RA_1 CG17509 CGCTCTGCGATCTTGCCATGTACATTATCGACTCCAAGTTCAGTCCATTTGATGGCAACACGAGCACCT 69 FBan0017509 FBgn0033676 CG17509 2 2R CG17509 CG17509 anon-WO0118547.183 CDMC21816 2 12 11 DAC17-N23 12-CG17509-RA_1 CG17509 CGCTCTGCGATCTTGCCATGTACATTATCGACTCCAAGTTCAGTCCATTTGATGGCAACACGAGCACCT 69 FBan0017509 FBgn0033676 CG17509 2 2R CG17509 CG17509 anon-WO0118547.183 CDMC21817 2 13 11 DAC18-B11 23-CG3129-RA_1 CG3129 CGCGTCTACGTGTTACTGTTGATTTCGAATGTTATGCGTGCTTTTGTCAAATTTATATCGTGTATTTAT 69 FBan0003129 FBgn0015794 Rab-RP4 X X "MAPKKK cascade; GO:0000165; cell adhesion; GO:0007155; intracellular protein transport; GO:0006886; regulation of cell shape; GO:0008360; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160; vesicle-mediated transport; GO:0016192" "DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525; ; GO:0003677" Rab-RP4 Rab-related protein 4 "CG3129, DRABR4, DRabRP4, rab-related protein 4, DmRab18, AAF46057, Rab-r4" CDMC21817 2 14 11 DAC18-B11 23-CG3129-RA_1 CG3129 CGCGTCTACGTGTTACTGTTGATTTCGAATGTTATGCGTGCTTTTGTCAAATTTATATCGTGTATTTAT 69 FBan0003129 FBgn0015794 Rab-RP4 X X "MAPKKK cascade; GO:0000165; cell adhesion; GO:0007155; intracellular protein transport; GO:0006886; regulation of cell shape; GO:0008360; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160; vesicle-mediated transport; GO:0016192" "DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525; ; GO:0003677" Rab-RP4 Rab-related protein 4 "CG3129, DRABR4, DRabRP4, rab-related protein 4, DmRab18, AAF46057, Rab-r4" CDMC21818 2 15 11 DAC18-B23 18-CG31311-RA_8 CG31311 TGAAACAAGCGCGCTTAAAACAGATAATGTAGATAAGTCCCCGACACCGCCTAAGGGTTAAGCCATCCG 69 FBgn0051311 CDMC21818 2 16 11 DAC18-B23 18-CG31311-RA_8 CG31311 TGAAACAAGCGCGCTTAAAACAGATAATGTAGATAAGTCCCCGACACCGCCTAAGGGTTAAGCCATCCG 69 FBgn0051311 CDMC21819 2 17 11 DAC18-F11 17-CG31348-RA_1 CG31348 ACGAGCAGTTTGCCTATAACATCGCAATTTGTGGATGCCTCGTTGACTTCGCTATCATTAACAGCCACA 69 FBgn0051348 CDMC21819 2 18 11 DAC18-F11 17-CG31348-RA_1 CG31348 ACGAGCAGTTTGCCTATAACATCGCAATTTGTGGATGCCTCGTTGACTTCGCTATCATTAACAGCCACA 69 FBgn0051348 CDMC21820 2 19 11 DAC18-F23 16-CG31358-RA_1 CG31358 GGAGCTGTGCTCAATCGCGGATAAGATTTATGAAATGTGTTCCGCCCCGATTTGTTCACTTTTTCCCGG 69 FBan0031358 FBgn0051358 CG31358 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 integral to plasma membrane; GO:0005887 CG31358 CG31358 "CG17424, CG18141, CG18142" CDMC21820 2 20 11 DAC18-F23 16-CG31358-RA_1 CG31358 GGAGCTGTGCTCAATCGCGGATAAGATTTATGAAATGTGTTCCGCCCCGATTTGTTCACTTTTTCCCGG 69 FBan0031358 FBgn0051358 CG31358 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 integral to plasma membrane; GO:0005887 CG31358 CG31358 "CG17424, CG18141, CG18142" CDMC21821 2 21 11 DAC18-J11 13-CG31391-RA_1 CG31391 GCCCATTCTGTGGATAGGAAAGCGTAAGTATAGGGGCACTGATCCTCACATCGCTCAGATCGAGTTGGA 69 FBan0031391 FBgn0051391 CG31391 3 3R CG31391 CG31391 "CG6471, CG6471, BcDNA:AT04406" CDMC21821 2 22 11 DAC18-J11 13-CG31391-RA_1 CG31391 GCCCATTCTGTGGATAGGAAAGCGTAAGTATAGGGGCACTGATCCTCACATCGCTCAGATCGAGTTGGA 69 FBan0031391 FBgn0051391 CG31391 3 3R CG31391 CG31391 "CG6471, CG6471, BcDNA:AT04406" CDMC21822 2 23 11 DAC18-J23 12-CG31406-RA_3 CG31406 ACGTTAGCTTTGAACCGAAAATGGTGGTTACTCGCAGTGCAGCTACGAAGAAGCAGAACCAAGTGCTGA 69 FBan0031406 FBgn0051406 CG31406 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31406 CG31406 BcDNA:AT13367 CDMC21822 2 24 11 DAC18-J23 12-CG31406-RA_3 CG31406 ACGTTAGCTTTGAACCGAAAATGGTGGTTACTCGCAGTGCAGCTACGAAGAAGCAGAACCAAGTGCTGA 69 FBan0031406 FBgn0051406 CG31406 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31406 CG31406 BcDNA:AT13367 CDMC21823 2 25 11 DAC18-N11 15-CG31448-RA_2 CG31448 CCGTTTTGGTTTTTTTGTCCTTTGGGTTCTTCCTCTTTTTGGTTGCTGTCCGCATCAACAGACCGGAGT 69 FBan0031448 FBgn0051448 CG31448 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31448 CG31448 CDMC21823 2 26 11 DAC18-N11 15-CG31448-RA_2 CG31448 CCGTTTTGGTTTTTTTGTCCTTTGGGTTCTTCCTCTTTTTGGTTGCTGTCCGCATCAACAGACCGGAGT 69 FBan0031448 FBgn0051448 CG31448 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31448 CG31448 CDMC21824 2 1 12 DAC18-N23 6-CG31460-RA_1 CG31460 CCCAGCGTGGATGCTCCTACGACGAGAAAGGGCGGAAAGAAGTTCAAATGAACCATTCGTCTGCTTCTT 69 FBan0031460 FBgn0051460 CG31460 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31460 CG31460 "CG11745, CG11745, CG11745, BcDNA:RE67710" CDMC21824 2 2 12 DAC18-N23 6-CG31460-RA_1 CG31460 CCCAGCGTGGATGCTCCTACGACGAGAAAGGGCGGAAAGAAGTTCAAATGAACCATTCGTCTGCTTCTT 69 FBan0031460 FBgn0051460 CG31460 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31460 CG31460 "CG11745, CG11745, CG11745, BcDNA:RE67710" CDMC21825 2 3 12 DAC19-B11 1-CG6011-RA_1 CG6011 TCCAGGGTCTCAAACGACTGATGACCAAGTGCCAAGAGTACTTTCCCACCGATCCCTCCAAGTGC 65 FBan0006011 FBgn0027784 Prp18 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "poly(U) binding; GO:0008266; ; GO:0008266; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 Prp18 Prp18 "CG6011, CG6011" CDMC21825 2 4 12 DAC19-B11 1-CG6011-RA_1 CG6011 TCCAGGGTCTCAAACGACTGATGACCAAGTGCCAAGAGTACTTTCCCACCGATCCCTCCAAGTGC 65 FBan0006011 FBgn0027784 Prp18 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "poly(U) binding; GO:0008266; ; GO:0008266; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 Prp18 Prp18 "CG6011, CG6011" CDMC21826 2 5 12 DAC19-B23 16-CG6046-RA_1 CG6046 AGACACTTGCTCAGGCCAAATTCAGCATTGGAGACTTTCTGGACATCTCGATTACTCCGCCCAAC 65 FBan0006046 FBgn0024491 Bin1 3 3R "negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892" chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; protein binding; GO:0005515; ; GO:0003714; ; GO:0005515 Sin3 complex; GO:0016580; nucleus; GO:0005634 Bin1 Bicoid interacting protein 1 "CG6046, dSAP18, bin1, SAP18, Sin3A-associated polypeptide p18, bin1/dSAP18, dSap18, sap18, BcDNA:RE02417, Bicoid interacting protein 1" CDMC21826 2 6 12 DAC19-B23 16-CG6046-RA_1 CG6046 AGACACTTGCTCAGGCCAAATTCAGCATTGGAGACTTTCTGGACATCTCGATTACTCCGCCCAAC 65 FBan0006046 FBgn0024491 Bin1 3 3R "negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892" chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; protein binding; GO:0005515; ; GO:0003714; ; GO:0005515 Sin3 complex; GO:0016580; nucleus; GO:0005634 Bin1 Bicoid interacting protein 1 "CG6046, dSAP18, bin1, SAP18, Sin3A-associated polypeptide p18, bin1/dSAP18, dSap18, sap18, BcDNA:RE02417, Bicoid interacting protein 1" CDMC21827 2 7 12 DAC19-F11 3-CG6138-RA_1 CG6138 AAGCCATGGAGGATGACTTGGAGTTTCTTATCAACGCCCTGTCGGTGCCAAACACTCCACTCACC 65 FBan0006138 FBgn0032268 CG6138 2 2L CG6138 CG6138 BcDNA:AT25107 CDMC21827 2 8 12 DAC19-F11 3-CG6138-RA_1 CG6138 AAGCCATGGAGGATGACTTGGAGTTTCTTATCAACGCCCTGTCGGTGCCAAACACTCCACTCACC 65 FBan0006138 FBgn0032268 CG6138 2 2L CG6138 CG6138 BcDNA:AT25107 CDMC21828 2 9 12 DAC19-F23 3-CG6193-RA_1 CG6193 TGATGCACGGTCCAAGTCGCTATTTGAGCAGTGCATTCTGAGCGGCATGCATAAGTCCAACGACG 65 FBan0006193 FBgn0026598 Apc2 3 3R "Wnt receptor signaling pathway; GO:0016055; apoptosis; GO:0006915; cell adhesion; GO:0007155; cytokinesis; GO:0000910; establishment and/or maintenance of cell polarity; GO:0007163; establishment of mitotic spindle localization; GO:0040001; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of proteolysis; GO:0045862; regulation of progression through cell cycle; GO:0000074" microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 adherens junction; GO:0005912; apicolateral plasma membrane; GO:0016327; cytoplasm; GO:0005737; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Apc2 Adenomatous polyposis coli tumor suppressor homolog 2 "CG6193, CG6193, D-APC2, dApc2, E-APC: Epithelial Adenomatous Polyposis Coli, dAPC2, d-APC2, APC2, APC, dAPC2/E-APC, apc2, E-APC dAPC2, Epithelial Adenomatous Polyposis Coli, E-APC" CDMC21828 2 10 12 DAC19-F23 3-CG6193-RA_1 CG6193 TGATGCACGGTCCAAGTCGCTATTTGAGCAGTGCATTCTGAGCGGCATGCATAAGTCCAACGACG 65 FBan0006193 FBgn0026598 Apc2 3 3R "Wnt receptor signaling pathway; GO:0016055; apoptosis; GO:0006915; cell adhesion; GO:0007155; cytokinesis; GO:0000910; establishment and/or maintenance of cell polarity; GO:0007163; establishment of mitotic spindle localization; GO:0040001; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of proteolysis; GO:0045862; regulation of progression through cell cycle; GO:0000074" microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 adherens junction; GO:0005912; apicolateral plasma membrane; GO:0016327; cytoplasm; GO:0005737; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Apc2 Adenomatous polyposis coli tumor suppressor homolog 2 "CG6193, CG6193, D-APC2, dApc2, E-APC: Epithelial Adenomatous Polyposis Coli, dAPC2, d-APC2, APC2, APC, dAPC2/E-APC, apc2, E-APC dAPC2, Epithelial Adenomatous Polyposis Coli, E-APC" CDMC21829 2 11 12 DAC19-J11 3-CG6308-RA_1 CG6308 AACAGACGGAGAAGTACCAGCCAATTAGACTGATCCTGGCCAACAGTGACTCTACCTCCGAGCGC 65 FBan0006308 FBgn0030645 CG6308 X X carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG6308 CG6308 CDMC21829 2 12 12 DAC19-J11 3-CG6308-RA_1 CG6308 AACAGACGGAGAAGTACCAGCCAATTAGACTGATCCTGGCCAACAGTGACTCTACCTCCGAGCGC 65 FBan0006308 FBgn0030645 CG6308 X X carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG6308 CG6308 CDMC21830 2 13 12 DAC19-J23 2-CG6333-RA_1 CG6333 TACGAGTTCCAGCCTGAAGCGCATAGGAAGTCCGATCTCCGAGGAAGAATTTGGTGTCCTGGTGC 65 FBan0006333 FBgn0036731 CG6333 3 3L CG6333 CG6333 CDMC21830 2 14 12 DAC19-J23 2-CG6333-RA_1 CG6333 TACGAGTTCCAGCCTGAAGCGCATAGGAAGTCCGATCTCCGAGGAAGAATTTGGTGTCCTGGTGC 65 FBan0006333 FBgn0036731 CG6333 3 3L CG6333 CG6333 CDMC21831 2 15 12 DAC19-N11 2-CG6432-RA_2 CG6432 ATCTTCTCGGTACCTACCTCCTTCCGTGTTATCCGTCGTGCTGATCCGGACATCAGCTATGGGCG 65 FBan0006432 FBgn0039184 CG6432 3 3R fatty acid metabolism; GO:0006631 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 CG6432 CG6432 CDMC21831 2 16 12 DAC19-N11 2-CG6432-RA_2 CG6432 ATCTTCTCGGTACCTACCTCCTTCCGTGTTATCCGTCGTGCTGATCCGGACATCAGCTATGGGCG 65 FBan0006432 FBgn0039184 CG6432 3 3R fatty acid metabolism; GO:0006631 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 CG6432 CG6432 CDMC21832 2 17 12 DAC19-N23 1-CG6447-RA_2 CG6447 CTCCAGAAGGAGTTCTTCACCTACTCCGCCAACGAGCAGGACTTCGATGAGCCACAAGAACTGGA 65 FBan0006447 FBgn0039437 CG6447 3 3R CG6447 CG6447 CDMC21832 2 18 12 DAC19-N23 1-CG6447-RA_2 CG6447 CTCCAGAAGGAGTTCTTCACCTACTCCGCCAACGAGCAGGACTTCGATGAGCCACAAGAACTGGA 65 FBan0006447 FBgn0039437 CG6447 3 3R CG6447 CG6447 CDMC21833 2 19 12 DAC20-B11 1-CG30042-RA_3 CG30042 TTCTACGAGTACACTGGACCCGACGGCATCCTCTACCGCGTGGACTATGTAGCAGACGACAATGG 65 FBan0030042 FBgn0050042 CG30042 2 2R CG30042 CG30042 CG8496 CDMC21833 2 20 12 DAC20-B11 1-CG30042-RA_3 CG30042 TTCTACGAGTACACTGGACCCGACGGCATCCTCTACCGCGTGGACTATGTAGCAGACGACAATGG 65 FBan0030042 FBgn0050042 CG30042 2 2R CG30042 CG30042 CG8496 CDMC21834 2 21 12 DAC20-B23 3-CG30084-RA_3 CG30084 TCAAACCACCATGTCGGAGGAGAACGAAAGGGCCGTAAGTCAGTTGCTCAAGGAGGGTAAGCGTC 65 FBan0030084 FBgn0050084 2 2R CDMC21834 2 22 12 DAC20-B23 3-CG30084-RA_3 CG30084 TCAAACCACCATGTCGGAGGAGAACGAAAGGGCCGTAAGTCAGTTGCTCAAGGAGGGTAAGCGTC 65 FBan0030084 FBgn0050084 2 2R CDMC21835 2 23 12 DAC20-F11 3-CG30185-RA_1 CG30185 AGGAGGTATATTTGAATCTCTCCCGCTGGTTCGATCACCTCCAGAATCGCGCGGATGTGCACCAG 65 FBan0030185 FBgn0050185 CG30185 2 2R CG30185 CG30185 "CG5365, CG5365, CG5365, anon-EST:Posey25" CDMC21835 2 24 12 DAC20-F11 3-CG30185-RA_1 CG30185 AGGAGGTATATTTGAATCTCTCCCGCTGGTTCGATCACCTCCAGAATCGCGCGGATGTGCACCAG 65 FBan0030185 FBgn0050185 CG30185 2 2R CG30185 CG30185 "CG5365, CG5365, CG5365, anon-EST:Posey25" CDMC21836 2 25 12 DAC20-F23 3-CG30263-RA_9 CG30263 AGAAGCTACACGTGGACCTGGTGGAGTACTCGTCCAAGATGAAGGGAGCTATTCCCGTACTGCCG 65 FBan0030263 FBgn0050263 CG30263 2 2R CG30263 CG30263 "CG15677, CG15679, CT35864" CDMC21836 2 26 12 DAC20-F23 3-CG30263-RA_9 CG30263 AGAAGCTACACGTGGACCTGGTGGAGTACTCGTCCAAGATGAAGGGAGCTATTCCCGTACTGCCG 65 FBan0030263 FBgn0050263 CG30263 2 2R CG30263 CG30263 "CG15677, CG15679, CT35864" CDMC21837 2 1 13 DAC20-J11 3-CG30374-RA_5 CG30374 GCCCATCTGCTTACCTCTTCAAGGGTCGTCCATTGAGCAGACACACTGTGTGATTTCCGGATGGG 65 FBan0030374 FBgn0050374 CG30374 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0030234; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4 CG30374 CG30374 CDMC21837 2 2 13 DAC20-J11 3-CG30374-RA_5 CG30374 GCCCATCTGCTTACCTCTTCAAGGGTCGTCCATTGAGCAGACACACTGTGTGATTTCCGGATGGG 65 FBan0030374 FBgn0050374 CG30374 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0030234; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4 CG30374 CG30374 CDMC21838 2 3 13 DAC20-J23 1-CG3038-RA_1 CG3038 CATCGACTGCTGTGTGCGAGATCTCAAGAAGCACAACTATGAGTGCGAGTACTCCGTGGGACCCA 65 FBan0003038 FBgn0040373 CG3038 X X protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG3038 CG3038 EG:BACR37P7.1 CDMC21838 2 4 13 DAC20-J23 1-CG3038-RA_1 CG3038 CATCGACTGCTGTGTGCGAGATCTCAAGAAGCACAACTATGAGTGCGAGTACTCCGTGGGACCCA 65 FBan0003038 FBgn0040373 CG3038 X X protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG3038 CG3038 EG:BACR37P7.1 CDMC21839 2 5 13 DAC20-N11 20-CG30479-RA_1 CG30479 CGGGGTCCCGGAATCGCCTACGGACCACCGCCACCTCGAGTGAATGTCGGCATCAATATCGGCGG 65 FBan0030479 FBgn0050479 CG30479 2 2R CG30479 CG30479 CG18373 CDMC21839 2 6 13 DAC20-N11 20-CG30479-RA_1 CG30479 CGGGGTCCCGGAATCGCCTACGGACCACCGCCACCTCGAGTGAATGTCGGCATCAATATCGGCGG 65 FBan0030479 FBgn0050479 CG30479 2 2R CG30479 CG30479 CG18373 CDMC21840 2 7 13 DAC20-N23 4-CG3051-RB_1 CG3051 CACTCGGACAGTCCTGAGGATTGACCATTACCCGGAAGACACAGTCCCACAAAGGAAAGCTGGGG 65 FBan0003051 FBgn0023169 SNF1A X X protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- AMP-activated protein kinase complex; GO:0031588; nucleus; GO:0005634 SNF1A SNF1A/AMP-activated protein kinase "CG3051, CG3051, CG3051, Gprk-4, EG:132E8.2, FBgn0023169, DmAMPK alpha, snf1a, AMPK, Gprk4, G protein-coupled receptor kinase 4" CDMC21840 2 8 13 DAC20-N23 4-CG3051-RB_1 CG3051 CACTCGGACAGTCCTGAGGATTGACCATTACCCGGAAGACACAGTCCCACAAAGGAAAGCTGGGG 65 FBan0003051 FBgn0023169 SNF1A X X protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- AMP-activated protein kinase complex; GO:0031588; nucleus; GO:0005634 SNF1A SNF1A/AMP-activated protein kinase "CG3051, CG3051, CG3051, Gprk-4, EG:132E8.2, FBgn0023169, DmAMPK alpha, snf1a, AMPK, Gprk4, G protein-coupled receptor kinase 4" CDMC21841 2 9 13 DAC21-B11 23-CG3894-RA_2 CG3894 TTTGGTTCTAGTTACCAATACACTCTTTACCTGGACGACCTATGTTGTAGATCATAATCCTCGCCATC 68 FBan0003894 FBgn0035059 CG3894 2 2R intracellular signaling cascade; GO:0007242 CG3894 CG3894 "CG9197, dmNeural-like" CDMC21841 2 10 13 DAC21-B11 23-CG3894-RA_2 CG3894 TTTGGTTCTAGTTACCAATACACTCTTTACCTGGACGACCTATGTTGTAGATCATAATCCTCGCCATC 68 FBan0003894 FBgn0035059 CG3894 2 2R intracellular signaling cascade; GO:0007242 CG3894 CG3894 "CG9197, dmNeural-like" CDMC21842 2 11 13 DAC21-B23 17-CG3992-RA_1 CG3992 ATCGAGCACATTATCGTCCCTGAGTCACAGCAACATTATTAGTCTGCAGAATCCGTATCACCAGGCCG 68 FBan0003992 FBgn0003507 srp 3 3R "amnioserosa maintenance; GO:0046665; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cellular physiological process; GO:0050875; crystal cell differentiation; GO:0042688; defense response; GO:0006952; dorsal closure; GO:0007391; embryonic development (sensu Insecta); GO:0001700; embryonic hemopoiesis; GO:0035162; endoderm development; GO:0007492; endoderm formation; GO:0001706; fat body development; GO:0007503; germ cell migration; GO:0008354; germ-band shortening; GO:0007390; head involution; GO:0008258; hemocyte development; GO:0007516; hemopoiesis; GO:0030097; lymph gland development (sensu Arthropoda); GO:0048542; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; midgut development; GO:0007494; negative regulation of crystal cell differentiation; GO:0042690; organ morphogenesis; GO:0009887; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcriptional activator activity; GO:0016563; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016563; ; GO:0016251; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 srp serpent "CG3992, CG3992, spt: spermatheca, ABF, dGATAb, A7.1, l(3)01549, GATAb, DmGATAb, Srp, GATA, Abf: A-box-binding factor, abf, l(3)89B2, l(3)neo45, A-box-binding factor, spt" CDMC21842 2 12 13 DAC21-B23 17-CG3992-RA_1 CG3992 ATCGAGCACATTATCGTCCCTGAGTCACAGCAACATTATTAGTCTGCAGAATCCGTATCACCAGGCCG 68 FBan0003992 FBgn0003507 srp 3 3R "amnioserosa maintenance; GO:0046665; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cellular physiological process; GO:0050875; crystal cell differentiation; GO:0042688; defense response; GO:0006952; dorsal closure; GO:0007391; embryonic development (sensu Insecta); GO:0001700; embryonic hemopoiesis; GO:0035162; endoderm development; GO:0007492; endoderm formation; GO:0001706; fat body development; GO:0007503; germ cell migration; GO:0008354; germ-band shortening; GO:0007390; head involution; GO:0008258; hemocyte development; GO:0007516; hemopoiesis; GO:0030097; lymph gland development (sensu Arthropoda); GO:0048542; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; midgut development; GO:0007494; negative regulation of crystal cell differentiation; GO:0042690; organ morphogenesis; GO:0009887; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcriptional activator activity; GO:0016563; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016563; ; GO:0016251; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 srp serpent "CG3992, CG3992, spt: spermatheca, ABF, dGATAb, A7.1, l(3)01549, GATAb, DmGATAb, Srp, GATA, Abf: A-box-binding factor, abf, l(3)89B2, l(3)neo45, A-box-binding factor, spt" CDMC21843 2 13 13 DAC21-F11 15-CG4276-RD_1 CG4276 CTCGCTCGCAGGAGTGTGCAAACCAGAACTAACCTTAAGACTAACCTAAGTGGAGCTCCAGACGGGAG 68 FBan0004276 FBgn0029095 aru 2 2L epidermal growth factor receptor signaling pathway; GO:0007173; protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 aru arouser "CG4276, CG4276, arouser" CDMC21843 2 14 13 DAC21-F11 15-CG4276-RD_1 CG4276 CTCGCTCGCAGGAGTGTGCAAACCAGAACTAACCTTAAGACTAACCTAAGTGGAGCTCCAGACGGGAG 68 FBan0004276 FBgn0029095 aru 2 2L epidermal growth factor receptor signaling pathway; GO:0007173; protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 aru arouser "CG4276, CG4276, arouser" CDMC21844 2 15 13 DAC21-F23 3-CG4432-RB_2 CG4432 CCCACCAATTTGTCCTTTTCTGCCCAACACTGTCGGACGCAAGGCCGTCACAGTTACAGTGGTTTTTG 68 FBan0004432 FBgn0035976 PGRP-LC 3 3L "anti-Gram-negative bacterial polypeptide induction; GO:0006964; antibacterial humoral response; GO:0019731; antibacterial polypeptide induction; GO:0006963; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; response to bacteria; GO:0009617; response to pest, pathogen or parasite; GO:0009613" transcription factor activity; GO:0003700; protein binding; GO:0005515; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; Gram-negative bacterial binding; GO:0008368; ; GO:0016019; ; GO:0008368; protein dimerization activity; GO:0046983; ; GO:0003700; ; GO:0005515; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0046983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622 PGRP-LC Peptidoglycan recognition protein LC "CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, ird7, immune response deficient 7, tot, totem, PGRP-LCx" CDMC21844 2 16 13 DAC21-F23 3-CG4432-RB_2 CG4432 CCCACCAATTTGTCCTTTTCTGCCCAACACTGTCGGACGCAAGGCCGTCACAGTTACAGTGGTTTTTG 68 FBan0004432 FBgn0035976 PGRP-LC 3 3L "anti-Gram-negative bacterial polypeptide induction; GO:0006964; antibacterial humoral response; GO:0019731; antibacterial polypeptide induction; GO:0006963; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; response to bacteria; GO:0009617; response to pest, pathogen or parasite; GO:0009613" transcription factor activity; GO:0003700; protein binding; GO:0005515; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; Gram-negative bacterial binding; GO:0008368; ; GO:0016019; ; GO:0008368; protein dimerization activity; GO:0046983; ; GO:0003700; ; GO:0005515; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0046983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622 PGRP-LC Peptidoglycan recognition protein LC "CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, ird7, immune response deficient 7, tot, totem, PGRP-LCx" CDMC21845 2 17 13 DAC21-J11 15-CG4971-RA_2 CG4971 CCATTCCAAAGATGCTCCATCTCATCGCACTTCTGCTTTCCGTTTTAGGCTACCGAGAGAGTGCGTTC 68 FBan0004971 FBgn0031903 Wnt10 2 2L development; GO:0007275; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0004871 extracellular region; GO:0005576 Wnt10 Wnt10 "CG4971, DWnt10, DWnt-10" CDMC21845 2 18 13 DAC21-J11 15-CG4971-RA_2 CG4971 CCATTCCAAAGATGCTCCATCTCATCGCACTTCTGCTTTCCGTTTTAGGCTACCGAGAGAGTGCGTTC 68 FBan0004971 FBgn0031903 Wnt10 2 2L development; GO:0007275; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0004871 extracellular region; GO:0005576 Wnt10 Wnt10 "CG4971, DWnt10, DWnt-10" CDMC21846 2 19 13 DAC21-J23 2-CG5064-RA_2 CG5064 ACCCCTGACATGGAACCCATACCATGCAAACCGATTTTCTTTGACCTGGCTATGACCTACGTGGAGCT 68 FBan0005064 FBgn0035947 CG5064 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0003729; ; GO:0008312 signal recognition particle (sensu Eukaryota); GO:0005786 CG5064 CG5064 CDMC21846 2 20 13 DAC21-J23 2-CG5064-RA_2 CG5064 ACCCCTGACATGGAACCCATACCATGCAAACCGATTTTCTTTGACCTGGCTATGACCTACGTGGAGCT 68 FBan0005064 FBgn0035947 CG5064 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0003729; ; GO:0008312 signal recognition particle (sensu Eukaryota); GO:0005786 CG5064 CG5064 CDMC21847 2 21 13 DAC21-N11 2-CG5442-RA_1 CG5442 ACTAGGGCCAATGCTGTATCCTGTTCCGGATCTATGGCTCCATCTGTGTCATGCTGTACCCGAACAGC 68 FBan0005442 FBgn0040286 SC35 2 2L "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 NOT omega speckle; GO:0035062; chromatin; GO:0000785; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 SC35 SC35 "CG5442, CG5542, CG5442, CG5442, CG5542, cg5442, dSC35" CDMC21847 2 22 13 DAC21-N11 2-CG5442-RA_1 CG5442 ACTAGGGCCAATGCTGTATCCTGTTCCGGATCTATGGCTCCATCTGTGTCATGCTGTACCCGAACAGC 68 FBan0005442 FBgn0040286 SC35 2 2L "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 NOT omega speckle; GO:0035062; chromatin; GO:0000785; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 SC35 SC35 "CG5442, CG5542, CG5442, CG5442, CG5542, cg5442, dSC35" CDMC21848 2 23 13 DAC21-N23 2-CG5538-RA_3 CG5538 TGTGGCAGTCCCTTATGCCTGCAATCCACAATGAGTCAATCTCTGGCGCACGATTCAGCTCCAACTAC 68 FBan0005538 FBgn0038052 CG5538 3 3R CG5538 CG5538 "bs11a11.y1, anon-WO0140519.84" CDMC21848 2 24 13 DAC21-N23 2-CG5538-RA_3 CG5538 TGTGGCAGTCCCTTATGCCTGCAATCCACAATGAGTCAATCTCTGGCGCACGATTCAGCTCCAACTAC 68 FBan0005538 FBgn0038052 CG5538 3 3R CG5538 CG5538 "bs11a11.y1, anon-WO0140519.84" CDMC21849 2 25 13 DAC22-B11 1-CG40448-RA_3 CG40448 GACAATTAGCCCGACCATGTGACGTTCCTGACAAGGGTTTACTTTGCGACCTCCTATGGTCAGACCCCG 69 CDMC21849 2 26 13 DAC22-B11 1-CG40448-RA_3 CG40448 GACAATTAGCCCGACCATGTGACGTTCCTGACAAGGGTTTACTTTGCGACCTCCTATGGTCAGACCCCG 69 CDMC21850 2 1 14 DAC22-B23 3-CG40461-RA_1 CG40461 TGCCGGCCATTGAAATCCGACGAAGAGTTCTTCAACCGACCATCTACTCGAAGATGGCCATTGTGACCA 69 CDMC21850 2 2 14 DAC22-B23 3-CG40461-RA_1 CG40461 TGCCGGCCATTGAAATCCGACGAAGAGTTCTTCAACCGACCATCTACTCGAAGATGGCCATTGTGACCA 69 CDMC21851 2 3 14 DAC22-F11 23-CG4060-RA_1 CG4060 AACCAGTTCTAAGTATTCTTCATTGCTCGTCACATCCAGATCTAGTTAGCTGTCATCAACACCACTTAG 69 FBan0004060 FBgn0038487 CG4060 3 3R CG4060 CG4060 CDMC21851 2 4 14 DAC22-F11 23-CG4060-RA_1 CG4060 AACCAGTTCTAAGTATTCTTCATTGCTCGTCACATCCAGATCTAGTTAGCTGTCATCAACACCACTTAG 69 FBan0004060 FBgn0038487 CG4060 3 3R CG4060 CG4060 CDMC21852 2 5 14 DAC22-F23 12-CG4070-RA_1 CG4070 TCGCAGTCCAATTTGAAACGCAAATATGCCAAGGCAAATGGATTTCCGGTGGCGTAACTTCGTTGCAGA 69 FBan0004070 FBgn0011837 Tis11 X X RNA catabolism; GO:0006401; intracellular signaling cascade; GO:0007242 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003729 nucleus; GO:0005634 Tis11 Tis11 homolog "CG4070, DTIS11, TIS11cc1, clone 1.28, l(1)G0124, TIScc1, dTis11, dTTP, anon-EST:Liang-1.28" CDMC21852 2 6 14 DAC22-F23 12-CG4070-RA_1 CG4070 TCGCAGTCCAATTTGAAACGCAAATATGCCAAGGCAAATGGATTTCCGGTGGCGTAACTTCGTTGCAGA 69 FBan0004070 FBgn0011837 Tis11 X X RNA catabolism; GO:0006401; intracellular signaling cascade; GO:0007242 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003729 nucleus; GO:0005634 Tis11 Tis11 homolog "CG4070, DTIS11, TIS11cc1, clone 1.28, l(1)G0124, TIScc1, dTis11, dTTP, anon-EST:Liang-1.28" CDMC21853 2 7 14 DAC22-J11 2-CG41049-RA_2 CG41049 CCCGTACAACATCCTGTGCGCTCTACCGCTAAAGGGGCTCTGGCCTTAATTCTGGATAATGAGCTCACA 69 FBgn0069963 CG41049 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41049 CG41049 CDMC21853 2 8 14 DAC22-J11 2-CG41049-RA_2 CG41049 CCCGTACAACATCCTGTGCGCTCTACCGCTAAAGGGGCTCTGGCCTTAATTCTGGATAATGAGCTCACA 69 FBgn0069963 CG41049 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41049 CG41049 CDMC21854 2 9 14 DAC22-J23 15-CG41069-RA_2 CG41069 GGGCCTTCGGATTCCGACCGAACCTATCTATCTCTCCCTAAGTACCACCGTTATTATTCTGATGGCGGT 69 FBgn0069953 CG41069 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41069 CG41069 CG40180 CDMC21854 2 10 14 DAC22-J23 15-CG41069-RA_2 CG41069 GGGCCTTCGGATTCCGACCGAACCTATCTATCTCTCCCTAAGTACCACCGTTATTATTCTGATGGCGGT 69 FBgn0069953 CG41069 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41069 CG41069 CG40180 CDMC21855 2 11 14 DAC22-N11 1-CG41120-RA_1 CG41120 GGCACAGGCTTGGAAAGGGAAAAGGAAAGTCTTTGGTTGGTAACGGTGGTTCTGCGAAAAGCTTCCGTT 69 FBgn0069931 CG41120 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41120 CG41120 CDMC21855 2 12 14 DAC22-N11 1-CG41120-RA_1 CG41120 GGCACAGGCTTGGAAAGGGAAAAGGAAAGTCTTTGGTTGGTAACGGTGGTTCTGCGAAAAGCTTCCGTT 69 FBgn0069931 CG41120 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41120 CG41120 CDMC21856 2 13 14 DAC22-N23 2-CG41141-RA_1 CG41141 GCGCCGCTTGTATCTTGGCAGAGGTTCTCGAGTTTCAATCGGCTGGTAAGAACGACAGCATGGATCCTA 69 FBgn0069914 CG41141 CG41141 CG41141 CDMC21856 2 14 14 DAC22-N23 2-CG41141-RA_1 CG41141 GCGCCGCTTGTATCTTGGCAGAGGTTCTCGAGTTTCAATCGGCTGGTAAGAACGACAGCATGGATCCTA 69 FBgn0069914 CG41141 CG41141 CG41141 CDMC21857 2 15 14 DAC23-B11 1-CG33340-RA_1 CG33340 GGCACTGAGTGTTAATCCCTCCCGAGTACTGTTCCGTCCAATTTTTGGTGCGGTTAACAGCTGTGTGCG 69 FBan0033340 FBgn0053340 CG33340 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33340 CG33340 "CG13612, CG13612, BEST:GH24664, BcDNA:AT31672" CDMC21857 2 16 14 DAC23-B11 1-CG33340-RA_1 CG33340 GGCACTGAGTGTTAATCCCTCCCGAGTACTGTTCCGTCCAATTTTTGGTGCGGTTAACAGCTGTGTGCG 69 FBan0033340 FBgn0053340 CG33340 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33340 CG33340 "CG13612, CG13612, BEST:GH24664, BcDNA:AT31672" CDMC21858 2 17 14 DAC23-B23 23-CG33351-RA_2 CG33351 ATTGGTATAAGTATTGGACAAGGTTTATAACCAATCGCCATGAGGTGGAAAAGAAGTGCTTCAGAGGGC 69 CDMC21858 2 18 14 DAC23-B23 23-CG33351-RA_2 CG33351 ATTGGTATAAGTATTGGACAAGGTTTATAACCAATCGCCATGAGGTGGAAAAGAAGTGCTTCAGAGGGC 69 CDMC21859 2 19 14 DAC23-F11 2-CG3346-RA_1 CG3346 CCGCCAAGTGAGCAGGTTGGCTCCACAGATTCAATTGGTGCGTCGATTTTTAGGGGATTTCAAATGGCA 69 FBan0003346 FBgn0025739 pon X X asymmetric protein localization; GO:0008105; neuroblast division; GO:0045034 basal cortex; GO:0045180; basal part of cell; GO:0045178 pon partner of numb "CG3346, PON, Partner of Numb, Pon" CDMC21859 2 20 14 DAC23-F11 2-CG3346-RA_1 CG3346 CCGCCAAGTGAGCAGGTTGGCTCCACAGATTCAATTGGTGCGTCGATTTTTAGGGGATTTCAAATGGCA 69 FBan0003346 FBgn0025739 pon X X asymmetric protein localization; GO:0008105; neuroblast division; GO:0045034 basal cortex; GO:0045180; basal part of cell; GO:0045178 pon partner of numb "CG3346, PON, Partner of Numb, Pon" CDMC21860 2 21 14 DAC23-F23 9-CG33478-RA_4 CG33478 CCTGCATCACCAACATAGGATTCGACTCACTCTGCTCCTCACTGTTCATCTTCCTCAAGTGCCAGCTGG 69 FBgn0026387 CDMC21860 2 22 14 DAC23-F23 9-CG33478-RA_4 CG33478 CCTGCATCACCAACATAGGATTCGACTCACTCTGCTCCTCACTGTTCATCTTCCTCAAGTGCCAGCTGG 69 FBgn0026387 CDMC21861 2 23 14 DAC23-J11 23-CG3349-RA_8 CG3349 GAAGCCATGGATTTTCCAAAACAAATAGCGAATTCCGAAAAAACACTTTTGGACCAAATCGCTTCGCTA 69 FBan0003349 FBgn0036459 CG3349 3 3L CG3349 CG3349 CDMC21861 2 24 14 DAC23-J11 23-CG3349-RA_8 CG3349 GAAGCCATGGATTTTCCAAAACAAATAGCGAATTCCGAAAAAACACTTTTGGACCAAATCGCTTCGCTA 69 FBan0003349 FBgn0036459 CG3349 3 3L CG3349 CG3349 CDMC21862 2 25 14 DAC23-J23 23-CG3354-RA_11 CG3354 AGCCAGCATACAAACAGTTAGTACACTACCTTTGAACGAGGAACAACTAAAATATTTCGATAAAATTGA 69 FBan0003354 FBgn0000093 Mst77F 3 3L Mst77F Male-specific transcript 77F "CG3354, 18c, mst77F, R1-18c" CDMC21862 2 26 14 DAC23-J23 23-CG3354-RA_11 CG3354 AGCCAGCATACAAACAGTTAGTACACTACCTTTGAACGAGGAACAACTAAAATATTTCGATAAAATTGA 69 FBan0003354 FBgn0000093 Mst77F 3 3L Mst77F Male-specific transcript 77F "CG3354, 18c, mst77F, R1-18c" CDMC21863 2 1 15 DAC23-N11 3-CG3407-RA_2 CG3407 GCGTGAAACCCTTTAAATGCGACAAGTGCGAGTTTCAGTTTCGGCAGTGGGGTGACCTGAAGTACCACA 69 FBan0003407 FBgn0031573 CG3407 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3407 CG3407 CDMC21863 2 2 15 DAC23-N11 3-CG3407-RA_2 CG3407 GCGTGAAACCCTTTAAATGCGACAAGTGCGAGTTTCAGTTTCGGCAGTGGGGTGACCTGAAGTACCACA 69 FBan0003407 FBgn0031573 CG3407 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3407 CG3407 CDMC21864 2 3 15 DAC23-N23 2-CG3419-RA_2 CG3419 TGCGCCCAAACTAATCACAGGATTTAGTGCCAAGTATCCCTTCCAAAAGGACCACCCACTCTTGCGCTT 69 FBan0003419 FBgn0035002 CG3419 2 2R CG3419 CG3419 CDMC21864 2 4 15 DAC23-N23 2-CG3419-RA_2 CG3419 TGCGCCCAAACTAATCACAGGATTTAGTGCCAAGTATCCCTTCCAAAAGGACCACCCACTCTTGCGCTT 69 FBan0003419 FBgn0035002 CG3419 2 2R CG3419 CG3419 CDMC21865 2 5 15 DAC24-B11 17-CG33166-RA_2 CG33166 CACCTGGCCAATGTGCTTCTCAACTATCACCAGATGCGTTATGGAGTCATCAAGCTGCTTCACATTCTG 69 FBgn0041725 CDMC21865 2 6 15 DAC24-B11 17-CG33166-RA_2 CG33166 CACCTGGCCAATGTGCTTCTCAACTATCACCAGATGCGTTATGGAGTCATCAAGCTGCTTCACATTCTG 69 FBgn0041725 CDMC21866 2 7 15 DAC24-B23 1-CG33173-RA_1 CG33173 GGAATCAGTGGTTCGATCGGGAGACGAAATCCTGCCAAGATCGCGAGTTGGTACTGAATTGCCCAGTCA 69 FBan0033173 FBgn0053173 CG33173 X X chitin metabolism; GO:0006030; transport; GO:0006810 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166; ; GO:0008061" ATP-binding cassette (ABC) transporter complex; GO:0043190; extracellular region; GO:0005576 CG33173 CG33173 "CG8473, CG8473" CDMC21866 2 8 15 DAC24-B23 1-CG33173-RA_1 CG33173 GGAATCAGTGGTTCGATCGGGAGACGAAATCCTGCCAAGATCGCGAGTTGGTACTGAATTGCCCAGTCA 69 FBan0033173 FBgn0053173 CG33173 X X chitin metabolism; GO:0006030; transport; GO:0006810 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166; ; GO:0008061" ATP-binding cassette (ABC) transporter complex; GO:0043190; extracellular region; GO:0005576 CG33173 CG33173 "CG8473, CG8473" CDMC21867 2 9 15 DAC24-F11 23-CG33197-RB_10 CG33197 ACTTCGTAAGTACTCCAAACTGAATGACAATCGCCACCTAAAGTAGTCCGCCTTGAAACCGATCTTCAA 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC21867 2 10 15 DAC24-F11 23-CG33197-RB_10 CG33197 ACTTCGTAAGTACTCCAAACTGAATGACAATCGCCACCTAAAGTAGTCCGCCTTGAAACCGATCTTCAA 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC21868 2 11 15 DAC24-F23 17-CG33203-RC_3 CG33203 GCTCCAATCTGTGCATAGTTGTGAACGAAACTCAACCGCTCATTTTCTTGCTGATGAGTGCCCAGTAGT 69 FBan0033203 FBgn0053203 CG33203 3 3R integral to membrane; GO:0016021 CG33203 CG33203 "CG31046, CG14522, CG14524, CG14525" CDMC21868 2 12 15 DAC24-F23 17-CG33203-RC_3 CG33203 GCTCCAATCTGTGCATAGTTGTGAACGAAACTCAACCGCTCATTTTCTTGCTGATGAGTGCCCAGTAGT 69 FBan0033203 FBgn0053203 CG33203 3 3R integral to membrane; GO:0016021 CG33203 CG33203 "CG31046, CG14522, CG14524, CG14525" CDMC21869 2 13 15 DAC24-J11 8-CG33228-RA_4 CG33228 CGAAGTGGAACGGAAGCTCCTCTTTGGCGACAGGCTACCAGATAACTATAAACTGATTTACCGGGCCCC 69 FBan0033228 FBgn0053228 CG33228 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33228 CG33228 CG4806 CDMC21869 2 14 15 DAC24-J11 8-CG33228-RA_4 CG33228 CGAAGTGGAACGGAAGCTCCTCTTTGGCGACAGGCTACCAGATAACTATAAACTGATTTACCGGGCCCC 69 FBan0033228 FBgn0053228 CG33228 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33228 CG33228 CG4806 CDMC21870 2 15 15 DAC24-J23 14-CG33248-RA_1 CG33248 ACATCCGGTTTGAGTTCATTCGATTCCAACGCGTCCAACCAAAGACGTTTCAATCGCAAACATTCGGCT 69 FBan0033248 FBgn0053248 CG33248 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33248 CG33248 "CG1846, CG1846" CDMC21870 2 16 15 DAC24-J23 14-CG33248-RA_1 CG33248 ACATCCGGTTTGAGTTCATTCGATTCCAACGCGTCCAACCAAAGACGTTTCAATCGCAAACATTCGGCT 69 FBan0033248 FBgn0053248 CG33248 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33248 CG33248 "CG1846, CG1846" CDMC21871 2 17 15 DAC24-N11 17-CG33290-RA_4 CG33290 AAGGACAAGTACGCCCAAACTAAAAATACAGCCCTGGAGAACTTTAATGGAGTTTCGGGACCCAAGGAT 69 FBan0033290 FBgn0053290 CG33290 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33290 CG33290 CDMC21871 2 18 15 DAC24-N11 17-CG33290-RA_4 CG33290 AAGGACAAGTACGCCCAAACTAAAAATACAGCCCTGGAGAACTTTAATGGAGTTTCGGGACCCAAGGAT 69 FBan0033290 FBgn0053290 CG33290 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33290 CG33290 CDMC21872 2 19 15 DAC24-N23 1-CG33298-RB_1 CG33298 TGCGGAGAGTGATGTAGGAATCTGGGAGTTTGGTACGACGATAACGGCATCCTGTCTCTTCGCCAACCT 69 FBan0033298 FBgn0032120 CG33298 2 2L cation transport; GO:0006812; lipid metabolism; GO:0006629; phospholipid transport; GO:0015914 ATP binding; GO:0005524; ; GO:0005524; phospholipid-translocating ATPase activity; GO:0004012 ; EC:3.6.3.1; ; GO:0004012 ; EC:3.6.3.1 integral to membrane; GO:0016021 CG33298 CG33298 "CG18419, CG13112, CG18419" CDMC21872 2 20 15 DAC24-N23 1-CG33298-RB_1 CG33298 TGCGGAGAGTGATGTAGGAATCTGGGAGTTTGGTACGACGATAACGGCATCCTGTCTCTTCGCCAACCT 69 FBan0033298 FBgn0032120 CG33298 2 2L cation transport; GO:0006812; lipid metabolism; GO:0006629; phospholipid transport; GO:0015914 ATP binding; GO:0005524; ; GO:0005524; phospholipid-translocating ATPase activity; GO:0004012 ; EC:3.6.3.1; ; GO:0004012 ; EC:3.6.3.1 integral to membrane; GO:0016021 CG33298 CG33298 "CG18419, CG13112, CG18419" CDMC21873 2 21 15 DAC25-B11 3-CG10353-RB_2 CG10353 GCCGGAAGATCCGCATCCCTATAAACGTCCCATGATATATTGGAAGATACTGACGGGTCGGCTGGCCTT 69 FBan0010353 FBgn0030349 CG10353 X X CG10353 CG10353 CDMC21873 2 22 15 DAC25-B11 3-CG10353-RB_2 CG10353 GCCGGAAGATCCGCATCCCTATAAACGTCCCATGATATATTGGAAGATACTGACGGGTCGGCTGGCCTT 69 FBan0010353 FBgn0030349 CG10353 X X CG10353 CG10353 CDMC21874 2 23 15 DAC25-B23 14-CG10366-RA_6 CG10366 TGCCGACTACGAACCGAATGAAGATCGTGTACTAATGAGCCTCTGCGATGTGTATGGCATTCAGGAGGA 69 FBan0010366 FBgn0032814 CG10366 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; nucleus; GO:0005634 CG10366 CG10366 CDMC21874 2 24 15 DAC25-B23 14-CG10366-RA_6 CG10366 TGCCGACTACGAACCGAATGAAGATCGTGTACTAATGAGCCTCTGCGATGTGTATGGCATTCAGGAGGA 69 FBan0010366 FBgn0032814 CG10366 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; nucleus; GO:0005634 CG10366 CG10366 CDMC21875 2 25 15 DAC25-F11 1-CG10407-RA_1 CG10407 TGCACTCAGTGTACCGAAATGTCAAAGTCACAGGCATCTCAAAGCACACGGTCAATGAGCTGCGTCTGG 69 FBan0010407 FBgn0038395 CG10407 3 3R CG10407 CG10407 CDMC21875 2 26 15 DAC25-F11 1-CG10407-RA_1 CG10407 TGCACTCAGTGTACCGAAATGTCAAAGTCACAGGCATCTCAAAGCACACGGTCAATGAGCTGCGTCTGG 69 FBan0010407 FBgn0038395 CG10407 3 3R CG10407 CG10407 CDMC21876 2 1 16 DAC25-F23 3-CG1041-RA_2 CG1041 ACCCTAGCTTCGGGCAATCTGGCTCACAGGACTTTGCTCCTGCACAGAAAATACAGTTCTCTTCGAGCA 69 FBan0001041 FBgn0037440 CG1041 3 3R amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 mitochondrion; GO:0005739; peroxisome; GO:0005777 CG1041 CG1041 CDMC21876 2 2 16 DAC25-F23 3-CG1041-RA_2 CG1041 ACCCTAGCTTCGGGCAATCTGGCTCACAGGACTTTGCTCCTGCACAGAAAATACAGTTCTCTTCGAGCA 69 FBan0001041 FBgn0037440 CG1041 3 3R amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 mitochondrion; GO:0005739; peroxisome; GO:0005777 CG1041 CG1041 CDMC21877 2 3 16 DAC25-J11 2-CG10472-RA_1 CG10472 AGCAGATCATCTTCGTGGAGACAAAGAATGTGATCGTGCACGAGGATTGGATCGCCGAGACCATCACCA 69 FBan0010472 FBgn0035670 CG10472 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG10472 CG10472 "SP78, anon-WO0140519.101" CDMC21877 2 4 16 DAC25-J11 2-CG10472-RA_1 CG10472 AGCAGATCATCTTCGTGGAGACAAAGAATGTGATCGTGCACGAGGATTGGATCGCCGAGACCATCACCA 69 FBan0010472 FBgn0035670 CG10472 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG10472 CG10472 "SP78, anon-WO0140519.101" CDMC21878 2 5 16 DAC25-J23 12-CG10488-RA_2 CG10488 CCTTGGAATCAGCGGATGAGAACCGGCACATAGACTCCGATTATCTGGATGACGATGATGAGCCCAAGT 69 FBan0010488 FBgn0000625 eyg 3 3L cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; eye development; GO:0001654; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland morphogenesis; GO:0007435 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 transcription factor complex; GO:0005667 eyg eyegone "CG10488, BK27, Bk27, lun, lune, eye gone" CDMC21878 2 6 16 DAC25-J23 12-CG10488-RA_2 CG10488 CCTTGGAATCAGCGGATGAGAACCGGCACATAGACTCCGATTATCTGGATGACGATGATGAGCCCAAGT 69 FBan0010488 FBgn0000625 eyg 3 3L cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; eye development; GO:0001654; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland morphogenesis; GO:0007435 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 transcription factor complex; GO:0005667 eyg eyegone "CG10488, BK27, Bk27, lun, lune, eye gone" CDMC21879 2 7 16 DAC25-N11 18-CG10527-RA_1 CG10527 GCCTACAAGGAGTTCGAAATCTATGTGACCAACTAAGCCACGGATCGAATGTCCAACGCACTGAAACAA 69 FBan0010527 FBgn0034583 CG10527 2 2R farnesoic acid O-methyltransferase activity; GO:0019010; ; GO:0019010 CG10527 CG10527 CDMC21879 2 8 16 DAC25-N11 18-CG10527-RA_1 CG10527 GCCTACAAGGAGTTCGAAATCTATGTGACCAACTAAGCCACGGATCGAATGTCCAACGCACTGAAACAA 69 FBan0010527 FBgn0034583 CG10527 2 2R farnesoic acid O-methyltransferase activity; GO:0019010; ; GO:0019010 CG10527 CG10527 CDMC21880 2 9 16 DAC25-N23 18-CG10534-RA_1 CG10534 GCCCCAAACATTACCAAACCAATCCTATCCCTGTTTTCAAAGGATGGGAACTAAGTCAACCAGCACCAC 69 FBan0010534 FBgn0020637 Lcp65Ag2 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ag2 Lcp65Ag2 "CG10534, LCP8, L[[3]]CP8, Lcp-g2, BcDNA:RE01644, DCP8-beta, Lcp8" CDMC21880 2 10 16 DAC25-N23 18-CG10534-RA_1 CG10534 GCCCCAAACATTACCAAACCAATCCTATCCCTGTTTTCAAAGGATGGGAACTAAGTCAACCAGCACCAC 69 FBan0010534 FBgn0020637 Lcp65Ag2 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ag2 Lcp65Ag2 "CG10534, LCP8, L[[3]]CP8, Lcp-g2, BcDNA:RE01644, DCP8-beta, Lcp8" CDMC21881 2 11 16 DAC26-B11 11-CG15280-RA_1 CG15280 TGCCAGCTTCACAAACCGACAGTGCAAATATGCAAGTGTGTACACGGACGTTATGAGCCACATCGACTT 69 FBan0015280 FBgn0028867 CR15280 2 2L CR15280 CR15280 "CG15280, BG:DS06874.4, SPH204" CDMC21881 2 12 16 DAC26-B11 11-CG15280-RA_1 CG15280 TGCCAGCTTCACAAACCGACAGTGCAAATATGCAAGTGTGTACACGGACGTTATGAGCCACATCGACTT 69 FBan0015280 FBgn0028867 CR15280 2 2L CR15280 CR15280 "CG15280, BG:DS06874.4, SPH204" CDMC21882 2 13 16 DAC26-B23 2-CG15293-RA_2 CG15293 GGCATTCTGGTCCCAGGCAGTAATGTATTCAAGCAGATATTCCCCGACATCTCCAGAGAGCCTGGTCCA 69 FBan0015293 FBgn0028526 CG15293 2 2L CG15293 CG15293 "BG:DS01759.2, CT35241" CDMC21882 2 14 16 DAC26-B23 2-CG15293-RA_2 CG15293 GGCATTCTGGTCCCAGGCAGTAATGTATTCAAGCAGATATTCCCCGACATCTCCAGAGAGCCTGGTCCA 69 FBan0015293 FBgn0028526 CG15293 2 2L CG15293 CG15293 "BG:DS01759.2, CT35241" CDMC21883 2 15 16 DAC26-F11 12-CG15345-RA_1 CG15345 AGGAAACGTTTGATCCACACTTCCACTTAGCCGCTAGCAATGAGCAGCAATTCCAAGTCGAGATGGAGG 69 FBan0015345 FBgn0040928 CG15345 X X CG15345 CG15345 BcDNA:RE52922 CDMC21883 2 16 16 DAC26-F11 12-CG15345-RA_1 CG15345 AGGAAACGTTTGATCCACACTTCCACTTAGCCGCTAGCAATGAGCAGCAATTCCAAGTCGAGATGGAGG 69 FBan0015345 FBgn0040928 CG15345 X X CG15345 CG15345 BcDNA:RE52922 CDMC21884 2 17 16 DAC26-F23 12-CG15366-RA_1 CG15366 ACCCTGAAAGCAAGCAATCTGGCTACCGTTTATGAGGTGGATATGTTTTCAGGTCATGTGAGCGGCACT 69 FBan0015366 FBgn0030080 CG15366 X X CG15366 CG15366 CDMC21884 2 18 16 DAC26-F23 12-CG15366-RA_1 CG15366 ACCCTGAAAGCAAGCAATCTGGCTACCGTTTATGAGGTGGATATGTTTTCAGGTCATGTGAGCGGCACT 69 FBan0015366 FBgn0030080 CG15366 X X CG15366 CG15366 CDMC21885 2 19 16 DAC26-J11 5-CG15405-RA_1 CG15405 GGCCGAGTGGACGATGAAGTTCCCCTACGACTATCGGGATGAGCGGATGATGAGCCATGTCAAACATAT 69 FBan0015405 FBgn0031509 CG15405 2 2L intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG15405 CG15405 CDMC21885 2 20 16 DAC26-J11 5-CG15405-RA_1 CG15405 GGCCGAGTGGACGATGAAGTTCCCCTACGACTATCGGGATGAGCGGATGATGAGCCATGTCAAACATAT 69 FBan0015405 FBgn0031509 CG15405 2 2L intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG15405 CG15405 CDMC21886 2 21 16 DAC26-J23 3-CG15427-RE_5 CG15427 GCGCAATCGCATCAAGATCTCCGGGGGCAATATCACCATTGAGAATCTGAGGAGGGAGGACTTTGGCTA 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC21886 2 22 16 DAC26-J23 3-CG15427-RE_5 CG15427 GCGCAATCGCATCAAGATCTCCGGGGGCAATATCACCATTGAGAATCTGAGGAGGGAGGACTTTGGCTA 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC21887 2 23 16 DAC26-N11 3-CG15462-RA_1 CG15462 GGGTGAGGATGGAGTGAGTGGTGTGCAAATTTTCACAGGTGCAGACTCCGAGGAATCTCAGCGAGAGAT 69 FBan0015462 FBgn0031102 CG15462 X X CG15462 CG15462 CDMC21887 2 24 16 DAC26-N11 3-CG15462-RA_1 CG15462 GGGTGAGGATGGAGTGAGTGGTGTGCAAATTTTCACAGGTGCAGACTCCGAGGAATCTCAGCGAGAGAT 69 FBan0015462 FBgn0031102 CG15462 X X CG15462 CG15462 CDMC21888 2 25 16 DAC26-N23 3-CG15472-RA_1 CG15472 AGTGGCCTTCAACGGAGAACGCTGTACCCTGGTCTTTGATGTTTCTCAGCTGATTGGAACGCAGACCAT 69 FBan0015472 FBgn0029724 CG15472 X X CG15472 CG15472 CDMC21888 2 26 16 DAC26-N23 3-CG15472-RA_1 CG15472 AGTGGCCTTCAACGGAGAACGCTGTACCCTGGTCTTTGATGTTTCTCAGCTGATTGGAACGCAGACCAT 69 FBan0015472 FBgn0029724 CG15472 X X CG15472 CG15472 CDMC21889 2 1 17 DAC27-B11 24-CG9747-RA_3 CG9747 ATAGACGACAACTACAAAATATGCTCTCAGTCCGAGACAAATAAAAAGAAAATAAATATTTGCAAATAA 69 FBan0009747 FBgn0039754 CG9747 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 acyl-CoA delta11-desaturase activity; GO:0017105; stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0017105; ; GO:0005506; ; GO:0004768 ; EC:1.14.19.1 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG9747 CG9747 CDMC21889 2 2 17 DAC27-B11 24-CG9747-RA_3 CG9747 ATAGACGACAACTACAAAATATGCTCTCAGTCCGAGACAAATAAAAAGAAAATAAATATTTGCAAATAA 69 FBan0009747 FBgn0039754 CG9747 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 acyl-CoA delta11-desaturase activity; GO:0017105; stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0017105; ; GO:0005506; ; GO:0004768 ; EC:1.14.19.1 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG9747 CG9747 CDMC21890 2 3 17 DAC27-B23 14-CG9764-RA_1 CG9764 CCGGGGGTCCCAGAACCGAAAAAATGACTTACCACACACCAACGAAATGTTAAGTGCAAGCAATCCACT 69 FBgn0038155 CDMC21890 2 4 17 DAC27-B23 14-CG9764-RA_1 CG9764 CCGGGGGTCCCAGAACCGAAAAAATGACTTACCACACACCAACGAAATGTTAAGTGCAAGCAATCCACT 69 FBgn0038155 CDMC21891 2 5 17 DAC27-F11 9-CG9799-RA_1 CG9799 ACCAATCTGAACTTTGAGCTGGCTCAATCGTATCTAAGCGTCTTCTTGCGATCCCACGGTCTCGGGTTG 69 FBan0009799 FBgn0038146 CG9799 3 3R CG9799 CG9799 CDMC21891 2 6 17 DAC27-F11 9-CG9799-RA_1 CG9799 ACCAATCTGAACTTTGAGCTGGCTCAATCGTATCTAAGCGTCTTCTTGCGATCCCACGGTCTCGGGTTG 69 FBan0009799 FBgn0038146 CG9799 3 3R CG9799 CG9799 CDMC21892 2 7 17 DAC27-F23 2-CG9813-RB_1 CG9813 GGCGCGGGTTAATCTGGCCAACCCATTTTACAGGCTTCCAATACACGCCCCTAGCCAATAAAGACACAT 69 FBan0009813 FBgn0038143 CG9813 3 3R CG9813 CG9813 CDMC21892 2 8 17 DAC27-F23 2-CG9813-RB_1 CG9813 GGCGCGGGTTAATCTGGCCAACCCATTTTACAGGCTTCCAATACACGCCCCTAGCCAATAAAGACACAT 69 FBan0009813 FBgn0038143 CG9813 3 3R CG9813 CG9813 CDMC21893 2 9 17 DAC27-J11 3-CG9858-RA_2 CG9858 ACCTGTTCCAGATGGCAGGTGACGAGACCGAGATGAATAGGGATGACTTGATGGTCACGGAACGGCTAT 69 FBan0009858 FBgn0000326 clt 2 2R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 clt cricklet "CG9858, CG9858, CG9858, anon-57Fb, JHE-related" CDMC21893 2 10 17 DAC27-J11 3-CG9858-RA_2 CG9858 ACCTGTTCCAGATGGCAGGTGACGAGACCGAGATGAATAGGGATGACTTGATGGTCACGGAACGGCTAT 69 FBan0009858 FBgn0000326 clt 2 2R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 clt cricklet "CG9858, CG9858, CG9858, anon-57Fb, JHE-related" CDMC21894 2 11 17 DAC27-J23 18-CG9876-RA_1 CG9876 GGCGCGGCTAGCTTTAATGGGCCCCATGAGGTTACTTCATGCATATGTATTTCAATTAGCCAAATTGCA 69 FBan0009876 FBgn0034821 CG9876 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9876 CG9876 CDMC21894 2 12 17 DAC27-J23 18-CG9876-RA_1 CG9876 GGCGCGGCTAGCTTTAATGGGCCCCATGAGGTTACTTCATGCATATGTATTTCAATTAGCCAAATTGCA 69 FBan0009876 FBgn0034821 CG9876 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9876 CG9876 CDMC21895 2 13 17 DAC27-N11 14-CG9915-RA_1 CG9915 CCGAAGGTGACAAAGAAGCGTGTAAAAATCACGGACACAGACAATGAAGAGGATGAGCAGGACAAGGGC 69 FBan0009915 FBgn0030738 CG9915 X X CG9915 CG9915 CDMC21895 2 14 17 DAC27-N11 14-CG9915-RA_1 CG9915 CCGAAGGTGACAAAGAAGCGTGTAAAAATCACGGACACAGACAATGAAGAGGATGAGCAGGACAAGGGC 69 FBan0009915 FBgn0030738 CG9915 X X CG9915 CG9915 CDMC21896 2 15 17 DAC27-N23 23-CG9922-RA_3 CG9922 AGATTATTAGTTAAATTATGTCGATTGTGTTATCGCTAGTAGTCCATCTCTAATCGCACGAGGTGAAGA 69 FBan0009922 FBgn0038196 CG9922 3 3R CG9922 CG9922 "BcDNA:RE55111, NEST:bs28g09" CDMC21896 2 16 17 DAC27-N23 23-CG9922-RA_3 CG9922 AGATTATTAGTTAAATTATGTCGATTGTGTTATCGCTAGTAGTCCATCTCTAATCGCACGAGGTGAAGA 69 FBan0009922 FBgn0038196 CG9922 3 3R CG9922 CG9922 "BcDNA:RE55111, NEST:bs28g09" CDMC21897 2 17 17 DAC28-B11 2-CG11791-RA_1 CG11791 TCAGCACCTGCCAAACAAACCCAGAGCGTTACGTTCGTGAGGACCAGTAATGCACCAGCTGTTTG 65 FBan0011791 FBgn0039266 CG11791 3 3R CG11791 CG11791 CDMC21897 2 18 17 DAC28-B11 2-CG11791-RA_1 CG11791 TCAGCACCTGCCAAACAAACCCAGAGCGTTACGTTCGTGAGGACCAGTAATGCACCAGCTGTTTG 65 FBan0011791 FBgn0039266 CG11791 3 3R CG11791 CG11791 CDMC21898 2 19 17 DAC28-B23 1-CG11835-RA_1 CG11835 TCCAGTTCCAGAAGTTATCAAAACGCTAGCACCGGAAGTCCCCAACGTTTCTCAGGCACCTGCAC 65 FBan0011835 FBgn0031264 CG11835 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367; visual perception; GO:0007601" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0003700 integral to membrane; GO:0016021; nucleus; GO:0005634 CG11835 CG11835 CDMC21898 2 20 17 DAC28-B23 1-CG11835-RA_1 CG11835 TCCAGTTCCAGAAGTTATCAAAACGCTAGCACCGGAAGTCCCCAACGTTTCTCAGGCACCTGCAC 65 FBan0011835 FBgn0031264 CG11835 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367; visual perception; GO:0007601" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0003700 integral to membrane; GO:0016021; nucleus; GO:0005634 CG11835 CG11835 CDMC21899 2 21 17 DAC28-F11 2-CG11929-RA_2 CG11929 GAGGACATTCCCACGTTCTGTGAGCTGGACAAAAACAGGCAGTACGATCCCAGGGACTGTCCACT 65 FBan0011929 FBgn0031620 CG11929 2 2L CG11929 CG11929 CDMC21899 2 22 17 DAC28-F11 2-CG11929-RA_2 CG11929 GAGGACATTCCCACGTTCTGTGAGCTGGACAAAAACAGGCAGTACGATCCCAGGGACTGTCCACT 65 FBan0011929 FBgn0031620 CG11929 2 2L CG11929 CG11929 CDMC21900 2 23 17 DAC28-F23 3-CG11989-RA_2 CG11989 GTACTACTTTTACCACGGACTAACCTGGCCTCAGCTTAGCTACGTGGCCGTTGACGACAAGGGCG 65 FBan0011989 FBgn0036064 Ard1 3 3L protein amino acid acetylation; GO:0006473 peptide alpha-N-acetyltransferase activity; GO:0004596 ; EC:2.3.1.88; ; GO:0004596 ; EC:2.3.1.88 Ard1 Ard1 "CG11989, CG11989, CG11989, DmAAF50178, dArd1, ARD1" CDMC21900 2 24 17 DAC28-F23 3-CG11989-RA_2 CG11989 GTACTACTTTTACCACGGACTAACCTGGCCTCAGCTTAGCTACGTGGCCGTTGACGACAAGGGCG 65 FBan0011989 FBgn0036064 Ard1 3 3L protein amino acid acetylation; GO:0006473 peptide alpha-N-acetyltransferase activity; GO:0004596 ; EC:2.3.1.88; ; GO:0004596 ; EC:2.3.1.88 Ard1 Ard1 "CG11989, CG11989, CG11989, DmAAF50178, dArd1, ARD1" CDMC21901 2 25 17 DAC28-J11 3-CG12090-RA_1 CG12090 GCGTGGAACCACATGATTCCGAACAAGAAATGGAAGGCCCAGACGATAAACAACTCCGCGGACGG 65 FBan0012090 FBgn0035227 CG12090 3 3L CG12090 CG12090 CDMC21901 2 26 17 DAC28-J11 3-CG12090-RA_1 CG12090 GCGTGGAACCACATGATTCCGAACAAGAAATGGAAGGCCCAGACGATAAACAACTCCGCGGACGG 65 FBan0012090 FBgn0035227 CG12090 3 3L CG12090 CG12090 CDMC21902 2 1 18 DAC28-J23 18-CG12115-RA_1 CG12115 GCATTCGAAAGAAGACATGCAAGGTCAAGTTTACCACCAAGGGCATCCTGTACGTTGCCAATGGA 65 FBan0012115 FBgn0030097 CG12115 X X CG12115 CG12115 BcDNA:LP02922 CDMC21902 2 2 18 DAC28-J23 18-CG12115-RA_1 CG12115 GCATTCGAAAGAAGACATGCAAGGTCAAGTTTACCACCAAGGGCATCCTGTACGTTGCCAATGGA 65 FBan0012115 FBgn0030097 CG12115 X X CG12115 CG12115 BcDNA:LP02922 CDMC21903 2 3 18 DAC28-N11 2-CG12172-RA_3 CG12172 TTGGGGTGTGGATATCCGCTCCTGAAGGTCTGGGTAACACGATCAAGGATCGCAATCTCTTCGCC 65 FBan0012172 FBgn0024294 Spn43Aa 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Aa Serine protease inhibitor 43Aa "CG12172, SER1, Serine protease inhibitor 1, Ser1: Serine protease 1, anon-WO0118057.1" CDMC21903 2 4 18 DAC28-N11 2-CG12172-RA_3 CG12172 TTGGGGTGTGGATATCCGCTCCTGAAGGTCTGGGTAACACGATCAAGGATCGCAATCTCTTCGCC 65 FBan0012172 FBgn0024294 Spn43Aa 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Aa Serine protease inhibitor 43Aa "CG12172, SER1, Serine protease inhibitor 1, Ser1: Serine protease 1, anon-WO0118057.1" CDMC21904 2 5 18 DAC28-N23 41-CG12199-RB_2 CG12199 CGACACCGTCTATGTGGCCAATCACTCGCGCGACGAAGAAGCCGTCTCAGTGGCCATGTCGGATA 65 FBan0012199 FBgn0031016 kek5 X X cell adhesion; GO:0007155; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transmission of nerve impulse; GO:0019226 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004601 ; EC:1.11.1.7 kek5 kekkon5 "CG12199, CG12199, CG12199, CT10486, kekkon-like, Kek5" CDMC21904 2 6 18 DAC28-N23 41-CG12199-RB_2 CG12199 CGACACCGTCTATGTGGCCAATCACTCGCGCGACGAAGAAGCCGTCTCAGTGGCCATGTCGGATA 65 FBan0012199 FBgn0031016 kek5 X X cell adhesion; GO:0007155; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transmission of nerve impulse; GO:0019226 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004601 ; EC:1.11.1.7 kek5 kekkon5 "CG12199, CG12199, CG12199, CT10486, kekkon-like, Kek5" CDMC21905 2 7 18 DAC29-B11 23-CG3075-RA_1 CG3075 TAAACCTAGCACTTAGAGAGAATAATGGGAAATCGAGTGTATTAGTGTATGTATGTGACGGGTGACGGA 69 FBan0003075 FBgn0029905 CG3075 X X cellular physiological process; GO:0050875; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3075 CG3075 NF-YC-like CDMC21905 2 8 18 DAC29-B11 23-CG3075-RA_1 CG3075 TAAACCTAGCACTTAGAGAGAATAATGGGAAATCGAGTGTATTAGTGTATGTATGTGACGGGTGACGGA 69 FBan0003075 FBgn0029905 CG3075 X X cellular physiological process; GO:0050875; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3075 CG3075 NF-YC-like CDMC21906 2 9 18 DAC29-B23 3-CG3090-RA_1 CG3090 GGGTGATACCTCCTCCAAGCCTAAGTACGAAGTTAAGATGGAGTCTGCTGAGCAGCTCAACTCCGCCGA 69 FBan0003090 FBgn0005612 Sox14 2 2R ectoderm development; GO:0007398; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox14 Sox box protein 14 "CG3090, CG17263, CG3090, CG17263, CG17263, CG3090, CG17263, CG3090, CG3090, DSox-14, DSox60B, Dsox-14, DSox14, SOX14, SOX60B, SOXC" CDMC21906 2 10 18 DAC29-B23 3-CG3090-RA_1 CG3090 GGGTGATACCTCCTCCAAGCCTAAGTACGAAGTTAAGATGGAGTCTGCTGAGCAGCTCAACTCCGCCGA 69 FBan0003090 FBgn0005612 Sox14 2 2R ectoderm development; GO:0007398; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox14 Sox box protein 14 "CG3090, CG17263, CG3090, CG17263, CG17263, CG3090, CG17263, CG3090, CG3090, DSox-14, DSox60B, Dsox-14, DSox14, SOX14, SOX60B, SOXC" CDMC21907 2 11 18 DAC29-F11 3-CG31015-RA_1 CG31015 GTGCTCTACCACGATGTGCTCTCACCCAAGGAAATCAAAGAGCTCCAAGGTATGGCCACTCCTGGTCTA 69 FBan0031015 FBgn0051015 PH4alphaPV 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaPV prolyl-4-hydroxylase-alpha PV "CG9713, CG31015, CG9713, prolyl-4-hydroxylase-alpha PV" CDMC21907 2 12 18 DAC29-F11 3-CG31015-RA_1 CG31015 GTGCTCTACCACGATGTGCTCTCACCCAAGGAAATCAAAGAGCTCCAAGGTATGGCCACTCCTGGTCTA 69 FBan0031015 FBgn0051015 PH4alphaPV 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaPV prolyl-4-hydroxylase-alpha PV "CG9713, CG31015, CG9713, prolyl-4-hydroxylase-alpha PV" CDMC21908 2 13 18 DAC29-F23 2-CG31021-RA_1 CG31021 GCGAGCTTAATGACTGGGTCCATTCGTTCCTTGCCTACGCACCCATTAAGTTTGAGGACCTGCAACAGG 69 FBan0031021 FBgn0051021 CG31021 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31021 CG31021 CG9708 CDMC21908 2 14 18 DAC29-F23 2-CG31021-RA_1 CG31021 GCGAGCTTAATGACTGGGTCCATTCGTTCCTTGCCTACGCACCCATTAAGTTTGAGGACCTGCAACAGG 69 FBan0031021 FBgn0051021 CG31021 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31021 CG31021 CG9708 CDMC21909 2 15 18 DAC29-J11 3-CG31056-RA_1 CG31056 GCAGCCTCCGCACGAATAAGGGGACACACTATCAAAGGATGACGAGGATGTCCAAGTGAATCACCAGCT 69 FBan0031056 FBgn0013745 Acp98AB 3 3R "negative regulation of female receptivity, post-mating; GO:0045434" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp98AB Accessory gland-specific peptide 98AB "CG31056, Acp98B: Accessory gland-specific peptide 98B, Accessory gland protein 98AB, Acp98, Accessory gland-specific peptide 98B, Acp98B" CDMC21909 2 16 18 DAC29-J11 3-CG31056-RA_1 CG31056 GCAGCCTCCGCACGAATAAGGGGACACACTATCAAAGGATGACGAGGATGTCCAAGTGAATCACCAGCT 69 FBan0031056 FBgn0013745 Acp98AB 3 3R "negative regulation of female receptivity, post-mating; GO:0045434" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp98AB Accessory gland-specific peptide 98AB "CG31056, Acp98B: Accessory gland-specific peptide 98B, Accessory gland protein 98AB, Acp98, Accessory gland-specific peptide 98B, Acp98B" CDMC21910 2 17 18 DAC29-J23 18-CG31061-RA_1 CG31061 CGTGGCACTCGGACCCTACCTCCACTGGACAAATAAAGTGCTCACCGAAATCATTCTGATAATGCTACA 69 FBan0031061 FBgn0046885 Gr98d 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98d Gustatory receptor 98d "CG12884, CG31061, CG12884, 98B.1, Gustatory receptor 98B.1, Gr98A1, Gr98B1, GR98B.1, Gustatory receptor 98d" CDMC21910 2 18 18 DAC29-J23 18-CG31061-RA_1 CG31061 CGTGGCACTCGGACCCTACCTCCACTGGACAAATAAAGTGCTCACCGAAATCATTCTGATAATGCTACA 69 FBan0031061 FBgn0046885 Gr98d 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98d Gustatory receptor 98d "CG12884, CG31061, CG12884, 98B.1, Gustatory receptor 98B.1, Gr98A1, Gr98B1, GR98B.1, Gustatory receptor 98d" CDMC21911 2 19 18 DAC29-N11 3-CG3108-RA_1 CG3108 GCCTCACCTGGCAGGCCTACCATCGTCTGGAGGACATTCACGGCTTCATTGACTATATGGCTAAAACCT 69 FBan0003108 FBgn0029807 CG3108 X X proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.-; ; GO:0004182 ; EC:3.4.17.1 CG3108 CG3108 CDMC21911 2 20 18 DAC29-N11 3-CG3108-RA_1 CG3108 GCCTCACCTGGCAGGCCTACCATCGTCTGGAGGACATTCACGGCTTCATTGACTATATGGCTAAAACCT 69 FBan0003108 FBgn0029807 CG3108 X X proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.-; ; GO:0004182 ; EC:3.4.17.1 CG3108 CG3108 CDMC21912 2 21 18 DAC29-N23 1-CG31098-RA_1 CG31098 GCCTGACTCCACTGATCTTCAGGGAGGGAGCTGGTTTCGAAAACCTTGAGGATCTGAACTCACGCACTG 69 FBan0031098 FBgn0051098 CG31098 3 3R CG31098 CG31098 "CG10634, BcDNA:GH27183, BcDNA:RE13429" CDMC21912 2 22 18 DAC29-N23 1-CG31098-RA_1 CG31098 GCCTGACTCCACTGATCTTCAGGGAGGGAGCTGGTTTCGAAAACCTTGAGGATCTGAACTCACGCACTG 69 FBan0031098 FBgn0051098 CG31098 3 3R CG31098 CG31098 "CG10634, BcDNA:GH27183, BcDNA:RE13429" CDMC21913 2 23 18 DAC30-B11 3-CG1968-RA_3 CG1968 GCAGTGTGGATACCAAACAGCAGCCATCGACATCATGGAGGAGATGACATTGCATCAGGAGGGCG 65 FBan0001968 FBgn0033401 CG1968 2 2R CG1968 CG1968 CDMC21913 2 24 18 DAC30-B11 3-CG1968-RA_3 CG1968 GCAGTGTGGATACCAAACAGCAGCCATCGACATCATGGAGGAGATGACATTGCATCAGGAGGGCG 65 FBan0001968 FBgn0033401 CG1968 2 2R CG1968 CG1968 CDMC21914 2 25 18 DAC30-B23 7-CG2014-RA_1 CG2014 GAAATGATGCACATTGCGGCTCCTCGCTACGACATGGATCGCTACGGTGTGGTGTTCCGAGCATC 65 FBan0002014 FBgn0039669 CG2014 3 3R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG2014 CG2014 CDMC21914 2 26 18 DAC30-B23 7-CG2014-RA_1 CG2014 GAAATGATGCACATTGCGGCTCCTCGCTACGACATGGATCGCTACGGTGTGGTGTTCCGAGCATC 65 FBan0002014 FBgn0039669 CG2014 3 3R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG2014 CG2014 CDMC21915 2 1 19 DAC30-F11 3-CG2161-RA_2 CG2161 TCAGAGCAATCGGAGTTCACGATGTCTAACGAGGACTTCCCTGCGTTACCGGGCACCCAAAACTC 65 FBan0002161 FBgn0017550 Rga 3 3R "mRNA transcription; GO:0009299; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528 nucleus; GO:0005634 Rga Regena "CG2138, CG2161, CG2138, l(3)03834, NOT2" CDMC21915 2 2 19 DAC30-F11 3-CG2161-RA_2 CG2161 TCAGAGCAATCGGAGTTCACGATGTCTAACGAGGACTTCCCTGCGTTACCGGGCACCCAAAACTC 65 FBan0002161 FBgn0017550 Rga 3 3R "mRNA transcription; GO:0009299; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528 nucleus; GO:0005634 Rga Regena "CG2138, CG2161, CG2138, l(3)03834, NOT2" CDMC21916 2 3 19 DAC30-F23 12-CG2216-RA_2 CG2216 CTCCCTGGCTGTTCCTGAGATTACCAAGGACTGGGTGGACATGAAGGATGCCTGCATAAAGGGCA 65 FBan0002216 FBgn0015222 Fer1HCH 3 3R iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 Fer1HCH Ferritin 1 heavy chain homologue "CG2216, CG2216, CG2216, CG2216, CG2216, l(3)00451, l(3)j10B4, Fer-L: Ferritin-Light, Ferritin-Light, Ferritin, ferritin, Fer1, ferritin subunit 1, 1HCH, T9, T21, HCH, FER1, FerHCH, BEST:LD36673, Fer-L" CDMC21916 2 4 19 DAC30-F23 12-CG2216-RA_2 CG2216 CTCCCTGGCTGTTCCTGAGATTACCAAGGACTGGGTGGACATGAAGGATGCCTGCATAAAGGGCA 65 FBan0002216 FBgn0015222 Fer1HCH 3 3R iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 Fer1HCH Ferritin 1 heavy chain homologue "CG2216, CG2216, CG2216, CG2216, CG2216, l(3)00451, l(3)j10B4, Fer-L: Ferritin-Light, Ferritin-Light, Ferritin, ferritin, Fer1, ferritin subunit 1, 1HCH, T9, T21, HCH, FER1, FerHCH, BEST:LD36673, Fer-L" CDMC21917 2 5 19 DAC30-J11 12-CG2453-RA_4 CG2453 CAGGAGATTCGTCCACACCCGAACGGCATCTCAATCGGCCCAGAACTCCAAAGGAATGGCAAGTG 65 FBan0002453 FBgn0030460 CG2453 X X coenzyme biosynthesis; GO:0009108 "S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; GO:0008425 ; EC:2.1.1.-; ; GO:0008425 ; EC:2.1.1.-" CG2453 CG2453 CDMC21917 2 6 19 DAC30-J11 12-CG2453-RA_4 CG2453 CAGGAGATTCGTCCACACCCGAACGGCATCTCAATCGGCCCAGAACTCCAAAGGAATGGCAAGTG 65 FBan0002453 FBgn0030460 CG2453 X X coenzyme biosynthesis; GO:0009108 "S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; GO:0008425 ; EC:2.1.1.-; ; GO:0008425 ; EC:2.1.1.-" CG2453 CG2453 CDMC21918 2 7 19 DAC30-J23 3-CG2666-RB_1 CG2666 AGCGAAGCGGACGTGTCTCGAATGCAGGCATCAGCATCAAGGATGTATTCAATGTGAACGGTGGT 65 FBan0002666 FBgn0001311 kkv 3 3R Malpighian tubule morphogenesis; GO:0007443; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362 chitin synthase activity; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16 integral to membrane; GO:0016021 kkv krotzkopf verkehrt "CG2666, l(3)82Fh, blimp, DmCS-1, Chitin synthase 1, DmeChSB, ChSB, Chitin Synthase B, CS-1/kkv, CS-1" CDMC21918 2 8 19 DAC30-J23 3-CG2666-RB_1 CG2666 AGCGAAGCGGACGTGTCTCGAATGCAGGCATCAGCATCAAGGATGTATTCAATGTGAACGGTGGT 65 FBan0002666 FBgn0001311 kkv 3 3R Malpighian tubule morphogenesis; GO:0007443; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362 chitin synthase activity; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16 integral to membrane; GO:0016021 kkv krotzkopf verkehrt "CG2666, l(3)82Fh, blimp, DmCS-1, Chitin synthase 1, DmeChSB, ChSB, Chitin Synthase B, CS-1/kkv, CS-1" CDMC21919 2 9 19 DAC30-N11 23-CG2889-RA_1 CG2889 CGGCCGACGTTTAAACCTGACCCCTCACAATTGTGTTTAATCATTATACGTATAATTAAACTGTA 65 FBan0002889 FBgn0030206 CG2889 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2889 CG2889 CDMC21919 2 10 19 DAC30-N11 23-CG2889-RA_1 CG2889 CGGCCGACGTTTAAACCTGACCCCTCACAATTGTGTTTAATCATTATACGTATAATTAAACTGTA 65 FBan0002889 FBgn0030206 CG2889 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2889 CG2889 CDMC21920 2 11 19 DAC30-N23 2-CG2924-RA_1 CG2924 TAACGCATGCCAGCCTACACCAATCAACACCACTCCTCACACCGCCAAAATTAGCCTGTCCACAT 65 FBan0002924 FBgn0023528 CG2924 X X proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0004840; ; GO:0016740 ; EC:2.-.-.- CG2924 CG2924 EG:25E8.2 CDMC21920 2 12 19 DAC30-N23 2-CG2924-RA_1 CG2924 TAACGCATGCCAGCCTACACCAATCAACACCACTCCTCACACCGCCAAAATTAGCCTGTCCACAT 65 FBan0002924 FBgn0023528 CG2924 X X proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0004840; ; GO:0016740 ; EC:2.-.-.- CG2924 CG2924 EG:25E8.2 CDMC21921 2 13 19 DAC31-B11 17-CG31745-RA_1 CG31745 ACGAGTATACATATGCACCTGGATCTGGAATGGGATTGAGGTTCACCCAGAATTGTCCGCAAAAGGTG 68 FBan0031745 FBgn0051745 CG31745 2 2L lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG31745 CG31745 CDMC21921 2 14 19 DAC31-B11 17-CG31745-RA_1 CG31745 ACGAGTATACATATGCACCTGGATCTGGAATGGGATTGAGGTTCACCCAGAATTGTCCGCAAAAGGTG 68 FBan0031745 FBgn0051745 CG31745 2 2L lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG31745 CG31745 CDMC21922 2 15 19 DAC31-B23 22-CG31845-RA_1 CG31845 GCGTATGAGCAATGTTTAAAGGGTGCTACCTGACAGAGTTCAGTCCACTCACCTGACAAACAACTGCT 68 FBan0031845 FBgn0051845 CG31845 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31845 CG31845 CDMC21922 2 16 19 DAC31-B23 22-CG31845-RA_1 CG31845 GCGTATGAGCAATGTTTAAAGGGTGCTACCTGACAGAGTTCAGTCCACTCACCTGACAAACAACTGCT 68 FBan0031845 FBgn0051845 CG31845 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31845 CG31845 CDMC21923 2 17 19 DAC31-F11 27-CG3228-RA_6 CG3228 GCACCAATGTGGCAGAGACATCTCTCACCATCCCGCACATCAAGTATGTTGTTGACTGTGGTCGCCAG 68 FBan0003228 FBgn0001330 kz X X "nuclear mRNA splicing, via spliceosome; GO:0000398; proteolysis; GO:0006508" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026; ; GO:0004386; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008026; ; GO:0004295 ; EC:3.4.21.4 nucleus; GO:0005634 kz kurz "CG3228, CG3228, N1, l67, N8, EG:30B8.2, l(1)2Eb, l(1)N4" CDMC21923 2 18 19 DAC31-F11 27-CG3228-RA_6 CG3228 GCACCAATGTGGCAGAGACATCTCTCACCATCCCGCACATCAAGTATGTTGTTGACTGTGGTCGCCAG 68 FBan0003228 FBgn0001330 kz X X "nuclear mRNA splicing, via spliceosome; GO:0000398; proteolysis; GO:0006508" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026; ; GO:0004386; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008026; ; GO:0004295 ; EC:3.4.21.4 nucleus; GO:0005634 kz kurz "CG3228, CG3228, N1, l67, N8, EG:30B8.2, l(1)2Eb, l(1)N4" CDMC21924 2 19 19 DAC31-F23 3-CG32356-RB_1 CG32356 CGGCAACATCGAGAAAGCAACCTGCGATCGCAATGCTCAATGGAAACGCTTTTACGGTTAAGCGGCTC 68 FBan0032356 FBgn0001253 ImpE1 3 3L imaginal disc eversion; GO:0007561 lipoprotein binding; GO:0008034; ; GO:0008034 extrinsic to membrane; GO:0019898 ImpE1 Ecdysone-inducible gene E1 "CG13668, CG7116, CG32356, CG13668, CG7116, CG7116, IMP-E1, Imp-E1, CT22003, CT33103, Y1-like, BcDNA:RE39082" CDMC21924 2 20 19 DAC31-F23 3-CG32356-RB_1 CG32356 CGGCAACATCGAGAAAGCAACCTGCGATCGCAATGCTCAATGGAAACGCTTTTACGGTTAAGCGGCTC 68 FBan0032356 FBgn0001253 ImpE1 3 3L imaginal disc eversion; GO:0007561 lipoprotein binding; GO:0008034; ; GO:0008034 extrinsic to membrane; GO:0019898 ImpE1 Ecdysone-inducible gene E1 "CG13668, CG7116, CG32356, CG13668, CG7116, CG7116, IMP-E1, Imp-E1, CT22003, CT33103, Y1-like, BcDNA:RE39082" CDMC21925 2 21 19 DAC31-J11 3-CG3290-RA_2 CG3290 TGCATCCAGCATAATTGGTACCTTCCAATCGGGCTTGATGGACTTTCACATGGACGCTGATCCCACCT 68 FBan0003290 FBgn0034711 CG3290 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3290 CG3290 CDMC21925 2 22 19 DAC31-J11 3-CG3290-RA_2 CG3290 TGCATCCAGCATAATTGGTACCTTCCAATCGGGCTTGATGGACTTTCACATGGACGCTGATCCCACCT 68 FBan0003290 FBgn0034711 CG3290 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3290 CG3290 CDMC21926 2 23 19 DAC31-J23 2-CG33153-RA_2 CG33153 CCGCCATTGTCTTGTCATCGTCATTGTCATTCCCAGATCGCAGGACTGGTGGACTGTTCGATTTGGGG 68 FBgn0053153 CG33153 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33153 CG33153 CDMC21926 2 24 19 DAC31-J23 2-CG33153-RA_2 CG33153 CCGCCATTGTCTTGTCATCGTCATTGTCATTCCCAGATCGCAGGACTGGTGGACTGTTCGATTTGGGG 68 FBgn0053153 CG33153 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33153 CG33153 CDMC21927 2 25 19 DAC31-N11 3-CG3474-RA_1 CG3474 TGTGAAGTCACAGAGTGAGTCACGACATGGCCACACGGTTACCGGACACTATGAGTTGATCGATGCCG 68 FBan0003474 FBgn0028871 CG3474 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011 CG3474 CG3474 "BG:DS06238.4, DS06283.4" CDMC21927 2 26 19 DAC31-N11 3-CG3474-RA_1 CG3474 TGTGAAGTCACAGAGTGAGTCACGACATGGCCACACGGTTACCGGACACTATGAGTTGATCGATGCCG 68 FBan0003474 FBgn0028871 CG3474 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011 CG3474 CG3474 "BG:DS06238.4, DS06283.4" CDMC21928 2 1 20 DAC31-N23 3-CG3573-RA_2 CG3573 ACCAGCCACAGATCAATGTCGAGAAGACGGTCATCGATTTCGGGACTGTGCGATTTAACGAGCCGAGC 68 FBan0003573 FBgn0023508 CG3573 X X dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242 inositol trisphosphate phosphatase activity; GO:0046030; inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0046030; ; GO:0004445 ; EC:3.1.3.56 CG3573 CG3573 "inositol 5-phosphatase, EG:86E4.5" CDMC21928 2 2 20 DAC31-N23 3-CG3573-RA_2 CG3573 ACCAGCCACAGATCAATGTCGAGAAGACGGTCATCGATTTCGGGACTGTGCGATTTAACGAGCCGAGC 68 FBan0003573 FBgn0023508 CG3573 X X dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242 inositol trisphosphate phosphatase activity; GO:0046030; inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0046030; ; GO:0004445 ; EC:3.1.3.56 CG3573 CG3573 "inositol 5-phosphatase, EG:86E4.5" CDMC21929 2 3 20 DAC32-B11 3-CG15744-RA_1 CG15744 GAGAGCGATCTGAACTACCAAAACTCGGAGATAAGCATCCGAAGCCATGGACTGTATGCTCCCCAGGCG 69 FBan0015744 FBgn0030466 CG15744 X X CG15744 CG15744 CT35992 CDMC21929 2 4 20 DAC32-B11 3-CG15744-RA_1 CG15744 GAGAGCGATCTGAACTACCAAAACTCGGAGATAAGCATCCGAAGCCATGGACTGTATGCTCCCCAGGCG 69 FBan0015744 FBgn0030466 CG15744 X X CG15744 CG15744 CT35992 CDMC21930 2 5 20 DAC32-B23 2-CG15772-RA_1 CG15772 GATGCACCTCCAGAACTACACTCCCCTGATCCTTCTCATCGATTTCGTGGAGAAGACCCGAACCAAGCG 69 FBan0015772 FBgn0029799 CG15772 X X CG15772 CG15772 CDMC21930 2 6 20 DAC32-B23 2-CG15772-RA_1 CG15772 GATGCACCTCCAGAACTACACTCCCCTGATCCTTCTCATCGATTTCGTGGAGAAGACCCGAACCAAGCG 69 FBan0015772 FBgn0029799 CG15772 X X CG15772 CG15772 CDMC21931 2 7 20 DAC32-F11 23-CG15835-RA_10 CG15835 GCTGTAGCTGTAGGGCAGACTGAATTTGTCCGTTCACATTTTAATTTAACAAGTGTCTGTTCCCACCGA 69 FBan0015835 FBgn0033233 CG15835 2 2R "cell communication; GO:0007154; hormone secretion; GO:0046879; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG15835 CG15835 CDMC21931 2 8 20 DAC32-F11 23-CG15835-RA_10 CG15835 GCTGTAGCTGTAGGGCAGACTGAATTTGTCCGTTCACATTTTAATTTAACAAGTGTCTGTTCCCACCGA 69 FBan0015835 FBgn0033233 CG15835 2 2R "cell communication; GO:0007154; hormone secretion; GO:0046879; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG15835 CG15835 CDMC21932 2 9 20 DAC32-F23 15-CG15859-RA_1 CG15859 ACCGCCAGTGGTCTACAACTACAACTACAACTACAGAAGGCAGCCAAATGTGACTTCGCAACTGACACT 69 FBan0015859 FBgn0035071 CG15859 2 2R CG15859 CG15859 CDMC21932 2 10 20 DAC32-F23 15-CG15859-RA_1 CG15859 ACCGCCAGTGGTCTACAACTACAACTACAACTACAGAAGGCAGCCAAATGTGACTTCGCAACTGACACT 69 FBan0015859 FBgn0035071 CG15859 2 2R CG15859 CG15859 CDMC21933 2 11 20 DAC32-J11 15-CG15908-RA_1 CG15908 GCGCGCTTCCACCAGTACTTTATATTTGGCAAGGACACAGATTGCTCCCAATGGCTAACTGATTACCGT 69 FBan0015908 FBgn0033085 CG15908 2 2R CG15908 CG15908 CDMC21933 2 12 20 DAC32-J11 15-CG15908-RA_1 CG15908 GCGCGCTTCCACCAGTACTTTATATTTGGCAAGGACACAGATTGCTCCCAATGGCTAACTGATTACCGT 69 FBan0015908 FBgn0033085 CG15908 2 2R CG15908 CG15908 CDMC21934 2 13 20 DAC32-J23 3-CG1591-RA_1 CG1591 AATGCCTAACGACACTGTGGTAAAGGTGCAGGAGTACAAGGACTCGTTGATCCTCAAGGCAGAGCTGCT 69 FBan0001591 FBgn0029133 REG X X proteolysis; GO:0006508 proteasome activator activity; GO:0008538; ; GO:0008538 NOT nucleolus; GO:0005730; nucleus; GO:0005634; proteasome activator complex; GO:0008537; proteasome complex (sensu Eukaryota); GO:0000502 REG REG "CG1591, dREG" CDMC21934 2 14 20 DAC32-J23 3-CG1591-RA_1 CG1591 AATGCCTAACGACACTGTGGTAAAGGTGCAGGAGTACAAGGACTCGTTGATCCTCAAGGCAGAGCTGCT 69 FBan0001591 FBgn0029133 REG X X proteolysis; GO:0006508 proteasome activator activity; GO:0008538; ; GO:0008538 NOT nucleolus; GO:0005730; nucleus; GO:0005634; proteasome activator complex; GO:0008537; proteasome complex (sensu Eukaryota); GO:0000502 REG REG "CG1591, dREG" CDMC21935 2 15 20 DAC32-N11 16-CG1623-RB_1 CG1623 GGTCCCCAAAGCGTCATTTCGGGACTAGCTAGACCAAACTACGTGTATTGCAATAGACACCATTTGCTT 69 FBan0001623 FBgn0033448 CG1623 2 2R CG1623 CG1623 CDMC21935 2 16 20 DAC32-N11 16-CG1623-RB_1 CG1623 GGTCCCCAAAGCGTCATTTCGGGACTAGCTAGACCAAACTACGTGTATTGCAATAGACACCATTTGCTT 69 FBan0001623 FBgn0033448 CG1623 2 2R CG1623 CG1623 CDMC21936 2 17 20 DAC32-N23 23-CG1632-RA_2 CG1632 TGTGTGTAGCAAAGCAAGTAAGGCAATTAAGCATATGTACTATGTAACTAACCTGCTCTAATGTTACTC 69 FBan0001632 FBgn0030027 CG1632 X X development; GO:0007275; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0004295 ; EC:3.4.21.4 membrane; GO:0016020 CG1632 CG1632 SPH198 CDMC21936 2 18 20 DAC32-N23 23-CG1632-RA_2 CG1632 TGTGTGTAGCAAAGCAAGTAAGGCAATTAAGCATATGTACTATGTAACTAACCTGCTCTAATGTTACTC 69 FBan0001632 FBgn0030027 CG1632 X X development; GO:0007275; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0004295 ; EC:3.4.21.4 membrane; GO:0016020 CG1632 CG1632 SPH198 CDMC21937 2 19 20 DAC33-B11 9-CG11333-RA_1 CG11333 CGCCTGCGTCACATTGGCTGCAACATAGCAACTTCCGAGAGTGTGATATTTAATCTGCTGGGGGACAAG 69 FBan0011333 FBgn0039850 CG11333 3 3R CG11333 CG11333 BcDNA:AT02774 CDMC21937 2 20 20 DAC33-B11 9-CG11333-RA_1 CG11333 CGCCTGCGTCACATTGGCTGCAACATAGCAACTTCCGAGAGTGTGATATTTAATCTGCTGGGGGACAAG 69 FBan0011333 FBgn0039850 CG11333 3 3R CG11333 CG11333 BcDNA:AT02774 CDMC21938 2 21 20 DAC33-B23 12-CG11342-RA_1 CG11342 ACCACAGCCCTGGAAATGCTATCAGAAAGCAGAGAGACGCCTGAAAAAAGCCGGAGAGATATTCCCTCT 69 FBan0011342 FBgn0035537 CG11342 3 3L CG11342 CG11342 CDMC21938 2 22 20 DAC33-B23 12-CG11342-RA_1 CG11342 ACCACAGCCCTGGAAATGCTATCAGAAAGCAGAGAGACGCCTGAAAAAAGCCGGAGAGATATTCCCTCT 69 FBan0011342 FBgn0035537 CG11342 3 3L CG11342 CG11342 CDMC21939 2 23 20 DAC33-F11 18-CG11376-RA_1 CG11376 ACAACTGTACCGACAAAACACCAAAACAAACTTCGGTTGTGCTTTCGCGAGTTTTCAAAGCGTTGTGCT 69 FBan0011376 FBgn0031216 CG11376 2 2L CG11376 CG11376 anon-EST:Posey54 CDMC21939 2 24 20 DAC33-F11 18-CG11376-RA_1 CG11376 ACAACTGTACCGACAAAACACCAAAACAAACTTCGGTTGTGCTTTCGCGAGTTTTCAAAGCGTTGTGCT 69 FBan0011376 FBgn0031216 CG11376 2 2L CG11376 CG11376 anon-EST:Posey54 CDMC21940 2 25 20 DAC33-F23 23-CG11387-RA_5 CG11387 TAGCCGTTAAGGTAGCCTTAGGTTGAGGAGTTGTAATAGTTGTAGCTAAAAGTTTAGAGACGCTATGCG 69 FBan0011387 FBgn0004198 ct X X Malpighian tubule morphogenesis; GO:0007443; antennal morphogenesis; GO:0007469; cell fate commitment; GO:0045165; central nervous system development; GO:0007417; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; female gonad development; GO:0008585; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360; spiracle morphogenesis; GO:0035277; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; catalytic activity; GO:0003824; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003824; ; GO:0003700 nucleus; GO:0005634 ct cut "CG11387, CG11387, kf: kinked-femur, kinked-femur, Cut, Ct, BcDNA:GH10590, l(1)7Ba, l(1)7Bb, l(1)VE614, kf, cut" CDMC21940 2 26 20 DAC33-F23 23-CG11387-RA_5 CG11387 TAGCCGTTAAGGTAGCCTTAGGTTGAGGAGTTGTAATAGTTGTAGCTAAAAGTTTAGAGACGCTATGCG 69 FBan0011387 FBgn0004198 ct X X Malpighian tubule morphogenesis; GO:0007443; antennal morphogenesis; GO:0007469; cell fate commitment; GO:0045165; central nervous system development; GO:0007417; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; female gonad development; GO:0008585; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360; spiracle morphogenesis; GO:0035277; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; catalytic activity; GO:0003824; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003824; ; GO:0003700 nucleus; GO:0005634 ct cut "CG11387, CG11387, kf: kinked-femur, kinked-femur, Cut, Ct, BcDNA:GH10590, l(1)7Ba, l(1)7Bb, l(1)VE614, kf, cut" CDMC21941 2 1 21 DAC33-J11 2-CG11419-RA_1 CG11419 GGGCAAGCACTATCCTCTGGAACTGTTTGGCAAGTTTGGAACGGTCGACTTTCAGAAGTTCGCCACCAT 69 FBan0011419 FBgn0034231 CG11419 2 2R mitotic anaphase; GO:0000090; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005515 anaphase-promoting complex; GO:0005680 CG11419 CG11419 CDMC21941 2 2 21 DAC33-J11 2-CG11419-RA_1 CG11419 GGGCAAGCACTATCCTCTGGAACTGTTTGGCAAGTTTGGAACGGTCGACTTTCAGAAGTTCGCCACCAT 69 FBan0011419 FBgn0034231 CG11419 2 2R mitotic anaphase; GO:0000090; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005515 anaphase-promoting complex; GO:0005680 CG11419 CG11419 CDMC21942 2 3 21 DAC33-J23 23-CG11430-RA_9 CG11430 AAGTGGATCGAACGAAAAAGACAGCGGCTCAGGGTAAGCTTCAGATTATTTTTAGTGAAACACACATAT 69 FBan0011430 FBgn0041585 olf186-F 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- olf186-F olf186-F "CG11430, CG11430, l(2)k11505[k11505], SPH206, BcDNA:LD03241, l(2)k11505, lethal (2) k11505" CDMC21942 2 4 21 DAC33-J23 23-CG11430-RA_9 CG11430 AAGTGGATCGAACGAAAAAGACAGCGGCTCAGGGTAAGCTTCAGATTATTTTTAGTGAAACACACATAT 69 FBan0011430 FBgn0041585 olf186-F 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- olf186-F olf186-F "CG11430, CG11430, l(2)k11505[k11505], SPH206, BcDNA:LD03241, l(2)k11505, lethal (2) k11505" CDMC21943 2 5 21 DAC33-N11 2-CG11482-RA_1 CG11482 GCGAGCCCTGTTCCAGCATGAAACGCGCCTTTATATGTGCAACACACGGTCGTTTAGTGAGGAACTGTT 69 FBan0011482 FBgn0011659 Mlh1 2 2R mismatch repair; GO:0006298 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676 nucleus; GO:0005634 Mlh1 Mlh1 "CG11482, dmlh-1, dmlh1" CDMC21943 2 6 21 DAC33-N11 2-CG11482-RA_1 CG11482 GCGAGCCCTGTTCCAGCATGAAACGCGCCTTTATATGTGCAACACACGGTCGTTTAGTGAGGAACTGTT 69 FBan0011482 FBgn0011659 Mlh1 2 2R mismatch repair; GO:0006298 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676 nucleus; GO:0005634 Mlh1 Mlh1 "CG11482, dmlh-1, dmlh1" CDMC21944 2 7 21 DAC33-N23 15-CG11491-RA_1 CG11491 ACCGGGCATCCAATAGGAGCTAAGTTGGAACGCCATCTTTTAGAGAACGAAGGAGAGCTGGTCAGTCAG 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC21944 2 8 21 DAC33-N23 15-CG11491-RA_1 CG11491 ACCGGGCATCCAATAGGAGCTAAGTTGGAACGCCATCTTTTAGAGAACGAAGGAGAGCTGGTCAGTCAG 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC21945 2 9 21 DAC34-B11 16-CG14577-RA_1 CG14577 TGTCTGTACACCCGAAACAACACGGAACACTTTATCCCAAACTTTATATCCCTGGTGGTCGTCACGC 67 FBan0014577 FBgn0037110 ORMDL 3 3L endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 ORMDL ORMDL CG14577 CDMC21945 2 10 21 DAC34-B11 16-CG14577-RA_1 CG14577 TGTCTGTACACCCGAAACAACACGGAACACTTTATCCCAAACTTTATATCCCTGGTGGTCGTCACGC 67 FBan0014577 FBgn0037110 ORMDL 3 3L endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 ORMDL ORMDL CG14577 CDMC21946 2 11 21 DAC34-B23 1-CG14654-RA_1 CG14654 GGATGATGGGGATGAAACTACGGTAGATATAGATACCCCCAAGCAGTCGAGTGGGCTTCGCTGGGCG 67 FBan0014654 FBgn0037273 CG14654 3 3R CG14654 CG14654 CDMC21946 2 12 21 DAC34-B23 1-CG14654-RA_1 CG14654 GGATGATGGGGATGAAACTACGGTAGATATAGATACCCCCAAGCAGTCGAGTGGGCTTCGCTGGGCG 67 FBan0014654 FBgn0037273 CG14654 3 3R CG14654 CG14654 CDMC21947 2 13 21 DAC34-F11 23-CG15016-RA_2 CG15016 AAATTAAATTCCTTACCAGCTCATACAATTCACCGGTCACAATGCCTTCTTACGAACTAGCACTGGT 67 FBan0015016 FBgn0035534 mRpS6 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS6 mitochondrial ribosomal protein S6 "CG15016, MRP-S6, BcDNA:RH10862, mitochondrial ribosomal protein S6" CDMC21947 2 14 21 DAC34-F11 23-CG15016-RA_2 CG15016 AAATTAAATTCCTTACCAGCTCATACAATTCACCGGTCACAATGCCTTCTTACGAACTAGCACTGGT 67 FBan0015016 FBgn0035534 mRpS6 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS6 mitochondrial ribosomal protein S6 "CG15016, MRP-S6, BcDNA:RH10862, mitochondrial ribosomal protein S6" CDMC21948 2 15 21 DAC34-F23 2-CG15083-RA_2 CG15083 TGCCATTGAAGCCATCTCCTTTCCGTTTGCCGTCTTCGGGGTTATCTTCCACTACGGAGGATATCGC 67 FBan0015083 FBgn0034399 CG15083 2 2R CG15083 CG15083 BcDNA:RH17222 CDMC21948 2 16 21 DAC34-F23 2-CG15083-RA_2 CG15083 TGCCATTGAAGCCATCTCCTTTCCGTTTGCCGTCTTCGGGGTTATCTTCCACTACGGAGGATATCGC 67 FBan0015083 FBgn0034399 CG15083 2 2R CG15083 CG15083 BcDNA:RH17222 CDMC21949 2 17 21 DAC34-J11 3-CG15609-RC_1 CG15609 CCGAGGAGACAGAGGAGCAACTGCTATCGCAATGGTTTACGCTGGTCAACAAGAAGAACGCACTCCT 67 FBan0015609 FBgn0034180 CG15609 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 CG15609 CG15609 CDMC21949 2 18 21 DAC34-J11 3-CG15609-RC_1 CG15609 CCGAGGAGACAGAGGAGCAACTGCTATCGCAATGGTTTACGCTGGTCAACAAGAAGAACGCACTCCT 67 FBan0015609 FBgn0034180 CG15609 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 CG15609 CG15609 CDMC21950 2 19 21 DAC34-J23 5-CG15727-RA_1 CG15727 TGGCCATGACCGATACGCAACTGGATATAGGCTCTGGAACCATTACGATGCCAATGCCTATGGTGCA 67 FBan0015727 FBgn0030410 CG15727 X X CG15727 CG15727 CDMC21950 2 20 21 DAC34-J23 5-CG15727-RA_1 CG15727 TGGCCATGACCGATACGCAACTGGATATAGGCTCTGGAACCATTACGATGCCAATGCCTATGGTGCA 67 FBan0015727 FBgn0030410 CG15727 X X CG15727 CG15727 CDMC21951 2 21 21 DAC34-N11 5-CG1678-RA_1 CG1678 ACAAAATCAAAATGCGTGTAATCTTCCTCATCGTTGTGCTCGCCATGGTGGCTCTGGCTGCTGTCCA 67 FBan0001678 FBgn0031176 CG1678 X X CG1678 CG1678 BcDNA:GH04760 CDMC21951 2 22 21 DAC34-N11 5-CG1678-RA_1 CG1678 ACAAAATCAAAATGCGTGTAATCTTCCTCATCGTTGTGCTCGCCATGGTGGCTCTGGCTGCTGTCCA 67 FBan0001678 FBgn0031176 CG1678 X X CG1678 CG1678 BcDNA:GH04760 CDMC21952 2 23 21 DAC34-N23 2-CG17054-RC_2 CG17054 TCACGGCGTCCAACCTGAACACTTGACCAAGTTCTTCCTCGAAATGACAGTGCAGGAGATGAGCACG 67 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC21952 2 24 21 DAC34-N23 2-CG17054-RC_2 CG17054 TCACGGCGTCCAACCTGAACACTTGACCAAGTTCTTCCTCGAAATGACAGTGCAGGAGATGAGCACG 67 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC21953 2 25 21 DAC35-B11 12-CG11759-RA_1 CG11759 ACACGTATCTGCGCTCCGAGTACTTGGACAATTGCGATCTCTACAACGACAATGCCGACAATGACAGCA 69 FBgn0030287 CDMC21953 2 26 21 DAC35-B11 12-CG11759-RA_1 CG11759 ACACGTATCTGCGCTCCGAGTACTTGGACAATTGCGATCTCTACAACGACAATGCCGACAATGACAGCA 69 FBgn0030287 CDMC21954 2 1 22 DAC35-B23 1-CG1176-RA_1 CG1176 CGGGGCTATGCCATCGTCAAGTGCGTGTTTACTAGAGCCCTCACGGATGCTAGAAACAAACCCACTGTA 69 FBan0001176 FBgn0011282 Pbprp4 3 3R transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp4 Pheromone-binding protein-related protein 4 "CG1176, pbprp-4, PBPRP4, 84a, PBP4, PBPRP-4, Obp84a" CDMC21954 2 2 22 DAC35-B23 1-CG1176-RA_1 CG1176 CGGGGCTATGCCATCGTCAAGTGCGTGTTTACTAGAGCCCTCACGGATGCTAGAAACAAACCCACTGTA 69 FBan0001176 FBgn0011282 Pbprp4 3 3R transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp4 Pheromone-binding protein-related protein 4 "CG1176, pbprp-4, PBPRP4, 84a, PBP4, PBPRP-4, Obp84a" CDMC21955 2 3 22 DAC35-F11 7-CG11808-RA_1 CG11808 GCAAAAGCAGAACCAGGGATCATCACAAATCGCGGTCTATTTCGCAGAGGAAAACCAGGGGTCCAAGTT 69 FBan0011808 FBgn0034000 CG11808 2 2R CG11808 CG11808 CDMC21955 2 4 22 DAC35-F11 7-CG11808-RA_1 CG11808 GCAAAAGCAGAACCAGGGATCATCACAAATCGCGGTCTATTTCGCAGAGGAAAACCAGGGGTCCAAGTT 69 FBan0011808 FBgn0034000 CG11808 2 2R CG11808 CG11808 CDMC21956 2 5 22 DAC35-F23 23-CG11825-RA_9 CG11825 AAGAGGGAACAAGTTTTCTAACCTATTCAAAATGAGTTCCAATTCTCTATTCGAAACCGACGAAGATGT 69 FBan0011825 FBgn0033519 CG11825 2 2R CG11825 CG11825 BcDNA:RE25483 CDMC21956 2 6 22 DAC35-F23 23-CG11825-RA_9 CG11825 AAGAGGGAACAAGTTTTCTAACCTATTCAAAATGAGTTCCAATTCTCTATTCGAAACCGACGAAGATGT 69 FBan0011825 FBgn0033519 CG11825 2 2R CG11825 CG11825 BcDNA:RE25483 CDMC21957 2 7 22 DAC35-J11 24-CG11866-RA_1 CG11866 AAGCATTAGGACCTACGCATATACACTTTACATATTTTTTACCACTTATTTACATATAAAGCGTGCATG 69 FBan0011866 FBgn0033486 CG11866 2 2R CG11866 CG11866 CDMC21957 2 8 22 DAC35-J11 24-CG11866-RA_1 CG11866 AAGCATTAGGACCTACGCATATACACTTTACATATTTTTTACCACTTATTTACATATAAAGCGTGCATG 69 FBan0011866 FBgn0033486 CG11866 2 2R CG11866 CG11866 CDMC21958 2 9 22 DAC35-J23 5-CG11882-RA_1 CG11882 CCGCCTTCCACCGATGTTGCAATCCTCAAGGAGCACATCGACATGAGATTTGAGAAGCTGACGCTGTTA 69 FBan0011882 FBgn0039642 CG11882 3 3R CG11882 CG11882 CDMC21958 2 10 22 DAC35-J23 5-CG11882-RA_1 CG11882 CCGCCTTCCACCGATGTTGCAATCCTCAAGGAGCACATCGACATGAGATTTGAGAAGCTGACGCTGTTA 69 FBan0011882 FBgn0039642 CG11882 3 3R CG11882 CG11882 CDMC21959 2 11 22 DAC35-N11 2-CG11910-RA_1 CG11910 ACAGGTTCTGCGCATGGAAAACTGTTCGCTGGAAACTTTCGAAAAACCGCAGTTTGAAGGTGCCAGCAA 69 FBan0011910 FBgn0039332 CG11910 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952 G-protein coupled receptor activity; GO:0004930; protein binding; GO:0005515; ; GO:0004930; ; GO:0005515 insulin-like growth factor binding protein complex; GO:0016942 CG11910 CG11910 CT37074 CDMC21959 2 12 22 DAC35-N11 2-CG11910-RA_1 CG11910 ACAGGTTCTGCGCATGGAAAACTGTTCGCTGGAAACTTTCGAAAAACCGCAGTTTGAAGGTGCCAGCAA 69 FBan0011910 FBgn0039332 CG11910 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952 G-protein coupled receptor activity; GO:0004930; protein binding; GO:0005515; ; GO:0004930; ; GO:0005515 insulin-like growth factor binding protein complex; GO:0016942 CG11910 CG11910 CT37074 CDMC21960 2 13 22 DAC35-N23 1-CG11926-RA_1 CG11926 ACGAACTGTACGCCATATTCGAGCCGGTTGTGGACAAAGCCACTGTGATCAAGTACGTGGACAAGCTGA 69 FBan0011926 FBgn0031640 CG11926 2 2L CG11926 CG11926 CDMC21960 2 14 22 DAC35-N23 1-CG11926-RA_1 CG11926 ACGAACTGTACGCCATATTCGAGCCGGTTGTGGACAAAGCCACTGTGATCAAGTACGTGGACAAGCTGA 69 FBan0011926 FBgn0031640 CG11926 2 2L CG11926 CG11926 CDMC21961 2 15 22 DAC36-B11 2-CG8613-RA_4 CG8613 GCCACCGGGTAATGTTCCAGCCTACAGCGATCCCCATGGTCATCTCACTGGCAAGAACATTCTAATCGT 69 FBan0008613 FBgn0033924 CG8613 2 2R CG8613 CG8613 CDMC21961 2 16 22 DAC36-B11 2-CG8613-RA_4 CG8613 GCCACCGGGTAATGTTCCAGCCTACAGCGATCCCCATGGTCATCTCACTGGCAAGAACATTCTAATCGT 69 FBan0008613 FBgn0033924 CG8613 2 2R CG8613 CG8613 CDMC21962 2 17 22 DAC36-B23 9-CG8626-RA_1 CG8626 GCCCATCAGTTTGGCAAGAAGGCGATATACGATCGACCGGAATGTCTCGTACAAACCTTTACCACCGGA 69 FBan0008626 FBgn0034152 Acp53C14a 2 2R Acp53C14a Acp53C14a "CG8626, CG8626" CDMC21962 2 18 22 DAC36-B23 9-CG8626-RA_1 CG8626 GCCCATCAGTTTGGCAAGAAGGCGATATACGATCGACCGGAATGTCTCGTACAAACCTTTACCACCGGA 69 FBan0008626 FBgn0034152 Acp53C14a 2 2R Acp53C14a Acp53C14a "CG8626, CG8626" CDMC21963 2 19 22 DAC36-F11 6-CG8661-RA_1 CG8661 GCAGCTGCTTTGTTAAGACTCTGCGCAAGGTGTGGTCCCTAAAGAAGCAAGTGGACAATGCCATCAAGC 69 FBan0008661 FBgn0030837 CG8661 X X CG8661 CG8661 BcDNA:LP01183 CDMC21963 2 20 22 DAC36-F11 6-CG8661-RA_1 CG8661 GCAGCTGCTTTGTTAAGACTCTGCGCAAGGTGTGGTCCCTAAAGAAGCAAGTGGACAATGCCATCAAGC 69 FBan0008661 FBgn0030837 CG8661 X X CG8661 CG8661 BcDNA:LP01183 CDMC21964 2 21 22 DAC36-F23 3-CG8674-RA_2 CG8674 ACCTCTCCAAGTTGGACATGGTCAACTACCTTCTCAACTTCATCGCCACAGACACGGTGCTCTTCCAGT 69 FBgn0032937 CDMC21964 2 22 22 DAC36-F23 3-CG8674-RA_2 CG8674 ACCTCTCCAAGTTGGACATGGTCAACTACCTTCTCAACTTCATCGCCACAGACACGGTGCTCTTCCAGT 69 FBgn0032937 CDMC21965 2 23 22 DAC36-J11 4-CG8710-RB_1 CG8710 CGCCCGAGGCATCTGACCAGGTAGAGAATGAACCTGCTCCTAAGAGTATTTCTCGATGCACGCTCAAGG 69 FBan0008710 FBgn0033265 CG8710 2 2R CG8710 CG8710 CDMC21965 2 24 22 DAC36-J11 4-CG8710-RB_1 CG8710 CGCCCGAGGCATCTGACCAGGTAGAGAATGAACCTGCTCCTAAGAGTATTTCTCGATGCACGCTCAAGG 69 FBan0008710 FBgn0033265 CG8710 2 2R CG8710 CG8710 CDMC21966 2 25 22 DAC36-J23 23-CG8722-RA_1 CG8722 TTTTGTTATTTTTCGCTCGATTTTTTATTCGTATTTCACGCGTAATTCGGACCACTAACTCGGTGTGAC 69 FBan0008722 FBgn0033247 Nup44A 2 2R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup44A Nup44A "CG8722, nup44A, nucleoporin-44A" CDMC21966 2 26 22 DAC36-J23 23-CG8722-RA_1 CG8722 TTTTGTTATTTTTCGCTCGATTTTTTATTCGTATTTCACGCGTAATTCGGACCACTAACTCGGTGTGAC 69 FBan0008722 FBgn0033247 Nup44A 2 2R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup44A Nup44A "CG8722, nup44A, nucleoporin-44A" CDMC21967 2 1 23 DAC36-N11 13-CG8756-RA_1 CG8756 GCGATGTGCTCGAGAGTAAATGTACCAAGTCGGGTTTGAAAGAAATTCAGTGTCCTTCGGGTCTGGCCT 69 FBan0008756 FBgn0036901 LCBP1 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 LCBP1 LDLa domain containing chitin binding protein 1 "CG8756, CG8756, LDLa domain containing chitin binding protein 1" CDMC21967 2 2 23 DAC36-N11 13-CG8756-RA_1 CG8756 GCGATGTGCTCGAGAGTAAATGTACCAAGTCGGGTTTGAAAGAAATTCAGTGTCCTTCGGGTCTGGCCT 69 FBan0008756 FBgn0036901 LCBP1 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 LCBP1 LDLa domain containing chitin binding protein 1 "CG8756, CG8756, LDLa domain containing chitin binding protein 1" CDMC21968 2 3 23 DAC36-N23 2-CG8767-RA_1 CG8767 TGCAAGCGCGTAGATTGCCCTATCACACACTCGATTGCAATGAGACCATAGCCTACCAGGTGGTCAAGC 69 FBan0008767 FBgn0033773 mos 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 mos mos "CG8767, CG8767, MOS, D-mos, DMOS" CDMC21968 2 4 23 DAC36-N23 2-CG8767-RA_1 CG8767 TGCAAGCGCGTAGATTGCCCTATCACACACTCGATTGCAATGAGACCATAGCCTACCAGGTGGTCAAGC 69 FBan0008767 FBgn0033773 mos 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 mos mos "CG8767, CG8767, MOS, D-mos, DMOS" CDMC21969 2 5 23 DAC37-B11 2-CG8997-RA_1 CG8997 TGCCGGACATGCCAAATTCGCCATCAAGGATATGGTTATCTGGGGCACTATGAAGTACTCACTCGGCGT 69 FBan0008997 FBgn0028920 CG8997 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8997 CG8997 "BG:DS00941.12, DS00941.12, CT25774" CDMC21969 2 6 23 DAC37-B11 2-CG8997-RA_1 CG8997 TGCCGGACATGCCAAATTCGCCATCAAGGATATGGTTATCTGGGGCACTATGAAGTACTCACTCGGCGT 69 FBan0008997 FBgn0028920 CG8997 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8997 CG8997 "BG:DS00941.12, DS00941.12, CT25774" CDMC21970 2 7 23 DAC37-B23 23-CG9007-RA_17 CG9007 GTACAGAACTTGGCAAATAATACAAACTGTAATTGTTAGAGAGACCAGCGAAAACAAAATCCGGAACTA 69 FBan0009007 FBgn0036398 CG9007 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG9007 CG9007 CDMC21970 2 8 23 DAC37-B23 23-CG9007-RA_17 CG9007 GTACAGAACTTGGCAAATAATACAAACTGTAATTGTTAGAGAGACCAGCGAAAACAAAATCCGGAACTA 69 FBan0009007 FBgn0036398 CG9007 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG9007 CG9007 CDMC21971 2 9 23 DAC37-F11 23-CG9042-RA_5 CG9042 CCCCTGTTCACGGCTATTCACAAAATATGCACAAATCAGCTCAAGCCTAATGATTTAATTGATTGCATA 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC21971 2 10 23 DAC37-F11 23-CG9042-RA_5 CG9042 CCCCTGTTCACGGCTATTCACAAAATATGCACAAATCAGCTCAAGCCTAATGATTTAATTGATTGCATA 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC21972 2 11 23 DAC37-F23 23-CG9048-RA_1 CG9048 CGACTGCCGAGAAACATAAGCTTTGATGGATTTGACAAAAAATATACCCAAAAATATGTACTGCAATTA 69 FBan0009048 FBgn0003979 Vm26Aa 2 2L oogenesis (sensu Insecta); GO:0009993; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm26Aa Vitelline membrane 26Aa "CG9048, TU-2, Vm26A, Vm26A1, VM26A.1, sV17, Vm26A.1" CDMC21972 2 12 23 DAC37-F23 23-CG9048-RA_1 CG9048 CGACTGCCGAGAAACATAAGCTTTGATGGATTTGACAAAAAATATACCCAAAAATATGTACTGCAATTA 69 FBan0009048 FBgn0003979 Vm26Aa 2 2L oogenesis (sensu Insecta); GO:0009993; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm26Aa Vitelline membrane 26Aa "CG9048, TU-2, Vm26A, Vm26A1, VM26A.1, sV17, Vm26A.1" CDMC21973 2 13 23 DAC37-J11 6-CG9089-RA_1 CG9089 AGTGGCTGGAAAGGATAAGACCAACGATACCTCCAAAGGATCTCCCTCGAAGGCTAAGTCCAATGGCCA 69 FBan0009089 FBgn0030805 wus X X tracheal system development (sensu Insecta); GO:0007424 wus wurst "CG9089, CG9089, l(1)G0162, wurst" CDMC21973 2 14 23 DAC37-J11 6-CG9089-RA_1 CG9089 AGTGGCTGGAAAGGATAAGACCAACGATACCTCCAAAGGATCTCCCTCGAAGGCTAAGTCCAATGGCCA 69 FBan0009089 FBgn0030805 wus X X tracheal system development (sensu Insecta); GO:0007424 wus wurst "CG9089, CG9089, l(1)G0162, wurst" CDMC21974 2 15 23 DAC37-J23 3-CG9097-RA_1 CG9097 GCGGAAAAGCCCACTGAAATCGGGAAAATGGCACTGGTTTCCGCAAACGAAGCTTGGAATGCCCTATAT 69 FBan0009097 FBgn0004870 bab1 3 3L behavior; GO:0007610; chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; female sex differentiation; GO:0046660; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of male pigmentation; GO:0048092; negative regulation of pigmentation; GO:0048086; regulation of developmental pigmentation; GO:0048070; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bab1 bric a brac 1 "CG9097, CG13910, bab, bric-a-brac, bab-I, bric a brac I, BAB1, bric a brac, anon-WO0118547.639, bric a brac 1" CDMC21974 2 16 23 DAC37-J23 3-CG9097-RA_1 CG9097 GCGGAAAAGCCCACTGAAATCGGGAAAATGGCACTGGTTTCCGCAAACGAAGCTTGGAATGCCCTATAT 69 FBan0009097 FBgn0004870 bab1 3 3L behavior; GO:0007610; chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; female sex differentiation; GO:0046660; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of male pigmentation; GO:0048092; negative regulation of pigmentation; GO:0048086; regulation of developmental pigmentation; GO:0048070; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bab1 bric a brac 1 "CG9097, CG13910, bab, bric-a-brac, bab-I, bric a brac I, BAB1, bric a brac, anon-WO0118547.639, bric a brac 1" CDMC21975 2 17 23 DAC37-N11 17-CG9134-RA_1 CG9134 TCCAACTGGTCTTAGCTGGCGATTACTCCGGTGAATTTGAATGTTCATTTCGGACACTCATTGCTGACA 69 FBan0009134 FBgn0035199 CG9134 3 3L sugar binding; GO:0005529; ; GO:0005529 CG9134 CG9134 CDMC21975 2 18 23 DAC37-N11 17-CG9134-RA_1 CG9134 TCCAACTGGTCTTAGCTGGCGATTACTCCGGTGAATTTGAATGTTCATTTCGGACACTCATTGCTGACA 69 FBan0009134 FBgn0035199 CG9134 3 3L sugar binding; GO:0005529; ; GO:0005529 CG9134 CG9134 CDMC21976 2 19 23 DAC37-N23 21-CG9149-RA_3 CG9149 CCAGGCCATCCGCTCGGGAGACGCACAGATTGTTGTGGCAGGAGGTCAGGAGAGCATGTCCCTGGCTCC 69 FBan0009149 FBgn0035203 CG9149 3 3L acetyl-CoA C-acetyltransferase activity; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9 cytosol; GO:0005829 CG9149 CG9149 CDMC21976 2 20 23 DAC37-N23 21-CG9149-RA_3 CG9149 CCAGGCCATCCGCTCGGGAGACGCACAGATTGTTGTGGCAGGAGGTCAGGAGAGCATGTCCCTGGCTCC 69 FBan0009149 FBgn0035203 CG9149 3 3L acetyl-CoA C-acetyltransferase activity; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9 cytosol; GO:0005829 CG9149 CG9149 CDMC21977 2 21 23 DAC38-B11 11-CG5637-RA_4 CG5637 ACCCACTGGCTGAACAACTACCGGGAGCATCTGAACAACGTGTGGCGAAACATGTCGTATATACCA 66 FBan0005637 FBgn0002962 nos 3 3R "cell fate determination; GO:0001709; dendrite morphogenesis; GO:0016358; determination of anterior/posterior axis, embryo; GO:0008595; female meiosis chromosome segregation; GO:0016321; germ cell development; GO:0007281; germ cell migration; GO:0008354; germ-line cyst formation; GO:0048134; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of transcription, DNA-dependent; GO:0045892; negative regulation of translation; GO:0016478; oocyte anterior/posterior axis determination; GO:0007314; oogenesis (sensu Insecta); GO:0009993; pole cell migration; GO:0007280; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515; ; GO:0005515 pole plasm; GO:0045495 nos nanos "CG5637, l(3)j3B6, DRONANOS, NANOS, l(3)07117, l(3)j4B6, nanos" CDMC21977 2 22 23 DAC38-B11 11-CG5637-RA_4 CG5637 ACCCACTGGCTGAACAACTACCGGGAGCATCTGAACAACGTGTGGCGAAACATGTCGTATATACCA 66 FBan0005637 FBgn0002962 nos 3 3R "cell fate determination; GO:0001709; dendrite morphogenesis; GO:0016358; determination of anterior/posterior axis, embryo; GO:0008595; female meiosis chromosome segregation; GO:0016321; germ cell development; GO:0007281; germ cell migration; GO:0008354; germ-line cyst formation; GO:0048134; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of transcription, DNA-dependent; GO:0045892; negative regulation of translation; GO:0016478; oocyte anterior/posterior axis determination; GO:0007314; oogenesis (sensu Insecta); GO:0009993; pole cell migration; GO:0007280; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515; ; GO:0005515 pole plasm; GO:0045495 nos nanos "CG5637, l(3)j3B6, DRONANOS, NANOS, l(3)07117, l(3)j4B6, nanos" CDMC21978 2 23 23 DAC38-B23 3-CG5818-RA_1 CG5818 TGTTCCCCGCCAATATTTGCCAGGCTAGCGATGATCTGGGCTATGTCAACCTGATGCCAACCTTTG 66 FBan0005818 FBgn0001995 mRpL4 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL4 mitochondrial ribosomal protein L4 "CG5818, l(2)35Fe: lethal(2)35Fe, l35Fe, l(2)k14608, BG:DS02740.17, Rpl4, L4, lethal(2)35Fe, l(2)35Fe, mitochondrial ribosomal protein L4" CDMC21978 2 24 23 DAC38-B23 3-CG5818-RA_1 CG5818 TGTTCCCCGCCAATATTTGCCAGGCTAGCGATGATCTGGGCTATGTCAACCTGATGCCAACCTTTG 66 FBan0005818 FBgn0001995 mRpL4 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL4 mitochondrial ribosomal protein L4 "CG5818, l(2)35Fe: lethal(2)35Fe, l35Fe, l(2)k14608, BG:DS02740.17, Rpl4, L4, lethal(2)35Fe, l(2)35Fe, mitochondrial ribosomal protein L4" CDMC21979 2 25 23 DAC38-F11 3-CG6241-RA_3 CG6241 AGAATTCGGAGGCATGACAAGCATGAACTGCGTCAGTTGTTCCCCTGTTCCTTCCGTTGGCTCTTG 66 FBan0006241 FBgn0037792 CG6241 3 3R CG6241 CG6241 CDMC21979 2 26 23 DAC38-F11 3-CG6241-RA_3 CG6241 AGAATTCGGAGGCATGACAAGCATGAACTGCGTCAGTTGTTCCCCTGTTCCTTCCGTTGGCTCTTG 66 FBan0006241 FBgn0037792 CG6241 3 3R CG6241 CG6241 CDMC21980 2 1 24 DAC38-F23 3-CG6378-RA_1 CG6378 CGAAGATCTGCTGGATGAGGACCTCGACCTGTCCGACATCGATGAGAACGAAGAGGAGTTCCTGCG 66 FBan0006378 FBgn0026562 BM-40-SPARC 3 3R cell adhesion; GO:0007155; cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; signal transduction; GO:0007165 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; growth factor activity; GO:0008083; ; GO:0005198; ; GO:0005509; ; GO:0008083 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 BM-40-SPARC BM-40-SPARC "CG6378, CG6378, SPARC, CT19876, BM40, dSPARC, BM-40/SPARC, dsparc, anon-EST:Posey291" CDMC21980 2 2 24 DAC38-F23 3-CG6378-RA_1 CG6378 CGAAGATCTGCTGGATGAGGACCTCGACCTGTCCGACATCGATGAGAACGAAGAGGAGTTCCTGCG 66 FBan0006378 FBgn0026562 BM-40-SPARC 3 3R cell adhesion; GO:0007155; cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; signal transduction; GO:0007165 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; growth factor activity; GO:0008083; ; GO:0005198; ; GO:0005509; ; GO:0008083 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 BM-40-SPARC BM-40-SPARC "CG6378, CG6378, SPARC, CT19876, BM40, dSPARC, BM-40/SPARC, dsparc, anon-EST:Posey291" CDMC21981 2 3 24 DAC38-J11 24-CG6840-RA_2 CG6840 TTTTAATAAACAATTTATAAGTTTTGCAGTAACTAACGAAAAGTAAGACATCAAAATGAACGCACC 66 FBan0006840 FBgn0032634 Rpb11 2 2L mRNA transcription; GO:0009299; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb11 Rpb11 "CG6840, CG6840, RPB11, BcDNA:GM15177" CDMC21981 2 4 24 DAC38-J11 24-CG6840-RA_2 CG6840 TTTTAATAAACAATTTATAAGTTTTGCAGTAACTAACGAAAAGTAAGACATCAAAATGAACGCACC 66 FBan0006840 FBgn0032634 Rpb11 2 2L mRNA transcription; GO:0009299; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb11 Rpb11 "CG6840, CG6840, RPB11, BcDNA:GM15177" CDMC21982 2 5 24 DAC38-J23 3-CG7021-RA_5 CG7021 GGTTACTTCCCGGGAACTGGTGCCTATCCTGGCTATCCCTACCCCGGAGTATACTTGCCACAGTAC 66 FBan0007021 FBgn0013949 Ela 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 Ela Elastin-like "CG7021, elastin-like" CDMC21982 2 6 24 DAC38-J23 3-CG7021-RA_5 CG7021 GGTTACTTCCCGGGAACTGGTGCCTATCCTGGCTATCCCTACCCCGGAGTATACTTGCCACAGTAC 66 FBan0007021 FBgn0013949 Ela 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 Ela Elastin-like "CG7021, elastin-like" CDMC21983 2 7 24 DAC38-N11 9-CG7507-RA_6 CG7507 GCAAGTGCTCAAGCGTACTGTGGAGAACATCAAGGATCCGTTGTACCGATACTTCGAGCGCGAGGT 66 FBan0007507 FBgn0010349 Dhc64C 3 3L cell motility; GO:0006928; centrosome cycle; GO:0007098; cystoblast division; GO:0007282; dendrite morphogenesis; GO:0016358; establishment of mitotic spindle localization; GO:0040001; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; mushroom body development; GO:0016319; oocyte fate determination (sensu Insecta); GO:0007294; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723; ovarian ring canal formation; GO:0007301; proteolysis; GO:0006508; vesicle-mediated transport; GO:0016192 "microtubule motor activity; GO:0003777; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" cytoplasm; GO:0005737; cytoplasmic dynein complex; GO:0005868; fusome; GO:0045169; microtubule associated complex; GO:0005875; ring canal (sensu Insecta); GO:0045172 Dhc64C Dynein heavy chain 64C "CG7507, CG7507, CG7507, Fs(3)Laborc, Lab, HMW MAP, cytoplasmic dynein heavy chain, Fs(3)Lab, Dhc, Cdhc: Cytoplasmic dynein heavy chain, dynein heavy chain, cDhc64C, DHC, dhc64C, CD, dhc, Laborc, DHC64C, cytoplasmic dynein, dynein, cDhc, Dhc64c, cytoplasmic dynenin, Dhc64, Cytoplasmic dynein, Fs(3)Sz18, l(3)64Ca, Cytoplasmic dynein heavy chain, Female sterile(3)Laborc, Cdhc" CDMC21983 2 8 24 DAC38-N11 9-CG7507-RA_6 CG7507 GCAAGTGCTCAAGCGTACTGTGGAGAACATCAAGGATCCGTTGTACCGATACTTCGAGCGCGAGGT 66 FBan0007507 FBgn0010349 Dhc64C 3 3L cell motility; GO:0006928; centrosome cycle; GO:0007098; cystoblast division; GO:0007282; dendrite morphogenesis; GO:0016358; establishment of mitotic spindle localization; GO:0040001; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; mushroom body development; GO:0016319; oocyte fate determination (sensu Insecta); GO:0007294; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723; ovarian ring canal formation; GO:0007301; proteolysis; GO:0006508; vesicle-mediated transport; GO:0016192 "microtubule motor activity; GO:0003777; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" cytoplasm; GO:0005737; cytoplasmic dynein complex; GO:0005868; fusome; GO:0045169; microtubule associated complex; GO:0005875; ring canal (sensu Insecta); GO:0045172 Dhc64C Dynein heavy chain 64C "CG7507, CG7507, CG7507, Fs(3)Laborc, Lab, HMW MAP, cytoplasmic dynein heavy chain, Fs(3)Lab, Dhc, Cdhc: Cytoplasmic dynein heavy chain, dynein heavy chain, cDhc64C, DHC, dhc64C, CD, dhc, Laborc, DHC64C, cytoplasmic dynein, dynein, cDhc, Dhc64c, cytoplasmic dynenin, Dhc64, Cytoplasmic dynein, Fs(3)Sz18, l(3)64Ca, Cytoplasmic dynein heavy chain, Female sterile(3)Laborc, Cdhc" CDMC21984 2 9 24 DAC38-N23 3-CG7722-RA_4 CG7722 GGAAGTGGCCAAACAACATGCGGAATCCTGGACCGATGAGTGCTCCTGTGCAAAAAAAGGAGTTGC 66 FBan0007722 FBgn0033574 CG7722 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG7722 CG7722 CDMC21984 2 10 24 DAC38-N23 3-CG7722-RA_4 CG7722 GGAAGTGGCCAAACAACATGCGGAATCCTGGACCGATGAGTGCTCCTGTGCAAAAAAAGGAGTTGC 66 FBan0007722 FBgn0033574 CG7722 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG7722 CG7722 CDMC21985 2 11 24 DAC39-B11 23-CG32043-RA_5 CG32043 CCCAACCTGTCCTAGATTATAGTTTTCCGTTGATGTGCATCGTCATATTAGTTTTTTAGTGTGCTCCTC 69 FBan0032043 FBgn0052043 CG32043 3 3L CG32043 CG32043 "CG18632, CG3628, CG18632, anon-WO0118547.368, anon-WO0118547.427" CDMC21985 2 12 24 DAC39-B11 23-CG32043-RA_5 CG32043 CCCAACCTGTCCTAGATTATAGTTTTCCGTTGATGTGCATCGTCATATTAGTTTTTTAGTGTGCTCCTC 69 FBan0032043 FBgn0052043 CG32043 3 3L CG32043 CG32043 "CG18632, CG3628, CG18632, anon-WO0118547.368, anon-WO0118547.427" CDMC21986 2 13 24 DAC39-B23 23-CG32052-RA_3 CG32052 GTGTCATGATGCGGAAATAGATAGTAATGGATATACGTAGGAATGGGTGAGCTAACAAAGGTCCAGCGA 69 FBgn0052052 CDMC21986 2 14 24 DAC39-B23 23-CG32052-RA_3 CG32052 GTGTCATGATGCGGAAATAGATAGTAATGGATATACGTAGGAATGGGTGAGCTAACAAAGGTCCAGCGA 69 FBgn0052052 CDMC21987 2 15 24 DAC39-F11 9-CG32081-RA_1 CG32081 TGGCCTCCATACTCATCTACACCGGATTCTCCCTGATGATGTACTATCTGTTCGTCGACCTGCCTCCGA 69 FBan0032081 FBgn0052081 CG32081 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG32081 CG32081 "CG11806, CG11806, CG11806, BcDNA:AT27573" CDMC21987 2 16 24 DAC39-F11 9-CG32081-RA_1 CG32081 TGGCCTCCATACTCATCTACACCGGATTCTCCCTGATGATGTACTATCTGTTCGTCGACCTGCCTCCGA 69 FBan0032081 FBgn0052081 CG32081 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG32081 CG32081 "CG11806, CG11806, CG11806, BcDNA:AT27573" CDMC21988 2 17 24 DAC39-F23 23-CG32096-RB_8 CG32096 CATCATGAGATCACCGATTTGTAAATGTCGATTGTTGTGTATTGTTGTACTCGTCGTATACCCTTCGAA 69 FBan0032096 FBgn0041096 rols 3 3L cell proliferation; GO:0008283; myoblast fusion; GO:0007520; protein ubiquitination; GO:0016567 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; catalytic activity; GO:0003824; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0003824; ; GO:0008270; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 rols rolling pebbles "CG17155, CG32096, CG12277, CG5679, CG17155, l(3)08232, l(3)68Fd, ants, antisocial, ANTS, Antisocial, rols\ants, Rol/Ants, Ants, Rols7, anon-WO0257455.19, l(3)j2A6, rolling pebbles" CDMC21988 2 18 24 DAC39-F23 23-CG32096-RB_8 CG32096 CATCATGAGATCACCGATTTGTAAATGTCGATTGTTGTGTATTGTTGTACTCGTCGTATACCCTTCGAA 69 FBan0032096 FBgn0041096 rols 3 3L cell proliferation; GO:0008283; myoblast fusion; GO:0007520; protein ubiquitination; GO:0016567 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; catalytic activity; GO:0003824; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0003824; ; GO:0008270; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 rols rolling pebbles "CG17155, CG32096, CG12277, CG5679, CG17155, l(3)08232, l(3)68Fd, ants, antisocial, ANTS, Antisocial, rols\ants, Rol/Ants, Ants, Rols7, anon-WO0257455.19, l(3)j2A6, rolling pebbles" CDMC21989 2 19 24 DAC39-J11 17-CG32131-RA_5 CG32131 GCGGAGCAGAATGGTGGTTCAACGACTGAACAAACACATGAACACAATCCAAACGTCGTACCTGATCAT 69 FBan0032131 FBgn0052131 CG32131 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 CG32131 CG32131 anon-AE003536.1 CDMC21989 2 20 24 DAC39-J11 17-CG32131-RA_5 CG32131 GCGGAGCAGAATGGTGGTTCAACGACTGAACAAACACATGAACACAATCCAAACGTCGTACCTGATCAT 69 FBan0032131 FBgn0052131 CG32131 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 CG32131 CG32131 anon-AE003536.1 CDMC21990 2 21 24 DAC39-J23 17-CG3213-RA_4 CG3213 ACAGTGCGTCTCCCTAGAGAAGCTGAACATGAACAACAAACGAATCGAACAGCAGATCAACACGGAGGT 69 FBan0003213 FBgn0031545 CG3213 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG3213 CG3213 bs30c03.y1 CDMC21990 2 22 24 DAC39-J23 17-CG3213-RA_4 CG3213 ACAGTGCGTCTCCCTAGAGAAGCTGAACATGAACAACAAACGAATCGAACAGCAGATCAACACGGAGGT 69 FBan0003213 FBgn0031545 CG3213 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG3213 CG3213 bs30c03.y1 CDMC21991 2 23 24 DAC39-N11 23-CG32171-RA_4 CG32171 AGTCGAACGCGATGAAAGTTTCCTAACCGCTGGTTTCAGTTCTAAACAGTTCTATTGTATTAAAAACCA 69 FBan0032171 FBgn0036672 Lmpt 3 3L heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Lmpt Limpet "CG11914, CG32171, CG11916, CG9959, CG11914, CG11914, CG11914, BcDNA:RE37250" CDMC21991 2 24 24 DAC39-N11 23-CG32171-RA_4 CG32171 AGTCGAACGCGATGAAAGTTTCCTAACCGCTGGTTTCAGTTCTAAACAGTTCTATTGTATTAAAAACCA 69 FBan0032171 FBgn0036672 Lmpt 3 3L heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Lmpt Limpet "CG11914, CG32171, CG11916, CG9959, CG11914, CG11914, CG11914, BcDNA:RE37250" CDMC21992 2 25 24 DAC39-N23 14-CG32180-RA_1 CG32180 GGCCACGCGAGATAGGGATTTCTTTGTACATGCGTTGAGTTTCTTGGTTAGCCAGCGATAAGCGTAGGT 69 FBan0032180 FBgn0000567 Eip74EF 3 3L "autophagy; GO:0006914; cell death; GO:0008219; cellular physiological process; GO:0050875; mesoderm development; GO:0007498; oogenesis (sensu Insecta); GO:0009993; regulation of development, heterochronic; GO:0040034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; salivary gland cell autophagic cell death; GO:0035071" transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 Eip74EF Ecdysone-induced protein 74EF "CG6273, CG32180, CG6285, CG6273, CG6273, E74, E74A, E74B, e74, mE74, E-74, E74-B, 3.3, ECIP, ecdysone inducible protein, Eip74E, l(3)24, l(3)neo24" CDMC21992 2 26 24 DAC39-N23 14-CG32180-RA_1 CG32180 GGCCACGCGAGATAGGGATTTCTTTGTACATGCGTTGAGTTTCTTGGTTAGCCAGCGATAAGCGTAGGT 69 FBan0032180 FBgn0000567 Eip74EF 3 3L "autophagy; GO:0006914; cell death; GO:0008219; cellular physiological process; GO:0050875; mesoderm development; GO:0007498; oogenesis (sensu Insecta); GO:0009993; regulation of development, heterochronic; GO:0040034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; salivary gland cell autophagic cell death; GO:0035071" transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 Eip74EF Ecdysone-induced protein 74EF "CG6273, CG32180, CG6285, CG6273, CG6273, E74, E74A, E74B, e74, mE74, E-74, E74-B, 3.3, ECIP, ecdysone inducible protein, Eip74E, l(3)24, l(3)neo24" CDMC21993 2 1 25 DAC40-B11 3-CG9565-RA_1 CG9565 GTGCGAGGTGTGGTAAGGGGATAGTGCAATTTCGATCTCAGAACGAGCCAAAGATGGAGCCAAAGCCAA 69 FBan0009565 FBgn0031081 Nep3 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep3 Neprilysin 3 "CG9565, CG9565, CEC, dNEP3, Neprilysin 3" CDMC21993 2 2 25 DAC40-B11 3-CG9565-RA_1 CG9565 GTGCGAGGTGTGGTAAGGGGATAGTGCAATTTCGATCTCAGAACGAGCCAAAGATGGAGCCAAAGCCAA 69 FBan0009565 FBgn0031081 Nep3 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep3 Neprilysin 3 "CG9565, CG9565, CEC, dNEP3, Neprilysin 3" CDMC21994 2 3 25 DAC40-B23 15-CG9579-RA_3 CG9579 TCGCAAAAAAGTCCCAGGAGAAAGACTGATTCGTGTGAAGTCGTCTACTGAAGAGCCACAAGGAACCCA 69 FBan0009579 FBgn0000084 AnnX X X defense response; GO:0006952; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; ; GO:0005544; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005543 AnnX Annexin X "CG9579, CG9579, anxX, Ann, Annx" CDMC21994 2 4 25 DAC40-B23 15-CG9579-RA_3 CG9579 TCGCAAAAAAGTCCCAGGAGAAAGACTGATTCGTGTGAAGTCGTCTACTGAAGAGCCACAAGGAACCCA 69 FBan0009579 FBgn0000084 AnnX X X defense response; GO:0006952; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; ; GO:0005544; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005543 AnnX Annexin X "CG9579, CG9579, anxX, Ann, Annx" CDMC21995 2 5 25 DAC40-F11 9-CG9614-RD_1 CG9614 CCCCCAAGGCCGAGATTGACGTGTTGTTTTTCAATCGGGTTCCGAAGACAGGAAGTATGCAGCTGATTG 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC21995 2 6 25 DAC40-F11 9-CG9614-RD_1 CG9614 CCCCCAAGGCCGAGATTGACGTGTTGTTTTTCAATCGGGTTCCGAAGACAGGAAGTATGCAGCTGATTG 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC21996 2 7 25 DAC40-F23 23-CG9619-RA_5 CG9619 AATGTCCACAAATCCAAATGACTTAGACTGAAGCGTGAGTATGCAAAAAGTGTTATGAGATCTGCCCAA 69 FBan0009619 FBgn0036862 CG9619 3 3L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9619 CG9619 CDMC21996 2 8 25 DAC40-F23 23-CG9619-RA_5 CG9619 AATGTCCACAAATCCAAATGACTTAGACTGAAGCGTGAGTATGCAAAAAGTGTTATGAGATCTGCCCAA 69 FBan0009619 FBgn0036862 CG9619 3 3L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9619 CG9619 CDMC21997 2 9 25 DAC40-J11 3-CG9657-RA_5 CG9657 GGACCTGGAGTTGTGTGGCAGAAGGCCCAAGAAACAGCTCGATTGGAAGTACCCAATTTTAGTGCGGAT 69 FBan0009657 FBgn0029950 CG9657 X X cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG9657 CG9657 CDMC21997 2 10 25 DAC40-J11 3-CG9657-RA_5 CG9657 GGACCTGGAGTTGTGTGGCAGAAGGCCCAAGAAACAGCTCGATTGGAAGTACCCAATTTTAGTGCGGAT 69 FBan0009657 FBgn0029950 CG9657 X X cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG9657 CG9657 CDMC21998 2 11 25 DAC40-J23 20-CG9666-RA_1 CG9666 ATTCGCACATTTGGTTCAGTTCGAATACCGCTACTATTTCCGCCACACTACAGTACTCGCCAGTGTGAC 69 FBan0009666 FBgn0036856 CG9666 3 3L DNA methylation; GO:0006306 DNA binding; GO:0003677; site-specific DNA-methyltransferase (adenine-specific) activity; GO:0009007 ; EC:2.1.1.72; ; GO:0009007 ; EC:2.1.1.72; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG9666 CG9666 CDMC21998 2 12 25 DAC40-J23 20-CG9666-RA_1 CG9666 ATTCGCACATTTGGTTCAGTTCGAATACCGCTACTATTTCCGCCACACTACAGTACTCGCCAGTGTGAC 69 FBan0009666 FBgn0036856 CG9666 3 3L DNA methylation; GO:0006306 DNA binding; GO:0003677; site-specific DNA-methyltransferase (adenine-specific) activity; GO:0009007 ; EC:2.1.1.72; ; GO:0009007 ; EC:2.1.1.72; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG9666 CG9666 CDMC21999 2 13 25 DAC40-N11 14-CG9703-RA_2 CG9703 GCTCTGCTGAACAACGTCTTTGCGGTGCACATTGATATGTGGAAGCTGTGCAACATCTTTAAGCGACCA 69 FBan0009703 FBgn0000152 Axs X X female meiosis chromosome segregation; GO:0016321; meiosis; GO:0007126; meiotic spindle organization and biogenesis; GO:0000212 cell cortex; GO:0005938; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; nuclear outer membrane; GO:0005640; spindle; GO:0005819 Axs Abnormal X segregation "CG9703, CG9703, axs, Aberrant X segregation" CDMC21999 2 14 25 DAC40-N11 14-CG9703-RA_2 CG9703 GCTCTGCTGAACAACGTCTTTGCGGTGCACATTGATATGTGGAAGCTGTGCAACATCTTTAAGCGACCA 69 FBan0009703 FBgn0000152 Axs X X female meiosis chromosome segregation; GO:0016321; meiosis; GO:0007126; meiotic spindle organization and biogenesis; GO:0000212 cell cortex; GO:0005938; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; nuclear outer membrane; GO:0005640; spindle; GO:0005819 Axs Abnormal X segregation "CG9703, CG9703, axs, Aberrant X segregation" CDMC22000 2 15 25 DAC40-N23 23-CG9712-RA_1 CG9712 CATGCAGATAAAGGTATCGATGTATGTGGATCATAATGGCAAGGTATATCTGCCTTACTTGCACGACTG 69 FBan0009712 FBgn0036666 TSG101 3 3L negative regulation of growth; GO:0045926; protein modification; GO:0006464; protein transport; GO:0015031; regulation of JAK-STAT cascade; GO:0046425; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004840 TSG101 tumor suppressor protein 101 "CG9712, DmTSG101, ept, erupted, tumor suppressor protein 101" CDMC22000 2 16 25 DAC40-N23 23-CG9712-RA_1 CG9712 CATGCAGATAAAGGTATCGATGTATGTGGATCATAATGGCAAGGTATATCTGCCTTACTTGCACGACTG 69 FBan0009712 FBgn0036666 TSG101 3 3L negative regulation of growth; GO:0045926; protein modification; GO:0006464; protein transport; GO:0015031; regulation of JAK-STAT cascade; GO:0046425; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004840 TSG101 tumor suppressor protein 101 "CG9712, DmTSG101, ept, erupted, tumor suppressor protein 101" CDMC22001 2 17 25 DAC41-B11 AutoBlank AutoBlank CDMC22001 2 18 25 DAC41-B11 AutoBlank AutoBlank CDMC22002 2 19 25 DAC41-B23 AutoBlank AutoBlank CDMC22002 2 20 25 DAC41-B23 AutoBlank AutoBlank CDMC22003 2 21 25 DAC41-F11 AutoBlank AutoBlank CDMC22003 2 22 25 DAC41-F11 AutoBlank AutoBlank CDMC22004 2 23 25 DAC41-F23 AutoBlank AutoBlank CDMC22004 2 24 25 DAC41-F23 AutoBlank AutoBlank CDMC22005 2 25 25 DAC41-J11 AutoBlank AutoBlank CDMC22005 2 26 25 DAC41-J11 AutoBlank AutoBlank CDMC22006 2 1 26 DAC41-J23 AutoBlank AutoBlank CDMC22006 2 2 26 DAC41-J23 AutoBlank AutoBlank CDMC22007 2 3 26 DAC41-N11 AutoBlank AutoBlank CDMC22007 2 4 26 DAC41-N11 AutoBlank AutoBlank CDMC22008 2 5 26 DAC41-N23 AutoBlank AutoBlank CDMC22008 2 6 26 DAC41-N23 AutoBlank AutoBlank CDMC22009 2 7 26 DAC42-B11 150mM NaPO4 Blank CDMC22009 2 8 26 DAC42-B11 150mM NaPO4 Blank CDMC22010 2 9 26 DAC42-B23 150mM NaPO4 Blank CDMC22010 2 10 26 DAC42-B23 150mM NaPO4 Blank CDMC22011 2 11 26 DAC42-F11 150mM NaPO4 Blank CDMC22011 2 12 26 DAC42-F11 150mM NaPO4 Blank CDMC22012 2 13 26 DAC42-F23 150mM NaPO4 Blank CDMC22012 2 14 26 DAC42-F23 150mM NaPO4 Blank CDMC22013 2 15 26 DAC42-J11 150mM NaPO4 Blank CDMC22013 2 16 26 DAC42-J11 150mM NaPO4 Blank CDMC22014 2 17 26 DAC42-J23 5uM MSP 5uM MSP CDMC22014 2 18 26 DAC42-J23 5uM MSP 5uM MSP CDMC22015 2 19 26 DAC42-N11 10uM MSP 10uM MSP CDMC22015 2 20 26 DAC42-N11 10uM MSP 10uM MSP CDMC22016 2 21 26 DAC42-N23 20uM MSP 20uM MSP CDMC22016 2 22 26 DAC42-N23 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC22017 3 1 1 DAC01-C11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22017 3 2 1 DAC01-C11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22018 3 3 1 DAC01-C23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22018 3 4 1 DAC01-C23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22019 3 5 1 DAC01-G11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22019 3 6 1 DAC01-G11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22020 3 7 1 DAC01-G23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22020 3 8 1 DAC01-G23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22021 3 9 1 DAC01-K11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22021 3 10 1 DAC01-K11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22022 3 11 1 DAC01-K23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22022 3 12 1 DAC01-K23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22023 3 13 1 DAC01-O11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22023 3 14 1 DAC01-O11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22024 3 15 1 DAC01-O23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22024 3 16 1 DAC01-O23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22025 3 17 1 DAC02-C11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22025 3 18 1 DAC02-C11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22026 3 19 1 DAC02-C23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22026 3 20 1 DAC02-C23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22027 3 21 1 DAC02-G11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22027 3 22 1 DAC02-G11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22028 3 23 1 DAC02-G23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22028 3 24 1 DAC02-G23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22029 3 25 1 DAC02-K11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22029 3 26 1 DAC02-K11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22030 3 1 2 DAC02-K23 AutoBlank AutoBlank CDMC22030 3 2 2 DAC02-K23 AutoBlank AutoBlank CDMC22031 3 3 2 DAC02-O11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22031 3 4 2 DAC02-O11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22032 3 5 2 DAC02-O23 AutoBlank AutoBlank CDMC22032 3 6 2 DAC02-O23 AutoBlank AutoBlank CDMC22033 3 7 2 DAC03-C11 13-CG17117-RD_2 CG17117 CCCCCTTTGGAGTTGTATGCTAGGCGAACCCCTAAGCTTGCAAGCGAAACTCAAAGATACGAAAATCGT 69 FBan0017117 FBgn0001235 hth 3 3R brain development; GO:0007420; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor fate commitment (sensu Endopterygota); GO:0001752; leg disc proximal/distal pattern formation; GO:0007479; peripheral nervous system development; GO:0007422; proximal/distal pattern formation; GO:0009954; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; specification of organ identity; GO:0010092 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hth homothorax "CG17117, CG17117, dorsotonals, Gene II, 1323/07, 1422/04, dtl, clone 2.13, hth1, hth2, P53, Hth, Dm-HTH, anon-EST:Liang-2.13, Meis1, l(3)05745, l(3)86Ca" CDMC22033 3 8 2 DAC03-C11 13-CG17117-RD_2 CG17117 CCCCCTTTGGAGTTGTATGCTAGGCGAACCCCTAAGCTTGCAAGCGAAACTCAAAGATACGAAAATCGT 69 FBan0017117 FBgn0001235 hth 3 3R brain development; GO:0007420; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor fate commitment (sensu Endopterygota); GO:0001752; leg disc proximal/distal pattern formation; GO:0007479; peripheral nervous system development; GO:0007422; proximal/distal pattern formation; GO:0009954; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; specification of organ identity; GO:0010092 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hth homothorax "CG17117, CG17117, dorsotonals, Gene II, 1323/07, 1422/04, dtl, clone 2.13, hth1, hth2, P53, Hth, Dm-HTH, anon-EST:Liang-2.13, Meis1, l(3)05745, l(3)86Ca" CDMC22034 3 9 2 DAC03-C23 23-CG17136-RA_1 CG17136 GGCCGTATTTTCTGTAGGAATTCCTATGTCGATTGCGATCCAAGTAAATTTACTTCAGATGACAATATA 69 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC22034 3 10 2 DAC03-C23 23-CG17136-RA_1 CG17136 GGCCGTATTTTCTGTAGGAATTCCTATGTCGATTGCGATCCAAGTAAATTTACTTCAGATGACAATATA 69 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC22035 3 11 2 DAC03-G11 3-CG17173-RA_3 CG17173 CGCTCAACCTGATCGCCACTCATCGAAACTCGCTGTTGAAGCATAATCTCGACCTGGTAGAGGGGGAAA 69 FBan0017173 FBgn0036447 CG17173 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG17173 CG17173 CDMC22035 3 12 2 DAC03-G11 3-CG17173-RA_3 CG17173 CGCTCAACCTGATCGCCACTCATCGAAACTCGCTGTTGAAGCATAATCTCGACCTGGTAGAGGGGGAAA 69 FBan0017173 FBgn0036447 CG17173 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG17173 CG17173 CDMC22036 3 13 2 DAC03-G23 9-CG17183-RA_1 CG17183 TGAGTACCGGAAAGTCCTGCAGGAGAACCATGAACTCATAGAGACCGTCAAGCTGAAGAACAGGCAGCT 69 FBan0017183 FBgn0035149 MED30 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED30 Mediator complex subunit 30 "CG17183, CG17183, dTRAP25, dMED20, Med11/TRAP25, Trap25, Med30, Med20, Mediator complex subunit 30" CDMC22036 3 14 2 DAC03-G23 9-CG17183-RA_1 CG17183 TGAGTACCGGAAAGTCCTGCAGGAGAACCATGAACTCATAGAGACCGTCAAGCTGAAGAACAGGCAGCT 69 FBan0017183 FBgn0035149 MED30 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED30 Mediator complex subunit 30 "CG17183, CG17183, dTRAP25, dMED20, Med11/TRAP25, Trap25, Med30, Med20, Mediator complex subunit 30" CDMC22037 3 15 2 DAC03-K11 2-CG17216-RA_2 CG17216 TCGGAGTCCCATTACTCAGTCGCCAAGTCAAGCTTCAGAATGCACCAGAACACCACCGACTCATTTCGA 69 FBan0017216 FBgn0026063 KP78b 3 3R cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 KP78b KP78b "CG17216, CG17216, KP78B, Kp78B" CDMC22037 3 16 2 DAC03-K11 2-CG17216-RA_2 CG17216 TCGGAGTCCCATTACTCAGTCGCCAAGTCAAGCTTCAGAATGCACCAGAACACCACCGACTCATTTCGA 69 FBan0017216 FBgn0026063 KP78b 3 3R cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 KP78b KP78b "CG17216, CG17216, KP78B, Kp78B" CDMC22038 3 17 2 DAC03-K23 16-CG17226-RA_2 CG17226 GGTGGATATCAACTGCATCGGGAACGTGATCAAGTCATGCGTAACTTATTCCCAGATGTGGCGTTTTCG 69 FBan0017226 FBgn0034866 Or59c 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59c Odorant receptor 59c "CG17226, 59E.2, DOR120, 59c" CDMC22038 3 18 2 DAC03-K23 16-CG17226-RA_2 CG17226 GGTGGATATCAACTGCATCGGGAACGTGATCAAGTCATGCGTAACTTATTCCCAGATGTGGCGTTTTCG 69 FBan0017226 FBgn0034866 Or59c 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59c Odorant receptor 59c "CG17226, 59E.2, DOR120, 59c" CDMC22039 3 19 2 DAC03-O11 23-CG17265-RA_10 CG17265 GACTTCGCAGAATCAAGTAATCAACGCAATTGTTGTCTATTTACGATTTGGAGCAACTTTCTTGTGGTC 69 FBan0017265 FBgn0031488 CG17265 2 2L CG17265 CG17265 CDMC22039 3 20 2 DAC03-O11 23-CG17265-RA_10 CG17265 GACTTCGCAGAATCAAGTAATCAACGCAATTGTTGTCTATTTACGATTTGGAGCAACTTTCTTGTGGTC 69 FBan0017265 FBgn0031488 CG17265 2 2L CG17265 CG17265 CDMC22040 3 21 2 DAC03-O23 AutoBlank AutoBlank CDMC22040 3 22 2 DAC03-O23 AutoBlank AutoBlank CDMC22041 3 23 2 DAC04-C11 3-CG1603-RA_2 CG1603 ACTGTGACTACTGCGATAAACGTTTCCACGGCGACTACAACCTACGGGTGCACATCGTCAAGGCG 65 FBan0001603 FBgn0033185 CG1603 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1603 CG1603 CDMC22041 3 24 2 DAC04-C11 3-CG1603-RA_2 CG1603 ACTGTGACTACTGCGATAAACGTTTCCACGGCGACTACAACCTACGGGTGCACATCGTCAAGGCG 65 FBan0001603 FBgn0033185 CG1603 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1603 CG1603 CDMC22042 3 25 2 DAC04-C23 3-CG1665-RA_4 CG1665 GGAGAGGATACACTTTTTTCCGGTCAAGTCCTGTGCCCCTATGGACATCTCGAAGCCCGGAGTGG 65 FBan0001665 FBgn0033451 CG1665 2 2R CG1665 CG1665 CDMC22042 3 26 2 DAC04-C23 3-CG1665-RA_4 CG1665 GGAGAGGATACACTTTTTTCCGGTCAAGTCCTGTGCCCCTATGGACATCTCGAAGCCCGGAGTGG 65 FBan0001665 FBgn0033451 CG1665 2 2R CG1665 CG1665 CDMC22043 3 1 3 DAC04-G11 6-CG16817-RA_2 CG16817 AGGGCGTAAACGTGCTGGATCCGTCGAAGAAGTACGAGGTCACACTGAACTTCCTCCACGAGGTG 65 FBan0016817 FBgn0037728 CG16817 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG16817 CG16817 YC17 CDMC22043 3 2 3 DAC04-G11 6-CG16817-RA_2 CG16817 AGGGCGTAAACGTGCTGGATCCGTCGAAGAAGTACGAGGTCACACTGAACTTCCTCCACGAGGTG 65 FBan0016817 FBgn0037728 CG16817 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG16817 CG16817 YC17 CDMC22044 3 3 3 DAC04-G23 2-CG16869-RA_1 CG16869 CGCCATGTCCCTGGGATCTTCGGTTCACTATAGGGAGGTGCTAAAGGTTCTTCTTGGTGAGCCGG 65 FBan0016869 FBgn0032535 Ance-2 2 2L proteolysis; GO:0006508 NOT peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-2 Ance-2 "CG16869, CG31844, CG16869" CDMC22044 3 4 3 DAC04-G23 2-CG16869-RA_1 CG16869 CGCCATGTCCCTGGGATCTTCGGTTCACTATAGGGAGGTGCTAAAGGTTCTTCTTGGTGAGCCGG 65 FBan0016869 FBgn0032535 Ance-2 2 2L proteolysis; GO:0006508 NOT peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-2 Ance-2 "CG16869, CG31844, CG16869" CDMC22045 3 5 3 DAC04-K11 23-CG16997-RA_1 CG16997 CAGCGAGCACAACACAGAAGAGGCAAATCACCCACTATGTGATCAATGATCTTTATACCGGCGGA 65 FBan0016997 FBgn0032413 CG16997 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16997 CG16997 SP147 CDMC22045 3 6 3 DAC04-K11 23-CG16997-RA_1 CG16997 CAGCGAGCACAACACAGAAGAGGCAAATCACCCACTATGTGATCAATGATCTTTATACCGGCGGA 65 FBan0016997 FBgn0032413 CG16997 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16997 CG16997 SP147 CDMC22046 3 7 3 DAC04-K23 23-CG17082-RA_2 CG17082 TCAGGACTTTTCGGAATTTCTCAATGAGTATTATCTGCAAAGCAATTCCCAAAGTATCGAACCTG 65 FBgn0039994 CG17082 CG17082 CG17082 "CG40286, CG40286, BcDNA:LD04957" CDMC22046 3 8 3 DAC04-K23 23-CG17082-RA_2 CG17082 TCAGGACTTTTCGGAATTTCTCAATGAGTATTATCTGCAAAGCAATTCCCAAAGTATCGAACCTG 65 FBgn0039994 CG17082 CG17082 CG17082 "CG40286, CG40286, BcDNA:LD04957" CDMC22047 3 9 3 DAC04-O11 3-CG17193-RA_3 CG17193 CTGGCAACCACGTGGTGAGCAAGTCCTTTTAAGATCCTGCAGATGAAGAGCACTTACGGCGGAGC 65 FBan0017193 FBgn0040571 CG17193 3 3R CG17193 CG17193 BcDNA:RE41733 CDMC22047 3 10 3 DAC04-O11 3-CG17193-RA_3 CG17193 CTGGCAACCACGTGGTGAGCAAGTCCTTTTAAGATCCTGCAGATGAAGAGCACTTACGGCGGAGC 65 FBan0017193 FBgn0040571 CG17193 3 3R CG17193 CG17193 BcDNA:RE41733 CDMC22048 3 11 3 DAC04-O23 AutoBlank AutoBlank CDMC22048 3 12 3 DAC04-O23 AutoBlank AutoBlank CDMC22049 3 13 3 DAC05-C11 3-CG10496-RA_3 CG10496 CCGAGGGAAATCCCGACATGGTTCCCGGTACAAGTCTACCAAAGCTATATGGCGCCACTACAGCGAAC 68 FBan0010496 FBgn0034631 CG10496 2 2R CG10496 CG10496 CDMC22049 3 14 3 DAC05-C11 3-CG10496-RA_3 CG10496 CCGAGGGAAATCCCGACATGGTTCCCGGTACAAGTCTACCAAAGCTATATGGCGCCACTACAGCGAAC 68 FBan0010496 FBgn0034631 CG10496 2 2R CG10496 CG10496 CDMC22050 3 15 3 DAC05-C23 3-CG10663-RA_1 CG10663 TCCGAGGGGGAATTTCGTAATATCACCTGGATGCAGCCAGCAAAGGATGGAATAGCTCTCAGGCGACG 68 FBan0010663 FBgn0036287 CG10663 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10663 CG10663 "CT29868, SP30" CDMC22050 3 16 3 DAC05-C23 3-CG10663-RA_1 CG10663 TCCGAGGGGGAATTTCGTAATATCACCTGGATGCAGCCAGCAAAGGATGGAATAGCTCTCAGGCGACG 68 FBan0010663 FBgn0036287 CG10663 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10663 CG10663 "CT29868, SP30" CDMC22051 3 17 3 DAC05-G11 9-CG1116-RC_2 CG1116 CCACAACATCCGGTACTTCTACAAGATCACCATTGCTACGCAACGGGTCAAGTCCAAGGTGCAAACGC 68 FBan0001116 FBgn0037297 CG1116 3 3R CG1116 CG1116 anon-WO0118547.337 CDMC22051 3 18 3 DAC05-G11 9-CG1116-RC_2 CG1116 CCACAACATCCGGTACTTCTACAAGATCACCATTGCTACGCAACGGGTCAAGTCCAAGGTGCAAACGC 68 FBan0001116 FBgn0037297 CG1116 3 3R CG1116 CG1116 anon-WO0118547.337 CDMC22052 3 19 3 DAC05-G23 23-CG11206-RA_8 CG11206 ATATATGGTAAATACAAACGCACTCCCCAAAAAAAACCCTCGCACAACCAAAGAAAGTCAGTCAGCCT 68 FBan0011206 FBgn0034720 CG11206 2 2R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 CG11206 CG11206 CDMC22052 3 20 3 DAC05-G23 23-CG11206-RA_8 CG11206 ATATATGGTAAATACAAACGCACTCCCCAAAAAAAACCCTCGCACAACCAAAGAAAGTCAGTCAGCCT 68 FBan0011206 FBgn0034720 CG11206 2 2R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 CG11206 CG11206 CDMC22053 3 21 3 DAC05-K11 2-CG11620-RA_3 CG11620 CGTGCTGGAGATCCCTTTCGACAATACCAAGCCATTGCCTCAAGACCGATCATTATGCTCGCAGCCTC 68 FBan0011620 FBgn0031226 CG11620 2 2L CG11620 CG11620 CDMC22053 3 22 3 DAC05-K11 2-CG11620-RA_3 CG11620 CGTGCTGGAGATCCCTTTCGACAATACCAAGCCATTGCCTCAAGACCGATCATTATGCTCGCAGCCTC 68 FBan0011620 FBgn0031226 CG11620 2 2L CG11620 CG11620 CDMC22054 3 23 3 DAC05-K23 2-CG11784-RA_2 CG11784 TGACCAACTCTATCCGCGGGATTTGAAAAGGAGAGCCCACATCGACCATCGCATGCACTACGAGAACG 68 FBan0011784 FBgn0033381 CG11784 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG11784 CG11784 BcDNA:LD22317 CDMC22054 3 24 3 DAC05-K23 2-CG11784-RA_2 CG11784 TGACCAACTCTATCCGCGGGATTTGAAAAGGAGAGCCCACATCGACCATCGCATGCACTACGAGAACG 68 FBan0011784 FBgn0033381 CG11784 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG11784 CG11784 BcDNA:LD22317 CDMC22055 3 25 3 DAC05-O11 3-CG12209-RA_1 CG12209 TCTCCGTTAGAGGGCAGTTGGGTTCAGACGACACCGATTAATGGGGATGACGTCGTGGAAGACAATGA 68 FBan0012209 FBgn0033498 CG12209 2 2R CG12209 CG12209 BcDNA:AT13439 CDMC22055 3 26 3 DAC05-O11 3-CG12209-RA_1 CG12209 TCTCCGTTAGAGGGCAGTTGGGTTCAGACGACACCGATTAATGGGGATGACGTCGTGGAAGACAATGA 68 FBan0012209 FBgn0033498 CG12209 2 2R CG12209 CG12209 BcDNA:AT13439 CDMC22056 3 1 4 DAC05-O23 AutoBlank AutoBlank CDMC22056 3 2 4 DAC05-O23 AutoBlank AutoBlank CDMC22057 3 3 4 DAC06-C11 18-CG3301-RB_1 CG3301 ACACAAGCTGAGAATAGAGGATTGAGCCGGTGCAATATCATATTACACTCACTATCAAGCCGTGGGCGA 69 FBan0003301 FBgn0038878 CG3301 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG3301 CG3301 CDMC22057 3 4 4 DAC06-C11 18-CG3301-RB_1 CG3301 ACACAAGCTGAGAATAGAGGATTGAGCCGGTGCAATATCATATTACACTCACTATCAAGCCGTGGGCGA 69 FBan0003301 FBgn0038878 CG3301 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG3301 CG3301 CDMC22058 3 5 4 DAC06-C23 15-CG33047-RA_1 CG33047 GCACCGGTGGAGATATTCTGAATGAGCAAAGCACTGAGGTTGTCATGTTGGGCATGGAGGATACCAAAA 69 FBgn0053047 CDMC22058 3 6 4 DAC06-C23 15-CG33047-RA_1 CG33047 GCACCGGTGGAGATATTCTGAATGAGCAAAGCACTGAGGTTGTCATGTTGGGCATGGAGGATACCAAAA 69 FBgn0053047 CDMC22059 3 7 4 DAC06-G11 5-CG33082-RA_2 CG33082 CACGCATGAACTACCTGTTCCAGGCCTCGAATTTAATGGCAGTAGGCAATCAACCAAAATTGGCCGCCT 69 FBan0033082 FBgn0053082 CG33082 X X CG33082 CG33082 CDMC22059 3 8 4 DAC06-G11 5-CG33082-RA_2 CG33082 CACGCATGAACTACCTGTTCCAGGCCTCGAATTTAATGGCAGTAGGCAATCAACCAAAATTGGCCGCCT 69 FBan0033082 FBgn0053082 CG33082 X X CG33082 CG33082 CDMC22060 3 9 4 DAC06-G23 9-CG33094-RB_1 CG33094 AGCCTGCCCCAAATCTACGAGGAGTTCTCCCACACGATCAACAATGCAGACCAGCAGAAAGACCTAAAA 69 FBan0033094 FBgn0053094 Synd 3 3R intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Synd Syndapin "CG15694, CG33094, CG15694, syndapin, D-Synd, Syndapin" CDMC22060 3 10 4 DAC06-G23 9-CG33094-RB_1 CG33094 AGCCTGCCCCAAATCTACGAGGAGTTCTCCCACACGATCAACAATGCAGACCAGCAGAAAGACCTAAAA 69 FBan0033094 FBgn0053094 Synd 3 3R intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Synd Syndapin "CG15694, CG33094, CG15694, syndapin, D-Synd, Syndapin" CDMC22061 3 11 4 DAC06-K11 9-CG33115-RA_1 CG33115 CCACACTCAGCGATATGTGGTGGTTGTGAGTTCGGAGCTCTCACTTTTCCAGCATCACTGAGCAGTCTC 69 FBan0033115 FBgn0028542 CG33115 2 2L Wnt receptor signaling pathway; GO:0016055 structural molecule activity; GO:0005198; ; GO:0005198; Wnt-protein binding; GO:0017147; ; GO:0017147 CG33115 CG33115 "CG16882, BG:DS00180.8, DS00180.8, CT37470" CDMC22061 3 12 4 DAC06-K11 9-CG33115-RA_1 CG33115 CCACACTCAGCGATATGTGGTGGTTGTGAGTTCGGAGCTCTCACTTTTCCAGCATCACTGAGCAGTCTC 69 FBan0033115 FBgn0028542 CG33115 2 2L Wnt receptor signaling pathway; GO:0016055 structural molecule activity; GO:0005198; ; GO:0005198; Wnt-protein binding; GO:0017147; ; GO:0017147 CG33115 CG33115 "CG16882, BG:DS00180.8, DS00180.8, CT37470" CDMC22062 3 13 4 DAC06-K23 2-CG33122-RA_2 CG33122 CCGCCCAGGTTACCATGACAAACACGTCTGTGACAACACGAGTTCGCAATGTACTAGAGGTGGTCCACT 69 FBan0033122 FBgn0015376 cutlet 2 2L DNA replication; GO:0006260; cell proliferation; GO:0008283; proteolysis; GO:0006508 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.-; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 cutlet cutlet "CG10030, CG33122, CG10030, ctl, gilead, cutlet" CDMC22062 3 14 4 DAC06-K23 2-CG33122-RA_2 CG33122 CCGCCCAGGTTACCATGACAAACACGTCTGTGACAACACGAGTTCGCAATGTACTAGAGGTGGTCCACT 69 FBan0033122 FBgn0015376 cutlet 2 2L DNA replication; GO:0006260; cell proliferation; GO:0008283; proteolysis; GO:0006508 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.-; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 cutlet cutlet "CG10030, CG33122, CG10030, ctl, gilead, cutlet" CDMC22063 3 15 4 DAC06-O11 16-CG33143-RB_1 CG33143 TGGATCAACAGGGTTTCCGTTCAAGATCCTCCAAGAATCCTGGGAAACAGTTTTCATTCATGCCAGTCT 69 FBan0033143 FBgn0053143 CG33143 2 2R CG33143 CG33143 "CG13509, CG4232" CDMC22063 3 16 4 DAC06-O11 16-CG33143-RB_1 CG33143 TGGATCAACAGGGTTTCCGTTCAAGATCCTCCAAGAATCCTGGGAAACAGTTTTCATTCATGCCAGTCT 69 FBan0033143 FBgn0053143 CG33143 2 2R CG33143 CG33143 "CG13509, CG4232" CDMC22064 3 17 4 DAC06-O23 3-CG3314-RA_1 CG3314 CCGTGGTCAAGAAGGTTGTTAACCAGCTGTTCGAGAAGCGTCCCAAGAACTTCGGAATCGGCCAGAATG 69 FBan0003314 FBgn0014026 RpL7A X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7A Ribosomal protein L7A "CG3314, Surf-3/rpL7a, Surf3/rpL7a, L7A, L7a" CDMC22064 3 18 4 DAC06-O23 3-CG3314-RA_1 CG3314 CCGTGGTCAAGAAGGTTGTTAACCAGCTGTTCGAGAAGCGTCCCAAGAACTTCGGAATCGGCCAGAATG 69 FBan0003314 FBgn0014026 RpL7A X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7A Ribosomal protein L7A "CG3314, Surf-3/rpL7a, Surf3/rpL7a, L7A, L7a" CDMC22065 3 19 4 DAC07-C11 2-CG5804-RA_1 CG5804 CCGCCTACGTCGCCCTGTACGAGAAGTACAACCCCATCTACGGATAAGCTACAGTTTATGGCCCACTCT 69 FBan0005804 FBgn0035926 CG5804 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0000062; ; GO:0050809; ; GO:0004857 CG5804 CG5804 BcDNA:RE05521 CDMC22065 3 20 4 DAC07-C11 2-CG5804-RA_1 CG5804 CCGCCTACGTCGCCCTGTACGAGAAGTACAACCCCATCTACGGATAAGCTACAGTTTATGGCCCACTCT 69 FBan0005804 FBgn0035926 CG5804 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0000062; ; GO:0050809; ; GO:0004857 CG5804 CG5804 BcDNA:RE05521 CDMC22066 3 21 4 DAC07-C23 18-CG5812-RA_7 CG5812 CCACCTGGAAAGTCCGGACCCTACTAAATGGATCTTCAACCCATCGTGAACTCAAAATTGCGAACTTCG 69 FBan0005812 FBgn0029170 GCR(ich) 3 3R GCR(ich) GCR(ich) CG5812 CDMC22066 3 22 4 DAC07-C23 18-CG5812-RA_7 CG5812 CCACCTGGAAAGTCCGGACCCTACTAAATGGATCTTCAACCCATCGTGAACTCAAAATTGCGAACTTCG 69 FBan0005812 FBgn0029170 GCR(ich) 3 3R GCR(ich) GCR(ich) CG5812 CDMC22067 3 23 4 DAC07-G11 17-CG5849-RA_1 CG5849 GCCCGACTTTTCGACGAGTTTACGTGGAACAAGGTGTAAATTTAGCTGAAGATGGGATGTTCCGTGGGA 69 FBan0005849 FBgn0038897 CG5849 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG5849 CG5849 CDMC22067 3 24 4 DAC07-G11 17-CG5849-RA_1 CG5849 GCCCGACTTTTCGACGAGTTTACGTGGAACAAGGTGTAAATTTAGCTGAAGATGGGATGTTCCGTGGGA 69 FBan0005849 FBgn0038897 CG5849 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG5849 CG5849 CDMC22068 3 25 4 DAC07-G23 2-CG5860-RA_3 CG5860 GCCTGGGAGTCTTGTCCTGGTCCAATACGACACCATTTCTGGAACTTCTGTGCGCACAACGATTGCTTG 69 FBan0005860 FBgn0038506 CG5860 3 3R ATP synthesis coupled proton transport; GO:0015986; proteolysis; GO:0006508 "ATP binding; GO:0005524; ; GO:0005524; cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1" proton-transporting two-sector ATPase complex; GO:0016469 CG5860 CG5860 FBgn0038506 CDMC22068 3 26 4 DAC07-G23 2-CG5860-RA_3 CG5860 GCCTGGGAGTCTTGTCCTGGTCCAATACGACACCATTTCTGGAACTTCTGTGCGCACAACGATTGCTTG 69 FBan0005860 FBgn0038506 CG5860 3 3R ATP synthesis coupled proton transport; GO:0015986; proteolysis; GO:0006508 "ATP binding; GO:0005524; ; GO:0005524; cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1" proton-transporting two-sector ATPase complex; GO:0016469 CG5860 CG5860 FBgn0038506 CDMC22069 3 1 5 DAC07-K11 2-CG5889-RA_1 CG5889 CCCCCCTACAAACCGACCGCCTAGAACAATTGGCTAGACAGCAGAGCTAACTGGTGAGAACAACCCAAA 69 FBan0005889 FBgn0029155 Mdh 3 3R malate metabolism; GO:0006108; pyruvate metabolism; GO:0006090; tricarboxylic acid cycle; GO:0006099 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 mitochondrion; GO:0005739 Mdh Mdh "CG5889, CG5889, CG5889, MDH, Malic DH, anon-EST:Posey79" CDMC22069 3 2 5 DAC07-K11 2-CG5889-RA_1 CG5889 CCCCCCTACAAACCGACCGCCTAGAACAATTGGCTAGACAGCAGAGCTAACTGGTGAGAACAACCCAAA 69 FBan0005889 FBgn0029155 Mdh 3 3R malate metabolism; GO:0006108; pyruvate metabolism; GO:0006090; tricarboxylic acid cycle; GO:0006099 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 mitochondrion; GO:0005739 Mdh Mdh "CG5889, CG5889, CG5889, MDH, Malic DH, anon-EST:Posey79" CDMC22070 3 3 5 DAC07-K23 3-CG5911-RB_2 CG5911 CCGGCTACTACAACCTGCTGTACTTCTCGCGCTTCATGCTCTACCTAAACTCAGCCATGAACCCGATCC 69 FBan0005911 FBgn0038874 ETHR 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; amine receptor activity; GO:0008227; ecdysis-triggering hormone receptor activity; GO:0042654; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008528; ; GO:0042654; ; GO:0008188; ; GO:0008227; ; GO:0042654; ; GO:0008528" integral to membrane; GO:0016021 ETHR ETHR "CG5911, CG5911a, CG5911b, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911a, CG5911b, CG5911, anon-WO0170980.37, anon-WO0170980.38" CDMC22070 3 4 5 DAC07-K23 3-CG5911-RB_2 CG5911 CCGGCTACTACAACCTGCTGTACTTCTCGCGCTTCATGCTCTACCTAAACTCAGCCATGAACCCGATCC 69 FBan0005911 FBgn0038874 ETHR 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; amine receptor activity; GO:0008227; ecdysis-triggering hormone receptor activity; GO:0042654; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008528; ; GO:0042654; ; GO:0008188; ; GO:0008227; ; GO:0042654; ; GO:0008528" integral to membrane; GO:0016021 ETHR ETHR "CG5911, CG5911a, CG5911b, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911a, CG5911b, CG5911, anon-WO0170980.37, anon-WO0170980.38" CDMC22071 3 5 5 DAC07-O11 23-CG5939-RA_6 CG5939 ATACTTGTACGTAGAGAGATGAGAGAGATCAACCGAGTTGGCTGAACAATAACGTTTAATGGAAATGGA 69 FBan0005939 FBgn0003149 Prm 3 3L mesoderm development; GO:0007498 cytoskeletal protein binding; GO:0008092; structural constituent of muscle; GO:0008307; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003774; ; GO:0008307; ; GO:0008307 myosin; GO:0016459; striated muscle thick filament; GO:0005863 Prm Paramyosin "CG5939, CG5939, paramyosin, Para, l(3)10631, PM/mPM, Paramyosin/Miniparamyosin, 0106/05, PM, mPM, miniparamyosin, FBgn0003149, paramyosin/miniparamyosin, prm, l(3)S010605, lethal (3) S010605" CDMC22071 3 6 5 DAC07-O11 23-CG5939-RA_6 CG5939 ATACTTGTACGTAGAGAGATGAGAGAGATCAACCGAGTTGGCTGAACAATAACGTTTAATGGAAATGGA 69 FBan0005939 FBgn0003149 Prm 3 3L mesoderm development; GO:0007498 cytoskeletal protein binding; GO:0008092; structural constituent of muscle; GO:0008307; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003774; ; GO:0008307; ; GO:0008307 myosin; GO:0016459; striated muscle thick filament; GO:0005863 Prm Paramyosin "CG5939, CG5939, paramyosin, Para, l(3)10631, PM/mPM, Paramyosin/Miniparamyosin, 0106/05, PM, mPM, miniparamyosin, FBgn0003149, paramyosin/miniparamyosin, prm, l(3)S010605, lethal (3) S010605" CDMC22072 3 7 5 DAC07-O23 23-CG5958-RA_2 CG5958 TGGTGATTGGCCCCATTTCAATACTACACTGACATTCGCATCCTACATTGACATTAGCTTAACTTTATG 69 FBan0005958 FBgn0031913 CG5958 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 CG5958 CG5958 CDMC22072 3 8 5 DAC07-O23 23-CG5958-RA_2 CG5958 TGGTGATTGGCCCCATTTCAATACTACACTGACATTCGCATCCTACATTGACATTAGCTTAACTTTATG 69 FBan0005958 FBgn0031913 CG5958 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 CG5958 CG5958 CDMC22073 3 9 5 DAC08-C11 23-CG8246-RA_11 CG8246 CGCCCCATTCAAACAGTACTAATTTAATCTAAGTTGGAACTCGAATTGATGGAATTTCTGTGGTCACAC 69 FBan0008246 FBgn0003130 Poxn 2 2R "antennal morphogenesis; GO:0007469; cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; leg morphogenesis (sensu Endopterygota); GO:0007480; male courtship behavior (sensu Insecta); GO:0016542; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleus; GO:0005634 Poxn Pox neuro "CG8246, P4, pox-neural, poxn, pox-neuro, pox-n, pox neuro, neuro, Pox-n: Paired box neural, Paired box neural, Pox-neuro, Pox-n" CDMC22073 3 10 5 DAC08-C11 23-CG8246-RA_11 CG8246 CGCCCCATTCAAACAGTACTAATTTAATCTAAGTTGGAACTCGAATTGATGGAATTTCTGTGGTCACAC 69 FBan0008246 FBgn0003130 Poxn 2 2R "antennal morphogenesis; GO:0007469; cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; leg morphogenesis (sensu Endopterygota); GO:0007480; male courtship behavior (sensu Insecta); GO:0016542; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleus; GO:0005634 Poxn Pox neuro "CG8246, P4, pox-neural, poxn, pox-neuro, pox-n, pox neuro, neuro, Pox-n: Paired box neural, Paired box neural, Pox-neuro, Pox-n" CDMC22074 3 11 5 DAC08-C23 10-CG8257-RA_1 CG8257 AGCCCGTGCACTTGTTAGACGAGGGAGCGTTAAAGGCCCAACTGACTCATACAGTAACCGAATTCGATA 69 FBan0008257 FBgn0033900 CG8257 2 2R cysteinyl-tRNA aminoacylation; GO:0006423; protein metabolism; GO:0019538 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; cysteine-tRNA ligase activity; GO:0004817 ; EC:6.1.1.16; ; GO:0003729; ; GO:0004817 ; EC:6.1.1.16 CG8257 CG8257 CDMC22074 3 12 5 DAC08-C23 10-CG8257-RA_1 CG8257 AGCCCGTGCACTTGTTAGACGAGGGAGCGTTAAAGGCCCAACTGACTCATACAGTAACCGAATTCGATA 69 FBan0008257 FBgn0033900 CG8257 2 2R cysteinyl-tRNA aminoacylation; GO:0006423; protein metabolism; GO:0019538 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; cysteine-tRNA ligase activity; GO:0004817 ; EC:6.1.1.16; ; GO:0003729; ; GO:0004817 ; EC:6.1.1.16 CG8257 CG8257 CDMC22075 3 13 5 DAC08-G11 24-CG8295-RB_1 CG8295 TTTTACTAACTATCCGATAAAACAGAAACAGAATTGCATACTATAAATTTCTGCTAATTACATTCCCAA 69 FBan0008295 FBgn0034051 Mlf 2 2R cytoplasm; GO:0005737 Mlf Myelodysplasia/myeloid leukemia factor "CG8295, dMLF, dmlf, BcDNA:SD18148, Myelodysplasia/myeloid leukemia factor" CDMC22075 3 14 5 DAC08-G11 24-CG8295-RB_1 CG8295 TTTTACTAACTATCCGATAAAACAGAAACAGAATTGCATACTATAAATTTCTGCTAATTACATTCCCAA 69 FBan0008295 FBgn0034051 Mlf 2 2R cytoplasm; GO:0005737 Mlf Myelodysplasia/myeloid leukemia factor "CG8295, dMLF, dmlf, BcDNA:SD18148, Myelodysplasia/myeloid leukemia factor" CDMC22076 3 15 5 DAC08-G23 23-CG8311-RA_1 CG8311 GGCCTGGCCTAAATAGAATGCATATTTATGTAAATTAGTTTTAGTGTACGCATTCCTCGGTGTATTTAT 69 FBan0008311 FBgn0034141 CG8311 2 2R phospholipid biosynthesis; GO:0008654 dolichol kinase activity; GO:0004168 ; EC:2.7.1.108; phosphatidate cytidylyltransferase activity; GO:0004605 ; EC:2.7.7.41; ; GO:0004168 ; EC:2.7.1.108; ; GO:0004605 ; EC:2.7.7.41 membrane; GO:0016020 CG8311 CG8311 CDMC22076 3 16 5 DAC08-G23 23-CG8311-RA_1 CG8311 GGCCTGGCCTAAATAGAATGCATATTTATGTAAATTAGTTTTAGTGTACGCATTCCTCGGTGTATTTAT 69 FBan0008311 FBgn0034141 CG8311 2 2R phospholipid biosynthesis; GO:0008654 dolichol kinase activity; GO:0004168 ; EC:2.7.1.108; phosphatidate cytidylyltransferase activity; GO:0004605 ; EC:2.7.7.41; ; GO:0004168 ; EC:2.7.1.108; ; GO:0004605 ; EC:2.7.7.41 membrane; GO:0016020 CG8311 CG8311 CDMC22077 3 17 5 DAC08-K11 23-CG8339-RA_5 CG8339 GCGTCACAACTGACAGGATGAAAATTTGACGGAATTGCGATGGAAAATCTATCACACTCGTTTCCAGTT 69 FBan0008339 FBgn0020251 sfl 3 3L "Wnt receptor signaling pathway; GO:0016055; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; fibroblast growth factor receptor signaling pathway; GO:0008543; glycosaminoglycan biosynthesis; GO:0006024; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; mesoderm migration; GO:0007509; primary tracheal branching (sensu Insecta); GO:0007428; segment polarity determination; GO:0007367; sulfur metabolism; GO:0006790; tracheal epithelial cell migration (sensu Insecta); GO:0007427" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; [heparan sulfate]-glucosamine N-sulfotransferase activity; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- cellular component unknown; GO:0008372 sfl sulfateless "CG8339, CG8339, dw, diet-wingless, CT24567, NDST, l(3)03844, sulfateless" CDMC22077 3 18 5 DAC08-K11 23-CG8339-RA_5 CG8339 GCGTCACAACTGACAGGATGAAAATTTGACGGAATTGCGATGGAAAATCTATCACACTCGTTTCCAGTT 69 FBan0008339 FBgn0020251 sfl 3 3L "Wnt receptor signaling pathway; GO:0016055; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; fibroblast growth factor receptor signaling pathway; GO:0008543; glycosaminoglycan biosynthesis; GO:0006024; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; mesoderm migration; GO:0007509; primary tracheal branching (sensu Insecta); GO:0007428; segment polarity determination; GO:0007367; sulfur metabolism; GO:0006790; tracheal epithelial cell migration (sensu Insecta); GO:0007427" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; [heparan sulfate]-glucosamine N-sulfotransferase activity; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0015016 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- cellular component unknown; GO:0008372 sfl sulfateless "CG8339, CG8339, dw, diet-wingless, CT24567, NDST, l(3)03844, sulfateless" CDMC22078 3 19 5 DAC08-K23 39-CG8355-RC_5 CG8355 CCGCTGTCCAGACGACTATACGGGCAAGTACTGTGAAGGCCACAACATGATCTCGATGATGTATCCACA 69 FBan0008355 FBgn0003425 sli 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; glial cell migration; GO:0008347; gliogenesis; GO:0042063; mesoderm migration; GO:0007509; negative chemotaxis; GO:0050919; neuron differentiation; GO:0030182; neuron migration; GO:0001764; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 sli slit "CG8355, dSlit, l(2)05248, Slit, CT21700, CT37068, wdh, lethal (2) 05248, slit" CDMC22078 3 20 5 DAC08-K23 39-CG8355-RC_5 CG8355 CCGCTGTCCAGACGACTATACGGGCAAGTACTGTGAAGGCCACAACATGATCTCGATGATGTATCCACA 69 FBan0008355 FBgn0003425 sli 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; glial cell migration; GO:0008347; gliogenesis; GO:0042063; mesoderm migration; GO:0007509; negative chemotaxis; GO:0050919; neuron differentiation; GO:0030182; neuron migration; GO:0001764; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 sli slit "CG8355, dSlit, l(2)05248, Slit, CT21700, CT37068, wdh, lethal (2) 05248, slit" CDMC22079 3 21 5 DAC08-O11 4-CG8399-RA_1 CG8399 TCCTAGGCCCCCTAATTCGGATGTCCTGTAACCTGTCCCCTTCCAATACTCGTGTCAGTTTTGTGTGCT 69 FBan0008399 FBgn0034067 CG8399 2 2R CG8399 CG8399 anon-EST:ParkEST009 CDMC22079 3 22 5 DAC08-O11 4-CG8399-RA_1 CG8399 TCCTAGGCCCCCTAATTCGGATGTCCTGTAACCTGTCCCCTTCCAATACTCGTGTCAGTTTTGTGTGCT 69 FBan0008399 FBgn0034067 CG8399 2 2R CG8399 CG8399 anon-EST:ParkEST009 CDMC22080 3 23 5 DAC08-O23 1-CG8414-RA_1 CG8414 GCGCCCAGCTAGACAGGATTAAGACCAGCTTTCAGCGTCAGACGAATGCAATAGTACTGCTCCACCGAA 69 FBan0008414 FBgn0034073 CG8414 2 2R CG8414 CG8414 CDMC22080 3 24 5 DAC08-O23 1-CG8414-RA_1 CG8414 GCGCCCAGCTAGACAGGATTAAGACCAGCTTTCAGCGTCAGACGAATGCAATAGTACTGCTCCACCGAA 69 FBan0008414 FBgn0034073 CG8414 2 2R CG8414 CG8414 CDMC22081 3 25 5 DAC09-C12 23-CG12838-RA_1 CG12838 GCGCTGAATAAGATTGATCAAAAATAAAGAAACAGAAAAAACTGCATCGCAAGTAAAAAATGCCCACGG 69 FBan0012838 FBgn0033136 Tsp42Eo 2 2R integral to membrane; GO:0016021 Tsp42Eo Tetraspanin 42Eo "CG12838, CG12838, CG12838, Dm.Tsp42Eo, tetraspanin 42E, BcDNA:RH51444, Tetraspanin 42Eo" CDMC22081 3 26 5 DAC09-C12 23-CG12838-RA_1 CG12838 GCGCTGAATAAGATTGATCAAAAATAAAGAAACAGAAAAAACTGCATCGCAAGTAAAAAATGCCCACGG 69 FBan0012838 FBgn0033136 Tsp42Eo 2 2R integral to membrane; GO:0016021 Tsp42Eo Tetraspanin 42Eo "CG12838, CG12838, CG12838, Dm.Tsp42Eo, tetraspanin 42E, BcDNA:RH51444, Tetraspanin 42Eo" CDMC22082 3 1 6 DAC09-C24 8-CG12846-RA_1 CG12846 TGTGGGTGGACCATGTGCAGATACAGCAATCTTTGGAGAAGATCGTCCAGACCATATGGGATCAACGCA 69 FBan0012846 FBgn0029507 Tsp42Ed 2 2R integral to membrane; GO:0016021 Tsp42Ed Tetraspanin 42Ed "CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, BcDNA:GH07074, GH07074, Dm.Tsp42Ed, tetraspanin 42E, Tetraspanin 42Ed" CDMC22082 3 2 6 DAC09-C24 8-CG12846-RA_1 CG12846 TGTGGGTGGACCATGTGCAGATACAGCAATCTTTGGAGAAGATCGTCCAGACCATATGGGATCAACGCA 69 FBan0012846 FBgn0029507 Tsp42Ed 2 2R integral to membrane; GO:0016021 Tsp42Ed Tetraspanin 42Ed "CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, CG12846, BcDNA:GH07074, GH07074, Dm.Tsp42Ed, tetraspanin 42E, Tetraspanin 42Ed" CDMC22083 3 3 6 DAC09-G12 16-CG12879-RA_4 CG12879 TGCCTATAAAAGTCAGCATTTGTACACACGTCCTACCAAAATGAGGCTGGTCATCATCTACGCGGCCAT 69 FBan0012879 FBgn0039540 CG12879 3 3R CG12879 CG12879 CDMC22083 3 4 6 DAC09-G12 16-CG12879-RA_4 CG12879 TGCCTATAAAAGTCAGCATTTGTACACACGTCCTACCAAAATGAGGCTGGTCATCATCTACGCGGCCAT 69 FBan0012879 FBgn0039540 CG12879 3 3R CG12879 CG12879 CDMC22084 3 5 6 DAC09-G24 23-CG12896-RA_1 CG12896 CCACTGAGAACTATTAAAGACCTACATACCTGCATGTATTTTTCTTCCTGTTGTGCCATAAAAAGTTAA 69 FBan0012896 FBgn0033521 CG12896 2 2R defense response; GO:0006952; mesoderm development; GO:0007498; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG12896 CG12896 "AOP2-related, BEST:LD11278" CDMC22084 3 6 6 DAC09-G24 23-CG12896-RA_1 CG12896 CCACTGAGAACTATTAAAGACCTACATACCTGCATGTATTTTTCTTCCTGTTGTGCCATAAAAAGTTAA 69 FBan0012896 FBgn0033521 CG12896 2 2R defense response; GO:0006952; mesoderm development; GO:0007498; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG12896 CG12896 "AOP2-related, BEST:LD11278" CDMC22085 3 7 6 DAC09-K12 18-CG12938-RA_4 CG12938 GCACCCCTTTGATCACTTTATGGTGCGGAATCGAATGATACGGCAGATCCACATACCTTCGTACTTGGA 69 FBan0012938 FBgn0033554 CG12938 2 2R CG12938 CG12938 CDMC22085 3 8 6 DAC09-K12 18-CG12938-RA_4 CG12938 GCACCCCTTTGATCACTTTATGGTGCGGAATCGAATGATACGGCAGATCCACATACCTTCGTACTTGGA 69 FBan0012938 FBgn0033554 CG12938 2 2R CG12938 CG12938 CDMC22086 3 9 6 DAC09-K24 9-CG12950-RA_3 CG12950 ACACCCATTACGGAACTGGACTACGGAACCCTTTTGTGTTTGGCGTCGAACAAAATTGGCAAACAGCGA 69 FBan0012950 FBgn0037736 CG12950 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG12950 CG12950 CT32101 CDMC22086 3 10 6 DAC09-K24 9-CG12950-RA_3 CG12950 ACACCCATTACGGAACTGGACTACGGAACCCTTTTGTGTTTGGCGTCGAACAAAATTGGCAAACAGCGA 69 FBan0012950 FBgn0037736 CG12950 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG12950 CG12950 CT32101 CDMC22087 3 11 6 DAC09-O12 15-CG13000-RA_1 CG13000 TCTGGAGCCATCTGATCCATATACTGCTGCAGTTCATCCAGACCAACTGCTGGAATCACATCACACAGA 69 FBan0013000 FBgn0030807 CG13000 X X CG13000 CG13000 CDMC22087 3 12 6 DAC09-O12 15-CG13000-RA_1 CG13000 TCTGGAGCCATCTGATCCATATACTGCTGCAGTTCATCCAGACCAACTGCTGGAATCACATCACACAGA 69 FBan0013000 FBgn0030807 CG13000 X X CG13000 CG13000 CDMC22088 3 13 6 DAC09-O24 AutoBlank AutoBlank CDMC22088 3 14 6 DAC09-O24 AutoBlank AutoBlank CDMC22089 3 15 6 DAC10-C11 2-CG10961-RA_1 CG10961 GGCACCGATGTCTTCCGATTGCGTTAAGTTTGCACCAAGGTGGATCGTGAATCATAGGGACCCAAAGGT 69 FBan0010961 FBgn0026318 Traf2 X X I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; Toll signaling pathway; GO:0008063; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; dorsal closure; GO:0007391; induction of apoptosis; GO:0006917; protein ubiquitination; GO:0016567; signal transduction; GO:0007165 receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Traf2 TNF-receptor-associated factor 2 "CG10961, DTRAF2, dTRAF6, TRAF2, dTraf2, dTRAF2, TRAF, dtraf2" CDMC22089 3 16 6 DAC10-C11 2-CG10961-RA_1 CG10961 GGCACCGATGTCTTCCGATTGCGTTAAGTTTGCACCAAGGTGGATCGTGAATCATAGGGACCCAAAGGT 69 FBan0010961 FBgn0026318 Traf2 X X I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; Toll signaling pathway; GO:0008063; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; dorsal closure; GO:0007391; induction of apoptosis; GO:0006917; protein ubiquitination; GO:0016567; signal transduction; GO:0007165 receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Traf2 TNF-receptor-associated factor 2 "CG10961, DTRAF2, dTRAF6, TRAF2, dTraf2, dTRAF2, TRAF, dtraf2" CDMC22090 3 17 6 DAC10-C23 14-CG10972-RA_1 CG10972 AGGCCACCTCCATTTTGAAGGTTCCTTTTCCGGCAATAACCATATGCAATATGAACCAGGTGCAGAGGA 69 FBan0010972 FBgn0034730 ppk12 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk12 pickpocket 12 "CG10972, CG10972, CG10972, PPK12" CDMC22090 3 18 6 DAC10-C23 14-CG10972-RA_1 CG10972 AGGCCACCTCCATTTTGAAGGTTCCTTTTCCGGCAATAACCATATGCAATATGAACCAGGTGCAGAGGA 69 FBan0010972 FBgn0034730 ppk12 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk12 pickpocket 12 "CG10972, CG10972, CG10972, PPK12" CDMC22091 3 19 6 DAC10-G11 12-CG11012-RA_5 CG11012 GCTGAACTCTCTGATTGGCAATCCCCATGATAAAGTGGAGAAGGAGAAGGGCATGACCTTTGGACAGCG 69 FBan0011012 FBgn0026756 Ugt37a1 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt37a1 UDP-glycosyltransferase 37a1 "CG11012, CG11012, CG11012, CG11012, DmeUgt37a1, 38C.41, DmUgt37a1, UDP-glycosyltransferase 37a1" CDMC22091 3 20 6 DAC10-G11 12-CG11012-RA_5 CG11012 GCTGAACTCTCTGATTGGCAATCCCCATGATAAAGTGGAGAAGGAGAAGGGCATGACCTTTGGACAGCG 69 FBan0011012 FBgn0026756 Ugt37a1 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt37a1 UDP-glycosyltransferase 37a1 "CG11012, CG11012, CG11012, CG11012, DmeUgt37a1, 38C.41, DmUgt37a1, UDP-glycosyltransferase 37a1" CDMC22092 3 21 6 DAC10-G23 1-CG11033-RA_1 CG11033 ACCCAGTCGGTGATTCGCTTTGCAAGCAACTCCAAGCATGATCTTTGCGTCAGAGACATCAAGCTGGTA 69 FBan0011033 FBgn0037659 CG11033 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG11033 CG11033 CDMC22092 3 22 6 DAC10-G23 1-CG11033-RA_1 CG11033 ACCCAGTCGGTGATTCGCTTTGCAAGCAACTCCAAGCATGATCTTTGCGTCAGAGACATCAAGCTGGTA 69 FBan0011033 FBgn0037659 CG11033 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG11033 CG11033 CDMC22093 3 23 6 DAC10-K11 22-CG11062-RA_2 CG11062 CAAAGCACTAGGTTGGGATGACTGGATTATTGCACCCAGAGGATATTTTGCAAACTATTGCCGAGGCGA 69 FBan0011062 FBgn0024913 activin-beta 4 4 cell growth; GO:0016049; cell-cell signaling; GO:0007267; dendrite morphogenesis; GO:0016358; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160; ; GO:0005160 extracellular region; GO:0005576 activin-beta activin-beta "CG11062, activin beta, dActivin, activin, activin 102F, dACT, dAct, activin-b, dact, anon-WO02059370.79" CDMC22093 3 24 6 DAC10-K11 22-CG11062-RA_2 CG11062 CAAAGCACTAGGTTGGGATGACTGGATTATTGCACCCAGAGGATATTTTGCAAACTATTGCCGAGGCGA 69 FBan0011062 FBgn0024913 activin-beta 4 4 cell growth; GO:0016049; cell-cell signaling; GO:0007267; dendrite morphogenesis; GO:0016358; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160; ; GO:0005160 extracellular region; GO:0005576 activin-beta activin-beta "CG11062, activin beta, dActivin, activin, activin 102F, dACT, dAct, activin-b, dact, anon-WO02059370.79" CDMC22094 3 25 6 DAC10-K23 2-CG11076-RA_1 CG11076 GGCACTGGGCTATTTGAGATCTATGGGTCCCTATGCCCTCCGGAAAATTCCCTTTGTCGGCTATGTGGT 69 FBan0011076 FBgn0039929 CG11076 4 4 CG11076 CG11076 CDMC22094 3 26 6 DAC10-K23 2-CG11076-RA_1 CG11076 GGCACTGGGCTATTTGAGATCTATGGGTCCCTATGCCCTCCGGAAAATTCCCTTTGTCGGCTATGTGGT 69 FBan0011076 FBgn0039929 CG11076 4 4 CG11076 CG11076 CDMC22095 3 1 7 DAC10-O11 23-CG11113-RA_1 CG11113 TCCAGCTAAAATTGCCAACTTTCGGATAACCAACAAGAACACTGTGCAAAACTACATAATCCTGCCGAC 69 FBan0011113 FBgn0033165 CG11113 2 2R CG11113 CG11113 CDMC22095 3 2 7 DAC10-O11 23-CG11113-RA_1 CG11113 TCCAGCTAAAATTGCCAACTTTCGGATAACCAACAAGAACACTGTGCAAAACTACATAATCCTGCCGAC 69 FBan0011113 FBgn0033165 CG11113 2 2R CG11113 CG11113 CDMC22096 3 3 7 DAC10-O23 AutoBlank AutoBlank CDMC22096 3 4 7 DAC10-O23 AutoBlank AutoBlank CDMC22097 3 5 7 DAC11-C11 15-CG12202-RA_1 CG12202 CGTCGTCATCCGTCACACAGCATCCTACAAAATGGTTTCGGACGAGGACGAGTCGATGAGGAATAGGAA 69 FBan0012202 FBgn0031020 Nat1 X X peptide alpha-N-acetyltransferase activity; GO:0004596 ; EC:2.3.1.88; ; GO:0004596 ; EC:2.3.1.88 Nat1 Nat1 "CG12202, CG12202, CG12202, CG12202, dNat1, l(1)G0311" CDMC22097 3 6 7 DAC11-C11 15-CG12202-RA_1 CG12202 CGTCGTCATCCGTCACACAGCATCCTACAAAATGGTTTCGGACGAGGACGAGTCGATGAGGAATAGGAA 69 FBan0012202 FBgn0031020 Nat1 X X peptide alpha-N-acetyltransferase activity; GO:0004596 ; EC:2.3.1.88; ; GO:0004596 ; EC:2.3.1.88 Nat1 Nat1 "CG12202, CG12202, CG12202, CG12202, dNat1, l(1)G0311" CDMC22098 3 7 7 DAC11-C23 2-CG12213-RA_3 CG12213 ACACGGAACACGCACTGCAGGAGAAGTTCGACGCTCAGGTGGAAAAGTACAAGCTGCTGGAGATTAAGT 69 FBan0012213 FBgn0037968 CG12213 3 3R CG12213 CG12213 CDMC22098 3 8 7 DAC11-C23 2-CG12213-RA_3 CG12213 ACACGGAACACGCACTGCAGGAGAAGTTCGACGCTCAGGTGGAAAAGTACAAGCTGCTGGAGATTAAGT 69 FBan0012213 FBgn0037968 CG12213 3 3R CG12213 CG12213 CDMC22099 3 9 7 DAC11-G11 22-CG12244-RA_2 CG12244 TGTGTCCCCCGTCTGTGTGACAGCAAAAGGAATAAAACTTTATTTGAATGGAGTCCAAGGAAACCCCAA 69 FBan0012244 FBgn0015763 lic X X activation of MAPK activity; GO:0000187; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.- lic licorne "CG12244, CG12244, DMEK3, MEK-kinase 3, Mek3, D-MKK3, Drosophila MAP kinase kinase 3, l(1)G0252, DMKK3/lic, MKK3, MAP kinase kinase 3, p38MAPKK, DMKK3, MEK3/MKK3, p38, Mpk3, licorne" CDMC22099 3 10 7 DAC11-G11 22-CG12244-RA_2 CG12244 TGTGTCCCCCGTCTGTGTGACAGCAAAAGGAATAAAACTTTATTTGAATGGAGTCCAAGGAAACCCCAA 69 FBan0012244 FBgn0015763 lic X X activation of MAPK activity; GO:0000187; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.- lic licorne "CG12244, CG12244, DMEK3, MEK-kinase 3, Mek3, D-MKK3, Drosophila MAP kinase kinase 3, l(1)G0252, DMKK3/lic, MKK3, MAP kinase kinase 3, p38MAPKK, DMKK3, MEK3/MKK3, p38, Mpk3, licorne" CDMC22100 3 11 7 DAC11-G23 23-CG1225-RA_7 CG1225 TTGGCTTGGATTTATCGCGTGGTATAACTTGGGCTTATTTACGTTTTGAGAACTTCCAAACCGAAACCA 69 FBan0001225 FBgn0035128 RhoGEF3 3 3L signal transduction; GO:0007165 Rho guanyl-nucleotide exchange factor activity; GO:0005089; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005089 RhoGEF3 RhoGEF3 "CG1225, CG1225, DrhoGEF3" CDMC22100 3 12 7 DAC11-G23 23-CG1225-RA_7 CG1225 TTGGCTTGGATTTATCGCGTGGTATAACTTGGGCTTATTTACGTTTTGAGAACTTCCAAACCGAAACCA 69 FBan0001225 FBgn0035128 RhoGEF3 3 3L signal transduction; GO:0007165 Rho guanyl-nucleotide exchange factor activity; GO:0005089; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005089 RhoGEF3 RhoGEF3 "CG1225, CG1225, DrhoGEF3" CDMC22101 3 13 7 DAC11-K11 18-CG12303-RA_1 CG12303 ATGAAGGACGATGCCTATCGCCATGGAATTCAAAGTGGTTTGCTAAATTTGGCATTTCGTGATCGGCAT 69 FBan0012303 FBgn0036083 CG12303 3 3L CG12303 CG12303 CDMC22101 3 14 7 DAC11-K11 18-CG12303-RA_1 CG12303 ATGAAGGACGATGCCTATCGCCATGGAATTCAAAGTGGTTTGCTAAATTTGGCATTTCGTGATCGGCAT 69 FBan0012303 FBgn0036083 CG12303 3 3L CG12303 CG12303 CDMC22102 3 15 7 DAC11-K23 3-CG12313-RA_1 CG12313 ACGCCGAGGAGGTAGAAAAAACTAGCAAGTCTAGGCCCGTTGTCAAGAACTGGACCCGTGGCTTCATAA 69 FBan0012313 FBgn0035124 CG12313 3 3L CG12313 CG12313 CDMC22102 3 16 7 DAC11-K23 3-CG12313-RA_1 CG12313 ACGCCGAGGAGGTAGAAAAAACTAGCAAGTCTAGGCCCGTTGTCAAGAACTGGACCCGTGGCTTCATAA 69 FBan0012313 FBgn0035124 CG12313 3 3L CG12313 CG12313 CDMC22103 3 17 7 DAC11-O11 17-CG12348-RA_2 CG12348 TTACCGGATAATGAGAAACAGAGAAAAGTCTGGCTGCTCTTCGAGTATCCAGAAAGTTCGCAAGCCGCC 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC22103 3 18 7 DAC11-O11 17-CG12348-RA_2 CG12348 TTACCGGATAATGAGAAACAGAGAAAAGTCTGGCTGCTCTTCGAGTATCCAGAAAGTTCGCAAGCCGCC 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC22104 3 19 7 DAC11-O23 AutoBlank AutoBlank CDMC22104 3 20 7 DAC11-O23 AutoBlank AutoBlank CDMC22105 3 21 7 DAC12-C11 23-CG7870-RA_3 CG7870 TAAAATTCTTGGAATTAAATACGTGGCTCTGTTTATCTCGCACAAATTGGAGAAGTAATGTCTGCTGGC 69 FBan0007870 FBgn0032012 CG7870 2 2L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate beta-glucosyltransferase activity; GO:0004581 ; EC:2.4.1.117; ; GO:0004581 ; EC:2.4.1.117 CG7870 CG7870 CDMC22105 3 22 7 DAC12-C11 23-CG7870-RA_3 CG7870 TAAAATTCTTGGAATTAAATACGTGGCTCTGTTTATCTCGCACAAATTGGAGAAGTAATGTCTGCTGGC 69 FBan0007870 FBgn0032012 CG7870 2 2L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate beta-glucosyltransferase activity; GO:0004581 ; EC:2.4.1.117; ; GO:0004581 ; EC:2.4.1.117 CG7870 CG7870 CDMC22106 3 23 7 DAC12-C23 5-CG7879-RA_2 CG7879 TTTTCCCTCGAGCACCTACGAATCGAGCATATCGAACAGCTTTTCAATGAACGCAACCAGAGCTCCGGC 69 FBan0007879 FBgn0035235 CG7879 3 3L "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG7879 CG7879 cg7879 CDMC22106 3 24 7 DAC12-C23 5-CG7879-RA_2 CG7879 TTTTCCCTCGAGCACCTACGAATCGAGCATATCGAACAGCTTTTCAATGAACGCAACCAGAGCTCCGGC 69 FBan0007879 FBgn0035235 CG7879 3 3L "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG7879 CG7879 cg7879 CDMC22107 3 25 7 DAC12-G11 2-CG7912-RA_1 CG7912 CCCCCTTTTCACACGGAGGATCCAGAGACTGGAGAAACCATTAGCTTCGGTGGCATGGTATCGAACGTA 69 FBan0007912 FBgn0039736 CG7912 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG7912 CG7912 CDMC22107 3 26 7 DAC12-G11 2-CG7912-RA_1 CG7912 CCCCCTTTTCACACGGAGGATCCAGAGACTGGAGAAACCATTAGCTTCGGTGGCATGGTATCGAACGTA 69 FBan0007912 FBgn0039736 CG7912 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG7912 CG7912 CDMC22108 3 1 8 DAC12-G23 23-CG7921-RA_6 CG7921 ACGAATACTAGCGATAGACCATACACATACATACATATGTACTAACTCGTATCCCCAGATTGTGCCGAA 69 FBan0007921 FBgn0039738 Mgat2 3 3R oligosaccharide biosynthesis; GO:0009312; protein amino acid terminal N-glycosylation; GO:0006496 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; GO:0008455 ; EC:2.4.1.143; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008455 ; EC:2.4.1.143; ; GO:0008455 ; EC:2.4.1.143" Golgi stack; GO:0005795; integral to membrane; GO:0016021 Mgat2 Mgat2 "CG7921, CG7921, GlcNAc-TII, dMGAT2, MGAT2" CDMC22108 3 2 8 DAC12-G23 23-CG7921-RA_6 CG7921 ACGAATACTAGCGATAGACCATACACATACATACATATGTACTAACTCGTATCCCCAGATTGTGCCGAA 69 FBan0007921 FBgn0039738 Mgat2 3 3R oligosaccharide biosynthesis; GO:0009312; protein amino acid terminal N-glycosylation; GO:0006496 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; GO:0008455 ; EC:2.4.1.143; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008455 ; EC:2.4.1.143; ; GO:0008455 ; EC:2.4.1.143" Golgi stack; GO:0005795; integral to membrane; GO:0016021 Mgat2 Mgat2 "CG7921, CG7921, GlcNAc-TII, dMGAT2, MGAT2" CDMC22109 3 3 8 DAC12-K11 17-CG7948-RB_1 CG7948 AGGAGGAAGAAGGTCCACTCAGCGTGACTAAGTTAATAGTGAGTAGGCTGCGATCTCGACCAGGATTAT 69 FBgn0011700 CDMC22109 3 4 8 DAC12-K11 17-CG7948-RB_1 CG7948 AGGAGGAAGAAGGTCCACTCAGCGTGACTAAGTTAATAGTGAGTAGGCTGCGATCTCGACCAGGATTAT 69 FBgn0011700 CDMC22110 3 5 8 DAC12-K23 1-CG7963-RA_1 CG7963 AGGCGGATCTTTACGAAATTGGGTTGCTACCAGGTCCACAATTGCTCCTATGCCAAGACACCCAAACGT 69 FBan0007963 FBgn0037584 CG7963 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7963 CG7963 CDMC22110 3 6 8 DAC12-K23 1-CG7963-RA_1 CG7963 AGGCGGATCTTTACGAAATTGGGTTGCTACCAGGTCCACAATTGCTCCTATGCCAAGACACCCAAACGT 69 FBan0007963 FBgn0037584 CG7963 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7963 CG7963 CDMC22111 3 7 8 DAC12-O11 13-CG7998-RA_1 CG7998 AGCGCCTATTGTGAATTGGCAAACTACCCATACTACCCCTAGCAAATCTTTCGTCTCAAGTCGGCGTGT 69 FBan0007998 FBgn0038587 CG7998 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759 CG7998 CG7998 CDMC22111 3 8 8 DAC12-O11 13-CG7998-RA_1 CG7998 AGCGCCTATTGTGAATTGGCAAACTACCCATACTACCCCTAGCAAATCTTTCGTCTCAAGTCGGCGTGT 69 FBan0007998 FBgn0038587 CG7998 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759 CG7998 CG7998 CDMC22112 3 9 8 DAC12-O23 23-CG8013-RA_2 CG8013 ACGTATACATGCATAAATAAAAATCCACTTCGAGCACACGCAAAATTAATATTGCTAAAAGCCACTGAA 69 FBan0008013 FBgn0020887 Su(z)12 3 3L cell proliferation; GO:0008283; chromatin silencing; GO:0006342; gene silencing; GO:0016458; histone methylation; GO:0016571 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; zinc ion binding; GO:0008270; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0005515; ; GO:0008270 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634; polytene chromosome band; GO:0005704 Su(z)12 Su(z)12 "CG8013, l(3)76BDo, SU(Z)12" CDMC22112 3 10 8 DAC12-O23 23-CG8013-RA_2 CG8013 ACGTATACATGCATAAATAAAAATCCACTTCGAGCACACGCAAAATTAATATTGCTAAAAGCCACTGAA 69 FBan0008013 FBgn0020887 Su(z)12 3 3L cell proliferation; GO:0008283; chromatin silencing; GO:0006342; gene silencing; GO:0016458; histone methylation; GO:0016571 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; zinc ion binding; GO:0008270; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0005515; ; GO:0008270 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634; polytene chromosome band; GO:0005704 Su(z)12 Su(z)12 "CG8013, l(3)76BDo, SU(Z)12" CDMC22113 3 11 8 DAC13-C11 24-CG13280-RA_1 CG13280 TAGGGTGTGTCATAACACTAATTTCATGATCGGATTATGATGTTTTTAAAGAAATCGACAATGCTCAAC 69 FBan0013280 FBgn0032609 CG13280 2 2L CG13280 CG13280 CDMC22113 3 12 8 DAC13-C11 24-CG13280-RA_1 CG13280 TAGGGTGTGTCATAACACTAATTTCATGATCGGATTATGATGTTTTTAAAGAAATCGACAATGCTCAAC 69 FBan0013280 FBgn0032609 CG13280 2 2L CG13280 CG13280 CDMC22114 3 13 8 DAC13-C23 3-CG13287-RA_4 CG13287 CGCGGGTTTATGATGATCCCAGTGTGGTCATACCCCTGGTGGATTCTCCAGAGGCACCATCAACTTCTT 69 FBan0013287 FBgn0035643 CG13287 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13287 CG13287 CDMC22114 3 14 8 DAC13-C23 3-CG13287-RA_4 CG13287 CGCGGGTTTATGATGATCCCAGTGTGGTCATACCCCTGGTGGATTCTCCAGAGGCACCATCAACTTCTT 69 FBan0013287 FBgn0035643 CG13287 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13287 CG13287 CDMC22115 3 15 8 DAC13-G11 3-CG13317-RA_3 CG13317 CGAGAAGGACATTTACCGACTGACACGGCGCAACAAAAAGAGGACGGGCAATGATGAGGCTTGGATCAA 69 FBgn0029673 CDMC22115 3 16 8 DAC13-G11 3-CG13317-RA_3 CG13317 CGAGAAGGACATTTACCGACTGACACGGCGCAACAAAAAGAGGACGGGCAATGATGAGGCTTGGATCAA 69 FBgn0029673 CDMC22116 3 17 8 DAC13-G23 1-CG13323-RA_1 CG13323 GCCGGATTCTACAACATCTCCGCCGTGATCGTCTACGACAACTTTAAGAACAACTCCGGCGCATCTCCT 69 FBan0013323 FBgn0033788 CG13323 2 2R CG13323 CG13323 FBgn0033788 CDMC22116 3 18 8 DAC13-G23 1-CG13323-RA_1 CG13323 GCCGGATTCTACAACATCTCCGCCGTGATCGTCTACGACAACTTTAAGAACAACTCCGGCGCATCTCCT 69 FBan0013323 FBgn0033788 CG13323 2 2R CG13323 CG13323 FBgn0033788 CDMC22117 3 19 8 DAC13-K11 2-CG13361-RA_2 CG13361 GGGCAACTACCCCGTTTTCGTGTACAATGGAACCAGGGGAGAACTGATTCTCAACACCATGCTGAGCAG 69 FBan0013361 FBgn0029532 CG13361 X X CG13361 CG13361 CDMC22117 3 20 8 DAC13-K11 2-CG13361-RA_2 CG13361 GGGCAACTACCCCGTTTTCGTGTACAATGGAACCAGGGGAGAACTGATTCTCAACACCATGCTGAGCAG 69 FBan0013361 FBgn0029532 CG13361 X X CG13361 CG13361 CDMC22118 3 21 8 DAC13-K23 1-CG13374-RA_1 CG13374 GCAGGGAACAAATTTCGTAGATGCATACTTCGACGGAATACTGGGCATGGGATTCCCCTCTTTGGCCGT 69 FBan0013374 FBgn0011822 pcl X X proteolysis; GO:0006508 cathepsin E activity; GO:0004193 ; EC:3.4.23.34; ; GO:0004193 ; EC:3.4.23.34; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 pcl pepsinogen-like "CG13374, CG13374, T2, scute beta, scbeta, EG:EG0001.1" CDMC22118 3 22 8 DAC13-K23 1-CG13374-RA_1 CG13374 GCAGGGAACAAATTTCGTAGATGCATACTTCGACGGAATACTGGGCATGGGATTCCCCTCTTTGGCCGT 69 FBan0013374 FBgn0011822 pcl X X proteolysis; GO:0006508 cathepsin E activity; GO:0004193 ; EC:3.4.23.34; ; GO:0004193 ; EC:3.4.23.34; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 pcl pepsinogen-like "CG13374, CG13374, T2, scute beta, scbeta, EG:EG0001.1" CDMC22119 3 23 8 DAC13-O11 3-CG13415-RA_1 CG13415 GCCGCTCTTCAACAAGAAGTTCGAGTCGAAGCCGATTCCAGTGCGTCAGGGACGTTGCAATATAGGACA 69 FBgn0038910 CDMC22119 3 24 8 DAC13-O11 3-CG13415-RA_1 CG13415 GCCGCTCTTCAACAAGAAGTTCGAGTCGAAGCCGATTCCAGTGCGTCAGGGACGTTGCAATATAGGACA 69 FBgn0038910 CDMC22120 3 25 8 DAC13-O23 AutoBlank AutoBlank CDMC22120 3 26 8 DAC13-O23 AutoBlank AutoBlank CDMC22121 3 1 9 DAC14-C11 23-CG8675-RA_3 CG8675 TTAGTCCTAAATAGTTTAGCAACTTGGTAGAGCACGATAAAGTGGACCTGGAGAACCGATTCCAG 65 FBan0008675 FBgn0030834 CG8675 X X CG8675 CG8675 CDMC22121 3 2 9 DAC14-C11 23-CG8675-RA_3 CG8675 TTAGTCCTAAATAGTTTAGCAACTTGGTAGAGCACGATAAAGTGGACCTGGAGAACCGATTCCAG 65 FBan0008675 FBgn0030834 CG8675 X X CG8675 CG8675 CDMC22122 3 3 9 DAC14-C23 2-CG8733-RA_1 CG8733 CATTGCAGGCTCCCAGACCACTAGCAATACGATCAACCTGGCCCTAATGGTACTTGCTATGCGCC 65 FBan0008733 FBgn0036910 Cyp305a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp305a1 Cyp305a1 "CG8733, 305a1, AAF49108.1, CYP305A1-Dm" CDMC22122 3 4 9 DAC14-C23 2-CG8733-RA_1 CG8733 CATTGCAGGCTCCCAGACCACTAGCAATACGATCAACCTGGCCCTAATGGTACTTGCTATGCGCC 65 FBan0008733 FBgn0036910 Cyp305a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp305a1 Cyp305a1 "CG8733, 305a1, AAF49108.1, CYP305A1-Dm" CDMC22123 3 5 9 DAC14-G11 2-CG8853-RA_1 CG8853 CAGCAAATCAGGAAAGCGATCGCCAAACTGAAGGATGACACTGCGCAACTGAATCTGGAGGTGGC 65 FBan0008853 FBgn0031550 CG8853 2 2L CG8853 CG8853 CDMC22123 3 6 9 DAC14-G11 2-CG8853-RA_1 CG8853 CAGCAAATCAGGAAAGCGATCGCCAAACTGAAGGATGACACTGCGCAACTGAATCTGGAGGTGGC 65 FBan0008853 FBgn0031550 CG8853 2 2L CG8853 CG8853 CDMC22124 3 7 9 DAC14-G23 2-CG8887-RA_1 CG8887 GAAGAGGGACACCGTTACTATCTCTCCCTAATGCGTGGTGATCTGCAGGTACGACAGGGCGATGC 65 FBan0008887 FBgn0005386 ash1 3 3L chromatin-mediated maintenance of transcription; GO:0048096; embryonic development (sensu Insecta); GO:0001700; histone methylation; GO:0016571; oogenesis (sensu Insecta); GO:0009993; oviposition; GO:0018991; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone methyltransferase activity; GO:0042054; histone lysine N-methyltransferase activity (H4-K20 specific); GO:0042799; ; GO:0042054; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; transcription regulator activity; GO:0030528; ; GO:0042800; ; GO:0042799; ; GO:0042800; ; GO:0042800; ; GO:0046974; ; GO:0030528; ; GO:0042800; ; GO:0042054; ; GO:0042799; ; GO:0046974; ; GO:0003677 nucleus; GO:0005634 ash1 "absent, small, or homeotic discs 1" "CG8887, CG8887, dash: discs absent, small, or homeotic, ash-1, ASH1, ash, Ash1, l(3)SG29a, discs absent, small, or homeotic" CDMC22124 3 8 9 DAC14-G23 2-CG8887-RA_1 CG8887 GAAGAGGGACACCGTTACTATCTCTCCCTAATGCGTGGTGATCTGCAGGTACGACAGGGCGATGC 65 FBan0008887 FBgn0005386 ash1 3 3L chromatin-mediated maintenance of transcription; GO:0048096; embryonic development (sensu Insecta); GO:0001700; histone methylation; GO:0016571; oogenesis (sensu Insecta); GO:0009993; oviposition; GO:0018991; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone methyltransferase activity; GO:0042054; histone lysine N-methyltransferase activity (H4-K20 specific); GO:0042799; ; GO:0042054; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; transcription regulator activity; GO:0030528; ; GO:0042800; ; GO:0042799; ; GO:0042800; ; GO:0042800; ; GO:0046974; ; GO:0030528; ; GO:0042800; ; GO:0042054; ; GO:0042799; ; GO:0046974; ; GO:0003677 nucleus; GO:0005634 ash1 "absent, small, or homeotic discs 1" "CG8887, CG8887, dash: discs absent, small, or homeotic, ash-1, ASH1, ash, Ash1, l(3)SG29a, discs absent, small, or homeotic" CDMC22125 3 9 9 DAC14-K11 2-CG8988-RA_2 CG8988 TTCTGCCTGCCGTTAGCATACACGGAGCTCTCCCACGACCACTTAAACAGTCTACGTTGGTTCCG 65 FBan0008988 FBgn0033656 S2P 2 2R proteolysis; GO:0006508; sterol regulatory element binding-protein cleavage; GO:0035103 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; sterol regulatory element-binding protein site 2 protease activity; GO:0017092; ; GO:0017092; ; GO:0008270; ; GO:0005515 membrane; GO:0016020 S2P S2P "CG8988, CG8988, dS2P, anon-WO0118547.346" CDMC22125 3 10 9 DAC14-K11 2-CG8988-RA_2 CG8988 TTCTGCCTGCCGTTAGCATACACGGAGCTCTCCCACGACCACTTAAACAGTCTACGTTGGTTCCG 65 FBan0008988 FBgn0033656 S2P 2 2R proteolysis; GO:0006508; sterol regulatory element binding-protein cleavage; GO:0035103 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; sterol regulatory element-binding protein site 2 protease activity; GO:0017092; ; GO:0017092; ; GO:0008270; ; GO:0005515 membrane; GO:0016020 S2P S2P "CG8988, CG8988, dS2P, anon-WO0118547.346" CDMC22126 3 11 9 DAC14-K23 6-CG9013-RA_1 CG9013 GATCGCGGTCCTGCTTGCTGGATCACTTAGCAGCCCCTATAGCGCCTACAAGGGTTTCCTAAACC 65 FBan0009013 FBgn0034169 CG9013 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG9013 CG9013 CDMC22126 3 12 9 DAC14-K23 6-CG9013-RA_1 CG9013 GATCGCGGTCCTGCTTGCTGGATCACTTAGCAGCCCCTATAGCGCCTACAAGGGTTTCCTAAACC 65 FBan0009013 FBgn0034169 CG9013 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG9013 CG9013 CDMC22127 3 13 9 DAC14-O11 1-CG9111-RA_1 CG9111 GGGTCAAAATCAGTTTAGAAGCAGTCATCGATGGACGGCAACCATCCGCTGCAGTAGTGCCAGGT 65 FBan0009111 FBgn0004426 LysC 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 LysC Lysozyme C "CG9111, lysC" CDMC22127 3 14 9 DAC14-O11 1-CG9111-RA_1 CG9111 GGGTCAAAATCAGTTTAGAAGCAGTCATCGATGGACGGCAACCATCCGCTGCAGTAGTGCCAGGT 65 FBan0009111 FBgn0004426 LysC 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 LysC Lysozyme C "CG9111, lysC" CDMC22128 3 15 9 DAC14-O23 2-CG9163-RA_1 CG9163 GAAAGACCACAACGCTCAAGTACGACCCGCCCTATTCGAAGAAGCCAATTGCCAAGAGCTACGGC 65 FBan0009163 FBgn0041109 mmd X X cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.- mmd mind-meld "CG9163, CT26192, Meltrin-like, mind-meld" CDMC22128 3 16 9 DAC14-O23 2-CG9163-RA_1 CG9163 GAAAGACCACAACGCTCAAGTACGACCCGCCCTATTCGAAGAAGCCAATTGCCAAGAGCTACGGC 65 FBan0009163 FBgn0041109 mmd X X cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.- mmd mind-meld "CG9163, CT26192, Meltrin-like, mind-meld" CDMC22129 3 17 9 DAC15-C11 8-CG8395-RA_1 CG8395 GCATCGAGACGGTTCCGCTGTTGGTCACAGTTTGCAAGATCGGTGATTATGTCCTGGTGGATCCTTC 67 FBan0008395 FBgn0034065 Rrp42 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- nuclear exosome (RNase complex); GO:0000176; nucleus; GO:0005634 Rrp42 Rrp42 "CG8395, CG8395, CG8395, dRrp42, anon-EST:Posey140, anon-EST:Posey187" CDMC22129 3 18 9 DAC15-C11 8-CG8395-RA_1 CG8395 GCATCGAGACGGTTCCGCTGTTGGTCACAGTTTGCAAGATCGGTGATTATGTCCTGGTGGATCCTTC 67 FBan0008395 FBgn0034065 Rrp42 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- nuclear exosome (RNase complex); GO:0000176; nucleus; GO:0005634 Rrp42 Rrp42 "CG8395, CG8395, CG8395, dRrp42, anon-EST:Posey140, anon-EST:Posey187" CDMC22130 3 19 9 DAC15-C23 1-CG8533-RB_2 CG8533 CGTCTCTTCGACCATAAGCTCATTTGGACGGGGACTTCACAGGCCTGGATTACCACCATTGACGAGC 67 FBan0008533 FBgn0036907 CG8533 3 3L glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG8533 CG8533 CT24909 CDMC22130 3 20 9 DAC15-C23 1-CG8533-RB_2 CG8533 CGTCTCTTCGACCATAAGCTCATTTGGACGGGGACTTCACAGGCCTGGATTACCACCATTGACGAGC 67 FBan0008533 FBgn0036907 CG8533 3 3L glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG8533 CG8533 CT24909 CDMC22131 3 21 9 DAC15-G11 3-CG9064-RA_1 CG9064 CGATGCCAACTTTCCGGGCAACTCTTACCAACATGATCCGAGTGGAGGGATTCAAGTCGCTCTACGC 67 FBan0009064 FBgn0031757 Ucp4C 2 2L proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4C Ucp4C "CG9064, CG9064, DmUCP4C, dmUCP4c, anon-WO02079478.1, anon-WO02079478.2, anon-WO0242455.3, anon-WO0242455.4, anon-WO03037362.7, anon-WO03061681.1, anon-WO03061681.2" CDMC22131 3 22 9 DAC15-G11 3-CG9064-RA_1 CG9064 CGATGCCAACTTTCCGGGCAACTCTTACCAACATGATCCGAGTGGAGGGATTCAAGTCGCTCTACGC 67 FBan0009064 FBgn0031757 Ucp4C 2 2L proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4C Ucp4C "CG9064, CG9064, DmUCP4C, dmUCP4c, anon-WO02079478.1, anon-WO02079478.2, anon-WO0242455.3, anon-WO0242455.4, anon-WO03037362.7, anon-WO03061681.1, anon-WO03061681.2" CDMC22132 3 23 9 DAC15-G23 1-CG9106-RA_1 CG9106 TCGATGGTATCGTCTATCTGCATGTGGTATGTGCCGGTGAGTCAAGCTCCAAGTGGGTCACTCTGGA 67 FBan0009106 FBgn0030624 CG9106 X X CG9106 CG9106 CDMC22132 3 24 9 DAC15-G23 1-CG9106-RA_1 CG9106 TCGATGGTATCGTCTATCTGCATGTGGTATGTGCCGGTGAGTCAAGCTCCAAGTGGGTCACTCTGGA 67 FBan0009106 FBgn0030624 CG9106 X X CG9106 CG9106 CDMC22133 3 25 9 DAC15-K11 2-CG9452-RA_1 CG9452 ATCGCTGAAACCGAGCCCTACGAACAAATGTTCCGCGAGCTGACAAATCTGACTGGAAAGGCGATCC 67 FBan0009452 FBgn0036877 CG9452 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9452 CG9452 CDMC22133 3 26 9 DAC15-K11 2-CG9452-RA_1 CG9452 ATCGCTGAAACCGAGCCCTACGAACAAATGTTCCGCGAGCTGACAAATCTGACTGGAAAGGCGATCC 67 FBan0009452 FBgn0036877 CG9452 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9452 CG9452 CDMC22134 3 1 10 DAC15-K23 2-CG9614-RK_1 CG9614 GGGAGGATACGAACACCACGTTGTCGGTTCTCGAGGGTTATATACCACGGTTCTTCAGTGGGGCCAA 67 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC22134 3 2 10 DAC15-K23 2-CG9614-RK_1 CG9614 GGGAGGATACGAACACCACGTTGTCGGTTCTCGAGGGTTATATACCACGGTTCTTCAGTGGGGCCAA 67 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC22135 3 3 10 DAC15-O11 1-CR30224-RA_1 CR30224 CCGAGTGGTTAAGGCGTCTGACTCGAAATCAGATTCCCTCTGGGAGCGTAGGTTCGAATCCTACCGG 67 FBan0030224 FBgn0028981 tRNA:S4:56D 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:S4:56D transfer RNA:ser4:56D "tRNA[Ser][[4]], 444-3, Ser tRNA[Ser], EST E, tRNA(4Ser), tRNA[Ser], AE002787.trna50-SerCGA, tRNA:ser4:64D, tRNA:S4:64D, tRNA:S4, tRNA:ser4, tRNA:S, tRNA:ser, CR30224, tRNA:S:CGA:AE002787, transfer RNA:ser4, transfer RNA:ser" CDMC22135 3 4 10 DAC15-O11 1-CR30224-RA_1 CR30224 CCGAGTGGTTAAGGCGTCTGACTCGAAATCAGATTCCCTCTGGGAGCGTAGGTTCGAATCCTACCGG 67 FBan0030224 FBgn0028981 tRNA:S4:56D 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:S4:56D transfer RNA:ser4:56D "tRNA[Ser][[4]], 444-3, Ser tRNA[Ser], EST E, tRNA(4Ser), tRNA[Ser], AE002787.trna50-SerCGA, tRNA:ser4:64D, tRNA:S4:64D, tRNA:S4, tRNA:ser4, tRNA:S, tRNA:ser, CR30224, tRNA:S:CGA:AE002787, transfer RNA:ser4, transfer RNA:ser" CDMC22136 3 5 10 DAC15-O23 AutoBlank AutoBlank CDMC22136 3 6 10 DAC15-O23 AutoBlank AutoBlank CDMC22137 3 7 10 DAC16-C11 15-CG4898-RE_3 CG4898 CTCGCCTTTGGCAGATCCATCTTCAGTTCGGACACCATGATGAAGTTCAACATCATCCGCAACGAGCTG 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC22137 3 8 10 DAC16-C11 15-CG4898-RE_3 CG4898 CTCGCCTTTGGCAGATCCATCTTCAGTTCGGACACCATGATGAAGTTCAACATCATCCGCAACGAGCTG 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC22138 3 9 10 DAC16-C23 16-CG4905-RA_1 CG4905 ACCCGACCAACATACGTAATCTGCAAACACCGCAACATGTTATACGAGTATCCAATTACCAGGGGGAGT 69 FBan0004905 FBgn0034135 Syn2 2 2R muscle contraction; GO:0006936; signal transduction; GO:0007165; synaptic transmission; GO:0007268 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008307 syntrophin complex; GO:0016013 Syn2 Syntrophin-like 2 "CG4905, CG4905, CG4905, CG4905, DmSYN-2, Syntrophin-like 2" CDMC22138 3 10 10 DAC16-C23 16-CG4905-RA_1 CG4905 ACCCGACCAACATACGTAATCTGCAAACACCGCAACATGTTATACGAGTATCCAATTACCAGGGGGAGT 69 FBan0004905 FBgn0034135 Syn2 2 2R muscle contraction; GO:0006936; signal transduction; GO:0007165; synaptic transmission; GO:0007268 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008307 syntrophin complex; GO:0016013 Syn2 Syntrophin-like 2 "CG4905, CG4905, CG4905, CG4905, DmSYN-2, Syntrophin-like 2" CDMC22139 3 11 10 DAC16-G11 3-CG4942-RA_1 CG4942 ACACGCTTGCAGAACATCGCCAACAATGTGTTCCGTGGATTGAGTGTTGTGATGGTTCCAGTAGCCTGT 69 FBan0004942 FBgn0035960 CG4942 3 3L cytochrome c oxidase complex assembly; GO:0008535 mitochondrial inner membrane; GO:0005743 CG4942 CG4942 CDMC22139 3 12 10 DAC16-G11 3-CG4942-RA_1 CG4942 ACACGCTTGCAGAACATCGCCAACAATGTGTTCCGTGGATTGAGTGTTGTGATGGTTCCAGTAGCCTGT 69 FBan0004942 FBgn0035960 CG4942 3 3L cytochrome c oxidase complex assembly; GO:0008535 mitochondrial inner membrane; GO:0005743 CG4942 CG4942 CDMC22140 3 13 10 DAC16-G23 3-CG4949-RB_1 CG4949 TGGTCTCCCAGAGATTCGCCTAGACGAAGGACAGAAGTTTGGAGCCACTACAGTGCCTTGGTAACCAGT 69 FBan0004949 FBgn0030813 CG4949 X X CG4949 CG4949 CDMC22140 3 14 10 DAC16-G23 3-CG4949-RB_1 CG4949 TGGTCTCCCAGAGATTCGCCTAGACGAAGGACAGAAGTTTGGAGCCACTACAGTGCCTTGGTAACCAGT 69 FBan0004949 FBgn0030813 CG4949 X X CG4949 CG4949 CDMC22141 3 15 10 DAC16-K11 2-CG4979-RA_2 CG4979 TCCCGGTAAGTGCGAAGTGTCCATTTCGGATGTAATCCAAGGCATGATTACCACTGAGGCTGGCGTCAT 69 FBan0004979 FBgn0038398 sxe2 3 3R lipid metabolism; GO:0006629 phosphatidylserine-specific phospholipase A1 activity; GO:0017063; ; GO:0017063 sxe2 sex-specific enzyme 2 "CG4979, CG4979, CG4979, sex-specific enzyme 2" CDMC22141 3 16 10 DAC16-K11 2-CG4979-RA_2 CG4979 TCCCGGTAAGTGCGAAGTGTCCATTTCGGATGTAATCCAAGGCATGATTACCACTGAGGCTGGCGTCAT 69 FBan0004979 FBgn0038398 sxe2 3 3R lipid metabolism; GO:0006629 phosphatidylserine-specific phospholipase A1 activity; GO:0017063; ; GO:0017063 sxe2 sex-specific enzyme 2 "CG4979, CG4979, CG4979, sex-specific enzyme 2" CDMC22142 3 17 10 DAC16-K23 23-CG4991-RB_7 CG4991 TCTGCAGCTATAACCCATTTTAATAATTGATTACCATAGCAATAGGGCTTTGATTGTGTGAGAGCCTGC 69 FBan0004991 FBgn0030817 CG4991 X X amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG4991 CG4991 CT15971 CDMC22142 3 18 10 DAC16-K23 23-CG4991-RB_7 CG4991 TCTGCAGCTATAACCCATTTTAATAATTGATTACCATAGCAATAGGGCTTTGATTGTGTGAGAGCCTGC 69 FBan0004991 FBgn0030817 CG4991 X X amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG4991 CG4991 CT15971 CDMC22143 3 19 10 DAC16-O11 8-CG5022-RA_1 CG5022 GCGCAACTCACCCGAAATGCTTTGTCTGCGCTATCAGTACTATCAGCCACTGAAGGAGTTCGTTCTGGA 69 FBan0005022 FBgn0032225 CG5022 2 2L cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 CG5022 CG5022 CDMC22143 3 20 10 DAC16-O11 8-CG5022-RA_1 CG5022 GCGCAACTCACCCGAAATGCTTTGTCTGCGCTATCAGTACTATCAGCCACTGAAGGAGTTCGTTCTGGA 69 FBan0005022 FBgn0032225 CG5022 2 2L cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 CG5022 CG5022 CDMC22144 3 21 10 DAC16-O23 3-CG5032-RA_1 CG5032 AGTGCCTGTCTATGGCGGTTCCTACACAGAAAGGGAGTCCTTGAAACACGGTGACCTTCTCAAGCAGAT 69 FBan0005032 FBgn0026309 aft 2 2R cell migration; GO:0016477; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 nucleus; GO:0005634 aft adrift "CG5032, EG:52C10.7, adrift" CDMC22144 3 22 10 DAC16-O23 3-CG5032-RA_1 CG5032 AGTGCCTGTCTATGGCGGTTCCTACACAGAAAGGGAGTCCTTGAAACACGGTGACCTTCTCAAGCAGAT 69 FBan0005032 FBgn0026309 aft 2 2R cell migration; GO:0016477; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 nucleus; GO:0005634 aft adrift "CG5032, EG:52C10.7, adrift" CDMC22145 3 23 10 DAC17-C11 14-CG7109-RA_1 CG7109 TGATGGAGGGCTACAACTGGTGTCACGATCGCAATGTGGTCACAATATTCTCAGCGCCAAACTATTGCT 69 FBan0007109 FBgn0004177 mts 2 2L R7 cell fate commitment; GO:0007465; actin filament organization; GO:0007015; cell adhesion; GO:0007155; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360; spindle organization and biogenesis; GO:0007051 protein phosphatase type 2A activity; GO:0000158; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0000158; ; GO:0000158; ; GO:0004722; ; GO:0000158 protein phosphatase type 2A complex; GO:0000159 mts microtubule star "CG7109, CG7109, CG7109, PP2A, PP2A 28D, catalytic subunit C of type 2A protein phosphatase, ER2-6, Pp2A, Pp2A-28D: Protein phosphatase 2A at 28D, 5559, dPP2A, PP2, phosphatase 2A catalytic subunit, PP2Ac, MTS/PP2A, PP2A[[C]], PP2a 28D, l(2)02496, l(2)s5286, Protein phosphatase 2A at 28D, Pp2A-28D" CDMC22145 3 24 10 DAC17-C11 14-CG7109-RA_1 CG7109 TGATGGAGGGCTACAACTGGTGTCACGATCGCAATGTGGTCACAATATTCTCAGCGCCAAACTATTGCT 69 FBan0007109 FBgn0004177 mts 2 2L R7 cell fate commitment; GO:0007465; actin filament organization; GO:0007015; cell adhesion; GO:0007155; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360; spindle organization and biogenesis; GO:0007051 protein phosphatase type 2A activity; GO:0000158; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0000158; ; GO:0000158; ; GO:0004722; ; GO:0000158 protein phosphatase type 2A complex; GO:0000159 mts microtubule star "CG7109, CG7109, CG7109, PP2A, PP2A 28D, catalytic subunit C of type 2A protein phosphatase, ER2-6, Pp2A, Pp2A-28D: Protein phosphatase 2A at 28D, 5559, dPP2A, PP2, phosphatase 2A catalytic subunit, PP2Ac, MTS/PP2A, PP2A[[C]], PP2a 28D, l(2)02496, l(2)s5286, Protein phosphatase 2A at 28D, Pp2A-28D" CDMC22146 3 25 10 DAC17-C23 3-CG7123-RA_2 CG7123 GCTGCTCCAGAGGGCCTCCAAACTAACAGTCGATACGAACGCCAAGCTAAAGGATCTGAACGATCTGCA 69 FBan0007123 FBgn0002527 LanB1 2 2L cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; embryonic morphogenesis; GO:0048598; organ morphogenesis; GO:0009887; signal transduction; GO:0007165; tissue development; GO:0009888 structural molecule activity; GO:0005198; ; GO:0005198 basal lamina; GO:0005605; basement membrane; GO:0005604 LanB1 Laminin B1 "CG7123, CG7123, laminin, lamB1, laminin beta, laminin B1, beta1, laminin beta-chain, LM-B1/beta, CT22015, Laminin, BcDNA:LD21794, Lam-B1" CDMC22146 3 26 10 DAC17-C23 3-CG7123-RA_2 CG7123 GCTGCTCCAGAGGGCCTCCAAACTAACAGTCGATACGAACGCCAAGCTAAAGGATCTGAACGATCTGCA 69 FBan0007123 FBgn0002527 LanB1 2 2L cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; embryonic morphogenesis; GO:0048598; organ morphogenesis; GO:0009887; signal transduction; GO:0007165; tissue development; GO:0009888 structural molecule activity; GO:0005198; ; GO:0005198 basal lamina; GO:0005605; basement membrane; GO:0005604 LanB1 Laminin B1 "CG7123, CG7123, laminin, lamB1, laminin beta, laminin B1, beta1, laminin beta-chain, LM-B1/beta, CT22015, Laminin, BcDNA:LD21794, Lam-B1" CDMC22147 3 1 11 DAC17-G11 1-CG7163-RA_2 CG7163 TCGACTAGTGCCCTCCGTCAAAGAGCTCCAGTCACTCTGTCCACCGGTTATTTTGTCGGGCGTTAACTA 69 FBan0007163 FBgn0035889 mkg-p 3 3L tRNA splicing; GO:0006388 "nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0016779 ; EC:2.7.7.-; ; GO:0008270; transferase activity, transferring phosphorus-containing groups; GO:0016772 ; EC:2.7.-.-; ; GO:0016772 ; EC:2.7.-.-" nucleus; GO:0005634 mkg-p monkey king protein "CG7163, mkg" CDMC22147 3 2 11 DAC17-G11 1-CG7163-RA_2 CG7163 TCGACTAGTGCCCTCCGTCAAAGAGCTCCAGTCACTCTGTCCACCGGTTATTTTGTCGGGCGTTAACTA 69 FBan0007163 FBgn0035889 mkg-p 3 3L tRNA splicing; GO:0006388 "nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0016779 ; EC:2.7.7.-; ; GO:0008270; transferase activity, transferring phosphorus-containing groups; GO:0016772 ; EC:2.7.-.-; ; GO:0016772 ; EC:2.7.-.-" nucleus; GO:0005634 mkg-p monkey king protein "CG7163, mkg" CDMC22148 3 3 11 DAC17-G23 15-CG7175-RA_3 CG7175 CGGTGGTCAACAAGCCGATAGAAGTCTTGAAGGCACATAATTACATCCCCTTCGATGTGAAGGTGGCGG 69 FBan0007175 FBgn0038584 CG7175 3 3R CG7175 CG7175 CDMC22148 3 4 11 DAC17-G23 15-CG7175-RA_3 CG7175 CGGTGGTCAACAAGCCGATAGAAGTCTTGAAGGCACATAATTACATCCCCTTCGATGTGAAGGTGGCGG 69 FBan0007175 FBgn0038584 CG7175 3 3R CG7175 CG7175 CDMC22149 3 5 11 DAC17-K11 14-CG7206-RA_1 CG7206 ACTCATATCCCATGTTCTCCTTATCGTCTCCCTAGCCTACCAGCGTCTCATGCTGTTAAGAGCTTCGCT 69 FBan0007206 FBgn0030892 CG7206 X X CG7206 CG7206 CDMC22149 3 6 11 DAC17-K11 14-CG7206-RA_1 CG7206 ACTCATATCCCATGTTCTCCTTATCGTCTCCCTAGCCTACCAGCGTCTCATGCTGTTAAGAGCTTCGCT 69 FBan0007206 FBgn0030892 CG7206 X X CG7206 CG7206 CDMC22150 3 7 11 DAC17-K23 2-CG7222-RA_1 CG7222 GCGCGAAGACTCCGACAACAGTCCCCTTTGAGACGTTACCTGACCGAAAATATGTCACTTGGCGACACA 69 FBan0007222 FBgn0033551 CG7222 2 2R CG7222 CG7222 CDMC22150 3 8 11 DAC17-K23 2-CG7222-RA_1 CG7222 GCGCGAAGACTCCGACAACAGTCCCCTTTGAGACGTTACCTGACCGAAAATATGTCACTTGGCGACACA 69 FBan0007222 FBgn0033551 CG7222 2 2R CG7222 CG7222 CDMC22151 3 9 11 DAC17-O11 2-CG7265-RA_1 CG7265 AGCTTCTTGCCTTTTGATGCGGCAGATATACCAGAGAACGACGTCAGCTTGGTGAGTGGAAGGCTACGA 69 FBan0007265 FBgn0038272 CG7265 3 3R defense response; GO:0006952; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 CG7265 CG7265 CDMC22151 3 10 11 DAC17-O11 2-CG7265-RA_1 CG7265 AGCTTCTTGCCTTTTGATGCGGCAGATATACCAGAGAACGACGTCAGCTTGGTGAGTGGAAGGCTACGA 69 FBan0007265 FBgn0038272 CG7265 3 3R defense response; GO:0006952; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 CG7265 CG7265 CDMC22152 3 11 11 DAC17-O23 23-CG7280-RA_9 CG7280 CCAACGCGTATCACAAAGTCAAAGTGAAGATTATCTGAAGGGGAGATTTCTGGCAATACTCAAGATAGA 69 FBan0007280 FBgn0030966 CG7280 X X electron transport; GO:0006118; nitrogen compound metabolism; GO:0006807; protein catabolism; GO:0030163; sulfur metabolism; GO:0006790 sulfite oxidase activity; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1 mitochondrial intermembrane space; GO:0005758 CG7280 CG7280 CDMC22152 3 12 11 DAC17-O23 23-CG7280-RA_9 CG7280 CCAACGCGTATCACAAAGTCAAAGTGAAGATTATCTGAAGGGGAGATTTCTGGCAATACTCAAGATAGA 69 FBan0007280 FBgn0030966 CG7280 X X electron transport; GO:0006118; nitrogen compound metabolism; GO:0006807; protein catabolism; GO:0030163; sulfur metabolism; GO:0006790 sulfite oxidase activity; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1; ; GO:0008482 ; EC:1.8.3.1 mitochondrial intermembrane space; GO:0005758 CG7280 CG7280 CDMC22153 3 13 11 DAC18-C11 18-CG32412-RA_7 CG32412 TGGAGGGCAATAACAATATGTTTTTAAGTCGTGTCAGCGGTGGTCTAGTCGACGATGATCATCGACCGT 69 FBan0032412 FBgn0052412 CG32412 3 3L amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; glutaminyl-peptide cyclotransferase activity; GO:0016603 ; EC:2.3.2.5; ; GO:0016603 ; EC:2.3.2.5 CG32412 CG32412 "CG10487, CG10487" CDMC22153 3 14 11 DAC18-C11 18-CG32412-RA_7 CG32412 TGGAGGGCAATAACAATATGTTTTTAAGTCGTGTCAGCGGTGGTCTAGTCGACGATGATCATCGACCGT 69 FBan0032412 FBgn0052412 CG32412 3 3L amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; glutaminyl-peptide cyclotransferase activity; GO:0016603 ; EC:2.3.2.5; ; GO:0016603 ; EC:2.3.2.5 CG32412 CG32412 "CG10487, CG10487" CDMC22154 3 15 11 DAC18-C23 23-CG3242-RA_3 CG3242 CCTTAGCTACTTTGGTTTAAGCCTTGGATATTTGTGACGTAAGCATAGCAGGAAAGTTTGACTTTGCGT 69 FBan0003242 FBgn0004892 sob 2 2L cell proliferation; GO:0008283; leg joint morphogenesis (sensu Endopterygota); GO:0016348; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003702; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sob sister of odd and bowl "CG3242, org1: odd skipped-related 1, odd skipped-related 1" CDMC22154 3 16 11 DAC18-C23 23-CG3242-RA_3 CG3242 CCTTAGCTACTTTGGTTTAAGCCTTGGATATTTGTGACGTAAGCATAGCAGGAAAGTTTGACTTTGCGT 69 FBan0003242 FBgn0004892 sob 2 2L cell proliferation; GO:0008283; leg joint morphogenesis (sensu Endopterygota); GO:0016348; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003702; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sob sister of odd and bowl "CG3242, org1: odd skipped-related 1, odd skipped-related 1" CDMC22155 3 17 11 DAC18-G11 1-CG32458-RA_1 CG32458 CGGCGGCAAACCATTAACAACCCATACGAACATATCCAAAGCCACCCATATGCAAGACCTGGCGACGTT 69 FBan0032458 FBgn0052458 CG32458 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32458 CG32458 CDMC22155 3 18 11 DAC18-G11 1-CG32458-RA_1 CG32458 CGGCGGCAAACCATTAACAACCCATACGAACATATCCAAAGCCACCCATATGCAAGACCTGGCGACGTT 69 FBan0032458 FBgn0052458 CG32458 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32458 CG32458 CDMC22156 3 19 11 DAC18-G23 18-CG32468-RA_2 CG32468 GCCGCCATTTGAGAGAGCTCAACATATTCAAAGTTGTGCACGAGCGCGATTCCAATTTCATTTTGTGCT 69 FBan0032468 FBgn0052468 CG32468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32468 CG32468 CDMC22156 3 20 11 DAC18-G23 18-CG32468-RA_2 CG32468 GCCGCCATTTGAGAGAGCTCAACATATTCAAAGTTGTGCACGAGCGCGATTCCAATTTCATTTTGTGCT 69 FBan0032468 FBgn0052468 CG32468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32468 CG32468 CDMC22157 3 21 11 DAC18-K11 15-CG32491-RN_3 CG32491 AGGAACTGGAGGAGTACATCGAGATCTGCACGTCGAACCCAAAGATATCACAGTATCTGGGCAGTAGCA 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC22157 3 22 11 DAC18-K11 15-CG32491-RN_3 CG32491 AGGAACTGGAGGAGTACATCGAGATCTGCACGTCGAACCCAAAGATATCACAGTATCTGGGCAGTAGCA 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC22158 3 23 11 DAC18-K23 17-CG32491-RZ_1 CG32491 AGACTGAGTGTCCCGAGCCTAGTTAGGATGGGTAAGTAGCCTGTTCATCTGGGATCTCAAAGTACCATT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC22158 3 24 11 DAC18-K23 17-CG32491-RZ_1 CG32491 AGACTGAGTGTCCCGAGCCTAGTTAGGATGGGTAAGTAGCCTGTTCATCTGGGATCTCAAAGTACCATT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC22159 3 25 11 DAC18-O11 16-CG32535-RA_1 CG32535 CCCCGGGGATCGTAAATACATAAGCTCTGCAACTCACGTACGTAATCTTTGAATCCGTCGTAGCACGAA 69 FBgn0052535 CDMC22159 3 26 11 DAC18-O11 16-CG32535-RA_1 CG32535 CCCCGGGGATCGTAAATACATAAGCTCTGCAACTCACGTACGTAATCTTTGAATCCGTCGTAGCACGAA 69 FBgn0052535 CDMC22160 3 1 12 DAC18-O23 3-CG32554-RA_2 CG32554 CGCAGACTGAGCGGCATAATCCAGGAGCAAATCGAGTTCTCTCTGGATGTACCCAATGGCGTAGGCAAA 69 FBan0032554 FBgn0052554 CG32554 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32554 CG32554 "CG7871, CG7871" CDMC22160 3 2 12 DAC18-O23 3-CG32554-RA_2 CG32554 CGCAGACTGAGCGGCATAATCCAGGAGCAAATCGAGTTCTCTCTGGATGTACCCAATGGCGTAGGCAAA 69 FBan0032554 FBgn0052554 CG32554 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32554 CG32554 "CG7871, CG7871" CDMC22161 3 3 12 DAC19-C11 2-CG8203-RA_2 CG8203 TAGCTGACTTTGGTCTCGCTAGAGCCTTTGGCATTCCCGTGAAGTGCTACTCCGCAGAAGTGGTG 65 FBan0008203 FBgn0013762 Cdk5 2 2R cell cycle; GO:0007049; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; synaptic vesicle transport; GO:0048489 ATP binding; GO:0005524; ; GO:0005524; cyclin binding; GO:0030332; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0030332 Cdk5 Cyclin-dependent kinase 5 "CG8203, CG8203, CG8203, cdk5, DmCdk5, CDK5" CDMC22161 3 4 12 DAC19-C11 2-CG8203-RA_2 CG8203 TAGCTGACTTTGGTCTCGCTAGAGCCTTTGGCATTCCCGTGAAGTGCTACTCCGCAGAAGTGGTG 65 FBan0008203 FBgn0013762 Cdk5 2 2R cell cycle; GO:0007049; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; synaptic vesicle transport; GO:0048489 ATP binding; GO:0005524; ; GO:0005524; cyclin binding; GO:0030332; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0030332 Cdk5 Cyclin-dependent kinase 5 "CG8203, CG8203, CG8203, cdk5, DmCdk5, CDK5" CDMC22162 3 5 12 DAC19-C23 3-CG8230-RA_2 CG8230 ATAGCGCAGTGTTTGTGAACGTCTCGACGACCCCGGAAGACATGCTACAAGATCTGAGCGTGCTG 65 FBan0008230 FBgn0027607 CG8230 2 2R CG8230 CG8230 BcDNA:GH02536 CDMC22162 3 6 12 DAC19-C23 3-CG8230-RA_2 CG8230 ATAGCGCAGTGTTTGTGAACGTCTCGACGACCCCGGAAGACATGCTACAAGATCTGAGCGTGCTG 65 FBan0008230 FBgn0027607 CG8230 2 2R CG8230 CG8230 BcDNA:GH02536 CDMC22163 3 7 12 DAC19-G11 6-CG8297-RA_3 CG8297 AGTGCCCTCCAGTATTTCGGGCTCTTCTCAAATTTGACGGTGTATTCCCTGGGAGTTTCGCGGGG 65 FBan0008297 FBgn0034050 CG8297 2 2R CG8297 CG8297 CDMC22163 3 8 12 DAC19-G11 6-CG8297-RA_3 CG8297 AGTGCCCTCCAGTATTTCGGGCTCTTCTCAAATTTGACGGTGTATTCCCTGGGAGTTTCGCGGGG 65 FBan0008297 FBgn0034050 CG8297 2 2R CG8297 CG8297 CDMC22164 3 9 12 DAC19-G23 23-CG8333-RA_4 CG8333 AGCTCAAAGAACTCAGCTTACATCGAAACTACAAAAAGAACAATAAGAAACACACAAAATGTCGT 65 FBan0008333 FBgn0002735 HLHmgamma 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 HLHmgamma E(spl) region transcript mgamma "CG8333, mB, HLH-mgamma, mgamma, E(spl)mgamma, E(spl)-mgamma, E(spl)gamma, E(spl) mgamma, E(spl)mB, clone 1.49, E(spl)Mgamma, Mgamma, split locus enhancer protein mB, E(Spl) HLH-m gamma, Enhancer of split mgamma, E(spl) m gamma, Dm-mB, e(spl)mgamma, mgamma, E(spl)mgamma, HLHmB: Enhancer of split region transcript HLHmB, anon-EST:Liang-1.49, Enhancer of split region transcript HLHmB" CDMC22164 3 10 12 DAC19-G23 23-CG8333-RA_4 CG8333 AGCTCAAAGAACTCAGCTTACATCGAAACTACAAAAAGAACAATAAGAAACACACAAAATGTCGT 65 FBan0008333 FBgn0002735 HLHmgamma 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 HLHmgamma E(spl) region transcript mgamma "CG8333, mB, HLH-mgamma, mgamma, E(spl)mgamma, E(spl)-mgamma, E(spl)gamma, E(spl) mgamma, E(spl)mB, clone 1.49, E(spl)Mgamma, Mgamma, split locus enhancer protein mB, E(Spl) HLH-m gamma, Enhancer of split mgamma, E(spl) m gamma, Dm-mB, e(spl)mgamma, mgamma, E(spl)mgamma, HLHmB: Enhancer of split region transcript HLHmB, anon-EST:Liang-1.49, Enhancer of split region transcript HLHmB" CDMC22165 3 11 12 DAC19-K11 3-CG8404-RA_2 CG8404 ATGAGCAGCTACACGGTCTCCATGGCGGATAACTGCGGAAATCTCAGGCTCAGCATGAACGAGTT 65 FBan0008404 FBgn0005613 Sox15 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004812 ; EC:6.1.1.- nucleus; GO:0005634 Sox15 Sox box protein 15 "CG8404, CG13945, CG8404, DSox-15, SoxE, Dsox-15, SOX15, SOX50E, SOXF, Sox F, Sox50E" CDMC22165 3 12 12 DAC19-K11 3-CG8404-RA_2 CG8404 ATGAGCAGCTACACGGTCTCCATGGCGGATAACTGCGGAAATCTCAGGCTCAGCATGAACGAGTT 65 FBan0008404 FBgn0005613 Sox15 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004812 ; EC:6.1.1.- nucleus; GO:0005634 Sox15 Sox box protein 15 "CG8404, CG13945, CG8404, DSox-15, SoxE, Dsox-15, SOX15, SOX50E, SOXF, Sox F, Sox50E" CDMC22166 3 13 12 DAC19-K23 8-CG8431-RA_5 CG8431 GAGGCCGCTTTTAATGAGTCGGAGTGGGTTAAGTACTTCCTGCACACGGGTCACCTCACCATAGC 65 FBgn0027536 CDMC22166 3 14 12 DAC19-K23 8-CG8431-RA_5 CG8431 GAGGCCGCTTTTAATGAGTCGGAGTGGGTTAAGTACTTCCTGCACACGGGTCACCTCACCATAGC 65 FBgn0027536 CDMC22167 3 15 12 DAC19-O11 3-CG8539-RA_5 CG8539 CCCACAGTAACCGGGTGACCCTAAAGGATGTGGCTCGGACCTACGAGAACAGAGCCCTGAAAATG 65 FBan0008539 FBgn0035791 CG8539 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8539 CG8539 CDMC22167 3 16 12 DAC19-O11 3-CG8539-RA_5 CG8539 CCCACAGTAACCGGGTGACCCTAAAGGATGTGGCTCGGACCTACGAGAACAGAGCCCTGAAAATG 65 FBan0008539 FBgn0035791 CG8539 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8539 CG8539 CDMC22168 3 17 12 DAC19-O23 5-CG8582-RB_1 CG8582 CAGCGCGTTCTGATGATCCTGGACAGCAAGAACATCAAGTACGACACGGTGGACATCACGGAGCC 65 FBan0008582 FBgn0035772 Sh3beta 3 3L superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" cellular component unknown; GO:0008372 Sh3beta Sh3beta "CG8582, LD12912" CDMC22168 3 18 12 DAC19-O23 5-CG8582-RB_1 CG8582 CAGCGCGTTCTGATGATCCTGGACAGCAAGAACATCAAGTACGACACGGTGGACATCACGGAGCC 65 FBan0008582 FBgn0035772 Sh3beta 3 3L superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" cellular component unknown; GO:0008372 Sh3beta Sh3beta "CG8582, LD12912" CDMC22169 3 19 12 DAC20-C11 3-CG7678-RA_1 CG7678 GCCTGCTGGACCAGTGGAGGAAGTGGACGAGATCGTAGAGAAGATAGAGGTGACAACTGGCAAGGAGAT 69 FBan0007678 FBgn0038613 CG7678 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 CG7678 CG7678 CDMC22169 3 20 12 DAC20-C11 3-CG7678-RA_1 CG7678 GCCTGCTGGACCAGTGGAGGAAGTGGACGAGATCGTAGAGAAGATAGAGGTGACAACTGGCAAGGAGAT 69 FBan0007678 FBgn0038613 CG7678 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 CG7678 CG7678 CDMC22170 3 21 12 DAC20-C23 23-CG7700-RA_1 CG7700 CCAAAGATAGAGCTTGCATTAAACTCCATTACAGACAATTGAATTTTAGTTTGTTTTTTCCGACGGTAT 69 FBan0007700 FBgn0044871 Gos28 3 3R ER to Golgi transport; GO:0006888; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 SNAP receptor activity; GO:0005484; ; GO:0005484; ; GO:0005484 Golgi trans cisterna; GO:0000138; integral to membrane; GO:0016021 Gos28 Gos28 "CG7700, CG7700, GOS28, dgos28" CDMC22170 3 22 12 DAC20-C23 23-CG7700-RA_1 CG7700 CCAAAGATAGAGCTTGCATTAAACTCCATTACAGACAATTGAATTTTAGTTTGTTTTTTCCGACGGTAT 69 FBan0007700 FBgn0044871 Gos28 3 3R ER to Golgi transport; GO:0006888; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 SNAP receptor activity; GO:0005484; ; GO:0005484; ; GO:0005484 Golgi trans cisterna; GO:0000138; integral to membrane; GO:0016021 Gos28 Gos28 "CG7700, CG7700, GOS28, dgos28" CDMC22171 3 23 12 DAC20-G11 2-CG7739-RA_4 CG7739 TACATCGGTCAGGCTGTGTTCATGGACTTCGAGCTAAAGGGCGTGCAGAACATTGTGGTTCCGTTTTGC 69 FBan0007739 FBgn0036509 CG7739 3 3L CG7739 CG7739 CDMC22171 3 24 12 DAC20-G11 2-CG7739-RA_4 CG7739 TACATCGGTCAGGCTGTGTTCATGGACTTCGAGCTAAAGGGCGTGCAGAACATTGTGGTTCCGTTTTGC 69 FBan0007739 FBgn0036509 CG7739 3 3L CG7739 CG7739 CDMC22172 3 25 12 DAC20-G23 2-CG7749-RA_2 CG7749 TGGGACTGTTCCGACTGGGTTCGCAAAAGCCATAATCCCTTGCCAGATATAACCGAAGTTCCTGGAGCA 69 FBan0007749 FBgn0036930 fat2 3 3L calcium-dependent cell-cell adhesion; GO:0016339; foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; homophilic cell adhesion; GO:0007156; negative regulation of imaginal disc growth; GO:0045571; protein amino acid phosphorylation; GO:0006468; salivary gland development; GO:0007431; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112 integral to plasma membrane; GO:0005887 fat2 fat2 "CG7749, CG7749, CG7749, fat-like, CT23445, Cad76E, DCad76E, ftl" CDMC22172 3 26 12 DAC20-G23 2-CG7749-RA_2 CG7749 TGGGACTGTTCCGACTGGGTTCGCAAAAGCCATAATCCCTTGCCAGATATAACCGAAGTTCCTGGAGCA 69 FBan0007749 FBgn0036930 fat2 3 3L calcium-dependent cell-cell adhesion; GO:0016339; foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; homophilic cell adhesion; GO:0007156; negative regulation of imaginal disc growth; GO:0045571; protein amino acid phosphorylation; GO:0006468; salivary gland development; GO:0007431; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112 integral to plasma membrane; GO:0005887 fat2 fat2 "CG7749, CG7749, CG7749, fat-like, CT23445, Cad76E, DCad76E, ftl" CDMC22173 3 1 13 DAC20-K11 14-CG7779-RA_2 CG7779 ACACACACCGAATTGATTTAGCGCACCATGATGCAACCAACTGACCGATCCGACGAGAAACATTTCACA 69 FBan0007779 FBgn0014462 Cng 2 2R cGMP-mediated signaling; GO:0019934; cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception of smell; GO:0007608 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 intracellular cyclic nucleotide activated cation channel complex; GO:0017071 Cng Cyclic-nucleotide-gated ion channel protein "CG7779, DmCNGC, dCNCalpha, CNG, CNG-channel, cng" CDMC22173 3 2 13 DAC20-K11 14-CG7779-RA_2 CG7779 ACACACACCGAATTGATTTAGCGCACCATGATGCAACCAACTGACCGATCCGACGAGAAACATTTCACA 69 FBan0007779 FBgn0014462 Cng 2 2R cGMP-mediated signaling; GO:0019934; cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception of smell; GO:0007608 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 intracellular cyclic nucleotide activated cation channel complex; GO:0017071 Cng Cyclic-nucleotide-gated ion channel protein "CG7779, DmCNGC, dCNCalpha, CNG, CNG-channel, cng" CDMC22174 3 3 13 DAC20-K23 2-CG7791-RA_2 CG7791 TGGATCTGGCAGACGTACTTTGAAGCCAACCCATTCAATCGTCAGGCTGGTGAGAAATATCGGGCCGAA 69 FBan0007791 FBgn0033038 CG7791 2 2R protein processing; GO:0016485; protein targeting to mitochondrion; GO:0006626; proteolysis; GO:0006508 zinc ion binding; GO:0008270; mitochondrial intermediate peptidase activity; GO:0004243 ; EC:3.4.24.59; ; GO:0004243 ; EC:3.4.24.59; ; GO:0004243 ; EC:3.4.24.59; ; GO:0008270 mitochondrion; GO:0005739 CG7791 CG7791 CDMC22174 3 4 13 DAC20-K23 2-CG7791-RA_2 CG7791 TGGATCTGGCAGACGTACTTTGAAGCCAACCCATTCAATCGTCAGGCTGGTGAGAAATATCGGGCCGAA 69 FBan0007791 FBgn0033038 CG7791 2 2R protein processing; GO:0016485; protein targeting to mitochondrion; GO:0006626; proteolysis; GO:0006508 zinc ion binding; GO:0008270; mitochondrial intermediate peptidase activity; GO:0004243 ; EC:3.4.24.59; ; GO:0004243 ; EC:3.4.24.59; ; GO:0004243 ; EC:3.4.24.59; ; GO:0008270 mitochondrion; GO:0005739 CG7791 CG7791 CDMC22175 3 5 13 DAC20-O11 7-CG7826-RA_1 CG7826 CCCACGAAACACACGAAAACTCACTCACCTGCGGTTCTTACTGATTAGTCACTTCGAGCTCTCACCGCC 69 FBan0007826 FBgn0002777 mnb X X brain development; GO:0007420; cell proliferation; GO:0008283; circadian rhythm; GO:0007623; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; learning and/or memory; GO:0007611; nervous system development; GO:0007399; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; visual behavior; GO:0007632 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004712 ; EC:2.7.1.- mnb minibrain "CG7826, CG7826, Mnb, ME-IV, Dyrk1, Minibrain, min" CDMC22175 3 6 13 DAC20-O11 7-CG7826-RA_1 CG7826 CCCACGAAACACACGAAAACTCACTCACCTGCGGTTCTTACTGATTAGTCACTTCGAGCTCTCACCGCC 69 FBan0007826 FBgn0002777 mnb X X brain development; GO:0007420; cell proliferation; GO:0008283; circadian rhythm; GO:0007623; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; learning and/or memory; GO:0007611; nervous system development; GO:0007399; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; visual behavior; GO:0007632 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004712 ; EC:2.7.1.- mnb minibrain "CG7826, CG7826, Mnb, ME-IV, Dyrk1, Minibrain, min" CDMC22176 3 7 13 DAC20-O23 3-CG7833-RA_1 CG7833 CGCCATTCTAGAGGAGAAAGTCGGTCTGACCTGCAACCTTCTCTCCCAGATCTCAACTTTGGTGCACCT 69 FBan0007833 FBgn0015271 Orc5 2 2L DNA replication; GO:0006260; DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342; mitotic chromosome condensation; GO:0007076; mitotic spindle organization and biogenesis; GO:0007052 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664 Orc5 Origin recognition complex subunit 5 "CG7833, l(2)br39, br39, l(2)34Df, DmORC5, ORC, ORC5, BG:DS00941.8, orc5, lethal(2)34Df" CDMC22176 3 8 13 DAC20-O23 3-CG7833-RA_1 CG7833 CGCCATTCTAGAGGAGAAAGTCGGTCTGACCTGCAACCTTCTCTCCCAGATCTCAACTTTGGTGCACCT 69 FBan0007833 FBgn0015271 Orc5 2 2L DNA replication; GO:0006260; DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342; mitotic chromosome condensation; GO:0007076; mitotic spindle organization and biogenesis; GO:0007052 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664 Orc5 Origin recognition complex subunit 5 "CG7833, l(2)br39, br39, l(2)34Df, DmORC5, ORC, ORC5, BG:DS00941.8, orc5, lethal(2)34Df" CDMC22177 3 9 13 DAC21-C11 1-CG2650-RA_1 CG2650 CGGAAAAATGCAGCTAACCGGTGCCTCTATGTTCCTCGTATGGGTGGGTCTACTCAGCTGGGTTTCCTG 69 FBan0002650 FBgn0000092 CG2650 X X circadian rhythm; GO:0007623 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2650 CG2650 "0.9, 0.9kb transcript, 0.9 gene, EG:155E2.1, anon-3B1.2: anonymous 0.9 kb RNA, anonymous 0.9 kb RNA, anon-3B1.2" CDMC22177 3 10 13 DAC21-C11 1-CG2650-RA_1 CG2650 CGGAAAAATGCAGCTAACCGGTGCCTCTATGTTCCTCGTATGGGTGGGTCTACTCAGCTGGGTTTCCTG 69 FBan0002650 FBgn0000092 CG2650 X X circadian rhythm; GO:0007623 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2650 CG2650 "0.9, 0.9kb transcript, 0.9 gene, EG:155E2.1, anon-3B1.2: anonymous 0.9 kb RNA, anonymous 0.9 kb RNA, anon-3B1.2" CDMC22178 3 11 13 DAC21-C23 23-CG2663-RA_1 CG2663 AGAACCCATTGCTAATCTATCGTATATCACCAGTACATTGCAGTAATTACAATAATAAAGAACCAGCGT 69 FBan0002663 FBgn0037323 CG2663 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG2663 CG2663 alpha tocopherol transfer protein CDMC22178 3 12 13 DAC21-C23 23-CG2663-RA_1 CG2663 AGAACCCATTGCTAATCTATCGTATATCACCAGTACATTGCAGTAATTACAATAATAAAGAACCAGCGT 69 FBan0002663 FBgn0037323 CG2663 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG2663 CG2663 alpha tocopherol transfer protein CDMC22179 3 13 13 DAC21-G11 14-CG2702-RA_2 CG2702 TGGGGTTTCGAGCCTTATGCATTCTTTCCGGAGATTGTCGCAAGGATACGGAAACACGTAGCTTCGAAT 69 FBan0002702 FBgn0037540 CG2702 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG2702 CG2702 "anon-WO0118547.359, BEST:LD28511" CDMC22179 3 14 13 DAC21-G11 14-CG2702-RA_2 CG2702 TGGGGTTTCGAGCCTTATGCATTCTTTCCGGAGATTGTCGCAAGGATACGGAAACACGTAGCTTCGAAT 69 FBan0002702 FBgn0037540 CG2702 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG2702 CG2702 "anon-WO0118547.359, BEST:LD28511" CDMC22180 3 15 13 DAC21-G23 22-CG2714-RB_1 CG2714 GCACACTCGTTCCGCACTACTCTAATTGGTTTCTAGCGCGTAAGTTCAATGCAGCATAGTAGCTTAGCT 69 FBan0002714 FBgn0000376 crm X X DNA replication; GO:0006260; regulation of transcription; GO:0045449; segment specification; GO:0007379 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 crm cramped "CG2714, CG2714, CG2714, l(1)3C1, sa, zw9, l(1)zw9, zw-9, ZW-9, swa, swollen-antenna, EG:95B7.2, l(1)3Ca, sta[P]: stubarista from P32, sparse-arista, stubarista from P32" CDMC22180 3 16 13 DAC21-G23 22-CG2714-RB_1 CG2714 GCACACTCGTTCCGCACTACTCTAATTGGTTTCTAGCGCGTAAGTTCAATGCAGCATAGTAGCTTAGCT 69 FBan0002714 FBgn0000376 crm X X DNA replication; GO:0006260; regulation of transcription; GO:0045449; segment specification; GO:0007379 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 crm cramped "CG2714, CG2714, CG2714, l(1)3C1, sa, zw9, l(1)zw9, zw-9, ZW-9, swa, swollen-antenna, EG:95B7.2, l(1)3Ca, sta[P]: stubarista from P32, sparse-arista, stubarista from P32" CDMC22181 3 17 13 DAC21-K11 3-CG2818-RA_2 CG2818 CCAAGGGCCATCGACCTCTGGGAATGATGCGTCTTGGTTATCTTATCGTGAAGCCCTCATCGCTGTGTG 69 FBan0002818 FBgn0031566 CG2818 2 2L CG2818 CG2818 CDMC22181 3 18 13 DAC21-K11 3-CG2818-RA_2 CG2818 CCAAGGGCCATCGACCTCTGGGAATGATGCGTCTTGGTTATCTTATCGTGAAGCCCTCATCGCTGTGTG 69 FBan0002818 FBgn0031566 CG2818 2 2L CG2818 CG2818 CDMC22182 3 19 13 DAC21-K23 14-CG2837-RC_2 CG2837 CCACCTCCTGCTCTTAGCCAGGATACCAATACGCTGAGCAATCCTGATCCTCTCAAGAGCAAATCTGAG 69 FBan0002837 FBgn0031646 CG2837 2 2L CG2837 CG2837 CDMC22182 3 20 13 DAC21-K23 14-CG2837-RC_2 CG2837 CCACCTCCTGCTCTTAGCCAGGATACCAATACGCTGAGCAATCCTGATCCTCTCAAGAGCAAATCTGAG 69 FBan0002837 FBgn0031646 CG2837 2 2L CG2837 CG2837 CDMC22183 3 21 13 DAC21-O11 23-CG2903-RA_3 CG2903 GCGGCTGTTAAGCGAAAAAATGTATGTTTTGTTTAGTTGAACGCGGTTATTAGTTACTATTTCAAAAGT 69 FBan0002903 FBgn0031450 Hrs 2 2L endocytosis; GO:0006897; endosome to lysosome transport; GO:0008333; endosome transport; GO:0016197; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082; torso signaling pathway; GO:0008293; vesicle organization and biogenesis; GO:0016050 protein binding; GO:0005515; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; early endosome; GO:0005769; endosome; GO:0005768; late endosome; GO:0005770; synaptic vesicle; GO:0008021 Hrs Hepatocyte growth factor regulated tyrosine kinase substrate "CG2903, CG2903, l(2)23AB5, l(2)23Ad, hrs, HRS, HRS-2, Hepatocyte growth factor regulated tyrosine kinase substrate" CDMC22183 3 22 13 DAC21-O11 23-CG2903-RA_3 CG2903 GCGGCTGTTAAGCGAAAAAATGTATGTTTTGTTTAGTTGAACGCGGTTATTAGTTACTATTTCAAAAGT 69 FBan0002903 FBgn0031450 Hrs 2 2L endocytosis; GO:0006897; endosome to lysosome transport; GO:0008333; endosome transport; GO:0016197; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082; torso signaling pathway; GO:0008293; vesicle organization and biogenesis; GO:0016050 protein binding; GO:0005515; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; early endosome; GO:0005769; endosome; GO:0005768; late endosome; GO:0005770; synaptic vesicle; GO:0008021 Hrs Hepatocyte growth factor regulated tyrosine kinase substrate "CG2903, CG2903, l(2)23AB5, l(2)23Ad, hrs, HRS, HRS-2, Hepatocyte growth factor regulated tyrosine kinase substrate" CDMC22184 3 23 13 DAC21-O23 AutoBlank AutoBlank CDMC22184 3 24 13 DAC21-O23 AutoBlank AutoBlank CDMC22185 3 25 13 DAC22-C11 3-CG14567-RA_1 CG14567 GATTTGGAGAGCCATCCAGTTCGCAGAGGCCAGCTCTAGTCAATCTACCGTTTGGAGCCTCCCAG 65 FBan0014567 FBgn0037126 CG14567 3 3L CG14567 CG14567 CDMC22185 3 26 13 DAC22-C11 3-CG14567-RA_1 CG14567 GATTTGGAGAGCCATCCAGTTCGCAGAGGCCAGCTCTAGTCAATCTACCGTTTGGAGCCTCCCAG 65 FBan0014567 FBgn0037126 CG14567 3 3L CG14567 CG14567 CDMC22186 3 1 14 DAC22-C23 11-CG14619-RA_1 CG14619 GGTAACACCAGCGTCACCTTTGATCCGTTCTGGGATCTGAGTGTACCGTTGCCGTCTTCGTCCCG 65 FBan0014619 FBgn0031187 CG14619 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG14619 CG14619 CDMC22186 3 2 14 DAC22-C23 11-CG14619-RA_1 CG14619 GGTAACACCAGCGTCACCTTTGATCCGTTCTGGGATCTGAGTGTACCGTTGCCGTCTTCGTCCCG 65 FBan0014619 FBgn0031187 CG14619 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG14619 CG14619 CDMC22187 3 3 14 DAC22-G11 17-CG14678-RA_1 CG14678 CGGATACGGAAATCAAATGGACGCAGAATAATCGGCCCTTCAAACGTGGCTTGTTGTCAACCAGC 65 FBan0014678 FBgn0037394 CG14678 3 3R CG14678 CG14678 CT34460 CDMC22187 3 4 14 DAC22-G11 17-CG14678-RA_1 CG14678 CGGATACGGAAATCAAATGGACGCAGAATAATCGGCCCTTCAAACGTGGCTTGTTGTCAACCAGC 65 FBan0014678 FBgn0037394 CG14678 3 3R CG14678 CG14678 CT34460 CDMC22188 3 5 14 DAC22-G23 2-CG14728-RA_1 CG14728 TACTTCACGCAGATTGTGCACAAGGTGTTTGAGCATAGCTCGCGACTGATGACATTCCCGCCTCG 65 FBan0014728 FBgn0003312 sad 3 3R central nervous system development; GO:0007417; dorsal closure; GO:0007391; ecdysone biosynthesis; GO:0006697; electron transport; GO:0006118; head involution; GO:0008258; midgut development; GO:0007494 electron transporter activity; GO:0005489; ecdysteroid 2-hydroxylase activity; GO:0042768; ; GO:0005489; ; GO:0005489; ; GO:0042768 membrane; GO:0016020; mitochondrion; GO:0005739 sad shadow "CG14728, Cyp315a1, 315a1, CYP315A1, karmoisin ghost, shadow" CDMC22188 3 6 14 DAC22-G23 2-CG14728-RA_1 CG14728 TACTTCACGCAGATTGTGCACAAGGTGTTTGAGCATAGCTCGCGACTGATGACATTCCCGCCTCG 65 FBan0014728 FBgn0003312 sad 3 3R central nervous system development; GO:0007417; dorsal closure; GO:0007391; ecdysone biosynthesis; GO:0006697; electron transport; GO:0006118; head involution; GO:0008258; midgut development; GO:0007494 electron transporter activity; GO:0005489; ecdysteroid 2-hydroxylase activity; GO:0042768; ; GO:0005489; ; GO:0005489; ; GO:0042768 membrane; GO:0016020; mitochondrion; GO:0005739 sad shadow "CG14728, Cyp315a1, 315a1, CYP315A1, karmoisin ghost, shadow" CDMC22189 3 7 14 DAC22-K11 2-CG14797-RA_1 CG14797 CTTCCTGGACCGAGGAAAAGCCCTCAAAGTTGCAGACCCTATTCCAGATCAGCATTACGGCCCTG 65 FBan0014797 FBgn0029587 CG14797 X X CG14797 CG14797 CDMC22189 3 8 14 DAC22-K11 2-CG14797-RA_1 CG14797 CTTCCTGGACCGAGGAAAAGCCCTCAAAGTTGCAGACCCTATTCCAGATCAGCATTACGGCCCTG 65 FBan0014797 FBgn0029587 CG14797 X X CG14797 CG14797 CDMC22190 3 9 14 DAC22-K23 14-CG14814-RB_3 CG14814 CCCCCCAAAATCCACTAAGCAGATTCCAAAACCTAGGAAGCAGAAGGATCTCTCACCCGTTGCGA 65 FBan0014814 FBgn0023515 CG14814 X X CG14814 CG14814 EG:63B12.6 CDMC22190 3 10 14 DAC22-K23 14-CG14814-RB_3 CG14814 CCCCCCAAAATCCACTAAGCAGATTCCAAAACCTAGGAAGCAGAAGGATCTCTCACCCGTTGCGA 65 FBan0014814 FBgn0023515 CG14814 X X CG14814 CG14814 EG:63B12.6 CDMC22191 3 11 14 DAC22-O11 3-CG14928-RA_3 CG14928 AGTCCAGAATCGAACAGCGTCTACGAAGTGGTGTCCCCTTCCGTTCTTTCAACCACGTCCACTGC 65 FBan0014928 FBgn0032362 CG14928 2 2L CG14928 CG14928 CDMC22191 3 12 14 DAC22-O11 3-CG14928-RA_3 CG14928 AGTCCAGAATCGAACAGCGTCTACGAAGTGGTGTCCCCTTCCGTTCTTTCAACCACGTCCACTGC 65 FBan0014928 FBgn0032362 CG14928 2 2L CG14928 CG14928 CDMC22192 3 13 14 DAC22-O23 AutoBlank AutoBlank CDMC22192 3 14 14 DAC22-O23 AutoBlank AutoBlank CDMC22193 3 15 14 DAC23-C11 18-CG6764-RA_5 CG6764 TCCGTCGTAAATTGCGAAAATGCGCATTCAAACGTGCTATTTTTGCTCTAGCAAAATATACCCGGGCCA 69 FBan0006764 FBgn0037899 CG6764 3 3R protein biosynthesis; GO:0006412; ribosome biogenesis and assembly; GO:0042254 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG6764 CG6764 CDMC22193 3 16 14 DAC23-C11 18-CG6764-RA_5 CG6764 TCCGTCGTAAATTGCGAAAATGCGCATTCAAACGTGCTATTTTTGCTCTAGCAAAATATACCCGGGCCA 69 FBan0006764 FBgn0037899 CG6764 3 3R protein biosynthesis; GO:0006412; ribosome biogenesis and assembly; GO:0042254 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG6764 CG6764 CDMC22194 3 17 14 DAC23-C23 24-CG6772-RA_1 CG6772 CGAACCCAAAACCAACAATGAACAACTCACAAAGAATATCTCACAATTCAAATTTACAAAACGAATATC 69 FBan0006772 FBgn0024290 Slob 2 2L protein amino acid phosphorylation; GO:0006468; regulation of synaptic transmission; GO:0050804 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 Slob Slowpoke binding protein "CG6772, slob, giant slob, Slowpoke binding protein" CDMC22194 3 18 14 DAC23-C23 24-CG6772-RA_1 CG6772 CGAACCCAAAACCAACAATGAACAACTCACAAAGAATATCTCACAATTCAAATTTACAAAACGAATATC 69 FBan0006772 FBgn0024290 Slob 2 2L protein amino acid phosphorylation; GO:0006468; regulation of synaptic transmission; GO:0050804 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 Slob Slowpoke binding protein "CG6772, slob, giant slob, Slowpoke binding protein" CDMC22195 3 19 14 DAC23-G11 17-CG6808-RA_1 CG6808 CCGCGTACCTGACAACCCTTTTACTTTTAATTCACTGCTCTGGCATTTGAATCGGCATTTGACGCGAAA 69 FBan0006808 FBgn0037921 CG6808 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6808 CG6808 CG31372 CDMC22195 3 20 14 DAC23-G11 17-CG6808-RA_1 CG6808 CCGCGTACCTGACAACCCTTTTACTTTTAATTCACTGCTCTGGCATTTGAATCGGCATTTGACGCGAAA 69 FBan0006808 FBgn0037921 CG6808 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6808 CG6808 CG31372 CDMC22196 3 21 14 DAC23-G23 2-CG6821-RA_1 CG6821 GCAGCTCCAAGGAGTTCAGCTGGACCGCTGAGGACAGGATTACATACACCGAGCTCTACAAGTACGTGA 69 FBan0006821 FBgn0002564 Lsp1gamma 3 3L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1gamma Larval serum protein 1 gamma "CG6821, CG6821, LSP-1gamma, LSP-1 gamma, Lsp-1gamma, LSP 1, Lsp1-gamma, Lsp1, DmeLSP1g" CDMC22196 3 22 14 DAC23-G23 2-CG6821-RA_1 CG6821 GCAGCTCCAAGGAGTTCAGCTGGACCGCTGAGGACAGGATTACATACACCGAGCTCTACAAGTACGTGA 69 FBan0006821 FBgn0002564 Lsp1gamma 3 3L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1gamma Larval serum protein 1 gamma "CG6821, CG6821, LSP-1gamma, LSP-1 gamma, Lsp-1gamma, LSP 1, Lsp1-gamma, Lsp1, DmeLSP1g" CDMC22197 3 23 14 DAC23-K11 4-CG6860-RA_1 CG6860 TAGCACCACCATTAAATCCCCAGTCAGCTCAACCACCAAACTTGGCACAGTAAAGACGCATCGTTCGGT 69 FBan0006860 FBgn0032633 CG6860 2 2L Ras protein signal transduction; GO:0007265; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.- CG6860 CG6860 CT21229 CDMC22197 3 24 14 DAC23-K11 4-CG6860-RA_1 CG6860 TAGCACCACCATTAAATCCCCAGTCAGCTCAACCACCAAACTTGGCACAGTAAAGACGCATCGTTCGGT 69 FBan0006860 FBgn0032633 CG6860 2 2L Ras protein signal transduction; GO:0007265; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.- CG6860 CG6860 CT21229 CDMC22198 3 25 14 DAC23-K23 16-CG6869-RA_1 CG6869 TCCCATGTTACTAGCCCCAAATGGTTTTGAGAGCACAAAAATCGACCCATCCTTCGCTAATCCATGTGT 69 FBan0006869 FBgn0036485 FucTA 3 3L defense response; GO:0006952; protein amino acid glycosylation; GO:0006486 "alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; glycoprotein 3-alpha-L-fucosyltransferase activity; GO:0018392 ; EC:2.4.1.214; ; GO:0018392 ; EC:2.4.1.214; ; GO:0046920 ; EC:2.4.1.-; ; GO:0018392 ; EC:2.4.1.214" Golgi trans cisterna; GO:0000138; plasma membrane; GO:0005886 FucTA FucTA "CG6869, CG6869, CG6869, alpha1,3-fucosyltransferase, anon-EST:Posey285" CDMC22198 3 26 14 DAC23-K23 16-CG6869-RA_1 CG6869 TCCCATGTTACTAGCCCCAAATGGTTTTGAGAGCACAAAAATCGACCCATCCTTCGCTAATCCATGTGT 69 FBan0006869 FBgn0036485 FucTA 3 3L defense response; GO:0006952; protein amino acid glycosylation; GO:0006486 "alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; glycoprotein 3-alpha-L-fucosyltransferase activity; GO:0018392 ; EC:2.4.1.214; ; GO:0018392 ; EC:2.4.1.214; ; GO:0046920 ; EC:2.4.1.-; ; GO:0018392 ; EC:2.4.1.214" Golgi trans cisterna; GO:0000138; plasma membrane; GO:0005886 FucTA FucTA "CG6869, CG6869, CG6869, alpha1,3-fucosyltransferase, anon-EST:Posey285" CDMC22199 3 1 15 DAC23-O11 6-CG6897-RA_5 CG6897 CGCTTGTCTGGCAGGAGCAAGTCAAGTGGTGGTCCCGACATCTTTAATAGTTCCATGCGCCGGAAACTC 69 FBan0006897 FBgn0036800 CG6897 3 3L CG6897 CG6897 CDMC22199 3 2 15 DAC23-O11 6-CG6897-RA_5 CG6897 CGCTTGTCTGGCAGGAGCAAGTCAAGTGGTGGTCCCGACATCTTTAATAGTTCCATGCGCCGGAAACTC 69 FBan0006897 FBgn0036800 CG6897 3 3L CG6897 CG6897 CDMC22200 3 3 15 DAC23-O23 9-CG6912-RA_3 CG6912 TGTCTCAGCTCCCGGATCAGCAAGCAAGTTAAACAGTATGCTTGTGAAGTCATTCAGATCGGCCCTGGT 69 FBan0006912 FBgn0038290 CG6912 3 3R CG6912 CG6912 "anon-WO0118547.571, anon-WO0140519.208" CDMC22200 3 4 15 DAC23-O23 9-CG6912-RA_3 CG6912 TGTCTCAGCTCCCGGATCAGCAAGCAAGTTAAACAGTATGCTTGTGAAGTCATTCAGATCGGCCCTGGT 69 FBan0006912 FBgn0038290 CG6912 3 3R CG6912 CG6912 "anon-WO0118547.571, anon-WO0140519.208" CDMC22201 3 5 15 DAC24-C11 23-CG2177-RB_6 CG2177 CTGGAACGTGTCAAGGAAAGAAGTATTAACGAGTGCTTCTCTTTCCACTTACCTGCGTTCTACCAAATC 69 FBan0002177 FBgn0039902 CG2177 4 4 CG2177 CG2177 CDMC22201 3 6 15 DAC24-C11 23-CG2177-RB_6 CG2177 CTGGAACGTGTCAAGGAAAGAAGTATTAACGAGTGCTTCTCTTTCCACTTACCTGCGTTCTACCAAATC 69 FBan0002177 FBgn0039902 CG2177 4 4 CG2177 CG2177 CDMC22202 3 7 15 DAC24-C23 11-CG2194-RC_1 CG2194 CGTGACTTCCCCGAGAAGATCGTGATAGCCAGCATTATGTGCAGCTTCAACGAGGAAGACTGGACGGAG 69 FBan0002194 FBgn0016718 Reg-3 X X 'de novo' pyrimidine base biosynthesis; GO:0006207; electron transport; GO:0006118; pyrimidine base metabolism; GO:0006206 dihydropyrimidine dehydrogenase (NADP+) activity; GO:0017113 ; EC:1.3.1.2; ; GO:0017113 ; EC:1.3.1.2; electron transporter activity; GO:0005489; ; GO:0017113 ; EC:1.3.1.2; iron ion binding; GO:0005506; dihydroorotate dehydrogenase activity; GO:0004152 ; EC:1.3.99.11; ; GO:0005489; ; GO:0005506; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; dihydroorotate oxidase activity; GO:0004158 ; EC:1.3.3.1; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004158 ; EC:1.3.3.1 cytoplasm; GO:0005737 Reg-3 Rhythmically expressed gene 3 "CG2194, Dreg-3, Drosophila Rhythmically expressed gene 3, Pyd1" CDMC22202 3 8 15 DAC24-C23 11-CG2194-RC_1 CG2194 CGTGACTTCCCCGAGAAGATCGTGATAGCCAGCATTATGTGCAGCTTCAACGAGGAAGACTGGACGGAG 69 FBan0002194 FBgn0016718 Reg-3 X X 'de novo' pyrimidine base biosynthesis; GO:0006207; electron transport; GO:0006118; pyrimidine base metabolism; GO:0006206 dihydropyrimidine dehydrogenase (NADP+) activity; GO:0017113 ; EC:1.3.1.2; ; GO:0017113 ; EC:1.3.1.2; electron transporter activity; GO:0005489; ; GO:0017113 ; EC:1.3.1.2; iron ion binding; GO:0005506; dihydroorotate dehydrogenase activity; GO:0004152 ; EC:1.3.99.11; ; GO:0005489; ; GO:0005506; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; dihydroorotate oxidase activity; GO:0004158 ; EC:1.3.3.1; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004158 ; EC:1.3.3.1 cytoplasm; GO:0005737 Reg-3 Rhythmically expressed gene 3 "CG2194, Dreg-3, Drosophila Rhythmically expressed gene 3, Pyd1" CDMC22203 3 9 15 DAC24-G11 23-CG2241-RA_2 CG2241 AGGCTTTCATTCATATTATACGCAGAAAATATCAGAGCTTCAGTTCACTGTGAACGAACGCCAAAAGAA 69 FBan0002241 FBgn0039788 CG2241 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" CG2241 CG2241 "DmCG2241, Dm_Rpt6b" CDMC22203 3 10 15 DAC24-G11 23-CG2241-RA_2 CG2241 AGGCTTTCATTCATATTATACGCAGAAAATATCAGAGCTTCAGTTCACTGTGAACGAACGCCAAAAGAA 69 FBan0002241 FBgn0039788 CG2241 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" CG2241 CG2241 "DmCG2241, Dm_Rpt6b" CDMC22204 3 11 15 DAC24-G23 23-CG2252-RB_2 CG2252 TCCGCACATGTTTCCAAAGCTTATTATTTTTAATATTATTGATTGCCTAGGCAAGTTTAGTTCGTAGGT 69 FBan0002252 FBgn0004656 fs(1)h X X MAPKKK cascade; GO:0000165; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003677; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0003682; ; GO:0003697; ; GO:0004672 ; EC:2.7.1.37 fs(1)h female sterile (1) homoeotic "CG2252, fs(1)M16, fs(1)1456, N72, fsh, fst(1)h, rnc, rancor, clone 1.81, l(1)G0495, l(1)G0093, l(1)7Da, anon-EST:Liang-1.81, fs(1)26/26A, fs(1)R10.4, anon-EST:fe1G2, anon-fast-evolving-1G2" CDMC22204 3 12 15 DAC24-G23 23-CG2252-RB_2 CG2252 TCCGCACATGTTTCCAAAGCTTATTATTTTTAATATTATTGATTGCCTAGGCAAGTTTAGTTCGTAGGT 69 FBan0002252 FBgn0004656 fs(1)h X X MAPKKK cascade; GO:0000165; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003677; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0003682; ; GO:0003697; ; GO:0004672 ; EC:2.7.1.37 fs(1)h female sterile (1) homoeotic "CG2252, fs(1)M16, fs(1)1456, N72, fsh, fst(1)h, rnc, rancor, clone 1.81, l(1)G0495, l(1)G0093, l(1)7Da, anon-EST:Liang-1.81, fs(1)26/26A, fs(1)R10.4, anon-EST:fe1G2, anon-fast-evolving-1G2" CDMC22205 3 13 15 DAC24-K11 23-CG2328-RA_8 CG2328 CGCACAGTCAACAACTAACTGCCTTCGTTAATATCCTCTGAATAAGCCAACTTTGAATCACAAGACGCA 69 FBan0002328 FBgn0000606 eve 2 2R "ATP synthesis coupled proton transport; GO:0015986; blastoderm segmentation; GO:0007350; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; central nervous system development; GO:0007417; cephalic furrow formation; GO:0007376; determination of anterior/posterior axis, embryo; GO:0008595; germ-band extension; GO:0007377; heart development; GO:0007507; muscle development; GO:0007517; negative regulation of cardioblast cell fate specification; GO:0009997; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; regulation of axonogenesis; GO:0050770; regulation of transcription, DNA-dependent; GO:0006355; trunk segmentation; GO:0035290" "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 eve even skipped "CG2328, CG2328, CG2328, CG2328, V: transcript group V, VI, l(2)46Ce, Group V, Group VI, lethal(2)46Ce, 20.35, 10.9, 14.10, 10.5, F, Complementation group F, even-skipped, EVE, E(eve), Even Skipped, evenskipped, Even-skipped, l(2)46Cg, l(2)46CFg, l(2)46CFh, l(2)46CFj, l(2)46CFp" CDMC22205 3 14 15 DAC24-K11 23-CG2328-RA_8 CG2328 CGCACAGTCAACAACTAACTGCCTTCGTTAATATCCTCTGAATAAGCCAACTTTGAATCACAAGACGCA 69 FBan0002328 FBgn0000606 eve 2 2R "ATP synthesis coupled proton transport; GO:0015986; blastoderm segmentation; GO:0007350; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; central nervous system development; GO:0007417; cephalic furrow formation; GO:0007376; determination of anterior/posterior axis, embryo; GO:0008595; germ-band extension; GO:0007377; heart development; GO:0007507; muscle development; GO:0007517; negative regulation of cardioblast cell fate specification; GO:0009997; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; regulation of axonogenesis; GO:0050770; regulation of transcription, DNA-dependent; GO:0006355; trunk segmentation; GO:0035290" "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 eve even skipped "CG2328, CG2328, CG2328, CG2328, V: transcript group V, VI, l(2)46Ce, Group V, Group VI, lethal(2)46Ce, 20.35, 10.9, 14.10, 10.5, F, Complementation group F, even-skipped, EVE, E(eve), Even Skipped, evenskipped, Even-skipped, l(2)46Cg, l(2)46CFg, l(2)46CFh, l(2)46CFj, l(2)46CFp" CDMC22206 3 15 15 DAC24-K23 18-CG2358-RA_4 CG2358 GGCAACTCGGCCTAAACATACGTGTCGGAAATTTTCTGTCTTCGTGGACGAAGCCGAGAAGTTTTGTTA 69 FBan0002358 FBgn0026567 CG2358 3 3R proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0009003 signal peptidase complex; GO:0005787 CG2358 CG2358 "SPC 21-kDa-like, AF160889, BG:DS00004.11, BcDNA:GM04682" CDMC22206 3 16 15 DAC24-K23 18-CG2358-RA_4 CG2358 GGCAACTCGGCCTAAACATACGTGTCGGAAATTTTCTGTCTTCGTGGACGAAGCCGAGAAGTTTTGTTA 69 FBan0002358 FBgn0026567 CG2358 3 3R proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0009003 signal peptidase complex; GO:0005787 CG2358 CG2358 "SPC 21-kDa-like, AF160889, BG:DS00004.11, BcDNA:GM04682" CDMC22207 3 17 15 DAC24-O11 3-CG2505-RA_4 CG2505 TGCGGCGACTAAAGCAACTCTACTTCAACAACGAGATGCAGGAATCGATGGAGATGTTCGAGGCCCTGA 69 FBan0002505 FBgn0015570 alpha-Est2 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est2 alpha-Esterase-2 "CG2505, alphaE2, B, fragment B, aE2" CDMC22207 3 18 15 DAC24-O11 3-CG2505-RA_4 CG2505 TGCGGCGACTAAAGCAACTCTACTTCAACAACGAGATGCAGGAATCGATGGAGATGTTCGAGGCCCTGA 69 FBan0002505 FBgn0015570 alpha-Est2 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est2 alpha-Esterase-2 "CG2505, alphaE2, B, fragment B, aE2" CDMC22208 3 19 15 DAC24-O23 AutoBlank AutoBlank CDMC22208 3 20 15 DAC24-O23 AutoBlank AutoBlank CDMC22209 3 21 15 DAC25-C11 2-CG10110-RA_2 CG10110 CCAGAAACCTGGGAAATTGTGCCAGATGCATCAATTACCTTTGAGCCCTGGGAACACGTCACCGC 65 FBan0010110 FBgn0024698 cpsf 2 2R mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 cpsf cleavage and polyadenylation specificity factor "CG10110, CG10110, CG10110, CPSF, dCPSF-160, Drosophila cleavage and polyadenylation stimulation factor-160, Cpsf, anon-WO0118547.217, cleavage and polyadenylation specificity factor" CDMC22209 3 22 15 DAC25-C11 2-CG10110-RA_2 CG10110 CCAGAAACCTGGGAAATTGTGCCAGATGCATCAATTACCTTTGAGCCCTGGGAACACGTCACCGC 65 FBan0010110 FBgn0024698 cpsf 2 2R mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 cpsf cleavage and polyadenylation specificity factor "CG10110, CG10110, CG10110, CPSF, dCPSF-160, Drosophila cleavage and polyadenylation stimulation factor-160, Cpsf, anon-WO0118547.217, cleavage and polyadenylation specificity factor" CDMC22210 3 23 15 DAC25-C23 2-CG10154-RA_1 CG10154 CAAGTGTGCACCTACATGGAGGAGGTACAGTGTCTGCCCACCTGTGAGTCGTTCCGATTGAGCAG 65 FBan0010154 FBgn0036361 CG10154 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG10154 CG10154 CDMC22210 3 24 15 DAC25-C23 2-CG10154-RA_1 CG10154 CAAGTGTGCACCTACATGGAGGAGGTACAGTGTCTGCCCACCTGTGAGTCGTTCCGATTGAGCAG 65 FBan0010154 FBgn0036361 CG10154 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG10154 CG10154 CDMC22211 3 25 15 DAC25-G11 23-CG10263-RD_1 CG10263 AGTGAACAAGTGTATGTTAAGCTGAACTGAACACTATTAAAGATATTTTACGGGGTTAGGCCAAC 65 FBan0010263 FBgn0032812 CG10263 2 2L CG10263 CG10263 CDMC22211 3 26 15 DAC25-G11 23-CG10263-RD_1 CG10263 AGTGAACAAGTGTATGTTAAGCTGAACTGAACACTATTAAAGATATTTTACGGGGTTAGGCCAAC 65 FBan0010263 FBgn0032812 CG10263 2 2L CG10263 CG10263 CDMC22212 3 1 16 DAC25-G23 23-CG10297-RA_1 CG10297 AGTGTCGTGCATTGTTTTCTATTTTCCTTGTTACTCGCATTAAAGCCGAACTTTCGATTCTCGAA 65 FBan0010297 FBgn0020765 Acp65Aa 3 3L nucleic acid binding; GO:0003676; structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0003676; ; GO:0008012 Acp65Aa Acp65Aa "CG10297, Acp65A, DMACP65A, BcDNA:RH61147, DCP5" CDMC22212 3 2 16 DAC25-G23 23-CG10297-RA_1 CG10297 AGTGTCGTGCATTGTTTTCTATTTTCCTTGTTACTCGCATTAAAGCCGAACTTTCGATTCTCGAA 65 FBan0010297 FBgn0020765 Acp65Aa 3 3L nucleic acid binding; GO:0003676; structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0003676; ; GO:0008012 Acp65Aa Acp65Aa "CG10297, Acp65A, DMACP65A, BcDNA:RH61147, DCP5" CDMC22213 3 3 16 DAC25-K11 2-CG10387-RA_1 CG10387 CTAGGCAACTTGAACCCCTTCTCTATGAAGCGACTGGACTCTTGGACACCGGAAAAGGCATGGCC 65 FBan0010387 FBgn0015553 tos 2 2L DNA repair; GO:0006281 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0003676; exodeoxyribonuclease I activity; GO:0008852 ; EC:3.1.11.1; ; GO:0004518 ; EC:3.1.-.-; ; GO:0008852 ; EC:3.1.11.1; ; GO:0003677 tos tosca "CG10387, Tosca, DmTosca, tosca" CDMC22213 3 4 16 DAC25-K11 2-CG10387-RA_1 CG10387 CTAGGCAACTTGAACCCCTTCTCTATGAAGCGACTGGACTCTTGGACACCGGAAAAGGCATGGCC 65 FBan0010387 FBgn0015553 tos 2 2L DNA repair; GO:0006281 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0003676; exodeoxyribonuclease I activity; GO:0008852 ; EC:3.1.11.1; ; GO:0004518 ; EC:3.1.-.-; ; GO:0008852 ; EC:3.1.11.1; ; GO:0003677 tos tosca "CG10387, Tosca, DmTosca, tosca" CDMC22214 3 5 16 DAC25-K23 23-CG10436-RA_4 CG10436 AAAGATGGCTGTGATACCGCTTATGAAACCGTCAAGTGCTACATTGCTGTAAACGGAAAATTCAT 65 FBan0010436 FBgn0011279 Pbprp1 3 3L response to pheromone; GO:0019236; sensory perception; GO:0007600; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; ; GO:0008145; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Pbprp1 Pheromone-binding protein-related protein 1 "CG10436, pbprp-1, PB-PRP1, pbprp1, 69a, PBP1, PBPRP-1, Obp69a" CDMC22214 3 6 16 DAC25-K23 23-CG10436-RA_4 CG10436 AAAGATGGCTGTGATACCGCTTATGAAACCGTCAAGTGCTACATTGCTGTAAACGGAAAATTCAT 65 FBan0010436 FBgn0011279 Pbprp1 3 3L response to pheromone; GO:0019236; sensory perception; GO:0007600; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; ; GO:0008145; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Pbprp1 Pheromone-binding protein-related protein 1 "CG10436, pbprp-1, PB-PRP1, pbprp1, 69a, PBP1, PBPRP-1, Obp69a" CDMC22215 3 7 16 DAC25-O11 2-CG10566-RA_1 CG10566 AAATCGCAGACCACCAACAATCCCTGGCTGGATCTTTTCGCCGACTTGGATCCCTTAGCCAATCC 65 FBan0010566 FBgn0037050 CG10566 3 3L CG10566 CG10566 Dm ric-19 CDMC22215 3 8 16 DAC25-O11 2-CG10566-RA_1 CG10566 AAATCGCAGACCACCAACAATCCCTGGCTGGATCTTTTCGCCGACTTGGATCCCTTAGCCAATCC 65 FBan0010566 FBgn0037050 CG10566 3 3L CG10566 CG10566 Dm ric-19 CDMC22216 3 9 16 DAC25-O23 AutoBlank AutoBlank CDMC22216 3 10 16 DAC25-O23 AutoBlank AutoBlank CDMC22217 3 11 16 DAC26-C11 3-CG6192-RA_1 CG6192 TCCGCACTCCGTATCTCACCCTCACCCTAGTGATTAATGAAACTGCCACAAAGTGGTCCAATCCCAGGT 69 FBan0006192 FBgn0032341 CG6192 2 2L cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 calcium ion binding; GO:0005509; ; GO:0005509 CG6192 CG6192 CDMC22217 3 12 16 DAC26-C11 3-CG6192-RA_1 CG6192 TCCGCACTCCGTATCTCACCCTCACCCTAGTGATTAATGAAACTGCCACAAAGTGGTCCAATCCCAGGT 69 FBan0006192 FBgn0032341 CG6192 2 2L cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 calcium ion binding; GO:0005509; ; GO:0005509 CG6192 CG6192 CDMC22218 3 13 16 DAC26-C23 23-CG6203-RB_1 CG6203 CTCCCCTAAATATGGACATCATGTGGGGTCAAGAATACGAAAATTTGTACAGCAAGTTTATTAGTTATT 69 FBan0006203 FBgn0028734 Fmr1 3 3R "NOT chemotaxis; GO:0006935; NOT phototaxis; GO:0042331; NOT synaptic transmission; GO:0007268; axon guidance; GO:0007411; circadian rhythm; GO:0007623; induction of apoptosis; GO:0006917; larval locomotory behavior; GO:0008345; locomotion; GO:0040011; locomotor rhythm; GO:0045475; male courtship behavior (sensu Insecta); GO:0016542; negative regulation of dendrite morphogenesis; GO:0050774; negative regulation of translation; GO:0016478; neurotransmitter secretion; GO:0007269; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of dendrite morphogenesis; GO:0050773; regulation of synapse structure; GO:0050807; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of translation; GO:0006445; sperm axoneme assembly; GO:0007288; synaptogenesis; GO:0007416" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0003729 RNA-induced silencing complex; GO:0016442; cytoplasm; GO:0005737; micro-ribonucleoprotein complex; GO:0035068 Fmr1 Fmr1 "CG6203, CG6203, FXR, Fragile X related, Fragile-X-related, cg6203, dFMR1, dfmr1, dFXR, FMR1, dfxr, dFmr1, fragile X, AT24755, EP(3)3517, dmfr1, dFXR1, dFMRP, FMRP, dfxr1, fmr, Fragile X-related, dfmr, FMRp, Fragile X, dFMR, Fmrp, BcDNA:GM08679" CDMC22218 3 14 16 DAC26-C23 23-CG6203-RB_1 CG6203 CTCCCCTAAATATGGACATCATGTGGGGTCAAGAATACGAAAATTTGTACAGCAAGTTTATTAGTTATT 69 FBan0006203 FBgn0028734 Fmr1 3 3R "NOT chemotaxis; GO:0006935; NOT phototaxis; GO:0042331; NOT synaptic transmission; GO:0007268; axon guidance; GO:0007411; circadian rhythm; GO:0007623; induction of apoptosis; GO:0006917; larval locomotory behavior; GO:0008345; locomotion; GO:0040011; locomotor rhythm; GO:0045475; male courtship behavior (sensu Insecta); GO:0016542; negative regulation of dendrite morphogenesis; GO:0050774; negative regulation of translation; GO:0016478; neurotransmitter secretion; GO:0007269; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of dendrite morphogenesis; GO:0050773; regulation of synapse structure; GO:0050807; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of translation; GO:0006445; sperm axoneme assembly; GO:0007288; synaptogenesis; GO:0007416" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0003729 RNA-induced silencing complex; GO:0016442; cytoplasm; GO:0005737; micro-ribonucleoprotein complex; GO:0035068 Fmr1 Fmr1 "CG6203, CG6203, FXR, Fragile X related, Fragile-X-related, cg6203, dFMR1, dfmr1, dFXR, FMR1, dfxr, dFmr1, fragile X, AT24755, EP(3)3517, dmfr1, dFXR1, dFMRP, FMRP, dfxr1, fmr, Fragile X-related, dfmr, FMRp, Fragile X, dFMR, Fmrp, BcDNA:GM08679" CDMC22219 3 15 16 DAC26-G11 15-CG6231-RA_1 CG6231 GCCACCCCGTCCTAGTAGTTCGTAGTTTAGCTAACCAATTTCGCCTAGATCCTAAGAGCCCAGACCGTA 69 FBan0006231 FBgn0038720 CG6231 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6231 CG6231 CDMC22219 3 16 16 DAC26-G11 15-CG6231-RA_1 CG6231 GCCACCCCGTCCTAGTAGTTCGTAGTTTAGCTAACCAATTTCGCCTAGATCCTAAGAGCCCAGACCGTA 69 FBan0006231 FBgn0038720 CG6231 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6231 CG6231 CDMC22220 3 17 16 DAC26-G23 23-CG6244-RA_4 CG6244 TGCCCATTCTTTTCGATTGTCCATTCTGCAATCACAAGCAGTCATGTGAAGCGAAACTAGATAAGGCGA 69 FBan0006244 FBgn0036531 CG6244 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6244 CG6244 CDMC22220 3 18 16 DAC26-G23 23-CG6244-RA_4 CG6244 TGCCCATTCTTTTCGATTGTCCATTCTGCAATCACAAGCAGTCATGTGAAGCGAAACTAGATAAGGCGA 69 FBan0006244 FBgn0036531 CG6244 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6244 CG6244 CDMC22221 3 19 16 DAC26-K11 16-CG6297-RB_1 CG6297 GGCCCGCATTTGGTCAGTTTTTAAGAGCACCCCACTTAAACCCTCCGCTGACATAAACTTTTAAACCCT 69 FBan0006297 FBgn0020412 JIL-1 3 3L MAPKKK cascade; GO:0000165; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; histone phosphorylation; GO:0016572; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; histone serine kinase activity (H3-S10 specific); GO:0035175; ; GO:0035175 colocalizes_with nuclear chromatin; GO:0000790 JIL-1 JIL-1 "CG6297, CG6297, CG6297, CG6297, CG6297, Su-var(3)1, Su-var(3)103, 2Ab17, Su(var)3-103, Su(var)3-1, Jil-1, MSK, JIL1, JIL, Jil1, anon-WO0118547.379, Suppressor of variegation 3-1" CDMC22221 3 20 16 DAC26-K11 16-CG6297-RB_1 CG6297 GGCCCGCATTTGGTCAGTTTTTAAGAGCACCCCACTTAAACCCTCCGCTGACATAAACTTTTAAACCCT 69 FBan0006297 FBgn0020412 JIL-1 3 3L MAPKKK cascade; GO:0000165; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; histone phosphorylation; GO:0016572; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; histone serine kinase activity (H3-S10 specific); GO:0035175; ; GO:0035175 colocalizes_with nuclear chromatin; GO:0000790 JIL-1 JIL-1 "CG6297, CG6297, CG6297, CG6297, CG6297, Su-var(3)1, Su-var(3)103, 2Ab17, Su(var)3-103, Su(var)3-1, Jil-1, MSK, JIL1, JIL, Jil1, anon-WO0118547.379, Suppressor of variegation 3-1" CDMC22222 3 21 16 DAC26-K23 23-CG6305-RA_11 CG6305 CGGTTGTCTAGGAAATCAATCTAGCCGAACCTAAAAAGATAAAACCACCTCCTCTTTAACTGAGGCCCC 69 FBan0006305 FBgn0033869 CG6305 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG6305 CG6305 CDMC22222 3 22 16 DAC26-K23 23-CG6305-RA_11 CG6305 CGGTTGTCTAGGAAATCAATCTAGCCGAACCTAAAAAGATAAAACCACCTCCTCTTTAACTGAGGCCCC 69 FBan0006305 FBgn0033869 CG6305 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG6305 CG6305 CDMC22223 3 23 16 DAC26-O11 14-CG6352-RA_2 CG6352 GGATGCCCCAAATCCGGAAATTAGTCCCAATTCCGTAACCAATTCGTCCTCCGTGTATATGATCCGCCA 69 FBan0006352 FBgn0026058 OdsH X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 OdsH Ods-site homeobox "CG6352, OdsH[mel], Ods-site homeobox" CDMC22223 3 24 16 DAC26-O11 14-CG6352-RA_2 CG6352 GGATGCCCCAAATCCGGAAATTAGTCCCAATTCCGTAACCAATTCGTCCTCCGTGTATATGATCCGCCA 69 FBan0006352 FBgn0026058 OdsH X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 OdsH Ods-site homeobox "CG6352, OdsH[mel], Ods-site homeobox" CDMC22224 3 25 16 DAC26-O23 1-CG6369-RA_1 CG6369 AGCAGCCGTTGGAATCAAGCTTCACTGTCGAGCACCTAAACGCAGCGATGAAGAACGCATTGGAAAACT 69 FBan0006369 FBgn0039260 Smg6 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg6 Smg6 "CG6369, SMG6" CDMC22224 3 26 16 DAC26-O23 1-CG6369-RA_1 CG6369 AGCAGCCGTTGGAATCAAGCTTCACTGTCGAGCACCTAAACGCAGCGATGAAGAACGCATTGGAAAACT 69 FBan0006369 FBgn0039260 Smg6 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg6 Smg6 "CG6369, SMG6" CDMC22225 3 1 17 DAC27-C11 14-CG3711-RA_3 CG3711 TGGCCTTGCCAACAATCGGCTTCACGCATTCTGCAAATACTCTCTTGAGCACAACATTACGTTCGAGAA 69 FBan0003711 FBgn0040344 CG3711 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG3711 CG3711 EG:BACR7A4.19 CDMC22225 3 2 17 DAC27-C11 14-CG3711-RA_3 CG3711 TGGCCTTGCCAACAATCGGCTTCACGCATTCTGCAAATACTCTCTTGAGCACAACATTACGTTCGAGAA 69 FBan0003711 FBgn0040344 CG3711 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG3711 CG3711 EG:BACR7A4.19 CDMC22226 3 3 17 DAC27-C23 18-CG3725-RH_1 CG3725 ACGATTCCACCAAGCGAGCGTCCTAATGTTTCAAGAGTATCGTCCTATCCCTGGGCTTGTTTAACGTAA 69 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC22226 3 4 17 DAC27-C23 18-CG3725-RH_1 CG3725 ACGATTCCACCAAGCGAGCGTCCTAATGTTTCAAGAGTATCGTCCTATCCCTGGGCTTGTTTAACGTAA 69 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC22227 3 5 17 DAC27-G11 23-CG3760-RB_3 CG3760 ACATGCAGATTTTCTAGGCTTTTTGATTCATATAAACCACCACTGCTACTCTTACCCTAAACCACAAAC 69 FBan0003760 FBgn0022343 CG3760 2 2R CG3760 CG3760 "anon-fe2C9, anon2C9, anon-EST:fe2C9: anon-fast-evolving-2C9, anon-fast-evolving-2C9" CDMC22227 3 6 17 DAC27-G11 23-CG3760-RB_3 CG3760 ACATGCAGATTTTCTAGGCTTTTTGATTCATATAAACCACCACTGCTACTCTTACCCTAAACCACAAAC 69 FBan0003760 FBgn0022343 CG3760 2 2R CG3760 CG3760 "anon-fe2C9, anon2C9, anon-EST:fe2C9: anon-fast-evolving-2C9, anon-fast-evolving-2C9" CDMC22228 3 7 17 DAC27-G23 14-CG3772-RA_3 CG3772 CCGTTCTCTATGTCGGGAGCTGAATATCGACTTTGTCGAGAAGGTATCACACACGCTTTGGGATCCGCA 69 FBan0003772 FBgn0025680 cry 3 3R "DNA repair; GO:0006281; G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; circadian rhythm; GO:0007623; entrainment of circadian clock; GO:0009649; gravitactic behavior; GO:0048062; response to blue light; GO:0009637; response to light stimulus; GO:0009416" nucleic acid binding; GO:0003676; protein binding; GO:0005515; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; photoreceptor activity; GO:0009881; ; GO:0003676; ; GO:0005515; ; GO:0008020; DNA photolyase activity; GO:0003913 ; EC:4.1.99.-; ; GO:0009881; ; GO:0003913 ; EC:4.1.99.- cytoplasm; GO:0005737; nuclear membrane lumen; GO:0005641; nucleus; GO:0005634 cry cryptochrome "CG3772, cryb, Cry, Dm-CRY1, crybaby, DCry, dcry, dCRY, CRY, cryptochrome, DmCRY1, dCry, anon-WO0140519.17, anon-WO0140519.19, anon-WO0140519.20, anon-WO0172774.15, Blue-light receptor" CDMC22228 3 8 17 DAC27-G23 14-CG3772-RA_3 CG3772 CCGTTCTCTATGTCGGGAGCTGAATATCGACTTTGTCGAGAAGGTATCACACACGCTTTGGGATCCGCA 69 FBan0003772 FBgn0025680 cry 3 3R "DNA repair; GO:0006281; G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; circadian rhythm; GO:0007623; entrainment of circadian clock; GO:0009649; gravitactic behavior; GO:0048062; response to blue light; GO:0009637; response to light stimulus; GO:0009416" nucleic acid binding; GO:0003676; protein binding; GO:0005515; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; photoreceptor activity; GO:0009881; ; GO:0003676; ; GO:0005515; ; GO:0008020; DNA photolyase activity; GO:0003913 ; EC:4.1.99.-; ; GO:0009881; ; GO:0003913 ; EC:4.1.99.- cytoplasm; GO:0005737; nuclear membrane lumen; GO:0005641; nucleus; GO:0005634 cry cryptochrome "CG3772, cryb, Cry, Dm-CRY1, crybaby, DCry, dcry, dCRY, CRY, cryptochrome, DmCRY1, dCry, anon-WO0140519.17, anon-WO0140519.19, anon-WO0140519.20, anon-WO0172774.15, Blue-light receptor" CDMC22229 3 9 17 DAC27-K11 3-CG3817-RA_1 CG3817 GCGGGAAGCGCGCCAAATCCACACCCGTAGATAACGCTGTAAAGAAAGAGGAACAAGAAACGGATGACG 69 FBan0003817 FBgn0038275 CG3817 3 3R CG3817 CG3817 CDMC22229 3 10 17 DAC27-K11 3-CG3817-RA_1 CG3817 GCGGGAAGCGCGCCAAATCCACACCCGTAGATAACGCTGTAAAGAAAGAGGAACAAGAAACGGATGACG 69 FBan0003817 FBgn0038275 CG3817 3 3R CG3817 CG3817 CDMC22230 3 11 17 DAC27-K23 13-CG3831-RA_1 CG3831 ACCAGATACGGGTTCGTCCATTTGTTTACCACAATACCTCAGCGGAAGATCTCAACTCGACGTTGCTGT 69 FBan0003831 FBgn0034804 CG3831 2 2R CG3831 CG3831 CDMC22230 3 12 17 DAC27-K23 13-CG3831-RA_1 CG3831 ACCAGATACGGGTTCGTCCATTTGTTTACCACAATACCTCAGCGGAAGATCTCAACTCGACGTTGCTGT 69 FBan0003831 FBgn0034804 CG3831 2 2R CG3831 CG3831 CDMC22231 3 13 17 DAC27-O11 6-CG3868-RA_5 CG3868 GCCACGCACACCTACTAGGCACTTTGTGGCCTACGAGATCCATTCTACCCATAATCTCCCCCAGATGGA 69 FBan0003868 FBgn0036422 CG3868 3 3L CG3868 CG3868 CDMC22231 3 14 17 DAC27-O11 6-CG3868-RA_5 CG3868 GCCACGCACACCTACTAGGCACTTTGTGGCCTACGAGATCCATTCTACCCATAATCTCCCCCAGATGGA 69 FBan0003868 FBgn0036422 CG3868 3 3L CG3868 CG3868 CDMC22232 3 15 17 DAC27-O23 3-CG3881-RA_1 CG3881 CCGGTTTTGCAGTGAATTTGGAGTACATGGCGCAGTATCCCTATGTGAATATGCCGTACAAGCCCGGCT 69 FBan0003881 FBgn0032135 GlcAT-S 2 2L glycoprotein biosynthesis; GO:0009101; glycosphingolipid biosynthesis; GO:0006688; proteoglycan biosynthesis; GO:0030166 "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; GO:0015018 ; EC:2.4.1.135; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity; GO:0046987; asioloorosomucoid beta-1,3-glucuronosyltransferase activity; GO:0046988; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity; GO:0046989; ; GO:0015018 ; EC:2.4.1.135; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0046987; ; GO:0046988; ; GO:0046989; ; GO:0015018 ; EC:2.4.1.135" membrane; GO:0016020 GlcAT-S GlcAT-S "CG3881, CG3881, DGlcAT-S, DmGlcAT-BSI" CDMC22232 3 16 17 DAC27-O23 3-CG3881-RA_1 CG3881 CCGGTTTTGCAGTGAATTTGGAGTACATGGCGCAGTATCCCTATGTGAATATGCCGTACAAGCCCGGCT 69 FBan0003881 FBgn0032135 GlcAT-S 2 2L glycoprotein biosynthesis; GO:0009101; glycosphingolipid biosynthesis; GO:0006688; proteoglycan biosynthesis; GO:0030166 "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; GO:0015018 ; EC:2.4.1.135; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity; GO:0046987; asioloorosomucoid beta-1,3-glucuronosyltransferase activity; GO:0046988; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity; GO:0046989; ; GO:0015018 ; EC:2.4.1.135; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0046987; ; GO:0046988; ; GO:0046989; ; GO:0015018 ; EC:2.4.1.135" membrane; GO:0016020 GlcAT-S GlcAT-S "CG3881, CG3881, DGlcAT-S, DmGlcAT-BSI" CDMC22233 3 17 17 DAC28-C11 23-CG10200-RB_2 CG10200 ATTCCAACGGCGTTCTCAATATCAAGAAGACCGAATCCACTTACTCATCCAAATAGAACATAGGTTTTT 69 FBan0010200 FBgn0033968 CG10200 2 2R CG10200 CG10200 CDMC22233 3 18 17 DAC28-C11 23-CG10200-RB_2 CG10200 ATTCCAACGGCGTTCTCAATATCAAGAAGACCGAATCCACTTACTCATCCAAATAGAACATAGGTTTTT 69 FBan0010200 FBgn0033968 CG10200 2 2R CG10200 CG10200 CDMC22234 3 19 17 DAC28-C23 12-CG10210-RA_1 CG10210 GCGTCGGCTGCTATCAAGCGCGATATTGTTTTCACCGCATCCTTGTACACAGAACTGTGATCGAAGGAG 69 FBan0010210 FBgn0039117 tst 3 3R "RNA localization; GO:0006403; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ; GO:0004386 nucleus; GO:0005634 tst twister "CG10210, cg10210, SKI2, Ski2, twister" CDMC22234 3 20 17 DAC28-C23 12-CG10210-RA_1 CG10210 GCGTCGGCTGCTATCAAGCGCGATATTGTTTTCACCGCATCCTTGTACACAGAACTGTGATCGAAGGAG 69 FBan0010210 FBgn0039117 tst 3 3R "RNA localization; GO:0006403; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ; GO:0004386 nucleus; GO:0005634 tst twister "CG10210, cg10210, SKI2, Ski2, twister" CDMC22235 3 21 17 DAC28-G11 2-CG10243-RA_4 CG10243 GCGTGGTCGATGAAAAGATCTCCAGTTCTTCGCAGACCCTGGAAGTCACCGACATTGTGTCACGCTTCA 69 FBan0010243 FBgn0033979 Cyp6a19 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a19 Cyp6a19 "CG10243, CG10243, 6a19" CDMC22235 3 22 17 DAC28-G11 2-CG10243-RA_4 CG10243 GCGTGGTCGATGAAAAGATCTCCAGTTCTTCGCAGACCCTGGAAGTCACCGACATTGTGTCACGCTTCA 69 FBan0010243 FBgn0033979 Cyp6a19 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a19 Cyp6a19 "CG10243, CG10243, 6a19" CDMC22236 3 23 17 DAC28-G23 15-CG1024-RA_12 CG1024 GCACTAGCGGCTCCTGTAAACGAACCTAAGCCCATTTCAAATGTCAGCGAGCTGAATCTAGATCGGTGT 69 FBan0001024 FBgn0027514 CG1024 3 3R CG1024 CG1024 BcDNA:LD21969 CDMC22236 3 24 17 DAC28-G23 15-CG1024-RA_12 CG1024 GCACTAGCGGCTCCTGTAAACGAACCTAAGCCCATTTCAAATGTCAGCGAGCTGAATCTAGATCGGTGT 69 FBan0001024 FBgn0027514 CG1024 3 3R CG1024 CG1024 BcDNA:LD21969 CDMC22237 3 25 17 DAC28-K11 23-CG1028-RI_4 CG1028 GTTGAACTTCGCGTGAACAAACCTAAACTAAACTAAACAAAGAGCAGAGCTGAGAACTCTACCTACAAC 69 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC22237 3 26 17 DAC28-K11 23-CG1028-RI_4 CG1028 GTTGAACTTCGCGTGAACAAACCTAAACTAAACTAAACAAAGAGCAGAGCTGAGAACTCTACCTACAAC 69 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC22238 3 1 18 DAC28-K23 2-CG10300-RA_1 CG10300 ACGATCCCTTCCTGCTGAAGAAGGCATTTGCTCTGGTGGACCAATGCATACCACTGCGATTTGTTGAGA 69 FBan0010300 FBgn0039107 CG10300 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10300 CG10300 CDMC22238 3 2 18 DAC28-K23 2-CG10300-RA_1 CG10300 ACGATCCCTTCCTGCTGAAGAAGGCATTTGCTCTGGTGGACCAATGCATACCACTGCGATTTGTTGAGA 69 FBan0010300 FBgn0039107 CG10300 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10300 CG10300 CDMC22239 3 3 18 DAC28-O11 9-CG10336-RB_2 CG10336 GGCATCCCTGTTCGGAGATGATGGTGTGGATGACCTATTCAATGACAACATTCCGACTGACCCGGATCA 69 FBan0010336 FBgn0032698 CG10336 2 2L CG10336 CG10336 CDMC22239 3 4 18 DAC28-O11 9-CG10336-RB_2 CG10336 GGCATCCCTGTTCGGAGATGATGGTGTGGATGACCTATTCAATGACAACATTCCGACTGACCCGGATCA 69 FBan0010336 FBgn0032698 CG10336 2 2L CG10336 CG10336 CDMC22240 3 5 18 DAC28-O23 AutoBlank AutoBlank CDMC22240 3 6 18 DAC28-O23 AutoBlank AutoBlank CDMC22241 3 7 18 DAC29-C11 14-CG13917-RA_1 CG13917 CGAGTCGCTCTCGGGTAGCTCGAAACTGGCTAGAATTCAGCAGATTAATGGCCATTCAAAAGGAGCTGC 69 FBan0013917 FBgn0035237 CG13917 3 3L CG13917 CG13917 CDMC22241 3 8 18 DAC29-C11 14-CG13917-RA_1 CG13917 CGAGTCGCTCTCGGGTAGCTCGAAACTGGCTAGAATTCAGCAGATTAATGGCCATTCAAAAGGAGCTGC 69 FBan0013917 FBgn0035237 CG13917 3 3L CG13917 CG13917 CDMC22242 3 9 18 DAC29-C23 8-CG13936-RA_1 CG13936 TGCCAGGACATCCCCTCAAGGATCACAACACCAAGAAGAACGTTCAGTATATGTCGCCTTGCCACTTCA 69 FBan0013936 FBgn0035282 CG13936 3 3L CG13936 CG13936 CDMC22242 3 10 18 DAC29-C23 8-CG13936-RA_1 CG13936 TGCCAGGACATCCCCTCAAGGATCACAACACCAAGAAGAACGTTCAGTATATGTCGCCTTGCCACTTCA 69 FBan0013936 FBgn0035282 CG13936 3 3L CG13936 CG13936 CDMC22243 3 11 18 DAC29-G11 17-CG13981-RA_1 CG13981 TGCGTCCGGCAAATCGAGCATTAAATACCTATCGAATCTGAACGAGATCGACAAGTCGAAGCAGAAGCT 69 FBan0013981 FBgn0031807 CG13981 2 2L CG13981 CG13981 CDMC22243 3 12 18 DAC29-G11 17-CG13981-RA_1 CG13981 TGCGTCCGGCAAATCGAGCATTAAATACCTATCGAATCTGAACGAGATCGACAAGTCGAAGCAGAAGCT 69 FBan0013981 FBgn0031807 CG13981 2 2L CG13981 CG13981 CDMC22244 3 13 18 DAC29-G23 3-CG1399-RA_1 CG1399 TGGCTGGCTACTTCGCTTGGTTGATTTCGGTGCTCATCCTGTGCGTCTAACATTCGCATTTGCTGCATA 69 FBan0001399 FBgn0033212 CG1399 2 2R myosin I binding; GO:0017024; ; GO:0017024 CG1399 CG1399 "CG1576, Dcarmil" CDMC22244 3 14 18 DAC29-G23 3-CG1399-RA_1 CG1399 TGGCTGGCTACTTCGCTTGGTTGATTTCGGTGCTCATCCTGTGCGTCTAACATTCGCATTTGCTGCATA 69 FBan0001399 FBgn0033212 CG1399 2 2R myosin I binding; GO:0017024; ; GO:0017024 CG1399 CG1399 "CG1576, Dcarmil" CDMC22245 3 15 18 DAC29-K11 11-CG14032-RA_1 CG14032 GAGATCCGCGACATTTCCCGAAACCAGATCTGTTCCAGCCAGACAGATTTCTACCGGAGAACACAGTGA 69 FBan0014032 FBgn0031693 Cyp4ac1 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac1 Cyp4ac1 "CG14032, CG14032, 4ac1" CDMC22245 3 16 18 DAC29-K11 11-CG14032-RA_1 CG14032 GAGATCCGCGACATTTCCCGAAACCAGATCTGTTCCAGCCAGACAGATTTCTACCGGAGAACACAGTGA 69 FBan0014032 FBgn0031693 Cyp4ac1 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac1 Cyp4ac1 "CG14032, CG14032, 4ac1" CDMC22246 3 17 18 DAC29-K23 23-CG1403-RA_3 CG1403 TACCTTACCCTTATCTGTGTTGTCTCAAAGCGAGCAATTTATTTAGGTTATACTATATGTTGCGTGTCA 69 FBan0001403 FBgn0011710 1-Sep X X cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 1-Sep Septin-1 "CG1403, CG1403, tu1, sep1, septin, iby, septin 1, Diff6, anon-19Fa, innocent bystander" CDMC22246 3 18 18 DAC29-K23 23-CG1403-RA_3 CG1403 TACCTTACCCTTATCTGTGTTGTCTCAAAGCGAGCAATTTATTTAGGTTATACTATATGTTGCGTGTCA 69 FBan0001403 FBgn0011710 1-Sep X X cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 1-Sep Septin-1 "CG1403, CG1403, tu1, sep1, septin, iby, septin 1, Diff6, anon-19Fa, innocent bystander" CDMC22247 3 19 18 DAC29-O11 17-CG14064-RA_1 CG14064 CACTGCCTGAAGGACCTGAAGATATTTGTACCAGAGGCCGTATTAATGGGAAATGCAGCGACATTGTCT 69 FBan0014064 FBgn0039584 beat-VI 3 3R extracellular region; GO:0005576 beat-VI beat-VI "CG14064, CG12089, beat VI" CDMC22247 3 20 18 DAC29-O11 17-CG14064-RA_1 CG14064 CACTGCCTGAAGGACCTGAAGATATTTGTACCAGAGGCCGTATTAATGGGAAATGCAGCGACATTGTCT 69 FBan0014064 FBgn0039584 beat-VI 3 3R extracellular region; GO:0005576 beat-VI beat-VI "CG14064, CG12089, beat VI" CDMC22248 3 21 18 DAC29-O23 AutoBlank AutoBlank CDMC22248 3 22 18 DAC29-O23 AutoBlank AutoBlank CDMC22249 3 23 18 DAC30-C11 11-CG15117-RA_1 CG15117 GCTTCCCGGAAGATCTCTTCACCTACATCGCCGATCTGATATCCTAATGGTTGGGAGCCAGTTGATGGT 69 FBan0015117 FBgn0034417 CG15117 2 2R carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; beta-glucuronidase activity; GO:0004566 ; EC:3.2.1.31; ; GO:0008270; ; GO:0004566 ; EC:3.2.1.31 CG15117 CG15117 CDMC22249 3 24 18 DAC30-C11 11-CG15117-RA_1 CG15117 GCTTCCCGGAAGATCTCTTCACCTACATCGCCGATCTGATATCCTAATGGTTGGGAGCCAGTTGATGGT 69 FBan0015117 FBgn0034417 CG15117 2 2R carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; beta-glucuronidase activity; GO:0004566 ; EC:3.2.1.31; ; GO:0008270; ; GO:0004566 ; EC:3.2.1.31 CG15117 CG15117 CDMC22250 3 25 18 DAC30-C23 8-CG15124-RA_1 CG15124 TGGCAGCGTTGCAAGAGCTTAAGAAGTATCTGCTGGATTTGCATTCGGAGATCAAAAAGCCCGGTGCAG 69 FBan0015124 FBgn0034461 CG15124 2 2R CG15124 CG15124 CDMC22250 3 26 18 DAC30-C23 8-CG15124-RA_1 CG15124 TGGCAGCGTTGCAAGAGCTTAAGAAGTATCTGCTGGATTTGCATTCGGAGATCAAAAAGCCCGGTGCAG 69 FBan0015124 FBgn0034461 CG15124 2 2R CG15124 CG15124 CDMC22251 3 1 19 DAC30-G11 7-CG15162-RA_1 CG15162 GCCTCGAAGCCACAACCCAACACAACCACGAAGAAATCCAGGAAAAACCAACCCTTAGTTCGTATGGCT 69 FBan0015162 FBgn0032694 MESR3 2 2L MESR3 Misexpression suppressor of ras 3 "CG15162, Misexpression suppressor of ras 3" CDMC22251 3 2 19 DAC30-G11 7-CG15162-RA_1 CG15162 GCCTCGAAGCCACAACCCAACACAACCACGAAGAAATCCAGGAAAAACCAACCCTTAGTTCGTATGGCT 69 FBan0015162 FBgn0032694 MESR3 2 2L MESR3 Misexpression suppressor of ras 3 "CG15162, Misexpression suppressor of ras 3" CDMC22252 3 3 19 DAC30-G23 2-CG15178-RA_1 CG15178 CGATTTGCTTTCGAGGTCTATGATACCAAAGGCACTGGCGTTATTGATCGCGAGCAAGTTGGCACGGCT 69 FBan0015178 FBgn0037460 CG15178 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15178 CG15178 CDMC22252 3 4 19 DAC30-G23 2-CG15178-RA_1 CG15178 CGATTTGCTTTCGAGGTCTATGATACCAAAGGCACTGGCGTTATTGATCGCGAGCAAGTTGGCACGGCT 69 FBan0015178 FBgn0037460 CG15178 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15178 CG15178 CDMC22253 3 5 19 DAC30-K11 3-CG15214-RA_2 CG15214 GGGGGAAACGGAAGGCTCCATACGTGTTTACGACCCTGAATCCACACGACCCTACGAGTATATGTGCAC 69 FBan0015214 FBgn0035606 CG15214 3 3L CG15214 CG15214 CT35147 CDMC22253 3 6 19 DAC30-K11 3-CG15214-RA_2 CG15214 GGGGGAAACGGAAGGCTCCATACGTGTTTACGACCCTGAATCCACACGACCCTACGAGTATATGTGCAC 69 FBan0015214 FBgn0035606 CG15214 3 3L CG15214 CG15214 CT35147 CDMC22254 3 7 19 DAC30-K23 15-CG15224-RB_1 CG15224 CAAGCGGAAAGCAAAACAATGGCAGAAGGATCCCTTTTCCATGATGTGCACACACTGTTATCCAACCGA 69 FBan0015224 FBgn0000259 CkIIbeta X X circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; mushroom body development; GO:0016319; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; protein kinase CK2 activity; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682; ; GO:0008605; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIbeta Casein kinase II beta subunit "CG15224, CG15224, And, Ds cas kin, CK-2, Andante, Casein kinase II, CKII, CK-II beta, CK2, CK-IIbeta, CCK2, betaCK2, CkII, CKIIbeta, mbu, mushroom bodies undersized, CKII-beta1, CK II, DmCKIIbeta, CKIIb, DmCkIIbeta, CkIIbeta1, CK2beta, CKIIbeta, DmCK2beta, CkII-beta, dCKII, casein kinase 2, CK2beta, CkIIbeta, Cask-II-b" CDMC22254 3 8 19 DAC30-K23 15-CG15224-RB_1 CG15224 CAAGCGGAAAGCAAAACAATGGCAGAAGGATCCCTTTTCCATGATGTGCACACACTGTTATCCAACCGA 69 FBan0015224 FBgn0000259 CkIIbeta X X circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; mushroom body development; GO:0016319; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; protein kinase CK2 activity; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682; ; GO:0008605; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIbeta Casein kinase II beta subunit "CG15224, CG15224, And, Ds cas kin, CK-2, Andante, Casein kinase II, CKII, CK-II beta, CK2, CK-IIbeta, CCK2, betaCK2, CkII, CKIIbeta, mbu, mushroom bodies undersized, CKII-beta1, CK II, DmCKIIbeta, CKIIb, DmCkIIbeta, CkIIbeta1, CK2beta, CKIIbeta, DmCK2beta, CkII-beta, dCKII, casein kinase 2, CK2beta, CkIIbeta, Cask-II-b" CDMC22255 3 9 19 DAC30-O11 8-CG15262-RA_1 CG15262 TGGAGCGCACTCTATCCAAGGAAGAGCTGTATGTGACGTACGGATACCATCCCCAGATGTCGGGTATTT 69 FBan0015262 FBgn0028852 CG15262 2 2L CG15262 CG15262 BG:DS07851.5 CDMC22255 3 10 19 DAC30-O11 8-CG15262-RA_1 CG15262 TGGAGCGCACTCTATCCAAGGAAGAGCTGTATGTGACGTACGGATACCATCCCCAGATGTCGGGTATTT 69 FBan0015262 FBgn0028852 CG15262 2 2L CG15262 CG15262 BG:DS07851.5 CDMC22256 3 11 19 DAC30-O23 AutoBlank AutoBlank CDMC22256 3 12 19 DAC30-O23 AutoBlank AutoBlank CDMC22257 3 13 19 DAC31-C11 3-CG12868-RA_2 CG12868 CCTAAAGTGGTTTACGACGGGAAATCTCCTGGAAGCCCCACCTAAAAGCCACTTCAACGACGAGCGA 67 FBan0012868 FBgn0033945 CG12868 2 2R CG12868 CG12868 CT32008 CDMC22257 3 14 19 DAC31-C11 3-CG12868-RA_2 CG12868 CCTAAAGTGGTTTACGACGGGAAATCTCCTGGAAGCCCCACCTAAAAGCCACTTCAACGACGAGCGA 67 FBan0012868 FBgn0033945 CG12868 2 2R CG12868 CG12868 CT32008 CDMC22258 3 15 19 DAC31-C23 2-CG1299-RA_1 CG1299 GCACACAGTACTTCATGGACTGGATCATCCAACAGGTCCAGGACACACCCTGATTTGCCATCGCCAT 67 FBan0001299 FBgn0035501 CG1299 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG1299 CG1299 "c-SP18, SP18" CDMC22258 3 16 19 DAC31-C23 2-CG1299-RA_1 CG1299 GCACACAGTACTTCATGGACTGGATCATCCAACAGGTCCAGGACACACCCTGATTTGCCATCGCCAT 67 FBan0001299 FBgn0035501 CG1299 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG1299 CG1299 "c-SP18, SP18" CDMC22259 3 17 19 DAC31-G11 3-CG13403-RA_1 CG13403 GCGTCCATCCGGTGCATACACAGCTACAGGAATTCCAATCCTCTCAAGCAACACACCGAGCTTACCC 67 FBan0013403 FBgn0030544 CG13403 X X CG13403 CG13403 CDMC22259 3 18 19 DAC31-G11 3-CG13403-RA_1 CG13403 GCGTCCATCCGGTGCATACACAGCTACAGGAATTCCAATCCTCTCAAGCAACACACCGAGCTTACCC 67 FBan0013403 FBgn0030544 CG13403 X X CG13403 CG13403 CDMC22260 3 19 19 DAC31-G23 13-CG13545-RA_1 CG13545 GCTTTGGCCCTATTAATCCATACTATCATCTGCAGTTCCTCGTCTGCTTGGCTCTCTTCATCGCCGC 67 FBan0013545 FBgn0034828 CG13545 2 2R CG13545 CG13545 CDMC22260 3 20 19 DAC31-G23 13-CG13545-RA_1 CG13545 GCTTTGGCCCTATTAATCCATACTATCATCTGCAGTTCCTCGTCTGCTTGGCTCTCTTCATCGCCGC 67 FBan0013545 FBgn0034828 CG13545 2 2R CG13545 CG13545 CDMC22261 3 21 19 DAC31-K11 3-CG13840-RA_1 CG13840 CGGCCAATCCAGTTAAGCGTCAGCAGGAAGAGTCCCTATCGAGTCATCATCCAAACCGGGAGCAAAG 67 FBan0013840 FBgn0039028 CG13840 3 3R CG13840 CG13840 CDMC22261 3 22 19 DAC31-K11 3-CG13840-RA_1 CG13840 CGGCCAATCCAGTTAAGCGTCAGCAGGAAGAGTCCCTATCGAGTCATCATCCAAACCGGGAGCAAAG 67 FBan0013840 FBgn0039028 CG13840 3 3R CG13840 CG13840 CDMC22262 3 23 19 DAC31-K23 3-CG13922-RA_4 CG13922 AGCGTCTCCCTGTGGTGTCCAAGTCCCTTAATCCGCTGGAAAAACAGTTCCAAGACTTGCTATGGCG 67 FBan0013922 FBgn0035272 mRpL46 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL46 mitochondrial ribosomal protein L46 "CG13922, MRP-L46, mitochondrial ribosomal protein L46" CDMC22262 3 24 19 DAC31-K23 3-CG13922-RA_4 CG13922 AGCGTCTCCCTGTGGTGTCCAAGTCCCTTAATCCGCTGGAAAAACAGTTCCAAGACTTGCTATGGCG 67 FBan0013922 FBgn0035272 mRpL46 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL46 mitochondrial ribosomal protein L46 "CG13922, MRP-L46, mitochondrial ribosomal protein L46" CDMC22263 3 25 19 DAC31-O11 1-CG14365-RA_1 CG14365 TTGGTGGTAGCAATCCGTCGGATGATGGCAATCCTAACGAAGATGGTGCTGGTGAAAACACGGAGGA 67 FBan0014365 FBgn0038177 CG14365 3 3R CG14365 CG14365 CDMC22263 3 26 19 DAC31-O11 1-CG14365-RA_1 CG14365 TTGGTGGTAGCAATCCGTCGGATGATGGCAATCCTAACGAAGATGGTGCTGGTGAAAACACGGAGGA 67 FBan0014365 FBgn0038177 CG14365 3 3R CG14365 CG14365 CDMC22264 3 1 20 DAC31-O23 AutoBlank AutoBlank CDMC22264 3 2 20 DAC31-O23 AutoBlank AutoBlank CDMC22265 3 3 20 DAC32-C11 16-CG31730-RA_2 CG31730 GGGCTGCCTATCAATTGTACACTTCTTTGGGTTATGCTCATCGCCAAACATTCCTGGACTACTATCCGG 69 FBan0031730 FBgn0051730 CG31730 2 2L protein amino acid acetylation; GO:0006473; protein metabolism; GO:0019538; protein modification; GO:0006464 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG31730 CG31730 CDMC22265 3 4 20 DAC32-C11 16-CG31730-RA_2 CG31730 GGGCTGCCTATCAATTGTACACTTCTTTGGGTTATGCTCATCGCCAAACATTCCTGGACTACTATCCGG 69 FBan0031730 FBgn0051730 CG31730 2 2L protein amino acid acetylation; GO:0006473; protein metabolism; GO:0019538; protein modification; GO:0006464 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG31730 CG31730 CDMC22266 3 5 20 DAC32-C23 8-CG31738-RB_2 CG31738 GCCCAACCATGACTACAGGCAATTGTATCGCGGTCCAGAGACCAAATTCACCATTGACAATCTGGCAGC 69 FBan0031738 FBgn0051738 CG31738 2 2L muscle contraction; GO:0006936; protein biosynthesis; GO:0006412 structural constituent of cytoskeleton; GO:0005200; structural constituent of ribosome; GO:0003735; ; GO:0005200; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG31738 CG31738 "CG4668, CG13261, CG4668, clone 1.16, CT15043, CT15049, anon-EST:Liang-1.16" CDMC22266 3 6 20 DAC32-C23 8-CG31738-RB_2 CG31738 GCCCAACCATGACTACAGGCAATTGTATCGCGGTCCAGAGACCAAATTCACCATTGACAATCTGGCAGC 69 FBan0031738 FBgn0051738 CG31738 2 2L muscle contraction; GO:0006936; protein biosynthesis; GO:0006412 structural constituent of cytoskeleton; GO:0005200; structural constituent of ribosome; GO:0003735; ; GO:0005200; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG31738 CG31738 "CG4668, CG13261, CG4668, clone 1.16, CT15043, CT15049, anon-EST:Liang-1.16" CDMC22267 3 7 20 DAC32-G11 23-CG31762-RB_6 CG31762 TGTTCTTTGCAAAGTTTCGCCATTTATTTCATTTTTGGAAATGCGATGTCAAGTGGTAGCTGATGCAAG 69 FBan0031762 FBgn0000114 aret 2 2L "female germ-line cyst formation (sensu Insecta); GO:0030727; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of oskar mRNA translation; GO:0046011; spermatid development; GO:0007286" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730; ; GO:0005515; ; GO:0003729 nucleus; GO:0005634 aret arrest "CG6319, CG31762, CG6319, CG6319, bruno, bru, Bruno, Bru, Dm Bru, arrest/Bruno, BcDNA:GM15173, ms(2)01284, NEST:bs01g04, NEST:bs34h11" CDMC22267 3 8 20 DAC32-G11 23-CG31762-RB_6 CG31762 TGTTCTTTGCAAAGTTTCGCCATTTATTTCATTTTTGGAAATGCGATGTCAAGTGGTAGCTGATGCAAG 69 FBan0031762 FBgn0000114 aret 2 2L "female germ-line cyst formation (sensu Insecta); GO:0030727; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of oskar mRNA translation; GO:0046011; spermatid development; GO:0007286" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730; ; GO:0005515; ; GO:0003729 nucleus; GO:0005634 aret arrest "CG6319, CG31762, CG6319, CG6319, bruno, bru, Bruno, Bru, Dm Bru, arrest/Bruno, BcDNA:GM15173, ms(2)01284, NEST:bs01g04, NEST:bs34h11" CDMC22268 3 9 20 DAC32-G23 2-CG31769-RA_1 CG31769 AGGCGACGGAACTGACTCGACAATCGATGACTTTTTGGCAAAGGTGGATCTCACTGTCGCGGACATCAA 69 FBan0031769 FBgn0051769 CG31769 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31769 CG31769 BcDNA:RH26533 CDMC22268 3 10 20 DAC32-G23 2-CG31769-RA_1 CG31769 AGGCGACGGAACTGACTCGACAATCGATGACTTTTTGGCAAAGGTGGATCTCACTGTCGCGGACATCAA 69 FBan0031769 FBgn0051769 CG31769 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31769 CG31769 BcDNA:RH26533 CDMC22269 3 11 20 DAC32-K11 23-CG31802-RA_13 CG31802 TGCCCTGGGATTCGAGCCGAAGAAAGAGGATATAAAGCGTATGATGGACGAAATCGATAAGGACAAGAC 69 FBan0031802 FBgn0051802 CG31802 2 2L calcium-mediated signaling; GO:0019722; chromosome segregation; GO:0007059; mitosis; GO:0007067 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 centrosome; GO:0005813; cytoskeleton; GO:0005856 CG31802 CG31802 "CG15158, CG15158, CG15158, CG15158, BcDNA:AT22559" CDMC22269 3 12 20 DAC32-K11 23-CG31802-RA_13 CG31802 TGCCCTGGGATTCGAGCCGAAGAAAGAGGATATAAAGCGTATGATGGACGAAATCGATAAGGACAAGAC 69 FBan0031802 FBgn0051802 CG31802 2 2L calcium-mediated signaling; GO:0019722; chromosome segregation; GO:0007059; mitosis; GO:0007067 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 centrosome; GO:0005813; cytoskeleton; GO:0005856 CG31802 CG31802 "CG15158, CG15158, CG15158, CG15158, BcDNA:AT22559" CDMC22270 3 13 20 DAC32-K23 1-CG3180-RA_1 CG3180 TGCCGTCAACGTGCAAAAGATCTCCACCTTCCTTCAGGAGTACGGCTATCATCTTCGAGGCAATGAGGT 69 FBan0003180 FBgn0003276 RpII140 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII140 RNA polymerase II 140kD subunit "CG3180, CG3180, DmRP140, RNA polymerase II, 150kDa polypeptide, wimp, RPII140, l(3)RplII140, RNApolII, RNAP II, PolIIc, II, polII, RNA polymerase subunit IIc, H5, RNA polymerase II second largest subunit, RNA polII, subunit IIc of RNA Pol II, RNA pol II, RP140, RNA Pol II, RNA Pol IIc, PolII, rpII140/wimp, RNAP, Pol II" CDMC22270 3 14 20 DAC32-K23 1-CG3180-RA_1 CG3180 TGCCGTCAACGTGCAAAAGATCTCCACCTTCCTTCAGGAGTACGGCTATCATCTTCGAGGCAATGAGGT 69 FBan0003180 FBgn0003276 RpII140 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII140 RNA polymerase II 140kD subunit "CG3180, CG3180, DmRP140, RNA polymerase II, 150kDa polypeptide, wimp, RPII140, l(3)RplII140, RNApolII, RNAP II, PolIIc, II, polII, RNA polymerase subunit IIc, H5, RNA polymerase II second largest subunit, RNA polII, subunit IIc of RNA Pol II, RNA pol II, RP140, RNA Pol II, RNA Pol IIc, PolII, rpII140/wimp, RNAP, Pol II" CDMC22271 3 15 20 DAC32-O11 13-CG31835-RA_3 CG31835 TCCGAATTCAAGGATATTCGATATATCCGTATGGCTGTCAACTGGACGTGTGAGCTCCGATCCCCAGCT 69 FBan0031835 FBgn0051835 CG31835 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31835 CG31835 BG:DS00810.1 CDMC22271 3 16 20 DAC32-O11 13-CG31835-RA_3 CG31835 TCCGAATTCAAGGATATTCGATATATCCGTATGGCTGTCAACTGGACGTGTGAGCTCCGATCCCCAGCT 69 FBan0031835 FBgn0051835 CG31835 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31835 CG31835 BG:DS00810.1 CDMC22272 3 17 20 DAC32-O23 15-CG31849-RA_1 CG31849 CCCTTCTGTGTTTTTGGCCAGGTGAATTCCAAATTTAGTATCTCAGCAGACAGGACAGACAGACCCGCC 69 FBan0031849 FBgn0051849 CG31849 2 2L CG31849 CG31849 BcDNA:LD34806 CDMC22272 3 18 20 DAC32-O23 15-CG31849-RA_1 CG31849 CCCTTCTGTGTTTTTGGCCAGGTGAATTCCAAATTTAGTATCTCAGCAGACAGGACAGACAGACCCGCC 69 FBan0031849 FBgn0051849 CG31849 2 2L CG31849 CG31849 BcDNA:LD34806 CDMC22273 3 19 20 DAC33-C11 12-CG15545-RA_2 CG15545 GCCAAAATATGTGACGGCCATTCCATACAAGGCATCTGGTTATGGATCCGATATCCACAAGCCCTCCGG 69 FBan0015545 FBgn0039806 CG15545 3 3R CG15545 CG15545 CDMC22273 3 20 20 DAC33-C11 12-CG15545-RA_2 CG15545 GCCAAAATATGTGACGGCCATTCCATACAAGGCATCTGGTTATGGATCCGATATCCACAAGCCCTCCGG 69 FBan0015545 FBgn0039806 CG15545 3 3R CG15545 CG15545 CDMC22274 3 21 20 DAC33-C23 18-CG15555-RA_2 CG15555 CCGACATGGGATTGGTCTTGACTCTGAAAACGGACCCCAGTGACAACTTTTACAAGATTAATGGCCACA 69 FBan0015555 FBgn0039839 CG15555 3 3R cation transport; GO:0006812; ion transport; GO:0006811; sodium ion transport; GO:0006814; transport; GO:0006810 alpha-type channel activity; GO:0015268; sodium channel activity; GO:0005272; ; GO:0015268; ; GO:0005272 membrane; GO:0016020 CG15555 CG15555 CDMC22274 3 22 20 DAC33-C23 18-CG15555-RA_2 CG15555 CCGACATGGGATTGGTCTTGACTCTGAAAACGGACCCCAGTGACAACTTTTACAAGATTAATGGCCACA 69 FBan0015555 FBgn0039839 CG15555 3 3R cation transport; GO:0006812; ion transport; GO:0006811; sodium ion transport; GO:0006814; transport; GO:0006810 alpha-type channel activity; GO:0015268; sodium channel activity; GO:0005272; ; GO:0015268; ; GO:0005272 membrane; GO:0016020 CG15555 CG15555 CDMC22275 3 23 20 DAC33-G11 8-CG15599-RA_1 CG15599 AGCGTGCCGAAAAAGCAAAGGAAAAGGCCAAGAACTCGAATGGGAAAAACGCGTTGGCTATTCAATCCA 69 FBan0015599 FBgn0030667 CG15599 X X CG15599 CG15599 CDMC22275 3 24 20 DAC33-G11 8-CG15599-RA_1 CG15599 AGCGTGCCGAAAAAGCAAAGGAAAAGGCCAAGAACTCGAATGGGAAAAACGCGTTGGCTATTCAATCCA 69 FBan0015599 FBgn0030667 CG15599 X X CG15599 CG15599 CDMC22276 3 25 20 DAC33-G23 8-CG1560-RA_1 CG1560 CCACGACCACTGTCTGTGCTTGAACCGGAAATCAGAAGGAACCCCAACCAGTCAAACTTAAACACCAGC 69 FBan0001560 FBgn0004657 mys X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; calcium-dependent cell-cell adhesion; GO:0016339; calcium-dependent cell-matrix adhesion; GO:0016340; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-matrix adhesion; GO:0007160; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; dorsal closure; GO:0007391; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; muscle attachment; GO:0016203; muscle development; GO:0007517; regulation of cell shape; GO:0008360; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0004872; ; GO:0050839 focal adhesion; GO:0005925; integrin complex; GO:0008305 mys myospheroid "CG1560, CG1560, EM28, l(1)93p, lethal(1)93 pupal, l(1)mys, nj42: non-jumper-42, lethal(1)myospheroid, olfC, beta[[PS]], PS integrin beta subunit, PSbeta, lethal myospheroid, betaPS, BetaPS, beta-integrin, PS-beta-integrin, beta integrin, bPS, beta[[P]]S, l(1)968, l(1)7Db, beta-PS, betaPS, l(1)G0233, l(1)G0281, b[[PS]], CT40473, MAb6G11, beta[[PS]]-integrin, betamys, myo-spheroid, integrin beta[[PS]], betaPS1, Myospheroid, beta-PS Integrin, beta PS integrin, PSbeta-integrin, &bgr\;PS, Mys, betaps-integrin, PS[[beta]], l(1)7Dn, l(1)DA551, l(1)EM28, non-jumper-42, olfactory C, nj42" CDMC22276 3 26 20 DAC33-G23 8-CG1560-RA_1 CG1560 CCACGACCACTGTCTGTGCTTGAACCGGAAATCAGAAGGAACCCCAACCAGTCAAACTTAAACACCAGC 69 FBan0001560 FBgn0004657 mys X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; calcium-dependent cell-cell adhesion; GO:0016339; calcium-dependent cell-matrix adhesion; GO:0016340; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-matrix adhesion; GO:0007160; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; dorsal closure; GO:0007391; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; muscle attachment; GO:0016203; muscle development; GO:0007517; regulation of cell shape; GO:0008360; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0004872; ; GO:0050839 focal adhesion; GO:0005925; integrin complex; GO:0008305 mys myospheroid "CG1560, CG1560, EM28, l(1)93p, lethal(1)93 pupal, l(1)mys, nj42: non-jumper-42, lethal(1)myospheroid, olfC, beta[[PS]], PS integrin beta subunit, PSbeta, lethal myospheroid, betaPS, BetaPS, beta-integrin, PS-beta-integrin, beta integrin, bPS, beta[[P]]S, l(1)968, l(1)7Db, beta-PS, betaPS, l(1)G0233, l(1)G0281, b[[PS]], CT40473, MAb6G11, beta[[PS]]-integrin, betamys, myo-spheroid, integrin beta[[PS]], betaPS1, Myospheroid, beta-PS Integrin, beta PS integrin, PSbeta-integrin, &bgr\;PS, Mys, betaps-integrin, PS[[beta]], l(1)7Dn, l(1)DA551, l(1)EM28, non-jumper-42, olfactory C, nj42" CDMC22277 3 1 21 DAC33-K11 23-CG15658-RA_5 CG15658 ATTACCTACCATTTATGCGTTAGTTTAGCCTTAGGACAACCGTCTACCTAGCAAACTGCCTTGAATCCT 69 FBan0015658 FBgn0034602 CG15658 2 2R CG15658 CG15658 CT35842 CDMC22277 3 2 21 DAC33-K11 23-CG15658-RA_5 CG15658 ATTACCTACCATTTATGCGTTAGTTTAGCCTTAGGACAACCGTCTACCTAGCAAACTGCCTTGAATCCT 69 FBan0015658 FBgn0034602 CG15658 2 2R CG15658 CG15658 CT35842 CDMC22278 3 3 21 DAC33-K23 13-CG15678-RA_3 CG15678 ACCGACAGACTGGACGGTGATTTTTACGAGTGATTAGCAGCGGAAAGAAACGATACCGGCGGTAATTCA 69 FBan0015678 FBgn0034647 CG15678 2 2R CG15678 CG15678 BcDNA:SD16010 CDMC22278 3 4 21 DAC33-K23 13-CG15678-RA_3 CG15678 ACCGACAGACTGGACGGTGATTTTTACGAGTGATTAGCAGCGGAAAGAAACGATACCGGCGGTAATTCA 69 FBan0015678 FBgn0034647 CG15678 2 2R CG15678 CG15678 BcDNA:SD16010 CDMC22279 3 5 21 DAC33-O11 7-CG1572-RA_1 CG1572 TGGTGCTTCCATTGTGGGAATTCTGGCGTTCAACTACCAGGACTACCACAGATACTTCTATGGCCAGCA 69 FBan0001572 FBgn0030309 CG1572 X X CG1572 CG1572 CDMC22279 3 6 21 DAC33-O11 7-CG1572-RA_1 CG1572 TGGTGCTTCCATTGTGGGAATTCTGGCGTTCAACTACCAGGACTACCACAGATACTTCTATGGCCAGCA 69 FBan0001572 FBgn0030309 CG1572 X X CG1572 CG1572 CDMC22280 3 7 21 DAC33-O23 AutoBlank AutoBlank CDMC22280 3 8 21 DAC33-O23 AutoBlank AutoBlank CDMC22281 3 9 21 DAC34-C11 3-CG31152-RA_8 CG31152 GGAGGTGCAGAAGATGACGGACTTTGCAGTGCCGATCAAAAATCCTGTGCACAAAGTGAACCCGACCAA 69 FBan0031152 FBgn0051152 CG31152 3 3R CG31152 CG31152 "CG17138, CG17138" CDMC22281 3 10 21 DAC34-C11 3-CG31152-RA_8 CG31152 GGAGGTGCAGAAGATGACGGACTTTGCAGTGCCGATCAAAAATCCTGTGCACAAAGTGAACCCGACCAA 69 FBan0031152 FBgn0051152 CG31152 3 3R CG31152 CG31152 "CG17138, CG17138" CDMC22282 3 11 21 DAC34-C23 23-CG31163-RB_20 CG31163 ATCGTGCAAATCCGTCAGAAACTTGTAAAAATTAATGCCGAAAATTGCCAAATCGAGCAAACAAAAGTA 69 FBan0031163 FBgn0051163 CG31163 3 3R SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31163 CG31163 "CG13863, CG13864, CG5736, CG7086, CG7087" CDMC22282 3 12 21 DAC34-C23 23-CG31163-RB_20 CG31163 ATCGTGCAAATCCGTCAGAAACTTGTAAAAATTAATGCCGAAAATTGCCAAATCGAGCAAACAAAAGTA 69 FBan0031163 FBgn0051163 CG31163 3 3R SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31163 CG31163 "CG13863, CG13864, CG5736, CG7086, CG7087" CDMC22283 3 13 21 DAC34-G11 3-CG31196-RA_1 CG31196 GCGAGCCCAAAGAGCAAATCCAGGATGTTGAGGATCAGGACGTGTCGTAATTTAAGTAAACCCCCGCCC 69 FBan0031196 FBgn0020238 14-3-3epsilon 3 3R DNA damage checkpoint; GO:0000077; Ras protein signal transduction; GO:0007265; imaginal disc development; GO:0007444; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic checkpoint; GO:0007093; nonassociative learning; GO:0046958; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; regulation of mitosis; GO:0007088; response to external stimulus; GO:0009605; response to radiation; GO:0009314 transcription regulator activity; GO:0030528; ; GO:0030528; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0004863; protein domain specific binding; GO:0019904; ; GO:0019904 chromosome; GO:0005694; cytoplasm; GO:0005737; nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3epsilon 14-3-3epsilon "CG31196, SR3-9, Suppressor of Ras85D 3-9, 14-3-3, d14-3-3epsilon, 14-3-3epsilon, 14-3-3e, CT24092, EK3-5, D14-3-3epsilon, 14-3-3-e, D14-3-3e, par-5, Par-5, PAR5, anon-WO0172774.141, anon-WO02059370.52, Su(Raf)3B, l(3)j2B10" CDMC22283 3 14 21 DAC34-G11 3-CG31196-RA_1 CG31196 GCGAGCCCAAAGAGCAAATCCAGGATGTTGAGGATCAGGACGTGTCGTAATTTAAGTAAACCCCCGCCC 69 FBan0031196 FBgn0020238 14-3-3epsilon 3 3R DNA damage checkpoint; GO:0000077; Ras protein signal transduction; GO:0007265; imaginal disc development; GO:0007444; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic checkpoint; GO:0007093; nonassociative learning; GO:0046958; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; regulation of mitosis; GO:0007088; response to external stimulus; GO:0009605; response to radiation; GO:0009314 transcription regulator activity; GO:0030528; ; GO:0030528; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0004863; protein domain specific binding; GO:0019904; ; GO:0019904 chromosome; GO:0005694; cytoplasm; GO:0005737; nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3epsilon 14-3-3epsilon "CG31196, SR3-9, Suppressor of Ras85D 3-9, 14-3-3, d14-3-3epsilon, 14-3-3epsilon, 14-3-3e, CT24092, EK3-5, D14-3-3epsilon, 14-3-3-e, D14-3-3e, par-5, Par-5, PAR5, anon-WO0172774.141, anon-WO02059370.52, Su(Raf)3B, l(3)j2B10" CDMC22284 3 15 21 DAC34-G23 3-CG31202-RA_5 CG31202 GGCGACTTCGCAACCTACAAGCTTGGTGCCACTATCATCGAGAGCTTGGACACTTTGCATTTGATGGGT 69 FBan0031202 FBgn0051202 CG31202 3 3R protein amino acid N-linked glycosylation; GO:0006487 "calcium ion binding; GO:0005509; ; GO:0005509; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG31202 CG31202 CG7880 CDMC22284 3 16 21 DAC34-G23 3-CG31202-RA_5 CG31202 GGCGACTTCGCAACCTACAAGCTTGGTGCCACTATCATCGAGAGCTTGGACACTTTGCATTTGATGGGT 69 FBan0031202 FBgn0051202 CG31202 3 3R protein amino acid N-linked glycosylation; GO:0006487 "calcium ion binding; GO:0005509; ; GO:0005509; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG31202 CG31202 CG7880 CDMC22285 3 17 21 DAC34-K11 22-CG31230-RA_1 CG31230 AGTTCCTCGGAGAGTAGTTGCAGCGAACCAAACTAGACGCATCTATGTAGAATATGGCTGACCGAATCT 69 FBan0031230 FBgn0051230 CG31230 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31230 CG31230 CDMC22285 3 18 21 DAC34-K11 22-CG31230-RA_1 CG31230 AGTTCCTCGGAGAGTAGTTGCAGCGAACCAAACTAGACGCATCTATGTAGAATATGGCTGACCGAATCT 69 FBan0031230 FBgn0051230 CG31230 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31230 CG31230 CDMC22286 3 19 21 DAC34-K23 2-CG31244-RA_1 CG31244 TCCTCAGCTCAAGTCCAGCGTTACTCCCTACAGACCAAAGCCGAACCTAATCCGTAGTGATTCCCCGAA 69 FBan0031244 FBgn0051244 CG31244 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31244 CG31244 "CG18491, CG18491" CDMC22286 3 20 21 DAC34-K23 2-CG31244-RA_1 CG31244 TCCTCAGCTCAAGTCCAGCGTTACTCCCTACAGACCAAAGCCGAACCTAATCCGTAGTGATTCCCCGAA 69 FBan0031244 FBgn0051244 CG31244 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31244 CG31244 "CG18491, CG18491" CDMC22287 3 21 21 DAC34-O11 15-CG31281-RA_5 CG31281 CCTGTCACGAGAGAATCCAATTTCGAATCAAGCTTAGCCAAGCGGTTACACAATCGCCGTAAGTTCCGC 69 FBan0031281 FBgn0051281 CG31281 3 3R CG31281 CG31281 "NEST:bs11b10, NEST:bs30g09" CDMC22287 3 22 21 DAC34-O11 15-CG31281-RA_5 CG31281 CCTGTCACGAGAGAATCCAATTTCGAATCAAGCTTAGCCAAGCGGTTACACAATCGCCGTAAGTTCCGC 69 FBan0031281 FBgn0051281 CG31281 3 3R CG31281 CG31281 "NEST:bs11b10, NEST:bs30g09" CDMC22288 3 23 21 DAC34-O23 9-CG31288-RA_2 CG31288 AGCAGCTATCTGCCGGACGGAACTCTCGAGAAGCTGATACTAATCGACTTCCAGATTGTCATGTGGGGT 69 FBan0031288 FBgn0051288 CG31288 3 3R CG31288 CG31288 CG13665 CDMC22288 3 24 21 DAC34-O23 9-CG31288-RA_2 CG31288 AGCAGCTATCTGCCGGACGGAACTCTCGAGAAGCTGATACTAATCGACTTCCAGATTGTCATGTGGGGT 69 FBan0031288 FBgn0051288 CG31288 3 3R CG31288 CG31288 CG13665 CDMC22289 3 25 21 DAC35-C11 1-CG8152-RA_2 CG8152 CTCGTGCAGAGAGGGGTCCAAGTAGAGACCTCAGACAAATCCGGAAACACAGCTCTGAAACTGGCC 66 FBan0008152 FBgn0034008 CG8152 2 2R biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG8152 CG8152 CDMC22289 3 26 21 DAC35-C11 1-CG8152-RA_2 CG8152 CTCGTGCAGAGAGGGGTCCAAGTAGAGACCTCAGACAAATCCGGAAACACAGCTCTGAAACTGGCC 66 FBan0008152 FBgn0034008 CG8152 2 2R biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG8152 CG8152 CDMC22290 3 1 22 DAC35-C23 2-CG8272-RA_1 CG8272 GGTTCCCTGCAGTCCATTAAGATATCGCTCAGGAGCAAGGCCGAGGATGAGATTGTTCGGGATGCC 66 FBan0008272 FBgn0033337 CG8272 2 2R CG8272 CG8272 CT8327 CDMC22290 3 2 22 DAC35-C23 2-CG8272-RA_1 CG8272 GGTTCCCTGCAGTCCATTAAGATATCGCTCAGGAGCAAGGCCGAGGATGAGATTGTTCGGGATGCC 66 FBan0008272 FBgn0033337 CG8272 2 2R CG8272 CG8272 CT8327 CDMC22291 3 3 22 DAC35-G11 3-CG8841-RC_1 CG8841 GGAGGTCAAGCTCTTCGAGATTCAGCGCGTCTAGGTCAGTAAGTGGACTCCCAGCTACACCAGCAG 66 FBan0008841 FBgn0033713 CG8841 2 2R CG8841 CG8841 CDMC22291 3 4 22 DAC35-G11 3-CG8841-RC_1 CG8841 GGAGGTCAAGCTCTTCGAGATTCAGCGCGTCTAGGTCAGTAAGTGGACTCCCAGCTACACCAGCAG 66 FBan0008841 FBgn0033713 CG8841 2 2R CG8841 CG8841 CDMC22292 3 5 22 DAC35-G23 2-CG8942-RA_1 CG8942 GCGATCCGGGTTATCGCTTCAAGGACAACTCCCATCACGAATGCGATCCTATTTGCGACAGTGGCT 66 FBan0008942 FBgn0028545 CG8942 2 2L Wnt receptor signaling pathway; GO:0016055 structural molecule activity; GO:0005198; ; GO:0005198; Wnt-protein binding; GO:0017147; sugar binding; GO:0005529; ; GO:0017147; ; GO:0005529 CG8942 CG8942 "BG:DS00180.10, CT25688" CDMC22292 3 6 22 DAC35-G23 2-CG8942-RA_1 CG8942 GCGATCCGGGTTATCGCTTCAAGGACAACTCCCATCACGAATGCGATCCTATTTGCGACAGTGGCT 66 FBan0008942 FBgn0028545 CG8942 2 2L Wnt receptor signaling pathway; GO:0016055 structural molecule activity; GO:0005198; ; GO:0005198; Wnt-protein binding; GO:0017147; sugar binding; GO:0005529; ; GO:0017147; ; GO:0005529 CG8942 CG8942 "BG:DS00180.10, CT25688" CDMC22293 3 7 22 DAC35-K11 1-CG9451-RA_1 CG9451 CCTGCGGTCACGATTGGACCATCACAAATGTGCTATCCGCCTTGAATGTTTGGGAGGCTCAGATGC 66 FBan0009451 FBgn0036876 CG9451 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9451 CG9451 CDMC22293 3 8 22 DAC35-K11 1-CG9451-RA_1 CG9451 CCTGCGGTCACGATTGGACCATCACAAATGTGCTATCCGCCTTGAATGTTTGGGAGGCTCAGATGC 66 FBan0009451 FBgn0036876 CG9451 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9451 CG9451 CDMC22294 3 9 22 DAC35-K23 3-CG9633-RA_3 CG9633 ACTTTGACGGTCATGTGCAGCCTGTGATCCTGGTCAAGGGAACACGCATTAACGAGTTCAATGGCG 66 FBan0009633 FBgn0010173 RpA-70 3 3R DNA-dependent DNA replication; GO:0006261 single-stranded DNA binding; GO:0003697; ; GO:0003697; ; GO:0003697 DNA replication factor A complex; GO:0005662; nucleus; GO:0005634 RpA-70 Replication Protein A 70 "CG9633, CG9633, CG9633, D-SSB, dRP-A, RP-A, DRP-A, Drosophila Replication Protein A, RPA70, dmrpa1, Rpa-70, RPA 70, RPA, i164, D-RPA70, Ssb-70: Single stranded-binding protein 70, Single stranded-binding protein 70" CDMC22294 3 10 22 DAC35-K23 3-CG9633-RA_3 CG9633 ACTTTGACGGTCATGTGCAGCCTGTGATCCTGGTCAAGGGAACACGCATTAACGAGTTCAATGGCG 66 FBan0009633 FBgn0010173 RpA-70 3 3R DNA-dependent DNA replication; GO:0006261 single-stranded DNA binding; GO:0003697; ; GO:0003697; ; GO:0003697 DNA replication factor A complex; GO:0005662; nucleus; GO:0005634 RpA-70 Replication Protein A 70 "CG9633, CG9633, CG9633, D-SSB, dRP-A, RP-A, DRP-A, Drosophila Replication Protein A, RPA70, dmrpa1, Rpa-70, RPA 70, RPA, i164, D-RPA70, Ssb-70: Single stranded-binding protein 70, Single stranded-binding protein 70" CDMC22295 3 11 22 DAC35-O11 2-CR31930-RA_1 CR31930 TCTAAATTGCCGGTACTGAACGTCTTGGTCGTCTCGATGGTCAAGTTGGGAACCCTTCTCCTGGCC 66 FBan0031930 FBgn0045498 Gr22d 2 2L Gr22d Gustatory receptor 22d "Gr2940.2, Gustatory receptor 2940.2, Gr22dP, CR31930, Gustatory receptor 22d" CDMC22295 3 12 22 DAC35-O11 2-CR31930-RA_1 CR31930 TCTAAATTGCCGGTACTGAACGTCTTGGTCGTCTCGATGGTCAAGTTGGGAACCCTTCTCCTGGCC 66 FBan0031930 FBgn0045498 Gr22d 2 2L Gr22d Gustatory receptor 22d "Gr2940.2, Gustatory receptor 2940.2, Gr22dP, CR31930, Gustatory receptor 22d" CDMC22296 3 13 22 DAC35-O23 AutoBlank AutoBlank CDMC22296 3 14 22 DAC35-O23 AutoBlank AutoBlank CDMC22297 3 15 22 DAC36-C11 16-CG1821-RC_1 CG1821 GGCACCACCGATGTGAGGATCGACACCCGTCTGAACAAGCACATCTGGTCCAAGGGTATCAGGTC 65 FBan0001821 FBgn0025286 RpL31 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL31 Ribosomal protein L31 "CG1821, BcDNA:RE59131, anon-EST:Posey68, Ribosomal protein L31" CDMC22297 3 16 22 DAC36-C11 16-CG1821-RC_1 CG1821 GGCACCACCGATGTGAGGATCGACACCCGTCTGAACAAGCACATCTGGTCCAAGGGTATCAGGTC 65 FBan0001821 FBgn0025286 RpL31 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL31 Ribosomal protein L31 "CG1821, BcDNA:RE59131, anon-EST:Posey68, Ribosomal protein L31" CDMC22298 3 17 22 DAC36-C23 42-CG18290-RB_2 CG18290 TCCATACCCAATCCGAATACCGAAAGCCCACTTCTCACTTCTCCTTCTAAAAACCGCCTCCGTTC 65 FBan0018290 FBgn0000046 Act87E 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act87E Actin 87E "CG18290, CG18290, CG18290, CG18290, actin, Actin, act87E, act 87E, mus87E, E" CDMC22298 3 18 22 DAC36-C23 42-CG18290-RB_2 CG18290 TCCATACCCAATCCGAATACCGAAAGCCCACTTCTCACTTCTCCTTCTAAAAACCGCCTCCGTTC 65 FBan0018290 FBgn0000046 Act87E 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act87E Actin 87E "CG18290, CG18290, CG18290, CG18290, actin, Actin, act87E, act 87E, mus87E, E" CDMC22299 3 19 22 DAC36-G11 24-CG18508-RA_1 CG18508 TCCAAGAAGGAGATCTAGTCGAAATGTTCCAAATATTGTAATTTAACACATAGTACATTTTTTTT 65 FBan0018508 FBgn0028746 CG18508 X X CG18508 CG18508 "CG4015, CG4015, CG4015, EG:140G11.3" CDMC22299 3 20 22 DAC36-G11 24-CG18508-RA_1 CG18508 TCCAAGAAGGAGATCTAGTCGAAATGTTCCAAATATTGTAATTTAACACATAGTACATTTTTTTT 65 FBan0018508 FBgn0028746 CG18508 X X CG18508 CG18508 "CG4015, CG4015, CG4015, EG:140G11.3" CDMC22300 3 21 22 DAC36-G23 2-CG18550-RA_1 CG18550 TTGAGATTCCGCAGAGCATAGTGGAGATCGGACGTGGACTAGCCAGCATCACAATCGATGTGGGC 65 FBan0018550 FBgn0041710 yellow-f 3 3R ectoderm development; GO:0007398; indole derivative biosynthesis; GO:0042435; larval or pupal development (sensu Insecta); GO:0002165; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066 dopachrome isomerase activity; GO:0004167 ; EC:5.3.3.12; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0004167 ; EC:5.3.3.12; intramolecular oxidoreductase activity; GO:0016860 ; EC:5.3.-.-; ; GO:0005102; ; GO:0005198; ; GO:0016860 ; EC:5.3.-.- extracellular region; GO:0005576 yellow-f yellow-f "CG18550, CG18550, yellow f, yellow-f" CDMC22300 3 22 22 DAC36-G23 2-CG18550-RA_1 CG18550 TTGAGATTCCGCAGAGCATAGTGGAGATCGGACGTGGACTAGCCAGCATCACAATCGATGTGGGC 65 FBan0018550 FBgn0041710 yellow-f 3 3R ectoderm development; GO:0007398; indole derivative biosynthesis; GO:0042435; larval or pupal development (sensu Insecta); GO:0002165; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066 dopachrome isomerase activity; GO:0004167 ; EC:5.3.3.12; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0004167 ; EC:5.3.3.12; intramolecular oxidoreductase activity; GO:0016860 ; EC:5.3.-.-; ; GO:0005102; ; GO:0005198; ; GO:0016860 ; EC:5.3.-.- extracellular region; GO:0005576 yellow-f yellow-f "CG18550, CG18550, yellow f, yellow-f" CDMC22301 3 23 22 DAC36-K11 6-CG18673-RA_2 CG18673 CCCTCTATTAATGGCAGTCTCTTGCCCGGGAATTTCGAGGCCCAGAGTGTCCACTTCCATTGGGG 65 FBan0018673 FBgn0040629 CG18673 3 3R metabolism; GO:0008152; one-carbon compound metabolism; GO:0006730 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG18673 CG18673 CDMC22301 3 24 22 DAC36-K11 6-CG18673-RA_2 CG18673 CCCTCTATTAATGGCAGTCTCTTGCCCGGGAATTTCGAGGCCCAGAGTGTCCACTTCCATTGGGG 65 FBan0018673 FBgn0040629 CG18673 3 3R metabolism; GO:0008152; one-carbon compound metabolism; GO:0006730 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG18673 CG18673 CDMC22302 3 25 22 DAC36-K23 3-CG18734-RG_2 CG18734 GTTGTGGGCAGTGGTAGTGCGTACAAAAGCAGCGAATCCAAGCACGGATCCTTCGAGAACGATGG 65 FBan0018734 FBgn0004598 Fur2 X X protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004276 ; EC:3.4.21.75; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- plasma membrane; GO:0005886 Fur2 Furin 2 "CG18734, CG4235, Dfur2, Dfurin2, fur2, furin, DMH#11, FUR2, Furin-like protease, Furin, Furin 2" CDMC22302 3 26 22 DAC36-K23 3-CG18734-RG_2 CG18734 GTTGTGGGCAGTGGTAGTGCGTACAAAAGCAGCGAATCCAAGCACGGATCCTTCGAGAACGATGG 65 FBan0018734 FBgn0004598 Fur2 X X protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004276 ; EC:3.4.21.75; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- plasma membrane; GO:0005886 Fur2 Furin 2 "CG18734, CG4235, Dfur2, Dfurin2, fur2, furin, DMH#11, FUR2, Furin-like protease, Furin, Furin 2" CDMC22303 3 1 23 DAC36-O11 3-CG1907-RA_1 CG1907 TGCTCTGCTGAGACAGGCAACCTACACCACGGGAAGATTGGGCATGTACACGTATCTGAACGACC 65 FBan0001907 FBgn0039674 CG1907 3 3R alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG1907 CG1907 CDMC22303 3 2 23 DAC36-O11 3-CG1907-RA_1 CG1907 TGCTCTGCTGAGACAGGCAACCTACACCACGGGAAGATTGGGCATGTACACGTATCTGAACGACC 65 FBan0001907 FBgn0039674 CG1907 3 3R alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG1907 CG1907 CDMC22304 3 3 23 DAC36-O23 AutoBlank AutoBlank CDMC22304 3 4 23 DAC36-O23 AutoBlank AutoBlank CDMC22305 3 5 23 DAC37-C11 18-CG1692-RA_12 CG1692 GCTCCTGGCCATTGACGGATCAAGGTTTGAAATATGACCGTGAGTGGATGATCGTGGACATGAATGGCA 69 FBan0001692 FBgn0002641 mal X X Mo-molybdopterin cofactor biosynthesis; GO:0006777; ommochrome biosynthesis; GO:0006727 Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265 mal maroon-like "CG1692, ma-l, 5, section 5, bz: bronzy, bronzy, bz" CDMC22305 3 6 23 DAC37-C11 18-CG1692-RA_12 CG1692 GCTCCTGGCCATTGACGGATCAAGGTTTGAAATATGACCGTGAGTGGATGATCGTGGACATGAATGGCA 69 FBan0001692 FBgn0002641 mal X X Mo-molybdopterin cofactor biosynthesis; GO:0006777; ommochrome biosynthesis; GO:0006727 Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265 mal maroon-like "CG1692, ma-l, 5, section 5, bz: bronzy, bronzy, bz" CDMC22306 3 7 23 DAC37-C23 1-CG16940-RA_1 CG16940 AATAGGGTGCTATGGCTGCACGACATTGCAAGCTCCATCCGTAAGACACGTTTAGACAATGGCGCACTC 69 FBan0016940 FBgn0035111 CG16940 3 3L RNA catabolism; GO:0006401; mitosis; GO:0007067 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; exoribonuclease II activity; GO:0008859 ; EC:3.1.13.1; ; GO:0003676; ; GO:0003729; ; GO:0008859 ; EC:3.1.13.1 cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 CG16940 CG16940 CDMC22306 3 8 23 DAC37-C23 1-CG16940-RA_1 CG16940 AATAGGGTGCTATGGCTGCACGACATTGCAAGCTCCATCCGTAAGACACGTTTAGACAATGGCGCACTC 69 FBan0016940 FBgn0035111 CG16940 3 3L RNA catabolism; GO:0006401; mitosis; GO:0007067 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; exoribonuclease II activity; GO:0008859 ; EC:3.1.13.1; ; GO:0003676; ; GO:0003729; ; GO:0008859 ; EC:3.1.13.1 cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 CG16940 CG16940 CDMC22307 3 9 23 DAC37-G11 23-CG16973-RA_13 CG16973 TTTGCTCAACCGGCAACAAAATCAACCCATAAACATTTTCTTCTTATTTTACCACAAAAGGCAAACGAA 69 FBan0016973 FBgn0010909 msn 3 3L JNK cascade; GO:0007254; activation of MAPKKK activity; GO:0000185; dorsal closure; GO:0007391; embryonic eye morphogenesis (sensu Endopterygota); GO:0048049; establishment of planar polarity; GO:0001736; nuclear migration; GO:0007097; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase kinase activity; GO:0008349 ; EC:2.7.1.-; ; GO:0008349 ; EC:2.7.1.-; ; GO:0008349 ; EC:2.7.1.-; JUN kinase kinase kinase kinase activity; GO:0042656; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042656; ; GO:0008349 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; small GTPase regulator activity; GO:0005083; ; GO:0005083 msn misshapen "CG16973, CG16973, CG16973, l(3)j1E2, l(3)06946, 6286, msm, Mishappen, l(3)6286, MESR5, NIK, Msn, MSN, DMSN, Nik, l(3)03349, misshapen" CDMC22307 3 10 23 DAC37-G11 23-CG16973-RA_13 CG16973 TTTGCTCAACCGGCAACAAAATCAACCCATAAACATTTTCTTCTTATTTTACCACAAAAGGCAAACGAA 69 FBan0016973 FBgn0010909 msn 3 3L JNK cascade; GO:0007254; activation of MAPKKK activity; GO:0000185; dorsal closure; GO:0007391; embryonic eye morphogenesis (sensu Endopterygota); GO:0048049; establishment of planar polarity; GO:0001736; nuclear migration; GO:0007097; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase kinase activity; GO:0008349 ; EC:2.7.1.-; ; GO:0008349 ; EC:2.7.1.-; ; GO:0008349 ; EC:2.7.1.-; JUN kinase kinase kinase kinase activity; GO:0042656; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042656; ; GO:0008349 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; small GTPase regulator activity; GO:0005083; ; GO:0005083 msn misshapen "CG16973, CG16973, CG16973, l(3)j1E2, l(3)06946, 6286, msm, Mishappen, l(3)6286, MESR5, NIK, Msn, MSN, DMSN, Nik, l(3)03349, misshapen" CDMC22308 3 11 23 DAC37-G23 2-CG16982-RA_1 CG16982 CAACCGCGAGTGGGATTTCCAGAAGTACGGCCACTAAAATCTACAAAACCCCCAAGACCCACCAGATGG 69 FBan0016982 FBgn0025638 Roc1a X X cell proliferation; GO:0008283; protein ubiquitination; GO:0016567; protein ubiquitination during ubiquitin-dependent protein catabolism; GO:0042787; proteolysis; GO:0006508; smoothened signaling pathway; GO:0007224; ubiquitin cycle; GO:0006512 protein binding; GO:0005515; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 SCF ubiquitin ligase complex; GO:0019005; cytoplasm; GO:0005737; nucleus; GO:0005634 Roc1a Roc1a "CG16982, CG16982, CG16982, CG16982, CG16982, CK01110, dRoc1a, EG:115C2.11, ROC1, dRbx1, Rbx1, Rbx1/Roc, Roc1alpha, BEST:CK01110, anon-EST:Posey65" CDMC22308 3 12 23 DAC37-G23 2-CG16982-RA_1 CG16982 CAACCGCGAGTGGGATTTCCAGAAGTACGGCCACTAAAATCTACAAAACCCCCAAGACCCACCAGATGG 69 FBan0016982 FBgn0025638 Roc1a X X cell proliferation; GO:0008283; protein ubiquitination; GO:0016567; protein ubiquitination during ubiquitin-dependent protein catabolism; GO:0042787; proteolysis; GO:0006508; smoothened signaling pathway; GO:0007224; ubiquitin cycle; GO:0006512 protein binding; GO:0005515; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 SCF ubiquitin ligase complex; GO:0019005; cytoplasm; GO:0005737; nucleus; GO:0005634 Roc1a Roc1a "CG16982, CG16982, CG16982, CG16982, CG16982, CK01110, dRoc1a, EG:115C2.11, ROC1, dRbx1, Rbx1, Rbx1/Roc, Roc1alpha, BEST:CK01110, anon-EST:Posey65" CDMC22309 3 13 23 DAC37-K11 15-CG1701-RA_4 CG1701 AGCTGCCGAGCTTTAAAATGCCGAACATCACAATTGTCATCGTGGAAGACGAGTTGTCCAAGATTGCGA 69 FBan0001701 FBgn0033167 CG1701 2 2R CG1701 CG1701 CDMC22309 3 14 23 DAC37-K11 15-CG1701-RA_4 CG1701 AGCTGCCGAGCTTTAAAATGCCGAACATCACAATTGTCATCGTGGAAGACGAGTTGTCCAAGATTGCGA 69 FBan0001701 FBgn0033167 CG1701 2 2R CG1701 CG1701 CDMC22310 3 15 23 DAC37-K23 22-CG17028-RA_1 CG17028 TCACCGTGTACGACAAGCAAATAGAAGCCACTCTAACAGATGGTTTGCTAAAGACCTTTCCGGAATCCA 69 FBan0017028 FBgn0036552 CG17028 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17028 CG17028 IMP CDMC22310 3 16 23 DAC37-K23 22-CG17028-RA_1 CG17028 TCACCGTGTACGACAAGCAAATAGAAGCCACTCTAACAGATGGTTTGCTAAAGACCTTTCCGGAATCCA 69 FBan0017028 FBgn0036552 CG17028 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17028 CG17028 IMP CDMC22311 3 17 23 DAC37-O11 6-CG17059-RA_1 CG17059 TGATCTGTTCGATGAAGACAACTGGGCCAAGATGAAAACCGATGGGAAACAGTAGAGGCCACCACGCAA 69 FBan0017059 FBgn0040754 CG17059 2 2R CG17059 CG17059 BcDNA:GH04581 CDMC22311 3 18 23 DAC37-O11 6-CG17059-RA_1 CG17059 TGATCTGTTCGATGAAGACAACTGGGCCAAGATGAAAACCGATGGGAAACAGTAGAGGCCACCACGCAA 69 FBan0017059 FBgn0040754 CG17059 2 2R CG17059 CG17059 BcDNA:GH04581 CDMC22312 3 19 23 DAC37-O23 AutoBlank AutoBlank CDMC22312 3 20 23 DAC37-O23 AutoBlank AutoBlank CDMC22313 3 21 23 DAC38-C11 7-CG17594-RA_1 CG17594 ACTATGGCGAATCCGTACGCTATGGGAACCTTATATCACAGCCCAGGTGTACAGACCTATTGCGGACCT 69 CDMC22313 3 22 23 DAC38-C11 7-CG17594-RA_1 CG17594 ACTATGGCGAATCCGTACGCTATGGGAACCTTATATCACAGCCCAGGTGTACAGACCTATTGCGGACCT 69 CDMC22314 3 23 23 DAC38-C23 18-CG17601-RA_4 CG17601 TCCACTGGCAACTGAAACAATAAATCGGCGTCCGGATACATTCTCATATTTTCTCCCCGGTCCAAATGA 69 FBan0017601 FBgn0031197 CG17601 X X CG17601 CG17601 CDMC22314 3 24 23 DAC38-C23 18-CG17601-RA_4 CG17601 TCCACTGGCAACTGAAACAATAAATCGGCGTCCGGATACATTCTCATATTTTCTCCCCGGTCCAAATGA 69 FBan0017601 FBgn0031197 CG17601 X X CG17601 CG17601 CDMC22315 3 25 23 DAC38-G11 23-CG17648-RA_1 CG17648 GAATCATTTAAAAATATCAAATTTCAAATGATTTCGATTGCTCAGTTGCTGACCTCTTTTACGGCCGGA 69 FBan0017648 FBgn0031364 CG17648 2 2L CG17648 CG17648 BcDNA:GH02930 CDMC22315 3 26 23 DAC38-G11 23-CG17648-RA_1 CG17648 GAATCATTTAAAAATATCAAATTTCAAATGATTTCGATTGCTCAGTTGCTGACCTCTTTTACGGCCGGA 69 FBan0017648 FBgn0031364 CG17648 2 2L CG17648 CG17648 BcDNA:GH02930 CDMC22316 3 1 24 DAC38-G23 23-CG17665-RA_11 CG17665 GTCAACGCTATGAAGAAAAACTGTCTGAAATCATTGCTTCCCTGCTTACATCAAAATACCCCAGTTCAT 69 FBgn0039997 CG17665 CG17665 CG17665 CDMC22316 3 2 24 DAC38-G23 23-CG17665-RA_11 CG17665 GTCAACGCTATGAAGAAAAACTGTCTGAAATCATTGCTTCCCTGCTTACATCAAAATACCCCAGTTCAT 69 FBgn0039997 CG17665 CG17665 CG17665 CDMC22317 3 3 24 DAC38-K11 3-CG17712-RA_1 CG17712 CCGACAGCCCCCTGAATCACGACCAGATAATTCGATATGCACGCATGTCCACAATGTGAGGGAGTCTGT 69 FBan0017712 FBgn0027597 CG17712 2 2L CG17712 CG17712 BcDNA:GH03377 CDMC22317 3 4 24 DAC38-K11 3-CG17712-RA_1 CG17712 CCGACAGCCCCCTGAATCACGACCAGATAATTCGATATGCACGCATGTCCACAATGTGAGGGAGTCTGT 69 FBan0017712 FBgn0027597 CG17712 2 2L CG17712 CG17712 BcDNA:GH03377 CDMC22318 3 5 24 DAC38-K23 11-CG17723-RB_4 CG17723 TTGCCGAAAAGGTGAAGGAGTTCTTCCACAACGAGGGTATCCACTCTACCACCATTCAGCCAGAGTTCA 69 FBan0017723 FBgn0035432 CG17723 3 3L cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG17723 CG17723 CDMC22318 3 6 24 DAC38-K23 11-CG17723-RB_4 CG17723 TTGCCGAAAAGGTGAAGGAGTTCTTCCACAACGAGGGTATCCACTCTACCACCATTCAGCCAGAGTTCA 69 FBan0017723 FBgn0035432 CG17723 3 3L cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG17723 CG17723 CDMC22319 3 7 24 DAC38-O11 23-CG1775-RA_2 CG1775 GCAAGCGAAACAAGTAGATGTAACATAAGTGTAATAAACAGACCGTGAAATTACGATTCTAAAGGCTTC 69 FBan0001775 FBgn0011655 Med 3 3R "BMP signaling pathway; GO:0030509; cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476" "DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity; GO:0030616; ; GO:0003702; protein binding; GO:0005515; ; GO:0030616; ; GO:0005515" cytoplasm; GO:0005737; nucleus; GO:0005634 Med Medea "CG1775, l(3)11m-254, l(3)12m-137, l(3)SG70: lethal(3)SG70, medea, dSmad4, med: medusa, E(zen)3, anon-EST:Posey121, l(3)SG36: lethal(3)SG36, l(3)XIIm137, lethal(3)SG36, lethal(3)SG70, med, l(3)SG70, Medea" CDMC22319 3 8 24 DAC38-O11 23-CG1775-RA_2 CG1775 GCAAGCGAAACAAGTAGATGTAACATAAGTGTAATAAACAGACCGTGAAATTACGATTCTAAAGGCTTC 69 FBan0001775 FBgn0011655 Med 3 3R "BMP signaling pathway; GO:0030509; cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476" "DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity; GO:0030616; ; GO:0003702; protein binding; GO:0005515; ; GO:0030616; ; GO:0005515" cytoplasm; GO:0005737; nucleus; GO:0005634 Med Medea "CG1775, l(3)11m-254, l(3)12m-137, l(3)SG70: lethal(3)SG70, medea, dSmad4, med: medusa, E(zen)3, anon-EST:Posey121, l(3)SG36: lethal(3)SG36, l(3)XIIm137, lethal(3)SG36, lethal(3)SG70, med, l(3)SG70, Medea" CDMC22320 3 9 24 DAC38-O23 AutoBlank AutoBlank CDMC22320 3 10 24 DAC38-O23 AutoBlank AutoBlank CDMC22321 3 11 24 DAC39-C11 17-CG32226-RA_1 CG32226 ACCTACTATGTGTACGAAAATCAACGTTGGAATCCAATCAGTGGTTTCACGGCGAAGAGCCTGCC 65 FBan0032226 FBgn0052226 CG32226 3 3L sugar binding; GO:0005529; ; GO:0005529 integral to membrane; GO:0016021 CG32226 CG32226 "CG6468, CG18565, CG6468, CG18565" CDMC22321 3 12 24 DAC39-C11 17-CG32226-RA_1 CG32226 ACCTACTATGTGTACGAAAATCAACGTTGGAATCCAATCAGTGGTTTCACGGCGAAGAGCCTGCC 65 FBan0032226 FBgn0052226 CG32226 3 3L sugar binding; GO:0005529; ; GO:0005529 integral to membrane; GO:0016021 CG32226 CG32226 "CG6468, CG18565, CG6468, CG18565" CDMC22322 3 13 24 DAC39-C23 3-CG32256-RA_1 CG32256 CTACGAACTGGTGCTCATCAACCAAATGGCTGGATCTGAGGTGCAAAAGAGCTTCTGCGAGGGCG 65 FBan0032256 FBgn0045477 Gr64c 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64c Gustatory receptor 64c "CG14986, CG32256, CG14986, Gustatory receptor 64c" CDMC22322 3 14 24 DAC39-C23 3-CG32256-RA_1 CG32256 CTACGAACTGGTGCTCATCAACCAAATGGCTGGATCTGAGGTGCAAAAGAGCTTCTGCGAGGGCG 65 FBan0032256 FBgn0045477 Gr64c 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64c Gustatory receptor 64c "CG14986, CG32256, CG14986, Gustatory receptor 64c" CDMC22323 3 15 24 DAC39-G11 23-CG32408-RA_1 CG32408 CTTTTGTGGTGGCAGTCTGTTTATTTACGCCGCATTGTATGTAGAAACTTACATATGGGCGAGCC 65 FBan0032408 FBgn0052408 CG32408 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32408 CG32408 CDMC22323 3 16 24 DAC39-G11 23-CG32408-RA_1 CG32408 CTTTTGTGGTGGCAGTCTGTTTATTTACGCCGCATTGTATGTAGAAACTTACATATGGGCGAGCC 65 FBan0032408 FBgn0052408 CG32408 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32408 CG32408 CDMC22324 3 17 24 DAC39-G23 23-CG32431-RA_1 CG32431 AGCTCACTACGACACCCATAAAGGCAAGTTTTATGCCCTAACTTGATCGTTAAACTCCCATGAGG 65 FBan0032431 FBgn0052431 CG32431 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32431 CG32431 CDMC22324 3 18 24 DAC39-G23 23-CG32431-RA_1 CG32431 AGCTCACTACGACACCCATAAAGGCAAGTTTTATGCCCTAACTTGATCGTTAAACTCCCATGAGG 65 FBan0032431 FBgn0052431 CG32431 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32431 CG32431 CDMC22325 3 19 24 DAC39-K11 6-CG32506-RA_1 CG32506 CAATCACCTGACTGTGAAACCCATTCCGAGAGCCATGAAGACCAGCACGGATTCGGGTCACGTGG 65 FBan0032506 FBgn0052506 CG32506 X X intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG32506 CG32506 CDMC22325 3 20 24 DAC39-K11 6-CG32506-RA_1 CG32506 CAATCACCTGACTGTGAAACCCATTCCGAGAGCCATGAAGACCAGCACGGATTCGGGTCACGTGG 65 FBan0032506 FBgn0052506 CG32506 X X intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG32506 CG32506 CDMC22326 3 21 24 DAC39-K23 19-CG32531-RA_2 CG32531 TTACGTCACGTCCGCGCGGAGTTGTCCACAAGTACAGGCTCAGTCGAATCGTGTGGCGCCACCTC 65 FBan0032531 FBgn0044030 mRpS14 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpS14 mitochondrial ribosomal protein S14 "CG12211, CG32531, CG12211, CG12211, cg12211, MRP-S14, Mitochondrial ribosomal protein S14, S14, MrpS14, mitochondrial ribosomal protein S14" CDMC22326 3 22 24 DAC39-K23 19-CG32531-RA_2 CG32531 TTACGTCACGTCCGCGCGGAGTTGTCCACAAGTACAGGCTCAGTCGAATCGTGTGGCGCCACCTC 65 FBan0032531 FBgn0044030 mRpS14 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpS14 mitochondrial ribosomal protein S14 "CG12211, CG32531, CG12211, CG12211, cg12211, MRP-S14, Mitochondrial ribosomal protein S14, S14, MrpS14, mitochondrial ribosomal protein S14" CDMC22327 3 23 24 DAC39-O11 23-CG32596-RA_2 CG32596 CTGCGGAGTGACATTGACAAAGTTTGCACAAAAACGATGTCTGAACTGACAGCTAAGTTGCCGCT 65 FBgn0052596 CG32596 CG32596 CG32596 CDMC22327 3 24 24 DAC39-O11 23-CG32596-RA_2 CG32596 CTGCGGAGTGACATTGACAAAGTTTGCACAAAAACGATGTCTGAACTGACAGCTAAGTTGCCGCT 65 FBgn0052596 CG32596 CG32596 CG32596 CDMC22328 3 25 24 DAC39-O23 AutoBlank AutoBlank CDMC22328 3 26 24 DAC39-O23 AutoBlank AutoBlank CDMC22329 3 1 25 DAC40-C11 16-CG41135-RA_1 CG41135 GAGTGCCGCTCGAGTCCGTCTTTGCAATTACGAGATCATCATGGCCCGGGGGGTACGAGATCGGC 65 FBgn0069917 CG41135 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41135 CG41135 CDMC22329 3 2 25 DAC40-C11 16-CG41135-RA_1 CG41135 GAGTGCCGCTCGAGTCCGTCTTTGCAATTACGAGATCATCATGGCCCGGGGGGTACGAGATCGGC 65 FBgn0069917 CG41135 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41135 CG41135 CDMC22330 3 3 25 DAC40-C23 3-CG4143-RB_2 CG4143 CGGACTGGGACTCTGTGACTGTTCTTCGGAAGAAAGCACCGAAATCGTCGACCCTCAAGACGGAA 65 FBan0004143 FBgn0026208 mbf1 3 3L central nervous system development; GO:0007417; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 methyl-CpG binding; GO:0008327; transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0008327 cytoplasm; GO:0005737; nucleus; GO:0005634 mbf1 multiprotein bridging factor 1 "CG4143, MBF1, BcDNA:GH10148, BcDNA:GM01267, multiprotein bridging factor 1" CDMC22330 3 4 25 DAC40-C23 3-CG4143-RB_2 CG4143 CGGACTGGGACTCTGTGACTGTTCTTCGGAAGAAAGCACCGAAATCGTCGACCCTCAAGACGGAA 65 FBan0004143 FBgn0026208 mbf1 3 3L central nervous system development; GO:0007417; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 methyl-CpG binding; GO:0008327; transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0008327 cytoplasm; GO:0005737; nucleus; GO:0005634 mbf1 multiprotein bridging factor 1 "CG4143, MBF1, BcDNA:GH10148, BcDNA:GM01267, multiprotein bridging factor 1" CDMC22331 3 5 25 DAC40-G11 9-CG4278-RA_3 CG4278 TCAGCTATCATCCGCCAATTTTCAAGCCCCTGACCAGGATTACGCAGTCACATTGGAAGGAGCGC 65 FBan0004278 FBgn0014092 CG4278 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4278 CG4278 "BG:DS02740.16, un5, anon-35F/36A" CDMC22331 3 6 25 DAC40-G11 9-CG4278-RA_3 CG4278 TCAGCTATCATCCGCCAATTTTCAAGCCCCTGACCAGGATTACGCAGTCACATTGGAAGGAGCGC 65 FBan0004278 FBgn0014092 CG4278 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4278 CG4278 "BG:DS02740.16, un5, anon-35F/36A" CDMC22332 3 7 25 DAC40-G23 3-CG4303-RA_2 CG4303 TGAGCTGATCATCTCCACCAGCCAATTCGTGGAGTCCACCGTCAAGAGACCTCCATAAACCGTGC 65 FBan0004303 FBgn0025463 Bap60 X X "chromatin assembly or disassembly; GO:0006333; positive regulation of transcription, DNA-dependent; GO:0045893" chromatin binding; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585 Bap60 Brahma associated protein 60kD "CG4303, CG4303, BAP60, BRM-associated protein 60, brahma associated protein 60 kDa, BAPp60, i133, i127" CDMC22332 3 8 25 DAC40-G23 3-CG4303-RA_2 CG4303 TGAGCTGATCATCTCCACCAGCCAATTCGTGGAGTCCACCGTCAAGAGACCTCCATAAACCGTGC 65 FBan0004303 FBgn0025463 Bap60 X X "chromatin assembly or disassembly; GO:0006333; positive regulation of transcription, DNA-dependent; GO:0045893" chromatin binding; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585 Bap60 Brahma associated protein 60kD "CG4303, CG4303, BAP60, BRM-associated protein 60, brahma associated protein 60 kDa, BAPp60, i133, i127" CDMC22333 3 9 25 DAC40-K11 9-CG4409-RA_4 CG4409 GGGTTTTCCCCAGGACGATCTAATTAAGCCGGGTAGTGACGAATCGGATGTGAGTGGCATTGGCT 65 FBan0004409 FBgn0034128 CG4409 2 2R CG4409 CG4409 CDMC22333 3 10 25 DAC40-K11 9-CG4409-RA_4 CG4409 GGGTTTTCCCCAGGACGATCTAATTAAGCCGGGTAGTGACGAATCGGATGTGAGTGGCATTGGCT 65 FBan0004409 FBgn0034128 CG4409 2 2R CG4409 CG4409 CDMC22334 3 11 25 DAC40-K23 23-CG4464-RB_3 CG4464 ACTTCTATTGTAAGCGCTTTTTGTTTGCACGAGAGAGATGAGAAAATAAAACCAACCACAATTTG 65 FBan0004464 FBgn0010412 RpS19a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS19a Ribosomal protein S19a "CG4464, CG4464, S19: Shell-19, ribosomal protein S19, RpS19: Ribosomal protein S19, BcDNA:GM26647, Ribosomal protein S19, RpS19, S19, Ribosomal protein S19a" CDMC22334 3 12 25 DAC40-K23 23-CG4464-RB_3 CG4464 ACTTCTATTGTAAGCGCTTTTTGTTTGCACGAGAGAGATGAGAAAATAAAACCAACCACAATTTG 65 FBan0004464 FBgn0010412 RpS19a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS19a Ribosomal protein S19a "CG4464, CG4464, S19: Shell-19, ribosomal protein S19, RpS19: Ribosomal protein S19, BcDNA:GM26647, Ribosomal protein S19, RpS19, S19, Ribosomal protein S19a" CDMC22335 3 13 25 DAC40-O11 18-CG4585-RA_1 CG4585 ATCCGCTTTGCCATGTGACCGTGAAGGCCATTCTGTTGGACCACACCAACCACTACCTGTTCGCC 65 FBan0004585 FBgn0025335 CG4585 2 2R CG4585 CG4585 "UD2, undefined 2, CK00282, anon-60Ab" CDMC22335 3 14 25 DAC40-O11 18-CG4585-RA_1 CG4585 ATCCGCTTTGCCATGTGACCGTGAAGGCCATTCTGTTGGACCACACCAACCACTACCTGTTCGCC 65 FBan0004585 FBgn0025335 CG4585 2 2R CG4585 CG4585 "UD2, undefined 2, CK00282, anon-60Ab" CDMC22336 3 15 25 DAC40-O23 AutoBlank AutoBlank CDMC22336 3 16 25 DAC40-O23 AutoBlank AutoBlank CDMC22337 3 17 25 DAC41-C11 23-CG4584-RA_1 CG4584 CTCTGTACTTTCGAAGCATTCCTGTAATAACTCAATTTGCTCCAAATGCCATCAACCGATTTCGCCGAC 69 FBgn0027890 CDMC22337 3 18 25 DAC41-C11 23-CG4584-RA_1 CG4584 CTCTGTACTTTCGAAGCATTCCTGTAATAACTCAATTTGCTCCAAATGCCATCAACCGATTTCGCCGAC 69 FBgn0027890 CDMC22338 3 19 25 DAC41-C23 14-CG4597-RA_1 CG4597 ACGAACAAGGATCTCTGCAAGCTCCTCGATTCACTTCGCAATATTACAGTGGAGGAAATTCCGGGCGAA 69 FBan0004597 FBgn0035594 CG4597 3 3L CG4597 CG4597 CDMC22338 3 20 25 DAC41-C23 14-CG4597-RA_1 CG4597 ACGAACAAGGATCTCTGCAAGCTCCTCGATTCACTTCGCAATATTACAGTGGAGGAAATTCCGGGCGAA 69 FBan0004597 FBgn0035594 CG4597 3 3L CG4597 CG4597 CDMC22339 3 21 25 DAC41-G11 3-CG4620-RB_8 CG4620 AGTGGAAGGAGCGCTATGACCTAGCACAGATACAGCTAAATTTGCCAGCAGAGCTTCGGGACTTGTCCA 69 FBan0004620 FBgn0004395 unk 3 3R bristle morphogenesis; GO:0008407; eye development (sensu Endopterygota); GO:0007456; larval development; GO:0002164; protein ubiquitination; GO:0016567; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 unk unkempt CG4620 CDMC22339 3 22 25 DAC41-G11 3-CG4620-RB_8 CG4620 AGTGGAAGGAGCGCTATGACCTAGCACAGATACAGCTAAATTTGCCAGCAGAGCTTCGGGACTTGTCCA 69 FBan0004620 FBgn0004395 unk 3 3R bristle morphogenesis; GO:0008407; eye development (sensu Endopterygota); GO:0007456; larval development; GO:0002164; protein ubiquitination; GO:0016567; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 unk unkempt CG4620 CDMC22340 3 23 25 DAC41-G23 3-CG4629-RA_1 CG4629 CGCTGGGTCTTTGAGTTCCCCGAGAGGAAAGGCAAACTGGGTGTGTCGCTTTTGAAAGGAATCTAAGGT 69 FBan0004629 FBgn0031299 CG4629 2 2L cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG4629 CG4629 anon-WO0257455.15 CDMC22340 3 24 25 DAC41-G23 3-CG4629-RA_1 CG4629 CGCTGGGTCTTTGAGTTCCCCGAGAGGAAAGGCAAACTGGGTGTGTCGCTTTTGAAAGGAATCTAAGGT 69 FBan0004629 FBgn0031299 CG4629 2 2L cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG4629 CG4629 anon-WO0257455.15 CDMC22341 3 25 25 DAC41-K11 9-CG4661-RA_2 CG4661 TGCTGCCTAATGCTAGGGATCAAGACACGATTGGCTAGTGAGCGCCAAACTTTGGATAACCACTGTCCG 69 FBan0004661 FBgn0030429 CG4661 X X CG4661 CG4661 CDMC22341 3 26 25 DAC41-K11 9-CG4661-RA_2 CG4661 TGCTGCCTAATGCTAGGGATCAAGACACGATTGGCTAGTGAGCGCCAAACTTTGGATAACCACTGTCCG 69 FBan0004661 FBgn0030429 CG4661 X X CG4661 CG4661 CDMC22342 3 1 26 DAC41-K23 8-CG4670-RA_1 CG4670 TGTGATGATGGTGTTGGCATTTAAATTGTTCGCCTTCAAGGGATACCGCAAGAAGCCCTATGGCCACGA 69 FBan0004670 FBgn0033814 CG4670 2 2R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG4670 CG4670 CDMC22342 3 2 26 DAC41-K23 8-CG4670-RA_1 CG4670 TGTGATGATGGTGTTGGCATTTAAATTGTTCGCCTTCAAGGGATACCGCAAGAAGCCCTATGGCCACGA 69 FBan0004670 FBgn0033814 CG4670 2 2R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG4670 CG4670 CDMC22343 3 3 26 DAC41-O11 3-CG4697-RA_1 CG4697 GGCCTTTGCGCTCTAGCCACTTTCGATCGGGAAACCTTACAGCTGAACGCTATCAACTCGGAAGCATTT 69 FBgn0028869 CDMC22343 3 4 26 DAC41-O11 3-CG4697-RA_1 CG4697 GGCCTTTGCGCTCTAGCCACTTTCGATCGGGAAACCTTACAGCTGAACGCTATCAACTCGGAAGCATTT 69 FBgn0028869 CDMC22344 3 5 26 DAC41-O23 23-CG4703-RA_1 CG4703 CGGGCTCCATTCTAAAGGAATATGCTAGTTAAGATCAAAGTTATATATCCGTACTACTTGTGTCTCGTT 69 FBan0004703 FBgn0038742 Arc42 3 3R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 mediator complex; GO:0000119 Arc42 Arc42 "CG4703, CG4703, dARC42" CDMC22344 3 6 26 DAC41-O23 23-CG4703-RA_1 CG4703 CGGGCTCCATTCTAAAGGAATATGCTAGTTAAGATCAAAGTTATATATCCGTACTACTTGTGTCTCGTT 69 FBan0004703 FBgn0038742 Arc42 3 3R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 mediator complex; GO:0000119 Arc42 Arc42 "CG4703, CG4703, dARC42" CDMC22345 3 7 26 DAC42-C11 150mM NaPO4 Blank CDMC22345 3 8 26 DAC42-C11 150mM NaPO4 Blank CDMC22346 3 9 26 DAC42-C23 150mM NaPO4 Blank CDMC22346 3 10 26 DAC42-C23 150mM NaPO4 Blank CDMC22347 3 11 26 DAC42-G11 150mM NaPO4 Blank CDMC22347 3 12 26 DAC42-G11 150mM NaPO4 Blank CDMC22348 3 13 26 DAC42-G23 150mM NaPO4 Blank CDMC22348 3 14 26 DAC42-G23 150mM NaPO4 Blank CDMC22349 3 15 26 DAC42-K11 150mM NaPO4 Blank CDMC22349 3 16 26 DAC42-K11 150mM NaPO4 Blank CDMC22350 3 17 26 DAC42-K23 5uM MSP 5uM MSP CDMC22350 3 18 26 DAC42-K23 5uM MSP 5uM MSP CDMC22351 3 19 26 DAC42-O11 10uM MSP 10uM MSP CDMC22351 3 20 26 DAC42-O11 10uM MSP 10uM MSP CDMC22352 3 21 26 DAC42-O23 20uM MSP 20uM MSP CDMC22352 3 22 26 DAC42-O23 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC22353 4 1 1 DAC01-D11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22353 4 2 1 DAC01-D11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22354 4 3 1 DAC01-D23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22354 4 4 1 DAC01-D23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22355 4 5 1 DAC01-H11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22355 4 6 1 DAC01-H11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22356 4 7 1 DAC01-H23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22356 4 8 1 DAC01-H23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22357 4 9 1 DAC01-L11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22357 4 10 1 DAC01-L11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22358 4 11 1 DAC01-L23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22358 4 12 1 DAC01-L23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22359 4 13 1 DAC01-P11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22359 4 14 1 DAC01-P11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22360 4 15 1 DAC01-P23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22360 4 16 1 DAC01-P23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22361 4 17 1 DAC02-D11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22361 4 18 1 DAC02-D11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22362 4 19 1 DAC02-D23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22362 4 20 1 DAC02-D23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22363 4 21 1 DAC02-H11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22363 4 22 1 DAC02-H11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22364 4 23 1 DAC02-H23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22364 4 24 1 DAC02-H23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22365 4 25 1 DAC02-L11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22365 4 26 1 DAC02-L11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22366 4 1 2 DAC02-L23 N/A CG9075 (00957-01195) CDMC22366 4 2 2 DAC02-L23 N/A CG9075 (00957-01195) CDMC22367 4 3 2 DAC02-P11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22367 4 4 2 DAC02-P11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22368 4 5 2 DAC02-P23 AutoBlank AutoBlank CDMC22368 4 6 2 DAC02-P23 AutoBlank AutoBlank CDMC22369 4 7 2 DAC03-D11 2-CG3889-RA_1 CG3889 CTTTGATCATGGGCAAGCAGTACCAGCGTCATACCCGCATGCTTGTTCTTCGTGCTGCAATGCTC 65 FBan0003889 FBgn0027057 CSN1b 3 3L signal transduction; GO:0007165 small GTPase regulator activity; GO:0005083; ; GO:0005083 signalosome complex; GO:0008180 CSN1b COP9 complex homolog subunit 1 b "CG3889, Dch1-2, Drosophila COP9 signalosome homolog 1, DCH1-2, COP9 complex homolog subunit 1-2, CSN1, dCSN1, csn1, CH1-2" CDMC22369 4 8 2 DAC03-D11 2-CG3889-RA_1 CG3889 CTTTGATCATGGGCAAGCAGTACCAGCGTCATACCCGCATGCTTGTTCTTCGTGCTGCAATGCTC 65 FBan0003889 FBgn0027057 CSN1b 3 3L signal transduction; GO:0007165 small GTPase regulator activity; GO:0005083; ; GO:0005083 signalosome complex; GO:0008180 CSN1b COP9 complex homolog subunit 1 b "CG3889, Dch1-2, Drosophila COP9 signalosome homolog 1, DCH1-2, COP9 complex homolog subunit 1-2, CSN1, dCSN1, csn1, CH1-2" CDMC22370 4 9 2 DAC03-D23 4-CG3911-RA_1 CG3911 GACGCCAAGAAAGTGAACTCGGAGTTCCTGACACTCACCTACGGAGCACTCGTCACCCAGATGCT 65 FBan0003911 FBgn0035992 CG3911 3 3L CG3911 CG3911 CDMC22370 4 10 2 DAC03-D23 4-CG3911-RA_1 CG3911 GACGCCAAGAAAGTGAACTCGGAGTTCCTGACACTCACCTACGGAGCACTCGTCACCCAGATGCT 65 FBan0003911 FBgn0035992 CG3911 3 3L CG3911 CG3911 CDMC22371 4 11 2 DAC03-H11 1-CG40043-RA_1 CG40043 TGGTCTTTCGGAGGAAACGACAAGGACCTGACGTATTTGAAAGGGGCAGTGGAGTCAGTGGTCGG 65 FBgn0058043 CG40043 CG40043 CG40043 CDMC22371 4 12 2 DAC03-H11 1-CG40043-RA_1 CG40043 TGGTCTTTCGGAGGAAACGACAAGGACCTGACGTATTTGAAAGGGGCAGTGGAGTCAGTGGTCGG 65 FBgn0058043 CG40043 CG40043 CG40043 CDMC22372 4 13 2 DAC03-H23 1-CG40121-RA_1 CG40121 AACTTTGGAGACACAATTTAGCTCAGCAGCCCCAACCGCATCAACACCACATGCCCATCAGGATC 65 FBgn0058121 CG40121 CG40121 CG40121 CDMC22372 4 14 2 DAC03-H23 1-CG40121-RA_1 CG40121 AACTTTGGAGACACAATTTAGCTCAGCAGCCCCAACCGCATCAACACCACATGCCCATCAGGATC 65 FBgn0058121 CG40121 CG40121 CG40121 CDMC22373 4 15 2 DAC03-L11 24-CG40270-RA_3 CG40270 CAAAAATGAATTTAGTGGGAAACATTTCGACTTTAAGAATTTTTTGAGAGCTAAGTGCCTAATGA 65 FBgn0058270 CG40270 CG40270 CG40270 CDMC22373 4 16 2 DAC03-L11 24-CG40270-RA_3 CG40270 CAAAAATGAATTTAGTGGGAAACATTTCGACTTTAAGAATTTTTTGAGAGCTAAGTGCCTAATGA 65 FBgn0058270 CG40270 CG40270 CG40270 CDMC22374 4 17 2 DAC03-L23 23-CG40339-RA_5 CG40339 ATCAAGCAGACTTGTATACTCCTGTTCTCTGGAAATCATATTGGTAATGATCATCCTCGTAAGCA 65 FBgn0058339 CG40339 CG40339 CG40339 CDMC22374 4 18 2 DAC03-L23 23-CG40339-RA_5 CG40339 ATCAAGCAGACTTGTATACTCCTGTTCTCTGGAAATCATATTGGTAATGATCATCCTCGTAAGCA 65 FBgn0058339 CG40339 CG40339 CG40339 CDMC22375 4 19 2 DAC03-P11 3-CG4058-RA_1 CG4058 ACAGCTCCTGCCATCGTCAATGCCTATTATAGCCGCAACAAGAACCAGATCATGTTTCCCGCCGG 65 FBan0004058 FBgn0038818 Nep4 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep4 Neprilysin 4 "CG4058, CG4058, CG4058, CG4058, CG4058, dNEP4, Neprilysin 4" CDMC22375 4 20 2 DAC03-P11 3-CG4058-RA_1 CG4058 ACAGCTCCTGCCATCGTCAATGCCTATTATAGCCGCAACAAGAACCAGATCATGTTTCCCGCCGG 65 FBan0004058 FBgn0038818 Nep4 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep4 Neprilysin 4 "CG4058, CG4058, CG4058, CG4058, CG4058, dNEP4, Neprilysin 4" CDMC22376 4 21 2 DAC03-P23 AutoBlank AutoBlank CDMC22376 4 22 2 DAC03-P23 AutoBlank AutoBlank CDMC22377 4 23 2 DAC04-D11 3-CG31533-RA_1 CG31533 GCACCCAGACTGCAATGAAGGAGCCACCAGTTATACCGCCTCCATATCCAGTAGCCCACAATCACTTCT 69 FBan0031533 FBgn0051533 CG31533 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31533 CG31533 "BcDNA:AT30147, NEST:bs16a07, BEST:LP07046" CDMC22377 4 24 2 DAC04-D11 3-CG31533-RA_1 CG31533 GCACCCAGACTGCAATGAAGGAGCCACCAGTTATACCGCCTCCATATCCAGTAGCCCACAATCACTTCT 69 FBan0031533 FBgn0051533 CG31533 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31533 CG31533 "BcDNA:AT30147, NEST:bs16a07, BEST:LP07046" CDMC22378 4 25 2 DAC04-D23 2-CG31544-RA_1 CG31544 GGCCAACATGACCTTCGCTCCAGGTTACAAGCCAAAGGAAAAGACTTCATGGCAAACTCGAACCTGCGT 69 FBan0031544 FBgn0051544 CG31544 3 3R CG31544 CG31544 CDMC22378 4 26 2 DAC04-D23 2-CG31544-RA_1 CG31544 GGCCAACATGACCTTCGCTCCAGGTTACAAGCCAAAGGAAAAGACTTCATGGCAAACTCGAACCTGCGT 69 FBan0031544 FBgn0051544 CG31544 3 3R CG31544 CG31544 CDMC22379 4 1 3 DAC04-H11 23-CG31618-RA_1 CG31618 AAGAAGGCCTAAACGTTTCAAAGGCTAAGCTAAAAACCTACATGTACATAAAATCGTCAATCAAACCGT 69 FBan0031618 FBgn0051618 His2A:CG31618 2 2L chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His2A:CG31618 His2A:CG31618 "CG31618, CG31618, BEST:CK01438" CDMC22379 4 2 3 DAC04-H11 23-CG31618-RA_1 CG31618 AAGAAGGCCTAAACGTTTCAAAGGCTAAGCTAAAAACCTACATGTACATAAAATCGTCAATCAAACCGT 69 FBan0031618 FBgn0051618 His2A:CG31618 2 2L chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His2A:CG31618 His2A:CG31618 "CG31618, CG31618, BEST:CK01438" CDMC22380 4 3 3 DAC04-H23 4-CG31622-RC_1 CG31622 CGTCATGGTCACATATTGGCGTAGGTGCTTCAAAAGCGAGCTTACCACGACTGGAAACCACTTCGACCG 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC22380 4 4 3 DAC04-H23 4-CG31622-RC_1 CG31622 CGTCATGGTCACATATTGGCGTAGGTGCTTCAAAAGCGAGCTTACCACGACTGGAAACCACTTCGACCG 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC22381 4 5 3 DAC04-L11 23-CG31646-RA_1 CG31646 AATGCCGTCTTAAATCTTGTAAACCCCTTTCCTTCGAAATGTGTCGTTTTTTGGTGGAAATAAAAAAAC 69 FBan0031646 FBgn0051646 CG31646 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31646 CG31646 "CG14009, CG14008, CG14009, CT33566" CDMC22381 4 6 3 DAC04-L11 23-CG31646-RA_1 CG31646 AATGCCGTCTTAAATCTTGTAAACCCCTTTCCTTCGAAATGTGTCGTTTTTTGGTGGAAATAAAAAAAC 69 FBan0031646 FBgn0051646 CG31646 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31646 CG31646 "CG14009, CG14008, CG14009, CT33566" CDMC22382 4 7 3 DAC04-L23 3-CG31652-RA_9 CG31652 TGGATCGCGTACAGACCATTGTCCAGAAGAGTTTCAATCGCTTCTTTGGGAAGAGCACCACTCCGGAGA 69 FBan0031652 FBgn0051652 CG31652 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31652 CG31652 CDMC22382 4 8 3 DAC04-L23 3-CG31652-RA_9 CG31652 TGGATCGCGTACAGACCATTGTCCAGAAGAGTTTCAATCGCTTCTTTGGGAAGAGCACCACTCCGGAGA 69 FBan0031652 FBgn0051652 CG31652 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31652 CG31652 CDMC22383 4 9 3 DAC04-P11 14-CG31681-RA_3 CG31681 TTCCTGGGCCAGAGGAACGGATTGTCGGAGGTTCATACATCCCCATCGAATATGTTCCTTGGCAAGTGT 69 FBan0031681 FBgn0051681 CG31681 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 CG31681 CG31681 CDMC22383 4 10 3 DAC04-P11 14-CG31681-RA_3 CG31681 TTCCTGGGCCAGAGGAACGGATTGTCGGAGGTTCATACATCCCCATCGAATATGTTCCTTGGCAAGTGT 69 FBan0031681 FBgn0051681 CG31681 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 CG31681 CG31681 CDMC22384 4 11 3 DAC04-P23 2-CG31694-RA_1 CG31694 TCGGTACCGAGTCGCTGACACTAGATTCCTGGTCCATCCATCATCAGTATTCGGCCATGTGCACTGTCA 69 FBan0031694 FBgn0051694 CG31694 2 2L development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 "receptor binding; GO:0005102; hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0005102; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016799 ; EC:3.2.2.-" CG31694 CG31694 "CG15401, CG3098, CG15401, CG3098" CDMC22384 4 12 3 DAC04-P23 2-CG31694-RA_1 CG31694 TCGGTACCGAGTCGCTGACACTAGATTCCTGGTCCATCCATCATCAGTATTCGGCCATGTGCACTGTCA 69 FBan0031694 FBgn0051694 CG31694 2 2L development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 "receptor binding; GO:0005102; hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0005102; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016799 ; EC:3.2.2.-" CG31694 CG31694 "CG15401, CG3098, CG15401, CG3098" CDMC22385 4 13 3 DAC05-D11 3-CG6004-RB_3 CG6004 GCAGGTTTTATGTTTGTGCCAATGGACGGGCTATACCTCGACAGTGTCCCCAGGGCCTACATTTTGACA 69 FBan0006004 FBgn0036203 CG6004 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; transcription cofactor activity; GO:0003712; cation transporter activity; GO:0008324; carbohydrate transporter activity; GO:0015144; ; GO:0003712; ; GO:0008324; ; GO:0016490; ; GO:0015144; ; GO:0008061 extracellular region; GO:0005576 CG6004 CG6004 "anon-WO0153538.47, anon-WO0153538.48" CDMC22385 4 14 3 DAC05-D11 3-CG6004-RB_3 CG6004 GCAGGTTTTATGTTTGTGCCAATGGACGGGCTATACCTCGACAGTGTCCCCAGGGCCTACATTTTGACA 69 FBan0006004 FBgn0036203 CG6004 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; transcription cofactor activity; GO:0003712; cation transporter activity; GO:0008324; carbohydrate transporter activity; GO:0015144; ; GO:0003712; ; GO:0008324; ; GO:0016490; ; GO:0015144; ; GO:0008061 extracellular region; GO:0005576 CG6004 CG6004 "anon-WO0153538.47, anon-WO0153538.48" CDMC22386 4 15 3 DAC05-D23 8-CG6018-RA_1 CG6018 GCTCTACGAGTGCCTTCACATTCTGAGCATCAAGAACTTCTGGCACGATATCCATCGCACCTTGCTCGC 69 FBan0006018 FBgn0034736 CG6018 2 2R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG6018 CG6018 CDMC22386 4 16 3 DAC05-D23 8-CG6018-RA_1 CG6018 GCTCTACGAGTGCCTTCACATTCTGAGCATCAAGAACTTCTGGCACGATATCCATCGCACCTTGCTCGC 69 FBan0006018 FBgn0034736 CG6018 2 2R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG6018 CG6018 CDMC22387 4 17 3 DAC05-H11 15-CG6049-RB_6 CG6049 ACATTACTATGGATGAGTTTGCCGATCTGATGGGCAAGTGTGGCATGGTAATGAGAGATCCGCAGACGC 69 FBan0006049 FBgn0037081 CG6049 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG6049 CG6049 "cg6049, Tat-SF1" CDMC22387 4 18 3 DAC05-H11 15-CG6049-RB_6 CG6049 ACATTACTATGGATGAGTTTGCCGATCTGATGGGCAAGTGTGGCATGGTAATGAGAGATCCGCAGACGC 69 FBan0006049 FBgn0037081 CG6049 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG6049 CG6049 "cg6049, Tat-SF1" CDMC22388 4 19 3 DAC05-H23 2-CG6059-RA_1 CG6059 GCCTGCATCATCTGGAGAACAAGGAGAACTTCATTGGCAAGGGGGATTTCTCGATTCGCAGTGGCAAGG 69 FBan0006059 FBgn0039491 CG6059 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG6059 CG6059 CDMC22388 4 20 3 DAC05-H23 2-CG6059-RA_1 CG6059 GCCTGCATCATCTGGAGAACAAGGAGAACTTCATTGGCAAGGGGGATTTCTCGATTCGCAGTGGCAAGG 69 FBan0006059 FBgn0039491 CG6059 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG6059 CG6059 CDMC22389 4 21 3 DAC05-L11 23-CG6104-RA_1 CG6104 TCGTACCCCCCTTATTATTGTAATTTCATTTATTTATTTCCCTGCGCAATATTAACGTTGTTGATGTGA 69 FBan0006104 FBgn0002592 m2 3 3R Notch signaling pathway; GO:0007219 m2 E(spl) region transcript m2 "CG6104, E(spl)m2" CDMC22389 4 22 3 DAC05-L11 23-CG6104-RA_1 CG6104 TCGTACCCCCCTTATTATTGTAATTTCATTTATTTATTTCCCTGCGCAATATTAACGTTGTTGATGTGA 69 FBan0006104 FBgn0002592 m2 3 3R Notch signaling pathway; GO:0007219 m2 E(spl) region transcript m2 "CG6104, E(spl)m2" CDMC22390 4 23 3 DAC05-L23 24-CG6119-RA_1 CG6119 TTTCGTATACTTAGTCATTATCATTGTTTTTAGCCCTAAGTTCAGCTTAATTTGTTTGTAATAAAACTA 69 FBgn0033849 CDMC22390 4 24 3 DAC05-L23 24-CG6119-RA_1 CG6119 TTTCGTATACTTAGTCATTATCATTGTTTTTAGCCCTAAGTTCAGCTTAATTTGTTTGTAATAAAACTA 69 FBgn0033849 CDMC22391 4 25 3 DAC05-P11 3-CG6149-RA_1 CG6149 TCACTGGACTGGGTGCCTTCATGTTGGGATATCTGGTGTGGATACATATCGTTTGGTTCCGGACCGACA 69 FBan0006149 FBgn0036158 CG6149 3 3L CG6149 CG6149 CDMC22391 4 26 3 DAC05-P11 3-CG6149-RA_1 CG6149 TCACTGGACTGGGTGCCTTCATGTTGGGATATCTGGTGTGGATACATATCGTTTGGTTCCGGACCGACA 69 FBan0006149 FBgn0036158 CG6149 3 3L CG6149 CG6149 CDMC22392 4 1 4 DAC05-P23 8-CG6163-RA_1 CG6163 CCGCTCCACGTGGGAACACTTCGATCGAATGTCCTTCATGCGGGAAATTCTGCTAAAGAAGGTCGATGA 69 FBan0006163 FBgn0036155 CG6163 3 3L CG6163 CG6163 CDMC22392 4 2 4 DAC05-P23 8-CG6163-RA_1 CG6163 CCGCTCCACGTGGGAACACTTCGATCGAATGTCCTTCATGCGGGAAATTCTGCTAAAGAAGGTCGATGA 69 FBan0006163 FBgn0036155 CG6163 3 3L CG6163 CG6163 CDMC22393 4 3 4 DAC06-D11 8-CG11561-RA_1 CG11561 TCGGTCTAATGACTCACTTAGCTGCTCCTCTGAAGAGCTGGATGTGGCTTTGGACGTAGGAAGCCTTCT 69 FBan0011561 FBgn0003444 smo 2 2L "Bolwig's organ morphogenesis; GO:0001746; G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; anterior/posterior lineage restriction, imaginal disc; GO:0048099; blastoderm segmentation; GO:0007350; eye-antennal disc morphogenesis; GO:0007455; regulation of progression through mitotic cell cycle; GO:0007346; signal transduction; GO:0007165; smoothened signaling pathway; GO:0007224; wing disc anterior/posterior pattern formation; GO:0048100" G-protein coupled receptor activity; GO:0004930; transmembrane receptor activity; GO:0004888; ; GO:0004930; hedgehog receptor activity; GO:0008158; protein binding; GO:0005515; ; GO:0004888; ; GO:0004930; ; GO:0008158; ; GO:0004930; ; GO:0005515 endosome; GO:0005768; integral to membrane; GO:0016021; plasma membrane; GO:0005886 smo smoothened "CG11561, CG11561, smooth, dSmo, Smo, smoothened" CDMC22393 4 4 4 DAC06-D11 8-CG11561-RA_1 CG11561 TCGGTCTAATGACTCACTTAGCTGCTCCTCTGAAGAGCTGGATGTGGCTTTGGACGTAGGAAGCCTTCT 69 FBan0011561 FBgn0003444 smo 2 2L "Bolwig's organ morphogenesis; GO:0001746; G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; anterior/posterior lineage restriction, imaginal disc; GO:0048099; blastoderm segmentation; GO:0007350; eye-antennal disc morphogenesis; GO:0007455; regulation of progression through mitotic cell cycle; GO:0007346; signal transduction; GO:0007165; smoothened signaling pathway; GO:0007224; wing disc anterior/posterior pattern formation; GO:0048100" G-protein coupled receptor activity; GO:0004930; transmembrane receptor activity; GO:0004888; ; GO:0004930; hedgehog receptor activity; GO:0008158; protein binding; GO:0005515; ; GO:0004888; ; GO:0004930; ; GO:0008158; ; GO:0004930; ; GO:0005515 endosome; GO:0005768; integral to membrane; GO:0016021; plasma membrane; GO:0005886 smo smoothened "CG11561, CG11561, smooth, dSmo, Smo, smoothened" CDMC22394 4 5 4 DAC06-D23 3-CG11577-RA_1 CG11577 AGGTCACCCAAATGAAGACCCAGTGCGAAAACCTACTGGAGGAGTACGAGGAAACCATCAGCGAATGGT 69 FBan0011577 FBgn0036847 CG11577 3 3L CG11577 CG11577 anon-WO0118547.323 CDMC22394 4 6 4 DAC06-D23 3-CG11577-RA_1 CG11577 AGGTCACCCAAATGAAGACCCAGTGCGAAAACCTACTGGAGGAGTACGAGGAAACCATCAGCGAATGGT 69 FBan0011577 FBgn0036847 CG11577 3 3L CG11577 CG11577 anon-WO0118547.323 CDMC22395 4 7 4 DAC06-H11 2-CG11621-RA_1 CG11621 GCGGTCAGGAGCCCAACACATATGTGAAGTGCTACCTAAAACCGGATCCCAAAAAGGAGACCAAACGCA 69 FBan0011621 FBgn0015278 Pi3K68D 3 3L defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; phospholipid binding; GO:0005543; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; ; GO:0005543" phosphoinositide 3-kinase complex; GO:0005942 Pi3K68D Phosphotidylinositol 3 kinase 68D "CG11621, CG11621, dPIK, PI3K-68D, PI3K_68D, cpk, PI3K 68_D, Cpk, PI3K-68D/E, PI3K, PI3K 68D, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, BcDNA:LD15217, Pi3K, Phosphotidylinositol 3 kinase 68D" CDMC22395 4 8 4 DAC06-H11 2-CG11621-RA_1 CG11621 GCGGTCAGGAGCCCAACACATATGTGAAGTGCTACCTAAAACCGGATCCCAAAAAGGAGACCAAACGCA 69 FBan0011621 FBgn0015278 Pi3K68D 3 3L defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; phospholipid binding; GO:0005543; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; ; GO:0005543" phosphoinositide 3-kinase complex; GO:0005942 Pi3K68D Phosphotidylinositol 3 kinase 68D "CG11621, CG11621, dPIK, PI3K-68D, PI3K_68D, cpk, PI3K 68_D, Cpk, PI3K-68D/E, PI3K, PI3K 68D, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, BcDNA:LD15217, Pi3K, Phosphotidylinositol 3 kinase 68D" CDMC22396 4 9 4 DAC06-H23 12-CG11634-RA_1 CG11634 ACCAATGGCTTCACCCATTTTTGTGTGTGACTGTACGCACGATAAGCTGGGAAGTTACCCAACTGGAGT 69 FBan0011634 FBgn0032968 CG11634 2 2L CG11634 CG11634 BcDNA:AT09142 CDMC22396 4 10 4 DAC06-H23 12-CG11634-RA_1 CG11634 ACCAATGGCTTCACCCATTTTTGTGTGTGACTGTACGCACGATAAGCTGGGAAGTTACCCAACTGGAGT 69 FBan0011634 FBgn0032968 CG11634 2 2L CG11634 CG11634 BcDNA:AT09142 CDMC22397 4 11 4 DAC06-L11 16-CG11668-RA_1 CG11668 TGGACCACACTCCAGTAATCTCCTGCAAATCATGCTTTACCACCTGAATTTCCAACAATGCCAGAGGTA 69 FBan0011668 FBgn0038113 CG11668 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11668 CG11668 SP115 CDMC22397 4 12 4 DAC06-L11 16-CG11668-RA_1 CG11668 TGGACCACACTCCAGTAATCTCCTGCAAATCATGCTTTACCACCTGAATTTCCAACAATGCCAGAGGTA 69 FBan0011668 FBgn0038113 CG11668 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11668 CG11668 SP115 CDMC22398 4 13 4 DAC06-L23 1-CG11679-RA_1 CG11679 GCAGCGACTTCAATGTCACGTCACGGGCATTCTTCCAGAATGGCAAGTTCTTTGTTACCGCCGATACGG 69 FBan0011679 FBgn0030678 CG11679 X X CG11679 CG11679 CDMC22398 4 14 4 DAC06-L23 1-CG11679-RA_1 CG11679 GCAGCGACTTCAATGTCACGTCACGGGCATTCTTCCAGAATGGCAAGTTCTTTGTTACCGCCGATACGG 69 FBan0011679 FBgn0030678 CG11679 X X CG11679 CG11679 CDMC22399 4 15 4 DAC06-P11 15-CG11734-RB_3 CG11734 CACGAGGGTTGAACCGAACCCACTGTCCATCCTGCCCGAAATGAACAATTAAATTAACGACTTACCGCA 69 FBan0011734 FBgn0031107 HERC2 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 guanyl-nucleotide exchange factor activity; GO:0005085; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005085; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 HERC2 HERC2 CG11734 CDMC22399 4 16 4 DAC06-P11 15-CG11734-RB_3 CG11734 CACGAGGGTTGAACCGAACCCACTGTCCATCCTGCCCGAAATGAACAATTAAATTAACGACTTACCGCA 69 FBan0011734 FBgn0031107 HERC2 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 guanyl-nucleotide exchange factor activity; GO:0005085; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005085; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 HERC2 HERC2 CG11734 CDMC22400 4 17 4 DAC06-P23 AutoBlank AutoBlank CDMC22400 4 18 4 DAC06-P23 AutoBlank AutoBlank CDMC22401 4 19 4 DAC07-D11 17-CG15055-RA_1 CG15055 GATACGGAGGCTATGGCTCCTATAGTGCCGCTCCGGTCATCTCGCACGGATATCTGGCCCATGCC 65 FBan0015055 FBgn0030919 CG15055 X X CG15055 CG15055 CDMC22401 4 20 4 DAC07-D11 17-CG15055-RA_1 CG15055 GATACGGAGGCTATGGCTCCTATAGTGCCGCTCCGGTCATCTCGCACGGATATCTGGCCCATGCC 65 FBan0015055 FBgn0030919 CG15055 X X CG15055 CG15055 CDMC22402 4 21 4 DAC07-D23 23-CG15069-RB_1 CG15069 TTGTCTGTCTATGATTATTCTTAATTTTCTTTTTTTTCCTCGTCTCAGTTCCCGACCATGTGCGT 65 FBan0015069 FBgn0034357 Rgk2 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Rgk2 Rgk2 "CG15069, CG15069" CDMC22402 4 22 4 DAC07-D23 23-CG15069-RB_1 CG15069 TTGTCTGTCTATGATTATTCTTAATTTTCTTTTTTTTCCTCGTCTCAGTTCCCGACCATGTGCGT 65 FBan0015069 FBgn0034357 Rgk2 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Rgk2 Rgk2 "CG15069, CG15069" CDMC22403 4 23 4 DAC07-H11 2-CG15161-RA_2 CG15161 CTGGCGCTCAAAGTGAGCCCAGTCTGCTGAATATGAAACTTCGGTCGGTACTGAGTGGCAGCATG 65 FBan0015161 FBgn0032692 CG15161 2 2L CG15161 CG15161 CDMC22403 4 24 4 DAC07-H11 2-CG15161-RA_2 CG15161 CTGGCGCTCAAAGTGAGCCCAGTCTGCTGAATATGAAACTTCGGTCGGTACTGAGTGGCAGCATG 65 FBan0015161 FBgn0032692 CG15161 2 2L CG15161 CG15161 CDMC22404 4 25 4 DAC07-H23 23-CG15189-RA_1 CG15189 ACCTTAAGCAAGCAGAGAAGCAAACACCAAAATAAAGTAGACAAATAAATGCCTTGAATATGCTG 65 FBan0015189 FBgn0037429 Osi19 3 3R Osi19 Osiris 19 "CG15189, Osiris, Osiris 19" CDMC22404 4 26 4 DAC07-H23 23-CG15189-RA_1 CG15189 ACCTTAAGCAAGCAGAGAAGCAAACACCAAAATAAAGTAGACAAATAAATGCCTTGAATATGCTG 65 FBan0015189 FBgn0037429 Osi19 3 3R Osi19 Osiris 19 "CG15189, Osiris, Osiris 19" CDMC22405 4 1 5 DAC07-L11 2-CG15261-RA_1 CG15261 CTCAACGATTTCGGGGCAGTCAATGAGGTCTACAAGCGGGTGTTCAATAAGGATTTCCCGGCCCG 65 FBan0015261 FBgn0028510 CG15261 2 2L negative regulation of protein biosynthesis; GO:0017148; regulation of translation; GO:0006445 CG15261 CG15261 "BG:DS07851.3, BcDNA:GM01181" CDMC22405 4 2 5 DAC07-L11 2-CG15261-RA_1 CG15261 CTCAACGATTTCGGGGCAGTCAATGAGGTCTACAAGCGGGTGTTCAATAAGGATTTCCCGGCCCG 65 FBan0015261 FBgn0028510 CG15261 2 2L negative regulation of protein biosynthesis; GO:0017148; regulation of translation; GO:0006445 CG15261 CG15261 "BG:DS07851.3, BcDNA:GM01181" CDMC22406 4 3 5 DAC07-L23 15-CG15313-RA_1 CG15313 GCCGGCCAAGACTGCCGTAATCTCAGCCACGTCAAGTAGTCAATTTCTGGACGAGGGATTCCCGG 65 FBan0015313 FBgn0030173 CG15313 X X CG15313 CG15313 CDMC22406 4 4 5 DAC07-L23 15-CG15313-RA_1 CG15313 GCCGGCCAAGACTGCCGTAATCTCAGCCACGTCAAGTAGTCAATTTCTGGACGAGGGATTCCCGG 65 FBan0015313 FBgn0030173 CG15313 X X CG15313 CG15313 CDMC22407 4 5 5 DAC07-P11 23-CG15377-RA_1 CG15377 TACGACATGGAGTGGTACAAATGCGATGCGAGGACTAGGAAAGTGATTTTAATGATATTGCGCCG 65 FBan0015377 FBgn0026396 Or22c 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or22c Odorant receptor 22c "CG15377, CG15377, DOR22C.1, Olfactory receptor 22C.1, 22C.1, DOR16, 22c, Or22C.1" CDMC22407 4 6 5 DAC07-P11 23-CG15377-RA_1 CG15377 TACGACATGGAGTGGTACAAATGCGATGCGAGGACTAGGAAAGTGATTTTAATGATATTGCGCCG 65 FBan0015377 FBgn0026396 Or22c 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or22c Odorant receptor 22c "CG15377, CG15377, DOR22C.1, Olfactory receptor 22C.1, 22C.1, DOR16, 22c, Or22C.1" CDMC22408 4 7 5 DAC07-P23 AutoBlank AutoBlank CDMC22408 4 8 5 DAC07-P23 AutoBlank AutoBlank CDMC22409 4 9 5 DAC08-D11 1-CG14672-RA_1 CG14672 AAAGCCGTCTCACCTTATAAGGCAACCGAGGTGCATAGCCCACGCTACACAACTCTACGTGCACAG 66 FBan0014672 FBgn0044823 Spec2 3 3R Spec2 Spec2 "CG14672, dSPEC, dSPEC2, BcDNA:LD24607, SPEC" CDMC22409 4 10 5 DAC08-D11 1-CG14672-RA_1 CG14672 AAAGCCGTCTCACCTTATAAGGCAACCGAGGTGCATAGCCCACGCTACACAACTCTACGTGCACAG 66 FBan0014672 FBgn0044823 Spec2 3 3R Spec2 Spec2 "CG14672, dSPEC, dSPEC2, BcDNA:LD24607, SPEC" CDMC22410 4 11 5 DAC08-D23 6-CG14708-RA_1 CG14708 TCGCCTCAAGTCCATCTACGATCATCTGGAGGACATGTTCATCAACGGCAATCGCAGAACGGCCTC 66 FBan0014708 FBgn0037910 CG14708 3 3R CG14708 CG14708 CDMC22410 4 12 5 DAC08-D23 6-CG14708-RA_1 CG14708 TCGCCTCAAGTCCATCTACGATCATCTGGAGGACATGTTCATCAACGGCAATCGCAGAACGGCCTC 66 FBan0014708 FBgn0037910 CG14708 3 3R CG14708 CG14708 CDMC22411 4 13 5 DAC08-H11 2-CG14969-RA_3 CG14969 CCTGTTGGACGAGTCCAGTGATGAAGAACCTCCTAGGGGGAAAAAGGTTGCTCACAGTCCCGCATC 66 FBan0014969 FBgn0035440 CG14969 3 3L CG14969 CG14969 CDMC22411 4 14 5 DAC08-H11 2-CG14969-RA_3 CG14969 CCTGTTGGACGAGTCCAGTGATGAAGAACCTCCTAGGGGGAAAAAGGTTGCTCACAGTCCCGCATC 66 FBan0014969 FBgn0035440 CG14969 3 3L CG14969 CG14969 CDMC22412 4 15 5 DAC08-H23 2-CG15084-RA_1 CG15084 AGAAACTAGTGGAGCGCAACATGAGCGTCTGGGATGACAGCTATATGGCCAATAGTCGCCTACGCG 66 FBan0015084 FBgn0034402 CG15084 2 2R CG15084 CG15084 CDMC22412 4 16 5 DAC08-H23 2-CG15084-RA_1 CG15084 AGAAACTAGTGGAGCGCAACATGAGCGTCTGGGATGACAGCTATATGGCCAATAGTCGCCTACGCG 66 FBan0015084 FBgn0034402 CG15084 2 2R CG15084 CG15084 CDMC22413 4 17 5 DAC08-L11 12-CG15564-RA_1 CG15564 AGGACACCGTCGCACGATAGGTACGCATCCAAGCACAAGCATCCACCAAAGAACTGTCAGCTGACC 66 FBan0015564 FBgn0039833 CG15564 3 3R CG15564 CG15564 CDMC22413 4 18 5 DAC08-L11 12-CG15564-RA_1 CG15564 AGGACACCGTCGCACGATAGGTACGCATCCAAGCACAAGCATCCACCAAAGAACTGTCAGCTGACC 66 FBan0015564 FBgn0039833 CG15564 3 3R CG15564 CG15564 CDMC22414 4 19 5 DAC08-L23 14-CG15754-RA_1 CG15754 GAACTCAACGAAGACGGAAGCTATATCTTTGGCTACTCCATTCCCCATGGCATTCGTCGCTGGGAG 66 FBan0015754 FBgn0030492 CG15754 X X CG15754 CG15754 CDMC22414 4 20 5 DAC08-L23 14-CG15754-RA_1 CG15754 GAACTCAACGAAGACGGAAGCTATATCTTTGGCTACTCCATTCCCCATGGCATTCGTCGCTGGGAG 66 FBan0015754 FBgn0030492 CG15754 X X CG15754 CG15754 CDMC22415 4 21 5 DAC08-P11 AutoBlank AutoBlank CDMC22415 4 22 5 DAC08-P11 AutoBlank AutoBlank CDMC22416 4 23 5 DAC08-P23 AutoBlank AutoBlank CDMC22416 4 24 5 DAC08-P23 AutoBlank AutoBlank CDMC22417 4 25 5 DAC09-D12 8-CG14117-RA_1 CG14117 GGCCAGCCAAAAATGTGTTCTACGTGCTTGGAGGCTTTTCCCATCGACAACTTTTCATCTCACGCATGC 69 FBan0014117 FBgn0036331 CG14117 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14117 CG14117 BcDNA:RE44251 CDMC22417 4 26 5 DAC09-D12 8-CG14117-RA_1 CG14117 GGCCAGCCAAAAATGTGTTCTACGTGCTTGGAGGCTTTTCCCATCGACAACTTTTCATCTCACGCATGC 69 FBan0014117 FBgn0036331 CG14117 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14117 CG14117 BcDNA:RE44251 CDMC22418 4 1 6 DAC09-D24 2-CG14121-RA_2 CG14121 TGCATCCGATTCACTTCTGCACCTGCATCATCTACGCCTTTGTAACTGGCAATGGAACGCACAACGAGT 69 FBan0014121 FBgn0036297 CG14121 3 3L CG14121 CG14121 "anon-WO0172774.86, anon-WO0172774.87, anon-WO0172774.89" CDMC22418 4 2 6 DAC09-D24 2-CG14121-RA_2 CG14121 TGCATCCGATTCACTTCTGCACCTGCATCATCTACGCCTTTGTAACTGGCAATGGAACGCACAACGAGT 69 FBan0014121 FBgn0036297 CG14121 3 3L CG14121 CG14121 "anon-WO0172774.86, anon-WO0172774.87, anon-WO0172774.89" CDMC22419 4 3 6 DAC09-H12 13-CG14183-RA_1 CG14183 ACGTCGGAAGAAATTGAGAGACGCTGGAGTCATCGATATTGGCTACGAGCTAACTGCAAGCAAGGCAAT 69 FBan0014183 FBgn0036931 CG14183 3 3L immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG14183 CG14183 CDMC22419 4 4 6 DAC09-H12 13-CG14183-RA_1 CG14183 ACGTCGGAAGAAATTGAGAGACGCTGGAGTCATCGATATTGGCTACGAGCTAACTGCAAGCAAGGCAAT 69 FBan0014183 FBgn0036931 CG14183 3 3L immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG14183 CG14183 CDMC22420 4 5 6 DAC09-H24 24-CG14193-RA_4 CG14193 AGCAGATCTCCAAATTGACTTTATCCATTATCATTATCCATCCATGAAGAAAATGTTAAAAGATCTTGA 69 FBan0014193 FBgn0030994 CG14193 X X CG14193 CG14193 CDMC22420 4 6 6 DAC09-H24 24-CG14193-RA_4 CG14193 AGCAGATCTCCAAATTGACTTTATCCATTATCATTATCCATCCATGAAGAAAATGTTAAAAGATCTTGA 69 FBan0014193 FBgn0030994 CG14193 X X CG14193 CG14193 CDMC22421 4 7 6 DAC09-L12 3-CG14227-RA_1 CG14227 CCTGTGCGGGCCTAAGTGTCTGCACCAATGTGACTTTCTACATGGACTGGATCTGGGATGCTCTGGTTA 69 FBan0014227 FBgn0031058 CG14227 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14227 CG14227 SPH158 CDMC22421 4 8 6 DAC09-L12 3-CG14227-RA_1 CG14227 CCTGTGCGGGCCTAAGTGTCTGCACCAATGTGACTTTCTACATGGACTGGATCTGGGATGCTCTGGTTA 69 FBan0014227 FBgn0031058 CG14227 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14227 CG14227 SPH158 CDMC22422 4 9 6 DAC09-L24 9-CG14239-RA_1 CG14239 TCCGGACTGCGATCTTGAGGGATTCTTGTGTCTGGAGAAGACTCGTATGATCAAGCCAGATTCCAGGGT 69 FBan0014239 FBgn0039424 CG14239 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG14239 CG14239 CDMC22422 4 10 6 DAC09-L24 9-CG14239-RA_1 CG14239 TCCGGACTGCGATCTTGAGGGATTCTTGTGTCTGGAGAAGACTCGTATGATCAAGCCAGATTCCAGGGT 69 FBan0014239 FBgn0039424 CG14239 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG14239 CG14239 CDMC22423 4 11 6 DAC09-P12 22-CG14296-RB_1 CG14296 ATCCAGTCAAGTCAATCGAAGCATAGCAACACTTACGAACCTACTAACGCGTTTACCAACCGCAACTCT 69 FBan0014296 FBgn0038659 endoA 3 3R neurotransmitter secretion; GO:0007269; regulation of synapse structure and function; GO:0050803; synaptic vesicle endocytosis; GO:0048488 lysophosphatidic acid acyltransferase activity; GO:0042171; ; GO:0042171; protein binding; GO:0005515; ; GO:0042171; ; GO:0005515 cytoplasm; GO:0005737 endoA endophilin A "CG14296, CG14296, CG14296, endophilin, D-endo, D-endoA, Dendo-A, endo: endophilin, Endo, endo" CDMC22423 4 12 6 DAC09-P12 22-CG14296-RB_1 CG14296 ATCCAGTCAAGTCAATCGAAGCATAGCAACACTTACGAACCTACTAACGCGTTTACCAACCGCAACTCT 69 FBan0014296 FBgn0038659 endoA 3 3R neurotransmitter secretion; GO:0007269; regulation of synapse structure and function; GO:0050803; synaptic vesicle endocytosis; GO:0048488 lysophosphatidic acid acyltransferase activity; GO:0042171; ; GO:0042171; protein binding; GO:0005515; ; GO:0042171; ; GO:0005515 cytoplasm; GO:0005737 endoA endophilin A "CG14296, CG14296, CG14296, endophilin, D-endo, D-endoA, Dendo-A, endo: endophilin, Endo, endo" CDMC22424 4 13 6 DAC09-P24 AutoBlank AutoBlank CDMC22424 4 14 6 DAC09-P24 AutoBlank AutoBlank CDMC22425 4 15 6 DAC10-D11 2-CG1978-RA_4 CG1978 GCTCTGGAAATAGTTGGATTCGATCCCAGTACTCCGCAACTGAGTCTGAAACATCCCATCTGGGCCGGG 69 FBan0001978 FBgn0033404 Or45a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or45a Odorant receptor 45a "CG1978, CG1978, CG1978, 45C.1, DOR58, 45a" CDMC22425 4 16 6 DAC10-D11 2-CG1978-RA_4 CG1978 GCTCTGGAAATAGTTGGATTCGATCCCAGTACTCCGCAACTGAGTCTGAAACATCCCATCTGGGCCGGG 69 FBan0001978 FBgn0033404 Or45a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or45a Odorant receptor 45a "CG1978, CG1978, CG1978, 45C.1, DOR58, 45a" CDMC22426 4 17 6 DAC10-D23 6-CG1986-RA_2 CG1986 GGATTTCGTCGCCTCGATCCTAACAAAAAGTTGGCCCTATTTTTGCACGGCTGGAATGATCAGGGCAGC 69 FBan0001986 FBgn0030162 CG1986 X X lipid metabolism; GO:0006629 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG1986 CG1986 CDMC22426 4 18 6 DAC10-D23 6-CG1986-RA_2 CG1986 GGATTTCGTCGCCTCGATCCTAACAAAAAGTTGGCCCTATTTTTGCACGGCTGGAATGATCAGGGCAGC 69 FBan0001986 FBgn0030162 CG1986 X X lipid metabolism; GO:0006629 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG1986 CG1986 CDMC22427 4 19 6 DAC10-H11 10-CG2041-RA_1 CG2041 AACTGCCGGAAGTGTCAGTGCTACTAACGGTGTCTCTGGCATCAATTTCGTAGGTCCCTCTTCTACGGA 69 FBan0002041 FBgn0039907 lgs 4 4 Wnt receptor signaling pathway; GO:0016055; frizzled signaling pathway; GO:0007222; positive regulation of Wnt receptor signaling pathway; GO:0030177; regulation of Wnt receptor signaling pathway; GO:0030111; segment polarity determination; GO:0007367 protein binding; GO:0005515; beta-catenin binding; GO:0008013; ; GO:0008013; ; GO:0005515 nucleus; GO:0005634 lgs legless "CG2041, Lgl, Lgs, legless" CDMC22427 4 20 6 DAC10-H11 10-CG2041-RA_1 CG2041 AACTGCCGGAAGTGTCAGTGCTACTAACGGTGTCTCTGGCATCAATTTCGTAGGTCCCTCTTCTACGGA 69 FBan0002041 FBgn0039907 lgs 4 4 Wnt receptor signaling pathway; GO:0016055; frizzled signaling pathway; GO:0007222; positive regulation of Wnt receptor signaling pathway; GO:0030177; regulation of Wnt receptor signaling pathway; GO:0030111; segment polarity determination; GO:0007367 protein binding; GO:0005515; beta-catenin binding; GO:0008013; ; GO:0008013; ; GO:0005515 nucleus; GO:0005634 lgs legless "CG2041, Lgl, Lgs, legless" CDMC22428 4 21 6 DAC10-H23 14-CG2049-RD_6 CG2049 GATGCGGAGGATGTTAAGAAACAGGCATTCTTCCGGTCAATTGTGTGGGATGACCTGCTCCTGCGAAAG 69 FBgn0033398 CDMC22428 4 22 6 DAC10-H23 14-CG2049-RD_6 CG2049 GATGCGGAGGATGTTAAGAAACAGGCATTCTTCCGGTCAATTGTGTGGGATGACCTGCTCCTGCGAAAG 69 FBgn0033398 CDMC22429 4 23 6 DAC10-L11 23-CG2082-RC_13 CG2082 ACAAAGTTCGAACAGTCTAAGTTGAGACCAGCTTTGCGAAAGATGCACACGGATTATATATACTCGTAT 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC22429 4 24 6 DAC10-L11 23-CG2082-RC_13 CG2082 ACAAAGTTCGAACAGTCTAAGTTGAGACCAGCTTTGCGAAAGATGCACACGGATTATATATACTCGTAT 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC22430 4 25 6 DAC10-L23 13-CG2095-RA_1 CG2095 TGCAGTCTACTGTGATGGTCGAACGGAGGTTGATGGAAACTAAGAACCTCATTCAAGACTTGCCCTGCT 69 FBan0002095 FBgn0037373 CG2095 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 exocyst; GO:0000145 CG2095 CG2095 "Sec8, sec8" CDMC22430 4 26 6 DAC10-L23 13-CG2095-RA_1 CG2095 TGCAGTCTACTGTGATGGTCGAACGGAGGTTGATGGAAACTAAGAACCTCATTCAAGACTTGCCCTGCT 69 FBan0002095 FBgn0037373 CG2095 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 exocyst; GO:0000145 CG2095 CG2095 "Sec8, sec8" CDMC22431 4 1 7 DAC10-P11 3-CG2129-RA_1 CG2129 GCGGCAAGATCTACCATGGCAAATACAGTCTGCGTCAGCATTTAAAGCGGGATCATGACAACGGCGAGG 69 FBan0002129 FBgn0030008 CG2129 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2129 CG2129 CDMC22431 4 2 7 DAC10-P11 3-CG2129-RA_1 CG2129 GCGGCAAGATCTACCATGGCAAATACAGTCTGCGTCAGCATTTAAAGCGGGATCATGACAACGGCGAGG 69 FBan0002129 FBgn0030008 CG2129 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2129 CG2129 CDMC22432 4 3 7 DAC10-P23 AutoBlank AutoBlank CDMC22432 4 4 7 DAC10-P23 AutoBlank AutoBlank CDMC22433 4 5 7 DAC11-D11 24-CG9277-RA_1 CG9277 TGTAAAAGATTTGTTCTCTTAACAACGTAATCAATAAAGTCGGATCCAATTTTGTTCACAAGTCT 65 FBan0009277 FBgn0003887 betaTub56D 2 2R cell motility; GO:0006928; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; muscle attachment; GO:0016203 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 microtubule; GO:0005874; tubulin; GO:0045298 betaTub56D beta-Tubulin at 56D "CG9277, CG9277, CG9277, beta1 tubulin, DTB2, beta56D, beta[[1]]-tubulin, beta1, beta[[1]] tubulin, beta1-tubulin, 1t, beta-1-tubulin, T, B1t, beta1t: beta1 tubulin, beta1Tub, beta-tubulin, Dmbeta1, beta tubulin, beta1tub, tubulin, beta-1 tubulin, beta-Tub56D, BETA 56D, Tubulin, betatubulin, betaTub56D, beta-Tubulin, Beta tubulin, beta-tub, betaTub1, beta1t" CDMC22433 4 6 7 DAC11-D11 24-CG9277-RA_1 CG9277 TGTAAAAGATTTGTTCTCTTAACAACGTAATCAATAAAGTCGGATCCAATTTTGTTCACAAGTCT 65 FBan0009277 FBgn0003887 betaTub56D 2 2R cell motility; GO:0006928; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; muscle attachment; GO:0016203 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 microtubule; GO:0005874; tubulin; GO:0045298 betaTub56D beta-Tubulin at 56D "CG9277, CG9277, CG9277, beta1 tubulin, DTB2, beta56D, beta[[1]]-tubulin, beta1, beta[[1]] tubulin, beta1-tubulin, 1t, beta-1-tubulin, T, B1t, beta1t: beta1 tubulin, beta1Tub, beta-tubulin, Dmbeta1, beta tubulin, beta1tub, tubulin, beta-1 tubulin, beta-Tub56D, BETA 56D, Tubulin, betatubulin, betaTub56D, beta-Tubulin, Beta tubulin, beta-tub, betaTub1, beta1t" CDMC22434 4 7 7 DAC11-D23 2-CG9300-RA_2 CG9300 CCATGTCCAGCACTTGATGAGCCACCTGTTCGATCTGGTCAATGACCCCAATGTCCAGTTGGAGG 65 FBan0009300 FBgn0036886 CG9300 3 3L CG9300 CG9300 CDMC22434 4 8 7 DAC11-D23 2-CG9300-RA_2 CG9300 CCATGTCCAGCACTTGATGAGCCACCTGTTCGATCTGGTCAATGACCCCAATGTCCAGTTGGAGG 65 FBan0009300 FBgn0036886 CG9300 3 3L CG9300 CG9300 CDMC22435 4 9 7 DAC11-H11 3-CG9394-RA_3 CG9394 ATCTGGTGGAAGTTTATGCCGAACAACCGGATGAGGACCTGGTCCGTCTCCTAGGATACTCGCAC 65 FBan0009394 FBgn0034588 CG9394 2 2R CG9394 CG9394 anon-EST:Posey227 CDMC22435 4 10 7 DAC11-H11 3-CG9394-RA_3 CG9394 ATCTGGTGGAAGTTTATGCCGAACAACCGGATGAGGACCTGGTCCGTCTCCTAGGATACTCGCAC 65 FBan0009394 FBgn0034588 CG9394 2 2R CG9394 CG9394 anon-EST:Posey227 CDMC22436 4 11 7 DAC11-H23 4-CG9449-RB_1 CG9449 CAAGCTCTACGATCCCGGCGCTGATAAATCCACGCTCGAGCTGCTGCATGTGGTATTCCGACATG 65 FBan0009449 FBgn0036875 CG9449 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9449 CG9449 CDMC22436 4 12 7 DAC11-H23 4-CG9449-RB_1 CG9449 CAAGCTCTACGATCCCGGCGCTGATAAATCCACGCTCGAGCTGCTGCATGTGGTATTCCGACATG 65 FBan0009449 FBgn0036875 CG9449 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9449 CG9449 CDMC22437 4 13 7 DAC11-L11 3-CG9556-RA_4 CG9556 ACAGTCACTCCACATCAAGTCGGCCATTCCTCATCCCCTAATCATGGGTGTCATCCGTGAGTGCG 65 FBan0009556 FBgn0013746 alien 2 2L "cell cycle; GO:0007049; development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; protein targeting; GO:0006605; proteolysis; GO:0006508; signal transduction; GO:0007165" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003714; ; GO:0004871 cytoplasm; GO:0005737; signalosome complex; GO:0008180 alien alien "CG9556, Alien, d-Alien, Dch2, Drosophila COP9 signalosome homolog 2, DCH2, COP9 complex homolog subunit 2, CSN2, BcDNA:LD10463, CH2" CDMC22437 4 14 7 DAC11-L11 3-CG9556-RA_4 CG9556 ACAGTCACTCCACATCAAGTCGGCCATTCCTCATCCCCTAATCATGGGTGTCATCCGTGAGTGCG 65 FBan0009556 FBgn0013746 alien 2 2L "cell cycle; GO:0007049; development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; protein targeting; GO:0006605; proteolysis; GO:0006508; signal transduction; GO:0007165" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003714; ; GO:0004871 cytoplasm; GO:0005737; signalosome complex; GO:0008180 alien alien "CG9556, Alien, d-Alien, Dch2, Drosophila COP9 signalosome homolog 2, DCH2, COP9 complex homolog subunit 2, CSN2, BcDNA:LD10463, CH2" CDMC22438 4 15 7 DAC11-L23 3-CG9595-RA_6 CG9595 ACAGGACCGATTCACAGAGGATGAATTCGATGTGCTGAAGCACTACGTGGAGGTGCAAGGAGGCA 65 FBan0009595 FBgn0031829 osm-6 2 2L microtubule-based movement; GO:0007018 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-6 osm-6 "CG9595, CG9595, CG9595, CG9595, CG9595, CG9595" CDMC22438 4 16 7 DAC11-L23 3-CG9595-RA_6 CG9595 ACAGGACCGATTCACAGAGGATGAATTCGATGTGCTGAAGCACTACGTGGAGGTGCAAGGAGGCA 65 FBan0009595 FBgn0031829 osm-6 2 2L microtubule-based movement; GO:0007018 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-6 osm-6 "CG9595, CG9595, CG9595, CG9595, CG9595, CG9595" CDMC22439 4 17 7 DAC11-P11 6-CG9681-RA_3 CG9681 GTACGAGGGTCGTGGTTTCGGGCTCCAGGGATCACACTCCCCCAACTATAATCGCAAGAGCATTG 65 FBan0009681 FBgn0043578 PGRP-SB1 3 3L defense response; GO:0006952; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 receptor activity; GO:0004872; ; GO:0004872; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SB1 PGRP-SB1 "CG9681, CG9681, CG9681, CG9681, PGRP SB1" CDMC22439 4 18 7 DAC11-P11 6-CG9681-RA_3 CG9681 GTACGAGGGTCGTGGTTTCGGGCTCCAGGGATCACACTCCCCCAACTATAATCGCAAGAGCATTG 65 FBan0009681 FBgn0043578 PGRP-SB1 3 3L defense response; GO:0006952; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 receptor activity; GO:0004872; ; GO:0004872; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SB1 PGRP-SB1 "CG9681, CG9681, CG9681, CG9681, PGRP SB1" CDMC22440 4 19 7 DAC11-P23 3-CG9726-RA_6 CG9726 GATGGGGACAAGAACGGGTTGCTTCACTTGACAGCACGAAGACCTGGAGACTACCATGAGTCCCG 65 FBan0009726 FBgn0026190 PH4alphaMP 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaMP prolyl-4-hydroxylase-alpha MP "CG9726, 59D7T, DM59D7T, prolyl-4-hydroxylase-alpha, alpha subunit, ESTS:59D7T, prolyl-4-hydroxylase-alpha MP" CDMC22440 4 20 7 DAC11-P23 3-CG9726-RA_6 CG9726 GATGGGGACAAGAACGGGTTGCTTCACTTGACAGCACGAAGACCTGGAGACTACCATGAGTCCCG 65 FBan0009726 FBgn0026190 PH4alphaMP 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaMP prolyl-4-hydroxylase-alpha MP "CG9726, 59D7T, DM59D7T, prolyl-4-hydroxylase-alpha, alpha subunit, ESTS:59D7T, prolyl-4-hydroxylase-alpha MP" CDMC22441 4 21 7 DAC12-D11 20-CG15458-RA_1 CG15458 GCCACCTGGGCCTCGTTGGGACTCGTCTACGTCCTGGTCAAGATGCACCGCCGCAACACGAAGCG 65 FBan0015458 FBgn0040651 CG15458 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG15458 CG15458 CDMC22441 4 22 7 DAC12-D11 20-CG15458-RA_1 CG15458 GCCACCTGGGCCTCGTTGGGACTCGTCTACGTCCTGGTCAAGATGCACCGCCGCAACACGAAGCG 65 FBan0015458 FBgn0040651 CG15458 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG15458 CG15458 CDMC22442 4 23 7 DAC12-D23 1-CG15485-RA_1 CG15485 AATGGCGATAAGCTCCGGAGACTGAAGACTGATGTCCACGCCTATGATGAGTTCCGGGTTCAGGG 65 FBan0015485 FBgn0032442 CG15485 2 2L proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG15485 CG15485 CDMC22442 4 24 7 DAC12-D23 1-CG15485-RA_1 CG15485 AATGGCGATAAGCTCCGGAGACTGAAGACTGATGTCCACGCCTATGATGAGTTCCGGGTTCAGGG 65 FBan0015485 FBgn0032442 CG15485 2 2L proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG15485 CG15485 CDMC22443 4 25 7 DAC12-H11 1-CG15577-RA_1 CG15577 AGGGAAACCAGTTTTCGCTGCGATCCCGACGCCTTGGTGAACTGATGTCTACTCTTGGATCCTCG 65 FBan0015577 FBgn0040904 CG15577 X X CG15577 CG15577 CDMC22443 4 26 7 DAC12-H11 1-CG15577-RA_1 CG15577 AGGGAAACCAGTTTTCGCTGCGATCCCGACGCCTTGGTGAACTGATGTCTACTCTTGGATCCTCG 65 FBan0015577 FBgn0040904 CG15577 X X CG15577 CG15577 CDMC22444 4 1 8 DAC12-H23 6-CG15611-RA_1 CG15611 CACTTTCCCACCCGGAAAAAGTACCGCTCCAAGGTGTTCCTGTTCGATCGCTGTTTGGTGTGCAC 65 FBan0015611 FBgn0034194 CG15611 2 2R CG15611 CG15611 CDMC22444 4 2 8 DAC12-H23 6-CG15611-RA_1 CG15611 CACTTTCCCACCCGGAAAAAGTACCGCTCCAAGGTGTTCCTGTTCGATCGCTGTTTGGTGTGCAC 65 FBan0015611 FBgn0034194 CG15611 2 2R CG15611 CG15611 CDMC22445 4 3 8 DAC12-L11 2-CG15685-RA_1 CG15685 AATTGGTATGATGGAATCACGGAAACCTCGCACACCATAGCCCGTTCTTCGGTGACCATCCTGGG 65 FBan0015685 FBgn0038789 CG15685 3 3R CG15685 CG15685 CDMC22445 4 4 8 DAC12-L11 2-CG15685-RA_1 CG15685 AATTGGTATGATGGAATCACGGAAACCTCGCACACCATAGCCCGTTCTTCGGTGACCATCCTGGG 65 FBan0015685 FBgn0038789 CG15685 3 3R CG15685 CG15685 CDMC22446 4 5 8 DAC12-L23 3-CG15729-RA_1 CG15729 AGGTGGCGGTTGTAACAAATCCCTTAGCCAACATGTCCTGCAAACACGTACCGCTTCCTCGGAAC 65 FBan0015729 FBgn0030399 CG15729 X X CG15729 CG15729 CDMC22446 4 6 8 DAC12-L23 3-CG15729-RA_1 CG15729 AGGTGGCGGTTGTAACAAATCCCTTAGCCAACATGTCCTGCAAACACGTACCGCTTCCTCGGAAC 65 FBan0015729 FBgn0030399 CG15729 X X CG15729 CG15729 CDMC22447 4 7 8 DAC12-P11 21-CG15803-RA_1 CG15803 CGGCACTCACGTTCCGTCGGTCATAAATACCTCGCAAAATCCGGAGGCCTTTGAGACTCGTAGCC 65 FBan0015803 FBgn0038606 CG15803 3 3R protein targeting; GO:0006605 transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG15803 CG15803 CDMC22447 4 8 8 DAC12-P11 21-CG15803-RA_1 CG15803 CGGCACTCACGTTCCGTCGGTCATAAATACCTCGCAAAATCCGGAGGCCTTTGAGACTCGTAGCC 65 FBan0015803 FBgn0038606 CG15803 3 3R protein targeting; GO:0006605 transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG15803 CG15803 CDMC22448 4 9 8 DAC12-P23 AutoBlank AutoBlank CDMC22448 4 10 8 DAC12-P23 AutoBlank AutoBlank CDMC22449 4 11 8 DAC13-D11 23-CG1304-RA_6 CG1304 GCCAGGGTGTACTACCACAACGAATGGATTAAGAATAACTCGGATGTGAAATAATGCTGGCATAGCTGT 69 FBan0001304 FBgn0031141 CG1304 X X proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG1304 CG1304 SP46 CDMC22449 4 12 8 DAC13-D11 23-CG1304-RA_6 CG1304 GCCAGGGTGTACTACCACAACGAATGGATTAAGAATAACTCGGATGTGAAATAATGCTGGCATAGCTGT 69 FBan0001304 FBgn0031141 CG1304 X X proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG1304 CG1304 SP46 CDMC22450 4 13 8 DAC13-D23 7-CG13070-RA_2 CG13070 TGGCAGAGGATTCATTTTACCAGGAACCAGAACGGATTGAAGGGATTCAGTTCATCGAAGACCCCGCCA 69 FBan0013070 FBgn0036586 CG13070 3 3L CG13070 CG13070 CDMC22450 4 14 8 DAC13-D23 7-CG13070-RA_2 CG13070 TGGCAGAGGATTCATTTTACCAGGAACCAGAACGGATTGAAGGGATTCAGTTCATCGAAGACCCCGCCA 69 FBan0013070 FBgn0036586 CG13070 3 3L CG13070 CG13070 CDMC22451 4 15 8 DAC13-H11 14-CG13101-RB_1 CG13101 TGATTGACTGGAGCAAACCTCAAAATGCCTTCACCACGGTAGTTGGCGTACTTTTGTTGTCCTGTTGCA 69 FBan0013101 FBgn0032084 CG13101 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG13101 CG13101 CDMC22451 4 16 8 DAC13-H11 14-CG13101-RB_1 CG13101 TGATTGACTGGAGCAAACCTCAAAATGCCTTCACCACGGTAGTTGGCGTACTTTTGTTGTCCTGTTGCA 69 FBan0013101 FBgn0032084 CG13101 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG13101 CG13101 CDMC22452 4 17 8 DAC13-H23 8-CG13113-RA_1 CG13113 AGATGCTGAGGCGACTTACCAGTGGTCGTAGTAAAGCTGACACCATTGATGTGGAAATGGCAAGTCGCA 69 FBan0013113 FBgn0032126 CG13113 2 2L CG13113 CG13113 CDMC22452 4 18 8 DAC13-H23 8-CG13113-RA_1 CG13113 AGATGCTGAGGCGACTTACCAGTGGTCGTAGTAAAGCTGACACCATTGATGTGGAAATGGCAAGTCGCA 69 FBan0013113 FBgn0032126 CG13113 2 2L CG13113 CG13113 CDMC22453 4 19 8 DAC13-L11 23-CG13167-RA_2 CG13167 TTTGTAACAAAGTCTACAATTCGGCCAAATTCAAACTCTACGTGATCAGAGTCCAATTCCAAAGTCACC 69 FBan0013167 FBgn0033706 CG13167 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG13167 CG13167 CDMC22453 4 20 8 DAC13-L11 23-CG13167-RA_2 CG13167 TTTGTAACAAAGTCTACAATTCGGCCAAATTCAAACTCTACGTGATCAGAGTCCAATTCCAAAGTCACC 69 FBan0013167 FBgn0033706 CG13167 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG13167 CG13167 CDMC22454 4 21 8 DAC13-L23 2-CG13186-RA_1 CG13186 CCAAGGATCGTTCCATGATCTACATCGAGCACACGTACGAGTGTCCCATTTTCCAGACCAAGGCCGACG 69 FBan0013186 FBgn0033680 CG13186 2 2R CG13186 CG13186 "AAF58585, BcDNA:AT11581" CDMC22454 4 22 8 DAC13-L23 2-CG13186-RA_1 CG13186 CCAAGGATCGTTCCATGATCTACATCGAGCACACGTACGAGTGTCCCATTTTCCAGACCAAGGCCGACG 69 FBan0013186 FBgn0033680 CG13186 2 2R CG13186 CG13186 "AAF58585, BcDNA:AT11581" CDMC22455 4 23 8 DAC13-P11 23-CG13211-RA_1 CG13211 TGAGACCTTCCATCTTGTTAATCAATACAATCGCCCTGTAAATGACTAAATCATAAACCAGTAAACGTA 69 FBan0013211 FBgn0033613 CG13211 2 2R CG13211 CG13211 BcDNA:AT13707 CDMC22455 4 24 8 DAC13-P11 23-CG13211-RA_1 CG13211 TGAGACCTTCCATCTTGTTAATCAATACAATCGCCCTGTAAATGACTAAATCATAAACCAGTAAACGTA 69 FBan0013211 FBgn0033613 CG13211 2 2R CG13211 CG13211 BcDNA:AT13707 CDMC22456 4 25 8 DAC13-P23 AutoBlank AutoBlank CDMC22456 4 26 8 DAC13-P23 AutoBlank AutoBlank CDMC22457 4 1 9 DAC14-D11 15-CG40181-RA_3 CG40181 CCGAGACGATGGGAGATTTACGGTGAACTGCTGTATTTTCTGTCAGGAGTTGGAATCAGGACGTTGCCA 69 FBgn0058181 CG40181 CG40181 CG40181 CDMC22457 4 2 9 DAC14-D11 15-CG40181-RA_3 CG40181 CCGAGACGATGGGAGATTTACGGTGAACTGCTGTATTTTCTGTCAGGAGTTGGAATCAGGACGTTGCCA 69 FBgn0058181 CG40181 CG40181 CG40181 CDMC22458 4 3 9 DAC14-D23 14-CG40198-RA_2 CG40198 ACCACCGAAAGGCCTGTGACACACCATACCACCGAGGTAAACACAGACTTTACTCCGGATGAATCTAGT 69 FBgn0058198 CG40198 CG40198 CG40198 BcDNA:RE21703 CDMC22458 4 4 9 DAC14-D23 14-CG40198-RA_2 CG40198 ACCACCGAAAGGCCTGTGACACACCATACCACCGAGGTAAACACAGACTTTACTCCGGATGAATCTAGT 69 FBgn0058198 CG40198 CG40198 CG40198 BcDNA:RE21703 CDMC22459 4 5 9 DAC14-H11 23-CG40251-RA_3 CG40251 AGTTTTTTTGCCACAACTTTAAAAATAATTTTTTAATGACTCCCCTCATCCCCTTACAAAAAAGGCGTA 69 FBgn0058251 CG40251 CG40251 CG40251 CDMC22459 4 6 9 DAC14-H11 23-CG40251-RA_3 CG40251 AGTTTTTTTGCCACAACTTTAAAAATAATTTTTTAATGACTCCCCTCATCCCCTTACAAAAAAGGCGTA 69 FBgn0058251 CG40251 CG40251 CG40251 CDMC22460 4 7 9 DAC14-H23 23-CG4026-RA_2 CG4026 ATCAACAAGCAGCATTTGTTTGATTGAAACAGGTTTAAACTAAGTATTTGTGCAAAGCAATCCAAATCA 69 FBan0004026 FBgn0032147 IP3K1 2 2L response to oxidative stress; GO:0006979 inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 IP3K1 "Inositol 1,4,5-triphosphate kinase 1" "CG4026, CG4026, CG4026, CG4026, CG4026, UY530, D-IP3K1, dmIP3Kalpha, anon-WO0118547.189, Inositol 1,4,5-triphosphate kinase 1" CDMC22460 4 8 9 DAC14-H23 23-CG4026-RA_2 CG4026 ATCAACAAGCAGCATTTGTTTGATTGAAACAGGTTTAAACTAAGTATTTGTGCAAAGCAATCCAAATCA 69 FBan0004026 FBgn0032147 IP3K1 2 2L response to oxidative stress; GO:0006979 inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 IP3K1 "Inositol 1,4,5-triphosphate kinase 1" "CG4026, CG4026, CG4026, CG4026, CG4026, UY530, D-IP3K1, dmIP3Kalpha, anon-WO0118547.189, Inositol 1,4,5-triphosphate kinase 1" CDMC22461 4 9 9 DAC14-L11 1-CG40337-RA_1 CG40337 ACGCCAATAGCATCACCAACGACAACCAAGTCAGCCACAATAACGCCGATCAATCCAATGCGAGCATCA 69 FBgn0058337 CG40337 CG40337 CG40337 CDMC22461 4 10 9 DAC14-L11 1-CG40337-RA_1 CG40337 ACGCCAATAGCATCACCAACGACAACCAAGTCAGCCACAATAACGCCGATCAATCCAATGCGAGCATCA 69 FBgn0058337 CG40337 CG40337 CG40337 CDMC22462 4 11 9 DAC14-L23 9-CG40351-RB_1 CG40351 GCCACCGCCATCAAAAAAGCGAAGAAAAGACGACGAACTGATCCGACATAAGACTGGATGTGCGCGAAC 69 FBgn0040022 CG40351 chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; ; GO:0030528; ; GO:0008168 ; EC:2.1.1.-; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0018024 ; EC:2.1.1.43 nucleus; GO:0005634 CG40351 CG40351 "CG17395, CG17396, aaf45425 Dm" CDMC22462 4 12 9 DAC14-L23 9-CG40351-RB_1 CG40351 GCCACCGCCATCAAAAAAGCGAAGAAAAGACGACGAACTGATCCGACATAAGACTGGATGTGCGCGAAC 69 FBgn0040022 CG40351 chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; ; GO:0030528; ; GO:0008168 ; EC:2.1.1.-; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0018024 ; EC:2.1.1.43 nucleus; GO:0005634 CG40351 CG40351 "CG17395, CG17396, aaf45425 Dm" CDMC22463 4 13 9 DAC14-P11 1-CG40402-RA_1 CG40402 GTCGACTGGAACACGCTGAGAGCTATACCACCGAATCGAGAAGAGATCCGCGACATCCTAAGCCCCATT 69 FBgn0058402 CG40402 CG40402 CG40402 CDMC22463 4 14 9 DAC14-P11 1-CG40402-RA_1 CG40402 GTCGACTGGAACACGCTGAGAGCTATACCACCGAATCGAGAAGAGATCCGCGACATCCTAAGCCCCATT 69 FBgn0058402 CG40402 CG40402 CG40402 CDMC22464 4 15 9 DAC14-P23 23-CG40439-RA_12 CG40439 CTTCGTTCGTCACACAAGTATGGATTTCAAAATTCAGACGACTTTCTGTTGGTCATACGAATCGTGTCA 69 FBgn0058439 CG40439 CG40439 CG40439 CDMC22464 4 16 9 DAC14-P23 23-CG40439-RA_12 CG40439 CTTCGTTCGTCACACAAGTATGGATTTCAAAATTCAGACGACTTTCTGTTGGTCATACGAATCGTGTCA 69 FBgn0058439 CG40439 CG40439 CG40439 CDMC22465 4 17 9 DAC15-D11 17-CG7309-RA_2 CG7309 GCCTTCAGCTTTAGCTATAGTTCCGCTGTTTGTGGATTGAACACCTACTTGGCGGATTCGATGAACTCC 69 FBan0007309 FBgn0032314 CG7309 2 2L dicarboxylic acid transporter activity; GO:0005310; polyspecific organic cation transporter activity; GO:0015354; symporter activity; GO:0015293; tricarboxylic acid transporter activity; GO:0015142; ; GO:0015142; ; GO:0005310; ; GO:0015354; ; GO:0015293 CG7309 CG7309 CDMC22465 4 18 9 DAC15-D11 17-CG7309-RA_2 CG7309 GCCTTCAGCTTTAGCTATAGTTCCGCTGTTTGTGGATTGAACACCTACTTGGCGGATTCGATGAACTCC 69 FBan0007309 FBgn0032314 CG7309 2 2L dicarboxylic acid transporter activity; GO:0005310; polyspecific organic cation transporter activity; GO:0015354; symporter activity; GO:0015293; tricarboxylic acid transporter activity; GO:0015142; ; GO:0015142; ; GO:0005310; ; GO:0015354; ; GO:0015293 CG7309 CG7309 CDMC22466 4 19 9 DAC15-D23 23-CG7323-RA_5 CG7323 AGATTATTATCCGTCGGTTAAGCTGCATGGATATGGGTGATACTGCTTTATTTGAGTTTGCGAAAAACT 69 FBan0007323 FBgn0036943 CG7323 3 3L cell adhesion; GO:0007155; proteolysis; GO:0006508; regulation of cell shape; GO:0008360 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG7323 CG7323 CDMC22466 4 20 9 DAC15-D23 23-CG7323-RA_5 CG7323 AGATTATTATCCGTCGGTTAAGCTGCATGGATATGGGTGATACTGCTTTATTTGAGTTTGCGAAAAACT 69 FBan0007323 FBgn0036943 CG7323 3 3L cell adhesion; GO:0007155; proteolysis; GO:0006508; regulation of cell shape; GO:0008360 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG7323 CG7323 CDMC22467 4 21 9 DAC15-H11 23-CG7349-RA_3 CG7349 ACTGGGCAATACACCGATACATCCTATTAACTACATTTTAACCAAGGACCTCATGGACTTTACGTTAGA 69 FBan0007349 FBgn0030975 CG7349 X X electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; electron transporter activity; GO:0005489; ; GO:0000104 ; EC:1.3.99.1; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG7349 CG7349 CDMC22467 4 22 9 DAC15-H11 23-CG7349-RA_3 CG7349 ACTGGGCAATACACCGATACATCCTATTAACTACATTTTAACCAAGGACCTCATGGACTTTACGTTAGA 69 FBan0007349 FBgn0030975 CG7349 X X electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; electron transporter activity; GO:0005489; ; GO:0000104 ; EC:1.3.99.1; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG7349 CG7349 CDMC22468 4 23 9 DAC15-H23 14-CG7359-RA_1 CG7359 CTCGCCCATACGCATTCATCGAGTTTGACGTGTACATACAGAAGGCGAAAAAACAGTTGACGGACCGCA 69 FBan0007359 FBgn0025617 CG7359 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886 SNAP receptor activity; GO:0005484; ; GO:0005484 CG7359 CG7359 "EG:34F3.8, 34F3.8" CDMC22468 4 24 9 DAC15-H23 14-CG7359-RA_1 CG7359 CTCGCCCATACGCATTCATCGAGTTTGACGTGTACATACAGAAGGCGAAAAAACAGTTGACGGACCGCA 69 FBan0007359 FBgn0025617 CG7359 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886 SNAP receptor activity; GO:0005484; ; GO:0005484 CG7359 CG7359 "EG:34F3.8, 34F3.8" CDMC22469 4 25 9 DAC15-L11 17-CG7386-RA_1 CG7386 TCGCCTTATGAGCTGTTCCATCTGCCAGCAAAAGTTCAAAAAGCAATCAAAGTTCGAGGAGCACATGAA 69 FBan0007386 FBgn0035691 CG7386 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG7386 CG7386 CDMC22469 4 26 9 DAC15-L11 17-CG7386-RA_1 CG7386 TCGCCTTATGAGCTGTTCCATCTGCCAGCAAAAGTTCAAAAAGCAATCAAAGTTCGAGGAGCACATGAA 69 FBan0007386 FBgn0035691 CG7386 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG7386 CG7386 CDMC22470 4 1 10 DAC15-L23 17-CG7398-RA_1 CG7398 CGTTCGCGTATTTTCGTCGCTCGTTCGTAATCGTAATCGTCGTTCGTGGTATCTCGTCGGGTAAAACAA 69 FBan0007398 FBgn0024921 Trn 3 3L "protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear pore; GO:0005643 Trn Transportin "CG7398, CG7398, dTRN, TRN, transportin, Tm, Transportin, Trn1" CDMC22470 4 2 10 DAC15-L23 17-CG7398-RA_1 CG7398 CGTTCGCGTATTTTCGTCGCTCGTTCGTAATCGTAATCGTCGTTCGTGGTATCTCGTCGGGTAAAACAA 69 FBan0007398 FBgn0024921 Trn 3 3L "protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear pore; GO:0005643 Trn Transportin "CG7398, CG7398, dTRN, TRN, transportin, Tm, Transportin, Trn1" CDMC22471 4 3 10 DAC15-P11 12-CG7446-RA_2 CG7446 TCGCGCCTCGAGGATCGTCTTCCCACTGCTATTCATCCTTATCAACGTGTTCTACTGGTACGGCTACTT 69 FBan0007446 FBgn0001134 Grd 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; ligand-gated ion channel activity; GO:0015276; GABA receptor activity; GO:0016917; ; GO:0015276; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Grd Glycine receptor "CG7446, CG7446, GRD, GABA-and-glycine-receptor-like-subunit-of-Drosophila, DmGABA(GRD)" CDMC22471 4 4 10 DAC15-P11 12-CG7446-RA_2 CG7446 TCGCGCCTCGAGGATCGTCTTCCCACTGCTATTCATCCTTATCAACGTGTTCTACTGGTACGGCTACTT 69 FBan0007446 FBgn0001134 Grd 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; ligand-gated ion channel activity; GO:0015276; GABA receptor activity; GO:0016917; ; GO:0015276; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Grd Glycine receptor "CG7446, CG7446, GRD, GABA-and-glycine-receptor-like-subunit-of-Drosophila, DmGABA(GRD)" CDMC22472 4 5 10 DAC15-P23 14-CG7457-RA_2 CG7457 CCGTTTTGGATCTATCATGCAACTTTATTGGCAACGAGGGATGTCAGCAGTTAGCAAAGTCGCTGCCCA 69 FBan0007457 FBgn0035812 CG7457 3 3L CG7457 CG7457 CT13960 CDMC22472 4 6 10 DAC15-P23 14-CG7457-RA_2 CG7457 CCGTTTTGGATCTATCATGCAACTTTATTGGCAACGAGGGATGTCAGCAGTTAGCAAAGTCGCTGCCCA 69 FBan0007457 FBgn0035812 CG7457 3 3L CG7457 CG7457 CT13960 CDMC22473 4 7 10 DAC16-D11 3-CG12587-RA_1 CG12587 GAGCCAGGTTGCACAGATGACGGCCTTGTTAGAGGGGAAGGCGAAGGATGTGGATGAGAAAGTCTT 66 FBan0012587 FBgn0040685 CG12587 3 3R CG12587 CG12587 CDMC22473 4 8 10 DAC16-D11 3-CG12587-RA_1 CG12587 GAGCCAGGTTGCACAGATGACGGCCTTGTTAGAGGGGAAGGCGAAGGATGTGGATGAGAAAGTCTT 66 FBan0012587 FBgn0040685 CG12587 3 3R CG12587 CG12587 CDMC22474 4 9 10 DAC16-D23 5-CG12781-RA_1 CG12781 TGCTCTCCTTCTTCGATCTTTCCGAGACACGTTTGTACATCGTCCTGGGACTAATTGCGGCCCTGG 66 FBan0012781 FBgn0034797 nahoda 2 2R catecholamine metabolism; GO:0006584 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1 nahoda nahoda "CG12781, CG12781, CT36793, nahoda" CDMC22474 4 10 10 DAC16-D23 5-CG12781-RA_1 CG12781 TGCTCTCCTTCTTCGATCTTTCCGAGACACGTTTGTACATCGTCCTGGGACTAATTGCGGCCCTGG 66 FBan0012781 FBgn0034797 nahoda 2 2R catecholamine metabolism; GO:0006584 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1 nahoda nahoda "CG12781, CG12781, CT36793, nahoda" CDMC22475 4 11 10 DAC16-H11 2-CG13308-RA_1 CG13308 ACCGCAAATGACGTAACGTGCAATACAGACGTGGCCCAAAGATCCTGTATAGGTTGTGGCACCTGC 66 FBan0013308 FBgn0035932 CG13308 3 3L CG13308 CG13308 CDMC22475 4 12 10 DAC16-H11 2-CG13308-RA_1 CG13308 ACCGCAAATGACGTAACGTGCAATACAGACGTGGCCCAAAGATCCTGTATAGGTTGTGGCACCTGC 66 FBan0013308 FBgn0035932 CG13308 3 3L CG13308 CG13308 CDMC22476 4 13 10 DAC16-H23 9-CG1343-RA_1 CG1343 ACTATAGCTCCGCATTGAGTCATTCGCTGTTGGGATCGGGACAACATTTGCTGCAGGACACCTACA 66 FBan0001343 FBgn0020378 Sp1 X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sp1 Sp1 "CG1343, D-Sp1, D.Sp1" CDMC22476 4 14 10 DAC16-H23 9-CG1343-RA_1 CG1343 ACTATAGCTCCGCATTGAGTCATTCGCTGTTGGGATCGGGACAACATTTGCTGCAGGACACCTACA 66 FBan0001343 FBgn0020378 Sp1 X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sp1 Sp1 "CG1343, D-Sp1, D.Sp1" CDMC22477 4 15 10 DAC16-L11 6-CG13889-RA_1 CG13889 CGCAATCTCGTGGAGAAGTTGCGATCGGAGAACAAGTTCCTGAAGGATGGTCGACGATCCACGGAG 66 FBan0013889 FBgn0035168 CG13889 3 3L response to oxidative stress; GO:0006979 structural constituent of cytoskeleton; GO:0005200; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0005200; ; GO:0004601 ; EC:1.11.1.7 CG13889 CG13889 CDMC22477 4 16 10 DAC16-L11 6-CG13889-RA_1 CG13889 CGCAATCTCGTGGAGAAGTTGCGATCGGAGAACAAGTTCCTGAAGGATGGTCGACGATCCACGGAG 66 FBan0013889 FBgn0035168 CG13889 3 3L response to oxidative stress; GO:0006979 structural constituent of cytoskeleton; GO:0005200; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0005200; ; GO:0004601 ; EC:1.11.1.7 CG13889 CG13889 CDMC22478 4 17 10 DAC16-L23 3-CG14073-RA_1 CG14073 GGACCAGGATCGGGTGACAACAACGATCAAGCAGAACGGGGAGACGAGTGCAACAAAGACTGGATC 66 FBan0014073 FBgn0036814 CG14073 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 spindle microtubule; GO:0005876 CG14073 CG14073 Nirvana CDMC22478 4 18 10 DAC16-L23 3-CG14073-RA_1 CG14073 GGACCAGGATCGGGTGACAACAACGATCAAGCAGAACGGGGAGACGAGTGCAACAAAGACTGGATC 66 FBan0014073 FBgn0036814 CG14073 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 spindle microtubule; GO:0005876 CG14073 CG14073 Nirvana CDMC22479 4 19 10 DAC16-P11 AutoBlank AutoBlank CDMC22479 4 20 10 DAC16-P11 AutoBlank AutoBlank CDMC22480 4 21 10 DAC16-P23 AutoBlank AutoBlank CDMC22480 4 22 10 DAC16-P23 AutoBlank AutoBlank CDMC22481 4 23 10 DAC17-D11 23-CG17309-RB_10 CG17309 TTATGAAGTAAGTTTTGTAAGCCTAAGCGAAGGAACCCAACACAATCAAGCAATGTTAGTGAGTTGCGC 69 FBan0017309 FBgn0037925 Csk 3 3R intracellular signaling cascade; GO:0007242; negative regulation of growth; GO:0045926; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Csk C-terminal Src kinase "CG17309, CG17309, CSK, dCsk, dCSK, dcsk, csk, DCsk, C-terminal Src kinase" CDMC22481 4 24 10 DAC17-D11 23-CG17309-RB_10 CG17309 TTATGAAGTAAGTTTTGTAAGCCTAAGCGAAGGAACCCAACACAATCAAGCAATGTTAGTGAGTTGCGC 69 FBan0017309 FBgn0037925 Csk 3 3R intracellular signaling cascade; GO:0007242; negative regulation of growth; GO:0045926; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Csk C-terminal Src kinase "CG17309, CG17309, CSK, dCsk, dCSK, dcsk, csk, DCsk, C-terminal Src kinase" CDMC22482 4 25 10 DAC17-D23 7-CG17329-RA_1 CG17329 AGCTCCATTCGGGTGTGAAGACACTCAATCAGCGTCTGGACAGAATGGTGGAGAATTCAACTTGCTCCA 69 FBan0017329 FBgn0028896 CG17329 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; sugar binding; GO:0005529; ; GO:0008270; ; GO:0005529 ubiquitin ligase complex; GO:0000151 CG17329 CG17329 "BG:DS02740.5, DS02740.5, BcDNA:AT18988" CDMC22482 4 26 10 DAC17-D23 7-CG17329-RA_1 CG17329 AGCTCCATTCGGGTGTGAAGACACTCAATCAGCGTCTGGACAGAATGGTGGAGAATTCAACTTGCTCCA 69 FBan0017329 FBgn0028896 CG17329 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; sugar binding; GO:0005529; ; GO:0008270; ; GO:0005529 ubiquitin ligase complex; GO:0000151 CG17329 CG17329 "BG:DS02740.5, DS02740.5, BcDNA:AT18988" CDMC22483 4 1 11 DAC17-H11 2-CG17376-RA_1 CG17376 GCGGCGGAACTGAGAACCGTTGGACCATGTTGTGTAACACGTTTTGGTTAGCAACTCGATCGGATGCAT 69 FBan0017376 FBgn0042189 CG17376 2 2L CG17376 CG17376 "CG18461, bs29c06.y1" CDMC22483 4 2 11 DAC17-H11 2-CG17376-RA_1 CG17376 GCGGCGGAACTGAGAACCGTTGGACCATGTTGTGTAACACGTTTTGGTTAGCAACTCGATCGGATGCAT 69 FBan0017376 FBgn0042189 CG17376 2 2L CG17376 CG17376 "CG18461, bs29c06.y1" CDMC22484 4 3 11 DAC17-H23 12-CG17382-RA_6 CG17382 TGGCCGAGAGTTTGACCAGGTACCGATCAGTAAGGGTACTTATCGAGGTGCAGGATAAAGAAGGCTCCT 69 FBan0017382 FBgn0039080 CG17382 3 3R CG17382 CG17382 CDMC22484 4 4 11 DAC17-H23 12-CG17382-RA_6 CG17382 TGGCCGAGAGTTTGACCAGGTACCGATCAGTAAGGGTACTTATCGAGGTGCAGGATAAAGAAGGCTCCT 69 FBan0017382 FBgn0039080 CG17382 3 3R CG17382 CG17382 CDMC22485 4 5 11 DAC17-L11 17-CG17469-RA_1 CG17469 GCACCGCACTCAGCACCAATGTAAGTATACCCTTCTTTATTACGAACATCCAGTGTGAATGGCAGCTGA 69 FBan0017469 FBgn0067895 Mitf 4 4 compound eye morphogenesis (sensu Endopterygota); GO:0001745; regulation of transcription; GO:0045449 transcription regulator activity; GO:0030528; ; GO:0030528 cellular component unknown; GO:0008372 Mitf Mitf "CG40476, CG17469, CG40476, MITF" CDMC22485 4 6 11 DAC17-L11 17-CG17469-RA_1 CG17469 GCACCGCACTCAGCACCAATGTAAGTATACCCTTCTTTATTACGAACATCCAGTGTGAATGGCAGCTGA 69 FBan0017469 FBgn0067895 Mitf 4 4 compound eye morphogenesis (sensu Endopterygota); GO:0001745; regulation of transcription; GO:0045449 transcription regulator activity; GO:0030528; ; GO:0030528 cellular component unknown; GO:0008372 Mitf Mitf "CG40476, CG17469, CG40476, MITF" CDMC22486 4 7 11 DAC17-L23 23-CG1747-RA_2 CG1747 AGTGGGCAGTAGTGAAATATTAAATCCGTGTGCTTTGCAAAGCCTTAATCATAACGAGATACATTCGAA 69 FBan0001747 FBgn0030300 Sk1 X X anti-apoptosis; GO:0006916; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165; sphingolipid metabolism; GO:0006665; sphingosine metabolism; GO:0006670 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0017050; ; GO:0017050; carbohydrate kinase activity; GO:0019200; ; GO:0004143 ; EC:2.7.1.107; ; GO:0017050; ; GO:0019200; ; GO:0017050; ; GO:0017050 Sk1 Sphingosine kinase 1 "CG1747, SK1, Sphk1, Sphingosine kinase I, Sphingosine kinase 1" CDMC22486 4 8 11 DAC17-L23 23-CG1747-RA_2 CG1747 AGTGGGCAGTAGTGAAATATTAAATCCGTGTGCTTTGCAAAGCCTTAATCATAACGAGATACATTCGAA 69 FBan0001747 FBgn0030300 Sk1 X X anti-apoptosis; GO:0006916; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165; sphingolipid metabolism; GO:0006665; sphingosine metabolism; GO:0006670 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0017050; ; GO:0017050; carbohydrate kinase activity; GO:0019200; ; GO:0004143 ; EC:2.7.1.107; ; GO:0017050; ; GO:0019200; ; GO:0017050; ; GO:0017050 Sk1 Sphingosine kinase 1 "CG1747, SK1, Sphk1, Sphingosine kinase I, Sphingosine kinase 1" CDMC22487 4 9 11 DAC17-P11 3-CG1751-RA_1 CG1751 CCAACGAGGTCAACCGTCTGTTCAACGCCTTAGCTGCCGACAAGAAGAACGCTAGCAGCCTTTCTTCTA 69 FBan0001751 FBgn0030306 CG1751 X X proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; microsome; GO:0005792; signal peptidase complex; GO:0005787 CG1751 CG1751 CDMC22487 4 10 11 DAC17-P11 3-CG1751-RA_1 CG1751 CCAACGAGGTCAACCGTCTGTTCAACGCCTTAGCTGCCGACAAGAAGAACGCTAGCAGCCTTTCTTCTA 69 FBan0001751 FBgn0030306 CG1751 X X proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; microsome; GO:0005792; signal peptidase complex; GO:0005787 CG1751 CG1751 CDMC22488 4 11 11 DAC17-P23 AutoBlank AutoBlank CDMC22488 4 12 11 DAC17-P23 AutoBlank AutoBlank CDMC22489 4 13 11 DAC18-D11 3-CG3131-RA_5 CG3131 ACGGGTCTCAAGGCGGTGAATCACTTTGGTCGCCCAGATATGTCCAGCTTCTTGAAGTTCGTGCAAAAG 69 FBan0003131 FBgn0031464 CG3131 2 2L electron transport; GO:0006118; immune response; GO:0006955; oxygen and reactive oxygen species metabolism; GO:0006800 superoxide-generating NADPH oxidase activity; GO:0016175 ; EC:1.6.3.-; calcium ion binding; GO:0005509; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0005509; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016175 ; EC:1.6.3.- membrane; GO:0016020 CG3131 CG3131 CDMC22489 4 14 11 DAC18-D11 3-CG3131-RA_5 CG3131 ACGGGTCTCAAGGCGGTGAATCACTTTGGTCGCCCAGATATGTCCAGCTTCTTGAAGTTCGTGCAAAAG 69 FBan0003131 FBgn0031464 CG3131 2 2L electron transport; GO:0006118; immune response; GO:0006955; oxygen and reactive oxygen species metabolism; GO:0006800 superoxide-generating NADPH oxidase activity; GO:0016175 ; EC:1.6.3.-; calcium ion binding; GO:0005509; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0005509; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016175 ; EC:1.6.3.- membrane; GO:0016020 CG3131 CG3131 CDMC22490 4 15 11 DAC18-D23 5-CG31335-RA_1 CG31335 TCGCGGTGGAAGTGGATATCGGTTACCTTACGGATTGTGCCCCTCTGCATCTATGCGTTTACGTATGCT 69 FBan0031335 FBgn0045468 Gr93d 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr93d Gustatory receptor 93d "CG31335, 93F.4, Gustatory receptor 93F.4, Gr93F4, DmGr93d, GR93F.4, Gustatory receptor 93d" CDMC22490 4 16 11 DAC18-D23 5-CG31335-RA_1 CG31335 TCGCGGTGGAAGTGGATATCGGTTACCTTACGGATTGTGCCCCTCTGCATCTATGCGTTTACGTATGCT 69 FBan0031335 FBgn0045468 Gr93d 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr93d Gustatory receptor 93d "CG31335, 93F.4, Gustatory receptor 93F.4, Gr93F4, DmGr93d, GR93F.4, Gustatory receptor 93d" CDMC22491 4 17 11 DAC18-H11 3-CG31365-RA_2 CG31365 GCGACAGAGGCCAGGAAGGATGCAAAAGAAGAGGAATTCATATTGGGCTGCAATACCGACCCCGCAAAT 69 FBan0031365 FBgn0051365 CG31365 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG31365 CG31365 "CG4639, CG4639" CDMC22491 4 18 11 DAC18-H11 3-CG31365-RA_2 CG31365 GCGACAGAGGCCAGGAAGGATGCAAAAGAAGAGGAATTCATATTGGGCTGCAATACCGACCCCGCAAAT 69 FBan0031365 FBgn0051365 CG31365 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG31365 CG31365 "CG4639, CG4639" CDMC22492 4 19 11 DAC18-H23 13-CG31371-RA_1 CG31371 ACGAGGAGTCCCTGAATCATCTGCTACATCTGCAATCCGTCTACGAATTGGACTCGAATAGCCTCTCCT 69 FBan0031371 FBgn0051371 CG31371 3 3R CG31371 CG31371 CG15542 CDMC22492 4 20 11 DAC18-H23 13-CG31371-RA_1 CG31371 ACGAGGAGTCCCTGAATCATCTGCTACATCTGCAATCCGTCTACGAATTGGACTCGAATAGCCTCTCCT 69 FBan0031371 FBgn0051371 CG31371 3 3R CG31371 CG31371 CG15542 CDMC22493 4 21 11 DAC18-L11 17-CG31418-RA_3 CG31418 GGGTGCCAGTTCACCACAGCAGACTAAATGGCGAACGGATTGTTCACGACAAGGGTATTTATAAACTCT 69 FBan0031418 FBgn0051418 CG31418 3 3R CG31418 CG31418 CG5329 CDMC22493 4 22 11 DAC18-L11 17-CG31418-RA_3 CG31418 GGGTGCCAGTTCACCACAGCAGACTAAATGGCGAACGGATTGTTCACGACAAGGGTATTTATAAACTCT 69 FBan0031418 FBgn0051418 CG31418 3 3R CG31418 CG31418 CG5329 CDMC22494 4 23 11 DAC18-L23 2-CG31431-RA_1 CG31431 GTGACGGAGCGGTATTCGGGACTGTACAAATGCAGCATTAATCCGCACATTTGGGATAAAGCCCAGGCT 69 FBan0031431 FBgn0051431 CG31431 3 3R fibroblast growth factor receptor signaling pathway; GO:0008543 fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007 integral to membrane; GO:0016021 CG31431 CG31431 "CG13414, CT32770" CDMC22494 4 24 11 DAC18-L23 2-CG31431-RA_1 CG31431 GTGACGGAGCGGTATTCGGGACTGTACAAATGCAGCATTAATCCGCACATTTGGGATAAAGCCCAGGCT 69 FBan0031431 FBgn0051431 CG31431 3 3R fibroblast growth factor receptor signaling pathway; GO:0008543 fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007 integral to membrane; GO:0016021 CG31431 CG31431 "CG13414, CT32770" CDMC22495 4 25 11 DAC18-P11 3-CG31478-RA_2 CG31478 CCCGACCTGAAGAAGGAGAACAAGGACTTCTACTGCACTGTGACCATAAACAAGCTGGAACAGGCGCGA 69 FBan0031478 FBgn0038319 mRpL9 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL9 mitochondrial ribosomal protein L9 "CG4923, CG31478, CG4923, L9, mitochondrial ribosomal protein L9" CDMC22495 4 26 11 DAC18-P11 3-CG31478-RA_2 CG31478 CCCGACCTGAAGAAGGAGAACAAGGACTTCTACTGCACTGTGACCATAAACAAGCTGGAACAGGCGCGA 69 FBan0031478 FBgn0038319 mRpL9 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL9 mitochondrial ribosomal protein L9 "CG4923, CG31478, CG4923, L9, mitochondrial ribosomal protein L9" CDMC22496 4 1 12 DAC18-P23 17-CG31507-RA_1 CG31507 GCCAACACCCAGGTGGATATTGCTTATGAAGTCATCGGAATTTATGATAAATACAAGGGCCAGGGGGGA 69 FBan0031507 FBgn0044809 TotZ 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotZ Turandot Z "CG31507, tot" CDMC22496 4 2 12 DAC18-P23 17-CG31507-RA_1 CG31507 GCCAACACCCAGGTGGATATTGCTTATGAAGTCATCGGAATTTATGATAAATACAAGGGCCAGGGGGGA 69 FBan0031507 FBgn0044809 TotZ 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotZ Turandot Z "CG31507, tot" CDMC22497 4 3 12 DAC19-D11 3-CG6084-RB_3 CG6084 TGGAAGAGGGTCTGGTCAAGTCCATTGGTGTTTCCAACTTCAACAGAAGGCAGATCGAGCGCGTG 65 FBan0006084 FBgn0036182 CG6084 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG6084 CG6084 CDMC22497 4 4 12 DAC19-D11 3-CG6084-RB_3 CG6084 TGGAAGAGGGTCTGGTCAAGTCCATTGGTGTTTCCAACTTCAACAGAAGGCAGATCGAGCGCGTG 65 FBan0006084 FBgn0036182 CG6084 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG6084 CG6084 CDMC22498 4 5 12 DAC19-D23 33-CG6118-RA_2 CG6118 TTGCAGTCCCTACTTCCAACAGATCTTTCTGGAGAACCCATCGAGTCACCCCATCCTGCTGATGG 65 FBan0006118 FBgn0038339 CG6118 3 3R "chromatin assembly or disassembly; GO:0006333; development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG6118 CG6118 CDMC22498 4 6 12 DAC19-D23 33-CG6118-RA_2 CG6118 TTGCAGTCCCTACTTCCAACAGATCTTTCTGGAGAACCCATCGAGTCACCCCATCCTGCTGATGG 65 FBan0006118 FBgn0038339 CG6118 3 3R "chromatin assembly or disassembly; GO:0006333; development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG6118 CG6118 CDMC22499 4 7 12 DAC19-H11 15-CG6210-RA_1 CG6210 GCCGACAATGCACCACAGTGACGAGACCACACAGTCGAATGAGAATATAGTTGCCTCAGCAGCCA 65 FBan0006210 FBgn0036141 MRP 3 3L biological process unknown; GO:0000004 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0042626" cellular component unknown; GO:0008372 MRP Multidrug-Resistance like Protein 1 "CG6210, dMRP, Multidrug-Resistance like Protein 1" CDMC22499 4 8 12 DAC19-H11 15-CG6210-RA_1 CG6210 GCCGACAATGCACCACAGTGACGAGACCACACAGTCGAATGAGAATATAGTTGCCTCAGCAGCCA 65 FBan0006210 FBgn0036141 MRP 3 3L biological process unknown; GO:0000004 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0042626" cellular component unknown; GO:0008372 MRP Multidrug-Resistance like Protein 1 "CG6210, dMRP, Multidrug-Resistance like Protein 1" CDMC22500 4 9 12 DAC19-H23 1-CG6271-RA_5 CG6271 AACTTCTACCTCTTCACGCCCAAGAACCCCTCGAGCAGCAAGCACATCTACGCCACTACCAAGTC 65 FBan0006271 FBgn0039476 CG6271 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6271 CG6271 CDMC22500 4 10 12 DAC19-H23 1-CG6271-RA_5 CG6271 AACTTCTACCTCTTCACGCCCAAGAACCCCTCGAGCAGCAAGCACATCTACGCCACTACCAAGTC 65 FBan0006271 FBgn0039476 CG6271 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6271 CG6271 CDMC22501 4 11 12 DAC19-L11 2-CG6359-RA_2 CG6359 TAGCCAGTGCAAAACCCGTTTCTTCCAACCGATAAAAGGGGCGTCTATAGCTCTGCCGATCCGGA 65 FBan0006359 FBgn0038065 CG6359 3 3R intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 CG6359 CG6359 CDMC22501 4 12 12 DAC19-L11 2-CG6359-RA_2 CG6359 TAGCCAGTGCAAAACCCGTTTCTTCCAACCGATAAAAGGGGCGTCTATAGCTCTGCCGATCCGGA 65 FBan0006359 FBgn0038065 CG6359 3 3R intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 CG6359 CG6359 CDMC22502 4 13 12 DAC19-L23 3-CG6383-RA_1 CG6383 CAGTGCATCTGCCAGAAACCCTATTGCGGAGCCTACTGCAACTTTACGGATCCCTGCAACGCTAC 65 FBan0006383 FBgn0000368 crb 3 3R "cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; dorsal closure, amnioserosa morphology change; GO:0046664; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment of epithelial cell polarity; GO:0045198; eye photoreceptor development (sensu Endopterygota); GO:0042051; intercellular junction assembly; GO:0007043; membrane organization and biogenesis; GO:0016044; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; nervous system development; GO:0007399; photoreceptor maintenance; GO:0045494; protein localization; GO:0008104; rhabdomere development; GO:0042052; salivary gland development; GO:0007431; zonula adherens assembly; GO:0045186; zonula adherens maintenance; GO:0045218" protein binding; GO:0005515; spectrin binding; GO:0030507; receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0005515; ; GO:0004872; ; GO:0005509; ; GO:0030507 apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell-cell adherens junction; GO:0005913; integral to membrane; GO:0016021; plasma membrane; GO:0005886; septate junction; GO:0005918; subapical complex; GO:0035003 crb crumbs "CG6383, CRB, 1384/04, 0509/20, l(3)j1B5, CT19912, Crb, Crumbs, crumb, l(3)S050920, l(3)S058104" CDMC22502 4 14 12 DAC19-L23 3-CG6383-RA_1 CG6383 CAGTGCATCTGCCAGAAACCCTATTGCGGAGCCTACTGCAACTTTACGGATCCCTGCAACGCTAC 65 FBan0006383 FBgn0000368 crb 3 3R "cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; dorsal closure, amnioserosa morphology change; GO:0046664; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment of epithelial cell polarity; GO:0045198; eye photoreceptor development (sensu Endopterygota); GO:0042051; intercellular junction assembly; GO:0007043; membrane organization and biogenesis; GO:0016044; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; nervous system development; GO:0007399; photoreceptor maintenance; GO:0045494; protein localization; GO:0008104; rhabdomere development; GO:0042052; salivary gland development; GO:0007431; zonula adherens assembly; GO:0045186; zonula adherens maintenance; GO:0045218" protein binding; GO:0005515; spectrin binding; GO:0030507; receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0005515; ; GO:0004872; ; GO:0005509; ; GO:0030507 apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell-cell adherens junction; GO:0005913; integral to membrane; GO:0016021; plasma membrane; GO:0005886; septate junction; GO:0005918; subapical complex; GO:0035003 crb crumbs "CG6383, CRB, 1384/04, 0509/20, l(3)j1B5, CT19912, Crb, Crumbs, crumb, l(3)S050920, l(3)S058104" CDMC22503 4 15 12 DAC19-P11 2-CG6472-RA_1 CG6472 AAAGGACGCGTTTCTCAGGAGGGGCAACTACAATGTCATCCTCATCGACTGGAGCGCGATGACAG 65 FBan0006472 FBgn0034166 CG6472 2 2R lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG6472 CG6472 CDMC22503 4 16 12 DAC19-P11 2-CG6472-RA_1 CG6472 AAAGGACGCGTTTCTCAGGAGGGGCAACTACAATGTCATCCTCATCGACTGGAGCGCGATGACAG 65 FBan0006472 FBgn0034166 CG6472 2 2R lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG6472 CG6472 CDMC22504 4 17 12 DAC19-P23 AutoBlank AutoBlank CDMC22504 4 18 12 DAC19-P23 AutoBlank AutoBlank CDMC22505 4 19 12 DAC20-D11 4-CG30114-RA_1 CG30114 CCTGCGGTGCTTAAAAATTCTGAGGCATCTGTCAAGTCGAGCGAAGGTGAAGGTTTCGCGCAGGC 65 FBan0030114 FBgn0050114 CG30114 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG30114 CG30114 CDMC22505 4 20 12 DAC20-D11 4-CG30114-RA_1 CG30114 CCTGCGGTGCTTAAAAATTCTGAGGCATCTGTCAAGTCGAGCGAAGGTGAAGGTTTCGCGCAGGC 65 FBan0030114 FBgn0050114 CG30114 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG30114 CG30114 CDMC22506 4 21 12 DAC20-D23 18-CG30157-RA_1 CG30157 CGCGGCGTCCTTGAAAATTGTACCAAAGGACTATGCATATCCACTTCTAGAGGATCCGCAAGGCG 65 FBan0030157 FBgn0050157 CG30157 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30157 CG30157 CDMC22506 4 22 12 DAC20-D23 18-CG30157-RA_1 CG30157 CGCGGCGTCCTTGAAAATTGTACCAAAGGACTATGCATATCCACTTCTAGAGGATCCGCAAGGCG 65 FBan0030157 FBgn0050157 CG30157 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30157 CG30157 CDMC22507 4 23 12 DAC20-H11 2-CG30285-RA_1 CG30285 AAATGGTCCCCATGAGTTCGGCACACCTGGAAACGGCATTTACATACGGGGTCAGAACGAAGGAC 65 FBan0030285 FBgn0050285 CG30285 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30285 CG30285 CDMC22507 4 24 12 DAC20-H11 2-CG30285-RA_1 CG30285 AAATGGTCCCCATGAGTTCGGCACACCTGGAAACGGCATTTACATACGGGGTCAGAACGAAGGAC 65 FBan0030285 FBgn0050285 CG30285 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30285 CG30285 CDMC22508 4 25 12 DAC20-H23 15-CG30344-RA_10 CG30344 TATGATGACAACCTCTCTGCTAGAGAGCATTATTCCTGCCTTCGCGAGTCTGTTCCTGGGTCCCT 65 FBan0030344 FBgn0050344 CG30344 2 2R CG30344 CG30344 "CG8054, CG8054" CDMC22508 4 26 12 DAC20-H23 15-CG30344-RA_10 CG30344 TATGATGACAACCTCTCTGCTAGAGAGCATTATTCCTGCCTTCGCGAGTCTGTTCCTGGGTCCCT 65 FBan0030344 FBgn0050344 CG30344 2 2R CG30344 CG30344 "CG8054, CG8054" CDMC22509 4 1 13 DAC20-L11 2-CG30416-RA_1 CG30416 GTACCGTGCAGGTAAAGGTCACCAATAGAAAGGAGGCATCCGTGAGGGGTCATCATGACCGGGAG 65 FBan0030416 FBgn0050416 CG30416 2 2R CG30416 CG30416 "CG9803, CG9803, BcDNA:AT11052" CDMC22509 4 2 13 DAC20-L11 2-CG30416-RA_1 CG30416 GTACCGTGCAGGTAAAGGTCACCAATAGAAAGGAGGCATCCGTGAGGGGTCATCATGACCGGGAG 65 FBan0030416 FBgn0050416 CG30416 2 2R CG30416 CG30416 "CG9803, CG9803, BcDNA:AT11052" CDMC22510 4 3 13 DAC20-L23 9-CG30446-RA_3 CG30446 GCTTTCGGCTGAAGGGTTCCGACAAGCTGAATGAGAAGCTGCTGAGCATAATCAACGAGTCCGGC 65 FBan0030446 FBgn0050446 Tdc2 2 2R amino acid metabolism; GO:0006520; transmission of nerve impulse; GO:0019226 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Tdc2 Tdc2 "CG3686, CG30446, CG3686" CDMC22510 4 4 13 DAC20-L23 9-CG30446-RA_3 CG30446 GCTTTCGGCTGAAGGGTTCCGACAAGCTGAATGAGAAGCTGCTGAGCATAATCAACGAGTCCGGC 65 FBan0030446 FBgn0050446 Tdc2 2 2R amino acid metabolism; GO:0006520; transmission of nerve impulse; GO:0019226 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Tdc2 Tdc2 "CG3686, CG30446, CG3686" CDMC22511 4 5 13 DAC20-P11 2-CG3092-RA_1 CG3092 ACATCATCCGTCAGCAGAGTGCCGATAAGATTAGCGAGTATACGACACCGGTGGGCTTCCAGCAG 65 FBan0003092 FBgn0034835 CG3092 2 2R CG3092 CG3092 anon-WO0140519.90 CDMC22511 4 6 13 DAC20-P11 2-CG3092-RA_1 CG3092 ACATCATCCGTCAGCAGAGTGCCGATAAGATTAGCGAGTATACGACACCGGTGGGCTTCCAGCAG 65 FBan0003092 FBgn0034835 CG3092 2 2R CG3092 CG3092 anon-WO0140519.90 CDMC22512 4 7 13 DAC20-P23 AutoBlank AutoBlank CDMC22512 4 8 13 DAC20-P23 AutoBlank AutoBlank CDMC22513 4 9 13 DAC21-D11 8-CG4020-RA_2 CG4020 GGCGAGGTGATCGATATCGGTAAGACGTTCATCCGCAAGAATCCATTCGAGAAGACACTCTGGCTGCC 68 FBan0004020 FBgn0029821 CG4020 X X oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG4020 CG4020 CDMC22513 4 10 13 DAC21-D11 8-CG4020-RA_2 CG4020 GGCGAGGTGATCGATATCGGTAAGACGTTCATCCGCAAGAATCCATTCGAGAAGACACTCTGGCTGCC 68 FBan0004020 FBgn0029821 CG4020 X X oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG4020 CG4020 CDMC22514 4 11 13 DAC21-D23 23-CG41134-RA_11 CG41134 TCTGAAGAGGAAAAAACAGTAGAGCAAAAAGATCCAGAGTTGGGAAATCGAAAGTGTGGAAGTTTTTT 68 FBgn0069918 CG41134 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41134 CG41134 CDMC22514 4 12 13 DAC21-D23 23-CG41134-RA_11 CG41134 TCTGAAGAGGAAAAAACAGTAGAGCAAAAAGATCCAGAGTTGGGAAATCGAAAGTGTGGAAGTTTTTT 68 FBgn0069918 CG41134 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41134 CG41134 CDMC22515 4 13 13 DAC21-H11 3-CG4550-RA_2 CG4550 ACCTGGTCATCAACTGCATGGGACTGTTCAAGTTCGAGGGCCTTACACCACTGAATACCATTTGGGGA 68 FBan0004550 FBgn0002940 ninaE 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; phototransduction; GO:0007602; rhabdomere development; GO:0042052; visual perception; GO:0007601 G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 cytoplasmic membrane-bound vesicle; GO:0016023; inaD signaling complex; GO:0016027; integral to membrane; GO:0016021; multivesicular body; GO:0005771; rhabdomere; GO:0016028; rough endoplasmic reticulum; GO:0005791; secondary lysosome; GO:0005767; subrhabdomeral cisterna; GO:0016029 ninaE neither inactivation nor afterpotential E "CG4550, Rh1, 1F9, ora: outer-rhabdomeres-absent, rh1, RH1, opsin, Dm Rh1, Rh, Rh1/ninaE, rhodopsin, rhodopsin 1, DmRh1, DMELRH1, rhodopsin-1, Rhodopsin, rh1/ninaE, Rhodopsin 1, FBgn0002940, Nina E, BEST:GH11778, ora" CDMC22515 4 14 13 DAC21-H11 3-CG4550-RA_2 CG4550 ACCTGGTCATCAACTGCATGGGACTGTTCAAGTTCGAGGGCCTTACACCACTGAATACCATTTGGGGA 68 FBan0004550 FBgn0002940 ninaE 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; phototransduction; GO:0007602; rhabdomere development; GO:0042052; visual perception; GO:0007601 G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 cytoplasmic membrane-bound vesicle; GO:0016023; inaD signaling complex; GO:0016027; integral to membrane; GO:0016021; multivesicular body; GO:0005771; rhabdomere; GO:0016028; rough endoplasmic reticulum; GO:0005791; secondary lysosome; GO:0005767; subrhabdomeral cisterna; GO:0016029 ninaE neither inactivation nor afterpotential E "CG4550, Rh1, 1F9, ora: outer-rhabdomeres-absent, rh1, RH1, opsin, Dm Rh1, Rh, Rh1/ninaE, rhodopsin, rhodopsin 1, DmRh1, DMELRH1, rhodopsin-1, Rhodopsin, rh1/ninaE, Rhodopsin 1, FBgn0002940, Nina E, BEST:GH11778, ora" CDMC22516 4 15 13 DAC21-H23 6-CG4763-RA_4 CG4763 GCACTCGATGCACTTTTGTCATCCTGGCACTAACCATTCTGCCAAACCAATTCCATTGCCAGGTGGGT 68 FBan0004763 FBgn0034910 CG4763 2 2R CG4763 CG4763 CDMC22516 4 16 13 DAC21-H23 6-CG4763-RA_4 CG4763 GCACTCGATGCACTTTTGTCATCCTGGCACTAACCATTCTGCCAAACCAATTCCATTGCCAGGTGGGT 68 FBan0004763 FBgn0034910 CG4763 2 2R CG4763 CG4763 CDMC22517 4 17 13 DAC21-L11 2-CG5179-RA_1 CG5179 GCCCCAGGACAACAGTATGATTGACCGGGTTTGGTAGACTGCCAGAGGTGTACGCACCCGACTAATAG 68 FBan0005179 FBgn0019949 Cdk9 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368; cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; response to heat; GO:0009408; transcription; GO:0006350 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; RNA polymerase II transcription factor activity; GO:0003702; positive transcription elongation factor activity; GO:0008159; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0003702; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0008159; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome puff; GO:0005703; transcription elongation factor complex b; GO:0008024 Cdk9 Cyclin-dependent kinase 9 "CG5179, CG5179, P-TEF, P-TEFb, Positive transcription elongation factor b, CDK9, p43 PITALRE, positive transcription elongation factor b, cdk9, Cyclin-dependent kinase9 2.7, PTefb, Positive transcription elongation factor b, small subunit" CDMC22517 4 18 13 DAC21-L11 2-CG5179-RA_1 CG5179 GCCCCAGGACAACAGTATGATTGACCGGGTTTGGTAGACTGCCAGAGGTGTACGCACCCGACTAATAG 68 FBan0005179 FBgn0019949 Cdk9 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368; cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; response to heat; GO:0009408; transcription; GO:0006350 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; RNA polymerase II transcription factor activity; GO:0003702; positive transcription elongation factor activity; GO:0008159; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0003702; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0008159; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome puff; GO:0005703; transcription elongation factor complex b; GO:0008024 Cdk9 Cyclin-dependent kinase 9 "CG5179, CG5179, P-TEF, P-TEFb, Positive transcription elongation factor b, CDK9, p43 PITALRE, positive transcription elongation factor b, cdk9, Cyclin-dependent kinase9 2.7, PTefb, Positive transcription elongation factor b, small subunit" CDMC22518 4 19 13 DAC21-L23 11-CG5289-RA_1 CG5289 GCCGCATGAAGGTGACCAACGAGGACTTCAAGAAGTCAAAGGAGAGCGTCTTGTACCGGAAGAAGGAG 68 FBan0005289 FBgn0015282 Pros26.4 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros26.4 Proteasome 26S subunit subunit 4 ATPase "CG5289, proteasome 26S, P26s4, S4, 26S proteasome subunit 4 ATPase, p56, DmP26S4, Dm_Rpt2, dRpt2, pros26.4, p54" CDMC22518 4 20 13 DAC21-L23 11-CG5289-RA_1 CG5289 GCCGCATGAAGGTGACCAACGAGGACTTCAAGAAGTCAAAGGAGAGCGTCTTGTACCGGAAGAAGGAG 68 FBan0005289 FBgn0015282 Pros26.4 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros26.4 Proteasome 26S subunit subunit 4 ATPase "CG5289, proteasome 26S, P26s4, S4, 26S proteasome subunit 4 ATPase, p56, DmP26S4, Dm_Rpt2, dRpt2, pros26.4, p54" CDMC22519 4 21 13 DAC21-P11 14-CG5663-RA_1 CG5663 GCAATCTGCTGTATCCAATTCTCTCTGAGTGCCGAGTGATCAAGTCACCCGAAGAGATCGAGGTGCTG 68 FBan0005663 FBgn0000455 Dip-C 3 3R proteolysis; GO:0006508 X-Pro dipeptidase activity; GO:0004251 ; EC:3.4.13.9; dipeptidyl-peptidase activity; GO:0008239; ; GO:0008239; ; GO:0004251 ; EC:3.4.13.9 Dip-C Dipeptidase C "CG5663, CG5663, CG5663" CDMC22519 4 22 13 DAC21-P11 14-CG5663-RA_1 CG5663 GCAATCTGCTGTATCCAATTCTCTCTGAGTGCCGAGTGATCAAGTCACCCGAAGAGATCGAGGTGCTG 68 FBan0005663 FBgn0000455 Dip-C 3 3R proteolysis; GO:0006508 X-Pro dipeptidase activity; GO:0004251 ; EC:3.4.13.9; dipeptidyl-peptidase activity; GO:0008239; ; GO:0008239; ; GO:0004251 ; EC:3.4.13.9 Dip-C Dipeptidase C "CG5663, CG5663, CG5663" CDMC22520 4 23 13 DAC21-P23 AutoBlank AutoBlank CDMC22520 4 24 13 DAC21-P23 AutoBlank AutoBlank CDMC22521 4 25 13 DAC22-D11 13-CG40478-RC_1 CG40478 TCGGCCAACTCATTGTCACATTTGGAGCAAGCCACAAAATTAGATGCTTTGGGAGAATACTCGGCGTCA 69 FBgn0069975 CDMC22521 4 26 13 DAC22-D11 13-CG40478-RC_1 CG40478 TCGGCCAACTCATTGTCACATTTGGAGCAAGCCACAAAATTAGATGCTTTGGGAGAATACTCGGCGTCA 69 FBgn0069975 CDMC22522 4 1 14 DAC22-D23 2-CG4050-RB_2 CG4050 GCGGAGAAGTGCTATCGCAGCATACTTCACTACGATCCCCACAACACTCAGGGCTTGCACAATCTCTGT 69 FBan0004050 FBgn0020312 CG4050 2 2R UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase complex; GO:0017122 CG4050 CG4050 "anon-DM192, anon-j" CDMC22522 4 2 14 DAC22-D23 2-CG4050-RB_2 CG4050 GCGGAGAAGTGCTATCGCAGCATACTTCACTACGATCCCCACAACACTCAGGGCTTGCACAATCTCTGT 69 FBan0004050 FBgn0020312 CG4050 2 2R UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase complex; GO:0017122 CG4050 CG4050 "anon-DM192, anon-j" CDMC22523 4 3 14 DAC22-H11 23-CG4083-RA_2 CG4083 CGTAACGCCGAAAAATAAAACTGTACCGAGAGTTTCGAATTTAACATAGCCACATTTAGACATTCTGGG 69 FBan0004083 FBgn0017572 Mo25 3 3L embryonic development (sensu Insecta); GO:0001700 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mo25 Mo25 "CG4083, l(3)00274, dMo25" CDMC22523 4 4 14 DAC22-H11 23-CG4083-RA_2 CG4083 CGTAACGCCGAAAAATAAAACTGTACCGAGAGTTTCGAATTTAACATAGCCACATTTAGACATTCTGGG 69 FBan0004083 FBgn0017572 Mo25 3 3L embryonic development (sensu Insecta); GO:0001700 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mo25 Mo25 "CG4083, l(3)00274, dMo25" CDMC22524 4 5 14 DAC22-H23 22-CG4095-RA_1 CG4095 GTTGGGTGAGTCGGAAATGTGTTTTCCAAGTGGAAAAACATGCATACATAACCTTCTCCTCCCAGCTGA 69 FBan0004095 FBgn0029890 CG4095 X X fumarate metabolism; GO:0006106; tricarboxylic acid cycle; GO:0006099 fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2 cytoplasm; GO:0005737; mitochondrion; GO:0005739; tricarboxylic acid cycle enzyme complex; GO:0045239 CG4095 CG4095 CDMC22524 4 6 14 DAC22-H23 22-CG4095-RA_1 CG4095 GTTGGGTGAGTCGGAAATGTGTTTTCCAAGTGGAAAAACATGCATACATAACCTTCTCCTCCCAGCTGA 69 FBan0004095 FBgn0029890 CG4095 X X fumarate metabolism; GO:0006106; tricarboxylic acid cycle; GO:0006099 fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2 cytoplasm; GO:0005737; mitochondrion; GO:0005739; tricarboxylic acid cycle enzyme complex; GO:0045239 CG4095 CG4095 CDMC22525 4 7 14 DAC22-L11 23-CG4108-RA_5 CG4108 TGCAAACCAACACCTAATATTTTTTCTTCGTTCGTCATTGTAAATTCGTCAAGCTGGGTAACGACATGT 69 FBan0004108 FBgn0036805 Chmp1 3 3L Chmp1 Chmp1 "CG4108, CHMP1" CDMC22525 4 8 14 DAC22-L11 23-CG4108-RA_5 CG4108 TGCAAACCAACACCTAATATTTTTTCTTCGTTCGTCATTGTAAATTCGTCAAGCTGGGTAACGACATGT 69 FBan0004108 FBgn0036805 Chmp1 3 3L Chmp1 Chmp1 "CG4108, CHMP1" CDMC22526 4 9 14 DAC22-L23 8-CG41106-RA_1 CG41106 GCCTTCTCCCTGGCAACCATATGCCTGCTAATCTTTTATGGATTCAATCACGCCACTAAGCAGGACCCC 69 FBgn0069938 CG41106 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41106 CG41106 CDMC22526 4 10 14 DAC22-L23 8-CG41106-RA_1 CG41106 GCCTTCTCCCTGGCAACCATATGCCTGCTAATCTTTTATGGATTCAATCACGCCACTAAGCAGGACCCC 69 FBgn0069938 CG41106 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41106 CG41106 CDMC22527 4 11 14 DAC22-P11 14-CG4122-RA_1 CG4122 TTGATGTGGCTGACGATAGCGAAGACGACATAGTGATGTTGCATAACAACGGGAACAAGAGACGGCACT 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC22527 4 12 14 DAC22-P11 14-CG4122-RA_1 CG4122 TTGATGTGGCTGACGATAGCGAAGACGACATAGTGATGTTGCATAACAACGGGAACAAGAGACGGCACT 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC22528 4 13 14 DAC22-P23 1-CG4133-RA_1 CG4133 GGTCTGGGTCAGAACGAGCACTACATCTACGTGACCTATCCACCGGACCTCAAGAAGCGCTACTTCGAG 69 FBan0004133 FBgn0031257 CG4133 2 2L CG4133 CG4133 CDMC22528 4 14 14 DAC22-P23 1-CG4133-RA_1 CG4133 GGTCTGGGTCAGAACGAGCACTACATCTACGTGACCTATCCACCGGACCTCAAGAAGCGCTACTTCGAG 69 FBan0004133 FBgn0031257 CG4133 2 2L CG4133 CG4133 CDMC22529 4 15 14 DAC23-D11 18-CG33453-RA_1 CG33453 CAAATCCTGGGCTGTTTTTCATTATTGCCGGCTAAAGGCTTACTCGCGTAACAAGACCAGCTTGAACAT 69 FBan0033453 FBgn0053453 CG33453 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33453 CG33453 CDMC22529 4 16 14 DAC23-D11 18-CG33453-RA_1 CG33453 CAAATCCTGGGCTGTTTTTCATTATTGCCGGCTAAAGGCTTACTCGCGTAACAAGACCAGCTTGAACAT 69 FBan0033453 FBgn0053453 CG33453 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33453 CG33453 CDMC22530 4 17 14 DAC23-D23 10-CG33461-RA_1 CG33461 GGGTCTCACGTCTACCGATTTGAATACCAAGTCATCCCGCGTTCTCATGGAACTGAATCTCTACCGCCG 69 FBan0033461 FBgn0053461 CG33461 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33461 CG33461 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41" CDMC22530 4 18 14 DAC23-D23 10-CG33461-RA_1 CG33461 GGGTCTCACGTCTACCGATTTGAATACCAAGTCATCCCGCGTTCTCATGGAACTGAATCTCTACCGCCG 69 FBan0033461 FBgn0053461 CG33461 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33461 CG33461 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41" CDMC22531 4 19 14 DAC23-H11 22-CG33481-RB_1 CG33481 CGGCTCGAGCAAAAATTCTTGGATCTACGGAAATTCATGTAAAACGGGATAGCACTATTGCCCTGGCTT 69 FBan0033481 FBgn0053481 dpr7 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr7 dpr7 "CG33481, CG33481, Dpr-7" CDMC22531 4 20 14 DAC23-H11 22-CG33481-RB_1 CG33481 CGGCTCGAGCAAAAATTCTTGGATCTACGGAAATTCATGTAAAACGGGATAGCACTATTGCCCTGGCTT 69 FBan0033481 FBgn0053481 dpr7 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr7 dpr7 "CG33481, CG33481, Dpr-7" CDMC22532 4 21 14 DAC23-H23 23-CG3348-RA_4 CG3348 CGAGCCAAGATCAGTCAATCGGTGTCCACAAATTAGTGATATCTTACGGCTAAACTTAATTTAATGCTA 69 FBan0003348 FBgn0040609 CG3348 3 3R CG3348 CG3348 CDMC22532 4 22 14 DAC23-H23 23-CG3348-RA_4 CG3348 CGAGCCAAGATCAGTCAATCGGTGTCCACAAATTAGTGATATCTTACGGCTAAACTTAATTTAATGCTA 69 FBan0003348 FBgn0040609 CG3348 3 3R CG3348 CG3348 CDMC22533 4 23 14 DAC23-L11 3-CG3371-RA_3 CG3371 GGCCGTGTACGATTGGATACGCCGCATGATGTACTACAAGGACTTCAGCATCTCCGACGGACTCATCCA 69 FBan0003371 FBgn0035153 CG3371 3 3L DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG3371 CG3371 EP3592 CDMC22533 4 24 14 DAC23-L11 3-CG3371-RA_3 CG3371 GGCCGTGTACGATTGGATACGCCGCATGATGTACTACAAGGACTTCAGCATCTCCGACGGACTCATCCA 69 FBan0003371 FBgn0035153 CG3371 3 3L DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG3371 CG3371 EP3592 CDMC22534 4 25 14 DAC23-L23 16-CG3386-RA_2 CG3386 TCCAGAGCAACTACAACAATCAGTGGGAGTATGTGAGGTGTTTACCAACACTAGACGCTAGAAGTGGCA 69 FBan0003386 FBgn0035152 CG3386 3 3L CG3386 CG3386 CDMC22534 4 26 14 DAC23-L23 16-CG3386-RA_2 CG3386 TCCAGAGCAACTACAACAATCAGTGGGAGTATGTGAGGTGTTTACCAACACTAGACGCTAGAAGTGGCA 69 FBan0003386 FBgn0035152 CG3386 3 3L CG3386 CG3386 CDMC22535 4 1 15 DAC23-P11 10-CG3425-RA_1 CG3425 ACTTCGTTTGAGAATCCTCTACTCAGTTTGCTTTCCTAAGCTGCAGGAAGAAGACCGACGCTGGGACCA 69 FBan0003425 FBgn0017482 T3dh 2 2R carbohydrate metabolism; GO:0005975 alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0004022 ; EC:1.1.1.1; iron ion binding; GO:0005506; ; GO:0005506 T3dh Type III alcohol dehydrogenase CG3425 CDMC22535 4 2 15 DAC23-P11 10-CG3425-RA_1 CG3425 ACTTCGTTTGAGAATCCTCTACTCAGTTTGCTTTCCTAAGCTGCAGGAAGAAGACCGACGCTGGGACCA 69 FBan0003425 FBgn0017482 T3dh 2 2R carbohydrate metabolism; GO:0005975 alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0004022 ; EC:1.1.1.1; iron ion binding; GO:0005506; ; GO:0005506 T3dh Type III alcohol dehydrogenase CG3425 CDMC22536 4 3 15 DAC23-P23 23-CG3446-RA_5 CG3446 AAGCGCCAAAAAAAGAAAGTATCGACCAATTATAATGTCAGATCAGATTGGCTGAAATACCGATTCTCT 69 FBan0003446 FBgn0029868 CG3446 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3446 CG3446 CDMC22536 4 4 15 DAC23-P23 23-CG3446-RA_5 CG3446 AAGCGCCAAAAAAAGAAAGTATCGACCAATTATAATGTCAGATCAGATTGGCTGAAATACCGATTCTCT 69 FBan0003446 FBgn0029868 CG3446 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3446 CG3446 CDMC22537 4 5 15 DAC24-D11 14-CG33182-RA_1 CG33182 AGCAATGCAATCCTACCAAGGCCAAGAGTTTCAAAGAGCGTAATCCCGATCTGGACCTGGATGAAATCC 69 FBan0033182 FBgn0053182 CG33182 2 2R "cell communication; GO:0007154; hormone secretion; GO:0046879; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG33182 CG33182 CG4037 CDMC22537 4 6 15 DAC24-D11 14-CG33182-RA_1 CG33182 AGCAATGCAATCCTACCAAGGCCAAGAGTTTCAAAGAGCGTAATCCCGATCTGGACCTGGATGAAATCC 69 FBan0033182 FBgn0053182 CG33182 2 2R "cell communication; GO:0007154; hormone secretion; GO:0046879; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG33182 CG33182 CG4037 CDMC22538 4 7 15 DAC24-D23 23-CG3318-RB_7 CG3318 GTGGCGGGTTCCCAGTAGTGTATCAACGTTCGATTCAGCGTAGTGTAAACAAACAGTACAAGTTACGTA 69 FBan0003318 FBgn0019643 Dat 2 2R "behavior; GO:0007610; biogenic amine catabolism; GO:0042402; catecholamine metabolism; GO:0006584; dopamine catabolism; GO:0042420; octopamine catabolism; GO:0046334; pigmentation during development; GO:0048066; regulation of circadian sleep/wake cycle, sleep; GO:0045187; serotonin catabolism; GO:0042429; sleep; GO:0030431" aralkylamine N-acetyltransferase activity; GO:0004059 ; EC:2.3.1.87; arylamine N-acetyltransferase activity; GO:0004060 ; EC:2.3.1.5; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004059 ; EC:2.3.1.87; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004060 ; EC:2.3.1.5; ; GO:0008080 ; EC:2.3.1.- Dat Dopamine N acetyltransferase "CG3318, aaNAT, aaNAT1, NAT1, aaNat, AA-NAT1, Dat1, Aanat1, Arylalkylamine N-acetyltransferase-1" CDMC22538 4 8 15 DAC24-D23 23-CG3318-RB_7 CG3318 GTGGCGGGTTCCCAGTAGTGTATCAACGTTCGATTCAGCGTAGTGTAAACAAACAGTACAAGTTACGTA 69 FBan0003318 FBgn0019643 Dat 2 2R "behavior; GO:0007610; biogenic amine catabolism; GO:0042402; catecholamine metabolism; GO:0006584; dopamine catabolism; GO:0042420; octopamine catabolism; GO:0046334; pigmentation during development; GO:0048066; regulation of circadian sleep/wake cycle, sleep; GO:0045187; serotonin catabolism; GO:0042429; sleep; GO:0030431" aralkylamine N-acetyltransferase activity; GO:0004059 ; EC:2.3.1.87; arylamine N-acetyltransferase activity; GO:0004060 ; EC:2.3.1.5; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004059 ; EC:2.3.1.87; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004060 ; EC:2.3.1.5; ; GO:0008080 ; EC:2.3.1.- Dat Dopamine N acetyltransferase "CG3318, aaNAT, aaNAT1, NAT1, aaNat, AA-NAT1, Dat1, Aanat1, Arylalkylamine N-acetyltransferase-1" CDMC22539 4 9 15 DAC24-H11 10-CG3320-RB_1 CG3320 GCCACTGACAACGCTAGCAAAGTGAAAATCGATCAAGGACGTCCAGTGGAAAACACCAAATCCGGTTGC 69 FBan0003320 FBgn0016700 Rab1 3 3R "ER to Golgi transport; GO:0006888; actin filament organization; GO:0007015; cell adhesion; GO:0007155; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab1 Rab-protein 1 "CG3320, CG3320, CG3320, DRAB1, DRab1, rab1, dRab1, DmRab1, drab1, AAF55873, Dm Rab1" CDMC22539 4 10 15 DAC24-H11 10-CG3320-RB_1 CG3320 GCCACTGACAACGCTAGCAAAGTGAAAATCGATCAAGGACGTCCAGTGGAAAACACCAAATCCGGTTGC 69 FBan0003320 FBgn0016700 Rab1 3 3R "ER to Golgi transport; GO:0006888; actin filament organization; GO:0007015; cell adhesion; GO:0007155; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab1 Rab-protein 1 "CG3320, CG3320, CG3320, DRAB1, DRab1, rab1, dRab1, DmRab1, drab1, AAF55873, Dm Rab1" CDMC22540 4 11 15 DAC24-H23 14-CG33220-RA_1 CG33220 CGGAACAGGCTAGAAAGGAACATATATTGCCCCAAAACCTCAACGACACACCGTATTGGGAAAGCCGAA 69 FBan0033220 FBgn0053220 CG33220 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33220 CG33220 CDMC22540 4 12 15 DAC24-H23 14-CG33220-RA_1 CG33220 CGGAACAGGCTAGAAAGGAACATATATTGCCCCAAAACCTCAACGACACACCGTATTGGGAAAGCCGAA 69 FBan0033220 FBgn0053220 CG33220 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33220 CG33220 CDMC22541 4 13 15 DAC24-L11 15-CG33261-RB_1 CG33261 GGTGGAGCACCATCAGTTGGACCAGGAGCACATAATCATAGATCATCACCAACAGACGGAGGATGATCA 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC22541 4 14 15 DAC24-L11 15-CG33261-RB_1 CG33261 GGTGGAGCACCATCAGTTGGACCAGGAGCACATAATCATAGATCATCACCAACAGACGGAGGATGATCA 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC22542 4 15 15 DAC24-L23 14-CG33279-RA_1 CG33279 TGGCGAGCTGTCTGAGTTATTGGACCACAAGAAAAGTTATTGCAAGCTGAGGTTCACATGCAAGTGCCA 69 FBan0033279 FBgn0053279 CG33279 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33279 CG33279 "CG18656, CG18656, cg18656" CDMC22542 4 16 15 DAC24-L23 14-CG33279-RA_1 CG33279 TGGCGAGCTGTCTGAGTTATTGGACCACAAGAAAAGTTATTGCAAGCTGAGGTTCACATGCAAGTGCCA 69 FBan0033279 FBgn0053279 CG33279 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33279 CG33279 "CG18656, CG18656, cg18656" CDMC22543 4 17 15 DAC24-P11 14-CG33310-RA_1 CG33310 ACGGCGACTATGGACACAATCCGCGTTTTGGAACGTGTACTGCGAATGAAAAGTTTGGCTATCCAAGCG 69 FBan0033310 FBgn0053310 CG33310 2 2L potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 membrane; GO:0016020 CG33310 CG33310 "CG15274, CG15274, BG:DS00929.6" CDMC22543 4 18 15 DAC24-P11 14-CG33310-RA_1 CG33310 ACGGCGACTATGGACACAATCCGCGTTTTGGAACGTGTACTGCGAATGAAAAGTTTGGCTATCCAAGCG 69 FBan0033310 FBgn0053310 CG33310 2 2L potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 membrane; GO:0016020 CG33310 CG33310 "CG15274, CG15274, BG:DS00929.6" CDMC22544 4 19 15 DAC24-P23 16-CG33325-RA_1 CG33325 AAACAAATTCCGCATGAGACAAATCCGTGCAGGGTCGATCTAATTCGCTTGAAAAAAGAACTGGGACGC 69 FBan0033325 FBgn0053325 CG33325 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33325 CG33325 CDMC22544 4 20 15 DAC24-P23 16-CG33325-RA_1 CG33325 AAACAAATTCCGCATGAGACAAATCCGTGCAGGGTCGATCTAATTCGCTTGAAAAAAGAACTGGGACGC 69 FBan0033325 FBgn0053325 CG33325 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33325 CG33325 CDMC22545 4 21 15 DAC25-D11 3-CG10379-RA_2 CG10379 CGCCAAGGCACGTGACTCAACTGATTTTACCAGCCTGTCGCAAAACATGGATTGGACCCCGAATGGTTA 69 FBan0010379 FBgn0015513 mbc 3 3R cellular morphogenesis; GO:0000902; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; larval visceral muscle development; GO:0007523; mesoderm development; GO:0007498; myoblast fusion; GO:0007520; phagocytosis; GO:0006909; striated muscle development; GO:0007519 GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; protein binding; GO:0005515; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 ruffle; GO:0001726 mbc myoblast city "CG10379, Su(rac)1, Mbc, Crk/DOCK180, MBC, Myoblast City, myoblast city" CDMC22545 4 22 15 DAC25-D11 3-CG10379-RA_2 CG10379 CGCCAAGGCACGTGACTCAACTGATTTTACCAGCCTGTCGCAAAACATGGATTGGACCCCGAATGGTTA 69 FBan0010379 FBgn0015513 mbc 3 3R cellular morphogenesis; GO:0000902; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; larval visceral muscle development; GO:0007523; mesoderm development; GO:0007498; myoblast fusion; GO:0007520; phagocytosis; GO:0006909; striated muscle development; GO:0007519 GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; protein binding; GO:0005515; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 ruffle; GO:0001726 mbc myoblast city "CG10379, Su(rac)1, Mbc, Crk/DOCK180, MBC, Myoblast City, myoblast city" CDMC22546 4 23 15 DAC25-D23 18-CG10391-RA_2 CG10391 GCCAACGATGTGGGCCAATGTGAAGACAAGACAAAGAGCAATGTTTTTATAGGATTTGGCATTGGGGGA 69 FBan0010391 FBgn0032693 Cyp310a1 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp310a1 Cyp310a1 "CG10391, CG10391, H, 310a1, Cyp310a, anon-EST:CL1d7" CDMC22546 4 24 15 DAC25-D23 18-CG10391-RA_2 CG10391 GCCAACGATGTGGGCCAATGTGAAGACAAGACAAAGAGCAATGTTTTTATAGGATTTGGCATTGGGGGA 69 FBan0010391 FBgn0032693 Cyp310a1 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp310a1 Cyp310a1 "CG10391, CG10391, H, 310a1, Cyp310a, anon-EST:CL1d7" CDMC22547 4 25 15 DAC25-H11 16-CG10433-RA_1 CG10433 TGCTGCGTCCTGATTTAGTTATACTTAACCACACCATACACATACCCGTGCAGAGGAACAGCATCGTCA 69 FBan0010433 FBgn0034638 CG10433 2 2R defense response; GO:0006952 CG10433 CG10433 CDMC22547 4 26 15 DAC25-H11 16-CG10433-RA_1 CG10433 TGCTGCGTCCTGATTTAGTTATACTTAACCACACCATACACATACCCGTGCAGAGGAACAGCATCGTCA 69 FBan0010433 FBgn0034638 CG10433 2 2R defense response; GO:0006952 CG10433 CG10433 CDMC22548 4 1 16 DAC25-H23 11-CG1044-RA_2 CG1044 ACCAACAAACCGCCATTGCTAAATCGATCCAGCATGAGTGTGGGGAATCTGTACTCACAAGGCGGAAAT 69 FBan0001044 FBgn0016794 dos 3 3L "determination of anterior/posterior axis, embryo; GO:0008595; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" SH2 domain binding; GO:0042169; ; GO:0042169; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 plasma membrane; GO:0005886 dos daughter of sevenless "CG1044, E(csw[CS])3A, Enhancer of corkscrew-CS, Su(sev[S11])3A, Suppressor of sevenless-S11, Dos, DOS, E(csw)3A, Su(sev)3A" CDMC22548 4 2 16 DAC25-H23 11-CG1044-RA_2 CG1044 ACCAACAAACCGCCATTGCTAAATCGATCCAGCATGAGTGTGGGGAATCTGTACTCACAAGGCGGAAAT 69 FBan0001044 FBgn0016794 dos 3 3L "determination of anterior/posterior axis, embryo; GO:0008595; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" SH2 domain binding; GO:0042169; ; GO:0042169; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 plasma membrane; GO:0005886 dos daughter of sevenless "CG1044, E(csw[CS])3A, Enhancer of corkscrew-CS, Su(sev[S11])3A, Suppressor of sevenless-S11, Dos, DOS, E(csw)3A, Su(sev)3A" CDMC22549 4 3 16 DAC25-L11 22-CG10498-RB_1 CG10498 CCGCTCCTTGTTTCCTGGAGACAGCGAGATCGATCAACTTTATAGGATTTTCCGTACCTTAAGCACACC 69 FBan0010498 FBgn0004107 cdc2c 3 3R G1/S transition of mitotic cell cycle; GO:0000082; G2/M transition of mitotic cell cycle; GO:0000086; JAK-STAT cascade; GO:0007259; cellular physiological process; GO:0050875; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- cdc2c cdc2c "CG10498, CG10498, CDC2c, Cdc2c, Dmcdc2c, Dcdc2c, cdk2, DmCdc2, Cdk2, DmCdk2, S(Sev-CycE)3A, CDK2, CDK2/CDC2c, cyclin E-CDK2" CDMC22549 4 4 16 DAC25-L11 22-CG10498-RB_1 CG10498 CCGCTCCTTGTTTCCTGGAGACAGCGAGATCGATCAACTTTATAGGATTTTCCGTACCTTAAGCACACC 69 FBan0010498 FBgn0004107 cdc2c 3 3R G1/S transition of mitotic cell cycle; GO:0000082; G2/M transition of mitotic cell cycle; GO:0000086; JAK-STAT cascade; GO:0007259; cellular physiological process; GO:0050875; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- cdc2c cdc2c "CG10498, CG10498, CDC2c, Cdc2c, Dmcdc2c, Dcdc2c, cdk2, DmCdc2, Cdk2, DmCdk2, S(Sev-CycE)3A, CDK2, CDK2/CDC2c, cyclin E-CDK2" CDMC22550 4 5 16 DAC25-L23 16-CG10512-RA_1 CG10512 CCCCTGAGCTTTGTTTAAACTCGAAAGAACTGGTGGACTTACACTAGGGAGTCAAGCATACCCATTGCC 69 FBan0010512 FBgn0037057 CG10512 3 3L carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10512 CG10512 CDMC22550 4 6 16 DAC25-L23 16-CG10512-RA_1 CG10512 CCCCTGAGCTTTGTTTAAACTCGAAAGAACTGGTGGACTTACACTAGGGAGTCAAGCATACCCATTGCC 69 FBan0010512 FBgn0037057 CG10512 3 3L carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10512 CG10512 CDMC22551 4 7 16 DAC25-P11 3-CG10541-RA_2 CG10541 AGGCCCTGAAGTACCAAACATTTTAGTCGGGCAGCACTACATCCAGTACAGCACCAGTCCAGTAGTCGC 69 FBan0010541 FBgn0035638 Tektin-C 3 3L microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Tektin-C Tektin C "CG10541, CG10541, CG10541, TEKTIN C, Tektin C" CDMC22551 4 8 16 DAC25-P11 3-CG10541-RA_2 CG10541 AGGCCCTGAAGTACCAAACATTTTAGTCGGGCAGCACTACATCCAGTACAGCACCAGTCCAGTAGTCGC 69 FBan0010541 FBgn0035638 Tektin-C 3 3L microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Tektin-C Tektin C "CG10541, CG10541, CG10541, TEKTIN C, Tektin C" CDMC22552 4 9 16 DAC25-P23 AutoBlank AutoBlank CDMC22552 4 10 16 DAC25-P23 AutoBlank AutoBlank CDMC22553 4 11 16 DAC26-D11 10-CG15311-RA_1 CG15311 CCCATGACAATGGCAATTGGTATCGCCGTATCAGTCCGGTTTTGCGAAATGGCGTTAAAAGTGATCCGC 69 FBan0015311 FBgn0030182 CG15311 X X CG15311 CG15311 CDMC22553 4 12 16 DAC26-D11 10-CG15311-RA_1 CG15311 CCCATGACAATGGCAATTGGTATCGCCGTATCAGTCCGGTTTTGCGAAATGGCGTTAAAAGTGATCCGC 69 FBan0015311 FBgn0030182 CG15311 X X CG15311 CG15311 CDMC22554 4 13 16 DAC26-D23 3-CG15327-RA_1 CG15327 GCCACTGGATTTGCTGAGTCCATGAGCTTCGTTGTGGCAGCACTTAATTGCTTGATGGGAGCACTCTGT 69 FBan0015327 FBgn0029967 CG15327 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15327 CG15327 CT35327 CDMC22554 4 14 16 DAC26-D23 3-CG15327-RA_1 CG15327 GCCACTGGATTTGCTGAGTCCATGAGCTTCGTTGTGGCAGCACTTAATTGCTTGATGGGAGCACTCTGT 69 FBan0015327 FBgn0029967 CG15327 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15327 CG15327 CT35327 CDMC22555 4 15 16 DAC26-H11 9-CG15380-RB_1 CG15380 GGAGCCCAAGATGTCCATGGCCTTTCAGCTGAACATCATCGGTGAGTGGCATTTGACGAGATGTGAAAT 69 FBgn0031387 CDMC22555 4 16 16 DAC26-H11 9-CG15380-RB_1 CG15380 GGAGCCCAAGATGTCCATGGCCTTTCAGCTGAACATCATCGGTGAGTGGCATTTGACGAGATGTGAAAT 69 FBgn0031387 CDMC22556 4 17 16 DAC26-H23 2-CG15394-RA_1 CG15394 GGGCAAAGACCTCGTACGTAAATGACTTTGTATTCCCCACCGAAGATGAGCAAGTCATTCGCCCCTGGC 69 FBan0015394 FBgn0031439 CG15394 2 2L CG15394 CG15394 CDMC22556 4 18 16 DAC26-H23 2-CG15394-RA_1 CG15394 GGGCAAAGACCTCGTACGTAAATGACTTTGTATTCCCCACCGAAGATGAGCAAGTCATTCGCCCCTGGC 69 FBan0015394 FBgn0031439 CG15394 2 2L CG15394 CG15394 CDMC22557 4 19 16 DAC26-L11 18-CG15441-RA_1 CG15441 CGAACTTGTTGACTTTGTAACATTACATAATCGGAAGCCCAGAGTGAGGAGAACTGCTGCGAGATGGCC 69 FBan0015441 FBgn0019982 Gs1l 2 2L metabolism; GO:0008152 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004356 ; EC:6.3.1.2 Gs1l GS1-like "CG15441, GS1l, GS1like, GS1-like protein, GS1-like" CDMC22557 4 20 16 DAC26-L11 18-CG15441-RA_1 CG15441 CGAACTTGTTGACTTTGTAACATTACATAATCGGAAGCCCAGAGTGAGGAGAACTGCTGCGAGATGGCC 69 FBan0015441 FBgn0019982 Gs1l 2 2L metabolism; GO:0008152 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004356 ; EC:6.3.1.2 Gs1l GS1-like "CG15441, GS1l, GS1like, GS1-like protein, GS1-like" CDMC22558 4 21 16 DAC26-L23 14-CG15452-RA_1 CG15452 ACCCATGCACAATCCACTAAGTCGACGCCACACTGTGAACAGCTCTCGACTCCAGTACATTAATGACAA 69 FBan0015452 FBgn0031130 CG15452 X X CG15452 CG15452 CDMC22558 4 22 16 DAC26-L23 14-CG15452-RA_1 CG15452 ACCCATGCACAATCCACTAAGTCGACGCCACACTGTGAACAGCTCTCGACTCCAGTACATTAATGACAA 69 FBan0015452 FBgn0031130 CG15452 X X CG15452 CG15452 CDMC22559 4 23 16 DAC26-P11 8-CG15484-RA_1 CG15484 CGCCAGTGGAGAACAGTCCGGATAACTCAGCCGATGACTCATTTCACACCGCTAAAAGTCTGAGCAACT 69 FBan0015484 FBgn0032452 CG15484 2 2L CG15484 CG15484 CDMC22559 4 24 16 DAC26-P11 8-CG15484-RA_1 CG15484 CGCCAGTGGAGAACAGTCCGGATAACTCAGCCGATGACTCATTTCACACCGCTAAAAGTCTGAGCAACT 69 FBan0015484 FBgn0032452 CG15484 2 2L CG15484 CG15484 CDMC22560 4 25 16 DAC26-P23 AutoBlank AutoBlank CDMC22560 4 26 16 DAC26-P23 AutoBlank AutoBlank CDMC22561 4 1 17 DAC27-D11 23-CG9773-RA_2 CG9773 TACAAGTATCGCGTATATTAGTAATGCAATGTGCGTTGTAAATTATTCTGCGTTTAGTTGCTAAGCCAC 69 FBan0009773 FBgn0037609 CG9773 3 3R CG9773 CG9773 CDMC22561 4 2 17 DAC27-D11 23-CG9773-RA_2 CG9773 TACAAGTATCGCGTATATTAGTAATGCAATGTGCGTTGTAAATTATTCTGCGTTTAGTTGCTAAGCCAC 69 FBan0009773 FBgn0037609 CG9773 3 3R CG9773 CG9773 CDMC22562 4 3 17 DAC27-D23 23-CG9786-RA_7 CG9786 ACTGTAGCCACCTTTCAATCTGTCTCCTATACACTCTTGTATTTTCGAAATCGACTAAAAACCCTGAAA 69 FBan0009786 FBgn0001180 hb 3 3R "anterior region determination; GO:0007355; branching morphogenesis; GO:0001763; central nervous system development; GO:0007417; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; ganglion mother cell fate determination; GO:0007402; neuroblast fate determination; GO:0007400; positive regulation of transcription; GO:0045941; posterior head segmentation; GO:0035289; regulation of cell fate specification; GO:0042659; regulation of development, heterochronic; GO:0040034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional activator activity; GO:0016563; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 hb hunchback "CG9786, Rg-pbx: Regulator of postbithorax, Rg-bx, hbHLH, Hb, R-pbx: Regulator-of-postbithorax, l(3)85Ah, Regulator-of-postbithorax, Rg-pbx, hunchback" CDMC22562 4 4 17 DAC27-D23 23-CG9786-RA_7 CG9786 ACTGTAGCCACCTTTCAATCTGTCTCCTATACACTCTTGTATTTTCGAAATCGACTAAAAACCCTGAAA 69 FBan0009786 FBgn0001180 hb 3 3R "anterior region determination; GO:0007355; branching morphogenesis; GO:0001763; central nervous system development; GO:0007417; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; ganglion mother cell fate determination; GO:0007402; neuroblast fate determination; GO:0007400; positive regulation of transcription; GO:0045941; posterior head segmentation; GO:0035289; regulation of cell fate specification; GO:0042659; regulation of development, heterochronic; GO:0040034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional activator activity; GO:0016563; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 hb hunchback "CG9786, Rg-pbx: Regulator of postbithorax, Rg-bx, hbHLH, Hb, R-pbx: Regulator-of-postbithorax, l(3)85Ah, Regulator-of-postbithorax, Rg-pbx, hunchback" CDMC22563 4 5 17 DAC27-H11 8-CG9834-RA_1 CG9834 TGCCCAAAGAGCTACGCTACTCCGTTGCACAGATCACGCTGTAATCAAATATGCATTCTGGCTGCCTGA 69 FBan0009834 FBgn0034433 endoB 2 2R endocytosis; GO:0006897; membrane organization and biogenesis; GO:0016044; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 endoB endophilin B "CG9834, D-endoB, endophilin, endophilin B" CDMC22563 4 6 17 DAC27-H11 8-CG9834-RA_1 CG9834 TGCCCAAAGAGCTACGCTACTCCGTTGCACAGATCACGCTGTAATCAAATATGCATTCTGGCTGCCTGA 69 FBan0009834 FBgn0034433 endoB 2 2R endocytosis; GO:0006897; membrane organization and biogenesis; GO:0016044; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 endoB endophilin B "CG9834, D-endoB, endophilin, endophilin B" CDMC22564 4 7 17 DAC27-H23 2-CG9849-RA_2 CG9849 ACCGATCACAACGCAGGACATAATAGCGGGTGACGTGTTTTTTGAAATCCTGTCCCCCTCGGAACTGGA 69 FBan0009849 FBgn0034803 CG9849 2 2R muscle cell fate determination; GO:0007521 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG9849 CG9849 CDMC22564 4 8 17 DAC27-H23 2-CG9849-RA_2 CG9849 ACCGATCACAACGCAGGACATAATAGCGGGTGACGTGTTTTTTGAAATCCTGTCCCCCTCGGAACTGGA 69 FBan0009849 FBgn0034803 CG9849 2 2R muscle cell fate determination; GO:0007521 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG9849 CG9849 CDMC22565 4 9 17 DAC27-L11 18-CG9884-RB_1 CG9884 TGGACGCGGACATTCGAATGCAAGCCACTGGGTGAAGGTTATACTACAGCAAAAAAGGAGTAAAACGAA 69 FBan0009884 FBgn0011818 oaf 2 2L eclosion; GO:0007562; female meiosis chromosome segregation; GO:0016321; nervous system development; GO:0007399 oaf out at first "CG9884, l(2)ND1, near dpp complementation group 1, tnd: transcript near decapentaplegic, transcript-near-decapentaplegic, l(2)22Fb, transcript near decapentaplegic, tnd" CDMC22565 4 10 17 DAC27-L11 18-CG9884-RB_1 CG9884 TGGACGCGGACATTCGAATGCAAGCCACTGGGTGAAGGTTATACTACAGCAAAAAAGGAGTAAAACGAA 69 FBan0009884 FBgn0011818 oaf 2 2L eclosion; GO:0007562; female meiosis chromosome segregation; GO:0016321; nervous system development; GO:0007399 oaf out at first "CG9884, l(2)ND1, near dpp complementation group 1, tnd: transcript near decapentaplegic, transcript-near-decapentaplegic, l(2)22Fb, transcript near decapentaplegic, tnd" CDMC22566 4 11 17 DAC27-L23 8-CG9897-RA_1 CG9897 TGGCTCTCTTGAAAACCTGCGAGCTACTCAACACCACCGATGAAATAAAGCCAATTGAGAGGGCCGACA 69 FBan0009897 FBgn0034807 CG9897 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9897 CG9897 SPH195 CDMC22566 4 12 17 DAC27-L23 8-CG9897-RA_1 CG9897 TGGCTCTCTTGAAAACCTGCGAGCTACTCAACACCACCGATGAAATAAAGCCAATTGAGAGGGCCGACA 69 FBan0009897 FBgn0034807 CG9897 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9897 CG9897 SPH195 CDMC22567 4 13 17 DAC27-P11 3-CG9938-RA_1 CG9938 AGGGATCAGGTGATCAGCAAGAAGTGTGATTTGCCCGATCGCAAAGCCTTAGACCAGCTAATCGGCGAT 69 FBan0009938 FBgn0030500 CG9938 X X CG9938 CG9938 CDMC22567 4 14 17 DAC27-P11 3-CG9938-RA_1 CG9938 AGGGATCAGGTGATCAGCAAGAAGTGTGATTTGCCCGATCGCAAAGCCTTAGACCAGCTAATCGGCGAT 69 FBan0009938 FBgn0030500 CG9938 X X CG9938 CG9938 CDMC22568 4 15 17 DAC27-P23 15-CG9954-RA_3 CG9954 GCACCACTTTCGCCATGTCCAATTCCGGATATTACCGATGACGATTTGGTGAGCATTTCGGTAAGGGAT 69 FBan0009954 FBgn0034534 maf-S 2 2R autophagic cell death; GO:0048102; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; transcription; GO:0006350 protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0046982; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 maf-S maf-S "CG9954, CG9954, anon-EST:Posey173" CDMC22568 4 16 17 DAC27-P23 15-CG9954-RA_3 CG9954 GCACCACTTTCGCCATGTCCAATTCCGGATATTACCGATGACGATTTGGTGAGCATTTCGGTAAGGGAT 69 FBan0009954 FBgn0034534 maf-S 2 2R autophagic cell death; GO:0048102; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; transcription; GO:0006350 protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0046982; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 maf-S maf-S "CG9954, CG9954, anon-EST:Posey173" CDMC22569 4 17 17 DAC28-D11 3-CG11872-RA_5 CG11872 AAGAGCTCATTCACCGGACATAGCCCAGCAGTTCTTTAGACCCCTGAAACTGAGTCCCGTGGGAA 65 FBan0011872 FBgn0037806 CG11872 3 3R CG11872 CG11872 CDMC22569 4 18 17 DAC28-D11 3-CG11872-RA_5 CG11872 AAGAGCTCATTCACCGGACATAGCCCAGCAGTTCTTTAGACCCCTGAAACTGAGTCCCGTGGGAA 65 FBan0011872 FBgn0037806 CG11872 3 3R CG11872 CG11872 CDMC22570 4 19 17 DAC28-D23 2-CG11892-RA_2 CG11892 TTGATGCCATTCCCAAGCTCACCGTTCCCGAGTCTCTTGTGCCGGAAGAAACTTCGGTTTTCCTG 65 FBan0011892 FBgn0039313 CG11892 3 3R CG11892 CG11892 CDMC22570 4 20 17 DAC28-D23 2-CG11892-RA_2 CG11892 TTGATGCCATTCCCAAGCTCACCGTTCCCGAGTCTCTTGTGCCGGAAGAAACTTCGGTTTTCCTG 65 FBan0011892 FBgn0039313 CG11892 3 3R CG11892 CG11892 CDMC22571 4 21 17 DAC28-H11 1-CG12014-RA_1 CG12014 GGCCAGGGATGACTTCAAGCACTCCAACATATCCTTTCCCTACGGACCGATATCCCCACTCCAGG 65 FBan0012014 FBgn0035445 CG12014 3 3L sulfur metabolism; GO:0006790 iduronate-2-sulfatase activity; GO:0004423 ; EC:3.1.6.13; ; GO:0004423 ; EC:3.1.6.13 CG12014 CG12014 anon-EST:Posey282 CDMC22571 4 22 17 DAC28-H11 1-CG12014-RA_1 CG12014 GGCCAGGGATGACTTCAAGCACTCCAACATATCCTTTCCCTACGGACCGATATCCCCACTCCAGG 65 FBan0012014 FBgn0035445 CG12014 3 3L sulfur metabolism; GO:0006790 iduronate-2-sulfatase activity; GO:0004423 ; EC:3.1.6.13; ; GO:0004423 ; EC:3.1.6.13 CG12014 CG12014 anon-EST:Posey282 CDMC22572 4 23 17 DAC28-H23 3-CG12050-RA_4 CG12050 ACTTTATGATGCGAGGAATCCACGGCTTCCTCTCCAAACCCTCAGCTGTCCTCCCGGCTTAGATG 65 FBan0012050 FBgn0032915 CG12050 2 2L CG12050 CG12050 CDMC22572 4 24 17 DAC28-H23 3-CG12050-RA_4 CG12050 ACTTTATGATGCGAGGAATCCACGGCTTCCTCTCCAAACCCTCAGCTGTCCTCCCGGCTTAGATG 65 FBan0012050 FBgn0032915 CG12050 2 2L CG12050 CG12050 CDMC22573 4 25 17 DAC28-L11 14-CG1212-RA_2 CG1212 CACGCACGACACCTACTACGCCCTGCAAGTCGCCAGAGATGACCGACAAAGACAAGAAGCTGGTG 65 FBan0001212 FBgn0035101 p130CAS 3 3L cell adhesion; GO:0007155; cytoskeletal anchoring; GO:0007016; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; regulation of progression through cell cycle; GO:0000074 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0005351 focal adhesion; GO:0005925 p130CAS p130CAS "CG1212, CG1212, CT1293" CDMC22573 4 26 17 DAC28-L11 14-CG1212-RA_2 CG1212 CACGCACGACACCTACTACGCCCTGCAAGTCGCCAGAGATGACCGACAAAGACAAGAAGCTGGTG 65 FBan0001212 FBgn0035101 p130CAS 3 3L cell adhesion; GO:0007155; cytoskeletal anchoring; GO:0007016; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; regulation of progression through cell cycle; GO:0000074 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0005351 focal adhesion; GO:0005925 p130CAS p130CAS "CG1212, CG1212, CT1293" CDMC22574 4 1 18 DAC28-L23 6-CG12156-RA_4 CG12156 CATTCGATCCGGCGAATATAAGGCGGAGGATGGATGGGACGGCATCAAGTCTGGCTTTTCGCGAC 65 FBan0012156 FBgn0029959 Rab39 X X intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab39 Rab39 "CG12156, DmRab39, AAF46271" CDMC22574 4 2 18 DAC28-L23 6-CG12156-RA_4 CG12156 CATTCGATCCGGCGAATATAAGGCGGAGGATGGATGGGACGGCATCAAGTCTGGCTTTTCGCGAC 65 FBan0012156 FBgn0029959 Rab39 X X intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab39 Rab39 "CG12156, DmRab39, AAF46271" CDMC22575 4 3 18 DAC28-P11 1-CG12242-RA_1 CG12242 AAGTACGGCAAGGATGACACCCTCTTCCCCAAGGATCCCAAGAAGCAGGCTTTAGTCAACCAACG 65 FBan0012242 FBgn0010041 GstD5 3 3R glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD5 Glutathione S transferase D5 "CG12242, CG12242, CG12242, DmGST24, gstD24, GST, Gst, DmGSTD5, GstD24: Glutathione S transferase D24, Glutathione S transferase D24, Glutathione S transferase D5" CDMC22575 4 4 18 DAC28-P11 1-CG12242-RA_1 CG12242 AAGTACGGCAAGGATGACACCCTCTTCCCCAAGGATCCCAAGAAGCAGGCTTTAGTCAACCAACG 65 FBan0012242 FBgn0010041 GstD5 3 3R glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD5 Glutathione S transferase D5 "CG12242, CG12242, CG12242, DmGST24, gstD24, GST, Gst, DmGSTD5, GstD24: Glutathione S transferase D24, Glutathione S transferase D24, Glutathione S transferase D5" CDMC22576 4 5 18 DAC28-P23 AutoBlank AutoBlank CDMC22576 4 6 18 DAC28-P23 AutoBlank AutoBlank CDMC22577 4 7 18 DAC29-D11 2-CG31002-RA_3 CG31002 TGATGGGCAACGTCTCACCGATTTCTTACCTGCAGTCTCCCTCTTCTCGATTCTACGATCTGGAGGCCT 69 FBan0031002 FBgn0051002 CG31002 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG31002 CG31002 "CG15569, CG15569" CDMC22577 4 8 18 DAC29-D11 2-CG31002-RA_3 CG31002 TGATGGGCAACGTCTCACCGATTTCTTACCTGCAGTCTCCCTCTTCTCGATTCTACGATCTGGAGGCCT 69 FBan0031002 FBgn0051002 CG31002 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG31002 CG31002 "CG15569, CG15569" CDMC22578 4 9 18 DAC29-D23 3-CG3100-RA_4 CG3100 TGGCAAACGCTTCCAAATGCTAAGTAACTCAGCCAACGTGCAGTTCATCGACGAAACGGAGACCCACAT 69 FBan0003100 FBgn0024897 b6 X X neuronal pentraxin receptor activity; GO:0008030; ; GO:0008030 b6 b6 "CG3100, CG3100, CG3100, CG3100, EG:9D2.1" CDMC22578 4 10 18 DAC29-D23 3-CG3100-RA_4 CG3100 TGGCAAACGCTTCCAAATGCTAAGTAACTCAGCCAACGTGCAGTTCATCGACGAAACGGAGACCCACAT 69 FBan0003100 FBgn0024897 b6 X X neuronal pentraxin receptor activity; GO:0008030; ; GO:0008030 b6 b6 "CG3100, CG3100, CG3100, CG3100, EG:9D2.1" CDMC22579 4 11 18 DAC29-H11 23-CG31035-RA_1 CG31035 GGAATCAATAACAAAAAACCATAGAGAAAATCGTAATTTGGTGGATAATTTGCATACGATTGGGTGGTT 69 FBan0031035 FBgn0051035 CG31035 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31035 CG31035 CDMC22579 4 12 18 DAC29-H11 23-CG31035-RA_1 CG31035 GGAATCAATAACAAAAAACCATAGAGAAAATCGTAATTTGGTGGATAATTTGCATACGATTGGGTGGTT 69 FBan0031035 FBgn0051035 CG31035 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31035 CG31035 CDMC22580 4 13 18 DAC29-H23 23-CG31047-RA_3 CG31047 GCACTTCTTAAAGCTTATTTTGGGGATTCAAAAGATTCTTGTTTACTTTTTGGCATGCAATTCTAAGGT 69 FBan0031047 FBgn0051047 CG31047 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31047 CG31047 CDMC22580 4 14 18 DAC29-H23 23-CG31047-RA_3 CG31047 GCACTTCTTAAAGCTTATTTTGGGGATTCAAAAGATTCTTGTTTACTTTTTGGCATGCAATTCTAAGGT 69 FBan0031047 FBgn0051047 CG31047 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31047 CG31047 CDMC22581 4 15 18 DAC29-L11 16-CG31069-RA_5 CG31069 TAAGGCTCACAAAATGCTGCAGAAAATCCACTATGTGAGGTGCCCGAAACTGGATCAATTAATGGCCAC 69 FBgn0051069 CDMC22581 4 16 18 DAC29-L11 16-CG31069-RA_5 CG31069 TAAGGCTCACAAAATGCTGCAGAAAATCCACTATGTGAGGTGCCCGAAACTGGATCAATTAATGGCCAC 69 FBgn0051069 CDMC22582 4 17 18 DAC29-L23 23-CG31083-RA_1 CG31083 TAATTATTTTAAAAGTGTCCATTCTTACCTGTCCTCGATGAAATTCCGACCAAGATCACAGCTTTTGGC 69 FBgn0051083 CG31083 CG31083 CG31083 BcDNA:RH14203 CDMC22582 4 18 18 DAC29-L23 23-CG31083-RA_1 CG31083 TAATTATTTTAAAAGTGTCCATTCTTACCTGTCCTCGATGAAATTCCGACCAAGATCACAGCTTTTGGC 69 FBgn0051083 CG31083 CG31083 CG31083 BcDNA:RH14203 CDMC22583 4 19 18 DAC29-P11 16-CG31104-RA_1 CG31104 TGCAACGCCTAGAGGTTGAGATGCATGAATATCACAAATATCGGCGAAACGATCGGTACTACGTCCTGT 69 FBan0031104 FBgn0051104 CG31104 3 3R CG31104 CG31104 CG13657 CDMC22583 4 20 18 DAC29-P11 16-CG31104-RA_1 CG31104 TGCAACGCCTAGAGGTTGAGATGCATGAATATCACAAATATCGGCGAAACGATCGGTACTACGTCCTGT 69 FBan0031104 FBgn0051104 CG31104 3 3R CG31104 CG31104 CG13657 CDMC22584 4 21 18 DAC29-P23 4-CG31111-RA_1 CG31111 AGGCCGAACTATCTGTGACCCGATCCCAAAGACTTTACTTGATAGAGCGCCTCATGTTTCACGAGGGCT 69 FBan0031111 FBgn0051111 CG31111 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31111 CG31111 CG13649 CDMC22584 4 22 18 DAC29-P23 4-CG31111-RA_1 CG31111 AGGCCGAACTATCTGTGACCCGATCCCAAAGACTTTACTTGATAGAGCGCCTCATGTTTCACGAGGGCT 69 FBan0031111 FBgn0051111 CG31111 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31111 CG31111 CG13649 CDMC22585 4 23 18 DAC30-D11 3-CG2061-RA_1 CG2061 ACTGGGACGTTGGAGTGAAAGATGGAGAAGGATGCTAGGTGCTGCATAGATCCCAGGTCCCGATG 65 FBan0002061 FBgn0027498 CG2061 X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG2061 CG2061 BcDNA:LD28247 CDMC22585 4 24 18 DAC30-D11 3-CG2061-RA_1 CG2061 ACTGGGACGTTGGAGTGAAAGATGGAGAAGGATGCTAGGTGCTGCATAGATCCCAGGTCCCGATG 65 FBan0002061 FBgn0027498 CG2061 X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG2061 CG2061 BcDNA:LD28247 CDMC22586 4 25 18 DAC30-D23 2-CG2118-RA_2 CG2118 GTCCGAGAAGGAGATGAGGTGTCTGTGCACTACGACCCCATGATTGCCAAGCTAGTCGTTTGGGG 65 FBan0002118 FBgn0039877 CG2118 3 3R fatty acid biosynthesis; GO:0006633; leucine metabolism; GO:0006551 ATP binding; GO:0005524; ; GO:0005524; methylcrotonoyl-CoA carboxylase activity; GO:0004485 ; EC:6.4.1.4; ; GO:0004485 ; EC:6.4.1.4; ; GO:0004485 ; EC:6.4.1.4; biotin binding; GO:0009374; ; GO:0009374 mitochondrial matrix; GO:0005759 CG2118 CG2118 CDMC22586 4 26 18 DAC30-D23 2-CG2118-RA_2 CG2118 GTCCGAGAAGGAGATGAGGTGTCTGTGCACTACGACCCCATGATTGCCAAGCTAGTCGTTTGGGG 65 FBan0002118 FBgn0039877 CG2118 3 3R fatty acid biosynthesis; GO:0006633; leucine metabolism; GO:0006551 ATP binding; GO:0005524; ; GO:0005524; methylcrotonoyl-CoA carboxylase activity; GO:0004485 ; EC:6.4.1.4; ; GO:0004485 ; EC:6.4.1.4; ; GO:0004485 ; EC:6.4.1.4; biotin binding; GO:0009374; ; GO:0009374 mitochondrial matrix; GO:0005759 CG2118 CG2118 CDMC22587 4 1 19 DAC30-H11 3-CG2246-RA_3 CG2246 TCGGCTCGTTCGATCGTGGGAGTGATTCCATATTTGCCCTATTCCAAGCAGTGCAAGATGCGCAA 65 FBan0002246 FBgn0039790 CG2246 3 3R nucleoside metabolism; GO:0009116; nucleotide biosynthesis; GO:0009165; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 nucleotide kinase activity; GO:0019201; ; GO:0019201; ribose phosphate diphosphokinase activity; GO:0004749 ; EC:2.7.6.1; ; GO:0004749 ; EC:2.7.6.1 CG2246 CG2246 CDMC22587 4 2 19 DAC30-H11 3-CG2246-RA_3 CG2246 TCGGCTCGTTCGATCGTGGGAGTGATTCCATATTTGCCCTATTCCAAGCAGTGCAAGATGCGCAA 65 FBan0002246 FBgn0039790 CG2246 3 3R nucleoside metabolism; GO:0009116; nucleotide biosynthesis; GO:0009165; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 nucleotide kinase activity; GO:0019201; ; GO:0019201; ribose phosphate diphosphokinase activity; GO:0004749 ; EC:2.7.6.1; ; GO:0004749 ; EC:2.7.6.1 CG2246 CG2246 CDMC22588 4 3 19 DAC30-H23 2-CG2277-RA_1 CG2277 TCCCAGTGTGATGAACTGGCTCGGGGAACTGCGAAAATCCGGCAAGAAGCTATTTTTGCTCACCG 65 FBan0002277 FBgn0035204 CG2277 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG2277 CG2277 CDMC22588 4 4 19 DAC30-H23 2-CG2277-RA_1 CG2277 TCCCAGTGTGATGAACTGGCTCGGGGAACTGCGAAAATCCGGCAAGAAGCTATTTTTGCTCACCG 65 FBan0002277 FBgn0035204 CG2277 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG2277 CG2277 CDMC22589 4 5 19 DAC30-L11 2-CG2759-RA_1 CG2759 GGCTCGGTGCCAGTATACCTCAAATGGTTGTCGTACCTCTCATGGTTCCGTTACGCCAACGAGGG 65 FBan0002759 FBgn0003996 w X X anion transport; GO:0006820; eye pigment biosynthesis; GO:0006726; eye pigment metabolism; GO:0042441; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; eye pigment precursor transporter activity; GO:0005395; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; ; GO:0005395; ; GO:0004888; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 w white "CG2759, CG2759, CG2759, DMWHITE, w(AT)[[13]], EG:BACN33B1.1, BACN33B1.1, e(g), m(g): modifier of garnet, enhancer of garnet, modifier of garnet, white" CDMC22589 4 6 19 DAC30-L11 2-CG2759-RA_1 CG2759 GGCTCGGTGCCAGTATACCTCAAATGGTTGTCGTACCTCTCATGGTTCCGTTACGCCAACGAGGG 65 FBan0002759 FBgn0003996 w X X anion transport; GO:0006820; eye pigment biosynthesis; GO:0006726; eye pigment metabolism; GO:0042441; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; eye pigment precursor transporter activity; GO:0005395; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; ; GO:0005395; ; GO:0004888; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 w white "CG2759, CG2759, CG2759, DMWHITE, w(AT)[[13]], EG:BACN33B1.1, BACN33B1.1, e(g), m(g): modifier of garnet, enhancer of garnet, modifier of garnet, white" CDMC22590 4 7 19 DAC30-L23 11-CG2851-RA_1 CG2851 CGGATCCGATCACTACTCCGCGCAGCTAGTGCACATCAAGAGCGATCCCAATGGGTACAGCGATG 65 FBan0002851 FBgn0010323 Gsc 2 2L "anterior/posterior axis specification; GO:0009948; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcriptional repressor activity; GO:0016564; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016564; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Gsc Goosecoid "CG2851, PPH25, Muenster 72, D-Gsc, 60Mun1, D-gsc, l(2)05341, 60Mun2, Pph25, gsc, M72: Muenster 72" CDMC22590 4 8 19 DAC30-L23 11-CG2851-RA_1 CG2851 CGGATCCGATCACTACTCCGCGCAGCTAGTGCACATCAAGAGCGATCCCAATGGGTACAGCGATG 65 FBan0002851 FBgn0010323 Gsc 2 2L "anterior/posterior axis specification; GO:0009948; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcriptional repressor activity; GO:0016564; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016564; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Gsc Goosecoid "CG2851, PPH25, Muenster 72, D-Gsc, 60Mun1, D-gsc, l(2)05341, 60Mun2, Pph25, gsc, M72: Muenster 72" CDMC22591 4 9 19 DAC30-P11 3-CG2969-RA_1 CG2969 AATTGGAGCGGGTCTCGATGTTCGTGCTGATCTGTGTGCTAAACTCACTGGTGGCACAATCGCTG 65 FBan0002969 FBgn0020762 Atet 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 Atet ABC transporter expressed in trachea "CG2969, CG2969, ABC transporter expressed in trachea" CDMC22591 4 10 19 DAC30-P11 3-CG2969-RA_1 CG2969 AATTGGAGCGGGTCTCGATGTTCGTGCTGATCTGTGTGCTAAACTCACTGGTGGCACAATCGCTG 65 FBan0002969 FBgn0020762 Atet 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 Atet ABC transporter expressed in trachea "CG2969, CG2969, ABC transporter expressed in trachea" CDMC22592 4 11 19 DAC30-P23 AutoBlank AutoBlank CDMC22592 4 12 19 DAC30-P23 AutoBlank AutoBlank CDMC22593 4 13 19 DAC31-D11 6-CG32026-RA_3 CG32026 CCCGAGCAGGTGATCGAGAGTATGAACCGAACGAAAGTTGGTCTCAAAGGTCCACTGATGACACCCGT 68 FBan0032026 FBgn0052026 CG32026 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 isocitrate dehydrogenase complex (NAD+) (sensu Eukaryota); GO:0005962 CG32026 CG32026 "anon-WO0140519.202, BcDNA:GH12815" CDMC22593 4 14 19 DAC31-D11 6-CG32026-RA_3 CG32026 CCCGAGCAGGTGATCGAGAGTATGAACCGAACGAAAGTTGGTCTCAAAGGTCCACTGATGACACCCGT 68 FBan0032026 FBgn0052026 CG32026 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 isocitrate dehydrogenase complex (NAD+) (sensu Eukaryota); GO:0005962 CG32026 CG32026 "anon-WO0140519.202, BcDNA:GH12815" CDMC22594 4 15 19 DAC31-D23 3-CG32095-RA_1 CG32095 CAGCCGCAGTATTGCACAATCTACTGGAAGAACTGAGCGAACCACACATGCTTGAGTGGGGCAACTCG 68 FBan0032095 FBgn0052095 CG32095 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32095 CG32095 "BcDNA:GH03217, BEST:GH03217" CDMC22594 4 16 19 DAC31-D23 3-CG32095-RA_1 CG32095 CAGCCGCAGTATTGCACAATCTACTGGAAGAACTGAGCGAACCACACATGCTTGAGTGGGGCAACTCG 68 FBan0032095 FBgn0052095 CG32095 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32095 CG32095 "BcDNA:GH03217, BEST:GH03217" CDMC22595 4 17 19 DAC31-H11 18-CG32429-RA_1 CG32429 AGAAATGGAAAATTCGTAACTGGTACATGGCCCTTCATTTCTGGCTTTGCTACCTTGACGCCACCAAA 68 FBgn0052429 CDMC22595 4 18 19 DAC31-H11 18-CG32429-RA_1 CG32429 AGAAATGGAAAATTCGTAACTGGTACATGGCCCTTCATTTCTGGCTTTGCTACCTTGACGCCACCAAA 68 FBgn0052429 CDMC22596 4 19 19 DAC31-H23 23-CG32580-RA_5 CG32580 AAGTGTTGGAACTATTACACAAAACTGAAAGTGATGTTCCATAAGGCAATGCAAGAGACGAGTGCCAG 68 FBan0032580 FBgn0052580 CG32580 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32580 CG32580 CDMC22596 4 20 19 DAC31-H23 23-CG32580-RA_5 CG32580 AAGTGTTGGAACTATTACACAAAACTGAAAGTGATGTTCCATAAGGCAATGCAAGAGACGAGTGCCAG 68 FBan0032580 FBgn0052580 CG32580 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32580 CG32580 CDMC22597 4 21 19 DAC31-L11 3-CG33280-RA_1 CG33280 CGACCAACTCCGCTTGGCTAAAAACATCCCGCACACTATCTCCGGAAAAGTCCGCAATCTGCTGGTAG 68 FBan0033280 FBgn0053280 CG33280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33280 CG33280 CDMC22597 4 22 19 DAC31-L11 3-CG33280-RA_1 CG33280 CGACCAACTCCGCTTGGCTAAAAACATCCCGCACACTATCTCCGGAAAAGTCCGCAATCTGCTGGTAG 68 FBan0033280 FBgn0053280 CG33280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33280 CG33280 CDMC22598 4 23 19 DAC31-L23 3-CG33459-RA_1 CG33459 GGTACGGACATTCTGTCGATCATACCCACATCTGTGCCGGAAGTAGCAAATCATTTGCCTGCGTCGGG 68 FBan0033459 FBgn0053459 CG33459 2 2R CG33459 CG33459 HDC06756 CDMC22598 4 24 19 DAC31-L23 3-CG33459-RA_1 CG33459 GGTACGGACATTCTGTCGATCATACCCACATCTGTGCCGGAAGTAGCAAATCATTTGCCTGCGTCGGG 68 FBan0033459 FBgn0053459 CG33459 2 2R CG33459 CG33459 HDC06756 CDMC22599 4 25 19 DAC31-P11 1-CG3679-RA_1 CG3679 GCCGCTTGAGGAATCCAGCCATAAACGAATCGGTGTCCAAACCCAGTGGAAGTGTTAAGGCGACGAAG 68 FBan0003679 FBgn0027521 CG3679 X X CG3679 CG3679 BcDNA:LD21675 CDMC22599 4 26 19 DAC31-P11 1-CG3679-RA_1 CG3679 GCCGCTTGAGGAATCCAGCCATAAACGAATCGGTGTCCAAACCCAGTGGAAGTGTTAAGGCGACGAAG 68 FBan0003679 FBgn0027521 CG3679 X X CG3679 CG3679 BcDNA:LD21675 CDMC22600 4 1 20 DAC31-P23 AutoBlank AutoBlank CDMC22600 4 2 20 DAC31-P23 AutoBlank AutoBlank CDMC22601 4 3 20 DAC32-D11 10-CG15792-RA_1 CG15792 GGGCGACCTGAAAGAGATCGAAACCACCATGGAGATGCATAACAAGGTGAAGGAAGATGCGTTGAAGCA 69 FBan0015792 FBgn0005634 zip 2 2R "Malpighian tubule morphogenesis; GO:0007443; NOT muscle attachment; GO:0016203; cytokinesis; GO:0000910; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; establishment of neuroblast polarity; GO:0045200; establishment of planar polarity; GO:0001736; follicle cell migration (sensu Insecta); GO:0007297; head involution; GO:0008258; mitosis; GO:0007067; morphogenesis; GO:0009653; muscle contraction; GO:0006936; myofibril assembly; GO:0030239; salivary gland morphogenesis; GO:0007435; sarcomere organization; GO:0045214" "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" Z disc; GO:0030018; apical cortex; GO:0045179; cytoskeleton; GO:0005856; myosin; GO:0016459; unconventional myosin; GO:0016461 zip zipper "CG15792, CG15792, cytoplasmic myosin heavy chain, cytoplasmic myosin, E(br): Enhancer of broad, nonmuscle myosin heavy chain, zpr: zen-pattern-related, Enhancer of broad, Mhc-c: myosin-heavy-chain-cytoplasmic, myosin II, Dronm-MII, cytoplasmic myosin-II, cytoplasmic myosin II, l(2)02957, non muscle myosin, DROMHC, nmMHC, myosin heavy chain, nonmuscle myosin II, nmy-2, myosin, Myo, Myosin II, DmnmII, Dm nmII, nonmuscle myosin-II heavy chain, Nonmuscle myosin-II, Myosin, MyoII, Myosin-II, myosin II heavy chain, Myosin heavy chain, non-muscle myosin, non-muscle myosin II heavy chain, non-muscle myosin II, myoII, Mhc-c[1]: Myosin heavy chain-cytoplasmic, anon-WO0140519.37, myosin-heavy-chain-cytoplasmic, Myosin heavy chain-cytoplasmic, Mhc-c, E(br), zipper, zpr" CDMC22601 4 4 20 DAC32-D11 10-CG15792-RA_1 CG15792 GGGCGACCTGAAAGAGATCGAAACCACCATGGAGATGCATAACAAGGTGAAGGAAGATGCGTTGAAGCA 69 FBan0015792 FBgn0005634 zip 2 2R "Malpighian tubule morphogenesis; GO:0007443; NOT muscle attachment; GO:0016203; cytokinesis; GO:0000910; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; establishment of neuroblast polarity; GO:0045200; establishment of planar polarity; GO:0001736; follicle cell migration (sensu Insecta); GO:0007297; head involution; GO:0008258; mitosis; GO:0007067; morphogenesis; GO:0009653; muscle contraction; GO:0006936; myofibril assembly; GO:0030239; salivary gland morphogenesis; GO:0007435; sarcomere organization; GO:0045214" "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" Z disc; GO:0030018; apical cortex; GO:0045179; cytoskeleton; GO:0005856; myosin; GO:0016459; unconventional myosin; GO:0016461 zip zipper "CG15792, CG15792, cytoplasmic myosin heavy chain, cytoplasmic myosin, E(br): Enhancer of broad, nonmuscle myosin heavy chain, zpr: zen-pattern-related, Enhancer of broad, Mhc-c: myosin-heavy-chain-cytoplasmic, myosin II, Dronm-MII, cytoplasmic myosin-II, cytoplasmic myosin II, l(2)02957, non muscle myosin, DROMHC, nmMHC, myosin heavy chain, nonmuscle myosin II, nmy-2, myosin, Myo, Myosin II, DmnmII, Dm nmII, nonmuscle myosin-II heavy chain, Nonmuscle myosin-II, Myosin, MyoII, Myosin-II, myosin II heavy chain, Myosin heavy chain, non-muscle myosin, non-muscle myosin II heavy chain, non-muscle myosin II, myoII, Mhc-c[1]: Myosin heavy chain-cytoplasmic, anon-WO0140519.37, myosin-heavy-chain-cytoplasmic, Myosin heavy chain-cytoplasmic, Mhc-c, E(br), zipper, zpr" CDMC22602 4 5 20 DAC32-D23 23-CG15819-RA_13 CG15819 AATCCAAATTTGGTGGCTTTTAATCCGAACCGAAACTAACCGTAAGCGCTTTCTGACAAAATTCGGCTA 69 FBan0015819 FBgn0031919 CG15819 2 2L GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020 CG15819 CG15819 BcDNA:RH71439 CDMC22602 4 6 20 DAC32-D23 23-CG15819-RA_13 CG15819 AATCCAAATTTGGTGGCTTTTAATCCGAACCGAAACTAACCGTAAGCGCTTTCTGACAAAATTCGGCTA 69 FBan0015819 FBgn0031919 CG15819 2 2L GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020 CG15819 CG15819 BcDNA:RH71439 CDMC22603 4 7 20 DAC32-H11 2-CG15879-RA_1 CG15879 TCCCGGACATGGAAGATCCGCTCACATTCAGCCTGGAATGCACTACGCCGTCAACGATTACGTGTTAAT 69 FBan0015879 FBgn0035309 CG15879 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG15879 CG15879 CDMC22603 4 8 20 DAC32-H11 2-CG15879-RA_1 CG15879 TCCCGGACATGGAAGATCCGCTCACATTCAGCCTGGAATGCACTACGCCGTCAACGATTACGTGTTAAT 69 FBan0015879 FBgn0035309 CG15879 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG15879 CG15879 CDMC22604 4 9 20 DAC32-H23 15-CG15890-RA_7 CG15890 CGGCGAGATGGCAGTCACGTATCTATTCACGCGATTCCGGTTCAATTGGTCGGAAGTGGAGTTTAGTTT 69 FBan0015890 FBgn0030576 CG15890 X X CG15890 CG15890 CDMC22604 4 10 20 DAC32-H23 15-CG15890-RA_7 CG15890 CGGCGAGATGGCAGTCACGTATCTATTCACGCGATTCCGGTTCAATTGGTCGGAAGTGGAGTTTAGTTT 69 FBan0015890 FBgn0030576 CG15890 X X CG15890 CG15890 CDMC22605 4 11 20 DAC32-L11 23-CG15926-RA_2 CG15926 AGATTGAGATTCAGACAACACAAGAATGAACTAGAGGAACATTAGGAAAACCAAGCTCTCTGACCAACA 69 FBgn0030393 CDMC22605 4 12 20 DAC32-L11 23-CG15926-RA_2 CG15926 AGATTGAGATTCAGACAACACAAGAATGAACTAGAGGAACATTAGGAAAACCAAGCTCTCTGACCAACA 69 FBgn0030393 CDMC22606 4 13 20 DAC32-L23 1-CG1602-RA_1 CG1602 AGCATGCCATTTATGCCGGAAGTACAGCCGAGAAGTTCTACCTAGAGGTGTGTCGGTTCATGCCTGCAA 69 FBan0001602 FBgn0033186 CG1602 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1602 CG1602 CDMC22606 4 14 20 DAC32-L23 1-CG1602-RA_1 CG1602 AGCATGCCATTTATGCCGGAAGTACAGCCGAGAAGTTCTACCTAGAGGTGTGTCGGTTCATGCCTGCAA 69 FBan0001602 FBgn0033186 CG1602 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1602 CG1602 CDMC22607 4 15 20 DAC32-P11 23-CG1639-RA_5 CG1639 TGCTCCGGTTAGATTCCATGTGGACGCATTATTGGCATCTTTATTCGACACAAATAATCCTCATAATAC 69 FBan0001639 FBgn0001491 l(1)10Bb X X transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 l(1)10Bb lethal (1) 10Bb "CG1639, l(1)GLM14, 10Ba, l(1)G0169, lethal(1)10Bb, l(1)G14" CDMC22607 4 16 20 DAC32-P11 23-CG1639-RA_5 CG1639 TGCTCCGGTTAGATTCCATGTGGACGCATTATTGGCATCTTTATTCGACACAAATAATCCTCATAATAC 69 FBan0001639 FBgn0001491 l(1)10Bb X X transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 l(1)10Bb lethal (1) 10Bb "CG1639, l(1)GLM14, 10Ba, l(1)G0169, lethal(1)10Bb, l(1)G14" CDMC22608 4 17 20 DAC32-P23 AutoBlank AutoBlank CDMC22608 4 18 20 DAC32-P23 AutoBlank AutoBlank CDMC22609 4 19 20 DAC33-D11 18-CG11353-RB_1 CG11353 GCAGAGCAAGCCAAAATCGATTTAAAGATGCTAGCCCTAAACTAGATCGTTAAGGTCACCGCACACGCC 69 FBan0011353 FBgn0035557 CG11353 3 3L CG11353 CG11353 anon-WO0172774.162 CDMC22609 4 20 20 DAC33-D11 18-CG11353-RB_1 CG11353 GCAGAGCAAGCCAAAATCGATTTAAAGATGCTAGCCCTAAACTAGATCGTTAAGGTCACCGCACACGCC 69 FBan0011353 FBgn0035557 CG11353 3 3L CG11353 CG11353 anon-WO0172774.162 CDMC22610 4 21 20 DAC33-D23 16-CG1136-RA_1 CG1136 TCCCCCGACTTACGATTAACCTGTACATATAACCACGCTCAAAGCTTTCCTTTCTCAAGGTCCCACTGT 69 FBan0001136 FBgn0035490 CG1136 3 3L CG1136 CG1136 novel CDMC22610 4 22 20 DAC33-D23 16-CG1136-RA_1 CG1136 TCCCCCGACTTACGATTAACCTGTACATATAACCACGCTCAAAGCTTTCCTTTCTCAAGGTCCCACTGT 69 FBan0001136 FBgn0035490 CG1136 3 3L CG1136 CG1136 novel CDMC22611 4 23 20 DAC33-H11 3-CG11398-RA_1 CG11398 CGCCCTCGACAGCGCAGGATACCTGGAGAATTCACAATTTTCGAACACCGGCAAGATGACTGCCATATT 69 FBan0011398 FBgn0040366 CG11398 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11398 CG11398 EG:BACR42I17.11 CDMC22611 4 24 20 DAC33-H11 3-CG11398-RA_1 CG11398 CGCCCTCGACAGCGCAGGATACCTGGAGAATTCACAATTTTCGAACACCGGCAAGATGACTGCCATATT 69 FBan0011398 FBgn0040366 CG11398 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11398 CG11398 EG:BACR42I17.11 CDMC22612 4 25 20 DAC33-H23 3-CG1140-RB_1 CG1140 ACTGGAGCCAAGTTCACAGTGTCGCCCAATCTGAAGAAAATGGGTCAAATTCCGGTCTGATGAGCCACG 69 FBan0001140 FBgn0035298 CG1140 3 3L fatty acid metabolism; GO:0006631; ketone body catabolism; GO:0046952 3-oxoacid CoA-transferase activity; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5 mitochondrial matrix; GO:0005759 CG1140 CG1140 "cDNA B, 3-oxoacid CoA-transferase, citric acid synthetase, CT1116, BcDNA:RH54340, 3-oxoacid-CoA-transferase" CDMC22612 4 26 20 DAC33-H23 3-CG1140-RB_1 CG1140 ACTGGAGCCAAGTTCACAGTGTCGCCCAATCTGAAGAAAATGGGTCAAATTCCGGTCTGATGAGCCACG 69 FBan0001140 FBgn0035298 CG1140 3 3L fatty acid metabolism; GO:0006631; ketone body catabolism; GO:0046952 3-oxoacid CoA-transferase activity; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5; ; GO:0008260 ; EC:2.8.3.5 mitochondrial matrix; GO:0005759 CG1140 CG1140 "cDNA B, 3-oxoacid CoA-transferase, citric acid synthetase, CT1116, BcDNA:RH54340, 3-oxoacid-CoA-transferase" CDMC22613 4 1 21 DAC33-L11 23-CG11447-RA_1 CG11447 AGGCGATCTAATTTCGATATTACACAATGCGTCTTGTTTTTACGGGTAATTGTGTTTTTAAACGCCTGC 69 FBan0011447 FBgn0038737 CG11447 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG11447 CG11447 CDMC22613 4 2 21 DAC33-L11 23-CG11447-RA_1 CG11447 AGGCGATCTAATTTCGATATTACACAATGCGTCTTGTTTTTACGGGTAATTGTGTTTTTAAACGCCTGC 69 FBan0011447 FBgn0038737 CG11447 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG11447 CG11447 CDMC22614 4 3 21 DAC33-L23 23-CG11462-RA_1 CG11462 TTTGCATTTACTTGCTTTCTTGCTTTTTTCCGGTGAAAAATTGACATATTTCGGTACTTGCAACTGGAG 69 FBan0011462 FBgn0029815 CG11462 X X CG11462 CG11462 BcDNA:GH09844 CDMC22614 4 4 21 DAC33-L23 23-CG11462-RA_1 CG11462 TTTGCATTTACTTGCTTTCTTGCTTTTTTCCGGTGAAAAATTGACATATTTCGGTACTTGCAACTGGAG 69 FBan0011462 FBgn0029815 CG11462 X X CG11462 CG11462 BcDNA:GH09844 CDMC22615 4 5 21 DAC33-P11 1-CG11501-RA_1 CG11501 TGGTCACAGGAATTTGTGAGGAGGAACCAGCAGTACGGAATCCAGATCATCAAAGTCACCAGGCTGCCA 69 FBan0011501 FBgn0039666 CG11501 3 3R CG11501 CG11501 BcDNA:RH38110 CDMC22615 4 6 21 DAC33-P11 1-CG11501-RA_1 CG11501 TGGTCACAGGAATTTGTGAGGAGGAACCAGCAGTACGGAATCCAGATCATCAAAGTCACCAGGCTGCCA 69 FBan0011501 FBgn0039666 CG11501 3 3R CG11501 CG11501 BcDNA:RH38110 CDMC22616 4 7 21 DAC33-P23 AutoBlank AutoBlank CDMC22616 4 8 21 DAC33-P23 AutoBlank AutoBlank CDMC22617 4 9 21 DAC34-D11 11-CG14837-RA_1 CG14837 TCACTACGATGGTCATTTTAGCGGTGAAAACTCACAGAGTGCCTCCCAATCGGATTTGTCCAGCGGC 67 FBan0014837 FBgn0035797 CG14837 3 3L CG14837 CG14837 CDMC22617 4 10 21 DAC34-D11 11-CG14837-RA_1 CG14837 TCACTACGATGGTCATTTTAGCGGTGAAAACTCACAGAGTGCCTCCCAATCGGATTTGTCCAGCGGC 67 FBan0014837 FBgn0035797 CG14837 3 3L CG14837 CG14837 CDMC22618 4 11 21 DAC34-D23 7-CG14896-RA_1 CG14896 ACCAATCAACCACCCGTGAAATCAGAGGATACACCCGACAACACAGTTTCTCTTTCGGAGCCCACAA 67 FBan0014896 FBgn0038433 CG14896 3 3R CG14896 CG14896 "clone 1.14, anon-EST:Liang-1.14" CDMC22618 4 12 21 DAC34-D23 7-CG14896-RA_1 CG14896 ACCAATCAACCACCCGTGAAATCAGAGGATACACCCGACAACACAGTTTCTCTTTCGGAGCCCACAA 67 FBan0014896 FBgn0038433 CG14896 3 3R CG14896 CG14896 "clone 1.14, anon-EST:Liang-1.14" CDMC22619 4 13 21 DAC34-H11 1-CG15348-RA_1 CG15348 GCCCAAGACCTGCGGAAAAGTACGTGAGCTGTTCCAATACATGAACGCCTTCAACAACCTCTTGGGC 67 FBgn0030042 CDMC22619 4 14 21 DAC34-H11 1-CG15348-RA_1 CG15348 GCCCAAGACCTGCGGAAAAGTACGTGAGCTGTTCCAATACATGAACGCCTTCAACAACCTCTTGGGC 67 FBgn0030042 CDMC22620 4 15 21 DAC34-H23 3-CG15506-RB_1 CG15506 TCGGCAGCACACCATTTTGATTCTCCTACTGCTACTGGGACTTGTTCTGTGGACCGATTCCTCGCTG 67 FBan0015506 FBgn0039686 CG15506 3 3R CG15506 CG15506 CDMC22620 4 16 21 DAC34-H23 3-CG15506-RB_1 CG15506 TCGGCAGCACACCATTTTGATTCTCCTACTGCTACTGGGACTTGTTCTGTGGACCGATTCCTCGCTG 67 FBan0015506 FBgn0039686 CG15506 3 3R CG15506 CG15506 CDMC22621 4 17 21 DAC34-L11 23-CG15782-RA_1 CG15782 GCTACTAGGTATGGAGCAGAAATGTAAATGCAACAATCATATCAAAACTATCAAACTAGCCAGCTAA 67 FBgn0029773 CDMC22621 4 18 21 DAC34-L11 23-CG15782-RA_1 CG15782 GCTACTAGGTATGGAGCAGAAATGTAAATGCAACAATCATATCAAAACTATCAAACTAGCCAGCTAA 67 FBgn0029773 CDMC22622 4 19 21 DAC34-L23 23-CG1668-RA_9 CG1668 ACAATCACTCATCTCACCCAGAGCTGTTGATCGATTTAATTACAAGCGGGATTTCTCATCTCTCATT 67 FBan0001668 FBgn0011280 Pbprp2 X X transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp2 Pheromone-binding protein-related protein 2 "CG1668, CG1668, pbprp-2, PB-PRP2, PBPRP2, pbprp2, 19d, PBP2, PBPRP-2, Obp19d, BcDNA:RH68082, BcDNA:HL07789" CDMC22622 4 20 21 DAC34-L23 23-CG1668-RA_9 CG1668 ACAATCACTCATCTCACCCAGAGCTGTTGATCGATTTAATTACAAGCGGGATTTCTCATCTCTCATT 67 FBan0001668 FBgn0011280 Pbprp2 X X transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp2 Pheromone-binding protein-related protein 2 "CG1668, CG1668, pbprp-2, PB-PRP2, PBPRP2, pbprp2, 19d, PBP2, PBPRP-2, Obp19d, BcDNA:RH68082, BcDNA:HL07789" CDMC22623 4 21 21 DAC34-P11 3-CG17230-RA_5 CG17230 GCGCCCAGATCGAAAGCATGTACGAGTCAGAGGCCAAGTACAACCTACAGCGCAGTGAGGAAAACTG 67 FBan0017230 FBgn0046225 CG17230 3 3R CG17230 CG17230 "CG5286, BcDNA:GH24095" CDMC22623 4 22 21 DAC34-P11 3-CG17230-RA_5 CG17230 GCGCCCAGATCGAAAGCATGTACGAGTCAGAGGCCAAGTACAACCTACAGCGCAGTGAGGAAAACTG 67 FBan0017230 FBgn0046225 CG17230 3 3R CG17230 CG17230 "CG5286, BcDNA:GH24095" CDMC22624 4 23 21 DAC34-P23 AutoBlank AutoBlank CDMC22624 4 24 21 DAC34-P23 AutoBlank AutoBlank CDMC22625 4 25 21 DAC35-D11 18-CG11780-RA_1 CG11780 GCCGGACCGAAGCTACATCCCAAATACCACTATGATAACTTCGTTGGAGGAATATTACTGGTGCGACGC 69 FBan0011780 FBgn0039258 beta4GalT7 3 3R chondroitin sulfate biosynthesis; GO:0030206; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; proteoglycan biosynthesis; GO:0030166 galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; xylosylprotein 4-beta-galactosyltransferase activity; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0008378 ; EC:2.4.1.-; metal ion binding; GO:0046872; ; GO:0008378 ; EC:2.4.1.-; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046872 Golgi apparatus; GO:0005794; integral to membrane; GO:0016021 beta4GalT7 beta-4-galactosyltransferase 7 "CG11780, CG11780, CG11780, CG11780, CG11780, Dbeta4GalT7, dbeta4GalTI, glycosaminoglycan galactosyltransferase I, beta-4-galactosyltransferase 7" CDMC22625 4 26 21 DAC35-D11 18-CG11780-RA_1 CG11780 GCCGGACCGAAGCTACATCCCAAATACCACTATGATAACTTCGTTGGAGGAATATTACTGGTGCGACGC 69 FBan0011780 FBgn0039258 beta4GalT7 3 3R chondroitin sulfate biosynthesis; GO:0030206; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; proteoglycan biosynthesis; GO:0030166 galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; xylosylprotein 4-beta-galactosyltransferase activity; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046525 ; EC:2.4.1.133; ; GO:0008378 ; EC:2.4.1.-; metal ion binding; GO:0046872; ; GO:0008378 ; EC:2.4.1.-; ; GO:0046525 ; EC:2.4.1.133; ; GO:0046872 Golgi apparatus; GO:0005794; integral to membrane; GO:0016021 beta4GalT7 beta-4-galactosyltransferase 7 "CG11780, CG11780, CG11780, CG11780, CG11780, Dbeta4GalT7, dbeta4GalTI, glycosaminoglycan galactosyltransferase I, beta-4-galactosyltransferase 7" CDMC22626 4 1 22 DAC35-D23 3-CG11796-RA_1 CG11796 CGGTCGCCCAAAGATGTCCTTCTAAACGGATTGCCCTCCACCAAGCTGAACTTCATTGATCACGTGGTG 69 FBan0011796 FBgn0036992 CG11796 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 4-hydroxyphenylpyruvate dioxygenase activity; GO:0003868 ; EC:1.13.11.27; ; GO:0003868 ; EC:1.13.11.27; ; GO:0003868 ; EC:1.13.11.27 CG11796 CG11796 CDMC22626 4 2 22 DAC35-D23 3-CG11796-RA_1 CG11796 CGGTCGCCCAAAGATGTCCTTCTAAACGGATTGCCCTCCACCAAGCTGAACTTCATTGATCACGTGGTG 69 FBan0011796 FBgn0036992 CG11796 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 4-hydroxyphenylpyruvate dioxygenase activity; GO:0003868 ; EC:1.13.11.27; ; GO:0003868 ; EC:1.13.11.27; ; GO:0003868 ; EC:1.13.11.27 CG11796 CG11796 CDMC22627 4 3 22 DAC35-H11 2-CG11847-RA_1 CG11847 TCCCAAAACGTTGCTAGAGGCAGGATCCATGGCTATTTCGTACAGTGTTGCTTGGGATGCCAAAGTGGT 69 FBan0011847 FBgn0039281 CG11847 3 3R CG11847 CG11847 CDMC22627 4 4 22 DAC35-H11 2-CG11847-RA_1 CG11847 TCCCAAAACGTTGCTAGAGGCAGGATCCATGGCTATTTCGTACAGTGTTGCTTGGGATGCCAAAGTGGT 69 FBan0011847 FBgn0039281 CG11847 3 3R CG11847 CG11847 CDMC22628 4 5 22 DAC35-H23 8-CG11857-RA_1 CG11857 CGCCAACAGCATCGTCCATCAAACCACCGCAGATCATTGCCATTGAGGACTACTAGAGAAAGCTACCGA 69 FBan0011857 FBgn0039303 CG11857 3 3R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 integral to membrane; GO:0016021 CG11857 CG11857 CDMC22628 4 6 22 DAC35-H23 8-CG11857-RA_1 CG11857 CGCCAACAGCATCGTCCATCAAACCACCGCAGATCATTGCCATTGAGGACTACTAGAGAAAGCTACCGA 69 FBan0011857 FBgn0039303 CG11857 3 3R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 integral to membrane; GO:0016021 CG11857 CG11857 CDMC22629 4 7 22 DAC35-L11 11-CG11895-RA_1 CG11895 GCGGCGATATCGGGTTCTCAGTGCGACTTTAGTTTGAGAACGTTTGTGTGCCTCGAGCTTTTTATGCCA 69 FBan0011895 FBgn0024836 stan 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; R3/R4 development (sensu Endopterygota); GO:0048057; axonogenesis; GO:0007409; calcium-dependent cell-cell adhesion; GO:0016339; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; frizzled signaling pathway; GO:0007222; homophilic cell adhesion; GO:0007156; mushroom body development; GO:0016319; negative regulation of frizzled signaling pathway; GO:0045810; neuropeptide signaling pathway; GO:0007218; ommatidial rotation; GO:0016318; positive regulation of frizzled signaling pathway; GO:0045811; segment polarity determination; GO:0007367; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; G-protein coupled receptor activity; GO:0004930; ; GO:0005057; transmembrane receptor activity; GO:0004888; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004888; ; GO:0004872; ; GO:0005509; ; GO:0005057; ; GO:0004930; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 stan starry night "CG11895, CG11895, fmi, flamingo, serpentine cadherin, Fmi, Flamingo, CT20776, fmi/stan, Stan, Flam, starry night" CDMC22629 4 8 22 DAC35-L11 11-CG11895-RA_1 CG11895 GCGGCGATATCGGGTTCTCAGTGCGACTTTAGTTTGAGAACGTTTGTGTGCCTCGAGCTTTTTATGCCA 69 FBan0011895 FBgn0024836 stan 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; R3/R4 development (sensu Endopterygota); GO:0048057; axonogenesis; GO:0007409; calcium-dependent cell-cell adhesion; GO:0016339; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; frizzled signaling pathway; GO:0007222; homophilic cell adhesion; GO:0007156; mushroom body development; GO:0016319; negative regulation of frizzled signaling pathway; GO:0045810; neuropeptide signaling pathway; GO:0007218; ommatidial rotation; GO:0016318; positive regulation of frizzled signaling pathway; GO:0045811; segment polarity determination; GO:0007367; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; G-protein coupled receptor activity; GO:0004930; ; GO:0005057; transmembrane receptor activity; GO:0004888; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004888; ; GO:0004872; ; GO:0005509; ; GO:0005057; ; GO:0004930; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 stan starry night "CG11895, CG11895, fmi, flamingo, serpentine cadherin, Fmi, Flamingo, CT20776, fmi/stan, Stan, Flam, starry night" CDMC22630 4 9 22 DAC35-L23 23-CG11902-RA_6 CG11902 TCCTCTTATACGTGCAATATGTGCCAACTAAGATGTTTACGGAAATTCGAGCTATATCAGCACCAGCAG 69 FBan0011902 FBgn0028647 CG11902 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; copper ion binding; GO:0005507; ; GO:0008270; ; GO:0005507 nucleus; GO:0005634 CG11902 CG11902 anon-96CDa CDMC22630 4 10 22 DAC35-L23 23-CG11902-RA_6 CG11902 TCCTCTTATACGTGCAATATGTGCCAACTAAGATGTTTACGGAAATTCGAGCTATATCAGCACCAGCAG 69 FBan0011902 FBgn0028647 CG11902 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; copper ion binding; GO:0005507; ; GO:0008270; ; GO:0005507 nucleus; GO:0005634 CG11902 CG11902 anon-96CDa CDMC22631 4 11 22 DAC35-P11 3-CG11951-RA_4 CG11951 GGCCAGTTTGTGTGTGGAGGACATCCATCCACAGTGGCGTACCCTTCAATTGGAATCAATGTCCAACCT 69 FBan0011951 FBgn0039656 CG11951 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG11951 CG11951 CDMC22631 4 12 22 DAC35-P11 3-CG11951-RA_4 CG11951 GGCCAGTTTGTGTGTGGAGGACATCCATCCACAGTGGCGTACCCTTCAATTGGAATCAATGTCCAACCT 69 FBan0011951 FBgn0039656 CG11951 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG11951 CG11951 CDMC22632 4 13 22 DAC35-P23 AutoBlank AutoBlank CDMC22632 4 14 22 DAC35-P23 AutoBlank AutoBlank CDMC22633 4 15 22 DAC36-D11 23-CG8634-RA_2 CG8634 TCACATGTTGAGCGTTATTCGAGCTAGTTTTAAGTCATTTGAAAATAAACTTTGTTTGAGCCATCAACC 69 FBan0008634 FBgn0035737 CG8634 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG8634 CG8634 CDMC22633 4 16 22 DAC36-D11 23-CG8634-RA_2 CG8634 TCACATGTTGAGCGTTATTCGAGCTAGTTTTAAGTCATTTGAAAATAAACTTTGTTTGAGCCATCAACC 69 FBan0008634 FBgn0035737 CG8634 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG8634 CG8634 CDMC22634 4 17 22 DAC36-D23 3-CG8646-RA_2 CG8646 GGGTCTCATGTGGTCACCTCTGCTGAAGAAAAGCCAACGAGTGTCCAACCAGACCATGCACATCATTGA 69 FBan0008646 FBgn0033763 CG8646 2 2R phospholipid metabolism; GO:0006644; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG8646 CG8646 CDMC22634 4 18 22 DAC36-D23 3-CG8646-RA_2 CG8646 GGGTCTCATGTGGTCACCTCTGCTGAAGAAAAGCCAACGAGTGTCCAACCAGACCATGCACATCATTGA 69 FBan0008646 FBgn0033763 CG8646 2 2R phospholipid metabolism; GO:0006644; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG8646 CG8646 CDMC22635 4 19 22 DAC36-H11 9-CG8679-RA_2 CG8679 GGGGTTTGGCAGCGTTTTCTGGACTCCATTTTTTACATAGGCAAGGGTAAATGTTCGCGACCGTACGCT 69 FBan0008679 FBgn0032934 CG8679 2 2L nuclear membrane; GO:0005635 CG8679 CG8679 CDMC22635 4 20 22 DAC36-H11 9-CG8679-RA_2 CG8679 GGGGTTTGGCAGCGTTTTCTGGACTCCATTTTTTACATAGGCAAGGGTAAATGTTCGCGACCGTACGCT 69 FBan0008679 FBgn0032934 CG8679 2 2L nuclear membrane; GO:0005635 CG8679 CG8679 CDMC22636 4 21 22 DAC36-H23 3-CG8696-RA_1 CG8696 TGGCTCCCACATTCCCTTCAACTTTGACTTCCTTACGAGCATCAACAACGCCTCTAAGGCCGGAGAGTA 69 FBan0008696 FBgn0002570 LvpH 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpH Larval visceral protein H "CG8696, CG8696, V: transcript group V, gene V, H, maltase, hdl cuticle gene cluster." CDMC22636 4 22 22 DAC36-H23 3-CG8696-RA_1 CG8696 TGGCTCCCACATTCCCTTCAACTTTGACTTCCTTACGAGCATCAACAACGCCTCTAAGGCCGGAGAGTA 69 FBan0008696 FBgn0002570 LvpH 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpH Larval visceral protein H "CG8696, CG8696, V: transcript group V, gene V, H, maltase, hdl cuticle gene cluster." CDMC22637 4 23 22 DAC36-L11 17-CG8732-RA_2 CG8732 TGGCAGATATGTAGCTGAAGCTGAGTTTGGTTTGGAAATGCGCTGTGTATGTGCTAGGAATGCTGTTCA 69 FBan0008732 FBgn0010609 l(2)44DEa 2 2R fatty acid metabolism; GO:0006631 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 l(2)44DEa lethal (2) 44DEa "CG8732, CG8732, l(2)k05304, l(2)05847, 7447, l(2)7447, Fatty acyl CoA synthetase, Fatty acyl-CoA synthetase, anon-WO0172774.173" CDMC22637 4 24 22 DAC36-L11 17-CG8732-RA_2 CG8732 TGGCAGATATGTAGCTGAAGCTGAGTTTGGTTTGGAAATGCGCTGTGTATGTGCTAGGAATGCTGTTCA 69 FBan0008732 FBgn0010609 l(2)44DEa 2 2R fatty acid metabolism; GO:0006631 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 l(2)44DEa lethal (2) 44DEa "CG8732, CG8732, l(2)k05304, l(2)05847, 7447, l(2)7447, Fatty acyl CoA synthetase, Fatty acyl-CoA synthetase, anon-WO0172774.173" CDMC22638 4 25 22 DAC36-L23 23-CG8740-RA_3 CG8740 AACGCACCTAGTTGCTAGTTGTAATCATTAATGCGAACTCGAAACGTAATTCTAATCAATTCAACTGAC 69 FBan0008740 FBgn0027585 CG8740 2 2R CG8740 CG8740 BcDNA:GH05582 CDMC22638 4 26 22 DAC36-L23 23-CG8740-RA_3 CG8740 AACGCACCTAGTTGCTAGTTGTAATCATTAATGCGAACTCGAAACGTAATTCTAATCAATTCAACTGAC 69 FBan0008740 FBgn0027585 CG8740 2 2R CG8740 CG8740 BcDNA:GH05582 CDMC22639 4 1 23 DAC36-P11 17-CG8780-RA_1 CG8780 CGGCGAAATGTACATGATGGAGAGTCTTTACTGTAGCAGTTGTCCGATCTGCAAGAGGAAGTACGCCTT 69 FBan0008780 FBgn0036899 CG8780 3 3L CG8780 CG8780 CDMC22639 4 2 23 DAC36-P11 17-CG8780-RA_1 CG8780 CGGCGAAATGTACATGATGGAGAGTCTTTACTGTAGCAGTTGTCCGATCTGCAAGAGGAAGTACGCCTT 69 FBan0008780 FBgn0036899 CG8780 3 3L CG8780 CG8780 CDMC22640 4 3 23 DAC36-P23 15-CG8798-RA_5 CG8798 ACGGACAAGCATATCAACATTTCCGAGGATGCCCTAAACATGCTGATTCGCAGTTATTGCCGGGAATCC 69 FBan0008798 FBgn0036892 CG8798 3 3L ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; endopeptidase La activity; GO:0008846 ; EC:3.4.21.53; ; GO:0008846 ; EC:3.4.21.53; ; GO:0008846 ; EC:3.4.21.53; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0017111 ; EC:3.6.1.15 mitochondrial matrix; GO:0005759 CG8798 CG8798 anon-WO0118547.350 CDMC22640 4 4 23 DAC36-P23 15-CG8798-RA_5 CG8798 ACGGACAAGCATATCAACATTTCCGAGGATGCCCTAAACATGCTGATTCGCAGTTATTGCCGGGAATCC 69 FBan0008798 FBgn0036892 CG8798 3 3L ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; endopeptidase La activity; GO:0008846 ; EC:3.4.21.53; ; GO:0008846 ; EC:3.4.21.53; ; GO:0008846 ; EC:3.4.21.53; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0017111 ; EC:3.6.1.15 mitochondrial matrix; GO:0005759 CG8798 CG8798 anon-WO0118547.350 CDMC22641 4 5 23 DAC37-D11 11-CG9019-RA_1 CG9019 CCGCGCCCTTACTTACAAATCACTTCCCATCCCACATCCAGCAATTCCGTGGTTTGAATTCTTTCGTGC 69 FBan0009019 FBgn0015381 dsf 2 2L "copulation; GO:0007620; courtship behavior; GO:0007619; intracellular signaling cascade; GO:0007242; male courtship behavior; GO:0008049; mating behavior; GO:0007617; mating behavior, sex discrimination; GO:0048047; oviposition; GO:0018991; regulation of female receptivity; GO:0045924; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; somatic sex determination; GO:0018993" ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0004879; ; GO:0003707; ; GO:0004879 nucleus; GO:0005634 dsf dissatisfaction "CG9019, DSF" CDMC22641 4 6 23 DAC37-D11 11-CG9019-RA_1 CG9019 CCGCGCCCTTACTTACAAATCACTTCCCATCCCACATCCAGCAATTCCGTGGTTTGAATTCTTTCGTGC 69 FBan0009019 FBgn0015381 dsf 2 2L "copulation; GO:0007620; courtship behavior; GO:0007619; intracellular signaling cascade; GO:0007242; male courtship behavior; GO:0008049; mating behavior; GO:0007617; mating behavior, sex discrimination; GO:0048047; oviposition; GO:0018991; regulation of female receptivity; GO:0045924; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; somatic sex determination; GO:0018993" ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0004879; ; GO:0003707; ; GO:0004879 nucleus; GO:0005634 dsf dissatisfaction "CG9019, DSF" CDMC22642 4 7 23 DAC37-D23 3-CG9030-RA_5 CG9030 AGCGTGCAGGCAGATTGTTTTGGTTCTCCGAGCAGATATTCCCCCTCATGTTCTACTATGCTCTGGGCA 69 FBan0009030 FBgn0030599 CG9030 X X CG9030 CG9030 CDMC22642 4 8 23 DAC37-D23 3-CG9030-RA_5 CG9030 AGCGTGCAGGCAGATTGTTTTGGTTCTCCGAGCAGATATTCCCCCTCATGTTCTACTATGCTCTGGGCA 69 FBan0009030 FBgn0030599 CG9030 X X CG9030 CG9030 CDMC22643 4 9 23 DAC37-H11 23-CG9065-RA_1 CG9065 CCAGCCCCTTCAACTGTTTGTTTTTGTTGCATCTCAAGCTAATTATAGAACTAAATTAATTGAAAACCA 69 FBan0009065 FBgn0030610 CG9065 X X copper ion transport; GO:0006825; cytochrome c oxidase complex assembly; GO:0008535 copper ion binding; GO:0005507; copper chaperone activity; GO:0016531; ; GO:0016531; ; GO:0016531; ; GO:0005507 mitochondrial intermembrane space; GO:0005758 CG9065 CG9065 CDMC22643 4 10 23 DAC37-H11 23-CG9065-RA_1 CG9065 CCAGCCCCTTCAACTGTTTGTTTTTGTTGCATCTCAAGCTAATTATAGAACTAAATTAATTGAAAACCA 69 FBan0009065 FBgn0030610 CG9065 X X copper ion transport; GO:0006825; cytochrome c oxidase complex assembly; GO:0008535 copper ion binding; GO:0005507; copper chaperone activity; GO:0016531; ; GO:0016531; ; GO:0016531; ; GO:0005507 mitochondrial intermembrane space; GO:0005758 CG9065 CG9065 CDMC22644 4 11 23 DAC37-H23 12-CG9079-RA_2 CG9079 GCGAACGCGGTGATTCTCAAGCAGAACTTCGACCTGAATCCCGATGGCTCCTATCAGTACAACTACGAG 69 FBan0009079 FBgn0033597 CG9079 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9079 CG9079 CDMC22644 4 12 23 DAC37-H23 12-CG9079-RA_2 CG9079 GCGAACGCGGTGATTCTCAAGCAGAACTTCGACCTGAATCCCGATGGCTCCTATCAGTACAACTACGAG 69 FBan0009079 FBgn0033597 CG9079 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9079 CG9079 CDMC22645 4 13 23 DAC37-L11 23-CG9116-RA_2 CG9116 TCTTCGAGATAAGTATCTGTGAGCTGAAGACATCTTAATCGGATAAAGTCGAACAATAGCCAGTTAGTG 69 FBan0009116 FBgn0004429 LysP 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysP Lysozyme P "CG9116, lysozyme, lysP" CDMC22645 4 14 23 DAC37-L11 23-CG9116-RA_2 CG9116 TCTTCGAGATAAGTATCTGTGAGCTGAAGACATCTTAATCGGATAAAGTCGAACAATAGCCAGTTAGTG 69 FBan0009116 FBgn0004429 LysP 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysP Lysozyme P "CG9116, lysozyme, lysP" CDMC22646 4 15 23 DAC37-L23 4-CG9124-RA_1 CG9124 GCCGAGTTCACGTCGTGGGTCTTTTCGCTTACAATTCGTCAACATGGCAAATCGCGCAAATCGTCATGC 69 FBan0009124 FBgn0022023 eIF-3p40 2 2L regulation of translation; GO:0006445; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF-3p40 Eukaryotic initiation factor 3 p40 subunit "CG9124, CG9124, CG9124, l(2)k09003, eIF-3, eIF3-S3, eIf3-p44, BcDNA:GM14618, Eukaryotic initiation factor 3 p40 subunit" CDMC22646 4 16 23 DAC37-L23 4-CG9124-RA_1 CG9124 GCCGAGTTCACGTCGTGGGTCTTTTCGCTTACAATTCGTCAACATGGCAAATCGCGCAAATCGTCATGC 69 FBan0009124 FBgn0022023 eIF-3p40 2 2L regulation of translation; GO:0006445; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF-3p40 Eukaryotic initiation factor 3 p40 subunit "CG9124, CG9124, CG9124, l(2)k09003, eIF-3, eIF3-S3, eIf3-p44, BcDNA:GM14618, Eukaryotic initiation factor 3 p40 subunit" CDMC22647 4 17 23 DAC37-P11 3-CG9159-RA_3 CG9159 AGCTCCTGCAGCATTTTCAGACAAATCGCATAGATTCCGCGCTATGGGCACTACGTCTGCTGGTCATCT 69 FBan0009159 FBgn0028419 Kr-h2 2 2L integral to membrane; GO:0016021 Kr-h2 Kruppel homolog 2 "CG9159, Kruppel homolog, Kr-h" CDMC22647 4 18 23 DAC37-P11 3-CG9159-RA_3 CG9159 AGCTCCTGCAGCATTTTCAGACAAATCGCATAGATTCCGCGCTATGGGCACTACGTCTGCTGGTCATCT 69 FBan0009159 FBgn0028419 Kr-h2 2 2L integral to membrane; GO:0016021 Kr-h2 Kruppel homolog 2 "CG9159, Kruppel homolog, Kr-h" CDMC22648 4 19 23 DAC37-P23 23-CG9172-RB_2 CG9172 CGTTCTGTTAACGTTCAGTTGTTGTATACATTGTTTGTTGGATCACGAGGATATTGCAAATAAATGCCT 69 FBan0009172 FBgn0030718 CG9172 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9172 CG9172 CDMC22648 4 20 23 DAC37-P23 23-CG9172-RB_2 CG9172 CGTTCTGTTAACGTTCAGTTGTTGTATACATTGTTTGTTGGATCACGAGGATATTGCAAATAAATGCCT 69 FBan0009172 FBgn0030718 CG9172 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9172 CG9172 CDMC22649 4 21 23 DAC38-D11 5-CG6053-RA_1 CG6053 TGTCTCGAGTACAACCAGAAGGATCCAACCAGTCTCGTGAGTGGCATGTACAATGGTCAGGTGGCC 66 FBan0006053 FBgn0036195 CG6053 3 3L RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; microtubule associated complex; GO:0005875 CG6053 CG6053 CDMC22649 4 22 23 DAC38-D11 5-CG6053-RA_1 CG6053 TGTCTCGAGTACAACCAGAAGGATCCAACCAGTCTCGTGAGTGGCATGTACAATGGTCAGGTGGCC 66 FBan0006053 FBgn0036195 CG6053 3 3L RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; microtubule associated complex; GO:0005875 CG6053 CG6053 CDMC22650 4 23 23 DAC38-D23 2-CG6144-RA_3 CG6144 GTGCTGGAGTTTGTCAAGCGTGAGGACACCACAACTGAAACAGAAGCTGGAGATCAGACGACCCGT 66 FBan0006144 FBgn0032259 CG6144 2 2L CG6144 CG6144 CDMC22650 4 24 23 DAC38-D23 2-CG6144-RA_3 CG6144 GTGCTGGAGTTTGTCAAGCGTGAGGACACCACAACTGAAACAGAAGCTGGAGATCAGACGACCCGT 66 FBan0006144 FBgn0032259 CG6144 2 2L CG6144 CG6144 CDMC22651 4 25 23 DAC38-H11 3-CG6500-RA_3 CG6500 TGTGTGGGCGACCGTTTCTACCTGTGCGAGAACAAGATACTCTGCGAGTACGACTATGAGGAGCGC 66 FBan0006500 FBgn0000242 Bx X X cell proliferation; GO:0008283; ectoderm development; GO:0007398; hemopoiesis; GO:0030097; leg disc development; GO:0035218; leg segmentation; GO:0035286; locomotor rhythm; GO:0045475; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to cocaine; GO:0042220; wing morphogenesis; GO:0007476 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bx Beadex "CG6500, CG6500, fliH, flightless-H, hld: heldwing, hdp: heldup, rhombotin, mgt, Dlmo, DLMO, dLMO, dttg, beadex/dLMO, dlmo, Bd: Beaded, Lmo, Ptd: Pointedoid, Rho: Rhombotin, hdp-a, mgg, LIM-only, Pointedoid, Rhombotin, heldup a, heldwing, maggot, hdp, hld, Bd" CDMC22651 4 26 23 DAC38-H11 3-CG6500-RA_3 CG6500 TGTGTGGGCGACCGTTTCTACCTGTGCGAGAACAAGATACTCTGCGAGTACGACTATGAGGAGCGC 66 FBan0006500 FBgn0000242 Bx X X cell proliferation; GO:0008283; ectoderm development; GO:0007398; hemopoiesis; GO:0030097; leg disc development; GO:0035218; leg segmentation; GO:0035286; locomotor rhythm; GO:0045475; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to cocaine; GO:0042220; wing morphogenesis; GO:0007476 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bx Beadex "CG6500, CG6500, fliH, flightless-H, hld: heldwing, hdp: heldup, rhombotin, mgt, Dlmo, DLMO, dLMO, dttg, beadex/dLMO, dlmo, Bd: Beaded, Lmo, Ptd: Pointedoid, Rho: Rhombotin, hdp-a, mgg, LIM-only, Pointedoid, Rhombotin, heldup a, heldwing, maggot, hdp, hld, Bd" CDMC22652 4 1 24 DAC38-H23 3-CG6668-RA_3 CG6668 GGCATCTTTGGATTGGTGGGTCTCTATACGTTCGCCAACTTCTGCAACCTGGTTATGGGTGTGGCG 66 FBan0006668 FBgn0039213 atl 3 3R immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 atl atlastin "CG6668, CG6668, D-atlastin, atlastin" CDMC22652 4 2 24 DAC38-H23 3-CG6668-RA_3 CG6668 GGCATCTTTGGATTGGTGGGTCTCTATACGTTCGCCAACTTCTGCAACCTGGTTATGGGTGTGGCG 66 FBan0006668 FBgn0039213 atl 3 3R immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 atl atlastin "CG6668, CG6668, D-atlastin, atlastin" CDMC22653 4 3 24 DAC38-L11 3-CG7152-RA_2 CG7152 CGAGGATGGAGAGATTGAACTGGACATGGAGTGTTGTCCCAAGCCGGTTGTCTTCGTCGTGCACAA 66 FBan0007152 FBgn0037130 Syn1 3 3L muscle contraction; GO:0006936; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transport; GO:0006810 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307; structural constituent of cytoskeleton; GO:0005200; transporter activity; GO:0005215; ; GO:0005200; ; GO:0005215; ; GO:0008307 syntrophin complex; GO:0016013 Syn1 Syntrophin-like 1 "CG7151, CG7152, CG7151, CG7152, CG7152, DmSYN-1, Syntrophin-like 1" CDMC22653 4 4 24 DAC38-L11 3-CG7152-RA_2 CG7152 CGAGGATGGAGAGATTGAACTGGACATGGAGTGTTGTCCCAAGCCGGTTGTCTTCGTCGTGCACAA 66 FBan0007152 FBgn0037130 Syn1 3 3L muscle contraction; GO:0006936; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transport; GO:0006810 cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307; structural constituent of cytoskeleton; GO:0005200; transporter activity; GO:0005215; ; GO:0005200; ; GO:0005215; ; GO:0008307 syntrophin complex; GO:0016013 Syn1 Syntrophin-like 1 "CG7151, CG7152, CG7151, CG7152, CG7152, DmSYN-1, Syntrophin-like 1" CDMC22654 4 5 24 DAC38-L23 2-CG7255-RB_1 CG7255 AGAATCTCCATCGCGTGAGGACGAACAGTCGGTAATCGCAATGTTGGACGATGTCCTGAATGCCCA 66 FBan0007255 FBgn0036493 CG7255 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG7255 CG7255 CDMC22654 4 6 24 DAC38-L23 2-CG7255-RB_1 CG7255 AGAATCTCCATCGCGTGAGGACGAACAGTCGGTAATCGCAATGTTGGACGATGTCCTGAATGCCCA 66 FBan0007255 FBgn0036493 CG7255 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG7255 CG7255 CDMC22655 4 7 24 DAC38-P11 AutoBlank AutoBlank CDMC22655 4 8 24 DAC38-P11 AutoBlank AutoBlank CDMC22656 4 9 24 DAC38-P23 AutoBlank AutoBlank CDMC22656 4 10 24 DAC38-P23 AutoBlank AutoBlank CDMC22657 4 11 24 DAC39-D11 23-CG32062-RB_1 CG32062 TCATTTATCCCGATCCATTTTGTGACCCCCAAAAATTCTGTAATCTGTGTAGTCTAACCATAAGCCAGC 69 FBan0032062 FBgn0052062 CG32062 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG32062 CG32062 "CG14155, CG18441, CG14155, cg18441, BcDNA:GM06073" CDMC22657 4 12 24 DAC39-D11 23-CG32062-RB_1 CG32062 TCATTTATCCCGATCCATTTTGTGACCCCCAAAAATTCTGTAATCTGTGTAGTCTAACCATAAGCCAGC 69 FBan0032062 FBgn0052062 CG32062 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG32062 CG32062 "CG14155, CG18441, CG14155, cg18441, BcDNA:GM06073" CDMC22658 4 13 24 DAC39-D23 1-CG32071-RA_1 CG32071 CCAGAATCCGTAGAGAAGTCACCATGCGTCCTATTCTTGTGCTATCCCTGGTCATCTTGGCCACGCTGG 69 FBan0032071 FBgn0052071 CG32071 3 3L CG32071 CG32071 CG6261 CDMC22658 4 14 24 DAC39-D23 1-CG32071-RA_1 CG32071 CCAGAATCCGTAGAGAAGTCACCATGCGTCCTATTCTTGTGCTATCCCTGGTCATCTTGGCCACGCTGG 69 FBan0032071 FBgn0052071 CG32071 3 3L CG32071 CG32071 CG6261 CDMC22659 4 15 24 DAC39-H11 11-CG32106-RA_1 CG32106 GCCACCGGAATTTTCACTGCAGCCAAATTTTGTTCACGGAGAACAGCATCCTACTTTCAGACACCACGC 69 FBan0032106 FBgn0052106 CG32106 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32106 CG32106 BcDNA:GH24302 CDMC22659 4 16 24 DAC39-H11 11-CG32106-RA_1 CG32106 GCCACCGGAATTTTCACTGCAGCCAAATTTTGTTCACGGAGAACAGCATCCTACTTTCAGACACCACGC 69 FBan0032106 FBgn0052106 CG32106 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32106 CG32106 BcDNA:GH24302 CDMC22660 4 17 24 DAC39-H23 16-CG32112-RA_2 CG32112 TTCAGCTCTTGATCCCCAATAAGTGGAAAAACGAAAAGCACAAGCCCATATGCATTCATCTGGCCGGAA 69 FBan0032112 FBgn0052112 CG32112 3 3L CG32112 CG32112 CG10982 CDMC22660 4 18 24 DAC39-H23 16-CG32112-RA_2 CG32112 TTCAGCTCTTGATCCCCAATAAGTGGAAAAACGAAAAGCACAAGCCCATATGCATTCATCTGGCCGGAA 69 FBan0032112 FBgn0052112 CG32112 3 3L CG32112 CG32112 CG10982 CDMC22661 4 19 24 DAC39-L11 3-CG3214-RA_1 CG3214 ACCACAGCGAGAATCTTTCCGGAACTAAGGAGGCCTACTACCCCTACTCCACAACACCCAACAAAGTGG 69 FBan0003214 FBgn0031436 CG3214 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3214 CG3214 "BcDNA:GH12382, anon-EST:Posey62" CDMC22661 4 20 24 DAC39-L11 3-CG3214-RA_1 CG3214 ACCACAGCGAGAATCTTTCCGGAACTAAGGAGGCCTACTACCCCTACTCCACAACACCCAACAAAGTGG 69 FBan0003214 FBgn0031436 CG3214 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3214 CG3214 "BcDNA:GH12382, anon-EST:Posey62" CDMC22662 4 21 24 DAC39-L23 14-CG3215-RA_1 CG3215 GCAGACACTGGACGAAAAGGTGCCCATGTACGTTTATGAGGAAATTGTTGAAGGTCGCAAACTCACGGA 69 FBan0003215 FBgn0034825 CG3215 2 2R carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 glycerol-3-phosphate dehydrogenase complex; GO:0009331 CG3215 CG3215 CDMC22662 4 22 24 DAC39-L23 14-CG3215-RA_1 CG3215 GCAGACACTGGACGAAAAGGTGCCCATGTACGTTTATGAGGAAATTGTTGAAGGTCGCAAACTCACGGA 69 FBan0003215 FBgn0034825 CG3215 2 2R carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 glycerol-3-phosphate dehydrogenase complex; GO:0009331 CG3215 CG3215 CDMC22663 4 23 24 DAC39-P11 1-CG32189-RA_1 CG32189 AGTTCCTGATCTTCTACGAACCCTATCGTCATGCGCTTTCTACTAGCTCTCTCCCTGGCCGTCCTGGTC 69 FBan0032189 FBgn0052189 CG32189 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32189 CG32189 BcDNA:RE39957 CDMC22663 4 24 24 DAC39-P11 1-CG32189-RA_1 CG32189 AGTTCCTGATCTTCTACGAACCCTATCGTCATGCGCTTTCTACTAGCTCTCTCCCTGGCCGTCCTGGTC 69 FBan0032189 FBgn0052189 CG32189 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32189 CG32189 BcDNA:RE39957 CDMC22664 4 25 24 DAC39-P23 12-CG32196-RA_1 CG32196 TCCACACGATCGACAGCCTTCGCAAACGTACCTTAAAGTTTTGGTGAAAGGAGCTACGGAATCCGGAGT 69 FBan0032196 FBgn0052196 CG32196 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32196 CG32196 CDMC22664 4 26 24 DAC39-P23 12-CG32196-RA_1 CG32196 TCCACACGATCGACAGCCTTCGCAAACGTACCTTAAAGTTTTGGTGAAAGGAGCTACGGAATCCGGAGT 69 FBan0032196 FBgn0052196 CG32196 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32196 CG32196 CDMC22665 4 1 25 DAC40-D11 11-CG9591-RA_1 CG9591 CGTGTGTGCATGGAATAATGGAGCGTCTGCGAGTGTTGAGTGTGGAATTTGGAATGTGCGAAATGTGCG 69 FBan0009591 FBgn0038168 CG9591 3 3R CG9591 CG9591 CDMC22665 4 2 25 DAC40-D11 11-CG9591-RA_1 CG9591 CGTGTGTGCATGGAATAATGGAGCGTCTGCGAGTGTTGAGTGTGGAATTTGGAATGTGCGAAATGTGCG 69 FBan0009591 FBgn0038168 CG9591 3 3R CG9591 CG9591 CDMC22666 4 3 25 DAC40-D23 5-CG9606-RA_2 CG9606 CCGTCGAGAAGCATGTGTGGTGCATCCGTGTCAACGTCAATGTGCTCAATCACGACGGGAATCTGTATG 69 FBan0009606 FBgn0030789 Rrp45 X X mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; exosome (RNase complex); GO:0000178; nuclear exosome (RNase complex); GO:0000176 Rrp45 Rrp45 "CG9606, CG9606, CG9606, dRrp45" CDMC22666 4 4 25 DAC40-D23 5-CG9606-RA_2 CG9606 CCGTCGAGAAGCATGTGTGGTGCATCCGTGTCAACGTCAATGTGCTCAATCACGACGGGAATCTGTATG 69 FBan0009606 FBgn0030789 Rrp45 X X mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; exosome (RNase complex); GO:0000178; nuclear exosome (RNase complex); GO:0000176 Rrp45 Rrp45 "CG9606, CG9606, CG9606, dRrp45" CDMC22667 4 5 25 DAC40-H11 9-CG9634-RA_1 CG9634 AGGCCCTTGGACTTACCAGGCGCTTGAGAATACCCGGTCTGAGGTCTTTCAACGAGAACGAACTCTTTA 69 FBan0009634 FBgn0027528 CG9634 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; endothelin-converting enzyme activity; GO:0016511; ; GO:0016511 CG9634 CG9634 BcDNA:LD21405 CDMC22667 4 6 25 DAC40-H11 9-CG9634-RA_1 CG9634 AGGCCCTTGGACTTACCAGGCGCTTGAGAATACCCGGTCTGAGGTCTTTCAACGAGAACGAACTCTTTA 69 FBan0009634 FBgn0027528 CG9634 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; endothelin-converting enzyme activity; GO:0016511; ; GO:0016511 CG9634 CG9634 BcDNA:LD21405 CDMC22668 4 7 25 DAC40-H23 2-CG9643-RA_1 CG9643 ACGATGCAGTCAGTCTTTGTCCGGATAATGCCAAGGAGAAACGTGCTCTCTACCTGGACACGGTGGAAA 69 FBan0009643 FBgn0031485 CG9643 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG9643 CG9643 CDMC22668 4 8 25 DAC40-H23 2-CG9643-RA_1 CG9643 ACGATGCAGTCAGTCTTTGTCCGGATAATGCCAAGGAGAAACGTGCTCTCTACCTGGACACGGTGGAAA 69 FBan0009643 FBgn0031485 CG9643 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG9643 CG9643 CDMC22669 4 9 25 DAC40-L11 3-CG9677-RA_6 CG9677 GGCCAAGTACCTCTACGAGTGCGGCAACTATCAGGAGTCCACCTCTTACCTGTACTTCTGCCTCATCGT 69 FBan0009677 FBgn0025582 Int6 3 3L regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 Int6 Int6 homologue "CG9677, CG9677, l(3)10547, DINT6, eIF-3p48/INT-6, BcDNA.GM01233, eIF3-S6, eIF3-p48/INT6, BcDNA:GM01233, l(3)j9E8, Int6 homologue" CDMC22669 4 10 25 DAC40-L11 3-CG9677-RA_6 CG9677 GGCCAAGTACCTCTACGAGTGCGGCAACTATCAGGAGTCCACCTCTTACCTGTACTTCTGCCTCATCGT 69 FBan0009677 FBgn0025582 Int6 3 3L regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 Int6 Int6 homologue "CG9677, CG9677, l(3)10547, DINT6, eIF-3p48/INT-6, BcDNA.GM01233, eIF3-S6, eIF3-p48/INT6, BcDNA:GM01233, l(3)j9E8, Int6 homologue" CDMC22670 4 11 25 DAC40-L23 10-CG9696-RA_1 CG9696 TGAGCTCAAGGTGAAACGCTGAAGATTACAACGATGATCGCTTCAATCAGCTCAAGGCATGGAAGCCGT 69 FBan0009696 FBgn0020306 dom 2 2R "DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260; DNA topological change; GO:0006265; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; hemopoiesis; GO:0030097; larval or pupal development (sensu Insecta); GO:0002165; negative regulation of hemocyte proliferation (sensu Arthropoda); GO:0035207; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0016251; ; GO:0003678; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003918 ; EC:5.99.1.3 chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dom domino "CG9696, CG9696, CG9696, CG9696, CG9696, l(2)81/8, 27/4, DomA, anon-WO0172774.190, l(2)k02704, l(2)k08108, domino" CDMC22670 4 12 25 DAC40-L23 10-CG9696-RA_1 CG9696 TGAGCTCAAGGTGAAACGCTGAAGATTACAACGATGATCGCTTCAATCAGCTCAAGGCATGGAAGCCGT 69 FBan0009696 FBgn0020306 dom 2 2R "DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260; DNA topological change; GO:0006265; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; hemopoiesis; GO:0030097; larval or pupal development (sensu Insecta); GO:0002165; negative regulation of hemocyte proliferation (sensu Arthropoda); GO:0035207; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0016251; ; GO:0003678; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003918 ; EC:5.99.1.3 chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dom domino "CG9696, CG9696, CG9696, CG9696, CG9696, l(2)81/8, 27/4, DomA, anon-WO0172774.190, l(2)k02704, l(2)k08108, domino" CDMC22671 4 13 25 DAC40-P11 30-CG9723-RA_5 CG9723 TCGGCTGGACTACTGATGCTAACCGTGGCTGGATATTTCACATCGGGTATTCCTGGCAATACGGCTTCC 69 FBan0009723 FBgn0030768 CG9723 X X CG9723 CG9723 CDMC22671 4 14 25 DAC40-P11 30-CG9723-RA_5 CG9723 TCGGCTGGACTACTGATGCTAACCGTGGCTGGATATTTCACATCGGGTATTCCTGGCAATACGGCTTCC 69 FBan0009723 FBgn0030768 CG9723 X X CG9723 CG9723 CDMC22672 4 15 25 DAC40-P23 23-CG9739-RB_20 CG9739 TCGCTCCCGCTTTTTGGTTAGGGCACTCTTAGCAAAGGTTTTCCAGAAATGCCATATAAATTCGAGTAG 69 FBan0009739 FBgn0016797 fz2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; female gonad development; GO:0008585; frizzled signaling pathway; GO:0007222; frizzled-2 signaling pathway; GO:0007223; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; ; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz2 frizzled 2 "CG9739, Dfz2, frizzled2, D-Fz2, fz-2, D-frizzled2, Dfrz2, dfz2r, DFz2, DFZ2, DFz-2, dFz2, Dfrizzled2, dfz(2)" CDMC22672 4 16 25 DAC40-P23 23-CG9739-RB_20 CG9739 TCGCTCCCGCTTTTTGGTTAGGGCACTCTTAGCAAAGGTTTTCCAGAAATGCCATATAAATTCGAGTAG 69 FBan0009739 FBgn0016797 fz2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; female gonad development; GO:0008585; frizzled signaling pathway; GO:0007222; frizzled-2 signaling pathway; GO:0007223; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; ; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz2 frizzled 2 "CG9739, Dfz2, frizzled2, D-Fz2, fz-2, D-frizzled2, Dfrz2, dfz2r, DFz2, DFZ2, DFz-2, dFz2, Dfrizzled2, dfz(2)" CDMC22673 4 17 25 DAC41-D11 AutoBlank AutoBlank CDMC22673 4 18 25 DAC41-D11 AutoBlank AutoBlank CDMC22674 4 19 25 DAC41-D23 AutoBlank AutoBlank CDMC22674 4 20 25 DAC41-D23 AutoBlank AutoBlank CDMC22675 4 21 25 DAC41-H11 AutoBlank AutoBlank CDMC22675 4 22 25 DAC41-H11 AutoBlank AutoBlank CDMC22676 4 23 25 DAC41-H23 AutoBlank AutoBlank CDMC22676 4 24 25 DAC41-H23 AutoBlank AutoBlank CDMC22677 4 25 25 DAC41-L11 AutoBlank AutoBlank CDMC22677 4 26 25 DAC41-L11 AutoBlank AutoBlank CDMC22678 4 1 26 DAC41-L23 AutoBlank AutoBlank CDMC22678 4 2 26 DAC41-L23 AutoBlank AutoBlank CDMC22679 4 3 26 DAC41-P11 AutoBlank AutoBlank CDMC22679 4 4 26 DAC41-P11 AutoBlank AutoBlank CDMC22680 4 5 26 DAC41-P23 AutoBlank AutoBlank CDMC22680 4 6 26 DAC41-P23 AutoBlank AutoBlank CDMC22681 4 7 26 DAC42-D11 150mM NaPO4 Blank CDMC22681 4 8 26 DAC42-D11 150mM NaPO4 Blank CDMC22682 4 9 26 DAC42-D23 150mM NaPO4 Blank CDMC22682 4 10 26 DAC42-D23 150mM NaPO4 Blank CDMC22683 4 11 26 DAC42-H11 150mM NaPO4 Blank CDMC22683 4 12 26 DAC42-H11 150mM NaPO4 Blank CDMC22684 4 13 26 DAC42-H23 150mM NaPO4 Blank CDMC22684 4 14 26 DAC42-H23 150mM NaPO4 Blank CDMC22685 4 15 26 DAC42-L11 150mM NaPO4 Blank CDMC22685 4 16 26 DAC42-L11 150mM NaPO4 Blank CDMC22686 4 17 26 DAC42-L23 5uM MSP 5uM MSP CDMC22686 4 18 26 DAC42-L23 5uM MSP 5uM MSP CDMC22687 4 19 26 DAC42-P11 10uM MSP 10uM MSP CDMC22687 4 20 26 DAC42-P11 10uM MSP 10uM MSP CDMC22688 4 21 26 DAC42-P23 20uM MSP 20uM MSP CDMC22688 4 22 26 DAC42-P23 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC22689 1 1 1 DAC01-A10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22689 1 2 1 DAC01-A10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC22690 1 3 1 DAC01-A22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22690 1 4 1 DAC01-A22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC22691 1 5 1 DAC01-E10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22691 1 6 1 DAC01-E10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC22692 1 7 1 DAC01-E22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22692 1 8 1 DAC01-E22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC22693 1 9 1 DAC01-I10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22693 1 10 1 DAC01-I10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC22694 1 11 1 DAC01-I22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22694 1 12 1 DAC01-I22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC22695 1 13 1 DAC01-M10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22695 1 14 1 DAC01-M10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC22696 1 15 1 DAC01-M22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22696 1 16 1 DAC01-M22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC22697 1 17 1 DAC02-A10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22697 1 18 1 DAC02-A10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC22698 1 19 1 DAC02-A22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22698 1 20 1 DAC02-A22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC22699 1 21 1 DAC02-E10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22699 1 22 1 DAC02-E10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC22700 1 23 1 DAC02-E22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22700 1 24 1 DAC02-E22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC22701 1 25 1 DAC02-I10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22701 1 26 1 DAC02-I10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC22702 1 1 2 DAC02-I22 N/A CG9075 (00240-00478) CDMC22702 1 2 2 DAC02-I22 N/A CG9075 (00240-00478) CDMC22703 1 3 2 DAC02-M10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22703 1 4 2 DAC02-M10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC22704 1 5 2 DAC02-M22 AutoBlank AutoBlank CDMC22704 1 6 2 DAC02-M22 AutoBlank AutoBlank CDMC22705 1 7 2 DAC03-A10 17-CG32206-RC_2 CG32206 GCATAGGCCGAAAATGCATTTTTACTGCCGCCAATTGAGGACAAAACTAAAAATCGAAAACACGGCCGG 69 FBan0032206 FBgn0052206 CG32206 3 3L CG32206 CG32206 "CG14090, CG14091, CG14092, CG9600" CDMC22705 1 8 2 DAC03-A10 17-CG32206-RC_2 CG32206 GCATAGGCCGAAAATGCATTTTTACTGCCGCCAATTGAGGACAAAACTAAAAATCGAAAACACGGCCGG 69 FBan0032206 FBgn0052206 CG32206 3 3L CG32206 CG32206 "CG14090, CG14091, CG14092, CG9600" CDMC22706 1 9 2 DAC03-A22 23-CG32219-RA_11 CG32219 AAGAGAGTTACTTTGCATTAATCCTAGGACCTACTCAACCCCCGTCAAAAGACCCGGATGAGTTAATCA 69 FBan0032219 FBgn0052219 CG32219 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32219 CG32219 BcDNA:AT25132 CDMC22706 1 10 2 DAC03-A22 23-CG32219-RA_11 CG32219 AAGAGAGTTACTTTGCATTAATCCTAGGACCTACTCAACCCCCGTCAAAAGACCCGGATGAGTTAATCA 69 FBan0032219 FBgn0052219 CG32219 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32219 CG32219 BcDNA:AT25132 CDMC22707 1 11 2 DAC03-E10 24-CG32247-RA_1 CG32247 ACTTCGATAACATTCGACAACATTTGATAACTTCGATAACATTCCACGATTATTATATTACACTAAAAT 69 FBan0032247 FBgn0052247 CG32247 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32247 CG32247 CDMC22707 1 12 2 DAC03-E10 24-CG32247-RA_1 CG32247 ACTTCGATAACATTCGACAACATTTGATAACTTCGATAACATTCCACGATTATTATATTACACTAAAAT 69 FBan0032247 FBgn0052247 CG32247 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32247 CG32247 CDMC22708 1 13 2 DAC03-E22 9-CG32253-RA_1 CG32253 CGAGGCCACGCGACCTATTAGAGCCTACGATGGCATGGATAACGATGAGCTATTCGAGGACGATGATCC 69 FBgn0052253 CDMC22708 1 14 2 DAC03-E22 9-CG32253-RA_1 CG32253 CGAGGCCACGCGACCTATTAGAGCCTACGATGGCATGGATAACGATGAGCTATTCGAGGACGATGATCC 69 FBgn0052253 CDMC22709 1 15 2 DAC03-I10 2-CG32281-RA_1 CG32281 CGAGCTGTGGACCAATCTCGAGAGATCCTACTACATCCAACGCCTGTCAAAAACTGGGATTCCCTGCCA 69 FBan0032281 FBgn0052281 CG32281 3 3L methionine metabolism; GO:0006555; tRNA modification; GO:0006400 tRNA methyltransferase activity; GO:0008175 ; EC:2.1.1.-; ; GO:0008175 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG32281 CG32281 "CG12032, CG12032, CG12032" CDMC22709 1 16 2 DAC03-I10 2-CG32281-RA_1 CG32281 CGAGCTGTGGACCAATCTCGAGAGATCCTACTACATCCAACGCCTGTCAAAAACTGGGATTCCCTGCCA 69 FBan0032281 FBgn0052281 CG32281 3 3L methionine metabolism; GO:0006555; tRNA modification; GO:0006400 tRNA methyltransferase activity; GO:0008175 ; EC:2.1.1.-; ; GO:0008175 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG32281 CG32281 "CG12032, CG12032, CG12032" CDMC22710 1 17 2 DAC03-I22 8-CG32305-RA_1 CG32305 GGCTGAAGGAGAGCTCGAGGAAAATGTATCTGAAGGCGATGAACTGGAGGTCTCGATACATGAGCGCCA 69 FBan0032305 FBgn0052305 CG32305 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32305 CG32305 "CG8970, CG8970, AC" CDMC22710 1 18 2 DAC03-I22 8-CG32305-RA_1 CG32305 GGCTGAAGGAGAGCTCGAGGAAAATGTATCTGAAGGCGATGAACTGGAGGTCTCGATACATGAGCGCCA 69 FBan0032305 FBgn0052305 CG32305 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32305 CG32305 "CG8970, CG8970, AC" CDMC22711 1 19 2 DAC03-M10 2-CG3234-RC_1 CG3234 CCGGGAGTTCCTCCAGGCCATTGATACGTACAACAAAGTGACTCATCTGAACGAGGACGACAAAGCCCA 69 FBan0003234 FBgn0014396 tim 2 2L "circadian behavior; GO:0048512; circadian rhythm; GO:0007623; copulation; GO:0007620; eclosion rhythm; GO:0008062; entrainment of circadian clock; GO:0009649; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; protein import into nucleus; GO:0006606; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431" protein binding; GO:0005515; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0005515; ; GO:0046982 cytoplasm; GO:0005737; nucleus; GO:0005634 tim timeless "CG3234, rit, Ritsu, TIM, dTIM, dtimeless, tim1, dtim, dTim, ritsu, timeless" CDMC22711 1 20 2 DAC03-M10 2-CG3234-RC_1 CG3234 CCGGGAGTTCCTCCAGGCCATTGATACGTACAACAAAGTGACTCATCTGAACGAGGACGACAAAGCCCA 69 FBan0003234 FBgn0014396 tim 2 2L "circadian behavior; GO:0048512; circadian rhythm; GO:0007623; copulation; GO:0007620; eclosion rhythm; GO:0008062; entrainment of circadian clock; GO:0009649; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; protein import into nucleus; GO:0006606; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431" protein binding; GO:0005515; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0005515; ; GO:0046982 cytoplasm; GO:0005737; nucleus; GO:0005634 tim timeless "CG3234, rit, Ritsu, TIM, dTIM, dtimeless, tim1, dtim, dTim, ritsu, timeless" CDMC22712 1 21 2 DAC03-M22 18-CG32356-RA_2 CG32356 CGGTCACCATTTCGAAATCAACTGATTGATTGACCCGCTCCTGTCTTCCGAAACCTTCGAATCTATCGC 69 FBan0032356 FBgn0001253 ImpE1 3 3L imaginal disc eversion; GO:0007561 lipoprotein binding; GO:0008034; ; GO:0008034 extrinsic to membrane; GO:0019898 ImpE1 Ecdysone-inducible gene E1 "CG13668, CG7116, CG32356, CG13668, CG7116, CG7116, IMP-E1, Imp-E1, CT22003, CT33103, Y1-like, BcDNA:RE39082" CDMC22712 1 22 2 DAC03-M22 18-CG32356-RA_2 CG32356 CGGTCACCATTTCGAAATCAACTGATTGATTGACCCGCTCCTGTCTTCCGAAACCTTCGAATCTATCGC 69 FBan0032356 FBgn0001253 ImpE1 3 3L imaginal disc eversion; GO:0007561 lipoprotein binding; GO:0008034; ; GO:0008034 extrinsic to membrane; GO:0019898 ImpE1 Ecdysone-inducible gene E1 "CG13668, CG7116, CG32356, CG13668, CG7116, CG7116, IMP-E1, Imp-E1, CT22003, CT33103, Y1-like, BcDNA:RE39082" CDMC22713 1 23 2 DAC04-A10 1-CG2926-RA_2 CG2926 AGCGTGGTGTCGAGTTCGCAGCACATACCTTCAATTTCCAGTCCCACACCTCCTTCTAAGAAGCTCACT 69 FBan0002926 FBgn0037344 CG2926 3 3R "protein ubiquitination; GO:0016567; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG2926 CG2926 CDMC22713 1 24 2 DAC04-A10 1-CG2926-RA_2 CG2926 AGCGTGGTGTCGAGTTCGCAGCACATACCTTCAATTTCCAGTCCCACACCTCCTTCTAAGAAGCTCACT 69 FBan0002926 FBgn0037344 CG2926 3 3R "protein ubiquitination; GO:0016567; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG2926 CG2926 CDMC22714 1 25 2 DAC04-A22 23-CG2941-RA_2 CG2941 CCGCCGCTAATCGACTAAAGACGTACATATATAATAATCATAACGCTAGGATGATGTTCAATCCAGATA 69 FBan0002941 FBgn0029686 CG2941 X X CG2941 CG2941 CDMC22714 1 26 2 DAC04-A22 23-CG2941-RA_2 CG2941 CCGCCGCTAATCGACTAAAGACGTACATATATAATAATCATAACGCTAGGATGATGTTCAATCCAGATA 69 FBan0002941 FBgn0029686 CG2941 X X CG2941 CG2941 CDMC22715 1 1 3 DAC04-E10 3-CG2982-RB_1 CG2982 TGGCAGCGTGCGTATCTACCACCATGTGGACAATGGCCTGGATTACTGCAAGTACGAGCCCTATTTCAT 69 FBan0002982 FBgn0029704 CG2982 X X CG2982 CG2982 CDMC22715 1 2 3 DAC04-E10 3-CG2982-RB_1 CG2982 TGGCAGCGTGCGTATCTACCACCATGTGGACAATGGCCTGGATTACTGCAAGTACGAGCCCTATTTCAT 69 FBan0002982 FBgn0029704 CG2982 X X CG2982 CG2982 CDMC22716 1 3 3 DAC04-E22 3-CG2990-RA_2 CG2990 GGCTATTACCCGTGCCAAGAACAAGCTCATCCTACTGGGGGACATTAAGTGCCTGGAGCAATACGGTCC 69 FBan0002990 FBgn0030170 CG2990 X X DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of transcription from RNA polymerase II promoter; GO:0006357; tRNA metabolism; GO:0006399; transport; GO:0006810 nucleic acid binding; GO:0003676; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0003676; transporter activity; GO:0005215; ; GO:0005215; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0000014; ; GO:0004003 membrane; GO:0016020 CG2990 CG2990 CDMC22716 1 4 3 DAC04-E22 3-CG2990-RA_2 CG2990 GGCTATTACCCGTGCCAAGAACAAGCTCATCCTACTGGGGGACATTAAGTGCCTGGAGCAATACGGTCC 69 FBan0002990 FBgn0030170 CG2990 X X DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of transcription from RNA polymerase II promoter; GO:0006357; tRNA metabolism; GO:0006399; transport; GO:0006810 nucleic acid binding; GO:0003676; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0003676; transporter activity; GO:0005215; ; GO:0005215; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0000014; ; GO:0004003 membrane; GO:0016020 CG2990 CG2990 CDMC22717 1 5 3 DAC04-I10 23-CG30018-RC_10 CG30018 TCAGTTCGTCTTTTACAGTACTTTTGCCTACGGGATATCTGCTATACCACTCGGAATCATCATTTCGAT 69 FBan0030018 FBgn0050018 mthl13 2 2R mthl13 methuselah-like 13 CG30018 CDMC22717 1 6 3 DAC04-I10 23-CG30018-RC_10 CG30018 TCAGTTCGTCTTTTACAGTACTTTTGCCTACGGGATATCTGCTATACCACTCGGAATCATCATTTCGAT 69 FBan0030018 FBgn0050018 mthl13 2 2R mthl13 methuselah-like 13 CG30018 CDMC22718 1 7 3 DAC04-I22 22-CG30027-RA_1 CG30027 GCAGTTGCTTGCTTGCTAATTTTTACCCACTAACCGAGGAGAGATGTGGCTGAGAGCGTTTGTTTAACA 69 FBan0030027 FBgn0050027 CG30027 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30027 CG30027 CDMC22718 1 8 3 DAC04-I22 22-CG30027-RA_1 CG30027 GCAGTTGCTTGCTTGCTAATTTTTACCCACTAACCGAGGAGAGATGTGGCTGAGAGCGTTTGTTTAACA 69 FBan0030027 FBgn0050027 CG30027 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30027 CG30027 CDMC22719 1 9 3 DAC04-M10 23-CG30056-RA_1 CG30056 AAATTCTAAAAAATTACCCTAGTTTTTGATCTACGCTGCGAAAAAGACCAAGATACGAGAATGTGCCCG 69 FBan0030056 FBgn0050056 CG30056 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30056 CG30056 "NEST:bs07b11, NEST:bs07h07, NEST:bs33g02" CDMC22719 1 10 3 DAC04-M10 23-CG30056-RA_1 CG30056 AAATTCTAAAAAATTACCCTAGTTTTTGATCTACGCTGCGAAAAAGACCAAGATACGAGAATGTGCCCG 69 FBan0030056 FBgn0050056 CG30056 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30056 CG30056 "NEST:bs07b11, NEST:bs07h07, NEST:bs33g02" CDMC22720 1 11 3 DAC04-M22 9-CG30070-RA_2 CG30070 CCGCTGGTTGCCAAAACTGCACAGTGAAGGAGGAAAATGAGGCAGGTAGTGAAGAAGTGGAGGAAATCA 69 FBan0030070 FBgn0050070 CG30070 2 2R CG30070 CG30070 "CG13940, CG13940" CDMC22720 1 12 3 DAC04-M22 9-CG30070-RA_2 CG30070 CCGCTGGTTGCCAAAACTGCACAGTGAAGGAGGAAAATGAGGCAGGTAGTGAAGAAGTGGAGGAAATCA 69 FBan0030070 FBgn0050070 CG30070 2 2R CG30070 CG30070 "CG13940, CG13940" CDMC22721 1 13 3 DAC05-A10 3-CG17806-RA_1 CG17806 GCCAGCATCCGAAATGCCCCAAGTCATGAAGGAAGAGCCCAGAACACTACAAGTCATCGGGGAAGTAC 68 FBan0017806 FBgn0038548 CG17806 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17806 CG17806 CDMC22721 1 14 3 DAC05-A10 3-CG17806-RA_1 CG17806 GCCAGCATCCGAAATGCCCCAAGTCATGAAGGAAGAGCCCAGAACACTACAAGTCATCGGGGAAGTAC 68 FBan0017806 FBgn0038548 CG17806 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17806 CG17806 CDMC22722 1 15 3 DAC05-A22 2-CG18048-RA_2 CG18048 CCACCGTATTGCAGGAACAGAAGTTGAGTCACTCACAGGTGGTCCTCATCGATCGAATGTCCCTGCGG 68 FBan0018048 FBgn0037435 CG18048 3 3R CG18048 CG18048 CDMC22722 1 16 3 DAC05-A22 2-CG18048-RA_2 CG18048 CCACCGTATTGCAGGAACAGAAGTTGAGTCACTCACAGGTGGTCCTCATCGATCGAATGTCCCTGCGG 68 FBan0018048 FBgn0037435 CG18048 3 3R CG18048 CG18048 CDMC22723 1 17 3 DAC05-E10 2-CG2092-RB_2 CG2092 GCACCAAAAGAAAAGGGCCTACTGACGGTCAAGGACATAACCATTCCACTGCGACAGGAGTACGTGCG 68 FBan0002092 FBgn0004243 scra 2 2R cell motility; GO:0006928; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 contractile ring; GO:0005826; cytoplasm; GO:0005737; nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 scra scraps "CG2092, CG2092, CG2092, ABP8, Ani, anillin, l(2)43Ec, Anillin, annilin, ani, Abp8: Actin-binding protein 8, l(2)03427, Actin-binding protein 8" CDMC22723 1 18 3 DAC05-E10 2-CG2092-RB_2 CG2092 GCACCAAAAGAAAAGGGCCTACTGACGGTCAAGGACATAACCATTCCACTGCGACAGGAGTACGTGCG 68 FBan0002092 FBgn0004243 scra 2 2R cell motility; GO:0006928; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 contractile ring; GO:0005826; cytoplasm; GO:0005737; nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 scra scraps "CG2092, CG2092, CG2092, ABP8, Ani, anillin, l(2)43Ec, Anillin, annilin, ani, Abp8: Actin-binding protein 8, l(2)03427, Actin-binding protein 8" CDMC22724 1 19 3 DAC05-E22 1-CG2211-RA_1 CG2211 ACACACGCATCTGGTACCATGCCAATTCAATTCCCAAGGGTCAGTTTTCGCTCACCGTTCAGTCCGAG 68 FBan0002211 FBgn0035211 CG2211 3 3L CG2211 CG2211 anon-WO0118547.230 CDMC22724 1 20 3 DAC05-E22 1-CG2211-RA_1 CG2211 ACACACGCATCTGGTACCATGCCAATTCAATTCCCAAGGGTCAGTTTTCGCTCACCGTTCAGTCCGAG 68 FBan0002211 FBgn0035211 CG2211 3 3L CG2211 CG2211 anon-WO0118547.230 CDMC22725 1 21 3 DAC05-I10 2-CG30111-RA_1 CG30111 TCAGCAGCTACTCCATCACTACTACAGCCCAGGTGATCAGGTCAAGGATCAGGGATTGGTTTTGCCCC 68 FBan0030111 FBgn0050111 CG30111 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30111 CG30111 BcDNA:LD38807 CDMC22725 1 22 3 DAC05-I10 2-CG30111-RA_1 CG30111 TCAGCAGCTACTCCATCACTACTACAGCCCAGGTGATCAGGTCAAGGATCAGGGATTGGTTTTGCCCC 68 FBan0030111 FBgn0050111 CG30111 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30111 CG30111 BcDNA:LD38807 CDMC22726 1 23 3 DAC05-I22 2-CG30320-RA_1 CG30320 GGGGTTACGAAGATCCCGGTCGTGCGATAAGCAGACGACATTTATGCCAGGTAGACACTTCCAACGCG 68 FBan0030320 FBgn0050320 CG30320 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30320 CG30320 BcDNA:RE02263 CDMC22726 1 24 3 DAC05-I22 2-CG30320-RA_1 CG30320 GGGGTTACGAAGATCCCGGTCGTGCGATAAGCAGACGACATTTATGCCAGGTAGACACTTCCAACGCG 68 FBan0030320 FBgn0050320 CG30320 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30320 CG30320 BcDNA:RE02263 CDMC22727 1 25 3 DAC05-M10 1-CG31258-RA_3 CG31258 TGGAGTTTTTGCAGCGTAGTCAGAACATGTCAAAGAGTCGTCCCCCGGATGAATCAAGCGCGGATGTG 68 FBan0031258 FBgn0051258 CG31258 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31258 CG31258 "CG11746, CG11745, CG11746, CG11745" CDMC22727 1 26 3 DAC05-M10 1-CG31258-RA_3 CG31258 TGGAGTTTTTGCAGCGTAGTCAGAACATGTCAAAGAGTCGTCCCCCGGATGAATCAAGCGCGGATGTG 68 FBan0031258 FBgn0051258 CG31258 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31258 CG31258 "CG11746, CG11745, CG11746, CG11745" CDMC22728 1 1 4 DAC05-M22 9-CG31342-RA_1 CG31342 GGTCAGTGCCTGGGTCTGATTCGGGATGGAAACACTTCGACAATCGTGGATGTGGTGCCAAATAGTTT 68 FBan0031342 FBgn0051342 CG31342 3 3R CG31342 CG31342 "CG7472, CG18551, CG7472" CDMC22728 1 2 4 DAC05-M22 9-CG31342-RA_1 CG31342 GGTCAGTGCCTGGGTCTGATTCGGGATGGAAACACTTCGACAATCGTGGATGTGGTGCCAAATAGTTT 68 FBan0031342 FBgn0051342 CG31342 3 3R CG31342 CG31342 "CG7472, CG18551, CG7472" CDMC22729 1 3 4 DAC06-A10 23-CG5226-RA_16 CG5226 GCTCATCCTCGGTTACCAAGCAATTACCCGTACTCAATACCACAAAGAACTAATCAACGCACAGCAATT 69 FBan0005226 FBgn0034355 CG5226 2 2R extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 transporter activity; GO:0005215; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005215; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG5226 CG5226 anon-WO0149848.1 CDMC22729 1 4 4 DAC06-A10 23-CG5226-RA_16 CG5226 GCTCATCCTCGGTTACCAAGCAATTACCCGTACTCAATACCACAAAGAACTAATCAACGCACAGCAATT 69 FBan0005226 FBgn0034355 CG5226 2 2R extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 transporter activity; GO:0005215; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005215; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG5226 CG5226 anon-WO0149848.1 CDMC22730 1 5 4 DAC06-A22 3-CG5242-RA_1 CG5242 CCGATGGCGACTACCTGCACCAATCCATGAAGTGGGAGGTCAAATGAGGCGTGTAAGTTCCGGATGTTA 69 FBan0005242 FBgn0037892 mRpL40 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL40 mitochondrial ribosomal protein L40 "CG5242, CG5242, MRPL22(24), mitochondrial ribosomal protein L22/24, mRpL22-24, mitochondrial ribosomal protein L40" CDMC22730 1 6 4 DAC06-A22 3-CG5242-RA_1 CG5242 CCGATGGCGACTACCTGCACCAATCCATGAAGTGGGAGGTCAAATGAGGCGTGTAAGTTCCGGATGTTA 69 FBan0005242 FBgn0037892 mRpL40 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL40 mitochondrial ribosomal protein L40 "CG5242, CG5242, MRPL22(24), mitochondrial ribosomal protein L22/24, mRpL22-24, mitochondrial ribosomal protein L40" CDMC22731 1 7 4 DAC06-E10 2-CG5277-RA_4 CG5277 AGACCGGAAAGACAAAGCGAAAGGCATGGAAGCGCATGGTCACAAAAGTCACATTCGTCGGTGAGAACT 69 FBan0005277 FBgn0025366 Ip259 2 2L Ip259 Intronic Protein 259 "CG5277, CG5277, IP259, Intronic Protein 259" CDMC22731 1 8 4 DAC06-E10 2-CG5277-RA_4 CG5277 AGACCGGAAAGACAAAGCGAAAGGCATGGAAGCGCATGGTCACAAAAGTCACATTCGTCGGTGAGAACT 69 FBan0005277 FBgn0025366 Ip259 2 2L Ip259 Intronic Protein 259 "CG5277, CG5277, IP259, Intronic Protein 259" CDMC22732 1 9 4 DAC06-E22 2-CG5295-RA_1 CG5295 CCAGCCTCACTTCGATGCCACAGGACTTCTTCATTCCAGCCGCTTATATGGACCCCGTGTTTCAATCCT 69 FBan0005295 FBgn0036449 CG5295 3 3L CG5295 CG5295 CDMC22732 1 10 4 DAC06-E22 2-CG5295-RA_1 CG5295 CCAGCCTCACTTCGATGCCACAGGACTTCTTCATTCCAGCCGCTTATATGGACCCCGTGTTTCAATCCT 69 FBan0005295 FBgn0036449 CG5295 3 3L CG5295 CG5295 CDMC22733 1 11 4 DAC06-I10 3-CG5337-RA_2 CG5337 GCTCCGGAAATGTGTCTTCTTTGGTGGCTTGGAAAAGAGTCTGCGAAAGACGGTGTGGCCATTCCTTCT 69 FBan0005337 FBgn0032249 CG5337 2 2L intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; ; GO:0005096 CG5337 CG5337 CDMC22733 1 12 4 DAC06-I10 3-CG5337-RA_2 CG5337 GCTCCGGAAATGTGTCTTCTTTGGTGGCTTGGAAAAGAGTCTGCGAAAGACGGTGTGGCCATTCCTTCT 69 FBan0005337 FBgn0032249 CG5337 2 2L intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; ; GO:0005096 CG5337 CG5337 CDMC22734 1 13 4 DAC06-I22 6-CG5352-RA_1 CG5352 AGGACTCGCGTACCTTCATCGGTACCTTCAAAGCCTTCGACAAACACATGAACTTGATCCTCGGCGACT 69 FBan0005352 FBgn0010083 SmB 2 2L "RNA metabolism; GO:0016070; nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmB Small ribonucleoprotein particle protein B "CG5352, CG5352, snRNP B, Sm B, B, polypeptide B" CDMC22734 1 14 4 DAC06-I22 6-CG5352-RA_1 CG5352 AGGACTCGCGTACCTTCATCGGTACCTTCAAAGCCTTCGACAAACACATGAACTTGATCCTCGGCGACT 69 FBan0005352 FBgn0010083 SmB 2 2L "RNA metabolism; GO:0016070; nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmB Small ribonucleoprotein particle protein B "CG5352, CG5352, snRNP B, Sm B, B, polypeptide B" CDMC22735 1 15 4 DAC06-M10 6-CG5390-RA_2 CG5390 TGGATGCTGGCCATTCTCCGGGAAGAAGGCAACCTTAACCTGTACGAATGTGGAGGAGCATTGATAGCT 69 FBan0005390 FBgn0032213 CG5390 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5390 CG5390 "gh06341, SPH35, c-SPH35, BEST:GH06341" CDMC22735 1 16 4 DAC06-M10 6-CG5390-RA_2 CG5390 TGGATGCTGGCCATTCTCCGGGAAGAAGGCAACCTTAACCTGTACGAATGTGGAGGAGCATTGATAGCT 69 FBan0005390 FBgn0032213 CG5390 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5390 CG5390 "gh06341, SPH35, c-SPH35, BEST:GH06341" CDMC22736 1 17 4 DAC06-M22 15-CG5399-RA_1 CG5399 GCTTCCTTGCCTTTGCCCTTTTGCTGATCAAGGCCTAAAAATGGAGATGTATCCAATGGCTGCTTTGCC 69 FBan0005399 FBgn0038353 CG5399 3 3R CG5399 CG5399 CDMC22736 1 18 4 DAC06-M22 15-CG5399-RA_1 CG5399 GCTTCCTTGCCTTTGCCCTTTTGCTGATCAAGGCCTAAAAATGGAGATGTATCCAATGGCTGCTTTGCC 69 FBan0005399 FBgn0038353 CG5399 3 3R CG5399 CG5399 CDMC22737 1 19 4 DAC07-A10 2-CG9753-RA_1 CG9753 CTGTCCCATCTGAACTCGGCGGTAAATCCGGTCCTGTATGCCTATCACCTCAAGGACTTCAGGGC 65 FBan0009753 FBgn0039747 CG9753 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 "adenosine receptor activity, G-protein coupled; GO:0001609; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0001609" integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG9753 CG9753 "anon-WO0170980.109, anon-WO0170980.110" CDMC22737 1 20 4 DAC07-A10 2-CG9753-RA_1 CG9753 CTGTCCCATCTGAACTCGGCGGTAAATCCGGTCCTGTATGCCTATCACCTCAAGGACTTCAGGGC 65 FBan0009753 FBgn0039747 CG9753 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 "adenosine receptor activity, G-protein coupled; GO:0001609; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0001609" integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG9753 CG9753 "anon-WO0170980.109, anon-WO0170980.110" CDMC22738 1 21 4 DAC07-A22 24-CG9782-RA_1 CG9782 ATATATAAAATCAATTATAAATACACAAGTGTTTTTTTTCTAGTTTAAGTTTAAGACGCGCGCGT 65 FBan0009782 FBgn0030763 CG9782 X X CG9782 CG9782 CDMC22738 1 22 4 DAC07-A22 24-CG9782-RA_1 CG9782 ATATATAAAATCAATTATAAATACACAAGTGTTTTTTTTCTAGTTTAAGTTTAAGACGCGCGCGT 65 FBan0009782 FBgn0030763 CG9782 X X CG9782 CG9782 CDMC22739 1 23 4 DAC07-E10 2-CG9903-RA_2 CG9903 GTGCGGTGACGGAGACATATCCAAAACCCCTGCCAATAACAGTGCTCAGAACACAGGTGGTGGAC 65 FBan0009903 FBgn0030756 CG9903 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 bile acid:sodium symporter activity; GO:0008508; ; GO:0008508 membrane; GO:0016020 CG9903 CG9903 CDMC22739 1 24 4 DAC07-E10 2-CG9903-RA_2 CG9903 GTGCGGTGACGGAGACATATCCAAAACCCCTGCCAATAACAGTGCTCAGAACACAGGTGGTGGAC 65 FBan0009903 FBgn0030756 CG9903 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 bile acid:sodium symporter activity; GO:0008508; ; GO:0008508 membrane; GO:0016020 CG9903 CG9903 CDMC22740 1 25 4 DAC07-E22 3-CG9953-RA_7 CG9953 GCCAGTGGACATATCAGACCTGCCACGAATTCGGCTTCTATCAGACCTCGGATAACCCGGCTGAC 65 FBan0009953 FBgn0035726 CG9953 3 3L proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG9953 CG9953 CDMC22740 1 26 4 DAC07-E22 3-CG9953-RA_7 CG9953 GCCAGTGGACATATCAGACCTGCCACGAATTCGGCTTCTATCAGACCTCGGATAACCCGGCTGAC 65 FBan0009953 FBgn0035726 CG9953 3 3L proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG9953 CG9953 CDMC22741 1 1 5 DAC07-I10 2-CR31273-RB_1 CR31273 ACTGACCTCGTCGAGCATTCAGATCCAATTGGAGGGCAAGTTCAATGGCATTGGGGATTCCAGGG 65 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC22741 1 2 5 DAC07-I10 2-CR31273-RB_1 CR31273 ACTGACCTCGTCGAGCATTCAGATCCAATTGGAGGGCAAGTTCAATGGCATTGGGGATTCCAGGG 65 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC22742 1 3 5 DAC07-I22 23-CR31485-RA_1 CR31485 AGCTTAGTTGGTAAAGCGTTGGATTCTTAAATCATTGGTACACGGTTCAAGTTCATGCTCAGATG 65 FBan0031485 FBgn0051485 CR31485 3 3R CR31485 CR31485 "AE002699.trna6-LysCTT, tRNA:KPsi:CTT:AE002699" CDMC22742 1 4 5 DAC07-I22 23-CR31485-RA_1 CR31485 AGCTTAGTTGGTAAAGCGTTGGATTCTTAAATCATTGGTACACGGTTCAAGTTCATGCTCAGATG 65 FBan0031485 FBgn0051485 CR31485 3 3R CR31485 CR31485 "AE002699.trna6-LysCTT, tRNA:KPsi:CTT:AE002699" CDMC22743 1 5 5 DAC07-M10 24-CR32893-RA_1 CR32893 ACACTTTATTTAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATAAAAGTTGCTGATT 65 FBan0032893 FBgn0063375 snoRNA:snR38:54Ea 2 2R snoRNA:snR38:54Ea snoRNA:snR38:54Ea "Snr38snoRNA, CR32893" CDMC22743 1 6 5 DAC07-M10 24-CR32893-RA_1 CR32893 ACACTTTATTTAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATAAAAGTTGCTGATT 65 FBan0032893 FBgn0063375 snoRNA:snR38:54Ea 2 2R snoRNA:snR38:54Ea snoRNA:snR38:54Ea "Snr38snoRNA, CR32893" CDMC22744 1 7 5 DAC07-M22 24-CR32901-RA_1 CR32901 ACACCTTATTTAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATATATTCAGCTGACA 65 FBan0032901 FBgn0063373 snoRNA:snR38:54Ec 2 2R snoRNA:snR38:54Ec snoRNA:snR38:54Ec "Snr38snoRNA, CR32901" CDMC22744 1 8 5 DAC07-M22 24-CR32901-RA_1 CR32901 ACACCTTATTTAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATATATTCAGCTGACA 65 FBan0032901 FBgn0063373 snoRNA:snR38:54Ec 2 2R snoRNA:snR38:54Ec snoRNA:snR38:54Ec "Snr38snoRNA, CR32901" CDMC22745 1 9 5 DAC08-A10 15-CG5603-RA_10 CG5603 ACCGAGCTAGCGATTGGTTCCCTCGTCGAAGTCTCGAATCCTGGAGTATGTGAAGATCTATATGGCGTT 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC22745 1 10 5 DAC08-A10 15-CG5603-RA_10 CG5603 ACCGAGCTAGCGATTGGTTCCCTCGTCGAAGTCTCGAATCCTGGAGTATGTGAAGATCTATATGGCGTT 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC22746 1 11 5 DAC08-A22 3-CG5611-RA_1 CG5611 AGGTCAAGCTGTTAATCTGGCCTTTTCCATTGCCAAGTTCCCCATGGCTTCCCTAATGCACGACAGGAA 69 FBan0005611 FBgn0039531 CG5611 3 3R fatty acid beta-oxidation; GO:0006635 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; delta5-delta2,4-dienoyl-CoA isomerase activity; GO:0008416 ; EC:5.3.3.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008416 ; EC:5.3.3.-" CG5611 CG5611 CDMC22746 1 12 5 DAC08-A22 3-CG5611-RA_1 CG5611 AGGTCAAGCTGTTAATCTGGCCTTTTCCATTGCCAAGTTCCCCATGGCTTCCCTAATGCACGACAGGAA 69 FBan0005611 FBgn0039531 CG5611 3 3R fatty acid beta-oxidation; GO:0006635 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; delta5-delta2,4-dienoyl-CoA isomerase activity; GO:0008416 ; EC:5.3.3.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008416 ; EC:5.3.3.-" CG5611 CG5611 CDMC22747 1 13 5 DAC08-E10 23-CG5646-RA_9 CG5646 ATTAGGAGCCTTAGTTTGTATGCTGTGTACATTGTTGTCAACTGAGAATGAGTGTGATCGAAAAATGCA 69 FBan0005646 FBgn0039525 CG5646 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG5646 CG5646 CDMC22747 1 14 5 DAC08-E10 23-CG5646-RA_9 CG5646 ATTAGGAGCCTTAGTTTGTATGCTGTGTACATTGTTGTCAACTGAGAATGAGTGTGATCGAAAAATGCA 69 FBan0005646 FBgn0039525 CG5646 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG5646 CG5646 CDMC22748 1 15 5 DAC08-E22 4-CG5660-RA_2 CG5660 GCGGGCATTATTACGCCTTCAGAGTTAAAGGCCTCCACGATTGGAATGACGCAAATGTTCCCCAATGGC 69 FBan0005660 FBgn0035942 CG5660 3 3L tRNA aminoacylation for protein translation; GO:0006418; valyl-tRNA aminoacylation; GO:0006438 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; valine-tRNA ligase activity; GO:0004832 ; EC:6.1.1.9; ; GO:0003729; ; GO:0004832 ; EC:6.1.1.9 CG5660 CG5660 CDMC22748 1 16 5 DAC08-E22 4-CG5660-RA_2 CG5660 GCGGGCATTATTACGCCTTCAGAGTTAAAGGCCTCCACGATTGGAATGACGCAAATGTTCCCCAATGGC 69 FBan0005660 FBgn0035942 CG5660 3 3L tRNA aminoacylation for protein translation; GO:0006418; valyl-tRNA aminoacylation; GO:0006438 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; valine-tRNA ligase activity; GO:0004832 ; EC:6.1.1.9; ; GO:0003729; ; GO:0004832 ; EC:6.1.1.9 CG5660 CG5660 CDMC22749 1 17 5 DAC08-I10 11-CG5690-RA_2 CG5690 AGCAGGCCCTTGCTATCCTCACCACTCCTAGTCAAAACTCCATTATCCAATCCAGTGACACTGAAGCCA 69 FBan0005690 FBgn0035295 CG5690 3 3L CG5690 CG5690 "cDNA C, anon-62BCa" CDMC22749 1 18 5 DAC08-I10 11-CG5690-RA_2 CG5690 AGCAGGCCCTTGCTATCCTCACCACTCCTAGTCAAAACTCCATTATCCAATCCAGTGACACTGAAGCCA 69 FBan0005690 FBgn0035295 CG5690 3 3L CG5690 CG5690 "cDNA C, anon-62BCa" CDMC22750 1 19 5 DAC08-I22 16-CG5704-RA_1 CG5704 CCACCGGGAATGTACTACAGTGTGTACGAGTACGTGTTCACTATTCCACTGGTCATGAAGGAGTACGGA 69 FBan0005704 FBgn0026570 CG5704 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5704 CG5704 "LD30049, BEST:LD30049" CDMC22750 1 20 5 DAC08-I22 16-CG5704-RA_1 CG5704 CCACCGGGAATGTACTACAGTGTGTACGAGTACGTGTTCACTATTCCACTGGTCATGAAGGAGTACGGA 69 FBan0005704 FBgn0026570 CG5704 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5704 CG5704 "LD30049, BEST:LD30049" CDMC22751 1 21 5 DAC08-M10 23-CG5730-RA_6 CG5730 TATCTATGAGCAATACCCCACTGTTCAAGTAGAAAATGCCAAAAACAAAAAAACGTTGCATTTCCCCAA 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC22751 1 22 5 DAC08-M10 23-CG5730-RA_6 CG5730 TATCTATGAGCAATACCCCACTGTTCAAGTAGAAAATGCCAAAAACAAAAAAACGTTGCATTTCCCCAA 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC22752 1 23 5 DAC08-M22 16-CG5744-RB_1 CG5744 ACAATGGCCGATTACCGATAACAGACCCGATTCCAATTCCACAAAAACCAAGCGCGCAATAAACTGAAA 69 FBan0005744 FBgn0030897 Frq1 X X calcium-mediated signaling; GO:0019722; intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; sensory perception; GO:0007600; signal transduction; GO:0007165; synaptic transmission; GO:0007268; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium sensitive guanylate cyclase activator activity; GO:0008048; ; GO:0008048; ; GO:0008048; ; GO:0005516; ; GO:0005509; ; GO:0005509; ; GO:0008048 synapse; GO:0045202 Frq1 Frequenin 1 "CG5744, CG5744, Frq, Frequenin, Frequinin, frequenin, HL-II, frq1" CDMC22752 1 24 5 DAC08-M22 16-CG5744-RB_1 CG5744 ACAATGGCCGATTACCGATAACAGACCCGATTCCAATTCCACAAAAACCAAGCGCGCAATAAACTGAAA 69 FBan0005744 FBgn0030897 Frq1 X X calcium-mediated signaling; GO:0019722; intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; sensory perception; GO:0007600; signal transduction; GO:0007165; synaptic transmission; GO:0007268; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium sensitive guanylate cyclase activator activity; GO:0008048; ; GO:0008048; ; GO:0008048; ; GO:0005516; ; GO:0005509; ; GO:0005509; ; GO:0008048 synapse; GO:0045202 Frq1 Frequenin 1 "CG5744, CG5744, Frq, Frequenin, Frequinin, frequenin, HL-II, frq1" CDMC22753 1 25 5 DAC09-A11 3-CG31203-RC_1 CG31203 TGGCATGAAACTGGCCGGAGTTATCCTGATTGGCATCGGATTTTTCCTCGTCATGTTTCCCGCCAAC 67 FBan0031203 FBgn0051203 CG31203 3 3R CG31203 CG31203 "CG15688, CG15689" CDMC22753 1 26 5 DAC09-A11 3-CG31203-RC_1 CG31203 TGGCATGAAACTGGCCGGAGTTATCCTGATTGGCATCGGATTTTTCCTCGTCATGTTTCCCGCCAAC 67 FBan0031203 FBgn0051203 CG31203 3 3R CG31203 CG31203 "CG15688, CG15689" CDMC22754 1 1 6 DAC09-A23 2-CG31357-RA_1 CG31357 AAGCTCCGCAAGATCAACTCGACCATTGAATTCAGCCTGAGGGTGCAAGAGTTCATCGAGCTCGTGC 67 FBan0031357 FBgn0051357 CG31357 3 3R CG31357 CG31357 CG13638 CDMC22754 1 2 6 DAC09-A23 2-CG31357-RA_1 CG31357 AAGCTCCGCAAGATCAACTCGACCATTGAATTCAGCCTGAGGGTGCAAGAGTTCATCGAGCTCGTGC 67 FBan0031357 FBgn0051357 CG31357 3 3R CG31357 CG31357 CG13638 CDMC22755 1 3 6 DAC09-E11 3-CG32030-RA_1 CG32030 CGTAGATACCCGCATCACATCCGAGATAATACCATCCCCCAGTGACGTCACAAGTCGGGCACTACGC 67 FBan0032030 FBgn0052030 CG32030 3 3L cell organization and biogenesis; GO:0016043 actin binding; GO:0003779; ; GO:0003779 CG32030 CG32030 "CG5797, CG5775, CG5797, CG5797, CG5797, CG5797" CDMC22755 1 4 6 DAC09-E11 3-CG32030-RA_1 CG32030 CGTAGATACCCGCATCACATCCGAGATAATACCATCCCCCAGTGACGTCACAAGTCGGGCACTACGC 67 FBan0032030 FBgn0052030 CG32030 3 3L cell organization and biogenesis; GO:0016043 actin binding; GO:0003779; ; GO:0003779 CG32030 CG32030 "CG5797, CG5775, CG5797, CG5797, CG5797, CG5797" CDMC22756 1 5 6 DAC09-E23 3-CG32091-RB_3 CG32091 AGCGACCTAACCGAAAACGGGAAGCTGATCTATGTGGTCAGTCAGTCTGAGCAATTGGCACCTCAGC 67 FBan0032091 FBgn0052091 CG32091 3 3L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG32091 CG32091 "CG7346, CG14136, CG7346" CDMC22756 1 6 6 DAC09-E23 3-CG32091-RB_3 CG32091 AGCGACCTAACCGAAAACGGGAAGCTGATCTATGTGGTCAGTCAGTCTGAGCAATTGGCACCTCAGC 67 FBan0032091 FBgn0052091 CG32091 3 3L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG32091 CG32091 "CG7346, CG14136, CG7346" CDMC22757 1 7 6 DAC09-I11 1-CG32534-RA_1 CG32534 GCATGGCACAAATAGCACCATAAATACCATCGACGCCACCACGACCTCAACCAACAACAGCACCACC 67 FBan0032534 FBgn0052534 CG32534 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32534 CG32534 CDMC22757 1 8 6 DAC09-I11 1-CG32534-RA_1 CG32534 GCATGGCACAAATAGCACCATAAATACCATCGACGCCACCACGACCTCAACCAACAACAGCACCACC 67 FBan0032534 FBgn0052534 CG32534 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32534 CG32534 CDMC22758 1 9 6 DAC09-I23 1-CG32675-RA_1 CG32675 TCTTCGAGACATTCGTGATCGGCATGGTGTGCTACTTTGTGGTGTCCATCGTTAACTCCTTGGCCCA 67 FBan0032675 FBgn0052675 CG32675 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32675 CG32675 "CG1534, CG1534" CDMC22758 1 10 6 DAC09-I23 1-CG32675-RA_1 CG32675 TCTTCGAGACATTCGTGATCGGCATGGTGTGCTACTTTGTGGTGTCCATCGTTAACTCCTTGGCCCA 67 FBan0032675 FBgn0052675 CG32675 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32675 CG32675 "CG1534, CG1534" CDMC22759 1 11 6 DAC09-M11 11-CG33312-RA_1 CG33312 ACGAAGACAAGTGCAGGCTCTTTGCTTTTCAGCTGGTTCGATGTACCTGAAAATCTCAGCCGAAGCC 67 FBan0033312 FBgn0053312 CG33312 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33312 CG33312 CDMC22759 1 12 6 DAC09-M11 11-CG33312-RA_1 CG33312 ACGAAGACAAGTGCAGGCTCTTTGCTTTTCAGCTGGTTCGATGTACCTGAAAATCTCAGCCGAAGCC 67 FBan0033312 FBgn0053312 CG33312 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33312 CG33312 CDMC22760 1 13 6 DAC09-M23 2-CG3380-RA_3 CG3380 GAAGGTGGAGGAGAATCGACGACGCGAAAAGGAACGACTGTCGGTGAAGAGTACGGAGAAGGAACGC 67 FBan0003380 FBgn0034716 Oatp58Dc 2 2R organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 integral to membrane; GO:0016021 Oatp58Dc Organic anion transporting polypeptide 58Dc "CG3380, oatp 58Dc, Organic anion transporting polypeptide 58Dc" CDMC22760 1 14 6 DAC09-M23 2-CG3380-RA_3 CG3380 GAAGGTGGAGGAGAATCGACGACGCGAAAAGGAACGACTGTCGGTGAAGAGTACGGAGAAGGAACGC 67 FBan0003380 FBgn0034716 Oatp58Dc 2 2R organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 integral to membrane; GO:0016021 Oatp58Dc Organic anion transporting polypeptide 58Dc "CG3380, oatp 58Dc, Organic anion transporting polypeptide 58Dc" CDMC22761 1 15 6 DAC10-A10 8-CG18316-RA_1 CG18316 CCCGGGATTGCCTTATGCAGCGGGACTACAAGAACTTGGCAAAAATACTGGCCTCCAATCATATGGGAG 69 FBan0018316 FBgn0033261 CG18316 2 2R CG18316 CG18316 CDMC22761 1 16 6 DAC10-A10 8-CG18316-RA_1 CG18316 CCCGGGATTGCCTTATGCAGCGGGACTACAAGAACTTGGCAAAAATACTGGCCTCCAATCATATGGGAG 69 FBan0018316 FBgn0033261 CG18316 2 2R CG18316 CG18316 CDMC22762 1 17 6 DAC10-A22 23-CG18330-RA_2 CG18330 AATGGAACAGCGCAGTAGGCACTTTTATACATATTTAAAAGAGCTACCAGAAAAAGTATGCGCTTAAAA 69 FBan0018330 FBgn0035231 Cct2 3 3L biosynthesis; GO:0009058; phospholipid metabolism; GO:0006644 choline-phosphate cytidylyltransferase activity; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15 Cct2 CTP:phosphocholine cytidylyltransferase 2 "CG18330, cct2, CT1187, CCT2, CTP:phosphocholine cytidylyltransferase 2" CDMC22762 1 18 6 DAC10-A22 23-CG18330-RA_2 CG18330 AATGGAACAGCGCAGTAGGCACTTTTATACATATTTAAAAGAGCTACCAGAAAAAGTATGCGCTTAAAA 69 FBan0018330 FBgn0035231 Cct2 3 3L biosynthesis; GO:0009058; phospholipid metabolism; GO:0006644 choline-phosphate cytidylyltransferase activity; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15 Cct2 CTP:phosphocholine cytidylyltransferase 2 "CG18330, cct2, CT1187, CCT2, CTP:phosphocholine cytidylyltransferase 2" CDMC22763 1 19 6 DAC10-E10 12-CG18397-RA_3 CG18397 GCTGTTGGACGTGATGACCGTCATCCTGAACTGCAGTTTAGTGAATGACCAATGGACAACGAACAGCGA 69 FBan0018397 FBgn0032723 CG18397 2 2L CG18397 CG18397 CG10666 CDMC22763 1 20 6 DAC10-E10 12-CG18397-RA_3 CG18397 GCTGTTGGACGTGATGACCGTCATCCTGAACTGCAGTTTAGTGAATGACCAATGGACAACGAACAGCGA 69 FBan0018397 FBgn0032723 CG18397 2 2L CG18397 CG18397 CG10666 CDMC22764 1 21 6 DAC10-E22 12-CG1840-RA_5 CG1840 TGGGAGAAACGTCCATGGGACTTGAGACGAGTTTTGGACACATTCGTGGGTATATGGTTCGCCGTCAAA 69 FBan0001840 FBgn0030351 CG1840 X X CG1840 CG1840 "AAF48112, BcDNA:LD12750" CDMC22764 1 22 6 DAC10-E22 12-CG1840-RA_5 CG1840 TGGGAGAAACGTCCATGGGACTTGAGACGAGTTTTGGACACATTCGTGGGTATATGGTTCGCCGTCAAA 69 FBan0001840 FBgn0030351 CG1840 X X CG1840 CG1840 "AAF48112, BcDNA:LD12750" CDMC22765 1 23 6 DAC10-I10 12-CG1847-RB_1 CG1847 GCAGCAGGCACGTAACGTCCAGGATCGCATTCACATGCAGAAGCTCTTCTAGAACATAAGTTGCGTCAA 69 FBan0001847 FBgn0030345 CG1847 X X protein folding; GO:0006457 aryl hydrocarbon receptor binding; GO:0017162; ; GO:0017162 CG1847 CG1847 CDMC22765 1 24 6 DAC10-I10 12-CG1847-RB_1 CG1847 GCAGCAGGCACGTAACGTCCAGGATCGCATTCACATGCAGAAGCTCTTCTAGAACATAAGTTGCGTCAA 69 FBan0001847 FBgn0030345 CG1847 X X protein folding; GO:0006457 aryl hydrocarbon receptor binding; GO:0017162; ; GO:0017162 CG1847 CG1847 CDMC22766 1 25 6 DAC10-I22 23-CG18495-RB_6 CG18495 TTTCGGGCTGAGAATGACAATCTGAATTTTGCACAGTAGGTTCGATTTGAAGCGACATTTTCCCTGCTA 69 FBan0018495 FBgn0026781 Prosalpha6 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha6 Proteasome alpha6 subunit "CG18495, CG18495, 20S proteasome subunit alpha1, 20S proteasome, 20s proteasome, Prosalpha1" CDMC22766 1 26 6 DAC10-I22 23-CG18495-RB_6 CG18495 TTTCGGGCTGAGAATGACAATCTGAATTTTGCACAGTAGGTTCGATTTGAAGCGACATTTTCCCTGCTA 69 FBan0018495 FBgn0026781 Prosalpha6 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha6 Proteasome alpha6 subunit "CG18495, CG18495, 20S proteasome subunit alpha1, 20S proteasome, 20s proteasome, Prosalpha1" CDMC22767 1 1 7 DAC10-M10 3-CG18548-RA_1 CG18548 GCACTGGGTGTGGAGTTCGATAAGAAGACCATTATCAACACCCGAGCTAGGGAGCAATTCACGCCGGAA 69 FBan0018548 FBgn0042206 GstD10 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD10 Glutathione S transferase D10 "CG17392, CG18548, CG17392, DmGSTD10, Glutathione S transferase D10" CDMC22767 1 2 7 DAC10-M10 3-CG18548-RA_1 CG18548 GCACTGGGTGTGGAGTTCGATAAGAAGACCATTATCAACACCCGAGCTAGGGAGCAATTCACGCCGGAA 69 FBan0018548 FBgn0042206 GstD10 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD10 Glutathione S transferase D10 "CG17392, CG18548, CG17392, DmGSTD10, Glutathione S transferase D10" CDMC22768 1 3 7 DAC10-M22 3-CG18572-RA_1 CG18572 GCCATGGTCGTTGGTGGACGCAATACGGCGCTCTAGAGGATTTACCCATGGAAAACCCACAATCTTTGA 69 FBan0018572 FBgn0003189 r X X "'de novo' pyrimidine base biosynthesis; GO:0006207; amino acid biosynthesis; GO:0008652; arginine biosynthesis; GO:0006526; nitrogen compound metabolism; GO:0006807; regulation of transcription, DNA-dependent; GO:0006355" ATP binding; GO:0005524; ; GO:0005524; aspartate carbamoyltransferase activity; GO:0004070 ; EC:2.1.3.2; carbamoyl-phosphate synthase (ammonia) activity; GO:0004087 ; EC:6.3.4.16; dihydroorotase activity; GO:0004151 ; EC:3.5.2.3; transcription factor activity; GO:0003700; ; GO:0004070 ; EC:2.1.3.2; ; GO:0004087 ; EC:6.3.4.16; ; GO:0004151 ; EC:3.5.2.3; ; GO:0003700; amino acid binding; GO:0016597; anthranilate synthase activity; GO:0004049 ; EC:4.1.3.27; ; GO:0016597; ; GO:0004049 ; EC:4.1.3.27 aspartate carbamoyltransferase complex; GO:0009347; cytoplasm; GO:0005737 r rudimentary "CG18572, CG4601, CG18572, fs(1)M34, Su(b): Suppressor of black, CAD, csp2, carbamoylphosphate synthetase, PYR1, DRORUD, rudimentary gene, ACT, CPS, DHO, GAT, fs(1)829, l(1)Ab, Suppressor-of-black, Su(b), rudimentary" CDMC22768 1 4 7 DAC10-M22 3-CG18572-RA_1 CG18572 GCCATGGTCGTTGGTGGACGCAATACGGCGCTCTAGAGGATTTACCCATGGAAAACCCACAATCTTTGA 69 FBan0018572 FBgn0003189 r X X "'de novo' pyrimidine base biosynthesis; GO:0006207; amino acid biosynthesis; GO:0008652; arginine biosynthesis; GO:0006526; nitrogen compound metabolism; GO:0006807; regulation of transcription, DNA-dependent; GO:0006355" ATP binding; GO:0005524; ; GO:0005524; aspartate carbamoyltransferase activity; GO:0004070 ; EC:2.1.3.2; carbamoyl-phosphate synthase (ammonia) activity; GO:0004087 ; EC:6.3.4.16; dihydroorotase activity; GO:0004151 ; EC:3.5.2.3; transcription factor activity; GO:0003700; ; GO:0004070 ; EC:2.1.3.2; ; GO:0004087 ; EC:6.3.4.16; ; GO:0004151 ; EC:3.5.2.3; ; GO:0003700; amino acid binding; GO:0016597; anthranilate synthase activity; GO:0004049 ; EC:4.1.3.27; ; GO:0016597; ; GO:0004049 ; EC:4.1.3.27 aspartate carbamoyltransferase complex; GO:0009347; cytoplasm; GO:0005737 r rudimentary "CG18572, CG4601, CG18572, fs(1)M34, Su(b): Suppressor of black, CAD, csp2, carbamoylphosphate synthetase, PYR1, DRORUD, rudimentary gene, ACT, CPS, DHO, GAT, fs(1)829, l(1)Ab, Suppressor-of-black, Su(b), rudimentary" CDMC22769 1 5 7 DAC11-A10 3-CG10160-RA_1 CG10160 CCAACGGTGTGACATCCGTGGTCAAGCAGATCCTGACTCCCACCGAAGTTGAACAACTGCAGAAGTC 67 FBan0010160 FBgn0001258 ImpL3 3 3L glycolysis; GO:0006096; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-lactate dehydrogenase activity; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27 ImpL3 Ecdysone-inducible gene L3 "CG10160, CG10160, CG10160, LDH, Imp-L3, IMP-L3, Ldh, lactate dehydrogenase, lactic DH, dmLDH" CDMC22769 1 6 7 DAC11-A10 3-CG10160-RA_1 CG10160 CCAACGGTGTGACATCCGTGGTCAAGCAGATCCTGACTCCCACCGAAGTTGAACAACTGCAGAAGTC 67 FBan0010160 FBgn0001258 ImpL3 3 3L glycolysis; GO:0006096; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-lactate dehydrogenase activity; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27 ImpL3 Ecdysone-inducible gene L3 "CG10160, CG10160, CG10160, LDH, Imp-L3, IMP-L3, Ldh, lactate dehydrogenase, lactic DH, dmLDH" CDMC22770 1 7 7 DAC11-A22 2-CG10321-RA_1 CG10321 CCGATGTGCACCATTTGCAATCGAACCTTCAAGTCCAAGGCGATCTTGTACAGGCACAGACAGACGC 67 FBan0010321 FBgn0034643 CG10321 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10321 CG10321 CDMC22770 1 8 7 DAC11-A22 2-CG10321-RA_1 CG10321 CCGATGTGCACCATTTGCAATCGAACCTTCAAGTCCAAGGCGATCTTGTACAGGCACAGACAGACGC 67 FBan0010321 FBgn0034643 CG10321 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10321 CG10321 CDMC22771 1 9 7 DAC11-E10 3-CG10726-RB_2 CG10726 GGTAGACGGGAATTCCAAGCTAGAGTACTCCTACAGGCCGATGGACCAGATCTCCCAGTTTTGGGCC 67 FBan0010726 FBgn0014127 barr 2 2L Malpighian tubule morphogenesis; GO:0007443; ectodermal gut morphogenesis; GO:0048567; head involution; GO:0008258; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; tracheal system development (sensu Insecta); GO:0007424 condensin complex; GO:0000796; nucleus; GO:0005634 barr barren "CG10726, 38B.3, CAP-H, Barren, barren" CDMC22771 1 10 7 DAC11-E10 3-CG10726-RB_2 CG10726 GGTAGACGGGAATTCCAAGCTAGAGTACTCCTACAGGCCGATGGACCAGATCTCCCAGTTTTGGGCC 67 FBan0010726 FBgn0014127 barr 2 2L Malpighian tubule morphogenesis; GO:0007443; ectodermal gut morphogenesis; GO:0048567; head involution; GO:0008258; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; tracheal system development (sensu Insecta); GO:0007424 condensin complex; GO:0000796; nucleus; GO:0005634 barr barren "CG10726, 38B.3, CAP-H, Barren, barren" CDMC22772 1 11 7 DAC11-E22 2-CG10874-RB_1 CG10874 CGCAAACTCCTGAAAGGTGGTTCCCGATGTTAAGCACATGGAAAGAGCTCTCCTCGGACTGCTGGAC 67 FBan0010874 FBgn0031395 CG10874 2 2L CG10874 CG10874 CDMC22772 1 12 7 DAC11-E22 2-CG10874-RB_1 CG10874 CGCAAACTCCTGAAAGGTGGTTCCCGATGTTAAGCACATGGAAAGAGCTCTCCTCGGACTGCTGGAC 67 FBan0010874 FBgn0031395 CG10874 2 2L CG10874 CG10874 CDMC22773 1 13 7 DAC11-I10 11-CG11221-RA_1 CG11221 TCCAGAAGGAGTTCCACTACAACTACGAGCTGTCGCATCACCATCACATACTGAGCGCATATGCGGT 67 FBan0011221 FBgn0031855 CG11221 2 2L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG11221 CG11221 PKN CDMC22773 1 14 7 DAC11-I10 11-CG11221-RA_1 CG11221 TCCAGAAGGAGTTCCACTACAACTACGAGCTGTCGCATCACCATCACATACTGAGCGCATATGCGGT 67 FBan0011221 FBgn0031855 CG11221 2 2L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG11221 CG11221 PKN CDMC22774 1 15 7 DAC11-I22 23-CG11260-RA_2 CG11260 TTGCAATCAGACGTACTCAGTATGAAGTTTGTCAGAAGTTAAAAGGAAAGGAAAATTCTTTGGCCCT 67 FBan0011260 FBgn0039912 CG11260 4 4 CG11260 CG11260 CDMC22774 1 16 7 DAC11-I22 23-CG11260-RA_2 CG11260 TTGCAATCAGACGTACTCAGTATGAAGTTTGTCAGAAGTTAAAAGGAAAGGAAAATTCTTTGGCCCT 67 FBan0011260 FBgn0039912 CG11260 4 4 CG11260 CG11260 CDMC22775 1 17 7 DAC11-M10 13-CG11966-RA_1 CG11966 ACGGACAATCCAAATGGTCTGATGATCAATCCGCGCTACTTGAGTAATCCGACCAACAATCAGGCGA 67 FBan0011966 FBgn0037645 CG11966 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; caspase activity; GO:0030693; ; GO:0008270; ; GO:0030693 nucleus; GO:0005634 CG11966 CG11966 CDMC22775 1 18 7 DAC11-M10 13-CG11966-RA_1 CG11966 ACGGACAATCCAAATGGTCTGATGATCAATCCGCGCTACTTGAGTAATCCGACCAACAATCAGGCGA 67 FBan0011966 FBgn0037645 CG11966 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; caspase activity; GO:0030693; ; GO:0008270; ; GO:0030693 nucleus; GO:0005634 CG11966 CG11966 CDMC22776 1 19 7 DAC11-M22 11-CG12054-RA_1 CG12054 GCCGTCAACGAAGAGACGTAGCCTATACTCAAGCAGCTACTGATGCACCGAAAACTGACGCTGGAGC 67 FBan0012054 FBgn0039831 CG12054 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12054 CG12054 CDMC22776 1 20 7 DAC11-M22 11-CG12054-RA_1 CG12054 GCCGTCAACGAAGAGACGTAGCCTATACTCAAGCAGCTACTGATGCACCGAAAACTGACGCTGGAGC 67 FBan0012054 FBgn0039831 CG12054 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12054 CG12054 CDMC22777 1 21 7 DAC12-A10 3-CG10122-RA_2 CG10122 GGTGCCAGGTCAAGTTGAATCTGAGTGTGCGGTACCAGAAGCCCGATCTTACCTCCATAATCCGGG 66 FBan0010122 FBgn0019938 RpI1 2 2R transcription from RNA polymerase I promoter; GO:0006360 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736; nucleus; GO:0005634 RpI1 RNA polymerase I subunit "CG10122, DmRPA1, RNA polymerase I, RPA1" CDMC22777 1 22 7 DAC12-A10 3-CG10122-RA_2 CG10122 GGTGCCAGGTCAAGTTGAATCTGAGTGTGCGGTACCAGAAGCCCGATCTTACCTCCATAATCCGGG 66 FBan0010122 FBgn0019938 RpI1 2 2R transcription from RNA polymerase I promoter; GO:0006360 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736; nucleus; GO:0005634 RpI1 RNA polymerase I subunit "CG10122, DmRPA1, RNA polymerase I, RPA1" CDMC22778 1 23 7 DAC12-A22 24-CG10205-RA_2 CG10205 CGTAGTCGTAACTATAATATTATAAATGCTTATTGCCGCAATAAACCCATGTCTAAAATTAGCTAA 66 FBan0010205 FBgn0033970 CG10205 2 2R CG10205 CG10205 CT28709 CDMC22778 1 24 7 DAC12-A22 24-CG10205-RA_2 CG10205 CGTAGTCGTAACTATAATATTATAAATGCTTATTGCCGCAATAAACCCATGTCTAAAATTAGCTAA 66 FBan0010205 FBgn0033970 CG10205 2 2R CG10205 CG10205 CT28709 CDMC22779 1 25 7 DAC12-E10 6-CG10610-RA_2 CG10610 CCCAAGGGCAAGTTCATACCCACCAACATGTTCCAGGCAGAGTTCATGCACTACCCCAAACAGCAG 66 FBan0010610 FBgn0028436 ECSIT 3 3R Toll signaling pathway; GO:0008063; defense response; GO:0006952; innate immune response; GO:0045087; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 ECSIT ECSIT "CG10610, dECSIT, DmECSIT" CDMC22779 1 26 7 DAC12-E10 6-CG10610-RA_2 CG10610 CCCAAGGGCAAGTTCATACCCACCAACATGTTCCAGGCAGAGTTCATGCACTACCCCAAACAGCAG 66 FBan0010610 FBgn0028436 ECSIT 3 3R Toll signaling pathway; GO:0008063; defense response; GO:0006952; innate immune response; GO:0045087; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 ECSIT ECSIT "CG10610, dECSIT, DmECSIT" CDMC22780 1 1 8 DAC12-E22 2-CG10772-RF_2 CG10772 ACGAGGAGACATTCAGCTCTTTTTGAGGTCTCCCGCAAACACCAGTGTCACGCTCCTAACGCCTAG 66 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC22780 1 2 8 DAC12-E22 2-CG10772-RF_2 CG10772 ACGAGGAGACATTCAGCTCTTTTTGAGGTCTCCCGCAAACACCAGTGTCACGCTCCTAACGCCTAG 66 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC22781 1 3 8 DAC12-I10 24-CG11131-RA_1 CG11131 CCCTTCCTAATACTTATTCACTCAGTTGTCACAGCATATGGAATAATAAAATTTATTCACAAAAAA 66 FBan0011131 FBgn0037204 CG11131 3 3L CG11131 CG11131 CDMC22781 1 4 8 DAC12-I10 24-CG11131-RA_1 CG11131 CCCTTCCTAATACTTATTCACTCAGTTGTCACAGCATATGGAATAATAAAATTTATTCACAAAAAA 66 FBan0011131 FBgn0037204 CG11131 3 3L CG11131 CG11131 CDMC22782 1 5 8 DAC12-I22 3-CG11159-RA_1 CG11159 TGTTGCGCCATGACTTTCCCCGCAGTTATCTATCAAATTGGGTTTGCCTGGTGGAAGCGGAGAGTG 66 FBan0011159 FBgn0034539 CG11159 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG11159 CG11159 CDMC22782 1 6 8 DAC12-I22 3-CG11159-RA_1 CG11159 TGTTGCGCCATGACTTTCCCCGCAGTTATCTATCAAATTGGGTTTGCCTGGTGGAAGCGGAGAGTG 66 FBan0011159 FBgn0034539 CG11159 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG11159 CG11159 CDMC22783 1 7 8 DAC12-M10 3-CG11828-RA_1 CG11828 GGATCGGCCTTGGTTTGGCATAATACTGACAACTCCGGCAATTGTGATACCCGAAGCTTGCAGGCC 66 FBan0011828 FBgn0039616 CG11828 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11828 CG11828 CDMC22783 1 8 8 DAC12-M10 3-CG11828-RA_1 CG11828 GGATCGGCCTTGGTTTGGCATAATACTGACAACTCCGGCAATTGTGATACCCGAAGCTTGCAGGCC 66 FBan0011828 FBgn0039616 CG11828 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11828 CG11828 CDMC22784 1 9 8 DAC12-M22 2-CG12034-RA_2 CG12034 CGAATACAAACTGCCTTTTCCGGAGCGAGTACCCGGCGAGAAATTTAGCTTCTCCGACCACGAGGC 66 FBan0012034 FBgn0035421 CG12034 3 3L intracellular signaling cascade; GO:0007242; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG12034 CG12034 nSMase CDMC22784 1 10 8 DAC12-M22 2-CG12034-RA_2 CG12034 CGAATACAAACTGCCTTTTCCGGAGCGAGTACCCGGCGAGAAATTTAGCTTCTCCGACCACGAGGC 66 FBan0012034 FBgn0035421 CG12034 3 3L intracellular signaling cascade; GO:0007242; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG12034 CG12034 nSMase CDMC22785 1 11 8 DAC13-A10 12-CG14528-RA_3 CG14528 GCAGCGACTCTGCAGGAATCATTGTCCCTCTATACGGTGGCCGATCTTCAAGAGAAATACAGCGACCAT 69 FBan0014528 FBgn0039611 CG14528 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14528 CG14528 CDMC22785 1 12 8 DAC13-A10 12-CG14528-RA_3 CG14528 GCAGCGACTCTGCAGGAATCATTGTCCCTCTATACGGTGGCCGATCTTCAAGAGAAATACAGCGACCAT 69 FBan0014528 FBgn0039611 CG14528 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14528 CG14528 CDMC22786 1 13 8 DAC13-A22 23-CG14542-RA_8 CG14542 CCGTTTGTATCTCCCAGAAGCGAATGTTATATTAAAGAGAATGCTTGTGATTTTCGTTCCCTGCGTGTT 69 FBan0014542 FBgn0039402 CG14542 3 3R CG14542 CG14542 NEST:bs02f06 CDMC22786 1 14 8 DAC13-A22 23-CG14542-RA_8 CG14542 CCGTTTGTATCTCCCAGAAGCGAATGTTATATTAAAGAGAATGCTTGTGATTTTCGTTCCCTGCGTGTT 69 FBan0014542 FBgn0039402 CG14542 3 3R CG14542 CG14542 NEST:bs02f06 CDMC22787 1 15 8 DAC13-E10 14-CG14579-RA_1 CG14579 GCGTCGAGCAGAGCCTATTATCAGATATGTGTGCTGCAGATCGTTGACAAGCTTGAGGAGATAGGCGTG 69 FBan0014579 FBgn0031163 CG14579 X X CG14579 CG14579 CDMC22787 1 16 8 DAC13-E10 14-CG14579-RA_1 CG14579 GCGTCGAGCAGAGCCTATTATCAGATATGTGTGCTGCAGATCGTTGACAAGCTTGAGGAGATAGGCGTG 69 FBan0014579 FBgn0031163 CG14579 X X CG14579 CG14579 CDMC22788 1 17 8 DAC13-E22 12-CG14590-RA_4 CG14590 AGCCGCTGTCTCGATCCAACGGAATATGGCACCTATATAAGTGCGCTGACTTGTCTGGGGGATGTAAAT 69 FBan0014590 FBgn0033061 CG14590 2 2R CG14590 CG14590 CDMC22788 1 18 8 DAC13-E22 12-CG14590-RA_4 CG14590 AGCCGCTGTCTCGATCCAACGGAATATGGCACCTATATAAGTGCGCTGACTTGTCTGGGGGATGTAAAT 69 FBan0014590 FBgn0033061 CG14590 2 2R CG14590 CG14590 CDMC22789 1 19 8 DAC13-I10 14-CG14632-RB_1 CG14632 AGGATGCGGAAAGAAGAGCCAGAAACAAGGACAAGCGCAATCAGAAGAGACGTTAAGCTCAAACCACAA 69 FBan0014632 FBgn0029538 CG14632 X X CG14632 CG14632 CDMC22789 1 20 8 DAC13-I10 14-CG14632-RB_1 CG14632 AGGATGCGGAAAGAAGAGCCAGAAACAAGGACAAGCGCAATCAGAAGAGACGTTAAGCTCAAACCACAA 69 FBan0014632 FBgn0029538 CG14632 X X CG14632 CG14632 CDMC22790 1 21 8 DAC13-I22 13-CG14646-RA_1 CG14646 TACTACGGAAAAGTGTTTTGCCTGCATGCTAAACGAACCAAACACCAAGATCCACAAGCAGTGTGCCGA 69 FBan0014646 FBgn0037241 CG14646 3 3R CG14646 CG14646 anon-WO0118547.373 CDMC22790 1 22 8 DAC13-I22 13-CG14646-RA_1 CG14646 TACTACGGAAAAGTGTTTTGCCTGCATGCTAAACGAACCAAACACCAAGATCCACAAGCAGTGTGCCGA 69 FBan0014646 FBgn0037241 CG14646 3 3R CG14646 CG14646 anon-WO0118547.373 CDMC22791 1 23 8 DAC13-M10 9-CG14680-RA_1 CG14680 GCCGTGGACATTCGGCATTTGGTGATCGAATCGATTTGCTCTGTTGCCCTGAACACACATCTTGGCTTA 69 FBan0014680 FBgn0037817 Cyp12e1 3 3R electron transport; GO:0006118; protein biosynthesis; GO:0006412 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; structural constituent of ribosome; GO:0003735; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003735; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739; ribosome; GO:0005840 Cyp12e1 Cyp12e1 "CG14680, 12e1" CDMC22791 1 24 8 DAC13-M10 9-CG14680-RA_1 CG14680 GCCGTGGACATTCGGCATTTGGTGATCGAATCGATTTGCTCTGTTGCCCTGAACACACATCTTGGCTTA 69 FBan0014680 FBgn0037817 Cyp12e1 3 3R electron transport; GO:0006118; protein biosynthesis; GO:0006412 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; structural constituent of ribosome; GO:0003735; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003735; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739; ribosome; GO:0005840 Cyp12e1 Cyp12e1 "CG14680, 12e1" CDMC22792 1 25 8 DAC13-M22 16-CG14691-RA_2 CG14691 CGGTAGCTGGAATTGGTCTGGTCGGTTTTCTGATCATTTTTCCCTTAATGCGATTCCAAGTGGTCTCGA 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC22792 1 26 8 DAC13-M22 16-CG14691-RA_2 CG14691 CGGTAGCTGGAATTGGTCTGGTCGGTTTTCTGATCATTTTTCCCTTAATGCGATTCCAAGTGGTCTCGA 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC22793 1 1 9 DAC14-A10 3-CG17242-RA_2 CG17242 TCAATTGATGTGCGCGACAAACCTTGCTCTGAAGGGCAGACTTATGAGTGTGGGCGAGATCTGCG 65 FBan0017242 FBgn0042188 CG17242 2 2L metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17242 CG17242 SPH187 CDMC22793 1 2 9 DAC14-A10 3-CG17242-RA_2 CG17242 TCAATTGATGTGCGCGACAAACCTTGCTCTGAAGGGCAGACTTATGAGTGTGGGCGAGATCTGCG 65 FBan0017242 FBgn0042188 CG17242 2 2L metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17242 CG17242 SPH187 CDMC22794 1 3 9 DAC14-A22 1-CG17267-RA_1 CG17267 TTGGAATAGCTTCGTCCGCAGTGTTCAGCCCGCTTTCAGTTTCCGTAACCTGACCAATCCGTTGG 65 FBan0017267 FBgn0038821 CG17267 3 3R CG17267 CG17267 CDMC22794 1 4 9 DAC14-A22 1-CG17267-RA_1 CG17267 TTGGAATAGCTTCGTCCGCAGTGTTCAGCCCGCTTTCAGTTTCCGTAACCTGACCAATCCGTTGG 65 FBan0017267 FBgn0038821 CG17267 3 3R CG17267 CG17267 CDMC22795 1 5 9 DAC14-E10 3-CG17404-RA_1 CG17404 GAGTATCGATCGCAGGGGAAAGACTTCGTTGGTGGAGGAGTTCCAGTAACCTTGACGGGATGGGG 65 FBan0017404 FBgn0038001 CG17404 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG17404 CG17404 SP149 CDMC22795 1 6 9 DAC14-E10 3-CG17404-RA_1 CG17404 GAGTATCGATCGCAGGGGAAAGACTTCGTTGGTGGAGGAGTTCCAGTAACCTTGACGGGATGGGG 65 FBan0017404 FBgn0038001 CG17404 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG17404 CG17404 SP149 CDMC22796 1 7 9 DAC14-E22 3-CG17508-RA_3 CG17508 GAAGCCTCAATTCCCCTTCCAATCAATGTGGACTCTGCGGAAACAACTCGATTCTCCCCCCAGCG 65 FBan0017508 FBgn0039970 CG17508 2 2R CG17508 CG17508 CDMC22796 1 8 9 DAC14-E22 3-CG17508-RA_3 CG17508 GAAGCCTCAATTCCCCTTCCAATCAATGTGGACTCTGCGGAAACAACTCGATTCTCCCCCCAGCG 65 FBan0017508 FBgn0039970 CG17508 2 2R CG17508 CG17508 CDMC22797 1 9 9 DAC14-I10 2-CG1764-RA_1 CG1764 GAGAGGTTCAACCGACCGGAGTGAGAAGCATTGCCATGAGAAACATGCACAACAGGCCCAAGGAG 65 FBan0001764 FBgn0030467 CG1764 X X cell proliferation; GO:0008283 dimethylargininase activity; GO:0016403 ; EC:3.5.3.18; ; GO:0016403 ; EC:3.5.3.18 CG1764 CG1764 CDMC22797 1 10 9 DAC14-I10 2-CG1764-RA_1 CG1764 GAGAGGTTCAACCGACCGGAGTGAGAAGCATTGCCATGAGAAACATGCACAACAGGCCCAAGGAG 65 FBan0001764 FBgn0030467 CG1764 X X cell proliferation; GO:0008283 dimethylargininase activity; GO:0016403 ; EC:3.5.3.18; ; GO:0016403 ; EC:3.5.3.18 CG1764 CG1764 CDMC22798 1 11 9 DAC14-I22 3-CG17680-RA_1 CG17680 ATCCGGACACTTGACAATCTCCATGTGGGAGTGCCTCCTAGTCGGGATAAATGTGTTGGCAACGC 65 FBgn0034303 CDMC22798 1 12 9 DAC14-I22 3-CG17680-RA_1 CG17680 ATCCGGACACTTGACAATCTCCATGTGGGAGTGCCTCCTAGTCGGGATAAATGTGTTGGCAACGC 65 FBgn0034303 CDMC22799 1 13 9 DAC14-M10 3-CG17824-RA_1 CG17824 CAAAGTGATGGAACCTGTCTCTTGGAGAACGGGGAAAGAGTGGGAGTCTGCAACGGAAAGCACGG 65 FBan0017824 FBgn0036234 CG17824 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17824 CG17824 CDMC22799 1 14 9 DAC14-M10 3-CG17824-RA_1 CG17824 CAAAGTGATGGAACCTGTCTCTTGGAGAACGGGGAAAGAGTGGGAGTCTGCAACGGAAAGCACGG 65 FBan0017824 FBgn0036234 CG17824 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17824 CG17824 CDMC22800 1 15 9 DAC14-M22 3-CG17843-RA_2 CG17843 ATTCGCTTGAAAATGGTCGAAGGGTGTTTAAGGCAAGGCGATACGTTGGCTGCATTGGATCGCGG 65 FBan0017843 FBgn0038919 CG17843 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG17843 CG17843 anon-WO0140519.66 CDMC22800 1 16 9 DAC14-M22 3-CG17843-RA_2 CG17843 ATTCGCTTGAAAATGGTCGAAGGGTGTTTAAGGCAAGGCGATACGTTGGCTGCATTGGATCGCGG 65 FBan0017843 FBgn0038919 CG17843 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG17843 CG17843 anon-WO0140519.66 CDMC22801 1 17 9 DAC15-A10 2-CG12481-RA_1 CG12481 GCCAGACGGAAATGGAACCGATGCTCATCAATGTGACCACAAGCAGACCCAAGCTGGTCATTGAGGAG 68 FBan0012481 FBgn0030542 CG12481 X X CG12481 CG12481 CDMC22801 1 18 9 DAC15-A10 2-CG12481-RA_1 CG12481 GCCAGACGGAAATGGAACCGATGCTCATCAATGTGACCACAAGCAGACCCAAGCTGGTCATTGAGGAG 68 FBan0012481 FBgn0030542 CG12481 X X CG12481 CG12481 CDMC22802 1 19 9 DAC15-A22 1-CG12725-RA_3 CG12725 CCTACAAGGGTCGCGAGCTGTCCAATCAGAGCATACTGGAGGATGTGGGCCATAAGTCCATTCTGGAT 68 FBan0012725 FBgn0030483 CG12725 X X CG12725 CG12725 CDMC22802 1 20 9 DAC15-A22 1-CG12725-RA_3 CG12725 CCTACAAGGGTCGCGAGCTGTCCAATCAGAGCATACTGGAGGATGTGGGCCATAAGTCCATTCTGGAT 68 FBan0012725 FBgn0030483 CG12725 X X CG12725 CG12725 CDMC22803 1 21 9 DAC15-E10 3-CG13333-RA_1 CG13333 CCCCGTCCTGAGCTGAGTTTAATGCAGCGTTTCGGTGACTTTGTGAAGCAGTACAACCTGTGGTCTGG 68 FBan0013333 FBgn0033855 CG13333 2 2R CG13333 CG13333 CDMC22803 1 22 9 DAC15-E10 3-CG13333-RA_1 CG13333 CCCCGTCCTGAGCTGAGTTTAATGCAGCGTTTCGGTGACTTTGTGAAGCAGTACAACCTGTGGTCTGG 68 FBan0013333 FBgn0033855 CG13333 2 2R CG13333 CG13333 CDMC22804 1 23 9 DAC15-E22 3-CG1340-RA_5 CG1340 CGAGGTGGTTTCAATAGCCGTGTTGCTGTAGGTGGAAATGGCAATCGTTACCAAGGAGGAGCTCCACG 68 FBan0001340 FBgn0039797 CG1340 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829 CG1340 CG1340 "cg1340, eIF4H" CDMC22804 1 24 9 DAC15-E22 3-CG1340-RA_5 CG1340 CGAGGTGGTTTCAATAGCCGTGTTGCTGTAGGTGGAAATGGCAATCGTTACCAAGGAGGAGCTCCACG 68 FBan0001340 FBgn0039797 CG1340 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829 CG1340 CG1340 "cg1340, eIF4H" CDMC22805 1 25 9 DAC15-I10 13-CG13766-RA_1 CG13766 CAAGTGCGTACATCACGGGAAAGTACCTCACTGGACTCTCCAATTTAAAGACCCTAGTCGCACCCGAA 68 FBan0013766 FBgn0031834 CG13766 2 2L CG13766 CG13766 CDMC22805 1 26 9 DAC15-I10 13-CG13766-RA_1 CG13766 CAAGTGCGTACATCACGGGAAAGTACCTCACTGGACTCTCCAATTTAAAGACCCTAGTCGCACCCGAA 68 FBan0013766 FBgn0031834 CG13766 2 2L CG13766 CG13766 CDMC22806 1 1 10 DAC15-I22 1-CG13845-RA_1 CG13845 CCCAGGGTACACCCATTCACGAGATGGTCCAAAACTTACATGACATGGCAGCAAAAGTATCGGCGGGG 68 FBan0013845 FBgn0038971 CG13845 3 3R CG13845 CG13845 CDMC22806 1 2 10 DAC15-I22 1-CG13845-RA_1 CG13845 CCCAGGGTACACCCATTCACGAGATGGTCCAAAACTTACATGACATGGCAGCAAAAGTATCGGCGGGG 68 FBan0013845 FBgn0038971 CG13845 3 3R CG13845 CG13845 CDMC22807 1 3 10 DAC15-M10 1-CG1427-RA_1 CG1427 CGCCGTCACTACAACTTCGGTCATGGTATCGGCAGATCTGGAGACTTACTAGAGGCACAACCCAAGGC 68 FBan0001427 FBgn0037347 CG1427 3 3R CG1427 CG1427 CDMC22807 1 4 10 DAC15-M10 1-CG1427-RA_1 CG1427 CGCCGTCACTACAACTTCGGTCATGGTATCGGCAGATCTGGAGACTTACTAGAGGCACAACCCAAGGC 68 FBan0001427 FBgn0037347 CG1427 3 3R CG1427 CG1427 CDMC22808 1 5 10 DAC15-M22 2-CG14370-RA_2 CG14370 GCCAGGGCATCATGCAACTCAGCCGACTATTCCGGATATGCGCCTATAGTCGCACCTGGATCATGATA 68 FBan0014370 FBgn0038158 CG14370 3 3R CG14370 CG14370 CDMC22808 1 6 10 DAC15-M22 2-CG14370-RA_2 CG14370 GCCAGGGCATCATGCAACTCAGCCGACTATTCCGGATATGCGCCTATAGTCGCACCTGGATCATGATA 68 FBan0014370 FBgn0038158 CG14370 3 3R CG14370 CG14370 CDMC22809 1 7 10 DAC16-A10 3-CG31045-RC_2 CG31045 GCTCGCCTTGAAGTGCAGGTGAACCGTCACAAAGAGGCTCTGGAAAAACTGCAGAACGAGGTGAC 65 FBan0031045 FBgn0026059 Mhcl 3 3R cell motility; GO:0006928; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 Mhcl Myosin heavy chain-like "CG10218, CG10224, CG31045 (PDZ), CG10218 (PDZ), CG10224 (PDZ), CG10218, CG10218, CG10224, myosin heavy chain, DmPDZ, MHCL(PDZ), PDZ-myosin, myosin XVII (PDZ), Myosin-heavy-chain-like (PDZ), Myosin heavy chain-like, myosin XVII" CDMC22809 1 8 10 DAC16-A10 3-CG31045-RC_2 CG31045 GCTCGCCTTGAAGTGCAGGTGAACCGTCACAAAGAGGCTCTGGAAAAACTGCAGAACGAGGTGAC 65 FBan0031045 FBgn0026059 Mhcl 3 3R cell motility; GO:0006928; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 Mhcl Myosin heavy chain-like "CG10218, CG10224, CG31045 (PDZ), CG10218 (PDZ), CG10224 (PDZ), CG10218, CG10218, CG10224, myosin heavy chain, DmPDZ, MHCL(PDZ), PDZ-myosin, myosin XVII (PDZ), Myosin-heavy-chain-like (PDZ), Myosin heavy chain-like, myosin XVII" CDMC22810 1 9 10 DAC16-A22 23-CG31076-RA_6 CG31076 CAGTCGCTGAGTAAACTGAAATTTCTGGATCATGGACTGGTTCAACGCACCTACAAATACGAAAG 65 FBan0031076 FBgn0051076 CG31076 3 3R CG31076 CG31076 "CG6309, CT19744" CDMC22810 1 10 10 DAC16-A22 23-CG31076-RA_6 CG31076 CAGTCGCTGAGTAAACTGAAATTTCTGGATCATGGACTGGTTCAACGCACCTACAAATACGAAAG 65 FBan0031076 FBgn0051076 CG31076 3 3R CG31076 CG31076 "CG6309, CT19744" CDMC22811 1 11 10 DAC16-E10 8-CG31176-RA_1 CG31176 AGTGCGGCGATCTCACCTACAAGTCCTCCCGAAATATGCATCAACTACACAAGGCACCCGTGTGC 65 FBan0031176 FBgn0051176 CG31176 3 3R CG31176 CG31176 "CG6328, CG15495, CG6328, EP(3)3662, RE56061, EP3662" CDMC22811 1 12 10 DAC16-E10 8-CG31176-RA_1 CG31176 AGTGCGGCGATCTCACCTACAAGTCCTCCCGAAATATGCATCAACTACACAAGGCACCCGTGTGC 65 FBan0031176 FBgn0051176 CG31176 3 3R CG31176 CG31176 "CG6328, CG15495, CG6328, EP(3)3662, RE56061, EP3662" CDMC22812 1 13 10 DAC16-E22 2-CG31227-RA_3 CG31227 GATTGGCACACCCCCCTGTTGCACGGGAGTTTTGGAGCCATGACTTTGCCAGTGCATTAATTAGC 65 FBgn0051227 CG31227 CG31227 CG31227 CDMC22812 1 14 10 DAC16-E22 2-CG31227-RA_3 CG31227 GATTGGCACACCCCCCTGTTGCACGGGAGTTTTGGAGCCATGACTTTGCCAGTGCATTAATTAGC 65 FBgn0051227 CG31227 CG31227 CG31227 CDMC22813 1 15 10 DAC16-I10 17-CG31306-RA_1 CG31306 CAGCACCCCCAAGACAAAGTCTCAGAGCGCCCTCAACCACACGCCCTCTAATTTGTCCACCGTTT 65 FBgn0010940 CDMC22813 1 16 10 DAC16-I10 17-CG31306-RA_1 CG31306 CAGCACCCCCAAGACAAAGTCTCAGAGCGCCCTCAACCACACGCCCTCTAATTTGTCCACCGTTT 65 FBgn0010940 CDMC22814 1 17 10 DAC16-I22 8-CG31347-RA_1 CG31347 CGTGGTTTACCCAATGGAGTACGGGCACCAAATGGACTTCGACAGAGGCTTCCAGATGCAGGGAC 65 FBan0031347 FBgn0051347 CG31347 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31347 CG31347 CDMC22814 1 18 10 DAC16-I22 8-CG31347-RA_1 CG31347 CGTGGTTTACCCAATGGAGTACGGGCACCAAATGGACTTCGACAGAGGCTTCCAGATGCAGGGAC 65 FBan0031347 FBgn0051347 CG31347 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31347 CG31347 CDMC22815 1 19 10 DAC16-M10 6-CG31466-RA_1 CG31466 GAAAGCTTCGGTCGCTAGCCACAGGTTCTGAGCAACAGGTTGTCGATGTGTGCTCTCGCTCTGAC 65 FBan0031466 FBgn0051466 CG31466 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31466 CG31466 CDMC22815 1 20 10 DAC16-M10 6-CG31466-RA_1 CG31466 GAAAGCTTCGGTCGCTAGCCACAGGTTCTGAGCAACAGGTTGTCGATGTGTGCTCTCGCTCTGAC 65 FBan0031466 FBgn0051466 CG31466 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31466 CG31466 CDMC22816 1 21 10 DAC16-M22 1-CG31499-RA_1 CG31499 GAGGATGTGATAGCCCGGCACAATCTGTTCCGCAATCACGACGATATGGACCTGTACGAGGGACC 65 FBan0031499 FBgn0051499 CG31499 3 3R CG31499 CG31499 CDMC22816 1 22 10 DAC16-M22 1-CG31499-RA_1 CG31499 GAGGATGTGATAGCCCGGCACAATCTGTTCCGCAATCACGACGATATGGACCTGTACGAGGGACC 65 FBan0031499 FBgn0051499 CG31499 3 3R CG31499 CG31499 CDMC22817 1 23 10 DAC17-A10 23-CG32659-RA_1 CG32659 ATCCCTTGGATCTTCCATTTGATACCAACCATCCAATGTACATAAGCAGAAATGGAGAGAGAGGT 65 FBan0032659 FBgn0004446 Ten-a X X cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576; plasma membrane; GO:0005886 Ten-a Tenascin accessory "CG2578, CG32659, CG11270, CG2590, CG18182, CG2578, ten[a], Ten[a], tenA, 1.2, tenA(AT)[[14]], ten-a, Dmtena, Ten11A" CDMC22817 1 24 10 DAC17-A10 23-CG32659-RA_1 CG32659 ATCCCTTGGATCTTCCATTTGATACCAACCATCCAATGTACATAAGCAGAAATGGAGAGAGAGGT 65 FBan0032659 FBgn0004446 Ten-a X X cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576; plasma membrane; GO:0005886 Ten-a Tenascin accessory "CG2578, CG32659, CG11270, CG2590, CG18182, CG2578, ten[a], Ten[a], tenA, 1.2, tenA(AT)[[14]], ten-a, Dmtena, Ten11A" CDMC22818 1 25 10 DAC17-A22 23-CG32689-RA_2 CG32689 CCACCGAATGTTGTATTCTTTGTTGTGACACGAAAGTTATGCTAAAACTTTATCCTGGCAGTGGT 65 FBan0032689 FBgn0052689 CG32689 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32689 CG32689 CDMC22818 1 26 10 DAC17-A22 23-CG32689-RA_2 CG32689 CCACCGAATGTTGTATTCTTTGTTGTGACACGAAAGTTATGCTAAAACTTTATCCTGGCAGTGGT 65 FBan0032689 FBgn0052689 CG32689 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32689 CG32689 CDMC22819 1 1 11 DAC17-E10 9-CG32820-RB_1 CG32820 GATCTGCGCAACAAAGTCAATGCCCTGTTCATCGACCGAGAGAAGTGCATGAGTCTCCGGCGCTC 65 FBan0032820 FBgn0052820 CG32820 X X microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG32820 CG32820 CDMC22819 1 2 11 DAC17-E10 9-CG32820-RB_1 CG32820 GATCTGCGCAACAAAGTCAATGCCCTGTTCATCGACCGAGAGAAGTGCATGAGTCTCCGGCGCTC 65 FBan0032820 FBgn0052820 CG32820 X X microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG32820 CG32820 CDMC22820 1 3 11 DAC17-E22 2-CG32833-RA_2 CG32833 AGAGGACGACGAAAACGACTGCAACCGGACGACTCTTGGTGGTCATCCCGTGAACATAACCACAG 65 FBan0032833 FBgn0052833 CG32833 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG32833 CG32833 "CG9898, CG30331, CG9898, SPH196, BcDNA:GH11992" CDMC22820 1 4 11 DAC17-E22 2-CG32833-RA_2 CG32833 AGAGGACGACGAAAACGACTGCAACCGGACGACTCTTGGTGGTCATCCCGTGAACATAACCACAG 65 FBan0032833 FBgn0052833 CG32833 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG32833 CG32833 "CG9898, CG30331, CG9898, SPH196, BcDNA:GH11992" CDMC22821 1 5 11 DAC17-I10 2-CG33066-RA_1 CG33066 TTGCTTGCTTTTATTGCATCTCTGCTCGATTTGCCCGCAATGGAGACGACGTTGGACTTGCCACC 65 FBgn0053066 CDMC22821 1 6 11 DAC17-I10 2-CG33066-RA_1 CG33066 TTGCTTGCTTTTATTGCATCTCTGCTCGATTTGCCCGCAATGGAGACGACGTTGGACTTGCCACC 65 FBgn0053066 CDMC22822 1 7 11 DAC17-I22 1-CG33105-RA_1 CG33105 AAAGTCACTGCAAATAGCCGAAAATGCGCGACCAATTCATCAGCCTGGCCCTGATTCTGTGCGTC 65 FBan0033105 FBgn0053105 CG33105 3 3R intracellular protein transport; GO:0006886 protein carrier activity; GO:0008320; ; GO:0008320 Golgi apparatus; GO:0005794; membrane; GO:0016020 CG33105 CG33105 CG9443 CDMC22822 1 8 11 DAC17-I22 1-CG33105-RA_1 CG33105 AAAGTCACTGCAAATAGCCGAAAATGCGCGACCAATTCATCAGCCTGGCCCTGATTCTGTGCGTC 65 FBan0033105 FBgn0053105 CG33105 3 3R intracellular protein transport; GO:0006886 protein carrier activity; GO:0008320; ; GO:0008320 Golgi apparatus; GO:0005794; membrane; GO:0016020 CG33105 CG33105 CG9443 CDMC22823 1 9 11 DAC17-M10 3-CG3319-RA_2 CG3319 ATTCGGATCTGGATCAGCTGACACGGATCTTTTCCACACTGGGAACACCCACGGAAGCTGAATGG 65 FBan0003319 FBgn0015617 Cdk7 X X mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cyclin dependent protein kinase activity; GO:0000079; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016251; ; GO:0004693 ; EC:2.7.1.- transcription factor TFIIH complex; GO:0005675 Cdk7 Cyclin-dependent kinase 7 "CG3319, CG3319, CG3319, DmCdk7, DmCDK7, Dmcdk7, p40[MO15], DmMO15, cdk7, CDK7" CDMC22823 1 10 11 DAC17-M10 3-CG3319-RA_2 CG3319 ATTCGGATCTGGATCAGCTGACACGGATCTTTTCCACACTGGGAACACCCACGGAAGCTGAATGG 65 FBan0003319 FBgn0015617 Cdk7 X X mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cyclin dependent protein kinase activity; GO:0000079; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016251; ; GO:0004693 ; EC:2.7.1.- transcription factor TFIIH complex; GO:0005675 Cdk7 Cyclin-dependent kinase 7 "CG3319, CG3319, CG3319, DmCdk7, DmCDK7, Dmcdk7, p40[MO15], DmMO15, cdk7, CDK7" CDMC22824 1 11 11 DAC17-M22 2-CG33250-RA_1 CG33250 AAAGGCTCTTCGATGAATCCGTCAGGTCGGACTGGTGGAAACAGCTTAATCTGTGCAGCGATGGC 65 FBgn0053250 CDMC22824 1 12 11 DAC17-M22 2-CG33250-RA_1 CG33250 AAAGGCTCTTCGATGAATCCGTCAGGTCGGACTGGTGGAAACAGCTTAATCTGTGCAGCGATGGC 65 FBgn0053250 CDMC22825 1 13 11 DAC18-A10 1-CG5861-RA_1 CG5861 GGCCACCCTGATCTGGCTCTTCACCCGTCACGATTTGAACAAGGCATTAAAGCCGCTGGTTAGTCTAC 68 FBan0005861 FBgn0015338 CG5861 2 2L receptor activity; GO:0004872; ; GO:0004872 CG5861 CG5861 "III, BG:DS02740.11, anon-35Fa, anon-35Fc" CDMC22825 1 14 11 DAC18-A10 1-CG5861-RA_1 CG5861 GGCCACCCTGATCTGGCTCTTCACCCGTCACGATTTGAACAAGGCATTAAAGCCGCTGGTTAGTCTAC 68 FBan0005861 FBgn0015338 CG5861 2 2L receptor activity; GO:0004872; ; GO:0004872 CG5861 CG5861 "III, BG:DS02740.11, anon-35Fa, anon-35Fc" CDMC22826 1 15 11 DAC18-A22 3-CG5912-RA_7 CG5912 GCGTATTGGAAAGAGTCGAACAGAGCCTAAGGATGACCAGGCCACTGATCCATTGTCACCCTCGACGC 68 FBan0005912 FBgn0000119 arr 2 2R Wnt receptor signaling pathway; GO:0016055; cholesterol metabolism; GO:0008203; compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0005041; ; GO:0005041 plasma membrane; GO:0005886 arr arrow "CG5912, CG5912, CG5912, CG5912, CG5912, l(2)k08131, CK00539, LRP6, LDL-related protein 6, CT15575, LDLR-like, LRP5/6, LRP, BEST:CK00539" CDMC22826 1 16 11 DAC18-A22 3-CG5912-RA_7 CG5912 GCGTATTGGAAAGAGTCGAACAGAGCCTAAGGATGACCAGGCCACTGATCCATTGTCACCCTCGACGC 68 FBan0005912 FBgn0000119 arr 2 2R Wnt receptor signaling pathway; GO:0016055; cholesterol metabolism; GO:0008203; compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0005041; ; GO:0005041 plasma membrane; GO:0005886 arr arrow "CG5912, CG5912, CG5912, CG5912, CG5912, l(2)k08131, CK00539, LRP6, LDL-related protein 6, CT15575, LDLR-like, LRP5/6, LRP, BEST:CK00539" CDMC22827 1 17 11 DAC18-E10 8-CG6281-RB_1 CG6281 ACGAAACTATGCCGATACATGCAAGTGGTCGCCTTTTGGAAAATGCGAGACGAACTACAGTGCCTGCA 68 FBan0006281 FBgn0025879 Timp 3 3R proteolysis; GO:0006508 metalloendopeptidase inhibitor activity; GO:0008191; ; GO:0008191; ; GO:0008191; ; GO:0008191 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 Timp Tissue inhibitor of metalloproteases "CG6281, CG6281, DTIMP, timp: tissue inhibitor of metalloproteases, tissue inhibitor of metalloproteases, TIMP, dTIMP, timp" CDMC22827 1 18 11 DAC18-E10 8-CG6281-RB_1 CG6281 ACGAAACTATGCCGATACATGCAAGTGGTCGCCTTTTGGAAAATGCGAGACGAACTACAGTGCCTGCA 68 FBan0006281 FBgn0025879 Timp 3 3R proteolysis; GO:0006508 metalloendopeptidase inhibitor activity; GO:0008191; ; GO:0008191; ; GO:0008191; ; GO:0008191 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 Timp Tissue inhibitor of metalloproteases "CG6281, CG6281, DTIMP, timp: tissue inhibitor of metalloproteases, tissue inhibitor of metalloproteases, TIMP, dTIMP, timp" CDMC22828 1 19 11 DAC18-E22 3-CG6401-RA_6 CG6401 ACATTGTAGTGGCCTCCCGTCTTGTCTACCGCAAAGGCATTGATTTGCTAGCTGGCATCATTCCACGG 68 FBan0006401 FBgn0034270 CG6401 2 2R GPI anchor biosynthesis; GO:0006506; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0016757 ; EC:2.4.-.-; ; GO:0017176 ; EC:2.4.1.198" integral to endoplasmic reticulum membrane; GO:0030176 CG6401 CG6401 Dm*AAF57802/5-442 CDMC22828 1 20 11 DAC18-E22 3-CG6401-RA_6 CG6401 ACATTGTAGTGGCCTCCCGTCTTGTCTACCGCAAAGGCATTGATTTGCTAGCTGGCATCATTCCACGG 68 FBan0006401 FBgn0034270 CG6401 2 2R GPI anchor biosynthesis; GO:0006506; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0016757 ; EC:2.4.-.-; ; GO:0017176 ; EC:2.4.1.198" integral to endoplasmic reticulum membrane; GO:0030176 CG6401 CG6401 Dm*AAF57802/5-442 CDMC22829 1 21 11 DAC18-I10 6-CG6763-RA_1 CG6763 TATGGCCACAATTGAAAATGCCATTGGTGAGTACCATCGTCGGACGTGCATTCGGTTTGTGAAGCGCA 68 FBan0006763 FBgn0039069 CG6763 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG6763 CG6763 CDMC22829 1 22 11 DAC18-I10 6-CG6763-RA_1 CG6763 TATGGCCACAATTGAAAATGCCATTGGTGAGTACCATCGTCGGACGTGCATTCGGTTTGTGAAGCGCA 68 FBan0006763 FBgn0039069 CG6763 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG6763 CG6763 CDMC22830 1 23 11 DAC18-I22 2-CG6965-RA_1 CG6965 GCGCCGGATCATCAACAGCCCTATCTTCCGATCCCAACCTAGTGCTGGTCAACAAATGTTGCGAGAAG 68 FBan0006965 FBgn0037960 mthl5 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl5 methuselah-like 5 "CG6965, mth-like 5, Mth-like 5, anon-WO0170980.70, anon-WO0170980.71" CDMC22830 1 24 11 DAC18-I22 2-CG6965-RA_1 CG6965 GCGCCGGATCATCAACAGCCCTATCTTCCGATCCCAACCTAGTGCTGGTCAACAAATGTTGCGAGAAG 68 FBan0006965 FBgn0037960 mthl5 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl5 methuselah-like 5 "CG6965, mth-like 5, Mth-like 5, anon-WO0170980.70, anon-WO0170980.71" CDMC22831 1 25 11 DAC18-M10 3-CG7367-RA_2 CG7367 ATGGGCTATGCTGGTTCGTACACTAAGTACAGGGTAAACCGCATCACTGGCTTGGATCCAGCTCGTCC 68 FBan0007367 FBgn0031976 CG7367 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG7367 CG7367 CDMC22831 1 26 11 DAC18-M10 3-CG7367-RA_2 CG7367 ATGGGCTATGCTGGTTCGTACACTAAGTACAGGGTAAACCGCATCACTGGCTTGGATCCAGCTCGTCC 68 FBan0007367 FBgn0031976 CG7367 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG7367 CG7367 CDMC22832 1 1 12 DAC18-M22 2-CG7447-RA_1 CG7447 TGACCACTCCGTTCATGTGTAGCTAGATGCTCCTGCTTGTAAGCCATTCCCGAATGCGAGTCGAGTGC 68 FBan0007447 FBgn0035539 CG7447 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG7447 CG7447 "CT22877, N-like" CDMC22832 1 2 12 DAC18-M22 2-CG7447-RA_1 CG7447 TGACCACTCCGTTCATGTGTAGCTAGATGCTCCTGCTTGTAAGCCATTCCCGAATGCGAGTCGAGTGC 68 FBan0007447 FBgn0035539 CG7447 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG7447 CG7447 "CT22877, N-like" CDMC22833 1 3 12 DAC19-A10 6-CG17770-RA_1 CG17770 TCGCACCCACAATCTGACCGAAGAACAGGTCAAGGATTTGGAGATTGCCTTTTCCCTGTTTGACGACCA 69 FBan0017770 FBgn0039374 CG17770 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17770 CG17770 CDMC22833 1 4 12 DAC19-A10 6-CG17770-RA_1 CG17770 TCGCACCCACAATCTGACCGAAGAACAGGTCAAGGATTTGGAGATTGCCTTTTCCCTGTTTGACGACCA 69 FBan0017770 FBgn0039374 CG17770 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17770 CG17770 CDMC22834 1 5 12 DAC19-A22 7-CG17795-RA_1 CG17795 TCAGTCGGCACTATTGGAAATGTCTTACCAATCCCTGTGCCTCGATGAACATTCGGTCAGAACGTGCGT 69 FBan0017795 FBgn0035623 mthl2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 mthl2 methuselah-like 2 "CG17795, CG17795, mth-like 2, Mth-like 2, anon-WO0170980.28, anon-WO0170980.29" CDMC22834 1 6 12 DAC19-A22 7-CG17795-RA_1 CG17795 TCAGTCGGCACTATTGGAAATGTCTTACCAATCCCTGTGCCTCGATGAACATTCGGTCAGAACGTGCGT 69 FBan0017795 FBgn0035623 mthl2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 mthl2 methuselah-like 2 "CG17795, CG17795, mth-like 2, Mth-like 2, anon-WO0170980.28, anon-WO0170980.29" CDMC22835 1 7 12 DAC19-E10 11-CG17839-RA_1 CG17839 AGGACACAACAATAAGCATTAATGGCCTCAAGAAGGATGTGCTCTACGAGTTGGTGGTGAAGGCTGGCA 69 FBan0017839 FBgn0036454 CG17839 3 3L CG17839 CG17839 CT39634 CDMC22835 1 8 12 DAC19-E10 11-CG17839-RA_1 CG17839 AGGACACAACAATAAGCATTAATGGCCTCAAGAAGGATGTGCTCTACGAGTTGGTGGTGAAGGCTGGCA 69 FBan0017839 FBgn0036454 CG17839 3 3L CG17839 CG17839 CT39634 CDMC22836 1 9 12 DAC19-E22 3-CG17867-RA_2 CG17867 GCCGAGCCATGTTCTCCTGTCCGTGGCAGCTTTTTAAGCCTAAACAACGTCGACTCGTTCAGCTTTTGA 69 FBan0017867 FBgn0030298 Or10a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or10a Odorant receptor 10a "CG17867, 10B.1, DOR92, 10a" CDMC22836 1 10 12 DAC19-E22 3-CG17867-RA_2 CG17867 GCCGAGCCATGTTCTCCTGTCCGTGGCAGCTTTTTAAGCCTAAACAACGTCGACTCGTTCAGCTTTTGA 69 FBan0017867 FBgn0030298 Or10a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or10a Odorant receptor 10a "CG17867, 10B.1, DOR92, 10a" CDMC22837 1 11 12 DAC19-I10 23-CG17919-RA_1 CG17919 GCGGAGCTCCTATATATTGGTTTTCTCAAGATCTTATCGTCTACCGAATAATCTCTCCACAAAGATGCT 69 FBan0017919 FBgn0037433 CG17919 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG17919 CG17919 CDMC22837 1 12 12 DAC19-I10 23-CG17919-RA_1 CG17919 GCGGAGCTCCTATATATTGGTTTTCTCAAGATCTTATCGTCTACCGAATAATCTCTCCACAAAGATGCT 69 FBan0017919 FBgn0037433 CG17919 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG17919 CG17919 CDMC22838 1 13 12 DAC19-I22 12-CG17929-RA_4 CG17929 AGGCTCGCAAATGCCACGCGAAACTATTGGGAAGCTTTAACCACTCAGTGGATCAGGAATTTGAGGAGA 69 FBan0017929 FBgn0038415 CG17929 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG17929 CG17929 CDMC22838 1 14 12 DAC19-I22 12-CG17929-RA_4 CG17929 AGGCTCGCAAATGCCACGCGAAACTATTGGGAAGCTTTAACCACTCAGTGGATCAGGAATTTGAGGAGA 69 FBan0017929 FBgn0038415 CG17929 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG17929 CG17929 CDMC22839 1 15 12 DAC19-M10 23-CG1796-RA_1 CG1796 GCCGCAAATTCTAGACTCCTAGTTTGTAAGCCTATCCATAATAGAATACGATTTTCCAAACGATTTCAT 69 FBan0001796 FBgn0030365 CG1796 X X signal transduction; GO:0007165 CG1796 CG1796 CDMC22839 1 16 12 DAC19-M10 23-CG1796-RA_1 CG1796 GCCGCAAATTCTAGACTCCTAGTTTGTAAGCCTATCCATAATAGAATACGATTTTCCAAACGATTTCAT 69 FBan0001796 FBgn0030365 CG1796 X X signal transduction; GO:0007165 CG1796 CG1796 CDMC22840 1 17 12 DAC19-M22 11-CG17988-RA_3 CG17988 ACGAAGGATTGCATGCCTATGTACGTCGCAAGCTGAGGGATTACTATGGTCCAGATCGGATAAACCGCA 69 FBan0017988 FBgn0032536 Ance-3 2 2L proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.- membrane; GO:0016020 Ance-3 Ance-3 "CG17988, CG31843, CG31766, CG17988, CG17988, DS00180.5, BG:DS00180.5, CT40163" CDMC22840 1 18 12 DAC19-M22 11-CG17988-RA_3 CG17988 ACGAAGGATTGCATGCCTATGTACGTCGCAAGCTGAGGGATTACTATGGTCCAGATCGGATAAACCGCA 69 FBan0017988 FBgn0032536 Ance-3 2 2L proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.- membrane; GO:0016020 Ance-3 Ance-3 "CG17988, CG31843, CG31766, CG17988, CG17988, DS00180.5, BG:DS00180.5, CT40163" CDMC22841 1 19 12 DAC20-A10 23-CG10597-RA_2 CG10597 CGAGGAGCGCTAAGGATCTTAAAGAGTTAGTCTCGTTAACGATATCCTTCAAGGTCTTTGTGTGC 65 FBan0010597 FBgn0030832 CG10597 X X CG10597 CG10597 CDMC22841 1 20 12 DAC20-A10 23-CG10597-RA_2 CG10597 CGAGGAGCGCTAAGGATCTTAAAGAGTTAGTCTCGTTAACGATATCCTTCAAGGTCTTTGTGTGC 65 FBan0010597 FBgn0030832 CG10597 X X CG10597 CG10597 CDMC22842 1 21 12 DAC20-A22 3-CG10650-RA_10 CG10650 CTCTAACTCGTGGCTGCTTGATTAATGGCACTGCGTGCACCTTACCATCCTGCTCGACCTGCAAG 65 FBan0010650 FBgn0046302 CG10650 2 2L metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10650 CG10650 BEST:GH09876 CDMC22842 1 22 12 DAC20-A22 3-CG10650-RA_10 CG10650 CTCTAACTCGTGGCTGCTTGATTAATGGCACTGCGTGCACCTTACCATCCTGCTCGACCTGCAAG 65 FBan0010650 FBgn0046302 CG10650 2 2L metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10650 CG10650 BEST:GH09876 CDMC22843 1 23 12 DAC20-E10 3-CG10739-RA_3 CG10739 CGCCTTTCACCTTATCGCACGGACATCTGGACTCGCTTATGGGACCTTCTCAACGAGTCAGCCAA 65 FBan0010739 FBgn0010309 pigeon 2 2L associative learning; GO:0008306; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 pigeon pigeon "CG10739, lio: linotte, pio, lionette, linotte, lio" CDMC22843 1 24 12 DAC20-E10 3-CG10739-RA_3 CG10739 CGCCTTTCACCTTATCGCACGGACATCTGGACTCGCTTATGGGACCTTCTCAACGAGTCAGCCAA 65 FBan0010739 FBgn0010309 pigeon 2 2L associative learning; GO:0008306; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 pigeon pigeon "CG10739, lio: linotte, pio, lionette, linotte, lio" CDMC22844 1 25 12 DAC20-E22 6-CG1078-RA_5 CG1078 TGGCCAGCCTCACTCAGAATGTGAATCAGAATGCCCCCATTGGAATCCTCACAGATGGCGGTATG 65 FBan0001078 FBgn0037255 CG1078 3 3R CG1078 CG1078 "clone 1.35, anon-EST:Liang-1.35" CDMC22844 1 26 12 DAC20-E22 6-CG1078-RA_5 CG1078 TGGCCAGCCTCACTCAGAATGTGAATCAGAATGCCCCCATTGGAATCCTCACAGATGGCGGTATG 65 FBan0001078 FBgn0037255 CG1078 3 3R CG1078 CG1078 "clone 1.35, anon-EST:Liang-1.35" CDMC22845 1 1 13 DAC20-I10 3-CG1090-RA_2 CG1090 TTATGGTGTGGATGATCACCGTGATTGGGTCCACGCTTGCCATTCCGGACACCGTAATGGGTTTG 65 FBan0001090 FBgn0037238 CG1090 3 3R cation transport; GO:0006812 "alpha-type channel activity; GO:0015268; ; GO:0015268; calcium, potassium:sodium antiporter activity; GO:0008273; ; GO:0008273" integral to membrane; GO:0016021 CG1090 CG1090 CDMC22845 1 2 13 DAC20-I10 3-CG1090-RA_2 CG1090 TTATGGTGTGGATGATCACCGTGATTGGGTCCACGCTTGCCATTCCGGACACCGTAATGGGTTTG 65 FBan0001090 FBgn0037238 CG1090 3 3R cation transport; GO:0006812 "alpha-type channel activity; GO:0015268; ; GO:0015268; calcium, potassium:sodium antiporter activity; GO:0008273; ; GO:0008273" integral to membrane; GO:0016021 CG1090 CG1090 CDMC22846 1 3 13 DAC20-I22 2-CG1092-RA_3 CG1092 AATTTAAAACGCCGCGAGTCTACTTCCATGCTAGAGACCTGAGCCGGGAGTACAAGGACCTGCGG 65 FBan0001092 FBgn0037228 CG1092 3 3R CG1092 CG1092 CDMC22846 1 4 13 DAC20-I22 2-CG1092-RA_3 CG1092 AATTTAAAACGCCGCGAGTCTACTTCCATGCTAGAGACCTGAGCCGGGAGTACAAGGACCTGCGG 65 FBan0001092 FBgn0037228 CG1092 3 3R CG1092 CG1092 CDMC22847 1 5 13 DAC20-M10 6-CG11079-RB_1 CG11079 CCCAAACTGCAAGCCTAAACTTTCCCCAGACCGCTCCACTTCCATTTGTTTACGAACAGCGCTGC 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC22847 1 6 13 DAC20-M10 6-CG11079-RB_1 CG11079 CCCAAACTGCAAGCCTAAACTTTCCCCAGACCGCTCCACTTCCATTTGTTTACGAACAGCGCTGC 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC22848 1 7 13 DAC20-M22 3-CG11100-RA_1 CG11100 CTCATCCAAATGGTGCACGACAATCCAATTCTCTGGGACTCCCGTCTCCCGAATTTCAAGGGCGC 65 FBan0011100 FBgn0037207 Mes2 3 3L embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 Mes2 Mes2 "CG11100, CG11100, CG11100, CG11100, CG11100, CG11100, adfR" CDMC22848 1 8 13 DAC20-M22 3-CG11100-RA_1 CG11100 CTCATCCAAATGGTGCACGACAATCCAATTCTCTGGGACTCCCGTCTCCCGAATTTCAAGGGCGC 65 FBan0011100 FBgn0037207 Mes2 3 3L embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 Mes2 Mes2 "CG11100, CG11100, CG11100, CG11100, CG11100, CG11100, adfR" CDMC22849 1 9 13 DAC21-A10 9-CG11181-RA_1 CG11181 CAGCAGGAGGTTCACTCCCAGATTGGCGAGTCAAGACCCAAACGGAGCGAATATTGAGCCAAGGC 65 FBan0011181 FBgn0000392 cup 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; female meiosis; GO:0007143; follicle cell migration (sensu Insecta); GO:0007297; meiotic chromosome segregation; GO:0045132; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of translation; GO:0006445 protein binding; GO:0005515; translation regulator activity; GO:0045182; ; GO:0005515; ; GO:0045182 cytoplasm; GO:0005737; nuclear membrane lumen; GO:0005641; plasma membrane; GO:0005886 cup cup "CG11181, CG11181, CG11181, fs(1)cup, fs(2)cup, i239, Cup" CDMC22849 1 10 13 DAC21-A10 9-CG11181-RA_1 CG11181 CAGCAGGAGGTTCACTCCCAGATTGGCGAGTCAAGACCCAAACGGAGCGAATATTGAGCCAAGGC 65 FBan0011181 FBgn0000392 cup 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; female meiosis; GO:0007143; follicle cell migration (sensu Insecta); GO:0007297; meiotic chromosome segregation; GO:0045132; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of translation; GO:0006445 protein binding; GO:0005515; translation regulator activity; GO:0045182; ; GO:0005515; ; GO:0045182 cytoplasm; GO:0005737; nuclear membrane lumen; GO:0005641; plasma membrane; GO:0005886 cup cup "CG11181, CG11181, CG11181, fs(1)cup, fs(2)cup, i239, Cup" CDMC22850 1 11 13 DAC21-A22 2-CG1120-RA_1 CG1120 CACATGGTTTTTCTGCCCCTCACTCGATCAGCGTTGGTTCAGTACTGCGTGGGAGCCATCATCAG 65 FBan0001120 FBgn0035462 CG1120 3 3L CG1120 CG1120 CDMC22850 1 12 13 DAC21-A22 2-CG1120-RA_1 CG1120 CACATGGTTTTTCTGCCCCTCACTCGATCAGCGTTGGTTCAGTACTGCGTGGGAGCCATCATCAG 65 FBan0001120 FBgn0035462 CG1120 3 3L CG1120 CG1120 CDMC22851 1 13 13 DAC21-E10 3-CG11320-RA_3 CG11320 ACGCAGACGATACTGAGCATCCAGAACCACGTCATCACCAAGAACCATCGCATCTCCATCTCCCA 65 FBan0011320 FBgn0031837 CG11320 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 plasma membrane; GO:0005886 CG11320 CG11320 CT31597 CDMC22851 1 14 13 DAC21-E10 3-CG11320-RA_3 CG11320 ACGCAGACGATACTGAGCATCCAGAACCACGTCATCACCAAGAACCATCGCATCTCCATCTCCCA 65 FBan0011320 FBgn0031837 CG11320 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 plasma membrane; GO:0005886 CG11320 CG11320 CT31597 CDMC22852 1 15 13 DAC21-E22 2-CG11388-RA_1 CG11388 GTACTTCAGCTCAACCCCGAACTCGTACTACAGCGACTCCCTCTTTTTCCTGTCCCTCGGCCTTC 65 FBan0011388 FBgn0034959 CG11388 2 2R CG11388 CG11388 anon-EST:Posey287 CDMC22852 1 16 13 DAC21-E22 2-CG11388-RA_1 CG11388 GTACTTCAGCTCAACCCCGAACTCGTACTACAGCGACTCCCTCTTTTTCCTGTCCCTCGGCCTTC 65 FBan0011388 FBgn0034959 CG11388 2 2R CG11388 CG11388 anon-EST:Posey287 CDMC22853 1 17 13 DAC21-I10 3-CG11523-RA_1 CG11523 CAGTCGTGGCTTCAAGATCGTCTCCTCCCAGTACGACACCATAGACGAGGACAGCCGGATCTCTG 65 FBan0011523 FBgn0037156 CG11523 3 3L CG11523 CG11523 CDMC22853 1 18 13 DAC21-I10 3-CG11523-RA_1 CG11523 CAGTCGTGGCTTCAAGATCGTCTCCTCCCAGTACGACACCATAGACGAGGACAGCCGGATCTCTG 65 FBan0011523 FBgn0037156 CG11523 3 3L CG11523 CG11523 CDMC22854 1 19 13 DAC21-I22 2-CG11551-RA_3 CG11551 GGGTGTGGAAGTGGCAAACCAACCCCCAGAACAGAGTCTCGAGGTATATAAGAACCGGGTGAGGG 65 FBan0011551 FBgn0025776 ind 3 3L "brain development; GO:0007420; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 ind intermediate neuroblasts defective "CG11551, intermediate nerve cord defective" CDMC22854 1 20 13 DAC21-I22 2-CG11551-RA_3 CG11551 GGGTGTGGAAGTGGCAAACCAACCCCCAGAACAGAGTCTCGAGGTATATAAGAACCGGGTGAGGG 65 FBan0011551 FBgn0025776 ind 3 3L "brain development; GO:0007420; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 ind intermediate neuroblasts defective "CG11551, intermediate nerve cord defective" CDMC22855 1 21 13 DAC21-M10 3-CG11654-RA_1 CG11654 GTGAACGTGAAGCCCCAAGTAGATCGGTACACAATGCAGAGTGGCAAGCACATCATCCTGCTGGC 65 FBan0011654 FBgn0014455 Ahcy13 X X one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 Ahcy13 Adenosylhomocysteinase at 13 "CG11654, CG11654, CG11654, S-Adenosyl-L-homocysteine hydrolase, AdoHcyase, SAHH, ahcY" CDMC22855 1 22 13 DAC21-M10 3-CG11654-RA_1 CG11654 GTGAACGTGAAGCCCCAAGTAGATCGGTACACAATGCAGAGTGGCAAGCACATCATCCTGCTGGC 65 FBan0011654 FBgn0014455 Ahcy13 X X one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 Ahcy13 Adenosylhomocysteinase at 13 "CG11654, CG11654, CG11654, S-Adenosyl-L-homocysteine hydrolase, AdoHcyase, SAHH, ahcY" CDMC22856 1 23 13 DAC21-M22 3-CG11680-RB_1 CG11680 CTTCGCCTTGAGGAGCCCTATGCACAGCTGGTCAAAGTGGTCAAAGACCTTTGCGTTAAGAGCGC 65 FBan0011680 FBgn0002774 mle 2 2R "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" double-stranded RNA binding; GO:0003725; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003725; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; ; GO:0008026 chromatin; GO:0000785; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 mle maleless "CG11680, CG11680, nap, nap[ts]: no action potential, MLE, no action potential, mls, mak: male-killer, mll: male-lethal, male-killer, male-lethal, nap[ts]" CDMC22856 1 24 13 DAC21-M22 3-CG11680-RB_1 CG11680 CTTCGCCTTGAGGAGCCCTATGCACAGCTGGTCAAAGTGGTCAAAGACCTTTGCGTTAAGAGCGC 65 FBan0011680 FBgn0002774 mle 2 2R "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" double-stranded RNA binding; GO:0003725; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003725; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; ; GO:0008026 chromatin; GO:0000785; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 mle maleless "CG11680, CG11680, nap, nap[ts]: no action potential, MLE, no action potential, mls, mak: male-killer, mll: male-lethal, male-killer, male-lethal, nap[ts]" CDMC22857 1 25 13 DAC22-A10 1-CG31617-RA_1 CG31617 AGCGGTGTCTGCAAAACCCAAAAAGACGGTGAAGAAAGCATCGGTTTCTGCTACCGCCAAGAAGC 65 FBan0031617 FBgn0051617 His1:CG31617 2 2L chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His1:CG31617 His1:CG31617 CG31617 CDMC22857 1 26 13 DAC22-A10 1-CG31617-RA_1 CG31617 AGCGGTGTCTGCAAAACCCAAAAAGACGGTGAAGAAAGCATCGGTTTCTGCTACCGCCAAGAAGC 65 FBan0031617 FBgn0051617 His1:CG31617 2 2L chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His1:CG31617 His1:CG31617 CG31617 CDMC22858 1 1 14 DAC22-A22 6-CG31643-RA_1 CG31643 TCCGGAGAGGGTCCTTAACCTGGTTATGCAACTGAATCGCACAGTATGCCTGGACTTTCCCGAGG 65 FBan0031643 FBgn0051643 CG31643 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31643 CG31643 "CG31643PA, CG31643PA, BcDNA:LD32258" CDMC22858 1 2 14 DAC22-A22 6-CG31643-RA_1 CG31643 TCCGGAGAGGGTCCTTAACCTGGTTATGCAACTGAATCGCACAGTATGCCTGGACTTTCCCGAGG 65 FBan0031643 FBgn0051643 CG31643 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31643 CG31643 "CG31643PA, CG31643PA, BcDNA:LD32258" CDMC22859 1 3 14 DAC22-E10 1-CG31732-RA_1 CG31732 GTCAGACCTCGATCAATCCTGCCTAATCTCCGTTGATCCCGAATCAGGGCCCTGTGATCTGGACG 65 FBgn0028877 CDMC22859 1 4 14 DAC22-E10 1-CG31732-RA_1 CG31732 GTCAGACCTCGATCAATCCTGCCTAATCTCCGTTGATCCCGAATCAGGGCCCTGTGATCTGGACG 65 FBgn0028877 CDMC22860 1 5 14 DAC22-E22 3-CG31763-RA_1 CG31763 AACAACATTGGCGGCAATATCAACGGAAACGGAAATGGAAATGGCGGAGTCAGCGAACAACGCCC 65 FBan0031763 FBgn0051763 CG31763 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31763 CG31763 CDMC22860 1 6 14 DAC22-E22 3-CG31763-RA_1 CG31763 AACAACATTGGCGGCAATATCAACGGAAACGGAAATGGAAATGGCGGAGTCAGCGAACAACGCCC 65 FBan0031763 FBgn0051763 CG31763 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31763 CG31763 CDMC22861 1 7 14 DAC22-I10 23-CG31912-RA_1 CG31912 TGTAATGTGCAATAGATGTTAGATCTCAATCACAAGGTCTTTCTGTCAAGGAACTGAAGGCAACT 65 FBan0031912 FBgn0051912 CG31912 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31912 CG31912 CDMC22861 1 8 14 DAC22-I10 23-CG31912-RA_1 CG31912 TGTAATGTGCAATAGATGTTAGATCTCAATCACAAGGTCTTTCTGTCAAGGAACTGAAGGCAACT 65 FBan0031912 FBgn0051912 CG31912 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31912 CG31912 CDMC22862 1 9 14 DAC22-I22 23-CG31938-RA_1 CG31938 AAAGACACACGCGGATTTTTTGTTTGGAGTTTTCAAATCGTAAAAGCAACATTAAAATGAGCGCG 65 FBan0031938 FBgn0051938 CG31938 2 2L rRNA processing; GO:0006364 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- exosome (RNase complex); GO:0000178 CG31938 CG31938 CDMC22862 1 10 14 DAC22-I22 23-CG31938-RA_1 CG31938 AAAGACACACGCGGATTTTTTGTTTGGAGTTTTCAAATCGTAAAAGCAACATTAAAATGAGCGCG 65 FBan0031938 FBgn0051938 CG31938 2 2L rRNA processing; GO:0006364 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- exosome (RNase complex); GO:0000178 CG31938 CG31938 CDMC22863 1 11 14 DAC22-M10 15-CG32073-RA_1 CG32073 TGGCCATTTGCCTGTATTCCGTTGATTGCACCACATCCGGTACAGGATCAGCTGCTACCAGCGGA 65 FBan0032073 FBgn0052073 CG32073 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32073 CG32073 CDMC22863 1 12 14 DAC22-M10 15-CG32073-RA_1 CG32073 TGGCCATTTGCCTGTATTCCGTTGATTGCACCACATCCGGTACAGGATCAGCTGCTACCAGCGGA 65 FBan0032073 FBgn0052073 CG32073 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32073 CG32073 CDMC22864 1 13 14 DAC22-M22 3-CG3210-RA_2 CG3210 GACCAACAACACTCCGGTTCACAATAACATCGTGAGTCCAGTGAAGCCGGTCAATCTGCTGCCCG 65 FBgn0031438 CDMC22864 1 14 14 DAC22-M22 3-CG3210-RA_2 CG3210 GACCAACAACACTCCGGTTCACAATAACATCGTGAGTCCAGTGAAGCCGGTCAATCTGCTGCCCG 65 FBgn0031438 CDMC22865 1 15 14 DAC23-A10 15-CG10734-RA_1 CG10734 TGCCCGGATTCAAGCGGCAAAACTCAAGAAGGAGACATTGGAAGCCAATATGAGAAAGAGCAAACAGGA 69 FBan0010734 FBgn0034082 CG10734 2 2R CG10734 CG10734 CDMC22865 1 16 14 DAC23-A10 15-CG10734-RA_1 CG10734 TGCCCGGATTCAAGCGGCAAAACTCAAGAAGGAGACATTGGAAGCCAATATGAGAAAGAGCAAACAGGA 69 FBan0010734 FBgn0034082 CG10734 2 2R CG10734 CG10734 CDMC22866 1 17 14 DAC23-A22 3-CG10749-RA_1 CG10749 CCACTCTGGATGTGGTACGAGCCCAGACCTTTGTAGCGGACATTCTCAACGTTGATCCCCAGAAAGTGA 69 FBan0010749 FBgn0036328 CG10749 3 3L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG10749 CG10749 CDMC22866 1 18 14 DAC23-A22 3-CG10749-RA_1 CG10749 CCACTCTGGATGTGGTACGAGCCCAGACCTTTGTAGCGGACATTCTCAACGTTGATCCCCAGAAAGTGA 69 FBan0010749 FBgn0036328 CG10749 3 3L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG10749 CG10749 CDMC22867 1 19 14 DAC23-E10 23-CG10790-RB_6 CG10790 CCCTCAGAGTCAAATAGAATATAGTGTCGAAATGAAGTTGACAAAGTTATGGTTGCTTTTTGTGTGCCT 69 FBan0010790 FBgn0003086 Pig1 X X Pig1 Pre-intermoult gene 1 "CG10790, CG10790, Pig-1, gsg: gland specific gene, pig1, EG:96G10.1, gland specific gene, gsg" CDMC22867 1 20 14 DAC23-E10 23-CG10790-RB_6 CG10790 CCCTCAGAGTCAAATAGAATATAGTGTCGAAATGAAGTTGACAAAGTTATGGTTGCTTTTTGTGTGCCT 69 FBan0010790 FBgn0003086 Pig1 X X Pig1 Pre-intermoult gene 1 "CG10790, CG10790, Pig-1, gsg: gland specific gene, pig1, EG:96G10.1, gland specific gene, gsg" CDMC22868 1 21 14 DAC23-E22 3-CG10802-RA_1 CG10802 GCGCGGAGATCCAGAAATTGTCGGGAAACTCGGTCCCCAATTTATGGAAATTCTCGAGGGCAAGGGAAA 69 FBan0010802 FBgn0029664 CG10802 X X alanyl-tRNA aminoacylation; GO:0006419; protein metabolism; GO:0019538; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0003824; ; GO:0004812 ; EC:6.1.1.-; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7 CG10802 CG10802 anon-EST:Posey113 CDMC22868 1 22 14 DAC23-E22 3-CG10802-RA_1 CG10802 GCGCGGAGATCCAGAAATTGTCGGGAAACTCGGTCCCCAATTTATGGAAATTCTCGAGGGCAAGGGAAA 69 FBan0010802 FBgn0029664 CG10802 X X alanyl-tRNA aminoacylation; GO:0006419; protein metabolism; GO:0019538; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0003824; ; GO:0004812 ; EC:6.1.1.-; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7 CG10802 CG10802 anon-EST:Posey113 CDMC22869 1 23 14 DAC23-I10 23-CG10833-RA_1 CG10833 CATCAAGGTTAATCCCAAAACTCGCAAGGATAATGAAATTGATGATACCTACTTTATGCCAGCCTTAAA 69 FBan0010833 FBgn0031689 Cyp28d1 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28d1 Cyp28d1 "CG10833, CG10833, 28d1" CDMC22869 1 24 14 DAC23-I10 23-CG10833-RA_1 CG10833 CATCAAGGTTAATCCCAAAACTCGCAAGGATAATGAAATTGATGATACCTACTTTATGCCAGCCTTAAA 69 FBan0010833 FBgn0031689 Cyp28d1 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28d1 Cyp28d1 "CG10833, CG10833, 28d1" CDMC22870 1 25 14 DAC23-I22 12-CG10842-RA_3 CG10842 CATAACCAAGGGGCTCGTCTACAACTTCCTACATCCATTCCTAAGGACGGGCTTGCTGACATCGACTGG 69 FBan0010842 FBgn0015037 Cyp4p1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p1 Cytochrome P450-4p1 "CG10842, P450, P-450, 4p1, anon-WO0140519.35" CDMC22870 1 26 14 DAC23-I22 12-CG10842-RA_3 CG10842 CATAACCAAGGGGCTCGTCTACAACTTCCTACATCCATTCCTAAGGACGGGCTTGCTGACATCGACTGG 69 FBan0010842 FBgn0015037 Cyp4p1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p1 Cytochrome P450-4p1 "CG10842, P450, P-450, 4p1, anon-WO0140519.35" CDMC22871 1 1 15 DAC23-M10 2-CG10881-RA_1 CG10881 CAGCTGCCGCTATAAGTGATCCCAGCAAGACCGGAAAATATGTACCACCCTTCATGAAGGACGGCGGAG 69 FBan0010881 FBgn0038796 CG10881 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG10881 CG10881 "cg10881, eIF3-S4" CDMC22871 1 2 15 DAC23-M10 2-CG10881-RA_1 CG10881 CAGCTGCCGCTATAAGTGATCCCAGCAAGACCGGAAAATATGTACCACCCTTCATGAAGGACGGCGGAG 69 FBan0010881 FBgn0038796 CG10881 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG10881 CG10881 "cg10881, eIF3-S4" CDMC22872 1 3 15 DAC23-M22 16-CG10901-RB_1 CG10901 CATTTGGGCATCTTTGTGCATCCATTTAACGGCATGAACATAATGAAGAGACGCCACGAAATGACGCCC 69 FBan0010901 FBgn0003015 osk 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; long-term memory; GO:0007616; maintenance of pole plasm mRNA localization; GO:0046594; oocyte anterior/posterior axis determination; GO:0007314; polar granule organization and biogenesis; GO:0030719; pole cell development; GO:0007277; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm protein localization; GO:0007318; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011" polar granule; GO:0018994; pole plasm; GO:0045495 osk oskar "CG10901, oskar" CDMC22872 1 4 15 DAC23-M22 16-CG10901-RB_1 CG10901 CATTTGGGCATCTTTGTGCATCCATTTAACGGCATGAACATAATGAAGAGACGCCACGAAATGACGCCC 69 FBan0010901 FBgn0003015 osk 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; long-term memory; GO:0007616; maintenance of pole plasm mRNA localization; GO:0046594; oocyte anterior/posterior axis determination; GO:0007314; polar granule organization and biogenesis; GO:0030719; pole cell development; GO:0007277; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm protein localization; GO:0007318; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011" polar granule; GO:0018994; pole plasm; GO:0045495 osk oskar "CG10901, oskar" CDMC22873 1 5 15 DAC24-A10 8-CG14925-RA_1 CG14925 CGTGAGGAGGGTGTACGACGATTGCCAAGACAAAAACGATTTCATTGGCTGCCTGAAACAGAAAGCCCT 69 FBan0014925 FBgn0032359 Osi21 2 2L Osi21 Osiris 21 "CG14925, CG14925, CG14925, CG14925, Osiris, Osiris 21" CDMC22873 1 6 15 DAC24-A10 8-CG14925-RA_1 CG14925 CGTGAGGAGGGTGTACGACGATTGCCAAGACAAAAACGATTTCATTGGCTGCCTGAAACAGAAAGCCCT 69 FBan0014925 FBgn0032359 Osi21 2 2L Osi21 Osiris 21 "CG14925, CG14925, CG14925, CG14925, Osiris, Osiris 21" CDMC22874 1 7 15 DAC24-A22 23-CG14933-RA_9 CG14933 AAACCCCCATTCATTCCACACATCCACACGTATAGAAAACATGAAGTATCTGACTTTGCTGCTCGTTTT 69 FBan0014933 FBgn0040968 CG14933 2 2L CG14933 CG14933 CDMC22874 1 8 15 DAC24-A22 23-CG14933-RA_9 CG14933 AAACCCCCATTCATTCCACACATCCACACGTATAGAAAACATGAAGTATCTGACTTTGCTGCTCGTTTT 69 FBan0014933 FBgn0040968 CG14933 2 2L CG14933 CG14933 CDMC22875 1 9 15 DAC24-E10 6-CG14962-RA_1 CG14962 TGTTTGACTTGCAAACCTCTGCCCACATGTACACCCAAACTTGCGACGATTTGTTTGAGGAACTGGGGC 69 FBan0014962 FBgn0035407 CG14962 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14962 CG14962 CDMC22875 1 10 15 DAC24-E10 6-CG14962-RA_1 CG14962 TGTTTGACTTGCAAACCTCTGCCCACATGTACACCCAAACTTGCGACGATTTGTTTGAGGAACTGGGGC 69 FBan0014962 FBgn0035407 CG14962 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14962 CG14962 CDMC22876 1 11 15 DAC24-E22 5-CG14972-RA_1 CG14972 ACGACAAGTGGAGCTCGAGGATAGTGTGATAGCGTGGCAGGATAAGTACGATCGGCTCTACGAATCGCA 69 FBan0014972 FBgn0035450 CG14972 3 3L CG14972 CG14972 CDMC22876 1 12 15 DAC24-E22 5-CG14972-RA_1 CG14972 ACGACAAGTGGAGCTCGAGGATAGTGTGATAGCGTGGCAGGATAAGTACGATCGGCTCTACGAATCGCA 69 FBan0014972 FBgn0035450 CG14972 3 3L CG14972 CG14972 CDMC22877 1 13 15 DAC24-I10 17-CG1499-RA_1 CG1499 GCCGGGAACACTTAGCTGGGAACAAACGCAATATGCCTCGAAAGCTTCAAAAGATTCGATGAGACTTGA 69 FBan0001499 FBgn0039852 CG1499 3 3R CG1499 CG1499 "clone 2.47, anon-EST:Liang-2.47" CDMC22877 1 14 15 DAC24-I10 17-CG1499-RA_1 CG1499 GCCGGGAACACTTAGCTGGGAACAAACGCAATATGCCTCGAAAGCTTCAAAAGATTCGATGAGACTTGA 69 FBan0001499 FBgn0039852 CG1499 3 3R CG1499 CG1499 "clone 2.47, anon-EST:Liang-2.47" CDMC22878 1 15 15 DAC24-I22 23-CG15009-RC_3 CG15009 AACAAAAGGCTATTGGATTGACGACGGAAATTCATCTAGTTAGTTAGATAGATCAAATGCCTTCGAAGA 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC22878 1 16 15 DAC24-I22 23-CG15009-RC_3 CG15009 AACAAAAGGCTATTGGATTGACGACGGAAATTCATCTAGTTAGTTAGATAGATCAAATGCCTTCGAAGA 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC22879 1 17 15 DAC24-M10 3-CG15040-RA_1 CG15040 GGGAGCGCCGAGATGCAACAGCAAATAAACAGACCTCCCGATCCACGACAGACTTTCGAACACAATGTT 69 FBan0015040 FBgn0030940 CG15040 X X CG15040 CG15040 CDMC22879 1 18 15 DAC24-M10 3-CG15040-RA_1 CG15040 GGGAGCGCCGAGATGCAACAGCAAATAAACAGACCTCCCGATCCACGACAGACTTTCGAACACAATGTT 69 FBan0015040 FBgn0030940 CG15040 X X CG15040 CG15040 CDMC22880 1 19 15 DAC24-M22 15-CG15060-RA_1 CG15060 CCGCCTGCAACTGTCTGGGTATTACACGACTGTCTCCCGCACATTTCCACTACCAATACCAATACCAAT 69 FBan0015060 FBgn0030903 CG15060 X X CG15060 CG15060 CDMC22880 1 20 15 DAC24-M22 15-CG15060-RA_1 CG15060 CCGCCTGCAACTGTCTGGGTATTACACGACTGTCTCCCGCACATTTCCACTACCAATACCAATACCAAT 69 FBan0015060 FBgn0030903 CG15060 X X CG15060 CG15060 CDMC22881 1 21 15 DAC25-A10 3-CG14306-RA_1 CG14306 ACTCAGAGTGGGGGATCAGTACTTCACATTGCCGAGTCAGAACCTTTGCATCCATCACCGAATGCCCAA 69 FBan0014306 FBgn0038628 CG14306 3 3R zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622 CG14306 CG14306 CDMC22881 1 22 15 DAC25-A10 3-CG14306-RA_1 CG14306 ACTCAGAGTGGGGGATCAGTACTTCACATTGCCGAGTCAGAACCTTTGCATCCATCACCGAATGCCCAA 69 FBan0014306 FBgn0038628 CG14306 3 3R zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622 CG14306 CG14306 CDMC22882 1 23 15 DAC25-A22 3-CG14315-RA_1 CG14315 TGCACTGCCTCATTGCGTTGGATGTCCTTCTGTCGAATGACGATTCGGATAACGAACGCGAGTCATCCA 69 FBan0014315 FBgn0038568 CG14315 3 3R CG14315 CG14315 CDMC22882 1 24 15 DAC25-A22 3-CG14315-RA_1 CG14315 TGCACTGCCTCATTGCGTTGGATGTCCTTCTGTCGAATGACGATTCGGATAACGAACGCGAGTCATCCA 69 FBan0014315 FBgn0038568 CG14315 3 3R CG14315 CG14315 CDMC22883 1 25 15 DAC25-E10 3-CG14355-RA_2 CG14355 ACCGTTAACCATGGCACCCAGACATCCAAGAAAGACCAGATGCCACTACCTCCAAAGTATCCCATCCGA 69 FBan0014355 FBgn0038208 CG14355 3 3R CG14355 CG14355 CDMC22883 1 26 15 DAC25-E10 3-CG14355-RA_2 CG14355 ACCGTTAACCATGGCACCCAGACATCCAAGAAAGACCAGATGCCACTACCTCCAAAGTATCCCATCCGA 69 FBan0014355 FBgn0038208 CG14355 3 3R CG14355 CG14355 CDMC22884 1 1 16 DAC25-E22 3-CG14369-RA_1 CG14369 CCGTTCCTCAACTGGGCCAGTGGCTATTCTTGGGCATATCCTGGCTATCCGTACAACTACTATGGCTCA 69 FBan0014369 FBgn0038159 CG14369 3 3R CG14369 CG14369 CDMC22884 1 2 16 DAC25-E22 3-CG14369-RA_1 CG14369 CCGTTCCTCAACTGGGCCAGTGGCTATTCTTGGGCATATCCTGGCTATCCGTACAACTACTATGGCTCA 69 FBan0014369 FBgn0038159 CG14369 3 3R CG14369 CG14369 CDMC22885 1 3 16 DAC25-I10 15-CG14422-RA_1 CG14422 CGACGATGAGGAGTTTGACCAGGATGTGGAGGAAGAGAAGTATCTGAAGGACGAGGATGAAGTGCAGGA 69 FBan0014422 FBgn0029645 CG14422 X X CG14422 CG14422 CDMC22885 1 4 16 DAC25-I10 15-CG14422-RA_1 CG14422 CGACGATGAGGAGTTTGACCAGGATGTGGAGGAAGAGAAGTATCTGAAGGACGAGGATGAAGTGCAGGA 69 FBan0014422 FBgn0029645 CG14422 X X CG14422 CG14422 CDMC22886 1 5 16 DAC25-I22 1-CG14431-RA_2 CG14431 AGCCCGATGAGATCAAGACCGACTCGCAAGGCTCAAGCTACTTCACCTCCATCATCGATATCGAGCCAA 69 FBan0014431 FBgn0029922 CG14431 X X CG14431 CG14431 CDMC22886 1 6 16 DAC25-I22 1-CG14431-RA_2 CG14431 AGCCCGATGAGATCAAGACCGACTCGCAAGGCTCAAGCTACTTCACCTCCATCATCGATATCGAGCCAA 69 FBan0014431 FBgn0029922 CG14431 X X CG14431 CG14431 CDMC22887 1 7 16 DAC25-M10 18-CG14480-RA_1 CG14480 GCGCTCACTTTATGAACGCCTCAAACAAAATAAGGACAAGAAGGACATGGAGTTCGAGGAAGCCCACAA 69 FBan0014480 FBgn0034242 CG14480 2 2R CG14480 CG14480 CDMC22887 1 8 16 DAC25-M10 18-CG14480-RA_1 CG14480 GCGCTCACTTTATGAACGCCTCAAACAAAATAAGGACAAGAAGGACATGGAGTTCGAGGAAGCCCACAA 69 FBan0014480 FBgn0034242 CG14480 2 2R CG14480 CG14480 CDMC22888 1 9 16 DAC25-M22 16-CG14491-RA_2 CG14491 ATCTATCCGGAATCGATGGTTGTAGTCTGCTGTCGAACAAGAATCAGATCGCCTTCATTCAACTGGGCC 69 FBan0014491 FBgn0034284 CG14491 2 2R CG14491 CG14491 CDMC22888 1 10 16 DAC25-M22 16-CG14491-RA_2 CG14491 ATCTATCCGGAATCGATGGTTGTAGTCTGCTGTCGAACAAGAATCAGATCGCCTTCATTCAACTGGGCC 69 FBan0014491 FBgn0034284 CG14491 2 2R CG14491 CG14491 CDMC22889 1 11 16 DAC26-A10 16-CG4713-RA_1 CG4713 GGTCGCAAGCAAGTAGGTGGAAAATTGGAAGTCAAGATACGCGTTCGCAATCCTATTCTCACCAAGCAA 69 FBan0004713 FBgn0032342 CG4713 2 2L CG4713 CG4713 CDMC22889 1 12 16 DAC26-A10 16-CG4713-RA_1 CG4713 GGTCGCAAGCAAGTAGGTGGAAAATTGGAAGTCAAGATACGCGTTCGCAATCCTATTCTCACCAAGCAA 69 FBan0004713 FBgn0032342 CG4713 2 2L CG4713 CG4713 CDMC22890 1 13 16 DAC26-A22 9-CG4723-RA_6 CG4723 GGTGGGCCAGGAAAAACTTAGGAACCTAAAGCTGCAGATGCCCACTTACGAGCGTCCAGTGATCCTTAA 69 FBan0004723 FBgn0039023 CG4723 3 3R proteolysis; GO:0006508 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 CG4723 CG4723 CDMC22890 1 14 16 DAC26-A22 9-CG4723-RA_6 CG4723 GGTGGGCCAGGAAAAACTTAGGAACCTAAAGCTGCAGATGCCCACTTACGAGCGTCCAGTGATCCTTAA 69 FBan0004723 FBgn0039023 CG4723 3 3R proteolysis; GO:0006508 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 CG4723 CG4723 CDMC22891 1 15 16 DAC26-E10 2-CG4752-RA_1 CG4752 GCATCACTGATCCGGAGATCCTTGAACTGCGCTATCCCATGATCCTGAAGAGATTCTGCCTTCGCACCG 69 FBan0004752 FBgn0034733 CG4752 2 2R defense response; GO:0006952; response to toxin; GO:0009636 5-oxoprolinase (ATP-hydrolyzing) activity; GO:0017168 ; EC:3.5.2.9; ; GO:0017168 ; EC:3.5.2.9 CG4752 CG4752 CDMC22891 1 16 16 DAC26-E10 2-CG4752-RA_1 CG4752 GCATCACTGATCCGGAGATCCTTGAACTGCGCTATCCCATGATCCTGAAGAGATTCTGCCTTCGCACCG 69 FBan0004752 FBgn0034733 CG4752 2 2R defense response; GO:0006952; response to toxin; GO:0009636 5-oxoprolinase (ATP-hydrolyzing) activity; GO:0017168 ; EC:3.5.2.9; ; GO:0017168 ; EC:3.5.2.9 CG4752 CG4752 CDMC22892 1 17 16 DAC26-E22 2-CG4758-RA_1 CG4758 GACGGCTCCGAGGCATACGTCTGGATCTACGATCCCATACCGCTCCACTACTGGATATTCGGCTTCATC 69 FBan0004758 FBgn0011584 Trp1 2 2L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 protein transporter activity; GO:0008565; ; GO:0008565 integral to membrane; GO:0016021; translocon complex; GO:0005784 Trp1 Translocation protein 1 "CG4758, Dtrp1, Tp1: Temporal-protein-1" CDMC22892 1 18 16 DAC26-E22 2-CG4758-RA_1 CG4758 GACGGCTCCGAGGCATACGTCTGGATCTACGATCCCATACCGCTCCACTACTGGATATTCGGCTTCATC 69 FBan0004758 FBgn0011584 Trp1 2 2L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 protein transporter activity; GO:0008565; ; GO:0008565 integral to membrane; GO:0016021; translocon complex; GO:0005784 Trp1 Translocation protein 1 "CG4758, Dtrp1, Tp1: Temporal-protein-1" CDMC22893 1 19 16 DAC26-I10 9-CG4786-RA_3 CG4786 CCCGCAATGCTGTTCAGTGCAATCATTATTATCGGTGCAACAATCCCGTTGAGGTCAAGGGACAGTGCT 69 FBan0004786 FBgn0037012 CG4786 3 3L CG4786 CG4786 CT15369 CDMC22893 1 20 16 DAC26-I10 9-CG4786-RA_3 CG4786 CCCGCAATGCTGTTCAGTGCAATCATTATTATCGGTGCAACAATCCCGTTGAGGTCAAGGGACAGTGCT 69 FBan0004786 FBgn0037012 CG4786 3 3L CG4786 CG4786 CT15369 CDMC22894 1 21 16 DAC26-I22 2-CG4795-RB_2 CG4795 AAGCAGTTGAAGAGGTTCCCACTTCGGAAATCCCCGAACAATCATCGTCACCCTCAGATTCCGTTCCCG 69 FBan0004795 FBgn0010218 Cpn 3 3R rhabdomere development; GO:0042052 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 cytoplasm; GO:0005737 Cpn Calphotin "CG4795, cap, Ag 72H5, calphotin, calcium-binding protein, Ag72H5" CDMC22894 1 22 16 DAC26-I22 2-CG4795-RB_2 CG4795 AAGCAGTTGAAGAGGTTCCCACTTCGGAAATCCCCGAACAATCATCGTCACCCTCAGATTCCGTTCCCG 69 FBan0004795 FBgn0010218 Cpn 3 3R rhabdomere development; GO:0042052 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 cytoplasm; GO:0005737 Cpn Calphotin "CG4795, cap, Ag 72H5, calphotin, calcium-binding protein, Ag72H5" CDMC22895 1 23 16 DAC26-M10 16-CG4832-RB_1 CG4832 GCATACTCGACCTGATTCTTGTCTCGCATAACCCTCCATTTTCCAATCATTTGCGTGTAGTGACTGCCT 69 FBan0004832 FBgn0013765 cnn 2 2R central nervous system development; GO:0007417; centrosome cycle; GO:0007098; female meiosis chromosome segregation; GO:0016321; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; midgut development; GO:0007494; mitotic spindle organization and biogenesis; GO:0007052; nuclear division; GO:0000280; peripheral nervous system development; GO:0007422 "microtubule binding; GO:0008017; ; GO:0008017; ATPase activity, coupled; GO:0042623; ; GO:0042623" centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule associated complex; GO:0005875; myosin; GO:0016459; pericentriolar material; GO:0000242 cnn centrosomin "CG4832, CG18370, CG4832, CG4832, mat(2)synHK21, mat(2)syn-C, Cnn: Centrosomin, oblivious, CNN, obv: oblivious, mfs, Centrosomin, maternal effect syncytial blastoderm arrest C, Cnn, obv" CDMC22895 1 24 16 DAC26-M10 16-CG4832-RB_1 CG4832 GCATACTCGACCTGATTCTTGTCTCGCATAACCCTCCATTTTCCAATCATTTGCGTGTAGTGACTGCCT 69 FBan0004832 FBgn0013765 cnn 2 2R central nervous system development; GO:0007417; centrosome cycle; GO:0007098; female meiosis chromosome segregation; GO:0016321; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; midgut development; GO:0007494; mitotic spindle organization and biogenesis; GO:0007052; nuclear division; GO:0000280; peripheral nervous system development; GO:0007422 "microtubule binding; GO:0008017; ; GO:0008017; ATPase activity, coupled; GO:0042623; ; GO:0042623" centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule associated complex; GO:0005875; myosin; GO:0016459; pericentriolar material; GO:0000242 cnn centrosomin "CG4832, CG18370, CG4832, CG4832, mat(2)synHK21, mat(2)syn-C, Cnn: Centrosomin, oblivious, CNN, obv: oblivious, mfs, Centrosomin, maternal effect syncytial blastoderm arrest C, Cnn, obv" CDMC22896 1 25 16 DAC26-M22 22-CG4846-RA_4 CG4846 TCGGCAGGATCAACAGCAGATGTATCAGGCAATTAACATGATTCAATTGTCACACAACTCCAGTGCCAT 69 FBan0004846 FBgn0013433 beat-Ia 2 2L Bolwig's organ morphogenesis; GO:0001746; axon choice point recognition; GO:0016198; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ia beaten path Ia "CG4846, beat: beaten path, beaten path, l(2)35Eb, l(2)35Ea: lethal(2)35Ea, l(2)br47, l(2)br48, tric, triclops, BG:DS00913.3, CT15567, beat Ia, Beat Ia, beat, l(2)35Ea" CDMC22896 1 26 16 DAC26-M22 22-CG4846-RA_4 CG4846 TCGGCAGGATCAACAGCAGATGTATCAGGCAATTAACATGATTCAATTGTCACACAACTCCAGTGCCAT 69 FBan0004846 FBgn0013433 beat-Ia 2 2L Bolwig's organ morphogenesis; GO:0001746; axon choice point recognition; GO:0016198; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ia beaten path Ia "CG4846, beat: beaten path, beaten path, l(2)35Eb, l(2)35Ea: lethal(2)35Ea, l(2)br47, l(2)br48, tric, triclops, BG:DS00913.3, CT15567, beat Ia, Beat Ia, beat, l(2)35Ea" CDMC22897 1 1 17 DAC27-A10 23-CG3458-RA_1 CG3458 TGGCGTCGTATTTCGTTTGAGGACACTGAATTGCATTTAGAAGAACAATAACTAAACAAGAAAAAAAAA 69 FBan0003458 FBgn0026015 Top3beta X X "DNA catabolism, endonucleolytic; GO:0000737; DNA modification; GO:0006304; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268; tRNA aminoacylation for protein translation; GO:0006418" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; endodeoxyribonuclease activity; GO:0004520; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004520; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2; ; GO:0004812 ; EC:6.1.1.- Top3beta Topoisomerase 3beta "CG3458, TOP3, top3[beta], topo III[beta], Topoisomerase 3, Top3beta, Top3: Topoisomerase 3, Topoisomerase 3beta" CDMC22897 1 2 17 DAC27-A10 23-CG3458-RA_1 CG3458 TGGCGTCGTATTTCGTTTGAGGACACTGAATTGCATTTAGAAGAACAATAACTAAACAAGAAAAAAAAA 69 FBan0003458 FBgn0026015 Top3beta X X "DNA catabolism, endonucleolytic; GO:0000737; DNA modification; GO:0006304; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268; tRNA aminoacylation for protein translation; GO:0006418" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; endodeoxyribonuclease activity; GO:0004520; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004520; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2; ; GO:0004812 ; EC:6.1.1.- Top3beta Topoisomerase 3beta "CG3458, TOP3, top3[beta], topo III[beta], Topoisomerase 3, Top3beta, Top3: Topoisomerase 3, Topoisomerase 3beta" CDMC22898 1 3 17 DAC27-A22 2-CG3480-RA_3 CG3480 CGAAAGGCAGTCCAAAGCAGGTTGAAGGGAAGGAGAACAGCGAAGTTGACAAGATGGACCACAGTAGCC 69 FBan0003480 FBgn0023509 mip130 X X chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 DNA binding; GO:0003677; ; GO:0003677 Myb complex; GO:0031523; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 mip130 Myb-interacting protein 130 "CG3480, CG3480, CG3480, 86E4.4, EG:86E4.4, twit, twilight, Mip130, TWIT, Myb-interacting protein 130" CDMC22898 1 4 17 DAC27-A22 2-CG3480-RA_3 CG3480 CGAAAGGCAGTCCAAAGCAGGTTGAAGGGAAGGAGAACAGCGAAGTTGACAAGATGGACCACAGTAGCC 69 FBan0003480 FBgn0023509 mip130 X X chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 DNA binding; GO:0003677; ; GO:0003677 Myb complex; GO:0031523; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 mip130 Myb-interacting protein 130 "CG3480, CG3480, CG3480, 86E4.4, EG:86E4.4, twit, twilight, Mip130, TWIT, Myb-interacting protein 130" CDMC22899 1 5 17 DAC27-E10 14-CG3524-RA_1 CG3524 TCGCGAATATCATGGGACTGAGGGATGTAAAGAGTGTCTCCGATAAGACCACCCTCTTCGATCTTGGCA 69 FBan0003524 FBgn0042627 v(2)k05816 2 2L fatty acid biosynthesis; GO:0006633 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; 3-oxoacyl-[acyl-carrier protein] synthase activity; GO:0004315 ; EC:2.3.1.41; [acyl-carrier protein] S-acetyltransferase activity; GO:0004313 ; EC:2.3.1.38; [acyl-carrier protein] S-malonyltransferase activity; GO:0004314 ; EC:2.3.1.39; ; GO:0004315 ; EC:2.3.1.41; ; GO:0004313 ; EC:2.3.1.38; ; GO:0004314 ; EC:2.3.1.39; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" v(2)k05816 v(2)k05816 "CG3524, DM_7295849" CDMC22899 1 6 17 DAC27-E10 14-CG3524-RA_1 CG3524 TCGCGAATATCATGGGACTGAGGGATGTAAAGAGTGTCTCCGATAAGACCACCCTCTTCGATCTTGGCA 69 FBan0003524 FBgn0042627 v(2)k05816 2 2L fatty acid biosynthesis; GO:0006633 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; 3-oxoacyl-[acyl-carrier protein] synthase activity; GO:0004315 ; EC:2.3.1.41; [acyl-carrier protein] S-acetyltransferase activity; GO:0004313 ; EC:2.3.1.38; [acyl-carrier protein] S-malonyltransferase activity; GO:0004314 ; EC:2.3.1.39; ; GO:0004315 ; EC:2.3.1.41; ; GO:0004313 ; EC:2.3.1.38; ; GO:0004314 ; EC:2.3.1.39; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" v(2)k05816 v(2)k05816 "CG3524, DM_7295849" CDMC22900 1 7 17 DAC27-E22 15-CG3533-RA_4 CG3533 GCACACGAAACTTTGGCCTGGTACAGCAATTAATGTTACGCTACGTGGCAATTATGTGACCCTGGAGGC 69 FBan0003533 FBgn0004055 uzip 2 2R axonogenesis; GO:0007409 integral to membrane; GO:0016021; plasma membrane; GO:0005886 uzip unzipped "CG3533, zip, zipper, nzip: not-zipper, not-zipper" CDMC22900 1 8 17 DAC27-E22 15-CG3533-RA_4 CG3533 GCACACGAAACTTTGGCCTGGTACAGCAATTAATGTTACGCTACGTGGCAATTATGTGACCCTGGAGGC 69 FBan0003533 FBgn0004055 uzip 2 2R axonogenesis; GO:0007409 integral to membrane; GO:0016021; plasma membrane; GO:0005886 uzip unzipped "CG3533, zip, zipper, nzip: not-zipper, not-zipper" CDMC22901 1 9 17 DAC27-I10 1-CG3576-RB_1 CG3576 TGTCCGGTGACATACGTTCCAGTGATAGTGAGGATCTCACAGACAGTTCGGGGAATGCACGTCTGACCA 69 FBan0003576 FBgn0040918 Lag1 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 integral to membrane; GO:0016021; nucleus; GO:0005634; plasma membrane; GO:0005886 Lag1 Longevity assurance gene 1 "CG3576, CG15898, CG3576, l(1)G0061, l(1)G0365, l(1)G0489, DLAG1, lon, longevity, Dlag1" CDMC22901 1 10 17 DAC27-I10 1-CG3576-RB_1 CG3576 TGTCCGGTGACATACGTTCCAGTGATAGTGAGGATCTCACAGACAGTTCGGGGAATGCACGTCTGACCA 69 FBan0003576 FBgn0040918 Lag1 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 integral to membrane; GO:0016021; nucleus; GO:0005634; plasma membrane; GO:0005886 Lag1 Longevity assurance gene 1 "CG3576, CG15898, CG3576, l(1)G0061, l(1)G0365, l(1)G0489, DLAG1, lon, longevity, Dlag1" CDMC22902 1 11 17 DAC27-I22 7-CG3589-RA_1 CG3589 AGGTACCGGGACCTTCATAAGAGTACACAACAAGCGCTTTATCCTCACTTGTGCACATGTGGTGGGACA 69 FBan0003589 FBgn0035065 CG3589 2 2R CG3589 CG3589 CDMC22902 1 12 17 DAC27-I22 7-CG3589-RA_1 CG3589 AGGTACCGGGACCTTCATAAGAGTACACAACAAGCGCTTTATCCTCACTTGTGCACATGTGGTGGGACA 69 FBan0003589 FBgn0035065 CG3589 2 2R CG3589 CG3589 CDMC22903 1 13 17 DAC27-M10 23-CG3630-RA_2 CG3630 CCAAAGGAGCCAGTTTCCTCAATTTGTTAACCATTACTCTATGGAAATGAACTACGGTTTCCCACTCAC 69 FBan0003630 FBgn0023540 CG3630 X X CG3630 CG3630 "152A3.3, EG:152A3.3" CDMC22903 1 14 17 DAC27-M10 23-CG3630-RA_2 CG3630 CCAAAGGAGCCAGTTTCCTCAATTTGTTAACCATTACTCTATGGAAATGAACTACGGTTTCCCACTCAC 69 FBan0003630 FBgn0023540 CG3630 X X CG3630 CG3630 "152A3.3, EG:152A3.3" CDMC22904 1 15 17 DAC27-M22 2-CG3640-RA_1 CG3640 GGTTCAAGTACAGCGCATCCCATCCATCGAAAGTTTTGGGTGCTGATCGTGATGTAGCCTTCCATCCCA 69 FBan0003640 FBgn0035042 CG3640 2 2R extracellular region; GO:0005576 CG3640 CG3640 CDMC22904 1 16 17 DAC27-M22 2-CG3640-RA_1 CG3640 GGTTCAAGTACAGCGCATCCCATCCATCGAAAGTTTTGGGTGCTGATCGTGATGTAGCCTTCCATCCCA 69 FBan0003640 FBgn0035042 CG3640 2 2R extracellular region; GO:0005576 CG3640 CG3640 CDMC22905 1 17 17 DAC28-A10 2-CG1472-RA_3 CG1472 CGCCATGGATTGCATGAAAACGCTACCGCTGGACCAGCTAATGAAGTACGTGTACCCGGAGCTGTACAA 69 FBan0001472 FBgn0033460 CG1472 2 2R ER to Golgi transport; GO:0006888; intracellular protein transport; GO:0006886 protein binding; GO:0005515; ; GO:0005515 COPII vesicle coat; GO:0030127; COPII-coated vesicle; GO:0030138 CG1472 CG1472 CDMC22905 1 18 17 DAC28-A10 2-CG1472-RA_3 CG1472 CGCCATGGATTGCATGAAAACGCTACCGCTGGACCAGCTAATGAAGTACGTGTACCCGGAGCTGTACAA 69 FBan0001472 FBgn0033460 CG1472 2 2R ER to Golgi transport; GO:0006888; intracellular protein transport; GO:0006886 protein binding; GO:0005515; ; GO:0005515 COPII vesicle coat; GO:0030127; COPII-coated vesicle; GO:0030138 CG1472 CG1472 CDMC22906 1 19 17 DAC28-A22 23-CG14748-RA_6 CG14748 AGCAATTAACTTATTAACTTAACTCCCCTGAATGTTGAATGCAACCCAAATGACAGCTTGCGTGCAGGC 69 FBan0014748 FBgn0033305 CG14748 2 2R CG14748 CG14748 CDMC22906 1 20 17 DAC28-A22 23-CG14748-RA_6 CG14748 AGCAATTAACTTATTAACTTAACTCCCCTGAATGTTGAATGCAACCCAAATGACAGCTTGCGTGCAGGC 69 FBan0014748 FBgn0033305 CG14748 2 2R CG14748 CG14748 CDMC22907 1 21 17 DAC28-E10 9-CG14796-RA_2 CG14796 GGGGACCTAGAATACGATAGTTCCGGGAGCTCTGACTATGTGAACGACGCGAATGACATTTCGAGCGGT 69 FBan0014796 FBgn0025390 CG14796 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14796 CG14796 EG:56G7.1 CDMC22907 1 22 17 DAC28-E10 9-CG14796-RA_2 CG14796 GGGGACCTAGAATACGATAGTTCCGGGAGCTCTGACTATGTGAACGACGCGAATGACATTTCGAGCGGT 69 FBan0014796 FBgn0025390 CG14796 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14796 CG14796 EG:56G7.1 CDMC22908 1 23 17 DAC28-E22 13-CG1480-RA_1 CG1480 CTGGTCCATGGAGTTGAGGGAAAAAGTGCTGGAAATGTCCAAGCGAAATAATGGCCAGGAGAAACCACA 69 FBan0001480 FBgn0004389 bnk 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; membrane organization and biogenesis; GO:0016044" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 bnk bottleneck "CG1480, CG1480, bottleneck" CDMC22908 1 24 17 DAC28-E22 13-CG1480-RA_1 CG1480 CTGGTCCATGGAGTTGAGGGAAAAAGTGCTGGAAATGTCCAAGCGAAATAATGGCCAGGAGAAACCACA 69 FBan0001480 FBgn0004389 bnk 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; membrane organization and biogenesis; GO:0016044" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 bnk bottleneck "CG1480, CG1480, bottleneck" CDMC22909 1 25 17 DAC28-I10 2-CG14841-RA_1 CG14841 AGCAAGCGAAAAGAAGCAGACTGCAAGTGGAGGATCATCGGAAGGGTGTGAAACAAGTTCTGCTGTGCA 69 FBan0014841 FBgn0038218 CG14841 3 3R CG14841 CG14841 BcDNA:AT04690 CDMC22909 1 26 17 DAC28-I10 2-CG14841-RA_1 CG14841 AGCAAGCGAAAAGAAGCAGACTGCAAGTGGAGGATCATCGGAAGGGTGTGAAACAAGTTCTGCTGTGCA 69 FBan0014841 FBgn0038218 CG14841 3 3R CG14841 CG14841 BcDNA:AT04690 CDMC22910 1 1 18 DAC28-I22 7-CG14861-RA_1 CG14861 AGGCGGGGAAGACTTTGGAAGCTCTAGAGGTAGCGGAAGATAACGAAGGCTACACAACACCGAAAGAGT 69 FBan0014861 FBgn0038280 CG14861 3 3R CG14861 CG14861 CDMC22910 1 2 18 DAC28-I22 7-CG14861-RA_1 CG14861 AGGCGGGGAAGACTTTGGAAGCTCTAGAGGTAGCGGAAGATAACGAAGGCTACACAACACCGAAAGAGT 69 FBan0014861 FBgn0038280 CG14861 3 3R CG14861 CG14861 CDMC22911 1 3 18 DAC28-M10 23-CG14889-RA_15 CG14889 ATTCGAATAGAACTCGTTCATACAAAGCATTATTGCCAAAGCTTCGATGTGAAACACAAGGCTAAGGGC 69 FBan0014889 FBgn0038443 CG14889 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14889 CG14889 CDMC22911 1 4 18 DAC28-M10 23-CG14889-RA_15 CG14889 ATTCGAATAGAACTCGTTCATACAAAGCATTATTGCCAAAGCTTCGATGTGAAACACAAGGCTAAGGGC 69 FBan0014889 FBgn0038443 CG14889 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14889 CG14889 CDMC22912 1 5 18 DAC28-M22 5-CG14899-RA_1 CG14899 AGCGCTGTTCCCTATCCATTAACACGTCTCAATCCTGGAGTGCACAACATCCGGTGAGAGGACTACCAA 69 FBan0014899 FBgn0038438 CG14899 3 3R CG14899 CG14899 CDMC22912 1 6 18 DAC28-M22 5-CG14899-RA_1 CG14899 AGCGCTGTTCCCTATCCATTAACACGTCTCAATCCTGGAGTGCACAACATCCGGTGAGAGGACTACCAA 69 FBan0014899 FBgn0038438 CG14899 3 3R CG14899 CG14899 CDMC22913 1 7 18 DAC29-A10 2-CG6376-RA_1 CG6376 GGCTGTTTGACTTCGGTTCGGATGCCTATGGACCCTAAGAGGAGACGTCCACGAACACAATCACAACCA 69 FBan0006376 FBgn0011766 E2f 3 3R DNA endoreduplication; GO:0042023; G1/S transition of mitotic cell cycle; GO:0000082; G1/S-specific transcription in mitotic cell cycle; GO:0000083; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; growth; GO:0040007; imaginal disc development; GO:0007444; nurse cell apoptosis; GO:0045476; positive regulation of cell proliferation; GO:0008284; positive regulation of nurse cell apoptosis; GO:0045850; positive regulation of transcription; GO:0045941; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016563; ; GO:0003700; ; GO:0005515 Rb-E2F complex; GO:0035189; nucleus; GO:0005634; transcription factor complex; GO:0005667 E2f E2F transcription factor "CG6376, CG6376, CG6376, drosE2F1, E2F, E(var)3-93E, Evar(3)164, dE2F, DRTF1/E2F, DmE2F-1, E(var)3-95E, dE2f, dE2F1, de2f1, E(Sev-CycE)3A, E2F1, E2f1, e2f, E2F-1, e2f1, dE2f1, def21, E(var)93E, l(3)07172, l(3)j3B1, l(3)j3C2, l(3)rM729" CDMC22913 1 8 18 DAC29-A10 2-CG6376-RA_1 CG6376 GGCTGTTTGACTTCGGTTCGGATGCCTATGGACCCTAAGAGGAGACGTCCACGAACACAATCACAACCA 69 FBan0006376 FBgn0011766 E2f 3 3R DNA endoreduplication; GO:0042023; G1/S transition of mitotic cell cycle; GO:0000082; G1/S-specific transcription in mitotic cell cycle; GO:0000083; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; growth; GO:0040007; imaginal disc development; GO:0007444; nurse cell apoptosis; GO:0045476; positive regulation of cell proliferation; GO:0008284; positive regulation of nurse cell apoptosis; GO:0045850; positive regulation of transcription; GO:0045941; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016563; ; GO:0003700; ; GO:0005515 Rb-E2F complex; GO:0035189; nucleus; GO:0005634; transcription factor complex; GO:0005667 E2f E2F transcription factor "CG6376, CG6376, CG6376, drosE2F1, E2F, E(var)3-93E, Evar(3)164, dE2F, DRTF1/E2F, DmE2F-1, E(var)3-95E, dE2f, dE2F1, de2f1, E(Sev-CycE)3A, E2F1, E2f1, e2f, E2F-1, e2f1, dE2f1, def21, E(var)93E, l(3)07172, l(3)j3B1, l(3)j3C2, l(3)rM729" CDMC22914 1 9 18 DAC29-A22 6-CG6392-RA_2 CG6392 CCTCGAGGAAAAGTTGTGCTCGGCTAACGATATTGTGGCTAAGCTTGAGACGGAAATAGCCGCGTTGCG 69 FBan0006392 FBgn0040232 cmet 2 2L cell cycle; GO:0007049; microtubule-based movement; GO:0007018; mitotic metaphase plate congression; GO:0007080; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 "chromosome, pericentric region; GO:0000775; kinesin complex; GO:0005871; kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940" cmet CENP-meta "CG6392, CG6392, CG6392, CG6392, l(2)04431, DmCmeta, Cmet, KIF10, CENP-E meta, CENP-meta" CDMC22914 1 10 18 DAC29-A22 6-CG6392-RA_2 CG6392 CCTCGAGGAAAAGTTGTGCTCGGCTAACGATATTGTGGCTAAGCTTGAGACGGAAATAGCCGCGTTGCG 69 FBan0006392 FBgn0040232 cmet 2 2L cell cycle; GO:0007049; microtubule-based movement; GO:0007018; mitotic metaphase plate congression; GO:0007080; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 "chromosome, pericentric region; GO:0000775; kinesin complex; GO:0005871; kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940" cmet CENP-meta "CG6392, CG6392, CG6392, CG6392, l(2)04431, DmCmeta, Cmet, KIF10, CENP-E meta, CENP-meta" CDMC22915 1 11 18 DAC29-E10 23-CG6426-RA_1 CG6426 ATAGAGGTCGGTTGTTTACAGATAGTTGTGATACTGTTCAGTGACTTTTCAAATTGCATTTGCAAACAA 69 FBan0006426 FBgn0034162 CG6426 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 calcium ion binding; GO:0005509; ; GO:0005509 CG6426 CG6426 "n(2)k04810, l(2)k04810, BcDNA:RH01665" CDMC22915 1 12 18 DAC29-E10 23-CG6426-RA_1 CG6426 ATAGAGGTCGGTTGTTTACAGATAGTTGTGATACTGTTCAGTGACTTTTCAAATTGCATTTGCAAACAA 69 FBan0006426 FBgn0034162 CG6426 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 calcium ion binding; GO:0005509; ; GO:0005509 CG6426 CG6426 "n(2)k04810, l(2)k04810, BcDNA:RH01665" CDMC22916 1 13 18 DAC29-E22 23-CG6438-RA_20 CG6438 TCCGTTGAGTGTCCTAGCGAACTCTGTAGTCGATATCGAAGGCAACCACAAAATAAGAACATAGAAAAC 69 FBan0006438 FBgn0023179 amon 3 3R hatching behavior; GO:0035187; peptide hormone processing; GO:0016486; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; subtilisin activity; GO:0004291 ; EC:3.4.21.62; ; GO:0008233 ; EC:3.4.-.-; proprotein convertase 2 activity; GO:0004286 ; EC:3.4.21.94; ; GO:0004291 ; EC:3.4.21.62; ; GO:0004286 ; EC:3.4.21.94 amon amontillado "CG6438, Ppp, dPC2, DMH#5, PC2, PPP, Prohormone processing protease, amontillado" CDMC22916 1 14 18 DAC29-E22 23-CG6438-RA_20 CG6438 TCCGTTGAGTGTCCTAGCGAACTCTGTAGTCGATATCGAAGGCAACCACAAAATAAGAACATAGAAAAC 69 FBan0006438 FBgn0023179 amon 3 3R hatching behavior; GO:0035187; peptide hormone processing; GO:0016486; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; subtilisin activity; GO:0004291 ; EC:3.4.21.62; ; GO:0008233 ; EC:3.4.-.-; proprotein convertase 2 activity; GO:0004286 ; EC:3.4.21.94; ; GO:0004291 ; EC:3.4.21.62; ; GO:0004286 ; EC:3.4.21.94 amon amontillado "CG6438, Ppp, dPC2, DMH#5, PC2, PPP, Prohormone processing protease, amontillado" CDMC22917 1 15 18 DAC29-I10 3-CG6476-RA_2 CG6476 GGCCGAAGTAGACGCCTATGAGCCACTCAATCTGCAGATCGATCTTATACTGCTCGCCCAATATCGCGC 69 FBan0006476 FBgn0003600 Su(var)3-9 3 3R DNA methylation; GO:0006306; chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; chromatin silencing at telomere; GO:0006348; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; histone H3-K9 methylation; GO:0051567; histone methylation; GO:0016571; histone modification; GO:0016570; oogenesis (sensu Insecta); GO:0009993; translational initiation; GO:0006413 chromatin binding; GO:0003682; GTP binding; GO:0005525; ; GO:0003682; ; GO:0005525; tRNA binding; GO:0000049; histone methyltransferase activity; GO:0042054; translation initiation factor activity; GO:0003743; ; GO:0042054; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046974; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0003743; ; GO:0000049; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008270 "chromosome, pericentric region; GO:0000775; cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; heterochromatin; GO:0000792; nucleus; GO:0005634" Su(var)3-9 Suppressor of variegation 3-9 "CG6476, CG6476, Su-var(3)9, Su-var(3)902, E(var)3-2, Enhancer of variegation 3-2, Suvar(3)9, Su(var)3-902, Su(Var)3-9, eIF2gamma, dIF2, ptn, pitkin, caa56376 Suvar39 Dm, eIF-2G, eIF2G, SUV39H1, SU(VAR)3-9, SUV39, su(var)3-9, dSU(VAR)3-9, SuVar3-9, Suvar3-9, Suvar39, Su(var)306, Su(var)310, Su(var)328, eIF-2gamma, Suppressor of variegation 306, Suppressor of variegation 310, Suppressor of variegation 328" CDMC22917 1 16 18 DAC29-I10 3-CG6476-RA_2 CG6476 GGCCGAAGTAGACGCCTATGAGCCACTCAATCTGCAGATCGATCTTATACTGCTCGCCCAATATCGCGC 69 FBan0006476 FBgn0003600 Su(var)3-9 3 3R DNA methylation; GO:0006306; chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; chromatin silencing at telomere; GO:0006348; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; histone H3-K9 methylation; GO:0051567; histone methylation; GO:0016571; histone modification; GO:0016570; oogenesis (sensu Insecta); GO:0009993; translational initiation; GO:0006413 chromatin binding; GO:0003682; GTP binding; GO:0005525; ; GO:0003682; ; GO:0005525; tRNA binding; GO:0000049; histone methyltransferase activity; GO:0042054; translation initiation factor activity; GO:0003743; ; GO:0042054; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046974; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0003743; ; GO:0000049; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008270 "chromosome, pericentric region; GO:0000775; cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; heterochromatin; GO:0000792; nucleus; GO:0005634" Su(var)3-9 Suppressor of variegation 3-9 "CG6476, CG6476, Su-var(3)9, Su-var(3)902, E(var)3-2, Enhancer of variegation 3-2, Suvar(3)9, Su(var)3-902, Su(Var)3-9, eIF2gamma, dIF2, ptn, pitkin, caa56376 Suvar39 Dm, eIF-2G, eIF2G, SUV39H1, SU(VAR)3-9, SUV39, su(var)3-9, dSU(VAR)3-9, SuVar3-9, Suvar3-9, Suvar39, Su(var)306, Su(var)310, Su(var)328, eIF-2gamma, Suppressor of variegation 306, Suppressor of variegation 310, Suppressor of variegation 328" CDMC22918 1 17 18 DAC29-I22 2-CG6485-RA_1 CG6485 CCGGTGAATGCCACTGAAATACGCAAAGCACTGAAGTTCGAGTTCTCCAAGGATAACCAGCGGAGGGTG 69 FBan0006485 FBgn0036706 CG6485 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6485 CG6485 CDMC22918 1 18 18 DAC29-I22 2-CG6485-RA_1 CG6485 CCGGTGAATGCCACTGAAATACGCAAAGCACTGAAGTTCGAGTTCTCCAAGGATAACCAGCGGAGGGTG 69 FBan0006485 FBgn0036706 CG6485 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6485 CG6485 CDMC22919 1 19 18 DAC29-M10 23-CG6522-RA_2 CG6522 TACAACCGACTAATTTGATTGGCTTTTTAAATGAAAACGACGCCTAAATATTTACAATTCCAACCGCTT 69 FBan0006522 FBgn0034223 CG6522 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG6522 CG6522 CDMC22919 1 20 18 DAC29-M10 23-CG6522-RA_2 CG6522 TACAACCGACTAATTTGATTGGCTTTTTAAATGAAAACGACGCCTAAATATTTACAATTCCAACCGCTT 69 FBan0006522 FBgn0034223 CG6522 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG6522 CG6522 CDMC22920 1 21 18 DAC29-M22 15-CG6536-RB_1 CG6536 ACCGATTGCTGCCAGAAAATCCGTTCCGTGCATACAACTTATACGCCTGGGGTATACCGCTAATCATGA 69 FBan0006536 FBgn0034219 mthl4 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl4 methuselah-like 4 "CG6536, CG6536, CG6536, CG6536, CG6536, CG6536, mth-like 4, Mth-like 4, anon-WO0170980.55, anon-WO0170980.56" CDMC22920 1 22 18 DAC29-M22 15-CG6536-RB_1 CG6536 ACCGATTGCTGCCAGAAAATCCGTTCCGTGCATACAACTTATACGCCTGGGGTATACCGCTAATCATGA 69 FBan0006536 FBgn0034219 mthl4 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl4 methuselah-like 4 "CG6536, CG6536, CG6536, CG6536, CG6536, CG6536, mth-like 4, Mth-like 4, anon-WO0170980.55, anon-WO0170980.56" CDMC22921 1 23 18 DAC30-A10 13-CG3744-RA_2 CG3744 AGCTGGTGTACTTTGTGGGACTTCGAGATACGCCGCTAGAAAAACACCTGTACGTTGTGAGTCTGGA 67 FBan0003744 FBgn0039240 CG3744 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236; X-Pro dipeptidyl-peptidase activity; GO:0017088 ; EC:3.4.14.11; ; GO:0017088 ; EC:3.4.14.11 CG3744 CG3744 CDMC22921 1 24 18 DAC30-A10 13-CG3744-RA_2 CG3744 AGCTGGTGTACTTTGTGGGACTTCGAGATACGCCGCTAGAAAAACACCTGTACGTTGTGAGTCTGGA 67 FBan0003744 FBgn0039240 CG3744 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236; X-Pro dipeptidyl-peptidase activity; GO:0017088 ; EC:3.4.14.11; ; GO:0017088 ; EC:3.4.14.11 CG3744 CG3744 CDMC22922 1 25 18 DAC30-A22 18-CG3887-RA_1 CG3887 ACCGAAAAGGTGCAGGAGAATCCGGACTTTGTTAAATAATAGCATTGGACTGACTGGACGGACGGAG 67 FBan0003887 FBgn0031670 CG3887 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3887 CG3887 CDMC22922 1 26 18 DAC30-A22 18-CG3887-RA_1 CG3887 ACCGAAAAGGTGCAGGAGAATCCGGACTTTGTTAAATAATAGCATTGGACTGACTGGACGGACGGAG 67 FBan0003887 FBgn0031670 CG3887 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3887 CG3887 CDMC22923 1 1 19 DAC30-E10 1-CG41066-RA_1 CG41066 GCTACGACCCTGCTACCGGCTTATTCCAGTTGGTCACTTCAGCTATAGTCACCGATCGTGGACACCA 67 FBgn0069954 CG41066 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41066 CG41066 CDMC22923 1 2 19 DAC30-E10 1-CG41066-RA_1 CG41066 GCTACGACCCTGCTACCGGCTTATTCCAGTTGGTCACTTCAGCTATAGTCACCGATCGTGGACACCA 67 FBgn0069954 CG41066 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41066 CG41066 CDMC22924 1 3 19 DAC30-E22 11-CG4139-RA_2 CG4139 ACACGGAGGACATATATGAGGGCATCTACAACACATACGTTCTGGACACGGACTACGACACCTGGGG 67 FBan0004139 FBgn0030334 Karl X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Karl Karl "CG4139, CG4139" CDMC22924 1 4 19 DAC30-E22 11-CG4139-RA_2 CG4139 ACACGGAGGACATATATGAGGGCATCTACAACACATACGTTCTGGACACGGACTACGACACCTGGGG 67 FBan0004139 FBgn0030334 Karl X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Karl Karl "CG4139, CG4139" CDMC22925 1 5 19 DAC30-I10 12-CG4616-RB_1 CG4616 CCCAGACTCCAAAACAGGCTGATCCACTAAGATCCCAAACGAAATCGAAGACTGTGTCGCCGATGGC 67 FBan0004616 FBgn0033806 CG4616 2 2R CG4616 CG4616 CDMC22925 1 6 19 DAC30-I10 12-CG4616-RB_1 CG4616 CCCAGACTCCAAAACAGGCTGATCCACTAAGATCCCAAACGAAATCGAAGACTGTGTCGCCGATGGC 67 FBan0004616 FBgn0033806 CG4616 2 2R CG4616 CG4616 CDMC22926 1 7 19 DAC30-I22 2-CG4835-RA_1 CG4835 CCCACGGAATTGACCTGCATGGATCCCGAACTAGCTGGTTGTAGCACTAAGTTAACCACACCAGGGC 67 FBan0004835 FBgn0035607 CG4835 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG4835 CG4835 CDMC22926 1 8 19 DAC30-I22 2-CG4835-RA_1 CG4835 CCCACGGAATTGACCTGCATGGATCCCGAACTAGCTGGTTGTAGCACTAAGTTAACCACACCAGGGC 67 FBan0004835 FBgn0035607 CG4835 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG4835 CG4835 CDMC22927 1 9 19 DAC30-M10 27-CG5248-RA_3 CG5248 CGGACAGAATTCCTTGAGCGATCTGCACAGCTCTAGGTCATCTTTGTCCTCGTTTGATGCGGGCACA 67 FBan0005248 FBgn0020278 loco 3 3R "cytoplasmic transport, nurse cell to oocyte; GO:0007303; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; glial cell differentiation; GO:0010001; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277" protein binding; GO:0005515; GTPase activator activity; GO:0005096; regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; ; GO:0016299; ; GO:0005515; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 loco locomotion defects "CG17229, CG5248, CG17229, dLoco, locomotion defects" CDMC22927 1 10 19 DAC30-M10 27-CG5248-RA_3 CG5248 CGGACAGAATTCCTTGAGCGATCTGCACAGCTCTAGGTCATCTTTGTCCTCGTTTGATGCGGGCACA 67 FBan0005248 FBgn0020278 loco 3 3R "cytoplasmic transport, nurse cell to oocyte; GO:0007303; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; glial cell differentiation; GO:0010001; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277" protein binding; GO:0005515; GTPase activator activity; GO:0005096; regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; ; GO:0016299; ; GO:0005515; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 loco locomotion defects "CG17229, CG5248, CG17229, dLoco, locomotion defects" CDMC22928 1 11 19 DAC30-M22 18-CG5369-RA_1 CG5369 CGAGGAGTCCGTGGACATAGACATTACCGACCTATCCGTATCCGAGAGCAATACGATCCTCGCTATC 67 FBan0005369 FBgn0032227 CG5369 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG5369 CG5369 CDMC22928 1 12 19 DAC30-M22 18-CG5369-RA_1 CG5369 CGAGGAGTCCGTGGACATAGACATTACCGACCTATCCGTATCCGAGAGCAATACGATCCTCGCTATC 67 FBan0005369 FBgn0032227 CG5369 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG5369 CG5369 CDMC22929 1 13 19 DAC31-A10 17-CG7465-RA_1 CG7465 GCGCCGCCACTAAATCATCCGATAAAGGCTTCACTAGGTGATCGAATTGTGCTCATTTTTGAGTGCAGA 69 FBan0007465 FBgn0035551 CG7465 3 3L CG7465 CG7465 CDMC22929 1 14 19 DAC31-A10 17-CG7465-RA_1 CG7465 GCGCCGCCACTAAATCATCCGATAAAGGCTTCACTAGGTGATCGAATTGTGCTCATTTTTGAGTGCAGA 69 FBan0007465 FBgn0035551 CG7465 3 3L CG7465 CG7465 CDMC22930 1 15 19 DAC31-A22 22-CG7483-RA_4 CG7483 AGGCCACCCCTAGTAAGCGGACCGCATTTTTTTCTGTGAAAGTCAGAAAAATTAGCCGAAAAAGACTGT 69 FBan0007483 FBgn0037573 eIF4AIII 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; translational initiation; GO:0006413" ATP binding; GO:0005524; ; GO:0005524; translation initiation factor activity; GO:0003743; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003743; ; GO:0004004; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 eIF4AIII eIF4AIII "CG7483, CG7483, CG7483, CG7483, l(3)84Fi, eIF4A, DmRH28, anon-WO0118547.364, lethal(3)84Fi" CDMC22930 1 16 19 DAC31-A22 22-CG7483-RA_4 CG7483 AGGCCACCCCTAGTAAGCGGACCGCATTTTTTTCTGTGAAAGTCAGAAAAATTAGCCGAAAAAGACTGT 69 FBan0007483 FBgn0037573 eIF4AIII 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; translational initiation; GO:0006413" ATP binding; GO:0005524; ; GO:0005524; translation initiation factor activity; GO:0003743; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003743; ; GO:0004004; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 eIF4AIII eIF4AIII "CG7483, CG7483, CG7483, CG7483, l(3)84Fi, eIF4A, DmRH28, anon-WO0118547.364, lethal(3)84Fi" CDMC22931 1 17 19 DAC31-E10 8-CG7524-RB_1 CG7524 TCGGAGGTGCCGTATCGAGAGGTGCAAGACTAAACAGAGTCCAGCCTATTCACACACATCACCAACACT 69 FBan0007524 FBgn0003501 Src64B 3 3L "JNK cascade; GO:0007254; cellularization; GO:0007349; dorsal closure; GO:0007391; learning and/or memory; GO:0007611; mushroom body development; GO:0016319; olfactory learning; GO:0008355; ovarian ring canal formation; GO:0007301; ovarian ring canal stabilization; GO:0008335; parallel actin filament bundle formation; GO:0030046; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064; ring canal formation, actin assembly; GO:0008302" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- ring canal (sensu Insecta); GO:0045172 Src64B Src oncogene at 64B "CG7524, CG7524, CG7524, c-src, D-src, Dsrc, Dsrc64B, Src1, Dsrc64, DSrc, DSRC64, Src, Dm SRC1, Src64, dSrc, dsrc, DmHD-358, DSrc64, src, src64, SRC 64B, DSrc64B, src64b, src64B, C-src1, HD-358, src1" CDMC22931 1 18 19 DAC31-E10 8-CG7524-RB_1 CG7524 TCGGAGGTGCCGTATCGAGAGGTGCAAGACTAAACAGAGTCCAGCCTATTCACACACATCACCAACACT 69 FBan0007524 FBgn0003501 Src64B 3 3L "JNK cascade; GO:0007254; cellularization; GO:0007349; dorsal closure; GO:0007391; learning and/or memory; GO:0007611; mushroom body development; GO:0016319; olfactory learning; GO:0008355; ovarian ring canal formation; GO:0007301; ovarian ring canal stabilization; GO:0008335; parallel actin filament bundle formation; GO:0030046; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064; ring canal formation, actin assembly; GO:0008302" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- ring canal (sensu Insecta); GO:0045172 Src64B Src oncogene at 64B "CG7524, CG7524, CG7524, c-src, D-src, Dsrc, Dsrc64B, Src1, Dsrc64, DSrc, DSRC64, Src, Dm SRC1, Src64, dSrc, dsrc, DmHD-358, DSrc64, src, src64, SRC 64B, DSrc64B, src64b, src64B, C-src1, HD-358, src1" CDMC22932 1 19 19 DAC31-E22 23-CG7532-RA_7 CG7532 CGCGTCACAAAAGACATCGATGTGGAGTAGTGCTTGTGATAGATGTTTTCATGATTTGTTCAAAATCCT 69 FBan0007532 FBgn0028915 CG7532 2 2L serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG7532 CG7532 "BG:DS01068.5, DS01068.5, BcDNA:RE60882, anon-EST:ParkEST060" CDMC22932 1 20 19 DAC31-E22 23-CG7532-RA_7 CG7532 CGCGTCACAAAAGACATCGATGTGGAGTAGTGCTTGTGATAGATGTTTTCATGATTTGTTCAAAATCCT 69 FBan0007532 FBgn0028915 CG7532 2 2L serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG7532 CG7532 "BG:DS01068.5, DS01068.5, BcDNA:RE60882, anon-EST:ParkEST060" CDMC22933 1 21 19 DAC31-I10 7-CG7568-RA_1 CG7568 AGGCCATAGCGCTGAGTTATCCAACTGCGTTTGGAATTTTAGCGGATCTCTGATTGCTACTGGCTCCCT 69 FBan0007568 FBgn0039673 CG7568 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" CG7568 CG7568 CDMC22933 1 22 19 DAC31-I10 7-CG7568-RA_1 CG7568 AGGCCATAGCGCTGAGTTATCCAACTGCGTTTGGAATTTTAGCGGATCTCTGATTGCTACTGGCTCCCT 69 FBan0007568 FBgn0039673 CG7568 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" CG7568 CG7568 CDMC22934 1 23 19 DAC31-I22 21-CG7578-RA_1 CG7578 TAGGCGTGTGTTCATGCGCATCGGTCCAGTATTCAATATAATGAGCGTTAAATAGTCACGGAGGAGCCG 69 FBan0007578 FBgn0028538 CG7578 2 2L ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; ; GO:0005086; ; GO:0005086 Golgi apparatus; GO:0005794 CG7578 CG7578 "BG:DS00797.7, BIG1" CDMC22934 1 24 19 DAC31-I22 21-CG7578-RA_1 CG7578 TAGGCGTGTGTTCATGCGCATCGGTCCAGTATTCAATATAATGAGCGTTAAATAGTCACGGAGGAGCCG 69 FBan0007578 FBgn0028538 CG7578 2 2L ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; ; GO:0005086; ; GO:0005086 Golgi apparatus; GO:0005794 CG7578 CG7578 "BG:DS00797.7, BIG1" CDMC22935 1 25 19 DAC31-M10 9-CG7608-RA_1 CG7608 TGCGTGGCTGTTCAGGCTCAAACTCGTGAACAAGAAATTTGCCGTCAAGAAAACGAAACTTGCCGTCGA 69 FBan0007608 FBgn0004590 Eig71Ec 3 3L Eig71Ec Ecdysone-induced gene 71Ec "CG7608, gene III, III, Gene III, 71E-Gene-III, L71-3, L71, gene-III" CDMC22935 1 26 19 DAC31-M10 9-CG7608-RA_1 CG7608 TGCGTGGCTGTTCAGGCTCAAACTCGTGAACAAGAAATTTGCCGTCAAGAAAACGAAACTTGCCGTCGA 69 FBan0007608 FBgn0004590 Eig71Ec 3 3L Eig71Ec Ecdysone-induced gene 71Ec "CG7608, gene III, III, Gene III, 71E-Gene-III, L71-3, L71, gene-III" CDMC22936 1 1 20 DAC31-M22 23-CG7622-RA_2 CG7622 TCCAACTGCCATACTGTTTCCTGTCCAACTTTTTTCGCTCTTTCTTTCTTTTAACAGCGTCTGAGTTAA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC22936 1 2 20 DAC31-M22 23-CG7622-RA_2 CG7622 TCCAACTGCCATACTGTTTCCTGTCCAACTTTTTTCGCTCTTTCTTTCTTTTAACAGCGTCTGAGTTAA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC22937 1 3 20 DAC32-A10 9-CG14723-RA_2 CG14723 TGCGGTTGCCTGAGAACATGAGTGAGCAGTATCGCATATTGGATGTCGACTGGTTGCACAGCATTTGG 68 FBan0014723 FBgn0037950 HisCl1 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 histamine-gated chloride channel activity; GO:0019182; ; GO:0019182; GABA-A receptor activity; GO:0004890; glycine-gated ion channel activity; GO:0016933; ; GO:0016933; neurotransmitter receptor activity; GO:0030594; ; GO:0004890; ; GO:0030594 histamine-gated chloride channel complex; GO:0019183; postsynaptic membrane; GO:0045211 HisCl1 Histamine-gated chloride channel subunit 1 "CG14723, CG14723, CG14723, DmHisCl1, hisCl1, hclB" CDMC22937 1 4 20 DAC32-A10 9-CG14723-RA_2 CG14723 TGCGGTTGCCTGAGAACATGAGTGAGCAGTATCGCATATTGGATGTCGACTGGTTGCACAGCATTTGG 68 FBan0014723 FBgn0037950 HisCl1 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 histamine-gated chloride channel activity; GO:0019182; ; GO:0019182; GABA-A receptor activity; GO:0004890; glycine-gated ion channel activity; GO:0016933; ; GO:0016933; neurotransmitter receptor activity; GO:0030594; ; GO:0004890; ; GO:0030594 histamine-gated chloride channel complex; GO:0019183; postsynaptic membrane; GO:0045211 HisCl1 Histamine-gated chloride channel subunit 1 "CG14723, CG14723, CG14723, DmHisCl1, hisCl1, hclB" CDMC22938 1 5 20 DAC32-A22 3-CG14847-RA_1 CG14847 GCAGGAGTCCAGCAGCTTGATGAATTGTCTCGTTCCACGGAATCAGATAGCGGCTTTGACAGCAGCAG 68 FBan0014847 FBgn0038228 CG14847 3 3R CG14847 CG14847 CDMC22938 1 6 20 DAC32-A22 3-CG14847-RA_1 CG14847 GCAGGAGTCCAGCAGCTTGATGAATTGTCTCGTTCCACGGAATCAGATAGCGGCTTTGACAGCAGCAG 68 FBan0014847 FBgn0038228 CG14847 3 3R CG14847 CG14847 CDMC22939 1 7 20 DAC32-E10 3-CG15302-RA_2 CG15302 AATCGAAGTGTGGCCTGATGCGCGGGAAATCATCGAGGTGGAGAACCAAAGTGACCAAATGCTCAGTC 68 FBan0015302 FBgn0030204 Or9a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or9a Odorant receptor 9a "CG15302, 9E.1, DOR95, 9a" CDMC22939 1 8 20 DAC32-E10 3-CG15302-RA_2 CG15302 AATCGAAGTGTGGCCTGATGCGCGGGAAATCATCGAGGTGGAGAACCAAAGTGACCAAATGCTCAGTC 68 FBan0015302 FBgn0030204 Or9a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or9a Odorant receptor 9a "CG15302, 9E.1, DOR95, 9a" CDMC22940 1 9 20 DAC32-E22 3-CG15355-RA_3 CG15355 CCAAGGATGAGCAACGTGTCCGACGAAATGCAGATCTACGGTTACCGGGTGGCCTACATGAGTGACAC 68 FBgn0031382 CDMC22940 1 10 20 DAC32-E22 3-CG15355-RA_3 CG15355 CCAAGGATGAGCAACGTGTCCGACGAAATGCAGATCTACGGTTACCGGGTGGCCTACATGAGTGACAC 68 FBgn0031382 CDMC22941 1 11 20 DAC32-I10 3-CG15768-RA_1 CG15768 TGGCTTCACCGGATGCCCAATTCAATGAGGTGGTCGCATTATTCGGTGAGTCAAAACACATACCCCGG 68 FBan0015768 FBgn0029806 CG15768 X X CG15768 CG15768 CDMC22941 1 12 20 DAC32-I10 3-CG15768-RA_1 CG15768 TGGCTTCACCGGATGCCCAATTCAATGAGGTGGTCGCATTATTCGGTGAGTCAAAACACATACCCCGG 68 FBan0015768 FBgn0029806 CG15768 X X CG15768 CG15768 CDMC22942 1 13 20 DAC32-I22 1-CG1635-RA_1 CG1635 GCGGGAGGTACCAAAAGTTAACCCGTGCCTTGTTCCTGATGGCAGCAAGAAACGCTAACAATACCGGA 68 FBan0001635 FBgn0039854 CG1635 3 3R lipid metabolism; GO:0006629 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG1635 CG1635 CDMC22942 1 14 20 DAC32-I22 1-CG1635-RA_1 CG1635 GCGGGAGGTACCAAAAGTTAACCCGTGCCTTGTTCCTGATGGCAGCAAGAAACGCTAACAATACCGGA 68 FBan0001635 FBgn0039854 CG1635 3 3R lipid metabolism; GO:0006629 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG1635 CG1635 CDMC22943 1 15 20 DAC32-M10 2-CG17054-RB_1 CG17054 GCGCACAGCGGATGAATTCCAAAGTCATGACCCGTAAGCGAATGTCTCTCGAGATGAACCTCAGTGGC 68 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC22943 1 16 20 DAC32-M10 2-CG17054-RB_1 CG17054 GCGCACAGCGGATGAATTCCAAAGTCATGACCCGTAAGCGAATGTCTCTCGAGATGAACCTCAGTGGC 68 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC22944 1 17 20 DAC32-M22 2-CG1722-RA_1 CG1722 GGGTAAGGATTCAAGGACCACCAAGATGCCCAAGAAAATGAAGCCCTCAAGCGAAAAGCCTGCAAGCG 68 FBan0001722 FBgn0031168 CG1722 X X CG1722 CG1722 CDMC22944 1 18 20 DAC32-M22 2-CG1722-RA_1 CG1722 GGGTAAGGATTCAAGGACCACCAAGATGCCCAAGAAAATGAAGCCCTCAAGCGAAAAGCCTGCAAGCG 68 FBan0001722 FBgn0031168 CG1722 X X CG1722 CG1722 CDMC22945 1 19 20 DAC33-A10 2-CG31390-RA_3 CG31390 TGTGCGCGAGATCGTTAATACCGCCTTCTCAGCTCTGCCGGTTCTAGATGATGACGACGATAGCGG 66 FBan0031390 FBgn0051390 MED7 3 3R positive regulation of transcription; GO:0045941; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; transcription coactivator activity; GO:0003713; ; GO:0003712; ; GO:0016455; ; GO:0003713 mediator complex; GO:0000119; nucleus; GO:0005634 MED7 Mediator complex subunit 7 "CG31390, CG6529, Med7, dTRAP34, dMED7, Mediator, Mediator complex subunit 7" CDMC22945 1 20 20 DAC33-A10 2-CG31390-RA_3 CG31390 TGTGCGCGAGATCGTTAATACCGCCTTCTCAGCTCTGCCGGTTCTAGATGATGACGACGATAGCGG 66 FBan0031390 FBgn0051390 MED7 3 3R positive regulation of transcription; GO:0045941; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; transcription coactivator activity; GO:0003713; ; GO:0003712; ; GO:0016455; ; GO:0003713 mediator complex; GO:0000119; nucleus; GO:0005634 MED7 Mediator complex subunit 7 "CG31390, CG6529, Med7, dTRAP34, dMED7, Mediator, Mediator complex subunit 7" CDMC22946 1 21 20 DAC33-A22 3-CG3157-RA_4 CG3157 GCGCCTTTCTTGACCAGTTTCGACGCGAGGACATCTTCAAGGACGACCTCAATGAGCTGGACGAAT 66 FBan0003157 FBgn0004176 gammaTub23C 2 2L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; guanyl nucleotide binding; GO:0019001; ; GO:0019001; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0019001; ; GO:0015631; ; GO:0005200; ; GO:0005525 gamma-tubulin small complex; GO:0008275; microtubule; GO:0005874; microtubule organizing center; GO:0005815; tubulin; GO:0045298 gammaTub23C gamma-Tubulin at 23C "CG3157, CG3157, CG3157, CG3157, gamma tubulin, gammaTub23CD, gamma[zy], gamma-tubulin, gamma-tubulin-1, gammatub23C, gammaTUB23C, gammatub, gamma-tubulin, gammatubulin, GTUB, gamma tubulin, D.m.GAMMA-23C, gammaTub23C, GAMMA23C, gama-tubulin, Gamma-tubulin, gamma-Tub, gamma-tub23, gamma-Tubulin, gammaTUB, g-Tubulin, gammaTub" CDMC22946 1 22 20 DAC33-A22 3-CG3157-RA_4 CG3157 GCGCCTTTCTTGACCAGTTTCGACGCGAGGACATCTTCAAGGACGACCTCAATGAGCTGGACGAAT 66 FBan0003157 FBgn0004176 gammaTub23C 2 2L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; guanyl nucleotide binding; GO:0019001; ; GO:0019001; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0019001; ; GO:0015631; ; GO:0005200; ; GO:0005525 gamma-tubulin small complex; GO:0008275; microtubule; GO:0005874; microtubule organizing center; GO:0005815; tubulin; GO:0045298 gammaTub23C gamma-Tubulin at 23C "CG3157, CG3157, CG3157, CG3157, gamma tubulin, gammaTub23CD, gamma[zy], gamma-tubulin, gamma-tubulin-1, gammatub23C, gammaTUB23C, gammatub, gamma-tubulin, gammatubulin, GTUB, gamma tubulin, D.m.GAMMA-23C, gammaTub23C, GAMMA23C, gama-tubulin, Gamma-tubulin, gamma-Tub, gamma-tub23, gamma-Tubulin, gammaTUB, g-Tubulin, gammaTub" CDMC22947 1 23 20 DAC33-E10 11-CG32150-RA_1 CG32150 GGAACACGCTCTAACACGTCAGCTATCGGAAATGTGCCGACTGTACCGATTGCAGAACGAACGGTA 66 FBan0032150 FBgn0052150 CG32150 3 3L CG32150 CG32150 "CG12712, CG15714" CDMC22947 1 24 20 DAC33-E10 11-CG32150-RA_1 CG32150 GGAACACGCTCTAACACGTCAGCTATCGGAAATGTGCCGACTGTACCGATTGCAGAACGAACGGTA 66 FBan0032150 FBgn0052150 CG32150 3 3L CG32150 CG32150 "CG12712, CG15714" CDMC22948 1 25 20 DAC33-E22 1-CG32231-RA_1 CG32231 CGATATGGAGTAGGGATTCCGATTCCTATCTCCAGCTCCTGGCATCACCCCTGGTGTCGCGATCTC 66 FBan0032231 FBgn0052231 CG32231 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32231 CG32231 CDMC22948 1 26 20 DAC33-E22 1-CG32231-RA_1 CG32231 CGATATGGAGTAGGGATTCCGATTCCTATCTCCAGCTCCTGGCATCACCCCTGGTGTCGCGATCTC 66 FBan0032231 FBgn0052231 CG32231 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32231 CG32231 CDMC22949 1 1 21 DAC33-I10 18-CG32662-RA_1 CG32662 GACGAAGCGCCGGAAGAGATAAGAATTAGCGATATGTTTGCTGTGCGTCTTTAGCCTGGTGGTGCT 66 FBan0032662 FBgn0052662 CG32662 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32662 CG32662 "CG1905, CG1905, CG1905, CG1905, clone 2.41, anon-EST:Liang-2.41" CDMC22949 1 2 21 DAC33-I10 18-CG32662-RA_1 CG32662 GACGAAGCGCCGGAAGAGATAAGAATTAGCGATATGTTTGCTGTGCGTCTTTAGCCTGGTGGTGCT 66 FBan0032662 FBgn0052662 CG32662 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32662 CG32662 "CG1905, CG1905, CG1905, CG1905, clone 2.41, anon-EST:Liang-2.41" CDMC22950 1 3 21 DAC33-I22 2-CG32779-RA_1 CG32779 CGCCCAATCCTCGACGTCCTTCATCAACGATCTCTTTTCCTATGAGAGCAGTCTTCTGGTGCCCGC 66 FBan0032779 FBgn0052779 CG32779 X X CG32779 CG32779 "CG15238, CG18771" CDMC22950 1 4 21 DAC33-I22 2-CG32779-RA_1 CG32779 CGCCCAATCCTCGACGTCCTTCATCAACGATCTCTTTTCCTATGAGAGCAGTCTTCTGGTGCCCGC 66 FBan0032779 FBgn0052779 CG32779 X X CG32779 CG32779 "CG15238, CG18771" CDMC22951 1 5 21 DAC33-M10 3-CG33274-RA_5 CG33274 CGTTCATCCCTCCTGTCATTCGTACAAGCCCCAGTCCTACCGCCAATCCACTGATTCCATCTAGCC 66 FBan0033274 FBgn0035864 CG33274 3 3L cell adhesion; GO:0007155; cell proliferation; GO:0008283; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG33274 CG33274 "CG18630, CG7060, CG18630, CG7060, CG7060, CT21829" CDMC22951 1 6 21 DAC33-M10 3-CG33274-RA_5 CG33274 CGTTCATCCCTCCTGTCATTCGTACAAGCCCCAGTCCTACCGCCAATCCACTGATTCCATCTAGCC 66 FBan0033274 FBgn0035864 CG33274 3 3L cell adhesion; GO:0007155; cell proliferation; GO:0008283; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG33274 CG33274 "CG18630, CG7060, CG18630, CG7060, CG7060, CT21829" CDMC22952 1 7 21 DAC33-M22 2-CG3402-RA_1 CG3402 CCATGGTCACCCACAAAAAGGCCGTGAGCTACATCCGGAAAAACCCGATACTCAACATGCTGGTGG 66 FBan0003402 FBgn0035148 CG3402 3 3L protein binding; GO:0005515; ; GO:0005515 CG3402 CG3402 BcDNA:LD06317 CDMC22952 1 8 21 DAC33-M22 2-CG3402-RA_1 CG3402 CCATGGTCACCCACAAAAAGGCCGTGAGCTACATCCGGAAAAACCCGATACTCAACATGCTGGTGG 66 FBan0003402 FBgn0035148 CG3402 3 3L protein binding; GO:0005515; ; GO:0005515 CG3402 CG3402 BcDNA:LD06317 CDMC22953 1 9 21 DAC34-A10 15-CG13432-RA_11 CG13432 GGGCACACCTTTGACAATGGAAATCAATCTGGATGAGGACTCTGCACCTGTTTATGGTCTGGGTGTCAA 69 FBan0013432 FBgn0028622 l(2)05510 2 2R l(2)05510 lethal (2) 05510 "CG13432, CG13433, CG13432, CG13432, CG13432, CG13432, CG13432, EP2356, l(2)k009920" CDMC22953 1 10 21 DAC34-A10 15-CG13432-RA_11 CG13432 GGGCACACCTTTGACAATGGAAATCAATCTGGATGAGGACTCTGCACCTGTTTATGGTCTGGGTGTCAA 69 FBan0013432 FBgn0028622 l(2)05510 2 2R l(2)05510 lethal (2) 05510 "CG13432, CG13433, CG13432, CG13432, CG13432, CG13432, CG13432, EP2356, l(2)k009920" CDMC22954 1 11 21 DAC34-A22 17-CG13449-RA_6 CG13449 GGGGTAAACACGAGAACATAAAGCGTAAGAAGATCATTTTGGACCTACGGAGATCGCACTCCCAGGAGA 69 FBan0013449 FBgn0036520 CG13449 3 3L CG13449 CG13449 CDMC22954 1 12 21 DAC34-A22 17-CG13449-RA_6 CG13449 GGGGTAAACACGAGAACATAAAGCGTAAGAAGATCATTTTGGACCTACGGAGATCGCACTCCCAGGAGA 69 FBan0013449 FBgn0036520 CG13449 3 3L CG13449 CG13449 CDMC22955 1 13 21 DAC34-E10 11-CG13491-RA_5 CG13491 AGGACTCTGCAATCTGCACTACGATTCCTCGAATCATCGGTTCATCCTCAATCATGTGCCCACAGTGGT 69 FBan0013491 FBgn0041237 Gr58c 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58c Gustatory receptor 58c "CG13491, CG13491, 58A.3, Gustatory receptor 58A.3, Gr58A3, 58A3, GR58A.3, Gustatory receptor 58c" CDMC22955 1 14 21 DAC34-E10 11-CG13491-RA_5 CG13491 AGGACTCTGCAATCTGCACTACGATTCCTCGAATCATCGGTTCATCCTCAATCATGTGCCCACAGTGGT 69 FBan0013491 FBgn0041237 Gr58c 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58c Gustatory receptor 58c "CG13491, CG13491, 58A.3, Gustatory receptor 58A.3, Gr58A3, 58A3, GR58A.3, Gustatory receptor 58c" CDMC22956 1 15 21 DAC34-E22 23-CG13502-RB_2 CG13502 ACTTGTTCAGCTCCCGGTGTTAAGTTTCTGTTTGAATTGAGTTGGCTTGATAAGCTGGTATTGAATAAA 69 FBan0013502 FBgn0034692 CG13502 2 2R CG13502 CG13502 CDMC22956 1 16 21 DAC34-E22 23-CG13502-RB_2 CG13502 ACTTGTTCAGCTCCCGGTGTTAAGTTTCTGTTTGAATTGAGTTGGCTTGATAAGCTGGTATTGAATAAA 69 FBan0013502 FBgn0034692 CG13502 2 2R CG13502 CG13502 CDMC22957 1 17 21 DAC34-I10 17-CG13564-RA_1 CG13564 GCCCGCTGGAATCAACAGTAGTGTTCGAAAGATCTCTGAGCTTCGATTAAATGTGGGCTTCCTCTCGAT 69 FBan0013564 FBgn0034973 CG13564 2 2R CG13564 CG13564 CDMC22957 1 18 21 DAC34-I10 17-CG13564-RA_1 CG13564 GCCCGCTGGAATCAACAGTAGTGTTCGAAAGATCTCTGAGCTTCGATTAAATGTGGGCTTCCTCTCGAT 69 FBan0013564 FBgn0034973 CG13564 2 2R CG13564 CG13564 CDMC22958 1 19 21 DAC34-I22 1-CG13570-RA_2 CG13570 AGGTCCACCCAAAGCTGAGACCATTGCTAAGACCTCCAAAGAAGTCAAGCCTACCAAACAGACTGCGGT 69 FBan0013570 FBgn0015544 spag 2 2R "cell proliferation; GO:0008283; imaginal disc development; GO:0007444; imaginal disc fusion, thorax closure; GO:0046529; imaginal disc growth; GO:0007446" protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; chaperone binding; GO:0051087; ; GO:0051087 spag spaghetti "CG13570, l(2)k12101, spaghetti" CDMC22958 1 20 21 DAC34-I22 1-CG13570-RA_2 CG13570 AGGTCCACCCAAAGCTGAGACCATTGCTAAGACCTCCAAAGAAGTCAAGCCTACCAAACAGACTGCGGT 69 FBan0013570 FBgn0015544 spag 2 2R "cell proliferation; GO:0008283; imaginal disc development; GO:0007444; imaginal disc fusion, thorax closure; GO:0046529; imaginal disc growth; GO:0007446" protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; chaperone binding; GO:0051087; ; GO:0051087 spag spaghetti "CG13570, l(2)k12101, spaghetti" CDMC22959 1 21 21 DAC34-M10 15-CG13606-RA_2 CG13606 CCGCCCCAGCAAAGTAATGCGAACCTCTTTAAGCGCACTGTCTGAACACAGATAGAGATAGCTGCTACT 69 FBan0013606 FBgn0039161 CG13606 3 3R CG13606 CG13606 CDMC22959 1 22 21 DAC34-M10 15-CG13606-RA_2 CG13606 CCGCCCCAGCAAAGTAATGCGAACCTCTTTAAGCGCACTGTCTGAACACAGATAGAGATAGCTGCTACT 69 FBan0013606 FBgn0039161 CG13606 3 3R CG13606 CG13606 CDMC22960 1 23 21 DAC34-M22 18-CG13616-RA_3 CG13616 TCCCGGCGAGCTTTTTACGATGAGGTGCAGTCTTTATTTGATAACATGGGTTTCAATGGTCGTTCGTGT 69 FBan0013616 FBgn0039200 CG13616 3 3R CG13616 CG13616 CDMC22960 1 24 21 DAC34-M22 18-CG13616-RA_3 CG13616 TCCCGGCGAGCTTTTTACGATGAGGTGCAGTCTTTATTTGATAACATGGGTTTCAATGGTCGTTCGTGT 69 FBan0013616 FBgn0039200 CG13616 3 3R CG13616 CG13616 CDMC22961 1 25 21 DAC35-A10 1-CG17342-RA_1 CG17342 AACGTGACCAAACCGACGACTACTGCTGAGGGGACAACAATGCAAACGACTTTTGGCATGTCAGCG 66 FBan0017342 FBgn0017581 Lk6 3 3R intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; protein amino acid phosphorylation; GO:0006468; regulation of growth; GO:0040008 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; kinase activity; GO:0016301; ; GO:0016301 centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule; GO:0005874; nuclear membrane; GO:0005635 Lk6 Lk6 "CG17342, CG6929, CG17342, CG17342, CG17342, LK6, MESR8, MNK/LK6, lk6, anon-WO0172774.84" CDMC22961 1 26 21 DAC35-A10 1-CG17342-RA_1 CG17342 AACGTGACCAAACCGACGACTACTGCTGAGGGGACAACAATGCAAACGACTTTTGGCATGTCAGCG 66 FBan0017342 FBgn0017581 Lk6 3 3R intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; protein amino acid phosphorylation; GO:0006468; regulation of growth; GO:0040008 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; kinase activity; GO:0016301; ; GO:0016301 centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule; GO:0005874; nuclear membrane; GO:0005635 Lk6 Lk6 "CG17342, CG6929, CG17342, CG17342, CG17342, LK6, MESR8, MNK/LK6, lk6, anon-WO0172774.84" CDMC22962 1 1 22 DAC35-A22 11-CG17754-RD_2 CG17754 CTCGCCTCGCTCTCGTCTGTGTTCTGACATGATTCCCTGTGGTATGGCATACACCCAGAACTCACC 66 FBan0017754 FBgn0030114 CG17754 X X apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 CG17754 CG17754 BcDNA:LP02641 CDMC22962 1 2 22 DAC35-A22 11-CG17754-RD_2 CG17754 CTCGCCTCGCTCTCGTCTGTGTTCTGACATGATTCCCTGTGGTATGGCATACACCCAGAACTCACC 66 FBan0017754 FBgn0030114 CG17754 X X apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 CG17754 CG17754 BcDNA:LP02641 CDMC22963 1 3 22 DAC35-E10 11-CG1850-RA_2 CG1850 AGCCCCAAGCATTCACCTTCCCAGAAAAAAAAGCTCCTCAACCTATCCAGGAAACTCCAGAGGTCG 66 FBan0001850 FBgn0033154 CG1850 2 2R CG1850 CG1850 CDMC22963 1 4 22 DAC35-E10 11-CG1850-RA_2 CG1850 AGCCCCAAGCATTCACCTTCCCAGAAAAAAAAGCTCCTCAACCTATCCAGGAAACTCCAGAGGTCG 66 FBan0001850 FBgn0033154 CG1850 2 2R CG1850 CG1850 CDMC22964 1 5 22 DAC35-E22 1-CG2056-RA_1 CG2056 AACGGAGGATGAGCATTCGGTCTACCCATTGCATACCCACTCGTGTGTATCTGCACCTTCTGCTGG 66 FBan0002056 FBgn0030051 CG2056 X X protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; trypsin activity; GO:0004295 ; EC:3.4.21.4; protein kinase activity; GO:0004672 ; EC:2.7.1.37; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG2056 CG2056 "c-SP33, SP33" CDMC22964 1 6 22 DAC35-E22 1-CG2056-RA_1 CG2056 AACGGAGGATGAGCATTCGGTCTACCCATTGCATACCCACTCGTGTGTATCTGCACCTTCTGCTGG 66 FBan0002056 FBgn0030051 CG2056 X X protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; trypsin activity; GO:0004295 ; EC:3.4.21.4; protein kinase activity; GO:0004672 ; EC:2.7.1.37; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG2056 CG2056 "c-SP33, SP33" CDMC22965 1 7 22 DAC35-I10 24-CG2952-RA_2 CG2952 AAGAGAAGCCACTAATAACGGTCTATAGCTTTCTCGCTGTGTAGAAAATACCAAATAAATTAATGA 66 FBan0002952 FBgn0000487 Dox-A3 2 2R defense response; GO:0006952; metabolism; GO:0008152; transport; GO:0006810 monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 Dox-A3 Diphenol oxidase A3 "CG2952, Diphenol oxidase, DPO, phenol oxidase, Dox-3, A[[3]], prophenoloxidase A[[3]], phenoloxidase, prophenol oxidase A3, DmePPO3, PO, prophenoloxidase, doxA3, PO A3, proPO, Dox3, DoxA3" CDMC22965 1 8 22 DAC35-I10 24-CG2952-RA_2 CG2952 AAGAGAAGCCACTAATAACGGTCTATAGCTTTCTCGCTGTGTAGAAAATACCAAATAAATTAATGA 66 FBan0002952 FBgn0000487 Dox-A3 2 2R defense response; GO:0006952; metabolism; GO:0008152; transport; GO:0006810 monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 Dox-A3 Diphenol oxidase A3 "CG2952, Diphenol oxidase, DPO, phenol oxidase, Dox-3, A[[3]], prophenoloxidase A[[3]], phenoloxidase, prophenol oxidase A3, DmePPO3, PO, prophenoloxidase, doxA3, PO A3, proPO, Dox3, DoxA3" CDMC22966 1 9 22 DAC35-I22 3-CG30092-RD_4 CG30092 GCATGACTTGGATTTGACTTGGAGCGGCTTAACCATCACCCAATGTCCCAGGAGTGCCTTCGTCAC 66 FBan0030092 FBgn0028371 jbug 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 jbug jitterbug "CG11605, CG13525, CG3550, CG30092, CG11605, CG13525, CG3550, CG11605, CG11605, Filamin, filamin, shi kong, AAF46896, jitterbug" CDMC22966 1 10 22 DAC35-I22 3-CG30092-RD_4 CG30092 GCATGACTTGGATTTGACTTGGAGCGGCTTAACCATCACCCAATGTCCCAGGAGTGCCTTCGTCAC 66 FBan0030092 FBgn0028371 jbug 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 jbug jitterbug "CG11605, CG13525, CG3550, CG30092, CG11605, CG13525, CG3550, CG11605, CG11605, Filamin, filamin, shi kong, AAF46896, jitterbug" CDMC22967 1 11 22 DAC35-M10 1-CG31055-RA_1 CG31055 TCCTTGGAGCCAATGACACCCAATTTGTCGAGCCAGATCGGGGATAGCGAGTCAAGGGAGAATCTC 66 FBan0031055 FBgn0051055 CG31055 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31055 CG31055 "bs23c05.y1, BcDNA:AT22836, BcDNA:AT11054, NEST:bs01f03, NEST:bs23c05" CDMC22967 1 12 22 DAC35-M10 1-CG31055-RA_1 CG31055 TCCTTGGAGCCAATGACACCCAATTTGTCGAGCCAGATCGGGGATAGCGAGTCAAGGGAGAATCTC 66 FBan0031055 FBgn0051055 CG31055 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31055 CG31055 "bs23c05.y1, BcDNA:AT22836, BcDNA:AT11054, NEST:bs01f03, NEST:bs23c05" CDMC22968 1 13 22 DAC35-M22 1-CG3114-RA_1 CG3114 CGCCTGGATTAAGCGATTGACGTGCCATGTTTTCTGGGCATCGTAGCTCTCCTGACTGACTACCCG 66 FBan0003114 FBgn0005427 ewg X X central nervous system development; GO:0007417; ectoderm development; GO:0007398; imaginal disc morphogenesis; GO:0007560; mesoderm development; GO:0007498; muscle development; GO:0007517 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003704; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003704 nucleus; GO:0005634 ewg erect wing "CG3114, CG3114, EC3, l(1)EC3, l[EC3], l(1)DA659, EWG, l(1)1Ag, EG:BACR37P7.7, NRF-1, l(1)EC3f, l(1)VA720, erect wing" CDMC22968 1 14 22 DAC35-M22 1-CG3114-RA_1 CG3114 CGCCTGGATTAAGCGATTGACGTGCCATGTTTTCTGGGCATCGTAGCTCTCCTGACTGACTACCCG 66 FBan0003114 FBgn0005427 ewg X X central nervous system development; GO:0007417; ectoderm development; GO:0007398; imaginal disc morphogenesis; GO:0007560; mesoderm development; GO:0007498; muscle development; GO:0007517 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003704; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003704 nucleus; GO:0005634 ewg erect wing "CG3114, CG3114, EC3, l(1)EC3, l[EC3], l(1)DA659, EWG, l(1)1Ag, EG:BACR37P7.7, NRF-1, l(1)EC3f, l(1)VA720, erect wing" CDMC22969 1 15 22 DAC36-A10 3-CG17524-RA_1 CG17524 GATGCCCTGGAGGGTGTCTACAAGTCCCTCAATCTGTTTCTGGAGAATGGCAATTATCTGGCCGGCG 67 FBgn0034337 CDMC22969 1 16 22 DAC36-A10 3-CG17524-RA_1 CG17524 GATGCCCTGGAGGGTGTCTACAAGTCCCTCAATCTGTTTCTGGAGAATGGCAATTATCTGGCCGGCG 67 FBgn0034337 CDMC22970 1 17 22 DAC36-A22 3-CG1774-RA_2 CG1774 ATGCAGTCTACGATGATTGCTCCATTTCCGGAGAACAGGAATGCGCAGAACACCATCTTTGGGGGCT 67 FBan0001774 FBgn0039856 CG1774 3 3R lipid metabolism; GO:0006629 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG1774 CG1774 CDMC22970 1 18 22 DAC36-A22 3-CG1774-RA_2 CG1774 ATGCAGTCTACGATGATTGCTCCATTTCCGGAGAACAGGAATGCGCAGAACACCATCTTTGGGGGCT 67 FBan0001774 FBgn0039856 CG1774 3 3R lipid metabolism; GO:0006629 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG1774 CG1774 CDMC22971 1 19 22 DAC36-E10 2-CG18547-RA_2 CG18547 GCAAGATTCATTGGAGTGTCCGCTTACCCGATTTCGGTGCTTAAGGAGTTCCTGACCCGAACAGCCG 67 FBan0018547 FBgn0037973 CG18547 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18547 CG18547 CDMC22971 1 20 22 DAC36-E10 2-CG18547-RA_2 CG18547 GCAAGATTCATTGGAGTGTCCGCTTACCCGATTTCGGTGCTTAAGGAGTTCCTGACCCGAACAGCCG 67 FBan0018547 FBgn0037973 CG18547 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18547 CG18547 CDMC22972 1 21 22 DAC36-E22 3-CG18625-RA_1 CG18625 CCGTTCACCTACCCGGGATCACCTGTTCCCTCTAACTTCTTTGACTTCGAGGAGGTAGTACCGCCAC 67 FBan0018625 FBgn0034017 CG18625 2 2R CG18625 CG18625 CDMC22972 1 22 22 DAC36-E22 3-CG18625-RA_1 CG18625 CCGTTCACCTACCCGGGATCACCTGTTCCCTCTAACTTCTTTGACTTCGAGGAGGTAGTACCGCCAC 67 FBan0018625 FBgn0034017 CG18625 2 2R CG18625 CG18625 CDMC22973 1 23 22 DAC36-I10 2-CG2641-RA_1 CG2641 CGCTTCAACAACGTCTTCAAGCAGCCACTGACGGTCATACAGACCTACAACCTCAACATGAGCCCCC 67 FBan0002641 FBgn0037518 CG2641 3 3R CG2641 CG2641 CDMC22973 1 24 22 DAC36-I10 2-CG2641-RA_1 CG2641 CGCTTCAACAACGTCTTCAAGCAGCCACTGACGGTCATACAGACCTACAACCTCAACATGAGCCCCC 67 FBan0002641 FBgn0037518 CG2641 3 3R CG2641 CG2641 CDMC22974 1 25 22 DAC36-I22 8-CG2930-RD_5 CG2930 GCTTGTGAGCAGTACCATCTGGACAGCCCTGACCACCAAATGTAAGGAGAAAAAGACCAATCCGCGG 67 FBan0002930 FBgn0028491 CG2930 X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG2930 CG2930 "CG32780, CG32787, BcDNA:GH06717" CDMC22974 1 26 22 DAC36-I22 8-CG2930-RD_5 CG2930 GCTTGTGAGCAGTACCATCTGGACAGCCCTGACCACCAAATGTAAGGAGAAAAAGACCAATCCGCGG 67 FBan0002930 FBgn0028491 CG2930 X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG2930 CG2930 "CG32780, CG32787, BcDNA:GH06717" CDMC22975 1 1 23 DAC36-M10 3-CG30339-RA_1 CG30339 GCGGCCTGGAAAGCGTGTTAATGCGGATTCAATTTTTGGCGCTGAGGGATCCTTCCGAAAACTCGAC 67 FBan0030339 FBgn0050339 CG30339 2 2R CG30339 CG30339 BcDNA:RE54230 CDMC22975 1 2 23 DAC36-M10 3-CG30339-RA_1 CG30339 GCGGCCTGGAAAGCGTGTTAATGCGGATTCAATTTTTGGCGCTGAGGGATCCTTCCGAAAACTCGAC 67 FBan0030339 FBgn0050339 CG30339 2 2R CG30339 CG30339 BcDNA:RE54230 CDMC22976 1 3 23 DAC36-M22 1-CG30404-RA_1 CG30404 AGCGACGCCAAATATGCCCACGAGATTAACGACAAGATGCGGGTTCCCAAAAGAATAAAGGCCACCG 67 FBan0030404 FBgn0050404 CG30404 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30404 CG30404 "BcDNA:LD22567, anon-EST:fe1F11, BEST:LD33633, anon-fast-evolving-1F11" CDMC22976 1 4 23 DAC36-M22 1-CG30404-RA_1 CG30404 AGCGACGCCAAATATGCCCACGAGATTAACGACAAGATGCGGGTTCCCAAAAGAATAAAGGCCACCG 67 FBan0030404 FBgn0050404 CG30404 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30404 CG30404 "BcDNA:LD22567, anon-EST:fe1F11, BEST:LD33633, anon-fast-evolving-1F11" CDMC22977 1 5 23 DAC37-A10 3-CG7565-RA_5 CG7565 GAGACGGATTCCGATGTCCTTTTTGAGACCCGCACCAAGTCCAATGGTCTGGGCAAGCACAAGTC 65 FBan0007565 FBgn0035833 CG7565 3 3L chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14 CG7565 CG7565 CT23145 CDMC22977 1 6 23 DAC37-A10 3-CG7565-RA_5 CG7565 GAGACGGATTCCGATGTCCTTTTTGAGACCCGCACCAAGTCCAATGGTCTGGGCAAGCACAAGTC 65 FBan0007565 FBgn0035833 CG7565 3 3L chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14 CG7565 CG7565 CT23145 CDMC22978 1 7 23 DAC37-A22 3-CG7598-RA_1 CG7598 AGGTCCCCACTGGCAGATAGCGAAGATTCCCTTCTCCAAGTTCTTCCTGTCTTCCAAGGGACGTG 65 FBan0007598 FBgn0039689 CG7598 3 3R cytochrome complex assembly; GO:0017004; oxidative phosphorylation; GO:0006119 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG7598 CG7598 CDMC22978 1 8 23 DAC37-A22 3-CG7598-RA_1 CG7598 AGGTCCCCACTGGCAGATAGCGAAGATTCCCTTCTCCAAGTTCTTCCTGTCTTCCAAGGGACGTG 65 FBan0007598 FBgn0039689 CG7598 3 3R cytochrome complex assembly; GO:0017004; oxidative phosphorylation; GO:0006119 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG7598 CG7598 CDMC22979 1 9 23 DAC37-E10 15-CG7709-RA_3 CG7709 GACCTTCTTCATCCTACGAAGCACCAGTTGCACCTCCATCGTCCTCGTACGGAGCTCCTTCCTCT 65 FBan0007709 FBgn0038642 CG7709 3 3R CG7709 CG7709 CDMC22979 1 10 23 DAC37-E10 15-CG7709-RA_3 CG7709 GACCTTCTTCATCCTACGAAGCACCAGTTGCACCTCCATCGTCCTCGTACGGAGCTCCTTCCTCT 65 FBan0007709 FBgn0038642 CG7709 3 3R CG7709 CG7709 CDMC22980 1 11 23 DAC37-E22 2-CG7761-RA_1 CG7761 TTAACCATGCTACCCAGAAGGTGATGGATGCCGAAACGCAGAAAGCCGACTGTCATGCTGAGCAC 65 FBan0007761 FBgn0033988 pcs 2 2R programmed cell death; GO:0012501 protein tyrosine kinase inhibitor activity; GO:0030292; SH3 domain binding; GO:0017124; ; GO:0030292; ; GO:0017124; ; GO:0017124 cytoplasm; GO:0005737 pcs parcas "CG7761, CG7761, CG7761, CG7761, prt, poirot, parcas" CDMC22980 1 12 23 DAC37-E22 2-CG7761-RA_1 CG7761 TTAACCATGCTACCCAGAAGGTGATGGATGCCGAAACGCAGAAAGCCGACTGTCATGCTGAGCAC 65 FBan0007761 FBgn0033988 pcs 2 2R programmed cell death; GO:0012501 protein tyrosine kinase inhibitor activity; GO:0030292; SH3 domain binding; GO:0017124; ; GO:0030292; ; GO:0017124; ; GO:0017124 cytoplasm; GO:0005737 pcs parcas "CG7761, CG7761, CG7761, CG7761, prt, poirot, parcas" CDMC22981 1 13 23 DAC37-I10 2-CG7914-RA_1 CG7914 GTCCGTATTCGCCCTATTGGAGCGACTTTGTGGCCAAAGAGTTCCGTATCCTGGTGAAGCTGCAG 65 FBan0007914 FBgn0030995 CG7914 X X CG7914 CG7914 CDMC22981 1 14 23 DAC37-I10 2-CG7914-RA_1 CG7914 GTCCGTATTCGCCCTATTGGAGCGACTTTGTGGCCAAAGAGTTCCGTATCCTGGTGAAGCTGCAG 65 FBan0007914 FBgn0030995 CG7914 X X CG7914 CG7914 CDMC22982 1 15 23 DAC37-I22 1-CG7937-RA_1 CG7937 CCAGTGAGAATCTGCCCTTCAGCATATCACGCCTGCTATCCAAGCCCTTCGAGACGAGTCACCAC 65 FBan0007937 FBgn0004863 C15 3 3R "elongation of arista core; GO:0035015; leg disc development; GO:0035218; mesodermal cell fate specification; GO:0007501; positive regulation of Notch signaling pathway; GO:0045747; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 C15 C15 "CG7937, 311, Ect5, cll, clawless, 93Bal, Hox11-311" CDMC22982 1 16 23 DAC37-I22 1-CG7937-RA_1 CG7937 CCAGTGAGAATCTGCCCTTCAGCATATCACGCCTGCTATCCAAGCCCTTCGAGACGAGTCACCAC 65 FBan0007937 FBgn0004863 C15 3 3R "elongation of arista core; GO:0035015; leg disc development; GO:0035218; mesodermal cell fate specification; GO:0007501; positive regulation of Notch signaling pathway; GO:0045747; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 C15 C15 "CG7937, 311, Ect5, cll, clawless, 93Bal, Hox11-311" CDMC22983 1 17 23 DAC37-M10 15-CG8016-RA_3 CG8016 CGACGCGCACCAAAAGTTGAAGAATGGCCGTAAGATTTGCTGGAACTTTAGAAGGGGACGCTGCC 65 FBan0008016 FBgn0003194 rad201 2 2R DNA repair; GO:0006281 nucleic acid binding; GO:0003676; ; GO:0003676 rad201 radiation-resistant "CG8016, rad(2)201, RAD201, rad(2)201[G1]" CDMC22983 1 18 23 DAC37-M10 15-CG8016-RA_3 CG8016 CGACGCGCACCAAAAGTTGAAGAATGGCCGTAAGATTTGCTGGAACTTTAGAAGGGGACGCTGCC 65 FBan0008016 FBgn0003194 rad201 2 2R DNA repair; GO:0006281 nucleic acid binding; GO:0003676; ; GO:0003676 rad201 radiation-resistant "CG8016, rad(2)201, RAD201, rad(2)201[G1]" CDMC22984 1 19 23 DAC37-M22 6-CG8036-RB_1 CG8036 ATCAGCTGGAGAAGAACTGCATCACCGTCCGTGTGATCGATCCGTTCACCGTGAAGCCATTGGAC 65 FBan0008036 FBgn0037607 CG8036 3 3R pentose-phosphate shunt; GO:0006098 transketolase activity; GO:0004802 ; EC:2.2.1.1; ; GO:0004802 ; EC:2.2.1.1 CG8036 CG8036 anon-WO0118547.344 CDMC22984 1 20 23 DAC37-M22 6-CG8036-RB_1 CG8036 ATCAGCTGGAGAAGAACTGCATCACCGTCCGTGTGATCGATCCGTTCACCGTGAAGCCATTGGAC 65 FBan0008036 FBgn0037607 CG8036 3 3R pentose-phosphate shunt; GO:0006098 transketolase activity; GO:0004802 ; EC:2.2.1.1; ; GO:0004802 ; EC:2.2.1.1 CG8036 CG8036 anon-WO0118547.344 CDMC22985 1 21 23 DAC38-A10 23-CG4147-RA_2 CG4147 AAAGCGGTAGCAAGAAACAGACAAATGTTATATGTATAAGCGAATAATGTGGTCCCAATTCCTGCGATA 69 FBan0004147 FBgn0001218 Hsc70-3 X X defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408; sleep; GO:0030431 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887 endoplasmic reticulum; GO:0005783 Hsc70-3 Heat shock protein cognate 3 "CG4147, CG1579, CG4147, CG4147, Hsc3, hsc70, hsc72, HSC3, Hsc70, dhsc70, BiP, HSC70, l(1)G0292, l(1)G0407, l(1)G0111, l(1)G0102, Hsc3p, Bip, l(1)G0341, HSC-70, hsc70-3, Grp78, dmHsc72, anon-WO0138581.7, l(1)G0466" CDMC22985 1 22 23 DAC38-A10 23-CG4147-RA_2 CG4147 AAAGCGGTAGCAAGAAACAGACAAATGTTATATGTATAAGCGAATAATGTGGTCCCAATTCCTGCGATA 69 FBan0004147 FBgn0001218 Hsc70-3 X X defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408; sleep; GO:0030431 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887 endoplasmic reticulum; GO:0005783 Hsc70-3 Heat shock protein cognate 3 "CG4147, CG1579, CG4147, CG4147, Hsc3, hsc70, hsc72, HSC3, Hsc70, dhsc70, BiP, HSC70, l(1)G0292, l(1)G0407, l(1)G0111, l(1)G0102, Hsc3p, Bip, l(1)G0341, HSC-70, hsc70-3, Grp78, dmHsc72, anon-WO0138581.7, l(1)G0466" CDMC22986 1 23 23 DAC38-A22 9-CG4159-RA_1 CG4159 TGCTGCAGAAGGTTAAAGAAACCCTGAAGCTCTACGAGGGCACGAAGAACTTCCACAACTTCACCAGCA 69 FBan0004159 FBgn0038811 CG4159 3 3R tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70 CG4159 CG4159 CDMC22986 1 24 23 DAC38-A22 9-CG4159-RA_1 CG4159 TGCTGCAGAAGGTTAAAGAAACCCTGAAGCTCTACGAGGGCACGAAGAACTTCCACAACTTCACCAGCA 69 FBan0004159 FBgn0038811 CG4159 3 3R tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70 CG4159 CG4159 CDMC22987 1 25 23 DAC38-E10 23-CG4200-RA_13 CG4200 CATAACACTAAGCATTCAAGTCTGTTGTCCTCTAAATGTTGTATTTGTGCGTGAGATTGATTCAGGAGA 69 FBan0004200 FBgn0003416 sl X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629 phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11 sl small wing "CG4200, CG4200, plc-gammad, PLC-gamma, PLC-gammaD, PLCgamma, p145, PLC, Plcgamma: Phospholipase C gamma, PLC-gamma D, phospholipase Cgamma, PLCgammaDmel, Phospholipase C gamma" CDMC22987 1 26 23 DAC38-E10 23-CG4200-RA_13 CG4200 CATAACACTAAGCATTCAAGTCTGTTGTCCTCTAAATGTTGTATTTGTGCGTGAGATTGATTCAGGAGA 69 FBan0004200 FBgn0003416 sl X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629 phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11 sl small wing "CG4200, CG4200, plc-gammad, PLC-gamma, PLC-gammaD, PLCgamma, p145, PLC, Plcgamma: Phospholipase C gamma, PLC-gamma D, phospholipase Cgamma, PLCgammaDmel, Phospholipase C gamma" CDMC22988 1 1 24 DAC38-E22 23-CG4206-RA_2 CG4206 ACGAACGATTGCATCCATCAATCCATCCTTTATCCATCAACCATTCTAGCGCTTAAGTTGTCATTTTTG 69 FBan0004206 FBgn0024332 Mcm3 X X DNA replication initiation; GO:0006270; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003682; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 Mcm3 Minichromosome maintenance 3 "CG4206, PCR2, dMCM3, DmMCM3, DmMcm3, MCM3, Mcp-PCR2, Minichromosome maintenance-PCR2, Minichromosome maintenance 3" CDMC22988 1 2 24 DAC38-E22 23-CG4206-RA_2 CG4206 ACGAACGATTGCATCCATCAATCCATCCTTTATCCATCAACCATTCTAGCGCTTAAGTTGTCATTTTTG 69 FBan0004206 FBgn0024332 Mcm3 X X DNA replication initiation; GO:0006270; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003682; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 Mcm3 Minichromosome maintenance 3 "CG4206, PCR2, dMCM3, DmMCM3, DmMcm3, MCM3, Mcp-PCR2, Minichromosome maintenance-PCR2, Minichromosome maintenance 3" CDMC22989 1 3 24 DAC38-I10 23-CG4237-RA_1 CG4237 TGCTATGCGCGCATTTAATGTAACCAACTGAATTGTGTATTCATTCTTCGACTTCAAACATAAAGTGCA 69 FBan0004237 FBgn0020655 Gap69C 3 3L intracellular protein transport; GO:0006886; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; ; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060 cytosol; GO:0005829 Gap69C GTPase-activating protein 69C "CG4237, CG4237, ARF1-GAP, GAP69C, i51" CDMC22989 1 4 24 DAC38-I10 23-CG4237-RA_1 CG4237 TGCTATGCGCGCATTTAATGTAACCAACTGAATTGTGTATTCATTCTTCGACTTCAAACATAAAGTGCA 69 FBan0004237 FBgn0020655 Gap69C 3 3L intracellular protein transport; GO:0006886; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; ; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060 cytosol; GO:0005829 Gap69C GTPase-activating protein 69C "CG4237, CG4237, ARF1-GAP, GAP69C, i51" CDMC22990 1 5 24 DAC38-I22 22-CG4249-RA_2 CG4249 GCGACACTCAATAGCTCAGGATCCAACTGACATCTTACCGGATAAAATGCCCAGATTGGATGATTGCGA 69 FBan0004249 FBgn0028525 c(2)M 2 2L meiosis; GO:0007126; meiotic recombination; GO:0007131; resolution of meiotic joint molecules as recombinants; GO:0000712 synaptonemal complex; GO:0000795 c(2)M crossover suppressor on 2 of Manheim "CG4249, BG:DS02740.10, mei-910, DS02740.10, MEI-910, crossover suppressor on 2 of Manheim" CDMC22990 1 6 24 DAC38-I22 22-CG4249-RA_2 CG4249 GCGACACTCAATAGCTCAGGATCCAACTGACATCTTACCGGATAAAATGCCCAGATTGGATGATTGCGA 69 FBan0004249 FBgn0028525 c(2)M 2 2L meiosis; GO:0007126; meiotic recombination; GO:0007131; resolution of meiotic joint molecules as recombinants; GO:0000712 synaptonemal complex; GO:0000795 c(2)M crossover suppressor on 2 of Manheim "CG4249, BG:DS02740.10, mei-910, DS02740.10, MEI-910, crossover suppressor on 2 of Manheim" CDMC22991 1 7 24 DAC38-M10 3-CG4287-RA_2 CG4287 TGGGCATCACCTATGGGAGTTACGGAAGTTACCAGCACAAAGCAGATCCTGGTCAACTGGAAACCTGCA 69 FBan0004287 FBgn0038388 CG4287 3 3R CG4287 CG4287 CDMC22991 1 8 24 DAC38-M10 3-CG4287-RA_2 CG4287 TGGGCATCACCTATGGGAGTTACGGAAGTTACCAGCACAAAGCAGATCCTGGTCAACTGGAAACCTGCA 69 FBan0004287 FBgn0038388 CG4287 3 3R CG4287 CG4287 CDMC22992 1 9 24 DAC38-M22 2-CG4311-RA_1 CG4311 GAGCACCTTCGATGCTATCCTATTCCACACACCGTTCTGCAAGTTGGTGCAAAAATCTGTGGGTCGCCT 69 FBan0004311 FBgn0010611 Hmgs 2 2R cholesterol metabolism; GO:0008203; embryonic development (sensu Insecta); GO:0001700 hydroxymethylglutaryl-CoA synthase activity; GO:0004421 ; EC:2.3.3.10; ; GO:0004421 ; EC:2.3.3.10; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0004421 ; EC:2.3.3.10 Hmgs HMG Coenzyme A synthase "CG16796, CG4311, CG16796, CG4311, CG4311, l(2)06214, HMG-CoA synthase, HMG Coenzyme A synthase" CDMC22992 1 10 24 DAC38-M22 2-CG4311-RA_1 CG4311 GAGCACCTTCGATGCTATCCTATTCCACACACCGTTCTGCAAGTTGGTGCAAAAATCTGTGGGTCGCCT 69 FBan0004311 FBgn0010611 Hmgs 2 2R cholesterol metabolism; GO:0008203; embryonic development (sensu Insecta); GO:0001700 hydroxymethylglutaryl-CoA synthase activity; GO:0004421 ; EC:2.3.3.10; ; GO:0004421 ; EC:2.3.3.10; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0004421 ; EC:2.3.3.10 Hmgs HMG Coenzyme A synthase "CG16796, CG4311, CG16796, CG4311, CG4311, l(2)06214, HMG-CoA synthase, HMG Coenzyme A synthase" CDMC22993 1 11 24 DAC39-A10 18-CG6920-RA_4 CG6920 CGGGAATGCGGGAGATTCACGAGCGTTGCTATACAGATCTATTGGATCTATGTCGAACCATTGCCAGCC 69 FBan0006920 FBgn0002906 mus309 3 3R DNA replication; GO:0006260; DNA synthesis during DNA repair; GO:0000731; DNA unwinding during replication; GO:0006268; double-strand break repair; GO:0006302; double-strand break repair via synthesis-dependent strand annealing; GO:0045003 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003 nucleus; GO:0005634 mus309 mutagen-sensitive 309 "CG6920, RecQ, RecQ-like, gesta1, genome stabilizer 1, Dmblm, bloom, DmKu70, blm, DmBlm, mus 309, DmBLM" CDMC22993 1 12 24 DAC39-A10 18-CG6920-RA_4 CG6920 CGGGAATGCGGGAGATTCACGAGCGTTGCTATACAGATCTATTGGATCTATGTCGAACCATTGCCAGCC 69 FBan0006920 FBgn0002906 mus309 3 3R DNA replication; GO:0006260; DNA synthesis during DNA repair; GO:0000731; DNA unwinding during replication; GO:0006268; double-strand break repair; GO:0006302; double-strand break repair via synthesis-dependent strand annealing; GO:0045003 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003 nucleus; GO:0005634 mus309 mutagen-sensitive 309 "CG6920, RecQ, RecQ-like, gesta1, genome stabilizer 1, Dmblm, bloom, DmKu70, blm, DmBlm, mus 309, DmBLM" CDMC22994 1 13 24 DAC39-A22 3-CG6934-RA_2 CG6934 ACCCCAAGCCCTTGCTACTGACACGAACATCATCGCCTCAATTGACAACATTGCCGACAACAAATGGCT 69 FBan0006934 FBgn0038289 CG6934 3 3R CG6934 CG6934 anon-WO0118547.79 CDMC22994 1 14 24 DAC39-A22 3-CG6934-RA_2 CG6934 ACCCCAAGCCCTTGCTACTGACACGAACATCATCGCCTCAATTGACAACATTGCCGACAACAAATGGCT 69 FBan0006934 FBgn0038289 CG6934 3 3R CG6934 CG6934 anon-WO0118547.79 CDMC22995 1 15 24 DAC39-E10 18-CG6967-RB_8 CG6967 GGCAGCGTGGAGACATACCAGGGTCGCGAAAAGACCATAATCATTGCTAGTTTGGTTAAATCCTTCACA 69 FBan0006967 FBgn0034187 CG6967 2 2R "DNA replication; GO:0006260; mRNA catabolism, nonsense-mediated decay; GO:0000184" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678 CG6967 CG6967 CT21565 CDMC22995 1 16 24 DAC39-E10 18-CG6967-RB_8 CG6967 GGCAGCGTGGAGACATACCAGGGTCGCGAAAAGACCATAATCATTGCTAGTTTGGTTAAATCCTTCACA 69 FBan0006967 FBgn0034187 CG6967 2 2R "DNA replication; GO:0006260; mRNA catabolism, nonsense-mediated decay; GO:0000184" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678 CG6967 CG6967 CT21565 CDMC22996 1 17 24 DAC39-E22 15-CG6977-RA_1 CG6977 CCTCGCCGTGGTTAAGTTCAACCGAATCTGTTCTGTTGCACCTTTGAGTTCGTCGTTGCGTTTTCATCA 69 FBan0006977 FBgn0037963 Cad87A 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad87A Cad87A "CG6977, CG6977, CG6977, CG6977, CT21611, DCad87A" CDMC22996 1 18 24 DAC39-E22 15-CG6977-RA_1 CG6977 CCTCGCCGTGGTTAAGTTCAACCGAATCTGTTCTGTTGCACCTTTGAGTTCGTCGTTGCGTTTTCATCA 69 FBan0006977 FBgn0037963 Cad87A 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad87A Cad87A "CG6977, CG6977, CG6977, CG6977, CT21611, DCad87A" CDMC22997 1 19 24 DAC39-I10 14-CG7004-RA_3 CG7004 GCAGCAATGTACATTCGTTAGGTGGACTTCAGTTCCAGGAAGATGACGTGTGGTCACAAGAGGAGGACG 69 FBan0007004 FBgn0004373 fwd 3 3L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; determination of adult life span; GO:0008340; intracellular signaling cascade; GO:0007242; male meiosis cytokinesis; GO:0007112; meiotic spindle stabilization; GO:0043147; phosphorylation; GO:0016310; testicular ring canal formation; GO:0030726" 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 fwd four wheel drive "CG7004, CG7004, CG7004, PI4K, anon-WO0118547.259" CDMC22997 1 20 24 DAC39-I10 14-CG7004-RA_3 CG7004 GCAGCAATGTACATTCGTTAGGTGGACTTCAGTTCCAGGAAGATGACGTGTGGTCACAAGAGGAGGACG 69 FBan0007004 FBgn0004373 fwd 3 3L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; determination of adult life span; GO:0008340; intracellular signaling cascade; GO:0007242; male meiosis cytokinesis; GO:0007112; meiotic spindle stabilization; GO:0043147; phosphorylation; GO:0016310; testicular ring canal formation; GO:0030726" 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 fwd four wheel drive "CG7004, CG7004, CG7004, PI4K, anon-WO0118547.259" CDMC22998 1 21 24 DAC39-I22 23-CG7014-RA_3 CG7014 CAAGTCGAATCGTTAAGCTGCGGATTTTCTGCATTTCCATGAATTGATGCCGACTTACATAAGTTGCTA 69 FBan0007014 FBgn0038277 RpS5b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS5b Ribosomal protein S5b "CG7014, Ribosomal protein S5b" CDMC22998 1 22 24 DAC39-I22 23-CG7014-RA_3 CG7014 CAAGTCGAATCGTTAAGCTGCGGATTTTCTGCATTTCCATGAATTGATGCCGACTTACATAAGTTGCTA 69 FBan0007014 FBgn0038277 RpS5b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS5b Ribosomal protein S5b "CG7014, Ribosomal protein S5b" CDMC22999 1 23 24 DAC39-M10 11-CG7044-RA_1 CG7044 ACCGCCAGTTTAGCAATCAGGGCATGATAGATGGCTCTTTTCCCACAGTGACCTTCTCTAAGGAGCAGA 69 FBan0007044 FBgn0038854 CG7044 3 3R CG7044 CG7044 CDMC22999 1 24 24 DAC39-M10 11-CG7044-RA_1 CG7044 ACCGCCAGTTTAGCAATCAGGGCATGATAGATGGCTCTTTTCCCACAGTGACCTTCTCTAAGGAGCAGA 69 FBan0007044 FBgn0038854 CG7044 3 3R CG7044 CG7044 CDMC23000 1 25 24 DAC39-M22 11-CG7052-RA_5 CG7052 AGCACTTGGCTTACCGCCTATGTCATGCGTTCCTTCCATCAAGCTGGAACATACACGGATATCGATCCT 69 FBan0007052 FBgn0041182 TepII 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; wide-spectrum protease inhibitor activity; GO:0017114; ; GO:0017114 TepII Thiolester containing protein II "CG7052, CG18589, CG7052, CG18589, CG7052, CG18589, CG7052, CG7052, dTEPII, Tep2, T13, TEP2, Thiolester containing protein II" CDMC23000 1 26 24 DAC39-M22 11-CG7052-RA_5 CG7052 AGCACTTGGCTTACCGCCTATGTCATGCGTTCCTTCCATCAAGCTGGAACATACACGGATATCGATCCT 69 FBan0007052 FBgn0041182 TepII 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; wide-spectrum protease inhibitor activity; GO:0017114; ; GO:0017114 TepII Thiolester containing protein II "CG7052, CG18589, CG7052, CG18589, CG7052, CG18589, CG7052, CG7052, dTEPII, Tep2, T13, TEP2, Thiolester containing protein II" CDMC23001 1 1 25 DAC40-A10 15-CG33299-RA_1 CG33299 ATCCCGGTGCCTAAGCCCTATCCTGTTCCGTTTACCATCTACAAACACGTCCTGCAAAAGGAGCA 65 FBan0033299 FBgn0053299 CG33299 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33299 CG33299 CDMC23001 1 2 25 DAC40-A10 15-CG33299-RA_1 CG33299 ATCCCGGTGCCTAAGCCCTATCCTGTTCCGTTTACCATCTACAAACACGTCCTGCAAAAGGAGCA 65 FBan0033299 FBgn0053299 CG33299 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33299 CG33299 CDMC23002 1 3 25 DAC40-A22 30-CG33316-RB_8 CG33316 GGGGGATCGCGATTCCACGACATTGACAACGGTTACCTTTCGGAGGGTAGCAGCGGTCTAAATGG 65 FBan0033316 FBgn0032826 CG33316 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33316 CG33316 "CG13960, CG13959, CG13961, CG13960" CDMC23002 1 4 25 DAC40-A22 30-CG33316-RB_8 CG33316 GGGGGATCGCGATTCCACGACATTGACAACGGTTACCTTTCGGAGGGTAGCAGCGGTCTAAATGG 65 FBan0033316 FBgn0032826 CG33316 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33316 CG33316 "CG13960, CG13959, CG13961, CG13960" CDMC23003 1 5 25 DAC40-E10 3-CG3361-RA_6 CG3361 ATATCAGTGTCCAGTCGACAGGAATGCGTATGAAGACGGTGCCAATGAGGGACACGGGCTACTCG 65 FBan0003361 FBgn0039507 mrt 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mrt martik "CG3361, martik" CDMC23003 1 6 25 DAC40-E10 3-CG3361-RA_6 CG3361 ATATCAGTGTCCAGTCGACAGGAATGCGTATGAAGACGGTGCCAATGAGGGACACGGGCTACTCG 65 FBan0003361 FBgn0039507 mrt 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mrt martik "CG3361, martik" CDMC23004 1 7 25 DAC40-E22 2-CG3409-RA_4 CG3409 TCGATCCGGAACTCCAACTTCCTTAAGGATATGCGCATTCACCGCAACTCGATCCACTACCGCGG 65 FBan0003409 FBgn0033095 CG3409 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG3409 CG3409 CDMC23004 1 8 25 DAC40-E22 2-CG3409-RA_4 CG3409 TCGATCCGGAACTCCAACTTCCTTAAGGATATGCGCATTCACCGCAACTCGATCCACTACCGCGG 65 FBan0003409 FBgn0033095 CG3409 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG3409 CG3409 CDMC23005 1 9 25 DAC40-I10 2-CG3563-RA_1 CG3563 AATAGCACCAGCAACTCGTATCTGCACTCCTCACAGCACGACTACGAGACCAATCGCTCTTCGGC 65 FBan0003563 FBgn0038259 CG3563 3 3R CG3563 CG3563 "anon-WO0153538.4, anon-WO0153538.5" CDMC23005 1 10 25 DAC40-I10 2-CG3563-RA_1 CG3563 AATAGCACCAGCAACTCGTATCTGCACTCCTCACAGCACGACTACGAGACCAATCGCTCTTCGGC 65 FBan0003563 FBgn0038259 CG3563 3 3R CG3563 CG3563 "anon-WO0153538.4, anon-WO0153538.5" CDMC23006 1 11 25 DAC40-I22 2-CG3599-RA_1 CG3599 ACCCAGCACTCACAACTTGGATCACATGCAGCCGAATGGAACTCAGTCCAATCCTTCGACTTCCG 65 FBan0003599 FBgn0029848 CG3599 X X cell communication; GO:0007154; cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 "hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" CG3599 CG3599 CT12113 CDMC23006 1 12 25 DAC40-I22 2-CG3599-RA_1 CG3599 ACCCAGCACTCACAACTTGGATCACATGCAGCCGAATGGAACTCAGTCCAATCCTTCGACTTCCG 65 FBan0003599 FBgn0029848 CG3599 X X cell communication; GO:0007154; cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 "hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" CG3599 CG3599 CT12113 CDMC23007 1 13 25 DAC40-M10 6-CG3687-RA_1 CG3687 CCGCTCTGCTGGACCTAACGGCCAAGGGATTCATACGCTTCATTACCAATGGATACCGCACCCTG 65 FBan0003687 FBgn0034097 CG3687 2 2R CG3687 CG3687 BcDNA:AT22273 CDMC23007 1 14 25 DAC40-M10 6-CG3687-RA_1 CG3687 CCGCTCTGCTGGACCTAACGGCCAAGGGATTCATACGCTTCATTACCAATGGATACCGCACCCTG 65 FBan0003687 FBgn0034097 CG3687 2 2R CG3687 CG3687 BcDNA:AT22273 CDMC23008 1 15 25 DAC40-M22 18-CG3703-RA_2 CG3703 GAGTCAACCGAATTCTCCGACACTGGCAATCCGGTTATTAACTCACAAAACGGAGCACTGACCCT 65 FBan0003703 FBgn0040348 CG3703 X X CG3703 CG3703 "EG:BACR7A4.15, BACR7A4.15" CDMC23008 1 16 25 DAC40-M22 18-CG3703-RA_2 CG3703 GAGTCAACCGAATTCTCCGACACTGGCAATCCGGTTATTAACTCACAAAACGGAGCACTGACCCT 65 FBan0003703 FBgn0040348 CG3703 X X CG3703 CG3703 "EG:BACR7A4.15, BACR7A4.15" CDMC23009 1 17 25 DAC41-A10 AutoBlank AutoBlank CDMC23009 1 18 25 DAC41-A10 AutoBlank AutoBlank CDMC23010 1 19 25 DAC41-A22 AutoBlank AutoBlank CDMC23010 1 20 25 DAC41-A22 AutoBlank AutoBlank CDMC23011 1 21 25 DAC41-E10 AutoBlank AutoBlank CDMC23011 1 22 25 DAC41-E10 AutoBlank AutoBlank CDMC23012 1 23 25 DAC41-E22 AutoBlank AutoBlank CDMC23012 1 24 25 DAC41-E22 AutoBlank AutoBlank CDMC23013 1 25 25 DAC41-I10 AutoBlank AutoBlank CDMC23013 1 26 25 DAC41-I10 AutoBlank AutoBlank CDMC23014 1 1 26 DAC41-I22 AutoBlank AutoBlank CDMC23014 1 2 26 DAC41-I22 AutoBlank AutoBlank CDMC23015 1 3 26 DAC41-M10 AutoBlank AutoBlank CDMC23015 1 4 26 DAC41-M10 AutoBlank AutoBlank CDMC23016 1 5 26 DAC41-M22 AutoBlank AutoBlank CDMC23016 1 6 26 DAC41-M22 AutoBlank AutoBlank CDMC23017 1 7 26 DAC42-A10 150mM NaPO4 Blank CDMC23017 1 8 26 DAC42-A10 150mM NaPO4 Blank CDMC23018 1 9 26 DAC42-A22 150mM NaPO4 Blank CDMC23018 1 10 26 DAC42-A22 150mM NaPO4 Blank CDMC23019 1 11 26 DAC42-E10 150mM NaPO4 Blank CDMC23019 1 12 26 DAC42-E10 150mM NaPO4 Blank CDMC23020 1 13 26 DAC42-E22 150mM NaPO4 Blank CDMC23020 1 14 26 DAC42-E22 150mM NaPO4 Blank CDMC23021 1 15 26 DAC42-I10 150mM NaPO4 Blank CDMC23021 1 16 26 DAC42-I10 150mM NaPO4 Blank CDMC23022 1 17 26 DAC42-I22 5uM MSP 5uM MSP CDMC23022 1 18 26 DAC42-I22 5uM MSP 5uM MSP CDMC23023 1 19 26 DAC42-M10 10uM MSP 10uM MSP CDMC23023 1 20 26 DAC42-M10 10uM MSP 10uM MSP CDMC23024 1 21 26 DAC42-M22 20uM MSP 20uM MSP CDMC23024 1 22 26 DAC42-M22 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC23025 2 1 1 DAC01-B10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23025 2 2 1 DAC01-B10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23026 2 3 1 DAC01-B22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23026 2 4 1 DAC01-B22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23027 2 5 1 DAC01-F10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23027 2 6 1 DAC01-F10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23028 2 7 1 DAC01-F22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23028 2 8 1 DAC01-F22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23029 2 9 1 DAC01-J10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23029 2 10 1 DAC01-J10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23030 2 11 1 DAC01-J22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23030 2 12 1 DAC01-J22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23031 2 13 1 DAC01-N10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23031 2 14 1 DAC01-N10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23032 2 15 1 DAC01-N22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23032 2 16 1 DAC01-N22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23033 2 17 1 DAC02-B10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23033 2 18 1 DAC02-B10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23034 2 19 1 DAC02-B22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23034 2 20 1 DAC02-B22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23035 2 21 1 DAC02-F10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23035 2 22 1 DAC02-F10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23036 2 23 1 DAC02-F22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23036 2 24 1 DAC02-F22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23037 2 25 1 DAC02-J10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23037 2 26 1 DAC02-J10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23038 2 1 2 DAC02-J22 N/A CG9075 (00718-00956) CDMC23038 2 2 2 DAC02-J22 N/A CG9075 (00718-00956) CDMC23039 2 3 2 DAC02-N10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23039 2 4 2 DAC02-N10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23040 2 5 2 DAC02-N22 AutoBlank AutoBlank CDMC23040 2 6 2 DAC02-N22 AutoBlank AutoBlank CDMC23041 2 7 2 DAC03-B10 8-CG5432-RA_2 CG5432 CCCTCAGAAAGAAGGGCATCCTGACGGGAATAAAGGTAGACAAGCACTTTTCACCACTCTTCGGCTCCG 69 FBan0005432 FBgn0039425 CG5432 3 3R glycolysis; GO:0006096 fructose-bisphosphate aldolase activity; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13 CG5432 CG5432 CDMC23041 2 8 2 DAC03-B10 8-CG5432-RA_2 CG5432 CCCTCAGAAAGAAGGGCATCCTGACGGGAATAAAGGTAGACAAGCACTTTTCACCACTCTTCGGCTCCG 69 FBan0005432 FBgn0039425 CG5432 3 3R glycolysis; GO:0006096 fructose-bisphosphate aldolase activity; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13 CG5432 CG5432 CDMC23042 2 9 2 DAC03-B22 23-CG5444-RC_2 CG5444 GTTTTATACAGCTTTACGATTTCATCCACTTGCAATATATTTTAGCCTCAACTTTAAATGCGTCGCGTG 69 FBan0005444 FBgn0010280 Taf4 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003700; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf4 TBP-associated factor 4 "CG5444, CG5444, TAFII110, TBP associated factor 110, TAF110, dTAF[[II]]110, TATA-associated factor 110, TBP-associated factor 110, p110, Taf110: TBP-associated factor 110kD, l(3)72Dj, Taf[[II]]110, TAF[[II]]110, SR3-3, TFIID 110, SY3-2 TAF110, d110, TFIID, dTAFII110, TAF4, TAF[II]110, TAF[[II]], taf110, dmTAF4, TAF, dTAF4, TBP-associated factor 110kD, lethal(3)72Dj, Taf110" CDMC23042 2 10 2 DAC03-B22 23-CG5444-RC_2 CG5444 GTTTTATACAGCTTTACGATTTCATCCACTTGCAATATATTTTAGCCTCAACTTTAAATGCGTCGCGTG 69 FBan0005444 FBgn0010280 Taf4 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003700; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf4 TBP-associated factor 4 "CG5444, CG5444, TAFII110, TBP associated factor 110, TAF110, dTAF[[II]]110, TATA-associated factor 110, TBP-associated factor 110, p110, Taf110: TBP-associated factor 110kD, l(3)72Dj, Taf[[II]]110, TAF[[II]]110, SR3-3, TFIID 110, SY3-2 TAF110, d110, TFIID, dTAFII110, TAF4, TAF[II]110, TAF[[II]], taf110, dmTAF4, TAF, dTAF4, TBP-associated factor 110kD, lethal(3)72Dj, Taf110" CDMC23043 2 11 2 DAC03-F10 18-CG5471-RA_2 CG5471 GCAGAGCGTTTTGCATAGCAGTGGCTTTCATCTGCATAAAAGCGAAAGAACCATCTCACACCATCATCA 69 FBan0005471 FBgn0039440 CG5471 3 3R CG5471 CG5471 CDMC23043 2 12 2 DAC03-F10 18-CG5471-RA_2 CG5471 GCAGAGCGTTTTGCATAGCAGTGGCTTTCATCTGCATAAAAGCGAAAGAACCATCTCACACCATCATCA 69 FBan0005471 FBgn0039440 CG5471 3 3R CG5471 CG5471 CDMC23044 2 13 2 DAC03-F22 13-CG5475-RA_1 CG5475 GCGCATTCGTGTGTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCA 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC23044 2 14 2 DAC03-F22 13-CG5475-RA_1 CG5475 GCGCATTCGTGTGTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCA 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC23045 2 15 2 DAC03-J10 15-CG5500-RA_4 CG5500 GGCGTGTGAAATGCTCATCACTTCCTCTGGGCCTTTTCAATCGTAACTTTCGAACTCTTTCGGGGATCG 69 FBan0005500 FBgn0039461 CG5500 3 3R CG5500 CG5500 CDMC23045 2 16 2 DAC03-J10 15-CG5500-RA_4 CG5500 GGCGTGTGAAATGCTCATCACTTCCTCTGGGCCTTTTCAATCGTAACTTTCGAACTCTTTCGGGGATCG 69 FBan0005500 FBgn0039461 CG5500 3 3R CG5500 CG5500 CDMC23046 2 17 2 DAC03-J22 2-CG5514-RA_1 CG5514 GCCACACCAGTCCCAATCTCGAATGAGCAAAGCGACGAATTTAGTGCCGACTTTGTGACCCACTTCGAA 69 FBan0005514 FBgn0039560 CG5514 3 3R CG5514 CG5514 CDMC23046 2 18 2 DAC03-J22 2-CG5514-RA_1 CG5514 GCCACACCAGTCCCAATCTCGAATGAGCAAAGCGACGAATTTAGTGCCGACTTTGTGACCCACTTCGAA 69 FBan0005514 FBgn0039560 CG5514 3 3R CG5514 CG5514 CDMC23047 2 19 2 DAC03-N10 14-CG5555-RA_1 CG5555 ATCTGCTGAACTTTATTGCCCCCTGTCATGCAGAGATTAAACACATCCAGATTGTACGTGACGGCAGCC 69 FBan0005555 FBgn0038686 CG5555 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5555 CG5555 CDMC23047 2 20 2 DAC03-N10 14-CG5555-RA_1 CG5555 ATCTGCTGAACTTTATTGCCCCCTGTCATGCAGAGATTAAACACATCCAGATTGTACGTGACGGCAGCC 69 FBan0005555 FBgn0038686 CG5555 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5555 CG5555 CDMC23048 2 21 2 DAC03-N22 17-CG5562-RA_1 CG5562 GGCTGGGAGCACTACCCGTTCTGTACCACCTGAACGACGAGAATGTGAACCTGAAAAAGTATAGAAACA 69 FBan0005562 FBgn0024234 gbb 2 2R cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; dorsal closure; GO:0007391; growth; GO:0040007; mesoderm development; GO:0007498; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 signal transducer activity; GO:0004871; transforming growth factor beta receptor binding; GO:0005160; ; GO:0005160; ; GO:0005160; growth factor activity; GO:0008083; ; GO:0004871; ; GO:0008083; ; GO:0005160 extracellular region; GO:0005576 gbb glass bottom boat "CG5562, 60A, SixtyA, Tgfbeta-60A, gbb-60A, glass bottom boat-60A, Tgfb-60, TGFbeta-60A, tgfb-60A, Gbb-60A, l(2)60A-J, gcn: gonial-cell-neoplasm, Gbb, TGF-b, Dm-GBB, Tgfbeta-60A, vgr/60A, Transforming growth factor beta at 60A, gcn, glass bottom boat" CDMC23048 2 22 2 DAC03-N22 17-CG5562-RA_1 CG5562 GGCTGGGAGCACTACCCGTTCTGTACCACCTGAACGACGAGAATGTGAACCTGAAAAAGTATAGAAACA 69 FBan0005562 FBgn0024234 gbb 2 2R cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; dorsal closure; GO:0007391; growth; GO:0040007; mesoderm development; GO:0007498; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 signal transducer activity; GO:0004871; transforming growth factor beta receptor binding; GO:0005160; ; GO:0005160; ; GO:0005160; growth factor activity; GO:0008083; ; GO:0004871; ; GO:0008083; ; GO:0005160 extracellular region; GO:0005576 gbb glass bottom boat "CG5562, 60A, SixtyA, Tgfbeta-60A, gbb-60A, glass bottom boat-60A, Tgfb-60, TGFbeta-60A, tgfb-60A, Gbb-60A, l(2)60A-J, gcn: gonial-cell-neoplasm, Gbb, TGF-b, Dm-GBB, Tgfbeta-60A, vgr/60A, Transforming growth factor beta at 60A, gcn, glass bottom boat" CDMC23049 2 23 2 DAC04-B10 1-CG12361-RA_1 CG12361 AGCAGCACCAAGGTGGCTCCGAGTTCATGAAACTCTACTACGATGACTACGACGACTCCAACTCGGACA 69 FBan0012361 FBgn0035292 CG12361 3 3L "ectoderm development; GO:0007398; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG12361 CG12361 CDMC23049 2 24 2 DAC04-B10 1-CG12361-RA_1 CG12361 AGCAGCACCAAGGTGGCTCCGAGTTCATGAAACTCTACTACGATGACTACGACGACTCCAACTCGGACA 69 FBan0012361 FBgn0035292 CG12361 3 3L "ectoderm development; GO:0007398; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG12361 CG12361 CDMC23050 2 25 2 DAC04-B22 40-CG12372-RA_1 CG12372 ACTGCCGCAGTCTACCTTACGTGACATGAAGAATCGTGGAATTGTCTACAAATCTCGGGACAGAAGTCA 69 FBan0012372 FBgn0028683 spt4 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; non-covalent chromatin modification; GO:0016582; positive regulation of transcription; GO:0045941 chromatin binding; GO:0003682; ; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; zinc ion binding; GO:0008270; ; GO:0016251; positive transcription elongation factor activity; GO:0008159; ; GO:0008270; ; GO:0008159 nucleus; GO:0005634 spt4 spt4 "CG12372, CG12372, l(2)k05316, Dspt4, SPT4, dDSIF, Spt4, DSIF" CDMC23050 2 26 2 DAC04-B22 40-CG12372-RA_1 CG12372 ACTGCCGCAGTCTACCTTACGTGACATGAAGAATCGTGGAATTGTCTACAAATCTCGGGACAGAAGTCA 69 FBan0012372 FBgn0028683 spt4 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; non-covalent chromatin modification; GO:0016582; positive regulation of transcription; GO:0045941 chromatin binding; GO:0003682; ; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; zinc ion binding; GO:0008270; ; GO:0016251; positive transcription elongation factor activity; GO:0008159; ; GO:0008270; ; GO:0008159 nucleus; GO:0005634 spt4 spt4 "CG12372, CG12372, l(2)k05316, Dspt4, SPT4, dDSIF, Spt4, DSIF" CDMC23051 2 1 3 DAC04-F10 23-CG12408-RA_4 CG12408 CAGGTTGACCCACATTGCTCTTTTTTGACATGCTGTGCAAAAGCTCAGATATGGCAGACAATGCAAAAT 69 FBan0012408 FBgn0033027 TpnC4 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC4 TpnC4 "CG12408, CG12408, CG12408, CG12408, CG12408, CG12408, tnC4, DmTnC4, TpnC IIIb, DmTpnC41F, TnC, DmTpnCIIIb, BcDNA:RH03361" CDMC23051 2 2 3 DAC04-F10 23-CG12408-RA_4 CG12408 CAGGTTGACCCACATTGCTCTTTTTTGACATGCTGTGCAAAAGCTCAGATATGGCAGACAATGCAAAAT 69 FBan0012408 FBgn0033027 TpnC4 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC4 TpnC4 "CG12408, CG12408, CG12408, CG12408, CG12408, CG12408, tnC4, DmTnC4, TpnC IIIb, DmTpnC41F, TnC, DmTpnCIIIb, BcDNA:RH03361" CDMC23052 2 3 3 DAC04-F22 2-CG1241-RA_1 CG1241 TGTGTTCTTCCGCGAGGTGATCTTCAGTCCAGCACTACCCATTTGCTTTGACTATCATGGACGGCGGAT 69 FBgn0035373 CDMC23052 2 4 3 DAC04-F22 2-CG1241-RA_1 CG1241 TGTGTTCTTCCGCGAGGTGATCTTCAGTCCAGCACTACCCATTTGCTTTGACTATCATGGACGGCGGAT 69 FBgn0035373 CDMC23053 2 5 3 DAC04-J10 8-CG12455-RB_2 CG12455 GGTGGAAAGGGGCATCTTTCTCAGCATAGAGGTCTACGATTACCAGGAGCAATGCAAGGAGGAGCCAAA 69 FBan0012455 FBgn0028859 CG12455 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 calcium channel activity; GO:0005262; voltage-gated calcium channel activity; GO:0005245; ; GO:0005262; ; GO:0005245 membrane; GO:0016020 CG12455 CG12455 "BG:DS07473.1, DS07473.1A, anon-WO0138359.9" CDMC23053 2 6 3 DAC04-J10 8-CG12455-RB_2 CG12455 GGTGGAAAGGGGCATCTTTCTCAGCATAGAGGTCTACGATTACCAGGAGCAATGCAAGGAGGAGCCAAA 69 FBan0012455 FBgn0028859 CG12455 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 calcium channel activity; GO:0005262; voltage-gated calcium channel activity; GO:0005245; ; GO:0005262; ; GO:0005245 membrane; GO:0016020 CG12455 CG12455 "BG:DS07473.1, DS07473.1A, anon-WO0138359.9" CDMC23054 2 7 3 DAC04-J22 23-CG12483-RA_2 CG12483 AGAAGAAAGCCGACAGTACAGAGCTTTAATTAATTACCGCTGCTTTGTTAAAAAATGTCAAAATTTGTT 69 FBan0012483 FBgn0040688 CG12483 3 3L CG12483 CG12483 BcDNA:RH38463 CDMC23054 2 8 3 DAC04-J22 23-CG12483-RA_2 CG12483 AGAAGAAAGCCGACAGTACAGAGCTTTAATTAATTACCGCTGCTTTGTTAAAAAATGTCAAAATTTGTT 69 FBan0012483 FBgn0040688 CG12483 3 3L CG12483 CG12483 BcDNA:RH38463 CDMC23055 2 9 3 DAC04-N10 23-CG12521-RA_1 CG12521 CGGCGACACTTATTTCCGTCCGTGAGTGAAATAGTTATTTAATAAATTTCGAAACAAATGTGCTTAAAA 69 FBan0012521 FBgn0040816 CG12521 3 3L CG12521 CG12521 CDMC23055 2 10 3 DAC04-N10 23-CG12521-RA_1 CG12521 CGGCGACACTTATTTCCGTCCGTGAGTGAAATAGTTATTTAATAAATTTCGAAACAAATGTGCTTAAAA 69 FBan0012521 FBgn0040816 CG12521 3 3L CG12521 CG12521 CDMC23056 2 11 3 DAC04-N22 8-CG12532-RA_1 CG12532 TCCATGGCGCACATCCGATGGCATAGGATAAGCACAAAGCAATTGGAGCTATCGATTTGCGTGTGTTGA 69 FBan0012532 FBgn0010380 Bap X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 AP-1 adaptor complex; GO:0030121; coated vesicle; GO:0030135; colocalizes_with plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Bap Beta Adaptin "CG12532, CG12532, CG12532, CG12532, BAD1, Beta Adaptin Drosophila 1, beta-adaptin, AP-2beta, bap, beta1/2, cg12532, AP-beta1" CDMC23056 2 12 3 DAC04-N22 8-CG12532-RA_1 CG12532 TCCATGGCGCACATCCGATGGCATAGGATAAGCACAAAGCAATTGGAGCTATCGATTTGCGTGTGTTGA 69 FBan0012532 FBgn0010380 Bap X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 AP-1 adaptor complex; GO:0030121; coated vesicle; GO:0030135; colocalizes_with plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Bap Beta Adaptin "CG12532, CG12532, CG12532, CG12532, BAD1, Beta Adaptin Drosophila 1, beta-adaptin, AP-2beta, bap, beta1/2, cg12532, AP-beta1" CDMC23057 2 13 3 DAC05-B10 6-CG5041-RA_1 CG5041 ATTGGCTACGTCTGCTCGGTTTGCCTCTCGGTCTTCTGCAAATACAGTCCCATATGCACCACTTGCCAC 69 FBan0005041 FBgn0031309 Tfb4 2 2L "DNA repair; GO:0006281; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 transcription factor TFIIH complex; GO:0005675 Tfb4 Tfb4 "CG5041, CG5041, TFB4" CDMC23057 2 14 3 DAC05-B10 6-CG5041-RA_1 CG5041 ATTGGCTACGTCTGCTCGGTTTGCCTCTCGGTCTTCTGCAAATACAGTCCCATATGCACCACTTGCCAC 69 FBan0005041 FBgn0031309 Tfb4 2 2L "DNA repair; GO:0006281; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 transcription factor TFIIH complex; GO:0005675 Tfb4 Tfb4 "CG5041, CG5041, TFB4" CDMC23058 2 15 3 DAC05-B22 15-CG5052-RA_1 CG5052 TGCACCAAACTCCTGGAATAACCCCGTTCAAAAGCACTTCTCTGAAACTCGAGGGTAGTATTGCCAAGC 69 FBan0005052 FBgn0003087 pim 2 2L Malpighian tubule morphogenesis; GO:0007443; mitotic sister chromatid segregation; GO:0000070 pim pimples "CG5052, PIM, l(2)31Df, pimples" CDMC23058 2 16 3 DAC05-B22 15-CG5052-RA_1 CG5052 TGCACCAAACTCCTGGAATAACCCCGTTCAAAAGCACTTCTCTGAAACTCGAGGGTAGTATTGCCAAGC 69 FBan0005052 FBgn0003087 pim 2 2L Malpighian tubule morphogenesis; GO:0007443; mitotic sister chromatid segregation; GO:0000070 pim pimples "CG5052, PIM, l(2)31Df, pimples" CDMC23059 2 17 3 DAC05-F10 2-CG5081-RB_1 CG5081 GCAGGCCCCTAAACCCCGTAATTCCCCACCCAATCCTTTGGACCTTAGGCGAGATTATGGCTTTAATCC 69 FBan0005081 FBgn0033583 Syx7 3 3L lysosomal transport; GO:0007041; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx7 Syntaxin 7 "CG5081, SYX7, Dm Syx7, DmSyx7, Syntaxin7, syntaxin, Syntaxin 7" CDMC23059 2 18 3 DAC05-F10 2-CG5081-RB_1 CG5081 GCAGGCCCCTAAACCCCGTAATTCCCCACCCAATCCTTTGGACCTTAGGCGAGATTATGGCTTTAATCC 69 FBan0005081 FBgn0033583 Syx7 3 3L lysosomal transport; GO:0007041; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx7 Syntaxin 7 "CG5081, SYX7, Dm Syx7, DmSyx7, Syntaxin7, syntaxin, Syntaxin 7" CDMC23060 2 19 3 DAC05-F22 23-CG5093-RA_2 CG5093 CCATCGTCTGCGTAGTGTCTAAGCTGAATTGTGATATTTTGCAGTTAATTAGGATTTCCAGGTATTTGC 69 FBan0005093 FBgn0035954 Doc3 3 3L mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc3 Dorsocross3 "CG5093, CG5093, CG5093, Dm-DOC3, Dorsocross3" CDMC23060 2 20 3 DAC05-F22 23-CG5093-RA_2 CG5093 CCATCGTCTGCGTAGTGTCTAAGCTGAATTGTGATATTTTGCAGTTAATTAGGATTTCCAGGTATTTGC 69 FBan0005093 FBgn0035954 Doc3 3 3L mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc3 Dorsocross3 "CG5093, CG5093, CG5093, Dm-DOC3, Dorsocross3" CDMC23061 2 21 3 DAC05-J10 9-CG5127-RA_3 CG5127 GCTGGACGAGATGCATGACTATGTGGCCAGGAAGCTACCCAAACTAACCGAGCTTAAGAGCAAAGTCCT 69 FBan0005127 FBgn0039335 CG5127 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 CG5127 CG5127 CDMC23061 2 22 3 DAC05-J10 9-CG5127-RA_3 CG5127 GCTGGACGAGATGCATGACTATGTGGCCAGGAAGCTACCCAAACTAACCGAGCTTAAGAGCAAAGTCCT 69 FBan0005127 FBgn0039335 CG5127 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 CG5127 CG5127 CDMC23062 2 23 3 DAC05-J22 18-CG5139-RA_3 CG5139 GCACCCAATCCTGCCAAGAAAAGGAGGGTGGTCAAGAAGAGCAAGATCAATATCTTGAAACAGAGGAGT 69 FBan0005139 FBgn0031323 CG5139 2 2L CG5139 CG5139 CDMC23062 2 24 3 DAC05-J22 18-CG5139-RA_3 CG5139 GCACCCAATCCTGCCAAGAAAAGGAGGGTGGTCAAGAAGAGCAAGATCAATATCTTGAAACAGAGGAGT 69 FBan0005139 FBgn0031323 CG5139 2 2L CG5139 CG5139 CDMC23063 2 25 3 DAC05-N10 14-CG5174-RK_1 CG5174 CGCCGTGTTTCACGCCACTTCCTTTAACACAATAACCAACTCTCGCCTGTTTGTAACTAAAGCGCACCT 69 FBan0005174 FBgn0034345 CG5174 2 2R CG5174 CG5174 "BcDNA:RE18604, BcDNA:RH27395" CDMC23063 2 26 3 DAC05-N10 14-CG5174-RK_1 CG5174 CGCCGTGTTTCACGCCACTTCCTTTAACACAATAACCAACTCTCGCCTGTTTGTAACTAAAGCGCACCT 69 FBan0005174 FBgn0034345 CG5174 2 2R CG5174 CG5174 "BcDNA:RE18604, BcDNA:RH27395" CDMC23064 2 1 4 DAC05-N22 23-CG5186-RA_3 CG5186 GCTATATCGAAACACGGCCCTGATATAATGTTTCACCCTCATTAAATCCAACACACATCCCACTTTGCA 69 FBan0005186 FBgn0026173 slim 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 slim scruin like at the midline "CG5186, scruin like at the midline" CDMC23064 2 2 4 DAC05-N22 23-CG5186-RA_3 CG5186 GCTATATCGAAACACGGCCCTGATATAATGTTTCACCCTCATTAAATCCAACACACATCCCACTTTGCA 69 FBan0005186 FBgn0026173 slim 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 slim scruin like at the midline "CG5186, scruin like at the midline" CDMC23065 2 3 4 DAC06-B10 23-CG9369-RA_1 CG9369 ACTGACGCACACATACAAAACCGACTACCATTTTCCATTGATAGTATGAACAAAAGCAAATGCAACTCC 69 FBan0009369 FBgn0002577 m X X cellular morphogenesis; GO:0000902; wing morphogenesis; GO:0007476 structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 integral to membrane; GO:0016021 m miniature "CG9369, CG9369, CG9369, min" CDMC23065 2 4 4 DAC06-B10 23-CG9369-RA_1 CG9369 ACTGACGCACACATACAAAACCGACTACCATTTTCCATTGATAGTATGAACAAAAGCAAATGCAACTCC 69 FBan0009369 FBgn0002577 m X X cellular morphogenesis; GO:0000902; wing morphogenesis; GO:0007476 structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 integral to membrane; GO:0016021 m miniature "CG9369, CG9369, CG9369, min" CDMC23066 2 5 4 DAC06-B22 3-CG9383-RA_2 CG9383 GCCATGCCAATGGAGAACGGAATCAAGGCCTTGAACGAGAACTCCAACTCACTGGCCATGGAATGTTGA 69 FBan0009383 FBgn0029094 asf1 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325; nucleosome assembly; GO:0006334; regulation of progression through cell cycle; GO:0000074 chromatin binding; GO:0003682; ; GO:0003682; protein binding; GO:0005515; ; GO:0005515 RCAF complex; GO:0035059; chromatin assembly complex; GO:0005678 asf1 anti-silencing factor 1 "CG9383, dASF1, ASF1, Asf1" CDMC23066 2 6 4 DAC06-B22 3-CG9383-RA_2 CG9383 GCCATGCCAATGGAGAACGGAATCAAGGCCTTGAACGAGAACTCCAACTCACTGGCCATGGAATGTTGA 69 FBan0009383 FBgn0029094 asf1 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325; nucleosome assembly; GO:0006334; regulation of progression through cell cycle; GO:0000074 chromatin binding; GO:0003682; ; GO:0003682; protein binding; GO:0005515; ; GO:0005515 RCAF complex; GO:0035059; chromatin assembly complex; GO:0005678 asf1 anti-silencing factor 1 "CG9383, dASF1, ASF1, Asf1" CDMC23067 2 7 4 DAC06-F10 26-CG9425-RB_1 CG9425 GCAACCGTCTCCGAGCTCTATGAGATTTGGACCAATGACGCACGAGCTACTCCCACCCAATGTAAGCAT 69 FBan0009425 FBgn0036451 CG9425 3 3L "DNA metabolism; GO:0006259; DNA replication; GO:0006260; DNA restriction-modification system; GO:0009307; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA aminoacylation for protein translation; GO:0006418" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0004812 ; EC:6.1.1.-; ; GO:0008270; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 nucleus; GO:0005634 CG9425 CG9425 CDMC23067 2 8 4 DAC06-F10 26-CG9425-RB_1 CG9425 GCAACCGTCTCCGAGCTCTATGAGATTTGGACCAATGACGCACGAGCTACTCCCACCCAATGTAAGCAT 69 FBan0009425 FBgn0036451 CG9425 3 3L "DNA metabolism; GO:0006259; DNA replication; GO:0006260; DNA restriction-modification system; GO:0009307; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA aminoacylation for protein translation; GO:0006418" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0004812 ; EC:6.1.1.-; ; GO:0008270; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 nucleus; GO:0005634 CG9425 CG9425 CDMC23068 2 9 4 DAC06-F22 16-CG9432-RA_1 CG9432 ACTGAATTCGCAGGCTGTGTGTCCATAAAATTGAGGTTTCCTCGCACTAATCCTAAACAGTCTGGCACA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC23068 2 10 4 DAC06-F22 16-CG9432-RA_1 CG9432 ACTGAATTCGCAGGCTGTGTGTCCATAAAATTGAGGTTTCCTCGCACTAATCCTAAACAGTCTGGCACA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC23069 2 11 4 DAC06-J10 18-CG9463-RA_7 CG9463 TGGATCAGACTGAGGGCAATGTGGTCAGTTTCAGTATTCGGCAAATTTTCGATGATCTTGGTGGACTGG 69 FBan0009463 FBgn0032066 CG9463 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9463 CG9463 CDMC23069 2 12 4 DAC06-J10 18-CG9463-RA_7 CG9463 TGGATCAGACTGAGGGCAATGTGGTCAGTTTCAGTATTCGGCAAATTTTCGATGATCTTGGTGGACTGG 69 FBan0009463 FBgn0032066 CG9463 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9463 CG9463 CDMC23070 2 13 4 DAC06-J22 12-CG9474-RA_1 CG9474 GGCAACTACTCCTGGCAAACGCAAGCGTAACAAACCCATCTACTTACAAGAACTTTAAGCCGCCGAGCC 69 FBan0009474 FBgn0028401 Snap24 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of exocytosis; GO:0017157; vesicle-mediated transport; GO:0016192 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 colocalizes_with secretory granule; GO:0030141 Snap24 Synapse protein 24 "CG9474, CG9474, SNAP-24, SNAP24, Synapse protein 24" CDMC23070 2 14 4 DAC06-J22 12-CG9474-RA_1 CG9474 GGCAACTACTCCTGGCAAACGCAAGCGTAACAAACCCATCTACTTACAAGAACTTTAAGCCGCCGAGCC 69 FBan0009474 FBgn0028401 Snap24 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of exocytosis; GO:0017157; vesicle-mediated transport; GO:0016192 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 colocalizes_with secretory granule; GO:0030141 Snap24 Synapse protein 24 "CG9474, CG9474, SNAP-24, SNAP24, Synapse protein 24" CDMC23071 2 15 4 DAC06-N10 3-CG9509-RA_2 CG9509 CGCAGTGAGGAGTACTGGCGATGCTATGCCAAATACTTCACCGTCACCTGTTACCATCAATCGGGCACC 69 FBan0009509 FBgn0030594 CG9509 X X electron transport; GO:0006118; mesoderm development; GO:0007498 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9509 CG9509 CDMC23071 2 16 4 DAC06-N10 3-CG9509-RA_2 CG9509 CGCAGTGAGGAGTACTGGCGATGCTATGCCAAATACTTCACCGTCACCTGTTACCATCAATCGGGCACC 69 FBan0009509 FBgn0030594 CG9509 X X electron transport; GO:0006118; mesoderm development; GO:0007498 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9509 CG9509 CDMC23072 2 17 4 DAC06-N22 3-CG9519-RA_1 CG9519 TCGCGGCATCGAGCAGGCAGTAAGTTTACTGGATATGCCCGCATTTAAGGCAATCGGTGCACACTTATT 69 FBan0009519 FBgn0030589 CG9519 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9519 CG9519 CDMC23072 2 18 4 DAC06-N22 3-CG9519-RA_1 CG9519 TCGCGGCATCGAGCAGGCAGTAAGTTTACTGGATATGCCCGCATTTAAGGCAATCGGTGCACACTTATT 69 FBan0009519 FBgn0030589 CG9519 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9519 CG9519 CDMC23073 2 19 4 DAC07-B10 2-CG6570-RA_3 CG6570 GGAGTACCTGCTCCATTGGCTCTGATCAACGAAAGATTGCAAATACCCTTGGTGCCGAATTGCCCTCCG 69 FBan0006570 FBgn0008651 lbl 3 3R "central nervous system development; GO:0007417; heart development; GO:0007507; mesodermal cell fate specification; GO:0007501; muscle development; GO:0007517; regulation of cell fate specification; GO:0042659; regulation of neuron differentiation; GO:0045664; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 lbl ladybird late "CG6570, nkch4, NK-cluster homeobox 4, lady-bird-late, ladybird, lb, Lb, Ladybird, NK?, NKch4, ladybird late" CDMC23073 2 20 4 DAC07-B10 2-CG6570-RA_3 CG6570 GGAGTACCTGCTCCATTGGCTCTGATCAACGAAAGATTGCAAATACCCTTGGTGCCGAATTGCCCTCCG 69 FBan0006570 FBgn0008651 lbl 3 3R "central nervous system development; GO:0007417; heart development; GO:0007507; mesodermal cell fate specification; GO:0007501; muscle development; GO:0007517; regulation of cell fate specification; GO:0042659; regulation of neuron differentiation; GO:0045664; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 lbl ladybird late "CG6570, nkch4, NK-cluster homeobox 4, lady-bird-late, ladybird, lb, Lb, Ladybird, NK?, NKch4, ladybird late" CDMC23074 2 21 4 DAC07-B22 11-CG6579-RA_1 CG6579 TGCGAATGTGGAGCGTGCTGAAAACAAACCCGAAACTAATTTCAGTTGTTCAGCGTCTGCCAAACGGTT 69 FBan0006579 FBgn0032422 CG6579 2 2L CG6579 CG6579 CDMC23074 2 22 4 DAC07-B22 11-CG6579-RA_1 CG6579 TGCGAATGTGGAGCGTGCTGAAAACAAACCCGAAACTAATTTCAGTTGTTCAGCGTCTGCCAAACGGTT 69 FBan0006579 FBgn0032422 CG6579 2 2L CG6579 CG6579 CDMC23075 2 23 4 DAC07-F10 3-CG6607-RA_1 CG6607 AGCCCTGCAAATGCTCGAAGAGGAGTTGACTACGACGCGTATTAACTACGAGGAGCAAATCAGCGTGCT 69 FBan0006607 FBgn0039204 CG6607 3 3R CG6607 CG6607 CDMC23075 2 24 4 DAC07-F10 3-CG6607-RA_1 CG6607 AGCCCTGCAAATGCTCGAAGAGGAGTTGACTACGACGCGTATTAACTACGAGGAGCAAATCAGCGTGCT 69 FBan0006607 FBgn0039204 CG6607 3 3R CG6607 CG6607 CDMC23076 2 25 4 DAC07-F22 23-CG6620-RA_1 CG6620 GGCCAGAAATTGACTGGTTTCGAGTTTGCATTGTGTAACGACTTATTTCAGATTTTACTTTTATGTTTA 69 FBan0006620 FBgn0024227 ial 2 2L attachment of spindle microtubules to kinetochore; GO:0008608; cytokinesis; GO:0000910; establishment and/or maintenance of chromatin architecture; GO:0006325; histone phosphorylation; GO:0016572; intracellular signaling cascade; GO:0007242; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 "chromosome, pericentric region; GO:0000775; kinetochore; GO:0000776; midbody; GO:0030496; spindle; GO:0005819" ial IplI-aurora-like kinase "CG6620, CG6620, DmAIRK2, IAL, IAL1, AURORA-like, aurB, auroraB, DmAuroraB, aurora B kinase, DmAurB, Aurora B, aurora B, AuroraB, aurora-B, Aurora-B, AurB, dAurora B, IplI-aurora-like kinase" CDMC23076 2 26 4 DAC07-F22 23-CG6620-RA_1 CG6620 GGCCAGAAATTGACTGGTTTCGAGTTTGCATTGTGTAACGACTTATTTCAGATTTTACTTTTATGTTTA 69 FBan0006620 FBgn0024227 ial 2 2L attachment of spindle microtubules to kinetochore; GO:0008608; cytokinesis; GO:0000910; establishment and/or maintenance of chromatin architecture; GO:0006325; histone phosphorylation; GO:0016572; intracellular signaling cascade; GO:0007242; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 "chromosome, pericentric region; GO:0000775; kinetochore; GO:0000776; midbody; GO:0030496; spindle; GO:0005819" ial IplI-aurora-like kinase "CG6620, CG6620, DmAIRK2, IAL, IAL1, AURORA-like, aurB, auroraB, DmAuroraB, aurora B kinase, DmAurB, Aurora B, aurora B, AuroraB, aurora-B, Aurora-B, AurB, dAurora B, IplI-aurora-like kinase" CDMC23077 2 1 5 DAC07-J10 2-CG6654-RA_1 CG6654 TCGCGGTGGAGAAATCGTTGATGATCCACAGACGCCAAAAGGGCTGCATTAATCGCAACTACAAGTGCA 69 FBan0006654 FBgn0038301 CG6654 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6654 CG6654 CDMC23077 2 2 5 DAC07-J10 2-CG6654-RA_1 CG6654 TCGCGGTGGAGAAATCGTTGATGATCCACAGACGCCAAAAGGGCTGCATTAATCGCAACTACAAGTGCA 69 FBan0006654 FBgn0038301 CG6654 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6654 CG6654 CDMC23078 2 3 5 DAC07-J22 9-CG6662-RA_1 CG6662 AGGATCGTGCTGTCAAGTGTTTCTATCTGGATGGACAGACCCATGCCAAATACATGAACTCCCGGCGAT 69 FBan0006662 FBgn0035907 CG6662 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6662 CG6662 CDMC23078 2 4 5 DAC07-J22 9-CG6662-RA_1 CG6662 AGGATCGTGCTGTCAAGTGTTTCTATCTGGATGGACAGACCCATGCCAAATACATGAACTCCCGGCGAT 69 FBan0006662 FBgn0035907 CG6662 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6662 CG6662 CDMC23079 2 5 5 DAC07-N10 3-CG6690-RA_3 CG6690 GGTTGGATCCCATCTTTGCGGAACAACAATACGTCGGTTGCTTGGGTTCTACACCCCATACTCGACGGT 69 FBan0006690 FBgn0038918 CG6690 3 3R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG6690 CG6690 CDMC23079 2 6 5 DAC07-N10 3-CG6690-RA_3 CG6690 GGTTGGATCCCATCTTTGCGGAACAACAATACGTCGGTTGCTTGGGTTCTACACCCCATACTCGACGGT 69 FBan0006690 FBgn0038918 CG6690 3 3R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG6690 CG6690 CDMC23080 2 7 5 DAC07-N22 17-CG6700-RA_2 CG6700 CCACCACGAACTACAACTGCAACGAGATCCAGCCTGCATGCAAAATTATCGGAAGTTCAAACTCAACGT 69 FBan0006700 FBgn0032305 CG6700 2 2L CG6700 CG6700 CDMC23080 2 8 5 DAC07-N22 17-CG6700-RA_2 CG6700 CCACCACGAACTACAACTGCAACGAGATCCAGCCTGCATGCAAAATTATCGGAAGTTCAAACTCAACGT 69 FBan0006700 FBgn0032305 CG6700 2 2L CG6700 CG6700 CDMC23081 2 9 5 DAC08-B10 3-CG31860-RA_1 CG31860 GGGCAATGTTTGAGCCCTTCGGATAAAAGTGGAAAACGGAAATCCTCGGATCCGGAAAAGGGCGAAGGA 69 FBan0031860 FBgn0051860 CG31860 2 2L proteolysis; GO:0006508; zinc ion transport; GO:0006829 zinc ion transporter activity; GO:0005385; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0005385; ; GO:0004182 ; EC:3.4.17.1 membrane; GO:0016020 CG31860 CG31860 "CG17215, CG17215" CDMC23081 2 10 5 DAC08-B10 3-CG31860-RA_1 CG31860 GGGCAATGTTTGAGCCCTTCGGATAAAAGTGGAAAACGGAAATCCTCGGATCCGGAAAAGGGCGAAGGA 69 FBan0031860 FBgn0051860 CG31860 2 2L proteolysis; GO:0006508; zinc ion transport; GO:0006829 zinc ion transporter activity; GO:0005385; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0005385; ; GO:0004182 ; EC:3.4.17.1 membrane; GO:0016020 CG31860 CG31860 "CG17215, CG17215" CDMC23082 2 11 5 DAC08-B22 23-CG31868-RA_2 CG31868 CAGCTAGTTAGCAGCGATCCTGTCCACATACGTATTTATGCTAACTAAATTGCATTTCACCTGCTAAAA 69 FBan0031868 FBgn0032330 Samuel 2 2L spermatogenesis; GO:0007283 nucleus; GO:0005634 Samuel SAM-motif ubiquitously expressed punctatedly localized protein "CG14917, CG31868, CG12291, CG14918, CG14917, CG31868, Moses, middleman of seventy-eight signaling, SAM-motif ubiquitously expressed punctatedly localized protein" CDMC23082 2 12 5 DAC08-B22 23-CG31868-RA_2 CG31868 CAGCTAGTTAGCAGCGATCCTGTCCACATACGTATTTATGCTAACTAAATTGCATTTCACCTGCTAAAA 69 FBan0031868 FBgn0032330 Samuel 2 2L spermatogenesis; GO:0007283 nucleus; GO:0005634 Samuel SAM-motif ubiquitously expressed punctatedly localized protein "CG14917, CG31868, CG12291, CG14918, CG14917, CG31868, Moses, middleman of seventy-eight signaling, SAM-motif ubiquitously expressed punctatedly localized protein" CDMC23083 2 13 5 DAC08-F10 3-CG3189-RA_1 CG3189 GGCGCTCTGCTCTTCTATGTGGTGCACAAGGATTCGCGAGTGGAACAGGAGTTTATAAACGAACGGCGA 69 FBan0003189 FBgn0033083 Dpit47 2 2R nucleus; GO:0005634 Dpit47 DNA polymerase interacting tpr containing protein of 47kD "CG3189, DNA polymerase interacting tpr containing protein of 47kD" CDMC23083 2 14 5 DAC08-F10 3-CG3189-RA_1 CG3189 GGCGCTCTGCTCTTCTATGTGGTGCACAAGGATTCGCGAGTGGAACAGGAGTTTATAAACGAACGGCGA 69 FBan0003189 FBgn0033083 Dpit47 2 2R nucleus; GO:0005634 Dpit47 DNA polymerase interacting tpr containing protein of 47kD "CG3189, DNA polymerase interacting tpr containing protein of 47kD" CDMC23084 2 15 5 DAC08-F22 16-CG31907-RA_2 CG31907 GGATTGCGAATTGCGAGGCTTTGAGGATCTGAAAACAGGAGCAGTATATTGCCAACTGATGCACAGACT 69 FBan0031907 FBgn0051907 CG31907 2 2L microtubule cytoskeleton; GO:0015630 CG31907 CG31907 "NEST:bs06f02, NEST:bs29b10, NEST:bs25f07" CDMC23084 2 16 5 DAC08-F22 16-CG31907-RA_2 CG31907 GGATTGCGAATTGCGAGGCTTTGAGGATCTGAAAACAGGAGCAGTATATTGCCAACTGATGCACAGACT 69 FBan0031907 FBgn0051907 CG31907 2 2L microtubule cytoskeleton; GO:0015630 CG31907 CG31907 "NEST:bs06f02, NEST:bs29b10, NEST:bs25f07" CDMC23085 2 17 5 DAC08-J10 2-CG31936-RA_3 CG31936 TGCGTATGGCTTTGTCCTGAATGCCGCATTCATTCTGCTGGTCGTTACCAATGACACGGAGAGCGAAAC 69 FBan0031936 FBgn0045497 Gr22e 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr22e Gustatory receptor 22e "CG31936, Gr2940.1, Gustatory receptor 2940.1, Gustatory receptor 22e" CDMC23085 2 18 5 DAC08-J10 2-CG31936-RA_3 CG31936 TGCGTATGGCTTTGTCCTGAATGCCGCATTCATTCTGCTGGTCGTTACCAATGACACGGAGAGCGAAAC 69 FBan0031936 FBgn0045497 Gr22e 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr22e Gustatory receptor 22e "CG31936, Gr2940.1, Gustatory receptor 2940.1, Gustatory receptor 22e" CDMC23086 2 19 5 DAC08-J22 24-CG31958-RA_2 CG31958 CGCCCATTCTAAATTACAATCATACTGCAGTTAAAGGAATATTTTATGGTTTATTGTTGGATTATTTTA 69 FBan0031958 FBgn0051958 CG31958 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31958 CG31958 CG10022 CDMC23086 2 20 5 DAC08-J22 24-CG31958-RA_2 CG31958 CGCCCATTCTAAATTACAATCATACTGCAGTTAAAGGAATATTTTATGGTTTATTGTTGGATTATTTTA 69 FBan0031958 FBgn0051958 CG31958 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31958 CG31958 CG10022 CDMC23087 2 21 5 DAC08-N10 17-CG32005-RA_1 CG32005 ACCTTCAACCCCATCGACTGGTAGTAATAGTGGATGCTCTACTGGAATGGTTTCTGGAATTTTCGGGCT 69 FBan0032005 FBgn0052005 CG32005 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32005 CG32005 CDMC23087 2 22 5 DAC08-N10 17-CG32005-RA_1 CG32005 ACCTTCAACCCCATCGACTGGTAGTAATAGTGGATGCTCTACTGGAATGGTTTCTGGAATTTTCGGGCT 69 FBan0032005 FBgn0052005 CG32005 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32005 CG32005 CDMC23088 2 23 5 DAC08-N22 8-CG32019-RA_1 CG32019 GGATGGCGATGCAGTGAATCTGGCTTGTCGCATAATTGGAGCTCAACATTTCGATGTCGTATGGCTGCA 69 FBan0032019 FBgn0005666 bt 4 4 carbohydrate metabolism; GO:0005975; cell communication; GO:0007154; cell motility; GO:0006928; cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 ATP binding; GO:0005524; structural constituent of cytoskeleton; GO:0005200; ; GO:0005524; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004687 ; EC:2.7.1.117 cytoplasm; GO:0005737 bt bent "CG1479, CG32019, CG10285, CG1479, CG1479, CG1479, CG32019, l(2)2, l(2)23, l(4)2, l(4)23, projectin, twitchin, Projectin, l(4)PT-2, lethal(4) Powell, Tennessee-2, titin, C-protein, myosin LCK, PROJECTIN, CT8086, CT3598, Prj: Projectin, l(4)102CDa, l(4)21, l(4)37, l(4)38" CDMC23088 2 24 5 DAC08-N22 8-CG32019-RA_1 CG32019 GGATGGCGATGCAGTGAATCTGGCTTGTCGCATAATTGGAGCTCAACATTTCGATGTCGTATGGCTGCA 69 FBan0032019 FBgn0005666 bt 4 4 carbohydrate metabolism; GO:0005975; cell communication; GO:0007154; cell motility; GO:0006928; cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 ATP binding; GO:0005524; structural constituent of cytoskeleton; GO:0005200; ; GO:0005524; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004687 ; EC:2.7.1.117 cytoplasm; GO:0005737 bt bent "CG1479, CG32019, CG10285, CG1479, CG1479, CG1479, CG32019, l(2)2, l(2)23, l(4)2, l(4)23, projectin, twitchin, Projectin, l(4)PT-2, lethal(4) Powell, Tennessee-2, titin, C-protein, myosin LCK, PROJECTIN, CT8086, CT3598, Prj: Projectin, l(4)102CDa, l(4)21, l(4)37, l(4)38" CDMC23089 2 25 5 DAC09-B11 2-CG5387-RA_3 CG5387 ACAACAAGAACTCCATGTCGAACCACAACAAGCTGATCCAGAAACAGCCCCTGACGCTCAGCCTG 65 FBan0005387 FBgn0027491 Cdk5alpha 2 2L protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; cyclin-dependent protein kinase 5 activator regulator activity; GO:0016536; ; GO:0004693 ; EC:2.7.1.-; ; GO:0016536; cyclin-dependent protein kinase 5 activator activity; GO:0016534; ; GO:0016534 cyclin-dependent protein kinase 5 activator complex; GO:0016533 Cdk5alpha Cdk5 activator-like protein "CG5387, CG5387, CG5387, dCdk5alpha, Cdk5a, p35, Dp35, P35, p35-31C" CDMC23089 2 26 5 DAC09-B11 2-CG5387-RA_3 CG5387 ACAACAAGAACTCCATGTCGAACCACAACAAGCTGATCCAGAAACAGCCCCTGACGCTCAGCCTG 65 FBan0005387 FBgn0027491 Cdk5alpha 2 2L protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; cyclin-dependent protein kinase 5 activator regulator activity; GO:0016536; ; GO:0004693 ; EC:2.7.1.-; ; GO:0016536; cyclin-dependent protein kinase 5 activator activity; GO:0016534; ; GO:0016534 cyclin-dependent protein kinase 5 activator complex; GO:0016533 Cdk5alpha Cdk5 activator-like protein "CG5387, CG5387, CG5387, dCdk5alpha, Cdk5a, p35, Dp35, P35, p35-31C" CDMC23090 2 1 6 DAC09-B23 2-CG5413-RB_2 CG5413 TGGCAGAAGGACAACAAGGTCACACTCCTGTTCAGTGACGAGCAGACCCTAAGATGCAAGGAGGG 65 FBan0005413 FBgn0025456 CREG 3 3R negative regulation of transcription; GO:0016481 protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; ; GO:0005515; ; GO:0016564 nucleus; GO:0005634 CREG Cellular Repressor of E1A-stimulated Genes "CG5413, dCREG, cellular repressor of E1A-stimulated genes, BcDNA:LP11958" CDMC23090 2 2 6 DAC09-B23 2-CG5413-RB_2 CG5413 TGGCAGAAGGACAACAAGGTCACACTCCTGTTCAGTGACGAGCAGACCCTAAGATGCAAGGAGGG 65 FBan0005413 FBgn0025456 CREG 3 3R negative regulation of transcription; GO:0016481 protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; ; GO:0005515; ; GO:0016564 nucleus; GO:0005634 CREG Cellular Repressor of E1A-stimulated Genes "CG5413, dCREG, cellular repressor of E1A-stimulated genes, BcDNA:LP11958" CDMC23091 2 3 6 DAC09-F11 2-CG5567-RA_1 CG5567 CTGTTCGTGGCTACCAATACGGATGAGCGTTTCCCCATGCCCAATATGATAGTACCAGGCAGCGG 65 FBan0005567 FBgn0036760 CG5567 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG5567 CG5567 CDMC23091 2 4 6 DAC09-F11 2-CG5567-RA_1 CG5567 CTGTTCGTGGCTACCAATACGGATGAGCGTTTCCCCATGCCCAATATGATAGTACCAGGCAGCGG 65 FBan0005567 FBgn0036760 CG5567 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG5567 CG5567 CDMC23092 2 5 6 DAC09-F23 3-CG5586-RB_4 CG5586 GAAGTCCAAGAGCCTAGACTCCTGCGACCTGTTGTCCCTACAGACTAAGCTGTCCAGCAAGGAGC 65 FBan0005586 FBgn0039530 Tusp 3 3R intracellular signaling cascade; GO:0007242 Tusp Tusp "CG5586, TUSP, dmWSBa Tubby-like" CDMC23092 2 6 6 DAC09-F23 3-CG5586-RB_4 CG5586 GAAGTCCAAGAGCCTAGACTCCTGCGACCTGTTGTCCCTACAGACTAAGCTGTCCAGCAAGGAGC 65 FBan0005586 FBgn0039530 Tusp 3 3R intracellular signaling cascade; GO:0007242 Tusp Tusp "CG5586, TUSP, dmWSBa Tubby-like" CDMC23093 2 7 6 DAC09-J11 23-CG5725-RB_1 CG5725 ATTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC23093 2 8 6 DAC09-J11 23-CG5725-RB_1 CG5725 ATTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC23094 2 9 6 DAC09-J23 3-CG5745-RA_2 CG5745 AATTCCAAGTGGTGCTAGACTCGCCTCAACTGGACTTGGTGGCCCTCAAGAAGATCAGCTGGTCT 65 FBan0005745 FBgn0038855 CG5745 3 3R GTPase activator activity; GO:0005096; ; GO:0005096 CG5745 CG5745 CDMC23094 2 10 6 DAC09-J23 3-CG5745-RA_2 CG5745 AATTCCAAGTGGTGCTAGACTCGCCTCAACTGGACTTGGTGGCCCTCAAGAAGATCAGCTGGTCT 65 FBan0005745 FBgn0038855 CG5745 3 3R GTPase activator activity; GO:0005096; ; GO:0005096 CG5745 CG5745 CDMC23095 2 11 6 DAC09-N11 2-CG5904-RA_5 CG5904 CGGTCACAGAGGCAAACCAAACGAGAGGCTGAATCCTTTACGGGCAGTGTCAATTTGTACGGCGG 65 FBan0005904 FBgn0036557 mRpS31 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS31 mitochondrial ribosomal protein S31 "CG5904, MRP-S31, RpS31, mitochondrial ribosomal protein S31" CDMC23095 2 12 6 DAC09-N11 2-CG5904-RA_5 CG5904 CGGTCACAGAGGCAAACCAAACGAGAGGCTGAATCCTTTACGGGCAGTGTCAATTTGTACGGCGG 65 FBan0005904 FBgn0036557 mRpS31 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS31 mitochondrial ribosomal protein S31 "CG5904, MRP-S31, RpS31, mitochondrial ribosomal protein S31" CDMC23096 2 13 6 DAC09-N23 3-CG5917-RA_1 CG5917 CAAACGGACATGGAGCGACTCAAGCAGGGATTAGTCAGCGTCCAAGTGTGGTCAGCATATGTGCC 65 FBan0005917 FBgn0036215 CG5917 3 3L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0008239 CG5917 CG5917 CDMC23096 2 14 6 DAC09-N23 3-CG5917-RA_1 CG5917 CAAACGGACATGGAGCGACTCAAGCAGGGATTAGTCAGCGTCCAAGTGTGGTCAGCATATGTGCC 65 FBan0005917 FBgn0036215 CG5917 3 3L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0008239 CG5917 CG5917 CDMC23097 2 15 6 DAC10-B10 5-CG6498-RA_1 CG6498 TCTCCCACTGGAGTCGTTCCGCAGCTGTATCAGCGTCCATCCACTCTACATGGTCTCAAGCACAA 65 FBan0006498 FBgn0036511 CG6498 3 3L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004674 CG6498 CG6498 MAST 205 CDMC23097 2 16 6 DAC10-B10 5-CG6498-RA_1 CG6498 TCTCCCACTGGAGTCGTTCCGCAGCTGTATCAGCGTCCATCCACTCTACATGGTCTCAAGCACAA 65 FBan0006498 FBgn0036511 CG6498 3 3L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004674 CG6498 CG6498 MAST 205 CDMC23098 2 17 6 DAC10-B22 21-CG6517-RA_1 CG6517 CAGCCCGTCTATCCCCCCACCAGCTACGTGAACCAGGAGTACGGACACAGCGAGAAGGTGAAGGG 65 FBan0006517 FBgn0000357 Cp18 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp18 Chorion protein 18 "CG6517, s18, E5, s18-1, cp18, S18: Shell-18, Dms18, ACE3, CP18, S-18, s-18, Shell-18, S18" CDMC23098 2 18 6 DAC10-B22 21-CG6517-RA_1 CG6517 CAGCCCGTCTATCCCCCCACCAGCTACGTGAACCAGGAGTACGGACACAGCGAGAAGGTGAAGGG 65 FBan0006517 FBgn0000357 Cp18 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp18 Chorion protein 18 "CG6517, s18, E5, s18-1, cp18, S18: Shell-18, Dms18, ACE3, CP18, S-18, s-18, Shell-18, S18" CDMC23099 2 19 6 DAC10-F10 2-CG6647-RB_2 CG6647 GAACGTCAAGGCCGATTCGGATGTGAACATTGATCTGAAGGGCCCCTTGATCAATGCCTCTGCCG 65 FBan0006647 FBgn0004363 porin 2 2L anion transport; GO:0006820; mitochondrial transport; GO:0006839 voltage-gated ion channel activity; GO:0005244; ; GO:0005244; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308; ; GO:0008308; ; GO:0008308 Nebenkern; GO:0016006; mitochondrial outer membrane; GO:0005741 porin porin "CG6647, CG6647, l(2)k05123, DmVDAC, VDAC, POR-1, DmPorin1, anon-WO02059370.56, Vdac, Voltage-dependent anion-selective channel" CDMC23099 2 20 6 DAC10-F10 2-CG6647-RB_2 CG6647 GAACGTCAAGGCCGATTCGGATGTGAACATTGATCTGAAGGGCCCCTTGATCAATGCCTCTGCCG 65 FBan0006647 FBgn0004363 porin 2 2L anion transport; GO:0006820; mitochondrial transport; GO:0006839 voltage-gated ion channel activity; GO:0005244; ; GO:0005244; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308; ; GO:0008308; ; GO:0008308 Nebenkern; GO:0016006; mitochondrial outer membrane; GO:0005741 porin porin "CG6647, CG6647, l(2)k05123, DmVDAC, VDAC, POR-1, DmPorin1, anon-WO02059370.56, Vdac, Voltage-dependent anion-selective channel" CDMC23100 2 21 6 DAC10-F22 1-CG6696-RA_1 CG6696 CACAACAGTCCTGCCTTCAACTTCTGGACGGAGGACAGCGATACGAACATATGGGAGCATTGCGG 65 FBan0006696 FBgn0030947 CG6696 X X proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG6696 CG6696 CDMC23100 2 22 6 DAC10-F22 1-CG6696-RA_1 CG6696 CACAACAGTCCTGCCTTCAACTTCTGGACGGAGGACAGCGATACGAACATATGGGAGCATTGCGG 65 FBan0006696 FBgn0030947 CG6696 X X proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG6696 CG6696 CDMC23101 2 23 6 DAC10-J10 16-CG6788-RA_1 CG6788 AACCGCATACCTCATCCTGATTCTTTCGCTCTCGATATCCACTTCCTTGGCTAACGATCCGCAGA 65 FBan0006788 FBgn0030880 CG6788 X X cell adhesion; GO:0007155; defense response to bacteria; GO:0042742 CG6788 CG6788 CDMC23101 2 24 6 DAC10-J10 16-CG6788-RA_1 CG6788 AACCGCATACCTCATCCTGATTCTTTCGCTCTCGATATCCACTTCCTTGGCTAACGATCCGCAGA 65 FBan0006788 FBgn0030880 CG6788 X X cell adhesion; GO:0007155; defense response to bacteria; GO:0042742 CG6788 CG6788 CDMC23102 2 25 6 DAC10-J22 15-CG6824-RA_2 CG6824 AGCGCCTGCTCAATCGGCACATGAAGTGTCACTCGGACATCAAGCGGTATCTGTGCACGTTCTGC 65 FBan0006824 FBgn0003028 ovo X X cuticle biosynthesis; GO:0042335; female germ-line sex determination; GO:0019099; oogenesis (sensu Insecta); GO:0009993; pheromone metabolism; GO:0042810; regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366; trichome organization and biogenesis (sensu Insecta); GO:0035316 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003702 nucleus; GO:0005634 ovo ovo "CG6824, CG15467, CG6824, CG15467, CG15467, fs(1)M1, fs(1)M38, Fs(1)K1103, svb: shaven baby, shaven baby, Ovo, fs(1)K1237, ovo/svb, Shavenbaby, Svb, OVO, ovo/shaven-baby, shavenbaby, ovo/shavenbaby, Ovo-D, Fs(1)K1237, Fs(1)K155, svb" CDMC23102 2 26 6 DAC10-J22 15-CG6824-RA_2 CG6824 AGCGCCTGCTCAATCGGCACATGAAGTGTCACTCGGACATCAAGCGGTATCTGTGCACGTTCTGC 65 FBan0006824 FBgn0003028 ovo X X cuticle biosynthesis; GO:0042335; female germ-line sex determination; GO:0019099; oogenesis (sensu Insecta); GO:0009993; pheromone metabolism; GO:0042810; regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366; trichome organization and biogenesis (sensu Insecta); GO:0035316 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003702 nucleus; GO:0005634 ovo ovo "CG6824, CG15467, CG6824, CG15467, CG15467, fs(1)M1, fs(1)M38, Fs(1)K1103, svb: shaven baby, shaven baby, Ovo, fs(1)K1237, ovo/svb, Shavenbaby, Svb, OVO, ovo/shaven-baby, shavenbaby, ovo/shavenbaby, Ovo-D, Fs(1)K1237, Fs(1)K155, svb" CDMC23103 2 1 7 DAC10-N10 5-CG6905-RA_1 CG6905 CTCCCAGGTTATTCAGCGTAGTCTCCCGCGACCAACTGAAGTGAACACCAAGATTCTGCGACCGC 65 FBan0006905 FBgn0035136 CG6905 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" "DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6905 CG6905 CDMC23103 2 2 7 DAC10-N10 5-CG6905-RA_1 CG6905 CTCCCAGGTTATTCAGCGTAGTCTCCCGCGACCAACTGAAGTGAACACCAAGATTCTGCGACCGC 65 FBan0006905 FBgn0035136 CG6905 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" "DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6905 CG6905 CDMC23104 2 3 7 DAC10-N22 2-CG6939-RA_1 CG6939 TGGCAGGTTACCAGGACAAGTACTTCCACCCGCATCGTTTCGAGAAGCATCCATACACTACGCCC 65 FBan0006939 FBgn0025802 Sbf 3 3R intracellular signaling cascade; GO:0007242; protein metabolism; GO:0019538 diacylglycerol binding; GO:0019992; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0019992; ; GO:0008138 ; EC:3.1.3.- Sbf SET domain binding factor "CG6939, CG6939, DSbf1, sbf, dSbf1, Sbf1, SBF" CDMC23104 2 4 7 DAC10-N22 2-CG6939-RA_1 CG6939 TGGCAGGTTACCAGGACAAGTACTTCCACCCGCATCGTTTCGAGAAGCATCCATACACTACGCCC 65 FBan0006939 FBgn0025802 Sbf 3 3R intracellular signaling cascade; GO:0007242; protein metabolism; GO:0019538 diacylglycerol binding; GO:0019992; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0019992; ; GO:0008138 ; EC:3.1.3.- Sbf SET domain binding factor "CG6939, CG6939, DSbf1, sbf, dSbf1, Sbf1, SBF" CDMC23105 2 5 7 24-X06779.1_O3_3 X06779.1_O3_3 ATATCGCGGGCTATGTCATTAAAAAATTGAGAATCAGTGACAAAGTAAAAGAAAATTTGACATTTACAT 69 CDMC23105 2 6 7 24-X06779.1_O3_3 X06779.1_O3_3 ATATCGCGGGCTATGTCATTAAAAAATTGAGAATCAGTGACAAAGTAAAAGAAAATTTGACATTTACAT 69 CDMC23106 2 7 7 DAC11-B22 23-CG10011-RA_8 CG10011 CAAAGCGGTCCGTTCCTGTACCTTAACACTTGTCACTAATTTTATGTAACCCTTAAGCCGGACAAACCA 69 FBan0010011 FBgn0039590 CG10011 3 3R signal transduction; GO:0007165 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG10011 CG10011 CDMC23106 2 8 7 DAC11-B22 23-CG10011-RA_8 CG10011 CAAAGCGGTCCGTTCCTGTACCTTAACACTTGTCACTAATTTTATGTAACCCTTAAGCCGGACAAACCA 69 FBan0010011 FBgn0039590 CG10011 3 3R signal transduction; GO:0007165 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG10011 CG10011 CDMC23107 2 9 7 DAC11-F10 14-CG1004-RA_1 CG1004 GCTCGCAGGGATTCGGAATCTGCTTGAGCTTCAGGAGAGATCGAGAGACAGAGAGTTGGTGGAAAAGAA 69 FBan0001004 FBgn0004635 rho 3 3L brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; branching morphogenesis; GO:0001763; cytokinesis; GO:0000910; ectoderm development; GO:0007398; epidermal growth factor ligand processing; GO:0007174; epidermal growth factor receptor signaling pathway; GO:0007173; learning and/or memory; GO:0007611; leg disc proximal/distal pattern formation; GO:0007479; oenocyte development; GO:0007438; olfactory learning; GO:0008355; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; proteolysis; GO:0006508; regulation of epidermal growth factor receptor activity; GO:0007176; salivary gland determination; GO:0007432; salivary gland development; GO:0007431; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008236; ; GO:0008236; ; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; ; GO:0008236 Golgi apparatus; GO:0005794; NOT endoplasmic reticulum; GO:0005783; NOT plasma membrane; GO:0005886; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 rho rhomboid "CG1004, CG1004, ve: veinlet, Rho: Rhombotin, rhomboid/veinlet, DMRHOa, DMRHOb, Ve, DRORHO, DMRHO, RHOb, Rhomboid, rhom, RHO, veinlet, rho-1, rhomboid-1, Veinlet, Rhomboid-1, rho1, Rho-1, rhomboid1, Rhomboid 1, Rho1, Rho" CDMC23107 2 10 7 DAC11-F10 14-CG1004-RA_1 CG1004 GCTCGCAGGGATTCGGAATCTGCTTGAGCTTCAGGAGAGATCGAGAGACAGAGAGTTGGTGGAAAAGAA 69 FBan0001004 FBgn0004635 rho 3 3L brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; branching morphogenesis; GO:0001763; cytokinesis; GO:0000910; ectoderm development; GO:0007398; epidermal growth factor ligand processing; GO:0007174; epidermal growth factor receptor signaling pathway; GO:0007173; learning and/or memory; GO:0007611; leg disc proximal/distal pattern formation; GO:0007479; oenocyte development; GO:0007438; olfactory learning; GO:0008355; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; proteolysis; GO:0006508; regulation of epidermal growth factor receptor activity; GO:0007176; salivary gland determination; GO:0007432; salivary gland development; GO:0007431; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008236; ; GO:0008236; ; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; ; GO:0008236 Golgi apparatus; GO:0005794; NOT endoplasmic reticulum; GO:0005783; NOT plasma membrane; GO:0005886; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 rho rhomboid "CG1004, CG1004, ve: veinlet, Rho: Rhombotin, rhomboid/veinlet, DMRHOa, DMRHOb, Ve, DRORHO, DMRHO, RHOb, Rhomboid, rhom, RHO, veinlet, rho-1, rhomboid-1, Veinlet, Rhomboid-1, rho1, Rho-1, rhomboid1, Rhomboid 1, Rho1, Rho" CDMC23108 2 11 7 DAC11-F22 16-CG10060-RA_1 CG10060 TTCCGGACGTTTATTCTTTGCCAAGAGCTTGACAGCGTTATTTAAGGTGAACCTAAGGCCTGGAGTTGT 69 FBan0010060 FBgn0001104 G-ialpha65A 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034 GTP binding; GO:0005525; protein binding; GO:0005515; ; GO:0005515; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 cell cortex; GO:0005938; heterotrimeric G-protein complex; GO:0005834 G-ialpha65A G protein alphai subunit 65A "CG10060, DGalpha1, Gialpha, DG[[alpha1]], G[[i]]alpha, Galphai, Gi-alpha, i, G protein alpha-subunit, G protein alpha subunit, Galpha[[i]], Galpha[[i]], Galpha65A, Galpha[[i65A]], Gai, G protein alpha o subunit 65A, Galpha i, G[[alphai]], G-ia65A, G-ialpha65A, Gi, Galpha65A, G-alpha-65A, G-oalpha65A: G protein alphao subunit 65A, G protein alphao subunit 65A" CDMC23108 2 12 7 DAC11-F22 16-CG10060-RA_1 CG10060 TTCCGGACGTTTATTCTTTGCCAAGAGCTTGACAGCGTTATTTAAGGTGAACCTAAGGCCTGGAGTTGT 69 FBan0010060 FBgn0001104 G-ialpha65A 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034 GTP binding; GO:0005525; protein binding; GO:0005515; ; GO:0005515; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 cell cortex; GO:0005938; heterotrimeric G-protein complex; GO:0005834 G-ialpha65A G protein alphai subunit 65A "CG10060, DGalpha1, Gialpha, DG[[alpha1]], G[[i]]alpha, Galphai, Gi-alpha, i, G protein alpha-subunit, G protein alpha subunit, Galpha[[i]], Galpha[[i]], Galpha65A, Galpha[[i65A]], Gai, G protein alpha o subunit 65A, Galpha i, G[[alphai]], G-ia65A, G-ialpha65A, Gi, Galpha65A, G-alpha-65A, G-oalpha65A: G protein alphao subunit 65A, G protein alphao subunit 65A" CDMC23109 2 13 7 DAC11-J10 6-CG10084-RA_1 CG10084 TGCACCAGGTGACATGTCCGTTAGCCTAGAGAACCCCAAACAATTAATCCAGTCCGTCAGTGAGAGCGA 69 FBgn0032794 CDMC23109 2 14 7 DAC11-J10 6-CG10084-RA_1 CG10084 TGCACCAGGTGACATGTCCGTTAGCCTAGAGAACCCCAAACAATTAATCCAGTCCGTCAGTGAGAGCGA 69 FBgn0032794 CDMC23110 2 15 7 DAC11-J22 23-CG10095-RA_11 CG10095 TATTAACAGAGAGAGAATAAGGAAGATACACCCTCGGCAAGGCAATATATACAGGACTAAGGGCATAAG 69 FBan0010095 FBgn0037993 dpr15 3 3R dpr15 dpr15 "CG10095, CG10095, CG10095, CT28423, Dpr-15" CDMC23110 2 16 7 DAC11-J22 23-CG10095-RA_11 CG10095 TATTAACAGAGAGAGAATAAGGAAGATACACCCTCGGCAAGGCAATATATACAGGACTAAGGGCATAAG 69 FBan0010095 FBgn0037993 dpr15 3 3R dpr15 dpr15 "CG10095, CG10095, CG10095, CT28423, Dpr-15" CDMC23111 2 17 7 DAC11-N10 13-CG10129-RA_2 CG10129 ACGCATCAAAACCGTAGCCATTACCCGTATACACAATGCTACCAATTGCGATTCCTGCTACAAGCTGCA 69 FBan0010129 FBgn0002926 ndl 3 3L "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; egg activation; GO:0007343; insect chorion formation; GO:0007306; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; oocyte dorsal/ventral axis determination; GO:0007310; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 ndl nudel "CG10129, nud, Ndl, SP89, mat(3)2, mel(3)5" CDMC23111 2 18 7 DAC11-N10 13-CG10129-RA_2 CG10129 ACGCATCAAAACCGTAGCCATTACCCGTATACACAATGCTACCAATTGCGATTCCTGCTACAAGCTGCA 69 FBan0010129 FBgn0002926 ndl 3 3L "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; egg activation; GO:0007343; insect chorion formation; GO:0007306; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; oocyte dorsal/ventral axis determination; GO:0007310; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 ndl nudel "CG10129, nud, Ndl, SP89, mat(3)2, mel(3)5" CDMC23112 2 19 7 DAC11-N22 17-CG10138-RA_2 CG10138 TCTCGTCGTTCGACCGTTTTATCAACTGGTAAGGAGAGCTCCAAGGAGGAAAAGAATCGAATGTCCCAA 69 FBan0010138 FBgn0005778 PpD5 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 PpD5 Protein phosphatase D5 "CG10138, CG10138, CG10138, CG10138, D5, protein phosphatase from PCR fragment D5, PP1-like, anon-WO0140519.107" CDMC23112 2 20 7 DAC11-N22 17-CG10138-RA_2 CG10138 TCTCGTCGTTCGACCGTTTTATCAACTGGTAAGGAGAGCTCCAAGGAGGAAAAGAATCGAATGTCCCAA 69 FBan0010138 FBgn0005778 PpD5 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 PpD5 Protein phosphatase D5 "CG10138, CG10138, CG10138, CG10138, D5, protein phosphatase from PCR fragment D5, PP1-like, anon-WO0140519.107" CDMC23113 2 21 7 DAC12-B10 9-CG30095-RA_1 CG30095 CCAGCGGTATTCATCTCATCTCCAGTCTGGAGCATCAGCGCACTTTTCTTCATCTCTTCCATGTGCCCT 69 FBan0030095 FBgn0050095 CG30095 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30095 CG30095 "CG8425, CG8425, CG8425" CDMC23113 2 22 7 DAC12-B10 9-CG30095-RA_1 CG30095 CCAGCGGTATTCATCTCATCTCCAGTCTGGAGCATCAGCGCACTTTTCTTCATCTCTTCCATGTGCCCT 69 FBan0030095 FBgn0050095 CG30095 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30095 CG30095 "CG8425, CG8425, CG8425" CDMC23114 2 23 7 DAC12-B22 2-CG30101-RA_3 CG30101 AGCACAGCGAATTGTGGAGTAATTGTTCCCCCGTGAGACGTCGAATCAGCAGCTCAACAATGCGAATGT 69 FBan0030101 FBgn0050101 CG30101 2 2R CG30101 CG30101 "CG15901, CG6564, CG15901" CDMC23114 2 24 7 DAC12-B22 2-CG30101-RA_3 CG30101 AGCACAGCGAATTGTGGAGTAATTGTTCCCCCGTGAGACGTCGAATCAGCAGCTCAACAATGCGAATGT 69 FBan0030101 FBgn0050101 CG30101 2 2R CG30101 CG30101 "CG15901, CG6564, CG15901" CDMC23115 2 25 7 DAC12-F10 17-CG30143-RA_1 CG30143 GGCAACTCTCTCGCCTAATGTCCAAAACGTTGAAAGCATCAATATGCAAAGTGGATTTTCGGGCAAGGA 69 FBan0030143 FBgn0050143 CG30143 2 2R CG30143 CG30143 "CG12484, CT32777" CDMC23115 2 26 7 DAC12-F10 17-CG30143-RA_1 CG30143 GGCAACTCTCTCGCCTAATGTCCAAAACGTTGAAAGCATCAATATGCAAAGTGGATTTTCGGGCAAGGA 69 FBan0030143 FBgn0050143 CG30143 2 2R CG30143 CG30143 "CG12484, CT32777" CDMC23116 2 1 8 DAC12-F22 2-CG30152-RA_3 CG30152 TGCTGTAATCACCCAAGCACACAACGGTAAAGATAAAACCAGGCGAGATAACACCACGCACAGGTGCCA 69 FBgn0050152 CDMC23116 2 2 8 DAC12-F22 2-CG30152-RA_3 CG30152 TGCTGTAATCACCCAAGCACACAACGGTAAAGATAAAACCAGGCGAGATAACACCACGCACAGGTGCCA 69 FBgn0050152 CDMC23117 2 3 8 DAC12-J10 18-CG30182-RA_2 CG30182 ACAATGCTGAAGTTGGTCGAAAAGCTTTTCCAACTGTTGCGACCCAGGATGTGTCAGTTTTCACAATCC 69 FBan0030182 FBgn0050182 CG30182 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30182 CG30182 CDMC23117 2 4 8 DAC12-J10 18-CG30182-RA_2 CG30182 ACAATGCTGAAGTTGGTCGAAAAGCTTTTCCAACTGTTGCGACCCAGGATGTGTCAGTTTTCACAATCC 69 FBan0030182 FBgn0050182 CG30182 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30182 CG30182 CDMC23118 2 5 8 DAC12-J22 14-CG30190-RA_1 CG30190 GGAGCACATAAATGAAGTGGTGGCTAACTATGGAAGGGATGAAAAGTTGTTGCCCCAAGAGCGGAAGCA 69 FBan0030190 FBgn0050190 CG30190 2 2R CG30190 CG30190 CG9848 CDMC23118 2 6 8 DAC12-J22 14-CG30190-RA_1 CG30190 GGAGCACATAAATGAAGTGGTGGCTAACTATGGAAGGGATGAAAAGTTGTTGCCCCAAGAGCGGAAGCA 69 FBan0030190 FBgn0050190 CG30190 2 2R CG30190 CG30190 CG9848 CDMC23119 2 7 8 DAC12-N10 6-CG30279-RA_2 CG30279 TTGGGCTTGGTCGGTCTCAACTACCTGGATGTGTTCAAGTCCCAGCGACTAATTTCGGGGAAACGCATC 69 FBan0030279 FBgn0050279 CG30279 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30279 CG30279 CDMC23119 2 8 8 DAC12-N10 6-CG30279-RA_2 CG30279 TTGGGCTTGGTCGGTCTCAACTACCTGGATGTGTTCAAGTCCCAGCGACTAATTTCGGGGAAACGCATC 69 FBan0030279 FBgn0050279 CG30279 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30279 CG30279 CDMC23120 2 9 8 DAC12-N22 2-CG30288-RA_1 CG30288 TGGGCGAATACGATACCCGACATCCCATATTCGACTGCGATGATTTTGTCTGCACACCAAGGGCCTACA 69 FBan0030288 FBgn0050288 CG30288 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG30288 CG30288 CDMC23120 2 10 8 DAC12-N22 2-CG30288-RA_1 CG30288 TGGGCGAATACGATACCCGACATCCCATATTCGACTGCGATGATTTTGTCTGCACACCAAGGGCCTACA 69 FBan0030288 FBgn0050288 CG30288 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG30288 CG30288 CDMC23121 2 11 8 DAC13-B10 1-CG13228-RA_1 CG13228 CACCGATCCTCTCCAGCGTCGACGAGGAGAACATTAGAAGACCCCGTCACATTGGTGGATTTGGA 65 FBan0013228 FBgn0033588 CG13228 2 2R CG13228 CG13228 CDMC23121 2 12 8 DAC13-B10 1-CG13228-RA_1 CG13228 CACCGATCCTCTCCAGCGTCGACGAGGAGAACATTAGAAGACCCCGTCACATTGGTGGATTTGGA 65 FBan0013228 FBgn0033588 CG13228 2 2R CG13228 CG13228 CDMC23122 2 13 8 DAC13-B22 13-CG13240-RA_1 CG13240 TGTTGGCGTTTTCCAACGTCCACATCGCAAAGTTCGAAAACAAACGGTCCAAAATGGTAGCTGGT 65 FBgn0028508 CDMC23122 2 14 8 DAC13-B22 13-CG13240-RA_1 CG13240 TGTTGGCGTTTTCCAACGTCCACATCGCAAAGTTCGAAAACAAACGGTCCAAAATGGTAGCTGGT 65 FBgn0028508 CDMC23123 2 15 8 DAC13-F10 9-CG13419-RA_2 CG13419 TCGCTGTGCCAGTTATATCCAGGTTTCGGGCAGTAAGATCTGGCAAATGGAGCGTTCCTGCATGT 65 FBan0013419 FBgn0038901 burs 3 3R cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; regulation of adult cuticle pigmentation; GO:0048082; regulation of cuticle tanning; GO:0007564; wing morphogenesis; GO:0007476 neuropeptide hormone activity; GO:0005184; ; GO:0005184; hormone activity; GO:0005179; ; GO:0005179; contributes_to neuropeptide hormone activity; GO:0005184; ; GO:0005184 bursicon neuropeptide hormone complex; GO:0031395; extracellular region; GO:0005576 burs bursicon "CG13419, CG13419, CG13419, furled wing, bursalpha, bursicon alpha, burs-alpha, frl" CDMC23123 2 16 8 DAC13-F10 9-CG13419-RA_2 CG13419 TCGCTGTGCCAGTTATATCCAGGTTTCGGGCAGTAAGATCTGGCAAATGGAGCGTTCCTGCATGT 65 FBan0013419 FBgn0038901 burs 3 3R cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; regulation of adult cuticle pigmentation; GO:0048082; regulation of cuticle tanning; GO:0007564; wing morphogenesis; GO:0007476 neuropeptide hormone activity; GO:0005184; ; GO:0005184; hormone activity; GO:0005179; ; GO:0005179; contributes_to neuropeptide hormone activity; GO:0005184; ; GO:0005184 bursicon neuropeptide hormone complex; GO:0031395; extracellular region; GO:0005576 burs bursicon "CG13419, CG13419, CG13419, furled wing, bursalpha, bursicon alpha, burs-alpha, frl" CDMC23124 2 17 8 DAC13-F22 21-CG13439-RA_1 CG13439 AGATACAGATACAGCAGCACAATGTCCCTGCCATCCAGAGCCAATATCGGATTACTCAACTGGCT 65 FBan0013439 FBgn0040726 dpr 2 2R salt aversion; GO:0035199; sensory perception of salty taste; GO:0050914 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr defective proboscis extension response "CG13439, CG13439, CG13439, Dpr-1, DPR1, defective proboscis extension response" CDMC23124 2 18 8 DAC13-F22 21-CG13439-RA_1 CG13439 AGATACAGATACAGCAGCACAATGTCCCTGCCATCCAGAGCCAATATCGGATTACTCAACTGGCT 65 FBan0013439 FBgn0040726 dpr 2 2R salt aversion; GO:0035199; sensory perception of salty taste; GO:0050914 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr defective proboscis extension response "CG13439, CG13439, CG13439, Dpr-1, DPR1, defective proboscis extension response" CDMC23125 2 19 8 DAC13-J10 2-CG13541-RA_1 CG13541 TTCACGTGAACTGCTGCAAGTACAAGATCCGTTCGAGACCCATGAGGCGCAATCAGTGCAACCTG 65 FBan0013541 FBgn0034841 CG13541 2 2R CG13541 CG13541 CDMC23125 2 20 8 DAC13-J10 2-CG13541-RA_1 CG13541 TTCACGTGAACTGCTGCAAGTACAAGATCCGTTCGAGACCCATGAGGCGCAATCAGTGCAACCTG 65 FBan0013541 FBgn0034841 CG13541 2 2R CG13541 CG13541 CDMC23126 2 21 8 DAC13-J22 1-CG13560-RA_2 CG13560 TCAAAGTCCTTGGACCCAACGCTACCTGGTCATCTCACGGCTTCTGCTGGATTCACTGCCTCTAG 65 FBan0013560 FBgn0034899 CG13560 2 2R CG13560 CG13560 CDMC23126 2 22 8 DAC13-J22 1-CG13560-RA_2 CG13560 TCAAAGTCCTTGGACCCAACGCTACCTGGTCATCTCACGGCTTCTGCTGGATTCACTGCCTCTAG 65 FBan0013560 FBgn0034899 CG13560 2 2R CG13560 CG13560 CDMC23127 2 23 8 DAC13-N10 1-CG13670-RA_1 CG13670 GGGACGAGGTGAGAGGAGTGTACAGCGTAGTCGATCCGGATGGCACCTTGCGTGTGGTTAAATAC 65 FBan0013670 FBgn0035873 CG13670 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13670 CG13670 CDMC23127 2 24 8 DAC13-N10 1-CG13670-RA_1 CG13670 GGGACGAGGTGAGAGGAGTGTACAGCGTAGTCGATCCGGATGGCACCTTGCGTGTGGTTAAATAC 65 FBan0013670 FBgn0035873 CG13670 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13670 CG13670 CDMC23128 2 25 8 DAC13-N22 3-CG13685-RA_1 CG13685 AAAGCCTCCAGAAGATACCCTCGCCCATAGAGTTCCTCACCTGCTTTCTGGTGAAGAAGTCGCGC 65 FBan0013685 FBgn0035816 CG13685 3 3L CG13685 CG13685 CDMC23128 2 26 8 DAC13-N22 3-CG13685-RA_1 CG13685 AAAGCCTCCAGAAGATACCCTCGCCCATAGAGTTCCTCACCTGCTTTCTGGTGAAGAAGTCGCGC 65 FBan0013685 FBgn0035816 CG13685 3 3L CG13685 CG13685 CDMC23129 2 1 9 DAC14-B10 23-CG1655-RA_2 CG1655 ATCATTTCGGCAACTGATCTGTGTTCTATATCTATTACCTGTACTGAAGTATTTGGCTCGCAATTGCAG 69 FBan0001655 FBgn0030242 sofe X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067; two-component signal transduction system (phosphorelay); GO:0000160 receptor binding; GO:0005102; ; GO:0005102; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- heterotrimeric G-protein complex; GO:0005834 sofe sister of feo "CG1655, CG1655, CG1655, sister of feo" CDMC23129 2 2 9 DAC14-B10 23-CG1655-RA_2 CG1655 ATCATTTCGGCAACTGATCTGTGTTCTATATCTATTACCTGTACTGAAGTATTTGGCTCGCAATTGCAG 69 FBan0001655 FBgn0030242 sofe X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067; two-component signal transduction system (phosphorelay); GO:0000160 receptor binding; GO:0005102; ; GO:0005102; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- heterotrimeric G-protein complex; GO:0005834 sofe sister of feo "CG1655, CG1655, CG1655, sister of feo" CDMC23130 2 3 9 DAC14-B22 2-CG1662-RA_1 CG1662 GGCGCAGTTCGTCAACTTCTACTGGATCCCCACCCATTACCGCATCTTCTACGACAACATCATCAGCCT 69 FBan0001662 FBgn0030481 CG1662 X X receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; integral to peroxisomal membrane; GO:0005779 CG1662 CG1662 CDMC23130 2 4 9 DAC14-B22 2-CG1662-RA_1 CG1662 GGCGCAGTTCGTCAACTTCTACTGGATCCCCACCCATTACCGCATCTTCTACGACAACATCATCAGCCT 69 FBan0001662 FBgn0030481 CG1662 X X receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; integral to peroxisomal membrane; GO:0005779 CG1662 CG1662 CDMC23131 2 5 9 DAC14-F10 8-CG16728-RA_3 CG16728 TGGCGCGGACATAAGCGAGCAACTGAAGATTGCACGTGGAAAGTTGCAACTCGTGCCAAATAAGATGTT 69 FBan0016728 FBgn0033539 CG16728 2 2R regulation of GTPase activity; GO:0043087 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG16728 CG16728 CT37209 CDMC23131 2 6 9 DAC14-F10 8-CG16728-RA_3 CG16728 TGGCGCGGACATAAGCGAGCAACTGAAGATTGCACGTGGAAAGTTGCAACTCGTGCCAAATAAGATGTT 69 FBan0016728 FBgn0033539 CG16728 2 2R regulation of GTPase activity; GO:0043087 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG16728 CG16728 CT37209 CDMC23132 2 7 9 DAC14-F22 12-CG16738-RA_1 CG16738 GCTTGCCCCGTGGAAAAACCCGTGACGTCTAAATGCTGCATTTAGCAAATTCCTTTGGTCATCATCGCA 69 FBan0016738 FBgn0003430 slp1 2 2L "blastoderm segmentation; GO:0007350; determination of anterior/posterior axis, embryo; GO:0008595; heart development; GO:0007507; mesoderm formation; GO:0001707; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379; specification of segmental identity, head; GO:0007380; specification of segmental identity, mandibular segment; GO:0042305" transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 slp1 sloppy paired 1 "CG16738, CG16738, slp: sloppy paired, FD6, Slp, sloppy-paired, sloppy-paired 1, slp-1, slp-2, Slp-1, Dmslp1, Slp1, l(2)05965, sloppy paired, slp, sloppy paired 1" CDMC23132 2 8 9 DAC14-F22 12-CG16738-RA_1 CG16738 GCTTGCCCCGTGGAAAAACCCGTGACGTCTAAATGCTGCATTTAGCAAATTCCTTTGGTCATCATCGCA 69 FBan0016738 FBgn0003430 slp1 2 2L "blastoderm segmentation; GO:0007350; determination of anterior/posterior axis, embryo; GO:0008595; heart development; GO:0007507; mesoderm formation; GO:0001707; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379; specification of segmental identity, head; GO:0007380; specification of segmental identity, mandibular segment; GO:0042305" transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 slp1 sloppy paired 1 "CG16738, CG16738, slp: sloppy paired, FD6, Slp, sloppy-paired, sloppy-paired 1, slp-1, slp-2, Slp-1, Dmslp1, Slp1, l(2)05965, sloppy paired, slp, sloppy paired 1" CDMC23133 2 9 9 DAC14-J10 2-CG16777-RA_1 CG16777 CGGCTAATCCCAGTCATGTTCCGCATCATCAGATGGATCTATCGCCCCTGAGTGAGAATGGTTCGCCAA 69 FBan0016777 FBgn0037694 CG16777 3 3R CG16777 CG16777 CDMC23133 2 10 9 DAC14-J10 2-CG16777-RA_1 CG16777 CGGCTAATCCCAGTCATGTTCCGCATCATCAGATGGATCTATCGCCCCTGAGTGAGAATGGTTCGCCAA 69 FBan0016777 FBgn0037694 CG16777 3 3R CG16777 CG16777 CDMC23134 2 11 9 DAC14-J22 17-CG16787-RA_1 CG16787 CCCAGTTCCGGTGAAGGAAGTAGCACACAAAGTCCTTGCAAGATGTTGCGAAATTTCGGGATTTCATCA 69 FBan0016787 FBgn0034940 CG16787 2 2R CG16787 CG16787 CDMC23134 2 12 9 DAC14-J22 17-CG16787-RA_1 CG16787 CCCAGTTCCGGTGAAGGAAGTAGCACACAAAGTCCTTGCAAGATGTTGCGAAATTTCGGGATTTCATCA 69 FBan0016787 FBgn0034940 CG16787 2 2R CG16787 CG16787 CDMC23135 2 13 9 DAC14-N10 23-CG16836-RA_1 CG16836 TCCGGGAATTATAATTCCTCCAGACCATAAATCAGCTGGATCCATGTCTTACACACTCACATCTGGAGC 69 FBan0016836 FBgn0040735 CG16836 2 2R CG16836 CG16836 CDMC23135 2 14 9 DAC14-N10 23-CG16836-RA_1 CG16836 TCCGGGAATTATAATTCCTCCAGACCATAAATCAGCTGGATCCATGTCTTACACACTCACATCTGGAGC 69 FBan0016836 FBgn0040735 CG16836 2 2R CG16836 CG16836 CDMC23136 2 15 9 DAC14-N22 2-CG16848-RA_4 CG16848 AGCGCTATGGACTACAGCTGAGGCGATACGAAGGAGTCCTTAAGGTTGCTTTTGAGCAGCTGATAGCCG 69 FBan0016848 FBgn0032522 CG16848 2 2L metabolism; GO:0008152 FMN adenylyltransferase activity; GO:0003919 ; EC:2.7.7.2; ; GO:0003919 ; EC:2.7.7.2 CG16848 CG16848 FBgn0032522 CDMC23136 2 16 9 DAC14-N22 2-CG16848-RA_4 CG16848 AGCGCTATGGACTACAGCTGAGGCGATACGAAGGAGTCCTTAAGGTTGCTTTTGAGCAGCTGATAGCCG 69 FBan0016848 FBgn0032522 CG16848 2 2L metabolism; GO:0008152 FMN adenylyltransferase activity; GO:0003919 ; EC:2.7.7.2; ; GO:0003919 ; EC:2.7.7.2 CG16848 CG16848 FBgn0032522 CDMC23137 2 17 9 DAC15-B10 3-CG18627-RA_1 CG18627 AGCCAGTGCGTAGCCAATGTGTAGTGCAGCAGACCTCTGACGTATTCCCACGCTAGCGTTTCTTAGTTT 69 FBan0018627 FBgn0028970 betaggt-II 2 2L protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; CAAX-protein geranylgeranyltransferase activity; GO:0004662 ; EC:2.5.1.59; ; GO:0004662 ; EC:2.5.1.59 betaggt-II beta subunit of type II geranylgeranyl transferase "CG18627, CG18627, CG18627, GGT-II beta, betaggt, betaggt-II" CDMC23137 2 18 9 DAC15-B10 3-CG18627-RA_1 CG18627 AGCCAGTGCGTAGCCAATGTGTAGTGCAGCAGACCTCTGACGTATTCCCACGCTAGCGTTTCTTAGTTT 69 FBan0018627 FBgn0028970 betaggt-II 2 2L protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; CAAX-protein geranylgeranyltransferase activity; GO:0004662 ; EC:2.5.1.59; ; GO:0004662 ; EC:2.5.1.59 betaggt-II beta subunit of type II geranylgeranyl transferase "CG18627, CG18627, CG18627, GGT-II beta, betaggt, betaggt-II" CDMC23138 2 19 9 DAC15-B22 8-CG18641-RA_1 CG18641 TCGCGGATTTTATGCGGGTCCTTGTCCCAACTTGTTCTCCTATCTAATTGGTTGGTGTGAGCCCAAGGA 69 FBan0018641 FBgn0031426 CG18641 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG18641 CG18641 CG11535 CDMC23138 2 20 9 DAC15-B22 8-CG18641-RA_1 CG18641 TCGCGGATTTTATGCGGGTCCTTGTCCCAACTTGTTCTCCTATCTAATTGGTTGGTGTGAGCCCAAGGA 69 FBan0018641 FBgn0031426 CG18641 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG18641 CG18641 CG11535 CDMC23139 2 21 9 DAC15-F10 2-CG1873-RA_3 CG1873 GCCGTGGTGGTCTACTGCAGCTATCTGAACATGTATCGTCACCGCAAGTCCTTTCGTAGGAAACCACCC 69 FBan0001873 FBgn0000557 Ef1alpha100E 3 3R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0003924; ; GO:0003747; ; GO:0005525 cytoplasm; GO:0005737; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1alpha100E Elongation factor 1alpha100E "CG1873, CG1873, CG1873, CG1873, F2, EF-1alpha, Efla2, EF-1alpha F2, EF-1, Ef1a48, EF1-alpha, EF1alpha, elongation factor 1-alpha F2, eEF1alpha, Ef1 alpha100E, Ef1alpha100E, ef-1alpha, Ef1alpha2" CDMC23139 2 22 9 DAC15-F10 2-CG1873-RA_3 CG1873 GCCGTGGTGGTCTACTGCAGCTATCTGAACATGTATCGTCACCGCAAGTCCTTTCGTAGGAAACCACCC 69 FBan0001873 FBgn0000557 Ef1alpha100E 3 3R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0003924; ; GO:0003747; ; GO:0005525 cytoplasm; GO:0005737; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1alpha100E Elongation factor 1alpha100E "CG1873, CG1873, CG1873, CG1873, F2, EF-1alpha, Efla2, EF-1alpha F2, EF-1, Ef1a48, EF1-alpha, EF1alpha, elongation factor 1-alpha F2, eEF1alpha, Ef1 alpha100E, Ef1alpha100E, ef-1alpha, Ef1alpha2" CDMC23140 2 23 9 DAC15-F22 12-CG18764-RA_3 CG18764 AGCCAGCGACCACAAAACCCAAGCGGAAAAAACAGTACGTTACGTGGAAAAATATGACCGAGGAGCAGA 69 FBan0018764 FBgn0042205 CG18764 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18764 CG18764 CDMC23140 2 24 9 DAC15-F22 12-CG18764-RA_3 CG18764 AGCCAGCGACCACAAAACCCAAGCGGAAAAAACAGTACGTTACGTGGAAAAATATGACCGAGGAGCAGA 69 FBan0018764 FBgn0042205 CG18764 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18764 CG18764 CDMC23141 2 25 9 DAC15-J10 6-CG18812-RA_1 CG18812 ACCTGAAGGCCTTCTATATCGTGCACCCCACTTTCTGGACTAAGATGATGACCTGGTGGTTCACCACGT 69 FBan0018812 FBgn0042135 CG18812 2 2R CG18812 CG18812 "CG12040, CG18813" CDMC23141 2 26 9 DAC15-J10 6-CG18812-RA_1 CG18812 ACCTGAAGGCCTTCTATATCGTGCACCCCACTTTCTGGACTAAGATGATGACCTGGTGGTTCACCACGT 69 FBan0018812 FBgn0042135 CG18812 2 2R CG18812 CG18812 "CG12040, CG18813" CDMC23142 2 1 10 DAC15-J22 2-CG1883-RA_2 CG1883 AACCAGCAGACCACCATTGAACACAAAGTCGACACCTTCACCTCGGTCTACAAGAAGCTGACTGGTCGC 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC23142 2 2 10 DAC15-J22 2-CG1883-RA_2 CG1883 AACCAGCAGACCACCATTGAACACAAAGTCGACACCTTCACCTCGGTCTACAAGAAGCTGACTGGTCGC 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC23143 2 3 10 DAC15-N10 8-CG1906-RB_1 CG1906 AGGACCACACCGAACAGATTACTCCGATCGGATCCCTCTGAAGGACCCATCCATCTATGTGAACGTTGT 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC23143 2 4 10 DAC15-N10 8-CG1906-RB_1 CG1906 AGGACCACACCGAACAGATTACTCCGATCGGATCCCTCTGAAGGACCCATCCATCTATGTGAACGTTGT 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC23144 2 5 10 DAC15-N22 18-CG1916-RA_1 CG1916 GCTGGGCTCGAATTCGTGTTGTGTGCCTCGGATTTGCATCGTCATGTGGAAAATACATAACAAGCTCTT 69 FBan0001916 FBgn0004360 Wnt2 2 2R Wnt receptor signaling pathway; GO:0016055; frizzled-2 signaling pathway; GO:0007223; muscle development; GO:0007517; tracheal system development (sensu Insecta); GO:0007424 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt2 Wnt oncogene analog 2 "CG1916, DWnt-2, Dm-2, D-wnt-2, Dwnt-2, Wnt-2, Wnt, DWnt2, dWnt2" CDMC23144 2 6 10 DAC15-N22 18-CG1916-RA_1 CG1916 GCTGGGCTCGAATTCGTGTTGTGTGCCTCGGATTTGCATCGTCATGTGGAAAATACATAACAAGCTCTT 69 FBan0001916 FBgn0004360 Wnt2 2 2R Wnt receptor signaling pathway; GO:0016055; frizzled-2 signaling pathway; GO:0007223; muscle development; GO:0007517; tracheal system development (sensu Insecta); GO:0007424 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt2 Wnt oncogene analog 2 "CG1916, DWnt-2, Dm-2, D-wnt-2, Dwnt-2, Wnt-2, Wnt, DWnt2, dWnt2" CDMC23145 2 7 10 DAC16-B10 23-CG32741-RA_1 CG32741 CCATCCGCGATGCTCAGTAATTATTTTAATATTTAGTTTTTCGGGTTTCTTTTTGTTAAGCTTGGGAGG 69 FBan0032741 FBgn0052741 CG32741 X X lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG32741 CG32741 CDMC23145 2 8 10 DAC16-B10 23-CG32741-RA_1 CG32741 CCATCCGCGATGCTCAGTAATTATTTTAATATTTAGTTTTTCGGGTTTCTTTTTGTTAAGCTTGGGAGG 69 FBan0032741 FBgn0052741 CG32741 X X lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG32741 CG32741 CDMC23146 2 9 10 DAC16-B22 5-CG32751-RA_1 CG32751 GGGAAACCCTCGAGGAACACCAGTCACTACAGCTATCGAGTGGGCATCTATGAGGGTTGGCGTAATGAG 69 FBan0032751 FBgn0052751 CG32751 X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.-; ; GO:0016787 ; EC:3.-.-.- extrinsic to membrane; GO:0019898 CG32751 CG32751 "CG3648, CG3648" CDMC23146 2 10 10 DAC16-B22 5-CG32751-RA_1 CG32751 GGGAAACCCTCGAGGAACACCAGTCACTACAGCTATCGAGTGGGCATCTATGAGGGTTGGCGTAATGAG 69 FBan0032751 FBgn0052751 CG32751 X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.-; ; GO:0016787 ; EC:3.-.-.- extrinsic to membrane; GO:0019898 CG32751 CG32751 "CG3648, CG3648" CDMC23147 2 11 10 DAC16-F10 18-CG32791-RA_4 CG32791 TGCCCTTTAACCCCATCATGCACAGCTTGTAACCCCTTCTTACCAACTATTTCTTGGTGTTTGCCAAAA 69 FBan0032791 FBgn0052791 CG32791 X X cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG32791 CG32791 "CG13020, CG13019, CG13020, CG13020" CDMC23147 2 12 10 DAC16-F10 18-CG32791-RA_4 CG32791 TGCCCTTTAACCCCATCATGCACAGCTTGTAACCCCTTCTTACCAACTATTTCTTGGTGTTTGCCAAAA 69 FBan0032791 FBgn0052791 CG32791 X X cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG32791 CG32791 "CG13020, CG13019, CG13020, CG13020" CDMC23148 2 13 10 DAC16-F22 23-CG3279-RA_2 CG3279 TTTAGCTAGCAAACCAATAGCCAATGATCTTAGCCCAAATTCAAATGTTATAGAAGCCTGTCCATTCCA 69 FBan0003279 FBgn0035156 CG3279 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485 integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG3279 CG3279 CDMC23148 2 14 10 DAC16-F22 23-CG3279-RA_2 CG3279 TTTAGCTAGCAAACCAATAGCCAATGATCTTAGCCCAAATTCAAATGTTATAGAAGCCTGTCCATTCCA 69 FBan0003279 FBgn0035156 CG3279 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485 integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG3279 CG3279 CDMC23149 2 15 10 DAC16-J10 3-CG32832-RA_1 CG32832 TCTGGCCGTCAACATAGCCGTCTTTCTCATCCAGGGTTATCTAATGGTCAAGCACCTAAGGTGGCGCAG 69 FBan0032832 FBgn0052832 CG32832 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32832 CG32832 "bs21e09.y1, NEST:bs10d12, NEST:bs21e09" CDMC23149 2 16 10 DAC16-J10 3-CG32832-RA_1 CG32832 TCTGGCCGTCAACATAGCCGTCTTTCTCATCCAGGGTTATCTAATGGTCAAGCACCTAAGGTGGCGCAG 69 FBan0032832 FBgn0052832 CG32832 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32832 CG32832 "bs21e09.y1, NEST:bs10d12, NEST:bs21e09" CDMC23150 2 17 10 DAC16-J22 22-CG32846-RA_5 CG32846 GGCAAATGCCTGTGGAAATATCTTATCGAAGCACAGAATGAAGCGATCAAATCCTGAAGGCCTGTTGGA 69 FBan0032846 FBgn0052846 CG32846 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32846 CG32846 CDMC23150 2 18 10 DAC16-J22 22-CG32846-RA_5 CG32846 GGCAAATGCCTGTGGAAATATCTTATCGAAGCACAGAATGAAGCGATCAAATCCTGAAGGCCTGTTGGA 69 FBan0032846 FBgn0052846 CG32846 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32846 CG32846 CDMC23151 2 19 10 DAC16-N10 7-CG32921-RB_2 CG32921 AGTGCTCGTGCTTATCTTTCTCACGTACTTCTCGCTACAAGTCACACACATGGGTCTCTTCCGGCCGAA 69 FBgn0052921 CDMC23151 2 20 10 DAC16-N10 7-CG32921-RB_2 CG32921 AGTGCTCGTGCTTATCTTTCTCACGTACTTCTCGCTACAAGTCACACACATGGGTCTCTTCCGGCCGAA 69 FBgn0052921 CDMC23152 2 21 10 DAC16-N22 9-CG32940-RD_2 CG32940 CGTCACATTTACCGTCCACGTACGCTCAATCGAACTCTGGGTTTCCCTCTTCAAAAGAGCCTCTCCTGC 69 FBgn0052940 CDMC23152 2 22 10 DAC16-N22 9-CG32940-RD_2 CG32940 CGTCACATTTACCGTCCACGTACGCTCAATCGAACTCTGGGTTTCCCTCTTCAAAAGAGCCTCTCCTGC 69 FBgn0052940 CDMC23153 2 23 10 DAC17-B10 5-CG12279-RA_1 CG12279 ATGGCCACCTACGAGGAAGTCAAGGACATTCCAAACCACCCGGAGAAGTACCTGTTCGATGTGCG 65 FBan0012279 FBgn0038080 CG12279 3 3R protein folding; GO:0006457; sulfate transport; GO:0008272 unfolded protein binding; GO:0051082; ; GO:0051082; thiosulfate sulfurtransferase activity; GO:0004792 ; EC:2.8.1.1; ; GO:0004792 ; EC:2.8.1.1 CG12279 CG12279 BcDNA:RH54517 CDMC23153 2 24 10 DAC17-B10 5-CG12279-RA_1 CG12279 ATGGCCACCTACGAGGAAGTCAAGGACATTCCAAACCACCCGGAGAAGTACCTGTTCGATGTGCG 65 FBan0012279 FBgn0038080 CG12279 3 3R protein folding; GO:0006457; sulfate transport; GO:0008272 unfolded protein binding; GO:0051082; ; GO:0051082; thiosulfate sulfurtransferase activity; GO:0004792 ; EC:2.8.1.1; ; GO:0004792 ; EC:2.8.1.1 CG12279 CG12279 BcDNA:RH54517 CDMC23154 2 25 10 DAC17-B22 23-CG12333-RA_1 CG12333 GACGTCTAAGGCATTAACGCTTTAGCCAACATGAATAAACATAATCAACCACCCGATTCATCGCT 65 FBan0012333 FBgn0038617 CG12333 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG12333 CG12333 CDMC23154 2 26 10 DAC17-B22 23-CG12333-RA_1 CG12333 GACGTCTAAGGCATTAACGCTTTAGCCAACATGAATAAACATAATCAACCACCCGATTCATCGCT 65 FBan0012333 FBgn0038617 CG12333 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG12333 CG12333 CDMC23155 2 1 11 DAC17-F10 9-CG12479-RA_1 CG12479 TGGGCGTGGCATATCGTGGCTGTGAAAAGGAGCTCAACGATGTAAAGTTTGGCCAACGAAAGTGA 65 FBan0012479 FBgn0040871 CG12479 X X CG12479 CG12479 CDMC23155 2 2 11 DAC17-F10 9-CG12479-RA_1 CG12479 TGGGCGTGGCATATCGTGGCTGTGAAAAGGAGCTCAACGATGTAAAGTTTGGCCAACGAAAGTGA 65 FBan0012479 FBgn0040871 CG12479 X X CG12479 CG12479 CDMC23156 2 3 11 DAC17-F22 3-CG12509-RA_1 CG12509 ACAAGAAATCAGCGCGACATTTGTCCAACTGGCGAGTGGAAAATGGAGCCAGGAGACTGCAGTCG 65 FBan0012509 FBgn0040613 CG12509 3 3R CG12509 CG12509 CDMC23156 2 4 11 DAC17-F22 3-CG12509-RA_1 CG12509 ACAAGAAATCAGCGCGACATTTGTCCAACTGGCGAGTGGAAAATGGAGCCAGGAGACTGCAGTCG 65 FBan0012509 FBgn0040613 CG12509 3 3R CG12509 CG12509 CDMC23157 2 5 11 DAC17-J10 1-CG12625-RA_1 CG12625 ATTGGGCATTAAAAAGTCCAGCACGCAACGCAGCATCGAGATTATTGTGGACGCCAGTCAGTGCG 65 FBan0012625 FBgn0030282 CG12625 X X CG12625 CG12625 CDMC23157 2 6 11 DAC17-J10 1-CG12625-RA_1 CG12625 ATTGGGCATTAAAAAGTCCAGCACGCAACGCAGCATCGAGATTATTGTGGACGCCAGTCAGTGCG 65 FBan0012625 FBgn0030282 CG12625 X X CG12625 CG12625 CDMC23158 2 7 11 DAC17-J22 19-CG12655-RA_2 CG12655 GGATACGCCGGCATCGATTCGCGTGGTACCTACGGTGGAGCGGGTGGCAATGGAGCCTACTACGT 65 FBan0012655 FBgn0031080 CG12655 X X CG12655 CG12655 CDMC23158 2 8 11 DAC17-J22 19-CG12655-RA_2 CG12655 GGATACGCCGGCATCGATTCGCGTGGTACCTACGGTGGAGCGGGTGGCAATGGAGCCTACTACGT 65 FBan0012655 FBgn0031080 CG12655 X X CG12655 CG12655 CDMC23159 2 9 11 DAC17-N10 14-CG12755-RB_14 CG12755 TACACAACAAAGAATGCTGTAACCGGACATGTGAGCACGCAGACCTCCAATTCGCAAACTCCGAG 65 FBan0012755 FBgn0002440 l(3)mbn 3 3L plasmatocyte differentiation; GO:0042387 structural constituent of cuticle; GO:0042302; ; GO:0042302 cytoplasm; GO:0005737; plasma membrane; GO:0005886 l(3)mbn lethal (3) malignant blood neoplasm "CG12755, l(3)mbn-1, lethal(3)malignant blood neoplasm-1, MBN, l(3)malignant blood neoplasm1, l(3)mbn1" CDMC23159 2 10 11 DAC17-N10 14-CG12755-RB_14 CG12755 TACACAACAAAGAATGCTGTAACCGGACATGTGAGCACGCAGACCTCCAATTCGCAAACTCCGAG 65 FBan0012755 FBgn0002440 l(3)mbn 3 3L plasmatocyte differentiation; GO:0042387 structural constituent of cuticle; GO:0042302; ; GO:0042302 cytoplasm; GO:0005737; plasma membrane; GO:0005886 l(3)mbn lethal (3) malignant blood neoplasm "CG12755, l(3)mbn-1, lethal(3)malignant blood neoplasm-1, MBN, l(3)malignant blood neoplasm1, l(3)mbn1" CDMC23160 2 11 11 DAC17-N22 3-CG12800-RA_5 CG12800 ATCCGGGTCTTCCCATTCTGAATCGTGAATGCACCCAGGACTACACAGTACCCGACACCAACCAC 65 FBan0012800 FBgn0039006 Cyp6d4 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d4 Cyp6d4 "CG12800, 6d4" CDMC23160 2 12 11 DAC17-N22 3-CG12800-RA_5 CG12800 ATCCGGGTCTTCCCATTCTGAATCGTGAATGCACCCAGGACTACACAGTACCCGACACCAACCAC 65 FBan0012800 FBgn0039006 Cyp6d4 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d4 Cyp6d4 "CG12800, 6d4" CDMC23161 2 13 11 DAC18-B10 6-CG5730-RC_3 CG5730 CGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 67 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC23161 2 14 11 DAC18-B10 6-CG5730-RC_3 CG5730 CGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 67 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC23162 2 15 11 DAC18-B22 3-CG5935-RD_1 CG5935 AGTTTCCGATGCCGATAGTGATGTCCCAAAACGTAAACGTGGTTCCGTGGGTAAACGTGGACGACCG 67 FBgn0010567 CDMC23162 2 16 11 DAC18-B22 3-CG5935-RD_1 CG5935 AGTTTCCGATGCCGATAGTGATGTCCCAAAACGTAAACGTGGTTCCGTGGGTAAACGTGGACGACCG 67 FBgn0010567 CDMC23163 2 17 11 DAC18-F10 2-CG6501-RA_1 CG6501 ACGGTAACAGCCCGTATGGTGCTTAACGATTGGCAACGAGGCAAACTTCCTTTCTACGTTCCACCCG 67 FBan0006501 FBgn0034243 Ngp 2 2R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 GTP binding; GO:0005525; ; GO:0005525; receptor binding; GO:0005102; ; GO:0005102 nucleus; GO:0005634 Ngp Ngp "CG6501, CG6501" CDMC23163 2 18 11 DAC18-F10 2-CG6501-RA_1 CG6501 ACGGTAACAGCCCGTATGGTGCTTAACGATTGGCAACGAGGCAAACTTCCTTTCTACGTTCCACCCG 67 FBan0006501 FBgn0034243 Ngp 2 2R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 GTP binding; GO:0005525; ; GO:0005525; receptor binding; GO:0005102; ; GO:0005102 nucleus; GO:0005634 Ngp Ngp "CG6501, CG6501" CDMC23164 2 19 11 DAC18-F22 17-CG6604-RA_1 CG6604 CCACCAGCCTCCAATCGAGCAGAAAGTCCATAGGATACAGCTACCAACGAAAACAACTAAACCACCC 67 FBan0006604 FBgn0016660 H15 2 2L cardioblast cell fate commitment; GO:0042684; embryonic heart tube development; GO:0035050; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 H15 H15 "CG6604, dm-H15, nmr: neuromancer, neuromancer, Dm-H15, neuromancer1, nmr1, neuromancer 1, nmr" CDMC23164 2 20 11 DAC18-F22 17-CG6604-RA_1 CG6604 CCACCAGCCTCCAATCGAGCAGAAAGTCCATAGGATACAGCTACCAACGAAAACAACTAAACCACCC 67 FBan0006604 FBgn0016660 H15 2 2L cardioblast cell fate commitment; GO:0042684; embryonic heart tube development; GO:0035050; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 H15 H15 "CG6604, dm-H15, nmr: neuromancer, neuromancer, Dm-H15, neuromancer1, nmr1, neuromancer 1, nmr" CDMC23165 2 21 11 DAC18-J10 3-CG7135-RA_2 CG7135 TCCCGCTGATGAGCATGATCGGTGTGGACTCCGAGGACAACTCACTGAAGAACTTTCACGACGAGAC 67 FBan0007135 FBgn0030895 CG7135 X X CG7135 CG7135 CDMC23165 2 22 11 DAC18-J10 3-CG7135-RA_2 CG7135 TCCCGCTGATGAGCATGATCGGTGTGGACTCCGAGGACAACTCACTGAAGAACTTTCACGACGAGAC 67 FBan0007135 FBgn0030895 CG7135 X X CG7135 CG7135 CDMC23166 2 23 11 DAC18-J22 15-CG7233-RA_3 CG7233 ACCGAATACGTGACGCCAATGATTAGCACCGTCTTGAAGAAATACCAGACGAGTGCCACCAAATCGC 67 FBan0007233 FBgn0031967 snoN 2 2L ectoderm development; GO:0007398; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 snoN snoN "CG7233, CG7233, CG7233" CDMC23166 2 24 11 DAC18-J22 15-CG7233-RA_3 CG7233 ACCGAATACGTGACGCCAATGATTAGCACCGTCTTGAAGAAATACCAGACGAGTGCCACCAAATCGC 67 FBan0007233 FBgn0031967 snoN 2 2L ectoderm development; GO:0007398; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 snoN snoN "CG7233, CG7233, CG7233" CDMC23167 2 25 11 DAC18-N10 17-CG7866-RA_1 CG7866 TGGAAAAGTCGTCTCACCATCCCTGTCATAGTCACAACTGCATTTCTCGTCATGGACATCCGCCTGC 67 FBan0007866 FBgn0039725 CG7866 3 3R CG7866 CG7866 CDMC23167 2 26 11 DAC18-N10 17-CG7866-RA_1 CG7866 TGGAAAAGTCGTCTCACCATCCCTGTCATAGTCACAACTGCATTTCTCGTCATGGACATCCGCCTGC 67 FBan0007866 FBgn0039725 CG7866 3 3R CG7866 CG7866 CDMC23168 2 1 12 DAC18-N22 25-CG7985-RA_1 CG7985 TGGACTGAGCGTAATGCCTCTCGTTCAAACCTTTGGGCACATGGAATACGTCCTCAAACTCTCGGGC 67 FBan0007985 FBgn0028499 CG7985 3 3R CG7985 CG7985 BcDNA:GH04120 CDMC23168 2 2 12 DAC18-N22 25-CG7985-RA_1 CG7985 TGGACTGAGCGTAATGCCTCTCGTTCAAACCTTTGGGCACATGGAATACGTCCTCAAACTCTCGGGC 67 FBan0007985 FBgn0028499 CG7985 3 3R CG7985 CG7985 BcDNA:GH04120 CDMC23169 2 3 12 DAC19-B10 1-CG7869-RA_1 CG7869 GAGTCGTCGCACCAAGGCTTTGAAAAGAAAACGCAAACCCGTGACGTCCGTCAATTCAAGTTTCGGCG 68 FBan0007869 FBgn0025355 SuUR 3 3L DNA endoreduplication; GO:0042023; DNA replication; GO:0006260; chromatin assembly or disassembly; GO:0006333; negative regulation of DNA replication; GO:0008156 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524 "centric heterochromatin; GO:0005721; chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792; intercalary heterochromatin; GO:0005725; nuclear telomeric heterochromatin; GO:0005724; polytene chromosome; GO:0005700" SuUR Suppressor of Under-Replication "CG7869, CG7869, Su(UR)ES, Su(UR), su(UR)ES, Suppressor of Under-Replication" CDMC23169 2 4 12 DAC19-B10 1-CG7869-RA_1 CG7869 GAGTCGTCGCACCAAGGCTTTGAAAAGAAAACGCAAACCCGTGACGTCCGTCAATTCAAGTTTCGGCG 68 FBan0007869 FBgn0025355 SuUR 3 3L DNA endoreduplication; GO:0042023; DNA replication; GO:0006260; chromatin assembly or disassembly; GO:0006333; negative regulation of DNA replication; GO:0008156 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524 "centric heterochromatin; GO:0005721; chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792; intercalary heterochromatin; GO:0005725; nuclear telomeric heterochromatin; GO:0005724; polytene chromosome; GO:0005700" SuUR Suppressor of Under-Replication "CG7869, CG7869, Su(UR)ES, Su(UR), su(UR)ES, Suppressor of Under-Replication" CDMC23170 2 5 12 DAC19-B22 2-CG8009-RB_1 CG8009 CGCGAATGGTACTGGGAGACTTTAATATGAGCTGTGACGACACGGGGAAGCTGATACTCAAGCCGCGG 68 FBan0008009 FBgn0036090 CG8009 3 3L CG8009 CG8009 BcDNA:LD14173 CDMC23170 2 6 12 DAC19-B22 2-CG8009-RB_1 CG8009 CGCGAATGGTACTGGGAGACTTTAATATGAGCTGTGACGACACGGGGAAGCTGATACTCAAGCCGCGG 68 FBan0008009 FBgn0036090 CG8009 3 3L CG8009 CG8009 BcDNA:LD14173 CDMC23171 2 7 12 DAC19-F10 3-CG8564-RA_4 CG8564 CAAGTCCGCCAAATTTGTGGGCACTGATTGCAACCGAAATTACGACATCTTCTGGAACAGCGGACCCA 68 FBan0008564 FBgn0035776 CG8564 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8564 CG8564 CDMC23171 2 8 12 DAC19-F10 3-CG8564-RA_4 CG8564 CAAGTCCGCCAAATTTGTGGGCACTGATTGCAACCGAAATTACGACATCTTCTGGAACAGCGGACCCA 68 FBan0008564 FBgn0035776 CG8564 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8564 CG8564 CDMC23172 2 9 12 DAC19-F22 2-CG8727-RA_1 CG8727 GGCGTCGGGACAAGATGAACACGTACATCAACGAGCTCTCCTCCATGATTCCCATGTGCTTTGCGATG 68 FBan0008727 FBgn0023094 cyc 3 3L "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; ectoderm development; GO:0007398; locomotor rhythm; GO:0045475; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of circadian sleep/wake cycle, sleep; GO:0045187; rhythmic behavior; GO:0007622; signal transduction; GO:0007165" specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; protein heterodimerization activity; GO:0046982; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 cyc cycle "CG8727, dbmal1, dBMAL1, dBMAL, CYCLE, dBmal, bMAL1, MOP3, BMAL1, brain and muscle ARNT-like 1, Cyc, dBma1, bmal1, CYC, Bmal1, Cycle, dbmal, dCYC, Mop3, cycle" CDMC23172 2 10 12 DAC19-F22 2-CG8727-RA_1 CG8727 GGCGTCGGGACAAGATGAACACGTACATCAACGAGCTCTCCTCCATGATTCCCATGTGCTTTGCGATG 68 FBan0008727 FBgn0023094 cyc 3 3L "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; ectoderm development; GO:0007398; locomotor rhythm; GO:0045475; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of circadian sleep/wake cycle, sleep; GO:0045187; rhythmic behavior; GO:0007622; signal transduction; GO:0007165" specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; protein heterodimerization activity; GO:0046982; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 cyc cycle "CG8727, dbmal1, dBMAL1, dBMAL, CYCLE, dBmal, bMAL1, MOP3, BMAL1, brain and muscle ARNT-like 1, Cyc, dBma1, bmal1, CYC, Bmal1, Cycle, dbmal, dCYC, Mop3, cycle" CDMC23173 2 11 12 DAC19-J10 1-CG9170-RA_1 CG9170 CGCTGGAGGATCAGTTTCCCGAGAATACCCTGGATGCACCTTATCATCTGCGATACCCCTTCACCGAC 68 FBan0009170 FBgn0030716 CG9170 X X CG9170 CG9170 anon-WO0140519.214 CDMC23173 2 12 12 DAC19-J10 1-CG9170-RA_1 CG9170 CGCTGGAGGATCAGTTTCCCGAGAATACCCTGGATGCACCTTATCATCTGCGATACCCCTTCACCGAC 68 FBan0009170 FBgn0030716 CG9170 X X CG9170 CG9170 anon-WO0140519.214 CDMC23174 2 13 12 DAC19-J22 1-CG9318-RA_1 CG9318 CCTGTGCGTACCAACCAGATTCCCCGTCAGATTCCGGACCAATCGATCTACACACAGCCTATTCCTGG 68 FBan0009318 FBgn0032880 CG9318 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; phagocytosis; GO:0006909; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG9318 CG9318 38E.10 CDMC23174 2 14 12 DAC19-J22 1-CG9318-RA_1 CG9318 CCTGTGCGTACCAACCAGATTCCCCGTCAGATTCCGGACCAATCGATCTACACACAGCCTATTCCTGG 68 FBan0009318 FBgn0032880 CG9318 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; phagocytosis; GO:0006909; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG9318 CG9318 38E.10 CDMC23175 2 15 12 DAC19-N10 3-CG9885-RA_2 CG9885 CGTGGCCATGCTCTATCTCAACGACCAAAGTACGGTGGTGCTGAAGAACTACCAGGAGATGACCGTGG 68 FBan0009885 FBgn0000490 dpp 2 2L "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; anterior/posterior axis specification; GO:0009948; anterior/posterior pattern formation, imaginal disc; GO:0007448; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cardioblast differentiation; GO:0010002; cell fate determination; GO:0001709; cell fate specification; GO:0001708; cell-cell signaling; GO:0007267; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; embryonic development; GO:0009790; foregut morphogenesis; GO:0007440; genital disc development; GO:0035215; genital disc sexually dimorphic development; GO:0035263; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; larval development (sensu Insecta); GO:0002168; leg disc proximal/distal pattern formation; GO:0007479; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of cell proliferation; GO:0008285; negative regulation of salivary gland determination; GO:0045705; nurse cell apoptosis; GO:0045476; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; pigmentation during development; GO:0048066; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of cell proliferation; GO:0042127; regulation of organ size; GO:0046620; regulation of tracheal tube diameter; GO:0035158; sensory organ development; GO:0007423; stem cell division; GO:0017145; stem cell maintenance; GO:0019827; tracheal branch fusion; GO:0035147; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474; zygotic determination of anterior/posterior axis, embryo; GO:0007354; zygotic determination of dorsal/ventral axis; GO:0007352" signal transducer activity; GO:0004871; morphogen activity; GO:0016015; ; GO:0016015; transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0016015; ; GO:0004871; ; GO:0008083; ; GO:0005160; ; GO:0005160 extracellular region; GO:0005576; extracellular space; GO:0005615; intracellular; GO:0005622 dpp decapentaplegic "CG9885, CG9885, ho: heldout, M(2)LS1, shv, l(2)22Fa, Dpp, DPP, TGF-beta, l(2)10638, l(2)k17036, TGF-b, shortvein, Dm-DPP, TGF-beta, TGFbeta, BMP, DPP-C, Hin-d: Haplo-insufficient, M(2)23AB, Tg: Tegula, blk: blink, Haplo-insufficient, Tegula, blink, heldout, ho" CDMC23175 2 16 12 DAC19-N10 3-CG9885-RA_2 CG9885 CGTGGCCATGCTCTATCTCAACGACCAAAGTACGGTGGTGCTGAAGAACTACCAGGAGATGACCGTGG 68 FBan0009885 FBgn0000490 dpp 2 2L "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; anterior/posterior axis specification; GO:0009948; anterior/posterior pattern formation, imaginal disc; GO:0007448; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cardioblast differentiation; GO:0010002; cell fate determination; GO:0001709; cell fate specification; GO:0001708; cell-cell signaling; GO:0007267; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; embryonic development; GO:0009790; foregut morphogenesis; GO:0007440; genital disc development; GO:0035215; genital disc sexually dimorphic development; GO:0035263; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; larval development (sensu Insecta); GO:0002168; leg disc proximal/distal pattern formation; GO:0007479; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of cell proliferation; GO:0008285; negative regulation of salivary gland determination; GO:0045705; nurse cell apoptosis; GO:0045476; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; pigmentation during development; GO:0048066; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of cell proliferation; GO:0042127; regulation of organ size; GO:0046620; regulation of tracheal tube diameter; GO:0035158; sensory organ development; GO:0007423; stem cell division; GO:0017145; stem cell maintenance; GO:0019827; tracheal branch fusion; GO:0035147; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474; zygotic determination of anterior/posterior axis, embryo; GO:0007354; zygotic determination of dorsal/ventral axis; GO:0007352" signal transducer activity; GO:0004871; morphogen activity; GO:0016015; ; GO:0016015; transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0016015; ; GO:0004871; ; GO:0008083; ; GO:0005160; ; GO:0005160 extracellular region; GO:0005576; extracellular space; GO:0005615; intracellular; GO:0005622 dpp decapentaplegic "CG9885, CG9885, ho: heldout, M(2)LS1, shv, l(2)22Fa, Dpp, DPP, TGF-beta, l(2)10638, l(2)k17036, TGF-b, shortvein, Dm-DPP, TGF-beta, TGFbeta, BMP, DPP-C, Hin-d: Haplo-insufficient, M(2)23AB, Tg: Tegula, blk: blink, Haplo-insufficient, Tegula, blink, heldout, ho" CDMC23176 2 17 12 DAC19-N22 3-CG9916-RA_2 CG9916 GCGGTCGCAAGCCATACACGATGGTCTCTTTTTGTGCAACTCTGATTCGACAGTTTCGGCACAGGTCG 68 FBan0009916 FBgn0004432 Cyp1 X X autophagic cell death; GO:0048102; defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605; salivary gland cell autophagic cell death; GO:0035071 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0003755 ; EC:5.2.1.8; ; GO:0016538 ; EC:2.7.1.- cytoplasm; GO:0005737; cytosol; GO:0005829; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; transcription elongation factor complex b; GO:0008024 Cyp1 Cyclophilin 1 "CG9916, Cyp-1, CyP-1, Cpy1, cyp-1, BcDNA:GM09255, cyp1" CDMC23176 2 18 12 DAC19-N22 3-CG9916-RA_2 CG9916 GCGGTCGCAAGCCATACACGATGGTCTCTTTTTGTGCAACTCTGATTCGACAGTTTCGGCACAGGTCG 68 FBan0009916 FBgn0004432 Cyp1 X X autophagic cell death; GO:0048102; defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605; salivary gland cell autophagic cell death; GO:0035071 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0003755 ; EC:5.2.1.8; ; GO:0016538 ; EC:2.7.1.- cytoplasm; GO:0005737; cytosol; GO:0005829; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; transcription elongation factor complex b; GO:0008024 Cyp1 Cyclophilin 1 "CG9916, Cyp-1, CyP-1, Cpy1, cyp-1, BcDNA:GM09255, cyp1" CDMC23177 2 19 12 DAC20-B10 3-CG18039-RA_1 CG18039 TGGCCCTTCTGAGTTGGGCGTAGACAATCTGAGTGGCATCTACGTTGTCTTGGTCATCGGATCCATCAT 69 FBan0018039 FBgn0028422 KaiRIA 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; rhythmic excitation; GO:0043179 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; alpha-type channel activity; GO:0015268; ; GO:0015276; ; GO:0015277; ; GO:0015268; ionotropic glutamate receptor activity; GO:0004970; ; GO:0004970 ionotropic glutamate receptor complex; GO:0008328 KaiRIA KaiRIA "CG18039, DKaiR-IA, CT13538, GluRIA, brec, bad reception, GluRIID, GluR-IID, Kai-RIA" CDMC23177 2 20 12 DAC20-B10 3-CG18039-RA_1 CG18039 TGGCCCTTCTGAGTTGGGCGTAGACAATCTGAGTGGCATCTACGTTGTCTTGGTCATCGGATCCATCAT 69 FBan0018039 FBgn0028422 KaiRIA 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; rhythmic excitation; GO:0043179 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; alpha-type channel activity; GO:0015268; ; GO:0015276; ; GO:0015277; ; GO:0015268; ionotropic glutamate receptor activity; GO:0004970; ; GO:0004970 ionotropic glutamate receptor complex; GO:0008328 KaiRIA KaiRIA "CG18039, DKaiR-IA, CT13538, GluRIA, brec, bad reception, GluRIID, GluR-IID, Kai-RIA" CDMC23178 2 21 12 DAC20-B22 23-CG18066-RA_2 CG18066 ATAAACGGGTAGCTTCCAGAAATATCAACAATTTCCGTTTATTTTGTGATCAGTTAAAGTGAGTGGGGG 69 FBan0018066 FBgn0034517 CG18066 2 2R CG18066 CG18066 CDMC23178 2 22 12 DAC20-B22 23-CG18066-RA_2 CG18066 ATAAACGGGTAGCTTCCAGAAATATCAACAATTTCCGTTTATTTTGTGATCAGTTAAAGTGAGTGGGGG 69 FBan0018066 FBgn0034517 CG18066 2 2R CG18066 CG18066 CDMC23179 2 23 12 DAC20-F10 23-CG18108-RA_3 CG18108 GGCAAGTAGGAAGTTTCAACCCAAGGATTCGAAAAAGGACATAGTCTACAAACTAGAACACAAAAGCTG 69 FBan0018108 FBgn0034329 IM1 2 2R defense response; GO:0006952 extracellular region; GO:0005576 IM1 Immune induced molecule 1 "CG18108, CG18108, CG18108, CG18108, CG18108, DIM 1, IM2-like, DIM-1, BcDNA:RH08745" CDMC23179 2 24 12 DAC20-F10 23-CG18108-RA_3 CG18108 GGCAAGTAGGAAGTTTCAACCCAAGGATTCGAAAAAGGACATAGTCTACAAACTAGAACACAAAAGCTG 69 FBan0018108 FBgn0034329 IM1 2 2R defense response; GO:0006952 extracellular region; GO:0005576 IM1 Immune induced molecule 1 "CG18108, CG18108, CG18108, CG18108, CG18108, DIM 1, IM2-like, DIM-1, BcDNA:RH08745" CDMC23180 2 25 12 DAC20-F22 12-CG18136-RA_4 CG18136 CCGCTGCATGCATCTTAAAGACAAAGATCCCGATGCCTTCCTCAAGCTTTACAACCTGGAGGATCACCT 69 FBan0018136 FBgn0036839 CG18136 3 3L CG18136 CG18136 CDMC23180 2 26 12 DAC20-F22 12-CG18136-RA_4 CG18136 CCGCTGCATGCATCTTAAAGACAAAGATCCCGATGCCTTCCTCAAGCTTTACAACCTGGAGGATCACCT 69 FBan0018136 FBgn0036839 CG18136 3 3L CG18136 CG18136 CDMC23181 2 1 13 DAC20-J10 23-CG18193-RA_1 CG18193 CCCACAAAACACAAATACTCTGTACACGAATGCAAATACCAATTGTAACGACACATACATTAGTTAACT 69 FBan0018193 FBgn0037579 CG18193 3 3R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" electron transporter activity; GO:0005489; cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0005489 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG18193 CG18193 VIIa CDMC23181 2 2 13 DAC20-J10 23-CG18193-RA_1 CG18193 CCCACAAAACACAAATACTCTGTACACGAATGCAAATACCAATTGTAACGACACATACATTAGTTAACT 69 FBan0018193 FBgn0037579 CG18193 3 3R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" electron transporter activity; GO:0005489; cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0005489 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG18193 CG18193 VIIa CDMC23182 2 3 13 DAC20-J22 22-CG18214-RB_1 CG18214 GCCAGTTGGGCCAATGTACAGTGTAGCATACGAGGATAAGTCAGAGTCACTCAAATGCATGTGTCTCTT 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC23182 2 4 13 DAC20-J22 22-CG18214-RB_1 CG18214 GCCAGTTGGGCCAATGTACAGTGTAGCATACGAGGATAAGTCAGAGTCACTCAAATGCATGTGTCTCTT 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC23183 2 5 13 DAC20-N10 16-CG1825-RA_1 CG1825 GGCGTGGAAGCTCTTCAGTCTGATGCATCAGATCCATCAGGAGCCTAAAATCTCAATCAAGGAGGAGAA 69 FBan0001825 FBgn0010342 Map60 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017 centrosome; GO:0005813; microtubule associated complex; GO:0005875 Map60 Microtubule-associated protein 60 "CG1825, CG1825, DMAP60, DMAP-60, CP60, CP-60, Cp60, Centrosome associated protein 60" CDMC23183 2 6 13 DAC20-N10 16-CG1825-RA_1 CG1825 GGCGTGGAAGCTCTTCAGTCTGATGCATCAGATCCATCAGGAGCCTAAAATCTCAATCAAGGAGGAGAA 69 FBan0001825 FBgn0010342 Map60 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017 centrosome; GO:0005813; microtubule associated complex; GO:0005875 Map60 Microtubule-associated protein 60 "CG1825, CG1825, DMAP60, DMAP-60, CP60, CP-60, Cp60, Centrosome associated protein 60" CDMC23184 2 7 13 DAC20-N22 6-CG18271-RA_1 CG18271 GGGCGTGCCTGAAGAACTGCAGGATCATGACGAGGATCTGAGCGACGACATTGATGTAGACAGCGATAT 69 FBan0018271 FBgn0037263 CG18271 3 3R CG18271 CG18271 CDMC23184 2 8 13 DAC20-N22 6-CG18271-RA_1 CG18271 GGGCGTGCCTGAAGAACTGCAGGATCATGACGAGGATCTGAGCGACGACATTGATGTAGACAGCGATAT 69 FBan0018271 FBgn0037263 CG18271 3 3R CG18271 CG18271 CDMC23185 2 9 13 DAC21-B10 2-CG3897-RB_1 CG3897 GCGGAAGTTCAACGTCAATCCGGAAGAGTATTCCACGGAGCTGTGAAATCAGGGGAGGACCAGGAGTAG 69 FBan0003897 FBgn0027660 blot 3 3L ATP synthesis coupled proton transport; GO:0015986; morphogenesis of an epithelium; GO:0002009; neurotransmitter transport; GO:0006836; tRNA aminoacylation for protein translation; GO:0006418; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; neurotransmitter transporter activity; GO:0005326; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005326; ; GO:0004812 ; EC:6.1.1.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0005328" integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; proton-transporting two-sector ATPase complex; GO:0016469 blot bloated tubules "CG3897, l(3)1658" CDMC23185 2 10 13 DAC21-B10 2-CG3897-RB_1 CG3897 GCGGAAGTTCAACGTCAATCCGGAAGAGTATTCCACGGAGCTGTGAAATCAGGGGAGGACCAGGAGTAG 69 FBan0003897 FBgn0027660 blot 3 3L ATP synthesis coupled proton transport; GO:0015986; morphogenesis of an epithelium; GO:0002009; neurotransmitter transport; GO:0006836; tRNA aminoacylation for protein translation; GO:0006418; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; neurotransmitter transporter activity; GO:0005326; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005326; ; GO:0004812 ; EC:6.1.1.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0005328" integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; proton-transporting two-sector ATPase complex; GO:0016469 blot bloated tubules "CG3897, l(3)1658" CDMC23186 2 11 13 DAC21-B22 2-CG3917-RA_1 CG3917 TCACAAGCGCACATTTACCATCATTCCCCACGCATGTCTTCTCATTTGCCATCCAACAAAGCGCACCAA 69 FBan0003917 FBgn0026430 Grip84 X X microtubule nucleation; GO:0007020; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; tubulin binding; GO:0015631; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0015631; gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin small complex; GO:0008275; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 Grip84 gamma-tubulin ring protein 84 "CG3917, CG3917, CG3917, Dgrip84, GCP2, Dgrips84" CDMC23186 2 12 13 DAC21-B22 2-CG3917-RA_1 CG3917 TCACAAGCGCACATTTACCATCATTCCCCACGCATGTCTTCTCATTTGCCATCCAACAAAGCGCACCAA 69 FBan0003917 FBgn0026430 Grip84 X X microtubule nucleation; GO:0007020; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; tubulin binding; GO:0015631; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0015631; gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin small complex; GO:0008275; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 Grip84 gamma-tubulin ring protein 84 "CG3917, CG3917, CG3917, Dgrip84, GCP2, Dgrips84" CDMC23187 2 13 13 DAC21-F10 8-CG3947-RA_1 CG3947 ACAGGTGTGGACGCATTCGGAGTGTTGAGGGTGGGTTGAGTTTTGGTCCTTGAAAAGTTGTTTGCACAA 69 FBan0003947 FBgn0037019 CG3947 3 3L peroxisome organization and biogenesis; GO:0007031 CG3947 CG3947 CDMC23187 2 14 13 DAC21-F10 8-CG3947-RA_1 CG3947 ACAGGTGTGGACGCATTCGGAGTGTTGAGGGTGGGTTGAGTTTTGGTCCTTGAAAAGTTGTTTGCACAA 69 FBan0003947 FBgn0037019 CG3947 3 3L peroxisome organization and biogenesis; GO:0007031 CG3947 CG3947 CDMC23188 2 15 13 DAC21-F22 23-CG3957-RA_3 CG3957 CAGGAGCAACAACCAATCCAAGTACAAAGTAGCCACAAAACGTCAGTTATTCACTAAGTGCACAGTTCG 69 FBan0003957 FBgn0034876 CG3957 2 2R transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 receptor binding; GO:0005102; ; GO:0005102 CG3957 CG3957 CDMC23188 2 16 13 DAC21-F22 23-CG3957-RA_3 CG3957 CAGGAGCAACAACCAATCCAAGTACAAAGTAGCCACAAAACGTCAGTTATTCACTAAGTGCACAGTTCG 69 FBan0003957 FBgn0034876 CG3957 2 2R transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 receptor binding; GO:0005102; ; GO:0005102 CG3957 CG3957 CDMC23189 2 17 13 DAC21-J10 12-CG3994-RA_2 CG3994 ACATCGGCGGTTCATTTGCGCTATAACTTCTTTGAGACCACCATCCAGATCGAGGACTATACCGCCCAA 69 FBan0003994 FBgn0028516 CG3994 2 2L cation transport; GO:0006812 metal ion transporter activity; GO:0046873; zinc ion transporter activity; GO:0005385; ; GO:0046873; ; GO:0005385 membrane; GO:0016020 CG3994 CG3994 BG:DS07295.1 CDMC23189 2 18 13 DAC21-J10 12-CG3994-RA_2 CG3994 ACATCGGCGGTTCATTTGCGCTATAACTTCTTTGAGACCACCATCCAGATCGAGGACTATACCGCCCAA 69 FBan0003994 FBgn0028516 CG3994 2 2L cation transport; GO:0006812 metal ion transporter activity; GO:0046873; zinc ion transporter activity; GO:0005385; ; GO:0046873; ; GO:0005385 membrane; GO:0016020 CG3994 CG3994 BG:DS07295.1 CDMC23190 2 19 13 DAC21-J22 17-CG40042-RA_1 CG40042 GGCTGGGCATCTCGTCCCTCTATTGCTTATACCTAATAGCACAGGAAAACAGTTCGAACTCAAGTCCCA 69 FBgn0058042 CG40042 intracellular protein transport; GO:0006886; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane; GO:0005743 CG40042 CG40042 "LP07554, BcDNA:SD19278, BEST:GH02609" CDMC23190 2 20 13 DAC21-J22 17-CG40042-RA_1 CG40042 GGCTGGGCATCTCGTCCCTCTATTGCTTATACCTAATAGCACAGGAAAACAGTTCGAACTCAAGTCCCA 69 FBgn0058042 CG40042 intracellular protein transport; GO:0006886; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane; GO:0005743 CG40042 CG40042 "LP07554, BcDNA:SD19278, BEST:GH02609" CDMC23191 2 21 13 DAC21-N10 8-CG40096-RA_1 CG40096 GCGTTGTCAGCAAACTCTATCTTGCGCGTGTTTACTCCTCCCCTACTAGTTTGAAACGCGTCTTCGGGT 69 FBgn0058096 CG40096 CG40096 CG40096 CDMC23191 2 22 13 DAC21-N10 8-CG40096-RA_1 CG40096 GCGTTGTCAGCAAACTCTATCTTGCGCGTGTTTACTCCTCCCCTACTAGTTTGAAACGCGTCTTCGGGT 69 FBgn0058096 CG40096 CG40096 CG40096 CDMC23192 2 23 13 DAC21-N22 2-CG40113-RB_2 CG40113 TGTTGCGAACACCACAGCCTCTTGGTTGGTTTGGCCTTTTATCCAAGGGCGTCGGATTCAACGTCTTAT 69 FBgn0058113 CG40113 CG40113 CG40113 CDMC23192 2 24 13 DAC21-N22 2-CG40113-RB_2 CG40113 TGTTGCGAACACCACAGCCTCTTGGTTGGTTTGGCCTTTTATCCAAGGGCGTCGGATTCAACGTCTTAT 69 FBgn0058113 CG40113 CG40113 CG40113 CDMC23193 2 25 13 DAC22-B10 1-CG13737-RB_1 CG13737 TTGGGGTTTTGACGGTGGGTTTACTTTCACTTTTGCCGCACTTACTCAACAAGTTGTGGGGGCCC 65 FBan0013737 FBgn0036382 CG13737 3 3L CG13737 CG13737 CDMC23193 2 26 13 DAC22-B10 1-CG13737-RB_1 CG13737 TTGGGGTTTTGACGGTGGGTTTACTTTCACTTTTGCCGCACTTACTCAACAAGTTGTGGGGGCCC 65 FBan0013737 FBgn0036382 CG13737 3 3L CG13737 CG13737 CDMC23194 2 1 14 DAC22-B22 3-CG13778-RB_7 CG13778 GATCTCACCCTGCTCTCCATTGTCGTTGGATACATCGAGCTGTCTTTGACGACGGGAGAGGCTGC 65 FBan0013778 FBgn0031885 Mnn1 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 Mnn1 Menin 1 "CG33266, CG13778, CG33266, MEN1, menin, Menin1" CDMC23194 2 2 14 DAC22-B22 3-CG13778-RB_7 CG13778 GATCTCACCCTGCTCTCCATTGTCGTTGGATACATCGAGCTGTCTTTGACGACGGGAGAGGCTGC 65 FBan0013778 FBgn0031885 Mnn1 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 Mnn1 Menin 1 "CG33266, CG13778, CG33266, MEN1, menin, Menin1" CDMC23195 2 3 14 DAC22-F10 3-CG13834-RA_1 CG13834 ATCCTGCCGAGGCATCACATGCTGTGGTAAGTAGTCGCCACTTGTGCTCCATATTGTTGGCCTAA 65 FBan0013834 FBgn0039037 CG13834 3 3R CG13834 CG13834 CDMC23195 2 4 14 DAC22-F10 3-CG13834-RA_1 CG13834 ATCCTGCCGAGGCATCACATGCTGTGGTAAGTAGTCGCCACTTGTGCTCCATATTGTTGGCCTAA 65 FBan0013834 FBgn0039037 CG13834 3 3R CG13834 CG13834 CDMC23196 2 5 14 DAC22-F22 5-CG13862-RA_1 CG13862 CATTTACAATCACCAGGAAGTCGAGGTGGACAGCTCGTTCTTTGAGCCCACGCCGGATCGGATCG 65 FBan0013862 FBgn0038942 CG13862 3 3R CG13862 CG13862 CDMC23196 2 6 14 DAC22-F22 5-CG13862-RA_1 CG13862 CATTTACAATCACCAGGAAGTCGAGGTGGACAGCTCGTTCTTTGAGCCCACGCCGGATCGGATCG 65 FBan0013862 FBgn0038942 CG13862 3 3R CG13862 CG13862 CDMC23197 2 7 14 DAC22-J10 15-CG13941-RA_1 CG13941 TGGAGATCTTCGAGACGAAGCAGTCCTACGACGAAGTGATCGACTCATTCATCTGCAAGCAGCGA 65 FBan0013941 FBgn0033928 CG13941 2 2R CG13941 CG13941 "anon-WO0118547.456, BcDNA:SD11637" CDMC23197 2 8 14 DAC22-J10 15-CG13941-RA_1 CG13941 TGGAGATCTTCGAGACGAAGCAGTCCTACGACGAAGTGATCGACTCATTCATCTGCAAGCAGCGA 65 FBan0013941 FBgn0033928 CG13941 2 2R CG13941 CG13941 "anon-WO0118547.456, BcDNA:SD11637" CDMC23198 2 9 14 DAC22-J22 3-CG13952-RA_2 CG13952 TAGCAACACGATCCTTCTGCAAACCCCCATCAATGCCAGTCAGTTGGAGAGCGTTCTAAAGGCCC 65 FBan0013952 FBgn0033415 CG13952 2 2R CG13952 CG13952 CDMC23198 2 10 14 DAC22-J22 3-CG13952-RA_2 CG13952 TAGCAACACGATCCTTCTGCAAACCCCCATCAATGCCAGTCAGTTGGAGAGCGTTCTAAAGGCCC 65 FBan0013952 FBgn0033415 CG13952 2 2R CG13952 CG13952 CDMC23199 2 11 14 DAC22-N10 2-CG14025-RA_1 CG14025 GAGCTCAACGATTTGCATAGCCGAATCGAGACCCAGGGTGTTTTACTGGCCGATCAGACACAGCG 65 FBan0014025 FBgn0000228 Bsg25D 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Bsg25D Blastoderm-specific gene 25D "CG14025, bsq25D, brg25D, bsg25D" CDMC23199 2 12 14 DAC22-N10 2-CG14025-RA_1 CG14025 GAGCTCAACGATTTGCATAGCCGAATCGAGACCCAGGGTGTTTTACTGGCCGATCAGACACAGCG 65 FBan0014025 FBgn0000228 Bsg25D 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Bsg25D Blastoderm-specific gene 25D "CG14025, bsq25D, brg25D, bsg25D" CDMC23200 2 13 14 DAC22-N22 1-CG14068-RA_1 CG14068 CAGAGCAGATTACGCATTGCCAATGCTCAGCTGCTGGACACCGGAAACTATACGTGCATGCCGAC 65 FBgn0032316 CDMC23200 2 14 14 DAC22-N22 1-CG14068-RA_1 CG14068 CAGAGCAGATTACGCATTGCCAATGCTCAGCTGCTGGACACCGGAAACTATACGTGCATGCCGAC 65 FBgn0032316 CDMC23201 2 15 14 DAC23-B10 3-CG4646-RA_1 CG4646 ATGAAGTGCAAGATGTGCAGCCGGGAGAACAGCATCGACATCGTCGACAAGTCGAATGCTCCCTA 65 FBan0004646 FBgn0033810 CG4646 2 2R CG4646 CG4646 BcDNA:SD14289 CDMC23201 2 16 14 DAC23-B10 3-CG4646-RA_1 CG4646 ATGAAGTGCAAGATGTGCAGCCGGGAGAACAGCATCGACATCGTCGACAAGTCGAATGCTCCCTA 65 FBan0004646 FBgn0033810 CG4646 2 2R CG4646 CG4646 BcDNA:SD14289 CDMC23202 2 17 14 DAC23-B22 2-CG4709-RA_1 CG4709 TCCGCCGAAAGCAAAGAGATATGGCCAAGGTTAAACAGTCCCTGGACCGGAATTCTGGAGATGCG 65 FBan0004709 FBgn0032169 CG4709 2 2L CG4709 CG4709 CDMC23202 2 18 14 DAC23-B22 2-CG4709-RA_1 CG4709 TCCGCCGAAAGCAAAGAGATATGGCCAAGGTTAAACAGTCCCTGGACCGGAATTCTGGAGATGCG 65 FBan0004709 FBgn0032169 CG4709 2 2L CG4709 CG4709 CDMC23203 2 19 14 DAC23-F10 3-CG4867-RA_5 CG4867 ATCCGGCCCTGATGGAAACGCACGTGATGTTCATAGTCCTCTACCTGGTCGGATTCTTCCTGGAG 65 FBan0004867 FBgn0040239 bc10 3 3L bc10 bc10 "CG4867, dbc10" CDMC23203 2 20 14 DAC23-F10 3-CG4867-RA_5 CG4867 ATCCGGCCCTGATGGAAACGCACGTGATGTTCATAGTCCTCTACCTGGTCGGATTCTTCCTGGAG 65 FBan0004867 FBgn0040239 bc10 3 3L bc10 bc10 "CG4867, dbc10" CDMC23204 2 21 14 DAC23-F22 3-CG4911-RA_2 CG4911 CATTGAGTTGGTGCTGACCCTTGTGTATGCCTATGAGGCCATCGCACTACTGCAGCATCGTGTGC 65 FBan0004911 FBgn0035959 CG4911 3 3L CG4911 CG4911 CDMC23204 2 22 14 DAC23-F22 3-CG4911-RA_2 CG4911 CATTGAGTTGGTGCTGACCCTTGTGTATGCCTATGAGGCCATCGCACTACTGCAGCATCGTGTGC 65 FBan0004911 FBgn0035959 CG4911 3 3L CG4911 CG4911 CDMC23205 2 23 14 DAC23-J10 3-CG5115-RB_1 CG5115 ATCGGGACCGAACGAGATGGAGGTGTCAGTATATTGCCCGTGGCACGCTGTGAATTCGCAACTAG 65 FBan0005115 FBgn0040574 CG5115 3 3R CG5115 CG5115 CDMC23205 2 24 14 DAC23-J10 3-CG5115-RB_1 CG5115 ATCGGGACCGAACGAGATGGAGGTGTCAGTATATTGCCCGTGGCACGCTGTGAATTCGCAACTAG 65 FBan0005115 FBgn0040574 CG5115 3 3R CG5115 CG5115 CDMC23206 2 25 14 DAC23-J22 3-CG5163-RA_2 CG5163 GAATTAAGGCAGCCACTATGTCGTATCAACTGTACCGCAACACCACGCTCGGCAACACCCTGCAG 65 FBan0005163 FBgn0013347 TfIIA-S 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-S Transcription-factor-IIA-S "CG5163, CG5163, F121, TFIIA, dTFIIA-S, TFIIA-S, dTFIIA, BcDNA:RE44302" CDMC23206 2 26 14 DAC23-J22 3-CG5163-RA_2 CG5163 GAATTAAGGCAGCCACTATGTCGTATCAACTGTACCGCAACACCACGCTCGGCAACACCCTGCAG 65 FBan0005163 FBgn0013347 TfIIA-S 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-S Transcription-factor-IIA-S "CG5163, CG5163, F121, TFIIA, dTFIIA-S, TFIIA-S, dTFIIA, BcDNA:RE44302" CDMC23207 2 1 15 DAC23-N10 9-CG5252-RA_2 CG5252 TGGTGTTGCCACTCAGGACAACCGTTTGACCACAATAACATTCAAAGAACTGGTGGACGACCCCA 65 FBan0005252 FBgn0037894 Ranbp9 3 3R "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp9 Ranbp9 CG5252 CDMC23207 2 2 15 DAC23-N10 9-CG5252-RA_2 CG5252 TGGTGTTGCCACTCAGGACAACCGTTTGACCACAATAACATTCAAAGAACTGGTGGACGACCCCA 65 FBan0005252 FBgn0037894 Ranbp9 3 3R "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp9 Ranbp9 CG5252 CDMC23208 2 3 15 DAC23-N22 6-CG5288-RB_2 CG5288 CGAATGCTCTCATCCTGATGTAGAGCGCCTGATTGCCATATCGAACCAGCAGAACGTTAGCGCCC 65 FBan0005288 FBgn0035950 CG5288 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996; phosphorylation; GO:0016310 ATP binding; GO:0005524; ; GO:0005524; galactokinase activity; GO:0004335 ; EC:2.7.1.6; ; GO:0004335 ; EC:2.7.1.6 cytoplasm; GO:0005737 CG5288 CG5288 CT16885 CDMC23208 2 4 15 DAC23-N22 6-CG5288-RB_2 CG5288 CGAATGCTCTCATCCTGATGTAGAGCGCCTGATTGCCATATCGAACCAGCAGAACGTTAGCGCCC 65 FBan0005288 FBgn0035950 CG5288 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996; phosphorylation; GO:0016310 ATP binding; GO:0005524; ; GO:0005524; galactokinase activity; GO:0004335 ; EC:2.7.1.6; ; GO:0004335 ; EC:2.7.1.6 cytoplasm; GO:0005737 CG5288 CG5288 CT16885 CDMC23209 2 5 15 DAC24-B10 1-CG9186-RB_1 CG9186 ACCTGGCCCAGACAATCAGCCCTGTCCATTACCTAATCCATCCATGCCAATAGACTTGGGAATCCGGAT 69 FBan0009186 FBgn0035206 CG9186 3 3L CG9186 CG9186 CDMC23209 2 6 15 DAC24-B10 1-CG9186-RB_1 CG9186 ACCTGGCCCAGACAATCAGCCCTGTCCATTACCTAATCCATCCATGCCAATAGACTTGGGAATCCGGAT 69 FBan0009186 FBgn0035206 CG9186 3 3L CG9186 CG9186 CDMC23210 2 7 15 DAC24-B22 12-CG9203-RA_3 CG9203 GGGAGTCCTACGATGATGACGTAATGGTCAGGGATGTTCATACGCCCATCGTCAACTTGGTCGAAAGCT 69 FBan0009203 FBgn0030646 CG9203 X X CG9203 CG9203 CDMC23210 2 8 15 DAC24-B22 12-CG9203-RA_3 CG9203 GGGAGTCCTACGATGATGACGTAATGGTCAGGGATGTTCATACGCCCATCGTCAACTTGGTCGAAAGCT 69 FBan0009203 FBgn0030646 CG9203 X X CG9203 CG9203 CDMC23211 2 9 15 DAC24-F10 15-CG9241-RA_1 CG9241 TGCGGAAATCGAACTACTACCGTATTCAAGTTGCCCAAACAGAGCTGTAAGAATTGCAAGGGGTCGCGA 69 FBan0009241 FBgn0032929 Mcm10 2 2L DNA replication; GO:0006260; chromosome condensation; GO:0030261; female meiosis chromosome segregation; GO:0016321; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682 pre-replicative complex; GO:0005656 Mcm10 Sensitized chromosome inheritance modifier 19 "CG9241, CG9241, CG9241, CG9241, CG9241, Scim19, DmMCM10, Sensitized chromosome inheritance modifier 19" CDMC23211 2 10 15 DAC24-F10 15-CG9241-RA_1 CG9241 TGCGGAAATCGAACTACTACCGTATTCAAGTTGCCCAAACAGAGCTGTAAGAATTGCAAGGGGTCGCGA 69 FBan0009241 FBgn0032929 Mcm10 2 2L DNA replication; GO:0006260; chromosome condensation; GO:0030261; female meiosis chromosome segregation; GO:0016321; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682 pre-replicative complex; GO:0005656 Mcm10 Sensitized chromosome inheritance modifier 19 "CG9241, CG9241, CG9241, CG9241, CG9241, Scim19, DmMCM10, Sensitized chromosome inheritance modifier 19" CDMC23212 2 11 15 DAC24-F22 2-CG9247-RA_1 CG9247 TGCGCCTTCAAATGCCTCACCACTACTTGGACCTTCGCAATCTCTGGTTGGAGTTAAAAAAGCAGCGCT 69 FBan0009247 FBgn0032924 CG9247 2 2L CG9247 CG9247 CDMC23212 2 12 15 DAC24-F22 2-CG9247-RA_1 CG9247 TGCGCCTTCAAATGCCTCACCACTACTTGGACCTTCGCAATCTCTGGTTGGAGTTAAAAAAGCAGCGCT 69 FBan0009247 FBgn0032924 CG9247 2 2L CG9247 CG9247 CDMC23213 2 13 15 DAC24-J10 9-CG9288-RA_2 CG9288 AGCACCCTGCTCTAGCTCAAGGCATCTCATCGGTCAACTTTGATATAGGGAACGTAGATCGCAGCCAGA 69 FBan0009288 FBgn0038182 CG9288 3 3R CG9288 CG9288 CDMC23213 2 14 15 DAC24-J10 9-CG9288-RA_2 CG9288 AGCACCCTGCTCTAGCTCAAGGCATCTCATCGGTCAACTTTGATATAGGGAACGTAGATCGCAGCCAGA 69 FBan0009288 FBgn0038182 CG9288 3 3R CG9288 CG9288 CDMC23214 2 15 15 DAC24-J22 2-CG9298-RA_1 CG9298 TGCGAAAGGTTTACGAGCTGTACTCAGACTACGTGCTCAAGAACCCCTTCTACTCCCTGGAGATGCCCA 69 FBan0009298 FBgn0032060 CG9298 2 2L ER to Golgi transport; GO:0006888; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 protein binding; GO:0005515; ; GO:0005515 Golgi cis-face; GO:0005801 CG9298 CG9298 CDMC23214 2 16 15 DAC24-J22 2-CG9298-RA_1 CG9298 TGCGAAAGGTTTACGAGCTGTACTCAGACTACGTGCTCAAGAACCCCTTCTACTCCCTGGAGATGCCCA 69 FBan0009298 FBgn0032060 CG9298 2 2L ER to Golgi transport; GO:0006888; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 protein binding; GO:0005515; ; GO:0005515 Golgi cis-face; GO:0005801 CG9298 CG9298 CDMC23215 2 17 15 DAC24-N10 3-CG9326-RB_1 CG9326 GGAGCAGTGGGTGCCTGTCAACTGGATCTACTAGAATCCCATGACCCTTTGCAATTGCGCCTTTATGCA 69 FBan0009326 FBgn0032885 CG9326 2 2L asymmetric protein localization; GO:0008105; protein targeting; GO:0006605; purine base metabolism; GO:0006144; signal transduction; GO:0007165 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; protein binding; GO:0005515; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 membrane; GO:0016020 CG9326 CG9326 38E.21 CDMC23215 2 18 15 DAC24-N10 3-CG9326-RB_1 CG9326 GGAGCAGTGGGTGCCTGTCAACTGGATCTACTAGAATCCCATGACCCTTTGCAATTGCGCCTTTATGCA 69 FBan0009326 FBgn0032885 CG9326 2 2L asymmetric protein localization; GO:0008105; protein targeting; GO:0006605; purine base metabolism; GO:0006144; signal transduction; GO:0007165 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; protein binding; GO:0005515; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 membrane; GO:0016020 CG9326 CG9326 38E.21 CDMC23216 2 19 15 DAC24-N22 18-CG9337-RA_1 CG9337 AGGAACATTTTATGCCCCCAGTCATCTACATACCTAGGAGCTATGAGTACAGCAAACCCGCCCATCAAG 69 FBan0009337 FBgn0032898 CR9337 2 2L CR9337 CR9337 "CG9337, CG9337, cg9337, BcDNA:GH05725" CDMC23216 2 20 15 DAC24-N22 18-CG9337-RA_1 CG9337 AGGAACATTTTATGCCCCCAGTCATCTACATACCTAGGAGCTATGAGTACAGCAAACCCGCCCATCAAG 69 FBan0009337 FBgn0032898 CR9337 2 2L CR9337 CR9337 "CG9337, CG9337, cg9337, BcDNA:GH05725" CDMC23217 2 21 15 DAC25-B10 17-CG10570-RA_1 CG10570 AAAGTACTCACCCTGTTGCAAACTGTACCGTGAACTTTGACTTCTCTACAAACGCATTGGAAGCGCAGC 69 FBan0010570 FBgn0040992 CG10570 2 2L CG10570 CG10570 CDMC23217 2 22 15 DAC25-B10 17-CG10570-RA_1 CG10570 AAAGTACTCACCCTGTTGCAAACTGTACCGTGAACTTTGACTTCTCTACAAACGCATTGGAAGCGCAGC 69 FBan0010570 FBgn0040992 CG10570 2 2L CG10570 CG10570 CDMC23218 2 23 15 DAC25-B22 6-CG1057-RA_1 CG1057 GCGAAATACCTCATGTACCCAATGTGCCTCTACTTCCTCGATCTGCTGCAGTACGAACACTTCCGCCGG 69 FBan0001057 FBgn0037262 MED31 3 3R regulation of transcription; GO:0045449; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0003702; ; GO:0016455 mediator complex; GO:0000119 MED31 Mediator complex subunit 31 "CG1057, Trap18, dTRAP18, p36, Mediator, dSOH1, Med31, BcDNA:GM28912, Mediator complex subunit 31" CDMC23218 2 24 15 DAC25-B22 6-CG1057-RA_1 CG1057 GCGAAATACCTCATGTACCCAATGTGCCTCTACTTCCTCGATCTGCTGCAGTACGAACACTTCCGCCGG 69 FBan0001057 FBgn0037262 MED31 3 3R regulation of transcription; GO:0045449; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0003702; ; GO:0016455 mediator complex; GO:0000119 MED31 Mediator complex subunit 31 "CG1057, Trap18, dTRAP18, p36, Mediator, dSOH1, Med31, BcDNA:GM28912, Mediator complex subunit 31" CDMC23219 2 25 15 DAC25-F10 3-CG10612-RA_3 CG10612 GACGACTCCAAGCGTCGCGACCTGTTTGTATTCGTGAGGCAAACCATGTGTATAGCGGCCATGTATCCC 69 FBan0010612 FBgn0037322 Or83a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; sugar porter activity; GO:0005351; ; GO:0004984; ; GO:0005351; ; GO:0005549 integral to membrane; GO:0016021; membrane; GO:0016020 Or83a Odorant receptor 83a "CG10612, 83A.1, DOR44, 83a" CDMC23219 2 26 15 DAC25-F10 3-CG10612-RA_3 CG10612 GACGACTCCAAGCGTCGCGACCTGTTTGTATTCGTGAGGCAAACCATGTGTATAGCGGCCATGTATCCC 69 FBan0010612 FBgn0037322 Or83a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; sugar porter activity; GO:0005351; ; GO:0004984; ; GO:0005351; ; GO:0005549 integral to membrane; GO:0016021; membrane; GO:0016020 Or83a Odorant receptor 83a "CG10612, 83A.1, DOR44, 83a" CDMC23220 2 1 16 DAC25-F22 23-CG10622-RB_1 CG10622 ACCGACAAAGTTACGAAAATAAATTAATACCAAGTTAGCCAAGGTATTCAGTTACCACCGCAGATCAGC 69 FBan0010622 FBgn0029118 Sucb 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Sucb Sucb "CG10622, sucb, sucB" CDMC23220 2 2 16 DAC25-F22 23-CG10622-RB_1 CG10622 ACCGACAAAGTTACGAAAATAAATTAATACCAAGTTAGCCAAGGTATTCAGTTACCACCGCAGATCAGC 69 FBan0010622 FBgn0029118 Sucb 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Sucb Sucb "CG10622, sucb, sucB" CDMC23221 2 3 16 DAC25-J10 2-CG10648-RA_1 CG10648 CGGAGAGAGCGCATATGCCGAGCAAATTGTGGGAGAGGATCAAGTTGTCCAGAAACTTCGAGAAGGCCA 69 FBan0010648 FBgn0030067 CG10648 X X cell cycle; GO:0007049; protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10648 CG10648 CDMC23221 2 4 16 DAC25-J10 2-CG10648-RA_1 CG10648 CGGAGAGAGCGCATATGCCGAGCAAATTGTGGGAGAGGATCAAGTTGTCCAGAAACTTCGAGAAGGCCA 69 FBan0010648 FBgn0030067 CG10648 X X cell cycle; GO:0007049; protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10648 CG10648 CDMC23222 2 5 16 DAC25-J22 11-CG10657-RA_1 CG10657 TGATGAGGATTCTCAGGTGGCTGGATATGTGTACATCAACGACGAGAGTGGCATGAACATGGGCTTCGT 69 FBan0010657 FBgn0036289 CG10657 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 CG10657 CG10657 "retinaldehyde-binding related protein, BEST:LD32330" CDMC23222 2 6 16 DAC25-J22 11-CG10657-RA_1 CG10657 TGATGAGGATTCTCAGGTGGCTGGATATGTGTACATCAACGACGAGAGTGGCATGAACATGGGCTTCGT 69 FBan0010657 FBgn0036289 CG10657 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 CG10657 CG10657 "retinaldehyde-binding related protein, BEST:LD32330" CDMC23223 2 7 16 DAC25-N10 3-CG10689-RA_2 CG10689 CGGCGTGGGCATACAAGCATGAACTGGAGGACAATACCGTTCCGGAGATACAGCGTATTAATCTGGGCA 69 FBan0010689 FBgn0032759 CG10689 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 spliceosome complex; GO:0005681 CG10689 CG10689 cg10689 CDMC23223 2 8 16 DAC25-N10 3-CG10689-RA_2 CG10689 CGGCGTGGGCATACAAGCATGAACTGGAGGACAATACCGTTCCGGAGATACAGCGTATTAATCTGGGCA 69 FBan0010689 FBgn0032759 CG10689 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 spliceosome complex; GO:0005681 CG10689 CG10689 cg10689 CDMC23224 2 9 16 DAC25-N22 9-CG10698-RA_2 CG10698 GCGTAGGATTAGAGCTAGTCCGTACGAAGTGGTTGCCCTACACTGGGAGAAACTCGTGGTCACTTTGCA 69 FBan0010698 FBgn0036278 GRHRII 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; gonadotropin-releasing hormone receptor activity; GO:0004968; peptide receptor activity; GO:0001653; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500; ; GO:0004968; ; GO:0001653; corazonin receptor activity; GO:0035237; ; GO:0035237; ; GO:0035237 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHRII GRHRII "CG10698, CG10698, CG10698, CG10698, CG10698, CG10698, DGRHRII, DCR, Drosophila Corazonin Receptor, anon-WO0170980.196, anon-WO0170980.197" CDMC23224 2 10 16 DAC25-N22 9-CG10698-RA_2 CG10698 GCGTAGGATTAGAGCTAGTCCGTACGAAGTGGTTGCCCTACACTGGGAGAAACTCGTGGTCACTTTGCA 69 FBan0010698 FBgn0036278 GRHRII 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; gonadotropin-releasing hormone receptor activity; GO:0004968; peptide receptor activity; GO:0001653; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500; ; GO:0004968; ; GO:0001653; corazonin receptor activity; GO:0035237; ; GO:0035237; ; GO:0035237 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHRII GRHRII "CG10698, CG10698, CG10698, CG10698, CG10698, CG10698, DGRHRII, DCR, Drosophila Corazonin Receptor, anon-WO0170980.196, anon-WO0170980.197" CDMC23225 2 11 16 DAC26-B10 12-CG8027-RA_2 CG8027 GGCGGCAAACTTTGCAGTCCGACCCAAATATAACTTCCATGTCAGCCCAAAAAGAACTTCGCACAGCAA 69 FBan0008027 FBgn0033392 CG8027 2 2R cell differentiation; GO:0030154 membrane; GO:0016020 CG8027 CG8027 CDMC23225 2 12 16 DAC26-B10 12-CG8027-RA_2 CG8027 GGCGGCAAACTTTGCAGTCCGACCCAAATATAACTTCCATGTCAGCCCAAAAAGAACTTCGCACAGCAA 69 FBan0008027 FBgn0033392 CG8027 2 2R cell differentiation; GO:0030154 membrane; GO:0016020 CG8027 CG8027 CDMC23226 2 13 16 DAC26-B22 23-CG8044-RB_3 CG8044 AATCGCACTTGGAGTCATTCGAAGTACACAGAGTACATGTCCAAGATAAACCAAATAGATGTGCGGGGC 69 FBan0008044 FBgn0035829 CG8044 3 3L CG8044 CG8044 BcDNA:GM01628 CDMC23226 2 14 16 DAC26-B22 23-CG8044-RB_3 CG8044 AATCGCACTTGGAGTCATTCGAAGTACACAGAGTACATGTCCAAGATAAACCAAATAGATGTGCGGGGC 69 FBan0008044 FBgn0035829 CG8044 3 3L CG8044 CG8044 BcDNA:GM01628 CDMC23227 2 15 16 DAC26-F10 12-CG8078-RA_6 CG8078 GGCATCACTGGATATCGGGATGACAGTTTGGAGACAGTGAAACAGAACCGTGACGACTACCAGATGCCA 69 FBan0008078 FBgn0033375 CG8078 2 2R nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8078 CG8078 anon-WO0118547.76 CDMC23227 2 16 16 DAC26-F10 12-CG8078-RA_6 CG8078 GGCATCACTGGATATCGGGATGACAGTTTGGAGACAGTGAAACAGAACCGTGACGACTACCAGATGCCA 69 FBan0008078 FBgn0033375 CG8078 2 2R nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8078 CG8078 anon-WO0118547.76 CDMC23228 2 17 16 DAC26-F22 6-CG8086-RC_1 CG8086 CCGCCTACAGCTTTGGGATCAAGCACTCCCAGTATTTGGGTCGCCTAAACGAGAAGAACACCGAGTTTG 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC23228 2 18 16 DAC26-F22 6-CG8086-RC_1 CG8086 CCGCCTACAGCTTTGGGATCAAGCACTCCCAGTATTTGGGTCGCCTAAACGAGAAGAACACCGAGTTTG 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC23229 2 19 16 DAC26-J10 23-CG8127-RA_8 CG8127 TTTCCACCCTTCTATCGATCTTTCTATCTGATCATCTAGCTACCCGTATTCCTGATTTCTCCTTTGGCA 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC23229 2 20 16 DAC26-J10 23-CG8127-RA_8 CG8127 TTTCCACCCTTCTATCGATCTTTCTATCTGATCATCTAGCTACCCGTATTCCTGATTTCTCCTTTGGCA 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC23230 2 21 16 DAC26-J22 3-CG8135-RA_1 CG8135 CGCATTATGGAGACGGTGTACACGCAGATCATGGGCCACATGGATGTTATTGGCATCATCTCGAACGGC 69 FBan0008135 FBgn0037689 CG8135 3 3R CG8135 CG8135 CDMC23230 2 22 16 DAC26-J22 3-CG8135-RA_1 CG8135 CGCATTATGGAGACGGTGTACACGCAGATCATGGGCCACATGGATGTTATTGGCATCATCTCGAACGGC 69 FBan0008135 FBgn0037689 CG8135 3 3R CG8135 CG8135 CDMC23231 2 23 16 DAC26-N10 3-CG8177-RK_2 CG8177 CGGCTGGTACATCGGTTTCGATACCTCTTCCACGTGGATACCATTTGCTTGTGTGATACCTGCCCTGCT 69 FBan0008177 FBgn0036043 CG8177 3 3L anion transport; GO:0006820; cell homeostasis; GO:0019725; cytoskeleton organization and biogenesis; GO:0007010; ion transport; GO:0006811 anion exchanger activity; GO:0015380; inorganic anion exchanger activity; GO:0005452; ; GO:0005452; ; GO:0015380 membrane; GO:0016020 CG8177 CG8177 "BcDNA:RE59468, anon-EST:Posey259" CDMC23231 2 24 16 DAC26-N10 3-CG8177-RK_2 CG8177 CGGCTGGTACATCGGTTTCGATACCTCTTCCACGTGGATACCATTTGCTTGTGTGATACCTGCCCTGCT 69 FBan0008177 FBgn0036043 CG8177 3 3L anion transport; GO:0006820; cell homeostasis; GO:0019725; cytoskeleton organization and biogenesis; GO:0007010; ion transport; GO:0006811 anion exchanger activity; GO:0015380; inorganic anion exchanger activity; GO:0005452; ; GO:0005452; ; GO:0015380 membrane; GO:0016020 CG8177 CG8177 "BcDNA:RE59468, anon-EST:Posey259" CDMC23232 2 25 16 DAC26-N22 2-CG8184-RB_1 CG8184 AGCCACCAGTAACCAACAAACCATGGACGCAACACTATTCCTACAACGCCCTCAAATACACGGGTGCAA 69 FBan0008184 FBgn0030674 CG8184 X X protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG8184 CG8184 CDMC23232 2 26 16 DAC26-N22 2-CG8184-RB_1 CG8184 AGCCACCAGTAACCAACAAACCATGGACGCAACACTATTCCTACAACGCCCTCAAATACACGGGTGCAA 69 FBan0008184 FBgn0030674 CG8184 X X protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG8184 CG8184 CDMC23233 2 1 17 DAC27-B10 16-CG8420-RA_1 CG8420 AGGTGACCACGGAATATATCCACAACGAGTTGTAGTATTCCAGTTGCAAATGGACAAGCGAGATCCGGA 69 FBan0008420 FBgn0037664 CG8420 3 3R CG8420 CG8420 anon-WO0140519.182 CDMC23233 2 2 17 DAC27-B10 16-CG8420-RA_1 CG8420 AGGTGACCACGGAATATATCCACAACGAGTTGTAGTATTCCAGTTGCAAATGGACAAGCGAGATCCGGA 69 FBan0008420 FBgn0037664 CG8420 3 3R CG8420 CG8420 anon-WO0140519.182 CDMC23234 2 3 17 DAC27-B22 23-CG8432-RA_2 CG8432 TCACTAGCCAACTCTTCGATCAATCAGACGCACAAATAATATTTAGCTCATACTTCACAATTGCTGCCC 69 FBan0008432 FBgn0026378 Rep 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid geranylgeranylation; GO:0018348; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 Rab escort protein activity; GO:0005084; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0005084; ; GO:0005084; contributes_to Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60; ; GO:0005084 Rab-protein geranylgeranyltransferase complex; GO:0005968; aster; GO:0005818; cytoplasm; GO:0005737; membrane; GO:0016020; perinuclear region; GO:0048471; spindle pole; GO:0000922; synaptic vesicle; GO:0008021 Rep Rab escort protein "CG8432, CG8432, REP, Rab escort protein homolog, rab escort protein" CDMC23234 2 4 17 DAC27-B22 23-CG8432-RA_2 CG8432 TCACTAGCCAACTCTTCGATCAATCAGACGCACAAATAATATTTAGCTCATACTTCACAATTGCTGCCC 69 FBan0008432 FBgn0026378 Rep 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid geranylgeranylation; GO:0018348; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 Rab escort protein activity; GO:0005084; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0005084; ; GO:0005084; contributes_to Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60; ; GO:0005084 Rab-protein geranylgeranyltransferase complex; GO:0005968; aster; GO:0005818; cytoplasm; GO:0005737; membrane; GO:0016020; perinuclear region; GO:0048471; spindle pole; GO:0000922; synaptic vesicle; GO:0008021 Rep Rab escort protein "CG8432, CG8432, REP, Rab escort protein homolog, rab escort protein" CDMC23235 2 5 17 DAC27-F10 1-CG8474-RA_1 CG8474 GGCGGCAATAATCAATCGCTTCTGTGCACAGAGTGTGGAGTGAGTTACTCGACTCAAAAGGCGTTGGCA 69 FBan0008474 FBgn0025874 Meics 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634; spindle; GO:0005819; spindle microtubule; GO:0005876 Meics Meiotic central spindle "CG8474, zinc-finger-motif-protein, Meiotic central spindle" CDMC23235 2 6 17 DAC27-F10 1-CG8474-RA_1 CG8474 GGCGGCAATAATCAATCGCTTCTGTGCACAGAGTGTGGAGTGAGTTACTCGACTCAAAAGGCGTTGGCA 69 FBan0008474 FBgn0025874 Meics 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634; spindle; GO:0005819; spindle microtubule; GO:0005876 Meics Meiotic central spindle "CG8474, zinc-finger-motif-protein, Meiotic central spindle" CDMC23236 2 7 17 DAC27-F22 7-CG8486-RA_1 CG8486 TGAGCCCAAAACACTACGACTACCGACCGTTGGTTATCAAAATGCATCGGGACAACGAGACCAATGGGT 69 FBan0008486 FBgn0031993 CG8486 2 2L CG8486 CG8486 "clone 1.32, anon-EST:Liang-1.32" CDMC23236 2 8 17 DAC27-F22 7-CG8486-RA_1 CG8486 TGAGCCCAAAACACTACGACTACCGACCGTTGGTTATCAAAATGCATCGGGACAACGAGACCAATGGGT 69 FBan0008486 FBgn0031993 CG8486 2 2L CG8486 CG8486 "clone 1.32, anon-EST:Liang-1.32" CDMC23237 2 9 17 DAC27-J10 16-CG8525-RA_1 CG8525 GGCAACGTCGTCATCAGCTGTCCAACAAGCAAATTGATAAGACTCTCCATGTTCTTCGGTTGAGGTTGA 69 FBan0008525 FBgn0033735 CG8525 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" deoxyribose-phosphate aldolase activity; GO:0004139 ; EC:4.1.2.4; ; GO:0004139 ; EC:4.1.2.4 CG8525 CG8525 CDMC23237 2 10 17 DAC27-J10 16-CG8525-RA_1 CG8525 GGCAACGTCGTCATCAGCTGTCCAACAAGCAAATTGATAAGACTCTCCATGTTCTTCGGTTGAGGTTGA 69 FBan0008525 FBgn0033735 CG8525 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" deoxyribose-phosphate aldolase activity; GO:0004139 ; EC:4.1.2.4; ; GO:0004139 ; EC:4.1.2.4 CG8525 CG8525 CDMC23238 2 11 17 DAC27-J22 9-CG8540-RA_1 CG8540 CCTCGGGTACCAGCTTTGCAGTCCAGCTCTCTGTTTCTGCCTCGTAACAATTGCTAGAAATCCATCGGT 69 FBan0008540 FBgn0035790 Cyp316a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp316a1 Cyp316a1 "CG8540, 316a1" CDMC23238 2 12 17 DAC27-J22 9-CG8540-RA_1 CG8540 CCTCGGGTACCAGCTTTGCAGTCCAGCTCTCTGTTTCTGCCTCGTAACAATTGCTAGAAATCCATCGGT 69 FBan0008540 FBgn0035790 Cyp316a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp316a1 Cyp316a1 "CG8540, 316a1" CDMC23239 2 13 17 DAC27-N10 1-CG8569-RA_1 CG8569 GCGCTGCGATAAAAGAACTGCAGTGTCACATGATGTTGTCCCACTATTCCGCCTCGCTATTCGGCTTCC 69 FBan0008569 FBgn0033752 CG8569 2 2R CG8569 CG8569 CDMC23239 2 14 17 DAC27-N10 1-CG8569-RA_1 CG8569 GCGCTGCGATAAAAGAACTGCAGTGTCACATGATGTTGTCCCACTATTCCGCCTCGCTATTCGGCTTCC 69 FBan0008569 FBgn0033752 CG8569 2 2R CG8569 CG8569 CDMC23240 2 15 17 DAC27-N22 9-CG8583-RA_1 CG8583 GGACGGATGGATAGACGTCCTGAACCCCAATCAACCTCAACCTCCTCTCTAATTCACTGGGACGGAAGA 69 FBan0008583 FBgn0035771 CG8583 3 3L protein folding; GO:0006457; protein targeting; GO:0006605 "signal recognition particle binding; GO:0005047; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0005047; ; GO:0051082" nucleus; GO:0005634; signal recognition particle receptor complex; GO:0005785 CG8583 CG8583 anon-WO0118547.333 CDMC23240 2 16 17 DAC27-N22 9-CG8583-RA_1 CG8583 GGACGGATGGATAGACGTCCTGAACCCCAATCAACCTCAACCTCCTCTCTAATTCACTGGGACGGAAGA 69 FBan0008583 FBgn0035771 CG8583 3 3L protein folding; GO:0006457; protein targeting; GO:0006605 "signal recognition particle binding; GO:0005047; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0005047; ; GO:0051082" nucleus; GO:0005634; signal recognition particle receptor complex; GO:0005785 CG8583 CG8583 anon-WO0118547.333 CDMC23241 2 17 17 DAC28-B10 8-CG3033-RA_1 CG3033 AGGCCATCGAGGGAATAGCCAGGAGTCTGAACAACCTTCTGGAGCGCTTCCATCAAAGCTTTTTCTTCT 69 FBan0003033 FBgn0029818 CG3033 X X attachment of GPI anchor to protein; GO:0016255 GPI-anchor transamidase complex; GO:0042765; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG3033 CG3033 CDMC23241 2 18 17 DAC28-B10 8-CG3033-RA_1 CG3033 AGGCCATCGAGGGAATAGCCAGGAGTCTGAACAACCTTCTGGAGCGCTTCCATCAAAGCTTTTTCTTCT 69 FBan0003033 FBgn0029818 CG3033 X X attachment of GPI anchor to protein; GO:0016255 GPI-anchor transamidase complex; GO:0042765; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG3033 CG3033 CDMC23242 2 19 17 DAC28-B22 11-CG30354-RA_1 CG30354 ACCACTGAGACATGCATGGAGGAATTGTTCGACTTCGTCGCTGAATTGGATCATTGCGTTGCTCACAGT 69 FBan0030354 FBgn0050354 CG30354 2 2R "electron transport; GO:0006118; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG30354 CG30354 NEST:bs01g03 CDMC23242 2 20 17 DAC28-B22 11-CG30354-RA_1 CG30354 ACCACTGAGACATGCATGGAGGAATTGTTCGACTTCGTCGCTGAATTGGATCATTGCGTTGCTCACAGT 69 FBan0030354 FBgn0050354 CG30354 2 2R "electron transport; GO:0006118; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG30354 CG30354 NEST:bs01g03 CDMC23243 2 21 17 DAC28-F10 12-CG30384-RA_5 CG30384 GCCGTGGATCCAGCAGCTGCGTAGGAAAAACCCATATCAGTATCTCTTGAAAAAACTGCGATCGCGGAA 69 FBan0030384 FBgn0050384 CG30384 2 2R CG30384 CG30384 "CG11074, CG11074" CDMC23243 2 22 17 DAC28-F10 12-CG30384-RA_5 CG30384 GCCGTGGATCCAGCAGCTGCGTAGGAAAAACCCATATCAGTATCTCTTGAAAAAACTGCGATCGCGGAA 69 FBan0030384 FBgn0050384 CG30384 2 2R CG30384 CG30384 "CG11074, CG11074" CDMC23244 2 23 17 DAC28-F22 15-CG30394-RA_1 CG30394 GTTACTGAAAACGAATCCTACCAAGCGAGTCCAAATGGAACCCAAACTTCGCTGCAGACGTAATGCGGA 69 FBan0030394 FBgn0050394 CG30394 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG30394 CG30394 "CG10500, CG15670, anon-WO0172774.187, anon-WO0172774.188" CDMC23244 2 24 17 DAC28-F22 15-CG30394-RA_1 CG30394 GTTACTGAAAACGAATCCTACCAAGCGAGTCCAAATGGAACCCAAACTTCGCTGCAGACGTAATGCGGA 69 FBan0030394 FBgn0050394 CG30394 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG30394 CG30394 "CG10500, CG15670, anon-WO0172774.187, anon-WO0172774.188" CDMC23245 2 25 17 DAC28-J10 23-CG30438-RB_6 CG30438 TTACTAGAGTGGGGTGCTTAAATCTTAAGAAGAATACGTTGCGATTCAAAGCGTCAAGCAAATGGATCG 69 FBan0030438 FBgn0050438 CG30438 2 2R carbohydrate metabolism; GO:0005975; defense response; GO:0006952; lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-" CG30438 CG30438 "BcDNA:LD09936, BcDNA:RE54684" CDMC23245 2 26 17 DAC28-J10 23-CG30438-RB_6 CG30438 TTACTAGAGTGGGGTGCTTAAATCTTAAGAAGAATACGTTGCGATTCAAAGCGTCAAGCAAATGGATCG 69 FBan0030438 FBgn0050438 CG30438 2 2R carbohydrate metabolism; GO:0005975; defense response; GO:0006952; lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-" CG30438 CG30438 "BcDNA:LD09936, BcDNA:RE54684" CDMC23246 2 1 18 DAC28-J22 8-CG30448-RA_1 CG30448 AGCGAGACATCCCATGACGAGTCTTGTGAATTCGCCTGGCAAATCTCCGAGTGCTACGAAGGAGTAAGA 69 FBan0030448 FBgn0043532 Obp56i 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56i Odorant-binding protein 56i "CG30448, 56i, 56I, anon-AE003794.2, Obp-a, Odorant-binding protein 56i" CDMC23246 2 2 18 DAC28-J22 8-CG30448-RA_1 CG30448 AGCGAGACATCCCATGACGAGTCTTGTGAATTCGCCTGGCAAATCTCCGAGTGCTACGAAGGAGTAAGA 69 FBan0030448 FBgn0043532 Obp56i 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56i Odorant-binding protein 56i "CG30448, 56i, 56I, anon-AE003794.2, Obp-a, Odorant-binding protein 56i" CDMC23247 2 3 18 DAC28-N10 12-CG30486-RA_7 CG30486 AGCCAGGAGGCGTTATCTACGGATTACTGCAACAAGGATCTGTGTCTGCCGGAAATAACGCATATCGCT 69 FBan0030486 FBgn0050486 CG30486 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG30486 CG30486 CDMC23247 2 4 18 DAC28-N10 12-CG30486-RA_7 CG30486 AGCCAGGAGGCGTTATCTACGGATTACTGCAACAAGGATCTGTGTCTGCCGGAAATAACGCATATCGCT 69 FBan0030486 FBgn0050486 CG30486 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG30486 CG30486 CDMC23248 2 5 18 DAC28-N22 15-CG30492-RD_1 CG30492 GCCAAGTACAGCAACAATAGTCTGCTATTCTAGGAGCTCTGGGGATCATTTTGGTCTTAGGCCCCACGA 69 FBan0030492 FBgn0050492 CG30492 2 2R CG30492 CG30492 "CG2088, CG17983, CG17984, CG2080, CG2088, BcDNA:HL07907" CDMC23248 2 6 18 DAC28-N22 15-CG30492-RD_1 CG30492 GCCAAGTACAGCAACAATAGTCTGCTATTCTAGGAGCTCTGGGGATCATTTTGGTCTTAGGCCCCACGA 69 FBan0030492 FBgn0050492 CG30492 2 2R CG30492 CG30492 "CG2088, CG17983, CG17984, CG2080, CG2088, BcDNA:HL07907" CDMC23249 2 7 18 DAC29-B10 3-CG9970-RA_9 CG9970 TGTTTAGCCTGCGCGAGTCTTTCAACCATCCGGAGAAGTTTGACCTCTTTAGCAAGGAACCCGGGATGT 69 FBan0009970 FBgn0035380 CG9970 3 3L CG9970 CG9970 CDMC23249 2 8 18 DAC29-B10 3-CG9970-RA_9 CG9970 TGTTTAGCCTGCGCGAGTCTTTCAACCATCCGGAGAAGTTTGACCTCTTTAGCAAGGAACCCGGGATGT 69 FBan0009970 FBgn0035380 CG9970 3 3L CG9970 CG9970 CDMC23250 2 9 18 DAC29-B22 14-CG9987-RA_1 CG9987 ACACCACACCCGATGATCTCGACATGCACGTTATCTATGACGTTTCGCACAATATTGCCAAGGTGGAGA 69 FBan0009987 FBgn0032781 CG9987 2 2L CG9987 CG9987 CDMC23250 2 10 18 DAC29-B22 14-CG9987-RA_1 CG9987 ACACCACACCCGATGATCTCGACATGCACGTTATCTATGACGTTTCGCACAATATTGCCAAGGTGGAGA 69 FBan0009987 FBgn0032781 CG9987 2 2L CG9987 CG9987 CDMC23251 2 11 18 DAC29-F10 2-CR30087-RA_1 CR30087 ACTGCCAGGGATCGAATTGCTCTCCCCGTTCTGAGGAGTATGGCATCATGAAGGCAATAACCCATCGAT 69 FBan0030087 FBgn0050087 CG30087 2 2R CG30087 CG30087 "CG8215, CG8215, CG8215, CG8215, CG8215, SP41, CR30087" CDMC23251 2 12 18 DAC29-F10 2-CR30087-RA_1 CR30087 ACTGCCAGGGATCGAATTGCTCTCCCCGTTCTGAGGAGTATGGCATCATGAAGGCAATAACCCATCGAT 69 FBan0030087 FBgn0050087 CG30087 2 2R CG30087 CG30087 "CG8215, CG8215, CG8215, CG8215, CG8215, SP41, CR30087" CDMC23252 2 13 18 DAC29-F22 4-CR31271-RB_2 CR31271 TGGCAAACATGGCATGTCACGGTCCCATTTAACGTGGAAAATCGGCCCAGAAATTCAACACGACGACAA 69 FBan0031271 FBgn0020546 iab-4 3 3R iab-4 iab-4 "domain I, I: Intensifier of Bar, iab: infraabdominal, CR31271, I, iab" CDMC23252 2 14 18 DAC29-F22 4-CR31271-RB_2 CR31271 TGGCAAACATGGCATGTCACGGTCCCATTTAACGTGGAAAATCGGCCCAGAAATTCAACACGACGACAA 69 FBan0031271 FBgn0020546 iab-4 3 3R iab-4 iab-4 "domain I, I: Intensifier of Bar, iab: infraabdominal, CR31271, I, iab" CDMC23253 2 15 18 DAC29-J10 1-CR32009-RA_1 CR32009 AATGAGGAGTTGCCACCTGCCGTTAAATGGCTCTTTGACTTACTTGATGAAGCTGCGCGACGCCATGAT 69 FBan0032009 FBgn0052009 CR32009 4 4 CR32009 CR32009 "CG32009, CG32009" CDMC23253 2 16 18 DAC29-J10 1-CR32009-RA_1 CR32009 AATGAGGAGTTGCCACCTGCCGTTAAATGGCTCTTTGACTTACTTGATGAAGCTGCGCGACGCCATGAT 69 FBan0032009 FBgn0052009 CR32009 4 4 CR32009 CR32009 "CG32009, CG32009" CDMC23254 2 17 18 DAC29-J22 22-CR32489-RA_2 CR32489 AGTGGGGTCAATCCAGTTTGTAAAGAGTGTTAGGATCGAGGGGTTATTTGTATGAATGTCCAGGCAGGT 69 FBan0032489 FBgn0046767 CR32489 3 3L CR32489 CR32489 BcDNA:LD42550 CDMC23254 2 18 18 DAC29-J22 22-CR32489-RA_2 CR32489 AGTGGGGTCAATCCAGTTTGTAAAGAGTGTTAGGATCGAGGGGTTATTTGTATGAATGTCCAGGCAGGT 69 FBan0032489 FBgn0046767 CR32489 3 3L CR32489 CR32489 BcDNA:LD42550 CDMC23255 2 19 18 DAC29-N10 22-CR32934-RA_1 CR32934 TCCTGACAATTAACTTGCAACACTCGCATGCCGGTTGGCTGACGGATATAAAGAAGAAATCTGAGGAGA 69 FBan0032934 FBgn0000281 Cec2 3 3R humoral immune response; GO:0006959 molecular function unknown; GO:0005554; ; GO:0005554 extracellular space; GO:0005615 Cec2 Cecropin 2 "CG32934, CG32924, pseudo-2, CecPsi2, cecropin Psi-2, Cecropin, CR32934, CR32924, cec-Psi2" CDMC23255 2 20 18 DAC29-N10 22-CR32934-RA_1 CR32934 TCCTGACAATTAACTTGCAACACTCGCATGCCGGTTGGCTGACGGATATAAAGAAGAAATCTGAGGAGA 69 FBan0032934 FBgn0000281 Cec2 3 3R humoral immune response; GO:0006959 molecular function unknown; GO:0005554; ; GO:0005554 extracellular space; GO:0005615 Cec2 Cecropin 2 "CG32934, CG32924, pseudo-2, CecPsi2, cecropin Psi-2, Cecropin, CR32934, CR32924, cec-Psi2" CDMC23256 2 21 18 DAC29-N22 17-CR33327-RA_1 CR33327 AGCTATTTATATGTCTACACCTTCGACCGACATCCAGAGAACCCCAACACACACCTCTCACACCCATTT 69 FBan0033327 FBgn0053327 pncr001:3R 3 3R pncr001:3R putative noncoding RNA 001:3R "CR33327, BcDNA:LD11162, putative noncoding RNA 001:3R" CDMC23256 2 22 18 DAC29-N22 17-CR33327-RA_1 CR33327 AGCTATTTATATGTCTACACCTTCGACCGACATCCAGAGAACCCCAACACACACCTCTCACACCCATTT 69 FBan0033327 FBgn0053327 pncr001:3R 3 3R pncr001:3R putative noncoding RNA 001:3R "CR33327, BcDNA:LD11162, putative noncoding RNA 001:3R" CDMC23257 2 23 18 DAC30-B10 2-CG11986-RA_1 CG11986 CCCAGGATGTGAAGCTTTTGCGAATGGCTGGACTTTTTGACGTCTGGGAGGATGAAAGTGGCGACAAGA 69 FBan0011986 FBgn0037656 CG11986 3 3R CG11986 CG11986 CDMC23257 2 24 18 DAC30-B10 2-CG11986-RA_1 CG11986 CCCAGGATGTGAAGCTTTTGCGAATGGCTGGACTTTTTGACGTCTGGGAGGATGAAAGTGGCGACAAGA 69 FBan0011986 FBgn0037656 CG11986 3 3R CG11986 CG11986 CDMC23258 2 25 18 DAC30-B22 3-CG11994-RA_2 CG11994 TGCTCACCTCAACGGTTCCTTGGGCATCAAAAGCCTATGTGATCTTGGCGAGCGATTGTATGGAACCTC 69 FBan0011994 FBgn0037661 Ada 3 3R purine base metabolism; GO:0006144; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0004000 ; EC:3.5.4.4 Ada Adenosine deaminase "CG11994, CG11994, DrosADA, ADA, dADA, Adenosine deaminase" CDMC23258 2 26 18 DAC30-B22 3-CG11994-RA_2 CG11994 TGCTCACCTCAACGGTTCCTTGGGCATCAAAAGCCTATGTGATCTTGGCGAGCGATTGTATGGAACCTC 69 FBan0011994 FBgn0037661 Ada 3 3R purine base metabolism; GO:0006144; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0004000 ; EC:3.5.4.4 Ada Adenosine deaminase "CG11994, CG11994, DrosADA, ADA, dADA, Adenosine deaminase" CDMC23259 2 1 19 DAC30-F10 23-CG12023-RB_2 CG12023 ACCGCCGATACCCGATATGCATTTAGAACTACCTATATATAATTGTACAAGAGATTAAAGCCAGACACC 69 FBgn0035278 CDMC23259 2 2 19 DAC30-F10 23-CG12023-RB_2 CG12023 ACCGCCGATACCCGATATGCATTTAGAACTACCTATATATAATTGTACAAGAGATTAAAGCCAGACACC 69 FBgn0035278 CDMC23260 2 3 19 DAC30-F22 2-CG12028-RA_1 CG12028 TGGCATCGATACCACTTCGTATGCCTCGGCATTTCTGCTCTATCACATAGCACGAAATCCGGAGGTGCA 69 FBan0012028 FBgn0000449 dib 3 3L central nervous system development; GO:0007417; dorsal closure; GO:0007391; ecdysone biosynthesis; GO:0006697; ecdysone metabolism; GO:0008205; electron transport; GO:0006118; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; head involution; GO:0008258; midgut development; GO:0007494 electron transporter activity; GO:0005489; ecdysteroid 22-hydroxylase activity; GO:0042767; ; GO:0005489; ; GO:0005489; ; GO:0042767 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 dib disembodied "CG12028, CG12028, l(3)64Ak, l(3)SH14, l(3)dib, CYP302A1, 302a1, Cyp302a1, disembodied" CDMC23260 2 4 19 DAC30-F22 2-CG12028-RA_1 CG12028 TGGCATCGATACCACTTCGTATGCCTCGGCATTTCTGCTCTATCACATAGCACGAAATCCGGAGGTGCA 69 FBan0012028 FBgn0000449 dib 3 3L central nervous system development; GO:0007417; dorsal closure; GO:0007391; ecdysone biosynthesis; GO:0006697; ecdysone metabolism; GO:0008205; electron transport; GO:0006118; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; head involution; GO:0008258; midgut development; GO:0007494 electron transporter activity; GO:0005489; ecdysteroid 22-hydroxylase activity; GO:0042767; ; GO:0005489; ; GO:0005489; ; GO:0042767 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 dib disembodied "CG12028, CG12028, l(3)64Ak, l(3)SH14, l(3)dib, CYP302A1, 302a1, Cyp302a1, disembodied" CDMC23261 2 5 19 DAC30-J10 23-CG12061-RB_5 CG12061 ATGCCTTGGTCTACCCTGGCTTCTGAAAATTCTTATTTACCAGCAAAAGATCGATATCGACTCCACAGC 69 FBgn0040031 CG12061 cation transport; GO:0006812 "calcium, potassium:sodium antiporter activity; GO:0008273; alpha-type channel activity; GO:0015268; ; GO:0015268; ; GO:0008273" CG12061 CG12061 CG40148 CDMC23261 2 6 19 DAC30-J10 23-CG12061-RB_5 CG12061 ATGCCTTGGTCTACCCTGGCTTCTGAAAATTCTTATTTACCAGCAAAAGATCGATATCGACTCCACAGC 69 FBgn0040031 CG12061 cation transport; GO:0006812 "calcium, potassium:sodium antiporter activity; GO:0008273; alpha-type channel activity; GO:0015268; ; GO:0015268; ; GO:0008273" CG12061 CG12061 CG40148 CDMC23262 2 7 19 DAC30-J22 22-CG12072-RA_1 CG12072 GCTAGCAATGTTAGACCAACTTGTTGAATGCCAAATGAAATTGTTTAGCCCCACGAGGAAAACGCGGGG 69 FBan0012072 FBgn0011739 wts 3 3R "G1/S transition of mitotic cell cycle; GO:0000082; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; eye development (sensu Endopterygota); GO:0007456; imaginal disc growth; GO:0007446; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; negative regulation of cell proliferation; GO:0008285; negative regulation of organ size; GO:0046621; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127; regulation of cell shape; GO:0008360; regulation of imaginal disc growth; GO:0045570; regulation of progression through cell cycle; GO:0000074; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- wts warts "CG12072, CG12072, lats: large tumor suppressor, large tumor suppressor, warts/lats, WTS/LATS, lts, LATS, dmLATS, miracle-gro, Warts, Dlats, l(3)100Aa, lats, warts" CDMC23262 2 8 19 DAC30-J22 22-CG12072-RA_1 CG12072 GCTAGCAATGTTAGACCAACTTGTTGAATGCCAAATGAAATTGTTTAGCCCCACGAGGAAAACGCGGGG 69 FBan0012072 FBgn0011739 wts 3 3R "G1/S transition of mitotic cell cycle; GO:0000082; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; eye development (sensu Endopterygota); GO:0007456; imaginal disc growth; GO:0007446; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; negative regulation of cell proliferation; GO:0008285; negative regulation of organ size; GO:0046621; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127; regulation of cell shape; GO:0008360; regulation of imaginal disc growth; GO:0045570; regulation of progression through cell cycle; GO:0000074; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- wts warts "CG12072, CG12072, lats: large tumor suppressor, large tumor suppressor, warts/lats, WTS/LATS, lts, LATS, dmLATS, miracle-gro, Warts, Dlats, l(3)100Aa, lats, warts" CDMC23263 2 9 19 DAC30-N10 11-CG12112-RA_1 CG12112 TGGAACCGACGCTACCCTCGGAAAAAGTCTTATTCAAAGCCATGAGATGCGTTAAGAATTGCGCAGCCA 69 FBan0012112 FBgn0030048 CG12112 X X CG12112 CG12112 CDMC23263 2 10 19 DAC30-N10 11-CG12112-RA_1 CG12112 TGGAACCGACGCTACCCTCGGAAAAAGTCTTATTCAAAGCCATGAGATGCGTTAAGAATTGCGCAGCCA 69 FBan0012112 FBgn0030048 CG12112 X X CG12112 CG12112 CDMC23264 2 11 19 DAC30-N22 8-CG1211-RA_4 CG1211 GCCCAAGGCATTCGAGACGGGTTTTAAATCACTGCTTGGATGGTTTCCGGGAAAAATCAAGGAGAGGGT 69 FBgn0035191 CDMC23264 2 12 19 DAC30-N22 8-CG1211-RA_4 CG1211 GCCCAAGGCATTCGAGACGGGTTTTAAATCACTGCTTGGATGGTTTCCGGGAAAAATCAAGGAGAGGGT 69 FBgn0035191 CDMC23265 2 13 19 DAC31-B10 2-CG3633-RA_2 CG3633 GCTTCAATGCCTTCTTCCATCCGGTTACTCGCATTTTCTCCGACAACAAGCAGCTCGTGACTCCGG 66 FBan0003633 FBgn0034727 mRpS29 2 2R apoptosis; GO:0006915; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS29 mitochondrial ribosomal protein S29 "CG3633, MRP-S29, DAP3, anon-WO0118547.102, mitochondrial ribosomal protein S29" CDMC23265 2 14 19 DAC31-B10 2-CG3633-RA_2 CG3633 GCTTCAATGCCTTCTTCCATCCGGTTACTCGCATTTTCTCCGACAACAAGCAGCTCGTGACTCCGG 66 FBan0003633 FBgn0034727 mRpS29 2 2R apoptosis; GO:0006915; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS29 mitochondrial ribosomal protein S29 "CG3633, MRP-S29, DAP3, anon-WO0118547.102, mitochondrial ribosomal protein S29" CDMC23266 2 15 19 DAC31-B22 15-CG3825-RA_6 CG3825 TCCTCTTTGTTCTCCGCCTGATTGCAAACATGAGTTCCCCTATCTACGAGCAATATCGGTTCGGGC 66 FBan0003825 FBgn0034948 CG3825 2 2R CG3825 CG3825 CDMC23266 2 16 19 DAC31-B22 15-CG3825-RA_6 CG3825 TCCTCTTTGTTCTCCGCCTGATTGCAAACATGAGTTCCCCTATCTACGAGCAATATCGGTTCGGGC 66 FBan0003825 FBgn0034948 CG3825 2 2R CG3825 CG3825 CDMC23267 2 17 19 DAC31-F10 2-CG4069-RA_2 CG4069 TGCCAGTCCCTCACAGCTGCAGTTCCATCACTACAAGGATCTCTGGAAGTTCGCACTGAAATCCCG 66 FBan0004069 FBgn0036301 CG4069 3 3L CG4069 CG4069 anon-WO0172774.58 CDMC23267 2 18 19 DAC31-F10 2-CG4069-RA_2 CG4069 TGCCAGTCCCTCACAGCTGCAGTTCCATCACTACAAGGATCTCTGGAAGTTCGCACTGAAATCCCG 66 FBan0004069 FBgn0036301 CG4069 3 3L CG4069 CG4069 anon-WO0172774.58 CDMC23268 2 19 19 DAC31-F22 2-CG4297-RB_1 CG4297 AGCATCCGAATCTCCCGATAGATGTGGTTCTGCTCCTACTCCCCGAGAACTAAGTGTCGAGGAGGC 66 FBan0004297 FBgn0031258 CG4297 2 2L CG4297 CG4297 CDMC23268 2 20 19 DAC31-F22 2-CG4297-RB_1 CG4297 AGCATCCGAATCTCCCGATAGATGTGGTTCTGCTCCTACTCCCCGAGAACTAAGTGTCGAGGAGGC 66 FBan0004297 FBgn0031258 CG4297 2 2L CG4297 CG4297 CDMC23269 2 21 19 DAC31-J10 8-CG4799-RA_3 CG4799 TGGAGGTTTACCAAGGCTGGGACTCCTTCTACAGCACAACAAAAGCAACATTGTGAAGGAGGCTGC 66 FBan0004799 FBgn0011823 Pen 2 2L "NLS-bearing substrate import into nucleus; GO:0006607; cell proliferation; GO:0008283; cytoplasmic transport; GO:0016482; cytoplasmic transport, nurse cell to oocyte; GO:0007303; gravitactic behavior; GO:0048062; lymph gland development (sensu Arthropoda); GO:0048542; ovarian ring canal formation; GO:0007301; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; sperm individualization; GO:0007291" protein carrier activity; GO:0008320; ; GO:0008320 actin cytoskeleton; GO:0015629; cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Pen Pendulin "CG4799, l(2)144/1, pen, pen-2, OHO31, Oho31, DPend, oho31, alpha2A-Kap, 2.1, Dimp-alpha2, Kap alpha2, Importin-alpha2, importin alpha2/pendulin, bs29g06.y1, oho-31, Kap-alpha2, importin alpha2, importin-alpha2, imp-alpha2, Pendulum, importin-alpha2, alpha-importin, Imp-alpha2, Importin-alpha2, alpha2, pendulin, imp alpha2, Importin-a2, anon-WO0140519.258, l(2)k14401" CDMC23269 2 22 19 DAC31-J10 8-CG4799-RA_3 CG4799 TGGAGGTTTACCAAGGCTGGGACTCCTTCTACAGCACAACAAAAGCAACATTGTGAAGGAGGCTGC 66 FBan0004799 FBgn0011823 Pen 2 2L "NLS-bearing substrate import into nucleus; GO:0006607; cell proliferation; GO:0008283; cytoplasmic transport; GO:0016482; cytoplasmic transport, nurse cell to oocyte; GO:0007303; gravitactic behavior; GO:0048062; lymph gland development (sensu Arthropoda); GO:0048542; ovarian ring canal formation; GO:0007301; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; sperm individualization; GO:0007291" protein carrier activity; GO:0008320; ; GO:0008320 actin cytoskeleton; GO:0015629; cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Pen Pendulin "CG4799, l(2)144/1, pen, pen-2, OHO31, Oho31, DPend, oho31, alpha2A-Kap, 2.1, Dimp-alpha2, Kap alpha2, Importin-alpha2, importin alpha2/pendulin, bs29g06.y1, oho-31, Kap-alpha2, importin alpha2, importin-alpha2, imp-alpha2, Pendulum, importin-alpha2, alpha-importin, Imp-alpha2, Importin-alpha2, alpha2, pendulin, imp alpha2, Importin-a2, anon-WO0140519.258, l(2)k14401" CDMC23270 2 23 19 DAC31-J22 8-CG4871-RB_2 CG4871 GGCACACTGGAGGATTGGCTCACTAGCGCTGACTACGACCTCTTTTCCAACTACGAGCTGTACAGG 66 FBan0004871 FBgn0035050 ST6Gal 2 2R oligosaccharide metabolism; GO:0009311; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; protein modification; GO:0006464 "beta-galactoside alpha-2,6-sialyltransferase activity; GO:0003835 ; EC:2.4.99.1; ; GO:0003835 ; EC:2.4.99.1; sialyltransferase activity; GO:0008373 ; EC:2.4.99.-; ; GO:0003835 ; EC:2.4.99.1; ; GO:0008373 ; EC:2.4.99.-" Golgi apparatus; GO:0005794; extracellular region; GO:0005576; membrane; GO:0016020 ST6Gal Sialyltransferase "CG4871, CG4871, DmPST, sialyltransferase, dSiaT, sialyltransferase-like, D.SiaT, b-galactoside-a-2,6-sialyltransferase" CDMC23270 2 24 19 DAC31-J22 8-CG4871-RB_2 CG4871 GGCACACTGGAGGATTGGCTCACTAGCGCTGACTACGACCTCTTTTCCAACTACGAGCTGTACAGG 66 FBan0004871 FBgn0035050 ST6Gal 2 2R oligosaccharide metabolism; GO:0009311; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; protein modification; GO:0006464 "beta-galactoside alpha-2,6-sialyltransferase activity; GO:0003835 ; EC:2.4.99.1; ; GO:0003835 ; EC:2.4.99.1; sialyltransferase activity; GO:0008373 ; EC:2.4.99.-; ; GO:0003835 ; EC:2.4.99.1; ; GO:0008373 ; EC:2.4.99.-" Golgi apparatus; GO:0005794; extracellular region; GO:0005576; membrane; GO:0016020 ST6Gal Sialyltransferase "CG4871, CG4871, DmPST, sialyltransferase, dSiaT, sialyltransferase-like, D.SiaT, b-galactoside-a-2,6-sialyltransferase" CDMC23271 2 25 19 DAC31-N10 3-CG5147-RA_8 CG5147 ACCCAAGGGCAGTGTACTACGGCAGCTGGAAGAAGGGCAGATCGGCAAGATTCTGAGGTACAAATC 66 FBan0005147 FBgn0036775 CG5147 3 3L tRNA metabolism; GO:0006399; transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 CG5147 CG5147 CDMC23271 2 26 19 DAC31-N10 3-CG5147-RA_8 CG5147 ACCCAAGGGCAGTGTACTACGGCAGCTGGAAGAAGGGCAGATCGGCAAGATTCTGAGGTACAAATC 66 FBan0005147 FBgn0036775 CG5147 3 3L tRNA metabolism; GO:0006399; transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 CG5147 CG5147 CDMC23272 2 1 20 DAC31-N22 3-CG5336-RA_1 CG5336 AACCTGGCCTTTTCCATCACCTTCGAAAACATGGAGCACTCTACGTTGGACTTTGTGGCACCCGAC 66 FBan0005336 FBgn0032409 Ced-12 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; cell migration; GO:0016477; phagocytosis; GO:0006909 cytoskeleton; GO:0005856 Ced-12 Ced-12 "CG5336, CG5336, Dced-12, ELMO" CDMC23272 2 2 20 DAC31-N22 3-CG5336-RA_1 CG5336 AACCTGGCCTTTTCCATCACCTTCGAAAACATGGAGCACTCTACGTTGGACTTTGTGGCACCCGAC 66 FBan0005336 FBgn0032409 Ced-12 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; cell migration; GO:0016477; phagocytosis; GO:0006909 cytoskeleton; GO:0005856 Ced-12 Ced-12 "CG5336, CG5336, Dced-12, ELMO" CDMC23273 2 3 20 DAC32-B10 3-CG11137-RA_1 CG11137 CCGATTGGTTGGCATTTGTCCAGCCTCAGACACGCCTGGAATATTACGGCGGAGGAATTTCGTTTGTCT 69 FBan0011137 FBgn0037199 CG11137 3 3L CG11137 CG11137 "CT31141, BcDNA:LD31024" CDMC23273 2 4 20 DAC32-B10 3-CG11137-RA_1 CG11137 CCGATTGGTTGGCATTTGTCCAGCCTCAGACACGCCTGGAATATTACGGCGGAGGAATTTCGTTTGTCT 69 FBan0011137 FBgn0037199 CG11137 3 3L CG11137 CG11137 "CT31141, BcDNA:LD31024" CDMC23274 2 5 20 DAC32-B22 14-CG11146-RA_1 CG11146 TCTGCGTGGTCTCAATAGCAACAAGGAGCTAAACATGAATCTCAGCCAGGGATATGTCACTGCTGTGGA 69 FBan0011146 FBgn0030397 CG11146 X X intracellular signaling cascade; GO:0007242 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG11146 CG11146 CDMC23274 2 6 20 DAC32-B22 14-CG11146-RA_1 CG11146 TCTGCGTGGTCTCAATAGCAACAAGGAGCTAAACATGAATCTCAGCCAGGGATATGTCACTGCTGTGGA 69 FBan0011146 FBgn0030397 CG11146 X X intracellular signaling cascade; GO:0007242 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG11146 CG11146 CDMC23275 2 7 20 DAC32-F10 6-CG11180-RA_2 CG11180 GGCTACGGAATCAGCGAAAACGTCGAGCTAAATGTGGTGGACTGTCCTTACGATGAAACGCGCATTCGC 69 FBan0011180 FBgn0034528 CG11180 2 2R CG11180 CG11180 CDMC23275 2 8 20 DAC32-F10 6-CG11180-RA_2 CG11180 GGCTACGGAATCAGCGAAAACGTCGAGCTAAATGTGGTGGACTGTCCTTACGATGAAACGCGCATTCGC 69 FBan0011180 FBgn0034528 CG11180 2 2R CG11180 CG11180 CDMC23276 2 9 20 DAC32-F22 22-CG11199-RB_1 CG11199 GGGGCAGGACGAAAAACAGACAACAAAGGCAACCTACAACAATAATAACGTAAAGACCAGGGGCAAAGT 69 FBan0011199 FBgn0046704 Liprin-alpha 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; synaptogenesis; GO:0007416 receptor binding; GO:0005102; ; GO:0005102 synapse; GO:0045202 Liprin-alpha Liprin-alpha "CG11199, CG11199, CG11199, LIP.1, LAR-interacting protein 1, Liprin-alpha, DLiprin, oos, out of step, Dliprin-alpha, dliprin-alpha, Dliprin, liprin-alpha, LIP1" CDMC23276 2 10 20 DAC32-F22 22-CG11199-RB_1 CG11199 GGGGCAGGACGAAAAACAGACAACAAAGGCAACCTACAACAATAATAACGTAAAGACCAGGGGCAAAGT 69 FBan0011199 FBgn0046704 Liprin-alpha 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; synaptogenesis; GO:0007416 receptor binding; GO:0005102; ; GO:0005102 synapse; GO:0045202 Liprin-alpha Liprin-alpha "CG11199, CG11199, CG11199, LIP.1, LAR-interacting protein 1, Liprin-alpha, DLiprin, oos, out of step, Dliprin-alpha, dliprin-alpha, Dliprin, liprin-alpha, LIP1" CDMC23277 2 11 20 DAC32-J10 23-CG11255-RA_1 CG11255 ACACTCAGACACATACAAAAGCATACACATGTGAAATGACATGAACAAATAGAGAGAGTGAGGCTTGTG 69 FBan0011255 FBgn0036337 CG11255 3 3L "carbohydrate metabolism; GO:0005975; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine ribonucleoside salvage; GO:0006166" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; carbohydrate kinase activity; GO:0019200; ; GO:0019201; ; GO:0019200; ; GO:0004001 ; EC:2.7.1.20 CG11255 CG11255 CDMC23277 2 12 20 DAC32-J10 23-CG11255-RA_1 CG11255 ACACTCAGACACATACAAAAGCATACACATGTGAAATGACATGAACAAATAGAGAGAGTGAGGCTTGTG 69 FBan0011255 FBgn0036337 CG11255 3 3L "carbohydrate metabolism; GO:0005975; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine ribonucleoside salvage; GO:0006166" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; carbohydrate kinase activity; GO:0019200; ; GO:0019201; ; GO:0019200; ; GO:0004001 ; EC:2.7.1.20 CG11255 CG11255 CDMC23278 2 13 20 DAC32-J22 3-CG11263-RA_3 CG11263 GCCCAGTTTTTACGGACGACATCACCCCACGTCTATTTTGGTGGTAGCCACGTGCAATGGAACGTACAT 69 FBan0011263 FBgn0036330 CG11263 3 3L CG11263 CG11263 CDMC23278 2 14 20 DAC32-J22 3-CG11263-RA_3 CG11263 GCCCAGTTTTTACGGACGACATCACCCCACGTCTATTTTGGTGGTAGCCACGTGCAATGGAACGTACAT 69 FBan0011263 FBgn0036330 CG11263 3 3L CG11263 CG11263 CDMC23279 2 15 20 DAC32-N10 21-CG11298-RA_2 CG11298 GAGGATCCTGTGCGGAGTGATCCCCCCAGTGGACTGCATCGCAAGTATCGCCCATTTCCGACCCGCCCC 69 FBan0011298 FBgn0034721 CG11298 2 2R CG11298 CG11298 BcDNA:AT10824 CDMC23279 2 16 20 DAC32-N10 21-CG11298-RA_2 CG11298 GAGGATCCTGTGCGGAGTGATCCCCCCAGTGGACTGCATCGCAAGTATCGCCCATTTCCGACCCGCCCC 69 FBan0011298 FBgn0034721 CG11298 2 2R CG11298 CG11298 BcDNA:AT10824 CDMC23280 2 17 20 DAC32-N22 17-CG11310-RA_1 CG11310 TGATGTCGTTCGGCAAGATTGTGGTATTCCTGGTCCTAGTCCTAGTTCAACTAATCCATTGTACGCGCT 69 FBan0011310 FBgn0037067 CG11310 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG11310 CG11310 CDMC23280 2 18 20 DAC32-N22 17-CG11310-RA_1 CG11310 TGATGTCGTTCGGCAAGATTGTGGTATTCCTGGTCCTAGTCCTAGTTCAACTAATCCATTGTACGCGCT 69 FBan0011310 FBgn0037067 CG11310 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG11310 CG11310 CDMC23281 2 19 20 DAC33-B10 3-CG12584-RA_1 CG12584 CCCAATCGGACACTTCAGAAACCAGTCCCCAATTTGATTTTGTGGTGCTGGACATCGTTAGGGACGCCC 69 FBan0012584 FBgn0037257 CG12584 3 3R CG12584 CG12584 CDMC23281 2 20 20 DAC33-B10 3-CG12584-RA_1 CG12584 CCCAATCGGACACTTCAGAAACCAGTCCCCAATTTGATTTTGTGGTGCTGGACATCGTTAGGGACGCCC 69 FBan0012584 FBgn0037257 CG12584 3 3R CG12584 CG12584 CDMC23282 2 21 20 DAC33-B22 23-CG12593-RA_2 CG12593 TTGAAAAAAATCGAAAAAAATGGGTTGAAAACATTTTGATGCAAATATTAGATGGCAAGTGTCCTGGAT 69 FBgn0037909 CDMC23282 2 22 20 DAC33-B22 23-CG12593-RA_2 CG12593 TTGAAAAAAATCGAAAAAAATGGGTTGAAAACATTTTGATGCAAATATTAGATGGCAAGTGTCCTGGAT 69 FBgn0037909 CDMC23283 2 23 20 DAC33-F10 1-CG12640-RA_1 CG12640 CGCCACAAACCCACAACCAGAACCAGTACCAGTACCAGAATCACAGCCTGAATCCGAGTCCGAATCAGA 69 FBan0012640 FBgn0030202 CG12640 X X ATP binding; GO:0005524; ; GO:0005524 CG12640 CG12640 CDMC23283 2 24 20 DAC33-F10 1-CG12640-RA_1 CG12640 CGCCACAAACCCACAACCAGAACCAGTACCAGTACCAGAATCACAGCCTGAATCCGAGTCCGAATCAGA 69 FBan0012640 FBgn0030202 CG12640 X X ATP binding; GO:0005524; ; GO:0005524 CG12640 CG12640 CDMC23284 2 25 20 DAC33-F22 23-CG12660-RA_2 CG12660 TGCAAGTCTAACTCTTGGTTGGCCAAACAAATCTACAATAAAATTATATTTCGTGTGTGTGACAAAAAA 69 FBan0012660 FBgn0030069 CG12660 X X CG12660 CG12660 CDMC23284 2 26 20 DAC33-F22 23-CG12660-RA_2 CG12660 TGCAAGTCTAACTCTTGGTTGGCCAAACAAATCTACAATAAAATTATATTTCGTGTGTGTGACAAAAAA 69 FBan0012660 FBgn0030069 CG12660 X X CG12660 CG12660 CDMC23285 2 1 21 DAC33-J10 3-CG12697-RA_4 CG12697 GCCTTCGATGCACAGAACAAGCCGTTTCCCTACAAGATGATCTTTCCGTACGATGCCCAGAGCAGTTGG 69 FBan0012697 FBgn0030715 Or13a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or13a Odorant receptor 13a "CG12697, 13F.1, DOR38, 13a" CDMC23285 2 2 21 DAC33-J10 3-CG12697-RA_4 CG12697 GCCTTCGATGCACAGAACAAGCCGTTTCCCTACAAGATGATCTTTCCGTACGATGCCCAGAGCAGTTGG 69 FBan0012697 FBgn0030715 Or13a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or13a Odorant receptor 13a "CG12697, 13F.1, DOR38, 13a" CDMC23286 2 3 21 DAC33-J22 33-CG12717-RA_12 CG12717 CGGATCCGGACAAAGGAAGTGCCAGGATGTTGATTATCTACAGCAGTGGAAAGCAGCACATCGTCACCT 69 FBan0012717 FBgn0030420 CG12717 X X CG12717 CG12717 CDMC23286 2 4 21 DAC33-J22 33-CG12717-RA_12 CG12717 CGGATCCGGACAAAGGAAGTGCCAGGATGTTGATTATCTACAGCAGTGGAAAGCAGCACATCGTCACCT 69 FBan0012717 FBgn0030420 CG12717 X X CG12717 CG12717 CDMC23287 2 5 21 DAC33-N10 16-CG1275-RB_1 CG1275 ACGAAACCGAACCTGATCACACGGATGGTGCTTTCTTAGTGATGGAGATGGAGATTCGTCAAGATGAGT 69 FBan0001275 FBgn0035321 CG1275 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 integral to membrane; GO:0016021; transport vesicle; GO:0030133 CG1275 CG1275 anon-WO0118547.260 CDMC23287 2 6 21 DAC33-N10 16-CG1275-RB_1 CG1275 ACGAAACCGAACCTGATCACACGGATGGTGCTTTCTTAGTGATGGAGATGGAGATTCGTCAAGATGAGT 69 FBan0001275 FBgn0035321 CG1275 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 integral to membrane; GO:0016021; transport vesicle; GO:0030133 CG1275 CG1275 anon-WO0118547.260 CDMC23288 2 7 21 DAC33-N22 3-CG12772-RA_2 CG12772 TGGTCCATGTGCGATTTCGTTGACGTGCAAAATACCAGCATGAATCGCTCCATCAAGGAGGTGATCGCA 69 FBan0012772 FBgn0030055 CG12772 X X CG12772 CG12772 CDMC23288 2 8 21 DAC33-N22 3-CG12772-RA_2 CG12772 TGGTCCATGTGCGATTTCGTTGACGTGCAAAATACCAGCATGAATCGCTCCATCAAGGAGGTGATCGCA 69 FBan0012772 FBgn0030055 CG12772 X X CG12772 CG12772 CDMC23289 2 9 21 DAC34-B10 14-CG4346-RA_1 CG4346 AGCGTGTGAGCAACGACTCCCTCATCATGATATACTATCACGATCTGACCATAGCCGTAACGGAGCTGG 69 FBgn0030450 CDMC23289 2 10 21 DAC34-B10 14-CG4346-RA_1 CG4346 AGCGTGTGAGCAACGACTCCCTCATCATGATATACTATCACGATCTGACCATAGCCGTAACGGAGCTGG 69 FBgn0030450 CDMC23290 2 11 21 DAC34-B22 17-CG4354-RA_1 CG4354 AGCAAATCTCTAGTTCGTAAGTCGGAGAATCAAGCATCGCTTTACCTGCACAATCCCCAGAGGAAAGCC 69 FBan0004354 FBgn0005638 slbo 2 2R "border follicle cell migration (sensu Insecta); GO:0007298; cell fate specification; GO:0001708; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; protein heterodimerization activity; GO:0046982; ; GO:0030528; ; GO:0046982 nucleus; GO:0005634 slbo slow border cells "CG4354, C/EBP, DmC/EBP, CCAAT/enhancer binding protein, DC/EBP, slobo, Dm-c/EBP, fs(2)7, fs(2)8, fs(2)ry7, fs(2)ry8, slow border cells" CDMC23290 2 12 21 DAC34-B22 17-CG4354-RA_1 CG4354 AGCAAATCTCTAGTTCGTAAGTCGGAGAATCAAGCATCGCTTTACCTGCACAATCCCCAGAGGAAAGCC 69 FBan0004354 FBgn0005638 slbo 2 2R "border follicle cell migration (sensu Insecta); GO:0007298; cell fate specification; GO:0001708; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; protein heterodimerization activity; GO:0046982; ; GO:0030528; ; GO:0046982 nucleus; GO:0005634 slbo slow border cells "CG4354, C/EBP, DmC/EBP, CCAAT/enhancer binding protein, DC/EBP, slobo, Dm-c/EBP, fs(2)7, fs(2)8, fs(2)ry7, fs(2)ry8, slow border cells" CDMC23291 2 13 21 DAC34-F10 22-CG4386-RA_1 CG4386 CCGAGGTGATCACGCATCCCAAGTATAATGCCCGGAACTATGACAACGATATAGCCATCATCAAGTTGG 69 FBan0004386 FBgn0034661 CG4386 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4386 CG4386 SP17 CDMC23291 2 14 21 DAC34-F10 22-CG4386-RA_1 CG4386 CCGAGGTGATCACGCATCCCAAGTATAATGCCCGGAACTATGACAACGATATAGCCATCATCAAGTTGG 69 FBan0004386 FBgn0034661 CG4386 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4386 CG4386 SP17 CDMC23292 2 15 21 DAC34-F22 14-CG4407-RA_1 CG4407 CTGTCGCCGTAACTCATCAGTTAAATGTGCGCCAGTAAACAGTCGATGCAGCAACGAAACACATGAGCT 69 FBan0004407 FBgn0030431 CG4407 X X metabolism; GO:0008152 FMN adenylyltransferase activity; GO:0003919 ; EC:2.7.7.2; ; GO:0003919 ; EC:2.7.7.2 CG4407 CG4407 CDMC23292 2 16 21 DAC34-F22 14-CG4407-RA_1 CG4407 CTGTCGCCGTAACTCATCAGTTAAATGTGCGCCAGTAAACAGTCGATGCAGCAACGAAACACATGAGCT 69 FBan0004407 FBgn0030431 CG4407 X X metabolism; GO:0008152 FMN adenylyltransferase activity; GO:0003919 ; EC:2.7.7.2; ; GO:0003919 ; EC:2.7.7.2 CG4407 CG4407 CDMC23293 2 17 21 DAC34-J10 1-CG4439-RA_1 CG4439 GGCAGCCGCACTATCGTTGCCTATTAATGTGTCCGCCGTATTACCCCTGTGTGAAAATATGCCATCGGG 69 FBan0004439 FBgn0034132 CG4439 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1 intracellular; GO:0005622 CG4439 CG4439 anon-WO0140519.41 CDMC23293 2 18 21 DAC34-J10 1-CG4439-RA_1 CG4439 GGCAGCCGCACTATCGTTGCCTATTAATGTGTCCGCCGTATTACCCCTGTGTGAAAATATGCCATCGGG 69 FBan0004439 FBgn0034132 CG4439 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1 intracellular; GO:0005622 CG4439 CG4439 anon-WO0140519.41 CDMC23294 2 19 21 DAC34-J22 18-CG4451-RA_5 CG4451 AGCGTCGCATCGAGAAGCTAAACAGTCTGGACATTGAGCTGTATGCCTTTGCCAAGACTTTGCTCTTTC 69 FBan0004451 FBgn0038755 Hs6st 3 3R fibroblast growth factor receptor signaling pathway; GO:0008543; heparan sulfate proteoglycan biosynthesis; GO:0015012; primary tracheal branching (sensu Insecta); GO:0007428 heparan sulfate 6-O-sulfotransferase activity; GO:0017095 ; EC:2.8.2.-; ; GO:0017095 ; EC:2.8.2.- Hs6st Heparan sulfate 6-O-sulfotransferase "CG17188, CG4451, CG11683, CG18533, CG17188, dHS6ST, DmHs6st, Heparan sulfate 6-O-sulfotransferase" CDMC23294 2 20 21 DAC34-J22 18-CG4451-RA_5 CG4451 AGCGTCGCATCGAGAAGCTAAACAGTCTGGACATTGAGCTGTATGCCTTTGCCAAGACTTTGCTCTTTC 69 FBan0004451 FBgn0038755 Hs6st 3 3R fibroblast growth factor receptor signaling pathway; GO:0008543; heparan sulfate proteoglycan biosynthesis; GO:0015012; primary tracheal branching (sensu Insecta); GO:0007428 heparan sulfate 6-O-sulfotransferase activity; GO:0017095 ; EC:2.8.2.-; ; GO:0017095 ; EC:2.8.2.- Hs6st Heparan sulfate 6-O-sulfotransferase "CG17188, CG4451, CG11683, CG18533, CG17188, dHS6ST, DmHs6st, Heparan sulfate 6-O-sulfotransferase" CDMC23295 2 21 21 DAC34-N10 9-CG4486-RA_1 CG4486 CCAAGGACCATCAAGGATCTGTGGGGATCAGCGAGTGGATTCAATTTTACGCCTAGGTCCGGATTCTGG 69 FBan0004486 FBgn0015039 Cyp9b2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9b2 Cytochrome P450-9b2 "CG4486, P450, P-450, fly plexin a, 9b2, cyp9b2, BEST:GH08116" CDMC23295 2 22 21 DAC34-N10 9-CG4486-RA_1 CG4486 CCAAGGACCATCAAGGATCTGTGGGGATCAGCGAGTGGATTCAATTTTACGCCTAGGTCCGGATTCTGG 69 FBan0004486 FBgn0015039 Cyp9b2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9b2 Cytochrome P450-9b2 "CG4486, P450, P-450, fly plexin a, 9b2, cyp9b2, BEST:GH08116" CDMC23296 2 23 21 DAC34-N22 3-CG4510-RA_2 CG4510 CCAGGCGGAGATCGTGAAATGTCTGCGGGAGGAGTATGAAATCGAACACAACAAGGATCAGAAGCCGGA 69 FBan0004510 FBgn0038746 Surf6 3 3R cytochrome c oxidase complex assembly; GO:0008535; ribosome biogenesis; GO:0007046 heme transporter activity; GO:0015232; ; GO:0015232 nucleolus; GO:0005730 Surf6 Surfeit 6 "CG4510, Surfeit 6" CDMC23296 2 24 21 DAC34-N22 3-CG4510-RA_2 CG4510 CCAGGCGGAGATCGTGAAATGTCTGCGGGAGGAGTATGAAATCGAACACAACAAGGATCAGAAGCCGGA 69 FBan0004510 FBgn0038746 Surf6 3 3R cytochrome c oxidase complex assembly; GO:0008535; ribosome biogenesis; GO:0007046 heme transporter activity; GO:0015232; ; GO:0015232 nucleolus; GO:0005730 Surf6 Surfeit 6 "CG4510, Surfeit 6" CDMC23297 2 25 21 DAC35-B10 1-CG8806-RA_1 CG8806 GGCTCCGGGAGTTAAGGAGTTTGTGGATTTGACCAGGACGGAATTAGAATGACGAGCGGAGGAGTCGTG 69 FBan0008806 FBgn0033413 prel 2 2R development; GO:0007275; hemopoiesis; GO:0030097; mesoderm development; GO:0007498 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrion; GO:0005739 prel preli-like "CG8806, CG8806, BcDNA:LD36516, preli-like" CDMC23297 2 26 21 DAC35-B10 1-CG8806-RA_1 CG8806 GGCTCCGGGAGTTAAGGAGTTTGTGGATTTGACCAGGACGGAATTAGAATGACGAGCGGAGGAGTCGTG 69 FBan0008806 FBgn0033413 prel 2 2R development; GO:0007275; hemopoiesis; GO:0030097; mesoderm development; GO:0007498 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrion; GO:0005739 prel preli-like "CG8806, CG8806, BcDNA:LD36516, preli-like" CDMC23298 2 1 22 DAC35-B22 23-CG8815-RA_20 CG8815 CATGGCCAGATTCTTCATTCACATGACGACAATGAGAAGATGTGGGATGAATTGCCTGCATTGAAATAA 69 FBan0008815 FBgn0022764 Sin3A 2 2R "ATP synthesis coupled proton transport; GO:0015986; negative regulation of transcription; GO:0016481; negative regulation of transcription, DNA-dependent; GO:0045892; peripheral nervous system development; GO:0007422; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" "chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription factor activity; GO:0003702; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0003702; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0003712; ; GO:0019213; ; GO:0016564; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" Sin3 complex; GO:0016580; chromatin; GO:0000785; euchromatin; GO:0000791; nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 Sin3A Sin3A "CG8815, CG8815, CG8815, ld, 159A11T, ES2-3, Enhancer of GMR-sina 2-3, 27/3, 97/15, dSin3, dSin3A, sin3, Sin3, EY2-9, SIN3, Sin 3A, ESTS:159A11T, l(2)08269, l(2)k02703, l(2)k05415, l(2)k09715, sni3" CDMC23298 2 2 22 DAC35-B22 23-CG8815-RA_20 CG8815 CATGGCCAGATTCTTCATTCACATGACGACAATGAGAAGATGTGGGATGAATTGCCTGCATTGAAATAA 69 FBan0008815 FBgn0022764 Sin3A 2 2R "ATP synthesis coupled proton transport; GO:0015986; negative regulation of transcription; GO:0016481; negative regulation of transcription, DNA-dependent; GO:0045892; peripheral nervous system development; GO:0007422; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" "chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription factor activity; GO:0003702; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0003702; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0003712; ; GO:0019213; ; GO:0016564; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" Sin3 complex; GO:0016580; chromatin; GO:0000785; euchromatin; GO:0000791; nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 Sin3A Sin3A "CG8815, CG8815, CG8815, ld, 159A11T, ES2-3, Enhancer of GMR-sina 2-3, 27/3, 97/15, dSin3, dSin3A, sin3, Sin3, EY2-9, SIN3, Sin 3A, ESTS:159A11T, l(2)08269, l(2)k02703, l(2)k05415, l(2)k09715, sni3" CDMC23299 2 3 22 DAC35-F10 2-CG8849-RA_2 CG8849 CGGTATCATTATCAAGTCCGAGGCACCTTTGCACGTCACCAAGGACATTCGTCTGGTTGACCCATCGGA 69 FBan0008849 FBgn0031651 mRpL24 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL24 mitochondrial ribosomal protein L24 "CG8849, CG8849, L24, mitochondrial ribosomal protein L24" CDMC23299 2 4 22 DAC35-F10 2-CG8849-RA_2 CG8849 CGGTATCATTATCAAGTCCGAGGCACCTTTGCACGTCACCAAGGACATTCGTCTGGTTGACCCATCGGA 69 FBan0008849 FBgn0031651 mRpL24 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL24 mitochondrial ribosomal protein L24 "CG8849, CG8849, L24, mitochondrial ribosomal protein L24" CDMC23300 2 5 22 DAC35-F22 9-CG8858-RA_5 CG8858 CGAGCAGCCAGGAAATCGCTCCATTGCACTTACCATTCAGTCCATTAACAAGCGTCACCATGAACTGCT 69 FBan0008858 FBgn0033698 CG8858 2 2R protein catabolism; GO:0030163 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome complex (sensu Eukaryota); GO:0000502 CG8858 CG8858 CDMC23300 2 6 22 DAC35-F22 9-CG8858-RA_5 CG8858 CGAGCAGCCAGGAAATCGCTCCATTGCACTTACCATTCAGTCCATTAACAAGCGTCACCATGAACTGCT 69 FBan0008858 FBgn0033698 CG8858 2 2R protein catabolism; GO:0030163 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome complex (sensu Eukaryota); GO:0000502 CG8858 CG8858 CDMC23301 2 7 22 DAC35-J10 2-CG8902-RA_4 CG8902 GCCACGCTGAGCTACCTTTTCAACCATCTGGCCTACTACAAGGTGTTCAAAAAGAAGGTGCTGGGACCT 69 FBan0008902 FBgn0031886 CG8902 2 2L immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8902 CG8902 "l(2)SH2 2276, anon-WO0118547.214" CDMC23301 2 8 22 DAC35-J10 2-CG8902-RA_4 CG8902 GCCACGCTGAGCTACCTTTTCAACCATCTGGCCTACTACAAGGTGTTCAAAAAGAAGGTGCTGGGACCT 69 FBan0008902 FBgn0031886 CG8902 2 2L immune response; GO:0006955 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8902 CG8902 "l(2)SH2 2276, anon-WO0118547.214" CDMC23302 2 9 22 DAC35-J22 2-CG8915-RA_2 CG8915 TCCAGCTCCATAAAGTGCGAATGCTAACGGATCGTGAATTCGCCAAGTTGGTAGCGACGCGGAAGCTTA 69 FBan0008915 FBgn0030833 CG8915 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG8915 CG8915 cg8915 CDMC23302 2 10 22 DAC35-J22 2-CG8915-RA_2 CG8915 TCCAGCTCCATAAAGTGCGAATGCTAACGGATCGTGAATTCGCCAAGTTGGTAGCGACGCGGAAGCTTA 69 FBan0008915 FBgn0030833 CG8915 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG8915 CG8915 cg8915 CDMC23303 2 11 22 DAC35-N10 11-CG8953-RA_1 CG8953 GCGCCATCATCCACTCCTATCTTCCCGACCTCATTGACAAAACATACCTCGCCAAAAAGAAGCCCGAAG 69 FBan0008953 FBgn0015008 Actn3 3 3R actin filament bundle formation; GO:0051017 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; ; GO:0005509; actin filament binding; GO:0051015; ; GO:0051015 Actn3 alpha actinin 3 "CG8953, CG8953, CG8953, ORF1, alpha-actinin-like, open reading frame 1, dabp, acta-3" CDMC23303 2 12 22 DAC35-N10 11-CG8953-RA_1 CG8953 GCGCCATCATCCACTCCTATCTTCCCGACCTCATTGACAAAACATACCTCGCCAAAAAGAAGCCCGAAG 69 FBan0008953 FBgn0015008 Actn3 3 3R actin filament bundle formation; GO:0051017 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; ; GO:0005509; actin filament binding; GO:0051015; ; GO:0051015 Actn3 alpha actinin 3 "CG8953, CG8953, CG8953, ORF1, alpha-actinin-like, open reading frame 1, dabp, acta-3" CDMC23304 2 13 22 DAC35-N22 18-CG8962-RA_1 CG8962 ACCACTCTACGATCTGCTTTCTCAAATTCTCAACGAAAACGAACCTGAAAACGATCTCACCCCCTCCGA 69 FBan0008962 FBgn0025809 Paf-AHalpha X X phospholipid metabolism; GO:0006644 1-alkyl-2-acetylglycerophosphocholine esterase activity; GO:0003847 ; EC:3.1.1.47; ; GO:0003847 ; EC:3.1.1.47; ; GO:0003847 ; EC:3.1.1.47 Paf-AHalpha Platelet-activating factor acetylhydrolase alpha "CG8962, platelet-activating factor acetylhydrolase alpha subunit homolog"", AAC83820, PAFAHalpha" CDMC23304 2 14 22 DAC35-N22 18-CG8962-RA_1 CG8962 ACCACTCTACGATCTGCTTTCTCAAATTCTCAACGAAAACGAACCTGAAAACGATCTCACCCCCTCCGA 69 FBan0008962 FBgn0025809 Paf-AHalpha X X phospholipid metabolism; GO:0006644 1-alkyl-2-acetylglycerophosphocholine esterase activity; GO:0003847 ; EC:3.1.1.47; ; GO:0003847 ; EC:3.1.1.47; ; GO:0003847 ; EC:3.1.1.47 Paf-AHalpha Platelet-activating factor acetylhydrolase alpha "CG8962, platelet-activating factor acetylhydrolase alpha subunit homolog"", AAC83820, PAFAHalpha" CDMC23305 2 15 22 DAC36-B10 12-CG7053-RA_2 CG7053 CCTCCATGGGTAACGCCATGAAGAAGATCATCAAGGAAACGCTCGCAATGTGACGGGCTGTCGGG 65 FBan0007053 FBgn0030960 CG7053 X X CG7053 CG7053 CDMC23305 2 16 22 DAC36-B10 12-CG7053-RA_2 CG7053 CCTCCATGGGTAACGCCATGAAGAAGATCATCAAGGAAACGCTCGCAATGTGACGGGCTGTCGGG 65 FBan0007053 FBgn0030960 CG7053 X X CG7053 CG7053 CDMC23306 2 17 22 DAC36-B22 3-CG7074-RA_1 CG7074 GGGCAGCCATGATCTGCGTGTTCCACTTGAAAATTTTCCATGCCTGCAACATCCTATCGTCGGCG 65 FBan0007074 FBgn0031399 mio 2 2L maintenance of oocyte identity (sensu Insecta); GO:0016350; oocyte fate determination; GO:0030716; protein folding; GO:0006457; regulation of meiosis; GO:0040020 unfolded protein binding; GO:0051082; ; GO:0051082 mio missing oocyte "CG7074, CG15384, missing oocyte" CDMC23306 2 18 22 DAC36-B22 3-CG7074-RA_1 CG7074 GGGCAGCCATGATCTGCGTGTTCCACTTGAAAATTTTCCATGCCTGCAACATCCTATCGTCGGCG 65 FBan0007074 FBgn0031399 mio 2 2L maintenance of oocyte identity (sensu Insecta); GO:0016350; oocyte fate determination; GO:0030716; protein folding; GO:0006457; regulation of meiosis; GO:0040020 unfolded protein binding; GO:0051082; ; GO:0051082 mio missing oocyte "CG7074, CG15384, missing oocyte" CDMC23307 2 19 22 DAC36-F10 2-CG7211-RA_1 CG7211 GAAGGGGCAGCTAAAGAAGTCCGGACTTTCCCAAGTGACAGTCGCTGAGGCCTGGCTAAATGTTC 65 FBan0007211 FBgn0031941 CG7211 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG7211 CG7211 CDMC23307 2 20 22 DAC36-F10 2-CG7211-RA_1 CG7211 GAAGGGGCAGCTAAAGAAGTCCGGACTTTCCCAAGTGACAGTCGCTGAGGCCTGGCTAAATGTTC 65 FBan0007211 FBgn0031941 CG7211 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG7211 CG7211 CDMC23308 2 21 22 DAC36-F22 2-CG7241-RA_1 CG7241 CGACATGCTGGATCTGATCCGCAACGGTCCAAAGTATCCGCATGAGCACGAGATGGTGAAATCCG 65 FBan0007241 FBgn0038095 Cyp304a1 3 3R electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp304a1 Cyp304a1 "CG7241, 304a1, CYP304A1-Dm, BcDNA:LP06355" CDMC23308 2 22 22 DAC36-F22 2-CG7241-RA_1 CG7241 CGACATGCTGGATCTGATCCGCAACGGTCCAAAGTATCCGCATGAGCACGAGATGGTGAAATCCG 65 FBan0007241 FBgn0038095 Cyp304a1 3 3R electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp304a1 Cyp304a1 "CG7241, 304a1, CYP304A1-Dm, BcDNA:LP06355" CDMC23309 2 23 22 DAC36-J10 2-CG7324-RA_1 CG7324 TCCTGCACCAGAACCCATTGGCACTACCCGTCTATTTGTGGCTCTAGAAGAGGAGCTTCGTCAGG 65 FBan0007324 FBgn0037074 CG7324 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; regulation of progression through cell cycle; GO:0000074 Rab GTPase activator activity; GO:0005097; ; GO:0005097 CG7324 CG7324 CDMC23309 2 24 22 DAC36-J10 2-CG7324-RA_1 CG7324 TCCTGCACCAGAACCCATTGGCACTACCCGTCTATTTGTGGCTCTAGAAGAGGAGCTTCGTCAGG 65 FBan0007324 FBgn0037074 CG7324 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; regulation of progression through cell cycle; GO:0000074 Rab GTPase activator activity; GO:0005097; ; GO:0005097 CG7324 CG7324 CDMC23310 2 25 22 DAC36-J22 15-CG7368-RA_1 CG7368 GCAGACGGGACCAGCCATTGGGATCAACACCCTGGGCACGACAACCATTAGTATACCTCAGCAGG 65 FBan0007368 FBgn0036179 CG7368 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7368 CG7368 CDMC23310 2 26 22 DAC36-J22 15-CG7368-RA_1 CG7368 GCAGACGGGACCAGCCATTGGGATCAACACCCTGGGCACGACAACCATTAGTATACCTCAGCAGG 65 FBan0007368 FBgn0036179 CG7368 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7368 CG7368 CDMC23311 2 1 23 DAC36-N10 2-CG7434-RA_1 CG7434 GTGGTTTTCGACTGACAAGATGGCTCCTACCGCCAAGACCAACAAGGGTGATACCAAGACCGCTG 65 FBan0007434 FBgn0015288 RpL22 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL22 Ribosomal protein L22 "CG7434, CG7434, L22, RL22, PBP-12, PARP-binding protein-12, Rpl22, rpl22, EG:BACR19J1.4, rpL22, anon-EST:Posey53" CDMC23311 2 2 23 DAC36-N10 2-CG7434-RA_1 CG7434 GTGGTTTTCGACTGACAAGATGGCTCCTACCGCCAAGACCAACAAGGGTGATACCAAGACCGCTG 65 FBan0007434 FBgn0015288 RpL22 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL22 Ribosomal protein L22 "CG7434, CG7434, L22, RL22, PBP-12, PARP-binding protein-12, Rpl22, rpl22, EG:BACR19J1.4, rpL22, anon-EST:Posey53" CDMC23312 2 3 23 DAC36-N22 2-CG7462-RB_1 CG7462 CAACAGCCCATCTGCATCCTGAACATCGTTCTTCCGGAAGCTGTAATTCCCGATTCCACGACCGC 65 FBan0007462 FBgn0017645 Ank2 3 3L cytoskeletal anchoring; GO:0007016; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; receptor binding; GO:0005102; ; GO:0003779; ; GO:0005200; ; GO:0005102 plasma membrane; GO:0005886 Ank2 Ank2 "CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, ESTS:149B10S, Dank2" CDMC23312 2 4 23 DAC36-N22 2-CG7462-RB_1 CG7462 CAACAGCCCATCTGCATCCTGAACATCGTTCTTCCGGAAGCTGTAATTCCCGATTCCACGACCGC 65 FBan0007462 FBgn0017645 Ank2 3 3L cytoskeletal anchoring; GO:0007016; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; receptor binding; GO:0005102; ; GO:0003779; ; GO:0005200; ; GO:0005102 plasma membrane; GO:0005886 Ank2 Ank2 "CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, ESTS:149B10S, Dank2" CDMC23313 2 5 23 DAC37-B10 3-CG12883-RA_1 CG12883 ATCGCATCCAGAGCAAATGTCGCAACGAAATCGAGGGCAGCAGCGATTTTCGAGACTTCAGGGAC 65 FBan0012883 FBgn0039538 CG12883 3 3R CG12883 CG12883 CDMC23313 2 6 23 DAC37-B10 3-CG12883-RA_1 CG12883 ATCGCATCCAGAGCAAATGTCGCAACGAAATCGAGGGCAGCAGCGATTTTCGAGACTTCAGGGAC 65 FBan0012883 FBgn0039538 CG12883 3 3R CG12883 CG12883 CDMC23314 2 7 23 DAC37-B22 24-CG12921-RA_2 CG12921 ACCATTACAGAGTAAGCATACAAATGGTTTCAGTTTTCTTTTTGACGTATTAGCTATTTTTATCC 65 FBan0012921 FBgn0033480 mRpL42 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpL42 mitochondrial ribosomal protein L42 "CG12921, CG12921, MRP-S32, mitochondrial ribosomal protein S32, MRPL31, mRpS32, BcDNA:RE72116, mitochondrial ribosomal protein L42" CDMC23314 2 8 23 DAC37-B22 24-CG12921-RA_2 CG12921 ACCATTACAGAGTAAGCATACAAATGGTTTCAGTTTTCTTTTTGACGTATTAGCTATTTTTATCC 65 FBan0012921 FBgn0033480 mRpL42 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpL42 mitochondrial ribosomal protein L42 "CG12921, CG12921, MRP-S32, mitochondrial ribosomal protein S32, MRPL31, mRpS32, BcDNA:RE72116, mitochondrial ribosomal protein L42" CDMC23315 2 9 23 DAC37-F10 23-CG12998-RA_1 CG12998 TGGATGGTGGTAAAGAATCGAAGAGCTACCATCTCTAGGAGACGAAAAATCCAAGCACAATCCCA 65 FBan0012998 FBgn0030829 CG12998 X X CG12998 CG12998 "CT32204, BcDNA:RH61745" CDMC23315 2 10 23 DAC37-F10 23-CG12998-RA_1 CG12998 TGGATGGTGGTAAAGAATCGAAGAGCTACCATCTCTAGGAGACGAAAAATCCAAGCACAATCCCA 65 FBan0012998 FBgn0030829 CG12998 X X CG12998 CG12998 "CT32204, BcDNA:RH61745" CDMC23316 2 11 23 DAC37-F22 2-CG13030-RA_1 CG13030 CCGCAAAGGACTATTGACACTCCAACGGCATCCGGAGAAATGTTGACTCGTCGTCAATCGGCACC 65 FBan0013030 FBgn0036669 CG13030 3 3L protein ubiquitination; GO:0016567; regulation of R7 differentiation; GO:0045676; sensory organ development; GO:0007423; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ligase activity; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG13030 CG13030 anon-WO0140519.228 CDMC23316 2 12 23 DAC37-F22 2-CG13030-RA_1 CG13030 CCGCAAAGGACTATTGACACTCCAACGGCATCCGGAGAAATGTTGACTCGTCGTCAATCGGCACC 65 FBan0013030 FBgn0036669 CG13030 3 3L protein ubiquitination; GO:0016567; regulation of R7 differentiation; GO:0045676; sensory organ development; GO:0007423; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ligase activity; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG13030 CG13030 anon-WO0140519.228 CDMC23317 2 13 23 DAC37-J10 5-CG13062-RA_1 CG13062 ACCACCCCTACGATCCCTTCCATCTGCATCACCATCACGACTTCCACGACTACCATCTGCACTAA 65 FBan0013062 FBgn0036603 CG13062 3 3L CG13062 CG13062 CDMC23317 2 14 23 DAC37-J10 5-CG13062-RA_1 CG13062 ACCACCCCTACGATCCCTTCCATCTGCATCACCATCACGACTTCCACGACTACCATCTGCACTAA 65 FBan0013062 FBgn0036603 CG13062 3 3L CG13062 CG13062 CDMC23318 2 15 23 DAC37-J22 2-CG13083-RB_1 CG13083 AGCTGCTATCACAGGCCGTCATAGGGGAACTCATCGGCTTGGACAATAAAGCGAAGGTCCTCCAG 65 FBan0013083 FBgn0032789 CG13083 2 2L CG13083 CG13083 CDMC23318 2 16 23 DAC37-J22 2-CG13083-RB_1 CG13083 AGCTGCTATCACAGGCCGTCATAGGGGAACTCATCGGCTTGGACAATAAAGCGAAGGTCCTCCAG 65 FBan0013083 FBgn0032789 CG13083 2 2L CG13083 CG13083 CDMC23319 2 17 23 DAC37-N10 3-CG1315-RA_2 CG1315 CTGGACACTAGTTGCGTCCTCAAGTGGTTGCTGGACAAGCAGTATGAGGTCATTTGCGTCCTGGC 65 FBan0001315 FBgn0026565 CG1315 3 3R arginine biosynthesis; GO:0006526; argininosuccinate metabolism; GO:0000053; urea cycle; GO:0000050 ATP binding; GO:0005524; ; GO:0005524; argininosuccinate synthase activity; GO:0004055 ; EC:6.3.4.5; ; GO:0004055 ; EC:6.3.4.5; ; GO:0004055 ; EC:6.3.4.5 CG1315 CG1315 "argininosuccinate synthase, argininosuccinate synthase-like, BG:DS00004.14" CDMC23319 2 18 23 DAC37-N10 3-CG1315-RA_2 CG1315 CTGGACACTAGTTGCGTCCTCAAGTGGTTGCTGGACAAGCAGTATGAGGTCATTTGCGTCCTGGC 65 FBan0001315 FBgn0026565 CG1315 3 3R arginine biosynthesis; GO:0006526; argininosuccinate metabolism; GO:0000053; urea cycle; GO:0000050 ATP binding; GO:0005524; ; GO:0005524; argininosuccinate synthase activity; GO:0004055 ; EC:6.3.4.5; ; GO:0004055 ; EC:6.3.4.5; ; GO:0004055 ; EC:6.3.4.5 CG1315 CG1315 "argininosuccinate synthase, argininosuccinate synthase-like, BG:DS00004.14" CDMC23320 2 19 23 DAC37-N22 11-CG13170-RA_1 CG13170 AGAGCCTTCTGAGTCTGTCGACAGTCCTGTTTGTCCTGTCATTCGCGTGTGTGGTCCTGGCCAAC 65 FBan0013170 FBgn0033703 CG13170 2 2R CG13170 CG13170 CDMC23320 2 20 23 DAC37-N22 11-CG13170-RA_1 CG13170 AGAGCCTTCTGAGTCTGTCGACAGTCCTGTTTGTCCTGTCATTCGCGTGTGTGGTCCTGGCCAAC 65 FBan0013170 FBgn0033703 CG13170 2 2R CG13170 CG13170 CDMC23321 2 21 23 DAC38-B10 16-CG32568-RA_1 CG32568 CAATCCGATGCTTAGATGCCTGACTACTGTATGCATGAGCACCGATCATAGACCGATGAAACACGACGC 69 FBan0032568 FBgn0052568 CG32568 X X intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 CG32568 CG32568 "CG4724, CG4724" CDMC23321 2 22 23 DAC38-B10 16-CG32568-RA_1 CG32568 CAATCCGATGCTTAGATGCCTGACTACTGTATGCATGAGCACCGATCATAGACCGATGAAACACGACGC 69 FBan0032568 FBgn0052568 CG32568 X X intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 CG32568 CG32568 "CG4724, CG4724" CDMC23322 2 23 23 DAC38-B22 2-CG3257-RA_4 CG3257 TCGACGCGTTTCAAAAACAGTTTGGAGGAGTCTCTGGTAGGCGAGAGTTCCCGTAAACCCGTAAACCCA 69 FBan0003257 FBgn0034978 CG3257 2 2R CG3257 CG3257 anon-EST:Posey117 CDMC23322 2 24 23 DAC38-B22 2-CG3257-RA_4 CG3257 TCGACGCGTTTCAAAAACAGTTTGGAGGAGTCTCTGGTAGGCGAGAGTTCCCGTAAACCCGTAAACCCA 69 FBan0003257 FBgn0034978 CG3257 2 2R CG3257 CG3257 anon-EST:Posey117 CDMC23323 2 25 23 DAC38-F10 3-CG32604-RA_1 CG32604 AGTGGCGCCAGAACAATTACAGTTCGACCTGGTGCAACGAACATTTTATCCACATCAAGGCGATGCGGA 69 FBgn0052604 CDMC23323 2 26 23 DAC38-F10 3-CG32604-RA_1 CG32604 AGTGGCGCCAGAACAATTACAGTTCGACCTGGTGCAACGAACATTTTATCCACATCAAGGCGATGCGGA 69 FBgn0052604 CDMC23324 2 1 24 DAC38-F22 2-CG3262-RA_1 CG3262 TGGACGGGGATATCTTCGGGCCTACTATTCCACTTCTCATGAATGTCCATGGTGAGCCGGTTGTGAACG 69 FBan0003262 FBgn0032986 CG3262 2 2L ATP binding; GO:0005524; nucleotide binding; GO:0000166; ; GO:0005524; ; GO:0000166 CG3262 CG3262 CDMC23324 2 2 24 DAC38-F22 2-CG3262-RA_1 CG3262 TGGACGGGGATATCTTCGGGCCTACTATTCCACTTCTCATGAATGTCCATGGTGAGCCGGTTGTGAACG 69 FBan0003262 FBgn0032986 CG3262 2 2L ATP binding; GO:0005524; nucleotide binding; GO:0000166; ; GO:0005524; ; GO:0000166 CG3262 CG3262 CDMC23325 2 3 24 DAC38-J10 15-CG32653-RA_3 CG32653 TGCCATTCCAGATTGCCATCTGTGATGATTACAGCCTGCCCGTAGACTTTGTTAAAAAACGACCGTCCA 69 FBan0032653 FBgn0052653 CG32653 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG32653 CG32653 BcDNA:GH02424 CDMC23325 2 4 24 DAC38-J10 15-CG32653-RA_3 CG32653 TGCCATTCCAGATTGCCATCTGTGATGATTACAGCCTGCCCGTAGACTTTGTTAAAAAACGACCGTCCA 69 FBan0032653 FBgn0052653 CG32653 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG32653 CG32653 BcDNA:GH02424 CDMC23326 2 5 24 DAC38-J22 24-CG32667-RA_1 CG32667 AGTCGAACTGCAAATGTGAAATGAACTATGAAAACTGAATATATAACTATAGAAACATACATACCTTAA 69 FBan0032667 FBgn0052667 CG32667 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32667 CG32667 CDMC23326 2 6 24 DAC38-J22 24-CG32667-RA_1 CG32667 AGTCGAACTGCAAATGTGAAATGAACTATGAAAACTGAATATATAACTATAGAAACATACATACCTTAA 69 FBan0032667 FBgn0052667 CG32667 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32667 CG32667 CDMC23327 2 7 24 DAC38-N10 23-CG3269-RA_10 CG3269 AGGTAGTTGAAGGAACAGATTTCTTGTTTTCTATCTCAACCGTAACTAACCACGTAAACATAGCTACCA 69 FBan0003269 FBgn0014009 Rab2 2 2R "intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677 Rab2 Rab-protein 2 "CG3269, CG3269, Drab2, DRAB2, DRab2, rab2, DmRab2" CDMC23327 2 8 24 DAC38-N10 23-CG3269-RA_10 CG3269 AGGTAGTTGAAGGAACAGATTTCTTGTTTTCTATCTCAACCGTAACTAACCACGTAAACATAGCTACCA 69 FBan0003269 FBgn0014009 Rab2 2 2R "intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677 Rab2 Rab-protein 2 "CG3269, CG3269, Drab2, DRAB2, DRab2, rab2, DmRab2" CDMC23328 2 9 24 DAC38-N22 23-CG32705-RA_3 CG32705 CCCTAGTTCGTGACCTTTTTTTTACGAAATTATTTGGAGTGGAGAGCATGTAAGGGTGTATCTATCTAA 69 FBan0032705 FBgn0052705 CG32705 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; metal ion binding; GO:0046872; ; GO:0004812 ; EC:6.1.1.-; ; GO:0046872 CG32705 CG32705 "CG17251, CG12136, CG15372, CG17251, p16, Pen16, anon-Pen16, pen16" CDMC23328 2 10 24 DAC38-N22 23-CG32705-RA_3 CG32705 CCCTAGTTCGTGACCTTTTTTTTACGAAATTATTTGGAGTGGAGAGCATGTAAGGGTGTATCTATCTAA 69 FBan0032705 FBgn0052705 CG32705 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; metal ion binding; GO:0046872; ; GO:0004812 ; EC:6.1.1.-; ; GO:0046872 CG32705 CG32705 "CG17251, CG12136, CG15372, CG17251, p16, Pen16, anon-Pen16, pen16" CDMC23329 2 11 24 DAC39-B10 2-CG13659-RA_1 CG13659 AGCGGAGGCATGGATCCATTTATGGAAATGTTGGGACGGATTCCTGAACTCAGCAAATACCAGCCGCAT 69 FBan0013659 FBgn0039319 CG13659 3 3R CG13659 CG13659 CDMC23329 2 12 24 DAC39-B10 2-CG13659-RA_1 CG13659 AGCGGAGGCATGGATCCATTTATGGAAATGTTGGGACGGATTCCTGAACTCAGCAAATACCAGCCGCAT 69 FBan0013659 FBgn0039319 CG13659 3 3R CG13659 CG13659 CDMC23330 2 13 24 DAC39-B22 11-CG13671-RA_2 CG13671 ACGGCAGTTTTACGCCAGAACATTGCCAAGGACTCACAAAAATGCTCTTGCCATGATGGAATCTGGGTT 69 FBan0013671 FBgn0035867 CG13671 3 3L CG13671 CG13671 CDMC23330 2 14 24 DAC39-B22 11-CG13671-RA_2 CG13671 ACGGCAGTTTTACGCCAGAACATTGCCAAGGACTCACAAAAATGCTCTTGCCATGATGGAATCTGGGTT 69 FBan0013671 FBgn0035867 CG13671 3 3L CG13671 CG13671 CDMC23331 2 15 24 DAC39-F10 18-CG13721-RA_1 CG13721 ACGGCGGATATTGGCCACATTACAGCGGCAGTTACTACGGAATTGGTTATCCATACTATGGAGGTTACT 69 FBan0013721 FBgn0035554 CG13721 3 3L CG13721 CG13721 CDMC23331 2 16 24 DAC39-F10 18-CG13721-RA_1 CG13721 ACGGCGGATATTGGCCACATTACAGCGGCAGTTACTACGGAATTGGTTATCCATACTATGGAGGTTACT 69 FBan0013721 FBgn0035554 CG13721 3 3L CG13721 CG13721 CDMC23332 2 17 24 DAC39-F22 36-CG13739-RA_1 CG13739 CCGGCGATCCGACACCATTGACGTCCATCCGTCTACCAATTTTCAGATGAAGAAAACGCATTCCTTCCA 69 FBan0013739 FBgn0033403 CG13739 2 2R CG13739 CG13739 BcDNA:GH21254 CDMC23332 2 18 24 DAC39-F22 36-CG13739-RA_1 CG13739 CCGGCGATCCGACACCATTGACGTCCATCCGTCTACCAATTTTCAGATGAAGAAAACGCATTCCTTCCA 69 FBan0013739 FBgn0033403 CG13739 2 2R CG13739 CG13739 BcDNA:GH21254 CDMC23333 2 19 24 DAC39-J10 22-CG13777-RC_1 CG13777 AGCATTAGCAATAAACGGACACATGTTATCCAATCACTCGCGATCACACAAAAGCTCGCAGTTAGCAGG 69 FBan0013777 FBgn0022201 milt 2 2L axon transport of mitochondrion; GO:0019896 kinesin-associated mitochondrial adaptor activity; GO:0019895; ; GO:0019895 mitochondrion; GO:0005739 milt milton "CG13777, CG13777, l(2)k04704, Milton, anon-WO0153538.19" CDMC23333 2 20 24 DAC39-J10 22-CG13777-RC_1 CG13777 AGCATTAGCAATAAACGGACACATGTTATCCAATCACTCGCGATCACACAAAAGCTCGCAGTTAGCAGG 69 FBan0013777 FBgn0022201 milt 2 2L axon transport of mitochondrion; GO:0019896 kinesin-associated mitochondrial adaptor activity; GO:0019895; ; GO:0019895 mitochondrion; GO:0005739 milt milton "CG13777, CG13777, l(2)k04704, Milton, anon-WO0153538.19" CDMC23334 2 21 24 DAC39-J22 15-CG13787-RA_10 CG13787 GGTGCAAACATCGAAGTTCTCCTTCTTTGCCGGCATAGTGCACTTCCTGTTCTTCGTCCTGTGTTTTGG 69 FBan0013787 FBgn0041247 Gr28a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28a Gustatory receptor 28a "CG13787, CG13787, 28A.1, Gustatory receptor 28A.1, Gr28A1, Gr28A2, Gustatory receptor 28A2, GR28A.1, Gustatory receptor 28a" CDMC23334 2 22 24 DAC39-J22 15-CG13787-RA_10 CG13787 GGTGCAAACATCGAAGTTCTCCTTCTTTGCCGGCATAGTGCACTTCCTGTTCTTCGTCCTGTGTTTTGG 69 FBan0013787 FBgn0041247 Gr28a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28a Gustatory receptor 28a "CG13787, CG13787, 28A.1, Gustatory receptor 28A.1, Gr28A1, Gr28A2, Gustatory receptor 28A2, GR28A.1, Gustatory receptor 28a" CDMC23335 2 23 24 DAC39-N10 17-CG13829-RA_3 CG13829 ACTGCTGCTCTTTCTGACCGTCTTCCTTCTGTTTCCCGTGGTGATCTTCGTCATCTTCAAGTTCTTGAT 69 FBan0013829 FBgn0039059 CG13829 3 3R CG13829 CG13829 CDMC23335 2 24 24 DAC39-N10 17-CG13829-RA_3 CG13829 ACTGCTGCTCTTTCTGACCGTCTTCCTTCTGTTTCCCGTGGTGATCTTCGTCATCTTCAAGTTCTTGAT 69 FBan0013829 FBgn0039059 CG13829 3 3R CG13829 CG13829 CDMC23336 2 25 24 DAC39-N22 4-CG13850-RA_1 CG13850 ACCAAGCAATCCGAGTGGTTGAGCTTTGTGTGGTCGCTAACAATGTTGGGTCTAGTAGAACACGGCCAC 69 FBan0013850 FBgn0038961 CG13850 3 3R CG13850 CG13850 GH07286p CDMC23336 2 26 24 DAC39-N22 4-CG13850-RA_1 CG13850 ACCAAGCAATCCGAGTGGTTGAGCTTTGTGTGGTCGCTAACAATGTTGGGTCTAGTAGAACACGGCCAC 69 FBan0013850 FBgn0038961 CG13850 3 3R CG13850 CG13850 GH07286p CDMC23337 2 1 25 DAC40-B10 7-CG14132-RA_1 CG14132 AGTGCTGTCCGCAGTTCAAGTGCGTCGATTTCAAGACCGGCAAGGACTTTATCGTCTCGCTGTAG 65 FBan0014132 FBgn0040817 CG14132 3 3L CG14132 CG14132 CDMC23337 2 2 25 DAC40-B10 7-CG14132-RA_1 CG14132 AGTGCTGTCCGCAGTTCAAGTGCGTCGATTTCAAGACCGGCAAGGACTTTATCGTCTCGCTGTAG 65 FBan0014132 FBgn0040817 CG14132 3 3L CG14132 CG14132 CDMC23338 2 3 25 DAC40-B22 16-CG14148-RA_1 CG14148 GAACCGCTGCGTCTGCGTGGTCATTCTCCAGTGGAAGAACACCCCCTGCTCGCGAAAAGAATGCC 65 FBan0014148 FBgn0040821 CG14148 3 3L CG14148 CG14148 CDMC23338 2 4 25 DAC40-B22 16-CG14148-RA_1 CG14148 GAACCGCTGCGTCTGCGTGGTCATTCTCCAGTGGAAGAACACCCCCTGCTCGCGAAAAGAATGCC 65 FBan0014148 FBgn0040821 CG14148 3 3L CG14148 CG14148 CDMC23339 2 5 25 DAC40-F10 12-CG14225-RA_1 CG14225 GACATCCGGGTTGAACTGCCAGTGATGAGCGAAGAGCCCACAGCAAATCCACTTGGCGATGTACG 65 FBan0014225 FBgn0031055 CG14225 X X receptor activity; GO:0004872; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004872; ; GO:0004896 membrane; GO:0016020 CG14225 CG14225 CDMC23339 2 6 25 DAC40-F10 12-CG14225-RA_1 CG14225 GACATCCGGGTTGAACTGCCAGTGATGAGCGAAGAGCCCACAGCAAATCCACTTGGCGATGTACG 65 FBan0014225 FBgn0031055 CG14225 X X receptor activity; GO:0004872; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004872; ; GO:0004896 membrane; GO:0016020 CG14225 CG14225 CDMC23340 2 7 25 DAC40-F22 15-CG14247-RA_1 CG14247 TCGCCGGATCCCAACCGATTCTACCTGTGTCCCAGCATAAATGCCACACCTCTGCTGCTCAACTG 65 FBan0014247 FBgn0039454 CG14247 3 3R CG14247 CG14247 CDMC23340 2 8 25 DAC40-F22 15-CG14247-RA_1 CG14247 TCGCCGGATCCCAACCGATTCTACCTGTGTCCCAGCATAAATGCCACACCTCTGCTGCTCAACTG 65 FBan0014247 FBgn0039454 CG14247 3 3R CG14247 CG14247 CDMC23341 2 9 25 DAC40-J10 2-CG14314-RA_5 CG14314 AGTCTCAAATGGGAACAGAACGTCATTTGCAAGGTGATGCCAGAAAGTGTAGTCGCGCGGGAGGC 65 FBan0014314 FBgn0038581 CG14314 3 3R CG14314 CG14314 CDMC23341 2 10 25 DAC40-J10 2-CG14314-RA_5 CG14314 AGTCTCAAATGGGAACAGAACGTCATTTGCAAGGTGATGCCAGAAAGTGTAGTCGCGCGGGAGGC 65 FBan0014314 FBgn0038581 CG14314 3 3R CG14314 CG14314 CDMC23342 2 11 25 DAC40-J22 23-CG14360-RA_2 CG14360 TTATGCTCTCGGAGACATCAGATGTCCTTATCATCGCCCAGTATATATTACCCACTTTGGTCCTG 65 FBan0014360 FBgn0038203 Or88a 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or88a Odorant receptor 88a "CG14360, 88A.1, DOR99, 88a" CDMC23342 2 12 25 DAC40-J22 23-CG14360-RA_2 CG14360 TTATGCTCTCGGAGACATCAGATGTCCTTATCATCGCCCAGTATATATTACCCACTTTGGTCCTG 65 FBan0014360 FBgn0038203 Or88a 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or88a Odorant receptor 88a "CG14360, 88A.1, DOR99, 88a" CDMC23343 2 13 25 DAC40-N10 19-CG14421-RA_1 CG14421 TGCCAGCGCCAAGCCCCAGAACTTCCAGATCTTCGGTCGCCAGCGAGATGAGCCCGCCGCCCAAG 65 FBan0014421 FBgn0029644 CG14421 X X CG14421 CG14421 CDMC23343 2 14 25 DAC40-N10 19-CG14421-RA_1 CG14421 TGCCAGCGCCAAGCCCCAGAACTTCCAGATCTTCGGTCGCCAGCGAGATGAGCCCGCCGCCCAAG 65 FBan0014421 FBgn0029644 CG14421 X X CG14421 CG14421 CDMC23344 2 15 25 DAC40-N22 1-CG14460-RA_1 CG14460 CACACGAGCCTCGCATTTTCTCATCACCCAGCATCATGAGCACGACGACAACGACAACGACAACG 65 FBan0014460 FBgn0037161 CG14460 3 3L CG14460 CG14460 CDMC23344 2 16 25 DAC40-N22 1-CG14460-RA_1 CG14460 CACACGAGCCTCGCATTTTCTCATCACCCAGCATCATGAGCACGACGACAACGACAACGACAACG 65 FBan0014460 FBgn0037161 CG14460 3 3L CG14460 CG14460 CDMC23345 2 17 25 DAC41-B10 AutoBlank AutoBlank CDMC23345 2 18 25 DAC41-B10 AutoBlank AutoBlank CDMC23346 2 19 25 DAC41-B22 AutoBlank AutoBlank CDMC23346 2 20 25 DAC41-B22 AutoBlank AutoBlank CDMC23347 2 21 25 DAC41-F10 AutoBlank AutoBlank CDMC23347 2 22 25 DAC41-F10 AutoBlank AutoBlank CDMC23348 2 23 25 DAC41-F22 AutoBlank AutoBlank CDMC23348 2 24 25 DAC41-F22 AutoBlank AutoBlank CDMC23349 2 25 25 DAC41-J10 AutoBlank AutoBlank CDMC23349 2 26 25 DAC41-J10 AutoBlank AutoBlank CDMC23350 2 1 26 DAC41-J22 AutoBlank AutoBlank CDMC23350 2 2 26 DAC41-J22 AutoBlank AutoBlank CDMC23351 2 3 26 DAC41-N10 AutoBlank AutoBlank CDMC23351 2 4 26 DAC41-N10 AutoBlank AutoBlank CDMC23352 2 5 26 DAC41-N22 AutoBlank AutoBlank CDMC23352 2 6 26 DAC41-N22 AutoBlank AutoBlank CDMC23353 2 7 26 DAC42-B10 150mM NaPO4 Blank CDMC23353 2 8 26 DAC42-B10 150mM NaPO4 Blank CDMC23354 2 9 26 DAC42-B22 150mM NaPO4 Blank CDMC23354 2 10 26 DAC42-B22 150mM NaPO4 Blank CDMC23355 2 11 26 DAC42-F10 150mM NaPO4 Blank CDMC23355 2 12 26 DAC42-F10 150mM NaPO4 Blank CDMC23356 2 13 26 DAC42-F22 150mM NaPO4 Blank CDMC23356 2 14 26 DAC42-F22 150mM NaPO4 Blank CDMC23357 2 15 26 DAC42-J10 150mM NaPO4 Blank CDMC23357 2 16 26 DAC42-J10 150mM NaPO4 Blank CDMC23358 2 17 26 DAC42-J22 5uM MSP 5uM MSP CDMC23358 2 18 26 DAC42-J22 5uM MSP 5uM MSP CDMC23359 2 19 26 DAC42-N10 10uM MSP 10uM MSP CDMC23359 2 20 26 DAC42-N10 10uM MSP 10uM MSP CDMC23360 2 21 26 DAC42-N22 20uM MSP 20uM MSP CDMC23360 2 22 26 DAC42-N22 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC23361 3 1 1 DAC01-C10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23361 3 2 1 DAC01-C10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23362 3 3 1 DAC01-C22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23362 3 4 1 DAC01-C22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23363 3 5 1 DAC01-G10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23363 3 6 1 DAC01-G10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23364 3 7 1 DAC01-G22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23364 3 8 1 DAC01-G22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23365 3 9 1 DAC01-K10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23365 3 10 1 DAC01-K10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23366 3 11 1 DAC01-K22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23366 3 12 1 DAC01-K22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23367 3 13 1 DAC01-O10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23367 3 14 1 DAC01-O10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23368 3 15 1 DAC01-O22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23368 3 16 1 DAC01-O22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23369 3 17 1 DAC02-C10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23369 3 18 1 DAC02-C10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23370 3 19 1 DAC02-C22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23370 3 20 1 DAC02-C22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23371 3 21 1 DAC02-G10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23371 3 22 1 DAC02-G10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23372 3 23 1 DAC02-G22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23372 3 24 1 DAC02-G22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23373 3 25 1 DAC02-K10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23373 3 26 1 DAC02-K10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23374 3 1 2 DAC02-K22 N/A CG9075 (01435-01673) CDMC23374 3 2 2 DAC02-K22 N/A CG9075 (01435-01673) CDMC23375 3 3 2 DAC02-O10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23375 3 4 2 DAC02-O10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23376 3 5 2 DAC02-O22 AutoBlank AutoBlank CDMC23376 3 6 2 DAC02-O22 AutoBlank AutoBlank CDMC23377 3 7 2 DAC03-C10 15-CG3222-RA_6 CG3222 TCGAGTTGGTTTGGTTGCTTCGACTACACACACAAAATTCGTCCCCACACCCCAAACACAGAGAAACAA 69 FBan0003222 FBgn0036014 CG3222 3 3L CG3222 CG3222 "bs17c12.y1, NEST:bs17c12" CDMC23377 3 8 2 DAC03-C10 15-CG3222-RA_6 CG3222 TCGAGTTGGTTTGGTTGCTTCGACTACACACACAAAATTCGTCCCCACACCCCAAACACAGAGAAACAA 69 FBan0003222 FBgn0036014 CG3222 3 3L CG3222 CG3222 "bs17c12.y1, NEST:bs17c12" CDMC23378 3 9 2 DAC03-C22 2-CG3223-RA_5 CG3223 CGCCGCCGAAATCAACACGAAGCATATTCAAGAGCTGTTTTCGTTGACCTCGCACCTGCAAATCAGCGT 69 FBan0003223 FBgn0037538 CG3223 3 3R CG3223 CG3223 CDMC23378 3 10 2 DAC03-C22 2-CG3223-RA_5 CG3223 CGCCGCCGAAATCAACACGAAGCATATTCAAGAGCTGTTTTCGTTGACCTCGCACCTGCAAATCAGCGT 69 FBan0003223 FBgn0037538 CG3223 3 3R CG3223 CG3223 CDMC23379 3 11 2 DAC03-G10 12-CG32263-RA_2 CG32263 CGGCGATGCAATTGCTCAGCAGTACGAGAGGTTTGGTGAAAAGAAAGCCTTTGACTACTCTCGCTCAGG 69 FBan0032263 FBgn0052263 CG32263 3 3L development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG32263 CG32263 CG10854 CDMC23379 3 12 2 DAC03-G10 12-CG32263-RA_2 CG32263 CGGCGATGCAATTGCTCAGCAGTACGAGAGGTTTGGTGAAAAGAAAGCCTTTGACTACTCTCGCTCAGG 69 FBan0032263 FBgn0052263 CG32263 3 3L development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG32263 CG32263 CG10854 CDMC23380 3 13 2 DAC03-G22 23-CG32276-RB_2 CG32276 CGCAGTTTTAAATAGTGCAAAGTGTTAAAGCGTTGTTTTCTAATGCAAAGACGAGTAGAGAAGAAACTA 69 FBan0032276 FBgn0047135 CG32276 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; response to stress; GO:0006950 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 endoplasmic reticulum; GO:0005783; ribosome; GO:0005840 CG32276 CG32276 BcDNA:RE27904 CDMC23380 3 14 2 DAC03-G22 23-CG32276-RB_2 CG32276 CGCAGTTTTAAATAGTGCAAAGTGTTAAAGCGTTGTTTTCTAATGCAAAGACGAGTAGAGAAGAAACTA 69 FBan0032276 FBgn0047135 CG32276 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; response to stress; GO:0006950 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 endoplasmic reticulum; GO:0005783; ribosome; GO:0005840 CG32276 CG32276 BcDNA:RE27904 CDMC23381 3 15 2 DAC03-K10 15-CG32316-RB_1 CG32316 CGGCTCCAGCTCCTAATCTGGTTGATGAAGATTCAGCTGCTCGAAATAGGGAACCAGATGCTTCTGCAT 69 FBgn0052316 CDMC23381 3 16 2 DAC03-K10 15-CG32316-RB_1 CG32316 CGGCTCCAGCTCCTAATCTGGTTGATGAAGATTCAGCTGCTCGAAATAGGGAACCAGATGCTTCTGCAT 69 FBgn0052316 CDMC23382 3 17 2 DAC03-K22 2-CG32332-RA_1 CG32332 CCCATCGACCGGACTTGACGCTTACCCTTTCGGAACACATCCTTTGGCATTTTGGAAGCGACTCTTTGA 69 FBgn0052332 CDMC23382 3 18 2 DAC03-K22 2-CG32332-RA_1 CG32332 CCCATCGACCGGACTTGACGCTTACCCTTTCGGAACACATCCTTTGGCATTTTGGAAGCGACTCTTTGA 69 FBgn0052332 CDMC23383 3 19 2 DAC03-O10 10-CG32376-RA_1 CG32376 CTGGCCATGATGAAACTGAAATCCCCGGTCTACTTTGGCAAATGTGTTAGGCCTGTGAAGCTACCCTCT 69 FBan0032376 FBgn0052376 CG32376 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32376 CG32376 "CG8528, SP148" CDMC23383 3 20 2 DAC03-O10 10-CG32376-RA_1 CG32376 CTGGCCATGATGAAACTGAAATCCCCGGTCTACTTTGGCAAATGTGTTAGGCCTGTGAAGCTACCCTCT 69 FBan0032376 FBgn0052376 CG32376 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32376 CG32376 "CG8528, SP148" CDMC23384 3 21 2 DAC03-O22 6-CG3238-RA_5 CG3238 AGTGCATCGGCAATCGGATCCGGAGTTTGTAAAGATTCTGAACCACCTCCGAATTGGCCATGTGAACGA 69 FBan0003238 FBgn0031540 CG3238 2 2L CG3238 CG3238 CDMC23384 3 22 2 DAC03-O22 6-CG3238-RA_5 CG3238 AGTGCATCGGCAATCGGATCCGGAGTTTGTAAAGATTCTGAACCACCTCCGAATTGGCCATGTGAACGA 69 FBan0003238 FBgn0031540 CG3238 2 2L CG3238 CG3238 CDMC23385 3 23 2 DAC04-C10 3-CG2955-RA_3 CG2955 GCCCGAAAAGACCGAAGATGCACCGAAGCCCCTAGAAAAATTCGACGAAAAGCCTGACAGTTTCGTGGA 69 FBan0002955 FBgn0031585 CG2955 2 2L structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG2955 CG2955 anon-WO0140519.175 CDMC23385 3 24 2 DAC04-C10 3-CG2955-RA_3 CG2955 GCCCGAAAAGACCGAAGATGCACCGAAGCCCCTAGAAAAATTCGACGAAAAGCCTGACAGTTTCGTGGA 69 FBan0002955 FBgn0031585 CG2955 2 2L structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG2955 CG2955 anon-WO0140519.175 CDMC23386 3 25 2 DAC04-C22 11-CG2967-RA_1 CG2967 GCCCACGACATGGAATCTGCGTTACAATAGCGACACTTGCGATAGTGGAAGTATCTCGAGCACGGATCA 69 FBan0002967 FBgn0028486 CG2967 X X CG2967 CG2967 BcDNA:GH09358 CDMC23386 3 26 2 DAC04-C22 11-CG2967-RA_1 CG2967 GCCCACGACATGGAATCTGCGTTACAATAGCGACACTTGCGATAGTGGAAGTATCTCGAGCACGGATCA 69 FBan0002967 FBgn0028486 CG2967 X X CG2967 CG2967 BcDNA:GH09358 CDMC23387 3 1 3 DAC04-G10 12-CG30000-RA_3 CG30000 TCTGGCTGGAAAAGGACTTCTTAGTCGGCGACAAACTTACCGTGGCAGACATCTTCGGGTCTTCAGAAA 69 FBan0030000 FBgn0050000 CG30000 2 2R CG30000 CG30000 "CG12930B, CG12930, CG12930B, CG12930B, BcDNA:RE63575" CDMC23387 3 2 3 DAC04-G10 12-CG30000-RA_3 CG30000 TCTGGCTGGAAAAGGACTTCTTAGTCGGCGACAAACTTACCGTGGCAGACATCTTCGGGTCTTCAGAAA 69 FBan0030000 FBgn0050000 CG30000 2 2R CG30000 CG30000 "CG12930B, CG12930, CG12930B, CG12930B, BcDNA:RE63575" CDMC23388 3 3 3 DAC04-G22 23-CG3000-RA_5 CG3000 AACAAGTCCGTTCTGAATCTGTTTGCCAATATCAGATAAGGACAATAACTCCAAGCGAGCGAAGACTGA 69 FBan0003000 FBgn0003200 rap X X cyclin catabolism; GO:0008054; glial cell migration; GO:0008347; protein catabolism; GO:0030163; proteolysis; GO:0006508 centrosome; GO:0005813; spindle; GO:0005819 rap retina aberrant in pattern "CG3000, fizzy-related, dFZR, CDH1, l(1)G0326, l(1)G0418, Fzr, fzr, Fizzy-related, Cdh1[Fzr], Cdh1, rap/Fzr, rap/fizzy-related, Cdh[Fzr], Hec/Cdh[Fzr], Fizzy related, Cdh1/Fzr, wex, westfalenexpress, anon-WO03040301.193, retina aberrant in pattern" CDMC23388 3 4 3 DAC04-G22 23-CG3000-RA_5 CG3000 AACAAGTCCGTTCTGAATCTGTTTGCCAATATCAGATAAGGACAATAACTCCAAGCGAGCGAAGACTGA 69 FBan0003000 FBgn0003200 rap X X cyclin catabolism; GO:0008054; glial cell migration; GO:0008347; protein catabolism; GO:0030163; proteolysis; GO:0006508 centrosome; GO:0005813; spindle; GO:0005819 rap retina aberrant in pattern "CG3000, fizzy-related, dFZR, CDH1, l(1)G0326, l(1)G0418, Fzr, fzr, Fizzy-related, Cdh1[Fzr], Cdh1, rap/Fzr, rap/fizzy-related, Cdh[Fzr], Hec/Cdh[Fzr], Fizzy related, Cdh1/Fzr, wex, westfalenexpress, anon-WO03040301.193, retina aberrant in pattern" CDMC23389 3 5 3 DAC04-K10 23-CG30038-RA_2 CG30038 AAGCTAGGACACACAGAGTACCATTTTCCCACACTGTTTCACCTTTTTGTGCAAATTACTCCAATGTAA 69 FBan0030038 FBgn0050038 CG30038 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30038 CG30038 CDMC23389 3 6 3 DAC04-K10 23-CG30038-RA_2 CG30038 AAGCTAGGACACACAGAGTACCATTTTCCCACACTGTTTCACCTTTTTGTGCAAATTACTCCAATGTAA 69 FBan0030038 FBgn0050038 CG30038 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30038 CG30038 CDMC23390 3 7 3 DAC04-K22 2-CG30048-RA_1 CG30048 TGACCGACATTCAGACTGGTGAGACGCAGGTGTTTTTAGCCCGGAAATGGTTGGAGAAGGGTACACTGT 69 FBan0030048 FBgn0050048 CG30048 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30048 CG30048 CDMC23390 3 8 3 DAC04-K22 2-CG30048-RA_1 CG30048 TGACCGACATTCAGACTGGTGAGACGCAGGTGTTTTTAGCCCGGAAATGGTTGGAGAAGGGTACACTGT 69 FBan0030048 FBgn0050048 CG30048 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30048 CG30048 CDMC23391 3 9 3 DAC04-O10 6-CG30078-RA_3 CG30078 CCGGGATGAGCAAGTTTAGCTTTGTTCCCTGTGAGTCTATCGTGTCTGATGCTTTGTGAGCCGAGCAGC 69 FBan0030078 FBgn0050078 CG30078 2 2R NOT thermotaxis; GO:0043052; cation transport; GO:0006812; ion transport; GO:0006811 protein kinase activity; GO:0004672 ; EC:2.7.1.37; alpha-type channel activity; GO:0015268; ; GO:0004672 ; EC:2.7.1.37; cation channel activity; GO:0005261; ion channel activity; GO:0005216; ; GO:0015268; ; GO:0005216; ; GO:0005261 membrane; GO:0016020 CG30078 CG30078 "CG16805, TRPM, TrpM" CDMC23391 3 10 3 DAC04-O10 6-CG30078-RA_3 CG30078 CCGGGATGAGCAAGTTTAGCTTTGTTCCCTGTGAGTCTATCGTGTCTGATGCTTTGTGAGCCGAGCAGC 69 FBan0030078 FBgn0050078 CG30078 2 2R NOT thermotaxis; GO:0043052; cation transport; GO:0006812; ion transport; GO:0006811 protein kinase activity; GO:0004672 ; EC:2.7.1.37; alpha-type channel activity; GO:0015268; ; GO:0004672 ; EC:2.7.1.37; cation channel activity; GO:0005261; ion channel activity; GO:0005216; ; GO:0015268; ; GO:0005216; ; GO:0005261 membrane; GO:0016020 CG30078 CG30078 "CG16805, TRPM, TrpM" CDMC23392 3 11 3 DAC04-O22 13-CG30089-RA_1 CG30089 GCCAGGCCTCTAAAGTTTTGTATTCAGAGCGGGGTAAACATCCGAGTTTCTCTGAGTGGGGTATTCGGA 69 FBan0030089 FBgn0050089 CG30089 2 2R CG30089 CG30089 "CG12305, CG12966, CG12967, CG12305" CDMC23392 3 12 3 DAC04-O22 13-CG30089-RA_1 CG30089 GCCAGGCCTCTAAAGTTTTGTATTCAGAGCGGGGTAAACATCCGAGTTTCTCTGAGTGGGGTATTCGGA 69 FBan0030089 FBgn0050089 CG30089 2 2R CG30089 CG30089 "CG12305, CG12966, CG12967, CG12305" CDMC23393 3 13 3 DAC05-C10 2-CG18522-RA_1 CG18522 CGCGGATTGGGTTTGTGTATCATGGAGTACCAGATCGGTTACTTCGGACAATACCCCGCTACGGTGGC 68 FBan0018522 FBgn0038347 CG18522 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18522 CG18522 "DmAO1, CT42272" CDMC23393 3 14 3 DAC05-C10 2-CG18522-RA_1 CG18522 CGCGGATTGGGTTTGTGTATCATGGAGTACCAGATCGGTTACTTCGGACAATACCCCGCTACGGTGGC 68 FBan0018522 FBgn0038347 CG18522 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18522 CG18522 "DmAO1, CT42272" CDMC23394 3 15 3 DAC05-C22 2-CG1911-RA_2 CG1911 GCTGGCGCCATTTATCATAGAGATTTGCAAGCGTCCAGGTGAGTTTGGTGATCCCACGTTGCAACAGG 68 FBan0001911 FBgn0039680 CAP-D2 3 3R chromatin assembly or disassembly; GO:0006333; chromosome condensation; GO:0030261; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070 nucleic acid binding; GO:0003676; ; GO:0003676 condensin complex; GO:0000796; nucleus; GO:0005634 CAP-D2 CAP-D2 condensin subunit "CG1911, CG1911, CG1911, CG1911, CAP-D2 condensin subunit" CDMC23394 3 16 3 DAC05-C22 2-CG1911-RA_2 CG1911 GCTGGCGCCATTTATCATAGAGATTTGCAAGCGTCCAGGTGAGTTTGGTGATCCCACGTTGCAACAGG 68 FBan0001911 FBgn0039680 CAP-D2 3 3R chromatin assembly or disassembly; GO:0006333; chromosome condensation; GO:0030261; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070 nucleic acid binding; GO:0003676; ; GO:0003676 condensin complex; GO:0000796; nucleus; GO:0005634 CAP-D2 CAP-D2 condensin subunit "CG1911, CG1911, CG1911, CG1911, CAP-D2 condensin subunit" CDMC23395 3 17 3 DAC05-G10 2-CG2682-RA_1 CG2682 CCCGAATCAAAGTTTCCGAGCCTATCAGTATCGCGAGCACAACCTTCAGCACTCCCACCATCAAACGC 68 FBan0002682 FBgn0033015 d4 2 2R protein ubiquitination; GO:0016567; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 d4 d4 "CG2682, CG2682, CG2682, dd4" CDMC23395 3 18 3 DAC05-G10 2-CG2682-RA_1 CG2682 CCCGAATCAAAGTTTCCGAGCCTATCAGTATCGCGAGCACAACCTTCAGCACTCCCACCATCAAACGC 68 FBan0002682 FBgn0033015 d4 2 2R protein ubiquitination; GO:0016567; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 d4 d4 "CG2682, CG2682, CG2682, dd4" CDMC23396 3 19 3 DAC05-G22 2-CG2950-RA_1 CG2950 GGTGAGGTCATTCGTAATTCGGGCAAGTTCCCCAAACCGACCAAGATTCCTGGCAAGACGTACTGCAA 68 FBan0002950 FBgn0031637 CG2950 2 2L nucleic acid binding; GO:0003676; ; GO:0003676 CG2950 CG2950 "cg2950, BcDNA:GH06479" CDMC23396 3 20 3 DAC05-G22 2-CG2950-RA_1 CG2950 GGTGAGGTCATTCGTAATTCGGGCAAGTTCCCCAAACCGACCAAGATTCCTGGCAAGACGTACTGCAA 68 FBan0002950 FBgn0031637 CG2950 2 2L nucleic acid binding; GO:0003676; ; GO:0003676 CG2950 CG2950 "cg2950, BcDNA:GH06479" CDMC23397 3 21 3 DAC05-K10 2-CG30498-RA_1 CG30498 GGCGTAACCATCGAGAACAAGGAGTACCCAGGTGTCAATGCGAAAAAGGACGAACTGTAGGCCGGTTC 68 FBan0030498 FBgn0004132 boca 2 2R ER to Golgi transport; GO:0006888; Wnt receptor signaling pathway; GO:0016055; oogenesis (sensu Insecta); GO:0009993; proboscis development; GO:0048728; protein targeting to membrane; GO:0006612; secretory pathway; GO:0045045 apical part of cell; GO:0045177; cytoplasm; GO:0005737; endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 boca boca "CG1364, CG30498, CG1364, CG1364, CG1364, l(2)43Ea: lethal(2)43Ea, lethal(2)43Ea, l(2)43Ea, boca" CDMC23397 3 22 3 DAC05-K10 2-CG30498-RA_1 CG30498 GGCGTAACCATCGAGAACAAGGAGTACCCAGGTGTCAATGCGAAAAAGGACGAACTGTAGGCCGGTTC 68 FBan0030498 FBgn0004132 boca 2 2R ER to Golgi transport; GO:0006888; Wnt receptor signaling pathway; GO:0016055; oogenesis (sensu Insecta); GO:0009993; proboscis development; GO:0048728; protein targeting to membrane; GO:0006612; secretory pathway; GO:0045045 apical part of cell; GO:0045177; cytoplasm; GO:0005737; endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 boca boca "CG1364, CG30498, CG1364, CG1364, CG1364, l(2)43Ea: lethal(2)43Ea, lethal(2)43Ea, l(2)43Ea, boca" CDMC23398 3 23 3 DAC05-K22 3-CG31116-RC_1 CG31116 GCGACCATCTCGATTCGAGGTCCTTCCAGCTCCGGATATTCTCAGTTTACGCCAGATTGCCAACGACG 68 FBan0031116 FBgn0051116 CG31116 3 3R chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG31116 CG31116 "CG6942, CG14726, CG6942, FBgn0037951" CDMC23398 3 24 3 DAC05-K22 3-CG31116-RC_1 CG31116 GCGACCATCTCGATTCGAGGTCCTTCCAGCTCCGGATATTCTCAGTTTACGCCAGATTGCCAACGACG 68 FBan0031116 FBgn0051116 CG31116 3 3R chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG31116 CG31116 "CG6942, CG14726, CG6942, FBgn0037951" CDMC23399 3 25 3 DAC05-O10 2-CG31551-RA_2 CG31551 TGCAGAGAGACCAATCAGTTCCAGTCAAGAGTACTTTCAGCCAGGATCCCTGCATACTCGCAGCGAGC 68 FBan0031551 FBgn0051551 CG31551 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0005200; ; GO:0005198 CG31551 CG31551 "CG11005, CG11005" CDMC23399 3 26 3 DAC05-O10 2-CG31551-RA_2 CG31551 TGCAGAGAGACCAATCAGTTCCAGTCAAGAGTACTTTCAGCCAGGATCCCTGCATACTCGCAGCGAGC 68 FBan0031551 FBgn0051551 CG31551 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0005200; ; GO:0005198 CG31551 CG31551 "CG11005, CG11005" CDMC23400 3 1 4 DAC05-O22 AutoBlank AutoBlank CDMC23400 3 2 4 DAC05-O22 AutoBlank AutoBlank CDMC23401 3 3 4 DAC06-C10 15-CG5261-RA_1 CG5261 GCACTTCCGCGACTACATGGAGGATCCTTCCAATATGGTATTGTAAGCGGACAGAAACGACCCATCACA 69 FBan0005261 FBgn0031912 CG5261 2 2L acetyl-CoA biosynthesis from pyruvate; GO:0006086; glycolysis; GO:0006096; tricarboxylic acid cycle; GO:0006099 protein binding; GO:0005515; dihydrolipoyllysine-residue acetyltransferase activity; GO:0004742 ; EC:2.3.1.12; ; GO:0004742 ; EC:2.3.1.12; ; GO:0004742 ; EC:2.3.1.12; ; GO:0005515 pyruvate dehydrogenase complex (sensu Eukaryota); GO:0005967 CG5261 CG5261 anon-WO0118547.121 CDMC23401 3 4 4 DAC06-C10 15-CG5261-RA_1 CG5261 GCACTTCCGCGACTACATGGAGGATCCTTCCAATATGGTATTGTAAGCGGACAGAAACGACCCATCACA 69 FBan0005261 FBgn0031912 CG5261 2 2L acetyl-CoA biosynthesis from pyruvate; GO:0006086; glycolysis; GO:0006096; tricarboxylic acid cycle; GO:0006099 protein binding; GO:0005515; dihydrolipoyllysine-residue acetyltransferase activity; GO:0004742 ; EC:2.3.1.12; ; GO:0004742 ; EC:2.3.1.12; ; GO:0004742 ; EC:2.3.1.12; ; GO:0005515 pyruvate dehydrogenase complex (sensu Eukaryota); GO:0005967 CG5261 CG5261 anon-WO0118547.121 CDMC23402 3 5 4 DAC06-C22 17-CG5268-RA_2 CG5268 AGCCAAGCAGATCCTGAATATAGATGACCCCAAAAACGTGGACGCTATCACCAAGAACTACGAGCATCT 69 FBan0005268 FBgn0038387 blp 3 3R embryonic development (sensu Insecta); GO:0001700; larval development (sensu Insecta); GO:0002168 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 blp black pearl "CG5268, l(3)01618, BcDNA:RE11908, black pearl" CDMC23402 3 6 4 DAC06-C22 17-CG5268-RA_2 CG5268 AGCCAAGCAGATCCTGAATATAGATGACCCCAAAAACGTGGACGCTATCACCAAGAACTACGAGCATCT 69 FBan0005268 FBgn0038387 blp 3 3R embryonic development (sensu Insecta); GO:0001700; larval development (sensu Insecta); GO:0002168 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 blp black pearl "CG5268, l(3)01618, BcDNA:RE11908, black pearl" CDMC23403 3 7 4 DAC06-G10 17-CG5316-RA_2 CG5316 TCATCTCCAAGGACTTCGTATCAACAAGCCTGAAGACCAAGAAGCATTGGAACTCATTCAACACCGAGC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC23403 3 8 4 DAC06-G10 17-CG5316-RA_2 CG5316 TCATCTCCAAGGACTTCGTATCAACAAGCCTGAAGACCAAGAAGCATTGGAACTCATTCAACACCGAGC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC23404 3 9 4 DAC06-G22 18-CG5326-RA_1 CG5326 TAGTATTTTGTTAGTTCGAGGAAAGCGGCCCCATTTGTACTTGTTTGGATCAGTCGCCATTGCAGAGGG 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC23404 3 10 4 DAC06-G22 18-CG5326-RA_1 CG5326 TAGTATTTTGTTAGTTCGAGGAAAGCGGCCCCATTTGTACTTGTTTGGATCAGTCGCCATTGCAGAGGG 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC23405 3 11 4 DAC06-K10 5-CG5361-RA_1 CG5361 AGTGGCCAGTGTTTCCCGAGCTCTTTGGTTGGGAATTCCTTTGGATAAAGTCCCAGACAATCAGCAGGA 69 FBan0005361 FBgn0037786 CG5361 3 3R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5361 CG5361 CDMC23405 3 12 4 DAC06-K10 5-CG5361-RA_1 CG5361 AGTGGCCAGTGTTTCCCGAGCTCTTTGGTTGGGAATTCCTTTGGATAAAGTCCCAGACAATCAGCAGGA 69 FBan0005361 FBgn0037786 CG5361 3 3R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5361 CG5361 CDMC23406 3 13 4 DAC06-K22 13-CG5377-RA_2 CG5377 TGAAGAGCCCTTGAGAAGCAGCTAAGTTTGTTGCCATACTCCAAAATCCCCGTTAGATCCCGCTTACGT 69 FBan0005377 FBgn0038974 CG5377 3 3R defense response; GO:0006952; response to toxin; GO:0009636 serine hydrolase activity; GO:0017171; ; GO:0017171 CG5377 CG5377 CDMC23406 3 14 4 DAC06-K22 13-CG5377-RA_2 CG5377 TGAAGAGCCCTTGAGAAGCAGCTAAGTTTGTTGCCATACTCCAAAATCCCCGTTAGATCCCGCTTACGT 69 FBan0005377 FBgn0038974 CG5377 3 3R defense response; GO:0006952; response to toxin; GO:0009636 serine hydrolase activity; GO:0017171; ; GO:0017171 CG5377 CG5377 CDMC23407 3 15 4 DAC06-O10 23-CG5407-RA_7 CG5407 CAGGACTCCATGAGATATGTACATATATTTTTCAAACAAACTGTATGCGGCAGGGTAAACTAATCTGGC 69 FBan0005407 FBgn0038504 Sur-8 3 3R MAPKKK cascade; GO:0000165; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 kinase regulator activity; GO:0019207; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0019207; ; GO:0004675 ; EC:2.7.1.-; Ras GTPase binding; GO:0017016; ; GO:0017016 Sur-8 Sur-8 "CG5407, CT17146, SUR-8, Sur8" CDMC23407 3 16 4 DAC06-O10 23-CG5407-RA_7 CG5407 CAGGACTCCATGAGATATGTACATATATTTTTCAAACAAACTGTATGCGGCAGGGTAAACTAATCTGGC 69 FBan0005407 FBgn0038504 Sur-8 3 3R MAPKKK cascade; GO:0000165; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 kinase regulator activity; GO:0019207; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0019207; ; GO:0004675 ; EC:2.7.1.-; Ras GTPase binding; GO:0017016; ; GO:0017016 Sur-8 Sur-8 "CG5407, CT17146, SUR-8, Sur8" CDMC23408 3 17 4 DAC06-O22 2-CG5422-RD_1 CG5422 GCGAGGTACATGGAAACCTGGTAAAGTGCTTCTGGGGCAAAGAGAACGGAGGCGATAACTCGGCCAATA 69 FBan0005422 FBgn0005649 Rox8 3 3R "induction of apoptosis; GO:0006917; nuclear mRNA splicing, via spliceosome; GO:0000398; protein metabolism; GO:0019538; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0003729 nucleus; GO:0005634; snRNP U1; GO:0005685 Rox8 Rox8 "CG5422, CG5422, rrm12, DmTIAR, rox8, ROX8, TIAR, RRM12, Rbp12, RNA-binding protein 12" CDMC23408 3 18 4 DAC06-O22 2-CG5422-RD_1 CG5422 GCGAGGTACATGGAAACCTGGTAAAGTGCTTCTGGGGCAAAGAGAACGGAGGCGATAACTCGGCCAATA 69 FBan0005422 FBgn0005649 Rox8 3 3R "induction of apoptosis; GO:0006917; nuclear mRNA splicing, via spliceosome; GO:0000398; protein metabolism; GO:0019538; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0003729 nucleus; GO:0005634; snRNP U1; GO:0005685 Rox8 Rox8 "CG5422, CG5422, rrm12, DmTIAR, rox8, ROX8, TIAR, RRM12, Rbp12, RNA-binding protein 12" CDMC23409 3 19 4 DAC07-C10 2-CG9820-RA_5 CG9820 GTGTCGAATCTTCTCGTGACCCTGTGCTACCCCGTTCACCTGGGAATATCCCTCTTTCGCAACCG 65 FBan0009820 FBgn0026384 Or59a 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; electron transport; GO:0006118; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59a Odorant receptor 59a "CG9820, CG9820, DOR59D.1, Olfactory receptor 59D.1, dor46, AN6, 59D.1, DOR46, 59a, Or46, Or59D.1" CDMC23409 3 20 4 DAC07-C10 2-CG9820-RA_5 CG9820 GTGTCGAATCTTCTCGTGACCCTGTGCTACCCCGTTCACCTGGGAATATCCCTCTTTCGCAACCG 65 FBan0009820 FBgn0026384 Or59a 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; electron transport; GO:0006118; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59a Odorant receptor 59a "CG9820, CG9820, DOR59D.1, Olfactory receptor 59D.1, dor46, AN6, 59D.1, DOR46, 59a, Or46, Or59D.1" CDMC23410 3 21 4 DAC07-C22 1-CG9868-RA_1 CG9868 ACCACCACTCTGGGTTTCAAGTATCGCGGAGGAGTGATTCTGTGTGCTGATTCTAGGGCCACCTC 65 FBan0009868 FBgn0034842 Prosbeta5R1 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta5R1 Prosbeta5R1 CG9868 CDMC23410 3 22 4 DAC07-C22 1-CG9868-RA_1 CG9868 ACCACCACTCTGGGTTTCAAGTATCGCGGAGGAGTGATTCTGTGTGCTGATTCTAGGGCCACCTC 65 FBan0009868 FBgn0034842 Prosbeta5R1 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta5R1 Prosbeta5R1 CG9868 CDMC23411 3 23 4 DAC07-G10 23-CG9976-RA_1 CG9976 AGATAACCACTAAGCAACCCGTAAACTTATCTCGCACTTCTGCAAATATATCATTGGGTATAAAA 65 FBan0009976 FBgn0016675 Lectin-galC1 2 2L defense response; GO:0006952 galactose binding; GO:0005534; ; GO:0005534; sugar binding; GO:0005529; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005534; ; GO:0005529 Lectin-galC1 Galactose-specific C-type lectin "CG9976, Dgal-1, galactose specific C-type lectin, galactin, AC007082a, lectin-galC1" CDMC23411 3 24 4 DAC07-G10 23-CG9976-RA_1 CG9976 AGATAACCACTAAGCAACCCGTAAACTTATCTCGCACTTCTGCAAATATATCATTGGGTATAAAA 65 FBan0009976 FBgn0016675 Lectin-galC1 2 2L defense response; GO:0006952 galactose binding; GO:0005534; ; GO:0005534; sugar binding; GO:0005529; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005534; ; GO:0005529 Lectin-galC1 Galactose-specific C-type lectin "CG9976, Dgal-1, galactose specific C-type lectin, galactin, AC007082a, lectin-galC1" CDMC23412 3 25 4 DAC07-G22 10-CR30082-RA_1 CR30082 AATCAACACCGCCACAGTTCTGCAAACAGTGAACCTGATCAGGCTTGACCAAAGCGACTGTGAGC 65 FBan0030082 FBgn0050082 CR30082 2 2R CR30082 CR30082 CG30082 CDMC23412 3 26 4 DAC07-G22 10-CR30082-RA_1 CR30082 AATCAACACCGCCACAGTTCTGCAAACAGTGAACCTGATCAGGCTTGACCAAAGCGACTGTGAGC 65 FBan0030082 FBgn0050082 CR30082 2 2R CR30082 CR30082 CG30082 CDMC23413 3 1 5 DAC07-K10 1-CR32205-RA_1 CR32205 GACTGCTTTGGACTACACTGCTCACGTGGTTCCTCTGCTTCACTCCGGTCTGACTGTCGTGGTAG 65 FBan0032205 FBgn0052205 CR32205 3 3L CR32205 CR32205 BcDNA:RE73739 CDMC23413 3 2 5 DAC07-K10 1-CR32205-RA_1 CR32205 GACTGCTTTGGACTACACTGCTCACGTGGTTCCTCTGCTTCACTCCGGTCTGACTGTCGTGGTAG 65 FBan0032205 FBgn0052205 CR32205 3 3L CR32205 CR32205 BcDNA:RE73739 CDMC23414 3 3 5 DAC07-K22 1-CR32864-RA_1 CR32864 GACTGGAAGGTTGGCAGCTTCTGTAATCACGCTTCTGTGAGGTCTGATTGTGGGATGGCCTGAGG 65 FBan0032864 FBgn0000003 7SLRNA 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614 signal recognition particle (sensu Eukaryota); GO:0005786 7SLRNA RNA 7SL CR32864 CDMC23414 3 4 5 DAC07-K22 1-CR32864-RA_1 CR32864 GACTGGAAGGTTGGCAGCTTCTGTAATCACGCTTCTGTGAGGTCTGATTGTGGGATGGCCTGAGG 65 FBan0032864 FBgn0000003 7SLRNA 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614 signal recognition particle (sensu Eukaryota); GO:0005786 7SLRNA RNA 7SL CR32864 CDMC23415 3 5 5 DAC07-O10 23-CR33313-RA_1 CR33313 CCGTAAATCCGAACTTGTGCTGTTTTATATCTGTTACAAGACCGGCATTATGGGAGTCTGTCAAT 65 FBgn0053313 CDMC23415 3 6 5 DAC07-O10 23-CR33313-RA_1 CR33313 CCGTAAATCCGAACTTGTGCTGTTTTATATCTGTTACAAGACCGGCATTATGGGAGTCTGTCAAT 65 FBgn0053313 CDMC23416 3 7 5 DAC07-O22 24-CR40459-RA_9 CR40459 ATTATATAAAATAATCTTATCTGGTAAAGCGAATGATTAGAGGCCTTAGGGTCGAAACGATCTTA 65 FBgn0058459 28SrRNA:CR40459 28SrRNA:CR40459 28SrRNA:CR40459 CR40459 CDMC23416 3 8 5 DAC07-O22 24-CR40459-RA_9 CR40459 ATTATATAAAATAATCTTATCTGGTAAAGCGAATGATTAGAGGCCTTAGGGTCGAAACGATCTTA 65 FBgn0058459 28SrRNA:CR40459 28SrRNA:CR40459 28SrRNA:CR40459 CR40459 CDMC23417 3 9 5 DAC08-C10 2-CG5621-RA_1 CG5621 AGCTCGAAATCGAAAGGCTCTTCCATGTCAGTGGATTCATTGCCCGAGGATACCTCAGAAGCTGACGCA 69 FBan0005621 FBgn0038840 CG5621 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 plasma membrane; GO:0005886 CG5621 CG5621 "CT17756, anon-WO0138359.5" CDMC23417 3 10 5 DAC08-C10 2-CG5621-RA_1 CG5621 AGCTCGAAATCGAAAGGCTCTTCCATGTCAGTGGATTCATTGCCCGAGGATACCTCAGAAGCTGACGCA 69 FBan0005621 FBgn0038840 CG5621 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 plasma membrane; GO:0005886 CG5621 CG5621 "CT17756, anon-WO0138359.5" CDMC23418 3 11 5 DAC08-C22 23-CG5634-RA_8 CG5634 AGAATATTTGCCTCGACTTTCTTCTACTAACCACACACAAAAGTCAAGCTAGCAAGTTGATAATCCGCA 69 FBan0005634 FBgn0039528 dsd 3 3R cell adhesion; GO:0007155; defense response; GO:0006952; development; GO:0007275 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005102; ; GO:0005198; ; GO:0004872 membrane; GO:0016020 dsd distracted "CG5634, CG5634, CT17798, distracted" CDMC23418 3 12 5 DAC08-C22 23-CG5634-RA_8 CG5634 AGAATATTTGCCTCGACTTTCTTCTACTAACCACACACAAAAGTCAAGCTAGCAAGTTGATAATCCGCA 69 FBan0005634 FBgn0039528 dsd 3 3R cell adhesion; GO:0007155; defense response; GO:0006952; development; GO:0007275 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005102; ; GO:0005198; ; GO:0004872 membrane; GO:0016020 dsd distracted "CG5634, CG5634, CT17798, distracted" CDMC23419 3 13 5 DAC08-G10 17-CG5670-RE_5 CG5670 ACGGCTTCTTGCCCAAGAAACTGTTTGGCATTCGTAAGATGTGGGACTCAAAGGCTGTTAACGATCTAA 69 FBan0005670 FBgn0002921 Atpalpha 3 3R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; embryonic development (sensu Insecta); GO:0001700; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; septate junction assembly; GO:0019991 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; septate junction; GO:0005918; sodium:potassium-exchanging ATPase complex; GO:0005890 Atpalpha Na pump alpha subunit "CG5670, CG5670, CG5670, l(3)04492, alpha-subunit of ATPase, ATPase alpha subunit, Na[+],K[+]-ATPase alpha-subunit, l(3)01164, Na,K-ATPase alpha subunit, Na,K-ATPase, Atpalpha, Na/K-ATPase alpha-subunit, Da-47, Na+,K+ ATPase alpha-subunit., Na+/K+ ATPase alpha subunit, sodium/potassium transporting ATPase alpha, Na,K ATPase, Na,K ATPase alpha subunit, Na/K-ATPase, Na/K-ATPase alpha-subunit, Na[+]/K[+]-ATPase, Na[+]-K[+]-ATPase alpha[[5]]-subunit, Na[+],K[+]-ATPase alpha subunit, Na[+],K[+]-ATPase, Na[+]/K[+]ATPase, Na+-K+-ATPase, Atp a, ATPalpha, ATPa, NaK ATPase, Na[+], K[+] -ATPase, ATPalpha, Na[+]K[+]ATPase, ATPBagr, Na[+]/K[+] ATPase, JY, Na-p, l(3)01453, l(3)j3B2, l(3)j3B7, l(3)j6A4, l(3)rM454, l(3)ry136" CDMC23419 3 14 5 DAC08-G10 17-CG5670-RE_5 CG5670 ACGGCTTCTTGCCCAAGAAACTGTTTGGCATTCGTAAGATGTGGGACTCAAAGGCTGTTAACGATCTAA 69 FBan0005670 FBgn0002921 Atpalpha 3 3R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; embryonic development (sensu Insecta); GO:0001700; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; septate junction assembly; GO:0019991 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; septate junction; GO:0005918; sodium:potassium-exchanging ATPase complex; GO:0005890 Atpalpha Na pump alpha subunit "CG5670, CG5670, CG5670, l(3)04492, alpha-subunit of ATPase, ATPase alpha subunit, Na[+],K[+]-ATPase alpha-subunit, l(3)01164, Na,K-ATPase alpha subunit, Na,K-ATPase, Atpalpha, Na/K-ATPase alpha-subunit, Da-47, Na+,K+ ATPase alpha-subunit., Na+/K+ ATPase alpha subunit, sodium/potassium transporting ATPase alpha, Na,K ATPase, Na,K ATPase alpha subunit, Na/K-ATPase, Na/K-ATPase alpha-subunit, Na[+]/K[+]-ATPase, Na[+]-K[+]-ATPase alpha[[5]]-subunit, Na[+],K[+]-ATPase alpha subunit, Na[+],K[+]-ATPase, Na[+]/K[+]ATPase, Na+-K+-ATPase, Atp a, ATPalpha, ATPa, NaK ATPase, Na[+], K[+] -ATPase, ATPalpha, Na[+]K[+]ATPase, ATPBagr, Na[+]/K[+] ATPase, JY, Na-p, l(3)01453, l(3)j3B2, l(3)j3B7, l(3)j6A4, l(3)rM454, l(3)ry136" CDMC23420 3 15 5 DAC08-G22 3-CG5680-RB_3 CG5680 GGGACACCAACTTCACCATCCACAGTCGGTACATTAATCTACGGCCCATAGGATCAGGTGCCCAAGGAA 69 FBan0005680 FBgn0000229 bsk 2 2L "JNK cascade; GO:0007254; JUN phosphorylation; GO:0007258; MAPKKK cascade; GO:0000165; NOT photoreceptor fate commitment (sensu Endopterygota); GO:0007459; antibacterial humoral response (sensu Protostomia); GO:0006961; cell proliferation; GO:0008283; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; embryonic morphogenesis; GO:0048598; establishment of planar polarity; GO:0001736; frizzled signaling pathway; GO:0007222; initiation of dorsal closure; GO:0007392; micropyle formation; GO:0046844; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950; wound healing; GO:0042060; wound healing, spreading of epidermal cells; GO:0035313" ATP binding; GO:0005524; ; GO:0005524; JUN kinase activity; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 bsk basket "CG5680, CG5680, D-junk, JNK, DJNK, SAPKa, D-JNK, JNK/SAPK, DJNK/bsk, dJNK, Jun-kinase, DBSK/JNK, Jun kinase, Bsk, Junk, Jun N-terminal kinase, basket" CDMC23420 3 16 5 DAC08-G22 3-CG5680-RB_3 CG5680 GGGACACCAACTTCACCATCCACAGTCGGTACATTAATCTACGGCCCATAGGATCAGGTGCCCAAGGAA 69 FBan0005680 FBgn0000229 bsk 2 2L "JNK cascade; GO:0007254; JUN phosphorylation; GO:0007258; MAPKKK cascade; GO:0000165; NOT photoreceptor fate commitment (sensu Endopterygota); GO:0007459; antibacterial humoral response (sensu Protostomia); GO:0006961; cell proliferation; GO:0008283; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; embryonic morphogenesis; GO:0048598; establishment of planar polarity; GO:0001736; frizzled signaling pathway; GO:0007222; initiation of dorsal closure; GO:0007392; micropyle formation; GO:0046844; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950; wound healing; GO:0042060; wound healing, spreading of epidermal cells; GO:0035313" ATP binding; GO:0005524; ; GO:0005524; JUN kinase activity; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004705 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004705 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 bsk basket "CG5680, CG5680, D-junk, JNK, DJNK, SAPKa, D-JNK, JNK/SAPK, DJNK/bsk, dJNK, Jun-kinase, DBSK/JNK, Jun kinase, Bsk, Junk, Jun N-terminal kinase, basket" CDMC23421 3 17 5 DAC08-K10 5-CG5712-RA_1 CG5712 GCCCCTCCACCAATGTGAACTTCAACGCCAAGTACTCGCATATCCTGCTGATGATCATAACGTTCGGCA 69 FBan0005712 FBgn0040507 ACXD 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXD ACXD "CG5712, CG5712, DACXD, AC" CDMC23421 3 18 5 DAC08-K10 5-CG5712-RA_1 CG5712 GCCCCTCCACCAATGTGAACTTCAACGCCAAGTACTCGCATATCCTGCTGATGATCATAACGTTCGGCA 69 FBan0005712 FBgn0040507 ACXD 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXD ACXD "CG5712, CG5712, DACXD, AC" CDMC23422 3 19 5 DAC08-K22 16-CG5722-RA_1 CG5722 TGGCCCTAGAGTCGGCTAGAAAGATATCCGCGAATATTACGCAAATGTTGCAGGGCAGACTAATGTCAA 69 FBan0005722 FBgn0024320 NPC1 2 2L cholesterol transport; GO:0030301; lipid metabolism; GO:0006629; lipid transport; GO:0006869 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; ; GO:0008158 integral to membrane; GO:0016021; lysosomal membrane; GO:0005765 NPC1 Niemann-Pick Type C-1 "CG5722, dmNPC1, DmNPC, dNPC1, NPC1a, Npc1_Dm, dNPC1a, Niemann-Pick Type C-1" CDMC23422 3 20 5 DAC08-K22 16-CG5722-RA_1 CG5722 TGGCCCTAGAGTCGGCTAGAAAGATATCCGCGAATATTACGCAAATGTTGCAGGGCAGACTAATGTCAA 69 FBan0005722 FBgn0024320 NPC1 2 2L cholesterol transport; GO:0030301; lipid metabolism; GO:0006629; lipid transport; GO:0006869 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; ; GO:0008158 integral to membrane; GO:0016021; lysosomal membrane; GO:0005765 NPC1 Niemann-Pick Type C-1 "CG5722, dmNPC1, DmNPC, dNPC1, NPC1a, Npc1_Dm, dNPC1a, Niemann-Pick Type C-1" CDMC23423 3 21 5 DAC08-O10 17-CG5757-RA_3 CG5757 CGCAGTTCCAGCATTGGTCAGGTGATAAACTCCTATTTAACGAACAGCAAGGATCTTCCGGATGAGGTG 69 FBan0005757 FBgn0034299 CG5757 2 2R "dTDP biosynthesis; GO:0006233; dTTP biosynthesis; GO:0006235; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" ATP binding; GO:0005524; ; GO:0005524; thymidylate kinase activity; GO:0004798 ; EC:2.7.4.9; ; GO:0004798 ; EC:2.7.4.9 CG5757 CG5757 CDMC23423 3 22 5 DAC08-O10 17-CG5757-RA_3 CG5757 CGCAGTTCCAGCATTGGTCAGGTGATAAACTCCTATTTAACGAACAGCAAGGATCTTCCGGATGAGGTG 69 FBan0005757 FBgn0034299 CG5757 2 2R "dTDP biosynthesis; GO:0006233; dTTP biosynthesis; GO:0006235; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" ATP binding; GO:0005524; ; GO:0005524; thymidylate kinase activity; GO:0004798 ; EC:2.7.4.9; ; GO:0004798 ; EC:2.7.4.9 CG5757 CG5757 CDMC23424 3 23 5 DAC08-O22 24-CG5771-RA_2 CG5771 GGAAAGAAAGCAAGCAAAACTAAACACTCCAAATTCAGTTTAAGCTGTAGAACTATAATTTATATAAAT 69 FBan0005771 FBgn0015790 Rab11 3 3R "actin cytoskeleton reorganization; GO:0031532; cellularization (sensu Metazoa); GO:0009796; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; receptor mediated endocytosis; GO:0006898; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677 Rab11 Rab-protein 11 "CG5771, CG5771, rlr7, l(3)j2D1, Drab11, DRAB11, DRab11, l(3)93Bi, rab11, rab-11, DmRab11, AAF55850, Dm Rab11, Rab-r11, lethal(3)93Bi" CDMC23424 3 24 5 DAC08-O22 24-CG5771-RA_2 CG5771 GGAAAGAAAGCAAGCAAAACTAAACACTCCAAATTCAGTTTAAGCTGTAGAACTATAATTTATATAAAT 69 FBan0005771 FBgn0015790 Rab11 3 3R "actin cytoskeleton reorganization; GO:0031532; cellularization (sensu Metazoa); GO:0009796; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; receptor mediated endocytosis; GO:0006898; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677 Rab11 Rab-protein 11 "CG5771, CG5771, rlr7, l(3)j2D1, Drab11, DRAB11, DRab11, l(3)93Bi, rab11, rab-11, DmRab11, AAF55850, Dm Rab11, Rab-r11, lethal(3)93Bi" CDMC23425 3 25 5 DAC09-C11 2-CG31647-RA_1 CG31647 CACCACCCAGCGAGTAACGAGTAACCGTGGCGTATCATCTTACCTTTTGGGCCAACCTTGAACTGGC 67 FBan0031647 FBgn0051647 CG31647 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31647 CG31647 BcDNA:RE16275 CDMC23425 3 26 5 DAC09-C11 2-CG31647-RA_1 CG31647 CACCACCCAGCGAGTAACGAGTAACCGTGGCGTATCATCTTACCTTTTGGGCCAACCTTGAACTGGC 67 FBan0031647 FBgn0051647 CG31647 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31647 CG31647 BcDNA:RE16275 CDMC23426 3 1 6 DAC09-C23 1-CG31839-RA_2 CG31839 CATCAAGAGCGGCATCAAGGGACGCCAGACCTGCCAGGCCGTCTAACTTAGACTTTCGCACTTTATT 67 FBan0031839 FBgn0028543 CG31839 2 2L cell-matrix adhesion; GO:0007160; mesoderm development; GO:0007498; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 extracellular region; GO:0005576 CG31839 CG31839 "CG16882, CG16882, BG:DS00180.7, DS00180.7, CT37470" CDMC23426 3 2 6 DAC09-C23 1-CG31839-RA_2 CG31839 CATCAAGAGCGGCATCAAGGGACGCCAGACCTGCCAGGCCGTCTAACTTAGACTTTCGCACTTTATT 67 FBan0031839 FBgn0028543 CG31839 2 2L cell-matrix adhesion; GO:0007160; mesoderm development; GO:0007498; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 extracellular region; GO:0005576 CG31839 CG31839 "CG16882, CG16882, BG:DS00180.7, DS00180.7, CT37470" CDMC23427 3 3 6 DAC09-G11 2-CG32236-RA_1 CG32236 TCCAATCTCTGGATGGAGGCTGAACTTGTACCGGCTGTTCATGATTCCCTGCACAATCACCACAGCG 67 FBan0032236 FBgn0046793 CG32236 3 3L CG32236 CG32236 "BcDNA:GH16763, NEST:bs27g09" CDMC23427 3 4 6 DAC09-G11 2-CG32236-RA_1 CG32236 TCCAATCTCTGGATGGAGGCTGAACTTGTACCGGCTGTTCATGATTCCCTGCACAATCACCACAGCG 67 FBan0032236 FBgn0046793 CG32236 3 3L CG32236 CG32236 "BcDNA:GH16763, NEST:bs27g09" CDMC23428 3 5 6 DAC09-G23 18-CG32464-RD_2 CG32464 ACCGGAAATCTACTATCCCAAACCAGTATTAGTCGAAGAAGACTCCAAGGAGCTACCCGAGCAGCAG 67 FBan0032464 FBgn0013576 l(3)82Fd 3 3R cell wall catabolism; GO:0016998 l(3)82Fd l(3)82Fd "CG10199, CG32464, CG10196, CG10199, L82, late puff gene at 82F, anon-EST:Posey263" CDMC23428 3 6 6 DAC09-G23 18-CG32464-RD_2 CG32464 ACCGGAAATCTACTATCCCAAACCAGTATTAGTCGAAGAAGACTCCAAGGAGCTACCCGAGCAGCAG 67 FBan0032464 FBgn0013576 l(3)82Fd 3 3R cell wall catabolism; GO:0016998 l(3)82Fd l(3)82Fd "CG10199, CG32464, CG10196, CG10199, L82, late puff gene at 82F, anon-EST:Posey263" CDMC23429 3 7 6 DAC09-K11 8-CG33075-RC_1 CG33075 ACATCGTCAACAAACACGCCGTAGCACACGATTCGCCTTCTCATCTCATCTCACATCACCGTTTGCC 67 FBgn0053075 CDMC23429 3 8 6 DAC09-K11 8-CG33075-RC_1 CG33075 ACATCGTCAACAAACACGCCGTAGCACACGATTCGCCTTCTCATCTCATCTCACATCACCGTTTGCC 67 FBgn0053075 CDMC23430 3 9 6 DAC09-K23 1-CG33230-RA_1 CG33230 GCTACTCCACTCCGTATTTCTGCTCCATACCCGAGCTACAGTGTCTGCCAGAATCCCTGCTAGAGCG 67 FBan0033230 FBgn0053230 CG33230 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33230 CG33230 CDMC23430 3 10 6 DAC09-K23 1-CG33230-RA_1 CG33230 GCTACTCCACTCCGTATTTCTGCTCCATACCCGAGCTACAGTGTCTGCCAGAATCCCTGCTAGAGCG 67 FBan0033230 FBgn0053230 CG33230 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33230 CG33230 CDMC23431 3 11 6 DAC09-O11 1-CG3540-RA_3 CG3540 CGAGGACTTTGTGGAGGTCTTTGACCAACAGAGCGCAACTATGGTCCAGAAGCTTTACGATCGGGCA 67 FBan0003540 FBgn0023541 Cyp4d14 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d14 Cyp4d14 "CG3540, CG3540, CYP4D14, EG:152A3.2, 4d14" CDMC23431 3 12 6 DAC09-O11 1-CG3540-RA_3 CG3540 CGAGGACTTTGTGGAGGTCTTTGACCAACAGAGCGCAACTATGGTCCAGAAGCTTTACGATCGGGCA 67 FBan0003540 FBgn0023541 Cyp4d14 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d14 Cyp4d14 "CG3540, CG3540, CYP4D14, EG:152A3.2, 4d14" CDMC23432 3 13 6 DAC09-O23 AutoBlank AutoBlank CDMC23432 3 14 6 DAC09-O23 AutoBlank AutoBlank CDMC23433 3 15 6 DAC10-C10 2-CG1835-RA_2 CG1835 CGCCCAAAGGAATCGGAAGTCTGATGTCTCCGAAAAGAAGGCAGTAGAGACAACAGTCGAATGGGGGCG 69 FBan0001835 FBgn0031127 CG1835 X X CG1835 CG1835 "anon-WO0140519.219, BcDNA:GH25431" CDMC23433 3 16 6 DAC10-C10 2-CG1835-RA_2 CG1835 CGCCCAAAGGAATCGGAAGTCTGATGTCTCCGAAAAGAAGGCAGTAGAGACAACAGTCGAATGGGGGCG 69 FBan0001835 FBgn0031127 CG1835 X X CG1835 CG1835 "anon-WO0140519.219, BcDNA:GH25431" CDMC23434 3 17 6 DAC10-C22 2-CG18374-RA_5 CG18374 TCAACGCACGGATTACTAACGACTGTTGGCTACCAACTAGGACGGAAGGCAGTCCCATTTTACGCCCTT 69 FBan0018374 FBgn0025592 Gyk 3 3L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629; transport; GO:0006810 glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; carbohydrate kinase activity; GO:0019200; ; GO:0016491 ; EC:1.-.-.-; ; GO:0019200; ; GO:0004370 ; EC:2.7.1.30 Gyk Glycerol kinase "CG18374, Glycerol kinase" CDMC23434 3 18 6 DAC10-C22 2-CG18374-RA_5 CG18374 TCAACGCACGGATTACTAACGACTGTTGGCTACCAACTAGGACGGAAGGCAGTCCCATTTTACGCCCTT 69 FBan0018374 FBgn0025592 Gyk 3 3L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629; transport; GO:0006810 glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; carbohydrate kinase activity; GO:0019200; ; GO:0016491 ; EC:1.-.-.-; ; GO:0019200; ; GO:0004370 ; EC:2.7.1.30 Gyk Glycerol kinase "CG18374, Glycerol kinase" CDMC23435 3 19 6 DAC10-G10 11-CG18432-RA_2 CG18432 TGGAGCCAGATCTCCAGATATCCATCAACGAATGCATTGGAGTGCTTTTGGAACGCTCTCTCCCAGAGA 69 FBan0018432 FBgn0034238 CG18432 2 2R CG18432 CG18432 CDMC23435 3 20 6 DAC10-G10 11-CG18432-RA_2 CG18432 TGGAGCCAGATCTCCAGATATCCATCAACGAATGCATTGGAGTGCTTTTGGAACGCTCTCTCCCAGAGA 69 FBan0018432 FBgn0034238 CG18432 2 2R CG18432 CG18432 CDMC23436 3 21 6 DAC10-G22 9-CG18468-RA_1 CG18468 TGCCGAAAACCAAGTGTCAGGAGTTTCTTCTCAGTCAGTTGCCTTTCGTGAAATCTATGGCGCAAGCGG 69 FBan0018468 FBgn0034217 CG18468 2 2R CG18468 CG18468 CDMC23436 3 22 6 DAC10-G22 9-CG18468-RA_1 CG18468 TGCCGAAAACCAAGTGTCAGGAGTTTCTTCTCAGTCAGTTGCCTTTCGTGAAATCTATGGCGCAAGCGG 69 FBan0018468 FBgn0034217 CG18468 2 2R CG18468 CG18468 CDMC23437 3 23 6 DAC10-K10 13-CG18507-RB_2 CG18507 GGTCAACCTGTGCTTCATGTACTTTGATGCCACACAGTGCGTTAATTTCCTGAACGAGTTCCTGGAGCA 69 FBan0018507 FBgn0028527 CG18507 2 2L CG18507 CG18507 "BG:DS01368.1, DS01368.1, bg:ds01368" CDMC23437 3 24 6 DAC10-K10 13-CG18507-RB_2 CG18507 GGTCAACCTGTGCTTCATGTACTTTGATGCCACACAGTGCGTTAATTTCCTGAACGAGTTCCTGGAGCA 69 FBan0018507 FBgn0028527 CG18507 2 2L CG18507 CG18507 "BG:DS01368.1, DS01368.1, bg:ds01368" CDMC23438 3 25 6 DAC10-K22 17-CG18537-RA_1 CG18537 CGACTACCTCAACTCCTACTACAAGGATGTGATAATGAAGAACTTTGCCCCCTGTTCCAATGTGCCGCA 69 FBan0018537 FBgn0034323 CG18537 2 2R CG18537 CG18537 CDMC23438 3 26 6 DAC10-K22 17-CG18537-RA_1 CG18537 CGACTACCTCAACTCCTACTACAAGGATGTGATAATGAAGAACTTTGCCCCCTGTTCCAATGTGCCGCA 69 FBan0018537 FBgn0034323 CG18537 2 2R CG18537 CG18537 CDMC23439 3 1 7 DAC10-O10 23-CG18591-RA_1 CG18591 GAAAATTTGTTTAACTCAAATTAAGTCGTCGGAAATCAGCAAAAATGTCGTTCAAAGGAAATCCCAAGG 69 FBan0018591 FBgn0031962 CG18591 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; spliceosome assembly; GO:0000245" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG18591 CG18591 BcDNA:GM19936 CDMC23439 3 2 7 DAC10-O10 23-CG18591-RA_1 CG18591 GAAAATTTGTTTAACTCAAATTAAGTCGTCGGAAATCAGCAAAAATGTCGTTCAAAGGAAATCCCAAGG 69 FBan0018591 FBgn0031962 CG18591 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; spliceosome assembly; GO:0000245" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG18591 CG18591 BcDNA:GM19936 CDMC23440 3 3 7 DAC10-O22 2-CG18605-RA_3 CG18605 CGTTCCCCGTACGACACTCTAATGGCCTATGAGTGCAGCACACAGTACCGGGCCTTGTTGGATTTTGAT 69 FBan0018605 FBgn0034411 CG18605 2 2R CG18605 CG18605 CDMC23440 3 4 7 DAC10-O22 2-CG18605-RA_3 CG18605 CGTTCCCCGTACGACACTCTAATGGCCTATGAGTGCAGCACACAGTACCGGGCCTTGTTGGATTTTGAT 69 FBan0018605 FBgn0034411 CG18605 2 2R CG18605 CG18605 CDMC23441 3 5 7 DAC11-C10 2-CG10467-RA_1 CG10467 ACCACTCCCGTGAATCTCACCAACCACTCCTATTTCAACCTAGCTGGCCACAAATCTGGAGCCAACG 67 FBan0010467 FBgn0035679 CG10467 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG10467 CG10467 CDMC23441 3 6 7 DAC11-C10 2-CG10467-RA_1 CG10467 ACCACTCCCGTGAATCTCACCAACCACTCCTATTTCAACCTAGCTGGCCACAAATCTGGAGCCAACG 67 FBan0010467 FBgn0035679 CG10467 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG10467 CG10467 CDMC23442 3 7 7 DAC11-C22 2-CG10646-RA_1 CG10646 GTGGATCCGTGGATCTTTGCTTCGCTCAGCTACGATGGTCGCGTCATAATCTCAAAGGTGCCCAAGC 67 FBan0010646 FBgn0036292 CG10646 3 3L CG10646 CG10646 anon-WO0172774.52 CDMC23442 3 8 7 DAC11-C22 2-CG10646-RA_1 CG10646 GTGGATCCGTGGATCTTTGCTTCGCTCAGCTACGATGGTCGCGTCATAATCTCAAAGGTGCCCAAGC 67 FBan0010646 FBgn0036292 CG10646 3 3L CG10646 CG10646 anon-WO0172774.52 CDMC23443 3 9 7 DAC11-G10 3-CG10946-RA_4 CG10946 CGCCAGTCGATGCATCATCCCGCATCCTGTTACCGTATCCCGTAAGTCGGCATATGAAGACACTCCG 67 FBan0010946 FBgn0029974 dpr14 X X dpr14 dpr14 "CG10946, CG10946, CG10946, CT30653, Dpr-14" CDMC23443 3 10 7 DAC11-G10 3-CG10946-RA_4 CG10946 CGCCAGTCGATGCATCATCCCGCATCCTGTTACCGTATCCCGTAAGTCGGCATATGAAGACACTCCG 67 FBan0010946 FBgn0029974 dpr14 X X dpr14 dpr14 "CG10946, CG10946, CG10946, CT30653, Dpr-14" CDMC23444 3 11 7 DAC11-G22 13-CG11051-RA_1 CG11051 AGAGTTCCGCAGCAGTTACAAAAAACCAACACAAAAATGGCCAAGCTCGCAATTTGCATCCTCGTGT 67 FBan0011051 FBgn0040813 Nplp2 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp2 Neuropeptide-like precursor 2 "CG11051, CG11051, CG11051, CG11051, NPLP2, NEF peptide, neuropeptide-like precursor 2, BcDNA:RH08410, Neuropeptide-like precursor 2" CDMC23444 3 12 7 DAC11-G22 13-CG11051-RA_1 CG11051 AGAGTTCCGCAGCAGTTACAAAAAACCAACACAAAAATGGCCAAGCTCGCAATTTGCATCCTCGTGT 67 FBan0011051 FBgn0040813 Nplp2 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp2 Neuropeptide-like precursor 2 "CG11051, CG11051, CG11051, CG11051, NPLP2, NEF peptide, neuropeptide-like precursor 2, BcDNA:RH08410, Neuropeptide-like precursor 2" CDMC23445 3 13 7 DAC11-K10 3-CG11403-RA_2 CG11403 GCAGGCAACGAATACTACGAGAATCTCTGCGTAAAGGCTGTCAACCAGTGCATAGGACGGGCAGTGC 67 FBan0011403 FBgn0026876 CG11403 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634 CG11403 CG11403 "cg11403, EG:33C11.2" CDMC23445 3 14 7 DAC11-K10 3-CG11403-RA_2 CG11403 GCAGGCAACGAATACTACGAGAATCTCTGCGTAAAGGCTGTCAACCAGTGCATAGGACGGGCAGTGC 67 FBan0011403 FBgn0026876 CG11403 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634 CG11403 CG11403 "cg11403, EG:33C11.2" CDMC23446 3 15 7 DAC11-K22 3-CG11574-RA_1 CG11574 TGATGGAGACAATTCCTCCACAACTTCGTTGACCTCTATGGAGGCCCAGTTTTCTCAGGCTCCCAGC 67 FBan0011574 FBgn0039878 CG11574 3 3R CG11574 CG11574 CDMC23446 3 16 7 DAC11-K22 3-CG11574-RA_1 CG11574 TGATGGAGACAATTCCTCCACAACTTCGTTGACCTCTATGGAGGCCCAGTTTTCTCAGGCTCCCAGC 67 FBan0011574 FBgn0039878 CG11574 3 3R CG11574 CG11574 CDMC23447 3 17 7 DAC11-O10 2-CG12192-RA_1 CG12192 GGAAGGGGATGGAGAGAAGTCTCCCGATCTCAACGAGGAATCAGAGCCAGAAATGATGGCCGACGAG 67 FBan0012192 FBgn0034827 Klp59D 2 2R intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871 Klp59D Klp59D "CG12192, CG12192, CG12192, CG12192, KLP59D, DmKlp59D" CDMC23447 3 18 7 DAC11-O10 2-CG12192-RA_1 CG12192 GGAAGGGGATGGAGAGAAGTCTCCCGATCTCAACGAGGAATCAGAGCCAGAAATGATGGCCGACGAG 67 FBan0012192 FBgn0034827 Klp59D 2 2R intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871 Klp59D Klp59D "CG12192, CG12192, CG12192, CG12192, KLP59D, DmKlp59D" CDMC23448 3 19 7 DAC11-O22 AutoBlank AutoBlank CDMC23448 3 20 7 DAC11-O22 AutoBlank AutoBlank CDMC23449 3 21 7 DAC12-C10 1-CG1028-RH_1 CG1028 ACTGACTGCATGTGGTACTGCTTTAGGCTTAGAGGATGTTGCATAAGTGGGGATAGGGCTCGGCCG 66 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC23449 3 22 7 DAC12-C10 1-CG1028-RH_1 CG1028 ACTGACTGCATGTGGTACTGCTTTAGGCTTAGAGGATGTTGCATAAGTGGGGATAGGGCTCGGCCG 66 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC23450 3 23 7 DAC12-C22 1-CG10479-RA_1 CG10479 GCTGGAATCTCCGATTGCTGTCAACTCTTAGCTGAGAATTCCCCCAACACCATGAGCAAACGCCGT 66 FBan0010479 FBgn0035656 CG10479 3 3L CG10479 CG10479 CDMC23450 3 24 7 DAC12-C22 1-CG10479-RA_1 CG10479 GCTGGAATCTCCGATTGCTGTCAACTCTTAGCTGAGAATTCCCCCAACACCATGAGCAAACGCCGT 66 FBan0010479 FBgn0035656 CG10479 3 3L CG10479 CG10479 CDMC23451 3 25 7 DAC12-G10 3-CG10965-RA_7 CG10965 AAAGGATGGCCGATATCAGGAGCAGCTTGAAGGTTCTCTTCCAGGGCGAGACCAACCTCATCACTT 66 FBan0010965 FBgn0030028 Corp X X "DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630" Corp Companion of reaper "CG10965, CG10965" CDMC23451 3 26 7 DAC12-G10 3-CG10965-RA_7 CG10965 AAAGGATGGCCGATATCAGGAGCAGCTTGAAGGTTCTCTTCCAGGGCGAGACCAACCTCATCACTT 66 FBan0010965 FBgn0030028 Corp X X "DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630" Corp Companion of reaper "CG10965, CG10965" CDMC23452 3 1 8 DAC12-G22 3-CG1102-RA_5 CG1102 ATCAAGCTGAAGGCTGAGTTGGATACGGTACCGACGTCCGAATGCAACCAAAGATACGCCACCCAA 66 FBan0001102 FBgn0027930 CG1102 3 3R "defense response; GO:0006952; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG1102 CG1102 "proPO-AE, SP25, BEST:GH02921" CDMC23452 3 2 8 DAC12-G22 3-CG1102-RA_5 CG1102 ATCAAGCTGAAGGCTGAGTTGGATACGGTACCGACGTCCGAATGCAACCAAAGATACGCCACCCAA 66 FBan0001102 FBgn0027930 CG1102 3 3R "defense response; GO:0006952; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG1102 CG1102 "proPO-AE, SP25, BEST:GH02921" CDMC23453 3 3 8 DAC12-K10 1-CG11268-RA_1 CG11268 GCTGGCTGTTCTTCCACGATCGCATCTACGTCGAGGAGTACTCCCTGCTCAACTTCTTCCAGTCGG 66 FBan0011268 FBgn0036336 CG11268 3 3L C-terminal protein amino acid methylation; GO:0006481; protein amino acid methylation; GO:0006479; signal transduction; GO:0007165 protein-S-isoprenylcysteine O-methyltransferase activity; GO:0004671 ; EC:2.1.1.100; ; GO:0004671 ; EC:2.1.1.100 integral to membrane; GO:0016021 CG11268 CG11268 CDMC23453 3 4 8 DAC12-K10 1-CG11268-RA_1 CG11268 GCTGGCTGTTCTTCCACGATCGCATCTACGTCGAGGAGTACTCCCTGCTCAACTTCTTCCAGTCGG 66 FBan0011268 FBgn0036336 CG11268 3 3L C-terminal protein amino acid methylation; GO:0006481; protein amino acid methylation; GO:0006479; signal transduction; GO:0007165 protein-S-isoprenylcysteine O-methyltransferase activity; GO:0004671 ; EC:2.1.1.100; ; GO:0004671 ; EC:2.1.1.100 integral to membrane; GO:0016021 CG11268 CG11268 CDMC23454 3 5 8 DAC12-K22 3-CG11453-RA_1 CG11453 TCTCCTGGGAGGTGATCATACCGTCGCTATTCTCTGTACTTCGGGAACTACGGGTCTGCCAAAGGC 66 FBan0011453 FBgn0038734 CG11453 3 3R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016207 ; EC:6.2.1.12 CG11453 CG11453 CDMC23454 3 6 8 DAC12-K22 3-CG11453-RA_1 CG11453 TCTCCTGGGAGGTGATCATACCGTCGCTATTCTCTGTACTTCGGGAACTACGGGTCTGCCAAAGGC 66 FBan0011453 FBgn0038734 CG11453 3 3R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016207 ; EC:6.2.1.12 CG11453 CG11453 CDMC23455 3 7 8 DAC12-O10 2-CG12155-RA_5 CG12155 ACGCAGCAAATTTCCCTGGTGGATGTAACAGAGGCGACCAGTACCAGTGTGACGATTTCAAGCACG 66 FBan0012155 FBgn0029957 CG12155 X X CG12155 CG12155 CDMC23455 3 8 8 DAC12-O10 2-CG12155-RA_5 CG12155 ACGCAGCAAATTTCCCTGGTGGATGTAACAGAGGCGACCAGTACCAGTGTGACGATTTCAAGCACG 66 FBan0012155 FBgn0029957 CG12155 X X CG12155 CG12155 CDMC23456 3 9 8 DAC12-O22 AutoBlank AutoBlank CDMC23456 3 10 8 DAC12-O22 AutoBlank AutoBlank CDMC23457 3 11 8 DAC13-C10 1-CG1454-RA_1 CG1454 TCGACGAATGCTCTACCAGTGCGATCTGGGAACTACTATCTACCCGCCTTTACGCTGAATGCACACGGA 69 FBan0001454 FBgn0005642 wdn 3 3R "cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wdn wings down "CG1454, pqp: pourquoi-pas, sry-h1, pourquoi-pas?, sry h-l, Sryc: Serendipity cognate, sry-c: serendipity-cognate, Serendipity cognate, pourquoi-pas, serendipity-cognate, pqp" CDMC23457 3 12 8 DAC13-C10 1-CG1454-RA_1 CG1454 TCGACGAATGCTCTACCAGTGCGATCTGGGAACTACTATCTACCCGCCTTTACGCTGAATGCACACGGA 69 FBan0001454 FBgn0005642 wdn 3 3R "cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wdn wings down "CG1454, pqp: pourquoi-pas, sry-h1, pourquoi-pas?, sry h-l, Sryc: Serendipity cognate, sry-c: serendipity-cognate, Serendipity cognate, pourquoi-pas, serendipity-cognate, pqp" CDMC23458 3 13 8 DAC13-C22 3-CG14563-RA_1 CG14563 CGGATACCCCTACAGCTACGGCGGATATCCGTACTACTCGTATCCCGGCTACAACCCGTACTCGATGTA 69 FBan0014563 FBgn0037139 CG14563 3 3L CG14563 CG14563 CDMC23458 3 14 8 DAC13-C22 3-CG14563-RA_1 CG14563 CGGATACCCCTACAGCTACGGCGGATATCCGTACTACTCGTATCCCGGCTACAACCCGTACTCGATGTA 69 FBan0014563 FBgn0037139 CG14563 3 3L CG14563 CG14563 CDMC23459 3 15 8 DAC13-G10 9-CG14609-RA_7 CG14609 TCGCCAGCCCAAATTACTACGTGCGCAGTATCCCAACTCGTACTTGAAGCTCCCGTTGCTAAAATTCGA 69 FBan0014609 FBgn0037483 CG14609 3 3R CG14609 CG14609 CDMC23459 3 16 8 DAC13-G10 9-CG14609-RA_7 CG14609 TCGCCAGCCCAAATTACTACGTGCGCAGTATCCCAACTCGTACTTGAAGCTCCCGTTGCTAAAATTCGA 69 FBan0014609 FBgn0037483 CG14609 3 3R CG14609 CG14609 CDMC23460 3 17 8 DAC13-G22 14-CG1461-RA_1 CG1461 GGCTCCAAGCTATCCCTTAACACGCACAATCGCATTCGGAACATTGTCGAGTCGCTAAAGATCAAACCG 69 FBan0001461 FBgn0030558 CG1461 X X amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; biosynthesis; GO:0009058; metal ion transport; GO:0030001 metal ion binding; GO:0046872; tyrosine transaminase activity; GO:0004838 ; EC:2.6.1.5; ; GO:0004838 ; EC:2.6.1.5; ; GO:0046872; 1-aminocyclopropane-1-carboxylate synthase activity; GO:0016847 ; EC:4.4.1.14; ; GO:0016847 ; EC:4.4.1.14 CG1461 CG1461 CDMC23460 3 18 8 DAC13-G22 14-CG1461-RA_1 CG1461 GGCTCCAAGCTATCCCTTAACACGCACAATCGCATTCGGAACATTGTCGAGTCGCTAAAGATCAAACCG 69 FBan0001461 FBgn0030558 CG1461 X X amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; biosynthesis; GO:0009058; metal ion transport; GO:0030001 metal ion binding; GO:0046872; tyrosine transaminase activity; GO:0004838 ; EC:2.6.1.5; ; GO:0004838 ; EC:2.6.1.5; ; GO:0046872; 1-aminocyclopropane-1-carboxylate synthase activity; GO:0016847 ; EC:4.4.1.14; ; GO:0016847 ; EC:4.4.1.14 CG1461 CG1461 CDMC23461 3 19 8 DAC13-K10 17-CG14659-RA_1 CG14659 AGGAGCGTGATATACACAGGATGGAGACCAAGTTGAAGATAAAGAAGGAGGCCAACTTCATTCCACCCA 69 FBan0014659 FBgn0037284 CG14659 3 3R CG14659 CG14659 CDMC23461 3 20 8 DAC13-K10 17-CG14659-RA_1 CG14659 AGGAGCGTGATATACACAGGATGGAGACCAAGTTGAAGATAAAGAAGGAGGCCAACTTCATTCCACCCA 69 FBan0014659 FBgn0037284 CG14659 3 3R CG14659 CG14659 CDMC23462 3 21 8 DAC13-K22 15-CG14668-RA_2 CG14668 AGCCAGCAATGCAATAAGAGGCTCCAAATTTCACTGATACATCATGCAAGCCGGGAATTCAGCCACTCT 69 FBan0014668 FBgn0037320 CG14668 3 3R CG14668 CG14668 CDMC23462 3 22 8 DAC13-K22 15-CG14668-RA_2 CG14668 AGCCAGCAATGCAATAAGAGGCTCCAAATTTCACTGATACATCATGCAAGCCGGGAATTCAGCCACTCT 69 FBan0014668 FBgn0037320 CG14668 3 3R CG14668 CG14668 CDMC23463 3 23 8 DAC13-O10 15-CG14701-RA_1 CG14701 TCCCAGCTGCTCCCTAGTCATCAAGGTCATATACGATCCGGAGATGTTCAAAGCTGAGGAGGATGAAGA 69 FBan0014701 FBgn0037883 CG14701 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14701 CG14701 CDMC23463 3 24 8 DAC13-O10 15-CG14701-RA_1 CG14701 TCCCAGCTGCTCCCTAGTCATCAAGGTCATATACGATCCGGAGATGTTCAAAGCTGAGGAGGATGAAGA 69 FBan0014701 FBgn0037883 CG14701 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14701 CG14701 CDMC23464 3 25 8 DAC13-O22 23-CG14715-RA_2 CG14715 GAATAGGGCCACAAATAGGCATTCCATGCTACACCCAAAGTTTACTTTCAACTAAAGTCATAAACATTT 69 FBan0014715 FBgn0037930 CG14715 3 3R calcium-mediated signaling; GO:0019722; protein folding; GO:0006457; regulation of progression through cell cycle; GO:0000074 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG14715 CG14715 "BcDNA:GM09283, BcDNA:RH50927" CDMC23464 3 26 8 DAC13-O22 23-CG14715-RA_2 CG14715 GAATAGGGCCACAAATAGGCATTCCATGCTACACCCAAAGTTTACTTTCAACTAAAGTCATAAACATTT 69 FBan0014715 FBgn0037930 CG14715 3 3R calcium-mediated signaling; GO:0019722; protein folding; GO:0006457; regulation of progression through cell cycle; GO:0000074 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG14715 CG14715 "BcDNA:GM09283, BcDNA:RH50927" CDMC23465 3 1 9 DAC14-C10 1-CG17327-RA_1 CG17327 GAGCCAGAAGTATGCCCACGTCAAGTAGCATCCTGCAGAAGTTCCTCAGCAACGGTTTGGCCTTC 65 FBan0017327 FBgn0038107 CG17327 3 3R CG17327 CG17327 CDMC23465 3 2 9 DAC14-C10 1-CG17327-RA_1 CG17327 GAGCCAGAAGTATGCCCACGTCAAGTAGCATCCTGCAGAAGTTCCTCAGCAACGGTTTGGCCTTC 65 FBan0017327 FBgn0038107 CG17327 3 3R CG17327 CG17327 CDMC23466 3 3 9 DAC14-C22 3-CG17367-RA_2 CG17367 TTTCCGGAGCAAGTCTATTTCCATTTGGATCCCACAACGCTAACAGTGCACGGATCACCGCCACC 65 FBan0017367 FBgn0028717 Lnk 3 3R B cell mediated immunity; GO:0019724; JAK-STAT cascade; GO:0007259; MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cellular defense response; GO:0006968; cytoskeleton organization and biogenesis; GO:0007010; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 signal transducer activity; GO:0004871; ; GO:0004871 cellular component unknown; GO:0008372 Lnk Lnk "CG5908, CG17367, CG5908" CDMC23466 3 4 9 DAC14-C22 3-CG17367-RA_2 CG17367 TTTCCGGAGCAAGTCTATTTCCATTTGGATCCCACAACGCTAACAGTGCACGGATCACCGCCACC 65 FBan0017367 FBgn0028717 Lnk 3 3R B cell mediated immunity; GO:0019724; JAK-STAT cascade; GO:0007259; MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cellular defense response; GO:0006968; cytoskeleton organization and biogenesis; GO:0007010; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 signal transducer activity; GO:0004871; ; GO:0004871 cellular component unknown; GO:0008372 Lnk Lnk "CG5908, CG17367, CG5908" CDMC23467 3 5 9 DAC14-G10 2-CG17565-RA_2 CG17565 GTGCCATAGACCGACCGACTTTGGTCCAGTTCCTGTTCAGTGTACGTGACTCAGACGGCTCCTTC 65 FBan0017565 FBgn0038424 CG17565 3 3R protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60 Rab-protein geranylgeranyltransferase complex; GO:0005968 CG17565 CG17565 CDMC23467 3 6 9 DAC14-G10 2-CG17565-RA_2 CG17565 GTGCCATAGACCGACCGACTTTGGTCCAGTTCCTGTTCAGTGTACGTGACTCAGACGGCTCCTTC 65 FBan0017565 FBgn0038424 CG17565 3 3R protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60 Rab-protein geranylgeranyltransferase complex; GO:0005968 CG17565 CG17565 CDMC23468 3 7 9 DAC14-G22 23-CG17622-RA_1 CG17622 CACTGATGGTGAAATCATTGAATTTGCCCAAAGACGATAGCAATTTGGTCTATCGCCGCAAATCC 65 FBan0017622 FBgn0038998 CG17622 3 3R CG17622 CG17622 CDMC23468 3 8 9 DAC14-G22 23-CG17622-RA_1 CG17622 CACTGATGGTGAAATCATTGAATTTGCCCAAAGACGATAGCAATTTGGTCTATCGCCGCAAATCC 65 FBan0017622 FBgn0038998 CG17622 3 3R CG17622 CG17622 CDMC23469 3 9 9 DAC14-K10 15-CG17737-RA_2 CG17737 GGGCGATCAGCGTGAGAACATCTGTCAATGGTTGACGAAGGTGGGTCTAGCTAAGCCGGATCAGC 65 FBan0017737 FBgn0035423 CG17737 3 3L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 CG17737 CG17737 "BcDNA:RE14985, anon-EST:Posey272" CDMC23469 3 10 9 DAC14-K10 15-CG17737-RA_2 CG17737 GGGCGATCAGCGTGAGAACATCTGTCAATGGTTGACGAAGGTGGGTCTAGCTAAGCCGGATCAGC 65 FBan0017737 FBgn0035423 CG17737 3 3L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 CG17737 CG17737 "BcDNA:RE14985, anon-EST:Posey272" CDMC23470 3 11 9 DAC14-K22 21-CG17777-RA_1 CG17777 GAAGAAGACGGAGAAGAGAGGCATCTACGGGTTCGGCCACGGCTATGGCGGCTACGGCGGATACG 65 FBan0017777 FBgn0040900 CG17777 X X CG17777 CG17777 CDMC23470 3 12 9 DAC14-K22 21-CG17777-RA_1 CG17777 GAAGAAGACGGAGAAGAGAGGCATCTACGGGTTCGGCCACGGCTATGGCGGCTACGGCGGATACG 65 FBan0017777 FBgn0040900 CG17777 X X CG17777 CG17777 CDMC23471 3 13 9 DAC14-O10 3-CG17952-RB_1 CG17952 TACCGTCTCTCCCTGGTGACCACCTTGATCTATGCCACCTGCTACATCTACCAGACGCTCGTGTG 65 FBan0017952 FBgn0034657 LBR 2 2R receptor activity; GO:0004872; lamin binding; GO:0005521; ; GO:0004872; ; GO:0005521 nuclear inner membrane; GO:0005637 LBR Lamin B receptor "CG17952, CG17952, CG17952, CG17952, CG17952, dLBR, Lamin B receptor" CDMC23471 3 14 9 DAC14-O10 3-CG17952-RB_1 CG17952 TACCGTCTCTCCCTGGTGACCACCTTGATCTATGCCACCTGCTACATCTACCAGACGCTCGTGTG 65 FBan0017952 FBgn0034657 LBR 2 2R receptor activity; GO:0004872; lamin binding; GO:0005521; ; GO:0004872; ; GO:0005521 nuclear inner membrane; GO:0005637 LBR Lamin B receptor "CG17952, CG17952, CG17952, CG17952, CG17952, dLBR, Lamin B receptor" CDMC23472 3 15 9 DAC14-O22 AutoBlank AutoBlank CDMC23472 3 16 9 DAC14-O22 AutoBlank AutoBlank CDMC23473 3 17 9 DAC15-C10 2-CG12926-RA_1 CG12926 GCAGGCTGATGGTCCTCGCATCCACATCTCCCGCTACGGTCAATACGACTCGAAGAAGTACTCCATTG 68 FBan0012926 FBgn0033437 CG12926 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG12926 CG12926 CDMC23473 3 18 9 DAC15-C10 2-CG12926-RA_1 CG12926 GCAGGCTGATGGTCCTCGCATCCACATCTCCCGCTACGGTCAATACGACTCGAAGAAGTACTCCATTG 68 FBan0012926 FBgn0033437 CG12926 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG12926 CG12926 CDMC23474 3 19 9 DAC15-C22 2-CG13085-RA_1 CG13085 TGCAGCCGCAACTACTCAACAGATTGCCATCGCTGAAGCTCATTCACCTAACCACCTTGGGTTCCATG 68 FBan0013085 FBgn0032780 CG13085 2 2L CG13085 CG13085 CDMC23474 3 20 9 DAC15-C22 2-CG13085-RA_1 CG13085 TGCAGCCGCAACTACTCAACAGATTGCCATCGCTGAAGCTCATTCACCTAACCACCTTGGGTTCCATG 68 FBan0013085 FBgn0032780 CG13085 2 2L CG13085 CG13085 CDMC23475 3 21 9 DAC15-G10 2-CG13524-RA_2 CG13524 CCTGTCGAAGCCCCTCTTCAAGCAAATGTCCAAGCAATTCTGCGATCCGAAGTCTAGTGTCGTCCTGG 68 FBan0013524 FBgn0034769 Obp58c 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp58c Odorant-binding protein 58c "CG13524, CG13524, AAF46892, Odorant-binding protein 58c" CDMC23475 3 22 9 DAC15-G10 2-CG13524-RA_2 CG13524 CCTGTCGAAGCCCCTCTTCAAGCAAATGTCCAAGCAATTCTGCGATCCGAAGTCTAGTGTCGTCCTGG 68 FBan0013524 FBgn0034769 Obp58c 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp58c Odorant-binding protein 58c "CG13524, CG13524, AAF46892, Odorant-binding protein 58c" CDMC23476 3 23 9 DAC15-G22 1-CG1367-RA_1 CG1367 TGGCTAAAGAAAATTGGCAAGAAAATCGAACGTGTTGGTCAGCACACTCGCGACGCCACAATCCAGGG 68 FBan0001367 FBgn0000277 CecA2 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecA2 Cecropin A2 "CG1367, CG1367, CG1367, CecA, Cecropin, cecropin, cecropin A, cecropin A2, cec, cecA, cecA2, Cec, Cecropin A" CDMC23476 3 24 9 DAC15-G22 1-CG1367-RA_1 CG1367 TGGCTAAAGAAAATTGGCAAGAAAATCGAACGTGTTGGTCAGCACACTCGCGACGCCACAATCCAGGG 68 FBan0001367 FBgn0000277 CecA2 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecA2 Cecropin A2 "CG1367, CG1367, CG1367, CecA, Cecropin, cecropin, cecropin A, cecropin A2, cec, cecA, cecA2, Cec, Cecropin A" CDMC23477 3 25 9 DAC15-K10 3-CG1391-RB_3 CG1391 TGGATGGCAGTGACGCAATTTCGATGCTACCCCGCGATATGTCGCTGTTCGAATCCTGATTTGCATGC 68 FBan0001391 FBgn0003464 sol X X ectoderm development; GO:0007398; nervous system development; GO:0007399; proteolysis; GO:0006508; visual behavior; GO:0007632 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622 sol small optic lobes "CG1391, DmSol, CalpD, SOL, small optic lobe, PC79, nofE, w5000, small optic lobes" CDMC23477 3 26 9 DAC15-K10 3-CG1391-RB_3 CG1391 TGGATGGCAGTGACGCAATTTCGATGCTACCCCGCGATATGTCGCTGTTCGAATCCTGATTTGCATGC 68 FBan0001391 FBgn0003464 sol X X ectoderm development; GO:0007398; nervous system development; GO:0007399; proteolysis; GO:0006508; visual behavior; GO:0007632 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622 sol small optic lobes "CG1391, DmSol, CalpD, SOL, small optic lobe, PC79, nofE, w5000, small optic lobes" CDMC23478 3 1 10 DAC15-K22 2-CG14079-RA_1 CG14079 GCCATTTGGATCAGCCTCGAAAGCAGCAAACCGTGTGTCATGGGAGGCAATCCAATTGTTGTCCAAGT 68 FBan0014079 FBgn0036849 CG14079 3 3L CG14079 CG14079 CDMC23478 3 2 10 DAC15-K22 2-CG14079-RA_1 CG14079 GCCATTTGGATCAGCCTCGAAAGCAGCAAACCGTGTGTCATGGGAGGCAATCCAATTGTTGTCCAAGT 68 FBan0014079 FBgn0036849 CG14079 3 3L CG14079 CG14079 CDMC23479 3 3 10 DAC15-O10 1-CG14514-RA_1 CG14514 CCGGAACTAATAGATCACCAAGCCACTAGGGAAGCACAAAGCAAGTCAGGCAAGGACACAGCGGGAAA 68 FBan0014514 FBgn0039654 Brd8 3 3R Brd8 Brd8 "CG14514, CG14514, CG14514, dBrd8" CDMC23479 3 4 10 DAC15-O10 1-CG14514-RA_1 CG14514 CCGGAACTAATAGATCACCAAGCCACTAGGGAAGCACAAAGCAAGTCAGGCAAGGACACAGCGGGAAA 68 FBan0014514 FBgn0039654 Brd8 3 3R Brd8 Brd8 "CG14514, CG14514, CG14514, dBrd8" CDMC23480 3 5 10 DAC15-O22 AutoBlank AutoBlank CDMC23480 3 6 10 DAC15-O22 AutoBlank AutoBlank CDMC23481 3 7 10 DAC16-C10 5-CG31093-RA_1 CG31093 GGCCAACTGAGTGAAAGGGGTTTTGCATGCGATTAGACCAGCTGATGGGACGGGTGATGTTAGCC 65 FBan0031093 FBgn0051093 CG31093 3 3R CG31093 CG31093 "CG4964, BcDNA:AT30660" CDMC23481 3 8 10 DAC16-C10 5-CG31093-RA_1 CG31093 GGCCAACTGAGTGAAAGGGGTTTTGCATGCGATTAGACCAGCTGATGGGACGGGTGATGTTAGCC 65 FBan0031093 FBgn0051093 CG31093 3 3R CG31093 CG31093 "CG4964, BcDNA:AT30660" CDMC23482 3 9 10 DAC16-C22 2-CG31132-RA_2 CG31132 CAACAACCAGCGGTTTCCACCCACGATCACAACTACCTAGGCAACGTGAATTCATCGAGGGCACC 65 FBgn0051132 CDMC23482 3 10 10 DAC16-C22 2-CG31132-RA_2 CG31132 CAACAACCAGCGGTTTCCACCCACGATCACAACTACCTAGGCAACGTGAATTCATCGAGGGCACC 65 FBgn0051132 CDMC23483 3 11 10 DAC16-G10 6-CG31256-RA_1 CG31256 CTACGATCTGCCCGGACCCAGTAGGAAACGTCCCAAACTTGAAGTGGGTCTGCCAGTCAGCAAAG 65 FBan0031256 FBgn0038499 Brf 3 3R regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor binding; GO:0008134; RNA polymerase III transcription factor activity; GO:0003709; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003709; ; GO:0008134 nucleus; GO:0005634; transcription factor TFIIIB complex; GO:0000126; transcription factor complex; GO:0005667 Brf Brf "CG31256, CG4155, CG5419, BRF, BRF1, TFIIIB" CDMC23483 3 12 10 DAC16-G10 6-CG31256-RA_1 CG31256 CTACGATCTGCCCGGACCCAGTAGGAAACGTCCCAAACTTGAAGTGGGTCTGCCAGTCAGCAAAG 65 FBan0031256 FBgn0038499 Brf 3 3R regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor binding; GO:0008134; RNA polymerase III transcription factor activity; GO:0003709; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003709; ; GO:0008134 nucleus; GO:0005634; transcription factor TFIIIB complex; GO:0000126; transcription factor complex; GO:0005667 Brf Brf "CG31256, CG4155, CG5419, BRF, BRF1, TFIIIB" CDMC23484 3 13 10 DAC16-G22 3-CG31280-RA_2 CG31280 CATGGGCAAGCCGTACGATGGTCTTGGATCGCTGATCAATCTGGTTTTCCTCTCCATCTCGCTGG 65 FBan0031280 FBgn0041225 Gr94a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr94a Gustatory receptor 94a "CG31280, 94E.1, Gustatory receptor 94E.1, Gr94E1, GR94E.1, Gustatory receptor 94a" CDMC23484 3 14 10 DAC16-G22 3-CG31280-RA_2 CG31280 CATGGGCAAGCCGTACGATGGTCTTGGATCGCTGATCAATCTGGTTTTCCTCTCCATCTCGCTGG 65 FBan0031280 FBgn0041225 Gr94a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr94a Gustatory receptor 94a "CG31280, 94E.1, Gustatory receptor 94E.1, Gr94E1, GR94E.1, Gustatory receptor 94a" CDMC23485 3 15 10 DAC16-K10 13-CG31388-RA_1 CG31388 GCACCAAGTGCAAGAGCCAATTCCACAATCACATTCTGCTGGAGACTCACAAACAGCGGTGTCTC 65 FBan0031388 FBgn0051388 CG31388 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31388 CG31388 "CG17722, CG5135, BcDNA:GH10523" CDMC23485 3 16 10 DAC16-K10 13-CG31388-RA_1 CG31388 GCACCAAGTGCAAGAGCCAATTCCACAATCACATTCTGCTGGAGACTCACAAACAGCGGTGTCTC 65 FBan0031388 FBgn0051388 CG31388 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31388 CG31388 "CG17722, CG5135, BcDNA:GH10523" CDMC23486 3 17 10 DAC16-K22 3-CG31426-RA_1 CG31426 GTGCGCCCCGACGACACTCTGATCGAGCTGTATGGTAACAGAGAGGTTTCGCTAAGCGAGATGTG 65 FBan0031426 FBgn0041588 ligatin 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 ligatin ligatin "CG31426, Ligatin, BcDNA:LD24540, ligatin" CDMC23486 3 18 10 DAC16-K22 3-CG31426-RA_1 CG31426 GTGCGCCCCGACGACACTCTGATCGAGCTGTATGGTAACAGAGAGGTTTCGCTAAGCGAGATGTG 65 FBan0031426 FBgn0041588 ligatin 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 ligatin ligatin "CG31426, Ligatin, BcDNA:LD24540, ligatin" CDMC23487 3 19 10 DAC16-O10 8-CG31543-RA_1 CG31543 GCCTGAAGATCCTCAACGAGGTTCGAAGCATGTACAACGCAGGAGCCTTCCAGGATGGCCAAGTG 65 FBan0031543 FBgn0037308 Hph 3 3R protein localization; GO:0008104; protein metabolism; GO:0019538; response to hypoxia; GO:0001666; tracheal system development (sensu Insecta); GO:0007424 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-; peptidyl-proline 4-dioxygenase activity; GO:0031545; ; GO:0031545" Hph HIF prolyl hydroxylase "CG1114, CG14665, CG31543, CG1114, CG14665, CG1114, CG31543, l(3)02255, Dm.egl-9, dmHPH, fatiga, HIF-1a prolyl hyroxylase, fga, HIF prolyl 4-hydroxylase, hph, anon-EST:Posey69, HIF prolyl hydroxylase" CDMC23487 3 20 10 DAC16-O10 8-CG31543-RA_1 CG31543 GCCTGAAGATCCTCAACGAGGTTCGAAGCATGTACAACGCAGGAGCCTTCCAGGATGGCCAAGTG 65 FBan0031543 FBgn0037308 Hph 3 3R protein localization; GO:0008104; protein metabolism; GO:0019538; response to hypoxia; GO:0001666; tracheal system development (sensu Insecta); GO:0007424 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-; peptidyl-proline 4-dioxygenase activity; GO:0031545; ; GO:0031545" Hph HIF prolyl hydroxylase "CG1114, CG14665, CG31543, CG1114, CG14665, CG1114, CG31543, l(3)02255, Dm.egl-9, dmHPH, fatiga, HIF-1a prolyl hyroxylase, fga, HIF prolyl 4-hydroxylase, hph, anon-EST:Posey69, HIF prolyl hydroxylase" CDMC23488 3 21 10 DAC16-O22 AutoBlank AutoBlank CDMC23488 3 22 10 DAC16-O22 AutoBlank AutoBlank CDMC23489 3 23 10 DAC17-C10 3-CG32727-RA_1 CG32727 ATGCTGGCTAAACATCCGGATCGAAACGGCTCACCATATCTGGCGGGAAAAATCCACAAGCCCAA 65 FBan0032727 FBgn0052727 CG32727 X X response to heat; GO:0009408 CG32727 CG32727 CDMC23489 3 24 10 DAC17-C10 3-CG32727-RA_1 CG32727 ATGCTGGCTAAACATCCGGATCGAAACGGCTCACCATATCTGGCGGGAAAAATCCACAAGCCCAA 65 FBan0032727 FBgn0052727 CG32727 X X response to heat; GO:0009408 CG32727 CG32727 CDMC23490 3 25 10 DAC17-C22 23-CG32794-RA_2 CG32794 GCACCCAATGCCAAAAATCAATTGCTTGGCCTAGAATCTAGAAAACGATCTCTCAGTGTGTGACT 65 FBan0032794 FBgn0052794 CG32794 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32794 CG32794 CDMC23490 3 26 10 DAC17-C22 23-CG32794-RA_2 CG32794 GCACCCAATGCCAAAAATCAATTGCTTGGCCTAGAATCTAGAAAACGATCTCTCAGTGTGTGACT 65 FBan0032794 FBgn0052794 CG32794 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32794 CG32794 CDMC23491 3 1 11 DAC17-G10 3-CG32922-RB_1 CG32922 TGGGCCCGATGAAGAAGAGTTATATGCGGATGAGCTGGAACTAGACATGGATGACCGAGTGGCCG 65 FBgn0052922 CDMC23491 3 2 11 DAC17-G10 3-CG32922-RB_1 CG32922 TGGGCCCGATGAAGAAGAGTTATATGCGGATGAGCTGGAACTAGACATGGATGACCGAGTGGCCG 65 FBgn0052922 CDMC23492 3 3 11 DAC17-G22 1-CG33008-RC_1 CG33008 TGACGGCCATGGAAAGATGATTGGAAGAGCAAAAGCCTAGACACTAGCAGCACCCTTGACCTCCG 65 FBgn0053008 CDMC23492 3 4 11 DAC17-G22 1-CG33008-RC_1 CG33008 TGACGGCCATGGAAAGATGATTGGAAGAGCAAAAGCCTAGACACTAGCAGCACCCTTGACCTCCG 65 FBgn0053008 CDMC23493 3 5 11 DAC17-K10 9-CG33138-RA_7 CG33138 CTATCGCTTCGACGGAGTGACCTCTATGCTATACCATTCCCGTGGCATTGGGGAGGGCTTCAGCG 65 FBan0033138 FBgn0053138 CG33138 2 2R glycogen metabolism; GO:0005977 "alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; 1,4-alpha-glucan branching enzyme activity; GO:0003844 ; EC:2.4.1.18; ; GO:0003844 ; EC:2.4.1.18; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-; ; GO:0004556 ; EC:3.2.1.1" CG33138 CG33138 "CG4023, CG4023" CDMC23493 3 6 11 DAC17-K10 9-CG33138-RA_7 CG33138 CTATCGCTTCGACGGAGTGACCTCTATGCTATACCATTCCCGTGGCATTGGGGAGGGCTTCAGCG 65 FBan0033138 FBgn0053138 CG33138 2 2R glycogen metabolism; GO:0005977 "alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; 1,4-alpha-glucan branching enzyme activity; GO:0003844 ; EC:2.4.1.18; ; GO:0003844 ; EC:2.4.1.18; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-; ; GO:0004556 ; EC:3.2.1.1" CG33138 CG33138 "CG4023, CG4023" CDMC23494 3 7 11 DAC17-K22 3-CG33160-RA_1 CG33160 ATATCTCGTACAGGTCACCACATCAGAGGAGCTATGTGGCGGATCACTGGTTAAGCCGCGTTGGG 65 FBan0033160 FBgn0053160 CG33160 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33160 CG33160 "CG11531, CG11531, SP183" CDMC23494 3 8 11 DAC17-K22 3-CG33160-RA_1 CG33160 ATATCTCGTACAGGTCACCACATCAGAGGAGCTATGTGGCGGATCACTGGTTAAGCCGCGTTGGG 65 FBan0033160 FBgn0053160 CG33160 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33160 CG33160 "CG11531, CG11531, SP183" CDMC23495 3 9 11 DAC17-O10 2-CG33264-RB_1 CG33264 AGCGGCCCAACTTCCCAGATACACGTGGAATGGCAGACGATCCTTGGAAGTTAAACGCAACTTGG 65 FBgn0036326 CDMC23495 3 10 11 DAC17-O10 2-CG33264-RB_1 CG33264 AGCGGCCCAACTTCCCAGATACACGTGGAATGGCAGACGATCCTTGGAAGTTAAACGCAACTTGG 65 FBgn0036326 CDMC23496 3 11 11 DAC17-O22 AutoBlank AutoBlank CDMC23496 3 12 11 DAC17-O22 AutoBlank AutoBlank CDMC23497 3 13 11 DAC18-C10 2-CG5996-RA_6 CG5996 CAGCACAATCCAGCCCAATTGGTCAAACCAAGACGACATGAGCAGACGCAGAGTCAACACGATTCGGT 68 FBan0005996 FBgn0032593 trpgamma 2 2L L-phenylalanine biosynthesis; GO:0009094; calcium ion transport; GO:0006816; cation transport; GO:0006812; detection of light stimulus during visual perception; GO:0050908; response to light stimulus; GO:0009416 calcium channel activity; GO:0005262; cation channel activity; GO:0005261; protein binding; GO:0005515; ; GO:0005262; ; GO:0005261; prephenate dehydratase activity; GO:0004664 ; EC:4.2.1.51; ; GO:0004664 ; EC:4.2.1.51; ; GO:0005262; ; GO:0005515; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; rhabdomere; GO:0016028 trpgamma trpgamma "CG5996, TRPgamma, trp-gamma, dTRPg, TRPgamma" CDMC23497 3 14 11 DAC18-C10 2-CG5996-RA_6 CG5996 CAGCACAATCCAGCCCAATTGGTCAAACCAAGACGACATGAGCAGACGCAGAGTCAACACGATTCGGT 68 FBan0005996 FBgn0032593 trpgamma 2 2L L-phenylalanine biosynthesis; GO:0009094; calcium ion transport; GO:0006816; cation transport; GO:0006812; detection of light stimulus during visual perception; GO:0050908; response to light stimulus; GO:0009416 calcium channel activity; GO:0005262; cation channel activity; GO:0005261; protein binding; GO:0005515; ; GO:0005262; ; GO:0005261; prephenate dehydratase activity; GO:0004664 ; EC:4.2.1.51; ; GO:0004664 ; EC:4.2.1.51; ; GO:0005262; ; GO:0005515; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; rhabdomere; GO:0016028 trpgamma trpgamma "CG5996, TRPgamma, trp-gamma, dTRPg, TRPgamma" CDMC23498 3 15 11 DAC18-C22 1-CG6169-RA_1 CG6169 CGCCGTCGTAGGAGGTACTGTATCCTCGAAGCGTCAACTGTTCCATAGCCAAAGTCAGAACGATGCGC 68 FBan0006169 FBgn0036534 CG6169 3 3L CG6169 CG6169 "LD07107, BEST:LD07107" CDMC23498 3 16 11 DAC18-C22 1-CG6169-RA_1 CG6169 CGCCGTCGTAGGAGGTACTGTATCCTCGAAGCGTCAACTGTTCCATAGCCAAAGTCAGAACGATGCGC 68 FBan0006169 FBgn0036534 CG6169 3 3L CG6169 CG6169 "LD07107, BEST:LD07107" CDMC23499 3 17 11 DAC18-G10 17-CG6597-RA_2 CG6597 CGGATCTAGCTGAGAAAAGCTGTATCGAGTCGCCTATTTCTAGTTCAACTTTGGGAGCTCAGTGCGGA 68 FBan0006597 FBgn0036967 CG6597 3 3L CG6597 CG6597 CDMC23499 3 18 11 DAC18-G10 17-CG6597-RA_2 CG6597 CGGATCTAGCTGAGAAAAGCTGTATCGAGTCGCCTATTTCTAGTTCAACTTTGGGAGCTCAGTGCGGA 68 FBan0006597 FBgn0036967 CG6597 3 3L CG6597 CG6597 CDMC23500 3 19 11 DAC18-G22 2-CG6705-RA_1 CG6705 TGGGCGAGAAGGAAGCTGCAGTACGAGTACTATGTGGTCAAGTATGTGACCCTGCTGAAACTGCACGG 68 FBan0006705 FBgn0003867 tsl 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; embryonic pattern specification; GO:0009880; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" torso binding; GO:0005122; ; GO:0005122 extracellular region; GO:0005576 tsl torso-like "CG6705, fs(3)torso-like, Torsolike, torso like, fs(3)00617, torso-like" CDMC23500 3 20 11 DAC18-G22 2-CG6705-RA_1 CG6705 TGGGCGAGAAGGAAGCTGCAGTACGAGTACTATGTGGTCAAGTATGTGACCCTGCTGAAACTGCACGG 68 FBan0006705 FBgn0003867 tsl 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; embryonic pattern specification; GO:0009880; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" torso binding; GO:0005122; ; GO:0005122 extracellular region; GO:0005576 tsl torso-like "CG6705, fs(3)torso-like, Torsolike, torso like, fs(3)00617, torso-like" CDMC23501 3 21 11 DAC18-K10 3-CG7108-RA_4 CG7108 GCAGACTACTGCTGTGCATGCCTACAATCCCGAAGTCCTGCAGGATATGTTGCCCGTGTATTACAGGC 68 FBan0007108 FBgn0011762 DNApol-alpha50 3 3L "DNA replication; GO:0006260; DNA replication, synthesis of RNA primer; GO:0006269" nucleic acid binding; GO:0003676; DNA primase activity; GO:0003896 ; EC:2.7.7.-; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003889; ; GO:0003889 alpha DNA polymerase:primase complex; GO:0005658 DNApol-alpha50 DNA polymerase alpha 50kD "CG7108, CG7108, pol alpha, DNApol-alpha, DNA polymerase alpha, DNApolalpha, POLA, DNA-polymerase alpha, Polalpha, PRI1, polalpha, DNA polymerase alpha 50 kda primase subunit, Dpri50, polalpha50, DNA polymerase 50K, DNA polalpha, DNApol-alpha50, p50 subunit of DNA polymerase alpha, DNApolalpha50, anon-WO0140519.257" CDMC23501 3 22 11 DAC18-K10 3-CG7108-RA_4 CG7108 GCAGACTACTGCTGTGCATGCCTACAATCCCGAAGTCCTGCAGGATATGTTGCCCGTGTATTACAGGC 68 FBan0007108 FBgn0011762 DNApol-alpha50 3 3L "DNA replication; GO:0006260; DNA replication, synthesis of RNA primer; GO:0006269" nucleic acid binding; GO:0003676; DNA primase activity; GO:0003896 ; EC:2.7.7.-; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003889; ; GO:0003889 alpha DNA polymerase:primase complex; GO:0005658 DNApol-alpha50 DNA polymerase alpha 50kD "CG7108, CG7108, pol alpha, DNApol-alpha, DNA polymerase alpha, DNApolalpha, POLA, DNA-polymerase alpha, Polalpha, PRI1, polalpha, DNA polymerase alpha 50 kda primase subunit, Dpri50, polalpha50, DNA polymerase 50K, DNA polalpha, DNApol-alpha50, p50 subunit of DNA polymerase alpha, DNApolalpha50, anon-WO0140519.257" CDMC23502 3 23 11 DAC18-K22 3-CG7220-RB_1 CG7220 TAGCAGCCATATCCCCGATCGCTCTCATTGTCACCAGTCCTGCACTCTGTAATCTACCCACATTGCCC 68 FBan0007220 FBgn0033544 CG7220 2 2R protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG7220 CG7220 "BcDNA:GH28095, BEST:GH28095" CDMC23502 3 24 11 DAC18-K22 3-CG7220-RB_1 CG7220 TAGCAGCCATATCCCCGATCGCTCTCATTGTCACCAGTCCTGCACTCTGTAATCTACCCACATTGCCC 68 FBan0007220 FBgn0033544 CG7220 2 2R protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG7220 CG7220 "BcDNA:GH28095, BEST:GH28095" CDMC23503 3 25 11 DAC18-O10 7-CG7497-RA_1 CG7497 TCGAACGCAATTATCATACCGGCAAAATGGAAACCACAACACCTGTGCTCGACCTGTTGATGCCGCAC 68 FBan0007497 FBgn0036742 CG7497 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 "G-protein coupled receptor activity, unknown ligand; GO:0016526; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG7497 CG7497 "CHED-related, anon-WO0170980.88, anon-WO0170980.89, BcDNA:GH27361" CDMC23503 3 26 11 DAC18-O10 7-CG7497-RA_1 CG7497 TCGAACGCAATTATCATACCGGCAAAATGGAAACCACAACACCTGTGCTCGACCTGTTGATGCCGCAC 68 FBan0007497 FBgn0036742 CG7497 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 "G-protein coupled receptor activity, unknown ligand; GO:0016526; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG7497 CG7497 "CHED-related, anon-WO0170980.88, anon-WO0170980.89, BcDNA:GH27361" CDMC23504 3 1 12 DAC18-O22 AutoBlank AutoBlank CDMC23504 3 2 12 DAC18-O22 AutoBlank AutoBlank CDMC23505 3 3 12 DAC19-C10 3-CG17803-RA_2 CG17803 CGGAAGCAGACCCTTCCAGTGCAAGATTTGCCAGATGAAATTCGCTGACCCATCTGCCATGAAACGACA 69 FBan0017803 FBgn0038547 CG17803 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17803 CG17803 CDMC23505 3 4 12 DAC19-C10 3-CG17803-RA_2 CG17803 CGGAAGCAGACCCTTCCAGTGCAAGATTTGCCAGATGAAATTCGCTGACCCATCTGCCATGAAACGACA 69 FBan0017803 FBgn0038547 CG17803 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17803 CG17803 CDMC23506 3 5 12 DAC19-C22 2-CG17828-RA_2 CG17828 GGCAAGTCCTTTGAAACGTTGGTAGTTTGCAACCGGGTTTGCCAACTTCCTTTGGAGTTCAGTGGTGCT 69 FBan0017828 FBgn0016038 mod(r) X X mod(r) modifier of rudimentary "CG17828, CG17828, EG:115C2.5, anon-WO0153538.78, modifier of rudimentary" CDMC23506 3 6 12 DAC19-C22 2-CG17828-RA_2 CG17828 GGCAAGTCCTTTGAAACGTTGGTAGTTTGCAACCGGGTTTGCCAACTTCCTTTGGAGTTCAGTGGTGCT 69 FBan0017828 FBgn0016038 mod(r) X X mod(r) modifier of rudimentary "CG17828, CG17828, EG:115C2.5, anon-WO0153538.78, modifier of rudimentary" CDMC23507 3 7 12 DAC19-G10 24-CG17876-RA_1 CG17876 AGCCGAGCAATTACTTGAGATTATTCATTTTTAAAATATATATTATGCGATTATAACACAGAAAAAGGA 69 FBan0017876 FBgn0000078 Amy-d 2 2R carbohydrate metabolism; GO:0005975 calcium ion binding; GO:0005509; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0005509; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 Amy-d Amylase distal "CG17876, CG17876, CG17876, alpha-amylase, Amy, AMY, alpha-AMY, AmyB: Amylase-B, alpha-amylase, alphaAmy, Amylase, amy-d, amyB(3), Amy1, alpha-amylase distal, Amy6, Amy3, amylase, amy, Amylase-B, AmyB" CDMC23507 3 8 12 DAC19-G10 24-CG17876-RA_1 CG17876 AGCCGAGCAATTACTTGAGATTATTCATTTTTAAAATATATATTATGCGATTATAACACAGAAAAAGGA 69 FBan0017876 FBgn0000078 Amy-d 2 2R carbohydrate metabolism; GO:0005975 calcium ion binding; GO:0005509; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0005509; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 Amy-d Amylase distal "CG17876, CG17876, CG17876, alpha-amylase, Amy, AMY, alpha-AMY, AmyB: Amylase-B, alpha-amylase, alphaAmy, Amylase, amy-d, amyB(3), Amy1, alpha-amylase distal, Amy6, Amy3, amylase, amy, Amylase-B, AmyB" CDMC23508 3 9 12 DAC19-G22 16-CG17903-RA_1 CG17903 TGTCCATCAACTTACCCACAACCACTGCAGGATGTCAAACTGTATTATTGTGTTCAGTCACAGTCCGGC 69 FBan0017903 FBgn0000409 Cyt-c-p 2 2L electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 "electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; GO:0045155; ; GO:0045155; ; GO:0005489" mitochondrial inner membrane; GO:0005743; mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Cyt-c-p Cytochrome c proximal "CG17903, CG17903, DC4, pDMc01, DMc01, cytochrome c, cyt.c, Cytochrome C, Cyt-c2, cyt-c2, Cytc, cytochrome c DC4, cytochrome C, Cytochrome c, cyt-c-p, l(2)SH1590, CytC-2" CDMC23508 3 10 12 DAC19-G22 16-CG17903-RA_1 CG17903 TGTCCATCAACTTACCCACAACCACTGCAGGATGTCAAACTGTATTATTGTGTTCAGTCACAGTCCGGC 69 FBan0017903 FBgn0000409 Cyt-c-p 2 2L electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 "electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; GO:0045155; ; GO:0045155; ; GO:0005489" mitochondrial inner membrane; GO:0005743; mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Cyt-c-p Cytochrome c proximal "CG17903, CG17903, DC4, pDMc01, DMc01, cytochrome c, cyt.c, Cytochrome C, Cyt-c2, cyt-c2, Cytc, cytochrome c DC4, cytochrome C, Cytochrome c, cyt-c-p, l(2)SH1590, CytC-2" CDMC23509 3 11 12 DAC19-K10 23-CG1793-RA_11 CG1793 ATGAGCTCAGTAACATTAGTGCGAAACCGCTGAAATCGTTTGATTCAACAATGAAGCTGCCATCACTTG 69 FBan0001793 FBgn0039923 MED26 4 4 ciliary or flagellar motility; GO:0001539; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; RNA polymerase II transcription mediator activity; GO:0016455; structural molecule activity; GO:0005198; motor activity; GO:0003774; ; GO:0003700; ; GO:0005198; ; GO:0016455; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288; mediator complex; GO:0000119 MED26 Mediator complex subunit 26 "CG1793, CG1823, dARC70, Arc70, Med26, Mediator complex subunit 26" CDMC23509 3 12 12 DAC19-K10 23-CG1793-RA_11 CG1793 ATGAGCTCAGTAACATTAGTGCGAAACCGCTGAAATCGTTTGATTCAACAATGAAGCTGCCATCACTTG 69 FBan0001793 FBgn0039923 MED26 4 4 ciliary or flagellar motility; GO:0001539; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; RNA polymerase II transcription mediator activity; GO:0016455; structural molecule activity; GO:0005198; motor activity; GO:0003774; ; GO:0003700; ; GO:0005198; ; GO:0016455; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288; mediator complex; GO:0000119 MED26 Mediator complex subunit 26 "CG1793, CG1823, dARC70, Arc70, Med26, Mediator complex subunit 26" CDMC23510 3 13 12 DAC19-K22 2-CG1794-RA_1 CG1794 GTGGCGCATTGGAACTTCTGGTCTGTATAATGGCTATCCCACGGAGATCAGGAGACATTGGTCCGCTCT 69 FBan0001794 FBgn0033438 Mmp2 2 2R anti-apoptosis; GO:0006916; oogenesis (sensu Insecta); GO:0009993; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; stromelysin 3 activity; GO:0004249 ; EC:3.4.24.-; ; GO:0004249 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578; plasma membrane; GO:0005886 Mmp2 Matrix metalloproteinase 2 "CG1794, CG1794, l(2)02353, Dm2-MMP, 2-MMP, dm-2MMP, anon-WO0118547.84, Matrix metalloproteinase 2" CDMC23510 3 14 12 DAC19-K22 2-CG1794-RA_1 CG1794 GTGGCGCATTGGAACTTCTGGTCTGTATAATGGCTATCCCACGGAGATCAGGAGACATTGGTCCGCTCT 69 FBan0001794 FBgn0033438 Mmp2 2 2R anti-apoptosis; GO:0006916; oogenesis (sensu Insecta); GO:0009993; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; stromelysin 3 activity; GO:0004249 ; EC:3.4.24.-; ; GO:0004249 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578; plasma membrane; GO:0005886 Mmp2 Matrix metalloproteinase 2 "CG1794, CG1794, l(2)02353, Dm2-MMP, 2-MMP, dm-2MMP, anon-WO0118547.84, Matrix metalloproteinase 2" CDMC23511 3 15 12 DAC19-O10 15-CG18004-RB_2 CG18004 TCGTCCGATAACAATGCTTGGGTTGATGATGTGCGAAAAACTGGCAGTTATCGCAATGCTCCCATCTCT 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC23511 3 16 12 DAC19-O10 15-CG18004-RB_2 CG18004 TCGTCCGATAACAATGCTTGGGTTGATGATGTGCGAAAAACTGGCAGTTATCGCAATGCTCCCATCTCT 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC23512 3 17 12 DAC19-O22 10-CG18023-RA_1 CG18023 GCGGATTGTGGAGTTTGCGAAACGCGTACCTGGCTTCTGTGATTTCACCCAAGATGACCAGCTTATACT 69 FBan0018023 FBgn0004865 Eip78C 3 3L intracellular signaling cascade; GO:0007242; larval or pupal development (sensu Insecta); GO:0002165; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; ; GO:0004879; ; GO:0003704 nucleus; GO:0005634 Eip78C Ecdysone-induced protein 78C "CG18023, CG18023, CG18023, E78D, DR-78, E78, E78B, E78A, dE78, NR1E1, Eip78, nuclear hormone receptor, anon-WO0172774.42, anon-WO0172774.44, Eip78D" CDMC23512 3 18 12 DAC19-O22 10-CG18023-RA_1 CG18023 GCGGATTGTGGAGTTTGCGAAACGCGTACCTGGCTTCTGTGATTTCACCCAAGATGACCAGCTTATACT 69 FBan0018023 FBgn0004865 Eip78C 3 3L intracellular signaling cascade; GO:0007242; larval or pupal development (sensu Insecta); GO:0002165; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; ; GO:0004879; ; GO:0003704 nucleus; GO:0005634 Eip78C Ecdysone-induced protein 78C "CG18023, CG18023, CG18023, E78D, DR-78, E78, E78B, E78A, dE78, NR1E1, Eip78, nuclear hormone receptor, anon-WO0172774.42, anon-WO0172774.44, Eip78D" CDMC23513 3 19 12 DAC20-C10 2-CG10687-RA_2 CG10687 GCACGGAAAGCTCTGTAGTCCTGTTCGGTACCCTGAAACTAGTTCCAGAAGGAAAGACGGCGCCG 65 FBgn0028492 CDMC23513 3 20 12 DAC20-C10 2-CG10687-RA_2 CG10687 GCACGGAAAGCTCTGTAGTCCTGTTCGGTACCCTGAAACTAGTTCCAGAAGGAAAGACGGCGCCG 65 FBgn0028492 CDMC23514 3 21 12 DAC20-C22 18-CG10713-RA_1 CG10713 CATCGCCATGCATTTCTGGATTGACAAGCGCTCACAGCAGTGCGGATTTGGACGGTCTCGCGTGG 65 FBan0010713 FBgn0036360 CG10713 3 3L CG10713 CG10713 CT28585 CDMC23514 3 22 12 DAC20-C22 18-CG10713-RA_1 CG10713 CATCGCCATGCATTTCTGGATTGACAAGCGCTCACAGCAGTGCGGATTTGGACGGTCTCGCGTGG 65 FBan0010713 FBgn0036360 CG10713 3 3L CG10713 CG10713 CT28585 CDMC23515 3 23 12 DAC20-G10 15-CG10846-RB_1 CG10846 CCGCCATGCAGGACGAGATGATCAACTACACTAAGTCATTCTACGAGCATTTCGTGAGGGCTCCA 65 FBan0010846 FBgn0040228 dyn-p25 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 dyn-p25 dynactin-subunit-p25 "CG10846, CG10846, C4, lethal group C4, l(2)br2, lethal 2 in the black-reduced region, br2, l(2)35Bf, BG:DS00929.1, DS00929.1, dynactin, p25 subunit, p25, lethal(2)35Bf, dynactin-subunit-p25" CDMC23515 3 24 12 DAC20-G10 15-CG10846-RB_1 CG10846 CCGCCATGCAGGACGAGATGATCAACTACACTAAGTCATTCTACGAGCATTTCGTGAGGGCTCCA 65 FBan0010846 FBgn0040228 dyn-p25 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 dyn-p25 dynactin-subunit-p25 "CG10846, CG10846, C4, lethal group C4, l(2)br2, lethal 2 in the black-reduced region, br2, l(2)35Bf, BG:DS00929.1, DS00929.1, dynactin, p25 subunit, p25, lethal(2)35Bf, dynactin-subunit-p25" CDMC23516 3 25 12 DAC20-G22 3-CG10882-RA_3 CG10882 ACGACAAGCTGGCACCAGAAGAGAACGTGTACCTTCAAGTCGCACTCTTGTACACCTCGTGCAGC 65 FBan0010882 FBgn0031408 CG10882 2 2L ER to Golgi transport; GO:0006888; G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; protein binding; GO:0005515; ; GO:0005515; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 COPII vesicle coat; GO:0030127; integral to membrane; GO:0016021 CG10882 CG10882 BcDNA:LP05220 CDMC23516 3 26 12 DAC20-G22 3-CG10882-RA_3 CG10882 ACGACAAGCTGGCACCAGAAGAGAACGTGTACCTTCAAGTCGCACTCTTGTACACCTCGTGCAGC 65 FBan0010882 FBgn0031408 CG10882 2 2L ER to Golgi transport; GO:0006888; G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; protein binding; GO:0005515; ; GO:0005515; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 COPII vesicle coat; GO:0030127; integral to membrane; GO:0016021 CG10882 CG10882 BcDNA:LP05220 CDMC23517 3 1 13 DAC20-K10 3-CG10958-RA_3 CG10958 TGGCCAACCGGATGAAAAGGAGCATAGGTCGACAGGGGATACATTTCTACCCAAGAGCGAGGTGG 65 FBan0010958 FBgn0030004 CG10958 X X CG10958 CG10958 CDMC23517 3 2 13 DAC20-K10 3-CG10958-RA_3 CG10958 TGGCCAACCGGATGAAAAGGAGCATAGGTCGACAGGGGATACATTTCTACCCAAGAGCGAGGTGG 65 FBan0010958 FBgn0030004 CG10958 X X CG10958 CG10958 CDMC23518 3 3 13 DAC20-K22 3-CG10999-RB_1 CG10999 CCGCGGCGTTCAATATGAAGTCGAAGGGCAATCGCAACCGTTCAACTTACAGTAGTGCTGCCCAG 65 FBan0010999 FBgn0037381 CG10999 3 3R CG10999 CG10999 anon-WO0140519.247 CDMC23518 3 4 13 DAC20-K22 3-CG10999-RB_1 CG10999 CCGCGGCGTTCAATATGAAGTCGAAGGGCAATCGCAACCGTTCAACTTACAGTAGTGCTGCCCAG 65 FBan0010999 FBgn0037381 CG10999 3 3R CG10999 CG10999 anon-WO0140519.247 CDMC23519 3 5 13 DAC20-O10 2-CG11125-RA_2 CG11125 TACGAACAGCTGGTTAATGAACTGAACCACATGCCCATGACTGCACAGACGTTGAGGGTGCGCAA 65 FBan0011125 FBgn0033174 CG11125 2 2R CG11125 CG11125 CDMC23519 3 6 13 DAC20-O10 2-CG11125-RA_2 CG11125 TACGAACAGCTGGTTAATGAACTGAACCACATGCCCATGACTGCACAGACGTTGAGGGTGCGCAA 65 FBan0011125 FBgn0033174 CG11125 2 2R CG11125 CG11125 CDMC23520 3 7 13 DAC20-O22 AutoBlank AutoBlank CDMC23520 3 8 13 DAC20-O22 AutoBlank AutoBlank CDMC23521 3 9 13 DAC21-C10 9-CG11249-RA_5 CG11249 CGATGTCCGCTATGCACTGCGATGGCATGAGACTGTACGCTAGAGTGGTGCTCAACGAGGTCCAG 65 FBan0011249 FBgn0037115 CG11249 3 3L glycolysis; GO:0006096 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG11249 CG11249 CDMC23521 3 10 13 DAC21-C10 9-CG11249-RA_5 CG11249 CGATGTCCGCTATGCACTGCGATGGCATGAGACTGTACGCTAGAGTGGTGCTCAACGAGGTCCAG 65 FBan0011249 FBgn0037115 CG11249 3 3L glycolysis; GO:0006096 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG11249 CG11249 CDMC23522 3 11 13 DAC21-C22 1-CG11294-RA_1 CG11294 GATCCGATTCCGAGGAGATTGATCTCACCTCCGGCGCCTGTATCGATTTCTCCCAGAGCAGCAAG 65 FBan0011294 FBgn0030058 CG11294 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transcription factor activity; GO:0003700; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003700 nucleus; GO:0005634 CG11294 CG11294 CT31519 CDMC23522 3 12 13 DAC21-C22 1-CG11294-RA_1 CG11294 GATCCGATTCCGAGGAGATTGATCTCACCTCCGGCGCCTGTATCGATTTCTCCCAGAGCAGCAAG 65 FBan0011294 FBgn0030058 CG11294 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transcription factor activity; GO:0003700; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003700 nucleus; GO:0005634 CG11294 CG11294 CT31519 CDMC23523 3 13 13 DAC21-G10 2-CG11425-RA_1 CG11425 TCCACTGGCTGGGACTGTACCTTCCACTGATCAGTCTGGTCGTCCTTGAAAGCTTTCTCAGCCAC 65 FBan0011425 FBgn0037167 CG11425 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11425 CG11425 WUN-like CDMC23523 3 14 13 DAC21-G10 2-CG11425-RA_1 CG11425 TCCACTGGCTGGGACTGTACCTTCCACTGATCAGTCTGGTCGTCCTTGAAAGCTTTCTCAGCCAC 65 FBan0011425 FBgn0037167 CG11425 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11425 CG11425 WUN-like CDMC23524 3 15 13 DAC21-G22 23-CG11491-RB_2 CG11491 ACTACCACGTAGACATTTCAATTTCGGATCTCACAGAACGGAAAATTCAAAGACTTTTTCGGCCA 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC23524 3 16 13 DAC21-G22 23-CG11491-RB_2 CG11491 ACTACCACGTAGACATTTCAATTTCGGATCTCACAGAACGGAAAATTCAAAGACTTTTTCGGCCA 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC23525 3 17 13 DAC21-K10 23-CG11586-RA_1 CG11586 GCTGAAAGGTGAACAGTATTAGATATATAGACCATTTAAACTGCCGAATAAACCCACCAAGAACA 65 FBan0011586 FBgn0035520 CG11586 3 3L CG11586 CG11586 CDMC23525 3 18 13 DAC21-K10 23-CG11586-RA_1 CG11586 GCTGAAAGGTGAACAGTATTAGATATATAGACCATTTAAACTGCCGAATAAACCCACCAAGAACA 65 FBan0011586 FBgn0035520 CG11586 3 3L CG11586 CG11586 CDMC23526 3 19 13 DAC21-K22 2-CG11606-RA_1 CG11606 CAAAAAGGATCCGGGCAAACGTGGGTCCGAGATGTTTCCCGAGCCTCATAAGATCGAGCATCTGC 65 FBan0011606 FBgn0022246 Rpp30 2 2L tRNA processing; GO:0008033 nucleic acid binding; GO:0003676; ; GO:0003676; endoribonuclease activity; GO:0004521; ; GO:0004521 ribonuclease P complex; GO:0030677 Rpp30 RNaseP protein p30 "CG11606, l(2)k01901, #19/1, RNase P, RNaseP protein p30" CDMC23526 3 20 13 DAC21-K22 2-CG11606-RA_1 CG11606 CAAAAAGGATCCGGGCAAACGTGGGTCCGAGATGTTTCCCGAGCCTCATAAGATCGAGCATCTGC 65 FBan0011606 FBgn0022246 Rpp30 2 2L tRNA processing; GO:0008033 nucleic acid binding; GO:0003676; ; GO:0003676; endoribonuclease activity; GO:0004521; ; GO:0004521 ribonuclease P complex; GO:0030677 Rpp30 RNaseP protein p30 "CG11606, l(2)k01901, #19/1, RNase P, RNaseP protein p30" CDMC23527 3 21 13 DAC21-O10 2-CG1169-RA_2 CG1169 TTGCCAAGCCCAAGATTGTCAACTACGAGGTGGTGCACTATCCCCATCACGTGGATCATGTGGTG 65 FBan0001169 FBgn0037428 Osi18 3 3R Osi18 Osiris 18 "CG1169, CG1169, Osiris, Osiris 18" CDMC23527 3 22 13 DAC21-O10 2-CG1169-RA_2 CG1169 TTGCCAAGCCCAAGATTGTCAACTACGAGGTGGTGCACTATCCCCATCACGTGGATCATGTGGTG 65 FBan0001169 FBgn0037428 Osi18 3 3R Osi18 Osiris 18 "CG1169, CG1169, Osiris, Osiris 18" CDMC23528 3 23 13 DAC21-O22 AutoBlank AutoBlank CDMC23528 3 24 13 DAC21-O22 AutoBlank AutoBlank CDMC23529 3 25 13 DAC22-C10 1-CG31683-RA_1 CG31683 CCCTGGTTTTCTTGCAGGAGCAAACCCTCCAATGGAAGGCGAAATACGTGAAGCGCATGATCAGC 65 FBan0031683 FBgn0051683 CG31683 2 2L cholesterol metabolism; GO:0008203; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; steroid metabolism; GO:0008202 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0016298 ; EC:3.1.1.-; phosphatidylcholine-sterol O-acyltransferase activity; GO:0004607 ; EC:2.3.1.43; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004607 ; EC:2.3.1.43 CG31683 CG31683 BcDNA:GH02384 CDMC23529 3 26 13 DAC22-C10 1-CG31683-RA_1 CG31683 CCCTGGTTTTCTTGCAGGAGCAAACCCTCCAATGGAAGGCGAAATACGTGAAGCGCATGATCAGC 65 FBan0031683 FBgn0051683 CG31683 2 2L cholesterol metabolism; GO:0008203; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; steroid metabolism; GO:0008202 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0016298 ; EC:3.1.1.-; phosphatidylcholine-sterol O-acyltransferase activity; GO:0004607 ; EC:2.3.1.43; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004607 ; EC:2.3.1.43 CG31683 CG31683 BcDNA:GH02384 CDMC23530 3 1 14 DAC22-C22 2-CG31709-RA_1 CG31709 CAGTCGGAATGGTCAGAACCAACAGGTCGAAGACGGCAATGATCGGAATCTTCAACCGGCAGCTC 65 FBan0031709 FBgn0051709 CG31709 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31709 CG31709 BEST:LP04712 CDMC23530 3 2 14 DAC22-C22 2-CG31709-RA_1 CG31709 CAGTCGGAATGGTCAGAACCAACAGGTCGAAGACGGCAATGATCGGAATCTTCAACCGGCAGCTC 65 FBan0031709 FBgn0051709 CG31709 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31709 CG31709 BEST:LP04712 CDMC23531 3 3 14 DAC22-G10 3-CG31800-RA_2 CG31800 CTTCAGGCCCAAGCGATGGAGATACTTAAGGAGTCCACTCTCAACCGAGATCTGCACAGTGCGGC 65 FBan0031800 FBgn0051800 CG31800 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31800 CG31800 CDMC23531 3 4 14 DAC22-G10 3-CG31800-RA_2 CG31800 CTTCAGGCCCAAGCGATGGAGATACTTAAGGAGTCCACTCTCAACCGAGATCTGCACAGTGCGGC 65 FBan0031800 FBgn0051800 CG31800 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31800 CG31800 CDMC23532 3 5 14 DAC22-G22 18-CG31852-RA_1 CG31852 CGGTTTTCGGCTTGGGATACCCCAGTTTGCCCATTATGACTGTTGATGAATTCTACCAGCAGCGC 65 FBan0031852 FBgn0051852 Tap42 2 2L defense response; GO:0006952; regulation of signal transduction; GO:0009966; signal transduction; GO:0007165 Tap42 Two A-associated protein of 42kDa "CG31852, CG6537, Two A-associated protein of 42kDa" CDMC23532 3 6 14 DAC22-G22 18-CG31852-RA_1 CG31852 CGGTTTTCGGCTTGGGATACCCCAGTTTGCCCATTATGACTGTTGATGAATTCTACCAGCAGCGC 65 FBan0031852 FBgn0051852 Tap42 2 2L defense response; GO:0006952; regulation of signal transduction; GO:0009966; signal transduction; GO:0007165 Tap42 Two A-associated protein of 42kDa "CG31852, CG6537, Two A-associated protein of 42kDa" CDMC23533 3 7 14 DAC22-K10 6-CG31959-RB_1 CG31959 CTACTCCAGCCACATGGATCGCAGCTACGACTCCGAGGATGAACACACTGGTCGCCGAAGACTTC 65 FBan0031959 FBgn0051959 CG31959 2 2L CG31959 CG31959 CG10020 CDMC23533 3 8 14 DAC22-K10 6-CG31959-RB_1 CG31959 CTACTCCAGCCACATGGATCGCAGCTACGACTCCGAGGATGAACACACTGGTCGCCGAAGACTTC 65 FBan0031959 FBgn0051959 CG31959 2 2L CG31959 CG31959 CG10020 CDMC23534 3 9 14 DAC22-K22 3-CG32023-RA_1 CG32023 CAAGGGATCGACTCCAGCTTCCTGCACTCCAGATGCCGAAATATCGTGTCCTCCTTGCAGTGGAG 65 FBan0032023 FBgn0052023 CG32023 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32023 CG32023 CDMC23534 3 10 14 DAC22-K22 3-CG32023-RA_1 CG32023 CAAGGGATCGACTCCAGCTTCCTGCACTCCAGATGCCGAAATATCGTGTCCTCCTTGCAGTGGAG 65 FBan0032023 FBgn0052023 CG32023 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32023 CG32023 CDMC23535 3 11 14 DAC22-O10 23-CG32143-RA_1 CG32143 ACCATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTC 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC23535 3 12 14 DAC22-O10 23-CG32143-RA_1 CG32143 ACCATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTC 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC23536 3 13 14 DAC22-O22 AutoBlank AutoBlank CDMC23536 3 14 14 DAC22-O22 AutoBlank AutoBlank CDMC23537 3 15 14 DAC23-C10 3-CG10756-RA_1 CG10756 CCTGGTGCGCAAAGATCCCCGAAAGTACGCTAGGGTGAAGGATCTTCTGACCATGAACGAGGAGTTGAA 69 FBan0010756 FBgn0032847 Taf13 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf13 TBP-associated factor 13 "CG10756, CG10756, CG10756, CG10756, TAF18, TFIID, 38B.15, TAF13, TAF[[II]]18, TAF[[II]], dTAF[[II]]18, TAF, Taf18: TBP-associated factor 18kD, TBP-associated factor 18kD" CDMC23537 3 16 14 DAC23-C10 3-CG10756-RA_1 CG10756 CCTGGTGCGCAAAGATCCCCGAAAGTACGCTAGGGTGAAGGATCTTCTGACCATGAACGAGGAGTTGAA 69 FBan0010756 FBgn0032847 Taf13 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf13 TBP-associated factor 13 "CG10756, CG10756, CG10756, CG10756, TAF18, TFIID, 38B.15, TAF13, TAF[[II]]18, TAF[[II]], dTAF[[II]]18, TAF, Taf18: TBP-associated factor 18kD, TBP-associated factor 18kD" CDMC23538 3 17 14 DAC23-C22 23-CG10777-RB_13 CG10777 AAGACGCCACATTCATCCATAAAAACAATTAAAGCGAACACGAAACAAGAGGAAAAGAAGGAGGAACAC 69 FBan0010777 FBgn0029979 CG10777 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10777 CG10777 "cg10777, DmRH1" CDMC23538 3 18 14 DAC23-C22 23-CG10777-RB_13 CG10777 AAGACGCCACATTCATCCATAAAAACAATTAAAGCGAACACGAAACAAGAGGAAAAGAAGGAGGAACAC 69 FBan0010777 FBgn0029979 CG10777 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10777 CG10777 "cg10777, DmRH1" CDMC23539 3 19 14 DAC23-G10 23-CG10810-RA_3 CG10810 CAGAAATCATTTACCAAGCTCCGTGAGAACCTTTTCCAATATGATGCAGATCAAGTACTTGTTCGCCCT 69 FBan0010810 FBgn0010381 Drs 3 3L antibacterial humoral response (sensu Protostomia); GO:0006961; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal humoral response; GO:0019732; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to fungi; GO:0050832; innate immune response; GO:0045087; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 Drs Drosomycin "CG10810, CG10810, CG10810, drosomycin, Drom, DIM 19, Drosophila Immune induced molecule 19, drom, cysteine-rich peptide, DROM, drs, drsm, DRS, DRO, BcDNA:LP03851, Crp: Cysteine-rich-protein, Cysteine-rich-protein" CDMC23539 3 20 14 DAC23-G10 23-CG10810-RA_3 CG10810 CAGAAATCATTTACCAAGCTCCGTGAGAACCTTTTCCAATATGATGCAGATCAAGTACTTGTTCGCCCT 69 FBan0010810 FBgn0010381 Drs 3 3L antibacterial humoral response (sensu Protostomia); GO:0006961; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal humoral response; GO:0019732; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to fungi; GO:0050832; innate immune response; GO:0045087; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 Drs Drosomycin "CG10810, CG10810, CG10810, drosomycin, Drom, DIM 19, Drosophila Immune induced molecule 19, drom, cysteine-rich peptide, DROM, drs, drsm, DRS, DRO, BcDNA:LP03851, Crp: Cysteine-rich-protein, Cysteine-rich-protein" CDMC23540 3 21 14 DAC23-G22 3-CG10822-RA_1 CG10822 CGGTGAAAACCTCGATGGATCGTCAGGAGGGCTTGCAGTACGCCTGTCTATATGACAATTTGCGGGAGA 69 FBan0010822 FBgn0034478 CG10822 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG10822 CG10822 CDMC23540 3 22 14 DAC23-G22 3-CG10822-RA_1 CG10822 CGGTGAAAACCTCGATGGATCGTCAGGAGGGCTTGCAGTACGCCTGTCTATATGACAATTTGCGGGAGA 69 FBan0010822 FBgn0034478 CG10822 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG10822 CG10822 CDMC23541 3 23 14 DAC23-K10 6-CG1084-RA_3 CG1084 CCCGTCTACCGTGCGGGTTGTTTGGAGATATGTTTCACCTTCGCAAGACGAGGAACCAGTAGAGGGTTA 69 FBan0001084 FBgn0037240 Cont 3 3R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; establishment and/or maintenance of epithelial cell polarity; GO:0045197; nervous system development; GO:0007399; septate junction assembly; GO:0019991 sugar binding; GO:0005529; ; GO:0005529 pleated septate junction; GO:0005919; septate junction; GO:0005918 Cont Contactin "CG1084, CG1084, CG1084, CT1481, DCONT, contactin, D-Axonin, cont, Contactin" CDMC23541 3 24 14 DAC23-K10 6-CG1084-RA_3 CG1084 CCCGTCTACCGTGCGGGTTGTTTGGAGATATGTTTCACCTTCGCAAGACGAGGAACCAGTAGAGGGTTA 69 FBan0001084 FBgn0037240 Cont 3 3R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; establishment and/or maintenance of epithelial cell polarity; GO:0045197; nervous system development; GO:0007399; septate junction assembly; GO:0019991 sugar binding; GO:0005529; ; GO:0005529 pleated septate junction; GO:0005919; septate junction; GO:0005918 Cont Contactin "CG1084, CG1084, CG1084, CT1481, DCONT, contactin, D-Axonin, cont, Contactin" CDMC23542 3 25 14 DAC23-K22 14-CG10861-RA_2 CG10861 TGCCCCGGATCAGATAATCAAGAACTTGTACGAGTGCCATGGAACCAATGGGAAACTGGTGCTCTACTA 69 FBan0010861 FBgn0036255 Atg12 3 3L autophagic cell death; GO:0048102; autophagic vacuole formation; GO:0000045; autophagy; GO:0006914; salivary gland cell autophagic cell death; GO:0035071 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Atg12 Autophagy-specific gene 12 "CG10861, CG10861, CG10861, Autophagy-specific gene 12" CDMC23542 3 26 14 DAC23-K22 14-CG10861-RA_2 CG10861 TGCCCCGGATCAGATAATCAAGAACTTGTACGAGTGCCATGGAACCAATGGGAAACTGGTGCTCTACTA 69 FBan0010861 FBgn0036255 Atg12 3 3L autophagic cell death; GO:0048102; autophagic vacuole formation; GO:0000045; autophagy; GO:0006914; salivary gland cell autophagic cell death; GO:0035071 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Atg12 Autophagy-specific gene 12 "CG10861, CG10861, CG10861, Autophagy-specific gene 12" CDMC23543 3 1 15 DAC23-O10 3-CG10913-RA_2 CG10913 AGTTGACCGTGGAAGAGGTCCATGTCAAGTTCCCCAAGTTTAAGGTGGACTACTCCCTGGAATTGGCCG 69 FBan0010913 FBgn0028983 Spn6 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Spn6 Serine protease inhibitor 6 "CG10913, CG10913, CG10913, CG10913, sp6: serpin 6, serpin 6, sp-6, sp6" CDMC23543 3 2 15 DAC23-O10 3-CG10913-RA_2 CG10913 AGTTGACCGTGGAAGAGGTCCATGTCAAGTTCCCCAAGTTTAAGGTGGACTACTCCCTGGAATTGGCCG 69 FBan0010913 FBgn0028983 Spn6 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Spn6 Serine protease inhibitor 6 "CG10913, CG10913, CG10913, CG10913, sp6: serpin 6, serpin 6, sp-6, sp6" CDMC23544 3 3 15 DAC23-O22 23-CG10922-RA_3 CG10922 TCTTTTGATCGCAGTAGACCAAGCTTAATTGTTACTCGGTAGATCTAGTTGACCTAGCTTTAAGGCCTT 69 FBan0010922 FBgn0011638 La 2 2L RNA export from nucleus; GO:0006405; RNA processing; GO:0006396; tRNA metabolism; GO:0006399 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; 5S rRNA primary transcript binding; GO:0008098; ; GO:0008098; ; GO:0008098; RNA polymerase III transcription termination factor activity; GO:0003718; ; GO:0003718; ; GO:0003718 cytoplasm; GO:0005737; nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 La La autoantigen-like "CG10922, D-La, dmLa, DLa/SS-B, ribonucleoprotein La, 38C.38, BEST:LD24519" CDMC23544 3 4 15 DAC23-O22 23-CG10922-RA_3 CG10922 TCTTTTGATCGCAGTAGACCAAGCTTAATTGTTACTCGGTAGATCTAGTTGACCTAGCTTTAAGGCCTT 69 FBan0010922 FBgn0011638 La 2 2L RNA export from nucleus; GO:0006405; RNA processing; GO:0006396; tRNA metabolism; GO:0006399 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; 5S rRNA primary transcript binding; GO:0008098; ; GO:0008098; ; GO:0008098; RNA polymerase III transcription termination factor activity; GO:0003718; ; GO:0003718; ; GO:0003718 cytoplasm; GO:0005737; nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 La La autoantigen-like "CG10922, D-La, dmLa, DLa/SS-B, ribonucleoprotein La, 38C.38, BEST:LD24519" CDMC23545 3 5 15 DAC24-C10 3-CG14943-RA_1 CG14943 TGCGTCCTCACGCTGGACGGGTACTCCTATGTCATAGGTAAGTGGCTGCTGGTCGGATTTAATGCAATT 69 FBan0014943 FBgn0032383 CG14943 2 2L CG14943 CG14943 CDMC23545 3 6 15 DAC24-C10 3-CG14943-RA_1 CG14943 TGCGTCCTCACGCTGGACGGGTACTCCTATGTCATAGGTAAGTGGCTGCTGGTCGGATTTAATGCAATT 69 FBan0014943 FBgn0032383 CG14943 2 2L CG14943 CG14943 CDMC23546 3 7 15 DAC24-C22 15-CG14956-RA_2 CG14956 GCTCGTCCTTCATTCTGGAACATGGTCCACACATGGCCGTCTGTCGAATTTGTTTTTTTGTCAGCAGGA 69 FBan0014956 FBgn0035403 CG14956 3 3L CG14956 CG14956 BcDNA:GH07729 CDMC23546 3 8 15 DAC24-C22 15-CG14956-RA_2 CG14956 GCTCGTCCTTCATTCTGGAACATGGTCCACACATGGCCGTCTGTCGAATTTGTTTTTTTGTCAGCAGGA 69 FBan0014956 FBgn0035403 CG14956 3 3L CG14956 CG14956 BcDNA:GH07729 CDMC23547 3 9 15 DAC24-G10 18-CG14981-RB_2 CG14981 GCCCCCAAAAAAAGGACGTCCTCATCAATCGAAACGAGCCGTTGCAAAACTTCAGATAGGTGTTAGCAT 69 FBan0014981 FBgn0035473 mge 3 3L protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 mge maggie "CG14981, l(3)SH3, l(3)63Fc, BcDNA:LP07226, maggie" CDMC23547 3 10 15 DAC24-G10 18-CG14981-RB_2 CG14981 GCCCCCAAAAAAAGGACGTCCTCATCAATCGAAACGAGCCGTTGCAAAACTTCAGATAGGTGTTAGCAT 69 FBan0014981 FBgn0035473 mge 3 3L protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 mge maggie "CG14981, l(3)SH3, l(3)63Fc, BcDNA:LP07226, maggie" CDMC23548 3 11 15 DAC24-G22 23-CG14994-RB_19 CG14994 AACGTGTTGCTAGATGTTCCTTTACGATTTCTCATTCTGTTATCCGTTGACCGTTATTCGTTAAGCGTC 69 FBan0014994 FBgn0004516 Gad1 3 3L gamma-aminobutyric acid biosynthesis; GO:0009449; glutamate catabolism; GO:0006538; larval locomotory behavior; GO:0008345; neuromuscular junction development; GO:0007528; neurotransmitter biosynthesis; GO:0042136; neurotransmitter receptor metabolism; GO:0045213; synaptogenesis; GO:0007416 glutamate decarboxylase activity; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15 Gad1 Glutamic acid decarboxylase 1 "CG14994, Gad, GAD[[1]], GAD, DGad1, l(3)SH10, l(3)64An, gad, dGad1, gad1, dgad1, GAD1, DGAD1, Glb" CDMC23548 3 12 15 DAC24-G22 23-CG14994-RB_19 CG14994 AACGTGTTGCTAGATGTTCCTTTACGATTTCTCATTCTGTTATCCGTTGACCGTTATTCGTTAAGCGTC 69 FBan0014994 FBgn0004516 Gad1 3 3L gamma-aminobutyric acid biosynthesis; GO:0009449; glutamate catabolism; GO:0006538; larval locomotory behavior; GO:0008345; neuromuscular junction development; GO:0007528; neurotransmitter biosynthesis; GO:0042136; neurotransmitter receptor metabolism; GO:0045213; synaptogenesis; GO:0007416 glutamate decarboxylase activity; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15 Gad1 Glutamic acid decarboxylase 1 "CG14994, Gad, GAD[[1]], GAD, DGad1, l(3)SH10, l(3)64An, gad, dGad1, gad1, dgad1, GAD1, DGAD1, Glb" CDMC23549 3 13 15 DAC24-K10 2-CG15017-RA_1 CG15017 GCGCGGCTGCAAGTACAGTTTGGAGCGGGCCAAGTCCAAGTTAGATAAGTACTACACGCTGAAGACCAA 69 FBgn0035535 CDMC23549 3 14 15 DAC24-K10 2-CG15017-RA_1 CG15017 GCGCGGCTGCAAGTACAGTTTGGAGCGGGCCAAGTCCAAGTTAGATAAGTACTACACGCTGAAGACCAA 69 FBgn0035535 CDMC23550 3 15 15 DAC24-K22 11-CG15029-RA_1 CG15029 AGTGGATGATGTGGCTTCACGCTATGAGGAAGAGGTTCCACCAAAAGAAGAATTGCCTCCACCAACAGT 69 FBan0015029 FBgn0030619 CG15029 X X CG15029 CG15029 CDMC23550 3 16 15 DAC24-K22 11-CG15029-RA_1 CG15029 AGTGGATGATGTGGCTTCACGCTATGAGGAAGAGGTTCCACCAAAAGAAGAATTGCCTCCACCAACAGT 69 FBan0015029 FBgn0030619 CG15029 X X CG15029 CG15029 CDMC23551 3 17 15 DAC24-O10 18-CG15071-RA_4 CG15071 ACCCAACAGTTCCTCCACGGCAGATCTAATAGGTCTGATCAACGAAATCGAACAGGAGAAACTTGTGCT 69 FBan0015071 FBgn0034377 CG15071 2 2R CG15071 CG15071 CDMC23551 3 18 15 DAC24-O10 18-CG15071-RA_4 CG15071 ACCCAACAGTTCCTCCACGGCAGATCTAATAGGTCTGATCAACGAAATCGAACAGGAGAAACTTGTGCT 69 FBan0015071 FBgn0034377 CG15071 2 2R CG15071 CG15071 CDMC23552 3 19 15 DAC24-O22 14-CG15085-RA_1 CG15085 CCCGAGCAATGGCCCTGCTATCATAGGGATTACCCATATATCTCACGGATACCCAGTCCTCTCTATGGT 69 FBgn0034373 CDMC23552 3 20 15 DAC24-O22 14-CG15085-RA_1 CG15085 CCCGAGCAATGGCCCTGCTATCATAGGGATTACCCATATATCTCACGGATACCCAGTCCTCTCTATGGT 69 FBgn0034373 CDMC23553 3 21 15 DAC25-C10 3-CG14329-RA_1 CG14329 ACAAGTGCAGCCAGTTTACCAAACGGGAGGCTATCGGTCAAGGGATCAACGAAGCAGCTACGGATAAGT 69 FBan0014329 FBgn0038525 CG14329 3 3R CG14329 CG14329 CDMC23553 3 22 15 DAC25-C10 3-CG14329-RA_1 CG14329 ACAAGTGCAGCCAGTTTACCAAACGGGAGGCTATCGGTCAAGGGATCAACGAAGCAGCTACGGATAAGT 69 FBan0014329 FBgn0038525 CG14329 3 3R CG14329 CG14329 CDMC23554 3 23 15 DAC25-C22 2-CG14343-RA_1 CG14343 GGCAACTACGAATCCTGCCTCAGCTTGGATCTCAGCAAGAGTCTGGGCAATGTCATGACCATCAATGCC 69 FBan0014343 FBgn0031325 CG14343 2 2L CG14343 CG14343 CDMC23554 3 24 15 DAC25-C22 2-CG14343-RA_1 CG14343 GGCAACTACGAATCCTGCCTCAGCTTGGATCTCAGCAAGAGTCTGGGCAATGTCATGACCATCAATGCC 69 FBan0014343 FBgn0031325 CG14343 2 2L CG14343 CG14343 CDMC23555 3 25 15 DAC25-G10 2-CG1438-RA_2 CG1438 AGCCAGAAGTTTGTGAACAAGAGCCACGACTACGACTATCTGCATCCTTGGTTGGGAGAGGGTCTGCTT 69 FBan0001438 FBgn0015032 Cyp4c3 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4c3 Cytochrome P450-4c3 "CG1438, CG1438, P450, P-450, 4C3" CDMC23555 3 26 15 DAC25-G10 2-CG1438-RA_2 CG1438 AGCCAGAAGTTTGTGAACAAGAGCCACGACTACGACTATCTGCATCCTTGGTTGGGAGAGGGTCTGCTT 69 FBan0001438 FBgn0015032 Cyp4c3 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4c3 Cytochrome P450-4c3 "CG1438, CG1438, P450, P-450, 4C3" CDMC23556 3 1 16 DAC25-G22 3-CG14405-RA_1 CG14405 CCCCTTCGTTGTGGTTCCCCGACTAAATAACGTGTTGGGACCCACTCTCAAAGGACGCTACAAAGTGGT 69 FBan0014405 FBgn0032888 CheB38c 2 2L CheB38c CheB38c CG14405 CDMC23556 3 2 16 DAC25-G22 3-CG14405-RA_1 CG14405 CCCCTTCGTTGTGGTTCCCCGACTAAATAACGTGTTGGGACCCACTCTCAAAGGACGCTACAAAGTGGT 69 FBan0014405 FBgn0032888 CheB38c 2 2L CheB38c CheB38c CG14405 CDMC23557 3 3 16 DAC25-K10 3-CG14443-RA_4 CG14443 GCCGCTAATTATCGGAAACGCCACAATATCACCTTGACCAGCTGGAATATGCGAAACCTTCCGGAGCCT 69 FBan0014443 FBgn0029880 CG14443 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG14443 CG14443 cg14443 CDMC23557 3 4 16 DAC25-K10 3-CG14443-RA_4 CG14443 GCCGCTAATTATCGGAAACGCCACAATATCACCTTGACCAGCTGGAATATGCGAAACCTTCCGGAGCCT 69 FBan0014443 FBgn0029880 CG14443 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG14443 CG14443 cg14443 CDMC23558 3 5 16 DAC25-K22 17-CG14457-RA_2 CG14457 TGGATGTGCTGAAGAAGATATTTCACTTCATTCCAGCCAACTTCTTTGTGAGCGACATCCCGACGCCGG 69 FBan0014457 FBgn0037174 CG14457 3 3L CG14457 CG14457 "CG18618, BcDNA:LP08817" CDMC23558 3 6 16 DAC25-K22 17-CG14457-RA_2 CG14457 TGGATGTGCTGAAGAAGATATTTCACTTCATTCCAGCCAACTTCTTTGTGAGCGACATCCCGACGCCGG 69 FBan0014457 FBgn0037174 CG14457 3 3L CG14457 CG14457 "CG18618, BcDNA:LP08817" CDMC23559 3 7 16 DAC25-O10 1-CG14506-RA_1 CG14506 TCCCCTAGTGCCTAAGCCCAAACCTGTTCTTCGAAAAGTTTCCAAGTCAGATCTCCGCTACGCCGTTCT 69 FBan0014506 FBgn0039659 CG14506 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG14506 CG14506 cg14506 CDMC23559 3 8 16 DAC25-O10 1-CG14506-RA_1 CG14506 TCCCCTAGTGCCTAAGCCCAAACCTGTTCTTCGAAAAGTTTCCAAGTCAGATCTCCGCTACGCCGTTCT 69 FBan0014506 FBgn0039659 CG14506 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG14506 CG14506 cg14506 CDMC23560 3 9 16 DAC25-O22 3-CG14517-RA_3 CG14517 CCGCAGGTGACCAGAAATGTCTCCCAGCAGGAAGTTTTCGAATGCACCTACTCGGAGATCATTGCCGAA 69 FBan0014517 FBgn0039625 beta4GalNAcTB 3 3R N-acetylglucosamine metabolism; GO:0006044; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; ; GO:0008376 ; EC:2.4.1.- beta4GalNAcTB beta4GalNAcTB "CG14517, CG14517, dbeta4GalTB, beta4GalTB" CDMC23560 3 10 16 DAC25-O22 3-CG14517-RA_3 CG14517 CCGCAGGTGACCAGAAATGTCTCCCAGCAGGAAGTTTTCGAATGCACCTACTCGGAGATCATTGCCGAA 69 FBan0014517 FBgn0039625 beta4GalNAcTB 3 3R N-acetylglucosamine metabolism; GO:0006044; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; ; GO:0008376 ; EC:2.4.1.- beta4GalNAcTB beta4GalNAcTB "CG14517, CG14517, dbeta4GalTB, beta4GalTB" CDMC23561 3 11 16 DAC26-C10 17-CG4733-RA_1 CG4733 CGCTGGGCGATTTGAAACGATGCAAAATGACGCACGTCTTCTTCGATACCTTCTTCAATCTGGAGAAGT 69 FBan0004733 FBgn0038744 CG4733 3 3R signal transduction; GO:0007165; transport; GO:0006810 calcium ion binding; GO:0005509; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0005509; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 membrane; GO:0016020 CG4733 CG4733 "dPR72, PR-72" CDMC23561 3 12 16 DAC26-C10 17-CG4733-RA_1 CG4733 CGCTGGGCGATTTGAAACGATGCAAAATGACGCACGTCTTCTTCGATACCTTCTTCAATCTGGAGAAGT 69 FBan0004733 FBgn0038744 CG4733 3 3R signal transduction; GO:0007165; transport; GO:0006810 calcium ion binding; GO:0005509; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0005509; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 membrane; GO:0016020 CG4733 CG4733 "dPR72, PR-72" CDMC23562 3 13 16 DAC26-C22 14-CG4743-RA_4 CG4743 GCGGGAGATTCCATTTAGTCTGATACAGTTTCCGCTCTGGGAGTACTTTAAGCTGCAATGGACTCCCCT 69 FBan0004743 FBgn0039357 CG4743 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4743 CG4743 CDMC23562 3 14 16 DAC26-C22 14-CG4743-RA_4 CG4743 GCGGGAGATTCCATTTAGTCTGATACAGTTTCCGCTCTGGGAGTACTTTAAGCTGCAATGGACTCCCCT 69 FBan0004743 FBgn0039357 CG4743 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4743 CG4743 CDMC23563 3 15 16 DAC26-G10 23-CG4768-RA_3 CG4768 ATTATGCAAACGACAAATGAAGCTGTGTAAATAACAACAAAATAAGAGACACCCCCAGAAATCCGAAGC 69 FBan0004768 FBgn0030790 CG4768 X X CG4768 CG4768 CDMC23563 3 16 16 DAC26-G10 23-CG4768-RA_3 CG4768 ATTATGCAAACGACAAATGAAGCTGTGTAAATAACAACAAAATAAGAGACACCCCCAGAAATCCGAAGC 69 FBan0004768 FBgn0030790 CG4768 X X CG4768 CG4768 CDMC23564 3 17 16 DAC26-G22 3-CG4778-RA_4 CG4778 CGCCGATGGCATGGTCTTCAATGACTACTCACCCATCGAGGAGAAGTGCGATCTGCCCTACAACATTGA 69 FBan0004778 FBgn0027600 CG4778 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG4778 CG4778 "BEST:CK00178, BcDNA:GH02976, CK00178" CDMC23564 3 18 16 DAC26-G22 3-CG4778-RA_4 CG4778 CGCCGATGGCATGGTCTTCAATGACTACTCACCCATCGAGGAGAAGTGCGATCTGCCCTACAACATTGA 69 FBan0004778 FBgn0027600 CG4778 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG4778 CG4778 "BEST:CK00178, BcDNA:GH02976, CK00178" CDMC23565 3 19 16 DAC26-K10 9-CG4806-RA_9 CG4806 CCACTCCAAGGGTACAGCCTTCGTTAAATTCAAAGCCAAGGAGTCAGCGGATCTTTGTCTGCAAGCTGG 69 FBan0004806 FBgn0035048 CG4806 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ; GO:0003729 CG4806 CG4806 cg4806 CDMC23565 3 20 16 DAC26-K10 9-CG4806-RA_9 CG4806 CCACTCCAAGGGTACAGCCTTCGTTAAATTCAAAGCCAAGGAGTCAGCGGATCTTTGTCTGCAAGCTGG 69 FBan0004806 FBgn0035048 CG4806 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ; GO:0003729 CG4806 CG4806 cg4806 CDMC23566 3 21 16 DAC26-K22 17-CG4815-RA_2 CG4815 GGACTGGCAGGTTCCATCCCAGGATTTATAATGGCATAAAGACGACTGTCGAATCTCTTGGAGGAGTGG 69 FBan0004815 FBgn0039568 CG4815 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4815 CG4815 SP189 CDMC23566 3 22 16 DAC26-K22 17-CG4815-RA_2 CG4815 GGACTGGCAGGTTCCATCCCAGGATTTATAATGGCATAAAGACGACTGTCGAATCTCTTGGAGGAGTGG 69 FBan0004815 FBgn0039568 CG4815 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4815 CG4815 SP189 CDMC23567 3 23 16 DAC26-O10 15-CG4854-RA_9 CG4854 AGGCTGCTTCCTTTACCTGCAACATTTGCAACAATGTCTACTCAGAGCGCGTAAAGTTGACCAACCACA 69 FBan0004854 FBgn0038766 CG4854 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4854 CG4854 CDMC23567 3 24 16 DAC26-O10 15-CG4854-RA_9 CG4854 AGGCTGCTTCCTTTACCTGCAACATTTGCAACAATGTCTACTCAGAGCGCGTAAAGTTGACCAACCACA 69 FBan0004854 FBgn0038766 CG4854 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4854 CG4854 CDMC23568 3 25 16 DAC26-O22 23-CG4863-RA_2 CG4863 GGCAGCGATCAATAAACAGATTTTGGCTAAGCTGACTCATTAATCTTTTCAATTGCATCTAATGGGAAA 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC23568 3 26 16 DAC26-O22 23-CG4863-RA_2 CG4863 GGCAGCGATCAATAAACAGATTTTGGCTAAGCTGACTCATTAATCTTTTCAATTGCATCTAATGGGAAA 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC23569 3 1 17 DAC27-C10 23-CG3497-RA_10 CG3497 CAACCCCTCGTGACGTAAACCAAAATGTGTCCCCTTCTCTCTAAAGTGAATCATACTTTACACATGTAT 69 FBan0003497 FBgn0004837 Su(H) 2 2L "DNA recombination; GO:0006310; NOT dorsal/ventral lineage restriction, imaginal disc; GO:0007451; Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; cell fate determination; GO:0001709; crystal cell differentiation; GO:0042688; hemopoiesis; GO:0030097; lateral inhibition; GO:0046331; negative regulation of cone cell fate specification (sensu Endopterygota); GO:0010000; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; sensory organ precursor cell fate determination; GO:0016360; transcription initiation from RNA polymerase II promoter; GO:0006367; transport; GO:0006810" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; transporter activity; GO:0005215; ; GO:0003702; ; GO:0005515; ; GO:0016563; ; GO:0016564; ; GO:0005215 cytoplasm; GO:0005737; nucleus; GO:0005634 Su(H) Suppressor of Hairless "CG3497, SuH, l(2)br7, lethal 7 in the black-reduced region, br7, dRBP-J[[Kappa]], C: Group C, transcription unit C, RBP-J[[Kappa]], l(2)35Bh, l(2)k07904, su(H), BG:DS00929.10, dRBP-Jk, dRBP-JK, oss, FTZ-F2, suppressor of hairless, Su(h), RBP-J kappa, D, anon-WO0257455.3, E(H), RBP-Jkappa, l(1)br7, lethal group D" CDMC23569 3 2 17 DAC27-C10 23-CG3497-RA_10 CG3497 CAACCCCTCGTGACGTAAACCAAAATGTGTCCCCTTCTCTCTAAAGTGAATCATACTTTACACATGTAT 69 FBan0003497 FBgn0004837 Su(H) 2 2L "DNA recombination; GO:0006310; NOT dorsal/ventral lineage restriction, imaginal disc; GO:0007451; Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; cell fate determination; GO:0001709; crystal cell differentiation; GO:0042688; hemopoiesis; GO:0030097; lateral inhibition; GO:0046331; negative regulation of cone cell fate specification (sensu Endopterygota); GO:0010000; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; sensory organ precursor cell fate determination; GO:0016360; transcription initiation from RNA polymerase II promoter; GO:0006367; transport; GO:0006810" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; transporter activity; GO:0005215; ; GO:0003702; ; GO:0005515; ; GO:0016563; ; GO:0016564; ; GO:0005215 cytoplasm; GO:0005737; nucleus; GO:0005634 Su(H) Suppressor of Hairless "CG3497, SuH, l(2)br7, lethal 7 in the black-reduced region, br7, dRBP-J[[Kappa]], C: Group C, transcription unit C, RBP-J[[Kappa]], l(2)35Bh, l(2)k07904, su(H), BG:DS00929.10, dRBP-Jk, dRBP-JK, oss, FTZ-F2, suppressor of hairless, Su(h), RBP-J kappa, D, anon-WO0257455.3, E(H), RBP-Jkappa, l(1)br7, lethal group D" CDMC23570 3 3 17 DAC27-C22 2-CG3505-RA_1 CG3505 CGGTCACTGCATTTCGATCCGGGAGTGTGACTACTTCATGAGAATCCTGCTATCCGGCAATCTCAGCCA 69 FBan0003505 FBgn0038250 CG3505 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG3505 CG3505 "proPO-AE, SPH9" CDMC23570 3 4 17 DAC27-C22 2-CG3505-RA_1 CG3505 CGGTCACTGCATTTCGATCCGGGAGTGTGACTACTTCATGAGAATCCTGCTATCCGGCAATCTCAGCCA 69 FBan0003505 FBgn0038250 CG3505 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG3505 CG3505 "proPO-AE, SPH9" CDMC23571 3 5 17 DAC27-G10 27-CG3546-RA_3 CG3546 AGGGTCGCTGGAGAGACCATGATCGAGGTGGACGAAAATGGCGATGAGTACGAGCTGAAGCGATTCTAT 69 FBan0003546 FBgn0029716 CG3546 X X CG3546 CG3546 CDMC23571 3 6 17 DAC27-G10 27-CG3546-RA_3 CG3546 AGGGTCGCTGGAGAGACCATGATCGAGGTGGACGAAAATGGCGATGAGTACGAGCTGAAGCGATTCTAT 69 FBan0003546 FBgn0029716 CG3546 X X CG3546 CG3546 CDMC23572 3 7 17 DAC27-G22 16-CG3566-RC_1 CG3566 ATCAACCCCTCTAGAAATGCCTGCAAAACCGTGTAATCCTAGCTAGCTAACCAAAGTGCACCCAGTTTT 69 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC23572 3 8 17 DAC27-G22 16-CG3566-RC_1 CG3566 ATCAACCCCTCTAGAAATGCCTGCAAAACCGTGTAATCCTAGCTAGCTAACCAAAGTGCACCCAGTTTT 69 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC23573 3 9 17 DAC27-K10 3-CG3605-RA_7 CG3605 TGTGGCAGAACTGAAACAACTGGTCTCTCGACCTGACGTAGTGGAGATGCACGATGTCACAGCGAGAGA 69 FBan0003605 FBgn0031493 CG3605 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG3605 CG3605 CDMC23573 3 10 17 DAC27-K10 3-CG3605-RA_7 CG3605 TGTGGCAGAACTGAAACAACTGGTCTCTCGACCTGACGTAGTGGAGATGCACGATGTCACAGCGAGAGA 69 FBan0003605 FBgn0031493 CG3605 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG3605 CG3605 CDMC23574 3 11 17 DAC27-K22 2-CG3616-RA_1 CG3616 GCACTTCGGGTCCCCGTGATGGACATGAATAACGTGGACTACTTCAAAAAGCTGGTCTTCGGTGCCATG 69 FBan0003616 FBgn0015040 Cyp9c1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9c1 Cytochrome P450-9c1 "CG3616, CG3616, P450, P-450, 9c1" CDMC23574 3 12 17 DAC27-K22 2-CG3616-RA_1 CG3616 GCACTTCGGGTCCCCGTGATGGACATGAATAACGTGGACTACTTCAAAAAGCTGGTCTTCGGTGCCATG 69 FBan0003616 FBgn0015040 Cyp9c1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9c1 Cytochrome P450-9c1 "CG3616, CG3616, P450, P-450, 9c1" CDMC23575 3 13 17 DAC27-O10 18-CG3661-RA_1 CG3661 ACGGGGTGTTTATATACTTTGAGGACAATGCCGGGGTAATAGTAAACAACAAGGGCGAAATGAAGGGCT 69 FBan0003661 FBgn0010078 RpL23 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL23 Ribosomal protein L23 "CG3661, CG3661, RL17, RPL17A, Rpl17A, L17, RpL17A: Ribosomal protein L17A, Ribosomal protein L17A, Ribosomal protein L23, RpL17A" CDMC23575 3 14 17 DAC27-O10 18-CG3661-RA_1 CG3661 ACGGGGTGTTTATATACTTTGAGGACAATGCCGGGGTAATAGTAAACAACAAGGGCGAAATGAAGGGCT 69 FBan0003661 FBgn0010078 RpL23 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL23 Ribosomal protein L23 "CG3661, CG3661, RL17, RPL17A, Rpl17A, L17, RpL17A: Ribosomal protein L17A, Ribosomal protein L17A, Ribosomal protein L23, RpL17A" CDMC23576 3 15 17 DAC27-O22 23-CG3671-RA_2 CG3671 TCGGAGAGGACCTGGGATCAGTGTAACACAATAACTAAATTCTAATTGAAAAGCGTACCAAAAACGGTT 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC23576 3 16 17 DAC27-O22 23-CG3671-RA_2 CG3671 TCGGAGAGGACCTGGGATCAGTGTAACACAATAACTAAATTCTAATTGAAAAGCGTACCAAAAACGGTT 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC23577 3 17 17 DAC28-C10 3-CG14762-RA_1 CG14762 CCCAGTCGAAATTCGCAAGCTCCTCGAGTCCATGTGTCGTGTTAACCAATTCTCAGCAACCATGGCCAA 69 FBan0014762 FBgn0033250 CG14762 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG14762 CG14762 "CT34565, gp150-like" CDMC23577 3 18 17 DAC28-C10 3-CG14762-RA_1 CG14762 CCCAGTCGAAATTCGCAAGCTCCTCGAGTCCATGTGTCGTGTTAACCAATTCTCAGCAACCATGGCCAA 69 FBan0014762 FBgn0033250 CG14762 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG14762 CG14762 "CT34565, gp150-like" CDMC23578 3 19 17 DAC28-C22 2-CG14788-RA_2 CG14788 TGGAACCTAGCAAGATGAACATGATCCTGGTAAACAAGTCGGACCTGCTCACTGAGGAACAGCGTCGCC 69 FBgn0027792 CDMC23578 3 20 17 DAC28-C22 2-CG14788-RA_2 CG14788 TGGAACCTAGCAAGATGAACATGATCCTGGTAAACAAGTCGGACCTGCTCACTGAGGAACAGCGTCGCC 69 FBgn0027792 CDMC23579 3 21 17 DAC28-G10 22-CG14823-RA_1 CG14823 ACTGGGGAGCCTGTCTGAGAGGAGATTGGAAAACTGCTTGAAATACAGGGGGATTACTTAAAACCGATT 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC23579 3 22 17 DAC28-G10 22-CG14823-RA_1 CG14823 ACTGGGGAGCCTGTCTGAGAGGAGATTGGAAAACTGCTTGAAATACAGGGGGATTACTTAAAACCGATT 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC23580 3 23 17 DAC28-G22 3-CG14834-RA_4 CG14834 CGCCAGCACTTCAATGCAGTCGCCTCGAAATCGTCGCTCAAACATAACCATCTACAAGCCCTCCACAAA 69 FBan0014834 FBgn0035768 CG14834 3 3L CG14834 CG14834 CT34650 CDMC23580 3 24 17 DAC28-G22 3-CG14834-RA_4 CG14834 CGCCAGCACTTCAATGCAGTCGCCTCGAAATCGTCGCTCAAACATAACCATCTACAAGCCCTCCACAAA 69 FBan0014834 FBgn0035768 CG14834 3 3L CG14834 CG14834 CT34650 CDMC23581 3 25 17 DAC28-K10 7-CG14872-RB_1 CG14872 CGCCGTTGTCTGTGGATACGGGAGCACCTCTTTGATACCTATCTTCAAGTTCTTCACTCGAGACCGCGA 69 FBan0014872 FBgn0038346 CG14872 3 3R CG14872 CG14872 CDMC23581 3 26 17 DAC28-K10 7-CG14872-RB_1 CG14872 CGCCGTTGTCTGTGGATACGGGAGCACCTCTTTGATACCTATCTTCAAGTTCTTCACTCGAGACCGCGA 69 FBan0014872 FBgn0038346 CG14872 3 3R CG14872 CG14872 CDMC23582 3 1 18 DAC28-K22 8-CG14882-RA_3 CG14882 CCTGGCCGGATTTACAAGCGATGACAAAGAGCGTTGTTTCCTGTCCTGTCTGTCCTCTAAACAGGCCAC 69 FBan0014882 FBgn0038429 CG14882 3 3R electron transport; GO:0006118 [methionine synthase] reductase activity; GO:0030586 ; EC:1.16.1.8; ; GO:0030586 ; EC:1.16.1.8; ; GO:0030586 ; EC:1.16.1.8 CG14882 CG14882 BcDNA:SD10961 CDMC23582 3 2 18 DAC28-K22 8-CG14882-RA_3 CG14882 CCTGGCCGGATTTACAAGCGATGACAAAGAGCGTTGTTTCCTGTCCTGTCTGTCCTCTAAACAGGCCAC 69 FBan0014882 FBgn0038429 CG14882 3 3R electron transport; GO:0006118 [methionine synthase] reductase activity; GO:0030586 ; EC:1.16.1.8; ; GO:0030586 ; EC:1.16.1.8; ; GO:0030586 ; EC:1.16.1.8 CG14882 CG14882 BcDNA:SD10961 CDMC23583 3 3 18 DAC28-O10 17-CG14904-RA_1 CG14904 AGGCAGATCTCAACCCTCCCGACTTGATGATCCGTCGTTGTTAGTTGAGTGTTGTTTTCTCTCCAAGAA 69 FBan0014904 FBgn0020907 Scp2 3 3R calcium ion binding; GO:0005509; GTPase activity; GO:0003924; ; GO:0005509; ; GO:0003924; ; GO:0005509; ; GO:0003924 sarcoplasmic reticulum; GO:0016529 Scp2 Sarcoplasmic calcium-binding protein 2 "CG14904, Dcabp-A.2, Drosophila Ca[2+]-binding protein A.2, SCP2, Cex Ca2+-sensing low molecular weight, JHDK, dSCP2, CE, cex, Calexcitin, Cex, Ca2+-sensing low molecular weight GTPase" CDMC23583 3 4 18 DAC28-O10 17-CG14904-RA_1 CG14904 AGGCAGATCTCAACCCTCCCGACTTGATGATCCGTCGTTGTTAGTTGAGTGTTGTTTTCTCTCCAAGAA 69 FBan0014904 FBgn0020907 Scp2 3 3R calcium ion binding; GO:0005509; GTPase activity; GO:0003924; ; GO:0005509; ; GO:0003924; ; GO:0005509; ; GO:0003924 sarcoplasmic reticulum; GO:0016529 Scp2 Sarcoplasmic calcium-binding protein 2 "CG14904, Dcabp-A.2, Drosophila Ca[2+]-binding protein A.2, SCP2, Cex Ca2+-sensing low molecular weight, JHDK, dSCP2, CE, cex, Calexcitin, Cex, Ca2+-sensing low molecular weight GTPase" CDMC23584 3 5 18 DAC28-O22 1-CG14914-RA_1 CG14914 TGGCAGCGATCGGCCAAGTACAAATGGTTAGGAGATGCAACAGTAACAGCGAAAACAGCAACAGCCACA 69 FBan0014914 FBgn0032334 CG14914 2 2L CG14914 CG14914 CDMC23584 3 6 18 DAC28-O22 1-CG14914-RA_1 CG14914 TGGCAGCGATCGGCCAAGTACAAATGGTTAGGAGATGCAACAGTAACAGCGAAAACAGCAACAGCCACA 69 FBan0014914 FBgn0032334 CG14914 2 2L CG14914 CG14914 CDMC23585 3 7 18 DAC29-C10 3-CG6404-RA_1 CG6404 TCTGGTTCACGGATCTCACAATGGCGGATCCCTTCTATCTACTGCCCTTAATCACCAGTGCCACGTTGT 69 FBan0006404 FBgn0027615 CG6404 3 3L cytochrome c oxidase complex assembly; GO:0008535 protein transporter activity; GO:0008565; carrier activity; GO:0005386; ; GO:0005386; ; GO:0008565 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6404 CG6404 BcDNA:GH02220 CDMC23585 3 8 18 DAC29-C10 3-CG6404-RA_1 CG6404 TCTGGTTCACGGATCTCACAATGGCGGATCCCTTCTATCTACTGCCCTTAATCACCAGTGCCACGTTGT 69 FBan0006404 FBgn0027615 CG6404 3 3L cytochrome c oxidase complex assembly; GO:0008535 protein transporter activity; GO:0008565; carrier activity; GO:0005386; ; GO:0005386; ; GO:0008565 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6404 CG6404 BcDNA:GH02220 CDMC23586 3 9 18 DAC29-C22 11-CG6415-RA_1 CG6415 CCGGGAAAGCTTCTCTCGATCAACTCTACTTCATGAGTTCCTTCGTCACCACATTGGCTGGAATCCCCA 69 FBan0006415 FBgn0032287 CG6415 2 2L glycine catabolism; GO:0006546 aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 glycine cleavage complex; GO:0005960 CG6415 CG6415 anon-32Aa CDMC23586 3 10 18 DAC29-C22 11-CG6415-RA_1 CG6415 CCGGGAAAGCTTCTCTCGATCAACTCTACTTCATGAGTTCCTTCGTCACCACATTGGCTGGAATCCCCA 69 FBan0006415 FBgn0032287 CG6415 2 2L glycine catabolism; GO:0006546 aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 glycine cleavage complex; GO:0005960 CG6415 CG6415 anon-32Aa CDMC23587 3 11 18 DAC29-G10 23-CG6450-RC_1 CG6450 AGCCCGTACTCCTACGACTAGCACTTTAATAACAAATCATTACACTAACTTCGATCCTGGCCTTCCTTG 69 FBan0006450 FBgn0029688 lva X X cellularization; GO:0007349 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; spectrin binding; GO:0030507; ; GO:0005515; ; GO:0030507 Golgi apparatus; GO:0005794; cell cortex; GO:0005938 lva lava lamp "CG6450, CG6450, CG6450, ABP2, CG#6450, LVA, Lava Lamp, lava, Lva, lava lamp" CDMC23587 3 12 18 DAC29-G10 23-CG6450-RC_1 CG6450 AGCCCGTACTCCTACGACTAGCACTTTAATAACAAATCATTACACTAACTTCGATCCTGGCCTTCCTTG 69 FBan0006450 FBgn0029688 lva X X cellularization; GO:0007349 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; spectrin binding; GO:0030507; ; GO:0005515; ; GO:0030507 Golgi apparatus; GO:0005794; cell cortex; GO:0005938 lva lava lamp "CG6450, CG6450, CG6450, ABP2, CG#6450, LVA, Lava Lamp, lava, Lva, lava lamp" CDMC23588 3 13 18 DAC29-G22 23-CG6459-RA_2 CG6459 CGGTGGCAAGTGAATGTTCGTCCCACTTAATCTTAAAGCATAAAGTTGTGTAGGTTTTTAAGTTTCTAT 69 FBan0006459 FBgn0034259 CG6459 2 2R defense response to bacteria; GO:0042742 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG6459 CG6459 CDMC23588 3 14 18 DAC29-G22 23-CG6459-RA_2 CG6459 CGGTGGCAAGTGAATGTTCGTCCCACTTAATCTTAAAGCATAAAGTTGTGTAGGTTTTTAAGTTTCTAT 69 FBan0006459 FBgn0034259 CG6459 2 2R defense response to bacteria; GO:0042742 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG6459 CG6459 CDMC23589 3 15 18 DAC29-K10 23-CG6496-RA_5 CG6496 TTTTGGTGCGTCGAAGGAAAATGAAAATCCGCAGATAAAAGCCGGTGTAGTCATCTAATAGAGAGAAAA 69 FBan0006496 FBgn0023178 Pdf 3 3R circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; gravitactic behavior; GO:0048062; locomotor rhythm; GO:0045475; neuropeptide signaling pathway; GO:0007218; response to light stimulus; GO:0009416 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Pdf Pigment-dispersing factor "CG6496, PDH, Pigment-dispersing hormone-like peptide, PDF, Pigment-dispersing hormone, Drm-PDF, Drm-pdf, pdf, pigment-dispersing hormone, PAP: Pelle associated protein, Drm-PDH, pigment dispersing factor, pigment-dispersing factor, pigment dispersing hormone, Pigment dispersing factor, anon-WO0140519.261, anon-WO0140519.3, BcDNA:RH08487, cPDH, PAP, Pigment-dispersing factor" CDMC23589 3 16 18 DAC29-K10 23-CG6496-RA_5 CG6496 TTTTGGTGCGTCGAAGGAAAATGAAAATCCGCAGATAAAAGCCGGTGTAGTCATCTAATAGAGAGAAAA 69 FBan0006496 FBgn0023178 Pdf 3 3R circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; gravitactic behavior; GO:0048062; locomotor rhythm; GO:0045475; neuropeptide signaling pathway; GO:0007218; response to light stimulus; GO:0009416 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Pdf Pigment-dispersing factor "CG6496, PDH, Pigment-dispersing hormone-like peptide, PDF, Pigment-dispersing hormone, Drm-PDF, Drm-pdf, pdf, pigment-dispersing hormone, PAP: Pelle associated protein, Drm-PDH, pigment dispersing factor, pigment-dispersing factor, pigment dispersing hormone, Pigment dispersing factor, anon-WO0140519.261, anon-WO0140519.3, BcDNA:RH08487, cPDH, PAP, Pigment-dispersing factor" CDMC23590 3 17 18 DAC29-K22 3-CG6512-RA_2 CG6512 AGGCCACCACTAGTCTGCTGACCAAGCACAAGGAGAATGTTCAAAAAGTGGCGGAAAGACTGCTCCAAA 69 FBan0006512 FBgn0036702 CG6512 3 3L ATP-dependent proteolysis; GO:0006510; mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0004222 ; EC:3.4.24.-; ; GO:0000166 endoplasmic reticulum; GO:0005783; membrane; GO:0016020; mitochondrion; GO:0005739 CG6512 CG6512 DmCG6512 CDMC23590 3 18 18 DAC29-K22 3-CG6512-RA_2 CG6512 AGGCCACCACTAGTCTGCTGACCAAGCACAAGGAGAATGTTCAAAAAGTGGCGGAAAGACTGCTCCAAA 69 FBan0006512 FBgn0036702 CG6512 3 3L ATP-dependent proteolysis; GO:0006510; mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0004222 ; EC:3.4.24.-; ; GO:0000166 endoplasmic reticulum; GO:0005783; membrane; GO:0016020; mitochondrion; GO:0005739 CG6512 CG6512 DmCG6512 CDMC23591 3 19 18 DAC29-O10 10-CG6546-RA_1 CG6546 TGCGCAAACTGCCAGAGAACCTAACTCAGTCGTGGCAAAACTACATGTTGCAGCTCATGATGCAAGACT 69 FBgn0034216 CDMC23591 3 20 18 DAC29-O10 10-CG6546-RA_1 CG6546 TGCGCAAACTGCCAGAGAACCTAACTCAGTCGTGGCAAAACTACATGTTGCAGCTCATGATGCAAGACT 69 FBgn0034216 CDMC23592 3 21 18 DAC29-O22 22-CG6559-RA_2 CG6559 CAGCAGCAACCAATCCCCAGAATTCAGGCCATTGTTCGCTTATTGAAATTTCAGCCAAAGGAAAACGGA 69 FBan0006559 FBgn0036081 CG6559 3 3L CG6559 CG6559 CDMC23592 3 22 18 DAC29-O22 22-CG6559-RA_2 CG6559 CAGCAGCAACCAATCCCCAGAATTCAGGCCATTGTTCGCTTATTGAAATTTCAGCCAAAGGAAAACGGA 69 FBan0006559 FBgn0036081 CG6559 3 3L CG6559 CG6559 CDMC23593 3 23 18 DAC30-C10 12-CG40168-RA_1 CG40168 GCCTCCGGCCATCAACAGTTTCGCCATCAAGGTGAATCTACACGAACTTAAAGGCTCTGAGCTCTGA 67 CDMC23593 3 24 18 DAC30-C10 12-CG40168-RA_1 CG40168 GCCTCCGGCCATCAACAGTTTCGCCATCAAGGTGAATCTACACGAACTTAAAGGCTCTGAGCTCTGA 67 CDMC23594 3 25 18 DAC30-C22 23-CG40294-RA_3 CG40294 AGTTAAAGGAGCATGCTCAAATTTAATAGAAACTCTTCCGAACGTTTGCTGATTTTGCAGGTTCAGA 67 FBgn0058294 CG40294 CG40294 CG40294 CDMC23594 3 26 18 DAC30-C22 23-CG40294-RA_3 CG40294 AGTTAAAGGAGCATGCTCAAATTTAATAGAAACTCTTCCGAACGTTTGCTGATTTTGCAGGTTCAGA 67 FBgn0058294 CG40294 CG40294 CG40294 CDMC23595 3 1 19 DAC30-G10 3-CG4291-RA_2 CG4291 CCGTGGTTTCCGCCTCGAGTGAACCAGAACCTCCAGTCAAGAAGTTCAAGGAAAAGACGATTGGCGG 67 FBan0004291 FBgn0031287 CG4291 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; FH1 domain binding; GO:0017058; ; GO:0017058; ; GO:0008270 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG4291 CG4291 CDMC23595 3 2 19 DAC30-G10 3-CG4291-RA_2 CG4291 CCGTGGTTTCCGCCTCGAGTGAACCAGAACCTCCAGTCAAGAAGTTCAAGGAAAAGACGATTGGCGG 67 FBan0004291 FBgn0031287 CG4291 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; FH1 domain binding; GO:0017058; ; GO:0017058; ; GO:0008270 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG4291 CG4291 CDMC23596 3 3 19 DAC30-G22 9-CG4480-RA_2 CG4480 CCGGAACTGAGCCAGAATTATCCTCCGGCAATCTCCAAGAGCCCTTAAGTTTACGCGATGAGCTCCG 67 FBan0004480 FBgn0032553 CG4480 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG4480 CG4480 CDMC23596 3 4 19 DAC30-G22 9-CG4480-RA_2 CG4480 CCGGAACTGAGCCAGAATTATCCTCCGGCAATCTCCAAGAGCCCTTAAGTTTACGCGATGAGCTCCG 67 FBan0004480 FBgn0032553 CG4480 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG4480 CG4480 CDMC23597 3 5 19 DAC30-K10 1-CG4995-RB_1 CG4995 CCAAAACGCGACTCCAATTGTCCACGCAGGTTGATAGCGGCATCAAGTTCACTGGACCCATTCACTG 67 FBan0004995 FBgn0032219 CG4995 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4995 CG4995 "CG18626, CG18626" CDMC23597 3 6 19 DAC30-K10 1-CG4995-RB_1 CG4995 CCAAAACGCGACTCCAATTGTCCACGCAGGTTGATAGCGGCATCAAGTTCACTGGACCCATTCACTG 67 FBan0004995 FBgn0032219 CG4995 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4995 CG4995 "CG18626, CG18626" CDMC23598 3 7 19 DAC30-K22 2-CG5144-RA_1 CG5144 TGCCAGCAAAGGAAATGTGGACAAGGAGGTGATGGAGCAAATGGAGAAGGGCTACAAGAAGTTGGCC 67 FBan0005144 FBgn0035957 CG5144 3 3L arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 CG5144 CG5144 CDMC23598 3 8 19 DAC30-K22 2-CG5144-RA_1 CG5144 TGCCAGCAAAGGAAATGTGGACAAGGAGGTGATGGAGCAAATGGAGAAGGGCTACAAGAAGTTGGCC 67 FBan0005144 FBgn0035957 CG5144 3 3L arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 CG5144 CG5144 CDMC23599 3 9 19 DAC30-O10 9-CG5572-RA_3 CG5572 GCGGATATCAAGTGGGTGTTACTGAGTGCCTGTCTGACTCTCATCCAGTGTTGTTCATGCCGCCTGT 67 FBan0005572 FBgn0039548 CG5572 3 3R CG5572 CG5572 CDMC23599 3 10 19 DAC30-O10 9-CG5572-RA_3 CG5572 GCGGATATCAAGTGGGTGTTACTGAGTGCCTGTCTGACTCTCATCCAGTGTTGTTCATGCCGCCTGT 67 FBan0005572 FBgn0039548 CG5572 3 3R CG5572 CG5572 CDMC23600 3 11 19 DAC30-O22 AutoBlank AutoBlank CDMC23600 3 12 19 DAC30-O22 AutoBlank AutoBlank CDMC23601 3 13 19 DAC31-C10 3-CG7498-RA_1 CG7498 AGCACGCTGAGCAAGGTGTTTCGCTTCGTGGTGAACTTTTTCATCCTCTAAGCGACTGGATTGAAGCCA 69 FBan0007498 FBgn0040833 CG7498 3 3L CG7498 CG7498 CDMC23601 3 14 19 DAC31-C10 3-CG7498-RA_1 CG7498 AGCACGCTGAGCAAGGTGTTTCGCTTCGTGGTGAACTTTTTCATCCTCTAAGCGACTGGATTGAAGCCA 69 FBan0007498 FBgn0040833 CG7498 3 3L CG7498 CG7498 CDMC23602 3 15 19 DAC31-C22 22-CG7510-RA_3 CG7510 GGCCCAAGTACCTCACGTCAAAGTTGTCAGACTATTATCGAGCGATATGAGGATCAGAACAGAAGGGGA 69 FBan0007510 FBgn0036741 CG7510 3 3L CG7510 CG7510 anon-74EFa CDMC23602 3 16 19 DAC31-C22 22-CG7510-RA_3 CG7510 GGCCCAAGTACCTCACGTCAAAGTTGTCAGACTATTATCGAGCGATATGAGGATCAGAACAGAAGGGGA 69 FBan0007510 FBgn0036741 CG7510 3 3L CG7510 CG7510 anon-74EFa CDMC23603 3 17 19 DAC31-G10 16-CG7546-RA_1 CG7546 ACACACAATGGGTCAAGACGCAACAGAGCCCAATCAAAAACAATTTTTGCGGTGCATGAATGAGCAAAA 69 FBan0007546 FBgn0035793 CG7546 3 3L CG7546 CG7546 "clone 2.45, anon-EST:Liang-2.45" CDMC23603 3 18 19 DAC31-G10 16-CG7546-RA_1 CG7546 ACACACAATGGGTCAAGACGCAACAGAGCCCAATCAAAAACAATTTTTGCGGTGCATGAATGAGCAAAA 69 FBan0007546 FBgn0035793 CG7546 3 3L CG7546 CG7546 "clone 2.45, anon-EST:Liang-2.45" CDMC23604 3 19 19 DAC31-G22 23-CG7555-RA_1 CG7555 AAAACTCACACACTACACATACACCTTATACAAGCAGAGAAAAAAGGATCCCAATAAAGCTGCGCATGG 69 FBan0007555 FBgn0036736 Nedd4 3 3L axon guidance; GO:0007411; protein ubiquitination; GO:0016567; proteolysis; GO:0006508 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 Nedd4 Nedd4 "CG7555, DNedd4, dNedd4, dNedd4-1, nedd4" CDMC23604 3 20 19 DAC31-G22 23-CG7555-RA_1 CG7555 AAAACTCACACACTACACATACACCTTATACAAGCAGAGAAAAAAGGATCCCAATAAAGCTGCGCATGG 69 FBan0007555 FBgn0036736 Nedd4 3 3L axon guidance; GO:0007411; protein ubiquitination; GO:0016567; proteolysis; GO:0006508 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 Nedd4 Nedd4 "CG7555, DNedd4, dNedd4, dNedd4-1, nedd4" CDMC23605 3 21 19 DAC31-K10 13-CG7588-RA_1 CG7588 GGAGAAACTTAGAGGACGTTGGATTTGGCGGGATGTAAGGCGTTGTGATATGCAAATTGTTGCGTGCGA 69 FBan0007588 FBgn0014850 Eig71Ej 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ej Eig71Ej "CG7588, L71-10, L71" CDMC23605 3 22 19 DAC31-K10 13-CG7588-RA_1 CG7588 GGAGAAACTTAGAGGACGTTGGATTTGGCGGGATGTAAGGCGTTGTGATATGCAAATTGTTGCGTGCGA 69 FBan0007588 FBgn0014850 Eig71Ej 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ej Eig71Ej "CG7588, L71-10, L71" CDMC23606 3 23 19 DAC31-K22 15-CG7597-RB_1 CG7597 AGCAACCATGGTGGGGGATGCTTAGCATTTGCTGTTTGCTTCGCTACTTAATGTGAAGGAGAGCTACAT 69 FBan0007597 FBgn0037093 CG7597 3 3L mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 CG7597 CG7597 "AC017581, anon-WO0140519.165" CDMC23606 3 24 19 DAC31-K22 15-CG7597-RB_1 CG7597 AGCAACCATGGTGGGGGATGCTTAGCATTTGCTGTTTGCTTCGCTACTTAATGTGAAGGAGAGCTACAT 69 FBan0007597 FBgn0037093 CG7597 3 3L mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 CG7597 CG7597 "AC017581, anon-WO0140519.165" CDMC23607 3 25 19 DAC31-O10 23-CG7630-RA_2 CG7630 AGCGTTCCCTTACGTGTAAATTAATCCAACATTTGTGTTAAATAAGCTTAAAGTGGCGACATAGTAAAT 69 FBan0007630 FBgn0040793 CG7630 3 3L CG7630 CG7630 "BcDNA:RH19679, anon-EST:Posey153, anon-EST:Posey228" CDMC23607 3 26 19 DAC31-O10 23-CG7630-RA_2 CG7630 AGCGTTCCCTTACGTGTAAATTAATCCAACATTTGTGTTAAATAAGCTTAAAGTGGCGACATAGTAAAT 69 FBan0007630 FBgn0040793 CG7630 3 3L CG7630 CG7630 "BcDNA:RH19679, anon-EST:Posey153, anon-EST:Posey228" CDMC23608 3 1 20 DAC31-O22 12-CG7639-RA_5 CG7639 AGGGCCAATGATCTACAACTGAAGTTCTGGAAACCCTTCTTCCACACACGCTTCAAGGAAAATCGGCCT 69 FBan0007639 FBgn0033989 CG7639 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7639 CG7639 CDMC23608 3 2 20 DAC31-O22 12-CG7639-RA_5 CG7639 AGGGCCAATGATCTACAACTGAAGTTCTGGAAACCCTTCTTCCACACACGCTTCAAGGAAAATCGGCCT 69 FBan0007639 FBgn0033989 CG7639 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7639 CG7639 CDMC23609 3 3 20 DAC32-C10 3-CG15011-RA_6 CG15011 CCAAATGTCACCATGCCATTAAGCATCGTTGTCACAAGGGTGACTGTCCTCCATGTGGCCAAGTGTGC 68 FBan0015011 FBgn0035518 CG15011 3 3L protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; receptor activity; GO:0004872; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0004872; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG15011 CG15011 CDMC23609 3 4 20 DAC32-C10 3-CG15011-RA_6 CG15011 CCAAATGTCACCATGCCATTAAGCATCGTTGTCACAAGGGTGACTGTCCTCCATGTGGCCAAGTGTGC 68 FBan0015011 FBgn0035518 CG15011 3 3L protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; receptor activity; GO:0004872; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0004872; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG15011 CG15011 CDMC23610 3 5 20 DAC32-C22 2-CG15116-RA_1 CG15116 GGGAGGGAGCCAACATAGGACACCTCTTTGCCAAGATAGATGTAAAGGGAGCTCAGGCAGATCCGCTG 68 FBan0015116 FBgn0034415 CG15116 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to oxidative stress; GO:0006979; response to stress; GO:0006950; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 CG15116 CG15116 CDMC23610 3 6 20 DAC32-C22 2-CG15116-RA_1 CG15116 GGGAGGGAGCCAACATAGGACACCTCTTTGCCAAGATAGATGTAAAGGGAGCTCAGGCAGATCCGCTG 68 FBan0015116 FBgn0034415 CG15116 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to oxidative stress; GO:0006979; response to stress; GO:0006950; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 CG15116 CG15116 CDMC23611 3 7 20 DAC32-G10 2-CG1548-RA_4 CG1548 TCCAAGAAGTGCCACCTGACCAACATCGCCTGTTTGATGCACAACAAGTACGATGCCTCCAAGTCGAA 68 FBan0001548 FBgn0029093 cathD 2 2R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 cathD cathD "CG1548, CG1548, CG1548, CG1548, CG1548, CG1548, cathepsin D, CT3996, T17, CATH" CDMC23611 3 8 20 DAC32-G10 2-CG1548-RA_4 CG1548 TCCAAGAAGTGCCACCTGACCAACATCGCCTGTTTGATGCACAACAAGTACGATGCCTCCAAGTCGAA 68 FBan0001548 FBgn0029093 cathD 2 2R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 cathD cathD "CG1548, CG1548, CG1548, CG1548, CG1548, CG1548, cathepsin D, CT3996, T17, CATH" CDMC23612 3 9 20 DAC32-G22 2-CG15628-RA_2 CG15628 TGGATGGTCCATTCATACTACGGTGCCATGTTCTCAATGCAAACACGTCCAGACTTCAGGCGCATGGG 68 FBan0015628 FBgn0031632 CG15628 2 2L CG15628 CG15628 anon-WO02059370.23 CDMC23612 3 10 20 DAC32-G22 2-CG15628-RA_2 CG15628 TGGATGGTCCATTCATACTACGGTGCCATGTTCTCAATGCAAACACGTCCAGACTTCAGGCGCATGGG 68 FBan0015628 FBgn0031632 CG15628 2 2L CG15628 CG15628 anon-WO02059370.23 CDMC23613 3 11 20 DAC32-K10 11-CG16879-RA_1 CG16879 ACAGCTGCTAAAGTCGCGGGATAATCTGCTGCGATACTATAACTTCATGAGGCGCTTCTATGCCGGGG 68 FBan0016879 FBgn0028904 CG16879 2 2L CG16879 CG16879 "BG:DS01759.1, DS01759.1" CDMC23613 3 12 20 DAC32-K10 11-CG16879-RA_1 CG16879 ACAGCTGCTAAAGTCGCGGGATAATCTGCTGCGATACTATAACTTCATGAGGCGCTTCTATGCCGGGG 68 FBan0016879 FBgn0028904 CG16879 2 2L CG16879 CG16879 "BG:DS01759.1, DS01759.1" CDMC23614 3 13 20 DAC32-K22 1-CG16993-RA_1 CG16993 AGAAATCCAAGCACTATCGCAGGCATCTATCGGAATCCTCGAGAGCACAGACGAACTCGAACGGGCAC 68 FBan0016993 FBgn0001259 in 3 3L establishment and/or maintenance of cell polarity; GO:0007163; establishment of planar polarity; GO:0001736; establishment of wing hair orientation; GO:0001737; trichome organization and biogenesis (sensu Insecta); GO:0035316 protein binding; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 in inturned "CG16993, B, transcript B, intwined, inturned" CDMC23614 3 14 20 DAC32-K22 1-CG16993-RA_1 CG16993 AGAAATCCAAGCACTATCGCAGGCATCTATCGGAATCCTCGAGAGCACAGACGAACTCGAACGGGCAC 68 FBan0016993 FBgn0001259 in 3 3L establishment and/or maintenance of cell polarity; GO:0007163; establishment of planar polarity; GO:0001736; establishment of wing hair orientation; GO:0001737; trichome organization and biogenesis (sensu Insecta); GO:0035316 protein binding; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 in inturned "CG16993, B, transcript B, intwined, inturned" CDMC23615 3 15 20 DAC32-O10 2-CG17352-RC_3 CG17352 CGGCAGAGAGTCCTGTGACAACCGACCAGAACCAATTGCAGAAACAAAGTCCGGAGCAGACAATCAGC 68 FBan0017352 FBgn0035880 CG17352 3 3L CG17352 CG17352 CT33100 CDMC23615 3 16 20 DAC32-O10 2-CG17352-RC_3 CG17352 CGGCAGAGAGTCCTGTGACAACCGACCAGAACCAATTGCAGAAACAAAGTCCGGAGCAGACAATCAGC 68 FBan0017352 FBgn0035880 CG17352 3 3L CG17352 CG17352 CT33100 CDMC23616 3 17 20 DAC32-O22 AutoBlank AutoBlank CDMC23616 3 18 20 DAC32-O22 AutoBlank AutoBlank CDMC23617 3 19 20 DAC33-C10 1-CG31702-RA_2 CG31702 CAGATCGAAAAATCTGGCCAGCATCGGTACCAAGTCCTTAGTTCTACACGCGGGGTCCATGTGCCT 66 FBan0031702 FBgn0051702 CG31702 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31702 CG31702 CDMC23617 3 20 20 DAC33-C10 1-CG31702-RA_2 CG31702 CAGATCGAAAAATCTGGCCAGCATCGGTACCAAGTCCTTAGTTCTACACGCGGGGTCCATGTGCCT 66 FBan0031702 FBgn0051702 CG31702 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31702 CG31702 CDMC23618 3 21 20 DAC33-C22 2-CG31798-RA_2 CG31798 AGAGATTAACTTTGATCGCGAGACCATAAGGCAAGGAATCACCCCCCTGACCTACGATGAGGCGCG 66 FBan0031798 FBgn0051798 CG31798 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31798 CG31798 anon-WO0140519.187 CDMC23618 3 22 20 DAC33-C22 2-CG31798-RA_2 CG31798 AGAGATTAACTTTGATCGCGAGACCATAAGGCAAGGAATCACCCCCCTGACCTACGATGAGGCGCG 66 FBan0031798 FBgn0051798 CG31798 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31798 CG31798 anon-WO0140519.187 CDMC23619 3 23 20 DAC33-G10 3-CG32423-RA_5 CG32423 CGTGGCATCTCGATGATGGTTAGCGGTGATACGGGCGTGCCATATGGAACAATGATGCCTCAGTTG 66 FBan0032423 FBgn0052423 CG32423 3 3L mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729 CG32423 CG32423 "CG10668, CG10647, CG10649, CG10668, cg10668, anon-EST:Posey83, anon-WO0118547.198, anon-WO0172774.41, BcDNA:LD40028, BcDNA:RH63980" CDMC23619 3 24 20 DAC33-G10 3-CG32423-RA_5 CG32423 CGTGGCATCTCGATGATGGTTAGCGGTGATACGGGCGTGCCATATGGAACAATGATGCCTCAGTTG 66 FBan0032423 FBgn0052423 CG32423 3 3L mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729 CG32423 CG32423 "CG10668, CG10647, CG10649, CG10668, cg10668, anon-EST:Posey83, anon-WO0118547.198, anon-WO0172774.41, BcDNA:LD40028, BcDNA:RH63980" CDMC23620 3 25 20 DAC33-G22 3-CG32557-RA_1 CG32557 TCTTCAACGGCGTTTCGAACTGTCCGATCAGCTTCAGCATCGATAAGCACGACCTGGTGGTGATCG 66 FBan0032557 FBgn0052557 CG32557 X X defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0005507; ; GO:0008471 ; EC:1.10.3.2 CG32557 CG32557 "CG7871, CG7871, CG7871" CDMC23620 3 26 20 DAC33-G22 3-CG32557-RA_1 CG32557 TCTTCAACGGCGTTTCGAACTGTCCGATCAGCTTCAGCATCGATAAGCACGACCTGGTGGTGATCG 66 FBan0032557 FBgn0052557 CG32557 X X defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0005507; ; GO:0008471 ; EC:1.10.3.2 CG32557 CG32557 "CG7871, CG7871, CG7871" CDMC23621 3 1 21 DAC33-K10 12-CG3291-RA_3 CG3291 ACGATCCAAGATTTTGTGCCCATACAGGCGTACCGTCCCAAGAAATTAAATCGCGTCCAACCAGCC 66 FBan0003291 FBgn0020261 pcm X X DNA repair; GO:0006281; RNA catabolism; GO:0006401; gastrulation; GO:0007369 nucleic acid binding; GO:0003676; 5'-3' exoribonuclease activity; GO:0004534 ; EC:3.1.13.-; ; GO:0004534 ; EC:3.1.13.-; ; GO:0003676; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004534 ; EC:3.1.13.- cytoplasm; GO:0005737; nucleus; GO:0005634 pcm pacman "CG3291, CG3291, Pacman, XRN1, pacman" CDMC23621 3 2 21 DAC33-K10 12-CG3291-RA_3 CG3291 ACGATCCAAGATTTTGTGCCCATACAGGCGTACCGTCCCAAGAAATTAAATCGCGTCCAACCAGCC 66 FBan0003291 FBgn0020261 pcm X X DNA repair; GO:0006281; RNA catabolism; GO:0006401; gastrulation; GO:0007369 nucleic acid binding; GO:0003676; 5'-3' exoribonuclease activity; GO:0004534 ; EC:3.1.13.-; ; GO:0004534 ; EC:3.1.13.-; ; GO:0003676; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004534 ; EC:3.1.13.- cytoplasm; GO:0005737; nucleus; GO:0005634 pcm pacman "CG3291, CG3291, Pacman, XRN1, pacman" CDMC23622 3 3 21 DAC33-K22 1-CG33221-RA_7 CG33221 GCTCTTTCTGCCTTAAGCCTTTCTCTTTGCCTGTCGTCGATCTGCCGGAGTTCGTGTGTGTGGAGA 66 FBan0033221 FBgn0053221 CG33221 X X biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG33221 CG33221 CG12260 CDMC23622 3 4 21 DAC33-K22 1-CG33221-RA_7 CG33221 GCTCTTTCTGCCTTAAGCCTTTCTCTTTGCCTGTCGTCGATCTGCCGGAGTTCGTGTGTGTGGAGA 66 FBan0033221 FBgn0053221 CG33221 X X biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG33221 CG33221 CG12260 CDMC23623 3 5 21 DAC33-O10 1-CG3560-RA_3 CG3560 CAGAAAGGGACCCGCAGTTCTCTCAAATCTGGGCAGATGGGCCTACAATCTCTCCGGATTCAACCA 66 FBan0003560 FBgn0030733 CG3560 X X "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG3560 CG3560 "BcDNA:RH44664, anon-EST:Posey167" CDMC23623 3 6 21 DAC33-O10 1-CG3560-RA_3 CG3560 CAGAAAGGGACCCGCAGTTCTCTCAAATCTGGGCAGATGGGCCTACAATCTCTCCGGATTCAACCA 66 FBan0003560 FBgn0030733 CG3560 X X "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG3560 CG3560 "BcDNA:RH44664, anon-EST:Posey167" CDMC23624 3 7 21 DAC33-O22 AutoBlank AutoBlank CDMC23624 3 8 21 DAC33-O22 AutoBlank AutoBlank CDMC23625 3 9 21 DAC34-C10 11-CG13463-RA_1 CG13463 AGGGTCCACAGTCCAGTGCAGAGGAATCCCACGAGATTTCCCAAGAGTTTTCTCATGAGATTTCCCAGA 69 FBan0013463 FBgn0036470 CG13463 3 3L CG13463 CG13463 BcDNA:RE10167 CDMC23625 3 10 21 DAC34-C10 11-CG13463-RA_1 CG13463 AGGGTCCACAGTCCAGTGCAGAGGAATCCCACGAGATTTCCCAAGAGTTTTCTCATGAGATTTCCCAGA 69 FBan0013463 FBgn0036470 CG13463 3 3L CG13463 CG13463 BcDNA:RE10167 CDMC23626 3 11 21 DAC34-C22 5-CG13476-RB_1 CG13476 GGCGTTTCTCGACTTGGATCCGAGTTCCGACGAGACAGAAGTTCTGAATGACCGTAGTCTTGCAGCGTC 69 FBan0013476 FBgn0036441 CG13476 3 3L CG13476 CG13476 CDMC23626 3 12 21 DAC34-C22 5-CG13476-RB_1 CG13476 GGCGTTTCTCGACTTGGATCCGAGTTCCGACGAGACAGAAGTTCTGAATGACCGTAGTCTTGCAGCGTC 69 FBan0013476 FBgn0036441 CG13476 3 3L CG13476 CG13476 CDMC23627 3 13 21 DAC34-G10 12-CG13530-RA_1 CG13530 TCCACGTGTACAACTTTGGCCTCCAAATGCGAGAATCTAGCACCCGAAAGTCACCAAATGATCTGCGAA 69 FBan0013530 FBgn0034777 CG13530 2 2R CG13530 CG13530 CDMC23627 3 14 21 DAC34-G10 12-CG13530-RA_1 CG13530 TCCACGTGTACAACTTTGGCCTCCAAATGCGAGAATCTAGCACCCGAAAGTCACCAAATGATCTGCGAA 69 FBan0013530 FBgn0034777 CG13530 2 2R CG13530 CG13530 CDMC23628 3 15 21 DAC34-G22 1-CG13549-RA_1 CG13549 GGGCCTTCACTTATTCAGCATGGAGTGTGGAAAGTCACGCATGGTGATGTATGGTGCAAAGGGCAGAGA 69 FBan0013549 FBgn0040063 yip3 2 2R ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 yip3 yippee interacting protein 3 "CG13549, bs18b12.y1, BcDNA:AT20887, NEST:bs18b12, yippee interacting protein 3" CDMC23628 3 16 21 DAC34-G22 1-CG13549-RA_1 CG13549 GGGCCTTCACTTATTCAGCATGGAGTGTGGAAAGTCACGCATGGTGATGTATGGTGCAAAGGGCAGAGA 69 FBan0013549 FBgn0040063 yip3 2 2R ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 yip3 yippee interacting protein 3 "CG13549, bs18b12.y1, BcDNA:AT20887, NEST:bs18b12, yippee interacting protein 3" CDMC23629 3 17 21 DAC34-K10 3-CG13588-RA_1 CG13588 CCCGAGCTTCTCGATAAGCTGCACAAGGAAGGGAAGATTGTGTTTACGCCGTGCAAAAACATTCCCGGT 69 FBan0013588 FBgn0035038 CG13588 2 2R CG13588 CG13588 CDMC23629 3 18 21 DAC34-K10 3-CG13588-RA_1 CG13588 CCCGAGCTTCTCGATAAGCTGCACAAGGAAGGGAAGATTGTGTTTACGCCGTGCAAAAACATTCCCGGT 69 FBan0013588 FBgn0035038 CG13588 2 2R CG13588 CG13588 CDMC23630 3 19 21 DAC34-K22 3-CG13599-RA_2 CG13599 CGATCTTGGCGTGCGGAATCTGGATAAATCTGGGGAAGACGTTAGCCAGACCAACGAAGAGCATGACGT 69 FBan0013599 FBgn0039128 CG13599 3 3R CG13599 CG13599 CDMC23630 3 20 21 DAC34-K22 3-CG13599-RA_2 CG13599 CGATCTTGGCGTGCGGAATCTGGATAAATCTGGGGAAGACGTTAGCCAGACCAACGAAGAGCATGACGT 69 FBan0013599 FBgn0039128 CG13599 3 3R CG13599 CG13599 CDMC23631 3 21 21 DAC34-O10 1-CG13627-RA_1 CG13627 ACCGAAGTACAGTGTGCATGAGGACGAGACCAATGACCAAACCATTCGTGATCCCATTTCGGGTTCGCA 69 FBan0013627 FBgn0039217 CG13627 3 3R CG13627 CG13627 CDMC23631 3 22 21 DAC34-O10 1-CG13627-RA_1 CG13627 ACCGAAGTACAGTGTGCATGAGGACGAGACCAATGACCAAACCATTCGTGATCCCATTTCGGGTTCGCA 69 FBan0013627 FBgn0039217 CG13627 3 3R CG13627 CG13627 CDMC23632 3 23 21 DAC34-O22 2-CG13641-RA_1 CG13641 TCTCAGCCGTCTCATCCTGCCAGTGTCCATTATCCGCACAAGAATCAGGATCTTTACGGAGGTGGAGGT 69 FBan0013641 FBgn0039239 CG13641 3 3R CG13641 CG13641 CDMC23632 3 24 21 DAC34-O22 2-CG13641-RA_1 CG13641 TCTCAGCCGTCTCATCCTGCCAGTGTCCATTATCCGCACAAGAATCAGGATCTTTACGGAGGTGGAGGT 69 FBan0013641 FBgn0039239 CG13641 3 3R CG13641 CG13641 CDMC23633 3 25 21 DAC35-C10 2-CG17996-RA_1 CG17996 TCGGAAACAGAACTCAGCCCTGAAGGAATGCCTCACCCAGTGGTATCAGAACGAAGCCTTCAAGGA 66 FBan0017996 FBgn0032595 CG17996 2 2L CG17996 CG17996 BcDNA:GM20557 CDMC23633 3 26 21 DAC35-C10 2-CG17996-RA_1 CG17996 TCGGAAACAGAACTCAGCCCTGAAGGAATGCCTCACCCAGTGGTATCAGAACGAAGCCTTCAAGGA 66 FBan0017996 FBgn0032595 CG17996 2 2L CG17996 CG17996 BcDNA:GM20557 CDMC23634 3 1 22 DAC35-C22 3-CG18319-RA_3 CG18319 ACGCCCGAGGTCAGGAGGAAAGTCAGAAAGCGGATCCGTCAGTTGTATCGGCGTTTTTCCAGAAAG 66 FBan0018319 FBgn0000173 ben X X axon target recognition; GO:0007412; axonogenesis; GO:0007409; flight behavior; GO:0007629; grooming behavior; GO:0007625; jump response; GO:0007630; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein ubiquitination; GO:0016567; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004840; ; GO:0004840; ; GO:0004842 ; EC:6.3.2.19 ben bendless "CG18319, UbcD3, Ben, anon-WO03040301.242, nj-262: nonjumper-262, nonjumper-262, bendless" CDMC23634 3 2 22 DAC35-C22 3-CG18319-RA_3 CG18319 ACGCCCGAGGTCAGGAGGAAAGTCAGAAAGCGGATCCGTCAGTTGTATCGGCGTTTTTCCAGAAAG 66 FBan0018319 FBgn0000173 ben X X axon target recognition; GO:0007412; axonogenesis; GO:0007409; flight behavior; GO:0007629; grooming behavior; GO:0007625; jump response; GO:0007630; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein ubiquitination; GO:0016567; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004840; ; GO:0004840; ; GO:0004842 ; EC:6.3.2.19 ben bendless "CG18319, UbcD3, Ben, anon-WO03040301.242, nj-262: nonjumper-262, nonjumper-262, bendless" CDMC23635 3 3 22 DAC35-G10 2-CG2611-RA_1 CG2611 TCGGGGCACTGACCTTCATCCCGGGAAGCTACTATGTGTACGTGCTCTTCTGCATAATGCTCAACC 66 FBan0002611 FBgn0032871 CG2611 2 2L CG2611 CG2611 38D.27 CDMC23635 3 4 22 DAC35-G10 2-CG2611-RA_1 CG2611 TCGGGGCACTGACCTTCATCCCGGGAAGCTACTATGTGTACGTGCTCTTCTGCATAATGCTCAACC 66 FBan0002611 FBgn0032871 CG2611 2 2L CG2611 CG2611 38D.27 CDMC23636 3 5 22 DAC35-G22 17-CG2846-RA_2 CG2846 ACACGACTTTAACTGTGACCTTTACGGCCAGACACTCAAGATATGCATTGTAGGCTACCTGCGACC 66 FBan0002846 FBgn0014930 CG2846 3 3R riboflavin biosynthesis; GO:0009231 riboflavin kinase activity; GO:0008531 ; EC:2.7.1.26; ; GO:0008531 ; EC:2.7.1.26 cytoplasm; GO:0005737 CG2846 CG2846 "transcript C, C: Group C, anon-84Ea" CDMC23636 3 6 22 DAC35-G22 17-CG2846-RA_2 CG2846 ACACGACTTTAACTGTGACCTTTACGGCCAGACACTCAAGATATGCATTGTAGGCTACCTGCGACC 66 FBan0002846 FBgn0014930 CG2846 3 3R riboflavin biosynthesis; GO:0009231 riboflavin kinase activity; GO:0008531 ; EC:2.7.1.26; ; GO:0008531 ; EC:2.7.1.26 cytoplasm; GO:0005737 CG2846 CG2846 "transcript C, C: Group C, anon-84Ea" CDMC23637 3 7 22 DAC35-K10 2-CG30197-RA_2 CG30197 GCGGGTGATTGTCCTTCATCCACCAAGGTTCAGAACTGTACGCCAAAATGCCTGCATGACAGCGAG 66 FBan0030197 FBgn0050197 CG30197 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30197 CG30197 BcDNA:RE05231 CDMC23637 3 8 22 DAC35-K10 2-CG30197-RA_2 CG30197 GCGGGTGATTGTCCTTCATCCACCAAGGTTCAGAACTGTACGCCAAAATGCCTGCATGACAGCGAG 66 FBan0030197 FBgn0050197 CG30197 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30197 CG30197 BcDNA:RE05231 CDMC23638 3 9 22 DAC35-K22 3-CG30471-RA_3 CG30471 GTGGTCCTACGGCATTGGAATCGCCAAGAAGTTCGAGTTCTCCTTCGACTCCACCTATGCGACTGG 66 FBan0030471 FBgn0050471 CG30471 2 2R CG30471 CG30471 CG8185 CDMC23638 3 10 22 DAC35-K22 3-CG30471-RA_3 CG30471 GTGGTCCTACGGCATTGGAATCGCCAAGAAGTTCGAGTTCTCCTTCGACTCCACCTATGCGACTGG 66 FBan0030471 FBgn0050471 CG30471 2 2R CG30471 CG30471 CG8185 CDMC23639 3 11 22 DAC35-O10 15-CG31285-RA_2 CG31285 TCGACTTACTGCACTTGCTCCGAGAAAAGGTGGAGAATTATCAGGTGTTCGAAGGAGCCTTGGGCA 66 FBan0031285 FBgn0051285 CG31285 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31285 CG31285 CDMC23639 3 12 22 DAC35-O10 15-CG31285-RA_2 CG31285 TCGACTTACTGCACTTGCTCCGAGAAAAGGTGGAGAATTATCAGGTGTTCGAAGGAGCCTTGGGCA 66 FBan0031285 FBgn0051285 CG31285 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31285 CG31285 CDMC23640 3 13 22 DAC35-O22 AutoBlank AutoBlank CDMC23640 3 14 22 DAC35-O22 AutoBlank AutoBlank CDMC23641 3 15 22 DAC36-C10 2-CG17958-RA_1 CG17958 GCAAGACCTTCAACCATCACACGCTCATTCACAAGGAGAACCGCCCAAGACACTACTGCTCCGTCTG 67 FBan0017958 FBgn0003512 Sry-delta 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; oogenesis (sensu Insecta); GO:0009993; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 Sry-delta Serendipity delta "CG17958, EH8, sry delta, Srydelta, srydelta, Sry-delta, sry, Sry delta, serendipity delta, sry-delta, anon-EH8" CDMC23641 3 16 22 DAC36-C10 2-CG17958-RA_1 CG17958 GCAAGACCTTCAACCATCACACGCTCATTCACAAGGAGAACCGCCCAAGACACTACTGCTCCGTCTG 67 FBan0017958 FBgn0003512 Sry-delta 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; oogenesis (sensu Insecta); GO:0009993; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 Sry-delta Serendipity delta "CG17958, EH8, sry delta, Srydelta, srydelta, Sry-delta, sry, Sry delta, serendipity delta, sry-delta, anon-EH8" CDMC23642 3 17 22 DAC36-C22 2-CG18262-RA_1 CG18262 GGACGTCGTCGAAGTACAGGGAAATGAGGAGCTACATGAGGAACTGGCAAAGGAAGCTAGCCCGGAC 67 FBan0018262 FBgn0030012 CG18262 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18262 CG18262 CDMC23642 3 18 22 DAC36-C22 2-CG18262-RA_1 CG18262 GGACGTCGTCGAAGTACAGGGAAATGAGGAGCTACATGAGGAACTGGCAAAGGAAGCTAGCCCGGAC 67 FBan0018262 FBgn0030012 CG18262 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18262 CG18262 CDMC23643 3 19 22 DAC36-G10 16-CG2004-RA_1 CG2004 GCAGAGTCTATCATCTCCTGGGAATCACTGCAAGAGGAGCTAAAGAACTTTGGTCGCTTTGGTTGCG 67 FBan0002004 FBgn0030060 CG2004 X X CG2004 CG2004 CDMC23643 3 20 22 DAC36-G10 16-CG2004-RA_1 CG2004 GCAGAGTCTATCATCTCCTGGGAATCACTGCAAGAGGAGCTAAAGAACTTTGGTCGCTTTGGTTGCG 67 FBan0002004 FBgn0030060 CG2004 X X CG2004 CG2004 CDMC23644 3 21 22 DAC36-G22 3-CG2244-RA_4 CG2244 TCCTCCATTTCCATACACCATGGATGCACTGCTCAACTAGGAGCACTCTCTGGTTTGACTGACGGGC 67 FBan0002244 FBgn0027951 MTA1-like 3 3R histone deacetylase complex; GO:0000118 MTA1-like MTA1-like "CG2244, CG2244, p120, dMTA1-like, MTA-like, dMTA, metastasis-associated-1-like-protein" CDMC23644 3 22 22 DAC36-G22 3-CG2244-RA_4 CG2244 TCCTCCATTTCCATACACCATGGATGCACTGCTCAACTAGGAGCACTCTCTGGTTTGACTGACGGGC 67 FBan0002244 FBgn0027951 MTA1-like 3 3R histone deacetylase complex; GO:0000118 MTA1-like MTA1-like "CG2244, CG2244, p120, dMTA1-like, MTA-like, dMTA, metastasis-associated-1-like-protein" CDMC23645 3 23 22 DAC36-K10 3-CG30052-RA_3 CG30052 CGGATTCCCCATGTGTCCTCACGATGCTGGTCACCTCATGGGCTGTGTGTTCCGCAATATGATGAAG 67 FBan0030052 FBgn0050052 Obp49a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp49a Odorant-binding protein 49a "CG8769, CG30052, CG8769, CG30052, BcDNA:GH25962, Odorant-binding protein 49a" CDMC23645 3 24 22 DAC36-K10 3-CG30052-RA_3 CG30052 CGGATTCCCCATGTGTCCTCACGATGCTGGTCACCTCATGGGCTGTGTGTTCCGCAATATGATGAAG 67 FBan0030052 FBgn0050052 Obp49a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp49a Odorant-binding protein 49a "CG8769, CG30052, CG8769, CG30052, BcDNA:GH25962, Odorant-binding protein 49a" CDMC23646 3 25 22 DAC36-K22 2-CG30170-RA_2 CG30170 CGAGGTAAGCTGTCGATGAACAATCTCAACCAGATGTCCTGCAATTGGCACATGGTTAAGGCGGCCC 67 FBan0030170 FBgn0004581 bgcn 2 2R cystoblast division; GO:0007282; fusome organization and biogenesis; GO:0045478; germ cell development; GO:0007281; male meiosis; GO:0007140; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283; spermatogonial cell division; GO:0007284 nucleic acid binding; GO:0003676; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386 bgcn benign gonial cell neoplasm "CG10330, CG10331, CG30170, CG10330, CG10331, CG10331, b(2)gcn, b(2)cgn, pep: peppercorn, PNBP, Putative nuclear binding protein, cg10331, bcgn, ben(2)gcn: benign-(2)-gonial-cell-neoplasm, fs(2)eo-C, fs(2)eo6, fs(2)eoQS2, gcn: gonial-cell-neoplasm, benign-(2)-gonial-cell-neoplasm, gonial-cell-neoplasm, peppercorn, pep" CDMC23646 3 26 22 DAC36-K22 2-CG30170-RA_2 CG30170 CGAGGTAAGCTGTCGATGAACAATCTCAACCAGATGTCCTGCAATTGGCACATGGTTAAGGCGGCCC 67 FBan0030170 FBgn0004581 bgcn 2 2R cystoblast division; GO:0007282; fusome organization and biogenesis; GO:0045478; germ cell development; GO:0007281; male meiosis; GO:0007140; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283; spermatogonial cell division; GO:0007284 nucleic acid binding; GO:0003676; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386 bgcn benign gonial cell neoplasm "CG10330, CG10331, CG30170, CG10330, CG10331, CG10331, b(2)gcn, b(2)cgn, pep: peppercorn, PNBP, Putative nuclear binding protein, cg10331, bcgn, ben(2)gcn: benign-(2)-gonial-cell-neoplasm, fs(2)eo-C, fs(2)eo6, fs(2)eoQS2, gcn: gonial-cell-neoplasm, benign-(2)-gonial-cell-neoplasm, gonial-cell-neoplasm, peppercorn, pep" CDMC23647 3 1 23 DAC36-O10 3-CG3071-RA_1 CG3071 GCGCCAGTTTAACCACAAGAAGGCTTTGGACGACGTGATGAATGCGCAGAAGATGCAATACCAGCCG 67 FBan0003071 FBgn0023527 CG3071 X X "retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126 CG3071 CG3071 EG:25E8.3 CDMC23647 3 2 23 DAC36-O10 3-CG3071-RA_1 CG3071 GCGCCAGTTTAACCACAAGAAGGCTTTGGACGACGTGATGAATGCGCAGAAGATGCAATACCAGCCG 67 FBan0003071 FBgn0023527 CG3071 X X "retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126 CG3071 CG3071 EG:25E8.3 CDMC23648 3 3 23 DAC36-O22 AutoBlank AutoBlank CDMC23648 3 4 23 DAC36-O22 AutoBlank AutoBlank CDMC23649 3 5 23 DAC37-C10 12-CG7625-RA_1 CG7625 CGCAGCTGAACCCCCTCATCGGACCCAAACTAAGCATGAACGAAATCATGATCATGGCCCGCGAG 65 FBan0007625 FBgn0028663 VhaM9.7-2 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-2 VhaM9.7-2 "CG7625, CG7625, vhaM9.2-2, vhaM9.7-2, V-ATPase, Vha M9.7-2, anon-WO0118547.551" CDMC23649 3 6 23 DAC37-C10 12-CG7625-RA_1 CG7625 CGCAGCTGAACCCCCTCATCGGACCCAAACTAAGCATGAACGAAATCATGATCATGGCCCGCGAG 65 FBan0007625 FBgn0028663 VhaM9.7-2 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-2 VhaM9.7-2 "CG7625, CG7625, vhaM9.2-2, vhaM9.7-2, V-ATPase, Vha M9.7-2, anon-WO0118547.551" CDMC23650 3 7 23 DAC37-C22 1-CG7669-RA_1 CG7669 AGGAGGACGAACCAATTGTAACAGCTGTGTGCAAAAAGACGGTCCAGAAGGAGTTACCACCGCCC 65 FBan0007669 FBgn0038607 CG7669 3 3R CG7669 CG7669 anon-WO0140519.198 CDMC23650 3 8 23 DAC37-C22 1-CG7669-RA_1 CG7669 AGGAGGACGAACCAATTGTAACAGCTGTGTGCAAAAAGACGGTCCAGAAGGAGTTACCACCGCCC 65 FBan0007669 FBgn0038607 CG7669 3 3R CG7669 CG7669 anon-WO0140519.198 CDMC23651 3 9 23 DAC37-G10 24-CG7835-RA_1 CG7835 AAACTATATAAAAATAAACGAAATAAGCATATCATTTTGATTGAAAAAAGGAAGCGGTTAGTGCA 65 FBan0007835 FBgn0030879 CG7835 X X CG7835 CG7835 CDMC23651 3 10 23 DAC37-G10 24-CG7835-RA_1 CG7835 AAACTATATAAAAATAAACGAAATAAGCATATCATTTTGATTGAAAAAAGGAAGCGGTTAGTGCA 65 FBan0007835 FBgn0030879 CG7835 X X CG7835 CG7835 CDMC23652 3 11 23 DAC37-G22 14-CG7883-RA_1 CG7883 CTGCCGGAGAGCTCTTTTGCAGGTTCATCACCCTCAGTCTGGACGACAAGCACATGGAGGAGTGC 65 FBan0007883 FBgn0039726 eIF2B-alpha 3 3R translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-alpha eIF2B-alpha "CG7883, CG7883, CG7883, DeIF2Balpha, eIF2B-alpha" CDMC23652 3 12 23 DAC37-G22 14-CG7883-RA_1 CG7883 CTGCCGGAGAGCTCTTTTGCAGGTTCATCACCCTCAGTCTGGACGACAAGCACATGGAGGAGTGC 65 FBan0007883 FBgn0039726 eIF2B-alpha 3 3R translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-alpha eIF2B-alpha "CG7883, CG7883, CG7883, DeIF2Balpha, eIF2B-alpha" CDMC23653 3 13 23 DAC37-K10 2-CG7952-RB_1 CG7952 CTCCTCTGCAGAGGTCCTGGATCTTTCCCGTCGATGTGACAGCGTAGAGACACCCAGGAAGACTC 65 FBan0007952 FBgn0001150 gt X X "negative regulation of transcription from RNA polymerase II promoter; GO:0000122; posterior head segmentation; GO:0035289; ring gland development; GO:0035271; salivary gland development; GO:0007431; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; ; GO:0003677; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0046982; ; GO:0042803; ; GO:0016566; ; GO:0003704 nucleus; GO:0005634 gt giant "CG7952, CG7952, l(1)giant, GIAN_DROME, EG:BACH7M4.5, Giant, l(1)3Aa" CDMC23653 3 14 23 DAC37-K10 2-CG7952-RB_1 CG7952 CTCCTCTGCAGAGGTCCTGGATCTTTCCCGTCGATGTGACAGCGTAGAGACACCCAGGAAGACTC 65 FBan0007952 FBgn0001150 gt X X "negative regulation of transcription from RNA polymerase II promoter; GO:0000122; posterior head segmentation; GO:0035289; ring gland development; GO:0035271; salivary gland development; GO:0007431; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; ; GO:0003677; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0046982; ; GO:0042803; ; GO:0016566; ; GO:0003704 nucleus; GO:0005634 gt giant "CG7952, CG7952, l(1)giant, GIAN_DROME, EG:BACH7M4.5, Giant, l(1)3Aa" CDMC23654 3 15 23 DAC37-K22 42-CG7991-RA_3 CG7991 CTGGTCACCGGGATCAGGAGGAGAGCTTCGAGTACAGCTCCGACTATGTGGAGATCGACGAGCTG 65 FBan0007991 FBgn0035260 CG7991 3 3L CG7991 CG7991 CDMC23654 3 16 23 DAC37-K22 42-CG7991-RA_3 CG7991 CTGGTCACCGGGATCAGGAGGAGAGCTTCGAGTACAGCTCCGACTATGTGGAGATCGACGAGCTG 65 FBan0007991 FBgn0035260 CG7991 3 3L CG7991 CG7991 CDMC23655 3 17 23 DAC37-O10 3-CG8085-RB_1 CG8085 TAAGATCGTAGCCACTTTCAGCGAGTCATCGTTGGCAGTCCAACCCAAATGCGTCACCATCTCGC 65 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC23655 3 18 23 DAC37-O10 3-CG8085-RB_1 CG8085 TAAGATCGTAGCCACTTTCAGCGAGTCATCGTTGGCAGTCCAACCCAAATGCGTCACCATCTCGC 65 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC23656 3 19 23 DAC37-O22 AutoBlank AutoBlank CDMC23656 3 20 23 DAC37-O22 AutoBlank AutoBlank CDMC23657 3 21 23 DAC38-C10 16-CG4174-RA_1 CG4174 GCCAAAGCTAAAACATTTGCAATCGAATCCTGCCAAACTCACAAAACCGAAGAAAGTGTTCCAGCTGCA 69 FBan0004174 FBgn0036793 CG4174 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG4174 CG4174 CDMC23657 3 22 23 DAC38-C10 16-CG4174-RA_1 CG4174 GCCAAAGCTAAAACATTTGCAATCGAATCCTGCCAAACTCACAAAACCGAAGAAAGTGTTCCAGCTGCA 69 FBan0004174 FBgn0036793 CG4174 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG4174 CG4174 CDMC23658 3 23 23 DAC38-C22 12-CG4186-RA_1 CG4186 CCGAAAGGAGAGCCAAGGGAATAGCTCCTTATTTGCCGCCCTTAGAAGAACGCGATGGGATTAAAGCAG 69 FBan0004186 FBgn0040634 CG4186 3 3L CG4186 CG4186 CDMC23658 3 24 23 DAC38-C22 12-CG4186-RA_1 CG4186 CCGAAAGGAGAGCCAAGGGAATAGCTCCTTATTTGCCGCCCTTAGAAGAACGCGATGGGATTAAAGCAG 69 FBan0004186 FBgn0040634 CG4186 3 3L CG4186 CG4186 CDMC23659 3 25 23 DAC38-G10 23-CG4211-RB_3 CG4211 TGGCAATAGCAATTCGCCATTCGAGGTTTTTAGAGGCAATAACAATAACAATTCCACAATGATTGGAAA 69 FBan0004211 FBgn0004227 nonA X X "hemopoiesis; GO:0030097; male courtship behavior (sensu Insecta), song production; GO:0045433; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398; phototaxis; GO:0042331; visual behavior; GO:0007632; visual perception; GO:0007601" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA no on or off transient A "CG4211, CG4211, diss: dissonance, dissonance, Bj6: Bj6-monoclonal-antibody, Bj6-1, non-A, NonA, no-on-transient A, no-on transient A, nonA/diss, opm2, x14, Bj6-monoclonal-antibody, Positive spike II group, diss, Bj6" CDMC23659 3 26 23 DAC38-G10 23-CG4211-RB_3 CG4211 TGGCAATAGCAATTCGCCATTCGAGGTTTTTAGAGGCAATAACAATAACAATTCCACAATGATTGGAAA 69 FBan0004211 FBgn0004227 nonA X X "hemopoiesis; GO:0030097; male courtship behavior (sensu Insecta), song production; GO:0045433; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398; phototaxis; GO:0042331; visual behavior; GO:0007632; visual perception; GO:0007601" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA no on or off transient A "CG4211, CG4211, diss: dissonance, dissonance, Bj6: Bj6-monoclonal-antibody, Bj6-1, non-A, NonA, no-on-transient A, no-on transient A, nonA/diss, opm2, x14, Bj6-monoclonal-antibody, Positive spike II group, diss, Bj6" CDMC23660 3 1 24 DAC38-G22 24-CG4220-RC_3 CG4220 TGGTTGCTACTAAACGCAAACGGTAATTTTAATTTAATTTATTCTATTCAAGCGATTACGATTACGGAA 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC23660 3 2 24 DAC38-G22 24-CG4220-RC_3 CG4220 TGGTTGCTACTAAACGCAAACGGTAATTTTAATTTAATTTATTCTATTCAAGCGATTACGATTACGGAA 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC23661 3 3 24 DAC38-K10 3-CG4259-RA_5 CG4259 CTCAAGACGGTCCAGGTCGATCTTTTGAGCATGGGTATGTGTAGCTCTCGAAAGCTGCCCATCCAGCAA 69 FBan0004259 FBgn0031389 CG4259 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4259 CG4259 SPH173 CDMC23661 3 4 24 DAC38-K10 3-CG4259-RA_5 CG4259 CTCAAGACGGTCCAGGTCGATCTTTTGAGCATGGGTATGTGTAGCTCTCGAAAGCTGCCCATCCAGCAA 69 FBan0004259 FBgn0031389 CG4259 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4259 CG4259 SPH173 CDMC23662 3 5 24 DAC38-K22 16-CG4268-RD_1 CG4268 CCGAGAACCGAATACAGAAAACCCGAGATTCGCAATAGAGATCCGATAAGCTCCGAACCGATGGATCGA 69 FBan0004268 FBgn0016696 Pitslre 3 3L cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- nucleus; GO:0005634 Pitslre Pitslre "CG4268, CG4268, group 3, PITSLRE, Gat: Gat-like, Gta, Gat-like, Galactosyltransferase-associated kinase-like" CDMC23662 3 6 24 DAC38-K22 16-CG4268-RD_1 CG4268 CCGAGAACCGAATACAGAAAACCCGAGATTCGCAATAGAGATCCGATAAGCTCCGAACCGATGGATCGA 69 FBan0004268 FBgn0016696 Pitslre 3 3L cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- nucleus; GO:0005634 Pitslre Pitslre "CG4268, CG4268, group 3, PITSLRE, Gat: Gat-like, Gta, Gat-like, Galactosyltransferase-associated kinase-like" CDMC23663 3 7 24 DAC38-O10 2-CG4320-RA_4 CG4320 GCCGCAGATTGCAGTGGCCTACAGGGAGAAGGTTCTGGTGTACGACTTTCAGTACAATTCGGTACGCAC 69 FBan0004320 FBgn0029840 raptor X X positive regulation of protein amino acid phosphorylation; GO:0001934 raptor raptor "CG4320, CG4320, CG4320, dRaptor, raptor" CDMC23663 3 8 24 DAC38-O10 2-CG4320-RA_4 CG4320 GCCGCAGATTGCAGTGGCCTACAGGGAGAAGGTTCTGGTGTACGACTTTCAGTACAATTCGGTACGCAC 69 FBan0004320 FBgn0029840 raptor X X positive regulation of protein amino acid phosphorylation; GO:0001934 raptor raptor "CG4320, CG4320, CG4320, dRaptor, raptor" CDMC23664 3 9 24 DAC38-O22 2-CG4330-RA_1 CG4330 GCTGGCAACCAGATGAATCACATAGCGCTCAGTCCACGATATGCAGGCACCATGTATGGCATCACCAAT 69 FBan0004330 FBgn0030452 CG4330 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4330 CG4330 AA202479 CDMC23664 3 10 24 DAC38-O22 2-CG4330-RA_1 CG4330 GCTGGCAACCAGATGAATCACATAGCGCTCAGTCCACGATATGCAGGCACCATGTATGGCATCACCAAT 69 FBan0004330 FBgn0030452 CG4330 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4330 CG4330 AA202479 CDMC23665 3 11 24 DAC39-C10 3-CG6950-RA_5 CG6950 GCAAGGAGCTAAATCCCCTCAGCGACATACTGATTACCTCAGGCGCCTATGAGGCTCTCTACTCCACCA 69 FBan0006950 FBgn0037955 CG6950 3 3R amino acid biosynthesis; GO:0008652; nitrogen compound metabolism; GO:0006807 kynurenine-oxoglutarate transaminase activity; GO:0016212 ; EC:2.6.1.7; 1-aminocyclopropane-1-carboxylate synthase activity; GO:0016847 ; EC:4.4.1.14; ; GO:0016212 ; EC:2.6.1.7; ; GO:0016847 ; EC:4.4.1.14 CG6950 CG6950 CDMC23665 3 12 24 DAC39-C10 3-CG6950-RA_5 CG6950 GCAAGGAGCTAAATCCCCTCAGCGACATACTGATTACCTCAGGCGCCTATGAGGCTCTCTACTCCACCA 69 FBan0006950 FBgn0037955 CG6950 3 3R amino acid biosynthesis; GO:0008652; nitrogen compound metabolism; GO:0006807 kynurenine-oxoglutarate transaminase activity; GO:0016212 ; EC:2.6.1.7; 1-aminocyclopropane-1-carboxylate synthase activity; GO:0016847 ; EC:4.4.1.14; ; GO:0016212 ; EC:2.6.1.7; ; GO:0016847 ; EC:4.4.1.14 CG6950 CG6950 CDMC23666 3 13 24 DAC39-C22 14-CG6957-RA_3 CG6957 TGCCCACGGGATCTACGCCATTGGGAATGTACAAAGAACTGATCGAGTTTCATAAGCAGGGCAAGGTAT 69 FBan0006957 FBgn0031717 Oscillin 2 2L N-acetylglucosamine metabolism; GO:0006044; monosaccharide metabolism; GO:0005996 glucosamine-6-phosphate deaminase activity; GO:0004342 ; EC:3.5.99.6; ; GO:0004342 ; EC:3.5.99.6 Oscillin Oscillin CG6957 CDMC23666 3 14 24 DAC39-C22 14-CG6957-RA_3 CG6957 TGCCCACGGGATCTACGCCATTGGGAATGTACAAAGAACTGATCGAGTTTCATAAGCAGGGCAAGGTAT 69 FBan0006957 FBgn0031717 Oscillin 2 2L N-acetylglucosamine metabolism; GO:0006044; monosaccharide metabolism; GO:0005996 glucosamine-6-phosphate deaminase activity; GO:0004342 ; EC:3.5.99.6; ; GO:0004342 ; EC:3.5.99.6 Oscillin Oscillin CG6957 CDMC23667 3 15 24 DAC39-G10 11-CG6986-RB_1 CG6986 TTGGTGCCCAACAAATTGTCGAATATGGTGGCATAGTCCTTAGTTAGCATATCCTGCGAGACTGCGGCC 69 FBan0006986 FBgn0029723 CG6986 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; cysteine protease inhibitor activity; GO:0004869; ; GO:0008188; ; GO:0004930; ; GO:0004869; ; GO:0008528; proctolin receptor activity; GO:0035236; ; GO:0035236" integral to membrane; GO:0016021 CG6986 CG6986 "anon-WO0170980.73, anon-WO0170980.74" CDMC23667 3 16 24 DAC39-G10 11-CG6986-RB_1 CG6986 TTGGTGCCCAACAAATTGTCGAATATGGTGGCATAGTCCTTAGTTAGCATATCCTGCGAGACTGCGGCC 69 FBan0006986 FBgn0029723 CG6986 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; cysteine protease inhibitor activity; GO:0004869; ; GO:0008188; ; GO:0004930; ; GO:0004869; ; GO:0008528; proctolin receptor activity; GO:0035236; ; GO:0035236" integral to membrane; GO:0016021 CG6986 CG6986 "anon-WO0170980.73, anon-WO0170980.74" CDMC23668 3 17 24 DAC39-G22 1-CG6996-RA_1 CG6996 TGCATCCGCGATTTTCCGTGCTCGAATAAAATGGACCCGGATAGCTATTGCAACATCTTGCCGGATGGG 69 FBan0006996 FBgn0036950 CG6996 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6996 CG6996 CDMC23668 3 18 24 DAC39-G22 1-CG6996-RA_1 CG6996 TGCATCCGCGATTTTCCGTGCTCGAATAAAATGGACCCGGATAGCTATTGCAACATCTTGCCGGATGGG 69 FBan0006996 FBgn0036950 CG6996 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6996 CG6996 CDMC23669 3 19 24 DAC39-K10 22-CG7024-RA_3 CG7024 CGGCATACCGTTGTCATGCCTGGACCTATTTAATGGGTGTTTCCCTTTACGAAATAATGGCGGAATTGT 69 FBan0007024 FBgn0029722 CG7024 X X tricarboxylic acid cycle; GO:0006099 pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1 pyruvate dehydrogenase complex; GO:0045254 CG7024 CG7024 CDMC23669 3 20 24 DAC39-K10 22-CG7024-RA_3 CG7024 CGGCATACCGTTGTCATGCCTGGACCTATTTAATGGGTGTTTCCCTTTACGAAATAATGGCGGAATTGT 69 FBan0007024 FBgn0029722 CG7024 X X tricarboxylic acid cycle; GO:0006099 pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1 pyruvate dehydrogenase complex; GO:0045254 CG7024 CG7024 CDMC23670 3 21 24 DAC39-K22 1-CG7036-RB_1 CG7036 AGCTCAGGTAGCAATAACGACAACAACGGGAAGACTGGAGCAGCTAGTAGTGCAGGTAAGAGGCGAGGA 69 FBan0007036 FBgn0035106 rno 3 3L "negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 rno rhinoceros "CG7036, CG7036, CG7036, CG7036, CG7036, CG7036, rhinoceros" CDMC23670 3 22 24 DAC39-K22 1-CG7036-RB_1 CG7036 AGCTCAGGTAGCAATAACGACAACAACGGGAAGACTGGAGCAGCTAGTAGTGCAGGTAAGAGGCGAGGA 69 FBan0007036 FBgn0035106 rno 3 3L "negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 rno rhinoceros "CG7036, CG7036, CG7036, CG7036, CG7036, CG7036, rhinoceros" CDMC23671 3 23 24 DAC39-O10 7-CG7067-RA_1 CG7067 ACGACATCTACGCCTTAACAGCCTACAACCTTCGTAGCAAAGAACCAACCCAGGATCGACCATTTGCCA 69 FBan0007067 FBgn0024945 NitFhit 3 3L "nitrogen compound metabolism; GO:0006807; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "nitrilase activity; GO:0000257 ; EC:3.5.5.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0000257 ; EC:3.5.5.1; bis(5'-adenosyl)-triphosphatase activity; GO:0047710 ; EC:3.6.1.29; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0047710 ; EC:3.6.1.29; ; GO:0016810 ; EC:3.5.-.-" cellular component unknown; GO:0008372 NitFhit Nitrilase and fragile histidine triad fusion protein "CG7067, NitFlit" CDMC23671 3 24 24 DAC39-O10 7-CG7067-RA_1 CG7067 ACGACATCTACGCCTTAACAGCCTACAACCTTCGTAGCAAAGAACCAACCCAGGATCGACCATTTGCCA 69 FBan0007067 FBgn0024945 NitFhit 3 3L "nitrogen compound metabolism; GO:0006807; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "nitrilase activity; GO:0000257 ; EC:3.5.5.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0000257 ; EC:3.5.5.1; bis(5'-adenosyl)-triphosphatase activity; GO:0047710 ; EC:3.6.1.29; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0047710 ; EC:3.6.1.29; ; GO:0016810 ; EC:3.5.-.-" cellular component unknown; GO:0008372 NitFhit Nitrilase and fragile histidine triad fusion protein "CG7067, NitFlit" CDMC23672 3 25 24 DAC39-O22 23-CG7073-RC_16 CG7073 GCTACAAAATTTCCAAAAATGATTAGAGACCGCAGAAAGAACAGAACCCAAGGGATGTGAACCCAGCCC 69 FBan0007073 FBgn0038947 sar1 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 COPII-coated vesicle; GO:0030138 sar1 sar1 "CG7073, CG7073, l(3)05712, 5712, clone 1.48, dsar1, Sar1, NP_732719, Dm Sar1, anon-EST:Liang-1.48" CDMC23672 3 26 24 DAC39-O22 23-CG7073-RC_16 CG7073 GCTACAAAATTTCCAAAAATGATTAGAGACCGCAGAAAGAACAGAACCCAAGGGATGTGAACCCAGCCC 69 FBan0007073 FBgn0038947 sar1 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 COPII-coated vesicle; GO:0030138 sar1 sar1 "CG7073, CG7073, l(3)05712, 5712, clone 1.48, dsar1, Sar1, NP_732719, Dm Sar1, anon-EST:Liang-1.48" CDMC23673 3 1 25 DAC40-C10 1-CG33336-RA_1 CG33336 CAGGGCAAGGGAATTTCCGAGCGTTTTTCCGTTGTAGTCCCCCTGAACATGAGCCGGTCTGTAAC 65 FBan0033336 FBgn0039044 p53 3 3R "DNA damage response, signal transduction by p53 class mediator; GO:0030330; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; GO:0042771; DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; apoptosis; GO:0006915; cell death; GO:0008219; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to DNA damage stimulus; GO:0006974; response to radiation; GO:0009314" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 p53 p53 "CG10873, CG31325, CG33336, CG10873, CG10873, dp53, Dmp53, dmp53, Dm-P53, prac, p53-like regulator of apoptosis and cell cycle, DmP53" CDMC23673 3 2 25 DAC40-C10 1-CG33336-RA_1 CG33336 CAGGGCAAGGGAATTTCCGAGCGTTTTTCCGTTGTAGTCCCCCTGAACATGAGCCGGTCTGTAAC 65 FBan0033336 FBgn0039044 p53 3 3R "DNA damage response, signal transduction by p53 class mediator; GO:0030330; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; GO:0042771; DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; apoptosis; GO:0006915; cell death; GO:0008219; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to DNA damage stimulus; GO:0006974; response to radiation; GO:0009314" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 p53 p53 "CG10873, CG31325, CG33336, CG10873, CG10873, dp53, Dmp53, dmp53, Dm-P53, prac, p53-like regulator of apoptosis and cell cycle, DmP53" CDMC23674 3 3 25 DAC40-C22 3-CG33464-RA_1 CG33464 CTCTATCGCGGAGACTCGGAGAGCTCCAAGTACGAGCCCATACGCAACCTGACGCACAAGTTTTC 65 FBan0033464 FBgn0053464 CG33464 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33464 CG33464 CDMC23674 3 4 25 DAC40-C22 3-CG33464-RA_1 CG33464 CTCTATCGCGGAGACTCGGAGAGCTCCAAGTACGAGCCCATACGCAACCTGACGCACAAGTTTTC 65 FBan0033464 FBgn0053464 CG33464 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33464 CG33464 CDMC23675 3 5 25 DAC40-G10 3-CG3433-RA_3 CG3433 ATGAGCACGATCCCACCTACTACCCGCGCTTTAAGAAGTGGTGCGACGACTACTTCCGCATCAAG 65 FBan0003433 FBgn0021944 Coprox 2 2L coenzyme metabolism; GO:0006732; heme biosynthesis; GO:0006783 coproporphyrinogen oxidase activity; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3 mitochondrion; GO:0005739 Coprox Coproporphyrinogen oxidase "CG3433, l(2)k10617, l(2)k11018, BcDNA:GM14838, Coproporphyrinogen oxidase" CDMC23675 3 6 25 DAC40-G10 3-CG3433-RA_3 CG3433 ATGAGCACGATCCCACCTACTACCCGCGCTTTAAGAAGTGGTGCGACGACTACTTCCGCATCAAG 65 FBan0003433 FBgn0021944 Coprox 2 2L coenzyme metabolism; GO:0006732; heme biosynthesis; GO:0006783 coproporphyrinogen oxidase activity; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3; ; GO:0004109 ; EC:1.3.3.3 mitochondrion; GO:0005739 Coprox Coproporphyrinogen oxidase "CG3433, l(2)k10617, l(2)k11018, BcDNA:GM14838, Coproporphyrinogen oxidase" CDMC23676 3 7 25 DAC40-G22 1-CG3513-RA_1 CG3513 CATGGCTTTTATGCCGGCCTGGACCTATGATGCCTCCAAAAACGCCTGCACCGAGTTCATTTTCG 65 FBan0003513 FBgn0031559 CG3513 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG3513 CG3513 CDMC23676 3 8 25 DAC40-G22 1-CG3513-RA_1 CG3513 CATGGCTTTTATGCCGGCCTGGACCTATGATGCCTCCAAAAACGCCTGCACCGAGTTCATTTTCG 65 FBan0003513 FBgn0031559 CG3513 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG3513 CG3513 CDMC23677 3 9 25 DAC40-K10 3-CG3626-RA_2 CG3626 GGATCAGGCGGATCTTTTATCGTATGGTGGTGTGACCACGGTCAAAGGCACCGGAATACCAACGG 65 FBan0003626 FBgn0029706 CG3626 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; [pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity; GO:0019909; ; GO:0016491 ; EC:1.-.-.-; aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0019909; ; GO:0004047 ; EC:2.1.2.10 pyruvate dehydrogenase (lipoamide) phosphatase complex (sensu Eukaryota); GO:0019910 CG3626 CG3626 CDMC23677 3 10 25 DAC40-K10 3-CG3626-RA_2 CG3626 GGATCAGGCGGATCTTTTATCGTATGGTGGTGTGACCACGGTCAAAGGCACCGGAATACCAACGG 65 FBan0003626 FBgn0029706 CG3626 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; [pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity; GO:0019909; ; GO:0016491 ; EC:1.-.-.-; aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0019909; ; GO:0004047 ; EC:2.1.2.10 pyruvate dehydrogenase (lipoamide) phosphatase complex (sensu Eukaryota); GO:0019910 CG3626 CG3626 CDMC23678 3 11 25 DAC40-K22 23-CG3652-RA_3 CG3652 TCTCGTGGTTGGTTCTTTCCCACAATTAGTCCAATCTATGACGCCTCGTTTAGTGATTAGTTCGT 65 FBan0003652 FBgn0031600 CG3652 2 2L CG3652 CG3652 CDMC23678 3 12 25 DAC40-K22 23-CG3652-RA_3 CG3652 TCTCGTGGTTGGTTCTTTCCCACAATTAGTCCAATCTATGACGCCTCGTTTAGTGATTAGTTCGT 65 FBan0003652 FBgn0031600 CG3652 2 2L CG3652 CG3652 CDMC23679 3 13 25 DAC40-O10 12-CG3731-RA_2 CG3731 AGGATATGCTCTTCAACGTGCAGACCGAGTGGATGCGTCTGTGCACCATGGTTACCGAGGCTGAG 65 FBan0003731 FBgn0038271 CG3731 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; protein processing; GO:0016485; proteolysis; GO:0006508" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; mitochondrial processing peptidase activity; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0008121 ; EC:1.10.2.2 mitochondrial matrix; GO:0005759; mitochondrial processing peptidase complex; GO:0017087; respiratory chain complex III (sensu Eukaryota); GO:0005750 CG3731 CG3731 CDMC23679 3 14 25 DAC40-O10 12-CG3731-RA_2 CG3731 AGGATATGCTCTTCAACGTGCAGACCGAGTGGATGCGTCTGTGCACCATGGTTACCGAGGCTGAG 65 FBan0003731 FBgn0038271 CG3731 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; protein processing; GO:0016485; proteolysis; GO:0006508" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; mitochondrial processing peptidase activity; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0008121 ; EC:1.10.2.2 mitochondrial matrix; GO:0005759; mitochondrial processing peptidase complex; GO:0017087; respiratory chain complex III (sensu Eukaryota); GO:0005750 CG3731 CG3731 CDMC23680 3 15 25 DAC40-O22 AutoBlank AutoBlank CDMC23680 3 16 25 DAC40-O22 AutoBlank AutoBlank CDMC23681 3 17 25 DAC41-C10 AutoBlank AutoBlank CDMC23681 3 18 25 DAC41-C10 AutoBlank AutoBlank CDMC23682 3 19 25 DAC41-C22 AutoBlank AutoBlank CDMC23682 3 20 25 DAC41-C22 AutoBlank AutoBlank CDMC23683 3 21 25 DAC41-G10 AutoBlank AutoBlank CDMC23683 3 22 25 DAC41-G10 AutoBlank AutoBlank CDMC23684 3 23 25 DAC41-G22 AutoBlank AutoBlank CDMC23684 3 24 25 DAC41-G22 AutoBlank AutoBlank CDMC23685 3 25 25 DAC41-K10 AutoBlank AutoBlank CDMC23685 3 26 25 DAC41-K10 AutoBlank AutoBlank CDMC23686 3 1 26 DAC41-K22 AutoBlank AutoBlank CDMC23686 3 2 26 DAC41-K22 AutoBlank AutoBlank CDMC23687 3 3 26 DAC41-O10 AutoBlank AutoBlank CDMC23687 3 4 26 DAC41-O10 AutoBlank AutoBlank CDMC23688 3 5 26 DAC41-O22 AutoBlank AutoBlank CDMC23688 3 6 26 DAC41-O22 AutoBlank AutoBlank CDMC23689 3 7 26 DAC42-C10 150mM NaPO4 Blank CDMC23689 3 8 26 DAC42-C10 150mM NaPO4 Blank CDMC23690 3 9 26 DAC42-C22 150mM NaPO4 Blank CDMC23690 3 10 26 DAC42-C22 150mM NaPO4 Blank CDMC23691 3 11 26 DAC42-G10 150mM NaPO4 Blank CDMC23691 3 12 26 DAC42-G10 150mM NaPO4 Blank CDMC23692 3 13 26 DAC42-G22 150mM NaPO4 Blank CDMC23692 3 14 26 DAC42-G22 150mM NaPO4 Blank CDMC23693 3 15 26 DAC42-K10 150mM NaPO4 Blank CDMC23693 3 16 26 DAC42-K10 150mM NaPO4 Blank CDMC23694 3 17 26 DAC42-K22 5uM MSP 5uM MSP CDMC23694 3 18 26 DAC42-K22 5uM MSP 5uM MSP CDMC23695 3 19 26 DAC42-O10 10uM MSP 10uM MSP CDMC23695 3 20 26 DAC42-O10 10uM MSP 10uM MSP CDMC23696 3 21 26 DAC42-O22 20uM MSP 20uM MSP CDMC23696 3 22 26 DAC42-O22 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC23697 4 1 1 DAC01-D10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23697 4 2 1 DAC01-D10 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC23698 4 3 1 DAC01-D22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23698 4 4 1 DAC01-D22 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC23699 4 5 1 DAC01-H10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23699 4 6 1 DAC01-H10 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC23700 4 7 1 DAC01-H22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23700 4 8 1 DAC01-H22 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC23701 4 9 1 DAC01-L10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23701 4 10 1 DAC01-L10 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC23702 4 11 1 DAC01-L22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23702 4 12 1 DAC01-L22 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC23703 4 13 1 DAC01-P10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23703 4 14 1 DAC01-P10 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC23704 4 15 1 DAC01-P22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23704 4 16 1 DAC01-P22 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC23705 4 17 1 DAC02-D10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23705 4 18 1 DAC02-D10 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC23706 4 19 1 DAC02-D22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23706 4 20 1 DAC02-D22 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC23707 4 21 1 DAC02-H10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23707 4 22 1 DAC02-H10 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC23708 4 23 1 DAC02-H22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23708 4 24 1 DAC02-H22 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC23709 4 25 1 DAC02-L10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23709 4 26 1 DAC02-L10 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC23710 4 1 2 DAC02-L22 N/A CG9075 (00718-00956) CDMC23710 4 2 2 DAC02-L22 N/A CG9075 (00718-00956) CDMC23711 4 3 2 DAC02-P10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23711 4 4 2 DAC02-P10 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC23712 4 5 2 DAC02-P22 AutoBlank AutoBlank CDMC23712 4 6 2 DAC02-P22 AutoBlank AutoBlank CDMC23713 4 7 2 DAC03-D10 23-CG5452-RA_3 CG5452 CCCATTAGTACCTAATTGTGTGTAGTACAGACGTTTAAAATAATATTATAAGAGGCCTAGACGAGCCGA 69 FBan0005452 FBgn0022338 dnk 3 3R TMP biosynthesis; GO:0006230; nucleoside diphosphate phosphorylation; GO:0006165; phosphorylation; GO:0016310; pyrimidine base metabolism; GO:0006206 "ATP binding; GO:0005524; ; GO:0005524; deoxynucleoside kinase activity; GO:0019136 ; EC:2.7.1.145; ; GO:0019136 ; EC:2.7.1.145; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0019136 ; EC:2.7.1.145; thymidine kinase activity; GO:0004797 ; EC:2.7.1.21; ; GO:0004797 ; EC:2.7.1.21; phosphotransferase activity, alcohol group as acceptor; GO:0016773 ; EC:2.7.1.-; ; GO:0016773 ; EC:2.7.1.-" mitochondrion; GO:0005739 dnk deoxyribonucleoside kinase "CG5452, Dm-dNK, DM-dNK, dNK, DmdNK" CDMC23713 4 8 2 DAC03-D10 23-CG5452-RA_3 CG5452 CCCATTAGTACCTAATTGTGTGTAGTACAGACGTTTAAAATAATATTATAAGAGGCCTAGACGAGCCGA 69 FBan0005452 FBgn0022338 dnk 3 3R TMP biosynthesis; GO:0006230; nucleoside diphosphate phosphorylation; GO:0006165; phosphorylation; GO:0016310; pyrimidine base metabolism; GO:0006206 "ATP binding; GO:0005524; ; GO:0005524; deoxynucleoside kinase activity; GO:0019136 ; EC:2.7.1.145; ; GO:0019136 ; EC:2.7.1.145; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0019136 ; EC:2.7.1.145; thymidine kinase activity; GO:0004797 ; EC:2.7.1.21; ; GO:0004797 ; EC:2.7.1.21; phosphotransferase activity, alcohol group as acceptor; GO:0016773 ; EC:2.7.1.-; ; GO:0016773 ; EC:2.7.1.-" mitochondrion; GO:0005739 dnk deoxyribonucleoside kinase "CG5452, Dm-dNK, DM-dNK, dNK, DmdNK" CDMC23714 4 9 2 DAC03-D22 16-CG5463-RA_1 CG5463 TGGCCAATGATGGAAAAATGACTTTCCCCGTGATAACACCAGGCAAAAAAGTTTACTACAAGACCGCCA 69 FBan0005463 FBgn0039153 CG5463 3 3R amino acid metabolism; GO:0006520; glutaminyl-tRNA aminoacylation; GO:0006425 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; ; GO:0017068 ; EC:6.3.5.-; ; GO:0017068 ; EC:6.3.5.- mitochondrion; GO:0005739 CG5463 CG5463 CDMC23714 4 10 2 DAC03-D22 16-CG5463-RA_1 CG5463 TGGCCAATGATGGAAAAATGACTTTCCCCGTGATAACACCAGGCAAAAAAGTTTACTACAAGACCGCCA 69 FBan0005463 FBgn0039153 CG5463 3 3R amino acid metabolism; GO:0006520; glutaminyl-tRNA aminoacylation; GO:0006425 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; ; GO:0017068 ; EC:6.3.5.-; ; GO:0017068 ; EC:6.3.5.- mitochondrion; GO:0005739 CG5463 CG5463 CDMC23715 4 11 2 DAC03-H10 3-CG5483-RA_1 CG5483 GGCAATCTGCACGCCTATAGCACATCCACCTATGCCCACCTGTTTTCCTACATGCTCGATCCCAACATT 69 FBan0005483 FBgn0038816 CG5483 3 3R protein amino acid phosphorylation; GO:0006468; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005525 CG5483 CG5483 CT17358 CDMC23715 4 12 2 DAC03-H10 3-CG5483-RA_1 CG5483 GGCAATCTGCACGCCTATAGCACATCCACCTATGCCCACCTGTTTTCCTACATGCTCGATCCCAACATT 69 FBan0005483 FBgn0038816 CG5483 3 3R protein amino acid phosphorylation; GO:0006468; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005525 CG5483 CG5483 CT17358 CDMC23716 4 13 2 DAC03-H22 3-CG5492-RB_1 CG5492 ACGAGGAGGGGAATCCCATGGTCACGCAGGAAAATCAGATACCAAGGTCCACAGTCCAGAAGAAACACA 69 FBan0005492 FBgn0036769 Tsp74F 3 3L cell motility; GO:0006928; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp74F Tetraspanin 74F "CG5492, CG5492, CG5492, CG5492, Dm.Tsp74F, Tetraspanin 74F" CDMC23716 4 14 2 DAC03-H22 3-CG5492-RB_1 CG5492 ACGAGGAGGGGAATCCCATGGTCACGCAGGAAAATCAGATACCAAGGTCCACAGTCCAGAAGAAACACA 69 FBan0005492 FBgn0036769 Tsp74F 3 3L cell motility; GO:0006928; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp74F Tetraspanin 74F "CG5492, CG5492, CG5492, CG5492, Dm.Tsp74F, Tetraspanin 74F" CDMC23717 4 15 2 DAC03-L10 3-CG5527-RA_4 CG5527 CCGGCATCACGCCAGTAATCGGCAGTTACAAAAACGAAGAGCTGTCGGACACTCTAATCCGCGAGATCA 69 FBan0005527 FBgn0039564 CG5527 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 CG5527 CG5527 CDMC23717 4 16 2 DAC03-L10 3-CG5527-RA_4 CG5527 CCGGCATCACGCCAGTAATCGGCAGTTACAAAAACGAAGAGCTGTCGGACACTCTAATCCGCGAGATCA 69 FBan0005527 FBgn0039564 CG5527 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 CG5527 CG5527 CDMC23718 4 17 2 DAC03-L22 2-CG5543-RA_2 CG5543 GCCGCTGCATACCTGGACAAACCTGTTCTCCCGCTACGACACAACAGATTGCTGCTTTAGTCCAGATGA 69 FBan0005543 FBgn0034908 CG5543 2 2R CG5543 CG5543 anon-WO0118547.181 CDMC23718 4 18 2 DAC03-L22 2-CG5543-RA_2 CG5543 GCCGCTGCATACCTGGACAAACCTGTTCTCCCGCTACGACACAACAGATTGCTGCTTTAGTCCAGATGA 69 FBan0005543 FBgn0034908 CG5543 2 2R CG5543 CG5543 anon-WO0118547.181 CDMC23719 4 19 2 DAC03-P10 3-CG5577-RA_1 CG5577 AGGGACTACGTACCGAGCGAACGCTTATGATTGGTGACTGCCTCAAAATAGATGTCGGTTTCGCCAGCA 69 FBan0005577 FBgn0036759 CG5577 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG5577 CG5577 CDMC23719 4 20 2 DAC03-P10 3-CG5577-RA_1 CG5577 AGGGACTACGTACCGAGCGAACGCTTATGATTGGTGACTGCCTCAAAATAGATGTCGGTTTCGCCAGCA 69 FBan0005577 FBgn0036759 CG5577 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG5577 CG5577 CDMC23720 4 21 2 DAC03-P22 3-CG5591-RA_1 CG5591 CGCTCACTTCCGAAATGGGAGACGACTTCAATATCCTGGAGTACGCGGACCCAGAACTGGACGTCAATG 69 FBan0005591 FBgn0034926 CG5591 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG5591 CG5591 CDMC23720 4 22 2 DAC03-P22 3-CG5591-RA_1 CG5591 CGCTCACTTCCGAAATGGGAGACGACTTCAATATCCTGGAGTACGCGGACCCAGAACTGGACGTCAATG 69 FBan0005591 FBgn0034926 CG5591 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG5591 CG5591 CDMC23721 4 23 2 DAC04-D10 23-CG12384-RA_1 CG12384 TAATCTCTTTGATCTTTTGTTGAAATTCTATGAGTCCTCTCAATGGTATTGAAATCGCCTTTGAATGCG 69 FBan0012384 FBgn0033624 CG12384 2 2R I-kappaB kinase/NF-kappaB cascade; GO:0007249; apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; ; GO:0030234; ; GO:0008047 CG12384 CG12384 "BcDNA:RH17411, BcDNA:GH16986" CDMC23721 4 24 2 DAC04-D10 23-CG12384-RA_1 CG12384 TAATCTCTTTGATCTTTTGTTGAAATTCTATGAGTCCTCTCAATGGTATTGAAATCGCCTTTGAATGCG 69 FBan0012384 FBgn0033624 CG12384 2 2R I-kappaB kinase/NF-kappaB cascade; GO:0007249; apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; ; GO:0030234; ; GO:0008047 CG12384 CG12384 "BcDNA:RH17411, BcDNA:GH16986" CDMC23722 4 25 2 DAC04-D22 3-CG12391-RA_1 CG12391 TGTCCCAACTGCGACTTGACGTTCTCGCGCAAACAATCCTATGTGCTGCATCGTAAGACTCACGAGAGA 69 FBan0012391 FBgn0033581 CG12391 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12391 CG12391 anon-WO0140519.201 CDMC23722 4 26 2 DAC04-D22 3-CG12391-RA_1 CG12391 TGTCCCAACTGCGACTTGACGTTCTCGCGCAAACAATCCTATGTGCTGCATCGTAAGACTCACGAGAGA 69 FBan0012391 FBgn0033581 CG12391 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12391 CG12391 anon-WO0140519.201 CDMC23723 4 1 3 DAC04-H10 6-CG12432-RA_1 CG12432 ACTGCCGGGTTTCTCCACCTCAACGTCGAGCATCAATGATACGGGCTTATCGGGTGAGTTCATCACTAA 69 FBan0012432 FBgn0030843 CG12432 X X CG12432 CG12432 CDMC23723 4 2 3 DAC04-H10 6-CG12432-RA_1 CG12432 ACTGCCGGGTTTCTCCACCTCAACGTCGAGCATCAATGATACGGGCTTATCGGGTGAGTTCATCACTAA 69 FBan0012432 FBgn0030843 CG12432 X X CG12432 CG12432 CDMC23724 4 3 3 DAC04-H22 12-CG12444-RA_1 CG12444 TGAAGGCGGCAAATGTGAACATACTACTCCAGACGCACAACATCAGACCCAATTCAGTTTACGGCAGCT 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC23724 4 4 3 DAC04-H22 12-CG12444-RA_1 CG12444 TGAAGGCGGCAAATGTGAACATACTACTCCAGACGCACAACATCAGACCCAATTCAGTTTACGGCAGCT 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC23725 4 5 3 DAC04-L10 23-CG12493-RA_5 CG12493 TTGGATCAGGAAAGATGGCAATCGATGATATGAAGGACCTATTGATCGTAAATGTTTCTGACCAAGAGG 69 FBan0012493 FBgn0035571 CG12493 3 3L double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG12493 CG12493 cg12493 CDMC23725 4 6 3 DAC04-L10 23-CG12493-RA_5 CG12493 TTGGATCAGGAAAGATGGCAATCGATGATATGAAGGACCTATTGATCGTAAATGTTTCTGACCAAGAGG 69 FBan0012493 FBgn0035571 CG12493 3 3L double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG12493 CG12493 cg12493 CDMC23726 4 7 3 DAC04-L22 13-CG12502-RA_3 CG12502 CCAGTCGAACATCCAGTATCGAGTCTCGGCGTGTTCAAGTAGATCTTCATAGTCCCGAAGTGATGCCCA 69 FBan0012502 FBgn0035171 CG12502 3 3L CG12502 CG12502 CDMC23726 4 8 3 DAC04-L22 13-CG12502-RA_3 CG12502 CCAGTCGAACATCCAGTATCGAGTCTCGGCGTGTTCAAGTAGATCTTCATAGTCCCGAAGTGATGCCCA 69 FBan0012502 FBgn0035171 CG12502 3 3L CG12502 CG12502 CDMC23727 4 9 3 DAC04-P10 9-CG12547-RA_4 CG12547 AGGAATTCAGGGAAATGATCGAATAGGTGGACGTCTAGGACCATTGCAACCACTGTCGTCACCGTGGGA 69 FBgn0040521 CG12547 CG12547 CG12547 "CG40277, CG40277" CDMC23727 4 10 3 DAC04-P10 9-CG12547-RA_4 CG12547 AGGAATTCAGGGAAATGATCGAATAGGTGGACGTCTAGGACCATTGCAACCACTGTCGTCACCGTGGGA 69 FBgn0040521 CG12547 CG12547 CG12547 "CG40277, CG40277" CDMC23728 4 11 3 DAC04-P22 15-CG12565-RA_3 CG12565 GGATCGCCGACATCAGCTGTAGCCAGGAGCATACTACCAAATTTTCACCAAAATTGTCCCAAGTAGCCA 69 FBan0012565 FBgn0031180 CG12565 X X CG12565 CG12565 "pp-CT34321, BcDNA:RE23430" CDMC23728 4 12 3 DAC04-P22 15-CG12565-RA_3 CG12565 GGATCGCCGACATCAGCTGTAGCCAGGAGCATACTACCAAATTTTCACCAAAATTGTCCCAAGTAGCCA 69 FBan0012565 FBgn0031180 CG12565 X X CG12565 CG12565 "pp-CT34321, BcDNA:RE23430" CDMC23729 4 13 3 DAC05-D10 22-CG5059-RA_1 CG5059 AGCGTGGCATACTCCTTACCCGTGTGGTCATTGACTGAAAGATGCCATAAACAAAAAGGAGAAAGAGGA 69 FBan0005059 FBgn0037007 CG5059 3 3L CG5059 CG5059 CDMC23729 4 14 3 DAC05-D10 22-CG5059-RA_1 CG5059 AGCGTGGCATACTCCTTACCCGTGTGGTCATTGACTGAAAGATGCCATAAACAAAAAGGAGAAAGAGGA 69 FBan0005059 FBgn0037007 CG5059 3 3L CG5059 CG5059 CDMC23730 4 15 3 DAC05-D22 23-CG5073-RA_4 CG5073 GGAAAAAAAACGAGAAACAGGAAATGTATGTACTACGGGGAGATGACAAACAAAAACATTAACGGAACA 69 FBan0005073 FBgn0038331 CG5073 3 3R CG5073 CG5073 CDMC23730 4 16 3 DAC05-D22 23-CG5073-RA_4 CG5073 GGAAAAAAAACGAGAAACAGGAAATGTATGTACTACGGGGAGATGACAAACAAAAACATTAACGGAACA 69 FBan0005073 FBgn0038331 CG5073 3 3R CG5073 CG5073 CDMC23731 4 17 3 DAC05-H10 17-CG5107-RA_1 CG5107 TGCCTTAAAATCCTTCGCAAGGCATTGAAAACGGTTCGAGGCACCAACTGTATTATCAAGGAGGTGACA 69 FBan0005107 FBgn0039342 CG5107 3 3R CG5107 CG5107 anon-WO0140519.57 CDMC23731 4 18 3 DAC05-H10 17-CG5107-RA_1 CG5107 TGCCTTAAAATCCTTCGCAAGGCATTGAAAACGGTTCGAGGCACCAACTGTATTATCAAGGAGGTGACA 69 FBan0005107 FBgn0039342 CG5107 3 3R CG5107 CG5107 anon-WO0140519.57 CDMC23732 4 19 3 DAC05-H22 17-CG5119-RB_1 CG5119 TGCGCAGGGGAGGATTGCCAAGGACACACAATTAACACAGAAAAACAAAGCGAAAAATCTACGGCTTTT 69 FBan0005119 FBgn0003031 pAbp 2 2R histone mRNA 3'-end processing; GO:0006398; positive regulation of translation; GO:0045946; synaptic transmission; GO:0007268 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 pAbp polyA-binding protein "CG5119, CG5119, CG5119, CG5119, PABP, l(2)k10109, duo, doppio fuso, pabp, PAbp, pAB, dPABP, Pabp, BcDNA:LD24412, anon-EST:Posey249, anon-EST:Posey247" CDMC23732 4 20 3 DAC05-H22 17-CG5119-RB_1 CG5119 TGCGCAGGGGAGGATTGCCAAGGACACACAATTAACACAGAAAAACAAAGCGAAAAATCTACGGCTTTT 69 FBan0005119 FBgn0003031 pAbp 2 2R histone mRNA 3'-end processing; GO:0006398; positive regulation of translation; GO:0045946; synaptic transmission; GO:0007268 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 pAbp polyA-binding protein "CG5119, CG5119, CG5119, CG5119, PABP, l(2)k10109, duo, doppio fuso, pabp, PAbp, pAB, dPABP, Pabp, BcDNA:LD24412, anon-EST:Posey249, anon-EST:Posey247" CDMC23733 4 21 3 DAC05-L10 18-CG5157-RA_1 CG5157 GCCATTCCTCCGACGCAGAAAAGGATCTAAAGAACTACAAAATCGGAGAAATCAACTCAGCTGCACCCA 69 FBan0005157 FBgn0036575 CG5157 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489 CG5157 CG5157 CDMC23733 4 22 3 DAC05-L10 18-CG5157-RA_1 CG5157 GCCATTCCTCCGACGCAGAAAAGGATCTAAAGAACTACAAAATCGGAGAAATCAACTCAGCTGCACCCA 69 FBan0005157 FBgn0036575 CG5157 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489 CG5157 CG5157 CDMC23734 4 23 3 DAC05-L22 2-CG5168-RA_2 CG5168 AGGCGTACCATCGGACTGGATCCACCTTAAATAATATGGCTGCCGAGATAAAACCAGCTCAGCGGACCA 69 FBan0005168 FBgn0032246 CG5168 2 2L zinc ion binding; GO:0008270; ; GO:0008270 CG5168 CG5168 CDMC23734 4 24 3 DAC05-L22 2-CG5168-RA_2 CG5168 AGGCGTACCATCGGACTGGATCCACCTTAAATAATATGGCTGCCGAGATAAAACCAGCTCAGCGGACCA 69 FBan0005168 FBgn0032246 CG5168 2 2L zinc ion binding; GO:0008270; ; GO:0008270 CG5168 CG5168 CDMC23735 4 25 3 DAC05-P10 12-CG5196-RB_3 CG5196 TCTTGGCTTTCAGGCATCATCAAGTGCATAACGCTGACAACGCTCTATATGAACTCGATGTGGTGGCCG 69 FBan0005196 FBgn0038039 CG5196 3 3R electron transport; GO:0006118 metal ion binding; GO:0046872; ; GO:0046872 CG5196 CG5196 CDMC23735 4 26 3 DAC05-P10 12-CG5196-RB_3 CG5196 TCTTGGCTTTCAGGCATCATCAAGTGCATAACGCTGACAACGCTCTATATGAACTCGATGTGGTGGCCG 69 FBan0005196 FBgn0038039 CG5196 3 3R electron transport; GO:0006118 metal ion binding; GO:0046872; ; GO:0046872 CG5196 CG5196 CDMC23736 4 1 4 DAC05-P22 23-CG5212-RA_15 CG5212 TGATTTGAAATTATGAAAGCGAGGCATACAAACGCAATGATCAGCAAGCAGCACACATCAACCATACGA 69 FBan0005212 FBgn0025574 Pli 3 3R Toll signaling pathway; GO:0008063; defense response; GO:0006952; immune response; GO:0006955; signal transduction; GO:0007165 kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019207 cellular component unknown; GO:0008372 Pli Pellino "CG5212, pellino, PAP: Pelle associated protein, Pelle associated protein" CDMC23736 4 2 4 DAC05-P22 23-CG5212-RA_15 CG5212 TGATTTGAAATTATGAAAGCGAGGCATACAAACGCAATGATCAGCAAGCAGCACACATCAACCATACGA 69 FBan0005212 FBgn0025574 Pli 3 3R Toll signaling pathway; GO:0008063; defense response; GO:0006952; immune response; GO:0006955; signal transduction; GO:0007165 kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019207 cellular component unknown; GO:0008372 Pli Pellino "CG5212, pellino, PAP: Pelle associated protein, Pelle associated protein" CDMC23737 4 3 4 DAC06-D10 15-CG9397-RA_1 CG9397 AGAGGGAAAATGTCAGTCACTCAGCCAAAGGATACGGCATTAAAGACCAAGGAGTCGGCAGCTGAAGTA 69 FBan0009397 FBgn0010347 1.28 2 2R "ATP synthesis coupled proton transport; GO:0015986; specification of segmental identity, maxillary segment; GO:0007382" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 1.28 1.28 "CG9397, CG9397, CG9397, deformed, CT9093" CDMC23737 4 4 4 DAC06-D10 15-CG9397-RA_1 CG9397 AGAGGGAAAATGTCAGTCACTCAGCCAAAGGATACGGCATTAAAGACCAAGGAGTCGGCAGCTGAAGTA 69 FBan0009397 FBgn0010347 1.28 2 2R "ATP synthesis coupled proton transport; GO:0015986; specification of segmental identity, maxillary segment; GO:0007382" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 1.28 1.28 "CG9397, CG9397, CG9397, deformed, CT9093" CDMC23738 4 5 4 DAC06-D22 23-CG9413-RB_6 CG9413 TTTTGCGACTTGTGTCTGCTTTGACAAATCGTTGCAACCAAAACTAGAACTAGATTTAGAGAGACGGTT 69 FBan0009413 FBgn0030574 CG9413 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG9413 CG9413 CDMC23738 4 6 4 DAC06-D22 23-CG9413-RB_6 CG9413 TTTTGCGACTTGTGTCTGCTTTGACAAATCGTTGCAACCAAAACTAGAACTAGATTTAGAGAGACGGTT 69 FBan0009413 FBgn0030574 CG9413 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG9413 CG9413 CDMC23739 4 7 4 DAC06-H10 4-CG9438-RA_1 CG9438 TCATCAGCCGGTTCAGGGTATCCGTCTGCGATACGACAGAGATCCCACTGAAGTATAGTCCCATGTCCA 69 FBan0009438 FBgn0000473 Cyp6a2 2 2R electron transport; GO:0006118; response to insecticide; GO:0017085; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a2 Cytochrome P450-6a2 "CG9438, P-450-B, P450-B, P450-B1, P450, CYP6A2, P-450, 91R, 91-R, Cyp6A2, cytochrome P450-B1, 6a2, cyp6a2, Cyt-P450-B1: Cytochrome P450 B1, Cytochrome P450 B1" CDMC23739 4 8 4 DAC06-H10 4-CG9438-RA_1 CG9438 TCATCAGCCGGTTCAGGGTATCCGTCTGCGATACGACAGAGATCCCACTGAAGTATAGTCCCATGTCCA 69 FBan0009438 FBgn0000473 Cyp6a2 2 2R electron transport; GO:0006118; response to insecticide; GO:0017085; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a2 Cytochrome P450-6a2 "CG9438, P-450-B, P450-B, P450-B1, P450, CYP6A2, P-450, 91R, 91-R, Cyp6A2, cytochrome P450-B1, 6a2, cyp6a2, Cyt-P450-B1: Cytochrome P450 B1, Cytochrome P450 B1" CDMC23740 4 9 4 DAC06-H22 3-CG9453-RA_4 CG9453 TGCCGACCATCCTTTCACCTATGTCCTTGTGCATCAGAAGGATCTGCCATTGTTTTGGGGCTCAGTTGT 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC23740 4 10 4 DAC06-H22 3-CG9453-RA_4 CG9453 TGCCGACCATCCTTTCACCTATGTCCTTGTGCATCAGAAGGATCTGCCATTGTTTTGGGGCTCAGTTGT 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC23741 4 11 4 DAC06-L10 15-CG9490-RA_1 CG9490 CGCGACGAGTCGAGTCGACCCAGTTTCCGCGAGATACATTTGTATCTGCAGCGCAAGAATTTAGGTTTT 69 FBgn0031797 CDMC23741 4 12 4 DAC06-L10 15-CG9490-RA_1 CG9490 CGCGACGAGTCGAGTCGACCCAGTTTCCGCGAGATACATTTGTATCTGCAGCGCAAGAATTTAGGTTTT 69 FBgn0031797 CDMC23742 4 13 4 DAC06-L22 8-CG9499-RA_1 CG9499 ACCGGATGTGTACGCAAACAACTCCTATGTGGACCTGGATGTGCACTTTCGCTTCGAGACCATTATGGT 69 FBan0009499 FBgn0031802 ppk7 2 2L cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280; ; GO:0005272 membrane; GO:0016020 ppk7 pickpocket 7 "CG9499, CG9499, CG9499, CG9499, PPK7" CDMC23742 4 14 4 DAC06-L22 8-CG9499-RA_1 CG9499 ACCGGATGTGTACGCAAACAACTCCTATGTGGACCTGGATGTGCACTTTCGCTTCGAGACCATTATGGT 69 FBan0009499 FBgn0031802 ppk7 2 2L cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280; ; GO:0005272 membrane; GO:0016020 ppk7 pickpocket 7 "CG9499, CG9499, CG9499, CG9499, PPK7" CDMC23743 4 15 4 DAC06-P10 23-CG9528-RA_8 CG9528 AAACATTCGAATGCAGAACGTTTTTGATTGCACACTAATTACCCCGTCATTTGTACGCCCTTAATTGCT 69 FBan0009528 FBgn0031814 retm 2 2L intracellular protein transport; GO:0006886 phosphatidylinositol transporter activity; GO:0008526; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0008526 mitochondrion; GO:0005739 retm real-time "CG9528, CG9528, real-time" CDMC23743 4 16 4 DAC06-P10 23-CG9528-RA_8 CG9528 AAACATTCGAATGCAGAACGTTTTTGATTGCACACTAATTACCCCGTCATTTGTACGCCCTTAATTGCT 69 FBan0009528 FBgn0031814 retm 2 2L intracellular protein transport; GO:0006886 phosphatidylinositol transporter activity; GO:0008526; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0008526 mitochondrion; GO:0005739 retm real-time "CG9528, CG9528, real-time" CDMC23744 4 17 4 DAC06-P22 2-CG9542-RA_1 CG9542 CCACCTTCATCGAGCAAAGTCGCCACTACGCTGATGTGCTGAGAAAGAAGGGCTACAAGGCGAGCTTTA 69 FBan0009542 FBgn0031821 CG9542 2 2L CG9542 CG9542 CDMC23744 4 18 4 DAC06-P22 2-CG9542-RA_1 CG9542 CCACCTTCATCGAGCAAAGTCGCCACTACGCTGATGTGCTGAGAAAGAAGGGCTACAAGGCGAGCTTTA 69 FBan0009542 FBgn0031821 CG9542 2 2L CG9542 CG9542 CDMC23745 4 19 4 DAC07-D10 1-CG6588-RC_1 CG6588 GCCCGATGTTGAGTGCACCAACGGAATTATCCACGTCATCGACTACCCACTCCTGGAGGAAAAGGATGT 69 FBan0006588 FBgn0000634 Fas1 3 3R axon guidance; GO:0007411; calcium-independent cell-cell adhesion; GO:0016338; homophilic cell adhesion; GO:0007156; neuron adhesion; GO:0007158; neuron recognition; GO:0008038 cell adhesion molecule binding; GO:0050839; ; GO:0050839 plasma membrane; GO:0005886 Fas1 Fasciclin 1 "CG6588, fasciclin I, fas I, fasI, gasI, Fasciclin I, FasI, fas-I, DROFAS1, DROFAS, DROFASI, Fas I" CDMC23745 4 20 4 DAC07-D10 1-CG6588-RC_1 CG6588 GCCCGATGTTGAGTGCACCAACGGAATTATCCACGTCATCGACTACCCACTCCTGGAGGAAAAGGATGT 69 FBan0006588 FBgn0000634 Fas1 3 3R axon guidance; GO:0007411; calcium-independent cell-cell adhesion; GO:0016338; homophilic cell adhesion; GO:0007156; neuron adhesion; GO:0007158; neuron recognition; GO:0008038 cell adhesion molecule binding; GO:0050839; ; GO:0050839 plasma membrane; GO:0005886 Fas1 Fasciclin 1 "CG6588, fasciclin I, fas I, fasI, gasI, Fasciclin I, FasI, fas-I, DROFAS1, DROFAS, DROFASI, Fas I" CDMC23746 4 21 4 DAC07-D22 11-CG6600-RA_1 CG6600 TGCTCCGCTACTTTTGGCTATATTCACCCCATTCGTGGTACCCGAATCAGCTCGTTGGTTAGTCTCCCA 69 FBan0006600 FBgn0035672 CG6600 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6600 CG6600 CDMC23746 4 22 4 DAC07-D22 11-CG6600-RA_1 CG6600 TGCTCCGCTACTTTTGGCTATATTCACCCCATTCGTGGTACCCGAATCAGCTCGTTGGTTAGTCTCCCA 69 FBan0006600 FBgn0035672 CG6600 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6600 CG6600 CDMC23747 4 23 4 DAC07-H10 14-CG6629-RA_1 CG6629 TGCTCCCAAGGATACCAAAAAGGAACCCAAGAAGGATGCAAAGGACAAGAAGAAAGACGAGGAAGGCAA 69 FBan0006629 FBgn0037860 CG6629 3 3R "mitochondrial electron transport, succinate to ubiquinone; GO:0006121; succinate metabolism; GO:0006105; tricarboxylic acid cycle; GO:0006099" succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; ; GO:0000104 ; EC:1.3.99.1 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG6629 CG6629 CDMC23747 4 24 4 DAC07-H10 14-CG6629-RA_1 CG6629 TGCTCCCAAGGATACCAAAAAGGAACCCAAGAAGGATGCAAAGGACAAGAAGAAAGACGAGGAAGGCAA 69 FBan0006629 FBgn0037860 CG6629 3 3R "mitochondrial electron transport, succinate to ubiquinone; GO:0006121; succinate metabolism; GO:0006105; tricarboxylic acid cycle; GO:0006099" succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; ; GO:0000104 ; EC:1.3.99.1 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG6629 CG6629 CDMC23748 4 25 4 DAC07-H22 3-CG6640-RA_1 CG6640 GCCTTCTCATCCAACTCGGCCTACCTGACGGAGGCATATCCCATGGGAGTTAAGCAACACTTTATCGGT 69 FBan0006640 FBgn0036068 CG6640 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG6640 CG6640 anon-WO0140519.30 CDMC23748 4 26 4 DAC07-H22 3-CG6640-RA_1 CG6640 GCCTTCTCATCCAACTCGGCCTACCTGACGGAGGCATATCCCATGGGAGTTAAGCAACACTTTATCGGT 69 FBan0006640 FBgn0036068 CG6640 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG6640 CG6640 anon-WO0140519.30 CDMC23749 4 1 5 DAC07-L10 15-CG6672-RA_1 CG6672 ACCCACCGGTGTCCTTGTACAATGATCTGTATAGTTATCAGCGCATGTTGAATGTTTGTGGGCAGTGCG 69 FBan0006672 FBgn0037875 CG6672 3 3R cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG6672 CG6672 CDMC23749 4 2 5 DAC07-L10 15-CG6672-RA_1 CG6672 ACCCACCGGTGTCCTTGTACAATGATCTGTATAGTTATCAGCGCATGTTGAATGTTTGTGGGCAGTGCG 69 FBan0006672 FBgn0037875 CG6672 3 3R cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG6672 CG6672 CDMC23750 4 3 5 DAC07-L22 8-CG6683-RA_2 CG6683 ACACGCGACTTATTGAGCTGGTTAGGGCTAATCCCAAGCTTTATGAGCGCGAACTTAGAAACGCACCCT 69 FBan0006683 FBgn0035902 CG6683 3 3L CG6683 CG6683 CDMC23750 4 4 5 DAC07-L22 8-CG6683-RA_2 CG6683 ACACGCGACTTATTGAGCTGGTTAGGGCTAATCCCAAGCTTTATGAGCGCGAACTTAGAAACGCACCCT 69 FBan0006683 FBgn0035902 CG6683 3 3L CG6683 CG6683 CDMC23751 4 5 5 DAC07-P10 9-CG6708-RA_1 CG6708 GCAGAGGGGCACAAATGCATCCTGAACTTTATCCCCTACTCGTACTTTAGTCGCGATGTGCAGCGAAGC 69 FBan0006708 FBgn0020626 Osbp 3 3R cholesterol metabolism; GO:0008203 oxysterol binding; GO:0008142; ; GO:0008142; ; GO:0008142 Osbp Oxysterol binding protein "CG6708, OSBP-Dm, oxysterol binding protein" CDMC23751 4 6 5 DAC07-P10 9-CG6708-RA_1 CG6708 GCAGAGGGGCACAAATGCATCCTGAACTTTATCCCCTACTCGTACTTTAGTCGCGATGTGCAGCGAAGC 69 FBan0006708 FBgn0020626 Osbp 3 3R cholesterol metabolism; GO:0008203 oxysterol binding; GO:0008142; ; GO:0008142; ; GO:0008142 Osbp Oxysterol binding protein "CG6708, OSBP-Dm, oxysterol binding protein" CDMC23752 4 7 5 DAC07-P22 12-CG6726-RA_5 CG6726 TGGGATTCAGTTTCGACGAGGGAATCTCTAGTGCGGATGAAACCTACGCTCTGTACTACGCTGAACGGA 69 FBan0006726 FBgn0039049 CG6726 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6726 CG6726 CDMC23752 4 8 5 DAC07-P22 12-CG6726-RA_5 CG6726 TGGGATTCAGTTTCGACGAGGGAATCTCTAGTGCGGATGAAACCTACGCTCTGTACTACGCTGAACGGA 69 FBan0006726 FBgn0039049 CG6726 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6726 CG6726 CDMC23753 4 9 5 DAC08-D10 2-CG31874-RA_3 CG31874 GGTGCCGTGCACATTCCTCTCGATCGAATGTTCGGTCCGCAAACCATGAGATCCCTGATGAAATTTCCA 69 FBan0031874 FBgn0051874 CG31874 2 2L carbohydrate metabolism; GO:0005975; fumarate metabolism; GO:0006106 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004333 ; EC:4.2.1.2 mitochondrion; GO:0005739 CG31874 CG31874 NEST:bs10e11 CDMC23753 4 10 5 DAC08-D10 2-CG31874-RA_3 CG31874 GGTGCCGTGCACATTCCTCTCGATCGAATGTTCGGTCCGCAAACCATGAGATCCCTGATGAAATTTCCA 69 FBan0031874 FBgn0051874 CG31874 2 2L carbohydrate metabolism; GO:0005975; fumarate metabolism; GO:0006106 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; fumarate hydratase activity; GO:0004333 ; EC:4.2.1.2; ; GO:0004333 ; EC:4.2.1.2; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004333 ; EC:4.2.1.2 mitochondrion; GO:0005739 CG31874 CG31874 NEST:bs10e11 CDMC23754 4 11 5 DAC08-D22 16-CG31884-RB_1 CG31884 AGCAAAACCTATCGCATAGATGTGCCAATCGGTCTATCCATTCGAAATTCACCTTCACCAAACGCGACA 69 FBan0031884 FBgn0040070 Trx-2 2 2L cell redox homeostasis; GO:0045454; electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 cellular component unknown; GO:0008372 Trx-2 thioredoxin-2 "CG3864, CG31884, CG3864, CG3864, thioredoxin, dmtrx-2, DmTrx-2, anon-WO0118547.188, thioredoxin-2" CDMC23754 4 12 5 DAC08-D22 16-CG31884-RB_1 CG31884 AGCAAAACCTATCGCATAGATGTGCCAATCGGTCTATCCATTCGAAATTCACCTTCACCAAACGCGACA 69 FBan0031884 FBgn0040070 Trx-2 2 2L cell redox homeostasis; GO:0045454; electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 cellular component unknown; GO:0008372 Trx-2 thioredoxin-2 "CG3864, CG31884, CG3864, CG3864, thioredoxin, dmtrx-2, DmTrx-2, anon-WO0118547.188, thioredoxin-2" CDMC23755 4 13 5 DAC08-H10 5-CG31918-RA_1 CG31918 GAACGCGTGCCGAACTAAGCTTACTGGACCAACCGAACTTCAAAGACCGGCGATACATGCTCCATTCAT 69 FBgn0051918 CDMC23755 4 14 5 DAC08-H10 5-CG31918-RA_1 CG31918 GAACGCGTGCCGAACTAAGCTTACTGGACCAACCGAACTTCAAAGACCGGCGATACATGCTCCATTCAT 69 FBgn0051918 CDMC23756 4 15 5 DAC08-H22 23-CG31925-RA_5 CG31925 ATGCGCAATTATAACATCCCAACAATGCATTCAGTGGTGTGTAAGTCTTCATGTTAAATAAGCCGAAAA 69 FBan0031925 FBgn0051925 CG31925 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31925 CG31925 CDMC23756 4 16 5 DAC08-H22 23-CG31925-RA_5 CG31925 ATGCGCAATTATAACATCCCAACAATGCATTCAGTGGTGTGTAAGTCTTCATGTTAAATAAGCCGAAAA 69 FBan0031925 FBgn0051925 CG31925 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31925 CG31925 CDMC23757 4 17 5 DAC08-L10 2-CG31976-RA_2 CG31976 GGCACATACGTCATGATCAACATGCGCGTAAGCCCCAAAAACCCACTTCTGAGCCTTCTCTACCAACCG 69 FBan0031976 FBgn0051976 CG31976 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31976 CG31976 "CG11623, CG11623" CDMC23757 4 18 5 DAC08-L10 2-CG31976-RA_2 CG31976 GGCACATACGTCATGATCAACATGCGCGTAAGCCCCAAAAACCCACTTCTGAGCCTTCTCTACCAACCG 69 FBan0031976 FBgn0051976 CG31976 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31976 CG31976 "CG11623, CG11623" CDMC23758 4 19 5 DAC08-L22 7-CG31997-RA_1 CG31997 AGATTTTCCGGGAATGTGCTTTGCTTCAACTCGATGTGCCACTGTTGAGCCTGGAAAGTCGTGGGACCT 69 FBan0031997 FBgn0051997 CG31997 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31997 CG31997 "BcDNA:RE42475, BEST:GH25016" CDMC23758 4 20 5 DAC08-L22 7-CG31997-RA_1 CG31997 AGATTTTCCGGGAATGTGCTTTGCTTCAACTCGATGTGCCACTGTTGAGCCTGGAAAGTCGTGGGACCT 69 FBan0031997 FBgn0051997 CG31997 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31997 CG31997 "BcDNA:RE42475, BEST:GH25016" CDMC23759 4 21 5 DAC08-P10 9-CG32029-RA_1 CG32029 AGTGCCCGCGTTCCGTCGTCCAAGTGTGATCTAGTATCCAGTAAACCCTTAGCAACATGCAACTCCTTT 69 FBan0032029 FBgn0052029 CG32029 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG32029 CG32029 "CG6469, CG6458, CG6469" CDMC23759 4 22 5 DAC08-P10 9-CG32029-RA_1 CG32029 AGTGCCCGCGTTCCGTCGTCCAAGTGTGATCTAGTATCCAGTAAACCCTTAGCAACATGCAACTCCTTT 69 FBan0032029 FBgn0052029 CG32029 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG32029 CG32029 "CG6469, CG6458, CG6469" CDMC23760 4 23 5 DAC08-P22 15-CG32038-RA_2 CG32038 TCGCGGATATTATTCCCGGAGTTCAAGGACATGGGCTCAAGGTCACCTAAAATACCGATCAGACCATGC 69 FBan0032038 FBgn0052038 CG32038 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32038 CG32038 CDMC23760 4 24 5 DAC08-P22 15-CG32038-RA_2 CG32038 TCGCGGATATTATTCCCGGAGTTCAAGGACATGGGCTCAAGGTCACCTAAAATACCGATCAGACCATGC 69 FBan0032038 FBgn0052038 CG32038 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32038 CG32038 CDMC23761 4 25 5 DAC09-D11 2-CG5454-RA_1 CG5454 TAGTGCAATGCCAAAGTACTATTGCGACTACTGCGACACCTACTTGACCCACGACTCGCCCTCGG 65 FBan0005454 FBgn0038667 CG5454 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003729 nucleus; GO:0005634; snRNP U1; GO:0005685; snRNP U11; GO:0005692 CG5454 CG5454 "U1C, BcDNA:RH29440" CDMC23761 4 26 5 DAC09-D11 2-CG5454-RA_1 CG5454 TAGTGCAATGCCAAAGTACTATTGCGACTACTGCGACACCTACTTGACCCACGACTCGCCCTCGG 65 FBan0005454 FBgn0038667 CG5454 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003729 nucleus; GO:0005634; snRNP U1; GO:0005685; snRNP U11; GO:0005692 CG5454 CG5454 "U1C, BcDNA:RH29440" CDMC23762 4 1 6 DAC09-D23 2-CG5510-RA_2 CG5510 CCTGCCACACTGGGACTTCCTGGGTAACACGATGGTGACCAGCAACTATATAAGACTGACGCCGG 65 FBan0005510 FBgn0039160 CG5510 3 3R intracellular protein transport; GO:0006886 membrane; GO:0016020 CG5510 CG5510 CDMC23762 4 2 6 DAC09-D23 2-CG5510-RA_2 CG5510 CCTGCCACACTGGGACTTCCTGGGTAACACGATGGTGACCAGCAACTATATAAGACTGACGCCGG 65 FBan0005510 FBgn0039160 CG5510 3 3R intracellular protein transport; GO:0006886 membrane; GO:0016020 CG5510 CG5510 CDMC23763 4 3 6 DAC09-H11 6-CG5641-RA_1 CG5641 AGGCTGTTCTCGACAATCTGGTGGTTGCACCCGGGGATCTGACAACTTGTCAACTGGAGGAAGTG 65 FBan0005641 FBgn0038046 CG5641 3 3R "defense response; GO:0006952; immune response; GO:0006955; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; double-stranded RNA binding; GO:0003725; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0030528; protein binding; GO:0005515; ; GO:0003712; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003677; ; GO:0003702; ; GO:0003725; ; GO:0005515; ; GO:0030528 nucleolus; GO:0005730; nucleus; GO:0005634 CG5641 CG5641 Interleukin enhancer binding factor CDMC23763 4 4 6 DAC09-H11 6-CG5641-RA_1 CG5641 AGGCTGTTCTCGACAATCTGGTGGTTGCACCCGGGGATCTGACAACTTGTCAACTGGAGGAAGTG 65 FBan0005641 FBgn0038046 CG5641 3 3R "defense response; GO:0006952; immune response; GO:0006955; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; double-stranded RNA binding; GO:0003725; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0030528; protein binding; GO:0005515; ; GO:0003712; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003677; ; GO:0003702; ; GO:0003725; ; GO:0005515; ; GO:0030528 nucleolus; GO:0005730; nucleus; GO:0005634 CG5641 CG5641 Interleukin enhancer binding factor CDMC23764 4 5 6 DAC09-H23 23-CG5662-RA_2 CG5662 ACTTCAACAATTCCATAAAAAGAAACCCACAGTCAAAATTTTCGGCACTTTAAGCATGGAGTTGG 65 FBan0005662 FBgn0030620 CG5662 X X protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386 mitochondrial outer membrane; GO:0005741 CG5662 CG5662 CDMC23764 4 6 6 DAC09-H23 23-CG5662-RA_2 CG5662 ACTTCAACAATTCCATAAAAAGAAACCCACAGTCAAAATTTTCGGCACTTTAAGCATGGAGTTGG 65 FBan0005662 FBgn0030620 CG5662 X X protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386 mitochondrial outer membrane; GO:0005741 CG5662 CG5662 CDMC23765 4 7 6 DAC09-L11 17-CG5791-RA_1 CG5791 GTGGTGAATGGCGTCTGTCTGACTTGTCCCAATCCGAATGGTGAACCCGTCTACCTGGATGGCCA 65 FBan0005791 FBgn0040582 CG5791 3 3R CG5791 CG5791 BcDNA:RH16331 CDMC23765 4 8 6 DAC09-L11 17-CG5791-RA_1 CG5791 GTGGTGAATGGCGTCTGTCTGACTTGTCCCAATCCGAATGGTGAACCCGTCTACCTGGATGGCCA 65 FBan0005791 FBgn0040582 CG5791 3 3R CG5791 CG5791 BcDNA:RH16331 CDMC23766 4 9 6 DAC09-L23 1-CG5834-RA_1 CG5834 CAAAGTCTGCTGCAGGAGTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGC 65 FBan0005834 FBgn0051354 Hsp70Bbb 3 3R response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 cellular component unknown; GO:0008372 Hsp70Bbb Hsp70Bbb "CG5834, CG31354, CG5834, CG31354, Hsp70, hsp70, HSP70, Hsp70Bb, hsp70Bb-prime, hsp70B" CDMC23766 4 10 6 DAC09-L23 1-CG5834-RA_1 CG5834 CAAAGTCTGCTGCAGGAGTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGC 65 FBan0005834 FBgn0051354 Hsp70Bbb 3 3R response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 cellular component unknown; GO:0008372 Hsp70Bbb Hsp70Bbb "CG5834, CG31354, CG5834, CG31354, Hsp70, hsp70, HSP70, Hsp70Bb, hsp70Bb-prime, hsp70B" CDMC23767 4 11 6 DAC09-P11 15-CG5954-RB_2 CG5954 CCCGAGAATATCAGACGTGGATGGGCGAAGAAAACAAAGCGTGCCTGTTCGGAGGCCAAGCAAGC 65 FBan0005954 FBgn0002441 l(3)mbt 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through preblastoderm mitotic cell cycle; GO:0007347; regulation of transcription; GO:0045449; syncytial nuclear migration; GO:0035190 chromatin binding; GO:0003682; transcription factor activity; GO:0003700; ; GO:0003682; ; GO:0003700 Myb complex; GO:0031523; nucleus; GO:0005634 l(3)mbt lethal (3) malignant brain tumor "CG5954, MBT, tumor-supressor, l(3)malignant braintumor, L(3)MBT/LIN-61, mbt" CDMC23767 4 12 6 DAC09-P11 15-CG5954-RB_2 CG5954 CCCGAGAATATCAGACGTGGATGGGCGAAGAAAACAAAGCGTGCCTGTTCGGAGGCCAAGCAAGC 65 FBan0005954 FBgn0002441 l(3)mbt 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through preblastoderm mitotic cell cycle; GO:0007347; regulation of transcription; GO:0045449; syncytial nuclear migration; GO:0035190 chromatin binding; GO:0003682; transcription factor activity; GO:0003700; ; GO:0003682; ; GO:0003700 Myb complex; GO:0031523; nucleus; GO:0005634 l(3)mbt lethal (3) malignant brain tumor "CG5954, MBT, tumor-supressor, l(3)malignant braintumor, L(3)MBT/LIN-61, mbt" CDMC23768 4 13 6 DAC09-P23 AutoBlank AutoBlank CDMC23768 4 14 6 DAC09-P23 AutoBlank AutoBlank CDMC23769 4 15 6 DAC10-D10 1-CG6547-RA_1 CG6547 GTCCAGACTGACGGTAGGACGTTCCACTTCGGAGTGTTGCAGCTGAATACCCTCGATCTTGGTGC 65 FBan0006547 FBgn0037833 mRpL37 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL37 mitochondrial ribosomal protein L37 "CG6547, MRP-L2, mitochondrial ribosomal protein L2a, mRpL2a, mitochondrial ribosomal protein L37" CDMC23769 4 16 6 DAC10-D10 1-CG6547-RA_1 CG6547 GTCCAGACTGACGGTAGGACGTTCCACTTCGGAGTGTTGCAGCTGAATACCCTCGATCTTGGTGC 65 FBan0006547 FBgn0037833 mRpL37 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL37 mitochondrial ribosomal protein L37 "CG6547, MRP-L2, mitochondrial ribosomal protein L2a, mRpL2a, mitochondrial ribosomal protein L37" CDMC23770 4 17 6 DAC10-D22 3-CG6618-RB_1 CG6618 TATTGCGTGATGATCGAGGGCTTCACGATGCTCTATGTGCTGGGACTCATCGAGGCGGTTGTGTT 65 FBan0006618 FBgn0029137 Patsas 2 2L cell proliferation; GO:0008283; sensory perception; GO:0007600 GTPase activity; GO:0003924; ; GO:0003924; metal ion binding; GO:0046872; ; GO:0046872 Patsas Patsas CG6618 CDMC23770 4 18 6 DAC10-D22 3-CG6618-RB_1 CG6618 TATTGCGTGATGATCGAGGGCTTCACGATGCTCTATGTGCTGGGACTCATCGAGGCGGTTGTGTT 65 FBan0006618 FBgn0029137 Patsas 2 2L cell proliferation; GO:0008283; sensory perception; GO:0007600 GTPase activity; GO:0003924; ; GO:0003924; metal ion binding; GO:0046872; ; GO:0046872 Patsas Patsas CG6618 CDMC23771 4 19 6 DAC10-H10 2-CG6728-RA_1 CG6728 TTTGCGTCATTCGGTGGTACAGCAGTTCCTTAACCCGGTCATACATCACTCCAATCTGCGCCTGC 65 FBan0006728 FBgn0037896 ninaG 3 3R electron transport; GO:0006118; proteolysis; GO:0006508 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0004197 ; EC:3.4.22.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" ninaG ninaG "CG6728, CG6728" CDMC23771 4 20 6 DAC10-H10 2-CG6728-RA_1 CG6728 TTTGCGTCATTCGGTGGTACAGCAGTTCCTTAACCCGGTCATACATCACTCCAATCTGCGCCTGC 65 FBan0006728 FBgn0037896 ninaG 3 3R electron transport; GO:0006118; proteolysis; GO:0006508 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0004197 ; EC:3.4.22.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" ninaG ninaG "CG6728, CG6728" CDMC23772 4 21 6 DAC10-H22 3-CG6754-RB_1 CG6754 TTGTCATTCGCTCCCAGGAGGAAGTGGATGCTTCTCTTGAGGATTCTGTGAACAAGCATGGCGGC 65 FBan0006754 FBgn0026198 nbs 3 3L "DNA metabolism; GO:0006259; DNA recombination; GO:0006310; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 intracellular; GO:0005622 nbs nbs "CG6754, CG6754, Nbs1" CDMC23772 4 22 6 DAC10-H22 3-CG6754-RB_1 CG6754 TTGTCATTCGCTCCCAGGAGGAAGTGGATGCTTCTCTTGAGGATTCTGTGAACAAGCATGGCGGC 65 FBan0006754 FBgn0026198 nbs 3 3L "DNA metabolism; GO:0006259; DNA recombination; GO:0006310; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 intracellular; GO:0005622 nbs nbs "CG6754, CG6754, Nbs1" CDMC23773 4 23 6 DAC10-L10 2-CG6850-RA_1 CG6850 TTTGGGATGGTCAGGCCACTTTACCCCCTCGAAAAGCTTTGGTGACTGCGTATGTGCGTTAGGTG 65 FBan0006850 FBgn0014075 Ugt 3 3L protein amino acid glycosylation; GO:0006486 UDP-glucose:glycoprotein glucosyltransferase activity; GO:0003980 ; EC:2.4.1.-; ; GO:0003980 ; EC:2.4.1.- cytoplasm; GO:0005737; endoplasmic reticulum; GO:0005783; nuclear membrane; GO:0005635; rough endoplasmic reticulum; GO:0005791 Ugt UDP-glucose-glycoprotein glucosyltransferase "CG6850, DUGT, UGT, UDP-glucose:glycoprotein glucosyltransferase, GT, anon-WO0172774.73, anon-WO0172774.75" CDMC23773 4 24 6 DAC10-L10 2-CG6850-RA_1 CG6850 TTTGGGATGGTCAGGCCACTTTACCCCCTCGAAAAGCTTTGGTGACTGCGTATGTGCGTTAGGTG 65 FBan0006850 FBgn0014075 Ugt 3 3L protein amino acid glycosylation; GO:0006486 UDP-glucose:glycoprotein glucosyltransferase activity; GO:0003980 ; EC:2.4.1.-; ; GO:0003980 ; EC:2.4.1.- cytoplasm; GO:0005737; endoplasmic reticulum; GO:0005783; nuclear membrane; GO:0005635; rough endoplasmic reticulum; GO:0005791 Ugt UDP-glucose-glycoprotein glucosyltransferase "CG6850, DUGT, UGT, UDP-glucose:glycoprotein glucosyltransferase, GT, anon-WO0172774.73, anon-WO0172774.75" CDMC23774 4 25 6 DAC10-L22 1-CG6893-RA_1 CG6893 TGACCAGGGAAGAGGGCTTTACGAAGCTGTACAGCGGATGTTTCCTCTCCTTTATGCGGTCCAGC 65 FBan0006893 FBgn0036807 CG6893 3 3L transport; GO:0006810 dicarboxylic acid transporter activity; GO:0005310; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 membrane; GO:0016020; mitochondrion; GO:0005739 CG6893 CG6893 CDMC23774 4 26 6 DAC10-L22 1-CG6893-RA_1 CG6893 TGACCAGGGAAGAGGGCTTTACGAAGCTGTACAGCGGATGTTTCCTCTCCTTTATGCGGTCCAGC 65 FBan0006893 FBgn0036807 CG6893 3 3L transport; GO:0006810 dicarboxylic acid transporter activity; GO:0005310; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 membrane; GO:0016020; mitochondrion; GO:0005739 CG6893 CG6893 CDMC23775 4 1 7 DAC10-P10 3-CG6992-RI_2 CG6992 CAATGTCACCTGTGACTCCTACCACGAGGTGGATGGTGACGAGCTGTCCATTATTGAGCTGGGCG 65 FBan0006992 FBgn0004620 GluRIIA 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; synaptic transmission; GO:0007268 kainate selective glutamate receptor activity; GO:0015277; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066 plasma membrane; GO:0005886 GluRIIA Glutamate receptor IIA "CG6992, DGluR-II, GluR, dGluRII, DGluRIIA, DGluR-IIA, DGluR2a, dglur-IIA, dGluRIIA, glurIIA, GlurIIA, DgluRII, GluR2a, dglurIIA, glutamate receptor, D-GluRIIA, GluRII, GluRIIa, GluRII-A, Glu-RIIA, Glu-RII" CDMC23775 4 2 7 DAC10-P10 3-CG6992-RI_2 CG6992 CAATGTCACCTGTGACTCCTACCACGAGGTGGATGGTGACGAGCTGTCCATTATTGAGCTGGGCG 65 FBan0006992 FBgn0004620 GluRIIA 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; synaptic transmission; GO:0007268 kainate selective glutamate receptor activity; GO:0015277; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066 plasma membrane; GO:0005886 GluRIIA Glutamate receptor IIA "CG6992, DGluR-II, GluR, dGluRII, DGluRIIA, DGluR-IIA, DGluR2a, dglur-IIA, dGluRIIA, glurIIA, GlurIIA, DgluRII, GluR2a, dglurIIA, glutamate receptor, D-GluRIIA, GluRII, GluRIIa, GluRII-A, Glu-RIIA, Glu-RII" CDMC23776 4 3 7 DAC10-P22 AutoBlank AutoBlank CDMC23776 4 4 7 DAC10-P22 AutoBlank AutoBlank CDMC23777 4 5 7 DAC11-D10 2-CG10023-RA_1 CG10023 CGGCGGATCATTTGTCCAGCTTGACATCTGCAGAAGAACAGATGGGTTCAAATGCACGAAACCTGGGCA 69 FBan0010023 FBgn0020440 Fak56D 2 2R JAK-STAT cascade; GO:0007259; cytoskeletal anchoring; GO:0007016; defense response; GO:0006952; integrin-mediated signaling pathway; GO:0007229; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- cytoskeleton; GO:0005856; focal adhesion; GO:0005925 Fak56D Focal Adhesion Kinase "CG10023, CG10023, DFAK, DmFAK, DFak56, Dfak56, Dfak, focal adhesion kinase homolog, Fak56, FAK, CT28129, DFak, Fak, Focal Adhesion Kinase" CDMC23777 4 6 7 DAC11-D10 2-CG10023-RA_1 CG10023 CGGCGGATCATTTGTCCAGCTTGACATCTGCAGAAGAACAGATGGGTTCAAATGCACGAAACCTGGGCA 69 FBan0010023 FBgn0020440 Fak56D 2 2R JAK-STAT cascade; GO:0007259; cytoskeletal anchoring; GO:0007016; defense response; GO:0006952; integrin-mediated signaling pathway; GO:0007229; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- cytoskeleton; GO:0005856; focal adhesion; GO:0005925 Fak56D Focal Adhesion Kinase "CG10023, CG10023, DFAK, DmFAK, DFak56, Dfak56, Dfak, focal adhesion kinase homolog, Fak56, FAK, CT28129, DFak, Fak, Focal Adhesion Kinase" CDMC23778 4 7 7 DAC11-D22 12-CG10038-RA_3 CG10038 TTGTCTACGCTTTGCTGGAGAAAAACGGTCTTAGTCGCACCTACATCCCTTTTGACCAGCCTCCAGAGC 69 FBan0010038 FBgn0038013 CG10038 3 3R CG10038 CG10038 CDMC23778 4 8 7 DAC11-D22 12-CG10038-RA_3 CG10038 TTGTCTACGCTTTGCTGGAGAAAAACGGTCTTAGTCGCACCTACATCCCTTTTGACCAGCCTCCAGAGC 69 FBan0010038 FBgn0038013 CG10038 3 3R CG10038 CG10038 CDMC23779 4 9 7 DAC11-H10 11-CG10072-RA_1 CG10072 GCGGCAGTTGCTTTCAGAAGGACATCCTCAATCTGATTTACATCTGCGAGAACCTCAATCTGCCCGAGG 69 FBan0010072 FBgn0010851 sgl 3 3L "Wnt receptor signaling pathway; GO:0016055; cell surface receptor linked signal transduction; GO:0007166; chondroitin sulfate biosynthesis; GO:0030206; electron transport; GO:0006118; fibroblast growth factor receptor signaling pathway; GO:0008543; glycosaminoglycan biosynthesis; GO:0006024; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; lipid metabolism; GO:0006629; mesoderm migration; GO:0007509; primary tracheal branching (sensu Insecta); GO:0007428; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; tracheal epithelial cell migration (sensu Insecta); GO:0007427" UDP-glucose 6-dehydrogenase activity; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22 sgl sugarless "CG10072, CG10072, CG10072, l(3)SG9, XIII, Distal W5.4 Group XIII, sl, ska: suppenkasper, suppenkasper, kiwi, 8310, UDP-glucose dehydrogenase, UDP-GlcDH, UDPGDH: UDP-glucose 6-dehydrogenase, l(3)05007, l(3)08310, l(3)10503, l(3)65CEd, UDP-glucose 6-dehydrogenase, lethal(3)SG9, ska, UDPGDH, sugarless" CDMC23779 4 10 7 DAC11-H10 11-CG10072-RA_1 CG10072 GCGGCAGTTGCTTTCAGAAGGACATCCTCAATCTGATTTACATCTGCGAGAACCTCAATCTGCCCGAGG 69 FBan0010072 FBgn0010851 sgl 3 3L "Wnt receptor signaling pathway; GO:0016055; cell surface receptor linked signal transduction; GO:0007166; chondroitin sulfate biosynthesis; GO:0030206; electron transport; GO:0006118; fibroblast growth factor receptor signaling pathway; GO:0008543; glycosaminoglycan biosynthesis; GO:0006024; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; lipid metabolism; GO:0006629; mesoderm migration; GO:0007509; primary tracheal branching (sensu Insecta); GO:0007428; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; tracheal epithelial cell migration (sensu Insecta); GO:0007427" UDP-glucose 6-dehydrogenase activity; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22; ; GO:0003979 ; EC:1.1.1.22 sgl sugarless "CG10072, CG10072, CG10072, l(3)SG9, XIII, Distal W5.4 Group XIII, sl, ska: suppenkasper, suppenkasper, kiwi, 8310, UDP-glucose dehydrogenase, UDP-GlcDH, UDPGDH: UDP-glucose 6-dehydrogenase, l(3)05007, l(3)08310, l(3)10503, l(3)65CEd, UDP-glucose 6-dehydrogenase, lethal(3)SG9, ska, UDPGDH, sugarless" CDMC23780 4 11 7 DAC11-H22 23-CG10077-RB_6 CG10077 TCCCTTCCATCGAAGTATGTTCCTCCTTTTAAACCAAATCAGCACCCTTCTATCATAAGCTTTGATCAT 69 FBan0010077 FBgn0035720 CG10077 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10077 CG10077 "cg10077, p90, DmRH5, BcDNA:HL07910, BcDNA:HL01868" CDMC23780 4 12 7 DAC11-H22 23-CG10077-RB_6 CG10077 TCCCTTCCATCGAAGTATGTTCCTCCTTTTAAACCAAATCAGCACCCTTCTATCATAAGCTTTGATCAT 69 FBan0010077 FBgn0035720 CG10077 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10077 CG10077 "cg10077, p90, DmRH5, BcDNA:HL07910, BcDNA:HL01868" CDMC23781 4 13 7 DAC11-L10 23-CG10109-RA_6 CG10109 CGGATGATCTTCGATTGGAAATGTGTATTTTCTTCGTTCGACGAGTGTACGCCTATCATCGGCTGTTGC 69 FBan0010109 FBgn0001332 L 2 2R regulation of imaginal disc growth; GO:0045570 L Lobe "CG10109, CG10109, l(2)02637" CDMC23781 4 14 7 DAC11-L10 23-CG10109-RA_6 CG10109 CGGATGATCTTCGATTGGAAATGTGTATTTTCTTCGTTCGACGAGTGTACGCCTATCATCGGCTGTTGC 69 FBan0010109 FBgn0001332 L 2 2R regulation of imaginal disc growth; GO:0045570 L Lobe "CG10109, CG10109, l(2)02637" CDMC23782 4 15 7 DAC11-L22 3-CG10119-RA_1 CG10119 CCCAACTCACCGCAGAGACTCACAGACTCCGAGCTGCACATTCAAACCACACACAGATCTGTTCTGCAT 69 FBan0010119 FBgn0010397 LamC 2 2R cytoskeleton organization and biogenesis; GO:0007010; mitotic nuclear envelope reassembly; GO:0007084 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 lamin filament; GO:0005638 LamC Lamin C "CG10119, pG-IF, lamin C, LAMC, G-IF, G intermediate filament" CDMC23782 4 16 7 DAC11-L22 3-CG10119-RA_1 CG10119 CCCAACTCACCGCAGAGACTCACAGACTCCGAGCTGCACATTCAAACCACACACAGATCTGTTCTGCAT 69 FBan0010119 FBgn0010397 LamC 2 2R cytoskeleton organization and biogenesis; GO:0007010; mitotic nuclear envelope reassembly; GO:0007084 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 lamin filament; GO:0005638 LamC Lamin C "CG10119, pG-IF, lamin C, LAMC, G-IF, G intermediate filament" CDMC23783 4 17 7 DAC11-P10 24-CG1014-RA_1 CG1014 CACCCATCCAAAAAAGAAAAAAGAAATCTAGTCATAAAATTATAAAACGAACATTTATGCGTGTGACCG 69 FBan0001014 FBgn0028567 robl62A 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 robl62A robl62A "CG1014, CG1014" CDMC23783 4 18 7 DAC11-P10 24-CG1014-RA_1 CG1014 CACCCATCCAAAAAAGAAAAAAGAAATCTAGTCATAAAATTATAAAACGAACATTTATGCGTGTGACCG 69 FBan0001014 FBgn0028567 robl62A 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 robl62A robl62A "CG1014, CG1014" CDMC23784 4 19 7 DAC11-P22 2-CG10166-RA_1 CG10166 CCGAACGCCAGTGATTTGACCGGCTCCTTCAGGCTCTACAAGAAGGATGTACTGGAGAAATGCATTGCC 69 FBan0010166 FBgn0032799 CG10166 2 2L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate beta-D-mannosyltransferase activity; GO:0004582 ; EC:2.4.1.83; ; GO:0004582 ; EC:2.4.1.83 endoplasmic reticulum; GO:0005783 CG10166 CG10166 CDMC23784 4 20 7 DAC11-P22 2-CG10166-RA_1 CG10166 CCGAACGCCAGTGATTTGACCGGCTCCTTCAGGCTCTACAAGAAGGATGTACTGGAGAAATGCATTGCC 69 FBan0010166 FBgn0032799 CG10166 2 2L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate beta-D-mannosyltransferase activity; GO:0004582 ; EC:2.4.1.83; ; GO:0004582 ; EC:2.4.1.83 endoplasmic reticulum; GO:0005783 CG10166 CG10166 CDMC23785 4 21 7 DAC12-D10 16-CG30116-RA_1 CG30116 CCAGCACCCCTTTTTGCCACTCTTTTTACGTAGTTTTGGCCATGCCTAGTTGTTTCCCAGTAGTCAACT 69 FBan0030116 FBgn0028496 CG30116 2 2R apoptotic protease activator activity; GO:0016505; ; GO:0016505 CG30116 CG30116 "CG17671, CG5512, BcDNA:GH04922" CDMC23785 4 22 7 DAC12-D10 16-CG30116-RA_1 CG30116 CCAGCACCCCTTTTTGCCACTCTTTTTACGTAGTTTTGGCCATGCCTAGTTGTTTCCCAGTAGTCAACT 69 FBan0030116 FBgn0028496 CG30116 2 2R apoptotic protease activator activity; GO:0016505; ; GO:0016505 CG30116 CG30116 "CG17671, CG5512, BcDNA:GH04922" CDMC23786 4 23 7 DAC12-D22 15-CG30125-RA_6 CG30125 TCCGGGAAAGCAGACCTCACAGTACGAGTTATTTCAGCAGCCAGATAACTTGAGAGCGGAAAATGGAGT 69 FBan0030125 FBgn0050125 CG30125 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30125 CG30125 CDMC23786 4 24 7 DAC12-D22 15-CG30125-RA_6 CG30125 TCCGGGAAAGCAGACCTCACAGTACGAGTTATTTCAGCAGCCAGATAACTTGAGAGCGGAAAATGGAGT 69 FBan0030125 FBgn0050125 CG30125 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30125 CG30125 CDMC23787 4 25 7 DAC12-H10 2-CG30163-RA_1 CG30163 GCAGTTCCAGCATGAGATCACGGTCAGCAATGGGATCCAAGTGAAAGCTCAAGGCAATGTGAACGGCAT 69 FBan0030163 FBgn0050163 CG30163 2 2R CG30163 CG30163 "CG4856, BcDNA:RH24125" CDMC23787 4 26 7 DAC12-H10 2-CG30163-RA_1 CG30163 GCAGTTCCAGCATGAGATCACGGTCAGCAATGGGATCCAAGTGAAAGCTCAAGGCAATGTGAACGGCAT 69 FBan0030163 FBgn0050163 CG30163 2 2R CG30163 CG30163 "CG4856, BcDNA:RH24125" CDMC23788 4 1 8 DAC12-H22 6-CG30173-RA_1 CG30173 TGCCAGCATAAAGAGAATCACCGACTTTCTGAACTCTTTCGATATGTCCTGTCGCTCCCGTCTGGCGGT 69 FBgn0050173 CDMC23788 4 2 8 DAC12-H22 6-CG30173-RA_1 CG30173 TGCCAGCATAAAGAGAATCACCGACTTTCTGAACTCTTTCGATATGTCCTGTCGCTCCCGTCTGGCGGT 69 FBgn0050173 CDMC23789 4 3 8 DAC12-L10 12-CG30222-RB_5 CG30222 ATGACCTCTCCCTCAAACTTATGGATCAGGAGACAACCGGAACGTTGGATTCCGAGTGTGCAGATGGAA 69 FBan0030222 FBgn0050222 CG30222 2 2R CG30222 CG30222 "CG12709, CG15672" CDMC23789 4 4 8 DAC12-L10 12-CG30222-RB_5 CG30222 ATGACCTCTCCCTCAAACTTATGGATCAGGAGACAACCGGAACGTTGGATTCCGAGTGTGCAGATGGAA 69 FBan0030222 FBgn0050222 CG30222 2 2R CG30222 CG30222 "CG12709, CG15672" CDMC23790 4 5 8 DAC12-L22 12-CG30269-RA_1 CG30269 CAACTCGCGCACCCATCTGATAGCCTTGATATTATGCCTGTTCCAGTTGTACTGCTGTGTGTGTCTGCC 69 FBan0030269 FBgn0050269 CG30269 2 2R CG30269 CG30269 "CG13515, CG13515" CDMC23790 4 6 8 DAC12-L22 12-CG30269-RA_1 CG30269 CAACTCGCGCACCCATCTGATAGCCTTGATATTATGCCTGTTCCAGTTGTACTGCTGTGTGTGTCTGCC 69 FBan0030269 FBgn0050269 CG30269 2 2R CG30269 CG30269 "CG13515, CG13515" CDMC23791 4 7 8 DAC12-P10 22-CG3029-RA_1 CG3029 AGTGCTTTTTCGCAGTCCTTCATGAATTTCCAACAGCTGTCGACTGTTCCGTAATATTAGGTCCCACGT 69 FBan0003029 FBgn0003008 or 2 2R eye pigment biosynthesis; GO:0006726; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; neurotransmitter secretion; GO:0007269; ommochrome biosynthesis; GO:0006727; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 or orange "CG3029, CG3029, CG3029, CG3029, sigma3, AP-3sigma, cg3029" CDMC23791 4 8 8 DAC12-P10 22-CG3029-RA_1 CG3029 AGTGCTTTTTCGCAGTCCTTCATGAATTTCCAACAGCTGTCGACTGTTCCGTAATATTAGGTCCCACGT 69 FBan0003029 FBgn0003008 or 2 2R eye pigment biosynthesis; GO:0006726; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; neurotransmitter secretion; GO:0007269; ommochrome biosynthesis; GO:0006727; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 or orange "CG3029, CG3029, CG3029, CG3029, sigma3, AP-3sigma, cg3029" CDMC23792 4 9 8 DAC12-P22 2-CG30332-RA_1 CG30332 TGGCCCCTTCATGAGTTATGGTCCCCCATTCCCAGAGAGATCGCGGTAATTAAATGCGCTTTTCCCTCT 69 FBan0030332 FBgn0050332 CG30332 2 2R CG30332 CG30332 BcDNA:AT17896 CDMC23792 4 10 8 DAC12-P22 2-CG30332-RA_1 CG30332 TGGCCCCTTCATGAGTTATGGTCCCCCATTCCCAGAGAGATCGCGGTAATTAAATGCGCTTTTCCCTCT 69 FBan0030332 FBgn0050332 CG30332 2 2R CG30332 CG30332 BcDNA:AT17896 CDMC23793 4 11 8 DAC13-D10 2-CG13279-RA_1 CG13279 CCAGCGGAAAGGTGCTCGGATCGGTAAAGTTTGTGCCACAGACGTCAAGGATCAAAAGGACTCGG 65 FBan0013279 FBgn0000406 Cyt-b5-r 2 2L electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489 mitochondrion; GO:0005739 Cyt-b5-r Cytochrome b5-related "CG13279, TU-36B, Cytb, Cyt-b5, Cyt-b, Cytb5, TU36B" CDMC23793 4 12 8 DAC13-D10 2-CG13279-RA_1 CG13279 CCAGCGGAAAGGTGCTCGGATCGGTAAAGTTTGTGCCACAGACGTCAAGGATCAAAAGGACTCGG 65 FBan0013279 FBgn0000406 Cyt-b5-r 2 2L electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489 mitochondrion; GO:0005739 Cyt-b5-r Cytochrome b5-related "CG13279, TU-36B, Cytb, Cyt-b5, Cyt-b, Cytb5, TU36B" CDMC23794 4 13 8 DAC13-D22 24-CG13364-RA_1 CG13364 ATGTGGACCATAATCTTTTTATACTTACGATTACCATTAAATAGATCATTGTACGTCAGGATAGA 65 FBan0013364 FBgn0026879 CG13364 X X CG13364 CG13364 "CG18451, CG18451, EG:115C2.12, anon-EST:Posey36" CDMC23794 4 14 8 DAC13-D22 24-CG13364-RA_1 CG13364 ATGTGGACCATAATCTTTTTATACTTACGATTACCATTAAATAGATCATTGTACGTCAGGATAGA 65 FBan0013364 FBgn0026879 CG13364 X X CG13364 CG13364 "CG18451, CG18451, EG:115C2.12, anon-EST:Posey36" CDMC23795 4 15 8 DAC13-H10 8-CG13484-RA_1 CG13484 CGAGGACAAACAGGGCCAGCAAAATGTTCCTCATTTCTACCAGAACAAATCCCCACAGGAGCCGC 65 FBan0013484 FBgn0036406 CG13484 3 3L CG13484 CG13484 CDMC23795 4 16 8 DAC13-H10 8-CG13484-RA_1 CG13484 CGAGGACAAACAGGGCCAGCAAAATGTTCCTCATTTCTACCAGAACAAATCCCCACAGGAGCCGC 65 FBan0013484 FBgn0036406 CG13484 3 3L CG13484 CG13484 CDMC23796 4 17 8 DAC13-H22 2-CG13512-RA_1 CG13512 AGACCTCCCAGTACTGTCCCAACTGCAACTCCTGCTTGGGTTCGTTTTGAAGACGCAGCGAAAAC 65 FBan0013512 FBgn0034760 CG13512 2 2R CG13512 CG13512 BcDNA:GM16166 CDMC23796 4 18 8 DAC13-H22 2-CG13512-RA_1 CG13512 AGACCTCCCAGTACTGTCCCAACTGCAACTCCTGCTTGGGTTCGTTTTGAAGACGCAGCGAAAAC 65 FBan0013512 FBgn0034760 CG13512 2 2R CG13512 CG13512 BcDNA:GM16166 CDMC23797 4 19 8 DAC13-L10 3-CG13615-RA_2 CG13615 CCACAACCCGTGATTGTGCCTCTGAATCCCGCAGATCCCATACAGTCCTTCTACTTCGCCTACCC 65 FBan0013615 FBgn0039199 CG13615 3 3R CG13615 CG13615 CDMC23797 4 20 8 DAC13-L10 3-CG13615-RA_2 CG13615 CCACAACCCGTGATTGTGCCTCTGAATCCCGCAGATCCCATACAGTCCTTCTACTTCGCCTACCC 65 FBan0013615 FBgn0039199 CG13615 3 3R CG13615 CG13615 CDMC23798 4 21 8 DAC13-L22 17-CG13633-RA_1 CG13633 ACTTATATACTTGGGGCAATCTCTCTCAGAAAGAGCGACACGAGTGGCATTCGTTGTGGTCGTCG 65 FBan0013633 FBgn0015591 Ast 3 3R neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005179; ; GO:0005184; ; GO:0005179; ; GO:0005179 cellular component unknown; GO:0008372 Ast Allatostatin "CG13633, CG13633, CG13633, DAP, Drm-AST-1, Drm-AST-2, Drm-AST-3, Drm-AST-4, Drm-AST-A, AST-1, allatostatin-A-like, DAP-A, drostatin-A1, drostatin-A2, drostatin-A3, drostatin-A4, DST-1A, DST-2A, DST-3A, DST-4A, Drostatin-A2, AstA-1, BcDNA:RE16553" CDMC23798 4 22 8 DAC13-L22 17-CG13633-RA_1 CG13633 ACTTATATACTTGGGGCAATCTCTCTCAGAAAGAGCGACACGAGTGGCATTCGTTGTGGTCGTCG 65 FBan0013633 FBgn0015591 Ast 3 3R neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005179; ; GO:0005184; ; GO:0005179; ; GO:0005179 cellular component unknown; GO:0008372 Ast Allatostatin "CG13633, CG13633, CG13633, DAP, Drm-AST-1, Drm-AST-2, Drm-AST-3, Drm-AST-4, Drm-AST-A, AST-1, allatostatin-A-like, DAP-A, drostatin-A1, drostatin-A2, drostatin-A3, drostatin-A4, DST-1A, DST-2A, DST-3A, DST-4A, Drostatin-A2, AstA-1, BcDNA:RE16553" CDMC23799 4 23 8 DAC13-P10 18-CG13712-RA_1 CG13712 AGAGGAGAGAGCAATCCGTGAGCTATGCCCTCTACCTCCACCGTAGGGAGTTGGGTCGTCCCAGG 65 FBan0013712 FBgn0035570 CG13712 3 3L CG13712 CG13712 HL4 CDMC23799 4 24 8 DAC13-P10 18-CG13712-RA_1 CG13712 AGAGGAGAGAGCAATCCGTGAGCTATGCCCTCTACCTCCACCGTAGGGAGTTGGGTCGTCCCAGG 65 FBan0013712 FBgn0035570 CG13712 3 3L CG13712 CG13712 HL4 CDMC23800 4 25 8 DAC13-P22 AutoBlank AutoBlank CDMC23800 4 26 8 DAC13-P22 AutoBlank AutoBlank CDMC23801 4 1 9 DAC14-D10 17-CG16705-RA_2 CG16705 AGTGCGATCAAGCTGAAGATCACCGTCAACGTTTGGAACCTAACGAGTTGTCAGGAAAAGTACTCCAGC 69 FBan0016705 FBgn0039102 CG16705 3 3R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG16705 CG16705 "proPO-AE, CT37173, c-SP4, SP4" CDMC23801 4 2 9 DAC14-D10 17-CG16705-RA_2 CG16705 AGTGCGATCAAGCTGAAGATCACCGTCAACGTTTGGAACCTAACGAGTTGTCAGGAAAAGTACTCCAGC 69 FBan0016705 FBgn0039102 CG16705 3 3R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG16705 CG16705 "proPO-AE, CT37173, c-SP4, SP4" CDMC23802 4 3 9 DAC14-D22 3-CG16716-RB_1 CG16716 TGGACAGCCAGAACCATCAACGAAGCGGAAACTGACCAACTTCTTAGCTGGCGAAAGGAAAGAGCCAAT 69 FBan0016716 FBgn0034459 CG16716 2 2R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG16716 CG16716 anon-WO0140519.27 CDMC23802 4 4 9 DAC14-D22 3-CG16716-RB_1 CG16716 TGGACAGCCAGAACCATCAACGAAGCGGAAACTGACCAACTTCTTAGCTGGCGAAAGGAAAGAGCCAAT 69 FBan0016716 FBgn0034459 CG16716 2 2R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG16716 CG16716 anon-WO0140519.27 CDMC23803 4 5 9 DAC14-H10 22-CG16743-RA_1 CG16743 GGCTCGAGCGTTATTAATCATTCCCTTAAGGTCAACAAGGAATACAACGAGGACGGTCACCACCAATCT 69 FBan0016743 FBgn0032322 CG16743 2 2L CG16743 CG16743 BcDNA:RH23514 CDMC23803 4 6 9 DAC14-H10 22-CG16743-RA_1 CG16743 GGCTCGAGCGTTATTAATCATTCCCTTAAGGTCAACAAGGAATACAACGAGGACGGTCACCACCAATCT 69 FBan0016743 FBgn0032322 CG16743 2 2L CG16743 CG16743 BcDNA:RH23514 CDMC23804 4 7 9 DAC14-H22 8-CG16753-RA_1 CG16753 CCGACTGAGTGCCAACGAGAAGATCCGGAAAAAACGCACTGAAATGGTCAACACCGTCAAGTCCTTCGA 69 FBan0016753 FBgn0035393 CG16753 3 3L CG16753 CG16753 CDMC23804 4 8 9 DAC14-H22 8-CG16753-RA_1 CG16753 CCGACTGAGTGCCAACGAGAAGATCCGGAAAAAACGCACTGAAATGGTCAACACCGTCAAGTCCTTCGA 69 FBan0016753 FBgn0035393 CG16753 3 3L CG16753 CG16753 CDMC23805 4 9 9 DAC14-L10 22-CG16799-RA_2 CG16799 GGAGCACGAAAGTTACTTGGACACCACCAAAGTAACGAAAAAGGGAAACGAAAGCAAGAACTATGGCCT 69 FBan0016799 FBgn0034538 CG16799 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; defense response; GO:0006952; disaccharide metabolism; GO:0005984; induction of apoptosis; GO:0006917 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16799 CG16799 CDMC23805 4 10 9 DAC14-L10 22-CG16799-RA_2 CG16799 GGAGCACGAAAGTTACTTGGACACCACCAAAGTAACGAAAAAGGGAAACGAAAGCAAGAACTATGGCCT 69 FBan0016799 FBgn0034538 CG16799 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; defense response; GO:0006952; disaccharide metabolism; GO:0005984; induction of apoptosis; GO:0006917 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16799 CG16799 CDMC23806 4 11 9 DAC14-L22 6-CG16820-RA_3 CG16820 CGTCCGTTACTCTGTCCAGTGGCTCGAATGAGGTGACACCCTGTAGCTTGAACTCTCCGGACTTGAATG 69 FBan0016820 FBgn0032495 CG16820 2 2L CG16820 CG16820 CDMC23806 4 12 9 DAC14-L22 6-CG16820-RA_3 CG16820 CGTCCGTTACTCTGTCCAGTGGCTCGAATGAGGTGACACCCTGTAGCTTGAACTCTCCGGACTTGAATG 69 FBan0016820 FBgn0032495 CG16820 2 2L CG16820 CG16820 CDMC23807 4 13 9 DAC14-P10 3-CG16873-RA_2 CG16873 ACCTGGACCAGCCAACTTCCAAGATCCCAGAAATGTGGAGTTGCAGCCGAAACGACGAGAGTATCTCAT 69 FBan0016873 FBgn0028936 CG16873 2 2L CG16873 CG16873 BG:DS00180.9 CDMC23807 4 14 9 DAC14-P10 3-CG16873-RA_2 CG16873 ACCTGGACCAGCCAACTTCCAAGATCCCAGAAATGTGGAGTTGCAGCCGAAACGACGAGAGTATCTCAT 69 FBan0016873 FBgn0028936 CG16873 2 2L CG16873 CG16873 BG:DS00180.9 CDMC23808 4 15 9 DAC14-P22 1-CG16886-RA_1 CG16886 ATCCCAGGATACGAGGCTTCCCTGTACTGCTACGATTTGTGTTTGTGAACCTTGGATGGACGGAAGCGA 69 FBan0016886 FBgn0028938 CG16886 2 2L CG16886 CG16886 BG:DS00180.2 CDMC23808 4 16 9 DAC14-P22 1-CG16886-RA_1 CG16886 ATCCCAGGATACGAGGCTTCCCTGTACTGCTACGATTTGTGTTTGTGAACCTTGGATGGACGGAAGCGA 69 FBan0016886 FBgn0028938 CG16886 2 2L CG16886 CG16886 BG:DS00180.2 CDMC23809 4 17 9 DAC15-D10 23-CG18659-RA_5 CG18659 TCGGAACTCTCGCTAACTACGCATACTTACATACATATTGTACGCTGGACTTCCAAATCAAAAGACACA 69 FBan0018659 FBgn0027561 CG18659 2 2R proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG18659 CG18659 "CG30347, CG30348, CG8059, BcDNA:GH08789, anon-WO0118547.140, anon-WO0118547.145" CDMC23809 4 18 9 DAC15-D10 23-CG18659-RA_5 CG18659 TCGGAACTCTCGCTAACTACGCATACTTACATACATATTGTACGCTGGACTTCCAAATCAAAAGACACA 69 FBan0018659 FBgn0027561 CG18659 2 2R proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG18659 CG18659 "CG30347, CG30348, CG8059, BcDNA:GH08789, anon-WO0118547.140, anon-WO0118547.145" CDMC23810 4 19 9 DAC15-D22 3-CG18675-RA_2 CG18675 GAACCGTCCAAGGCTCAGTTCTGGTTTGCAGGACACCAGATGCTGATGGGGAAGCTAATGAGCGACTAT 69 FBan0018675 FBgn0040696 CG18675 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG18675 CG18675 CDMC23810 4 20 9 DAC15-D22 3-CG18675-RA_2 CG18675 GAACCGTCCAAGGCTCAGTTCTGGTTTGCAGGACACCAGATGCTGATGGGGAAGCTAATGAGCGACTAT 69 FBan0018675 FBgn0040696 CG18675 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG18675 CG18675 CDMC23811 4 21 9 DAC15-H10 6-CG18778-RA_1 CG18778 GCTGGTCAGCTCCAGATGGCAAAAAATACGAGATTAGTTTCACGGCCGACGAAACTGGCTACCATCCCA 69 FBan0018778 FBgn0042119 CG18778 3 3L CG18778 CG18778 BcDNA:GH21145 CDMC23811 4 22 9 DAC15-H10 6-CG18778-RA_1 CG18778 GCTGGTCAGCTCCAGATGGCAAAAAATACGAGATTAGTTTCACGGCCGACGAAACTGGCTACCATCCCA 69 FBan0018778 FBgn0042119 CG18778 3 3L CG18778 CG18778 BcDNA:GH21145 CDMC23812 4 23 9 DAC15-H22 3-CG1878-RA_1 CG1878 AGCCTGGGAAACTCAGAGGCTGGTTGGCTTAGGAAGCTGGGAAAAAAAATCGAACGCATTGGTCAGCAT 69 FBan0001878 FBgn0000278 CecB 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; autophagic cell death; GO:0048102; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832; salivary gland cell autophagic cell death; GO:0035071 extracellular region; GO:0005576 CecB Cecropin B "CG1878, CG1878, CG1878, Cecropin, cecropin, cecropin B, cec, cecB, Cec" CDMC23812 4 24 9 DAC15-H22 3-CG1878-RA_1 CG1878 AGCCTGGGAAACTCAGAGGCTGGTTGGCTTAGGAAGCTGGGAAAAAAAATCGAACGCATTGGTCAGCAT 69 FBan0001878 FBgn0000278 CecB 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; autophagic cell death; GO:0048102; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832; salivary gland cell autophagic cell death; GO:0035071 extracellular region; GO:0005576 CecB Cecropin B "CG1878, CG1878, CG1878, Cecropin, cecropin, cecropin B, cec, cecB, Cec" CDMC23813 4 25 9 DAC15-L10 2-CG1888-RA_1 CG1888 GCCGTTGCACATGGAACAGCCGTCAGAGCAGGAAGAATTGCACAAGCCTGAAGATCTGGTCAAGACAAT 69 FBan0001888 FBgn0033421 CG1888 2 2R CG1888 CG1888 CDMC23813 4 26 9 DAC15-L10 2-CG1888-RA_1 CG1888 GCCGTTGCACATGGAACAGCCGTCAGAGCAGGAAGAATTGCACAAGCCTGAAGATCTGGTCAAGACAAT 69 FBan0001888 FBgn0033421 CG1888 2 2R CG1888 CG1888 CDMC23814 4 1 10 DAC15-L22 13-CG1897-RA_1 CG1897 GCGGTCCTCGAGCGGAAACCCCCAAAATTTTGCTGTGATGTTAGCGCATTTTACGTTACGATACTTCCA 69 FBan0001897 FBgn0000492 Dr 3 3R "brain development; GO:0007420; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; muscle development; GO:0007517; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of cell fate specification; GO:0042659; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Dr Drop "CG1897, msh, 99B, Dr-distal, msh-1, Msh, muscle segment homeobox, muscle specific homeobox, Muscle specific homeobox, msh1: muscle-specific homeodomain 1, l(3)FA30, ltt, lottchen, muscle-specific homeodomain 1, msh1" CDMC23814 4 2 10 DAC15-L22 13-CG1897-RA_1 CG1897 GCGGTCCTCGAGCGGAAACCCCCAAAATTTTGCTGTGATGTTAGCGCATTTTACGTTACGATACTTCCA 69 FBan0001897 FBgn0000492 Dr 3 3R "brain development; GO:0007420; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; muscle development; GO:0007517; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of cell fate specification; GO:0042659; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Dr Drop "CG1897, msh, 99B, Dr-distal, msh-1, Msh, muscle segment homeobox, muscle specific homeobox, Muscle specific homeobox, msh1: muscle-specific homeodomain 1, l(3)FA30, ltt, lottchen, muscle-specific homeodomain 1, msh1" CDMC23815 4 3 10 DAC15-P10 22-CG1925-RA_1 CG1925 GGGAACTCCAGCAAATCGAGCACTGGAACAAACTCCTTGAACACCACTTCTAATGCCAATCAATACTCG 69 FBan0001925 FBgn0002891 mus205 2 2R DNA replication; GO:0006260; bypass DNA synthesis; GO:0019985 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zeta DNA polymerase activity; GO:0003894; ; GO:0003894; ; GO:0003894; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 zeta DNA polymerase complex; GO:0016035 mus205 mutagen-sensitive 205 "CG1925, CG1925, mus(2)205, mus-205, mus 205, DhRev3, DmREV3, AAF59191" CDMC23815 4 4 10 DAC15-P10 22-CG1925-RA_1 CG1925 GGGAACTCCAGCAAATCGAGCACTGGAACAAACTCCTTGAACACCACTTCTAATGCCAATCAATACTCG 69 FBan0001925 FBgn0002891 mus205 2 2R DNA replication; GO:0006260; bypass DNA synthesis; GO:0019985 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zeta DNA polymerase activity; GO:0003894; ; GO:0003894; ; GO:0003894; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 zeta DNA polymerase complex; GO:0016035 mus205 mutagen-sensitive 205 "CG1925, CG1925, mus(2)205, mus-205, mus 205, DhRev3, DmREV3, AAF59191" CDMC23816 4 5 10 DAC15-P22 16-CG1942-RA_1 CG1942 TGGTGCGTAGTCTGATGGTAACTTACTTGGCCTACGTCTTTGTGCACCACAAGAAAACCCAATCCGTTG 69 FBan0001942 FBgn0033215 CG1942 2 2R mesoderm development; GO:0007498 CG1942 CG1942 CDMC23816 4 6 10 DAC15-P22 16-CG1942-RA_1 CG1942 TGGTGCGTAGTCTGATGGTAACTTACTTGGCCTACGTCTTTGTGCACCACAAGAAAACCCAATCCGTTG 69 FBan0001942 FBgn0033215 CG1942 2 2R mesoderm development; GO:0007498 CG1942 CG1942 CDMC23817 4 7 10 DAC16-D10 23-CG32767-RA_1 CG32767 GGATGGGGAATCGGATACAATAAAGAAGGAGAAAAAGAATCCACATAACAAAAACTTCTATCAAAGCAT 69 FBan0032767 FBgn0052767 CG32767 X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32767 CG32767 "CG5086, CG5113, CG5086, CG5086, LD34931, i7, BcDNA:GM08530" CDMC23817 4 8 10 DAC16-D10 23-CG32767-RA_1 CG32767 GGATGGGGAATCGGATACAATAAAGAAGGAGAAAAAGAATCCACATAACAAAAACTTCTATCAAAGCAT 69 FBan0032767 FBgn0052767 CG32767 X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32767 CG32767 "CG5086, CG5113, CG5086, CG5086, LD34931, i7, BcDNA:GM08530" CDMC23818 4 9 10 DAC16-D22 9-CG3277-RB_1 CG3277 ACCTTCGACGCCCTGTACAAGGTGCTCAGTCCAAAGACTACCTACGTGGACATCAACAGTCTGAGTGAT 69 FBan0003277 FBgn0031518 CG3277 2 2L protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG3277 CG3277 CDMC23818 4 10 10 DAC16-D22 9-CG3277-RB_1 CG3277 ACCTTCGACGCCCTGTACAAGGTGCTCAGTCCAAAGACTACCTACGTGGACATCAACAGTCTGAGTGAT 69 FBan0003277 FBgn0031518 CG3277 2 2L protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG3277 CG3277 CDMC23819 4 11 10 DAC16-H10 1-CG32810-RB_1 CG32810 CGAAATCCGAGTCCCCCGGAATTTGTAGAGTCGCAGAGTTCTGCTCCGTAGTTCTGCTGCTTGCTGTAC 69 FBan0032810 FBgn0025394 CG32810 X X ion transport; GO:0006811; potassium ion transport; GO:0006813 ion channel activity; GO:0005216; voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005216; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG32810 CG32810 "CG14783, CG14784, CG14783, EG:196F3.2" CDMC23819 4 12 10 DAC16-H10 1-CG32810-RB_1 CG32810 CGAAATCCGAGTCCCCCGGAATTTGTAGAGTCGCAGAGTTCTGCTCCGTAGTTCTGCTGCTTGCTGTAC 69 FBan0032810 FBgn0025394 CG32810 X X ion transport; GO:0006811; potassium ion transport; GO:0006813 ion channel activity; GO:0005216; voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005216; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG32810 CG32810 "CG14783, CG14784, CG14783, EG:196F3.2" CDMC23820 4 13 10 DAC16-H22 23-CG32817-RA_2 CG32817 TGCAATTTGGAAATTTTAAGGGTTCTGATTGCACTTCTCGCTGACCTCAAACAAATCAAAGAAGACAAT 69 FBan0032817 FBgn0052817 CG32817 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32817 CG32817 CDMC23820 4 14 10 DAC16-H22 23-CG32817-RA_2 CG32817 TGCAATTTGGAAATTTTAAGGGTTCTGATTGCACTTCTCGCTGACCTCAAACAAATCAAAGAAGACAAT 69 FBan0032817 FBgn0052817 CG32817 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32817 CG32817 CDMC23821 4 15 10 DAC16-L10 11-CG32852-RA_1 CG32852 CGCACATCGAAAGTTCCAGGCATCCAAAGCCAAAACTGAGCTACAGCAAACCAAAGACAGATTCCTGGG 69 FBan0032852 FBgn0052852 CG32852 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32852 CG32852 CDMC23821 4 16 10 DAC16-L10 11-CG32852-RA_1 CG32852 CGCACATCGAAAGTTCCAGGCATCCAAAGCCAAAACTGAGCTACAGCAAACCAAAGACAGATTCCTGGG 69 FBan0032852 FBgn0052852 CG32852 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32852 CG32852 CDMC23822 4 17 10 DAC16-L22 2-CG3285-RA_3 CG3285 CGGTTGACTGGTTACCCCTTGTGATCTTGTCCTGCTTCGTATTCCTCTGCAACATCGGCTTGGTGGGAT 69 FBan0003285 FBgn0031522 CG3285 2 2L DNA methylation; GO:0006306; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 DNA binding; GO:0003677; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- integral to membrane; GO:0016021; membrane; GO:0016020 CG3285 CG3285 CDMC23822 4 18 10 DAC16-L22 2-CG3285-RA_3 CG3285 CGGTTGACTGGTTACCCCTTGTGATCTTGTCCTGCTTCGTATTCCTCTGCAACATCGGCTTGGTGGGAT 69 FBan0003285 FBgn0031522 CG3285 2 2L DNA methylation; GO:0006306; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 DNA binding; GO:0003677; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- integral to membrane; GO:0016021; membrane; GO:0016020 CG3285 CG3285 CDMC23823 4 19 10 DAC16-P10 18-CG32953-RA_1 CG32953 AGGGCATCGATGACTTGGTCAACGAGAAGGAGGAAATTGATACCAATGCAAAAAAAGGCCCCAAAAAGA 69 FBgn0052953 CDMC23823 4 20 10 DAC16-P10 18-CG32953-RA_1 CG32953 AGGGCATCGATGACTTGGTCAACGAGAAGGAGGAAATTGATACCAATGCAAAAAAAGGCCCCAAAAAGA 69 FBgn0052953 CDMC23824 4 21 10 DAC16-P22 23-CG3295-RA_4 CG3295 GCATCTACTTTTAAGCCACATCTATGTATTCACCTTATGATAATCACCACTGCTTATATGACCAGGCTC 69 FBan0003295 FBgn0034573 CG3295 2 2R CG3295 CG3295 CDMC23824 4 22 10 DAC16-P22 23-CG3295-RA_4 CG3295 GCATCTACTTTTAAGCCACATCTATGTATTCACCTTATGATAATCACCACTGCTTATATGACCAGGCTC 69 FBan0003295 FBgn0034573 CG3295 2 2R CG3295 CG3295 CDMC23825 4 23 10 DAC17-D10 3-CG1239-RA_1 CG1239 AGATCGGGGGCTAATAAATGATGCCCAAAAAACCGTCAGTCACCTGAAACGTCACGCAACCCCGG 65 FBan0001239 FBgn0037368 CG1239 3 3R methyltransferase activity; GO:0008168 ; EC:2.1.1.-; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004652 ; EC:2.7.7.19; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG1239 CG1239 cg1239 CDMC23825 4 24 10 DAC17-D10 3-CG1239-RA_1 CG1239 AGATCGGGGGCTAATAAATGATGCCCAAAAAACCGTCAGTCACCTGAAACGTCACGCAACCCCGG 65 FBan0001239 FBgn0037368 CG1239 3 3R methyltransferase activity; GO:0008168 ; EC:2.1.1.-; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004652 ; EC:2.7.7.19; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG1239 CG1239 cg1239 CDMC23826 4 25 10 DAC17-D22 23-CG12454-RA_1 CG12454 GACCGCATCTCAGATCGCGCGATAAGGTAATTGGACTATTATGTCAAAAAGTATTTGGCGTTTAA 65 FBan0012454 FBgn0040870 CG12454 X X CG12454 CG12454 CDMC23826 4 26 10 DAC17-D22 23-CG12454-RA_1 CG12454 GACCGCATCTCAGATCGCGCGATAAGGTAATTGGACTATTATGTCAAAAAGTATTTGGCGTTTAA 65 FBan0012454 FBgn0040870 CG12454 X X CG12454 CG12454 CDMC23827 4 1 11 DAC17-H10 2-CG12529-RA_1 CG12529 AGGAGATGGTGCAGAACCTGATGACCATACGCTTCGGCAACAAGATCCTCAGCTCGACGTGGAAC 65 FBan0012529 FBgn0004057 Zw X X pentose-phosphate shunt; GO:0006098 glucose-6-phosphate 1-dehydrogenase activity; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49 Zw Zwischenferment "CG12529, G6PD, glucose-6-phosphate dehydrogenase, Glucose-6-phosphate dehydrogenase, G6pd, G6PDH, G-6PD, G6-pd, G-6-pdh, g6pd, G-6pd, Glucose-6-phosphate DH, G-6-PD, glucose-6-phosphate 1dehydrogenase, G6pdh" CDMC23827 4 2 11 DAC17-H10 2-CG12529-RA_1 CG12529 AGGAGATGGTGCAGAACCTGATGACCATACGCTTCGGCAACAAGATCCTCAGCTCGACGTGGAAC 65 FBan0012529 FBgn0004057 Zw X X pentose-phosphate shunt; GO:0006098 glucose-6-phosphate 1-dehydrogenase activity; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49 Zw Zwischenferment "CG12529, G6PD, glucose-6-phosphate dehydrogenase, Glucose-6-phosphate dehydrogenase, G6pd, G6PDH, G-6PD, G6-pd, G-6-pdh, g6pd, G-6pd, Glucose-6-phosphate DH, G-6-PD, glucose-6-phosphate 1dehydrogenase, G6pdh" CDMC23828 4 3 11 DAC17-H22 24-CG12560-RA_1 CG12560 TTGTGAGAAGTTTAATTAAATATAATATTAATTTGGGTGCTTATGACGACAAGGGAAAGTTGGTT 65 FBan0012560 FBgn0031974 CG12560 2 2L CG12560 CG12560 CDMC23828 4 4 11 DAC17-H22 24-CG12560-RA_1 CG12560 TTGTGAGAAGTTTAATTAAATATAATATTAATTTGGGTGCTTATGACGACAAGGGAAAGTTGGTT 65 FBan0012560 FBgn0031974 CG12560 2 2L CG12560 CG12560 CDMC23829 4 5 11 DAC17-L10 3-CG12685-RA_1 CG12685 CTGCTGAATGTTGGACGTGGAAGCTACTGCTGGACGGATTGTCATGTGCTGTGTCTGCTCCTCTG 65 FBan0012685 FBgn0040910 CG12685 X X CG12685 CG12685 CDMC23829 4 6 11 DAC17-L10 3-CG12685-RA_1 CG12685 CTGCTGAATGTTGGACGTGGAAGCTACTGCTGGACGGATTGTCATGTGCTGTGTCTGCTCCTCTG 65 FBan0012685 FBgn0040910 CG12685 X X CG12685 CG12685 CDMC23830 4 7 11 DAC17-L22 6-CG12723-RA_2 CG12723 CGGCCATACCGCAGATACCCCAAATACCACAATTTCCCGGATTCCCTCAATTTCCCGGCTTTCCC 65 FBan0012723 FBgn0030459 CG12723 X X CG12723 CG12723 CDMC23830 4 8 11 DAC17-L22 6-CG12723-RA_2 CG12723 CGGCCATACCGCAGATACCCCAAATACCACAATTTCCCGGATTCCCTCAATTTCCCGGCTTTCCC 65 FBan0012723 FBgn0030459 CG12723 X X CG12723 CG12723 CDMC23831 4 9 11 DAC17-P10 2-CG12836-RA_1 CG12836 TACGAATCGGACGGCAAAGTCAGGGGTCCCATCGTGGAGGAAAGATGTTCGCAGATAACCGCATC 65 FBan0012836 FBgn0033140 CG12836 2 2R CG12836 CG12836 CDMC23831 4 10 11 DAC17-P10 2-CG12836-RA_1 CG12836 TACGAATCGGACGGCAAAGTCAGGGGTCCCATCGTGGAGGAAAGATGTTCGCAGATAACCGCATC 65 FBan0012836 FBgn0033140 CG12836 2 2R CG12836 CG12836 CDMC23832 4 11 11 DAC17-P22 AutoBlank AutoBlank CDMC23832 4 12 11 DAC17-P22 AutoBlank AutoBlank CDMC23833 4 13 11 DAC18-D10 12-CG6124-RA_2 CG6124 AGGAATGAGGACGACAACAATTTGATCTGTCTTCCGATTTGCGAACCCGAGTGCCTCAATGGGCTCT 67 FBan0006124 FBgn0039484 CG6124 3 3R cell communication; GO:0007154; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG6124 CG6124 "C901-like, CT19227" CDMC23833 4 14 11 DAC18-D10 12-CG6124-RA_2 CG6124 AGGAATGAGGACGACAACAATTTGATCTGTCTTCCGATTTGCGAACCCGAGTGCCTCAATGGGCTCT 67 FBan0006124 FBgn0039484 CG6124 3 3R cell communication; GO:0007154; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG6124 CG6124 "C901-like, CT19227" CDMC23834 4 15 11 DAC18-D22 3-CG6332-RA_3 CG6332 GGAAATCCACAGAATGACCATCCAAGGACTGAAGTGTGACCTCAGCCCGACGGTGACCACTTGTCTG 67 FBan0006332 FBgn0038921 CG6332 3 3R CG6332 CG6332 anon-WO0140519.231 CDMC23834 4 16 11 DAC18-D22 3-CG6332-RA_3 CG6332 GGAAATCCACAGAATGACCATCCAAGGACTGAAGTGTGACCTCAGCCCGACGGTGACCACTTGTCTG 67 FBan0006332 FBgn0038921 CG6332 3 3R CG6332 CG6332 anon-WO0140519.231 CDMC23835 4 17 11 DAC18-H10 2-CG6743-RA_1 CG6743 CGGCGAGATCTCTGCAATCGATCAGCGCAAGATCTCAGCATTGGAGTGGCTAATCCATTTGCCGGAG 67 FBan0006743 FBgn0027868 Nup170 2 2L protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 Nup170 Nup170 "CG6743, CG6743, BcDNA:LD18761" CDMC23835 4 18 11 DAC18-H10 2-CG6743-RA_1 CG6743 CGGCGAGATCTCTGCAATCGATCAGCGCAAGATCTCAGCATTGGAGTGGCTAATCCATTTGCCGGAG 67 FBan0006743 FBgn0027868 Nup170 2 2L protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 Nup170 Nup170 "CG6743, CG6743, BcDNA:LD18761" CDMC23836 4 19 11 DAC18-H22 2-CG6995-RA_3 CG6995 AGCAAGCGATTGGATTACTCCAGCAAGCGTAACGACTACAGCAGTTCTTCTGGATCCAAGCGTGGCG 67 FBan0006995 FBgn0039229 CG6995 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677 nucleus; GO:0005634 CG6995 CG6995 "cg6995, SAF-B, LD22822" CDMC23836 4 20 11 DAC18-H22 2-CG6995-RA_3 CG6995 AGCAAGCGATTGGATTACTCCAGCAAGCGTAACGACTACAGCAGTTCTTCTGGATCCAAGCGTGGCG 67 FBan0006995 FBgn0039229 CG6995 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677 nucleus; GO:0005634 CG6995 CG6995 "cg6995, SAF-B, LD22822" CDMC23837 4 21 11 DAC18-L10 2-CG7549-RA_2 CG7549 AAAGTGCAACTGGTGGTTCTACGTCGACTGCAGCTCTAGCACGAGCGTCTACGACTCCAACATTCCC 67 FBan0007549 FBgn0037559 CG7549 3 3R CG7549 CG7549 CDMC23837 4 22 11 DAC18-L10 2-CG7549-RA_2 CG7549 AAAGTGCAACTGGTGGTTCTACGTCGACTGCAGCTCTAGCACGAGCGTCTACGACTCCAACATTCCC 67 FBan0007549 FBgn0037559 CG7549 3 3R CG7549 CG7549 CDMC23838 4 23 11 DAC18-L22 15-CG7729-RA_1 CG7729 GGCATGGCGTTCGTTACCTGACTTTGGAGTAAGCCTGTTCATCATTAAGTTCGACGGGCATCGGAAG 67 FBan0007729 FBgn0036688 Fit2 3 3L cytoskeleton; GO:0005856 Fit2 Fermitin 2 "CG7729, CG7729, Fermitin 2" CDMC23838 4 24 11 DAC18-L22 15-CG7729-RA_1 CG7729 GGCATGGCGTTCGTTACCTGACTTTGGAGTAAGCCTGTTCATCATTAAGTTCGACGGGCATCGGAAG 67 FBan0007729 FBgn0036688 Fit2 3 3L cytoskeleton; GO:0005856 Fit2 Fermitin 2 "CG7729, CG7729, Fermitin 2" CDMC23839 4 25 11 DAC18-P10 3-CG8070-RA_1 CG8070 AGGAGGCTGCACAGGAACTGGCTCTTACTCGCATATTCACGGACGAAGATTTCAAGCGCATCAACGC 67 FBan0008070 FBgn0033379 Mys45A 2 2R Mys45A Mystery 45A "CG8070, anon-WO0118547.170" CDMC23839 4 26 11 DAC18-P10 3-CG8070-RA_1 CG8070 AGGAGGCTGCACAGGAACTGGCTCTTACTCGCATATTCACGGACGAAGATTTCAAGCGCATCAACGC 67 FBan0008070 FBgn0033379 Mys45A 2 2R Mys45A Mystery 45A "CG8070, anon-WO0118547.170" CDMC23840 4 1 12 DAC18-P22 AutoBlank AutoBlank CDMC23840 4 2 12 DAC18-P22 AutoBlank AutoBlank CDMC23841 4 3 12 DAC19-D10 14-CG8188-RA_1 CG8188 GGCATCAAGGTGCTAATCAATGAGAGCGATGTGACGGATATTCAGGCATTGATCGATGGACCTGCTGG 68 FBan0008188 FBgn0030863 CG8188 X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG8188 CG8188 Ubc CDMC23841 4 4 12 DAC19-D10 14-CG8188-RA_1 CG8188 GGCATCAAGGTGCTAATCAATGAGAGCGATGTGACGGATATTCAGGCATTGATCGATGGACCTGCTGG 68 FBan0008188 FBgn0030863 CG8188 X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG8188 CG8188 Ubc CDMC23842 4 5 12 DAC19-D22 5-CG8411-RA_1 CG8411 GGCTTCAACTTTGGCATGGATCTCATCCTGATCATGGACTCGCGTAGACTGAACATTCGTCGGCACCA 68 FBan0008411 FBgn0005695 gcl 2 2R "germ cell development; GO:0007281; negative regulation of transcription from RNA polymerase III promoter; GO:0016480; negative regulation of transcription, DNA-dependent; GO:0045892; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113" protein binding; GO:0005515; ; GO:0005515 nuclear pore; GO:0005643; nucleus; GO:0005634; pole plasm; GO:0045495 gcl germ cell-less "CG8411, gcl-1, GCL" CDMC23842 4 6 12 DAC19-D22 5-CG8411-RA_1 CG8411 GGCTTCAACTTTGGCATGGATCTCATCCTGATCATGGACTCGCGTAGACTGAACATTCGTCGGCACCA 68 FBan0008411 FBgn0005695 gcl 2 2R "germ cell development; GO:0007281; negative regulation of transcription from RNA polymerase III promoter; GO:0016480; negative regulation of transcription, DNA-dependent; GO:0045892; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113" protein binding; GO:0005515; ; GO:0005515 nuclear pore; GO:0005643; nucleus; GO:0005634; pole plasm; GO:0045495 gcl germ cell-less "CG8411, gcl-1, GCL" CDMC23843 4 7 12 DAC19-H10 1-CG8863-RA_1 CG8863 GCGCTTGCAAGTGCCGAAGAACTCCCAAAAGCACCTTAAAACACCATCCAATTCACACTAGGAGGCCC 68 FBan0008863 FBgn0038145 CG8863 3 3R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG8863 CG8863 anon-WO0118547.404 CDMC23843 4 8 12 DAC19-H10 1-CG8863-RA_1 CG8863 GCGCTTGCAAGTGCCGAAGAACTCCCAAAAGCACCTTAAAACACCATCCAATTCACACTAGGAGGCCC 68 FBan0008863 FBgn0038145 CG8863 3 3R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG8863 CG8863 anon-WO0118547.404 CDMC23844 4 9 12 DAC19-H22 2-CG8987-RA_1 CG8987 CATTGCCCGCATGATGTCCTACTGGCGCAACAATAGGGATCGAATTATGGGTCAGATGGTGGTCTGGC 68 FBan0008987 FBgn0004406 tam 2 2L DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261; cell cycle; GO:0007049; determination of adult life span; GO:0008340; eclosion; GO:0007562; mitochondrial DNA replication; GO:0006264 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; gamma DNA-directed DNA polymerase activity; GO:0003895; ; GO:0003895; ; GO:0003895; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0003895; ; GO:0008296; ; GO:0003895; ; GO:0003677 gamma DNA polymerase complex; GO:0005760; mitochondrion; GO:0005739 tam tamas "CG8987, l(2)br14, l(2)br5, lethal 14 in the black-reduced region, lethal 5 in the black-reduced region, br5, DNApol-gamma125, l(2)34Dc, DNA polymerase gamma, 34Dc, cDNA 2, DNApol-gamma, l(2)brS, Polgamma, alpha subunit, polgamma, BG:DS00941.6, catalytic(alpha)subunit, anon-34Dc, MtPolA, DNA polymerase gamma, pol gamma-alpha, polgamma-alpha, mtDNA pol, AAC47658, mtDNA polymerase alpha, mitochondrial gamma polymerase, DNA polymerase gamma 125kD, lethal(2)34Dc, tamas" CDMC23844 4 10 12 DAC19-H22 2-CG8987-RA_1 CG8987 CATTGCCCGCATGATGTCCTACTGGCGCAACAATAGGGATCGAATTATGGGTCAGATGGTGGTCTGGC 68 FBan0008987 FBgn0004406 tam 2 2L DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261; cell cycle; GO:0007049; determination of adult life span; GO:0008340; eclosion; GO:0007562; mitochondrial DNA replication; GO:0006264 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; gamma DNA-directed DNA polymerase activity; GO:0003895; ; GO:0003895; ; GO:0003895; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0003895; ; GO:0008296; ; GO:0003895; ; GO:0003677 gamma DNA polymerase complex; GO:0005760; mitochondrion; GO:0005739 tam tamas "CG8987, l(2)br14, l(2)br5, lethal 14 in the black-reduced region, lethal 5 in the black-reduced region, br5, DNApol-gamma125, l(2)34Dc, DNA polymerase gamma, 34Dc, cDNA 2, DNApol-gamma, l(2)brS, Polgamma, alpha subunit, polgamma, BG:DS00941.6, catalytic(alpha)subunit, anon-34Dc, MtPolA, DNA polymerase gamma, pol gamma-alpha, polgamma-alpha, mtDNA pol, AAC47658, mtDNA polymerase alpha, mitochondrial gamma polymerase, DNA polymerase gamma 125kD, lethal(2)34Dc, tamas" CDMC23845 4 11 12 DAC19-L10 9-CG9426-RA_2 CG9426 ACGCTACAGCTTCGACGAGGATAAGTGGACTACAGTGTGTGCATTAAACGTGCCCAGAGCCATTCCTG 68 FBan0009426 FBgn0032485 CG9426 2 2L cytoplasmic sequestering of transcription factor; GO:0042994 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737 CG9426 CG9426 CDMC23845 4 12 12 DAC19-L10 9-CG9426-RA_2 CG9426 ACGCTACAGCTTCGACGAGGATAAGTGGACTACAGTGTGTGCATTAAACGTGCCCAGAGCCATTCCTG 68 FBan0009426 FBgn0032485 CG9426 2 2L cytoplasmic sequestering of transcription factor; GO:0042994 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737 CG9426 CG9426 CDMC23846 4 13 12 DAC19-L22 1-CG9569-RA_1 CG9569 CGCCGTGGTCGTGATGCCATTTGCTGTCTACTTTCTGGAGCCAGTGGAGCCCACAACATGTATAATGG 68 FBgn0031084 CDMC23846 4 14 12 DAC19-L22 1-CG9569-RA_1 CG9569 CGCCGTGGTCGTGATGCCATTTGCTGTCTACTTTCTGGAGCCAGTGGAGCCCACAACATGTATAATGG 68 FBgn0031084 CDMC23847 4 15 12 DAC19-P10 17-CR31625-RA_2 CR31625 CCGTAACCAATGAAGTCCTCCTGAGGTGCGGTTATTGCTAGTTGAAAACTTTAACCAATACCCCGCCA 68 FBan0031625 FBgn0003930 snRNA:U4:39B 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U4; GO:0005687 snRNA:U4:39B small nuclear RNA U4 at 39B "dU4, U4-2, U4, l(2)k09410, K3, U4 small nuclear RNA, U4-39B, snRNA:U4, U4snRNA, CR31625, U4snRNA39B, small nuclear RNA U4" CDMC23847 4 16 12 DAC19-P10 17-CR31625-RA_2 CR31625 CCGTAACCAATGAAGTCCTCCTGAGGTGCGGTTATTGCTAGTTGAAAACTTTAACCAATACCCCGCCA 68 FBan0031625 FBgn0003930 snRNA:U4:39B 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U4; GO:0005687 snRNA:U4:39B small nuclear RNA U4 at 39B "dU4, U4-2, U4, l(2)k09410, K3, U4 small nuclear RNA, U4-39B, snRNA:U4, U4snRNA, CR31625, U4snRNA39B, small nuclear RNA U4" CDMC23848 4 17 12 DAC19-P22 AutoBlank AutoBlank CDMC23848 4 18 12 DAC19-P22 AutoBlank AutoBlank CDMC23849 4 19 12 DAC20-D10 23-CG18087-RA_1 CG18087 TGCGGAGAACCACAATGGATGATTTAGACACCAATCACTTTTAAAGATCACAAAAATTCTTCCTTAATA 69 FBan0018087 FBgn0003377 Sgs7 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs7 Salivary gland secretion 7 "CG18087, 68C GIII, Gene III, group III, sgs-7, Sgs-7, sgs7" CDMC23849 4 20 12 DAC20-D10 23-CG18087-RA_1 CG18087 TGCGGAGAACCACAATGGATGATTTAGACACCAATCACTTTTAAAGATCACAAAAATTCTTCCTTAATA 69 FBan0018087 FBgn0003377 Sgs7 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs7 Salivary gland secretion 7 "CG18087, 68C GIII, Gene III, group III, sgs-7, Sgs-7, sgs7" CDMC23850 4 21 12 DAC20-D22 13-CG18102-RB_1 CG18102 ACGAAGACCACCCGTGACATGGTGCCCAAAGCAATTATGATGCTGATCATCAACAATGCCAAGGACTTT 69 FBan0018102 FBgn0003392 shi X X cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; memory; GO:0007613; microtubule-based process; GO:0007017; pole cell formation; GO:0007279; receptor mediated endocytosis; GO:0006898; synaptic vesicle budding; GO:0016185; synaptic vesicle endocytosis; GO:0048488; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; GTP binding; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003777; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 microtubule associated complex; GO:0005875; plasma membrane; GO:0005886; synapse; GO:0045202 shi shibire "CG18102, CG18102, l(1)shi, Ddyn, dynamin, Ddyn3, Ddyn4, Dynamin, shibiri, Shibire, Shi, Dyn, anon-WO0153538.12, anon-WO0153538.13, anon-WO0153538.14, l(1)VII, shibire" CDMC23850 4 22 12 DAC20-D22 13-CG18102-RB_1 CG18102 ACGAAGACCACCCGTGACATGGTGCCCAAAGCAATTATGATGCTGATCATCAACAATGCCAAGGACTTT 69 FBan0018102 FBgn0003392 shi X X cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; memory; GO:0007613; microtubule-based process; GO:0007017; pole cell formation; GO:0007279; receptor mediated endocytosis; GO:0006898; synaptic vesicle budding; GO:0016185; synaptic vesicle endocytosis; GO:0048488; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; GTP binding; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003777; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 microtubule associated complex; GO:0005875; plasma membrane; GO:0005886; synapse; GO:0045202 shi shibire "CG18102, CG18102, l(1)shi, Ddyn, dynamin, Ddyn3, Ddyn4, Dynamin, shibiri, Shibire, Shi, Dyn, anon-WO0153538.12, anon-WO0153538.13, anon-WO0153538.14, l(1)VII, shibire" CDMC23851 4 23 12 DAC20-H10 23-CG18156-RA_1 CG18156 GCGAACATATTGTGCAGGACATAATTAAGAAGGGTATTGGTCAGATCATCGACAAGATCAAGACACCCG 69 FBan0018156 FBgn0035725 CG18156 3 3L CG18156 CG18156 BcDNA:RE19545 CDMC23851 4 24 12 DAC20-H10 23-CG18156-RA_1 CG18156 GCGAACATATTGTGCAGGACATAATTAAGAAGGGTATTGGTCAGATCATCGACAAGATCAAGACACCCG 69 FBan0018156 FBgn0035725 CG18156 3 3L CG18156 CG18156 BcDNA:RE19545 CDMC23852 4 25 12 DAC20-H22 6-CG18178-RA_4 CG18178 AGCGTGCTACTAAGAAGGTCCTCACCAAGGGTAACTTCACCTCGTCCGTGGTCATTACCAATCTGCCAA 69 FBan0018178 FBgn0036035 CG18178 3 3L CG18178 CG18178 CDMC23852 4 26 12 DAC20-H22 6-CG18178-RA_4 CG18178 AGCGTGCTACTAAGAAGGTCCTCACCAAGGGTAACTTCACCTCGTCCGTGGTCATTACCAATCTGCCAA 69 FBan0018178 FBgn0036035 CG18178 3 3L CG18178 CG18178 CDMC23853 4 1 13 DAC20-L10 2-CG18231-RA_1 CG18231 TGCTTTGGGAGAGCACAAATTTAAAAGGGAGGACTACCAACGGGCTTCTATGTGGTTTCGCGTGGCCAT 69 FBan0018231 FBgn0036796 CG18231 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18231 CG18231 CDMC23853 4 2 13 DAC20-L10 2-CG18231-RA_1 CG18231 TGCTTTGGGAGAGCACAAATTTAAAAGGGAGGACTACCAACGGGCTTCTATGTGGTTTCGCGTGGCCAT 69 FBan0018231 FBgn0036796 CG18231 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18231 CG18231 CDMC23854 4 3 13 DAC20-L22 16-CG18250-RC_1 CG18250 AATCTGTTTGCCATTCGATTGGCTTCAATTGAGCGAGCTGTACCCTCCACAAATACACAGGCAAATCAA 69 FBan0018250 FBgn0034072 Dg 2 2R cytoskeletal anchoring; GO:0007016; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; oocyte anterior/posterior axis determination; GO:0007314 structural constituent of muscle; GO:0008307; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005509; ; GO:0008307; ; GO:0005515 dystroglycan complex; GO:0016011 Dg Dystroglycan "CG18250, CG18250, CG18250, CG18250, CG18250, CG18250, DmDG, CT41273, dgn, dys, dg, dystroglycan-like, DG" CDMC23854 4 4 13 DAC20-L22 16-CG18250-RC_1 CG18250 AATCTGTTTGCCATTCGATTGGCTTCAATTGAGCGAGCTGTACCCTCCACAAATACACAGGCAAATCAA 69 FBan0018250 FBgn0034072 Dg 2 2R cytoskeletal anchoring; GO:0007016; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; oocyte anterior/posterior axis determination; GO:0007314 structural constituent of muscle; GO:0008307; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005509; ; GO:0008307; ; GO:0005515 dystroglycan complex; GO:0016011 Dg Dystroglycan "CG18250, CG18250, CG18250, CG18250, CG18250, CG18250, DmDG, CT41273, dgn, dys, dg, dystroglycan-like, DG" CDMC23855 4 5 13 DAC20-P10 23-CG18285-RA_7 CG18285 AAAAGACAAATGCAAGGAAACTGCTGAACAAATTTTTGGGAAATCATTTCCATTTTGTCGGGCCAATGC 69 FBan0018285 FBgn0013467 igl 2 2R calmodulin binding; GO:0005516; ; GO:0005516 igl igloo "CG18285, invertebrate GAP-43-like, igloo" CDMC23855 4 6 13 DAC20-P10 23-CG18285-RA_7 CG18285 AAAAGACAAATGCAAGGAAACTGCTGAACAAATTTTTGGGAAATCATTTCCATTTTGTCGGGCCAATGC 69 FBan0018285 FBgn0013467 igl 2 2R calmodulin binding; GO:0005516; ; GO:0005516 igl igloo "CG18285, invertebrate GAP-43-like, igloo" CDMC23856 4 7 13 DAC20-P22 12-CG18302-RA_1 CG18302 GGCTTCCTGCTTAGCGATATGGGATACGATGTTTGGTTGCTAAACACGCGGGGAAATAGGTATTCCCGG 69 FBan0018302 FBgn0032266 CG18302 2 2L lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18302 CG18302 CDMC23856 4 8 13 DAC20-P22 12-CG18302-RA_1 CG18302 GGCTTCCTGCTTAGCGATATGGGATACGATGTTTGGTTGCTAAACACGCGGGGAAATAGGTATTCCCGG 69 FBan0018302 FBgn0032266 CG18302 2 2L lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18302 CG18302 CDMC23857 4 9 13 DAC21-D10 14-CG3926-RA_1 CG3926 ACCGAGAGAGACAGCCCATAAAAACCAACTCCCATCACCAAACAGTAGTAACACCCATTCTACCTGGCA 69 FBan0003926 FBgn0014031 Spat X X carbohydrate metabolism; GO:0005975; defense response; GO:0006952; response to toxin; GO:0009636 alanine-glyoxylate transaminase activity; GO:0008453 ; EC:2.6.1.44; serine-pyruvate transaminase activity; GO:0004760 ; EC:2.6.1.51; ; GO:0008453 ; EC:2.6.1.44; ; GO:0004760 ; EC:2.6.1.51; ; GO:0008453 ; EC:2.6.1.44; ; GO:0004760 ; EC:2.6.1.51 mitochondrial matrix; GO:0005759; peroxisome; GO:0005777 Spat Serine pyruvate aminotransferase "CG3926, spa, serine pyruvate aminotransferase, Dm-Spat" CDMC23857 4 10 13 DAC21-D10 14-CG3926-RA_1 CG3926 ACCGAGAGAGACAGCCCATAAAAACCAACTCCCATCACCAAACAGTAGTAACACCCATTCTACCTGGCA 69 FBan0003926 FBgn0014031 Spat X X carbohydrate metabolism; GO:0005975; defense response; GO:0006952; response to toxin; GO:0009636 alanine-glyoxylate transaminase activity; GO:0008453 ; EC:2.6.1.44; serine-pyruvate transaminase activity; GO:0004760 ; EC:2.6.1.51; ; GO:0008453 ; EC:2.6.1.44; ; GO:0004760 ; EC:2.6.1.51; ; GO:0008453 ; EC:2.6.1.44; ; GO:0004760 ; EC:2.6.1.51 mitochondrial matrix; GO:0005759; peroxisome; GO:0005777 Spat Serine pyruvate aminotransferase "CG3926, spa, serine pyruvate aminotransferase, Dm-Spat" CDMC23858 4 11 13 DAC21-D22 3-CG3937-RC_3 CG3937 CGAGATGTACTCGGTGCGATTCTATCCACGCGAGAACGGAATCCATGCCATCCACGTCAAGTTCAACGG 69 FBan0003937 FBgn0014141 cher 3 3R "cytoskeleton organization and biogenesis; GO:0007010; determination of adult life span; GO:0008340; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; learning and/or memory; GO:0007611; muscle contraction; GO:0006936; olfactory learning; GO:0008355; ovarian ring canal formation; GO:0007301; protein localization; GO:0008104; ring canal formation; GO:0030725; ring canal formation, actin assembly; GO:0008302" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 ring canal inner rim; GO:0035183; ring canal outer rim; GO:0035182 cher cheerio "CG3937, CG3937, sko, shi kong, Filamin, filamin, filamin B, Filamin-1, Filamin-A, filamin-240, FLN, Cheerio" CDMC23858 4 12 13 DAC21-D22 3-CG3937-RC_3 CG3937 CGAGATGTACTCGGTGCGATTCTATCCACGCGAGAACGGAATCCATGCCATCCACGTCAAGTTCAACGG 69 FBan0003937 FBgn0014141 cher 3 3R "cytoskeleton organization and biogenesis; GO:0007010; determination of adult life span; GO:0008340; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; learning and/or memory; GO:0007611; muscle contraction; GO:0006936; olfactory learning; GO:0008355; ovarian ring canal formation; GO:0007301; protein localization; GO:0008104; ring canal formation; GO:0030725; ring canal formation, actin assembly; GO:0008302" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 ring canal inner rim; GO:0035183; ring canal outer rim; GO:0035182 cher cheerio "CG3937, CG3937, sko, shi kong, Filamin, filamin, filamin B, Filamin-1, Filamin-A, filamin-240, FLN, Cheerio" CDMC23859 4 13 13 DAC21-H10 2-CG3971-RB_1 CG3971 GGTGGCACACGACCGGTCGGATGAGAGTTTAATTTTGTAAGCCAAAAGTTGTACCGTGTGGACAGGCGT 69 FBan0003971 FBgn0036650 Baldspot 3 3L integral to membrane; GO:0016021 Baldspot Baldspot "CG3971, CG3971, CG3971, l(3)neo21, l(3)02281, l(3)neo22, noa, blp, baldspot, NEST:bs18f10, NEST:bs18g10" CDMC23859 4 14 13 DAC21-H10 2-CG3971-RB_1 CG3971 GGTGGCACACGACCGGTCGGATGAGAGTTTAATTTTGTAAGCCAAAAGTTGTACCGTGTGGACAGGCGT 69 FBan0003971 FBgn0036650 Baldspot 3 3L integral to membrane; GO:0016021 Baldspot Baldspot "CG3971, CG3971, CG3971, l(3)neo21, l(3)02281, l(3)neo22, noa, blp, baldspot, NEST:bs18f10, NEST:bs18g10" CDMC23860 4 15 13 DAC21-H22 18-CG3981-RB_1 CG3981 CGGAGTGCTTTTCCCGGCCGATTCGACCGACAGAACAAAATATGCAACAAAACATACATGCAATACACA 69 FBan0003981 FBgn0040395 Unc-76 X X axon cargo transport; GO:0008088; transmission of nerve impulse; GO:0019226 kinesin binding; GO:0019894; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0019894 microtubule; GO:0005874; microtubule cytoskeleton; GO:0015630 Unc-76 Unc-76 "CG3981, CG18851, CG3981, CG3981, CG3981, l(1)G0066, l(1)G0360, l(1)G0310, l(1)G0158, l(1)G0333, Dunc-76, EG:67A9.1, BcDNA:GH10260" CDMC23860 4 16 13 DAC21-H22 18-CG3981-RB_1 CG3981 CGGAGTGCTTTTCCCGGCCGATTCGACCGACAGAACAAAATATGCAACAAAACATACATGCAATACACA 69 FBan0003981 FBgn0040395 Unc-76 X X axon cargo transport; GO:0008088; transmission of nerve impulse; GO:0019226 kinesin binding; GO:0019894; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0019894 microtubule; GO:0005874; microtubule cytoskeleton; GO:0015630 Unc-76 Unc-76 "CG3981, CG18851, CG3981, CG3981, CG3981, l(1)G0066, l(1)G0360, l(1)G0310, l(1)G0158, l(1)G0333, Dunc-76, EG:67A9.1, BcDNA:GH10260" CDMC23861 4 17 13 DAC21-L10 12-CG40053-RA_2 CG40053 GGCATCAAACCAGTGGCGAAAATTGTGATGAGGGTGTGCGATATCAGCGGTCGATCGATAGGAAATGGA 69 FBgn0058053 CG40053 CG40053 CG40053 BcDNA:AT11374 CDMC23861 4 18 13 DAC21-L10 12-CG40053-RA_2 CG40053 GGCATCAAACCAGTGGCGAAAATTGTGATGAGGGTGTGCGATATCAGCGGTCGATCGATAGGAAATGGA 69 FBgn0058053 CG40053 CG40053 CG40053 BcDNA:AT11374 CDMC23862 4 19 13 DAC21-L22 22-CG40080-RA_1 CG40080 CCGGAACTTTTTGGAGACAATCAACTTTTTGCAGTCCTAGAACTGAAGTTTGCCGGAAGTGACATGGCA 69 CDMC23862 4 20 13 DAC21-L22 22-CG40080-RA_1 CG40080 CCGGAACTTTTTGGAGACAATCAACTTTTTGCAGTCCTAGAACTGAAGTTTGCCGGAAGTGACATGGCA 69 CDMC23863 4 21 13 DAC21-P10 24-CG40127-RA_1 CG40127 AGTTTCCCAACTACTTAAAACTAGTATTGAAATTTTCCCTTCGATATATTTGTTAGAGGTGTTTTCCTT 69 FBgn0058127 CG40127 CG40127 CG40127 "GM16138, BcDNA:GM16138, anon-EST:Posey156" CDMC23863 4 22 13 DAC21-P10 24-CG40127-RA_1 CG40127 AGTTTCCCAACTACTTAAAACTAGTATTGAAATTTTCCCTTCGATATATTTGTTAGAGGTGTTTTCCTT 69 FBgn0058127 CG40127 CG40127 CG40127 "GM16138, BcDNA:GM16138, anon-EST:Posey156" CDMC23864 4 23 13 DAC21-P22 22-CG40139-RA_1 CG40139 TCTACGCTGGCGTGCTCAGGATTTTCAGATCCCGAACTATATAAACTGCCTTCAGCAATAACCGTTTCG 69 FBgn0058139 CG40139 CG40139 CG40139 CDMC23864 4 24 13 DAC21-P22 22-CG40139-RA_1 CG40139 TCTACGCTGGCGTGCTCAGGATTTTCAGATCCCGAACTATATAAACTGCCTTCAGCAATAACCGTTTCG 69 FBgn0058139 CG40139 CG40139 CG40139 CDMC23865 4 25 13 DAC22-D10 9-CG13801-RA_1 CG13801 CACTGGTTGGGCTCTCAGGTGGTGTCTGTGATCCTCCGAGTGGACGAATCATACCAGACCATGGT 65 FBan0013801 FBgn0035332 CG13801 3 3L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021 CG13801 CG13801 CDMC23865 4 26 13 DAC22-D10 9-CG13801-RA_1 CG13801 CACTGGTTGGGCTCTCAGGTGGTGTCTGTGATCCTCCGAGTGGACGAATCATACCAGACCATGGT 65 FBan0013801 FBgn0035332 CG13801 3 3L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021 CG13801 CG13801 CDMC23866 4 1 14 DAC22-D22 11-CG13810-RA_2 CG13810 CTTCAGCTTCGTGGGATTGAGTGTGCAGTACTTGGCCGGATTTAGTTACGTGAGCCTGCGTTGTG 65 FBan0013810 FBgn0035313 CG13810 3 3L CG13810 CG13810 CDMC23866 4 2 14 DAC22-D22 11-CG13810-RA_2 CG13810 CTTCAGCTTCGTGGGATTGAGTGTGCAGTACTTGGCCGGATTTAGTTACGTGAGCCTGCGTTGTG 65 FBan0013810 FBgn0035313 CG13810 3 3L CG13810 CG13810 CDMC23867 4 3 14 DAC22-H10 3-CG1389-RA_3 CG1389 AAACATCGGTGGGAGTTACATTCCCAAAACCGCTGAAGCTCCAAAGGATCGGCCAAAACGGAAGC 65 FBan0001389 FBgn0003733 tor 2 2R "Malpighian tubule morphogenesis; GO:0007443; cell fate determination; GO:0001709; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; eggshell pattern formation (sensu Insecta); GO:0030381; gastrulation; GO:0007369; nervous system development; GO:0007399; pole cell migration; GO:0007280; protein amino acid phosphorylation; GO:0006468; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 tor torso "CG1389, CG1389, splc: spliced, Tor, spliced, splc, torso" CDMC23867 4 4 14 DAC22-H10 3-CG1389-RA_3 CG1389 AAACATCGGTGGGAGTTACATTCCCAAAACCGCTGAAGCTCCAAAGGATCGGCCAAAACGGAAGC 65 FBan0001389 FBgn0003733 tor 2 2R "Malpighian tubule morphogenesis; GO:0007443; cell fate determination; GO:0001709; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; eggshell pattern formation (sensu Insecta); GO:0030381; gastrulation; GO:0007369; nervous system development; GO:0007399; pole cell migration; GO:0007280; protein amino acid phosphorylation; GO:0006468; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 tor torso "CG1389, CG1389, splc: spliced, Tor, spliced, splc, torso" CDMC23868 4 5 14 DAC22-H22 3-CG13926-RA_1 CG13926 AATGTGCCCGACATAGAATCCGTCAACTACCTGGTAGTATTCCTCACCGGCGTATCACCCCTGCC 65 FBan0013926 FBgn0035243 CG13926 3 3L CG13926 CG13926 CDMC23868 4 6 14 DAC22-H22 3-CG13926-RA_1 CG13926 AATGTGCCCGACATAGAATCCGTCAACTACCTGGTAGTATTCCTCACCGGCGTATCACCCCTGCC 65 FBan0013926 FBgn0035243 CG13926 3 3L CG13926 CG13926 CDMC23869 4 7 14 DAC22-L10 3-CG13985-RA_1 CG13985 ACTCGGTGGAGAGAGCTTGGAGATCCTGATGGCAGATGCACCTATGACAATGATGTGTGGGCACT 65 FBgn0031794 CDMC23869 4 8 14 DAC22-L10 3-CG13985-RA_1 CG13985 ACTCGGTGGAGAGAGCTTGGAGATCCTGATGGCAGATGCACCTATGACAATGATGTGTGGGCACT 65 FBgn0031794 CDMC23870 4 9 14 DAC22-L22 11-CG13999-RA_1 CG13999 CAAGTCGACGGCTCTGACCATGGCAGATCCTCGCTTCAAGGAGGAGCATCTTGACTGGATCGCAG 65 FBan0013999 FBgn0031753 CG13999 2 2L CG13999 CG13999 CDMC23870 4 10 14 DAC22-L22 11-CG13999-RA_1 CG13999 CAAGTCGACGGCTCTGACCATGGCAGATCCTCGCTTCAAGGAGGAGCATCTTGACTGGATCGCAG 65 FBan0013999 FBgn0031753 CG13999 2 2L CG13999 CG13999 CDMC23871 4 11 14 DAC22-P10 16-CG14095-RA_1 CG14095 CTGCGCCCGTTTTGGCCAAATACGCTGCTCCACTGGCTTATGCCCCAGCACCTTTGAACTATGCC 65 FBan0014095 FBgn0036870 CG14095 3 3L CG14095 CG14095 CDMC23871 4 12 14 DAC22-P10 16-CG14095-RA_1 CG14095 CTGCGCCCGTTTTGGCCAAATACGCTGCTCCACTGGCTTATGCCCCAGCACCTTTGAACTATGCC 65 FBan0014095 FBgn0036870 CG14095 3 3L CG14095 CG14095 CDMC23872 4 13 14 DAC22-P22 AutoBlank AutoBlank CDMC23872 4 14 14 DAC22-P22 AutoBlank AutoBlank CDMC23873 4 15 14 DAC23-D10 2-CG4739-RA_1 CG4739 AATGACGCCCACTACGGTTTTGCAGAACATTTCGGAGCTCCACTGATCACTCTGAGCAGCTTGGG 65 FBan0004739 FBgn0040257 Ugt86Dc 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 Ugt86Dc Ugt86Dc "CG4739, CG4739, AC 006491C" CDMC23873 4 16 14 DAC23-D10 2-CG4739-RA_1 CG4739 AATGACGCCCACTACGGTTTTGCAGAACATTTCGGAGCTCCACTGATCACTCTGAGCAGCTTGGG 65 FBan0004739 FBgn0040257 Ugt86Dc 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 Ugt86Dc Ugt86Dc "CG4739, CG4739, AC 006491C" CDMC23874 4 17 14 DAC23-D22 14-CG4804-RA_1 CG4804 AAGCCCATTGTGATCAGCAATTCCTCCCGCCAGAAATTCTTCCGAGCTGACCATCCATTCTTCTT 65 FBan0004804 FBgn0032178 CG4804 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG4804 CG4804 CDMC23874 4 18 14 DAC23-D22 14-CG4804-RA_1 CG4804 AAGCCCATTGTGATCAGCAATTCCTCCCGCCAGAAATTCTTCCGAGCTGACCATCCATTCTTCTT 65 FBan0004804 FBgn0032178 CG4804 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG4804 CG4804 CDMC23875 4 19 14 DAC23-H10 2-CG4978-RA_5 CG4978 GCTGCTAATCCCGCTTTTGGACGCTACAATCCTCGTCGTACCGTGGAGCAGAACATTCAGCTTCC 65 FBan0004978 FBgn0020633 Mcm7 3 3L DNA replication initiation; GO:0006270; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003682; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634; pre-replicative complex; GO:0005656 Mcm7 Minichromosome maintenance 7 "CG4978, CG4978, CG4978, PCR1, DmMCM7, clone 1.66, MCM7, mcm7, Mcp-PCR1: Minichromosome maintenance-PCR1, anon-EST:Liang-1.66, Minichromosome maintenance-PCR1, Minichromosome maintenance 7" CDMC23875 4 20 14 DAC23-H10 2-CG4978-RA_5 CG4978 GCTGCTAATCCCGCTTTTGGACGCTACAATCCTCGTCGTACCGTGGAGCAGAACATTCAGCTTCC 65 FBan0004978 FBgn0020633 Mcm7 3 3L DNA replication initiation; GO:0006270; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003682; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634; pre-replicative complex; GO:0005656 Mcm7 Minichromosome maintenance 7 "CG4978, CG4978, CG4978, PCR1, DmMCM7, clone 1.66, MCM7, mcm7, Mcp-PCR1: Minichromosome maintenance-PCR1, anon-EST:Liang-1.66, Minichromosome maintenance-PCR1, Minichromosome maintenance 7" CDMC23876 4 21 14 DAC23-H22 23-CG5028-RA_2 CG5028 CACTATCGCACTACCGAATTCAACCAACTGCTAACAAATTCAGCAAGATAAACCAAATCGAACCA 65 FBan0005028 FBgn0039358 CG5028 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG5028 CG5028 CDMC23876 4 22 14 DAC23-H22 23-CG5028-RA_2 CG5028 CACTATCGCACTACCGAATTCAACCAACTGCTAACAAATTCAGCAAGATAAACCAAATCGAACCA 65 FBan0005028 FBgn0039358 CG5028 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG5028 CG5028 CDMC23877 4 23 14 DAC23-L10 9-CG5189-RA_1 CG5189 CTCAGCCAGGAGGGAGCTCTATTGGCCTACTCCGGTTATGGCGATAAGGATGCCAGGATAACGGC 65 FBan0005189 FBgn0034350 CG5189 2 2R Golgi apparatus; GO:0005794 CG5189 CG5189 CDMC23877 4 24 14 DAC23-L10 9-CG5189-RA_1 CG5189 CTCAGCCAGGAGGGAGCTCTATTGGCCTACTCCGGTTATGGCGATAAGGATGCCAGGATAACGGC 65 FBan0005189 FBgn0034350 CG5189 2 2R Golgi apparatus; GO:0005794 CG5189 CG5189 CDMC23878 4 25 14 DAC23-L22 2-CG5217-RA_1 CG5217 TCCCGATACCGATCCTCAGCCGACAGTCAAGGATGAGCACGATGAAATGGAACGTGGCACAGATC 65 FBan0005217 FBgn0038694 CG5217 3 3R CG5217 CG5217 anon-WO0140519.188 CDMC23878 4 26 14 DAC23-L22 2-CG5217-RA_1 CG5217 TCCCGATACCGATCCTCAGCCGACAGTCAAGGATGAGCACGATGAAATGGAACGTGGCACAGATC 65 FBan0005217 FBgn0038694 CG5217 3 3R CG5217 CG5217 anon-WO0140519.188 CDMC23879 4 1 15 DAC23-P10 3-CG5341-RA_2 CG5341 TATCCACGCTATCGGCACTGCTTAGCTCGGATATCGAACTGCTCGTCTTGGACCTGCACACCTTG 65 FBan0005341 FBgn0034367 sec6 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec6 sec6 "CG5341, CG5341, dsec6, Sec6, Sec6p, sec 6, Dsec6" CDMC23879 4 2 15 DAC23-P10 3-CG5341-RA_2 CG5341 TATCCACGCTATCGGCACTGCTTAGCTCGGATATCGAACTGCTCGTCTTGGACCTGCACACCTTG 65 FBan0005341 FBgn0034367 sec6 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec6 sec6 "CG5341, CG5341, dsec6, Sec6, Sec6p, sec 6, Dsec6" CDMC23880 4 3 15 DAC23-P22 AutoBlank AutoBlank CDMC23880 4 4 15 DAC23-P22 AutoBlank AutoBlank CDMC23881 4 5 15 DAC24-D10 10-CG9209-RA_1 CG9209 ACGTCAACGATGATGCCTGTACGAATGCCGAGTTTCTATTGCAAATCCTCGATCTGGTCACCCAGTCGA 69 FBan0009209 FBgn0003969 vap X X MAPKKK cascade; GO:0000165; behavioral response to ethanol; GO:0048149; mushroom body development; GO:0016319 Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099 vap vacuolar peduncle "CG9209, RasGap, rasGap, D-RasGAP, RasGAP" CDMC23881 4 6 15 DAC24-D10 10-CG9209-RA_1 CG9209 ACGTCAACGATGATGCCTGTACGAATGCCGAGTTTCTATTGCAAATCCTCGATCTGGTCACCCAGTCGA 69 FBan0009209 FBgn0003969 vap X X MAPKKK cascade; GO:0000165; behavioral response to ethanol; GO:0048149; mushroom body development; GO:0016319 Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099 vap vacuolar peduncle "CG9209, RasGap, rasGap, D-RasGAP, RasGAP" CDMC23882 4 7 15 DAC24-D22 16-CG9216-RA_1 CG9216 GCCGCAGCCGTACAGATGATCACTCACGGGAGAAGGGTAAAACTAGATGCTACGATCAGTCATCCAATA 69 FBan0009216 FBgn0030726 CG9216 X X CG9216 CG9216 CDMC23882 4 8 15 DAC24-D22 16-CG9216-RA_1 CG9216 GCCGCAGCCGTACAGATGATCACTCACGGGAGAAGGGTAAAACTAGATGCTACGATCAGTCATCCAATA 69 FBan0009216 FBgn0030726 CG9216 X X CG9216 CG9216 CDMC23883 4 9 15 DAC24-H10 1-CG9259-RA_1 CG9259 TGTCCTGACCGTTCTCACCATTCCCACTTCAAAAGAGTTCAGGGACGCCCATCTCAGTGAACTTCTGGC 69 FBan0009259 FBgn0032913 CG9259 2 2L CG9259 CG9259 CDMC23883 4 10 15 DAC24-H10 1-CG9259-RA_1 CG9259 TGTCCTGACCGTTCTCACCATTCCCACTTCAAAAGAGTTCAGGGACGCCCATCTCAGTGAACTTCTGGC 69 FBan0009259 FBgn0032913 CG9259 2 2L CG9259 CG9259 CDMC23884 4 11 15 DAC24-H22 3-CG9270-RB_3 CG9270 CCCCCCCGTGGATAATCCTGGTCAAATCGGTTTAGTTATTACCCAGGCTATGTCCATGACGGGGACTGT 69 FBan0009270 FBgn0032908 CG9270 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG9270 CG9270 CDMC23884 4 12 15 DAC24-H22 3-CG9270-RB_3 CG9270 CCCCCCCGTGGATAATCCTGGTCAAATCGGTTTAGTTATTACCCAGGCTATGTCCATGACGGGGACTGT 69 FBan0009270 FBgn0032908 CG9270 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG9270 CG9270 CDMC23885 4 13 15 DAC24-L10 9-CG9308-RA_4 CG9308 TGGGCAGCTTCACCTTTACGGCCATGAAAGAGGGACGGTACCAATTGTGCTTCGACAATAAGATGTCCA 69 FBan0009308 FBgn0034681 CG9308 2 2R intracellular protein transport; GO:0006886; vesicle organization and biogenesis; GO:0016050 protein carrier activity; GO:0008320; ; GO:0008320 Golgi to ER transport vesicle; GO:0030142; membrane; GO:0016020 CG9308 CG9308 CDMC23885 4 14 15 DAC24-L10 9-CG9308-RA_4 CG9308 TGGGCAGCTTCACCTTTACGGCCATGAAAGAGGGACGGTACCAATTGTGCTTCGACAATAAGATGTCCA 69 FBan0009308 FBgn0034681 CG9308 2 2R intracellular protein transport; GO:0006886; vesicle organization and biogenesis; GO:0016050 protein carrier activity; GO:0008320; ; GO:0008320 Golgi to ER transport vesicle; GO:0030142; membrane; GO:0016020 CG9308 CG9308 CDMC23886 4 15 15 DAC24-L22 8-CG9317-RA_1 CG9317 GTCGCACCCCCAATATGCGCTTAAAGACCATCCTAATCACGCTGAGTTGGTTTGCCAATGAGACGGTTT 69 FBan0009317 FBgn0032879 CG9317 2 2L anion transport; GO:0006820; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 integral to membrane; GO:0016021 CG9317 CG9317 38E.10 CDMC23886 4 16 15 DAC24-L22 8-CG9317-RA_1 CG9317 GTCGCACCCCCAATATGCGCTTAAAGACCATCCTAATCACGCTGAGTTGGTTTGCCAATGAGACGGTTT 69 FBan0009317 FBgn0032879 CG9317 2 2L anion transport; GO:0006820; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 integral to membrane; GO:0016021 CG9317 CG9317 38E.10 CDMC23887 4 17 15 DAC24-P10 23-CG9351-RB_20 CG9351 ATTTGCACTTGGAGATATCGAAATCTTTGCACATTATCGTGCTGTTCGAAATCCAGAGTCTTGAGATGT 69 FBgn0038169 CDMC23887 4 18 15 DAC24-P10 23-CG9351-RB_20 CG9351 ATTTGCACTTGGAGATATCGAAATCTTTGCACATTATCGTGCTGTTCGAAATCCAGAGTCTTGAGATGT 69 FBgn0038169 CDMC23888 4 19 15 DAC24-P22 12-CG9360-RA_1 CG9360 AGCTGACCATCAAGCCTGTCGGCGAAACCCTCTAGACTCTAGATTTCCCACTGGATGCTTCTGCTATTT 69 FBan0009360 FBgn0030332 CG9360 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG9360 CG9360 CDMC23888 4 20 15 DAC24-P22 12-CG9360-RA_1 CG9360 AGCTGACCATCAAGCCTGTCGGCGAAACCCTCTAGACTCTAGATTTCCCACTGGATGCTTCTGCTATTT 69 FBan0009360 FBgn0030332 CG9360 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG9360 CG9360 CDMC23889 4 21 15 DAC25-D10 11-CG10593-RA_6 CG10593 CGCAAGGCCGGACAATATGCGCCCAACAATAGTCGTCTGACTCTGGACAACTGTGATATCTTTGGAAGC 69 FBan0010593 FBgn0016122 Acer 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; zinc ion binding; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Acer Angiotensin-converting enzyme-related "CG10593, l(2)k07704, ACE, ACER" CDMC23889 4 22 15 DAC25-D10 11-CG10593-RA_6 CG10593 CGCAAGGCCGGACAATATGCGCCCAACAATAGTCGTCTGACTCTGGACAACTGTGATATCTTTGGAAGC 69 FBan0010593 FBgn0016122 Acer 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; zinc ion binding; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Acer Angiotensin-converting enzyme-related "CG10593, l(2)k07704, ACE, ACER" CDMC23890 4 23 15 DAC25-D22 6-CG10600-RA_1 CG10600 AGCACACCCCAATTGATCGTTGACCACGAAGAGGAGGTCTCTGAAGTGTGTTCCGAGGAGATTGTCGAA 69 FBan0010600 FBgn0032717 CG10600 2 2L CG10600 CG10600 CDMC23890 4 24 15 DAC25-D22 6-CG10600-RA_1 CG10600 AGCACACCCCAATTGATCGTTGACCACGAAGAGGAGGTCTCTGAAGTGTGTTCCGAGGAGATTGTCGAA 69 FBan0010600 FBgn0032717 CG10600 2 2L CG10600 CG10600 CDMC23891 4 25 15 DAC25-H10 2-CG10628-RA_2 CG10628 TCTGGGACGTCCCGGGGAGAATCGCACTGTAAATCTGGACCTAAAGCTAATAGCAGATGTGGGTCTCGT 69 FBan0010628 FBgn0032818 CG10628 2 2L GTP binding; GO:0005525; ; GO:0005525 CG10628 CG10628 CDMC23891 4 26 15 DAC25-H10 2-CG10628-RA_2 CG10628 TCTGGGACGTCCCGGGGAGAATCGCACTGTAAATCTGGACCTAAAGCTAATAGCAGATGTGGGTCTCGT 69 FBan0010628 FBgn0032818 CG10628 2 2L GTP binding; GO:0005525; ; GO:0005525 CG10628 CG10628 CDMC23892 4 1 16 DAC25-H22 22-CG10637-RC_2 CG10637 CGCTGCTCGATCGAAAAATTTAGCGTGCCATATAGATGGGGAATGACCCGCGAATACTACTTAAGTGCA 69 FBan0010637 FBgn0015772 Nak 2 2L asymmetric cell division; GO:0008356; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; structural constituent of ribosome; GO:0003735; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003735; ; GO:0005515; ; GO:0004674; ; GO:0004674 intracellular; GO:0005622; ribosome; GO:0005840 Nak Numb-associated kinase "CG10637, CG10637, nak, Numb-associated kinase" CDMC23892 4 2 16 DAC25-H22 22-CG10637-RC_2 CG10637 CGCTGCTCGATCGAAAAATTTAGCGTGCCATATAGATGGGGAATGACCCGCGAATACTACTTAAGTGCA 69 FBan0010637 FBgn0015772 Nak 2 2L asymmetric cell division; GO:0008356; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; structural constituent of ribosome; GO:0003735; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003735; ; GO:0005515; ; GO:0004674; ; GO:0004674 intracellular; GO:0005622; ribosome; GO:0005840 Nak Numb-associated kinase "CG10637, CG10637, nak, Numb-associated kinase" CDMC23893 4 3 16 DAC25-L10 14-CG1066-RB_1 CG1066 ACAACTGCACTGGGAAAGGTTATTGGTACTGTGTGTTGCATATGCGGTGTTCTGGTAATCGCTTTGCCT 69 FBan0001066 FBgn0003383 Shab 3 3L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shab Shaker cognate b "CG1066, shab, dShab" CDMC23893 4 4 16 DAC25-L10 14-CG1066-RB_1 CG1066 ACAACTGCACTGGGAAAGGTTATTGGTACTGTGTGTTGCATATGCGGTGTTCTGGTAATCGCTTTGCCT 69 FBan0001066 FBgn0003383 Shab 3 3L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shab Shaker cognate b "CG1066, shab, dShab" CDMC23894 4 5 16 DAC25-L22 23-CG10677-RA_3 CG10677 AGCCACCAAAAAATGCCAAAAATAAAGTTGCCCTCTTTATCGCACAACCAAACACTACCACTATTGCAA 69 FBan0010677 FBgn0035596 CG10677 3 3L CG10677 CG10677 anon-WO0172774.40 CDMC23894 4 6 16 DAC25-L22 23-CG10677-RA_3 CG10677 AGCCACCAAAAAATGCCAAAAATAAAGTTGCCCTCTTTATCGCACAACCAAACACTACCACTATTGCAA 69 FBan0010677 FBgn0035596 CG10677 3 3L CG10677 CG10677 anon-WO0172774.40 CDMC23895 4 7 16 DAC25-P10 9-CG10717-RB_1 CG10717 CCAGCAGACCCAACCCAAGGGCAAGGACATTGATAGGCTCAAGTACCAAGTAGCTTAGAAAGCAATGGC 69 FBan0010717 FBgn0001256 ImpL1 3 3L extracellular region; GO:0005576 ImpL1 Ecdysone-inducible gene L1 "CG10717, IMP-L1, Imp-L1" CDMC23895 4 8 16 DAC25-P10 9-CG10717-RB_1 CG10717 CCAGCAGACCCAACCCAAGGGCAAGGACATTGATAGGCTCAAGTACCAAGTAGCTTAGAAAGCAATGGC 69 FBan0010717 FBgn0001256 ImpL1 3 3L extracellular region; GO:0005576 ImpL1 Ecdysone-inducible gene L1 "CG10717, IMP-L1, Imp-L1" CDMC23896 4 9 16 DAC25-P22 23-CG1072-RB_8 CG1072 GGAAGGAAGCTCATTTGCGCGTCATATTAACCTGCAGTTAACGTATTCATTTCAGAATAACGCACAGAA 69 FBan0001072 FBgn0013751 Awh 3 3L "ectoderm development; GO:0007398; electron transport; GO:0006118; imaginal disc development; GO:0007444; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0008270; ; GO:0005489; ; GO:0005506; ; GO:0003700; ; GO:0005515; ; GO:0003700 nucleus; GO:0005634 Awh Arrowhead "CG1072, l(3)63Ea: lethal(3)63Ea, l(3)SH9, l63Ea, l(3)64Ea, arrowhead, l(3)63Ea/Awh, lethal(3)63Ea, l(3)63Ea" CDMC23896 4 10 16 DAC25-P22 23-CG1072-RB_8 CG1072 GGAAGGAAGCTCATTTGCGCGTCATATTAACCTGCAGTTAACGTATTCATTTCAGAATAACGCACAGAA 69 FBan0001072 FBgn0013751 Awh 3 3L "ectoderm development; GO:0007398; electron transport; GO:0006118; imaginal disc development; GO:0007444; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0008270; ; GO:0005489; ; GO:0005506; ; GO:0003700; ; GO:0005515; ; GO:0003700 nucleus; GO:0005634 Awh Arrowhead "CG1072, l(3)63Ea: lethal(3)63Ea, l(3)SH9, l63Ea, l(3)64Ea, arrowhead, l(3)63Ea/Awh, lethal(3)63Ea, l(3)63Ea" CDMC23897 4 11 16 DAC26-D10 15-CG8057-RA_1 CG8057 CGTCACCACGCTGCTGTACAAGCCCATTTAGGCAACTCGCAATTGGTATTTTAGCTGTAGGAACATGGT 69 FBan0008057 FBgn0033383 CG8057 2 2R protein amino acid phosphorylation; GO:0006468 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- CG8057 CG8057 "FBgn0033383, beta homologue" CDMC23897 4 12 16 DAC26-D10 15-CG8057-RA_1 CG8057 CGTCACCACGCTGCTGTACAAGCCCATTTAGGCAACTCGCAATTGGTATTTTAGCTGTAGGAACATGGT 69 FBan0008057 FBgn0033383 CG8057 2 2R protein amino acid phosphorylation; GO:0006468 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- CG8057 CG8057 "FBgn0033383, beta homologue" CDMC23898 4 13 16 DAC26-D22 14-CG8066-RA_1 CG8066 GGGGGAACCATATTCTTGCGACCTCAGGTAGCGTACAGAAGAGAGCCTTACCTTTACTATCTGGGAGGA 69 FBan0008066 FBgn0038243 CG8066 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG8066 CG8066 CDMC23898 4 14 16 DAC26-D22 14-CG8066-RA_1 CG8066 GGGGGAACCATATTCTTGCGACCTCAGGTAGCGTACAGAAGAGAGCCTTACCTTTACTATCTGGGAGGA 69 FBan0008066 FBgn0038243 CG8066 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG8066 CG8066 CDMC23899 4 15 16 DAC26-H10 11-CG8098-RA_4 CG8098 CGTGCACGAGGATCCCTCTTCGCATCCCACTATTGATGAGCGCGAGAAGAAGTACATTAACGATTCCCT 69 FBan0008098 FBgn0024315 Picot 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316; ; GO:0005316; phosphate transporter activity; GO:0015114; ; GO:0015114 integral to membrane; GO:0016021 Picot Picot "CG8098, picot" CDMC23899 4 16 16 DAC26-H10 11-CG8098-RA_4 CG8098 CGTGCACGAGGATCCCTCTTCGCATCCCACTATTGATGAGCGCGAGAAGAAGTACATTAACGATTCCCT 69 FBan0008098 FBgn0024315 Picot 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316; ; GO:0005316; phosphate transporter activity; GO:0015114; ; GO:0015114 integral to membrane; GO:0016021 Picot Picot "CG8098, picot" CDMC23900 4 17 16 DAC26-H22 2-CG8114-RA_1 CG8114 AGTTGCACCTGTCGATAGGAAGGCTCGCAAATGTTGAAGCGTTTGCCCGAGCTGTCGATTGATCATGAT 69 FBan0008114 FBgn0003041 pbl 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; Malpighian tubule morphogenesis; GO:0007443; cell adhesion; GO:0007155; cytokinesis; GO:0000910; cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring formation; GO:0000915; meiotic spindle assembly; GO:0051226; mesoderm migration; GO:0007509; mesodermal cell migration; GO:0008078; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360" guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005085; ; GO:0005089; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; nucleus; GO:0005634 pbl pebble "CG8114, CG8114, l(3)09645, 0083/20, 0293/09, 0542/03, PBL, PEBBLE, pebble, anon-WO0172774.22, anon-WO0172774.25" CDMC23900 4 18 16 DAC26-H22 2-CG8114-RA_1 CG8114 AGTTGCACCTGTCGATAGGAAGGCTCGCAAATGTTGAAGCGTTTGCCCGAGCTGTCGATTGATCATGAT 69 FBan0008114 FBgn0003041 pbl 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; Malpighian tubule morphogenesis; GO:0007443; cell adhesion; GO:0007155; cytokinesis; GO:0000910; cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring formation; GO:0000915; meiotic spindle assembly; GO:0051226; mesoderm migration; GO:0007509; mesodermal cell migration; GO:0008078; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360" guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005085; ; GO:0005089; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021; nucleus; GO:0005634 pbl pebble "CG8114, CG8114, l(3)09645, 0083/20, 0293/09, 0542/03, PBL, PEBBLE, pebble, anon-WO0172774.22, anon-WO0172774.25" CDMC23901 4 19 16 DAC26-L10 39-CG8144-RD_2 CG8144 GCTCGTTTTCCACACACGAATTCCCAGCTAACGCGCAGCCATTTTGACAGTGATTTTATTGGTTTGGCT 69 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC23901 4 20 16 DAC26-L10 39-CG8144-RD_2 CG8144 GCTCGTTTTCCACACACGAATTCCCAGCTAACGCGCAGCCATTTTGACAGTGATTTTATTGGTTTGGCT 69 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC23902 4 21 16 DAC26-L22 12-CG8166-RA_1 CG8166 ACTCCTGCTGACGCTTAAGGAGATGGGACGTCAGGATGTGCTAGACATCATAGTTGAAACCATAGGCCC 69 FBan0008166 FBgn0034013 unc-5 2 2R axon guidance; GO:0007411; ectoderm development; GO:0007398; glial cell migration; GO:0008347 netrin receptor activity; GO:0005042; repulsive netrin receptor activity; GO:0005043; ; GO:0005042; ; GO:0005043 unc-5 unc-5 "CG8166, CG8168, CG8166, Dunc5, CT20824, unc-5-like, AAF7419, Unc5d, UNC5D, Unc5, UNC5, Unc-5" CDMC23902 4 22 16 DAC26-L22 12-CG8166-RA_1 CG8166 ACTCCTGCTGACGCTTAAGGAGATGGGACGTCAGGATGTGCTAGACATCATAGTTGAAACCATAGGCCC 69 FBan0008166 FBgn0034013 unc-5 2 2R axon guidance; GO:0007411; ectoderm development; GO:0007398; glial cell migration; GO:0008347 netrin receptor activity; GO:0005042; repulsive netrin receptor activity; GO:0005043; ; GO:0005042; ; GO:0005043 unc-5 unc-5 "CG8166, CG8168, CG8166, Dunc5, CT20824, unc-5-like, AAF7419, Unc5d, UNC5D, Unc5, UNC5, Unc-5" CDMC23903 4 23 16 DAC26-P10 2-CG8196-RA_1 CG8196 GCCCAATAACACGGGACTGAGTAGCTTGGCTCTGCTGGAGTACTATCAACCTGTGTTGGACTGGCTCAA 69 FBan0008196 FBgn0033366 Ance-4 2 2R proteolysis; GO:0006508 NOT peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-4 Ance-4 "CG8196, CG8196" CDMC23903 4 24 16 DAC26-P10 2-CG8196-RA_1 CG8196 GCCCAATAACACGGGACTGAGTAGCTTGGCTCTGCTGGAGTACTATCAACCTGTGTTGGACTGGCTCAA 69 FBan0008196 FBgn0033366 Ance-4 2 2R proteolysis; GO:0006508 NOT peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-4 Ance-4 "CG8196, CG8196" CDMC23904 4 25 16 DAC26-P22 15-CG8207-RA_1 CG8207 GCTGGGTCGGCAATCTACGCAAATCGTCATTATCTTGGCCTGTACAAGAAAACGCATCCCGAGAGATTG 69 FBan0008207 FBgn0034035 CG8207 2 2R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mannose-1-phosphate guanylyltransferase activity; GO:0004475 ; EC:2.7.7.13; ; GO:0004475 ; EC:2.7.7.13 CG8207 CG8207 CDMC23904 4 26 16 DAC26-P22 15-CG8207-RA_1 CG8207 GCTGGGTCGGCAATCTACGCAAATCGTCATTATCTTGGCCTGTACAAGAAAACGCATCCCGAGAGATTG 69 FBan0008207 FBgn0034035 CG8207 2 2R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mannose-1-phosphate guanylyltransferase activity; GO:0004475 ; EC:2.7.7.13; ; GO:0004475 ; EC:2.7.7.13 CG8207 CG8207 CDMC23905 4 1 17 DAC27-D10 16-CG8443-RA_1 CG8443 CGCAAAAAGTCGCCTAGCTCTAACACACATGTATGTTTTGCCAAACCATTTGCAAACCCGTCAAATGCC 69 FBan0008443 FBgn0034087 CG8443 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8443 CG8443 anon-WO0118547.143 CDMC23905 4 2 17 DAC27-D10 16-CG8443-RA_1 CG8443 CGCAAAAAGTCGCCTAGCTCTAACACACATGTATGTTTTGCCAAACCATTTGCAAACCCGTCAAATGCC 69 FBan0008443 FBgn0034087 CG8443 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8443 CG8443 anon-WO0118547.143 CDMC23906 4 3 17 DAC27-D22 7-CG8454-RA_2 CG8454 TGCCATTGCGATACAAGTGGCCAAGCATTTAAATCTGCCCGAATCGTGGATCTTGGAACACTGGGCTTA 69 FBan0008454 FBgn0037674 Vps16A 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041 cytoplasm; GO:0005737 Vps16A Vps16A "CG8454, dVps16A" CDMC23906 4 4 17 DAC27-D22 7-CG8454-RA_2 CG8454 TGCCATTGCGATACAAGTGGCCAAGCATTTAAATCTGCCCGAATCGTGGATCTTGGAACACTGGGCTTA 69 FBan0008454 FBgn0037674 Vps16A 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041 cytoplasm; GO:0005737 Vps16A Vps16A "CG8454, dVps16A" CDMC23907 4 5 17 DAC27-H10 17-CG8500-RA_1 CG8500 TGCATTCGCATTCATCGTGTGAGCCAAGTAACGCGTACATCGAAGGATATTTGAAGAGCATATGGTGCA 69 FBan0008500 FBgn0037754 CG8500 3 3R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8500 CG8500 CDMC23907 4 6 17 DAC27-H10 17-CG8500-RA_1 CG8500 TGCATTCGCATTCATCGTGTGAGCCAAGTAACGCGTACATCGAAGGATATTTGAAGAGCATATGGTGCA 69 FBan0008500 FBgn0037754 CG8500 3 3R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8500 CG8500 CDMC23908 4 7 17 DAC27-H22 2-CG8507-RA_2 CG8507 TGCGCAAAACGTGAAGAGTTTCGAGAACGACCTTAACACTCTGCGAGGACATCACACGGGCATCAAGGA 69 FBan0008507 FBgn0037756 CG8507 3 3R CG8507 CG8507 CDMC23908 4 8 17 DAC27-H22 2-CG8507-RA_2 CG8507 TGCGCAAAACGTGAAGAGTTTCGAGAACGACCTTAACACTCTGCGAGGACATCACACGGGCATCAAGGA 69 FBan0008507 FBgn0037756 CG8507 3 3R CG8507 CG8507 CDMC23909 4 9 17 DAC27-L10 18-CG8547-RB_3 CG8547 GCCACCAAATGGAAATGGTTATCCACCGAATTCGACCACTTACAGCTACAAATACTCCTCGACCACCAA 69 FBan0008547 FBgn0033919 CG8547 2 2R CG8547 CG8547 CDMC23909 4 10 17 DAC27-L10 18-CG8547-RB_3 CG8547 GCCACCAAATGGAAATGGTTATCCACCGAATTCGACCACTTACAGCTACAAATACTCCTCGACCACCAA 69 FBan0008547 FBgn0033919 CG8547 2 2R CG8547 CG8547 CDMC23910 4 11 17 DAC27-L22 3-CG8556-RA_2 CG8556 GAGCTGCTGAACCCATCGATTGCCCAGTAGTACCACCAGTACAGTAGCCTTCATCATGCAGGCCATCAA 69 FBan0008556 FBgn0014011 Rac2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dorsal closure; GO:0007391; morphogenesis of an epithelium; GO:0002009; myoblast fusion; GO:0007520; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of axonogenesis; GO:0050770; rhabdomere development; GO:0042052; small GTPase mediated signal transduction; GO:0007264; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rac2 Rac2 "CG8556, CG8556, DRacB, Drac1b, Rac1b, DRac2, rac2, RacB mRNA., D-Rac2, Rac, Rac-2, Rac GTPase, Drac2, D-Rac 2, DmRAC2, RacB" CDMC23910 4 12 17 DAC27-L22 3-CG8556-RA_2 CG8556 GAGCTGCTGAACCCATCGATTGCCCAGTAGTACCACCAGTACAGTAGCCTTCATCATGCAGGCCATCAA 69 FBan0008556 FBgn0014011 Rac2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dorsal closure; GO:0007391; morphogenesis of an epithelium; GO:0002009; myoblast fusion; GO:0007520; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of axonogenesis; GO:0050770; rhabdomere development; GO:0042052; small GTPase mediated signal transduction; GO:0007264; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rac2 Rac2 "CG8556, CG8556, DRacB, Drac1b, Rac1b, DRac2, rac2, RacB mRNA., D-Rac2, Rac, Rac-2, Rac GTPase, Drac2, D-Rac 2, DmRAC2, RacB" CDMC23911 4 13 17 DAC27-P10 2-CG8593-RA_2 CG8593 TGTTACCCTTTGCCAAACCGAAAAGCCCACAGAGAACCCCTACCTTACTGTCAACCGAAACCAGAGCGA 69 FBan0008593 FBgn0019662 qm 3 3L germ cell migration; GO:0008354; isoprenoid biosynthesis; GO:0008299 farnesyltranstransferase activity; GO:0004311 ; EC:2.5.1.29; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; dimethylallyltranstransferase activity; GO:0004161 ; EC:2.5.1.1; ; GO:0004311 ; EC:2.5.1.29; geranyltranstransferase activity; GO:0004337 ; EC:2.5.1.10; ; GO:0004161 ; EC:2.5.1.1; ; GO:0004311 ; EC:2.5.1.29; ; GO:0004337 ; EC:2.5.1.10 qm quemao "CG8593, que mao, geranylgeranyl pyrophosphate synthase, quemao" CDMC23911 4 14 17 DAC27-P10 2-CG8593-RA_2 CG8593 TGTTACCCTTTGCCAAACCGAAAAGCCCACAGAGAACCCCTACCTTACTGTCAACCGAAACCAGAGCGA 69 FBan0008593 FBgn0019662 qm 3 3L germ cell migration; GO:0008354; isoprenoid biosynthesis; GO:0008299 farnesyltranstransferase activity; GO:0004311 ; EC:2.5.1.29; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; dimethylallyltranstransferase activity; GO:0004161 ; EC:2.5.1.1; ; GO:0004311 ; EC:2.5.1.29; geranyltranstransferase activity; GO:0004337 ; EC:2.5.1.10; ; GO:0004161 ; EC:2.5.1.1; ; GO:0004311 ; EC:2.5.1.29; ; GO:0004337 ; EC:2.5.1.10 qm quemao "CG8593, que mao, geranylgeranyl pyrophosphate synthase, quemao" CDMC23912 4 15 17 DAC27-P22 23-CG8603-RA_2 CG8603 CAGGATCGGCCAGTTTAGTCCGCAATGTGTATTAGTTTAAAACGATGTGCTTAATTACCACACCCACAC 69 FBan0008603 FBgn0033923 CG8603 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 CG8603 CG8603 CDMC23912 4 16 17 DAC27-P22 23-CG8603-RA_2 CG8603 CAGGATCGGCCAGTTTAGTCCGCAATGTGTATTAGTTTAAAACGATGTGCTTAATTACCACACCCACAC 69 FBan0008603 FBgn0033923 CG8603 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 CG8603 CG8603 CDMC23913 4 17 17 DAC28-D10 3-CG30360-RA_3 CG30360 TGATCCGGATGACTCCTCCTATCTGAAGCACATCTACACTCAGGATCTGCGCGAAACGGTGGAGATGGT 69 FBan0030360 FBgn0050360 CG30360 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30360 CG30360 "CG8689, CG8689, CG8689, CG8689" CDMC23913 4 18 17 DAC28-D10 3-CG30360-RA_3 CG30360 TGATCCGGATGACTCCTCCTATCTGAAGCACATCTACACTCAGGATCTGCGCGAAACGGTGGAGATGGT 69 FBan0030360 FBgn0050360 CG30360 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30360 CG30360 "CG8689, CG8689, CG8689, CG8689" CDMC23914 4 19 17 DAC28-D22 23-CG30373-RA_2 CG30373 ATTTTGTTATGAAATTTGCTTGAGTTTCCCATCGAAAATGCTGCGTTTGCTTACAAAAACAAGGGTGCT 69 FBan0030373 FBgn0050373 CG30373 2 2R CG30373 CG30373 BcDNA:RH67738 CDMC23914 4 20 17 DAC28-D22 23-CG30373-RA_2 CG30373 ATTTTGTTATGAAATTTGCTTGAGTTTCCCATCGAAAATGCTGCGTTTGCTTACAAAAACAAGGGTGCT 69 FBan0030373 FBgn0050373 CG30373 2 2R CG30373 CG30373 BcDNA:RH67738 CDMC23915 4 21 17 DAC28-H10 14-CG30413-RA_1 CG30413 CCCTCATCGCCAGTGAGACCATAACCAAGTCGAAATCCTTGCTGGGAATCACCACGAAGACGTATACTC 69 FBan0030413 FBgn0050413 CG30413 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30413 CG30413 CDMC23915 4 22 17 DAC28-H10 14-CG30413-RA_1 CG30413 CCCTCATCGCCAGTGAGACCATAACCAAGTCGAAATCCTTGCTGGGAATCACCACGAAGACGTATACTC 69 FBan0030413 FBgn0050413 CG30413 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30413 CG30413 CDMC23916 4 23 17 DAC28-H22 17-CG30428-RA_1 CG30428 CGCCCAGCGAACTAAAGCTAACACGGAAGCATTATTGGCTTTGAGTACGCAGATAGCCGATTTAATGCA 69 FBan0030428 FBgn0050428 CG30428 2 2R CG30428 CG30428 BcDNA:SD21514 CDMC23916 4 24 17 DAC28-H22 17-CG30428-RA_1 CG30428 CGCCCAGCGAACTAAAGCTAACACGGAAGCATTATTGGCTTTGAGTACGCAGATAGCCGATTTAATGCA 69 FBan0030428 FBgn0050428 CG30428 2 2R CG30428 CG30428 BcDNA:SD21514 CDMC23917 4 25 17 DAC28-L10 22-CG30463-RA_1 CG30463 AGCTGGTAAGCCCTAGACTAAGTCTAAGTTGGAAAGCATTTGGTGATAGCCTTTGTTTCGCCCAAGACC 69 FBan0030463 FBgn0050463 CG30463 2 2R polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 CG30463 CG30463 "CG8456, CG8463, CG15713, CG8456, CG8463, CG15713" CDMC23917 4 26 17 DAC28-L10 22-CG30463-RA_1 CG30463 AGCTGGTAAGCCCTAGACTAAGTCTAAGTTGGAAAGCATTTGGTGATAGCCTTTGTTTCGCCCAAGACC 69 FBan0030463 FBgn0050463 CG30463 2 2R polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 CG30463 CG30463 "CG8456, CG8463, CG15713, CG8456, CG8463, CG15713" CDMC23918 4 1 18 DAC28-L22 23-CG30476-RA_2 CG30476 CGATTTGTTTTTTGTGAAATGGGTGAAGAAACTATTAACTCAACGCAAAACAAAACCAGAACGAAAACT 69 FBan0030476 FBgn0050476 CG30476 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30476 CG30476 BcDNA:RE67675 CDMC23918 4 2 18 DAC28-L22 23-CG30476-RA_2 CG30476 CGATTTGTTTTTTGTGAAATGGGTGAAGAAACTATTAACTCAACGCAAAACAAAACCAGAACGAAAACT 69 FBan0030476 FBgn0050476 CG30476 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30476 CG30476 BcDNA:RE67675 CDMC23919 4 3 18 DAC28-P10 15-CG30500-RA_4 CG30500 AGGCGAAGGGTATGATGCGCGGAAGAACTGGATGTGCGTTTCGGTAAAGTGATGTGATGGTAAAACAAA 69 FBan0030500 FBgn0050500 CG30500 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30500 CG30500 CDMC23919 4 4 18 DAC28-P10 15-CG30500-RA_4 CG30500 AGGCGAAGGGTATGATGCGCGGAAGAACTGGATGTGCGTTTCGGTAAAGTGATGTGATGGTAAAACAAA 69 FBan0030500 FBgn0050500 CG30500 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30500 CG30500 CDMC23920 4 5 18 DAC28-P22 12-CG3057-RA_1 CG3057 AGGGCTGTAGGGCTAGTGAAAATTCAATTCAAAGGAGGTGCACATAGGTGGACTTTGAACCCTGCTGCA 69 FBan0003057 FBgn0019830 colt 2 2L acyl carnitine transport; GO:0006844; carnitine transport; GO:0015879; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839 transporter activity; GO:0005215; ; GO:0005215; binding; GO:0005488; ; GO:0005488; ; GO:0005215; carnitine:acyl carnitine antiporter activity; GO:0005476; ; GO:0005476; ; GO:0005476 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 colt congested-like trachea "CG3057, collapsed trachea, congested-like trachea" CDMC23920 4 6 18 DAC28-P22 12-CG3057-RA_1 CG3057 AGGGCTGTAGGGCTAGTGAAAATTCAATTCAAAGGAGGTGCACATAGGTGGACTTTGAACCCTGCTGCA 69 FBan0003057 FBgn0019830 colt 2 2L acyl carnitine transport; GO:0006844; carnitine transport; GO:0015879; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839 transporter activity; GO:0005215; ; GO:0005215; binding; GO:0005488; ; GO:0005488; ; GO:0005215; carnitine:acyl carnitine antiporter activity; GO:0005476; ; GO:0005476; ; GO:0005476 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 colt congested-like trachea "CG3057, collapsed trachea, congested-like trachea" CDMC23921 4 7 18 DAC29-D10 2-CG9994-RA_3 CG9994 GTGGCGCAATGAGTTCCTCAACTACGCAGATGTGGACCAGGACAAGTTTCCATTCATCGTGGTGGGAAA 69 FBan0009994 FBgn0032782 Rab9 2 2L "intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; retrograde transport, endosome to Golgi; GO:0042147; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab9 Rab9 "CG9994, DmRab9" CDMC23921 4 8 18 DAC29-D10 2-CG9994-RA_3 CG9994 GTGGCGCAATGAGTTCCTCAACTACGCAGATGTGGACCAGGACAAGTTTCCATTCATCGTGGTGGGAAA 69 FBan0009994 FBgn0032782 Rab9 2 2L "intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; retrograde transport, endosome to Golgi; GO:0042147; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab9 Rab9 "CG9994, DmRab9" CDMC23922 4 9 18 DAC29-D22 6-CR12953-RA_1 CR12953 ACCGGACGCAAGCAGATCAGAGGATTTGGATATCGCACATTTGTGGAGTACCTGCATCGCTACAATGCC 69 FBan0012953 FBgn0033997 CR12953 2 2R CR12953 CR12953 CG12953 CDMC23922 4 10 18 DAC29-D22 6-CR12953-RA_1 CR12953 ACCGGACGCAAGCAGATCAGAGGATTTGGATATCGCACATTTGTGGAGTACCTGCATCGCTACAATGCC 69 FBan0012953 FBgn0033997 CR12953 2 2R CR12953 CR12953 CG12953 CDMC23923 4 11 18 DAC29-H10 2-CR31490-RA_1 CR31490 CGGATAGCTCAGTCGGTAGAGCATTGGACTTTTAATCCAAGGGTCCAGGGTTCAAGTCCCTGTTCGGGC 69 FBan0031490 FBgn0026162 tRNA:K5:84ABd 3 3R tRNA:K5:84ABd tRNA:K5:84ABd "lys5:84ABd, AE002699.trna8-LysTTT, BG:DS00276.4, tRNA:K5, CR31490, tRNA:K:TTT:AE002699-c" CDMC23923 4 12 18 DAC29-H10 2-CR31490-RA_1 CR31490 CGGATAGCTCAGTCGGTAGAGCATTGGACTTTTAATCCAAGGGTCCAGGGTTCAAGTCCCTGTTCGGGC 69 FBan0031490 FBgn0026162 tRNA:K5:84ABd 3 3R tRNA:K5:84ABd tRNA:K5:84ABd "lys5:84ABd, AE002699.trna8-LysTTT, BG:DS00276.4, tRNA:K5, CR31490, tRNA:K:TTT:AE002699-c" CDMC23924 4 13 18 DAC29-H22 23-CR31853-RA_1 CR31853 TGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACTCT 69 FBan0031853 FBgn0003935 snRNA:U5:34A 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:34A small nuclear RNA U5 at 34AB "dU5, K2, snRNA[[3]], U5, U5 small nuclear RNA, U5-34A, snRNA:U5, U5snRNA, CR31853, U5snRNA34AB, snRNA3, snRNA4, snRNA:U5:34AB, small nuclear RNA U5" CDMC23924 4 14 18 DAC29-H22 23-CR31853-RA_1 CR31853 TGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACTCT 69 FBan0031853 FBgn0003935 snRNA:U5:34A 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:34A small nuclear RNA U5 at 34AB "dU5, K2, snRNA[[3]], U5, U5 small nuclear RNA, U5-34A, snRNA:U5, U5snRNA, CR31853, U5snRNA34AB, snRNA3, snRNA4, snRNA:U5:34AB, small nuclear RNA U5" CDMC23925 4 15 18 DAC29-L10 23-CR32665-RA_12 CR32665 CATTGATAATCGTTCGAAACGTTCTCCGAAGCAAAATCAAGCAAGAGTAACGATTTCCGCATAGTCGAA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC23925 4 16 18 DAC29-L10 23-CR32665-RA_12 CR32665 CATTGATAATCGTTCGAAACGTTCTCCGAAGCAAAATCAAGCAAGAGTAACGATTTCCGCATAGTCGAA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC23926 4 17 18 DAC29-L22 3-CR32865-RA_2 CR32865 TGGAGAGCGGGGGGAAGTAGATAGCGGGGGGAAGTAGATGTCTGTACGAAAGCGAGAAGCATACAGAAA 69 FBan0032865 FBgn0052865 alphagamma-element:CR32865 3 3R alphagamma-element:CR32865 alphagamma-element:CR32865 CR32865 CDMC23926 4 18 18 DAC29-L22 3-CR32865-RA_2 CR32865 TGGAGAGCGGGGGGAAGTAGATAGCGGGGGGAAGTAGATGTCTGTACGAAAGCGAGAAGCATACAGAAA 69 FBan0032865 FBgn0052865 alphagamma-element:CR32865 3 3R alphagamma-element:CR32865 alphagamma-element:CR32865 CR32865 CDMC23927 4 19 18 DAC29-P10 17-CR40375-RA_3 CR40375 TGAGTTACAAACTCATGAACCATCCAGCTGAAATAAGCCAGTACCCCTCTGCTGATACGGGTATCGTCA 69 FBgn0058375 CR40375 CR40375 CR40375 BcDNA:RE28552 CDMC23927 4 20 18 DAC29-P10 17-CR40375-RA_3 CR40375 TGAGTTACAAACTCATGAACCATCCAGCTGAAATAAGCCAGTACCCCTCTGCTGATACGGGTATCGTCA 69 FBgn0058375 CR40375 CR40375 CR40375 BcDNA:RE28552 CDMC23928 4 21 18 DAC29-P22 10-CR41115-RA_1 CR41115 GCGGGTAGCTAAGCGCTGGCAAAGGCAATGACAAAAACAAAGACAAAGGAAATGCCGACGAGATTGAGA 69 FBgn0069905 CR41115 CR41115 CR41115 CDMC23928 4 22 18 DAC29-P22 10-CR41115-RA_1 CR41115 GCGGGTAGCTAAGCGCTGGCAAAGGCAATGACAAAAACAAAGACAAAGGAAATGCCGACGAGATTGAGA 69 FBgn0069905 CR41115 CR41115 CR41115 CDMC23929 4 23 18 DAC30-D10 2-CG12005-RB_2 CG12005 GCAGCTTTCGCTTAATTCGGACAACGAACAGTTGCGTGTAATCGCTCACCACCTGCTCTGTAGCATGGT 69 FBan0012005 FBgn0037301 Mms19 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription cofactor activity; GO:0003712; ; GO:0003712 Mms19 Mms19 "CG12005, dMMS19, NEST:bs07f08" CDMC23929 4 24 18 DAC30-D10 2-CG12005-RB_2 CG12005 GCAGCTTTCGCTTAATTCGGACAACGAACAGTTGCGTGTAATCGCTCACCACCTGCTCTGTAGCATGGT 69 FBan0012005 FBgn0037301 Mms19 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription cofactor activity; GO:0003712; ; GO:0003712 Mms19 Mms19 "CG12005, dMMS19, NEST:bs07f08" CDMC23930 4 25 18 DAC30-D22 13-CG12013-RB_1 CG12013 CATCGCCAAGGACATTGAAAAGCTGCTGTAGATGTGCCCTAGACGTTAGCTGCTCTTTTGGACTGTGTT 69 FBan0012013 FBgn0035438 PHGPx 3 3L defense response; GO:0006952; response to lipid hydroperoxide; GO:0006982; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 cytoplasm; GO:0005737; mitochondrion; GO:0005739 PHGPx PHGPx "CG12013, CG12013, CG12013, CG12013, DmPHGPx, anon-WO0257455.17" CDMC23930 4 26 18 DAC30-D22 13-CG12013-RB_1 CG12013 CATCGCCAAGGACATTGAAAAGCTGCTGTAGATGTGCCCTAGACGTTAGCTGCTCTTTTGGACTGTGTT 69 FBan0012013 FBgn0035438 PHGPx 3 3L defense response; GO:0006952; response to lipid hydroperoxide; GO:0006982; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 cytoplasm; GO:0005737; mitochondrion; GO:0005739 PHGPx PHGPx "CG12013, CG12013, CG12013, CG12013, DmPHGPx, anon-WO0257455.17" CDMC23931 4 1 19 DAC30-H10 11-CG12052-RC_4 CG12052 GACAACAGCGTGTCATCAGTGGGCTCCGAAATGGTTATTGAACCCAAAGCCGAATACGATGACGATGCG 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC23931 4 2 19 DAC30-H10 11-CG12052-RC_4 CG12052 GACAACAGCGTGTCATCAGTGGGCTCCGAAATGGTTATTGAACCCAAAGCCGAATACGATGACGATGCG 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC23932 4 3 19 DAC30-H22 2-CG12052-RN_1 CG12052 CCAGTGCGACTTCTGTCTCAAGTGGTTCAAGCGACGATCCCATCTGAATCGCCACAAGAAACTCCACGA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC23932 4 4 19 DAC30-H22 2-CG12052-RN_1 CG12052 CCAGTGCGACTTCTGTCTCAAGTGGTTCAAGCGACGATCCCATCTGAATCGCCACAAGAAACTCCACGA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC23933 4 5 19 DAC30-L10 17-CG12086-RA_1 CG12086 GCAGCCTAATACTTAACACTCGCCTGGGACACTTAACACTCGCCAAACCAAACCATTTACTTAAGCCGA 69 FBgn0035225 CDMC23933 4 6 19 DAC30-L10 17-CG12086-RA_1 CG12086 GCAGCCTAATACTTAACACTCGCCTGGGACACTTAACACTCGCCAAACCAAACCATTTACTTAAGCCGA 69 FBgn0035225 CDMC23934 4 7 19 DAC30-L22 23-CG12105-RA_4 CG12105 CATGCGAGGTAATTTTTTAAGGATCTCAACTCGACATTCAGTTACGTTATAGTGAGTGATTCGTCCTAG 69 FBan0012105 FBgn0035241 CG12105 3 3L CG12105 CG12105 CDMC23934 4 8 19 DAC30-L22 23-CG12105-RA_4 CG12105 CATGCGAGGTAATTTTTTAAGGATCTCAACTCGACATTCAGTTACGTTATAGTGAGTGATTCGTCCTAG 69 FBan0012105 FBgn0035241 CG12105 3 3L CG12105 CG12105 CDMC23935 4 9 19 DAC30-P10 23-CG12132-RA_3 CG12132 CATCCAAGGGACCAACTCGATTAATTAGATGTGCAGTTATGTTGTGTGTGTTTGTAAATTATGACTTAG 69 FBan0012132 FBgn0040236 c11.1 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c11.1 c11.1 "CG12132, CG12132, CG12132" CDMC23935 4 10 19 DAC30-P10 23-CG12132-RA_3 CG12132 CATCCAAGGGACCAACTCGATTAATTAGATGTGCAGTTATGTTGTGTGTGTTTGTAAATTATGACTTAG 69 FBan0012132 FBgn0040236 c11.1 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c11.1 c11.1 "CG12132, CG12132, CG12132" CDMC23936 4 11 19 DAC30-P22 3-CG12151-RA_1 CG12151 CCGACAGCCAGTCGTTCCTCAAGTGCCACAATGACAACGTGGACTTTGTTAGCATGATCAAGCCCATGT 69 FBan0012151 FBgn0029958 CG12151 X X glycolysis; GO:0006096; protein amino acid dephosphorylation; GO:0006470; pyruvate metabolism; GO:0006090; signal transduction; GO:0007165 [pyruvate dehydrogenase (lipoamide)] phosphatase activity; GO:0004741 ; EC:3.1.3.43; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004741 ; EC:3.1.3.43; ; GO:0004741 ; EC:3.1.3.43 mitochondrial matrix; GO:0005759 CG12151 CG12151 CDMC23936 4 12 19 DAC30-P22 3-CG12151-RA_1 CG12151 CCGACAGCCAGTCGTTCCTCAAGTGCCACAATGACAACGTGGACTTTGTTAGCATGATCAAGCCCATGT 69 FBan0012151 FBgn0029958 CG12151 X X glycolysis; GO:0006096; protein amino acid dephosphorylation; GO:0006470; pyruvate metabolism; GO:0006090; signal transduction; GO:0007165 [pyruvate dehydrogenase (lipoamide)] phosphatase activity; GO:0004741 ; EC:3.1.3.43; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004741 ; EC:3.1.3.43; ; GO:0004741 ; EC:3.1.3.43 mitochondrial matrix; GO:0005759 CG12151 CG12151 CDMC23937 4 13 19 DAC31-D10 14-CG3919-RA_1 CG3919 ACTGCGTCCCGAAATCAAGCACATGAACTTCCACCAGAAGCTGTACTTCAAGCGACGTGTGTACGA 66 FBan0003919 FBgn0036423 CG3919 3 3L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3919 CG3919 CDMC23937 4 14 19 DAC31-D10 14-CG3919-RA_1 CG3919 ACTGCGTCCCGAAATCAAGCACATGAACTTCCACCAGAAGCTGTACTTCAAGCGACGTGTGTACGA 66 FBan0003919 FBgn0036423 CG3919 3 3L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3919 CG3919 CDMC23938 4 15 19 DAC31-D22 1-CG40323-RB_2 CG40323 CGAGTACGGAACCAGTACGGGACCCAGTACGGAATCGAGTACGGAATCGAGTACGGGACCAGTACG 66 FBgn0058323 CG40323 cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872 CG40323 CG40323 CDMC23938 4 16 19 DAC31-D22 1-CG40323-RB_2 CG40323 CGAGTACGGAACCAGTACGGGACCCAGTACGGAATCGAGTACGGAATCGAGTACGGGACCAGTACG 66 FBgn0058323 CG40323 cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872 CG40323 CG40323 CDMC23939 4 17 19 DAC31-H10 6-CG4500-RA_2 CG4500 GCTTGGTTTTCATGGGCTACTTGGGACTGCCGGATAAGACTGAGGAAACGGTCAAAGAGGATGGCT 66 FBan0004500 FBgn0028519 CG4500 2 2L fatty acid metabolism; GO:0006631; mesoderm development; GO:0007498 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG4500 CG4500 "I: Intensifier of Bar, BG:DS05899.1, 2a9, anon-EST:CL2a9, I" CDMC23939 4 18 19 DAC31-H10 6-CG4500-RA_2 CG4500 GCTTGGTTTTCATGGGCTACTTGGGACTGCCGGATAAGACTGAGGAAACGGTCAAAGAGGATGGCT 66 FBan0004500 FBgn0028519 CG4500 2 2L fatty acid metabolism; GO:0006631; mesoderm development; GO:0007498 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG4500 CG4500 "I: Intensifier of Bar, BG:DS05899.1, 2a9, anon-EST:CL2a9, I" CDMC23940 4 19 19 DAC31-H22 3-CG4627-RA_2 CG4627 GCGTCCTCAAATCTCGTGGGCTTCATCTACGTGAACGAGGAACAGGATCTGCTCAAGCTGGCCTAC 66 FBan0004627 FBgn0033808 CG4627 2 2R CG4627 CG4627 CDMC23940 4 20 19 DAC31-H22 3-CG4627-RA_2 CG4627 GCGTCCTCAAATCTCGTGGGCTTCATCTACGTGAACGAGGAACAGGATCTGCTCAAGCTGGCCTAC 66 FBan0004627 FBgn0033808 CG4627 2 2R CG4627 CG4627 CDMC23941 4 21 19 DAC31-L10 5-CG4968-RA_3 CG4968 GGCGACGAGATCTTCACCGCCAAGATCCAGGATCTGTCCAAAAAGTACAAGTTCATTCGCCGCACC 66 FBan0004968 FBgn0032214 CG4968 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4968 CG4968 CDMC23941 4 22 19 DAC31-L10 5-CG4968-RA_3 CG4968 GGCGACGAGATCTTCACCGCCAAGATCCAGGATCTGTCCAAAAAGTACAAGTTCATTCGCCGCACC 66 FBan0004968 FBgn0032214 CG4968 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4968 CG4968 CDMC23942 4 23 19 DAC31-L22 3-CG5061-RA_1 CG5061 CAAGTGTGAGGGATCCACTCTGACCGTCAAGGGCAAGGTGAACAACATCGTCTTCGACTCCTGCAA 66 FBan0033979 FBgn0028388 capt 2 2L actin filament organization; GO:0007015; actin polymerization and/or depolymerization; GO:0008154; bristle morphogenesis; GO:0008407; cellular morphogenesis; GO:0000902; eye development (sensu Endopterygota); GO:0007456; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; adenylate cyclase binding; GO:0008179; ; GO:0008179; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008179 membrane; GO:0016020; microtubule cytoskeleton; GO:0015630 capt capulet "CG33979, CG5061, CG5074, CG33979, l(2)06955, Cap, Dcap, Adenylyl cyclase-associated protein, acu, act up, cap, Act up, Acap, CAP, Capt, capping protein, cyclase-associated protein, BcDNA:LD24380, l(2)k00619, capulet" CDMC23942 4 24 19 DAC31-L22 3-CG5061-RA_1 CG5061 CAAGTGTGAGGGATCCACTCTGACCGTCAAGGGCAAGGTGAACAACATCGTCTTCGACTCCTGCAA 66 FBan0033979 FBgn0028388 capt 2 2L actin filament organization; GO:0007015; actin polymerization and/or depolymerization; GO:0008154; bristle morphogenesis; GO:0008407; cellular morphogenesis; GO:0000902; eye development (sensu Endopterygota); GO:0007456; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; adenylate cyclase binding; GO:0008179; ; GO:0008179; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008179 membrane; GO:0016020; microtubule cytoskeleton; GO:0015630 capt capulet "CG33979, CG5061, CG5074, CG33979, l(2)06955, Cap, Dcap, Adenylyl cyclase-associated protein, acu, act up, cap, Act up, Acap, CAP, Capt, capping protein, cyclase-associated protein, BcDNA:LD24380, l(2)k00619, capulet" CDMC23943 4 25 19 DAC31-P10 3-CG5508-RA_6 CG5508 AGGACATTGGTTTTTCCGGGGAATCCTCGCAAATTGTGGCATATGCCTGTGACCTACTCGGCTCAG 66 FBan0005508 FBgn0027579 CG5508 3 3R phospholipid biosynthesis; GO:0008654; plasma membrane organization and biogenesis; GO:0007009 glycerol-3-phosphate O-acyltransferase activity; GO:0004366 ; EC:2.3.1.15; ; GO:0004366 ; EC:2.3.1.15; ; GO:0004366 ; EC:2.3.1.15 mitochondrial outer membrane; GO:0005741 CG5508 CG5508 BcDNA:GH07066 CDMC23943 4 26 19 DAC31-P10 3-CG5508-RA_6 CG5508 AGGACATTGGTTTTTCCGGGGAATCCTCGCAAATTGTGGCATATGCCTGTGACCTACTCGGCTCAG 66 FBan0005508 FBgn0027579 CG5508 3 3R phospholipid biosynthesis; GO:0008654; plasma membrane organization and biogenesis; GO:0007009 glycerol-3-phosphate O-acyltransferase activity; GO:0004366 ; EC:2.3.1.15; ; GO:0004366 ; EC:2.3.1.15; ; GO:0004366 ; EC:2.3.1.15 mitochondrial outer membrane; GO:0005741 CG5508 CG5508 BcDNA:GH07066 CDMC23944 4 1 20 DAC31-P22 AutoBlank AutoBlank CDMC23944 4 2 20 DAC31-P22 AutoBlank AutoBlank CDMC23945 4 3 20 DAC32-D10 18-CG11156-RA_6 CG11156 GGTCCAACGTTAAGCGAGGAAGGTCAGAGCACTATTAACTTTGACAAGATTAGCTTCGAGGAGTCGGCC 69 FBan0011156 FBgn0002878 mus101 X X mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 intracellular; GO:0005622 mus101 mutagen-sensitive 101 "CG11156, mus-101, mus(1)101, fs(1)K451, mus 101, anon-WO0148202.1, DmMus101" CDMC23945 4 4 20 DAC32-D10 18-CG11156-RA_6 CG11156 GGTCCAACGTTAAGCGAGGAAGGTCAGAGCACTATTAACTTTGACAAGATTAGCTTCGAGGAGTCGGCC 69 FBan0011156 FBgn0002878 mus101 X X mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 intracellular; GO:0005622 mus101 mutagen-sensitive 101 "CG11156, mus-101, mus(1)101, fs(1)K451, mus 101, anon-WO0148202.1, DmMus101" CDMC23946 4 5 20 DAC32-D22 2-CG11168-RA_1 CG11168 GCCGCCAGTTCCTAAACCACGCACTCGAATAAACGGCGAATACAACGACTATGCGAATGTGGTGCCAAT 69 FBan0011168 FBgn0039249 CG11168 3 3R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG11168 CG11168 CDMC23946 4 6 20 DAC32-D22 2-CG11168-RA_1 CG11168 GCCGCCAGTTCCTAAACCACGCACTCGAATAAACGGCGAATACAACGACTATGCGAATGTGGTGCCAAT 69 FBan0011168 FBgn0039249 CG11168 3 3R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG11168 CG11168 CDMC23947 4 7 20 DAC32-H10 9-CG11219-RA_1 CG11219 AGCGGCAATTGGAGCAATCGGATCAATCGGATCAATCTGCTCATCAGGAGATCACCGACACAAGGAAGA 69 FBan0011219 FBgn0024943 PIP82 X X PIP82 PIP82 CG11219 CDMC23947 4 8 20 DAC32-H10 9-CG11219-RA_1 CG11219 AGCGGCAATTGGAGCAATCGGATCAATCGGATCAATCTGCTCATCAGGAGATCACCGACACAAGGAAGA 69 FBan0011219 FBgn0024943 PIP82 X X PIP82 PIP82 CG11219 CDMC23948 4 9 20 DAC32-H22 2-CG11242-RA_2 CG11242 ACGGTTCCAGGTAATCCAACACGACGAGGAACAATCCGATACAATGGTCCGCTCGAAGGGAAAAGTGGT 69 FBan0011242 FBgn0034451 CG11242 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein folding; GO:0006457 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" cytoskeleton; GO:0005856 CG11242 CG11242 CDMC23948 4 10 20 DAC32-H22 2-CG11242-RA_2 CG11242 ACGGTTCCAGGTAATCCAACACGACGAGGAACAATCCGATACAATGGTCCGCTCGAAGGGAAAAGTGGT 69 FBan0011242 FBgn0034451 CG11242 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein folding; GO:0006457 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" cytoskeleton; GO:0005856 CG11242 CG11242 CDMC23949 4 11 20 DAC32-L10 22-CG11271-RD_1 CG11271 TTTGCATTCGGTACAGTCATGCCACAATCACTACAATGAACACTCCACAGACCTCATTAGGAGCCGACG 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC23949 4 12 20 DAC32-L10 22-CG11271-RD_1 CG11271 TTTGCATTCGGTACAGTCATGCCACAATCACTACAATGAACACTCCACAGACCTCATTAGGAGCCGACG 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC23950 4 13 20 DAC32-L22 6-CG11282-RA_6 CG11282 AGCGGTGCCTTCAGTGGAAACACAAACCTGGAGCACCTTAACCTCTCCAGTAACAAGCAGTTGAACGAA 69 FBan0011282 FBgn0023095 caps 3 3L apoptosis; GO:0006915; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 membrane; GO:0016020 caps capricious "CG11282, CG11282, l(3)02937, CAPS, CT31495, Caps, BcDNA:LD07388, l(3)rM632, capricious" CDMC23950 4 14 20 DAC32-L22 6-CG11282-RA_6 CG11282 AGCGGTGCCTTCAGTGGAAACACAAACCTGGAGCACCTTAACCTCTCCAGTAACAAGCAGTTGAACGAA 69 FBan0011282 FBgn0023095 caps 3 3L apoptosis; GO:0006915; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 membrane; GO:0016020 caps capricious "CG11282, CG11282, l(3)02937, CAPS, CT31495, Caps, BcDNA:LD07388, l(3)rM632, capricious" CDMC23951 4 15 20 DAC32-P10 3-CG1131-RA_1 CG1131 CGAGCGATCTCGGTCTTAACCTAGATCCCAAACTGCGTGAGAACTACGGCTTGCAACTGAAGAAGGCGT 69 FBan0001131 FBgn0015569 alpha-Est10 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0004104 ; EC:3.1.1.8 alpha-Est10 alpha-Esterase-10 "CG1131, alphaE10, K, fragment K, aE10, alpha-Ests, anon-WO0172774.144" CDMC23951 4 16 20 DAC32-P10 3-CG1131-RA_1 CG1131 CGAGCGATCTCGGTCTTAACCTAGATCCCAAACTGCGTGAGAACTACGGCTTGCAACTGAAGAAGGCGT 69 FBan0001131 FBgn0015569 alpha-Est10 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0004104 ; EC:3.1.1.8 alpha-Est10 alpha-Esterase-10 "CG1131, alphaE10, K, fragment K, aE10, alpha-Ests, anon-WO0172774.144" CDMC23952 4 17 20 DAC32-P22 22-CG11325-RB_1 CG11325 ATCTCCCACTTTAAAGCCCATTTCTAGGCCGCAATTCATTTGATGTCAACACATCTGGTCATCAGCCAG 69 FBan0011325 FBgn0025595 GRHR 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; gonadotropin-releasing hormone receptor activity; GO:0004968; ; GO:0008188; ; GO:0004930; ; GO:0004968; ; GO:0001653 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHR Gonadotropin-releasing hormone receptor "CG11325, CG11325, CG11325, DGRHR, gonadotropin-releasing hormone receptor, gonadotrophin-releasing hormone receptor, hormone receptor, GRHR/CG11325, DAKHR, BEST:GH19447" CDMC23952 4 18 20 DAC32-P22 22-CG11325-RB_1 CG11325 ATCTCCCACTTTAAAGCCCATTTCTAGGCCGCAATTCATTTGATGTCAACACATCTGGTCATCAGCCAG 69 FBan0011325 FBgn0025595 GRHR 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; gonadotropin-releasing hormone receptor activity; GO:0004968; ; GO:0008188; ; GO:0004930; ; GO:0004968; ; GO:0001653 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHR Gonadotropin-releasing hormone receptor "CG11325, CG11325, CG11325, DGRHR, gonadotropin-releasing hormone receptor, gonadotrophin-releasing hormone receptor, hormone receptor, GRHR/CG11325, DAKHR, BEST:GH19447" CDMC23953 4 19 20 DAC33-D10 23-CG12607-RB_7 CG12607 TGCTTTGAACTTCTTAAGTGTAAATTGCTCGTTTGCTTCTGCTCGAGAAAATTTCGTGAAACCCCAAAA 69 FBan0012607 FBgn0035545 CG12607 3 3L CG12607 CG12607 BcDNA:RE67729 CDMC23953 4 20 20 DAC33-D10 23-CG12607-RB_7 CG12607 TGCTTTGAACTTCTTAAGTGTAAATTGCTCGTTTGCTTCTGCTCGAGAAAATTTCGTGAAACCCCAAAA 69 FBan0012607 FBgn0035545 CG12607 3 3L CG12607 CG12607 BcDNA:RE67729 CDMC23954 4 21 20 DAC33-D22 15-CG12624-RA_4 CG12624 TGCAGGAGCTGGATGAAAGTGGCTTGAAGGTGGTCTACAAATACTCATCGATGGCGGATGATCTGTTCT 69 FBan0012624 FBgn0030284 CG12624 X X CG12624 CG12624 CDMC23954 4 22 20 DAC33-D22 15-CG12624-RA_4 CG12624 TGCAGGAGCTGGATGAAAGTGGCTTGAAGGTGGTCTACAAATACTCATCGATGGCGGATGATCTGTTCT 69 FBan0012624 FBgn0030284 CG12624 X X CG12624 CG12624 CDMC23955 4 23 20 DAC33-H10 2-CG12673-RA_1 CG12673 GGCCGGAATGACACTGGAGGCACGTCTGATATCCTACGACTGGGAGAATCAATTTGGCGAATTCCAGGA 69 FBan0012673 FBgn0037153 olf413 3 3L catecholamine metabolism; GO:0006584; synaptic transmission; GO:0007268 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; copper ion binding; GO:0005507; ; GO:0004500 ; EC:1.14.17.1; ; GO:0005507 olf413 olf413 "CG7495, CG14461, CG12673, CG7495, CG14461, CG7495, CR33185" CDMC23955 4 24 20 DAC33-H10 2-CG12673-RA_1 CG12673 GGCCGGAATGACACTGGAGGCACGTCTGATATCCTACGACTGGGAGAATCAATTTGGCGAATTCCAGGA 69 FBan0012673 FBgn0037153 olf413 3 3L catecholamine metabolism; GO:0006584; synaptic transmission; GO:0007268 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; copper ion binding; GO:0005507; ; GO:0004500 ; EC:1.14.17.1; ; GO:0005507 olf413 olf413 "CG7495, CG14461, CG12673, CG7495, CG14461, CG7495, CR33185" CDMC23956 4 25 20 DAC33-H22 13-CG12682-RA_1 CG12682 CCACGTGGAAATCCCTCTTAAAGCAGATCGATGAAAAGGACATGCAAGAAACCAGGGACGTAACGGCAG 69 FBan0012682 FBgn0029729 CG12682 X X CG12682 CG12682 CDMC23956 4 26 20 DAC33-H22 13-CG12682-RA_1 CG12682 CCACGTGGAAATCCCTCTTAAAGCAGATCGATGAAAAGGACATGCAAGAAACCAGGGACGTAACGGCAG 69 FBan0012682 FBgn0029729 CG12682 X X CG12682 CG12682 CDMC23957 4 1 21 DAC33-L10 14-CG1273-RB_1 CG1273 CCCAGTGTAAGCCTTTCCAAGCCGAACTTCATGAACCTCAAGGAAATCATTCTGCAGAGGAATACCCCC 69 FBan0001273 FBgn0035522 CG1273 3 3L CG1273 CG1273 CDMC23957 4 2 21 DAC33-L10 14-CG1273-RB_1 CG1273 CCCAGTGTAAGCCTTTCCAAGCCGAACTTCATGAACCTCAAGGAAATCATTCTGCAGAGGAATACCCCC 69 FBan0001273 FBgn0035522 CG1273 3 3L CG1273 CG1273 CDMC23958 4 3 21 DAC33-L22 23-CG1274-RA_1 CG1274 TTCACGACTGAATCACGATGCAAACGAACAATCGCTAGAGTCCTCTGTACAGAAAATCCAAATCCGCAA 69 FBan0001274 FBgn0040308 Jafrac2 3 3L apoptosis; GO:0006915; defense response; GO:0006952; induction of apoptosis; GO:0006917; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.- extracellular region; GO:0005576 Jafrac2 thioredoxin peroxidase 2 "CG1274, CG1274, CG1274, DPx4156, Peroxiredoxin 4156, jafrac2, thioredoxin peroxidase, Prx4156, thioredoxin peroxidase 2" CDMC23958 4 4 21 DAC33-L22 23-CG1274-RA_1 CG1274 TTCACGACTGAATCACGATGCAAACGAACAATCGCTAGAGTCCTCTGTACAGAAAATCCAAATCCGCAA 69 FBan0001274 FBgn0040308 Jafrac2 3 3L apoptosis; GO:0006915; defense response; GO:0006952; induction of apoptosis; GO:0006917; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.- extracellular region; GO:0005576 Jafrac2 thioredoxin peroxidase 2 "CG1274, CG1274, CG1274, DPx4156, Peroxiredoxin 4156, jafrac2, thioredoxin peroxidase, Prx4156, thioredoxin peroxidase 2" CDMC23959 4 5 21 DAC33-P10 3-CG12785-RA_2 CG12785 TCCTTAAGCTACGATCTGGGGTCACCATTTGTTTCATTTAGCCAGCCAAACTTTAGCTTGCCCCGCGCA 69 FBan0012785 FBgn0038410 CG12785 3 3R CG12785 CG12785 CDMC23959 4 6 21 DAC33-P10 3-CG12785-RA_2 CG12785 TCCTTAAGCTACGATCTGGGGTCACCATTTGTTTCATTTAGCCAGCCAAACTTTAGCTTGCCCCGCGCA 69 FBan0012785 FBgn0038410 CG12785 3 3R CG12785 CG12785 CDMC23960 4 7 21 DAC33-P22 24-CG12798-RA_2 CG12798 GCCAGATAAACATAAAACATTTTAAAAAGATAGTTTTTCCAAAGAAATGTGTGAATCATTGTTTCAAAA 69 FBgn0039987 CG12798 CG12798 CG12798 "CT38386, SEK1/MKK4" CDMC23960 4 8 21 DAC33-P22 24-CG12798-RA_2 CG12798 GCCAGATAAACATAAAACATTTTAAAAAGATAGTTTTTCCAAAGAAATGTGTGAATCATTGTTTCAAAA 69 FBgn0039987 CG12798 CG12798 CG12798 "CT38386, SEK1/MKK4" CDMC23961 4 9 21 DAC34-D10 12-CG4365-RB_1 CG4365 GCCCCCAAACGGTCACACTCGCCCGAGCATAGCAGATTTGGAGAAAAAAACAACTTGCAAAAACTACGA 69 FBan0004365 FBgn0037024 CG4365 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydroxyacylglutathione hydrolase activity; GO:0004416 ; EC:3.1.2.6; ; GO:0004416 ; EC:3.1.2.6 CG4365 CG4365 CDMC23961 4 10 21 DAC34-D10 12-CG4365-RB_1 CG4365 GCCCCCAAACGGTCACACTCGCCCGAGCATAGCAGATTTGGAGAAAAAAACAACTTGCAAAAACTACGA 69 FBan0004365 FBgn0037024 CG4365 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydroxyacylglutathione hydrolase activity; GO:0004416 ; EC:3.1.2.6; ; GO:0004416 ; EC:3.1.2.6 CG4365 CG4365 CDMC23962 4 11 21 DAC34-D22 18-CG4379-RC_1 CG4379 TCGAAGACACAAGCCGGAACAACCTTTTCATCTAGTGTGTGAAGAAGAGTGGAAGGACTTGGAAGACGA 69 FBan0004379 FBgn0000273 Pka-C1 2 2L "activation of hh target transcription factor; GO:0007228; anterior/posterior pattern formation, imaginal disc; GO:0007448; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; eye development (sensu Endopterygota); GO:0007456; learning; GO:0007612; learning and/or memory; GO:0007611; leg morphogenesis (sensu Endopterygota); GO:0007480; locomotor rhythm; GO:0045475; memory; GO:0007613; negative regulation of smoothened signaling pathway; GO:0045879; olfactory learning; GO:0008355; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; rhythmic behavior; GO:0007622; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 Pka-C1 cAMP-dependent protein kinase 1 "CG4379, CG4379, l(2)cos[[1]], Cos-1, DC0, cos1: costal-1, dco, dcO, PKA, Pka, DCO, Cos, Costal, Cos1, pka, protein kinase A, Dco, Costal-1, pkA, pka-C1, l(2)01272, C: Group C, PKAc, Dc0, PKA-C1, 6353, pKA, Pka-C, Protein Kinase A, PKA Cl, PKAcA, dPKA, pka-c1, CdkA, Dcpk, l(2)s4402, costal-1, cos1" CDMC23962 4 12 21 DAC34-D22 18-CG4379-RC_1 CG4379 TCGAAGACACAAGCCGGAACAACCTTTTCATCTAGTGTGTGAAGAAGAGTGGAAGGACTTGGAAGACGA 69 FBan0004379 FBgn0000273 Pka-C1 2 2L "activation of hh target transcription factor; GO:0007228; anterior/posterior pattern formation, imaginal disc; GO:0007448; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; eye development (sensu Endopterygota); GO:0007456; learning; GO:0007612; learning and/or memory; GO:0007611; leg morphogenesis (sensu Endopterygota); GO:0007480; locomotor rhythm; GO:0045475; memory; GO:0007613; negative regulation of smoothened signaling pathway; GO:0045879; olfactory learning; GO:0008355; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; rhythmic behavior; GO:0007622; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 Pka-C1 cAMP-dependent protein kinase 1 "CG4379, CG4379, l(2)cos[[1]], Cos-1, DC0, cos1: costal-1, dco, dcO, PKA, Pka, DCO, Cos, Costal, Cos1, pka, protein kinase A, Dco, Costal-1, pkA, pka-C1, l(2)01272, C: Group C, PKAc, Dc0, PKA-C1, 6353, pKA, Pka-C, Protein Kinase A, PKA Cl, PKAcA, dPKA, pka-c1, CdkA, Dcpk, l(2)s4402, costal-1, cos1" CDMC23963 4 13 21 DAC34-H10 2-CG4422-RA_1 CG4422 AGGAGCAGTAAACGGGAATGAAGGCCTCATCTGGTTATGGTGCATTTGGACAGCTCAACATCAGCCACA 69 FBan0004422 FBgn0004868 Gdi 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 GDP-dissociation inhibitor activity; GO:0005092; ; GO:0005092; ; GO:0005092; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0005092; Rab GDP-dissociation inhibitor activity; GO:0005093; ; GO:0005093 synaptic vesicle; GO:0008021 Gdi GDP dissociation inhibitor "CG4422, CG4422, GDI, dGDI, l(2)N7-3, rab GDI, rab GDP dissociation inhibitor, N7-3, Gdi-related, GdI" CDMC23963 4 14 21 DAC34-H10 2-CG4422-RA_1 CG4422 AGGAGCAGTAAACGGGAATGAAGGCCTCATCTGGTTATGGTGCATTTGGACAGCTCAACATCAGCCACA 69 FBan0004422 FBgn0004868 Gdi 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 GDP-dissociation inhibitor activity; GO:0005092; ; GO:0005092; ; GO:0005092; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0005092; Rab GDP-dissociation inhibitor activity; GO:0005093; ; GO:0005093 synaptic vesicle; GO:0008021 Gdi GDP dissociation inhibitor "CG4422, CG4422, GDI, dGDI, l(2)N7-3, rab GDI, rab GDP dissociation inhibitor, N7-3, Gdi-related, GdI" CDMC23964 4 15 21 DAC34-H22 10-CG4432-RA_1 CG4432 AGGGCAGTTCCAATCGAAATCGGAAGAGAAAACGGAATCCAAGCGTATCAGCGTTGAGCACACTGTCAA 69 FBan0004432 FBgn0035976 PGRP-LC 3 3L "anti-Gram-negative bacterial polypeptide induction; GO:0006964; antibacterial humoral response; GO:0019731; antibacterial polypeptide induction; GO:0006963; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; response to bacteria; GO:0009617; response to pest, pathogen or parasite; GO:0009613" transcription factor activity; GO:0003700; protein binding; GO:0005515; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; Gram-negative bacterial binding; GO:0008368; ; GO:0016019; ; GO:0008368; protein dimerization activity; GO:0046983; ; GO:0003700; ; GO:0005515; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0046983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622 PGRP-LC Peptidoglycan recognition protein LC "CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, ird7, immune response deficient 7, tot, totem, PGRP-LCx" CDMC23964 4 16 21 DAC34-H22 10-CG4432-RA_1 CG4432 AGGGCAGTTCCAATCGAAATCGGAAGAGAAAACGGAATCCAAGCGTATCAGCGTTGAGCACACTGTCAA 69 FBan0004432 FBgn0035976 PGRP-LC 3 3L "anti-Gram-negative bacterial polypeptide induction; GO:0006964; antibacterial humoral response; GO:0019731; antibacterial polypeptide induction; GO:0006963; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; phagocytosis; GO:0006909; regulation of transcription, DNA-dependent; GO:0006355; response to bacteria; GO:0009617; response to pest, pathogen or parasite; GO:0009613" transcription factor activity; GO:0003700; protein binding; GO:0005515; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; Gram-negative bacterial binding; GO:0008368; ; GO:0016019; ; GO:0008368; protein dimerization activity; GO:0046983; ; GO:0003700; ; GO:0005515; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0046983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622 PGRP-LC Peptidoglycan recognition protein LC "CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, CG4432, ird7, immune response deficient 7, tot, totem, PGRP-LCx" CDMC23965 4 17 21 DAC34-L10 23-CG4466-RA_3 CG4466 GCGGCGAGAAAATGGAGACTAGCAAGTAAAAGACGAAAAGAGGAAGACTAGGAGATGAAGAAGACGAGA 69 FBan0004466 FBgn0001226 Hsp27 3 3L defense response; GO:0006952; determination of adult life span; GO:0008340; protein folding; GO:0006457; protein refolding; GO:0042026; response to heat; GO:0009408 Hsp27 Heat shock protein 27 "CG4466, hsp27, hsp28, hsp 27, 28, Protein 27, Hsp28, Dhsp27, 27K, hsp27/26, hsp26, HSP27, heat shock protein hsp27, hsp-27, DmHsp27, HSP28, anon-WO0140519.69" CDMC23965 4 18 21 DAC34-L10 23-CG4466-RA_3 CG4466 GCGGCGAGAAAATGGAGACTAGCAAGTAAAAGACGAAAAGAGGAAGACTAGGAGATGAAGAAGACGAGA 69 FBan0004466 FBgn0001226 Hsp27 3 3L defense response; GO:0006952; determination of adult life span; GO:0008340; protein folding; GO:0006457; protein refolding; GO:0042026; response to heat; GO:0009408 Hsp27 Heat shock protein 27 "CG4466, hsp27, hsp28, hsp 27, 28, Protein 27, Hsp28, Dhsp27, 27K, hsp27/26, hsp26, HSP27, heat shock protein hsp27, hsp-27, DmHsp27, HSP28, anon-WO0140519.69" CDMC23966 4 19 21 DAC34-L22 3-CG4477-RB_1 CG4477 TCCGCTTGCCTCGTACATGCTGTATATCGATGTGCAGGTGATAGATTCCGAGGCATGTGCCAAATGGCT 69 FBan0004477 FBgn0035971 CG4477 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4477 CG4477 CDMC23966 4 20 21 DAC34-L22 3-CG4477-RB_1 CG4477 TCCGCTTGCCTCGTACATGCTGTATATCGATGTGCAGGTGATAGATTCCGAGGCATGTGCCAAATGGCT 69 FBan0004477 FBgn0035971 CG4477 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4477 CG4477 CDMC23967 4 21 21 DAC34-P10 8-CG4527-RA_1 CG4527 TGTCTGCCACTGATACGAGAACTGGGACAAAGACAGACGAACCCCAAGCTCATCTTCAAACCGCTGCAA 69 FBan0004527 FBgn0035001 slik 2 2R MAPKKK cascade; GO:0000165; cell proliferation; GO:0008283; cytokinesis; GO:0000910; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; polo kinase kinase activity; GO:0042801; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042801 slik Sterile20-like kinase "CG4527, CG4527, CG4527, CG4527, CG4527, SLK, slk, DPlkk1, Polo kinase kinase 1, polo kinase kinase 1, Plkk1, Sterile20-like kinase" CDMC23967 4 22 21 DAC34-P10 8-CG4527-RA_1 CG4527 TGTCTGCCACTGATACGAGAACTGGGACAAAGACAGACGAACCCCAAGCTCATCTTCAAACCGCTGCAA 69 FBan0004527 FBgn0035001 slik 2 2R MAPKKK cascade; GO:0000165; cell proliferation; GO:0008283; cytokinesis; GO:0000910; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; polo kinase kinase activity; GO:0042801; ; GO:0004702 ; EC:2.7.1.-; ; GO:0042801 slik Sterile20-like kinase "CG4527, CG4527, CG4527, CG4527, CG4527, SLK, slk, DPlkk1, Polo kinase kinase 1, polo kinase kinase 1, Plkk1, Sterile20-like kinase" CDMC23968 4 23 21 DAC34-P22 23-CG4537-RA_2 CG4537 GAAATATGCGGTCAATCGGTAGCAAACAATCGATATTAATATCAATGGAATGGTCACTCTGTTTTTGCA 69 FBan0004537 FBgn0032153 CG4537 2 2L CG4537 CG4537 CDMC23968 4 24 21 DAC34-P22 23-CG4537-RA_2 CG4537 GAAATATGCGGTCAATCGGTAGCAAACAATCGATATTAATATCAATGGAATGGTCACTCTGTTTTTGCA 69 FBan0004537 FBgn0032153 CG4537 2 2L CG4537 CG4537 CDMC23969 4 25 21 DAC35-D10 1-CG8821-RB_1 CG8821 TGGGAGACTAGAGCCTCAAACCAAATACCCACGCAACAGATCCAGACTTCTCAAAGTGCCGAAGCGTGT 69 FBan0008821 FBgn0033748 vis 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0003700 nucleus; GO:0005634 vis vismay "CG8821, zaa, zuker-aly-like a, vismay" CDMC23969 4 26 21 DAC35-D10 1-CG8821-RB_1 CG8821 TGGGAGACTAGAGCCTCAAACCAAATACCCACGCAACAGATCCAGACTTCTCAAAGTGCCGAAGCGTGT 69 FBan0008821 FBgn0033748 vis 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0003700 nucleus; GO:0005634 vis vismay "CG8821, zaa, zuker-aly-like a, vismay" CDMC23970 4 1 22 DAC35-D22 12-CG8830-RB_1 CG8830 ACAGCCAGGATAGCGAGCACACCGGAGGCCACTAGAACATATACTTGTCTACTTTATGAAACACGCGCA 69 FBan0008830 FBgn0033738 CG8830 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG8830 CG8830 CDMC23970 4 2 22 DAC35-D22 12-CG8830-RB_1 CG8830 ACAGCCAGGATAGCGAGCACACCGGAGGCCACTAGAACATATACTTGTCTACTTTATGAAACACGCGCA 69 FBan0008830 FBgn0033738 CG8830 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG8830 CG8830 CDMC23971 4 3 22 DAC35-H10 23-CG8867-RA_4 CG8867 GACGTGCTATCAATTAATTTCCATTGGTATCAGAGGGCGAATTTCTTAGAGATAGGATAACGCCGAGTG 69 FBan0008867 FBgn0020906 Jon25Bi 2 2L proteolysis; GO:0006508 pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; elastase activity; GO:0042708; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008132 ; EC:3.4.21.-; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon25Bi Jonah 25Bi "CG8867, CG8867, 25B, Jon25B, Ser4: Serine protease 4, SP137, Jonah 25B, Serine protease 4, Jonah 25Bi" CDMC23971 4 4 22 DAC35-H10 23-CG8867-RA_4 CG8867 GACGTGCTATCAATTAATTTCCATTGGTATCAGAGGGCGAATTTCTTAGAGATAGGATAACGCCGAGTG 69 FBan0008867 FBgn0020906 Jon25Bi 2 2L proteolysis; GO:0006508 pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; elastase activity; GO:0042708; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008132 ; EC:3.4.21.-; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon25Bi Jonah 25Bi "CG8867, CG8867, 25B, Jon25B, Ser4: Serine protease 4, SP137, Jonah 25B, Serine protease 4, Jonah 25Bi" CDMC23972 4 5 22 DAC35-H22 6-CG8885-RA_4 CG8885 CAGTGCAGCCCATCTTTATCACCGTTGACCCAGAACGTGACTCCAAAGAGGTGGTGGCCAAATACGTAA 69 FBan0008885 FBgn0031656 CG8885 2 2L cation transport; GO:0006812; cytochrome c oxidase complex assembly; GO:0008535; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; copper chaperone activity; GO:0016531; ; GO:0016531; ; GO:0016531 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG8885 CG8885 CDMC23972 4 6 22 DAC35-H22 6-CG8885-RA_4 CG8885 CAGTGCAGCCCATCTTTATCACCGTTGACCCAGAACGTGACTCCAAAGAGGTGGTGGCCAAATACGTAA 69 FBan0008885 FBgn0031656 CG8885 2 2L cation transport; GO:0006812; cytochrome c oxidase complex assembly; GO:0008535; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; copper chaperone activity; GO:0016531; ; GO:0016531; ; GO:0016531 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG8885 CG8885 CDMC23973 4 7 22 DAC35-L10 8-CG8928-RA_1 CG8928 CCTGGACACAAGCCTGCGAGAGGACGAAAACATGCAACACATCCTGAAAACCTTTTACAGCAGCATCGA 69 FBan0008928 FBgn0030711 CG8928 X X CG8928 CG8928 CDMC23973 4 8 22 DAC35-L10 8-CG8928-RA_1 CG8928 CCTGGACACAAGCCTGCGAGAGGACGAAAACATGCAACACATCCTGAAAACCTTTTACAGCAGCATCGA 69 FBan0008928 FBgn0030711 CG8928 X X CG8928 CG8928 CDMC23974 4 9 22 DAC35-L22 24-CG8937-RC_3 CG8937 GGAGGTTGATTAGTGAAGTAGAAATTTACTATGGGTTCTACAGTTGATTTTAAAATGGTTTGAAATCCG 69 FBan0008937 FBgn0001216 Hsc70-1 3 3L defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-1 Heat shock protein cognate 1 "CG8937, hsc70, HSC1, Hsc70, dhsc70, HSC70, Hsc1, HSC-70, BcDNA:RH49358" CDMC23974 4 10 22 DAC35-L22 24-CG8937-RC_3 CG8937 GGAGGTTGATTAGTGAAGTAGAAATTTACTATGGGTTCTACAGTTGATTTTAAAATGGTTTGAAATCCG 69 FBan0008937 FBgn0001216 Hsc70-1 3 3L defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-1 Heat shock protein cognate 1 "CG8937, hsc70, HSC1, Hsc70, dhsc70, HSC70, Hsc1, HSC-70, BcDNA:RH49358" CDMC23975 4 11 22 DAC35-P10 1-CG8974-RA_1 CG8974 GGGGAACAAGGCAATACGAGGATGAACAGACCCTGTCCAAGCTGTTTTCGTATTTGGCCGTTGTGTGGA 69 FBan0008974 FBgn0030693 CG8974 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG8974 CG8974 CDMC23975 4 12 22 DAC35-P10 1-CG8974-RA_1 CG8974 GGGGAACAAGGCAATACGAGGATGAACAGACCCTGTCCAAGCTGTTTTCGTATTTGGCCGTTGTGTGGA 69 FBan0008974 FBgn0030693 CG8974 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG8974 CG8974 CDMC23976 4 13 22 DAC35-P22 10-CG8989-RB_1 CG8989 CCCAGCGATATCCATCCGTGTATATCCGTCAAGAGTCCACGACACAGCACAATCGTATCCTGGCCAATT 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC23976 4 14 22 DAC35-P22 10-CG8989-RB_1 CG8989 CCCAGCGATATCCATCCGTGTATATCCGTCAAGAGTCCACGACACAGCACAATCGTATCCTGGCCAATT 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC23977 4 15 22 DAC36-D10 1-CG7099-RA_1 CG7099 GAGAACAGCTTTGAAAGCCTTCGGCCGAAACTGCAGGAGAGTGGATATGACGATCGTGCCATCCG 65 FBan0007099 FBgn0032517 CG7099 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003712; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG7099 CG7099 CDMC23977 4 16 22 DAC36-D10 1-CG7099-RA_1 CG7099 GAGAACAGCTTTGAAAGCCTTCGGCCGAAACTGCAGGAGAGTGGATATGACGATCGTGCCATCCG 65 FBan0007099 FBgn0032517 CG7099 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003712; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG7099 CG7099 CDMC23978 4 17 22 DAC36-D22 2-CG7173-RA_2 CG7173 GCTTCAATGGCAATGTGATCATGAAGGACACCAAGCCAGTGTACGCACCCATCCAACAGCATGCG 65 FBan0007173 FBgn0037099 CG7173 3 3L CG7173 CG7173 CDMC23978 4 18 22 DAC36-D22 2-CG7173-RA_2 CG7173 GCTTCAATGGCAATGTGATCATGAAGGACACCAAGCCAGTGTACGCACCCATCCAACAGCATGCG 65 FBan0007173 FBgn0037099 CG7173 3 3L CG7173 CG7173 CDMC23979 4 19 22 DAC36-H10 1-CG7261-RA_1 CG7261 GAATGCCTGTTAAGAGCTCTTCAAGAGTACACCCTGGACAACCGTGGTGACATCGGAGCGTGGGT 65 FBan0007261 FBgn0027509 CG7261 2 2L cell cycle; GO:0007049; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG7261 CG7261 BcDNA:LD22320 CDMC23979 4 20 22 DAC36-H10 1-CG7261-RA_1 CG7261 GAATGCCTGTTAAGAGCTCTTCAAGAGTACACCCTGGACAACCGTGGTGACATCGGAGCGTGGGT 65 FBan0007261 FBgn0027509 CG7261 2 2L cell cycle; GO:0007049; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG7261 CG7261 BcDNA:LD22320 CDMC23980 4 21 22 DAC36-H22 3-CG7293-RA_1 CG7293 AACTCGCAGAATTGGAGGGTCAACTTGTTCGCGGCGGAAAAAACCTGCTGGACACGTACAGTGAG 65 FBan0007293 FBgn0004381 Klp68D 3 3L anterograde axon cargo transport; GO:0008089; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; motor activity; GO:0003774; ; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777 kinesin complex; GO:0005871; plus-end kinesin complex; GO:0005873 Klp68D Kinesin-like protein at 68D "CG7293, CG7293, CG7293, KLP-5, KLP5, KLP68D, DmKlp68D, KLP[[64D/68D]], kinesin II, klp68d, KIF3B, Klp5" CDMC23980 4 22 22 DAC36-H22 3-CG7293-RA_1 CG7293 AACTCGCAGAATTGGAGGGTCAACTTGTTCGCGGCGGAAAAAACCTGCTGGACACGTACAGTGAG 65 FBan0007293 FBgn0004381 Klp68D 3 3L anterograde axon cargo transport; GO:0008089; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; motor activity; GO:0003774; ; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777 kinesin complex; GO:0005871; plus-end kinesin complex; GO:0005873 Klp68D Kinesin-like protein at 68D "CG7293, CG7293, CG7293, KLP-5, KLP5, KLP68D, DmKlp68D, KLP[[64D/68D]], kinesin II, klp68d, KIF3B, Klp5" CDMC23981 4 23 22 DAC36-L10 9-CG7394-RA_3 CG7394 GACGCGCACAAGAAGATCATGCTGTTGAACCATCCGGATCGAGGAGGATCTCCCTATTTGGCGGC 65 FBan0007394 FBgn0036173 CG7394 3 3L CG7394 CG7394 "D.M.UKP, BcDNA:RE52392" CDMC23981 4 24 22 DAC36-L10 9-CG7394-RA_3 CG7394 GACGCGCACAAGAAGATCATGCTGTTGAACCATCCGGATCGAGGAGGATCTCCCTATTTGGCGGC 65 FBan0007394 FBgn0036173 CG7394 3 3L CG7394 CG7394 "D.M.UKP, BcDNA:RE52392" CDMC23982 4 25 22 DAC36-L22 5-CG7417-RA_2 CG7417 TTTGTGAGGCCTGTGAGAACGTTAGGATCCAGCCGGGTATGATACGCATTGTTCCCAGTGGAGGC 65 FBan0007417 FBgn0034431 Tab2 2 2R positive regulation of I-kappaB kinase/NF-kappaB cascade; GO:0043123; positive regulation of JNK cascade; GO:0046330; regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Tab2 Tab2 "CG7417, CG7417, CG7417, CG7417, CG7417, ORF1, 7417" CDMC23982 4 26 22 DAC36-L22 5-CG7417-RA_2 CG7417 TTTGTGAGGCCTGTGAGAACGTTAGGATCCAGCCGGGTATGATACGCATTGTTCCCAGTGGAGGC 65 FBan0007417 FBgn0034431 Tab2 2 2R positive regulation of I-kappaB kinase/NF-kappaB cascade; GO:0043123; positive regulation of JNK cascade; GO:0046330; regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Tab2 Tab2 "CG7417, CG7417, CG7417, CG7417, CG7417, ORF1, 7417" CDMC23983 4 1 23 DAC36-P10 3-CG7512-RA_7 CG7512 ACGCCGGAAGTGGTTAGTTCGAGATACAATAGTCGCCAGGAGTCGAACGACTTGGAGGTGGACCA 65 FBan0007512 FBgn0036168 CG7512 3 3L CG7512 CG7512 CDMC23983 4 2 23 DAC36-P10 3-CG7512-RA_7 CG7512 ACGCCGGAAGTGGTTAGTTCGAGATACAATAGTCGCCAGGAGTCGAACGACTTGGAGGTGGACCA 65 FBan0007512 FBgn0036168 CG7512 3 3L CG7512 CG7512 CDMC23984 4 3 23 DAC36-P22 AutoBlank AutoBlank CDMC23984 4 4 23 DAC36-P22 AutoBlank AutoBlank CDMC23985 4 5 23 DAC37-D10 18-CG12935-RA_5 CG12935 TCGGTGCGTTTTCTTATCTTGAGAAAGGGTGGTCAGAGCGTTTCCTTTGTGACCTACGGTCCCTT 65 FBan0012935 FBgn0033547 CG12935 2 2R CG12935 CG12935 CDMC23985 4 6 23 DAC37-D10 18-CG12935-RA_5 CG12935 TCGGTGCGTTTTCTTATCTTGAGAAAGGGTGGTCAGAGCGTTTCCTTTGTGACCTACGGTCCCTT 65 FBan0012935 FBgn0033547 CG12935 2 2R CG12935 CG12935 CDMC23986 4 7 23 DAC37-D22 2-CG12959-RA_1 CG12959 TTGGCTCCTGGGGAAAGTGCAACATTTGCGACTCCATTAACGGGTACACTCACTAACGCCCTTCG 65 FBan0012959 FBgn0034019 CG12959 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG12959 CG12959 CDMC23986 4 8 23 DAC37-D22 2-CG12959-RA_1 CG12959 TTGGCTCCTGGGGAAAGTGCAACATTTGCGACTCCATTAACGGGTACACTCACTAACGCCCTTCG 65 FBan0012959 FBgn0034019 CG12959 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG12959 CG12959 CDMC23987 4 9 23 DAC37-H10 23-CG13043-RA_3 CG13043 GCAAGAAACTCAAACCGATCACTCCCAATTCCAAACAGTCAATACAGACCTAACCCATTTCCAAA 65 FBan0013043 FBgn0036600 CG13043 3 3L CG13043 CG13043 "CT32262, BcDNA:RH10371" CDMC23987 4 10 23 DAC37-H10 23-CG13043-RA_3 CG13043 GCAAGAAACTCAAACCGATCACTCCCAATTCCAAACAGTCAATACAGACCTAACCCATTTCCAAA 65 FBan0013043 FBgn0036600 CG13043 3 3L CG13043 CG13043 "CT32262, BcDNA:RH10371" CDMC23988 4 11 23 DAC37-H22 3-CG13054-RA_1 CG13054 CTCGCCCGGTCTGGATTACTACGATCAGCAGGGACACATCTATGTGGAGGCTGTCTACAGACCCG 65 FBan0013054 FBgn0036584 CG13054 3 3L CG13054 CG13054 CDMC23988 4 12 23 DAC37-H22 3-CG13054-RA_1 CG13054 CTCGCCCGGTCTGGATTACTACGATCAGCAGGGACACATCTATGTGGAGGCTGTCTACAGACCCG 65 FBan0013054 FBgn0036584 CG13054 3 3L CG13054 CG13054 CDMC23989 4 13 23 DAC37-L10 16-CG13111-RA_1 CG13111 GGACGATCTCAGCGACGATGTCAACTCCTCGACGGATGACTGCGGGGACTGTTGTCTGGTGGACG 65 FBan0013111 FBgn0032112 CG13111 2 2L CG13111 CG13111 CDMC23989 4 14 23 DAC37-L10 16-CG13111-RA_1 CG13111 GGACGATCTCAGCGACGATGTCAACTCCTCGACGGATGACTGCGGGGACTGTTGTCTGGTGGACG 65 FBan0013111 FBgn0032112 CG13111 2 2L CG13111 CG13111 CDMC23990 4 15 23 DAC37-L22 18-CG13133-RA_2 CG13133 CGGCAGAGGCACTACTATCTCTCCCACGACCTGGACGTATGTGCGCGGGACTTTCACTTGCGGAT 65 FBan0013133 FBgn0032181 CG13133 2 2L CG13133 CG13133 CDMC23990 4 16 23 DAC37-L22 18-CG13133-RA_2 CG13133 CGGCAGAGGCACTACTATCTCTCCCACGACCTGGACGTATGTGCGCGGGACTTTCACTTGCGGAT 65 FBan0013133 FBgn0032181 CG13133 2 2L CG13133 CG13133 CDMC23991 4 17 23 DAC37-P10 3-CG13201-RA_1 CG13201 AATTGGACAACATTTCCAGGGTGAAGAGTTTGCTGGGACCACTGCGGGAGTCCATGTTCCTCACC 65 FBan0013201 FBgn0001276 ix 2 2R "female somatic sex determination; GO:0019101; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription, DNA-dependent; GO:0006355; sex determination; GO:0007530; sex differentiation; GO:0007548; somatic sex determination; GO:0018993" protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 mediator complex; GO:0000119 ix intersex "CG13201, CG13201, MED29, Intersex, Mediator complex subunit 29" CDMC23991 4 18 23 DAC37-P10 3-CG13201-RA_1 CG13201 AATTGGACAACATTTCCAGGGTGAAGAGTTTGCTGGGACCACTGCGGGAGTCCATGTTCCTCACC 65 FBan0013201 FBgn0001276 ix 2 2R "female somatic sex determination; GO:0019101; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription, DNA-dependent; GO:0006355; sex determination; GO:0007530; sex differentiation; GO:0007548; somatic sex determination; GO:0018993" protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 mediator complex; GO:0000119 ix intersex "CG13201, CG13201, MED29, Intersex, Mediator complex subunit 29" CDMC23992 4 19 23 DAC37-P22 AutoBlank AutoBlank CDMC23992 4 20 23 DAC37-P22 AutoBlank AutoBlank CDMC23993 4 21 23 DAC38-D10 13-CG3258-RA_2 CG3258 TGGGTTGCAATACATCAGAATACCAGGAACCAACACCTACCAACTGCTGACGACTGACTTATTGGGCGA 69 FBan0003258 FBgn0000137 ase X X "central nervous system development; GO:0007417; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 ase asense "CG3258, CG3258, T8, T1a, AS-C T8, ascT8, AS-C T8ase, as-T8, AS-T8, T1, EG:165H7.2, Asense, Ase, ASC, sc/T8" CDMC23993 4 22 23 DAC38-D10 13-CG3258-RA_2 CG3258 TGGGTTGCAATACATCAGAATACCAGGAACCAACACCTACCAACTGCTGACGACTGACTTATTGGGCGA 69 FBan0003258 FBgn0000137 ase X X "central nervous system development; GO:0007417; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 ase asense "CG3258, CG3258, T8, T1a, AS-C T8, ascT8, AS-C T8ase, as-T8, AS-T8, T1, EG:165H7.2, Asense, Ase, ASC, sc/T8" CDMC23994 4 23 23 DAC38-D22 7-CG32597-RA_1 CG32597 AGGGCCCCGACCTATGCATCTATCTATGCACCCATCATTCAACTACCGATTCACGCTTGCTTTGCTCAT 69 FBgn0052597 CDMC23994 4 24 23 DAC38-D22 7-CG32597-RA_1 CG32597 AGGGCCCCGACCTATGCATCTATCTATGCACCCATCATTCAACTACCGATTCACGCTTGCTTTGCTCAT 69 FBgn0052597 CDMC23995 4 25 23 DAC38-H10 23-CG3263-RC_5 CG3263 CATTTCCCAAAACTGCCAGCTAACGAGAAGATAACTGCAACAATTTATATCGGATAGCATGGGTTTGCC 69 FBan0003263 FBgn0000275 Pka-R1 3 3L actin filament organization; GO:0007015; cAMP-mediated signaling; GO:0019933; molting cycle (sensu Insecta); GO:0007591; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization; GO:0008103; protein amino acid phosphorylation; GO:0006468 cyclic nucleotide binding; GO:0030551; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603; ; GO:0008603; ; GO:0004702 ; EC:2.7.1.-; ; GO:0030551; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952; microtubule cytoskeleton; GO:0015630 Pka-R1 cAMP-dependent protein kinase R1 "CG3263, CG18677, RI, dr[[1]], PKA, pkA, PKC, DRI, Pka-RI, PKA-RI, dPKA-RI, pka-R1, PKAr, 18304, CdkR" CDMC23995 4 26 23 DAC38-H10 23-CG3263-RC_5 CG3263 CATTTCCCAAAACTGCCAGCTAACGAGAAGATAACTGCAACAATTTATATCGGATAGCATGGGTTTGCC 69 FBan0003263 FBgn0000275 Pka-R1 3 3L actin filament organization; GO:0007015; cAMP-mediated signaling; GO:0019933; molting cycle (sensu Insecta); GO:0007591; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization; GO:0008103; protein amino acid phosphorylation; GO:0006468 cyclic nucleotide binding; GO:0030551; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603; ; GO:0008603; ; GO:0004702 ; EC:2.7.1.-; ; GO:0030551; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952; microtubule cytoskeleton; GO:0015630 Pka-R1 cAMP-dependent protein kinase R1 "CG3263, CG18677, RI, dr[[1]], PKA, pkA, PKC, DRI, Pka-RI, PKA-RI, dPKA-RI, pka-R1, PKAr, 18304, CdkR" CDMC23996 4 1 24 DAC38-H22 14-CG32648-RA_1 CG32648 GGCCGGTTCTGGTAGTTCATGGAAATCGAGACTGCGCCAGTTCTCCGATTACTTTAGCTTCAGCTTTGA 69 FBan0032648 FBgn0052648 Pde9 X X cyclic nucleotide metabolism; GO:0009187; microtubule-based movement; GO:0007018; signal transduction; GO:0007165 "cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35" microtubule; GO:0005874 Pde9 Phosphodiesterase 9 "CG32648, CG1627, CG3761, CG3765, CG32648, CG32648, PDE9, Phosphodiesterase 9" CDMC23996 4 2 24 DAC38-H22 14-CG32648-RA_1 CG32648 GGCCGGTTCTGGTAGTTCATGGAAATCGAGACTGCGCCAGTTCTCCGATTACTTTAGCTTCAGCTTTGA 69 FBan0032648 FBgn0052648 Pde9 X X cyclic nucleotide metabolism; GO:0009187; microtubule-based movement; GO:0007018; signal transduction; GO:0007165 "cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.-; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35" microtubule; GO:0005874 Pde9 Phosphodiesterase 9 "CG32648, CG1627, CG3761, CG3765, CG32648, CG32648, PDE9, Phosphodiesterase 9" CDMC23997 4 3 24 DAC38-L10 6-CG32681-RA_4 CG32681 GGGTGGAACTAGGCCTAGATCGGGACACAATCCGCAACTGGATTACTACCATCAAAGAGGCTACAGCCA 69 FBan0032681 FBgn0052681 CG32681 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32681 CG32681 CDMC23997 4 4 24 DAC38-L10 6-CG32681-RA_4 CG32681 GGGTGGAACTAGGCCTAGATCGGGACACAATCCGCAACTGGATTACTACCATCAAAGAGGCTACAGCCA 69 FBan0032681 FBgn0052681 CG32681 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32681 CG32681 CDMC23998 4 5 24 DAC38-L22 17-CG32692-RA_2 CG32692 AGCGAGGGAGACAAAGGCATGAAAGTGAAAAACGAGAGACAGAAAGAGAAGACTGGTGAGTATGCGTGT 69 FBan0032692 FBgn0052692 CG32692 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32692 CG32692 CDMC23998 4 6 24 DAC38-L22 17-CG32692-RA_2 CG32692 AGCGAGGGAGACAAAGGCATGAAAGTGAAAAACGAGAGACAGAAAGAGAAGACTGGTGAGTATGCGTGT 69 FBan0032692 FBgn0052692 CG32692 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32692 CG32692 CDMC23999 4 7 24 DAC38-P10 23-CG32717-RC_5 CG32717 ACCCCTAGTACCCAATAAAATGTGTAATAATACCCATAAGCGACTCCGAATGTTAACAGAGCCAGAACA 69 FBan0032717 FBgn0003349 sdt X X NOT establishment and/or maintenance of neuroblast polarity; GO:0045196; asymmetric protein localization; GO:0008105; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; intercellular junction assembly; GO:0007043; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; protein targeting; GO:0006605; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; ; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515; ; GO:0004385 ; EC:2.7.4.8 adherens junction; GO:0005912; apical cortex; GO:0045179; apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell-cell adherens junction; GO:0005913; cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; subapical complex; GO:0035003 sdt stardust "CG15339, CG12657, CG15341, CG32717, CG15342, CG32716, CG12658, CG15340, CG1617, CG15339, CG12657, CG15339, CG15341, std, Std, PALS1, l(1)7Ef, anon-EST:fe2E6, anon-fast-evolving-2E6" CDMC23999 4 8 24 DAC38-P10 23-CG32717-RC_5 CG32717 ACCCCTAGTACCCAATAAAATGTGTAATAATACCCATAAGCGACTCCGAATGTTAACAGAGCCAGAACA 69 FBan0032717 FBgn0003349 sdt X X NOT establishment and/or maintenance of neuroblast polarity; GO:0045196; asymmetric protein localization; GO:0008105; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; intercellular junction assembly; GO:0007043; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; protein targeting; GO:0006605; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; ; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515; ; GO:0004385 ; EC:2.7.4.8 adherens junction; GO:0005912; apical cortex; GO:0045179; apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell-cell adherens junction; GO:0005913; cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; subapical complex; GO:0035003 sdt stardust "CG15339, CG12657, CG15341, CG32717, CG15342, CG32716, CG12658, CG15340, CG1617, CG15339, CG12657, CG15339, CG15341, std, Std, PALS1, l(1)7Ef, anon-EST:fe2E6, anon-fast-evolving-2E6" CDMC24000 4 9 24 DAC38-P22 23-CG32726-RA_5 CG32726 CAGTTCTTCGGGTTAAATAAATTGAAAGCAAAACACGAGAAAACTGGCAAAATTTCCATTGACGGACGA 69 FBan0032726 FBgn0052726 CG32726 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32726 CG32726 BcDNA:RH59280 CDMC24000 4 10 24 DAC38-P22 23-CG32726-RA_5 CG32726 CAGTTCTTCGGGTTAAATAAATTGAAAGCAAAACACGAGAAAACTGGCAAAATTTCCATTGACGGACGA 69 FBan0032726 FBgn0052726 CG32726 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32726 CG32726 BcDNA:RH59280 CDMC24001 4 11 24 DAC39-D10 9-CG13690-RA_1 CG13690 ACCAGGAGAAGTTGCTCAAACGTTTCCCCAGCTTTAAAATCACCGTGGCGAAAAAAGCTGACTCCACCT 69 FBan0013690 FBgn0031252 CG13690 2 2L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ribonuclease H1 activity; GO:0004524; ; GO:0004524; ; GO:0004524 CG13690 CG13690 CDMC24001 4 12 24 DAC39-D10 9-CG13690-RA_1 CG13690 ACCAGGAGAAGTTGCTCAAACGTTTCCCCAGCTTTAAAATCACCGTGGCGAAAAAAGCTGACTCCACCT 69 FBan0013690 FBgn0031252 CG13690 2 2L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ribonuclease H1 activity; GO:0004524; ; GO:0004524; ; GO:0004524 CG13690 CG13690 CDMC24002 4 13 24 DAC39-D22 5-CG13700-RA_1 CG13700 CGGAAGCCGGATCAAGATCGGACGAGACCATTGTCAACGATCCCAGTACTACCAGTTCAGCTCCATGTG 69 FBan0013700 FBgn0036785 CG13700 3 3L CG13700 CG13700 CDMC24002 4 14 24 DAC39-D22 5-CG13700-RA_1 CG13700 CGGAAGCCGGATCAAGATCGGACGAGACCATTGTCAACGATCCCAGTACTACCAGTTCAGCTCCATGTG 69 FBan0013700 FBgn0036785 CG13700 3 3L CG13700 CG13700 CDMC24003 4 15 24 DAC39-H10 8-CG13745-RA_3 CG13745 GGCCTGGTGCACAGAATGCTATTCGTTCAGCGTCAAAAGACCCACTTAGGTCCCTTCTTCGACAGTGTT 69 FBan0013745 FBgn0033354 CG13745 2 2R CG13745 CG13745 CDMC24003 4 16 24 DAC39-H10 8-CG13745-RA_3 CG13745 GGCCTGGTGCACAGAATGCTATTCGTTCAGCGTCAAAAGACCCACTTAGGTCCCTTCTTCGACAGTGTT 69 FBan0013745 FBgn0033354 CG13745 2 2R CG13745 CG13745 CDMC24004 4 17 24 DAC39-H22 3-CG13762-RA_2 CG13762 CGGCGGTGTTCATCGACTTTACGCTGTACAACGTGGACGTGAATCTGTTTAGCATTTGTACGCTGCGCG 69 FBan0013762 FBgn0040333 CG13762 X X calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG13762 CG13762 "CT33244, EG:BACR7C10.7" CDMC24004 4 18 24 DAC39-H22 3-CG13762-RA_2 CG13762 CGGCGGTGTTCATCGACTTTACGCTGTACAACGTGGACGTGAATCTGTTTAGCATTTGTACGCTGCGCG 69 FBan0013762 FBgn0040333 CG13762 X X calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG13762 CG13762 "CT33244, EG:BACR7C10.7" CDMC24005 4 19 24 DAC39-L10 15-CG13793-RA_2 CG13793 AGCTGAATGACTACGAGATTTCATGGCATTTATCGGGCCTGTTCGCTTTAGTTTGGGCCACGATTGCAT 69 FBan0013793 FBgn0031935 CG13793 2 2L CG13793 CG13793 CDMC24005 4 20 24 DAC39-L10 15-CG13793-RA_2 CG13793 AGCTGAATGACTACGAGATTTCATGGCATTTATCGGGCCTGTTCGCTTTAGTTTGGGCCACGATTGCAT 69 FBan0013793 FBgn0031935 CG13793 2 2L CG13793 CG13793 CDMC24006 4 21 24 DAC39-L22 8-CG13807-RA_1 CG13807 ACTCCCAATAACGAACCACCCATGAAGGTCAGACGCGACTATGGAAACTTTGTGCCTGCATCCAAGGAT 69 FBan0013807 FBgn0035323 CG13807 3 3L CG13807 CG13807 CDMC24006 4 22 24 DAC39-L22 8-CG13807-RA_1 CG13807 ACTCCCAATAACGAACCACCCATGAAGGTCAGACGCGACTATGGAAACTTTGTGCCTGCATCCAAGGAT 69 FBan0013807 FBgn0035323 CG13807 3 3L CG13807 CG13807 CDMC24007 4 23 24 DAC39-P10 23-CG13868-RA_3 CG13868 AATACTTTGTCCTTTCCACAGTAATATTCTTTTTAGTAGCATATAGGCACCTCTTACACCAGCACACAC 69 FBan0013868 FBgn0034501 CG13868 2 2R CG13868 CG13868 anon-WO0153538.60 CDMC24007 4 24 24 DAC39-P10 23-CG13868-RA_3 CG13868 AATACTTTGTCCTTTCCACAGTAATATTCTTTTTAGTAGCATATAGGCACCTCTTACACCAGCACACAC 69 FBan0013868 FBgn0034501 CG13868 2 2R CG13868 CG13868 anon-WO0153538.60 CDMC24008 4 25 24 DAC39-P22 9-CG13875-RA_1 CG13875 GGTGGCGGATATCCACCATGTGGAACGAAAACTTTTCACGGCCAATGAACAGCTTAAAGCCAAACTGGC 69 FBan0013875 FBgn0035104 CG13875 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG13875 CG13875 CDMC24008 4 26 24 DAC39-P22 9-CG13875-RA_1 CG13875 GGTGGCGGATATCCACCATGTGGAACGAAAACTTTTCACGGCCAATGAACAGCTTAAAGCCAAACTGGC 69 FBan0013875 FBgn0035104 CG13875 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG13875 CG13875 CDMC24009 4 1 25 DAC40-D10 6-CG14167-RA_1 CG14167 GACTCGACGTCTTCGGGATGGAGTCTTCGACGAGTGTTGCCTGAAGTCGTGCACCATGGATGAGG 65 FBgn0036047 CDMC24009 4 2 25 DAC40-D10 6-CG14167-RA_1 CG14167 GACTCGACGTCTTCGGGATGGAGTCTTCGACGAGTGTTGCCTGAAGTCGTGCACCATGGATGAGG 65 FBgn0036047 CDMC24010 4 3 25 DAC40-D22 2-CG14195-RA_1 CG14195 GATTCTTTGCAGGTATCGGCTCCAGCTTGTACCTGTGGAAGACGCACGTCATTCTGGAGGCAGTG 65 FBan0014195 FBgn0030998 CG14195 X X CG14195 CG14195 CDMC24010 4 4 25 DAC40-D22 2-CG14195-RA_1 CG14195 GATTCTTTGCAGGTATCGGCTCCAGCTTGTACCTGTGGAAGACGCACGTCATTCTGGAGGCAGTG 65 FBan0014195 FBgn0030998 CG14195 X X CG14195 CG14195 CDMC24011 4 5 25 DAC40-H10 3-CG14262-RA_1 CG14262 CCTCTGGATGGCATCTTTCCTGCCTTCGACCTAGCATTCCGGCATAACATCATCGATGTGGAGCG 65 FBan0014262 FBgn0039503 CG14262 3 3R CG14262 CG14262 CDMC24011 4 6 25 DAC40-H10 3-CG14262-RA_1 CG14262 CCTCTGGATGGCATCTTTCCTGCCTTCGACCTAGCATTCCGGCATAACATCATCGATGTGGAGCG 65 FBan0014262 FBgn0039503 CG14262 3 3R CG14262 CG14262 CDMC24012 4 7 25 DAC40-H22 17-CG14290-RB_9 CG14290 ATTAGCAAAGCGGTAGCATCATGTCGATCAGGAGAGCTATGTCCACAACGGCCTCAAAGGAGTGG 65 FBan0014290 FBgn0038662 CG14290 3 3R CG14290 CG14290 CDMC24012 4 8 25 DAC40-H22 17-CG14290-RB_9 CG14290 ATTAGCAAAGCGGTAGCATCATGTCGATCAGGAGAGCTATGTCCACAACGGCCTCAAAGGAGTGG 65 FBan0014290 FBgn0038662 CG14290 3 3R CG14290 CG14290 CDMC24013 4 9 25 DAC40-L10 3-CG14390-RA_1 CG14390 GATCAGACGGCCAATATGACAGTCGGAGTGTTGCCCAAATTCGATCCGTTCATTTCGGGCGTGCG 65 FBan0014390 FBgn0038084 beat-Vc 3 3R extracellular region; GO:0005576 beat-Vc beat-Vc "CG14390, beat Vc" CDMC24013 4 10 25 DAC40-L10 3-CG14390-RA_1 CG14390 GATCAGACGGCCAATATGACAGTCGGAGTGTTGCCCAAATTCGATCCGTTCATTTCGGGCGTGCG 65 FBan0014390 FBgn0038084 beat-Vc 3 3R extracellular region; GO:0005576 beat-Vc beat-Vc "CG14390, beat Vc" CDMC24014 4 11 25 DAC40-L22 2-CG14411-RA_1 CG14411 CTCACATCGGTTACCGGCAATCTGCAGCTATCGACCCTGTCGTCGTTCTTTCCCTTCGGGAATCC 65 FBan0014411 FBgn0030582 CG14411 X X protein metabolism; GO:0019538 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG14411 CG14411 CDMC24014 4 12 25 DAC40-L22 2-CG14411-RA_1 CG14411 CTCACATCGGTTACCGGCAATCTGCAGCTATCGACCCTGTCGTCGTTCTTTCCCTTCGGGAATCC 65 FBan0014411 FBgn0030582 CG14411 X X protein metabolism; GO:0019538 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG14411 CG14411 CDMC24015 4 13 25 DAC40-P10 3-CG14478-RA_2 CG14478 TGCAAAGGAGCTGACAGGACTGCTTGGAGACCGACGGACTGAAAGCGAGAAAGACAGACGATTGG 65 FBan0014478 FBgn0028953 CG14478 2 2R CG14478 CG14478 "GENE 4, gene 4, BEST:LD13441" CDMC24015 4 14 25 DAC40-P10 3-CG14478-RA_2 CG14478 TGCAAAGGAGCTGACAGGACTGCTTGGAGACCGACGGACTGAAAGCGAGAAAGACAGACGATTGG 65 FBan0014478 FBgn0028953 CG14478 2 2R CG14478 CG14478 "GENE 4, gene 4, BEST:LD13441" CDMC24016 4 15 25 DAC40-P22 AutoBlank AutoBlank CDMC24016 4 16 25 DAC40-P22 AutoBlank AutoBlank CDMC24017 4 17 25 DAC41-D10 AutoBlank AutoBlank CDMC24017 4 18 25 DAC41-D10 AutoBlank AutoBlank CDMC24018 4 19 25 DAC41-D22 AutoBlank AutoBlank CDMC24018 4 20 25 DAC41-D22 AutoBlank AutoBlank CDMC24019 4 21 25 DAC41-H10 AutoBlank AutoBlank CDMC24019 4 22 25 DAC41-H10 AutoBlank AutoBlank CDMC24020 4 23 25 DAC41-H22 AutoBlank AutoBlank CDMC24020 4 24 25 DAC41-H22 AutoBlank AutoBlank CDMC24021 4 25 25 DAC41-L10 AutoBlank AutoBlank CDMC24021 4 26 25 DAC41-L10 AutoBlank AutoBlank CDMC24022 4 1 26 DAC41-L22 AutoBlank AutoBlank CDMC24022 4 2 26 DAC41-L22 AutoBlank AutoBlank CDMC24023 4 3 26 DAC41-P10 AutoBlank AutoBlank CDMC24023 4 4 26 DAC41-P10 AutoBlank AutoBlank CDMC24024 4 5 26 DAC41-P22 AutoBlank AutoBlank CDMC24024 4 6 26 DAC41-P22 AutoBlank AutoBlank CDMC24025 4 7 26 DAC42-D10 150mM NaPO4 Blank CDMC24025 4 8 26 DAC42-D10 150mM NaPO4 Blank CDMC24026 4 9 26 DAC42-D22 150mM NaPO4 Blank CDMC24026 4 10 26 DAC42-D22 150mM NaPO4 Blank CDMC24027 4 11 26 DAC42-H10 150mM NaPO4 Blank CDMC24027 4 12 26 DAC42-H10 150mM NaPO4 Blank CDMC24028 4 13 26 DAC42-H22 150mM NaPO4 Blank CDMC24028 4 14 26 DAC42-H22 150mM NaPO4 Blank CDMC24029 4 15 26 DAC42-L10 150mM NaPO4 Blank CDMC24029 4 16 26 DAC42-L10 150mM NaPO4 Blank CDMC24030 4 17 26 DAC42-L22 5uM MSP 5uM MSP CDMC24030 4 18 26 DAC42-L22 5uM MSP 5uM MSP CDMC24031 4 19 26 DAC42-P10 10uM MSP 10uM MSP CDMC24031 4 20 26 DAC42-P10 10uM MSP 10uM MSP CDMC24032 4 21 26 DAC42-P22 20uM MSP 20uM MSP CDMC24032 4 22 26 DAC42-P22 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC24033 1 1 1 DAC01-A09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24033 1 2 1 DAC01-A09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24034 1 3 1 DAC01-A21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24034 1 4 1 DAC01-A21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24035 1 5 1 DAC01-E09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24035 1 6 1 DAC01-E09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24036 1 7 1 DAC01-E21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24036 1 8 1 DAC01-E21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24037 1 9 1 DAC01-I09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24037 1 10 1 DAC01-I09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24038 1 11 1 DAC01-I21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24038 1 12 1 DAC01-I21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24039 1 13 1 DAC01-M09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24039 1 14 1 DAC01-M09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24040 1 15 1 DAC01-M21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24040 1 16 1 DAC01-M21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24041 1 17 1 DAC02-A09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24041 1 18 1 DAC02-A09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24042 1 19 1 DAC02-A21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24042 1 20 1 DAC02-A21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24043 1 21 1 DAC02-E09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24043 1 22 1 DAC02-E09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24044 1 23 1 DAC02-E21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24044 1 24 1 DAC02-E21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24045 1 25 1 DAC02-I09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24045 1 26 1 DAC02-I09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24046 1 1 2 DAC02-I21 N/A CG9075 (00240-00478) CDMC24046 1 2 2 DAC02-I21 N/A CG9075 (00240-00478) CDMC24047 1 3 2 DAC02-M09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24047 1 4 2 DAC02-M09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24048 1 5 2 DAC02-M21 AutoBlank AutoBlank CDMC24048 1 6 2 DAC02-M21 AutoBlank AutoBlank CDMC24049 1 7 2 DAC03-A09 14-CG17082-RB_1 CG17082 TGATGCACGATCACAAAAGAAAAAATCGAGTGAAGTGCTGTCAGCCTCAGAGAATGAATGCGGTCGCCT 69 FBgn0039994 CG17082 CG17082 CG17082 "CG40286, CG40286, BcDNA:LD04957" CDMC24049 1 8 2 DAC03-A09 14-CG17082-RB_1 CG17082 TGATGCACGATCACAAAAGAAAAAATCGAGTGAAGTGCTGTCAGCCTCAGAGAATGAATGCGGTCGCCT 69 FBgn0039994 CG17082 CG17082 CG17082 "CG40286, CG40286, BcDNA:LD04957" CDMC24050 1 9 2 DAC03-A21 11-CG17098-RA_2 CG17098 ACCCGATCCGATCATTCCCAGTGTCTCGAGCAGGGATCCACACTACTTCATACAAAATCAAAGCCACCA 69 FBan0017098 FBgn0032276 CG17098 2 2L CG17098 CG17098 CDMC24050 1 10 2 DAC03-A21 11-CG17098-RA_2 CG17098 ACCCGATCCGATCATTCCCAGTGTCTCGAGCAGGGATCCACACTACTTCATACAAAATCAAAGCCACCA 69 FBan0017098 FBgn0032276 CG17098 2 2L CG17098 CG17098 CDMC24051 1 11 2 DAC03-E09 11-CG17143-RB_1 CG17143 CGGGGATGGAACTGGAGAGGATCGGAGAATAGTAGTGTTGCTGAAACAGTTCTTGAAGTGGGCCAGTGA 69 FBan0017143 FBgn0035110 thoc7 3 3L mRNA export from nucleus; GO:0006406 thoc7 thoc7 "CG17143, THOC7" CDMC24051 1 12 2 DAC03-E09 11-CG17143-RB_1 CG17143 CGGGGATGGAACTGGAGAGGATCGGAGAATAGTAGTGTTGCTGAAACAGTTCTTGAAGTGGGCCAGTGA 69 FBan0017143 FBgn0035110 thoc7 3 3L mRNA export from nucleus; GO:0006406 thoc7 thoc7 "CG17143, THOC7" CDMC24052 1 13 2 DAC03-E21 14-CG17153-RA_1 CG17153 AGTCTGGAAGTGCACCCAATACGACCAGCGAACACAATTCATTTGGCAGTCAACTTGACGAACCATTGA 69 FBan0017153 FBgn0036248 CG17153 3 3L CG17153 CG17153 CDMC24052 1 14 2 DAC03-E21 14-CG17153-RA_1 CG17153 AGTCTGGAAGTGCACCCAATACGACCAGCGAACACAATTCATTTGGCAGTCAACTTGACGAACCATTGA 69 FBan0017153 FBgn0036248 CG17153 3 3L CG17153 CG17153 CDMC24053 1 15 2 DAC03-I09 3-CG17192-RA_1 CG17192 GCCCATTGGAAAAGCCGCATTCTATGTGAGTGGAGGACGGAAACAACCAGGATGTGGAGTAGACCTTGC 69 FBan0017192 FBgn0039472 CG17192 3 3R lipid metabolism; GO:0006629; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 microtubule; GO:0005874 CG17192 CG17192 CDMC24053 1 16 2 DAC03-I09 3-CG17192-RA_1 CG17192 GCCCATTGGAAAAGCCGCATTCTATGTGAGTGGAGGACGGAAACAACCAGGATGTGGAGTAGACCTTGC 69 FBan0017192 FBgn0039472 CG17192 3 3R lipid metabolism; GO:0006629; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 microtubule; GO:0005874 CG17192 CG17192 CDMC24054 1 17 2 DAC03-I21 3-CG17203-RA_1 CG17203 ACCAAAGTCCACAGCCACACCATGAATGCTGCTACGGATTTTGCCTTGTCCTGCATCCATCACTCGAAA 69 FBgn0038792 CDMC24054 1 18 2 DAC03-I21 3-CG17203-RA_1 CG17203 ACCAAAGTCCACAGCCACACCATGAATGCTGCTACGGATTTTGCCTTGTCCTGCATCCATCACTCGAAA 69 FBgn0038792 CDMC24055 1 19 2 DAC03-M09 9-CG17240-RA_2 CG17240 ACTGGTGGACACTCTAATTTTCAATGCCGAAGTAAGACCTATCCAACTGGCCGATAGTGCACCCGCAGC 69 FBan0017240 FBgn0011832 Ser12 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004263 ; EC:3.4.21.1 Ser12 Serine protease 12 "CG17240, SP92" CDMC24055 1 20 2 DAC03-M09 9-CG17240-RA_2 CG17240 ACTGGTGGACACTCTAATTTTCAATGCCGAAGTAAGACCTATCCAACTGGCCGATAGTGCACCCGCAGC 69 FBan0017240 FBgn0011832 Ser12 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004263 ; EC:3.4.21.1 Ser12 Serine protease 12 "CG17240, SP92" CDMC24056 1 21 2 DAC03-M21 37-CG17256-RA_2 CG17256 AGCGAGTTGGATGGCAAGTTCCCAATTCTAGTTGATTCTGGAGAGGATTTCTACACACTGCCTTCGGGT 69 FBan0017256 FBgn0029970 Nek2 X X intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- centrosome; GO:0005813; midbody; GO:0030496 Nek2 Nek2 "CG17256, CG17256, CG17256, NEK2, DmNek2" CDMC24056 1 22 2 DAC03-M21 37-CG17256-RA_2 CG17256 AGCGAGTTGGATGGCAAGTTCCCAATTCTAGTTGATTCTGGAGAGGATTTCTACACACTGCCTTCGGGT 69 FBan0017256 FBgn0029970 Nek2 X X intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- centrosome; GO:0005813; midbody; GO:0030496 Nek2 Nek2 "CG17256, CG17256, CG17256, NEK2, DmNek2" CDMC24057 1 23 2 DAC04-A09 3-CG15870-RA_2 CG15870 TACGCTGGATACGCGGGAGTTCTTCCGGTTCCTCTTCCCGTACCCTATCCCGCAACCTATAATCG 65 FBan0015870 FBgn0033798 CG15870 2 2R CG15870 CG15870 CDMC24057 1 24 2 DAC04-A09 3-CG15870-RA_2 CG15870 TACGCTGGATACGCGGGAGTTCTTCCGGTTCCTCTTCCCGTACCCTATCCCGCAACCTATAATCG 65 FBan0015870 FBgn0033798 CG15870 2 2R CG15870 CG15870 CDMC24058 1 25 2 DAC04-A21 2-CG15896-RA_1 CG15896 CTATGTGCACTGCAATGCCAGCCTCTTCTTGACCAGCAATCTGTCGCACGATGATCCCTTCCTGC 65 FBan0015896 FBgn0029858 CG15896 X X CG15896 CG15896 CDMC24058 1 26 2 DAC04-A21 2-CG15896-RA_1 CG15896 CTATGTGCACTGCAATGCCAGCCTCTTCTTGACCAGCAATCTGTCGCACGATGATCCCTTCCTGC 65 FBan0015896 FBgn0029858 CG15896 X X CG15896 CG15896 CDMC24059 1 1 3 DAC04-E09 3-CG16758-RB_1 CG16758 TAGAGTCCAACATTCACGTCGGCGTATACTCCTGTCTGGGTGGTCCCAACTACGAGACCATCGCC 65 FBan0016758 FBgn0035348 CG16758 3 3L purine base metabolism; GO:0006144 purine-nucleoside phosphorylase activity; GO:0004731 ; EC:2.4.2.1; ; GO:0004731 ; EC:2.4.2.1 CG16758 CG16758 "CG16760, c62E-15" CDMC24059 1 2 3 DAC04-E09 3-CG16758-RB_1 CG16758 TAGAGTCCAACATTCACGTCGGCGTATACTCCTGTCTGGGTGGTCCCAACTACGAGACCATCGCC 65 FBan0016758 FBgn0035348 CG16758 3 3L purine base metabolism; GO:0006144 purine-nucleoside phosphorylase activity; GO:0004731 ; EC:2.4.2.1; ; GO:0004731 ; EC:2.4.2.1 CG16758 CG16758 "CG16760, c62E-15" CDMC24060 1 3 3 DAC04-E21 18-CG16779-RA_1 CG16779 TCCCGCGGTGGAGAAGCCCTATGTCTGCGAGATTGCCGACTGTTCAGCGAGCTTCAGTTCGAAGG 65 FBan0016779 FBgn0037698 CG16779 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG16779 CG16779 CDMC24060 1 4 3 DAC04-E21 18-CG16779-RA_1 CG16779 TCCCGCGGTGGAGAAGCCCTATGTCTGCGAGATTGCCGACTGTTCAGCGAGCTTCAGTTCGAAGG 65 FBan0016779 FBgn0037698 CG16779 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG16779 CG16779 CDMC24061 1 5 3 DAC04-I09 24-CG16905-RA_1 CG16905 TCAGCGTTTTTTGCAGTGATATTTAGCCAATTTTATTACCACAACTACATAAAGCCAGGAAAGAA 65 FBan0016905 FBgn0037762 CG16905 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG16905 CG16905 CDMC24061 1 6 3 DAC04-I09 24-CG16905-RA_1 CG16905 TCAGCGTTTTTTGCAGTGATATTTAGCCAATTTTATTACCACAACTACATAAAGCCAGGAAAGAA 65 FBan0016905 FBgn0037762 CG16905 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG16905 CG16905 CDMC24062 1 7 3 DAC04-I21 9-CG16947-RA_1 CG16947 CTGTCCCTGGTCACCGATGAACCATCCTCGGCGTGATATCCACCCGATTCAAACCACAGCATCAG 65 FBan0016947 FBgn0031816 CG16947 2 2L CG16947 CG16947 anon-EST:Posey20 CDMC24062 1 8 3 DAC04-I21 9-CG16947-RA_1 CG16947 CTGTCCCTGGTCACCGATGAACCATCCTCGGCGTGATATCCACCCGATTCAAACCACAGCATCAG 65 FBan0016947 FBgn0031816 CG16947 2 2L CG16947 CG16947 anon-EST:Posey20 CDMC24063 1 9 3 DAC04-M09 23-CG17110-RA_1 CG17110 AAAGTCAACAACTGATAATGCCATTAAGTCAATCCACACTCAGACTTCAAACCAAACAGCACGGT 65 FBan0017110 FBgn0039050 CG17110 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG17110 CG17110 CDMC24063 1 10 3 DAC04-M09 23-CG17110-RA_1 CG17110 AAAGTCAACAACTGATAATGCCATTAAGTCAATCCACACTCAGACTTCAAACCAAACAGCACGGT 65 FBan0017110 FBgn0039050 CG17110 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG17110 CG17110 CDMC24064 1 11 3 DAC04-M21 3-CG17147-RA_2 CG17147 GTGACAAGACCGGTAACCATGCGTCCAAGAGCTGCACTGTCACCTCCAAGAAGCGCGAGTATTTC 65 FBan0017147 FBgn0036954 CG17147 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17147 CG17147 CDMC24064 1 12 3 DAC04-M21 3-CG17147-RA_2 CG17147 GTGACAAGACCGGTAACCATGCGTCCAAGAGCTGCACTGTCACCTCCAAGAAGCGCGAGTATTTC 65 FBan0017147 FBgn0036954 CG17147 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17147 CG17147 CDMC24065 1 13 3 DAC05-A09 2-CG10237-RA_1 CG10237 CCATCGAACGAGGCCAACATCTTCAAGCACAACATCCTTACCGTCTTCCCCAACCGAGATCAACTGGG 68 FBan0010237 FBgn0032783 CG10237 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10237 CG10237 CDMC24065 1 14 3 DAC05-A09 2-CG10237-RA_1 CG10237 CCATCGAACGAGGCCAACATCTTCAAGCACAACATCCTTACCGTCTTCCCCAACCGAGATCAACTGGG 68 FBan0010237 FBgn0032783 CG10237 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10237 CG10237 CDMC24066 1 15 3 DAC05-A21 8-CG10354-RA_3 CG10354 TGCTGCCAAATGAGCAGTCTGGTAACAAGCATCGTCCCGTCATCGGTTTTAATAGCCACTTGACCAGG 68 FBan0010354 FBgn0031868 CG10354 2 2L "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; 5'-3' exoribonuclease activity; GO:0004534 ; EC:3.1.13.-; ; GO:0004534 ; EC:3.1.13.- nucleus; GO:0005634 CG10354 CG10354 "dhp1, RAT1" CDMC24066 1 16 3 DAC05-A21 8-CG10354-RA_3 CG10354 TGCTGCCAAATGAGCAGTCTGGTAACAAGCATCGTCCCGTCATCGGTTTTAATAGCCACTTGACCAGG 68 FBan0010354 FBgn0031868 CG10354 2 2L "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; 5'-3' exoribonuclease activity; GO:0004534 ; EC:3.1.13.-; ; GO:0004534 ; EC:3.1.13.- nucleus; GO:0005634 CG10354 CG10354 "dhp1, RAT1" CDMC24067 1 17 3 DAC05-E09 2-CG10869-RA_1 CG10869 CAGCCAGCTGAAGATCACGATGGAGCAGGTGAACAATATGACCCACTTGTTGATCGATCGCAAGCCGA 68 FBan0010869 FBgn0031347 CG10869 2 2L CG10869 CG10869 CDMC24067 1 18 3 DAC05-E09 2-CG10869-RA_1 CG10869 CAGCCAGCTGAAGATCACGATGGAGCAGGTGAACAATATGACCCACTTGTTGATCGATCGCAAGCCGA 68 FBan0010869 FBgn0031347 CG10869 2 2L CG10869 CG10869 CDMC24068 1 19 3 DAC05-E21 8-CG11009-RA_2 CG11009 TTCCTGGCGGATTTAATACCCCCGGATTTCAGCAACCGAATGGAAATCCAAATGGCTATCCAGGTGGA 68 FBan0011009 FBgn0036318 CG11009 3 3L CG11009 CG11009 CDMC24068 1 20 3 DAC05-E21 8-CG11009-RA_2 CG11009 TTCCTGGCGGATTTAATACCCCCGGATTTCAGCAACCGAATGGAAATCCAAATGGCTATCCAGGTGGA 68 FBan0011009 FBgn0036318 CG11009 3 3L CG11009 CG11009 CDMC24069 1 21 3 DAC05-I09 1-CG11274-RA_1 CG11274 CCAGTGACAGCGACTCAGAGGCCTCCTCCAAGCGCAAGAAGCATAAGAAACACAAGAAGCACAGCAAG 68 FBan0011274 FBgn0036340 SRm160 3 3L exon-exon junction complex; GO:0035145 SRm160 SRm160 "CG11274, CG11274, CG11274, CG11274, CG11274" CDMC24069 1 22 3 DAC05-I09 1-CG11274-RA_1 CG11274 CCAGTGACAGCGACTCAGAGGCCTCCTCCAAGCGCAAGAAGCATAAGAAACACAAGAAGCACAGCAAG 68 FBan0011274 FBgn0036340 SRm160 3 3L exon-exon junction complex; GO:0035145 SRm160 SRm160 "CG11274, CG11274, CG11274, CG11274, CG11274" CDMC24070 1 23 3 DAC05-I21 1-CG11381-RA_1 CG11381 GCAGTCCCACTCGTATCAGCTGCCTTCAACGTTTACTACTCACACGGAATGGACCCAGGACAAGGAGC 68 FBan0011381 FBgn0029568 CG11381 X X CG11381 CG11381 CDMC24070 1 24 3 DAC05-I21 1-CG11381-RA_1 CG11381 GCAGTCCCACTCGTATCAGCTGCCTTCAACGTTTACTACTCACACGGAATGGACCCAGGACAAGGAGC 68 FBan0011381 FBgn0029568 CG11381 X X CG11381 CG11381 CDMC24071 1 25 3 DAC05-M09 1-CG11942-RA_3 CG11942 GCAGATCAAGGGCCTACTGGAACTCACCTACAATGTGGTGGCCAATATGATTAGGGGCAAGACTCCCG 68 FBan0011942 FBgn0031074 skpE X X chromosome segregation; GO:0007059; mitosis; GO:0007067; proteolysis; GO:0006508 centromeric DNA binding; GO:0019237; ; GO:0019237; RNA polymerase II transcription elongation factor activity; GO:0016944; ; GO:0016944 skpE skpE "CG11942, CG11942" CDMC24071 1 26 3 DAC05-M09 1-CG11942-RA_3 CG11942 GCAGATCAAGGGCCTACTGGAACTCACCTACAATGTGGTGGCCAATATGATTAGGGGCAAGACTCCCG 68 FBan0011942 FBgn0031074 skpE X X chromosome segregation; GO:0007059; mitosis; GO:0007067; proteolysis; GO:0006508 centromeric DNA binding; GO:0019237; ; GO:0019237; RNA polymerase II transcription elongation factor activity; GO:0016944; ; GO:0016944 skpE skpE "CG11942, CG11942" CDMC24072 1 1 4 DAC05-M21 18-CG12075-RB_6 CG12075 CCAGTGCATCACCATCAACGCAAGGAGAATCTCACCGACAAGCAAAAGTTCATGGAGTATACCAGCAA 68 FBan0012075 FBgn0030065 CG12075 X X DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12075 CG12075 CDMC24072 1 2 4 DAC05-M21 18-CG12075-RB_6 CG12075 CCAGTGCATCACCATCAACGCAAGGAGAATCTCACCGACAAGCAAAAGTTCATGGAGTATACCAGCAA 68 FBan0012075 FBgn0030065 CG12075 X X DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12075 CG12075 CDMC24073 1 3 4 DAC06-A09 23-CG32984-RA_6 CG32984 GAGGACGCTTTCTCTTTTGTACAATACCAGAAGACTTCTCCGAACTTGGATATAGATCGAAAGGCTAGT 69 FBan0032984 FBgn0052984 CG32984 2 2L CG32984 CG32984 "CG17789, CG17789" CDMC24073 1 4 4 DAC06-A09 23-CG32984-RA_6 CG32984 GAGGACGCTTTCTCTTTTGTACAATACCAGAAGACTTCTCCGAACTTGGATATAGATCGAAAGGCTAGT 69 FBan0032984 FBgn0052984 CG32984 2 2L CG32984 CG32984 "CG17789, CG17789" CDMC24074 1 5 4 DAC06-A21 15-CG33002-RA_1 CG33002 CGCCAGGGCCAGAACATCTACAAGAAGTTCTTCAATGTTGTGCCCGAAAATCAGCATCAGCGATTTCGT 69 FBan0033002 FBgn0053002 mRpL27 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL27 mitochondrial ribosomal protein L27 "CG33002, CG15442, mitochondrial ribosomal protein L27" CDMC24074 1 6 4 DAC06-A21 15-CG33002-RA_1 CG33002 CGCCAGGGCCAGAACATCTACAAGAAGTTCTTCAATGTTGTGCCCGAAAATCAGCATCAGCGATTTCGT 69 FBan0033002 FBgn0053002 mRpL27 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL27 mitochondrial ribosomal protein L27 "CG33002, CG15442, mitochondrial ribosomal protein L27" CDMC24075 1 7 4 DAC06-E09 5-CG33054-RA_1 CG33054 TCGGCGAGCTTTTGTAGTCGGAATGTCATCCAAACCTCAGTACACCCTAAGCGAAGTGGATGGGGATCT 69 FBan0033054 FBgn0053054 CG33054 3 3L CG33054 CG33054 "CG10167, CG10517, CG10167, CG10517, CG10517" CDMC24075 1 8 4 DAC06-E09 5-CG33054-RA_1 CG33054 TCGGCGAGCTTTTGTAGTCGGAATGTCATCCAAACCTCAGTACACCCTAAGCGAAGTGGATGGGGATCT 69 FBan0033054 FBgn0053054 CG33054 3 3L CG33054 CG33054 "CG10167, CG10517, CG10167, CG10517, CG10517" CDMC24076 1 9 4 DAC06-E21 10-CG33067-RA_1 CG33067 GCCCACGCGCTTTAATTGGATAGTGGCCAGTCCTTTACTATTGGCACAACAGGGAGTTTACTACGCCGG 69 FBgn0053067 CDMC24076 1 10 4 DAC06-E21 10-CG33067-RA_1 CG33067 GCCCACGCGCTTTAATTGGATAGTGGCCAGTCCTTTACTATTGGCACAACAGGGAGTTTACTACGCCGG 69 FBgn0053067 CDMC24077 1 11 4 DAC06-I09 3-CG33099-RA_3 CG33099 CGGGTGGGTCAGCAACTCCACAAGGCTTTCACCGAAAAGGGAATTGCGTTTCTGGTTAACCATGGGATA 69 FBan0033099 FBgn0053099 CG33099 3 3R gibberellin 20-oxidase activity; GO:0045544; ; GO:0045544 CG33099 CG33099 CG5340 CDMC24077 1 12 4 DAC06-I09 3-CG33099-RA_3 CG33099 CGGGTGGGTCAGCAACTCCACAAGGCTTTCACCGAAAAGGGAATTGCGTTTCTGGTTAACCATGGGATA 69 FBan0033099 FBgn0053099 CG33099 3 3R gibberellin 20-oxidase activity; GO:0045544; ; GO:0045544 CG33099 CG33099 CG5340 CDMC24078 1 13 4 DAC06-I21 17-CG33106-RA_1 CG33106 GCTGCTACAGAGCTTGGTGTTCTTTGCCAGAAGTGAATGGTGTGGTCGATACCCCGAAAAATGTAGTTA 69 FBan0033106 FBgn0043884 mask 3 3R asymmetric protein localization; GO:0008105; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeletal anchoring; GO:0007016; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein targeting; GO:0006605; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 nucleic acid binding; GO:0003676; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; ; GO:0005200 mask multiple ankyrin repeats single KH domain "CG6268, CG6313, CG33106, CG31138, CG18671, CG6268, CG6313, CG6268, cg6313, multiple ankyrin repeats single KH domain" CDMC24078 1 14 4 DAC06-I21 17-CG33106-RA_1 CG33106 GCTGCTACAGAGCTTGGTGTTCTTTGCCAGAAGTGAATGGTGTGGTCGATACCCCGAAAAATGTAGTTA 69 FBan0033106 FBgn0043884 mask 3 3R asymmetric protein localization; GO:0008105; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeletal anchoring; GO:0007016; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein targeting; GO:0006605; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 nucleic acid binding; GO:0003676; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; ; GO:0005200 mask multiple ankyrin repeats single KH domain "CG6268, CG6313, CG33106, CG31138, CG18671, CG6268, CG6313, CG6268, cg6313, multiple ankyrin repeats single KH domain" CDMC24079 1 15 4 DAC06-M09 23-CG33129-RA_10 CG33129 AGCAGATGCAAACAGAATACGCGTCATAGTAAATAGTGAAGGAAGCCCTAATTTTTCGCAAAAAGTTAA 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC24079 1 16 4 DAC06-M09 23-CG33129-RA_10 CG33129 AGCAGATGCAAACAGAATACGCGTCATAGTAAATAGTGAAGGAAGCCCTAATTTTTCGCAAAAAGTTAA 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC24080 1 17 4 DAC06-M21 18-CG33136-RA_1 CG33136 AGCCAGTGCGTCTCAAGTCGACAATATTGCTTAACGAATACCGAAAACTGTACGAAACGCCGCGAAAAA 69 FBan0033136 FBgn0053136 CG33136 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33136 CG33136 NEST:bs04e10 CDMC24080 1 18 4 DAC06-M21 18-CG33136-RA_1 CG33136 AGCCAGTGCGTCTCAAGTCGACAATATTGCTTAACGAATACCGAAAACTGTACGAAACGCCGCGAAAAA 69 FBan0033136 FBgn0053136 CG33136 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33136 CG33136 NEST:bs04e10 CDMC24081 1 19 4 DAC07-A09 14-CG5785-RA_3 CG5785 CCGCTTTCTGCAGAGAAACAGCGAACAATTGGACGAATTCTATGGAAGAGCGCATAGTTGGATGCAGGA 69 FBan0005785 FBgn0003701 thr 2 2R Malpighian tubule morphogenesis; GO:0007443; foregut morphogenesis; GO:0007440; head involution; GO:0008258; hindgut morphogenesis; GO:0007442; mitotic sister chromatid segregation; GO:0000070; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; tracheal system development (sensu Insecta); GO:0007424 thr three rows "CG5785, CG5785, ana, anarchist, anch, THR" CDMC24081 1 20 4 DAC07-A09 14-CG5785-RA_3 CG5785 CCGCTTTCTGCAGAGAAACAGCGAACAATTGGACGAATTCTATGGAAGAGCGCATAGTTGGATGCAGGA 69 FBan0005785 FBgn0003701 thr 2 2R Malpighian tubule morphogenesis; GO:0007443; foregut morphogenesis; GO:0007440; head involution; GO:0008258; hindgut morphogenesis; GO:0007442; mitotic sister chromatid segregation; GO:0000070; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; tracheal system development (sensu Insecta); GO:0007424 thr three rows "CG5785, CG5785, ana, anarchist, anch, THR" CDMC24082 1 21 4 DAC07-A21 3-CG5793-RA_1 CG5793 GCCGATGCGTTCAAGGCAGGCGATGTAATTCAGTGTGGAATGGCCGATCTCGCTAAATTGACCTTCCAA 69 FBan0005793 FBgn0038858 CG5793 3 3R amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG5793 CG5793 CDMC24082 1 22 4 DAC07-A21 3-CG5793-RA_1 CG5793 GCCGATGCGTTCAAGGCAGGCGATGTAATTCAGTGTGGAATGGCCGATCTCGCTAAATTGACCTTCCAA 69 FBan0005793 FBgn0038858 CG5793 3 3R amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG5793 CG5793 CDMC24083 1 23 4 DAC07-E09 23-CG5825-RA_1 CG5825 AGTTCGGTCAATTGTCAAATCTGCTCAAAACCACTTAATTACCAGGTAAACGATGGCACGTACCAAGCA 69 FBan0005825 FBgn0014857 His3.3A 2 2L cell adhesion; GO:0007155; chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334; regulation of cell shape; GO:0008360 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His3.3A Histone H3.3A "CG5825, H3.3, PH3, histone H3.3A, H3L-like histone, His3.3" CDMC24083 1 24 4 DAC07-E09 23-CG5825-RA_1 CG5825 AGTTCGGTCAATTGTCAAATCTGCTCAAAACCACTTAATTACCAGGTAAACGATGGCACGTACCAAGCA 69 FBan0005825 FBgn0014857 His3.3A 2 2L cell adhesion; GO:0007155; chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334; regulation of cell shape; GO:0008360 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His3.3A Histone H3.3A "CG5825, H3.3, PH3, histone H3.3A, H3L-like histone, His3.3" CDMC24084 1 25 4 DAC07-E21 11-CG5840-RB_3 CG5840 CACAGTCCGCGGACTTTTTAACCCATTAACTAATGTCGGCAATCGGAAAGATCGGATTCCTGGGAGGCG 69 FBan0005840 FBgn0038516 CG5840 3 3R amino acid biosynthesis; GO:0008652; proline biosynthesis; GO:0006561 pyrroline-5-carboxylate reductase activity; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2 CG5840 CG5840 CT18319 CDMC24084 1 26 4 DAC07-E21 11-CG5840-RB_3 CG5840 CACAGTCCGCGGACTTTTTAACCCATTAACTAATGTCGGCAATCGGAAAGATCGGATTCCTGGGAGGCG 69 FBan0005840 FBgn0038516 CG5840 3 3R amino acid biosynthesis; GO:0008652; proline biosynthesis; GO:0006561 pyrroline-5-carboxylate reductase activity; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2 CG5840 CG5840 CT18319 CDMC24085 1 1 5 DAC07-I09 12-CG5871-RA_3 CG5871 GGCGAAGGAATAACCGTTGACGATTTGGTTCTTCTCTGCGACCTGTTCTATCTGCCCTTCGAACATGGC 69 FBan0005871 FBgn0038870 CG5871 3 3R hyalurononglucosaminidase activity; GO:0004415 ; EC:3.2.1.35; ; GO:0004415 ; EC:3.2.1.35 CG5871 CG5871 CDMC24085 1 2 5 DAC07-I09 12-CG5871-RA_3 CG5871 GGCGAAGGAATAACCGTTGACGATTTGGTTCTTCTCTGCGACCTGTTCTATCTGCCCTTCGAACATGGC 69 FBan0005871 FBgn0038870 CG5871 3 3R hyalurononglucosaminidase activity; GO:0004415 ; EC:3.2.1.35; ; GO:0004415 ; EC:3.2.1.35 CG5871 CG5871 CDMC24086 1 3 5 DAC07-I21 18-CG5878-RA_2 CG5878 TGCAAATGCATTCTATGCCATTTCCTGGCTGCAATGGAAGGATTTCTTTCAGCCCAACAGACATAACGT 69 FBan0005878 FBgn0039378 alpha4GT2 3 3R carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-" Golgi stack; GO:0005795 alpha4GT2 alpha4GT2 "CG5878, CG5878" CDMC24086 1 4 5 DAC07-I21 18-CG5878-RA_2 CG5878 TGCAAATGCATTCTATGCCATTTCCTGGCTGCAATGGAAGGATTTCTTTCAGCCCAACAGACATAACGT 69 FBan0005878 FBgn0039378 alpha4GT2 3 3R carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-" Golgi stack; GO:0005795 alpha4GT2 alpha4GT2 "CG5878, CG5878" CDMC24087 1 5 5 DAC07-M09 15-CG5921-RB_2 CG5921 GCCACATCGCCAATCCATTGATTGTCGGCTACTCGCAAAGGTCAAGCACTTCAATTGTTATCGATGGCT 69 FBan0005921 FBgn0029835 CG5921 X X sensory perception; GO:0007600; sensory perception of sound; GO:0007605 protein binding; GO:0005515; ; GO:0005515 CG5921 CG5921 CDMC24087 1 6 5 DAC07-M09 15-CG5921-RB_2 CG5921 GCCACATCGCCAATCCATTGATTGTCGGCTACTCGCAAAGGTCAAGCACTTCAATTGTTATCGATGGCT 69 FBan0005921 FBgn0029835 CG5921 X X sensory perception; GO:0007600; sensory perception of sound; GO:0007605 protein binding; GO:0005515; ; GO:0005515 CG5921 CG5921 CDMC24088 1 7 5 DAC07-M21 2-CG5931-RA_1 CG5931 GCACATCAAGACCAATTTGCTGCTTCAGGCTCATCTTTCGCGATTGCAACTGGGACCTGAACTGCAAGG 69 FBan0005931 FBgn0036548 CG5931 3 3L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; calcium ion binding; GO:0005509; ; GO:0003724 ; EC:2.7.7.-; ; GO:0005509; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG5931 CG5931 "clone 1.21, cg5931, Brr2, anon-EST:Liang-1.21" CDMC24088 1 8 5 DAC07-M21 2-CG5931-RA_1 CG5931 GCACATCAAGACCAATTTGCTGCTTCAGGCTCATCTTTCGCGATTGCAACTGGGACCTGAACTGCAAGG 69 FBan0005931 FBgn0036548 CG5931 3 3L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; calcium ion binding; GO:0005509; ; GO:0003724 ; EC:2.7.7.-; ; GO:0005509; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG5931 CG5931 "clone 1.21, cg5931, Brr2, anon-EST:Liang-1.21" CDMC24089 1 9 5 DAC08-A09 18-CG8222-RD_3 CG8222 ACCGTCAACGAGAAGGAGCAACGAAGGTATTAGGACGTCCCGGAGCCATTAGATTAAGTTTAGGACCTC 69 FBan0008222 FBgn0032006 Pvr 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; border follicle cell migration (sensu Insecta); GO:0007298; cell projection biogenesis; GO:0030031; cell proliferation; GO:0008283; ectoderm development; GO:0007398; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte migration (sensu Arthropoda); GO:0035099; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of hemocyte differentiation; GO:0045610; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; ventral cord development; GO:0007419 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; vascular endothelial growth factor receptor activity; GO:0005021; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004714 ; EC:2.7.1.-; platelet-derived growth factor receptor activity; GO:0005017; ; GO:0005021; ; GO:0005017; ; GO:0005515 plasma membrane; GO:0005886 Pvr PDGF- and VEGF-receptor related "CG8222, CG8222, CG8222, CG8222, CT24332, VGR1, vgr1, DmVEGFR, VEGF receptor, PVR, Vegfr, stai, stasis, Vegfr-b, Vegfr-c, VEGFR-A, VEGFR, pvr, Vgr1: Vascular endothelial growth factor receptor-1 like, Vascular endothelial growth factor receptor-1 like, PDGF- and VEGF-receptor related" CDMC24089 1 10 5 DAC08-A09 18-CG8222-RD_3 CG8222 ACCGTCAACGAGAAGGAGCAACGAAGGTATTAGGACGTCCCGGAGCCATTAGATTAAGTTTAGGACCTC 69 FBan0008222 FBgn0032006 Pvr 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; border follicle cell migration (sensu Insecta); GO:0007298; cell projection biogenesis; GO:0030031; cell proliferation; GO:0008283; ectoderm development; GO:0007398; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte migration (sensu Arthropoda); GO:0035099; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of hemocyte differentiation; GO:0045610; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; ventral cord development; GO:0007419 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; vascular endothelial growth factor receptor activity; GO:0005021; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004714 ; EC:2.7.1.-; platelet-derived growth factor receptor activity; GO:0005017; ; GO:0005021; ; GO:0005017; ; GO:0005515 plasma membrane; GO:0005886 Pvr PDGF- and VEGF-receptor related "CG8222, CG8222, CG8222, CG8222, CT24332, VGR1, vgr1, DmVEGFR, VEGF receptor, PVR, Vegfr, stai, stasis, Vegfr-b, Vegfr-c, VEGFR-A, VEGFR, pvr, Vgr1: Vascular endothelial growth factor receptor-1 like, Vascular endothelial growth factor receptor-1 like, PDGF- and VEGF-receptor related" CDMC24090 1 11 5 DAC08-A21 8-CG8231-RA_1 CG8231 CCGACCCATTCAATTTAACCAAGTTAATGCACCGCATGCTACTCAACCCGCGTCTCTCAAAGCCACACA 69 FBgn0030681 CDMC24090 1 12 5 DAC08-A21 8-CG8231-RA_1 CG8231 CCGACCCATTCAATTTAACCAAGTTAATGCACCGCATGCTACTCAACCCGCGTCTCTCAAAGCCACACA 69 FBgn0030681 CDMC24091 1 13 5 DAC08-E09 8-CG8274-RA_1 CG8274 GAACAGGAGGGCTACGAAGACTCGTACGAGCAGGACAATGAGATGGATGACAACGAAGGTGGTGACGAT 69 FBan0008274 FBgn0013756 Mtor 2 2R intracellular protein transport; GO:0006886; mitotic spindle assembly; GO:0051227 nuclear pore; GO:0005643; nucleus; GO:0005634; spindle midzone; GO:0051233 Mtor Megator "CG8274, l(2)k03905, Bx34, Tpr, TPR, lethal (2) k03905, Megator" CDMC24091 1 14 5 DAC08-E09 8-CG8274-RA_1 CG8274 GAACAGGAGGGCTACGAAGACTCGTACGAGCAGGACAATGAGATGGATGACAACGAAGGTGGTGACGAT 69 FBan0008274 FBgn0013756 Mtor 2 2R intracellular protein transport; GO:0006886; mitotic spindle assembly; GO:0051227 nuclear pore; GO:0005643; nucleus; GO:0005634; spindle midzone; GO:0051233 Mtor Megator "CG8274, l(2)k03905, Bx34, Tpr, TPR, lethal (2) k03905, Megator" CDMC24092 1 15 5 DAC08-E21 23-CG8285-RA_4 CG8285 CTCGCCCGATCACAACAAGATCACCCGGTTTTAGCCCACGAGTGTACAATGTGGCACTTCTAGTCAACG 69 FBan0008285 FBgn0000206 boss 3 3R R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; R8-mediated photoreceptor organization; GO:0045470; eye development (sensu Endopterygota); GO:0007456; sevenless signaling pathway; GO:0045500; signal transduction; GO:0007165; visual perception; GO:0007601 "receptor binding; GO:0005102; sevenless binding; GO:0005118; ; GO:0005118; ; GO:0005118; G-protein coupled receptor activity; GO:0004930; transmembrane receptor activity; GO:0004888; ; GO:0005102; ; GO:0004888; ; GO:0004930; ; GO:0005118; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021; microvillus; GO:0005902; plasma membrane; GO:0005886 boss bride of sevenless "CG8285, Bos, Boss, F, X55887, F transcript, bride of sevenless" CDMC24092 1 16 5 DAC08-E21 23-CG8285-RA_4 CG8285 CTCGCCCGATCACAACAAGATCACCCGGTTTTAGCCCACGAGTGTACAATGTGGCACTTCTAGTCAACG 69 FBan0008285 FBgn0000206 boss 3 3R R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; R8-mediated photoreceptor organization; GO:0045470; eye development (sensu Endopterygota); GO:0007456; sevenless signaling pathway; GO:0045500; signal transduction; GO:0007165; visual perception; GO:0007601 "receptor binding; GO:0005102; sevenless binding; GO:0005118; ; GO:0005118; ; GO:0005118; G-protein coupled receptor activity; GO:0004930; transmembrane receptor activity; GO:0004888; ; GO:0005102; ; GO:0004888; ; GO:0004930; ; GO:0005118; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021; microvillus; GO:0005902; plasma membrane; GO:0005886 boss bride of sevenless "CG8285, Bos, Boss, F, X55887, F transcript, bride of sevenless" CDMC24093 1 17 5 DAC08-I09 5-CG8318-RC_2 CG8318 GGGCTGTTTTGACAAGAAGGAGACCATAGCCGAGGTCATGATGAAGACAAGGGAAAAGCTGGAGTGGCA 69 FBan0008318 FBgn0015269 Nf1 3 3R cAMP-mediated signaling; GO:0019933; cell growth; GO:0016049; learning; GO:0007612; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; olfactory learning; GO:0008355; positive regulation of adenylate cyclase activity; GO:0045762; regulation of body size; GO:0040014; rhythmic behavior; GO:0007622; short-term memory; GO:0007614 Ras GTPase activator activity; GO:0005099; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005099; ; GO:0005099 Nf1 Neurofibromin 1 "CG8318, CG8318, NF1, Neurofibromin 1, NF-1, neurofibromatosis type 1, Neurofibromatosis-1, Nf-1" CDMC24093 1 18 5 DAC08-I09 5-CG8318-RC_2 CG8318 GGGCTGTTTTGACAAGAAGGAGACCATAGCCGAGGTCATGATGAAGACAAGGGAAAAGCTGGAGTGGCA 69 FBan0008318 FBgn0015269 Nf1 3 3R cAMP-mediated signaling; GO:0019933; cell growth; GO:0016049; learning; GO:0007612; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; olfactory learning; GO:0008355; positive regulation of adenylate cyclase activity; GO:0045762; regulation of body size; GO:0040014; rhythmic behavior; GO:0007622; short-term memory; GO:0007614 Ras GTPase activator activity; GO:0005099; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005099; ; GO:0005099 Nf1 Neurofibromin 1 "CG8318, CG8318, NF1, Neurofibromin 1, NF-1, neurofibromatosis type 1, Neurofibromatosis-1, Nf-1" CDMC24094 1 19 5 DAC08-I21 23-CG8326-RA_2 CG8326 CAGCTATACCGTCAGCTCAAAAACAAGACAACAGCAGATTCCTAACAGATTCTAGACTAGATACCAACG 69 FBan0008326 FBgn0030851 CG8326 X X CG8326 CG8326 BEST:LD29336 CDMC24094 1 20 5 DAC08-I21 23-CG8326-RA_2 CG8326 CAGCTATACCGTCAGCTCAAAAACAAGACAACAGCAGATTCCTAACAGATTCTAGACTAGATACCAACG 69 FBan0008326 FBgn0030851 CG8326 X X CG8326 CG8326 BEST:LD29336 CDMC24095 1 21 5 DAC08-M09 6-CG8368-RA_2 CG8368 CCGCAGAAATTATGGAGCAAGTGACCAAGAGGCTGGATGTTGTGCAAAAGGAAGTGTCCGAACTGCTGC 69 FBan0008368 FBgn0035707 CG8368 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG8368 CG8368 RNase H-like CDMC24095 1 22 5 DAC08-M09 6-CG8368-RA_2 CG8368 CCGCAGAAATTATGGAGCAAGTGACCAAGAGGCTGGATGTTGTGCAAAAGGAAGTGTCCGAACTGCTGC 69 FBan0008368 FBgn0035707 CG8368 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG8368 CG8368 RNase H-like CDMC24096 1 23 5 DAC08-M21 6-CG8380-RA_2 CG8380 CGAGGATATACGGGACATGATTGGTTTTCCACCGGGAAGATACTGGCAGGTGTGTTGGCGATTTGTGGC 69 FBan0008380 FBgn0034136 DAT 2 2R extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cocaine binding; GO:0019811; dopamine transporter activity; GO:0005329; ; GO:0019811; ; GO:0005329; dopamine:sodium symporter activity; GO:0005330; ; GO:0005330 integral to plasma membrane; GO:0005887; membrane; GO:0016020 DAT Dopamine transporter "CG8380, CG8380, Dopamine transporter" CDMC24096 1 24 5 DAC08-M21 6-CG8380-RA_2 CG8380 CGAGGATATACGGGACATGATTGGTTTTCCACCGGGAAGATACTGGCAGGTGTGTTGGCGATTTGTGGC 69 FBan0008380 FBgn0034136 DAT 2 2R extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cocaine binding; GO:0019811; dopamine transporter activity; GO:0005329; ; GO:0019811; ; GO:0005329; dopamine:sodium symporter activity; GO:0005330; ; GO:0005330 integral to plasma membrane; GO:0005887; membrane; GO:0016020 DAT Dopamine transporter "CG8380, CG8380, Dopamine transporter" CDMC24097 1 25 5 DAC09-A10 18-CG12809-RA_1 CG12809 TCCCTTTCAGTCATTCGATCAGCGTCGATTCTACTCTCTTGGGGAATTTTACCTATCGCAGCACTTGGA 69 FBan0012809 FBgn0041105 nerfin-2 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 nerfin-2 nervous fingers 2 "CG12809, nervous fingers 2" CDMC24097 1 26 5 DAC09-A10 18-CG12809-RA_1 CG12809 TCCCTTTCAGTCATTCGATCAGCGTCGATTCTACTCTCTTGGGGAATTTTACCTATCGCAGCACTTGGA 69 FBan0012809 FBgn0041105 nerfin-2 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 nerfin-2 nervous fingers 2 "CG12809, nervous fingers 2" CDMC24098 1 1 6 DAC09-A22 12-CG12818-RA_2 CG12818 AGGGGTGGATCTCTTTGCCGACTACAAGGCGAGAGTGAAGACCACTAACAAAGACTTGGAAAAGGAGCA 69 FBan0012818 FBgn0037809 CG12818 3 3R CG12818 CG12818 CDMC24098 1 2 6 DAC09-A22 12-CG12818-RA_2 CG12818 AGGGGTGGATCTCTTTGCCGACTACAAGGCGAGAGTGAAGACCACTAACAAAGACTTGGAAAAGGAGCA 69 FBan0012818 FBgn0037809 CG12818 3 3R CG12818 CG12818 CDMC24099 1 3 6 DAC09-E10 3-CG12855-RA_2 CG12855 CCAGCTGGTGCCAAAGACAAAACTCTGGAGCATGGTGGAGATCGCGAGAAATTACCTTAAGAAGGGCCA 69 FBan0012855 FBgn0033973 CG12855 2 2R CG12855 CG12855 CDMC24099 1 4 6 DAC09-E10 3-CG12855-RA_2 CG12855 CCAGCTGGTGCCAAAGACAAAACTCTGGAGCATGGTGGAGATCGCGAGAAATTACCTTAAGAAGGGCCA 69 FBan0012855 FBgn0033973 CG12855 2 2R CG12855 CG12855 CDMC24100 1 5 6 DAC09-E22 2-CG12864-RA_6 CG12864 CCACGTGGCACAAAACTGATCAAGAAGTCAGTGCAACAAGTGGCTACCAATCCCTCATTAGCCGGCACC 69 FBgn0033946 CDMC24100 1 6 6 DAC09-E22 2-CG12864-RA_6 CG12864 CCACGTGGCACAAAACTGATCAAGAAGTCAGTGCAACAAGTGGCTACCAATCCCTCATTAGCCGGCACC 69 FBgn0033946 CDMC24101 1 7 6 DAC09-I10 9-CG12908-RB_3 CG12908 TCCGCACCATCTCCAACGAACTGTCTTATCCCTTCGGCATTACCTTCACGCACGATCAGTTCTACTGGA 69 FBgn0033509 CDMC24101 1 8 6 DAC09-I10 9-CG12908-RB_3 CG12908 TCCGCACCATCTCCAACGAACTGTCTTATCCCTTCGGCATTACCTTCACGCACGATCAGTTCTACTGGA 69 FBgn0033509 CDMC24102 1 9 6 DAC09-I22 13-CG12918-RA_1 CG12918 GGTCAGATGAACCCAGACTCCTCGTTGGTTGACTTTGTGCAAGATGGTGATCTCAACAAAAGCCTGGGG 69 FBan0012918 FBgn0033477 CG12918 2 2R plasma membrane; GO:0005886 CG12918 CG12918 CDMC24102 1 10 6 DAC09-I22 13-CG12918-RA_1 CG12918 GGTCAGATGAACCCAGACTCCTCGTTGGTTGACTTTGTGCAAGATGGTGATCTCAACAAAAGCCTGGGG 69 FBan0012918 FBgn0033477 CG12918 2 2R plasma membrane; GO:0005886 CG12918 CG12918 CDMC24103 1 11 6 DAC09-M10 24-CG12963-RA_2 CG12963 GAAATGAACTTGTGTGATCTTATTGAGTACATACCTATTTAAGTTCTAGACATTAGGAGTCGCATATTG 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC24103 1 12 6 DAC09-M10 24-CG12963-RA_2 CG12963 GAAATGAACTTGTGTGATCTTATTGAGTACATACCTATTTAAGTTCTAGACATTAGGAGTCGCATATTG 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC24104 1 13 6 DAC09-M22 15-CG1298-RA_5 CG1298 CGCGTCGGGAAAGGTACAAGCGCTTAAACGAAATCAGCAATCGGGAGATCAGTGAATACGGAGATGAGT 69 FBan0001298 FBgn0033032 CG1298 2 2R CG1298 CG1298 CDMC24104 1 14 6 DAC09-M22 15-CG1298-RA_5 CG1298 CGCGTCGGGAAAGGTACAAGCGCTTAAACGAAATCAGCAATCGGGAGATCAGTGAATACGGAGATGAGT 69 FBan0001298 FBgn0033032 CG1298 2 2R CG1298 CG1298 CDMC24105 1 15 6 DAC10-A09 3-CG10933-RA_2 CG10933 CGGGCGCTGTATCGTCTTGTACACCTTTATAGCCAGGGACGAGAATGATTTGTCTGTGGAACGGGGTGA 69 FBan0010933 FBgn0034264 CG10933 2 2R CG10933 CG10933 CDMC24105 1 16 6 DAC10-A09 3-CG10933-RA_2 CG10933 CGGGCGCTGTATCGTCTTGTACACCTTTATAGCCAGGGACGAGAATGATTTGTCTGTGGAACGGGGTGA 69 FBan0010933 FBgn0034264 CG10933 2 2R CG10933 CG10933 CDMC24106 1 17 6 DAC10-A21 2-CG10949-RA_1 CG10949 CCCGTGCTGTATGATCGTCACAAGATCAGAGTCTCCAAGAACCTAGCAGCGAAAAACGAAGCCTGGCGA 69 FBan0010949 FBgn0032858 CG10949 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG10949 CG10949 "38C.46, FBgn0032858" CDMC24106 1 18 6 DAC10-A21 2-CG10949-RA_1 CG10949 CCCGTGCTGTATGATCGTCACAAGATCAGAGTCTCCAAGAACCTAGCAGCGAAAAACGAAGCCTGGCGA 69 FBan0010949 FBgn0032858 CG10949 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG10949 CG10949 "38C.46, FBgn0032858" CDMC24107 1 19 6 DAC10-E09 23-CG10986-RB_1 CG10986 CCATTTTCGTTAAGTTGAAACAATTGCCTCCTAAGAGAATGAAAAAAACCTAAAAAAATTATCGCTGCG 69 FBan0010986 FBgn0001087 g X X Golgi to endosome transport; GO:0006895; eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular transport; GO:0046907; lysosomal transport; GO:0007041; lysosome organization and biogenesis; GO:0007040; ocellus pigment biosynthesis; GO:0008055; ommochrome biosynthesis; GO:0006727 AP-3 adaptor complex; GO:0030123; Golgi stack; GO:0005795; Golgi vesicle; GO:0005798; clathrin adaptor complex; GO:0030131; endoplasmic reticulum; GO:0005783 g garnet "CG10986, CG11197, CG10986, CG11197, CG10986, CG10986, CG11197, CG11197, delta, cg11197, l(1)Mc19, lethal(1)Mc19, salmon, garnet" CDMC24107 1 20 6 DAC10-E09 23-CG10986-RB_1 CG10986 CCATTTTCGTTAAGTTGAAACAATTGCCTCCTAAGAGAATGAAAAAAACCTAAAAAAATTATCGCTGCG 69 FBan0010986 FBgn0001087 g X X Golgi to endosome transport; GO:0006895; eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular transport; GO:0046907; lysosomal transport; GO:0007041; lysosome organization and biogenesis; GO:0007040; ocellus pigment biosynthesis; GO:0008055; ommochrome biosynthesis; GO:0006727 AP-3 adaptor complex; GO:0030123; Golgi stack; GO:0005795; Golgi vesicle; GO:0005798; clathrin adaptor complex; GO:0030131; endoplasmic reticulum; GO:0005783 g garnet "CG10986, CG11197, CG10986, CG11197, CG10986, CG10986, CG11197, CG11197, delta, cg11197, l(1)Mc19, lethal(1)Mc19, salmon, garnet" CDMC24108 1 21 6 DAC10-E21 2-CG10992-RA_2 CG10992 TCGGCTCCAAGTCGTACTCGGTGAGGCGTAATGTGCGTGAAATTCAGGAGGAGATCATGACCAATGGAC 69 FBan0010992 FBgn0030521 CG10992 X X autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin B activity; GO:0004213 ; EC:3.4.22.1; ; GO:0004213 ; EC:3.4.22.1 CG10992 CG10992 anon-EST:ParkEST132 CDMC24108 1 22 6 DAC10-E21 2-CG10992-RA_2 CG10992 TCGGCTCCAAGTCGTACTCGGTGAGGCGTAATGTGCGTGAAATTCAGGAGGAGATCATGACCAATGGAC 69 FBan0010992 FBgn0030521 CG10992 X X autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin B activity; GO:0004213 ; EC:3.4.22.1; ; GO:0004213 ; EC:3.4.22.1 CG10992 CG10992 anon-EST:ParkEST132 CDMC24109 1 23 6 DAC10-I09 6-CG11043-RA_1 CG11043 AGTGCGGCCACTACTTCATCCTCAAGAATGTCCCACCCGTTTAGATCGATCACACAGAGCGCTGTACTT 69 FBan0011043 FBgn0031831 CG11043 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11043 CG11043 Vb CDMC24109 1 24 6 DAC10-I09 6-CG11043-RA_1 CG11043 AGTGCGGCCACTACTTCATCCTCAAGAATGTCCCACCCGTTTAGATCGATCACACAGAGCGCTGTACTT 69 FBan0011043 FBgn0031831 CG11043 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11043 CG11043 Vb CDMC24110 1 25 6 DAC10-I21 12-CG11052-RA_4 CG11052 TGACCTCCCAAGAAACGCAGACTGAGGGTGAACGTAGGAGGGTAACTCTTCCATCTTCGACACCAGATA 69 FBan0011052 FBgn0040524 CG11052 3 3R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.-; acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG11052 CG11052 CDMC24110 1 26 6 DAC10-I21 12-CG11052-RA_4 CG11052 TGACCTCCCAAGAAACGCAGACTGAGGGTGAACGTAGGAGGGTAACTCTTCCATCTTCGACACCAGATA 69 FBan0011052 FBgn0040524 CG11052 3 3R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.-; acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG11052 CG11052 CDMC24111 1 1 7 DAC10-M09 1-CG1108-RA_1 CG1108 GGCACGGCATACATAGGGTGGTCCTCTCCAGATTATCTCACGCACAAGCACCTACCTATCTGTACCGGT 69 FBan0001108 FBgn0015574 alpha-Est6 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est6 alpha-Esterase-6 "CG1108, alphaE6, E, F, G: Complementation group G, fragment E, fragment F, fragment G, aE6, G" CDMC24111 1 2 7 DAC10-M09 1-CG1108-RA_1 CG1108 GGCACGGCATACATAGGGTGGTCCTCTCCAGATTATCTCACGCACAAGCACCTACCTATCTGTACCGGT 69 FBan0001108 FBgn0015574 alpha-Est6 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est6 alpha-Esterase-6 "CG1108, alphaE6, E, F, G: Complementation group G, fragment E, fragment F, fragment G, aE6, G" CDMC24112 1 3 7 DAC10-M21 3-CG11098-RA_1 CG11098 AGCACCAGGGAGAGAATGCCAGCACAGTTGAGACCCAGACGCTGATGAAGAACGAAATCCAAACTCTGA 69 FBan0011098 FBgn0031842 CG11098 2 2L CG11098 CG11098 CDMC24112 1 4 7 DAC10-M21 3-CG11098-RA_1 CG11098 AGCACCAGGGAGAGAATGCCAGCACAGTTGAGACCCAGACGCTGATGAAGAACGAAATCCAAACTCTGA 69 FBan0011098 FBgn0031842 CG11098 2 2L CG11098 CG11098 CDMC24113 1 5 7 DAC11-A09 3-CG1216-RA_8 CG1216 CAAACAGGTGATGAAGGATCGCGGTCTGAAGAAGATACGCTGTGGCATAGAGGGATACCCCACCCACAA 69 FBan0001216 FBgn0035107 mri 3 3L autophagic cell death; GO:0048102; potassium ion transport; GO:0006813; salivary gland cell autophagic cell death; GO:0035071 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 mri mrityu "CG1216, CG1216, CG1216, CG1216, CG1216, mrityu" CDMC24113 1 6 7 DAC11-A09 3-CG1216-RA_8 CG1216 CAAACAGGTGATGAAGGATCGCGGTCTGAAGAAGATACGCTGTGGCATAGAGGGATACCCCACCCACAA 69 FBan0001216 FBgn0035107 mri 3 3L autophagic cell death; GO:0048102; potassium ion transport; GO:0006813; salivary gland cell autophagic cell death; GO:0035071 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 mri mrityu "CG1216, CG1216, CG1216, CG1216, CG1216, mrityu" CDMC24114 1 7 7 DAC11-A21 15-CG12186-RA_1 CG12186 AGTGCACACCAGCAAAGGAGAAACATATGAGCTCGATTTCAGTGAAACCCTGAAACTGGTGGCAGAACA 69 FBgn0035361 CDMC24114 1 8 7 DAC11-A21 15-CG12186-RA_1 CG12186 AGTGCACACCAGCAAAGGAGAAACATATGAGCTCGATTTCAGTGAAACCCTGAAACTGGTGGCAGAACA 69 FBgn0035361 CDMC24115 1 9 7 DAC11-E09 23-CG1221-RA_7 CG1221 CGACGGTCTAAACACAGATCCATCGTAGTTGCAGTGTAGGCAATTGGCATTTTAAAGTAGTTTACAACT 69 FBan0001221 FBgn0027111 miple 3 3L miple miple "CG1221, anon-EST:Posey203" CDMC24115 1 10 7 DAC11-E09 23-CG1221-RA_7 CG1221 CGACGGTCTAAACACAGATCCATCGTAGTTGCAGTGTAGGCAATTGGCATTTTAAAGTAGTTTACAACT 69 FBan0001221 FBgn0027111 miple 3 3L miple miple "CG1221, anon-EST:Posey203" CDMC24116 1 11 7 DAC11-E21 2-CG12230-RA_1 CG12230 GCGGCAATCGGGACTGCAGATGAGAATCCAGGATGCTAGGGGCGTTGTGAATGACACGATTACTAAGGA 69 FBan0012230 FBgn0000257 car X X endosome organization and biogenesis; GO:0007032; endosome to lysosome transport; GO:0008333; eye pigment granule organization and biogenesis; GO:0008057; eye pigmentation (sensu Endopterygota); GO:0048072; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; ommochrome biosynthesis; GO:0006727; protein targeting to lysosome; GO:0006622; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149; protein binding; GO:0005515; ; GO:0005515 cytosol; GO:0005829; lysosome; GO:0005764; membrane; GO:0016020 car carnation "CG12230, Dm-Vps33, Vps33, l(1)G0447, Vps33p, Vps33/carnation, Vacuolar protein sorting protein 33" CDMC24116 1 12 7 DAC11-E21 2-CG12230-RA_1 CG12230 GCGGCAATCGGGACTGCAGATGAGAATCCAGGATGCTAGGGGCGTTGTGAATGACACGATTACTAAGGA 69 FBan0012230 FBgn0000257 car X X endosome organization and biogenesis; GO:0007032; endosome to lysosome transport; GO:0008333; eye pigment granule organization and biogenesis; GO:0008057; eye pigmentation (sensu Endopterygota); GO:0048072; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; ommochrome biosynthesis; GO:0006727; protein targeting to lysosome; GO:0006622; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149; protein binding; GO:0005515; ; GO:0005515 cytosol; GO:0005829; lysosome; GO:0005764; membrane; GO:0016020 car carnation "CG12230, Dm-Vps33, Vps33, l(1)G0447, Vps33p, Vps33/carnation, Vacuolar protein sorting protein 33" CDMC24117 1 13 7 DAC11-I09 15-CG12267-RA_5 CG12267 GCAACTGGAATTCTGCTAAAATGCCTAGCCGAGAATGAAAACAAGGCAGAAAGTCCGGAGTCCTACCGC 69 FBan0012267 FBgn0038057 CG12267 3 3R transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666 CG12267 CG12267 CDMC24117 1 14 7 DAC11-I09 15-CG12267-RA_5 CG12267 GCAACTGGAATTCTGCTAAAATGCCTAGCCGAGAATGAAAACAAGGCAGAAAGTCCGGAGTCCTACCGC 69 FBan0012267 FBgn0038057 CG12267 3 3R transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666 CG12267 CG12267 CDMC24118 1 15 7 DAC11-I21 23-CG12290-RA_4 CG12290 TTTGCCCACTGAGGTCTAAACGGGGGGTTATGATAACTATACATATAGGAAGGTAAACAAACACTAAAC 69 FBan0012290 FBgn0039419 CG12290 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG12290 CG12290 "anon-WO0170980.49, anon-WO0170980.50" CDMC24118 1 16 7 DAC11-I21 23-CG12290-RA_4 CG12290 TTTGCCCACTGAGGTCTAAACGGGGGGTTATGATAACTATACATATAGGAAGGTAAACAAACACTAAAC 69 FBan0012290 FBgn0039419 CG12290 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG12290 CG12290 "anon-WO0170980.49, anon-WO0170980.50" CDMC24119 1 17 7 DAC11-M09 9-CG12327-RA_1 CG12327 CGCTCGATTGGGCATACCAAAAGTTGTCCCCGTGACCATGACGAAAAGCGAAGTCAGTTTGGAAAACGA 69 FBan0012327 FBgn0036492 Best3 3 3L ion transport; GO:0006811; transport; GO:0006810 Best3 Bestrophin 3 "CG12327, dbest3, Bestrophin 3" CDMC24119 1 18 7 DAC11-M09 9-CG12327-RA_1 CG12327 CGCTCGATTGGGCATACCAAAAGTTGTCCCCGTGACCATGACGAAAAGCGAAGTCAGTTTGGAAAACGA 69 FBan0012327 FBgn0036492 Best3 3 3L ion transport; GO:0006811; transport; GO:0006810 Best3 Bestrophin 3 "CG12327, dbest3, Bestrophin 3" CDMC24120 1 19 7 DAC11-M21 1-CG12342-RA_1 CG12342 AGTACGCCAACGTGATACGACGCTATCCGAACTCCAGTGAGACCTCAAATCCCTCCCAGAACTCCAACA 69 FBan0012342 FBgn0033552 CG12342 2 2R CG12342 CG12342 CDMC24120 1 20 7 DAC11-M21 1-CG12342-RA_1 CG12342 AGTACGCCAACGTGATACGACGCTATCCGAACTCCAGTGAGACCTCAAATCCCTCCCAGAACTCCAACA 69 FBan0012342 FBgn0033552 CG12342 2 2R CG12342 CG12342 CDMC24121 1 21 7 DAC12-A09 1-CG7845-RA_1 CG7845 TCGCTTTCTGAGCTCTGCAAGCCTAGACCGATACGTTCGTATCCATGATTCCGAAACCACAGTGCTGCT 69 FBan0007845 FBgn0033059 CG7845 2 2R CG7845 CG7845 CDMC24121 1 22 7 DAC12-A09 1-CG7845-RA_1 CG7845 TCGCTTTCTGAGCTCTGCAAGCCTAGACCGATACGTTCGTATCCATGATTCCGAAACCACAGTGCTGCT 69 FBan0007845 FBgn0033059 CG7845 2 2R CG7845 CG7845 CDMC24122 1 23 7 DAC12-A21 3-CG7855-RA_1 CG7855 AGCCAAGGAGTCAAAGGACTGCAATGACGATGGGACAGATAAAGCAGAGCTCGAGAAACCCAACACGGA 69 FBan0007855 FBgn0038118 timeout 3 3R development; GO:0007275; transmission of nerve impulse; GO:0019226 timeout timeout "CG8148, CG7855, CG14381, CG14382, CG8148, tim2, timeless 2, TIM2, dtim2" CDMC24122 1 24 7 DAC12-A21 3-CG7855-RA_1 CG7855 AGCCAAGGAGTCAAAGGACTGCAATGACGATGGGACAGATAAAGCAGAGCTCGAGAAACCCAACACGGA 69 FBan0007855 FBgn0038118 timeout 3 3R development; GO:0007275; transmission of nerve impulse; GO:0019226 timeout timeout "CG8148, CG7855, CG14381, CG14382, CG8148, tim2, timeless 2, TIM2, dtim2" CDMC24123 1 25 7 DAC12-E09 16-CG7887-RA_1 CG7887 TGCCCAAGGGAAACTCGATACCTTGTTGGGACTCAGTAAGGAAAGGTTGTTGCGGTCAGTAAAAGACTA 69 FBan0007887 FBgn0004622 Takr99D 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; ; GO:0004995 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Takr99D Tachykinin-like receptor at 99D "CG7887, CG7887, CG7887, DTKR, l(3)s2222, TAKR99D, TKR99D, anon-WO0131005.11, anon-WO0131005.9, Tak-r" CDMC24123 1 26 7 DAC12-E09 16-CG7887-RA_1 CG7887 TGCCCAAGGGAAACTCGATACCTTGTTGGGACTCAGTAAGGAAAGGTTGTTGCGGTCAGTAAAAGACTA 69 FBan0007887 FBgn0004622 Takr99D 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; ; GO:0004995 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Takr99D Tachykinin-like receptor at 99D "CG7887, CG7887, CG7887, DTKR, l(3)s2222, TAKR99D, TKR99D, anon-WO0131005.11, anon-WO0131005.9, Tak-r" CDMC24124 1 1 8 DAC12-E21 2-CG7900-RA_2 CG7900 GGCGCCTCTCTATTCGGCATTGGCTCAGATATTGGAGGTTCTATTCGCATTCCCAGCTTGTATTGCGGC 69 FBan0007900 FBgn0037548 CG7900 3 3R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG7900 CG7900 CDMC24124 1 2 8 DAC12-E21 2-CG7900-RA_2 CG7900 GGCGCCTCTCTATTCGGCATTGGCTCAGATATTGGAGGTTCTATTCGCATTCCCAGCTTGTATTGCGGC 69 FBan0007900 FBgn0037548 CG7900 3 3R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG7900 CG7900 CDMC24125 1 3 8 DAC12-I09 15-CG7930-RA_2 CG7930 TGGAACGAATACTCCGTGACGATCGCTTCGCAAGATTAGGCTGATCAGACAGATCCCATTGGCAAAGAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC24125 1 4 8 DAC12-I09 15-CG7930-RA_2 CG7930 TGGAACGAATACTCCGTGACGATCGCTTCGCAAGATTAGGCTGATCAGACAGATCCCATTGGCAAAGAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC24126 1 5 8 DAC12-I21 9-CG7940-RA_1 CG7940 AGCTGGACAAGTTTGAGCGAGCTCTACAGCAACAGCAGATTGGTACATTGGAGGACTTGGATTCCCTCA 69 FBan0007940 FBgn0038576 CG7940 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 CG7940 CG7940 CDMC24126 1 6 8 DAC12-I21 9-CG7940-RA_1 CG7940 AGCTGGACAAGTTTGAGCGAGCTCTACAGCAACAGCAGATTGGTACATTGGAGGACTTGGATTCCCTCA 69 FBan0007940 FBgn0038576 CG7940 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 CG7940 CG7940 CDMC24127 1 7 8 DAC12-M09 5-CG7973-RA_1 CG7973 CCGGAGTTGTGTGCAGATAGGTGTGGCGAAATGCTATGGAAACTCCAGAAGAATAGGTCGGAAAGCCCC 69 FBgn0036507 CDMC24127 1 8 8 DAC12-M09 5-CG7973-RA_1 CG7973 CCGGAGTTGTGTGCAGATAGGTGTGGCGAAATGCTATGGAAACTCCAGAAGAATAGGTCGGAAAGCCCC 69 FBgn0036507 CDMC24128 1 9 8 DAC12-M21 3-CG7986-RB_1 CG7986 GGGTGACGATCCCGTGGGACCCTCATCCGCTTAGACAAGGTCAATGATCAAAAATGAGAGATGCAGCGA 69 FBan0007986 FBgn0035850 Atg18 3 3L autophagy; GO:0006914 Atg18 Autophagy-specific gene 18 "CG7986, ATG18, Autophagy-specific gene 18" CDMC24128 1 10 8 DAC12-M21 3-CG7986-RB_1 CG7986 GGGTGACGATCCCGTGGGACCCTCATCCGCTTAGACAAGGTCAATGATCAAAAATGAGAGATGCAGCGA 69 FBan0007986 FBgn0035850 Atg18 3 3L autophagy; GO:0006914 Atg18 Autophagy-specific gene 18 "CG7986, ATG18, Autophagy-specific gene 18" CDMC24129 1 11 8 DAC13-A09 9-CG13245-RA_1 CG13245 CGCAGCTCTGCACACTGGCGAGTACTCAGAAAAAAAAGGAAGACGAATAAACGCCAGGAGGAAATGCGG 69 FBan0013245 FBgn0045827 CG13245 2 2L CG13245 CG13245 "bs34a02.y1, BEST:GH09435, BEST:GH21951, BEST:GH06096" CDMC24129 1 12 8 DAC13-A09 9-CG13245-RA_1 CG13245 CGCAGCTCTGCACACTGGCGAGTACTCAGAAAAAAAAGGAAGACGAATAAACGCCAGGAGGAAATGCGG 69 FBan0013245 FBgn0045827 CG13245 2 2L CG13245 CG13245 "bs34a02.y1, BEST:GH09435, BEST:GH21951, BEST:GH06096" CDMC24130 1 13 8 DAC13-A21 16-CG13255-RA_1 CG13255 GCGTTGCGACCCGTCTATTTACCTGAACCTGAGCTGTCTGGACTACACTCTTTAACATTTCCTTACGGA 69 FBan0013255 FBgn0040636 CG13255 3 3L CG13255 CG13255 CDMC24130 1 14 8 DAC13-A21 16-CG13255-RA_1 CG13255 GCGTTGCGACCCGTCTATTTACCTGAACCTGAGCTGTCTGGACTACACTCTTTAACATTTCCTTACGGA 69 FBan0013255 FBgn0040636 CG13255 3 3L CG13255 CG13255 CDMC24131 1 15 8 DAC13-E09 2-CG13297-RA_1 CG13297 ACAGGGCCTTAAGGTTCGCAAGTTGTCCGGAAAATCTCTTGCATCTCTGGCCGGATAAGACACCTCAGA 69 FBan0013297 FBgn0035685 CG13297 3 3L CG13297 CG13297 BcDNA:RE64858 CDMC24131 1 16 8 DAC13-E09 2-CG13297-RA_1 CG13297 ACAGGGCCTTAAGGTTCGCAAGTTGTCCGGAAAATCTCTTGCATCTCTGGCCGGATAAGACACCTCAGA 69 FBan0013297 FBgn0035685 CG13297 3 3L CG13297 CG13297 BcDNA:RE64858 CDMC24132 1 17 8 DAC13-E21 1-CG1330-RA_2 CG1330 CCCTGCGTACACCGTCGCCCAATTGTAAACACCCATGCGACCGCTGTTATTTTGAACCCTTGTTTTGTT 69 FBan0001330 FBgn0004779 Ccp84Ae 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ae Ccp84Ae "CG1330, BG:DS00004.5, cc4: cuticle cluster 4, cuticle cluster 4" CDMC24132 1 18 8 DAC13-E21 1-CG1330-RA_2 CG1330 CCCTGCGTACACCGTCGCCCAATTGTAAACACCCATGCGACCGCTGTTATTTTGAACCCTTGTTTTGTT 69 FBan0001330 FBgn0004779 Ccp84Ae 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ae Ccp84Ae "CG1330, BG:DS00004.5, cc4: cuticle cluster 4, cuticle cluster 4" CDMC24133 1 19 8 DAC13-I09 3-CG13332-RA_2 CG13332 ACAGCGGGATCATCCAGAAGCAAATCTGGGAGACGAGCATCAACAAGGATGTGCTGGAACGTCAGCTAA 69 FBan0013332 FBgn0033851 CG13332 2 2R CG13332 CG13332 CDMC24133 1 20 8 DAC13-I09 3-CG13332-RA_2 CG13332 ACAGCGGGATCATCCAGAAGCAAATCTGGGAGACGAGCATCAACAAGGATGTGCTGGAACGTCAGCTAA 69 FBan0013332 FBgn0033851 CG13332 2 2R CG13332 CG13332 CDMC24134 1 21 8 DAC13-I21 3-CG1333-RA_3 CG1333 GGGCATCTGGGGTCCCAACGTAAAGGAGTTTAAACGACGCTTTAGTCCAGAAACCACAAGCGGTGAAGG 69 FBan0001333 FBgn0028736 Ero1L 3 3L chaperone cofactor dependent protein folding; GO:0051085; intracellular protein transport; GO:0006886; protein folding; GO:0006457; protein metabolism; GO:0019538; vesicle-mediated transport; GO:0016192 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- endoplasmic reticulum; GO:0005783 Ero1L Ero1L "CG1333, ERO1-L" CDMC24134 1 22 8 DAC13-I21 3-CG1333-RA_3 CG1333 GGGCATCTGGGGTCCCAACGTAAAGGAGTTTAAACGACGCTTTAGTCCAGAAACCACAAGCGGTGAAGG 69 FBan0001333 FBgn0028736 Ero1L 3 3L chaperone cofactor dependent protein folding; GO:0051085; intracellular protein transport; GO:0006886; protein folding; GO:0006457; protein metabolism; GO:0019538; vesicle-mediated transport; GO:0016192 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- endoplasmic reticulum; GO:0005783 Ero1L Ero1L "CG1333, ERO1-L" CDMC24135 1 23 8 DAC13-M09 3-CG13390-RA_1 CG13390 GGCAACCGTTTCTTTACCACGGACAAGGAAACAAGTCCCAAGGTCAGCGAATACGGTCCTAGGGGTGAA 69 FBan0013390 FBgn0032031 CG13390 2 2L "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" CG13390 CG13390 CDMC24135 1 24 8 DAC13-M09 3-CG13390-RA_1 CG13390 GGCAACCGTTTCTTTACCACGGACAAGGAAACAAGTCCCAAGGTCAGCGAATACGGTCCTAGGGGTGAA 69 FBan0013390 FBgn0032031 CG13390 2 2L "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" CG13390 CG13390 CDMC24136 1 25 8 DAC13-M21 3-CG13397-RA_1 CG13397 CCATGCTGGACGACCCTTTAATGGTACCGCTTTCAAGCTGAAAGTCTCGCACGAAATCGAGCTGCCTTT 69 FBan0013397 FBgn0014417 CG13397 2 2L protein amino acid glycosylation; GO:0006486 "alpha-N-acetylglucosaminidase activity; GO:0004561 ; EC:3.2.1.50; ; GO:0004561 ; EC:3.2.1.50; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004561 ; EC:3.2.1.50" CG13397 CG13397 "172F5T, ESTS:172F5T, anon-sts19" CDMC24136 1 26 8 DAC13-M21 3-CG13397-RA_1 CG13397 CCATGCTGGACGACCCTTTAATGGTACCGCTTTCAAGCTGAAAGTCTCGCACGAAATCGAGCTGCCTTT 69 FBan0013397 FBgn0014417 CG13397 2 2L protein amino acid glycosylation; GO:0006486 "alpha-N-acetylglucosaminidase activity; GO:0004561 ; EC:3.2.1.50; ; GO:0004561 ; EC:3.2.1.50; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004561 ; EC:3.2.1.50" CG13397 CG13397 "172F5T, ESTS:172F5T, anon-sts19" CDMC24137 1 1 9 DAC14-A09 18-CG8597-RA_1 CG8597 GGTCGCGATGCCATACAGAATCTGAACGGTTATACGCTGAACGAGTTCGCCATCAAGGTGGAGGC 65 FBan0008597 FBgn0011640 lark 3 3L "NOT locomotion; GO:0040011; actin cytoskeleton organization and biogenesis; GO:0030036; circadian rhythm; GO:0007623; cytoplasmic transport, nurse cell to oocyte; GO:0007303; eclosion; GO:0007562; eclosion rhythm; GO:0008062; embryonic development; GO:0009790; locomotor rhythm; GO:0045475; negative regulation of eclosion; GO:0045804; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104" RNA binding; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003723 cytoplasm; GO:0005737; nucleus; GO:0005634 lark lark "CG8597, Lark, LARK, lark" CDMC24137 1 2 9 DAC14-A09 18-CG8597-RA_1 CG8597 GGTCGCGATGCCATACAGAATCTGAACGGTTATACGCTGAACGAGTTCGCCATCAAGGTGGAGGC 65 FBan0008597 FBgn0011640 lark 3 3L "NOT locomotion; GO:0040011; actin cytoskeleton organization and biogenesis; GO:0030036; circadian rhythm; GO:0007623; cytoplasmic transport, nurse cell to oocyte; GO:0007303; eclosion; GO:0007562; eclosion rhythm; GO:0008062; embryonic development; GO:0009790; locomotor rhythm; GO:0045475; negative regulation of eclosion; GO:0045804; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104" RNA binding; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003723 cytoplasm; GO:0005737; nucleus; GO:0005634 lark lark "CG8597, Lark, LARK, lark" CDMC24138 1 3 9 DAC14-A21 5-CG8642-RA_1 CG8642 GCACCCACGACAAGATGAAGTTCTCCACCTACGACCGGGACAATGACGCCTTCACGCACATGAAC 65 FBan0008642 FBgn0033312 CG8642 2 2R carbon utilization by fixation of carbon dioxide; GO:0015977; defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG8642 CG8642 CDMC24138 1 4 9 DAC14-A21 5-CG8642-RA_1 CG8642 GCACCCACGACAAGATGAAGTTCTCCACCTACGACCGGGACAATGACGCCTTCACGCACATGAAC 65 FBan0008642 FBgn0033312 CG8642 2 2R carbon utilization by fixation of carbon dioxide; GO:0015977; defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG8642 CG8642 CDMC24139 1 5 9 DAC14-E09 2-CG8777-RA_1 CG8777 AAAAACCTGTATCGCCAAGCAATCGAAGCCTTCACTCGGGCGTGTAAGTTGTGCGAACCTGGAGC 65 FBan0008777 FBgn0033376 CG8777 2 2R CG8777 CG8777 CDMC24139 1 6 9 DAC14-E09 2-CG8777-RA_1 CG8777 AAAAACCTGTATCGCCAAGCAATCGAAGCCTTCACTCGGGCGTGTAAGTTGTGCGAACCTGGAGC 65 FBan0008777 FBgn0033376 CG8777 2 2R CG8777 CG8777 CDMC24140 1 7 9 DAC14-E21 9-CG8791-RA_1 CG8791 TTTGGCAAGGCCACTATTCAGATTTGGAACGAACCTCCATCGACGTCTAGCACGATGACGCTCCG 65 FBan0008791 FBgn0033234 CG8791 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG8791 CG8791 anon-WO0140519.99 CDMC24140 1 8 9 DAC14-E21 9-CG8791-RA_1 CG8791 TTTGGCAAGGCCACTATTCAGATTTGGAACGAACCTCCATCGACGTCTAGCACGATGACGCTCCG 65 FBan0008791 FBgn0033234 CG8791 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG8791 CG8791 anon-WO0140519.99 CDMC24141 1 9 9 DAC14-I09 3-CG8913-RA_5 CG8913 CAAGCCAACCCATGCCGATATTTTGGCCTTCGATATCCAAAGGGGGAGAGATCACGGTCTGCTGC 65 FBan0008913 FBgn0038465 CG8913 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG8913 CG8913 Peroxidase CDMC24141 1 10 9 DAC14-I09 3-CG8913-RA_5 CG8913 CAAGCCAACCCATGCCGATATTTTGGCCTTCGATATCCAAAGGGGGAGAGATCACGGTCTGCTGC 65 FBan0008913 FBgn0038465 CG8913 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG8913 CG8913 Peroxidase CDMC24142 1 11 9 DAC14-I21 9-CG8965-RA_1 CG8965 AGGATGAAGACGAGTGTGCTAGCAGTTCTGGCTCCTCGGATAATTCCACAGAATGTGCCCTACGC 65 FBan0008965 FBgn0031745 CG8965 2 2L CG8965 CG8965 CDMC24142 1 12 9 DAC14-I21 9-CG8965-RA_1 CG8965 AGGATGAAGACGAGTGTGCTAGCAGTTCTGGCTCCTCGGATAATTCCACAGAATGTGCCCTACGC 65 FBan0008965 FBgn0031745 CG8965 2 2L CG8965 CG8965 CDMC24143 1 13 9 DAC14-M09 23-CG9035-RA_1 CG9035 TTCGTCATCGAGATTTTGAATGAAATTCATTCGCACTAAAGTCATGTACCATCAAATTGCCGGGT 65 FBan0009035 FBgn0021795 Tapdelta 2 2R protein retention in ER; GO:0006621 signal sequence binding; GO:0005048; ; GO:0005048 integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; translocon complex; GO:0005784 Tapdelta Translocon-associated protein delta "CG9035, l(2)k17005, Tapdelta, BcDNA:GM12291, Translocon-associated protein delta" CDMC24143 1 14 9 DAC14-M09 23-CG9035-RA_1 CG9035 TTCGTCATCGAGATTTTGAATGAAATTCATTCGCACTAAAGTCATGTACCATCAAATTGCCGGGT 65 FBan0009035 FBgn0021795 Tapdelta 2 2R protein retention in ER; GO:0006621 signal sequence binding; GO:0005048; ; GO:0005048 integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; translocon complex; GO:0005784 Tapdelta Translocon-associated protein delta "CG9035, l(2)k17005, Tapdelta, BcDNA:GM12291, Translocon-associated protein delta" CDMC24144 1 15 9 DAC14-M21 3-CG9070-RA_1 CG9070 AAGATGCCAATGTTCTCCGTGCCGAGCAGCAAGTGAATGTTGACGGCTTTGCTTACGCTGTTGAG 65 FBan0009070 FBgn0033604 CG9070 2 2R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; structural constituent of cuticle; GO:0042302; ; GO:0042302 extracellular region; GO:0005576 CG9070 CG9070 BcDNA:RE09259 CDMC24144 1 16 9 DAC14-M21 3-CG9070-RA_1 CG9070 AAGATGCCAATGTTCTCCGTGCCGAGCAGCAAGTGAATGTTGACGGCTTTGCTTACGCTGTTGAG 65 FBan0009070 FBgn0033604 CG9070 2 2R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; structural constituent of cuticle; GO:0042302; ; GO:0042302 extracellular region; GO:0005576 CG9070 CG9070 BcDNA:RE09259 CDMC24145 1 17 9 DAC15-A09 3-CG8173-RA_8 CG8173 CCGTGGCGTTATCACCAATGACGAGGGCATCAACACACTGGCACTTGAAATGTGCACCACTTCACTG 67 FBan0008173 FBgn0030864 CG8173 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 CG8173 CG8173 CDMC24145 1 18 9 DAC15-A09 3-CG8173-RA_8 CG8173 CCGTGGCGTTATCACCAATGACGAGGGCATCAACACACTGGCACTTGAAATGTGCACCACTTCACTG 67 FBan0008173 FBgn0030864 CG8173 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 CG8173 CG8173 CDMC24146 1 19 9 DAC15-A21 6-CG8292-RA_2 CG8292 GGAGGCGTCCTTTAGCAAGTACCTTGATCCCTCCTCCACCACATACAATCTGTCGTATGTGCGCTGG 67 FBan0008292 FBgn0032004 CG8292 2 2L CG8292 CG8292 CDMC24146 1 20 9 DAC15-A21 6-CG8292-RA_2 CG8292 GGAGGCGTCCTTTAGCAAGTACCTTGATCCCTCCTCCACCACATACAATCTGTCGTATGTGCGCTGG 67 FBan0008292 FBgn0032004 CG8292 2 2L CG8292 CG8292 CDMC24147 1 21 9 DAC15-E09 3-CG8635-RA_1 CG8635 TTCTCCCACGATCTTTCCCAGGAGAACAAGGTCGAAAAGCGGTCCATTTATGTGGACATGCGCGACG 67 FBan0008635 FBgn0033317 CG8635 2 2R CG8635 CG8635 CDMC24147 1 22 9 DAC15-E09 3-CG8635-RA_1 CG8635 TTCTCCCACGATCTTTCCCAGGAGAACAAGGTCGAAAAGCGGTCCATTTATGTGGACATGCGCGACG 67 FBan0008635 FBgn0033317 CG8635 2 2R CG8635 CG8635 CDMC24148 1 23 9 DAC15-E21 9-CG8866-RB_3 CG8866 GCGCATTTCGTTTGCAGACTTCTTTGCGCATCCCTTTCTCGATCTCAAGACGTTTCCCACGGAGCAC 67 FBan0008866 FBgn0037679 CG8866 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8866 CG8866 UNC 51-like CDMC24148 1 24 9 DAC15-E21 9-CG8866-RB_3 CG8866 GCGCATTTCGTTTGCAGACTTCTTTGCGCATCCCTTTCTCGATCTCAAGACGTTTCCCACGGAGCAC 67 FBan0008866 FBgn0037679 CG8866 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8866 CG8866 UNC 51-like CDMC24149 1 25 9 DAC15-I09 3-CG9231-RA_1 CG9231 AGATCCTTCGGCACCAGTCAGATGTTGCGAGAGACGATCAAGAACCACGAGCCAAACAATCTGGAGC 67 FBan0009231 FBgn0036887 CG9231 3 3L CG9231 CG9231 CDMC24149 1 26 9 DAC15-I09 3-CG9231-RA_1 CG9231 AGATCCTTCGGCACCAGTCAGATGTTGCGAGAGACGATCAAGAACCACGAGCCAAACAATCTGGAGC 67 FBan0009231 FBgn0036887 CG9231 3 3L CG9231 CG9231 CDMC24150 1 1 10 DAC15-I21 8-CG9323-RA_1 CG9323 TTTTCCTGCTCGACTCCACAATGGTTTTTCCCATGGCACTGATCATTTTCGGAGATGGCGTGGAAGC 67 FBan0009323 FBgn0032883 CG9323 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0008026; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG9323 CG9323 "cg9323, 38E.15" CDMC24150 1 2 10 DAC15-I21 8-CG9323-RA_1 CG9323 TTTTCCTGCTCGACTCCACAATGGTTTTTCCCATGGCACTGATCATTTTCGGAGATGGCGTGGAAGC 67 FBan0009323 FBgn0032883 CG9323 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0008026; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG9323 CG9323 "cg9323, 38E.15" CDMC24151 1 3 10 DAC15-M09 15-CG9769-RA_2 CG9769 GCGGAAATTTTCCTTGCAAATCTTGGCCACCGAAAATTACCATGTCGGCTCTCAATCTGACCGTGCG 67 FBan0009769 FBgn0037270 CG9769 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG9769 CG9769 eIF3-S5 CDMC24151 1 4 10 DAC15-M09 15-CG9769-RA_2 CG9769 GCGGAAATTTTCCTTGCAAATCTTGGCCACCGAAAATTACCATGTCGGCTCTCAATCTGACCGTGCG 67 FBan0009769 FBgn0037270 CG9769 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG9769 CG9769 eIF3-S5 CDMC24152 1 5 10 DAC15-M21 9-CG9866-RA_1 CG9866 CGGATCGCCGGGAGTCATGACAGCCAAGCGTTTGAATGAACTGCTAATGGGAAAGGCGAAGAAGGAG 67 FBan0009866 FBgn0031420 CG9866 2 2L CG9866 CG9866 CDMC24152 1 6 10 DAC15-M21 9-CG9866-RA_1 CG9866 CGGATCGCCGGGAGTCATGACAGCCAAGCGTTTGAATGAACTGCTAATGGGAAAGGCGAAGAAGGAG 67 FBan0009866 FBgn0031420 CG9866 2 2L CG9866 CG9866 CDMC24153 1 7 10 DAC16-A09 2-CG4878-RA_2 CG4878 CGCGTTACCCTGATGGAGATCCCCAAGAAGCGTGAGATCCGTAACAAGAACCTTTTCCATGTGGCCGAT 69 FBan0004878 FBgn0034237 eIF3-S9 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S9 eIF3-S9 "CG4878, CG4878, cg4878" CDMC24153 1 8 10 DAC16-A09 2-CG4878-RA_2 CG4878 CGCGTTACCCTGATGGAGATCCCCAAGAAGCGTGAGATCCGTAACAAGAACCTTTTCCATGTGGCCGAT 69 FBan0004878 FBgn0034237 eIF3-S9 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S9 eIF3-S9 "CG4878, CG4878, cg4878" CDMC24154 1 9 10 DAC16-A21 2-CG4892-RA_2 CG4892 CAGGCTGAGAGCCGTCTGCGTAAGGTTCCATCCAAGATGTCCGGAAAACCTCAAGCTCCTGATCTCAAC 69 FBan0004892 FBgn0028884 CG4892 2 2L CG4892 CG4892 "BG:DS04095.2, DS04095.2, BcDNA:AT24169" CDMC24154 1 10 10 DAC16-A21 2-CG4892-RA_2 CG4892 CAGGCTGAGAGCCGTCTGCGTAAGGTTCCATCCAAGATGTCCGGAAAACCTCAAGCTCCTGATCTCAAC 69 FBan0004892 FBgn0028884 CG4892 2 2L CG4892 CG4892 "BG:DS04095.2, DS04095.2, BcDNA:AT24169" CDMC24155 1 11 10 DAC16-E09 12-CG4919-RA_8 CG4919 AGGGCTGCAGTTGTCTGGACGGTCGCGAAAGTAGCAGATACCAAATAAGGAGAACACTTGTCACCATGA 69 FBan0004919 FBgn0046114 Gclm 3 3R glutathione biosynthesis; GO:0006750; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; positive regulation of glutamate-cysteine ligase activity; GO:0035229; regulation of glutamate-cysteine ligase activity; GO:0035227 enzyme binding; GO:0019899; enzyme regulator activity; GO:0030234; contributes_to glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; glutamate-cysteine ligase catalytic subunit binding; GO:0035226; ; GO:0004357 ; EC:6.3.2.2; ; GO:0030234; ; GO:0019899; ; GO:0035226 glutamate-cysteine ligase complex; GO:0017109 Gclm Glutamate-cysteine ligase modifier subunit "CG4919, CG4919, CG4919, CG4919, DmGCSl, gamma-Glutamylcysteine synthetase regulatory subunit, DmGCLM, GCSl, box, Gcsl, Glutamate-cysteine ligase modifier subunit" CDMC24155 1 12 10 DAC16-E09 12-CG4919-RA_8 CG4919 AGGGCTGCAGTTGTCTGGACGGTCGCGAAAGTAGCAGATACCAAATAAGGAGAACACTTGTCACCATGA 69 FBan0004919 FBgn0046114 Gclm 3 3R glutathione biosynthesis; GO:0006750; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; positive regulation of glutamate-cysteine ligase activity; GO:0035229; regulation of glutamate-cysteine ligase activity; GO:0035227 enzyme binding; GO:0019899; enzyme regulator activity; GO:0030234; contributes_to glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; glutamate-cysteine ligase catalytic subunit binding; GO:0035226; ; GO:0004357 ; EC:6.3.2.2; ; GO:0030234; ; GO:0019899; ; GO:0035226 glutamate-cysteine ligase complex; GO:0017109 Gclm Glutamate-cysteine ligase modifier subunit "CG4919, CG4919, CG4919, CG4919, DmGCSl, gamma-Glutamylcysteine synthetase regulatory subunit, DmGCLM, GCSl, box, Gcsl, Glutamate-cysteine ligase modifier subunit" CDMC24156 1 13 10 DAC16-E21 2-CG4927-RA_1 CG4927 GCAGCATCCCATATATTCGTGCCTGAAGCAAGTGATTGGCATCACCTCCTATGGATTGGTCTGCGGTGT 69 FBan0004927 FBgn0034139 CG4927 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4927 CG4927 SP42 CDMC24156 1 14 10 DAC16-E21 2-CG4927-RA_1 CG4927 GCAGCATCCCATATATTCGTGCCTGAAGCAAGTGATTGGCATCACCTCCTATGGATTGGTCTGCGGTGT 69 FBan0004927 FBgn0034139 CG4927 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4927 CG4927 SP42 CDMC24157 1 15 10 DAC16-I09 3-CG4954-RA_2 CG4954 TGCAATTCGTGGACAAGGTCACAAATCTGGTGGACGTCAACGAAAAGGTGTTCGACATGAAGCAGGGCA 69 FBan0004954 FBgn0034258 eIF3-S8 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S8 eIF3-S8 "CG4954, CG4954" CDMC24157 1 16 10 DAC16-I09 3-CG4954-RA_2 CG4954 TGCAATTCGTGGACAAGGTCACAAATCTGGTGGACGTCAACGAAAAGGTGTTCGACATGAAGCAGGGCA 69 FBan0004954 FBgn0034258 eIF3-S8 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S8 eIF3-S8 "CG4954, CG4954" CDMC24158 1 17 10 DAC16-I21 2-CG4966-RA_1 CG4966 TGGAGTACCACTAACACCCCTGATGGCCAAACTATCTGTTCTGGCTCTAAGCGAAACAACGCCCATCGA 69 FBan0004966 FBgn0034261 CG4966 2 2R CG4966 CG4966 CDMC24158 1 18 10 DAC16-I21 2-CG4966-RA_1 CG4966 TGGAGTACCACTAACACCCCTGATGGCCAAACTATCTGTTCTGGCTCTAAGCGAAACAACGCCCATCGA 69 FBan0004966 FBgn0034261 CG4966 2 2R CG4966 CG4966 CDMC24159 1 19 10 DAC16-M09 2-CG5000-RA_1 CG5000 CGATGGATCCCATATGCTGGACAATAAGGTGGTTGACGAGAACCTCTGCCTGAACGGAATGAACGCGCA 69 FBan0005000 FBgn0027948 msps 3 3R bicoid mRNA localization; GO:0045450; cytoplasmic microtubule organization and biogenesis; GO:0031122; female meiosis; GO:0007143; microtubule-based process; GO:0007017; mitosis; GO:0007067; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; pronuclear fusion; GO:0007344 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; protein binding; GO:0005515; ; GO:0005200; ; GO:0005515 centrosome; GO:0005813; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 msps mini spindles "CG5000, CG5000, MINISPINDLES, Msps, anon-WO0140519.136, mini spindles" CDMC24159 1 20 10 DAC16-M09 2-CG5000-RA_1 CG5000 CGATGGATCCCATATGCTGGACAATAAGGTGGTTGACGAGAACCTCTGCCTGAACGGAATGAACGCGCA 69 FBan0005000 FBgn0027948 msps 3 3R bicoid mRNA localization; GO:0045450; cytoplasmic microtubule organization and biogenesis; GO:0031122; female meiosis; GO:0007143; microtubule-based process; GO:0007017; mitosis; GO:0007067; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; pronuclear fusion; GO:0007344 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; protein binding; GO:0005515; ; GO:0005200; ; GO:0005515 centrosome; GO:0005813; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 msps mini spindles "CG5000, CG5000, MINISPINDLES, Msps, anon-WO0140519.136, mini spindles" CDMC24160 1 21 10 DAC16-M21 17-CG5010-RA_1 CG5010 GCCGGATGAACCCATCGGATGAACACCTCCGGATGAACTCTGTCCTATCCCTTCGTTTAGTTCTTAATT 69 FBan0005010 FBgn0030821 CG5010 X X CG5010 CG5010 BcDNA:RE73921 CDMC24160 1 22 10 DAC16-M21 17-CG5010-RA_1 CG5010 GCCGGATGAACCCATCGGATGAACACCTCCGGATGAACTCTGTCCTATCCCTTCGTTTAGTTCTTAATT 69 FBan0005010 FBgn0030821 CG5010 X X CG5010 CG5010 BcDNA:RE73921 CDMC24161 1 23 10 DAC17-A09 7-CG7091-RA_1 CG7091 TGCAGCAGTACGAACCTACAACCTTGGGATCCTCGTAGCAGAATGGAGAAAACTGCATCACCAAGTGCT 69 FBan0007091 FBgn0038099 CG7091 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG7091 CG7091 CDMC24161 1 24 10 DAC17-A09 7-CG7091-RA_1 CG7091 TGCAGCAGTACGAACCTACAACCTTGGGATCCTCGTAGCAGAATGGAGAAAACTGCATCACCAAGTGCT 69 FBan0007091 FBgn0038099 CG7091 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG7091 CG7091 CDMC24162 1 25 10 DAC17-A21 23-CG7100-RE_8 CG7100 TGAAGTTGGCAGAACTCTCTACGTAAATGGAAACTAAGAACTAGAAAACTAAAATAGGGGAAGGGAAGT 69 FBan0007100 FBgn0015609 CadN 2 2L axon guidance; GO:0007411; axon target recognition; GO:0007412; axonal fasciculation; GO:0007413; calcium-dependent cell-cell adhesion; GO:0016339; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; negative regulation of dendrite morphogenesis; GO:0050774; signal transduction; GO:0007165 beta-catenin binding; GO:0008013; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0008013 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intercellular junction; GO:0005911; plasma membrane; GO:0005886 CadN Cadherin-N "CG7100, l(2)Bld, N-cadherin, D-cad, DN-cadherin, B, Drosophila neuronal cadherin, DN-Cad, DN-Cadherin, l(2)36Da, DN, DN-cad, CT21941, ncad, Ncad, N-Cadherin, N-cad, S(DmcycE[JP])2.12, N-Cad, CadherinN, anon-EST:CL32, lethal(2)36Da, Cadherin-N" CDMC24162 1 26 10 DAC17-A21 23-CG7100-RE_8 CG7100 TGAAGTTGGCAGAACTCTCTACGTAAATGGAAACTAAGAACTAGAAAACTAAAATAGGGGAAGGGAAGT 69 FBan0007100 FBgn0015609 CadN 2 2L axon guidance; GO:0007411; axon target recognition; GO:0007412; axonal fasciculation; GO:0007413; calcium-dependent cell-cell adhesion; GO:0016339; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; negative regulation of dendrite morphogenesis; GO:0050774; signal transduction; GO:0007165 beta-catenin binding; GO:0008013; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0008013 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intercellular junction; GO:0005911; plasma membrane; GO:0005886 CadN Cadherin-N "CG7100, l(2)Bld, N-cadherin, D-cad, DN-cadherin, B, Drosophila neuronal cadherin, DN-Cad, DN-Cadherin, l(2)36Da, DN, DN-cad, CT21941, ncad, Ncad, N-Cadherin, N-cad, S(DmcycE[JP])2.12, N-Cad, CadherinN, anon-EST:CL32, lethal(2)36Da, Cadherin-N" CDMC24163 1 1 11 DAC17-E09 41-CG7134-RA_1 CG7134 GCGGGTAGATACGATGCACCTGAATGACCAGGATAACTTAGATGCAGCTTGTACGGATCAAACGGATGA 69 FBan0007134 FBgn0031952 CG7134 2 2L mitosis; GO:0007067; protein amino acid dephosphorylation; GO:0006470; regulation of progression through cell cycle; GO:0000074 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004725 ; EC:3.1.3.48 CG7134 CG7134 CDC14 CDMC24163 1 2 11 DAC17-E09 41-CG7134-RA_1 CG7134 GCGGGTAGATACGATGCACCTGAATGACCAGGATAACTTAGATGCAGCTTGTACGGATCAAACGGATGA 69 FBan0007134 FBgn0031952 CG7134 2 2L mitosis; GO:0007067; protein amino acid dephosphorylation; GO:0006470; regulation of progression through cell cycle; GO:0000074 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004725 ; EC:3.1.3.48 CG7134 CG7134 CDC14 CDMC24164 1 3 11 DAC17-E21 15-CG7147-RA_1 CG7147 CGCCCGCTGCTAGTCATCGAACTACATGTATGAGTTGTTGCTTCCCATCCACCGACAAACACAAACAGA 69 FBan0007147 FBgn0015954 kuz 2 2L Notch receptor processing; GO:0007220; Notch signaling pathway; GO:0007219; central nervous system development; GO:0007417; proteolysis; GO:0006508; regulation of axon extension; GO:0030516 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 kuz kuzbanian "CG7147, CG7147, l(2)br38, br38, 34Da, l34Da, l(2)34Da, l(2)k01403, BG:DS07660.3, CT22079, l(2)03782, l(2)c00136, lethal (2) c00136" CDMC24164 1 4 11 DAC17-E21 15-CG7147-RA_1 CG7147 CGCCCGCTGCTAGTCATCGAACTACATGTATGAGTTGTTGCTTCCCATCCACCGACAAACACAAACAGA 69 FBan0007147 FBgn0015954 kuz 2 2L Notch receptor processing; GO:0007220; Notch signaling pathway; GO:0007219; central nervous system development; GO:0007417; proteolysis; GO:0006508; regulation of axon extension; GO:0030516 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 kuz kuzbanian "CG7147, CG7147, l(2)br38, br38, 34Da, l34Da, l(2)34Da, l(2)k01403, BG:DS07660.3, CT22079, l(2)03782, l(2)c00136, lethal (2) c00136" CDMC24165 1 5 11 DAC17-I09 15-CG7181-RA_1 CG7181 TGGGTGCTCTACCACATCCGGGACTACAAGGGCGACAAGTAATCTGCATACGAGACCACACATAGTTAA 69 FBan0007181 FBgn0037097 CG7181 3 3L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG7181 CG7181 "VIII, anon-WO0118547.331, BcDNA:GH15688" CDMC24165 1 6 11 DAC17-I09 15-CG7181-RA_1 CG7181 TGGGTGCTCTACCACATCCGGGACTACAAGGGCGACAAGTAATCTGCATACGAGACCACACATAGTTAA 69 FBan0007181 FBgn0037097 CG7181 3 3L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG7181 CG7181 "VIII, anon-WO0118547.331, BcDNA:GH15688" CDMC24166 1 7 11 DAC17-I21 6-CG7189-RA_1 CG7189 TGGACATAGGTTCCATTGGCAAGAGTTCAGTGTCTGGTTCGGGGAAAAACAAAGTAGCACCAGTGGCCC 69 FBan0007189 FBgn0035870 Gr66a 3 3L sensory perception of smell; GO:0007608; sensory perception of taste; GO:0050909 odorant binding; GO:0005549; taste receptor activity; GO:0008527; ; GO:0008527; olfactory receptor activity; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Gr66a Gustatory receptor 66a "CG7189, CG7189, GR66C1, Gr66A, Gr66C1, Gustatory receptor 66C1, Gustatory receptor 66a" CDMC24166 1 8 11 DAC17-I21 6-CG7189-RA_1 CG7189 TGGACATAGGTTCCATTGGCAAGAGTTCAGTGTCTGGTTCGGGGAAAAACAAAGTAGCACCAGTGGCCC 69 FBan0007189 FBgn0035870 Gr66a 3 3L sensory perception of smell; GO:0007608; sensory perception of taste; GO:0050909 odorant binding; GO:0005549; taste receptor activity; GO:0008527; ; GO:0008527; olfactory receptor activity; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Gr66a Gustatory receptor 66a "CG7189, CG7189, GR66C1, Gr66A, Gr66C1, Gustatory receptor 66C1, Gustatory receptor 66a" CDMC24167 1 9 11 DAC17-M09 14-CG7231-RA_3 CG7231 AGCCGTTAAATTTTCGAACTAAAACTGAGTGTCGGGGGTGTAGTGTGGCCAGTTCTTCTAGCGCTCGTT 69 FBan0007231 FBgn0031968 CG7231 2 2L CG7231 CG7231 CDMC24167 1 10 11 DAC17-M09 14-CG7231-RA_3 CG7231 AGCCGTTAAATTTTCGAACTAAAACTGAGTGTCGGGGGTGTAGTGTGGCCAGTTCTTCTAGCGCTCGTT 69 FBan0007231 FBgn0031968 CG7231 2 2L CG7231 CG7231 CDMC24168 1 11 11 DAC17-M21 23-CG7250-RA_2 CG7250 GGCAGGCAGTTAGCATACTTTTTGGGATGGTTCACACAGACTGATACTTTTAGTTCTTTAAATAAATTA 69 FBan0007250 FBgn0036494 Toll-6 3 3L cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor activity; GO:0004888; ; GO:0004888; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004888; ; GO:0004675 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-6 Toll-6 "CG7250, CG7250, CG7250, Tl-6, 18w-like, CT22359, dTLR6, toll, dToll6, Toll-6" CDMC24168 1 12 11 DAC17-M21 23-CG7250-RA_2 CG7250 GGCAGGCAGTTAGCATACTTTTTGGGATGGTTCACACAGACTGATACTTTTAGTTCTTTAAATAAATTA 69 FBan0007250 FBgn0036494 Toll-6 3 3L cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor activity; GO:0004888; ; GO:0004888; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004888; ; GO:0004675 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-6 Toll-6 "CG7250, CG7250, CG7250, Tl-6, 18w-like, CT22359, dTLR6, toll, dToll6, Toll-6" CDMC24169 1 13 11 DAC18-A09 12-CG32397-RA_3 CG32397 GCCAGAAAATTGGAAAACAACTGCGCGAAGTTGAGGAAAATGTGGAAAAAGCAGCCGTGACAAAGGCCA 69 FBan0032397 FBgn0052397 CG32397 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32397 CG32397 anon-WO0138581.6 CDMC24169 1 14 11 DAC18-A09 12-CG32397-RA_3 CG32397 GCCAGAAAATTGGAAAACAACTGCGCGAAGTTGAGGAAAATGTGGAAAAAGCAGCCGTGACAAAGGCCA 69 FBan0032397 FBgn0052397 CG32397 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32397 CG32397 anon-WO0138581.6 CDMC24170 1 15 11 DAC18-A21 15-CG32404-RA_1 CG32404 AGGGCAGCGTCCATTGGGTGGGACCTGATGGTATTCACTATAAGCTGAACTATCTGGCCGATGAGAACG 69 FBan0032404 FBgn0052404 CG32404 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32404 CG32404 "CG10461, CG10461" CDMC24170 1 16 11 DAC18-A21 15-CG32404-RA_1 CG32404 AGGGCAGCGTCCATTGGGTGGGACCTGATGGTATTCACTATAAGCTGAACTATCTGGCCGATGAGAACG 69 FBan0032404 FBgn0052404 CG32404 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32404 CG32404 "CG10461, CG10461" CDMC24171 1 17 11 DAC18-E09 2-CG32438-RA_2 CG32438 CGCGCAGTGTCCATCGCCATATACTCATTGTCCTTGCAACATGTCACCCACGTGCCATTCAGGTGATTG 69 FBan0032438 FBgn0052438 Smc5 3 3L mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676 condensin complex; GO:0000796; nucleus; GO:0005634 Smc5 Smc5 "CG7783, CG32438, CG7783, SMC5, DmSMC5" CDMC24171 1 18 11 DAC18-E09 2-CG32438-RA_2 CG32438 CGCGCAGTGTCCATCGCCATATACTCATTGTCCTTGCAACATGTCACCCACGTGCCATTCAGGTGATTG 69 FBan0032438 FBgn0052438 Smc5 3 3L mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676 condensin complex; GO:0000796; nucleus; GO:0005634 Smc5 Smc5 "CG7783, CG32438, CG7783, SMC5, DmSMC5" CDMC24172 1 19 11 DAC18-E21 11-CG32448-RA_1 CG32448 CGGGGTCTTCGGCTACATCGCGTATATGAGGTACAAGTACGAGAGCTTGGGATACTATGTGGCTGTCCA 69 FBan0032448 FBgn0052448 CG32448 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32448 CG32448 CDMC24172 1 20 11 DAC18-E21 11-CG32448-RA_1 CG32448 CGGGGTCTTCGGCTACATCGCGTATATGAGGTACAAGTACGAGAGCTTGGGATACTATGTGGCTGTCCA 69 FBan0032448 FBgn0052448 CG32448 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32448 CG32448 CDMC24173 1 21 11 DAC18-I09 23-CG32479-RA_3 CG32479 TGCGATGTTTGCCTTCATGATATTCGAGTCCTTAACTTTCTTTTCTCAGACCTAGAGCATTTAGTTTGT 69 FBan0032479 FBgn0052479 CG32479 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG32479 CG32479 "CG13903, CG12503, CG13903" CDMC24173 1 22 11 DAC18-I09 23-CG32479-RA_3 CG32479 TGCGATGTTTGCCTTCATGATATTCGAGTCCTTAACTTTCTTTTCTCAGACCTAGAGCATTTAGTTTGT 69 FBan0032479 FBgn0052479 CG32479 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG32479 CG32479 "CG13903, CG12503, CG13903" CDMC24174 1 23 11 DAC18-I21 18-CG32491-RA_1 CG32491 GCTGTTGCACAAGAAGTTCCCCTTCATCCGAGAGAAGTGCATAAATGGAAAAACCTACTGGCGCTGCAC 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24174 1 24 11 DAC18-I21 18-CG32491-RA_1 CG32491 GCTGTTGCACAAGAAGTTCCCCTTCATCCGAGAGAAGTGCATAAATGGAAAAACCTACTGGCGCTGCAC 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24175 1 25 11 DAC18-M09 3-CG32508-RB_1 CG32508 CGACCCATAGAAGTGTTGCCCCAAGGACAAGATCAAAGTGTGAGGAGAACAGCAAATGGACAGCACCGG 69 FBan0032508 FBgn0003037 shakB X X jump response; GO:0007630; phototransduction; GO:0007602; signal transduction; GO:0007165 gap-junction forming channel activity; GO:0005243; ; GO:0005243 gap junction; GO:0005921 shakB shaking B "CG32508, CG1321, CG15451, 2, 3, section 2, section 3, 6, section 6, E81, R9-29, W3, l(1)W3, R-9-29, l(1)R-9-29, pas: passover, passover, pass, Pas, shak-B, shkB, Passover, shaking-B, ShakB, Shak-B, passover-vital protein, Shaking-B, shB, Shak B, l(1)19Eb, l(1)LB21, l(1)R-10-14, l(1)R-10-3, l(1)R-10-7, l(1)TH73, l(1)W3b, nj-156: non-jumper-156, nj156, non-jumper-156, pas" CDMC24175 1 26 11 DAC18-M09 3-CG32508-RB_1 CG32508 CGACCCATAGAAGTGTTGCCCCAAGGACAAGATCAAAGTGTGAGGAGAACAGCAAATGGACAGCACCGG 69 FBan0032508 FBgn0003037 shakB X X jump response; GO:0007630; phototransduction; GO:0007602; signal transduction; GO:0007165 gap-junction forming channel activity; GO:0005243; ; GO:0005243 gap junction; GO:0005921 shakB shaking B "CG32508, CG1321, CG15451, 2, 3, section 2, section 3, 6, section 6, E81, R9-29, W3, l(1)W3, R-9-29, l(1)R-9-29, pas: passover, passover, pass, Pas, shak-B, shkB, Passover, shaking-B, ShakB, Shak-B, passover-vital protein, Shaking-B, shB, Shak B, l(1)19Eb, l(1)LB21, l(1)R-10-14, l(1)R-10-3, l(1)R-10-7, l(1)TH73, l(1)W3b, nj-156: non-jumper-156, nj156, non-jumper-156, pas" CDMC24176 1 1 12 DAC18-M21 18-CG32523-RA_6 CG32523 TGTGGACCACACTGTGGACTGTTTTGCTATTGCTTTTATGTGGTGTCCAGGTAATACTGGGACAGGACG 69 FBan0032523 FBgn0052523 CG32523 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32523 CG32523 "CG1497, CG1497, SP50" CDMC24176 1 2 12 DAC18-M21 18-CG32523-RA_6 CG32523 TGTGGACCACACTGTGGACTGTTTTGCTATTGCTTTTATGTGGTGTCCAGGTAATACTGGGACAGGACG 69 FBan0032523 FBgn0052523 CG32523 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32523 CG32523 "CG1497, CG1497, SP50" CDMC24177 1 3 12 DAC19-A09 23-CG8119-RA_1 CG8119 CGTTGCCGTGTTCAGGTGAAGAAAAGCAAGCTAATTCTACATCCGCAACAATATCTGCAATCGGT 65 FBan0008119 FBgn0030664 CG8119 X X DNA binding; GO:0003677; ; GO:0003677 CG8119 CG8119 CDMC24177 1 4 12 DAC19-A09 23-CG8119-RA_1 CG8119 CGTTGCCGTGTTCAGGTGAAGAAAAGCAAGCTAATTCTACATCCGCAACAATATCTGCAATCGGT 65 FBan0008119 FBgn0030664 CG8119 X X DNA binding; GO:0003677; ; GO:0003677 CG8119 CG8119 CDMC24178 1 5 12 DAC19-A21 5-CG8161-RA_1 CG8161 ACCGGAAAGACAGCCAGAGTTCAAAGCGAGAAAGCCAACTGATGATCGTCATCCCTCCTGGCTGG 65 FBan0008161 FBgn0014022 Rlb1 3 3R Rlb1 Rlb1 "CG8161, Rlb" CDMC24178 1 6 12 DAC19-A21 5-CG8161-RA_1 CG8161 ACCGGAAAGACAGCCAGAGTTCAAAGCGAGAAAGCCAACTGATGATCGTCATCCCTCCTGGCTGG 65 FBan0008161 FBgn0014022 Rlb1 3 3R Rlb1 Rlb1 "CG8161, Rlb" CDMC24179 1 7 12 DAC19-E09 13-CG8248-RA_1 CG8248 TGGACGTTTTCGGAAAGGAATCCAATCGGAATCAGGCAGTTTCAAGAAGATCCCAAGGCAGGCCC 65 FBan0008248 FBgn0033347 CG8248 2 2R CG8248 CG8248 CDMC24179 1 8 12 DAC19-E09 13-CG8248-RA_1 CG8248 TGGACGTTTTCGGAAAGGAATCCAATCGGAATCAGGCAGTTTCAAGAAGATCCCAAGGCAGGCCC 65 FBan0008248 FBgn0033347 CG8248 2 2R CG8248 CG8248 CDMC24180 1 9 12 DAC19-E21 9-CG8264-RA_1 CG8264 CGGTGATCTGGATGCCATTGTAAATACCAAGCGTTTCGTGCCAGACAAGCAGTTCTCCGGTGCCT 65 FBan0008264 FBgn0004856 Bx42 X X embryonic development (sensu Insecta); GO:0001700; eye-antennal disc development; GO:0035214; transcription from RNA polymerase II promoter; GO:0006366 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 Bx42 Bx42 CG8264 CDMC24180 1 10 12 DAC19-E21 9-CG8264-RA_1 CG8264 CGGTGATCTGGATGCCATTGTAAATACCAAGCGTTTCGTGCCAGACAAGCAGTTCTCCGGTGCCT 65 FBan0008264 FBgn0004856 Bx42 X X embryonic development (sensu Insecta); GO:0001700; eye-antennal disc development; GO:0035214; transcription from RNA polymerase II promoter; GO:0006366 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 Bx42 Bx42 CG8264 CDMC24181 1 11 12 DAC19-I09 18-CG8349-RA_6 CG8349 AAGGTACTGGGAAAGTATATGATGACCTTGGAGGGATTTCTATGCGAGCTAGCACGCAGGGAGGC 65 FBan0008349 FBgn0032003 CG8349 2 2L pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8349 CG8349 CDMC24181 1 12 12 DAC19-I09 18-CG8349-RA_6 CG8349 AAGGTACTGGGAAAGTATATGATGACCTTGGAGGGATTTCTATGCGAGCTAGCACGCAGGGAGGC 65 FBan0008349 FBgn0032003 CG8349 2 2L pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8349 CG8349 CDMC24182 1 13 12 DAC19-I21 12-CG8383-RA_3 CG8383 AATACACCCAAGATGGCAAGAAGAACGAGCACAATGGGGACCGACCGTTCCCCCGAAATGCAACA 65 FBan0008383 FBgn0037737 Pnn 3 3R RNA processing; GO:0006396; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 desmosome; GO:0030057 Pnn Pinin CG8383 CDMC24182 1 14 12 DAC19-I21 12-CG8383-RA_3 CG8383 AATACACCCAAGATGGCAAGAAGAACGAGCACAATGGGGACCGACCGTTCCCCCGAAATGCAACA 65 FBan0008383 FBgn0037737 Pnn 3 3R RNA processing; GO:0006396; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 desmosome; GO:0030057 Pnn Pinin CG8383 CDMC24183 1 15 12 DAC19-M09 6-CG8458-RA_1 CG8458 TGGTGGGAGCTCTACTACAAAGATCACTGGAACAGGAATGCCGGTGCAAGCAACCAGGAGCTGTG 65 FBan0008458 FBgn0038134 wntD 3 3R defense response to Gram-positive bacteria; GO:0050830; development; GO:0007275; frizzled signaling pathway; GO:0007222; frizzled-2 signaling pathway; GO:0007223; regulation of embryonic development; GO:0045995 frizzled binding; GO:0005109; ; GO:0005109 extracellular matrix (sensu Metazoa); GO:0005578 wntD wnt inhibitor of Dorsal "CG8458, CG8458, DWnt8, Wnt8, DWnt-8, wnt inhibitor of Dorsal" CDMC24183 1 16 12 DAC19-M09 6-CG8458-RA_1 CG8458 TGGTGGGAGCTCTACTACAAAGATCACTGGAACAGGAATGCCGGTGCAAGCAACCAGGAGCTGTG 65 FBan0008458 FBgn0038134 wntD 3 3R defense response to Gram-positive bacteria; GO:0050830; development; GO:0007275; frizzled signaling pathway; GO:0007222; frizzled-2 signaling pathway; GO:0007223; regulation of embryonic development; GO:0045995 frizzled binding; GO:0005109; ; GO:0005109 extracellular matrix (sensu Metazoa); GO:0005578 wntD wnt inhibitor of Dorsal "CG8458, CG8458, DWnt8, Wnt8, DWnt-8, wnt inhibitor of Dorsal" CDMC24184 1 17 12 DAC19-M21 18-CG8495-RA_1 CG8495 TCTTTTCGAATTTCTCGTGGAAAACGCCAACATGGGTTTCGCTACTCTCTGGTACTCGCATCCCC 65 FBan0008495 FBgn0037752 RpS29 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS29 Ribosomal protein S29 "CG8495, anon-WO0118547.360, BcDNA:AT28563, BcDNA:AT13329, BcDNA:RH06643, anon-EST:fe3B4, anon-fast-evolving-3B4, Ribosomal protein S29" CDMC24184 1 18 12 DAC19-M21 18-CG8495-RA_1 CG8495 TCTTTTCGAATTTCTCGTGGAAAACGCCAACATGGGTTTCGCTACTCTCTGGTACTCGCATCCCC 65 FBan0008495 FBgn0037752 RpS29 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS29 Ribosomal protein S29 "CG8495, anon-WO0118547.360, BcDNA:AT28563, BcDNA:AT13329, BcDNA:RH06643, anon-EST:fe3B4, anon-fast-evolving-3B4, Ribosomal protein S29" CDMC24185 1 19 12 DAC20-A09 23-CG7655-RA_2 CG7655 TCGAAATAACAAGCTATTTTCTCAATTTTCCTGACAAAAATGACATCGATTGCCAAGTCCATAGTACTA 69 FBan0007655 FBgn0038536 CG7655 3 3R CG7655 CG7655 CDMC24185 1 20 12 DAC20-A09 23-CG7655-RA_2 CG7655 TCGAAATAACAAGCTATTTTCTCAATTTTCCTGACAAAAATGACATCGATTGCCAAGTCCATAGTACTA 69 FBan0007655 FBgn0038536 CG7655 3 3R CG7655 CG7655 CDMC24186 1 21 12 DAC20-A21 18-CG7668-RA_1 CG7668 TGGGTGGCGAGTTCTGGCTTGGCCTACAAAAATTGCATAAAATGACGACACATCGACGAATGGAACTAT 69 FBan0007668 FBgn0036929 CG7668 3 3L defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG7668 CG7668 "BcDNA:RE40293, BcDNA:GM07843" CDMC24186 1 22 12 DAC20-A21 18-CG7668-RA_1 CG7668 TGGGTGGCGAGTTCTGGCTTGGCCTACAAAAATTGCATAAAATGACGACACATCGACGAATGGAACTAT 69 FBan0007668 FBgn0036929 CG7668 3 3L defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG7668 CG7668 "BcDNA:RE40293, BcDNA:GM07843" CDMC24187 1 23 12 DAC20-E09 15-CG7710-RA_1 CG7710 ACAGCCAACTTTCGCACTCTTGCTGAACGTCTAAGCCGTTTATGTTTCCTTTCTGCCGCCAAGTTTTGA 69 FBan0007710 FBgn0038644 CG7710 3 3R CG7710 CG7710 BcDNA:LP06586 CDMC24187 1 24 12 DAC20-E09 15-CG7710-RA_1 CG7710 ACAGCCAACTTTCGCACTCTTGCTGAACGTCTAAGCCGTTTATGTTTCCTTTCTGCCGCCAAGTTTTGA 69 FBan0007710 FBgn0038644 CG7710 3 3R CG7710 CG7710 BcDNA:LP06586 CDMC24188 1 25 12 DAC20-E21 2-CG7719-RA_4 CG7719 CGACCGCCGATAAGATGTCAGGCATTCAGTACCATCTGAAACTGTCCGACGATCCCACGATGTCGCCTA 69 FBan0007719 FBgn0004461 gwl 3 3R mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 gwl greatwall "CG7719-related, CG7719, CG7719-related, CG7719-related, CG7719, CG7719, 1J, CT23435, EP0515, Pk91C: Protein kinase-like 91C, anon-WO2004063362.73, Pk?2, Protein kinase-like 91C, Pk91C, greatwall" CDMC24188 1 26 12 DAC20-E21 2-CG7719-RA_4 CG7719 CGACCGCCGATAAGATGTCAGGCATTCAGTACCATCTGAAACTGTCCGACGATCCCACGATGTCGCCTA 69 FBan0007719 FBgn0004461 gwl 3 3R mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 gwl greatwall "CG7719-related, CG7719, CG7719-related, CG7719-related, CG7719, CG7719, 1J, CT23435, EP0515, Pk91C: Protein kinase-like 91C, anon-WO2004063362.73, Pk?2, Protein kinase-like 91C, Pk91C, greatwall" CDMC24189 1 1 13 DAC20-I09 23-CG7758-RA_4 CG7758 GCAGTTGCCTTTGTTTTTGACTGGGAAAATATGGTATTCATAACGAAATTCGCAAGGATTGGGCTGCAG 69 FBan0007758 FBgn0027945 ppl 3 3L glycine catabolism; GO:0006546 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- glycine cleavage complex; GO:0005960; mitochondrion; GO:0005739 ppl pumpless "CG7758, CG7758, l(3)78Cb, l(3)00217, pumpless" CDMC24189 1 2 13 DAC20-I09 23-CG7758-RA_4 CG7758 GCAGTTGCCTTTGTTTTTGACTGGGAAAATATGGTATTCATAACGAAATTCGCAAGGATTGGGCTGCAG 69 FBan0007758 FBgn0027945 ppl 3 3L glycine catabolism; GO:0006546 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- glycine cleavage complex; GO:0005960; mitochondrion; GO:0005739 ppl pumpless "CG7758, CG7758, l(3)78Cb, l(3)00217, pumpless" CDMC24190 1 3 13 DAC20-I21 18-CG7768-RA_1 CG7768 GGTCGTTGAGGGAATGGATATCGTCCAGAAGGTAGAATCTTACGGTTCACAAGATGGGAAGACCAGCAA 69 FBan0007768 FBgn0036415 CG7768 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7768 CG7768 CDMC24190 1 4 13 DAC20-I21 18-CG7768-RA_1 CG7768 GGTCGTTGAGGGAATGGATATCGTCCAGAAGGTAGAATCTTACGGTTCACAAGATGGGAAGACCAGCAA 69 FBan0007768 FBgn0036415 CG7768 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7768 CG7768 CDMC24191 1 5 13 DAC20-M09 12-CG7802-RB_11 CG7802 CGACCACTTCATAATGGGTCCCATTTACAAGGGATCGGTTTCCGGCAAGATGCTGCTCTCCAATTTCGA 69 FBan0007802 FBgn0039704 CG7802 3 3R CG7802 CG7802 CDMC24191 1 6 13 DAC20-M09 12-CG7802-RB_11 CG7802 CGACCACTTCATAATGGGTCCCATTTACAAGGGATCGGTTTCCGGCAAGATGCTGCTCTCCAATTTCGA 69 FBan0007802 FBgn0039704 CG7802 3 3R CG7802 CG7802 CDMC24192 1 7 13 DAC20-M21 12-CG7814-RA_7 CG7814 GGCAAACTAAGGTTGTGGAACATACCCGACAAAAAGGTGGCACTGTGGAATGAGGTAGATGGCCAGACA 69 FBan0007814 FBgn0039715 CG7814 3 3R CG7814 CG7814 anon-WO0118547.417 CDMC24192 1 8 13 DAC20-M21 12-CG7814-RA_7 CG7814 GGCAAACTAAGGTTGTGGAACATACCCGACAAAAAGGTGGCACTGTGGAATGAGGTAGATGGCCAGACA 69 FBan0007814 FBgn0039715 CG7814 3 3R CG7814 CG7814 anon-WO0118547.417 CDMC24193 1 9 13 DAC21-A09 3-CG2556-RA_1 CG2556 TGGGAACGGTCGAGGCGATCATCTAAAGAATGTGGGTCGGGTACCCTTGCAGAAAACGGCAAAACAAAA 69 FBan0002556 FBgn0030396 CG2556 X X CG2556 CG2556 CDMC24193 1 10 13 DAC21-A09 3-CG2556-RA_1 CG2556 TGGGAACGGTCGAGGCGATCATCTAAAGAATGTGGGTCGGGTACCCTTGCAGAAAACGGCAAAACAAAA 69 FBan0002556 FBgn0030396 CG2556 X X CG2556 CG2556 CDMC24194 1 11 13 DAC21-A21 2-CG2608-RA_1 CG2608 GCGCAAGAGGCAACCACATCCACAGAGGACCCATGAGTCGCCTGTGACCCAATTAGTATACAGATAGCT 69 FBan0002608 FBgn0032870 CG2608 2 2L nucleic acid binding; GO:0003676; ; GO:0003676 CG2608 CG2608 38D.26 CDMC24194 1 12 13 DAC21-A21 2-CG2608-RA_1 CG2608 GCGCAAGAGGCAACCACATCCACAGAGGACCCATGAGTCGCCTGTGACCCAATTAGTATACAGATAGCT 69 FBan0002608 FBgn0032870 CG2608 2 2L nucleic acid binding; GO:0003676; ; GO:0003676 CG2608 CG2608 38D.26 CDMC24195 1 13 13 DAC21-E09 13-CG2670-RA_1 CG2670 GCAGCAGGTGCAAAAGTCAACGGAAATTGCTTCCATTCAGAATGCCACACTCAAACAACGAATGCAGGA 69 FBan0002670 FBgn0024909 Taf7 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003700; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf7 TBP-associated factor 7 "CG2670, CG2670, CG2670, E, TAF55, TFIID, TAF7, Taf55: TBP-associated factor 55kD, TAF[[II]], TAF[[II]]55, dTAF[[II]]55, TAF, anon-84Ec, TBP-associated factor 55kD, Taf55" CDMC24195 1 14 13 DAC21-E09 13-CG2670-RA_1 CG2670 GCAGCAGGTGCAAAAGTCAACGGAAATTGCTTCCATTCAGAATGCCACACTCAAACAACGAATGCAGGA 69 FBan0002670 FBgn0024909 Taf7 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003700; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf7 TBP-associated factor 7 "CG2670, CG2670, CG2670, E, TAF55, TFIID, TAF7, Taf55: TBP-associated factor 55kD, TAF[[II]], TAF[[II]]55, dTAF[[II]]55, TAF, anon-84Ec, TBP-associated factor 55kD, Taf55" CDMC24196 1 15 13 DAC21-E21 1-CG2679-RB_1 CG2679 GGATACCCGAACGATCTCAGAGCTCCCTATCGCTTAGACAAGCTCGTGATTGGGTGAGCCTGATGAGCA 69 FBan0002679 FBgn0004919 gol 2 2R "mesoderm development; GO:0007498; mesoderm formation; GO:0001707; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; peptidase activity; GO:0008233 ; EC:3.4.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 gol goliath "CG2679, g1, anon-G1, meso, goliath" CDMC24196 1 16 13 DAC21-E21 1-CG2679-RB_1 CG2679 GGATACCCGAACGATCTCAGAGCTCCCTATCGCTTAGACAAGCTCGTGATTGGGTGAGCCTGATGAGCA 69 FBan0002679 FBgn0004919 gol 2 2R "mesoderm development; GO:0007498; mesoderm formation; GO:0001707; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; peptidase activity; GO:0008233 ; EC:3.4.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 gol goliath "CG2679, g1, anon-G1, meso, goliath" CDMC24197 1 17 13 DAC21-I09 2-CG2747-RA_1 CG2747 CGCCGTTCTGGAGGTTTGTCTTTGCCTATTTGTTCGCCAAATACCTACGATGAATCCCACGAGGCAGGG 69 FBan0002747 FBgn0037541 CG2747 3 3R CG2747 CG2747 CDMC24197 1 18 13 DAC21-I09 2-CG2747-RA_1 CG2747 CGCCGTTCTGGAGGTTTGTCTTTGCCTATTTGTTCGCCAAATACCTACGATGAATCCCACGAGGCAGGG 69 FBan0002747 FBgn0037541 CG2747 3 3R CG2747 CG2747 CDMC24198 1 19 13 DAC21-I21 18-CG2789-RA_1 CG2789 CGAAAAACAAGTAATTTTGGGTGTCTTTCATGCAAATTGCAGGGCTTTCCGACCTATCGAACCAGGGCT 69 FBan0002789 FBgn0031263 CG2789 2 2L coenzyme metabolism; GO:0006732; lipid metabolism; GO:0006629; lipid transport; GO:0006869; prosthetic group metabolism; GO:0051189 transporter activity; GO:0005215; ; GO:0005215; benzodiazepine receptor activity; GO:0008503; ; GO:0008503 integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740 CG2789 CG2789 anon-EST:Posey116 CDMC24198 1 20 13 DAC21-I21 18-CG2789-RA_1 CG2789 CGAAAAACAAGTAATTTTGGGTGTCTTTCATGCAAATTGCAGGGCTTTCCGACCTATCGAACCAGGGCT 69 FBan0002789 FBgn0031263 CG2789 2 2L coenzyme metabolism; GO:0006732; lipid metabolism; GO:0006629; lipid transport; GO:0006869; prosthetic group metabolism; GO:0051189 transporter activity; GO:0005215; ; GO:0005215; benzodiazepine receptor activity; GO:0008503; ; GO:0008503 integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740 CG2789 CG2789 anon-EST:Posey116 CDMC24199 1 21 13 DAC21-M09 23-CG2849-RA_4 CG2849 CACACTAATGTTTCTGACAAGCTTTGGAGACTTTCCGTTACAAATAGTTATTTTCTTTGCCCTGGAACA 69 FBan0002849 FBgn0015286 Rala X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; negative regulation of JNK cascade; GO:0046329; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rala Ras-related protein "CG2849, CG2849, dRal, l(1)G0174, l(1)G0373, DRal, RALA, l(1)G0501, Ral, RalA, Ral-a, Drala, DRala, Dm RalA, ral, anon-EST:fe1H4, anon-fast-evolving-1H4" CDMC24199 1 22 13 DAC21-M09 23-CG2849-RA_4 CG2849 CACACTAATGTTTCTGACAAGCTTTGGAGACTTTCCGTTACAAATAGTTATTTTCTTTGCCCTGGAACA 69 FBan0002849 FBgn0015286 Rala X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; negative regulation of JNK cascade; GO:0046329; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rala Ras-related protein "CG2849, CG2849, dRal, l(1)G0174, l(1)G0373, DRal, RALA, l(1)G0501, Ral, RalA, Ral-a, Drala, DRala, Dm RalA, ral, anon-EST:fe1H4, anon-fast-evolving-1H4" CDMC24200 1 23 13 DAC21-M21 12-CG2865-RA_1 CG2865 GGAGCTGGTCGATTTCGACATGAACCAAAACCAAAAGGATTTCGAGGTGATCATGGACGCCTTGAGGCT 69 FBan0002865 FBgn0023526 CG2865 X X CG2865 CG2865 "EG:25E8.4, anon-WO03040301.165" CDMC24200 1 24 13 DAC21-M21 12-CG2865-RA_1 CG2865 GGAGCTGGTCGATTTCGACATGAACCAAAACCAAAAGGATTTCGAGGTGATCATGGACGCCTTGAGGCT 69 FBan0002865 FBgn0023526 CG2865 X X CG2865 CG2865 "EG:25E8.4, anon-WO03040301.165" CDMC24201 1 25 13 DAC22-A09 16-CG14515-RA_1 CG14515 CTCGAACGAGTGGATCGGCGAGTGGGTGCAGAGCGAGAACACCAAGACCATTCCAGAGTGCTCGG 65 FBan0014515 FBgn0039648 CG14515 3 3R CG14515 CG14515 CDMC24201 1 26 13 DAC22-A09 16-CG14515-RA_1 CG14515 CTCGAACGAGTGGATCGGCGAGTGGGTGCAGAGCGAGAACACCAAGACCATTCCAGAGTGCTCGG 65 FBan0014515 FBgn0039648 CG14515 3 3R CG14515 CG14515 CDMC24202 1 1 14 DAC22-A21 2-CG14538-RA_1 CG14538 GGCAAACGCTGGAGTACCTCTCGGGGTTGAGTCTGCGTAAGAAGTACAACTACGAGGGCTTCTCG 65 FBan0014538 FBgn0031943 CG14538 2 2L CG14538 CG14538 CDMC24202 1 2 14 DAC22-A21 2-CG14538-RA_1 CG14538 GGCAAACGCTGGAGTACCTCTCGGGGTTGAGTCTGCGTAAGAAGTACAACTACGAGGGCTTCTCG 65 FBan0014538 FBgn0031943 CG14538 2 2L CG14538 CG14538 CDMC24203 1 3 14 DAC22-E09 3-CG14631-RA_1 CG14631 ATGATTTGGCTAACGAGTACACCGGCAGTGAAGAGAGGAGTGGAGAAGCCTCCAAGCTCGGACTC 65 FBan0014631 FBgn0029552 CG14631 X X CG14631 CG14631 CDMC24203 1 4 14 DAC22-E09 3-CG14631-RA_1 CG14631 ATGATTTGGCTAACGAGTACACCGGCAGTGAAGAGAGGAGTGGAGAAGCCTCCAAGCTCGGACTC 65 FBan0014631 FBgn0029552 CG14631 X X CG14631 CG14631 CDMC24204 1 5 14 DAC22-E21 3-CG14641-RA_4 CG14641 AGCCGGACGATCCGCTATGTGAGCAAAACATCAAGGACAGGTACTACGGACGCAACGATCCTGTG 65 FBan0014641 FBgn0037220 CG14641 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG14641 CG14641 cg14641 CDMC24204 1 6 14 DAC22-E21 3-CG14641-RA_4 CG14641 AGCCGGACGATCCGCTATGTGAGCAAAACATCAAGGACAGGTACTACGGACGCAACGATCCTGTG 65 FBan0014641 FBgn0037220 CG14641 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG14641 CG14641 cg14641 CDMC24205 1 7 14 DAC22-I09 2-CG14754-RA_1 CG14754 GGTCAGCCAAAATGGAGTGCTGCGCACAATGGAATGCCGTGCTATAAATAAAGTGCCCGACCGAA 65 FBan0014754 FBgn0033300 CG14754 2 2R CG14754 CG14754 CDMC24205 1 8 14 DAC22-I09 2-CG14754-RA_1 CG14754 GGTCAGCCAAAATGGAGTGCTGCGCACAATGGAATGCCGTGCTATAAATAAAGTGCCCGACCGAA 65 FBan0014754 FBgn0033300 CG14754 2 2R CG14754 CG14754 CDMC24206 1 9 14 DAC22-I21 24-CG14780-RA_1 CG14780 TATGTAGTAACTATGTTCTAAACAAAATATTCATAATACACATTCACGTACAATGTAGCGACAGC 65 FBan0014780 FBgn0025383 CG14780 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14780 CG14780 "EG:80H7.3, SP95" CDMC24206 1 10 14 DAC22-I21 24-CG14780-RA_1 CG14780 TATGTAGTAACTATGTTCTAAACAAAATATTCATAATACACATTCACGTACAATGTAGCGACAGC 65 FBan0014780 FBgn0025383 CG14780 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14780 CG14780 "EG:80H7.3, SP95" CDMC24207 1 11 14 DAC22-M09 9-CG14846-RA_1 CG14846 CATTCACCGCAACCCCTTGTGCATCCTCGAAAAGTGCTGCCCATCCACCATCATGCCTTGAAGAG 65 FBan0014846 FBgn0038227 CG14846 3 3R CG14846 CG14846 CDMC24207 1 12 14 DAC22-M09 9-CG14846-RA_1 CG14846 CATTCACCGCAACCCCTTGTGCATCCTCGAAAAGTGCTGCCCATCCACCATCATGCCTTGAAGAG 65 FBan0014846 FBgn0038227 CG14846 3 3R CG14846 CG14846 CDMC24208 1 13 14 DAC22-M21 5-CG14871-RA_1 CG14871 ATGTGGCACAAAGCACTTTCGCACATGCTGCTTTAACTACCTTCGCAAGCGATCCGACCCCGATG 65 FBan0014871 FBgn0038343 CG14871 3 3R CG14871 CG14871 CDMC24208 1 14 14 DAC22-M21 5-CG14871-RA_1 CG14871 ATGTGGCACAAAGCACTTTCGCACATGCTGCTTTAACTACCTTCGCAAGCGATCCGACCCCGATG 65 FBan0014871 FBgn0038343 CG14871 3 3R CG14871 CG14871 CDMC24209 1 15 14 DAC23-A09 3-CG6737-RA_1 CG6737 CGTGCCGGGGCTGATTGAAAGTCTCAAGCTGAAGGAAACCAGTATATCGCCAATCGTGCTGGATCGCTA 69 FBan0006737 FBgn0032294 CG6737 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG6737 CG6737 CDMC24209 1 16 14 DAC23-A09 3-CG6737-RA_1 CG6737 CGTGCCGGGGCTGATTGAAAGTCTCAAGCTGAAGGAAACCAGTATATCGCCAATCGTGCTGGATCGCTA 69 FBan0006737 FBgn0032294 CG6737 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG6737 CG6737 CDMC24210 1 17 14 DAC23-A21 1-CG6751-RA_1 CG6751 TCACAGTCTGGGATCTAGACATACAGGACGCTATCGAGCCCACATTTAAGCTGGGTTCCAAAGGCAGCC 69 FBan0006751 FBgn0033562 CG6751 2 2R general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 CG6751 CG6751 CDMC24210 1 18 14 DAC23-A21 1-CG6751-RA_1 CG6751 TCACAGTCTGGGATCTAGACATACAGGACGCTATCGAGCCCACATTTAAGCTGGGTTCCAAAGGCAGCC 69 FBan0006751 FBgn0033562 CG6751 2 2R general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 CG6751 CG6751 CDMC24211 1 19 14 DAC23-E09 16-CG6784-RA_2 CG6784 GGCAACCTTTTCTATACCAAGGAAAGTTGCGTGGAATTTTGTGGCAAATACGACTGGAAGAAGGTGCGA 69 FBan0006784 FBgn0039074 CG6784 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6784 CG6784 CDMC24211 1 20 14 DAC23-E09 16-CG6784-RA_2 CG6784 GGCAACCTTTTCTATACCAAGGAAAGTTGCGTGGAATTTTGTGGCAAATACGACTGGAAGAAGGTGCGA 69 FBan0006784 FBgn0039074 CG6784 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6784 CG6784 CDMC24212 1 21 14 DAC23-E21 2-CG6796-RA_2 CG6796 GGCCATGACATACGGTTTAGGCAAGACATACACTCTCTCACCAGCCTTCCGAGCGGAGAACTCCAAGTC 69 FBan0006796 FBgn0034177 CG6796 2 2R asparaginyl-tRNA aminoacylation; GO:0006421; aspartyl-tRNA aminoacylation; GO:0006422; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; asparagine-tRNA ligase activity; GO:0004816 ; EC:6.1.1.22; ; GO:0004816 ; EC:6.1.1.22; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0004815 ; EC:6.1.1.12 cytoplasm; GO:0005737 CG6796 CG6796 CDMC24212 1 22 14 DAC23-E21 2-CG6796-RA_2 CG6796 GGCCATGACATACGGTTTAGGCAAGACATACACTCTCTCACCAGCCTTCCGAGCGGAGAACTCCAAGTC 69 FBan0006796 FBgn0034177 CG6796 2 2R asparaginyl-tRNA aminoacylation; GO:0006421; aspartyl-tRNA aminoacylation; GO:0006422; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; asparagine-tRNA ligase activity; GO:0004816 ; EC:6.1.1.22; ; GO:0004816 ; EC:6.1.1.22; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0004815 ; EC:6.1.1.12 cytoplasm; GO:0005737 CG6796 CG6796 CDMC24213 1 23 14 DAC23-I09 23-CG6831-RA_1 CG6831 ACGTGTTTATTTGCCATTAAATTGCCCATATATATTTATACGAGATGTGCGAACTTATTCAGGCAAGTT 69 FBgn0035910 CDMC24213 1 24 14 DAC23-I09 23-CG6831-RA_1 CG6831 ACGTGTTTATTTGCCATTAAATTGCCCATATATATTTATACGAGATGTGCGAACTTATTCAGGCAAGTT 69 FBgn0035910 CDMC24214 1 25 14 DAC23-I21 9-CG6845-RA_4 CG6845 AGCTTGCGTTTGACTTTGTTTGAGTTCGTGTCCATTGTTGAGAACGCCTGTTTCATGGCCACAACCTGC 69 FBan0006845 FBgn0035099 CG6845 3 3L CG6845 CG6845 BEST:LD22345 CDMC24214 1 26 14 DAC23-I21 9-CG6845-RA_4 CG6845 AGCTTGCGTTTGACTTTGTTTGAGTTCGTGTCCATTGTTGAGAACGCCTGTTTCATGGCCACAACCTGC 69 FBan0006845 FBgn0035099 CG6845 3 3L CG6845 CG6845 BEST:LD22345 CDMC24215 1 1 15 DAC23-M09 23-CG6878-RA_4 CG6878 TGCTGGCATTTGACTAGAGTTACTAAACAACCACAACCTTAAGCCCTACTCCAATCTTGTTTAAATTAC 69 FBan0006878 FBgn0036488 CG6878 3 3L CG6878 CG6878 CDMC24215 1 2 15 DAC23-M09 23-CG6878-RA_4 CG6878 TGCTGGCATTTGACTAGAGTTACTAAACAACCACAACCTTAAGCCCTACTCCAATCTTGTTTAAATTAC 69 FBan0006878 FBgn0036488 CG6878 3 3L CG6878 CG6878 CDMC24216 1 3 15 DAC23-M21 23-CG6889-RB_7 CG6889 GGCAAAACAGCGAACTCCTAGCCAAGTAAGTTTGAAACGGAAGCAAAACAAAATTCTATATTAGCGTAA 69 FBan0006889 FBgn0040071 tara 3 3R chromatin-mediated maintenance of transcription; GO:0048096 tara taranis "CG6889, CG6889, CG6889, l(3)03881, 5472, EP(3)3463, l(3)jlC5, anon-WO0257455.25, l(3)j1C5, taranis" CDMC24216 1 4 15 DAC23-M21 23-CG6889-RB_7 CG6889 GGCAAAACAGCGAACTCCTAGCCAAGTAAGTTTGAAACGGAAGCAAAACAAAATTCTATATTAGCGTAA 69 FBan0006889 FBgn0040071 tara 3 3R chromatin-mediated maintenance of transcription; GO:0048096 tara taranis "CG6889, CG6889, CG6889, l(3)03881, 5472, EP(3)3463, l(3)jlC5, anon-WO0257455.25, l(3)j1C5, taranis" CDMC24217 1 5 15 DAC24-A09 3-CG2157-RA_1 CG2157 GCTCTTGGTGGCTATGGATCGGGACTTAGTGGTTATGGTGGCTCCTACAACTCGAATCCATACGCCCTG 69 FBan0002157 FBgn0030244 CG2157 X X CG2157 CG2157 CDMC24217 1 6 15 DAC24-A09 3-CG2157-RA_1 CG2157 GCTCTTGGTGGCTATGGATCGGGACTTAGTGGTTATGGTGGCTCCTACAACTCGAATCCATACGCCCTG 69 FBan0002157 FBgn0030244 CG2157 X X CG2157 CG2157 CDMC24218 1 7 15 DAC24-A21 1-CG2168-RA_1 CG2168 AGTCTCAGCGCAAAACATGTTATGCTCAGCAATCGCAAGTCCGAAAGATTCGTGCTCGCATGACCGACA 69 FBan0002168 FBgn0017545 RpS3A 4 4 oogenesis (sensu Insecta); GO:0009993; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic ribosome (sensu Eukaryota); GO:0005830; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS3A Ribosomal protein S3A "CG2168, CG2168, M(4)[57g], M(4)57g, M[57g], C3, Clone 3, M57g, RpS3a, clone 2.29, ribosomal protein S3alpha, RPS3a, ribosomal protein S3a, M(4)101, RPS3A, anon-EST:Liang-2.29, l(4)102ABa, Minute(4)101" CDMC24218 1 8 15 DAC24-A21 1-CG2168-RA_1 CG2168 AGTCTCAGCGCAAAACATGTTATGCTCAGCAATCGCAAGTCCGAAAGATTCGTGCTCGCATGACCGACA 69 FBan0002168 FBgn0017545 RpS3A 4 4 oogenesis (sensu Insecta); GO:0009993; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic ribosome (sensu Eukaryota); GO:0005830; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS3A Ribosomal protein S3A "CG2168, CG2168, M(4)[57g], M(4)57g, M[57g], C3, Clone 3, M57g, RpS3a, clone 2.29, ribosomal protein S3alpha, RPS3a, ribosomal protein S3a, M(4)101, RPS3A, anon-EST:Liang-2.29, l(4)102ABa, Minute(4)101" CDMC24219 1 9 15 DAC24-E09 14-CG2202-RA_1 CG2202 TCCTGGGCTTCACACGGCTCCAACTCATCCCGAACATCAAACTATTCCAGTGTAGACTTAAGCTTTCCT 69 FBan0002202 FBgn0030240 CG2202 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2202 CG2202 CDMC24219 1 10 15 DAC24-E09 14-CG2202-RA_1 CG2202 TCCTGGGCTTCACACGGCTCCAACTCATCCCGAACATCAAACTATTCCAGTGTAGACTTAAGCTTTCCT 69 FBan0002202 FBgn0030240 CG2202 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2202 CG2202 CDMC24220 1 11 15 DAC24-E21 14-CG2217-RA_1 CG2217 CGGGGAAAACTTTCACTTAGGCGAATATTGCGAAACTATTGGGCTGCACAACCCGTTGACACAAATCGC 69 FBan0002217 FBgn0027544 CG2217 3 3R CG2217 CG2217 BcDNA:GH11688 CDMC24220 1 12 15 DAC24-E21 14-CG2217-RA_1 CG2217 CGGGGAAAACTTTCACTTAGGCGAATATTGCGAAACTATTGGGCTGCACAACCCGTTGACACAAATCGC 69 FBan0002217 FBgn0027544 CG2217 3 3R CG2217 CG2217 BcDNA:GH11688 CDMC24221 1 13 15 DAC24-I09 9-CG2264-RC_3 CG2264 ACCACCGAGGTCACACCAATACCATTGGCACTGGAGTTAATCCACACTCATATTCCGAGGATGCGAGTG 69 FBan0002264 FBgn0033478 CG2264 2 2R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG2264 CG2264 CT7504 CDMC24221 1 14 15 DAC24-I09 9-CG2264-RC_3 CG2264 ACCACCGAGGTCACACCAATACCATTGGCACTGGAGTTAATCCACACTCATATTCCGAGGATGCGAGTG 69 FBan0002264 FBgn0033478 CG2264 2 2R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG2264 CG2264 CT7504 CDMC24222 1 15 15 DAC24-I21 12-CG2291-RA_2 CG2291 ACGCTACACCACAGTACAACTGCATCCAGCTGAAGGCTAACCAATACCTAAGGTATCCGGACCACGAAA 69 FBan0002291 FBgn0033279 CG2291 2 2R CG2291 CG2291 BcDNA:AT16234 CDMC24222 1 16 15 DAC24-I21 12-CG2291-RA_2 CG2291 ACGCTACACCACAGTACAACTGCATCCAGCTGAAGGCTAACCAATACCTAAGGTATCCGGACCACGAAA 69 FBan0002291 FBgn0033279 CG2291 2 2R CG2291 CG2291 BcDNA:AT16234 CDMC24223 1 17 15 DAC24-M09 12-CG2380-RA_4 CG2380 AGGATCAGCTGAAAACCATTCATTTCAACACTCCCATACACTCCCACAAGGTCATGGTCATTCGCCGCA 69 FBgn0039899 CDMC24223 1 18 15 DAC24-M09 12-CG2380-RA_4 CG2380 AGGATCAGCTGAAAACCATTCATTTCAACACTCCCATACACTCCCACAAGGTCATGGTCATTCGCCGCA 69 FBgn0039899 CDMC24224 1 19 15 DAC24-M21 23-CG2446-RA_5 CG2446 GCGTATCCGGTGGAAAGACATATGTATGTAGTGCAGTTGAGTCGACATAGAGACATAGAGCAACATTAC 69 FBan0002446 FBgn0030328 CG2446 X X CG2446 CG2446 "EP1503, anon-WO03040301.104, anon-WO03040301.105, anon-WO03040301.107" CDMC24224 1 20 15 DAC24-M21 23-CG2446-RA_5 CG2446 GCGTATCCGGTGGAAAGACATATGTATGTAGTGCAGTTGAGTCGACATAGAGACATAGAGCAACATTAC 69 FBan0002446 FBgn0030328 CG2446 X X CG2446 CG2446 "EP1503, anon-WO03040301.104, anon-WO03040301.105, anon-WO03040301.107" CDMC24225 1 21 15 DAC25-A09 3-CG10026-RA_5 CG10026 GGCAGCCTGGAACCCATCTCACAGATTGTCGGAGGAGTGGGAATATTCGATCTGAAGGACCTGGG 65 FBan0010026 FBgn0032785 CG10026 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10026 CG10026 CDMC24225 1 22 15 DAC25-A09 3-CG10026-RA_5 CG10026 GGCAGCCTGGAACCCATCTCACAGATTGTCGGAGGAGTGGGAATATTCGATCTGAAGGACCTGGG 65 FBan0010026 FBgn0032785 CG10026 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG10026 CG10026 CDMC24226 1 23 15 DAC25-A21 6-CG10078-RB_2 CG10078 ACCGCTGTGCTTGGGAAAAATCGTGCCCGTTGATGCAGGACATGCGAATATCAATGACCAACTGG 65 FBan0010078 FBgn0041194 Prat2 3 3L 'de novo' IMP biosynthesis; GO:0006189; monosaccharide metabolism; GO:0005996; nucleoside metabolism; GO:0009116; proteolysis; GO:0006508; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 amidophosphoribosyltransferase activity; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 Prat2 Phosphoribosylamidotransferase 2 "CG10078, CG10078, Amidophosphoribosyltransferase, Phosphoribosylamidotransferase 2" CDMC24226 1 24 15 DAC25-A21 6-CG10078-RB_2 CG10078 ACCGCTGTGCTTGGGAAAAATCGTGCCCGTTGATGCAGGACATGCGAATATCAATGACCAACTGG 65 FBan0010078 FBgn0041194 Prat2 3 3L 'de novo' IMP biosynthesis; GO:0006189; monosaccharide metabolism; GO:0005996; nucleoside metabolism; GO:0009116; proteolysis; GO:0006508; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 amidophosphoribosyltransferase activity; GO:0004044 ; EC:2.4.2.14; ; GO:0004044 ; EC:2.4.2.14; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 Prat2 Phosphoribosylamidotransferase 2 "CG10078, CG10078, Amidophosphoribosyltransferase, Phosphoribosylamidotransferase 2" CDMC24227 1 25 15 DAC25-E09 23-CG10174-RA_1 CG10174 CGGATCGGAAACTCTAATCGTACCCCGTATATACTTGAACTAAAATGTCTCTGAATCTGCAGTAC 65 FBan0010174 FBgn0032680 Ntf-2r 2 2L protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 intracellular; GO:0005622; nucleus; GO:0005634 Ntf-2r Nuclear transport factor-2-related "CG10174, CG10174, CG10174, CG10174, Dntf-2r, Drosophila nuclear transport factor-2-related, Nuclear transport factor-2-related" CDMC24227 1 26 15 DAC25-E09 23-CG10174-RA_1 CG10174 CGGATCGGAAACTCTAATCGTACCCCGTATATACTTGAACTAAAATGTCTCTGAATCTGCAGTAC 65 FBan0010174 FBgn0032680 Ntf-2r 2 2L protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 intracellular; GO:0005622; nucleus; GO:0005634 Ntf-2r Nuclear transport factor-2-related "CG10174, CG10174, CG10174, CG10174, Dntf-2r, Drosophila nuclear transport factor-2-related, Nuclear transport factor-2-related" CDMC24228 1 1 16 DAC25-E21 9-CG10228-RA_2 CG10228 ACGAGTTGGAGCAGGGTGATGCAAACACCGATACGGATGCGGAATTGAATGGCGAGAAGCAGGAG 65 FBgn0033975 CDMC24228 1 2 16 DAC25-E21 9-CG10228-RA_2 CG10228 ACGAGTTGGAGCAGGGTGATGCAAACACCGATACGGATGCGGAATTGAATGGCGAGAAGCAGGAG 65 FBgn0033975 CDMC24229 1 3 16 DAC25-I09 23-CG10327-RB_1 CG10327 TGACACTGGATGGCTAATAACACAATTGATAAAACACACTTCAAAATAAATTCTGCGCCAAAGCT 65 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC24229 1 4 16 DAC25-I09 23-CG10327-RB_1 CG10327 TGACACTGGATGGCTAATAACACAATTGATAAAACACACTTCAAAATAAATTCTGCGCCAAAGCT 65 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC24230 1 5 16 DAC25-I21 18-CG10365-RC_2 CG10365 AACTCGTATTCGGAGCACAATTCTGGTTACCATAGATGGCTCACTTCAGTGGTCATCGCCAGCCG 65 FBan0010365 FBgn0039109 CG10365 3 3R CG10365 CG10365 anon-WO0118547.386 CDMC24230 1 6 16 DAC25-I21 18-CG10365-RC_2 CG10365 AACTCGTATTCGGAGCACAATTCTGGTTACCATAGATGGCTCACTTCAGTGGTCATCGCCAGCCG 65 FBan0010365 FBgn0039109 CG10365 3 3R CG10365 CG10365 anon-WO0118547.386 CDMC24231 1 7 16 DAC25-M09 23-CG10474-RA_1 CG10474 CATGGGATTGCAGTACGAATCACTAAACTCTGAGGACAACATAGAGTCATTGAAAAATTGGACGA 65 FBan0010474 FBgn0034427 CG10474 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG10474 CG10474 CDMC24231 1 8 16 DAC25-M09 23-CG10474-RA_1 CG10474 CATGGGATTGCAGTACGAATCACTAAACTCTGAGGACAACATAGAGTCATTGAAAAATTGGACGA 65 FBan0010474 FBgn0034427 CG10474 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG10474 CG10474 CDMC24232 1 9 16 DAC25-M21 2-CG10521-RA_3 CG10521 ATGGCTGGCACGACACCTACTCTCTGCTGGGTCTTTTGTGGCAGTCCAATTTCGATATGTGTCCC 65 FBan0010521 FBgn0015774 NetB X X axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; signal transduction; GO:0007165; synaptic target attraction; GO:0016200; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 NetB Netrin-B "CG10521, D-netrin-B, netrinB, netrin, Netrin, CT29512, Netrin B, NETRIN, netB, Netrin-B" CDMC24232 1 10 16 DAC25-M21 2-CG10521-RA_3 CG10521 ATGGCTGGCACGACACCTACTCTCTGCTGGGTCTTTTGTGGCAGTCCAATTTCGATATGTGTCCC 65 FBan0010521 FBgn0015774 NetB X X axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; signal transduction; GO:0007165; synaptic target attraction; GO:0016200; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 NetB Netrin-B "CG10521, D-netrin-B, netrinB, netrin, Netrin, CT29512, Netrin B, NETRIN, netB, Netrin-B" CDMC24233 1 11 16 DAC26-A09 15-CG6173-RA_1 CG6173 CCGTTCCAGTCCCAATTCCGTGTTGGACGACTCCAGAAATGTCTTTACCTTCACCACGCCTAAATGTGA 69 FBan0006173 FBgn0039155 kal-1 3 3R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 extracellular matrix (sensu Metazoa); GO:0005578 kal-1 kal-1 "CG6173, CG6173, CG6173, CG6173, CT19368, Kallmann, Dmkal" CDMC24233 1 12 16 DAC26-A09 15-CG6173-RA_1 CG6173 CCGTTCCAGTCCCAATTCCGTGTTGGACGACTCCAGAAATGTCTTTACCTTCACCACGCCTAAATGTGA 69 FBan0006173 FBgn0039155 kal-1 3 3R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 extracellular matrix (sensu Metazoa); GO:0005578 kal-1 kal-1 "CG6173, CG6173, CG6173, CG6173, CT19368, Kallmann, Dmkal" CDMC24234 1 13 16 DAC26-A21 23-CG6180-RA_6 CG6180 CAGCGCTTTAAATGGATTTAGAAAAGATTACATCCGATCAACCGGTGTGAATGTCAATTATTCAGCTGT 69 FBan0006180 FBgn0032453 CG6180 2 2L signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG6180 CG6180 CDMC24234 1 14 16 DAC26-A21 23-CG6180-RA_6 CG6180 CAGCGCTTTAAATGGATTTAGAAAAGATTACATCCGATCAACCGGTGTGAATGTCAATTATTCAGCTGT 69 FBan0006180 FBgn0032453 CG6180 2 2L signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG6180 CG6180 CDMC24235 1 15 16 DAC26-E09 17-CG6209-RA_3 CG6209 TGTATTGTTCACGCCGAGAAGATTGTCTACCAGAAGAAGTTCGCTGAACAAATCGCGATTGAGGAGGCT 69 FBan0006209 FBgn0033862 CG6209 2 2R CG6209 CG6209 CDMC24235 1 16 16 DAC26-E09 17-CG6209-RA_3 CG6209 TGTATTGTTCACGCCGAGAAGATTGTCTACCAGAAGAAGTTCGCTGAACAAATCGCGATTGAGGAGGCT 69 FBan0006209 FBgn0033862 CG6209 2 2R CG6209 CG6209 CDMC24236 1 17 16 DAC26-E21 5-CG6219-RA_1 CG6219 TCGGGGACGCAAATGTCTGCCTTCCTGAGAAAGTATCTAGCCGACGAGGACAAAAAAATTCGTGCGCAA 69 FBan0006219 FBgn0026257 cav 3 3R telomere capping; GO:0016233 satellite DNA binding; GO:0003696; ; GO:0003696 "chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; nuclear chromosome, telomeric region; GO:0000784; nucleus; GO:0005634" cav caravaggio "CG6219, Hoap, 1G5, anon1G5, Anon1G5, HOAP, HP1/ORC-associated protein, anon fe 1G5, p55, anonymous fast evolving gene IG5, anon-EST:fe1G5: anon-fast-evolving-1G5, anon-fast-evolving-1G5, caravaggio" CDMC24236 1 18 16 DAC26-E21 5-CG6219-RA_1 CG6219 TCGGGGACGCAAATGTCTGCCTTCCTGAGAAAGTATCTAGCCGACGAGGACAAAAAAATTCGTGCGCAA 69 FBan0006219 FBgn0026257 cav 3 3R telomere capping; GO:0016233 satellite DNA binding; GO:0003696; ; GO:0003696 "chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; nuclear chromosome, telomeric region; GO:0000784; nucleus; GO:0005634" cav caravaggio "CG6219, Hoap, 1G5, anon1G5, Anon1G5, HOAP, HP1/ORC-associated protein, anon fe 1G5, p55, anonymous fast evolving gene IG5, anon-EST:fe1G5: anon-fast-evolving-1G5, anon-fast-evolving-1G5, caravaggio" CDMC24237 1 19 16 DAC26-I09 9-CG6255-RA_1 CG6255 ACGCCCTCAAAGTGTTTCTGTCCGACAAGGAGATCAAGGGCATTGTCATGATTGGAGAGATTGGCGGAT 69 FBan0006255 FBgn0038708 CG6255 3 3R tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 CG6255 CG6255 "AAF55672, anon-WO0140519.197" CDMC24237 1 20 16 DAC26-I09 9-CG6255-RA_1 CG6255 ACGCCCTCAAAGTGTTTCTGTCCGACAAGGAGATCAAGGGCATTGTCATGATTGGAGAGATTGGCGGAT 69 FBan0006255 FBgn0038708 CG6255 3 3R tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 CG6255 CG6255 "AAF55672, anon-WO0140519.197" CDMC24238 1 21 16 DAC26-I21 17-CG6279-RA_1 CG6279 ACTGCCCGTTGGTTATCCGAAAGATGGATGCACAGTTCCCGACTTGGCGAGAAAGAATTTGTCAAATAT 69 FBan0006279 FBgn0036125 CG6279 3 3L electron transport; GO:0006118; rRNA processing; GO:0006364 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG6279 CG6279 CDMC24238 1 22 16 DAC26-I21 17-CG6279-RA_1 CG6279 ACTGCCCGTTGGTTATCCGAAAGATGGATGCACAGTTCCCGACTTGGCGAGAAAGAATTTGTCAAATAT 69 FBan0006279 FBgn0036125 CG6279 3 3L electron transport; GO:0006118; rRNA processing; GO:0006364 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG6279 CG6279 CDMC24239 1 23 16 DAC26-M09 1-CG6320-RB_2 CG6320 GCAAATCCGTCCCTAGTTATGCAAACGGCCCATTTATCGGCCTAGAGCTAGCCCTAGATCCCAGCATGA 69 FBan0006320 FBgn0015608 Ca-beta 2 2L calcium ion transport; GO:0006816 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891 Ca-beta Ca[2+]-channel-protein-beta-subunit "CG6320, CG6320, CG6320, Calcium channel beta, DmCa1beta, dmcab1, calcium channel beta subunit, Ca[2+]-channel-protein-beta-subunit" CDMC24239 1 24 16 DAC26-M09 1-CG6320-RB_2 CG6320 GCAAATCCGTCCCTAGTTATGCAAACGGCCCATTTATCGGCCTAGAGCTAGCCCTAGATCCCAGCATGA 69 FBan0006320 FBgn0015608 Ca-beta 2 2L calcium ion transport; GO:0006816 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891 Ca-beta Ca[2+]-channel-protein-beta-subunit "CG6320, CG6320, CG6320, Calcium channel beta, DmCa1beta, dmcab1, calcium channel beta subunit, Ca[2+]-channel-protein-beta-subunit" CDMC24240 1 25 16 DAC26-M21 9-CG6337-RA_1 CG6337 CCCCGTCATAGTCGAGTACAATCCGGCTACCTTTGGATTCATGCAGTACTCCAGTGGCGTCTATGTCCA 69 FBan0006337 FBgn0033873 CG6337 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG6337 CG6337 CDMC24240 1 26 16 DAC26-M21 9-CG6337-RA_1 CG6337 CCCCGTCATAGTCGAGTACAATCCGGCTACCTTTGGATTCATGCAGTACTCCAGTGGCGTCTATGTCCA 69 FBan0006337 FBgn0033873 CG6337 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG6337 CG6337 CDMC24241 1 1 17 DAC27-A09 3-CG3688-RA_2 CG3688 GCCTGCGGGAACGGTATAAGGATCCTTCGCTTCAGCTGAATCTCGTGTCCTGTCAGTTTGCCTTTCACT 69 FBan0003688 FBgn0001974 l(2)35Bd 2 2L mRNA capping; GO:0006370 nucleic acid binding; GO:0003676; mRNA (guanine-N7-)-methyltransferase activity; GO:0004482 ; EC:2.1.1.56; ; GO:0003676; ; GO:0004482 ; EC:2.1.1.56 l(2)35Bd lethal (2) 35Bd "CG3688, C2, lethal group C2, l(2)br9, lethal 9 in the black-reduced region, br9, BG:DS00929.5, l(2)10408" CDMC24241 1 2 17 DAC27-A09 3-CG3688-RA_2 CG3688 GCCTGCGGGAACGGTATAAGGATCCTTCGCTTCAGCTGAATCTCGTGTCCTGTCAGTTTGCCTTTCACT 69 FBan0003688 FBgn0001974 l(2)35Bd 2 2L mRNA capping; GO:0006370 nucleic acid binding; GO:0003676; mRNA (guanine-N7-)-methyltransferase activity; GO:0004482 ; EC:2.1.1.56; ; GO:0003676; ; GO:0004482 ; EC:2.1.1.56 l(2)35Bd lethal (2) 35Bd "CG3688, C2, lethal group C2, l(2)br9, lethal 9 in the black-reduced region, br9, BG:DS00929.5, l(2)10408" CDMC24242 1 3 17 DAC27-A21 23-CG3698-RA_2 CG3698 TGGCCAAAGAGGTTTGAGTTTCGTTTCGTTTACGCTGTTAAATTGTTATTGTTCGTTTTCGAAGTGCTT 69 FBan0003698 FBgn0037023 CG3698 3 3L CG3698 CG3698 CDMC24242 1 4 17 DAC27-A21 23-CG3698-RA_2 CG3698 TGGCCAAAGAGGTTTGAGTTTCGTTTCGTTTACGCTGTTAAATTGTTATTGTTCGTTTTCGAAGTGCTT 69 FBan0003698 FBgn0037023 CG3698 3 3L CG3698 CG3698 CDMC24243 1 5 17 DAC27-E09 2-CG3736-RA_1 CG3736 TGGCACCATGTCCATCAAGAAGCGATCGAAGGTTGTTGACCGATTCAATGACCCGGAGTCTGACAGCTT 69 FBan0003736 FBgn0002989 okr 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome condensation; GO:0030261; dorsal appendage formation; GO:0046843; double-strand break repair; GO:0006302; intracellular mRNA localization; GO:0008298; meiotic recombination; GO:0007131; oogenesis (sensu Insecta); GO:0009993; regulation of translation; GO:0006445 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003; ; GO:0003677 okr okra "CG3736, DmRAD54, DhR54, DmRad54, RAD54, rad54, Rad54, okra" CDMC24243 1 6 17 DAC27-E09 2-CG3736-RA_1 CG3736 TGGCACCATGTCCATCAAGAAGCGATCGAAGGTTGTTGACCGATTCAATGACCCGGAGTCTGACAGCTT 69 FBan0003736 FBgn0002989 okr 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome condensation; GO:0030261; dorsal appendage formation; GO:0046843; double-strand break repair; GO:0006302; intracellular mRNA localization; GO:0008298; meiotic recombination; GO:0007131; oogenesis (sensu Insecta); GO:0009993; regulation of translation; GO:0006445 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003; ; GO:0003677 okr okra "CG3736, DmRAD54, DhR54, DmRad54, RAD54, rad54, Rad54, okra" CDMC24244 1 7 17 DAC27-E21 1-CG3748-RB_1 CG3748 CCAGCGTCTTACAGATGCCCAACTGAGTACCATGTGCAAAAGCCACGGTCTCATTCTGGGTCCCATAAC 69 FBan0003748 FBgn0032110 CG3748 2 2L CG3748 CG3748 "anon-WO0140519.143, BcDNA:AT30262" CDMC24244 1 8 17 DAC27-E21 1-CG3748-RB_1 CG3748 CCAGCGTCTTACAGATGCCCAACTGAGTACCATGTGCAAAAGCCACGGTCTCATTCTGGGTCCCATAAC 69 FBan0003748 FBgn0032110 CG3748 2 2L CG3748 CG3748 "anon-WO0140519.143, BcDNA:AT30262" CDMC24245 1 9 17 DAC27-I09 2-CG3788-RA_1 CG3788 CGGGTCGGATGGAAAACTTTGCCTACTACGTGATGCAGGAGATCGGTCTGAAGATAAACGCGGCTACCA 69 FBan0003788 FBgn0034800 CG3788 2 2R nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG3788 CG3788 CDMC24245 1 10 17 DAC27-I09 2-CG3788-RA_1 CG3788 CGGGTCGGATGGAAAACTTTGCCTACTACGTGATGCAGGAGATCGGTCTGAAGATAAACGCGGCTACCA 69 FBan0003788 FBgn0034800 CG3788 2 2R nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG3788 CG3788 CDMC24246 1 11 17 DAC27-I21 21-CG3800-RA_13 CG3800 GCAGCATATGAATCCATAATCCTGAACATCATCCAGTAACCATCGCTGATTCCAAAAGCCGAGCCTGCA 69 FBan0003800 FBgn0034802 CG3800 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676 CG3800 CG3800 "CG11716, CG11716, anon-EST:fe2B6, anon-EST:fe1B4, BEST:GM06241, anon-fast-evolving-2B6, anon-fast-evolving-1B4" CDMC24246 1 12 17 DAC27-I21 21-CG3800-RA_13 CG3800 GCAGCATATGAATCCATAATCCTGAACATCATCCAGTAACCATCGCTGATTCCAAAAGCCGAGCCTGCA 69 FBan0003800 FBgn0034802 CG3800 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676 CG3800 CG3800 "CG11716, CG11716, anon-EST:fe2B6, anon-EST:fe1B4, BEST:GM06241, anon-fast-evolving-2B6, anon-fast-evolving-1B4" CDMC24247 1 13 17 DAC27-M09 18-CG3842-RA_3 CG3842 CCACATCATCGCTTGAAAAATTCGACTAAAGCGGAAGAGAACACTGACGGGGGAAACCAGAGATTGTGT 69 FBan0003842 FBgn0029866 CG3842 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3842 CG3842 CDMC24247 1 14 17 DAC27-M09 18-CG3842-RA_3 CG3842 CCACATCATCGCTTGAAAAATTCGACTAAAGCGGAAGAGAACACTGACGGGGGAAACCAGAGATTGTGT 69 FBan0003842 FBgn0029866 CG3842 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3842 CG3842 CDMC24248 1 15 17 DAC27-M21 23-CG3851-RA_19 CG3851 CGTGCAATCGGTTCTATGTAGCAGATCCCAATTGCGTTAAACAAATGCCAAAGTCAAATAGCAGAGGAA 69 FBan0003851 FBgn0002985 odd 2 2L cell proliferation; GO:0008283; leg joint morphogenesis (sensu Endopterygota); GO:0016348; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 odd odd skipped "CG3851, CG3851, ods, l(2)01863, ODD, Odd, Odd-skipped" CDMC24248 1 16 17 DAC27-M21 23-CG3851-RA_19 CG3851 CGTGCAATCGGTTCTATGTAGCAGATCCCAATTGCGTTAAACAAATGCCAAAGTCAAATAGCAGAGGAA 69 FBan0003851 FBgn0002985 odd 2 2L cell proliferation; GO:0008283; leg joint morphogenesis (sensu Endopterygota); GO:0016348; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 odd odd skipped "CG3851, CG3851, ods, l(2)01863, ODD, Odd, Odd-skipped" CDMC24249 1 17 17 DAC28-A09 3-CG10176-RA_4 CG10176 TGTCGGTCAGGAAGTTGAGTGCCCTATCGCTCTCCATTGGTGGAGTTCCGTTGATTCCAAGTGTTTCCT 69 FBan0010176 FBgn0032682 CG10176 2 2L CG10176 CG10176 CDMC24249 1 18 17 DAC28-A09 3-CG10176-RA_4 CG10176 TGTCGGTCAGGAAGTTGAGTGCCCTATCGCTCTCCATTGGTGGAGTTCCGTTGATTCCAAGTGTTTCCT 69 FBan0010176 FBgn0032682 CG10176 2 2L CG10176 CG10176 CDMC24250 1 19 17 DAC28-A21 13-CG10188-RA_1 CG10188 ACCGGAAGCCTGATCTTGGGCAATGAGGGGAACTGGAAATGTACTTCCATACCTGTTGAACTGTACCTA 69 FBan0010188 FBgn0032796 CG10188 2 2L cell surface receptor linked signal transduction; GO:0007166; hormone secretion; GO:0046879 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089 CG10188 CG10188 CDMC24250 1 20 17 DAC28-A21 13-CG10188-RA_1 CG10188 ACCGGAAGCCTGATCTTGGGCAATGAGGGGAACTGGAAATGTACTTCCATACCTGTTGAACTGTACCTA 69 FBan0010188 FBgn0032796 CG10188 2 2L cell surface receptor linked signal transduction; GO:0007166; hormone secretion; GO:0046879 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089 CG10188 CG10188 CDMC24251 1 21 17 DAC28-E09 23-CG1021-RA_3 CG1021 TGTATCAATTATCAACACGAACACACCCGAGAAACTGTACAAAATATTCATATACCCTATCACACACAC 69 FBan0001021 FBgn0037443 CG1021 3 3R CG1021 CG1021 anon-WO0118547.375 CDMC24251 1 22 17 DAC28-E09 23-CG1021-RA_3 CG1021 TGTATCAATTATCAACACGAACACACCCGAGAAACTGTACAAAATATTCATATACCCTATCACACACAC 69 FBan0001021 FBgn0037443 CG1021 3 3R CG1021 CG1021 anon-WO0118547.375 CDMC24252 1 23 17 DAC28-E21 11-CG10230-RA_2 CG10230 TGGCTCATCCCATTCTTGAGTCGCTTAAGGGCACGGAAAATGAGTGGCTCATGGAACTTCTTAAAGCCT 69 FBan0010230 FBgn0028691 Rpn9 3 3R proteolysis; GO:0006508; regulation of exit from mitosis; GO:0007096 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn9 Rpn9 "CG10230, 0718/06, Rpn94, p39A, rpn9, CT28749, 718/06, Nobody, l(3)S071806b, l(3)S071806, Rpn4" CDMC24252 1 24 17 DAC28-E21 11-CG10230-RA_2 CG10230 TGGCTCATCCCATTCTTGAGTCGCTTAAGGGCACGGAAAATGAGTGGCTCATGGAACTTCTTAAAGCCT 69 FBan0010230 FBgn0028691 Rpn9 3 3R proteolysis; GO:0006508; regulation of exit from mitosis; GO:0007096 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn9 Rpn9 "CG10230, 0718/06, Rpn94, p39A, rpn9, CT28749, 718/06, Nobody, l(3)S071806b, l(3)S071806, Rpn4" CDMC24253 1 25 17 DAC28-I09 23-CG10261-RA_3 CG10261 ACTGATGTTTCCGACTAATTTTTTAAACTGGATGCACTTTTGGCATATACTACCAGATGCTAGCAAAAT 69 FBan0010261 FBgn0022131 aPKC 2 2R apical protein localization; GO:0045176; asymmetric protein localization during cell fate commitment; GO:0045167; calcium-mediated signaling; GO:0019722; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; intercellular junction assembly; GO:0007043; intracellular signaling cascade; GO:0007242; morphogenesis of a polarized epithelium; GO:0001738; neuroblast division; GO:0045034; oocyte axis determination; GO:0007309; oocyte fate determination (sensu Insecta); GO:0007294; protein amino acid phosphorylation; GO:0006468; synaptogenesis; GO:0007416; transmission of nerve impulse; GO:0019226; zonula adherens assembly; GO:0045186 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; protein binding; GO:0005515; ; GO:0005524; atypical protein kinase C activity; GO:0004700 ; EC:2.7.1.-; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004700 ; EC:2.7.1.- apical cortex; GO:0045179; apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; subapical complex; GO:0035003 aPKC atypical protein kinase C "CG10261, CG10261, CG10261, CG10261, CG10261, l(2)k06403, DaPKC, PKCl,i, pkc-3, apkc, psu, pschur, dapkc, aPKC-zeta, atypical protein kinase C" CDMC24253 1 26 17 DAC28-I09 23-CG10261-RA_3 CG10261 ACTGATGTTTCCGACTAATTTTTTAAACTGGATGCACTTTTGGCATATACTACCAGATGCTAGCAAAAT 69 FBan0010261 FBgn0022131 aPKC 2 2R apical protein localization; GO:0045176; asymmetric protein localization during cell fate commitment; GO:0045167; calcium-mediated signaling; GO:0019722; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; intercellular junction assembly; GO:0007043; intracellular signaling cascade; GO:0007242; morphogenesis of a polarized epithelium; GO:0001738; neuroblast division; GO:0045034; oocyte axis determination; GO:0007309; oocyte fate determination (sensu Insecta); GO:0007294; protein amino acid phosphorylation; GO:0006468; synaptogenesis; GO:0007416; transmission of nerve impulse; GO:0019226; zonula adherens assembly; GO:0045186 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; protein binding; GO:0005515; ; GO:0005524; atypical protein kinase C activity; GO:0004700 ; EC:2.7.1.-; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004700 ; EC:2.7.1.- apical cortex; GO:0045179; apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; subapical complex; GO:0035003 aPKC atypical protein kinase C "CG10261, CG10261, CG10261, CG10261, CG10261, l(2)k06403, DaPKC, PKCl,i, pkc-3, apkc, psu, pschur, dapkc, aPKC-zeta, atypical protein kinase C" CDMC24254 1 1 18 DAC28-I21 11-CG10272-RB_1 CG10272 CGCCTTCGCACGACTTTGTCTGGCCCAACGAAACTATCAGCTGCCCATAGTAATCAAAATCTGAACGGA 69 FBgn0037444 CDMC24254 1 2 18 DAC28-I21 11-CG10272-RB_1 CG10272 CGCCTTCGCACGACTTTGTCTGGCCCAACGAAACTATCAGCTGCCCATAGTAATCAAAATCTGAACGGA 69 FBgn0037444 CDMC24255 1 3 18 DAC28-M09 14-CG10307-RA_4 CG10307 TGGTAGTTTGATGCGACTTCAGGTCCTCACGTTGGACTACAATAAACTGGACGAATTCCCGCTCTGCAT 69 FBan0010307 FBgn0034655 CG10307 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 structural molecule activity; GO:0005198; receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG10307 CG10307 CT28947 CDMC24255 1 4 18 DAC28-M09 14-CG10307-RA_4 CG10307 TGGTAGTTTGATGCGACTTCAGGTCCTCACGTTGGACTACAATAAACTGGACGAATTCCCGCTCTGCAT 69 FBan0010307 FBgn0034655 CG10307 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 structural molecule activity; GO:0005198; receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG10307 CG10307 CT28947 CDMC24256 1 5 18 DAC28-M21 3-CG10324-RA_6 CG10324 CGAGCATGGCCAGATTATTGTGAAGCAGGAAAATCCGTCAGGAAGAAGGGACAGAGACCGCAGGGAAGA 69 FBan0010324 FBgn0038454 CG10324 3 3R CG10324 CG10324 CDMC24256 1 6 18 DAC28-M21 3-CG10324-RA_6 CG10324 CGAGCATGGCCAGATTATTGTGAAGCAGGAAAATCCGTCAGGAAGAAGGGACAGAGACCGCAGGGAAGA 69 FBan0010324 FBgn0038454 CG10324 3 3R CG10324 CG10324 CDMC24257 1 7 18 DAC29-A09 9-CG13888-RA_3 CG13888 TGCTCGGTGGCATGAAGACCTTGGTCGGTGCCAATATTCTCTTCACAGAGGGTCTGAATGCCAAGAATA 69 FBan0013888 FBgn0035167 Gr61a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr61a Gustatory receptor 61a "CG13888, Gr61D1, Gustatory receptor 61D1, Gustatory receptor 61a" CDMC24257 1 8 18 DAC29-A09 9-CG13888-RA_3 CG13888 TGCTCGGTGGCATGAAGACCTTGGTCGGTGCCAATATTCTCTTCACAGAGGGTCTGAATGCCAAGAATA 69 FBan0013888 FBgn0035167 Gr61a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr61a Gustatory receptor 61a "CG13888, Gr61D1, Gustatory receptor 61D1, Gustatory receptor 61a" CDMC24258 1 9 18 DAC29-A21 10-CG13898-RA_1 CG13898 CCTTCGAGCTCTGTGATCCTGAGAAGACTGGAAGAATCAGAGCAGACGATTTGGGAGAAGTGATGCGCA 69 FBan0013898 FBgn0035161 CG13898 3 3L calcium-mediated signaling; GO:0019722; ectoderm development; GO:0007398 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG13898 CG13898 CDMC24258 1 10 18 DAC29-A21 10-CG13898-RA_1 CG13898 CCTTCGAGCTCTGTGATCCTGAGAAGACTGGAAGAATCAGAGCAGACGATTTGGGAGAAGTGATGCGCA 69 FBan0013898 FBgn0035161 CG13898 3 3L calcium-mediated signaling; GO:0019722; ectoderm development; GO:0007398 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG13898 CG13898 CDMC24259 1 11 18 DAC29-E09 2-CG13957-RA_2 CG13957 AGGCCCTTTCGCATCTCTTCCAGAGCCAGGATCAACCATTCCAGCAAAGTGCCTTAGACTATCGTCTCT 69 FBan0013957 FBgn0030739 CG13957 X X CG13957 CG13957 p116 CDMC24259 1 12 18 DAC29-E09 2-CG13957-RA_2 CG13957 AGGCCCTTTCGCATCTCTTCCAGAGCCAGGATCAACCATTCCAGCAAAGTGCCTTAGACTATCGTCTCT 69 FBan0013957 FBgn0030739 CG13957 X X CG13957 CG13957 p116 CDMC24260 1 13 18 DAC29-E21 18-CG13968-RA_2 CG13968 GCCATGTGAAGGATCAGCAGGAGATCAGCAGGCATCAATTACAAGAAAATCGTCAACAAGCTACACGGT 69 FBan0013968 FBgn0032840 sNPF 2 2L adult feeding behavior; GO:0008343; body growth; GO:0035264; larval feeding behavior; GO:0030536; neuropeptide signaling pathway; GO:0007218; positive regulation of body size; GO:0040018 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005184; ; GO:0005179 sNPF short neuropeptide F precursor "CG13968, CG13968, CG13968, CG13968, CG13968, Drm-sNPF, Drm-sNPF-1, Drm-sNPF-2, Drm-sNPF-3, Drm-sNPF-4, LRLRFamide, 38B.2, Drm-sNPF-AP1, sNPF1, small neuropeptide F-1, short neuropeptide F-1, sNPF-1, sNPF-2, sNPF-2s, sNPF-3, sNPF-4, snpf, short neuropeptide F precursor" CDMC24260 1 14 18 DAC29-E21 18-CG13968-RA_2 CG13968 GCCATGTGAAGGATCAGCAGGAGATCAGCAGGCATCAATTACAAGAAAATCGTCAACAAGCTACACGGT 69 FBan0013968 FBgn0032840 sNPF 2 2L adult feeding behavior; GO:0008343; body growth; GO:0035264; larval feeding behavior; GO:0030536; neuropeptide signaling pathway; GO:0007218; positive regulation of body size; GO:0040018 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005184; ; GO:0005179 sNPF short neuropeptide F precursor "CG13968, CG13968, CG13968, CG13968, CG13968, Drm-sNPF, Drm-sNPF-1, Drm-sNPF-2, Drm-sNPF-3, Drm-sNPF-4, LRLRFamide, 38B.2, Drm-sNPF-AP1, sNPF1, small neuropeptide F-1, short neuropeptide F-1, sNPF-1, sNPF-2, sNPF-2s, sNPF-3, sNPF-4, snpf, short neuropeptide F precursor" CDMC24261 1 15 18 DAC29-I09 3-CG14013-RA_1 CG14013 AGCCCATGCCACACCATCTCAGCTACTCGAATCCCCGGTATAACGTGGTCAAGTACACGGATAGCGATA 69 FBan0014013 FBgn0031720 CG14013 2 2L CG14013 CG14013 CDMC24261 1 16 18 DAC29-I09 3-CG14013-RA_1 CG14013 AGCCCATGCCACACCATCTCAGCTACTCGAATCCCCGGTATAACGTGGTCAAGTACACGGATAGCGATA 69 FBan0014013 FBgn0031720 CG14013 2 2L CG14013 CG14013 CDMC24262 1 17 18 DAC29-I21 2-CG14023-RA_2 CG14023 CCGGCGACGTACTCAACATTGTACAGCTCAGCAACGATTTGGGATTGAGTTTTCAGGAGTTCGCCAGCG 69 FBan0014023 FBgn0031698 CG14023 2 2L CG14023 CG14023 CDMC24262 1 18 18 DAC29-I21 2-CG14023-RA_2 CG14023 CCGGCGACGTACTCAACATTGTACAGCTCAGCAACGATTTGGGATTGAGTTTTCAGGAGTTCGCCAGCG 69 FBan0014023 FBgn0031698 CG14023 2 2L CG14023 CG14023 CDMC24263 1 19 18 DAC29-M09 7-CG14044-RA_1 CG14044 AGCGAGTCCGCCATGTATTTGCTTAGCATTCGTTACTACGGCGAGATGTTGGAACACACTAAGGTGCGT 69 FBan0014044 FBgn0031650 CG14044 2 2L CG14044 CG14044 CDMC24263 1 20 18 DAC29-M09 7-CG14044-RA_1 CG14044 AGCGAGTCCGCCATGTATTTGCTTAGCATTCGTTACTACGGCGAGATGTTGGAACACACTAAGGTGCGT 69 FBan0014044 FBgn0031650 CG14044 2 2L CG14044 CG14044 CDMC24264 1 21 18 DAC29-M21 15-CG14052-RA_2 CG14052 GGGGGGCCACCAGAAAAAAAAGAAAATCGTGATCCACGTGCCCATTCACAAGAAAATCGAAACGCACAT 69 FBan0014052 FBgn0029606 CG14052 X X CG14052 CG14052 CDMC24264 1 22 18 DAC29-M21 15-CG14052-RA_2 CG14052 GGGGGGCCACCAGAAAAAAAAGAAAATCGTGATCCACGTGCCCATTCACAAGAAAATCGAAACGCACAT 69 FBan0014052 FBgn0029606 CG14052 X X CG14052 CG14052 CDMC24265 1 23 18 DAC30-A09 23-CG15097-RA_3 CG15097 CACGCGCCTAATGCAGGAATTTGATTGTTCGAGTTCGTTATGGATAGACTTAAGAATATTTATATGACT 69 FBan0015097 FBgn0034396 CG15097 2 2R apoptosis; GO:0006915 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 CG15097 CG15097 Dm.CG15097 CDMC24265 1 24 18 DAC30-A09 23-CG15097-RA_3 CG15097 CACGCGCCTAATGCAGGAATTTGATTGTTCGAGTTCGTTATGGATAGACTTAAGAATATTTATATGACT 69 FBan0015097 FBgn0034396 CG15097 2 2R apoptosis; GO:0006915 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 CG15097 CG15097 Dm.CG15097 CDMC24266 1 25 18 DAC30-A21 23-CG15107-RA_5 CG15107 ACGCTCAATAAGTAGTACAGTAGGCATTCGTTGAAAACAAATTCTTGAGTAGTGTGTACCATATACCAA 69 FBan0015107 FBgn0041702 CG15107 2 2R CG15107 CG15107 CDMC24266 1 26 18 DAC30-A21 23-CG15107-RA_5 CG15107 ACGCTCAATAAGTAGTACAGTAGGCATTCGTTGAAAACAAATTCTTGAGTAGTGTGTACCATATACCAA 69 FBan0015107 FBgn0041702 CG15107 2 2R CG15107 CG15107 CDMC24267 1 1 19 DAC30-E09 2-CG15141-RA_1 CG15141 GGGAGCTGCTTTCTGGACAAATGACTGGCGAAAATCACTCTGTCAGTGCTCCGAATGCCTGTCGCTTTA 69 FBan0015141 FBgn0032635 CG15141 2 2L "regulation of transcription, DNA-dependent; GO:0006355; ubiquitin cycle; GO:0006512" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003677 CG15141 CG15141 BEST:LD24839 CDMC24267 1 2 19 DAC30-E09 2-CG15141-RA_1 CG15141 GGGAGCTGCTTTCTGGACAAATGACTGGCGAAAATCACTCTGTCAGTGCTCCGAATGCCTGTCGCTTTA 69 FBan0015141 FBgn0032635 CG15141 2 2L "regulation of transcription, DNA-dependent; GO:0006355; ubiquitin cycle; GO:0006512" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003677 CG15141 CG15141 BEST:LD24839 CDMC24268 1 3 19 DAC30-E21 3-CG1514-RA_4 CG1514 CCATGCCAATCTACGTAAGCGACCGTCGGGCATTTCCAGTGGTTGGGTAGTAATGCGCTCCCTTAATCA 69 FBan0001514 FBgn0029976 CG1514 X X intracellular signaling cascade; GO:0007242 signal transducer activity; GO:0004871; ; GO:0004871 CG1514 CG1514 CDMC24268 1 4 19 DAC30-E21 3-CG1514-RA_4 CG1514 CCATGCCAATCTACGTAAGCGACCGTCGGGCATTTCCAGTGGTTGGGTAGTAATGCGCTCCCTTAATCA 69 FBan0001514 FBgn0029976 CG1514 X X intracellular signaling cascade; GO:0007242 signal transducer activity; GO:0004871; ; GO:0004871 CG1514 CG1514 CDMC24269 1 5 19 DAC30-I09 23-CG15186-RA_4 CG15186 CGGCATTGTTTTTACGGCTAAGTGAATTATACTGAATTCCACAAAGGAGTGTACATTTCTAAATTCTCA 69 FBan0015186 FBgn0037448 CG15186 3 3R CG15186 CG15186 CDMC24269 1 6 19 DAC30-I09 23-CG15186-RA_4 CG15186 CGGCATTGTTTTTACGGCTAAGTGAATTATACTGAATTCCACAAAGGAGTGTACATTTCTAAATTCTCA 69 FBan0015186 FBgn0037448 CG15186 3 3R CG15186 CG15186 CDMC24270 1 7 19 DAC30-I21 23-CG15201-RA_5 CG15201 CTGCCTCAAGTGTCCCTAAATCCGAGGAGTTTCATTAAGAACAGTGTATTCAAATGTAGAAATGTAAAC 69 FBan0015201 FBgn0030272 CG15201 X X CG15201 CG15201 BcDNA:RH06304 CDMC24270 1 8 19 DAC30-I21 23-CG15201-RA_5 CG15201 CTGCCTCAAGTGTCCCTAAATCCGAGGAGTTTCATTAAGAACAGTGTATTCAAATGTAGAAATGTAAAC 69 FBan0015201 FBgn0030272 CG15201 X X CG15201 CG15201 BcDNA:RH06304 CDMC24271 1 9 19 DAC30-M09 16-CG15233-RA_2 CG15233 CGGATGGTGGTGTCTCTTCTGGGAATGTTTGCCATGCTAACCGAGTCGATCTACTTGACTCAGAAAGTT 69 FBan0015233 FBgn0033076 CG15233 2 2R CG15233 CG15233 BEST:LD11861 CDMC24271 1 10 19 DAC30-M09 16-CG15233-RA_2 CG15233 CGGATGGTGGTGTCTCTTCTGGGAATGTTTGCCATGCTAACCGAGTCGATCTACTTGACTCAGAAAGTT 69 FBan0015233 FBgn0033076 CG15233 2 2R CG15233 CG15233 BEST:LD11861 CDMC24272 1 11 19 DAC30-M21 9-CG15249-RA_9 CG15249 GGCTCTGGTTTTGGTACAAAGTAAGGATCCGAGTTCCCAGGATGCACCGCATATACGACACAAGCGCGG 69 FBan0015249 FBgn0030161 CG15249 X X CG15249 CG15249 CDMC24272 1 12 19 DAC30-M21 9-CG15249-RA_9 CG15249 GGCTCTGGTTTTGGTACAAAGTAAGGATCCGAGTTCCCAGGATGCACCGCATATACGACACAAGCGCGG 69 FBan0015249 FBgn0030161 CG15249 X X CG15249 CG15249 CDMC24273 1 13 19 DAC31-A09 2-CG12413-RA_1 CG12413 GGGAATTGTAGTGGAATCAAAGACTGATCCCCGTCGTGGCAAACTATCGACAGCCATCGTCTCCCGC 67 FBan0012413 FBgn0039588 CG12413 3 3R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0005525 mitochondrion; GO:0005739 CG12413 CG12413 CDMC24273 1 14 19 DAC31-A09 2-CG12413-RA_1 CG12413 GGGAATTGTAGTGGAATCAAAGACTGATCCCCGTCGTGGCAAACTATCGACAGCCATCGTCTCCCGC 67 FBan0012413 FBgn0039588 CG12413 3 3R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0005525 mitochondrion; GO:0005739 CG12413 CG12413 CDMC24274 1 15 19 DAC31-A21 2-CG12714-RB_1 CG12714 AAGGCGCAAGGAAAACATGCGGAGGCCCTTTACAGCTTTGAATCGCAATCACTACTTCGTCATCGGC 67 FBan0012714 FBgn0040862 CG12714 X X CG12714 CG12714 CDMC24274 1 16 19 DAC31-A21 2-CG12714-RB_1 CG12714 AAGGCGCAAGGAAAACATGCGGAGGCCCTTTACAGCTTTGAATCGCAATCACTACTTCGTCATCGGC 67 FBan0012714 FBgn0040862 CG12714 X X CG12714 CG12714 CDMC24275 1 17 19 DAC31-E09 3-CG13139-RA_4 CG13139 AGGCGAACAAGGGAAGAACCATGCTGGAGTTCCAGGAGCTTATGACCGTGTTCCAACTGCTTCACTG 67 FBan0013139 FBgn0032230 CG13139 2 2L CG13139 CG13139 CDMC24275 1 18 19 DAC31-E09 3-CG13139-RA_4 CG13139 AGGCGAACAAGGGAAGAACCATGCTGGAGTTCCAGGAGCTTATGACCGTGTTCCAACTGCTTCACTG 67 FBan0013139 FBgn0032230 CG13139 2 2L CG13139 CG13139 CDMC24276 1 19 19 DAC31-E21 3-CG13314-RA_3 CG13314 ATGGCAGTGGTACATCGTGAGGCGGAGAAAATACCGCGCGAACAGGTGTACAAGCTCTTCAAGAACG 67 FBan0013314 FBgn0035949 CG13314 3 3L CG13314 CG13314 CDMC24276 1 20 19 DAC31-E21 3-CG13314-RA_3 CG13314 ATGGCAGTGGTACATCGTGAGGCGGAGAAAATACCGCGCGAACAGGTGTACAAGCTCTTCAAGAACG 67 FBan0013314 FBgn0035949 CG13314 3 3L CG13314 CG13314 CDMC24277 1 21 19 DAC31-I09 23-CG13586-RA_1 CG13586 GGCAACCAGGAAACGATCGACCCGAGGAATGTGTACCACTTGAAGAAACAACTAAGCTAACATCTAG 67 FBan0013586 FBgn0035023 itp 2 2R neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005179 extracellular region; GO:0005576 itp ion transport peptide "CG13586, CG13586, CHH-like, BcDNA:SD05282, ion transport peptide" CDMC24277 1 22 19 DAC31-I09 23-CG13586-RA_1 CG13586 GGCAACCAGGAAACGATCGACCCGAGGAATGTGTACCACTTGAAGAAACAACTAAGCTAACATCTAG 67 FBan0013586 FBgn0035023 itp 2 2R neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005179 extracellular region; GO:0005576 itp ion transport peptide "CG13586, CG13586, CHH-like, BcDNA:SD05282, ion transport peptide" CDMC24278 1 23 19 DAC31-I21 2-CG13654-RA_1 CG13654 TGGAACCGCACGAGTGTCCATCATGGAGAGCGTTAAGGAGTTCATCAGGAAGCACCAGGACATGTTG 67 FBan0013654 FBgn0039290 CG13654 3 3R CG13654 CG13654 CDMC24278 1 24 19 DAC31-I21 2-CG13654-RA_1 CG13654 TGGAACCGCACGAGTGTCCATCATGGAGAGCGTTAAGGAGTTCATCAGGAAGCACCAGGACATGTTG 67 FBan0013654 FBgn0039290 CG13654 3 3R CG13654 CG13654 CDMC24279 1 25 19 DAC31-M09 1-CG14010-RA_1 CG14010 CCGCACACTCACGTACCCTCATCCAGGATGTGAACACAGGACGAGCTTATACTCACATGACTGCCGG 67 FBan0014010 FBgn0031725 CG14010 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG14010 CG14010 CT33567 CDMC24279 1 26 19 DAC31-M09 1-CG14010-RA_1 CG14010 CCGCACACTCACGTACCCTCATCCAGGATGTGAACACAGGACGAGCTTATACTCACATGACTGCCGG 67 FBan0014010 FBgn0031725 CG14010 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG14010 CG14010 CT33567 CDMC24280 1 1 20 DAC31-M21 2-CG14237-RA_1 CG14237 ACCGAGCACACCATGAAGACAGGACAACTGGCACTCCGAATCCTAGCGATAAGCCTATGCATTTGGG 67 FBan0014237 FBgn0039428 CG14237 3 3R CG14237 CG14237 CDMC24280 1 2 20 DAC31-M21 2-CG14237-RA_1 CG14237 ACCGAGCACACCATGAAGACAGGACAACTGGCACTCCGAATCCTAGCGATAAGCCTATGCATTTGGG 67 FBan0014237 FBgn0039428 CG14237 3 3R CG14237 CG14237 CDMC24281 1 3 20 DAC32-A09 15-CG31705-RA_5 CG31705 TCTCGGCGGAATCTATCGTCAAGGATGCGCATAGTATGGCAGAGCGAACTTTTGGACACTTTAGCTTCA 69 FBan0031705 FBgn0028490 CG31705 2 2L CG31705 CG31705 "CG6528, BcDNA:GH07269" CDMC24281 1 4 20 DAC32-A09 15-CG31705-RA_5 CG31705 TCTCGGCGGAATCTATCGTCAAGGATGCGCATAGTATGGCAGAGCGAACTTTTGGACACTTTAGCTTCA 69 FBan0031705 FBgn0028490 CG31705 2 2L CG31705 CG31705 "CG6528, BcDNA:GH07269" CDMC24282 1 5 20 DAC32-A21 13-CG31717-RA_1 CG31717 AGGATGTTCAGGTGTCGAAGCATTTTGTAGTAGCCGTCTCCAATCTGTCGTTCTTCAAATCCCTGCGGA 69 FBan0031717 FBgn0051717 CG31717 2 2L CG31717 CG31717 "Css2, BcDNA:AT30094" CDMC24282 1 6 20 DAC32-A21 13-CG31717-RA_1 CG31717 AGGATGTTCAGGTGTCGAAGCATTTTGTAGTAGCCGTCTCCAATCTGTCGTTCTTCAAATCCCTGCGGA 69 FBan0031717 FBgn0051717 CG31717 2 2L CG31717 CG31717 "Css2, BcDNA:AT30094" CDMC24283 1 7 20 DAC32-E09 14-CG31743-RA_1 CG31743 AACTGGTTTGGCTTTCGTTTTGCATTTCAATAGGCTTTTCGCTCCTGGGAAATTTCTCCACTGGCCTGC 69 FBgn0051743 CDMC24283 1 8 20 DAC32-E09 14-CG31743-RA_1 CG31743 AACTGGTTTGGCTTTCGTTTTGCATTTCAATAGGCTTTTCGCTCCTGGGAAATTTCTCCACTGGCCTGC 69 FBgn0051743 CDMC24284 1 9 20 DAC32-E21 16-CG31751-RA_6 CG31751 CGGATACGTCCTGAAAATCCTCAACTCACTGGACTCTAAGAAAGAGGACTTCGTGGATGCCCAAAACCA 69 FBan0031751 FBgn0051751 CG31751 2 2L CG31751 CG31751 "CG15163, CG15164" CDMC24284 1 10 20 DAC32-E21 16-CG31751-RA_6 CG31751 CGGATACGTCCTGAAAATCCTCAACTCACTGGACTCTAAGAAAGAGGACTTCGTGGATGCCCAAAACCA 69 FBan0031751 FBgn0051751 CG31751 2 2L CG31751 CG31751 "CG15163, CG15164" CDMC24285 1 11 20 DAC32-I09 23-CG31777-RA_1 CG31777 TGCCATTGATATCGAGGGATACTATTACGATCCGATAACATTTGACTGCAAGATGTACAAGATCGGGGC 69 FBan0031777 FBgn0051777 CG31777 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31777 CG31777 BEST:RH19272 CDMC24285 1 12 20 DAC32-I09 23-CG31777-RA_1 CG31777 TGCCATTGATATCGAGGGATACTATTACGATCCGATAACATTTGACTGCAAGATGTACAAGATCGGGGC 69 FBan0031777 FBgn0051777 CG31777 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31777 CG31777 BEST:RH19272 CDMC24286 1 13 20 DAC32-I21 3-CG31787-RA_2 CG31787 TCGAGAAGAGCGGGAATTGCGTGATCTTCGCCAGGAAATGTTAACCGACTACCACTTTGACGTGGCCTA 69 FBan0031787 FBgn0051787 CG31787 2 2L intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; protein carrier activity; GO:0008320; ; GO:0008320 membrane; GO:0016020 CG31787 CG31787 CDMC24286 1 14 20 DAC32-I21 3-CG31787-RA_2 CG31787 TCGAGAAGAGCGGGAATTGCGTGATCTTCGCCAGGAAATGTTAACCGACTACCACTTTGACGTGGCCTA 69 FBan0031787 FBgn0051787 CG31787 2 2L intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; protein carrier activity; GO:0008320; ; GO:0008320 membrane; GO:0016020 CG31787 CG31787 CDMC24287 1 15 20 DAC32-M09 16-CG31816-RA_1 CG31816 CGAGTGGTGGTTAAGGCTGCGAAAAACATCGAAAAAGTTCTGCAAAGTTGGGGCATAGAAGCGACAAAA 69 FBan0031816 FBgn0051816 CG31816 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31816 CG31816 "NEST:bs11b11, NEST:bs34h07, NEST:bs19f07" CDMC24287 1 16 20 DAC32-M09 16-CG31816-RA_1 CG31816 CGAGTGGTGGTTAAGGCTGCGAAAAACATCGAAAAAGTTCTGCAAAGTTGGGGCATAGAAGCGACAAAA 69 FBan0031816 FBgn0051816 CG31816 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31816 CG31816 "NEST:bs11b11, NEST:bs34h07, NEST:bs19f07" CDMC24288 1 17 20 DAC32-M21 17-CG31822-RA_4 CG31822 TGGCTGGGGTAAGAAGAACTTCGAGAACATCAATGTTCAGAAGAAAATGTGCCCCTGGTGGACAGATCT 69 FBan0031822 FBgn0051822 CG31822 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31822 CG31822 CDMC24288 1 18 20 DAC32-M21 17-CG31822-RA_4 CG31822 TGGCTGGGGTAAGAAGAACTTCGAGAACATCAATGTTCAGAAGAAAATGTGCCCCTGGTGGACAGATCT 69 FBan0031822 FBgn0051822 CG31822 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31822 CG31822 CDMC24289 1 19 20 DAC33-A09 2-CG1550-RA_1 CG1550 ACGACATCTTCCGTCTGCTCTTCCTAGACGAAGAAAACGACGATAGCTTCCGGGTACTGACGCCAGACA 69 FBan0001550 FBgn0033225 CG1550 2 2R protein modification; GO:0006464 tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG1550 CG1550 CDMC24289 1 20 20 DAC33-A09 2-CG1550-RA_1 CG1550 ACGACATCTTCCGTCTGCTCTTCCTAGACGAAGAAAACGACGATAGCTTCCGGGTACTGACGCCAGACA 69 FBan0001550 FBgn0033225 CG1550 2 2R protein modification; GO:0006464 tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG1550 CG1550 CDMC24290 1 21 20 DAC33-A21 11-CG15530-RB_1 CG15530 TCCAGAGGAGTATCCCTATGTTGTGGAGATACCCGAGCAGGAAGAAAAAAAACCGCAGAAGGGTAGCCA 69 FBan0015530 FBgn0039752 CG15530 3 3R CG15530 CG15530 CDMC24290 1 22 20 DAC33-A21 11-CG15530-RB_1 CG15530 TCCAGAGGAGTATCCCTATGTTGTGGAGATACCCGAGCAGGAAGAAAAAAAACCGCAGAAGGGTAGCCA 69 FBan0015530 FBgn0039752 CG15530 3 3R CG15530 CG15530 CDMC24291 1 23 20 DAC33-E09 12-CG15571-RA_1 CG15571 GCCTTGGATACGACCACGAGCAGTTTGAATTCCACAACGGAGGATAGCGAAAATACAACCGCAACCACA 69 FBan0015571 FBgn0029696 CG15571 X X CG15571 CG15571 CDMC24291 1 24 20 DAC33-E09 12-CG15571-RA_1 CG15571 GCCTTGGATACGACCACGAGCAGTTTGAATTCCACAACGGAGGATAGCGAAAATACAACCGCAACCACA 69 FBan0015571 FBgn0029696 CG15571 X X CG15571 CG15571 CDMC24292 1 25 20 DAC33-E21 16-CG1558-RA_1 CG1558 GCTGCAGTGCAATATGGACGATCACTACCTATTCATGCGGAACACCATGATCAACAACGCTATACACCA 69 FBgn0030312 CDMC24292 1 26 20 DAC33-E21 16-CG1558-RA_1 CG1558 GCTGCAGTGCAATATGGACGATCACTACCTATTCATGCGGAACACCATGATCAACAACGCTATACACCA 69 FBgn0030312 CDMC24293 1 1 21 DAC33-I09 17-CG15626-RA_1 CG15626 GGAGTCGGGGCCCGATGACTGGAACTTGTGAGATTTATGCTTATACACGCAACGTAGGCTTTAGCTATA 69 FBan0015626 FBgn0031635 CG15626 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 CG15626 CG15626 CDMC24293 1 2 21 DAC33-I09 17-CG15626-RA_1 CG15626 GGAGTCGGGGCCCGATGACTGGAACTTGTGAGATTTATGCTTATACACGCAACGTAGGCTTTAGCTATA 69 FBan0015626 FBgn0031635 CG15626 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 CG15626 CG15626 CDMC24294 1 3 21 DAC33-I21 12-CG15639-RA_4 CG15639 CCGCTGTGCTCCACGATGCTCCTGTTCGACTTTCTCGCCTGCTACATCTTTCTTGACTCCGCCAATGAC 69 FBan0015639 FBgn0032502 CG15639 2 2L CG15639 CG15639 CDMC24294 1 4 21 DAC33-I21 12-CG15639-RA_4 CG15639 CCGCTGTGCTCCACGATGCTCCTGTTCGACTTTCTCGCCTGCTACATCTTTCTTGACTCCGCCAATGAC 69 FBan0015639 FBgn0032502 CG15639 2 2L CG15639 CG15639 CDMC24295 1 5 21 DAC33-M09 18-CG15701-RA_1 CG15701 ACGGGCAAATCGTGTGCCATTCAAAACATCATACTCAACGAGCGTAGATCATTTGACCAGCAGATGGAT 69 FBan0015701 FBgn0034095 CG15701 2 2R CG15701 CG15701 CDMC24295 1 6 21 DAC33-M09 18-CG15701-RA_1 CG15701 ACGGGCAAATCGTGTGCCATTCAAAACATCATACTCAACGAGCGTAGATCATTTGACCAGCAGATGGAT 69 FBan0015701 FBgn0034095 CG15701 2 2R CG15701 CG15701 CDMC24296 1 7 21 DAC33-M21 3-CG15710-RA_1 CG15710 CGGATGAATCCTACGAAGGGGCGTACACCATCACCAAGACCTTCAATTGCGTCTTTTGTCGCACGGAGT 69 FBan0015710 FBgn0034120 CG15710 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15710 CG15710 CDMC24296 1 8 21 DAC33-M21 3-CG15710-RA_1 CG15710 CGGATGAATCCTACGAAGGGGCGTACACCATCACCAAGACCTTCAATTGCGTCTTTTGTCGCACGGAGT 69 FBan0015710 FBgn0034120 CG15710 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15710 CG15710 CDMC24297 1 9 21 DAC34-A09 23-CG31122-RA_4 CG31122 AAACATCGTAGAGCAAGCACTGTAATCGTAGCGTGTCTCAAGCAATTTATGTTTTAAGTACCCCAATGA 69 FBan0031122 FBgn0051122 CG31122 3 3R CG31122 CG31122 "CG7687, CG14308, CG7687" CDMC24297 1 10 21 DAC34-A09 23-CG31122-RA_4 CG31122 AAACATCGTAGAGCAAGCACTGTAATCGTAGCGTGTCTCAAGCAATTTATGTTTTAAGTACCCCAATGA 69 FBan0031122 FBgn0051122 CG31122 3 3R CG31122 CG31122 "CG7687, CG14308, CG7687" CDMC24298 1 11 21 DAC34-A21 14-CG31142-RA_1 CG31142 GGCGCTCCACTCAACGTTATATCCGAAAAACAAAAGACCTACGTGGACGACCTCCTAGGAAAACTGGCA 69 FBan0031142 FBgn0047114 CG31142 3 3R CG31142 CG31142 BcDNA:RE39515 CDMC24298 1 12 21 DAC34-A21 14-CG31142-RA_1 CG31142 GGCGCTCCACTCAACGTTATATCCGAAAAACAAAAGACCTACGTGGACGACCTCCTAGGAAAACTGGCA 69 FBan0031142 FBgn0047114 CG31142 3 3R CG31142 CG31142 BcDNA:RE39515 CDMC24299 1 13 21 DAC34-E09 8-CG31172-RA_1 CG31172 CCGCTGAGCCAGTGTGAGTAATTAACTAAGGCCAGTTAATGGATGGGTCGGTACGCCATGACGTATGCG 69 FBan0031172 FBgn0051172 CG31172 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31172 CG31172 CDMC24299 1 14 21 DAC34-E09 8-CG31172-RA_1 CG31172 CCGCTGAGCCAGTGTGAGTAATTAACTAAGGCCAGTTAATGGATGGGTCGGTACGCCATGACGTATGCG 69 FBan0031172 FBgn0051172 CG31172 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31172 CG31172 CDMC24300 1 15 21 DAC34-E21 23-CG31183-RA_1 CG31183 TGTTTGTGATAATAAGTTAAACCCAAGTTGAACAAGTTAGTGGTTAGTCAATAGTCGACCGAATCAAAT 69 FBan0031183 FBgn0051183 CG31183 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 "ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004383 ; EC:4.6.1.2; peptide receptor activity, G-protein coupled; GO:0008528; natriuretic peptide receptor activity; GO:0016941; ; GO:0008528; ; GO:0016941" membrane; GO:0016020 CG31183 CG31183 "CG11846, CG4224, GYC, FBgn0038379" CDMC24300 1 16 21 DAC34-E21 23-CG31183-RA_1 CG31183 TGTTTGTGATAATAAGTTAAACCCAAGTTGAACAAGTTAGTGGTTAGTCAATAGTCGACCGAATCAAAT 69 FBan0031183 FBgn0051183 CG31183 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 "ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004383 ; EC:4.6.1.2; peptide receptor activity, G-protein coupled; GO:0008528; natriuretic peptide receptor activity; GO:0016941; ; GO:0008528; ; GO:0016941" membrane; GO:0016020 CG31183 CG31183 "CG11846, CG4224, GYC, FBgn0038379" CDMC24301 1 17 21 DAC34-I09 15-CG31208-RA_1 CG31208 GCGACTTGTGCTGAGCATTCCCAACGTTGCAGTTATCTTGTGCTACCACATTTTTCGAGGGCCAGAAAT 69 FBan0031208 FBgn0045471 Gr92a 3 3R Gr92a Gustatory receptor 92a "CG31208, CG31208, Gr92D1, Gustatory receptor 92D1, DmGr92a, Gustatory receptor 92a" CDMC24301 1 18 21 DAC34-I09 15-CG31208-RA_1 CG31208 GCGACTTGTGCTGAGCATTCCCAACGTTGCAGTTATCTTGTGCTACCACATTTTTCGAGGGCCAGAAAT 69 FBan0031208 FBgn0045471 Gr92a 3 3R Gr92a Gustatory receptor 92a "CG31208, CG31208, Gr92D1, Gustatory receptor 92D1, DmGr92a, Gustatory receptor 92a" CDMC24302 1 19 21 DAC34-I21 13-CG31216-RA_1 CG31216 CGAGGTGGACTCTTATTCGGTGTTCTGGGACAACAAGAAGCTATCTGACACCACTCTAAATGCCCAGCT 69 FBan0031216 FBgn0051216 CG31216 3 3R coenzyme metabolism; GO:0006732; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189 calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG31216 CG31216 "CG7444, CG7500, AAM52663, anon-WO0172774.59, anon-WO0172774.60" CDMC24302 1 20 21 DAC34-I21 13-CG31216-RA_1 CG31216 CGAGGTGGACTCTTATTCGGTGTTCTGGGACAACAAGAAGCTATCTGACACCACTCTAAATGCCCAGCT 69 FBan0031216 FBgn0051216 CG31216 3 3R coenzyme metabolism; GO:0006732; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189 calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG31216 CG31216 "CG7444, CG7500, AAM52663, anon-WO0172774.59, anon-WO0172774.60" CDMC24303 1 21 21 DAC34-M09 3-CG3124-RA_4 CG3124 CCCCAACCAAATGATGAACAGCTCCAATATGTGGCAATACAGTCAGCCTATGCAGAGTCACCAGCCGCA 69 FBan0003124 FBgn0034840 CG3124 2 2R CG3124 CG3124 anon-WO0140519.230 CDMC24303 1 22 21 DAC34-M09 3-CG3124-RA_4 CG3124 CCCCAACCAAATGATGAACAGCTCCAATATGTGGCAATACAGTCAGCCTATGCAGAGTCACCAGCCGCA 69 FBan0003124 FBgn0034840 CG3124 2 2R CG3124 CG3124 anon-WO0140519.230 CDMC24304 1 23 21 DAC34-M21 23-CG31268-RA_10 CG31268 AACAACTTTGACTAAGAACTTACAAACAGTGACCAATTCCCAAAAACACAAAACAAACGCTCCAATGCG 69 FBan0031268 FBgn0051268 CG31268 3 3R phosphate transport; GO:0006817 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 CG31268 CG31268 CDMC24304 1 24 21 DAC34-M21 23-CG31268-RA_10 CG31268 AACAACTTTGACTAAGAACTTACAAACAGTGACCAATTCCCAAAAACACAAAACAAACGCTCCAATGCG 69 FBan0031268 FBgn0051268 CG31268 3 3R phosphate transport; GO:0006817 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 CG31268 CG31268 CDMC24305 1 25 21 DAC35-A09 1-CG7809-RA_4 CG7809 CAGACCACCGACTATTGAGCCACCGGCACAGAGCTTGTTCAAGACCTACTTCAATCCGGATGAGGC 66 FBan0007809 FBgn0036919 Grasp65 3 3L protein binding; GO:0005515; ; GO:0005515 Golgi membrane; GO:0000139 Grasp65 Grasp65 CG7809 CDMC24305 1 26 21 DAC35-A09 1-CG7809-RA_4 CG7809 CAGACCACCGACTATTGAGCCACCGGCACAGAGCTTGTTCAAGACCTACTTCAATCCGGATGAGGC 66 FBan0007809 FBgn0036919 Grasp65 3 3L protein binding; GO:0005515; ; GO:0005515 Golgi membrane; GO:0000139 Grasp65 Grasp65 CG7809 CDMC24306 1 1 22 DAC35-A21 2-CG7961-RB_1 CG7961 GAGGCCCAGCAACTCTTAAGGATCTGCGCTGAGTATATCGTTGGCCTGAAGATGGAGACTGTGCGC 66 FBan0007961 FBgn0025725 alphaCop 3 3L "endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890; vesicle-mediated transport; GO:0016192" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 alphaCop alpha-coatomer protein "CG7961, alpha-COP, alpha-COP, alphaCop" CDMC24306 1 2 22 DAC35-A21 2-CG7961-RB_1 CG7961 GAGGCCCAGCAACTCTTAAGGATCTGCGCTGAGTATATCGTTGGCCTGAAGATGGAGACTGTGCGC 66 FBan0007961 FBgn0025725 alphaCop 3 3L "endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890; vesicle-mediated transport; GO:0016192" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 alphaCop alpha-coatomer protein "CG7961, alpha-COP, alpha-COP, alphaCop" CDMC24307 1 3 22 DAC35-E09 3-CG8334-RA_3 CG8334 CCAGTAAGGAGGTTAAGGAAGAACTACCCAATCAAACGGGGTCCACAAAGGCTACGGCGTCGCCAC 66 FBan0008334 FBgn0036913 CG8334 3 3L proteolysis; GO:0006508; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511 calcium ion binding; GO:0005509; ; GO:0005509; ubiquitin-specific protease activity; GO:0004843; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004843 CG8334 CG8334 CDMC24307 1 4 22 DAC35-E09 3-CG8334-RA_3 CG8334 CCAGTAAGGAGGTTAAGGAAGAACTACCCAATCAAACGGGGTCCACAAAGGCTACGGCGTCGCCAC 66 FBan0008334 FBgn0036913 CG8334 3 3L proteolysis; GO:0006508; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511 calcium ion binding; GO:0005509; ; GO:0005509; ubiquitin-specific protease activity; GO:0004843; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004843 CG8334 CG8334 CDMC24308 1 5 22 DAC35-E21 3-CG8460-RA_1 CG8460 AGTCAACGACGTGCTGATCAAGTGCTGCAAGGATAATGGCTTCGATGGACTCGTCCTGGAGGTGTG 66 FBan0008460 FBgn0031996 CG8460 2 2L CG8460 CG8460 CDMC24308 1 6 22 DAC35-E21 3-CG8460-RA_1 CG8460 AGTCAACGACGTGCTGATCAAGTGCTGCAAGGATAATGGCTTCGATGGACTCGTCCTGGAGGTGTG 66 FBan0008460 FBgn0031996 CG8460 2 2L CG8460 CG8460 CDMC24309 1 7 22 DAC35-I09 3-CG9125-RA_1 CG9125 ACTGCGCGGTATTTTGCGGCAGATAATGTGCCTGCAGTATGATAATCGCTCATTCCGCGTCAAGGC 66 FBan0009125 FBgn0030793 CG9125 X X CG9125 CG9125 CG32566 CDMC24309 1 8 22 DAC35-I09 3-CG9125-RA_1 CG9125 ACTGCGCGGTATTTTGCGGCAGATAATGTGCCTGCAGTATGATAATCGCTCATTCCGCGTCAAGGC 66 FBan0009125 FBgn0030793 CG9125 X X CG9125 CG9125 CG32566 CDMC24310 1 9 22 DAC35-I21 1-CG9226-RA_2 CG9226 GTGCCCGTTCACCTAGACGGCATGCACGTTATAGAGATGCCCAGTGACCTCTACTCCGCAGATACG 66 FBan0009226 FBgn0031782 CG9226 2 2L guanyl nucleotide binding; GO:0019001; ; GO:0019001 CG9226 CG9226 CDMC24310 1 10 22 DAC35-I21 1-CG9226-RA_2 CG9226 GTGCCCGTTCACCTAGACGGCATGCACGTTATAGAGATGCCCAGTGACCTCTACTCCGCAGATACG 66 FBan0009226 FBgn0031782 CG9226 2 2L guanyl nucleotide binding; GO:0019001; ; GO:0019001 CG9226 CG9226 CDMC24311 1 11 22 DAC35-M09 2-CG9760-RB_2 CG9760 ACATCGGGTTCATGGTGCCTGATCTTCTACAGCTCTTCGTCCCAGTTTGGCTGCTACGACAGACAC 66 FBan0009760 FBgn0036259 CG9760 3 3L CG9760 CG9760 CDMC24311 1 12 22 DAC35-M09 2-CG9760-RB_2 CG9760 ACATCGGGTTCATGGTGCCTGATCTTCTACAGCTCTTCGTCCCAGTTTGGCTGCTACGACAGACAC 66 FBan0009760 FBgn0036259 CG9760 3 3L CG9760 CG9760 CDMC24312 1 13 22 DAC35-M21 3-CG9881-RA_1 CG9881 AAAGGCGGTCATAGAGTCACTACCCCAACTGTTCCCTGCCCCATAAACCGATTCATACGCATCGCG 66 FBan0009881 FBgn0031437 p16-ARC 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 p16-ARC p16-ARC "CG9881, CG9881, P16-ARC" CDMC24312 1 14 22 DAC35-M21 3-CG9881-RA_1 CG9881 AAAGGCGGTCATAGAGTCACTACCCCAACTGTTCCCTGCCCCATAAACCGATTCATACGCATCGCG 66 FBan0009881 FBgn0031437 p16-ARC 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 p16-ARC p16-ARC "CG9881, CG9881, P16-ARC" CDMC24313 1 15 22 DAC36-A09 3-CG1809-RA_1 CG1809 GTGTATGCCTCGGGACCCTATGCCCAGTACTTCAGTGGCAACTACGAGCAAAGCAATATTCCGGC 65 FBan0001809 FBgn0033423 CG1809 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1 CG1809 CG1809 CDMC24313 1 16 22 DAC36-A09 3-CG1809-RA_1 CG1809 GTGTATGCCTCGGGACCCTATGCCCAGTACTTCAGTGGCAACTACGAGCAAAGCAATATTCCGGC 65 FBan0001809 FBgn0033423 CG1809 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1 CG1809 CG1809 CDMC24314 1 17 22 DAC36-A21 19-CG18139-RA_1 CG18139 CCAAGAGCAGCCTTTGCCTGGAAAGCAAGGAGAGTGGTGGCCAGCACAAGGAGCTAGCGCAAGGA 65 FBan0018139 FBgn0038522 CG18139 3 3R CG18139 CG18139 CDMC24314 1 18 22 DAC36-A21 19-CG18139-RA_1 CG18139 CCAAGAGCAGCCTTTGCCTGGAAAGCAAGGAGAGTGGTGGCCAGCACAAGGAGCTAGCGCAAGGA 65 FBan0018139 FBgn0038522 CG18139 3 3R CG18139 CG18139 CDMC24315 1 19 22 DAC36-E09 7-CG18348-RA_1 CG18348 ACGGATATCGTCCTACTGGTGCTCATCTGCCCACGCCGCCTCCCATTCCTGATTACATCCTCAAG 65 FBan0018348 FBgn0036110 CG18348 3 3L CG18348 CG18348 CDMC24315 1 20 22 DAC36-E09 7-CG18348-RA_1 CG18348 ACGGATATCGTCCTACTGGTGCTCATCTGCCCACGCCGCCTCCCATTCCTGATTACATCCTCAAG 65 FBan0018348 FBgn0036110 CG18348 3 3L CG18348 CG18348 CDMC24316 1 21 22 DAC36-E21 23-CG18404-RA_1 CG18404 CAACCTCTGAAGAACTTTGGAGCAGTTCAATTAACAAATAAATATTCAATCGCGCAAAGAGCTTA 65 FBan0018404 FBgn0039761 CG18404 3 3R CG18404 CG18404 anon-WO0140519.106 CDMC24316 1 22 22 DAC36-E21 23-CG18404-RA_1 CG18404 CAACCTCTGAAGAACTTTGGAGCAGTTCAATTAACAAATAAATATTCAATCGCGCAAAGAGCTTA 65 FBan0018404 FBgn0039761 CG18404 3 3R CG18404 CG18404 anon-WO0140519.106 CDMC24317 1 23 22 DAC36-I09 3-CG18593-RA_1 CG18593 ACGGCCGCAGATCAGGGACAAGATGCTTGCCGATCTCGAAGACAAAAGCTCGGACTTCTACTGAG 65 FBan0018593 FBgn0036237 viaf 3 3L regulation of caspase activation; GO:0043026 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 viaf viral IAP-associated factor "CG18593, CG18593, CG18593, VIAF, anon-WO0134798.17, anon-WO0134798.18, viaf1, viral IAP-associated factor" CDMC24317 1 24 22 DAC36-I09 3-CG18593-RA_1 CG18593 ACGGCCGCAGATCAGGGACAAGATGCTTGCCGATCTCGAAGACAAAAGCTCGGACTTCTACTGAG 65 FBan0018593 FBgn0036237 viaf 3 3L regulation of caspase activation; GO:0043026 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 viaf viral IAP-associated factor "CG18593, CG18593, CG18593, VIAF, anon-WO0134798.17, anon-WO0134798.18, viaf1, viral IAP-associated factor" CDMC24318 1 25 22 DAC36-I21 6-CG18642-RA_2 CG18642 CACATTACGGTCAGCATCAAGACACCCGACGATGTCACTCTGCACGCCTTCTGGGTTACCCAACC 65 FBan0018642 FBgn0025109 Bem46 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Bem46 Bem46 "CG18642, c1.6" CDMC24318 1 26 22 DAC36-I21 6-CG18642-RA_2 CG18642 CACATTACGGTCAGCATCAAGACACCCGACGATGTCACTCTGCACGCCTTCTGGGTTACCCAACC 65 FBan0018642 FBgn0025109 Bem46 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Bem46 Bem46 "CG18642, c1.6" CDMC24319 1 1 23 DAC36-M09 9-CG18768-RD_3 CG18768 GGCATGTCAAAGGACGTGTCGGTAGATTCCCTAAACATGTGCGTGGAGCAAACAACCAGTTCGGC 65 FBan0018768 FBgn0035808 SP2523 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SP2523 SP2523 "CG18768, CG18025, CG18227, CG7493, sp2523" CDMC24319 1 2 23 DAC36-M09 9-CG18768-RD_3 CG18768 GGCATGTCAAAGGACGTGTCGGTAGATTCCCTAAACATGTGCGTGGAGCAAACAACCAGTTCGGC 65 FBan0018768 FBgn0035808 SP2523 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SP2523 SP2523 "CG18768, CG18025, CG18227, CG7493, sp2523" CDMC24320 1 3 23 DAC36-M21 1-CG1883-RB_2 CG1883 ATCTTCGCCAGGGGACGCAGAACAGTCAGGGCCAATTACTCGTTATTGCAGGCATTAGAAGCCAT 65 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC24320 1 4 23 DAC36-M21 1-CG1883-RB_2 CG1883 ATCTTCGCCAGGGGACGCAGAACAGTCAGGGCCAATTACTCGTTATTGCAGGCATTAGAAGCCAT 65 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC24321 1 5 23 DAC37-A09 1-CG16898-RA_1 CG16898 GCGAGCAATCCCCAATCAGCCGTAGCCATAGACTTTCAATTCAGCAACTTCACCTCCCCTGTCAACGAC 69 FBan0016898 FBgn0034480 CG16898 2 2R CG16898 CG16898 CDMC24321 1 6 23 DAC37-A09 1-CG16898-RA_1 CG16898 GCGAGCAATCCCCAATCAGCCGTAGCCATAGACTTTCAATTCAGCAACTTCACCTCCCCTGTCAACGAC 69 FBan0016898 FBgn0034480 CG16898 2 2R CG16898 CG16898 CDMC24322 1 7 23 DAC37-A21 3-CG16910-RA_1 CG16910 GGCGCCTCATCCCGGACTTCAGACACCACTTTGCGATGTCCGATCTGTTCAAAGTCCTTTAACGCCTTA 69 FBan0016910 FBgn0041205 key 2 2R "Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; protein catabolism; GO:0030163; response to pest, pathogen or parasite; GO:0009613" nucleic acid binding; GO:0003676; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0008270 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737; nucleus; GO:0005634 key kenny "CG16910, CG16910, DmIKKgamma, IKKgamma, Kenny, Dmikkgamma, dIKK, dmIKKgamma, IKK-gamma, dIKK-gamma, kenny" CDMC24322 1 8 23 DAC37-A21 3-CG16910-RA_1 CG16910 GGCGCCTCATCCCGGACTTCAGACACCACTTTGCGATGTCCGATCTGTTCAAAGTCCTTTAACGCCTTA 69 FBan0016910 FBgn0041205 key 2 2R "Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; protein catabolism; GO:0030163; response to pest, pathogen or parasite; GO:0009613" nucleic acid binding; GO:0003676; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0008270 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737; nucleus; GO:0005634 key kenny "CG16910, CG16910, DmIKKgamma, IKKgamma, Kenny, Dmikkgamma, dIKK, dmIKKgamma, IKK-gamma, dIKK-gamma, kenny" CDMC24323 1 9 23 DAC37-E09 6-CG16954-RB_3 CG16954 GCGTCATCCTGCTGAAGGAATCCCACAGTCCCTTCGATGAGGCTAAGATCCAGGAGGGTATAACCATCG 69 FBan0016954 FBgn0032525 CG16954 2 2L "'de novo' protein folding; GO:0006458; protein targeting to mitochondrion; GO:0006626; regulation of transcription, DNA-dependent; GO:0006355; response to heat; GO:0009408" "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; transcription factor activity; GO:0003700; unfolded protein binding; GO:0051082; ; GO:0003700; ; GO:0051082" mitochondrial matrix; GO:0005759 CG16954 CG16954 CDMC24323 1 10 23 DAC37-E09 6-CG16954-RB_3 CG16954 GCGTCATCCTGCTGAAGGAATCCCACAGTCCCTTCGATGAGGCTAAGATCCAGGAGGGTATAACCATCG 69 FBan0016954 FBgn0032525 CG16954 2 2L "'de novo' protein folding; GO:0006458; protein targeting to mitochondrion; GO:0006626; regulation of transcription, DNA-dependent; GO:0006355; response to heat; GO:0009408" "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; transcription factor activity; GO:0003700; unfolded protein binding; GO:0051082; ; GO:0003700; ; GO:0051082" mitochondrial matrix; GO:0005759 CG16954 CG16954 CDMC24324 1 11 23 DAC37-E21 18-CG16963-RA_1 CG16963 GACCCATCTAATGCATACAGCAAACTCTGCCAAGAATCTAACCCAAGCTCTAACGCTTTCCATTCCGCT 69 FBan0016963 FBgn0005664 Cry 2 2L structural constituent of eye lens; GO:0005212; ; GO:0005212; structural constituent of cuticle; GO:0042302; ; GO:0042302 Cry Crystallin "CG16963, drosocrystallin, dcy, Drosocrystallin" CDMC24324 1 12 23 DAC37-E21 18-CG16963-RA_1 CG16963 GACCCATCTAATGCATACAGCAAACTCTGCCAAGAATCTAACCCAAGCTCTAACGCTTTCCATTCCGCT 69 FBan0016963 FBgn0005664 Cry 2 2L structural constituent of eye lens; GO:0005212; ; GO:0005212; structural constituent of cuticle; GO:0042302; ; GO:0042302 Cry Crystallin "CG16963, drosocrystallin, dcy, Drosocrystallin" CDMC24325 1 13 23 DAC37-I09 23-CG16985-RA_1 CG16985 ACAGGTCAAGTACATTCAGTTCGACAAGGAAAAACTGGATTTTTAAAACAATTTTTGTAGATCGTCAGA 69 FBan0016985 FBgn0035355 CG16985 3 3L CG16985 CG16985 BcDNA:RE30174 CDMC24325 1 14 23 DAC37-I09 23-CG16985-RA_1 CG16985 ACAGGTCAAGTACATTCAGTTCGACAAGGAAAAACTGGATTTTTAAAACAATTTTTGTAGATCGTCAGA 69 FBan0016985 FBgn0035355 CG16985 3 3L CG16985 CG16985 BcDNA:RE30174 CDMC24326 1 15 23 DAC37-I21 15-CG16998-RA_2 CG16998 GTGGAGTAGAGGTGCCCATTCATCTTACACCATGGTTGGCTTCGATCACGGTGCATGGCAACTATAGTT 69 FBan0016998 FBgn0035795 CG16998 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG16998 CG16998 SP104 CDMC24326 1 16 23 DAC37-I21 15-CG16998-RA_2 CG16998 GTGGAGTAGAGGTGCCCATTCATCTTACACCATGGTTGGCTTCGATCACGGTGCATGGCAACTATAGTT 69 FBan0016998 FBgn0035795 CG16998 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG16998 CG16998 SP104 CDMC24327 1 17 23 DAC37-M09 12-CG17034-RB_3 CG17034 GGCAGCATACACAAAGGAAGTGATCTGGAGCGATGGCAAGACCAGTGATTACCTATTGATGGGCAACCT 69 FBan0017034 FBgn0033837 CG17034 2 2R cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0016820 ; EC:3.6.3.-; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG17034 CG17034 anon-WO0153538.54 CDMC24327 1 18 23 DAC37-M09 12-CG17034-RB_3 CG17034 GGCAGCATACACAAAGGAAGTGATCTGGAGCGATGGCAAGACCAGTGATTACCTATTGATGGGCAACCT 69 FBan0017034 FBgn0033837 CG17034 2 2R cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0016820 ; EC:3.6.3.-; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG17034 CG17034 anon-WO0153538.54 CDMC24328 1 19 23 DAC37-M21 3-CG17046-RA_3 CG17046 TGCCTACAAATGCGAACTGTGAACGAGGAGCTACCAGCAGATGACAAAGGATCCGTCGAGGAGTCCAAA 69 FBan0017046 FBgn0001316 klar 3 3L eye photoreceptor development (sensu Endopterygota); GO:0042051; membrane organization and biogenesis; GO:0016044; microtubule-based movement; GO:0007018; nuclear migration; GO:0007097; salivary gland development; GO:0007431 "ATPase activity, coupled; GO:0042623; transporter activity; GO:0005215; ; GO:0042623; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515" dynein complex; GO:0030286; membrane; GO:0016020; nuclear membrane; GO:0005635 klar klarsicht "CG17046, CG17046, marb, marbles, kls, Klar" CDMC24328 1 20 23 DAC37-M21 3-CG17046-RA_3 CG17046 TGCCTACAAATGCGAACTGTGAACGAGGAGCTACCAGCAGATGACAAAGGATCCGTCGAGGAGTCCAAA 69 FBan0017046 FBgn0001316 klar 3 3L eye photoreceptor development (sensu Endopterygota); GO:0042051; membrane organization and biogenesis; GO:0016044; microtubule-based movement; GO:0007018; nuclear migration; GO:0007097; salivary gland development; GO:0007431 "ATPase activity, coupled; GO:0042623; transporter activity; GO:0005215; ; GO:0042623; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515" dynein complex; GO:0030286; membrane; GO:0016020; nuclear membrane; GO:0005635 klar klarsicht "CG17046, CG17046, marb, marbles, kls, Klar" CDMC24329 1 21 23 DAC38-A09 12-CG17556-RA_4 CG17556 AGGCCATCAAGGAGCTCAACGAGTATCTGAAGAAGTTTATGTCTGACCAGGAGGCATGGCATGAGCTGT 69 FBan0017556 FBgn0038462 CG17556 3 3R CG17556 CG17556 CDMC24329 1 22 23 DAC38-A09 12-CG17556-RA_4 CG17556 AGGCCATCAAGGAGCTCAACGAGTATCTGAAGAAGTTTATGTCTGACCAGGAGGCATGGCATGAGCTGT 69 FBan0017556 FBgn0038462 CG17556 3 3R CG17556 CG17556 CDMC24330 1 23 23 DAC38-A21 23-CG17572-RA_1 CG17572 TCGAATTACCGGAAACCGAAGTTCTGAGCCCTTACCTACAAATAGTATTACAACTATAGAGTATAAAGT 69 FBan0017572 FBgn0032753 CG17572 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17572 CG17572 "SPH64, c-SPH64" CDMC24330 1 24 23 DAC38-A21 23-CG17572-RA_1 CG17572 TCGAATTACCGGAAACCGAAGTTCTGAGCCCTTACCTACAAATAGTATTACAACTATAGAGTATAAAGT 69 FBan0017572 FBgn0032753 CG17572 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17572 CG17572 "SPH64, c-SPH64" CDMC24331 1 25 23 DAC38-E09 18-CG17618-RA_2 CG17618 GCGACAGAGCTTTTCAAGCAGAGTGTAAGTGCATACAGGTTGAACCCAAAACCGACGCATATTTTTGCG 69 FBan0017618 FBgn0040587 CG17618 3 3R CG17618 CG17618 CDMC24331 1 26 23 DAC38-E09 18-CG17618-RA_2 CG17618 GCGACAGAGCTTTTCAAGCAGAGTGTAAGTGCATACAGGTTGAACCCAAAACCGACGCATATTTTTGCG 69 FBan0017618 FBgn0040587 CG17618 3 3R CG17618 CG17618 CDMC24332 1 1 24 DAC38-E21 14-CG17632-RA_1 CG17632 GCGGCACCTACATGAATGTGGACACAGTGCCTGGACTAAAGTACCTCTCGTTGTTCTTCTACTCCAACG 69 FBan0017632 FBgn0000241 bw 2 2R coenzyme metabolism; GO:0006732; eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 bw brown "CG17632, CG17632, Plum, Su(w[coJ]), Suppressor of white-coral J, Pm: Plum, Rosy, Su(w[co2]): Suppressor of white-coral-2, ptm: pteridine-modifier, Suppressor of white-coral-2, pteridine-modifier, brown" CDMC24332 1 2 24 DAC38-E21 14-CG17632-RA_1 CG17632 GCGGCACCTACATGAATGTGGACACAGTGCCTGGACTAAAGTACCTCTCGTTGTTCTTCTACTCCAACG 69 FBan0017632 FBgn0000241 bw 2 2R coenzyme metabolism; GO:0006732; eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 bw brown "CG17632, CG17632, Plum, Su(w[coJ]), Suppressor of white-coral J, Pm: Plum, Rosy, Su(w[co2]): Suppressor of white-coral-2, ptm: pteridine-modifier, Suppressor of white-coral-2, pteridine-modifier, brown" CDMC24333 1 3 24 DAC38-I09 1-CG17683-RD_1 CG17683 CGGGGTGGGTTTGTTACGCGGAGAAAACACACGGAAACTTCTTATTGCCTTACGTTTCCACGACCCGAT 69 FBgn0040002 CG17683 electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489; ferredoxin hydrogenase activity; GO:0008901 ; EC:1.12.7.2; ; GO:0008901 ; EC:1.12.7.2 CG17683 CG17683 CDMC24333 1 4 24 DAC38-I09 1-CG17683-RD_1 CG17683 CGGGGTGGGTTTGTTACGCGGAGAAAACACACGGAAACTTCTTATTGCCTTACGTTTCCACGACCCGAT 69 FBgn0040002 CG17683 electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489; ferredoxin hydrogenase activity; GO:0008901 ; EC:1.12.7.2; ; GO:0008901 ; EC:1.12.7.2 CG17683 CG17683 CDMC24334 1 5 24 DAC38-I21 23-CG17697-RA_13 CG17697 TAGCTCTAAGTCGAGTTGTATTTTGTAGGATTTCATTGCTATCGCGGTATACGAACCTGTAGCACCTAT 69 FBan0017697 FBgn0001085 fz 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; asymmetric protein localization; GO:0008105; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; establishment of cell polarity; GO:0030010; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; protein localization; GO:0008104; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; wing hair site selection; GO:0035320 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 cell cortex; GO:0005938; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 fz frizzled "CG3646, CG17697, CG3646, Dfz1, Fz1, DFZ1, Fz, frz, FZ, Frizzled 1, DFz, frizzled 1, Frizzled, fz1, DFz1, frizzled" CDMC24334 1 6 24 DAC38-I21 23-CG17697-RA_13 CG17697 TAGCTCTAAGTCGAGTTGTATTTTGTAGGATTTCATTGCTATCGCGGTATACGAACCTGTAGCACCTAT 69 FBan0017697 FBgn0001085 fz 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; asymmetric protein localization; GO:0008105; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; establishment of cell polarity; GO:0030010; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; protein localization; GO:0008104; sensory organ precursor cell fate determination; GO:0016360; signal transduction; GO:0007165; wing hair site selection; GO:0035320 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 cell cortex; GO:0005938; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 fz frizzled "CG3646, CG17697, CG3646, Dfz1, Fz1, DFZ1, Fz, frz, FZ, Frizzled 1, DFz, frizzled 1, Frizzled, fz1, DFz1, frizzled" CDMC24335 1 7 24 DAC38-M09 2-CG17732-RA_1 CG17732 CCCAACCCCTTGAGCCCAGAAACGACCATTTCGGAATAAACTCGGTCATGTCCAACTACGTGGCTAGCT 69 FBan0017732 FBgn0036923 CG17732 3 3L CG17732 CG17732 CDMC24335 1 8 24 DAC38-M09 2-CG17732-RA_1 CG17732 CCCAACCCCTTGAGCCCAGAAACGACCATTTCGGAATAAACTCGGTCATGTCCAACTACGTGGCTAGCT 69 FBan0017732 FBgn0036923 CG17732 3 3L CG17732 CG17732 CDMC24336 1 9 24 DAC38-M21 17-CG17744-RA_6 CG17744 GGGACTACCGGGTGATCTTAAGGCCATTGGTGAAAAGTTCGATTATGCCTATTCCGTTGCAAAGCCTAT 69 FBan0017744 FBgn0035730 CG17744 3 3L CG17744 CG17744 CDMC24336 1 10 24 DAC38-M21 17-CG17744-RA_6 CG17744 GGGACTACCGGGTGATCTTAAGGCCATTGGTGAAAAGTTCGATTATGCCTATTCCGTTGCAAAGCCTAT 69 FBan0017744 FBgn0035730 CG17744 3 3L CG17744 CG17744 CDMC24337 1 11 24 DAC39-A09 3-CG32170-RA_1 CG32170 GTCGCGAGTCCAAGGAGAACCGTCCCGATTTCCTGGTCTTCGACAATGATAACTACCGCCCTCAG 65 FBan0032170 FBgn0052170 CG32170 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32170 CG32170 "CT12913, BcDNA:RE28470" CDMC24337 1 12 24 DAC39-A09 3-CG32170-RA_1 CG32170 GTCGCGAGTCCAAGGAGAACCGTCCCGATTTCCTGGTCTTCGACAATGATAACTACCGCCCTCAG 65 FBan0032170 FBgn0052170 CG32170 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32170 CG32170 "CT12913, BcDNA:RE28470" CDMC24338 1 13 24 DAC39-A21 6-CG32191-RA_2 CG32191 GATTCGGTGCTCACCTACCGAGAACTGGACGACCTAGATCCCCGCGACAGTCGCTATGCAGTTAC 65 FBan0032191 FBgn0052191 CG32191 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG32191 CG32191 "CG5584, CG5584" CDMC24338 1 14 24 DAC39-A21 6-CG32191-RA_2 CG32191 GATTCGGTGCTCACCTACCGAGAACTGGACGACCTAGATCCCCGCGACAGTCGCTATGCAGTTAC 65 FBan0032191 FBgn0052191 CG32191 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG32191 CG32191 "CG5584, CG5584" CDMC24339 1 15 24 DAC39-E09 1-CG32274-RA_1 CG32274 ATTTTCCTGGGAGCGGAAGAATCACATGCCGACTGCCTTTCCGGAAGATATAGGGGTTCCTGTGC 65 FBan0032274 FBgn0052274 Drs-l 3 3L defense response; GO:0006952; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 Drs-l Drosomycin-like "CG11520, CG32274, CG11520, CG11520, CG11520, Dro-1, dro1b, Dro-H, drosomycin-1b, drosomycin-H" CDMC24339 1 16 24 DAC39-E09 1-CG32274-RA_1 CG32274 ATTTTCCTGGGAGCGGAAGAATCACATGCCGACTGCCTTTCCGGAAGATATAGGGGTTCCTGTGC 65 FBan0032274 FBgn0052274 Drs-l 3 3L defense response; GO:0006952; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 Drs-l Drosomycin-like "CG11520, CG32274, CG11520, CG11520, CG11520, Dro-1, dro1b, Dro-H, drosomycin-1b, drosomycin-H" CDMC24340 1 17 24 DAC39-E21 1-CG32344-RA_1 CG32344 TGGGACCGACGTTCAGCGCATGGGTAATGTTCTGACAAATCGCCTTCCTCCAATGAAACACTCCC 65 FBan0032344 FBgn0052344 CG32344 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG32344 CG32344 "CG6994, cg6994, DmRH20" CDMC24340 1 18 24 DAC39-E21 1-CG32344-RA_1 CG32344 TGGGACCGACGTTCAGCGCATGGGTAATGTTCTGACAAATCGCCTTCCTCCAATGAAACACTCCC 65 FBan0032344 FBgn0052344 CG32344 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG32344 CG32344 "CG6994, cg6994, DmRH20" CDMC24341 1 19 24 DAC39-I09 20-CG32462-RA_2 CG32462 CTCCCCAGCCAGTAGAGAAATGAGTTCGCTAGAGGGCCTCAACTACTTCTTCACGCGCTTTCAGT 65 FBan0032462 FBgn0052462 CG32462 3 3L CG32462 CG32462 CG8220 CDMC24341 1 20 24 DAC39-I09 20-CG32462-RA_2 CG32462 CTCCCCAGCCAGTAGAGAAATGAGTTCGCTAGAGGGCCTCAACTACTTCTTCACGCGCTTTCAGT 65 FBan0032462 FBgn0052462 CG32462 3 3L CG32462 CG32462 CG8220 CDMC24342 1 21 24 DAC39-I21 2-CG32491-RE_1 CG32491 TACCCTGCCCAAGCTACTGGACGGTAAGTTCTACAAGAACATCCAGCCGAACCAGAAGACGCCAG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24342 1 22 24 DAC39-I21 2-CG32491-RE_1 CG32491 TACCCTGCCCAAGCTACTGGACGGTAAGTTCTACAAGAACATCCAGCCGAACCAGAAGACGCCAG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24343 1 23 24 DAC39-M09 6-CG32541-RA_1 CG32541 CCACGGGCGCGAAACCCAAGAAGAACTTCTGGACCATGAAACCGTGATGCTACAAAAAGGCGCTG 65 FBan0032541 FBgn0052541 CG32541 X X CG32541 CG32541 "CG12527, CG14188, CG12527, CG14188, EP(X)1644, LD15404" CDMC24343 1 24 24 DAC39-M09 6-CG32541-RA_1 CG32541 CCACGGGCGCGAAACCCAAGAAGAACTTCTGGACCATGAAACCGTGATGCTACAAAAAGGCGCTG 65 FBan0032541 FBgn0052541 CG32541 X X CG32541 CG32541 "CG12527, CG14188, CG12527, CG14188, EP(X)1644, LD15404" CDMC24344 1 25 24 DAC39-M21 14-CG32559-RA_1 CG32559 CATGCCGCGTACTGTCCCACAGAATTCCCAGAACTCGCAGAACTCAACGCCAAATCCAGCCACAC 65 FBan0032559 FBgn0052559 CG32559 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32559 CG32559 CDMC24344 1 26 24 DAC39-M21 14-CG32559-RA_1 CG32559 CATGCCGCGTACTGTCCCACAGAATTCCCAGAACTCGCAGAACTCAACGCCAAATCCAGCCACAC 65 FBan0032559 FBgn0052559 CG32559 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32559 CG32559 CDMC24345 1 1 25 DAC40-A09 23-CG41042-RA_1 CG41042 GCACAGCAGAGTTGAAGTTGGACATACCTCGGATAGAGACGATTAAGAGAAACAGGACAACTTAG 65 FBgn0069965 CG41042 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41042 CG41042 CDMC24345 1 2 25 DAC40-A09 23-CG41042-RA_1 CG41042 GCACAGCAGAGTTGAAGTTGGACATACCTCGGATAGAGACGATTAAGAGAAACAGGACAACTTAG 65 FBgn0069965 CG41042 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41042 CG41042 CDMC24346 1 3 25 DAC40-A21 23-CG41104-RA_1 CG41104 CACTGTACAGTGTATTTGTGTGAGTGATGAGATTCTCGCTCCAATAAGCAAAGTGGTGTTGCCAT 65 FBgn0069940 CG41104 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41104 CG41104 CDMC24346 1 4 25 DAC40-A21 23-CG41104-RA_1 CG41104 CACTGTACAGTGTATTTGTGTGAGTGATGAGATTCTCGCTCCAATAAGCAAAGTGGTGTTGCCAT 65 FBgn0069940 CG41104 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41104 CG41104 CDMC24347 1 5 25 DAC40-E09 3-CG4167-RA_1 CG4167 CACTTCCAGTCGTCAAAGGCAGCCTGGAACGACAGGAGCGCATCGTAGACATCCAGCAGATATCG 65 FBan0004167 FBgn0001227 Hsp67Ba 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 Hsp67Ba Heat shock gene 67Ba "CG4167, CG4167, gene 1, Gene 1, gene1, DROHSP1, DROHSP, Hsp-G1" CDMC24347 1 6 25 DAC40-E09 3-CG4167-RA_1 CG4167 CACTTCCAGTCGTCAAAGGCAGCCTGGAACGACAGGAGCGCATCGTAGACATCCAGCAGATATCG 65 FBan0004167 FBgn0001227 Hsp67Ba 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 Hsp67Ba Heat shock gene 67Ba "CG4167, CG4167, gene 1, Gene 1, gene1, DROHSP1, DROHSP, Hsp-G1" CDMC24348 1 7 25 DAC40-E21 2-CG4198-RA_1 CG4198 CAGCTGGATTCGCAGTCCAATTCGAGTAGGTGGCATGAGGTCTCAATGATGCTGTCGTGGTTCGG 65 FBan0004198 FBgn0029753 CG4198 X X CG4198 CG4198 CDMC24348 1 8 25 DAC40-E21 2-CG4198-RA_1 CG4198 CAGCTGGATTCGCAGTCCAATTCGAGTAGGTGGCATGAGGTCTCAATGATGCTGTCGTGGTTCGG 65 FBan0004198 FBgn0029753 CG4198 X X CG4198 CG4198 CDMC24349 1 9 25 DAC40-I09 3-CG4329-RA_3 CG4329 AGCTCATCCGTGACCTGATGAAGGAGATGCAGGACAAGAAGGCCGAGTTCATTGAGTACTGCCGC 65 FBan0004329 FBgn0034745 CG4329 2 2R CG4329 CG4329 anon-WO0140519.244 CDMC24349 1 10 25 DAC40-I09 3-CG4329-RA_3 CG4329 AGCTCATCCGTGACCTGATGAAGGAGATGCAGGACAAGAAGGCCGAGTTCATTGAGTACTGCCGC 65 FBan0004329 FBgn0034745 CG4329 2 2R CG4329 CG4329 anon-WO0140519.244 CDMC24350 1 11 25 DAC40-I21 18-CG4379-RA_2 CG4379 CAGCACAAGCCCACGAAAGACTATTATGCCATGAAGATCCTCGACAAGCAGAAGGTGGTCAAGCT 65 FBan0004379 FBgn0000273 Pka-C1 2 2L "activation of hh target transcription factor; GO:0007228; anterior/posterior pattern formation, imaginal disc; GO:0007448; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; eye development (sensu Endopterygota); GO:0007456; learning; GO:0007612; learning and/or memory; GO:0007611; leg morphogenesis (sensu Endopterygota); GO:0007480; locomotor rhythm; GO:0045475; memory; GO:0007613; negative regulation of smoothened signaling pathway; GO:0045879; olfactory learning; GO:0008355; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; rhythmic behavior; GO:0007622; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 Pka-C1 cAMP-dependent protein kinase 1 "CG4379, CG4379, l(2)cos[[1]], Cos-1, DC0, cos1: costal-1, dco, dcO, PKA, Pka, DCO, Cos, Costal, Cos1, pka, protein kinase A, Dco, Costal-1, pkA, pka-C1, l(2)01272, C: Group C, PKAc, Dc0, PKA-C1, 6353, pKA, Pka-C, Protein Kinase A, PKA Cl, PKAcA, dPKA, pka-c1, CdkA, Dcpk, l(2)s4402, costal-1, cos1" CDMC24350 1 12 25 DAC40-I21 18-CG4379-RA_2 CG4379 CAGCACAAGCCCACGAAAGACTATTATGCCATGAAGATCCTCGACAAGCAGAAGGTGGTCAAGCT 65 FBan0004379 FBgn0000273 Pka-C1 2 2L "activation of hh target transcription factor; GO:0007228; anterior/posterior pattern formation, imaginal disc; GO:0007448; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; eye development (sensu Endopterygota); GO:0007456; learning; GO:0007612; learning and/or memory; GO:0007611; leg morphogenesis (sensu Endopterygota); GO:0007480; locomotor rhythm; GO:0045475; memory; GO:0007613; negative regulation of smoothened signaling pathway; GO:0045879; olfactory learning; GO:0008355; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; rhythmic behavior; GO:0007622; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 Pka-C1 cAMP-dependent protein kinase 1 "CG4379, CG4379, l(2)cos[[1]], Cos-1, DC0, cos1: costal-1, dco, dcO, PKA, Pka, DCO, Cos, Costal, Cos1, pka, protein kinase A, Dco, Costal-1, pkA, pka-C1, l(2)01272, C: Group C, PKAc, Dc0, PKA-C1, 6353, pKA, Pka-C, Protein Kinase A, PKA Cl, PKAcA, dPKA, pka-c1, CdkA, Dcpk, l(2)s4402, costal-1, cos1" CDMC24351 1 13 25 DAC40-M09 18-CG4497-RA_1 CG4497 GGTGGATGATGCCACTCTGATGGACGATGCCAAAAGTGAGACCTCATCGATCGGTGGATGCTCCA 65 FBan0004497 FBgn0031895 CG4497 2 2L CG4497 CG4497 CDMC24351 1 14 25 DAC40-M09 18-CG4497-RA_1 CG4497 GGTGGATGATGCCACTCTGATGGACGATGCCAAAAGTGAGACCTCATCGATCGGTGGATGCTCCA 65 FBan0004497 FBgn0031895 CG4497 2 2L CG4497 CG4497 CDMC24352 1 15 25 DAC40-M21 11-CG4556-RA_3 CG4556 ACTCGCAAGCGAATGAGAGCAATCGGGATCTCCATTCCCTGCTGAGTGAGATATCCCGGCGGAAG 65 FBan0004556 FBgn0027659 eyc 2 2R intracellular protein transport; GO:0006886; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; rhabdomere development; GO:0042052; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 eyc eyes closed "CG4556, l(2)4012" CDMC24352 1 16 25 DAC40-M21 11-CG4556-RA_3 CG4556 ACTCGCAAGCGAATGAGAGCAATCGGGATCTCCATTCCCTGCTGAGTGAGATATCCCGGCGGAAG 65 FBan0004556 FBgn0027659 eyc 2 2R intracellular protein transport; GO:0006886; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; rhabdomere development; GO:0042052; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 eyc eyes closed "CG4556, l(2)4012" CDMC24353 1 17 25 DAC41-A09 14-CG4551-RC_1 CG4551 TGCGAGTGCATGCTGTTGTACAACCACTTGCTCCTGATAATCCCTTCCCCACTCGAAATAGTTGCATCT 69 FBan0004551 FBgn0016930 smi35A 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nervous system development; GO:0007399; olfactory behavior; GO:0042048; protein amino acid phosphorylation; GO:0006468; response to chemical stimulus; GO:0042221 ATP binding; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; NOT protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0005524; ; GO:0004713 ; EC:2.7.1.112; ; GO:0016740 ; EC:2.-.-.- cytosol; GO:0005829 smi35A smell impaired 35A "CG4551, CG4551, CG4551, CG4551, Dyrk2, Dual specificity tyrosine phosphorylation-regulated kinase, BG:DS01523.3, DYRK2, DYRK, dDYRK2, smell impaired 35A" CDMC24353 1 18 25 DAC41-A09 14-CG4551-RC_1 CG4551 TGCGAGTGCATGCTGTTGTACAACCACTTGCTCCTGATAATCCCTTCCCCACTCGAAATAGTTGCATCT 69 FBan0004551 FBgn0016930 smi35A 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nervous system development; GO:0007399; olfactory behavior; GO:0042048; protein amino acid phosphorylation; GO:0006468; response to chemical stimulus; GO:0042221 ATP binding; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; NOT protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0005524; ; GO:0004713 ; EC:2.7.1.112; ; GO:0016740 ; EC:2.-.-.- cytosol; GO:0005829 smi35A smell impaired 35A "CG4551, CG4551, CG4551, CG4551, Dyrk2, Dual specificity tyrosine phosphorylation-regulated kinase, BG:DS01523.3, DYRK2, DYRK, dDYRK2, smell impaired 35A" CDMC24354 1 19 25 DAC41-A21 9-CG4568-RA_1 CG4568 TCAGCACTGGAGGCATTGCATATAAGGAATGGTCAGATTACGAATCCCTCGGGACAAACCCAACAGCGA 69 FBan0004568 FBgn0011596 fzo 3 3R Nebenkern formation; GO:0007287; mitochondrial fusion; GO:0008053; mitochondrion organization and biogenesis; GO:0007005; protein targeting to mitochondrion; GO:0006626; spermatogenesis; GO:0007283 GTP binding; GO:0005525; nucleotide phosphatase activity; GO:0019204; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0019204; ; GO:0005525 integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740; plasma membrane; GO:0005886 fzo fuzzy onions "CG4568, anon-WO0125274.1, anon-WO0125274.25, anon-WO0125274.26" CDMC24354 1 20 25 DAC41-A21 9-CG4568-RA_1 CG4568 TCAGCACTGGAGGCATTGCATATAAGGAATGGTCAGATTACGAATCCCTCGGGACAAACCCAACAGCGA 69 FBan0004568 FBgn0011596 fzo 3 3R Nebenkern formation; GO:0007287; mitochondrial fusion; GO:0008053; mitochondrion organization and biogenesis; GO:0007005; protein targeting to mitochondrion; GO:0006626; spermatogenesis; GO:0007283 GTP binding; GO:0005525; nucleotide phosphatase activity; GO:0019204; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0019204; ; GO:0005525 integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740; plasma membrane; GO:0005886 fzo fuzzy onions "CG4568, anon-WO0125274.1, anon-WO0125274.25, anon-WO0125274.26" CDMC24355 1 21 25 DAC41-E09 8-CG4604-RA_1 CG4604 CCCGACTACTGCCAGGTTCCGGAAAGTACCAGGTGCTATACACAGACTACGAGAACTTCGCCATCTTGT 69 FBan0004604 FBgn0033799 GLaz 2 2R lipid metabolism; GO:0006629; lipid transport; GO:0006869 binding; GO:0005488; carrier activity; GO:0005386; ; GO:0005488; ; GO:0005386 extracellular space; GO:0005615 GLaz Glial Lazarillo "CG4604, Glial Lazarillo" CDMC24355 1 22 25 DAC41-E09 8-CG4604-RA_1 CG4604 CCCGACTACTGCCAGGTTCCGGAAAGTACCAGGTGCTATACACAGACTACGAGAACTTCGCCATCTTGT 69 FBan0004604 FBgn0033799 GLaz 2 2R lipid metabolism; GO:0006629; lipid transport; GO:0006869 binding; GO:0005488; carrier activity; GO:0005386; ; GO:0005488; ; GO:0005386 extracellular space; GO:0005615 GLaz Glial Lazarillo "CG4604, Glial Lazarillo" CDMC24356 1 23 25 DAC41-E21 2-CG4610-RA_2 CG4610 CGGTTATGGCGTGGAGTACGACTTCATAGACCCCCGTGAGTTGTATCCCACACTGGAGACGAAACGAGT 69 FBan0004610 FBgn0034735 CG4610 2 2R CG4610 CG4610 CDMC24356 1 24 25 DAC41-E21 2-CG4610-RA_2 CG4610 CGGTTATGGCGTGGAGTACGACTTCATAGACCCCCGTGAGTTGTATCCCACACTGGAGACGAAACGAGT 69 FBan0004610 FBgn0034735 CG4610 2 2R CG4610 CG4610 CDMC24357 1 25 25 DAC41-I09 14-CG4641-RA_4 CG4641 GGCGAGCTAGCATACCCGAGGAATTGGACTCAAATCAATTGGCACGTTTGCAAAATCTGAAGGAGTCGA 69 FBan0004641 FBgn0035967 CG4641 3 3L CG4641 CG4641 CDMC24357 1 26 25 DAC41-I09 14-CG4641-RA_4 CG4641 GGCGAGCTAGCATACCCGAGGAATTGGACTCAAATCAATTGGCACGTTTGCAAAATCTGAAGGAGTCGA 69 FBan0004641 FBgn0035967 CG4641 3 3L CG4641 CG4641 CDMC24358 1 1 26 DAC41-I21 23-CG4649-RA_6 CG4649 TCTGAATACACACTCTTATCTATAAACCGAATAGTTCTTATTTTTGGAGCCTTGGAGCAATTCCGAGCT 69 FBan0004649 FBgn0022359 Sodh-2 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Sodh-2 Sorbitol dehydrogenase-2 "CG4649, SODH-2, Sdh-2, Sdh, DM_7299382, Sorbitol dehydrogenase-2" CDMC24358 1 2 26 DAC41-I21 23-CG4649-RA_6 CG4649 TCTGAATACACACTCTTATCTATAAACCGAATAGTTCTTATTTTTGGAGCCTTGGAGCAATTCCGAGCT 69 FBan0004649 FBgn0022359 Sodh-2 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Sodh-2 Sorbitol dehydrogenase-2 "CG4649, SODH-2, Sdh-2, Sdh, DM_7299382, Sorbitol dehydrogenase-2" CDMC24359 1 3 26 DAC41-M09 2-CG4676-RA_5 CG4676 TGGTGGCTGTCTTTGTGCCCGTGACATACATCTTCCATGTGACCATTGTTATGCCGGAACTGTTTGCCA 69 FBan0004676 FBgn0033815 CG4676 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG4676 CG4676 CDMC24359 1 4 26 DAC41-M09 2-CG4676-RA_5 CG4676 TGGTGGCTGTCTTTGTGCCCGTGACATACATCTTCCATGTGACCATTGTTATGCCGGAACTGTTTGCCA 69 FBan0004676 FBgn0033815 CG4676 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG4676 CG4676 CDMC24360 1 5 26 DAC41-M21 7-CG4683-RA_1 CG4683 TCGTCGCAATCGTATTGCCCATTGGGTATGTGAACATGTCAAAAGCGGATGCGTACAGGAGAGGGATGA 69 FBan0004683 FBgn0037857 CG4683 3 3R DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; endoribonuclease activity; GO:0004521; ; GO:0004520; endonuclease activity; GO:0004519; ; GO:0004521; ; GO:0004519 CG4683 CG4683 CDMC24360 1 6 26 DAC41-M21 7-CG4683-RA_1 CG4683 TCGTCGCAATCGTATTGCCCATTGGGTATGTGAACATGTCAAAAGCGGATGCGTACAGGAGAGGGATGA 69 FBan0004683 FBgn0037857 CG4683 3 3R DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; endoribonuclease activity; GO:0004521; ; GO:0004520; endonuclease activity; GO:0004519; ; GO:0004521; ; GO:0004519 CG4683 CG4683 CDMC24361 1 7 26 DAC42-A09 150mM NaPO4 Blank CDMC24361 1 8 26 DAC42-A09 150mM NaPO4 Blank CDMC24362 1 9 26 DAC42-A21 150mM NaPO4 Blank CDMC24362 1 10 26 DAC42-A21 150mM NaPO4 Blank CDMC24363 1 11 26 DAC42-E09 150mM NaPO4 Blank CDMC24363 1 12 26 DAC42-E09 150mM NaPO4 Blank CDMC24364 1 13 26 DAC42-E21 150mM NaPO4 Blank CDMC24364 1 14 26 DAC42-E21 150mM NaPO4 Blank CDMC24365 1 15 26 DAC42-I09 150mM NaPO4 Blank CDMC24365 1 16 26 DAC42-I09 150mM NaPO4 Blank CDMC24366 1 17 26 DAC42-I21 5uM MSP 5uM MSP CDMC24366 1 18 26 DAC42-I21 5uM MSP 5uM MSP CDMC24367 1 19 26 DAC42-M09 10uM MSP 10uM MSP CDMC24367 1 20 26 DAC42-M09 10uM MSP 10uM MSP CDMC24368 1 21 26 DAC42-M21 20uM MSP 20uM MSP CDMC24368 1 22 26 DAC42-M21 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC24369 2 1 1 DAC01-B09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24369 2 2 1 DAC01-B09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24370 2 3 1 DAC01-B21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24370 2 4 1 DAC01-B21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24371 2 5 1 DAC01-F09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24371 2 6 1 DAC01-F09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24372 2 7 1 DAC01-F21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24372 2 8 1 DAC01-F21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24373 2 9 1 DAC01-J09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24373 2 10 1 DAC01-J09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24374 2 11 1 DAC01-J21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24374 2 12 1 DAC01-J21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24375 2 13 1 DAC01-N09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24375 2 14 1 DAC01-N09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24376 2 15 1 DAC01-N21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24376 2 16 1 DAC01-N21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24377 2 17 1 DAC02-B09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24377 2 18 1 DAC02-B09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24378 2 19 1 DAC02-B21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24378 2 20 1 DAC02-B21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24379 2 21 1 DAC02-F09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24379 2 22 1 DAC02-F09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24380 2 23 1 DAC02-F21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24380 2 24 1 DAC02-F21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24381 2 25 1 DAC02-J09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24381 2 26 1 DAC02-J09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24382 2 1 2 DAC02-J21 N/A CG9075 (01435-01673) CDMC24382 2 2 2 DAC02-J21 N/A CG9075 (01435-01673) CDMC24383 2 3 2 DAC02-N09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24383 2 4 2 DAC02-N09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24384 2 5 2 DAC02-N21 AutoBlank AutoBlank CDMC24384 2 6 2 DAC02-N21 AutoBlank AutoBlank CDMC24385 2 7 2 DAC03-B09 2-CG3795-RA_1 CG3795 CTGATTCGGCTGGGATCTACACCGATGTCTACCACTTCCGGGATTGGATCACCGAGAACTCCTGC 65 FBan0003795 FBgn0025378 CG3795 X X proteolysis; GO:0006508; transport; GO:0006810 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; transporter activity; GO:0005215; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0005215; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 membrane; GO:0016020 CG3795 CG3795 "EG:9D2.4, SP160, BcDNA:GH24985" CDMC24385 2 8 2 DAC03-B09 2-CG3795-RA_1 CG3795 CTGATTCGGCTGGGATCTACACCGATGTCTACCACTTCCGGGATTGGATCACCGAGAACTCCTGC 65 FBan0003795 FBgn0025378 CG3795 X X proteolysis; GO:0006508; transport; GO:0006810 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; transporter activity; GO:0005215; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0005215; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 membrane; GO:0016020 CG3795 CG3795 "EG:9D2.4, SP160, BcDNA:GH24985" CDMC24386 2 9 2 DAC03-B21 11-CG3829-RA_2 CG3829 AGGACGACATCACCAAGTTCAGCATCATTACCCAGTTTAACGGCATGCCCCAGTTGGACTACTGG 65 FBan0003829 FBgn0035091 CG3829 2 2R apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG3829 CG3829 CDMC24386 2 10 2 DAC03-B21 11-CG3829-RA_2 CG3829 AGGACGACATCACCAAGTTCAGCATCATTACCCAGTTTAACGGCATGCCCCAGTTGGACTACTGG 65 FBan0003829 FBgn0035091 CG3829 2 2R apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG3829 CG3829 CDMC24387 2 11 2 DAC03-F09 1-CG3953-RA_1 CG3953 GCACTGGGATTCTCCGTGAGCTTGTACGCATTCTTTAGGGACGATGATGGAAAACCCCGAACGCC 65 FBan0003953 FBgn0002478 l(3)IX-14 3 3R cell adhesion; GO:0007155; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 membrane; GO:0016020 l(3)IX-14 lethal (3) IX-14 "CG3953, l(3)SG34" CDMC24387 2 12 2 DAC03-F09 1-CG3953-RA_1 CG3953 GCACTGGGATTCTCCGTGAGCTTGTACGCATTCTTTAGGGACGATGATGGAAAACCCCGAACGCC 65 FBan0003953 FBgn0002478 l(3)IX-14 3 3R cell adhesion; GO:0007155; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 membrane; GO:0016020 l(3)IX-14 lethal (3) IX-14 "CG3953, l(3)SG34" CDMC24388 2 13 2 DAC03-F21 18-CG3982-RA_3 CG3982 TTGCAGGATGTCGATGAGGCTTTTCTGGCATCCAACATTTTTGCTCGACCGTCCCGTGTCCGCCA 65 FBan0003982 FBgn0035988 CG3982 3 3L CG3982 CG3982 bs12d10.y1 CDMC24388 2 14 2 DAC03-F21 18-CG3982-RA_3 CG3982 TTGCAGGATGTCGATGAGGCTTTTCTGGCATCCAACATTTTTGCTCGACCGTCCCGTGTCCGCCA 65 FBan0003982 FBgn0035988 CG3982 3 3L CG3982 CG3982 bs12d10.y1 CDMC24389 2 15 2 DAC03-J09 24-CG40137-RA_2 CG40137 CGATCGGTGACTATAGTTTAGAACTAAGTAATACAAAGAAAGAAATCTTAAGATTACCCTATCTC 65 FBgn0063919 Max-element Max-element Max-element "CG17588, CG14768, CG40437, CG40213, CG40137, CG40134, CG40462, CG40326, CG40077, CG17588, CG17588, CG14768, CG14768, CG17588, CG14768, CG40437, CG17588, CG40213, Max, BcDNA:GH06606" CDMC24389 2 16 2 DAC03-J09 24-CG40137-RA_2 CG40137 CGATCGGTGACTATAGTTTAGAACTAAGTAATACAAAGAAAGAAATCTTAAGATTACCCTATCTC 65 FBgn0063919 Max-element Max-element Max-element "CG17588, CG14768, CG40437, CG40213, CG40137, CG40134, CG40462, CG40326, CG40077, CG17588, CG17588, CG14768, CG14768, CG17588, CG14768, CG40437, CG17588, CG40213, Max, BcDNA:GH06606" CDMC24390 2 17 2 DAC03-J21 1-CG40192-RA_1 CG40192 GTACAAGGTCCACATATTGTGCCGTTACTTCTCGGTGCGTCCTCTTTGCGTCCTCCACGGCCTAC 65 FBgn0058192 CG40192 CG40192 CG40192 CDMC24390 2 18 2 DAC03-J21 1-CG40192-RA_1 CG40192 GTACAAGGTCCACATATTGTGCCGTTACTTCTCGGTGCGTCCTCTTTGCGTCCTCCACGGCCTAC 65 FBgn0058192 CG40192 CG40192 CG40192 CDMC24391 2 19 2 DAC03-N09 1-CG40373-RA_1 CG40373 GTTCCCGTACTGGTCCCGTACTCGGTCCTCTCGTACTCGGTCCCGTACTAATCTCGTACTCGGTC 65 FBgn0058373 CG40373 CG40373 CG40373 CDMC24391 2 20 2 DAC03-N09 1-CG40373-RA_1 CG40373 GTTCCCGTACTGGTCCCGTACTCGGTCCTCTCGTACTCGGTCCCGTACTAATCTCGTACTCGGTC 65 FBgn0058373 CG40373 CG40373 CG40373 CDMC24392 2 21 2 DAC03-N21 3-CG4042-RA_2 CG4042 ATCGTGATGATGCAGAAGCCCATCGATCTAAGTCCGCGGAACATTCGACAGTGGTGGGAGAACCG 65 FBan0004042 FBgn0037018 CG4042 3 3L CG4042 CG4042 CDMC24392 2 22 2 DAC03-N21 3-CG4042-RA_2 CG4042 ATCGTGATGATGCAGAAGCCCATCGATCTAAGTCCGCGGAACATTCGACAGTGGTGGGAGAACCG 65 FBan0004042 FBgn0037018 CG4042 3 3L CG4042 CG4042 CDMC24393 2 23 2 DAC04-B09 23-CG31515-RA_11 CG31515 AAAGGTTAAAATACGAGAGTCCGATATACGACGTATAACAAAGATGGGAAGCTACAAGGTACGCCAAGG 69 FBan0031515 FBgn0051515 CG31515 3 3R CG31515 CG31515 CDMC24393 2 24 2 DAC04-B09 23-CG31515-RA_11 CG31515 AAAGGTTAAAATACGAGAGTCCGATATACGACGTATAACAAAGATGGGAAGCTACAAGGTACGCCAAGG 69 FBan0031515 FBgn0051515 CG31515 3 3R CG31515 CG31515 CDMC24394 2 25 2 DAC04-B21 23-CG31523-RA_12 CG31523 GTTAAGTGATTAGCGTGTAACTGAACCAGATTGAAGAACAAGACGAGCAAGAAACTTGGCAGAAGTAGC 69 FBan0031523 FBgn0051523 CG31523 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; copper ion binding; GO:0005507; ; GO:0005507 integral to membrane; GO:0016021 CG31523 CG31523 CG9798 CDMC24394 2 26 2 DAC04-B21 23-CG31523-RA_12 CG31523 GTTAAGTGATTAGCGTGTAACTGAACCAGATTGAAGAACAAGACGAGCAAGAAACTTGGCAGAAGTAGC 69 FBan0031523 FBgn0051523 CG31523 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; copper ion binding; GO:0005507; ; GO:0005507 integral to membrane; GO:0016021 CG31523 CG31523 CG9798 CDMC24395 2 1 3 DAC04-F09 15-CG31550-RA_5 CG31550 GGCAGCCGGATCTAAGCGACTACAAGGAGTACAAACTAAAGGAGGACAACATTGGCTTCCAAATGCTGC 69 FBan0031550 FBgn0051550 CG31550 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG31550 CG31550 "CG12167, CG12168" CDMC24395 2 2 3 DAC04-F09 15-CG31550-RA_5 CG31550 GGCAGCCGGATCTAAGCGACTACAAGGAGTACAAACTAAAGGAGGACAACATTGGCTTCCAAATGCTGC 69 FBan0031550 FBgn0051550 CG31550 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG31550 CG31550 "CG12167, CG12168" CDMC24396 2 3 3 DAC04-F21 15-CG31562-RA_1 CG31562 TGATGAGGAAAATTCAACCACAGTCCTCCCCGTTGACTTCCAGTTCAATACTTGGACATCTCCGGCAGT 69 FBan0031562 FBgn0051562 CG31562 3 3R CG31562 CG31562 "CG15587, CG15588" CDMC24396 2 4 3 DAC04-F21 15-CG31562-RA_1 CG31562 TGATGAGGAAAATTCAACCACAGTCCTCCCCGTTGACTTCCAGTTCAATACTTGGACATCTCCGGCAGT 69 FBan0031562 FBgn0051562 CG31562 3 3R CG31562 CG31562 "CG15587, CG15588" CDMC24397 2 5 3 DAC04-J09 11-CG31629-RB_1 CG31629 ACGTCGAAAGCAACGGAACCCAATGATGCCAAATCGGAGGATAATGATGTGAGTGAATCCAAGGGGGAT 69 FBan0031629 FBgn0031889 Pvf3 2 2L cellular physiological process; GO:0050875; hemocyte migration (sensu Arthropoda); GO:0035099 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf3 PDGF- and VEGF-related factor 3 "CG13782, CG13781, CG4492, CG31629, CG13782, CG13781, CG13782, CG4492, DmVEGF-3, Vegf27Ca, VEGF27Ca, PVF, PVFs, VEGF" CDMC24397 2 6 3 DAC04-J09 11-CG31629-RB_1 CG31629 ACGTCGAAAGCAACGGAACCCAATGATGCCAAATCGGAGGATAATGATGTGAGTGAATCCAAGGGGGAT 69 FBan0031629 FBgn0031889 Pvf3 2 2L cellular physiological process; GO:0050875; hemocyte migration (sensu Arthropoda); GO:0035099 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf3 PDGF- and VEGF-related factor 3 "CG13782, CG13781, CG4492, CG31629, CG13782, CG13781, CG13782, CG4492, DmVEGF-3, Vegf27Ca, VEGF27Ca, PVF, PVFs, VEGF" CDMC24398 2 7 3 DAC04-J21 23-CG31639-RB_5 CG31639 GGCCAAAACAGCACTGAAAATCTCTGAATAAAAATTCACTATCCAAATTCCAAGTTAACACCTTAAGTT 69 FBan0031639 FBgn0051639 CG31639 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31639 CG31639 "NEST:bs29d12, NEST:bs21c05" CDMC24398 2 8 3 DAC04-J21 23-CG31639-RB_5 CG31639 GGCCAAAACAGCACTGAAAATCTCTGAATAAAAATTCACTATCCAAATTCCAAGTTAACACCTTAAGTT 69 FBan0031639 FBgn0051639 CG31639 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31639 CG31639 "NEST:bs29d12, NEST:bs21c05" CDMC24399 2 9 3 DAC04-N09 3-CG31662-RA_4 CG31662 AGGCGCCTGAATCGTTCCAAGTGGCTTTTGGCATATGGCTTGGTGCTGAACCTTACTCTGCTGGTTTTA 69 FBan0031662 FBgn0045501 Gr22a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr22a Gustatory receptor 22a "CG31662, Gr2940.5, Gustatory receptor 2940.5, Gustatory receptor 22a" CDMC24399 2 10 3 DAC04-N09 3-CG31662-RA_4 CG31662 AGGCGCCTGAATCGTTCCAAGTGGCTTTTGGCATATGGCTTGGTGCTGAACCTTACTCTGCTGGTTTTA 69 FBan0031662 FBgn0045501 Gr22a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr22a Gustatory receptor 22a "CG31662, Gr2940.5, Gustatory receptor 2940.5, Gustatory receptor 22a" CDMC24400 2 11 3 DAC04-N21 9-CG31673-RA_1 CG31673 AGGTCCCAATGGAAAATCGAGCAGATCAACTGGATGATGGGTCAAGAGATTCGCGATTCCGTCATCGGT 69 FBan0031673 FBgn0051673 CG31673 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 glyoxylate reductase (NADP) activity; GO:0030267 ; EC:1.1.1.79; ; GO:0030267 ; EC:1.1.1.79 CG31673 CG31673 "CG9332, CG9332, BcDNA:LD14730" CDMC24400 2 12 3 DAC04-N21 9-CG31673-RA_1 CG31673 AGGTCCCAATGGAAAATCGAGCAGATCAACTGGATGATGGGTCAAGAGATTCGCGATTCCGTCATCGGT 69 FBan0031673 FBgn0051673 CG31673 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 glyoxylate reductase (NADP) activity; GO:0030267 ; EC:1.1.1.79; ; GO:0030267 ; EC:1.1.1.79 CG31673 CG31673 "CG9332, CG9332, BcDNA:LD14730" CDMC24401 2 13 3 DAC05-B09 22-CG5969-RA_2 CG5969 GGTTCCAAGGGCTCCAAAACGGACTAATCCTCATCTACCCCGGACTGTTACCCTATTTCCATTAACTTT 69 FBgn0052426 CDMC24401 2 14 3 DAC05-B09 22-CG5969-RA_2 CG5969 GGTTCCAAGGGCTCCAAAACGGACTAATCCTCATCTACCCCGGACTGTTACCCTATTTCCATTAACTTT 69 FBgn0052426 CDMC24402 2 15 3 DAC05-B21 2-CG5988-RA_1 CG5988 GCGCTATATGCTCTGCGAGATCGAGTTGACCATAAACGCCTCCTATCCGAACAGCAATGGTGCGAAGCT 69 FBan0005988 FBgn0030904 upd2 X X upd2 unpaired 2 "CG5988, CG5988, CG5988, CG5988, CG5988, cg5988, Upd2, unpaired 2" CDMC24402 2 16 3 DAC05-B21 2-CG5988-RA_1 CG5988 GCGCTATATGCTCTGCGAGATCGAGTTGACCATAAACGCCTCCTATCCGAACAGCAATGGTGCGAAGCT 69 FBan0005988 FBgn0030904 upd2 X X upd2 unpaired 2 "CG5988, CG5988, CG5988, CG5988, CG5988, cg5988, Upd2, unpaired 2" CDMC24403 2 17 3 DAC05-F09 17-CG6027-RA_2 CG6027 ATTGTACAGATGATCCCGGATCGATTTGAGAAGCAAGAACACTTATCATTGGCCAATCCCGTTCGGCTT 69 FBan0006027 FBgn0004876 cdi 3 3R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; embryonic development (sensu Insecta); GO:0001700; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hormone activity; GO:0005179; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005179; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112 extracellular region; GO:0005576 cdi center divider "CG6027, CG6027, CG6027, CG6027, CG6027, 91F, 91F gene, l(3)07013, B9.3, CDI/TSKI, Cdi, cdi/TESK1, central divider, center divider" CDMC24403 2 18 3 DAC05-F09 17-CG6027-RA_2 CG6027 ATTGTACAGATGATCCCGGATCGATTTGAGAAGCAAGAACACTTATCATTGGCCAATCCCGTTCGGCTT 69 FBan0006027 FBgn0004876 cdi 3 3R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; embryonic development (sensu Insecta); GO:0001700; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hormone activity; GO:0005179; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005179; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112 extracellular region; GO:0005576 cdi center divider "CG6027, CG6027, CG6027, CG6027, CG6027, 91F, 91F gene, l(3)07013, B9.3, CDI/TSKI, Cdi, cdi/TESK1, central divider, center divider" CDMC24404 2 19 3 DAC05-F21 11-CG6041-RA_1 CG6041 CGGTGCCCATAGTGTCGTATACAACCTGTCGCATTTCATACAATTCGATTCCGGTTTCCCAGGTGTGCG 69 FBan0006041 FBgn0029826 CG6041 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 CG6041 CG6041 SP86 CDMC24404 2 20 3 DAC05-F21 11-CG6041-RA_1 CG6041 CGGTGCCCATAGTGTCGTATACAACCTGTCGCATTTCATACAATTCGATTCCGGTTTCCCAGGTGTGCG 69 FBan0006041 FBgn0029826 CG6041 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 CG6041 CG6041 SP86 CDMC24405 2 21 3 DAC05-J09 6-CG6069-RA_3 CG6069 TCGGGTCACACTGCATCGACACCTCTAGGCCCGGCATGTACACCAACATCAGAAGAGTAAAACGATTCA 69 FBan0006069 FBgn0039418 CG6069 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG6069 CG6069 SPH192 CDMC24405 2 22 3 DAC05-J09 6-CG6069-RA_3 CG6069 TCGGGTCACACTGCATCGACACCTCTAGGCCCGGCATGTACACCAACATCAGAAGAGTAAAACGATTCA 69 FBan0006069 FBgn0039418 CG6069 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG6069 CG6069 SPH192 CDMC24406 2 23 3 DAC05-J21 16-CG6083-RA_1 CG6083 GAGCAGCAGATGAATAGACTTCTCAGTGTGGCCAAGCTTAAACCGGTAGTTCTTCAAATCGAGTGCCAC 69 FBan0006083 FBgn0036183 CG6083 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG6083 CG6083 CDMC24406 2 24 3 DAC05-J21 16-CG6083-RA_1 CG6083 GAGCAGCAGATGAATAGACTTCTCAGTGTGGCCAAGCTTAAACCGGTAGTTCTTCAAATCGAGTGCCAC 69 FBan0006083 FBgn0036183 CG6083 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG6083 CG6083 CDMC24407 2 25 3 DAC05-N09 15-CG6129-RB_1 CG6129 CCCGCCAAGAAGACGTAACGCTCACTGCCATTTGCATTTATTTAGAAAAAGGCTTCCTGGAGTCCTCCA 69 FBan0006129 FBgn0039152 CG6129 3 3R ciliary rootlet; GO:0035253 CG6129 CG6129 CDMC24407 2 26 3 DAC05-N09 15-CG6129-RB_1 CG6129 CCCGCCAAGAAGACGTAACGCTCACTGCCATTTGCATTTATTTAGAAAAAGGCTTCCTGGAGTCCTCCA 69 FBan0006129 FBgn0039152 CG6129 3 3R ciliary rootlet; GO:0035253 CG6129 CG6129 CDMC24408 2 1 4 DAC05-N21 3-CG6139-RB_1 CG6139 CGCGGCAATTCCAACAAATGTGCGTCAAAATCCGTGTTTAAATCGCAAGCACCACGCAAGCAAGCATCT 69 FBgn0033852 CDMC24408 2 2 4 DAC05-N21 3-CG6139-RB_1 CG6139 CGCGGCAATTCCAACAAATGTGCGTCAAAATCCGTGTTTAAATCGCAAGCACCACGCAAGCAAGCATCT 69 FBgn0033852 CDMC24409 2 3 4 DAC06-B09 6-CG11518-RA_1 CG11518 TGTGTGAGCGTCTGCATGTGAAGCGATCGAAGAGGACAACGTCGCAACAAGAAGACGGAATGAAAGCTG 69 FBan0011518 FBgn0043900 pygo 3 3R "Wnt receptor signaling pathway; GO:0016055; embryonic pattern specification; GO:0009880; eye-antennal disc development; GO:0035214; frizzled-2 signaling pathway; GO:0007223; positive regulation of Wnt receptor signaling pathway; GO:0030177; regulation of transcription, DNA-dependent; GO:0006355; tRNA aminoacylation for protein translation; GO:0006418; transcription, DNA-dependent; GO:0006351" DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; protein binding; GO:0005515; ; GO:0005515; ; GO:0004812 ; EC:6.1.1.-; ; GO:0003677 nucleus; GO:0005634 pygo pygopus "CG11518, CG11518, pNB5.2, BEST:LD21971, gam, gammy legs, Pygo, anon-WO02077023.1, pygopus" CDMC24409 2 4 4 DAC06-B09 6-CG11518-RA_1 CG11518 TGTGTGAGCGTCTGCATGTGAAGCGATCGAAGAGGACAACGTCGCAACAAGAAGACGGAATGAAAGCTG 69 FBan0011518 FBgn0043900 pygo 3 3R "Wnt receptor signaling pathway; GO:0016055; embryonic pattern specification; GO:0009880; eye-antennal disc development; GO:0035214; frizzled-2 signaling pathway; GO:0007223; positive regulation of Wnt receptor signaling pathway; GO:0030177; regulation of transcription, DNA-dependent; GO:0006355; tRNA aminoacylation for protein translation; GO:0006418; transcription, DNA-dependent; GO:0006351" DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; protein binding; GO:0005515; ; GO:0005515; ; GO:0004812 ; EC:6.1.1.-; ; GO:0003677 nucleus; GO:0005634 pygo pygopus "CG11518, CG11518, pNB5.2, BEST:LD21971, gam, gammy legs, Pygo, anon-WO02077023.1, pygopus" CDMC24410 2 5 4 DAC06-B21 2-CG11546-RA_2 CG11546 TGCTTTGACATATCCGAGAAGGACATTCTCTTCTGCACCCTCAACTCGCACAAGGTGGACATGACGCGT 69 FBan0011546 FBgn0010504 l(2)02045 2 2R regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 protein binding; GO:0005515; regulator of G-protein signaling activity; GO:0016299; ; GO:0005515; ; GO:0016299 l(2)02045 lethal (2) 02045 "CG11546, LD04728, BEST:LD04728" CDMC24410 2 6 4 DAC06-B21 2-CG11546-RA_2 CG11546 TGCTTTGACATATCCGAGAAGGACATTCTCTTCTGCACCCTCAACTCGCACAAGGTGGACATGACGCGT 69 FBan0011546 FBgn0010504 l(2)02045 2 2R regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 protein binding; GO:0005515; regulator of G-protein signaling activity; GO:0016299; ; GO:0005515; ; GO:0016299 l(2)02045 lethal (2) 02045 "CG11546, LD04728, BEST:LD04728" CDMC24411 2 7 4 DAC06-F09 2-CG11588-RA_1 CG11588 GCTTCTGCGCGAATGGTCAGAGTTACCTCCAATGCCATTTTGGTTACATCCGACCTCCACATGGAGCAC 69 FBan0011588 FBgn0036221 CG11588 3 3L CG11588 CG11588 CDMC24411 2 8 4 DAC06-F09 2-CG11588-RA_1 CG11588 GCTTCTGCGCGAATGGTCAGAGTTACCTCCAATGCCATTTTGGTTACATCCGACCTCCACATGGAGCAC 69 FBan0011588 FBgn0036221 CG11588 3 3L CG11588 CG11588 CDMC24412 2 9 4 DAC06-F21 2-CG11596-RB_1 CG11596 GCACCGGCATCCGTACCAAGTACGCACAGAACCCGTCTTCAATGAAACAGAGCGAGTACCAGAGTCTTT 69 FBan0011596 FBgn0023522 CG11596 X X CG11596 CG11596 EG:39E1.1 CDMC24412 2 10 4 DAC06-F21 2-CG11596-RB_1 CG11596 GCACCGGCATCCGTACCAAGTACGCACAGAACCCGTCTTCAATGAAACAGAGCGAGTACCAGAGTCTTT 69 FBan0011596 FBgn0023522 CG11596 X X CG11596 CG11596 EG:39E1.1 CDMC24413 2 11 4 DAC06-J09 23-CG1163-RA_3 CG1163 ACGCCGCACTTTACTATTTAATTTCGATTAAAACAATAGAAAAGCAGTGATGGATGATGCGGACTACGA 69 FBan0001163 FBgn0003275 RpII18 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII18 RNA polymerase II 18kD subunit "CG1163, CG1163, RNA polymerase II, RNApolII, Dm6, RNAP II, polII, H5, RNA polII, RNA pol II, RNA Pol II, Pol II, PolII, RNAP, BcDNA:RH21608, RpABC14, RNA-polymerase ABC 14kD subunit" CDMC24413 2 12 4 DAC06-J09 23-CG1163-RA_3 CG1163 ACGCCGCACTTTACTATTTAATTTCGATTAAAACAATAGAAAAGCAGTGATGGATGATGCGGACTACGA 69 FBan0001163 FBgn0003275 RpII18 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII18 RNA polymerase II 18kD subunit "CG1163, CG1163, RNA polymerase II, RNApolII, Dm6, RNAP II, polII, H5, RNA polII, RNA pol II, RNA Pol II, Pol II, PolII, RNAP, BcDNA:RH21608, RpABC14, RNA-polymerase ABC 14kD subunit" CDMC24414 2 13 4 DAC06-J21 16-CG11656-RA_1 CG11656 TCGGGCCCATAAGGAAAACAAGGAAAGCAAAATCGAGGAGTTCCAAGAAGAACAATAGTAAGGCCTCCT 69 FBan0011656 FBgn0038109 CG11656 3 3R CG11656 CG11656 anon-WO0140519.199 CDMC24414 2 14 4 DAC06-J21 16-CG11656-RA_1 CG11656 TCGGGCCCATAAGGAAAACAAGGAAAGCAAAATCGAGGAGTTCCAAGAAGAACAATAGTAAGGCCTCCT 69 FBan0011656 FBgn0038109 CG11656 3 3R CG11656 CG11656 anon-WO0140519.199 CDMC24415 2 15 4 DAC06-N09 17-CG11709-RA_4 CG11709 GGGCTTTTTGCTTGTCGCTTCGCAAATGTGATGCAAAACAAAAAGAACCGAACAAAGAACGCGGAGATT 69 FBan0011709 FBgn0030310 PGRP-SA X X "Toll signaling pathway; GO:0008063; anti-Gram-positive bacterial polypeptide induction; GO:0006965; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; regulation of Toll signaling pathway; GO:0008592; response to pest, pathogen or parasite; GO:0009613" peptidoglycan receptor activity; GO:0016019; ; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; ; GO:0016019; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SA Peptidoglycan recognition protein SA "CG11709, CG11709, CG11709, CG11709, CG11709, seml, semmelweis, semmelweiss, SEMMELWEIS, BcDNA:AT30827" CDMC24415 2 16 4 DAC06-N09 17-CG11709-RA_4 CG11709 GGGCTTTTTGCTTGTCGCTTCGCAAATGTGATGCAAAACAAAAAGAACCGAACAAAGAACGCGGAGATT 69 FBan0011709 FBgn0030310 PGRP-SA X X "Toll signaling pathway; GO:0008063; anti-Gram-positive bacterial polypeptide induction; GO:0006965; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253; regulation of Toll signaling pathway; GO:0008592; response to pest, pathogen or parasite; GO:0009613" peptidoglycan receptor activity; GO:0016019; ; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; pattern recognition receptor activity; GO:0008329; peptidoglycan binding; GO:0042834; ; GO:0008329; ; GO:0042834; ; GO:0016019; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SA Peptidoglycan recognition protein SA "CG11709, CG11709, CG11709, CG11709, CG11709, seml, semmelweis, semmelweiss, SEMMELWEIS, BcDNA:AT30827" CDMC24416 2 17 4 DAC06-N21 24-CG11720-RA_1 CG11720 ACTACGCTTTGTTTTTGTTATCATCAATTGATTTTACGTGTAAGAATTAATAAAATTAGTTAGACTGCA 69 FBan0011720 FBgn0003373 Sgs3 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs3 Salivary gland secretion 3 "CG11720, SGS-3, 68C GII, Gene IV, group IV, Sgs-3, sgs3, sgs-3, DMSGS378, SGS378, Sgs" CDMC24416 2 18 4 DAC06-N21 24-CG11720-RA_1 CG11720 ACTACGCTTTGTTTTTGTTATCATCAATTGATTTTACGTGTAAGAATTAATAAAATTAGTTAGACTGCA 69 FBan0011720 FBgn0003373 Sgs3 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs3 Salivary gland secretion 3 "CG11720, SGS-3, 68C GII, Gene IV, group IV, Sgs-3, sgs3, sgs-3, DMSGS378, SGS378, Sgs" CDMC24417 2 19 4 DAC07-B09 18-CG14992-RA_2 CG14992 TGTATGCCAGCAAGGATATGGTGTATAAGCAGAATCTCACACCCTTAAAGAACGGTGCAGCACCC 65 FBan0014992 FBgn0028484 Ack 3 3L defense response; GO:0006952; intracellular signaling cascade; GO:0007242; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; SH2 domain binding; GO:0042169; ; GO:0042169 cytoplasm; GO:0005737 Ack Ack "CG14992, CG14992, DACK, ACK, ACK2, dACK, p145, DAck, BcDNA:GH10777" CDMC24417 2 20 4 DAC07-B09 18-CG14992-RA_2 CG14992 TGTATGCCAGCAAGGATATGGTGTATAAGCAGAATCTCACACCCTTAAAGAACGGTGCAGCACCC 65 FBan0014992 FBgn0028484 Ack 3 3L defense response; GO:0006952; intracellular signaling cascade; GO:0007242; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; SH2 domain binding; GO:0042169; ; GO:0042169 cytoplasm; GO:0005737 Ack Ack "CG14992, CG14992, DACK, ACK, ACK2, dACK, p145, DAck, BcDNA:GH10777" CDMC24418 2 21 4 DAC07-B21 3-CG15025-RA_1 CG15025 TCAATGCCAAACCTGGTGAAGCCGAAGAGGTTAAAGGGGAAAAGGAAGGTCCTACTGGCAACGCC 65 FBan0015025 FBgn0038709 CG15025 3 3R CG15025 CG15025 CDMC24418 2 22 4 DAC07-B21 3-CG15025-RA_1 CG15025 TCAATGCCAAACCTGGTGAAGCCGAAGAGGTTAAAGGGGAAAAGGAAGGTCCTACTGGCAACGCC 65 FBan0015025 FBgn0038709 CG15025 3 3R CG15025 CG15025 CDMC24419 2 23 4 DAC07-F09 3-CG15098-RA_1 CG15098 TATCTCTACTACGGCATCTACTCGCTCTTCAAGCAGATCCAGGCATCCCGTGAGATCCAGCGCCC 65 FBan0015098 FBgn0034398 CG15098 2 2R CG15098 CG15098 CDMC24419 2 24 4 DAC07-F09 3-CG15098-RA_1 CG15098 TATCTCTACTACGGCATCTACTCGCTCTTCAAGCAGATCCAGGCATCCCGTGAGATCCAGCGCCC 65 FBan0015098 FBgn0034398 CG15098 2 2R CG15098 CG15098 CDMC24420 2 25 4 DAC07-F21 2-CG15133-RA_5 CG15133 AAAGGAGGACCAAGCGCTATCCATGTACGAGACAAACTTCCGTGGATGTACCCTATGCCCGCCTG 65 FBan0015133 FBgn0032619 CG15133 2 2L CG15133 CG15133 CDMC24420 2 26 4 DAC07-F21 2-CG15133-RA_5 CG15133 AAAGGAGGACCAAGCGCTATCCATGTACGAGACAAACTTCCGTGGATGTACCCTATGCCCGCCTG 65 FBan0015133 FBgn0032619 CG15133 2 2L CG15133 CG15133 CDMC24421 2 1 5 DAC07-J09 17-CG15204-RA_1 CG15204 CAGGATGACCTGCAGAATGCCCTGGACTCGGACAGCAACGAGAGTACCGACTACCGTCACCAGCG 65 FBan0015204 FBgn0030256 CG15204 X X CG15204 CG15204 CDMC24421 2 2 5 DAC07-J09 17-CG15204-RA_1 CG15204 CAGGATGACCTGCAGAATGCCCTGGACTCGGACAGCAACGAGAGTACCGACTACCGTCACCAGCG 65 FBan0015204 FBgn0030256 CG15204 X X CG15204 CG15204 CDMC24422 2 3 5 DAC07-J21 10-CG15245-RA_1 CG15245 CTGATCTTCTACAATCCGCATACCAAGCCACTCACCAGTCAGCTCCTCGTGTCCCGCAGGCTCAC 65 FBan0015245 FBgn0040936 CG15245 X X CG15245 CG15245 CDMC24422 2 4 5 DAC07-J21 10-CG15245-RA_1 CG15245 CTGATCTTCTACAATCCGCATACCAAGCCACTCACCAGTCAGCTCCTCGTGTCCCGCAGGCTCAC 65 FBan0015245 FBgn0040936 CG15245 X X CG15245 CG15245 CDMC24423 2 5 5 DAC07-N09 6-CG15343-RA_1 CG15343 CAGACCGGGTGCAGTACCGCCTTCAGAAGGATGGGAAATGGAAATCCATGCACGTGTCCACCTAA 65 FBan0015343 FBgn0030029 CG15343 X X pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 CG15343 CG15343 CDMC24423 2 6 5 DAC07-N09 6-CG15343-RA_1 CG15343 CAGACCGGGTGCAGTACCGCCTTCAGAAGGATGGGAAATGGAAATCCATGCACGTGTCCACCTAA 65 FBan0015343 FBgn0030029 CG15343 X X pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 CG15343 CG15343 CDMC24424 2 7 5 DAC07-N21 19-CG15361-RA_3 CG15361 GCTCTGGCTGTTCCCGCTCCAGTTGCCCGTGCCAATCCCGCCCCAATCCCGATTGCCAGCCCCGA 65 FBan0015361 FBgn0040717 Nplp4 2 2L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp4 Neuropeptide-like precursor 4 "CG15361, CG15361, CG15361, NPLP4, YSY peptide, neuropeptide-like precursor 4, Neuropeptide-like precursor 4" CDMC24424 2 8 5 DAC07-N21 19-CG15361-RA_3 CG15361 GCTCTGGCTGTTCCCGCTCCAGTTGCCCGTGCCAATCCCGCCCCAATCCCGATTGCCAGCCCCGA 65 FBan0015361 FBgn0040717 Nplp4 2 2L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp4 Neuropeptide-like precursor 4 "CG15361, CG15361, CG15361, NPLP4, YSY peptide, neuropeptide-like precursor 4, Neuropeptide-like precursor 4" CDMC24425 2 9 5 DAC08-B09 3-CG14446-RA_1 CG14446 AGCAATCCGATTGTCAACTACGACAATGGACGCCGTGTTAGCTCCTTTGACCAACAGCCCAAGCTG 66 FBan0014446 FBgn0029850 CG14446 X X CG14446 CG14446 CDMC24425 2 10 5 DAC08-B09 3-CG14446-RA_1 CG14446 AGCAATCCGATTGTCAACTACGACAATGGACGCCGTGTTAGCTCCTTTGACCAACAGCCCAAGCTG 66 FBan0014446 FBgn0029850 CG14446 X X CG14446 CG14446 CDMC24426 2 11 5 DAC08-B21 14-CG14516-RA_2 CG14516 GAAAACTGGATGGCGATCACAGAACACCTGATGGATGTGGACAACTTTGAGGACATTGCTCCTGCG 66 FBan0014516 FBgn0039640 CG14516 3 3R proteolysis; GO:0006508 receptor activity; GO:0004872; zinc ion binding; GO:0008270; ; GO:0004872; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG14516 CG14516 CDMC24426 2 12 5 DAC08-B21 14-CG14516-RA_2 CG14516 GAAAACTGGATGGCGATCACAGAACACCTGATGGATGTGGACAACTTTGAGGACATTGCTCCTGCG 66 FBan0014516 FBgn0039640 CG14516 3 3R proteolysis; GO:0006508 receptor activity; GO:0004872; zinc ion binding; GO:0008270; ; GO:0004872; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG14516 CG14516 CDMC24427 2 13 5 DAC08-F09 2-CG14743-RA_1 CG14743 TCCTCTTCAGCGAGTTCCTCCAAGCCATCAATCCGATCGACTCAGAGGGATGGTACCTCAGTGGTA 66 FBan0014743 FBgn0033326 CG14743 2 2R integral to membrane; GO:0016021 CG14743 CG14743 CDMC24427 2 14 5 DAC08-F09 2-CG14743-RA_1 CG14743 TCCTCTTCAGCGAGTTCCTCCAAGCCATCAATCCGATCGACTCAGAGGGATGGTACCTCAGTGGTA 66 FBan0014743 FBgn0033326 CG14743 2 2R integral to membrane; GO:0016021 CG14743 CG14743 CDMC24428 2 15 5 DAC08-F21 3-CG14815-RA_5 CG14815 GGGCTTCATCCGTGTGCGTTACAACGTGGGCGTATGTTGCATGAACCTTAAGGCCTACAAGGAAGC 66 FBan0014815 FBgn0023516 CG14815 X X protein targeting to peroxisome; GO:0006625 peroxisome targeting sequence binding; GO:0000268; ; GO:0000268; ; GO:0000268 CG14815 CG14815 EG:63B12.5 CDMC24428 2 16 5 DAC08-F21 3-CG14815-RA_5 CG14815 GGGCTTCATCCGTGTGCGTTACAACGTGGGCGTATGTTGCATGAACCTTAAGGCCTACAAGGAAGC 66 FBan0014815 FBgn0023516 CG14815 X X protein targeting to peroxisome; GO:0006625 peroxisome targeting sequence binding; GO:0000268; ; GO:0000268; ; GO:0000268 CG14815 CG14815 EG:63B12.5 CDMC24429 2 17 5 DAC08-J09 23-CG15251-RA_5 CG15251 AAATGGAAGCTGTAATTTATCGTTGAATCCCTATTCGTTTCTTCCCACATCCATCAGAATCTTTGT 66 FBan0015251 FBgn0030166 CG15251 X X CG15251 CG15251 BcDNA:RE65233 CDMC24429 2 18 5 DAC08-J09 23-CG15251-RA_5 CG15251 AAATGGAAGCTGTAATTTATCGTTGAATCCCTATTCGTTTCTTCCCACATCCATCAGAATCTTTGT 66 FBan0015251 FBgn0030166 CG15251 X X CG15251 CG15251 BcDNA:RE65233 CDMC24430 2 19 5 DAC08-J21 18-CG15387-RA_2 CG15387 AGGGTCATGGGTTTCCTGGAAACCGCGAGGGATTAGTCCAGTTCTCCCAGCTCATCAGAGAAATGG 66 FBan0015387 FBgn0031403 CG15387 2 2L CG15387 CG15387 CDMC24430 2 20 5 DAC08-J21 18-CG15387-RA_2 CG15387 AGGGTCATGGGTTTCCTGGAAACCGCGAGGGATTAGTCCAGTTCTCCCAGCTCATCAGAGAAATGG 66 FBan0015387 FBgn0031403 CG15387 2 2L CG15387 CG15387 CDMC24431 2 21 5 DAC08-N09 1-CG15882-RA_1 CG15882 TGAAGGAGCTGCTCAGTGAGGACACACTCTCTGAATTGGCTACCCCGAATGATGTCGACATTGCCG 66 FBan0015882 FBgn0030983 CG15882 X X CG15882 CG15882 CDMC24431 2 22 5 DAC08-N09 1-CG15882-RA_1 CG15882 TGAAGGAGCTGCTCAGTGAGGACACACTCTCTGAATTGGCTACCCCGAATGATGTCGACATTGCCG 66 FBan0015882 FBgn0030983 CG15882 X X CG15882 CG15882 CDMC24432 2 23 5 DAC08-N21 3-CG1676-RA_2 CG1676 AGACGAGGAGGATCCCCTGAATGAGCTGCGTAAAACAGTGCGTCTTTACCAGGCAGGGAACTACAG 66 FBan0001676 FBgn0031114 cactin X X defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 cactin cactin "CG1676, cactin" CDMC24432 2 24 5 DAC08-N21 3-CG1676-RA_2 CG1676 AGACGAGGAGGATCCCCTGAATGAGCTGCGTAAAACAGTGCGTCTTTACCAGGCAGGGAACTACAG 66 FBan0001676 FBgn0031114 cactin X X defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 cactin cactin "CG1676, cactin" CDMC24433 2 25 5 DAC09-B10 9-CG14087-RA_1 CG14087 TGACCACTGGTGAGGCGGATAATATGCTAAAGAAAGTGTACCCCATTACGGCCAATCACCGAAGGGCCA 69 FBan0014087 FBgn0036868 CG14087 3 3L CG14087 CG14087 CDMC24433 2 26 5 DAC09-B10 9-CG14087-RA_1 CG14087 TGACCACTGGTGAGGCGGATAATATGCTAAAGAAAGTGTACCCCATTACGGCCAATCACCGAAGGGCCA 69 FBan0014087 FBgn0036868 CG14087 3 3L CG14087 CG14087 CDMC24434 2 1 6 DAC09-B22 3-CG14102-RA_6 CG14102 TTCCCGGAGTTGGGTGAATTTAAAGGTCTCCGATCCCTGCGCCTAATCTCACGTTGGACAGCAGAAGTG 69 FBan0014102 FBgn0036906 CG14102 3 3L CG14102 CG14102 CDMC24434 2 2 6 DAC09-B22 3-CG14102-RA_6 CG14102 TTCCCGGAGTTGGGTGAATTTAAAGGTCTCCGATCCCTGCGCCTAATCTCACGTTGGACAGCAGAAGTG 69 FBan0014102 FBgn0036906 CG14102 3 3L CG14102 CG14102 CDMC24435 2 3 6 DAC09-F10 12-CG14147-RA_1 CG14147 GCACGCCCTGCACGGAAAGTACGGAAAGGTCAGGATCACCGAGACCCATTATTGAGAGATTCCAAAAAC 69 FBan0014147 FBgn0036112 CG14147 3 3L CG14147 CG14147 BcDNA:RE16005 CDMC24435 2 4 6 DAC09-F10 12-CG14147-RA_1 CG14147 GCACGCCCTGCACGGAAAGTACGGAAAGGTCAGGATCACCGAGACCCATTATTGAGAGATTCCAAAAAC 69 FBan0014147 FBgn0036112 CG14147 3 3L CG14147 CG14147 BcDNA:RE16005 CDMC24436 2 5 6 DAC09-F22 47-CG14162-RA_4 CG14162 GTCTGGCAGAAAAGCATGAAAAAAGCATAAGAAAAGCATAGTAAAGCAGAAGAAAAGCAGACAAAAGCA 69 FBan0014162 FBgn0040823 dpr6 3 3L dpr6 dpr6 "CG14162, CG14162, Dpr-6, BcDNA:LD13525" CDMC24436 2 6 6 DAC09-F22 47-CG14162-RA_4 CG14162 GTCTGGCAGAAAAGCATGAAAAAAGCATAAGAAAAGCATAGTAAAGCAGAAGAAAAGCAGACAAAAGCA 69 FBan0014162 FBgn0040823 dpr6 3 3L dpr6 dpr6 "CG14162, CG14162, Dpr-6, BcDNA:LD13525" CDMC24437 2 7 6 DAC09-J10 23-CG14207-RB_3 CG14207 ACCGAAATCACACACTTGAACGTCTTGAGTTTCGAATACATATAGAAAACCCATCGAGTTCCCTTTTTT 69 FBan0014207 FBgn0031037 CG14207 X X CG14207 CG14207 small heat shock protein hsp20 family CDMC24437 2 8 6 DAC09-J10 23-CG14207-RB_3 CG14207 ACCGAAATCACACACTTGAACGTCTTGAGTTTCGAATACATATAGAAAACCCATCGAGTTCCCTTTTTT 69 FBan0014207 FBgn0031037 CG14207 X X CG14207 CG14207 small heat shock protein hsp20 family CDMC24438 2 9 6 DAC09-J22 3-CG14215-RA_2 CG14215 GCAGCCCAAAGAAGGAGACAAGACGGAGAGCAAGGAAGCTTCCGAGGAGGAAACCCAACATAATCCAGA 69 FBan0014215 FBgn0031052 CG14215 X X metabolism; GO:0008152 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- CG14215 CG14215 CDMC24438 2 10 6 DAC09-J22 3-CG14215-RA_2 CG14215 GCAGCCCAAAGAAGGAGACAAGACGGAGAGCAAGGAAGCTTCCGAGGAGGAAACCCAACATAATCCAGA 69 FBan0014215 FBgn0031052 CG14215 X X metabolism; GO:0008152 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- CG14215 CG14215 CDMC24439 2 11 6 DAC09-N10 16-CG14254-RA_1 CG14254 GCCAAAGGATTACGGGCTTACTAAGCAGCAAAGGATTTCCGATTACCAGAAGCAAAATGCGTGTCTCCT 69 FBan0014254 FBgn0039469 CG14254 3 3R CG14254 CG14254 CDMC24439 2 12 6 DAC09-N10 16-CG14254-RA_1 CG14254 GCCAAAGGATTACGGGCTTACTAAGCAGCAAAGGATTTCCGATTACCAGAAGCAAAATGCGTGTCTCCT 69 FBan0014254 FBgn0039469 CG14254 3 3R CG14254 CG14254 CDMC24440 2 13 6 DAC09-N22 22-CG14271-RB_1 CG14271 GCGGTCCTGCGGGAATAATCACCGAGAATAAGTAGGACCTGCTGAAGAAAAGTCATATTCACAAGTCGG 69 FBan0014271 FBgn0029667 Gas8 X X sperm motility; GO:0030317 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Gas8 Growth arrest specific protein 8 "CG14271, CG14271, Growth arrest specific protein 8" CDMC24440 2 14 6 DAC09-N22 22-CG14271-RB_1 CG14271 GCGGTCCTGCGGGAATAATCACCGAGAATAAGTAGGACCTGCTGAAGAAAAGTCATATTCACAAGTCGG 69 FBan0014271 FBgn0029667 Gas8 X X sperm motility; GO:0030317 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Gas8 Growth arrest specific protein 8 "CG14271, CG14271, Growth arrest specific protein 8" CDMC24441 2 15 6 DAC10-B09 15-CG1957-RA_1 CG1957 TGCGCGCGTTTTTACTCCGCAGAAGGGGGAAATCATTGATGTCACCAGTGAGATTCACATCTATCAGGT 69 FBan0001957 FBgn0027873 CG1957 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG1957 CG1957 BcDNA:LD14168 CDMC24441 2 16 6 DAC10-B09 15-CG1957-RA_1 CG1957 TGCGCGCGTTTTTACTCCGCAGAAGGGGGAAATCATTGATGTCACCAGTGAGATTCACATCTATCAGGT 69 FBan0001957 FBgn0027873 CG1957 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG1957 CG1957 BcDNA:LD14168 CDMC24442 2 17 6 DAC10-B21 3-CG1968-RB_2 CG1968 TGGGCTACATAGCCGATGGAGTTTGTCATCCTCTAAAGGTTCGAGTGGAGACGATACTGCAGGCGGAGA 69 FBan0001968 FBgn0033401 CG1968 2 2R CG1968 CG1968 CDMC24442 2 18 6 DAC10-B21 3-CG1968-RB_2 CG1968 TGGGCTACATAGCCGATGGAGTTTGTCATCCTCTAAAGGTTCGAGTGGAGACGATACTGCAGGCGGAGA 69 FBan0001968 FBgn0033401 CG1968 2 2R CG1968 CG1968 CDMC24443 2 19 6 DAC10-F09 17-CG2006-RA_2 CG2006 ACAAGTACTATGACCACAACGACCTCATCGCCTACCGACGACCCATCTAGCGTTCTAATGGACATACAT 69 FBan0002006 FBgn0039664 CG2006 3 3R CG2006 CG2006 CDMC24443 2 20 6 DAC10-F09 17-CG2006-RA_2 CG2006 ACAAGTACTATGACCACAACGACCTCATCGCCTACCGACGACCCATCTAGCGTTCTAATGGACATACAT 69 FBan0002006 FBgn0039664 CG2006 3 3R CG2006 CG2006 CDMC24444 2 21 6 DAC10-F21 18-CG2023-RA_5 CG2023 TGGAGACATGGACAAGGATGCGTTTACATTACAGGCCATACGGCAGGACCTTATCGATAACAATCTGCA 69 FBan0002023 FBgn0037383 CG2023 3 3R apoptosis; GO:0006915; induction of apoptosis; GO:0006917 CG2023 CG2023 CDMC24444 2 22 6 DAC10-F21 18-CG2023-RA_5 CG2023 TGGAGACATGGACAAGGATGCGTTTACATTACAGGCCATACGGCAGGACCTTATCGATAACAATCTGCA 69 FBan0002023 FBgn0037383 CG2023 3 3R apoptosis; GO:0006915; induction of apoptosis; GO:0006917 CG2023 CG2023 CDMC24445 2 23 6 DAC10-J09 9-CG2054-RA_1 CG2054 CCGGTTGGCCCAGTGAGAAATTGAGGGAGTGCTCCGGTAGCCATAGTCTTAGAAACACATCACCTTGTT 69 FBan0002054 FBgn0022702 Cht2 3 3L cuticle chitin catabolism; GO:0006036 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" Cht2 Chitinase 2 "CG2054, DmCHT2, CHT2" CDMC24445 2 24 6 DAC10-J09 9-CG2054-RA_1 CG2054 CCGGTTGGCCCAGTGAGAAATTGAGGGAGTGCTCCGGTAGCCATAGTCTTAGAAACACATCACCTTGTT 69 FBan0002054 FBgn0022702 Cht2 3 3L cuticle chitin catabolism; GO:0006036 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" Cht2 Chitinase 2 "CG2054, DmCHT2, CHT2" CDMC24446 2 25 6 DAC10-J21 23-CG2071-RA_4 CG2071 GATATGCCAGGGTCTTTTACTTTAAGGACTGGATCAAAAAGCACTCTGATGTCTAAGAATGTCAAGCAC 69 FBan0002071 FBgn0011834 Ser6 X X proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- Ser6 Serine protease 6 "CG2071, SP47" CDMC24446 2 26 6 DAC10-J21 23-CG2071-RA_4 CG2071 GATATGCCAGGGTCTTTTACTTTAAGGACTGGATCAAAAAGCACTCTGATGTCTAAGAATGTCAAGCAC 69 FBan0002071 FBgn0011834 Ser6 X X proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- Ser6 Serine protease 6 "CG2071, SP47" CDMC24447 2 1 7 DAC10-N09 2-CG2104-RA_2 CG2104 CCGCCTGCAGGTAACCTATTCCGTGAACTCGTCCAACTGGCATGGTGGATACTCGCTGGATAAGTTTCA 69 FBan0002104 FBgn0037365 CG2104 3 3R protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160 CG2104 CG2104 CDMC24447 2 2 7 DAC10-N09 2-CG2104-RA_2 CG2104 CCGCCTGCAGGTAACCTATTCCGTGAACTCGTCCAACTGGCATGGTGGATACTCGCTGGATAAGTTTCA 69 FBan0002104 FBgn0037365 CG2104 3 3R protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160 CG2104 CG2104 CDMC24448 2 3 7 DAC10-N21 26-CG2116-RA_2 CG2116 CCGGGTGAAGGATTTGACGGATGACGAACAGATGCCGCAATTTGTGGTCAGGGAATTGGATATGAGCGA 69 FBan0002116 FBgn0030003 CG2116 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2116 CG2116 CDMC24448 2 4 7 DAC10-N21 26-CG2116-RA_2 CG2116 CCGGGTGAAGGATTTGACGGATGACGAACAGATGCCGCAATTTGTGGTCAGGGAATTGGATATGAGCGA 69 FBan0002116 FBgn0030003 CG2116 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2116 CG2116 CDMC24449 2 5 7 DAC11-B09 2-CG9192-RA_1 CG9192 AGGTCATCGGACACTCCCAACGTAGGCACCCGTCAGTTTAATCCATACGGTGGTCAGACCAATGC 65 FBan0009192 FBgn0035193 CG9192 3 3L CG9192 CG9192 CDMC24449 2 6 7 DAC11-B09 2-CG9192-RA_1 CG9192 AGGTCATCGGACACTCCCAACGTAGGCACCCGTCAGTTTAATCCATACGGTGGTCAGACCAATGC 65 FBan0009192 FBgn0035193 CG9192 3 3L CG9192 CG9192 CDMC24450 2 7 7 DAC11-B21 2-CG9233-RA_1 CG9233 ACTCACGCTATTACCACTGTGATGTCTGCGATCGAACTTTCCAACGGGAGAGGGACCTGCAACGC 65 FBan0009233 FBgn0029173 fu2 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 fu2 fu2 "CG9233, FU12" CDMC24450 2 8 7 DAC11-B21 2-CG9233-RA_1 CG9233 ACTCACGCTATTACCACTGTGATGTCTGCGATCGAACTTTCCAACGGGAGAGGGACCTGCAACGC 65 FBan0009233 FBgn0029173 fu2 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 fu2 fu2 "CG9233, FU12" CDMC24451 2 9 7 DAC11-F09 23-CG9344-RA_4 CG9344 TTGCTGCCAAAAGGTTTTGTAAACTGCATTTATTTTGAAATCATCTATTGAAAATGTCCCGCAAA 65 FBan0009344 FBgn0034564 CG9344 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG9344 CG9344 BcDNA:RE43665 CDMC24451 2 10 7 DAC11-F09 23-CG9344-RA_4 CG9344 TTGCTGCCAAAAGGTTTTGTAAACTGCATTTATTTTGAAATCATCTATTGAAAATGTCCCGCAAA 65 FBan0009344 FBgn0034564 CG9344 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG9344 CG9344 BcDNA:RE43665 CDMC24452 2 11 7 DAC11-F21 15-CG9373-RA_3 CG9373 AACGGAGGAGTTGGTGTTGATGGCAACGATTACAACACTGGCAATCCATTGGATGTCTATGGCGG 65 FBan0009373 FBgn0037701 CG9373 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG9373 CG9373 cg9373 CDMC24452 2 12 7 DAC11-F21 15-CG9373-RA_3 CG9373 AACGGAGGAGTTGGTGTTGATGGCAACGATTACAACACTGGCAATCCATTGGATGTCTATGGCGG 65 FBan0009373 FBgn0037701 CG9373 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG9373 CG9373 cg9373 CDMC24453 2 13 7 DAC11-J09 3-CG9494-RA_1 CG9494 GGGATGACATCCAGGATGAGTTCGAGTGCTGTGGTGTGACCTCATACAACGACTGGATCACCGCC 65 FBan0009494 FBgn0032074 Tsp29Fa 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp29Fa Tetraspanin 29Fa "CG9494, CG9494, CG9494, Dm.Tsp29Fa, Tetraspanin 29Fa" CDMC24453 2 14 7 DAC11-J09 3-CG9494-RA_1 CG9494 GGGATGACATCCAGGATGAGTTCGAGTGCTGTGGTGTGACCTCATACAACGACTGGATCACCGCC 65 FBan0009494 FBgn0032074 Tsp29Fa 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp29Fa Tetraspanin 29Fa "CG9494, CG9494, CG9494, Dm.Tsp29Fa, Tetraspanin 29Fa" CDMC24454 2 15 7 DAC11-J21 3-CG9540-RA_1 CG9540 GGTGGCCTGCAACTATGCTACCACCAATATGATCGGACGCCAGATCTACTCCAGCTGTGACTGGG 65 FBan0009540 FBgn0020508 Ag5r2 X X defense response; GO:0006952 extracellular region; GO:0005576 Ag5r2 Antigen 5-related 2 "CG9540, Agr2, Antigen 5-related 2" CDMC24454 2 16 7 DAC11-J21 3-CG9540-RA_1 CG9540 GGTGGCCTGCAACTATGCTACCACCAATATGATCGGACGCCAGATCTACTCCAGCTGTGACTGGG 65 FBan0009540 FBgn0020508 Ag5r2 X X defense response; GO:0006952 extracellular region; GO:0005576 Ag5r2 Antigen 5-related 2 "CG9540, Agr2, Antigen 5-related 2" CDMC24455 2 17 7 DAC11-N09 1-CG9614-RA_1 CG9614 CTACGTGAGAGCTCCGTGGTACTTCGTAGAGCGCAAAGCAGCTTTCCCGGATCTACCATTGCCAC 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24455 2 18 7 DAC11-N09 1-CG9614-RA_1 CG9614 CTACGTGAGAGCTCCGTGGTACTTCGTAGAGCGCAAAGCAGCTTTCCCGGATCTACCATTGCCAC 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24456 2 19 7 DAC11-N21 3-CG9631-RA_3 CG9631 GTCTATTTGGGCAGGCATGATCGCAACGAGAATCCTGAGAATGGAGCCTCCCTGGTTAGCGTGAC 65 FBan0009631 FBgn0027563 CG9631 3 3R defense response; GO:0006952; proteolysis; GO:0006508 elastase activity; GO:0042708; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9631 CG9631 "SP60, BcDNA:GH08420" CDMC24456 2 20 7 DAC11-N21 3-CG9631-RA_3 CG9631 GTCTATTTGGGCAGGCATGATCGCAACGAGAATCCTGAGAATGGAGCCTCCCTGGTTAGCGTGAC 65 FBan0009631 FBgn0027563 CG9631 3 3R defense response; GO:0006952; proteolysis; GO:0006508 elastase activity; GO:0042708; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9631 CG9631 "SP60, BcDNA:GH08420" CDMC24457 2 21 7 DAC12-B09 23-CG15427-RD_2 CG15427 TACACCAGCAGCAATAATCTGTATGGCAATGCGGATAGAAGTAGACCACTGCACATAAATACGAT 65 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC24457 2 22 7 DAC12-B09 23-CG15427-RD_2 CG15427 TACACCAGCAGCAATAATCTGTATGGCAATGCGGATAGAAGTAGACCACTGCACATAAATACGAT 65 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC24458 2 23 7 DAC12-B21 6-CG15438-RA_4 CG15438 GATACTTTCGTAGGCTGTCCTTCTGGGCCTGTGTGCTGACTCACGCCTGCGAGATGAACTGCTTC 65 FBan0015438 FBgn0025684 CG15438 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; sodium-dependent phosphate transporter activity; GO:0015321; ; GO:0015321; ; GO:0008270 integral to membrane; GO:0016021; nucleus; GO:0005634 CG15438 CG15438 "CK02623, BEST:CK02623" CDMC24458 2 24 7 DAC12-B21 6-CG15438-RA_4 CG15438 GATACTTTCGTAGGCTGTCCTTCTGGGCCTGTGTGCTGACTCACGCCTGCGAGATGAACTGCTTC 65 FBan0015438 FBgn0025684 CG15438 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; sodium-dependent phosphate transporter activity; GO:0015321; ; GO:0015321; ; GO:0008270 integral to membrane; GO:0016021; nucleus; GO:0005634 CG15438 CG15438 "CK02623, BEST:CK02623" CDMC24459 2 25 7 DAC12-F09 2-CG15515-RA_1 CG15515 GATGCTGATTCGCATCCGGATACCTCGACCGTGTTCCAGACCTACGACTTGGTATTGACCAGGGG 65 FBan0015515 FBgn0039719 CG15515 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15515 CG15515 BcDNA:RE21592 CDMC24459 2 26 7 DAC12-F09 2-CG15515-RA_1 CG15515 GATGCTGATTCGCATCCGGATACCTCGACCGTGTTCCAGACCTACGACTTGGTATTGACCAGGGG 65 FBan0015515 FBgn0039719 CG15515 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15515 CG15515 BcDNA:RE21592 CDMC24460 2 1 8 DAC12-F21 3-CG15533-RA_1 CG15533 CAAGATTCCCCAACTCCAGTGGTTCCACGATACCCTGTTGGAGGCCGAGAAGAACGGGGAGTATG 65 FBan0015533 FBgn0039768 CG15533 3 3R sphingomyelin catabolism; GO:0006685; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG15533 CG15533 aSMase CDMC24460 2 2 8 DAC12-F21 3-CG15533-RA_1 CG15533 CAAGATTCCCCAACTCCAGTGGTTCCACGATACCCTGTTGGAGGCCGAGAAGAACGGGGAGTATG 65 FBan0015533 FBgn0039768 CG15533 3 3R sphingomyelin catabolism; GO:0006685; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG15533 CG15533 aSMase CDMC24461 2 3 8 DAC12-J09 3-CG15633-RA_1 CG15633 ATACCTCATCGTGGAGATCAACAGCCATGTGGCACTGTTCCGGGATATGCTGATACACGTCGGCC 65 FBan0015633 FBgn0031624 CG15633 2 2L CG15633 CG15633 CDMC24461 2 4 8 DAC12-J09 3-CG15633-RA_1 CG15633 ATACCTCATCGTGGAGATCAACAGCCATGTGGCACTGTTCCGGGATATGCTGATACACGTCGGCC 65 FBan0015633 FBgn0031624 CG15633 2 2L CG15633 CG15633 CDMC24462 2 5 8 DAC12-J21 3-CG15661-RA_1 CG15661 AGGTGCCCAAGGTCAAGCACATGGAGCGTCAAATCTCAGTGATGCTACTAAACAGTCACGCACCG 65 FBan0015661 FBgn0034605 CG15661 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG15661 CG15661 CDMC24462 2 6 8 DAC12-J21 3-CG15661-RA_1 CG15661 AGGTGCCCAAGGTCAAGCACATGGAGCGTCAAATCTCAGTGATGCTACTAAACAGTCACGCACCG 65 FBan0015661 FBgn0034605 CG15661 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG15661 CG15661 CDMC24463 2 7 8 DAC12-N09 2-CG15756-RA_1 CG15756 TGTTCTACACCGCCGATCATCGTGGCTACCATGTGGACATGCAGACATTATCCGTAGAGCAGCCG 65 FBan0015756 FBgn0030493 CG15756 X X CG15756 CG15756 CDMC24463 2 8 8 DAC12-N09 2-CG15756-RA_1 CG15756 TGTTCTACACCGCCGATCATCGTGGCTACCATGTGGACATGCAGACATTATCCGTAGAGCAGCCG 65 FBan0015756 FBgn0030493 CG15756 X X CG15756 CG15756 CDMC24464 2 9 8 DAC12-N21 18-CG15776-RA_1 CG15776 CAGCTGGCGTTCTCTCACCCCAGGCTTCGCTCAAGTCCCAAACATCGATTCGCTCGCAAGGACAG 65 FBan0015776 FBgn0029782 CG15776 X X CG15776 CG15776 CDMC24464 2 10 8 DAC12-N21 18-CG15776-RA_1 CG15776 CAGCTGGCGTTCTCTCACCCCAGGCTTCGCTCAAGTCCCAAACATCGATTCGCTCGCAAGGACAG 65 FBan0015776 FBgn0029782 CG15776 X X CG15776 CG15776 CDMC24465 2 11 8 DAC13-B09 17-CG13025-RA_1 CG13025 CGAGGATAATACCTTAGTGGTTGGCTATCTCCAGGATAGTAAGCAGCTGATGATGCATGATGTGCGGCG 69 FBan0013025 FBgn0036660 CG13025 3 3L CG13025 CG13025 CDMC24465 2 12 8 DAC13-B09 17-CG13025-RA_1 CG13025 CGAGGATAATACCTTAGTGGTTGGCTATCTCCAGGATAGTAAGCAGCTGATGATGCATGATGTGCGGCG 69 FBan0013025 FBgn0036660 CG13025 3 3L CG13025 CG13025 CDMC24466 2 13 8 DAC13-B21 1-CG13036-RA_1 CG13036 GCAAGCGTTTCTACGTCTTGCCCGTCTACATGCACAGCACCAAGCAGAGCATTCGATTATGGTGGCAAT 69 FBan0013036 FBgn0036626 CG13036 3 3L CG13036 CG13036 CDMC24466 2 14 8 DAC13-B21 1-CG13036-RA_1 CG13036 GCAAGCGTTTCTACGTCTTGCCCGTCTACATGCACAGCACCAAGCAGAGCATTCGATTATGGTGGCAAT 69 FBan0013036 FBgn0036626 CG13036 3 3L CG13036 CG13036 CDMC24467 2 15 8 DAC13-F09 8-CG13075-RA_1 CG13075 TGCTCGGATACAACGACTCAGTCGCCCTCTGATTCTTCATCGACTGCTTCTTCAACTGAGTCCTCCTCC 69 FBan0013075 FBgn0036563 CG13075 3 3L CG13075 CG13075 CDMC24467 2 16 8 DAC13-F09 8-CG13075-RA_1 CG13075 TGCTCGGATACAACGACTCAGTCGCCCTCTGATTCTTCATCGACTGCTTCTTCAACTGAGTCCTCCTCC 69 FBan0013075 FBgn0036563 CG13075 3 3L CG13075 CG13075 CDMC24468 2 17 8 DAC13-F21 2-CG13086-RA_3 CG13086 GCGCGACGCGGAAGAAATATCGCCGGATTCGACTCCACATTTTCCTGGCATTATCCCTATGGTTCCTGA 69 FBan0013086 FBgn0032770 CG13086 2 2L CG13086 CG13086 CDMC24468 2 18 8 DAC13-F21 2-CG13086-RA_3 CG13086 GCGCGACGCGGAAGAAATATCGCCGGATTCGACTCCACATTTTCCTGGCATTATCCCTATGGTTCCTGA 69 FBan0013086 FBgn0032770 CG13086 2 2L CG13086 CG13086 CDMC24469 2 19 8 DAC13-J09 2-CG13124-RB_1 CG13124 GGCACTGTGCAAGCATCAGGACACCATGAGCAATTGATTCTGTTGTCGCATTGCATTTAGGGCCTGGAA 69 FBan0013124 FBgn0032156 CG13124 2 2L CG13124 CG13124 CDMC24469 2 20 8 DAC13-J09 2-CG13124-RB_1 CG13124 GGCACTGTGCAAGCATCAGGACACCATGAGCAATTGATTCTGTTGTCGCATTGCATTTAGGGCCTGGAA 69 FBan0013124 FBgn0032156 CG13124 2 2L CG13124 CG13124 CDMC24470 2 21 8 DAC13-J21 3-CG13138-RB_1 CG13138 GGAGACCGCCAACTCTGCTCCAGACTTTGTCAATAGCTCCAACGTAGACCTAAGTCCACAGGAATCGGC 69 FBan0013138 FBgn0032211 CG13138 2 2L CG13138 CG13138 CDMC24470 2 22 8 DAC13-J21 3-CG13138-RB_1 CG13138 GGAGACCGCCAACTCTGCTCCAGACTTTGTCAATAGCTCCAACGTAGACCTAAGTCCACAGGAATCGGC 69 FBan0013138 FBgn0032211 CG13138 2 2L CG13138 CG13138 CDMC24471 2 23 8 DAC13-N09 5-CG13190-RA_2 CG13190 GAATGGGTCTGCTCTAAGCTGGGTAGACCTGCAGATACGCCCTATGTTCATGAGTCGACTGGATTGGCC 69 FBan0013190 FBgn0033662 CG13190 2 2R CG13190 CG13190 CDMC24471 2 24 8 DAC13-N09 5-CG13190-RA_2 CG13190 GAATGGGTCTGCTCTAAGCTGGGTAGACCTGCAGATACGCCCTATGTTCATGAGTCGACTGGATTGGCC 69 FBan0013190 FBgn0033662 CG13190 2 2R CG13190 CG13190 CDMC24472 2 25 8 DAC13-N21 15-CG13198-RA_3 CG13198 GGAATCAGGTGGAACTTTCGCTGAAGGTCAGCCTGTTTCAGTTACCCATTCGCAATCTGACCACCAGAT 69 FBan0013198 FBgn0033640 CG13198 2 2R CG13198 CG13198 CDMC24472 2 26 8 DAC13-N21 15-CG13198-RA_3 CG13198 GGAATCAGGTGGAACTTTCGCTGAAGGTCAGCCTGTTTCAGTTACCCATTCGCAATCTGACCACCAGAT 69 FBan0013198 FBgn0033640 CG13198 2 2R CG13198 CG13198 CDMC24473 2 1 9 DAC14-B09 18-CG40157-RA_1 CG40157 CCGTAACATCTAATAAGGTGCAGACAGATCGAAGTGATGAAAATGGGCGGAATCCGTGTGAAGATGGGC 69 FBgn0058157 CG40157 CG40157 CG40157 CDMC24473 2 2 9 DAC14-B09 18-CG40157-RA_1 CG40157 CCGTAACATCTAATAAGGTGCAGACAGATCGAAGTGATGAAAATGGGCGGAATCCGTGTGAAGATGGGC 69 FBgn0058157 CG40157 CG40157 CG40157 CDMC24474 2 3 9 DAC14-B21 17-CG40164-RB_1 CG40164 AGGGAATCCGAAAACGCAAGCAAGGAGAAAATGAAGCATTTGAAGATTTCCAGGAAACCATGGAACGGT 69 FBgn0058164 CG40164 CG40164 CG40164 CDMC24474 2 4 9 DAC14-B21 17-CG40164-RB_1 CG40164 AGGGAATCCGAAAACGCAAGCAAGGAGAAAATGAAGCATTTGAAGATTTCCAGGAAACCATGGAACGGT 69 FBgn0058164 CG40164 CG40164 CG40164 CDMC24475 2 5 9 DAC14-F09 24-CG40209-RA_6 CG40209 GAAATGCAAAGTGATGAGAATTTCAGAATTCAGGATTCCAAATTTTCCAAAAAACCAAAGTTACAACTA 69 FBgn0058209 CG40209 CG40209 CG40209 CDMC24475 2 6 9 DAC14-F09 24-CG40209-RA_6 CG40209 GAAATGCAAAGTGATGAGAATTTCAGAATTCAGGATTCCAAATTTTCCAAAAAACCAAAGTTACAACTA 69 FBgn0058209 CG40209 CG40209 CG40209 CDMC24476 2 7 9 DAC14-F21 23-CG40228-RA_11 CG40228 ACAGTGGAAAAACTGTAGAGGCTTTAAAAAATGGGGAGAAGGAAGTCTAAAAGAAAACCGCCTCCGAAG 69 FBgn0063670 CG40228 CG40228 CG40228 BcDNA:RE67573 CDMC24476 2 8 9 DAC14-F21 23-CG40228-RA_11 CG40228 ACAGTGGAAAAACTGTAGAGGCTTTAAAAAATGGGGAGAAGGAAGTCTAAAAGAAAACCGCCTCCGAAG 69 FBgn0063670 CG40228 CG40228 CG40228 BcDNA:RE67573 CDMC24477 2 9 9 DAC14-J09 23-CG40293-RA_5 CG40293 ATGCGGCTATGCGACTATAATTTCCGCTTTTGGTCTAGGTGAGCTTCCTATCCGGTTCTTTCCTAATCA 69 CDMC24477 2 10 9 DAC14-J09 23-CG40293-RA_5 CG40293 ATGCGGCTATGCGACTATAATTTCCGCTTTTGGTCTAGGTGAGCTTCCTATCCGGTTCTTTCCTAATCA 69 CDMC24478 2 11 9 DAC14-J21 7-CG40305-RA_1 CG40305 TCCACCCGTACCATTCTCCTCTGGACAGAATTTTTTGGTGATTCGCGATGGAAGCTTTCCTGGGACACT 69 CDMC24478 2 12 9 DAC14-J21 7-CG40305-RA_1 CG40305 TCCACCCGTACCATTCTCCTCTGGACAGAATTTTTTGGTGATTCGCGATGGAAGCTTTCCTGGGACACT 69 CDMC24479 2 13 9 DAC14-N09 22-CG4035-RE_3 CG4035 TCAAGCTATCTCTCTTTCGCGGTCACTCGTTCTCTTTTTCTCTCCTTTCGCATTTGCATACGCATACCA 69 FBan0004035 FBgn0015218 eIF-4E 3 3L RNA metabolism; GO:0016070; autophagic cell death; GO:0048102; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; positive regulation of cell growth; GO:0030307; protein biosynthesis; GO:0006412; regulation of cell growth; GO:0001558; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743; ; GO:0000339 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4E Eukaryotic initiation factor 4E "CG4035, CG4035, CG4035, CG4035, CG4035, l(3)67Af, CBP, cap binding protein, l(3)07238, Eif4e, eIF4E, 1004/13, 0589/11, 0260/09, 0587/11, 0919/12, 7238, IF4E, eIF-4e, D-eIF4E, eukaryotic initiation factor 4E, CT13384, CT39424, CT39426, deIF4E, eIF-4E1,2, eIF4e, eIF-4EII, eif-4E, l(3)S091912, l(3)S058711, l(3)S026009, l(3)S025007, Eif4E, lethal(3)67Af, Eukaryotic initiation factor 4E" CDMC24479 2 14 9 DAC14-N09 22-CG4035-RE_3 CG4035 TCAAGCTATCTCTCTTTCGCGGTCACTCGTTCTCTTTTTCTCTCCTTTCGCATTTGCATACGCATACCA 69 FBan0004035 FBgn0015218 eIF-4E 3 3L RNA metabolism; GO:0016070; autophagic cell death; GO:0048102; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; positive regulation of cell growth; GO:0030307; protein biosynthesis; GO:0006412; regulation of cell growth; GO:0001558; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743; ; GO:0000339 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4E Eukaryotic initiation factor 4E "CG4035, CG4035, CG4035, CG4035, CG4035, l(3)67Af, CBP, cap binding protein, l(3)07238, Eif4e, eIF4E, 1004/13, 0589/11, 0260/09, 0587/11, 0919/12, 7238, IF4E, eIF-4e, D-eIF4E, eukaryotic initiation factor 4E, CT13384, CT39424, CT39426, deIF4E, eIF-4E1,2, eIF4e, eIF-4EII, eif-4E, l(3)S091912, l(3)S058711, l(3)S026009, l(3)S025007, Eif4E, lethal(3)67Af, Eukaryotic initiation factor 4E" CDMC24480 2 15 9 DAC14-N21 23-CG40382-RA_3 CG40382 AGCATACAAATACAAACAACACAACATCGGACTATTCTTCAAATCAACTTTCTGGGATTGTTGACCCAC 69 FBgn0058382 CG40382 CG40382 CG40382 CDMC24480 2 16 9 DAC14-N21 23-CG40382-RA_3 CG40382 AGCATACAAATACAAACAACACAACATCGGACTATTCTTCAAATCAACTTTCTGGGATTGTTGACCCAC 69 FBgn0058382 CG40382 CG40382 CG40382 CDMC24481 2 17 9 DAC15-B09 15-CG7288-RA_5 CG7288 TGGATTTCGATTTCGAGAAGCTTTGCTCCATTTCGCTGACGAGGATCAATGTTTATGCCTGCCTGGTGT 69 FBan0007288 FBgn0030969 CG7288 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG7288 CG7288 CDMC24481 2 18 9 DAC15-B09 15-CG7288-RA_5 CG7288 TGGATTTCGATTTCGAGAAGCTTTGCTCCATTTCGCTGACGAGGATCAATGTTTATGCCTGCCTGGTGT 69 FBan0007288 FBgn0030969 CG7288 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG7288 CG7288 CDMC24482 2 19 9 DAC15-B21 23-CG7296-RA_1 CG7296 GGTTAGACCGATCCAAACTATACTGGTATTTGGAGTTAAGCGATAAGAAATGACTGTGAATAAAACCTA 69 FBan0007296 FBgn0032283 CG7296 2 2L CG7296 CG7296 BcDNA:RH68528 CDMC24482 2 20 9 DAC15-B21 23-CG7296-RA_1 CG7296 GGTTAGACCGATCCAAACTATACTGGTATTTGGAGTTAAGCGATAAGAAATGACTGTGAATAAAACCTA 69 FBan0007296 FBgn0032283 CG7296 2 2L CG7296 CG7296 BcDNA:RH68528 CDMC24483 2 21 9 DAC15-F09 5-CG7330-RA_1 CG7330 TCCCCTTAGTCAGTCGCATCGGACATCTTTGTTAATCATCCATCTCTCGGCACTCACATCCAGCTGCCA 69 FBan0007330 FBgn0036780 CG7330 3 3L CG7330 CG7330 BcDNA:RE22290 CDMC24483 2 22 9 DAC15-F09 5-CG7330-RA_1 CG7330 TCCCCTTAGTCAGTCGCATCGGACATCTTTGTTAATCATCCATCTCTCGGCACTCACATCCAGCTGCCA 69 FBan0007330 FBgn0036780 CG7330 3 3L CG7330 CG7330 BcDNA:RE22290 CDMC24484 2 23 9 DAC15-F21 2-CG7338-RA_2 CG7338 TGCTGTCCTGCAATCCAGATCGTATTGTTCTCAAGCGCGTTGTTCTCAGCGGTCATCCCATGCGTATCA 69 FBan0007338 FBgn0037073 CG7338 3 3L CG7338 CG7338 CDMC24484 2 24 9 DAC15-F21 2-CG7338-RA_2 CG7338 TGCTGTCCTGCAATCCAGATCGTATTGTTCTCAAGCGCGTTGTTCTCAGCGGTCATCCCATGCGTATCA 69 FBan0007338 FBgn0037073 CG7338 3 3L CG7338 CG7338 CDMC24485 2 25 9 DAC15-J09 2-CG7365-RA_1 CG7365 GGCCCGTTCTCCTCCGTGAATTACTCCCTGTGATATCGCACCTAAGTCTTCTTCGCTAGCTTGCCAGTG 69 FBan0007365 FBgn0036939 CG7365 3 3L phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG7365 CG7365 CDMC24485 2 26 9 DAC15-J09 2-CG7365-RA_1 CG7365 GGCCCGTTCTCCTCCGTGAATTACTCCCTGTGATATCGCACCTAAGTCTTCTTCGCTAGCTTGCCAGTG 69 FBan0007365 FBgn0036939 CG7365 3 3L phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG7365 CG7365 CDMC24486 2 1 10 DAC15-J21 3-CG7376-RA_3 CG7376 CCGACGATCCTGAGGAGCAATCGAACTACAGAATACTGGCGTGCCAATTGGACGAGCAGCTACAGTTCA 69 FBan0007376 FBgn0035689 CG7376 3 3L "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG7376 CG7376 CDMC24486 2 2 10 DAC15-J21 3-CG7376-RA_3 CG7376 CCGACGATCCTGAGGAGCAATCGAACTACAGAATACTGGCGTGCCAATTGGACGAGCAGCTACAGTTCA 69 FBan0007376 FBgn0035689 CG7376 3 3L "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG7376 CG7376 CDMC24487 2 3 10 DAC15-N09 24-CG7406-RA_1 CG7406 TGTGCGCTTAGAAACCATTAATTTTTTTTGCTAATTTTTAAAGAAATACACAGAAAATGAAAAAGATAA 69 FBan0007406 FBgn0030980 CG7406 X X CG7406 CG7406 CDMC24487 2 4 10 DAC15-N09 24-CG7406-RA_1 CG7406 TGTGCGCTTAGAAACCATTAATTTTTTTTGCTAATTTTTAAAGAAATACACAGAAAATGAAAAAGATAA 69 FBan0007406 FBgn0030980 CG7406 X X CG7406 CG7406 CDMC24488 2 5 10 DAC15-N21 18-CG7430-RA_1 CG7430 GGCAAACCCATCAACTTCTAAGCACTTCCCAATCTCTGCCAGATAGTGAAGAATTTTGCACCGCGTTTG 69 FBan0007430 FBgn0036762 CG7430 3 3L electron transport; GO:0006118; glycine catabolism; GO:0006546; glycolysis; GO:0006096; lipoamide metabolism; GO:0006748; tricarboxylic acid cycle; GO:0006099 dihydrolipoyl dehydrogenase activity; GO:0004148 ; EC:1.8.1.4; metal ion binding; GO:0046872; ; GO:0004148 ; EC:1.8.1.4; ; GO:0004148 ; EC:1.8.1.4; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 alpha-ketoglutarate dehydrogenase complex (sensu Eukaryota); GO:0005947; glycine cleavage complex; GO:0005960 CG7430 CG7430 CDMC24488 2 6 10 DAC15-N21 18-CG7430-RA_1 CG7430 GGCAAACCCATCAACTTCTAAGCACTTCCCAATCTCTGCCAGATAGTGAAGAATTTTGCACCGCGTTTG 69 FBan0007430 FBgn0036762 CG7430 3 3L electron transport; GO:0006118; glycine catabolism; GO:0006546; glycolysis; GO:0006096; lipoamide metabolism; GO:0006748; tricarboxylic acid cycle; GO:0006099 dihydrolipoyl dehydrogenase activity; GO:0004148 ; EC:1.8.1.4; metal ion binding; GO:0046872; ; GO:0004148 ; EC:1.8.1.4; ; GO:0004148 ; EC:1.8.1.4; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 alpha-ketoglutarate dehydrogenase complex (sensu Eukaryota); GO:0005947; glycine cleavage complex; GO:0005960 CG7430 CG7430 CDMC24489 2 7 10 DAC16-B09 8-CG12240-RB_1 CG12240 AGCACGCCCAAGAAAGTGTACCTGTCCAACTTGACGTACTCGATTGTGAGGAAGATCCGTGTGGGC 66 FBan0012240 FBgn0020129 DnaJ-60 2 2R protein folding; GO:0006457; spermatogenesis; GO:0007283 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-60 DnaJ-like-60 "CG12240, CG13571, DnaJ60, anon-WO0172774.147, DmJ60" CDMC24489 2 8 10 DAC16-B09 8-CG12240-RB_1 CG12240 AGCACGCCCAAGAAAGTGTACCTGTCCAACTTGACGTACTCGATTGTGAGGAAGATCCGTGTGGGC 66 FBan0012240 FBgn0020129 DnaJ-60 2 2R protein folding; GO:0006457; spermatogenesis; GO:0007283 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-60 DnaJ-like-60 "CG12240, CG13571, DnaJ60, anon-WO0172774.147, DmJ60" CDMC24490 2 9 10 DAC16-B21 2-CG12360-RA_1 CG12360 GGCAGACCATGAAACTGGTGTGGCGTCTTACCTTCACGGACAGCATCAGCATTGAGGAGGTAGAGG 66 FBan0012360 FBgn0038111 CG12360 3 3R CG12360 CG12360 CDMC24490 2 10 10 DAC16-B21 2-CG12360-RA_1 CG12360 GGCAGACCATGAAACTGGTGTGGCGTCTTACCTTCACGGACAGCATCAGCATTGAGGAGGTAGAGG 66 FBan0012360 FBgn0038111 CG12360 3 3R CG12360 CG12360 CDMC24491 2 11 10 DAC16-F09 3-CG13012-RA_1 CG13012 CGTCTGCGGTTTCTGCAACTGGGGCAGTACGGTCGAAATTCCGCGAACATGGACTTGAAAATGGAG 66 FBan0013012 FBgn0030769 CG13012 X X CG13012 CG13012 CDMC24491 2 12 10 DAC16-F09 3-CG13012-RA_1 CG13012 CGTCTGCGGTTTCTGCAACTGGGGCAGTACGGTCGAAATTCCGCGAACATGGACTTGAAAATGGAG 66 FBan0013012 FBgn0030769 CG13012 X X CG13012 CG13012 CDMC24492 2 13 10 DAC16-F21 23-CG13159-RA_1 CG13159 CCACTTGATACGATCCTCATCACCTGAATAGCCAAATAAAAACACCAAATACCAAAAAACAAACAA 66 FBan0013159 FBgn0033721 CG13159 2 2R CG13159 CG13159 BcDNA:RE25177 CDMC24492 2 14 10 DAC16-F21 23-CG13159-RA_1 CG13159 CCACTTGATACGATCCTCATCACCTGAATAGCCAAATAAAAACACCAAATACCAAAAAACAAACAA 66 FBan0013159 FBgn0033721 CG13159 2 2R CG13159 CG13159 BcDNA:RE25177 CDMC24493 2 15 10 DAC16-J09 1-CG1347-RB_1 CG1347 CCACACCGTCATTGGACCCTTCGCAGACAGTTGTGGATATCAACCAGATCCCTCTGCCCTACTACG 66 FBan0001347 FBgn0037363 CG1347 3 3R CG1347 CG1347 CDMC24493 2 16 10 DAC16-J09 1-CG1347-RB_1 CG1347 CCACACCGTCATTGGACCCTTCGCAGACAGTTGTGGATATCAACCAGATCCCTCTGCCCTACTACG 66 FBan0001347 FBgn0037363 CG1347 3 3R CG1347 CG1347 CDMC24494 2 17 10 DAC16-J21 2-CG13592-RA_2 CG13592 CCTGTCCGCATACTTCGAAGCACATTAGCTCCTCGGGACTTTGAGTACTCCAACGAACAGGGTGGC 66 FBan0013592 FBgn0035019 CG13592 2 2R CG13592 CG13592 CDMC24494 2 18 10 DAC16-J21 2-CG13592-RA_2 CG13592 CCTGTCCGCATACTTCGAAGCACATTAGCTCCTCGGGACTTTGAGTACTCCAACGAACAGGGTGGC 66 FBan0013592 FBgn0035019 CG13592 2 2R CG13592 CG13592 CDMC24495 2 19 10 DAC16-N09 1-CG14125-RA_1 CG14125 AGGACAGCCCACTGGAGAAACGTCTAATCCATCAGATCAACCCACTGACAGTCCCACAGGTCAACC 66 FBan0014125 FBgn0036232 CG14125 3 3L CG14125 CG14125 CDMC24495 2 20 10 DAC16-N09 1-CG14125-RA_1 CG14125 AGGACAGCCCACTGGAGAAACGTCTAATCCATCAGATCAACCCACTGACAGTCCCACAGGTCAACC 66 FBan0014125 FBgn0036232 CG14125 3 3L CG14125 CG14125 CDMC24496 2 21 10 DAC16-N21 8-CG14221-RA_1 CG14221 CGCTGATTTGGGGAGAACATTCCAGCTCACTTCCGTTGATTCCGTTGCAGAATAAAAAGGGCGGCG 66 FBan0014221 FBgn0031042 CG14221 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG14221 CG14221 CDMC24496 2 22 10 DAC16-N21 8-CG14221-RA_1 CG14221 CGCTGATTTGGGGAGAACATTCCAGCTCACTTCCGTTGATTCCGTTGCAGAATAAAAAGGGCGGCG 66 FBan0014221 FBgn0031042 CG14221 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG14221 CG14221 CDMC24497 2 23 10 DAC17-B09 6-CG17284-RA_4 CG17284 TGAGCTCATGCTGTGATGTTCAAAAAAACGACAAGGCCATCAATTCGTGTCGCAAGTCCTTGCTGGGCA 69 FBan0017284 FBgn0038859 Obp93a 3 3R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp93a Odorant-binding protein 93a "CG17284, CG17284, Odorant-binding protein 93a" CDMC24497 2 24 10 DAC17-B09 6-CG17284-RA_4 CG17284 TGAGCTCATGCTGTGATGTTCAAAAAAACGACAAGGCCATCAATTCGTGTCGCAAGTCCTTGCTGGGCA 69 FBan0017284 FBgn0038859 Obp93a 3 3R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp93a Odorant-binding protein 93a "CG17284, CG17284, Odorant-binding protein 93a" CDMC24498 2 25 10 DAC17-B21 2-CG17293-RA_2 CG17293 GCCGCTGGCGTTAACTCGGAAAGCATTAAATTGTACGACCTTCGCTCTTTCGACAAAGGCCCCTTCGTC 69 FBan0017293 FBgn0032030 CG17293 2 2L microtubule severing; GO:0051013 katanin; GO:0008352 CG17293 CG17293 CDMC24498 2 26 10 DAC17-B21 2-CG17293-RA_2 CG17293 GCCGCTGGCGTTAACTCGGAAAGCATTAAATTGTACGACCTTCGCTCTTTCGACAAAGGCCCCTTCGTC 69 FBan0017293 FBgn0032030 CG17293 2 2L microtubule severing; GO:0051013 katanin; GO:0008352 CG17293 CG17293 CDMC24499 2 1 11 DAC17-F09 23-CG17334-RA_10 CG17334 CGTTTTCCTAATTTCCCCTTCGCTGAACCCAAAAATTCGAGAAAGTGCTGTAGCTGTGTTAGTGCGGGC 69 FBan0017334 FBgn0035626 lin-28 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 lin-28 lin-28 "CG17334, CG17334, CG17334, CG17334, EP(3)0915, BcDNA:RE05342" CDMC24499 2 2 11 DAC17-F09 23-CG17334-RA_10 CG17334 CGTTTTCCTAATTTCCCCTTCGCTGAACCCAAAAATTCGAGAAAGTGCTGTAGCTGTGTTAGTGCGGGC 69 FBan0017334 FBgn0035626 lin-28 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 lin-28 lin-28 "CG17334, CG17334, CG17334, CG17334, EP(3)0915, BcDNA:RE05342" CDMC24500 2 3 11 DAC17-F21 16-CG17358-RA_3 CG17358 GCCTTGCCCTCATACGGAAAACGATCAAGAAATACTAGAGGATTGGATCTAATCGGGTCGAGGCTCTGT 69 FBan0017358 FBgn0011290 Taf12 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf12 TBP-associated factor 12 "CG17358, CG17358, CG17358, 26kDa polypeptide, Taf30alpha: TBP-associated factor 30kD subunit alpha, TBP-associated factor 30kD subunit alpha, p22, p28, dTAF[[II]]30alpha, Taf[[II]]30alpha, TAF[[II]]30alpha, dTAF22, dTAF28, TAF[[II]]30alpha/28/22, TAF30a, dTAF[[II]]30, TAF30alpha, dTAFII30, dTAF[[II]]30alpha/22, TAF[[II]]30alpha/28 TAF[[II]]22, TAFII30alpha/22, TFIID 22, TFIID 28, dTAFII30 alpha, TAF30alpha/28/22, TAF30alpha/28, d28/22, TFIID, TAF12, TAF[[II]]230, TAF[II]30alpha, dmTAF12, TAF[[II]], TAF, dTAF12, TFIID-p28, Taf22, Taf28, Taf32, Taf30alpha" CDMC24500 2 4 11 DAC17-F21 16-CG17358-RA_3 CG17358 GCCTTGCCCTCATACGGAAAACGATCAAGAAATACTAGAGGATTGGATCTAATCGGGTCGAGGCTCTGT 69 FBan0017358 FBgn0011290 Taf12 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf12 TBP-associated factor 12 "CG17358, CG17358, CG17358, 26kDa polypeptide, Taf30alpha: TBP-associated factor 30kD subunit alpha, TBP-associated factor 30kD subunit alpha, p22, p28, dTAF[[II]]30alpha, Taf[[II]]30alpha, TAF[[II]]30alpha, dTAF22, dTAF28, TAF[[II]]30alpha/28/22, TAF30a, dTAF[[II]]30, TAF30alpha, dTAFII30, dTAF[[II]]30alpha/22, TAF[[II]]30alpha/28 TAF[[II]]22, TAFII30alpha/22, TFIID 22, TFIID 28, dTAFII30 alpha, TAF30alpha/28/22, TAF30alpha/28, d28/22, TFIID, TAF12, TAF[[II]]230, TAF[II]30alpha, dmTAF12, TAF[[II]], TAF, dTAF12, TFIID-p28, Taf22, Taf28, Taf32, Taf30alpha" CDMC24501 2 5 11 DAC17-J09 3-CG17390-RA_3 CG17390 AGGGTCCAGCCAAACTCTGTGACAAGTGCTGCCGTAAGCATAACCTAAATGGAAAACGTGGCAAGCACT 69 FBan0017390 FBgn0033939 CG17390 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17390 CG17390 CDMC24501 2 6 11 DAC17-J09 3-CG17390-RA_3 CG17390 AGGGTCCAGCCAAACTCTGTGACAAGTGCTGCCGTAAGCATAACCTAAATGGAAAACGTGGCAAGCACT 69 FBan0017390 FBgn0033939 CG17390 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17390 CG17390 CDMC24502 2 7 11 DAC17-J21 14-CG17437-RA_1 CG17437 GGGCAAGTGCCTGAAGACGTATACGGGTCACAAGAATGAGAAGTACTGCATATTCGCCAACTTCTCGGT 69 FBan0017437 FBgn0040066 wds X X cell proliferation; GO:0008283 wds will die slowly "CG17437, CG17437, zw8, l(1)zw8, zw-8, l(1)3Ad, l(1)G0251, EG:BACR25B3.7, l(1)16-94, lethal(1)3Ad, will die slowly" CDMC24502 2 8 11 DAC17-J21 14-CG17437-RA_1 CG17437 GGGCAAGTGCCTGAAGACGTATACGGGTCACAAGAATGAGAAGTACTGCATATTCGCCAACTTCTCGGT 69 FBan0017437 FBgn0040066 wds X X cell proliferation; GO:0008283 wds will die slowly "CG17437, CG17437, zw8, l(1)zw8, zw-8, l(1)3Ad, l(1)G0251, EG:BACR25B3.7, l(1)16-94, lethal(1)3Ad, will die slowly" CDMC24503 2 9 11 DAC17-N09 13-CG17490-RB_1 CG17490 GCAGGGGACATTTTGGAAGCTTTTGATATGCTATGACAACCGCATCAATGTCCTCCTACTGCCCACAGA 69 FBgn0040009 CG17490 CG17490 CG17490 CDMC24503 2 10 11 DAC17-N09 13-CG17490-RB_1 CG17490 GCAGGGGACATTTTGGAAGCTTTTGATATGCTATGACAACCGCATCAATGTCCTCCTACTGCCCACAGA 69 FBgn0040009 CG17490 CG17490 CG17490 CDMC24504 2 11 11 DAC17-N21 23-CG17506-RA_1 CG17506 CGCCGATTTTCCGTTACGAAAGAGTTTGAAAAGGCTGACATACTCGTTCATTAGACGATTAAATCTTTT 69 FBgn0040041 CG17506 CG17506 CG17506 CG40223 CDMC24504 2 12 11 DAC17-N21 23-CG17506-RA_1 CG17506 CGCCGATTTTCCGTTACGAAAGAGTTTGAAAAGGCTGACATACTCGTTCATTAGACGATTAAATCTTTT 69 FBgn0040041 CG17506 CG17506 CG17506 CG40223 CDMC24505 2 13 11 DAC18-B09 14-CG31296-RA_1 CG31296 TGCTAAATGCAAGGGTATTCCAGTTACCCCTCGATTTATCCATCGGTCGACAAGCTTATGTGCCAGCCA 69 FBan0031296 FBgn0051296 CG31296 3 3R defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31296 CG31296 NEST:bs01d08 CDMC24505 2 14 11 DAC18-B09 14-CG31296-RA_1 CG31296 TGCTAAATGCAAGGGTATTCCAGTTACCCCTCGATTTATCCATCGGTCGACAAGCTTATGTGCCAGCCA 69 FBan0031296 FBgn0051296 CG31296 3 3R defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31296 CG31296 NEST:bs01d08 CDMC24506 2 15 11 DAC18-B21 23-CG31308-RA_4 CG31308 ATCAGCAGCTTAGGCGATATGTTCAGCACATTCTATAGCATATATATGACTATATCCTCGGCTCACCTA 69 FBan0031308 FBgn0051308 CG31308 3 3R CG31308 CG31308 CDMC24506 2 16 11 DAC18-B21 23-CG31308-RA_4 CG31308 ATCAGCAGCTTAGGCGATATGTTCAGCACATTCTATAGCATATATATGACTATATCCTCGGCTCACCTA 69 FBan0031308 FBgn0051308 CG31308 3 3R CG31308 CG31308 CDMC24507 2 17 11 DAC18-F09 12-CG31345-RA_4 CG31345 TCGGCCTGGACCTGACTGATTCCGAAATCGATGAAATGTTCTCCAGATTCGACACAGATGGAAGTGGCA 69 FBan0031345 FBgn0051345 CG31345 3 3R detection of calcium ion; GO:0005513 calcium ion binding; GO:0005509; ; GO:0005509 CG31345 CG31345 "CG10135, CG14388, CG10135" CDMC24507 2 18 11 DAC18-F09 12-CG31345-RA_4 CG31345 TCGGCCTGGACCTGACTGATTCCGAAATCGATGAAATGTTCTCCAGATTCGACACAGATGGAAGTGGCA 69 FBan0031345 FBgn0051345 CG31345 3 3R detection of calcium ion; GO:0005513 calcium ion binding; GO:0005509; ; GO:0005509 CG31345 CG31345 "CG10135, CG14388, CG10135" CDMC24508 2 19 11 DAC18-F21 1-CG31355-RA_1 CG31355 CCGTGAACTTTGACAAGCTGTGCCTCATAATGATGCCAGACAAACGTCTCGAAATGAGCTCGCACCGGG 69 FBan0031355 FBgn0051355 CG31355 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31355 CG31355 CDMC24508 2 20 11 DAC18-F21 1-CG31355-RA_1 CG31355 CCGTGAACTTTGACAAGCTGTGCCTCATAATGATGCCAGACAAACGTCTCGAAATGAGCTCGCACCGGG 69 FBan0031355 FBgn0051355 CG31355 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31355 CG31355 CDMC24509 2 21 11 DAC18-J09 3-CG31389-RA_1 CG31389 GCAGCAGGAAAACCACAAGCAGGAAGAAGGAAGCCAAGCCTACACCTGTGCAGAAACACCGATACATGT 69 FBan0031389 FBgn0051389 CG31389 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31389 CG31389 CDMC24509 2 22 11 DAC18-J09 3-CG31389-RA_1 CG31389 GCAGCAGGAAAACCACAAGCAGGAAGAAGGAAGCCAAGCCTACACCTGTGCAGAAACACCGATACATGT 69 FBan0031389 FBgn0051389 CG31389 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31389 CG31389 CDMC24510 2 23 11 DAC18-J21 6-CG31405-RA_1 CG31405 TCTTTGGCGTATTTCGCATAAATCGCTCTTTGGCTTTCCGGAGTGCATCACTCATCCTGGTCCACGTGC 69 FBan0031405 FBgn0045473 Gr85a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr85a Gustatory receptor 85a "CG31405, Gustatory receptor 85a" CDMC24510 2 24 11 DAC18-J21 6-CG31405-RA_1 CG31405 TCTTTGGCGTATTTCGCATAAATCGCTCTTTGGCTTTCCGGAGTGCATCACTCATCCTGGTCCACGTGC 69 FBan0031405 FBgn0045473 Gr85a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr85a Gustatory receptor 85a "CG31405, Gustatory receptor 85a" CDMC24511 2 25 11 DAC18-N09 2-CG31441-RA_1 CG31441 CCGGATGTTGAGAAGCTACAGCAGGATTTGTGGGACCACACGGATCAGGAAATGTGTGTAGCAATGGCA 69 FBan0031441 FBgn0051441 CG31441 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31441 CG31441 CG5135 CDMC24511 2 26 11 DAC18-N09 2-CG31441-RA_1 CG31441 CCGGATGTTGAGAAGCTACAGCAGGATTTGTGGGACCACACGGATCAGGAAATGTGTGTAGCAATGGCA 69 FBan0031441 FBgn0051441 CG31441 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31441 CG31441 CG5135 CDMC24512 2 1 12 DAC18-N21 16-CG31459-RA_2 CG31459 CACCAGCGAAGAAAGCGTCCAAAATTTGAGTGCCTCAGAACTCAAGGAGTATTTTGCAAGGCCAAAGTT 69 FBan0031459 FBgn0051459 CG31459 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31459 CG31459 "BcDNA:AT26603, NEST:bs03f05, NEST:bs29d02" CDMC24512 2 2 12 DAC18-N21 16-CG31459-RA_2 CG31459 CACCAGCGAAGAAAGCGTCCAAAATTTGAGTGCCTCAGAACTCAAGGAGTATTTTGCAAGGCCAAAGTT 69 FBan0031459 FBgn0051459 CG31459 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31459 CG31459 "BcDNA:AT26603, NEST:bs03f05, NEST:bs29d02" CDMC24513 2 3 12 DAC19-B09 23-CG6008-RA_1 CG6008 TCAAGGGAAAACTCGATTATTTACGAAATTTGCGACTGAAATTTCTTCCCCAACGCGATGTCTGC 65 FBan0006008 FBgn0027785 NP15.6 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 NP15.6 NP15.6 "CG6008, anon-WO0118547.281" CDMC24513 2 4 12 DAC19-B09 23-CG6008-RA_1 CG6008 TCAAGGGAAAACTCGATTATTTACGAAATTTGCGACTGAAATTTCTTCCCCAACGCGATGTCTGC 65 FBan0006008 FBgn0027785 NP15.6 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 NP15.6 NP15.6 "CG6008, anon-WO0118547.281" CDMC24514 2 5 12 DAC19-B21 3-CG6034-RA_7 CG6034 CAAGGCTCTTACGGAATTGACGAACGCATTTGAGGTGCCTGGCGAACATGAGGGTTCCGTAGGTG 65 FBan0006034 FBgn0036750 CG6034 3 3L electron transport; GO:0006118; transport; GO:0006810 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transporter activity; GO:0005215; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005215 membrane; GO:0016020 CG6034 CG6034 CDMC24514 2 6 12 DAC19-B21 3-CG6034-RA_7 CG6034 CAAGGCTCTTACGGAATTGACGAACGCATTTGAGGTGCCTGGCGAACATGAGGGTTCCGTAGGTG 65 FBan0006034 FBgn0036750 CG6034 3 3L electron transport; GO:0006118; transport; GO:0006810 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transporter activity; GO:0005215; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005215 membrane; GO:0016020 CG6034 CG6034 CDMC24515 2 7 12 DAC19-F09 4-CG6137-RA_1 CG6137 CCAGAGCGCTACGACTTCTTCCTAGTGTCCCAGGCTGTTCGGATAGGAACTGTGTCGCCTACCAG 65 FBan0006137 FBgn0000146 aub 2 2L "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; chromatin silencing; GO:0006342; cystoblast division; GO:0007282; dorsal appendage formation; GO:0046843; karyosome formation; GO:0030717; maintenance of pole plasm mRNA localization; GO:0046594; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; pole cell formation; GO:0007279; positive regulation of oskar mRNA translation; GO:0046012; regulation of oskar mRNA translation; GO:0046011; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of translational initiation; GO:0006446; stem cell division; GO:0017145" cytoplasm; GO:0005737; polar granule; GO:0018994 aub aubergine "CG6137, sti, stellate-interacting gene, sting, ms(2)32D, aubergine" CDMC24515 2 8 12 DAC19-F09 4-CG6137-RA_1 CG6137 CCAGAGCGCTACGACTTCTTCCTAGTGTCCCAGGCTGTTCGGATAGGAACTGTGTCGCCTACCAG 65 FBan0006137 FBgn0000146 aub 2 2L "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; chromatin silencing; GO:0006342; cystoblast division; GO:0007282; dorsal appendage formation; GO:0046843; karyosome formation; GO:0030717; maintenance of pole plasm mRNA localization; GO:0046594; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; pole cell formation; GO:0007279; positive regulation of oskar mRNA translation; GO:0046012; regulation of oskar mRNA translation; GO:0046011; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of translational initiation; GO:0006446; stem cell division; GO:0017145" cytoplasm; GO:0005737; polar granule; GO:0018994 aub aubergine "CG6137, sti, stellate-interacting gene, sting, ms(2)32D, aubergine" CDMC24516 2 9 12 DAC19-F21 2-CG6191-RA_1 CG6191 CTCAGCGCCAAGATGAATGACGTGAAGGGTGACGCACTCAAGAGCCTCATCGAGAAGACGGAGAG 65 FBan0006191 FBgn0027581 CG6191 2 2R CG6191 CG6191 BcDNA:GH06193 CDMC24516 2 10 12 DAC19-F21 2-CG6191-RA_1 CG6191 CTCAGCGCCAAGATGAATGACGTGAAGGGTGACGCACTCAAGAGCCTCATCGAGAAGACGGAGAG 65 FBan0006191 FBgn0027581 CG6191 2 2R CG6191 CG6191 BcDNA:GH06193 CDMC24517 2 11 12 DAC19-J09 3-CG6298-RA_1 CG6298 GAATGCAAGCGCACCTACTACTCCACCATCCGTGACTCGAACATCTGTGTCTCCACTCCTGCTGG 65 FBgn0036737 CDMC24517 2 12 12 DAC19-J09 3-CG6298-RA_1 CG6298 GAATGCAAGCGCACCTACTACTCCACCATCCGTGACTCGAACATCTGTGTCTCCACTCCTGCTGG 65 FBgn0036737 CDMC24518 2 13 12 DAC19-J21 3-CG6329-RB_3 CG6329 GAGGTGAACTGCAGCAAACAGGAGCCTCTGGAGCATCTGAAGGACAAATACAAGCCCACCCTGTG 65 FBan0006329 FBgn0033872 CG6329 2 2R CG6329 CG6329 CDMC24518 2 14 12 DAC19-J21 3-CG6329-RB_3 CG6329 GAGGTGAACTGCAGCAAACAGGAGCCTCTGGAGCATCTGAAGGACAAATACAAGCCCACCCTGTG 65 FBan0006329 FBgn0033872 CG6329 2 2R CG6329 CG6329 CDMC24519 2 15 12 DAC19-N09 14-CG6421-RA_1 CG6421 TGGCAAACTGACGGTAAATGGAGAGCATCCCGATTCGGAAAAGGCTTTCATCAACTGCGCCAAGG 65 FBan0006421 FBgn0025827 CG6421 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 calcium ion binding; GO:0005509; ; GO:0005509 CG6421 CG6421 EG:EG0003.8 CDMC24519 2 16 12 DAC19-N09 14-CG6421-RA_1 CG6421 TGGCAAACTGACGGTAAATGGAGAGCATCCCGATTCGGAAAAGGCTTTCATCAACTGCGCCAAGG 65 FBan0006421 FBgn0025827 CG6421 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 calcium ion binding; GO:0005509; ; GO:0005509 CG6421 CG6421 EG:EG0003.8 CDMC24520 2 17 12 DAC19-N21 11-CG6443-RA_1 CG6443 GCGGCCAAGCGTAAGTCCTCCAAAAAGGACAAGAAGAGTGCCAAAAAGGTGGAGGTGAAAGCGGA 65 FBan0006443 FBgn0032290 CG6443 2 2L CG6443 CG6443 CDMC24520 2 18 12 DAC19-N21 11-CG6443-RA_1 CG6443 GCGGCCAAGCGTAAGTCCTCCAAAAAGGACAAGAAGAGTGCCAAAAAGGTGGAGGTGAAAGCGGA 65 FBan0006443 FBgn0032290 CG6443 2 2L CG6443 CG6443 CDMC24521 2 19 12 DAC20-B09 5-CG3003-RB_1 CG3003 CCAGCAGCTGGATAGGCGGTATCAAAGCATCCGACGCACCATTACCAATGAGAGTAGAGCTGCGC 65 FBan0003003 FBgn0030144 CG3003 X X CG3003 CG3003 CDMC24521 2 20 12 DAC20-B09 5-CG3003-RB_1 CG3003 CCAGCAGCTGGATAGGCGGTATCAAAGCATCCGACGCACCATTACCAATGAGAGTAGAGCTGCGC 65 FBan0003003 FBgn0030144 CG3003 X X CG3003 CG3003 CDMC24522 2 21 12 DAC20-B21 2-CG30077-RA_1 CG30077 TAGAGGGGGACATGCATACGATTAACCAGACCCTAGAGCTGGCCTACAAAGCCTCTCGAGCGACA 65 FBan0030077 FBgn0050077 CG30077 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG30077 CG30077 "CG10127, CG10127, CG10127" CDMC24522 2 22 12 DAC20-B21 2-CG30077-RA_1 CG30077 TAGAGGGGGACATGCATACGATTAACCAGACCCTAGAGCTGGCCTACAAAGCCTCTCGAGCGACA 65 FBan0030077 FBgn0050077 CG30077 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG30077 CG30077 "CG10127, CG10127, CG10127" CDMC24523 2 23 12 DAC20-F09 6-CG30179-RA_1 CG30179 CATCTATTGCCGATCGTGCTACGCCAAGTTCTATGGGCCAAAGGGTGTGGGCTACGGAATCGGAG 65 FBan0030179 FBgn0050179 CG30179 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30179 CG30179 "CG3220, CG3220, CG3220" CDMC24523 2 24 12 DAC20-F09 6-CG30179-RA_1 CG30179 CATCTATTGCCGATCGTGCTACGCCAAGTTCTATGGGCCAAAGGGTGTGGGCTACGGAATCGGAG 65 FBan0030179 FBgn0050179 CG30179 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30179 CG30179 "CG3220, CG3220, CG3220" CDMC24524 2 25 12 DAC20-F21 2-CG30259-RA_1 CG30259 TTCGAAGCCAACCTCTCCAACGTGGTTCTTTCGAGGACTTTGGCTAGGGGAAAGATGAACCTGGC 65 FBan0030259 FBgn0050259 CG30259 2 2R CG30259 CG30259 "CG13522, CG13523" CDMC24524 2 26 12 DAC20-F21 2-CG30259-RA_1 CG30259 TTCGAAGCCAACCTCTCCAACGTGGTTCTTTCGAGGACTTTGGCTAGGGGAAAGATGAACCTGGC 65 FBan0030259 FBgn0050259 CG30259 2 2R CG30259 CG30259 "CG13522, CG13523" CDMC24525 2 1 13 DAC20-J09 2-CG30363-RA_1 CG30363 CTGGCTACGACCAAAGGACTATTGCTGTCCCGATCAGGAGGTATATCAGCCCATGAATCGCCGCA 65 FBan0030363 FBgn0050363 CG30363 2 2R CG30363 CG30363 "CG2149, CG2149, CG2149" CDMC24525 2 2 13 DAC20-J09 2-CG30363-RA_1 CG30363 CTGGCTACGACCAAAGGACTATTGCTGTCCCGATCAGGAGGTATATCAGCCCATGAATCGCCGCA 65 FBan0030363 FBgn0050363 CG30363 2 2R CG30363 CG30363 "CG2149, CG2149, CG2149" CDMC24526 2 3 13 DAC20-J21 2-CG30385-RA_1 CG30385 ATCCAGAGTTCTCTCCCACCATTGACCGAACCTTTGCTAGTCAGCCCTTTCAACGTCACCTGCGA 65 FBan0030385 FBgn0050385 CG30385 2 2R CG30385 CG30385 "CG11074, BcDNA:AT12446" CDMC24526 2 4 13 DAC20-J21 2-CG30385-RA_1 CG30385 ATCCAGAGTTCTCTCCCACCATTGACCGAACCTTTGCTAGTCAGCCCTTTCAACGTCACCTGCGA 65 FBan0030385 FBgn0050385 CG30385 2 2R CG30385 CG30385 "CG11074, BcDNA:AT12446" CDMC24527 2 5 13 DAC20-N09 1-CG30475-RA_1 CG30475 CGACACTGGTGACTACGATGTGCCGCATCCGCACCCGTATACGCATCATTATATGCAGACGACGG 65 FBan0030475 FBgn0050475 CG30475 2 2R CG30475 CG30475 CDMC24527 2 6 13 DAC20-N09 1-CG30475-RA_1 CG30475 CGACACTGGTGACTACGATGTGCCGCATCCGCACCCGTATACGCATCATTATATGCAGACGACGG 65 FBan0030475 FBgn0050475 CG30475 2 2R CG30475 CG30475 CDMC24528 2 7 13 DAC20-N21 8-CG30503-RA_2 CG30503 CTGGAGGAAGCCTTTGGCCTGAGAAACGACGGGTTTTTCCCCATATTCTCGTGTGCCTGCGAGTC 65 FBan0030503 FBgn0050503 CG30503 2 2R CG30503 CG30503 "CG1672, BcDNA:RH50933" CDMC24528 2 8 13 DAC20-N21 8-CG30503-RA_2 CG30503 CTGGAGGAAGCCTTTGGCCTGAGAAACGACGGGTTTTTCCCCATATTCTCGTGTGCCTGCGAGTC 65 FBan0030503 FBgn0050503 CG30503 2 2R CG30503 CG30503 "CG1672, BcDNA:RH50933" CDMC24529 2 9 13 DAC21-B09 1-CG3875-RA_1 CG3875 ACAAACGCTACGCCATTTAAACGTGCATATCCGTATCCGACTGACATGAATCGTACGCGCGAACCGCC 68 FBan0003875 FBgn0034740 CG3875 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283; ubiquinone biosynthesis; GO:0006744" mRNA binding; GO:0003729; ; GO:0003729 CG3875 CG3875 cg3875 CDMC24529 2 10 13 DAC21-B09 1-CG3875-RA_1 CG3875 ACAAACGCTACGCCATTTAAACGTGCATATCCGTATCCGACTGACATGAATCGTACGCGCGAACCGCC 68 FBan0003875 FBgn0034740 CG3875 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283; ubiquinone biosynthesis; GO:0006744" mRNA binding; GO:0003729; ; GO:0003729 CG3875 CG3875 cg3875 CDMC24530 2 11 13 DAC21-B21 2-CG3983-RB_1 CG3983 GCCTCCGGAAGTTCAGGAAGGGCAAAGTGTGCATATAAGTGCCTCGATAGTACACTCAGAGGCTCGCG 68 FBan0003983 FBgn0038473 CG3983 3 3R "cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; protein metabolism; GO:0019538; regulation of translation; GO:0006445; signal transduction; GO:0007165; transport; GO:0006810" GTP binding; GO:0005525; receptor binding; GO:0005102; hormone activity; GO:0005179; ; GO:0005102; ; GO:0005179; ; GO:0005525 CG3983 CG3983 CDMC24530 2 12 13 DAC21-B21 2-CG3983-RB_1 CG3983 GCCTCCGGAAGTTCAGGAAGGGCAAAGTGTGCATATAAGTGCCTCGATAGTACACTCAGAGGCTCGCG 68 FBan0003983 FBgn0038473 CG3983 3 3R "cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; protein metabolism; GO:0019538; regulation of translation; GO:0006445; signal transduction; GO:0007165; transport; GO:0006810" GTP binding; GO:0005525; receptor binding; GO:0005102; hormone activity; GO:0005179; ; GO:0005102; ; GO:0005179; ; GO:0005525 CG3983 CG3983 CDMC24531 2 13 13 DAC21-F09 2-CG4236-RA_1 CG4236 CGGTCACACTGCCAAGATTAGCGATTTCTCGTGGAACCCCAATGAGCCATGGATCATTTGCTCCGTGT 68 FBan0004236 FBgn0015610 Caf1 3 3R DNA repair; GO:0006281; DNA replication-dependent nucleosome assembly; GO:0006335; chorion gene amplification; GO:0007307; chromatin silencing; GO:0006342; cytokinesis; GO:0000910; histone acetylation; GO:0016573; histone methylation; GO:0016571; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; transcription; GO:0006350 chromatin binding; GO:0003682; ; GO:0003682; histone binding; GO:0042393; histone acetyltransferase binding; GO:0035035; ; GO:0035035; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0042393; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0042393; ; GO:0042826; ; GO:0035035 ESC/E(Z) complex; GO:0035098; Myb complex; GO:0031523; NOT ACF complex; GO:0016590; NURF complex; GO:0016589; chromatin assembly complex; GO:0005678; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634; polytene chromosome; GO:0005700; transcription factor complex; GO:0005667 Caf1 Chromatin assembly factor 1 subunit "CG4236, dCAF-1, NURF-55, Nucleosome remodeling factor - 55kD, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, p55, d-CAF1, CAF-1, CAF1, dCAF-1 p55, dNURF, NURF55, Caf-1, p55/NURF-55, Nurf-55, 55, caf1 p55, Caf1p55, CAF1p55, caf-1, p55,CAF1, MSI1/RbAp48/CAC3/LIN-53, caf1, NURF, Chromatin assembly factor 1 subunit" CDMC24531 2 14 13 DAC21-F09 2-CG4236-RA_1 CG4236 CGGTCACACTGCCAAGATTAGCGATTTCTCGTGGAACCCCAATGAGCCATGGATCATTTGCTCCGTGT 68 FBan0004236 FBgn0015610 Caf1 3 3R DNA repair; GO:0006281; DNA replication-dependent nucleosome assembly; GO:0006335; chorion gene amplification; GO:0007307; chromatin silencing; GO:0006342; cytokinesis; GO:0000910; histone acetylation; GO:0016573; histone methylation; GO:0016571; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; transcription; GO:0006350 chromatin binding; GO:0003682; ; GO:0003682; histone binding; GO:0042393; histone acetyltransferase binding; GO:0035035; ; GO:0035035; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0042393; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0042393; ; GO:0042826; ; GO:0035035 ESC/E(Z) complex; GO:0035098; Myb complex; GO:0031523; NOT ACF complex; GO:0016590; NURF complex; GO:0016589; chromatin assembly complex; GO:0005678; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634; polytene chromosome; GO:0005700; transcription factor complex; GO:0005667 Caf1 Chromatin assembly factor 1 subunit "CG4236, dCAF-1, NURF-55, Nucleosome remodeling factor - 55kD, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, p55, d-CAF1, CAF-1, CAF1, dCAF-1 p55, dNURF, NURF55, Caf-1, p55/NURF-55, Nurf-55, 55, caf1 p55, Caf1p55, CAF1p55, caf-1, p55,CAF1, MSI1/RbAp48/CAC3/LIN-53, caf1, NURF, Chromatin assembly factor 1 subunit" CDMC24532 2 15 13 DAC21-F21 23-CG4423-RA_1 CG4423 ACGAGAACTTGGCAAGAATTCAAAGCGCCAAAAAATTTCTAGCCGAAAACTTAATAGAAAAGTTATAA 68 FBan0004423 FBgn0010042 GstD6 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD6 Glutathione S transferase D6 "CG4423, DmGST25, gstD25, GST, Gst, DmGSTD6, GstD25: Glutathione S transferase D25, Glutathione S transferase D25, Glutathione S transferase D6" CDMC24532 2 16 13 DAC21-F21 23-CG4423-RA_1 CG4423 ACGAGAACTTGGCAAGAATTCAAAGCGCCAAAAAATTTCTAGCCGAAAACTTAATAGAAAAGTTATAA 68 FBan0004423 FBgn0010042 GstD6 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD6 Glutathione S transferase D6 "CG4423, DmGST25, gstD25, GST, Gst, DmGSTD6, GstD25: Glutathione S transferase D25, Glutathione S transferase D25, Glutathione S transferase D6" CDMC24533 2 17 13 DAC21-J09 3-CG4938-RA_4 CG4938 GGTTTTAAGCTGATCTCCGTGCCGGACATACTGCCTAAGGAGGTGATCGAATCTTGTGGCATGCGCAC 68 FBan0004938 FBgn0021750 Aats-ser 3 3R seryl-tRNA aminoacylation; GO:0006434 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 Aats-ser Seryl-tRNA synthetase "CG4938, SRS, seryl-tRNA synthetase, SerRS, Aat-Ser, Seryl-tRNA synthetase" CDMC24533 2 18 13 DAC21-J09 3-CG4938-RA_4 CG4938 GGTTTTAAGCTGATCTCCGTGCCGGACATACTGCCTAAGGAGGTGATCGAATCTTGTGGCATGCGCAC 68 FBan0004938 FBgn0021750 Aats-ser 3 3R seryl-tRNA aminoacylation; GO:0006434 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 Aats-ser Seryl-tRNA synthetase "CG4938, SRS, seryl-tRNA synthetase, SerRS, Aat-Ser, Seryl-tRNA synthetase" CDMC24534 2 19 13 DAC21-J21 3-CG5063-RA_2 CG5063 GCAGCTCCTACTCTCCAGGATTGCAGGAGTTTATCGAGGCCTACACCTACATGGAGTACCTGTGCCAC 68 FBan0005063 FBgn0038327 Trax 3 3R Trax Translin associated factor X "CG5063, CG5063, Translin associated factor X" CDMC24534 2 20 13 DAC21-J21 3-CG5063-RA_2 CG5063 GCAGCTCCTACTCTCCAGGATTGCAGGAGTTTATCGAGGCCTACACCTACATGGAGTACCTGTGCCAC 68 FBan0005063 FBgn0038327 Trax 3 3R Trax Translin associated factor X "CG5063, CG5063, Translin associated factor X" CDMC24535 2 21 13 DAC21-N09 2-CG5414-RA_1 CG5414 ACTGCTATCAACAACTCTGCAAGAGCTTATGGCCCATTGTTCCCTTCCTGGTGGAGGAAAGCTGGAGC 68 FBan0005414 FBgn0036569 CG5414 3 3L isoleucyl-tRNA aminoacylation; GO:0006428; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; isoleucine-tRNA ligase activity; GO:0004822 ; EC:6.1.1.5; ; GO:0004822 ; EC:6.1.1.5 CG5414 CG5414 CDMC24535 2 22 13 DAC21-N09 2-CG5414-RA_1 CG5414 ACTGCTATCAACAACTCTGCAAGAGCTTATGGCCCATTGTTCCCTTCCTGGTGGAGGAAAGCTGGAGC 68 FBan0005414 FBgn0036569 CG5414 3 3L isoleucyl-tRNA aminoacylation; GO:0006428; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; isoleucine-tRNA ligase activity; GO:0004822 ; EC:6.1.1.5; ; GO:0004822 ; EC:6.1.1.5 CG5414 CG5414 CDMC24536 2 23 13 DAC21-N21 16-CG5535-RA_1 CG5535 TCAAGTTGGACATTCTCACATGGATTCGCTTCAGTATATGGATCGCCATAGGCCTGGCAATCTTCCTG 68 FBan0005535 FBgn0036764 CG5535 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG5535 CG5535 anon-WO0118547.111 CDMC24536 2 24 13 DAC21-N21 16-CG5535-RA_1 CG5535 TCAAGTTGGACATTCTCACATGGATTCGCTTCAGTATATGGATCGCCATAGGCCTGGCAATCTTCCTG 68 FBan0005535 FBgn0036764 CG5535 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG5535 CG5535 anon-WO0118547.111 CDMC24537 2 25 13 DAC22-B09 23-CG40446-RA_13 CG40446 CGAGCTCTAACTGAAGATGCAAGAACACCTACAGGAGTACATCGTTGGCGAATATTAAAAGGCGAAGAT 69 CDMC24537 2 26 13 DAC22-B09 23-CG40446-RA_13 CG40446 CGAGCTCTAACTGAAGATGCAAGAACACCTACAGGAGTACATCGTTGGCGAATATTAAAAGGCGAAGAT 69 CDMC24538 2 1 14 DAC22-B21 4-CG40460-RD_1 CG40460 AAACGCCGTGTAACCATGAGACTAGCCCCCTTGTGTTAGCATGTAGTGGGCCAAATTAGTTCCGTGCTT 69 FBgn0039945 CG17159 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17159 CG17159 "CG40460, CG40460, anon-20Ea" CDMC24538 2 2 14 DAC22-B21 4-CG40460-RD_1 CG40460 AAACGCCGTGTAACCATGAGACTAGCCCCCTTGTGTTAGCATGTAGTGGGCCAAATTAGTTCCGTGCTT 69 FBgn0039945 CG17159 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17159 CG17159 "CG40460, CG40460, anon-20Ea" CDMC24539 2 3 14 DAC22-F09 1-CG4059-RA_1 CG4059 CCGACGAGACGCAACTGAACAATGGTCAGGTGTTCAATCTGATGAGTCTGGGTTTGTTGGGAGTGCCAC 69 FBan0004059 FBgn0001078 ftz-f1 3 3L "cell death; GO:0008219; larval or pupal development (sensu Insecta); GO:0002165; metamorphosis (sensu Insecta); GO:0046698; periodic partitioning; GO:0007365; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to hormone stimulus; GO:0009725; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0003712; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 cytoplasm; GO:0005737; nucleus; GO:0005634 ftz-f1 ftz transcription factor 1 "CG4059, CG13378, CG4059, CG4059, FTZ-F1, FTZ-F1alpha, DEP1, ftz-f1alpha, alphaFTZ-F1, betaFTZ-F1, betaftz-F1, ftz-F1, DmFTZ-F1, FIP1, Ftz interacting protein 1, Ftz-F1, Ftz-f1, alphaFTZF1, betaFTZF1, l(3)03649, beta-Ftz-F1, FTZF1, NR5A3, dFtz-F1alpha, beta FTZ-F1, bFTZ-F1, alphaftz-f1, betaftz-f1, beta FTZ-F1, ftzf1, dFTZ-F1alpha" CDMC24539 2 4 14 DAC22-F09 1-CG4059-RA_1 CG4059 CCGACGAGACGCAACTGAACAATGGTCAGGTGTTCAATCTGATGAGTCTGGGTTTGTTGGGAGTGCCAC 69 FBan0004059 FBgn0001078 ftz-f1 3 3L "cell death; GO:0008219; larval or pupal development (sensu Insecta); GO:0002165; metamorphosis (sensu Insecta); GO:0046698; periodic partitioning; GO:0007365; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to hormone stimulus; GO:0009725; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0003712; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 cytoplasm; GO:0005737; nucleus; GO:0005634 ftz-f1 ftz transcription factor 1 "CG4059, CG13378, CG4059, CG4059, FTZ-F1, FTZ-F1alpha, DEP1, ftz-f1alpha, alphaFTZ-F1, betaFTZ-F1, betaftz-F1, ftz-F1, DmFTZ-F1, FIP1, Ftz interacting protein 1, Ftz-F1, Ftz-f1, alphaFTZF1, betaFTZF1, l(3)03649, beta-Ftz-F1, FTZF1, NR5A3, dFtz-F1alpha, beta FTZ-F1, bFTZ-F1, alphaftz-f1, betaftz-f1, beta FTZ-F1, ftzf1, dFTZ-F1alpha" CDMC24540 2 5 14 DAC22-F21 16-CG4066-RA_1 CG4066 ACTTCTTCGAGGCGTTGTCACCTCTTTTCAGAACTTAGACATTTTTGCCAACCGATCAATCGAAGCCGT 69 FBan0004066 FBgn0038011 CG4066 3 3R CG4066 CG4066 CDMC24540 2 6 14 DAC22-F21 16-CG4066-RA_1 CG4066 ACTTCTTCGAGGCGTTGTCACCTCTTTTCAGAACTTAGACATTTTTGCCAACCGATCAATCGAAGCCGT 69 FBan0004066 FBgn0038011 CG4066 3 3R CG4066 CG4066 CDMC24541 2 7 14 DAC22-J09 23-CG41040-RA_7 CG41040 TGGTGCGCGTATGAAAAAAATAAAAAAACAATGAAAAAAATGCACATACATACAAAGGAATGCAACAGA 69 FBgn0069967 CG41040 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41040 CG41040 CDMC24541 2 8 14 DAC22-J09 23-CG41040-RA_7 CG41040 TGGTGCGCGTATGAAAAAAATAAAAAAACAATGAAAAAAATGCACATACATACAAAGGAATGCAACAGA 69 FBgn0069967 CG41040 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41040 CG41040 CDMC24542 2 9 14 DAC22-J21 22-CG41063-RA_1 CG41063 TCTGCCGGATTTTGATCCAATCAAGGGATCTATCACATCGGAGCAATTCATCGCAAAGGTAGAGCAACT 69 FBgn0069956 CG41063 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41063 CG41063 CDMC24542 2 10 14 DAC22-J21 22-CG41063-RA_1 CG41063 TCTGCCGGATTTTGATCCAATCAAGGGATCTATCACATCGGAGCAATTCATCGCAAAGGTAGAGCAACT 69 FBgn0069956 CG41063 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41063 CG41063 CDMC24543 2 11 14 DAC22-N09 3-CG4111-RA_1 CG4111 TCGCCGTCAAGGCCTAGAATGCATCCAGATACTCCGACTGTCTATAGTGCGCGTTAAGGGTTCTTCGGT 69 FBan0004111 FBgn0029785 RpL35 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL35 Ribosomal protein L35 "CG4111, BcDNA:RE09547, anon-EST:Posey157, anon-EST:fe1C12, anon-fast-evolving-1C12, Ribosomal protein L35" CDMC24543 2 12 14 DAC22-N09 3-CG4111-RA_1 CG4111 TCGCCGTCAAGGCCTAGAATGCATCCAGATACTCCGACTGTCTATAGTGCGCGTTAAGGGTTCTTCGGT 69 FBan0004111 FBgn0029785 RpL35 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL35 Ribosomal protein L35 "CG4111, BcDNA:RE09547, anon-EST:Posey157, anon-EST:fe1C12, anon-fast-evolving-1C12, Ribosomal protein L35" CDMC24544 2 13 14 DAC22-N21 15-CG41133-RA_3 CG41133 AAAAAGTCTGGGTCAAGACACTCAGTTATAGGCCACAGCAGTTCAGACGAGAAAGGAAACGCGGTTGCA 69 FBgn0069919 CG41133 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41133 CG41133 CDMC24544 2 14 14 DAC22-N21 15-CG41133-RA_3 CG41133 AAAAAGTCTGGGTCAAGACACTCAGTTATAGGCCACAGCAGTTCAGACGAGAAAGGAAACGCGGTTGCA 69 FBgn0069919 CG41133 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41133 CG41133 CDMC24545 2 15 14 DAC23-B09 8-CG33339-RA_6 CG33339 CTTCAGTACAGCTTGGAGTTTGATATGTACGTTCCGGTTCCCGACACCATTGAGGGTTGGCAGCCCAAG 69 FBan0033339 FBgn0053339 CG33339 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33339 CG33339 CG13612 CDMC24545 2 16 14 DAC23-B09 8-CG33339-RA_6 CG33339 CTTCAGTACAGCTTGGAGTTTGATATGTACGTTCCGGTTCCCGACACCATTGAGGGTTGGCAGCCCAAG 69 FBan0033339 FBgn0053339 CG33339 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33339 CG33339 CG13612 CDMC24546 2 17 14 DAC23-B21 1-CG33349-RA_1 CG33349 CGGACGCTGATCATCAACCTGCAAATTTCGAGGATGGGCATAAATCGGCGGGTTGTATTCAGCACGGAT 69 CDMC24546 2 18 14 DAC23-B21 1-CG33349-RA_1 CG33349 CGGACGCTGATCATCAACCTGCAAATTTCGAGGATGGGCATAAATCGGCGGGTTGTATTCAGCACGGAT 69 CDMC24547 2 19 14 DAC23-F09 23-CG33469-RA_16 CG33469 TACGTCGTTGGATGCTGATACGATAGAATATTTCGGAATATTCAGTATTGACGAACCAAATGTCGCTGC 69 FBan0033469 FBgn0053469 CG33469 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33469 CG33469 CDMC24547 2 20 14 DAC23-F09 23-CG33469-RA_16 CG33469 TACGTCGTTGGATGCTGATACGATAGAATATTTCGGAATATTCAGTATTGACGAACCAAATGTCGCTGC 69 FBan0033469 FBgn0053469 CG33469 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33469 CG33469 CDMC24548 2 21 14 DAC23-F21 22-CG33477-RA_1 CG33477 AGCCTAGAGTCGCTGGATACCAGATGTGATCATGATTTCGTGGAATATTTCCATAGAGTGCCCGACTCT 69 FBan0033477 FBgn0053477 CG33477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33477 CG33477 CDMC24548 2 22 14 DAC23-F21 22-CG33477-RA_1 CG33477 AGCCTAGAGTCGCTGGATACCAGATGTGATCATGATTTCGTGGAATATTTCCATAGAGTGCCCGACTCT 69 FBan0033477 FBgn0053477 CG33477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33477 CG33477 CDMC24549 2 23 14 DAC23-J09 10-CG33495-RA_1 CG33495 ACACAATCGTTGCCAATCCGTCATGAAGACTCCGCTATTTCTCCTCTTGGTCGTATTGGCTTCCCTCCT 69 FBgn0053495 CDMC24549 2 24 14 DAC23-J09 10-CG33495-RA_1 CG33495 ACACAATCGTTGCCAATCCGTCATGAAGACTCCGCTATTTCTCCTCTTGGTCGTATTGGCTTCCCTCCT 69 FBgn0053495 CDMC24550 2 25 14 DAC23-J21 3-CG3352-RA_1 CG3352 CCTCGGCTGGGAGTATCTGCTCAATTGGGGACCTAGCTACGAAAATCTGATGGGCGTCTTCAAGGACAT 69 FBan0003352 FBgn0001075 ft 2 2L "calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; imaginal disc growth; GO:0007446; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of imaginal disc growth; GO:0045571; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; regulation of transcription, DNA-dependent; GO:0006355" receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; transcription factor activity; GO:0003700; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0003700 host cell nucleus; GO:0042025; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 ft fat "CG3352, CG3352, l(2)ft, l(2)fat, l(2)79/18, l(2)gd-1: giant-discs-1, l(2)k07918, 79/18, CT11259, Ft, l(2)24Da, l(2)fd: floppy-discs, l(2)gd-l, l(2)gd2: giant discs 2, floppy-discs, giant-discs-1, giant discs 2, l(2)gd-1, fat" CDMC24550 2 26 14 DAC23-J21 3-CG3352-RA_1 CG3352 CCTCGGCTGGGAGTATCTGCTCAATTGGGGACCTAGCTACGAAAATCTGATGGGCGTCTTCAAGGACAT 69 FBan0003352 FBgn0001075 ft 2 2L "calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; imaginal disc growth; GO:0007446; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of imaginal disc growth; GO:0045571; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; regulation of transcription, DNA-dependent; GO:0006355" receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; transcription factor activity; GO:0003700; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0003700 host cell nucleus; GO:0042025; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 ft fat "CG3352, CG3352, l(2)ft, l(2)fat, l(2)79/18, l(2)gd-1: giant-discs-1, l(2)k07918, 79/18, CT11259, Ft, l(2)24Da, l(2)fd: floppy-discs, l(2)gd-l, l(2)gd2: giant discs 2, floppy-discs, giant-discs-1, giant discs 2, l(2)gd-1, fat" CDMC24551 2 1 15 DAC23-N09 3-CG3403-RA_1 CG3403 AGGGACCAGGCTAGCATTCAGTTTCTGCCAGTGATTTTCTCATCAAGGCGTAGGCACAGACGTTGTGGA 69 FBan0003403 FBgn0033094 CG3403 2 2R CG3403 CG3403 CDMC24551 2 2 15 DAC23-N09 3-CG3403-RA_1 CG3403 AGGGACCAGGCTAGCATTCAGTTTCTGCCAGTGATTTTCTCATCAAGGCGTAGGCACAGACGTTGTGGA 69 FBan0003403 FBgn0033094 CG3403 2 2R CG3403 CG3403 CDMC24552 2 3 15 DAC23-N21 23-CG3413-RB_6 CG3413 CTGTAGATGAGAGATTTTATCAATTTATCAATTTAGCCAAATGCAATCTGATTGTGCAACTGGGAACCG 69 FBan0003413 FBgn0034718 wdp 2 2R plasma membrane; GO:0005886 wdp windpipe "CG3413, CG30504, CT11415, CT39092, connectin-like, windpipe" CDMC24552 2 4 15 DAC23-N21 23-CG3413-RB_6 CG3413 CTGTAGATGAGAGATTTTATCAATTTATCAATTTAGCCAAATGCAATCTGATTGTGCAACTGGGAACCG 69 FBan0003413 FBgn0034718 wdp 2 2R plasma membrane; GO:0005886 wdp windpipe "CG3413, CG30504, CT11415, CT39092, connectin-like, windpipe" CDMC24553 2 5 15 DAC24-B09 18-CG33162-RA_8 CG33162 CGCTGTGCTCACTCTAGATGAGTGCGTGTCATTTTCCCCATCCAATTTGTTTGGTGTTTTGTTAGCCGA 69 FBan0033162 FBgn0011509 SrpRbeta 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 signal recognition particle binding; GO:0005047; receptor activity; GO:0004872; GTPase activity; GO:0003924; ; GO:0004872; ; GO:0003924; ; GO:0005047; ; GO:0005047 signal recognition particle receptor complex; GO:0005785 SrpRbeta Signal recognition particle receptor beta "CG33162, CG5950, l(3)rK561, l(3)rL537, srpRbeta, SRbeta, Dm SRbeta, BcDNA:GM04779, Signal recognition particle receptor beta" CDMC24553 2 6 15 DAC24-B09 18-CG33162-RA_8 CG33162 CGCTGTGCTCACTCTAGATGAGTGCGTGTCATTTTCCCCATCCAATTTGTTTGGTGTTTTGTTAGCCGA 69 FBan0033162 FBgn0011509 SrpRbeta 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614 signal recognition particle binding; GO:0005047; receptor activity; GO:0004872; GTPase activity; GO:0003924; ; GO:0004872; ; GO:0003924; ; GO:0005047; ; GO:0005047 signal recognition particle receptor complex; GO:0005785 SrpRbeta Signal recognition particle receptor beta "CG33162, CG5950, l(3)rK561, l(3)rL537, srpRbeta, SRbeta, Dm SRbeta, BcDNA:GM04779, Signal recognition particle receptor beta" CDMC24554 2 7 15 DAC24-B21 3-CG33172-RA_2 CG33172 CGCATCCAAAACGAGTACCATTGAAGCGCGACTAATGGCCATAGATGTTGTCCAGCATTCGGATGGGGA 69 FBan0033172 FBgn0053172 CG33172 X X CG33172 CG33172 CG8473 CDMC24554 2 8 15 DAC24-B21 3-CG33172-RA_2 CG33172 CGCATCCAAAACGAGTACCATTGAAGCGCGACTAATGGCCATAGATGTTGTCCAGCATTCGGATGGGGA 69 FBan0033172 FBgn0053172 CG33172 X X CG33172 CG33172 CG8473 CDMC24555 2 9 15 DAC24-F09 23-CG33197-RA_3 CG33197 CGGCATGAAGCAAAAATAAAAACCACACCCAAAAATAAACCAATGCAATACCAATTCCAAGGGGCAAGT 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC24555 2 10 15 DAC24-F09 23-CG33197-RA_3 CG33197 CGGCATGAAGCAAAAATAAAAACCACACCCAAAAATAAACCAATGCAATACCAATTCCAAGGGGCAAGT 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC24556 2 11 15 DAC24-F21 16-CG33202-RB_2 CG33202 AGGGGAATCGGGATCTGGGAAATTCCTGCCATCAAACGAATGCCATTTTGGAAAAATGCTACTCGAATT 69 FBan0033202 FBgn0053202 dpr11 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr11 dpr11 "CG15183, CG31309, CG33202, CG15181, CG15182, CG15183, CG31309, CG15183, CG33202, CT35098, Dpr-11, BcDNA:GH22307" CDMC24556 2 12 15 DAC24-F21 16-CG33202-RB_2 CG33202 AGGGGAATCGGGATCTGGGAAATTCCTGCCATCAAACGAATGCCATTTTGGAAAAATGCTACTCGAATT 69 FBan0033202 FBgn0053202 dpr11 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr11 dpr11 "CG15183, CG31309, CG33202, CG15181, CG15182, CG15183, CG31309, CG15183, CG33202, CT35098, Dpr-11, BcDNA:GH22307" CDMC24557 2 13 15 DAC24-J09 3-CG33227-RB_1 CG33227 CCCCGATTTGTGGTTTGCCCCGAAAATATATCCTTAGCCAGGGATTTGCCTATCCTGACCACAGCGGAG 69 FBgn0050408 CDMC24557 2 14 15 DAC24-J09 3-CG33227-RB_1 CG33227 CCCCGATTTGTGGTTTGCCCCGAAAATATATCCTTAGCCAGGGATTTGCCTATCCTGACCACAGCGGAG 69 FBgn0050408 CDMC24558 2 15 15 DAC24-J21 17-CG33245-RA_2 CG33245 GAGCGTGGCCTGATTGCTATGCACCGAAAATATTTGCGAGGAGATTTTGGATCGTGTCCCAATATCTCC 69 FBan0033245 FBgn0053245 Ste:CG33245 X X regulation of protein kinase activity; GO:0045859 protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; ; GO:0008605 protein kinase CK2 complex; GO:0005956 Ste:CG33245 Ste:CG33245 "CG33245, CG32605" CDMC24558 2 16 15 DAC24-J21 17-CG33245-RA_2 CG33245 GAGCGTGGCCTGATTGCTATGCACCGAAAATATTTGCGAGGAGATTTTGGATCGTGTCCCAATATCTCC 69 FBan0033245 FBgn0053245 Ste:CG33245 X X regulation of protein kinase activity; GO:0045859 protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; ; GO:0008605 protein kinase CK2 complex; GO:0005956 Ste:CG33245 Ste:CG33245 "CG33245, CG32605" CDMC24559 2 17 15 DAC24-N09 17-CG33287-RA_1 CG33287 CTTCTCCATCAAGCATATTGCCTTAGAGCTGCACACCTACAATACCATGGCTCTGCAATGCAAGCTGAT 69 FBan0033287 FBgn0053287 CG33287 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33287 CG33287 "CG12982, CG12982" CDMC24559 2 18 15 DAC24-N09 17-CG33287-RA_1 CG33287 CTTCTCCATCAAGCATATTGCCTTAGAGCTGCACACCTACAATACCATGGCTCTGCAATGCAAGCTGAT 69 FBan0033287 FBgn0053287 CG33287 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33287 CG33287 "CG12982, CG12982" CDMC24560 2 19 15 DAC24-N21 2-CG33297-RA_1 CG33297 AGGAGTCAGAGGAAGGAGAGAATCGGAGAATCAGCATGGGAGGAGACCCACTAAACGCGACACACAACT 69 FBan0017291 FBgn0005776 Pp2A-29B 2 2L protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0008601; ; GO:0004722 protein phosphatase type 2A complex; GO:0000159; protein serine/threonine phosphatase complex; GO:0008287 Pp2A-29B Protein phosphatase 2A at 29B "CG17291, CG33297, PR65, regulatory subunit A of type 2A protein phosphatase, DPR65, 65 kDa regulatory subunit of protein phosphatase, PP2A, PP2A-29B, A/PR65, Pp2A" CDMC24560 2 20 15 DAC24-N21 2-CG33297-RA_1 CG33297 AGGAGTCAGAGGAAGGAGAGAATCGGAGAATCAGCATGGGAGGAGACCCACTAAACGCGACACACAACT 69 FBan0017291 FBgn0005776 Pp2A-29B 2 2L protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0008601; ; GO:0004722 protein phosphatase type 2A complex; GO:0000159; protein serine/threonine phosphatase complex; GO:0008287 Pp2A-29B Protein phosphatase 2A at 29B "CG17291, CG33297, PR65, regulatory subunit A of type 2A protein phosphatase, DPR65, 65 kDa regulatory subunit of protein phosphatase, PP2A, PP2A-29B, A/PR65, Pp2A" CDMC24561 2 21 15 DAC25-B09 17-CG1034-RA_1 CG1034 TGGGCGAATCGAACCAATATCAATGCACGATGGATACGATAATGCAAGCGTATAATCCCCATCGGAACG 69 FBan0001034 FBgn0000166 bcd 3 3R "anterior region determination; GO:0007355; anterior/posterior axis specification; GO:0009948; determination of anterior/posterior axis, embryo; GO:0008595; maternal determination of anterior/posterior axis, embryo; GO:0008358; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; regulation of translation; GO:0006445" DNA binding; GO:0003677; mRNA binding; GO:0003729; specific RNA polymerase II transcription factor activity; GO:0003704; translation regulator activity; GO:0045182; morphogen activity; GO:0016015; ; GO:0003729; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0016015; ; GO:0045182; ; GO:0003700; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634 bcd bicoid "CG1034, PRD gene 4, Bcd, bic, Bicoid, BCD, BG:DS00276.7, mum: multimorph, prd4, multimorph, bicoid" CDMC24561 2 22 15 DAC25-B09 17-CG1034-RA_1 CG1034 TGGGCGAATCGAACCAATATCAATGCACGATGGATACGATAATGCAAGCGTATAATCCCCATCGGAACG 69 FBan0001034 FBgn0000166 bcd 3 3R "anterior region determination; GO:0007355; anterior/posterior axis specification; GO:0009948; determination of anterior/posterior axis, embryo; GO:0008595; maternal determination of anterior/posterior axis, embryo; GO:0008358; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; regulation of translation; GO:0006445" DNA binding; GO:0003677; mRNA binding; GO:0003729; specific RNA polymerase II transcription factor activity; GO:0003704; translation regulator activity; GO:0045182; morphogen activity; GO:0016015; ; GO:0003729; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0016015; ; GO:0045182; ; GO:0003700; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634 bcd bicoid "CG1034, PRD gene 4, Bcd, bic, Bicoid, BCD, BG:DS00276.7, mum: multimorph, prd4, multimorph, bicoid" CDMC24562 2 23 15 DAC25-B21 3-CG10364-RA_1 CG10364 TCCTCGCTCTCCTCAGCTGAATCGCACTCCACTGGTCCTCGATGAGGTTCGTTCGCTTAATATGGATGA 69 FBan0010364 FBgn0027949 msb1l 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 msb1l msb1l "CG10364, CG10364, msh1l" CDMC24562 2 24 15 DAC25-B21 3-CG10364-RA_1 CG10364 TCCTCGCTCTCCTCAGCTGAATCGCACTCCACTGGTCCTCGATGAGGTTCGTTCGCTTAATATGGATGA 69 FBan0010364 FBgn0027949 msb1l 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 msb1l msb1l "CG10364, CG10364, msh1l" CDMC24563 2 25 15 DAC25-F09 12-CG10405-RA_1 CG10405 CCGTCCTGTCGTCGGTACTCAAAAGCACTACGGTACTGACAGTCAACCAAGAGAAGTGCCACAACGATC 69 FBan0010405 FBgn0038431 CG10405 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10405 CG10405 SP155 CDMC24563 2 26 15 DAC25-F09 12-CG10405-RA_1 CG10405 CCGTCCTGTCGTCGGTACTCAAAAGCACTACGGTACTGACAGTCAACCAAGAGAAGTGCCACAACGATC 69 FBan0010405 FBgn0038431 CG10405 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10405 CG10405 SP155 CDMC24564 2 1 16 DAC25-F21 23-CG10419-RA_1 CG10419 AGAAGTTACCCATTTAACCCATGTACACAAGTCAATTATTTCTGGAAAATGTACTGAAATGTGACCATT 69 FBan0010419 FBgn0036850 CG10419 3 3L CG10419 CG10419 CDMC24564 2 2 16 DAC25-F21 23-CG10419-RA_1 CG10419 AGAAGTTACCCATTTAACCCATGTACACAAGTCAATTATTTCTGGAAAATGTACTGAAATGTGACCATT 69 FBan0010419 FBgn0036850 CG10419 3 3L CG10419 CG10419 CDMC24565 2 3 16 DAC25-J09 13-CG10470-RA_2 CG10470 ACATGGGTGATGGTTTACCGGACGGAGAAGTACCAAAAGCTAAAGACCGAGGTGGAAAAGCAGAGCAAA 69 FBan0010470 FBgn0032746 CG10470 2 2L CG10470 CG10470 "B2, TU37B2, transcription unit 37B2, TUB2, TuB2, anon-37B-2" CDMC24565 2 4 16 DAC25-J09 13-CG10470-RA_2 CG10470 ACATGGGTGATGGTTTACCGGACGGAGAAGTACCAAAAGCTAAAGACCGAGGTGGAAAAGCAGAGCAAA 69 FBan0010470 FBgn0032746 CG10470 2 2L CG10470 CG10470 "B2, TU37B2, transcription unit 37B2, TUB2, TuB2, anon-37B-2" CDMC24566 2 5 16 DAC25-J21 1-CG10481-RA_1 CG10481 TGCGGTTGATACGAGTCCAGAGTTTCGCTACACCTTTGTCAGTCTGTTTAGGGGTCCCATTTCGGGTGT 69 FBan0010481 FBgn0032827 CG10481 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG10481 CG10481 CDMC24566 2 6 16 DAC25-J21 1-CG10481-RA_1 CG10481 TGCGGTTGATACGAGTCCAGAGTTTCGCTACACCTTTGTCAGTCTGTTTAGGGGTCCCATTTCGGGTGT 69 FBan0010481 FBgn0032827 CG10481 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG10481 CG10481 CDMC24567 2 7 16 DAC25-N09 16-CG10524-RA_1 CG10524 CGATGAAGACGAGCTCTTCTGGTCCATTTGCAATGAAATTCCATGGTTCCCAGTTTACATATCCGCCGA 69 FBan0010524 FBgn0030387 Pkcdelta X X MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.- Pkcdelta Protein kinase C delta "CG10524, PKCd, protein kinase C, Pkcdelta, Protein kinase C delta" CDMC24567 2 8 16 DAC25-N09 16-CG10524-RA_1 CG10524 CGATGAAGACGAGCTCTTCTGGTCCATTTGCAATGAAATTCCATGGTTCCCAGTTTACATATCCGCCGA 69 FBan0010524 FBgn0030387 Pkcdelta X X MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.- Pkcdelta Protein kinase C delta "CG10524, PKCd, protein kinase C, Pkcdelta, Protein kinase C delta" CDMC24568 2 9 16 DAC25-N21 23-CG10533-RA_1 CG10533 CCCCCGTGGTTTGAGCTATCCATCGTTAATATTGTTTTACTGAAAAATCCTTCAATTATGAATAAAACC 69 FBan0010533 FBgn0020639 Lcp65Af 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Af Lcp65Af "CG10533, CG10533, Lcp-f, DMLCP65f, DCP7" CDMC24568 2 10 16 DAC25-N21 23-CG10533-RA_1 CG10533 CCCCCGTGGTTTGAGCTATCCATCGTTAATATTGTTTTACTGAAAAATCCTTCAATTATGAATAAAACC 69 FBan0010533 FBgn0020639 Lcp65Af 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Af Lcp65Af "CG10533, CG10533, Lcp-f, DMLCP65f, DCP7" CDMC24569 2 11 16 DAC26-B09 1-CG1527-RA_1 CG1527 GCGCACGCAATTGTTGCTGATCGACGACCAGACTCTGCAGAATGGCTCCAAGAAAGGCTAAAGTTCAGA 69 FBan0001527 FBgn0004404 RpS14b X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS14b Ribosomal protein S14b "CG1527, CG1527, RPS14B, S14, RpS14, RpS14B, anon-EST:Posey115, anon-EST:Posey131, anon-EST:Posey154, anon-EST:Posey77, rpS14B" CDMC24569 2 12 16 DAC26-B09 1-CG1527-RA_1 CG1527 GCGCACGCAATTGTTGCTGATCGACGACCAGACTCTGCAGAATGGCTCCAAGAAAGGCTAAAGTTCAGA 69 FBan0001527 FBgn0004404 RpS14b X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS14b Ribosomal protein S14b "CG1527, CG1527, RPS14B, S14, RpS14, RpS14B, anon-EST:Posey115, anon-EST:Posey131, anon-EST:Posey154, anon-EST:Posey77, rpS14B" CDMC24570 2 13 16 DAC26-B21 13-CG1528-RA_1 CG1528 CGGTCATTCCATGTCCCAAGCTACCCTACAACGATCTGCAAACCACTTTTGTCATCGTAGAATTCCCGC 69 FBan0001528 FBgn0028968 gammaCop 3 3R "cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126 gammaCop gamma-coatomer protein "CG1528, copg, gammaCop, gamma-COP, anon-WO0118547.334, gamma-coatomer protein" CDMC24570 2 14 16 DAC26-B21 13-CG1528-RA_1 CG1528 CGGTCATTCCATGTCCCAAGCTACCCTACAACGATCTGCAAACCACTTTTGTCATCGTAGAATTCCCGC 69 FBan0001528 FBgn0028968 gammaCop 3 3R "cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126 gammaCop gamma-coatomer protein "CG1528, copg, gammaCop, gamma-COP, anon-WO0118547.334, gamma-coatomer protein" CDMC24571 2 15 16 DAC26-F09 2-CG15337-RA_1 CG15337 CGGGTCCTTCGATGGTCCAGAGATCGCGTATCAGGATCATGAATATCGTCCGGAATCTGAGCAACCGGT 69 FBan0015337 FBgn0030014 CG15337 X X CG15337 CG15337 CDMC24571 2 16 16 DAC26-F09 2-CG15337-RA_1 CG15337 CGGGTCCTTCGATGGTCCAGAGATCGCGTATCAGGATCATGAATATCGTCCGGAATCTGAGCAACCGGT 69 FBan0015337 FBgn0030014 CG15337 X X CG15337 CG15337 CDMC24572 2 17 16 DAC26-F21 16-CG15362-RA_2 CG15362 CCGACATGAGTTTCGGCAACAAGATCAGCTTTATGCCCTCATTCTGGTTCAAAAAGTCCAGTGATGCGA 69 FBan0015362 FBgn0031378 CG15362 2 2L CG15362 CG15362 CDMC24572 2 18 16 DAC26-F21 16-CG15362-RA_2 CG15362 CCGACATGAGTTTCGGCAACAAGATCAGCTTTATGCCCTCATTCTGGTTCAAAAAGTCCAGTGATGCGA 69 FBan0015362 FBgn0031378 CG15362 2 2L CG15362 CG15362 CDMC24573 2 19 16 DAC26-J09 18-CG15403-RA_4 CG15403 GTGGTCATTTCCGTCATTTCTCTTGGAGGCTTTTATGCACTTGTTTCCAGTGGAATAAACCTGGTGCCC 69 FBan0015403 FBgn0031504 CG15403 2 2L CG15403 CG15403 CDMC24573 2 20 16 DAC26-J09 18-CG15403-RA_4 CG15403 GTGGTCATTTCCGTCATTTCTCTTGGAGGCTTTTATGCACTTGTTTCCAGTGGAATAAACCTGGTGCCC 69 FBan0015403 FBgn0031504 CG15403 2 2L CG15403 CG15403 CDMC24574 2 21 16 DAC26-J21 7-CG15427-RC_1 CG15427 TCGTCCCCCCTGGTCCCATTCATCCATTTCCGTAGACAAAAGTGACTCCCCCTCAAATCTCAGTTGAAA 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC24574 2 22 16 DAC26-J21 7-CG15427-RC_1 CG15427 TCGTCCCCCCTGGTCCCATTCATCCATTTCCGTAGACAAAAGTGACTCCCCCTCAAATCTCAGTTGAAA 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC24575 2 23 16 DAC26-N09 22-CG15461-RA_1 CG15461 TGACGATCATCTATAATGACCACTTCTGCTGGACCTTCATAAAGAGCTATGGACTCTTCTCGCTGGCGA 69 FBan0015461 FBgn0040649 CG15461 X X CG15461 CG15461 CDMC24575 2 24 16 DAC26-N09 22-CG15461-RA_1 CG15461 TGACGATCATCTATAATGACCACTTCTGCTGGACCTTCATAAAGAGCTATGGACTCTTCTCGCTGGCGA 69 FBan0015461 FBgn0040649 CG15461 X X CG15461 CG15461 CDMC24576 2 25 16 DAC26-N21 3-CG15471-RA_2 CG15471 GCCCGCAGACAGACATTCGTTGACACAGATGATCGGCATCAAAGGAGGTGCGAATATCCAGCCGAGTAT 69 FBan0015471 FBgn0029726 CG15471 X X CG15471 CG15471 CDMC24576 2 26 16 DAC26-N21 3-CG15471-RA_2 CG15471 GCCCGCAGACAGACATTCGTTGACACAGATGATCGGCATCAAAGGAGGTGCGAATATCCAGCCGAGTAT 69 FBan0015471 FBgn0029726 CG15471 X X CG15471 CG15471 CDMC24577 2 1 17 DAC27-B09 1-CG9746-RA_1 CG9746 TGCCATCCCACAGAGCCTTCATACCTGATCTCAGCCTCGCAGTCAAACAATGAGGTATCCGTGTGGAAT 69 FBan0009746 FBgn0037663 CG9746 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 CG9746 CG9746 CDMC24577 2 2 17 DAC27-B09 1-CG9746-RA_1 CG9746 TGCCATCCCACAGAGCCTTCATACCTGATCTCAGCCTCGCAGTCAAACAATGAGGTATCCGTGTGGAAT 69 FBan0009746 FBgn0037663 CG9746 3 3R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674 CG9746 CG9746 CDMC24578 2 3 17 DAC27-B21 13-CG9762-RA_1 CG9762 CCCCATCTCGCGCTTTATTTCCCGCTACATTTTGAACTCGGATCAGCAAAACTACGAGAAATCCCTGCA 69 FBan0009762 FBgn0011455 l(3)neo18 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 l(3)neo18 lethal (3) neo18 CG9762 CDMC24578 2 4 17 DAC27-B21 13-CG9762-RA_1 CG9762 CCCCATCTCGCGCTTTATTTCCCGCTACATTTTGAACTCGGATCAGCAAAACTACGAGAAATCCCTGCA 69 FBan0009762 FBgn0011455 l(3)neo18 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 l(3)neo18 lethal (3) neo18 CG9762 CDMC24579 2 5 17 DAC27-F09 22-CG9796-RA_1 CG9796 TCCAAGTCAGCTCAAACCTTTGGCAATCGGGAATCTCAACACCTAATGCTGTATTTTGCTCTTGACCTT 69 FBan0009796 FBgn0038149 CG9796 3 3R CG9796 CG9796 CDMC24579 2 6 17 DAC27-F09 22-CG9796-RA_1 CG9796 TCCAAGTCAGCTCAAACCTTTGGCAATCGGGAATCTCAACACCTAATGCTGTATTTTGCTCTTGACCTT 69 FBan0009796 FBgn0038149 CG9796 3 3R CG9796 CG9796 CDMC24580 2 7 17 DAC27-F21 23-CG9812-RB_8 CG9812 TTCGAGATTCGTACGACCTCTGAAGCATCAAAGATACAGGAGGAATTAATAAAGCATCTGCACACTGGA 69 FBan0009812 FBgn0034860 CG9812 2 2R CG9812 CG9812 BcDNA:RH38235 CDMC24580 2 8 17 DAC27-F21 23-CG9812-RB_8 CG9812 TTCGAGATTCGTACGACCTCTGAAGCATCAAAGATACAGGAGGAATTAATAAAGCATCTGCACACTGGA 69 FBan0009812 FBgn0034860 CG9812 2 2R CG9812 CG9812 BcDNA:RH38235 CDMC24581 2 9 17 DAC27-J09 13-CG9856-RA_1 CG9856 TGGACACCTGCTTGCATGTACTCAACCTTGGAAAGTGTGAGTCGGAGTTTGACATCTACGATGACACCA 69 FBan0009856 FBgn0016641 PTP-ER 2 2R R7 cell fate commitment; GO:0007465; Ras protein signal transduction; GO:0007265; inactivation of MAPK activity; GO:0000188; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737 PTP-ER Protein tyrosine phosphatase-ERK/Enhancer of Ras1 "CG9856, CG9856, ER2-5, ptp-er, Protein tyrosine phosphatase-ERK/Enhancer of Ras1" CDMC24581 2 10 17 DAC27-J09 13-CG9856-RA_1 CG9856 TGGACACCTGCTTGCATGTACTCAACCTTGGAAAGTGTGAGTCGGAGTTTGACATCTACGATGACACCA 69 FBan0009856 FBgn0016641 PTP-ER 2 2R R7 cell fate commitment; GO:0007465; Ras protein signal transduction; GO:0007265; inactivation of MAPK activity; GO:0000188; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737 PTP-ER Protein tyrosine phosphatase-ERK/Enhancer of Ras1 "CG9856, CG9856, ER2-5, ptp-er, Protein tyrosine phosphatase-ERK/Enhancer of Ras1" CDMC24582 2 11 17 DAC27-J21 2-CG9875-RA_1 CG9875 TCGTGCCCAAGAAGAGCTCAAATCTCGCCATACTGCCACAGAACTGGAACTCGAATCAGATCCCCAGAA 69 FBan0009875 FBgn0034850 CG9875 2 2R metabolism; GO:0008152 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 CG9875 CG9875 BcDNA:GH23338 CDMC24582 2 12 17 DAC27-J21 2-CG9875-RA_1 CG9875 TCGTGCCCAAGAAGAGCTCAAATCTCGCCATACTGCCACAGAACTGGAACTCGAATCAGATCCCCAGAA 69 FBan0009875 FBgn0034850 CG9875 2 2R metabolism; GO:0008152 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 CG9875 CG9875 BcDNA:GH23338 CDMC24583 2 13 17 DAC27-N09 2-CG9911-RA_2 CG9911 GCACATGTATCTGTTCCCCCACTTCAGTGACATGTACTCGCCGGGTAAGCTGAAGCAGTTCCTTCAGGA 69 FBan0009911 FBgn0030734 CG9911 X X electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9911 CG9911 "CG9912, LD41494p" CDMC24583 2 14 17 DAC27-N09 2-CG9911-RA_2 CG9911 GCACATGTATCTGTTCCCCCACTTCAGTGACATGTACTCGCCGGGTAAGCTGAAGCAGTTCCTTCAGGA 69 FBan0009911 FBgn0030734 CG9911 X X electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9911 CG9911 "CG9912, LD41494p" CDMC24584 2 15 17 DAC27-N21 23-CG9921-RA_6 CG9921 GATGTTTGTCGTTTTGGAAGTCGTGATAGTTCGAGAAAACTATCGCTTTATTAGTGTGAACGCACGCAC 69 FBan0009921 FBgn0030743 CG9921 X X CG9921 CG9921 CDMC24584 2 16 17 DAC27-N21 23-CG9921-RA_6 CG9921 GATGTTTGTCGTTTTGGAAGTCGTGATAGTTCGAGAAAACTATCGCTTTATTAGTGTGAACGCACGCAC 69 FBan0009921 FBgn0030743 CG9921 X X CG9921 CG9921 CDMC24585 2 17 17 DAC28-B09 6-CG11788-RA_3 CG11788 GAAGTGGAACGGGAGGAGACCATCAATGCACTGAAGGGCATAGCTCCAGAGGATGTTGTGGCTGG 65 FBan0011788 FBgn0034495 CG11788 2 2R CG11788 CG11788 CDMC24585 2 18 17 DAC28-B09 6-CG11788-RA_3 CG11788 GAAGTGGAACGGGAGGAGACCATCAATGCACTGAAGGGCATAGCTCCAGAGGATGTTGTGGCTGG 65 FBan0011788 FBgn0034495 CG11788 2 2R CG11788 CG11788 CDMC24586 2 19 17 DAC28-B21 18-CG11824-RA_1 CG11824 CTGGCCCTGCTCAGGTTCTACGAGCCCGTCATCTTCCAGCCGAACATCATTCCCGTTTGCGTTCC 65 FBan0011824 FBgn0033360 CG11824 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11824 CG11824 SP59 CDMC24586 2 20 17 DAC28-B21 18-CG11824-RA_1 CG11824 CTGGCCCTGCTCAGGTTCTACGAGCCCGTCATCTTCCAGCCGAACATCATTCCCGTTTGCGTTCC 65 FBan0011824 FBgn0033360 CG11824 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11824 CG11824 SP59 CDMC24587 2 21 17 DAC28-F09 12-CG11922-RA_1 CG11922 CGGCGAAAACGTTTCCGCGTCAAGCAGCTCGAGAAGGATATTTCGAACTGGAAATTAGCCGCCGC 65 FBan0011922 FBgn0004898 fd96Cb 3 3R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd96Cb forkhead domain 96Cb "CG11922, CG11922, FD5, Dmfd5, fd5" CDMC24587 2 22 17 DAC28-F09 12-CG11922-RA_1 CG11922 CGGCGAAAACGTTTCCGCGTCAAGCAGCTCGAGAAGGATATTTCGAACTGGAAATTAGCCGCCGC 65 FBan0011922 FBgn0004898 fd96Cb 3 3R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd96Cb forkhead domain 96Cb "CG11922, CG11922, FD5, Dmfd5, fd5" CDMC24588 2 23 17 DAC28-F21 3-CG11982-RA_1 CG11982 GGCCGAGAGGGACTAGACACCATTGTCACCCAAATGCTCAACCAAATGGAAACTTCAGGACCGCC 65 FBan0011982 FBgn0037653 CG11982 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11982 CG11982 CDMC24588 2 24 17 DAC28-F21 3-CG11982-RA_1 CG11982 GGCCGAGAGGGACTAGACACCATTGTCACCCAAATGCTCAACCAAATGGAAACTTCAGGACCGCC 65 FBan0011982 FBgn0037653 CG11982 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11982 CG11982 CDMC24589 2 25 17 DAC28-J09 3-CG12085-RB_1 CG12085 GACCAGGGCATCTTCGATCAGGGAGATCTGTCCGGTTAGAAGGGGGAGCTATCCGAATTGCATGC 65 FBan0012085 FBgn0028577 pUf68 3 3L "DNA repair; GO:0006281; alternative nuclear mRNA splicing, via spliceosome; GO:0000380; cystoblast division; GO:0007282; mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of progression through cell cycle; GO:0000074" poly(U) binding; GO:0008266; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008266; ; GO:0008266 nucleus; GO:0005634; spliceosome complex; GO:0005681 pUf68 poly U binding factor 68kD "CG12085, CG12085, DPUF68, pUbsf, Puf60, hfp, half pint, dFIR, Half-pint, HFP, half-pint, PUF60, Hfp, anon-WO0118547.408, Fir, polyU binding splicing factor, poly U binding factor 68kD" CDMC24589 2 26 17 DAC28-J09 3-CG12085-RB_1 CG12085 GACCAGGGCATCTTCGATCAGGGAGATCTGTCCGGTTAGAAGGGGGAGCTATCCGAATTGCATGC 65 FBan0012085 FBgn0028577 pUf68 3 3L "DNA repair; GO:0006281; alternative nuclear mRNA splicing, via spliceosome; GO:0000380; cystoblast division; GO:0007282; mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of progression through cell cycle; GO:0000074" poly(U) binding; GO:0008266; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008266; ; GO:0008266 nucleus; GO:0005634; spliceosome complex; GO:0005681 pUf68 poly U binding factor 68kD "CG12085, CG12085, DPUF68, pUbsf, Puf60, hfp, half pint, dFIR, Half-pint, HFP, half-pint, PUF60, Hfp, anon-WO0118547.408, Fir, polyU binding splicing factor, poly U binding factor 68kD" CDMC24590 2 1 18 DAC28-J21 18-CG12107-RA_6 CG12107 ACGGAGGGGTATGGGAGCTGATCAAGGAGGGGTTCATGACGTCGTTTGCCGGATTCCTGGTCACG 65 FBan0012107 FBgn0033209 CG12107 2 2R CG12107 CG12107 CDMC24590 2 2 18 DAC28-J21 18-CG12107-RA_6 CG12107 ACGGAGGGGTATGGGAGCTGATCAAGGAGGGGTTCATGACGTCGTTTGCCGGATTCCTGGTCACG 65 FBan0012107 FBgn0033209 CG12107 2 2R CG12107 CG12107 CDMC24591 2 3 18 DAC28-N09 3-CG12170-RA_1 CG12170 CAACATTGAGCACCTCGATGTGGACGTCAATGTGGTCACGAAAGCTACTGATTGGTCGGCGGACC 65 FBan0012170 FBgn0037356 CG12170 3 3R fatty acid biosynthesis; GO:0006633; protein amino acid phosphorylation; GO:0006468; protein amino acid prenylation; GO:0018346 ATP binding; GO:0005524; ; GO:0005524; 3-oxoacyl-[acyl-carrier protein] synthase activity; GO:0004315 ; EC:2.3.1.41; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004315 ; EC:2.3.1.41; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- CG12170 CG12170 anon-WO0118547.367 CDMC24591 2 4 18 DAC28-N09 3-CG12170-RA_1 CG12170 CAACATTGAGCACCTCGATGTGGACGTCAATGTGGTCACGAAAGCTACTGATTGGTCGGCGGACC 65 FBan0012170 FBgn0037356 CG12170 3 3R fatty acid biosynthesis; GO:0006633; protein amino acid phosphorylation; GO:0006468; protein amino acid prenylation; GO:0018346 ATP binding; GO:0005524; ; GO:0005524; 3-oxoacyl-[acyl-carrier protein] synthase activity; GO:0004315 ; EC:2.3.1.41; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004315 ; EC:2.3.1.41; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- CG12170 CG12170 anon-WO0118547.367 CDMC24592 2 5 18 DAC28-N21 1-CG12191-RA_1 CG12191 CTGCAGGAGAAGTACTACGAGATCGATTCCACGCTACAGCTCTCCTGTGTGGTGCGAAACGTGGC 65 FBan0012191 FBgn0035170 dpr20 3 3L dpr20 dpr20 "CG12191, CG12191, CG12191, CG12191, CT9818, Dpr-20" CDMC24592 2 6 18 DAC28-N21 1-CG12191-RA_1 CG12191 CTGCAGGAGAAGTACTACGAGATCGATTCCACGCTACAGCTCTCCTGTGTGGTGCGAAACGTGGC 65 FBan0012191 FBgn0035170 dpr20 3 3L dpr20 dpr20 "CG12191, CG12191, CG12191, CG12191, CT9818, Dpr-20" CDMC24593 2 7 18 DAC29-B09 2-CG3073-RA_1 CG3073 CGACTCCCTGGCCAAATACCTAAACGTGGCTCTGCTGATTAATCCCGATGTGACCACCTTTTGGCACAT 69 FBgn0029609 CDMC24593 2 8 18 DAC29-B09 2-CG3073-RA_1 CG3073 CGACTCCCTGGCCAAATACCTAAACGTGGCTCTGCTGATTAATCCCGATGTGACCACCTTTTGGCACAT 69 FBgn0029609 CDMC24594 2 9 18 DAC29-B21 5-CG3085-RA_1 CG3085 CCTCGCAGACGGACAGGAACATAACGCTCACTCGCATGGAGAACGAGATTCCCAAAGACTAGACTTGGG 69 FBan0003085 FBgn0034816 CG3085 2 2R development; GO:0007275; gametogenesis; GO:0007276; microtubule cytoskeleton organization and biogenesis; GO:0000226; spermatogenesis; GO:0007283 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG3085 CG3085 anon-WO0140519.123 CDMC24594 2 10 18 DAC29-B21 5-CG3085-RA_1 CG3085 CCTCGCAGACGGACAGGAACATAACGCTCACTCGCATGGAGAACGAGATTCCCAAAGACTAGACTTGGG 69 FBan0003085 FBgn0034816 CG3085 2 2R development; GO:0007275; gametogenesis; GO:0007276; microtubule cytoskeleton organization and biogenesis; GO:0000226; spermatogenesis; GO:0007283 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG3085 CG3085 anon-WO0140519.123 CDMC24595 2 11 18 DAC29-F09 2-CG31014-RA_1 CG31014 CGGCTGCAGAATATGTACCAACTAAACACGGACCACCTAGCTTCTGGCGTTCTCCATCCTGGCGAGAAA 69 FBan0031014 FBgn0051014 PH4alphaSG1 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaSG1 prolyl-4-hydroxylase-alpha SG1 "CG15542, CG31014, CG15542, CG15542, PHalphaSG1, prolyl-4-hydroxylase-alpha SG1" CDMC24595 2 12 18 DAC29-F09 2-CG31014-RA_1 CG31014 CGGCTGCAGAATATGTACCAACTAAACACGGACCACCTAGCTTCTGGCGTTCTCCATCCTGGCGAGAAA 69 FBan0031014 FBgn0051014 PH4alphaSG1 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaSG1 prolyl-4-hydroxylase-alpha SG1 "CG15542, CG31014, CG15542, CG15542, PHalphaSG1, prolyl-4-hydroxylase-alpha SG1" CDMC24596 2 13 18 DAC29-F21 12-CG31020-RA_8 CG31020 GCTGGAAAGGCGCTTGGAGATCTACAAAAGCCAACAGATCTACCAAAGCCAACAAGTTGGAGCGGTAGT 69 FBgn0051020 CDMC24596 2 14 18 DAC29-F21 12-CG31020-RA_8 CG31020 GCTGGAAAGGCGCTTGGAGATCTACAAAAGCCAACAGATCTACCAAAGCCAACAAGTTGGAGCGGTAGT 69 FBgn0051020 CDMC24597 2 15 18 DAC29-J09 1-CG31054-RA_2 CG31054 TGGACAAGCCGCTTATAGAGCCAGTGAAGAAGCTCAAGTTCCAGATCAAGGAGCACGTGGGCATCTTGA 69 FBan0031054 FBgn0051054 CG31054 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; translational elongation; GO:0006414" translation elongation factor activity; GO:0003746; ; GO:0003746 small nuclear ribonucleoprotein complex; GO:0030532 CG31054 CG31054 CDMC24597 2 16 18 DAC29-J09 1-CG31054-RA_2 CG31054 TGGACAAGCCGCTTATAGAGCCAGTGAAGAAGCTCAAGTTCCAGATCAAGGAGCACGTGGGCATCTTGA 69 FBan0031054 FBgn0051054 CG31054 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; translational elongation; GO:0006414" translation elongation factor activity; GO:0003746; ; GO:0003746 small nuclear ribonucleoprotein complex; GO:0030532 CG31054 CG31054 CDMC24598 2 17 18 DAC29-J21 23-CG31060-RA_1 CG31060 ATATCATACATCCTTCATCAAATTGGATGCTTGCCTACAGCTGAAGAATTCCAAATGCTCAAAATGGGG 69 FBan0031060 FBgn0046886 Gr98c 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98c Gustatory receptor 98c "CG12884, CG31060, CG12884, 98B.3, Gustatory receptor 98B.3, Gr98A1, Gr98A2, Gr98B3, Gustatory receptor 98A2, GR98B.3, Gustatory receptor 98c" CDMC24598 2 18 18 DAC29-J21 23-CG31060-RA_1 CG31060 ATATCATACATCCTTCATCAAATTGGATGCTTGCCTACAGCTGAAGAATTCCAAATGCTCAAAATGGGG 69 FBan0031060 FBgn0046886 Gr98c 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98c Gustatory receptor 98c "CG12884, CG31060, CG12884, 98B.3, Gustatory receptor 98B.3, Gr98A1, Gr98A2, Gr98B3, Gustatory receptor 98A2, GR98B.3, Gustatory receptor 98c" CDMC24599 2 19 18 DAC29-N09 16-CG31089-RA_3 CG31089 CCAGCGGATTAGTGCGTTCTGTGGGTCCATATTTGGGTCATAGGAACACATATTCGGTGCTTTTTGGAT 69 FBan0031089 FBgn0051089 CG31089 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31089 CG31089 CG5990 CDMC24599 2 20 18 DAC29-N09 16-CG31089-RA_3 CG31089 CCAGCGGATTAGTGCGTTCTGTGGGTCCATATTTGGGTCATAGGAACACATATTCGGTGCTTTTTGGAT 69 FBan0031089 FBgn0051089 CG31089 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31089 CG31089 CG5990 CDMC24600 2 21 18 DAC29-N21 6-CG31097-RA_1 CG31097 AGGTGGGCAAAAGTTTCCGTACCAAGGTGTACACCAATCCCATCTTTGTGGAAGTCGTCAAGGAGCTGT 69 FBan0031097 FBgn0051097 CG31097 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112 CG31097 CG31097 CG13665 CDMC24600 2 22 18 DAC29-N21 6-CG31097-RA_1 CG31097 AGGTGGGCAAAAGTTTCCGTACCAAGGTGTACACCAATCCCATCTTTGTGGAAGTCGTCAAGGAGCTGT 69 FBan0031097 FBgn0051097 CG31097 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112 CG31097 CG31097 CG13665 CDMC24601 2 23 18 DAC30-B09 2-CG1966-RA_1 CG1966 TAGGGACATGCAGCTACCGTTTAGGCCTAGCGATATGAACGGGGAAGTCAAAGCTTGCTGAGCCG 65 FBan0001966 FBgn0027620 Acf1 3 3R "chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; NOT histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 ACF complex; GO:0016590; NOT NURF complex; GO:0016589; chromatin accessibility complex; GO:0008623; chromatin assembly complex; GO:0005678 Acf1 ATP-dependent chromatin assembly factor large subunit "CG1966, ACF, ATP-utilizing chromatin assembly and remodeling factor, CAF, acf1, p170/p185, CHRAC, Chromatin Accessibility Complex, dACF, dCHRAC, ACF1, Acf-1, Acf, CHRAC-175" CDMC24601 2 24 18 DAC30-B09 2-CG1966-RA_1 CG1966 TAGGGACATGCAGCTACCGTTTAGGCCTAGCGATATGAACGGGGAAGTCAAAGCTTGCTGAGCCG 65 FBan0001966 FBgn0027620 Acf1 3 3R "chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; NOT histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 ACF complex; GO:0016590; NOT NURF complex; GO:0016589; chromatin accessibility complex; GO:0008623; chromatin assembly complex; GO:0005678 Acf1 ATP-dependent chromatin assembly factor large subunit "CG1966, ACF, ATP-utilizing chromatin assembly and remodeling factor, CAF, acf1, p170/p185, CHRAC, Chromatin Accessibility Complex, dACF, dCHRAC, ACF1, Acf-1, Acf, CHRAC-175" CDMC24602 2 25 18 DAC30-B21 23-CG1998-RA_2 CG1998 TCCTATTTTGTACACCTCATATATAGACGTATGGTGCAGACACACCCCTAGTATTCCGCACAACC 65 FBan0001998 FBgn0030485 CG1998 X X cholesterol metabolism; GO:0008203 C-4 methylsterol oxidase activity; GO:0000254 ; EC:1.14.13.-; ; GO:0000254 ; EC:1.14.13.- CG1998 CG1998 CDMC24602 2 26 18 DAC30-B21 23-CG1998-RA_2 CG1998 TCCTATTTTGTACACCTCATATATAGACGTATGGTGCAGACACACCCCTAGTATTCCGCACAACC 65 FBan0001998 FBgn0030485 CG1998 X X cholesterol metabolism; GO:0008203 C-4 methylsterol oxidase activity; GO:0000254 ; EC:1.14.13.-; ; GO:0000254 ; EC:1.14.13.- CG1998 CG1998 CDMC24603 2 1 19 DAC30-F09 11-CG2151-RB_1 CG2151 GGCGTGACTGTGCAGAAGGACAAGATTCCAGTGGACTCCCAGGAGGCTACCAATGTGGCAAACAT 65 FBan0002151 FBgn0020653 Trxr-1 X X determination of adult life span; GO:0008340; sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; ; GO:0016209; NOT glutathione-disulfide reductase activity; GO:0004362 ; EC:1.8.1.7; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; ; GO:0004791 ; EC:1.8.1.9; ; GO:0004791 ; EC:1.8.1.9; glutathione-disulfide reductase activity; GO:0004362 ; EC:1.8.1.7; ; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0004362 ; EC:1.8.1.7; ; GO:0004362 ; EC:1.8.1.7; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-1 Thioredoxin reductase-1 "CG2151, CG2151, CG2151, Gr: Glutathione reductase, l(1)G0154, l(1)G0379, glutathione reductase, l(1)G0481, l(1)G0477, trxr-1, thioredoxin reductase-1, DmTrxR-1, dmtrxr-1, disulfide reductase, TrxR, DTR, Trxr1, thioredoxin reductase, TrxR-1, anon-WO03040301.185, anon-WO03040301.187, GR, gr, Glutathione reductase, Gr" CDMC24603 2 2 19 DAC30-F09 11-CG2151-RB_1 CG2151 GGCGTGACTGTGCAGAAGGACAAGATTCCAGTGGACTCCCAGGAGGCTACCAATGTGGCAAACAT 65 FBan0002151 FBgn0020653 Trxr-1 X X determination of adult life span; GO:0008340; sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; ; GO:0016209; NOT glutathione-disulfide reductase activity; GO:0004362 ; EC:1.8.1.7; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; ; GO:0004791 ; EC:1.8.1.9; ; GO:0004791 ; EC:1.8.1.9; glutathione-disulfide reductase activity; GO:0004362 ; EC:1.8.1.7; ; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0004362 ; EC:1.8.1.7; ; GO:0004362 ; EC:1.8.1.7; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-1 Thioredoxin reductase-1 "CG2151, CG2151, CG2151, Gr: Glutathione reductase, l(1)G0154, l(1)G0379, glutathione reductase, l(1)G0481, l(1)G0477, trxr-1, thioredoxin reductase-1, DmTrxR-1, dmtrxr-1, disulfide reductase, TrxR, DTR, Trxr1, thioredoxin reductase, TrxR-1, anon-WO03040301.185, anon-WO03040301.187, GR, gr, Glutathione reductase, Gr" CDMC24604 2 3 19 DAC30-F21 3-CG2213-RA_1 CG2213 GTACGCGCAACATGTGAGAAACCTAAAGGACGTGTGCGTATCCAAGACGGTGATGAAACCGGGGG 65 FBan0002213 FBgn0035210 CG2213 3 3L CG2213 CG2213 CDMC24604 2 4 19 DAC30-F21 3-CG2213-RA_1 CG2213 GTACGCGCAACATGTGAGAAACCTAAAGGACGTGTGCGTATCCAAGACGGTGATGAAACCGGGGG 65 FBan0002213 FBgn0035210 CG2213 3 3L CG2213 CG2213 CDMC24605 2 5 19 DAC30-J09 15-CG2448-RA_3 CG2448 CCTGAACGGGATCATTCTGGATATCCACCTGCTTTCCATGTCCGATCATCTGGTGTGCACCTTCT 65 FBan0002448 FBgn0030327 FucT6 X X protein amino acid glycosylation; GO:0006486 "fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; glycoprotein 6-alpha-L-fucosyltransferase activity; GO:0008424 ; EC:2.4.1.68; galactoside 6-L-fucosyltransferase activity; GO:0046702; ; GO:0008424 ; EC:2.4.1.68; ; GO:0008417 ; EC:2.4.1.-; ; GO:0046702; ; GO:0008424 ; EC:2.4.1.68; alpha(1,6)-fucosyltransferase activity; GO:0046921 ; EC:2.4.1.-; ; GO:0046921 ; EC:2.4.1.-" integral to Golgi membrane; GO:0030173 FucT6 FucT6 "CG2448, CG2448, CG2448, CK00490, Fuc-TVIII, BEST:CK00490" CDMC24605 2 6 19 DAC30-J09 15-CG2448-RA_3 CG2448 CCTGAACGGGATCATTCTGGATATCCACCTGCTTTCCATGTCCGATCATCTGGTGTGCACCTTCT 65 FBan0002448 FBgn0030327 FucT6 X X protein amino acid glycosylation; GO:0006486 "fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; glycoprotein 6-alpha-L-fucosyltransferase activity; GO:0008424 ; EC:2.4.1.68; galactoside 6-L-fucosyltransferase activity; GO:0046702; ; GO:0008424 ; EC:2.4.1.68; ; GO:0008417 ; EC:2.4.1.-; ; GO:0046702; ; GO:0008424 ; EC:2.4.1.68; alpha(1,6)-fucosyltransferase activity; GO:0046921 ; EC:2.4.1.-; ; GO:0046921 ; EC:2.4.1.-" integral to Golgi membrane; GO:0030173 FucT6 FucT6 "CG2448, CG2448, CG2448, CK00490, Fuc-TVIII, BEST:CK00490" CDMC24606 2 7 19 DAC30-J21 15-CG2637-RA_12 CG2637 GCCCGCTTTCAAGGACTTCCTCGTCATGGGTCTGAAGAACTTCCAGGAGTACCAGGTCTGCTGCG 65 FBan0002637 FBgn0000986 Fs(2)Ket 2 2L "NLS-bearing substrate import into nucleus; GO:0006607; actin filament organization; GO:0007015; eggshell formation (sensu Insecta); GO:0007304; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; regulation of cell shape; GO:0008360" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nuclear pore; GO:0005643 Fs(2)Ket Female sterile (2) Ketel "CG2637, Ketel, Hont, fs(2)lto2, Hon, Ket, ketel, importin beta, dKap-beta, 38E.11, imp-beta, Fs(2)Hon, Fs(2)Sz6, Fs(2)Sz7, fs(2)lo-B, fs(2)ltoHD43, female sterile(2)lto2" CDMC24606 2 8 19 DAC30-J21 15-CG2637-RA_12 CG2637 GCCCGCTTTCAAGGACTTCCTCGTCATGGGTCTGAAGAACTTCCAGGAGTACCAGGTCTGCTGCG 65 FBan0002637 FBgn0000986 Fs(2)Ket 2 2L "NLS-bearing substrate import into nucleus; GO:0006607; actin filament organization; GO:0007015; eggshell formation (sensu Insecta); GO:0007304; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; regulation of cell shape; GO:0008360" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nuclear pore; GO:0005643 Fs(2)Ket Female sterile (2) Ketel "CG2637, Ketel, Hont, fs(2)lto2, Hon, Ket, ketel, importin beta, dKap-beta, 38E.11, imp-beta, Fs(2)Hon, Fs(2)Sz6, Fs(2)Sz7, fs(2)lo-B, fs(2)ltoHD43, female sterile(2)lto2" CDMC24607 2 9 19 DAC30-N09 1-CG2885-RA_2 CG2885 CCATCGTTATGTACTTCACAACCCGATCAGCCCGATGCCATCTGAGCAGGAAGAGGAGGACGCTG 65 FBan0002885 FBgn0030200 RabX2 X X "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 RabX2 RabX2 "CG2885, CG2885, CG2885, CG2885, DmRabX2" CDMC24607 2 10 19 DAC30-N09 1-CG2885-RA_2 CG2885 CCATCGTTATGTACTTCACAACCCGATCAGCCCGATGCCATCTGAGCAGGAAGAGGAGGACGCTG 65 FBan0002885 FBgn0030200 RabX2 X X "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 RabX2 RabX2 "CG2885, CG2885, CG2885, CG2885, DmRabX2" CDMC24608 2 11 19 DAC30-N21 3-CG2922-RC_2 CG2922 TTTGTTGTTCTACAAGACCGAGGTCCTGTCCGAGGAGATCATCTTGCGCTGGTACAAGGAGGGCC 65 FBan0002922 FBgn0037346 eIF-5C 3 3R long-term memory; GO:0007616; neuron lineage restriction; GO:0042055; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0003743; ; GO:0008135" cytosol; GO:0005829 eIF-5C eukaryotic initiation factor 5C "CG2922, CG2922, l(3)03022, extra bases, CT7240, exb, extra-bases, krasavietz, elF-5C, anon-WO0172774.49" CDMC24608 2 12 19 DAC30-N21 3-CG2922-RC_2 CG2922 TTTGTTGTTCTACAAGACCGAGGTCCTGTCCGAGGAGATCATCTTGCGCTGGTACAAGGAGGGCC 65 FBan0002922 FBgn0037346 eIF-5C 3 3R long-term memory; GO:0007616; neuron lineage restriction; GO:0042055; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0003743; ; GO:0008135" cytosol; GO:0005829 eIF-5C eukaryotic initiation factor 5C "CG2922, CG2922, l(3)03022, extra bases, CT7240, exb, extra-bases, krasavietz, elF-5C, anon-WO0172774.49" CDMC24609 2 13 19 DAC31-B09 2-CG31723-RA_1 CG31723 GCTCTCACCAGTGCACTTTTGGGGATCCACAGAAAAATCCGCGAGTTCGGTAGCTCAGGCGAAATCAG 68 FBan0031723 FBgn0051723 CG31723 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31723 CG31723 CDMC24609 2 14 19 DAC31-B09 2-CG31723-RA_1 CG31723 GCTCTCACCAGTGCACTTTTGGGGATCCACAGAAAAATCCGCGAGTTCGGTAGCTCAGGCGAAATCAG 68 FBan0031723 FBgn0051723 CG31723 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31723 CG31723 CDMC24610 2 15 19 DAC31-B21 3-CG31790-RA_3 CG31790 CTCCGGCTCTTGGAACTGATACCAATCTAATGGCGGAGAACTTGCTTGAGAGAGCCGAGAGACTCGCC 68 FBan0031790 FBgn0051790 CG31790 2 2L CG31790 CG31790 CG15165 CDMC24610 2 16 19 DAC31-B21 3-CG31790-RA_3 CG31790 CTCCGGCTCTTGGAACTGATACCAATCTAATGGCGGAGAACTTGCTTGAGAGAGCCGAGAGACTCGCC 68 FBan0031790 FBgn0051790 CG31790 2 2L CG31790 CG31790 CG15165 CDMC24611 2 17 19 DAC31-F09 2-CG3225-RA_1 CG3225 GAGGGAGCAACTCATCACAGTGGCCAGAAAGAAGTACGGCATTCCAATCTTCTCGTGCAAGGGCGATG 68 FBan0003225 FBgn0031631 CG3225 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" "ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG3225 CG3225 cg3225 CDMC24611 2 18 19 DAC31-F09 2-CG3225-RA_1 CG3225 GAGGGAGCAACTCATCACAGTGGCCAGAAAGAAGTACGGCATTCCAATCTTCTCGTGCAAGGGCGATG 68 FBan0003225 FBgn0031631 CG3225 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" "ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG3225 CG3225 cg3225 CDMC24612 2 19 19 DAC31-F21 2-CG32346-RA_2 CG32346 TGAGTGGGAAACATGCTCAAGGGGCAGTGTGAATGAGGAAGCACTAACTCCCAGTCGCCAAACTGATG 68 FBan0032346 FBgn0000541 E(bx) 3 3L chromatin remodeling; GO:0006338; hemopoiesis; GO:0030097; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0030528; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 NURF complex; GO:0016589 E(bx) Enhancer of bithorax "CG17135, CG10894, CG32346, CG32478, CG7022, CG17135, CG10894, CG17135, l(3)ry122, Nurf-215, Nucleosome remodeling factor - 215kD, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, NURF-215, l(3)122, p301, dNURF, NURF301, NURF215, NURF-301, p215, nurf301, E(Bx), Nurf301, En-bx, NURF" CDMC24612 2 20 19 DAC31-F21 2-CG32346-RA_2 CG32346 TGAGTGGGAAACATGCTCAAGGGGCAGTGTGAATGAGGAAGCACTAACTCCCAGTCGCCAAACTGATG 68 FBan0032346 FBgn0000541 E(bx) 3 3L chromatin remodeling; GO:0006338; hemopoiesis; GO:0030097; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0030528; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 NURF complex; GO:0016589 E(bx) Enhancer of bithorax "CG17135, CG10894, CG32346, CG32478, CG7022, CG17135, CG10894, CG17135, l(3)ry122, Nurf-215, Nucleosome remodeling factor - 215kD, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, NURF-215, l(3)122, p301, dNURF, NURF301, NURF215, NURF-301, p215, nurf301, E(Bx), Nurf301, En-bx, NURF" CDMC24613 2 21 19 DAC31-J09 3-CG32815-RA_1 CG32815 CCGGAATGGCATTGAGCAGTTCGTAATTCGGGTGAACAAAACCAATCCGAGTGCTAGCACCACCAGGA 68 FBan0032815 FBgn0052815 CG32815 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32815 CG32815 "CG16994, CG18830, CG16994, CG18830, CG18830" CDMC24613 2 22 19 DAC31-J09 3-CG32815-RA_1 CG32815 CCGGAATGGCATTGAGCAGTTCGTAATTCGGGTGAACAAAACCAATCCGAGTGCTAGCACCACCAGGA 68 FBan0032815 FBgn0052815 CG32815 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32815 CG32815 "CG16994, CG18830, CG16994, CG18830, CG18830" CDMC24614 2 23 19 DAC31-J21 3-CG33098-RB_1 CG33098 TCTCGCTCTTCGATACGGACTGCGATGGACTGATCTCGAAGGATGATCTACGGTTCACCTACACGGCG 68 FBan0033098 FBgn0053098 CG33098 3 3R calcium ion binding; GO:0005509; ; GO:0005509 myosin II; GO:0016460 CG33098 CG33098 "CG17756, CT39356, BcDNA:RH08915, BcDNA:AT09395" CDMC24614 2 24 19 DAC31-J21 3-CG33098-RB_1 CG33098 TCTCGCTCTTCGATACGGACTGCGATGGACTGATCTCGAAGGATGATCTACGGTTCACCTACACGGCG 68 FBan0033098 FBgn0053098 CG33098 3 3R calcium ion binding; GO:0005509; ; GO:0005509 myosin II; GO:0016460 CG33098 CG33098 "CG17756, CT39356, BcDNA:RH08915, BcDNA:AT09395" CDMC24615 2 25 19 DAC31-N09 2-CG3460-RA_2 CG3460 GGGAAATCTCTCGCCATTGGTTCTGGTCAACCGGGTGTCTAGCAGCATTCACTTGATTGATCCCCTGA 68 FBan0003460 FBgn0023542 Nmd3 X X histone mRNA 3'-end processing; GO:0006398; ribosomal large subunit export from nucleus; GO:0000055 mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0003729 Nmd3 Nonsense-mediated mRNA 3 "CG3460, CG3460, TcD12, TcD13, transcription unit III, II, EG:152A3.1, anon-2Eb, dNmd3" CDMC24615 2 26 19 DAC31-N09 2-CG3460-RA_2 CG3460 GGGAAATCTCTCGCCATTGGTTCTGGTCAACCGGGTGTCTAGCAGCATTCACTTGATTGATCCCCTGA 68 FBan0003460 FBgn0023542 Nmd3 X X histone mRNA 3'-end processing; GO:0006398; ribosomal large subunit export from nucleus; GO:0000055 mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0003729 Nmd3 Nonsense-mediated mRNA 3 "CG3460, CG3460, TcD12, TcD13, transcription unit III, II, EG:152A3.1, anon-2Eb, dNmd3" CDMC24616 2 1 20 DAC31-N21 3-CG3556-RA_3 CG3556 GCGGTGCCCTTCGGACTTAGTTCCTCTGCAGAAGAGTCGGATGCCAAGAACATCTCCTACACGTACAC 68 FBan0003556 FBgn0029708 CG3556 X X CG3556 CG3556 CDMC24616 2 2 20 DAC31-N21 3-CG3556-RA_3 CG3556 GCGGTGCCCTTCGGACTTAGTTCCTCTGCAGAAGAGTCGGATGCCAAGAACATCTCCTACACGTACAC 68 FBan0003556 FBgn0029708 CG3556 X X CG3556 CG3556 CDMC24617 2 3 20 DAC32-B09 15-CG15742-RA_2 CG15742 AGTTGCCACCCATCGATCTGGCCGAAATACTTATGGACATGCTAAAGATGCAAATATTGCGCCGCAAGA 69 FBan0015742 FBgn0030462 CG15742 X X CG15742 CG15742 CDMC24617 2 4 20 DAC32-B09 15-CG15742-RA_2 CG15742 AGTTGCCACCCATCGATCTGGCCGAAATACTTATGGACATGCTAAAGATGCAAATATTGCGCCGCAAGA 69 FBan0015742 FBgn0030462 CG15742 X X CG15742 CG15742 CDMC24618 2 5 20 DAC32-B21 2-CG15764-RA_1 CG15764 GGAGATGGAGTACAGTGGGCGATCCATGAGATATCTGATAGAGGCCATTCAGTCGGACTGCGAGAGCCA 69 FBan0015764 FBgn0029817 CG15764 X X CG15764 CG15764 BcDNA:AT16792 CDMC24618 2 6 20 DAC32-B21 2-CG15764-RA_1 CG15764 GGAGATGGAGTACAGTGGGCGATCCATGAGATATCTGATAGAGGCCATTCAGTCGGACTGCGAGAGCCA 69 FBan0015764 FBgn0029817 CG15764 X X CG15764 CG15764 BcDNA:AT16792 CDMC24619 2 7 20 DAC32-F09 18-CG15831-RA_1 CG15831 CCTCCGCGATGTGTGTTCAAGTTACTGACAGAACAGTGTCATATGCCACAAGGCTCTGATTTGGCTTTT 69 FBgn0040034 CG15831 cell motility; GO:0006928; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; vesicle-mediated transport; GO:0016192 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" myosin; GO:0016459 CG15831 CG15831 CDMC24619 2 8 20 DAC32-F09 18-CG15831-RA_1 CG15831 CCTCCGCGATGTGTGTTCAAGTTACTGACAGAACAGTGTCATATGCCACAAGGCTCTGATTTGGCTTTT 69 FBgn0040034 CG15831 cell motility; GO:0006928; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; vesicle-mediated transport; GO:0016192 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" myosin; GO:0016459 CG15831 CG15831 CDMC24620 2 9 20 DAC32-F21 23-CG15855-RA_12 CG15855 ACAAGGAAAGCAAATAAAAAACCACAACTTTTGTATGGTATTTACAACAGGACTGCAAAGGCAAAGCAA 69 FBan0015855 FBgn0004910 Eip63F-1 3 3L autophagic cell death; GO:0048102; calcium-mediated signaling; GO:0019722; salivary gland cell autophagic cell death; GO:0035071 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509 cytoplasm; GO:0005737; nucleus; GO:0005634; plasma membrane; GO:0005886 Eip63F-1 Ecdysone-induced protein 63F 1 "CG15855, E63F, E63-1, Ca[2+] binding protein, 63F-1, Eip63Fa" CDMC24620 2 10 20 DAC32-F21 23-CG15855-RA_12 CG15855 ACAAGGAAAGCAAATAAAAAACCACAACTTTTGTATGGTATTTACAACAGGACTGCAAAGGCAAAGCAA 69 FBan0015855 FBgn0004910 Eip63F-1 3 3L autophagic cell death; GO:0048102; calcium-mediated signaling; GO:0019722; salivary gland cell autophagic cell death; GO:0035071 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509 cytoplasm; GO:0005737; nucleus; GO:0005634; plasma membrane; GO:0005886 Eip63F-1 Ecdysone-induced protein 63F 1 "CG15855, E63F, E63-1, Ca[2+] binding protein, 63F-1, Eip63Fa" CDMC24621 2 11 20 DAC32-J09 3-CG15902-RA_1 CG15902 ACCACTTCTTTGGCCATCTGGAGAAGAGCTTCCATGAGATCCGGCAAGACTTTGCATTGATGCTGCTCA 69 FBan0015902 FBgn0040250 Ugt86Dj 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dj Ugt86Dj "CG15902, CG15902, AC 006491J" CDMC24621 2 12 20 DAC32-J09 3-CG15902-RA_1 CG15902 ACCACTTCTTTGGCCATCTGGAGAAGAGCTTCCATGAGATCCGGCAAGACTTTGCATTGATGCTGCTCA 69 FBan0015902 FBgn0040250 Ugt86Dj 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dj Ugt86Dj "CG15902, CG15902, AC 006491J" CDMC24622 2 13 20 DAC32-J21 3-CG15917-RA_1 CG15917 AGGATGACGACGATACCAGCTCGAGATTCACATACTCGACCACAACGACAACTGAGGAACCCGCATCCA 69 FBan0015917 FBgn0034199 CG15917 2 2R CG15917 CG15917 CDMC24622 2 14 20 DAC32-J21 3-CG15917-RA_1 CG15917 AGGATGACGACGATACCAGCTCGAGATTCACATACTCGACCACAACGACAACTGAGGAACCCGCATCCA 69 FBan0015917 FBgn0034199 CG15917 2 2R CG15917 CG15917 CDMC24623 2 15 20 DAC32-N09 18-CG1621-RA_1 CG1621 CGCGACTGACTAACTCTGTGAATCTGCCTACATACGTAGCATGTAATCAGTATTCCGGCCTGCTTTCCT 69 FBan0001621 FBgn0033182 CG1621 2 2R DNA binding; GO:0003677; ; GO:0003677 CG1621 CG1621 CDMC24623 2 16 20 DAC32-N09 18-CG1621-RA_1 CG1621 CGCGACTGACTAACTCTGTGAATCTGCCTACATACGTAGCATGTAATCAGTATTCCGGCCTGCTTTCCT 69 FBan0001621 FBgn0033182 CG1621 2 2R DNA binding; GO:0003677; ; GO:0003677 CG1621 CG1621 CDMC24624 2 17 20 DAC32-N21 2-CG1631-RA_1 CG1631 GCGGCAAAAGTGTGACTCCCTCAGGGAACAGACAATCCTGGCTTTTTGTGCGAGTCAACAGCATCCATA 69 FBan0001631 FBgn0031101 CG1631 X X CG1631 CG1631 CDMC24624 2 18 20 DAC32-N21 2-CG1631-RA_1 CG1631 GCGGCAAAAGTGTGACTCCCTCAGGGAACAGACAATCCTGGCTTTTTGTGCGAGTCAACAGCATCCATA 69 FBan0001631 FBgn0031101 CG1631 X X CG1631 CG1631 CDMC24625 2 19 20 DAC33-B09 1-CG11330-RA_1 CG11330 GGTCTCCTACCGCAAGCTGTTCTTCAAGTCCATGGGCTACATAAGTTGCATTGAGTGGTCCCACGACGG 69 FBan0011330 FBgn0000351 cort 2 2L cellularization; GO:0007349; egg activation; GO:0007343; female meiosis; GO:0007143; homologous chromosome segregation; GO:0045143; pole cell formation; GO:0007279 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 cort cortex "CG11330, CG11330, cor, cortex" CDMC24625 2 20 20 DAC33-B09 1-CG11330-RA_1 CG11330 GGTCTCCTACCGCAAGCTGTTCTTCAAGTCCATGGGCTACATAAGTTGCATTGAGTGGTCCCACGACGG 69 FBan0011330 FBgn0000351 cort 2 2L cellularization; GO:0007349; egg activation; GO:0007343; female meiosis; GO:0007143; homologous chromosome segregation; GO:0045143; pole cell formation; GO:0007279 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 cort cortex "CG11330, CG11330, cor, cortex" CDMC24626 2 21 20 DAC33-B21 3-CG11340-RA_6 CG11340 GGTGTCGCCTTTGAACACCACGGATGCTTTCAGTGTGTCCATCAACCTGTCGCAATCGACTGTGAACAA 69 FBan0011340 FBgn0039840 CG11340 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG11340 CG11340 CDMC24626 2 22 20 DAC33-B21 3-CG11340-RA_6 CG11340 GGTGTCGCCTTTGAACACCACGGATGCTTTCAGTGTGTCCATCAACCTGTCGCAATCGACTGTGAACAA 69 FBan0011340 FBgn0039840 CG11340 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG11340 CG11340 CDMC24627 2 23 20 DAC33-F09 3-CG11375-RA_1 CG11375 TGGTCGACGATATACTTCAAATACGGCGCAGTTGCAACTAGCCCATCGTTCACCGCTAAGCCCAAAGCT 69 FBan0011375 FBgn0039227 baf180 3 3R "regulation of transcription, DNA-dependent; GO:0006355" zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 baf180 baf180 "CG11375, CG11375, BAF180, anon-WO0140519.158" CDMC24627 2 24 20 DAC33-F09 3-CG11375-RA_1 CG11375 TGGTCGACGATATACTTCAAATACGGCGCAGTTGCAACTAGCCCATCGTTCACCGCTAAGCCCAAAGCT 69 FBan0011375 FBgn0039227 baf180 3 3R "regulation of transcription, DNA-dependent; GO:0006355" zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 baf180 baf180 "CG11375, CG11375, BAF180, anon-WO0140519.158" CDMC24628 2 25 20 DAC33-F21 3-CG11382-RB_3 CG11382 TCCTCCGCTAAGCCAAAAAGAGATGCTGGCCTAAGTTTCGGAGGAATATCCAGCTATCACGGCCCTTCT 69 FBan0011382 FBgn0040367 CG11382 X X CG11382 CG11382 EG:BACR42I17.10 CDMC24628 2 26 20 DAC33-F21 3-CG11382-RB_3 CG11382 TCCTCCGCTAAGCCAAAAAGAGATGCTGGCCTAAGTTTCGGAGGAATATCCAGCTATCACGGCCCTTCT 69 FBan0011382 FBgn0040367 CG11382 X X CG11382 CG11382 EG:BACR42I17.10 CDMC24629 2 1 21 DAC33-J09 23-CG11418-RA_6 CG11418 TGACACCGCCCATGTACATACATACTTAGGATAAGCCACAACTTCACATTCATGGTGAGTCCAGCTTAA 69 FBan0011418 FBgn0024360 CG11418 X X nucleic acid binding; GO:0003676; ; GO:0003676 CG11418 CG11418 "EG:8D8.8, DmNP_569904" CDMC24629 2 2 21 DAC33-J09 23-CG11418-RA_6 CG11418 TGACACCGCCCATGTACATACATACTTAGGATAAGCCACAACTTCACATTCATGGTGAGTCCAGCTTAA 69 FBan0011418 FBgn0024360 CG11418 X X nucleic acid binding; GO:0003676; ; GO:0003676 CG11418 CG11418 "EG:8D8.8, DmNP_569904" CDMC24630 2 3 21 DAC33-J21 3-CG1142-RA_1 CG1142 TGGAGCTCTTTGGCCTAAAGTTGAACTCCAAGGAAGTGCTCGATGTCGTGAATTCCCTGCCTGACCGAA 69 FBan0001142 FBgn0037504 CG1142 3 3R CG1142 CG1142 CDMC24630 2 4 21 DAC33-J21 3-CG1142-RA_1 CG1142 TGGAGCTCTTTGGCCTAAAGTTGAACTCCAAGGAAGTGCTCGATGTCGTGAATTCCCTGCCTGACCGAA 69 FBan0001142 FBgn0037504 CG1142 3 3R CG1142 CG1142 CDMC24631 2 5 21 DAC33-N09 1-CG1147-RA_1 CG1147 GCAACTGCCACCTCTCTAGAACACTGAGCGAAATGCCGTGTCCTCTAATCGGGAAACACTCTGGCTGTA 69 FBan0001147 FBgn0037408 NPFR1 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0004995; neuropeptide F receptor activity; GO:0042263; ; GO:0008188; ; GO:0004995; ; GO:0004983; ; GO:0042263; ; GO:0042263 integral to membrane; GO:0016021 NPFR1 neuropeptide F receptor "CG1147, CG1147, CG1147, CG1147, CG1147, CG1147, CG1147, NPFR, dNPFR1, npfr1, anon-WO0131005.3, anon-WO0131005.5" CDMC24631 2 6 21 DAC33-N09 1-CG1147-RA_1 CG1147 GCAACTGCCACCTCTCTAGAACACTGAGCGAAATGCCGTGTCCTCTAATCGGGAAACACTCTGGCTGTA 69 FBan0001147 FBgn0037408 NPFR1 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0004995; neuropeptide F receptor activity; GO:0042263; ; GO:0008188; ; GO:0004995; ; GO:0004983; ; GO:0042263; ; GO:0042263 integral to membrane; GO:0016021 NPFR1 neuropeptide F receptor "CG1147, CG1147, CG1147, CG1147, CG1147, CG1147, CG1147, NPFR, dNPFR1, npfr1, anon-WO0131005.3, anon-WO0131005.5" CDMC24632 2 7 21 DAC33-N21 3-CG11490-RA_1 CG11490 GCCCCAACTTCCACCTACTGTTTTCGGTGGCCATCCTCGATCAAGAGACTAGAGTGATCATCGACAGCC 69 FBan0011490 FBgn0031233 CG11490 2 2L intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005096 CG11490 CG11490 CDMC24632 2 8 21 DAC33-N21 3-CG11490-RA_1 CG11490 GCCCCAACTTCCACCTACTGTTTTCGGTGGCCATCCTCGATCAAGAGACTAGAGTGATCATCGACAGCC 69 FBan0011490 FBgn0031233 CG11490 2 2L intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005096 CG11490 CG11490 CDMC24633 2 9 21 DAC34-B09 3-CG1448-RA_3 CG1448 CTGGGCGGTGCTTTCATGTCCTACGGTACGGATGTGCTCAAGTTCTCCAACATGGATCAGGACAAGC 67 FBan0001448 FBgn0028373 inx3 3 3R signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx3 innexin 3 "CG1448, Ix3, Dm-inx3, inx-3, innexin 3" CDMC24633 2 10 21 DAC34-B09 3-CG1448-RA_3 CG1448 CTGGGCGGTGCTTTCATGTCCTACGGTACGGATGTGCTCAAGTTCTCCAACATGGATCAGGACAAGC 67 FBan0001448 FBgn0028373 inx3 3 3R signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx3 innexin 3 "CG1448, Ix3, Dm-inx3, inx-3, innexin 3" CDMC24634 2 11 21 DAC34-B21 22-CG14638-RA_1 CG14638 ACGTGCTCAACAAGCAGGAGAACATTGGCAAGTGGATCACCAACCTGAATACTATCCGTAACAACAA 67 FBan0014638 FBgn0037223 CG14638 3 3R CG14638 CG14638 CDMC24634 2 12 21 DAC34-B21 22-CG14638-RA_1 CG14638 ACGTGCTCAACAAGCAGGAGAACATTGGCAAGTGGATCACCAACCTGAATACTATCCGTAACAACAA 67 FBan0014638 FBgn0037223 CG14638 3 3R CG14638 CG14638 CDMC24635 2 13 21 DAC34-F09 3-CG15006-RA_4 CG15006 CGAGCAGCAGTAGACCTCCAGTTCTCCACTACTCCATCGCAAACACCAAGCAATCCGTCCAGAATGG 67 FBan0015006 FBgn0035510 CG15006 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15006 CG15006 CDMC24635 2 14 21 DAC34-F09 3-CG15006-RA_4 CG15006 CGAGCAGCAGTAGACCTCCAGTTCTCCACTACTCCATCGCAAACACCAAGCAATCCGTCCAGAATGG 67 FBan0015006 FBgn0035510 CG15006 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15006 CG15006 CDMC24636 2 15 21 DAC34-F21 13-CG15066-RA_1 CG15066 TTGCACGCAGATTGAGAATGAAGTGCCTGATTCTGTCCTTTGCAATTTTCGTTGTCCTGGCTTCCCA 67 FBan0015066 FBgn0034328 IM23 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM23 Immune induced molecule 23 "CG15066, CG15066, CG15066, CG15066, DIM 23, BcDNA:RH67033, Immune induced molecule 23" CDMC24636 2 16 21 DAC34-F21 13-CG15066-RA_1 CG15066 TTGCACGCAGATTGAGAATGAAGTGCCTGATTCTGTCCTTTGCAATTTTCGTTGTCCTGGCTTCCCA 67 FBan0015066 FBgn0034328 IM23 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM23 Immune induced molecule 23 "CG15066, CG15066, CG15066, CG15066, DIM 23, BcDNA:RH67033, Immune induced molecule 23" CDMC24637 2 17 21 DAC34-J09 18-CG15597-RA_4 CG15597 TCAGGCAGCTTTAAATCGAAAGCAAACTTGGCTTTTGGCATTAGTTCTACTTGTGCCTCTCGAGCGT 67 FBan0015597 FBgn0037420 CG15597 3 3R CG15597 CG15597 CDMC24637 2 18 21 DAC34-J09 18-CG15597-RA_4 CG15597 TCAGGCAGCTTTAAATCGAAAGCAAACTTGGCTTTTGGCATTAGTTCTACTTGTGCCTCTCGAGCGT 67 FBan0015597 FBgn0037420 CG15597 3 3R CG15597 CG15597 CDMC24638 2 19 21 DAC34-J21 7-CG1567-RA_1 CG1567 CCCCGATTCCCCTCACATCTGGCGAAAAAACCGTAAAGGGTAATGCAACAAGCGTGTCGGTAGCGAC 67 FBan0001567 FBgn0021742 C901 X X cell communication; GO:0007154; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 membrane; GO:0016020 C901 C901 "CG1567, cDNA 901, 10, c901, CT4052, anon-10Ab" CDMC24638 2 20 21 DAC34-J21 7-CG1567-RA_1 CG1567 CCCCGATTCCCCTCACATCTGGCGAAAAAACCGTAAAGGGTAATGCAACAAGCGTGTCGGTAGCGAC 67 FBan0001567 FBgn0021742 C901 X X cell communication; GO:0007154; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 membrane; GO:0016020 C901 C901 "CG1567, cDNA 901, 10, c901, CT4052, anon-10Ab" CDMC24639 2 21 21 DAC34-N09 6-CG16785-RA_1 CG16785 GCGTGTGCTATCTGGAGCGAATCGTGTTCCACAATCAAGCAAGGATGCATGACGTCGAGCTGCAATG 67 FBan0016785 FBgn0027343 fz3 X X G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; frizzled signaling pathway; GO:0007222; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz3 frizzled 3 "CG16785, CG16785, Dfz3, Dfrizzled-3, EG:34F3.6, DFz3, dfz3, frizzled 3" CDMC24639 2 22 21 DAC34-N09 6-CG16785-RA_1 CG16785 GCGTGTGCTATCTGGAGCGAATCGTGTTCCACAATCAAGCAAGGATGCATGACGTCGAGCTGCAATG 67 FBan0016785 FBgn0027343 fz3 X X G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; frizzled signaling pathway; GO:0007222; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz3 frizzled 3 "CG16785, CG16785, Dfz3, Dfrizzled-3, EG:34F3.6, DFz3, dfz3, frizzled 3" CDMC24640 2 23 21 DAC34-N21 3-CG17033-RA_1 CG17033 ACAACCTCCACATGACTGAGGACGTCATGATCGATCCAGGTTTGGTCATGATCTTCGCCCATGGCAT 67 FBan0017033 FBgn0036546 CG17033 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17033 CG17033 CDMC24640 2 24 21 DAC34-N21 3-CG17033-RA_1 CG17033 ACAACCTCCACATGACTGAGGACGTCATGATCGATCCAGGTTTGGTCATGATCTTCGCCCATGGCAT 67 FBan0017033 FBgn0036546 CG17033 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17033 CG17033 CDMC24641 2 25 21 DAC35-B09 12-CG11757-RA_1 CG11757 GCTTTCCCGTCAAGTTTCGGACGTATCTGGGCAAGCCTATACCCTACGATGAGAACCTAACCCCGCAGG 69 FBan0011757 FBgn0030288 CG11757 X X CG11757 CG11757 CDMC24641 2 26 21 DAC35-B09 12-CG11757-RA_1 CG11757 GCTTTCCCGTCAAGTTTCGGACGTATCTGGGCAAGCCTATACCCTACGATGAGAACCTAACCCCGCAGG 69 FBan0011757 FBgn0030288 CG11757 X X CG11757 CG11757 CDMC24642 2 1 22 DAC35-B21 16-CG11767-RA_2 CG11767 GGCAACGCAACTAACATTCCTGCTACTATGCTGTGGATTTTGCACCAGTACTTCCTATTCCGTCAGACA 69 FBan0011767 FBgn0026394 Or24a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or24a Odorant receptor 24a "CG11767, CG11767, CG11767, DOR24D.1, Olfactory receptor 24D.1, 24D.1, DOR48, Or24D.1, 24a" CDMC24642 2 2 22 DAC35-B21 16-CG11767-RA_2 CG11767 GGCAACGCAACTAACATTCCTGCTACTATGCTGTGGATTTTGCACCAGTACTTCCTATTCCGTCAGACA 69 FBan0011767 FBgn0026394 Or24a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or24a Odorant receptor 24a "CG11767, CG11767, CG11767, DOR24D.1, Olfactory receptor 24D.1, 24D.1, DOR48, Or24D.1, 24a" CDMC24643 2 3 22 DAC35-F09 2-CG11807-RA_1 CG11807 CGACCTGACAGGCAATTTGCTAACCCAAATCGATGGCAGTGTACGAACAGCTCCAAAACTCAGACGCCT 69 FBan0011807 FBgn0033996 CG11807 2 2R intracellular signaling cascade; GO:0007242 CG11807 CG11807 CT14564 CDMC24643 2 4 22 DAC35-F09 2-CG11807-RA_1 CG11807 CGACCTGACAGGCAATTTGCTAACCCAAATCGATGGCAGTGTACGAACAGCTCCAAAACTCAGACGCCT 69 FBan0011807 FBgn0033996 CG11807 2 2R intracellular signaling cascade; GO:0007242 CG11807 CG11807 CT14564 CDMC24644 2 5 22 DAC35-F21 1-CG11821-RA_1 CG11821 TGGCACGATTGTGTCCATGATTCCCATAAATTCCCTGTACAGCGAGGAGTACTTCCCAAAGCCCACGGA 69 FBan0011821 FBgn0038680 Cyp12a5 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12a5 Cyp12a5 "CG11821, 12a5" CDMC24644 2 6 22 DAC35-F21 1-CG11821-RA_1 CG11821 TGGCACGATTGTGTCCATGATTCCCATAAATTCCCTGTACAGCGAGGAGTACTTCCCAAAGCCCACGGA 69 FBan0011821 FBgn0038680 Cyp12a5 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12a5 Cyp12a5 "CG11821, 12a5" CDMC24645 2 7 22 DAC35-J09 10-CG11865-RA_1 CG11865 GGGTTCAGGATGCTGGTCGTATGTAGGATATTTGGGAAGAGCAGACCAGACCCTCAATCTAGGCAGTGG 69 FBan0011865 FBgn0028947 CG11865 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 CG11865 CG11865 "BG:BACR44L22.4, BACR44L22.4" CDMC24645 2 8 22 DAC35-J09 10-CG11865-RA_1 CG11865 GGGTTCAGGATGCTGGTCGTATGTAGGATATTTGGGAAGAGCAGACCAGACCCTCAATCTAGGCAGTGG 69 FBan0011865 FBgn0028947 CG11865 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 CG11865 CG11865 "BG:BACR44L22.4, BACR44L22.4" CDMC24646 2 9 22 DAC35-J21 6-CG11880-RB_2 CG11880 TGCTTCTTCTGGTTGCTGGAGACCTTCCTGAAGTTCCTCAATCGGAATGCCTACATCATGTGCGCCATT 69 FBan0011880 FBgn0039637 CG11880 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG11880 CG11880 CDMC24646 2 10 22 DAC35-J21 6-CG11880-RB_2 CG11880 TGCTTCTTCTGGTTGCTGGAGACCTTCCTGAAGTTCCTCAATCGGAATGCCTACATCATGTGCGCCATT 69 FBan0011880 FBgn0039637 CG11880 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG11880 CG11880 CDMC24647 2 11 22 DAC35-N09 1-CG11909-RA_1 CG11909 TGGGAGGATTGCTATGGAGCCATGACCTTCAGGAAGAACAAGTTCCCCGATAGCAAGACCCTGACTGAT 69 FBan0011909 FBgn0039330 CG11909 3 3R monosaccharide metabolism; GO:0005996; polysaccharide metabolism; GO:0005976 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG11909 CG11909 CT33098 CDMC24647 2 12 22 DAC35-N09 1-CG11909-RA_1 CG11909 TGGGAGGATTGCTATGGAGCCATGACCTTCAGGAAGAACAAGTTCCCCGATAGCAAGACCCTGACTGAT 69 FBan0011909 FBgn0039330 CG11909 3 3R monosaccharide metabolism; GO:0005996; polysaccharide metabolism; GO:0005976 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG11909 CG11909 CT33098 CDMC24648 2 13 22 DAC35-N21 23-CG11924-RA_3 CG11924 GTAGCGGAAATGACAAAGGACCAATACGAAATTTAGTCATTTCTCAATTATTTGCACACGAGCAGGATC 69 FBan0011924 FBgn0000286 Cf2 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; ; GO:0003702; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Cf2 Chorion factor 2 "CG11924, CG11924, CF2, CF2.5, cf2, BcDNA:GM09668" CDMC24648 2 14 22 DAC35-N21 23-CG11924-RA_3 CG11924 GTAGCGGAAATGACAAAGGACCAATACGAAATTTAGTCATTTCTCAATTATTTGCACACGAGCAGGATC 69 FBan0011924 FBgn0000286 Cf2 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; ; GO:0003702; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Cf2 Chorion factor 2 "CG11924, CG11924, CF2, CF2.5, cf2, BcDNA:GM09668" CDMC24649 2 15 22 DAC36-B09 23-CG8611-RB_1 CG8611 GATTACTCGCCGTAATATGTTCGTTCATTTTTTGTGTGGAAAATATTAGAAATCCATTTTCCGCTCACT 69 FBan0008611 FBgn0027602 CG8611 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 CG8611 CG8611 "cg8611, DmRH11, BcDNA:GH02833" CDMC24649 2 16 22 DAC36-B09 23-CG8611-RB_1 CG8611 GATTACTCGCCGTAATATGTTCGTTCATTTTTTGTGTGGAAAATATTAGAAATCCATTTTCCGCTCACT 69 FBan0008611 FBgn0027602 CG8611 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 CG8611 CG8611 "cg8611, DmRH11, BcDNA:GH02833" CDMC24650 2 17 22 DAC36-B21 2-CG8625-RA_2 CG8625 GCCGTGTTTTGGGAGCGATGCACTGAGTTGCAGGATATTGAGCGAATAATGGGACAGATTGAGCGTGGA 69 FBan0008625 FBgn0011604 Iswi 2 2R "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ATPase activity; GO:0016887; general RNA polymerase II transcription factor activity; GO:0016251; DNA helicase activity; GO:0003678; ; GO:0005524; ; GO:0003676; nucleotide binding; GO:0000166; protein binding; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0016251; ; GO:0016887; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0000166; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0008026; ; GO:0005515 ACF complex; GO:0016590; NOT brahma complex; GO:0035060; NURF complex; GO:0016589; chromatin accessibility complex; GO:0008623; chromatin remodeling complex; GO:0016585; transcription factor complex; GO:0005667 Iswi Imitation SWI "CG8625, CG8625, ISWI, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, CHRAC, NURF-140, ISW, SWI, imitation-SWI, ISWI ATPase, ACF, dCHRAC, dNURF, dISWI, p140, p140/ISWI, iswi, Nurf-140: Nucleosome remodeling factor - 140kD, anon-EP1279744.124, Nucleosome remodeling factor - 140kD, NURF" CDMC24650 2 18 22 DAC36-B21 2-CG8625-RA_2 CG8625 GCCGTGTTTTGGGAGCGATGCACTGAGTTGCAGGATATTGAGCGAATAATGGGACAGATTGAGCGTGGA 69 FBan0008625 FBgn0011604 Iswi 2 2R "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; nucleosome assembly; GO:0006334; nucleosome mobilization; GO:0042766; nucleosome spacing; GO:0016584; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ATPase activity; GO:0016887; general RNA polymerase II transcription factor activity; GO:0016251; DNA helicase activity; GO:0003678; ; GO:0005524; ; GO:0003676; nucleotide binding; GO:0000166; protein binding; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0016251; ; GO:0016887; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0000166; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0008026; ; GO:0005515 ACF complex; GO:0016590; NOT brahma complex; GO:0035060; NURF complex; GO:0016589; chromatin accessibility complex; GO:0008623; chromatin remodeling complex; GO:0016585; transcription factor complex; GO:0005667 Iswi Imitation SWI "CG8625, CG8625, ISWI, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, CHRAC, NURF-140, ISW, SWI, imitation-SWI, ISWI ATPase, ACF, dCHRAC, dNURF, dISWI, p140, p140/ISWI, iswi, Nurf-140: Nucleosome remodeling factor - 140kD, anon-EP1279744.124, Nucleosome remodeling factor - 140kD, NURF" CDMC24651 2 19 22 DAC36-F09 3-CG8660-RC_2 CG8660 GCTGGAGCCACAAATGCGTGACCTTATCACCGAGAAGTACTATTCCATCGATGATGTGGTGGCTCGCGA 69 FBan0008660 FBgn0036911 Fibp 3 3L cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166 fibroblast growth factor binding; GO:0017134; ; GO:0017134; receptor binding; GO:0005102; ; GO:0005102; ; GO:0017134 intracellular; GO:0005622 Fibp Fibp "CG8660, CG8660, CG8660, DrFIBP" CDMC24651 2 20 22 DAC36-F09 3-CG8660-RC_2 CG8660 GCTGGAGCCACAAATGCGTGACCTTATCACCGAGAAGTACTATTCCATCGATGATGTGGTGGCTCGCGA 69 FBan0008660 FBgn0036911 Fibp 3 3L cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166 fibroblast growth factor binding; GO:0017134; ; GO:0017134; receptor binding; GO:0005102; ; GO:0005102; ; GO:0017134 intracellular; GO:0005622 Fibp Fibp "CG8660, CG8660, CG8660, DrFIBP" CDMC24652 2 21 22 DAC36-F21 13-CG8673-RA_1 CG8673 GGGCGAAGCGATACGGCTAAGATCCTTTAGGGAGCCTATTAAAGATTTCGACGATGGATTCGCCGTTCA 69 FBan0008673 FBgn0031986 CG8673 2 2L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG8673 CG8673 CDMC24652 2 22 22 DAC36-F21 13-CG8673-RA_1 CG8673 GGGCGAAGCGATACGGCTAAGATCCTTTAGGGAGCCTATTAAAGATTTCGACGATGGATTCGCCGTTCA 69 FBan0008673 FBgn0031986 CG8673 2 2L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG8673 CG8673 CDMC24653 2 23 22 DAC36-J09 12-CG8707-RA_3 CG8707 GGAGTCGACCAGTAAGATCGTGAAGGACGACATCAACAACTCCAGCTTTGTGCAGTTCCAGATCTGGGA 69 FBan0008707 FBgn0033272 CG8707 2 2R cellular physiological process; GO:0050875 GTPase activity; GO:0003924; ; GO:0003924 cytoplasm; GO:0005737; nucleus; GO:0005634 CG8707 CG8707 CDMC24653 2 24 22 DAC36-J09 12-CG8707-RA_3 CG8707 GGAGTCGACCAGTAAGATCGTGAAGGACGACATCAACAACTCCAGCTTTGTGCAGTTCCAGATCTGGGA 69 FBan0008707 FBgn0033272 CG8707 2 2R cellular physiological process; GO:0050875 GTPase activity; GO:0003924; ; GO:0003924 cytoplasm; GO:0005737; nucleus; GO:0005634 CG8707 CG8707 CDMC24654 2 25 22 DAC36-J21 23-CG8715-RC_1 CG8715 AGGCGTAAAACGATTTAACAGATTTAAGAGTGTAAGAGAGAAACCGGAAATGCAGAACAGTAAATTAAA 69 FBgn0033253 CDMC24654 2 26 22 DAC36-J21 23-CG8715-RC_1 CG8715 AGGCGTAAAACGATTTAACAGATTTAAGAGTGTAAGAGAGAAACCGGAAATGCAGAACAGTAAATTAAA 69 FBgn0033253 CDMC24655 2 1 23 DAC36-N09 16-CG8750-RA_1 CG8750 AGAGACGTGTCCAAGAGTGGAAGTCTTCAGGCCAAGTCTGAGATAAAACGTAAACTTGGGGATGATGCA 69 FBan0008750 FBgn0040812 CG8750 3 3L CG8750 CG8750 CDMC24655 2 2 23 DAC36-N09 16-CG8750-RA_1 CG8750 AGAGACGTGTCCAAGAGTGGAAGTCTTCAGGCCAAGTCTGAGATAAAACGTAAACTTGGGGATGATGCA 69 FBan0008750 FBgn0040812 CG8750 3 3L CG8750 CG8750 CDMC24656 2 3 23 DAC36-N21 1-CG8766-RA_2 CG8766 GCCCTACAACATCGACTGGATATTCCCTAGGCTGAGAAACCCCTCGAAGTTCTGGTACGTGGTCAGCCA 69 FBan0008766 FBgn0026619 tafazzin 2 2R metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- tafazzin tafazzin "CG8766, CG8766, tafazzins" CDMC24656 2 4 23 DAC36-N21 1-CG8766-RA_2 CG8766 GCCCTACAACATCGACTGGATATTCCCTAGGCTGAGAAACCCCTCGAAGTTCTGGTACGTGGTCAGCCA 69 FBan0008766 FBgn0026619 tafazzin 2 2R metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- tafazzin tafazzin "CG8766, CG8766, tafazzins" CDMC24657 2 5 23 DAC37-B09 17-CG8996-RA_1 CG8996 AGGCCGTGCCCGAACTAACCGGAAAGTTGTAAGGCGAGATTGTCACTTGCTGTAGTATAAAGATTGTGT 69 FBan0008996 FBgn0010516 wal 2 2R Malpighian tubule morphogenesis; GO:0007443; ectodermal gut morphogenesis; GO:0048567; electron transport; GO:0006118; head involution; GO:0008258; morphogenesis of an epithelium; GO:0002009; oxidative phosphorylation; GO:0006119; tracheal system development (sensu Insecta); GO:0007424 electron carrier activity; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; ; GO:0009055 electron transfer flavoprotein complex (sensu Eukaryota); GO:0017133; mitochondrial matrix; GO:0005759 wal walrus "CG8996, Etf, Electron transfer flavoprotein, P447, l(2)02516, BcDNA.LD07532, BcDNA:GH09945, BcDNA:LD07532, EP2253, walrus" CDMC24657 2 6 23 DAC37-B09 17-CG8996-RA_1 CG8996 AGGCCGTGCCCGAACTAACCGGAAAGTTGTAAGGCGAGATTGTCACTTGCTGTAGTATAAAGATTGTGT 69 FBan0008996 FBgn0010516 wal 2 2R Malpighian tubule morphogenesis; GO:0007443; ectodermal gut morphogenesis; GO:0048567; electron transport; GO:0006118; head involution; GO:0008258; morphogenesis of an epithelium; GO:0002009; oxidative phosphorylation; GO:0006119; tracheal system development (sensu Insecta); GO:0007424 electron carrier activity; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; ; GO:0009055 electron transfer flavoprotein complex (sensu Eukaryota); GO:0017133; mitochondrial matrix; GO:0005759 wal walrus "CG8996, Etf, Electron transfer flavoprotein, P447, l(2)02516, BcDNA.LD07532, BcDNA:GH09945, BcDNA:LD07532, EP2253, walrus" CDMC24658 2 7 23 DAC37-B21 3-CG9006-RA_6 CG9006 CGCGTGGTCGTGGATCTTCTGAAAGAGGTTGGAACTCCGTTGCAACAGCAGAGGTATCTCCAGGACTTG 69 FBgn0033637 CDMC24658 2 8 23 DAC37-B21 3-CG9006-RA_6 CG9006 CGCGTGGTCGTGGATCTTCTGAAAGAGGTTGGAACTCCGTTGCAACAGCAGAGGTATCTCCAGGACTTG 69 FBgn0033637 CDMC24659 2 9 23 DAC37-F09 14-CG9038-RB_1 CG9038 ATGGCATTGGCAATTGATTGTGCTGATTACATGCGACCTGGAAACTTGCCCATTTCGAATTCGGATGGG 69 FBan0009038 FBgn0026076 UBL3 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 UBL3 UBL3 "CG9038, HCG-1, Ubl3, Ubiquitin-like 3" CDMC24659 2 10 23 DAC37-F09 14-CG9038-RB_1 CG9038 ATGGCATTGGCAATTGATTGTGCTGATTACATGCGACCTGGAAACTTGCCCATTTCGAATTCGGATGGG 69 FBan0009038 FBgn0026076 UBL3 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 UBL3 UBL3 "CG9038, HCG-1, Ubl3, Ubiquitin-like 3" CDMC24660 2 11 23 DAC37-F21 1-CG9047-RB_1 CG9047 GGCGAACACGGTGTCACCTACGTCCCTTTTCAAAGTCCTACTCCAAACAGCCTTTTTCTGGGCGAGAAC 69 FBan0009047 FBgn0035075 CG9047 2 2R CG9047 CG9047 anon-WO0118547.94 CDMC24660 2 12 23 DAC37-F21 1-CG9047-RB_1 CG9047 GGCGAACACGGTGTCACCTACGTCCCTTTTCAAAGTCCTACTCCAAACAGCCTTTTTCTGGGCGAGAAC 69 FBan0009047 FBgn0035075 CG9047 2 2R CG9047 CG9047 anon-WO0118547.94 CDMC24661 2 13 23 DAC37-J09 1-CG9086-RA_2 CG9086 GCTGGTGGAGGAAGAATCGGAAGAGAATCAGGGTCATGGGCAAACAGTGGTGATACCCTGTGAATCGCA 69 FBan0009086 FBgn0030809 CG9086 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG9086 CG9086 Ubr1 CDMC24661 2 14 23 DAC37-J09 1-CG9086-RA_2 CG9086 GCTGGTGGAGGAAGAATCGGAAGAGAATCAGGGTCATGGGCAAACAGTGGTGATACCCTGTGAATCGCA 69 FBan0009086 FBgn0030809 CG9086 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG9086 CG9086 Ubr1 CDMC24662 2 15 23 DAC37-J21 15-CG9095-RA_1 CG9095 TGCAGCCAAATTATGTGCAACTTGGTTTCGTTTGAGGTCTCAAGCCCAATCGACTTGCTCATAGTCGCA 69 FBan0009095 FBgn0030617 CG9095 X X defense response; GO:0006952 sugar binding; GO:0005529; ; GO:0005529 CG9095 CG9095 CT26106 CDMC24662 2 16 23 DAC37-J21 15-CG9095-RA_1 CG9095 TGCAGCCAAATTATGTGCAACTTGGTTTCGTTTGAGGTCTCAAGCCCAATCGACTTGCTCATAGTCGCA 69 FBan0009095 FBgn0030617 CG9095 X X defense response; GO:0006952 sugar binding; GO:0005529; ; GO:0005529 CG9095 CG9095 CT26106 CDMC24663 2 17 23 DAC37-N09 23-CG9132-RB_1 CG9132 CACATAATTGTAGAGAAGGAAATCTTGCTAAATCTGAATTGTTGTTTCAGCCCCGATTACCCCGCTCCC 69 FBgn0052566 CDMC24663 2 18 23 DAC37-N09 23-CG9132-RB_1 CG9132 CACATAATTGTAGAGAAGGAAATCTTGCTAAATCTGAATTGTTGTTTCAGCCCCGATTACCCCGCTCCC 69 FBgn0052566 CDMC24664 2 19 23 DAC37-N21 1-CG9148-RA_1 CG9148 AGACCATAAGCTGGGATTCCTACATGCAGACTGTCTACGGCTTCATGGATGATCTGAGCCCCGACGAGA 69 FBan0009148 FBgn0025682 scf 3 3L calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.- scf supercoiling factor "CG9148, CK02682, DCB-45, SCF, BEST:CK02682, anon-EST:Posey14, supercoiling factor" CDMC24664 2 20 23 DAC37-N21 1-CG9148-RA_1 CG9148 AGACCATAAGCTGGGATTCCTACATGCAGACTGTCTACGGCTTCATGGATGATCTGAGCCCCGACGAGA 69 FBan0009148 FBgn0025682 scf 3 3L calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.- scf supercoiling factor "CG9148, CK02682, DCB-45, SCF, BEST:CK02682, anon-EST:Posey14, supercoiling factor" CDMC24665 2 21 23 DAC38-B09 15-CG5583-RA_1 CG5583 CGCTCCATCAGGCAGTACTACAAGAAGGGAATCATGAAGAAGACGGAGAGGTCACAGCGGCTGGTC 66 FBan0005583 FBgn0005659 Ets98B 3 3R germ cell migration; GO:0008354; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Ets98B Ets at 98B "CG5583, D-Ets-4, ETS4, D-ets-4, Ets, D-ets4, Ets4, ets98B" CDMC24665 2 22 23 DAC38-B09 15-CG5583-RA_1 CG5583 CGCTCCATCAGGCAGTACTACAAGAAGGGAATCATGAAGAAGACGGAGAGGTCACAGCGGCTGGTC 66 FBan0005583 FBgn0005659 Ets98B 3 3R germ cell migration; GO:0008354; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Ets98B Ets at 98B "CG5583, D-Ets-4, ETS4, D-ets-4, Ets, D-ets4, Ets4, ets98B" CDMC24666 2 23 23 DAC38-B21 6-CG5810-RA_2 CG5810 TGGTCGAGTGATTGGTGTCCAATTGGAGGCAAACCCAAAGCTGCATGAGTTGAAGATTTCGCAGCC 66 FBan0005810 FBgn0038866 CG5810 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; development; GO:0007275; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG5810 CG5810 CT18214 CDMC24666 2 24 23 DAC38-B21 6-CG5810-RA_2 CG5810 TGGTCGAGTGATTGGTGTCCAATTGGAGGCAAACCCAAAGCTGCATGAGTTGAAGATTTCGCAGCC 66 FBan0005810 FBgn0038866 CG5810 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; development; GO:0007275; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG5810 CG5810 CT18214 CDMC24667 2 25 23 DAC38-F09 18-CG6240-RA_2 CG6240 GATCCCGACCCGAAGTACTCCTTTGGCTACGACATCCAGGATGGTTATACTGGTGACCTGAAGTCA 66 FBan0006240 FBgn0038714 CG6240 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG6240 CG6240 CDMC24667 2 26 23 DAC38-F09 18-CG6240-RA_2 CG6240 GATCCCGACCCGAAGTACTCCTTTGGCTACGACATCCAGGATGGTTATACTGGTGACCTGAAGTCA 66 FBan0006240 FBgn0038714 CG6240 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG6240 CG6240 CDMC24668 2 1 24 DAC38-F21 9-CG6356-RA_1 CG6356 GGACAGAAACTCAAGAATGGTCCCCTGAAGTCCATCATCGAGCTGTATGCCAACTCCAAGGTGCGC 66 FBan0006356 FBgn0039178 CG6356 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6356 CG6356 CDMC24668 2 2 24 DAC38-F21 9-CG6356-RA_1 CG6356 GGACAGAAACTCAAGAATGGTCCCCTGAAGTCCATCATCGAGCTGTATGCCAACTCCAAGGTGCGC 66 FBan0006356 FBgn0039178 CG6356 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG6356 CG6356 CDMC24669 2 3 24 DAC38-J09 3-CG6815-RA_2 CG6815 GCCATCGCCACAAAGAACACACGTATCAACAAGGGCATGTACAGGAATGTTTTGATGCACGGGCCG 66 FBan0006815 FBgn0040237 bor 3 3R ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 cytoplasm; GO:0005737 bor belphegor "CG6815, CG6815, CP89BC, Cytoplasmic Protein 89BC, belphegor" CDMC24669 2 4 24 DAC38-J09 3-CG6815-RA_2 CG6815 GCCATCGCCACAAAGAACACACGTATCAACAAGGGCATGTACAGGAATGTTTTGATGCACGGGCCG 66 FBan0006815 FBgn0040237 bor 3 3R ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 cytoplasm; GO:0005737 bor belphegor "CG6815, CG6815, CP89BC, Cytoplasmic Protein 89BC, belphegor" CDMC24670 2 5 24 DAC38-J21 2-CG7017-RA_2 CG7017 CCAGGGATGCACACAGACCAACTACCACAACATCGCATGTTCCGTGTAGGCTGTCCCAGAAGATCG 66 FBan0007017 FBgn0036951 CG7017 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7017 CG7017 CDMC24670 2 6 24 DAC38-J21 2-CG7017-RA_2 CG7017 CCAGGGATGCACACAGACCAACTACCACAACATCGCATGTTCCGTGTAGGCTGTCCCAGAAGATCG 66 FBan0007017 FBgn0036951 CG7017 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7017 CG7017 CDMC24671 2 7 24 DAC38-N09 2-CG7464-RA_1 CG7464 GATGGCCAAGAAGGTGAGCTTTACGGCCTCAAACCGGAACAATATGGCTTTGTACGACAACGGCGG 66 FBan0007464 FBgn0029091 CS-2 3 3L chitin synthase activity; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16 CS-2 Chitin synthase 2 "CG7464, CG7464, DmCS-2, DmeChSA, ChSA, Chitin Synthase A, chitin-synthase, Chitin synthase 2" CDMC24671 2 8 24 DAC38-N09 2-CG7464-RA_1 CG7464 GATGGCCAAGAAGGTGAGCTTTACGGCCTCAAACCGGAACAATATGGCTTTGTACGACAACGGCGG 66 FBan0007464 FBgn0029091 CS-2 3 3L chitin synthase activity; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16; ; GO:0004100 ; EC:2.4.1.16 CS-2 Chitin synthase 2 "CG7464, CG7464, DmCS-2, DmeChSA, ChSA, Chitin Synthase A, chitin-synthase, Chitin synthase 2" CDMC24672 2 9 24 DAC38-N21 3-CG7643-RA_2 CG7643 CCCTCCACCTCGAAGACGAAGCCGGATGCAGACTTCATTACCCCCCAAGTACGAACAATTGGTTCC 66 FBgn0038534 CDMC24672 2 10 24 DAC38-N21 3-CG7643-RA_2 CG7643 CCCTCCACCTCGAAGACGAAGCCGGATGCAGACTTCATTACCCCCCAAGTACGAACAATTGGTTCC 66 FBgn0038534 CDMC24673 2 11 24 DAC39-B09 17-CG32042-RE_1 CG32042 GTCTCTCTTCCTCTCTGGAGCTCTGTTTAGTTTTACTGTCGCTCAAAAAGCTGGAAATTCCCAAGCCGC 69 FBan0032042 FBgn0035975 PGRP-LA 3 3L defense response; GO:0006952; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0042834 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 PGRP-LA Peptidoglycan recognition protein LA "CG4384, CG32042, CG18614, CG4361, CG4384" CDMC24673 2 12 24 DAC39-B09 17-CG32042-RE_1 CG32042 GTCTCTCTTCCTCTCTGGAGCTCTGTTTAGTTTTACTGTCGCTCAAAAAGCTGGAAATTCCCAAGCCGC 69 FBan0032042 FBgn0035975 PGRP-LA 3 3L defense response; GO:0006952; detection of bacteria; GO:0016045; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0042834 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 PGRP-LA Peptidoglycan recognition protein LA "CG4384, CG32042, CG18614, CG4361, CG4384" CDMC24674 2 13 24 DAC39-B21 18-CG32050-RA_4 CG32050 CGCGGACATGGAGTACAGACACGTATCGGATGTAATTGCCAACTATGAGCAATTGGCCAAAAAGGAGTT 69 FBan0032050 FBgn0052050 CG32050 3 3L CG32050 CG32050 CG14172 CDMC24674 2 14 24 DAC39-B21 18-CG32050-RA_4 CG32050 CGCGGACATGGAGTACAGACACGTATCGGATGTAATTGCCAACTATGAGCAATTGGCCAAAAAGGAGTT 69 FBan0032050 FBgn0052050 CG32050 3 3L CG32050 CG32050 CG14172 CDMC24675 2 15 24 DAC39-F09 16-CG32080-RA_1 CG32080 CGAGGGCAACTCAAGTTGATTGCATGTTCGGGCTCAGTTCATTTTCAACAGCATCAAGGATCAAATGCA 69 FBan0032080 FBgn0052080 CG32080 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32080 CG32080 CDMC24675 2 16 24 DAC39-F09 16-CG32080-RA_1 CG32080 CGAGGGCAACTCAAGTTGATTGCATGTTCGGGCTCAGTTCATTTTCAACAGCATCAAGGATCAAATGCA 69 FBan0032080 FBgn0052080 CG32080 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32080 CG32080 CDMC24676 2 17 24 DAC39-F21 2-CG32094-RA_1 CG32094 CGCGGGGTCGCATCTCTGGTTACATGAACTTCGAGGTCTGCCTCTATCTAATCGAACAGCCACGAGGAA 69 FBan0032094 FBgn0052094 CG32094 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0004872; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0005509; ; GO:0017026 ; EC:3.4.24.19 CG32094 CG32094 "CG5956, CT18701" CDMC24676 2 18 24 DAC39-F21 2-CG32094-RA_1 CG32094 CGCGGGGTCGCATCTCTGGTTACATGAACTTCGAGGTCTGCCTCTATCTAATCGAACAGCCACGAGGAA 69 FBan0032094 FBgn0052094 CG32094 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0004872; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0005509; ; GO:0017026 ; EC:3.4.24.19 CG32094 CG32094 "CG5956, CT18701" CDMC24677 2 19 24 DAC39-J09 7-CG3212-RA_1 CG3212 AGGACTTTGTTCGGGGAAGGTACATCAATGAAGGGTGTCGATGCCAAGAATCATGTCTGGTGAACGGCA 69 FBan0003212 FBgn0031547 Sr-CIV 2 2L defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 Sr-CIV "Scavenger receptor class C, type IV" "CG3212, CG3212, CG3212, CG3212, CG3212, CT10789, SR-CIV" CDMC24677 2 20 24 DAC39-J09 7-CG3212-RA_1 CG3212 AGGACTTTGTTCGGGGAAGGTACATCAATGAAGGGTGTCGATGCCAAGAATCATGTCTGGTGAACGGCA 69 FBan0003212 FBgn0031547 Sr-CIV 2 2L defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 Sr-CIV "Scavenger receptor class C, type IV" "CG3212, CG3212, CG3212, CG3212, CG3212, CT10789, SR-CIV" CDMC24678 2 21 24 DAC39-J21 6-CG32139-RA_1 CG32139 GGCAGCGAGGAGTTGAACTTGTCCATGACCTAGGAACAAGAAAGGGGATCGCTTCTTTTCCGTTCGCAA 69 FBan0032139 FBgn0042630 Sox21b 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA bending activity; GO:0008301; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0008301 nucleus; GO:0005634 Sox21b Sox21b "CG6419, CG13483, CG32139, CG6419, CG13483, CG6419, sox-like, SOXB2.2, Sox B2-2, SoxB2.2" CDMC24678 2 22 24 DAC39-J21 6-CG32139-RA_1 CG32139 GGCAGCGAGGAGTTGAACTTGTCCATGACCTAGGAACAAGAAAGGGGATCGCTTCTTTTCCGTTCGCAA 69 FBan0032139 FBgn0042630 Sox21b 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA bending activity; GO:0008301; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0008301 nucleus; GO:0005634 Sox21b Sox21b "CG6419, CG13483, CG32139, CG6419, CG13483, CG6419, sox-like, SOXB2.2, Sox B2-2, SoxB2.2" CDMC24679 2 23 24 DAC39-N09 23-CG32169-RA_4 CG32169 ACATTTCAAAGCGAAGATGTGGTAGACAAAGTTTGCGAAATTCATTTCCACGAGATAAACAACAAAATG 69 FBan0032169 FBgn0052169 CG32169 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG32169 CG32169 "CG14055, CG14056, CG6573, BcDNA:RE25373" CDMC24679 2 24 24 DAC39-N09 23-CG32169-RA_4 CG32169 ACATTTCAAAGCGAAGATGTGGTAGACAAAGTTTGCGAAATTCATTTCCACGAGATAAACAACAAAATG 69 FBan0032169 FBgn0052169 CG32169 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG32169 CG32169 "CG14055, CG14056, CG6573, BcDNA:RE25373" CDMC24680 2 25 24 DAC39-N21 12-CG3217-RA_3 CG3217 AGGCGCAGTCCATGATGCTTGCCATGCAAGTGATACGTTTCAAAGGACTTATTGGGAAGTACAGGGACA 69 FBan0003217 FBgn0025676 CkIIalpha-i3 3 3L CkIIalpha-i3 CKII-alpha subunit interactor-3 "CG3217, CkIIalpha-i3, CKIIalpha-i3" CDMC24680 2 26 24 DAC39-N21 12-CG3217-RA_3 CG3217 AGGCGCAGTCCATGATGCTTGCCATGCAAGTGATACGTTTCAAAGGACTTATTGGGAAGTACAGGGACA 69 FBan0003217 FBgn0025676 CkIIalpha-i3 3 3L CkIIalpha-i3 CKII-alpha subunit interactor-3 "CG3217, CkIIalpha-i3, CKIIalpha-i3" CDMC24681 2 1 25 DAC40-B09 9-CG9564-RA_1 CG9564 GGCGGTCAATTGGTGGGGATCAAGCGAGTTCATCGACATCCCAAATTCGATGCCTACACCATTGACTTT 69 FBan0009564 FBgn0015316 Try29F 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Try29F Trypsin 29F "CG9564, CG9564, try29F, try29F.2, SP106" CDMC24681 2 2 25 DAC40-B09 9-CG9564-RA_1 CG9564 GGCGGTCAATTGGTGGGGATCAAGCGAGTTCATCGACATCCCAAATTCGATGCCTACACCATTGACTTT 69 FBan0009564 FBgn0015316 Try29F 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Try29F Trypsin 29F "CG9564, CG9564, try29F, try29F.2, SP106" CDMC24682 2 3 25 DAC40-B21 8-CG9576-RA_1 CG9576 GGCGCCAATCCGTCACATTACCTTTGCACGTTGAAGACTCTCCAAAACTACGTCTGCAAGGTTTGCTCA 69 FBan0009576 FBgn0031091 CG9576 X X CG9576 CG9576 CDMC24682 2 4 25 DAC40-B21 8-CG9576-RA_1 CG9576 GGCGCCAATCCGTCACATTACCTTTGCACGTTGAAGACTCTCCAAAACTACGTCTGCAAGGTTTGCTCA 69 FBan0009576 FBgn0031091 CG9576 X X CG9576 CG9576 CDMC24683 2 5 25 DAC40-F09 8-CG9614-RC_2 CG9614 TCCGGAATGTCGATATGACTACGGACTTCTGTTCAAGGACGATTCTGCCGATCACAAGCGTCAGAGCCT 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24683 2 6 25 DAC40-F09 8-CG9614-RC_2 CG9614 TCCGGAATGTCGATATGACTACGGACTTCTGTTCAAGGACGATTCTGCCGATCACAAGCGTCAGAGCCT 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24684 2 7 25 DAC40-F21 2-CG9617-RA_4 CG9617 GGTGGTCATCACCGTGCTCCTGAAGAACGCCGTCGATAAGAACTATGCTGTGGAGATTACCCAGAAGCG 69 FBan0009617 FBgn0037568 CG9617 3 3R CG9617 CG9617 Q9VHT3 CDMC24684 2 8 25 DAC40-F21 2-CG9617-RA_4 CG9617 GGTGGTCATCACCGTGCTCCTGAAGAACGCCGTCGATAAGAACTATGCTGTGGAGATTACCCAGAAGCG 69 FBan0009617 FBgn0037568 CG9617 3 3R CG9617 CG9617 Q9VHT3 CDMC24685 2 9 25 DAC40-J09 23-CG9656-RA_5 CG9656 GGGACAAAACTAATCAAGACAACAAGAAGTAAACTGACAAAACACAATGCCAAACTGAGGACTCCTTGG 69 FBan0009656 FBgn0001138 grn 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; organ morphogenesis; GO:0009887; regulation of transcription from RNA polymerase II promoter; GO:0006357; tissue development; GO:0009888 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 grn grain "CG9656, gra, l(3)84Fa, dGATAc, dGATA-2, GATAc, Gata-c, dGatac, GRAIN, Gata2, GATA-factor-c, grain, lethal(3)84Fa" CDMC24685 2 10 25 DAC40-J09 23-CG9656-RA_5 CG9656 GGGACAAAACTAATCAAGACAACAAGAAGTAAACTGACAAAACACAATGCCAAACTGAGGACTCCTTGG 69 FBan0009656 FBgn0001138 grn 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; organ morphogenesis; GO:0009887; regulation of transcription from RNA polymerase II promoter; GO:0006357; tissue development; GO:0009888 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 grn grain "CG9656, gra, l(3)84Fa, dGATAc, dGATA-2, GATAc, Gata-c, dGatac, GRAIN, Gata2, GATA-factor-c, grain, lethal(3)84Fa" CDMC24686 2 11 25 DAC40-J21 9-CG9665-RA_4 CG9665 CCCTCTGTGGCTGATTTTCGTTTGACAGATCCAGATTTCCGACTGGCTAATGATTTTGGCAGGGGTGCT 69 FBan0009665 FBgn0036680 CG9665 3 3L CG9665 CG9665 CDMC24686 2 12 25 DAC40-J21 9-CG9665-RA_4 CG9665 CCCTCTGTGGCTGATTTTCGTTTGACAGATCCAGATTTCCGACTGGCTAATGATTTTGGCAGGGGTGCT 69 FBan0009665 FBgn0036680 CG9665 3 3L CG9665 CG9665 CDMC24687 2 13 25 DAC40-N09 3-CG9701-RA_5 CG9701 GCTGGTTCGGTCATCCCATCTTTTCCAAGCACGGTAACTATCCCAAGGTGATGATCGAGCGCATTCGGA 69 FBan0009701 FBgn0036659 CG9701 3 3L carbohydrate metabolism; GO:0005975 "hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-" CG9701 CG9701 CDMC24687 2 14 25 DAC40-N09 3-CG9701-RA_5 CG9701 GCTGGTTCGGTCATCCCATCTTTTCCAAGCACGGTAACTATCCCAAGGTGATGATCGAGCGCATTCGGA 69 FBan0009701 FBgn0036659 CG9701 3 3L carbohydrate metabolism; GO:0005975 "hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-" CG9701 CG9701 CDMC24688 2 15 25 DAC40-N21 3-CG9710-RA_2 CG9710 TCGAACCGAGATGGCATCTCCAAGCCCATCGAGAAAGTGGACGATGAATCCGATAAGAGTGAGCTGGGT 69 FBgn0036664 CDMC24688 2 16 25 DAC40-N21 3-CG9710-RA_2 CG9710 TCGAACCGAGATGGCATCTCCAAGCCCATCGAGAAAGTGGACGATGAATCCGATAAGAGTGAGCTGGGT 69 FBgn0036664 CDMC24689 2 17 25 DAC41-B09 AutoBlank AutoBlank CDMC24689 2 18 25 DAC41-B09 AutoBlank AutoBlank CDMC24690 2 19 25 DAC41-B21 AutoBlank AutoBlank CDMC24690 2 20 25 DAC41-B21 AutoBlank AutoBlank CDMC24691 2 21 25 DAC41-F09 AutoBlank AutoBlank CDMC24691 2 22 25 DAC41-F09 AutoBlank AutoBlank CDMC24692 2 23 25 DAC41-F21 AutoBlank AutoBlank CDMC24692 2 24 25 DAC41-F21 AutoBlank AutoBlank CDMC24693 2 25 25 DAC41-J09 AutoBlank AutoBlank CDMC24693 2 26 25 DAC41-J09 AutoBlank AutoBlank CDMC24694 2 1 26 DAC41-J21 AutoBlank AutoBlank CDMC24694 2 2 26 DAC41-J21 AutoBlank AutoBlank CDMC24695 2 3 26 DAC41-N09 AutoBlank AutoBlank CDMC24695 2 4 26 DAC41-N09 AutoBlank AutoBlank CDMC24696 2 5 26 DAC41-N21 AutoBlank AutoBlank CDMC24696 2 6 26 DAC41-N21 AutoBlank AutoBlank CDMC24697 2 7 26 DAC42-B09 150mM NaPO4 Blank CDMC24697 2 8 26 DAC42-B09 150mM NaPO4 Blank CDMC24698 2 9 26 DAC42-B21 150mM NaPO4 Blank CDMC24698 2 10 26 DAC42-B21 150mM NaPO4 Blank CDMC24699 2 11 26 DAC42-F09 150mM NaPO4 Blank CDMC24699 2 12 26 DAC42-F09 150mM NaPO4 Blank CDMC24700 2 13 26 DAC42-F21 150mM NaPO4 Blank CDMC24700 2 14 26 DAC42-F21 150mM NaPO4 Blank CDMC24701 2 15 26 DAC42-J09 150mM NaPO4 Blank CDMC24701 2 16 26 DAC42-J09 150mM NaPO4 Blank CDMC24702 2 17 26 DAC42-J21 5uM MSP 5uM MSP CDMC24702 2 18 26 DAC42-J21 5uM MSP 5uM MSP CDMC24703 2 19 26 DAC42-N09 10uM MSP 10uM MSP CDMC24703 2 20 26 DAC42-N09 10uM MSP 10uM MSP CDMC24704 2 21 26 DAC42-N21 20uM MSP 20uM MSP CDMC24704 2 22 26 DAC42-N21 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC24705 3 1 1 DAC01-C09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24705 3 2 1 DAC01-C09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC24706 3 3 1 DAC01-C21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24706 3 4 1 DAC01-C21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC24707 3 5 1 DAC01-G09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24707 3 6 1 DAC01-G09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC24708 3 7 1 DAC01-G21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24708 3 8 1 DAC01-G21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC24709 3 9 1 DAC01-K09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24709 3 10 1 DAC01-K09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC24710 3 11 1 DAC01-K21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24710 3 12 1 DAC01-K21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC24711 3 13 1 DAC01-O09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24711 3 14 1 DAC01-O09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC24712 3 15 1 DAC01-O21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24712 3 16 1 DAC01-O21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC24713 3 17 1 DAC02-C09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24713 3 18 1 DAC02-C09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC24714 3 19 1 DAC02-C21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24714 3 20 1 DAC02-C21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC24715 3 21 1 DAC02-G09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24715 3 22 1 DAC02-G09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC24716 3 23 1 DAC02-G21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24716 3 24 1 DAC02-G21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC24717 3 25 1 DAC02-K09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24717 3 26 1 DAC02-K09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC24718 3 1 2 DAC02-K21 N/A CG9075 (01196-01434) CDMC24718 3 2 2 DAC02-K21 N/A CG9075 (01196-01434) CDMC24719 3 3 2 DAC02-O09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24719 3 4 2 DAC02-O09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC24720 3 5 2 DAC02-O21 AutoBlank AutoBlank CDMC24720 3 6 2 DAC02-O21 AutoBlank AutoBlank CDMC24721 3 7 2 DAC03-C09 17-CG17117-RA_1 CG17117 AGGAAGAAGTACGAAGGAGCTGAATACACATGGATCCGATCCCAAAACTAAAGCATACCGCGTGGCAAT 69 FBan0017117 FBgn0001235 hth 3 3R brain development; GO:0007420; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor fate commitment (sensu Endopterygota); GO:0001752; leg disc proximal/distal pattern formation; GO:0007479; peripheral nervous system development; GO:0007422; proximal/distal pattern formation; GO:0009954; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; specification of organ identity; GO:0010092 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hth homothorax "CG17117, CG17117, dorsotonals, Gene II, 1323/07, 1422/04, dtl, clone 2.13, hth1, hth2, P53, Hth, Dm-HTH, anon-EST:Liang-2.13, Meis1, l(3)05745, l(3)86Ca" CDMC24721 3 8 2 DAC03-C09 17-CG17117-RA_1 CG17117 AGGAAGAAGTACGAAGGAGCTGAATACACATGGATCCGATCCCAAAACTAAAGCATACCGCGTGGCAAT 69 FBan0017117 FBgn0001235 hth 3 3R brain development; GO:0007420; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor fate commitment (sensu Endopterygota); GO:0001752; leg disc proximal/distal pattern formation; GO:0007479; peripheral nervous system development; GO:0007422; proximal/distal pattern formation; GO:0009954; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland determination; GO:0007432; specification of organ identity; GO:0010092 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hth homothorax "CG17117, CG17117, dorsotonals, Gene II, 1323/07, 1422/04, dtl, clone 2.13, hth1, hth2, P53, Hth, Dm-HTH, anon-EST:Liang-2.13, Meis1, l(3)05745, l(3)86Ca" CDMC24722 3 9 2 DAC03-C21 3-CG17134-RA_3 CG17134 CGCCATCGAATACGGAACTGGTAGTCTGTCGGGTTTCCTGTCCAACGACATTGTGACCATAGCGGGAAT 69 FBan0017134 FBgn0032304 CG17134 2 2L proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG17134 CG17134 CDMC24722 3 10 2 DAC03-C21 3-CG17134-RA_3 CG17134 CGCCATCGAATACGGAACTGGTAGTCTGTCGGGTTTCCTGTCCAACGACATTGTGACCATAGCGGGAAT 69 FBan0017134 FBgn0032304 CG17134 2 2L proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG17134 CG17134 CDMC24723 3 11 2 DAC03-G09 11-CG17170-RB_4 CG17170 ACGGCGTGCTAAACCGAAATGCGTTGCTATATTTTGCCTATGCGGACTTTGAAGAAGGACGGCTCAAGT 69 CDMC24723 3 12 2 DAC03-G09 11-CG17170-RB_4 CG17170 ACGGCGTGCTAAACCGAAATGCGTTGCTATATTTTGCCTATGCGGACTTTGAAGAAGGACGGCTCAAGT 69 CDMC24724 3 13 2 DAC03-G21 23-CG17180-RA_4 CG17180 ATGTTGGACAGCACCATGTAAAATAGGGCTACGCTATCCTGTGATCAACCAATCAAAGAGATCTTGTCT 69 FBan0017180 FBgn0035140 CG17180 3 3L CG17180 CG17180 CDMC24724 3 14 2 DAC03-G21 23-CG17180-RA_4 CG17180 ATGTTGGACAGCACCATGTAAAATAGGGCTACGCTATCCTGTGATCAACCAATCAAAGAGATCTTGTCT 69 FBan0017180 FBgn0035140 CG17180 3 3L CG17180 CG17180 CDMC24725 3 15 2 DAC03-K09 16-CG17212-RA_1 CG17212 AGCTAGTGAGTGTATGCAAAAAGTACTGATCTTCAAACCGGAATGGAACGTCGAGTACTGGCGCCTACT 69 FBan0017212 FBgn0032415 rho-6 2 2L development; GO:0007275; ectoderm development; GO:0007398; female gamete generation; GO:0007292; gametogenesis; GO:0007276; nervous system development; GO:0007399 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 rho-6 rhomboid-6 "CG17212, Rho-related [33C1], rhomboid-6" CDMC24725 3 16 2 DAC03-K09 16-CG17212-RA_1 CG17212 AGCTAGTGAGTGTATGCAAAAAGTACTGATCTTCAAACCGGAATGGAACGTCGAGTACTGGCGCCTACT 69 FBan0017212 FBgn0032415 rho-6 2 2L development; GO:0007275; ectoderm development; GO:0007398; female gamete generation; GO:0007292; gametogenesis; GO:0007276; nervous system development; GO:0007399 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 rho-6 rhomboid-6 "CG17212, Rho-related [33C1], rhomboid-6" CDMC24726 3 17 2 DAC03-K21 12-CG17224-RA_6 CG17224 ACCACCTGGACATCAATGTGGCCAATACCCGAGACACCAGTGAGTTACAGAATAGGTTCGGCGATGTTA 69 FBan0017224 FBgn0031489 CG17224 2 2L nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG17224 CG17224 CDMC24726 3 18 2 DAC03-K21 12-CG17224-RA_6 CG17224 ACCACCTGGACATCAATGTGGCCAATACCCGAGACACCAGTGAGTTACAGAATAGGTTCGGCGATGTTA 69 FBan0017224 FBgn0031489 CG17224 2 2L nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG17224 CG17224 CDMC24727 3 19 2 DAC03-O09 22-CG17264-RA_1 CG17264 TGCCTGTCTGCGATATTCCCAAGTGCAATGCATGTAATGACTTGCGGGGATATTAACTTTCATTTCGCT 69 FBan0017264 FBgn0031490 CG17264 2 2L CG17264 CG17264 CDMC24727 3 20 2 DAC03-O09 22-CG17264-RA_1 CG17264 TGCCTGTCTGCGATATTCCCAAGTGCAATGCATGTAATGACTTGCGGGGATATTAACTTTCATTTCGCT 69 FBan0017264 FBgn0031490 CG17264 2 2L CG17264 CG17264 CDMC24728 3 21 2 DAC03-O21 23-CG17273-RA_3 CG17273 TTGATGAGGACGTACTTAGTTTTTAAGATCATCAGGTGCAGTTTCAGATTTTTTGTATGCAAAGGGAAG 69 FBan0017273 FBgn0027493 CG17273 3 3R purine nucleotide biosynthesis; GO:0006164 GTP binding; GO:0005525; adenylosuccinate synthase activity; GO:0004019 ; EC:6.3.4.4; ; GO:0004019 ; EC:6.3.4.4; ; GO:0004019 ; EC:6.3.4.4; ; GO:0005525 CG17273 CG17273 BcDNA:LD32788 CDMC24728 3 22 2 DAC03-O21 23-CG17273-RA_3 CG17273 TTGATGAGGACGTACTTAGTTTTTAAGATCATCAGGTGCAGTTTCAGATTTTTTGTATGCAAAGGGAAG 69 FBan0017273 FBgn0027493 CG17273 3 3R purine nucleotide biosynthesis; GO:0006164 GTP binding; GO:0005525; adenylosuccinate synthase activity; GO:0004019 ; EC:6.3.4.4; ; GO:0004019 ; EC:6.3.4.4; ; GO:0004019 ; EC:6.3.4.4; ; GO:0005525 CG17273 CG17273 BcDNA:LD32788 CDMC24729 3 23 2 DAC04-C09 2-CG15930-RA_1 CG15930 TTTGTGCCCACCATCAACGATCTAATCGAGTCGCGGATCAAGTTGGAGTCCTGTTGCTATGCGCC 65 FBan0015930 FBgn0029754 CG15930 X X CG15930 CG15930 CDMC24729 3 24 2 DAC04-C09 2-CG15930-RA_1 CG15930 TTTGTGCCCACCATCAACGATCTAATCGAGTCGCGGATCAAGTTGGAGTCCTGTTGCTATGCGCC 65 FBan0015930 FBgn0029754 CG15930 X X CG15930 CG15930 CDMC24730 3 25 2 DAC04-C21 33-CG1650-RA_2 CG1650 AGTTAGTTTCGATCGCCCTGAAAGTGTGCTTTTGAGTGGGCAATATGGAACGACCGGCCTTGCTG 65 FBan0001650 FBgn0015561 unpg 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 unpg unplugged "CG1650, unp, upg, Gbx, anon-45C" CDMC24730 3 26 2 DAC04-C21 33-CG1650-RA_2 CG1650 AGTTAGTTTCGATCGCCCTGAAAGTGTGCTTTTGAGTGGGCAATATGGAACGACCGGCCTTGCTG 65 FBan0001650 FBgn0015561 unpg 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 unpg unplugged "CG1650, unp, upg, Gbx, anon-45C" CDMC24731 3 1 3 DAC04-G09 15-CG16815-RA_1 CG16815 AGCGCCGTCAGACACAGGGATTCTTCCGACCTTGGTTGGATAATGAGCAGAACCAACAGGCGGAG 65 FBan0016815 FBgn0032491 CG16815 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG16815 CG16815 CDMC24731 3 2 3 DAC04-G09 15-CG16815-RA_1 CG16815 AGCGCCGTCAGACACAGGGATTCTTCCGACCTTGGTTGGATAATGAGCAGAACCAACAGGCGGAG 65 FBan0016815 FBgn0032491 CG16815 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG16815 CG16815 CDMC24732 3 3 3 DAC04-G21 2-CG16865-RA_1 CG16865 CAGTCCCGACTCCCACGTAACCTTCGTCATGTCCAATGCCCTAATCCGCAACAAGGGTGAGAGTC 65 FBan0016865 FBgn0028919 CG16865 2 2L CG16865 CG16865 BG:DS00941.3 CDMC24732 3 4 3 DAC04-G21 2-CG16865-RA_1 CG16865 CAGTCCCGACTCCCACGTAACCTTCGTCATGTCCAATGCCCTAATCCGCAACAAGGGTGAGAGTC 65 FBan0016865 FBgn0028919 CG16865 2 2L CG16865 CG16865 BG:DS00941.3 CDMC24733 3 5 3 DAC04-K09 23-CG16996-RA_1 CG16996 TAGTCGAGTTTTTCCCTATTTTTTCAATAAAAGCAATCAAATGTGTGTCCCTAGTGGCGGTCACT 65 FBan0016996 FBgn0032412 CG16996 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16996 CG16996 SP134 CDMC24733 3 6 3 DAC04-K09 23-CG16996-RA_1 CG16996 TAGTCGAGTTTTTCCCTATTTTTTCAATAAAAGCAATCAAATGTGTGTCCCTAGTGGCGGTCACT 65 FBan0016996 FBgn0032412 CG16996 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16996 CG16996 SP134 CDMC24734 3 7 3 DAC04-K21 14-CG17063-RA_1 CG17063 TCCTCAACTTCTGGCTAATGGACGTGGTGTTCAATGGGTTCTGGTACAAGTACATCCACGCCCTG 65 FBan0017063 FBgn0027107 inx6 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; gap-junction forming channel activity; GO:0005243; ; GO:0015286; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 inx6 inx6 "CG17063, prp6, pas related protein 6, Dm-inx6" CDMC24734 3 8 3 DAC04-K21 14-CG17063-RA_1 CG17063 TCCTCAACTTCTGGCTAATGGACGTGGTGTTCAATGGGTTCTGGTACAAGTACATCCACGCCCTG 65 FBan0017063 FBgn0027107 inx6 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; gap-junction forming channel activity; GO:0005243; ; GO:0015286; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 inx6 inx6 "CG17063, prp6, pas related protein 6, Dm-inx6" CDMC24735 3 9 3 DAC04-O09 2-CG17191-RA_1 CG17191 TTTCGTAATCCACGGGTGGAATGGTCGCTACACTGATGGCATGAACGTCAAGATCACCCGAGCCT 65 FBan0017191 FBgn0039473 CG17191 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0008970 ; EC:3.1.1.32 CG17191 CG17191 CDMC24735 3 10 3 DAC04-O09 2-CG17191-RA_1 CG17191 TTTCGTAATCCACGGGTGGAATGGTCGCTACACTGATGGCATGAACGTCAAGATCACCCGAGCCT 65 FBan0017191 FBgn0039473 CG17191 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0008970 ; EC:3.1.1.32 CG17191 CG17191 CDMC24736 3 11 3 DAC04-O21 AutoBlank AutoBlank CDMC24736 3 12 3 DAC04-O21 AutoBlank AutoBlank CDMC24737 3 13 3 DAC05-C09 2-CG10493-RA_2 CG10493 CACCAACAAGTTCATCTCGACCAGCACTCCTCAATTACCCCAACCCATAACGACTTCTGTGCCCCTGG 68 FBan0010493 FBgn0032749 CG10493 2 2L cell adhesion; GO:0007155; defense response; GO:0006952; protein amino acid dephosphorylation; GO:0006470; regulation of apoptosis; GO:0042981; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 protein serine/threonine phosphatase activity; GO:0004722; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004722; protein binding; GO:0005515; ; GO:0004722; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515 cellular component unknown; GO:0008372 CG10493 CG10493 "PP2C, CT29458" CDMC24737 3 14 3 DAC05-C09 2-CG10493-RA_2 CG10493 CACCAACAAGTTCATCTCGACCAGCACTCCTCAATTACCCCAACCCATAACGACTTCTGTGCCCCTGG 68 FBan0010493 FBgn0032749 CG10493 2 2L cell adhesion; GO:0007155; defense response; GO:0006952; protein amino acid dephosphorylation; GO:0006470; regulation of apoptosis; GO:0042981; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 protein serine/threonine phosphatase activity; GO:0004722; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004722; protein binding; GO:0005515; ; GO:0004722; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515 cellular component unknown; GO:0008372 CG10493 CG10493 "PP2C, CT29458" CDMC24738 3 15 3 DAC05-C21 3-CG10592-RA_2 CG10592 GCCGTACCCATTATGAAGATGCAGAGCCATCCCTTTCCGACATGACAGAAGCGGCCATCAAGATGCTC 68 FBan0010592 FBgn0035619 CG10592 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1 CG10592 CG10592 CDMC24738 3 16 3 DAC05-C21 3-CG10592-RA_2 CG10592 GCCGTACCCATTATGAAGATGCAGAGCCATCCCTTTCCGACATGACAGAAGCGGCCATCAAGATGCTC 68 FBan0010592 FBgn0035619 CG10592 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1 CG10592 CG10592 CDMC24739 3 17 3 DAC05-G09 2-CG11164-RA_1 CG11164 ACCTGCACATTCCTAGCGAGATTCAGGCGATTGTTGAGGAGAAAGCAGCTTCTCAGAAGCGCAAGTCG 68 FBan0011164 FBgn0030507 CG11164 X X CG11164 CG11164 CDMC24739 3 18 3 DAC05-G09 2-CG11164-RA_1 CG11164 ACCTGCACATTCCTAGCGAGATTCAGGCGATTGTTGAGGAGAAAGCAGCTTCTCAGAAGCGCAAGTCG 68 FBan0011164 FBgn0030507 CG11164 X X CG11164 CG11164 CDMC24740 3 19 3 DAC05-G21 2-CG11205-RB_1 CG11205 GGCATCCTCATGGAACTGGCTGCAAGAATGTGAATACCGTGGACTGGTCAGCTGCTTATGCTTCGCTG 68 FBan0011205 FBgn0003082 phr 2 2R DNA repair; GO:0006281 nucleic acid binding; GO:0003676; deoxyribodipyrimidine photo-lyase activity; GO:0003904 ; EC:4.1.99.3; ; GO:0003676; ; GO:0003904 ; EC:4.1.99.3; ; GO:0003904 ; EC:4.1.99.3 phr photorepair "CG11205, Phl: Photolyase, Photolyase, C2PHR, Dm CPD, photolyase, anon-OV1, anonOV1, CPD photolyase, anonymous ovarian cDNA 1, Phl" CDMC24740 3 20 3 DAC05-G21 2-CG11205-RB_1 CG11205 GGCATCCTCATGGAACTGGCTGCAAGAATGTGAATACCGTGGACTGGTCAGCTGCTTATGCTTCGCTG 68 FBan0011205 FBgn0003082 phr 2 2R DNA repair; GO:0006281 nucleic acid binding; GO:0003676; deoxyribodipyrimidine photo-lyase activity; GO:0003904 ; EC:4.1.99.3; ; GO:0003676; ; GO:0003904 ; EC:4.1.99.3; ; GO:0003904 ; EC:4.1.99.3 phr photorepair "CG11205, Phl: Photolyase, Photolyase, C2PHR, Dm CPD, photolyase, anon-OV1, anonOV1, CPD photolyase, anonymous ovarian cDNA 1, Phl" CDMC24741 3 21 3 DAC05-K09 3-CG11498-RA_1 CG11498 GGATATTCAGCAGCGACTGATCGACAACAAGACCCTGCTCACAATGCTAGACAAGCCGGCTCTCAAGC 68 FBan0011498 FBgn0039749 CG11498 3 3R CG11498 CG11498 CDMC24741 3 22 3 DAC05-K09 3-CG11498-RA_1 CG11498 GGATATTCAGCAGCGACTGATCGACAACAAGACCCTGCTCACAATGCTAGACAAGCCGGCTCTCAAGC 68 FBan0011498 FBgn0039749 CG11498 3 3R CG11498 CG11498 CDMC24742 3 23 3 DAC05-K21 1-CG11769-RA_1 CG11769 CCAGCGGAGAGGGAGGATCCGGAGGTGGGCAGTGCCAGTGTCAGCCAGGTAATATAATATATTCTTGA 68 FBan0011769 FBgn0038441 CG11769 3 3R CG11769 CG11769 CDMC24742 3 24 3 DAC05-K21 1-CG11769-RA_1 CG11769 CCAGCGGAGAGGGAGGATCCGGAGGTGGGCAGTGCCAGTGTCAGCCAGGTAATATAATATATTCTTGA 68 FBan0011769 FBgn0038441 CG11769 3 3R CG11769 CG11769 CDMC24743 3 25 3 DAC05-O09 2-CG12181-RB_1 CG12181 AAAGGCGTGTGATTCAGGCAAGAAGAACACCACCAAGAAACCGCGGAAGACTCAGCCACAAAAAGGTG 68 FBan0012181 FBgn0003374 Sgs4 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs4 Salivary gland secretion 4 "CG12181, CG12181, Sgs-4, sgs4, SGS-4, Sgs, sgs-4, salivary gland secretion protein 4, EG:96G10.6" CDMC24743 3 26 3 DAC05-O09 2-CG12181-RB_1 CG12181 AAAGGCGTGTGATTCAGGCAAGAAGAACACCACCAAGAAACCGCGGAAGACTCAGCCACAAAAAGGTG 68 FBan0012181 FBgn0003374 Sgs4 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs4 Salivary gland secretion 4 "CG12181, CG12181, Sgs-4, sgs4, SGS-4, Sgs, sgs-4, salivary gland secretion protein 4, EG:96G10.6" CDMC24744 3 1 4 DAC05-O21 AutoBlank AutoBlank CDMC24744 3 2 4 DAC05-O21 AutoBlank AutoBlank CDMC24745 3 3 4 DAC06-C09 24-CG3301-RA_1 CG3301 CGTCGGGAACATTTTTAATGATGAATAATCCGGTATAAATCTTTATCTACCCATTTTTAATAAGAATAT 69 FBan0003301 FBgn0038878 CG3301 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG3301 CG3301 CDMC24745 3 4 4 DAC06-C09 24-CG3301-RA_1 CG3301 CGTCGGGAACATTTTTAATGATGAATAATCCGGTATAAATCTTTATCTACCCATTTTTAATAAGAATAT 69 FBan0003301 FBgn0038878 CG3301 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG3301 CG3301 CDMC24746 3 5 4 DAC06-C21 23-CG33045-RG_12 CG33045 GACTTGAGATCAGCGATATTAACTTAGACTCTAGTTTCAGGTCTTGCCCTGCTATTGATTGGGATGGCG 69 FBgn0026414 CDMC24746 3 6 4 DAC06-C21 23-CG33045-RG_12 CG33045 GACTTGAGATCAGCGATATTAACTTAGACTCTAGTTTCAGGTCTTGCCCTGCTATTGATTGGGATGGCG 69 FBgn0026414 CDMC24747 3 7 4 DAC06-G09 9-CG3307-RB_1 CG3307 GGTGCTATATGTACTACTTCAAGCACAAGTCCCAGCAGTACTGCATCGATGCAACCGTTGACACCGGCA 69 FBgn0038222 CDMC24747 3 8 4 DAC06-G09 9-CG3307-RB_1 CG3307 GGTGCTATATGTACTACTTCAAGCACAAGTCCCAGCAGTACTGCATCGATGCAACCGTTGACACCGGCA 69 FBgn0038222 CDMC24748 3 9 4 DAC06-G21 8-CG33093-RA_1 CG33093 TGCCAGGAGCACTCTTCATAAACTGCGGTGAAACCATGGCTATCTGGACAGATCAGTTCTACCACGCTT 69 FBan0033093 FBgn0053093 CG33093 3 3R antibiotic biosynthesis; GO:0017000 iron ion binding; GO:0005506; ; GO:0005506; isopenicillin-N synthase activity; GO:0016216 ; EC:1.21.3.1; ; GO:0016216 ; EC:1.21.3.1 CG33093 CG33093 CG5340 CDMC24748 3 10 4 DAC06-G21 8-CG33093-RA_1 CG33093 TGCCAGGAGCACTCTTCATAAACTGCGGTGAAACCATGGCTATCTGGACAGATCAGTTCTACCACGCTT 69 FBan0033093 FBgn0053093 CG33093 3 3R antibiotic biosynthesis; GO:0017000 iron ion binding; GO:0005506; ; GO:0005506; isopenicillin-N synthase activity; GO:0016216 ; EC:1.21.3.1; ; GO:0016216 ; EC:1.21.3.1 CG33093 CG33093 CG5340 CDMC24749 3 11 4 DAC06-K09 3-CG33113-RG_1 CG33113 GCGGTTGCATTATTCGCATTTCCTCGATCCGTGAACCGCGCGAAAAAGTCGTCCGAACTTTCGCTACAT 69 FBan0033113 FBgn0053113 Rtnl1 2 2L intracellular protein transport; GO:0006886 receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005057 endoplasmic reticulum; GO:0005783 Rtnl1 Rtnl1 "CG18623, CG8895, CG33113, CG18623, CG33113, G9" CDMC24749 3 12 4 DAC06-K09 3-CG33113-RG_1 CG33113 GCGGTTGCATTATTCGCATTTCCTCGATCCGTGAACCGCGCGAAAAAGTCGTCCGAACTTTCGCTACAT 69 FBan0033113 FBgn0053113 Rtnl1 2 2L intracellular protein transport; GO:0006886 receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005057 endoplasmic reticulum; GO:0005783 Rtnl1 Rtnl1 "CG18623, CG8895, CG33113, CG18623, CG33113, G9" CDMC24750 3 13 4 DAC06-K21 15-CG33121-RA_2 CG33121 ACCGCCGAGGAACTAAGAAGCGTTCTTGACCTACCAGTGGATGTGACAGAAATGGCCAAGAAATACGAA 69 FBan0033121 FBgn0053121 CG33121 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG33121 CG33121 CG12318 CDMC24750 3 14 4 DAC06-K21 15-CG33121-RA_2 CG33121 ACCGCCGAGGAACTAAGAAGCGTTCTTGACCTACCAGTGGATGTGACAGAAATGGCCAAGAAATACGAA 69 FBan0033121 FBgn0053121 CG33121 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG33121 CG33121 CG12318 CDMC24751 3 15 4 DAC06-O09 2-CG33142-RB_1 CG33142 TCCTTTGGTTCTGGCTGTTCTGGGCTACGTTCACCCTGTTGCTGGTATTTTTTTTGCCCTACTGCTGCA 69 FBgn0053142 CDMC24751 3 16 4 DAC06-O09 2-CG33142-RB_1 CG33142 TCCTTTGGTTCTGGCTGTTCTGGGCTACGTTCACCCTGTTGCTGGTATTTTTTTTGCCCTACTGCTGCA 69 FBgn0053142 CDMC24752 3 17 4 DAC06-O21 24-CG33149-RA_1 CG33149 CCACTTAAACAGAGAGTAAGGACTAAATAAGAAATATGTTTTGTATGAAAATTGTGTAAAATTCCTTGA 69 FBan0033149 FBgn0011643 Mlp60A 2 2R cell proliferation; GO:0008283; mesoderm development; GO:0007498; regulation of striated muscle development; GO:0016202 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 Mlp60A Muscle LIM protein at 60A "CG3220, CG33149, CG3220, CG3220, DmLIM-2, DMlp1, Muscle-specific LIM protein at 60A, DMLP1, MLP1, dMlp60A, BcDNA:RE14544, BcDNA:RH74176, DLim-2, MLP, Mlp1" CDMC24752 3 18 4 DAC06-O21 24-CG33149-RA_1 CG33149 CCACTTAAACAGAGAGTAAGGACTAAATAAGAAATATGTTTTGTATGAAAATTGTGTAAAATTCCTTGA 69 FBan0033149 FBgn0011643 Mlp60A 2 2R cell proliferation; GO:0008283; mesoderm development; GO:0007498; regulation of striated muscle development; GO:0016202 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 Mlp60A Muscle LIM protein at 60A "CG3220, CG33149, CG3220, CG3220, DmLIM-2, DMlp1, Muscle-specific LIM protein at 60A, DMLP1, MLP1, dMlp60A, BcDNA:RE14544, BcDNA:RH74176, DLim-2, MLP, Mlp1" CDMC24753 3 19 4 DAC07-C09 17-CG5803-RA_2 CG5803 AATCAGGAGTCGTTGAATATTGTGGAGGGAAGCGTACAGGAGATTCCAGCGACCAATAATGCCATCGAT 69 FBan0005803 FBgn0000636 Fas3 2 2L axon guidance; GO:0007411; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; ovarian follicle cell development (sensu Insecta); GO:0030707; synaptic target attraction; GO:0016200; synaptic target recognition; GO:0008039 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021; lateral plasma membrane; GO:0016328; plasma membrane; GO:0005886; septate junction; GO:0005918 Fas3 Fasciclin 3 "CG5803, CG5803, fasIII, fascIII, fasciclin III, Fasciclin, FASIII, FasIII, Fasciclin III, fasciclin II, fas-III, Fas-III, fas III, FasciclinIII, FAS3, Fas III, Fascicilin III, FsciclinIII, FAS III, Fas-3, Fasiciclin III, fasciclinIII, Fascilin III" CDMC24753 3 20 4 DAC07-C09 17-CG5803-RA_2 CG5803 AATCAGGAGTCGTTGAATATTGTGGAGGGAAGCGTACAGGAGATTCCAGCGACCAATAATGCCATCGAT 69 FBan0005803 FBgn0000636 Fas3 2 2L axon guidance; GO:0007411; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; ovarian follicle cell development (sensu Insecta); GO:0030707; synaptic target attraction; GO:0016200; synaptic target recognition; GO:0008039 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021; lateral plasma membrane; GO:0016328; plasma membrane; GO:0005886; septate junction; GO:0005918 Fas3 Fasciclin 3 "CG5803, CG5803, fasIII, fascIII, fasciclin III, Fasciclin, FASIII, FasIII, Fasciclin III, fasciclin II, fas-III, Fas-III, fas III, FasciclinIII, FAS3, Fas III, Fascicilin III, FsciclinIII, FAS III, Fas-3, Fasiciclin III, fasciclinIII, Fascilin III" CDMC24754 3 21 4 DAC07-C21 3-CG5811-RA_2 CG5811 GCGACATCCTGATGTCCTTCTTCTGCGTTCCGTCGTCCTTCATCTCGCTGTTCATCCTGAACTACTGGC 69 FBan0005811 FBgn0004842 NepYr 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0008188; ; GO:0004930; ; GO:0004995; ; GO:0004983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 NepYr Neuropeptide Y receptor-like "CG5811, CG5811/107368, CG5811, CG5811/107368, PR4, anon-WO0131005.13, anon-WO0131005.15" CDMC24754 3 22 4 DAC07-C21 3-CG5811-RA_2 CG5811 GCGACATCCTGATGTCCTTCTTCTGCGTTCCGTCGTCCTTCATCTCGCTGTTCATCCTGAACTACTGGC 69 FBan0005811 FBgn0004842 NepYr 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0008188; ; GO:0004930; ; GO:0004995; ; GO:0004983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 NepYr Neuropeptide Y receptor-like "CG5811, CG5811/107368, CG5811, CG5811/107368, PR4, anon-WO0131005.13, anon-WO0131005.15" CDMC24755 3 23 4 DAC07-G09 15-CG5848-RC_1 CG5848 ACGCCTCCGGACAGTGATTACGACAGTAGCGATATCGAAGATCTAGACGATACGAAGGTGAGCGTCACT 69 FBan0005848 FBgn0000250 cact 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cellular defense response; GO:0006968; cytoplasmic sequestering of transcription factor; GO:0042994; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal/ventral axis specification; GO:0009950; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; negative regulation of protein import into nucleus; GO:0042308; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 cact cactus "CG5848, CG5848, CG5848, cac, fs(2)ltoRN48, female-sterile-(2)-ltoRN48, BG:DS02740.15, n(2)k17003, dip6, CACT, cactus" CDMC24755 3 24 4 DAC07-G09 15-CG5848-RC_1 CG5848 ACGCCTCCGGACAGTGATTACGACAGTAGCGATATCGAAGATCTAGACGATACGAAGGTGAGCGTCACT 69 FBan0005848 FBgn0000250 cact 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cellular defense response; GO:0006968; cytoplasmic sequestering of transcription factor; GO:0042994; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal/ventral axis specification; GO:0009950; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; negative regulation of protein import into nucleus; GO:0042308; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 cact cactus "CG5848, CG5848, CG5848, cac, fs(2)ltoRN48, female-sterile-(2)-ltoRN48, BG:DS02740.15, n(2)k17003, dip6, CACT, cactus" CDMC24756 3 25 4 DAC07-G21 2-CG5857-RA_3 CG5857 TCGCTGCTGCCTACGATCAGTTACACCGCCGTATTTTGTCTTTTCGGACCCATGGTATGCCACAGACTT 69 FBan0005857 FBgn0039125 CG5857 3 3R CG5857 CG5857 CDMC24756 3 26 4 DAC07-G21 2-CG5857-RA_3 CG5857 TCGCTGCTGCCTACGATCAGTTACACCGCCGTATTTTGTCTTTTCGGACCCATGGTATGCCACAGACTT 69 FBan0005857 FBgn0039125 CG5857 3 3R CG5857 CG5857 CDMC24757 3 1 5 DAC07-K09 7-CG5887-RC_1 CG5887 AGGATGCTGTCATTACACACAAAAAAAGCGAATAGGCAGGTTGAGCGTAGGGCCAATCATGGGAGGGTT 69 FBan0005887 FBgn0043044 desat1 3 3R fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat1 desat1 "CG5887, CG5887, CG5887, CG5887, CG5887, desat, desaturase, fatty acid desaturase, fad, Stearoyl CoA desaturase, Fad, anon-WO0118547.726, anon-WO0118547.730, BEST:SD05462, Fatty acid desaturase" CDMC24757 3 2 5 DAC07-K09 7-CG5887-RC_1 CG5887 AGGATGCTGTCATTACACACAAAAAAAGCGAATAGGCAGGTTGAGCGTAGGGCCAATCATGGGAGGGTT 69 FBan0005887 FBgn0043044 desat1 3 3R fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat1 desat1 "CG5887, CG5887, CG5887, CG5887, CG5887, desat, desaturase, fatty acid desaturase, fad, Stearoyl CoA desaturase, Fad, anon-WO0118547.726, anon-WO0118547.730, BEST:SD05462, Fatty acid desaturase" CDMC24758 3 3 5 DAC07-K21 2-CG5909-RA_2 CG5909 GCATTCCGCCCTACGAGGAGTACGGCATAGAGCAGATACGAGTACATCCCAACTACGTGCATGGCAAGA 69 FBan0005909 FBgn0039495 CG5909 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5909 CG5909 "SP8, c-SP8" CDMC24758 3 4 5 DAC07-K21 2-CG5909-RA_2 CG5909 GCATTCCGCCCTACGAGGAGTACGGCATAGAGCAGATACGAGTACATCCCAACTACGTGCATGGCAAGA 69 FBan0005909 FBgn0039495 CG5909 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5909 CG5909 "SP8, c-SP8" CDMC24759 3 5 5 DAC07-O09 23-CG5938-RA_4 CG5938 AATTTTGCAAGAACTCTAGGCGGTAAGTTTGATTTCTCGTAACTTTAGGGCGCTCTACTTTTTCTGTTT 69 FBgn0039506 CDMC24759 3 6 5 DAC07-O09 23-CG5938-RA_4 CG5938 AATTTTGCAAGAACTCTAGGCGGTAAGTTTGATTTCTCGTAACTTTAGGGCGCTCTACTTTTTCTGTTT 69 FBgn0039506 CDMC24760 3 7 5 DAC07-O21 3-CG5949-RA_1 CG5949 CGAAAGGGATCCCGATGGTGCAGTTGCCTATGTGAAACAGGTGATAGCCGATCTCCTCTGCAATCGCAT 69 FBan0005949 FBgn0012066 DNApol-delta 3 3L DNA recombination; GO:0006310; DNA repair; GO:0006281; lagging strand elongation; GO:0006273; leading strand elongation; GO:0006272; lipid catabolism; GO:0016042; transport; GO:0006810 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003676; transporter activity; GO:0005215; calcium ion binding; GO:0005509; delta DNA polymerase activity; GO:0003891; ; GO:0003891; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0005509; ; GO:0005215; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; nucleotide binding; GO:0000166; ; GO:0008296; ; GO:0003891; ; GO:0008310; ; GO:0003891; ; GO:0003677; ; GO:0000166; ; GO:0004623 ; EC:3.1.1.4 delta DNA polymerase complex; GO:0005659; membrane; GO:0016020; nucleus; GO:0005634 DNApol-delta DNA-polymerase-delta "CG5949, CG5949, Dm Poldelta, DNA polymerase delta, CAA61369, DNApol-delta, DNA-polymerase-delta" CDMC24760 3 8 5 DAC07-O21 3-CG5949-RA_1 CG5949 CGAAAGGGATCCCGATGGTGCAGTTGCCTATGTGAAACAGGTGATAGCCGATCTCCTCTGCAATCGCAT 69 FBan0005949 FBgn0012066 DNApol-delta 3 3L DNA recombination; GO:0006310; DNA repair; GO:0006281; lagging strand elongation; GO:0006273; leading strand elongation; GO:0006272; lipid catabolism; GO:0016042; transport; GO:0006810 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003676; transporter activity; GO:0005215; calcium ion binding; GO:0005509; delta DNA polymerase activity; GO:0003891; ; GO:0003891; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0005509; ; GO:0005215; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; nucleotide binding; GO:0000166; ; GO:0008296; ; GO:0003891; ; GO:0008310; ; GO:0003891; ; GO:0003677; ; GO:0000166; ; GO:0004623 ; EC:3.1.1.4 delta DNA polymerase complex; GO:0005659; membrane; GO:0016020; nucleus; GO:0005634 DNApol-delta DNA-polymerase-delta "CG5949, CG5949, Dm Poldelta, DNA polymerase delta, CAA61369, DNApol-delta, DNA-polymerase-delta" CDMC24761 3 9 5 DAC08-C09 8-CG8245-RA_1 CG8245 TGGGGAGCGTAGGATAATAAGCCTGTATCGCGCCATTACAGCCATCTATGGTAGGGAAAAACGCTGCAA 69 FBan0008245 FBgn0033031 CG8245 2 2R CG8245 CG8245 CDMC24761 3 10 5 DAC08-C09 8-CG8245-RA_1 CG8245 TGGGGAGCGTAGGATAATAAGCCTGTATCGCGCCATTACAGCCATCTATGGTAGGGAAAAACGCTGCAA 69 FBan0008245 FBgn0033031 CG8245 2 2R CG8245 CG8245 CDMC24762 3 11 5 DAC08-C21 23-CG8256-RA_1 CG8256 CATCGGAGGCATGGACTAGACTTAAGATCGAACGTTTAAGATCAAACTTATTTTCATTTTGCTGTTAAT 69 FBan0008256 FBgn0022160 l(2)k05713 2 2R glycerol metabolism; GO:0006071 glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 mitochondrion; GO:0005739 l(2)k05713 lethal (2) k05713 "CG8256, CG18786, CG8256, CG8256, mitochondrial GPD, anon-WO0118547.114" CDMC24762 3 12 5 DAC08-C21 23-CG8256-RA_1 CG8256 CATCGGAGGCATGGACTAGACTTAAGATCGAACGTTTAAGATCAAACTTATTTTCATTTTGCTGTTAAT 69 FBan0008256 FBgn0022160 l(2)k05713 2 2R glycerol metabolism; GO:0006071 glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 mitochondrion; GO:0005739 l(2)k05713 lethal (2) k05713 "CG8256, CG18786, CG8256, CG8256, mitochondrial GPD, anon-WO0118547.114" CDMC24763 3 13 5 DAC08-G09 16-CG8293-RA_1 CG8293 TGCACGCTGAAATGACCTTATATAGATGAGCAGCTCTAATTCGCGCTGAAAAGGGTATCAATGCACCGG 69 FBan0008293 FBgn0015247 Iap2 2 2R anti-apoptosis; GO:0006916; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Iap2 Inhibitor of apoptosis 2 "CG8293, CG8293, DIAP2, dILP, IAP-like protein, DIHA, D-iap2, diap2, Diap2, DIAP-2, IAP, D-IAP2, DIAP, dIAP, dIAP2, Diap, Diha, Ilp: IAP-like protein" CDMC24763 3 14 5 DAC08-G09 16-CG8293-RA_1 CG8293 TGCACGCTGAAATGACCTTATATAGATGAGCAGCTCTAATTCGCGCTGAAAAGGGTATCAATGCACCGG 69 FBan0008293 FBgn0015247 Iap2 2 2R anti-apoptosis; GO:0006916; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Iap2 Inhibitor of apoptosis 2 "CG8293, CG8293, DIAP2, dILP, IAP-like protein, DIHA, D-iap2, diap2, Diap2, DIAP-2, IAP, D-IAP2, DIAP, dIAP, dIAP2, Diap, Diha, Ilp: IAP-like protein" CDMC24764 3 15 5 DAC08-G21 2-CG8308-RA_1 CG8308 ACGGTCATCGATGATGTTCGGAATGGCTGCATGAGGGAGCTCTATCATCCGGAGCAACTGATTTCTGGA 69 FBan0008308 FBgn0004236 alphaTub67C 3 3L cell motility; GO:0006928; central nervous system development; GO:0007417; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; embryonic cleavage; GO:0040016; embryonic development (sensu Metazoa); GO:0009792; embryonic development; GO:0009790; female pronucleus formation; GO:0035038; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; nuclear division; GO:0000280; peripheral nervous system development; GO:0007422; pronuclear migration; GO:0035046; sperm aster formation; GO:0035044 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub67C alpha-Tubulin at 67C "CG8308, CG8308, DTA2, alpha67C, Fs(3)Tomaj, 4t, alpha-tubulin, T, Tom, alpha4-t, alpha4Tub67C, alpha4-tubulin, alpha tubulin, tubulin, aTub67C, alpha4, alphatubulin, alphatub67C, alphaTub[67C], Tomaj, D.m.ALPHA-67C, ALPHA 67C, alpha-tub67C, alpha tubulin 67C, alpha-Tubulin, alpha-Tub, mum-tub67C, alphaTUB, alphaTub67C, alpha-tubulin, alpha-Tub67C, alpha4t, alphaTub4, Fs(3)Sz22, Fs(3)Tom: Tomaj" CDMC24764 3 16 5 DAC08-G21 2-CG8308-RA_1 CG8308 ACGGTCATCGATGATGTTCGGAATGGCTGCATGAGGGAGCTCTATCATCCGGAGCAACTGATTTCTGGA 69 FBan0008308 FBgn0004236 alphaTub67C 3 3L cell motility; GO:0006928; central nervous system development; GO:0007417; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; embryonic cleavage; GO:0040016; embryonic development (sensu Metazoa); GO:0009792; embryonic development; GO:0009790; female pronucleus formation; GO:0035038; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; nuclear division; GO:0000280; peripheral nervous system development; GO:0007422; pronuclear migration; GO:0035046; sperm aster formation; GO:0035044 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub67C alpha-Tubulin at 67C "CG8308, CG8308, DTA2, alpha67C, Fs(3)Tomaj, 4t, alpha-tubulin, T, Tom, alpha4-t, alpha4Tub67C, alpha4-tubulin, alpha tubulin, tubulin, aTub67C, alpha4, alphatubulin, alphatub67C, alphaTub[67C], Tomaj, D.m.ALPHA-67C, ALPHA 67C, alpha-tub67C, alpha tubulin 67C, alpha-Tubulin, alpha-Tub, mum-tub67C, alphaTUB, alphaTub67C, alpha-tubulin, alpha-Tub67C, alpha4t, alphaTub4, Fs(3)Sz22, Fs(3)Tom: Tomaj" CDMC24765 3 17 5 DAC08-K09 9-CG8336-RB_1 CG8336 ACGGGCAAAATATCGCAAGGCGAATCGATACTATCATTACCTGAGCAGACAGTTCGGTTGGCAGCAGCT 69 FBan0008336 FBgn0036020 CG8336 3 3L defense response; GO:0006952; intracellular protein transport; GO:0006886; protein folding; GO:0006457; protein metabolism; GO:0019538; protein targeting; GO:0006605 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG8336 CG8336 CDMC24765 3 18 5 DAC08-K09 9-CG8336-RB_1 CG8336 ACGGGCAAAATATCGCAAGGCGAATCGATACTATCATTACCTGAGCAGACAGTTCGGTTGGCAGCAGCT 69 FBan0008336 FBgn0036020 CG8336 3 3L defense response; GO:0006952; intracellular protein transport; GO:0006886; protein folding; GO:0006457; protein metabolism; GO:0019538; protein targeting; GO:0006605 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG8336 CG8336 CDMC24766 3 19 5 DAC08-K21 10-CG8353-RA_1 CG8353 GCCGAGCAGTTTTCACACCTATCGAAAGTAACGACCACTGCAGGCAAGAACCGAAAATAGGCAGAAGGT 69 FBan0008353 FBgn0032002 CG8353 2 2L cytidine metabolism; GO:0046087; pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8353 CG8353 CDMC24766 3 20 5 DAC08-K21 10-CG8353-RA_1 CG8353 GCCGAGCAGTTTTCACACCTATCGAAAGTAACGACCACTGCAGGCAAGAACCGAAAATAGGCAGAAGGT 69 FBan0008353 FBgn0032002 CG8353 2 2L cytidine metabolism; GO:0046087; pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8353 CG8353 CDMC24767 3 21 5 DAC08-O09 17-CG8397-RA_3 CG8397 GCCAGCCCTGTCATTGGATTTTACACAACCTCACAAACGGTCACATCATCGGCTGACAATTGGAAAATT 69 FBan0008397 FBgn0034066 CG8397 2 2R actin binding; GO:0003779; ; GO:0003779 CG8397 CG8397 CDMC24767 3 22 5 DAC08-O09 17-CG8397-RA_3 CG8397 GCCAGCCCTGTCATTGGATTTTACACAACCTCACAAACGGTCACATCATCGGCTGACAATTGGAAAATT 69 FBan0008397 FBgn0034066 CG8397 2 2R actin binding; GO:0003779; ; GO:0003779 CG8397 CG8397 CDMC24768 3 23 5 DAC08-O21 10-CG8412-RA_1 CG8412 GCAAGGACGAGACAATGAACTATACCCAGGCGGATTTGGTTGCATACACACATCTTTTGGTCGAGGCGA 69 FBan0008412 FBgn0037743 CG8412 3 3R dolichol-linked oligosaccharide biosynthesis; GO:0006488; protein amino acid glycosylation; GO:0006486 "alpha-1,6-mannosyltransferase activity; GO:0000009 ; EC:2.4.1.-; dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity; GO:0004584 ; EC:2.4.1.130; ; GO:0000009 ; EC:2.4.1.-; ; GO:0004584 ; EC:2.4.1.130" endoplasmic reticulum; GO:0005783 CG8412 CG8412 CDMC24768 3 24 5 DAC08-O21 10-CG8412-RA_1 CG8412 GCAAGGACGAGACAATGAACTATACCCAGGCGGATTTGGTTGCATACACACATCTTTTGGTCGAGGCGA 69 FBan0008412 FBgn0037743 CG8412 3 3R dolichol-linked oligosaccharide biosynthesis; GO:0006488; protein amino acid glycosylation; GO:0006486 "alpha-1,6-mannosyltransferase activity; GO:0000009 ; EC:2.4.1.-; dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity; GO:0004584 ; EC:2.4.1.130; ; GO:0000009 ; EC:2.4.1.-; ; GO:0004584 ; EC:2.4.1.130" endoplasmic reticulum; GO:0005783 CG8412 CG8412 CDMC24769 3 25 5 DAC09-C10 22-CG12837-RA_1 CG12837 TGTAATAGCAATCGATCAAATAGCTCCAAAGGACCAACTCATCCTGGGACTGTACATTGCCGTTGGGTC 69 FBan0012837 FBgn0033139 Tsp42Er 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Er Tetraspanin 42Er "CG12837, CG12837, CG12837, CG12837, Dm.Tsp42Er, tetraspanin 42E, Tetraspanin 42Er" CDMC24769 3 26 5 DAC09-C10 22-CG12837-RA_1 CG12837 TGTAATAGCAATCGATCAAATAGCTCCAAAGGACCAACTCATCCTGGGACTGTACATTGCCGTTGGGTC 69 FBan0012837 FBgn0033139 Tsp42Er 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Er Tetraspanin 42Er "CG12837, CG12837, CG12837, CG12837, Dm.Tsp42Er, tetraspanin 42E, Tetraspanin 42Er" CDMC24770 3 1 6 DAC09-C22 17-CG12845-RA_3 CG12845 TGGTGGTGCTACGTTGCACGCTGTTAGATTGAGGAAATTCGACATAGTTGCGACGATCTTCCAGAAAGT 69 FBan0012845 FBgn0033127 Tsp42Ef 2 2R integral to membrane; GO:0016021 Tsp42Ef Tetraspanin 42Ef "CG12845, CG12845, CG12845, Dm.Tsp42Ef, tetraspanin 42E, Tetraspanin 42Ef" CDMC24770 3 2 6 DAC09-C22 17-CG12845-RA_3 CG12845 TGGTGGTGCTACGTTGCACGCTGTTAGATTGAGGAAATTCGACATAGTTGCGACGATCTTCCAGAAAGT 69 FBan0012845 FBgn0033127 Tsp42Ef 2 2R integral to membrane; GO:0016021 Tsp42Ef Tetraspanin 42Ef "CG12845, CG12845, CG12845, Dm.Tsp42Ef, tetraspanin 42E, Tetraspanin 42Ef" CDMC24771 3 3 6 DAC09-G10 15-CG12878-RA_1 CG12878 ACAGCCCAGCTCCTAACTCAACTCATACGATTTTTTTTCCCCCATTCTGTCCTTGGGTCTGCGACTCAA 69 FBan0012878 FBgn0045862 btz 3 3R NOT bicoid mRNA localization; GO:0045450; NOT oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318 cytoplasm; GO:0005737; nuclear membrane; GO:0005635 btz barentsz "CG12878, wkl, weak localizer, Btz, barentsz" CDMC24771 3 4 6 DAC09-G10 15-CG12878-RA_1 CG12878 ACAGCCCAGCTCCTAACTCAACTCATACGATTTTTTTTCCCCCATTCTGTCCTTGGGTCTGCGACTCAA 69 FBan0012878 FBgn0045862 btz 3 3R NOT bicoid mRNA localization; GO:0045450; NOT oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318 cytoplasm; GO:0005737; nuclear membrane; GO:0005635 btz barentsz "CG12878, wkl, weak localizer, Btz, barentsz" CDMC24772 3 5 6 DAC09-G22 1-CG12891-RB_1 CG12891 CGCTTCTCGTTGACATATGAGGCTTCAATGACCCGTCTGTTCCGCGAAGGAAGAACTGAGACAGTGCGT 69 FBan0012891 FBgn0027842 CPTI 2 2R amino acid metabolism; GO:0006520 ATP binding; GO:0005524; ; GO:0005524; carnitine O-palmitoyltransferase activity; GO:0004095 ; EC:2.3.1.21; ; GO:0004095 ; EC:2.3.1.21; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0004095 ; EC:2.3.1.21 mitochondrion; GO:0005739 CPTI mitochondrial carnitine palmitoyltransferase I "CG12891, gh27794, BEST:GH27794" CDMC24772 3 6 6 DAC09-G22 1-CG12891-RB_1 CG12891 CGCTTCTCGTTGACATATGAGGCTTCAATGACCCGTCTGTTCCGCGAAGGAAGAACTGAGACAGTGCGT 69 FBan0012891 FBgn0027842 CPTI 2 2R amino acid metabolism; GO:0006520 ATP binding; GO:0005524; ; GO:0005524; carnitine O-palmitoyltransferase activity; GO:0004095 ; EC:2.3.1.21; ; GO:0004095 ; EC:2.3.1.21; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0004095 ; EC:2.3.1.21 mitochondrion; GO:0005739 CPTI mitochondrial carnitine palmitoyltransferase I "CG12891, gh27794, BEST:GH27794" CDMC24773 3 7 6 DAC09-K10 15-CG12934-RA_6 CG12934 ACAACATTCTTCGCAAAATCATCAGGTGGAACTGGAAATCAAGCAGGTGGAACAGAAGCCTCCACAGCA 69 FBan0012934 FBgn0033541 CG12934 2 2R CG12934 CG12934 CDMC24773 3 8 6 DAC09-K10 15-CG12934-RA_6 CG12934 ACAACATTCTTCGCAAAATCATCAGGTGGAACTGGAAATCAAGCAGGTGGAACAGAAGCCTCCACAGCA 69 FBan0012934 FBgn0033541 CG12934 2 2R CG12934 CG12934 CDMC24774 3 9 6 DAC09-K22 8-CG12948-RA_1 CG12948 TGGGCTAGGCCGACTAAAAAGACTTTGTTCGCACTCTGTAGCCCTTAGCCACGTTCATTTCATCGCCTA 69 FBan0012948 FBgn0037739 CG12948 3 3R CG12948 CG12948 CDMC24774 3 10 6 DAC09-K22 8-CG12948-RA_1 CG12948 TGGGCTAGGCCGACTAAAAAGACTTTGTTCGCACTCTGTAGCCCTTAGCCACGTTCATTTCATCGCCTA 69 FBan0012948 FBgn0037739 CG12948 3 3R CG12948 CG12948 CDMC24775 3 11 6 DAC09-O10 3-CG12996-RA_1 CG12996 ACGGAGAGCGAGCCCTATCACTTCTGTTCCGACGAGGATCATAGCAGTCACACGCAAACCATCAAGTTG 69 FBan0012996 FBgn0030835 CG12996 X X CG12996 CG12996 CDMC24775 3 12 6 DAC09-O10 3-CG12996-RA_1 CG12996 ACGGAGAGCGAGCCCTATCACTTCTGTTCCGACGAGGATCATAGCAGTCACACGCAAACCATCAAGTTG 69 FBan0012996 FBgn0030835 CG12996 X X CG12996 CG12996 CDMC24776 3 13 6 DAC09-O22 2-CG13008-RA_2 CG13008 CCCTGTGACATGGATATGCAATCCCTTGGACCCGACGATATGCAAACCCAGATTCAGATGACCGCCGAT 69 FBan0013008 FBgn0030780 CG13008 X X CG13008 CG13008 "CG13009, CG13009" CDMC24776 3 14 6 DAC09-O22 2-CG13008-RA_2 CG13008 CCCTGTGACATGGATATGCAATCCCTTGGACCCGACGATATGCAAACCCAGATTCAGATGACCGCCGAT 69 FBan0013008 FBgn0030780 CG13008 X X CG13008 CG13008 "CG13009, CG13009" CDMC24777 3 15 6 DAC10-C09 23-CG10960-RA_19 CG10960 ACTTGCTGTTAATATACGTTCGATTTAAGTTCGCGTTTAGTGCAAGTCTTTTGGCGTTTTCGATGGATG 69 FBan0010960 FBgn0036316 CG10960 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG10960 CG10960 CT30701 CDMC24777 3 16 6 DAC10-C09 23-CG10960-RA_19 CG10960 ACTTGCTGTTAATATACGTTCGATTTAAGTTCGCGTTTAGTGCAAGTCTTTTGGCGTTTTCGATGGATG 69 FBan0010960 FBgn0036316 CG10960 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG10960 CG10960 CT30701 CDMC24778 3 17 6 DAC10-C21 12-CG10970-RA_1 CG10970 TGGATACACGATAATTGGAGGCAATTACGATCGGATCTGGAGGTTCAAAGTCAGGGTCACAGAGCGCCG 69 FBan0010970 FBgn0030078 CG10970 X X acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG10970 CG10970 BcDNA:HL08157 CDMC24778 3 18 6 DAC10-C21 12-CG10970-RA_1 CG10970 TGGATACACGATAATTGGAGGCAATTACGATCGGATCTGGAGGTTCAAAGTCAGGGTCACAGAGCGCCG 69 FBan0010970 FBgn0030078 CG10970 X X acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG10970 CG10970 BcDNA:HL08157 CDMC24779 3 19 6 DAC10-G09 14-CG11010-RA_1 CG11010 TGCCGGGAACACTCAAGGAGGTCACTGGCAATATAATGACCCTGTCGTATAATGTTGGTCTGACGGTGG 69 FBan0011010 FBgn0036319 Ent3 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "nucleoside transporter activity, down a concentration gradient; GO:0015395; ; GO:0015395" membrane; GO:0016020 Ent3 Equilibrative nucleoside transporter 3 "CG11010, CG11010, DmENT3, Equilibrative nucleoside transporter 3" CDMC24779 3 20 6 DAC10-G09 14-CG11010-RA_1 CG11010 TGCCGGGAACACTCAAGGAGGTCACTGGCAATATAATGACCCTGTCGTATAATGTTGGTCTGACGGTGG 69 FBan0011010 FBgn0036319 Ent3 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "nucleoside transporter activity, down a concentration gradient; GO:0015395; ; GO:0015395" membrane; GO:0016020 Ent3 Equilibrative nucleoside transporter 3 "CG11010, CG11010, DmENT3, Equilibrative nucleoside transporter 3" CDMC24780 3 21 6 DAC10-G21 24-CG11027-RA_10 CG11027 AATCGAATGACTAGTTTACACGTCAATTTACTGAAGTTACTGAAGACAAGCTTTTTCCTATACGAAATA 69 FBan0011027 FBgn0013749 Arf102F 4 4 cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; NAD(P)+-protein-arginine ADP-ribosyltransferase activity; GO:0003956 ; EC:2.4.2.31; ; GO:0003956 ; EC:2.4.2.31 Arf102F ADP ribosylation factor 102F "CG11027, CG11027, dARFII, ADP ribosylation factor II, ARF2, ARFII, ADP ribosylation factor 102F" CDMC24780 3 22 6 DAC10-G21 24-CG11027-RA_10 CG11027 AATCGAATGACTAGTTTACACGTCAATTTACTGAAGTTACTGAAGACAAGCTTTTTCCTATACGAAATA 69 FBan0011027 FBgn0013749 Arf102F 4 4 cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; NAD(P)+-protein-arginine ADP-ribosyltransferase activity; GO:0003956 ; EC:2.4.2.31; ; GO:0003956 ; EC:2.4.2.31 Arf102F ADP ribosylation factor 102F "CG11027, CG11027, dARFII, ADP ribosylation factor II, ARF2, ARFII, ADP ribosylation factor 102F" CDMC24781 3 23 6 DAC10-K09 17-CG11061-RA_1 CG11061 CCACAACCATGCAGGAGACCATCTCAACTGTTGTATGGGCAAGTTCGAGGTAGTCTAAAAGAAGTGCAA 69 FBan0011061 FBgn0034697 GM130 2 2R Golgi organization and biogenesis; GO:0007030; mitosis; GO:0007067; protein targeting; GO:0006605 chromatin binding; GO:0003682; ; GO:0003682 Golgi cis cisterna; GO:0000137; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 GM130 GM130 "CG11061, CG11061, CG11061, dGM130, dgm130" CDMC24781 3 24 6 DAC10-K09 17-CG11061-RA_1 CG11061 CCACAACCATGCAGGAGACCATCTCAACTGTTGTATGGGCAAGTTCGAGGTAGTCTAAAAGAAGTGCAA 69 FBan0011061 FBgn0034697 GM130 2 2R Golgi organization and biogenesis; GO:0007030; mitosis; GO:0007067; protein targeting; GO:0006605 chromatin binding; GO:0003682; ; GO:0003682 Golgi cis cisterna; GO:0000137; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 GM130 GM130 "CG11061, CG11061, CG11061, dGM130, dgm130" CDMC24782 3 25 6 DAC10-K21 8-CG11070-RA_5 CG11070 GGCTGAAGCATTGGAATTTCTCTTGCCCTCACGGATTATGGGAAGCCATCGCAAGACTTTTGTCAGCCA 69 FBan0011070 FBgn0028467 CG11070 2 2L defense response; GO:0006952; protein ubiquitination; GO:0016567; response to stress; GO:0006950; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CG11070 CG11070 BcDNA:LD34475 CDMC24782 3 26 6 DAC10-K21 8-CG11070-RA_5 CG11070 GGCTGAAGCATTGGAATTTCTCTTGCCCTCACGGATTATGGGAAGCCATCGCAAGACTTTTGTCAGCCA 69 FBan0011070 FBgn0028467 CG11070 2 2L defense response; GO:0006952; protein ubiquitination; GO:0016567; response to stress; GO:0006950; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CG11070 CG11070 BcDNA:LD34475 CDMC24783 3 1 7 DAC10-O09 23-CG11112-RB_1 CG11112 CACGCGAAACCCAATACATATTCAAATAAGAAGGCAAACACTAAAGAGGACGAAAAGAGGCAATTCCTG 69 FBan0011112 FBgn0033164 CG11112 2 2R CG11112 CG11112 CT8227 CDMC24783 3 2 7 DAC10-O09 23-CG11112-RB_1 CG11112 CACGCGAAACCCAATACATATTCAAATAAGAAGGCAAACACTAAAGAGGACGAAAAGAGGCAATTCCTG 69 FBan0011112 FBgn0033164 CG11112 2 2R CG11112 CG11112 CT8227 CDMC24784 3 3 7 DAC10-O21 1-CG11128-RA_1 CG11128 GCCTCAGCGTCTTTGCGAATTTGTACCTGATGTTTCAGCTGGACCTGAACACATGGATCCGCTTCCTCA 69 FBan0011128 FBgn0037203 slif 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; growth; GO:0040007 amino acid transporter activity; GO:0015171; cationic amino acid transporter activity; GO:0015326; ; GO:0015326; ; GO:0015171; ; GO:0015326 membrane; GO:0016020 slif slimfast "CG11128, CG11128, CG11128, CG11128, slimfast" CDMC24784 3 4 7 DAC10-O21 1-CG11128-RA_1 CG11128 GCCTCAGCGTCTTTGCGAATTTGTACCTGATGTTTCAGCTGGACCTGAACACATGGATCCGCTTCCTCA 69 FBan0011128 FBgn0037203 slif 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; growth; GO:0040007 amino acid transporter activity; GO:0015171; cationic amino acid transporter activity; GO:0015326; ; GO:0015326; ; GO:0015171; ; GO:0015326 membrane; GO:0016020 slif slimfast "CG11128, CG11128, CG11128, CG11128, slimfast" CDMC24785 3 5 7 DAC11-C09 7-CG12201-RA_2 CG12201 GCGGTCTTCTACTGGTCTCTGATAGCTGGACTCTTGTCTGGCATGACTTCTGCCTTTATGGTCACCCCT 69 FBan0012201 FBgn0037970 CG12201 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; carnitine transporter activity; GO:0015226; acyl carnitine transporter activity; GO:0015227; ; GO:0015227; ; GO:0015226 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG12201 CG12201 CDMC24785 3 6 7 DAC11-C09 7-CG12201-RA_2 CG12201 GCGGTCTTCTACTGGTCTCTGATAGCTGGACTCTTGTCTGGCATGACTTCTGCCTTTATGGTCACCCCT 69 FBan0012201 FBgn0037970 CG12201 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; carnitine transporter activity; GO:0015226; acyl carnitine transporter activity; GO:0015227; ; GO:0015227; ; GO:0015226 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG12201 CG12201 CDMC24786 3 7 7 DAC11-C21 16-CG12210-RB_1 CG12210 ACGCGAATGACAACTACAATCAATTCGGTGACCATCAAATCAGGAACAACAATGCAGCCCAGAAGAAGC 69 FBan0012210 FBgn0003660 Syb 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle transport; GO:0048489; tracheal lumen formation; GO:0035149; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Syb Synaptobrevin "CG12210, CG12210, Vamp, syb, 21.15, J, Complementation group J, synaptobrevin, VAMP, c-Syb, l(2)46El, l(2)46CFq, Vesicle-associated membrane protein" CDMC24786 3 8 7 DAC11-C21 16-CG12210-RB_1 CG12210 ACGCGAATGACAACTACAATCAATTCGGTGACCATCAAATCAGGAACAACAATGCAGCCCAGAAGAAGC 69 FBan0012210 FBgn0003660 Syb 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle transport; GO:0048489; tracheal lumen formation; GO:0035149; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Syb Synaptobrevin "CG12210, CG12210, Vamp, syb, 21.15, J, Complementation group J, synaptobrevin, VAMP, c-Syb, l(2)46El, l(2)46CFq, Vesicle-associated membrane protein" CDMC24787 3 9 7 DAC11-G09 6-CG12241-RA_3 CG12241 AGGCTATCCTTAAAGTGGGTCGTCATTTCATCACCATTGAACCCAAGCTTGCCGGTCACATCCAGCTGA 69 FBan0012241 FBgn0038304 CG12241 3 3R regulation of progression through cell cycle; GO:0000074 GTPase activator activity; GO:0005096; ; GO:0005096 CG12241 CG12241 CDMC24787 3 10 7 DAC11-G09 6-CG12241-RA_3 CG12241 AGGCTATCCTTAAAGTGGGTCGTCATTTCATCACCATTGAACCCAAGCTTGCCGGTCACATCCAGCTGA 69 FBan0012241 FBgn0038304 CG12241 3 3R regulation of progression through cell cycle; GO:0000074 GTPase activator activity; GO:0005096; ; GO:0005096 CG12241 CG12241 CDMC24788 3 11 7 DAC11-G21 3-CG12259-RA_1 CG12259 AGCCGATGGGAGCCCTACGATCCCACCAAGTCCTACGACAAGTACACCATCAAGGACAAGGATAAGAGT 69 FBan0012259 FBgn0039557 CG12259 3 3R CG12259 CG12259 CDMC24788 3 12 7 DAC11-G21 3-CG12259-RA_1 CG12259 AGCCGATGGGAGCCCTACGATCCCACCAAGTCCTACGACAAGTACACCATCAAGGACAAGGATAAGAGT 69 FBan0012259 FBgn0039557 CG12259 3 3R CG12259 CG12259 CDMC24789 3 13 7 DAC11-K09 11-CG12301-RA_1 CG12301 TGCCCACGTTGAAGGTAACACAGAAAGCACGGAAATTCCAGCTGTGGATACCATAGATCCCAACAAGGT 69 FBan0012301 FBgn0036514 CG12301 3 3L CG12301 CG12301 CDMC24789 3 14 7 DAC11-K09 11-CG12301-RA_1 CG12301 TGCCCACGTTGAAGGTAACACAGAAAGCACGGAAATTCCAGCTGTGGATACCATAGATCCCAACAAGGT 69 FBan0012301 FBgn0036514 CG12301 3 3L CG12301 CG12301 CDMC24790 3 15 7 DAC11-K21 2-CG12311-RA_1 CG12311 TGCCCAAATGGATTCACCACGTTATCCTCGGACTGGTTCTCTCGATCCTGGTGTATAGTTTTGCCGCCT 69 FBan0012311 FBgn0025618 Pomt2 X X protein amino acid O-linked mannosylation; GO:0035269; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate-mannose-protein mannosyltransferase activity; GO:0004169 ; EC:2.4.1.109; ; GO:0004169 ; EC:2.4.1.109; ; GO:0004169 ; EC:2.4.1.109; mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0000030 ; EC:2.4.1.- integral to membrane; GO:0016021; membrane; GO:0016020 Pomt2 Protein O-mannosyltransferase 2 "CG12311, CG12311, CG12311, EG:34F3.7, dPOMT2, POMT2, Protein O-mannosyltransferase 2" CDMC24790 3 16 7 DAC11-K21 2-CG12311-RA_1 CG12311 TGCCCAAATGGATTCACCACGTTATCCTCGGACTGGTTCTCTCGATCCTGGTGTATAGTTTTGCCGCCT 69 FBan0012311 FBgn0025618 Pomt2 X X protein amino acid O-linked mannosylation; GO:0035269; protein amino acid glycosylation; GO:0006486 dolichyl-phosphate-mannose-protein mannosyltransferase activity; GO:0004169 ; EC:2.4.1.109; ; GO:0004169 ; EC:2.4.1.109; ; GO:0004169 ; EC:2.4.1.109; mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0000030 ; EC:2.4.1.- integral to membrane; GO:0016021; membrane; GO:0016020 Pomt2 Protein O-mannosyltransferase 2 "CG12311, CG12311, CG12311, EG:34F3.7, dPOMT2, POMT2, Protein O-mannosyltransferase 2" CDMC24791 3 17 7 DAC11-O09 17-CG12347-RA_1 CG12347 AGGCTTTGCCATGGACGAGTTACTAAATCTGGGTCTCAACGGCATACAGTTTGAACTGGAGGAATCTGC 69 FBan0012347 FBgn0038558 CG12347 3 3R CG12347 CG12347 CDMC24791 3 18 7 DAC11-O09 17-CG12347-RA_1 CG12347 AGGCTTTGCCATGGACGAGTTACTAAATCTGGGTCTCAACGGCATACAGTTTGAACTGGAGGAATCTGC 69 FBan0012347 FBgn0038558 CG12347 3 3R CG12347 CG12347 CDMC24792 3 19 7 DAC11-O21 23-CG12352-RA_2 CG12352 ATCGAGTTCTATAAGAAGTTTGGTTTCGAGATTGTTGACACCAAGGAGCAATACTATAAGCGCATCGAG 69 FBan0012352 FBgn0024188 san 2 2R mitotic sister chromatid cohesion; GO:0007064 fatty acid binding; GO:0005504; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.-; ; GO:0005504 cohesin core heterodimer; GO:0008280; cytoplasm; GO:0005737; protein acetyltransferase complex; GO:0031248 san separation anxiety "CG12352, CG12352, CG12352, DmAAF34715, span" CDMC24792 3 20 7 DAC11-O21 23-CG12352-RA_2 CG12352 ATCGAGTTCTATAAGAAGTTTGGTTTCGAGATTGTTGACACCAAGGAGCAATACTATAAGCGCATCGAG 69 FBan0012352 FBgn0024188 san 2 2R mitotic sister chromatid cohesion; GO:0007064 fatty acid binding; GO:0005504; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.-; ; GO:0005504 cohesin core heterodimer; GO:0008280; cytoplasm; GO:0005737; protein acetyltransferase complex; GO:0031248 san separation anxiety "CG12352, CG12352, CG12352, DmAAF34715, span" CDMC24793 3 21 7 DAC12-C09 23-CG7867-RA_11 CG7867 TGGCAGCTAAGAAGGTTTTTGCTAGGACAAGTGCTCCATTTTTCAAATCTTTCCATCACATGCATACTT 69 FBan0033991 FBgn0013718 nuf 3 3L "actin cytoskeleton reorganization; GO:0031532; cytokinesis, contractile ring formation; GO:0000915; microtubule-based process; GO:0007017" microtubule binding; GO:0008017; ; GO:0008017 centrosome; GO:0005813; microtubule associated complex; GO:0005875 nuf nuclear fallout "CG7867, CG32140, CG33991, CG7867, CG7867, CG32140, CG33991, nuclear-fallout, Cy3-23, D2, CIP-D2, EP3077, anon-D2, Corkscrew Interacting Protein-D2, nuclear fallout" CDMC24793 3 22 7 DAC12-C09 23-CG7867-RA_11 CG7867 TGGCAGCTAAGAAGGTTTTTGCTAGGACAAGTGCTCCATTTTTCAAATCTTTCCATCACATGCATACTT 69 FBan0033991 FBgn0013718 nuf 3 3L "actin cytoskeleton reorganization; GO:0031532; cytokinesis, contractile ring formation; GO:0000915; microtubule-based process; GO:0007017" microtubule binding; GO:0008017; ; GO:0008017 centrosome; GO:0005813; microtubule associated complex; GO:0005875 nuf nuclear fallout "CG7867, CG32140, CG33991, CG7867, CG7867, CG32140, CG33991, nuclear-fallout, Cy3-23, D2, CIP-D2, EP3077, anon-D2, Corkscrew Interacting Protein-D2, nuclear fallout" CDMC24794 3 23 7 DAC12-C21 2-CG7878-RA_2 CG7878 ACCAGGAGTACGTCGTTTAGCGCAGAGCTATATGAAGAATCCCATCCAGGTGTGTGTCGGATCGCTCGA 69 FBgn0037549 CG7878 "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG7878 CG7878 "cg7878, DmRH26" CDMC24794 3 24 7 DAC12-C21 2-CG7878-RA_2 CG7878 ACCAGGAGTACGTCGTTTAGCGCAGAGCTATATGAAGAATCCCATCCAGGTGTGTGTCGGATCGCTCGA 69 FBgn0037549 CG7878 "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG7878 CG7878 "cg7878, DmRH26" CDMC24795 3 25 7 DAC12-G09 2-CG7911-RA_1 CG7911 CGGCGAGACCCGTAGCTTAAGACCAAATGTCGAGTTCCCCAATGGATCAGTGACCTTCAAACTGGTGCA 69 FBan0007911 FBgn0039735 CG7911 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG7911 CG7911 CDMC24795 3 26 7 DAC12-G09 2-CG7911-RA_1 CG7911 CGGCGAGACCCGTAGCTTAAGACCAAATGTCGAGTTCCCCAATGGATCAGTGACCTTCAAACTGGTGCA 69 FBan0007911 FBgn0039735 CG7911 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG7911 CG7911 CDMC24796 3 1 8 DAC12-G21 16-CG7920-RB_2 CG7920 CGACGTGCGTGCCTACAACAGAGTACTCAGTACACACTACTACACTACACAGTCCACCATGAGCAAACA 69 FBan0007920 FBgn0039737 CG7920 3 3R acetyl-CoA metabolism; GO:0006084 4-hydroxybutyrate CoA-transferase activity; GO:0008411; ; GO:0008411 CG7920 CG7920 "GH02390.5prime, i130, BEST:GH02390, anon-WO0153538.36, anon-WO0153538.37" CDMC24796 3 2 8 DAC12-G21 16-CG7920-RB_2 CG7920 CGACGTGCGTGCCTACAACAGAGTACTCAGTACACACTACTACACTACACAGTCCACCATGAGCAAACA 69 FBan0007920 FBgn0039737 CG7920 3 3R acetyl-CoA metabolism; GO:0006084 4-hydroxybutyrate CoA-transferase activity; GO:0008411; ; GO:0008411 CG7920 CG7920 "GH02390.5prime, i130, BEST:GH02390, anon-WO0153538.36, anon-WO0153538.37" CDMC24797 3 3 8 DAC12-K09 23-CG7946-RA_1 CG7946 GCATCCGCTTATTACCAGACTAAAAAAAAGGTTTTTGCTTCGAAACCCCTAAATATTTTCTAAGTTTGT 69 FBan0007946 FBgn0039743 CG7946 3 3R CG7946 CG7946 CDMC24797 3 4 8 DAC12-K09 23-CG7946-RA_1 CG7946 GCATCCGCTTATTACCAGACTAAAAAAAAGGTTTTTGCTTCGAAACCCCTAAATATTTTCTAAGTTTGT 69 FBan0007946 FBgn0039743 CG7946 3 3R CG7946 CG7946 CDMC24798 3 5 8 DAC12-K21 12-CG7962-RA_4 CG7962 TCGCCACCGTCCTCTTTGGCATTCTGTTCTCGTATGTGCTGTGCAACTACCAGTACTTTATCTGTCCCA 69 FBan0007962 FBgn0010350 CdsA 3 3L "CDP-diacylglycerol biosynthesis; GO:0016024; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" phosphatidate cytidylyltransferase activity; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41 endoplasmic reticulum; GO:0005783; integral to plasma membrane; GO:0005887; nuclear membrane; GO:0005635; smooth endoplasmic reticulum; GO:0005790 CdsA CDP diglyceride synthetase "CG7962, cds, CDS, eye-CDS, eye-cds, CDP-diacylglycerol synthetase, CDP-DAG synthase, cdsA, winded" CDMC24798 3 6 8 DAC12-K21 12-CG7962-RA_4 CG7962 TCGCCACCGTCCTCTTTGGCATTCTGTTCTCGTATGTGCTGTGCAACTACCAGTACTTTATCTGTCCCA 69 FBan0007962 FBgn0010350 CdsA 3 3L "CDP-diacylglycerol biosynthesis; GO:0016024; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" phosphatidate cytidylyltransferase activity; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41; ; GO:0004605 ; EC:2.7.7.41 endoplasmic reticulum; GO:0005783; integral to plasma membrane; GO:0005887; nuclear membrane; GO:0005635; smooth endoplasmic reticulum; GO:0005790 CdsA CDP diglyceride synthetase "CG7962, cds, CDS, eye-CDS, eye-cds, CDP-diacylglycerol synthetase, CDP-DAG synthase, cdsA, winded" CDMC24799 3 7 8 DAC12-O09 1-CG7997-RA_1 CG7997 ACAGGATCCCCTTCACGGTCAAGGAGCTCGGATTGACGAATCCCAAGGGTTATAATGTGCAGGATCTGT 69 FBan0007997 FBgn0034117 CG7997 2 2R polysaccharide metabolism; GO:0005976 alpha-galactosidase activity; GO:0004557 ; EC:3.2.1.22; ; GO:0004557 ; EC:3.2.1.22 CG7997 CG7997 CT24026 CDMC24799 3 8 8 DAC12-O09 1-CG7997-RA_1 CG7997 ACAGGATCCCCTTCACGGTCAAGGAGCTCGGATTGACGAATCCCAAGGGTTATAATGTGCAGGATCTGT 69 FBan0007997 FBgn0034117 CG7997 2 2R polysaccharide metabolism; GO:0005976 alpha-galactosidase activity; GO:0004557 ; EC:3.2.1.22; ; GO:0004557 ; EC:3.2.1.22 CG7997 CG7997 CT24026 CDMC24800 3 9 8 DAC12-O21 23-CG8012-RA_1 CG8012 CAGCAATGTTCCACTTACTAGAAGCAGTGTGATTGGATTTACAAACGTAAGCTGAGTATAAGAAATTAA 69 FBan0008012 FBgn0040832 CG8012 3 3L CG8012 CG8012 BcDNA:GH26995 CDMC24800 3 10 8 DAC12-O21 23-CG8012-RA_1 CG8012 CAGCAATGTTCCACTTACTAGAAGCAGTGTGATTGGATTTACAAACGTAAGCTGAGTATAAGAAATTAA 69 FBan0008012 FBgn0040832 CG8012 3 3L CG8012 CG8012 BcDNA:GH26995 CDMC24801 3 11 8 DAC13-C09 1-CG13278-RA_1 CG13278 GGGTCGCTGCTACACCCTTAGACCCAAGGAATCCGCGAAGAGAGTATCAAAGGCTGTTGGTTACTCCAT 69 FBan0013278 FBgn0032602 CG13278 2 2L CG13278 CG13278 CDMC24801 3 12 8 DAC13-C09 1-CG13278-RA_1 CG13278 GGGTCGCTGCTACACCCTTAGACCCAAGGAATCCGCGAAGAGAGTATCAAAGGCTGTTGGTTACTCCAT 69 FBan0013278 FBgn0032602 CG13278 2 2L CG13278 CG13278 CDMC24802 3 13 8 DAC13-C21 3-CG13285-RA_1 CG13285 GCTACGGAGGTAATGGAGGTTTTAGGCAATACTCAGGCTATTGGCAGCGGGATTATCAGGGTCAGCGGA 69 FBan0013285 FBgn0035611 CG13285 3 3L CG13285 CG13285 CDMC24802 3 14 8 DAC13-C21 3-CG13285-RA_1 CG13285 GCTACGGAGGTAATGGAGGTTTTAGGCAATACTCAGGCTATTGGCAGCGGGATTATCAGGGTCAGCGGA 69 FBan0013285 FBgn0035611 CG13285 3 3L CG13285 CG13285 CDMC24803 3 15 8 DAC13-G09 12-CG13316-RB_1 CG13316 CCGGCAGCCACAAGAAAAGTGGACATAAGCAACTCACGGACACGCTCTTACTCACTGTCCAATGTTTCA 69 FBan0013316 FBgn0023215 Mnt X X regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Mnt Mnt "CG2856, CG13316, CG2856, CG2856, dMad, Mad-3E, DmMnt, dMnt, Mad, EG:114E2.2" CDMC24803 3 16 8 DAC13-G09 12-CG13316-RB_1 CG13316 CCGGCAGCCACAAGAAAAGTGGACATAAGCAACTCACGGACACGCTCTTACTCACTGTCCAATGTTTCA 69 FBan0013316 FBgn0023215 Mnt X X regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Mnt Mnt "CG2856, CG13316, CG2856, CG2856, dMad, Mad-3E, DmMnt, dMnt, Mad, EG:114E2.2" CDMC24804 3 17 8 DAC13-G21 2-CG13322-RB_1 CG13322 ATCCGGGTCTTGTGTCATAGTAGCCAGTCTCCAGTCTCTTCAGGGCCAAGCAACATTCAACTCGCCAAT 69 FBan0013322 FBgn0033784 CG13322 2 2R CG13322 CG13322 anon-WO0118547.137 CDMC24804 3 18 8 DAC13-G21 2-CG13322-RB_1 CG13322 ATCCGGGTCTTGTGTCATAGTAGCCAGTCTCCAGTCTCTTCAGGGCCAAGCAACATTCAACTCGCCAAT 69 FBan0013322 FBgn0033784 CG13322 2 2R CG13322 CG13322 anon-WO0118547.137 CDMC24805 3 19 8 DAC13-K09 2-CG13359-RA_1 CG13359 AGTGGCTGTAAGTCCGACGGCTCTTCAACACCCATTTGGAGAAGTGCTAGAACTGGTGCGGATCAGAAT 69 FBan0013359 FBgn0025616 CG13359 X X CG13359 CG13359 EG:34F3.9 CDMC24805 3 20 8 DAC13-K09 2-CG13359-RA_1 CG13359 AGTGGCTGTAAGTCCGACGGCTCTTCAACACCCATTTGGAGAAGTGCTAGAACTGGTGCGGATCAGAAT 69 FBan0013359 FBgn0025616 CG13359 X X CG13359 CG13359 EG:34F3.9 CDMC24806 3 21 8 DAC13-K21 16-CG13373-RA_1 CG13373 GCACGTCCCATCGAAGCTGAGTGTCTAACCCTCCTTTAAGTGTCTAACTCAACTGGAACTCTCCGATTT 69 FBan0013373 FBgn0029522 CG13373 X X CG13373 CG13373 CDMC24806 3 22 8 DAC13-K21 16-CG13373-RA_1 CG13373 GCACGTCCCATCGAAGCTGAGTGTCTAACCCTCCTTTAAGTGTCTAACTCAACTGGAACTCTCCGATTT 69 FBan0013373 FBgn0029522 CG13373 X X CG13373 CG13373 CDMC24807 3 23 8 DAC13-O09 18-CG13410-RA_1 CG13410 AGCCGCAACGAGTACTACGCCACACAGTCAAAGACCTTTAAGGTGTGACCTGGCTAATCAAAGATACTA 69 FBan0013410 FBgn0038923 mRpL35 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739 mRpL35 mitochondrial ribosomal protein L35 "CG13410, MRP-L35, BcDNA:RE35766, mitochondrial ribosomal protein L35" CDMC24807 3 24 8 DAC13-O09 18-CG13410-RA_1 CG13410 AGCCGCAACGAGTACTACGCCACACAGTCAAAGACCTTTAAGGTGTGACCTGGCTAATCAAAGATACTA 69 FBan0013410 FBgn0038923 mRpL35 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739 mRpL35 mitochondrial ribosomal protein L35 "CG13410, MRP-L35, BcDNA:RE35766, mitochondrial ribosomal protein L35" CDMC24808 3 25 8 DAC13-O21 15-CG13421-RA_2 CG13421 TCAGAACCGCCTTTCTGCGAGTAACAGTTTATCGTGAGGTGCTACTGTGCTAGGAAAACCCATGTCCAT 69 FBan0013421 FBgn0034509 Obp57c 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57c Odorant-binding protein 57c "CG13421, CG13421, CG13421, CG13421, CG13421, CG13421, CG13421, 57c, Obp57a, BcDNA:RH68952" CDMC24808 3 26 8 DAC13-O21 15-CG13421-RA_2 CG13421 TCAGAACCGCCTTTCTGCGAGTAACAGTTTATCGTGAGGTGCTACTGTGCTAGGAAAACCCATGTCCAT 69 FBan0013421 FBgn0034509 Obp57c 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57c Odorant-binding protein 57c "CG13421, CG13421, CG13421, CG13421, CG13421, CG13421, CG13421, 57c, Obp57a, BcDNA:RH68952" CDMC24809 3 1 9 DAC14-C09 2-CG8671-RB_1 CG8671 CGTCGGTTTCTCCTGGAGGGCTATGACTCAAGACACCGCCTAGACAACTCGATGTTGCGTGTGAG 65 FBan0008671 FBgn0032938 CG8671 2 2L CG8671 CG8671 anon-WO0118547.182 CDMC24809 3 2 9 DAC14-C09 2-CG8671-RB_1 CG8671 CGTCGGTTTCTCCTGGAGGGCTATGACTCAAGACACCGCCTAGACAACTCGATGTTGCGTGTGAG 65 FBan0008671 FBgn0032938 CG8671 2 2L CG8671 CG8671 anon-WO0118547.182 CDMC24810 3 3 9 DAC14-C21 1-CG8729-RA_1 CG8729 TAAGCGGAACAAGATCCCACGTCATGCCTCTCAGGTCTCAGAAGCCACAGGACTCAAGCAAGTGG 65 FBan0008729 FBgn0023171 rnh1 2 2R RNA catabolism; GO:0006401 nucleic acid binding; GO:0003676; ; GO:0003676; ribonuclease H1 activity; GO:0004524; ; GO:0004524; ; GO:0004524 rnh1 ribonuclease H1 "CG8729, l(2)k07624, l(2)43F1-5, 74/9, rnhl, RNase H1, RnH1, l(2)43Fa, l(2)k07409, RNaseH1, ribonuclease H1" CDMC24810 3 4 9 DAC14-C21 1-CG8729-RA_1 CG8729 TAAGCGGAACAAGATCCCACGTCATGCCTCTCAGGTCTCAGAAGCCACAGGACTCAAGCAAGTGG 65 FBan0008729 FBgn0023171 rnh1 2 2R RNA catabolism; GO:0006401 nucleic acid binding; GO:0003676; ; GO:0003676; ribonuclease H1 activity; GO:0004524; ; GO:0004524; ; GO:0004524 rnh1 ribonuclease H1 "CG8729, l(2)k07624, l(2)43F1-5, 74/9, rnhl, RNase H1, RnH1, l(2)43Fa, l(2)k07409, RNaseH1, ribonuclease H1" CDMC24811 3 5 9 DAC14-G09 2-CG8838-RA_4 CG8838 AAGAAGACCAGTGCCAATTCCTCCAAGACGGTCGTCATTCAGCCTCGCAAAAGGAAAGTAGCCGG 65 FBan0008838 FBgn0031526 CG8838 2 2L CG8838 CG8838 anon-WO0140519.135 CDMC24811 3 6 9 DAC14-G09 2-CG8838-RA_4 CG8838 AAGAAGACCAGTGCCAATTCCTCCAAGACGGTCGTCATTCAGCCTCGCAAAAGGAAAGTAGCCGG 65 FBan0008838 FBgn0031526 CG8838 2 2L CG8838 CG8838 anon-WO0140519.135 CDMC24812 3 7 9 DAC14-G21 3-CG8886-RB_1 CG8886 AGAAGGTGAAGCGACTGTACCACCAACGCTATCGCACAGAGTGGGAGAAATATCCGGAGCTCTCC 65 FBan0008886 FBgn0010607 l(2)05714 2 2L l(2)05714 lethal (2) 05714 "CG8886, l(2)05715" CDMC24812 3 8 9 DAC14-G21 3-CG8886-RB_1 CG8886 AGAAGGTGAAGCGACTGTACCACCAACGCTATCGCACAGAGTGGGAGAAATATCCGGAGCTCTCC 65 FBan0008886 FBgn0010607 l(2)05714 2 2L l(2)05714 lethal (2) 05714 "CG8886, l(2)05715" CDMC24813 3 9 9 DAC14-K09 23-CG8985-RA_1 CG8985 ACCTGGCAGTTATGCTGGAGTATATACCCTACACCATACACGACTACATCCTGACGGACAGTTTG 65 FBan0008985 FBgn0035331 DmsR-1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; negative regulation of muscle contraction; GO:0045932 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; myosuppressin receptor activity; GO:0035013; ; GO:0008188; ; GO:0004930; ; GO:0035013; ; GO:0035013 integral to membrane; GO:0016021 DmsR-1 Dromyosuppressin receptor 1 "CG8985, CG8985, CG8985, CG8985, CG8985, CG8985, DMSR-1, anon-WO0170980.106, anon-WO0170980.107, Dromyosuppressin receptor 1" CDMC24813 3 10 9 DAC14-K09 23-CG8985-RA_1 CG8985 ACCTGGCAGTTATGCTGGAGTATATACCCTACACCATACACGACTACATCCTGACGGACAGTTTG 65 FBan0008985 FBgn0035331 DmsR-1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; negative regulation of muscle contraction; GO:0045932 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; myosuppressin receptor activity; GO:0035013; ; GO:0008188; ; GO:0004930; ; GO:0035013; ; GO:0035013 integral to membrane; GO:0016021 DmsR-1 Dromyosuppressin receptor 1 "CG8985, CG8985, CG8985, CG8985, CG8985, CG8985, DMSR-1, anon-WO0170980.106, anon-WO0170980.107, Dromyosuppressin receptor 1" CDMC24814 3 11 9 DAC14-K21 2-CG9012-RD_1 CG9012 AACAAGGCAATCAACGAAGCCCTGAACGGACTCTTAATCGACGAGGAGGACTACCAGGGTCTGCG 65 FBan0009012 FBgn0000319 Chc X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; sperm individualization; GO:0007291; synaptic vesicle coating; GO:0016183 clathrin coat of coated pit; GO:0030132; clathrin coat of synaptic vesicle; GO:0030129; clathrin vesicle coat; GO:0030125; coated pit; GO:0005905; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 Chc Clathrin heavy chain "CG9012, CG9012, CG9012, CG9012, l(1)VI, chc, CLH, clathrin, l(1)G0438, D-Chc, CHC, clathrin heavy chain, Clathrin, l(1)13Fb" CDMC24814 3 12 9 DAC14-K21 2-CG9012-RD_1 CG9012 AACAAGGCAATCAACGAAGCCCTGAACGGACTCTTAATCGACGAGGAGGACTACCAGGGTCTGCG 65 FBan0009012 FBgn0000319 Chc X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; sperm individualization; GO:0007291; synaptic vesicle coating; GO:0016183 clathrin coat of coated pit; GO:0030132; clathrin coat of synaptic vesicle; GO:0030129; clathrin vesicle coat; GO:0030125; coated pit; GO:0005905; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 Chc Clathrin heavy chain "CG9012, CG9012, CG9012, CG9012, l(1)VI, chc, CLH, clathrin, l(1)G0438, D-Chc, CHC, clathrin heavy chain, Clathrin, l(1)13Fb" CDMC24815 3 13 9 DAC14-O09 3-CG9104-RA_1 CG9104 GCCACCATTGTTGAGGGCGATAACACTATATACCTGAAGATCGTCATGCACAAGCCGGACCCGCC 65 FBan0009104 FBgn0030800 CG9104 X X transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9104 CG9104 CDMC24815 3 14 9 DAC14-O09 3-CG9104-RA_1 CG9104 GCCACCATTGTTGAGGGCGATAACACTATATACCTGAAGATCGTCATGCACAAGCCGGACCCGCC 65 FBan0009104 FBgn0030800 CG9104 X X transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9104 CG9104 CDMC24816 3 15 9 DAC14-O21 23-CG9160-RA_1 CG9160 AAACGTTAAATTAACTTGTAGTCAGCAATTGTACACGAGGGCTATAATTAACTGCGGAATAGCAG 65 FBan0009160 FBgn0011361 mtacp1 3 3L "fatty acid biosynthesis; GO:0006633; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; cofactor binding; GO:0048037; ; GO:0048037; acyl carrier activity; GO:0000036; ; GO:0000036 mitochondrion; GO:0005739; respiratory chain complex I (sensu Eukaryota); GO:0005747 mtacp1 mitochondrial acyl carrier protein 1 "CG9160, ND-AcC, NADH-ubiquinone oxidoreductase acyl-carrier subunit, mtACP, l(3)j4A6, mitochondrial acyl carrier protein 1" CDMC24816 3 16 9 DAC14-O21 23-CG9160-RA_1 CG9160 AAACGTTAAATTAACTTGTAGTCAGCAATTGTACACGAGGGCTATAATTAACTGCGGAATAGCAG 65 FBan0009160 FBgn0011361 mtacp1 3 3L "fatty acid biosynthesis; GO:0006633; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; cofactor binding; GO:0048037; ; GO:0048037; acyl carrier activity; GO:0000036; ; GO:0000036 mitochondrion; GO:0005739; respiratory chain complex I (sensu Eukaryota); GO:0005747 mtacp1 mitochondrial acyl carrier protein 1 "CG9160, ND-AcC, NADH-ubiquinone oxidoreductase acyl-carrier subunit, mtACP, l(3)j4A6, mitochondrial acyl carrier protein 1" CDMC24817 3 17 9 DAC15-C09 2-CG8389-RA_1 CG8389 TGGGATGGGTGCGAGACTACGCCGACTCCTACCTAATCTGCCTTTATGCTCAAGGAGTCATTCTGCT 67 FBan0008389 FBgn0034063 CG8389 2 2R transport; GO:0006810 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8389 CG8389 CDMC24817 3 18 9 DAC15-C09 2-CG8389-RA_1 CG8389 TGGGATGGGTGCGAGACTACGCCGACTCCTACCTAATCTGCCTTTATGCTCAAGGAGTCATTCTGCT 67 FBan0008389 FBgn0034063 CG8389 2 2R transport; GO:0006810 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8389 CG8389 CDMC24818 3 19 9 DAC15-C21 2-CG8529-RA_1 CG8529 CCAACGCGAGCTAATTGCCCAACTGGAGTCCAAGAATAAGGAGATAATGCGGGAGATAGCGCGCCTG 67 FBan0008529 FBgn0033739 Dyb 2 2R cytoskeleton organization and biogenesis; GO:0007010; microtubule-based movement; GO:0007018; muscle contraction; GO:0006936; neuromuscular synaptic transmission; GO:0007274; nitric oxide mediated signal transduction; GO:0007263 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008307; ; GO:0008270 dystrobrevin complex; GO:0016014; dystrophin-associated glycoprotein complex; GO:0016010; microtubule; GO:0005874 Dyb Dystrobrevin-like "CG8529, CG8529, CG8529, CG8529, DmDYB, Dystrobrevin-like" CDMC24818 3 20 9 DAC15-C21 2-CG8529-RA_1 CG8529 CCAACGCGAGCTAATTGCCCAACTGGAGTCCAAGAATAAGGAGATAATGCGGGAGATAGCGCGCCTG 67 FBan0008529 FBgn0033739 Dyb 2 2R cytoskeleton organization and biogenesis; GO:0007010; microtubule-based movement; GO:0007018; muscle contraction; GO:0006936; neuromuscular synaptic transmission; GO:0007274; nitric oxide mediated signal transduction; GO:0007263 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008307; ; GO:0008270 dystrobrevin complex; GO:0016014; dystrophin-associated glycoprotein complex; GO:0016010; microtubule; GO:0005874 Dyb Dystrobrevin-like "CG8529, CG8529, CG8529, CG8529, DmDYB, Dystrobrevin-like" CDMC24819 3 21 9 DAC15-G09 23-CG9046-RA_1 CG9046 GCGAACTTTAAGGATCGAAACGAATCTGACTTGACATCTGAACCTAAGAATAAAGTAATGCTTTCAT 67 FBan0009046 FBgn0003980 Vm26Ab 2 2L egg activation; GO:0007343; eggshell formation (sensu Insecta); GO:0007304; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm26Ab Vitelline membrane 26Ab "CG9046, TU-4, Vm26A, Sv23, sV26, fs(2)QJ42, sV23, Dm sV23, VM26A.2, sv23" CDMC24819 3 22 9 DAC15-G09 23-CG9046-RA_1 CG9046 GCGAACTTTAAGGATCGAAACGAATCTGACTTGACATCTGAACCTAAGAATAAAGTAATGCTTTCAT 67 FBan0009046 FBgn0003980 Vm26Ab 2 2L egg activation; GO:0007343; eggshell formation (sensu Insecta); GO:0007304; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm26Ab Vitelline membrane 26Ab "CG9046, TU-4, Vm26A, Sv23, sV26, fs(2)QJ42, sV23, Dm sV23, VM26A.2, sv23" CDMC24820 3 23 9 DAC15-G21 23-CG9099-RA_1 CG9099 TTTGCAGTAGCCGACTTCTTAAAACTGTCATTATTTTAATATTTCAATAACCCGGAGCAAATCCCAG 67 FBan0009099 FBgn0030802 CG9099 X X CG9099 CG9099 CDMC24820 3 24 9 DAC15-G21 23-CG9099-RA_1 CG9099 TTTGCAGTAGCCGACTTCTTAAAACTGTCATTATTTTAATATTTCAATAACCCGGAGCAAATCCCAG 67 FBan0009099 FBgn0030802 CG9099 X X CG9099 CG9099 CDMC24821 3 25 9 DAC15-K09 3-CG9449-RA_4 CG9449 ATGGACGCACGCATACTTCCCGGAGAAGCTTCAGTTCCTCGCCGAACAGAGCTACATCTACAACGTG 67 FBan0009449 FBgn0036875 CG9449 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9449 CG9449 CDMC24821 3 26 9 DAC15-K09 3-CG9449-RA_4 CG9449 ATGGACGCACGCATACTTCCCGGAGAAGCTTCAGTTCCTCGCCGAACAGAGCTACATCTACAACGTG 67 FBan0009449 FBgn0036875 CG9449 3 3L phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG9449 CG9449 CDMC24822 3 1 10 DAC15-K21 16-CG9571-RA_1 CG9571 GCAATCAAAGCCCCTTCATATCCAGGAGCCATATCATCATACCCGCTACCATCTTCACCAAGAGTGA 67 FBan0009571 FBgn0031086 CG9571 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9571 CG9571 Dmcg9571 CDMC24822 3 2 10 DAC15-K21 16-CG9571-RA_1 CG9571 GCAATCAAAGCCCCTTCATATCCAGGAGCCATATCATCATACCCGCTACCATCTTCACCAAGAGTGA 67 FBan0009571 FBgn0031086 CG9571 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9571 CG9571 Dmcg9571 CDMC24823 3 3 10 DAC15-O09 2-CG9981-RA_1 CG9981 ACCTTTGGCACCATGCTCATCACCATTATCGTGATTGTGGGCAACCTGAAATTGCTGCTAGTGGCCC 67 FBan0009981 FBgn0030746 CG9981 X X cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG9981 CG9981 CDMC24823 3 4 10 DAC15-O09 2-CG9981-RA_1 CG9981 ACCTTTGGCACCATGCTCATCACCATTATCGTGATTGTGGGCAACCTGAAATTGCTGCTAGTGGCCC 67 FBan0009981 FBgn0030746 CG9981 X X cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG9981 CG9981 CDMC24824 3 5 10 DAC15-O21 AutoBlank AutoBlank CDMC24824 3 6 10 DAC15-O21 AutoBlank AutoBlank CDMC24825 3 7 10 DAC16-C09 22-CG4898-RC_1 CG4898 CACGACGATTACGAATGATGCTTGAGGGCAGTTAGAGCTTAGATCTAGACCTAGATCATGCACAGCCCG 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC24825 3 8 10 DAC16-C09 22-CG4898-RC_1 CG4898 CACGACGATTACGAATGATGCTTGAGGGCAGTTAGAGCTTAGATCTAGACCTAGATCATGCACAGCCCG 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC24826 3 9 10 DAC16-C21 6-CG4903-RA_1 CG4903 GCCGCCCACTCCTATACTGTCGCATCCAGAATCTTCTCTGTTTCCTGTAACGCCACTTACTCATCGCCA 69 FBan0004903 FBgn0034240 MESR4 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 MESR4 Misexpression suppressor of ras 4 "CG4903, CG4903, EP0386, EP(2)0988, EP988, EP0988, Misexpression suppressor of ras 4" CDMC24826 3 10 10 DAC16-C21 6-CG4903-RA_1 CG4903 GCCGCCCACTCCTATACTGTCGCATCCAGAATCTTCTCTGTTTCCTGTAACGCCACTTACTCATCGCCA 69 FBan0004903 FBgn0034240 MESR4 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 MESR4 Misexpression suppressor of ras 4 "CG4903, CG4903, EP0386, EP(2)0988, EP988, EP0988, Misexpression suppressor of ras 4" CDMC24827 3 11 10 DAC16-G09 3-CG4940-RA_2 CG4940 ATTCCATCACCGATCTTCGGGATAATGCCTCCATGCAGAGTTTCGTCTCAACAGCGTCAACTCAGCCGG 69 FBan0004940 FBgn0038036 CG4940 3 3R CG4940 CG4940 CDMC24827 3 12 10 DAC16-G09 3-CG4940-RA_2 CG4940 ATTCCATCACCGATCTTCGGGATAATGCCTCCATGCAGAGTTTCGTCTCAACAGCGTCAACTCAGCCGG 69 FBan0004940 FBgn0038036 CG4940 3 3R CG4940 CG4940 CDMC24828 3 13 10 DAC16-G21 3-CG4947-RA_1 CG4947 CCGGAGCACTCCATCGAAATCCAGAACGCCATTGGTGGGGATATTATGATGCAGCTGGATGATGTGGTC 69 FBan0004947 FBgn0031321 Tgt 2 2L queuosine biosynthesis; GO:0008616 queuine tRNA-ribosyltransferase activity; GO:0008479 ; EC:2.4.2.29; ; GO:0008479 ; EC:2.4.2.29 Tgt tRNA-guanine transglycosylase "CG4947, TGT, tRNA-guanine transglycosylase" CDMC24828 3 14 10 DAC16-G21 3-CG4947-RA_1 CG4947 CCGGAGCACTCCATCGAAATCCAGAACGCCATTGGTGGGGATATTATGATGCAGCTGGATGATGTGGTC 69 FBan0004947 FBgn0031321 Tgt 2 2L queuosine biosynthesis; GO:0008616 queuine tRNA-ribosyltransferase activity; GO:0008479 ; EC:2.4.2.29; ; GO:0008479 ; EC:2.4.2.29 Tgt tRNA-guanine transglycosylase "CG4947, TGT, tRNA-guanine transglycosylase" CDMC24829 3 15 10 DAC16-K09 2-CG4977-RA_1 CG4977 CGCAAAGAAATCCCAGGCCTAGAAGACTACTAGACATGTGGGGGGGTTCCTATGTGGGCTATGTGTGCT 69 FBan0004977 FBgn0015400 kek2 2 2L defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004675 ; EC:2.7.1.- plasma membrane; GO:0005886 kek2 kekkon-2 "CG4977, Kek2, NB7, CT15962, kekkon, Kekkon-2" CDMC24829 3 16 10 DAC16-K09 2-CG4977-RA_1 CG4977 CGCAAAGAAATCCCAGGCCTAGAAGACTACTAGACATGTGGGGGGGTTCCTATGTGGGCTATGTGTGCT 69 FBan0004977 FBgn0015400 kek2 2 2L defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004675 ; EC:2.7.1.- plasma membrane; GO:0005886 kek2 kekkon-2 "CG4977, Kek2, NB7, CT15962, kekkon, Kekkon-2" CDMC24830 3 17 10 DAC16-K21 12-CG4989-RA_1 CG4989 TCCTCTGTACGATCCCAGCCAGATATCTGCCTTTCAGTGTGATATCACAACGCAACAGGTGCATGACCA 69 FBan0004989 FBgn0034268 CG4989 2 2R CG4989 CG4989 CDMC24830 3 18 10 DAC16-K21 12-CG4989-RA_1 CG4989 TCCTCTGTACGATCCCAGCCAGATATCTGCCTTTCAGTGTGATATCACAACGCAACAGGTGCATGACCA 69 FBan0004989 FBgn0034268 CG4989 2 2R CG4989 CG4989 CDMC24831 3 19 10 DAC16-O09 15-CG5021-RA_1 CG5021 AATGCCGCCAATCTGTATGGCTACGTCAAGTGTAACTATGGTGCCAATAAGGATCTGAATTCCGCCGCC 69 FBan0005021 FBgn0035944 CG5021 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG5021 CG5021 CDMC24831 3 20 10 DAC16-O09 15-CG5021-RA_1 CG5021 AATGCCGCCAATCTGTATGGCTACGTCAAGTGTAACTATGGTGCCAATAAGGATCTGAATTCCGCCGCC 69 FBan0005021 FBgn0035944 CG5021 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG5021 CG5021 CDMC24832 3 21 10 DAC16-O21 3-CG5030-RA_4 CG5030 GGGTGCAGCCTGTATTAATTACCTAATGACCTCGCCTACAATGGTCCGTGGTCTCTTCCACCGGGCTAT 69 FBan0005030 FBgn0038776 CG5030 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG5030 CG5030 CDMC24832 3 22 10 DAC16-O21 3-CG5030-RA_4 CG5030 GGGTGCAGCCTGTATTAATTACCTAATGACCTCGCCTACAATGGTCCGTGGTCTCTTCCACCGGGCTAT 69 FBan0005030 FBgn0038776 CG5030 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG5030 CG5030 CDMC24833 3 23 10 DAC17-C09 2-CG7107-RA_1 CG7107 TGGGATGAGATCTCCAAGGACTCGAACGAGAAGATCTGGAACGAGAAGAAGGAGCAATACACCGGCCGT 69 FBan0007107 FBgn0004169 up X X mesoderm development; GO:0007498 tropomyosin binding; GO:0005523; ; GO:0005523; ; GO:0005523 troponin complex; GO:0005861 up upheld "CG7107, CG7107, int: indented thorax, dro TnT, wupB, troponin-T, Troponin T, indented thorax, TnT, troponin T, upheld2, FBgn0004169, TpnT, BcDNA:LD08591, int" CDMC24833 3 24 10 DAC17-C09 2-CG7107-RA_1 CG7107 TGGGATGAGATCTCCAAGGACTCGAACGAGAAGATCTGGAACGAGAAGAAGGAGCAATACACCGGCCGT 69 FBan0007107 FBgn0004169 up X X mesoderm development; GO:0007498 tropomyosin binding; GO:0005523; ; GO:0005523; ; GO:0005523 troponin complex; GO:0005861 up upheld "CG7107, CG7107, int: indented thorax, dro TnT, wupB, troponin-T, Troponin T, indented thorax, TnT, troponin T, upheld2, FBgn0004169, TpnT, BcDNA:LD08591, int" CDMC24834 3 25 10 DAC17-C21 1-CG7122-RA_4 CG7122 CGCTTACGTCTCATCCAAACCGCTCACCTACTGTGCCGTTGTGTCGAACGCTTTGCTAACCACTCGAAA 69 FBan0007122 FBgn0030893 RhoGAP16F X X GTPase activator activity; GO:0005096; ; GO:0005096 RhoGAP16F RhoGAP16F "CG7122, CG7122" CDMC24834 3 26 10 DAC17-C21 1-CG7122-RA_4 CG7122 CGCTTACGTCTCATCCAAACCGCTCACCTACTGTGCCGTTGTGTCGAACGCTTTGCTAACCACTCGAAA 69 FBan0007122 FBgn0030893 RhoGAP16F X X GTPase activator activity; GO:0005096; ; GO:0005096 RhoGAP16F RhoGAP16F "CG7122, CG7122" CDMC24835 3 1 11 DAC17-G09 3-CG7162-RA_1 CG7162 GCCGCAAGCATGGAAGGCTTCATCAAGGGGCTCCACAACAAATTCCAGATCCCAAAGTTATCGCAGAGA 69 FBan0007162 FBgn0037109 MED1 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED1 Mediator complex subunit 1 "CG7162, Trap220, dTRAP220, Mediator, Med1/SOP3/TRAP220, Med1, Mediator complex subunit 1" CDMC24835 3 2 11 DAC17-G09 3-CG7162-RA_1 CG7162 GCCGCAAGCATGGAAGGCTTCATCAAGGGGCTCCACAACAAATTCCAGATCCCAAAGTTATCGCAGAGA 69 FBan0007162 FBgn0037109 MED1 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED1 Mediator complex subunit 1 "CG7162, Trap220, dTRAP220, Mediator, Med1/SOP3/TRAP220, Med1, Mediator complex subunit 1" CDMC24836 3 3 11 DAC17-G21 2-CG7172-RA_1 CG7172 GGCCCAGAGCAATGTGAATCCCAAGATTTGCTTCGATTCCCACGGAGAGAAAGACAGCAGGCAGGTTAT 69 FBan0007172 FBgn0037102 CG7172 3 3L CG7172 CG7172 anon-WO0118547.316 CDMC24836 3 4 11 DAC17-G21 2-CG7172-RA_1 CG7172 GGCCCAGAGCAATGTGAATCCCAAGATTTGCTTCGATTCCCACGGAGAGAAAGACAGCAGGCAGGTTAT 69 FBan0007172 FBgn0037102 CG7172 3 3L CG7172 CG7172 anon-WO0118547.316 CDMC24837 3 5 11 DAC17-K09 22-CG7203-RA_1 CG7203 AGGTCTGTCCTCTGCTGAGATCCCGTTGGGTTCTCATTTCTTCAGCAATCTAAGTCAATCCTATCCAGT 69 FBan0007203 FBgn0031942 CG7203 2 2L CG7203 CG7203 CDMC24837 3 6 11 DAC17-K09 22-CG7203-RA_1 CG7203 AGGTCTGTCCTCTGCTGAGATCCCGTTGGGTTCTCATTTCTTCAGCAATCTAAGTCAATCCTATCCAGT 69 FBan0007203 FBgn0031942 CG7203 2 2L CG7203 CG7203 CDMC24838 3 7 11 DAC17-K21 2-CG7221-RA_1 CG7221 GCCGGAGAAATACTGGAGCATGATGGCCTACAACAATGCCAAGCTATGCAATGTCTTGTTCGCCCAGGA 69 FBan0007221 FBgn0031972 CG7221 2 2L apoptosis; GO:0006915; metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7221 CG7221 anon-EST:Posey177 CDMC24838 3 8 11 DAC17-K21 2-CG7221-RA_1 CG7221 GCCGGAGAAATACTGGAGCATGATGGCCTACAACAATGCCAAGCTATGCAATGTCTTGTTCGCCCAGGA 69 FBan0007221 FBgn0031972 CG7221 2 2L apoptosis; GO:0006915; metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7221 CG7221 anon-EST:Posey177 CDMC24839 3 9 11 DAC17-O09 2-CG7264-RA_1 CG7264 ACGCCCGAAGAACTTCGCGTGTTTCGTCTTGGACAAGATCAGCAGCTTCGTTTGTCTATTCAGCGCAAG 69 FBan0007264 FBgn0036214 CG7264 3 3L CG7264 CG7264 CDMC24839 3 10 11 DAC17-O09 2-CG7264-RA_1 CG7264 ACGCCCGAAGAACTTCGCGTGTTTCGTCTTGGACAAGATCAGCAGCTTCGTTTGTCTATTCAGCGCAAG 69 FBan0007264 FBgn0036214 CG7264 3 3L CG7264 CG7264 CDMC24840 3 11 11 DAC17-O21 14-CG7276-RA_1 CG7276 AGCCGGCATCTGATGTCACCATCTATAACTACTACAACATGGGACCAGCATTCGGCAAGAAGTTCCCAT 69 FBan0007276 FBgn0036499 CG7276 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG7276 CG7276 CDMC24840 3 12 11 DAC17-O21 14-CG7276-RA_1 CG7276 AGCCGGCATCTGATGTCACCATCTATAACTACTACAACATGGGACCAGCATTCGGCAAGAAGTTCCCAT 69 FBan0007276 FBgn0036499 CG7276 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG7276 CG7276 CDMC24841 3 13 11 DAC18-C09 8-CG32410-RA_1 CG32410 CGAGTTGAACCAGGAGTATTTGAAGGAGGGATCCGTGTTTGTGCACAACACTGATGTGGATGGCAAGCC 69 FBgn0052410 CDMC24841 3 14 11 DAC18-C09 8-CG32410-RA_1 CG32410 CGAGTTGAACCAGGAGTATTTGAAGGAGGGATCCGTGTTTGTGCACAACACTGATGTGGATGGCAAGCC 69 FBgn0052410 CDMC24842 3 15 11 DAC18-C21 17-CG32428-RA_1 CG32428 TAACCCAAAACATGTACTGTAGCTGAGAAAAGCGCACAAGAAACACATGCAACAGTTCACCGAGCGACG 69 FBan0032428 FBgn0052428 CG32428 3 3L CG32428 CG32428 "CG13249, CG5145" CDMC24842 3 16 11 DAC18-C21 17-CG32428-RA_1 CG32428 TAACCCAAAACATGTACTGTAGCTGAGAAAAGCGCACAAGAAACACATGCAACAGTTCACCGAGCGACG 69 FBan0032428 FBgn0052428 CG32428 3 3L CG32428 CG32428 "CG13249, CG5145" CDMC24843 3 17 11 DAC18-G09 13-CG32457-RA_1 CG32457 AGCGAATCGAAACAAGGATCATAGTCCCCATGATCCCCACAAAAACCTGAAAAGAAAGGCAGAGGCACT 69 FBan0032457 FBgn0052457 CG32457 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32457 CG32457 CDMC24843 3 18 11 DAC18-G09 13-CG32457-RA_1 CG32457 AGCGAATCGAAACAAGGATCATAGTCCCCATGATCCCCACAAAAACCTGAAAAGAAAGGCAGAGGCACT 69 FBan0032457 FBgn0052457 CG32457 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32457 CG32457 CDMC24844 3 19 11 DAC18-G21 9-CG32467-RA_1 CG32467 AACCGTCGGACATGAGGAGCAGAAACCCATCATCGAAGAGAACCCAACGCCGAATGTTAGTATGGGAAT 69 FBan0032467 FBgn0052467 CG32467 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32467 CG32467 CG14601 CDMC24844 3 20 11 DAC18-G21 9-CG32467-RA_1 CG32467 AACCGTCGGACATGAGGAGCAGAAACCCATCATCGAAGAGAACCCAACGCCGAATGTTAGTATGGGAAT 69 FBan0032467 FBgn0052467 CG32467 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32467 CG32467 CG14601 CDMC24845 3 21 11 DAC18-K09 5-CG32491-RM_1 CG32491 GGCCTGCGGAGTTCAGTCTTGCTGCTCATAGACGTCCGAGGCTAATCATTGCCAACAAGCACTTTATCG 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24845 3 22 11 DAC18-K09 5-CG32491-RM_1 CG32491 GGCCTGCGGAGTTCAGTCTTGCTGCTCATAGACGTCCGAGGCTAATCATTGCCAACAAGCACTTTATCG 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24846 3 23 11 DAC18-K21 3-CG32491-RX_8 CG32491 GCCCTTCTTCCGCAAGATGTTCACTCAGATGCCGTCGAACACCCACGCTATCGTATTCCTGAACAACGT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24846 3 24 11 DAC18-K21 3-CG32491-RX_8 CG32491 GCCCTTCTTCCGCAAGATGTTCACTCAGATGCCGTCGAACACCCACGCTATCGTATTCCTGAACAACGT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC24847 3 25 11 DAC18-O09 18-CG32532-RA_6 CG32532 TGCTGCAGTACCAGACATAATCAAAGACCTTTGACGACTTCTTTTAAAAGATCGCGCCCTAATGGCCCT 69 FBan0032532 FBgn0052532 CG32532 X X "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG32532 CG32532 "CG14203, CG14201, CG14202, CG14203" CDMC24847 3 26 11 DAC18-O09 18-CG32532-RA_6 CG32532 TGCTGCAGTACCAGACATAATCAAAGACCTTTGACGACTTCTTTTAAAAGATCGCGCCCTAATGGCCCT 69 FBan0032532 FBgn0052532 CG32532 X X "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG32532 CG32532 "CG14203, CG14201, CG14202, CG14203" CDMC24848 3 1 12 DAC18-O21 23-CG32553-RA_4 CG32553 CTCTGCCACTTAGCTGTTAAACTGTGTTTATTGTCTCGCCTGCAAGTTGTCGGTAGAAATTGAAGAGCA 69 FBan0032553 FBgn0052553 CG32553 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32553 CG32553 CDMC24848 3 2 12 DAC18-O21 23-CG32553-RA_4 CG32553 CTCTGCCACTTAGCTGTTAAACTGTGTTTATTGTCTCGCCTGCAAGTTGTCGGTAGAAATTGAAGAGCA 69 FBan0032553 FBgn0052553 CG32553 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32553 CG32553 CDMC24849 3 3 12 DAC19-C09 15-CG8200-RB_2 CG8200 CCAGCGCGACTTTGAGCTGAAGAAGGCAGCATACGATGTGGAAGTGCAGACCAAAAAGGCCGAGG 65 FBan0008200 FBgn0024754 Flo 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399 structural molecule activity; GO:0005198; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005198 flotillin complex; GO:0016600; integral to membrane; GO:0016021 Flo flotillin "CG8200, FLO[Dm], CK02126, flotillin-1, reggie-2, Flo[Dm], Flotillin-1, FLO1, flotillin" CDMC24849 3 4 12 DAC19-C09 15-CG8200-RB_2 CG8200 CCAGCGCGACTTTGAGCTGAAGAAGGCAGCATACGATGTGGAAGTGCAGACCAAAAAGGCCGAGG 65 FBan0008200 FBgn0024754 Flo 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399 structural molecule activity; GO:0005198; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005198 flotillin complex; GO:0016600; integral to membrane; GO:0016021 Flo flotillin "CG8200, FLO[Dm], CK02126, flotillin-1, reggie-2, Flo[Dm], Flotillin-1, FLO1, flotillin" CDMC24850 3 5 12 DAC19-C21 2-CG8229-RA_2 CG8229 AACACGGGAATGAACGGCTTGTTTCTAGACGCCATTAAACGCCATTCCACAGAAGCCAAACCCGC 65 FBan0008229 FBgn0033356 CG8229 2 2R CG8229 CG8229 CDMC24850 3 6 12 DAC19-C21 2-CG8229-RA_2 CG8229 AACACGGGAATGAACGGCTTGTTTCTAGACGCCATTAAACGCCATTCCACAGAAGCCAAACCCGC 65 FBan0008229 FBgn0033356 CG8229 2 2R CG8229 CG8229 CDMC24851 3 7 12 DAC19-G09 3-CG8295-RA_3 CG8295 ATGCAGATGCGCTCGATGAATCGCCTGATGAACAGCTTTATGCCCGATCCCTTCATGCAGGTCTC 65 FBan0008295 FBgn0034051 Mlf 2 2R cytoplasm; GO:0005737 Mlf Myelodysplasia/myeloid leukemia factor "CG8295, dMLF, dmlf, BcDNA:SD18148, Myelodysplasia/myeloid leukemia factor" CDMC24851 3 8 12 DAC19-G09 3-CG8295-RA_3 CG8295 ATGCAGATGCGCTCGATGAATCGCCTGATGAACAGCTTTATGCCCGATCCCTTCATGCAGGTCTC 65 FBan0008295 FBgn0034051 Mlf 2 2R cytoplasm; GO:0005737 Mlf Myelodysplasia/myeloid leukemia factor "CG8295, dMLF, dmlf, BcDNA:SD18148, Myelodysplasia/myeloid leukemia factor" CDMC24852 3 9 12 DAC19-G21 2-CG8329-RA_1 CG8329 GGAGCACTGGTCACTCACGACAATCCCATTCAAGTGGGCGTTATCACCTTTGCATCCATCGGCTG 65 FBan0008329 FBgn0036022 CG8329 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG8329 CG8329 SP170 CDMC24852 3 10 12 DAC19-G21 2-CG8329-RA_1 CG8329 GGAGCACTGGTCACTCACGACAATCCCATTCAAGTGGGCGTTATCACCTTTGCATCCATCGGCTG 65 FBan0008329 FBgn0036022 CG8329 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG8329 CG8329 SP170 CDMC24853 3 11 12 DAC19-K09 3-CG8403-RA_3 CG8403 ACACCATGAGCCAGGTGATCAGCTACAGCATCGATCTCAATCTGCGCATCAAGACGCACTCGGAG 65 FBan0008403 FBgn0034070 SP2353 2 2R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 SP2353 SP2353 "CG8403, CT18665, agrin-like, BcDNA:GH12319" CDMC24853 3 12 12 DAC19-K09 3-CG8403-RA_3 CG8403 ACACCATGAGCCAGGTGATCAGCTACAGCATCGATCTCAATCTGCGCATCAAGACGCACTCGGAG 65 FBan0008403 FBgn0034070 SP2353 2 2R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 SP2353 SP2353 "CG8403, CT18665, agrin-like, BcDNA:GH12319" CDMC24854 3 13 12 DAC19-K21 3-CG8430-RA_3 CG8430 ACTTTGGCCTCTACTGCGAACGTACCGGCAATCTGGCTGTGGTGCAAAAGAATGGTGCTACCAAG 65 FBgn0034079 CDMC24854 3 14 12 DAC19-K21 3-CG8430-RA_3 CG8430 ACTTTGGCCTCTACTGCGAACGTACCGGCAATCTGGCTGTGGTGCAAAAGAATGGTGCTACCAAG 65 FBgn0034079 CDMC24855 3 15 12 DAC19-O09 2-CG8527-RA_1 CG8527 TCTGGGAGAAGTTCCAGACCAATCCGACAATCACTGGCCTCGACACCGACTTCCACAACCAGAAC 65 FBan0008527 FBgn0030844 ppk23 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk23 pickpocket 23 "CG8527, CG8527, PPK23" CDMC24855 3 16 12 DAC19-O09 2-CG8527-RA_1 CG8527 TCTGGGAGAAGTTCCAGACCAATCCGACAATCACTGGCCTCGACACCGACTTCCACAACCAGAAC 65 FBan0008527 FBgn0030844 ppk23 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk23 pickpocket 23 "CG8527, CG8527, PPK23" CDMC24856 3 17 12 DAC19-O21 1-CG8577-RA_1 CG8577 CACTCACATCTGGAACGAGATCCGCGGCTGGTCCCACTGGTCTGGTTAGAGTGGTTCCTGAAAAG 65 FBan0008577 FBgn0033327 PGRP-SC1b 2 2R defense response; GO:0006952; detection of bacteria; GO:0016045; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; protein binding; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0042834; ; GO:0042834; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SC1b PGRP-SC1b "CG8577, CG8577, SC1B, PGRP-SC, CT8705, PGRP-SC1B" CDMC24856 3 18 12 DAC19-O21 1-CG8577-RA_1 CG8577 CACTCACATCTGGAACGAGATCCGCGGCTGGTCCCACTGGTCTGGTTAGAGTGGTTCCTGAAAAG 65 FBan0008577 FBgn0033327 PGRP-SC1b 2 2R defense response; GO:0006952; detection of bacteria; GO:0016045; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; protein binding; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0042834; ; GO:0042834; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SC1b PGRP-SC1b "CG8577, CG8577, SC1B, PGRP-SC, CT8705, PGRP-SC1B" CDMC24857 3 19 12 DAC20-C09 16-CG7676-RA_1 CG7676 GCCGAGAAGTACACCACTTTGAACGACTTAACCCATGTCACCAATTCCCAGAATCTTGTGGACGACATC 69 FBan0007676 FBgn0038612 CG7676 3 3R CG7676 CG7676 CDMC24857 3 20 12 DAC20-C09 16-CG7676-RA_1 CG7676 GCCGAGAAGTACACCACTTTGAACGACTTAACCCATGTCACCAATTCCCAGAATCTTGTGGACGACATC 69 FBan0007676 FBgn0038612 CG7676 3 3R CG7676 CG7676 CDMC24858 3 21 12 DAC20-C21 23-CG7697-RA_3 CG7697 ACCCAGCGCTGAAACTACTCTGGCTGAAACAAATGAAAAATCACCATTTCGCTCATGCATACTATAGTA 69 FBan0007697 FBgn0027841 CstF-64 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 mRNA binding; GO:0003729; ; GO:0003729 mRNA cleavage stimulating factor complex; GO:0005848 CstF-64 Cleavage stimulation factor 64 kilodalton subunit "CG7697, CG7697, CG7697, CStF 64" CDMC24858 3 22 12 DAC20-C21 23-CG7697-RA_3 CG7697 ACCCAGCGCTGAAACTACTCTGGCTGAAACAAATGAAAAATCACCATTTCGCTCATGCATACTATAGTA 69 FBan0007697 FBgn0027841 CstF-64 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 mRNA binding; GO:0003729; ; GO:0003729 mRNA cleavage stimulating factor complex; GO:0005848 CstF-64 Cleavage stimulation factor 64 kilodalton subunit "CG7697, CG7697, CG7697, CStF 64" CDMC24859 3 23 12 DAC20-G09 3-CG7737-RA_1 CG7737 ACGACTGGCCCAGTTTTACGGAATAAGCGTGTCCCGTTCTGGAACCAAATCGCAACTCTAGCTGTAGGC 69 FBan0007737 FBgn0033584 CG7737 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7737 CG7737 CDMC24859 3 24 12 DAC20-G09 3-CG7737-RA_1 CG7737 ACGACTGGCCCAGTTTTACGGAATAAGCGTGTCCCGTTCTGGAACCAAATCGCAACTCTAGCTGTAGGC 69 FBan0007737 FBgn0033584 CG7737 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7737 CG7737 CDMC24860 3 25 12 DAC20-G21 14-CG7748-RA_1 CG7748 TCGCCGCCTCAAATTCAACTTTCACATACTTCCCGACTCGTGCGACACAATTTTATCGAGTTGCTGCTT 69 FBan0007748 FBgn0011336 OstStt3 3 3R protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- oligosaccharyl transferase complex; GO:0008250 OstStt3 Oligosaccharyl transferase 3 "CG7748, CG7748, l(3)j2D9, BcDNA.GM01838, BcDNA:GM01838, anon-WO03054008.7, Oligosaccharyl transferase 3" CDMC24860 3 26 12 DAC20-G21 14-CG7748-RA_1 CG7748 TCGCCGCCTCAAATTCAACTTTCACATACTTCCCGACTCGTGCGACACAATTTTATCGAGTTGCTGCTT 69 FBan0007748 FBgn0011336 OstStt3 3 3R protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- oligosaccharyl transferase complex; GO:0008250 OstStt3 Oligosaccharyl transferase 3 "CG7748, CG7748, l(3)j2D9, BcDNA.GM01838, BcDNA:GM01838, anon-WO03054008.7, Oligosaccharyl transferase 3" CDMC24861 3 1 13 DAC20-K09 23-CG7778-RA_3 CG7778 AGCGCGAAAAACCAAACGCAAACGGTCCAATTAAACTAGCATAAATACTATACACTAAACAATTATCTA 69 FBan0007778 FBgn0032025 CG7778 2 2L CG7778 CG7778 CDMC24861 3 2 13 DAC20-K09 23-CG7778-RA_3 CG7778 AGCGCGAAAAACCAAACGCAAACGGTCCAATTAAACTAGCATAAATACTATACACTAAACAATTATCTA 69 FBan0007778 FBgn0032025 CG7778 2 2L CG7778 CG7778 CDMC24862 3 3 13 DAC20-K21 23-CG7788-RA_1 CG7788 CGGCCCACCCTTATCTATATCTACCTTAGACCATTTACAGACAAGACCTTTTTACAATTTTATACACAT 69 FBan0007788 FBgn0019972 Ice 3 3R apoptosis; GO:0006915; proteolysis; GO:0006508; regulation of retinal programmed cell death; GO:0046668 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 caspase complex; GO:0008303 Ice Ice "CG7788, CG7788, CG7788, drICE, DrICE, Drice, ice, DrIce, drice, DRICE, ICE" CDMC24862 3 4 13 DAC20-K21 23-CG7788-RA_1 CG7788 CGGCCCACCCTTATCTATATCTACCTTAGACCATTTACAGACAAGACCTTTTTACAATTTTATACACAT 69 FBan0007788 FBgn0019972 Ice 3 3R apoptosis; GO:0006915; proteolysis; GO:0006508; regulation of retinal programmed cell death; GO:0046668 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 caspase complex; GO:0008303 Ice Ice "CG7788, CG7788, CG7788, drICE, DrICE, Drice, ice, DrIce, drice, DRICE, ICE" CDMC24863 3 5 13 DAC20-O09 22-CG7825-RA_1 CG7825 ATTTGTCTGTGATGGGCTTAAACGTTGCCATACGAGGAGTTATGATGTCCAATACGTGCCCTGTCAGCG 69 FBan0007825 FBgn0025808 Rad17 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Rad17 Rad17 "CG7825, CG7825" CDMC24863 3 6 13 DAC20-O09 22-CG7825-RA_1 CG7825 ATTTGTCTGTGATGGGCTTAAACGTTGCCATACGAGGAGTTATGATGTCCAATACGTGCCCTGTCAGCG 69 FBan0007825 FBgn0025808 Rad17 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Rad17 Rad17 "CG7825, CG7825" CDMC24864 3 7 13 DAC20-O21 14-CG7832-RA_1 CG7832 CAGCAGCAATCGACTTTGGACCCCAGCTTACTTTCTTTGGACATTGCGAATATCAAGGCCGAGGAGATT 69 FBan0007832 FBgn0026578 CG7832 3 3R CG7832 CG7832 "LD14744, BEST:LD14744" CDMC24864 3 8 13 DAC20-O21 14-CG7832-RA_1 CG7832 CAGCAGCAATCGACTTTGGACCCCAGCTTACTTTCTTTGGACATTGCGAATATCAAGGCCGAGGAGATT 69 FBan0007832 FBgn0026578 CG7832 3 3R CG7832 CG7832 "LD14744, BEST:LD14744" CDMC24865 3 9 13 DAC21-C09 11-CG2647-RA_1 CG2647 ACGCTTCCGTGGGATGTCACCATTCAGTATCCGAACAAGTAACGAAAGCATCAGACGAACTGACGTGGA 69 FBan0002647 FBgn0003068 per X X "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; circadian sleep/wake cycle; GO:0042745; copulation; GO:0007620; courtship behavior; GO:0007619; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; long-term memory; GO:0007616; male courtship behavior (sensu Insecta), song production; GO:0045433; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of circadian sleep/wake cycle, sleep; GO:0045187; response to light stimulus; GO:0009416; response to temperature stimulus; GO:0009266; rhythmic behavior; GO:0007622; signal transduction; GO:0007165; ultradian rhythm; GO:0007624" transcription cofactor activity; GO:0003712; transcription corepressor activity; GO:0003714; protein heterodimerization activity; GO:0046982; ; GO:0046982; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003714; ; GO:0003712; ; GO:0004871 cytoplasm; GO:0005737; nucleus; GO:0005634 per period "CG2647, CG2647, CG2647, Clk, Per, dPER, dperiod, PER, EG:155E2.4, PERIOD, dper, period clock protein, clk-6: clock-6, Clock, clock-6, period" CDMC24865 3 10 13 DAC21-C09 11-CG2647-RA_1 CG2647 ACGCTTCCGTGGGATGTCACCATTCAGTATCCGAACAAGTAACGAAAGCATCAGACGAACTGACGTGGA 69 FBan0002647 FBgn0003068 per X X "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; circadian sleep/wake cycle; GO:0042745; copulation; GO:0007620; courtship behavior; GO:0007619; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; long-term memory; GO:0007616; male courtship behavior (sensu Insecta), song production; GO:0045433; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of circadian sleep/wake cycle, sleep; GO:0045187; response to light stimulus; GO:0009416; response to temperature stimulus; GO:0009266; rhythmic behavior; GO:0007622; signal transduction; GO:0007165; ultradian rhythm; GO:0007624" transcription cofactor activity; GO:0003712; transcription corepressor activity; GO:0003714; protein heterodimerization activity; GO:0046982; ; GO:0046982; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003714; ; GO:0003712; ; GO:0004871 cytoplasm; GO:0005737; nucleus; GO:0005634 per period "CG2647, CG2647, CG2647, Clk, Per, dPER, dperiod, PER, EG:155E2.4, PERIOD, dper, period clock protein, clk-6: clock-6, Clock, clock-6, period" CDMC24866 3 11 13 DAC21-C21 7-CG2662-RA_1 CG2662 TCCTTACGCCTAACGCCAATCACAGCTGTAGAGAGAAGAAGCCATCCAGTATCAACCTGGTCCGTGGAA 69 FBan0002662 FBgn0024993 CG2662 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG2662 CG2662 EG:100G10.6 CDMC24866 3 12 13 DAC21-C21 7-CG2662-RA_1 CG2662 TCCTTACGCCTAACGCCAATCACAGCTGTAGAGAGAAGAAGCCATCCAGTATCAACCTGGTCCGTGGAA 69 FBan0002662 FBgn0024993 CG2662 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG2662 CG2662 EG:100G10.6 CDMC24867 3 13 13 DAC21-G09 16-CG2701-RA_1 CG2701 AGCATTGCCAATTTCTATGACATGACTGTGCCCATGTTGTACAAGAACATCTACTTGGTGAACCCGGGT 69 FBan0002701 FBgn0024973 CG2701 X X CG2701 CG2701 "II, Coding Region II, transcript II, EG:95B7.9, anon-3Bd" CDMC24867 3 14 13 DAC21-G09 16-CG2701-RA_1 CG2701 AGCATTGCCAATTTCTATGACATGACTGTGCCCATGTTGTACAAGAACATCTACTTGGTGAACCCGGGT 69 FBan0002701 FBgn0024973 CG2701 X X CG2701 CG2701 "II, Coding Region II, transcript II, EG:95B7.9, anon-3Bd" CDMC24868 3 15 13 DAC21-G21 18-CG2713-RA_1 CG2713 CAGCACACTGGCCATATTTTTCGTCGACTTTTGGAGTAGTTAGTGGGAAGCAGTAGCAGACAGCAGACA 69 FBan0002713 FBgn0024978 CG2713 X X CG2713 CG2713 "EG:95B7.3, i238, i90" CDMC24868 3 16 13 DAC21-G21 18-CG2713-RA_1 CG2713 CAGCACACTGGCCATATTTTTCGTCGACTTTTGGAGTAGTTAGTGGGAAGCAGTAGCAGACAGCAGACA 69 FBan0002713 FBgn0024978 CG2713 X X CG2713 CG2713 "EG:95B7.3, i238, i90" CDMC24869 3 17 13 DAC21-K09 2-CG2813-RA_1 CG2813 CCTGCTCACCGCACTATTAGGACTTGGATCTTGGCTCATTCCACGCTCTTAGCCTCAAGAGCCTTTGCT 69 FBan0002813 FBgn0031268 CG2813 2 2L CG2813 CG2813 CDMC24869 3 18 13 DAC21-K09 2-CG2813-RA_1 CG2813 CCTGCTCACCGCACTATTAGGACTTGGATCTTGGCTCATTCCACGCTCTTAGCCTCAAGAGCCTTTGCT 69 FBan0002813 FBgn0031268 CG2813 2 2L CG2813 CG2813 CDMC24870 3 19 13 DAC21-K21 14-CG2835-RB_1 CG2835 GGACCGAGTGAGCACAATCAAGAATCCAAACTACACCCCTAATGAGCAGGATATTCTTCGGTGCCGTGT 69 FBan0002835 FBgn0001123 G-salpha60A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; adenylate cyclase activation; GO:0007190; behavioral response to cocaine; GO:0048148; larval or pupal development (sensu Insecta); GO:0002165; learning and/or memory; GO:0007611; neuromuscular junction development; GO:0007528; synaptic transmission; GO:0007268; visual behavior; GO:0007632; wing morphogenesis; GO:0007476 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; plasma membrane; GO:0005886 G-salpha60A G protein salpha 60A "CG2835, G[[s]]alpha, Gsalpha, dgsalpha, dgs, Gs, Galphas, G[[S]]alpha, Galpha[[s]], G-alpha s, GalphaS, GSalpha, Galpha[[s]]-, G-salpha60A, Gs-alpha60A, Galpha60A, Galpha60A, G-alpha-60A" CDMC24870 3 20 13 DAC21-K21 14-CG2835-RB_1 CG2835 GGACCGAGTGAGCACAATCAAGAATCCAAACTACACCCCTAATGAGCAGGATATTCTTCGGTGCCGTGT 69 FBan0002835 FBgn0001123 G-salpha60A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; adenylate cyclase activation; GO:0007190; behavioral response to cocaine; GO:0048148; larval or pupal development (sensu Insecta); GO:0002165; learning and/or memory; GO:0007611; neuromuscular junction development; GO:0007528; synaptic transmission; GO:0007268; visual behavior; GO:0007632; wing morphogenesis; GO:0007476 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; plasma membrane; GO:0005886 G-salpha60A G protein salpha 60A "CG2835, G[[s]]alpha, Gsalpha, dgsalpha, dgs, Gs, Galphas, G[[S]]alpha, Galpha[[s]], G-alpha s, GalphaS, GSalpha, Galpha[[s]]-, G-salpha60A, Gs-alpha60A, Galpha60A, Galpha60A, G-alpha-60A" CDMC24871 3 21 13 DAC21-O09 23-CG2902-RA_18 CG2902 CGATAGCCAGCTAAAGAGAATTTAACTGTAGCAAATTGATTGTTATCGCTGAATGGAATGGCCAGGACC 69 FBan0002902 FBgn0010399 Nmdar1 3 3R calcium-mediated signaling; GO:0019722; cation transport; GO:0006812; ectoderm development; GO:0007398; nerve-nerve synaptic transmission; GO:0007270; nervous system development; GO:0007399; potassium ion transport; GO:0006813 N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972; ; GO:0004972; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0004972; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 plasma membrane; GO:0005886 Nmdar1 NMDA receptor 1 "CG2902, CG2902, DNMDAR-I, DMNMDAR1, nmr: neuromancer, NRI, dnmdar-I, DrNR1, NMDA receptor I, NMDA receptor, DNmdar, Nmdar, nmr" CDMC24871 3 22 13 DAC21-O09 23-CG2902-RA_18 CG2902 CGATAGCCAGCTAAAGAGAATTTAACTGTAGCAAATTGATTGTTATCGCTGAATGGAATGGCCAGGACC 69 FBan0002902 FBgn0010399 Nmdar1 3 3R calcium-mediated signaling; GO:0019722; cation transport; GO:0006812; ectoderm development; GO:0007398; nerve-nerve synaptic transmission; GO:0007270; nervous system development; GO:0007399; potassium ion transport; GO:0006813 N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972; ; GO:0004972; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0004972; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 plasma membrane; GO:0005886 Nmdar1 NMDA receptor 1 "CG2902, CG2902, DNMDAR-I, DMNMDAR1, nmr: neuromancer, NRI, dnmdar-I, DrNR1, NMDA receptor I, NMDA receptor, DNmdar, Nmdar, nmr" CDMC24872 3 23 13 DAC21-O21 18-CG2911-RA_4 CG2911 AGCTACAAACAATTGATACTACAATGTCATCCCGACAAATTGCGACAGCTCGATGACCCAAATCCGGGA 69 FBan0002911 FBgn0037350 CG2911 3 3R CG2911 CG2911 CDMC24872 3 24 13 DAC21-O21 18-CG2911-RA_4 CG2911 AGCTACAAACAATTGATACTACAATGTCATCCCGACAAATTGCGACAGCTCGATGACCCAAATCCGGGA 69 FBan0002911 FBgn0037350 CG2911 3 3R CG2911 CG2911 CDMC24873 3 25 13 DAC22-C09 20-CG14566-RA_1 CG14566 CACTTTCCGCCGCAGCTCGTCCGGCCAAATTGAGTGCTGCCCGCTCCACCGTGCGACGCTTCTAA 65 FBan0014566 FBgn0037127 CG14566 3 3L CG14566 CG14566 CDMC24873 3 26 13 DAC22-C09 20-CG14566-RA_1 CG14566 CACTTTCCGCCGCAGCTCGTCCGGCCAAATTGAGTGCTGCCCGCTCCACCGTGCGACGCTTCTAA 65 FBan0014566 FBgn0037127 CG14566 3 3L CG14566 CG14566 CDMC24874 3 1 14 DAC22-C21 3-CG14618-RA_2 CG14618 AGTCATTCAAGAAGAACGAAGGCTGGGAGAACTGGCACGTGCAGTACTACTTCGATCGCGGGCAC 65 FBan0014618 FBgn0031189 CG14618 X X CG14618 CG14618 CDMC24874 3 2 14 DAC22-C21 3-CG14618-RA_2 CG14618 AGTCATTCAAGAAGAACGAAGGCTGGGAGAACTGGCACGTGCAGTACTACTTCGATCGCGGGCAC 65 FBan0014618 FBgn0031189 CG14618 X X CG14618 CG14618 CDMC24875 3 3 14 DAC22-G09 1-CG14671-RA_1 CG14671 TACTGCCACCGATGAGCTTGCGCAATGCTGTTAACAAGTTCAAGGACTGCATAGAGCTGGTCGCC 65 FBan0014671 FBgn0037340 CG14671 3 3R CG14671 CG14671 CDMC24875 3 4 14 DAC22-G09 1-CG14671-RA_1 CG14671 TACTGCCACCGATGAGCTTGCGCAATGCTGTTAACAAGTTCAAGGACTGCATAGAGCTGGTCGCC 65 FBan0014671 FBgn0037340 CG14671 3 3R CG14671 CG14671 CDMC24876 3 5 14 DAC22-G21 8-CG14722-RA_1 CG14722 TGACTCCAAGCTGGTGGTTGGTACCTCCAAGGGTCGCTTGTACACCTACAACTGGGGCCAATTTG 65 FBan0014722 FBgn0037943 CG14722 3 3R apoptotic protease activator activity; GO:0016505; ; GO:0016505 CG14722 CG14722 CDMC24876 3 6 14 DAC22-G21 8-CG14722-RA_1 CG14722 TGACTCCAAGCTGGTGGTTGGTACCTCCAAGGGTCGCTTGTACACCTACAACTGGGGCCAATTTG 65 FBan0014722 FBgn0037943 CG14722 3 3R apoptotic protease activator activity; GO:0016505; ; GO:0016505 CG14722 CG14722 CDMC24877 3 7 14 DAC22-K09 3-CG14795-RB_1 CG14795 GTACAAGCTGAATCCTGAAGAGAAGTACGAGGCAGACCTGGTGCCCGTCTCCTCCACCGTGATTC 65 FBan0014795 FBgn0025393 CG14795 X X CG14795 CG14795 EG:196F3.3 CDMC24877 3 8 14 DAC22-K09 3-CG14795-RB_1 CG14795 GTACAAGCTGAATCCTGAAGAGAAGTACGAGGCAGACCTGGTGCCCGTCTCCTCCACCGTGATTC 65 FBan0014795 FBgn0025393 CG14795 X X CG14795 CG14795 EG:196F3.3 CDMC24878 3 9 14 DAC22-K21 1-CG14811-RA_1 CG14811 TATGCCGAAATCAAGAGCCTCTGGTTGAAGGGTCATTTCTCCCAAGCTTGTAACCCCACCTCGCG 65 FBan0014811 FBgn0029590 CG14811 X X CG14811 CG14811 CDMC24878 3 10 14 DAC22-K21 1-CG14811-RA_1 CG14811 TATGCCGAAATCAAGAGCCTCTGGTTGAAGGGTCATTTCTCCCAAGCTTGTAACCCCACCTCGCG 65 FBan0014811 FBgn0029590 CG14811 X X CG14811 CG14811 CDMC24879 3 11 14 DAC22-O09 6-CG14910-RA_3 CG14910 TCCCTGGATGGTTCCATAGGTGAGTACCGATGGTTCCTTCTCTGCCTACTCCTCGCAAAGGGTCC 65 FBan0014910 FBgn0035700 CG14910 3 3L CG14910 CG14910 CDMC24879 3 12 14 DAC22-O09 6-CG14910-RA_3 CG14910 TCCCTGGATGGTTCCATAGGTGAGTACCGATGGTTCCTTCTCTGCCTACTCCTCGCAAAGGGTCC 65 FBan0014910 FBgn0035700 CG14910 3 3L CG14910 CG14910 CDMC24880 3 13 14 DAC22-O21 AutoBlank AutoBlank CDMC24880 3 14 14 DAC22-O21 AutoBlank AutoBlank CDMC24881 3 15 14 DAC23-C09 11-CG6759-RA_1 CG6759 GGCAGCCTATTTTAAGGCCACACAACTGATGCGAGGTTGTCATCTCCCGTTGCTTTACATAGGTGTGGA 69 FBan0006759 FBgn0025781 cdc16 3 3R cell cycle; GO:0007049; mitotic anaphase; GO:0000090; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 anaphase-promoting complex; GO:0005680 cdc16 cdc16 "CG6759, Dmcdc16" CDMC24881 3 16 14 DAC23-C09 11-CG6759-RA_1 CG6759 GGCAGCCTATTTTAAGGCCACACAACTGATGCGAGGTTGTCATCTCCCGTTGCTTTACATAGGTGTGGA 69 FBan0006759 FBgn0025781 cdc16 3 3R cell cycle; GO:0007049; mitotic anaphase; GO:0000090; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 anaphase-promoting complex; GO:0005680 cdc16 cdc16 "CG6759, Dmcdc16" CDMC24882 3 17 14 DAC23-C21 11-CG6770-RA_1 CG6770 GAGGCCCACTTCGATGAGTACGAGCACTACAACTTCGACCATGACAAGCACATCTTCTCTGGACACAGC 69 FBan0006770 FBgn0032400 CG6770 2 2L CG6770 CG6770 "CT21019, anon-WO02059370.25" CDMC24882 3 18 14 DAC23-C21 11-CG6770-RA_1 CG6770 GAGGCCCACTTCGATGAGTACGAGCACTACAACTTCGACCATGACAAGCACATCTTCTCTGGACACAGC 69 FBan0006770 FBgn0032400 CG6770 2 2L CG6770 CG6770 "CT21019, anon-WO02059370.25" CDMC24883 3 19 14 DAC23-G09 1-CG6806-RA_1 CG6806 CCACTACTGGCATCTGATGGAGACCTATCCGGAGTACCACAAGAAGGATTACGCCTTCGAGGGTGTCCA 69 FBan0006806 FBgn0002565 Lsp2 3 3L proteolysis; GO:0006508; transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp2 Larval serum protein 2 "CG6806, CG6806, CG6806, LSP-2, LSP2, Lsp-2, Pt-1: Protein-1, LSP 2, Larval serum protein-2, DmeLSP2, C23, LHP: larval-hemolymph-protein, larval-hemolymph-protein, Protein-1, Pt-1" CDMC24883 3 20 14 DAC23-G09 1-CG6806-RA_1 CG6806 CCACTACTGGCATCTGATGGAGACCTATCCGGAGTACCACAAGAAGGATTACGCCTTCGAGGGTGTCCA 69 FBan0006806 FBgn0002565 Lsp2 3 3L proteolysis; GO:0006508; transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp2 Larval serum protein 2 "CG6806, CG6806, CG6806, LSP-2, LSP2, Lsp-2, Pt-1: Protein-1, LSP 2, Larval serum protein-2, DmeLSP2, C23, LHP: larval-hemolymph-protein, larval-hemolymph-protein, Protein-1, Pt-1" CDMC24884 3 21 14 DAC23-G21 6-CG6818-RA_1 CG6818 CGCCTGCTTAAGGAGGTTTTTGGCGAAAGACTGCACGACAAAGCCATCCTGCACTATATGGACGATCCT 69 FBan0006818 FBgn0036846 MESR6 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESR6 Misexpression suppressor of ras 6 "CG6818, Misexpression suppressor of ras 6" CDMC24884 3 22 14 DAC23-G21 6-CG6818-RA_1 CG6818 CGCCTGCTTAAGGAGGTTTTTGGCGAAAGACTGCACGACAAAGCCATCCTGCACTATATGGACGATCCT 69 FBan0006818 FBgn0036846 MESR6 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESR6 Misexpression suppressor of ras 6 "CG6818, Misexpression suppressor of ras 6" CDMC24885 3 23 14 DAC23-K09 2-CG6859-RA_1 CG6859 GCACCTCGAAGAGCCAAAACGGTCTGGAGAACAATAACTTGCTGAACATCAACCGAGTGCTGTTGGCGT 69 FBan0006859 FBgn0036484 CG6859 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 integral to peroxisomal membrane; GO:0005779 CG6859 CG6859 CDMC24885 3 24 14 DAC23-K09 2-CG6859-RA_1 CG6859 GCACCTCGAAGAGCCAAAACGGTCTGGAGAACAATAACTTGCTGAACATCAACCGAGTGCTGTTGGCGT 69 FBan0006859 FBgn0036484 CG6859 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 integral to peroxisomal membrane; GO:0005779 CG6859 CG6859 CDMC24886 3 25 14 DAC23-K21 8-CG6868-RA_2 CG6868 GGTCATGAACTACCTCCAGTGGTGAATTCCGAGCAGAGTATCCTCAGGCTGGAGTTCTACTCGGATCGC 69 FBan0006868 FBgn0003719 tld 3 3R amnioserosa formation; GO:0007378; embryonic pattern specification; GO:0009880; positive regulation of BMP signaling pathway; GO:0030513; proteolysis; GO:0006508; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of dorsal/ventral axis; GO:0007352 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0004222 ; EC:3.4.24.-; ; GO:0005509; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0017026 ; EC:3.4.24.19 extracellular region; GO:0005576 tld tolloid "CG6868, CG6868, Tld, CT21278, Tolloid" CDMC24886 3 26 14 DAC23-K21 8-CG6868-RA_2 CG6868 GGTCATGAACTACCTCCAGTGGTGAATTCCGAGCAGAGTATCCTCAGGCTGGAGTTCTACTCGGATCGC 69 FBan0006868 FBgn0003719 tld 3 3R amnioserosa formation; GO:0007378; embryonic pattern specification; GO:0009880; positive regulation of BMP signaling pathway; GO:0030513; proteolysis; GO:0006508; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of dorsal/ventral axis; GO:0007352 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0004222 ; EC:3.4.24.-; ; GO:0005509; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0017026 ; EC:3.4.24.19 extracellular region; GO:0005576 tld tolloid "CG6868, CG6868, Tld, CT21278, Tolloid" CDMC24887 3 1 15 DAC23-O09 9-CG6896-RA_1 CG6896 GCTAGCAATGCCCATCCAATTGCAGCAGCTAATGCCACAACAACTAATGGTTCTGTTTTAGGAGCCGGC 69 FBan0006896 FBgn0036801 MYPT-75D 3 3L wing morphogenesis; GO:0007476 structural constituent of cytoskeleton; GO:0005200; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0005200; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.-; myosin phosphatase regulator activity; GO:0017020; ; GO:0017020 MYPT-75D MYPT-75D "CG6896, CG6896, MYPT-75D" CDMC24887 3 2 15 DAC23-O09 9-CG6896-RA_1 CG6896 GCTAGCAATGCCCATCCAATTGCAGCAGCTAATGCCACAACAACTAATGGTTCTGTTTTAGGAGCCGGC 69 FBan0006896 FBgn0036801 MYPT-75D 3 3L wing morphogenesis; GO:0007476 structural constituent of cytoskeleton; GO:0005200; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0005200; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.-; myosin phosphatase regulator activity; GO:0017020; ; GO:0017020 MYPT-75D MYPT-75D "CG6896, CG6896, MYPT-75D" CDMC24888 3 3 15 DAC23-O21 6-CG6910-RA_3 CG6910 CGCGGACAAGAATCCCTCCAAATTCCGGGACTACAGTATGGACACCACCGATCCTCTAAAGGAACGTGT 69 FBan0006910 FBgn0036262 CG6910 3 3L "carbohydrate metabolism; GO:0005975; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG6910 CG6910 CDMC24888 3 4 15 DAC23-O21 6-CG6910-RA_3 CG6910 CGCGGACAAGAATCCCTCCAAATTCCGGGACTACAGTATGGACACCACCGATCCTCTAAAGGAACGTGT 69 FBan0006910 FBgn0036262 CG6910 3 3L "carbohydrate metabolism; GO:0005975; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG6910 CG6910 CDMC24889 3 5 15 DAC24-C09 3-CG2175-RC_2 CG2175 TGGATCGAATGCCTATGGTGTTCCTCGTCCAGTCAATTCGTATCAAAGTCAAGGCTACAGGGCTGCCGT 69 FBan0002175 FBgn0000427 1-Dec X X eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600; extracellular region; GO:0005576 1-Dec defective chorion 1 "CG2175, fs(1)384, fs(1)1501, fs(1)A384, dec[[1]], fs(1)C1, fs(1)M102, Fc1, Fc, dec1, dec, Fcp7C: Follicle cell protein 7C, fs(1)11-549, fs(1)12-1873, fs(1)12-2514, fs(1)12-3512, fs(1)12-365, fs(1)12-3907, fs(1)12-403, fs(1)12-4860, fs(1)13-453, fs(1)13C-57, fs(1)13C-73, fs(1)14-963, fs(1)14A-114, fs(1)14E19, fs(1)5, fs(1)A257, fs(1)M1021, Follicle cell protein 7C" CDMC24889 3 6 15 DAC24-C09 3-CG2175-RC_2 CG2175 TGGATCGAATGCCTATGGTGTTCCTCGTCCAGTCAATTCGTATCAAAGTCAAGGCTACAGGGCTGCCGT 69 FBan0002175 FBgn0000427 1-Dec X X eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600; extracellular region; GO:0005576 1-Dec defective chorion 1 "CG2175, fs(1)384, fs(1)1501, fs(1)A384, dec[[1]], fs(1)C1, fs(1)M102, Fc1, Fc, dec1, dec, Fcp7C: Follicle cell protein 7C, fs(1)11-549, fs(1)12-1873, fs(1)12-2514, fs(1)12-3512, fs(1)12-365, fs(1)12-3907, fs(1)12-403, fs(1)12-4860, fs(1)13-453, fs(1)13C-57, fs(1)13C-73, fs(1)14-963, fs(1)14A-114, fs(1)14E19, fs(1)5, fs(1)A257, fs(1)M1021, Follicle cell protein 7C" CDMC24890 3 7 15 DAC24-C21 1-CG2191-RA_1 CG2191 GGGGAGAAGGAATTCAGCATCCTGGACCTCTCCTTTAACTGGTACACGGTCACAGGCTTCGTCATCACC 69 FBan0002191 FBgn0039873 CG2191 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG2191 CG2191 CDMC24890 3 8 15 DAC24-C21 1-CG2191-RA_1 CG2191 GGGGAGAAGGAATTCAGCATCCTGGACCTCTCCTTTAACTGGTACACGGTCACAGGCTTCGTCATCACC 69 FBan0002191 FBgn0039873 CG2191 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG2191 CG2191 CDMC24891 3 9 15 DAC24-G09 14-CG2239-RC_1 CG2239 TGTCGGTCAGGTGAGAAGATACACGATTGCCGAGAAAGTGGATAAAGAGGTATGCGATATGGGCCAGGA 69 FBan0002239 FBgn0027654 jdp 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 jdp jdp "CG2239, dJDP, p25a" CDMC24891 3 10 15 DAC24-G09 14-CG2239-RC_1 CG2239 TGTCGGTCAGGTGAGAAGATACACGATTGCCGAGAAAGTGGATAAAGAGGTATGCGATATGGGCCAGGA 69 FBan0002239 FBgn0027654 jdp 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 jdp jdp "CG2239, dJDP, p25a" CDMC24892 3 11 15 DAC24-G21 13-CG2252-RA_1 CG2252 TCGATTCGCACGTGAACCACATCAGAGTTGGGTGATGATCGGTCAGTATCACAGTATCAGACGGTTGGA 69 FBan0002252 FBgn0004656 fs(1)h X X MAPKKK cascade; GO:0000165; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003677; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0003682; ; GO:0003697; ; GO:0004672 ; EC:2.7.1.37 fs(1)h female sterile (1) homoeotic "CG2252, fs(1)M16, fs(1)1456, N72, fsh, fst(1)h, rnc, rancor, clone 1.81, l(1)G0495, l(1)G0093, l(1)7Da, anon-EST:Liang-1.81, fs(1)26/26A, fs(1)R10.4, anon-EST:fe1G2, anon-fast-evolving-1G2" CDMC24892 3 12 15 DAC24-G21 13-CG2252-RA_1 CG2252 TCGATTCGCACGTGAACCACATCAGAGTTGGGTGATGATCGGTCAGTATCACAGTATCAGACGGTTGGA 69 FBan0002252 FBgn0004656 fs(1)h X X MAPKKK cascade; GO:0000165; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003677; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0003682; ; GO:0003697; ; GO:0004672 ; EC:2.7.1.37 fs(1)h female sterile (1) homoeotic "CG2252, fs(1)M16, fs(1)1456, N72, fsh, fst(1)h, rnc, rancor, clone 1.81, l(1)G0495, l(1)G0093, l(1)7Da, anon-EST:Liang-1.81, fs(1)26/26A, fs(1)R10.4, anon-EST:fe1G2, anon-fast-evolving-1G2" CDMC24893 3 13 15 DAC24-K09 12-CG2321-RA_1 CG2321 CCAAGCGCTTGGTGCAACAGAACTTCCATGTGCACAAGGAAACCTTTTCGCATTTTTGCAAGAGCTTCA 69 FBan0002321 FBgn0039663 CG2321 3 3R CG2321 CG2321 CDMC24893 3 14 15 DAC24-K09 12-CG2321-RA_1 CG2321 CCAAGCGCTTGGTGCAACAGAACTTCCATGTGCACAAGGAAACCTTTTCGCATTTTTGCAAGAGCTTCA 69 FBan0002321 FBgn0039663 CG2321 3 3R CG2321 CG2321 CDMC24894 3 15 15 DAC24-K21 23-CG2346-RA_3 CG2346 ATATAACCCACTCCTCACACGAACTCCTGACTTATGCCTGAACTATGAATTTTTAATGAATGGGCTGGA 69 FBan0002346 FBgn0000715 Fmrf 2 2R muscle contraction; GO:0006936; negative regulation of heart contraction rate; GO:0045822; neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005179 Fmrf FMRFamide-related "CG2346, FMRFamide, FMRF-amide, DPKQDFMRFamide, SDNFMRFamide, TPAEDFMRFamide, FRMFamide, dFMRFamide, dFMRFa, fmrf, FMRF, FMRFamide prohormone, amino acid amidated neuropeptide, dFMRF, FMRFa, Drm-FMRF-1, Drm-FMRF-2, Drm-FMRF-3, Drm-FMRF-4, Drm-FMRF-5, Drm-FMRFa1, Drm-FMRFa2, Drm-FMRFa3, Drm-FMRFa4, Drm-FMRFamide-1, Drm-FMRFamide-2, Drm-FMRFamide-3, Drm-FMRFamide-4, Drm-FMRFamide-5, dFMRFa-1, DPKQDFMRF-amide, dFmrfa" CDMC24894 3 16 15 DAC24-K21 23-CG2346-RA_3 CG2346 ATATAACCCACTCCTCACACGAACTCCTGACTTATGCCTGAACTATGAATTTTTAATGAATGGGCTGGA 69 FBan0002346 FBgn0000715 Fmrf 2 2R muscle contraction; GO:0006936; negative regulation of heart contraction rate; GO:0045822; neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005179 Fmrf FMRFamide-related "CG2346, FMRFamide, FMRF-amide, DPKQDFMRFamide, SDNFMRFamide, TPAEDFMRFamide, FRMFamide, dFMRFamide, dFMRFa, fmrf, FMRF, FMRFamide prohormone, amino acid amidated neuropeptide, dFMRF, FMRFa, Drm-FMRF-1, Drm-FMRF-2, Drm-FMRF-3, Drm-FMRF-4, Drm-FMRF-5, Drm-FMRFa1, Drm-FMRFa2, Drm-FMRFa3, Drm-FMRFa4, Drm-FMRFamide-1, Drm-FMRFamide-2, Drm-FMRFamide-3, Drm-FMRFamide-4, Drm-FMRFamide-5, dFMRFa-1, DPKQDFMRF-amide, dFmrfa" CDMC24895 3 17 15 DAC24-O09 13-CG2488-RB_1 CG2488 GGAGCCTAGCACTACCGTACTAAGCCCTTACCTCAAATTTGGATGCCTTAGTGCCCGACTGTTCAATCA 69 FBan0002488 FBgn0016054 phr6-4 2 2L DNA repair; GO:0006281 nucleic acid binding; GO:0003676; DNA (6-4) photolyase activity; GO:0003914; ; GO:0003914; ; GO:0003676; ; GO:0003914 phr6-4 (6-4)-photolyase "CG2488, 64PHR, phr(6-4), 6-4 photolyase, D6-4, Dm 64, (6-4)photolyase, photolyase, 38D.25, (6-4)-photolyase" CDMC24895 3 18 15 DAC24-O09 13-CG2488-RB_1 CG2488 GGAGCCTAGCACTACCGTACTAAGCCCTTACCTCAAATTTGGATGCCTTAGTGCCCGACTGTTCAATCA 69 FBan0002488 FBgn0016054 phr6-4 2 2L DNA repair; GO:0006281 nucleic acid binding; GO:0003676; DNA (6-4) photolyase activity; GO:0003914; ; GO:0003914; ; GO:0003676; ; GO:0003914 phr6-4 (6-4)-photolyase "CG2488, 64PHR, phr(6-4), 6-4 photolyase, D6-4, Dm 64, (6-4)photolyase, photolyase, 38D.25, (6-4)-photolyase" CDMC24896 3 19 15 DAC24-O21 22-CG2522-RA_1 CG2522 CGTCGATCCGGCTATCCTTCCAATGCTCCTTGTTTGCATCCACTCTTTTCACCGAATCAAATATATGGC 69 FBan0002522 FBgn0010391 Gtp-bp X X SRP-dependent cotranslational protein targeting to membrane; GO:0006614; axonogenesis; GO:0007409; protein targeting; GO:0006605; regulation of protein secretion; GO:0050708 GTP binding; GO:0005525; mRNA binding; GO:0003729; ; GO:0005525; ; GO:0003729; signal recognition particle binding; GO:0005047; receptor activity; GO:0004872; ; GO:0003729; ; GO:0004872; ; GO:0005047; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0017111 ; EC:3.6.1.15 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; signal recognition particle receptor complex; GO:0005785 Gtp-bp GTP-binding protein "CG2522, CK00309, BEST:CK00309, GTP-binding protein" CDMC24896 3 20 15 DAC24-O21 22-CG2522-RA_1 CG2522 CGTCGATCCGGCTATCCTTCCAATGCTCCTTGTTTGCATCCACTCTTTTCACCGAATCAAATATATGGC 69 FBan0002522 FBgn0010391 Gtp-bp X X SRP-dependent cotranslational protein targeting to membrane; GO:0006614; axonogenesis; GO:0007409; protein targeting; GO:0006605; regulation of protein secretion; GO:0050708 GTP binding; GO:0005525; mRNA binding; GO:0003729; ; GO:0005525; ; GO:0003729; signal recognition particle binding; GO:0005047; receptor activity; GO:0004872; ; GO:0003729; ; GO:0004872; ; GO:0005047; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0017111 ; EC:3.6.1.15 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; signal recognition particle receptor complex; GO:0005785 Gtp-bp GTP-binding protein "CG2522, CK00309, BEST:CK00309, GTP-binding protein" CDMC24897 3 21 15 DAC25-C09 2-CG10108-RA_1 CG10108 AGAGCCACCACAAACAAGGAAACAGCCACCAAAATTCCCACCAAGCTTCAATCCAACTCGCTGGC 65 FBan0010108 FBgn0013725 phyl 2 2R R1/R6 cell fate commitment; GO:0007462; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; Ras protein signal transduction; GO:0007265; peripheral nervous system development; GO:0007422; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 phyl phyllopod "CG10108, SR2-3, Su(Raf)2C, PHYL, D(DmcycE[JP])2.2, phyllopod" CDMC24897 3 22 15 DAC25-C09 2-CG10108-RA_1 CG10108 AGAGCCACCACAAACAAGGAAACAGCCACCAAAATTCCCACCAAGCTTCAATCCAACTCGCTGGC 65 FBan0010108 FBgn0013725 phyl 2 2R R1/R6 cell fate commitment; GO:0007462; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; Ras protein signal transduction; GO:0007265; peripheral nervous system development; GO:0007422; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 phyl phyllopod "CG10108, SR2-3, Su(Raf)2C, PHYL, D(DmcycE[JP])2.2, phyllopod" CDMC24898 3 23 15 DAC25-C21 3-CG10152-RA_1 CG10152 TACCTGCACAAATACAACGACATCGTGCACAAACACGGGCTAATCACCTCGACATTGGGCCTGCA 65 FBan0010152 FBgn0039089 beat-IV 3 3R extracellular region; GO:0005576 beat-IV beat-IV "CG10152, CG13823, beat IV" CDMC24898 3 24 15 DAC25-C21 3-CG10152-RA_1 CG10152 TACCTGCACAAATACAACGACATCGTGCACAAACACGGGCTAATCACCTCGACATTGGGCCTGCA 65 FBan0010152 FBgn0039089 beat-IV 3 3R extracellular region; GO:0005576 beat-IV beat-IV "CG10152, CG13823, beat IV" CDMC24899 3 25 15 DAC25-G09 23-CG10263-RC_2 CG10263 GTGAACAAGTGTATGTTAAGCTGAACTGAACACTATTAAAGATATTTTACGGGGTTAGGCCAACC 65 FBan0010263 FBgn0032812 CG10263 2 2L CG10263 CG10263 CDMC24899 3 26 15 DAC25-G09 23-CG10263-RC_2 CG10263 GTGAACAAGTGTATGTTAAGCTGAACTGAACACTATTAAAGATATTTTACGGGGTTAGGCCAACC 65 FBan0010263 FBgn0032812 CG10263 2 2L CG10263 CG10263 CDMC24900 3 1 16 DAC25-G21 12-CG10293-RB_2 CG10293 CGTGGCAAGCCTAACTGGGAGCATCTGTCCGATGACCTGCATGTCCTGATAACCGTCGAGGACAC 65 FBan0010293 FBgn0017397 how 3 3R "apoptosis; GO:0006915; apposition of dorsal and ventral wing surfaces; GO:0007475; cell differentiation; GO:0030154; embryonic development; GO:0009790; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; somatic muscle development; GO:0007525" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 how held out wings "CG10293, CG10293, l(3)j5B5, SZ1, who: wings held out, wings held-out, struthio, qkr, qkr[93F], quaking related, 93F, stru, P62, sci, scorpion, Who/How, clone 2.39, How, HOW, anon-EST:Liang-2.39, KH93F, l(3)j5D5, l(3)s2612, KH motif at 93F, wings held out, who, held out wings" CDMC24900 3 2 16 DAC25-G21 12-CG10293-RB_2 CG10293 CGTGGCAAGCCTAACTGGGAGCATCTGTCCGATGACCTGCATGTCCTGATAACCGTCGAGGACAC 65 FBan0010293 FBgn0017397 how 3 3R "apoptosis; GO:0006915; apposition of dorsal and ventral wing surfaces; GO:0007475; cell differentiation; GO:0030154; embryonic development; GO:0009790; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; somatic muscle development; GO:0007525" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 how held out wings "CG10293, CG10293, l(3)j5B5, SZ1, who: wings held out, wings held-out, struthio, qkr, qkr[93F], quaking related, 93F, stru, P62, sci, scorpion, Who/How, clone 2.39, How, HOW, anon-EST:Liang-2.39, KH93F, l(3)j5D5, l(3)s2612, KH motif at 93F, wings held out, who, held out wings" CDMC24901 3 3 16 DAC25-K09 2-CG10382-RA_2 CG10382 AGCCTGCTACCGATCATGGAGTTCAAGCTCAAGTTCCGACAGATCCCCTCGAACAATGTCACCCG 65 FBan0010382 FBgn0025878 wrapper 2 2R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; gliogenesis; GO:0042063; nervous system development; GO:0007399; signal transduction; GO:0007165 extrinsic to plasma membrane; GO:0019897 wrapper wrapper "CG10382, CT19059" CDMC24901 3 4 16 DAC25-K09 2-CG10382-RA_2 CG10382 AGCCTGCTACCGATCATGGAGTTCAAGCTCAAGTTCCGACAGATCCCCTCGAACAATGTCACCCG 65 FBan0010382 FBgn0025878 wrapper 2 2R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; gliogenesis; GO:0042063; nervous system development; GO:0007399; signal transduction; GO:0007165 extrinsic to plasma membrane; GO:0019897 wrapper wrapper "CG10382, CT19059" CDMC24902 3 5 16 DAC25-K21 2-CG10426-RA_1 CG10426 GATCGCATTCTCTACAAGTACCGCCAAATGCAGGGACTAGTCATCCGTCGGCAGACCCTAGTGCC 65 FBan0010426 FBgn0036273 CG10426 3 3L dephosphorylation; GO:0016311; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; vesicle-mediated transport; GO:0016192 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG10426 CG10426 "IPP, pharbin-like" CDMC24902 3 6 16 DAC25-K21 2-CG10426-RA_1 CG10426 GATCGCATTCTCTACAAGTACCGCCAAATGCAGGGACTAGTCATCCGTCGGCAGACCCTAGTGCC 65 FBan0010426 FBgn0036273 CG10426 3 3L dephosphorylation; GO:0016311; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; vesicle-mediated transport; GO:0016192 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG10426 CG10426 "IPP, pharbin-like" CDMC24903 3 7 16 DAC25-O09 3-CG10561-RA_1 CG10561 GCAGGATTCGATGTATGAACTGCTACGCAACACGGAAGGCTTGGGGAAGCAGATAAAGCAGCCGG 65 FBan0010561 FBgn0002036 CG10561 2 2L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- cytoplasm; GO:0005737 CG10561 CG10561 "Cs, transcription unit No. 2, C2, TU37C2, transcription unit 37C2, TuC1, l(2)37Cs: lethal(2)37Cs, ORF1, cs, anon-37Cd, TU37C1, anon-37Cs, anon-37Cb, anon-37Cc, lethal(2)37Cs, l(2)37Cs" CDMC24903 3 8 16 DAC25-O09 3-CG10561-RA_1 CG10561 GCAGGATTCGATGTATGAACTGCTACGCAACACGGAAGGCTTGGGGAAGCAGATAAAGCAGCCGG 65 FBan0010561 FBgn0002036 CG10561 2 2L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- cytoplasm; GO:0005737 CG10561 CG10561 "Cs, transcription unit No. 2, C2, TU37C2, transcription unit 37C2, TuC1, l(2)37Cs: lethal(2)37Cs, ORF1, cs, anon-37Cd, TU37C1, anon-37Cs, anon-37Cb, anon-37Cc, lethal(2)37Cs, l(2)37Cs" CDMC24904 3 9 16 DAC25-O21 AutoBlank AutoBlank CDMC24904 3 10 16 DAC25-O21 AutoBlank AutoBlank CDMC24905 3 11 16 DAC26-C09 3-CG6190-RA_1 CG6190 AGGCCATCAACTACTCGAAGGGCTTCGGCATGCTGTAGACTATGGTCCAAACTGCAAGTGCAAGTCTGT 69 FBgn0036148 CDMC24905 3 12 16 DAC26-C09 3-CG6190-RA_1 CG6190 AGGCCATCAACTACTCGAAGGGCTTCGGCATGCTGTAGACTATGGTCCAAACTGCAAGTGCAAGTCTGT 69 FBgn0036148 CDMC24906 3 13 16 DAC26-C21 18-CG6203-RA_1 CG6203 CGTGCCGAGTCGGGAGAGGAGCATTGAACACAATCATCGAGTGACGCGAATCATTTCAATTGAATCATA 69 FBan0006203 FBgn0028734 Fmr1 3 3R "NOT chemotaxis; GO:0006935; NOT phototaxis; GO:0042331; NOT synaptic transmission; GO:0007268; axon guidance; GO:0007411; circadian rhythm; GO:0007623; induction of apoptosis; GO:0006917; larval locomotory behavior; GO:0008345; locomotion; GO:0040011; locomotor rhythm; GO:0045475; male courtship behavior (sensu Insecta); GO:0016542; negative regulation of dendrite morphogenesis; GO:0050774; negative regulation of translation; GO:0016478; neurotransmitter secretion; GO:0007269; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of dendrite morphogenesis; GO:0050773; regulation of synapse structure; GO:0050807; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of translation; GO:0006445; sperm axoneme assembly; GO:0007288; synaptogenesis; GO:0007416" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0003729 RNA-induced silencing complex; GO:0016442; cytoplasm; GO:0005737; micro-ribonucleoprotein complex; GO:0035068 Fmr1 Fmr1 "CG6203, CG6203, FXR, Fragile X related, Fragile-X-related, cg6203, dFMR1, dfmr1, dFXR, FMR1, dfxr, dFmr1, fragile X, AT24755, EP(3)3517, dmfr1, dFXR1, dFMRP, FMRP, dfxr1, fmr, Fragile X-related, dfmr, FMRp, Fragile X, dFMR, Fmrp, BcDNA:GM08679" CDMC24906 3 14 16 DAC26-C21 18-CG6203-RA_1 CG6203 CGTGCCGAGTCGGGAGAGGAGCATTGAACACAATCATCGAGTGACGCGAATCATTTCAATTGAATCATA 69 FBan0006203 FBgn0028734 Fmr1 3 3R "NOT chemotaxis; GO:0006935; NOT phototaxis; GO:0042331; NOT synaptic transmission; GO:0007268; axon guidance; GO:0007411; circadian rhythm; GO:0007623; induction of apoptosis; GO:0006917; larval locomotory behavior; GO:0008345; locomotion; GO:0040011; locomotor rhythm; GO:0045475; male courtship behavior (sensu Insecta); GO:0016542; negative regulation of dendrite morphogenesis; GO:0050774; negative regulation of translation; GO:0016478; neurotransmitter secretion; GO:0007269; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of dendrite morphogenesis; GO:0050773; regulation of synapse structure; GO:0050807; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of translation; GO:0006445; sperm axoneme assembly; GO:0007288; synaptogenesis; GO:0007416" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0003729 RNA-induced silencing complex; GO:0016442; cytoplasm; GO:0005737; micro-ribonucleoprotein complex; GO:0035068 Fmr1 Fmr1 "CG6203, CG6203, FXR, Fragile X related, Fragile-X-related, cg6203, dFMR1, dfmr1, dFXR, FMR1, dfxr, dFmr1, fragile X, AT24755, EP(3)3517, dmfr1, dFXR1, dFMRP, FMRP, dfxr1, fmr, Fragile X-related, dfmr, FMRp, Fragile X, dFMR, Fmrp, BcDNA:GM08679" CDMC24907 3 15 16 DAC26-G09 2-CG6230-RA_2 CG6230 GCACGCTGGTCACCACACTCCAAATGTTCAAGATCCTTGCTCTGAACGCCCTCATTCAAGCCTACTGTC 69 FBan0006230 FBgn0027582 CG6230 2 2L calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; metabolism; GO:0008152 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0016820 ; EC:3.6.3.-; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG6230 CG6230 "dCOD1, BcDNA:GH06032" CDMC24907 3 16 16 DAC26-G09 2-CG6230-RA_2 CG6230 GCACGCTGGTCACCACACTCCAAATGTTCAAGATCCTTGCTCTGAACGCCCTCATTCAAGCCTACTGTC 69 FBan0006230 FBgn0027582 CG6230 2 2L calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; metabolism; GO:0008152 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0016820 ; EC:3.6.3.-; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG6230 CG6230 "dCOD1, BcDNA:GH06032" CDMC24908 3 17 16 DAC26-G21 17-CG6238-RA_9 CG6238 GGCCATGCTCTGCTTAACAACATGCTAACTGCAAACTGCAACATTCACATACCACTTGCAACTTGCAAT 69 FBan0006238 FBgn0029157 ssh 3 3R MAPKKK cascade; GO:0000165; actin cytoskeleton organization and biogenesis; GO:0030036; mushroom body development; GO:0016319; protein amino acid dephosphorylation; GO:0006470; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of axonogenesis; GO:0050770 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; protein tyrosine/threonine phosphatase activity; GO:0008330 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0008330 ; EC:3.1.3.- ssh slingshot "CG6238, CG6238, l(3)01207, MKP, Mkph, MKP-like, Ssh, MAP-kinase-phosphatase" CDMC24908 3 18 16 DAC26-G21 17-CG6238-RA_9 CG6238 GGCCATGCTCTGCTTAACAACATGCTAACTGCAAACTGCAACATTCACATACCACTTGCAACTTGCAAT 69 FBan0006238 FBgn0029157 ssh 3 3R MAPKKK cascade; GO:0000165; actin cytoskeleton organization and biogenesis; GO:0030036; mushroom body development; GO:0016319; protein amino acid dephosphorylation; GO:0006470; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of axonogenesis; GO:0050770 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; protein tyrosine/threonine phosphatase activity; GO:0008330 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0008330 ; EC:3.1.3.- ssh slingshot "CG6238, CG6238, l(3)01207, MKP, Mkph, MKP-like, Ssh, MAP-kinase-phosphatase" CDMC24909 3 19 16 DAC26-K09 2-CG6294-RA_1 CG6294 CCACGATAGCTTCTATTTTGCACGCAACTGTGCCGTAATCCTGGCCCATCATCGCTGGCTGAATTTGGA 69 FBan0006294 FBgn0030640 CG6294 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG6294 CG6294 CDMC24909 3 20 16 DAC26-K09 2-CG6294-RA_1 CG6294 CCACGATAGCTTCTATTTTGCACGCAACTGTGCCGTAATCCTGGCCCATCATCGCTGGCTGAATTTGGA 69 FBan0006294 FBgn0030640 CG6294 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG6294 CG6294 CDMC24910 3 21 16 DAC26-K21 9-CG6304-RA_9 CG6304 GGCGTGTGAAGGTACAGTGAAGCTAAACGCCAATGCCCAAGAATTTGTGCCACGTTACAAGAGGGAACA 69 FBan0006304 FBgn0032624 CG6304 2 2L CG6304 CG6304 anon-WO0140519.248 CDMC24910 3 22 16 DAC26-K21 9-CG6304-RA_9 CG6304 GGCGTGTGAAGGTACAGTGAAGCTAAACGCCAATGCCCAAGAATTTGTGCCACGTTACAAGAGGGAACA 69 FBan0006304 FBgn0032624 CG6304 2 2L CG6304 CG6304 anon-WO0140519.248 CDMC24911 3 23 16 DAC26-O09 17-CG6347-RA_5 CG6347 TCGCCGGTCTTCGAGTCTTCAGCATCTTCGAATAGTTTTGTGATTTGTGAACGCGGAAGGTGTTTTGAA 69 FBan0006347 FBgn0033874 CG6347 2 2R proteolysis; GO:0006508 NOT cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG6347 CG6347 CDMC24911 3 24 16 DAC26-O09 17-CG6347-RA_5 CG6347 TCGCCGGTCTTCGAGTCTTCAGCATCTTCGAATAGTTTTGTGATTTGTGAACGCGGAAGGTGTTTTGAA 69 FBan0006347 FBgn0033874 CG6347 2 2R proteolysis; GO:0006508 NOT cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG6347 CG6347 CDMC24912 3 25 16 DAC26-O21 25-CG6362-RA_1 CG6362 TCCCAAAACTCCTCCATTGCAATTGCAAAAGGTCGAAGGCAGATGGGGGAATTGCTTTGATGCCGACTT 69 FBan0006362 FBgn0028740 CG6362 2 2R CG6362 CG6362 EG:52C10.6 CDMC24912 3 26 16 DAC26-O21 25-CG6362-RA_1 CG6362 TCCCAAAACTCCTCCATTGCAATTGCAAAAGGTCGAAGGCAGATGGGGGAATTGCTTTGATGCCGACTT 69 FBan0006362 FBgn0028740 CG6362 2 2R CG6362 CG6362 EG:52C10.6 CDMC24913 3 1 17 DAC27-C09 23-CG3710-RA_3 CG3710 CACACCACACATCCTTCATATTCTTAAATGAAACATTGTAAAGACACGACACGCGAGAAAACATTTTGT 69 FBan0003710 FBgn0010422 TfIIS 2 2L "RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcriptional elongation regulator activity; GO:0003711; ; GO:0003711; ; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003711; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 TfIIS RNA polymerase II elongation factor "CG3710, l(2)35Cf, br52, DmS-II, l35Cf, TFIIS, TFS-II, TFIISA, BG:DS00929.12, l(2)35cF, DmSII, RnpSII, l(2)br52, lethal(2)35Cf" CDMC24913 3 2 17 DAC27-C09 23-CG3710-RA_3 CG3710 CACACCACACATCCTTCATATTCTTAAATGAAACATTGTAAAGACACGACACGCGAGAAAACATTTTGT 69 FBan0003710 FBgn0010422 TfIIS 2 2L "RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcriptional elongation regulator activity; GO:0003711; ; GO:0003711; ; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003711; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 TfIIS RNA polymerase II elongation factor "CG3710, l(2)35Cf, br52, DmS-II, l35Cf, TFIIS, TFS-II, TFIISA, BG:DS00929.12, l(2)35cF, DmSII, RnpSII, l(2)br52, lethal(2)35Cf" CDMC24914 3 3 17 DAC27-C21 18-CG3724-RA_1 CG3724 CGGCCGAACTGGACTCCTTCCTCATTGAAATCACGCGTGATATTCTTAAGTACAAGGACGGCAAAGGTT 69 FBan0003724 FBgn0004654 Pgd X X pentose-phosphate shunt; GO:0006098 phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0004616 ; EC:1.1.1.44; ; GO:0004616 ; EC:1.1.1.44 Pgd Phosphogluconate dehydrogenase "CG3724, CG3724, CG3724, A7, l(1)A7, N1, l(1)Pgd, l(1)2Dc, 6PGD, 6Pgd, 6-Pgd, 6PGDH, l35, l(1)2De, 6-pgd, NADP-6 phosphogluconate dehydrogenase, PGD, l(1)G0385, 6Pgdh, Pdg, EG:87B1.4, 6-PGD, 6-phosphogluconate dehydrogenase, l(1)N1, l(1)N3[90], l(1)Pgd-A" CDMC24914 3 4 17 DAC27-C21 18-CG3724-RA_1 CG3724 CGGCCGAACTGGACTCCTTCCTCATTGAAATCACGCGTGATATTCTTAAGTACAAGGACGGCAAAGGTT 69 FBan0003724 FBgn0004654 Pgd X X pentose-phosphate shunt; GO:0006098 phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0004616 ; EC:1.1.1.44; ; GO:0004616 ; EC:1.1.1.44 Pgd Phosphogluconate dehydrogenase "CG3724, CG3724, CG3724, A7, l(1)A7, N1, l(1)Pgd, l(1)2Dc, 6PGD, 6Pgd, 6-Pgd, 6PGDH, l35, l(1)2De, 6-pgd, NADP-6 phosphogluconate dehydrogenase, PGD, l(1)G0385, 6Pgdh, Pdg, EG:87B1.4, 6-PGD, 6-phosphogluconate dehydrogenase, l(1)N1, l(1)N3[90], l(1)Pgd-A" CDMC24915 3 5 17 DAC27-G09 23-CG3758-RA_8 CG3758 AGTGCAGACACACAACTTCAAGCAGAATTTCACTTGTTTTTTAATTTCTAGTCAGCATTTTCTCCCAGA 69 FBan0003758 FBgn0001981 esg 2 2L electron transport; GO:0006118; fusion cell fate specification; GO:0035156; maintenance of imaginal histoblast diploidy; GO:0007489; neuroblast division; GO:0045034; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; zinc ion binding; GO:0008270; metal ion binding; GO:0046872; ; GO:0008270; ; GO:0046872 nucleus; GO:0005634 esg escargot "CG3758, CG3758, l(2)35Ce, l(2)br43, fleabag, br43, dgl: double-glazed, 4B7, l35Ce, shut off, l(2)esg, wiz, wizard, Fusion-1, BG:DS07851.7, flg: fleabag, l(2)07082, l(2)4B7, shof, double glazed, dgl" CDMC24915 3 6 17 DAC27-G09 23-CG3758-RA_8 CG3758 AGTGCAGACACACAACTTCAAGCAGAATTTCACTTGTTTTTTAATTTCTAGTCAGCATTTTCTCCCAGA 69 FBan0003758 FBgn0001981 esg 2 2L electron transport; GO:0006118; fusion cell fate specification; GO:0035156; maintenance of imaginal histoblast diploidy; GO:0007489; neuroblast division; GO:0045034; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; zinc ion binding; GO:0008270; metal ion binding; GO:0046872; ; GO:0008270; ; GO:0046872 nucleus; GO:0005634 esg escargot "CG3758, CG3758, l(2)35Ce, l(2)br43, fleabag, br43, dgl: double-glazed, 4B7, l35Ce, shut off, l(2)esg, wiz, wizard, Fusion-1, BG:DS07851.7, flg: fleabag, l(2)07082, l(2)4B7, shof, double glazed, dgl" CDMC24916 3 7 17 DAC27-G21 1-CG3767-RA_5 CG3767 GACATTGCGAGTCTCCTCTCCCATGGTCGATCTCAACGTCTTTCTAGCCGTGTCCATTTTTGCCGAGGT 69 FBan0003767 FBgn0028424 JhI-26 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 JhI-26 Juvenile hormone-inducible protein 26 "CG3767, CG3767, Juvenile hormone-inducible protein 26" CDMC24916 3 8 17 DAC27-G21 1-CG3767-RA_5 CG3767 GACATTGCGAGTCTCCTCTCCCATGGTCGATCTCAACGTCTTTCTAGCCGTGTCCATTTTTGCCGAGGT 69 FBan0003767 FBgn0028424 JhI-26 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 JhI-26 Juvenile hormone-inducible protein 26 "CG3767, CG3767, Juvenile hormone-inducible protein 26" CDMC24917 3 9 17 DAC27-K09 11-CG3815-RA_1 CG3815 AGGGTTAGGGTTAGCAGATACCAGTTCAACTTCATCGCATCAATCATCGCAATGCAAAGCCTCGGCAGT 69 FBan0003815 FBgn0029861 CG3815 X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 CG3815 CG3815 CDMC24917 3 10 17 DAC27-K09 11-CG3815-RA_1 CG3815 AGGGTTAGGGTTAGCAGATACCAGTTCAACTTCATCGCATCAATCATCGCAATGCAAAGCCTCGGCAGT 69 FBan0003815 FBgn0029861 CG3815 X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 CG3815 CG3815 CDMC24918 3 11 17 DAC27-K21 15-CG3830-RA_1 CG3830 CGACTTTGGGTCGGGATTTTGAGAGCGCTTCTTAAGCAAAACTGCAGTGTCTGTGTTTCTGTGTGAGCA 69 FBan0003830 FBgn0003975 vg 2 2R microtubule-based movement; GO:0007018; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476 structural molecule activity; GO:0005198; ; GO:0005198 microtubule; GO:0005874; nucleus; GO:0005634 vg vestigial "CG3830, vg21, VG, Vg" CDMC24918 3 12 17 DAC27-K21 15-CG3830-RA_1 CG3830 CGACTTTGGGTCGGGATTTTGAGAGCGCTTCTTAAGCAAAACTGCAGTGTCTGTGTTTCTGTGTGAGCA 69 FBan0003830 FBgn0003975 vg 2 2R microtubule-based movement; GO:0007018; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476 structural molecule activity; GO:0005198; ; GO:0005198 microtubule; GO:0005874; nucleus; GO:0005634 vg vestigial "CG3830, vg21, VG, Vg" CDMC24919 3 13 17 DAC27-O09 13-CG3862-RA_1 CG3862 TCCGGCCAACCTTGACGTGATCATTTATCCTACAGCCATTAAACTGCCGAGAGTTCAGGGAGAAACAGA 69 FBan0003862 FBgn0031286 CG3862 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG3862 CG3862 RCC GEF-related protein CDMC24919 3 14 17 DAC27-O09 13-CG3862-RA_1 CG3862 TCCGGCCAACCTTGACGTGATCATTTATCCTACAGCCATTAAACTGCCGAGAGTTCAGGGAGAAACAGA 69 FBan0003862 FBgn0031286 CG3862 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG3862 CG3862 RCC GEF-related protein CDMC24920 3 15 17 DAC27-O21 6-CG3879-RA_5 CG3879 GGCGTCGATCGAGGAGGCTTCTCAAGTGGCAGTCGAAGCTATTACCAATATCCGAACGGTCAATGGTCT 69 FBan0003879 FBgn0004512 Mdr49 2 2R defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0015239; ; GO:0042623" integral to plasma membrane; GO:0005887 Mdr49 Multi drug resistance 49 "CG3879, CG3879, Dm5, MDR5, MDR49, Mes5" CDMC24920 3 16 17 DAC27-O21 6-CG3879-RA_5 CG3879 GGCGTCGATCGAGGAGGCTTCTCAAGTGGCAGTCGAAGCTATTACCAATATCCGAACGGTCAATGGTCT 69 FBan0003879 FBgn0004512 Mdr49 2 2R defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0015239; ; GO:0042623" integral to plasma membrane; GO:0005887 Mdr49 Multi drug resistance 49 "CG3879, CG3879, Dm5, MDR5, MDR49, Mes5" CDMC24921 3 17 17 DAC28-C09 18-CG10200-RA_3 CG10200 AAGTGACGAAGTGTGTGTTCTTACAGATCCATACCGCTTCACAATGAAGTACGCTGTGATTGCCATCGC 69 FBan0010200 FBgn0033968 CG10200 2 2R CG10200 CG10200 CDMC24921 3 18 17 DAC28-C09 18-CG10200-RA_3 CG10200 AAGTGACGAAGTGTGTGTTCTTACAGATCCATACCGCTTCACAATGAAGTACGCTGTGATTGCCATCGC 69 FBan0010200 FBgn0033968 CG10200 2 2R CG10200 CG10200 CDMC24922 3 19 17 DAC28-C21 5-CG10209-RA_1 CG10209 AGCACGGTGACTACTCACTTGTCCCACAGCATGTACCAGTTGCAAAAGAAATACGAAAAGGGCGAGCGT 69 FBan0010209 FBgn0033971 CG10209 2 2R CG10209 CG10209 CDMC24922 3 20 17 DAC28-C21 5-CG10209-RA_1 CG10209 AGCACGGTGACTACTCACTTGTCCCACAGCATGTACCAGTTGCAAAAGAAATACGAAAAGGGCGAGCGT 69 FBan0010209 FBgn0033971 CG10209 2 2R CG10209 CG10209 CDMC24923 3 21 17 DAC28-G09 16-CG10242-RA_1 CG10242 GCAAAACCCGAATGCAGAGTTTGTGACAATCGGAAAAAGGGCGATCATAGAACGTCGTTATGGAGGACT 69 FBan0010242 FBgn0033978 Cyp6a23 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a23 Cyp6a23 "CG10242, 6a23" CDMC24923 3 22 17 DAC28-G09 16-CG10242-RA_1 CG10242 GCAAAACCCGAATGCAGAGTTTGTGACAATCGGAAAAAGGGCGATCATAGAACGTCGTTATGGAGGACT 69 FBan0010242 FBgn0033978 Cyp6a23 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a23 Cyp6a23 "CG10242, 6a23" CDMC24924 3 23 17 DAC28-G21 5-CG10249-RB_1 CG10249 GCCAAGGCGACCATTCAGGATCATTGGTTCACTAACTCCAGTACTGGCAAATCCGATCCCCATCAGGTT 69 FBan0010249 FBgn0027596 CG10249 2 2R CG10249 CG10249 "BcDNA:GH03482, BEST:GH19041" CDMC24924 3 24 17 DAC28-G21 5-CG10249-RB_1 CG10249 GCCAAGGCGACCATTCAGGATCATTGGTTCACTAACTCCAGTACTGGCAAATCCGATCCCCATCAGGTT 69 FBan0010249 FBgn0027596 CG10249 2 2R CG10249 CG10249 "BcDNA:GH03482, BEST:GH19041" CDMC24925 3 25 17 DAC28-K09 14-CG10287-RA_1 CG10287 TGGCTTTCGATGCCACAGACTCCAAGTACCTAACCGAAAACTGCGACTATCTACACAACGTGGATTGCG 69 FBan0010287 FBgn0026077 Gasp 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490 extracellular region; GO:0005576 Gasp Gasp "CG10287, gammaBert27, gasp, anon-EST:ParkEST180" CDMC24925 3 26 17 DAC28-K09 14-CG10287-RA_1 CG10287 TGGCTTTCGATGCCACAGACTCCAAGTACCTAACCGAAAACTGCGACTATCTACACAACGTGGATTGCG 69 FBan0010287 FBgn0026077 Gasp 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490 extracellular region; GO:0005576 Gasp Gasp "CG10287, gammaBert27, gasp, anon-EST:ParkEST180" CDMC24926 3 1 18 DAC28-K21 23-CG10298-RA_1 CG10298 CCCAAGTTATACAAGCAACTATCTGGCAAGAAGTAGTATCTTTCTCCTCATAATTAGGCTCCCAAATCC 69 FBan0010298 FBgn0037432 CG10298 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG10298 CG10298 BcDNA:GH28351 CDMC24926 3 2 18 DAC28-K21 23-CG10298-RA_1 CG10298 CCCAAGTTATACAAGCAACTATCTGGCAAGAAGTAGTATCTTTCTCCTCATAATTAGGCTCCCAAATCC 69 FBan0010298 FBgn0037432 CG10298 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG10298 CG10298 BcDNA:GH28351 CDMC24927 3 3 18 DAC28-O09 18-CG10335-RA_1 CG10335 GGTGCCGATTGCATCATCACCTACTACACACCCTTTCTGCTGGACATTATCGGAAAGGTCAAGTAATGG 69 FBan0010335 FBgn0036271 Pbgs 3 3L heme biosynthesis; GO:0006783; porphyrin metabolism; GO:0006778 porphobilinogen synthase activity; GO:0004655 ; EC:4.2.1.24; ; GO:0004655 ; EC:4.2.1.24; ; GO:0004655 ; EC:4.2.1.24 Pbgs Porphobilinogen synthase "CG10335, CG10335, DmPBGS, Porphobilinogen synthase" CDMC24927 3 4 18 DAC28-O09 18-CG10335-RA_1 CG10335 GGTGCCGATTGCATCATCACCTACTACACACCCTTTCTGCTGGACATTATCGGAAAGGTCAAGTAATGG 69 FBan0010335 FBgn0036271 Pbgs 3 3L heme biosynthesis; GO:0006783; porphyrin metabolism; GO:0006778 porphobilinogen synthase activity; GO:0004655 ; EC:4.2.1.24; ; GO:0004655 ; EC:4.2.1.24; ; GO:0004655 ; EC:4.2.1.24 Pbgs Porphobilinogen synthase "CG10335, CG10335, DmPBGS, Porphobilinogen synthase" CDMC24928 3 5 18 DAC28-O21 3-CG10346-RA_2 CG10346 GTACCCCGCACCATGCTAACATCACACCACAATCCTCAAATCCTCTCTTGAAGCCTCAGCAGTTGCTGG 69 FBan0010346 FBgn0032705 Grip71 2 2L gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin ring complex; GO:0008274 Grip71 Grip71 "CG10346, CG10346, Dgrip71, Dgp71WD" CDMC24928 3 6 18 DAC28-O21 3-CG10346-RA_2 CG10346 GTACCCCGCACCATGCTAACATCACACCACAATCCTCAAATCCTCTCTTGAAGCCTCAGCAGTTGCTGG 69 FBan0010346 FBgn0032705 Grip71 2 2L gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin ring complex; GO:0008274 Grip71 Grip71 "CG10346, CG10346, Dgrip71, Dgp71WD" CDMC24929 3 7 18 DAC29-C09 10-CG13908-RA_1 CG13908 CGAGGATCACACAGATCAGACACGAGCACTACGGAAAGGGTGGATTTACGAGGGTGGTAAAATTCGGGT 69 FBan0013908 FBgn0035178 CG13908 3 3L CG13908 CG13908 CDMC24929 3 8 18 DAC29-C09 10-CG13908-RA_1 CG13908 CGAGGATCACACAGATCAGACACGAGCACTACGGAAAGGGTGGATTTACGAGGGTGGTAAAATTCGGGT 69 FBan0013908 FBgn0035178 CG13908 3 3L CG13908 CG13908 CDMC24930 3 9 18 DAC29-C21 16-CG13935-RA_1 CG13935 AAAACCCAAATACAAAATGGCAAACTTCGTGTGCTTCGTTATCCTTTCGTTGGCTCTCTTCGCCAGTGT 69 FBan0013935 FBgn0035280 CG13935 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG13935 CG13935 CDMC24930 3 10 18 DAC29-C21 16-CG13935-RA_1 CG13935 AAAACCCAAATACAAAATGGCAAACTTCGTGTGCTTCGTTATCCTTTCGTTGGCTCTCTTCGCCAGTGT 69 FBan0013935 FBgn0035280 CG13935 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG13935 CG13935 CDMC24931 3 11 18 DAC29-G09 15-CG13980-RA_1 CG13980 CGACTCAGGCGCTACAACTTCAGCGAGTACACGTTTAAGAACTTCGAGCTCTTCCTCTACGAGACGCTT 69 FBan0013980 FBgn0039514 CG13980 3 3R CG13980 CG13980 CDMC24931 3 12 18 DAC29-G09 15-CG13980-RA_1 CG13980 CGACTCAGGCGCTACAACTTCAGCGAGTACACGTTTAAGAACTTCGAGCTCTTCCTCTACGAGACGCTT 69 FBan0013980 FBgn0039514 CG13980 3 3R CG13980 CG13980 CDMC24932 3 13 18 DAC29-G21 1-CG13998-RA_1 CG13998 TGGTCTCACCTACTGCCCACAAACTTCTACTCCGAGATGAACCAGCAGTACTACAGGAGATTCCGGCGA 69 FBan0013998 FBgn0040949 CG13998 2 2L CG13998 CG13998 CDMC24932 3 14 18 DAC29-G21 1-CG13998-RA_1 CG13998 TGGTCTCACCTACTGCCCACAAACTTCTACTCCGAGATGAACCAGCAGTACTACAGGAGATTCCGGCGA 69 FBan0013998 FBgn0040949 CG13998 2 2L CG13998 CG13998 CDMC24933 3 15 18 DAC29-K09 23-CG14030-RA_1 CG14030 ACTCCGCGTTCTAATTTTAAACTATTTTTCTGCGAACAAACTCCCTTTTATTTATTGTTTTGATGCCAA 69 FBan0014030 FBgn0031696 CG14030 2 2L chromosome segregation; GO:0007059; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG14030 CG14030 "BUB1-like, Bub1" CDMC24933 3 16 18 DAC29-K09 23-CG14030-RA_1 CG14030 ACTCCGCGTTCTAATTTTAAACTATTTTTCTGCGAACAAACTCCCTTTTATTTATTGTTTTGATGCCAA 69 FBan0014030 FBgn0031696 CG14030 2 2L chromosome segregation; GO:0007059; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG14030 CG14030 "BUB1-like, Bub1" CDMC24934 3 17 18 DAC29-K21 23-CG14039-RA_3 CG14039 CTTAGATTGCACGCCAAAATGAGCAAAACGATGTCTACGATTTTGGTTCGCGCTAAATTGCATTGTTTT 69 FBan0014039 FBgn0028572 qtc 2 2L courtship behavior; GO:0007619; male courtship behavior; GO:0008049 qtc quick-to-court "CG14039, CG14039, quick-to-court" CDMC24934 3 18 18 DAC29-K21 23-CG14039-RA_3 CG14039 CTTAGATTGCACGCCAAAATGAGCAAAACGATGTCTACGATTTTGGTTCGCGCTAAATTGCATTGTTTT 69 FBan0014039 FBgn0028572 qtc 2 2L courtship behavior; GO:0007619; male courtship behavior; GO:0008049 qtc quick-to-court "CG14039, CG14039, quick-to-court" CDMC24935 3 19 18 DAC29-O09 1-CG14063-RA_1 CG14063 GCCATAATAAGCGTGACCAGGACGAAGAGCAGCAACCAGCAGCAAAAGCAGGAGCATAAGCACGAACAG 69 FBan0014063 FBgn0040618 CG14063 3 3R CG14063 CG14063 CDMC24935 3 20 18 DAC29-O09 1-CG14063-RA_1 CG14063 GCCATAATAAGCGTGACCAGGACGAAGAGCAGCAACCAGCAGCAAAAGCAGGAGCATAAGCACGAACAG 69 FBan0014063 FBgn0040618 CG14063 3 3R CG14063 CG14063 CDMC24936 3 21 18 DAC29-O21 22-CG14077-RA_1 CG14077 TGGTTTTTAGCACTCGATCGGAAGAGGAGCGTCTTGAGTTTAAGAACTATGAGCATATGTACCGGCGGA 69 FBan0014077 FBgn0036830 CG14077 3 3L electron transport; GO:0006118 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG14077 CG14077 VIa CDMC24936 3 22 18 DAC29-O21 22-CG14077-RA_1 CG14077 TGGTTTTTAGCACTCGATCGGAAGAGGAGCGTCTTGAGTTTAAGAACTATGAGCATATGTACCGGCGGA 69 FBan0014077 FBgn0036830 CG14077 3 3L electron transport; GO:0006118 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG14077 CG14077 VIa CDMC24937 3 23 18 DAC30-C09 14-CG15115-RA_1 CG15115 AGCAAGGAATCAGGAGGAGAAGTCGCACTTGGAACAGAGAAAGCTAGAAAGCGATCGTGAAATGGAGGA 69 FBan0015115 FBgn0034413 CG15115 2 2R CG15115 CG15115 CDMC24937 3 24 18 DAC30-C09 14-CG15115-RA_1 CG15115 AGCAAGGAATCAGGAGGAGAAGTCGCACTTGGAACAGAGAAAGCTAGAAAGCGATCGTGAAATGGAGGA 69 FBan0015115 FBgn0034413 CG15115 2 2R CG15115 CG15115 CDMC24938 3 25 18 DAC30-C21 2-CG15122-RA_3 CG15122 TGGTGCACTTCGAATCGATGGAGGGTGTCAACCAACTCTTTGGGGTCTCCAAGTTTCCCGTCATGAGTT 69 FBan0015122 FBgn0034457 CG15122 2 2R CG15122 CG15122 CDMC24938 3 26 18 DAC30-C21 2-CG15122-RA_3 CG15122 TGGTGCACTTCGAATCGATGGAGGGTGTCAACCAACTCTTTGGGGTCTCCAAGTTTCCCGTCATGAGTT 69 FBan0015122 FBgn0034457 CG15122 2 2R CG15122 CG15122 CDMC24939 3 1 19 DAC30-G09 13-CG15160-RA_1 CG15160 CGTCAGCAGCCTTCATCAAGGGGAATCTAGGACAACACGTGCAAAGACTTTACACTTACACCCTCGACT 69 FBan0015160 FBgn0032688 CG15160 2 2L CG15160 CG15160 CDMC24939 3 2 19 DAC30-G09 13-CG15160-RA_1 CG15160 CGTCAGCAGCCTTCATCAAGGGGAATCTAGGACAACACGTGCAAAGACTTTACACTTACACCCTCGACT 69 FBan0015160 FBgn0032688 CG15160 2 2L CG15160 CG15160 CDMC24940 3 3 19 DAC30-G21 3-CG15177-RA_4 CG15177 GCAAGTTCTCGGCCCTGTACGGTGGATTGATTAAGGAGATCGCTGCAACCTCGAAGATGTCCACCTTGG 69 FBan0015177 FBgn0037461 CG15177 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15177 CG15177 CDMC24940 3 4 19 DAC30-G21 3-CG15177-RA_4 CG15177 GCAAGTTCTCGGCCCTGTACGGTGGATTGATTAAGGAGATCGCTGCAACCTCGAAGATGTCCACCTTGG 69 FBan0015177 FBgn0037461 CG15177 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15177 CG15177 CDMC24941 3 5 19 DAC30-K09 17-CG15212-RA_1 CG15212 CAGCCAATTGGGAACCTTGCCTCCCCCACTACATTCGATTTTCAAACCGTTTTGTTTAGACAATACCCA 69 FBan0015212 FBgn0040842 CG15212 3 3L CG15212 CG15212 BcDNA:RE28658 CDMC24941 3 6 19 DAC30-K09 17-CG15212-RA_1 CG15212 CAGCCAATTGGGAACCTTGCCTCCCCCACTACATTCGATTTTCAAACCGTTTTGTTTAGACAATACCCA 69 FBan0015212 FBgn0040842 CG15212 3 3L CG15212 CG15212 BcDNA:RE28658 CDMC24942 3 7 19 DAC30-K21 17-CG15224-RA_1 CG15224 GCGGCATCGCTCAAATGATCGAGAAATATCAAACTGGCGATTTCGGACATTGTCCACGTGTCTACTGTG 69 FBan0015224 FBgn0000259 CkIIbeta X X circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; mushroom body development; GO:0016319; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; protein kinase CK2 activity; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682; ; GO:0008605; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIbeta Casein kinase II beta subunit "CG15224, CG15224, And, Ds cas kin, CK-2, Andante, Casein kinase II, CKII, CK-II beta, CK2, CK-IIbeta, CCK2, betaCK2, CkII, CKIIbeta, mbu, mushroom bodies undersized, CKII-beta1, CK II, DmCKIIbeta, CKIIb, DmCkIIbeta, CkIIbeta1, CK2beta, CKIIbeta, DmCK2beta, CkII-beta, dCKII, casein kinase 2, CK2beta, CkIIbeta, Cask-II-b" CDMC24942 3 8 19 DAC30-K21 17-CG15224-RA_1 CG15224 GCGGCATCGCTCAAATGATCGAGAAATATCAAACTGGCGATTTCGGACATTGTCCACGTGTCTACTGTG 69 FBan0015224 FBgn0000259 CkIIbeta X X circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; mushroom body development; GO:0016319; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; protein kinase CK2 activity; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682; ; GO:0008605; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIbeta Casein kinase II beta subunit "CG15224, CG15224, And, Ds cas kin, CK-2, Andante, Casein kinase II, CKII, CK-II beta, CK2, CK-IIbeta, CCK2, betaCK2, CkII, CKIIbeta, mbu, mushroom bodies undersized, CKII-beta1, CK II, DmCKIIbeta, CKIIb, DmCkIIbeta, CkIIbeta1, CK2beta, CKIIbeta, DmCK2beta, CkII-beta, dCKII, casein kinase 2, CK2beta, CkIIbeta, Cask-II-b" CDMC24943 3 9 19 DAC30-O09 3-CG15259-RA_4 CG15259 GGGTCACGATGATGTTCCTCAACGATCTCGAGATTGCCGACTATGGATCATCGGATGACGAGACCGGCT 69 FBan0015259 FBgn0041103 nht 2 2L spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016986 transcription factor TFIID complex; GO:0005669 nht no hitter "CG15259, CG15259, BG:DS07851.6, TFIID, dmTAF4b, dTAF[[II]]110, nohitter, Nht, dTAF4L, TAF4, no hitter" CDMC24943 3 10 19 DAC30-O09 3-CG15259-RA_4 CG15259 GGGTCACGATGATGTTCCTCAACGATCTCGAGATTGCCGACTATGGATCATCGGATGACGAGACCGGCT 69 FBan0015259 FBgn0041103 nht 2 2L spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016986 transcription factor TFIID complex; GO:0005669 nht no hitter "CG15259, CG15259, BG:DS07851.6, TFIID, dmTAF4b, dTAF[[II]]110, nohitter, Nht, dTAF4L, TAF4, no hitter" CDMC24944 3 11 19 DAC30-O21 10-CG15274-RA_1 CG15274 TGGAGTGTGGCTTTGGCTTTCAACAAGACCATGGAACGATTGACAACCGGGAAGAAATCTCTGAGGGAT 69 FBan0015274 FBgn0028924 GABA-B-R1 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R1 metabotropic GABA-B receptor subtype 1 "CG15274, CG15274, CG15274, BG:DS00929.6, D-GABA[[B]]R1, D-Gaba1, GABA[[B]]R1, GB1, anon-WO0170980.175, anon-WO0170980.176, metabotropic GABA-B receptor subtype 1" CDMC24944 3 12 19 DAC30-O21 10-CG15274-RA_1 CG15274 TGGAGTGTGGCTTTGGCTTTCAACAAGACCATGGAACGATTGACAACCGGGAAGAAATCTCTGAGGGAT 69 FBan0015274 FBgn0028924 GABA-B-R1 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R1 metabotropic GABA-B receptor subtype 1 "CG15274, CG15274, CG15274, BG:DS00929.6, D-GABA[[B]]R1, D-Gaba1, GABA[[B]]R1, GB1, anon-WO0170980.175, anon-WO0170980.176, metabotropic GABA-B receptor subtype 1" CDMC24945 3 13 19 DAC31-C09 1-CG12863-RA_2 CG12863 GATGCCTGTGTGAAACCCAACTATGTGCATTGCTCCGACTGTAGAAGGTGCACGCAGAAGGAGGGAC 67 FBan0012863 FBgn0033948 CG12863 2 2R CG12863 CG12863 CDMC24945 3 14 19 DAC31-C09 1-CG12863-RA_2 CG12863 GATGCCTGTGTGAAACCCAACTATGTGCATTGCTCCGACTGTAGAAGGTGCACGCAGAAGGAGGGAC 67 FBan0012863 FBgn0033948 CG12863 2 2R CG12863 CG12863 CDMC24946 3 15 19 DAC31-C21 2-CG12970-RA_1 CG12970 CCCGCTCACACGATCTTTGTGAAGGGATCTTGCAAGTACTCCGTGGACTTTGTTCCGGCCATTAGGC 67 FBan0012970 FBgn0034047 CG12970 2 2R CG12970 CG12970 CDMC24946 3 16 19 DAC31-C21 2-CG12970-RA_1 CG12970 CCCGCTCACACGATCTTTGTGAAGGGATCTTGCAAGTACTCCGTGGACTTTGTTCCGGCCATTAGGC 67 FBan0012970 FBgn0034047 CG12970 2 2R CG12970 CG12970 CDMC24947 3 17 19 DAC31-G09 1-CG13400-RA_2 CG13400 GGCCAATGCTCCGTTGTGTCTCCAACCTCAGGACATAGGCCGTGTCATCAGTCTGTGTTCCGAATTG 67 FBan0013400 FBgn0027490 D12 2 2L "regulation of transcription, DNA-dependent; GO:0006355" nucleus; GO:0005634 D12 D12 CG13400 CDMC24947 3 18 19 DAC31-G09 1-CG13400-RA_2 CG13400 GGCCAATGCTCCGTTGTGTCTCCAACCTCAGGACATAGGCCGTGTCATCAGTCTGTGTTCCGAATTG 67 FBan0013400 FBgn0027490 D12 2 2L "regulation of transcription, DNA-dependent; GO:0006355" nucleus; GO:0005634 D12 D12 CG13400 CDMC24948 3 19 19 DAC31-G21 1-CG13534-RA_1 CG13534 GCATCATCAAATGACCAACTTGAGCTACCAATCCGACCGGGCACGCAGGGAAAAAACTTCTGGCCTG 67 FBan0013534 FBgn0034805 CG13534 2 2R CG13534 CG13534 CDMC24948 3 20 19 DAC31-G21 1-CG13534-RA_1 CG13534 GCATCATCAAATGACCAACTTGAGCTACCAATCCGACCGGGCACGCAGGGAAAAAACTTCTGGCCTG 67 FBan0013534 FBgn0034805 CG13534 2 2R CG13534 CG13534 CDMC24949 3 21 19 DAC31-K09 2-CG13788-RC_2 CG13788 TGCCTTTGTCCCAAACCATCGATTGGAGCGTTGCCTTCAGAAGTTTCACACCATGGACGTGCAACTC 67 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC24949 3 22 19 DAC31-K09 2-CG13788-RC_2 CG13788 TGCCTTTGTCCCAAACCATCGATTGGAGCGTTGCCTTCAGAAGTTTCACACCATGGACGTGCAACTC 67 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC24950 3 23 19 DAC31-K21 12-CG13920-RA_1 CG13920 TCGTCTAAAATTAGCGACCGGTGTGTTTTGGTAGGGTGTTGTATTGGCTAGGGGCTCCCAGTGAACT 67 FBan0013920 FBgn0025712 CG13920 3 3L CG13920 CG13920 "CK00246, BEST:CK00246" CDMC24950 3 24 19 DAC31-K21 12-CG13920-RA_1 CG13920 TCGTCTAAAATTAGCGACCGGTGTGTTTTGGTAGGGTGTTGTATTGGCTAGGGGCTCCCAGTGAACT 67 FBan0013920 FBgn0025712 CG13920 3 3L CG13920 CG13920 "CK00246, BEST:CK00246" CDMC24951 3 25 19 DAC31-O09 21-CG14358-RA_1 CG14358 TGCTAAACAGCATCCCTTGCCAAATTCATATGGCTTGGATAGCGTGGTGGAGCAACTGTACAACAAC 67 FBan0014358 FBgn0038199 CG14358 3 3R CG14358 CG14358 CDMC24951 3 26 19 DAC31-O09 21-CG14358-RA_1 CG14358 TGCTAAACAGCATCCCTTGCCAAATTCATATGGCTTGGATAGCGTGGTGGAGCAACTGTACAACAAC 67 FBan0014358 FBgn0038199 CG14358 3 3R CG14358 CG14358 CDMC24952 3 1 20 DAC31-O21 AutoBlank AutoBlank CDMC24952 3 2 20 DAC31-O21 AutoBlank AutoBlank CDMC24953 3 3 20 DAC32-C09 1-CG31729-RA_1 CG31729 GCTCGGTTGCTTTGTATCAGGGCTTTCTCATGGTCGGTTACTCGACGCTGTACACTATGTTCCCGGTGT 69 FBan0031729 FBgn0051729 CG31729 2 2L cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG31729 CG31729 "CG16823, CG6263" CDMC24953 3 4 20 DAC32-C09 1-CG31729-RA_1 CG31729 GCTCGGTTGCTTTGTATCAGGGCTTTCTCATGGTCGGTTACTCGACGCTGTACACTATGTTCCCGGTGT 69 FBan0031729 FBgn0051729 CG31729 2 2L cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG31729 CG31729 "CG16823, CG6263" CDMC24954 3 5 20 DAC32-C21 1-CG31736-RA_1 CG31736 TCTTCTTCGGTCCCCCCATTTCCTCGAACTCCCGGTTTCACTCCTATTCCCCATCGCATATAGGCAAAA 69 FBan0031736 FBgn0051736 CG31736 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31736 CG31736 CDMC24954 3 6 20 DAC32-C21 1-CG31736-RA_1 CG31736 TCTTCTTCGGTCCCCCCATTTCCTCGAACTCCCGGTTTCACTCCTATTCCCCATCGCATATAGGCAAAA 69 FBan0031736 FBgn0051736 CG31736 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31736 CG31736 CDMC24955 3 7 20 DAC32-G09 23-CG31761-RA_11 CG31761 TCTCGAGTGCACAAAAACGAAACGCAAAAATCAACCCTACCAAAGAAGTAGCTTAAAAGTTGCATCCCT 69 FBan0031761 FBgn0043904 bru-2 2 2L mRNA processing; GO:0006397; protein metabolism; GO:0019538 mRNA binding; GO:0003729; ; GO:0003729 bru-2 bruno-2 "CG6319, CG17008, CG31761, CG6319, CG6319, CG17008, Dm Bru-2, bruno-2" CDMC24955 3 8 20 DAC32-G09 23-CG31761-RA_11 CG31761 TCTCGAGTGCACAAAAACGAAACGCAAAAATCAACCCTACCAAAGAAGTAGCTTAAAAGTTGCATCCCT 69 FBan0031761 FBgn0043904 bru-2 2 2L mRNA processing; GO:0006397; protein metabolism; GO:0019538 mRNA binding; GO:0003729; ; GO:0003729 bru-2 bruno-2 "CG6319, CG17008, CG31761, CG6319, CG6319, CG17008, Dm Bru-2, bruno-2" CDMC24956 3 9 20 DAC32-G21 2-CG31766-RB_1 CG31766 CGGACGAACGAGTATGTGGGATGGAACTACGATGGTGACTACTGCAAGAGGAGCATCGAAACTGCTGGC 69 FBgn0051766 CDMC24956 3 10 20 DAC32-G21 2-CG31766-RB_1 CG31766 CGGACGAACGAGTATGTGGGATGGAACTACGATGGTGACTACTGCAAGAGGAGCATCGAAACTGCTGGC 69 FBgn0051766 CDMC24957 3 11 20 DAC32-K09 11-CG31801-RA_2 CG31801 TGCCGGAGCAAGAAGATCCATCAATGTGCCGAGATGAGTTTCTCAAGGATCTGATAAGGGAGCACGAGT 69 FBan0031801 FBgn0051801 CG31801 2 2L CG31801 CG31801 CG15165 CDMC24957 3 12 20 DAC32-K09 11-CG31801-RA_2 CG31801 TGCCGGAGCAAGAAGATCCATCAATGTGCCGAGATGAGTTTCTCAAGGATCTGATAAGGGAGCACGAGT 69 FBan0031801 FBgn0051801 CG31801 2 2L CG31801 CG31801 CG15165 CDMC24958 3 13 20 DAC32-K21 1-CG31809-RA_9 CG31809 GGAAAAGCTGATTGCAGTCACCAACGAGATTGTCAACAATGTGGGCACGATTCACGACCCGGAAAGCCT 69 FBan0031809 FBgn0051809 CG31809 2 2L lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016229 ; EC:1.1.1.- CG31809 CG31809 CDMC24958 3 14 20 DAC32-K21 1-CG31809-RA_9 CG31809 GGAAAAGCTGATTGCAGTCACCAACGAGATTGTCAACAATGTGGGCACGATTCACGACCCGGAAAGCCT 69 FBan0031809 FBgn0051809 CG31809 2 2L lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016229 ; EC:1.1.1.- CG31809 CG31809 CDMC24959 3 15 20 DAC32-O09 13-CG31834-RA_1 CG31834 GCCGTTCAGTGCGATGATAGTGCATTAAATGTGCTGCGATGGGAGATTGTTGTCTGTCGATGGAATGGT 69 FBgn0028927 CDMC24959 3 16 20 DAC32-O09 13-CG31834-RA_1 CG31834 GCCGTTCAGTGCGATGATAGTGCATTAAATGTGCTGCGATGGGAGATTGTTGTCTGTCGATGGAATGGT 69 FBgn0028927 CDMC24960 3 17 20 DAC32-O21 2-CG31848-RA_1 CG31848 CCCCAAAGCCGGGTCTTAGTTGTGCTGTTACTTCGGATCTGCAGATTGTCCACCATCTGCCCATTATCC 69 FBan0031848 FBgn0051848 CG31848 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31848 CG31848 CDMC24960 3 18 20 DAC32-O21 2-CG31848-RA_1 CG31848 CCCCAAAGCCGGGTCTTAGTTGTGCTGTTACTTCGGATCTGCAGATTGTCCACCATCTGCCCATTATCC 69 FBan0031848 FBgn0051848 CG31848 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31848 CG31848 CDMC24961 3 19 20 DAC33-C09 23-CG15544-RA_3 CG15544 AGATAAACCTAGATAGATGTACCCTAGAACTTAGCCACTAGTTGAGTTCCCACGAGATCAGTGTGTGTG 69 FBan0015544 FBgn0039804 CG15544 3 3R CG15544 CG15544 CDMC24961 3 20 20 DAC33-C09 23-CG15544-RA_3 CG15544 AGATAAACCTAGATAGATGTACCCTAGAACTTAGCCACTAGTTGAGTTCCCACGAGATCAGTGTGTGTG 69 FBan0015544 FBgn0039804 CG15544 3 3R CG15544 CG15544 CDMC24962 3 21 20 DAC33-C21 13-CG15553-RA_2 CG15553 TCATGGCACCTGTACCTATCTGTTGTCCTCGGAATCTTTCGTTCCATTCAGGGTCCCATGTTTCGAACA 69 FBan0015553 FBgn0039817 CG15553 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG15553 CG15553 CDMC24962 3 22 20 DAC33-C21 13-CG15553-RA_2 CG15553 TCATGGCACCTGTACCTATCTGTTGTCCTCGGAATCTTTCGTTCCATTCAGGGTCCCATGTTTCGAACA 69 FBan0015553 FBgn0039817 CG15553 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG15553 CG15553 CDMC24963 3 23 20 DAC33-G09 23-CG15598-RA_6 CG15598 CGTGAACGAGCAACTTTGAAGTCAAAATTTCCTTGTTAAAAACCGAACTGTAAATAAGATAAAACACGT 69 FBan0015598 FBgn0037427 Osi17 3 3R Osi17 Osiris 17 "CG15598, CG15598, Osiris, Osiris 17" CDMC24963 3 24 20 DAC33-G09 23-CG15598-RA_6 CG15598 CGTGAACGAGCAACTTTGAAGTCAAAATTTCCTTGTTAAAAACCGAACTGTAAATAAGATAAAACACGT 69 FBan0015598 FBgn0037427 Osi17 3 3R Osi17 Osiris 17 "CG15598, CG15598, Osiris, Osiris 17" CDMC24964 3 25 20 DAC33-G21 2-CG15605-RA_1 CG15605 GGGAACGCAAGGCAGGAGTTGTAAAGAGGGACAAGGCAGATAAGTGGAACCATGTAGAGACGGCTCGAT 69 FBan0015605 FBgn0034196 CG15605 2 2R CG15605 CG15605 BcDNA:AT23338 CDMC24964 3 26 20 DAC33-G21 2-CG15605-RA_1 CG15605 GGGAACGCAAGGCAGGAGTTGTAAAGAGGGACAAGGCAGATAAGTGGAACCATGTAGAGACGGCTCGAT 69 FBan0015605 FBgn0034196 CG15605 2 2R CG15605 CG15605 BcDNA:AT23338 CDMC24965 3 1 21 DAC33-K09 8-CG15654-RA_2 CG15654 TGGTAGACAATACGGATCCGTGGTCCTTCTGGGATGCCATGGTCTATTCCGCTACGATTTACACGACCA 69 FBan0015654 FBgn0034586 CG15654 2 2R CG15654 CG15654 CDMC24965 3 2 21 DAC33-K09 8-CG15654-RA_2 CG15654 TGGTAGACAATACGGATCCGTGGTCCTTCTGGGATGCCATGGTCTATTCCGCTACGATTTACACGACCA 69 FBan0015654 FBgn0034586 CG15654 2 2R CG15654 CG15654 CDMC24966 3 3 21 DAC33-K21 18-CG15676-RA_1 CG15676 ATTGCAACATGAGCACGATATCGACTATCTGCAGGATCAGGTGAACACGATTGAGATGAACCTAGCCGT 69 FBan0015676 FBgn0034651 CG15676 2 2R protein folding; GO:0006457 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG15676 CG15676 CDMC24966 3 4 21 DAC33-K21 18-CG15676-RA_1 CG15676 ATTGCAACATGAGCACGATATCGACTATCTGCAGGATCAGGTGAACACGATTGAGATGAACCTAGCCGT 69 FBan0015676 FBgn0034651 CG15676 2 2R protein folding; GO:0006457 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG15676 CG15676 CDMC24967 3 5 21 DAC33-O09 18-CG15728-RA_2 CG15728 CACCCAGGTGAAAAGAACTCTTTTCCTGCAAAAGTGCTTCAATTATATGGCATGCTCCGAGGAAAGCCA 69 FBan0015728 FBgn0030409 CG15728 X X CG15728 CG15728 CDMC24967 3 6 21 DAC33-O09 18-CG15728-RA_2 CG15728 CACCCAGGTGAAAAGAACTCTTTTCCTGCAAAAGTGCTTCAATTATATGGCATGCTCCGAGGAAAGCCA 69 FBan0015728 FBgn0030409 CG15728 X X CG15728 CG15728 CDMC24968 3 7 21 DAC33-O21 16-CG15735-RA_1 CG15735 TGAGGAAAACAGTTGAGCGAAGACAGGACTACTTGAAGTCTAAGAATGCTGATGTCAGTCCAGAGGCGC 69 FBan0015735 FBgn0030364 CG15735 X X CG15735 CG15735 BcDNA:LD05893 CDMC24968 3 8 21 DAC33-O21 16-CG15735-RA_1 CG15735 TGAGGAAAACAGTTGAGCGAAGACAGGACTACTTGAAGTCTAAGAATGCTGATGTCAGTCCAGAGGCGC 69 FBan0015735 FBgn0030364 CG15735 X X CG15735 CG15735 BcDNA:LD05893 CDMC24969 3 9 21 DAC34-C09 23-CG31151-RA_1 CG31151 CGAAGCAATATCAATCCATATACGATAACAATGATACATATTATTTAGCCGGGCACTATAACCCAAGGT 69 FBan0031151 FBgn0051151 CG31151 3 3R DNA binding; GO:0003677; ; GO:0003677 CG31151 CG31151 "CG17621, CG4902" CDMC24969 3 10 21 DAC34-C09 23-CG31151-RA_1 CG31151 CGAAGCAATATCAATCCATATACGATAACAATGATACATATTATTTAGCCGGGCACTATAACCCAAGGT 69 FBan0031151 FBgn0051151 CG31151 3 3R DNA binding; GO:0003677; ; GO:0003677 CG31151 CG31151 "CG17621, CG4902" CDMC24970 3 11 21 DAC34-C21 9-CG31161-RA_5 CG31161 ATGAGGCGGAGTGTCTGACATGCAACCTGGAGGAAAATCTACGGAAACAGTGCCGATGCATGGAGCAAA 69 FBan0031161 FBgn0051161 CG31161 3 3R CG31161 CG31161 "CG6943, CG6943" CDMC24970 3 12 21 DAC34-C21 9-CG31161-RA_5 CG31161 ATGAGGCGGAGTGTCTGACATGCAACCTGGAGGAAAATCTACGGAAACAGTGCCGATGCATGGAGCAAA 69 FBan0031161 FBgn0051161 CG31161 3 3R CG31161 CG31161 "CG6943, CG6943" CDMC24971 3 13 21 DAC34-G09 15-CG31193-RA_1 CG31193 GCACCACCTCAAGGAGGATCATTTGGAAACATATTTGGACACTTCCTAGGCAGAGTCGGAACCCGGTAT 69 FBan0031193 FBgn0044810 TotX 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotX Turandot X "CG31193, tot" CDMC24971 3 14 21 DAC34-G09 15-CG31193-RA_1 CG31193 GCACCACCTCAAGGAGGATCATTTGGAAACATATTTGGACACTTCCTAGGCAGAGTCGGAACCCGGTAT 69 FBan0031193 FBgn0044810 TotX 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotX Turandot X "CG31193, tot" CDMC24972 3 15 21 DAC34-G21 9-CG31201-RA_1 CG31201 GCGTCGACGATCTGGCCGATAACAAGGATGGTGTAGTTTACGGTGCAAAGAAAACTGGATCCACCAGGA 69 FBan0031201 FBgn0051201 GluRIIE 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 integral to membrane; GO:0016021 GluRIIE Glutamate receptor IIE "CG31201, GluR-IIE, Glutamate receptor IIE" CDMC24972 3 16 21 DAC34-G21 9-CG31201-RA_1 CG31201 GCGTCGACGATCTGGCCGATAACAAGGATGGTGTAGTTTACGGTGCAAAGAAAACTGGATCCACCAGGA 69 FBan0031201 FBgn0051201 GluRIIE 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 integral to membrane; GO:0016021 GluRIIE Glutamate receptor IIE "CG31201, GluR-IIE, Glutamate receptor IIE" CDMC24973 3 17 21 DAC34-K09 3-CG31225-RA_6 CG31225 GGCTCCCCGATGATGGTGGGAAATTGGTGTATGATGTTACCGACGGAGAGGGTAATAGGCAGCCATGAG 69 FBan0031225 FBgn0051225 CG31225 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31225 CG31225 CDMC24973 3 18 21 DAC34-K09 3-CG31225-RA_6 CG31225 GGCTCCCCGATGATGGTGGGAAATTGGTGTATGATGTTACCGACGGAGAGGGTAATAGGCAGCCATGAG 69 FBan0031225 FBgn0051225 CG31225 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31225 CG31225 CDMC24974 3 19 21 DAC34-K21 16-CG31243-RA_6 CG31243 CGCCACTTTTGGTTGAGACTTTTCTGCGTTTCCCCTACAAAGACTTGAACTTTTACTAGAGGCCCCCAA 69 FBan0031243 FBgn0000363 cpo 3 3R cellular physiological process; GO:0050875; peripheral nervous system development; GO:0007422; synaptic transmission; GO:0007268 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 cpo couch potato "CG12349, CG18435, CG31243, CG18434, CG12349, CG18435, CG18435, CG12349, 1824, 3603, 5339, 6015, l(3)6015, Cpo, cg18435, N, BcDNA:AT31405, E(sda)N, l(3)01432, l(3)j4A1, l(3)j4D4, l(3)j7E2, l(3)j9B3, l(3)rJ553, l(3)s2336" CDMC24974 3 20 21 DAC34-K21 16-CG31243-RA_6 CG31243 CGCCACTTTTGGTTGAGACTTTTCTGCGTTTCCCCTACAAAGACTTGAACTTTTACTAGAGGCCCCCAA 69 FBan0031243 FBgn0000363 cpo 3 3R cellular physiological process; GO:0050875; peripheral nervous system development; GO:0007422; synaptic transmission; GO:0007268 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 cpo couch potato "CG12349, CG18435, CG31243, CG18434, CG12349, CG18435, CG18435, CG12349, 1824, 3603, 5339, 6015, l(3)6015, Cpo, cg18435, N, BcDNA:AT31405, E(sda)N, l(3)01432, l(3)j4A1, l(3)j4D4, l(3)j7E2, l(3)j9B3, l(3)rJ553, l(3)s2336" CDMC24975 3 21 21 DAC34-O09 18-CG3127-RA_3 CG3127 CCAGAAAATCCAGAAAAATCCAAAGATGGCCTTCAATAAGCTGAGCATCGAAAACCTGGACTTGGCGGG 69 FBan0003127 FBgn0003075 Pgk 2 2L glycolysis; GO:0006096; phosphorylation; GO:0016310 phosphoglycerate kinase activity; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3; carbohydrate kinase activity; GO:0019200; ; GO:0019200; ; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3 cytoplasm; GO:0005737 Pgk Phosphoglycerate kinase "CG3127, PGK, 169C9S, pgk, ESTS:169C9S, anon-sts18" CDMC24975 3 22 21 DAC34-O09 18-CG3127-RA_3 CG3127 CCAGAAAATCCAGAAAAATCCAAAGATGGCCTTCAATAAGCTGAGCATCGAAAACCTGGACTTGGCGGG 69 FBan0003127 FBgn0003075 Pgk 2 2L glycolysis; GO:0006096; phosphorylation; GO:0016310 phosphoglycerate kinase activity; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3; carbohydrate kinase activity; GO:0019200; ; GO:0019200; ; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3 cytoplasm; GO:0005737 Pgk Phosphoglycerate kinase "CG3127, PGK, 169C9S, pgk, ESTS:169C9S, anon-sts18" CDMC24976 3 23 21 DAC34-O21 16-CG31287-RA_3 CG31287 ACTTCCCATCGATGATACCCTGAGATCAGTAAAGTGCACCATGCTTAGGGTAGAAATGGAGCTGCATGA 69 FBan0031287 FBgn0051287 CG31287 3 3R protein folding; GO:0006457 protein binding; GO:0005515; ; GO:0005515 prefoldin complex; GO:0016272 CG31287 CG31287 NEST:bs24f08 CDMC24976 3 24 21 DAC34-O21 16-CG31287-RA_3 CG31287 ACTTCCCATCGATGATACCCTGAGATCAGTAAAGTGCACCATGCTTAGGGTAGAAATGGAGCTGCATGA 69 FBan0031287 FBgn0051287 CG31287 3 3R protein folding; GO:0006457 protein binding; GO:0005515; ; GO:0005515 prefoldin complex; GO:0016272 CG31287 CG31287 NEST:bs24f08 CDMC24977 3 25 21 DAC35-C09 2-CG8141-RA_1 CG8141 ACCGTCGCAGGAATTTGCATCTGGATCCCTATGTGTGCAATGAGTGCAACCAGTATGTGCGTGGTG 66 FBan0008141 FBgn0038125 CG8141 3 3R CG8141 CG8141 BcDNA:AT26376 CDMC24977 3 26 21 DAC35-C09 2-CG8141-RA_1 CG8141 ACCGTCGCAGGAATTTGCATCTGGATCCCTATGTGTGCAATGAGTGCAACCAGTATGTGCGTGGTG 66 FBan0008141 FBgn0038125 CG8141 3 3R CG8141 CG8141 BcDNA:AT26376 CDMC24978 3 1 22 DAC35-C21 13-CG8261-RB_1 CG8261 ACCTTTTCAACCATAGGCCTATCCGAGACAGCCATCATGGACGTAATGTCATCATCCCTGCAGCAG 66 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC24978 3 2 22 DAC35-C21 13-CG8261-RB_1 CG8261 ACCTTTTCAACCATAGGCCTATCCGAGACAGCCATCATGGACGTAATGTCATCATCCCTGCAGCAG 66 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC24979 3 3 22 DAC35-G09 3-CG8781-RA_1 CG8781 GCTTCGTTAAGGGACCGAAGCGCGTTAAAAAGTCCGAAAAGCGTCGCAGATAAACGACTCCCAGCC 66 FBan0008781 FBgn0033378 tsu 2 2R RNA processing; GO:0006396; establishment of pole plasm mRNA localization; GO:0046595; mRNA export from nucleus; GO:0006406; microtubule cytoskeleton organization and biogenesis; GO:0000226; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 tsu tsunagi "CG8781, CG8781, CG8781, cg8781, y14, Y14, Y14/Tsunagi, tsunagi" CDMC24979 3 4 22 DAC35-G09 3-CG8781-RA_1 CG8781 GCTTCGTTAAGGGACCGAAGCGCGTTAAAAAGTCCGAAAAGCGTCGCAGATAAACGACTCCCAGCC 66 FBan0008781 FBgn0033378 tsu 2 2R RNA processing; GO:0006396; establishment of pole plasm mRNA localization; GO:0046595; mRNA export from nucleus; GO:0006406; microtubule cytoskeleton organization and biogenesis; GO:0000226; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 tsu tsunagi "CG8781, CG8781, CG8781, cg8781, y14, Y14, Y14/Tsunagi, tsunagi" CDMC24980 3 5 22 DAC35-G21 3-CG8938-RB_2 CG8938 TCACCGAGGTCTAAGTTCACCGAACAGGACTTGGGAGGATGGGAAAGCATTGCACAACCACTCAGA 66 FBan0008938 FBgn0010226 GstS1 2 2R cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; muscle contraction; GO:0006936; response to oxidative stress; GO:0006979; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18 cellular component unknown; GO:0008372 GstS1 Glutathione S transferase S1 "CG8938, CG8938, DmGST2, GST, DmGST-2, gstD2, Gst2: Glutathione S transferase 2, GST2, Glutathione S-transferase 2, DmGst-2, GST-2, GSTII, Est2, glutathione transferase-related protein, n(2)06253, l(2)04227, DmGSTS1-1, l(2)k08805, DmGSTS1, GST S1, GSTS1, Glutathione S-transferase, glutathione-S-transferase, Glutathione S transferase 2, Gst2, Glutathione S transferase S1" CDMC24980 3 6 22 DAC35-G21 3-CG8938-RB_2 CG8938 TCACCGAGGTCTAAGTTCACCGAACAGGACTTGGGAGGATGGGAAAGCATTGCACAACCACTCAGA 66 FBan0008938 FBgn0010226 GstS1 2 2R cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; muscle contraction; GO:0006936; response to oxidative stress; GO:0006979; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18 cellular component unknown; GO:0008372 GstS1 Glutathione S transferase S1 "CG8938, CG8938, DmGST2, GST, DmGST-2, gstD2, Gst2: Glutathione S transferase 2, GST2, Glutathione S-transferase 2, DmGst-2, GST-2, GSTII, Est2, glutathione transferase-related protein, n(2)06253, l(2)04227, DmGSTS1-1, l(2)k08805, DmGSTS1, GST S1, GSTS1, Glutathione S-transferase, glutathione-S-transferase, Glutathione S transferase 2, Gst2, Glutathione S transferase S1" CDMC24981 3 7 22 DAC35-K09 23-CG9422-RA_1 CG9422 CCATGCGAAGATTTTCTTATTTGCCCTTTGTAAGGATGTACAAATAAAGCCCAATTTATCACAAAA 66 FBan0009422 FBgn0033092 CG9422 2 2R CG9422 CG9422 BcDNA:RE35072 CDMC24981 3 8 22 DAC35-K09 23-CG9422-RA_1 CG9422 CCATGCGAAGATTTTCTTATTTGCCCTTTGTAAGGATGTACAAATAAAGCCCAATTTATCACAAAA 66 FBan0009422 FBgn0033092 CG9422 2 2R CG9422 CG9422 BcDNA:RE35072 CDMC24982 3 9 22 DAC35-K21 3-CG9614-RJ_4 CG9614 TGATCTTCAATCGACCAACCCGAGTAGACAGCGAGCAAATGGTCCCACTTTTCAGGCAATTGGCCG 66 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24982 3 10 22 DAC35-K21 3-CG9614-RJ_4 CG9614 TGATCTTCAATCGACCAACCCGAGTAGACAGCGAGCAAATGGTCCCACTTTTCAGGCAATTGGCCG 66 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC24983 3 11 22 DAC35-O09 2-CR31273-RD_1 CR31273 GGCAATGAACCCTTGACTTTTGGCCGCAATTCATCAAACAATTGGCCGACCATTTGCATGCGGTGG 66 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC24983 3 12 22 DAC35-O09 2-CR31273-RD_1 CR31273 GGCAATGAACCCTTGACTTTTGGCCGCAATTCATCAAACAATTGGCCGACCATTTGCATGCGGTGG 66 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC24984 3 13 22 DAC35-O21 AutoBlank AutoBlank CDMC24984 3 14 22 DAC35-O21 AutoBlank AutoBlank CDMC24985 3 15 22 DAC36-C09 3-CG1819-RA_2 CG1819 GATGGACGAACCAACGAGCGACATGGATCCCGTGACCAGGGACATGGTGTATGCCACTATCGAAC 65 FBan0001819 FBgn0031162 CG1819 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1819 CG1819 CDMC24985 3 16 22 DAC36-C09 3-CG1819-RA_2 CG1819 GATGGACGAACCAACGAGCGACATGGATCCCGTGACCAGGGACATGGTGTATGCCACTATCGAAC 65 FBan0001819 FBgn0031162 CG1819 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1819 CG1819 CDMC24986 3 17 22 DAC36-C21 15-CG1828-RA_4 CG1828 AATCGGATGAGGAGTCGGACGAAGATTCCGAGTACTCAGAGGCATCAGAAGACAGCGAGGAAAGC 65 FBan0001828 FBgn0002183 dre4 3 3L DNA unwinding during replication; GO:0006268; proteolysis; GO:0006508; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription cofactor activity; GO:0003712; ; GO:0003712; metalloexopeptidase activity; GO:0008235; ; GO:0008235 FACT complex; GO:0035101 dre4 dre4 "CG1828, l(3)dre4, l(3)62Bg: lethal(3)62Bg, DRE4/dSPT16, dspt16, supressor of Ty element 16, dSPT16, spt16, Spt16, lethal(3)62Bg, l(3)62Bg" CDMC24986 3 18 22 DAC36-C21 15-CG1828-RA_4 CG1828 AATCGGATGAGGAGTCGGACGAAGATTCCGAGTACTCAGAGGCATCAGAAGACAGCGAGGAAAGC 65 FBan0001828 FBgn0002183 dre4 3 3L DNA unwinding during replication; GO:0006268; proteolysis; GO:0006508; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription cofactor activity; GO:0003712; ; GO:0003712; metalloexopeptidase activity; GO:0008235; ; GO:0008235 FACT complex; GO:0035101 dre4 dre4 "CG1828, l(3)dre4, l(3)62Bg: lethal(3)62Bg, DRE4/dSPT16, dspt16, supressor of Ty element 16, dSPT16, spt16, Spt16, lethal(3)62Bg, l(3)62Bg" CDMC24987 3 19 22 DAC36-G09 2-CG18476-RA_1 CG18476 AAAGAAATCCCTCACCGTTCACCTGCTTAGCGTACATGCGGAGGAATCCAAGCTGATTCCCTGCC 65 FBan0018476 FBgn0037931 CG18476 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18476 CG18476 CG17822 CDMC24987 3 20 22 DAC36-G09 2-CG18476-RA_1 CG18476 AAAGAAATCCCTCACCGTTCACCTGCTTAGCGTACATGCGGAGGAATCCAAGCTGATTCCCTGCC 65 FBan0018476 FBgn0037931 CG18476 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18476 CG18476 CG17822 CDMC24988 3 21 22 DAC36-G21 23-CG18545-RA_2 CG18545 CCGACGAGAAGTCTTACAAAAGATCTCCCAAAATGAAGGTCATATCAATGAAGCAGTCACCTCTG 65 FBan0018545 FBgn0037812 CG18545 3 3R CG18545 CG18545 CDMC24988 3 22 22 DAC36-G21 23-CG18545-RA_2 CG18545 CCGACGAGAAGTCTTACAAAAGATCTCCCAAAATGAAGGTCATATCAATGAAGCAGTCACCTCTG 65 FBan0018545 FBgn0037812 CG18545 3 3R CG18545 CG18545 CDMC24989 3 23 22 DAC36-K09 2-CG18672-RA_2 CG18672 TGAAGGGTCGTTACTATGCCGATGGACTTCACTTCCATTGGGGGTCCTACAAATCCCGCGGATCC 65 FBan0018672 FBgn0040628 CG18672 3 3R metabolism; GO:0008152; one-carbon compound metabolism; GO:0006730 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG18672 CG18672 CDMC24989 3 24 22 DAC36-K09 2-CG18672-RA_2 CG18672 TGAAGGGTCGTTACTATGCCGATGGACTTCACTTCCATTGGGGGTCCTACAAATCCCGCGGATCC 65 FBan0018672 FBgn0040628 CG18672 3 3R metabolism; GO:0008152; one-carbon compound metabolism; GO:0006730 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG18672 CG18672 CDMC24990 3 25 22 DAC36-K21 3-CG18729-RA_5 CG18729 ATCAGCTGCGCATTCTGGTCTACATACGCGAGGACATCGTCTCCTACCACACGGATGTCAAGCAG 65 FBan0018729 FBgn0061476 zwilch 3 3R mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 zwilch zwilch "CG18729, CG18639" CDMC24990 3 26 22 DAC36-K21 3-CG18729-RA_5 CG18729 ATCAGCTGCGCATTCTGGTCTACATACGCGAGGACATCGTCTCCTACCACACGGATGTCAAGCAG 65 FBan0018729 FBgn0061476 zwilch 3 3R mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 zwilch zwilch "CG18729, CG18639" CDMC24991 3 1 23 DAC36-O09 18-CG1906-RA_4 CG1906 GCGGGTGGCAGTGTTATGATAAAGCGCGTAAATGGTACCCTGGCAGTGTCGAGAGCCCTTGGGGA 65 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC24991 3 2 23 DAC36-O09 18-CG1906-RA_4 CG1906 GCGGGTGGCAGTGTTATGATAAAGCGCGTAAATGGTACCCTGGCAGTGTCGAGAGCCCTTGGGGA 65 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC24992 3 3 23 DAC36-O21 AutoBlank AutoBlank CDMC24992 3 4 23 DAC36-O21 AutoBlank AutoBlank CDMC24993 3 5 23 DAC37-C09 14-CG16928-RA_4 CG16928 CGCTCATTCGGTTGCGTCTCCTCTACACAGATGAGTCCTGCATGTTTAATGCGATTCGGTTTGGAGAGA 69 FBan0016928 FBgn0020270 mre11 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; double-strand break repair; GO:0006302; meiosis; GO:0007126; nucleotide-excision repair; GO:0006289; telomere maintenance; GO:0000723 nucleic acid binding; GO:0003676; endonuclease activity; GO:0004519; exonuclease activity; GO:0004527; ; GO:0004519; ; GO:0004527; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; ; GO:0004519; ; GO:0004527; manganese ion binding; GO:0030145; ; GO:0030145 nucleus; GO:0005634 mre11 meiotic recombination 11 "CG16928, MRE11, Mre11" CDMC24993 3 6 23 DAC37-C09 14-CG16928-RA_4 CG16928 CGCTCATTCGGTTGCGTCTCCTCTACACAGATGAGTCCTGCATGTTTAATGCGATTCGGTTTGGAGAGA 69 FBan0016928 FBgn0020270 mre11 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; double-strand break repair; GO:0006302; meiosis; GO:0007126; nucleotide-excision repair; GO:0006289; telomere maintenance; GO:0000723 nucleic acid binding; GO:0003676; endonuclease activity; GO:0004519; exonuclease activity; GO:0004527; ; GO:0004519; ; GO:0004527; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; ; GO:0004519; ; GO:0004527; manganese ion binding; GO:0030145; ; GO:0030145 nucleus; GO:0005634 mre11 meiotic recombination 11 "CG16928, MRE11, Mre11" CDMC24994 3 7 23 DAC37-C21 23-CG1693-RB_3 CG1693 CACCAAAACTACTCCAAGTAGGTGTTGCTATTATACCATGGTGCACAAAAAAAAGAATCATAGCTGCAT 69 FBan0001693 FBgn0015558 tty X X tty tweety "CG1693, CG1693, twe, tweety" CDMC24994 3 8 23 DAC37-C21 23-CG1693-RB_3 CG1693 CACCAAAACTACTCCAAGTAGGTGTTGCTATTATACCATGGTGCACAAAAAAAAGAATCATAGCTGCAT 69 FBan0001693 FBgn0015558 tty X X tty tweety "CG1693, CG1693, twe, tweety" CDMC24995 3 9 23 DAC37-G09 12-CG16971-RB_3 CG16971 GCAACGATGATGAGGAACGGAACACAAACAAGAAACTACGTCGCAGTGGGTCACTGAATGAATCCGCGT 69 FBan0016971 FBgn0035114 CG16971 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG16971 CG16971 CDMC24995 3 10 23 DAC37-G09 12-CG16971-RB_3 CG16971 GCAACGATGATGAGGAACGGAACACAAACAAGAAACTACGTCGCAGTGGGTCACTGAATGAATCCGCGT 69 FBan0016971 FBgn0035114 CG16971 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG16971 CG16971 CDMC24996 3 11 23 DAC37-G21 3-CG1697-RA_3 CG1697 TCCCGACTACTTCCCAAAACAGGAGTACAACTAGCCCCATCACTAGCTCTAGCCCTAGCCCTAACCCTT 69 FBan0001697 FBgn0030318 rho-4 X X ectoderm development; GO:0007398; female gamete generation; GO:0007292; nervous system development; GO:0007399 serine-type peptidase activity; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005509; ; GO:0005057; ; GO:0008236 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rho-4 rhomboid-4 "CG1697, Rho-related [10C6], Rho-4, rhomboid-4" CDMC24996 3 12 23 DAC37-G21 3-CG1697-RA_3 CG1697 TCCCGACTACTTCCCAAAACAGGAGTACAACTAGCCCCATCACTAGCTCTAGCCCTAGCCCTAACCCTT 69 FBan0001697 FBgn0030318 rho-4 X X ectoderm development; GO:0007398; female gamete generation; GO:0007292; nervous system development; GO:0007399 serine-type peptidase activity; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005509; ; GO:0005057; ; GO:0008236 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rho-4 rhomboid-4 "CG1697, Rho-related [10C6], Rho-4, rhomboid-4" CDMC24997 3 13 23 DAC37-K09 23-CG17019-RA_1 CG17019 GATTTTTTAGAGCGTAATGATACGGCTAATCTTACGGTAACTGGACATAGTGTAATGATGGAAGCCGAT 69 FBan0017019 FBgn0033783 CG17019 2 2R negative regulation of apoptosis; GO:0043066; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17019 CG17019 CDMC24997 3 14 23 DAC37-K09 23-CG17019-RA_1 CG17019 GATTTTTTAGAGCGTAATGATACGGCTAATCTTACGGTAACTGGACATAGTGTAATGATGGAAGCCGAT 69 FBan0017019 FBgn0033783 CG17019 2 2R negative regulation of apoptosis; GO:0043066; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17019 CG17019 CDMC24998 3 15 23 DAC37-K21 3-CG17027-RA_1 CG17027 AGCGGGCGAGATCCTCATGGAGGGCTACGAGATGGCCAGTAAAAACGTCTCAATCAAAGGCGATTTCTA 69 FBan0017027 FBgn0036553 CG17027 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17027 CG17027 IMP CDMC24998 3 16 23 DAC37-K21 3-CG17027-RA_1 CG17027 AGCGGGCGAGATCCTCATGGAGGGCTACGAGATGGCCAGTAAAAACGTCTCAATCAAAGGCGATTTCTA 69 FBan0017027 FBgn0036553 CG17027 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17027 CG17027 IMP CDMC24999 3 17 23 DAC37-O09 16-CG17058-RB_1 CG17058 GCGTAACCGTTAAAACGTACAATCTTGGAGCGGAAGTTTCAAGTTTCTCCATTCCACTTTTTGCGCGCA 69 FBan0017058 FBgn0022770 Peritrophin-A X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490 extracellular region; GO:0005576 Peritrophin-A Peritrophin A "CG17058, PeriA, peritrophin A, Dm-peritrophin-A" CDMC24999 3 18 23 DAC37-O09 16-CG17058-RB_1 CG17058 GCGTAACCGTTAAAACGTACAATCTTGGAGCGGAAGTTTCAAGTTTCTCCATTCCACTTTTTGCGCGCA 69 FBan0017058 FBgn0022770 Peritrophin-A X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490 extracellular region; GO:0005576 Peritrophin-A Peritrophin A "CG17058, PeriA, peritrophin A, Dm-peritrophin-A" CDMC25000 3 19 23 DAC37-O21 23-CG17068-RA_5 CG17068 TGCATGCTTGATTTTAGCTGCCTAATGATAATGATTATCCAAACGTCCCTCTCAACGAACACCACTTAA 69 FBan0017068 FBgn0031098 CG17068 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG17068 CG17068 CDMC25000 3 20 23 DAC37-O21 23-CG17068-RA_5 CG17068 TGCATGCTTGATTTTAGCTGCCTAATGATAATGATTATCCAAACGTCCCTCTCAACGAACACCACTTAA 69 FBan0017068 FBgn0031098 CG17068 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG17068 CG17068 CDMC25001 3 21 23 DAC38-C09 13-CG17593-RA_1 CG17593 CCAGGCCCACATCAAAATTGAACTCACACGCGGTGTAATGGATGCCTTTGTATTTGCAGTTGGTACCAA 69 FBan0017593 FBgn0031544 CG17593 2 2L CG17593 CG17593 CDMC25001 3 22 23 DAC38-C09 13-CG17593-RA_1 CG17593 CCAGGCCCACATCAAAATTGAACTCACACGCGGTGTAATGGATGCCTTTGTATTTGCAGTTGGTACCAA 69 FBan0017593 FBgn0031544 CG17593 2 2L CG17593 CG17593 CDMC25002 3 23 23 DAC38-C21 23-CG17600-RA_1 CG17600 TGTGGGGCTTTGTCTGATAAATTACCCCTTTTATATCCATTACTCTATCAATGTACTTACATATGCGTA 69 FBan0017600 FBgn0031195 CG17600 X X CG17600 CG17600 "CG17602, CG17602" CDMC25002 3 24 23 DAC38-C21 23-CG17600-RA_1 CG17600 TGTGGGGCTTTGTCTGATAAATTACCCCTTTTATATCCATTACTCTATCAATGTACTTACATATGCGTA 69 FBan0017600 FBgn0031195 CG17600 X X CG17600 CG17600 "CG17602, CG17602" CDMC25003 3 25 23 DAC38-G09 3-CG17646-RA_1 CG17646 ACCCCGTTTCCATCTTGCCCTGTAAACACAATACTTCATCCACTGAGCTGGATCTCCGCGAAGACTCCA 69 FBan0017646 FBgn0031362 CG17646 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG17646 CG17646 "CG17647, BEST:GH05015" CDMC25003 3 26 23 DAC38-G09 3-CG17646-RA_1 CG17646 ACCCCGTTTCCATCTTGCCCTGTAAACACAATACTTCATCCACTGAGCTGGATCTCCGCGAAGACTCCA 69 FBan0017646 FBgn0031362 CG17646 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG17646 CG17646 "CG17647, BEST:GH05015" CDMC25004 3 1 24 DAC38-G21 18-CG17662-RA_1 CG17662 GCGACGAGGAGATCGATCTGAGGACTTCCGATGCCAAGATACGAATGATCGGAGAGGTTATAGTGCAAT 69 FBan0017662 FBgn0034884 CG17662 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015250 membrane; GO:0016020 CG17662 CG17662 CDMC25004 3 2 24 DAC38-G21 18-CG17662-RA_1 CG17662 GCGACGAGGAGATCGATCTGAGGACTTCCGATGCCAAGATACGAATGATCGGAGAGGTTATAGTGCAAT 69 FBan0017662 FBgn0034884 CG17662 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015250 membrane; GO:0016020 CG17662 CG17662 CDMC25005 3 3 24 DAC38-K09 23-CG1770-RB_19 CG1770 AGAGGCGTGAATCGGGAAAAATTCTGAAATAACCGTTCAATCGCTAACCGTTAACTGTAAAACCGCTGT 69 FBan0001770 FBgn0041210 HDAC4 X X regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0004407 ; EC:3.5.1.- HDAC4 HDAC4 "CG1770, CG1770, CG1770, CG1770, dHDAC4, HDAC, GC1770, dmHDA405, HDAC4a" CDMC25005 3 4 24 DAC38-K09 23-CG1770-RB_19 CG1770 AGAGGCGTGAATCGGGAAAAATTCTGAAATAACCGTTCAATCGCTAACCGTTAACTGTAAAACCGCTGT 69 FBan0001770 FBgn0041210 HDAC4 X X regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0004407 ; EC:3.5.1.- HDAC4 HDAC4 "CG1770, CG1770, CG1770, CG1770, dHDAC4, HDAC, GC1770, dmHDA405, HDAC4a" CDMC25006 3 5 24 DAC38-K21 2-CG17721-RA_1 CG17721 CGCCACTGTCCGGTCTGCAGAATGGGAATTAAGGAGTAGGTATCACCTAGTGATCATGCAGCCAGGCAA 69 FBan0017721 FBgn0037885 CG17721 3 3R CG17721 CG17721 BcDNA:LP09251 CDMC25006 3 6 24 DAC38-K21 2-CG17721-RA_1 CG17721 CGCCACTGTCCGGTCTGCAGAATGGGAATTAAGGAGTAGGTATCACCTAGTGATCATGCAGCCAGGCAA 69 FBan0017721 FBgn0037885 CG17721 3 3R CG17721 CG17721 BcDNA:LP09251 CDMC25007 3 7 24 DAC38-O09 24-CG17759-RF_1 CG17759 GGAAAAGTGGCAATGCAAATGAATTATTTATTTATAATGTATATGATTTGTTTTTCAAAGTCCCTCAAT 69 FBan0017759 FBgn0004435 Galpha49B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; axon midline choice point recognition; GO:0016199; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; protein amino acid ADP-ribosylation; GO:0006471; rhodopsin mediated signaling; GO:0016056; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 Galpha49B G protein alpha49B "CG17759, CG17759, CG17759, dgq, DGqalpha, DGq, dgqalpha, Dgq, DGalphaq, dGqalpha, dG[[q]]alpha, G[[qalpha]], Galphaq, dGqalpha-3, Gqalpha, Galpha[[q]]: G-protein-alpha[[q]], DmGalpha[[q]], G[[q]], Galpha, Galpha49B, Gqa-3, G[[q]]alpha, dGqa-49b, dGqalpha-49b, dGaalpha, G alpha 49B, Gaq, G[[a]]q, G[q], G[[alphaq]], Gq, Galpha49b, DGalpha[[q]], G-protein-alpha[[q]], Galpha[[q]]" CDMC25007 3 8 24 DAC38-O09 24-CG17759-RF_1 CG17759 GGAAAAGTGGCAATGCAAATGAATTATTTATTTATAATGTATATGATTTGTTTTTCAAAGTCCCTCAAT 69 FBan0017759 FBgn0004435 Galpha49B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; axon midline choice point recognition; GO:0016199; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; protein amino acid ADP-ribosylation; GO:0006471; rhodopsin mediated signaling; GO:0016056; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 Galpha49B G protein alpha49B "CG17759, CG17759, CG17759, dgq, DGqalpha, DGq, dgqalpha, Dgq, DGalphaq, dGqalpha, dG[[q]]alpha, G[[qalpha]], Galphaq, dGqalpha-3, Gqalpha, Galpha[[q]]: G-protein-alpha[[q]], DmGalpha[[q]], G[[q]], Galpha, Galpha49B, Gqa-3, G[[q]]alpha, dGqa-49b, dGqalpha-49b, dGaalpha, G alpha 49B, Gaq, G[[a]]q, G[q], G[[alphaq]], Gq, Galpha49b, DGalpha[[q]], G-protein-alpha[[q]], Galpha[[q]]" CDMC25008 3 9 24 DAC38-O21 3-CG17764-RA_1 CG17764 CCCGACCTCCAGTCCCAATCTCAGTTCAATCTGGAATCTGAACAGCAACCTCAACCGGAAACCAACAGC 69 FBan0017764 FBgn0029751 CG17764 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG17764 CG17764 CDMC25008 3 10 24 DAC38-O21 3-CG17764-RA_1 CG17764 CCCGACCTCCAGTCCCAATCTCAGTTCAATCTGGAATCTGAACAGCAACCTCAACCGGAAACCAACAGC 69 FBan0017764 FBgn0029751 CG17764 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG17764 CG17764 CDMC25009 3 11 24 DAC39-C09 3-CG32225-RA_2 CG32225 AGGATTGGGCAACTGCCTCAACGTGGCACTGATTTACTCAGCGCTCCTAGCACTTTTCATGACCG 65 FBan0032225 FBgn0052225 CG32225 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32225 CG32225 CDMC25009 3 12 24 DAC39-C09 3-CG32225-RA_2 CG32225 AGGATTGGGCAACTGCCTCAACGTGGCACTGATTTACTCAGCGCTCCTAGCACTTTTCATGACCG 65 FBan0032225 FBgn0052225 CG32225 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32225 CG32225 CDMC25010 3 13 24 DAC39-C21 3-CG32255-RA_1 CG32255 GTGTGCCCAAGGAGTCCTGGTGTCCGGAGGTGAAACGATTTACGGAGGAGGTAATCAGCGATGAG 65 FBan0032255 FBgn0052255 Gr64f 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64f Gustatory receptor 64f "CG14988, CG32255, CG14988, CG14988, Gr64A3, Gustatory receptor 64A3, DmGr64f, Gustatory receptor 64f" CDMC25010 3 14 24 DAC39-C21 3-CG32255-RA_1 CG32255 GTGTGCCCAAGGAGTCCTGGTGTCCGGAGGTGAAACGATTTACGGAGGAGGTAATCAGCGATGAG 65 FBan0032255 FBgn0052255 Gr64f 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64f Gustatory receptor 64f "CG14988, CG32255, CG14988, CG14988, Gr64A3, Gustatory receptor 64A3, DmGr64f, Gustatory receptor 64f" CDMC25011 3 15 24 DAC39-G09 2-CG3239-RA_2 CG3239 CGAGGACGATGGCTTTGATAGCGGTGATTTGGTTACGCGGATACCACCCTTTTGGATGATGCCCT 65 FBan0003239 FBgn0029769 CG3239 X X proteolysis; GO:0006508 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG3239 CG3239 BEST:GH09377 CDMC25011 3 16 24 DAC39-G09 2-CG3239-RA_2 CG3239 CGAGGACGATGGCTTTGATAGCGGTGATTTGGTTACGCGGATACCACCCTTTTGGATGATGCCCT 65 FBan0003239 FBgn0029769 CG3239 X X proteolysis; GO:0006508 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG3239 CG3239 BEST:GH09377 CDMC25012 3 17 24 DAC39-G21 1-CG32425-RB_3 CG32425 AACACGTGAGAGAGCGGGAGAAGTATGGGGCAAAGCATAGAACGCGATTACGATTACTGGGGGCC 65 FBan0032425 FBgn0052425 CG32425 3 3L CG32425 CG32425 "CG5100, CG15869, CG5100, CG5100, CG5100, CG15869" CDMC25012 3 18 24 DAC39-G21 1-CG32425-RB_3 CG32425 AACACGTGAGAGAGCGGGAGAAGTATGGGGCAAAGCATAGAACGCGATTACGATTACTGGGGGCC 65 FBan0032425 FBgn0052425 CG32425 3 3L CG32425 CG32425 "CG5100, CG15869, CG5100, CG5100, CG5100, CG15869" CDMC25013 3 19 24 DAC39-K09 1-CG32496-RA_1 CG32496 GATGGTTTCGGACGCGTGAGAGGTGAGTTTTTCATCGGCCTGGAGAAAGTGCACCTTATGACGCG 65 FBan0032496 FBgn0052496 CG32496 X X defense response; GO:0006952; defense response to bacteria; GO:0042742 CG32496 CG32496 CDMC25013 3 20 24 DAC39-K09 1-CG32496-RA_1 CG32496 GATGGTTTCGGACGCGTGAGAGGTGAGTTTTTCATCGGCCTGGAGAAAGTGCACCTTATGACGCG 65 FBan0032496 FBgn0052496 CG32496 X X defense response; GO:0006952; defense response to bacteria; GO:0042742 CG32496 CG32496 CDMC25014 3 21 24 DAC39-K21 23-CG32521-RC_2 CG32521 CAGCGATTTTGACGCAAATTATAAACGTACCAACTTTTGATCCAAGGGCGTGACATCGATAGCGA 65 FBan0032521 FBgn0052521 CG32521 X X CG32521 CG32521 "CG1726, CG1735, CG1726, CG1735" CDMC25014 3 22 24 DAC39-K21 23-CG32521-RC_2 CG32521 CAGCGATTTTGACGCAAATTATAAACGTACCAACTTTTGATCCAAGGGCGTGACATCGATAGCGA 65 FBan0032521 FBgn0052521 CG32521 X X CG32521 CG32521 "CG1726, CG1735, CG1726, CG1735" CDMC25015 3 23 24 DAC39-O09 18-CG32591-RA_15 CG32591 TTCTGCAGGAGAACAAGCAAAATGTGTCTAGAATGGAGACCAATGGCAGATGTATAGCGGCGGCC 65 FBan0032591 FBgn0052591 CG32591 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32591 CG32591 "NEST:bs09h01, NEST:bs18d12" CDMC25015 3 24 24 DAC39-O09 18-CG32591-RA_15 CG32591 TTCTGCAGGAGAACAAGCAAAATGTGTCTAGAATGGAGACCAATGGCAGATGTATAGCGGCGGCC 65 FBan0032591 FBgn0052591 CG32591 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32591 CG32591 "NEST:bs09h01, NEST:bs18d12" CDMC25016 3 25 24 DAC39-O21 AutoBlank AutoBlank CDMC25016 3 26 24 DAC39-O21 AutoBlank AutoBlank CDMC25017 3 1 25 DAC40-C09 10-CG41131-RA_1 CG41131 CTCGGAGGGGAAGACAAGTACCTGGCGTGTTCGAAAGGGACAGTGGAGTCAGTGGTCAAAGCTGG 65 FBgn0069920 CG41131 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41131 CG41131 CDMC25017 3 2 25 DAC40-C09 10-CG41131-RA_1 CG41131 CTCGGAGGGGAAGACAAGTACCTGGCGTGTTCGAAAGGGACAGTGGAGTCAGTGGTCAAAGCTGG 65 FBgn0069920 CG41131 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41131 CG41131 CDMC25018 3 3 25 DAC40-C21 1-CG4141-RA_1 CG4141 GCCGAGAACTACCCAATCGACAACCCCTCGATCCATAGCTGATAGTGTCGCTCCCACAAGTGCTC 65 FBan0004141 FBgn0015279 Pi3K92E 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; autophagy; GO:0006914; cell growth; GO:0016049; defense response; GO:0006952; insulin receptor signaling pathway; GO:0008286; phosphoinositide phosphorylation; GO:0046854; phosphorylation; GO:0016310; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; positive regulation of imaginal disc growth; GO:0045572; positive regulation of organ size; GO:0046622; regulation of body size; GO:0040014; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0035005 ; EC:2.7.1.154; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0046934 ; EC:2.7.1.153; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-" "phosphoinositide 3-kinase complex, class IA; GO:0035030" Pi3K92E Pi3K92E "CG4141, CG4141, rea, Dmp110, PI3K-92D, Dp110, p120, PI3K-92E/Dp110, PI3K, p110 PI3 kinase, phosphoinositide 3-kinase., PI(3)K, PI 3-kinase, p110, PI3-kinase, Pi3Kp110, PI-3-K, dPI 3-kinase, type-1 PI3K, dPI3K, dp110, PI3 kinase, Dp110/PI3K, Pi3K92D, anon-92Ed" CDMC25018 3 4 25 DAC40-C21 1-CG4141-RA_1 CG4141 GCCGAGAACTACCCAATCGACAACCCCTCGATCCATAGCTGATAGTGTCGCTCCCACAAGTGCTC 65 FBan0004141 FBgn0015279 Pi3K92E 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; autophagy; GO:0006914; cell growth; GO:0016049; defense response; GO:0006952; insulin receptor signaling pathway; GO:0008286; phosphoinositide phosphorylation; GO:0046854; phosphorylation; GO:0016310; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; positive regulation of imaginal disc growth; GO:0045572; positive regulation of organ size; GO:0046622; regulation of body size; GO:0040014; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0035005 ; EC:2.7.1.154; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0046934 ; EC:2.7.1.153; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-" "phosphoinositide 3-kinase complex, class IA; GO:0035030" Pi3K92E Pi3K92E "CG4141, CG4141, rea, Dmp110, PI3K-92D, Dp110, p120, PI3K-92E/Dp110, PI3K, p110 PI3 kinase, phosphoinositide 3-kinase., PI(3)K, PI 3-kinase, p110, PI3-kinase, Pi3Kp110, PI-3-K, dPI 3-kinase, type-1 PI3K, dPI3K, dp110, PI3 kinase, Dp110/PI3K, Pi3K92D, anon-92Ed" CDMC25019 3 5 25 DAC40-G09 3-CG4274-RA_1 CG4274 CAATGGTGAAGCAAGCCGATTTGACTGGACACACGTCACGAGTTCTCCAGATGGCCATGTCTCCG 65 FBan0004274 FBgn0001086 fzy 2 2L cell cycle; GO:0007049; cellular physiological process; GO:0050875; cyclin catabolism; GO:0008054; protein catabolism; GO:0030163; proteolysis; GO:0006508; regulation of exit from mitosis; GO:0007096; regulation of proteolysis; GO:0030162 centrosome; GO:0005813; cytoplasm; GO:0005737; kinetochore; GO:0000776; spindle; GO:0005819 fzy fizzy "CG4274, dFZY, CDC20, BG:DS02740.14, Cdc20[fizzy], Cdc20[Fzy], Cdc20, cdc20/fizzy, Fizzy, Cdc20/Fizzy" CDMC25019 3 6 25 DAC40-G09 3-CG4274-RA_1 CG4274 CAATGGTGAAGCAAGCCGATTTGACTGGACACACGTCACGAGTTCTCCAGATGGCCATGTCTCCG 65 FBan0004274 FBgn0001086 fzy 2 2L cell cycle; GO:0007049; cellular physiological process; GO:0050875; cyclin catabolism; GO:0008054; protein catabolism; GO:0030163; proteolysis; GO:0006508; regulation of exit from mitosis; GO:0007096; regulation of proteolysis; GO:0030162 centrosome; GO:0005813; cytoplasm; GO:0005737; kinetochore; GO:0000776; spindle; GO:0005819 fzy fizzy "CG4274, dFZY, CDC20, BG:DS02740.14, Cdc20[fizzy], Cdc20[Fzy], Cdc20, cdc20/fizzy, Fizzy, Cdc20/Fizzy" CDMC25020 3 7 25 DAC40-G21 12-CG4300-RA_6 CG4300 ACCACCAAGGCGTTTGTGCCGTCGTTCATGGAAGAGTGGCTCTTCTACCAAGTGACTTTCGCCTG 65 FBan0004300 FBgn0036272 CG4300 3 3L spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 CG4300 CG4300 anon-WO0118547.387 CDMC25020 3 8 25 DAC40-G21 12-CG4300-RA_6 CG4300 ACCACCAAGGCGTTTGTGCCGTCGTTCATGGAAGAGTGGCTCTTCTACCAAGTGACTTTCGCCTG 65 FBan0004300 FBgn0036272 CG4300 3 3L spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 CG4300 CG4300 anon-WO0118547.387 CDMC25021 3 9 25 DAC40-K09 3-CG4408-RA_1 CG4408 AAAGGATTGGGCCCATGGTCAGCTCAAGATACCGATTACCTTCTCCTACGAACTGCGTGGACCCG 65 FBan0004408 FBgn0039073 CG4408 3 3R proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG4408 CG4408 BEST:GH09055 CDMC25021 3 10 25 DAC40-K09 3-CG4408-RA_1 CG4408 AAAGGATTGGGCCCATGGTCAGCTCAAGATACCGATTACCTTCTCCTACGAACTGCGTGGACCCG 65 FBan0004408 FBgn0039073 CG4408 3 3R proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG4408 CG4408 BEST:GH09055 CDMC25022 3 11 25 DAC40-K21 15-CG4462-RA_2 CG4462 GTGTGTCCCCGGTAGTGCCACACTTGGAGCAGAGAAACACGAAGGAGCAGTCTCCATTGAACGCC 65 FBan0004462 FBgn0038752 CG4462 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 CG4462 CG4462 CDMC25022 3 12 25 DAC40-K21 15-CG4462-RA_2 CG4462 GTGTGTCCCCGGTAGTGCCACACTTGGAGCAGAGAAACACGAAGGAGCAGTCTCCATTGAACGCC 65 FBan0004462 FBgn0038752 CG4462 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 CG4462 CG4462 CDMC25023 3 13 25 DAC40-O09 3-CG4582-RA_3 CG4582 ATGGCAACTACAACATCTTCACTGTGGACTGGGGACGTGGAGCCATAGCGGACTACATAACGGCC 65 FBan0004582 FBgn0039344 CG4582 3 3R lipid metabolism; GO:0006629 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG4582 CG4582 CDMC25023 3 14 25 DAC40-O09 3-CG4582-RA_3 CG4582 ATGGCAACTACAACATCTTCACTGTGGACTGGGGACGTGGAGCCATAGCGGACTACATAACGGCC 65 FBan0004582 FBgn0039344 CG4582 3 3R lipid metabolism; GO:0006629 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG4582 CG4582 CDMC25024 3 15 25 DAC40-O21 AutoBlank AutoBlank CDMC25024 3 16 25 DAC40-O21 AutoBlank AutoBlank CDMC25025 3 17 25 DAC41-C09 5-CG4583-RA_1 CG4583 GGAATGTCCATCTGGACCCCATGATCACGGATGATTTGAGGAAGTACCGCGGATATATGGGCGCCAGTG 69 FBan0004583 FBgn0038736 ire-1 3 3R electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 ire-1 ire-1 "CG4583, CG4583, CG4583, CG4583, CG4583, IRE-like, dire-1" CDMC25025 3 18 25 DAC41-C09 5-CG4583-RA_1 CG4583 GGAATGTCCATCTGGACCCCATGATCACGGATGATTTGAGGAAGTACCGCGGATATATGGGCGCCAGTG 69 FBan0004583 FBgn0038736 ire-1 3 3R electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 ire-1 ire-1 "CG4583, CG4583, CG4583, CG4583, CG4583, IRE-like, dire-1" CDMC25026 3 19 25 DAC41-C21 18-CG4596-RA_3 CG4596 GGAACGCTCACCTGGTACAATATGTTCAACTATTACTGCGAGGAGAGGACGTACCTGCACAAGATCCTG 69 FBan0004596 FBgn0037849 CG4596 3 3R CG4596 CG4596 CDMC25026 3 20 25 DAC41-C21 18-CG4596-RA_3 CG4596 GGAACGCTCACCTGGTACAATATGTTCAACTATTACTGCGAGGAGAGGACGTACCTGCACAAGATCCTG 69 FBan0004596 FBgn0037849 CG4596 3 3R CG4596 CG4596 CDMC25027 3 21 25 DAC41-G09 23-CG4620-RA_5 CG4620 TTATGAATCTCCACGAGATGTACATGGGATGTCTATCGAACTACGCGTTTTTTCAACCCCATTCCAAAA 69 FBan0004620 FBgn0004395 unk 3 3R bristle morphogenesis; GO:0008407; eye development (sensu Endopterygota); GO:0007456; larval development; GO:0002164; protein ubiquitination; GO:0016567; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 unk unkempt CG4620 CDMC25027 3 22 25 DAC41-G09 23-CG4620-RA_5 CG4620 TTATGAATCTCCACGAGATGTACATGGGATGTCTATCGAACTACGCGTTTTTTCAACCCCATTCCAAAA 69 FBan0004620 FBgn0004395 unk 3 3R bristle morphogenesis; GO:0008407; eye development (sensu Endopterygota); GO:0007456; larval development; GO:0002164; protein ubiquitination; GO:0016567; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 unk unkempt CG4620 CDMC25028 3 23 25 DAC41-G21 15-CG4626-RB_2 CG4626 CCCACTTGCAGCAGTATGGCAATGAGACGCTACTCTAGACGGAATTGGATTAGGTACCATTTCAGGGCA 69 FBan0004626 FBgn0027342 fz4 X X G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; frizzled signaling pathway; GO:0007222; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz4 frizzled 4 "CG4626, CG4626, DFz4, anon-WO0170980.10, anon-WO0170980.11, frizzled 4" CDMC25028 3 24 25 DAC41-G21 15-CG4626-RB_2 CG4626 CCCACTTGCAGCAGTATGGCAATGAGACGCTACTCTAGACGGAATTGGATTAGGTACCATTTCAGGGCA 69 FBan0004626 FBgn0027342 fz4 X X G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; cell-cell signaling; GO:0007267; establishment and/or maintenance of cell polarity; GO:0007163; frizzled signaling pathway; GO:0007222; signal transduction; GO:0007165 Wnt-protein binding; GO:0017147; transmembrane receptor activity; GO:0004888; Wnt receptor activity; GO:0042813; G-protein coupled receptor activity; GO:0004930; ; GO:0004888; ; GO:0004930; ; GO:0042813; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 fz4 frizzled 4 "CG4626, CG4626, DFz4, anon-WO0170980.10, anon-WO0170980.11, frizzled 4" CDMC25029 3 25 25 DAC41-K09 23-CG4660-RA_4 CG4660 CCCGAATAATGAACTAGAAATACAAACAAAACTCCTTGGTAGTCCACAGTGTGTAAGCTATGATGTACA 69 FBan0004660 FBgn0029839 CG4660 X X CG4660 CG4660 BcDNA:RH58440 CDMC25029 3 26 25 DAC41-K09 23-CG4660-RA_4 CG4660 CCCGAATAATGAACTAGAAATACAAACAAAACTCCTTGGTAGTCCACAGTGTGTAAGCTATGATGTACA 69 FBan0004660 FBgn0029839 CG4660 X X CG4660 CG4660 BcDNA:RH58440 CDMC25030 3 1 26 DAC41-K21 13-CG4669-RA_1 CG4669 ACCCTGTATGGATCCCAGTAAACCGATGGATCTCGATGATTTTCCACGACAGATTCGCTTGGGTCAGTT 69 FBan0004669 FBgn0035598 CG4669 3 3L CG4669 CG4669 anon-WO0140519.194 CDMC25030 3 2 26 DAC41-K21 13-CG4669-RA_1 CG4669 ACCCTGTATGGATCCCAGTAAACCGATGGATCTCGATGATTTTCCACGACAGATTCGCTTGGGTCAGTT 69 FBan0004669 FBgn0035598 CG4669 3 3L CG4669 CG4669 anon-WO0140519.194 CDMC25031 3 3 26 DAC41-O09 17-CG4696-RA_1 CG4696 GTGCCCGACATCGATGTCTTCCAGACCGTCGATCTGTACGAGAAGAAGGATATTGCCAACGTTACCAAC 69 FBan0004696 FBgn0002789 Mp20 2 2R cell adhesion; GO:0007155; muscle contraction; GO:0006936; muscle development; GO:0007517; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 contractile fiber; GO:0043292 Mp20 Muscle protein 20 "CG4696, CG4696, mp20, DMMP20, myophilin, Dmmp20, Tpn" CDMC25031 3 4 26 DAC41-O09 17-CG4696-RA_1 CG4696 GTGCCCGACATCGATGTCTTCCAGACCGTCGATCTGTACGAGAAGAAGGATATTGCCAACGTTACCAAC 69 FBan0004696 FBgn0002789 Mp20 2 2R cell adhesion; GO:0007155; muscle contraction; GO:0006936; muscle development; GO:0007517; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 contractile fiber; GO:0043292 Mp20 Muscle protein 20 "CG4696, CG4696, mp20, DMMP20, myophilin, Dmmp20, Tpn" CDMC25032 3 5 26 DAC41-O21 3-CG4702-RA_3 CG4702 TCACCTGGTCTAACATGCTATCCACCGTGATGACCATGTTCTTCAACGGAGCCGTCAACTCACCAACCA 69 FBan0004702 FBgn0037992 CG4702 3 3R CG4702 CG4702 CDMC25032 3 6 26 DAC41-O21 3-CG4702-RA_3 CG4702 TCACCTGGTCTAACATGCTATCCACCGTGATGACCATGTTCTTCAACGGAGCCGTCAACTCACCAACCA 69 FBan0004702 FBgn0037992 CG4702 3 3R CG4702 CG4702 CDMC25033 3 7 26 DAC42-C09 150mM NaPO4 Blank CDMC25033 3 8 26 DAC42-C09 150mM NaPO4 Blank CDMC25034 3 9 26 DAC42-C21 150mM NaPO4 Blank CDMC25034 3 10 26 DAC42-C21 150mM NaPO4 Blank CDMC25035 3 11 26 DAC42-G09 150mM NaPO4 Blank CDMC25035 3 12 26 DAC42-G09 150mM NaPO4 Blank CDMC25036 3 13 26 DAC42-G21 150mM NaPO4 Blank CDMC25036 3 14 26 DAC42-G21 150mM NaPO4 Blank CDMC25037 3 15 26 DAC42-K09 150mM NaPO4 Blank CDMC25037 3 16 26 DAC42-K09 150mM NaPO4 Blank CDMC25038 3 17 26 DAC42-K21 5uM MSP 5uM MSP CDMC25038 3 18 26 DAC42-K21 5uM MSP 5uM MSP CDMC25039 3 19 26 DAC42-O09 10uM MSP 10uM MSP CDMC25039 3 20 26 DAC42-O09 10uM MSP 10uM MSP CDMC25040 3 21 26 DAC42-O21 20uM MSP 20uM MSP CDMC25040 3 22 26 DAC42-O21 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC25041 4 1 1 DAC01-D09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25041 4 2 1 DAC01-D09 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25042 4 3 1 DAC01-D21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25042 4 4 1 DAC01-D21 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25043 4 5 1 DAC01-H09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25043 4 6 1 DAC01-H09 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25044 4 7 1 DAC01-H21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25044 4 8 1 DAC01-H21 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25045 4 9 1 DAC01-L09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25045 4 10 1 DAC01-L09 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25046 4 11 1 DAC01-L21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25046 4 12 1 DAC01-L21 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25047 4 13 1 DAC01-P09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25047 4 14 1 DAC01-P09 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25048 4 15 1 DAC01-P21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25048 4 16 1 DAC01-P21 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25049 4 17 1 DAC02-D09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25049 4 18 1 DAC02-D09 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25050 4 19 1 DAC02-D21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25050 4 20 1 DAC02-D21 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25051 4 21 1 DAC02-H09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25051 4 22 1 DAC02-H09 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25052 4 23 1 DAC02-H21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25052 4 24 1 DAC02-H21 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25053 4 25 1 DAC02-L09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25053 4 26 1 DAC02-L09 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25054 4 1 2 DAC02-L21 N/A CG9075 (00957-01195) CDMC25054 4 2 2 DAC02-L21 N/A CG9075 (00957-01195) CDMC25055 4 3 2 DAC02-P09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25055 4 4 2 DAC02-P09 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25056 4 5 2 DAC02-P21 AutoBlank AutoBlank CDMC25056 4 6 2 DAC02-P21 AutoBlank AutoBlank CDMC25057 4 7 2 DAC03-D09 5-CG3884-RB_1 CG3884 AATGGAGAGCTGCTGTACTATGGGCGAGGACACTACCAGGGCAGTTTGACACCGGGTCTGATCTC 65 FBan0003884 FBgn0033786 CG3884 2 2R CG3884 CG3884 CDMC25057 4 8 2 DAC03-D09 5-CG3884-RB_1 CG3884 AATGGAGAGCTGCTGTACTATGGGCGAGGACACTACCAGGGCAGTTTGACACCGGGTCTGATCTC 65 FBan0003884 FBgn0033786 CG3884 2 2R CG3884 CG3884 CDMC25058 4 9 2 DAC03-D21 3-CG3910-RA_6 CG3910 ACTCCCTCATTTTTCAGACCAGCCTTTTCAACCTTGGACGCTGTGAGATGATCCTCGCCATGCCG 65 FBan0003910 FBgn0037778 mtTFB2 3 3R rRNA modification; GO:0000154 "rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-; ; GO:0008649 ; EC:2.1.1.-" mitochondrion; GO:0005739 mtTFB2 mitochondrial transcription factor B2 "CG3910, CG3910, d-mtTFB2, mitochondrial transcription factor B2" CDMC25058 4 10 2 DAC03-D21 3-CG3910-RA_6 CG3910 ACTCCCTCATTTTTCAGACCAGCCTTTTCAACCTTGGACGCTGTGAGATGATCCTCGCCATGCCG 65 FBan0003910 FBgn0037778 mtTFB2 3 3R rRNA modification; GO:0000154 "rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-; ; GO:0008649 ; EC:2.1.1.-" mitochondrion; GO:0005739 mtTFB2 mitochondrial transcription factor B2 "CG3910, CG3910, d-mtTFB2, mitochondrial transcription factor B2" CDMC25059 4 11 2 DAC03-H09 6-CG4003-RA_7 CG4003 TTAGCATCAGGCAGGACACGGATTTAGAGGCGCCATGAAGATCGAGGAAGTCAAGAGCACCGTGC 65 FBan0004003 FBgn0040078 pont 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA helicase activity; GO:0003678; ; GO:0003676; beta-catenin binding; GO:0008013; ; GO:0003678; TATA-binding protein binding; GO:0017025; ; GO:0017025; ; GO:0008013; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 pont pontin "CG4003, CG4003, 0229/05, dpon, pon, dpontin, Tip49/Pontin, Tip49, dPon, dPontin, anon-WO0118547.698, l(3)S022905" CDMC25059 4 12 2 DAC03-H09 6-CG4003-RA_7 CG4003 TTAGCATCAGGCAGGACACGGATTTAGAGGCGCCATGAAGATCGAGGAAGTCAAGAGCACCGTGC 65 FBan0004003 FBgn0040078 pont 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA helicase activity; GO:0003678; ; GO:0003676; beta-catenin binding; GO:0008013; ; GO:0003678; TATA-binding protein binding; GO:0017025; ; GO:0017025; ; GO:0008013; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 pont pontin "CG4003, CG4003, 0229/05, dpon, pon, dpontin, Tip49/Pontin, Tip49, dPon, dPontin, anon-WO0118547.698, l(3)S022905" CDMC25060 4 13 2 DAC03-H21 13-CG40120-RA_1 CG40120 TAGGAGCGATGGATCGTATATTTCCACACGTCGTCAACCACGCACAGATTTACGTAGCGCGGCTG 65 FBgn0058120 CG40120 CG40120 CG40120 CDMC25060 4 14 2 DAC03-H21 13-CG40120-RA_1 CG40120 TAGGAGCGATGGATCGTATATTTCCACACGTCGTCAACCACGCACAGATTTACGTAGCGCGGCTG 65 FBgn0058120 CG40120 CG40120 CG40120 CDMC25061 4 15 2 DAC03-L09 1-CG40265-RA_1 CG40265 ATTGCAACAGCGCGTTCTTAAGGGCGGAAGAGCTGGGGACTGTCATCGTTGGAATCGAACTGAAC 65 FBgn0058265 CG40265 CG40265 CG40265 CDMC25061 4 16 2 DAC03-L09 1-CG40265-RA_1 CG40265 ATTGCAACAGCGCGTTCTTAAGGGCGGAAGAGCTGGGGACTGTCATCGTTGGAATCGAACTGAAC 65 FBgn0058265 CG40265 CG40265 CG40265 CDMC25062 4 17 2 DAC03-L21 23-CG40336-RA_4 CG40336 ACGGAGTCAACAGATAAGGCTACTGAGGAAGTTCGAAAACAAGTGGAGAGAGAAGAGCCCCAGAC 65 FBgn0058336 CG40336 CG40336 CG40336 CDMC25062 4 18 2 DAC03-L21 23-CG40336-RA_4 CG40336 ACGGAGTCAACAGATAAGGCTACTGAGGAAGTTCGAAAACAAGTGGAGAGAGAAGAGCCCCAGAC 65 FBgn0058336 CG40336 CG40336 CG40336 CDMC25063 4 19 2 DAC03-P09 4-CG4052-RA_1 CG4052 CAATCAATGGATTCAATGCCGTGGTCAATCGCGAACCGCTGGTGAAGACCGTGGTCAAGACCGTG 65 FBan0004052 FBgn0029811 CG4052 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG4052 CG4052 CDMC25063 4 20 2 DAC03-P09 4-CG4052-RA_1 CG4052 CAATCAATGGATTCAATGCCGTGGTCAATCGCGAACCGCTGGTGAAGACCGTGGTCAAGACCGTG 65 FBan0004052 FBgn0029811 CG4052 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG4052 CG4052 CDMC25064 4 21 2 DAC03-P21 AutoBlank AutoBlank CDMC25064 4 22 2 DAC03-P21 AutoBlank AutoBlank CDMC25065 4 23 2 DAC04-D09 1-CG31532-RA_1 CG31532 TCGTGGTAGCTCCCGTTAAGCTTAAACAGAATGCTGGACAAACGCTCTAGGACATTGGTACTGCCCGCT 69 FBan0031532 FBgn0051532 CG31532 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31532 CG31532 CDMC25065 4 24 2 DAC04-D09 1-CG31532-RA_1 CG31532 TCGTGGTAGCTCCCGTTAAGCTTAAACAGAATGCTGGACAAACGCTCTAGGACATTGGTACTGCCCGCT 69 FBan0031532 FBgn0051532 CG31532 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31532 CG31532 CDMC25066 4 25 2 DAC04-D21 5-CG31538-RA_1 CG31538 CTCTGTCGATCCCATGCAGGGTTGGAAGCATCCAAAGAACCTTAAGTATCTCTCCGATATCCCGGCCGA 69 FBan0031538 FBgn0051538 CG31538 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31538 CG31538 "BEST:GH20014, NEST:bs26g11, BEST:LP11873, BEST:GH27336, BEST:GH11373, BcDNA:AT27831, NEST:bs02h07, NEST:bs09g01, NEST:bs09e09, NEST:bs10d08" CDMC25066 4 26 2 DAC04-D21 5-CG31538-RA_1 CG31538 CTCTGTCGATCCCATGCAGGGTTGGAAGCATCCAAAGAACCTTAAGTATCTCTCCGATATCCCGGCCGA 69 FBan0031538 FBgn0051538 CG31538 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31538 CG31538 "BEST:GH20014, NEST:bs26g11, BEST:LP11873, BEST:GH27336, BEST:GH11373, BcDNA:AT27831, NEST:bs02h07, NEST:bs09g01, NEST:bs09e09, NEST:bs10d08" CDMC25067 4 1 3 DAC04-H09 14-CG3160-RA_1 CG3160 CCTTTCCCAGGCAACCTCCAATGTGATGATCTCGATCATGACCCACTTGCCCATTACGTACGGTATACT 69 FBan0003160 FBgn0029789 CG3160 X X CG3160 CG3160 CDMC25067 4 2 3 DAC04-H09 14-CG3160-RA_1 CG3160 CCTTTCCCAGGCAACCTCCAATGTGATGATCTCGATCATGACCCACTTGCCCATTACGTACGGTATACT 69 FBan0003160 FBgn0029789 CG3160 X X CG3160 CG3160 CDMC25068 4 3 3 DAC04-H21 23-CG31622-RB_5 CG31622 ACCCACGATGAAATCCTACTGTTGGGTCAAAGAGAACTGATTGCCGTTTATGGTGGAGTTATACTATTT 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC25068 4 4 3 DAC04-H21 23-CG31622-RB_5 CG31622 ACCCACGATGAAATCCTACTGTTGGGTCAAAGAGAACTGATTGCCGTTTATGGTGGAGTTATACTATTT 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC25069 4 5 3 DAC04-L09 3-CG31645-RA_6 CG31645 TCCGCATGCTGATAATATTCGTGCTGACATTCGCCCTCTGCAATCTGCCGTATCATGCCCGCAAAATGT 69 FBan0031645 FBgn0051645 CG31645 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity; GO:0004930; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG31645 CG31645 "CG14003, CG14002, CG14003, CG14003, CG14003, anon-WO0170980.172, anon-WO0170980.173" CDMC25069 4 6 3 DAC04-L09 3-CG31645-RA_6 CG31645 TCCGCATGCTGATAATATTCGTGCTGACATTCGCCCTCTGCAATCTGCCGTATCATGCCCGCAAAATGT 69 FBan0031645 FBgn0051645 CG31645 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity; GO:0004930; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG31645 CG31645 "CG14003, CG14002, CG14003, CG14003, CG14003, anon-WO0170980.172, anon-WO0170980.173" CDMC25070 4 7 3 DAC04-L21 16-CG31651-RA_1 CG31651 CATAACCTGACTACGAGCGAAATTCCACAGATGATCATTGAAAGCAGCAAACCGATAAGACGCAGGCCA 69 FBgn0051651 CDMC25070 4 8 3 DAC04-L21 16-CG31651-RA_1 CG31651 CATAACCTGACTACGAGCGAAATTCCACAGATGATCATTGAAAGCAGCAAACCGATAAGACGCAGGCCA 69 FBgn0051651 CDMC25071 4 9 3 DAC04-P09 23-CG31680-RA_3 CG31680 AATCAGGAAGCTGAACTTGAAAGTGCCTACAAGTCCTCCAATGAAAGAAAACAACAGGTTCTCTACCAA 69 FBan0031680 FBgn0051680 CG31680 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31680 CG31680 BcDNA:AT19802 CDMC25071 4 10 3 DAC04-P09 23-CG31680-RA_3 CG31680 AATCAGGAAGCTGAACTTGAAAGTGCCTACAAGTCCTCCAATGAAAGAAAACAACAGGTTCTCTACCAA 69 FBan0031680 FBgn0051680 CG31680 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31680 CG31680 BcDNA:AT19802 CDMC25072 4 11 3 DAC04-P21 3-CG31692-RB_2 CG31692 TCCCTTGGATGGATCCTCCAACATAGACTGCCTGGTGTCGATCGGTTCAATCTTCGCCATTTACCGCAA 69 FBan0031692 FBgn0032820 fbp 2 2L carbohydrate metabolism; GO:0005975 fructose-bisphosphatase activity; GO:0042132 ; EC:3.1.3.11; ; GO:0042132 ; EC:3.1.3.11; ; GO:0042132 ; EC:3.1.3.11 fbp "fructose-1,6-bisphosphatase" "CG10611, CG31692, CG10611, FbPase, fructose-1,6-bisphosphatase" CDMC25072 4 12 3 DAC04-P21 3-CG31692-RB_2 CG31692 TCCCTTGGATGGATCCTCCAACATAGACTGCCTGGTGTCGATCGGTTCAATCTTCGCCATTTACCGCAA 69 FBan0031692 FBgn0032820 fbp 2 2L carbohydrate metabolism; GO:0005975 fructose-bisphosphatase activity; GO:0042132 ; EC:3.1.3.11; ; GO:0042132 ; EC:3.1.3.11; ; GO:0042132 ; EC:3.1.3.11 fbp "fructose-1,6-bisphosphatase" "CG10611, CG31692, CG10611, FbPase, fructose-1,6-bisphosphatase" CDMC25073 4 13 3 DAC05-D09 3-CG6000-RA_2 CG6000 AGCCAGGCTCCTCAAATTGGAATCGTGGACTACGACGTGGTCAAGAAACTACCCAGCGAACCACAGAAA 69 FBan0006000 FBgn0039145 CG6000 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG6000 CG6000 BcDNA:RE30346 CDMC25073 4 14 3 DAC05-D09 3-CG6000-RA_2 CG6000 AGCCAGGCTCCTCAAATTGGAATCGTGGACTACGACGTGGTCAAGAAACTACCCAGCGAACCACAGAAA 69 FBan0006000 FBgn0039145 CG6000 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG6000 CG6000 BcDNA:RE30346 CDMC25074 4 15 3 DAC05-D21 11-CG6017-RA_6 CG6017 TGCATCGGGCTGAAGAACCACAGTTACTTTATGGGATTCCTCTGGATGTTGCTGATTATGTGCGCCTGG 69 FBan0006017 FBgn0036555 CG6017 3 3L cell proliferation; GO:0008283; sensory perception; GO:0007600 GTPase activity; GO:0003924; ; GO:0003924; metal ion binding; GO:0046872; ; GO:0046872 CG6017 CG6017 "CG 6017, ankyrin domain" CDMC25074 4 16 3 DAC05-D21 11-CG6017-RA_6 CG6017 TGCATCGGGCTGAAGAACCACAGTTACTTTATGGGATTCCTCTGGATGTTGCTGATTATGTGCGCCTGG 69 FBan0006017 FBgn0036555 CG6017 3 3L cell proliferation; GO:0008283; sensory perception; GO:0007600 GTPase activity; GO:0003924; ; GO:0003924; metal ion binding; GO:0046872; ; GO:0046872 CG6017 CG6017 "CG 6017, ankyrin domain" CDMC25075 4 17 3 DAC05-H09 3-CG6045-RA_1 CG6045 TGAGTCCCATAATGCCAAGAATCGTTGGACGAAACGAGGTCTCGGATTGGCGGTAATGGACTACCCCAT 69 FBan0006045 FBgn0038349 CG6045 3 3R defense response; GO:0006952; electron transport; GO:0006118; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144 electron transporter activity; GO:0005489; ; GO:0005489; xanthine dehydrogenase activity; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4 CG6045 CG6045 DmAO3 CDMC25075 4 18 3 DAC05-H09 3-CG6045-RA_1 CG6045 TGAGTCCCATAATGCCAAGAATCGTTGGACGAAACGAGGTCTCGGATTGGCGGTAATGGACTACCCCAT 69 FBan0006045 FBgn0038349 CG6045 3 3R defense response; GO:0006952; electron transport; GO:0006118; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144 electron transporter activity; GO:0005489; ; GO:0005489; xanthine dehydrogenase activity; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4 CG6045 CG6045 DmAO3 CDMC25076 4 19 3 DAC05-H21 9-CG6056-RA_4 CG6056 GGCCAAGTGGTATATGAACTTCGATGACGACGAGAAGCAGAAACTGATTGAGGAGGTGCATGCCGTGGT 69 FBan0006056 FBgn0043012 AP-2sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-2sigma AP-2sigma "CG6056, CG6056, CG6056, sigma2, cg6056, AP-2sigma" CDMC25076 4 20 3 DAC05-H21 9-CG6056-RA_4 CG6056 GGCCAAGTGGTATATGAACTTCGATGACGACGAGAAGCAGAAACTGATTGAGGAGGTGCATGCCGTGGT 69 FBan0006056 FBgn0043012 AP-2sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-2sigma AP-2sigma "CG6056, CG6056, CG6056, sigma2, cg6056, AP-2sigma" CDMC25077 4 21 3 DAC05-L09 3-CG6103-RD_3 CG6103 GGCGAACAGCTCCCTGATGCAATTGGATCCCACGTACTACCTGTCCAATCGGATGTCCTACAACACCAA 69 FBan0006103 FBgn0014467 CrebB-17A X X "circadian rhythm; GO:0007623; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; long-term memory; GO:0007616; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein dimerization activity; GO:0046983; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0046983; ; GO:0003700 nucleus; GO:0005634 CrebB-17A Cyclic-AMP response element binding protein B at 17A "CG6103, CREB, S162, dCREB-B, dCREB2, dCREB2-a, dCREB2-b, Creb, dCREB2a, dCREB2b, dCREB-2a, activator, blocker, dCREB, CREB2b, cAMP-regulated enhancer-binding protein, CREB-B, dCbz, Creb2b, CREB2, CrebB17-A, CREB-b, dCrebB2, CREB2a, dCREB-2, l(1)17Af, lethal(1)17Af, Cyclic-AMP response element binding protein B at 17A" CDMC25077 4 22 3 DAC05-L09 3-CG6103-RD_3 CG6103 GGCGAACAGCTCCCTGATGCAATTGGATCCCACGTACTACCTGTCCAATCGGATGTCCTACAACACCAA 69 FBan0006103 FBgn0014467 CrebB-17A X X "circadian rhythm; GO:0007623; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; long-term memory; GO:0007616; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein dimerization activity; GO:0046983; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0046983; ; GO:0003700 nucleus; GO:0005634 CrebB-17A Cyclic-AMP response element binding protein B at 17A "CG6103, CREB, S162, dCREB-B, dCREB2, dCREB2-a, dCREB2-b, Creb, dCREB2a, dCREB2b, dCREB-2a, activator, blocker, dCREB, CREB2b, cAMP-regulated enhancer-binding protein, CREB-B, dCbz, Creb2b, CREB2, CrebB17-A, CREB-b, dCrebB2, CREB2a, dCREB-2, l(1)17Af, lethal(1)17Af, Cyclic-AMP response element binding protein B at 17A" CDMC25078 4 23 3 DAC05-L21 10-CG6117-RA_1 CG6117 CCTTTGGACGAGTTTGCTTATGTCGCGATCGCATTTCGGAGAAGTACTGTGCCATGAAGATTCTGGCCA 69 FBan0006117 FBgn0000489 Pka-C3 3 3L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; ; GO:0004691; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004691; ; GO:0004691; ; GO:0004713 ; EC:2.7.1.112 cAMP-dependent protein kinase complex; GO:0005952 Pka-C3 cAMP-dependent protein kinase "CG6117, CG6117, 5-23, DC2, PKA, PKA C3, Dpck, Pk72A: Protein-kinase-like-72A, Pk?5, Protein-kinase-like-72A" CDMC25078 4 24 3 DAC05-L21 10-CG6117-RA_1 CG6117 CCTTTGGACGAGTTTGCTTATGTCGCGATCGCATTTCGGAGAAGTACTGTGCCATGAAGATTCTGGCCA 69 FBan0006117 FBgn0000489 Pka-C3 3 3L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; ; GO:0004691; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004691; ; GO:0004691; ; GO:0004713 ; EC:2.7.1.112 cAMP-dependent protein kinase complex; GO:0005952 Pka-C3 cAMP-dependent protein kinase "CG6117, CG6117, 5-23, DC2, PKA, PKA C3, Dpck, Pk72A: Protein-kinase-like-72A, Pk?5, Protein-kinase-like-72A" CDMC25079 4 25 3 DAC05-P09 46-CG6148-RB_1 CG6148 TCGGTGGCTAATATTAGAGTCTTGCGACATGTTTAGCTTTCTGAAGCGCGAGAAGAACACCCAGGAGGT 69 FBan0006148 FBgn0016693 Past1 3 3R endocytosis; GO:0006897 calmodulin binding; GO:0005516; GTP binding; GO:0005525; ; GO:0005516; GTPase activity; GO:0003924; calcium ion binding; GO:0005509; ; GO:0003924; ; GO:0005509; ; GO:0005525 Past1 Putative Achaete Scute Target 1 "CG6148, PAST-1, Ehd, EH domain containing protein, PAST, dEHD, Putative Achaete Scute Target 1" CDMC25079 4 26 3 DAC05-P09 46-CG6148-RB_1 CG6148 TCGGTGGCTAATATTAGAGTCTTGCGACATGTTTAGCTTTCTGAAGCGCGAGAAGAACACCCAGGAGGT 69 FBan0006148 FBgn0016693 Past1 3 3R endocytosis; GO:0006897 calmodulin binding; GO:0005516; GTP binding; GO:0005525; ; GO:0005516; GTPase activity; GO:0003924; calcium ion binding; GO:0005509; ; GO:0003924; ; GO:0005509; ; GO:0005525 Past1 Putative Achaete Scute Target 1 "CG6148, PAST-1, Ehd, EH domain containing protein, PAST, dEHD, Putative Achaete Scute Target 1" CDMC25080 4 1 4 DAC05-P21 13-CG6159-RA_1 CG6159 TGCCAGCAAGAAACACCAAAAGACTGCAACTACTAAGGGCTTTCGGAGAAACATGGAGGTGCTGATAGC 69 FBan0006159 FBgn0027103 sec10 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 cytoplasm; GO:0005737; exocyst; GO:0000145 sec10 sec10 "CG6159, CG6159, dsec10, Sec10, Sec10p, P71" CDMC25080 4 2 4 DAC05-P21 13-CG6159-RA_1 CG6159 TGCCAGCAAGAAACACCAAAAGACTGCAACTACTAAGGGCTTTCGGAGAAACATGGAGGTGCTGATAGC 69 FBan0006159 FBgn0027103 sec10 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 cytoplasm; GO:0005737; exocyst; GO:0000145 sec10 sec10 "CG6159, CG6159, dsec10, Sec10, Sec10p, P71" CDMC25081 4 3 4 DAC06-D09 17-CG1155-RA_1 CG1155 ACACCACGCACACATCACCCGCAAGTCAAGTCGAATGTATGAATAAAACCAAGAGTATTGCACCCGAAA 69 FBan0001155 FBgn0040279 Osi14 3 3R Osi14 Osiris 14 "CG1155, CG1155, SP558, Sp558, Osiris, BEST:LD24139, Osiris 14" CDMC25081 4 4 4 DAC06-D09 17-CG1155-RA_1 CG1155 ACACCACGCACACATCACCCGCAAGTCAAGTCGAATGTATGAATAAAACCAAGAGTATTGCACCCGAAA 69 FBan0001155 FBgn0040279 Osi14 3 3R Osi14 Osiris 14 "CG1155, CG1155, SP558, Sp558, Osiris, BEST:LD24139, Osiris 14" CDMC25082 4 5 4 DAC06-D21 9-CG11575-RA_4 CG11575 CTTTTCGCTGTTCACATGGACGTGTGGTTATGCTTTCTGCTAGTGGGTCTGCTAGGAGCCCTAGTCTGG 69 FBan0011575 FBgn0039879 CG11575 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG11575 CG11575 CDMC25082 4 6 4 DAC06-D21 9-CG11575-RA_4 CG11575 CTTTTCGCTGTTCACATGGACGTGTGGTTATGCTTTCTGCTAGTGGGTCTGCTAGGAGCCCTAGTCTGG 69 FBan0011575 FBgn0039879 CG11575 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG11575 CG11575 CDMC25083 4 7 4 DAC06-H09 23-CG1161-RA_3 CG1161 GGCGACTTAAGACACGTATTCCAAGCAGTTATCCTTTGCGAAATTCCCCTTTGGATCAAATTGATTATC 69 FBan0001161 FBgn0037313 CG1161 3 3R integral to membrane; GO:0016021; membrane; GO:0016020 CG1161 CG1161 CDMC25083 4 8 4 DAC06-H09 23-CG1161-RA_3 CG1161 GGCGACTTAAGACACGTATTCCAAGCAGTTATCCTTTGCGAAATTCCCCTTTGGATCAAATTGATTATC 69 FBan0001161 FBgn0037313 CG1161 3 3R integral to membrane; GO:0016021; membrane; GO:0016020 CG1161 CG1161 CDMC25084 4 9 4 DAC06-H21 11-CG11630-RA_3 CG11630 ACGTCGGCAGTTTGTCAGTGTTGATCGTGGGCCTAGATTCTATTTCCCAAATGCATTTCCACAGGAGCA 69 FBan0011630 FBgn0032964 CG11630 2 2L CG11630 CG11630 CDMC25084 4 10 4 DAC06-H21 11-CG11630-RA_3 CG11630 ACGTCGGCAGTTTGTCAGTGTTGATCGTGGGCCTAGATTCTATTTCCCAAATGCATTTCCACAGGAGCA 69 FBan0011630 FBgn0032964 CG11630 2 2L CG11630 CG11630 CDMC25085 4 11 4 DAC06-L09 2-CG11665-RA_1 CG11665 CCAGAGGGGCGATCAAGCTCCAACAAACTGACTCTGCGAAATTCGTCAAAGTCACGGTTATCCAAGCGC 69 FBan0011665 FBgn0033028 CG11665 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG11665 CG11665 CDMC25085 4 12 4 DAC06-L09 2-CG11665-RA_1 CG11665 CCAGAGGGGCGATCAAGCTCCAACAAACTGACTCTGCGAAATTCGTCAAAGTCACGGTTATCCAAGCGC 69 FBan0011665 FBgn0033028 CG11665 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG11665 CG11665 CDMC25086 4 13 4 DAC06-L21 2-CG11678-RA_1 CG11678 GCGACCAGCCCCAACTTTGAAGAGTTTGTTTACACGCAAGACGACTACGAGGAGTACGGTTTCCAGGGT 69 FBan0011678 FBgn0011741 Actr13E X X cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005200 actin filament; GO:0005884 Actr13E Actin-related protein 13E "CG11678, CG11678, ARP, ARP(13E), arp4, Arp4, Arp13E, actin-related protein, ARP13E, Acrp" CDMC25086 4 14 4 DAC06-L21 2-CG11678-RA_1 CG11678 GCGACCAGCCCCAACTTTGAAGAGTTTGTTTACACGCAAGACGACTACGAGGAGTACGGTTTCCAGGGT 69 FBan0011678 FBgn0011741 Actr13E X X cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005200 actin filament; GO:0005884 Actr13E Actin-related protein 13E "CG11678, CG11678, ARP, ARP(13E), arp4, Arp4, Arp13E, actin-related protein, ARP13E, Acrp" CDMC25087 4 15 4 DAC06-P09 16-CG11732-RA_2 CG11732 TCCCCTGGGTCGGTGGTATTTTCCATGTTCCTAACACGTCCCAGTTTAGATAAAGGCAATTCCGAATGT 69 FBan0011732 FBgn0037589 Obp85a 3 3R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp85a Odorant-binding protein 85a "CG11732, CG11732, CG11732, Odorant-binding protein 85a" CDMC25087 4 16 4 DAC06-P09 16-CG11732-RA_2 CG11732 TCCCCTGGGTCGGTGGTATTTTCCATGTTCCTAACACGTCCCAGTTTAGATAAAGGCAATTCCGAATGT 69 FBan0011732 FBgn0037589 Obp85a 3 3R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp85a Odorant-binding protein 85a "CG11732, CG11732, CG11732, Odorant-binding protein 85a" CDMC25088 4 17 4 DAC06-P21 23-CG11750-RA_4 CG11750 GTAGATCAGTCAACTTCCGTACATACAACTAATACGAAATGAATCAGCACAGTTGCCCTACTAAACAAT 69 FBan0011750 FBgn0030294 CG11750 X X CG11750 CG11750 "BcDNA:RE09126, BcDNA:RH21749" CDMC25088 4 18 4 DAC06-P21 23-CG11750-RA_4 CG11750 GTAGATCAGTCAACTTCCGTACATACAACTAATACGAAATGAATCAGCACAGTTGCCCTACTAAACAAT 69 FBan0011750 FBgn0030294 CG11750 X X CG11750 CG11750 "BcDNA:RE09126, BcDNA:RH21749" CDMC25089 4 19 4 DAC07-D09 24-CG15048-RA_2 CG15048 AAGTGAAATGCAGTCTACAAGTCTTAAAATCTAATGAATGTCAACTATCTTGCAGATTTGCGACG 65 FBan0015048 FBgn0030935 CG15048 X X CG15048 CG15048 CDMC25089 4 20 4 DAC07-D09 24-CG15048-RA_2 CG15048 AAGTGAAATGCAGTCTACAAGTCTTAAAATCTAATGAATGTCAACTATCTTGCAGATTTGCGACG 65 FBan0015048 FBgn0030935 CG15048 X X CG15048 CG15048 CDMC25090 4 21 4 DAC07-D21 3-CG15069-RA_1 CG15069 CTGGATCGTACCTGTTCCGATAGCGTGGTCTCACTTCGCTACCGCAAATCCACCAGTGACCTGAC 65 FBan0015069 FBgn0034357 Rgk2 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Rgk2 Rgk2 "CG15069, CG15069" CDMC25090 4 22 4 DAC07-D21 3-CG15069-RA_1 CG15069 CTGGATCGTACCTGTTCCGATAGCGTGGTCTCACTTCGCTACCGCAAATCCACCAGTGACCTGAC 65 FBan0015069 FBgn0034357 Rgk2 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Rgk2 Rgk2 "CG15069, CG15069" CDMC25091 4 23 4 DAC07-H09 18-CG15159-RA_1 CG15159 GGGCGGCAAGCTCATAAAACTGTCGACACATGCAGCAGGCAAATTACACACGATGCAAAAAGCCT 65 FBan0015159 FBgn0032687 CG15159 2 2L CG15159 CG15159 CDMC25091 4 24 4 DAC07-H09 18-CG15159-RA_1 CG15159 GGGCGGCAAGCTCATAAAACTGTCGACACATGCAGCAGGCAAATTACACACGATGCAAAAAGCCT 65 FBan0015159 FBgn0032687 CG15159 2 2L CG15159 CG15159 CDMC25092 4 25 4 DAC07-H21 3-CG15173-RA_1 CG15173 TTACGCAAGTTATGGGCAGGTTCCGCGTTGTCGTGAATCCCAGAGATTACTGTCATCTTGCGCCG 65 FBan0015173 FBgn0032744 CG15173 2 2L CG15173 CG15173 CDMC25092 4 26 4 DAC07-H21 3-CG15173-RA_1 CG15173 TTACGCAAGTTATGGGCAGGTTCCGCGTTGTCGTGAATCCCAGAGATTACTGTCATCTTGCGCCG 65 FBan0015173 FBgn0032744 CG15173 2 2L CG15173 CG15173 CDMC25093 4 1 5 DAC07-L09 3-CG15260-RA_3 CG15260 TCCCGTTTCAGAACTGACACCCAGTGAGGTACTGACCAGACTTGAGGCACGCCTGGATTTCTTGG 65 FBan0015260 FBgn0028850 CG15260 2 2L CG15260 CG15260 BG:DS07851.8 CDMC25093 4 2 5 DAC07-L09 3-CG15260-RA_3 CG15260 TCCCGTTTCAGAACTGACACCCAGTGAGGTACTGACCAGACTTGAGGCACGCCTGGATTTCTTGG 65 FBan0015260 FBgn0028850 CG15260 2 2L CG15260 CG15260 BG:DS07851.8 CDMC25094 4 3 5 DAC07-L21 7-CG15309-RA_1 CG15309 TGGTGAAGACGTTTCAGGCCTATCTACCGTCCACGAATCGGACATACTCATGTGTTCACTGCCGC 65 FBan0015309 FBgn0030183 CG15309 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG15309 CG15309 BcDNA:GH10478 CDMC25094 4 4 5 DAC07-L21 7-CG15309-RA_1 CG15309 TGGTGAAGACGTTTCAGGCCTATCTACCGTCCACGAATCGGACATACTCATGTGTTCACTGCCGC 65 FBan0015309 FBgn0030183 CG15309 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG15309 CG15309 BcDNA:GH10478 CDMC25095 4 5 5 DAC07-P09 1-CG15376-RA_1 CG15376 CACTTCGACTCGTATATTTCCAAACTGCAGTCGCTATGCGTGCCCCCCGATGTTTATGCCCTGCC 65 FBan0015376 FBgn0029692 CG15376 X X CG15376 CG15376 CDMC25095 4 6 5 DAC07-P09 1-CG15376-RA_1 CG15376 CACTTCGACTCGTATATTTCCAAACTGCAGTCGCTATGCGTGCCCCCCGATGTTTATGCCCTGCC 65 FBan0015376 FBgn0029692 CG15376 X X CG15376 CG15376 CDMC25096 4 7 5 DAC07-P21 AutoBlank AutoBlank CDMC25096 4 8 5 DAC07-P21 AutoBlank AutoBlank CDMC25097 4 9 5 DAC08-D09 3-CG14670-RA_3 CG14670 AGCGGATCCGACAACGTGATAGCAACGCCGAACCTGACGATGAAGTTCTGTGGCAAGGACGATAAG 66 FBan0014670 FBgn0037332 CG14670 3 3R protein modification; GO:0006464 biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity; GO:0004080 ; EC:6.3.4.10; ; GO:0004080 ; EC:6.3.4.10; biotin-[acetyl-CoA-carboxylase] ligase activity; GO:0004077 ; EC:6.3.4.15; ; GO:0004077 ; EC:6.3.4.15 CG14670 CG14670 NEST:bs27h05 CDMC25097 4 10 5 DAC08-D09 3-CG14670-RA_3 CG14670 AGCGGATCCGACAACGTGATAGCAACGCCGAACCTGACGATGAAGTTCTGTGGCAAGGACGATAAG 66 FBan0014670 FBgn0037332 CG14670 3 3R protein modification; GO:0006464 biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity; GO:0004080 ; EC:6.3.4.10; ; GO:0004080 ; EC:6.3.4.10; biotin-[acetyl-CoA-carboxylase] ligase activity; GO:0004077 ; EC:6.3.4.15; ; GO:0004077 ; EC:6.3.4.15 CG14670 CG14670 NEST:bs27h05 CDMC25098 4 11 5 DAC08-D21 2-CG14704-RA_2 CG14704 GGCAGGGGATTCAATGTCATCGGAGCTCATGCACCCAAGTACAATGACAAGAGCGTGGGCATTGTG 66 FBan0014704 FBgn0037906 PGRP-LB 3 3R defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; detection of bacteria; GO:0016045; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253; peptidoglycan metabolism; GO:0000270 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0004040 ; EC:3.5.1.4; ; GO:0005515 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-LB Peptidoglycan recognition protein LB "CG14704, CG14704, CG14704, CG14704" CDMC25098 4 12 5 DAC08-D21 2-CG14704-RA_2 CG14704 GGCAGGGGATTCAATGTCATCGGAGCTCATGCACCCAAGTACAATGACAAGAGCGTGGGCATTGTG 66 FBan0014704 FBgn0037906 PGRP-LB 3 3R defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; detection of bacteria; GO:0016045; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253; peptidoglycan metabolism; GO:0000270 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834; ; GO:0004040 ; EC:3.5.1.4; ; GO:0005515 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-LB Peptidoglycan recognition protein LB "CG14704, CG14704, CG14704, CG14704" CDMC25099 4 13 5 DAC08-H09 5-CG1494-RA_1 CG1494 GCTACTGTCCGCAAAAAGACAGCCTTCCGTCGGAGTTTACCCCGCGTGAATTGCTGTACATTCACG 66 FBan0001494 FBgn0031169 CG1494 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1494 CG1494 CDMC25099 4 14 5 DAC08-H09 5-CG1494-RA_1 CG1494 GCTACTGTCCGCAAAAAGACAGCCTTCCGTCGGAGTTTACCCCGCGTGAATTGCTGTACATTCACG 66 FBan0001494 FBgn0031169 CG1494 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1494 CG1494 CDMC25100 4 15 5 DAC08-H21 1-CG15005-RA_1 CG15005 CGTTCCTTTCGAAGCCTCCAATCGCGATGAACAGGAGTCCTATCCACCCATCTTGGCATCCTCTCC 66 FBan0015005 FBgn0035508 CG15005 3 3L CG15005 CG15005 CDMC25100 4 16 5 DAC08-H21 1-CG15005-RA_1 CG15005 CGTTCCTTTCGAAGCCTCCAATCGCGATGAACAGGAGTCCTATCCACCCATCTTGGCATCCTCTCC 66 FBan0015005 FBgn0035508 CG15005 3 3L CG15005 CG15005 CDMC25101 4 17 5 DAC08-L09 16-CG15554-RA_1 CG15554 CCGGGGTCCGTGACTAAGACTTCCGACCTTATCGCATCCAATAAATCCAAAACTAAGACTCAGCCA 66 FBan0015554 FBgn0039820 CG15554 3 3R CG15554 CG15554 BcDNA:RE10288 CDMC25101 4 18 5 DAC08-L09 16-CG15554-RA_1 CG15554 CCGGGGTCCGTGACTAAGACTTCCGACCTTATCGCATCCAATAAATCCAAAACTAAGACTCAGCCA 66 FBan0015554 FBgn0039820 CG15554 3 3R CG15554 CG15554 BcDNA:RE10288 CDMC25102 4 19 5 DAC08-L21 11-CG15709-RA_1 CG15709 CCAGTTATGTGGAAAATGGCAGGAAGCTGATACAGTGGCGCTACTGCAAATCAATTTGCCTGCGCG 66 FBan0015709 FBgn0034100 CG15709 2 2R proteolysis; GO:0006508 endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92 CG15709 CG15709 CDMC25102 4 20 5 DAC08-L21 11-CG15709-RA_1 CG15709 CCAGTTATGTGGAAAATGGCAGGAAGCTGATACAGTGGCGCTACTGCAAATCAATTTGCCTGCGCG 66 FBan0015709 FBgn0034100 CG15709 2 2R proteolysis; GO:0006508 endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92 CG15709 CG15709 CDMC25103 4 21 5 DAC08-P09 15-CG17195-RA_3 CG17195 CATGCTGGCCTGCTATATGACTAGCTCATCGGTAAACACCTTGTCCAAGGACTCCCGATGCCCGAA 66 FBan0017195 FBgn0039369 CG17195 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17195 CG17195 CDMC25103 4 22 5 DAC08-P09 15-CG17195-RA_3 CG17195 CATGCTGGCCTGCTATATGACTAGCTCATCGGTAAACACCTTGTCCAAGGACTCCCGATGCCCGAA 66 FBan0017195 FBgn0039369 CG17195 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17195 CG17195 CDMC25104 4 23 5 DAC08-P21 AutoBlank AutoBlank CDMC25104 4 24 5 DAC08-P21 AutoBlank AutoBlank CDMC25105 4 25 5 DAC09-D10 15-CG14116-RA_3 CG14116 ACCAGGACCAACAAAGTCTTGAGTAGCTATCGATGGACTGTCTACAAGGGACTAGAGGGATTGGCCGAT 69 FBan0014116 FBgn0036344 CG14116 3 3L CG14116 CG14116 CDMC25105 4 26 5 DAC09-D10 15-CG14116-RA_3 CG14116 ACCAGGACCAACAAAGTCTTGAGTAGCTATCGATGGACTGTCTACAAGGGACTAGAGGGATTGGCCGAT 69 FBan0014116 FBgn0036344 CG14116 3 3L CG14116 CG14116 CDMC25106 4 1 6 DAC09-D22 5-CG14120-RA_1 CG14120 TGGCGGAAACTGGGAACGAATCGAGGACAGTGTGAGAAAGTTTGTGGCGGATGAAAACATCACAGTGGA 69 FBan0014120 FBgn0036321 CG14120 3 3L CG14120 CG14120 CDMC25106 4 2 6 DAC09-D22 5-CG14120-RA_1 CG14120 TGGCGGAAACTGGGAACGAATCGAGGACAGTGTGAGAAAGTTTGTGGCGGATGAAAACATCACAGTGGA 69 FBan0014120 FBgn0036321 CG14120 3 3L CG14120 CG14120 CDMC25107 4 3 6 DAC09-H10 17-CG14181-RA_1 CG14181 TGGCGGATCGCAATATCAATTCGCTAGGAAAAGAGGCTGAGAAACTGGAGCAACATTCGAAAAAAGCCT 69 FBan0014181 FBgn0035965 CG14181 3 3L CG14181 CG14181 CDMC25107 4 4 6 DAC09-H10 17-CG14181-RA_1 CG14181 TGGCGGATCGCAATATCAATTCGCTAGGAAAAGAGGCTGAGAAACTGGAGCAACATTCGAAAAAAGCCT 69 FBan0014181 FBgn0035965 CG14181 3 3L CG14181 CG14181 CDMC25108 4 5 6 DAC09-H22 3-CG14191-RA_1 CG14191 TCGCCCTTCCAGTCCGACACAGTCGCAGTTCTTCCGAAGCAATCAATACTCTCAAACACGCCAACATGA 69 FBan0014191 FBgn0030981 CG14191 X X CG14191 CG14191 BcDNA:RE09269 CDMC25108 4 6 6 DAC09-H22 3-CG14191-RA_1 CG14191 TCGCCCTTCCAGTCCGACACAGTCGCAGTTCTTCCGAAGCAATCAATACTCTCAAACACGCCAACATGA 69 FBan0014191 FBgn0030981 CG14191 X X CG14191 CG14191 BcDNA:RE09269 CDMC25109 4 7 6 DAC09-L10 15-CG14226-RA_1 CG14226 TCGCATCGATAATTCATCAACTCATCTTCAGCCGCATATCCTTCCAACGCCATGATCTGGTCACCGGAT 69 FBan0014226 FBgn0043903 dome X X ATP synthesis coupled proton transport; GO:0015986; JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; hindgut morphogenesis; GO:0007442; immune response; GO:0006955; morphogenesis of an epithelium; GO:0002009; protein amino acid dephosphorylation; GO:0006470; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 "ATP binding; GO:0005524; ; GO:0005524; cytokine binding; GO:0019955; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888; interleukin receptor activity; GO:0004907; ; GO:0004888; ; GO:0004888; ; GO:0004725 ; EC:3.1.3.48; ; GO:0019955; ; GO:0004907; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; plasma membrane; GO:0005886; proton-transporting two-sector ATPase complex; GO:0016469 dome domeless "CG14226, CG14226, CG14226, CG14226, CG14226, l(1)G0282, l(1)G0218, l(1)G0264, l(1)G0321, l(1)G0367, l(1)G0405, l(1)G0441, CT33841, mom, master of marelle, vsp, verstopft, DOME, Dome, l(1)G0217, l(1)G0468, anon-18DEb, domeless" CDMC25109 4 8 6 DAC09-L10 15-CG14226-RA_1 CG14226 TCGCATCGATAATTCATCAACTCATCTTCAGCCGCATATCCTTCCAACGCCATGATCTGGTCACCGGAT 69 FBan0014226 FBgn0043903 dome X X ATP synthesis coupled proton transport; GO:0015986; JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; hindgut morphogenesis; GO:0007442; immune response; GO:0006955; morphogenesis of an epithelium; GO:0002009; protein amino acid dephosphorylation; GO:0006470; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 "ATP binding; GO:0005524; ; GO:0005524; cytokine binding; GO:0019955; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888; interleukin receptor activity; GO:0004907; ; GO:0004888; ; GO:0004888; ; GO:0004725 ; EC:3.1.3.48; ; GO:0019955; ; GO:0004907; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; plasma membrane; GO:0005886; proton-transporting two-sector ATPase complex; GO:0016469 dome domeless "CG14226, CG14226, CG14226, CG14226, CG14226, l(1)G0282, l(1)G0218, l(1)G0264, l(1)G0321, l(1)G0367, l(1)G0405, l(1)G0441, CT33841, mom, master of marelle, vsp, verstopft, DOME, Dome, l(1)G0217, l(1)G0468, anon-18DEb, domeless" CDMC25110 4 9 6 DAC09-L22 9-CG14238-RA_2 CG14238 TCGGCGTGAAAGTCGAATGGCCAAGTCACGTCAGTTTCAATCTCGTCGAAAAGTGCAGGATGCTGATCA 69 FBan0014238 FBgn0039429 CG14238 3 3R CG14238 CG14238 CDMC25110 4 10 6 DAC09-L22 9-CG14238-RA_2 CG14238 TCGGCGTGAAAGTCGAATGGCCAAGTCACGTCAGTTTCAATCTCGTCGAAAAGTGCAGGATGCTGATCA 69 FBan0014238 FBgn0039429 CG14238 3 3R CG14238 CG14238 CDMC25111 4 11 6 DAC09-P10 5-CG1428-RA_1 CG1428 GCACTGCCTACGGTGAGGATAACGCCAAAGGTATCCTCTCCAATAGGAACGGGGATAAAGAGCTTCCCA 69 FBan0001428 FBgn0032967 CG1428 2 2L CG1428 CG1428 CDMC25111 4 12 6 DAC09-P10 5-CG1428-RA_1 CG1428 GCACTGCCTACGGTGAGGATAACGCCAAAGGTATCCTCTCCAATAGGAACGGGGATAAAGAGCTTCCCA 69 FBan0001428 FBgn0032967 CG1428 2 2L CG1428 CG1428 CDMC25112 4 13 6 DAC09-P22 3-CG1429-RF_2 CG1429 ACGCACTGTACAGTTGACTGTCTAAAGGACGTCCTACGGTCACAGGGACCACTCACAGCACGGAAGTAA 69 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC25112 4 14 6 DAC09-P22 3-CG1429-RF_2 CG1429 ACGCACTGTACAGTTGACTGTCTAAAGGACGTCCTACGGTCACAGGGACCACTCACAGCACGGAAGTAA 69 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC25113 4 15 6 DAC10-D09 2-CG1977-RA_2 CG1977 ACCCAACCCGTACACGTGGTTCACCATGGAAGCTCTTGAGGAGACCTGGCGTAATCTGCAAAAGATCAT 69 FBan0001977 FBgn0003470 alpha-Spec 3 3L "NOT ring canal formation, actin assembly; GO:0008302; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; female germ-line cyst formation (sensu Insecta); GO:0030727; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; larval development (sensu Insecta); GO:0002168; neuromuscular synaptic transmission; GO:0007274; oocyte construction; GO:0007308; oocyte fate determination (sensu Insecta); GO:0007294; ovarian follicle cell development (sensu Insecta); GO:0030707; plasma membrane organization and biogenesis; GO:0007009; regulation of cell shape; GO:0008360; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; calmodulin binding; GO:0005516; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0005516; ; GO:0008017; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; calcium ion binding; GO:0005509; ; GO:0003779; ; GO:0005509 Golgi apparatus; GO:0005794; cell cortex; GO:0005938; cytoskeleton; GO:0005856; fusome; GO:0045169; plasma membrane; GO:0005886; spectrin; GO:0008091; spectrosome; GO:0045170 alpha-Spec alpha Spectrin "CG1977, CG1977, CG1977, l(3)dre3, alpha-spectrin, alpha-spectrin, alpha spectrin, spectrin, l(3)62Bd, l(3)04276, alpha, Spectrin, l(3)alpha-Spec, alpha-spec, alpha-Spc, alpha spectrin, alpha-Spectrin, 3A9, alpha-Spectrin, dre3, alpha-spectrin II, alpha-Spec, anon-EST:fe2E2, anon-fast-evolving-2E2" CDMC25113 4 16 6 DAC10-D09 2-CG1977-RA_2 CG1977 ACCCAACCCGTACACGTGGTTCACCATGGAAGCTCTTGAGGAGACCTGGCGTAATCTGCAAAAGATCAT 69 FBan0001977 FBgn0003470 alpha-Spec 3 3L "NOT ring canal formation, actin assembly; GO:0008302; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; female germ-line cyst formation (sensu Insecta); GO:0030727; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; larval development (sensu Insecta); GO:0002168; neuromuscular synaptic transmission; GO:0007274; oocyte construction; GO:0007308; oocyte fate determination (sensu Insecta); GO:0007294; ovarian follicle cell development (sensu Insecta); GO:0030707; plasma membrane organization and biogenesis; GO:0007009; regulation of cell shape; GO:0008360; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; calmodulin binding; GO:0005516; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0005516; ; GO:0008017; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; calcium ion binding; GO:0005509; ; GO:0003779; ; GO:0005509 Golgi apparatus; GO:0005794; cell cortex; GO:0005938; cytoskeleton; GO:0005856; fusome; GO:0045169; plasma membrane; GO:0005886; spectrin; GO:0008091; spectrosome; GO:0045170 alpha-Spec alpha Spectrin "CG1977, CG1977, CG1977, l(3)dre3, alpha-spectrin, alpha-spectrin, alpha spectrin, spectrin, l(3)62Bd, l(3)04276, alpha, Spectrin, l(3)alpha-Spec, alpha-spec, alpha-Spc, alpha spectrin, alpha-Spectrin, 3A9, alpha-Spectrin, dre3, alpha-spectrin II, alpha-Spec, anon-EST:fe2E2, anon-fast-evolving-2E2" CDMC25114 4 17 6 DAC10-D21 17-CG1984-RA_2 CG1984 TGCCAGAAGCTTGTCAAAGAAATCACCATGCAGGCTAATGATGGCGATGTTACGAAGATCTGCAAGGAA 69 FBan0001984 FBgn0037463 djl 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with mitochondrial derivative; GO:0016007; flagellum; GO:0019861 djl don juan like "CG1984, dj like, don juan like" CDMC25114 4 18 6 DAC10-D21 17-CG1984-RA_2 CG1984 TGCCAGAAGCTTGTCAAAGAAATCACCATGCAGGCTAATGATGGCGATGTTACGAAGATCTGCAAGGAA 69 FBan0001984 FBgn0037463 djl 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with mitochondrial derivative; GO:0016007; flagellum; GO:0019861 djl don juan like "CG1984, dj like, don juan like" CDMC25115 4 19 6 DAC10-H09 18-CG2040-RC_1 CG2040 CCCGCTCACAGATCAACCCAATTAATGACTCTTGTGTTGTATTTCCGCCGAACAAACGACCGATTTCGA 69 FBan0002040 FBgn0010114 hig 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 extracellular region; GO:0005576; membrane; GO:0016020 hig hikaru genki "CG2040, HIG, CT6282, hikaru genki" CDMC25115 4 20 6 DAC10-H09 18-CG2040-RC_1 CG2040 CCCGCTCACAGATCAACCCAATTAATGACTCTTGTGTTGTATTTCCGCCGAACAAACGACCGATTTCGA 69 FBan0002040 FBgn0010114 hig 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 extracellular region; GO:0005576; membrane; GO:0016020 hig hikaru genki "CG2040, HIG, CT6282, hikaru genki" CDMC25116 4 21 6 DAC10-H21 17-CG2048-RB_1 CG2048 GCCGGCTCAACTTTTTCTTTGTTAACTTGAAGTCCCAGACCAAATCAGGCAGAACATGCAGAACCGATC 69 FBan0002048 FBgn0002413 dco 3 3R behavioral response to cocaine; GO:0048148; cell communication; GO:0007154; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; imaginal disc growth; GO:0007446; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468; regulation of ecdysteroid secretion; GO:0007555; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- cytoplasm; GO:0005737; nucleus; GO:0005634 dco discs overgrown "CG2048, CG2048, l(3)dco-1, l(3)dco, l(3)discs overgrown-1, l(3)discs overgrown, dbt, dco-1, 0538/13, 0915/10, 1396/02, 1447/01, 1460/09, double-time, l(3)S053813, l(3)S144701, Double-time, l(3)j3B9, DCO/CKIe, doubletime, Dbt, CKIepsilon, Doubletime, DBT, ck1epsilon, ddbt, CK1epsilon, Dco, Discs overgrown/Double time, DBT/CK1epsilon, l(3)rK215" CDMC25116 4 22 6 DAC10-H21 17-CG2048-RB_1 CG2048 GCCGGCTCAACTTTTTCTTTGTTAACTTGAAGTCCCAGACCAAATCAGGCAGAACATGCAGAACCGATC 69 FBan0002048 FBgn0002413 dco 3 3R behavioral response to cocaine; GO:0048148; cell communication; GO:0007154; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; imaginal disc growth; GO:0007446; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468; regulation of ecdysteroid secretion; GO:0007555; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- cytoplasm; GO:0005737; nucleus; GO:0005634 dco discs overgrown "CG2048, CG2048, l(3)dco-1, l(3)dco, l(3)discs overgrown-1, l(3)discs overgrown, dbt, dco-1, 0538/13, 0915/10, 1396/02, 1447/01, 1460/09, double-time, l(3)S053813, l(3)S144701, Double-time, l(3)j3B9, DCO/CKIe, doubletime, Dbt, CKIepsilon, Doubletime, DBT, ck1epsilon, ddbt, CK1epsilon, Dco, Discs overgrown/Double time, DBT/CK1epsilon, l(3)rK215" CDMC25117 4 23 6 DAC10-L09 23-CG2082-RA_17 CG2082 TTAGTCTGAGCAAAACGTATATGTGTGAACCCAGAGCCAAACAATCATCCCAAGTGTAACCGCTTTTCC 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC25117 4 24 6 DAC10-L09 23-CG2082-RA_17 CG2082 TTAGTCTGAGCAAAACGTATATGTGTGAACCCAGAGCCAAACAATCATCCCAAGTGTAACCGCTTTTCC 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC25118 4 25 6 DAC10-L21 8-CG2093-RA_1 CG2093 ACTCGTTGGAGGAGCAGAAGAGCTTTTACGATAACCTGCATTTGGGTCCGCTCAAGATCCATGTCAGCT 69 FBan0002093 FBgn0033194 CG2093 2 2R protein targeting to vacuole; GO:0006623 CG2093 CG2093 BEST:LD02743 CDMC25118 4 26 6 DAC10-L21 8-CG2093-RA_1 CG2093 ACTCGTTGGAGGAGCAGAAGAGCTTTTACGATAACCTGCATTTGGGTCCGCTCAAGATCCATGTCAGCT 69 FBan0002093 FBgn0033194 CG2093 2 2R protein targeting to vacuole; GO:0006623 CG2093 CG2093 BEST:LD02743 CDMC25119 4 1 7 DAC10-P09 2-CG2128-RA_3 CG2128 CGACGTGCGAATATCCGTAGCCGATGAGGACAAGCTGGTTGATGCTAAGAACGAGTTCTACGACGGCGA 69 FBan0002128 FBgn0025825 Hdac3 3 3R histone deacetylation; GO:0016575; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.- nucleus; GO:0005634 Hdac3 Hdac3 "CG2128, dHDAC3, DmHDAC3, HDAC, HDAC3, dmHDA402" CDMC25119 4 2 7 DAC10-P09 2-CG2128-RA_3 CG2128 CGACGTGCGAATATCCGTAGCCGATGAGGACAAGCTGGTTGATGCTAAGAACGAGTTCTACGACGGCGA 69 FBan0002128 FBgn0025825 Hdac3 3 3R histone deacetylation; GO:0016575; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.- nucleus; GO:0005634 Hdac3 Hdac3 "CG2128, dHDAC3, DmHDAC3, HDAC, HDAC3, dmHDA402" CDMC25120 4 3 7 DAC10-P21 2-CG2144-RA_2 CG2144 GCCTGTCCACCATTGACCTAACGCCTGGTTATATCGGACAGACAAACTACAACCCGTCGATCGTTGCCA 69 FBan0002144 FBgn0033187 CG2144 2 2R protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG2144 CG2144 CDMC25120 4 4 7 DAC10-P21 2-CG2144-RA_2 CG2144 GCCTGTCCACCATTGACCTAACGCCTGGTTATATCGGACAGACAAACTACAACCCGTCGATCGTTGCCA 69 FBan0002144 FBgn0033187 CG2144 2 2R protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG2144 CG2144 CDMC25121 4 5 7 DAC11-D09 9-CG9273-RA_1 CG9273 AAGGCGGTTCCAAAACCCTAATGATCTTCAAGCTACTGCCCGTTTTGGATCCCAACGAGGTGTGC 65 FBan0009273 FBgn0032906 CG9273 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; ; GO:0003677; ; GO:0003697 DNA replication factor A complex; GO:0005662 CG9273 CG9273 CDMC25121 4 6 7 DAC11-D09 9-CG9273-RA_1 CG9273 AAGGCGGTTCCAAAACCCTAATGATCTTCAAGCTACTGCCCGTTTTGGATCCCAACGAGGTGTGC 65 FBan0009273 FBgn0032906 CG9273 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; ; GO:0003677; ; GO:0003697 DNA replication factor A complex; GO:0005662 CG9273 CG9273 CDMC25122 4 7 7 DAC11-D21 18-CG9299-RA_1 CG9299 TCTGGCATCAGGCGCATCCTCTCTGGCCCATTTGGACTCCTCCCTGAGTGGATACTCACACGGAG 65 FBan0009299 FBgn0036881 CG9299 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9299 CG9299 CDMC25122 4 8 7 DAC11-D21 18-CG9299-RA_1 CG9299 TCTGGCATCAGGCGCATCCTCTCTGGCCCATTTGGACTCCTCCCTGAGTGGATACTCACACGGAG 65 FBan0009299 FBgn0036881 CG9299 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9299 CG9299 CDMC25123 4 9 7 DAC11-H09 15-CG9390-RA_4 CG9390 AACCATGAACGCTTCGAGGACACTTATTTCTCCAAGTTCCCAGGCTACTACTGCACTGGCGATGG 65 FBan0009390 FBgn0012034 AcCoAS 3 3L fatty acid metabolism; GO:0006631; metabolism; GO:0008152 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 cytoplasm; GO:0005737 AcCoAS Acetyl Coenzyme A synthase "CG9390, CG9390, CG9390, CG9390, acetate-coenzyme A ligase, acetyl-CoA synthetase, acetyl CoA synthase, Acetyl CoA synthase, ACS, Acetyl-CoA synthase, Acetyl CoA synthetase, BEST:GH28401" CDMC25123 4 10 7 DAC11-H09 15-CG9390-RA_4 CG9390 AACCATGAACGCTTCGAGGACACTTATTTCTCCAAGTTCCCAGGCTACTACTGCACTGGCGATGG 65 FBan0009390 FBgn0012034 AcCoAS 3 3L fatty acid metabolism; GO:0006631; metabolism; GO:0008152 acetate-CoA ligase activity; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1; ; GO:0003987 ; EC:6.2.1.1 cytoplasm; GO:0005737 AcCoAS Acetyl Coenzyme A synthase "CG9390, CG9390, CG9390, CG9390, acetate-coenzyme A ligase, acetyl-CoA synthetase, acetyl CoA synthase, Acetyl CoA synthase, ACS, Acetyl-CoA synthase, Acetyl CoA synthetase, BEST:GH28401" CDMC25124 4 11 7 DAC11-H21 6-CG9448-RA_1 CG9448 CAACGAGGAGTCAATGATGCGTCAATGGCTGGACGTGTGCGTAACTGATGGAGGCCTACTGGTGG 65 FBan0009448 FBgn0037734 CG9448 3 3R CG9448 CG9448 CDMC25124 4 12 7 DAC11-H21 6-CG9448-RA_1 CG9448 CAACGAGGAGTCAATGATGCGTCAATGGCTGGACGTGTGCGTAACTGATGGAGGCCTACTGGTGG 65 FBan0009448 FBgn0037734 CG9448 3 3R CG9448 CG9448 CDMC25125 4 13 7 DAC11-L09 23-CG9555-RA_2 CG9555 GAATCGTGCAGTAAGAAACCTGATGAAATTCCAGCTACTACTGCTTCACCGAAAGAACCAGCACA 65 FBan0009555 FBgn0032085 CG9555 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG9555 CG9555 CDMC25125 4 14 7 DAC11-L09 23-CG9555-RA_2 CG9555 GAATCGTGCAGTAAGAAACCTGATGAAATTCCAGCTACTACTGCTTCACCGAAAGAACCAGCACA 65 FBan0009555 FBgn0032085 CG9555 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG9555 CG9555 CDMC25126 4 15 7 DAC11-L21 11-CG9589-RA_1 CG9589 GCGATCATGCCGTGAATGCAAACAATCTGTGCGATCTGATCGTGGAGACGTTTGGACCCAAGAGG 65 FBan0009589 FBgn0038361 CG9589 3 3R heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; uroporphyrinogen-III synthase activity; GO:0004852 ; EC:4.2.1.75; ; GO:0004852 ; EC:4.2.1.75; ; GO:0004852 ; EC:4.2.1.75 CG9589 CG9589 BcDNA:AT11468 CDMC25126 4 16 7 DAC11-L21 11-CG9589-RA_1 CG9589 GCGATCATGCCGTGAATGCAAACAATCTGTGCGATCTGATCGTGGAGACGTTTGGACCCAAGAGG 65 FBan0009589 FBgn0038361 CG9589 3 3R heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; uroporphyrinogen-III synthase activity; GO:0004852 ; EC:4.2.1.75; ; GO:0004852 ; EC:4.2.1.75; ; GO:0004852 ; EC:4.2.1.75 CG9589 CG9589 BcDNA:AT11468 CDMC25127 4 17 7 DAC11-P09 11-CG9680-RA_1 CG9680 AGAAGCTGCAGGATCTACGACTCTTTCAGCCTCGTCTGTTCGCCACCGTACTTACCATGCCCGTG 65 FBan0009680 FBgn0004556 Dbp73D 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dbp73D Dead box protein 73D "CG9680, DmRH7, DBP73D" CDMC25127 4 18 7 DAC11-P09 11-CG9680-RA_1 CG9680 AGAAGCTGCAGGATCTACGACTCTTTCAGCCTCGTCTGTTCGCCACCGTACTTACCATGCCCGTG 65 FBan0009680 FBgn0004556 Dbp73D 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dbp73D Dead box protein 73D "CG9680, DmRH7, DBP73D" CDMC25128 4 19 7 DAC11-P21 5-CG9704-RA_1 CG9704 CAGCCGGAAGAGGACTACTTGCCCTGCAACTACTGGATCAGCAAGGATATTGTGCCGCGGTATGC 65 FBan0009704 FBgn0004108 Nrt 3 3L axon guidance; GO:0007411; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell adhesion; GO:0007155; central nervous system development; GO:0007417; ectoderm development; GO:0007398; nervous system development; GO:0007399 catalytic activity; GO:0003824; ; GO:0003824 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Nrt Neurotactin "CG9704, dab, disabled, nrt, MabBP106, BP106, DAB, Neur, Neurotactin, Dab, neu, Nrt BP106, BcDNA:LD22004, l(3)73Be" CDMC25128 4 20 7 DAC11-P21 5-CG9704-RA_1 CG9704 CAGCCGGAAGAGGACTACTTGCCCTGCAACTACTGGATCAGCAAGGATATTGTGCCGCGGTATGC 65 FBan0009704 FBgn0004108 Nrt 3 3L axon guidance; GO:0007411; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell adhesion; GO:0007155; central nervous system development; GO:0007417; ectoderm development; GO:0007398; nervous system development; GO:0007399 catalytic activity; GO:0003824; ; GO:0003824 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Nrt Neurotactin "CG9704, dab, disabled, nrt, MabBP106, BP106, DAB, Neur, Neurotactin, Dab, neu, Nrt BP106, BcDNA:LD22004, l(3)73Be" CDMC25129 4 21 7 DAC12-D09 15-CG15456-RA_1 CG15456 GATCCTTCGAGGTGTCCATCGACGGTCAGCTAGTGCACTCGAAGCTTTCCTGCCTGGCATTTCCC 65 FBan0015456 FBgn0040650 CG15456 X X CG15456 CG15456 CDMC25129 4 22 7 DAC12-D09 15-CG15456-RA_1 CG15456 GATCCTTCGAGGTGTCCATCGACGGTCAGCTAGTGCACTCGAAGCTTTCCTGCCTGGCATTTCCC 65 FBan0015456 FBgn0040650 CG15456 X X CG15456 CG15456 CDMC25130 4 23 7 DAC12-D21 1-CG15482-RA_1 CG15482 TCGTTTTGGCAAGCCTGATTACCTACCACAATGACTGCGCCATTTACCTCGCGTACCAACCAGGC 65 FBan0015482 FBgn0032483 CG15482 2 2L CG15482 CG15482 CDMC25130 4 24 7 DAC12-D21 1-CG15482-RA_1 CG15482 TCGTTTTGGCAAGCCTGATTACCTACCACAATGACTGCGCCATTTACCTCGCGTACCAACCAGGC 65 FBan0015482 FBgn0032483 CG15482 2 2L CG15482 CG15482 CDMC25131 4 25 7 DAC12-H09 1-CG15572-RA_1 CG15572 AGCGATCGGTGAGCTATCCGGAGATCATAAGCTGCCTATCCAAGAGACTCCATCGAGCGGAGGTG 65 FBan0015572 FBgn0029702 CG15572 X X CG15572 CG15572 CDMC25131 4 26 7 DAC12-H09 1-CG15572-RA_1 CG15572 AGCGATCGGTGAGCTATCCGGAGATCATAAGCTGCCTATCCAAGAGACTCCATCGAGCGGAGGTG 65 FBan0015572 FBgn0029702 CG15572 X X CG15572 CG15572 CDMC25132 4 1 8 DAC12-H21 17-CG15594-RB_1 CG15594 AGATCCAGAAGCTGTTTTTCCCCCTACTGATTGCCTACAAGCTCAAGTTCCTCACCCTCATCCCG 65 FBan0015594 FBgn0037421 CG15594 3 3R CG15594 CG15594 CDMC25132 4 2 8 DAC12-H21 17-CG15594-RB_1 CG15594 AGATCCAGAAGCTGTTTTTCCCCCTACTGATTGCCTACAAGCTCAAGTTCCTCACCCTCATCCCG 65 FBan0015594 FBgn0037421 CG15594 3 3R CG15594 CG15594 CDMC25133 4 3 8 DAC12-L09 6-CG15684-RA_1 CG15684 GTCAGTCGACAGGTGAGTGGAACCCCCTTTTACCCGCCCCACTCTCTGTTGTCGTGTTCTTTTCC 65 FBan0015684 FBgn0038785 CG15684 3 3R CG15684 CG15684 CDMC25133 4 4 8 DAC12-L09 6-CG15684-RA_1 CG15684 GTCAGTCGACAGGTGAGTGGAACCCCCTTTTACCCGCCCCACTCTCTGTTGTCGTGTTCTTTTCC 65 FBan0015684 FBgn0038785 CG15684 3 3R CG15684 CG15684 CDMC25134 4 5 8 DAC12-L21 2-CG15725-RA_5 CG15725 CAGTTGCGATGGACCGGTTCGTTTTCGAAGGATTCTCAACACAGCCTACGGTCACAAGCCAGAGG 65 FBan0015725 FBgn0030417 CG15725 X X CG15725 CG15725 CDMC25134 4 6 8 DAC12-L21 2-CG15725-RA_5 CG15725 CAGTTGCGATGGACCGGTTCGTTTTCGAAGGATTCTCAACACAGCCTACGGTCACAAGCCAGAGG 65 FBan0015725 FBgn0030417 CG15725 X X CG15725 CG15725 CDMC25135 4 7 8 DAC12-P09 23-CG15800-RA_1 CG15800 CGGTTACGTGGAGAAGATCCCAAGATTCCAGGATCATTTCATTGAGCAAATTCAAAAGGAATAGG 65 FBan0015800 FBgn0034904 CG15800 2 2R ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 nuclear ubiquitin ligase complex; GO:0000152 CG15800 CG15800 CDMC25135 4 8 8 DAC12-P09 23-CG15800-RA_1 CG15800 CGGTTACGTGGAGAAGATCCCAAGATTCCAGGATCATTTCATTGAGCAAATTCAAAAGGAATAGG 65 FBan0015800 FBgn0034904 CG15800 2 2R ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 nuclear ubiquitin ligase complex; GO:0000152 CG15800 CG15800 CDMC25136 4 9 8 DAC12-P21 AutoBlank AutoBlank CDMC25136 4 10 8 DAC12-P21 AutoBlank AutoBlank CDMC25137 4 11 8 DAC13-D09 3-CG13049-RA_1 CG13049 CTCCCGCCCCATACTTCTTCTAAGGACTTAGCTGTAGGATCACCCAGCTCATACACTCCCATCCGTCCT 69 FBan0013049 FBgn0036592 CG13049 3 3L CG13049 CG13049 BcDNA:RE26528 CDMC25137 4 12 8 DAC13-D09 3-CG13049-RA_1 CG13049 CTCCCGCCCCATACTTCTTCTAAGGACTTAGCTGTAGGATCACCCAGCTCATACACTCCCATCCGTCCT 69 FBan0013049 FBgn0036592 CG13049 3 3L CG13049 CG13049 BcDNA:RE26528 CDMC25138 4 13 8 DAC13-D21 9-CG13067-RA_1 CG13067 CCGCCTACCCCTATGCCGCCTACTACCGTTAAGACTGGATGAATGGATCGTGATCTTAACCTGACTGCT 69 FBan0013067 FBgn0036589 CG13067 3 3L CG13067 CG13067 "anon-WO0153538.39, anon-WO0153538.46" CDMC25138 4 14 8 DAC13-D21 9-CG13067-RA_1 CG13067 CCGCCTACCCCTATGCCGCCTACTACCGTTAAGACTGGATGAATGGATCGTGATCTTAACCTGACTGCT 69 FBan0013067 FBgn0036589 CG13067 3 3L CG13067 CG13067 "anon-WO0153538.39, anon-WO0153538.46" CDMC25139 4 15 8 DAC13-H09 3-CG13098-RA_1 CG13098 TGGCGGGAAATGGAGAAACGCATCCTCTACTTGTACAAGTTCCTCAACCGCAAGACGAAGACGGGCTAT 69 FBan0013098 FBgn0032053 mRpL51 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL51 mitochondrial ribosomal protein L51 "CG13098, CG13098, MRP-L51, mitochondrial ribosomal protein L51" CDMC25139 4 16 8 DAC13-H09 3-CG13098-RA_1 CG13098 TGGCGGGAAATGGAGAAACGCATCCTCTACTTGTACAAGTTCCTCAACCGCAAGACGAAGACGGGCTAT 69 FBan0013098 FBgn0032053 mRpL51 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL51 mitochondrial ribosomal protein L51 "CG13098, CG13098, MRP-L51, mitochondrial ribosomal protein L51" CDMC25140 4 17 8 DAC13-H21 3-CG13110-RA_2 CG13110 CAGCCCATCGTCTATCCGATCGACTATCACTCGGATATGGCACTGGGTAGACGGGACTGCGATCACATT 69 FBan0013110 FBgn0032111 CG13110 2 2L CG13110 CG13110 BcDNA:AT19071 CDMC25140 4 18 8 DAC13-H21 3-CG13110-RA_2 CG13110 CAGCCCATCGTCTATCCGATCGACTATCACTCGGATATGGCACTGGGTAGACGGGACTGCGATCACATT 69 FBan0013110 FBgn0032111 CG13110 2 2L CG13110 CG13110 BcDNA:AT19071 CDMC25141 4 19 8 DAC13-L09 3-CG13160-RA_7 CG13160 TGACTGGTCGCTTTGGCGTCTCCACCAATCCGGATATACTAATCGGCGCTCTATGTGGTTTTGGCACAA 69 FBan0013160 FBgn0033720 CG13160 2 2R CG13160 CG13160 CDMC25141 4 20 8 DAC13-L09 3-CG13160-RA_7 CG13160 TGACTGGTCGCTTTGGCGTCTCCACCAATCCGGATATACTAATCGGCGCTCTATGTGGTTTTGGCACAA 69 FBan0013160 FBgn0033720 CG13160 2 2R CG13160 CG13160 CDMC25142 4 21 8 DAC13-L21 18-CG1317-RB_1 CG1317 GGAGAAGGACACCAGAATGTTGAAGCCGTTGAAGTATTCGTCGTGCTTTTTCGTCGTGGAGATGCTTCT 69 FBan0001317 FBgn0035333 CG1317 3 3L CG1317 CG1317 CDMC25142 4 22 8 DAC13-L21 18-CG1317-RB_1 CG1317 GGAGAAGGACACCAGAATGTTGAAGCCGTTGAAGTATTCGTCGTGCTTTTTCGTCGTGGAGATGCTTCT 69 FBan0001317 FBgn0035333 CG1317 3 3L CG1317 CG1317 CDMC25143 4 23 8 DAC13-P09 18-CG1320-RA_4 CG1320 CCACCCAATGTGGTCACTTTTTCGGTGTCCATGGAAATGACCAAGTACGATGTGCGTAACTATCTGGAG 69 FBan0001320 FBgn0035335 mRpL23 3 3L protein biosynthesis; GO:0006412 RNA binding; GO:0003723; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003723; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL23 mitochondrial ribosomal protein L23 "CG1320, CG1320, L23, BcDNA:RE49852, mitochondrial ribosomal protein L23" CDMC25143 4 24 8 DAC13-P09 18-CG1320-RA_4 CG1320 CCACCCAATGTGGTCACTTTTTCGGTGTCCATGGAAATGACCAAGTACGATGTGCGTAACTATCTGGAG 69 FBan0001320 FBgn0035335 mRpL23 3 3L protein biosynthesis; GO:0006412 RNA binding; GO:0003723; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003723; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL23 mitochondrial ribosomal protein L23 "CG1320, CG1320, L23, BcDNA:RE49852, mitochondrial ribosomal protein L23" CDMC25144 4 25 8 DAC13-P21 22-CG13221-RA_1 CG13221 GGAGCACACTCCTAGTTGTTAGTTAAGAGGGCGGGTAATCATCTTAGGGACTGAGAGACAGGCTTGATT 69 FBan0013221 FBgn0041174 Vhl 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567; tracheal system development (sensu Insecta); GO:0007424 contributes_to ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 VCB complex; GO:0030891 Vhl von Hippel-Lindau "CG13221, VHL, d-vhl, d-VHL, dmVHL, dVHL, Von Hippel Lindau, BcDNA:RH61560, vhl, von Hippel-Lindau" CDMC25144 4 26 8 DAC13-P21 22-CG13221-RA_1 CG13221 GGAGCACACTCCTAGTTGTTAGTTAAGAGGGCGGGTAATCATCTTAGGGACTGAGAGACAGGCTTGATT 69 FBan0013221 FBgn0041174 Vhl 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567; tracheal system development (sensu Insecta); GO:0007424 contributes_to ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 VCB complex; GO:0030891 Vhl von Hippel-Lindau "CG13221, VHL, d-vhl, d-VHL, dmVHL, dVHL, Von Hippel Lindau, BcDNA:RH61560, vhl, von Hippel-Lindau" CDMC25145 4 1 9 DAC14-D09 2-CG4017-RA_1 CG4017 GCCCAAACGAGTCTATCGCTGGACATAGAGCCCATTGCGGATGCTAATCGGCGAAGTGATGACTACTCA 69 FBan0004017 FBgn0032143 CG4017 2 2L proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG4017 CG4017 CDMC25145 4 2 9 DAC14-D09 2-CG4017-RA_1 CG4017 GCCCAAACGAGTCTATCGCTGGACATAGAGCCCATTGCGGATGCTAATCGGCGAAGTGATGACTACTCA 69 FBan0004017 FBgn0032143 CG4017 2 2L proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG4017 CG4017 CDMC25146 4 3 9 DAC14-D21 16-CG40196-RB_1 CG40196 AGAGCCGTCATTGCAGTGGGTTATGAACTCAATCCATGCAAATTTATCGGCATTAGCGGGAGATCAGTA 69 FBgn0058196 CG40196 CG40196 CG40196 CDMC25146 4 4 9 DAC14-D21 16-CG40196-RB_1 CG40196 AGAGCCGTCATTGCAGTGGGTTATGAACTCAATCCATGCAAATTTATCGGCATTAGCGGGAGATCAGTA 69 FBgn0058196 CG40196 CG40196 CG40196 CDMC25147 4 5 9 DAC14-H09 23-CG40249-RA_12 CG40249 TGCCTTGGATACCTTTAACTGTGAAAACTGTATTCCTATTTGTGTTTTGGGTAACTTCGCGGCAATATT 69 FBgn0058249 CG40249 CG40249 CG40249 CDMC25147 4 6 9 DAC14-H09 23-CG40249-RA_12 CG40249 TGCCTTGGATACCTTTAACTGTGAAAACTGTATTCCTATTTGTGTTTTGGGTAACTTCGCGGCAATATT 69 FBgn0058249 CG40249 CG40249 CG40249 CDMC25148 4 7 9 DAC14-H21 23-CG40268-RA_1 CG40268 AGCGGTGAAAATGTGTTTGCTATAATTTCGGTATATGAATTCGTTCTTCATGGTGTGGATCAACAAGTC 69 FBgn0058268 CG40268 CG40268 CG40268 CDMC25148 4 8 9 DAC14-H21 23-CG40268-RA_1 CG40268 AGCGGTGAAAATGTGTTTGCTATAATTTCGGTATATGAATTCGTTCTTCATGGTGTGGATCAACAAGTC 69 FBgn0058268 CG40268 CG40268 CG40268 CDMC25149 4 9 9 DAC14-L09 1-CG40334-RA_2 CG40334 TCCCATTAGCTTTGAGCCTAATCCTGAGGCATCTCCTGAACCAGAGGAATTGGCCCTTCTTCCCCCAAA 69 FBgn0058334 CG40334 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 CG40334 CG40334 CDMC25149 4 10 9 DAC14-L09 1-CG40334-RA_2 CG40334 TCCCATTAGCTTTGAGCCTAATCCTGAGGCATCTCCTGAACCAGAGGAATTGGCCCTTCTTCCCCCAAA 69 FBgn0058334 CG40334 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 CG40334 CG40334 CDMC25150 4 11 9 DAC14-L21 11-CG40343-RA_1 CG40343 AGCCAACGGTGAAATTCTGTGGGAAAGGTTTTGTACAGCACTACGACTGCAATTTCGACAGAGTCGCGA 69 FBgn0058343 CG40343 CG40343 CG40343 CDMC25150 4 12 9 DAC14-L21 11-CG40343-RA_1 CG40343 AGCCAACGGTGAAATTCTGTGGGAAAGGTTTTGTACAGCACTACGACTGCAATTTCGACAGAGTCGCGA 69 FBgn0058343 CG40343 CG40343 CG40343 CDMC25151 4 13 9 DAC14-P09 15-CG40400-RA_1 CG40400 ACGAGCGCGTTTAAATGCACGATCATTTTCGAAACGAGCCGAATTCACTCCGTTCATTTCAGCACGACT 69 FBgn0058400 CG40400 CG40400 CG40400 CDMC25151 4 14 9 DAC14-P09 15-CG40400-RA_1 CG40400 ACGAGCGCGTTTAAATGCACGATCATTTTCGAAACGAGCCGAATTCACTCCGTTCATTTCAGCACGACT 69 FBgn0058400 CG40400 CG40400 CG40400 CDMC25152 4 15 9 DAC14-P21 24-CG40413-RA_6 CG40413 GAGAGAAGACGAAGACAGTTAATATTGATGAGCCAAATTTAATTGAATATTACATAAAGGGTATTCCAG 69 FBgn0058413 CG40413 CG40413 CG40413 CDMC25152 4 16 9 DAC14-P21 24-CG40413-RA_6 CG40413 GAGAGAAGACGAAGACAGTTAATATTGATGAGCCAAATTTAATTGAATATTACATAAAGGGTATTCCAG 69 FBgn0058413 CG40413 CG40413 CG40413 CDMC25153 4 17 9 DAC15-D09 2-CG7306-RA_1 CG7306 CCACAGCCAACAGTGAAGGTGCAGTAACCGTTTGCTATATCGTCGGATCGAGTGAGTACACCACCCTGC 69 FBan0007306 FBgn0036947 CG7306 3 3L chitin metabolism; GO:0006030; electron transport; GO:0006118 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; electron transporter activity; GO:0005489; ; GO:0016490; copper ion binding; GO:0005507; ; GO:0005489; ; GO:0005507; ; GO:0008061 extracellular region; GO:0005576 CG7306 CG7306 CDMC25153 4 18 9 DAC15-D09 2-CG7306-RA_1 CG7306 CCACAGCCAACAGTGAAGGTGCAGTAACCGTTTGCTATATCGTCGGATCGAGTGAGTACACCACCCTGC 69 FBan0007306 FBgn0036947 CG7306 3 3L chitin metabolism; GO:0006030; electron transport; GO:0006118 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; electron transporter activity; GO:0005489; ; GO:0016490; copper ion binding; GO:0005507; ; GO:0005489; ; GO:0005507; ; GO:0008061 extracellular region; GO:0005576 CG7306 CG7306 CDMC25154 4 19 9 DAC15-D21 12-CG7321-RA_2 CG7321 TGGCGCAGATAATGCTCGACGATCTGAATCTGTCGAATATCGTGATCGGCTGGTACAAGCTCTTTGGCA 69 FBgn0038556 CDMC25154 4 20 9 DAC15-D21 12-CG7321-RA_2 CG7321 TGGCGCAGATAATGCTCGACGATCTGAATCTGTCGAATATCGTGATCGGCTGGTACAAGCTCTTTGGCA 69 FBgn0038556 CDMC25155 4 21 9 DAC15-H09 2-CG7347-RA_2 CG7347 TGCACCTTCTGTCCCTTGTCTTTCACGAGTATTACCTCACCTGTCTGTTTCGCGACTCCGAGGAGACGA 69 FBan0007347 FBgn0002901 mus304 3 3L DNA damage checkpoint; GO:0000077; DNA repair; GO:0006281; cell cycle checkpoint; GO:0000075; female meiosis; GO:0007143; female meiosis chromosome segregation; GO:0016321; imaginal disc development; GO:0007444; meiotic recombination; GO:0007131; mitotic checkpoint; GO:0007093; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; response to DNA damage stimulus; GO:0006974; response to radiation; GO:0009314 ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003 cytoplasm; GO:0005737 mus304 mutagen-sensitive 304 "CG7347, CG7347, mus(3)304, mus-304, anon-WO0140519.82" CDMC25155 4 22 9 DAC15-H09 2-CG7347-RA_2 CG7347 TGCACCTTCTGTCCCTTGTCTTTCACGAGTATTACCTCACCTGTCTGTTTCGCGACTCCGAGGAGACGA 69 FBan0007347 FBgn0002901 mus304 3 3L DNA damage checkpoint; GO:0000077; DNA repair; GO:0006281; cell cycle checkpoint; GO:0000075; female meiosis; GO:0007143; female meiosis chromosome segregation; GO:0016321; imaginal disc development; GO:0007444; meiotic recombination; GO:0007131; mitotic checkpoint; GO:0007093; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; response to DNA damage stimulus; GO:0006974; response to radiation; GO:0009314 ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003 cytoplasm; GO:0005737 mus304 mutagen-sensitive 304 "CG7347, CG7347, mus(3)304, mus-304, anon-WO0140519.82" CDMC25156 4 23 9 DAC15-H21 14-CG7358-RA_1 CG7358 GCGAGAGCTGCGTTACCGAAAGCCACGTCACTATCGACTGGATATACAGATCTTTATGGGCGTGGAGAA 69 FBan0007358 FBgn0030974 CG7358 X X CG7358 CG7358 CDMC25156 4 24 9 DAC15-H21 14-CG7358-RA_1 CG7358 GCGAGAGCTGCGTTACCGAAAGCCACGTCACTATCGACTGGATATACAGATCTTTATGGGCGTGGAGAA 69 FBan0007358 FBgn0030974 CG7358 X X CG7358 CG7358 CDMC25157 4 25 9 DAC15-L09 16-CG7385-RA_4 CG7385 ACCAACGACACCTACAATCTGCAGAACTACGTGGAAAAGAATGGCTATGTTTTTGTGAGGGATCGGCCG 69 FBan0007385 FBgn0036937 CG7385 3 3L ion transport; GO:0006811 glutamate-gated ion channel activity; GO:0005234; receptor activity; GO:0004872; ; GO:0004872; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG7385 CG7385 CT22733 CDMC25157 4 26 9 DAC15-L09 16-CG7385-RA_4 CG7385 ACCAACGACACCTACAATCTGCAGAACTACGTGGAAAAGAATGGCTATGTTTTTGTGAGGGATCGGCCG 69 FBan0007385 FBgn0036937 CG7385 3 3L ion transport; GO:0006811 glutamate-gated ion channel activity; GO:0005234; receptor activity; GO:0004872; ; GO:0004872; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG7385 CG7385 CT22733 CDMC25158 4 1 10 DAC15-L21 2-CG7397-RA_2 CG7397 CGCCACAGAGCTATACCCAGCAGCTAAGAGATTACCGCAAGAGCATCTCACCCAGTTTCCAAAGTGCCT 69 FBan0007397 FBgn0038543 CG7397 3 3R CG7397 CG7397 FBgn0038543 CDMC25158 4 2 10 DAC15-L21 2-CG7397-RA_2 CG7397 CGCCACAGAGCTATACCCAGCAGCTAAGAGATTACCGCAAGAGCATCTCACCCAGTTTCCAAAGTGCCT 69 FBan0007397 FBgn0038543 CG7397 3 3R CG7397 CG7397 FBgn0038543 CDMC25159 4 3 10 DAC15-P09 12-CG7445-RA_1 CG7445 GCCAGTGTCCTTTAGTAAGCGCACCTAAATGTACCAATAGAACCGTCGGACGAACGGATGAGCACTCGT 69 FBan0007445 FBgn0005633 fln 3 3L muscle thick filament assembly; GO:0030241 contractile fiber; GO:0043292; myofibril; GO:0030016; striated muscle thick filament; GO:0005863 fln flightin "CG7445, mp27, Ftn: Flightin, Flightin, flightin" CDMC25159 4 4 10 DAC15-P09 12-CG7445-RA_1 CG7445 GCCAGTGTCCTTTAGTAAGCGCACCTAAATGTACCAATAGAACCGTCGGACGAACGGATGAGCACTCGT 69 FBan0007445 FBgn0005633 fln 3 3L muscle thick filament assembly; GO:0030241 contractile fiber; GO:0043292; myofibril; GO:0030016; striated muscle thick filament; GO:0005863 fln flightin "CG7445, mp27, Ftn: Flightin, Flightin, flightin" CDMC25160 4 5 10 DAC15-P21 8-CG7454-RA_1 CG7454 CCGGGGTCTACACCATAGCCATTCTATCCCAGACCTTTCCATTTTGCTATGTCTGTGAGCAGCTGAGCA 69 FBan0007454 FBgn0037576 Or85a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85a Odorant receptor 85a "CG7454, 85A.4, DOR31, 85a" CDMC25160 4 6 10 DAC15-P21 8-CG7454-RA_1 CG7454 CCGGGGTCTACACCATAGCCATTCTATCCCAGACCTTTCCATTTTGCTATGTCTGTGAGCAGCTGAGCA 69 FBan0007454 FBgn0037576 Or85a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85a Odorant receptor 85a "CG7454, 85A.4, DOR31, 85a" CDMC25161 4 7 10 DAC16-D09 2-CG1250-RB_1 CG1250 TCAAGCAGACATTCCAACGCGTCTTCGCACGTGATGGTCGCAACGACTTGAAGATGGCCTTCAATG 66 FBan0001250 FBgn0037357 sec23 3 3R ER to Golgi transport; GO:0006888; G-protein coupled receptor protein signaling pathway; GO:0007186; Golgi organization and biogenesis; GO:0007030; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; protein binding; GO:0005515; ; GO:0005096; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 COPII vesicle coat; GO:0030127; COPII-coated vesicle; GO:0030138; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 sec23 sec23 "CG1250, CG1250, CG1250, CG1250, CG1250, l(3)j13C8, Sec23A, dSec23, dSec23p, dsec23, dsec23p" CDMC25161 4 8 10 DAC16-D09 2-CG1250-RB_1 CG1250 TCAAGCAGACATTCCAACGCGTCTTCGCACGTGATGGTCGCAACGACTTGAAGATGGCCTTCAATG 66 FBan0001250 FBgn0037357 sec23 3 3R ER to Golgi transport; GO:0006888; G-protein coupled receptor protein signaling pathway; GO:0007186; Golgi organization and biogenesis; GO:0007030; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 GTPase activator activity; GO:0005096; protein binding; GO:0005515; ; GO:0005096; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 COPII vesicle coat; GO:0030127; COPII-coated vesicle; GO:0030138; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 sec23 sec23 "CG1250, CG1250, CG1250, CG1250, CG1250, l(3)j13C8, Sec23A, dSec23, dSec23p, dsec23, dsec23p" CDMC25162 4 9 10 DAC16-D21 15-CG12770-RA_1 CG12770 GAGCGCGAGAAGTACGACAACATGGCCGATCTATACGCAATCATCAACACCATCCAGCAGCTGGAG 66 FBan0012770 FBgn0021814 Vps28 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps28 Vps28 "CG12770, l(2)k16503, vps28, DmVps28" CDMC25162 4 10 10 DAC16-D21 15-CG12770-RA_1 CG12770 GAGCGCGAGAAGTACGACAACATGGCCGATCTATACGCAATCATCAACACCATCCAGCAGCTGGAG 66 FBan0012770 FBgn0021814 Vps28 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps28 Vps28 "CG12770, l(2)k16503, vps28, DmVps28" CDMC25163 4 11 10 DAC16-H09 11-CG13298-RA_1 CG13298 ACAACATTAAGGCCAAGTACAATCTGAAGACGCCTGAAGCTCCTTAGAACCCACACTTGGTGCGGC 66 FBan0013298 FBgn0035692 CG13298 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG13298 CG13298 cg13298 CDMC25163 4 12 10 DAC16-H09 11-CG13298-RA_1 CG13298 ACAACATTAAGGCCAAGTACAATCTGAAGACGCCTGAAGCTCCTTAGAACCCACACTTGGTGCGGC 66 FBan0013298 FBgn0035692 CG13298 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG13298 CG13298 cg13298 CDMC25164 4 13 10 DAC16-H21 3-CG13428-RA_1 CG13428 ACCTCCGAAATTCCGATCCCGTCGTGATACATTGGAGGACAAGCTCGTGGCCAATGATGATCCTCC 66 FBan0013428 FBgn0034515 CG13428 2 2R CG13428 CG13428 CDMC25164 4 14 10 DAC16-H21 3-CG13428-RA_1 CG13428 ACCTCCGAAATTCCGATCCCGTCGTGATACATTGGAGGACAAGCTCGTGGCCAATGATGATCCTCC 66 FBan0013428 FBgn0034515 CG13428 2 2R CG13428 CG13428 CDMC25165 4 15 10 DAC16-L09 11-CG13879-RA_1 CG13879 TACTTGCGCGACTTCTATTGTGCCAAGAAGAGGGAATGCATAGAAAACCGGCAGACCACAGTGCAG 66 FBan0013879 FBgn0035120 CG13879 3 3L CG13879 CG13879 CDMC25165 4 16 10 DAC16-L09 11-CG13879-RA_1 CG13879 TACTTGCGCGACTTCTATTGTGCCAAGAAGAGGGAATGCATAGAAAACCGGCAGACCACAGTGCAG 66 FBan0013879 FBgn0035120 CG13879 3 3L CG13879 CG13879 CDMC25166 4 17 10 DAC16-L21 1-CG14016-RA_1 CG14016 GCTGGCAAACCACCGATGGCTAGTAGTCACATTAACCCCATACCCATCTCACGACCCATAGCGACT 66 FBan0014016 FBgn0031715 tomb 2 2L tomb tombola "CG14016, tombola" CDMC25166 4 18 10 DAC16-L21 1-CG14016-RA_1 CG14016 GCTGGCAAACCACCGATGGCTAGTAGTCACATTAACCCCATACCCATCTCACGACCCATAGCGACT 66 FBan0014016 FBgn0031715 tomb 2 2L tomb tombola "CG14016, tombola" CDMC25167 4 19 10 DAC16-P09 6-CG14326-RA_1 CG14326 GGGAACTGGAGCTCAGCCTACTGGTGGGCAAGTAGACAATCGTATCCTTGGAAATCTCCTCGGTGG 66 FBan0014326 FBgn0038528 CG14326 3 3R CG14326 CG14326 BcDNA:RE19820 CDMC25167 4 20 10 DAC16-P09 6-CG14326-RA_1 CG14326 GGGAACTGGAGCTCAGCCTACTGGTGGGCAAGTAGACAATCGTATCCTTGGAAATCTCCTCGGTGG 66 FBan0014326 FBgn0038528 CG14326 3 3R CG14326 CG14326 BcDNA:RE19820 CDMC25168 4 21 10 DAC16-P21 AutoBlank AutoBlank CDMC25168 4 22 10 DAC16-P21 AutoBlank AutoBlank CDMC25169 4 23 10 DAC17-D09 3-CG17304-RA_1 CG17304 ACGAGCGCAAAATGATCATCGAGGTGCTCAACAGAGACGAGTCGGTGAGGCAGAGAGATGCCACTAGAA 69 FBan0017304 FBgn0038267 CG17304 3 3R CG17304 CG17304 CDMC25169 4 24 10 DAC17-D09 3-CG17304-RA_1 CG17304 ACGAGCGCAAAATGATCATCGAGGTGCTCAACAGAGACGAGTCGGTGAGGCAGAGAGATGCCACTAGAA 69 FBan0017304 FBgn0038267 CG17304 3 3R CG17304 CG17304 CDMC25170 4 25 10 DAC17-D21 3-CG17325-RA_4 CG17325 GCGTGCCCTGAATCCCCCTGTGGTCCAAGCTCACCCAAGCTCCTGTTGAAACTTGAAAGAAATCATTGA 69 FBan0017325 FBgn0040993 CG17325 2 2L CG17325 CG17325 BcDNA:RH02271 CDMC25170 4 26 10 DAC17-D21 3-CG17325-RA_4 CG17325 GCGTGCCCTGAATCCCCCTGTGGTCCAAGCTCACCCAAGCTCCTGTTGAAACTTGAAAGAAATCATTGA 69 FBan0017325 FBgn0040993 CG17325 2 2L CG17325 CG17325 BcDNA:RH02271 CDMC25171 4 1 11 DAC17-H09 16-CG17374-RA_1 CG17374 GGGCTTGGTAGCAGATATGGCAGAGGACAAAATTGACATGGAAATAGGCGGTACCCTTCAACAACGAAT 69 FBgn0040001 CG17374 fatty acid biosynthesis; GO:0006633 fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; ; GO:0004312 ; EC:2.3.1.85; cofactor binding; GO:0048037; ; GO:0048037 fatty acid synthase complex; GO:0005835 CG17374 CG17374 DM_7289423 CDMC25171 4 2 11 DAC17-H09 16-CG17374-RA_1 CG17374 GGGCTTGGTAGCAGATATGGCAGAGGACAAAATTGACATGGAAATAGGCGGTACCCTTCAACAACGAAT 69 FBgn0040001 CG17374 fatty acid biosynthesis; GO:0006633 fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; ; GO:0004312 ; EC:2.3.1.85; cofactor binding; GO:0048037; ; GO:0048037 fatty acid synthase complex; GO:0005835 CG17374 CG17374 DM_7289423 CDMC25172 4 3 11 DAC17-H21 17-CG17380-RA_5 CG17380 GCCAGGACTAAGGAGAACCAAGGCGACTAACAGTAGGTGCAACTGACCCATTTTGAATGTGGGAATAGT 69 FBan0017380 FBgn0039077 CG17380 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG17380 CG17380 BcDNA:AT18288 CDMC25172 4 4 11 DAC17-H21 17-CG17380-RA_5 CG17380 GCCAGGACTAAGGAGAACCAAGGCGACTAACAGTAGGTGCAACTGACCCATTTTGAATGTGGGAATAGT 69 FBan0017380 FBgn0039077 CG17380 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG17380 CG17380 BcDNA:AT18288 CDMC25173 4 5 11 DAC17-L09 22-CG17461-RA_1 CG17461 GGATCGGATGCCTTTGGAGGAATATGTAGAGGAAAACTAAGCTTAGTAGACCTAGCAGGCTCCGAGAGG 69 FBan0017461 FBgn0039925 Kif3C 4 4 microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; minus-end-directed microtubule motor activity; GO:0008569 ; EC:3.6.4.5; ; GO:0005200; ; GO:0003777; ; GO:0008569 ; EC:3.6.4.5; ; GO:0003777 kinesin complex; GO:0005871 Kif3C Kif3C "CG17459, CG17461, CG17459, CG17459, CG17461, CG17461, CP38609, KIF24, KIF3C, DmKIF3C" CDMC25173 4 6 11 DAC17-L09 22-CG17461-RA_1 CG17461 GGATCGGATGCCTTTGGAGGAATATGTAGAGGAAAACTAAGCTTAGTAGACCTAGCAGGCTCCGAGAGG 69 FBan0017461 FBgn0039925 Kif3C 4 4 microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; minus-end-directed microtubule motor activity; GO:0008569 ; EC:3.6.4.5; ; GO:0005200; ; GO:0003777; ; GO:0008569 ; EC:3.6.4.5; ; GO:0003777 kinesin complex; GO:0005871 Kif3C Kif3C "CG17459, CG17461, CG17459, CG17459, CG17461, CG17461, CP38609, KIF24, KIF3C, DmKIF3C" CDMC25174 4 7 11 DAC17-L21 12-CG17478-RA_2 CG17478 GGCGCTGGGTTCCGACGAAGCTAAACGTAGCAGACTTGGCAACAAAGTTCATTTCTAAACCCTAAGCGT 69 FBgn0032998 CG17478 CG17478 CG17478 "CG40280, CG40280, CG40280" CDMC25174 4 8 11 DAC17-L21 12-CG17478-RA_2 CG17478 GGCGCTGGGTTCCGACGAAGCTAAACGTAGCAGACTTGGCAACAAAGTTCATTTCTAAACCCTAAGCGT 69 FBgn0032998 CG17478 CG17478 CG17478 "CG40280, CG40280, CG40280" CDMC25175 4 9 11 DAC17-P09 23-CG17515-RA_2 CG17515 GGTACGTTTAGCAGCTAAACAAACCTAATTAGTTCCTGAAAGCTTTAACCCCTTAATTGTAGGTTGTGT 69 CDMC25175 4 10 11 DAC17-P09 23-CG17515-RA_2 CG17515 GGTACGTTTAGCAGCTAAACAAACCTAATTAGTTCCTGAAAGCTTTAACCCCTTAATTGTAGGTTGTGT 69 CDMC25176 4 11 11 DAC17-P21 6-CG17527-RA_1 CG17527 TGGTGGCGTTCGTGGAGATCGATAGGTTGAAATATCCCAGGATCATCGAATGGGTCAGGCGTTTGGAGA 69 FBgn0034339 CDMC25176 4 12 11 DAC17-P21 6-CG17527-RA_1 CG17527 TGGTGGCGTTCGTGGAGATCGATAGGTTGAAATATCCCAGGATCATCGAATGGGTCAGGCGTTTGGAGA 69 FBgn0034339 CDMC25177 4 13 11 DAC18-D09 16-CG31319-RA_1 CG31319 CCCAAGGACCACAAACATGAGCTTGCGTTTCATCCTGCAAAATGAGATGAGAAGCTAGATCGGAGAGAA 69 FBan0031319 FBgn0038226 RhoGAP88C 3 3R intracellular signaling cascade; GO:0007242 Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP88C RhoGAP88C "CG8480, CG31319, CG14845, CG8480, CG8480" CDMC25177 4 14 11 DAC18-D09 16-CG31319-RA_1 CG31319 CCCAAGGACCACAAACATGAGCTTGCGTTTCATCCTGCAAAATGAGATGAGAAGCTAGATCGGAGAGAA 69 FBan0031319 FBgn0038226 RhoGAP88C 3 3R intracellular signaling cascade; GO:0007242 Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP88C RhoGAP88C "CG8480, CG31319, CG14845, CG8480, CG8480" CDMC25178 4 15 11 DAC18-D21 17-CG31332-RA_1 CG31332 TGCATGTCCCCGGCATGTAGGCTTTTTATACGCAGTGCTATGGCAATTTAAACGCAAACATAAACTGGA 69 FBan0031332 FBgn0037733 unc-115 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 unc-115 unc-115 "CG31332, CG9489, dunc-115, anon-WO0140519.9" CDMC25178 4 16 11 DAC18-D21 17-CG31332-RA_1 CG31332 TGCATGTCCCCGGCATGTAGGCTTTTTATACGCAGTGCTATGGCAATTTAAACGCAAACATAAACTGGA 69 FBan0031332 FBgn0037733 unc-115 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 unc-115 unc-115 "CG31332, CG9489, dunc-115, anon-WO0140519.9" CDMC25179 4 17 11 DAC18-H09 17-CG31364-RA_1 CG31364 CGACCGATCGAGTTTTAGTGCTAAAGCGATTCGAAAGATTGTCTTGCTTAAACCAAAAGGGCCCCTCGA 69 FBgn0051364 CDMC25179 4 18 11 DAC18-H09 17-CG31364-RA_1 CG31364 CGACCGATCGAGTTTTAGTGCTAAAGCGATTCGAAAGATTGTCTTGCTTAAACCAAAAGGGCCCCTCGA 69 FBgn0051364 CDMC25180 4 19 11 DAC18-H21 12-CG31370-RA_1 CG31370 ATCTTGGCGAGATGGATTATGCTATGGTGCGAGATCGTGTGCTCACACATGGAGAGATATGTGGTGCCT 69 FBan0031370 FBgn0051370 CG31370 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31370 CG31370 CG13660 CDMC25180 4 20 11 DAC18-H21 12-CG31370-RA_1 CG31370 ATCTTGGCGAGATGGATTATGCTATGGTGCGAGATCGTGTGCTCACACATGGAGAGATATGTGGTGCCT 69 FBan0031370 FBgn0051370 CG31370 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31370 CG31370 CG13660 CDMC25181 4 21 11 DAC18-L09 2-CG31414-RA_1 CG31414 TGGCCTAGCTGTTCACTGGTACTGGGATGAACTGATAGGACCACAACTCATCGACCAGGCACATACGGA 69 FBan0031414 FBgn0051414 CG31414 3 3R lipid metabolism; GO:0006629; lysosome organization and biogenesis; GO:0007040; sphingolipid metabolism; GO:0006665; transport; GO:0006810 "transporter activity; GO:0005215; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0005215; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-; glucosylceramidase activity; GO:0004348 ; EC:3.2.1.45; ; GO:0004348 ; EC:3.2.1.45" lysosome; GO:0005764; membrane; GO:0016020 CG31414 CG31414 "CG10299, CG10299, CG10299, CG10299" CDMC25181 4 22 11 DAC18-L09 2-CG31414-RA_1 CG31414 TGGCCTAGCTGTTCACTGGTACTGGGATGAACTGATAGGACCACAACTCATCGACCAGGCACATACGGA 69 FBan0031414 FBgn0051414 CG31414 3 3R lipid metabolism; GO:0006629; lysosome organization and biogenesis; GO:0007040; sphingolipid metabolism; GO:0006665; transport; GO:0006810 "transporter activity; GO:0005215; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0005215; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-; glucosylceramidase activity; GO:0004348 ; EC:3.2.1.45; ; GO:0004348 ; EC:3.2.1.45" lysosome; GO:0005764; membrane; GO:0016020 CG31414 CG31414 "CG10299, CG10299, CG10299, CG10299" CDMC25182 4 23 11 DAC18-L21 15-CG31427-RA_2 CG31427 CTGCGTGTCCTCCACAGAGGTAAATCCCGAACACGACTTCTATATCCTTCGCACCTGCAGACAACTTTT 69 FBan0031427 FBgn0051427 CG31427 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG31427 CG31427 "CG11955, CG11955" CDMC25182 4 24 11 DAC18-L21 15-CG31427-RA_2 CG31427 CTGCGTGTCCTCCACAGAGGTAAATCCCGAACACGACTTCTATATCCTTCGCACCTGCAGACAACTTTT 69 FBan0031427 FBgn0051427 CG31427 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG31427 CG31427 "CG11955, CG11955" CDMC25183 4 25 11 DAC18-P09 3-CG31475-RA_2 CG31475 GCCAACCCCATCCACAGTCGCAAAAAGTGCAAAATGCCAGCAAATCCCCTAACCAGCCAGAAACAGTTA 69 FBan0031475 FBgn0051475 CG31475 3 3R calcium-mediated signaling; GO:0019722 calcium ion binding; GO:0005509; ; GO:0005509 CG31475 CG31475 "CG14281, CG3768, CG14281" CDMC25183 4 26 11 DAC18-P09 3-CG31475-RA_2 CG31475 GCCAACCCCATCCACAGTCGCAAAAAGTGCAAAATGCCAGCAAATCCCCTAACCAGCCAGAAACAGTTA 69 FBan0031475 FBgn0051475 CG31475 3 3R calcium-mediated signaling; GO:0019722 calcium ion binding; GO:0005509; ; GO:0005509 CG31475 CG31475 "CG14281, CG3768, CG14281" CDMC25184 4 1 12 DAC18-P21 12-CG31501-RA_2 CG31501 TGCTACACCTAGAAATAACTCCAGTGAAGGTCCTTTGTGCCACTCCACACCAAGATCCGTGAAAGGCGA 69 FBan0031501 FBgn0051501 nxf4 3 3R RNA export from nucleus; GO:0006405 nxf4 nuclear export factor 4 "CG31501, CG14604, BcDNA:AT07692, nuclear export factor 4" CDMC25184 4 2 12 DAC18-P21 12-CG31501-RA_2 CG31501 TGCTACACCTAGAAATAACTCCAGTGAAGGTCCTTTGTGCCACTCCACACCAAGATCCGTGAAAGGCGA 69 FBan0031501 FBgn0051501 nxf4 3 3R RNA export from nucleus; GO:0006405 nxf4 nuclear export factor 4 "CG31501, CG14604, BcDNA:AT07692, nuclear export factor 4" CDMC25185 4 3 12 DAC19-D09 2-CG6070-RA_1 CG6070 ATGTGGATTCCCGCCCTATTCGTCATCGTGTGCGCATTCTTAGTTGTCGTGCCCATCTATGTGGC 65 FBan0006070 FBgn0039487 CG6070 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG6070 CG6070 anon-WO0118547.295 CDMC25185 4 4 12 DAC19-D09 2-CG6070-RA_1 CG6070 ATGTGGATTCCCGCCCTATTCGTCATCGTGTGCGCATTCTTAGTTGTCGTGCCCATCTATGTGGC 65 FBan0006070 FBgn0039487 CG6070 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG6070 CG6070 anon-WO0118547.295 CDMC25186 4 5 12 DAC19-D21 23-CG6112-RA_4 CG6112 ACAGGTCGAGTTGACATTTACCCGTGATCGTGCGTATTATTTTACAACCGTTTTCATACCTGGCA 65 FBan0033989 FBgn0036542 pHCl 3 3L ion transport; GO:0006811 glycine-gated chloride channel activity; GO:0016934; GABA-A receptor activity; GO:0004890; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 pHCl pHCl "CG33989, CG13444, CG6112, CG33989, BP1024, BcDNA:GH21757" CDMC25186 4 6 12 DAC19-D21 23-CG6112-RA_4 CG6112 ACAGGTCGAGTTGACATTTACCCGTGATCGTGCGTATTATTTTACAACCGTTTTCATACCTGGCA 65 FBan0033989 FBgn0036542 pHCl 3 3L ion transport; GO:0006811 glycine-gated chloride channel activity; GO:0016934; GABA-A receptor activity; GO:0004890; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 pHCl pHCl "CG33989, CG13444, CG6112, CG33989, BP1024, BcDNA:GH21757" CDMC25187 4 7 12 DAC19-H09 8-CG6205-RA_3 CG6205 ACGCTGTGACGCGCTTCAATTTGGGTTCCTCTCAACTTCCAGCTGAATGGATAGCACTCCTGGGG 65 FBan0006205 FBgn0004957 por X X cell adhesion; GO:0007155; protein lipidation; GO:0006497; regulation of Wnt receptor signaling pathway; GO:0030111; segment specification; GO:0007379 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- plasma membrane; GO:0005886 por porcupine "CG6205, 15175, porc, poc, Porc, dmPorc, l(1)17Ac, porcupine" CDMC25187 4 8 12 DAC19-H09 8-CG6205-RA_3 CG6205 ACGCTGTGACGCGCTTCAATTTGGGTTCCTCTCAACTTCCAGCTGAATGGATAGCACTCCTGGGG 65 FBan0006205 FBgn0004957 por X X cell adhesion; GO:0007155; protein lipidation; GO:0006497; regulation of Wnt receptor signaling pathway; GO:0030111; segment specification; GO:0007379 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- plasma membrane; GO:0005886 por porcupine "CG6205, 15175, porc, poc, Porc, dmPorc, l(1)17Ac, porcupine" CDMC25188 4 9 12 DAC19-H21 5-CG6264-RA_1 CG6264 TCCATGAGAGCCAATGATCCACGTCCCAATGTCATGGACATATTCGCACAAACCTCGTCGGGAGC 65 FBan0006264 FBgn0040238 Best1 3 3R ion transport; GO:0006811; transport; GO:0006810 chloride channel activity; GO:0005254; ; GO:0005254 Best1 Bestrophin 1 "CG6264, CG6264, CG6264, Dbest, dbest1, dmBest1, best, anon-WO0118547.380, Bestrophin 1" CDMC25188 4 10 12 DAC19-H21 5-CG6264-RA_1 CG6264 TCCATGAGAGCCAATGATCCACGTCCCAATGTCATGGACATATTCGCACAAACCTCGTCGGGAGC 65 FBan0006264 FBgn0040238 Best1 3 3R ion transport; GO:0006811; transport; GO:0006810 chloride channel activity; GO:0005254; ; GO:0005254 Best1 Bestrophin 1 "CG6264, CG6264, CG6264, Dbest, dbest1, dmBest1, best, anon-WO0118547.380, Bestrophin 1" CDMC25189 4 11 12 DAC19-L09 24-CG6358-RA_1 CG6358 GCCCCCATCTTAAGTTCCTTACTCTGTAAACTCATGTTACATTAAAAACATAGTTTAGTGAATTC 65 FBan0006358 FBgn0004832 Xpac X X nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 Xpac Xeroderma pigmentosum group A-like "CG6358, dmXPA, Dxpa, DmXPA, DhR14, DhXPA, XPAC, Xpa, dxpa, EG:EG0007.8" CDMC25189 4 12 12 DAC19-L09 24-CG6358-RA_1 CG6358 GCCCCCATCTTAAGTTCCTTACTCTGTAAACTCATGTTACATTAAAAACATAGTTTAGTGAATTC 65 FBan0006358 FBgn0004832 Xpac X X nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 Xpac Xeroderma pigmentosum group A-like "CG6358, dmXPA, Dxpa, DmXPA, DhR14, DhXPA, XPAC, Xpa, dxpa, EG:EG0007.8" CDMC25190 4 13 12 DAC19-L21 3-CG6380-RA_2 CG6380 GCAATTTAGCCTGAAGGCAGCCAAATTTGATGAGGTCAACATACTGGCCACGTTCCACCCGGCTG 65 FBan0006380 FBgn0032632 CG6380 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG6380 CG6380 CDMC25190 4 14 12 DAC19-L21 3-CG6380-RA_2 CG6380 GCAATTTAGCCTGAAGGCAGCCAAATTTGATGAGGTCAACATACTGGCCACGTTCCACCCGGCTG 65 FBan0006380 FBgn0032632 CG6380 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG6380 CG6380 CDMC25191 4 15 12 DAC19-P09 3-CG6467-RA_1 CG6467 CCAGTGGTGTGGCTACCAATCTTCAGTATGTCGACCTGACTGTGATCACCAACACCAAGTGCGCC 65 FBan0006467 FBgn0035664 Jon65Aiv 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- Jon65Aiv Jonah 65Aiv "CG6467, Jon65A, SP117, Jonah 65A" CDMC25191 4 16 12 DAC19-P09 3-CG6467-RA_1 CG6467 CCAGTGGTGTGGCTACCAATCTTCAGTATGTCGACCTGACTGTGATCACCAACACCAAGTGCGCC 65 FBan0006467 FBgn0035664 Jon65Aiv 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- Jon65Aiv Jonah 65Aiv "CG6467, Jon65A, SP117, Jonah 65A" CDMC25192 4 17 12 DAC19-P21 AutoBlank AutoBlank CDMC25192 4 18 12 DAC19-P21 AutoBlank AutoBlank CDMC25193 4 19 12 DAC20-D09 4-CG30109-RA_1 CG30109 CCGGCTCGGAGTACGACAATGCGAGTAGTTCCGGCGGAAAGACGCAACCCAAGACAAAAAGTTGA 65 FBan0030109 FBgn0050109 CG30109 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30109 CG30109 CDMC25193 4 20 12 DAC20-D09 4-CG30109-RA_1 CG30109 CCGGCTCGGAGTACGACAATGCGAGTAGTTCCGGCGGAAAGACGCAACCCAAGACAAAAAGTTGA 65 FBan0030109 FBgn0050109 CG30109 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30109 CG30109 CDMC25194 4 21 12 DAC20-D21 5-CG30156-RA_1 CG30156 CTGTGCCTGGGACACTACGAGCACGCTCTGAGGCAGATCAACGAGGATCTGGAAGGCTTACAGAA 65 FBan0030156 FBgn0050156 CG30156 2 2R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG30156 CG30156 "BEST:GH05253, BcDNA:AT02529" CDMC25194 4 22 12 DAC20-D21 5-CG30156-RA_1 CG30156 CTGTGCCTGGGACACTACGAGCACGCTCTGAGGCAGATCAACGAGGATCTGGAAGGCTTACAGAA 65 FBan0030156 FBgn0050156 CG30156 2 2R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG30156 CG30156 "BEST:GH05253, BcDNA:AT02529" CDMC25195 4 23 12 DAC20-H09 3-CG30273-RA_1 CG30273 GTCAGGTGTCCACAGACCGACAGCTGTACGATGAAATTTCCCCAATGGGGTAAACAATCGGGCCG 65 FBan0030273 FBgn0050273 CG30273 2 2R CG30273 CG30273 "CG13515, CG13515" CDMC25195 4 24 12 DAC20-H09 3-CG30273-RA_1 CG30273 GTCAGGTGTCCACAGACCGACAGCTGTACGATGAAATTTCCCCAATGGGGTAAACAATCGGGCCG 65 FBan0030273 FBgn0050273 CG30273 2 2R CG30273 CG30273 "CG13515, CG13515" CDMC25196 4 25 12 DAC20-H21 3-CG30340-RA_5 CG30340 TCTTCCTCATCACAGCCGTGCTCAATCTCTCGGTAGTCAGCTACGATCGTCTCACGGCCATCGTG 65 FBan0030340 FBgn0050340 CG30340 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; metal ion transport; GO:0030001; signal transduction; GO:0007165 neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0008188; ; GO:0004930; metal ion binding; GO:0046872; ; GO:0004930; ; GO:0046872 integral to membrane; GO:0016021 CG30340 CG30340 "BG:BACR48G21.1, BACR48G21.1" CDMC25196 4 26 12 DAC20-H21 3-CG30340-RA_5 CG30340 TCTTCCTCATCACAGCCGTGCTCAATCTCTCGGTAGTCAGCTACGATCGTCTCACGGCCATCGTG 65 FBan0030340 FBgn0050340 CG30340 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; metal ion transport; GO:0030001; signal transduction; GO:0007165 neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0008188; ; GO:0004930; metal ion binding; GO:0046872; ; GO:0004930; ; GO:0046872 integral to membrane; GO:0016021 CG30340 CG30340 "BG:BACR48G21.1, BACR48G21.1" CDMC25197 4 1 13 DAC20-L09 2-CG30414-RA_1 CG30414 TCACCTGCTAGACTCCAGTTGTGGCACGACAAAACCAGAATTTATCCCAATGATCACCGGGGGCG 65 FBan0030414 FBgn0050414 CG30414 2 2R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30414 CG30414 "CG3487, CG3487, CG3487, SP62" CDMC25197 4 2 13 DAC20-L09 2-CG30414-RA_1 CG30414 TCACCTGCTAGACTCCAGTTGTGGCACGACAAAACCAGAATTTATCCCAATGATCACCGGGGGCG 65 FBan0030414 FBgn0050414 CG30414 2 2R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30414 CG30414 "CG3487, CG3487, CG3487, SP62" CDMC25198 4 3 13 DAC20-L21 15-CG30431-RA_4 CG30431 TTCCCTCGTACTGGGAATCGTCGGTAGATTCGGGAAGCCTAAACACTCCGCATCATCAGCCGGAG 65 FBan0030431 FBgn0050431 CG30431 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG30431 CG30431 "CG8324, CG8341" CDMC25198 4 4 13 DAC20-L21 15-CG30431-RA_4 CG30431 TTCCCTCGTACTGGGAATCGTCGGTAGATTCGGGAAGCCTAAACACTCCGCATCATCAGCCGGAG 65 FBan0030431 FBgn0050431 CG30431 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG30431 CG30431 "CG8324, CG8341" CDMC25199 4 5 13 DAC20-P09 6-CG3091-RA_4 CG3091 GCGGCCCCTGAGAGACGCATTGGGCTACAACAATGGATAAAGATACAGGGGATAAGGACTCCGCC 65 FBan0003091 FBgn0029608 CG3091 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG3091 CG3091 CDMC25199 4 6 13 DAC20-P09 6-CG3091-RA_4 CG3091 GCGGCCCCTGAGAGACGCATTGGGCTACAACAATGGATAAAGATACAGGGGATAAGGACTCCGCC 65 FBan0003091 FBgn0029608 CG3091 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG3091 CG3091 CDMC25200 4 7 13 DAC20-P21 AutoBlank AutoBlank CDMC25200 4 8 13 DAC20-P21 AutoBlank AutoBlank CDMC25201 4 9 13 DAC21-D09 2-CG4015-RA_1 CG4015 GGCTTGCCGACAAAGCCACTTATCCACCAGGAATTGGATCATATGTTTCCCTGCAATGCCATCGGTCG 68 FBan0004015 FBgn0000644 Fcp3C X X Fcp3C Follicle cell protein 3C "CG4015, CG4015, VMP3C, Ecp3C, EG:140G11.2" CDMC25201 4 10 13 DAC21-D09 2-CG4015-RA_1 CG4015 GGCTTGCCGACAAAGCCACTTATCCACCAGGAATTGGATCATATGTTTCCCTGCAATGCCATCGGTCG 68 FBan0004015 FBgn0000644 Fcp3C X X Fcp3C Follicle cell protein 3C "CG4015, CG4015, VMP3C, Ecp3C, EG:140G11.2" CDMC25202 4 11 13 DAC21-D21 2-CG41118-RA_3 CG41118 CCGTTATTTGGGGCGCAGAAAGAGAGAAAAGAACCGAAACAGGACGTCTACCGCGCTACCGAGAGACC 68 FBgn0069933 CG41118 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41118 CG41118 CDMC25202 4 12 13 DAC21-D21 2-CG41118-RA_3 CG41118 CCGTTATTTGGGGCGCAGAAAGAGAGAAAAGAACCGAAACAGGACGTCTACCGCGCTACCGAGAGACC 68 FBgn0069933 CG41118 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41118 CG41118 CDMC25203 4 13 13 DAC21-H09 2-CG4542-RA_1 CG4542 CGCTGCTCTTCGATGCGGATCTGTACATTCCCCGGTATTCCCTGTACATGTCGTACGTGGCCATGATG 68 FBan0004542 FBgn0029906 CG4542 X X protein amino acid N-linked glycosylation; GO:0006487 "dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; GO:0042283 ; EC:2.4.1.-; oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; ; GO:0042283 ; EC:2.4.1.-" endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 CG4542 CG4542 CDMC25203 4 14 13 DAC21-H09 2-CG4542-RA_1 CG4542 CGCTGCTCTTCGATGCGGATCTGTACATTCCCCGGTATTCCCTGTACATGTCGTACGTGGCCATGATG 68 FBan0004542 FBgn0029906 CG4542 X X protein amino acid N-linked glycosylation; GO:0006487 "dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; GO:0042283 ; EC:2.4.1.-; oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; ; GO:0042283 ; EC:2.4.1.-" endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 CG4542 CG4542 CDMC25204 4 15 13 DAC21-H21 3-CG4705-RA_1 CG4705 GCTTTGATCCTCAAGCACACGCAGAATACACCACCTCCAGTCCAGGGTGTGGAATTCGTTACCGAGTG 68 FBan0004705 FBgn0032339 CG4705 2 2L CG4705 CG4705 CDMC25204 4 16 13 DAC21-H21 3-CG4705-RA_1 CG4705 GCTTTGATCCTCAAGCACACGCAGAATACACCACCTCCAGTCCAGGGTGTGGAATTCGTTACCGAGTG 68 FBan0004705 FBgn0032339 CG4705 2 2L CG4705 CG4705 CDMC25205 4 17 13 DAC21-L09 2-CG5156-RA_1 CG5156 ACCCCTCCACTGAACCAACTGAAGTAATTCCAGCGACTAGCATTTCCCGCCAGAACTTAGTCGACCCC 68 FBan0005156 FBgn0031326 CG5156 2 2L CG5156 CG5156 CT16503 CDMC25205 4 18 13 DAC21-L09 2-CG5156-RA_1 CG5156 ACCCCTCCACTGAACCAACTGAAGTAATTCCAGCGACTAGCATTTCCCGCCAGAACTTAGTCGACCCC 68 FBan0005156 FBgn0031326 CG5156 2 2L CG5156 CG5156 CT16503 CDMC25206 4 19 13 DAC21-L21 2-CG5284-RA_1 CG5284 GGCACCGATCACAGTTACAGATCAAACGCCAATGGAGACGGTAGTGGACATGTTCCGAAAGCTGGGAC 68 FBan0005284 FBgn0036566 CG5284 3 3L anion transport; GO:0006820; chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG5284 CG5284 anon-WO0138359.7 CDMC25206 4 20 13 DAC21-L21 2-CG5284-RA_1 CG5284 GGCACCGATCACAGTTACAGATCAAACGCCAATGGAGACGGTAGTGGACATGTTCCGAAAGCTGGGAC 68 FBan0005284 FBgn0036566 CG5284 3 3L anion transport; GO:0006820; chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG5284 CG5284 anon-WO0138359.7 CDMC25207 4 21 13 DAC21-P09 2-CG5656-RA_1 CG5656 TAGGGTGGTGTTTAGTCGTACGGATCTCCTGAACAATGATGCGCAGAACACTGACTTCCTGCTGGGGC 68 FBan0005656 FBgn0037083 CG5656 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5656 CG5656 CDMC25207 4 22 13 DAC21-P09 2-CG5656-RA_1 CG5656 TAGGGTGGTGTTTAGTCGTACGGATCTCCTGAACAATGATGCGCAGAACACTGACTTCCTGCTGGGGC 68 FBan0005656 FBgn0037083 CG5656 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5656 CG5656 CDMC25208 4 23 13 DAC21-P21 AutoBlank AutoBlank CDMC25208 4 24 13 DAC21-P21 AutoBlank AutoBlank CDMC25209 4 25 13 DAC22-D09 10-CG40477-RA_1 CG40477 ACAGGGCGACTGGACAGTCCCACAAACCAACTCCACCAATAACCCAAGATAAGAACTCAGCTATGTCGA 69 CDMC25209 4 26 13 DAC22-D09 10-CG40477-RA_1 CG40477 ACAGGGCGACTGGACAGTCCCACAAACCAACTCCACCAATAACCCAAGATAAGAACTCAGCTATGTCGA 69 CDMC25210 4 1 14 DAC22-D21 23-CG40500-RA_9 CG40500 ATCCTTGACAAAATATCAGCAGGTTATCGGGCAAATTTAATTAACATATTGCGAGAAAAGTCACCGCGT 69 FBgn0069968 CG40500 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40500 CG40500 CDMC25210 4 2 14 DAC22-D21 23-CG40500-RA_9 CG40500 ATCCTTGACAAAATATCAGCAGGTTATCGGGCAAATTTAATTAACATATTGCGAGAAAAGTCACCGCGT 69 FBgn0069968 CG40500 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40500 CG40500 CDMC25211 4 3 14 DAC22-H09 6-CG4082-RA_6 CG4082 GCTGGGAGATCCTGGTACTGCCAAGTCACAGTTGTTAAAGTTTGTGGAGAAGGTGGCACCCATAGCAGT 69 FBan0004082 FBgn0017577 Mcm5 3 3R DNA replication initiation; GO:0006270; chromosome condensation; GO:0030261; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003682; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 Mcm5 Minichromosome maintenance 5 "CG4082, CG4082, DmCDC465, DmMCM5, PCR4, MCM5, DmMcm5, mcm5, DmCDC46" CDMC25211 4 4 14 DAC22-H09 6-CG4082-RA_6 CG4082 GCTGGGAGATCCTGGTACTGCCAAGTCACAGTTGTTAAAGTTTGTGGAGAAGGTGGCACCCATAGCAGT 69 FBan0004082 FBgn0017577 Mcm5 3 3R DNA replication initiation; GO:0006270; chromosome condensation; GO:0030261; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003682; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 Mcm5 Minichromosome maintenance 5 "CG4082, CG4082, DmCDC465, DmMCM5, PCR4, MCM5, DmMcm5, mcm5, DmCDC46" CDMC25212 4 5 14 DAC22-H21 47-CG4094-RA_1 CG4094 GTGAAAGATCACTTGCTTGCAAACTTATTTATTAATTACCGACTAAGGAATAAGCATAGAGATGGTGCT 69 FBgn0029889 CDMC25212 4 6 14 DAC22-H21 47-CG4094-RA_1 CG4094 GTGAAAGATCACTTGCTTGCAAACTTATTTATTAATTACCGACTAAGGAATAAGCATAGAGATGGTGCT 69 FBgn0029889 CDMC25213 4 7 14 DAC22-L09 14-CG41089-RA_1 CG41089 TCAGCAAGCAGTGAGATTAGTTCCGGCAGCTATCGAGGACAAGGTCATGGAAAACTTAGAGAAGCCCAA 69 FBgn0069946 CG41089 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41089 CG41089 CDMC25213 4 8 14 DAC22-L09 14-CG41089-RA_1 CG41089 TCAGCAAGCAGTGAGATTAGTTCCGGCAGCTATCGAGGACAAGGTCATGGAAAACTTAGAGAAGCCCAA 69 FBgn0069946 CG41089 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41089 CG41089 CDMC25214 4 9 14 DAC22-L21 23-CG41105-RB_2 CG41105 AGAACGAATTCCATATCAAGCCATCGAATATCAGATACCCCGTACATAATAGTTTACCTTCTTCCCTTT 69 FBgn0069939 CG41105 biological process unknown; GO:0000004 cellular component unknown; GO:0008372 CG41105 CG41105 CDMC25214 4 10 14 DAC22-L21 23-CG41105-RB_2 CG41105 AGAACGAATTCCATATCAAGCCATCGAATATCAGATACCCCGTACATAATAGTTTACCTTCTTCCCTTT 69 FBgn0069939 CG41105 biological process unknown; GO:0000004 cellular component unknown; GO:0008372 CG41105 CG41105 CDMC25215 4 11 14 DAC22-P09 3-CG4120-RA_1 CG4120 GCGGCTGTACAAAAAGCAGTTCGGCGACATATGCTTGATACCCGGATTATTCGGCATGCCATCCACTGT 69 FBan0004120 FBgn0036806 Cyp12c1 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12c1 Cyp12c1 "CG4120, 12c1" CDMC25215 4 12 14 DAC22-P09 3-CG4120-RA_1 CG4120 GCGGCTGTACAAAAAGCAGTTCGGCGACATATGCTTGATACCCGGATTATTCGGCATGCCATCCACTGT 69 FBan0004120 FBgn0036806 Cyp12c1 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12c1 Cyp12c1 "CG4120, 12c1" CDMC25216 4 13 14 DAC22-P21 3-CG4128-RE_1 CG4128 TCGATGGCACGTATCACACCAACATTGTGGTCAAACATAACGGCAGTTGTCTGTACGTGCCCCCTGGTA 69 FBan0004128 FBgn0032151 nAcRalpha-30D 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-30D nicotinic Acetylcholine Receptor alpha 30D "CG4128, CG4128, CG4128, CT13662, Dalpha6, nAChR, nAcRalpha-30D, BcDNA:GH01410" CDMC25216 4 14 14 DAC22-P21 3-CG4128-RE_1 CG4128 TCGATGGCACGTATCACACCAACATTGTGGTCAAACATAACGGCAGTTGTCTGTACGTGCCCCCTGGTA 69 FBan0004128 FBgn0032151 nAcRalpha-30D 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-30D nicotinic Acetylcholine Receptor alpha 30D "CG4128, CG4128, CG4128, CT13662, Dalpha6, nAChR, nAcRalpha-30D, BcDNA:GH01410" CDMC25217 4 15 14 DAC23-D09 3-CG3344-RA_1 CG3344 CGCGCGTGGGAATCACCGTAGATCGAGTTCTCGAGGGTTACGAGAAGACCTATGGCAACTTCAGCATGT 69 FBan0003344 FBgn0035154 CG3344 3 3L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG3344 CG3344 CDMC25217 4 16 14 DAC23-D09 3-CG3344-RA_1 CG3344 CGCGCGTGGGAATCACCGTAGATCGAGTTCTCGAGGGTTACGAGAAGACCTATGGCAACTTCAGCATGT 69 FBan0003344 FBgn0035154 CG3344 3 3L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG3344 CG3344 CDMC25218 4 17 14 DAC23-D21 2-CG3345-RA_1 CG3345 GTCAAGCAGACAGGGCAAGGAAAATTGATCTTAAAGCAGGATGCCTTAGCTCTGGCGGGAAGTAGCCCT 69 FBan0003345 FBgn0031240 CG3345 2 2L CG3345 CG3345 anon-WO0140519.207 CDMC25218 4 18 14 DAC23-D21 2-CG3345-RA_1 CG3345 GTCAAGCAGACAGGGCAAGGAAAATTGATCTTAAAGCAGGATGCCTTAGCTCTGGCGGGAAGTAGCCCT 69 FBan0003345 FBgn0031240 CG3345 2 2L CG3345 CG3345 anon-WO0140519.207 CDMC25219 4 19 14 DAC23-H09 16-CG33481-RA_1 CG33481 ACGCGAGCTTCATTAAGGGATTCTGGAAACTATACATGCGTTCCAAATGGAGCCATTCCAGCTTCTGTT 69 FBan0033481 FBgn0053481 dpr7 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr7 dpr7 "CG33481, CG33481, Dpr-7" CDMC25219 4 20 14 DAC23-H09 16-CG33481-RA_1 CG33481 ACGCGAGCTTCATTAAGGGATTCTGGAAACTATACATGCGTTCCAAATGGAGCCATTCCAGCTTCTGTT 69 FBan0033481 FBgn0053481 dpr7 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr7 dpr7 "CG33481, CG33481, Dpr-7" CDMC25220 4 21 14 DAC23-H21 14-CG33489-RA_1 CG33489 GCCCATCCGTCGGAGGAAATTCGTCATCAGTTAGAATTGGAGTGCAGAAGAAACAAGCCTCAACCCTTC 69 FBan0033489 FBgn0053489 CG33489 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33489 CG33489 CG6110 CDMC25220 4 22 14 DAC23-H21 14-CG33489-RA_1 CG33489 GCCCATCCGTCGGAGGAAATTCGTCATCAGTTAGAATTGGAGTGCAGAAGAAACAAGCCTCAACCCTTC 69 FBan0033489 FBgn0053489 CG33489 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33489 CG33489 CG6110 CDMC25221 4 23 14 DAC23-L09 17-CG3367-RA_1 CG3367 TGGTGCGATTCTGTTTCACAAATTGCAGAACTGGAGTGTCCTGGAATCGCTCTACTTTTGCTTCACCTC 69 FBan0003367 FBgn0029871 CG3367 X X ion transport; GO:0006811; potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG3367 CG3367 CDMC25221 4 24 14 DAC23-L09 17-CG3367-RA_1 CG3367 TGGTGCGATTCTGTTTCACAAATTGCAGAACTGGAGTGTCCTGGAATCGCTCTACTTTTGCTTCACCTC 69 FBan0003367 FBgn0029871 CG3367 X X ion transport; GO:0006811; potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG3367 CG3367 CDMC25222 4 25 14 DAC23-L21 23-CG3385-RA_3 CG3385 CCAGCAATTCTCAACCTGTGACTTAATGTATGAAATCGCATTTTTACCATCAGCACTTTCACACTCGAA 69 FBan0003385 FBgn0005636 nvy 2 2R "axon guidance; GO:0007411; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 nvy nervy "CG3385, nervy" CDMC25222 4 26 14 DAC23-L21 23-CG3385-RA_3 CG3385 CCAGCAATTCTCAACCTGTGACTTAATGTATGAAATCGCATTTTTACCATCAGCACTTTCACACTCGAA 69 FBan0003385 FBgn0005636 nvy 2 2R "axon guidance; GO:0007411; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 nvy nervy "CG3385, nervy" CDMC25223 4 1 15 DAC23-P09 12-CG3423-RA_1 CG3423 CAGGAGCAGAGTGAGGATGGCATAGTTTCAAAGAGTTCGCAAGAGTTTGTGGACCTCAAGGAGTTGGCC 69 FBan0003423 FBgn0020616 SA 2 2L ectoderm development; GO:0007398; hemopoiesis; GO:0030097; meiosis; GO:0007126; mesoderm development; GO:0007498; nervous system development; GO:0007399 chromatin binding; GO:0003682; ; GO:0003682 cohesin complex; GO:0008278; nucleus; GO:0005634 SA Stromalin "CG3423, DSA, SCC3, DmSA, ESTS:92H2T, Stromalin" CDMC25223 4 2 15 DAC23-P09 12-CG3423-RA_1 CG3423 CAGGAGCAGAGTGAGGATGGCATAGTTTCAAAGAGTTCGCAAGAGTTTGTGGACCTCAAGGAGTTGGCC 69 FBan0003423 FBgn0020616 SA 2 2L ectoderm development; GO:0007398; hemopoiesis; GO:0030097; meiosis; GO:0007126; mesoderm development; GO:0007498; nervous system development; GO:0007399 chromatin binding; GO:0003682; ; GO:0003682 cohesin complex; GO:0008278; nucleus; GO:0005634 SA Stromalin "CG3423, DSA, SCC3, DmSA, ESTS:92H2T, Stromalin" CDMC25224 4 3 15 DAC23-P21 12-CG3445-RA_5 CG3445 GCTGCTGGATGGCACGTCCCTAACATCCTAACTAGTAGTGCGCTTTAATGTGTGGCAGGTATTGGCATG 69 FBan0003445 FBgn0035997 phol 3 3L gene silencing; GO:0016458; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 phol pleiohomeotic like "CG3445, pho-like, pleiohomeotic like" CDMC25224 4 4 15 DAC23-P21 12-CG3445-RA_5 CG3445 GCTGCTGGATGGCACGTCCCTAACATCCTAACTAGTAGTGCGCTTTAATGTGTGGCAGGTATTGGCATG 69 FBan0003445 FBgn0035997 phol 3 3L gene silencing; GO:0016458; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 phol pleiohomeotic like "CG3445, pho-like, pleiohomeotic like" CDMC25225 4 5 15 DAC24-D09 3-CG33181-RA_2 CG33181 GTGCAGGCCAGCAAGATATCCACAATGCTGCACCAGAGCTCAATTATCGGGATTATACCACCGCACACG 69 FBan0033181 FBgn0053181 CG33181 X X cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 CG33181 CG33181 CG1521 CDMC25225 4 6 15 DAC24-D09 3-CG33181-RA_2 CG33181 GTGCAGGCCAGCAAGATATCCACAATGCTGCACCAGAGCTCAATTATCGGGATTATACCACCGCACACG 69 FBan0033181 FBgn0053181 CG33181 X X cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 CG33181 CG33181 CG1521 CDMC25226 4 7 15 DAC24-D21 16-CG3318-RA_1 CG3318 TGGTCCCAAATCGCGAGAAGAATTCCACCTCCCTAGCATTCGAGTACATATAAGATTCTCAAGCCTGCA 69 FBan0003318 FBgn0019643 Dat 2 2R "behavior; GO:0007610; biogenic amine catabolism; GO:0042402; catecholamine metabolism; GO:0006584; dopamine catabolism; GO:0042420; octopamine catabolism; GO:0046334; pigmentation during development; GO:0048066; regulation of circadian sleep/wake cycle, sleep; GO:0045187; serotonin catabolism; GO:0042429; sleep; GO:0030431" aralkylamine N-acetyltransferase activity; GO:0004059 ; EC:2.3.1.87; arylamine N-acetyltransferase activity; GO:0004060 ; EC:2.3.1.5; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004059 ; EC:2.3.1.87; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004060 ; EC:2.3.1.5; ; GO:0008080 ; EC:2.3.1.- Dat Dopamine N acetyltransferase "CG3318, aaNAT, aaNAT1, NAT1, aaNat, AA-NAT1, Dat1, Aanat1, Arylalkylamine N-acetyltransferase-1" CDMC25226 4 8 15 DAC24-D21 16-CG3318-RA_1 CG3318 TGGTCCCAAATCGCGAGAAGAATTCCACCTCCCTAGCATTCGAGTACATATAAGATTCTCAAGCCTGCA 69 FBan0003318 FBgn0019643 Dat 2 2R "behavior; GO:0007610; biogenic amine catabolism; GO:0042402; catecholamine metabolism; GO:0006584; dopamine catabolism; GO:0042420; octopamine catabolism; GO:0046334; pigmentation during development; GO:0048066; regulation of circadian sleep/wake cycle, sleep; GO:0045187; serotonin catabolism; GO:0042429; sleep; GO:0030431" aralkylamine N-acetyltransferase activity; GO:0004059 ; EC:2.3.1.87; arylamine N-acetyltransferase activity; GO:0004060 ; EC:2.3.1.5; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004059 ; EC:2.3.1.87; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004059 ; EC:2.3.1.87; ; GO:0004060 ; EC:2.3.1.5; ; GO:0008080 ; EC:2.3.1.- Dat Dopamine N acetyltransferase "CG3318, aaNAT, aaNAT1, NAT1, aaNat, AA-NAT1, Dat1, Aanat1, Arylalkylamine N-acetyltransferase-1" CDMC25227 4 9 15 DAC24-H09 6-CG33208-RF_2 CG33208 ACGCTAACGAGACACGAGAGCATAAGAAGCAACGTGCCATATCGAAGGCTTCACGACAAGCTGAGCTCA 69 FBan0033208 FBgn0053208 MICAL 3 3R axon guidance; GO:0007411; chromosome segregation; GO:0007059; mitosis; GO:0007067 actin binding; GO:0003779; centromeric DNA binding; GO:0019237; zinc ion binding; GO:0008270; ; GO:0019237; ; GO:0008270; ; GO:0003779 cytosol; GO:0005829 MICAL MICAL "CG33208, CG11685, CG11687, CG18484, CG18667, CG18668, CG33186, CG33190" CDMC25227 4 10 15 DAC24-H09 6-CG33208-RF_2 CG33208 ACGCTAACGAGACACGAGAGCATAAGAAGCAACGTGCCATATCGAAGGCTTCACGACAAGCTGAGCTCA 69 FBan0033208 FBgn0053208 MICAL 3 3R axon guidance; GO:0007411; chromosome segregation; GO:0007059; mitosis; GO:0007067 actin binding; GO:0003779; centromeric DNA binding; GO:0019237; zinc ion binding; GO:0008270; ; GO:0019237; ; GO:0008270; ; GO:0003779 cytosol; GO:0005829 MICAL MICAL "CG33208, CG11685, CG11687, CG18484, CG18667, CG18668, CG33186, CG33190" CDMC25228 4 11 15 DAC24-H21 23-CG3321-RB_1 CG3321 AGCCACCATCTATCGATCACTGACTATCGTTTTTGTGTTTTCCTCTGATGCTTGTGCAAAAAACAGAAT 69 FBan0003321 FBgn0038224 CG3321 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG3321 CG3321 "c550, anon-88Bd" CDMC25228 4 12 15 DAC24-H21 23-CG3321-RB_1 CG3321 AGCCACCATCTATCGATCACTGACTATCGTTTTTGTGTTTTCCTCTGATGCTTGTGCAAAAAACAGAAT 69 FBan0003321 FBgn0038224 CG3321 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG3321 CG3321 "c550, anon-88Bd" CDMC25229 4 13 15 DAC24-L09 23-CG33260-RA_1 CG33260 ATTGAAAACGGAGAAACTACGGGAAACTGAACGATACATGGATAAGATTCTGACGGGAAAACGCAAGAA 69 FBan0033260 FBgn0053260 CG33260 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33260 CG33260 CG13470 CDMC25229 4 14 15 DAC24-L09 23-CG33260-RA_1 CG33260 ATTGAAAACGGAGAAACTACGGGAAACTGAACGATACATGGATAAGATTCTGACGGGAAAACGCAAGAA 69 FBan0033260 FBgn0053260 CG33260 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33260 CG33260 CG13470 CDMC25230 4 15 15 DAC24-L21 23-CG33275-RA_2 CG33275 CAGCGTGTCAATGTCGAAGCAAGTTTCATACATATCTAGTTCTTAGTCCACACAATCGAACGATCCGCA 69 FBgn0035801 CDMC25230 4 16 15 DAC24-L21 23-CG33275-RA_2 CG33275 CAGCGTGTCAATGTCGAAGCAAGTTTCATACATATCTAGTTCTTAGTCCACACAATCGAACGATCCGCA 69 FBgn0035801 CDMC25231 4 17 15 DAC24-P09 6-CG3330-RA_5 CG3330 CCAAGTGCCGCTATTGTGAGAACATGGCCAAGAACTTTCTGTACCTGGAGAGCCTGATCCGGAACAACA 69 FBan0003330 FBgn0039511 CG3330 3 3R CG3330 CG3330 anon-WO0140519.147 CDMC25231 4 18 15 DAC24-P09 6-CG3330-RA_5 CG3330 CCAAGTGCCGCTATTGTGAGAACATGGCCAAGAACTTTCTGTACCTGGAGAGCCTGATCCGGAACAACA 69 FBan0003330 FBgn0039511 CG3330 3 3R CG3330 CG3330 anon-WO0140519.147 CDMC25232 4 19 15 DAC24-P21 6-CG33323-RA_3 CG33323 ACGCGTCGCCAATCAGCGGATCGGAAGTGTTAGCTTTACCGTTATGCACTTAACTGGCAATTAGGCACA 69 FBgn0053323 CDMC25232 4 20 15 DAC24-P21 6-CG33323-RA_3 CG33323 ACGCGTCGCCAATCAGCGGATCGGAAGTGTTAGCTTTACCGTTATGCACTTAACTGGCAATTAGGCACA 69 FBgn0053323 CDMC25233 4 21 15 DAC25-D09 23-CG10377-RC_8 CG10377 AGACAAGAGAACATTATTTCTTTCATGCGCCTCATAAACACCACACTCAACAAGCATTCTCCTGTACCC 69 FBan0010377 FBgn0004838 Hrb27C 2 2L RNA localization; GO:0006403; mRNA processing; GO:0006397; regulation of pole plasm oskar mRNA localization; GO:0007317 single-stranded DNA binding; GO:0003697; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003697; ; GO:0003729; ; GO:0003729 NOT nucleolus; GO:0005730; nucleoplasm; GO:0005654; ribonucleoprotein complex; GO:0030529 Hrb27C Heterogeneous nuclear ribonucleoprotein at 27C "CG10377, CG10377, hrp48, rrm7, l(2)10280, l(2)2647, l(2)02647, 10280, RRM7, hnRNP27C, Hrp48, linha, hrb27C, Hrb27-C, Rbp7, RNA-binding protein 7" CDMC25233 4 22 15 DAC25-D09 23-CG10377-RC_8 CG10377 AGACAAGAGAACATTATTTCTTTCATGCGCCTCATAAACACCACACTCAACAAGCATTCTCCTGTACCC 69 FBan0010377 FBgn0004838 Hrb27C 2 2L RNA localization; GO:0006403; mRNA processing; GO:0006397; regulation of pole plasm oskar mRNA localization; GO:0007317 single-stranded DNA binding; GO:0003697; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003697; ; GO:0003729; ; GO:0003729 NOT nucleolus; GO:0005730; nucleoplasm; GO:0005654; ribonucleoprotein complex; GO:0030529 Hrb27C Heterogeneous nuclear ribonucleoprotein at 27C "CG10377, CG10377, hrp48, rrm7, l(2)10280, l(2)2647, l(2)02647, 10280, RRM7, hnRNP27C, Hrp48, linha, hrb27C, Hrb27-C, Rbp7, RNA-binding protein 7" CDMC25234 4 23 15 DAC25-D21 2-CG10390-RA_1 CG10390 TGGGCATACATCAACCCCCTGATCTGCCGGAAGAGTTTATGGAGAGATATGGATCTTTGGGCACGCTGA 69 FBgn0037337 CDMC25234 4 24 15 DAC25-D21 2-CG10390-RA_1 CG10390 TGGGCATACATCAACCCCCTGATCTGCCGGAAGAGTTTATGGAGAGATATGGATCTTTGGGCACGCTGA 69 FBgn0037337 CDMC25235 4 25 15 DAC25-H09 1-CG10428-RA_1 CG10428 GGGCTACCAGGTCATTCTCACACGCTTAAAGCCCGAACAGTGTACGCCAAAGAATCACCTGCTAGTCGG 69 FBan0010428 FBgn0032724 CG10428 2 2L CG10428 CG10428 CDMC25235 4 26 15 DAC25-H09 1-CG10428-RA_1 CG10428 GGGCTACCAGGTCATTCTCACACGCTTAAAGCCCGAACAGTGTACGCCAAAGAATCACCTGCTAGTCGG 69 FBan0010428 FBgn0032724 CG10428 2 2L CG10428 CG10428 CDMC25236 4 1 16 DAC25-H21 2-CG10449-RA_1 CG10449 TGGTCACAGCCACGATATGAGCATTGGTCTGTGGGTCCTTGGAGGAATCATTGCCTTCCTTTCAGTGGA 69 FBan0010449 FBgn0002022 Catsup 2 2L metal ion transport; GO:0030001; nurse cell to oocyte transport (sensu Insecta); GO:0007300; regulation of catecholamine metabolism; GO:0042069 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to plasma membrane; GO:0005887 Catsup Catecholamines up "CG10449, l(2)E13, l(2)37Bc, Bc, l(2)k05402, l(2)k05424, catsup, dCATSUP, fs(2)ltoQT50" CDMC25236 4 2 16 DAC25-H21 2-CG10449-RA_1 CG10449 TGGTCACAGCCACGATATGAGCATTGGTCTGTGGGTCCTTGGAGGAATCATTGCCTTCCTTTCAGTGGA 69 FBan0010449 FBgn0002022 Catsup 2 2L metal ion transport; GO:0030001; nurse cell to oocyte transport (sensu Insecta); GO:0007300; regulation of catecholamine metabolism; GO:0042069 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to plasma membrane; GO:0005887 Catsup Catecholamines up "CG10449, l(2)E13, l(2)37Bc, Bc, l(2)k05402, l(2)k05424, catsup, dCATSUP, fs(2)ltoQT50" CDMC25237 4 3 16 DAC25-L09 7-CG10497-RA_1 CG10497 GGCCAACAATTCGTATGCGAAAAATGCGAATAACCGCGAGTTCTACGCCTGAGATAATGGCACGTCGCG 69 FBan0010497 FBgn0010415 Sdc 2 2R axon guidance; GO:0007411 cytoskeletal protein binding; GO:0008092; transmembrane receptor activity; GO:0004888; ; GO:0008092; ; GO:0004888 extracellular region; GO:0005576; focal adhesion; GO:0005925; plasma membrane; GO:0005886 Sdc Syndecan "CG10497, CG10497, CG10497, l(2)10608, syndecan, CT27296, Dsyndecan, dSyndecan, syn, Dsyn, sdc, Syd, Syndecan" CDMC25237 4 4 16 DAC25-L09 7-CG10497-RA_1 CG10497 GGCCAACAATTCGTATGCGAAAAATGCGAATAACCGCGAGTTCTACGCCTGAGATAATGGCACGTCGCG 69 FBan0010497 FBgn0010415 Sdc 2 2R axon guidance; GO:0007411 cytoskeletal protein binding; GO:0008092; transmembrane receptor activity; GO:0004888; ; GO:0008092; ; GO:0004888 extracellular region; GO:0005576; focal adhesion; GO:0005925; plasma membrane; GO:0005886 Sdc Syndecan "CG10497, CG10497, CG10497, l(2)10608, syndecan, CT27296, Dsyndecan, dSyndecan, syn, Dsyn, sdc, Syd, Syndecan" CDMC25238 4 5 16 DAC25-L21 24-CG10510-RA_2 CG10510 ATGAGGTGATTCTGGACTTTTGAAAATATGTGGCATTCAAAGTTATGTTTAAATATAAAAATGAGCTCA 69 FBan0010510 FBgn0037059 CG10510 3 3L CG10510 CG10510 CDMC25238 4 6 16 DAC25-L21 24-CG10510-RA_2 CG10510 ATGAGGTGATTCTGGACTTTTGAAAATATGTGGCATTCAAAGTTATGTTTAAATATAAAAATGAGCTCA 69 FBan0010510 FBgn0037059 CG10510 3 3L CG10510 CG10510 CDMC25239 4 7 16 DAC25-P09 23-CG10540-RA_2 CG10540 AGGAGCACTCATTCAAGTTTTTCGCTTTCCCGATTGTTCACAAACCAACCACCTAGTATGAGCATGAAT 69 FBan0010540 FBgn0034577 CG10540 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; microtubule-based movement; GO:0007018 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 F-actin capping protein complex; GO:0008290; dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 CG10540 CG10540 miro CDMC25239 4 8 16 DAC25-P09 23-CG10540-RA_2 CG10540 AGGAGCACTCATTCAAGTTTTTCGCTTTCCCGATTGTTCACAAACCAACCACCTAGTATGAGCATGAAT 69 FBan0010540 FBgn0034577 CG10540 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; microtubule-based movement; GO:0007018 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 F-actin capping protein complex; GO:0008290; dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 CG10540 CG10540 miro CDMC25240 4 9 16 DAC25-P21 12-CG10560-RA_2 CG10560 ACTGCCGAAGTGGGGATCAGTTGCGCAGGATTTGTATTATTTCTTGCTTTCATCGACCAGCCTGGACAT 69 FBan0010560 FBgn0039325 CG10560 3 3R CG10560 CG10560 CDMC25240 4 10 16 DAC25-P21 12-CG10560-RA_2 CG10560 ACTGCCGAAGTGGGGATCAGTTGCGCAGGATTTGTATTATTTCTTGCTTTCATCGACCAGCCTGGACAT 69 FBan0010560 FBgn0039325 CG10560 3 3R CG10560 CG10560 CDMC25241 4 11 16 DAC26-D09 2-CG1530-RA_2 CG1530 CGCGTCAGGTGATGAAGGACCACTGCTACTGGCCACTAGTCTCGGACTTTAACAACGTCCTTTCACACG 69 FBan0001530 FBgn0029983 CG1530 X X CG1530 CG1530 CDMC25241 4 12 16 DAC26-D09 2-CG1530-RA_2 CG1530 CGCGTCAGGTGATGAAGGACCACTGCTACTGGCCACTAGTCTCGGACTTTAACAACGTCCTTTCACACG 69 FBan0001530 FBgn0029983 CG1530 X X CG1530 CG1530 CDMC25242 4 13 16 DAC26-D21 2-CG15325-RA_1 CG15325 ACTTTCCCTCCAAGTTGCATAACCTCAACGGGTGCCCTTTGATTGTTTTGGCTAGGAAAGTGTCGCCCT 69 FBan0015325 FBgn0029968 CG15325 X X CG15325 CG15325 CDMC25242 4 14 16 DAC26-D21 2-CG15325-RA_1 CG15325 ACTTTCCCTCCAAGTTGCATAACCTCAACGGGTGCCCTTTGATTGTTTTGGCTAGGAAAGTGTCGCCCT 69 FBan0015325 FBgn0029968 CG15325 X X CG15325 CG15325 CDMC25243 4 15 16 DAC26-H09 6-CG15378-RA_2 CG15378 GCAGCAGTGGTGTGAGTAGTGGTGGATCGTCGACTCCCGCAAAGAAGAGAAAGTACTACTGCAAGGAGG 69 FBan0015378 FBgn0040105 lectin-22C 2 2L chitin metabolism; GO:0006030; spermatogenesis; GO:0007283 chitin binding; GO:0008061; galactose binding; GO:0005534; ; GO:0005534; ; GO:0008061 extracellular region; GO:0005576 lectin-22C lectin-22C "CG15378, CG15378, CG15378, AC 004716A, AC004716a, Lectin22C" CDMC25243 4 16 16 DAC26-H09 6-CG15378-RA_2 CG15378 GCAGCAGTGGTGTGAGTAGTGGTGGATCGTCGACTCCCGCAAAGAAGAGAAAGTACTACTGCAAGGAGG 69 FBan0015378 FBgn0040105 lectin-22C 2 2L chitin metabolism; GO:0006030; spermatogenesis; GO:0007283 chitin binding; GO:0008061; galactose binding; GO:0005534; ; GO:0005534; ; GO:0008061 extracellular region; GO:0005576 lectin-22C lectin-22C "CG15378, CG15378, CG15378, AC 004716A, AC004716a, Lectin22C" CDMC25244 4 17 16 DAC26-H21 2-CG15390-RA_3 CG15390 CCGGTAACCCCGCGATTTTGAAAAGAACGCCGGACAAAATAATAAGCTGCCTGGAAATCTGGAGGGCCT 69 FBan0015390 FBgn0031419 CG15390 2 2L CG15390 CG15390 BcDNA:RE18748 CDMC25244 4 18 16 DAC26-H21 2-CG15390-RA_3 CG15390 CCGGTAACCCCGCGATTTTGAAAAGAACGCCGGACAAAATAATAAGCTGCCTGGAAATCTGGAGGGCCT 69 FBan0015390 FBgn0031419 CG15390 2 2L CG15390 CG15390 BcDNA:RE18748 CDMC25245 4 19 16 DAC26-L09 3-CG15440-RA_1 CG15440 TGCGATTTGGCATCGAGGATGAGCAGAAATCAGCGCTGTACGACATGAACGGGTACATCGGATTGGGTA 69 FBan0015440 FBgn0031607 CG15440 2 2L "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nuclear mRNA splicing, via spliceosome; GO:0000398; protein metabolism; GO:0019538; spermatogenesis; GO:0007283" DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG15440 CG15440 cg15440 CDMC25245 4 20 16 DAC26-L09 3-CG15440-RA_1 CG15440 TGCGATTTGGCATCGAGGATGAGCAGAAATCAGCGCTGTACGACATGAACGGGTACATCGGATTGGGTA 69 FBan0015440 FBgn0031607 CG15440 2 2L "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nuclear mRNA splicing, via spliceosome; GO:0000398; protein metabolism; GO:0019538; spermatogenesis; GO:0007283" DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG15440 CG15440 cg15440 CDMC25246 4 21 16 DAC26-L21 23-CG15450-RA_1 CG15450 TTTGCAATACCGTACGCTGTTGGTATATTGATTGTATGACCCTTTTGATACTAGTAAATCGATCGATAT 69 FBan0015450 FBgn0031132 CG15450 X X metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG15450 CG15450 CDMC25246 4 22 16 DAC26-L21 23-CG15450-RA_1 CG15450 TTTGCAATACCGTACGCTGTTGGTATATTGATTGTATGACCCTTTTGATACTAGTAAATCGATCGATAT 69 FBan0015450 FBgn0031132 CG15450 X X metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG15450 CG15450 CDMC25247 4 23 16 DAC26-P09 8-CG15483-RA_1 CG15483 CCAACCTGGAGGAGTGGATAAATGCGAGCGTTGTCTCCAAGGAACTGAATGTCTTCAATGTTGGCCACC 69 FBan0015483 FBgn0032457 CG15483 2 2L "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG15483 CG15483 CDMC25247 4 24 16 DAC26-P09 8-CG15483-RA_1 CG15483 CCAACCTGGAGGAGTGGATAAATGCGAGCGTTGTCTCCAAGGAACTGAATGTCTTCAATGTTGGCCACC 69 FBan0015483 FBgn0032457 CG15483 2 2L "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG15483 CG15483 CDMC25248 4 25 16 DAC26-P21 16-CG15503-RA_1 CG15503 TGACAAAGCCGGAGTTAAGCGTGATAGGGACATTTGCATGGAAATCGTCGGTGACATTGTAAATGCCTA 69 FBan0015503 FBgn0038888 CheB93a 3 3R CheB93a CheB93a "CG15503, CG15503" CDMC25248 4 26 16 DAC26-P21 16-CG15503-RA_1 CG15503 TGACAAAGCCGGAGTTAAGCGTGATAGGGACATTTGCATGGAAATCGTCGGTGACATTGTAAATGCCTA 69 FBan0015503 FBgn0038888 CheB93a 3 3R CheB93a CheB93a "CG15503, CG15503" CDMC25249 4 1 17 DAC27-D09 3-CG9772-RC_9 CG9772 AGCCCTCGACAACAAATATTACAACCCGAATAGTGGCAGCGGACAGTTTCTTTGTGTTTCGCACCCCGG 69 FBan0009772 FBgn0037236 CG9772 3 3R ubiquitin-dependent protein catabolism; GO:0006511 SCF ubiquitin ligase complex; GO:0019005 CG9772 CG9772 CDMC25249 4 2 17 DAC27-D09 3-CG9772-RC_9 CG9772 AGCCCTCGACAACAAATATTACAACCCGAATAGTGGCAGCGGACAGTTTCTTTGTGTTTCGCACCCCGG 69 FBan0009772 FBgn0037236 CG9772 3 3R ubiquitin-dependent protein catabolism; GO:0006511 SCF ubiquitin ligase complex; GO:0019005 CG9772 CG9772 CDMC25250 4 3 17 DAC27-D21 9-CG9784-RA_1 CG9784 GCAGCTATCCATTGAGCAATGCTCGTATAAGTCCCATCCCCTGTACACCATCAGTGATCACAAGCCGGT 69 FBan0009784 FBgn0030761 CG9784 X X dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG9784 CG9784 IPP CDMC25250 4 4 17 DAC27-D21 9-CG9784-RA_1 CG9784 GCAGCTATCCATTGAGCAATGCTCGTATAAGTCCCATCCCCTGTACACCATCAGTGATCACAAGCCGGT 69 FBan0009784 FBgn0030761 CG9784 X X dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG9784 CG9784 IPP CDMC25251 4 5 17 DAC27-H09 3-CG9829-RA_2 CG9829 TGCCAGCTTTTTGATCAGCTGCGTTTTGGGTCAGAGATTGCGCATCTCAAATGCTGGAACTCTGCTCGT 69 FBgn0002506 did did diminished discs "l(3)IX-11, l(3)ds-15, l(3)SG67, l(3)ds15, l(3)B15" CDMC25251 4 6 17 DAC27-H09 3-CG9829-RA_2 CG9829 TGCCAGCTTTTTGATCAGCTGCGTTTTGGGTCAGAGATTGCGCATCTCAAATGCTGGAACTCTGCTCGT 69 FBgn0002506 did did diminished discs "l(3)IX-11, l(3)ds-15, l(3)SG67, l(3)ds15, l(3)B15" CDMC25252 4 7 17 DAC27-H21 8-CG9843-RA_1 CG9843 GACGTGGAACAAGGAGTGGAAGACGGTGGTTTTCTCCGATGAAAAGAAGTTCAACCTCGATGGACCGGA 69 FBgn0037237 CDMC25252 4 8 17 DAC27-H21 8-CG9843-RA_1 CG9843 GACGTGGAACAAGGAGTGGAAGACGGTGGTTTTCTCCGATGAAAAGAAGTTCAACCTCGATGGACCGGA 69 FBgn0037237 CDMC25253 4 9 17 DAC27-L09 23-CG9884-RA_6 CG9884 GCCTTTGACTTGTAACCTTTTCCACTTTGTATTCGAAACAAATGAAATACCTTAACGATGGCAAAACCT 69 FBan0009884 FBgn0011818 oaf 2 2L eclosion; GO:0007562; female meiosis chromosome segregation; GO:0016321; nervous system development; GO:0007399 oaf out at first "CG9884, l(2)ND1, near dpp complementation group 1, tnd: transcript near decapentaplegic, transcript-near-decapentaplegic, l(2)22Fb, transcript near decapentaplegic, tnd" CDMC25253 4 10 17 DAC27-L09 23-CG9884-RA_6 CG9884 GCCTTTGACTTGTAACCTTTTCCACTTTGTATTCGAAACAAATGAAATACCTTAACGATGGCAAAACCT 69 FBan0009884 FBgn0011818 oaf 2 2L eclosion; GO:0007562; female meiosis chromosome segregation; GO:0016321; nervous system development; GO:0007399 oaf out at first "CG9884, l(2)ND1, near dpp complementation group 1, tnd: transcript near decapentaplegic, transcript-near-decapentaplegic, l(2)22Fb, transcript near decapentaplegic, tnd" CDMC25254 4 11 17 DAC27-L21 12-CG9893-RA_1 CG9893 ACGACCCCGTTTCCAAATCCGTTCACCTGAAAATCTGGTTCCACTTAAGCTGAAGGCATCAGTTGCTCA 69 FBan0009893 FBgn0010622 l(2)06496 2 2R microtubule-based movement; GO:0007018 dynactin complex; GO:0005869 l(2)06496 lethal (2) 06496 "CG9893, CG9893, dynactin, p24 subunit" CDMC25254 4 12 17 DAC27-L21 12-CG9893-RA_1 CG9893 ACGACCCCGTTTCCAAATCCGTTCACCTGAAAATCTGGTTCCACTTAAGCTGAAGGCATCAGTTGCTCA 69 FBan0009893 FBgn0010622 l(2)06496 2 2R microtubule-based movement; GO:0007018 dynactin complex; GO:0005869 l(2)06496 lethal (2) 06496 "CG9893, CG9893, dynactin, p24 subunit" CDMC25255 4 13 17 DAC27-P09 16-CG9936-RD_2 CG9936 TGAAGGACGTAGAGGAAGGAGTAGGAGTAAGTAGAGGACGCGGATAGGAGTAGAGTTAGCATGAGCGGT 69 FBgn0024200 CDMC25255 4 14 17 DAC27-P09 16-CG9936-RD_2 CG9936 TGAAGGACGTAGAGGAAGGAGTAGGAGTAAGTAGAGGACGCGGATAGGAGTAGAGTTAGCATGAGCGGT 69 FBgn0024200 CDMC25256 4 15 17 DAC27-P21 23-CG9952-RA_5 CG9952 AACGACATTTACTTAACATGACTCTTCATAGCCAGAACTAGCTATTTTCCCGCTAAGACCGGTCAGCTC 69 FBan0009952 FBgn0020257 ppa 2 2R ubiquitin-dependent protein catabolism; GO:0006511 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 ppa partner of paired "CG9952, CG9952, CG9952, CG9952, I-55, Ppa, partner of paired" CDMC25256 4 16 17 DAC27-P21 23-CG9952-RA_5 CG9952 AACGACATTTACTTAACATGACTCTTCATAGCCAGAACTAGCTATTTTCCCGCTAAGACCGGTCAGCTC 69 FBan0009952 FBgn0020257 ppa 2 2R ubiquitin-dependent protein catabolism; GO:0006511 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 ppa partner of paired "CG9952, CG9952, CG9952, CG9952, I-55, Ppa, partner of paired" CDMC25257 4 17 17 DAC28-D09 23-CG11870-RB_1 CG11870 CCAAGAGGTGAATATCACAGAATAAAGAGTAAATACCTAGATCAGTAGTGAGACACGCCATTCAG 65 FBan0011870 FBgn0037804 CG11870 3 3R cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG11870 CG11870 "CG11871, CG11871, EMK/KIAA0537" CDMC25257 4 18 17 DAC28-D09 23-CG11870-RB_1 CG11870 CCAAGAGGTGAATATCACAGAATAAAGAGTAAATACCTAGATCAGTAGTGAGACACGCCATTCAG 65 FBan0011870 FBgn0037804 CG11870 3 3R cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG11870 CG11870 "CG11871, CG11871, EMK/KIAA0537" CDMC25258 4 19 17 DAC28-D21 24-CG11886-RA_1 CG11886 TAATTTTTATTTCAAGTACAAAGTTAAAACTATGAATCAAACACGCATCTTCGAGTCACAAGGCC 65 FBan0011886 FBgn0041186 Slbp 3 3R cell cycle; GO:0007049; histone mRNA 3'-end processing; GO:0006398; histone mRNA metabolism; GO:0008334; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleoplasm; GO:0005654; nucleus; GO:0005634 Slbp Stem-loop binding protein "CG11886, CG11886, dSLBP, dSLPB, slbp, SLBP, Stem-loop binding protein" CDMC25258 4 20 17 DAC28-D21 24-CG11886-RA_1 CG11886 TAATTTTTATTTCAAGTACAAAGTTAAAACTATGAATCAAACACGCATCTTCGAGTCACAAGGCC 65 FBan0011886 FBgn0041186 Slbp 3 3R cell cycle; GO:0007049; histone mRNA 3'-end processing; GO:0006398; histone mRNA metabolism; GO:0008334; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleoplasm; GO:0005654; nucleus; GO:0005634 Slbp Stem-loop binding protein "CG11886, CG11886, dSLBP, dSLPB, slbp, SLBP, Stem-loop binding protein" CDMC25259 4 21 17 DAC28-H09 1-CG12012-RA_1 CG12012 CCACCGAGATCATCGTGATTGGAGGATGCCCTGCATGTCGGATTGGATACCTGGAGGACACCTTC 65 FBan0012012 FBgn0035444 CG12012 3 3L CG12012 CG12012 CDMC25259 4 22 17 DAC28-H09 1-CG12012-RA_1 CG12012 CCACCGAGATCATCGTGATTGGAGGATGCCCTGCATGTCGGATTGGATACCTGGAGGACACCTTC 65 FBan0012012 FBgn0035444 CG12012 3 3L CG12012 CG12012 CDMC25260 4 23 17 DAC28-H21 3-CG12048-RA_3 CG12048 AAGAACACGATGCTCCCGATATTCCGCATACCATTCCCCTCGATTGGTCTCTGTCCGAGGAACCG 65 FBan0012048 FBgn0039675 ppk21 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk21 pickpocket 21 "CG12048, PPK21" CDMC25260 4 24 17 DAC28-H21 3-CG12048-RA_3 CG12048 AAGAACACGATGCTCCCGATATTCCGCATACCATTCCCCTCGATTGGTCTCTGTCCGAGGAACCG 65 FBan0012048 FBgn0039675 ppk21 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk21 pickpocket 21 "CG12048, PPK21" CDMC25261 4 25 17 DAC28-L09 1-CG12126-RA_1 CG12126 CACTGTCAGGCAGAGGTCTTCAACTCACCAGGAGACTTCATCGACGACCCCAGATCTGCCAGAAG 65 FBan0012126 FBgn0033280 CG12126 2 2R CG12126 CG12126 BcDNA:AT16918 CDMC25261 4 26 17 DAC28-L09 1-CG12126-RA_1 CG12126 CACTGTCAGGCAGAGGTCTTCAACTCACCAGGAGACTTCATCGACGACCCCAGATCTGCCAGAAG 65 FBan0012126 FBgn0033280 CG12126 2 2R CG12126 CG12126 BcDNA:AT16918 CDMC25262 4 1 18 DAC28-L21 1-CG12153-RA_2 CG12153 TGTACCACGGAATTAGGGGGACACTGCCTAGGGACATGGACCAAATGCAACAGAAGTTTCCGCTC 65 FBan0012153 FBgn0022786 Hira X X chromatin assembly or disassembly; GO:0006333; regulation of progression through cell cycle; GO:0000074; transcription from RNA polymerase II promoter; GO:0006366 chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 Hira Hira "CG12153, CG12153, Dhh: Drosophila hira homolog, Drosophila homolog of HIRA, dhira, HIRA, dHira, hira, Drosophila hira homolog, Dhh" CDMC25262 4 2 18 DAC28-L21 1-CG12153-RA_2 CG12153 TGTACCACGGAATTAGGGGGACACTGCCTAGGGACATGGACCAAATGCAACAGAAGTTTCCGCTC 65 FBan0012153 FBgn0022786 Hira X X chromatin assembly or disassembly; GO:0006333; regulation of progression through cell cycle; GO:0000074; transcription from RNA polymerase II promoter; GO:0006366 chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 Hira Hira "CG12153, CG12153, Dhh: Drosophila hira homolog, Drosophila homolog of HIRA, dhira, HIRA, dHira, hira, Drosophila hira homolog, Dhh" CDMC25263 4 3 18 DAC28-P09 23-CG12240-RA_5 CG12240 AACGACAAACCAAGAAAACCCGAAACACACTATGAAGTTTTGAATATTCGCAATGATTGCAGCAC 65 FBan0012240 FBgn0020129 DnaJ-60 2 2R protein folding; GO:0006457; spermatogenesis; GO:0007283 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-60 DnaJ-like-60 "CG12240, CG13571, DnaJ60, anon-WO0172774.147, DmJ60" CDMC25263 4 4 18 DAC28-P09 23-CG12240-RA_5 CG12240 AACGACAAACCAAGAAAACCCGAAACACACTATGAAGTTTTGAATATTCGCAATGATTGCAGCAC 65 FBan0012240 FBgn0020129 DnaJ-60 2 2R protein folding; GO:0006457; spermatogenesis; GO:0007283 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-60 DnaJ-like-60 "CG12240, CG13571, DnaJ60, anon-WO0172774.147, DmJ60" CDMC25264 4 5 18 DAC28-P21 AutoBlank AutoBlank CDMC25264 4 6 18 DAC28-P21 AutoBlank AutoBlank CDMC25265 4 7 18 DAC29-D09 22-CG31000-RE_4 CG31000 ATCCGTAGTACAAGAAAAATGCACGCAAACTTCTACTGAAATGGCAGACTCCAGAAGCACTACCCACCC 69 FBan0031000 FBgn0011224 heph 3 3R "Notch signaling pathway; GO:0007219; nuclear mRNA splicing, via spliceosome; GO:0000398; spermatid development; GO:0007286; wing margin morphogenesis; GO:0008587; wing vein morphogenesis; GO:0008586" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 spliceosome complex; GO:0005681 heph hephaestus "CG2094, CG2290, CG31000, CG2094, CG2094, CG2094, CG2094, CG2290, l(3)03429, PTB, Polypyrimidine Tract Binding protein, Ptb, ptb, ema, ectopic margin, dmPTB, l(3)j11B9, hephaestus" CDMC25265 4 8 18 DAC29-D09 22-CG31000-RE_4 CG31000 ATCCGTAGTACAAGAAAAATGCACGCAAACTTCTACTGAAATGGCAGACTCCAGAAGCACTACCCACCC 69 FBan0031000 FBgn0011224 heph 3 3R "Notch signaling pathway; GO:0007219; nuclear mRNA splicing, via spliceosome; GO:0000398; spermatid development; GO:0007286; wing margin morphogenesis; GO:0008587; wing vein morphogenesis; GO:0008586" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 spliceosome complex; GO:0005681 heph hephaestus "CG2094, CG2290, CG31000, CG2094, CG2094, CG2094, CG2094, CG2290, l(3)03429, PTB, Polypyrimidine Tract Binding protein, Ptb, ptb, ema, ectopic margin, dmPTB, l(3)j11B9, hephaestus" CDMC25266 4 9 18 DAC29-D21 23-CG31009-RA_4 CG31009 GACTTGTTAATATACTTAGCTGCCAATTTGTAATTTTAATAGTGCATTTTAACAACGAGAGCGGTTGCC 69 FBan0031009 FBgn0039709 Cad99C 3 3R NOT wing disc anterior/posterior pattern formation; GO:0048100; calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad99C Cad99C "CG7805, CG15511, CG31009, CG7805, CG15511, CT35624, CT4930, DCad99C, CA-10, cad99C" CDMC25266 4 10 18 DAC29-D21 23-CG31009-RA_4 CG31009 GACTTGTTAATATACTTAGCTGCCAATTTGTAATTTTAATAGTGCATTTTAACAACGAGAGCGGTTGCC 69 FBan0031009 FBgn0039709 Cad99C 3 3R NOT wing disc anterior/posterior pattern formation; GO:0048100; calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad99C Cad99C "CG7805, CG15511, CG31009, CG7805, CG15511, CT35624, CT4930, DCad99C, CA-10, cad99C" CDMC25267 4 11 18 DAC29-H09 2-CG31032-RA_1 CG31032 CACCCGTTGCTTGACTCCTCATTTGTTATTCGAGGACACCGGATGATCAGGTGCTAGGACGGCTTCTCT 69 FBan0031032 FBgn0051032 CG31032 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31032 CG31032 BcDNA:GH15189 CDMC25267 4 12 18 DAC29-H09 2-CG31032-RA_1 CG31032 CACCCGTTGCTTGACTCCTCATTTGTTATTCGAGGACACCGGATGATCAGGTGCTAGGACGGCTTCTCT 69 FBan0031032 FBgn0051032 CG31032 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31032 CG31032 BcDNA:GH15189 CDMC25268 4 13 18 DAC29-H21 3-CG31041-RA_1 CG31041 CGGATCTCTTCAACGTCGAATGCGTGGACTACTACAGCCCGCTCCTTAAGGGTCACGTGGACAAGTACA 69 FBan0031041 FBgn0051041 CG31041 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31041 CG31041 CDMC25268 4 14 18 DAC29-H21 3-CG31041-RA_1 CG31041 CGGATCTCTTCAACGTCGAATGCGTGGACTACTACAGCCCGCTCCTTAAGGGTCACGTGGACAAGTACA 69 FBan0031041 FBgn0051041 CG31041 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31041 CG31041 CDMC25269 4 15 18 DAC29-L09 3-CG31068-RA_3 CG31068 GCGGTGGGAAAGCAGGTCACATCCCTCAAACTTCTTTCCGATGATTCGTCTCCTAGCCGAGTTCCCTAC 69 FBan0031068 FBgn0051068 CG31068 3 3R CG31068 CG31068 BcDNA:AT10318 CDMC25269 4 16 18 DAC29-L09 3-CG31068-RA_3 CG31068 GCGGTGGGAAAGCAGGTCACATCCCTCAAACTTCTTTCCGATGATTCGTCTCCTAGCCGAGTTCCCTAC 69 FBan0031068 FBgn0051068 CG31068 3 3R CG31068 CG31068 BcDNA:AT10318 CDMC25270 4 17 18 DAC29-L21 12-CG31082-RA_1 CG31082 GGAGGCCATCTACAGCAACACCTCCTTCTTTGATTCGCGTCGAAGTAGTGACACTTCGGTATCCTGTCG 69 FBan0031082 FBgn0051082 CG31082 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31082 CG31082 CDMC25270 4 18 18 DAC29-L21 12-CG31082-RA_1 CG31082 GGAGGCCATCTACAGCAACACCTCCTTCTTTGATTCGCGTCGAAGTAGTGACACTTCGGTATCCTGTCG 69 FBan0031082 FBgn0051082 CG31082 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31082 CG31082 CDMC25271 4 19 18 DAC29-P09 12-CG31103-RA_1 CG31103 ACAAGTTTTGAGCTGCGATGAATTTACACTGAAGTCCGAGGATCCAGTGGGCGAAAACTTGTTGGGCGA 69 FBan0031103 FBgn0051103 CG31103 3 3R neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG31103 CG31103 CG13655 CDMC25271 4 20 18 DAC29-P09 12-CG31103-RA_1 CG31103 ACAAGTTTTGAGCTGCGATGAATTTACACTGAAGTCCGAGGATCCAGTGGGCGAAAACTTGTTGGGCGA 69 FBan0031103 FBgn0051103 CG31103 3 3R neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG31103 CG31103 CG13655 CDMC25272 4 21 18 DAC29-P21 16-CG31110-RA_3 CG31110 GCTGCATGCGAAAATTTCCCCTCCGTTTATTGTAAGACGCGCAGAAGAGCCCTAGTTCATACCATTGAA 69 FBan0031110 FBgn0051110 CG31110 3 3R dephosphorylation; GO:0016311; transmission of nerve impulse; GO:0019226 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030; ; GO:0046030 CG31110 CG31110 "CG7613, IPP, BcDNA:RE64196" CDMC25272 4 22 18 DAC29-P21 16-CG31110-RA_3 CG31110 GCTGCATGCGAAAATTTCCCCTCCGTTTATTGTAAGACGCGCAGAAGAGCCCTAGTTCATACCATTGAA 69 FBan0031110 FBgn0051110 CG31110 3 3R dephosphorylation; GO:0016311; transmission of nerve impulse; GO:0019226 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030; ; GO:0046030 CG31110 CG31110 "CG7613, IPP, BcDNA:RE64196" CDMC25273 4 23 18 DAC30-D09 3-CG2059-RA_4 CG2059 GATGACGGAAATTTTCGACGCGATGGTCTCCCTGGACCTTTCGCCAAGCATGTCCATGTCTGAGG 65 FBan0002059 FBgn0029942 CG2059 X X aromatic compound metabolism; GO:0006725; lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG2059 CG2059 CDMC25273 4 24 18 DAC30-D09 3-CG2059-RA_4 CG2059 GATGACGGAAATTTTCGACGCGATGGTCTCCCTGGACCTTTCGCCAAGCATGTCCATGTCTGAGG 65 FBan0002059 FBgn0029942 CG2059 X X aromatic compound metabolism; GO:0006725; lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG2059 CG2059 CDMC25274 4 25 18 DAC30-D21 2-CG2110-RA_1 CG2110 TTATTAGGGAGACCCTGCGCTTGTACCCTTCTGTCCCACTGATTGCTCGAACAAACCGCAATCCC 65 FBan0002110 FBgn0033292 Cyp4ad1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ad1 Cyp4ad1 "CG2110, CYP4-related, 4ad1, BEST:LD02646" CDMC25274 4 26 18 DAC30-D21 2-CG2110-RA_1 CG2110 TTATTAGGGAGACCCTGCGCTTGTACCCTTCTGTCCCACTGATTGCTCGAACAAACCGCAATCCC 65 FBan0002110 FBgn0033292 Cyp4ad1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ad1 Cyp4ad1 "CG2110, CYP4-related, 4ad1, BEST:LD02646" CDMC25275 4 1 19 DAC30-H09 16-CG2239-RA_1 CG2239 ACATATTGCGGATAGAGCAGACCAGATCCAGATCAAATCGGAACAGAAAGGGAGGAACAGCTGCA 65 FBan0002239 FBgn0027654 jdp 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 jdp jdp "CG2239, dJDP, p25a" CDMC25275 4 2 19 DAC30-H09 16-CG2239-RA_1 CG2239 ACATATTGCGGATAGAGCAGACCAGATCCAGATCAAATCGGAACAGAAAGGGAGGAACAGCTGCA 65 FBan0002239 FBgn0027654 jdp 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 jdp jdp "CG2239, dJDP, p25a" CDMC25276 4 3 19 DAC30-H21 2-CG2275-RB_1 CG2275 GAATCCTGAAGATCCCGAGCAACCCATGCCTCTGGAATTCTTTTCAAGTGCTAGCACCGGTGCCT 65 FBan0002275 FBgn0001291 Jra 2 2R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; micropyle formation; GO:0046844; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; ; GO:0008134; specific RNA polymerase II transcription factor activity; GO:0003704; protein heterodimerization activity; GO:0046982; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0003677; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Jra Jun-related antigen "CG2275, CG2275, l(2)IA109, dJRA, dJra, Djun, d-JRA, jun, dAP-1, dm-Jun, Jun, D-jun, lethal(2)1A109, D-Jun, DJun, dJUN, Jun oncogene, l(2R)IA109, V: transcript group V, Complementation group V, DJUN, dJun, c-Jun, d-Jun, cJun, jra, AP1, d-jun, AP-1, JRA, l(2)46Ef, lethal(2)IA109" CDMC25276 4 4 19 DAC30-H21 2-CG2275-RB_1 CG2275 GAATCCTGAAGATCCCGAGCAACCCATGCCTCTGGAATTCTTTTCAAGTGCTAGCACCGGTGCCT 65 FBan0002275 FBgn0001291 Jra 2 2R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; micropyle formation; GO:0046844; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; ; GO:0008134; specific RNA polymerase II transcription factor activity; GO:0003704; protein heterodimerization activity; GO:0046982; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0003677; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Jra Jun-related antigen "CG2275, CG2275, l(2)IA109, dJRA, dJra, Djun, d-JRA, jun, dAP-1, dm-Jun, Jun, D-jun, lethal(2)1A109, D-Jun, DJun, dJUN, Jun oncogene, l(2R)IA109, V: transcript group V, Complementation group V, DJUN, dJun, c-Jun, d-Jun, cJun, jra, AP1, d-jun, AP-1, JRA, l(2)46Ef, lethal(2)IA109" CDMC25277 4 5 19 DAC30-L09 15-CG2723-RA_12 CG2723 CTCGCTGGTTGCTGGGAAGAGTCGCTTCAGTTGAGTGCCTCCATTCCCCCAGAGTAAACCGTTCC 65 FBan0002723 FBgn0001255 ImpE3 3 3R imaginal disc eversion; GO:0007561 extrinsic to membrane; GO:0019898; plasma membrane; GO:0005886 ImpE3 Ecdysone-inducible gene E3 "CG2723, CG11046, IMP-E3, Imp-E3" CDMC25277 4 6 19 DAC30-L09 15-CG2723-RA_12 CG2723 CTCGCTGGTTGCTGGGAAGAGTCGCTTCAGTTGAGTGCCTCCATTCCCCCAGAGTAAACCGTTCC 65 FBan0002723 FBgn0001255 ImpE3 3 3R imaginal disc eversion; GO:0007561 extrinsic to membrane; GO:0019898; plasma membrane; GO:0005886 ImpE3 Ecdysone-inducible gene E3 "CG2723, CG11046, IMP-E3, Imp-E3" CDMC25278 4 7 19 DAC30-L21 6-CG2848-RA_2 CG2848 TCTGGTGATGAACCTGATCCAGGCATCCGTCTTTCAGCTGCACTCCTACATGCTGGTGGATGTGG 65 FBan0002848 FBgn0031456 Trn-SR 2 2L "mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; regulation of transcription, DNA-dependent; GO:0006355; splicing factor protein import into nucleus; GO:0035048" DNA binding; GO:0003677; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; transporter activity; GO:0005215; ; GO:0005515; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0003677; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Trn-SR Transportin-Serine/Arginine rich "CG2848, CG2848, CG2848, CG2848, dTRN-SR, anon-EST:Posey294, Transportin-Serine/Arginine rich" CDMC25278 4 8 19 DAC30-L21 6-CG2848-RA_2 CG2848 TCTGGTGATGAACCTGATCCAGGCATCCGTCTTTCAGCTGCACTCCTACATGCTGGTGGATGTGG 65 FBan0002848 FBgn0031456 Trn-SR 2 2L "mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; regulation of transcription, DNA-dependent; GO:0006355; splicing factor protein import into nucleus; GO:0035048" DNA binding; GO:0003677; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; transporter activity; GO:0005215; ; GO:0005515; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0003677; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Trn-SR Transportin-Serine/Arginine rich "CG2848, CG2848, CG2848, CG2848, dTRN-SR, anon-EST:Posey294, Transportin-Serine/Arginine rich" CDMC25279 4 9 19 DAC30-P09 23-CG2968-RA_4 CG2968 CAAAAACAGCGGCTGATCACTGAAGTTTTCTCGTGTTTTTCGCTATCAAACCGAAATAAAAACAG 65 FBgn0030184 CDMC25279 4 10 19 DAC30-P09 23-CG2968-RA_4 CG2968 CAAAAACAGCGGCTGATCACTGAAGTTTTCTCGTGTTTTTCGCTATCAAACCGAAATAAAAACAG 65 FBgn0030184 CDMC25280 4 11 19 DAC30-P21 AutoBlank AutoBlank CDMC25280 4 12 19 DAC30-P21 AutoBlank AutoBlank CDMC25281 4 13 19 DAC31-D09 23-CG3195-RC_2 CG3195 AAATTGTACGCGATACAGTCTGTAATAATTGACCCAATCGGACAGAATTTTACTTTCGAGCTCAATGC 68 FBgn0002611 CDMC25281 4 14 19 DAC31-D09 23-CG3195-RC_2 CG3195 AAATTGTACGCGATACAGTCTGTAATAATTGACCCAATCGGACAGAATTTTACTTTCGAGCTCAATGC 68 FBgn0002611 CDMC25282 4 15 19 DAC31-D21 3-CG32092-RB_1 CG32092 GGAGAATCCCTCCTACGAAGGACGCAACAGCTCATTGTGCACTTGGAAAATATCCGTACCAGCTGGCG 68 FBan0032092 FBgn0052092 CG32092 3 3L cell-cell signaling; GO:0007267; mesoderm development; GO:0007498; signal transduction; GO:0007165; skeletal development; GO:0001501 receptor activity; GO:0004872; transforming growth factor beta receptor binding; GO:0005160; ; GO:0004872; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0005160; ; GO:0017026 ; EC:3.4.24.19 CG32092 CG32092 "CG5956, CT18701" CDMC25282 4 16 19 DAC31-D21 3-CG32092-RB_1 CG32092 GGAGAATCCCTCCTACGAAGGACGCAACAGCTCATTGTGCACTTGGAAAATATCCGTACCAGCTGGCG 68 FBan0032092 FBgn0052092 CG32092 3 3L cell-cell signaling; GO:0007267; mesoderm development; GO:0007498; signal transduction; GO:0007165; skeletal development; GO:0001501 receptor activity; GO:0004872; transforming growth factor beta receptor binding; GO:0005160; ; GO:0004872; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0005160; ; GO:0017026 ; EC:3.4.24.19 CG32092 CG32092 "CG5956, CT18701" CDMC25283 4 17 19 DAC31-H09 3-CG32393-RA_1 CG32393 GCTGCGATGCGCTACAGACGGTAGCCAAGGAAATCACACACAGCAACTATCAGATGTTCTTGCGTCGC 68 FBan0032393 FBgn0052393 dikar 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dikar dikar "CG10115, CG32393, CG10115, CG10115, dikar" CDMC25283 4 18 19 DAC31-H09 3-CG32393-RA_1 CG32393 GCTGCGATGCGCTACAGACGGTAGCCAAGGAAATCACACACAGCAACTATCAGATGTTCTTGCGTCGC 68 FBan0032393 FBgn0052393 dikar 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dikar dikar "CG10115, CG32393, CG10115, CG10115, dikar" CDMC25284 4 19 19 DAC31-H21 2-CG32579-RA_4 CG32579 CGCGACACTGGCTTGCTTTTACGGCACCATTGTGTTCTTTGTGGACTCGCCAATGATCGCAAAATCCC 68 FBan0032579 FBgn0052579 CG32579 X X CG32579 CG32579 CDMC25284 4 20 19 DAC31-H21 2-CG32579-RA_4 CG32579 CGCGACACTGGCTTGCTTTTACGGCACCATTGTGTTCTTTGTGGACTCGCCAATGATCGCAAAATCCC 68 FBan0032579 FBgn0052579 CG32579 X X CG32579 CG32579 CDMC25285 4 21 19 DAC31-L09 2-CG33265-RA_1 CG33265 AGGAGAAGGTTTGCGGACCTGGAGTGGATTTCCTTGCACATCCAACGGACTGCACCATGTATTTGCAG 68 FBan0033265 FBgn0053265 CG33265 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33265 CG33265 CDMC25285 4 22 19 DAC31-L09 2-CG33265-RA_1 CG33265 AGGAGAAGGTTTGCGGACCTGGAGTGGATTTCCTTGCACATCCAACGGACTGCACCATGTATTTGCAG 68 FBan0033265 FBgn0053265 CG33265 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33265 CG33265 CDMC25286 4 23 19 DAC31-L21 3-CG33456-RA_4 CG33456 GGCGGCCCCCAACAGTTCCCCTCAAGTCGACAAACGAAAGTCACCTACTAAGAAGATCCGATCTCCTC 68 FBan0033456 FBgn0053456 CG33456 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33456 CG33456 "CG15610, CG15610" CDMC25286 4 24 19 DAC31-L21 3-CG33456-RA_4 CG33456 GGCGGCCCCCAACAGTTCCCCTCAAGTCGACAAACGAAAGTCACCTACTAAGAAGATCCGATCTCCTC 68 FBan0033456 FBgn0053456 CG33456 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33456 CG33456 "CG15610, CG15610" CDMC25287 4 25 19 DAC31-P09 3-CG3642-RA_2 CG3642 GCCCGAGTGCTACTTCTACTCGAGGTTCAACGCCTGCCACAACAAAGAGTGTCCCTTTTTGCACATCG 68 FBan0003642 FBgn0015621 Clp 2 2L mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 nucleic acid binding; GO:0003676; endoribonuclease activity; GO:0004521; ; GO:0003676; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 Clp Clipper "CG3642, CG3642, c6a, clp, CLP, Ssb-c6a, Single stranded-binding protein c6a, Clipper" CDMC25287 4 26 19 DAC31-P09 3-CG3642-RA_2 CG3642 GCCCGAGTGCTACTTCTACTCGAGGTTCAACGCCTGCCACAACAAAGAGTGTCCCTTTTTGCACATCG 68 FBan0003642 FBgn0015621 Clp 2 2L mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 nucleic acid binding; GO:0003676; endoribonuclease activity; GO:0004521; ; GO:0003676; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 Clp Clipper "CG3642, CG3642, c6a, clp, CLP, Ssb-c6a, Single stranded-binding protein c6a, Clipper" CDMC25288 4 1 20 DAC31-P21 AutoBlank AutoBlank CDMC25288 4 2 20 DAC31-P21 AutoBlank AutoBlank CDMC25289 4 3 20 DAC32-D09 15-CG1578-RA_2 CG1578 TGCCGAACATCTGGACGAAATCTTCACGTACGTGGTTAATCGTCTGCTAAAGGATTATCCGCTGGCCAA 69 FBan0001578 FBgn0030336 CG1578 X X CG1578 CG1578 CDMC25289 4 4 20 DAC32-D09 15-CG1578-RA_2 CG1578 TGCCGAACATCTGGACGAAATCTTCACGTACGTGGTTAATCGTCTGCTAAAGGATTATCCGCTGGCCAA 69 FBan0001578 FBgn0030336 CG1578 X X CG1578 CG1578 CDMC25290 4 5 20 DAC32-D21 14-CG15818-RA_1 CG15818 AGCCCAGCAAGCATTCCTTGTGAACAACATTTCGAAGGCAATCAAAACCGAGGACCTTGAGCAAAAACT 69 FBan0015818 FBgn0031910 CG15818 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG15818 CG15818 CDMC25290 4 6 20 DAC32-D21 14-CG15818-RA_1 CG15818 AGCCCAGCAAGCATTCCTTGTGAACAACATTTCGAAGGCAATCAAAACCGAGGACCTTGAGCAAAAACT 69 FBan0015818 FBgn0031910 CG15818 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG15818 CG15818 CDMC25291 4 7 20 DAC32-H09 14-CG15873-RA_1 CG15873 CGGCAAGGCCATGAAGTTCCTCAGCTTTCTGTACTACAAGGACTGGATTCTTCTCACCATCCAATCCCT 69 FBan0015873 FBgn0035003 CG15873 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG15873 CG15873 "SP184, SPH184" CDMC25291 4 8 20 DAC32-H09 14-CG15873-RA_1 CG15873 CGGCAAGGCCATGAAGTTCCTCAGCTTTCTGTACTACAAGGACTGGATTCTTCTCACCATCCAATCCCT 69 FBan0015873 FBgn0035003 CG15873 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG15873 CG15873 "SP184, SPH184" CDMC25292 4 9 20 DAC32-H21 1-CG15888-RA_1 CG15888 CCGGATGGGTCGTTCCCGAAGACGTGAGACCGAAGAAATGGACCTGCCCCTTATTAATATTCCGTCCAT 69 FBan0015888 FBgn0038131 CG15888 3 3R CG15888 CG15888 CDMC25292 4 10 20 DAC32-H21 1-CG15888-RA_1 CG15888 CCGGATGGGTCGTTCCCGAAGACGTGAGACCGAAGAAATGGACCTGCCCCTTATTAATATTCCGTCCAT 69 FBan0015888 FBgn0038131 CG15888 3 3R CG15888 CG15888 CDMC25293 4 11 20 DAC32-L09 16-CG15925-RA_1 CG15925 TGCCCGACGGCTTGACGAAAACTCTGCAGAATTACAATTTCCAAATTTCAGTCTCGTGAGGGAAATCGA 69 FBan0015925 FBgn0034129 CG15925 2 2R CG15925 CG15925 CDMC25293 4 12 20 DAC32-L09 16-CG15925-RA_1 CG15925 TGCCCGACGGCTTGACGAAAACTCTGCAGAATTACAATTTCCAAATTTCAGTCTCGTGAGGGAAATCGA 69 FBan0015925 FBgn0034129 CG15925 2 2R CG15925 CG15925 CDMC25294 4 13 20 DAC32-L21 23-CG1600-RC_3 CG1600 ACACGAAATTGTTACGCATGCGATGCAAATGTTTGATTCAATTGCTTGATGTTTGTACTCATTACGTAC 69 FBan0001600 FBgn0033188 CG1600 2 2R "zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG1600 CG1600 CDMC25294 4 14 20 DAC32-L21 23-CG1600-RC_3 CG1600 ACACGAAATTGTTACGCATGCGATGCAAATGTTTGATTCAATTGCTTGATGTTTGTACTCATTACGTAC 69 FBan0001600 FBgn0033188 CG1600 2 2R "zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG1600 CG1600 CDMC25295 4 15 20 DAC32-P09 3-CG1638-RA_1 CG1638 CGGAGCCGAAGTCCAGGGAGGATCTACTCAAGTACCAACCCAAGTTTGAGGACTTACCTGCGCGATCTA 69 FBan0001638 FBgn0039855 CG1638 3 3R lipid metabolism; GO:0006629 acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; ; GO:0016291 ; EC:3.1.2.- CG1638 CG1638 bs31f06.y1 CDMC25295 4 16 20 DAC32-P09 3-CG1638-RA_1 CG1638 CGGAGCCGAAGTCCAGGGAGGATCTACTCAAGTACCAACCCAAGTTTGAGGACTTACCTGCGCGATCTA 69 FBan0001638 FBgn0039855 CG1638 3 3R lipid metabolism; GO:0006629 acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; ; GO:0016291 ; EC:3.1.2.- CG1638 CG1638 bs31f06.y1 CDMC25296 4 17 20 DAC32-P21 2-CG1646-RC_1 CG1646 GGCATCAAGCGGCCTTATTTCCATGTGAAGCCACTCGAGAGGGCACAGCTCAAGAATTGGAAGGACTAC 69 FBan0001646 FBgn0039600 CG1646 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; snRNP U1; GO:0005685 CG1646 CG1646 Prp39 CDMC25296 4 18 20 DAC32-P21 2-CG1646-RC_1 CG1646 GGCATCAAGCGGCCTTATTTCCATGTGAAGCCACTCGAGAGGGCACAGCTCAAGAATTGGAAGGACTAC 69 FBan0001646 FBgn0039600 CG1646 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; snRNP U1; GO:0005685 CG1646 CG1646 Prp39 CDMC25297 4 19 20 DAC33-D09 22-CG11352-RC_1 CG11352 GTCCACACTTTTGCACACACAAGGCAGACAAAAGAAATCAGCTGGAACATCTTGTTTATCAAGCAGGCA 69 FBan0011352 FBgn0027339 jim 3 3L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 jim jim "CG11352, CG11352, ovfc.K, OVK, ovk, BcDNA:SD14927" CDMC25297 4 20 20 DAC33-D09 22-CG11352-RC_1 CG11352 GTCCACACTTTTGCACACACAAGGCAGACAAAAGAAATCAGCTGGAACATCTTGTTTATCAAGCAGGCA 69 FBan0011352 FBgn0027339 jim 3 3L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 jim jim "CG11352, CG11352, ovfc.K, OVK, ovk, BcDNA:SD14927" CDMC25298 4 21 20 DAC33-D21 14-CG11367-RA_2 CG11367 AGCCCAAACCATCAATGTTTACTTGGGTTCCACGCTAAGGTCCATGCATGAAGTGCTCAGTGATAACGA 69 FBan0011367 FBgn0037185 CG11367 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG11367 CG11367 CDMC25298 4 22 20 DAC33-D21 14-CG11367-RA_2 CG11367 AGCCCAAACCATCAATGTTTACTTGGGTTCCACGCTAAGGTCCATGCATGAAGTGCTCAGTGATAACGA 69 FBan0011367 FBgn0037185 CG11367 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG11367 CG11367 CDMC25299 4 23 20 DAC33-H09 2-CG11395-RA_3 CG11395 TGAGGAAGCAAGTCCAGAGTCGGTAAATCAGCGCAGTCTCTTCAACCTGGATCCCAAGTGTGCAGAAGG 69 FBan0011395 FBgn0034200 CG11395 2 2R CG11395 CG11395 CDMC25299 4 24 20 DAC33-H09 2-CG11395-RA_3 CG11395 TGAGGAAGCAAGTCCAGAGTCGGTAAATCAGCGCAGTCTCTTCAACCTGGATCCCAAGTGTGCAGAAGG 69 FBan0011395 FBgn0034200 CG11395 2 2R CG11395 CG11395 CDMC25300 4 25 20 DAC33-H21 1-CG11409-RB_1 CG11409 TCCCCCACCAAGATTAGTCTGAGTCTGGGCTTAGACGACATCGATGGAGACACCAAAGGAGCAGTTGGA 69 FBan0011409 FBgn0024366 CG11409 X X CG11409 CG11409 EG:8D8.2 CDMC25300 4 26 20 DAC33-H21 1-CG11409-RB_1 CG11409 TCCCCCACCAAGATTAGTCTGAGTCTGGGCTTAGACGACATCGATGGAGACACCAAAGGAGCAGTTGGA 69 FBan0011409 FBgn0024366 CG11409 X X CG11409 CG11409 EG:8D8.2 CDMC25301 4 1 21 DAC33-L09 11-CG11444-RA_1 CG11444 AGCCAGAGTAAAAGCTCTAGATACAAGCACATCGGACATACAGGAGGAGAGACCTGCGAATACCCGGGA 69 FBan0011444 FBgn0029715 CG11444 X X CG11444 CG11444 CDMC25301 4 2 21 DAC33-L09 11-CG11444-RA_1 CG11444 AGCCAGAGTAAAAGCTCTAGATACAAGCACATCGGACATACAGGAGGAGAGACCTGCGAATACCCGGGA 69 FBan0011444 FBgn0029715 CG11444 X X CG11444 CG11444 CDMC25302 4 3 21 DAC33-L21 3-CG11459-RA_2 CG11459 GGCATCGCCACAAAGGAATCCTATCCGTACGAGCCTGTATCAGGAGAATGCCTGTGGAAAAGCGACAGA 69 FBan0011459 FBgn0037396 CG11459 3 3R proteolysis; GO:0006508 NOT cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG11459 CG11459 CDMC25302 4 4 21 DAC33-L21 3-CG11459-RA_2 CG11459 GGCATCGCCACAAAGGAATCCTATCCGTACGAGCCTGTATCAGGAGAATGCCTGTGGAAAAGCGACAGA 69 FBan0011459 FBgn0037396 CG11459 3 3R proteolysis; GO:0006508 NOT cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG11459 CG11459 CDMC25303 4 5 21 DAC33-P09 8-CG1149-RA_1 CG1149 TCGGTGCAAGCGTCTGATAGTGGTGCTCTATCCAAACGTGAAGAACTTCGACAGTCTGGATAGCGAGCT 69 FBan0001149 FBgn0015770 MstProx 3 3R defense response; GO:0006952; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 MstProx MstProx "CG1149, CG1149, Toll-3, Tl-3, mstprox, dTLR3, toll, dToll3, DmMstProx" CDMC25303 4 6 21 DAC33-P09 8-CG1149-RA_1 CG1149 TCGGTGCAAGCGTCTGATAGTGGTGCTCTATCCAAACGTGAAGAACTTCGACAGTCTGGATAGCGAGCT 69 FBan0001149 FBgn0015770 MstProx 3 3R defense response; GO:0006952; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 MstProx MstProx "CG1149, CG1149, Toll-3, Tl-3, mstprox, dTLR3, toll, dToll3, DmMstProx" CDMC25304 4 7 21 DAC33-P21 8-CG11509-RA_1 CG11509 ACGTGGATTCTGGTGTTCCAAGATGTTCCATTCGGCTCCTTTCTACGCTCAGGATCAAGGACAAGCCAA 69 FBan0011509 FBgn0029584 CG11509 X X CG11509 CG11509 CDMC25304 4 8 21 DAC33-P21 8-CG11509-RA_1 CG11509 ACGTGGATTCTGGTGTTCCAAGATGTTCCATTCGGCTCCTTTCTACGCTCAGGATCAAGGACAAGCCAA 69 FBan0011509 FBgn0029584 CG11509 X X CG11509 CG11509 CDMC25305 4 9 21 DAC34-D09 9-CG14720-RA_1 CG14720 CATTGGCATTCCCGTAGAGAACCTGCACTTTGAGTCTGTTACCTCGGGCTATGTGCTCAAGGCGGAG 67 FBan0014720 FBgn0037940 CG14720 3 3R CG14720 CG14720 CDMC25305 4 10 21 DAC34-D09 9-CG14720-RA_1 CG14720 CATTGGCATTCCCGTAGAGAACCTGCACTTTGAGTCTGTTACCTCGGGCTATGTGCTCAAGGCGGAG 67 FBan0014720 FBgn0037940 CG14720 3 3R CG14720 CG14720 CDMC25306 4 11 21 DAC34-D21 3-CG14895-RB_3 CG14895 TCAAGAGCTGGGATAAGCTGAGTCCCAACCTTCAAGACTTTCTCGATCGCTGTCTCCAGGTGGAGGT 67 FBan0014895 FBgn0044826 Pak3 3 3R MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Pak3 Pak3 "CG14895, CG14895, PAK3, dPAK3, pak3, D-Pak3, DPAK3, DmPAK3, anon-WO0118547.285" CDMC25306 4 12 21 DAC34-D21 3-CG14895-RB_3 CG14895 TCAAGAGCTGGGATAAGCTGAGTCCCAACCTTCAAGACTTTCTCGATCGCTGTCTCCAGGTGGAGGT 67 FBan0014895 FBgn0044826 Pak3 3 3R MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Pak3 Pak3 "CG14895, CG14895, PAK3, dPAK3, pak3, D-Pak3, DPAK3, DmPAK3, anon-WO0118547.285" CDMC25307 4 13 21 DAC34-H09 1-CG15332-RB_2 CG15332 GCCGGGTGTACTTCCACGTGATTGCTATCCCGTTGATCTGATTAGGACGGAACATGAGGGCCCAATG 67 FBan0015332 FBgn0029986 CG15332 X X CG15332 CG15332 CDMC25307 4 14 21 DAC34-H09 1-CG15332-RB_2 CG15332 GCCGGGTGTACTTCCACGTGATTGCTATCCCGTTGATCTGATTAGGACGGAACATGAGGGCCCAATG 67 FBan0015332 FBgn0029986 CG15332 X X CG15332 CG15332 CDMC25308 4 15 21 DAC34-H21 3-CG15478-RA_1 CG15478 GGATGGCGAGAGCAGTCGATGTTCCAGCAATGACGAGGCTTCCATCACGCAAATCGATTGAGGCTAC 67 FBan0015478 FBgn0029955 CG15478 X X CG15478 CG15478 CDMC25308 4 16 21 DAC34-H21 3-CG15478-RA_1 CG15478 GGATGGCGAGAGCAGTCGATGTTCCAGCAATGACGAGGCTTCCATCACGCAAATCGATTGAGGCTAC 67 FBan0015478 FBgn0029955 CG15478 X X CG15478 CG15478 CDMC25309 4 17 21 DAC34-L09 3-CG15778-RA_1 CG15778 TGGCCAGATATCAGAGTAGCCTTAGCCTCGGAATCCTTGTGGTCCTGCTAATCGATCAGCTGGCCAA 67 FBan0015778 FBgn0029788 CG15778 X X CG15778 CG15778 CDMC25309 4 18 21 DAC34-L09 3-CG15778-RA_1 CG15778 TGGCCAGATATCAGAGTAGCCTTAGCCTCGGAATCCTTGTGGTCCTGCTAATCGATCAGCTGGCCAA 67 FBan0015778 FBgn0029788 CG15778 X X CG15778 CG15778 CDMC25310 4 19 21 DAC34-L21 3-CG1622-RA_1 CG1622 ACGCCTACCCACAACCGAATAACTACCGCAACGATTATGACGAGCGTGACTACTATGCTGCCGCGTC 67 FBan0001622 FBgn0030468 CG1622 X X CG1622 CG1622 CDMC25310 4 20 21 DAC34-L21 3-CG1622-RA_1 CG1622 ACGCCTACCCACAACCGAATAACTACCGCAACGATTATGACGAGCGTGACTACTATGCTGCCGCGTC 67 FBan0001622 FBgn0030468 CG1622 X X CG1622 CG1622 CDMC25311 4 21 21 DAC34-P09 3-CG17168-RA_2 CG17168 CCCACGCTCCATATTCATCGGCAGAGTTGCTTTCTGGTTGGACGCGATCGAAAAGTGGTCGATCTGG 67 FBgn0039943 CG17168 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG17168 CG17168 CDMC25311 4 22 21 DAC34-P09 3-CG17168-RA_2 CG17168 CCCACGCTCCATATTCATCGGCAGAGTTGCTTTCTGGTTGGACGCGATCGAAAAGTGGTCGATCTGG 67 FBgn0039943 CG17168 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG17168 CG17168 CDMC25312 4 23 21 DAC34-P21 AutoBlank AutoBlank CDMC25312 4 24 21 DAC34-P21 AutoBlank AutoBlank CDMC25313 4 25 21 DAC35-D09 17-CG11778-RA_1 CG11778 TGCTCGGAATCGTCTCGAATATCATCGCCTTCCTAGCCATTGTGTTCTTCCTAGACGCTGTAACGGAGT 69 FBan0011778 FBgn0033371 CG11778 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; ; GO:0005415 membrane; GO:0016020 CG11778 CG11778 CDMC25313 4 26 21 DAC35-D09 17-CG11778-RA_1 CG11778 TGCTCGGAATCGTCTCGAATATCATCGCCTTCCTAGCCATTGTGTTCTTCCTAGACGCTGTAACGGAGT 69 FBan0011778 FBgn0033371 CG11778 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; ; GO:0005415 membrane; GO:0016020 CG11778 CG11778 CDMC25314 4 1 22 DAC35-D21 23-CG11793-RA_4 CG11793 TTTCGTTTTGATAAATTGATTAATTCATTCGAAATGGTGGTTAAAGCTGTCTGCGTAATTAACGGCGAT 69 FBan0011793 FBgn0003462 Sod 3 3L aging; GO:0007568; defense response; GO:0006952; determination of adult life span; GO:0008340; removal of superoxide radicals; GO:0019430; superoxide metabolism; GO:0006801 "antioxidant activity; GO:0016209; copper, zinc superoxide dismutase activity; GO:0004785; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004785; ; GO:0046872" cytoplasm; GO:0005737 Sod Superoxide dismutase "CG11793, SOD, cSOD, l(3)G, CuZn SOD, SOD-1, Cu-Zn SOD, l(3)68Af', CuZnSOD, Cu,Zn Sod, Cu/ZnSOD, cSod, Sod1, sod, Cu-Zn superoxide dismutase., SOD1, Cu/Zn SOD, CnZnSOD, sod1, CuZn-SOD, To-1, tetrazolium oxidase-1, Cu,Zn-SOD, Cu/Zn superoxide dismutase, Cu[2+]/Zn[2+]SOD, superoxide-dismutase, Cu/Zn sod, Sod-1, G: Complementation group G, To: Tetrazolium oxidase, l(3)108, Complementation group G, Tetrazolium oxidase" CDMC25314 4 2 22 DAC35-D21 23-CG11793-RA_4 CG11793 TTTCGTTTTGATAAATTGATTAATTCATTCGAAATGGTGGTTAAAGCTGTCTGCGTAATTAACGGCGAT 69 FBan0011793 FBgn0003462 Sod 3 3L aging; GO:0007568; defense response; GO:0006952; determination of adult life span; GO:0008340; removal of superoxide radicals; GO:0019430; superoxide metabolism; GO:0006801 "antioxidant activity; GO:0016209; copper, zinc superoxide dismutase activity; GO:0004785; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004785; ; GO:0046872" cytoplasm; GO:0005737 Sod Superoxide dismutase "CG11793, SOD, cSOD, l(3)G, CuZn SOD, SOD-1, Cu-Zn SOD, l(3)68Af', CuZnSOD, Cu,Zn Sod, Cu/ZnSOD, cSod, Sod1, sod, Cu-Zn superoxide dismutase., SOD1, Cu/Zn SOD, CnZnSOD, sod1, CuZn-SOD, To-1, tetrazolium oxidase-1, Cu,Zn-SOD, Cu/Zn superoxide dismutase, Cu[2+]/Zn[2+]SOD, superoxide-dismutase, Cu/Zn sod, Sod-1, G: Complementation group G, To: Tetrazolium oxidase, l(3)108, Complementation group G, Tetrazolium oxidase" CDMC25315 4 3 22 DAC35-H09 10-CG11843-RA_1 CG11843 GGACCTTTGCTAATGTACCATCGGGAATATCCCTGTATGTACGTAGTTGTGGGAATCACGTCGGCCGGT 69 FBan0011843 FBgn0039630 CG11843 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11843 CG11843 SP43 CDMC25315 4 4 22 DAC35-H09 10-CG11843-RA_1 CG11843 GGACCTTTGCTAATGTACCATCGGGAATATCCCTGTATGTACGTAGTTGTGGGAATCACGTCGGCCGGT 69 FBan0011843 FBgn0039630 CG11843 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11843 CG11843 SP43 CDMC25316 4 5 22 DAC35-H21 14-CG11856-RA_1 CG11856 TCCAACGCCTTTGGAATACCCAAAATTGAAACCCAGTCACCTGCTAAAGACTTTGTGTTTGGCAGTGCA 69 FBan0011856 FBgn0039302 Nup358 3 3R intracellular protein transport; GO:0006886; protein targeting; GO:0006605 Ran GTPase binding; GO:0008536; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0008536 nuclear pore; GO:0005643 Nup358 Nup358 "CG11856, CG11856" CDMC25316 4 6 22 DAC35-H21 14-CG11856-RA_1 CG11856 TCCAACGCCTTTGGAATACCCAAAATTGAAACCCAGTCACCTGCTAAAGACTTTGTGTTTGGCAGTGCA 69 FBan0011856 FBgn0039302 Nup358 3 3R intracellular protein transport; GO:0006886; protein targeting; GO:0006605 Ran GTPase binding; GO:0008536; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0008536 nuclear pore; GO:0005643 Nup358 Nup358 "CG11856, CG11856" CDMC25317 4 7 22 DAC35-L09 18-CG11893-RA_2 CG11893 TGCATGGCTGAATGCCCAGTTTATTACTGACGTTCTTAGAACCTACGAAAAGTGTCCGGAACTGGAGGT 69 FBan0011893 FBgn0039316 CG11893 3 3R CG11893 CG11893 CDMC25317 4 8 22 DAC35-L09 18-CG11893-RA_2 CG11893 TGCATGGCTGAATGCCCAGTTTATTACTGACGTTCTTAGAACCTACGAAAAGTGTCCGGAACTGGAGGT 69 FBan0011893 FBgn0039316 CG11893 3 3R CG11893 CG11893 CDMC25318 4 9 22 DAC35-L21 23-CG11901-RA_2 CG11901 CGCCTCCTGCATTTTGTACTGGAGAATTTGTTTGTAACCGCCTAAGCATAACACAGCATGATATTGTCA 69 FBan0011901 FBgn0029176 Ef1gamma 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational elongation; GO:0006414 translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746 cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1gamma Ef1gamma "CG11901, CG11901, CG11901, CG11901, eEF1gamma, Ef1gamma, Ef1Bggr" CDMC25318 4 10 22 DAC35-L21 23-CG11901-RA_2 CG11901 CGCCTCCTGCATTTTGTACTGGAGAATTTGTTTGTAACCGCCTAAGCATAACACAGCATGATATTGTCA 69 FBan0011901 FBgn0029176 Ef1gamma 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational elongation; GO:0006414 translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746 cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1gamma Ef1gamma "CG11901, CG11901, CG11901, CG11901, eEF1gamma, Ef1gamma, Ef1Bggr" CDMC25319 4 11 22 DAC35-P09 3-CG11949-RA_1 CG11949 ACGCGATGGCATTGTGGAGACCCGAGTGGAACAGAAGATAACCATTCAGTCCGATGGAGATCCGATCGA 69 FBan0011949 FBgn0010434 cora 2 2R cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; embryonic development; GO:0009790; embryonic morphogenesis; GO:0048598; establishment and/or maintenance of cell polarity; GO:0007163; intercellular junction assembly and/or maintenance; GO:0045216; protein targeting to membrane; GO:0006612; regulation of tracheal tube size; GO:0035151; salivary gland morphogenesis; GO:0007435; septate junction assembly; GO:0019991 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 NOT fusome; GO:0045169; NOT spectrosome; GO:0045170; apicolateral plasma membrane; GO:0016327; cytoskeleton; GO:0005856; septate junction; GO:0005918 cora coracle "CG11949, CG11949, CG11949, l(2)k08713, D4.1, D4.1-Coracle, cor, Cor, Coracle, COR, coracle" CDMC25319 4 12 22 DAC35-P09 3-CG11949-RA_1 CG11949 ACGCGATGGCATTGTGGAGACCCGAGTGGAACAGAAGATAACCATTCAGTCCGATGGAGATCCGATCGA 69 FBan0011949 FBgn0010434 cora 2 2R cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; embryonic development; GO:0009790; embryonic morphogenesis; GO:0048598; establishment and/or maintenance of cell polarity; GO:0007163; intercellular junction assembly and/or maintenance; GO:0045216; protein targeting to membrane; GO:0006612; regulation of tracheal tube size; GO:0035151; salivary gland morphogenesis; GO:0007435; septate junction assembly; GO:0019991 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 NOT fusome; GO:0045169; NOT spectrosome; GO:0045170; apicolateral plasma membrane; GO:0016327; cytoskeleton; GO:0005856; septate junction; GO:0005918 cora coracle "CG11949, CG11949, CG11949, l(2)k08713, D4.1, D4.1-Coracle, cor, Cor, Coracle, COR, coracle" CDMC25320 4 13 22 DAC35-P21 2-CG11971-RA_1 CG11971 TCGCCGAAGTCACCACGGCTTCTGAGGGCTCAAATATTCCTGGGGAATCCACTGTTCCTGAAGATTCTA 69 FBan0011971 FBgn0022347 CG11971 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG11971 CG11971 "1E9, anon1E9, Anon1E9, anon-EST:fe1E9: anon-fast-evolving-1E9, anon-fast-evolving-1E9" CDMC25320 4 14 22 DAC35-P21 2-CG11971-RA_1 CG11971 TCGCCGAAGTCACCACGGCTTCTGAGGGCTCAAATATTCCTGGGGAATCCACTGTTCCTGAAGATTCTA 69 FBan0011971 FBgn0022347 CG11971 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG11971 CG11971 "1E9, anon1E9, Anon1E9, anon-EST:fe1E9: anon-fast-evolving-1E9, anon-fast-evolving-1E9" CDMC25321 4 15 22 DAC36-D09 5-CG8632-RB_2 CG8632 TGCGTGACTACCGCAGGGAAATGGGATCTCGAACCAAAGTAATGCTCGACAACAGAAAGGAGTCGGAGA 69 FBan0008632 FBgn0033762 CG8632 2 2R CG8632 CG8632 CDMC25321 4 16 22 DAC36-D09 5-CG8632-RB_2 CG8632 TGCGTGACTACCGCAGGGAAATGGGATCTCGAACCAAAGTAATGCTCGACAACAGAAAGGAGTCGGAGA 69 FBan0008632 FBgn0033762 CG8632 2 2R CG8632 CG8632 CDMC25322 4 17 22 DAC36-D21 14-CG8644-RA_1 CG8644 TGAGCAACGATATAGTGCATGTGAAACTGGATGGCGAGAATCTCAAGGAGATCATTGGAGCTCGCTGGT 69 FBan0008644 FBgn0038133 Osi22 3 3R Osi22 Osiris 22 "CG8644, CG8644, Osiris, Osiris 22" CDMC25322 4 18 22 DAC36-D21 14-CG8644-RA_1 CG8644 TGAGCAACGATATAGTGCATGTGAAACTGGATGGCGAGAATCTCAAGGAGATCATTGGAGCTCGCTGGT 69 FBan0008644 FBgn0038133 Osi22 3 3R Osi22 Osiris 22 "CG8644, CG8644, Osiris, Osiris 22" CDMC25323 4 19 22 DAC36-H09 23-CG8678-RA_5 CG8678 GGCAATTACCGCTAAGGATTGACTACGTAACCGTAACATCAAGGATATGGTTCGAGATAATAGACAGCA 69 FBan0008678 FBgn0032935 CG8678 2 2L CG8678 CG8678 l(2)k09410 CDMC25323 4 20 22 DAC36-H09 23-CG8678-RA_5 CG8678 GGCAATTACCGCTAAGGATTGACTACGTAACCGTAACATCAAGGATATGGTTCGAGATAATAGACAGCA 69 FBan0008678 FBgn0032935 CG8678 2 2L CG8678 CG8678 l(2)k09410 CDMC25324 4 21 22 DAC36-H21 7-CG8694-RA_1 CG8694 GCTGCCTCTAAGTCCCGAATATCAACGGTACAATGTGCAGACTGAACGCGGTGTTTCCAGATCTTCCCT 69 FBan0008694 FBgn0002569 LvpD 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpD Larval visceral protein D "CG8694, D, maltase, hdl cuticle gene cluster." CDMC25324 4 22 22 DAC36-H21 7-CG8694-RA_1 CG8694 GCTGCCTCTAAGTCCCGAATATCAACGGTACAATGTGCAGACTGAACGCGGTGTTTCCAGATCTTCCCT 69 FBan0008694 FBgn0002569 LvpD 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpD Larval visceral protein D "CG8694, D, maltase, hdl cuticle gene cluster." CDMC25325 4 23 22 DAC36-L09 2-CG8730-RA_3 CG8730 GCGCCCTGTACGTGGACAAGGGTCTCCTGTATTGTGAACAGTTTTGCCATGTATGTTTGTTCCCGCGAC 69 FBan0008730 FBgn0026722 drosha 2 2R RNA processing; GO:0006396; primary microRNA processing; GO:0031053; rRNA metabolism; GO:0016072 double-stranded RNA binding; GO:0003725; ; GO:0003725; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3 intracellular; GO:0005622; nucleus; GO:0005634 drosha drosha "CG8730, Drosha" CDMC25325 4 24 22 DAC36-L09 2-CG8730-RA_3 CG8730 GCGCCCTGTACGTGGACAAGGGTCTCCTGTATTGTGAACAGTTTTGCCATGTATGTTTGTTCCCGCGAC 69 FBan0008730 FBgn0026722 drosha 2 2R RNA processing; GO:0006396; primary microRNA processing; GO:0031053; rRNA metabolism; GO:0016072 double-stranded RNA binding; GO:0003725; ; GO:0003725; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3 intracellular; GO:0005622; nucleus; GO:0005634 drosha drosha "CG8730, Drosha" CDMC25326 4 25 22 DAC36-L21 2-CG8739-RB_2 CG8739 TGCTGTTCATCATGAACACCGTGCCAGACCTGTCCAAGAAGAGCAAGGGAGATCAAATGCTGCAGAACA 69 FBan0008739 FBgn0025937 cmp44E 2 2R cytokinesis; GO:0000910 plasma membrane; GO:0005886 cmp44E conserved membrane protein at 44E "CG8739, conserved membrane protein at 44E" CDMC25326 4 26 22 DAC36-L21 2-CG8739-RB_2 CG8739 TGCTGTTCATCATGAACACCGTGCCAGACCTGTCCAAGAAGAGCAAGGGAGATCAAATGCTGCAGAACA 69 FBan0008739 FBgn0025937 cmp44E 2 2R cytokinesis; GO:0000910 plasma membrane; GO:0005886 cmp44E conserved membrane protein at 44E "CG8739, conserved membrane protein at 44E" CDMC25327 4 1 23 DAC36-P09 8-CG8779-RA_1 CG8779 CACCCCCGTTCTTCATCAAGAACTTGCCACCGTACACGGGCATTTTGCATTCTTCACCAAATGCAACTT 69 FBan0008779 FBgn0005629 nrm 3 3L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; metabolism; GO:0008152; signal transduction; GO:0007165 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- plasma membrane; GO:0005886 nrm neuromusculin "CG8779, Neuromusculin, CT16082" CDMC25327 4 2 23 DAC36-P09 8-CG8779-RA_1 CG8779 CACCCCCGTTCTTCATCAAGAACTTGCCACCGTACACGGGCATTTTGCATTCTTCACCAAATGCAACTT 69 FBan0008779 FBgn0005629 nrm 3 3L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; metabolism; GO:0008152; signal transduction; GO:0007165 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- plasma membrane; GO:0005886 nrm neuromusculin "CG8779, Neuromusculin, CT16082" CDMC25328 4 3 23 DAC36-P21 1-CG8793-RA_2 CG8793 GCCCGCCATGAATGTAAGCTTTACTCCCGTTCCCAATCGACTGTTGGCTGGTGAAATTGTTCCCGTTCA 69 FBan0008793 FBgn0036894 CG8793 3 3L CG8793 CG8793 CDMC25328 4 4 23 DAC36-P21 1-CG8793-RA_2 CG8793 GCCCGCCATGAATGTAAGCTTTACTCCCGTTCCCAATCGACTGTTGGCTGGTGAAATTGTTCCCGTTCA 69 FBan0008793 FBgn0036894 CG8793 3 3L CG8793 CG8793 CDMC25329 4 5 23 DAC37-D09 17-CG9018-RB_1 CG9018 ACGCCTCGATGTACGTTCTTCATGGTCTAGGCAATGCATGGTCCTTGGGGTTGTTAGATAAAGATCGTT 69 FBan0009018 FBgn0035318 CG9018 3 3L CG9018 CG9018 CDMC25329 4 6 23 DAC37-D09 17-CG9018-RB_1 CG9018 ACGCCTCGATGTACGTTCTTCATGGTCTAGGCAATGCATGGTCCTTGGGGTTGTTAGATAAAGATCGTT 69 FBan0009018 FBgn0035318 CG9018 3 3L CG9018 CG9018 CDMC25330 4 7 23 DAC37-D21 24-CG9029-RA_2 CG9029 CTTCTGTATTCAATGTATGCATTTATGTATTCCAACTTCTAGCATGGGCATTAATAAAATTGCAAAAAA 69 FBan0009029 FBgn0031746 CG9029 2 2L defense response; GO:0006952 CG9029 CG9029 CDMC25330 4 8 23 DAC37-D21 24-CG9029-RA_2 CG9029 CTTCTGTATTCAATGTATGCATTTATGTATTCCAACTTCTAGCATGGGCATTAATAAAATTGCAAAAAA 69 FBan0009029 FBgn0031746 CG9029 2 2L defense response; GO:0006952 CG9029 CG9029 CDMC25331 4 9 23 DAC37-H09 2-CG9062-RB_2 CG9062 GTGGGGGCAATGCTAACAATTCACTGCAGAATAGCCAGAGCGATGCTAATTCGGAGGGATCCCAACTGC 69 FBan0009062 FBgn0033607 CG9062 2 2R CG9062 CG9062 CDMC25331 4 10 23 DAC37-H09 2-CG9062-RB_2 CG9062 GTGGGGGCAATGCTAACAATTCACTGCAGAATAGCCAGAGCGATGCTAATTCGGAGGGATCCCAACTGC 69 FBan0009062 FBgn0033607 CG9062 2 2R CG9062 CG9062 CDMC25332 4 11 23 DAC37-H21 2-CG9076-RA_2 CG9076 TGCCGGTGCCAATCCTCAAATCGGTGACCGAACAACTTAGCTCGGGTTCCTACCTATTTTCGTTCGAGT 69 FBan0009076 FBgn0033601 CG9076 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG9076 CG9076 CDMC25332 4 12 23 DAC37-H21 2-CG9076-RA_2 CG9076 TGCCGGTGCCAATCCTCAAATCGGTGACCGAACAACTTAGCTCGGGTTCCTACCTATTTTCGTTCGAGT 69 FBan0009076 FBgn0033601 CG9076 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG9076 CG9076 CDMC25333 4 13 23 DAC37-L09 20-CG9114-RA_1 CG9114 TCTCATTACCTTCGATGTGAAGAAACTGCTCGATAAAACAGAATCGTTGGCACCCACATTTTCGCCCGC 69 FBan0009114 FBgn0030628 CG9114 X X CG9114 CG9114 CDMC25333 4 14 23 DAC37-L09 20-CG9114-RA_1 CG9114 TCTCATTACCTTCGATGTGAAGAAACTGCTCGATAAAACAGAATCGTTGGCACCCACATTTTCGCCCGC 69 FBan0009114 FBgn0030628 CG9114 X X CG9114 CG9114 CDMC25334 4 15 23 DAC37-L21 2-CG9123-RA_2 CG9123 GCCTGGATTTCCCTCAAGGACGAGGATGATACACCACCCACCTTCATTCTTGCACACGAGGTAAGGGTC 69 FBan0009123 FBgn0030629 CG9123 X X CG9123 CG9123 CDMC25334 4 16 23 DAC37-L21 2-CG9123-RA_2 CG9123 GCCTGGATTTCCCTCAAGGACGAGGATGATACACCACCCACCTTCATTCTTGCACACGAGGTAAGGGTC 69 FBan0009123 FBgn0030629 CG9123 X X CG9123 CG9123 CDMC25335 4 17 23 DAC37-P09 18-CG9156-RA_1 CG9156 TCAACCGGATCGAGGGAAATGGCTCAACTACAACGTATACCTCCATGGATCCTAACTGTCTTCAGAGGT 69 FBan0009156 FBgn0003132 Pp1-13C X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0004722; ; GO:0000163 protein phosphatase type 1 complex; GO:0000164 Pp1-13C Protein phosphatase 1 at 13C "CG9156, CG9156, PP1 13C, Pp1, PP1alpha13C, PP1, PP13C, Protein phosphatase 1 13C, PP1c, pp1-13C" CDMC25335 4 18 23 DAC37-P09 18-CG9156-RA_1 CG9156 TCAACCGGATCGAGGGAAATGGCTCAACTACAACGTATACCTCCATGGATCCTAACTGTCTTCAGAGGT 69 FBan0009156 FBgn0003132 Pp1-13C X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0004722; ; GO:0000163 protein phosphatase type 1 complex; GO:0000164 Pp1-13C Protein phosphatase 1 at 13C "CG9156, CG9156, PP1 13C, Pp1, PP1alpha13C, PP1, PP13C, Protein phosphatase 1 13C, PP1c, pp1-13C" CDMC25336 4 19 23 DAC37-P21 3-CG9169-RA_2 CG9169 ACCAGCCGGAGTCACAATGACAAAGCTTTCGATGCAGTGGTCATCAGTGCCGATCATCCCTACTCCTTT 69 FBan0009169 FBgn0035217 FucTD 3 3L protein amino acid glycosylation; GO:0006486 "alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-" membrane; GO:0016020 FucTD FucTD "CG9169, CG9169, CG9169" CDMC25336 4 20 23 DAC37-P21 3-CG9169-RA_2 CG9169 ACCAGCCGGAGTCACAATGACAAAGCTTTCGATGCAGTGGTCATCAGTGCCGATCATCCCTACTCCTTT 69 FBan0009169 FBgn0035217 FucTD 3 3L protein amino acid glycosylation; GO:0006486 "alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-" membrane; GO:0016020 FucTD FucTD "CG9169, CG9169, CG9169" CDMC25337 4 21 23 DAC38-D09 2-CG5966-RA_1 CG5966 CCGACTGCACTATAGGATAACAGTGCGAGTTTCCGGACACGATGAGAGTACGCTACATGGCGGCGA 66 FBan0005966 FBgn0029831 CG5966 X X lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG5966 CG5966 CDMC25337 4 22 23 DAC38-D09 2-CG5966-RA_1 CG5966 CCGACTGCACTATAGGATAACAGTGCGAGTTTCCGGACACGATGAGAGTACGCTACATGGCGGCGA 66 FBan0005966 FBgn0029831 CG5966 X X lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG5966 CG5966 CDMC25338 4 23 23 DAC38-D21 3-CG6136-RA_2 CG6136 GACGTGGACCCCTACTACGGAACCAACTCCATCGTGGTGCGAAAGATGGTTACCATTGCGAAAGCG 66 FBan0006136 FBgn0038332 CG6136 3 3R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 CG6136 CG6136 CDMC25338 4 24 23 DAC38-D21 3-CG6136-RA_2 CG6136 GACGTGGACCCCTACTACGGAACCAACTCCATCGTGGTGCGAAAGATGGTTACCATTGCGAAAGCG 66 FBan0006136 FBgn0038332 CG6136 3 3R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 CG6136 CG6136 CDMC25339 4 25 23 DAC38-H09 2-CG6497-RA_3 CG6497 ATAGCCCGTCTCGATCGCATACAGTCGAAGATCTCAGCGAAGCGTAAGAGCCTCACCTTCCAGCAC 66 FBan0006497 FBgn0036704 CG6497 3 3L CG6497 CG6497 CDMC25339 4 26 23 DAC38-H09 2-CG6497-RA_3 CG6497 ATAGCCCGTCTCGATCGCATACAGTCGAAGATCTCAGCGAAGCGTAAGAGCCTCACCTTCCAGCAC 66 FBan0006497 FBgn0036704 CG6497 3 3L CG6497 CG6497 CDMC25340 4 1 24 DAC38-H21 47-CG6661-RA_2 CG6661 CCAAGTATTCACAGGAACCAGAGAGTATTAGTTAATCATGCCATTCAGGAGATTCAGCACAGGCCG 66 FBan0006661 FBgn0036403 CG6661 3 3L amino acid catabolism; GO:0009063; proline metabolism; GO:0006560 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG6661 CG6661 PUT2 CDMC25340 4 2 24 DAC38-H21 47-CG6661-RA_2 CG6661 CCAAGTATTCACAGGAACCAGAGAGTATTAGTTAATCATGCCATTCAGGAGATTCAGCACAGGCCG 66 FBan0006661 FBgn0036403 CG6661 3 3L amino acid catabolism; GO:0009063; proline metabolism; GO:0006560 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG6661 CG6661 PUT2 CDMC25341 4 3 24 DAC38-L09 1-CG7118-RA_1 CG7118 CGACTACCTGCAGTGTGTCGATCTCCAGATCATCCACAACTCCGAGTGCGCCAGCTACTACGGAAC 66 FBan0007118 FBgn0035886 Jon66Ci 3 3L proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- Jon66Ci Jonah 66Ci "CG7118, 66C, Jon66C, SP171, Jonah 66C" CDMC25341 4 4 24 DAC38-L09 1-CG7118-RA_1 CG7118 CGACTACCTGCAGTGTGTCGATCTCCAGATCATCCACAACTCCGAGTGCGCCAGCTACTACGGAAC 66 FBan0007118 FBgn0035886 Jon66Ci 3 3L proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- Jon66Ci Jonah 66Ci "CG7118, 66C, Jon66C, SP171, Jonah 66C" CDMC25342 4 5 24 DAC38-L21 3-CG7227-RA_9 CG7227 GAGCTTGGTCCGTATCGCTTCACCGAACGGATGCAGAAGGTCAATGTGGAGTGGCACGATGAGAAC 66 FBan0007227 FBgn0031970 CG7227 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7227 CG7227 CDMC25342 4 6 24 DAC38-L21 3-CG7227-RA_9 CG7227 GAGCTTGGTCCGTATCGCTTCACCGAACGGATGCAGAAGGTCAATGTGGAGTGGCACGATGAGAAC 66 FBan0007227 FBgn0031970 CG7227 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7227 CG7227 CDMC25343 4 7 24 DAC38-P09 1-CG7760-RA_1 CG7760 GGCGGAGTAACAGCTTCACAGGATCGGACGGTAGGAAGAGCAGTCCAGAGCAGACCAATCTCAGTC 66 FBan0007760 FBgn0024249 cato 2 2R "regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 cato cousin of atonal "CG7760, DATH-B, Drosophila atonal homologue, Cato, cousin of atonal" CDMC25343 4 8 24 DAC38-P09 1-CG7760-RA_1 CG7760 GGCGGAGTAACAGCTTCACAGGATCGGACGGTAGGAAGAGCAGTCCAGAGCAGACCAATCTCAGTC 66 FBan0007760 FBgn0024249 cato 2 2R "regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 cato cousin of atonal "CG7760, DATH-B, Drosophila atonal homologue, Cato, cousin of atonal" CDMC25344 4 9 24 DAC38-P21 AutoBlank AutoBlank CDMC25344 4 10 24 DAC38-P21 AutoBlank AutoBlank CDMC25345 4 11 24 DAC39-D09 23-CG32058-RA_19 CG32058 GCCCATTTTCAAGATTCTAAAAGAGGTGTACGACCAAAGACCTGTATTTGTGGCACTTCGACATGGATT 69 FBan0032058 FBgn0052058 CG32058 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32058 CG32058 CDMC25345 4 12 24 DAC39-D09 23-CG32058-RA_19 CG32058 GCCCATTTTCAAGATTCTAAAAGAGGTGTACGACCAAAGACCTGTATTTGTGGCACTTCGACATGGATT 69 FBan0032058 FBgn0052058 CG32058 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32058 CG32058 CDMC25346 4 13 24 DAC39-D21 23-CG3206-RA_3 CG3206 GATTGTGCGAGAACCTGACCATAACTATTACCGATATTGTGGCCAATTTGAAGTTTGCGAATGTGTACA 69 FBan0003206 FBgn0023523 Or2a X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or2a Odorant receptor 2a "CG3206, CG3206, CG3206, DOR2F.1, Olfactory receptor 2F.1, dor62, AN4, Dor62, 2F.1, DOR62, EG:30B8.7, 2a, Or2F.1: Olfactory receptor 2F.1, Or62: Odorant receptor 62, Odorant receptor 62" CDMC25346 4 14 24 DAC39-D21 23-CG3206-RA_3 CG3206 GATTGTGCGAGAACCTGACCATAACTATTACCGATATTGTGGCCAATTTGAAGTTTGCGAATGTGTACA 69 FBan0003206 FBgn0023523 Or2a X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or2a Odorant receptor 2a "CG3206, CG3206, CG3206, DOR2F.1, Olfactory receptor 2F.1, dor62, AN4, Dor62, 2F.1, DOR62, EG:30B8.7, 2a, Or2F.1: Olfactory receptor 2F.1, Or62: Odorant receptor 62, Odorant receptor 62" CDMC25347 4 15 24 DAC39-H09 6-CG32105-RB_3 CG32105 ACATGCTGGCCAACCTGAACAACAGCCTGATAAACCCCATCGACAAGCTGTATCTCATGCAGAACTCGT 69 FBan0032105 FBgn0052105 CG32105 3 3L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 CG32105 CG32105 "CG10432, CG17615, CG10432, CG17615" CDMC25347 4 16 24 DAC39-H09 6-CG32105-RB_3 CG32105 ACATGCTGGCCAACCTGAACAACAGCCTGATAAACCCCATCGACAAGCTGTATCTCATGCAGAACTCGT 69 FBan0032105 FBgn0052105 CG32105 3 3L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 CG32105 CG32105 "CG10432, CG17615, CG10432, CG17615" CDMC25348 4 17 24 DAC39-H21 23-CG32111-RA_5 CG32111 GGCTGCGAATATATTTATTGTTTTCCGCTTACTACCTGAATACGAATTAGCATTGGGACCCACCCCTCC 69 FBan0032111 FBgn0052111 CG32111 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32111 CG32111 CDMC25348 4 18 24 DAC39-H21 23-CG32111-RA_5 CG32111 GGCTGCGAATATATTTATTGTTTTCCGCTTACTACCTGAATACGAATTAGCATTGGGACCCACCCCTCC 69 FBan0032111 FBgn0052111 CG32111 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32111 CG32111 CDMC25349 4 19 24 DAC39-L09 23-CG32148-RA_9 CG32148 TAAAATTTCTGCCCAAAAACGAGTTGCTTCATCAATCACTATACTTTTGCAGAGGAATGGCCAAAAAGA 69 FBan0032148 FBgn0047338 CG32148 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32148 CG32148 "BcDNA:AT21341, NEST:bs21b09" CDMC25349 4 20 24 DAC39-L09 23-CG32148-RA_9 CG32148 TAAAATTTCTGCCCAAAAACGAGTTGCTTCATCAATCACTATACTTTTGCAGAGGAATGGCCAAAAAGA 69 FBan0032148 FBgn0047338 CG32148 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32148 CG32148 "BcDNA:AT21341, NEST:bs21b09" CDMC25350 4 21 24 DAC39-L21 11-CG32159-RB_1 CG32159 ATCGCGTGCTCGAATTCCAGCAGAGCATCATTTGGGACTAAGTTCCGGAAATACCAAGCAACCAATCCT 69 FBan0032159 FBgn0052159 CG32159 3 3L CG32159 CG32159 "CG13034, CG4541" CDMC25350 4 22 24 DAC39-L21 11-CG32159-RB_1 CG32159 ATCGCGTGCTCGAATTCCAGCAGAGCATCATTTGGGACTAAGTTCCGGAAATACCAAGCAACCAATCCT 69 FBan0032159 FBgn0052159 CG32159 3 3L CG32159 CG32159 "CG13034, CG4541" CDMC25351 4 23 24 DAC39-P09 14-CG32187-RA_1 CG32187 CGACAGGACGCAAAAAATCATAAAACGAGGCAAAACTTCGGAGATTGCAAACGTCATGGAGGAACGCGC 69 FBan0032187 FBgn0052187 CG32187 3 3L CG32187 CG32187 "CG5584, CG5584" CDMC25351 4 24 24 DAC39-P09 14-CG32187-RA_1 CG32187 CGACAGGACGCAAAAAATCATAAAACGAGGCAAAACTTCGGAGATTGCAAACGTCATGGAGGAACGCGC 69 FBan0032187 FBgn0052187 CG32187 3 3L CG32187 CG32187 "CG5584, CG5584" CDMC25352 4 25 24 DAC39-P21 12-CG32195-RA_4 CG32195 TCGAGAGAGCTTTGGCGAGAGCTTATGGTTGTGAAATGCTTCGCGTTGAGAACTTTCACATCAAGGCGG 69 FBan0032195 FBgn0052195 CG32195 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32195 CG32195 CDMC25352 4 26 24 DAC39-P21 12-CG32195-RA_4 CG32195 TCGAGAGAGCTTTGGCGAGAGCTTATGGTTGTGAAATGCTTCGCGTTGAGAACTTTCACATCAAGGCGG 69 FBan0032195 FBgn0052195 CG32195 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32195 CG32195 CDMC25353 4 1 25 DAC40-D09 3-CG9590-RA_5 CG9590 TGCCCGTGCAGAGTTGCAGGAAACGATAAACGAGGTGAAGGAACTGATCGAACTGGAGGATCTGGATGT 69 FBan0009590 FBgn0038360 CG9590 3 3R CG9590 CG9590 CDMC25353 4 2 25 DAC40-D09 3-CG9590-RA_5 CG9590 TGCCCGTGCAGAGTTGCAGGAAACGATAAACGAGGTGAAGGAACTGATCGAACTGGAGGATCTGGATGT 69 FBan0009590 FBgn0038360 CG9590 3 3R CG9590 CG9590 CDMC25354 4 3 25 DAC40-D21 3-CG9603-RA_4 CG9603 ATGGGCAAGCTTTTCTACGAGCTGAGTGTTCCCAAGAAGGAGTGAAGTCGCAGTACCGAACCCTAAGCT 69 FBan0009603 FBgn0040529 CG9603 3 3R "electron transport; GO:0006118; mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; electron transporter activity; GO:0005489; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0005489 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG9603 CG9603 VIIa CDMC25354 4 4 25 DAC40-D21 3-CG9603-RA_4 CG9603 ATGGGCAAGCTTTTCTACGAGCTGAGTGTTCCCAAGAAGGAGTGAAGTCGCAGTACCGAACCCTAAGCT 69 FBan0009603 FBgn0040529 CG9603 3 3R "electron transport; GO:0006118; mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; electron transporter activity; GO:0005489; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0005489 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG9603 CG9603 VIIa CDMC25355 4 5 25 DAC40-H09 3-CG9630-RA_4 CG9630 CGTGCGGGGTTGAGAAATCCTGTTCTCGTATCAGTCAAAGAGAAGGCATCCGTAAACACTCCAGCCCGC 69 FBan0009630 FBgn0037561 CG9630 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG9630 CG9630 "cg9630, DmRH16" CDMC25355 4 6 25 DAC40-H09 3-CG9630-RA_4 CG9630 CGTGCGGGGTTGAGAAATCCTGTTCTCGTATCAGTCAAAGAGAAGGCATCCGTAAACACTCCAGCCCGC 69 FBan0009630 FBgn0037561 CG9630 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG9630 CG9630 "cg9630, DmRH16" CDMC25356 4 7 25 DAC40-H21 7-CG9642-RA_1 CG9642 TGGCAGTGCCTTCTTAATCCGGAGCACACACTGAAACAGGAGTTTGTCTCGAATATGCTGGAACGTGCT 69 FBan0009642 FBgn0034183 CG9642 2 2R CG9642 CG9642 CDMC25356 4 8 25 DAC40-H21 7-CG9642-RA_1 CG9642 TGGCAGTGCCTTCTTAATCCGGAGCACACACTGAAACAGGAGTTTGTCTCGAATATGCTGGAACGTGCT 69 FBan0009642 FBgn0034183 CG9642 2 2R CG9642 CG9642 CDMC25357 4 9 25 DAC40-L09 18-CG9676-RA_1 CG9676 GCTTTTCAGTTAGCTAAGCCCAACCAGTCATGTTACCATTCTGGACATCTCTACTCGTCCTTTGCGCAG 69 FBan0009676 FBgn0030773 CG9676 X X proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9676 CG9676 SP99 CDMC25357 4 10 25 DAC40-L09 18-CG9676-RA_1 CG9676 GCTTTTCAGTTAGCTAAGCCCAACCAGTCATGTTACCATTCTGGACATCTCTACTCGTCCTTTGCGCAG 69 FBan0009676 FBgn0030773 CG9676 X X proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9676 CG9676 SP99 CDMC25358 4 11 25 DAC40-L21 14-CG9695-RA_1 CG9695 ACTTGCAATATCGTAACACTCCAACGAGGACTGTAGAGTTCCCTCTTACTCCCAGTTCTGCCCAAGCCA 69 FBan0009695 FBgn0000414 Dab 3 3L ectoderm development; GO:0007398; eye photoreceptor development (sensu Endopterygota); GO:0042051; nervous system development; GO:0007399; proteolysis; GO:0006508; sevenless signaling pathway; GO:0045500 receptor binding; GO:0005102; catalytic activity; GO:0003824; ; GO:0005102; protein binding; GO:0005515; SH3 domain binding; GO:0017124; SH2 domain binding; GO:0042169; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003824; ; GO:0004197 ; EC:3.4.22.-; ; GO:0042169; ; GO:0017124; ; GO:0005515 cytoplasm; GO:0005737 Dab Disabled "CG9695, dab, cDNA C, disabled" CDMC25358 4 12 25 DAC40-L21 14-CG9695-RA_1 CG9695 ACTTGCAATATCGTAACACTCCAACGAGGACTGTAGAGTTCCCTCTTACTCCCAGTTCTGCCCAAGCCA 69 FBan0009695 FBgn0000414 Dab 3 3L ectoderm development; GO:0007398; eye photoreceptor development (sensu Endopterygota); GO:0042051; nervous system development; GO:0007399; proteolysis; GO:0006508; sevenless signaling pathway; GO:0045500 receptor binding; GO:0005102; catalytic activity; GO:0003824; ; GO:0005102; protein binding; GO:0005515; SH3 domain binding; GO:0017124; SH2 domain binding; GO:0042169; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003824; ; GO:0004197 ; EC:3.4.22.-; ; GO:0042169; ; GO:0017124; ; GO:0005515 cytoplasm; GO:0005737 Dab Disabled "CG9695, dab, cDNA C, disabled" CDMC25359 4 13 25 DAC40-P09 2-CG9722-RA_1 CG9722 GCGAGGATTCATCCGGAAGGTGTACCTCATCCTGTTGGCCCAACTGATCACTTCCCTGGTGGTTATAGT 69 FBan0009722 FBgn0038209 CG9722 3 3R receptor binding; GO:0005102; ; GO:0005102 CG9722 CG9722 CDMC25359 4 14 25 DAC40-P09 2-CG9722-RA_1 CG9722 GCGAGGATTCATCCGGAAGGTGTACCTCATCCTGTTGGCCCAACTGATCACTTCCCTGGTGGTTATAGT 69 FBan0009722 FBgn0038209 CG9722 3 3R receptor binding; GO:0005102; ; GO:0005102 CG9722 CG9722 CDMC25360 4 15 25 DAC40-P21 22-CG9738-RA_1 CG9738 GCCATTCCTGCCCAAAAATATTCACAGCCAAACAATTGCACCGTCTATGTCCCCGTCTCAAAAAAGAAA 69 FBan0009738 FBgn0024326 Mkk4 3 3R activation of JNK activity; GO:0007257; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.- Mkk4 MAP kinase kinase 4 "CG9738, CG9738, D-MKK4, Drosophila MAP kinase kinase 4, DMKK4, MKK4, MAP kinase kinase 4, JNKK2, JNK kinase 2, CT27508, SEK1/MKK4, mkk4, dMKK4, Mpk4" CDMC25360 4 16 25 DAC40-P21 22-CG9738-RA_1 CG9738 GCCATTCCTGCCCAAAAATATTCACAGCCAAACAATTGCACCGTCTATGTCCCCGTCTCAAAAAAGAAA 69 FBan0009738 FBgn0024326 Mkk4 3 3R activation of JNK activity; GO:0007257; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.- Mkk4 MAP kinase kinase 4 "CG9738, CG9738, D-MKK4, Drosophila MAP kinase kinase 4, DMKK4, MKK4, MAP kinase kinase 4, JNKK2, JNK kinase 2, CT27508, SEK1/MKK4, mkk4, dMKK4, Mpk4" CDMC25361 4 17 25 DAC41-D09 AutoBlank AutoBlank CDMC25361 4 18 25 DAC41-D09 AutoBlank AutoBlank CDMC25362 4 19 25 DAC41-D21 AutoBlank AutoBlank CDMC25362 4 20 25 DAC41-D21 AutoBlank AutoBlank CDMC25363 4 21 25 DAC41-H09 AutoBlank AutoBlank CDMC25363 4 22 25 DAC41-H09 AutoBlank AutoBlank CDMC25364 4 23 25 DAC41-H21 AutoBlank AutoBlank CDMC25364 4 24 25 DAC41-H21 AutoBlank AutoBlank CDMC25365 4 25 25 DAC41-L09 AutoBlank AutoBlank CDMC25365 4 26 25 DAC41-L09 AutoBlank AutoBlank CDMC25366 4 1 26 DAC41-L21 AutoBlank AutoBlank CDMC25366 4 2 26 DAC41-L21 AutoBlank AutoBlank CDMC25367 4 3 26 DAC41-P09 AutoBlank AutoBlank CDMC25367 4 4 26 DAC41-P09 AutoBlank AutoBlank CDMC25368 4 5 26 DAC41-P21 AutoBlank AutoBlank CDMC25368 4 6 26 DAC41-P21 AutoBlank AutoBlank CDMC25369 4 7 26 DAC42-D09 150mM NaPO4 Blank CDMC25369 4 8 26 DAC42-D09 150mM NaPO4 Blank CDMC25370 4 9 26 DAC42-D21 150mM NaPO4 Blank CDMC25370 4 10 26 DAC42-D21 150mM NaPO4 Blank CDMC25371 4 11 26 DAC42-H09 150mM NaPO4 Blank CDMC25371 4 12 26 DAC42-H09 150mM NaPO4 Blank CDMC25372 4 13 26 DAC42-H21 150mM NaPO4 Blank CDMC25372 4 14 26 DAC42-H21 150mM NaPO4 Blank CDMC25373 4 15 26 DAC42-L09 150mM NaPO4 Blank CDMC25373 4 16 26 DAC42-L09 150mM NaPO4 Blank CDMC25374 4 17 26 DAC42-L21 5uM MSP 5uM MSP CDMC25374 4 18 26 DAC42-L21 5uM MSP 5uM MSP CDMC25375 4 19 26 DAC42-P09 10uM MSP 10uM MSP CDMC25375 4 20 26 DAC42-P09 10uM MSP 10uM MSP CDMC25376 4 21 26 DAC42-P21 20uM MSP 20uM MSP CDMC25376 4 22 26 DAC42-P21 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC25377 1 1 1 DAC01-A08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25377 1 2 1 DAC01-A08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25378 1 3 1 DAC01-A20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25378 1 4 1 DAC01-A20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25379 1 5 1 DAC01-E08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25379 1 6 1 DAC01-E08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25380 1 7 1 DAC01-E20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25380 1 8 1 DAC01-E20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25381 1 9 1 DAC01-I08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25381 1 10 1 DAC01-I08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25382 1 11 1 DAC01-I20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25382 1 12 1 DAC01-I20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25383 1 13 1 DAC01-M08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25383 1 14 1 DAC01-M08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25384 1 15 1 DAC01-M20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25384 1 16 1 DAC01-M20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25385 1 17 1 DAC02-A08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25385 1 18 1 DAC02-A08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25386 1 19 1 DAC02-A20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25386 1 20 1 DAC02-A20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25387 1 21 1 DAC02-E08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25387 1 22 1 DAC02-E08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25388 1 23 1 DAC02-E20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25388 1 24 1 DAC02-E20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25389 1 25 1 DAC02-I08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25389 1 26 1 DAC02-I08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25390 1 1 2 DAC02-I20 N/A CG9075 (01674-01910) CDMC25390 1 2 2 DAC02-I20 N/A CG9075 (01674-01910) CDMC25391 1 3 2 DAC02-M08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25391 1 4 2 DAC02-M08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25392 1 5 2 DAC02-M20 AutoBlank AutoBlank CDMC25392 1 6 2 DAC02-M20 AutoBlank AutoBlank CDMC25393 1 7 2 DAC03-A08 23-CG32204-RA_4 CG32204 GCCGTTTTTGGTCCACAAGGTACATTACAGTCAACAGAACTTGAAACATACTGTCTCAATGTCAGCAGA 69 FBan0032204 FBgn0052204 CG32204 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32204 CG32204 CDMC25393 1 8 2 DAC03-A08 23-CG32204-RA_4 CG32204 GCCGTTTTTGGTCCACAAGGTACATTACAGTCAACAGAACTTGAAACATACTGTCTCAATGTCAGCAGA 69 FBan0032204 FBgn0052204 CG32204 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32204 CG32204 CDMC25394 1 9 2 DAC03-A20 16-CG32217-RA_1 CG32217 CCTGCTGGGACTACTTCGATGAGACCATCCGCAGATTCCCATGTAAAAAGGCAAAACAAGCAAGAAACT 69 FBgn0028435 CDMC25394 1 10 2 DAC03-A20 16-CG32217-RA_1 CG32217 CCTGCTGGGACTACTTCGATGAGACCATCCGCAGATTCCCATGTAAAAAGGCAAAACAAGCAAGAAACT 69 FBgn0028435 CDMC25395 1 11 2 DAC03-E08 2-CG32246-RA_1 CG32246 CCGTCATCTACTGGCCAACCATGGGTTTCCTGGACACTACCGAATTAGGCGGAGTGACCATTGGATGTT 69 FBan0032246 FBgn0052246 CG32246 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 cellular component unknown; GO:0008372 CG32246 CG32246 CDMC25395 1 12 2 DAC03-E08 2-CG32246-RA_1 CG32246 CCGTCATCTACTGGCCAACCATGGGTTTCCTGGACACTACCGAATTAGGCGGAGTGACCATTGGATGTT 69 FBan0032246 FBgn0052246 CG32246 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 cellular component unknown; GO:0008372 CG32246 CG32246 CDMC25396 1 13 2 DAC03-E20 22-CG32252-RA_1 CG32252 GCGTTCAGAAGGAAGAGCCACTAAATAGCCTAGATTGGATCTGAATGAACTTCCTAAAGTGACCCGGCC 69 FBan0032252 FBgn0052252 CG32252 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32252 CG32252 BcDNA:AT23419 CDMC25396 1 14 2 DAC03-E20 22-CG32252-RA_1 CG32252 GCGTTCAGAAGGAAGAGCCACTAAATAGCCTAGATTGGATCTGAATGAACTTCCTAAAGTGACCCGGCC 69 FBan0032252 FBgn0052252 CG32252 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32252 CG32252 BcDNA:AT23419 CDMC25397 1 15 2 DAC03-I08 16-CG32280-RA_1 CG32280 AGCCTGATTACGAGCACAAAAGTCGCTTGTGTGTCCATTTTGAAGAACAGGCCCTTTGATATTGCACAA 69 FBan0032280 FBgn0052280 CG32280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG32280 CG32280 BcDNA:GM08588 CDMC25397 1 16 2 DAC03-I08 16-CG32280-RA_1 CG32280 AGCCTGATTACGAGCACAAAAGTCGCTTGTGTGTCCATTTTGAAGAACAGGCCCTTTGATATTGCACAA 69 FBan0032280 FBgn0052280 CG32280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG32280 CG32280 BcDNA:GM08588 CDMC25398 1 17 2 DAC03-I20 8-CG32304-RA_1 CG32304 TCCAACGGGCTTTACCTTTGATGACGAGCTGCAGATTTGCCTGAACACAGGATCTGATGACGACGAGTT 69 FBan0032304 FBgn0052304 CG32304 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32304 CG32304 "CG13805, CG13805, CG13805" CDMC25398 1 18 2 DAC03-I20 8-CG32304-RA_1 CG32304 TCCAACGGGCTTTACCTTTGATGACGAGCTGCAGATTTGCCTGAACACAGGATCTGATGACGACGAGTT 69 FBan0032304 FBgn0052304 CG32304 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32304 CG32304 "CG13805, CG13805, CG13805" CDMC25399 1 19 2 DAC03-M08 9-CG3234-RB_2 CG3234 CCATGAGCACGGTTAATCCCACAACCACTTTGAGCCTGAACATGCTAAACACCTTCATGGGAAGCCACA 69 FBan0003234 FBgn0014396 tim 2 2L "circadian behavior; GO:0048512; circadian rhythm; GO:0007623; copulation; GO:0007620; eclosion rhythm; GO:0008062; entrainment of circadian clock; GO:0009649; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; protein import into nucleus; GO:0006606; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431" protein binding; GO:0005515; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0005515; ; GO:0046982 cytoplasm; GO:0005737; nucleus; GO:0005634 tim timeless "CG3234, rit, Ritsu, TIM, dTIM, dtimeless, tim1, dtim, dTim, ritsu, timeless" CDMC25399 1 20 2 DAC03-M08 9-CG3234-RB_2 CG3234 CCATGAGCACGGTTAATCCCACAACCACTTTGAGCCTGAACATGCTAAACACCTTCATGGGAAGCCACA 69 FBan0003234 FBgn0014396 tim 2 2L "circadian behavior; GO:0048512; circadian rhythm; GO:0007623; copulation; GO:0007620; eclosion rhythm; GO:0008062; entrainment of circadian clock; GO:0009649; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; protein import into nucleus; GO:0006606; regulation of circadian sleep/wake cycle, sleep; GO:0045187; regulation of protein import into nucleus; GO:0042306; rhythmic behavior; GO:0007622; sleep; GO:0030431" protein binding; GO:0005515; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0005515; ; GO:0046982 cytoplasm; GO:0005737; nucleus; GO:0005634 tim timeless "CG3234, rit, Ritsu, TIM, dTIM, dtimeless, tim1, dtim, dTim, ritsu, timeless" CDMC25400 1 21 2 DAC03-M20 3-CG32355-RA_1 CG32355 TGGGCAGTCCCATCCTGGTTTTGTTATCCTTTGGAGCGGTATTGCATTTTGGAGCATCGAATCTGGCCA 69 FBan0032355 FBgn0052355 CG32355 3 3L CG32355 CG32355 "CG6239, CG6239" CDMC25400 1 22 2 DAC03-M20 3-CG32355-RA_1 CG32355 TGGGCAGTCCCATCCTGGTTTTGTTATCCTTTGGAGCGGTATTGCATTTTGGAGCATCGAATCTGGCCA 69 FBan0032355 FBgn0052355 CG32355 3 3L CG32355 CG32355 "CG6239, CG6239" CDMC25401 1 23 2 DAC04-A08 12-CG2921-RA_3 CG2921 GGCGCTAACGGATAGCATTGATGATATACTGGCCCTGACCAAGTACACACGACGATCAGAGAACAGCGT 69 FBan0002921 FBgn0034689 CG2921 2 2R CG2921 CG2921 CDMC25401 1 24 2 DAC04-A08 12-CG2921-RA_3 CG2921 GGCGCTAACGGATAGCATTGATGATATACTGGCCCTGACCAAGTACACACGACGATCAGAGAACAGCGT 69 FBan0002921 FBgn0034689 CG2921 2 2R CG2921 CG2921 CDMC25402 1 25 2 DAC04-A20 2-CG2937-RA_1 CG2937 GCCGCCAAAATGGCCATACCAACGATTGGCATAGTGGACAGCAATTGCAATCCCAACCTGATCACCTAT 69 FBan0002937 FBgn0031639 mRpS2 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS2 mitochondrial ribosomal protein S2 "CG2937, CG2937, MRP-S2, mitochondrial ribosomal protein S2" CDMC25402 1 26 2 DAC04-A20 2-CG2937-RA_1 CG2937 GCCGCCAAAATGGCCATACCAACGATTGGCATAGTGGACAGCAATTGCAATCCCAACCTGATCACCTAT 69 FBan0002937 FBgn0031639 mRpS2 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS2 mitochondrial ribosomal protein S2 "CG2937, CG2937, MRP-S2, mitochondrial ribosomal protein S2" CDMC25403 1 1 3 DAC04-E08 14-CG2981-RA_1 CG2981 GGGTCATCAACTTGATGATGCAACTCTTGCTGACATTATCGCTGAAGTCGATGAGGATGGTTCGGGCCA 69 FBan0002981 FBgn0013348 TpnC41C 2 2R calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 TpnC41C Troponin C at 41C "CG2981, CG2981, CG2981, TnC41C, TPNC, TnC, DmTnC1, TpnC IIIa, DmTpnC41C, DmTpnCIIIa" CDMC25403 1 2 3 DAC04-E08 14-CG2981-RA_1 CG2981 GGGTCATCAACTTGATGATGCAACTCTTGCTGACATTATCGCTGAAGTCGATGAGGATGGTTCGGGCCA 69 FBan0002981 FBgn0013348 TpnC41C 2 2R calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 TpnC41C Troponin C at 41C "CG2981, CG2981, CG2981, TnC41C, TPNC, TnC, DmTnC1, TpnC IIIa, DmTpnC41C, DmTpnCIIIa" CDMC25404 1 3 3 DAC04-E20 2-CG2989-RA_2 CG2989 ACCCACTTACGTAAGACCCATTGTACCCCTCCTAAGACCCGAGTCCAATGAGTCCTCACCACTGGTCAT 69 FBan0002989 FBgn0030171 CG2989 X X cell-cell signaling; GO:0007267; chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG2989 CG2989 CT5624 CDMC25404 1 4 3 DAC04-E20 2-CG2989-RA_2 CG2989 ACCCACTTACGTAAGACCCATTGTACCCCTCCTAAGACCCGAGTCCAATGAGTCCTCACCACTGGTCAT 69 FBan0002989 FBgn0030171 CG2989 X X cell-cell signaling; GO:0007267; chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG2989 CG2989 CT5624 CDMC25405 1 5 3 DAC04-I08 7-CG30017-RA_1 CG30017 ACTCGCGTAAGATGCACGACCTTGACAATCTCTGGCCAAGAGTCTCGGCACAATTATCGTGTTTGGCTT 69 FBan0030017 FBgn0050017 CG30017 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30017 CG30017 "anon-WO0153538.22, anon-WO0153538.29, BcDNA:HL05382" CDMC25405 1 6 3 DAC04-I08 7-CG30017-RA_1 CG30017 ACTCGCGTAAGATGCACGACCTTGACAATCTCTGGCCAAGAGTCTCGGCACAATTATCGTGTTTGGCTT 69 FBan0030017 FBgn0050017 CG30017 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30017 CG30017 "anon-WO0153538.22, anon-WO0153538.29, BcDNA:HL05382" CDMC25406 1 7 3 DAC04-I20 7-CG30023-RA_1 CG30023 TGGCCTCGACACAAACCCCTCCCGGACATGTAACCAAAACACTGATCAAGGAGAATACCCACATCGATT 69 FBgn0050023 CDMC25406 1 8 3 DAC04-I20 7-CG30023-RA_1 CG30023 TGGCCTCGACACAAACCCCTCCCGGACATGTAACCAAAACACTGATCAAGGAGAATACCCACATCGATT 69 FBgn0050023 CDMC25407 1 9 3 DAC04-M08 3-CG30055-RA_2 CG30055 CCATTGTCACCCAGCCATGTGGTGGAAACGATGATCAGAACATCTGGGTAAGACACCCTGTTTGAGCCA 69 FBan0030055 FBgn0050055 CG30055 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30055 CG30055 BcDNA:GM14547 CDMC25407 1 10 3 DAC04-M08 3-CG30055-RA_2 CG30055 CCATTGTCACCCAGCCATGTGGTGGAAACGATGATCAGAACATCTGGGTAAGACACCCTGTTTGAGCCA 69 FBan0030055 FBgn0050055 CG30055 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30055 CG30055 BcDNA:GM14547 CDMC25408 1 11 3 DAC04-M20 16-CG3006-RA_1 CG3006 CGGACTTGTCGCAAACTGCAGGAGTTAAGAACATCAAGCCTGTGATGACCAAATTGCACAACGAAAGCA 69 FBan0003006 FBgn0034943 Fmo-1 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 dimethylaniline monooxygenase (N-oxide-forming) activity; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; monooxygenase activity; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; ; GO:0004497 cytosol; GO:0005829; microsome; GO:0005792; mitochondrion; GO:0005739 Fmo-1 Flavin-containing monooxygenase 1 "CG3006, FMO-1, DmFMO-1, Flavin-containing monooxygenase 1" CDMC25408 1 12 3 DAC04-M20 16-CG3006-RA_1 CG3006 CGGACTTGTCGCAAACTGCAGGAGTTAAGAACATCAAGCCTGTGATGACCAAATTGCACAACGAAAGCA 69 FBan0003006 FBgn0034943 Fmo-1 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 dimethylaniline monooxygenase (N-oxide-forming) activity; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; monooxygenase activity; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; ; GO:0004497 cytosol; GO:0005829; microsome; GO:0005792; mitochondrion; GO:0005739 Fmo-1 Flavin-containing monooxygenase 1 "CG3006, FMO-1, DmFMO-1, Flavin-containing monooxygenase 1" CDMC25409 1 13 3 DAC05-A08 3-CG17681-RA_1 CG17681 CCAGCAACTGTGTCGGCTACTTCTGGCTGGACAACTACTTGCGATGGATGGATCAAAACCCGACGTTG 68 FBan0017681 FBgn0032668 CG17681 2 2L CG17681 CG17681 CDMC25409 1 14 3 DAC05-A08 3-CG17681-RA_1 CG17681 CCAGCAACTGTGTCGGCTACTTCTGGCTGGACAACTACTTGCGATGGATGGATCAAAACCCGACGTTG 68 FBan0017681 FBgn0032668 CG17681 2 2L CG17681 CG17681 CDMC25410 1 15 3 DAC05-A20 12-CG18031-RA_9 CG18031 CGCAGGACATTGGCATCAAGAGCATGCTGTGTTACACCAAAATGGGCTACGATATTTACAGGCAGGGC 68 FBan0018031 FBgn0023550 CG18031 X X oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18031 CG18031 EG:103B4.2 CDMC25410 1 16 3 DAC05-A20 12-CG18031-RA_9 CG18031 CGCAGGACATTGGCATCAAGAGCATGCTGTGTTACACCAAAATGGGCTACGATATTTACAGGCAGGGC 68 FBan0018031 FBgn0023550 CG18031 X X oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18031 CG18031 EG:103B4.2 CDMC25411 1 17 3 DAC05-E08 2-CG2072-RA_1 CG2072 CGAGAGGAGTTCCGCGATGTGTGCTACATGCTGCTAGGCTATAGGATCGATCGAATCGGTGCCAACAG 68 FBan0002072 FBgn0026326 TXBP181-like 2 2R TXBP181-like TXBP181-like CG2072 CDMC25411 1 18 3 DAC05-E08 2-CG2072-RA_1 CG2072 CGAGAGGAGTTCCGCGATGTGTGCTACATGCTGCTAGGCTATAGGATCGATCGAATCGGTGCCAACAG 68 FBan0002072 FBgn0026326 TXBP181-like 2 2R TXBP181-like TXBP181-like CG2072 CDMC25412 1 19 3 DAC05-E20 2-CG2206-RA_1 CG2206 CCACCCGCAGTGAAGGCTGCTTTAAGGATCTCTACTGTTCCCGTCAGCCGAAATGTAGTGGTCGTCTG 68 FBgn0029984 CDMC25412 1 20 3 DAC05-E20 2-CG2206-RA_1 CG2206 CCACCCGCAGTGAAGGCTGCTTTAAGGATCTCTACTGTTCCCGTCAGCCGAAATGTAGTGGTCGTCTG 68 FBgn0029984 CDMC25413 1 21 3 DAC05-I08 2-CG30097-RA_1 CG30097 CCATGGCGAAAAATCACGAACGTCCTGCAGTTTTTCCCCTCTCGAATCCAACTGCCAACTCGGAATGC 68 FBgn0050097 CDMC25413 1 22 3 DAC05-I08 2-CG30097-RA_1 CG30097 CCATGGCGAAAAATCACGAACGTCCTGCAGTTTTTCCCCTCTCGAATCCAACTGCCAACTCGGAATGC 68 FBgn0050097 CDMC25414 1 23 3 DAC05-I20 2-CG30296-RA_2 CG30296 CCATGAGTCCCAGATTTTGGTTGCCGACTCCCAGATCAAACGCGAAGAAGTCTACGACTCGGAGCTCA 68 FBan0030296 FBgn0050296 CG30296 2 2R CG30296 CG30296 "CG9349, CG15652, CG9349" CDMC25414 1 24 3 DAC05-I20 2-CG30296-RA_2 CG30296 CCATGAGTCCCAGATTTTGGTTGCCGACTCCCAGATCAAACGCGAAGAAGTCTACGACTCGGAGCTCA 68 FBan0030296 FBgn0050296 CG30296 2 2R CG30296 CG30296 "CG9349, CG15652, CG9349" CDMC25415 1 25 3 DAC05-M08 3-CG31251-RA_2 CG31251 AGCGACTACAAAAACGGAGATGTGTTCGAAACGCACTGCTGGTCACAAACCCTCAAGGATGTGGAGGT 68 FBan0031251 FBgn0051251 CG31251 3 3R cell cycle; GO:0007049; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG31251 CG31251 "CG7477, CG7477" CDMC25415 1 26 3 DAC05-M08 3-CG31251-RA_2 CG31251 AGCGACTACAAAAACGGAGATGTGTTCGAAACGCACTGCTGGTCACAAACCCTCAAGGATGTGGAGGT 68 FBan0031251 FBgn0051251 CG31251 3 3R cell cycle; GO:0007049; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG31251 CG31251 "CG7477, CG7477" CDMC25416 1 1 4 DAC05-M20 2-CG31322-RA_4 CG31322 CGCAGCAAGTGATAGGGAAGGACATCCTCAAGTTCCATGGCATTTACTGGACAGCTTTCCTCCTGGCT 68 FBgn0051322 CDMC25416 1 2 4 DAC05-M20 2-CG31322-RA_4 CG31322 CGCAGCAAGTGATAGGGAAGGACATCCTCAAGTTCCATGGCATTTACTGGACAGCTTTCCTCCTGGCT 68 FBgn0051322 CDMC25417 1 3 4 DAC06-A08 2-CG5225-RA_4 CG5225 GGACACCACCATCACTATTATCCACCAGGACACGATAAGGGAGGCTACTATCCGTATCCACCCCACGGT 69 FBan0005225 FBgn0038468 CG5225 3 3R CG5225 CG5225 CDMC25417 1 4 4 DAC06-A08 2-CG5225-RA_4 CG5225 GGACACCACCATCACTATTATCCACCAGGACACGATAAGGGAGGCTACTATCCGTATCCACCCCACGGT 69 FBan0005225 FBgn0038468 CG5225 3 3R CG5225 CG5225 CDMC25418 1 5 4 DAC06-A20 5-CG5237-RA_1 CG5237 CGCGTGGTAACTCAAGGGACAACAAAGCCGTTTCTCGCTATCTTCCCTGGCTAAACAATGCTCCATCGT 69 FBan0005237 FBgn0038693 CG5237 3 3R CG5237 CG5237 "anon-WO0153538.74, anon-WO0172774.15" CDMC25418 1 6 4 DAC06-A20 5-CG5237-RA_1 CG5237 CGCGTGGTAACTCAAGGGACAACAAAGCCGTTTCTCGCTATCTTCCCTGGCTAAACAATGCTCCATCGT 69 FBan0005237 FBgn0038693 CG5237 3 3R CG5237 CG5237 "anon-WO0153538.74, anon-WO0172774.15" CDMC25419 1 7 4 DAC06-E08 2-CG5276-RA_1 CG5276 CGAGAGTGGAACCTGGTCAGAGGAAAGGAATCGCTGGTTTTTCCTGCCTAGGCGGTGTTCGAAAGAGAA 69 FBan0005276 FBgn0037900 CG5276 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" ATP binding; GO:0005524; ; GO:0005524; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; nucleoside-diphosphatase activity; GO:0017110 ; EC:3.6.1.6; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0017110 ; EC:3.6.1.6; ; GO:0017111 ; EC:3.6.1.15 CG5276 CG5276 CDMC25419 1 8 4 DAC06-E08 2-CG5276-RA_1 CG5276 CGAGAGTGGAACCTGGTCAGAGGAAAGGAATCGCTGGTTTTTCCTGCCTAGGCGGTGTTCGAAAGAGAA 69 FBan0005276 FBgn0037900 CG5276 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" ATP binding; GO:0005524; ; GO:0005524; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; nucleoside-diphosphatase activity; GO:0017110 ; EC:3.6.1.6; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0017110 ; EC:3.6.1.6; ; GO:0017111 ; EC:3.6.1.15 CG5276 CG5276 CDMC25420 1 9 4 DAC06-E20 8-CG5290-RA_1 CG5290 CCAAACGCCACTGAAGAAGGCCGAGAAACTGGTAAAATCGTATCGTGCGTACACACCGAAGCATTTGGG 69 FBan0005290 FBgn0036772 CG5290 3 3L CG5290 CG5290 CDMC25420 1 10 4 DAC06-E20 8-CG5290-RA_1 CG5290 CCAAACGCCACTGAAGAAGGCCGAGAAACTGGTAAAATCGTATCGTGCGTACACACCGAAGCATTTGGG 69 FBan0005290 FBgn0036772 CG5290 3 3L CG5290 CG5290 CDMC25421 1 11 4 DAC06-I08 3-CG5335-RA_1 CG5335 CCAAGCGCGAAGAGCTACACTTCAGTGTGCGTTTCGATGAGAAGGCAGTAGTGCGCAATTCCATGAACA 69 FBan0005335 FBgn0034365 CG5335 2 2R sugar binding; GO:0005529; ; GO:0005529 CG5335 CG5335 CDMC25421 1 12 4 DAC06-I08 3-CG5335-RA_1 CG5335 CCAAGCGCGAAGAGCTACACTTCAGTGTGCGTTTCGATGAGAAGGCAGTAGTGCGCAATTCCATGAACA 69 FBan0005335 FBgn0034365 CG5335 2 2R sugar binding; GO:0005529; ; GO:0005529 CG5335 CG5335 CDMC25422 1 13 4 DAC06-I20 10-CG5348-RA_1 CG5348 GGGAACACTGTGGCCTACGTAAGAAGTTTGGTGGGCAATCGCTCTGAACACCACATGGAAGAATATGGT 69 FBan0005348 FBgn0034156 CG5348 2 2R CG5348 CG5348 CDMC25422 1 14 4 DAC06-I20 10-CG5348-RA_1 CG5348 GGGAACACTGTGGCCTACGTAAGAAGTTTGGTGGGCAATCGCTCTGAACACCACATGGAAGAATATGGT 69 FBan0005348 FBgn0034156 CG5348 2 2R CG5348 CG5348 CDMC25423 1 15 4 DAC06-M08 12-CG5385-RA_1 CG5385 CCTGCGCCCCAAAGAACCACGTCACGAAATGCATTTCTTAAGAGCAGAGTTCACATTATTTTGGCGGCT 69 FBan0005385 FBgn0032215 CG5385 2 2L CG5385 CG5385 CDMC25423 1 16 4 DAC06-M08 12-CG5385-RA_1 CG5385 CCTGCGCCCCAAAGAACCACGTCACGAAATGCATTTCTTAAGAGCAGAGTTCACATTATTTTGGCGGCT 69 FBan0005385 FBgn0032215 CG5385 2 2L CG5385 CG5385 CDMC25424 1 17 4 DAC06-M20 2-CG5398-RA_1 CG5398 TGGTGCCCTTCGTGTGGAATCATGCGTATACGCCACCTTATAAGCCCTTGGAAATTCCAGTGTGCAACT 69 FBan0005398 FBgn0034882 CG5398 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; ; GO:0015250 membrane; GO:0016020 CG5398 CG5398 anon-WO0140519.151 CDMC25424 1 18 4 DAC06-M20 2-CG5398-RA_1 CG5398 TGGTGCCCTTCGTGTGGAATCATGCGTATACGCCACCTTATAAGCCCTTGGAAATTCCAGTGTGCAACT 69 FBan0005398 FBgn0034882 CG5398 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; ; GO:0015250 membrane; GO:0016020 CG5398 CG5398 anon-WO0140519.151 CDMC25425 1 19 4 DAC07-A08 2-CG9752-RA_2 CG9752 TTTCCATCCTAAAACGAGCGCAAATCCTAGTGGGCGATGTGTGGTCCTGCTACAGAGGTCAGGGA 65 FBan0009752 FBgn0034614 CG9752 2 2R CG9752 CG9752 CDMC25425 1 20 4 DAC07-A08 2-CG9752-RA_2 CG9752 TTTCCATCCTAAAACGAGCGCAAATCCTAGTGGGCGATGTGTGGTCCTGCTACAGAGGTCAGGGA 65 FBan0009752 FBgn0034614 CG9752 2 2R CG9752 CG9752 CDMC25426 1 21 4 DAC07-A20 6-CG9779-RA_3 CG9779 GAGCCTGGTGCGCTATCCAGAGCTTGCAGGCATCATGCGCGACATGTCAAAGGAAATGATGAAGG 65 FBan0009779 FBgn0037231 CG9779 3 3R development; GO:0007275 CG9779 CG9779 CDMC25426 1 22 4 DAC07-A20 6-CG9779-RA_3 CG9779 GAGCCTGGTGCGCTATCCAGAGCTTGCAGGCATCATGCGCGACATGTCAAAGGAAATGATGAAGG 65 FBan0009779 FBgn0037231 CG9779 3 3R development; GO:0007275 CG9779 CG9779 CDMC25427 1 23 4 DAC07-E08 3-CG9896-RA_4 CG9896 TCTACCACGACACCAACCAGTTCATCAGGGATCTGTGCAACAAGGGTGCCTTCCAGGACGAGTAC 65 FBan0009896 FBgn0034808 CG9896 2 2R CG9896 CG9896 CDMC25427 1 24 4 DAC07-E08 3-CG9896-RA_4 CG9896 TCTACCACGACACCAACCAGTTCATCAGGGATCTGTGCAACAAGGGTGCCTTCCAGGACGAGTAC 65 FBan0009896 FBgn0034808 CG9896 2 2R CG9896 CG9896 CDMC25428 1 25 4 DAC07-E20 3-CG9930-RA_1 CG9930 TATCCATGGTTGCTCAGCCGACACGGACGCATTTTTCCACGATTCCCAGGCAATTTCCTGTTCCA 65 FBan0009930 FBgn0008646 E5 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 E5 E5 "CG9930, CG9930, CG9930, CG9930, CG9930" CDMC25428 1 26 4 DAC07-E20 3-CG9930-RA_1 CG9930 TATCCATGGTTGCTCAGCCGACACGGACGCATTTTTCCACGATTCCCAGGCAATTTCCTGTTCCA 65 FBan0009930 FBgn0008646 E5 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 E5 E5 "CG9930, CG9930, CG9930, CG9930, CG9930" CDMC25429 1 1 5 DAC07-I08 2-CR30508-RA_1 CR30508 GTCTAAGGCGCCAGACTCAAGTTCTGGTCCTCTTTGAGGGCGTGGGTTCGAATCCCACTTCTGAC 65 FBan0030508 FBgn0011910 tRNA:L3:49Fb 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:L3:49Fb transfer RNA:leu:49Fb "leu-b, DtL[b], tRNA[Leu], AE002787.trna41-LeuCAA, CR30508, CR30248, tRNA:leu3:49Fb, tRNA:L:CAA:AE002787-b" CDMC25429 1 2 5 DAC07-I08 2-CR30508-RA_1 CR30508 GTCTAAGGCGCCAGACTCAAGTTCTGGTCCTCTTTGAGGGCGTGGGTTCGAATCCCACTTCTGAC 65 FBan0030508 FBgn0011910 tRNA:L3:49Fb 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:L3:49Fb transfer RNA:leu:49Fb "leu-b, DtL[b], tRNA[Leu], AE002787.trna41-LeuCAA, CR30508, CR30248, tRNA:leu3:49Fb, tRNA:L:CAA:AE002787-b" CDMC25430 1 3 5 DAC07-I20 1-CR31480-RA_1 CR31480 TTAGCTCAGTGGTAGAGCGTTGGTCTCGTAAACCAAAGGCCGTGAGTTCAACCCTCACAGGAGGC 65 FBan0031480 FBgn0051480 CR31480 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31480 CR31480 "tRNA[Thr][[4]], tRNA[Thr][[3]], AE002708.trna23-ThrCGT, tRNA:T:CGT:AE002708-a, tRNA:T4:93A, tRNA:thr4:93A, tRNA:T3:93AB, transfer RNA:thr4:93A" CDMC25430 1 4 5 DAC07-I20 1-CR31480-RA_1 CR31480 TTAGCTCAGTGGTAGAGCGTTGGTCTCGTAAACCAAAGGCCGTGAGTTCAACCCTCACAGGAGGC 65 FBan0031480 FBgn0051480 CR31480 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31480 CR31480 "tRNA[Thr][[4]], tRNA[Thr][[3]], AE002708.trna23-ThrCGT, tRNA:T:CGT:AE002708-a, tRNA:T4:93A, tRNA:thr4:93A, tRNA:T3:93AB, transfer RNA:thr4:93A" CDMC25431 1 5 5 DAC07-M08 23-CR32892-RA_1 CR32892 TGTGATGTCAAACCAATAGACAAGCATATAACCGAACAATCATGTTGATTTTCACACGACTGAGC 65 FBan0032892 FBgn0063388 snoRNA:U27:54Ea 2 2R snoRNA:U27:54Ea snoRNA:U27:54Ea "U27snoRNA, CR32892" CDMC25431 1 6 5 DAC07-M08 23-CR32892-RA_1 CR32892 TGTGATGTCAAACCAATAGACAAGCATATAACCGAACAATCATGTTGATTTTCACACGACTGAGC 65 FBan0032892 FBgn0063388 snoRNA:U27:54Ea 2 2R snoRNA:U27:54Ea snoRNA:U27:54Ea "U27snoRNA, CR32892" CDMC25432 1 7 5 DAC07-M20 23-CR32900-RA_1 CR32900 GATGACAAACCAATAGACAAGCATATACCTGAATTCACGTGTGTTGCTAACATTTTTGACTGAAC 65 FBan0032900 FBgn0063387 snoRNA:U27:54Eb 2 2R snoRNA:U27:54Eb snoRNA:U27:54Eb "U27snoRNA, CR32900" CDMC25432 1 8 5 DAC07-M20 23-CR32900-RA_1 CR32900 GATGACAAACCAATAGACAAGCATATACCTGAATTCACGTGTGTTGCTAACATTTTTGACTGAAC 65 FBan0032900 FBgn0063387 snoRNA:U27:54Eb 2 2R snoRNA:U27:54Eb snoRNA:U27:54Eb "U27snoRNA, CR32900" CDMC25433 1 9 5 DAC08-A08 15-CG5597-RA_5 CG5597 TGGAGGAGAGCCCGAAGTTCATCACCGTCAAATGGTACAGAGACGACAAGTCCATATACCAGTGGATCT 69 FBan0005597 FBgn0034920 CG5597 2 2R CG5597 CG5597 CT17698 CDMC25433 1 10 5 DAC08-A08 15-CG5597-RA_5 CG5597 TGGAGGAGAGCCCGAAGTTCATCACCGTCAAATGGTACAGAGACGACAAGTCCATATACCAGTGGATCT 69 FBan0005597 FBgn0034920 CG5597 2 2R CG5597 CG5597 CT17698 CDMC25434 1 11 5 DAC08-A20 23-CG5610-RA_4 CG5610 CGATGATCGTGGATAATATACGATGAGCCAAACCATGAGTATTTCCTCGGCGTTGTACAACACTAACAG 69 FBan0005610 FBgn0000036 nAcRalpha-96Aa 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-96Aa nicotinic Acetylcholine Receptor alpha 96Aa "CG5610, als, ALS: alpha-like subunit, alpha-like subunit, ALs, Acr96Aa, alpha-like, alpha1, nicotinic acetylcholine receptor alpha-like, nAcRs, nAcr96Aa, nAChR, dALS, Acid Labile Subunit, Dalpha1, Acr96A, AcrB, alpha-Like Subunit, alpha-like-subunit" CDMC25434 1 12 5 DAC08-A20 23-CG5610-RA_4 CG5610 CGATGATCGTGGATAATATACGATGAGCCAAACCATGAGTATTTCCTCGGCGTTGTACAACACTAACAG 69 FBan0005610 FBgn0000036 nAcRalpha-96Aa 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-96Aa nicotinic Acetylcholine Receptor alpha 96Aa "CG5610, als, ALS: alpha-like subunit, alpha-like subunit, ALs, Acr96Aa, alpha-like, alpha1, nicotinic acetylcholine receptor alpha-like, nAcRs, nAcr96Aa, nAChR, dALS, Acid Labile Subunit, Dalpha1, Acr96A, AcrB, alpha-Like Subunit, alpha-like-subunit" CDMC25435 1 13 5 DAC08-E08 11-CG5645-RA_2 CG5645 TGTCGATGAAGGCGAGGAGAAACCAGAATGTCCCTCGGATATCGATGAATTGGTGCTGGAAGATTGGGA 69 FBan0005645 FBgn0036254 CG5645 3 3L CG5645 CG5645 CDMC25435 1 14 5 DAC08-E08 11-CG5645-RA_2 CG5645 TGTCGATGAAGGCGAGGAGAAACCAGAATGTCCCTCGGATATCGATGAATTGGTGCTGGAAGATTGGGA 69 FBan0005645 FBgn0036254 CG5645 3 3L CG5645 CG5645 CDMC25436 1 15 5 DAC08-E20 23-CG5659-RC_5 CG5659 AGATGTTGTCGGAGTATTTGGAACGTGATATTACATCCGAGAATTTGGCTGATATTAAGCAGAAAGTGC 69 FBan0005659 FBgn0017418 ari-1 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 ari-1 ariadne "CG5659, CG5659, CG5659, ari, HL-V, Ari-1, Ariadne-1, l(1)16Fj, ariadne" CDMC25436 1 16 5 DAC08-E20 23-CG5659-RC_5 CG5659 AGATGTTGTCGGAGTATTTGGAACGTGATATTACATCCGAGAATTTGGCTGATATTAAGCAGAAAGTGC 69 FBan0005659 FBgn0017418 ari-1 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 ari-1 ariadne "CG5659, CG5659, CG5659, ari, HL-V, Ari-1, Ariadne-1, l(1)16Fj, ariadne" CDMC25437 1 17 5 DAC08-I08 3-CG5688-RA_3 CG5688 TTGTGCACAGCCGATTCCATTGAGGCGTTGTACAAGCAGCATGTTGCCTACTTAAAGCGGGTAGCCTTC 69 FBan0005688 FBgn0026432 Grip163 3 3L microtubule cytoskeleton organization and biogenesis; GO:0000226 gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip163 Grip163 "CG5688, Dgrip163, grip163, Dgrips163" CDMC25437 1 18 5 DAC08-I08 3-CG5688-RA_3 CG5688 TTGTGCACAGCCGATTCCATTGAGGCGTTGTACAAGCAGCATGTTGCCTACTTAAAGCGGGTAGCCTTC 69 FBan0005688 FBgn0026432 Grip163 3 3L microtubule cytoskeleton organization and biogenesis; GO:0000226 gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip163 Grip163 "CG5688, Dgrip163, grip163, Dgrips163" CDMC25438 1 19 5 DAC08-I20 18-CG5700-RB_9 CG5700 AGGTTGCTACTTACAGGGAAGCAAACAGGGAACTCTTCAATACCATCAGTCAGTTTGGCAACAACGCAA 69 FBan0005700 FBgn0028573 prc 3 3L cell migration; GO:0016477; establishment and/or maintenance of apical/basal cell polarity; GO:0035088; heart development; GO:0007507; morphogenesis of an epithelium; GO:0002009 basal lamina; GO:0005605; extracellular matrix (sensu Metazoa); GO:0005578 prc pericardin "CG5700, CK01593, Pc, pericardin, EC11, Pericardin, Prc, BEST:CK01593" CDMC25438 1 20 5 DAC08-I20 18-CG5700-RB_9 CG5700 AGGTTGCTACTTACAGGGAAGCAAACAGGGAACTCTTCAATACCATCAGTCAGTTTGGCAACAACGCAA 69 FBan0005700 FBgn0028573 prc 3 3L cell migration; GO:0016477; establishment and/or maintenance of apical/basal cell polarity; GO:0035088; heart development; GO:0007507; morphogenesis of an epithelium; GO:0002009 basal lamina; GO:0005605; extracellular matrix (sensu Metazoa); GO:0005578 prc pericardin "CG5700, CK01593, Pc, pericardin, EC11, Pericardin, Prc, BEST:CK01593" CDMC25439 1 21 5 DAC08-M08 22-CG5729-RA_2 CG5729 GCATGTGCCCCAATAAACTATTTCGTGTCCCGTTCTTGTCCACTGTACATTGTGCTATATGCCAAACCA 69 FBan0005729 FBgn0027836 Dgp-1 2 2R protein biosynthesis; GO:0006412 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" cellular component unknown; GO:0008372 Dgp-1 Dgp-1 CG5729 CDMC25439 1 22 5 DAC08-M08 22-CG5729-RA_2 CG5729 GCATGTGCCCCAATAAACTATTTCGTGTCCCGTTCTTGTCCACTGTACATTGTGCTATATGCCAAACCA 69 FBan0005729 FBgn0027836 Dgp-1 2 2R protein biosynthesis; GO:0006412 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" cellular component unknown; GO:0008372 Dgp-1 Dgp-1 CG5729 CDMC25440 1 23 5 DAC08-M20 23-CG5740-RA_3 CG5740 TGAGCGGTCAAAACTTTCTATATACATAGATCTTCCAATTTTGTGGCTGTATTCTTCGAGATCCCCAGG 69 FBan0005740 FBgn0038932 CG5740 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG5740 CG5740 CDMC25440 1 24 5 DAC08-M20 23-CG5740-RA_3 CG5740 TGAGCGGTCAAAACTTTCTATATACATAGATCTTCCAATTTTGTGGCTGTATTCTTCGAGATCCCCAGG 69 FBan0005740 FBgn0038932 CG5740 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG5740 CG5740 CDMC25441 1 25 5 DAC09-A09 1-CG31177-RA_1 CG31177 TGCCAAGGGAGCTTGCATTGTAAGGATGTGGCGAAATCTCATGGGAGCCGAAAACTTTGACACAGCC 67 FBan0031177 FBgn0051177 CG31177 3 3R proteolysis; GO:0006508 NOT membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004179 ; EC:3.4.11.2 CG31177 CG31177 "CG5845, CG5845" CDMC25441 1 26 5 DAC09-A09 1-CG31177-RA_1 CG31177 TGCCAAGGGAGCTTGCATTGTAAGGATGTGGCGAAATCTCATGGGAGCCGAAAACTTTGACACAGCC 67 FBan0031177 FBgn0051177 CG31177 3 3R proteolysis; GO:0006508 NOT membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004179 ; EC:3.4.11.2 CG31177 CG31177 "CG5845, CG5845" CDMC25442 1 1 6 DAC09-A21 12-CG31353-RA_1 CG31353 GCCAAGTTTTATGCAGGCAGTTGCCACTATTTGTTGGCTAGGCTAGAGAACTGTGGCACAACCTCGC 67 FBan0031353 FBgn0051353 CG31353 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31353 CG31353 CDMC25442 1 2 6 DAC09-A21 12-CG31353-RA_1 CG31353 GCCAAGTTTTATGCAGGCAGTTGCCACTATTTGTTGGCTAGGCTAGAGAACTGTGGCACAACCTCGC 67 FBan0031353 FBgn0051353 CG31353 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31353 CG31353 CDMC25443 1 3 6 DAC09-E09 1-CG31933-RA_1 CG31933 ACTGCAACACTTCCCACATCCCGAGTAAGTTCTGTCTGTGCCACAAGCAGATTCCCATTCCCGAGAG 67 FBan0031933 FBgn0051933 CG31933 2 2L CG31933 CG31933 "CG15622, CG15622" CDMC25443 1 4 6 DAC09-E09 1-CG31933-RA_1 CG31933 ACTGCAACACTTCCCACATCCCGAGTAAGTTCTGTCTGTGCCACAAGCAGATTCCCATTCCCGAGAG 67 FBan0031933 FBgn0051933 CG31933 2 2L CG31933 CG31933 "CG15622, CG15622" CDMC25444 1 5 6 DAC09-E21 3-CG32068-RA_3 CG32068 AACTCGTCGCTATTTTGTGGGCGAACCTGTCTGGGCTCCACACAATCGTCCTGCTGATGAAATGGAC 67 FBan0032068 FBgn0052068 CG32068 3 3L CG32068 CG32068 "CG8000, CG8000, CG8000" CDMC25444 1 6 6 DAC09-E21 3-CG32068-RA_3 CG32068 AACTCGTCGCTATTTTGTGGGCGAACCTGTCTGGGCTCCACACAATCGTCCTGCTGATGAAATGGAC 67 FBan0032068 FBgn0052068 CG32068 3 3L CG32068 CG32068 "CG8000, CG8000, CG8000" CDMC25445 1 7 6 DAC09-I09 3-CG32505-RE_3 CG32505 TCTCCCAGTTCAACCGCACGAACGATATCGACATGATTTGCCGTGCACACCAGTTGGTAATGGAGGG 67 FBan0032505 FBgn0023177 Pp4-19C X X M phase specific microtubule process; GO:0000072; microtubule-based process; GO:0007017; protein amino acid dephosphorylation; GO:0006470; regulation of progression through mitotic cell cycle; GO:0007346 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule cytoskeleton; GO:0015630; nucleus; GO:0005634 Pp4-19C Protein phosphatase 19C "CG1459, CG32505, CG1596, CG18339, CG1459, PPX, PP4, PP4 19C, pp4, PpX, Protein phosphatase X" CDMC25445 1 8 6 DAC09-I09 3-CG32505-RE_3 CG32505 TCTCCCAGTTCAACCGCACGAACGATATCGACATGATTTGCCGTGCACACCAGTTGGTAATGGAGGG 67 FBan0032505 FBgn0023177 Pp4-19C X X M phase specific microtubule process; GO:0000072; microtubule-based process; GO:0007017; protein amino acid dephosphorylation; GO:0006470; regulation of progression through mitotic cell cycle; GO:0007346 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 centrosome; GO:0005813; cytoplasm; GO:0005737; microtubule cytoskeleton; GO:0015630; nucleus; GO:0005634 Pp4-19C Protein phosphatase 19C "CG1459, CG32505, CG1596, CG18339, CG1459, PPX, PP4, PP4 19C, pp4, PpX, Protein phosphatase X" CDMC25446 1 9 6 DAC09-I21 3-CG32664-RA_3 CG32664 CGGTGAAGTTGGTAAGGGTTCAGTTAGCCAGGTGCGAGTCCACTTTGCGATCTACGCCTTTGTGCTG 67 FBan0032664 FBgn0045502 Gr10a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr10a Gustatory receptor 10a "CG32664, Gr10B1, Gustatory receptor 10B1, Gustatory receptor 10a" CDMC25446 1 10 6 DAC09-I21 3-CG32664-RA_3 CG32664 CGGTGAAGTTGGTAAGGGTTCAGTTAGCCAGGTGCGAGTCCACTTTGCGATCTACGCCTTTGTGCTG 67 FBan0032664 FBgn0045502 Gr10a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr10a Gustatory receptor 10a "CG32664, Gr10B1, Gustatory receptor 10B1, Gustatory receptor 10a" CDMC25447 1 11 6 DAC09-M09 2-CG33301-RA_1 CG33301 GGACCGCGAGTACAACACCATGATTCTGGAGGATTTGGCACCGTACAAGTTCGTCAATGCGGATCGC 67 FBan0033301 FBgn0053301 CG33301 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33301 CG33301 "CG4791, CG4791" CDMC25447 1 12 6 DAC09-M09 2-CG33301-RA_1 CG33301 GGACCGCGAGTACAACACCATGATTCTGGAGGATTTGGCACCGTACAAGTTCGTCAATGCGGATCGC 67 FBan0033301 FBgn0053301 CG33301 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33301 CG33301 "CG4791, CG4791" CDMC25448 1 13 6 DAC09-M21 24-CG3355-RA_3 CG3355 AAAAAACTCATTTCCTTGCCTCATTCCTAAGTTATTCTAAATTATTGAAAAAAGAAGTTCACAGCAA 67 FBan0003355 FBgn0031619 CG3355 2 2L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; enteropeptidase activity; GO:0004275 ; EC:3.4.21.9; ; GO:0004275 ; EC:3.4.21.9; ; GO:0004263 ; EC:3.4.21.1 CG3355 CG3355 SP21 CDMC25448 1 14 6 DAC09-M21 24-CG3355-RA_3 CG3355 AAAAAACTCATTTCCTTGCCTCATTCCTAAGTTATTCTAAATTATTGAAAAAAGAAGTTCACAGCAA 67 FBan0003355 FBgn0031619 CG3355 2 2L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; enteropeptidase activity; GO:0004275 ; EC:3.4.21.9; ; GO:0004275 ; EC:3.4.21.9; ; GO:0004263 ; EC:3.4.21.1 CG3355 CG3355 SP21 CDMC25449 1 15 6 DAC10-A08 22-CG18314-RA_1 CG18314 CCGTCGTCTGGATCGGCATATTGAATTCGTTTTGGAAAATTCTGATCATGACCAGTATGTCGCCGCAAT 69 FBan0018314 FBgn0035538 DopEcR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 DopEcR DopEcR "CG18314, CG18314, CG18314, CG18314, anon-WO0170980.139, anon-WO0170980.140" CDMC25449 1 16 6 DAC10-A08 22-CG18314-RA_1 CG18314 CCGTCGTCTGGATCGGCATATTGAATTCGTTTTGGAAAATTCTGATCATGACCAGTATGTCGCCGCAAT 69 FBan0018314 FBgn0035538 DopEcR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 DopEcR DopEcR "CG18314, CG18314, CG18314, CG18314, anon-WO0170980.139, anon-WO0170980.140" CDMC25450 1 17 6 DAC10-A20 13-CG1832-RA_2 CG1832 CCACCCTGCTTAGCTTCAGTTTATCGAGCGTTACTATGATCATCTGCCTCCACCTATGCTAGCCCCAGA 69 FBan0001832 FBgn0032979 CG1832 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1832 CG1832 CDMC25450 1 18 6 DAC10-A20 13-CG1832-RA_2 CG1832 CCACCCTGCTTAGCTTCAGTTTATCGAGCGTTACTATGATCATCTGCCTCCACCTATGCTAGCCCCAGA 69 FBan0001832 FBgn0032979 CG1832 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1832 CG1832 CDMC25451 1 19 6 DAC10-E08 23-CG18396-RA_2 CG18396 GGACCATGCTGATCTGTAAAACAGCTGGAAAGATCTACTTGACGTCTGCCAAAAACATTTTGTGACAAC 69 FBan0018396 FBgn0004171 Mst98Cb 3 3R Mst98Cb Male-specific RNA 98Cb "CG18396, Mst98C, Mst, MST98Cb, anon-WO0140519.46, mst(3)gl-13" CDMC25451 1 20 6 DAC10-E08 23-CG18396-RA_2 CG18396 GGACCATGCTGATCTGTAAAACAGCTGGAAAGATCTACTTGACGTCTGCCAAAAACATTTTGTGACAAC 69 FBan0018396 FBgn0004171 Mst98Cb 3 3R Mst98Cb Male-specific RNA 98Cb "CG18396, Mst98C, Mst, MST98Cb, anon-WO0140519.46, mst(3)gl-13" CDMC25452 1 21 6 DAC10-E20 23-CG18408-RA_2 CG18408 AATTTAAATGACTAAAACGATATAAAATGTTTCAAAGTGCTAAGATTCAAGTGCCCTTGTTGAGTCGGC 69 FBan0018408 FBgn0033504 CAP 2 2R MAPKKK cascade; GO:0000165; cytoskeleton organization and biogenesis; GO:0007010 vinculin binding; GO:0017166; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0017166 focal adhesion; GO:0005925 CAP CAP "CG18409, CG18408, CG3451, CG18409, DCAP, Rexin, rexin, CAP/Vinexin" CDMC25452 1 22 6 DAC10-E20 23-CG18408-RA_2 CG18408 AATTTAAATGACTAAAACGATATAAAATGTTTCAAAGTGCTAAGATTCAAGTGCCCTTGTTGAGTCGGC 69 FBan0018408 FBgn0033504 CAP 2 2R MAPKKK cascade; GO:0000165; cytoskeleton organization and biogenesis; GO:0007010 vinculin binding; GO:0017166; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0017166 focal adhesion; GO:0005925 CAP CAP "CG18409, CG18408, CG3451, CG18409, DCAP, Rexin, rexin, CAP/Vinexin" CDMC25453 1 23 6 DAC10-I08 9-CG18478-RA_2 CG18478 TGGGGCACTTTTCTGTCCAATGACCGAGGATCCCAAACAGTTCGAGCAAATTGGCATTGTTAACTGGGG 69 FBan0018478 FBgn0028517 CG18478 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18478 CG18478 "BG:DS07108.5, DS07108.5, SPH157" CDMC25453 1 24 6 DAC10-I08 9-CG18478-RA_2 CG18478 TGGGGCACTTTTCTGTCCAATGACCGAGGATCCCAAACAGTTCGAGCAAATTGGCATTGTTAACTGGGG 69 FBan0018478 FBgn0028517 CG18478 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18478 CG18478 "BG:DS07108.5, DS07108.5, SPH157" CDMC25454 1 25 6 DAC10-I20 9-CG18493-RA_1 CG18493 AGCTCTGGCTCAAGGAATCAACCTTTTGGCACCAAGTTCCCTGCCACACTTTACATCAATCTATGCGGT 69 FBan0018493 FBgn0038701 CG18493 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- CG18493 CG18493 CDMC25454 1 26 6 DAC10-I20 9-CG18493-RA_1 CG18493 AGCTCTGGCTCAAGGAATCAACCTTTTGGCACCAAGTTCCCTGCCACACTTTACATCAATCTATGCGGT 69 FBan0018493 FBgn0038701 CG18493 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- CG18493 CG18493 CDMC25455 1 1 7 DAC10-M08 15-CG18543-RA_1 CG18543 CCGATGAGGATTGCAACCGTATCATGGATGTGCTCCACACTCTTTAAGTGAATCGCTGGCATGTCCATC 69 FBan0018543 FBgn0010431 mtrm 3 3L cell cycle arrest; GO:0007050; female meiosis chromosome segregation; GO:0016321 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 mtrm matrimony "CG18543, D52, anon-D52, anonD52, matrimony" CDMC25455 1 2 7 DAC10-M08 15-CG18543-RA_1 CG18543 CCGATGAGGATTGCAACCGTATCATGGATGTGCTCCACACTCTTTAAGTGAATCGCTGGCATGTCCATC 69 FBan0018543 FBgn0010431 mtrm 3 3L cell cycle arrest; GO:0007050; female meiosis chromosome segregation; GO:0016321 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 mtrm matrimony "CG18543, D52, anon-D52, anonD52, matrimony" CDMC25456 1 3 7 DAC10-M20 17-CG1856-RD_4 CG1856 CGCGTAGTCAAAGACCGAAAATCAAGTAGTTGCTTTGGCTGACACTTTACAAACCCATCCACTAGGGGT 69 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC25456 1 4 7 DAC10-M20 17-CG1856-RD_4 CG1856 CGCGTAGTCAAAGACCGAAAATCAAGTAGTTGCTTTGGCTGACACTTTACAAACCCATCCACTAGGGGT 69 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC25457 1 5 7 DAC11-A08 1-CG10123-RA_1 CG10123 GCTCGCCAGAACACTGTCCGTAAGAATGGACCCAACCTAGGCAGGCTGTACTACAAGTGTCCCAAAC 67 FBan0010123 FBgn0040268 Top3alpha 2 2L DNA metabolism; GO:0006259; DNA modification; GO:0006304; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2 Top3alpha Topoisomerase 3alpha "CG10123, Topoisomerase IIIalpha, dTopoIIIa, Top3a, Topoisomerase IIIa, DmTop3alpha, Topoisomerase 3alpha" CDMC25457 1 6 7 DAC11-A08 1-CG10123-RA_1 CG10123 GCTCGCCAGAACACTGTCCGTAAGAATGGACCCAACCTAGGCAGGCTGTACTACAAGTGTCCCAAAC 67 FBan0010123 FBgn0040268 Top3alpha 2 2L DNA metabolism; GO:0006259; DNA modification; GO:0006304; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003917 ; EC:5.99.1.2 Top3alpha Topoisomerase 3alpha "CG10123, Topoisomerase IIIalpha, dTopoIIIa, Top3a, Topoisomerase IIIa, DmTop3alpha, Topoisomerase 3alpha" CDMC25458 1 7 7 DAC11-A20 16-CG10280-RA_3 CG10280 ACGCAAATCAGGAAAGACAGGCCATTATTCAAGCCGTAAAAACCTTCAACTCCCTAACGTGTGTGCA 67 FBan0010280 FBgn0037395 CG10280 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG10280 CG10280 CDMC25458 1 8 7 DAC11-A20 16-CG10280-RA_3 CG10280 ACGCAAATCAGGAAAGACAGGCCATTATTCAAGCCGTAAAAACCTTCAACTCCCTAACGTGTGTGCA 67 FBan0010280 FBgn0037395 CG10280 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG10280 CG10280 CDMC25459 1 9 7 DAC11-E08 3-CG10721-RA_6 CG10721 TGGGAGCTAGTTTTCAGACACTAGTGGATCGCCTGGATCACATCAACAGCAGGGAGCATTGCATCCG 67 FBan0010721 FBgn0032846 CG10721 2 2L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG10721 CG10721 38B.14 CDMC25459 1 10 7 DAC11-E08 3-CG10721-RA_6 CG10721 TGGGAGCTAGTTTTCAGACACTAGTGGATCGCCTGGATCACATCAACAGCAGGGAGCATTGCATCCG 67 FBan0010721 FBgn0032846 CG10721 2 2L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG10721 CG10721 38B.14 CDMC25460 1 11 7 DAC11-E20 2-CG10824-RA_1 CG10824 CGGGGGAATACTTTCACGGAATAGCCTGCATGTATCGCTTGCCCGAAAAAGAGGGTGTGGACTCCTC 67 FBan0010824 FBgn0038865 CG10824 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.- CG10824 CG10824 CT11359 CDMC25460 1 12 7 DAC11-E20 2-CG10824-RA_1 CG10824 CGGGGGAATACTTTCACGGAATAGCCTGCATGTATCGCTTGCCCGAAAAAGAGGGTGTGGACTCCTC 67 FBan0010824 FBgn0038865 CG10824 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.- CG10824 CG10824 CT11359 CDMC25461 1 13 7 DAC11-I08 2-CG11207-RA_3 CG11207 TCGACGATATGCGCGAAAAGATCCATGTGCTGTGGGACAGACTCCAGGAGACAGACGAGTATGCCAT 67 FBan0011207 FBgn0030241 feo X X "cytokinesis; GO:0000910; cytokinesis, contractile ring contraction; GO:0000916; mitosis; GO:0007067; mitotic spindle stabilization; GO:0043148" receptor binding; GO:0005102; ; GO:0005102 cytoplasm; GO:0005737; spindle midzone; GO:0051233 feo fascetto "CG11207, CG11207, CG11207, CG11207, CG11207, l(1)BP1, Q54, l(1)9Fe, EA86, lethal(1)9Fe, fascetto" CDMC25461 1 14 7 DAC11-I08 2-CG11207-RA_3 CG11207 TCGACGATATGCGCGAAAAGATCCATGTGCTGTGGGACAGACTCCAGGAGACAGACGAGTATGCCAT 67 FBan0011207 FBgn0030241 feo X X "cytokinesis; GO:0000910; cytokinesis, contractile ring contraction; GO:0000916; mitosis; GO:0007067; mitotic spindle stabilization; GO:0043148" receptor binding; GO:0005102; ; GO:0005102 cytoplasm; GO:0005737; spindle midzone; GO:0051233 feo fascetto "CG11207, CG11207, CG11207, CG11207, CG11207, l(1)BP1, Q54, l(1)9Fe, EA86, lethal(1)9Fe, fascetto" CDMC25462 1 15 7 DAC11-I20 2-CG11251-RA_2 CG11251 TGTCTCCCACGTCCAGAGAAGCATCTCCAGAACCACATATTCCGTCAGCTCCAGACGAATCACCCAT 67 FBan0011251 FBgn0036346 CG11251 3 3L amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG11251 CG11251 CDMC25462 1 16 7 DAC11-I20 2-CG11251-RA_2 CG11251 TGTCTCCCACGTCCAGAGAAGCATCTCCAGAACCACATATTCCGTCAGCTCCAGACGAATCACCCAT 67 FBan0011251 FBgn0036346 CG11251 3 3L amino acid catabolism; GO:0009063; amino acid metabolism; GO:0006520 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016831 ; EC:4.1.1.- CG11251 CG11251 CDMC25463 1 17 7 DAC11-M08 11-CG11963-RA_1 CG11963 CCAGACCGCTGAAGAACTTTCAAGCAAAATGATCGATCAGCTTCTGGTCACCAAGCAAACCGGAGCA 67 FBan0011963 FBgn0037643 CG11963 3 3R tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (ADP-forming) activity; GO:0004775 ; EC:6.2.1.5; ; GO:0004775 ; EC:6.2.1.5; ; GO:0004775 ; EC:6.2.1.5 succinate-CoA ligase complex (ADP-forming); GO:0009361 CG11963 CG11963 CDMC25463 1 18 7 DAC11-M08 11-CG11963-RA_1 CG11963 CCAGACCGCTGAAGAACTTTCAAGCAAAATGATCGATCAGCTTCTGGTCACCAAGCAAACCGGAGCA 67 FBan0011963 FBgn0037643 CG11963 3 3R tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (ADP-forming) activity; GO:0004775 ; EC:6.2.1.5; ; GO:0004775 ; EC:6.2.1.5; ; GO:0004775 ; EC:6.2.1.5 succinate-CoA ligase complex (ADP-forming); GO:0009361 CG11963 CG11963 CDMC25464 1 19 7 DAC11-M20 2-CG12052-RU_1 CG12052 GCATCCGGAGCAAATCAGTGATACATTCGCGGGTTCTTCGGGATCTAGCGATGGGGTCAGGGATAGA 67 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC25464 1 20 7 DAC11-M20 2-CG12052-RU_1 CG12052 GCATCCGGAGCAAATCAGTGATACATTCGCGGGTTCTTCGGGATCTAGCGATGGGGTCAGGGATAGA 67 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC25465 1 21 7 DAC12-A08 3-CG10121-RB_1 CG10121 TCTGATTGGATTGGCTCGCGATGAGAGGGATCCGAAACTGGAGTTCTGGTCCTGCACCTACCAATG 66 FBan0010121 FBgn0035710 SP1173 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SP1173 SP1173 CG10121 CDMC25465 1 22 7 DAC12-A08 3-CG10121-RB_1 CG10121 TCTGATTGGATTGGCTCGCGATGAGAGGGATCCGAAACTGGAGTTCTGGTCCTGCACCTACCAATG 66 FBan0010121 FBgn0035710 SP1173 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SP1173 SP1173 CG10121 CDMC25466 1 23 7 DAC12-A20 3-CG10191-RA_2 CG10191 TCGCTGGCCTATCAGCTCTCGGAAGAAAACTTTCAGGTGCTCGACAGTAAACATTCGACGCAGCCG 66 FBan0010191 FBgn0036354 CG10191 3 3L CG10191 CG10191 CDMC25466 1 24 7 DAC12-A20 3-CG10191-RA_2 CG10191 TCGCTGGCCTATCAGCTCTCGGAAGAAAACTTTCAGGTGCTCGACAGTAAACATTCGACGCAGCCG 66 FBan0010191 FBgn0036354 CG10191 3 3L CG10191 CG10191 CDMC25467 1 25 7 DAC12-E08 2-CG10591-RA_1 CG10591 GGTGCAGATCGATCGACCGCAGAATCTGCCCAGTGAACTGTTCGATACACCGGTGAACCAAGGTTC 66 FBan0010591 FBgn0035621 CG10591 3 3L CG10591 CG10591 CDMC25467 1 26 7 DAC12-E08 2-CG10591-RA_1 CG10591 GGTGCAGATCGATCGACCGCAGAATCTGCCCAGTGAACTGTTCGATACACCGGTGAACCAAGGTTC 66 FBan0010591 FBgn0035621 CG10591 3 3L CG10591 CG10591 CDMC25468 1 1 8 DAC12-E20 3-CG10763-RA_2 CG10763 CCTAAGCCATGTGGCACCTTATTGTTGGGGGATGCATTTGTCCAGGACAGATGCCGTCTCGCTTTG 66 FBan0010763 FBgn0030011 Gbeta5 X X G-protein coupled receptor protein signaling pathway; GO:0007186 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Gbeta5 Gbeta5 "CG10763, Gbetagamma, G[[beta]], Gbeta, Gbeta 5" CDMC25468 1 2 8 DAC12-E20 3-CG10763-RA_2 CG10763 CCTAAGCCATGTGGCACCTTATTGTTGGGGGATGCATTTGTCCAGGACAGATGCCGTCTCGCTTTG 66 FBan0010763 FBgn0030011 Gbeta5 X X G-protein coupled receptor protein signaling pathway; GO:0007186 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Gbeta5 Gbeta5 "CG10763, Gbetagamma, G[[beta]], Gbeta, Gbeta 5" CDMC25469 1 3 8 DAC12-I08 3-CG11130-RA_5 CG11130 GGCTACTATCTGGACGCCCTAATAGCCTTGGGTCCATTTTGCAAGAGTCCGCTACAGTGCACCCTG 66 FBan0011130 FBgn0020909 Rtc1 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0003729; RNA-3'-phosphate cyclase activity; GO:0003963 ; EC:6.5.1.4; ; GO:0016849 ; EC:4.6.-.-; ; GO:0003963 ; EC:6.5.1.4 nucleus; GO:0005634 Rtc1 Rtc1 CG11130 CDMC25469 1 4 8 DAC12-I08 3-CG11130-RA_5 CG11130 GGCTACTATCTGGACGCCCTAATAGCCTTGGGTCCATTTTGCAAGAGTCCGCTACAGTGCACCCTG 66 FBan0011130 FBgn0020909 Rtc1 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0003729; RNA-3'-phosphate cyclase activity; GO:0003963 ; EC:6.5.1.4; ; GO:0016849 ; EC:4.6.-.-; ; GO:0003963 ; EC:6.5.1.4 nucleus; GO:0005634 Rtc1 Rtc1 CG11130 CDMC25470 1 5 8 DAC12-I20 3-CG11151-RA_1 CG11151 AAAATCGCCGATTGCACGCCTTCTGCTCATTACTTCGCGTTCCGCTCTCAAAGCAAATACCCCCAC 66 FBan0011151 FBgn0030519 CG11151 X X female gamete generation; GO:0007292 estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; ; GO:0004303 ; EC:1.1.1.62; sterol carrier activity; GO:0005498; ; GO:0005498 CG11151 CG11151 "2, transcript 2" CDMC25470 1 6 8 DAC12-I20 3-CG11151-RA_1 CG11151 AAAATCGCCGATTGCACGCCTTCTGCTCATTACTTCGCGTTCCGCTCTCAAAGCAAATACCCCCAC 66 FBan0011151 FBgn0030519 CG11151 X X female gamete generation; GO:0007292 estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; ; GO:0004303 ; EC:1.1.1.62; sterol carrier activity; GO:0005498; ; GO:0005498 CG11151 CG11151 "2, transcript 2" CDMC25471 1 7 8 DAC12-M08 5-CG11804-RA_1 CG11804 TCAGCTTAACCTTGACGACTTCTCGCTGGAGAGTTTGGATCCCCTGCGAAAGTAGAGCGGTGCTAC 66 FBan0011804 FBgn0029092 ced-6 2 2R MAPKKK cascade; GO:0000165; apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 receptor binding; GO:0005102; ; GO:0005102 ced-6 ced-6 "CG11804, CG11804, CG11804, drced-6" CDMC25471 1 8 8 DAC12-M08 5-CG11804-RA_1 CG11804 TCAGCTTAACCTTGACGACTTCTCGCTGGAGAGTTTGGATCCCCTGCGAAAGTAGAGCGGTGCTAC 66 FBan0011804 FBgn0029092 ced-6 2 2R MAPKKK cascade; GO:0000165; apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 receptor binding; GO:0005102; ; GO:0005102 ced-6 ced-6 "CG11804, CG11804, CG11804, drced-6" CDMC25472 1 9 8 DAC12-M20 6-CG12016-RA_1 CG12016 CCAGCTGAGGGACAAGAAGGTCAATTTCCTCCTGGTCGAGGGATTCATGATCTTCAACCAGCCGGA 66 FBan0012016 FBgn0035436 CG12016 3 3L CG12016 CG12016 CDMC25472 1 10 8 DAC12-M20 6-CG12016-RA_1 CG12016 CCAGCTGAGGGACAAGAAGGTCAATTTCCTCCTGGTCGAGGGATTCATGATCTTCAACCAGCCGGA 66 FBan0012016 FBgn0035436 CG12016 3 3L CG12016 CG12016 CDMC25473 1 11 8 DAC13-A08 2-CG14523-RA_2 CG14523 CCAAGTGACGCGGACTACGTTGATGTCTCAAAACTCACCCAGTTCGTGGAAACTGTCCTTGACCGGGAG 69 FBan0014523 FBgn0039612 CG14523 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14523 CG14523 CDMC25473 1 12 8 DAC13-A08 2-CG14523-RA_2 CG14523 CCAAGTGACGCGGACTACGTTGATGTCTCAAAACTCACCCAGTTCGTGGAAACTGTCCTTGACCGGGAG 69 FBan0014523 FBgn0039612 CG14523 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14523 CG14523 CDMC25474 1 13 8 DAC13-A20 2-CG14540-RA_3 CG14540 GGCACGGTAAACCCTAATGGCTATGGCATGTCCAAGTCGAAGGAGACATACCGAATGAAGCACCGCGAA 69 FBan0014540 FBgn0039398 CG14540 3 3R CG14540 CG14540 CDMC25474 1 14 8 DAC13-A20 2-CG14540-RA_3 CG14540 GGCACGGTAAACCCTAATGGCTATGGCATGTCCAAGTCGAAGGAGACATACCGAATGAAGCACCGCGAA 69 FBan0014540 FBgn0039398 CG14540 3 3R CG14540 CG14540 CDMC25475 1 15 8 DAC13-E08 1-CG14578-RD_1 CG14578 CCACTGCACACATGACGGAGCACTACAGCGAGTCATTCAACGCCTACTACAACTACAATGGAGGCCACA 69 FBgn0040059 CG14578 specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 CG14578 CG14578 "CG40105, CG40105" CDMC25475 1 16 8 DAC13-E08 1-CG14578-RD_1 CG14578 CCACTGCACACATGACGGAGCACTACAGCGAGTCATTCAACGCCTACTACAACTACAATGGAGGCCACA 69 FBgn0040059 CG14578 specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 CG14578 CG14578 "CG40105, CG40105" CDMC25476 1 17 8 DAC13-E20 23-CG1458-RA_2 CG1458 GAATTTAATAGCCAGTTAAATAAAAAAGGCGTTTCGAAATGGAGCCCATATCACATCTGGTGAAGTCCT 69 FBgn0039653 CDMC25476 1 18 8 DAC13-E20 23-CG1458-RA_2 CG1458 GAATTTAATAGCCAGTTAAATAAAAAAGGCGTTTCGAAATGGAGCCCATATCACATCTGGTGAAGTCCT 69 FBgn0039653 CDMC25477 1 19 8 DAC13-I08 2-CG14630-RA_1 CG14630 TCGTGGCCCGCTGAATATACCAGTGTCCCAAGTGGCCTACAACAAGGAGAGGAAACAGTTGGAGATCAT 69 FBan0014630 FBgn0014903 CG14630 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG14630 CG14630 "B, Transcription unit B, EG:BACR7A4.9, anon-1Eb" CDMC25477 1 20 8 DAC13-I08 2-CG14630-RA_1 CG14630 TCGTGGCCCGCTGAATATACCAGTGTCCCAAGTGGCCTACAACAAGGAGAGGAAACAGTTGGAGATCAT 69 FBan0014630 FBgn0014903 CG14630 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG14630 CG14630 "B, Transcription unit B, EG:BACR7A4.9, anon-1Eb" CDMC25478 1 21 8 DAC13-I20 3-CG14645-RA_4 CG14645 AGCTCGCTCTAACCTCCCTACTAGTGATTTCTTTTGGCATTGCCCTCGCCTATGATGGTGACGGACAGC 69 FBan0014645 FBgn0040687 CG14645 3 3R CG14645 CG14645 CDMC25478 1 22 8 DAC13-I20 3-CG14645-RA_4 CG14645 AGCTCGCTCTAACCTCCCTACTAGTGATTTCTTTTGGCATTGCCCTCGCCTATGATGGTGACGGACAGC 69 FBan0014645 FBgn0040687 CG14645 3 3R CG14645 CG14645 CDMC25479 1 23 8 DAC13-M08 23-CG1467-RA_1 CG1467 AAACTGGAAAAAATCTGATTGAGTTTTCAGCGGACTTGGATCAATCCTTCCAATCCCCAAGAAATCGGG 69 FBan0001467 FBgn0031106 Syx16 X X neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 Golgi apparatus; GO:0005794; Golgi membrane; GO:0000139; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Syx16 Syntaxin 16 "CG1467, SYX16, Dm Syx16, DmSyx16, dSyx16, syntaxin, Syntaxin 16" CDMC25479 1 24 8 DAC13-M08 23-CG1467-RA_1 CG1467 AAACTGGAAAAAATCTGATTGAGTTTTCAGCGGACTTGGATCAATCCTTCCAATCCCCAAGAAATCGGG 69 FBan0001467 FBgn0031106 Syx16 X X neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 Golgi apparatus; GO:0005794; Golgi membrane; GO:0000139; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Syx16 Syntaxin 16 "CG1467, SYX16, Dm Syx16, DmSyx16, dSyx16, syntaxin, Syntaxin 16" CDMC25480 1 25 8 DAC13-M20 23-CG14690-RA_2 CG14690 CTACCAGTAGCCTTTGAAATACTCCAAAATTGATGGTCTCTGTTTTTTCTCGAACAAAACGATAACTTT 69 FBan0014690 FBgn0037828 tomboy20 3 3R protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742 tomboy20 tomboy20 "CG14690, CG14690, dtomboy20" CDMC25480 1 26 8 DAC13-M20 23-CG14690-RA_2 CG14690 CTACCAGTAGCCTTTGAAATACTCCAAAATTGATGGTCTCTGTTTTTTCTCGAACAAAACGATAACTTT 69 FBan0014690 FBgn0037828 tomboy20 3 3R protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742 tomboy20 tomboy20 "CG14690, CG14690, dtomboy20" CDMC25481 1 1 9 DAC14-A08 3-CG17241-RA_1 CG17241 GTGCCCTGATCATCTGCTTTAGTGGATACCGCTTGCAGCATGTGGGAATTCGCGATAATCCCGGC 65 FBan0017241 FBgn0039033 Or94a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or94a Odorant receptor 94a "CG17241, 94D.1, DOR108, 94a" CDMC25481 1 2 9 DAC14-A08 3-CG17241-RA_1 CG17241 GTGCCCTGATCATCTGCTTTAGTGGATACCGCTTGCAGCATGTGGGAATTCGCGATAATCCCGGC 65 FBan0017241 FBgn0039033 Or94a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or94a Odorant receptor 94a "CG17241, 94D.1, DOR108, 94a" CDMC25482 1 3 9 DAC14-A20 2-CG17260-RA_1 CG17260 GGACGCTACACCTACAGAGTAATCGCTGTTGTTCCGGACAGCTATCCCATGCAGAGTGTGGAGCT 65 FBan0017260 FBgn0031498 CG17260 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17260 CG17260 CDMC25482 1 4 9 DAC14-A20 2-CG17260-RA_1 CG17260 GGACGCTACACCTACAGAGTAATCGCTGTTGTTCCGGACAGCTATCCCATGCAGAGTGTGGAGCT 65 FBan0017260 FBgn0031498 CG17260 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17260 CG17260 CDMC25483 1 5 9 DAC14-E08 6-CG17389-RA_3 CG17389 GTTGCAGAGCCTGGACAGCTTTTACTCAGCAATCAACACCAAGCTGAACTCGGGCCAGCATTCGG 65 FBan0017389 FBgn0033938 CG17389 2 2R CG17389 CG17389 CDMC25483 1 6 9 DAC14-E08 6-CG17389-RA_3 CG17389 GTTGCAGAGCCTGGACAGCTTTTACTCAGCAATCAACACCAAGCTGAACTCGGGCCAGCATTCGG 65 FBan0017389 FBgn0033938 CG17389 2 2R CG17389 CG17389 CDMC25484 1 7 9 DAC14-E20 2-CG17462-RA_1 CG17462 AACGAACTAGTCAGCCAAGGAGTAACTGATCCGGACACTGTGACCGTCCTCGACAAGGCCTCTGT 65 FBan0017462 FBgn0039251 CG17462 3 3R DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062; transport; GO:0006810 nucleic acid binding; GO:0003676; ; GO:0003676; transporter activity; GO:0005215; sigma DNA polymerase activity; GO:0019984; ; GO:0019984; ; GO:0005215; ; GO:0019984 membrane; GO:0016020; nucleus; GO:0005634 CG17462 CG17462 AAF56369 CDMC25484 1 8 9 DAC14-E20 2-CG17462-RA_1 CG17462 AACGAACTAGTCAGCCAAGGAGTAACTGATCCGGACACTGTGACCGTCCTCGACAAGGCCTCTGT 65 FBan0017462 FBgn0039251 CG17462 3 3R DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062; transport; GO:0006810 nucleic acid binding; GO:0003676; ; GO:0003676; transporter activity; GO:0005215; sigma DNA polymerase activity; GO:0019984; ; GO:0019984; ; GO:0005215; ; GO:0019984 membrane; GO:0016020; nucleus; GO:0005634 CG17462 CG17462 AAF56369 CDMC25485 1 9 9 DAC14-I08 3-CG17645-RA_1 CG17645 AGAAGGATCACGAGTACTACGCCTGCATTGTTGAGGATCCGCGCTACAAGGACCAACTGAAGCCG 65 FBan0017645 FBgn0011270 Pglym87 3 3R glycolysis; GO:0006096 phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 Pglym87 Pglym87 "CG17645, CG17645, pglym87, Pglym" CDMC25485 1 10 9 DAC14-I08 3-CG17645-RA_1 CG17645 AGAAGGATCACGAGTACTACGCCTGCATTGTTGAGGATCCGCGCTACAAGGACCAACTGAAGCCG 65 FBan0017645 FBgn0011270 Pglym87 3 3R glycolysis; GO:0006096 phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 Pglym87 Pglym87 "CG17645, CG17645, pglym87, Pglym" CDMC25486 1 11 9 DAC14-I20 3-CG17673-RA_1 CG17673 CAAAGTTTCCAATTCCAAGCCCCAATCCTCGTGATAAGTGGTGCCGTCTTAATTTGGGGCCCGCC 65 FBan0017673 FBgn0003034 Acp70A 3 3L "juvenile hormone biosynthesis; GO:0006718; negative regulation of female receptivity; GO:0007621; negative regulation of female receptivity, post-mating; GO:0045434; oogenesis (sensu Insecta); GO:0009993; oviposition; GO:0018991; post-mating behavior; GO:0045297; regulation of female receptivity, post-mating; GO:0046008; regulation of juvenile hormone biosynthesis; GO:0007557; regulation of oviposition; GO:0046662; regulation of oviposition, post-mating; GO:0048042" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp70A Accessory gland peptide 70A "CG17673, SP: sex-peptide, sex peptide, sex-peptide, Sex-peptide, Acp70, Sex peptide, ACP, Sex-Peptide, PapB: Paragonial-peptide-B, Spg70: sex peptide gene in 70, Paragonial-peptide-B, sex peptide gene in 70, SP" CDMC25486 1 12 9 DAC14-I20 3-CG17673-RA_1 CG17673 CAAAGTTTCCAATTCCAAGCCCCAATCCTCGTGATAAGTGGTGCCGTCTTAATTTGGGGCCCGCC 65 FBan0017673 FBgn0003034 Acp70A 3 3L "juvenile hormone biosynthesis; GO:0006718; negative regulation of female receptivity; GO:0007621; negative regulation of female receptivity, post-mating; GO:0045434; oogenesis (sensu Insecta); GO:0009993; oviposition; GO:0018991; post-mating behavior; GO:0045297; regulation of female receptivity, post-mating; GO:0046008; regulation of juvenile hormone biosynthesis; GO:0007557; regulation of oviposition; GO:0046662; regulation of oviposition, post-mating; GO:0048042" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp70A Accessory gland peptide 70A "CG17673, SP: sex-peptide, sex peptide, sex-peptide, Sex-peptide, Acp70, Sex peptide, ACP, Sex-Peptide, PapB: Paragonial-peptide-B, Spg70: sex peptide gene in 70, Paragonial-peptide-B, sex peptide gene in 70, SP" CDMC25487 1 13 9 DAC14-M08 2-CG17818-RA_1 CG17818 GACCAAAGTGGAGGACTTCATTCAGCGCGGAATTCGGGAGATTCTACTACTGGGACACCGGCAGG 65 FBan0017818 FBgn0027872 rdgBbeta 2 2R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 carrier activity; GO:0005386; ; GO:0005386; phosphatidylinositol transporter activity; GO:0008526; ; GO:0008526 intracellular; GO:0005622 rdgBbeta rdgBbeta "CG17818, CG17818, DrdgBbeta, BcDNA.LD14189, RdgB-beta, RdgBbeta, BcDNA:LD14189" CDMC25487 1 14 9 DAC14-M08 2-CG17818-RA_1 CG17818 GACCAAAGTGGAGGACTTCATTCAGCGCGGAATTCGGGAGATTCTACTACTGGGACACCGGCAGG 65 FBan0017818 FBgn0027872 rdgBbeta 2 2R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 carrier activity; GO:0005386; ; GO:0005386; phosphatidylinositol transporter activity; GO:0008526; ; GO:0008526 intracellular; GO:0005622 rdgBbeta rdgBbeta "CG17818, CG17818, DrdgBbeta, BcDNA.LD14189, RdgB-beta, RdgBbeta, BcDNA:LD14189" CDMC25488 1 15 9 DAC14-M20 3-CG17840-RA_1 CG17840 CAAGATTATGCGTGGCATTACCCTGCGTCCACTCAGTGACTACGGCACCGACTCCTATCTCAGCG 65 FBan0017840 FBgn0031611 CG17840 2 2L CG17840 CG17840 CDMC25488 1 16 9 DAC14-M20 3-CG17840-RA_1 CG17840 CAAGATTATGCGTGGCATTACCCTGCGTCCACTCAGTGACTACGGCACCGACTCCTATCTCAGCG 65 FBan0017840 FBgn0031611 CG17840 2 2L CG17840 CG17840 CDMC25489 1 17 9 DAC15-A08 14-CG12442-RA_1 CG12442 TCGAATTCGAGTTGGAAAAGATGGAAAGGGGCAGTTCTAATGGGGAAAGCGAAGAGGAAAGTCAGCGG 68 FBan0012442 FBgn0033770 CG12442 2 2R CG12442 CG12442 BcDNA:AT27450 CDMC25489 1 18 9 DAC15-A08 14-CG12442-RA_1 CG12442 TCGAATTCGAGTTGGAAAAGATGGAAAGGGGCAGTTCTAATGGGGAAAGCGAAGAGGAAAGTCAGCGG 68 FBan0012442 FBgn0033770 CG12442 2 2R CG12442 CG12442 BcDNA:AT27450 CDMC25490 1 19 9 DAC15-A20 3-CG12720-RA_5 CG12720 CGCACCCAATCGCTACTCATGTCCCTTCGCAAGCATTCCGACTACAAGCTGAAGTACGAGGAGAAGGG 68 FBan0012720 FBgn0030379 CG12720 X X CG12720 CG12720 CDMC25490 1 20 9 DAC15-A20 3-CG12720-RA_5 CG12720 CGCACCCAATCGCTACTCATGTCCCTTCGCAAGCATTCCGACTACAAGCTGAAGTACGAGGAGAAGGG 68 FBan0012720 FBgn0030379 CG12720 X X CG12720 CG12720 CDMC25491 1 21 9 DAC15-E08 1-CG13330-RA_1 CG13330 CGGAAGACTAGAGTATGTCAGGATCCTAGAAGTGTCTCGTCCGCTACCCGTTCACTTACTCCCCCGCC 68 FBan0013330 FBgn0033848 CG13330 2 2R CG13330 CG13330 CDMC25491 1 22 9 DAC15-E08 1-CG13330-RA_1 CG13330 CGGAAGACTAGAGTATGTCAGGATCCTAGAAGTGTCTCGTCCGCTACCCGTTCACTTACTCCCCCGCC 68 FBan0013330 FBgn0033848 CG13330 2 2R CG13330 CG13330 CDMC25492 1 23 9 DAC15-E20 1-CG1339-RA_1 CG1339 CCGTCATGCTGGATTCCTTGTGGTACAAGCCCTACTTCCTCTCGTCCATCTTCCTCTACTGGGTGCTG 68 FBan0001339 FBgn0033202 Gr43b 2 2R biological process unknown; GO:0000004 NOT taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr43b Gr43b "CG1339, CG1339" CDMC25492 1 24 9 DAC15-E20 1-CG1339-RA_1 CG1339 CCGTCATGCTGGATTCCTTGTGGTACAAGCCCTACTTCCTCTCGTCCATCTTCCTCTACTGGGTGCTG 68 FBan0001339 FBgn0033202 Gr43b 2 2R biological process unknown; GO:0000004 NOT taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr43b Gr43b "CG1339, CG1339" CDMC25493 1 25 9 DAC15-I08 3-CG13761-RB_4 CG13761 GGACATGGAATGCCTGGACTGGTCGAAAATCTTCATCAGCTACATCGACCTGCTCAATACGCCGGAGC 68 FBan0013761 FBgn0011566 Bzd X X translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 cellular component unknown; GO:0008372 Bzd Buzidau "CG13761, CG13761, CG13761, CG13761, EG:BACR7C10.4" CDMC25493 1 26 9 DAC15-I08 3-CG13761-RB_4 CG13761 GGACATGGAATGCCTGGACTGGTCGAAAATCTTCATCAGCTACATCGACCTGCTCAATACGCCGGAGC 68 FBan0013761 FBgn0011566 Bzd X X translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 cellular component unknown; GO:0008372 Bzd Buzidau "CG13761, CG13761, CG13761, CG13761, EG:BACR7C10.4" CDMC25494 1 1 10 DAC15-I20 2-CG13842-RA_3 CG13842 AGCACGATGTCAAGCTGTGCCTGAATGTCTTCATTACCTTCCAACTGCCCAAACTCACTGCCGACCTG 68 FBan0013842 FBgn0039009 CG13842 3 3R CG13842 CG13842 CDMC25494 1 2 10 DAC15-I20 2-CG13842-RA_3 CG13842 AGCACGATGTCAAGCTGTGCCTGAATGTCTTCATTACCTTCCAACTGCCCAAACTCACTGCCGACCTG 68 FBan0013842 FBgn0039009 CG13842 3 3R CG13842 CG13842 CDMC25495 1 3 10 DAC15-M08 3-CG14228-RA_2 CG14228 TCGAGCCCAAGGAGTTCATACTCACCGACAACGAGATGGAGCAGATCACCAATGAGATGGAGCGCAAC 68 FBan0014228 FBgn0013951 Mer X X axis specification; GO:0009798; cell-cell signaling; GO:0007267; cytoskeleton organization and biogenesis; GO:0007010; endocytosis; GO:0006897; negative regulation of imaginal disc growth; GO:0045571; pole plasm mRNA localization; GO:0019094; regulation of cell growth; GO:0001558; regulation of cell proliferation; GO:0042127 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein binding; GO:0005515; ; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 NOT fusome; GO:0045169; adherens junction; GO:0005912; apical plasma membrane; GO:0016324; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; zonula adherens; GO:0005915 Mer Merlin "CG14228, CG14228, Dmerlin, merlin, EMR2, D Merlin, Emr2: Ezrin-moesin-radixin-2, Ezrin-moesin-radixin-2, Merlin" CDMC25495 1 4 10 DAC15-M08 3-CG14228-RA_2 CG14228 TCGAGCCCAAGGAGTTCATACTCACCGACAACGAGATGGAGCAGATCACCAATGAGATGGAGCGCAAC 68 FBan0014228 FBgn0013951 Mer X X axis specification; GO:0009798; cell-cell signaling; GO:0007267; cytoskeleton organization and biogenesis; GO:0007010; endocytosis; GO:0006897; negative regulation of imaginal disc growth; GO:0045571; pole plasm mRNA localization; GO:0019094; regulation of cell growth; GO:0001558; regulation of cell proliferation; GO:0042127 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein binding; GO:0005515; ; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 NOT fusome; GO:0045169; adherens junction; GO:0005912; apical plasma membrane; GO:0016324; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; zonula adherens; GO:0005915 Mer Merlin "CG14228, CG14228, Dmerlin, merlin, EMR2, D Merlin, Emr2: Ezrin-moesin-radixin-2, Ezrin-moesin-radixin-2, Merlin" CDMC25496 1 5 10 DAC15-M20 3-CG14339-RA_2 CG14339 ACCTAAACATCACCATTCCAACCAGTCGGGGCACCATGTTTCTGGAGGTCTTTAGAACATTCGCGCGG 68 FBan0014339 FBgn0031301 CG14339 2 2L CG14339 CG14339 CDMC25496 1 6 10 DAC15-M20 3-CG14339-RA_2 CG14339 ACCTAAACATCACCATTCCAACCAGTCGGGGCACCATGTTTCTGGAGGTCTTTAGAACATTCGCGCGG 68 FBan0014339 FBgn0031301 CG14339 2 2L CG14339 CG14339 CDMC25497 1 7 10 DAC16-A08 6-CG31044-RA_1 CG31044 GCACGGCCATGAAGCTACTCCTCCCACACGATTTGCTTCACGCTCATTTAAATGCCAACGCACCG 65 FBan0031044 FBgn0051044 CG31044 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31044 CG31044 BcDNA:SD09455 CDMC25497 1 8 10 DAC16-A08 6-CG31044-RA_1 CG31044 GCACGGCCATGAAGCTACTCCTCCCACACGATTTGCTTCACGCTCATTTAAATGCCAACGCACCG 65 FBan0031044 FBgn0051044 CG31044 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31044 CG31044 BcDNA:SD09455 CDMC25498 1 9 10 DAC16-A20 2-CG31075-RA_2 CG31075 GTCCCCAGATCGACGATGACATGCTGACCAAGGTGTTGGGCTACATCGAGAGTGGCAAGAAGGAG 65 FBan0031075 FBgn0051075 CG31075 3 3R amino acid catabolism; GO:0009063; pyruvate metabolism; GO:0006090 aldehyde dehydrogenase (NAD) activity; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG31075 CG31075 "CG6309, CG6309, CT19744" CDMC25498 1 10 10 DAC16-A20 2-CG31075-RA_2 CG31075 GTCCCCAGATCGACGATGACATGCTGACCAAGGTGTTGGGCTACATCGAGAGTGGCAAGAAGGAG 65 FBan0031075 FBgn0051075 CG31075 3 3R amino acid catabolism; GO:0009063; pyruvate metabolism; GO:0006090 aldehyde dehydrogenase (NAD) activity; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG31075 CG31075 "CG6309, CG6309, CT19744" CDMC25499 1 11 10 DAC16-E08 3-CG31175-RA_2 CG31175 TGCAAGGAGTACCCGATCGTCGGCTTCCGCTACAGATGCCTCAAGTGCTTCAACTTCGACATGTG 65 FBan0031175 FBgn0024242 Dys 3 3R cytoskeleton organization and biogenesis; GO:0007010; muscle development; GO:0007517; nitric oxide mediated signal transduction; GO:0007263; synaptic transmission; GO:0007268 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307; structural molecule activity; GO:0005198; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0008307; ; GO:0008270; ; GO:0003779; ; GO:0005200; ; GO:0008307 cytoskeleton; GO:0005856; dystrophin-associated glycoprotein complex; GO:0016010 Dys dystrophin "CG7240, CG7243, CG31175, CG17750, CG7240, CG7243, CG7240, CG7243, GI3046716, DmDYS, dmDLP, DLP2, Dystrophin-like protein 2, DLP186, Dystrophin-like protein 186, DLP1, Dystrophin-like protein 1, DLP3, Dystrophin-like protein 3, dmDp186, DmDLP" CDMC25499 1 12 10 DAC16-E08 3-CG31175-RA_2 CG31175 TGCAAGGAGTACCCGATCGTCGGCTTCCGCTACAGATGCCTCAAGTGCTTCAACTTCGACATGTG 65 FBan0031175 FBgn0024242 Dys 3 3R cytoskeleton organization and biogenesis; GO:0007010; muscle development; GO:0007517; nitric oxide mediated signal transduction; GO:0007263; synaptic transmission; GO:0007268 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307; structural molecule activity; GO:0005198; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0008307; ; GO:0008270; ; GO:0003779; ; GO:0005200; ; GO:0008307 cytoskeleton; GO:0005856; dystrophin-associated glycoprotein complex; GO:0016010 Dys dystrophin "CG7240, CG7243, CG31175, CG17750, CG7240, CG7243, CG7240, CG7243, GI3046716, DmDYS, dmDLP, DLP2, Dystrophin-like protein 2, DLP186, Dystrophin-like protein 186, DLP1, Dystrophin-like protein 1, DLP3, Dystrophin-like protein 3, dmDp186, DmDLP" CDMC25500 1 13 10 DAC16-E20 8-CG31224-RA_2 CG31224 CGGCAAGAGCTCCACAACGAAGACCAACCACAACAAGCATCTGAAGATCCACCATTCGCGCGATC 65 FBan0031224 FBgn0051224 CG31224 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31224 CG31224 "CG7696, CG17796, CG7696, l(3)c00083, lethal (3) c00083" CDMC25500 1 14 10 DAC16-E20 8-CG31224-RA_2 CG31224 CGGCAAGAGCTCCACAACGAAGACCAACCACAACAAGCATCTGAAGATCCACCATTCGCGCGATC 65 FBan0031224 FBgn0051224 CG31224 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31224 CG31224 "CG7696, CG17796, CG7696, l(3)c00083, lethal (3) c00083" CDMC25501 1 15 10 DAC16-I08 2-CG31305-RA_1 CG31305 CGACGGCCCGCATTGTTCGTTAACCTTGAGCACGACTTTTGACGTTACAGCGGAACGGAATCTGC 65 FBgn0051305 CDMC25501 1 16 10 DAC16-I08 2-CG31305-RA_1 CG31305 CGACGGCCCGCATTGTTCGTTAACCTTGAGCACGACTTTTGACGTTACAGCGGAACGGAATCTGC 65 FBgn0051305 CDMC25502 1 17 10 DAC16-I20 4-CG3132-RA_1 CG3132 GATACCCCCATTCTGAACGCGAGGACCGTTTAGTCGTCGGCCTAAGGACCATTGCGACTTGCATC 65 FBan0003132 FBgn0037977 Ect3 3 3R autophagic cell death; GO:0048102; carbohydrate metabolism; GO:0005975; salivary gland cell autophagic cell death; GO:0035071 beta-galactosidase activity; GO:0004565 ; EC:3.2.1.23; ; GO:0004565 ; EC:3.2.1.23 beta-galactosidase complex; GO:0009341; lysosome; GO:0005764 Ect3 Ect3 "CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, beta-galactosidase" CDMC25502 1 18 10 DAC16-I20 4-CG3132-RA_1 CG3132 GATACCCCCATTCTGAACGCGAGGACCGTTTAGTCGTCGGCCTAAGGACCATTGCGACTTGCATC 65 FBan0003132 FBgn0037977 Ect3 3 3R autophagic cell death; GO:0048102; carbohydrate metabolism; GO:0005975; salivary gland cell autophagic cell death; GO:0035071 beta-galactosidase activity; GO:0004565 ; EC:3.2.1.23; ; GO:0004565 ; EC:3.2.1.23 beta-galactosidase complex; GO:0009341; lysosome; GO:0005764 Ect3 Ect3 "CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, CG3132, beta-galactosidase" CDMC25503 1 19 10 DAC16-M08 47-CG31462-RA_1 CG31462 ATCTACAAGAGCTACAAATCCGAGATTGATCTCAGCAAGAACCTGCACTATTTGGATGCCTACTT 65 FBan0031462 FBgn0051462 CG31462 3 3R CG31462 CG31462 CG11729 CDMC25503 1 20 10 DAC16-M08 47-CG31462-RA_1 CG31462 ATCTACAAGAGCTACAAATCCGAGATTGATCTCAGCAAGAACCTGCACTATTTGGATGCCTACTT 65 FBan0031462 FBgn0051462 CG31462 3 3R CG31462 CG31462 CG11729 CDMC25504 1 21 10 DAC16-M20 23-CG31496-RA_1 CG31496 CCACAGGTTATCCTACTCTCAAAGAAAACCGTTTATTATCCCAAAAAGCGATCATCTGCACCCAC 65 FBan0031496 FBgn0051496 CG31496 3 3R CG31496 CG31496 CG14604 CDMC25504 1 22 10 DAC16-M20 23-CG31496-RA_1 CG31496 CCACAGGTTATCCTACTCTCAAAGAAAACCGTTTATTATCCCAAAAAGCGATCATCTGCACCCAC 65 FBan0031496 FBgn0051496 CG31496 3 3R CG31496 CG31496 CG14604 CDMC25505 1 23 10 DAC17-A08 18-CG32639-RA_1 CG32639 GTGGGTCGTATGGAGGATGATCCATCCCTTAATCCCAAGCCATCAAGGGAGCGAAGTACGGCCGG 65 FBan0032639 FBgn0052639 CG32639 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32639 CG32639 CDMC25505 1 24 10 DAC17-A08 18-CG32639-RA_1 CG32639 GTGGGTCGTATGGAGGATGATCCATCCCTTAATCCCAAGCCATCAAGGGAGCGAAGTACGGCCGG 65 FBan0032639 FBgn0052639 CG32639 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32639 CG32639 CDMC25506 1 25 10 DAC17-A20 15-CG32682-RA_1 CG32682 AGCAGCAACCGAATAAGATTGTCATCGAAATTGGTCTGAGCAATGACAGCGGACCAAGCAGTGCG 65 FBan0032682 FBgn0052682 CG32682 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32682 CG32682 CDMC25506 1 26 10 DAC17-A20 15-CG32682-RA_1 CG32682 AGCAGCAACCGAATAAGATTGTCATCGAAATTGGTCTGAGCAATGACAGCGGACCAAGCAGTGCG 65 FBan0032682 FBgn0052682 CG32682 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32682 CG32682 CDMC25507 1 1 11 DAC17-E08 1-CG32808-RA_1 CG32808 GTGTCGGCCTACGTGGACTGGATTGTAGAGACGGTAAATAGCTATTCGCCCCCGTCGTCGCTTTG 65 FBan0032808 FBgn0052808 CG32808 X X defense response; GO:0006952; protein metabolism; GO:0019538; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004263 ; EC:3.4.21.1 CG32808 CG32808 EG:80H7.1 CDMC25507 1 2 11 DAC17-E08 1-CG32808-RA_1 CG32808 GTGTCGGCCTACGTGGACTGGATTGTAGAGACGGTAAATAGCTATTCGCCCCCGTCGTCGCTTTG 65 FBan0032808 FBgn0052808 CG32808 X X defense response; GO:0006952; protein metabolism; GO:0019538; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004263 ; EC:3.4.21.1 CG32808 CG32808 EG:80H7.1 CDMC25508 1 3 11 DAC17-E20 23-CG32829-RA_3 CG32829 ACAAGAAGGGTCACAAGGAATTAGAATACCACAAGAAGTTCAAAAAGGACGAGTACATCAAGGAG 65 FBan0032829 FBgn0052829 CG32829 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32829 CG32829 CDMC25508 1 4 11 DAC17-E20 23-CG32829-RA_3 CG32829 ACAAGAAGGGTCACAAGGAATTAGAATACCACAAGAAGTTCAAAAAGGACGAGTACATCAAGGAG 65 FBan0032829 FBgn0052829 CG32829 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32829 CG32829 CDMC25509 1 5 11 DAC17-I08 23-CG33061-RA_1 CG33061 ACCGGTGGCGAGTCTTTTAATCAATAGATGTCAACACAACCAGATGGCATACCTGAAGTTGAGCA 65 FBan0033061 FBgn0053061 CG33061 3 3L CG33061 CG33061 "CG13057, CG13057" CDMC25509 1 6 11 DAC17-I08 23-CG33061-RA_1 CG33061 ACCGGTGGCGAGTCTTTTAATCAATAGATGTCAACACAACCAGATGGCATACCTGAAGTTGAGCA 65 FBan0033061 FBgn0053061 CG33061 3 3L CG33061 CG33061 "CG13057, CG13057" CDMC25510 1 7 11 DAC17-I20 2-CG33102-RA_2 CG33102 ATACGAAGGCACAGGAGGTGATGGACAAGTTTCGCATACGTCACTGCAAGGAACGGGATCTGGCT 65 FBan0033102 FBgn0042711 Hex-t1 3 3R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-t1 Hex-t1 "CG5443, CG54430, CG33102, CG5443, CG5443, CG54430, Hex, Hexokinase, HK, hexokinase, DHK-453" CDMC25510 1 8 11 DAC17-I20 2-CG33102-RA_2 CG33102 ATACGAAGGCACAGGAGGTGATGGACAAGTTTCGCATACGTCACTGCAAGGAACGGGATCTGGCT 65 FBan0033102 FBgn0042711 Hex-t1 3 3R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-t1 Hex-t1 "CG5443, CG54430, CG33102, CG5443, CG5443, CG54430, Hex, Hexokinase, HK, hexokinase, DHK-453" CDMC25511 1 9 11 DAC17-M08 1-CG33199-RA_2 CG33199 TGGAACGGACCATGAAAACAAGCAATCTCGGCCTGTACGCTTTCCGTTTAACCTTCGGTCAGGCG 65 FBan0033199 FBgn0053199 CG33199 2 2R CG33199 CG33199 CDMC25511 1 10 11 DAC17-M08 1-CG33199-RA_2 CG33199 TGGAACGGACCATGAAAACAAGCAATCTCGGCCTGTACGCTTTCCGTTTAACCTTCGGTCAGGCG 65 FBan0033199 FBgn0053199 CG33199 2 2R CG33199 CG33199 CDMC25512 1 11 11 DAC17-M20 3-CG33235-RA_2 CG33235 AGAAAACCAAAGCAGAGGTGGCTAACCCTACCCTAGCCGAAGTGTCGCCACAGGAAGATGAGAGC 65 FBgn0053235 CDMC25512 1 12 11 DAC17-M20 3-CG33235-RA_2 CG33235 AGAAAACCAAAGCAGAGGTGGCTAACCCTACCCTAGCCGAAGTGTCGCCACAGGAAGATGAGAGC 65 FBgn0053235 CDMC25513 1 13 11 DAC18-A08 3-CG5851-RA_4 CG5851 GCTGGAGCTGTATGACAACCAGATCACCAAGATTGAGAATTTGGACGACTTGCCCCACCTGGAGGTGC 68 FBan0005851 FBgn0028992 sds22 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; intracellular protein transport; GO:0006886; mitosis; GO:0007067; phagocytosis; GO:0006909; regulation of progression through cell cycle; GO:0000074 phosphatase regulator activity; GO:0019208; ; GO:0019208; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 extracellular region; GO:0005576 sds22 sds22 "CG5851, CT18355" CDMC25513 1 14 11 DAC18-A08 3-CG5851-RA_4 CG5851 GCTGGAGCTGTATGACAACCAGATCACCAAGATTGAGAATTTGGACGACTTGCCCCACCTGGAGGTGC 68 FBan0005851 FBgn0028992 sds22 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; intracellular protein transport; GO:0006886; mitosis; GO:0007067; phagocytosis; GO:0006909; regulation of progression through cell cycle; GO:0000074 phosphatase regulator activity; GO:0019208; ; GO:0019208; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 extracellular region; GO:0005576 sds22 sds22 "CG5851, CT18355" CDMC25514 1 15 11 DAC18-A20 18-CG5895-RA_8 CG5895 GTAGTTTTCCCATCGGCTTTTACAAGCATCCAGAGATCTACAGCTCGCTATTCCGGCTAATTCGCCAG 68 FBan0005895 FBgn0036560 CG5895 3 3L CG5895 CG5895 CDMC25514 1 16 11 DAC18-A20 18-CG5895-RA_8 CG5895 GTAGTTTTCCCATCGGCTTTTACAAGCATCCAGAGATCTACAGCTCGCTATTCCGGCTAATTCGCCAG 68 FBan0005895 FBgn0036560 CG5895 3 3L CG5895 CG5895 CDMC25515 1 17 11 DAC18-E08 1-CG6262-RD_2 CG6262 GGAGTGTGTGGCAAGCATCAAGAGTCCTGTGGTCCGAGAGGTTATGTACACCGAACTCAAGTCGGCTG 68 FBan0006262 FBgn0034121 CG6262 2 2R disaccharide metabolism; GO:0005984; trehalose metabolism; GO:0005991 "trehalase activity; GO:0015927 ; EC:3.2.1.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; ; GO:0015927 ; EC:3.2.1.-; ; GO:0004555 ; EC:3.2.1.28" CG6262 CG6262 CDMC25515 1 18 11 DAC18-E08 1-CG6262-RD_2 CG6262 GGAGTGTGTGGCAAGCATCAAGAGTCCTGTGGTCCGAGAGGTTATGTACACCGAACTCAAGTCGGCTG 68 FBan0006262 FBgn0034121 CG6262 2 2R disaccharide metabolism; GO:0005984; trehalose metabolism; GO:0005991 "trehalase activity; GO:0015927 ; EC:3.2.1.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; ; GO:0015927 ; EC:3.2.1.-; ; GO:0004555 ; EC:3.2.1.28" CG6262 CG6262 CDMC25516 1 19 11 DAC18-E20 2-CG6339-RA_1 CG6339 CCCACCACGAACTTGGATCGCGCCAATATAAACTCGCTATGTGAAGCCCTGAATTGCATCGTGGAGGA 68 FBan0006339 FBgn0034728 rad50 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; larval development (sensu Insecta); GO:0002168; telomere maintenance; GO:0000723 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684; endodeoxyribonuclease activity; GO:0004520; exodeoxyribonuclease activity; GO:0004529; lyase activity; GO:0016829 ; EC:4.-.-.-; ATPase activity; GO:0016887; ; GO:0004520; ; GO:0004529; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016887 Mre11 complex; GO:0030870 rad50 rad50 "CG6339, Dmrad50, Rad50" CDMC25516 1 20 11 DAC18-E20 2-CG6339-RA_1 CG6339 CCCACCACGAACTTGGATCGCGCCAATATAAACTCGCTATGTGAAGCCCTGAATTGCATCGTGGAGGA 68 FBan0006339 FBgn0034728 rad50 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; larval development (sensu Insecta); GO:0002168; telomere maintenance; GO:0000723 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684; endodeoxyribonuclease activity; GO:0004520; exodeoxyribonuclease activity; GO:0004529; lyase activity; GO:0016829 ; EC:4.-.-.-; ATPase activity; GO:0016887; ; GO:0004520; ; GO:0004529; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016887 Mre11 complex; GO:0030870 rad50 rad50 "CG6339, Dmrad50, Rad50" CDMC25517 1 21 11 DAC18-I08 2-CG6745-RA_1 CG6745 ACAGGCAATGGCTAAGGAGGACAATGAAAAGAAGGCGGTAGGAACCCAGGAGGAACAAATGGAGGTGG 68 FBan0006745 FBgn0035901 CG6745 3 3L CG6745 CG6745 CT20937 CDMC25517 1 22 11 DAC18-I08 2-CG6745-RA_1 CG6745 ACAGGCAATGGCTAAGGAGGACAATGAAAAGAAGGCGGTAGGAACCCAGGAGGAACAAATGGAGGTGG 68 FBan0006745 FBgn0035901 CG6745 3 3L CG6745 CG6745 CT20937 CDMC25518 1 23 11 DAC18-I20 1-CG6947-RA_3 CG6947 AGCGCTCTGGACTTCAATACCTTCCCTGTTTCGAGTGATCCCTCCGGTTTTTGCTACTGCCTCGACTC 68 FBan0006947 FBgn0036233 CG6947 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6947 CG6947 CDMC25518 1 24 11 DAC18-I20 1-CG6947-RA_3 CG6947 AGCGCTCTGGACTTCAATACCTTCCCTGTTTCGAGTGATCCCTCCGGTTTTTGCTACTGCCTCGACTC 68 FBan0006947 FBgn0036233 CG6947 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6947 CG6947 CDMC25519 1 25 11 DAC18-M08 1-CG7335-RA_1 CG7335 GCGAAGAGCACGGACTCAATGGGAAAAAAGCCAGCCCAAAAAGATGCCCTATCTACCTCCTGATCCCC 68 FBan0007335 FBgn0036941 CG7335 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7335 CG7335 BcDNA:AT09463 CDMC25519 1 26 11 DAC18-M08 1-CG7335-RA_1 CG7335 GCGAAGAGCACGGACTCAATGGGAAAAAAGCCAGCCCAAAAAGATGCCCTATCTACCTCCTGATCCCC 68 FBan0007335 FBgn0036941 CG7335 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7335 CG7335 BcDNA:AT09463 CDMC25520 1 1 12 DAC18-M20 3-CG7436-RA_2 CG7436 GGAGGACGATGATGCCATGTTCCGTTTCGATTACCAACCCGAGTTTCTAAAGTGGTCGCTGCAGCCAC 68 FBan0007436 FBgn0020392 Nmt 3 3L N-terminal protein myristoylation; GO:0006499; dorsal closure; GO:0007391 glycylpeptide N-tetradecanoyltransferase activity; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97 Nmt N-myristoyl transferase "CG7436, l(3)j1C7, dNMT, l(3)j1c7, Nmt1, N-myristoyl transferase" CDMC25520 1 2 12 DAC18-M20 3-CG7436-RA_2 CG7436 GGAGGACGATGATGCCATGTTCCGTTTCGATTACCAACCCGAGTTTCTAAAGTGGTCGCTGCAGCCAC 68 FBan0007436 FBgn0020392 Nmt 3 3L N-terminal protein myristoylation; GO:0006499; dorsal closure; GO:0007391 glycylpeptide N-tetradecanoyltransferase activity; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97 Nmt N-myristoyl transferase "CG7436, l(3)j1C7, dNMT, l(3)j1c7, Nmt1, N-myristoyl transferase" CDMC25521 1 3 12 DAC19-A08 18-CG1776-RA_1 CG1776 GCCTGGCATCCTTGTAGCGGATGACCAGCCCTATTAACCACTTTACACTGTGATAAAGACAGCCATTGA 69 FBan0001776 FBgn0033441 CG1776 2 2R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; ; GO:0004687 ; EC:2.7.1.117 CG1776 CG1776 MLCK-like CDMC25521 1 4 12 DAC19-A08 18-CG1776-RA_1 CG1776 GCCTGGCATCCTTGTAGCGGATGACCAGCCCTATTAACCACTTTACACTGTGATAAAGACAGCCATTGA 69 FBan0001776 FBgn0033441 CG1776 2 2R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; ; GO:0004687 ; EC:2.7.1.117 CG1776 CG1776 MLCK-like CDMC25522 1 5 12 DAC19-A20 23-CG17786-RA_9 CG17786 TGCACAAATAACAATCCCATAGTTAACCCGACCCATCATCAATACACCGCATTTGTAACCCACACACAA 69 FBan0017786 FBgn0039167 CG17786 3 3R CG17786 CG17786 CDMC25522 1 6 12 DAC19-A20 23-CG17786-RA_9 CG17786 TGCACAAATAACAATCCCATAGTTAACCCGACCCATCATCAATACACCGCATTTGTAACCCACACACAA 69 FBan0017786 FBgn0039167 CG17786 3 3R CG17786 CG17786 CDMC25523 1 7 12 DAC19-E08 8-CG17838-RD_1 CG17838 CCGTCCAGGGATCCATAGATCTGGCAGACGATCCTTTTTATTACACTGCCCCATTTATCGCCGCTACCC 69 FBan0017838 FBgn0038826 CG17838 3 3R mRNA binding; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG17838 CG17838 "l(3)03806, cg17838, AI945337, anon-WO0118547.613" CDMC25523 1 8 12 DAC19-E08 8-CG17838-RD_1 CG17838 CCGTCCAGGGATCCATAGATCTGGCAGACGATCCTTTTTATTACACTGCCCCATTTATCGCCGCTACCC 69 FBan0017838 FBgn0038826 CG17838 3 3R mRNA binding; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG17838 CG17838 "l(3)03806, cg17838, AI945337, anon-WO0118547.613" CDMC25524 1 9 12 DAC19-E20 17-CG17866-RA_6 CG17866 GGCGGATGGTTGAGGAAAAACCAATGCCTTCAGGATCCACTACCGATGGAACTAATTTGTCCATTACCA 69 CDMC25524 1 10 12 DAC19-E20 17-CG17866-RA_6 CG17866 GGCGGATGGTTGAGGAAAAACCAATGCCTTCAGGATCCACTACCGATGGAACTAATTTGTCCATTACCA 69 CDMC25525 1 11 12 DAC19-I08 2-CG17912-RA_1 CG17912 GGATCTCAGGGATCACGAACGTCAGAAGAATGGTGGCAAGTCTGATTCGGACGATGATGAACCGGTGGC 69 FBan0017912 FBgn0032600 CG17912 2 2L DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG17912 CG17912 BcDNA:LD27810 CDMC25525 1 12 12 DAC19-I08 2-CG17912-RA_1 CG17912 GGATCTCAGGGATCACGAACGTCAGAAGAATGGTGGCAAGTCTGATTCGGACGATGATGAACCGGTGGC 69 FBan0017912 FBgn0032600 CG17912 2 2L DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG17912 CG17912 BcDNA:LD27810 CDMC25526 1 13 12 DAC19-I20 2-CG17928-RA_1 CG17928 CCTGGTCCTTTCCCTGACCAAAAGAAACGTTCTGTGCTGGGATGATCTCATTGGCTTCAGTCTGCCCAT 69 FBan0017928 FBgn0032603 CG17928 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17928 CG17928 anon-WO0118547.16 CDMC25526 1 14 12 DAC19-I20 2-CG17928-RA_1 CG17928 CCTGGTCCTTTCCCTGACCAAAAGAAACGTTCTGTGCTGGGATGATCTCATTGGCTTCAGTCTGCCCAT 69 FBan0017928 FBgn0032603 CG17928 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17928 CG17928 anon-WO0118547.16 CDMC25527 1 15 12 DAC19-M08 24-CG17967-RA_1 CG17967 TCATCAGAATGCCAGTTAATAGCTGCCTTACAAAATAATATATTTTACACACCTTTTAATGGAATAGCT 69 FBan0017967 FBgn0000425 DebA 2 2R plasma membrane; GO:0005886 DebA Developmental embryonic A "CG17967, Deb-A, Deb" CDMC25527 1 16 12 DAC19-M08 24-CG17967-RA_1 CG17967 TCATCAGAATGCCAGTTAATAGCTGCCTTACAAAATAATATATTTTACACACCTTTTAATGGAATAGCT 69 FBan0017967 FBgn0000425 DebA 2 2R plasma membrane; GO:0005886 DebA Developmental embryonic A "CG17967, Deb-A, Deb" CDMC25528 1 17 12 DAC19-M20 3-CG17985-RA_4 CG17985 GCGCCTGAACAAGATCGACCGCGAAAATGAAATCCACGCACATCGGGTTATTCGCATTCCGGTTACAGT 69 FBan0017985 FBgn0033199 CG17985 2 2R CG17985 CG17985 CDMC25528 1 18 12 DAC19-M20 3-CG17985-RA_4 CG17985 GCGCCTGAACAAGATCGACCGCGAAAATGAAATCCACGCACATCGGGTTATTCGCATTCCGGTTACAGT 69 FBan0017985 FBgn0033199 CG17985 2 2R CG17985 CG17985 CDMC25529 1 19 12 DAC20-A08 3-CG10594-RA_2 CG10594 TAGCATCGGGAAGCGGACTTGCATCGGCCAGAATTTGGTGAGAGGATTTGGTTTTCTGGTCGTGG 65 FBgn0035618 CDMC25529 1 20 12 DAC20-A08 3-CG10594-RA_2 CG10594 TAGCATCGGGAAGCGGACTTGCATCGGCCAGAATTTGGTGAGAGGATTTGGTTTTCTGGTCGTGG 65 FBgn0035618 CDMC25530 1 21 12 DAC20-A20 3-CG10637-RA_5 CG10637 ATACCTACCCCTGCGAAACCCAAGAAGGAGAAGTCCAATCTGGCTGTAAGGGTTCTGCCGGGAAA 65 FBan0010637 FBgn0015772 Nak 2 2L asymmetric cell division; GO:0008356; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; structural constituent of ribosome; GO:0003735; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003735; ; GO:0005515; ; GO:0004674; ; GO:0004674 intracellular; GO:0005622; ribosome; GO:0005840 Nak Numb-associated kinase "CG10637, CG10637, nak, Numb-associated kinase" CDMC25530 1 22 12 DAC20-A20 3-CG10637-RA_5 CG10637 ATACCTACCCCTGCGAAACCCAAGAAGGAGAAGTCCAATCTGGCTGTAAGGGTTCTGCCGGGAAA 65 FBan0010637 FBgn0015772 Nak 2 2L asymmetric cell division; GO:0008356; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; structural constituent of ribosome; GO:0003735; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003735; ; GO:0005515; ; GO:0004674; ; GO:0004674 intracellular; GO:0005622; ribosome; GO:0005840 Nak Numb-associated kinase "CG10637, CG10637, nak, Numb-associated kinase" CDMC25531 1 23 12 DAC20-E08 3-CG10738-RB_4 CG10738 CGCTGCGTAGCTGACCAGTTGAAGAAGGGTCACAAGGTGGACCCCGAACACTACGAACAGGTTAG 65 FBan0010738 FBgn0036368 CG10738 3 3L cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; receptor activity; GO:0004872; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 CG10738 CG10738 GYC CDMC25531 1 24 12 DAC20-E08 3-CG10738-RB_4 CG10738 CGCTGCGTAGCTGACCAGTTGAAGAAGGGTCACAAGGTGGACCCCGAACACTACGAACAGGTTAG 65 FBan0010738 FBgn0036368 CG10738 3 3L cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; receptor activity; GO:0004872; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 CG10738 CG10738 GYC CDMC25532 1 25 12 DAC20-E20 14-CG1076-RA_1 CG1076 CAATCTGGCCGTTCCCACTGTGCTGGAGATTCCCTCGAAACAGCATCCCTACGATTCCTCCAGGG 65 FBan0001076 FBgn0037402 CG1076 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG1076 CG1076 CDMC25532 1 26 12 DAC20-E20 14-CG1076-RA_1 CG1076 CAATCTGGCCGTTCCCACTGTGCTGGAGATTCCCTCGAAACAGCATCCCTACGATTCCTCCAGGG 65 FBan0001076 FBgn0037402 CG1076 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG1076 CG1076 CDMC25533 1 1 13 DAC20-I08 3-CG10898-RA_3 CG10898 CCCGGGAAGTTTTCGAAGAGACTGGTCTAAATGCCGAGCTGACCACTCTATTAGCGGTGGAGGCC 65 FBan0010898 FBgn0037911 CG10898 3 3R DNA repair; GO:0006281 CG10898 CG10898 anon-WO0118547.280 CDMC25533 1 2 13 DAC20-I08 3-CG10898-RA_3 CG10898 CCCGGGAAGTTTTCGAAGAGACTGGTCTAAATGCCGAGCTGACCACTCTATTAGCGGTGGAGGCC 65 FBan0010898 FBgn0037911 CG10898 3 3R DNA repair; GO:0006281 CG10898 CG10898 anon-WO0118547.280 CDMC25534 1 3 13 DAC20-I20 23-CG10919-RA_2 CG10919 TCCACAGAAGTATTCAAAATAATAACTCATACACGTAATACCCGGCACTTCAATACAACATCCAA 65 FBan0010919 FBgn0037514 CG10919 3 3R CG10919 CG10919 CDMC25534 1 4 13 DAC20-I20 23-CG10919-RA_2 CG10919 TCCACAGAAGTATTCAAAATAATAACTCATACACGTAATACCCGGCACTTCAATACAACATCCAA 65 FBan0010919 FBgn0037514 CG10919 3 3R CG10919 CG10919 CDMC25535 1 5 13 DAC20-M08 9-CG11073-RA_1 CG11073 CCAACGACTTGGAGCCACCATTTGAGCCCTTCGTAGATCTGGGAAACATTCAGCTGACACCACCA 65 FBan0011073 FBgn0034693 CG11073 2 2R CG11073 CG11073 CDMC25535 1 6 13 DAC20-M08 9-CG11073-RA_1 CG11073 CCAACGACTTGGAGCCACCATTTGAGCCCTTCGTAGATCTGGGAAACATTCAGCTGACACCACCA 65 FBan0011073 FBgn0034693 CG11073 2 2R CG11073 CG11073 CDMC25536 1 7 13 DAC20-M20 1-CG11091-RA_1 CG11091 TAGTGCTGCCCGCCTCTGGCACGTCTTGTGGAAAGTGTAGAATCTGTTGTAGATGCAGGACCACT 65 FBan0011091 FBgn0039931 sphinx 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sphinx sphinx "CG11091, CG11091, spx" CDMC25536 1 8 13 DAC20-M20 1-CG11091-RA_1 CG11091 TAGTGCTGCCCGCCTCTGGCACGTCTTGTGGAAAGTGTAGAATCTGTTGTAGATGCAGGACCACT 65 FBan0011091 FBgn0039931 sphinx 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sphinx sphinx "CG11091, CG11091, spx" CDMC25537 1 9 13 DAC21-A08 17-CG11173-RA_2 CG11173 CAAAATTCGACATTTTGGAAGTTTCCCTCGCCACAAGAAATGGCCCATAACTACCTGCAGCCAGT 65 FBan0011173 FBgn0034913 usnp 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; soluble NSF attachment protein activity; GO:0005483; ; GO:0005486; ; GO:0005483 usnp ubisnap "CG11173, CG11173, CG11173, CG11173, Ubisnap, SNAP-29, ubisnap" CDMC25537 1 10 13 DAC21-A08 17-CG11173-RA_2 CG11173 CAAAATTCGACATTTTGGAAGTTTCCCTCGCCACAAGAAATGGCCCATAACTACCTGCAGCCAGT 65 FBan0011173 FBgn0034913 usnp 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; soluble NSF attachment protein activity; GO:0005483; ; GO:0005486; ; GO:0005483 usnp ubisnap "CG11173, CG11173, CG11173, CG11173, Ubisnap, SNAP-29, ubisnap" CDMC25538 1 11 13 DAC21-A20 3-CG11208-RA_1 CG11208 GACAGCGCCTTTGGATTCTCGGGCATGGAAATTGAGACTATGGTGCGCTATAAGCTGCCCGTCAC 65 FBan0011208 FBgn0034488 CG11208 2 2R carbohydrate metabolism; GO:0005975 oxalyl-CoA decarboxylase activity; GO:0008949 ; EC:4.1.1.8; ; GO:0008949 ; EC:4.1.1.8 CG11208 CG11208 anon-WO0118547.196 CDMC25538 1 12 13 DAC21-A20 3-CG11208-RA_1 CG11208 GACAGCGCCTTTGGATTCTCGGGCATGGAAATTGAGACTATGGTGCGCTATAAGCTGCCCGTCAC 65 FBan0011208 FBgn0034488 CG11208 2 2R carbohydrate metabolism; GO:0005975 oxalyl-CoA decarboxylase activity; GO:0008949 ; EC:4.1.1.8; ; GO:0008949 ; EC:4.1.1.8 CG11208 CG11208 anon-WO0118547.196 CDMC25539 1 13 13 DAC21-E08 24-CG11314-RA_1 CG11314 AAAATAAATTACCGTGATGTTTAAATGATGTGCAAGTTTCTTAAAATACAAGGAGCTATATTGGC 65 FBan0011314 FBgn0039800 CG11314 3 3R mesoderm development; GO:0007498 CG11314 CG11314 BcDNA:RE56164 CDMC25539 1 14 13 DAC21-E08 24-CG11314-RA_1 CG11314 AAAATAAATTACCGTGATGTTTAAATGATGTGCAAGTTTCTTAAAATACAAGGAGCTATATTGGC 65 FBan0011314 FBgn0039800 CG11314 3 3R mesoderm development; GO:0007498 CG11314 CG11314 BcDNA:RE56164 CDMC25540 1 15 13 DAC21-E20 12-CG11378-RA_2 CG11378 ACGCAGATCACCACCGCTAATATCGTTCAGTCCGTCTTCCGTTTCGTGAAGAACGAGACCGACTG 65 FBan0011378 FBgn0040364 CG11378 X X CG11378 CG11378 EG:BACR42I17.2 CDMC25540 1 16 13 DAC21-E20 12-CG11378-RA_2 CG11378 ACGCAGATCACCACCGCTAATATCGTTCAGTCCGTCTTCCGTTTCGTGAAGAACGAGACCGACTG 65 FBan0011378 FBgn0040364 CG11378 X X CG11378 CG11378 EG:BACR42I17.2 CDMC25541 1 17 13 DAC21-I08 9-CG11522-RB_1 CG11522 CAAAAAGGGCAAGAAGCACCCCGTCAACTCCTACCTGAAGGGCGGTATCCTGCGTTACTCCAAGG 65 FBan0011522 FBgn0039857 RpL6 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL6 Ribosomal protein L6 "CG11522, Ribosomal protein L6" CDMC25541 1 18 13 DAC21-I08 9-CG11522-RB_1 CG11522 CAAAAAGGGCAAGAAGCACCCCGTCAACTCCTACCTGAAGGGCGGTATCCTGCGTTACTCCAAGG 65 FBan0011522 FBgn0039857 RpL6 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL6 Ribosomal protein L6 "CG11522, Ribosomal protein L6" CDMC25542 1 19 13 DAC21-I20 23-CG1153-RA_1 CG1153 AACCCAAATCGTTAAACGTGCAAGAACAAAAACCAACCAAACAAAAACGCATAATGGCAAGCCAT 65 FBan0001153 FBgn0037414 Osi7 3 3R Osi7 Osiris 7 "CG1153, CG1153, Osiris, Osiris 7" CDMC25542 1 20 13 DAC21-I20 23-CG1153-RA_1 CG1153 AACCCAAATCGTTAAACGTGCAAGAACAAAAACCAACCAAACAAAAACGCATAATGGCAAGCCAT 65 FBan0001153 FBgn0037414 Osi7 3 3R Osi7 Osiris 7 "CG1153, CG1153, Osiris, Osiris 7" CDMC25543 1 21 13 DAC21-M08 23-CG1162-RA_2 CG1162 CGCGACATTTCCACACGGTTATCCTGTTATGACTTTTCCTTTGTTCCAACGTATTTTTAGCGAAT 65 FBan0001162 FBgn0026564 CG1162 3 3R CG1162 CG1162 "ORF1, BG:DS00276.8" CDMC25543 1 22 13 DAC21-M08 23-CG1162-RA_2 CG1162 CGCGACATTTCCACACGGTTATCCTGTTATGACTTTTCCTTTGTTCCAACGTATTTTTAGCGAAT 65 FBan0001162 FBgn0026564 CG1162 3 3R CG1162 CG1162 "ORF1, BG:DS00276.8" CDMC25544 1 23 13 DAC21-M20 1-CG11676-RA_1 CG11676 ATTGCAGAAAGGACTCCCATCGCTCCGCGGATGATGACGGAAATGAGGAGGACTTCTACCTCGAG 65 FBgn0037771 CDMC25544 1 24 13 DAC21-M20 1-CG11676-RA_1 CG11676 ATTGCAGAAAGGACTCCCATCGCTCCGCGGATGATGACGGAAATGAGGAGGACTTCTACCTCGAG 65 FBgn0037771 CDMC25545 1 25 13 DAC22-A08 1-CG31613-RA_1 CG31613 AACTTGTGTGCCATTCATGCCAAGCGTGTCACCATAATGCCCAAAGACATCCAGTTAGCGCGACG 65 FBan0031613 FBgn0051613 His3:CG31613 2 2L nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3:CG31613 His3:CG31613 "CG31613, CG31613, CG31613" CDMC25545 1 26 13 DAC22-A08 1-CG31613-RA_1 CG31613 AACTTGTGTGCCATTCATGCCAAGCGTGTCACCATAATGCCCAAAGACATCCAGTTAGCGCGACG 65 FBan0031613 FBgn0051613 His3:CG31613 2 2L nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3:CG31613 His3:CG31613 "CG31613, CG31613, CG31613" CDMC25546 1 1 14 DAC22-A20 2-CG31638-RA_1 CG31638 CAATGATCTTCGCCAGATCTTTGATGACTCGCAGGCAGGTTTGAGGAGCTCCCACAATGGCAGCG 65 FBan0031638 FBgn0051638 CG31638 2 2L myosin; GO:0016459 CG31638 CG31638 "CG13764, CG9545, CG13764" CDMC25546 1 2 14 DAC22-A20 2-CG31638-RA_1 CG31638 CAATGATCTTCGCCAGATCTTTGATGACTCGCAGGCAGGTTTGAGGAGCTCCCACAATGGCAGCG 65 FBan0031638 FBgn0051638 CG31638 2 2L myosin; GO:0016459 CG31638 CG31638 "CG13764, CG9545, CG13764" CDMC25547 1 3 14 DAC22-E08 2-CG3172-RA_1 CG3172 TTCACACTGAGATCAATACGAATACGCGGCACCAAACTCTGGGTGGGATCAATTGCCCGCTGAGC 65 FBan0003172 FBgn0038206 twf 3 3R actin filament depolymerization; GO:0030042; bristle morphogenesis; GO:0008407; cell motility; GO:0006928 actin binding; GO:0003779; ; GO:0003779; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004713 ; EC:2.7.1.112 intracellular; GO:0005622 twf twinfilin "CG3172, CG3172, A6, twinfillin" CDMC25547 1 4 14 DAC22-E08 2-CG3172-RA_1 CG3172 TTCACACTGAGATCAATACGAATACGCGGCACCAAACTCTGGGTGGGATCAATTGCCCGCTGAGC 65 FBan0003172 FBgn0038206 twf 3 3R actin filament depolymerization; GO:0030042; bristle morphogenesis; GO:0008407; cell motility; GO:0006928 actin binding; GO:0003779; ; GO:0003779; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004713 ; EC:2.7.1.112 intracellular; GO:0005622 twf twinfilin "CG3172, CG3172, A6, twinfillin" CDMC25548 1 5 14 DAC22-E20 3-CG31758-RA_1 CG31758 ATATCGCCCATTAGCTGCGATGATACGGAAAAGGTGGTGAGGCCAATCTGTCCCTGTCCCAGGAA 65 FBan0031758 FBgn0051758 CG31758 2 2L regulation of proteolysis; GO:0030162 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31758 CG31758 CG14942 CDMC25548 1 6 14 DAC22-E20 3-CG31758-RA_1 CG31758 ATATCGCCCATTAGCTGCGATGATACGGAAAAGGTGGTGAGGCCAATCTGTCCCTGTCCCAGGAA 65 FBan0031758 FBgn0051758 CG31758 2 2L regulation of proteolysis; GO:0030162 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31758 CG31758 CG14942 CDMC25549 1 7 14 DAC22-I08 3-CG31900-RA_1 CG31900 CTGACGCCCGAATCCCAGAATTGTGGTGAACGTTTTTGGACTGTGGATGTGACCGCTCAGGACTG 65 FBan0031900 FBgn0051900 CG31900 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31900 CG31900 CDMC25549 1 8 14 DAC22-I08 3-CG31900-RA_1 CG31900 CTGACGCCCGAATCCCAGAATTGTGGTGAACGTTTTTGGACTGTGGATGTGACCGCTCAGGACTG 65 FBan0031900 FBgn0051900 CG31900 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31900 CG31900 CDMC25550 1 9 14 DAC22-I20 18-CG31923-RA_2 CG31923 GCAAAAGTTTCGTTTGGGATTTCGAAAATAGTCACTGCCTGCTTTTGACCATCGATTTGCGCCGG 65 FBan0031923 FBgn0051923 CG31923 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31923 CG31923 BcDNA:RH63623 CDMC25550 1 10 14 DAC22-I20 18-CG31923-RA_2 CG31923 GCAAAAGTTTCGTTTGGGATTTCGAAAATAGTCACTGCCTGCTTTTGACCATCGATTTGCGCCGG 65 FBan0031923 FBgn0051923 CG31923 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31923 CG31923 BcDNA:RH63623 CDMC25551 1 11 14 DAC22-M08 10-CG32070-RA_1 CG32070 GTGGTGCTGTTACTGTTGTTGGTGGTGCTGGCTACCGATCAGAGGCCTGGCACGAAGATCAAAGC 65 FBan0032070 FBgn0052070 CG32070 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32070 CG32070 CDMC25551 1 12 14 DAC22-M08 10-CG32070-RA_1 CG32070 GTGGTGCTGTTACTGTTGTTGGTGGTGCTGGCTACCGATCAGAGGCCTGGCACGAAGATCAAAGC 65 FBan0032070 FBgn0052070 CG32070 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32070 CG32070 CDMC25552 1 13 14 DAC22-M20 3-CG32099-RA_1 CG32099 CCACGACCAACCCATGGACAATTGGCATTTCGAGGAGCATTTACTGCAGGAGGACTACTGTGCGG 65 FBan0032099 FBgn0052099 eap 3 3L fatty acid biosynthesis; GO:0006633; protein amino acid phosphopantetheinylation; GO:0018215 magnesium ion binding; GO:0000287; phosphopantetheinyltransferase activity; GO:0008897 ; EC:2.7.8.7; ; GO:0008897 ; EC:2.7.8.7; ; GO:0000287 eap ebony activating protein "CG32099, CG32099, EAP, Ebony Activating Protein, BcDNA:GH12334, ebony activating protein" CDMC25552 1 14 14 DAC22-M20 3-CG32099-RA_1 CG32099 CCACGACCAACCCATGGACAATTGGCATTTCGAGGAGCATTTACTGCAGGAGGACTACTGTGCGG 65 FBan0032099 FBgn0052099 eap 3 3L fatty acid biosynthesis; GO:0006633; protein amino acid phosphopantetheinylation; GO:0018215 magnesium ion binding; GO:0000287; phosphopantetheinyltransferase activity; GO:0008897 ; EC:2.7.8.7; ; GO:0008897 ; EC:2.7.8.7; ; GO:0000287 eap ebony activating protein "CG32099, CG32099, EAP, Ebony Activating Protein, BcDNA:GH12334, ebony activating protein" CDMC25553 1 15 14 DAC23-A08 12-CG10733-RC_1 CG10733 TGGCAAGCTGGTCAACATCTATATCACGGTGGTGAAGTACGATGCATGGGACAAGTACGCCAAGGAGAT 69 FBgn0035680 CDMC25553 1 16 14 DAC23-A08 12-CG10733-RC_1 CG10733 TGGCAAGCTGGTCAACATCTATATCACGGTGGTGAAGTACGATGCATGGGACAAGTACGCCAAGGAGAT 69 FBgn0035680 CDMC25554 1 17 14 DAC23-A20 12-CG10748-RA_5 CG10748 GCCGCAGCTGAGGTTCTTATGGCCCATGGAACTTTTGATTCTCGTCGGCTCTTCGGTATTACGACTTTG 69 FBan0010748 FBgn0036327 CG10748 3 3L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759 CG10748 CG10748 CDMC25554 1 18 14 DAC23-A20 12-CG10748-RA_5 CG10748 GCCGCAGCTGAGGTTCTTATGGCCCATGGAACTTTTGATTCTCGTCGGCTCTTCGGTATTACGACTTTG 69 FBan0010748 FBgn0036327 CG10748 3 3L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 mitochondrial matrix; GO:0005759 CG10748 CG10748 CDMC25555 1 19 14 DAC23-E08 15-CG10789-RA_1 CG10789 CGGAGCCTGATGTCGCTTACCAAAGCATTGACTATCATCCCGAGGACTACATCGATTCCTTCACCGACT 69 FBan0010789 FBgn0010296 ng4 X X meiosis I; GO:0007127; puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng4 new glue 4 "CG10789, ng-4, ng, EG:96G10.2" CDMC25555 1 20 14 DAC23-E08 15-CG10789-RA_1 CG10789 CGGAGCCTGATGTCGCTTACCAAAGCATTGACTATCATCCCGAGGACTACATCGATTCCTTCACCGACT 69 FBan0010789 FBgn0010296 ng4 X X meiosis I; GO:0007127; puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng4 new glue 4 "CG10789, ng-4, ng, EG:96G10.2" CDMC25556 1 21 14 DAC23-E20 3-CG10801-RA_1 CG10801 TGTCAGGCGATCATTGCCATTGGACAGCCGGAATATCGAAGGTCGAGACTGGTTCGTCGCATGTTAAGG 69 FBan0010801 FBgn0029660 CG10801 X X CG10801 CG10801 CDMC25556 1 22 14 DAC23-E20 3-CG10801-RA_1 CG10801 TGTCAGGCGATCATTGCCATTGGACAGCCGGAATATCGAAGGTCGAGACTGGTTCGTCGCATGTTAAGG 69 FBan0010801 FBgn0029660 CG10801 X X CG10801 CG10801 CDMC25557 1 23 14 DAC23-I08 23-CG10830-RA_11 CG10830 AATGCCAAATACAAAATACCAAATGGTCACAAGGACTTCCAGAAGTACGATGGGAATACGACACATACG 69 FBan0010830 FBgn0038839 CG10830 3 3R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10830 CG10830 CDMC25557 1 24 14 DAC23-I08 23-CG10830-RA_11 CG10830 AATGCCAAATACAAAATACCAAATGGTCACAAGGACTTCCAGAAGTACGATGGGAATACGACACATACG 69 FBan0010830 FBgn0038839 CG10830 3 3R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10830 CG10830 CDMC25558 1 25 14 DAC23-I20 8-CG10841-RA_5 CG10841 TGAGCGCGGTCTATCGAACATGGGAGTGGGAAAATATCTGACCCAAAGGGAAATGTCCATTCTGCTGGA 69 FBan0010841 FBgn0038163 CG10841 3 3R CG10841 CG10841 anon-WO0140519.42 CDMC25558 1 26 14 DAC23-I20 8-CG10841-RA_5 CG10841 TGAGCGCGGTCTATCGAACATGGGAGTGGGAAAATATCTGACCCAAAGGGAAATGTCCATTCTGCTGGA 69 FBan0010841 FBgn0038163 CG10841 3 3R CG10841 CG10841 anon-WO0140519.42 CDMC25559 1 1 15 DAC23-M08 8-CG10877-RA_4 CG10877 AGCAGTTGCGTAAGGTGAATCCCAAACTGATCTATTGCTCAATGACGGGTTATGGCTCTGTGGGACCGT 69 FBan0010877 FBgn0038804 CG10877 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; lyase activity; GO:0016829 ; EC:4.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.- CG10877 CG10877 CDMC25559 1 2 15 DAC23-M08 8-CG10877-RA_4 CG10877 AGCAGTTGCGTAAGGTGAATCCCAAACTGATCTATTGCTCAATGACGGGTTATGGCTCTGTGGGACCGT 69 FBan0010877 FBgn0038804 CG10877 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; lyase activity; GO:0016829 ; EC:4.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.- CG10877 CG10877 CDMC25560 1 3 15 DAC23-M20 18-CG10901-RA_1 CG10901 GGGCGTGGTACGTATACATATGAGCCATGCTGCATTTTGGCCGTAATGAAAATGCACTGCTTTACTTGG 69 FBan0010901 FBgn0003015 osk 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; long-term memory; GO:0007616; maintenance of pole plasm mRNA localization; GO:0046594; oocyte anterior/posterior axis determination; GO:0007314; polar granule organization and biogenesis; GO:0030719; pole cell development; GO:0007277; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm protein localization; GO:0007318; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011" polar granule; GO:0018994; pole plasm; GO:0045495 osk oskar "CG10901, oskar" CDMC25560 1 4 15 DAC23-M20 18-CG10901-RA_1 CG10901 GGGCGTGGTACGTATACATATGAGCCATGCTGCATTTTGGCCGTAATGAAAATGCACTGCTTTACTTGG 69 FBan0010901 FBgn0003015 osk 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; long-term memory; GO:0007616; maintenance of pole plasm mRNA localization; GO:0046594; oocyte anterior/posterior axis determination; GO:0007314; polar granule organization and biogenesis; GO:0030719; pole cell development; GO:0007277; pole cell fate determination; GO:0007278; pole cell formation; GO:0007279; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm protein localization; GO:0007318; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011" polar granule; GO:0018994; pole plasm; GO:0045495 osk oskar "CG10901, oskar" CDMC25561 1 5 15 DAC24-A08 9-CG14921-RA_2 CG14921 AGCCCGCATTGTGCTGGTTAAGAAAGAGAAGGGCTTATGGCCTGAGATGTTCCAGAAGCTGGACAAGGA 69 FBan0014921 FBgn0032345 CG14921 2 2L CG14921 CG14921 CDMC25561 1 6 15 DAC24-A08 9-CG14921-RA_2 CG14921 AGCCCGCATTGTGCTGGTTAAGAAAGAGAAGGGCTTATGGCCTGAGATGTTCCAGAAGCTGGACAAGGA 69 FBan0014921 FBgn0032345 CG14921 2 2L CG14921 CG14921 CDMC25562 1 7 15 DAC24-A20 16-CG14932-RA_1 CG14932 CGTCCCCACAGTGCTTTGGAGATTACCGAAATTACCGAGTTTCCGAAAATTCCAAAGAAAAACCCCACC 69 FBan0014932 FBgn0032375 CG14932 2 2L CG14932 CG14932 CDMC25562 1 8 15 DAC24-A20 16-CG14932-RA_1 CG14932 CGTCCCCACAGTGCTTTGGAGATTACCGAAATTACCGAGTTTCCGAAAATTCCAAAGAAAAACCCCACC 69 FBan0014932 FBgn0032375 CG14932 2 2L CG14932 CG14932 CDMC25563 1 9 15 DAC24-E08 1-CG14961-RA_1 CG14961 AGCCCTACCTCAGGAACCACGTTGGACCCACTGTGTTGTATTCAAAGTCACAAACTCCCAGGACGTACT 69 FBan0014961 FBgn0035439 CG14961 3 3L CG14961 CG14961 CDMC25563 1 10 15 DAC24-E08 1-CG14961-RA_1 CG14961 AGCCCTACCTCAGGAACCACGTTGGACCCACTGTGTTGTATTCAAAGTCACAAACTCCCAGGACGTACT 69 FBan0014961 FBgn0035439 CG14961 3 3L CG14961 CG14961 CDMC25564 1 11 15 DAC24-E20 3-CG14971-RA_1 CG14971 GCCGGGCTCATCGCGGTAATAGAAGATCTGCACAACCACACTTCGAATGAGATAACTTGGGCCATTGCG 69 FBan0014971 FBgn0035449 CG14971 3 3L CG14971 CG14971 CDMC25564 1 12 15 DAC24-E20 3-CG14971-RA_1 CG14971 GCCGGGCTCATCGCGGTAATAGAAGATCTGCACAACCACACTTCGAATGAGATAACTTGGGCCATTGCG 69 FBan0014971 FBgn0035449 CG14971 3 3L CG14971 CG14971 CDMC25565 1 13 15 DAC24-I08 15-CG14999-RA_1 CG14999 GCAAGCGCATCAACATCGATGAGCATTTGAAGCTGGACTTTATCCGTGAGATCGGAATCACCCACATGA 69 FBan0014999 FBgn0015287 RfC40 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260; DNA strand elongation; GO:0006271; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; ; GO:0004003; ; GO:0000166 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 RfC40 Replication-factor-C 40kD subunit "CG14999, rfc, l(3)64Ai, l(3)SH17, rfc[40], DRas2, l(3)rfc40, rfc4, Rfc40, BEST:GH24992" CDMC25565 1 14 15 DAC24-I08 15-CG14999-RA_1 CG14999 GCAAGCGCATCAACATCGATGAGCATTTGAAGCTGGACTTTATCCGTGAGATCGGAATCACCCACATGA 69 FBan0014999 FBgn0015287 RfC40 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260; DNA strand elongation; GO:0006271; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; ; GO:0004003; ; GO:0000166 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 RfC40 Replication-factor-C 40kD subunit "CG14999, rfc, l(3)64Ai, l(3)SH17, rfc[40], DRas2, l(3)rfc40, rfc4, Rfc40, BEST:GH24992" CDMC25566 1 15 15 DAC24-I20 22-CG15009-RB_1 CG15009 AGCCGACCTGCTTCTGCTTTACCTGATCTATCATCGTCCAACGTTGGGGAGAAATTTGCAAACATTTTT 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC25566 1 16 15 DAC24-I20 22-CG15009-RB_1 CG15009 AGCCGACCTGCTTCTGCTTTACCTGATCTATCATCGTCCAACGTTGGGGAGAAATTTGCAAACATTTTT 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC25567 1 17 15 DAC24-M08 23-CG1503-RA_1 CG1503 CCTTGCGACCCTACATTCGTTTGCTTTACATTTGTTGACGCATAAGAAAATCAGTAAAAAATTCAAATA 69 FBan0001503 FBgn0031157 CG1503 X X CG1503 CG1503 CDMC25567 1 18 15 DAC24-M08 23-CG1503-RA_1 CG1503 CCTTGCGACCCTACATTCGTTTGCTTTACATTTGTTGACGCATAAGAAAATCAGTAAAAAATTCAAATA 69 FBan0001503 FBgn0031157 CG1503 X X CG1503 CG1503 CDMC25568 1 19 15 DAC24-M20 24-CG1505-RA_3 CG1505 AGTTTCATTACGAAAACTTCTGATTATGGCATTTCAGTTTTATTTTTATCTAAGACAGTAGGGCAATTC 69 FBan0001505 FBgn0000808 gd X X "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008132 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 extracellular region; GO:0005576 gd gastrulation-defective "CG1505, fs(1)M18, fs(1)573, fs(1)gd, SP186, Gastrulation Defective, GD, fs(1)18, fs(1)190-5, fs(1)A573, gas" CDMC25568 1 20 15 DAC24-M20 24-CG1505-RA_3 CG1505 AGTTTCATTACGAAAACTTCTGATTATGGCATTTCAGTTTTATTTTTATCTAAGACAGTAGGGCAATTC 69 FBan0001505 FBgn0000808 gd X X "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008132 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 extracellular region; GO:0005576 gd gastrulation-defective "CG1505, fs(1)M18, fs(1)573, fs(1)gd, SP186, Gastrulation Defective, GD, fs(1)18, fs(1)190-5, fs(1)A573, gas" CDMC25569 1 21 15 DAC25-A08 22-CG14305-RC_2 CG14305 ATCATTCGCTTGATGCCATTACCAAATCACCTAGTTGCAAACTCTCGGAAAACTACACTACACGCACGC 69 FBan0014305 FBgn0038630 CG14305 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG14305 CG14305 CDMC25569 1 22 15 DAC25-A08 22-CG14305-RC_2 CG14305 ATCATTCGCTTGATGCCATTACCAAATCACCTAGTTGCAAACTCTCGGAAAACTACACTACACGCACGC 69 FBan0014305 FBgn0038630 CG14305 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG14305 CG14305 CDMC25570 1 23 15 DAC25-A20 6-CG14310-RB_2 CG14310 TCGCACTCACACTTTGGTCGGCTATAATGACACAAGTACGCAGCACTACACACTCGAGACCCTTGCTGA 69 FBan0014310 FBgn0040569 CG14310 3 3R CG14310 CG14310 CDMC25570 1 24 15 DAC25-A20 6-CG14310-RB_2 CG14310 TCGCACTCACACTTTGGTCGGCTATAATGACACAAGTACGCAGCACTACACACTCGAGACCCTTGCTGA 69 FBan0014310 FBgn0040569 CG14310 3 3R CG14310 CG14310 CDMC25571 1 25 15 DAC25-E08 11-CG14353-RA_1 CG14353 GCGGTCTCCTTGTCTTCGATATGAGAACCCAACATCCGACCAAGGGATTTAGTTACGTGGAGGAACGCA 69 FBan0014353 FBgn0036771 CG14353 3 3L CG14353 CG14353 CDMC25571 1 26 15 DAC25-E08 11-CG14353-RA_1 CG14353 GCGGTCTCCTTGTCTTCGATATGAGAACCCAACATCCGACCAAGGGATTTAGTTACGTGGAGGAACGCA 69 FBan0014353 FBgn0036771 CG14353 3 3L CG14353 CG14353 CDMC25572 1 1 16 DAC25-E20 17-CG14366-RA_1 CG14366 CCGAGGACAAGATCTATCGCAAGTTTGCCTTTAAGTGCGAGCATCAGAATATGCGTACCTATTGGCTGG 69 FBan0014366 FBgn0038176 CG14366 3 3R CG14366 CG14366 CDMC25572 1 2 16 DAC25-E20 17-CG14366-RA_1 CG14366 CCGAGGACAAGATCTATCGCAAGTTTGCCTTTAAGTGCGAGCATCAGAATATGCGTACCTATTGGCTGG 69 FBan0014366 FBgn0038176 CG14366 3 3R CG14366 CG14366 CDMC25573 1 3 16 DAC25-I08 3-CG14420-RA_1 CG14420 TGGTGTGGAAATGCCGAGCACTGAGTGAGCTGAAGCAAGCAGAGAACTGACATCCCAGAACATCTGTGT 69 FBan0014420 FBgn0029643 CG14420 X X CG14420 CG14420 CDMC25573 1 4 16 DAC25-I08 3-CG14420-RA_1 CG14420 TGGTGTGGAAATGCCGAGCACTGAGTGAGCTGAAGCAAGCAGAGAACTGACATCCCAGAACATCTGTGT 69 FBan0014420 FBgn0029643 CG14420 X X CG14420 CG14420 CDMC25574 1 5 16 DAC25-I20 17-CG1442-RA_1 CG1442 AGGCCTGCGATCACTGCGATCAGATTTGTGGGGCTTTTGTCAGGATTCGCAAAAATATCAACAAAATCT 69 FBan0001442 FBgn0039622 CG1442 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG1442 CG1442 "eIF4E, BcDNA:RH55324" CDMC25574 1 6 16 DAC25-I20 17-CG1442-RA_1 CG1442 AGGCCTGCGATCACTGCGATCAGATTTGTGGGGCTTTTGTCAGGATTCGCAAAAATATCAACAAAATCT 69 FBan0001442 FBgn0039622 CG1442 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG1442 CG1442 "eIF4E, BcDNA:RH55324" CDMC25575 1 7 16 DAC25-M08 23-CG1447-RB_6 CG1447 CAACGGAACCCCTTTAACTAATCAAGCCAAATAGCCATCCCAAAGATCATATAGTCGCTCCTAGTTCCA 69 FBan0001447 FBgn0020912 Ptx1 3 3R development; GO:0007275; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 transcription factor complex; GO:0005667 Ptx1 Ptx1 "CG1447, D-Ptx1, ptx1, Ptx" CDMC25575 1 8 16 DAC25-M08 23-CG1447-RB_6 CG1447 CAACGGAACCCCTTTAACTAATCAAGCCAAATAGCCATCCCAAAGATCATATAGTCGCTCCTAGTTCCA 69 FBan0001447 FBgn0020912 Ptx1 3 3R development; GO:0007275; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 transcription factor complex; GO:0005667 Ptx1 Ptx1 "CG1447, D-Ptx1, ptx1, Ptx" CDMC25576 1 9 16 DAC25-M20 22-CG14489-RA_1 CG14489 TGACCTGTGACCCATGTGATCATCTTGTCTTGTCCATTAGTCATTACAAGTGCCGCGTACTTAGCTGTT 69 FBan0014489 FBgn0015522 olf186-M 2 2R olf186-M olf186-M "CG14489, CG14489" CDMC25576 1 10 16 DAC25-M20 22-CG14489-RA_1 CG14489 TGACCTGTGACCCATGTGATCATCTTGTCTTGTCCATTAGTCATTACAAGTGCCGCGTACTTAGCTGTT 69 FBan0014489 FBgn0015522 olf186-M 2 2R olf186-M olf186-M "CG14489, CG14489" CDMC25577 1 11 16 DAC26-A08 14-CG4710-RA_1 CG4710 ACCTTCCAATGGCACCATTTGGTTTGCGCACATTACCTGTTCTATCCAGGAGAAGACTTCTTTCTGCCT 69 FBgn0031303 CDMC25577 1 12 16 DAC26-A08 14-CG4710-RA_1 CG4710 ACCTTCCAATGGCACCATTTGGTTTGCGCACATTACCTGTTCTATCCAGGAGAAGACTTCTTTCTGCCT 69 FBgn0031303 CDMC25578 1 13 16 DAC26-A20 23-CG4722-RA_13 CG4722 AATGTACACAAGTCTCAGCCCCATATAGTCTAGCATAGTCCTAGTTTAGATAGACGCAGCATAGCCACA 69 FBan0004722 FBgn0000180 bib 2 2L Notch signaling pathway; GO:0007219; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; ovarian follicle cell development (sensu Insecta); GO:0030707; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; water channel activity; GO:0015250; ; GO:0015250; nonselective cation channel activity; GO:0015281; ; GO:0015281 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 bib big brain "CG4722, m-bib, BIB_DROME, EP(2)2278, l(2)neo66, l(2)neo91, big brain" CDMC25578 1 14 16 DAC26-A20 23-CG4722-RA_13 CG4722 AATGTACACAAGTCTCAGCCCCATATAGTCTAGCATAGTCCTAGTTTAGATAGACGCAGCATAGCCACA 69 FBan0004722 FBgn0000180 bib 2 2L Notch signaling pathway; GO:0007219; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; ovarian follicle cell development (sensu Insecta); GO:0030707; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; water channel activity; GO:0015250; ; GO:0015250; nonselective cation channel activity; GO:0015281; ; GO:0015281 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 bib big brain "CG4722, m-bib, BIB_DROME, EP(2)2278, l(2)neo66, l(2)neo91, big brain" CDMC25579 1 15 16 DAC26-E08 16-CG4751-RA_1 CG4751 TCATCATCCGTATAGATTTCGCCAGTCCTACGAGTGAATTTCCGCTTTTATTCACCTCACGAGCGCTGT 69 FBan0004751 FBgn0032348 CG4751 2 2L CG4751 CG4751 CDMC25579 1 16 16 DAC26-E08 16-CG4751-RA_1 CG4751 TCATCATCCGTATAGATTTCGCCAGTCCTACGAGTGAATTTCCGCTTTTATTCACCTCACGAGCGCTGT 69 FBan0004751 FBgn0032348 CG4751 2 2L CG4751 CG4751 CDMC25580 1 17 16 DAC26-E20 3-CG4757-RA_4 CG4757 AAGCTGGAGTACCCGAAATCACTTAAGGGTATGGGTGAACTCTTGAGCGACGCCCTGATTGGAGTGTCC 69 FBan0004757 FBgn0027584 CG4757 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG4757 CG4757 "BcDNA:GH05741, GH05702" CDMC25580 1 18 16 DAC26-E20 3-CG4757-RA_4 CG4757 AAGCTGGAGTACCCGAAATCACTTAAGGGTATGGGTGAACTCTTGAGCGACGCCCTGATTGGAGTGTCC 69 FBan0004757 FBgn0027584 CG4757 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG4757 CG4757 "BcDNA:GH05741, GH05702" CDMC25581 1 19 16 DAC26-I08 2-CG4785-RA_1 CG4785 ACGGAGCCCTCAAAATGGAGAACATGGCAGCTCTGGTTCGAGTGGGTGACAAGTGGTACGGATTCATAT 69 FBan0004785 FBgn0031314 CG4785 2 2L CG4785 CG4785 Q9VPY0 CDMC25581 1 20 16 DAC26-I08 2-CG4785-RA_1 CG4785 ACGGAGCCCTCAAAATGGAGAACATGGCAGCTCTGGTTCGAGTGGGTGACAAGTGGTACGGATTCATAT 69 FBan0004785 FBgn0031314 CG4785 2 2L CG4785 CG4785 Q9VPY0 CDMC25582 1 21 16 DAC26-I20 12-CG4793-RC_10 CG4793 TGCACCTATAAAATTGGCCCTCCATAATCCCATAAACACCTCTCAACTGGAACCATTTCCGGGGGTGGA 69 FBan0004793 FBgn0028514 CG4793 2 2L carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 "NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" CG4793 CG4793 "BG:DS07486.3, SPH208" CDMC25582 1 22 16 DAC26-I20 12-CG4793-RC_10 CG4793 TGCACCTATAAAATTGGCCCTCCATAATCCCATAAACACCTCTCAACTGGAACCATTTCCGGGGGTGGA 69 FBan0004793 FBgn0028514 CG4793 2 2L carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 "NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" CG4793 CG4793 "BG:DS07486.3, SPH208" CDMC25583 1 23 16 DAC26-M08 2-CG4825-RA_3 CG4825 GGAGTATGGCGTCAATTGTTCGGACATCAGTTGGGATCGCGTTAAAGGCCACTTGGACGTCTTTGCCTG 69 FBan0004825 FBgn0037010 CG4825 3 3L lipid metabolism; GO:0006629; phosphatidylserine biosynthesis; GO:0006659 CDP-diacylglycerol-serine O-phosphatidyltransferase activity; GO:0003882 ; EC:2.7.8.8; ; GO:0003882 ; EC:2.7.8.8 CG4825 CG4825 Phosphatidylserine synthase CDMC25583 1 24 16 DAC26-M08 2-CG4825-RA_3 CG4825 GGAGTATGGCGTCAATTGTTCGGACATCAGTTGGGATCGCGTTAAAGGCCACTTGGACGTCTTTGCCTG 69 FBan0004825 FBgn0037010 CG4825 3 3L lipid metabolism; GO:0006629; phosphatidylserine biosynthesis; GO:0006659 CDP-diacylglycerol-serine O-phosphatidyltransferase activity; GO:0003882 ; EC:2.7.8.8; ; GO:0003882 ; EC:2.7.8.8 CG4825 CG4825 Phosphatidylserine synthase CDMC25584 1 25 16 DAC26-M20 3-CG4845-RA_1 CG4845 CGCTGTACGCCTTCCTTCTGTCCGTGTTGAACGACAAGCTGCAGGTAAGCTCAAAGACCAAGACCAAGA 69 FBan0004845 FBgn0038764 CG4845 3 3R CG4845 CG4845 CDMC25584 1 26 16 DAC26-M20 3-CG4845-RA_1 CG4845 CGCTGTACGCCTTCCTTCTGTCCGTGTTGAACGACAAGCTGCAGGTAAGCTCAAAGACCAAGACCAAGA 69 FBan0004845 FBgn0038764 CG4845 3 3R CG4845 CG4845 CDMC25585 1 1 17 DAC27-A08 6-CG3456-RA_2 CG3456 CGACACTTGGTTAGATTAAGTCCTAGACCTAGGCCAGCCATGTACCGAGGTATGCGTGTATGCCGCAGC 69 FBan0003456 FBgn0023549 Mct1 X X cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 Mct1 Monocarboxylate transporter 1 "CG3456, CG3456, EG:103B4.3" CDMC25585 1 2 17 DAC27-A08 6-CG3456-RA_2 CG3456 CGACACTTGGTTAGATTAAGTCCTAGACCTAGGCCAGCCATGTACCGAGGTATGCGTGTATGCCGCAGC 69 FBan0003456 FBgn0023549 Mct1 X X cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 Mct1 Monocarboxylate transporter 1 "CG3456, CG3456, EG:103B4.3" CDMC25586 1 3 17 DAC27-A20 8-CG3479-RA_1 CG3479 GCCACCCGAGAAAATGGAGCAAAGTCTCTTCGTGATACCCTCCCATATGCTAAACAGTTCCCTCGTGCC 69 FBan0003479 FBgn0003016 osp 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 osp outspread "CG3479, CG3479, arc-like wing, BG:DS01486.7, BG:DS01486.5, BG:DS07721.2, v(2)rJ571, alw: arclike wing, anon-WO02059370.75, l(2)rJ571, arclike wing" CDMC25586 1 4 17 DAC27-A20 8-CG3479-RA_1 CG3479 GCCACCCGAGAAAATGGAGCAAAGTCTCTTCGTGATACCCTCCCATATGCTAAACAGTTCCCTCGTGCC 69 FBan0003479 FBgn0003016 osp 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 osp outspread "CG3479, CG3479, arc-like wing, BG:DS01486.7, BG:DS01486.5, BG:DS07721.2, v(2)rJ571, alw: arclike wing, anon-WO02059370.75, l(2)rJ571, arclike wing" CDMC25587 1 5 17 DAC27-E08 17-CG3522-RB_2 CG3522 AGGCTCTGATGGAAGATCTGTTCTATCGCATTGAAGACTGTCCCAAGTGGAATCCTGCTCTTTTGGAGT 69 FBan0003522 FBgn0035028 Start1 2 2R lipid metabolism; GO:0006629; lipid transport; GO:0006869; steroid biosynthesis; GO:0006694 carrier activity; GO:0005386; ; GO:0005386; cholesterol binding; GO:0015485; cholesterol transporter activity; GO:0017127; ; GO:0015485; ; GO:0017127 Start1 Start1 "CG3522, CG3522, Start" CDMC25587 1 6 17 DAC27-E08 17-CG3522-RB_2 CG3522 AGGCTCTGATGGAAGATCTGTTCTATCGCATTGAAGACTGTCCCAAGTGGAATCCTGCTCTTTTGGAGT 69 FBan0003522 FBgn0035028 Start1 2 2R lipid metabolism; GO:0006629; lipid transport; GO:0006869; steroid biosynthesis; GO:0006694 carrier activity; GO:0005386; ; GO:0005386; cholesterol binding; GO:0015485; cholesterol transporter activity; GO:0017127; ; GO:0015485; ; GO:0017127 Start1 Start1 "CG3522, CG3522, Start" CDMC25588 1 7 17 DAC27-E20 3-CG3532-RA_1 CG3532 GCGCTTGGTTCCCGTGCTAAATACCATTCTCCGCCTGAGTCGCAACGAAATGGAAATGCTGAACTGTGT 69 FBan0003532 FBgn0037979 CG3532 3 3R cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG3532 CG3532 CDMC25588 1 8 17 DAC27-E20 3-CG3532-RA_1 CG3532 GCGCTTGGTTCCCGTGCTAAATACCATTCTCCGCCTGAGTCGCAACGAAATGGAAATGCTGAACTGTGT 69 FBan0003532 FBgn0037979 CG3532 3 3R cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG3532 CG3532 CDMC25589 1 9 17 DAC27-I08 23-CG3572-RC_10 CG3572 ACACACTCAGAACCGGAGAAAATAGTAGTTTTCACCCCAAAGCAACGATTCAGATGTAGACTTGACTGT 69 FBan0003572 FBgn0022960 vimar 2 2R intracellular signaling cascade; GO:0007242 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; Ral GTPase binding; GO:0017160; ; GO:0017160 vimar visceral mesodermal armadillo-repeats "CG3572, l(2)k16722, anon-EST:Posey213, visceral mesodermal armadillo-repeats" CDMC25589 1 10 17 DAC27-I08 23-CG3572-RC_10 CG3572 ACACACTCAGAACCGGAGAAAATAGTAGTTTTCACCCCAAAGCAACGATTCAGATGTAGACTTGACTGT 69 FBan0003572 FBgn0022960 vimar 2 2R intracellular signaling cascade; GO:0007242 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; Ral GTPase binding; GO:0017160; ; GO:0017160 vimar visceral mesodermal armadillo-repeats "CG3572, l(2)k16722, anon-EST:Posey213, visceral mesodermal armadillo-repeats" CDMC25590 1 11 17 DAC27-I20 9-CG3588-RA_1 CG3588 CGGTGCCAATGCGAACAGCAATGCCTTTGGTGGCTACGATGGATTCGGATTCTTCGGACGTTAGTTTTA 69 FBan0003588 FBgn0025643 CG3588 X X CG3588 CG3588 EG:100G7.6 CDMC25590 1 12 17 DAC27-I20 9-CG3588-RA_1 CG3588 CGGTGCCAATGCGAACAGCAATGCCTTTGGTGGCTACGATGGATTCGGATTCTTCGGACGTTAGTTTTA 69 FBan0003588 FBgn0025643 CG3588 X X CG3588 CG3588 EG:100G7.6 CDMC25591 1 13 17 DAC27-M08 21-CG3629-RB_5 CG3629 AACAGCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 69 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC25591 1 14 17 DAC27-M08 21-CG3629-RB_5 CG3629 AACAGCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 69 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC25592 1 15 17 DAC27-M20 16-CG3639-RA_2 CG3639 CGGCACTGAGCAAGATATTCGACTACTTTGGACTACGCCTGGACTTTAAACTATGGGGGAGTTTGAGGA 69 FBan0003639 FBgn0031282 CG3639 2 2L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625; protein ubiquitination; GO:0016567 carrier activity; GO:0005386; binding; GO:0005488; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005488; ; GO:0005386; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 integral to peroxisomal membrane; GO:0005779; ubiquitin ligase complex; GO:0000151 CG3639 CG3639 CDMC25592 1 16 17 DAC27-M20 16-CG3639-RA_2 CG3639 CGGCACTGAGCAAGATATTCGACTACTTTGGACTACGCCTGGACTTTAAACTATGGGGGAGTTTGAGGA 69 FBan0003639 FBgn0031282 CG3639 2 2L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625; protein ubiquitination; GO:0016567 carrier activity; GO:0005386; binding; GO:0005488; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005488; ; GO:0005386; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 integral to peroxisomal membrane; GO:0005779; ubiquitin ligase complex; GO:0000151 CG3639 CG3639 CDMC25593 1 17 17 DAC28-A08 15-CG14724-RA_1 CG14724 GCCCGAATTGGCCCTGAAGTCCGTGTACGATGCCTAAGCGGAGAACACTAGTTTAAAAACACAGAACAC 69 FBan0014724 FBgn0019624 CoVa 3 3R "electron transport; GO:0006118; mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CoVa Cytochrome c oxidase subunit Va "CG14724, cytochrome c oxidase subunit Va, COX, Va, l(3)S011041, l(3)S011046" CDMC25593 1 18 17 DAC28-A08 15-CG14724-RA_1 CG14724 GCCCGAATTGGCCCTGAAGTCCGTGTACGATGCCTAAGCGGAGAACACTAGTTTAAAAACACAGAACAC 69 FBan0014724 FBgn0019624 CoVa 3 3R "electron transport; GO:0006118; mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CoVa Cytochrome c oxidase subunit Va "CG14724, cytochrome c oxidase subunit Va, COX, Va, l(3)S011041, l(3)S011046" CDMC25594 1 19 17 DAC28-A20 1-CG14747-RA_1 CG14747 ACTTCTCGCACGATCTGTATCCGCTCTACAAGTATCCCACGCTTTACGAGAGCAACTATCCGTCGCCCA 69 FBan0014747 FBgn0033306 CG14747 2 2R CG14747 CG14747 CDMC25594 1 20 17 DAC28-A20 1-CG14747-RA_1 CG14747 ACTTCTCGCACGATCTGTATCCGCTCTACAAGTATCCCACGCTTTACGAGAGCAACTATCCGTCGCCCA 69 FBan0014747 FBgn0033306 CG14747 2 2R CG14747 CG14747 CDMC25595 1 21 17 DAC28-E08 1-CG14794-RA_3 CG14794 CGAAAGCATACGCCAATCGCCACTTTGAACACTGCCAGCTGCCAGCACAATAGCACAACAAGTAGACGA 69 FBgn0044503 CDMC25595 1 22 17 DAC28-E08 1-CG14794-RA_3 CG14794 CGAAAGCATACGCCAATCGCCACTTTGAACACTGCCAGCTGCCAGCACAATAGCACAACAAGTAGACGA 69 FBgn0044503 CDMC25596 1 23 17 DAC28-E20 18-CG14808-RA_1 CG14808 CACGTGATCCGAATGGCATGATTGAGAATCATTTATTCCTGGGACACGATAAGTTCGAGTGCCTGTCGG 69 FBan0014808 FBgn0025391 Scgdelta X X cytoskeletal anchoring; GO:0007016; mesoderm development; GO:0007498; muscle contraction; GO:0006936 structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307 integral to membrane; GO:0016021; sarcoglycan complex; GO:0016012 Scgdelta Sarcoglycan delta "CG14808, CG14808, CG14808, DmSCG-gammadelta, CT34621, EG:4F1.1, GH21860, Scgdelta, BEST:GH21860, Sarcoglycan delta" CDMC25596 1 24 17 DAC28-E20 18-CG14808-RA_1 CG14808 CACGTGATCCGAATGGCATGATTGAGAATCATTTATTCCTGGGACACGATAAGTTCGAGTGCCTGTCGG 69 FBan0014808 FBgn0025391 Scgdelta X X cytoskeletal anchoring; GO:0007016; mesoderm development; GO:0007498; muscle contraction; GO:0006936 structural constituent of muscle; GO:0008307; ; GO:0008307; ; GO:0008307 integral to membrane; GO:0016021; sarcoglycan complex; GO:0016012 Scgdelta Sarcoglycan delta "CG14808, CG14808, CG14808, DmSCG-gammadelta, CT34621, EG:4F1.1, GH21860, Scgdelta, BEST:GH21860, Sarcoglycan delta" CDMC25597 1 25 17 DAC28-I08 23-CG14840-RA_1 CG14840 CCGAATTCGGGGATCAACTGATCTTTTCTATATTTTGTTACGTTTCGATTTCGGTTTAATAAGTTTCCT 69 FBan0014840 FBgn0038217 CG14840 3 3R CG14840 CG14840 CDMC25597 1 26 17 DAC28-I08 23-CG14840-RA_1 CG14840 CCGAATTCGGGGATCAACTGATCTTTTCTATATTTTGTTACGTTTCGATTTCGGTTTAATAAGTTTCCT 69 FBan0014840 FBgn0038217 CG14840 3 3R CG14840 CG14840 CDMC25598 1 1 18 DAC28-I20 17-CG14860-RA_1 CG14860 AGAGCGAGGATTCTGGCATTGACGAGGAAAGCTTTAAGGAGAGTAAGCCTCATAATAATCCATGCGCCA 69 FBan0014860 FBgn0038273 CG14860 3 3R CG14860 CG14860 CDMC25598 1 2 18 DAC28-I20 17-CG14860-RA_1 CG14860 AGAGCGAGGATTCTGGCATTGACGAGGAAAGCTTTAAGGAGAGTAAGCCTCATAATAATCCATGCGCCA 69 FBan0014860 FBgn0038273 CG14860 3 3R CG14860 CG14860 CDMC25599 1 3 18 DAC28-M08 1-CG14888-RA_1 CG14888 GCTGGGCTATGCGGAGATAGTTGCTGTTAAGGACTTGCAAGAAGCAGGCGTCAATGTATCCGCTTCCAC 69 FBan0014888 FBgn0038442 CG14888 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14888 CG14888 CDMC25599 1 4 18 DAC28-M08 1-CG14888-RA_1 CG14888 GCTGGGCTATGCGGAGATAGTTGCTGTTAAGGACTTGCAAGAAGCAGGCGTCAATGTATCCGCTTCCAC 69 FBan0014888 FBgn0038442 CG14888 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14888 CG14888 CDMC25600 1 5 18 DAC28-M20 1-CG14897-RB_2 CG14897 AGCGCTTCCCTAGAGGATCCTCTGACAAGCACCACCTACAAAGCTACCATGCATGCCAATCCCAATCTT 69 FBan0014897 FBgn0038434 CG14897 3 3R CG14897 CG14897 CDMC25600 1 6 18 DAC28-M20 1-CG14897-RB_2 CG14897 AGCGCTTCCCTAGAGGATCCTCTGACAAGCACCACCTACAAAGCTACCATGCATGCCAATCCCAATCTT 69 FBan0014897 FBgn0038434 CG14897 3 3R CG14897 CG14897 CDMC25601 1 7 18 DAC29-A08 1-CG6375-RB_1 CG6375 GCAAGTCGATTGGATTGTGCAGTACGATCCTCCAGATGATCCACGCGAGTATATTCACAGGGTGGGCCG 69 FBan0006375 FBgn0025140 pit 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleolus; GO:0005730; nucleus; GO:0005634 pit pitchoune "CG6375, DmRH15, PIT" CDMC25601 1 8 18 DAC29-A08 1-CG6375-RB_1 CG6375 GCAAGTCGATTGGATTGTGCAGTACGATCCTCCAGATGATCCACGCGAGTATATTCACAGGGTGGGCCG 69 FBan0006375 FBgn0025140 pit 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleolus; GO:0005730; nucleus; GO:0005634 pit pitchoune "CG6375, DmRH15, PIT" CDMC25602 1 9 18 DAC29-A20 16-CG6391-RA_1 CG6391 CATGCACACCACACTTAACTGCGAGACTAACACTAACCCCAAAACTAAACCCATACCGAGAACCAACCA 69 FBan0006391 FBgn0036111 Aps 3 3L phospholipid metabolism; GO:0006644 diphosphoinositol-polyphosphate diphosphatase activity; GO:0008486 ; EC:3.6.1.52; ; GO:0008486 ; EC:3.6.1.52 Aps Aps "CG6391, anon-WO0118547.266" CDMC25602 1 10 18 DAC29-A20 16-CG6391-RA_1 CG6391 CATGCACACCACACTTAACTGCGAGACTAACACTAACCCCAAAACTAAACCCATACCGAGAACCAACCA 69 FBan0006391 FBgn0036111 Aps 3 3L phospholipid metabolism; GO:0006644 diphosphoinositol-polyphosphate diphosphatase activity; GO:0008486 ; EC:3.6.1.52; ; GO:0008486 ; EC:3.6.1.52 Aps Aps "CG6391, anon-WO0118547.266" CDMC25603 1 11 18 DAC29-E08 23-CG6425-RA_9 CG6425 ACCAGCCCCTGAATACAATCAGCTTCCCTTCAGCGAGTACCAATTGTGATGAGCAAAGTTAGAGTTTAA 69 FBan0006425 FBgn0039449 CG6425 3 3R CG6425 CG6425 CDMC25603 1 12 18 DAC29-E08 23-CG6425-RA_9 CG6425 ACCAGCCCCTGAATACAATCAGCTTCCCTTCAGCGAGTACCAATTGTGATGAGCAAAGTTAGAGTTTAA 69 FBan0006425 FBgn0039449 CG6425 3 3R CG6425 CG6425 CDMC25604 1 13 18 DAC29-E20 1-CG6434-RA_1 CG6434 GATGGCGACTTGAACATCGTGGCTTCTTTCGATCGCAGAGGCAAACACATCTACACAGGCAACGCCAAG 69 FBan0006434 FBgn0036972 CG6434 3 3L CG6434 CG6434 CDMC25604 1 14 18 DAC29-E20 1-CG6434-RA_1 CG6434 GATGGCGACTTGAACATCGTGGCTTCTTTCGATCGCAGAGGCAAACACATCTACACAGGCAACGCCAAG 69 FBan0006434 FBgn0036972 CG6434 3 3L CG6434 CG6434 CDMC25605 1 15 18 DAC29-I08 3-CG6475-RA_2 CG6475 CGAGGATGATCAGCTGCCCAATCTTCCGGACAACGTAAAGGTCGAAAAGTGGTTACCCCAGGCTGACAT 69 FBan0006475 FBgn0038886 CG6475 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG6475 CG6475 CDMC25605 1 16 18 DAC29-I08 3-CG6475-RA_2 CG6475 CGAGGATGATCAGCTGCCCAATCTTCCGGACAACGTAAAGGTCGAAAAGTGGTTACCCCAGGCTGACAT 69 FBan0006475 FBgn0038886 CG6475 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG6475 CG6475 CDMC25606 1 17 18 DAC29-I20 3-CG6484-RA_7 CG6484 ACTGTGATCTGCATTCCCATTGGTTTCGCCATCGATTGGATCGGCAGGAGACCCACTATGTTAGCCCTA 69 FBan0006484 FBgn0034247 CG6484 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG6484 CG6484 CDMC25606 1 18 18 DAC29-I20 3-CG6484-RA_7 CG6484 ACTGTGATCTGCATTCCCATTGGTTTCGCCATCGATTGGATCGGCAGGAGACCCACTATGTTAGCCCTA 69 FBan0006484 FBgn0034247 CG6484 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG6484 CG6484 CDMC25607 1 19 18 DAC29-M08 23-CG6521-RA_4 CG6521 CCGAGCAACTTTAAGCTTTGTCTTCATTCTGACAAAAGGATGTCATCGAGTATGTTAGTTTTGGCCAAC 69 FBan0006521 FBgn0027363 Stam 2 2L JAK-STAT cascade; GO:0007259; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of JAK-STAT cascade; GO:0046425; synaptic vesicle endocytosis; GO:0048488 JAK pathway signal transduction adaptor activity; GO:0008269; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008269; receptor signaling protein tyrosine kinase signaling protein activity; GO:0008268; ; GO:0008268 Stam Signal transducing adaptor molecule "CG6521, CG6521, STAM, stam, Dstam, Signal transducing adaptor molecule" CDMC25607 1 20 18 DAC29-M08 23-CG6521-RA_4 CG6521 CCGAGCAACTTTAAGCTTTGTCTTCATTCTGACAAAAGGATGTCATCGAGTATGTTAGTTTTGGCCAAC 69 FBan0006521 FBgn0027363 Stam 2 2L JAK-STAT cascade; GO:0007259; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of JAK-STAT cascade; GO:0046425; synaptic vesicle endocytosis; GO:0048488 JAK pathway signal transduction adaptor activity; GO:0008269; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008269; receptor signaling protein tyrosine kinase signaling protein activity; GO:0008268; ; GO:0008268 Stam Signal transducing adaptor molecule "CG6521, CG6521, STAM, stam, Dstam, Signal transducing adaptor molecule" CDMC25608 1 21 18 DAC29-M20 12-CG6535-RA_5 CG6535 TGGTTGGCTACGTTCTTGGACTGGGTGATCGGCACACACAAAATATCCTAGTAGACCAGCAGACAGCGG 69 FBgn0038308 CDMC25608 1 22 18 DAC29-M20 12-CG6535-RA_5 CG6535 TGGTTGGCTACGTTCTTGGACTGGGTGATCGGCACACACAAAATATCCTAGTAGACCAGCAGACAGCGG 69 FBgn0038308 CDMC25609 1 23 18 DAC30-A08 2-CG3715-RA_1 CG3715 TGGTCCGAACCAAAGATCGCATCTTCGACAGCATTAGCCATCTGATCAACTACCACTGGGCACACGC 67 FBan0003715 FBgn0015296 Shc 3 3L MAPKKK cascade; GO:0000165; epidermal growth factor receptor signaling pathway; GO:0007173; regulation of progression through cell cycle; GO:0000074; torso signaling pathway; GO:0008293; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 Shc SHC-adaptor protein "CG3715, dshc, dShc, D-Shc, shc, DSHC" CDMC25609 1 24 18 DAC30-A08 2-CG3715-RA_1 CG3715 TGGTCCGAACCAAAGATCGCATCTTCGACAGCATTAGCCATCTGATCAACTACCACTGGGCACACGC 67 FBan0003715 FBgn0015296 Shc 3 3L MAPKKK cascade; GO:0000165; epidermal growth factor receptor signaling pathway; GO:0007173; regulation of progression through cell cycle; GO:0000074; torso signaling pathway; GO:0008293; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 Shc SHC-adaptor protein "CG3715, dshc, dShc, D-Shc, shc, DSHC" CDMC25610 1 25 18 DAC30-A20 2-CG3836-RA_3 CG3836 GGATTTGAGCACATTACAGATCCGGAACTTCGATTGGTCAGGGAGCTAGTCAGCATGGTGAGCGCGG 67 FBan0003836 FBgn0003459 stwl 3 3L NOT female germ-line cyst formation (sensu Insecta); GO:0030727; oocyte fate determination (sensu Insecta); GO:0007294; protein localization; GO:0008104; regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 stwl stonewall "CG3836, snw, alpha transcript, fs(3)02024" CDMC25610 1 26 18 DAC30-A20 2-CG3836-RA_3 CG3836 GGATTTGAGCACATTACAGATCCGGAACTTCGATTGGTCAGGGAGCTAGTCAGCATGGTGAGCGCGG 67 FBan0003836 FBgn0003459 stwl 3 3L NOT female germ-line cyst formation (sensu Insecta); GO:0030727; oocyte fate determination (sensu Insecta); GO:0007294; protein localization; GO:0008104; regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 stwl stonewall "CG3836, snw, alpha transcript, fs(3)02024" CDMC25611 1 1 19 DAC30-E08 2-CG4088-RB_2 CG4088 GCTGACCCACGAGGATATGGAAACCATCAGAAGGCTCCCATCGTTTCGTCCGTACGTCGAGCAGATC 67 FBan0004088 FBgn0005654 lat 2 2R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; larval feeding behavior; GO:0030536; learning; GO:0007612; learning and/or memory; GO:0007611; olfactory learning; GO:0008355 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688 nuclear origin of replication recognition complex; GO:0005664 lat latheo "CG4088, l(2)49Fd, vr6, DmORC3, Origin recognition complex subunit 3, vr-6, ORC, ORC3, Orc3, l(2)vr6" CDMC25611 1 2 19 DAC30-E08 2-CG4088-RB_2 CG4088 GCTGACCCACGAGGATATGGAAACCATCAGAAGGCTCCCATCGTTTCGTCCGTACGTCGAGCAGATC 67 FBan0004088 FBgn0005654 lat 2 2R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; larval feeding behavior; GO:0030536; learning; GO:0007612; learning and/or memory; GO:0007611; olfactory learning; GO:0008355 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688 nuclear origin of replication recognition complex; GO:0005664 lat latheo "CG4088, l(2)49Fd, vr6, DmORC3, Origin recognition complex subunit 3, vr-6, ORC, ORC3, Orc3, l(2)vr6" CDMC25612 1 3 19 DAC30-E20 3-CG4122-RC_2 CG4122 AGTGGCTTGGTGCAGAACGATAAAGGACAACCATTGAGGGAGGCCTATGTCCGATTGTTGGAGCACG 67 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC25612 1 4 19 DAC30-E20 3-CG4122-RC_2 CG4122 AGTGGCTTGGTGCAGAACGATAAAGGACAACCATTGAGGGAGGCCTATGTCCGATTGTTGGAGCACG 67 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC25613 1 5 19 DAC30-I08 3-CG4587-RA_4 CG4587 GGAACCAGACAGCTTTGTGTACAGTGTACCCTTTGGCTCGGGCTATGCCATTAAGTCGAACGCCACT 67 FBan0004587 FBgn0028863 CG4587 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 membrane; GO:0016020 CG4587 CG4587 "BG:DS07108.2, DS07108.2" CDMC25613 1 6 19 DAC30-I08 3-CG4587-RA_4 CG4587 GGAACCAGACAGCTTTGTGTACAGTGTACCCTTTGGCTCGGGCTATGCCATTAAGTCGAACGCCACT 67 FBan0004587 FBgn0028863 CG4587 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 membrane; GO:0016020 CG4587 CG4587 "BG:DS07108.2, DS07108.2" CDMC25614 1 7 19 DAC30-I20 2-CG4827-RA_2 CG4827 GTGCAACCTTGGCAACTTGGTGACAGATGCCATGATCTATAGTCGCGTGTTGGAAAACAAGGGCGGC 67 FBan0004827 FBgn0034225 CG4827 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG4827 CG4827 "5' nucleotidase precursor, 5'-nucleotidase-precursor" CDMC25614 1 8 19 DAC30-I20 2-CG4827-RA_2 CG4827 GTGCAACCTTGGCAACTTGGTGACAGATGCCATGATCTATAGTCGCGTGTTGGAAAACAAGGGCGGC 67 FBan0004827 FBgn0034225 CG4827 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG4827 CG4827 "5' nucleotidase precursor, 5'-nucleotidase-precursor" CDMC25615 1 9 19 DAC30-M08 18-CG5241-RA_4 CG5241 GGCCAAGTTCCAGTTTAATCACTACAAAAGCAAGTACGACCTCGTGGTCAACAGCAGATTGGGCAAG 67 FBan0005241 FBgn0036564 CG5241 3 3L amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516; protein amino acid glycosylation; GO:0006486 asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1 CG5241 CG5241 anon-WO0118547.172 CDMC25615 1 10 19 DAC30-M08 18-CG5241-RA_4 CG5241 GGCCAAGTTCCAGTTTAATCACTACAAAAGCAAGTACGACCTCGTGGTCAACAGCAGATTGGGCAAG 67 FBan0005241 FBgn0036564 CG5241 3 3L amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516; protein amino acid glycosylation; GO:0006486 asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1 CG5241 CG5241 anon-WO0118547.172 CDMC25616 1 11 19 DAC30-M20 3-CG5363-RA_2 CG5363 GTTCACCCCGGTATTCCTGTCCCGTCGATATCTGGTCCATTGGATGCATATTCGCGGAGATGGCAAC 67 FBan0005363 FBgn0004106 cdc2 2 2L G1/S transition of mitotic cell cycle; GO:0000082; G2/M transition of mitotic cell cycle; GO:0000086; cell cycle; GO:0007049; cellular physiological process; GO:0050875; hyperphosphorylation of RNA polymerase II; GO:0016245; male meiosis I; GO:0007141; meiotic G2/MI transition; GO:0008315; mitosis; GO:0007067; neuroblast division; GO:0045034; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 cdc2 cdc2 "CG5363, CG5363, CG5363, cdc2Dm, group 4, CDC2, Cdc2, Dmcdc2, Dcdc2, Dm cdc2, CDCDm, DmCdc2, cdc, cdk1, Cdk1, DmCdk1, CDK1, CDK1/CDC2, Cdc2 kinase, CDC2 kinase, l(2)31Eh" CDMC25616 1 12 19 DAC30-M20 3-CG5363-RA_2 CG5363 GTTCACCCCGGTATTCCTGTCCCGTCGATATCTGGTCCATTGGATGCATATTCGCGGAGATGGCAAC 67 FBan0005363 FBgn0004106 cdc2 2 2L G1/S transition of mitotic cell cycle; GO:0000082; G2/M transition of mitotic cell cycle; GO:0000086; cell cycle; GO:0007049; cellular physiological process; GO:0050875; hyperphosphorylation of RNA polymerase II; GO:0016245; male meiosis I; GO:0007141; meiotic G2/MI transition; GO:0008315; mitosis; GO:0007067; neuroblast division; GO:0045034; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 cdc2 cdc2 "CG5363, CG5363, CG5363, cdc2Dm, group 4, CDC2, Cdc2, Dmcdc2, Dcdc2, Dm cdc2, CDCDm, DmCdc2, cdc, cdk1, Cdk1, DmCdk1, CDK1, CDK1/CDC2, Cdc2 kinase, CDC2 kinase, l(2)31Eh" CDMC25617 1 13 19 DAC31-A08 23-CG7463-RA_3 CG7463 AGTACGGTGGACAGACTGGAAATTGAAGGCAAAAGCGAATTAGCAAGCAAACCAATTAACAATAGCATT 69 FBan0007463 FBgn0036504 yellow-k 3 3L yellow-k yellow-k "CG7463, CG7463" CDMC25617 1 14 19 DAC31-A08 23-CG7463-RA_3 CG7463 AGTACGGTGGACAGACTGGAAATTGAAGGCAAAAGCGAATTAGCAAGCAAACCAATTAACAATAGCATT 69 FBan0007463 FBgn0036504 yellow-k 3 3L yellow-k yellow-k "CG7463, CG7463" CDMC25618 1 15 19 DAC31-A20 9-CG7480-RA_4 CG7480 ACGAAAAGGTGCCCAAGACCTATGATTATGGAGACATTAGCGATCGCCTCAAGCTTAGGGAGCGTCTGC 69 FBan0007480 FBgn0001970 Pgant35A 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 Pgant35A Polypeptide N-acetylgalactosaminyltransferase 35A "CG7480, CG7480, CG7480, A3, lethal group A3, l(2)br12, lethal 12 in the black-reduced region, br12, l(2)35Aa, l35Aa, GalNAc-T, BG:DS01068.8, pgant35A, dGalNAc-T1, pgant35, Polypeptide N-acetylgalactosaminyltransferase 35A" CDMC25618 1 16 19 DAC31-A20 9-CG7480-RA_4 CG7480 ACGAAAAGGTGCCCAAGACCTATGATTATGGAGACATTAGCGATCGCCTCAAGCTTAGGGAGCGTCTGC 69 FBan0007480 FBgn0001970 Pgant35A 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 Pgant35A Polypeptide N-acetylgalactosaminyltransferase 35A "CG7480, CG7480, CG7480, A3, lethal group A3, l(2)br12, lethal 12 in the black-reduced region, br12, l(2)35Aa, l35Aa, GalNAc-T, BG:DS01068.8, pgant35A, dGalNAc-T1, pgant35, Polypeptide N-acetylgalactosaminyltransferase 35A" CDMC25619 1 17 19 DAC31-E08 23-CG7523-RA_3 CG7523 GACAAATAAACAAAGCAGCAATAGTTCGAAAACTACGCATTCTAGAGCAGAGCAAATGGAGCAACCAGC 69 FBan0007523 FBgn0038533 CG7523 3 3R CG7523 CG7523 CDMC25619 1 18 19 DAC31-E08 23-CG7523-RA_3 CG7523 GACAAATAAACAAAGCAGCAATAGTTCGAAAACTACGCATTCTAGAGCAGAGCAAATGGAGCAACCAGC 69 FBan0007523 FBgn0038533 CG7523 3 3R CG7523 CG7523 CDMC25620 1 19 19 DAC31-E20 22-CG7530-RA_1 CG7530 CGAGGAGCGGAGATGGAATCCGGGACTCTAGTAGACTAAAGCTTAGTGTAAATAGTTTATGGGGCGCTC 69 FBan0007530 FBgn0038256 CG7530 3 3R CG7530 CG7530 CDMC25620 1 20 19 DAC31-E20 22-CG7530-RA_1 CG7530 CGAGGAGCGGAGATGGAATCCGGGACTCTAGTAGACTAAAGCTTAGTGTAAATAGTTTATGGGGCGCTC 69 FBan0007530 FBgn0038256 CG7530 3 3R CG7530 CG7530 CDMC25621 1 21 19 DAC31-I08 9-CG7563-RB_1 CG7563 GGTTGCCATGTTGGATGCTGATAAGTCTGGAAAGCTGGGATTCGAGGAGTTCGAGACTTTGCTCTCGGA 69 FBan0007563 FBgn0012051 CalpA 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; protein autoprocessing; GO:0016540; protein metabolism; GO:0019538; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737 CalpA Calpain-A "CG7563, CG18152, CG7563, calpain, Calpain lacking calmodulin-like domain., Calpain, EST C, Calpain A" CDMC25621 1 22 19 DAC31-I08 9-CG7563-RB_1 CG7563 GGTTGCCATGTTGGATGCTGATAAGTCTGGAAAGCTGGGATTCGAGGAGTTCGAGACTTTGCTCTCGGA 69 FBan0007563 FBgn0012051 CalpA 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; protein autoprocessing; GO:0016540; protein metabolism; GO:0019538; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737 CalpA Calpain-A "CG7563, CG18152, CG7563, calpain, Calpain lacking calmodulin-like domain., Calpain, EST C, Calpain A" CDMC25622 1 23 19 DAC31-I20 2-CG7577-RA_1 CG7577 TCTTCAGGGTGGATGTGCACTACCAAGTGGAGACCACACCTTTGTATCGCACAAGCCTGGAGTTTACCA 69 FBan0007577 FBgn0039676 ppk20 3 3R cation transport; GO:0006812; proteolysis; GO:0006508; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0005272 membrane; GO:0016020 ppk20 pickpocket 20 "CG7577, PPK20" CDMC25622 1 24 19 DAC31-I20 2-CG7577-RA_1 CG7577 TCTTCAGGGTGGATGTGCACTACCAAGTGGAGACCACACCTTTGTATCGCACAAGCCTGGAGTTTACCA 69 FBan0007577 FBgn0039676 ppk20 3 3R cation transport; GO:0006812; proteolysis; GO:0006508; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0005272 membrane; GO:0016020 ppk20 pickpocket 20 "CG7577, PPK20" CDMC25623 1 25 19 DAC31-M08 23-CG7607-RA_2 CG7607 CCCACTTTTCAGCCATTACAAAATCCTTTGACACAGTAAAGCTGAGATGTAACTATAAACTACAATGCT 69 FBan0007607 FBgn0036145 CG7607 3 3L CG7607 CG7607 "CT23219, BcDNA:RH68451" CDMC25623 1 26 19 DAC31-M08 23-CG7607-RA_2 CG7607 CCCACTTTTCAGCCATTACAAAATCCTTTGACACAGTAAAGCTGAGATGTAACTATAAACTACAATGCT 69 FBan0007607 FBgn0036145 CG7607 3 3L CG7607 CG7607 "CT23219, BcDNA:RH68451" CDMC25624 1 1 20 DAC31-M20 23-CG7620-RA_5 CG7620 ACTACTTCGATGTTTGTTTTCACTCTAGGATACCAAGTAATCCTGGCATTGTTAAATCCCTTGTGTTGT 69 FBan0007620 FBgn0002354 l(3)87Df 3 3R l(3)87Df lethal (3) 87Df "CG7620, l(3)S12, S12, l(3)s12, BcDNA:SD27354" CDMC25624 1 2 20 DAC31-M20 23-CG7620-RA_5 CG7620 ACTACTTCGATGTTTGTTTTCACTCTAGGATACCAAGTAATCCTGGCATTGTTAAATCCCTTGTGTTGT 69 FBan0007620 FBgn0002354 l(3)87Df 3 3R l(3)87Df lethal (3) 87Df "CG7620, l(3)S12, S12, l(3)s12, BcDNA:SD27354" CDMC25625 1 3 20 DAC32-A08 16-CG14693-RA_1 CG14693 CTGGAGATATGATGGGTGATGTGGAGCTCTTAGAGGGTATCAAGCGAACTCACACCTTCAGAGCAGCA 68 FBan0014693 FBgn0037837 CG14693 3 3R CG14693 CG14693 CDMC25625 1 4 20 DAC32-A08 16-CG14693-RA_1 CG14693 CTGGAGATATGATGGGTGATGTGGAGCTCTTAGAGGGTATCAAGCGAACTCACACCTTCAGAGCAGCA 68 FBan0014693 FBgn0037837 CG14693 3 3R CG14693 CG14693 CDMC25626 1 5 20 DAC32-A20 14-CG14818-RA_1 CG14818 CGGAAAAACTCCGGGGAAAATTCCAGGGAAAATGTCACCCAAAAACAATCATGATCCCTCGTCGTCCG 68 FBan0014818 FBgn0026088 CG14818 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14818 CG14818 "EG:63B12.12, CT34631, BcDNA:RE09176, BcDNA:RH52516" CDMC25626 1 6 20 DAC32-A20 14-CG14818-RA_1 CG14818 CGGAAAAACTCCGGGGAAAATTCCAGGGAAAATGTCACCCAAAAACAATCATGATCCCTCGTCGTCCG 68 FBan0014818 FBgn0026088 CG14818 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14818 CG14818 "EG:63B12.12, CT34631, BcDNA:RE09176, BcDNA:RH52516" CDMC25627 1 7 20 DAC32-E08 3-CG15295-RA_1 CG15295 GCGGCTGCAGTTCAAGAACGATGTGGAGTTCGTTGCCTACCTTTTGAACCTGGCGGATAACGATACGG 68 FBan0015295 FBgn0030220 CG15295 X X CG15295 CG15295 BcDNA:RH11383 CDMC25627 1 8 20 DAC32-E08 3-CG15295-RA_1 CG15295 GCGGCTGCAGTTCAAGAACGATGTGGAGTTCGTTGCCTACCTTTTGAACCTGGCGGATAACGATACGG 68 FBan0015295 FBgn0030220 CG15295 X X CG15295 CG15295 BcDNA:RH11383 CDMC25628 1 9 20 DAC32-E20 1-CG15349-RA_2 CG15349 TCAGGAAGATCAGCAGTTCCAGCTCCAGTTATGCGTACAAGGACTACAAGGATTCCAGCGAGAGCGGC 68 FBgn0030043 CDMC25628 1 10 20 DAC32-E20 1-CG15349-RA_2 CG15349 TCAGGAAGATCAGCAGTTCCAGCTCCAGTTATGCGTACAAGGACTACAAGGATTCCAGCGAGAGCGGC 68 FBgn0030043 CDMC25629 1 11 20 DAC32-I08 24-CG15757-RA_1 CG15757 TGTCCACATTTTTGTTGTGTTCAATGAAATGGGATTAAAAAATAATAAAAATTTATTAAGGCAAAGCA 68 FBan0015757 FBgn0030494 CG15757 X X structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15757 CG15757 BcDNA:LP12385 CDMC25629 1 12 20 DAC32-I08 24-CG15757-RA_1 CG15757 TGTCCACATTTTTGTTGTGTTCAATGAAATGGGATTAAAAAATAATAAAAATTTATTAAGGCAAAGCA 68 FBan0015757 FBgn0030494 CG15757 X X structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15757 CG15757 BcDNA:LP12385 CDMC25630 1 13 20 DAC32-I20 2-CG1616-RA_1 CG1616 GCCGCCAGAATTTCAGATCGGAAATTCACCTGCTGTTATGCGGTGATCCGGGTACTTCCAAGTCCCAG 68 FBan0001616 FBgn0015929 dpa 2 2R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; NOT DNA endoreduplication; GO:0042023; mitotic spindle organization and biogenesis; GO:0007052 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634 dpa disc proliferation abnormal "CG1616, Dpa, l(2)43Ca, DmMCM4, 43Ca, MCM4, DmMcm4, Drosophila proliferation abnormal, Mcm4" CDMC25630 1 14 20 DAC32-I20 2-CG1616-RA_1 CG1616 GCCGCCAGAATTTCAGATCGGAAATTCACCTGCTGTTATGCGGTGATCCGGGTACTTCCAAGTCCCAG 68 FBan0001616 FBgn0015929 dpa 2 2R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; NOT DNA endoreduplication; GO:0042023; mitotic spindle organization and biogenesis; GO:0007052 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0008094; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634 dpa disc proliferation abnormal "CG1616, Dpa, l(2)43Ca, DmMCM4, 43Ca, MCM4, DmMcm4, Drosophila proliferation abnormal, Mcm4" CDMC25631 1 15 20 DAC32-M08 18-CG17048-RA_1 CG17048 ATGGCCAGGTGTCCAGGCAGTTCCACGATAACTGGCGTCTATTTGGTATTATGATGGTACCGCTGATG 68 FBan0017048 FBgn0033828 CG17048 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17048 CG17048 CDMC25631 1 16 20 DAC32-M08 18-CG17048-RA_1 CG17048 ATGGCCAGGTGTCCAGGCAGTTCCACGATAACTGGCGTCTATTTGGTATTATGATGGTACCGCTGATG 68 FBan0017048 FBgn0033828 CG17048 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG17048 CG17048 CDMC25632 1 17 20 DAC32-M20 2-CG17190-RA_1 CG17190 ACTCCAGTGATTCTGGCACCAAGAATGGAATGCTGCATGTGACCAGCTTTGTGAACCAGAAGCCCAAG 68 FBan0017190 FBgn0038761 CG17190 3 3R CG17190 CG17190 CDMC25632 1 18 20 DAC32-M20 2-CG17190-RA_1 CG17190 ACTCCAGTGATTCTGGCACCAAGAATGGAATGCTGCATGTGACCAGCTTTGTGAACCAGAAGCCCAAG 68 FBan0017190 FBgn0038761 CG17190 3 3R CG17190 CG17190 CDMC25633 1 19 20 DAC33-A08 18-CG31349-RF_9 CG31349 GTGGTGCATCCACCTACGACAGTGTGTCCAGCTACGACTCGTACAACAATACACAAATGGCCATGC 66 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC25633 1 20 20 DAC33-A08 18-CG31349-RF_9 CG31349 GTGGTGCATCCACCTACGACAGTGTGTCCAGCTACGACTCGTACAACAATACACAAATGGCCATGC 66 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC25634 1 21 20 DAC33-A20 3-CG31530-RA_2 CG31530 ACAGGGAACCCAAAACATCACCTCGCAGTTCACCATCATTGACGGCATGGACAACAAGGGGTACAG 66 FBan0031530 FBgn0051530 CG31530 3 3R extracellular transport; GO:0006858; organic cation transport; GO:0015695 polyspecific organic cation transporter activity; GO:0015354; ; GO:0015354 integral to membrane; GO:0016021 CG31530 CG31530 "CG12588, CG9767" CDMC25634 1 22 20 DAC33-A20 3-CG31530-RA_2 CG31530 ACAGGGAACCCAAAACATCACCTCGCAGTTCACCATCATTGACGGCATGGACAACAAGGGGTACAG 66 FBan0031530 FBgn0051530 CG31530 3 3R extracellular transport; GO:0006858; organic cation transport; GO:0015695 polyspecific organic cation transporter activity; GO:0015354; ; GO:0015354 integral to membrane; GO:0016021 CG31530 CG31530 "CG12588, CG9767" CDMC25635 1 23 20 DAC33-E08 12-CG31992-RD_2 CG31992 TGCAGCACTTACCACAAACTCCTTCCTCTACAAGCTCTAGTGGAACTAGTGGTGGCAACGTCGGAG 66 FBan0031992 FBgn0051992 CG31992 4 4 mRNA binding; GO:0003729; ; GO:0003729 CG31992 CG31992 "CG11484, CG9905, CG11484, CG9905, anon-EST:Posey205" CDMC25635 1 24 20 DAC33-E08 12-CG31992-RD_2 CG31992 TGCAGCACTTACCACAAACTCCTTCCTCTACAAGCTCTAGTGGAACTAGTGGTGGCAACGTCGGAG 66 FBan0031992 FBgn0051992 CG31992 4 4 mRNA binding; GO:0003729; ; GO:0003729 CG31992 CG31992 "CG11484, CG9905, CG11484, CG9905, anon-EST:Posey205" CDMC25636 1 25 20 DAC33-E20 3-CG32223-RA_5 CG32223 ACCGCCTACGAGCACAATCTGGACCGCGTACATAATGTCTATCGAGAGAGCTTGGACTCGCGAACC 66 FBgn0052223 CDMC25636 1 26 20 DAC33-E20 3-CG32223-RA_5 CG32223 ACCGCCTACGAGCACAATCTGGACCGCGTACATAATGTCTATCGAGAGAGCTTGGACTCGCGAACC 66 FBgn0052223 CDMC25637 1 1 21 DAC33-I08 3-CG32647-RA_2 CG32647 AATCGGAATCTTGCCCGGATTGCATAGAGCGTACTGGGAGTGAGAGAGTGGTTCGTCACACTTGCA 66 FBan0032647 FBgn0052647 CG32647 X X DNA methylation; GO:0006306 DNA binding; GO:0003677; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- cellular component unknown; GO:0008372 CG32647 CG32647 "CG3794, CG15723, CG18453, CG15723, CT35953, BcDNA:RH40632" CDMC25637 1 2 21 DAC33-I08 3-CG32647-RA_2 CG32647 AATCGGAATCTTGCCCGGATTGCATAGAGCGTACTGGGAGTGAGAGAGTGGTTCGTCACACTTGCA 66 FBan0032647 FBgn0052647 CG32647 X X DNA methylation; GO:0006306 DNA binding; GO:0003677; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- cellular component unknown; GO:0008372 CG32647 CG32647 "CG3794, CG15723, CG18453, CG15723, CT35953, BcDNA:RH40632" CDMC25638 1 3 21 DAC33-I20 14-CG32711-RA_2 CG32711 TCCTTAGCTGCAGCGACATTAGTTTAAATTTCAAGCCGGCTATCGCATGGTGATTCCACCTGCACG 66 FBan0032711 FBgn0052711 CG32711 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32711 CG32711 BcDNA:RH09582 CDMC25638 1 4 21 DAC33-I20 14-CG32711-RA_2 CG32711 TCCTTAGCTGCAGCGACATTAGTTTAAATTTCAAGCCGGCTATCGCATGGTGATTCCACCTGCACG 66 FBan0032711 FBgn0052711 CG32711 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32711 CG32711 BcDNA:RH09582 CDMC25639 1 5 21 DAC33-M08 17-CG33261-RF_1 CG33261 AGCGAAGGACAAAAGGTAGAGACTATTGTGACCATGGACCCCAACAACATGATACCGGTAACGTCG 66 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC25639 1 6 21 DAC33-M08 17-CG33261-RF_1 CG33261 AGCGAAGGACAAAAGGTAGAGACTATTGTGACCATGGACCCCAACAACATGATACCGGTAACGTCG 66 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC25640 1 7 21 DAC33-M20 14-CG3368-RA_2 CG3368 TCTTGTGCGCGACACAGAACTGAGGCCAGCTATGAGCAAGTACTACAATGAGATTCTGCTGGTGGC 66 FBan0003368 FBgn0039508 CG3368 3 3R CG3368 CG3368 CDMC25640 1 8 21 DAC33-M20 14-CG3368-RA_2 CG3368 TCTTGTGCGCGACACAGAACTGAGGCCAGCTATGAGCAAGTACTACAATGAGATTCTGCTGGTGGC 66 FBan0003368 FBgn0039508 CG3368 3 3R CG3368 CG3368 CDMC25641 1 9 21 DAC34-A08 17-CG13431-RA_1 CG13431 GGCGAAACCTGATTAGAATCGAAGGTCCAGTTCGCATTCAATACACTACTAGGGAGCAGTACAAGCGGA 69 FBan0013431 FBgn0034521 Mgat1 2 2R protein amino acid N-linked glycosylation; GO:0006487; protein amino acid glycosylation; GO:0006486 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; GO:0003827 ; EC:2.4.1.101; ; GO:0003827 ; EC:2.4.1.101; ; GO:0008375 ; EC:2.4.1.-; ; GO:0003827 ; EC:2.4.1.101" Golgi membrane; GO:0000139 Mgat1 "UDP-GlcNAc:a-3-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase I" "CG13431, CG13431, CG13431, GlcNAc-TI, N-acetylglucosaminyltransferase I, dMGAT1, MGAT1, UDP-GlcNAc:a-3-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase I" CDMC25641 1 10 21 DAC34-A08 17-CG13431-RA_1 CG13431 GGCGAAACCTGATTAGAATCGAAGGTCCAGTTCGCATTCAATACACTACTAGGGAGCAGTACAAGCGGA 69 FBan0013431 FBgn0034521 Mgat1 2 2R protein amino acid N-linked glycosylation; GO:0006487; protein amino acid glycosylation; GO:0006486 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; GO:0003827 ; EC:2.4.1.101; ; GO:0003827 ; EC:2.4.1.101; ; GO:0008375 ; EC:2.4.1.-; ; GO:0003827 ; EC:2.4.1.101" Golgi membrane; GO:0000139 Mgat1 "UDP-GlcNAc:a-3-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase I" "CG13431, CG13431, CG13431, GlcNAc-TI, N-acetylglucosaminyltransferase I, dMGAT1, MGAT1, UDP-GlcNAc:a-3-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase I" CDMC25642 1 11 21 DAC34-A20 2-CG13446-RA_1 CG13446 CATCGGCGAGGAAAACTACAGCTATCGATCGACCTCGACCATAGTCCTCATGGTTTCCGCCTGGATCCT 69 FBan0013446 FBgn0036524 CG13446 3 3L CG13446 CG13446 CDMC25642 1 12 21 DAC34-A20 2-CG13446-RA_1 CG13446 CATCGGCGAGGAAAACTACAGCTATCGATCGACCTCGACCATAGTCCTCATGGTTTCCGCCTGGATCCT 69 FBan0013446 FBgn0036524 CG13446 3 3L CG13446 CG13446 CDMC25643 1 13 21 DAC34-E08 2-CG13487-RA_1 CG13487 ACCGGAGCATCTTTACGAGCGGTTCGATCACTACGAGTATCCGGACACTCACACCATGAGCAAGCTGAA 69 FBan0013487 FBgn0034669 CG13487 2 2R CG13487 CG13487 CT32855 CDMC25643 1 14 21 DAC34-E08 2-CG13487-RA_1 CG13487 ACCGGAGCATCTTTACGAGCGGTTCGATCACTACGAGTATCCGGACACTCACACCATGAGCAAGCTGAA 69 FBan0013487 FBgn0034669 CG13487 2 2R CG13487 CG13487 CT32855 CDMC25644 1 15 21 DAC34-E20 15-CG13501-RA_7 CG13501 GCACTGCCCAAATTGCTCAAAGAACTGGATAGTGATGTTAGGCTGACCCATTGGAAGGCAGTCGTATCG 69 FBan0013501 FBgn0034684 CG13501 2 2R CG13501 CG13501 CDMC25644 1 16 21 DAC34-E20 15-CG13501-RA_7 CG13501 GCACTGCCCAAATTGCTCAAAGAACTGGATAGTGATGTTAGGCTGACCCATTGGAAGGCAGTCGTATCG 69 FBan0013501 FBgn0034684 CG13501 2 2R CG13501 CG13501 CDMC25645 1 17 21 DAC34-I08 3-CG13562-RA_1 CG13562 TGGGCAGCCATGGTCTCTGCGTCGACATATACATCAACACGTTCGACTATCCCTTCTACGCCGTGAACT 69 FBan0013562 FBgn0034928 CG13562 2 2R lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824 CG13562 CG13562 CDMC25645 1 18 21 DAC34-I08 3-CG13562-RA_1 CG13562 TGGGCAGCCATGGTCTCTGCGTCGACATATACATCAACACGTTCGACTATCCCTTCTACGCCGTGAACT 69 FBan0013562 FBgn0034928 CG13562 2 2R lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824 CG13562 CG13562 CDMC25646 1 19 21 DAC34-I20 2-CG13569-RB_3 CG13569 GCCCAGGGAGAAGCTCAACCTGAAGGAGATATATTCGAAAGCGTTCACACCGATGTTCGCCGAGTACCA 69 FBan0013569 FBgn0034979 CG13569 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG13569 CG13569 CDMC25646 1 20 21 DAC34-I20 2-CG13569-RB_3 CG13569 GCCCAGGGAGAAGCTCAACCTGAAGGAGATATATTCGAAAGCGTTCACACCGATGTTCGCCGAGTACCA 69 FBan0013569 FBgn0034979 CG13569 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG13569 CG13569 CDMC25647 1 21 21 DAC34-M08 1-CG13605-RA_1 CG13605 GGCTTTATGTGTTGGTGGAGTACATTTCGCAGTTCTACCGGGCAATGACACCCATTACCCAGTGGCTCC 69 FBan0013605 FBgn0039150 CG13605 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG13605 CG13605 CDMC25647 1 22 21 DAC34-M08 1-CG13605-RA_1 CG13605 GGCTTTATGTGTTGGTGGAGTACATTTCGCAGTTCTACCGGGCAATGACACCCATTACCCAGTGGCTCC 69 FBan0013605 FBgn0039150 CG13605 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG13605 CG13605 CDMC25648 1 23 21 DAC34-M20 9-CG13613-RA_1 CG13613 CCCTGCATCCTTTCGCTGAGGACCACTTCTATGGAATGGTCACCCAAGTTATAACCTTCCTGCTCACGT 69 FBan0013613 FBgn0039193 CG13613 3 3R CG13613 CG13613 CDMC25648 1 24 21 DAC34-M20 9-CG13613-RA_1 CG13613 CCCTGCATCCTTTCGCTGAGGACCACTTCTATGGAATGGTCACCCAAGTTATAACCTTCCTGCTCACGT 69 FBan0013613 FBgn0039193 CG13613 3 3R CG13613 CG13613 CDMC25649 1 25 21 DAC35-A08 33-CG17320-RA_1 CG17320 CCTGTTTTACTCGCGATCCTGTAGCTGCAAAATGTCGAAGACCCGTGTGTACGTTGTCGGTGTGGG 66 FBan0017320 FBgn0015808 ScpX 2 2L phospholipid transport; GO:0015914 sterol carrier protein X-related thiolase activity; GO:0004770; ; GO:0004770; carrier activity; GO:0005386; ; GO:0005386; phospholipid transporter activity; GO:0005548; ; GO:0004770; ; GO:0005548; sterol carrier activity; GO:0005498; ; GO:0005498 cytoplasm; GO:0005737; mitochondrion; GO:0005739; peroxisome; GO:0005777 ScpX Sterol carrier protein X-related thiolase "CG17320, sterol carrier protein X-related thiolase, sterol carrier protein x" CDMC25649 1 26 21 DAC35-A08 33-CG17320-RA_1 CG17320 CCTGTTTTACTCGCGATCCTGTAGCTGCAAAATGTCGAAGACCCGTGTGTACGTTGTCGGTGTGGG 66 FBan0017320 FBgn0015808 ScpX 2 2L phospholipid transport; GO:0015914 sterol carrier protein X-related thiolase activity; GO:0004770; ; GO:0004770; carrier activity; GO:0005386; ; GO:0005386; phospholipid transporter activity; GO:0005548; ; GO:0004770; ; GO:0005548; sterol carrier activity; GO:0005498; ; GO:0005498 cytoplasm; GO:0005737; mitochondrion; GO:0005739; peroxisome; GO:0005777 ScpX Sterol carrier protein X-related thiolase "CG17320, sterol carrier protein X-related thiolase, sterol carrier protein x" CDMC25650 1 1 22 DAC35-A20 1-CG17754-RA_1 CG17754 GCGGACGTGATGGGCTAAAGACCCTGAACACCGTAGAGAGTTTGGACCTGAATACAATGGCCTGGG 66 FBan0017754 FBgn0030114 CG17754 X X apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 CG17754 CG17754 BcDNA:LP02641 CDMC25650 1 2 22 DAC35-A20 1-CG17754-RA_1 CG17754 GCGGACGTGATGGGCTAAAGACCCTGAACACCGTAGAGAGTTTGGACCTGAATACAATGGCCTGGG 66 FBan0017754 FBgn0030114 CG17754 X X apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 CG17754 CG17754 BcDNA:LP02641 CDMC25651 1 3 22 DAC35-E08 3-CG18507-RA_1 CG18507 CGATGGAGACGCTGGTAAACGACTACCGCTTCACCGTGTACAACATCTGCTACAAGCGCATCCTGG 66 FBan0018507 FBgn0028527 CG18507 2 2L CG18507 CG18507 "BG:DS01368.1, DS01368.1, bg:ds01368" CDMC25651 1 4 22 DAC35-E08 3-CG18507-RA_1 CG18507 CGATGGAGACGCTGGTAAACGACTACCGCTTCACCGTGTACAACATCTGCTACAAGCGCATCCTGG 66 FBan0018507 FBgn0028527 CG18507 2 2L CG18507 CG18507 "BG:DS01368.1, DS01368.1, bg:ds01368" CDMC25652 1 5 22 DAC35-E20 1-CG18869-RA_1 CG18869 AGCCCAAAATTTCTTCGTGGCCAATTCCCTAGATGTCCTGACCGTGCCTCTCATTGTTCTCCTGGC 66 FBan0018869 FBgn0042179 CG18869 3 3L carbohydrate metabolism; GO:0005975; defense response; GO:0006952; lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-" CG18869 CG18869 "UDP-glycosyl-transferase, anon-WO0140519.104, anon-WO0153538.77" CDMC25652 1 6 22 DAC35-E20 1-CG18869-RA_1 CG18869 AGCCCAAAATTTCTTCGTGGCCAATTCCCTAGATGTCCTGACCGTGCCTCTCATTGTTCTCCTGGC 66 FBan0018869 FBgn0042179 CG18869 3 3L carbohydrate metabolism; GO:0005975; defense response; GO:0006952; lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-" CG18869 CG18869 "UDP-glycosyl-transferase, anon-WO0140519.104, anon-WO0153538.77" CDMC25653 1 7 22 DAC35-I08 5-CG2922-RA_3 CG2922 GGAGGAGCTGGTTACCGATCAGGCTGTTCGTCATCTGAAGAACTACTGCCCACTGTTGCAGGCTTT 66 FBan0002922 FBgn0037346 eIF-5C 3 3R long-term memory; GO:0007616; neuron lineage restriction; GO:0042055; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0003743; ; GO:0008135" cytosol; GO:0005829 eIF-5C eukaryotic initiation factor 5C "CG2922, CG2922, l(3)03022, extra bases, CT7240, exb, extra-bases, krasavietz, elF-5C, anon-WO0172774.49" CDMC25653 1 8 22 DAC35-I08 5-CG2922-RA_3 CG2922 GGAGGAGCTGGTTACCGATCAGGCTGTTCGTCATCTGAAGAACTACTGCCCACTGTTGCAGGCTTT 66 FBan0002922 FBgn0037346 eIF-5C 3 3R long-term memory; GO:0007616; neuron lineage restriction; GO:0042055; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0003743; ; GO:0008135" cytosol; GO:0005829 eIF-5C eukaryotic initiation factor 5C "CG2922, CG2922, l(3)03022, extra bases, CT7240, exb, extra-bases, krasavietz, elF-5C, anon-WO0172774.49" CDMC25654 1 9 22 DAC35-I20 2-CG30067-RB_1 CG30067 TCAATGCCAGCTCGGTTCTGCAGGGAAATCGATTGATCCAAGCGAAAGTTCGACCCATGTTGGAGC 66 FBan0030067 FBgn0050067 Obp50a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50a Odorant-binding protein 50a "CG30067, CG30067, anon-AE003814.2, Odorant-binding protein 50a" CDMC25654 1 10 22 DAC35-I20 2-CG30067-RB_1 CG30067 TCAATGCCAGCTCGGTTCTGCAGGGAAATCGATTGATCCAAGCGAAAGTTCGACCCATGTTGGAGC 66 FBan0030067 FBgn0050067 Obp50a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50a Odorant-binding protein 50a "CG30067, CG30067, anon-AE003814.2, Odorant-binding protein 50a" CDMC25655 1 11 22 DAC35-M08 2-CG3088-RA_1 CG3088 GCAGTGGCACTATTATAGGCGACACCTGGATCCTTACATCCGCTCAGTGTCTAACGGGCAGTTCCG 66 FBan0003088 FBgn0036015 CG3088 3 3L protein biosynthesis; GO:0006412; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; structural constituent of ribosome; GO:0003735; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0003735; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 intracellular; GO:0005622; ribosome; GO:0005840 CG3088 CG3088 SPH188 CDMC25655 1 12 22 DAC35-M08 2-CG3088-RA_1 CG3088 GCAGTGGCACTATTATAGGCGACACCTGGATCCTTACATCCGCTCAGTGTCTAACGGGCAGTTCCG 66 FBan0003088 FBgn0036015 CG3088 3 3L protein biosynthesis; GO:0006412; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; structural constituent of ribosome; GO:0003735; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0003735; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 intracellular; GO:0005622; ribosome; GO:0005840 CG3088 CG3088 SPH188 CDMC25656 1 13 22 DAC35-M20 6-CG31126-RA_1 CG31126 GGTCGGAGTCCCACTTCCGTGTGTTCGTCGTCTCGGAGAAGTTCAACGATCTGACGCTCATCAAGC 66 FBan0031126 FBgn0051126 CG31126 3 3R biological process unknown; GO:0000004 transcription regulator activity; GO:0030528; ; GO:0030528 cellular component unknown; GO:0008372 CG31126 CG31126 "CG13621, CG13621" CDMC25656 1 14 22 DAC35-M20 6-CG31126-RA_1 CG31126 GGTCGGAGTCCCACTTCCGTGTGTTCGTCGTCTCGGAGAAGTTCAACGATCTGACGCTCATCAAGC 66 FBan0031126 FBgn0051126 CG31126 3 3R biological process unknown; GO:0000004 transcription regulator activity; GO:0030528; ; GO:0030528 cellular component unknown; GO:0008372 CG31126 CG31126 "CG13621, CG13621" CDMC25657 1 15 22 DAC36-A08 1-CG17368-RA_1 CG17368 ATGTCGCGCGACCAGCAAATCGATCATGGTTTCGGCATTTGCGTTAAAGGAGGCAAAGACTCAGGTG 67 FBan0017368 FBgn0036384 CG17368 3 3L CG17368 CG17368 CDMC25657 1 16 22 DAC36-A08 1-CG17368-RA_1 CG17368 ATGTCGCGCGACCAGCAAATCGATCATGGTTTCGGCATTTGCGTTAAAGGAGGCAAAGACTCAGGTG 67 FBan0017368 FBgn0036384 CG17368 3 3L CG17368 CG17368 CDMC25658 1 17 22 DAC36-A20 23-CG17746-RA_1 CG17746 ACGATGCGTGTATATGCCTTGTCTAACTATTTAATGTATGATTTACTATGCTTTGTGATGCCCGAGC 67 FBan0017746 FBgn0035425 CG17746 3 3L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG17746 CG17746 PP2C CDMC25658 1 18 22 DAC36-A20 23-CG17746-RA_1 CG17746 ACGATGCGTGTATATGCCTTGTCTAACTATTTAATGTATGATTTACTATGCTTTGTGATGCCCGAGC 67 FBan0017746 FBgn0035425 CG17746 3 3L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG17746 CG17746 PP2C CDMC25659 1 19 22 DAC36-E08 13-CG1851-RA_1 CG1851 CGCCTGGCTCTCAATCTCAGTGCACCCTACATTGTGAGGAAAAATCACCAGGCTATGATGAAGCTGG 67 FBan0001851 FBgn0026602 Ady43A 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; ; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004001 ; EC:2.7.1.20 Ady43A Ady43A "CG1851, Adk43A, Ady" CDMC25659 1 20 22 DAC36-E08 13-CG1851-RA_1 CG1851 CGCCTGGCTCTCAATCTCAGTGCACCCTACATTGTGAGGAAAAATCACCAGGCTATGATGAAGCTGG 67 FBan0001851 FBgn0026602 Ady43A 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; ; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004001 ; EC:2.7.1.20 Ady43A Ady43A "CG1851, Adk43A, Ady" CDMC25660 1 21 22 DAC36-E20 2-CG18581-RA_1 CG18581 GCCAACTGGAGAGGAAACCGAGGAACCTTCTGGAGAGGAAACTCACAGTCCTACGGGAGAGGAAACC 67 FBan0018581 FBgn0036466 CG18581 3 3L CG18581 CG18581 CDMC25660 1 22 22 DAC36-E20 2-CG18581-RA_1 CG18581 GCCAACTGGAGAGGAAACCGAGGAACCTTCTGGAGAGGAAACTCACAGTCCTACGGGAGAGGAAACC 67 FBan0018581 FBgn0036466 CG18581 3 3L CG18581 CG18581 CDMC25661 1 23 22 DAC36-I08 2-CG2616-RA_3 CG2616 CCAAGAAAAGTCTACCGTCGGTGGTTCCCATGATGTCCGGGGTGACTGCTCGGATTTGTGCTGTTAC 67 FBan0002616 FBgn0037512 CG2616 3 3R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 CG2616 CG2616 CDMC25661 1 24 22 DAC36-I08 2-CG2616-RA_3 CG2616 CCAAGAAAAGTCTACCGTCGGTGGTTCCCATGATGTCCGGGGTGACTGCTCGGATTTGTGCTGTTAC 67 FBan0002616 FBgn0037512 CG2616 3 3R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 CG2616 CG2616 CDMC25662 1 25 22 DAC36-I20 1-CG2906-RA_2 CG2906 AGGTGTATCACGATCGTCTGAGGATGGGGGATTACCAACATCTCCGCATACACTCCCTAAGAGCCGC 67 FBan0002906 FBgn0033240 CG2906 2 2R CG2906 CG2906 CDMC25662 1 26 22 DAC36-I20 1-CG2906-RA_2 CG2906 AGGTGTATCACGATCGTCTGAGGATGGGGGATTACCAACATCTCCGCATACACTCCCTAAGAGCCGC 67 FBan0002906 FBgn0033240 CG2906 2 2R CG2906 CG2906 CDMC25663 1 1 23 DAC36-M08 2-CG30286-RA_1 CG30286 GCCCATCGGAAGCTGCAAACCACATCCTAAAGTCCATTCGCGTAACCAGAGTGAATTGGGGTGTGTG 67 FBan0030286 FBgn0050286 CG30286 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG30286 CG30286 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC25663 1 2 23 DAC36-M08 2-CG30286-RA_1 CG30286 GCCCATCGGAAGCTGCAAACCACATCCTAAAGTCCATTCGCGTAACCAGAGTGAATTGGGGTGTGTG 67 FBan0030286 FBgn0050286 CG30286 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG30286 CG30286 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC25664 1 3 23 DAC36-M20 12-CG30398-RA_1 CG30398 GCCAACCAATTTCTTTCGATCCCAGCAATGACAACCAGTCCCAACGTAGCAGAAGTGGATGATGGCG 67 FBan0030398 FBgn0050398 CG30398 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30398 CG30398 CDMC25664 1 4 23 DAC36-M20 12-CG30398-RA_1 CG30398 GCCAACCAATTTCTTTCGATCCCAGCAATGACAACCAGTCCCAACGTAGCAGAAGTGGATGATGGCG 67 FBan0030398 FBgn0050398 CG30398 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30398 CG30398 CDMC25665 1 5 23 DAC37-A08 23-CG7564-RA_2 CG7564 AAAACAACAGGAACCGAATATTCTTAGCGTAACCAATAAAGCAACCTAGAGCCACACTTTCGACG 65 FBan0007564 FBgn0036734 CG7564 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U1; GO:0005685 CG7564 CG7564 CDMC25665 1 6 23 DAC37-A08 23-CG7564-RA_2 CG7564 AAAACAACAGGAACCGAATATTCTTAGCGTAACCAATAAAGCAACCTAGAGCCACACTTTCGACG 65 FBan0007564 FBgn0036734 CG7564 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U1; GO:0005685 CG7564 CG7564 CDMC25666 1 7 23 DAC37-A20 2-CG7595-RA_1 CG7595 AAACCACACAGATCTTCCACAAGGTCTACTTCCCGGACGACACAGACGAGGCCTTCGAAGTGGAC 65 FBan0007595 FBgn0000317 ck 2 2L antennal morphogenesis; GO:0007469; intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; transporter activity; GO:0005215; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0005215" myosin; GO:0016459; unconventional myosin; GO:0016461 ck crinkled "CG7595, CG7595, CG7595, CG7595, D2, lethal group D2, l(2)br27, lethal 27 in the black-reduced region, Mhc35BC, Myosin heavy chain at 35BC, D, transcription unit D, br27, l35Ca, Dro35B, myosin-VII, l(2)35Ca, 53D10S, myosin VIIA, BG:DS00929.11, anon-35Bb, DmVIIA, Dm 35B, DMyoVIIa, mysoin VIIa, myosin VIIa, ESTS:53D10S, l(1)35Ca, l(2)07130" CDMC25666 1 8 23 DAC37-A20 2-CG7595-RA_1 CG7595 AAACCACACAGATCTTCCACAAGGTCTACTTCCCGGACGACACAGACGAGGCCTTCGAAGTGGAC 65 FBan0007595 FBgn0000317 ck 2 2L antennal morphogenesis; GO:0007469; intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; transporter activity; GO:0005215; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0005215" myosin; GO:0016459; unconventional myosin; GO:0016461 ck crinkled "CG7595, CG7595, CG7595, CG7595, D2, lethal group D2, l(2)br27, lethal 27 in the black-reduced region, Mhc35BC, Myosin heavy chain at 35BC, D, transcription unit D, br27, l35Ca, Dro35B, myosin-VII, l(2)35Ca, 53D10S, myosin VIIA, BG:DS00929.11, anon-35Bb, DmVIIA, Dm 35B, DMyoVIIa, mysoin VIIa, myosin VIIa, ESTS:53D10S, l(1)35Ca, l(2)07130" CDMC25667 1 9 23 DAC37-E08 1-CG7704-RA_1 CG7704 TCACCACCCTGTTGAGGCACACTAGCACTGTGACCACGATCACCTTTAGTCGCGATGGAACAGTC 65 FBan0007704 FBgn0010356 Taf5 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 SAGA complex; GO:0000124; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf5 TBP-associated factor 5 "CG7704, CG7704, CG7704, TAFII80, TBP associated factor 80, Taf80: TBP-associated factor 80kD, TBP-associated factor 80, p85, dTAF[[II]]80, dTAFii80, Taf[[II]]80, TAF[[II]]80, TAF[[II]]80/85, TAF80, TFIID 85, TAF80/85, d80, TFIID, dTAFII85, TAF5, TAF[[II]], dmTaf5, TAF, Taf85, TBP-associated factor 80kD, Taf80" CDMC25667 1 10 23 DAC37-E08 1-CG7704-RA_1 CG7704 TCACCACCCTGTTGAGGCACACTAGCACTGTGACCACGATCACCTTTAGTCGCGATGGAACAGTC 65 FBan0007704 FBgn0010356 Taf5 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 SAGA complex; GO:0000124; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf5 TBP-associated factor 5 "CG7704, CG7704, CG7704, TAFII80, TBP associated factor 80, Taf80: TBP-associated factor 80kD, TBP-associated factor 80, p85, dTAF[[II]]80, dTAFii80, Taf[[II]]80, TAF[[II]]80, TAF[[II]]80/85, TAF80, TFIID 85, TAF80/85, d80, TFIID, dTAFII85, TAF5, TAF[[II]], dmTaf5, TAF, Taf85, TBP-associated factor 80kD, Taf80" CDMC25668 1 11 23 DAC37-E20 3-CG7756-RA_4 CG7756 TTTGCCGAGGAATTCAAGCGGAAGCACAAGTCGGACATCAAGGGAAATGCCAGAGCGTTGAGACG 65 FBan0007756 FBgn0001217 Hsc70-2 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-2 Heat shock protein cognate 2 "CG7756, Hsc70.2, Hsc2, hsc2, hsc70, HSC2, Hsc70, dhsc70, HSC70, HSC-70" CDMC25668 1 12 23 DAC37-E20 3-CG7756-RA_4 CG7756 TTTGCCGAGGAATTCAAGCGGAAGCACAAGTCGGACATCAAGGGAAATGCCAGAGCGTTGAGACG 65 FBan0007756 FBgn0001217 Hsc70-2 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-2 Heat shock protein cognate 2 "CG7756, Hsc70.2, Hsc2, hsc2, hsc70, HSC2, Hsc70, dhsc70, HSC70, HSC-70" CDMC25669 1 13 23 DAC37-I08 3-CG7899-RA_2 CG7899 AACCAGATCGTTCGATGTGGGTCTACAGTGCTCATGACACCACGGTAGCCAGCGTTTTGAATGCG 65 FBan0007899 FBgn0000032 Acph-1 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 Acph-1 Acid phosphatase 1 "CG7899, CG7899, Acph, APH, ACPH, ACP" CDMC25669 1 14 23 DAC37-I08 3-CG7899-RA_2 CG7899 AACCAGATCGTTCGATGTGGGTCTACAGTGCTCATGACACCACGGTAGCCAGCGTTTTGAATGCG 65 FBan0007899 FBgn0000032 Acph-1 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 Acph-1 Acid phosphatase 1 "CG7899, CG7899, Acph, APH, ACPH, ACP" CDMC25670 1 15 23 DAC37-I20 5-CG7935-RA_1 CG7935 CAATGAGTCGGGCTTCGAAGTGAAAGCCGAAATCAAGGACGACGATGCTGACTCGGACGGTGACG 65 FBan0007935 FBgn0026252 msk 3 3L "epidermal growth factor receptor signaling pathway; GO:0007173; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" protein carrier activity; GO:0008320; ; GO:0008320; Ran GTPase binding; GO:0008536; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0008536 cell cortex; GO:0005938; cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 msk moleskin "CG7935, CG7935, CG7935, 61, CIP-61, Corkscrew Interacting Protein-61, DmRanBP7, dim-7, diminished-7, DIM-7, dim7, moleskin" CDMC25670 1 16 23 DAC37-I20 5-CG7935-RA_1 CG7935 CAATGAGTCGGGCTTCGAAGTGAAAGCCGAAATCAAGGACGACGATGCTGACTCGGACGGTGACG 65 FBan0007935 FBgn0026252 msk 3 3L "epidermal growth factor receptor signaling pathway; GO:0007173; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" protein carrier activity; GO:0008320; ; GO:0008320; Ran GTPase binding; GO:0008536; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0008536 cell cortex; GO:0005938; cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 msk moleskin "CG7935, CG7935, CG7935, 61, CIP-61, Corkscrew Interacting Protein-61, DmRanBP7, dim-7, diminished-7, DIM-7, dim7, moleskin" CDMC25671 1 17 23 DAC37-M08 2-CG8008-RA_1 CG8008 ATCCCTGACCACCTATCCCGGTCTGTTCAACTTCGTCAGCTCGTTCCTGTACCTGCTTTCGTTCG 65 FBan0008008 FBgn0033387 CG8008 2 2R CG8008 CG8008 CDMC25671 1 18 23 DAC37-M08 2-CG8008-RA_1 CG8008 ATCCCTGACCACCTATCCCGGTCTGTTCAACTTCGTCAGCTCGTTCCTGTACCTGCTTTCGTTCG 65 FBan0008008 FBgn0033387 CG8008 2 2R CG8008 CG8008 CDMC25672 1 19 23 DAC37-M20 11-CG8034-RA_1 CG8034 CGTGGATCCGCACTGAGCAACTTCACCCTAACCGTATCCGAATATTGCTCACTGGAGAAGCTGCC 65 FBan0008034 FBgn0031011 CG8034 X X CG8034 CG8034 CDMC25672 1 20 23 DAC37-M20 11-CG8034-RA_1 CG8034 CGTGGATCCGCACTGAGCAACTTCACCCTAACCGTATCCGAATATTGCTCACTGGAGAAGCTGCC 65 FBan0008034 FBgn0031011 CG8034 X X CG8034 CG8034 CDMC25673 1 21 23 DAC38-A08 3-CG4144-RB_6 CG4144 AAAGAGTGAAACCAGGGTGATCATAAACACCCGGCTACTGACCACCAAAGACTCTAGCTCGCGAGGCAT 69 FBan0004144 FBgn0040322 GNBP2 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976 Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- GNBP2 Gram-negative bacteria binding protein 2 "CG4144, DGNBP-2, GNBP, Gram-negative bacteria binding protein 2" CDMC25673 1 22 23 DAC38-A08 3-CG4144-RB_6 CG4144 AAAGAGTGAAACCAGGGTGATCATAAACACCCGGCTACTGACCACCAAAGACTCTAGCTCGCGAGGCAT 69 FBan0004144 FBgn0040322 GNBP2 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976 Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- GNBP2 Gram-negative bacteria binding protein 2 "CG4144, DGNBP-2, GNBP, Gram-negative bacteria binding protein 2" CDMC25674 1 23 23 DAC38-A20 2-CG4158-RA_1 CG4158 ACAAGTGCTATGCCACCTATGCAGGATTGGTAAAGCATCAACAAACGCACGCCTACGAAAGCACCGAGT 69 FBan0004158 FBgn0001983 wor 2 2L brain development; GO:0007420; neuroblast division; GO:0045034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wor worniu "CG4158, l(2)br35, br35, l35Da, l(2)35Da: lethal(2)35Da, BG:DS03023.1, schnecke, warniu, lethal(2)35Da, l(2)35Da, worniu" CDMC25674 1 24 23 DAC38-A20 2-CG4158-RA_1 CG4158 ACAAGTGCTATGCCACCTATGCAGGATTGGTAAAGCATCAACAAACGCACGCCTACGAAAGCACCGAGT 69 FBan0004158 FBgn0001983 wor 2 2L brain development; GO:0007420; neuroblast division; GO:0045034; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wor worniu "CG4158, l(2)br35, br35, l35Da, l(2)35Da: lethal(2)35Da, BG:DS03023.1, schnecke, warniu, lethal(2)35Da, l(2)35Da, worniu" CDMC25675 1 25 23 DAC38-E08 3-CG4199-RD_3 CG4199 GGGCGTGAAGGTAAATCGTAACGGATCCGTGGACGTCACTGATTTCCTGGAGTCCAATGTACCCGATGT 69 FBan0004199 FBgn0025628 CG4199 X X defense response; GO:0006952; electron transport; GO:0006118; ferredoxin metabolism; GO:0006124; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG4199 CG4199 EG:22E5.5 CDMC25675 1 26 23 DAC38-E08 3-CG4199-RD_3 CG4199 GGGCGTGAAGGTAAATCGTAACGGATCCGTGGACGTCACTGATTTCCTGGAGTCCAATGTACCCGATGT 69 FBan0004199 FBgn0025628 CG4199 X X defense response; GO:0006952; electron transport; GO:0006118; ferredoxin metabolism; GO:0006124; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG4199 CG4199 EG:22E5.5 CDMC25676 1 1 24 DAC38-E20 24-CG4205-RA_1 CG4205 CCAAGCCACATTAACATTATTGTTATATCCCGCATTATTAATAATATATAACGACTGTTGAATTACCAT 69 FBan0004205 FBgn0011769 Fdxh 3 3L ferredoxin metabolism; GO:0006124 electron carrier activity; GO:0009055; ; GO:0009055; ; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.- Fdxh Ferredoxin "CG4205, CG4205, BcDNA:RH67819" CDMC25676 1 2 24 DAC38-E20 24-CG4205-RA_1 CG4205 CCAAGCCACATTAACATTATTGTTATATCCCGCATTATTAATAATATATAACGACTGTTGAATTACCAT 69 FBan0004205 FBgn0011769 Fdxh 3 3L ferredoxin metabolism; GO:0006124 electron carrier activity; GO:0009055; ; GO:0009055; ; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.- Fdxh Ferredoxin "CG4205, CG4205, BcDNA:RH67819" CDMC25677 1 3 24 DAC38-I08 23-CG4231-RA_4 CG4231 TTCTTAGCTCAATCCAGATTGGCGTTAACATGTACGGAAGCAGCTTTAAAAGTTATTTGACCATGATGG 69 FBan0004231 FBgn0026397 Or22b 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 dendrite; GO:0030425; integral to membrane; GO:0016021 Or22b Odorant receptor 22b "CG4231, CG4231, DOR22A.2, Olfactory receptor 22A.2, dor67, AN12, Dor67, 22A.2, DOR67, DOR22b, 22b, Or22A.2, Or67: Odorant receptor 67, Odorant receptor 67" CDMC25677 1 4 24 DAC38-I08 23-CG4231-RA_4 CG4231 TTCTTAGCTCAATCCAGATTGGCGTTAACATGTACGGAAGCAGCTTTAAAAGTTATTTGACCATGATGG 69 FBan0004231 FBgn0026397 Or22b 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 dendrite; GO:0030425; integral to membrane; GO:0016021 Or22b Odorant receptor 22b "CG4231, CG4231, DOR22A.2, Olfactory receptor 22A.2, dor67, AN12, Dor67, 22A.2, DOR67, DOR22b, 22b, Or22A.2, Or67: Odorant receptor 67, Odorant receptor 67" CDMC25678 1 5 24 DAC38-I20 18-CG4247-RA_2 CG4247 TCGGTGCATATCTACAAGAAACATCGCGTACAGTACGAGGTGCGAACCCACTTCCGCTATATGAACTTC 69 FBan0004247 FBgn0038307 mRpS10 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpS10 mitochondrial ribosomal protein S10 "CG4247, CG4247, MRP-S10, Mitochondrial ribosomal protein S10, BcDNA:GM25447, MrpS10, mitochondrial ribosomal protein S10" CDMC25678 1 6 24 DAC38-I20 18-CG4247-RA_2 CG4247 TCGGTGCATATCTACAAGAAACATCGCGTACAGTACGAGGTGCGAACCCACTTCCGCTATATGAACTTC 69 FBan0004247 FBgn0038307 mRpS10 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 mRpS10 mitochondrial ribosomal protein S10 "CG4247, CG4247, MRP-S10, Mitochondrial ribosomal protein S10, BcDNA:GM25447, MrpS10, mitochondrial ribosomal protein S10" CDMC25679 1 7 24 DAC38-M08 15-CG4285-RA_1 CG4285 CGGATGGACGGAGATGGATGAGGAAAGCTTGCTCGAAAACGGTTCCTGTTCCGCTTTTGGTTGTAATAG 69 FBan0004285 FBgn0038310 CG4285 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4285 CG4285 "CG31154, BcDNA:SD12744" CDMC25679 1 8 24 DAC38-M08 15-CG4285-RA_1 CG4285 CGGATGGACGGAGATGGATGAGGAAAGCTTGCTCGAAAACGGTTCCTGTTCCGCTTTTGGTTGTAATAG 69 FBan0004285 FBgn0038310 CG4285 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4285 CG4285 "CG31154, BcDNA:SD12744" CDMC25680 1 9 24 DAC38-M20 16-CG4306-RA_1 CG4306 CCTAAGGACTCCATTCCCTTATCCAGACAGCCCTCGAAAACATATCTGCAATGTCTCGTTAAAGGCGCT 69 FBan0004306 FBgn0036787 CG4306 3 3L CG4306 CG4306 CDMC25680 1 10 24 DAC38-M20 16-CG4306-RA_1 CG4306 CCTAAGGACTCCATTCCCTTATCCAGACAGCCCTCGAAAACATATCTGCAATGTCTCGTTAAAGGCGCT 69 FBan0004306 FBgn0036787 CG4306 3 3L CG4306 CG4306 CDMC25681 1 11 24 DAC39-A08 22-CG6919-RA_1 CG6919 TGCGCAGTGCACAGCAAGTGTTCTCCAGAAAACCAGATTGCCAGCTTACAAATACAAATCACTCGATAA 69 FBan0006919 FBgn0038980 oa2 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; NOT elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; ; GO:0008227; octopamine receptor activity; GO:0004989; adrenoceptor activity; GO:0004935; ; GO:0004935; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 oa2 octopamine receptor 2 "CG6919, CG6919, CG6919, CG6919, CG6919, DmCG6919, Dmoa2, OctBeta1, anon-WO0170980.67, anon-WO0170980.68, octopamine receptor 2" CDMC25681 1 12 24 DAC39-A08 22-CG6919-RA_1 CG6919 TGCGCAGTGCACAGCAAGTGTTCTCCAGAAAACCAGATTGCCAGCTTACAAATACAAATCACTCGATAA 69 FBan0006919 FBgn0038980 oa2 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; NOT elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; ; GO:0008227; octopamine receptor activity; GO:0004989; adrenoceptor activity; GO:0004935; ; GO:0004935; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 oa2 octopamine receptor 2 "CG6919, CG6919, CG6919, CG6919, CG6919, DmCG6919, Dmoa2, OctBeta1, anon-WO0170980.67, anon-WO0170980.68, octopamine receptor 2" CDMC25682 1 13 24 DAC39-A20 18-CG6931-RA_2 CG6931 GGTGTGTATGCTGTACGAATCTACCAGTTCCAACAATCCCAAGTTCTATCTGCTAGAGCTGAGCACCCT 69 FBan0006931 FBgn0036236 CG6931 3 3L CG6931 CG6931 CDMC25682 1 14 24 DAC39-A20 18-CG6931-RA_2 CG6931 GGTGTGTATGCTGTACGAATCTACCAGTTCCAACAATCCCAAGTTCTATCTGCTAGAGCTGAGCACCCT 69 FBan0006931 FBgn0036236 CG6931 3 3L CG6931 CG6931 CDMC25683 1 15 24 DAC39-E08 17-CG6964-RD_1 CG6964 ACAGCACACTTCACACCAGACACTCACTGACCAAGGCATCCAGAATCAAAAAGCAGAAACCAACTACAA 69 FBan0006964 FBgn0010825 Gug 3 3L leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of transcription; GO:0016481; segment specification; GO:0007379 DNA binding; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 Gug Grunge "CG6964, l(3)03928, l(3)01323, Atro, Atrophin, atro, gug, l(3)j5A3, l(3)rO116, Grunge" CDMC25683 1 16 24 DAC39-E08 17-CG6964-RD_1 CG6964 ACAGCACACTTCACACCAGACACTCACTGACCAAGGCATCCAGAATCAAAAAGCAGAAACCAACTACAA 69 FBan0006964 FBgn0010825 Gug 3 3L leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of transcription; GO:0016481; segment specification; GO:0007379 DNA binding; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 Gug Grunge "CG6964, l(3)03928, l(3)01323, Atro, Atrophin, atro, gug, l(3)j5A3, l(3)rO116, Grunge" CDMC25684 1 17 24 DAC39-E20 6-CG6976-RA_1 CG6976 GGAGCTCGGGTAAGAACCACTTCCACATTCGTTTTGGTAACATGATCGGAGCATCGAAGCTGCTGTGCA 69 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC25684 1 18 24 DAC39-E20 6-CG6976-RA_1 CG6976 GGAGCTCGGGTAAGAACCACTTCCACATTCGTTTTGGTAACATGATCGGAGCATCGAAGCTGCTGTGCA 69 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC25685 1 19 24 DAC39-I08 1-CG7002-RA_1 CG7002 GCCTGCACAAAGTGCGATGATGGACTCCACTTGCCTGACGAGAAATGGAAGAAGGATAAGTGCACCGAA 69 FBan0007002 FBgn0029167 Hml 3 3L cell adhesion; GO:0007155; chitin metabolism; GO:0006030; defense response; GO:0006952; hemostasis; GO:0007599 chitin binding; GO:0008061; sugar binding; GO:0005529; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005529; ; GO:0008061; ; GO:0005529 extracellular region; GO:0005576 Hml Hemolectin "CG7002, CG7002, CG7002, CT21553, hml, d-hml, hemolectin" CDMC25685 1 20 24 DAC39-I08 1-CG7002-RA_1 CG7002 GCCTGCACAAAGTGCGATGATGGACTCCACTTGCCTGACGAGAAATGGAAGAAGGATAAGTGCACCGAA 69 FBan0007002 FBgn0029167 Hml 3 3L cell adhesion; GO:0007155; chitin metabolism; GO:0006030; defense response; GO:0006952; hemostasis; GO:0007599 chitin binding; GO:0008061; sugar binding; GO:0005529; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005529; ; GO:0008061; ; GO:0005529 extracellular region; GO:0005576 Hml Hemolectin "CG7002, CG7002, CG7002, CT21553, hml, d-hml, hemolectin" CDMC25686 1 21 24 DAC39-I20 21-CG7013-RA_2 CG7013 GCTCAAGCACAGTCGAAGTAATAACAAAATGAAGACGTGGTACATGGTGGTAGTGATCGGCTTCCTGGC 69 FBan0007013 FBgn0027095 ARP-like 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 ARP-like ARP-like "CG7013, anon-EST:ParkEST188" CDMC25686 1 22 24 DAC39-I20 21-CG7013-RA_2 CG7013 GCTCAAGCACAGTCGAAGTAATAACAAAATGAAGACGTGGTACATGGTGGTAGTGATCGGCTTCCTGGC 69 FBan0007013 FBgn0027095 ARP-like 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 ARP-like ARP-like "CG7013, anon-EST:ParkEST188" CDMC25687 1 23 24 DAC39-M08 14-CG7042-RA_3 CG7042 GCGCGCTAATCGCTTTGGGTAACGGACGTATCGACGAGAGGTGCCTATATCAGATGCTCACCGTTCCCT 69 FBan0007042 FBgn0035105 CG7042 3 3L intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470; protein modification; GO:0006464; tRNA processing; GO:0008033 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; ; GO:0008138 ; EC:3.1.3.- CG7042 CG7042 CDMC25687 1 24 24 DAC39-M08 14-CG7042-RA_3 CG7042 GCGCGCTAATCGCTTTGGGTAACGGACGTATCGACGAGAGGTGCCTATATCAGATGCTCACCGTTCCCT 69 FBan0007042 FBgn0035105 CG7042 3 3L intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470; protein modification; GO:0006464; tRNA processing; GO:0008033 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; ; GO:0008138 ; EC:3.1.3.- CG7042 CG7042 CDMC25688 1 25 24 DAC39-M20 10-CG7051-RB_1 CG7051 TCGCCACACTTCCAATACGACGAGTTAGAGAAAGCCATTTTCAAGGCAATTGGCAACGACCACGAGCTT 69 FBan0007051 FBgn0035100 CG7051 3 3L microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG7051 CG7051 CDMC25688 1 26 24 DAC39-M20 10-CG7051-RB_1 CG7051 TCGCCACACTTCCAATACGACGAGTTAGAGAAAGCCATTTTCAAGGCAATTGGCAACGACCACGAGCTT 69 FBan0007051 FBgn0035100 CG7051 3 3L microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG7051 CG7051 CDMC25689 1 1 25 DAC40-A08 3-CG33291-RA_1 CG33291 TGCAGATCAACGACATACGCTACCACATCTTCCAGCTTGTGATGCAGTTCCTTTACTGCGGCGGC 65 FBgn0037113 CDMC25689 1 2 25 DAC40-A08 3-CG33291-RA_1 CG33291 TGCAGATCAACGACATACGCTACCACATCTTCCAGCTTGTGATGCAGTTCCTTTACTGCGGCGGC 65 FBgn0037113 CDMC25690 1 3 25 DAC40-A20 17-CG33308-RA_1 CG33308 CCAGTCGCGCCATTATCTCACAAACGATCCCAAAGAGTTGAGTGCCCATCTTGTTGGTCCACCAA 65 FBan0033308 FBgn0053308 CG33308 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33308 CG33308 CDMC25690 1 4 25 DAC40-A20 17-CG33308-RA_1 CG33308 CCAGTCGCGCCATTATCTCACAAACGATCCCAAAGAGTTGAGTGCCCATCTTGTTGGTCCACCAA 65 FBan0033308 FBgn0053308 CG33308 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33308 CG33308 CDMC25691 1 5 25 DAC40-E08 23-CG3358-RA_1 CG3358 GGCCATGAAATATATTGGTAACTTGAGAGAAATTAACTCCTGCAGGCTTGACTAGCTAACACCTG 65 FBan0003358 FBgn0033117 CG3358 2 2R "DNA catabolism; GO:0006308; DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0004518 ; EC:3.1.-.- CG3358 CG3358 CDMC25691 1 6 25 DAC40-E08 23-CG3358-RA_1 CG3358 GGCCATGAAATATATTGGTAACTTGAGAGAAATTAACTCCTGCAGGCTTGACTAGCTAACACCTG 65 FBan0003358 FBgn0033117 CG3358 2 2R "DNA catabolism; GO:0006308; DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0004518 ; EC:3.1.-.- CG3358 CG3358 CDMC25692 1 7 25 DAC40-E20 2-CG3399-RA_1 CG3399 ATCTCTTTTTGGAGACCATGCGCTTCTACCACTTCTCACCCAAAGCCTGCACCCTAACGTTGGCC 65 FBan0003399 FBgn0000256 capu 2 2L cell organization and biogenesis; GO:0016043; eggshell formation (sensu Insecta); GO:0007304; intracellular signaling cascade; GO:0007242; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 DNA binding; GO:0003677; actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003677 nucleus; GO:0005634 capu cappuccino "CG3399, CG15420, CG3399, capp, Capu, cappucino" CDMC25692 1 8 25 DAC40-E20 2-CG3399-RA_1 CG3399 ATCTCTTTTTGGAGACCATGCGCTTCTACCACTTCTCACCCAAAGCCTGCACCCTAACGTTGGCC 65 FBan0003399 FBgn0000256 capu 2 2L cell organization and biogenesis; GO:0016043; eggshell formation (sensu Insecta); GO:0007304; intracellular signaling cascade; GO:0007242; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 DNA binding; GO:0003677; actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003677 nucleus; GO:0005634 capu cappuccino "CG3399, CG15420, CG3399, capp, Capu, cappucino" CDMC25693 1 9 25 DAC40-I08 3-CG3557-RA_3 CG3557 CTCCACTAGTGCCCTGCAGTCCAATGGATACTCCGAAATCTTCCTGCTTCAAGACCGCGAGTCGG 65 FBan0003557 FBgn0031423 CG3557 2 2L CG3557 CG3557 CDMC25693 1 10 25 DAC40-I08 3-CG3557-RA_3 CG3557 CTCCACTAGTGCCCTGCAGTCCAATGGATACTCCGAAATCTTCCTGCTTCAAGACCGCGAGTCGG 65 FBan0003557 FBgn0031423 CG3557 2 2L CG3557 CG3557 CDMC25694 1 11 25 DAC40-I20 2-CG3597-RA_1 CG3597 CTCCTGAAAAACGACGTCATTGGGGAGGTAACCCAGGTTAAGGTACAGCACGGTTTTCGCCTGGC 65 FBan0003597 FBgn0031417 CG3597 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3597 CG3597 BVRA CDMC25694 1 12 25 DAC40-I20 2-CG3597-RA_1 CG3597 CTCCTGAAAAACGACGTCATTGGGGAGGTAACCCAGGTTAAGGTACAGCACGGTTTTCGCCTGGC 65 FBan0003597 FBgn0031417 CG3597 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3597 CG3597 BVRA CDMC25695 1 13 25 DAC40-M08 2-CG3669-RA_2 CG3669 CCTGGACGGTGTTCTCCCAGGTTCTGCCCGTACCCTATTCGTCGGTGTCGAAATTCTGGAAACTG 65 FBan0003669 FBgn0039838 CG3669 3 3R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG3669 CG3669 CDMC25695 1 14 25 DAC40-M08 2-CG3669-RA_2 CG3669 CCTGGACGGTGTTCTCCCAGGTTCTGCCCGTACCCTATTCGTCGGTGTCGAAATTCTGGAAACTG 65 FBan0003669 FBgn0039838 CG3669 3 3R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG3669 CG3669 CDMC25696 1 15 25 DAC40-M20 3-CG3702-RA_1 CG3702 AGAGTGACGAGGATCAGGACTCGCTGAAGGAGACTCTGCTGGACACCAATATCTACCTGCTGGGC 65 FBan0003702 FBgn0031590 CG3702 2 2L CG3702 CG3702 CDMC25696 1 16 25 DAC40-M20 3-CG3702-RA_1 CG3702 AGAGTGACGAGGATCAGGACTCGCTGAAGGAGACTCTGCTGGACACCAATATCTACCTGCTGGGC 65 FBan0003702 FBgn0031590 CG3702 2 2L CG3702 CG3702 CDMC25697 1 17 25 DAC41-A08 AutoBlank AutoBlank CDMC25697 1 18 25 DAC41-A08 AutoBlank AutoBlank CDMC25698 1 19 25 DAC41-A20 AutoBlank AutoBlank CDMC25698 1 20 25 DAC41-A20 AutoBlank AutoBlank CDMC25699 1 21 25 DAC41-E08 AutoBlank AutoBlank CDMC25699 1 22 25 DAC41-E08 AutoBlank AutoBlank CDMC25700 1 23 25 DAC41-E20 AutoBlank AutoBlank CDMC25700 1 24 25 DAC41-E20 AutoBlank AutoBlank CDMC25701 1 25 25 DAC41-I08 AutoBlank AutoBlank CDMC25701 1 26 25 DAC41-I08 AutoBlank AutoBlank CDMC25702 1 1 26 DAC41-I20 AutoBlank AutoBlank CDMC25702 1 2 26 DAC41-I20 AutoBlank AutoBlank CDMC25703 1 3 26 DAC41-M08 AutoBlank AutoBlank CDMC25703 1 4 26 DAC41-M08 AutoBlank AutoBlank CDMC25704 1 5 26 DAC41-M20 AutoBlank AutoBlank CDMC25704 1 6 26 DAC41-M20 AutoBlank AutoBlank CDMC25705 1 7 26 DAC42-A08 150mM NaPO4 Blank CDMC25705 1 8 26 DAC42-A08 150mM NaPO4 Blank CDMC25706 1 9 26 DAC42-A20 150mM NaPO4 Blank CDMC25706 1 10 26 DAC42-A20 150mM NaPO4 Blank CDMC25707 1 11 26 DAC42-E08 150mM NaPO4 Blank CDMC25707 1 12 26 DAC42-E08 150mM NaPO4 Blank CDMC25708 1 13 26 DAC42-E20 150mM NaPO4 Blank CDMC25708 1 14 26 DAC42-E20 150mM NaPO4 Blank CDMC25709 1 15 26 DAC42-I08 150mM NaPO4 Blank CDMC25709 1 16 26 DAC42-I08 150mM NaPO4 Blank CDMC25710 1 17 26 DAC42-I20 5uM MSP 5uM MSP CDMC25710 1 18 26 DAC42-I20 5uM MSP 5uM MSP CDMC25711 1 19 26 DAC42-M08 10uM MSP 10uM MSP CDMC25711 1 20 26 DAC42-M08 10uM MSP 10uM MSP CDMC25712 1 21 26 DAC42-M20 20uM MSP 20uM MSP CDMC25712 1 22 26 DAC42-M20 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC25713 2 1 1 DAC01-B08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25713 2 2 1 DAC01-B08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC25714 2 3 1 DAC01-B20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25714 2 4 1 DAC01-B20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC25715 2 5 1 DAC01-F08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25715 2 6 1 DAC01-F08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC25716 2 7 1 DAC01-F20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25716 2 8 1 DAC01-F20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC25717 2 9 1 DAC01-J08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25717 2 10 1 DAC01-J08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC25718 2 11 1 DAC01-J20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25718 2 12 1 DAC01-J20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC25719 2 13 1 DAC01-N08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25719 2 14 1 DAC01-N08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC25720 2 15 1 DAC01-N20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25720 2 16 1 DAC01-N20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC25721 2 17 1 DAC02-B08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25721 2 18 1 DAC02-B08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC25722 2 19 1 DAC02-B20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25722 2 20 1 DAC02-B20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC25723 2 21 1 DAC02-F08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25723 2 22 1 DAC02-F08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC25724 2 23 1 DAC02-F20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25724 2 24 1 DAC02-F20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC25725 2 25 1 DAC02-J08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25725 2 26 1 DAC02-J08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC25726 2 1 2 DAC02-J20 AutoBlank AutoBlank CDMC25726 2 2 2 DAC02-J20 AutoBlank AutoBlank CDMC25727 2 3 2 DAC02-N08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25727 2 4 2 DAC02-N08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC25728 2 5 2 DAC02-N20 AutoBlank AutoBlank CDMC25728 2 6 2 DAC02-N20 AutoBlank AutoBlank CDMC25729 2 7 2 DAC03-B08 2-CG5431-RA_1 CG5431 AGGCCAATGTCCGGATACAAGAGGTTCTTGCGAAGAACGGTGTGACTTTGGACGAACTACTGCTCCTGA 69 FBan0005431 FBgn0034888 CG5431 2 2R tyrosine-ester sulfotransferase activity; GO:0017067 ; EC:2.8.2.9; ; GO:0017067 ; EC:2.8.2.9 CG5431 CG5431 CDMC25729 2 8 2 DAC03-B08 2-CG5431-RA_1 CG5431 AGGCCAATGTCCGGATACAAGAGGTTCTTGCGAAGAACGGTGTGACTTTGGACGAACTACTGCTCCTGA 69 FBan0005431 FBgn0034888 CG5431 2 2R tyrosine-ester sulfotransferase activity; GO:0017067 ; EC:2.8.2.9; ; GO:0017067 ; EC:2.8.2.9 CG5431 CG5431 CDMC25730 2 9 2 DAC03-B20 23-CG5444-RB_3 CG5444 CGTTCATCCATTAAGAATGGCGATTCATTAGGCTCCATAGATCCATAAATCCCCTAATCCAATCTGAAC 69 FBan0005444 FBgn0010280 Taf4 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003700; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf4 TBP-associated factor 4 "CG5444, CG5444, TAFII110, TBP associated factor 110, TAF110, dTAF[[II]]110, TATA-associated factor 110, TBP-associated factor 110, p110, Taf110: TBP-associated factor 110kD, l(3)72Dj, Taf[[II]]110, TAF[[II]]110, SR3-3, TFIID 110, SY3-2 TAF110, d110, TFIID, dTAFII110, TAF4, TAF[II]110, TAF[[II]], taf110, dmTAF4, TAF, dTAF4, TBP-associated factor 110kD, lethal(3)72Dj, Taf110" CDMC25730 2 10 2 DAC03-B20 23-CG5444-RB_3 CG5444 CGTTCATCCATTAAGAATGGCGATTCATTAGGCTCCATAGATCCATAAATCCCCTAATCCAATCTGAAC 69 FBan0005444 FBgn0010280 Taf4 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003700; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf4 TBP-associated factor 4 "CG5444, CG5444, TAFII110, TBP associated factor 110, TAF110, dTAF[[II]]110, TATA-associated factor 110, TBP-associated factor 110, p110, Taf110: TBP-associated factor 110kD, l(3)72Dj, Taf[[II]]110, TAF[[II]]110, SR3-3, TFIID 110, SY3-2 TAF110, d110, TFIID, dTAFII110, TAF4, TAF[II]110, TAF[[II]], taf110, dmTAF4, TAF, dTAF4, TBP-associated factor 110kD, lethal(3)72Dj, Taf110" CDMC25731 2 11 2 DAC03-F08 17-CG5470-RA_1 CG5470 GCAATGGCAACAACTTCAATACCCAAGCTCGATGTCACAAAATTTGCCTAGCCCAAGTCTCTTTGCCAA 69 FBan0005470 FBgn0038384 CG5470 3 3R CG5470 CG5470 CDMC25731 2 12 2 DAC03-F08 17-CG5470-RA_1 CG5470 GCAATGGCAACAACTTCAATACCCAAGCTCGATGTCACAAAATTTGCCTAGCCCAAGTCTCTTTGCCAA 69 FBan0005470 FBgn0038384 CG5470 3 3R CG5470 CG5470 CDMC25732 2 13 2 DAC03-F20 23-CG5474-RA_1 CG5474 CAAATTGATTCCATGCGTTGTTCATCTATTCAACCCACACATCTAATTTACTCCAGTCTGGGACTGTCG 69 FBan0005474 FBgn0011016 SsRbeta 3 3L protein retention in ER; GO:0006621; vesicle-mediated transport; GO:0016192 signal sequence binding; GO:0005048; ; GO:0005048; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005048 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786 SsRbeta Signal sequence receptor beta "CG5474, l(3)s1939, clone 1.1, BcDNA.LD10457, SsRbeta, BcDNA:LD10457, anon-EST:Liang-1.1, Signal sequence receptor beta" CDMC25732 2 14 2 DAC03-F20 23-CG5474-RA_1 CG5474 CAAATTGATTCCATGCGTTGTTCATCTATTCAACCCACACATCTAATTTACTCCAGTCTGGGACTGTCG 69 FBan0005474 FBgn0011016 SsRbeta 3 3L protein retention in ER; GO:0006621; vesicle-mediated transport; GO:0016192 signal sequence binding; GO:0005048; ; GO:0005048; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005048 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786 SsRbeta Signal sequence receptor beta "CG5474, l(3)s1939, clone 1.1, BcDNA.LD10457, SsRbeta, BcDNA:LD10457, anon-EST:Liang-1.1, Signal sequence receptor beta" CDMC25733 2 15 2 DAC03-J08 3-CG5498-RB_1 CG5498 CGTTGTGGAGAACGCGAGCCAGGAAGATGATCAACTTGAGCAGGAATTGCGTGAACTGGCTGGAGAATC 69 FBan0005498 FBgn0027565 CG5498 3 3L CG5498 CG5498 "transcript 2, BcDNA:GH08385" CDMC25733 2 16 2 DAC03-J08 3-CG5498-RB_1 CG5498 CGTTGTGGAGAACGCGAGCCAGGAAGATGATCAACTTGAGCAGGAATTGCGTGAACTGGCTGGAGAATC 69 FBan0005498 FBgn0027565 CG5498 3 3L CG5498 CG5498 "transcript 2, BcDNA:GH08385" CDMC25734 2 17 2 DAC03-J20 7-CG5509-RA_1 CG5509 TGGACGAGGAAGATCAGTCGTCTACGGGTTCAGTGGAATCGGGTAGCATGTCCTTCGAAATGAAACGGA 69 FBan0005509 FBgn0038054 CG5509 3 3R CG5509 CG5509 CDMC25734 2 18 2 DAC03-J20 7-CG5509-RA_1 CG5509 TGGACGAGGAAGATCAGTCGTCTACGGGTTCAGTGGAATCGGGTAGCATGTCCTTCGAAATGAAACGGA 69 FBan0005509 FBgn0038054 CG5509 3 3R CG5509 CG5509 CDMC25735 2 19 2 DAC03-N08 23-CG5554-RA_2 CG5554 GCCAAGCATTTTTGTATTTTGTGTTCAACTTGGTTTCCACACAATTCATTTCTCTTAAGCATTTCATTT 69 FBan0005554 FBgn0034914 CG5554 2 2R electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464; sulfur metabolism; GO:0006790 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 integral to membrane; GO:0016021 CG5554 CG5554 CDMC25735 2 20 2 DAC03-N08 23-CG5554-RA_2 CG5554 GCCAAGCATTTTTGTATTTTGTGTTCAACTTGGTTTCCACACAATTCATTTCTCTTAAGCATTTCATTT 69 FBan0005554 FBgn0034914 CG5554 2 2R electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464; sulfur metabolism; GO:0006790 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 integral to membrane; GO:0016021 CG5554 CG5554 CDMC25736 2 21 2 DAC03-N20 12-CG5561-RA_1 CG5561 TGCCGGAAGCTCGATATTCCGATGAGTTGGGAATCGTTTCGGTATGAACTTAACGAGCGAACCTCCCAT 69 FBan0005561 FBgn0031333 CG5561 2 2L DNA methylation; GO:0006306; metabolism; GO:0008152 DNA binding; GO:0003677; catalytic activity; GO:0003824; ; GO:0003824; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG5561 CG5561 CDMC25736 2 22 2 DAC03-N20 12-CG5561-RA_1 CG5561 TGCCGGAAGCTCGATATTCCGATGAGTTGGGAATCGTTTCGGTATGAACTTAACGAGCGAACCTCCCAT 69 FBan0005561 FBgn0031333 CG5561 2 2L DNA methylation; GO:0006306; metabolism; GO:0008152 DNA binding; GO:0003677; catalytic activity; GO:0003824; ; GO:0003824; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG5561 CG5561 CDMC25737 2 23 2 DAC04-B08 13-CG12359-RA_1 CG12359 GCAGCACTTGTTCAACTTGCTCATCTTCTGACACTGAGCCAATGTTGGTTAAAGATAGCCCGGAGGTCA 69 FBan0012359 FBgn0027603 Ulp1 X X protein deubiquitination; GO:0016579; protein processing; GO:0016485; protein targeting; GO:0006605; proteolysis; GO:0006508 ubiquitin-specific protease activity; GO:0004843; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004843; SUMO-specific protease activity; GO:0016929; ; GO:0016929 nuclear inner membrane; GO:0005637; nuclear pore; GO:0005643 Ulp1 Ulp1 "CG12359, CG12359, CG12359, DmUlp1, BcDNA:GH02751" CDMC25737 2 24 2 DAC04-B08 13-CG12359-RA_1 CG12359 GCAGCACTTGTTCAACTTGCTCATCTTCTGACACTGAGCCAATGTTGGTTAAAGATAGCCCGGAGGTCA 69 FBan0012359 FBgn0027603 Ulp1 X X protein deubiquitination; GO:0016579; protein processing; GO:0016485; protein targeting; GO:0006605; proteolysis; GO:0006508 ubiquitin-specific protease activity; GO:0004843; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004843; SUMO-specific protease activity; GO:0016929; ; GO:0016929 nuclear inner membrane; GO:0005637; nuclear pore; GO:0005643 Ulp1 Ulp1 "CG12359, CG12359, CG12359, DmUlp1, BcDNA:GH02751" CDMC25738 2 25 2 DAC04-B20 9-CG12370-RA_4 CG12370 CCTATCTGTTGGTGCTAACAGGCCCGGAACAGGGTATCAGTCGTAATCTCTTCGAGGCCATAAGAGCCT 69 FBan0012370 FBgn0033744 CG12370 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; neuropeptide receptor activity; GO:0008188; neuropeptide hormone activity; GO:0005184; diuretic hormone receptor activity; GO:0008036; secretin-like receptor activity; GO:0001633; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0005184; ; GO:0008188; ; GO:0008036; ; GO:0001633; ; GO:0008270 integral to membrane; GO:0016021; nucleus; GO:0005634 CG12370 CG12370 "anon-WO0170980.103, anon-WO0170980.104" CDMC25738 2 26 2 DAC04-B20 9-CG12370-RA_4 CG12370 CCTATCTGTTGGTGCTAACAGGCCCGGAACAGGGTATCAGTCGTAATCTCTTCGAGGCCATAAGAGCCT 69 FBan0012370 FBgn0033744 CG12370 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; neuropeptide receptor activity; GO:0008188; neuropeptide hormone activity; GO:0005184; diuretic hormone receptor activity; GO:0008036; secretin-like receptor activity; GO:0001633; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0005184; ; GO:0008188; ; GO:0008036; ; GO:0001633; ; GO:0008270 integral to membrane; GO:0016021; nucleus; GO:0005634 CG12370 CG12370 "anon-WO0170980.103, anon-WO0170980.104" CDMC25739 2 1 3 DAC04-F08 23-CG12404-RA_1 CG12404 CTGCGCGTTTACTCAATACTTTTGTTGTCAGCCAATGTAATAAATTTGATTGCGAATAAAAAAATGGTT 69 FBan0012404 FBgn0032465 CG12404 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- Golgi membrane; GO:0000139 CG12404 CG12404 CDMC25739 2 2 3 DAC04-F08 23-CG12404-RA_1 CG12404 CTGCGCGTTTACTCAATACTTTTGTTGTCAGCCAATGTAATAAATTTGATTGCGAATAAAAAAATGGTT 69 FBan0012404 FBgn0032465 CG12404 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- Golgi membrane; GO:0000139 CG12404 CG12404 CDMC25740 2 3 3 DAC04-F20 2-CG12419-RA_2 CG12419 GCTGCAGAACCACCATCATGCACACTATGGCAATGAATTACTACGTGGAGCGCAGTGACTACGAGGGCT 69 FBan0012419 FBgn0037769 CG12419 3 3R CG12419 CG12419 CDMC25740 2 4 3 DAC04-F20 2-CG12419-RA_2 CG12419 GCTGCAGAACCACCATCATGCACACTATGGCAATGAATTACTACGTGGAGCGCAGTGACTACGAGGGCT 69 FBan0012419 FBgn0037769 CG12419 3 3R CG12419 CG12419 CDMC25741 2 5 3 DAC04-J08 22-CG12455-RA_1 CG12455 ACCAATTCAACGACTGTTGCCTCATCAACTTTTTCAACAACAGAGAGTATGGCCATCCATTCAACCCCT 69 FBan0012455 FBgn0028859 CG12455 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 calcium channel activity; GO:0005262; voltage-gated calcium channel activity; GO:0005245; ; GO:0005262; ; GO:0005245 membrane; GO:0016020 CG12455 CG12455 "BG:DS07473.1, DS07473.1A, anon-WO0138359.9" CDMC25741 2 6 3 DAC04-J08 22-CG12455-RA_1 CG12455 ACCAATTCAACGACTGTTGCCTCATCAACTTTTTCAACAACAGAGAGTATGGCCATCCATTCAACCCCT 69 FBan0012455 FBgn0028859 CG12455 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936 calcium channel activity; GO:0005262; voltage-gated calcium channel activity; GO:0005245; ; GO:0005262; ; GO:0005245 membrane; GO:0016020 CG12455 CG12455 "BG:DS07473.1, DS07473.1A, anon-WO0138359.9" CDMC25742 2 7 3 DAC04-J20 24-CG12480-RA_1 CG12480 GCGGCTATATTTACTAAGACAAATAACTGAGAGCCACAGAGTCTAATATAATCTTAAATTTATAACTTT 69 FBan0012480 FBgn0030537 CG12480 X X CG12480 CG12480 CDMC25742 2 8 3 DAC04-J20 24-CG12480-RA_1 CG12480 GCGGCTATATTTACTAAGACAAATAACTGAGAGCCACAGAGTCTAATATAATCTTAAATTTATAACTTT 69 FBan0012480 FBgn0030537 CG12480 X X CG12480 CG12480 CDMC25743 2 9 3 DAC04-N08 9-CG12520-RA_5 CG12520 GCAGGTCCAGTGGCAATCTTCGCAGTCTTCATTTGGGCTATGCCTGCATACAGAAGAATTTGAGCCACA 69 FBan0012520 FBgn0036324 CG12520 3 3L CG12520 CG12520 CDMC25743 2 10 3 DAC04-N08 9-CG12520-RA_5 CG12520 GCAGGTCCAGTGGCAATCTTCGCAGTCTTCATTTGGGCTATGCCTGCATACAGAAGAATTTGAGCCACA 69 FBan0012520 FBgn0036324 CG12520 3 3L CG12520 CG12520 CDMC25744 2 11 3 DAC04-N20 12-CG12531-RA_4 CG12531 CATCGCCATCACAGTGAACATCTACCTGATATTCAAGCTGAGCATCCTCACGCTGGTACGCTTCACCGT 69 FBan0012531 FBgn0031064 CG12531 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 cationic amino acid transporter activity; GO:0015326; transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171; ; GO:0015326 membrane; GO:0016020 CG12531 CG12531 CDMC25744 2 12 3 DAC04-N20 12-CG12531-RA_4 CG12531 CATCGCCATCACAGTGAACATCTACCTGATATTCAAGCTGAGCATCCTCACGCTGGTACGCTTCACCGT 69 FBan0012531 FBgn0031064 CG12531 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 cationic amino acid transporter activity; GO:0015326; transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171; ; GO:0015326 membrane; GO:0016020 CG12531 CG12531 CDMC25745 2 13 3 DAC05-B08 16-CG5039-RA_1 CG5039 TCTTTGTACATCCCCTGAAAACGATGAAGTTACTTGAGCCTCAGACGACCATTAGTCCTGAACCGGACA 69 FBan0005039 FBgn0039356 CG5039 3 3R CG5039 CG5039 BcDNA:LD35121 CDMC25745 2 14 3 DAC05-B08 16-CG5039-RA_1 CG5039 TCTTTGTACATCCCCTGAAAACGATGAAGTTACTTGAGCCTCAGACGACCATTAGTCCTGAACCGGACA 69 FBan0005039 FBgn0039356 CG5039 3 3R CG5039 CG5039 BcDNA:LD35121 CDMC25746 2 15 3 DAC05-B20 14-CG5050-RA_1 CG5050 CCATGAAGACCAAAAACGAACTGCACGTATGTGGCACATTGATGCGTGTGGAGGAAAAACGAAACAGGG 69 FBan0005050 FBgn0032637 CG5050 2 2L CG5050 CG5050 CDMC25746 2 16 3 DAC05-B20 14-CG5050-RA_1 CG5050 CCATGAAGACCAAAAACGAACTGCACGTATGTGGCACATTGATGCGTGTGGAGGAAAAACGAAACAGGG 69 FBan0005050 FBgn0032637 CG5050 2 2L CG5050 CG5050 CDMC25747 2 17 3 DAC05-F08 15-CG5078-RA_10 CG5078 TGGCTGTGCCCGAAACATTACAACAAAACGTTAGATCCACTGGATTGAGCTGGAAACAAGCGGATCCTT 69 FBan0005078 FBgn0037005 CG5078 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG5078 CG5078 CDMC25747 2 18 3 DAC05-F08 15-CG5078-RA_10 CG5078 TGGCTGTGCCCGAAACATTACAACAAAACGTTAGATCCACTGGATTGAGCTGGAAACAAGCGGATCCTT 69 FBan0005078 FBgn0037005 CG5078 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG5078 CG5078 CDMC25748 2 19 3 DAC05-F20 17-CG5091-RA_1 CG5091 CGTTCCGGCACCTACAAAGTATCCAGATCTTTGGCCCCTTATTATTTCGGTTACAAGCTGTGGACACTT 69 FBan0005091 FBgn0032234 CG5091 2 2L protein amino acid N-linked glycosylation; GO:0006487 "dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; GO:0042281 ; EC:2.4.1.-; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0042281 ; EC:2.4.1.-" endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 CG5091 CG5091 CDMC25748 2 20 3 DAC05-F20 17-CG5091-RA_1 CG5091 CGTTCCGGCACCTACAAAGTATCCAGATCTTTGGCCCCTTATTATTTCGGTTACAAGCTGTGGACACTT 69 FBan0005091 FBgn0032234 CG5091 2 2L protein amino acid N-linked glycosylation; GO:0006487 "dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; GO:0042281 ; EC:2.4.1.-; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0042281 ; EC:2.4.1.-" endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 CG5091 CG5091 CDMC25749 2 21 3 DAC05-J08 2-CG5126-RA_1 CG5126 CCGCCTATGAGAATGTGCTTCGGACGAGTCACCTGGAAAGCGAAGTGGTAAAGAACTGGGTTCCCTGTT 69 FBan0005126 FBgn0031320 CG5126 2 2L CG5126 CG5126 CDMC25749 2 22 3 DAC05-J08 2-CG5126-RA_1 CG5126 CCGCCTATGAGAATGTGCTTCGGACGAGTCACCTGGAAAGCGAAGTGGTAAAGAACTGGGTTCCCTGTT 69 FBan0005126 FBgn0031320 CG5126 2 2L CG5126 CG5126 CDMC25750 2 23 3 DAC05-J20 2-CG5137-RA_1 CG5137 TCCTGGAGGCGTGTATAAAGGAAACTCTGCGGATGTATCCTTCAGGTCCACTCACTGCCAGAAAAGCCA 69 FBan0005137 FBgn0036778 Cyp312a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp312a1 Cyp312a1 "CG5137, 312a1" CDMC25750 2 24 3 DAC05-J20 2-CG5137-RA_1 CG5137 TCCTGGAGGCGTGTATAAAGGAAACTCTGCGGATGTATCCTTCAGGTCCACTCACTGCCAGAAAAGCCA 69 FBan0005137 FBgn0036778 Cyp312a1 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp312a1 Cyp312a1 "CG5137, 312a1" CDMC25751 2 25 3 DAC05-N08 9-CG5174-RA_2 CG5174 GGCATTTCGTCGAAACTGTCGCAAATGAAAAACTCCGAATCGATGCGTTCTATCGAGGCTTCGGTGGGC 69 FBan0005174 FBgn0034345 CG5174 2 2R CG5174 CG5174 "BcDNA:RE18604, BcDNA:RH27395" CDMC25751 2 26 3 DAC05-N08 9-CG5174-RA_2 CG5174 GGCATTTCGTCGAAACTGTCGCAAATGAAAAACTCCGAATCGATGCGTTCTATCGAGGCTTCGGTGGGC 69 FBan0005174 FBgn0034345 CG5174 2 2R CG5174 CG5174 "BcDNA:RE18604, BcDNA:RH27395" CDMC25752 2 1 4 DAC05-N20 5-CG5184-RA_1 CG5184 TGGGTGGGCTGAACATCGTTTCCATTACCGACAACACACATGTTTCCTTCAATCCTCCAAGACCCCGAA 69 FBan0005184 FBgn0038474 mRpS11 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS11 mitochondrial ribosomal protein S11 "CG5184, MRP-S11, BcDNA:RH70248, mitochondrial ribosomal protein S11" CDMC25752 2 2 4 DAC05-N20 5-CG5184-RA_1 CG5184 TGGGTGGGCTGAACATCGTTTCCATTACCGACAACACACATGTTTCCTTCAATCCTCCAAGACCCCGAA 69 FBan0005184 FBgn0038474 mRpS11 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS11 mitochondrial ribosomal protein S11 "CG5184, MRP-S11, BcDNA:RH70248, mitochondrial ribosomal protein S11" CDMC25753 2 3 4 DAC06-B08 23-CG9368-RB_14 CG9368 AGACTCTTAGTTGTTTACACAGGTTTCCTCGAACATCCTCATCAAATTCATCAACTAATCCGCACACAC 69 FBan0009368 FBgn0036890 CG9368 3 3L CG9368 CG9368 BcDNA:RH51268 CDMC25753 2 4 4 DAC06-B08 23-CG9368-RB_14 CG9368 AGACTCTTAGTTGTTTACACAGGTTTCCTCGAACATCCTCATCAAATTCATCAACTAATCCGCACACAC 69 FBan0009368 FBgn0036890 CG9368 3 3L CG9368 CG9368 BcDNA:RH51268 CDMC25754 2 5 4 DAC06-B20 23-CG9381-RA_4 CG9381 TTTGTGTGTCTGGAGAATGATAATGGCGTAAAGCAAGTGTCTGTATATAAGCCAAGATTTGCACAAAAA 69 FBan0009381 FBgn0037705 mura 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mura murashka "CG9381, CG9382, CG9381, CG9381, CG9381, CG9381, CG9381, murashka" CDMC25754 2 6 4 DAC06-B20 23-CG9381-RA_4 CG9381 TTTGTGTGTCTGGAGAATGATAATGGCGTAAAGCAAGTGTCTGTATATAAGCCAAGATTTGCACAAAAA 69 FBan0009381 FBgn0037705 mura 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mura murashka "CG9381, CG9382, CG9381, CG9381, CG9381, CG9381, CG9381, murashka" CDMC25755 2 7 4 DAC06-F08 23-CG9423-RA_8 CG9423 AGATAAGTTAAGCGGAATTTTATAAGAACAAGTGTGTCGCGTTTCAAGACCAGGCATTCGAGTTGTCCG 69 FBan0009423 FBgn0027338 Kap-alpha3 3 3R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; protein transporter activity; GO:0008565; ; GO:0008565 nuclear pore; GO:0005643 Kap-alpha3 karyopherin alpha3 "CG9423, 0335/13, karyopherin a3, importin alpha-3, Kap alpha3, imp-alpha3, Importin-alpha3, dKap-alpha3, importin alpha3, karyopherin-alpha3, Kap-alpha3, karyopherin-alpha3, Imp alpha-3, imp alpha3, Importin alpha-3, imp-a3, l(3)S033513, importin-alpha3, importin a3, karyopherin-alpha4, karyopherin alpha4" CDMC25755 2 8 4 DAC06-F08 23-CG9423-RA_8 CG9423 AGATAAGTTAAGCGGAATTTTATAAGAACAAGTGTGTCGCGTTTCAAGACCAGGCATTCGAGTTGTCCG 69 FBan0009423 FBgn0027338 Kap-alpha3 3 3R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; protein transporter activity; GO:0008565; ; GO:0008565 nuclear pore; GO:0005643 Kap-alpha3 karyopherin alpha3 "CG9423, 0335/13, karyopherin a3, importin alpha-3, Kap alpha3, imp-alpha3, Importin-alpha3, dKap-alpha3, importin alpha3, karyopherin-alpha3, Kap-alpha3, karyopherin-alpha3, Imp alpha-3, imp alpha3, Importin alpha-3, imp-a3, l(3)S033513, importin-alpha3, importin a3, karyopherin-alpha4, karyopherin alpha4" CDMC25756 2 9 4 DAC06-F20 3-CG9431-RA_2 CG9431 CCGGCAGAGTTCCTTGCAATCAACAGGCTGCTCAAGAAAGAAGGGACAAATCGATGAACTCCAACCGGA 69 FBan0009431 FBgn0032484 kek4 2 2L kek4 kekkon4 "CG9431, CG9431, CG9431, CT26742, kekkon-like, kekkon4" CDMC25756 2 10 4 DAC06-F20 3-CG9431-RA_2 CG9431 CCGGCAGAGTTCCTTGCAATCAACAGGCTGCTCAAGAAAGAAGGGACAAATCGATGAACTCCAACCGGA 69 FBan0009431 FBgn0032484 kek4 2 2L kek4 kekkon4 "CG9431, CG9431, CG9431, CT26742, kekkon-like, kekkon4" CDMC25757 2 11 4 DAC06-J08 23-CG9459-RA_7 CG9459 GGTGTTGACCATCCTTGGAATCTATCTAGTCTTCATAAAAATAGTGGGTCCTTGGTTTATGCAGAATCA 69 FBan0009459 FBgn0037764 CG9459 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG9459 CG9459 CT26804 CDMC25757 2 12 4 DAC06-J08 23-CG9459-RA_7 CG9459 GGTGTTGACCATCCTTGGAATCTATCTAGTCTTCATAAAAATAGTGGGTCCTTGGTTTATGCAGAATCA 69 FBan0009459 FBgn0037764 CG9459 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG9459 CG9459 CT26804 CDMC25758 2 13 4 DAC06-J20 23-CG9473-RA_3 CG9473 ACAATAAAAGCTCGCTACAAAGGACAGTTAATCAGCAAAACACTTACAGTATTAACGTGAAGGTGGAGC 69 FBan0009473 FBgn0024330 MED6 3 3R regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED6 Mediator complex subunit 6 "CG9473, dMed6, Med6, dTRAP32, p35, Mediator, dMED6, BcDNA:LD15729, Trap32, anon-EST:Posey279, Mediator complex subunit 6" CDMC25758 2 14 4 DAC06-J20 23-CG9473-RA_3 CG9473 ACAATAAAAGCTCGCTACAAAGGACAGTTAATCAGCAAAACACTTACAGTATTAACGTGAAGGTGGAGC 69 FBan0009473 FBgn0024330 MED6 3 3R regulation of transcription; GO:0045449; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED6 Mediator complex subunit 6 "CG9473, dMed6, Med6, dTRAP32, p35, Mediator, dMED6, BcDNA:LD15729, Trap32, anon-EST:Posey279, Mediator complex subunit 6" CDMC25759 2 15 4 DAC06-N08 1-CG9508-RA_1 CG9508 GCGGGTTTACAGTGCCTGAACCGGAACAGTACACAGTATCTGGACGAGCGTATTGCAGACATTGCTGGA 69 FBan0009508 FBgn0031809 CG9508 2 2L cell adhesion; GO:0007155; proteolysis; GO:0006508 neprilysin activity; GO:0004245 ; EC:3.4.24.11; zinc ion binding; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0008270 membrane; GO:0016020 CG9508 CG9508 CT26920 CDMC25759 2 16 4 DAC06-N08 1-CG9508-RA_1 CG9508 GCGGGTTTACAGTGCCTGAACCGGAACAGTACACAGTATCTGGACGAGCGTATTGCAGACATTGCTGGA 69 FBan0009508 FBgn0031809 CG9508 2 2L cell adhesion; GO:0007155; proteolysis; GO:0006508 neprilysin activity; GO:0004245 ; EC:3.4.24.11; zinc ion binding; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0008270 membrane; GO:0016020 CG9508 CG9508 CT26920 CDMC25760 2 17 4 DAC06-N20 16-CG9518-RA_1 CG9518 AGGCGGAGTTTCGTAACCTCGTACTTCCCATTGAATCTCATCGCATGACGTCCTCAAAAACTGTACACA 69 FBan0009518 FBgn0030590 CG9518 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9518 CG9518 CDMC25760 2 18 4 DAC06-N20 16-CG9518-RA_1 CG9518 AGGCGGAGTTTCGTAACCTCGTACTTCCCATTGAATCTCATCGCATGACGTCCTCAAAAACTGTACACA 69 FBan0009518 FBgn0030590 CG9518 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9518 CG9518 CDMC25761 2 19 4 DAC07-B08 2-CG6569-RA_1 CG6569 CCGAGACCTACAAGGAGGAGATGACCCACCTAGCCTCCAATATCGGTACCATAATGGATGAGGCCTCCA 69 FBan0006569 FBgn0038909 CG6569 3 3R CG6569 CG6569 CDMC25761 2 20 4 DAC07-B08 2-CG6569-RA_1 CG6569 CCGAGACCTACAAGGAGGAGATGACCCACCTAGCCTCCAATATCGGTACCATAATGGATGAGGCCTCCA 69 FBan0006569 FBgn0038909 CG6569 3 3R CG6569 CG6569 CDMC25762 2 21 4 DAC07-B20 2-CG6577-RA_2 CG6577 ACCTGCCATCGACTTACTTGTACACAACTTCTCCCTCCGATGAGGTCGTGATTTGTGCCACCTTCTCGG 69 FBan0006577 FBgn0011569 can 3 3L male meiosis I; GO:0007141; meiosis; GO:0007126; regulation of transcription; GO:0045449; spermatid development; GO:0007286; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 can cannonball "CG6577, CG6577, TAF5L, dmTAF5b, dTAF[[II]]80, dTAF5L" CDMC25762 2 22 4 DAC07-B20 2-CG6577-RA_2 CG6577 ACCTGCCATCGACTTACTTGTACACAACTTCTCCCTCCGATGAGGTCGTGATTTGTGCCACCTTCTCGG 69 FBan0006577 FBgn0011569 can 3 3L male meiosis I; GO:0007141; meiosis; GO:0007126; regulation of transcription; GO:0045449; spermatid development; GO:0007286; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 can cannonball "CG6577, CG6577, TAF5L, dmTAF5b, dTAF[[II]]80, dTAF5L" CDMC25763 2 23 4 DAC07-F08 23-CG6606-RA_11 CG6606 CCGCGAACAGCAAAATTCAAGTGCTTTCTAAAACGTATTGCTAAGAGGGAAACTAAGTGCACGCGTAAA 69 FBgn0030942 CDMC25763 2 24 4 DAC07-F08 23-CG6606-RA_11 CG6606 CCGCGAACAGCAAAATTCAAGTGCTTTCTAAAACGTATTGCTAAGAGGGAAACTAAGTGCACGCGTAAA 69 FBgn0030942 CDMC25764 2 25 4 DAC07-F20 23-CG6617-RA_1 CG6617 AATTTCCAGCGTCATTTGTGCATTGCAAGTTAGTAAACAATAAAAGCGCATAAACAGGGCTAGGAAAAG 69 FBan0006617 FBgn0030944 CG6617 X X CG6617 CG6617 anon-EST:Posey180 CDMC25764 2 26 4 DAC07-F20 23-CG6617-RA_1 CG6617 AATTTCCAGCGTCATTTGTGCATTGCAAGTTAGTAAACAATAAAAGCGCATAAACAGGGCTAGGAAAAG 69 FBan0006617 FBgn0030944 CG6617 X X CG6617 CG6617 anon-EST:Posey180 CDMC25765 2 1 5 DAC07-J08 4-CG6653-RA_1 CG6653 TCAACTGGTTTGATCTCGACACCTATGGAGGACGTCTGGGTCACTTTGTGGATCAGTCCATGGCTTGGA 69 FBan0006653 FBgn0040255 Ugt86De 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86De Ugt86De "CG6653, CG6653, AC 006491E" CDMC25765 2 2 5 DAC07-J08 4-CG6653-RA_1 CG6653 TCAACTGGTTTGATCTCGACACCTATGGAGGACGTCTGGGTCACTTTGTGGATCAGTCCATGGCTTGGA 69 FBan0006653 FBgn0040255 Ugt86De 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86De Ugt86De "CG6653, CG6653, AC 006491E" CDMC25766 2 3 5 DAC07-J20 18-CG6660-RA_3 CG6660 GTACGCCTCGTATGCGTACTACATGCTCAAGTATCTGGATCTGCTCGACACGGTATTCATAGTGCTGCG 69 FBan0006660 FBgn0039030 CG6660 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6660 CG6660 CDMC25766 2 4 5 DAC07-J20 18-CG6660-RA_3 CG6660 GTACGCCTCGTATGCGTACTACATGCTCAAGTATCTGGATCTGCTCGACACGGTATTCATAGTGCTGCG 69 FBan0006660 FBgn0039030 CG6660 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6660 CG6660 CDMC25767 2 5 5 DAC07-N08 13-CG6689-RA_1 CG6689 TGCAGGTGGAGATCATGTTGAAGATGAAGCGACATCAGATGACCAAACAAGTCAAGAGGCAGTCGACGA 69 FBan0006689 FBgn0037877 CG6689 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG6689 CG6689 dmCG6689 CDMC25767 2 6 5 DAC07-N08 13-CG6689-RA_1 CG6689 TGCAGGTGGAGATCATGTTGAAGATGAAGCGACATCAGATGACCAAACAAGTCAAGAGGCAGTCGACGA 69 FBan0006689 FBgn0037877 CG6689 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG6689 CG6689 dmCG6689 CDMC25768 2 7 5 DAC07-N20 15-CG6697-RA_1 CG6697 CCATCGCAAGTGGGAGCACTACCATCCCAAGAAGAACTCCTGAACTTATCCTCGGTTGCAAACATTTGT 69 FBan0006697 FBgn0027526 CG6697 3 3R CG6697 CG6697 BcDNA:LD21504 CDMC25768 2 8 5 DAC07-N20 15-CG6697-RA_1 CG6697 CCATCGCAAGTGGGAGCACTACCATCCCAAGAAGAACTCCTGAACTTATCCTCGGTTGCAAACATTTGT 69 FBan0006697 FBgn0027526 CG6697 3 3R CG6697 CG6697 BcDNA:LD21504 CDMC25769 2 9 5 DAC08-B08 23-CG31858-RA_3 CG31858 TTATGTAAATGAGGAGCGAAATGAACTGACTGTTTCGAAATTACTGGCTACCAATCTACCCGATTTGCC 69 FBan0031858 FBgn0051858 CG31858 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31858 CG31858 CDMC25769 2 10 5 DAC08-B08 23-CG31858-RA_3 CG31858 TTATGTAAATGAGGAGCGAAATGAACTGACTGTTTCGAAATTACTGGCTACCAATCTACCCGATTTGCC 69 FBan0031858 FBgn0051858 CG31858 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31858 CG31858 CDMC25770 2 11 5 DAC08-B20 2-CG31867-RA_1 CG31867 GGGCCTAAGCCTATTCCCTTGCCATTTGTGGGAGTTTCTTGCGAATGAGGTGTGCTTAGAGACCGACAA 69 FBan0031867 FBgn0051867 CG31867 2 2L CG31867 CG31867 "CG6275, CG6275, BcDNA:AT02643" CDMC25770 2 12 5 DAC08-B20 2-CG31867-RA_1 CG31867 GGGCCTAAGCCTATTCCCTTGCCATTTGTGGGAGTTTCTTGCGAATGAGGTGTGCTTAGAGACCGACAA 69 FBan0031867 FBgn0051867 CG31867 2 2L CG31867 CG31867 "CG6275, CG6275, BcDNA:AT02643" CDMC25771 2 13 5 DAC08-F08 10-CG31898-RA_1 CG31898 TGCCCCTTGCTATCCAGATTTCCCCAAGAACTCCTCCCTCAGTTTCATATGAAGGACGTGAGACAAGCT 69 FBan0031898 FBgn0051898 CG31898 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31898 CG31898 BcDNA:LD28680 CDMC25771 2 14 5 DAC08-F08 10-CG31898-RA_1 CG31898 TGCCCCTTGCTATCCAGATTTCCCCAAGAACTCCTCCCTCAGTTTCATATGAAGGACGTGAGACAAGCT 69 FBan0031898 FBgn0051898 CG31898 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31898 CG31898 BcDNA:LD28680 CDMC25772 2 15 5 DAC08-F20 3-CG31906-RA_1 CG31906 AGGCTGCCAAATTGGATGGATCCTGCTCAAACAACAGTCAGATTAGTCCGGCCAACATAACACCCGTCT 69 FBan0031906 FBgn0051906 CG31906 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31906 CG31906 CDMC25772 2 16 5 DAC08-F20 3-CG31906-RA_1 CG31906 AGGCTGCCAAATTGGATGGATCCTGCTCAAACAACAGTCAGATTAGTCCGGCCAACATAACACCCGTCT 69 FBan0031906 FBgn0051906 CG31906 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31906 CG31906 CDMC25773 2 17 5 DAC08-J08 16-CG31934-RA_1 CG31934 TGCTGCTTGAAGAACTTTTGCCAGGCAAAAAACTTTCAGGTGTGAGCTTTGGATACTTCAGCAGAGTGA 69 FBan0031934 FBgn0051934 CG31934 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31934 CG31934 CDMC25773 2 18 5 DAC08-J08 16-CG31934-RA_1 CG31934 TGCTGCTTGAAGAACTTTTGCCAGGCAAAAAACTTTCAGGTGTGAGCTTTGGATACTTCAGCAGAGTGA 69 FBan0031934 FBgn0051934 CG31934 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31934 CG31934 CDMC25774 2 19 5 DAC08-J20 22-CG31956-RA_1 CG31956 ACCTGCCCCATGGTGGATACTATTTCGCATGAAGATTTCTCTTACTTTAGCGGAAATAAGGACGGAGCA 69 FBan0031956 FBgn0051956 pgant4 2 2L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 pgant4 polypeptide GalNAc transferase 4 "CG8845b, CG31956, CG8845, CG8845b, CG31956, polypeptide GalNAc transferase 4" CDMC25774 2 20 5 DAC08-J20 22-CG31956-RA_1 CG31956 ACCTGCCCCATGGTGGATACTATTTCGCATGAAGATTTCTCTTACTTTAGCGGAAATAAGGACGGAGCA 69 FBan0031956 FBgn0051956 pgant4 2 2L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 pgant4 polypeptide GalNAc transferase 4 "CG8845b, CG31956, CG8845, CG8845b, CG31956, polypeptide GalNAc transferase 4" CDMC25775 2 21 5 DAC08-N08 14-CG32000-RG_1 CG32000 GGGTTCATCTGCATCAACAGCCCTGGTTTAAAGCTTTCGAGCCTGCGGATGAAGATCATTTAGGTTGCT 69 FBan0032000 FBgn0052000 CG32000 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; metabolism; GO:0008152; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ATPase activity, coupled to transmembrane movement of ions; GO:0042625; ; GO:0042625; ; GO:0015662" integral to membrane; GO:0016021 CG32000 CG32000 "BcDNA:LD05303, BcDNA:LD19039, BcDNA:SD17880" CDMC25775 2 22 5 DAC08-N08 14-CG32000-RG_1 CG32000 GGGTTCATCTGCATCAACAGCCCTGGTTTAAAGCTTTCGAGCCTGCGGATGAAGATCATTTAGGTTGCT 69 FBan0032000 FBgn0052000 CG32000 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; metabolism; GO:0008152; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ATPase activity, coupled to transmembrane movement of ions; GO:0042625; ; GO:0042625; ; GO:0015662" integral to membrane; GO:0016021 CG32000 CG32000 "BcDNA:LD05303, BcDNA:LD19039, BcDNA:SD17880" CDMC25776 2 23 5 DAC08-N20 8-CG32018-RB_1 CG32018 GGCCGCGGATGTTATCCCCTGGATGACCATGTTCTATGTAAAAGCTGCAATGCAAAAAGGGTTCAGGCT 69 FBgn0052018 CDMC25776 2 24 5 DAC08-N20 8-CG32018-RB_1 CG32018 GGCCGCGGATGTTATCCCCTGGATGACCATGTTCTATGTAAAAGCTGCAATGCAAAAAGGGTTCAGGCT 69 FBgn0052018 CDMC25777 2 25 5 DAC09-B09 8-CG5383-RA_1 CG5383 GCAAGCTCCTGGATGACTATGTGGTGCCCAAGTATTTTCGCGACGACCTCTTCCAGTACTGCGGC 65 FBan0005383 FBgn0038948 PSR 3 3R negative regulation of apoptosis; GO:0043066 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 PSR phosphatidylserine receptor "CG5383, CG5383, L0022859, PS, dPSR, BEST:LD22859, phosphatidylserine receptor" CDMC25777 2 26 5 DAC09-B09 8-CG5383-RA_1 CG5383 GCAAGCTCCTGGATGACTATGTGGTGCCCAAGTATTTTCGCGACGACCTCTTCCAGTACTGCGGC 65 FBan0005383 FBgn0038948 PSR 3 3R negative regulation of apoptosis; GO:0043066 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 PSR phosphatidylserine receptor "CG5383, CG5383, L0022859, PS, dPSR, BEST:LD22859, phosphatidylserine receptor" CDMC25778 2 1 6 DAC09-B21 2-CG5412-RA_1 CG5412 CACGTTGCACATCTACGGACAGACGGATGAGATCATTCCCAAGGAGATGAGCGAGTCCCTGGCTG 65 FBan0005412 FBgn0038806 CG5412 3 3R CG5412 CG5412 CDMC25778 2 2 6 DAC09-B21 2-CG5412-RA_1 CG5412 CACGTTGCACATCTACGGACAGACGGATGAGATCATTCCCAAGGAGATGAGCGAGTCCCTGGCTG 65 FBan0005412 FBgn0038806 CG5412 3 3R CG5412 CG5412 CDMC25779 2 3 6 DAC09-F09 12-CG5556-RA_2 CG5556 GGAACCGCCTCCAAAAAAACCGAAGGCTTCAAGTCATCGTAGCTCCCAAAAATCTGCGGGAAGTC 65 FBan0005556 FBgn0031332 CG5556 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5556 CG5556 CDMC25779 2 4 6 DAC09-F09 12-CG5556-RA_2 CG5556 GGAACCGCCTCCAAAAAAACCGAAGGCTTCAAGTCATCGTAGCTCCCAAAAATCTGCGGGAAGTC 65 FBan0005556 FBgn0031332 CG5556 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5556 CG5556 CDMC25780 2 5 6 DAC09-F21 1-CG5585-RA_1 CG5585 AAGAGCGGGAGTCAGAGTTCGACATTGCGGACGAAGACAAGTCTGTGGATCTGAATGCAGACGCG 65 FBan0005585 FBgn0036973 CG5585 3 3L CG5585 CG5585 CDMC25780 2 6 6 DAC09-F21 1-CG5585-RA_1 CG5585 AAGAGCGGGAGTCAGAGTTCGACATTGCGGACGAAGACAAGTCTGTGGATCTGAATGCAGACGCG 65 FBan0005585 FBgn0036973 CG5585 3 3L CG5585 CG5585 CDMC25781 2 7 6 DAC09-J09 23-CG5725-RA_1 CG5725 GTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCCCG 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC25781 2 8 6 DAC09-J09 23-CG5725-RA_1 CG5725 GTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCCCG 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC25782 2 9 6 DAC09-J21 1-CG5737-RA_3 CG5737 AAGAAGCTCTGCACCTACAAGAACTGCAAGTGCGCCAAGTGTGTCCTGATCTTTGAGAGGCAGCG 65 FBan0005737 FBgn0038851 dmrt93B 3 3R "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt93B doublesex-Mab related 93B "CG5737, doublesex-Mab related 93B" CDMC25782 2 10 6 DAC09-J21 1-CG5737-RA_3 CG5737 AAGAAGCTCTGCACCTACAAGAACTGCAAGTGCGCCAAGTGTGTCCTGATCTTTGAGAGGCAGCG 65 FBan0005737 FBgn0038851 dmrt93B 3 3R "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt93B doublesex-Mab related 93B "CG5737, doublesex-Mab related 93B" CDMC25783 2 11 6 DAC09-N09 23-CG5897-RA_1 CG5897 ATGAGCTATTGCGACAGTGCACCGATGAATATCCCAATCATAGGGTGTGCTACATGGATGGATAA 65 FBan0005897 FBgn0036220 CG5897 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG5897 CG5897 CDMC25783 2 12 6 DAC09-N09 23-CG5897-RA_1 CG5897 ATGAGCTATTGCGACAGTGCACCGATGAATATCCCAATCATAGGGTGTGCTACATGGATGGATAA 65 FBan0005897 FBgn0036220 CG5897 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG5897 CG5897 CDMC25784 2 13 6 DAC09-N21 3-CG5913-RA_5 CG5913 TTAAGAAGCCCTTGACTGATGCACAATGGCAATTGTTGGAGACCCTGCACCGAGAACTGGAGGCG 65 FBan0005913 FBgn0039385 CG5913 3 3R CG5913 CG5913 CDMC25784 2 14 6 DAC09-N21 3-CG5913-RA_5 CG5913 TTAAGAAGCCCTTGACTGATGCACAATGGCAATTGTTGGAGACCCTGCACCGAGAACTGGAGGCG 65 FBan0005913 FBgn0039385 CG5913 3 3R CG5913 CG5913 CDMC25785 2 15 6 DAC10-B08 24-CG6492-RA_1 CG6492 TTTTTTTATTGCGCTGATAACTACGGGTTTTTTAGTTTTTTATAAAGGATATAAATAGAGCGGCT 65 FBan0006492 FBgn0030872 Ucp4A X X mitochondrial transport; GO:0006839; proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4A Ucp4A "CG6492, CG6492, DmUCP4A, Ucp4a, dmUCP4a" CDMC25785 2 16 6 DAC10-B08 24-CG6492-RA_1 CG6492 TTTTTTTATTGCGCTGATAACTACGGGTTTTTTAGTTTTTTATAAAGGATATAAATAGAGCGGCT 65 FBan0006492 FBgn0030872 Ucp4A X X mitochondrial transport; GO:0006839; proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4A Ucp4A "CG6492, CG6492, DmUCP4A, Ucp4a, dmUCP4a" CDMC25786 2 17 6 DAC10-B20 3-CG6514-RA_1 CG6514 CAACAGCATGGGTCAGATGTTCGACGATAGCGAACTGCAGGCTCTGATCGACGACAACGATCCGG 65 FBan0006514 FBgn0031692 TpnC25D 2 2L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC25D TpnC25D "CG6514, TpnC II, DmTpnC25D, TnC, DmTpnCII, BcDNA:RE53289, anon-EST:Posey103" CDMC25786 2 18 6 DAC10-B20 3-CG6514-RA_1 CG6514 CAACAGCATGGGTCAGATGTTCGACGATAGCGAACTGCAGGCTCTGATCGACGACAACGATCCGG 65 FBan0006514 FBgn0031692 TpnC25D 2 2L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC25D TpnC25D "CG6514, TpnC II, DmTpnC25D, TnC, DmTpnCII, BcDNA:RE53289, anon-EST:Posey103" CDMC25787 2 19 6 DAC10-F08 2-CG6646-RA_1 CG6646 CGTGCCGGATACTTCACTGGAAGAGGCCGTGACCAGAGGTGACTACGATGTGGTTGTTCTTCCTG 65 FBan0006646 FBgn0033885 CG6646 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 CG6646 CG6646 CDMC25787 2 20 6 DAC10-F08 2-CG6646-RA_1 CG6646 CGTGCCGGATACTTCACTGGAAGAGGCCGTGACCAGAGGTGACTACGATGTGGTTGTTCTTCCTG 65 FBan0006646 FBgn0033885 CG6646 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 CG6646 CG6646 CDMC25788 2 21 6 DAC10-F20 2-CG6680-RA_3 CG6680 GTCAGCCATATCCAGTCCATGAGAAGCAACTTCGACACGGATGTCCTGGTCAGCATTTCGCAGGG 65 FBan0006680 FBgn0036968 CG6680 3 3L apoptosis; GO:0006915; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6680 CG6680 CDMC25788 2 22 6 DAC10-F20 2-CG6680-RA_3 CG6680 GTCAGCCATATCCAGTCCATGAGAAGCAACTTCGACACGGATGTCCTGGTCAGCATTTCGCAGGG 65 FBan0006680 FBgn0036968 CG6680 3 3L apoptosis; GO:0006915; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG6680 CG6680 CDMC25789 2 23 6 DAC10-J08 15-CG6779-RA_3 CG6779 TCAGCGTGCCAAGTCGATGAAATTCGTCGATGGCCTGATGATCCATTCGGGAGATCCGTGCAACG 65 FBan0006779 FBgn0002622 RpS3 3 3R DNA repair; GO:0006281; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS3 Ribosomal protein S3 "CG6779, M[[w]], Mw, M(3)w, M(3R)w, M(3)95A: Minute(3)95A, rpS3, S3, RS3, rps3 gene, ribosomal protein S3, dS3, DmRpS3, X72921, Rps3, M(3)124, M(3)B, M(3)B2, M(3)Fla, Minute(3)95A, M(3)95A" CDMC25789 2 24 6 DAC10-J08 15-CG6779-RA_3 CG6779 TCAGCGTGCCAAGTCGATGAAATTCGTCGATGGCCTGATGATCCATTCGGGAGATCCGTGCAACG 65 FBan0006779 FBgn0002622 RpS3 3 3R DNA repair; GO:0006281; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS3 Ribosomal protein S3 "CG6779, M[[w]], Mw, M(3)w, M(3R)w, M(3)95A: Minute(3)95A, rpS3, S3, RS3, rps3 gene, ribosomal protein S3, dS3, DmRpS3, X72921, Rps3, M(3)124, M(3)B, M(3)B2, M(3)Fla, Minute(3)95A, M(3)95A" CDMC25790 2 25 6 DAC10-J20 23-CG6803-RC_1 CG6803 AGGGTAAGGATATCAAAGACATTTTCTAAATCCAATGCCAGACACAAAAGTCCGACACCAACATC 65 FBan0006803 FBgn0038294 Zeelin1 3 3R muscle thick filament assembly; GO:0030241 Zeelin1 Zeelin1 "CG6803, z1, BcDNA:GH23305, Zeelin1" CDMC25790 2 26 6 DAC10-J20 23-CG6803-RC_1 CG6803 AGGGTAAGGATATCAAAGACATTTTCTAAATCCAATGCCAGACACAAAAGTCCGACACCAACATC 65 FBan0006803 FBgn0038294 Zeelin1 3 3R muscle thick filament assembly; GO:0030241 Zeelin1 Zeelin1 "CG6803, z1, BcDNA:GH23305, Zeelin1" CDMC25791 2 1 7 DAC10-N08 16-CG6904-RB_1 CG6904 CCGGAGTTCCTCACATCCACAAATCCTCTGTTTGGAATCGACTACGAAGAATTTGTCCGTGGCTG 65 FBan0006904 FBgn0038293 CG6904 3 3R glycogen biosynthesis; GO:0005978 glycogen (starch) synthase activity; GO:0004373 ; EC:2.4.1.11; ; GO:0004373 ; EC:2.4.1.11 CG6904 CG6904 "CG6940, CG6940, Glycogen synthase, anon-WO0118547.108" CDMC25791 2 2 7 DAC10-N08 16-CG6904-RB_1 CG6904 CCGGAGTTCCTCACATCCACAAATCCTCTGTTTGGAATCGACTACGAAGAATTTGTCCGTGGCTG 65 FBan0006904 FBgn0038293 CG6904 3 3R glycogen biosynthesis; GO:0005978 glycogen (starch) synthase activity; GO:0004373 ; EC:2.4.1.11; ; GO:0004373 ; EC:2.4.1.11 CG6904 CG6904 "CG6940, CG6940, Glycogen synthase, anon-WO0118547.108" CDMC25792 2 3 7 DAC10-N20 1-CG6938-RA_1 CG6938 AAATGGCCCCAAGGATTACGAACCCTATGGACTGAGTCCCCATTACTGGCATGTCTTTGCTGCCC 65 FBan0006938 FBgn0036235 CG6938 3 3L CG6938 CG6938 CDMC25792 2 4 7 DAC10-N20 1-CG6938-RA_1 CG6938 AAATGGCCCCAAGGATTACGAACCCTATGGACTGAGTCCCCATTACTGGCATGTCTTTGCTGCCC 65 FBan0006938 FBgn0036235 CG6938 3 3L CG6938 CG6938 CDMC25793 2 5 7 DAC11B8 22-X06779.1_O2_2 X06779.1_O2_2 TACATATTAACAAGCCGTCTCAACCAAGACATTGTGGAGCATTTTTTTGGCAGCATGCGATCGAGAGGT 69 CDMC25793 2 6 7 DAC11B8 22-X06779.1_O2_2 X06779.1_O2_2 TACATATTAACAAGCCGTCTCAACCAAGACATTGTGGAGCATTTTTTTGGCAGCATGCGATCGAGAGGT 69 CDMC25794 2 7 7 DAC11-B20 9-CG10009-RA_1 CG10009 AGGAAGAGGACGAGACCACAGAAAGTGAACCGGAGAAGGAAACCGACAAAAAGGCCACCAAATAAGGCT 69 FBan0010009 FBgn0026400 Noa36 3 3R biological process unknown; GO:0000004 metal ion binding; GO:0046872; ; GO:0046872 "chromosome, pericentric region; GO:0000775; midbody; GO:0030496; nucleolus; GO:0005730" Noa36 Noa36 "CG10009, NOA36, NOA 36" CDMC25794 2 8 7 DAC11-B20 9-CG10009-RA_1 CG10009 AGGAAGAGGACGAGACCACAGAAAGTGAACCGGAGAAGGAAACCGACAAAAAGGCCACCAAATAAGGCT 69 FBan0010009 FBgn0026400 Noa36 3 3R biological process unknown; GO:0000004 metal ion binding; GO:0046872; ; GO:0046872 "chromosome, pericentric region; GO:0000775; midbody; GO:0030496; nucleolus; GO:0005730" Noa36 Noa36 "CG10009, NOA36, NOA 36" CDMC25795 2 9 7 DAC11-F08 17-CG10047-RA_2 CG10047 TAGCTCAAACCGAACGCAATAAGCACTACAGGTGTATCTAGCGGCACTACCTTTAAAGGCAACGGATGG 69 FBan0010047 FBgn0028400 SytIV 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; transporter activity; GO:0005215; ; GO:0005215 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 SytIV Synaptotagmin IV "CG10047, D.Syt IV, synaptotagmin IV, SYT4, Syt4, sytIV, Synaptotagmin IV" CDMC25795 2 10 7 DAC11-F08 17-CG10047-RA_2 CG10047 TAGCTCAAACCGAACGCAATAAGCACTACAGGTGTATCTAGCGGCACTACCTTTAAAGGCAACGGATGG 69 FBan0010047 FBgn0028400 SytIV 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; transporter activity; GO:0005215; ; GO:0005215 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 SytIV Synaptotagmin IV "CG10047, D.Syt IV, synaptotagmin IV, SYT4, Syt4, sytIV, Synaptotagmin IV" CDMC25796 2 11 7 DAC11-F20 17-CG10059-RA_1 CG10059 CCAAGGTTCGCGCCATTCTAAACTACATCCTTGATCATACCGCCCAGAAGATTCCCATAAAGGACAAGG 69 FBan0010059 FBgn0037481 MAGE 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MAGE MAGE CG10059 CDMC25796 2 12 7 DAC11-F20 17-CG10059-RA_1 CG10059 CCAAGGTTCGCGCCATTCTAAACTACATCCTTGATCATACCGCCCAGAAGATTCCCATAAAGGACAAGG 69 FBan0010059 FBgn0037481 MAGE 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MAGE MAGE CG10059 CDMC25797 2 13 7 DAC11-J08 8-CG10083-RA_2 CG10083 TGGCCCATGAGAGCGAACAGTTCTCGACTATCAAGCGATCACCCCATAGTAAATCGAACTCGCTGCAGT 69 FBan0010083 FBgn0036372 CG10083 3 3L cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG10083 CG10083 Debrin-like CDMC25797 2 14 7 DAC11-J08 8-CG10083-RA_2 CG10083 TGGCCCATGAGAGCGAACAGTTCTCGACTATCAAGCGATCACCCCATAGTAAATCGAACTCGCTGCAGT 69 FBan0010083 FBgn0036372 CG10083 3 3L cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG10083 CG10083 Debrin-like CDMC25798 2 15 7 DAC11-J20 13-CG10094-RA_1 CG10094 TGCCGAAAAAGTCCTCACGTCACCCTTCTGCATCAACAGAAGTTCTCAGACAACTAATGCTCTCGCACT 69 FBan0010094 FBgn0038006 Cyp313a2 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a2 Cyp313a2 "CG10094, 313a2" CDMC25798 2 16 7 DAC11-J20 13-CG10094-RA_1 CG10094 TGCCGAAAAAGTCCTCACGTCACCCTTCTGCATCAACAGAAGTTCTCAGACAACTAATGCTCTCGCACT 69 FBan0010094 FBgn0038006 Cyp313a2 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a2 Cyp313a2 "CG10094, 313a2" CDMC25799 2 17 7 DAC11-N08 14-CG10128-RE_3 CG10128 ACCGTAGCATTTGTCAAGTCACACAAATTTTCCAACTGTCAGTTACCAAGGCGTGCAAGAACCACCCGA 69 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC25799 2 18 7 DAC11-N08 14-CG10128-RE_3 CG10128 ACCGTAGCATTTGTCAAGTCACACAAATTTTCCAACTGTCAGTTACCAAGGCGTGCAAGAACCACCCGA 69 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC25800 2 19 7 DAC11-N20 23-CG10137-RA_7 CG10137 AGCGTACACTTAATCGATCTATTGGCCTAGCGAATTAGCGAATTTATTAGAGCAACTATTCTAGTCAGG 69 FBan0010137 FBgn0032800 CG10137 2 2L glutamate binding; GO:0016595; glycine binding; GO:0016594; thienylcyclohexylpiperidine binding; GO:0016596; ; GO:0016595; ; GO:0016594; ; GO:0016596 CG10137 CG10137 CDMC25800 2 20 7 DAC11-N20 23-CG10137-RA_7 CG10137 AGCGTACACTTAATCGATCTATTGGCCTAGCGAATTAGCGAATTTATTAGAGCAACTATTCTAGTCAGG 69 FBan0010137 FBgn0032800 CG10137 2 2L glutamate binding; GO:0016595; glycine binding; GO:0016594; thienylcyclohexylpiperidine binding; GO:0016596; ; GO:0016595; ; GO:0016594; ; GO:0016596 CG10137 CG10137 CDMC25801 2 21 7 DAC12-B08 24-CG30094-RA_8 CG30094 GGAGGAGGTTCCAAAAAGAAGAACGGAAAATAGGAGGGAGTATGATTATGTTAGTTTATTAAATCTTTA 69 FBan0030094 FBgn0050094 CG30094 2 2R CG30094 CG30094 "CG15700, CG15700, BcDNA:SD13256" CDMC25801 2 22 7 DAC12-B08 24-CG30094-RA_8 CG30094 GGAGGAGGTTCCAAAAAGAAGAACGGAAAATAGGAGGGAGTATGATTATGTTAGTTTATTAAATCTTTA 69 FBan0030094 FBgn0050094 CG30094 2 2R CG30094 CG30094 "CG15700, CG15700, BcDNA:SD13256" CDMC25802 2 23 7 DAC12-B20 2-CG30100-RA_5 CG30100 ACGGCAATCACCTAAAGCTGACCGACAAGAACTACTTTCTGGGAAGAGTTCGCCACGAGTTTCGGGACA 69 FBan0030100 FBgn0050100 CG30100 2 2R translational termination; GO:0006415 translation release factor activity; GO:0003747; ; GO:0003747 CG30100 CG30100 CDMC25802 2 24 7 DAC12-B20 2-CG30100-RA_5 CG30100 ACGGCAATCACCTAAAGCTGACCGACAAGAACTACTTTCTGGGAAGAGTTCGCCACGAGTTTCGGGACA 69 FBan0030100 FBgn0050100 CG30100 2 2R translational termination; GO:0006415 translation release factor activity; GO:0003747; ; GO:0003747 CG30100 CG30100 CDMC25803 2 25 7 DAC12-F08 11-CG30142-RA_1 CG30142 GGAGAAGGCTCCCGAAGAACTTTGTGCGTACAGTTTTAGACTGGTGATGTGTGCATTTAAGGCTGGCCA 69 FBan0030142 FBgn0043534 Obp57b 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57b Odorant-binding protein 57b "CG30142, 57b, anon-AE003792.2, Obp-e, Odorant-binding protein 57b" CDMC25803 2 26 7 DAC12-F08 11-CG30142-RA_1 CG30142 GGAGAAGGCTCCCGAAGAACTTTGTGCGTACAGTTTTAGACTGGTGATGTGTGCATTTAAGGCTGGCCA 69 FBan0030142 FBgn0043534 Obp57b 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57b Odorant-binding protein 57b "CG30142, 57b, anon-AE003792.2, Obp-e, Odorant-binding protein 57b" CDMC25804 2 1 8 DAC12-F20 2-CG30151-RA_1 CG30151 GGCCAGGAGGTCCATACGAAAGTACTGCTCAAGAGGGTTTAATCTCTGGAGTGGATACGGGAGGTCCCT 69 FBan0030151 FBgn0050151 CG30151 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30151 CG30151 BcDNA:RE70748 CDMC25804 2 2 8 DAC12-F20 2-CG30151-RA_1 CG30151 GGCCAGGAGGTCCATACGAAAGTACTGCTCAAGAGGGTTTAATCTCTGGAGTGGATACGGGAGGTCCCT 69 FBan0030151 FBgn0050151 CG30151 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30151 CG30151 BcDNA:RE70748 CDMC25805 2 3 8 DAC12-J08 12-CG30181-RA_3 CG30181 GCAGTCACGCTGTGCTACTACGACCACATCGACTCCTTCAAGGCCAATGAGTACATACAGGAGATGTGG 69 FBan0030181 FBgn0050181 CG30181 2 2R CG30181 CG30181 "CG15872, CG15872" CDMC25805 2 4 8 DAC12-J08 12-CG30181-RA_3 CG30181 GCAGTCACGCTGTGCTACTACGACCACATCGACTCCTTCAAGGCCAATGAGTACATACAGGAGATGTGG 69 FBan0030181 FBgn0050181 CG30181 2 2R CG30181 CG30181 "CG15872, CG15872" CDMC25806 2 5 8 DAC12-J20 3-CG3018-RB_1 CG3018 CGGAAAGGATTTCCCAGCAAATGTGCAGTCGAGCACTTGTTGGTCGTCAGTAGCCGTACAGCTGGATTT 69 FBan0003018 FBgn0010602 lwr 2 2L female meiosis; GO:0007143; female meiosis chromosome segregation; GO:0016321; hemocyte proliferation (sensu Arthropoda); GO:0035172; protein import into nucleus; GO:0006606; protein modification; GO:0006464; ubiquitin cycle; GO:0006512; zygotic determination of dorsal/ventral axis; GO:0007352 SUMO conjugating enzyme activity; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0019949; ; GO:0004840; ; GO:0005515 nucleus; GO:0005634 lwr lesswright "CG3018, CG3018, Lwr, Lesswright, Ubc9, hbl, hunchback-like, DmUbc9, Dmubc9, Ubiquitin conjugating enzyme 9, semi, semushi, ubc9, dUBC9, UBC9, ubiquitin-conjugating enzyme 9, dUbc9, dip4, DUbc9, l(2)01519, i105, i56, FBgn0010602, l(2)02858, l(2)05486, l(2)05487, lesswright" CDMC25806 2 6 8 DAC12-J20 3-CG3018-RB_1 CG3018 CGGAAAGGATTTCCCAGCAAATGTGCAGTCGAGCACTTGTTGGTCGTCAGTAGCCGTACAGCTGGATTT 69 FBan0003018 FBgn0010602 lwr 2 2L female meiosis; GO:0007143; female meiosis chromosome segregation; GO:0016321; hemocyte proliferation (sensu Arthropoda); GO:0035172; protein import into nucleus; GO:0006606; protein modification; GO:0006464; ubiquitin cycle; GO:0006512; zygotic determination of dorsal/ventral axis; GO:0007352 SUMO conjugating enzyme activity; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ; GO:0019949; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0019949; ; GO:0004840; ; GO:0005515 nucleus; GO:0005634 lwr lesswright "CG3018, CG3018, Lwr, Lesswright, Ubc9, hbl, hunchback-like, DmUbc9, Dmubc9, Ubiquitin conjugating enzyme 9, semi, semushi, ubc9, dUBC9, UBC9, ubiquitin-conjugating enzyme 9, dUbc9, dip4, DUbc9, l(2)01519, i105, i56, FBgn0010602, l(2)02858, l(2)05486, l(2)05487, lesswright" CDMC25807 2 7 8 DAC12-N08 3-CG30278-RA_2 CG30278 CGTTTCCCGGCTAAAAAATTGTACGGCCTTCAAAATGTCCGCTCCGGAGAACAGTTGTAGGCGGTGGAT 69 FBan0030278 FBgn0050278 CG30278 2 2R CG30278 CG30278 "CG3387, CG3387" CDMC25807 2 8 8 DAC12-N08 3-CG30278-RA_2 CG30278 CGTTTCCCGGCTAAAAAATTGTACGGCCTTCAAAATGTCCGCTCCGGAGAACAGTTGTAGGCGGTGGAT 69 FBan0030278 FBgn0050278 CG30278 2 2R CG30278 CG30278 "CG3387, CG3387" CDMC25808 2 9 8 DAC12-N20 2-CG30287-RA_1 CG30287 GGTGGTCAGCTATGGTGCGGTTCACTGCTTTGGCCCTACTGTCTACACAAACGTCATTCACTTTGCGAA 69 FBan0030287 FBgn0050287 CG30287 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30287 CG30287 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC25808 2 10 8 DAC12-N20 2-CG30287-RA_1 CG30287 GGTGGTCAGCTATGGTGCGGTTCACTGCTTTGGCCCTACTGTCTACACAAACGTCATTCACTTTGCGAA 69 FBan0030287 FBgn0050287 CG30287 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30287 CG30287 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC25809 2 11 8 DAC13-B08 23-CG13227-RA_1 CG13227 AAGTTGGAGAAGGAATACGACATCGAAATGGATCACAAGTGGATAATATTTTTCTTCAGCATTGC 65 FBan0013227 FBgn0033589 CG13227 2 2R CG13227 CG13227 CDMC25809 2 12 8 DAC13-B08 23-CG13227-RA_1 CG13227 AAGTTGGAGAAGGAATACGACATCGAAATGGATCACAAGTGGATAATATTTTTCTTCAGCATTGC 65 FBan0013227 FBgn0033589 CG13227 2 2R CG13227 CG13227 CDMC25810 2 13 8 DAC13-B20 3-CG13239-RA_1 CG13239 GTGGCCCACAGCAGGCTGCACCATATGTAGCTGCGTCGCAGTACTACCAAGCCTATTTTGGATAG 65 FBan0013239 FBgn0037197 CG13239 3 3L CG13239 CG13239 CDMC25810 2 14 8 DAC13-B20 3-CG13239-RA_1 CG13239 GTGGCCCACAGCAGGCTGCACCATATGTAGCTGCGTCGCAGTACTACCAAGCCTATTTTGGATAG 65 FBan0013239 FBgn0037197 CG13239 3 3L CG13239 CG13239 CDMC25811 2 15 8 DAC13-F08 23-CG13408-RA_1 CG13408 GTGTGAGAAGCTCACTGGGCAGTGTGATTTTAATTTACTTTGTCATCTTGCTTCGTTTGGTCAAC 65 FBan0013408 FBgn0038929 CG13408 3 3R CG13408 CG13408 CDMC25811 2 16 8 DAC13-F08 23-CG13408-RA_1 CG13408 GTGTGAGAAGCTCACTGGGCAGTGTGATTTTAATTTACTTTGTCATCTTGCTTCGTTTGGTCAAC 65 FBan0013408 FBgn0038929 CG13408 3 3R CG13408 CG13408 CDMC25812 2 17 8 DAC13-F20 18-CG13436-RA_14 CG13436 AGGCGGCACTGGATGACCTCATAAACATAGATCATAAGGACGAGACCTTGACCTACCGCGTGCCC 65 FBan0013436 FBgn0034532 CG13436 2 2R CG13436 CG13436 CDMC25812 2 18 8 DAC13-F20 18-CG13436-RA_14 CG13436 AGGCGGCACTGGATGACCTCATAAACATAGATCATAAGGACGAGACCTTGACCTACCGCGTGCCC 65 FBan0013436 FBgn0034532 CG13436 2 2R CG13436 CG13436 CDMC25813 2 19 8 DAC13-J08 6-CG13538-RA_1 CG13538 TCGCCAATAGCTACCGCAAGTGCTACAACTTTGCCATGGACCTAACCTCGGAGCTAAAGGCGCAC 65 FBan0013538 FBgn0034820 CG13538 2 2R CG13538 CG13538 CDMC25813 2 20 8 DAC13-J08 6-CG13538-RA_1 CG13538 TCGCCAATAGCTACCGCAAGTGCTACAACTTTGCCATGGACCTAACCTCGGAGCTAAAGGCGCAC 65 FBan0013538 FBgn0034820 CG13538 2 2R CG13538 CG13538 CDMC25814 2 21 8 DAC13-J20 1-CG13559-RA_3 CG13559 GATCACACAGCACCACGTGGCTGCTCGCGGAGAATACCTCATCACTCATGATCTGTCCAATGTGC 65 FBan0013559 FBgn0034870 CG13559 2 2R CG13559 CG13559 CDMC25814 2 22 8 DAC13-J20 1-CG13559-RA_3 CG13559 GATCACACAGCACCACGTGGCTGCTCGCGGAGAATACCTCATCACTCATGATCTGTCCAATGTGC 65 FBan0013559 FBgn0034870 CG13559 2 2R CG13559 CG13559 CDMC25815 2 23 8 DAC13-N08 14-CG13653-RA_1 CG13653 CAAGACGCGCCAGAACACTGAGTACGGATCCTTCCAGGACCTCATTATGCAGGCCAAGATGAACG 65 FBan0013653 FBgn0039288 CG13653 3 3R CG13653 CG13653 CDMC25815 2 24 8 DAC13-N08 14-CG13653-RA_1 CG13653 CAAGACGCGCCAGAACACTGAGTACGGATCCTTCCAGGACCTCATTATGCAGGCCAAGATGAACG 65 FBan0013653 FBgn0039288 CG13653 3 3R CG13653 CG13653 CDMC25816 2 25 8 DAC13-N20 3-CG13681-RA_1 CG13681 ATAAATATGCGCCTGGAAGAAGGCTAGCTGCGCGGCAAACTCTTCGATTGGCAATACCGAAGGCG 65 FBan0013681 FBgn0035832 CG13681 3 3L CG13681 CG13681 CDMC25816 2 26 8 DAC13-N20 3-CG13681-RA_1 CG13681 ATAAATATGCGCCTGGAAGAAGGCTAGCTGCGCGGCAAACTCTTCGATTGGCAATACCGAAGGCG 65 FBan0013681 FBgn0035832 CG13681 3 3L CG13681 CG13681 CDMC25817 2 1 9 DAC14-B08 12-CG1652-RA_1 CG1652 GCTATTTGCGCAGGATCAACGGCAAGTGCTACTACTTTTCGGTGAAAAAGATGAACTGGTTTGGCGCCC 69 FBan0001652 FBgn0040092 lectin-46Cb 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Cb lectin-46Cb "CG1652, AC 007330B, AC007330b" CDMC25817 2 2 9 DAC14-B08 12-CG1652-RA_1 CG1652 GCTATTTGCGCAGGATCAACGGCAAGTGCTACTACTTTTCGGTGAAAAAGATGAACTGGTTTGGCGCCC 69 FBan0001652 FBgn0040092 lectin-46Cb 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Cb lectin-46Cb "CG1652, AC 007330B, AC007330b" CDMC25818 2 3 9 DAC14-B20 18-CG1660-RA_1 CG1660 TCCGACTTCCTAATGTCCTACAACAAACTGTCCGAGACGTGCTTCACAGATTGCATACGCGACTTTACA 69 FBan0001660 FBgn0030480 Tim9a X X protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim9a Tim9a "CG1660, CG1660, Tim9" CDMC25818 2 4 9 DAC14-B20 18-CG1660-RA_1 CG1660 TCCGACTTCCTAATGTCCTACAACAAACTGTCCGAGACGTGCTTCACAGATTGCATACGCGACTTTACA 69 FBan0001660 FBgn0030480 Tim9a X X protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim9a Tim9a "CG1660, CG1660, Tim9" CDMC25819 2 5 9 DAC14-F08 15-CG16726-RA_2 CG16726 GCACTGTCTGCCCTATATAGTCATTGCCAAGCCGGTGTTTATGCCCAAATTGAACACGACCATTTGCGA 69 FBgn0036026 CDMC25819 2 6 9 DAC14-F08 15-CG16726-RA_2 CG16726 GCACTGTCTGCCCTATATAGTCATTGCCAAGCCGGTGTTTATGCCCAAATTGAACACGACCATTTGCGA 69 FBgn0036026 CDMC25820 2 7 9 DAC14-F20 1-CG16736-RA_1 CG16736 TGCTGATTAAGACTACGGCCCAACTGTTGTCGCATCCCATGGAGCTAGTTCGTGTGAATATGCAGGCGA 69 FBan0016736 FBgn0037668 CG16736 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG16736 CG16736 CDMC25820 2 8 9 DAC14-F20 1-CG16736-RA_1 CG16736 TGCTGATTAAGACTACGGCCCAACTGTTGTCGCATCCCATGGAGCTAGTTCGTGTGAATATGCAGGCGA 69 FBan0016736 FBgn0037668 CG16736 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG16736 CG16736 CDMC25821 2 9 9 DAC14-J08 2-CG16775-RA_1 CG16775 GTCCACAACACCCCGCCTCTCAACAATCGAATCATGTTCTCAGCCAAGAGTTCTGCAATTGTGGCCGTA 69 FBan0016775 FBgn0036767 CG16775 3 3L CG16775 CG16775 CDMC25821 2 10 9 DAC14-J08 2-CG16775-RA_1 CG16775 GTCCACAACACCCCGCCTCTCAACAATCGAATCATGTTCTCAGCCAAGAGTTCTGCAATTGTGGCCGTA 69 FBan0016775 FBgn0036767 CG16775 3 3L CG16775 CG16775 CDMC25822 2 11 9 DAC14-J20 2-CG16786-RA_3 CG16786 AGGCTGGGTCGGAAATCAACCTGGACCTCGAGTTCGGAGATGAAGATAATACGGGCAAATTCGACGCAA 69 FBan0016786 FBgn0034974 CG16786 2 2R CG16786 CG16786 CDMC25822 2 12 9 DAC14-J20 2-CG16786-RA_3 CG16786 AGGCTGGGTCGGAAATCAACCTGGACCTCGAGTTCGGAGATGAAGATAATACGGGCAAATTCGACGCAA 69 FBan0016786 FBgn0034974 CG16786 2 2R CG16786 CG16786 CDMC25823 2 13 9 DAC14-N08 15-CG16834-RA_1 CG16834 AGCCTTTGGGTATCACGATATAGAGTGCAAGGTTCAGTTTCCATATGTGTGCCAGAGGGAACCAGCAGA 69 FBan0016834 FBgn0040096 lectin-33A 2 2L galactose binding; GO:0005534; ; GO:0005534 lectin-33A lectin-33A "CG16834, AC 007083A, AC007083a" CDMC25823 2 14 9 DAC14-N08 15-CG16834-RA_1 CG16834 AGCCTTTGGGTATCACGATATAGAGTGCAAGGTTCAGTTTCCATATGTGTGCCAGAGGGAACCAGCAGA 69 FBan0016834 FBgn0040096 lectin-33A 2 2L galactose binding; GO:0005534; ; GO:0005534 lectin-33A lectin-33A "CG16834, AC 007083A, AC007083a" CDMC25824 2 15 9 DAC14-N20 16-CG16844-RA_1 CG16844 ACGCGGGAGTCAAGCTCAGAATTCAACCACAAAAACCAACAACATGAAATTCCTATCACTCGCCTTCGT 69 FBan0016844 FBgn0040736 IM3 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM3 Immune induced molecule 3 "CG16844, CG16844, CG16844, CG16844, DIM 3, CT37419, BcDNA:RH58911, Immune induced molecule 3" CDMC25824 2 16 9 DAC14-N20 16-CG16844-RA_1 CG16844 ACGCGGGAGTCAAGCTCAGAATTCAACCACAAAAACCAACAACATGAAATTCCTATCACTCGCCTTCGT 69 FBan0016844 FBgn0040736 IM3 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM3 Immune induced molecule 3 "CG16844, CG16844, CG16844, CG16844, DIM 3, CT37419, BcDNA:RH58911, Immune induced molecule 3" CDMC25825 2 17 9 DAC15-B08 23-CG18619-RD_4 CG18619 TTGAGAGTTATAATGGCTGATATGGAGATACAGAGCAACAAAATGTCAATAACGGAGGAAACACAAGTG 69 FBan0018619 FBgn0032202 CG18619 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 CG18619 CG18619 BcDNA:RH73910 CDMC25825 2 18 9 DAC15-B08 23-CG18619-RD_4 CG18619 TTGAGAGTTATAATGGCTGATATGGAGATACAGAGCAACAAAATGTCAATAACGGAGGAAACACAAGTG 69 FBan0018619 FBgn0032202 CG18619 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 CG18619 CG18619 BcDNA:RH73910 CDMC25826 2 19 9 DAC15-B20 1-CG1863-RA_2 CG1863 TGGCTAAGAGGGCAACTGAACAACCACACCTTGCAAGATCTGGAGAACCGTAGCTACAGGCTCAACTCA 69 FBan0001863 FBgn0033435 CG1863 2 2R CG1863 CG1863 CDMC25826 2 20 9 DAC15-B20 1-CG1863-RA_2 CG1863 TGGCTAAGAGGGCAACTGAACAACCACACCTTGCAAGATCTGGAGAACCGTAGCTACAGGCTCAACTCA 69 FBan0001863 FBgn0033435 CG1863 2 2R CG1863 CG1863 CDMC25827 2 21 9 DAC15-F08 6-CG18731-RA_1 CG18731 TGCTGGCGGACATGGAAACGTTCGAGGTCAATCAGCCTACGATAAGCGGATCTACAGACAACTTGGACT 69 FBan0018731 FBgn0042213 CG18731 3 3R CG18731 CG18731 CDMC25827 2 22 9 DAC15-F08 6-CG18731-RA_1 CG18731 TGCTGGCGGACATGGAAACGTTCGAGGTCAATCAGCCTACGATAAGCGGATCTACAGACAACTTGGACT 69 FBan0018731 FBgn0042213 CG18731 3 3R CG18731 CG18731 CDMC25828 2 23 9 DAC15-F20 16-CG18754-RA_1 CG18754 CCAACCCATTTGTCTATTGGACGCCGAATTTCCCCTACAGGATTTGAATTTGCAAATCTCTGGCTGGGA 69 FBan0018754 FBgn0042106 CG18754 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18754 CG18754 SP61 CDMC25828 2 24 9 DAC15-F20 16-CG18754-RA_1 CG18754 CCAACCCATTTGTCTATTGGACGCCGAATTTCCCCTACAGGATTTGAATTTGCAAATCTCTGGCTGGGA 69 FBan0018754 FBgn0042106 CG18754 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18754 CG18754 SP61 CDMC25829 2 25 9 DAC15-J08 23-CG18811-RA_5 CG18811 CGTCCAAGGAAAACAAACGACAGATGGGCAAAACTTGTATGTAACTTGGATCTGCCATTTCTTGCTTGA 69 FBan0018811 FBgn0042134 CG18811 3 3L CG18811 CG18811 "anon-WO0118547.253, NEST:bs19b07" CDMC25829 2 26 9 DAC15-J08 23-CG18811-RA_5 CG18811 CGTCCAAGGAAAACAAACGACAGATGGGCAAAACTTGTATGTAACTTGGATCTGCCATTTCTTGCTTGA 69 FBan0018811 FBgn0042134 CG18811 3 3L CG18811 CG18811 "anon-WO0118547.253, NEST:bs19b07" CDMC25830 2 1 10 DAC15-J20 23-CG1882-RA_2 CG1882 GCCTGTATCTATTAGCTTAGTGTCTTTGCCTAGTATTAAATGGTCATCTTATCCAATTAGCCGCTATTT 69 FBan0001882 FBgn0033226 CG1882 2 2R aromatic compound metabolism; GO:0006725 hydrolase activity; GO:0016787 ; EC:3.-.-.-; catalytic activity; GO:0003824; ; GO:0016787 ; EC:3.-.-.-; ; GO:0003824 CG1882 CG1882 CDMC25830 2 2 10 DAC15-J20 23-CG1882-RA_2 CG1882 GCCTGTATCTATTAGCTTAGTGTCTTTGCCTAGTATTAAATGGTCATCTTATCCAATTAGCCGCTATTT 69 FBan0001882 FBgn0033226 CG1882 2 2R aromatic compound metabolism; GO:0006725 hydrolase activity; GO:0016787 ; EC:3.-.-.-; catalytic activity; GO:0003824; ; GO:0016787 ; EC:3.-.-.-; ; GO:0003824 CG1882 CG1882 CDMC25831 2 3 10 DAC15-N08 2-CG1903-RB_3 CG1903 ACTGGACGGAACAGTATGATGCCTCGGTTAACACCTGTTCGCACGCATACTGGAACGGCAACTGTAGAA 69 FBan0001903 FBgn0005410 sno X X Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; embryonic development; GO:0009790; epidermal growth factor receptor signaling pathway; GO:0007173; imaginal disc morphogenesis; GO:0007560; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of proteolysis; GO:0030162; wing margin morphogenesis; GO:0008587 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; helicase activity; GO:0004386; ; GO:0004386 nucleus; GO:0005634 sno strawberry notch "CG1903, g-l: glossy-like, glossy-like, Strawberry Notch, Sno, l(1)11Ea, g-l" CDMC25831 2 4 10 DAC15-N08 2-CG1903-RB_3 CG1903 ACTGGACGGAACAGTATGATGCCTCGGTTAACACCTGTTCGCACGCATACTGGAACGGCAACTGTAGAA 69 FBan0001903 FBgn0005410 sno X X Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; embryonic development; GO:0009790; epidermal growth factor receptor signaling pathway; GO:0007173; imaginal disc morphogenesis; GO:0007560; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of proteolysis; GO:0030162; wing margin morphogenesis; GO:0008587 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; helicase activity; GO:0004386; ; GO:0004386 nucleus; GO:0005634 sno strawberry notch "CG1903, g-l: glossy-like, glossy-like, Strawberry Notch, Sno, l(1)11Ea, g-l" CDMC25832 2 5 10 DAC15-N20 23-CG1913-RA_16 CG1913 TAACCGTCGAAATCAGTGTTTACGCTTCCAATCGCAACAAAAAATTCACTGCAACACTGAAAAGCATAC 69 FBan0001913 FBgn0003884 alphaTub84B 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub84B alpha-Tubulin at 84B "CG1913, CG1913, CG1913, alpha1 tubulin, alphaT, DTA1, alpha84B, alphaTub, tubA84B, 1t, alpha1t, alpha-tubulin, alpha1-tubulin, alphat-1, Talpha1, T, a1t, nc33, Tubulin-alpha1, Tuba84B, alpha1, Tubalpha1, alpha-Tubulin, alphatubulin, alpha tubulin, tubulin, aTub84B, clone 1.59, clone 2.30, tubulin 1alpha, alpha1tub, ALPHA 84C, DM1alpha, alpha-Tub, tubulin alpha1, alphaTUB, alphaTub84B, Tubulin 1 alpha-chain, alpha-tubulin, alpha-Tub84B, alphaTub1, anon-EST:Liang-1.59, anon-EST:Liang-2.30, l(3)84Bd, l(3)g3, ms(3)nc33, BEST:LD32507" CDMC25832 2 6 10 DAC15-N20 23-CG1913-RA_16 CG1913 TAACCGTCGAAATCAGTGTTTACGCTTCCAATCGCAACAAAAAATTCACTGCAACACTGAAAAGCATAC 69 FBan0001913 FBgn0003884 alphaTub84B 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub84B alpha-Tubulin at 84B "CG1913, CG1913, CG1913, alpha1 tubulin, alphaT, DTA1, alpha84B, alphaTub, tubA84B, 1t, alpha1t, alpha-tubulin, alpha1-tubulin, alphat-1, Talpha1, T, a1t, nc33, Tubulin-alpha1, Tuba84B, alpha1, Tubalpha1, alpha-Tubulin, alphatubulin, alpha tubulin, tubulin, aTub84B, clone 1.59, clone 2.30, tubulin 1alpha, alpha1tub, ALPHA 84C, DM1alpha, alpha-Tub, tubulin alpha1, alphaTUB, alphaTub84B, Tubulin 1 alpha-chain, alpha-tubulin, alpha-Tub84B, alphaTub1, anon-EST:Liang-1.59, anon-EST:Liang-2.30, l(3)84Bd, l(3)g3, ms(3)nc33, BEST:LD32507" CDMC25833 2 7 10 DAC16-B08 9-CG3273-RA_1 CG3273 GCATCTGCTCTTCCCGTAGCGAACGAATGCTTTGTACAGCCAAATCTGGAGAAGGAGTACGAGGATCGC 69 FBgn0033082 CDMC25833 2 8 10 DAC16-B08 9-CG3273-RA_1 CG3273 GCATCTGCTCTTCCCGTAGCGAACGAATGCTTTGTACAGCCAAATCTGGAGAAGGAGTACGAGGATCGC 69 FBgn0033082 CDMC25834 2 9 10 DAC16-B20 2-CG32750-RA_1 CG32750 GGTGGTCAATGTCAAGGAGCGTGTTTCGGAGCAGTGTACTTCGGATGAGACATGTTCCAGTCGTGGCTA 69 FBan0032750 FBgn0052750 CG32750 X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.-; ; GO:0016787 ; EC:3.-.-.- extrinsic to membrane; GO:0019898 CG32750 CG32750 "CG3648, CG3648" CDMC25834 2 10 10 DAC16-B20 2-CG32750-RA_1 CG32750 GGTGGTCAATGTCAAGGAGCGTGTTTCGGAGCAGTGTACTTCGGATGAGACATGTTCCAGTCGTGGCTA 69 FBan0032750 FBgn0052750 CG32750 X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.-; ; GO:0016787 ; EC:3.-.-.- extrinsic to membrane; GO:0019898 CG32750 CG32750 "CG3648, CG3648" CDMC25835 2 11 10 DAC16-F08 3-CG32790-RA_1 CG32790 AGCCATGCCATACAAGCACAAGCCAGCTCACCAAATCCCAATTCCACACTCTTCTCACGTTTCCACAGA 69 FBan0032790 FBgn0052790 CG32790 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32790 CG32790 CG4985 CDMC25835 2 12 10 DAC16-F08 3-CG32790-RA_1 CG32790 AGCCATGCCATACAAGCACAAGCCAGCTCACCAAATCCCAATTCCACACTCTTCTCACGTTTCCACAGA 69 FBan0032790 FBgn0052790 CG32790 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32790 CG32790 CG4985 CDMC25836 2 13 10 DAC16-F20 3-CG32799-RA_1 CG32799 CGCGCCCTTAGGATTCTTAGTGTTGTGCGATGCTTCTTTCTGGACGAAGCCAGCCGAAAGTTGCTGTAT 69 FBgn0052799 CDMC25836 2 14 10 DAC16-F20 3-CG32799-RA_1 CG32799 CGCGCCCTTAGGATTCTTAGTGTTGTGCGATGCTTCTTTCTGGACGAAGCCAGCCGAAAGTTGCTGTAT 69 FBgn0052799 CDMC25837 2 15 10 DAC16-J08 15-CG32827-RA_1 CG32827 TGGACCTTTTTCGGTATGGCTAAAGAGCTTATGGGCCAAATCTAACTGAAGGGTTATCCGCTGCTGGCT 69 FBan0032827 FBgn0052827 CG32827 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32827 CG32827 CDMC25837 2 16 10 DAC16-J08 15-CG32827-RA_1 CG32827 TGGACCTTTTTCGGTATGGCTAAAGAGCTTATGGGCCAAATCTAACTGAAGGGTTATCCGCTGCTGGCT 69 FBan0032827 FBgn0052827 CG32827 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32827 CG32827 CDMC25838 2 17 10 DAC16-J20 2-CG32845-RA_4 CG32845 CGCCTCCTATGGTGATGGGGACAGTGGGCTATCGAACCTAACTGAAGAACGTACTTCCGAAAGGCCAAA 69 FBan0032845 FBgn0052845 CG32845 3 3L cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067; protein folding; GO:0006457; protein metabolism; GO:0019538 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG32845 CG32845 CDMC25838 2 18 10 DAC16-J20 2-CG32845-RA_4 CG32845 CGCCTCCTATGGTGATGGGGACAGTGGGCTATCGAACCTAACTGAAGAACGTACTTCCGAAAGGCCAAA 69 FBan0032845 FBgn0052845 CG32845 3 3L cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067; protein folding; GO:0006457; protein metabolism; GO:0019538 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG32845 CG32845 CDMC25839 2 19 10 DAC16-N08 23-CG32920-RA_3 CG32920 GCCCGAAAACACTAGAAACTCATACATGCTAATGCTAGGCCGCAATGATATCAATTACGTCTTCAAAAG 69 FBgn0052920 CDMC25839 2 20 10 DAC16-N08 23-CG32920-RA_3 CG32920 GCCCGAAAACACTAGAAACTCATACATGCTAATGCTAGGCCGCAATGATATCAATTACGTCTTCAAAAG 69 FBgn0052920 CDMC25840 2 21 10 DAC16-N20 18-CG32940-RA_15 CG32940 GGAGGTAGAAGAAAAAACTCCTAGCACAGTACTAAGGGAAATCTGTGAGAGACCCACAACCGTGGCGTC 69 FBgn0052940 CDMC25840 2 22 10 DAC16-N20 18-CG32940-RA_15 CG32940 GGAGGTAGAAGAAAAAACTCCTAGCACAGTACTAAGGGAAATCTGTGAGAGACCCACAACCGTGGCGTC 69 FBgn0052940 CDMC25841 2 23 10 DAC17-B08 2-CG12276-RA_1 CG12276 GCCACACCGTAATCTGTTCGTTTTTGACCCAGAGACTTGTGCCGGATACGTTGAGGCCATCGGAG 65 FBan0012276 FBgn0029512 Aos1 3 3R SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein modification; GO:0006464; protein sumoylation; GO:0016925; protein targeting; GO:0006605; ubiquitin cycle; GO:0006512 SUMO activating enzyme activity; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ubiquitin activating enzyme activity; GO:0004839; ; GO:0004839; ; GO:0005515; ; GO:0019948 SUMO activating enzyme complex; GO:0031510; nucleus; GO:0005634 Aos1 Aos1 "CG12276, CG12276, CG12276, DmAos1, DmSAE1, SAE1, Smt3 activating enzyme 1, Dmaos1, DmSae1, Ubiquitin activating enzyme, Sae1" CDMC25841 2 24 10 DAC17-B08 2-CG12276-RA_1 CG12276 GCCACACCGTAATCTGTTCGTTTTTGACCCAGAGACTTGTGCCGGATACGTTGAGGCCATCGGAG 65 FBan0012276 FBgn0029512 Aos1 3 3R SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein modification; GO:0006464; protein sumoylation; GO:0016925; protein targeting; GO:0006605; ubiquitin cycle; GO:0006512 SUMO activating enzyme activity; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ubiquitin activating enzyme activity; GO:0004839; ; GO:0004839; ; GO:0005515; ; GO:0019948 SUMO activating enzyme complex; GO:0031510; nucleus; GO:0005634 Aos1 Aos1 "CG12276, CG12276, CG12276, DmAos1, DmSAE1, SAE1, Smt3 activating enzyme 1, Dmaos1, DmSae1, Ubiquitin activating enzyme, Sae1" CDMC25842 2 25 10 DAC17-B20 24-CG12324-RA_1 CG12324 TTTTGAACTACATCTAAGAGAAGTACTTACGGAAGTTTTCAAGTAAAGGTTTTTTCCCTTTTTCA 65 FBan0012324 FBgn0033555 RpS15Ab 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15Ab Ribosomal protein S15Ab "CG12324, CG12324, CT22283, Ribosomal protein S15Ab" CDMC25842 2 26 10 DAC17-B20 24-CG12324-RA_1 CG12324 TTTTGAACTACATCTAAGAGAAGTACTTACGGAAGTTTTCAAGTAAAGGTTTTTTCCCTTTTTCA 65 FBan0012324 FBgn0033555 RpS15Ab 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15Ab Ribosomal protein S15Ab "CG12324, CG12324, CT22283, Ribosomal protein S15Ab" CDMC25843 2 1 11 DAC17-F08 15-CG12478-RA_4 CG12478 AAATGGCCGGTCACATGAACCTGCTGAATCCGTTCGTCTTTAATCAGTTCAGTCCGTACGGCGCC 65 FBan0012478 FBgn0036379 bru-3 3 3L protein metabolism; GO:0019538 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 bru-3 bruno-3 "CG10046, CG12478, CG10046, CG10046, CG12478, Dm Bru-3, cg10046, cg12478, bruno-3" CDMC25843 2 2 11 DAC17-F08 15-CG12478-RA_4 CG12478 AAATGGCCGGTCACATGAACCTGCTGAATCCGTTCGTCTTTAATCAGTTCAGTCCGTACGGCGCC 65 FBan0012478 FBgn0036379 bru-3 3 3L protein metabolism; GO:0019538 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 bru-3 bruno-3 "CG10046, CG12478, CG10046, CG10046, CG12478, Dm Bru-3, cg10046, cg12478, bruno-3" CDMC25844 2 3 11 DAC17-F20 19-CG12508-RA_1 CG12508 GCGGAGCCAATGACCTCGACCTCGGCCGCGACCTCGACCTCGACTTCGATCTCCGCCACCCAGGA 65 FBan0012508 FBgn0040995 CG12508 2 2L CG12508 CG12508 CDMC25844 2 4 11 DAC17-F20 19-CG12508-RA_1 CG12508 GCGGAGCCAATGACCTCGACCTCGGCCGCGACCTCGACCTCGACTTCGATCTCCGCCACCCAGGA 65 FBan0012508 FBgn0040995 CG12508 2 2L CG12508 CG12508 CDMC25845 2 5 11 DAC17-J08 6-CG12620-RA_4 CG12620 CGGAGAGTCAACTAAGCGTGGATGATGAACATATCTCCGAGATCGCCGAAGAGGAGTGTCCGCCC 65 FBan0012620 FBgn0032626 CG12620 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG12620 CG12620 CDMC25845 2 6 11 DAC17-J08 6-CG12620-RA_4 CG12620 CGGAGAGTCAACTAAGCGTGGATGATGAACATATCTCCGAGATCGCCGAAGAGGAGTGTCCGCCC 65 FBan0012620 FBgn0032626 CG12620 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG12620 CG12620 CDMC25846 2 7 11 DAC17-J20 3-CG12654-RA_1 CG12654 ATCCCTCCGCACTATCGCTGCGATATGATCGAGGATTGTGAGGACAAATCGGATGAGGCGCAGTG 65 FBan0012654 FBgn0030131 CG12654 X X low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041 CG12654 CG12654 CDMC25846 2 8 11 DAC17-J20 3-CG12654-RA_1 CG12654 ATCCCTCCGCACTATCGCTGCGATATGATCGAGGATTGTGAGGACAAATCGGATGAGGCGCAGTG 65 FBan0012654 FBgn0030131 CG12654 X X low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041 CG12654 CG12654 CDMC25847 2 9 11 DAC17-N08 2-CG12754-RA_1 CG12754 GTGCTCCGGTATGTGTACCTCACCTGGACGCTAATGACGTTCGTGTGGTGTACAACGTACCTGCC 65 FBan0012754 FBgn0033043 Or42b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or42b Odorant receptor 42b "CG12754, 41E.1, DOR118, 42b" CDMC25847 2 10 11 DAC17-N08 2-CG12754-RA_1 CG12754 GTGCTCCGGTATGTGTACCTCACCTGGACGCTAATGACGTTCGTGTGGTGTACAACGTACCTGCC 65 FBan0012754 FBgn0033043 Or42b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or42b Odorant receptor 42b "CG12754, 41E.1, DOR118, 42b" CDMC25848 2 11 11 DAC17-N20 6-CG12799-RA_1 CG12799 CAACATCGAGAGTAGCGATGAGTCCCTGCTGATGTGGACGGGTCTTTTGGTTCCGGAAAAGGCGC 65 FBan0012799 FBgn0017456 Ubc84D 3 3R protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Ubc84D Ubiquitin conjugating enzyme 84D "CG12799, ubc" CDMC25848 2 12 11 DAC17-N20 6-CG12799-RA_1 CG12799 CAACATCGAGAGTAGCGATGAGTCCCTGCTGATGTGGACGGGTCTTTTGGTTCCGGAAAAGGCGC 65 FBan0012799 FBgn0017456 Ubc84D 3 3R protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Ubc84D Ubiquitin conjugating enzyme 84D "CG12799, ubc" CDMC25849 2 13 11 DAC18-B08 11-CG5705-RA_1 CG5705 CCAGGAGGCAATGCTATTCGCCCAAGAATTGTACGAAATGTACACCGGCTATTTCGAGCACATGGGC 67 FBan0005705 FBgn0032486 CG5705 2 2L translational termination; GO:0006415 "translation release factor activity, codon specific; GO:0016149; ; GO:0016149; ; GO:0016149" mitochondrion; GO:0005739 CG5705 CG5705 CDMC25849 2 14 11 DAC18-B08 11-CG5705-RA_1 CG5705 CCAGGAGGCAATGCTATTCGCCCAAGAATTGTACGAAATGTACACCGGCTATTTCGAGCACATGGGC 67 FBan0005705 FBgn0032486 CG5705 2 2L translational termination; GO:0006415 "translation release factor activity, codon specific; GO:0016149; ; GO:0016149; ; GO:0016149" mitochondrion; GO:0005739 CG5705 CG5705 CDMC25850 2 15 11 DAC18-B20 3-CG5892-RA_5 CG5892 GGTTTCCTGTTCGGTTACTTCCTGCATACGATCCGTGGAAAAGCGATCAAGCTGAGCCGACCTGCTG 67 FBan0005892 FBgn0038873 CG5892 3 3R "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG5892 CG5892 CDMC25850 2 16 11 DAC18-B20 3-CG5892-RA_5 CG5892 GGTTTCCTGTTCGGTTACTTCCTGCATACGATCCGTGGAAAAGCGATCAAGCTGAGCCGACCTGCTG 67 FBan0005892 FBgn0038873 CG5892 3 3R "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG5892 CG5892 CDMC25851 2 17 11 DAC18-F08 1-CG6441-RA_1 CG6441 CGATCAGGCGAAGTTGGCGAACAGACCTGAGACCGTTCTAATTGCCCAATTCCTCATCCGGGTCAAC 67 FBan0006441 FBgn0031920 CG6441 2 2L CG6441 CG6441 anon-WO0140519.45 CDMC25851 2 18 11 DAC18-F08 1-CG6441-RA_1 CG6441 CGATCAGGCGAAGTTGGCGAACAGACCTGAGACCGTTCTAATTGCCCAATTCCTCATCCGGGTCAAC 67 FBan0006441 FBgn0031920 CG6441 2 2L CG6441 CG6441 anon-WO0140519.45 CDMC25852 2 19 11 DAC18-F20 13-CG6599-RA_2 CG6599 CCCAAAGAGGGTCAAGCACCTGGGGAAAATCATGACGAGGAGGTAAAGGAACACCAAAATCCTCCAA 67 FBan0006599 FBgn0039513 CG6599 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein amino acid ADP-ribosylation; GO:0006471; protein metabolism; GO:0019538; protein modification; GO:0006464; transcription, RNA-dependent; GO:0006410" receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005057; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG6599 CG6599 CDMC25852 2 20 11 DAC18-F20 13-CG6599-RA_2 CG6599 CCCAAAGAGGGTCAAGCACCTGGGGAAAATCATGACGAGGAGGTAAAGGAACACCAAAATCCTCCAA 67 FBan0006599 FBgn0039513 CG6599 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein amino acid ADP-ribosylation; GO:0006471; protein metabolism; GO:0019538; protein modification; GO:0006464; transcription, RNA-dependent; GO:0006410" receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005057; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG6599 CG6599 CDMC25853 2 21 11 DAC18-J08 2-CG7133-RA_3 CG7133 GGGCCTTGTACGATTGCTGCTTCCAGTCCATGGACGTTGAAGCCATTATTCCCGCTGAGAACGCTAA 67 FBan0007133 FBgn0037150 CG7133 3 3L protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG7133 CG7133 CDMC25853 2 22 11 DAC18-J08 2-CG7133-RA_3 CG7133 GGGCCTTGTACGATTGCTGCTTCCAGTCCATGGACGTTGAAGCCATTATTCCCGCTGAGAACGCTAA 67 FBan0007133 FBgn0037150 CG7133 3 3L protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG7133 CG7133 CDMC25854 2 23 11 DAC18-J20 3-CG7213-RA_5 CG7213 GCATCATCCGTATGCTCGGGTCGGACGTACGACATTAAGTACTCGGTGCTGACCTTCAACGACGTGC 67 FBan0007213 FBgn0035861 CG7213 3 3L CG7213 CG7213 CDMC25854 2 24 11 DAC18-J20 3-CG7213-RA_5 CG7213 GCATCATCCGTATGCTCGGGTCGGACGTACGACATTAAGTACTCGGTGCTGACCTTCAACGACGTGC 67 FBan0007213 FBgn0035861 CG7213 3 3L CG7213 CG7213 CDMC25855 2 25 11 DAC18-N08 3-CG7829-RA_1 CG7829 CCAGCCGATATCGCCAACATTCCGTACATAGTGTCCATCCAACTGTACGGCATCCACCATTGTGGCG 67 FBan0007829 FBgn0039703 CG7829 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG7829 CG7829 SP136 CDMC25855 2 26 11 DAC18-N08 3-CG7829-RA_1 CG7829 CCAGCCGATATCGCCAACATTCCGTACATAGTGTCCATCCAACTGTACGGCATCCACCATTGTGGCG 67 FBan0007829 FBgn0039703 CG7829 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG7829 CG7829 SP136 CDMC25856 2 1 12 DAC18-N20 24-CG7960-RA_1 CG7960 TGCTATATATTACCCTCATAGCTTTAAGTAACATCTAAGTAAATCAACAATAAATATCTGAAACCCA 67 FBan0007960 FBgn0013755 Bro 3 3L eye development (sensu Endopterygota); GO:0007456; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor binding; GO:0008134; ; GO:0008134; transcription coactivator activity; GO:0003713; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003713; ; GO:0003713 core-binding factor complex; GO:0016513; nucleus; GO:0005634 Bro Brother "CG7960, Beta for Runt and OTHERs, bro, rpbeta1, runt domain partner beta1, Brother" CDMC25856 2 2 12 DAC18-N20 24-CG7960-RA_1 CG7960 TGCTATATATTACCCTCATAGCTTTAAGTAACATCTAAGTAAATCAACAATAAATATCTGAAACCCA 67 FBan0007960 FBgn0013755 Bro 3 3L eye development (sensu Endopterygota); GO:0007456; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor binding; GO:0008134; ; GO:0008134; transcription coactivator activity; GO:0003713; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003713; ; GO:0003713 core-binding factor complex; GO:0016513; nucleus; GO:0005634 Bro Brother "CG7960, Beta for Runt and OTHERs, bro, rpbeta1, runt domain partner beta1, Brother" CDMC25857 2 3 12 DAC19-B08 2-CG7838-RA_2 CG7838 CCTCCGCGGGAAAACTTTGTTCACCCCACCTCAAACGGAGATCAAACTGTTTTGAACGAAACGCTGGC 68 FBan0007838 FBgn0025458 Bub1 2 2R chromosome segregation; GO:0007059; mitotic spindle checkpoint; GO:0007094; protein amino acid phosphorylation; GO:0006468; regulation of exit from mitosis; GO:0007096 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940 Bub1 Bub1 "CG7838, CG7838, CG7838, CG7838, l(2)k03113, 31/13, bub1, dBUB1, l(2)k06109, DmBUB1, Dmbub1, BubR1, BUB1, BcDNA:LD23835" CDMC25857 2 4 12 DAC19-B08 2-CG7838-RA_2 CG7838 CCTCCGCGGGAAAACTTTGTTCACCCCACCTCAAACGGAGATCAAACTGTTTTGAACGAAACGCTGGC 68 FBan0007838 FBgn0025458 Bub1 2 2R chromosome segregation; GO:0007059; mitotic spindle checkpoint; GO:0007094; protein amino acid phosphorylation; GO:0006468; regulation of exit from mitosis; GO:0007096 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940 Bub1 Bub1 "CG7838, CG7838, CG7838, CG7838, l(2)k03113, 31/13, bub1, dBUB1, l(2)k06109, DmBUB1, Dmbub1, BubR1, BUB1, BcDNA:LD23835" CDMC25858 2 5 12 DAC19-B20 3-CG8007-RA_2 CG8007 TGCTGGGAGTGGTGTTCTTTACGTTCGTAATCCTCTGGTCGCCATTCTTCGTCCTCAATCTCCTGCCC 68 FBan0008007 FBgn0037600 CG8007 3 3R serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609 integral to membrane; GO:0016021 CG8007 CG8007 "anon-WO0170980.97, anon-WO0170980.98" CDMC25858 2 6 12 DAC19-B20 3-CG8007-RA_2 CG8007 TGCTGGGAGTGGTGTTCTTTACGTTCGTAATCCTCTGGTCGCCATTCTTCGTCCTCAATCTCCTGCCC 68 FBan0008007 FBgn0037600 CG8007 3 3R serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609 integral to membrane; GO:0016021 CG8007 CG8007 "anon-WO0170980.97, anon-WO0170980.98" CDMC25859 2 7 12 DAC19-F08 9-CG8508-RA_1 CG8508 GCATCCCGAACAAGAGGGGCATCAGACTGGTTTAGATAGAAATCCTCAAGCTAAACACGCTTGCCCGG 68 FBan0008508 FBgn0038123 CG8508 3 3R CG8508 CG8508 anon-WO0140519.216 CDMC25859 2 8 12 DAC19-F08 9-CG8508-RA_1 CG8508 GCATCCCGAACAAGAGGGGCATCAGACTGGTTTAGATAGAAATCCTCAAGCTAAACACGCTTGCCCGG 68 FBan0008508 FBgn0038123 CG8508 3 3R CG8508 CG8508 anon-WO0140519.216 CDMC25860 2 9 12 DAC19-F20 17-CG8709-RA_2 CG8709 TCGCTAGAAGTCGACGAATACTTTCCCCTGCTAACCAACCAAGATGAATTCGATTACCGGACGGACAT 68 FBan0008709 FBgn0033269 CG8709 2 2R development; GO:0007275; lipid metabolism; GO:0006629 CG8709 CG8709 anon-WO0118547.133 CDMC25860 2 10 12 DAC19-F20 17-CG8709-RA_2 CG8709 TCGCTAGAAGTCGACGAATACTTTCCCCTGCTAACCAACCAAGATGAATTCGATTACCGGACGGACAT 68 FBan0008709 FBgn0033269 CG8709 2 2R development; GO:0007275; lipid metabolism; GO:0006629 CG8709 CG8709 anon-WO0118547.133 CDMC25861 2 11 12 DAC19-J08 2-CG9121-RA_3 CG9121 AACCTTCGAAACCACCGGAGAGTTCATATCATCCCAGTGCTGTGTCTCCTGTCGCGAACATGATCCGC 68 FBan0009121 FBgn0031675 CG9121 2 2L "DNA replication; GO:0006260; cytoskeletal anchoring; GO:0007016; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; structural constituent of cytoskeleton; GO:0005200; ; GO:0016779 ; EC:2.7.7.-; ; GO:0005200 CG9121 CG9121 CDMC25861 2 12 12 DAC19-J08 2-CG9121-RA_3 CG9121 AACCTTCGAAACCACCGGAGAGTTCATATCATCCCAGTGCTGTGTCTCCTGTCGCGAACATGATCCGC 68 FBan0009121 FBgn0031675 CG9121 2 2L "DNA replication; GO:0006260; cytoskeletal anchoring; GO:0007016; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; structural constituent of cytoskeleton; GO:0005200; ; GO:0016779 ; EC:2.7.7.-; ; GO:0005200 CG9121 CG9121 CDMC25862 2 13 12 DAC19-J20 2-CG9266-RB_1 CG9266 GGTGGCCATCTTACCTGGCGCTTGATTGATTCCACCAGCCAAAAAATAAACACCTGGAACGACGCCAG 68 FBan0009266 FBgn0032909 CG9266 2 2L CG9266 CG9266 BcDNA:GM06547 CDMC25862 2 14 12 DAC19-J20 2-CG9266-RB_1 CG9266 GGTGGCCATCTTACCTGGCGCTTGATTGATTCCACCAGCCAAAAAATAAACACCTGGAACGACGCCAG 68 FBan0009266 FBgn0032909 CG9266 2 2L CG9266 CG9266 BcDNA:GM06547 CDMC25863 2 15 12 DAC19-N08 1-CG9792-RA_1 CG9792 AGTCCGAGATTCATGAGCACCGCTTTGTTCTGATGGATGGAGTGGTCGGTTTGACTTTCGATGAGCGC 68 FBan0009792 FBgn0041711 yellow-e 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e yellow-e "CG9792, yellow-e" CDMC25863 2 16 12 DAC19-N08 1-CG9792-RA_1 CG9792 AGTCCGAGATTCATGAGCACCGCTTTGTTCTGATGGATGGAGTGGTCGGTTTGACTTTCGATGAGCGC 68 FBan0009792 FBgn0041711 yellow-e 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e yellow-e "CG9792, yellow-e" CDMC25864 2 17 12 DAC19-N20 2-CG9914-RA_2 CG9914 GGCCAACTATTTCGAACGCTACTCGAACACCATCTATGCGGTTAGCGAGACAATGGGACCGACACCGA 68 FBan0009914 FBgn0030737 CG9914 X X cytoskeleton organization and biogenesis; GO:0007010; fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG9914 CG9914 Enoyl-CoA hydratase mitochondrial CDMC25864 2 18 12 DAC19-N20 2-CG9914-RA_2 CG9914 GGCCAACTATTTCGAACGCTACTCGAACACCATCTATGCGGTTAGCGAGACAATGGGACCGACACCGA 68 FBan0009914 FBgn0030737 CG9914 X X cytoskeleton organization and biogenesis; GO:0007010; fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG9914 CG9914 Enoyl-CoA hydratase mitochondrial CDMC25865 2 19 12 DAC20-B08 23-CG18030-RA_3 CG18030 ACGAATTTAGCAAATTTTAAAGAACACTCTGTCTGCAGTCATTTAGATTACGGATGAGAGACTCCAAAT 69 FBan0018030 FBgn0039778 Jon99Fi 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Fi Jonah 99Fi "CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, Jon99F, SPH181, Jonah 99F" CDMC25865 2 20 12 DAC20-B08 23-CG18030-RA_3 CG18030 ACGAATTTAGCAAATTTTAAAGAACACTCTGTCTGCAGTCATTTAGATTACGGATGAGAGACTCCAAAT 69 FBan0018030 FBgn0039778 Jon99Fi 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Fi Jonah 99Fi "CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, CG18030, Jon99F, SPH181, Jonah 99F" CDMC25866 2 21 12 DAC20-B20 23-CG18064-RA_1 CG18064 ACACTTGCCTGCCATTCTAGGAACCTTTCCAAAGTGTCCTATGCCTAAAGAAATAAAACGTTAAGGTAC 69 FBan0018064 FBgn0028415 Met75Cb 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Met75Cb Met75Cb "CG18064, bs14h01.y1" CDMC25866 2 22 12 DAC20-B20 23-CG18064-RA_1 CG18064 ACACTTGCCTGCCATTCTAGGAACCTTTCCAAAGTGTCCTATGCCTAAAGAAATAAAACGTTAAGGTAC 69 FBan0018064 FBgn0028415 Met75Cb 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Met75Cb Met75Cb "CG18064, bs14h01.y1" CDMC25867 2 23 12 DAC20-F08 10-CG18107-RA_1 CG18107 CCGTTGTCACCCGATCCAGGAAATGTTATCATCAATGGCGACTGTGTGAATTGCAATGTTCGTGGTGGC 69 FBan0018107 FBgn0034330 CG18107 2 2R CG18107 CG18107 BcDNA:RH09147 CDMC25867 2 24 12 DAC20-F08 10-CG18107-RA_1 CG18107 CCGTTGTCACCCGATCCAGGAAATGTTATCATCAATGGCGACTGTGTGAATTGCAATGTTCGTGGTGGC 69 FBan0018107 FBgn0034330 CG18107 2 2R CG18107 CG18107 BcDNA:RH09147 CDMC25868 2 25 12 DAC20-F20 11-CG18132-RA_6 CG18132 TGAGTGTGAAGGCAAGATCCGCAGATCAGTGCACTCCTGGCACGATACTTAAGCTGAGAGTGGACAATT 69 FBan0018132 FBgn0031345 CG18132 2 2L CG18132 CG18132 CDMC25868 2 26 12 DAC20-F20 11-CG18132-RA_6 CG18132 TGAGTGTGAAGGCAAGATCCGCAGATCAGTGCACTCCTGGCACGATACTTAAGCTGAGAGTGGACAATT 69 FBan0018132 FBgn0031345 CG18132 2 2L CG18132 CG18132 CDMC25869 2 1 13 DAC20-J08 2-CG18190-RA_1 CG18190 TCCAGGAAGCCTTCAATCGCTTGAAGCTGGACAAAACGGTACCAATCGATCGACTGATCAAGGGTCGCT 69 FBan0018190 FBgn0034403 CG18190 2 2R cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; receptor binding; GO:0005102; ; GO:0008017; ; GO:0005102 CG18190 CG18190 CDMC25869 2 2 13 DAC20-J08 2-CG18190-RA_1 CG18190 TCCAGGAAGCCTTCAATCGCTTGAAGCTGGACAAAACGGTACCAATCGATCGACTGATCAAGGGTCGCT 69 FBan0018190 FBgn0034403 CG18190 2 2R cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; receptor binding; GO:0005102; ; GO:0008017; ; GO:0005102 CG18190 CG18190 CDMC25870 2 3 13 DAC20-J20 23-CG18213-RA_12 CG18213 AGTCGTTGGTGTGACAGCTAAAAAAGTCCATAAAGGCGAGGAATTAGTGATATGCCCTGATTTTGCTAG 69 FBan0018213 FBgn0038470 CG18213 3 3R CG18213 CG18213 CDMC25870 2 4 13 DAC20-J20 23-CG18213-RA_12 CG18213 AGTCGTTGGTGTGACAGCTAAAAAAGTCCATAAAGGCGAGGAATTAGTGATATGCCCTGATTTTGCTAG 69 FBan0018213 FBgn0038470 CG18213 3 3R CG18213 CG18213 CDMC25871 2 5 13 DAC20-N08 24-CG18259-RA_7 CG18259 ACTAAAGCAACTAGATAATTTTTCTCATCATTTTCATCATCTCCGTAGTATTTAGTTCAACAACGTAGT 69 FBan0018259 FBgn0030956 CG18259 X X CG18259 CG18259 CDMC25871 2 6 13 DAC20-N08 24-CG18259-RA_7 CG18259 ACTAAAGCAACTAGATAATTTTTCTCATCATTTTCATCATCTCCGTAGTATTTAGTTCAACAACGTAGT 69 FBan0018259 FBgn0030956 CG18259 X X CG18259 CG18259 CDMC25872 2 7 13 DAC20-N20 23-CG1826-RA_5 CG1826 TTGTACTTGAAATACTCCTGTGGTCTGTTAGCTGTTAGTCTCCGCGCTTAGTTATATTTTGCAGACCGT 69 FBan0001826 FBgn0030228 CG1826 X X actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 CG1826 CG1826 CDMC25872 2 8 13 DAC20-N20 23-CG1826-RA_5 CG1826 TTGTACTTGAAATACTCCTGTGGTCTGTTAGCTGTTAGTCTCCGCGCTTAGTTATATTTTGCAGACCGT 69 FBan0001826 FBgn0030228 CG1826 X X actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 CG1826 CG1826 CDMC25873 2 9 13 DAC21-B08 9-CG3896-RA_3 CG3896 TGGGCCAGCGAGATACCCAAGTCTGTGATGAATCTGCGGAAGGTAGACTTCTTCTGGATCAACAGGGAT 69 FBan0003896 FBgn0034112 CG3896 2 2R defense response; GO:0006952; electron transport; GO:0006118; immune response; GO:0006955 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; calcium ion binding; GO:0005509; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005509 membrane; GO:0016020 CG3896 CG3896 CDMC25873 2 10 13 DAC21-B08 9-CG3896-RA_3 CG3896 TGGGCCAGCGAGATACCCAAGTCTGTGATGAATCTGCGGAAGGTAGACTTCTTCTGGATCAACAGGGAT 69 FBan0003896 FBgn0034112 CG3896 2 2R defense response; GO:0006952; electron transport; GO:0006118; immune response; GO:0006955 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; calcium ion binding; GO:0005509; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005509 membrane; GO:0016020 CG3896 CG3896 CDMC25874 2 11 13 DAC21-B20 8-CG3916-RA_1 CG3916 TGCAGGCTTTGAACTATCGCACCATCTCGAACGAGGATTGCAATCAAAAGGGATTTCGGGTGACTCGGA 69 FBan0003916 FBgn0038003 CG3916 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1 CG3916 CG3916 SP154 CDMC25874 2 12 13 DAC21-B20 8-CG3916-RA_1 CG3916 TGCAGGCTTTGAACTATCGCACCATCTCGAACGAGGATTGCAATCAAAAGGGATTTCGGGTGACTCGGA 69 FBan0003916 FBgn0038003 CG3916 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1 CG3916 CG3916 SP154 CDMC25875 2 13 13 DAC21-F08 10-CG3945-RA_1 CG3945 GCACGGAGGTTTGCTTTATCAACACAGACGACTCTCAACAACCTAAACCTGCGAAAAGCTCCTCCGACG 69 FBan0003945 FBgn0025807 Rad9 3 3L DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; ; GO:0019209 Rad9 Rad9 CG3945 CDMC25875 2 14 13 DAC21-F08 10-CG3945-RA_1 CG3945 GCACGGAGGTTTGCTTTATCAACACAGACGACTCTCAACAACCTAAACCTGCGAAAAGCTCCTCCGACG 69 FBan0003945 FBgn0025807 Rad9 3 3L DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; ; GO:0019209 Rad9 Rad9 CG3945 CDMC25876 2 15 13 DAC21-F20 23-CG3956-RA_1 CG3956 TTCAGCTATAGTATTCTAAGTTTAAGTTCATGTATATTGCCTCATTGTCACACGCAGCATTTTACCAAA 69 FBan0003956 FBgn0003448 sna 2 2L "Malpighian tubule morphogenesis; GO:0007443; anterior midgut invagination; GO:0007375; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm and mesoderm interaction; GO:0007499; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell fate specification; GO:0007501; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; neuroblast division; GO:0045034; regulation of transcription; GO:0045449; ventral furrow formation; GO:0007370" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; specific transcriptional repressor activity; GO:0016566; ; GO:0003702; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 sna snail "CG3956, l(2)br28, l(3)br28, br28, l35Db, l(2)35Db, BG:DS01845.1, sn, snail" CDMC25876 2 16 13 DAC21-F20 23-CG3956-RA_1 CG3956 TTCAGCTATAGTATTCTAAGTTTAAGTTCATGTATATTGCCTCATTGTCACACGCAGCATTTTACCAAA 69 FBan0003956 FBgn0003448 sna 2 2L "Malpighian tubule morphogenesis; GO:0007443; anterior midgut invagination; GO:0007375; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm and mesoderm interaction; GO:0007499; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell fate specification; GO:0007501; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; neuroblast division; GO:0045034; regulation of transcription; GO:0045449; ventral furrow formation; GO:0007370" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; specific transcriptional repressor activity; GO:0016566; ; GO:0003702; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 sna snail "CG3956, l(2)br28, l(3)br28, br28, l35Db, l(2)35Db, BG:DS01845.1, sn, snail" CDMC25877 2 17 13 DAC21-J08 3-CG3991-RD_3 CG3991 CTACAATCAGTGCATAGTGGGAGGTCGTAAATACGTCTCGAGTCCGCTAAGGCTGTCCACTCGGGTGCT 69 FBan0003991 FBgn0020370 TppII 2 2R proteolysis; GO:0006508 tripeptidyl-peptidase II activity; GO:0004294 ; EC:3.4.14.10; ; GO:0004294 ; EC:3.4.14.10; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.-; ; GO:0004294 ; EC:3.4.14.10; ; GO:0004294 ; EC:3.4.14.10 cytoplasm; GO:0005737 TppII tripeptidyl-peptidase II "CG3991, CG3991, dTPPII, dTPP II, tripeptidyl peptidase II, TPPII, TPP II, anon-WO0118547.127, l(2)k14301, tripeptidyl-peptidase II" CDMC25877 2 18 13 DAC21-J08 3-CG3991-RD_3 CG3991 CTACAATCAGTGCATAGTGGGAGGTCGTAAATACGTCTCGAGTCCGCTAAGGCTGTCCACTCGGGTGCT 69 FBan0003991 FBgn0020370 TppII 2 2R proteolysis; GO:0006508 tripeptidyl-peptidase II activity; GO:0004294 ; EC:3.4.14.10; ; GO:0004294 ; EC:3.4.14.10; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.-; ; GO:0004294 ; EC:3.4.14.10; ; GO:0004294 ; EC:3.4.14.10 cytoplasm; GO:0005737 TppII tripeptidyl-peptidase II "CG3991, CG3991, dTPPII, dTPP II, tripeptidyl peptidase II, TPPII, TPP II, anon-WO0118547.127, l(2)k14301, tripeptidyl-peptidase II" CDMC25878 2 19 13 DAC21-J20 17-CG40041-RB_2 CG40041 GGATGCCATCGTCGTGTATACACGTATAAAGTGACACAGTCCGATCTTCAAGGACACGAGTGTTGGGAC 69 CDMC25878 2 20 13 DAC21-J20 17-CG40041-RB_2 CG40041 GGATGCCATCGTCGTGTATACACGTATAAAGTGACACAGTCCGATCTTCAAGGACACGAGTGTTGGGAC 69 CDMC25879 2 21 13 DAC21-N08 10-CG40092-RA_1 CG40092 TGGGCATGATGAGATGAGATAACTAGCGTGACCAAAACGTCCGCATCTTGAACATTCGCCTTGTGGCTT 69 FBgn0058092 CG40092 CG40092 CG40092 CDMC25879 2 22 13 DAC21-N08 10-CG40092-RA_1 CG40092 TGGGCATGATGAGATGAGATAACTAGCGTGACCAAAACGTCCGCATCTTGAACATTCGCCTTGTGGCTT 69 FBgn0058092 CG40092 CG40092 CG40092 CDMC25880 2 23 13 DAC21-N20 2-CG40113-RA_1 CG40113 GGCGTTGGCGTTAAATGACATCATTCGAGGACTGTCGTATGGACTCGGTCCGAAAAGGTTTCGCTCGGA 69 FBgn0058113 CG40113 CG40113 CG40113 CDMC25880 2 24 13 DAC21-N20 2-CG40113-RA_1 CG40113 GGCGTTGGCGTTAAATGACATCATTCGAGGACTGTCGTATGGACTCGGTCCGAAAAGGTTTCGCTCGGA 69 FBgn0058113 CG40113 CG40113 CG40113 CDMC25881 2 25 13 DAC22-B08 23-CG13732-RA_1 CG13732 TCAATGTCAAGAATCTACACGAGTTCAAGAACTTCGTAAAAGCAGTTGAATCAGCAGCTGGTCAG 65 FBan0013732 FBgn0036730 CG13732 3 3L CG13732 CG13732 CDMC25881 2 26 13 DAC22-B08 23-CG13732-RA_1 CG13732 TCAATGTCAAGAATCTACACGAGTTCAAGAACTTCGTAAAAGCAGTTGAATCAGCAGCTGGTCAG 65 FBan0013732 FBgn0036730 CG13732 3 3L CG13732 CG13732 CDMC25882 2 1 14 DAC22-B20 12-CG13778-RA_1 CG13778 GGTTCGCGGTGTGGAGAAACATTCGGCCACAATTTCAGCCACCATCACTGCAATCTCTTCCAGTT 65 FBan0013778 FBgn0031885 Mnn1 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 Mnn1 Menin 1 "CG33266, CG13778, CG33266, MEN1, menin, Menin1" CDMC25882 2 2 14 DAC22-B20 12-CG13778-RA_1 CG13778 GGTTCGCGGTGTGGAGAAACATTCGGCCACAATTTCAGCCACCATCACTGCAATCTCTTCCAGTT 65 FBan0013778 FBgn0031885 Mnn1 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 Mnn1 Menin 1 "CG33266, CG13778, CG33266, MEN1, menin, Menin1" CDMC25883 2 3 14 DAC22-F08 9-CG13833-RA_1 CG13833 CGCAGCTGACGCATACCATAGGATTTGGCGACGTATATCCACTGTTCACCGGAGAGGAGGTCGCC 65 FBan0013833 FBgn0039040 CG13833 3 3R metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG13833 CG13833 CDMC25883 2 4 14 DAC22-F08 9-CG13833-RA_1 CG13833 CGCAGCTGACGCATACCATAGGATTTGGCGACGTATATCCACTGTTCACCGGAGAGGAGGTCGCC 65 FBan0013833 FBgn0039040 CG13833 3 3R metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG13833 CG13833 CDMC25884 2 5 14 DAC22-F20 19-CG1385-RA_1 CG1385 GAAGCGAGCCACATGCGACCTACTCTCCAAGTGGAACTGGAACCACACCGCCTGCGCCGGCCACT 65 FBan0001385 FBgn0010385 Def 2 2R anti-Gram-positive bacterial polypeptide induction; GO:0006965; antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742 Def Defensin "CG1385, CG1385, CG1385, CG1385, defensin, def" CDMC25884 2 6 14 DAC22-F20 19-CG1385-RA_1 CG1385 GAAGCGAGCCACATGCGACCTACTCTCCAAGTGGAACTGGAACCACACCGCCTGCGCCGGCCACT 65 FBan0001385 FBgn0010385 Def 2 2R anti-Gram-positive bacterial polypeptide induction; GO:0006965; antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742 Def Defensin "CG1385, CG1385, CG1385, CG1385, defensin, def" CDMC25885 2 7 14 DAC22-J08 3-CG13934-RA_1 CG13934 GAAATCATGACGAGGAAAGGCTCCACTACTCGCATCAGTACCACATCTCCGACGTGGCCAGTCGG 65 FBan0013934 FBgn0035279 CG13934 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG13934 CG13934 CDMC25885 2 8 14 DAC22-J08 3-CG13934-RA_1 CG13934 GAAATCATGACGAGGAAAGGCTCCACTACTCGCATCAGTACCACATCTCCGACGTGGCCAGTCGG 65 FBan0013934 FBgn0035279 CG13934 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG13934 CG13934 CDMC25886 2 9 14 DAC22-J20 6-CG13950-RA_3 CG13950 GAACGTTTGGAAAGCAAAGGTCCTAACGGAGGTCCCATTCGGACACGTCCTCATCGTCAGTGGGC 65 FBan0013950 FBgn0031289 CG13950 2 2L sugar binding; GO:0005529; ; GO:0005529 CG13950 CG13950 CDMC25886 2 10 14 DAC22-J20 6-CG13950-RA_3 CG13950 GAACGTTTGGAAAGCAAAGGTCCTAACGGAGGTCCCATTCGGACACGTCCTCATCGTCAGTGGGC 65 FBan0013950 FBgn0031289 CG13950 2 2L sugar binding; GO:0005529; ; GO:0005529 CG13950 CG13950 CDMC25887 2 11 14 DAC22-N08 23-CG14024-RA_13 CG14024 CAACGTTGGACCAATTGCTCAAGATATATCGCATCGATTTCGAGCTCTTTGACTACGACTATCGC 65 FBan0014024 FBgn0031697 CG14024 2 2L HNK-1 sulfotransferase activity; GO:0016232 ; EC:2.8.2.-; ; GO:0016232 ; EC:2.8.2.- CG14024 CG14024 CDMC25887 2 12 14 DAC22-N08 23-CG14024-RA_13 CG14024 CAACGTTGGACCAATTGCTCAAGATATATCGCATCGATTTCGAGCTCTTTGACTACGACTATCGC 65 FBan0014024 FBgn0031697 CG14024 2 2L HNK-1 sulfotransferase activity; GO:0016232 ; EC:2.8.2.-; ; GO:0016232 ; EC:2.8.2.- CG14024 CG14024 CDMC25888 2 13 14 DAC22-N20 18-CG14067-RA_2 CG14067 TTGCTTCGGTGAATAGGAAATTTCCCCAGTTCGGAAATTCCATCGATGATGAACGAGAGGCCGAG 65 FBgn0032317 CDMC25888 2 14 14 DAC22-N20 18-CG14067-RA_2 CG14067 TTGCTTCGGTGAATAGGAAATTTCCCCAGTTCGGAAATTCCATCGATGATGAACGAGAGGCCGAG 65 FBgn0032317 CDMC25889 2 15 14 DAC23-B08 17-CG4633-RA_2 CG4633 AGCGTGTGTGATAGCGTGGTCAAGGCTCGCTGTTGTGTACCAGAAAAGTGTATCACGGAGAAATT 65 FBan0004633 FBgn0028962 Aats-ala-m 3 3L alanyl-tRNA aminoacylation; GO:0006419 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7; ; GO:0003729; ; GO:0004813 ; EC:6.1.1.7 mitochondrion; GO:0005739 Aats-ala-m mitochondrial alanyl-tRNA synthetase "CG4633, CG4633, AlaS, Dm mt AlaRS" CDMC25889 2 16 14 DAC23-B08 17-CG4633-RA_2 CG4633 AGCGTGTGTGATAGCGTGGTCAAGGCTCGCTGTTGTGTACCAGAAAAGTGTATCACGGAGAAATT 65 FBan0004633 FBgn0028962 Aats-ala-m 3 3L alanyl-tRNA aminoacylation; GO:0006419 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7; ; GO:0003729; ; GO:0004813 ; EC:6.1.1.7 mitochondrion; GO:0005739 Aats-ala-m mitochondrial alanyl-tRNA synthetase "CG4633, CG4633, AlaS, Dm mt AlaRS" CDMC25890 2 17 14 DAC23-B20 24-CG4692-RA_1 CG4692 AGTAGCAGGCGTAATTTTATGTTTCATAAGAATCCGATTTAAGAATATATCTCAACCAAACCAGC 65 FBan0004692 FBgn0035032 CG4692 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG4692 CG4692 "ATP synthase, anon-EST:Posey45" CDMC25890 2 18 14 DAC23-B20 24-CG4692-RA_1 CG4692 AGTAGCAGGCGTAATTTTATGTTTCATAAGAATCCGATTTAAGAATATATCTCAACCAAACCAGC 65 FBan0004692 FBgn0035032 CG4692 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG4692 CG4692 "ATP synthase, anon-EST:Posey45" CDMC25891 2 19 14 DAC23-F08 9-CG4865-RA_1 CG4865 GAAGCAGTGCCTGGAACATCTGAACACCACCCACAAACCGCGCCTAAATCTATGCCGGCAACAAC 65 FBan0004865 FBgn0026085 CG4865 X X CG4865 CG4865 "EG0007.10, EG:EG0007.10, BcDNA:SD26403" CDMC25891 2 20 14 DAC23-F08 9-CG4865-RA_1 CG4865 GAAGCAGTGCCTGGAACATCTGAACACCACCCACAAACCGCGCCTAAATCTATGCCGGCAACAAC 65 FBan0004865 FBgn0026085 CG4865 X X CG4865 CG4865 "EG0007.10, EG:EG0007.10, BcDNA:SD26403" CDMC25892 2 21 14 DAC23-F20 23-CG4910-RA_1 CG4910 GGAAATCTTTCGGCAAAAGAACAAACAGAAAATGTTGCAAAATGAAAAGGAGATGCAGCAATTGG 65 FBan0004910 FBgn0039007 Ccap 3 3R neuropeptide signaling pathway; GO:0007218; positive regulation of heart contraction rate; GO:0045823; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Ccap Cardioacceleratory peptide "CG4910, CG4910, CCAP, DmCCAP, Crustacean Cardioactive Peptide, Cardioacceleratory peptide" CDMC25892 2 22 14 DAC23-F20 23-CG4910-RA_1 CG4910 GGAAATCTTTCGGCAAAAGAACAAACAGAAAATGTTGCAAAATGAAAAGGAGATGCAGCAATTGG 65 FBan0004910 FBgn0039007 Ccap 3 3R neuropeptide signaling pathway; GO:0007218; positive regulation of heart contraction rate; GO:0045823; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Ccap Cardioacceleratory peptide "CG4910, CG4910, CCAP, DmCCAP, Crustacean Cardioactive Peptide, Cardioacceleratory peptide" CDMC25893 2 23 14 DAC23-J08 3-CG5111-RA_2 CG5111 AACTGCCAGATGCACAGCGACGTTTGGATATTTGCGAGAGGGGCTTTGTCAAGAGCTATGGCGAG 65 FBan0005111 FBgn0039343 CG5111 3 3R CG5111 CG5111 CDMC25893 2 24 14 DAC23-J08 3-CG5111-RA_2 CG5111 AACTGCCAGATGCACAGCGACGTTTGGATATTTGCGAGAGGGGCTTTGTCAAGAGCTATGGCGAG 65 FBan0005111 FBgn0039343 CG5111 3 3R CG5111 CG5111 CDMC25894 2 25 14 DAC23-J20 23-CG5162-RA_3 CG5162 GGCGCTGGCTTCAAACAAAATCAAGTCGAAATACTCGCCGGATATCAATAAAATGAACTTCCAAC 65 FBan0005162 FBgn0030828 CG5162 X X female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipase activity; GO:0016298 ; EC:3.1.1.-; structural molecule activity; GO:0005198; ; GO:0016298 ; EC:3.1.1.-; ; GO:0005198 CG5162 CG5162 CDMC25894 2 26 14 DAC23-J20 23-CG5162-RA_3 CG5162 GGCGCTGGCTTCAAACAAAATCAAGTCGAAATACTCGCCGGATATCAATAAAATGAACTTCCAAC 65 FBan0005162 FBgn0030828 CG5162 X X female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipase activity; GO:0016298 ; EC:3.1.1.-; structural molecule activity; GO:0005198; ; GO:0016298 ; EC:3.1.1.-; ; GO:0005198 CG5162 CG5162 CDMC25895 2 1 15 DAC23-N08 23-CG5249-RA_1 CG5249 GACCAGACCAGGAAGTGATGTAATCCAAGTGCAATAAAGTTAAATAGAGTTAAGCGACAGACAGG 65 FBan0005249 FBgn0035625 Blimp-1 3 3L Blimp-1 Blimp-1 "CG5249, CG5249" CDMC25895 2 2 15 DAC23-N08 23-CG5249-RA_1 CG5249 GACCAGACCAGGAAGTGATGTAATCCAAGTGCAATAAAGTTAAATAGAGTTAAGCGACAGACAGG 65 FBan0005249 FBgn0035625 Blimp-1 3 3L Blimp-1 Blimp-1 "CG5249, CG5249" CDMC25896 2 3 15 DAC23-N20 18-CG5280-RA_4 CG5280 ATTATTAGCTTTACAGAATGAGCCGACATCGCTTCAACAACGTGCAGATCAAGGCATTGCCCGGT 65 FBan0005280 FBgn0035952 CG5280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5280 CG5280 CDMC25896 2 4 15 DAC23-N20 18-CG5280-RA_4 CG5280 ATTATTAGCTTTACAGAATGAGCCGACATCGCTTCAACAACGTGCAGATCAAGGCATTGCCCGGT 65 FBan0005280 FBgn0035952 CG5280 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5280 CG5280 CDMC25897 2 5 15 DAC24-B08 23-CG9184-RA_5 CG9184 GCGTGATGCATTGTAGTTCTTACTTATCATCGCATGCGTTCTAGTTTATAGCCCTATTCAATATCTAAT 69 FBan0009184 FBgn0035208 CG9184 3 3L CG9184 CG9184 CDMC25897 2 6 15 DAC24-B08 23-CG9184-RA_5 CG9184 GCGTGATGCATTGTAGTTCTTACTTATCATCGCATGCGTTCTAGTTTATAGCCCTATTCAATATCTAAT 69 FBan0009184 FBgn0035208 CG9184 3 3L CG9184 CG9184 CDMC25898 2 7 15 DAC24-B20 3-CG9198-RA_2 CG9198 GGTGATGCTGCTATTCTACAATGCCGTGGTCAAGGATCGCATGCATTTCCTGCCGGTTTACCTAACCCT 69 FBgn0030639 CDMC25898 2 8 15 DAC24-B20 3-CG9198-RA_2 CG9198 GGTGATGCTGCTATTCTACAATGCCGTGGTCAAGGATCGCATGCATTTCCTGCCGGTTTACCTAACCCT 69 FBgn0030639 CDMC25899 2 9 15 DAC24-F08 23-CG9239-RA_11 CG9239 TGCGAGGCCTTGCTTAAGATCGGTAAAATGTTTTGAATAGGCTTTTGGAGCAATCAGCCACAAAATCAA 69 FBan0009239 FBgn0023407 B4 2 2L circadian rhythm; GO:0007623; imaginal disc development; GO:0007444 B4 B4 "CG9239, CG9260, BG:DS07660.4, n(2)05337" CDMC25899 2 10 15 DAC24-F08 23-CG9239-RA_11 CG9239 TGCGAGGCCTTGCTTAAGATCGGTAAAATGTTTTGAATAGGCTTTTGGAGCAATCAGCCACAAAATCAA 69 FBan0009239 FBgn0023407 B4 2 2L circadian rhythm; GO:0007623; imaginal disc development; GO:0007444 B4 B4 "CG9239, CG9260, BG:DS07660.4, n(2)05337" CDMC25900 2 11 15 DAC24-F20 1-CG9246-RA_1 CG9246 CCGGAGTGATTCGACTGATACCCACCGCTCAATACTTCCCATTGCGATTCCACTGTCTGCAGACCCTAA 69 FBan0009246 FBgn0032925 CG9246 2 2L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cellular component unknown; GO:0008372 CG9246 CG9246 CDMC25900 2 12 15 DAC24-F20 1-CG9246-RA_1 CG9246 CCGGAGTGATTCGACTGATACCCACCGCTCAATACTTCCCATTGCGATTCCACTGTCTGCAGACCCTAA 69 FBan0009246 FBgn0032925 CG9246 2 2L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cellular component unknown; GO:0008372 CG9246 CG9246 CDMC25901 2 13 15 DAC24-J08 3-CG9287-RA_1 CG9287 GGGCGGTTGTCCCAAAAATGCCGGATCCCGAGTGCTCAACGAGATTGTTGACAATGACTTTGAGGGAAA 69 FBan0009287 FBgn0032057 CG9287 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9287 CG9287 CDMC25901 2 14 15 DAC24-J08 3-CG9287-RA_1 CG9287 GGGCGGTTGTCCCAAAAATGCCGGATCCCGAGTGCTCAACGAGATTGTTGACAATGACTTTGAGGGAAA 69 FBan0009287 FBgn0032057 CG9287 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9287 CG9287 CDMC25902 2 15 15 DAC24-J20 16-CG9297-RB_1 CG9297 ACAAAGCATAACCCTAAAATCCGACCCCTCATTGGCTAATAGCAGCGTATAATTCCCATGTTCCCGGTT 69 FBan0009297 FBgn0038181 CG9297 3 3R calcium ion transport; GO:0006816 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG9297 CG9297 CDMC25902 2 16 15 DAC24-J20 16-CG9297-RB_1 CG9297 ACAAAGCATAACCCTAAAATCCGACCCCTCATTGGCTAATAGCAGCGTATAATTCCCATGTTCCCGGTT 69 FBan0009297 FBgn0038181 CG9297 3 3R calcium ion transport; GO:0006816 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG9297 CG9297 CDMC25903 2 17 15 DAC24-N08 23-CG9325-RF_11 CG9325 AATGCAATTCACACAACAATTTGTATGATAAACGAGAATGAGGTTTGCAGGTGTACACGCAATATCCGA 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC25903 2 18 15 DAC24-N08 23-CG9325-RF_11 CG9325 AATGCAATTCACACAACAATTTGTATGATAAACGAGAATGAGGTTTGCAGGTGTACACGCAATATCCGA 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC25904 2 19 15 DAC24-N20 15-CG9335-RA_1 CG9335 CGGGCCTCATCCAACAGTTTGCCATCTAAGCAAAAGATCCCCAGGTCGATTTTCAGTTGGAACGTGATA 69 FBan0009335 FBgn0032895 CG9335 2 2L CG9335 CG9335 BcDNA:LD40063 CDMC25904 2 20 15 DAC24-N20 15-CG9335-RA_1 CG9335 CGGGCCTCATCCAACAGTTTGCCATCTAAGCAAAAGATCCCCAGGTCGATTTTCAGTTGGAACGTGATA 69 FBan0009335 FBgn0032895 CG9335 2 2L CG9335 CG9335 BcDNA:LD40063 CDMC25905 2 21 15 DAC25-B08 14-CG1056-RA_1 CG1056 ACGAGGAGCACCATCCAGCGTCTGGGATGCATCAAATTTATATCGACGTATCGGCAGAAACAAAACGGA 69 FBan0001056 FBgn0013743 5-HT2 3 3R germ-band extension; GO:0007377; serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT2 receptor activity; GO:0001587; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001587 integral to membrane; GO:0016021; plasma membrane; GO:0005886 5-HT2 Serotonin receptor 2 "CG1056, 5HT-dro[[1]], 5-HT2Dro, 5-HT[[2]], 5HT2Dro, 5-ht2Dro, 5HT[[2Dro]], 5-HT[[2Dro]], 5HT2-Dro, Dm5HT2, 5HT-R82A" CDMC25905 2 22 15 DAC25-B08 14-CG1056-RA_1 CG1056 ACGAGGAGCACCATCCAGCGTCTGGGATGCATCAAATTTATATCGACGTATCGGCAGAAACAAAACGGA 69 FBan0001056 FBgn0013743 5-HT2 3 3R germ-band extension; GO:0007377; serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT2 receptor activity; GO:0001587; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001587 integral to membrane; GO:0016021; plasma membrane; GO:0005886 5-HT2 Serotonin receptor 2 "CG1056, 5HT-dro[[1]], 5-HT2Dro, 5-HT[[2]], 5HT2Dro, 5-ht2Dro, 5HT[[2Dro]], 5-HT[[2Dro]], 5HT2-Dro, Dm5HT2, 5HT-R82A" CDMC25906 2 23 15 DAC25-B20 16-CG10579-RB_1 CG10579 TCCTCTCTGTGGATGGCGTACGTTTCTACTGTTAGGATCCAAATCACCCAATCAACATCCTCCTGGACT 69 FBan0010579 FBgn0005640 Eip63E 3 3L embryonic development (sensu Insecta); GO:0001700; larval development (sensu Insecta); GO:0002168; metamorphosis (sensu Insecta); GO:0046698; mitosis; GO:0007067; morphogenesis of an epithelium; GO:0002009; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; cyclin binding; GO:0030332; ; GO:0004713 ; EC:2.7.1.112; ; GO:0030332; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- Eip63E Ecdysone-induced protein 63E "CG10579, CG10579, PFTAIRE, L63, Pftaire, cdc2-63E" CDMC25906 2 24 15 DAC25-B20 16-CG10579-RB_1 CG10579 TCCTCTCTGTGGATGGCGTACGTTTCTACTGTTAGGATCCAAATCACCCAATCAACATCCTCCTGGACT 69 FBan0010579 FBgn0005640 Eip63E 3 3L embryonic development (sensu Insecta); GO:0001700; larval development (sensu Insecta); GO:0002168; metamorphosis (sensu Insecta); GO:0046698; mitosis; GO:0007067; morphogenesis of an epithelium; GO:0002009; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; cyclin binding; GO:0030332; ; GO:0004713 ; EC:2.7.1.112; ; GO:0030332; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- Eip63E Ecdysone-induced protein 63E "CG10579, CG10579, PFTAIRE, L63, Pftaire, cdc2-63E" CDMC25907 2 25 15 DAC25-F08 23-CG10605-RA_7 CG10605 GCTACCGCATAAGATCTTTAGGAAACATCACGTTGTATTAGTGCTAGTATCCTGTGAATTTCCAGGAGC 69 FBan0010605 FBgn0015919 caup 3 3L compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; equator specification; GO:0045317; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 caup caupolican "CG10605, CG10605, iro, iroquois, Iroquois, Iro-C, IRO-C, iroquois-complex, iro-C, Iroquis complex, Iro, iroquois gene complex, caupolican" CDMC25907 2 26 15 DAC25-F08 23-CG10605-RA_7 CG10605 GCTACCGCATAAGATCTTTAGGAAACATCACGTTGTATTAGTGCTAGTATCCTGTGAATTTCCAGGAGC 69 FBan0010605 FBgn0015919 caup 3 3L compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; equator specification; GO:0045317; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 caup caupolican "CG10605, CG10605, iro, iroquois, Iroquois, Iro-C, IRO-C, iroquois-complex, iro-C, Iroquis complex, Iro, iroquois gene complex, caupolican" CDMC25908 2 1 16 DAC25-F20 12-CG10621-RA_1 CG10621 TGGTGCCGATATCATTTTGACCAACACCTACCAGTCCAGTGTCGATGGTTACATGGAGTACCTGGAGCT 69 FBan0010621 FBgn0032726 CG10621 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10621 CG10621 "selenocysteine methyltransferase, anon-WO0140519.13, BEST:LD26123" CDMC25908 2 2 16 DAC25-F20 12-CG10621-RA_1 CG10621 TGGTGCCGATATCATTTTGACCAACACCTACCAGTCCAGTGTCGATGGTTACATGGAGTACCTGGAGCT 69 FBan0010621 FBgn0032726 CG10621 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10621 CG10621 "selenocysteine methyltransferase, anon-WO0140519.13, BEST:LD26123" CDMC25909 2 3 16 DAC25-J08 2-CG10645-RB_1 CG10645 GCATCAGCGATTTCCATGCCTTTGCGGGTCCAGTCTTTCTGAGATTCCAACATACTCAGCCCAGGACTC 69 FBan0010645 FBgn0016031 lama 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 lama lamina ancestor CG10645 CDMC25909 2 4 16 DAC25-J08 2-CG10645-RB_1 CG10645 GCATCAGCGATTTCCATGCCTTTGCGGGTCCAGTCTTTCTGAGATTCCAACATACTCAGCCCAGGACTC 69 FBan0010645 FBgn0016031 lama 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 lama lamina ancestor CG10645 CDMC25910 2 5 16 DAC25-J20 2-CG10655-RA_1 CG10655 TGGATGGTCAGTTCAGAACCATCGACCTCTCTCGTCTGAGCTTCGACCGGCTGATTGTTGACCAACCTA 69 FBan0010655 FBgn0002021 l(2)37Bb 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- l(2)37Bb lethal (2) 37Bb "CG10655, CG10655, CG10655, l(2)E58, Bb, l(2)35B2" CDMC25910 2 6 16 DAC25-J20 2-CG10655-RA_1 CG10655 TGGATGGTCAGTTCAGAACCATCGACCTCTCTCGTCTGAGCTTCGACCGGCTGATTGTTGACCAACCTA 69 FBan0010655 FBgn0002021 l(2)37Bb 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- l(2)37Bb lethal (2) 37Bb "CG10655, CG10655, CG10655, l(2)E58, Bb, l(2)35B2" CDMC25911 2 7 16 DAC25-N08 7-CG10686-RA_1 CG10686 GCCTGAGGAGGATGATGTTGCTGTGTGCTACGACAAGACCAAATCGTTCTTCGACAACATCTCGTGCGA 69 FBgn0045828 CDMC25911 2 8 16 DAC25-N08 7-CG10686-RA_1 CG10686 GCCTGAGGAGGATGATGTTGCTGTGTGCTACGACAAGACCAAATCGTTCTTCGACAACATCTCGTGCGA 69 FBgn0045828 CDMC25912 2 9 16 DAC25-N20 3-CG10695-RA_1 CG10695 GCCTGCGTCTGTTTGGGAACTCATACTCTGGCCTGGAGTACGATTATTTGGGTCTGTGCCACGTCTACG 69 FBan0010695 FBgn0029878 Pat1 X X microtubule-based movement; GO:0007018 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Pat1 Pat1 "CG10695, CG10695, PAT1" CDMC25912 2 10 16 DAC25-N20 3-CG10695-RA_1 CG10695 GCCTGCGTCTGTTTGGGAACTCATACTCTGGCCTGGAGTACGATTATTTGGGTCTGTGCCACGTCTACG 69 FBan0010695 FBgn0029878 Pat1 X X microtubule-based movement; GO:0007018 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Pat1 Pat1 "CG10695, CG10695, PAT1" CDMC25913 2 11 16 DAC26-B08 2-CG8026-RB_1 CG8026 TAACCGCATTGTGTTTGGTTCTCTTTGCAGGTTTGAGGGCTACAGAGGCTTCTACAAGGGGCTGAAGGC 69 FBan0008026 FBgn0033391 CG8026 2 2R folic acid transport; GO:0015884; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; folic acid transporter activity; GO:0008517; ; GO:0008517 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8026 CG8026 "anon-WO0242455.53, anon-WO0242455.6, anon-WO0242455.7" CDMC25913 2 12 16 DAC26-B08 2-CG8026-RB_1 CG8026 TAACCGCATTGTGTTTGGTTCTCTTTGCAGGTTTGAGGGCTACAGAGGCTTCTACAAGGGGCTGAAGGC 69 FBan0008026 FBgn0033391 CG8026 2 2R folic acid transport; GO:0015884; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; folic acid transporter activity; GO:0008517; ; GO:0008517 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8026 CG8026 "anon-WO0242455.53, anon-WO0242455.6, anon-WO0242455.7" CDMC25914 2 13 16 DAC26-B20 23-CG8042-RA_2 CG8042 GCAATAGAATAACGCAATTCCTTTACAGTAATCTGTTTGACGACAGTCTATAGCTATCGAACTATGCAA 69 FBan0008042 FBgn0027554 CG8042 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG8042 CG8042 "anon-WO0140519.245, anon-WO0172774.24, BcDNA:GH10229" CDMC25914 2 14 16 DAC26-B20 23-CG8042-RA_2 CG8042 GCAATAGAATAACGCAATTCCTTTACAGTAATCTGTTTGACGACAGTCTATAGCTATCGAACTATGCAA 69 FBan0008042 FBgn0027554 CG8042 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG8042 CG8042 "anon-WO0140519.245, anon-WO0172774.24, BcDNA:GH10229" CDMC25915 2 15 16 DAC26-F08 23-CG8075-RA_19 CG8075 AGAAACAATGCTCAAAAGCCCAGTGTATCATCCTAAACCGACGCGAACATATCACACCCTTTGATAAGC 69 FBan0008075 FBgn0015838 Vang 2 2R establishment and/or maintenance of cell polarity; GO:0007163; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736 integral to membrane; GO:0016021 Vang Van Gogh "CG8075, stb, strabismus, stbm, Strabismus, Stbm, vang/stbm, Vang/Stbm, stbm/vang, Vang-gogh, vangogh/strabismus, strabismus/Van Gogh, Van Gogh" CDMC25915 2 16 16 DAC26-F08 23-CG8075-RA_19 CG8075 AGAAACAATGCTCAAAAGCCCAGTGTATCATCCTAAACCGACGCGAACATATCACACCCTTTGATAAGC 69 FBan0008075 FBgn0015838 Vang 2 2R establishment and/or maintenance of cell polarity; GO:0007163; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736 integral to membrane; GO:0016021 Vang Van Gogh "CG8075, stb, strabismus, stbm, Strabismus, Stbm, vang/stbm, Vang/Stbm, stbm/vang, Vang-gogh, vangogh/strabismus, strabismus/Van Gogh, Van Gogh" CDMC25916 2 17 16 DAC26-F20 3-CG8086-RB_3 CG8086 GCCAACGGCCGGTCGCGTTGAAAACCTTCCAGATACCAGCTCCTAATGTCTACAAAATACCGACCGTCA 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC25916 2 18 16 DAC26-F20 3-CG8086-RB_3 CG8086 GCCAACGGCCGGTCGCGTTGAAAACCTTCCAGATACCAGCTCCTAATGTCTACAAAATACCGACCGTCA 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC25917 2 19 16 DAC26-J08 17-CG8121-RA_1 CG8121 CCATCCACCAGTTTAGTGCCTTAGAGATGCGCCTCTCGAATACCACAAATTTTAACCGCGAATCAGCGT 69 FBan0008121 FBgn0037680 CG8121 3 3R CG8121 CG8121 CDMC25917 2 20 16 DAC26-J08 17-CG8121-RA_1 CG8121 CCATCCACCAGTTTAGTGCCTTAGAGATGCGCCTCTCGAATACCACAAATTTTAACCGCGAATCAGCGT 69 FBan0008121 FBgn0037680 CG8121 3 3R CG8121 CG8121 CDMC25918 2 21 16 DAC26-J20 23-CG8134-RA_2 CG8134 GTGCCTACACGCATAAAAATTGAATTAAATTAACAAACGAATGACCAGGTGAATGCAGCAATAAACAGA 69 FBan0008134 FBgn0030671 CG8134 X X CG8134 CG8134 CDMC25918 2 22 16 DAC26-J20 23-CG8134-RA_2 CG8134 GTGCCTACACGCATAAAAATTGAATTAAATTAACAAACGAATGACCAGGTGAATGCAGCAATAAACAGA 69 FBan0008134 FBgn0030671 CG8134 X X CG8134 CG8134 CDMC25919 2 23 16 DAC26-N08 15-CG8177-RG_2 CG8177 AAATATCCTTCCCACGGAAAGGAGCGTCACACAATGATTGCATCACACGCAAAAGAAACCAACGAGCGG 69 FBan0008177 FBgn0036043 CG8177 3 3L anion transport; GO:0006820; cell homeostasis; GO:0019725; cytoskeleton organization and biogenesis; GO:0007010; ion transport; GO:0006811 anion exchanger activity; GO:0015380; inorganic anion exchanger activity; GO:0005452; ; GO:0005452; ; GO:0015380 membrane; GO:0016020 CG8177 CG8177 "BcDNA:RE59468, anon-EST:Posey259" CDMC25919 2 24 16 DAC26-N08 15-CG8177-RG_2 CG8177 AAATATCCTTCCCACGGAAAGGAGCGTCACACAATGATTGCATCACACGCAAAAGAAACCAACGAGCGG 69 FBan0008177 FBgn0036043 CG8177 3 3L anion transport; GO:0006820; cell homeostasis; GO:0019725; cytoskeleton organization and biogenesis; GO:0007010; ion transport; GO:0006811 anion exchanger activity; GO:0015380; inorganic anion exchanger activity; GO:0005452; ; GO:0005452; ; GO:0015380 membrane; GO:0016020 CG8177 CG8177 "BcDNA:RE59468, anon-EST:Posey259" CDMC25920 2 25 16 DAC26-N20 17-CG8183-RB_4 CG8183 ACCCAAAAACGAAACTGAAACTGAAATCCAACAGAAAACAGTTGGGGACGTGTCAAAGGTCAAGCCCAA 69 FBan0008183 FBgn0019968 Khc-73 2 2R exocytosis; GO:0006887; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 microtubule binding; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0008017; ; GO:0003777 kinesin complex; GO:0005871 Khc-73 Kinesin-73 "CG8183, CG8183, kinesin-73, DmKIN73, DmKlp73, anon-EST:fe3C9, anon-fast-evolving-3C9, Kinesin-73" CDMC25920 2 26 16 DAC26-N20 17-CG8183-RB_4 CG8183 ACCCAAAAACGAAACTGAAACTGAAATCCAACAGAAAACAGTTGGGGACGTGTCAAAGGTCAAGCCCAA 69 FBan0008183 FBgn0019968 Khc-73 2 2R exocytosis; GO:0006887; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 microtubule binding; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0008017; ; GO:0003777 kinesin complex; GO:0005871 Khc-73 Kinesin-73 "CG8183, CG8183, kinesin-73, DmKIN73, DmKlp73, anon-EST:fe3C9, anon-fast-evolving-3C9, Kinesin-73" CDMC25921 2 1 17 DAC27-B08 6-CG8417-RA_2 CG8417 AGCCGAAGATATCAGGGACTACATCGATGAGTTCCAGCCGCTGAGTAAACTCATTGGCAAGGAGGCTGT 69 FBan0008417 FBgn0037744 CG8417 3 3R monosaccharide metabolism; GO:0005996 mannose-6-phosphate isomerase activity; GO:0004476 ; EC:5.3.1.8; zinc ion binding; GO:0008270; ; GO:0004476 ; EC:5.3.1.8; ; GO:0008270 CG8417 CG8417 CDMC25921 2 2 17 DAC27-B08 6-CG8417-RA_2 CG8417 AGCCGAAGATATCAGGGACTACATCGATGAGTTCCAGCCGCTGAGTAAACTCATTGGCAAGGAGGCTGT 69 FBan0008417 FBgn0037744 CG8417 3 3R monosaccharide metabolism; GO:0005996 mannose-6-phosphate isomerase activity; GO:0004476 ; EC:5.3.1.8; zinc ion binding; GO:0008270; ; GO:0004476 ; EC:5.3.1.8; ; GO:0008270 CG8417 CG8417 CDMC25922 2 3 17 DAC27-B20 10-CG8426-RA_1 CG8426 ACAACGGAACTTCAACTGGTAGTGGTCTCATGAATGTAGCAAACGCTACTGGTCAGCCTATCAGCGGCA 69 FBan0008426 FBgn0033029 l(2)NC136 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 l(2)NC136 lethal (2) NC136 "CG8426, NOT3/5" CDMC25922 2 4 17 DAC27-B20 10-CG8426-RA_1 CG8426 ACAACGGAACTTCAACTGGTAGTGGTCTCATGAATGTAGCAAACGCTACTGGTCAGCCTATCAGCGGCA 69 FBan0008426 FBgn0033029 l(2)NC136 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 l(2)NC136 lethal (2) NC136 "CG8426, NOT3/5" CDMC25923 2 5 17 DAC27-F08 11-CG8472-RA_1 CG8472 GCAACGGCACAATTGACTTCCCTGAATTCCTTACCATGATGGCACGCAAAATGAAGGACACCGATAGCG 69 FBan0008472 FBgn0000253 Cam 2 2R adaptation of rhodopsin mediated signaling; GO:0016062; deactivation of rhodopsin mediated signaling; GO:0016059; detection of calcium ion; GO:0005513; metarhodopsin inactivation; GO:0016060; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of light-activated channel activity; GO:0016061; rhodopsin mediated signaling; GO:0016056 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 cytoplasm; GO:0005737; rhabdomere; GO:0016028 Cam Calmodulin "CG8472, CG8472, CaM, D-CaM, 3909, CAM, cam, calmodulin, l(2)3909, dCaM, DmCalm, Cal, Cal49A, l(2)03909, anon-EST:Posey59" CDMC25923 2 6 17 DAC27-F08 11-CG8472-RA_1 CG8472 GCAACGGCACAATTGACTTCCCTGAATTCCTTACCATGATGGCACGCAAAATGAAGGACACCGATAGCG 69 FBan0008472 FBgn0000253 Cam 2 2R adaptation of rhodopsin mediated signaling; GO:0016062; deactivation of rhodopsin mediated signaling; GO:0016059; detection of calcium ion; GO:0005513; metarhodopsin inactivation; GO:0016060; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of light-activated channel activity; GO:0016061; rhodopsin mediated signaling; GO:0016056 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 cytoplasm; GO:0005737; rhabdomere; GO:0016028 Cam Calmodulin "CG8472, CG8472, CaM, D-CaM, 3909, CAM, cam, calmodulin, l(2)3909, dCaM, DmCalm, Cal, Cal49A, l(2)03909, anon-EST:Posey59" CDMC25924 2 7 17 DAC27-F20 9-CG8485-RB_1 CG8485 ACAGATAGCTAATAGCGGAGTGCCAAGCCATTCACGTACAAAGATTGTCGTCTCGGTGGATGCAACGCT 69 FBan0008485 FBgn0033915 CG8485 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0016909 ; EC:2.7.1.- CG8485 CG8485 SNRK CDMC25924 2 8 17 DAC27-F20 9-CG8485-RB_1 CG8485 ACAGATAGCTAATAGCGGAGTGCCAAGCCATTCACGTACAAAGATTGTCGTCTCGGTGGATGCAACGCT 69 FBan0008485 FBgn0033915 CG8485 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0016909 ; EC:2.7.1.- CG8485 CG8485 SNRK CDMC25925 2 9 17 DAC27-J08 12-CG8523-RA_1 CG8523 GCCCGTTCCCTGATGTTCTTTGCCTATGCTGCTTGCATGTATTATGGAACATGGTGTGTGATTCACCGC 69 FBan0008523 FBgn0010241 Mdr50 2 2R defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0015239; ; GO:0042623" integral to membrane; GO:0016021 Mdr50 Multi drug resistance 50 "CG8523, CG8523, Multi drug resistance 50, Dm2, Dm3, MDR50" CDMC25925 2 10 17 DAC27-J08 12-CG8523-RA_1 CG8523 GCCCGTTCCCTGATGTTCTTTGCCTATGCTGCTTGCATGTATTATGGAACATGGTGTGTGATTCACCGC 69 FBan0008523 FBgn0010241 Mdr50 2 2R defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0015239; ; GO:0042623" integral to membrane; GO:0016021 Mdr50 Multi drug resistance 50 "CG8523, CG8523, Multi drug resistance 50, Dm2, Dm3, MDR50" CDMC25926 2 11 17 DAC27-J20 1-CG8538-RA_1 CG8538 GCCAGCTCAGTCTCAGCCTCAAGAAGACGATGAATGGTCGGACTTTGTCTCTGTTCCAGTCACCCAACA 69 FBan0008538 FBgn0038223 CG8538 3 3R CG8538 CG8538 CDMC25926 2 12 17 DAC27-J20 1-CG8538-RA_1 CG8538 GCCAGCTCAGTCTCAGCCTCAAGAAGACGATGAATGGTCGGACTTTGTCTCTGTTCCAGTCACCCAACA 69 FBan0008538 FBgn0038223 CG8538 3 3R CG8538 CG8538 CDMC25927 2 13 17 DAC27-N08 14-CG8568-RA_5 CG8568 AGCCAGAGATTCAACAGCCTTCAGAAAATACACTGGATGAAGATGAACCGATGGGCTATCAACCCCCGA 69 FBan0008568 FBgn0030841 CG8568 X X CG8568 CG8568 CDMC25927 2 14 17 DAC27-N08 14-CG8568-RA_5 CG8568 AGCCAGAGATTCAACAGCCTTCAGAAAATACACTGGATGAAGATGAACCGATGGGCTATCAACCCCCGA 69 FBan0008568 FBgn0030841 CG8568 X X CG8568 CG8568 CDMC25928 2 15 17 DAC27-N20 23-CG8581-RA_20 CG8581 AGAAATTAGGCGAACAGTAGCGTCTATTGTGCAGGATCGGTTCTGTCTCTAAACTGTCACACGACATTT 69 FBan0008581 FBgn0011592 fra 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; proteolysis; GO:0006508; signal transduction; GO:0007165 netrin receptor activity; GO:0005042; ; GO:0005042; ; GO:0005042; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 plasma membrane; GO:0005886 fra frazzled "CG8581, CT24981, frazzled" CDMC25928 2 16 17 DAC27-N20 23-CG8581-RA_20 CG8581 AGAAATTAGGCGAACAGTAGCGTCTATTGTGCAGGATCGGTTCTGTCTCTAAACTGTCACACGACATTT 69 FBan0008581 FBgn0011592 fra 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; proteolysis; GO:0006508; signal transduction; GO:0007165 netrin receptor activity; GO:0005042; ; GO:0005042; ; GO:0005042; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 plasma membrane; GO:0005886 fra frazzled "CG8581, CT24981, frazzled" CDMC25929 2 17 17 DAC28-B08 22-CG30338-RA_1 CG30338 AACCCGCTACTAGCCTTCTATCCCATTTGGAGTATGTGGTCAAATTGACTCTACCAGGCAAACAGTGCG 69 FBan0030338 FBgn0050338 CG30338 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30338 CG30338 CDMC25929 2 18 17 DAC28-B08 22-CG30338-RA_1 CG30338 AACCCGCTACTAGCCTTCTATCCCATTTGGAGTATGTGGTCAAATTGACTCTACCAGGCAAACAGTGCG 69 FBan0030338 FBgn0050338 CG30338 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30338 CG30338 CDMC25930 2 19 17 DAC28-B20 12-CG30353-RA_1 CG30353 TGCTTTGCGGAAGTGCCTGTTGCATATCTATAGCAAACTGGGTTGCATAAACAAGCAGCAGGAAGTGCA 69 FBan0030353 FBgn0050353 CG30353 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30353 CG30353 CDMC25930 2 20 17 DAC28-B20 12-CG30353-RA_1 CG30353 TGCTTTGCGGAAGTGCCTGTTGCATATCTATAGCAAACTGGGTTGCATAAACAAGCAGCAGGAAGTGCA 69 FBan0030353 FBgn0050353 CG30353 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30353 CG30353 CDMC25931 2 21 17 DAC28-F08 9-CG30383-RA_4 CG30383 TGCCAATATCGGCCGTATTGCTCGATCTACGCTTTTGCACGATGCTGAACAATCGATCCACAGGGAGTT 69 FBan0030383 FBgn0050383 CG30383 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30383 CG30383 CDMC25931 2 22 17 DAC28-F08 9-CG30383-RA_4 CG30383 TGCCAATATCGGCCGTATTGCTCGATCTACGCTTTTGCACGATGCTGAACAATCGATCCACAGGGAGTT 69 FBan0030383 FBgn0050383 CG30383 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30383 CG30383 CDMC25932 2 23 17 DAC28-F20 3-CG30393-RA_4 CG30393 CCGAGAGTGATGCCGAGTTTGCGATCTTGAATCTGGATTGCAACGAAGGTTTGGAGAGCTCGGTGACCA 69 FBan0030393 FBgn0050393 CG30393 2 2R CG30393 CG30393 "CG15662, CG15662, CG15662" CDMC25932 2 24 17 DAC28-F20 3-CG30393-RA_4 CG30393 CCGAGAGTGATGCCGAGTTTGCGATCTTGAATCTGGATTGCAACGAAGGTTTGGAGAGCTCGGTGACCA 69 FBan0030393 FBgn0050393 CG30393 2 2R CG30393 CG30393 "CG15662, CG15662, CG15662" CDMC25933 2 25 17 DAC28-J08 13-CG30437-RA_1 CG30437 CCCAATTTGTCACATCCTTTCCATTTGCACGGTTACGGGTTCAGTGTCATTGGTATTGGCCGTTCTCCT 69 FBan0030437 FBgn0050437 CG30437 2 2R defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507 CG30437 CG30437 "CG10408, CG10398, CG10408" CDMC25933 2 26 17 DAC28-J08 13-CG30437-RA_1 CG30437 CCCAATTTGTCACATCCTTTCCATTTGCACGGTTACGGGTTCAGTGTCATTGGTATTGGCCGTTCTCCT 69 FBan0030437 FBgn0050437 CG30437 2 2R defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507 CG30437 CG30437 "CG10408, CG10398, CG10408" CDMC25934 2 1 18 DAC28-J20 15-CG30447-RA_1 CG30447 AGCGACGCCACTAGTAGCGACTTACGTAACGAGTCAGCACATCCAACATTCTCTGGGACTAAGCAACTT 69 FBan0030447 FBgn0050447 CG30447 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30447 CG30447 CDMC25934 2 2 18 DAC28-J20 15-CG30447-RA_1 CG30447 AGCGACGCCACTAGTAGCGACTTACGTAACGAGTCAGCACATCCAACATTCTCTGGGACTAAGCAACTT 69 FBan0030447 FBgn0050447 CG30447 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30447 CG30447 CDMC25935 2 3 18 DAC28-N08 2-CG30485-RA_1 CG30485 TGCACAGATTACTTGCTCACCTCACGGCCAACTGAGTCACAAAATCCGGGCATACGTCGAGGATTGGTT 69 FBan0030485 FBgn0050485 CG30485 2 2R CG30485 CG30485 "CG13342, CG13342" CDMC25935 2 4 18 DAC28-N08 2-CG30485-RA_1 CG30485 TGCACAGATTACTTGCTCACCTCACGGCCAACTGAGTCACAAAATCCGGGCATACGTCGAGGATTGGTT 69 FBan0030485 FBgn0050485 CG30485 2 2R CG30485 CG30485 "CG13342, CG13342" CDMC25936 2 5 18 DAC28-N20 13-CG30492-RC_1 CG30492 AGCGATGAATCCGATACGGTTCGCATTTACGACTTTAACAAGCAGGAAACGACGGTTATCAGGGCTGCT 69 FBan0030492 FBgn0050492 CG30492 2 2R CG30492 CG30492 "CG2088, CG17983, CG17984, CG2080, CG2088, BcDNA:HL07907" CDMC25936 2 6 18 DAC28-N20 13-CG30492-RC_1 CG30492 AGCGATGAATCCGATACGGTTCGCATTTACGACTTTAACAAGCAGGAAACGACGGTTATCAGGGCTGCT 69 FBan0030492 FBgn0050492 CG30492 2 2R CG30492 CG30492 "CG2088, CG17983, CG17984, CG2080, CG2088, BcDNA:HL07907" CDMC25937 2 7 18 DAC29-B08 23-CG9968-RA_5 CG9968 ACGAAGCCAGACAATTATGATCCACAACGTAGACTATAAGTGCACACAAATAATACCTGAACGGGATCA 69 FBan0009968 FBgn0030749 Anxb11 X X cell adhesion; GO:0007155; lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819; proteolysis; GO:0006508; regulation of cell shape; GO:0008360 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; ; GO:0005544; calcium ion binding; GO:0005509; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0005509; ; GO:0008237; ; GO:0008270 Anxb11 Annexin B11 "CG9968, CG9968, BcDNA:GH16395, Annexin B11" CDMC25937 2 8 18 DAC29-B08 23-CG9968-RA_5 CG9968 ACGAAGCCAGACAATTATGATCCACAACGTAGACTATAAGTGCACACAAATAATACCTGAACGGGATCA 69 FBan0009968 FBgn0030749 Anxb11 X X cell adhesion; GO:0007155; lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819; proteolysis; GO:0006508; regulation of cell shape; GO:0008360 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; ; GO:0005544; calcium ion binding; GO:0005509; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0005509; ; GO:0008237; ; GO:0008270 Anxb11 Annexin B11 "CG9968, CG9968, BcDNA:GH16395, Annexin B11" CDMC25938 2 9 18 DAC29-B20 12-CG9986-RA_2 CG9986 ACGCATGTTATTTTTCACCTGATTTCGGACGAACCCATCAACAGTCCCAGTGAGATCAACTCGCGGCAT 69 FBan0009986 FBgn0039589 CG9986 3 3R CG9986 CG9986 CDMC25938 2 10 18 DAC29-B20 12-CG9986-RA_2 CG9986 ACGCATGTTATTTTTCACCTGATTTCGGACGAACCCATCAACAGTCCCAGTGAGATCAACTCGCGGCAT 69 FBan0009986 FBgn0039589 CG9986 3 3R CG9986 CG9986 CDMC25939 2 11 18 DAC29-F08 9-CR30068-RA_1 CR30068 TGTGCGCTGGACTTGTATTAGTTAATGCCAAAAATCGAAGCGGAAGTTGCACCCATACCTGCACACCCA 69 FBan0030068 FBgn0047303 CR30068 2 2R CR30068 CR30068 BcDNA:GH25778 CDMC25939 2 12 18 DAC29-F08 9-CR30068-RA_1 CR30068 TGTGCGCTGGACTTGTATTAGTTAATGCCAAAAATCGAAGCGGAAGTTGCACCCATACCTGCACACCCA 69 FBan0030068 FBgn0047303 CR30068 2 2R CR30068 CR30068 BcDNA:GH25778 CDMC25940 2 13 18 DAC29-F20 8-CR31271-RA_1 CR31271 TGACAAGTGCTGGCTAAACGTCTGTGGTTATCGCAATCATTTTCGATTTTCGGGCCCCATCCCTGTTGA 69 FBan0031271 FBgn0020546 iab-4 3 3R iab-4 iab-4 "domain I, I: Intensifier of Bar, iab: infraabdominal, CR31271, I, iab" CDMC25940 2 14 18 DAC29-F20 8-CR31271-RA_1 CR31271 TGACAAGTGCTGGCTAAACGTCTGTGGTTATCGCAATCATTTTCGATTTTCGGGCCCCATCCCTGTTGA 69 FBan0031271 FBgn0020546 iab-4 3 3R iab-4 iab-4 "domain I, I: Intensifier of Bar, iab: infraabdominal, CR31271, I, iab" CDMC25941 2 15 18 DAC29-J08 15-CR31972-RA_2 CR31972 TGAGTGTCTCGTTTTATTGTTGCTTCGCGCTCGTTTGATGATGCTCACCGATGTCTAGACAAGCGGCCG 69 FBan0031972 FBgn0047314 CR31972 2 2L CR31972 CR31972 BcDNA:GH10270 CDMC25941 2 16 18 DAC29-J08 15-CR31972-RA_2 CR31972 TGAGTGTCTCGTTTTATTGTTGCTTCGCGCTCGTTTGATGATGCTCACCGATGTCTAGACAAGCGGCCG 69 FBan0031972 FBgn0047314 CR31972 2 2L CR31972 CR31972 BcDNA:GH10270 CDMC25942 2 17 18 DAC29-J20 16-CR32477-RA_1 CR32477 AGTAGGCTGGAGGTATCATTTCTTCACTAAGCACCATCGATTTCACACTACTGGCTTGGGATAGCACCT 69 FBan0032477 FBgn0052477 CR32477 3 3L CR32477 CR32477 "CG32477, CG13878, CG32477, BcDNA:GH06422, anon-EST:fe1H7, anon-fast-evolving-1H7" CDMC25942 2 18 18 DAC29-J20 16-CR32477-RA_1 CR32477 AGTAGGCTGGAGGTATCATTTCTTCACTAAGCACCATCGATTTCACACTACTGGCTTGGGATAGCACCT 69 FBan0032477 FBgn0052477 CR32477 3 3L CR32477 CR32477 "CG32477, CG13878, CG32477, BcDNA:GH06422, anon-EST:fe1H7, anon-fast-evolving-1H7" CDMC25943 2 19 18 DAC29-N08 2-CR32926-RA_1 CR32926 TGTCCTCATCCTGACCACTTATTGGCCACAATTGGAAGCTGGCTTCGACGGGACATTAGACGTTGGTCT 69 FBan0032926 FBgn0000280 Cec-Psi1 3 3R Cec-Psi1 Cecropin pseudogene 1 "pseudo-1, CecPsi1, cecropin Psi-1, CR32926, cec-Psi1" CDMC25943 2 20 18 DAC29-N08 2-CR32926-RA_1 CR32926 TGTCCTCATCCTGACCACTTATTGGCCACAATTGGAAGCTGGCTTCGACGGGACATTAGACGTTGGTCT 69 FBan0032926 FBgn0000280 Cec-Psi1 3 3R Cec-Psi1 Cecropin pseudogene 1 "pseudo-1, CecPsi1, cecropin Psi-1, CR32926, cec-Psi1" CDMC25944 2 21 18 DAC29-N20 3-CR33319-RA_1 CR33319 CCCCGCGTCCTAGCAGTTCCTTGAATCCGAGCCAACATGCGTTGAGCCAACAACTAACATTTTGGTCTT 69 FBan0033319 FBgn0053319 CR33319 2 2L CR33319 CR33319 "CG18078, CG18078, CG18078, CG18078" CDMC25944 2 22 18 DAC29-N20 3-CR33319-RA_1 CR33319 CCCCGCGTCCTAGCAGTTCCTTGAATCCGAGCCAACATGCGTTGAGCCAACAACTAACATTTTGGTCTT 69 FBan0033319 FBgn0053319 CR33319 2 2L CR33319 CR33319 "CG18078, CG18078, CG18078, CG18078" CDMC25945 2 23 18 DAC30-B08 17-CG11985-RA_1 CG11985 GGCCAGCTACATGGGTCACTACGATATTCTCAACTACTTTGCCATAGCGGAAAATGAATCGAAGGCACG 69 FBan0011985 FBgn0040534 CG11985 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleus; GO:0005634 CG11985 CG11985 CDMC25945 2 24 18 DAC30-B08 17-CG11985-RA_1 CG11985 GGCCAGCTACATGGGTCACTACGATATTCTCAACTACTTTGCCATAGCGGAAAATGAATCGAAGGCACG 69 FBan0011985 FBgn0040534 CG11985 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleus; GO:0005634 CG11985 CG11985 CDMC25946 2 25 18 DAC30-B20 23-CG11993-RA_15 CG11993 AGAAGTCGCAAATCCAATCTCCATTGCAATTTTGAACACCATTCCTTTGCATAACTATTGCCCACGCAA 69 FBan0011993 FBgn0028708 Mst85C 3 3R Mst85C Mst85C CG11993 CDMC25946 2 26 18 DAC30-B20 23-CG11993-RA_15 CG11993 AGAAGTCGCAAATCCAATCTCCATTGCAATTTTGAACACCATTCCTTTGCATAACTATTGCCCACGCAA 69 FBan0011993 FBgn0028708 Mst85C 3 3R Mst85C Mst85C CG11993 CDMC25947 2 1 19 DAC30-F08 17-CG12023-RA_1 CG12023 CGCGATCGACGGCTAGCAGCTGAAAAACAAGCAAACATTTAAGCGAACATTACCTTTAAGACTTGCCCA 69 FBgn0035278 CDMC25947 2 2 19 DAC30-F08 17-CG12023-RA_1 CG12023 CGCGATCGACGGCTAGCAGCTGAAAAACAAGCAAACATTTAAGCGAACATTACCTTTAAGACTTGCCCA 69 FBgn0035278 CDMC25948 2 3 19 DAC30-F20 23-CG12027-RA_8 CG12027 AAAAATGTTTAGCCGTTTCCTAAAACCAAGCCTAGTTTTATGTAGGAGTGTGAGCAATACCGCATCCCT 69 FBan0012027 FBgn0035585 CG12027 3 3L ATP synthesis coupled proton transport; GO:0015986 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG12027 CG12027 CDMC25948 2 4 19 DAC30-F20 23-CG12027-RA_8 CG12027 AAAAATGTTTAGCCGTTTCCTAAAACCAAGCCTAGTTTTATGTAGGAGTGTGAGCAATACCGCATCCCT 69 FBan0012027 FBgn0035585 CG12027 3 3L ATP synthesis coupled proton transport; GO:0015986 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG12027 CG12027 CDMC25949 2 5 19 DAC30-J08 23-CG12057-RA_2 CG12057 TACCGTCGTCGCTAGGTGAACACAAACTTATTTACCTGGATTCTGCAAATAAAAATTATGCATGTTCTA 69 FBan0012057 FBgn0030098 CG12057 X X CG12057 CG12057 BcDNA:LP05863 CDMC25949 2 6 19 DAC30-J08 23-CG12057-RA_2 CG12057 TACCGTCGTCGCTAGGTGAACACAAACTTATTTACCTGGATTCTGCAAATAAAAATTATGCATGTTCTA 69 FBan0012057 FBgn0030098 CG12057 X X CG12057 CG12057 BcDNA:LP05863 CDMC25950 2 7 19 DAC30-J20 1-CG12071-RA_1 CG12071 CGCCGTTTCGCAATTTCAGACCCTCCAGAGTAGTATCCCCACATAGACCCGTATGCAAACCGAACGTGT 69 FBan0012071 FBgn0039808 CG12071 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12071 CG12071 CDMC25950 2 8 19 DAC30-J20 1-CG12071-RA_1 CG12071 CGCCGTTTCGCAATTTCAGACCCTCCAGAGTAGTATCCCCACATAGACCCGTATGCAAACCGAACGTGT 69 FBan0012071 FBgn0039808 CG12071 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12071 CG12071 CDMC25951 2 9 19 DAC30-N08 23-CG12111-RA_2 CG12111 GGAACCGAAAACCTTCAAGTTCACCTACATTAAGTGGTAGTTTTCGATTGGTTCTAAAATAAAACCAGC 69 FBan0012111 FBgn0030050 CG12111 X X sugar binding; GO:0005529; ; GO:0005529 CG12111 CG12111 CDMC25951 2 10 19 DAC30-N08 23-CG12111-RA_2 CG12111 GGAACCGAAAACCTTCAAGTTCACCTACATTAAGTGGTAGTTTTCGATTGGTTCTAAAATAAAACCAGC 69 FBan0012111 FBgn0030050 CG12111 X X sugar binding; GO:0005529; ; GO:0005529 CG12111 CG12111 CDMC25952 2 11 19 DAC30-N20 3-CG12119-RA_3 CG12119 GGGCACTATATCCACTCTTTGGCGTCGTCAATCACGACTGCATTCCCAACGCCTACTACACCTTCGAGG 69 FBan0012119 FBgn0030102 CG12119 X X CG12119 CG12119 CDMC25952 2 12 19 DAC30-N20 3-CG12119-RA_3 CG12119 GGGCACTATATCCACTCTTTGGCGTCGTCAATCACGACTGCATTCCCAACGCCTACTACACCTTCGAGG 69 FBan0012119 FBgn0030102 CG12119 X X CG12119 CG12119 CDMC25953 2 13 19 DAC31-B08 3-CG3625-RB_1 CG3625 ACGGCAGTCGTGCAATTTGGCTACGGCATCTATTACGACTACAACTACGTGCAGTTCCCCACCAGC 66 FBan0003625 FBgn0031245 CG3625 2 2L CG3625 CG3625 CDMC25953 2 14 19 DAC31-B08 3-CG3625-RB_1 CG3625 ACGGCAGTCGTGCAATTTGGCTACGGCATCTATTACGACTACAACTACGTGCAGTTCCCCACCAGC 66 FBan0003625 FBgn0031245 CG3625 2 2L CG3625 CG3625 CDMC25954 2 15 19 DAC31-B20 2-CG3808-RA_4 CG3808 GGAGGGAGCTGCACAGTCAAAGTCTGAGGCAACCGAAGAAGCTGTTAGCGAGGAGAACACCACATC 66 FBan0003808 FBgn0036838 CG3808 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG3808 CG3808 cg3808 CDMC25954 2 16 19 DAC31-B20 2-CG3808-RA_4 CG3808 GGAGGGAGCTGCACAGTCAAAGTCTGAGGCAACCGAAGAAGCTGTTAGCGAGGAGAACACCACATC 66 FBan0003808 FBgn0036838 CG3808 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG3808 CG3808 cg3808 CDMC25955 2 17 19 DAC31-F08 2-CG4067-RA_2 CG4067 CCGGCTCCAGAAATTGGGAATCACCAAAACCGATCCCGATACCCTTACCGCTGACGAATACGGACC 66 FBan0004067 FBgn0020385 pug 3 3R amino acid biosynthesis; GO:0008652; folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; formate-tetrahydrofolate ligase activity; GO:0004329 ; EC:6.3.4.3; methenyltetrahydrofolate cyclohydrolase activity; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NADP+) activity; GO:0004488 ; EC:1.5.1.5; ; GO:0004488 ; EC:1.5.1.5; ; GO:0004329 ; EC:6.3.4.3; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5 pug pugilist "CG4067, CG4067, Pug: Pugilist, Pugilist, MTHFD, pugD, bs14h02.y1, Pug" CDMC25955 2 18 19 DAC31-F08 2-CG4067-RA_2 CG4067 CCGGCTCCAGAAATTGGGAATCACCAAAACCGATCCCGATACCCTTACCGCTGACGAATACGGACC 66 FBan0004067 FBgn0020385 pug 3 3R amino acid biosynthesis; GO:0008652; folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; formate-tetrahydrofolate ligase activity; GO:0004329 ; EC:6.3.4.3; methenyltetrahydrofolate cyclohydrolase activity; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NADP+) activity; GO:0004488 ; EC:1.5.1.5; ; GO:0004488 ; EC:1.5.1.5; ; GO:0004329 ; EC:6.3.4.3; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5 pug pugilist "CG4067, CG4067, Pug: Pugilist, Pugilist, MTHFD, pugD, bs14h02.y1, Pug" CDMC25956 2 19 19 DAC31-F20 2-CG4290-RA_1 CG4290 GGAGCTCATGCCTTCAGTCAGATGAACCTCAAGACTTCCTACATCAGCCAATCGGACCAGGTGCCT 66 FBan0004290 FBgn0025625 CG4290 X X cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG4290 CG4290 EG:22E5.8 CDMC25956 2 20 19 DAC31-F20 2-CG4290-RA_1 CG4290 GGAGCTCATGCCTTCAGTCAGATGAACCTCAAGACTTCCTACATCAGCCAATCGGACCAGGTGCCT 66 FBan0004290 FBgn0025625 CG4290 X X cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG4290 CG4290 EG:22E5.8 CDMC25957 2 21 19 DAC31-J08 3-CG4793-RB_2 CG4793 GGCCACGTGAACCGTATAGGAGTGGGCTTCACCATAACTAACGCGAGAGACATCGCACAGAAAGGC 66 FBan0004793 FBgn0028514 CG4793 2 2L carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 "NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" CG4793 CG4793 "BG:DS07486.3, SPH208" CDMC25957 2 22 19 DAC31-J08 3-CG4793-RB_2 CG4793 GGCCACGTGAACCGTATAGGAGTGGGCTTCACCATAACTAACGCGAGAGACATCGCACAGAAAGGC 66 FBan0004793 FBgn0028514 CG4793 2 2L carbohydrate metabolism; GO:0005975; proteolysis; GO:0006508 "NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" CG4793 CG4793 "BG:DS07486.3, SPH208" CDMC25958 2 23 19 DAC31-J20 2-CG4842-RA_2 CG4842 AGGCTTCCTTACCATCTGTCCCGGATTCACGGACACTGGGCTACTGGAGGATATTGGCAACAAGAC 66 FBan0004842 FBgn0036620 CG4842 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0016616 ; EC:1.1.1.-; ; GO:0004022 ; EC:1.1.1.1" CG4842 CG4842 CDMC25958 2 24 19 DAC31-J20 2-CG4842-RA_2 CG4842 AGGCTTCCTTACCATCTGTCCCGGATTCACGGACACTGGGCTACTGGAGGATATTGGCAACAAGAC 66 FBan0004842 FBgn0036620 CG4842 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0016616 ; EC:1.1.1.-; ; GO:0004022 ; EC:1.1.1.1" CG4842 CG4842 CDMC25959 2 25 19 DAC31-N08 6-CG5112-RA_1 CG5112 CCGAACGGGTTATGTACAAGATTCGCAAACATTTCGAGGCAGTGAGTGGAAAGGACGTGCGGCACG 66 FBan0005112 FBgn0039341 CG5112 3 3R nitrogen compound metabolism; GO:0006807; tRNA aminoacylation for protein translation; GO:0006418 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG5112 CG5112 CDMC25959 2 26 19 DAC31-N08 6-CG5112-RA_1 CG5112 CCGAACGGGTTATGTACAAGATTCGCAAACATTTCGAGGCAGTGAGTGGAAAGGACGTGCGGCACG 66 FBan0005112 FBgn0039341 CG5112 3 3R nitrogen compound metabolism; GO:0006807; tRNA aminoacylation for protein translation; GO:0006418 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG5112 CG5112 CDMC25960 2 1 20 DAC31-N20 12-CG5325-RA_1 CG5325 AGAAGCAGATGGAGCTGTACAAGGTGATTGAGGGGCATTTACAGAGCGAGAAGACCGAGGATTCGG 66 FBan0005325 FBgn0032407 CG5325 2 2L CG5325 CG5325 "Peroxisomal farnesylated protein, BEST:GH03076" CDMC25960 2 2 20 DAC31-N20 12-CG5325-RA_1 CG5325 AGAAGCAGATGGAGCTGTACAAGGTGATTGAGGGGCATTTACAGAGCGAGAAGACCGAGGATTCGG 66 FBan0005325 FBgn0032407 CG5325 2 2L CG5325 CG5325 "Peroxisomal farnesylated protein, BEST:GH03076" CDMC25961 2 3 20 DAC32-B08 23-CG11134-RA_5 CG11134 AAAGTTCGAGAGCTCATAAGGAAGTGAAGCTGATACGAACGCACATTCTACTTGTCGTTTAACCCTATA 69 FBan0011134 FBgn0030518 CG11134 X X carbohydrate metabolism; GO:0005975 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.- CG11134 CG11134 "1, transcript 1" CDMC25961 2 4 20 DAC32-B08 23-CG11134-RA_5 CG11134 AAAGTTCGAGAGCTCATAAGGAAGTGAAGCTGATACGAACGCACATTCTACTTGTCGTTTAACCCTATA 69 FBan0011134 FBgn0030518 CG11134 X X carbohydrate metabolism; GO:0005975 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.- CG11134 CG11134 "1, transcript 1" CDMC25962 2 5 20 DAC32-B20 22-CG11145-RA_1 CG11145 CGGGGGAGTTGGCTTAGTAACTGCCTTTGGAGTGGATAATTTTAGGTCTTTGGGTGGAAGTGTTTCGTA 69 FBan0011145 FBgn0033168 CG11145 2 2R CG11145 CG11145 BcDNA:AT20622 CDMC25962 2 6 20 DAC32-B20 22-CG11145-RA_1 CG11145 CGGGGGAGTTGGCTTAGTAACTGCCTTTGGAGTGGATAATTTTAGGTCTTTGGGTGGAAGTGTTTCGTA 69 FBan0011145 FBgn0033168 CG11145 2 2R CG11145 CG11145 BcDNA:AT20622 CDMC25963 2 7 20 DAC32-F08 16-CG11177-RA_2 CG11177 GGTAGTTGTGCCCAAAACAAAGCGTTCAGCAATAGAGCCCTATGATCGATGATTGGCAAATCCTCTCGA 69 FBan0011177 FBgn0030501 BthD X X redox signal response; GO:0006980 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BthD BthD selenoprotein "CG11177, CG11177, CG11177, dselM, BthD selenoprotein" CDMC25963 2 8 20 DAC32-F08 16-CG11177-RA_2 CG11177 GGTAGTTGTGCCCAAAACAAAGCGTTCAGCAATAGAGCCCTATGATCGATGATTGGCAAATCCTCTCGA 69 FBan0011177 FBgn0030501 BthD X X redox signal response; GO:0006980 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BthD BthD selenoprotein "CG11177, CG11177, CG11177, dselM, BthD selenoprotein" CDMC25964 2 9 20 DAC32-F20 9-CG11196-RA_1 CG11196 GCCCATTGGCCTTCTACAAGGGATTCATTCCGGCCCTGATACGAGTGTCACCCAATACGATTATCACCT 69 FBan0011196 FBgn0033248 CG11196 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; dicarboxylic acid transporter activity; GO:0005310; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG11196 CG11196 CDMC25964 2 10 20 DAC32-F20 9-CG11196-RA_1 CG11196 GCCCATTGGCCTTCTACAAGGGATTCATTCCGGCCCTGATACGAGTGTCACCCAATACGATTATCACCT 69 FBan0011196 FBgn0033248 CG11196 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; dicarboxylic acid transporter activity; GO:0005310; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG11196 CG11196 CDMC25965 2 11 20 DAC32-J08 1-CG11254-RC_1 CG11254 CGGCATGCGAATATTCGTTGAAGGAGGGAATCCGATCCATCTACAGCACCATGATTGACCCCGGTCAGA 69 FBan0011254 FBgn0016034 mael 3 3L cytoskeleton organization and biogenesis; GO:0007010; dorsal/ventral axis specification; GO:0009950; intracellular mRNA localization; GO:0008298; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 cytoplasm; GO:0005737; nucleus; GO:0005634; polar granule; GO:0018994 mael maelstrom "CG11254, maelstrom" CDMC25965 2 12 20 DAC32-J08 1-CG11254-RC_1 CG11254 CGGCATGCGAATATTCGTTGAAGGAGGGAATCCGATCCATCTACAGCACCATGATTGACCCCGGTCAGA 69 FBan0011254 FBgn0016034 mael 3 3L cytoskeleton organization and biogenesis; GO:0007010; dorsal/ventral axis specification; GO:0009950; intracellular mRNA localization; GO:0008298; oocyte anterior/posterior axis determination; GO:0007314; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 cytoplasm; GO:0005737; nucleus; GO:0005634; polar granule; GO:0018994 mael maelstrom "CG11254, maelstrom" CDMC25966 2 13 20 DAC32-J20 2-CG11262-RA_1 CG11262 TGCCTGGCGTTTTATTGGCGGCTGTAGCGGGCTATGCTGTCATGTATGTGACCATGAGGAAATCTTTGT 69 FBan0011262 FBgn0036329 CG11262 3 3L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021 CG11262 CG11262 CDMC25966 2 14 20 DAC32-J20 2-CG11262-RA_1 CG11262 TGCCTGGCGTTTTATTGGCGGCTGTAGCGGGCTATGCTGTCATGTATGTGACCATGAGGAAATCTTTGT 69 FBan0011262 FBgn0036329 CG11262 3 3L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021 CG11262 CG11262 CDMC25967 2 15 20 DAC32-N08 16-CG11297-RA_1 CG11297 AACCCCAAGCCAAACAAGCTGATAAAGTTAAAAGCAGCCACATGAGTGAGTTTGCTTACACGCGAAACT 69 FBan0011297 FBgn0011295 CG11297 2 2L CG11297 CG11297 "P28, anon-21DEa, anon-2L, anon2L" CDMC25967 2 16 20 DAC32-N08 16-CG11297-RA_1 CG11297 AACCCCAAGCCAAACAAGCTGATAAAGTTAAAAGCAGCCACATGAGTGAGTTTGCTTACACGCGAAACT 69 FBan0011297 FBgn0011295 CG11297 2 2L CG11297 CG11297 "P28, anon-21DEa, anon-2L, anon2L" CDMC25968 2 17 20 DAC32-N20 22-CG1130-RA_1 CG1130 AGCCACTTATGCCATGTAAGCATAGAATACATTGGGCGCGCTACAGAAATCTCTAAGGACTTGAAGCCA 69 FBan0001130 FBgn0004880 scrt 3 3L cell proliferation; GO:0008283; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 scrt scratch "CG1130, clone 1.31, clone 1.67, anon-WO02059370.57, BcDNA:RH71479, anon-EST:Liang-1.31, anon-EST:Liang-1.67, scratch" CDMC25968 2 18 20 DAC32-N20 22-CG1130-RA_1 CG1130 AGCCACTTATGCCATGTAAGCATAGAATACATTGGGCGCGCTACAGAAATCTCTAAGGACTTGAAGCCA 69 FBan0001130 FBgn0004880 scrt 3 3L cell proliferation; GO:0008283; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 scrt scratch "CG1130, clone 1.31, clone 1.67, anon-WO02059370.57, BcDNA:RH71479, anon-EST:Liang-1.31, anon-EST:Liang-1.67, scratch" CDMC25969 2 19 20 DAC33-B08 2-CG12582-RA_1 CG12582 GCATAGCTCTCGACCTCAGCCACTGGTCTCCTCACCTTCAAATGGCAAAGCTAGTGAACCGGACAACTA 69 FBan0012582 FBgn0037215 CG12582 3 3R carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; beta-mannosidase activity; GO:0004567 ; EC:3.2.1.25; ; GO:0004567 ; EC:3.2.1.25" CG12582 CG12582 CG12583 CDMC25969 2 20 20 DAC33-B08 2-CG12582-RA_1 CG12582 GCATAGCTCTCGACCTCAGCCACTGGTCTCCTCACCTTCAAATGGCAAAGCTAGTGAACCGGACAACTA 69 FBan0012582 FBgn0037215 CG12582 3 3R carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; beta-mannosidase activity; GO:0004567 ; EC:3.2.1.25; ; GO:0004567 ; EC:3.2.1.25" CG12582 CG12582 CG12583 CDMC25970 2 21 20 DAC33-B20 1-CG12592-RA_1 CG12592 ACGGTGGTCGATGAGCCGCCCACTAAAGTTCCCATAATCGAGCTGATTAAGACAAGTTCGGGCATGGTT 69 FBan0012592 FBgn0037811 CG12592 3 3R CG12592 CG12592 CDMC25970 2 22 20 DAC33-B20 1-CG12592-RA_1 CG12592 ACGGTGGTCGATGAGCCGCCCACTAAAGTTCCCATAATCGAGCTGATTAAGACAAGTTCGGGCATGGTT 69 FBan0012592 FBgn0037811 CG12592 3 3R CG12592 CG12592 CDMC25971 2 23 20 DAC33-F08 15-CG1263-RB_4 CG1263 CGCCGCATTTGCAATATGGAGTTCGAGTACTAATCCCGTGAATTTGTCTTGCAGCAATGGGTCGCGTTA 69 FBan0001263 FBgn0024939 RpL8 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL8 Ribosomal protein L8 "CG1263, CG1263, rpL8, L8, anon-EST:Posey5, Ribosomal protein L8" CDMC25971 2 24 20 DAC33-F08 15-CG1263-RB_4 CG1263 CGCCGCATTTGCAATATGGAGTTCGAGTACTAATCCCGTGAATTTGTCTTGCAGCAATGGGTCGCGTTA 69 FBan0001263 FBgn0024939 RpL8 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL8 Ribosomal protein L8 "CG1263, CG1263, rpL8, L8, anon-EST:Posey5, Ribosomal protein L8" CDMC25972 2 25 20 DAC33-F20 17-CG12659-RB_4 CG12659 TCTGGCCATCTCAATTGCAAGCTTGAAACGTGTGAAATATGGAACAAAATGCGAAGCCTAAACGCTCCT 69 FBan0012659 FBgn0040929 CG12659 X X CG12659 CG12659 CDMC25972 2 26 20 DAC33-F20 17-CG12659-RB_4 CG12659 TCTGGCCATCTCAATTGCAAGCTTGAAACGTGTGAAATATGGAACAAAATGCGAAGCCTAAACGCTCCT 69 FBan0012659 FBgn0040929 CG12659 X X CG12659 CG12659 CDMC25973 2 1 21 DAC33-J08 16-CG12693-RB_1 CG12693 TCGCAGCCTTTGAAGGGAAAAGGACTGCCCAATGACAATAGTCGCAATTTAAACAGCTCCAATCCGATT 69 FBan0012693 FBgn0029705 CG12693 X X CG12693 CG12693 CDMC25973 2 2 21 DAC33-J08 16-CG12693-RB_1 CG12693 TCGCAGCCTTTGAAGGGAAAAGGACTGCCCAATGACAATAGTCGCAATTTAAACAGCTCCAATCCGATT 69 FBan0012693 FBgn0029705 CG12693 X X CG12693 CG12693 CDMC25974 2 3 21 DAC33-J20 2-CG12703-RA_1 CG12703 TCGGCGTCAAGCAACTTTGGACCAAACAAGGGCATCATGTGCTTCGAGGACAACATTATCCGCTTCGAA 69 FBan0012703 FBgn0031069 CG12703 X X lipid metabolism; GO:0006629; lipid transport; GO:0006869; peroxisome organization and biogenesis; GO:0007031 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; integral to peroxisomal membrane; GO:0005779 CG12703 CG12703 i17 CDMC25974 2 4 21 DAC33-J20 2-CG12703-RA_1 CG12703 TCGGCGTCAAGCAACTTTGGACCAAACAAGGGCATCATGTGCTTCGAGGACAACATTATCCGCTTCGAA 69 FBan0012703 FBgn0031069 CG12703 X X lipid metabolism; GO:0006629; lipid transport; GO:0006869; peroxisome organization and biogenesis; GO:0007031 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; integral to peroxisomal membrane; GO:0005779 CG12703 CG12703 i17 CDMC25975 2 5 21 DAC33-N08 23-CG12758-RB_1 CG12758 CAGATTCCAATGGAGTATTTGATGAGAATATTTCGACCGGATGGAACCACGACAAAATGAAAGGCTGCC 69 FBan0012758 FBgn0034408 sano 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sano serrano "CG12758, serrano" CDMC25975 2 6 21 DAC33-N08 23-CG12758-RB_1 CG12758 CAGATTCCAATGGAGTATTTGATGAGAATATTTCGACCGGATGGAACCACGACAAAATGAAAGGCTGCC 69 FBan0012758 FBgn0034408 sano 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sano serrano "CG12758, serrano" CDMC25976 2 7 21 DAC33-N20 23-CG1276-RA_3 CG1276 GGACAGCTGAGCAGGCATTGTTTAGATTTTGTAAATTGTTGATTTCTCGCAGCAGAAAGTTTTTTTTCG 69 FBan0001276 FBgn0015829 TfIIEbeta 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIE complex; GO:0005673 TfIIEbeta Transcription factor IIEbeta "CG1276, CG1276, TFIIE, TfIIE, dTFIIE-S, dTFIIES, E[[S]], TfIIEbeta, Transcription factor IIEbeta" CDMC25976 2 8 21 DAC33-N20 23-CG1276-RA_3 CG1276 GGACAGCTGAGCAGGCATTGTTTAGATTTTGTAAATTGTTGATTTCTCGCAGCAGAAAGTTTTTTTTCG 69 FBan0001276 FBgn0015829 TfIIEbeta 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIE complex; GO:0005673 TfIIEbeta Transcription factor IIEbeta "CG1276, CG1276, TFIIE, TfIIE, dTFIIE-S, dTFIIES, E[[S]], TfIIEbeta, Transcription factor IIEbeta" CDMC25977 2 9 21 DAC34-B08 3-CG4342-RA_2 CG4342 ACGAGTGCACCGCGATACTGAAGACCATCAGTCATCAAATCAATAGCGAGCACAGCGAGCTCCAATCCC 69 FBan0004342 FBgn0038791 CG4342 3 3R CG4342 CG4342 CDMC25977 2 10 21 DAC34-B08 3-CG4342-RA_2 CG4342 ACGAGTGCACCGCGATACTGAAGACCATCAGTCATCAAATCAATAGCGAGCACAGCGAGCTCCAATCCC 69 FBan0004342 FBgn0038791 CG4342 3 3R CG4342 CG4342 CDMC25978 2 11 21 DAC34-B20 5-CG4353-RC_1 CG4353 CGGGGCAGAGTCCCACAAATCCGCAGAAGACAATAAAACCCACTCAGATACCGAGTTACCAGCAGCAAC 69 FBan0004353 FBgn0010303 hep X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cable formation; GO:0045011; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, spreading of leading edge cells; GO:0007395; eggshell pattern formation (sensu Insecta); GO:0030381; establishment of planar polarity; GO:0001736; filopodium formation; GO:0046847; imaginal disc fusion, thorax closure; GO:0046529; lamellipodium biogenesis; GO:0030032; micropyle formation; GO:0046844; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; wound healing; GO:0042060" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0005515 hep hemipterous "CG4353, CG2190, CG4353, CG2190, hp, DMKK7, JNKK, l(1)G0107, l(1)G0208, HEP, HEP/MKK7, DHEP/MKK7, MKK7, hem, l(1)7P1" CDMC25978 2 12 21 DAC34-B20 5-CG4353-RC_1 CG4353 CGGGGCAGAGTCCCACAAATCCGCAGAAGACAATAAAACCCACTCAGATACCGAGTTACCAGCAGCAAC 69 FBan0004353 FBgn0010303 hep X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cable formation; GO:0045011; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, spreading of leading edge cells; GO:0007395; eggshell pattern formation (sensu Insecta); GO:0030381; establishment of planar polarity; GO:0001736; filopodium formation; GO:0046847; imaginal disc fusion, thorax closure; GO:0046529; lamellipodium biogenesis; GO:0030032; micropyle formation; GO:0046844; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; wound healing; GO:0042060" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0005515 hep hemipterous "CG4353, CG2190, CG4353, CG2190, hp, DMKK7, JNKK, l(1)G0107, l(1)G0208, HEP, HEP/MKK7, DHEP/MKK7, MKK7, hem, l(1)7P1" CDMC25979 2 13 21 DAC34-F08 18-CG4385-RB_1 CG4385 CGAAATTGTTTTTTGTGCGCGTGTACGAGCCGAGTACACAGAACAATTGTGTTGAACGAGAACACAGCA 69 FBan0004385 FBgn0003310 S 2 2L branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; embryonic development; GO:0009790; epidermal growth factor ligand processing; GO:0007174; epidermal growth factor receptor signaling pathway; GO:0007173; eye photoreceptor development (sensu Endopterygota); GO:0042051; mesoderm development; GO:0007498; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell development; GO:0042461; protein targeting to Golgi; GO:0000042; regulation of epidermal growth factor receptor signaling pathway; GO:0042058 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 S Star "CG4385, CG4385, Star/asteroid, fltr: floater, floater, ES2-4, Enhancer of GMR-sina 2-4, EY2-4, l(2)05671, l(2)07056, EK2-2, star, E(Raf)2B, l(2)21Eb, l(2)k09538, l(2)rK134, l(2)c00080, lethal (2) c00080, fltr, Star" CDMC25979 2 14 21 DAC34-F08 18-CG4385-RB_1 CG4385 CGAAATTGTTTTTTGTGCGCGTGTACGAGCCGAGTACACAGAACAATTGTGTTGAACGAGAACACAGCA 69 FBan0004385 FBgn0003310 S 2 2L branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; embryonic development; GO:0009790; epidermal growth factor ligand processing; GO:0007174; epidermal growth factor receptor signaling pathway; GO:0007173; eye photoreceptor development (sensu Endopterygota); GO:0042051; mesoderm development; GO:0007498; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell development; GO:0042461; protein targeting to Golgi; GO:0000042; regulation of epidermal growth factor receptor signaling pathway; GO:0042058 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 S Star "CG4385, CG4385, Star/asteroid, fltr: floater, floater, ES2-4, Enhancer of GMR-sina 2-4, EY2-4, l(2)05671, l(2)07056, EK2-2, star, E(Raf)2B, l(2)21Eb, l(2)k09538, l(2)rK134, l(2)c00080, lethal (2) c00080, fltr, Star" CDMC25980 2 15 21 DAC34-F20 15-CG4406-RA_8 CG4406 CCATGTGGATCCATCGATTGGAGTCTACATGATAGACCGGTACACCTACTACGCCTTGGAGTTCCTGGA 69 FBan0004406 FBgn0023545 CG4406 X X protein amino acid glycosylation; GO:0006486; protein lipidation; GO:0006497; proteolysis; GO:0006508 GPI-anchor transamidase activity; GO:0003923 ; EC:3.-.-.-; ; GO:0003923 ; EC:3.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0016740 ; EC:2.-.-.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0003923 ; EC:3.-.-.-; ; GO:0004197 ; EC:3.4.22.-; legumain activity; GO:0001509 ; EC:3.4.22.34; ; GO:0001509 ; EC:3.4.22.34 CG4406 CG4406 EG:133E12.3 CDMC25980 2 16 21 DAC34-F20 15-CG4406-RA_8 CG4406 CCATGTGGATCCATCGATTGGAGTCTACATGATAGACCGGTACACCTACTACGCCTTGGAGTTCCTGGA 69 FBan0004406 FBgn0023545 CG4406 X X protein amino acid glycosylation; GO:0006486; protein lipidation; GO:0006497; proteolysis; GO:0006508 GPI-anchor transamidase activity; GO:0003923 ; EC:3.-.-.-; ; GO:0003923 ; EC:3.-.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0016740 ; EC:2.-.-.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0003923 ; EC:3.-.-.-; ; GO:0004197 ; EC:3.4.22.-; legumain activity; GO:0001509 ; EC:3.4.22.34; ; GO:0001509 ; EC:3.4.22.34 CG4406 CG4406 EG:133E12.3 CDMC25981 2 17 21 DAC34-J08 12-CG4438-RA_1 CG4438 TCGCAATCAGAAATCGTCGTCAGATGAGGTGGACAGTTCTTCCGAGGATTGCGAAACGGAATCTCGTGT 69 FBan0004438 FBgn0032115 CG4438 2 2L CG4438 CG4438 CDMC25981 2 18 21 DAC34-J08 12-CG4438-RA_1 CG4438 TCGCAATCAGAAATCGTCGTCAGATGAGGTGGACAGTTCTTCCGAGGATTGCGAAACGGAATCTCGTGT 69 FBan0004438 FBgn0032115 CG4438 2 2L CG4438 CG4438 CDMC25982 2 19 21 DAC34-J20 16-CG4449-RA_1 CG4449 ACAGAGCGCTCCCTATCACCGGTATCCCTGTTGATATTGGAGATGGAAAAGAAAAATGGCCAGCAATCG 69 FBan0004449 FBgn0039065 CG4449 3 3R CG4449 CG4449 CDMC25982 2 20 21 DAC34-J20 16-CG4449-RA_1 CG4449 ACAGAGCGCTCCCTATCACCGGTATCCCTGTTGATATTGGAGATGGAAAAGAAAAATGGCCAGCAATCG 69 FBan0004449 FBgn0039065 CG4449 3 3R CG4449 CG4449 CDMC25983 2 21 21 DAC34-N08 5-CG4485-RA_1 CG4485 GCGTCACCGAGAACCACCAGGGATATGTGGGAATCAGCACGAGGGTTCAATATAATTCCTACGACCGGA 69 FBan0004485 FBgn0015038 Cyp9b1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9b1 Cytochrome P450-9b1 "CG4485, P450, P-450, 9b1" CDMC25983 2 22 21 DAC34-N08 5-CG4485-RA_1 CG4485 GCGTCACCGAGAACCACCAGGGATATGTGGGAATCAGCACGAGGGTTCAATATAATTCCTACGACCGGA 69 FBan0004485 FBgn0015038 Cyp9b1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9b1 Cytochrome P450-9b1 "CG4485, P450, P-450, 9b1" CDMC25984 2 23 21 DAC34-N20 23-CG4502-RA_9 CG4502 TCTCTGTTTCATCTACTTGTCAAGTAACGAACGATTTCAATTGCAAACCATCCAAAGCAACAAGACGAA 69 FBan0004502 FBgn0031896 CG4502 2 2L protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG4502 CG4502 anon-WO0118547.403 CDMC25984 2 24 21 DAC34-N20 23-CG4502-RA_9 CG4502 TCTCTGTTTCATCTACTTGTCAAGTAACGAACGATTTCAATTGCAAACCATCCAAAGCAACAAGACGAA 69 FBan0004502 FBgn0031896 CG4502 2 2L protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG4502 CG4502 anon-WO0118547.403 CDMC25985 2 25 21 DAC35-B08 23-CG8805-RA_2 CG8805 CGCTTTAAGATGTCTTATCTGGCGCAATTTCAGTTTTATCATTGTTTTAATTTGACCATGTCTGCATAG 69 FBan0008805 FBgn0041087 wun2 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; germ cell repulsion; GO:0035233; lipid metabolism; GO:0006629; pole cell development; GO:0007277; pole cell migration; GO:0007280 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 integral to membrane; GO:0016021; plasma membrane; GO:0005886 wun2 wunen-2 "CG8805, CG8805, CG8805, CK02248, DrPAP2[G], Pap2G, Tunen, WUN-like, Wunen2, wun-2, wunen2, N14, BEST:CK02248, wunen-2" CDMC25985 2 26 21 DAC35-B08 23-CG8805-RA_2 CG8805 CGCTTTAAGATGTCTTATCTGGCGCAATTTCAGTTTTATCATTGTTTTAATTTGACCATGTCTGCATAG 69 FBan0008805 FBgn0041087 wun2 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; germ cell repulsion; GO:0035233; lipid metabolism; GO:0006629; pole cell development; GO:0007277; pole cell migration; GO:0007280 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 integral to membrane; GO:0016021; plasma membrane; GO:0005886 wun2 wunen-2 "CG8805, CG8805, CG8805, CK02248, DrPAP2[G], Pap2G, Tunen, WUN-like, Wunen2, wun-2, wunen2, N14, BEST:CK02248, wunen-2" CDMC25986 2 1 22 DAC35-B20 16-CG8813-RA_1 CG8813 CAGGCTGGAGACCAACCGTATGAACACCACCTATCAGATCGATTACTGTAACATGAACGAGTACCCGGA 69 FBan0008813 FBgn0031476 CG8813 2 2L CG8813 CG8813 anon-WO0140519.96 CDMC25986 2 2 22 DAC35-B20 16-CG8813-RA_1 CG8813 CAGGCTGGAGACCAACCGTATGAACACCACCTATCAGATCGATTACTGTAACATGAACGAGTACCCGGA 69 FBan0008813 FBgn0031476 CG8813 2 2L CG8813 CG8813 anon-WO0140519.96 CDMC25987 2 3 22 DAC35-F08 3-CG8843-RA_1 CG8843 CGCTCACGAGTGCTGCGATAATTTGGTTGGTGTCTACTCCGAGATCTACAGCATTTCACCGGCACTGCT 69 FBan0008843 FBgn0031537 sec5 2 2L cytokinesis; GO:0000910; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec5 sec5 "CG8843, dsec5, Sec5, Sec5p, Sec-5" CDMC25987 2 4 22 DAC35-F08 3-CG8843-RA_1 CG8843 CGCTCACGAGTGCTGCGATAATTTGGTTGGTGTCTACTCCGAGATCTACAGCATTTCACCGGCACTGCT 69 FBan0008843 FBgn0031537 sec5 2 2L cytokinesis; GO:0000910; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec5 sec5 "CG8843, dsec5, Sec5, Sec5p, Sec-5" CDMC25988 2 5 22 DAC35-F20 1-CG8856-RA_2 CG8856 CGGATTTTCACCACCCCAGAACAGGACCACGATACGATCACACCTTTGGAAACACTTCGGGTGGACACT 69 FBan0008856 FBgn0020377 Sr-CII 2 2R defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 Sr-CII "Scavenger receptor class C, type II" "CG8856, CG8856, dSR-CII, CT25430, Scavenger Receptor, SR-CII" CDMC25988 2 6 22 DAC35-F20 1-CG8856-RA_2 CG8856 CGGATTTTCACCACCCCAGAACAGGACCACGATACGATCACACCTTTGGAAACACTTCGGGTGGACACT 69 FBan0008856 FBgn0020377 Sr-CII 2 2R defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 Sr-CII "Scavenger receptor class C, type II" "CG8856, CG8856, dSR-CII, CT25430, Scavenger Receptor, SR-CII" CDMC25989 2 7 22 DAC35-J08 2-CG8896-RA_1 CG8896 GCCAAGCTTTCCTGGTCTAAAAACTCCCCCTATGGCCATATCCATCTCACTCAGCCTCGCAGGGTTCTT 69 FBan0008896 FBgn0004364 18w 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; development; GO:0007275; embryonic morphogenesis; GO:0048598; immune response; GO:0006955; macrophage activation; GO:0042116; morphogenesis; GO:0009653; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888 cytoplasm; GO:0005737; integral to membrane; GO:0016021; membrane fraction; GO:0005624; plasma membrane; GO:0005886 18w 18 wheeler "CG8896, tlr, Toll like receptor, 18-wheeler, wheeler, 18-Wheeler, 18W, CT25100, 18 Wheeler, toll, l(2)00053" CDMC25989 2 8 22 DAC35-J08 2-CG8896-RA_1 CG8896 GCCAAGCTTTCCTGGTCTAAAAACTCCCCCTATGGCCATATCCATCTCACTCAGCCTCGCAGGGTTCTT 69 FBan0008896 FBgn0004364 18w 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; development; GO:0007275; embryonic morphogenesis; GO:0048598; immune response; GO:0006955; macrophage activation; GO:0042116; morphogenesis; GO:0009653; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888; ; GO:0004888 cytoplasm; GO:0005737; integral to membrane; GO:0016021; membrane fraction; GO:0005624; plasma membrane; GO:0005886 18w 18 wheeler "CG8896, tlr, Toll like receptor, 18-wheeler, wheeler, 18-Wheeler, 18W, CT25100, 18 Wheeler, toll, l(2)00053" CDMC25990 2 9 22 DAC35-J20 8-CG8914-RA_1 CG8914 TGGATGGAGCCTTCTTTGGCACTGGATTCCCTCATATGTTCTTTATGGAGAAACCGGATGCTAGGCCCA 69 FBan0008914 FBgn0026136 CkIIbeta2 2 2R protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; kinase activity; GO:0016301; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0008605; ; GO:0008605 protein kinase CK2 complex; GO:0005956 CkIIbeta2 Casein kinase II beta2 subunit "CG8914, CG8914, CKIIb2, DmCKIIbeta', CK2beta', CK2, CKIIbeta', CkIIbeta2" CDMC25990 2 10 22 DAC35-J20 8-CG8914-RA_1 CG8914 TGGATGGAGCCTTCTTTGGCACTGGATTCCCTCATATGTTCTTTATGGAGAAACCGGATGCTAGGCCCA 69 FBan0008914 FBgn0026136 CkIIbeta2 2 2R protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; kinase activity; GO:0016301; protein kinase CK2 regulator activity; GO:0008605; ; GO:0008605; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0008605; ; GO:0008605 protein kinase CK2 complex; GO:0005956 CkIIbeta2 Casein kinase II beta2 subunit "CG8914, CG8914, CKIIb2, DmCKIIbeta', CK2beta', CK2, CKIIbeta', CkIIbeta2" CDMC25991 2 11 22 DAC35-N08 3-CG8948-RC_1 CG8948 GCTGTGCCGGTTAGTAGCACGAGTAACTTTCGACATCCCGAGTACCTAATGACCACGGCCAATCCAGTT 69 FBan0008948 FBgn0030685 Graf X X cell-cell adhesion; GO:0016337; intracellular signaling cascade; GO:0007242; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; Rho GTPase activator activity; GO:0005100; ; GO:0005100 Graf Graf "CG8948, CG8948, D-Graf" CDMC25991 2 12 22 DAC35-N08 3-CG8948-RC_1 CG8948 GCTGTGCCGGTTAGTAGCACGAGTAACTTTCGACATCCCGAGTACCTAATGACCACGGCCAATCCAGTT 69 FBan0008948 FBgn0030685 Graf X X cell-cell adhesion; GO:0016337; intracellular signaling cascade; GO:0007242; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; Rho GTPase activator activity; GO:0005100; ; GO:0005100 Graf Graf "CG8948, CG8948, D-Graf" CDMC25992 2 13 22 DAC35-N20 16-CG8961-RA_1 CG8961 GCCCATCCAAGAAGACAACATACCTGGAACATGTTTTGACACTCCTACAAAGCCCATACCGAGCTCATC 69 FBan0008961 FBgn0043472 tef 2 2R male meiosis I; GO:0007141; male meiosis chromosome segregation; GO:0007060; synapsis; GO:0007129 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 tef teflon "CG8961, teflon" CDMC25992 2 14 22 DAC35-N20 16-CG8961-RA_1 CG8961 GCCCATCCAAGAAGACAACATACCTGGAACATGTTTTGACACTCCTACAAAGCCCATACCGAGCTCATC 69 FBan0008961 FBgn0043472 tef 2 2R male meiosis I; GO:0007141; male meiosis chromosome segregation; GO:0007060; synapsis; GO:0007129 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 tef teflon "CG8961, teflon" CDMC25993 2 15 22 DAC36-B08 3-CG7049-RA_2 CG7049 CAAGCTGATGCCAAGGAATGAACATTGGCTGAACATCTGGCAGGGAGACTTTCCCGATGGCAACC 65 FBan0007049 FBgn0035102 CG7049 3 3L CG7049 CG7049 CDMC25993 2 16 22 DAC36-B08 3-CG7049-RA_2 CG7049 CAAGCTGATGCCAAGGAATGAACATTGGCTGAACATCTGGCAGGGAGACTTTCCCGATGGCAACC 65 FBan0007049 FBgn0035102 CG7049 3 3L CG7049 CG7049 CDMC25994 2 17 22 DAC36-B20 3-CG7070-RA_1 CG7070 GTGTTCGTCGATGACGGTCTGATCTCACTGATTGTCCGCGAGGTAGGCAAGGATTCCCTCACCTG 65 FBan0007070 FBgn0003178 PyK 3 3R glycolysis; GO:0006096; phosphorylation; GO:0016310 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; carbohydrate kinase activity; GO:0019200; ; GO:0019200; ; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 cytosol; GO:0005829 PyK Pyruvate kinase "CG7070, CG7070, Pyk, pyruvate kinase" CDMC25994 2 18 22 DAC36-B20 3-CG7070-RA_1 CG7070 GTGTTCGTCGATGACGGTCTGATCTCACTGATTGTCCGCGAGGTAGGCAAGGATTCCCTCACCTG 65 FBan0007070 FBgn0003178 PyK 3 3R glycolysis; GO:0006096; phosphorylation; GO:0016310 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; carbohydrate kinase activity; GO:0019200; ; GO:0019200; ; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 cytosol; GO:0005829 PyK Pyruvate kinase "CG7070, CG7070, Pyk, pyruvate kinase" CDMC25995 2 19 22 DAC36-F08 3-CG7204-RA_3 CG7204 GGCTGGCAAGTTGAGAAGCACGATCCACTGTCCAACACCATATGCAAGTCCTGTCTGGAGGATGC 65 FBan0007204 FBgn0037085 Neu2 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Neu2 Neu2 "CG7204, CG7204, CG7204" CDMC25995 2 20 22 DAC36-F08 3-CG7204-RA_3 CG7204 GGCTGGCAAGTTGAGAAGCACGATCCACTGTCCAACACCATATGCAAGTCCTGTCTGGAGGATGC 65 FBan0007204 FBgn0037085 Neu2 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Neu2 Neu2 "CG7204, CG7204, CG7204" CDMC25996 2 21 22 DAC36-F20 12-CG7238-RA_1 CG7238 ACGAGCTCATCGATCCCATGTACATGGCCCAACTACTGGACAGACACTTCTTCCCGCGCTGGATG 65 FBan0007238 FBgn0024191 sip1 2 2L mesoderm development; GO:0007498; skeletal development; GO:0001501 nucleic acid binding; GO:0003676; ; GO:0003676 extracellular matrix (sensu Metazoa); GO:0005578; intracellular; GO:0005622 sip1 septin interacting protein 1 "CG7238, GH11690, BcDNA:GH11690, septin interacting protein 1" CDMC25996 2 22 22 DAC36-F20 12-CG7238-RA_1 CG7238 ACGAGCTCATCGATCCCATGTACATGGCCCAACTACTGGACAGACACTTCTTCCCGCGCTGGATG 65 FBan0007238 FBgn0024191 sip1 2 2L mesoderm development; GO:0007498; skeletal development; GO:0001501 nucleic acid binding; GO:0003676; ; GO:0003676 extracellular matrix (sensu Metazoa); GO:0005578; intracellular; GO:0005622 sip1 septin interacting protein 1 "CG7238, GH11690, BcDNA:GH11690, septin interacting protein 1" CDMC25997 2 23 22 DAC36-J08 5-CG7322-RA_1 CG7322 CCCCGCTTGAAAGACGGAGCCTCAATTGTCAACGTGTCCTCGATAGCGTCATCCCGATCCTTTGG 65 FBan0007322 FBgn0030968 CG7322 X X lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7322 CG7322 CDMC25997 2 24 22 DAC36-J08 5-CG7322-RA_1 CG7322 CCCCGCTTGAAAGACGGAGCCTCAATTGTCAACGTGTCCTCGATAGCGTCATCCCGATCCTTTGG 65 FBan0007322 FBgn0030968 CG7322 X X lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7322 CG7322 CDMC25998 2 25 22 DAC36-J20 3-CG7360-RA_6 CG7360 ACGGACATCCACCTCCAAATTCACGAATGTCAGCCACGAGATCACGAACTTGAAATGGGCGCTGC 65 FBan0007360 FBgn0038722 Nup58 3 3R nucleocytoplasmic transport; GO:0006913 nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 Nup58 Nup58 "CG7360, CG7360" CDMC25998 2 26 22 DAC36-J20 3-CG7360-RA_6 CG7360 ACGGACATCCACCTCCAAATTCACGAATGTCAGCCACGAGATCACGAACTTGAAATGGGCGCTGC 65 FBan0007360 FBgn0038722 Nup58 3 3R nucleocytoplasmic transport; GO:0006913 nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 Nup58 Nup58 "CG7360, CG7360" CDMC25999 2 1 23 DAC36-N08 3-CG7432-RA_7 CG7432 TTTCCTCATCCTCCACTGTTTTGACCACTCAGAAACCTCTGAGGCTGACCACTCGTCCCACGACG 65 FBan0007432 FBgn0038727 CG7432 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG7432 CG7432 "c-SP19, SP19" CDMC25999 2 2 23 DAC36-N08 3-CG7432-RA_7 CG7432 TTTCCTCATCCTCCACTGTTTTGACCACTCAGAAACCTCTGAGGCTGACCACTCGTCCCACGACG 65 FBan0007432 FBgn0038727 CG7432 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG7432 CG7432 "c-SP19, SP19" CDMC26000 2 3 23 DAC36-N20 3-CG7458-RA_1 CG7458 ATCTTTCCCACAAACGTGCGAAACACCCTGTTGTCGCTCTGTTCCATGGTGGGACGGATAGGATC 65 FBan0007458 FBgn0037144 CG7458 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG7458 CG7458 CDMC26000 2 4 23 DAC36-N20 3-CG7458-RA_1 CG7458 ATCTTTCCCACAAACGTGCGAAACACCCTGTTGTCGCTCTGTTCCATGGTGGGACGGATAGGATC 65 FBan0007458 FBgn0037144 CG7458 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG7458 CG7458 CDMC26001 2 5 23 DAC37-B08 8-CG12876-RA_3 CG12876 GTCAATCGCATGGCAGAGCCTCAGATGAGTCTGGATGGTGGGCAGACAAGATGGGTGGTATTCGG 65 FBan0012876 FBgn0039541 CG12876 3 3R induction of apoptosis; GO:0006917; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; signal transducer activity; GO:0004871; ; GO:0005057; ; GO:0004871 CG12876 CG12876 CDMC26001 2 6 23 DAC37-B08 8-CG12876-RA_3 CG12876 GTCAATCGCATGGCAGAGCCTCAGATGAGTCTGGATGGTGGGCAGACAAGATGGGTGGTATTCGG 65 FBan0012876 FBgn0039541 CG12876 3 3R induction of apoptosis; GO:0006917; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; signal transducer activity; GO:0004871; ; GO:0005057; ; GO:0004871 CG12876 CG12876 CDMC26002 2 7 23 DAC37-B20 1-CG12920-RA_1 CG12920 ATCGGACATTGTCTCTGATGTGCATGGCGACTACCATAGCGAATCTCCCTCTGGACCAAGTGGCC 65 FBan0012920 FBgn0033481 CG12920 2 2R CG12920 CG12920 CDMC26002 2 8 23 DAC37-B20 1-CG12920-RA_1 CG12920 ATCGGACATTGTCTCTGATGTGCATGGCGACTACCATAGCGAATCTCCCTCTGGACCAAGTGGCC 65 FBan0012920 FBgn0033481 CG12920 2 2R CG12920 CG12920 CDMC26003 2 9 23 DAC37-F08 1-CG12997-RA_1 CG12997 GGGATTTCCAACTGGAGAGACTGGACAGTGCACTGGATAATCCCGAGCTGCCTCCTGACTTCCAG 65 FBan0012997 FBgn0030831 CG12997 X X CG12997 CG12997 CDMC26003 2 10 23 DAC37-F08 1-CG12997-RA_1 CG12997 GGGATTTCCAACTGGAGAGACTGGACAGTGCACTGGATAATCCCGAGCTGCCTCCTGACTTCCAG 65 FBan0012997 FBgn0030831 CG12997 X X CG12997 CG12997 CDMC26004 2 11 23 DAC37-F20 23-CG13023-RA_1 CG13023 ATGAAGCGTGTACAAAAAACTTTGGAGATTGAAGAGGAGATATTGAAGCAACAATCCGCCAGGAT 65 FBan0013023 FBgn0036677 CG13023 3 3L CG13023 CG13023 CDMC26004 2 12 23 DAC37-F20 23-CG13023-RA_1 CG13023 ATGAAGCGTGTACAAAAAACTTTGGAGATTGAAGAGGAGATATTGAAGCAACAATCCGCCAGGAT 65 FBan0013023 FBgn0036677 CG13023 3 3L CG13023 CG13023 CDMC26005 2 13 23 DAC37-J08 16-CG13059-RA_1 CG13059 GTACATGCCGCTCCTCTGGTCAAGACTGTGATCCCTGCCGCTCCCCTGGTCAAGACTGTGATCCC 65 FBan0013059 FBgn0036607 CG13059 3 3L CG13059 CG13059 CDMC26005 2 14 23 DAC37-J08 16-CG13059-RA_1 CG13059 GTACATGCCGCTCCTCTGGTCAAGACTGTGATCCCTGCCGCTCCCCTGGTCAAGACTGTGATCCC 65 FBan0013059 FBgn0036607 CG13059 3 3L CG13059 CG13059 CDMC26006 2 15 23 DAC37-J20 3-CG13078-RA_1 CG13078 ACTGTGCGTTACTCCCGGAATTACAAGACTGCCTTTCACGTGGTCCTTCAGATCCTTGGGGGAGG 65 FBan0013078 FBgn0032809 CG13078 2 2L CG13078 CG13078 CDMC26006 2 16 23 DAC37-J20 3-CG13078-RA_1 CG13078 ACTGTGCGTTACTCCCGGAATTACAAGACTGCCTTTCACGTGGTCCTTCAGATCCTTGGGGGAGG 65 FBan0013078 FBgn0032809 CG13078 2 2L CG13078 CG13078 CDMC26007 2 17 23 DAC37-N08 3-CG13154-RA_2 CG13154 AACGCTGCCAACAAGCACATCAACCTCAATCTCAAGTGGCTTAACACCTACGAGAGGGCCATGGG 65 FBan0013154 FBgn0033736 CG13154 2 2R CG13154 CG13154 CDMC26007 2 18 23 DAC37-N08 3-CG13154-RA_2 CG13154 AACGCTGCCAACAAGCACATCAACCTCAATCTCAAGTGGCTTAACACCTACGAGAGGGCCATGGG 65 FBan0013154 FBgn0033736 CG13154 2 2R CG13154 CG13154 CDMC26008 2 19 23 DAC37-N20 23-CG13169-RA_1 CG13169 CTTCATCGACCTCGACTTCCAACTCACAATTGTCCAACATACTCTCCACCATTCTGATATCATCA 65 FBan0013169 FBgn0033704 CG13169 2 2R CG13169 CG13169 CDMC26008 2 20 23 DAC37-N20 23-CG13169-RA_1 CG13169 CTTCATCGACCTCGACTTCCAACTCACAATTGTCCAACATACTCTCCACCATTCTGATATCATCA 65 FBan0013169 FBgn0033704 CG13169 2 2R CG13169 CG13169 CDMC26009 2 21 23 DAC38-B08 24-CG32564-RA_5 CG32564 GGACTCCAAAATCTAACCTAACCTAACCGTACTCAACTATTTTTTTTCTAGTTCTAAAACGAATACCTT 69 FBan0032564 FBgn0052564 CG32564 X X CG32564 CG32564 "CG5095, CG5095" CDMC26009 2 22 23 DAC38-B08 24-CG32564-RA_5 CG32564 GGACTCCAAAATCTAACCTAACCTAACCGTACTCAACTATTTTTTTTCTAGTTCTAAAACGAATACCTT 69 FBan0032564 FBgn0052564 CG32564 X X CG32564 CG32564 "CG5095, CG5095" CDMC26010 2 23 23 DAC38-B20 11-CG32578-RA_1 CG32578 AGCACCGATTGCGACTTTCTGGAGCTCTCTAGACTGAATCAACCAACTGCTGACAACCAAAACAAGGCA 69 FBan0032578 FBgn0042713 Gpi1 X X GPI anchor biosynthesis; GO:0006506; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0017176 ; EC:2.4.1.198" endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 Gpi1 Gpi1 "CG32578, dGpi1, Dm_CAC10056/216-441" CDMC26010 2 24 23 DAC38-B20 11-CG32578-RA_1 CG32578 AGCACCGATTGCGACTTTCTGGAGCTCTCTAGACTGAATCAACCAACTGCTGACAACCAAAACAAGGCA 69 FBan0032578 FBgn0042713 Gpi1 X X GPI anchor biosynthesis; GO:0006506; polysaccharide metabolism; GO:0005976 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0017176 ; EC:2.4.1.198" endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 Gpi1 Gpi1 "CG32578, dGpi1, Dm_CAC10056/216-441" CDMC26011 2 25 23 DAC38-F08 18-CG32603-RA_2 CG32603 GCAGATTGGCTGTGAAGAAGGTACTAGTGTTCTCACAACTTCGGTCCCAGCAACATGAAATTCTTCGCT 69 FBan0032603 FBgn0052603 CG32603 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32603 CG32603 CDMC26011 2 26 23 DAC38-F08 18-CG32603-RA_2 CG32603 GCAGATTGGCTGTGAAGAAGGTACTAGTGTTCTCACAACTTCGGTCCCAGCAACATGAAATTCTTCGCT 69 FBan0032603 FBgn0052603 CG32603 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32603 CG32603 CDMC26012 2 1 24 DAC38-F20 23-CG32628-RA_6 CG32628 CAGGTGCATCACCGAGTTTTTTCATTCAAAATTTTAGTCAAATTTAATCCGTTTTAGACCCGTCCGTTT 69 FBan0032628 FBgn0052628 CG32628 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 cellular component unknown; GO:0008372 CG32628 CG32628 "CG11428, CG11428" CDMC26012 2 2 24 DAC38-F20 23-CG32628-RA_6 CG32628 CAGGTGCATCACCGAGTTTTTTCATTCAAAATTTTAGTCAAATTTAATCCGTTTTAGACCCGTCCGTTT 69 FBan0032628 FBgn0052628 CG32628 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 cellular component unknown; GO:0008372 CG32628 CG32628 "CG11428, CG11428" CDMC26013 2 3 24 DAC38-J08 23-CG32652-RA_10 CG32652 TTGCGCTTACAATCAATGCAAGCCATAGAAGCCTACTCTTCATACACTATGTTAATAAGCCATCTTATG 69 FBan0032652 FBgn0052652 CG32652 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32652 CG32652 "bs14f06.y1, bs08g03.y1, bs30c01.y1, bs13e06.y1, bs16e05.y1, bs24h05.y1, bs27e03.y1, bs27g02.y1, bs14d08.y1, bs02c02.y1, NEST:bs14f06, NEST:bs02c02, NEST:bs08g03, NEST:bs13e06, NEST:bs16e05, NEST:bs23h05, NEST:bs24h05, NEST:bs27e03, NEST:bs27g02, NEST:bs29d03, NEST:bs30c01" CDMC26013 2 4 24 DAC38-J08 23-CG32652-RA_10 CG32652 TTGCGCTTACAATCAATGCAAGCCATAGAAGCCTACTCTTCATACACTATGTTAATAAGCCATCTTATG 69 FBan0032652 FBgn0052652 CG32652 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32652 CG32652 "bs14f06.y1, bs08g03.y1, bs30c01.y1, bs13e06.y1, bs16e05.y1, bs24h05.y1, bs27e03.y1, bs27g02.y1, bs14d08.y1, bs02c02.y1, NEST:bs14f06, NEST:bs02c02, NEST:bs08g03, NEST:bs13e06, NEST:bs16e05, NEST:bs23h05, NEST:bs24h05, NEST:bs27e03, NEST:bs27g02, NEST:bs29d03, NEST:bs30c01" CDMC26014 2 5 24 DAC38-J20 23-CG32666-RB_6 CG32666 TTCGCCTAGGGGGAATCAGAATTTAGAGAATGTTACCAGCCAAGCAAAATTGTTAATCGTGTGTCTCGG 69 FBan0032666 FBgn0052666 CG32666 X X cell adhesion; GO:0007155; induction of apoptosis; GO:0006917; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG32666 CG32666 "CG1760, CG11713, CG1760, CG1760, EP(X)1452, EP1452" CDMC26014 2 6 24 DAC38-J20 23-CG32666-RB_6 CG32666 TTCGCCTAGGGGGAATCAGAATTTAGAGAATGTTACCAGCCAAGCAAAATTGTTAATCGTGTGTCTCGG 69 FBan0032666 FBgn0052666 CG32666 X X cell adhesion; GO:0007155; induction of apoptosis; GO:0006917; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005200; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG32666 CG32666 "CG1760, CG11713, CG1760, CG1760, EP(X)1452, EP1452" CDMC26015 2 7 24 DAC38-N08 17-CG32699-RA_1 CG32699 TAGCTCTACAGCGAATCCAGTCAGCAAATAGACAGGGAAAGCTTTGTGCGATTGATGAGACACGCTGGC 69 FBan0032699 FBgn0052699 CG32699 X X metabolism; GO:0008152 calcium ion binding; GO:0005509; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0005509; ; GO:0008415 ; EC:2.3.1.- cellular component unknown; GO:0008372 CG32699 CG32699 "CG15318, CG2996, CG18535, CG15318, CG2996, CG2996, CT7882, tok-like" CDMC26015 2 8 24 DAC38-N08 17-CG32699-RA_1 CG32699 TAGCTCTACAGCGAATCCAGTCAGCAAATAGACAGGGAAAGCTTTGTGCGATTGATGAGACACGCTGGC 69 FBan0032699 FBgn0052699 CG32699 X X metabolism; GO:0008152 calcium ion binding; GO:0005509; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0005509; ; GO:0008415 ; EC:2.3.1.- cellular component unknown; GO:0008372 CG32699 CG32699 "CG15318, CG2996, CG18535, CG15318, CG2996, CG2996, CT7882, tok-like" CDMC26016 2 9 24 DAC38-N20 3-CG32704-RA_2 CG32704 AGCTGGCCCTTAACGCTAGCAAGGATTTCAAGAAGTTCCGCATCTGGGACTATCCGATCAAGGAGCAGT 69 FBan0032704 FBgn0052704 CG32704 X X cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG32704 CG32704 "CG12122, CG12666, CT7438" CDMC26016 2 10 24 DAC38-N20 3-CG32704-RA_2 CG32704 AGCTGGCCCTTAACGCTAGCAAGGATTTCAAGAAGTTCCGCATCTGGGACTATCCGATCAAGGAGCAGT 69 FBan0032704 FBgn0052704 CG32704 X X cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG32704 CG32704 "CG12122, CG12666, CT7438" CDMC26017 2 11 24 DAC39-B08 10-CG13658-RA_1 CG13658 TCTGGCGGACACTCTGAAAAAAATAGGCTTCAAAGGTGAAATGCCAACTCAGACAGGAGTGTGGGAGCA 69 FBan0013658 FBgn0039315 CG13658 3 3R CG13658 CG13658 CDMC26017 2 12 24 DAC39-B08 10-CG13658-RA_1 CG13658 TCTGGCGGACACTCTGAAAAAAATAGGCTTCAAAGGTGAAATGCCAACTCAGACAGGAGTGTGGGAGCA 69 FBan0013658 FBgn0039315 CG13658 3 3R CG13658 CG13658 CDMC26018 2 13 24 DAC39-B20 6-CG13667-RA_8 CG13667 ACTACAGAATCTGGGAGCAAATAGCGTGTGTCCAGTGGGTCTGTGTGATGATCAGCATGACTACGGGCA 69 FBan0013667 FBgn0035890 CG13667 3 3L amino acid metabolism; GO:0006520; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 CG13667 CG13667 CDMC26018 2 14 24 DAC39-B20 6-CG13667-RA_8 CG13667 ACTACAGAATCTGGGAGCAAATAGCGTGTGTCCAGTGGGTCTGTGTGATGATCAGCATGACTACGGGCA 69 FBan0013667 FBgn0035890 CG13667 3 3L amino acid metabolism; GO:0006520; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 CG13667 CG13667 CDMC26019 2 15 24 DAC39-F08 7-CG13720-RA_1 CG13720 AGCCAGGCGATAAAAGTGGATAGTGGGAGCAAGGAAGGAGATTCCAGTAGCACTCCAAGTCCTCCTCTT 69 FBan0013720 FBgn0035555 CG13720 3 3L CG13720 CG13720 CDMC26019 2 16 24 DAC39-F08 7-CG13720-RA_1 CG13720 AGCCAGGCGATAAAAGTGGATAGTGGGAGCAAGGAAGGAGATTCCAGTAGCACTCCAAGTCCTCCTCTT 69 FBan0013720 FBgn0035555 CG13720 3 3L CG13720 CG13720 CDMC26020 2 17 24 DAC39-F20 18-CG13738-RA_2 CG13738 CGATGAAGTACTTTGTGATCTGTGTTTTGGCTGCAATCGTTCTTTTCCAGTCCGCATCGGGATTCAAGC 69 FBan0013738 FBgn0036390 CG13738 3 3L CG13738 CG13738 BcDNA:RE61257 CDMC26020 2 18 24 DAC39-F20 18-CG13738-RA_2 CG13738 CGATGAAGTACTTTGTGATCTGTGTTTTGGCTGCAATCGTTCTTTTCCAGTCCGCATCGGGATTCAAGC 69 FBan0013738 FBgn0036390 CG13738 3 3L CG13738 CG13738 BcDNA:RE61257 CDMC26021 2 19 24 DAC39-J08 23-CG13777-RA_5 CG13777 GGATGCCTTTTGCGAGTGAAGTAACATTTTTATTTAAGCACTACGCGAGAACAAGTTGAATAACGAAAC 69 FBan0013777 FBgn0022201 milt 2 2L axon transport of mitochondrion; GO:0019896 kinesin-associated mitochondrial adaptor activity; GO:0019895; ; GO:0019895 mitochondrion; GO:0005739 milt milton "CG13777, CG13777, l(2)k04704, Milton, anon-WO0153538.19" CDMC26021 2 20 24 DAC39-J08 23-CG13777-RA_5 CG13777 GGATGCCTTTTGCGAGTGAAGTAACATTTTTATTTAAGCACTACGCGAGAACAAGTTGAATAACGAAAC 69 FBan0013777 FBgn0022201 milt 2 2L axon transport of mitochondrion; GO:0019896 kinesin-associated mitochondrial adaptor activity; GO:0019895; ; GO:0019895 mitochondrion; GO:0005739 milt milton "CG13777, CG13777, l(2)k04704, Milton, anon-WO0153538.19" CDMC26022 2 21 24 DAC39-J20 2-CG13786-RA_1 CG13786 CCCCAATCCGCCAAAAAGATTTTGGGGTGTGACACCTGTAGGATTCCTTCCGCGGAATCAGATAAGGCA 69 FBan0013786 FBgn0031900 CG13786 2 2L CG13786 CG13786 CDMC26022 2 22 24 DAC39-J20 2-CG13786-RA_1 CG13786 CCCCAATCCGCCAAAAAGATTTTGGGGTGTGACACCTGTAGGATTCCTTCCGCGGAATCAGATAAGGCA 69 FBan0013786 FBgn0031900 CG13786 2 2L CG13786 CG13786 CDMC26023 2 23 24 DAC39-N08 17-CG13827-RA_2 CG13827 CGAGCACAAGATTGTGGATGTCAAGAATGCGGATAACTGGGACAATGTCAACTCCATATTCTGGGTGCT 69 FBan0013827 FBgn0039068 CG13827 3 3R CG13827 CG13827 BcDNA:RE30473 CDMC26023 2 24 24 DAC39-N08 17-CG13827-RA_2 CG13827 CGAGCACAAGATTGTGGATGTCAAGAATGCGGATAACTGGGACAATGTCAACTCCATATTCTGGGTGCT 69 FBan0013827 FBgn0039068 CG13827 3 3R CG13827 CG13827 BcDNA:RE30473 CDMC26024 2 25 24 DAC39-N20 2-CG13848-RA_1 CG13848 CCAAGATAAGATCGCGACTTTTCGTGCGTCGTGAAGGAACATCCGTGAGCTGCGATCAGTTGCCAAAGG 69 FBan0013848 FBgn0038966 CG13848 3 3R carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 CG13848 CG13848 CT33362 CDMC26024 2 26 24 DAC39-N20 2-CG13848-RA_1 CG13848 CCAAGATAAGATCGCGACTTTTCGTGCGTCGTGAAGGAACATCCGTGAGCTGCGATCAGTTGCCAAAGG 69 FBan0013848 FBgn0038966 CG13848 3 3R carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 CG13848 CG13848 CT33362 CDMC26025 2 1 25 DAC40-B08 1-CG14128-RA_1 CG14128 AAGTACCACGTTTCCATGAGAGTCCTTACCGTTCCCCCTCCTTCTCAGGCGAGGGTCAAATCGAG 65 FBan0014128 FBgn0036218 CG14128 3 3L CG14128 CG14128 CDMC26025 2 2 25 DAC40-B08 1-CG14128-RA_1 CG14128 AAGTACCACGTTTCCATGAGAGTCCTTACCGTTCCCCCTCCTTCTCAGGCGAGGGTCAAATCGAG 65 FBan0014128 FBgn0036218 CG14128 3 3L CG14128 CG14128 CDMC26026 2 3 25 DAC40-B20 2-CG14145-RA_1 CG14145 CTGGACGCATACAGCATAGCCCTAGAAAATCGCGTCAAGTGCGTGCTGCAAAGGAAATCCGGAGG 65 FBan0014145 FBgn0036118 CG14145 3 3L CG14145 CG14145 CDMC26026 2 4 25 DAC40-B20 2-CG14145-RA_1 CG14145 CTGGACGCATACAGCATAGCCCTAGAAAATCGCGTCAAGTGCGTGCTGCAAAGGAAATCCGGAGG 65 FBan0014145 FBgn0036118 CG14145 3 3L CG14145 CG14145 CDMC26027 2 5 25 DAC40-F08 18-CG14220-RA_1 CG14220 CGCCCAGAAGGAGTACGACGAAAAGATGATGGACCTCAAAGACAACCTGATCTCGGACTTCGAGG 65 FBan0014220 FBgn0031036 CG14220 X X CG14220 CG14220 CDMC26027 2 6 25 DAC40-F08 18-CG14220-RA_1 CG14220 CGCCCAGAAGGAGTACGACGAAAAGATGATGGACCTCAAAGACAACCTGATCTCGGACTTCGAGG 65 FBan0014220 FBgn0031036 CG14220 X X CG14220 CG14220 CDMC26028 2 7 25 DAC40-F20 13-CG14244-RA_1 CG14244 CTGCAAATCCCCCAGCGTTATTGTTTGGACCCCACCAAGTACTGGCTCTGCAGCGCCATCAACTC 65 FBan0014244 FBgn0040607 CG14244 3 3R CG14244 CG14244 CDMC26028 2 8 25 DAC40-F20 13-CG14244-RA_1 CG14244 CTGCAAATCCCCCAGCGTTATTGTTTGGACCCCACCAAGTACTGGCTCTGCAGCGCCATCAACTC 65 FBan0014244 FBgn0040607 CG14244 3 3R CG14244 CG14244 CDMC26029 2 9 25 DAC40-J08 1-CG14310-RA_1 CG14310 CTACTACCCACCCCTCTGCTGCTTCCACGTCCACATCCTCATCCAAATCCAAAGTCACCCTCCTC 65 FBan0014310 FBgn0040569 CG14310 3 3R CG14310 CG14310 CDMC26029 2 10 25 DAC40-J08 1-CG14310-RA_1 CG14310 CTACTACCCACCCCTCTGCTGCTTCCACGTCCACATCCTCATCCAAATCCAAAGTCACCCTCCTC 65 FBan0014310 FBgn0040569 CG14310 3 3R CG14310 CG14310 CDMC26030 2 11 25 DAC40-J20 3-CG14356-RA_2 CG14356 GTCAGGTGTTGCCCATACAACCCGTGTTGATTTACCCCAAGCCACGTGAGAATCTCTACCAGGCG 65 FBan0014356 FBgn0038207 CG14356 3 3R CG14356 CG14356 CDMC26030 2 12 25 DAC40-J20 3-CG14356-RA_2 CG14356 GTCAGGTGTTGCCCATACAACCCGTGTTGATTTACCCCAAGCCACGTGAGAATCTCTACCAGGCG 65 FBan0014356 FBgn0038207 CG14356 3 3R CG14356 CG14356 CDMC26031 2 13 25 DAC40-N08 24-CG1441-RA_1 CG1441 ATGATAAGTACTTTACTTGTTATGAAAAGCAGCTAATAAAAAAAATTGGTTTATGTATGGCGACG 65 FBan0001441 FBgn0033464 CG1441 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG1441 CG1441 CDMC26031 2 14 25 DAC40-N08 24-CG1441-RA_1 CG1441 ATGATAAGTACTTTACTTGTTATGAAAAGCAGCTAATAAAAAAAATTGGTTTATGTATGGCGACG 65 FBan0001441 FBgn0033464 CG1441 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG1441 CG1441 CDMC26032 2 15 25 DAC40-N20 2-CG14455-RA_1 CG14455 AAGACGCACCAGGACATAGAGGACGTTCAGCTGGTGGTAGACTTTGGTTTGGAGACGGACAAGGG 65 FBan0014455 FBgn0037175 CG14455 3 3L CG14455 CG14455 CDMC26032 2 16 25 DAC40-N20 2-CG14455-RA_1 CG14455 AAGACGCACCAGGACATAGAGGACGTTCAGCTGGTGGTAGACTTTGGTTTGGAGACGGACAAGGG 65 FBan0014455 FBgn0037175 CG14455 3 3L CG14455 CG14455 CDMC26033 2 17 25 DAC41-B08 AutoBlank AutoBlank CDMC26033 2 18 25 DAC41-B08 AutoBlank AutoBlank CDMC26034 2 19 25 DAC41-B20 AutoBlank AutoBlank CDMC26034 2 20 25 DAC41-B20 AutoBlank AutoBlank CDMC26035 2 21 25 DAC41-F08 AutoBlank AutoBlank CDMC26035 2 22 25 DAC41-F08 AutoBlank AutoBlank CDMC26036 2 23 25 DAC41-F20 AutoBlank AutoBlank CDMC26036 2 24 25 DAC41-F20 AutoBlank AutoBlank CDMC26037 2 25 25 DAC41-J08 AutoBlank AutoBlank CDMC26037 2 26 25 DAC41-J08 AutoBlank AutoBlank CDMC26038 2 1 26 DAC41-J20 AutoBlank AutoBlank CDMC26038 2 2 26 DAC41-J20 AutoBlank AutoBlank CDMC26039 2 3 26 DAC41-N08 AutoBlank AutoBlank CDMC26039 2 4 26 DAC41-N08 AutoBlank AutoBlank CDMC26040 2 5 26 DAC41-N20 AutoBlank AutoBlank CDMC26040 2 6 26 DAC41-N20 AutoBlank AutoBlank CDMC26041 2 7 26 DAC42-B08 150mM NaPO4 Blank CDMC26041 2 8 26 DAC42-B08 150mM NaPO4 Blank CDMC26042 2 9 26 DAC42-B20 150mM NaPO4 Blank CDMC26042 2 10 26 DAC42-B20 150mM NaPO4 Blank CDMC26043 2 11 26 DAC42-F08 150mM NaPO4 Blank CDMC26043 2 12 26 DAC42-F08 150mM NaPO4 Blank CDMC26044 2 13 26 DAC42-F20 150mM NaPO4 Blank CDMC26044 2 14 26 DAC42-F20 150mM NaPO4 Blank CDMC26045 2 15 26 DAC42-J08 150mM NaPO4 Blank CDMC26045 2 16 26 DAC42-J08 150mM NaPO4 Blank CDMC26046 2 17 26 DAC42-J20 5uM MSP 5uM MSP CDMC26046 2 18 26 DAC42-J20 5uM MSP 5uM MSP CDMC26047 2 19 26 DAC42-N08 10uM MSP 10uM MSP CDMC26047 2 20 26 DAC42-N08 10uM MSP 10uM MSP CDMC26048 2 21 26 DAC42-N20 20uM MSP 20uM MSP CDMC26048 2 22 26 DAC42-N20 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC26049 3 1 1 DAC01-C08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26049 3 2 1 DAC01-C08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26050 3 3 1 DAC01-C20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26050 3 4 1 DAC01-C20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26051 3 5 1 DAC01-G08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26051 3 6 1 DAC01-G08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26052 3 7 1 DAC01-G20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26052 3 8 1 DAC01-G20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26053 3 9 1 DAC01-K08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26053 3 10 1 DAC01-K08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26054 3 11 1 DAC01-K20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26054 3 12 1 DAC01-K20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26055 3 13 1 DAC01-O08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26055 3 14 1 DAC01-O08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26056 3 15 1 DAC01-O20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26056 3 16 1 DAC01-O20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26057 3 17 1 DAC02-C08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26057 3 18 1 DAC02-C08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26058 3 19 1 DAC02-C20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26058 3 20 1 DAC02-C20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26059 3 21 1 DAC02-G08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26059 3 22 1 DAC02-G08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26060 3 23 1 DAC02-G20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26060 3 24 1 DAC02-G20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26061 3 25 1 DAC02-K08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26061 3 26 1 DAC02-K08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26062 3 1 2 DAC02-K20 N/A CG9075 (00718-00956) CDMC26062 3 2 2 DAC02-K20 N/A CG9075 (00718-00956) CDMC26063 3 3 2 DAC02-O08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26063 3 4 2 DAC02-O08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26064 3 5 2 DAC02-O20 AutoBlank AutoBlank CDMC26064 3 6 2 DAC02-O20 AutoBlank AutoBlank CDMC26065 3 7 2 DAC03-C08 18-CG32228-RA_1 CG32228 GCCTGTTCGGAAAAAAAGTGCCTGCATTATATGCCGAACTATTAGAGGCAATCACGGAGCAAAGGAAGC 69 FBan0032228 FBgn0052228 CG32228 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32228 CG32228 CDMC26065 3 8 2 DAC03-C08 18-CG32228-RA_1 CG32228 GCCTGTTCGGAAAAAAAGTGCCTGCATTATATGCCGAACTATTAGAGGCAATCACGGAGCAAAGGAAGC 69 FBan0032228 FBgn0052228 CG32228 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32228 CG32228 CDMC26066 3 9 2 DAC03-C20 15-CG32237-RA_1 CG32237 GCCGTGCCCTGTAAGTCTGGATGACTGCGAATACACTTGTACCTGAACTTCTCGTTCGCGACTTGATTC 69 FBan0032237 FBgn0052237 CG32237 3 3L CG32237 CG32237 "CG13706, CG13703, CG13706, BcDNA:RE17910" CDMC26066 3 10 2 DAC03-C20 15-CG32237-RA_1 CG32237 GCCGTGCCCTGTAAGTCTGGATGACTGCGAATACACTTGTACCTGAACTTCTCGTTCGCGACTTGATTC 69 FBan0032237 FBgn0052237 CG32237 3 3L CG32237 CG32237 "CG13706, CG13703, CG13706, BcDNA:RE17910" CDMC26067 3 11 2 DAC03-G08 3-CG32262-RA_5 CG32262 AGGGACCTCTTCACCACTACGTGTACAACTGGATGGACAGGGTAATGCCGGCTCGTACGCTAAAGAACA 69 FBan0032262 FBgn0052262 CG32262 3 3L receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG32262 CG32262 CG10854 CDMC26067 3 12 2 DAC03-G08 3-CG32262-RA_5 CG32262 AGGGACCTCTTCACCACTACGTGTACAACTGGATGGACAGGGTAATGCCGGCTCGTACGCTAAAGAACA 69 FBan0032262 FBgn0052262 CG32262 3 3L receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG32262 CG32262 CG10854 CDMC26068 3 13 2 DAC03-G20 23-CG32276-RA_9 CG32276 AGCCCAATCAATAGGCAATTAACAAACAATTCATTTGCGAATTTCAGTGAGATTGTGCTTCAACAACAA 69 FBan0032276 FBgn0047135 CG32276 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; response to stress; GO:0006950 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 endoplasmic reticulum; GO:0005783; ribosome; GO:0005840 CG32276 CG32276 BcDNA:RE27904 CDMC26068 3 14 2 DAC03-G20 23-CG32276-RA_9 CG32276 AGCCCAATCAATAGGCAATTAACAAACAATTCATTTGCGAATTTCAGTGAGATTGTGCTTCAACAACAA 69 FBan0032276 FBgn0047135 CG32276 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; response to stress; GO:0006950 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 endoplasmic reticulum; GO:0005783; ribosome; GO:0005840 CG32276 CG32276 BcDNA:RE27904 CDMC26069 3 15 2 DAC03-K08 3-CG32315-RA_2 CG32315 ACCCGGAATCTTTGACGGCTTGATCAGCATTAGTTTTGTGCAGGAGATGGCAAACAGTGCGGACAGCTT 69 FBan0032315 FBgn0024510 dlt 3 3L S phase of mitotic cell cycle; GO:0000084; cellular physiological process; GO:0050875; imaginal disc morphogenesis; GO:0007560; morphogenesis of a polarized epithelium; GO:0001738; olfactory behavior; GO:0042048; protein targeting; GO:0006605; regulation of cell proliferation; GO:0042127 transcription regulator activity; GO:0030528; ; GO:0030528 cytoplasm; GO:0005737 dlt discs lost "CG1977, CG32315, CG1977, CG32315, CG32315, l(3)dre1, l(3)62Ba, dre1, l(3)04276, Van, Vanaso, vanaso, lethal(3)62Ba, discs lost" CDMC26069 3 16 2 DAC03-K08 3-CG32315-RA_2 CG32315 ACCCGGAATCTTTGACGGCTTGATCAGCATTAGTTTTGTGCAGGAGATGGCAAACAGTGCGGACAGCTT 69 FBan0032315 FBgn0024510 dlt 3 3L S phase of mitotic cell cycle; GO:0000084; cellular physiological process; GO:0050875; imaginal disc morphogenesis; GO:0007560; morphogenesis of a polarized epithelium; GO:0001738; olfactory behavior; GO:0042048; protein targeting; GO:0006605; regulation of cell proliferation; GO:0042127 transcription regulator activity; GO:0030528; ; GO:0030528 cytoplasm; GO:0005737 dlt discs lost "CG1977, CG32315, CG1977, CG32315, CG32315, l(3)dre1, l(3)62Ba, dre1, l(3)04276, Van, Vanaso, vanaso, lethal(3)62Ba, discs lost" CDMC26070 3 17 2 DAC03-K20 16-CG32331-RA_1 CG32331 GCCATGCCAAGGTGCTTCGAGGAAAGTGCAAACAGCAGATGTAATGGATATGGAAAGGCAAATCGAAAA 69 FBan0032331 FBgn0046769 CG32331 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32331 CG32331 BcDNA:LD40851 CDMC26070 3 18 2 DAC03-K20 16-CG32331-RA_1 CG32331 GCCATGCCAAGGTGCTTCGAGGAAAGTGCAAACAGCAGATGTAATGGATATGGAAAGGCAAATCGAAAA 69 FBan0032331 FBgn0046769 CG32331 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32331 CG32331 BcDNA:LD40851 CDMC26071 3 19 2 DAC03-O08 2-CG32373-RB_1 CG32373 CCCTCGCATTGAGTTGTCCAGTTTTGACACCCCCTCGCAATGGACGTTTCTATCCTGCAAGCTGCAATA 69 FBan0032373 FBgn0052373 CG32373 3 3L CG32373 CG32373 BcDNA:RE64043 CDMC26071 3 20 2 DAC03-O08 2-CG32373-RB_1 CG32373 CCCTCGCATTGAGTTGTCCAGTTTTGACACCCCCTCGCAATGGACGTTTCTATCCTGCAAGCTGCAATA 69 FBan0032373 FBgn0052373 CG32373 3 3L CG32373 CG32373 BcDNA:RE64043 CDMC26072 3 21 2 DAC03-O20 7-CG32389-RA_1 CG32389 TATCGAGCACGTTCAAATCGCAAGACTCCATACAGTGCCACATACCCACATTGGTCAAGTCGCCATCGA 69 FBan0032389 FBgn0052389 CG32389 3 3L CG32389 CG32389 "CG8619, CT14584" CDMC26072 3 22 2 DAC03-O20 7-CG32389-RA_1 CG32389 TATCGAGCACGTTCAAATCGCAAGACTCCATACAGTGCCACATACCCACATTGGTCAAGTCGCCATCGA 69 FBan0032389 FBgn0052389 CG32389 3 3L CG32389 CG32389 "CG8619, CT14584" CDMC26073 3 23 2 DAC04-C08 14-CG2948-RA_1 CG2948 AGGGCGAACCGTTTACCTCCTTCCTTTGGCTAGGGTAGATGATTTGGGACTGAAAATGGATGTCCTCAT 69 FBan0002948 FBgn0037345 rev7 3 3R rev7 rev7 "CG2948, CG2948, DmREV7" CDMC26073 3 24 2 DAC04-C08 14-CG2948-RA_1 CG2948 AGGGCGAACCGTTTACCTCCTTCCTTTGGCTAGGGTAGATGATTTGGGACTGAAAATGGATGTCCTCAT 69 FBan0002948 FBgn0037345 rev7 3 3R rev7 rev7 "CG2948, CG2948, DmREV7" CDMC26074 3 25 2 DAC04-C20 38-CG2964-RA_7 CG2964 ACGCGGACACCATATACACCATGATAATGCGCGGAGTGAACATATTCCGTCTGAACTTCTCCCACGAAT 69 FBan0002964 FBgn0031462 CG2964 2 2L glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG2964 CG2964 CDMC26074 3 26 2 DAC04-C20 38-CG2964-RA_7 CG2964 ACGCGGACACCATATACACCATGATAATGCGCGGAGTGAACATATTCCGTCTGAACTTCTCCCACGAAT 69 FBan0002964 FBgn0031462 CG2964 2 2L glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG2964 CG2964 CDMC26075 3 1 3 DAC04-G08 22-CG2999-RA_1 CG2999 TCTGAGCGGGGTAATGGACATATCAAAAGAAGTAGAAAAAAACTTGTCACCCAAGCAATGCGCAGTGCT 69 FBan0002999 FBgn0025726 unc-13 4 4 intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; signal transduction; GO:0007165; synaptic transmission; GO:0007268; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082 calmodulin binding; GO:0005516; diacylglycerol binding; GO:0019992; ; GO:0005516; ; GO:0019992; receptor activity; GO:0004872; ; GO:0004872 synaptic vesicle; GO:0008021 unc-13 unc-13 "CG2999, CG2999, dUNC-13, Dunc-13, UNC-13, UNC-13-B, l(4)ry16, dunc-13, drunc13, Munc-13, dUnc-13, Dunc13, Munc-13/UNC-13, lethal (4) ry16" CDMC26075 3 2 3 DAC04-G08 22-CG2999-RA_1 CG2999 TCTGAGCGGGGTAATGGACATATCAAAAGAAGTAGAAAAAAACTTGTCACCCAAGCAATGCGCAGTGCT 69 FBan0002999 FBgn0025726 unc-13 4 4 intracellular signaling cascade; GO:0007242; neurotransmitter secretion; GO:0007269; signal transduction; GO:0007165; synaptic transmission; GO:0007268; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082 calmodulin binding; GO:0005516; diacylglycerol binding; GO:0019992; ; GO:0005516; ; GO:0019992; receptor activity; GO:0004872; ; GO:0004872 synaptic vesicle; GO:0008021 unc-13 unc-13 "CG2999, CG2999, dUNC-13, Dunc-13, UNC-13, UNC-13-B, l(4)ry16, dunc-13, drunc13, Munc-13, dUnc-13, Dunc13, Munc-13/UNC-13, lethal (4) ry16" CDMC26076 3 3 3 DAC04-G20 12-CG30008-RA_1 CG30008 TAAGGATCCCTGGTACATGATCACAGTGCTGGTCCTCTATCTGTACTTCGTCACCAAAGCGGGTCCGCA 69 FBan0030008 FBgn0050008 CG30008 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG30008 CG30008 "CG12138, anon-WO0140519.246" CDMC26076 3 4 3 DAC04-G20 12-CG30008-RA_1 CG30008 TAAGGATCCCTGGTACATGATCACAGTGCTGGTCCTCTATCTGTACTTCGTCACCAAAGCGGGTCCGCA 69 FBan0030008 FBgn0050008 CG30008 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG30008 CG30008 "CG12138, anon-WO0140519.246" CDMC26077 3 5 3 DAC04-K08 23-CG30035-RA_1 CG30035 GTTGCGTGAATTTATCGGTGTAAAAAAAATGACATGAATCGTAGTTAGTTGTAGTGCAAAAGCAAGCGC 69 FBan0030035 FBgn0050035 CG30035 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005355 integral to membrane; GO:0016021 CG30035 CG30035 "CG7797, CG7801" CDMC26077 3 6 3 DAC04-K08 23-CG30035-RA_1 CG30035 GTTGCGTGAATTTATCGGTGTAAAAAAAATGACATGAATCGTAGTTAGTTGTAGTGCAAAAGCAAGCGC 69 FBan0030035 FBgn0050035 CG30035 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005355 integral to membrane; GO:0016021 CG30035 CG30035 "CG7797, CG7801" CDMC26078 3 7 3 DAC04-K20 16-CG30045-RA_1 CG30045 CCCAGGATCACAGGATACAGCTCGGTTCGACATGCAATACACAGTAAGATGGAAGAGATCAACTTGGGT 69 FBan0030045 FBgn0050045 CG30045 2 2R CG30045 CG30045 CG8496 CDMC26078 3 8 3 DAC04-K20 16-CG30045-RA_1 CG30045 CCCAGGATCACAGGATACAGCTCGGTTCGACATGCAATACACAGTAAGATGGAAGAGATCAACTTGGGT 69 FBan0030045 FBgn0050045 CG30045 2 2R CG30045 CG30045 CG8496 CDMC26079 3 9 3 DAC04-O08 11-CG30076-RA_6 CG30076 TGAGTCCTCGGTGATGATCTCCCACGGAATCCACAAAGATCATCGCATGAGACAGTTGGAAAAGGAGCA 69 FBan0030076 FBgn0050076 CG30076 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30076 CG30076 CDMC26079 3 10 3 DAC04-O08 11-CG30076-RA_6 CG30076 TGAGTCCTCGGTGATGATCTCCCACGGAATCCACAAAGATCATCGCATGAGACAGTTGGAAAAGGAGCA 69 FBan0030076 FBgn0050076 CG30076 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30076 CG30076 CDMC26080 3 11 3 DAC04-O20 23-CG30084-RB_5 CG30084 ACCGAACTACCGAACCCCAGATAACTATGTATGTACTGTGGCCAGAGTTAATTTACTTAGTTGAGCCTG 69 FBan0030084 FBgn0050084 2 2R CDMC26080 3 12 3 DAC04-O20 23-CG30084-RB_5 CG30084 ACCGAACTACCGAACCCCAGATAACTATGTATGTACTGTGGCCAGAGTTAATTTACTTAGTTGAGCCTG 69 FBan0030084 FBgn0050084 2 2R CDMC26081 3 13 3 DAC05-C08 16-CG18412-RA_1 CG18412 AGCTTTCAGAATCGTTTCCTATTTTGGGAGCCTCAACAGAAGTACCTCCAATGTCACTGCCAGTCCAA 68 FBan0018412 FBgn0004861 ph-p X X chromatin silencing; GO:0006342; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; gene silencing; GO:0016458; mRNA transcription; GO:0009299; stalk formation (sensu Insecta); GO:0030713; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 PRC1 complex; GO:0035102; nucleus; GO:0005634 ph-p polyhomeotic proximal "CG18414, CG18412, CG18414, ph: polyhomeotic, phm, ph-P, ph[P], php, Ph, PH, Polyhomeotic, polyhomeotic, EG:87B1.5, PH-p, ph" CDMC26081 3 14 3 DAC05-C08 16-CG18412-RA_1 CG18412 AGCTTTCAGAATCGTTTCCTATTTTGGGAGCCTCAACAGAAGTACCTCCAATGTCACTGCCAGTCCAA 68 FBan0018412 FBgn0004861 ph-p X X chromatin silencing; GO:0006342; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; gene silencing; GO:0016458; mRNA transcription; GO:0009299; stalk formation (sensu Insecta); GO:0030713; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 PRC1 complex; GO:0035102; nucleus; GO:0005634 ph-p polyhomeotic proximal "CG18414, CG18412, CG18414, ph: polyhomeotic, phm, ph-P, ph[P], php, Ph, PH, Polyhomeotic, polyhomeotic, EG:87B1.5, PH-p, ph" CDMC26082 3 15 3 DAC05-C20 8-CG18870-RA_1 CG18870 ACGACCAGTACTCGTGCATTTCGCGTCATTTTGTGCGGGACAATATCACCAATTGCCTGTATCCGTGC 68 FBan0018870 FBgn0042180 CG18870 2 2R CG18870 CG18870 anon-57Fa CDMC26082 3 16 3 DAC05-C20 8-CG18870-RA_1 CG18870 ACGACCAGTACTCGTGCATTTCGCGTCATTTTGTGCGGGACAATATCACCAATTGCCTGTATCCGTGC 68 FBan0018870 FBgn0042180 CG18870 2 2R CG18870 CG18870 anon-57Fa CDMC26083 3 17 3 DAC05-G08 2-CG2678-RA_1 CG2678 TGCCCACGCACTTATATGCAAAAATCGAACCTCAAGCGGCATTTGCGAAACCACCTAAGCAAGCCAGC 68 FBan0002678 FBgn0014931 CG2678 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2678 CG2678 "transcript B, B, anon-84Eb" CDMC26083 3 18 3 DAC05-G08 2-CG2678-RA_1 CG2678 TGCCCACGCACTTATATGCAAAAATCGAACCTCAAGCGGCATTTGCGAAACCACCTAAGCAAGCCAGC 68 FBan0002678 FBgn0014931 CG2678 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2678 CG2678 "transcript B, B, anon-84Eb" CDMC26084 3 19 3 DAC05-G20 3-CG2939-RA_1 CG2939 GCCTCTTCACAAACCCGTCACCGTAGTCTCCCGCAATAGCTGAAGATTCTGGCGAGAAGAATCGGAGG 68 FBan0002939 FBgn0004567 slp2 2 2L periodic partitioning; GO:0007365; phosphate transport; GO:0006817; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 cytoplasm; GO:0005737; nucleus; GO:0005634 slp2 sloppy paired 2 "CG2939, FD7, slp: sloppy paired, sloppy-paired 2, Dmslp2, sloppy-paired, sloppy paired, slp, sloppy paired 2" CDMC26084 3 20 3 DAC05-G20 3-CG2939-RA_1 CG2939 GCCTCTTCACAAACCCGTCACCGTAGTCTCCCGCAATAGCTGAAGATTCTGGCGAGAAGAATCGGAGG 68 FBan0002939 FBgn0004567 slp2 2 2L periodic partitioning; GO:0007365; phosphate transport; GO:0006817; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 cytoplasm; GO:0005737; nucleus; GO:0005634 slp2 sloppy paired 2 "CG2939, FD7, slp: sloppy paired, sloppy-paired 2, Dmslp2, sloppy-paired, sloppy paired, slp, sloppy paired 2" CDMC26085 3 21 3 DAC05-K08 2-CG30470-RA_1 CG30470 GACCGCTCCACAATGACACTAGCAACAACCATGTCATGCCGATGCAGAAATCGTTCCATCTCCCAGCC 68 FBan0030470 FBgn0050470 CG30470 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30470 CG30470 CDMC26085 3 22 3 DAC05-K08 2-CG30470-RA_1 CG30470 GACCGCTCCACAATGACACTAGCAACAACCATGTCATGCCGATGCAGAAATCGTTCCATCTCCCAGCC 68 FBan0030470 FBgn0050470 CG30470 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30470 CG30470 CDMC26086 3 23 3 DAC05-K20 3-CG31053-RA_1 CG31053 GACACCCTCTGTGACCACATCGGATAATACCCAGTCGGATGAGCACATGACAACCTTCTGCCTGGACT 68 FBan0031053 FBgn0051053 CG31053 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31053 CG31053 CDMC26086 3 24 3 DAC05-K20 3-CG31053-RA_1 CG31053 GACACCCTCTGTGACCACATCGGATAATACCCAGTCGGATGAGCACATGACAACCTTCTGCCTGGACT 68 FBan0031053 FBgn0051053 CG31053 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31053 CG31053 CDMC26087 3 25 3 DAC05-O08 3-CG31531-RB_2 CG31531 TGTCAGAGCAGCTCACTCGAAGGCTTTGATGGACACTTGTGAGCAGATCATTGCAGAGGAGCGCAAAG 68 FBan0031531 FBgn0051531 CG31531 3 3R CG31531 CG31531 "CG1054, CG14653" CDMC26087 3 26 3 DAC05-O08 3-CG31531-RB_2 CG31531 TGTCAGAGCAGCTCACTCGAAGGCTTTGATGGACACTTGTGAGCAGATCATTGCAGAGGAGCGCAAAG 68 FBan0031531 FBgn0051531 CG31531 3 3R CG31531 CG31531 "CG1054, CG14653" CDMC26088 3 1 4 DAC05-O20 2-CG31672-RA_3 CG31672 GCAGGCTTCTAGTGCCACAGATGGGATTTTCGTACCCCAAGGATCCGAAAAGGCTTCACGAATCCGAC 68 FBan0031672 FBgn0028952 CG31672 2 2L CG31672 CG31672 "CG4248, n(2)k09932, BEST:LD15963" CDMC26088 3 2 4 DAC05-O20 2-CG31672-RA_3 CG31672 GCAGGCTTCTAGTGCCACAGATGGGATTTTCGTACCCCAAGGATCCGAAAAGGCTTCACGAATCCGAC 68 FBan0031672 FBgn0028952 CG31672 2 2L CG31672 CG31672 "CG4248, n(2)k09932, BEST:LD15963" CDMC26089 3 3 4 DAC06-C08 17-CG5255-RA_1 CG5255 GCACTCACCTAAGTCTATCCAAAACGGACAGCTCTGAGGATATCGAGGAGGAAATGATTGCTCTCCAGG 69 FBan0005255 FBgn0038485 CG5255 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5255 CG5255 SP141 CDMC26089 3 4 4 DAC06-C08 17-CG5255-RA_1 CG5255 GCACTCACCTAAGTCTATCCAAAACGGACAGCTCTGAGGATATCGAGGAGGAAATGATTGCTCTCCAGG 69 FBan0005255 FBgn0038485 CG5255 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5255 CG5255 SP141 CDMC26090 3 5 4 DAC06-C20 8-CG5267-RA_1 CG5267 CCGAGCCAACCTTGGAGTCTGAGTTGACCTGGCCCAATGAACTTCCGGTAACAGTAACTAATGGCATGA 69 FBan0005267 FBgn0034154 CG5267 2 2R CG5267 CG5267 CDMC26090 3 6 4 DAC06-C20 8-CG5267-RA_1 CG5267 CCGAGCCAACCTTGGAGTCTGAGTTGACCTGGCCCAATGAACTTCCGGTAACAGTAACTAATGGCATGA 69 FBan0005267 FBgn0034154 CG5267 2 2R CG5267 CG5267 CDMC26091 3 7 4 DAC06-G08 2-CG5315-RA_1 CG5315 TGCGCTGCTGATCATGGGTTCCTTTGTGCCTTGGCTGTACTATGGCTTCTACTGTCATTACCAGCCAAA 69 FBan0005315 FBgn0038984 CG5315 3 3R fatty acid oxidation; GO:0019395; hormone-mediated signaling; GO:0009755 hormone binding; GO:0042562; ; GO:0042562 integral to membrane; GO:0016021 CG5315 CG5315 CDMC26091 3 8 4 DAC06-G08 2-CG5315-RA_1 CG5315 TGCGCTGCTGATCATGGGTTCCTTTGTGCCTTGGCTGTACTATGGCTTCTACTGTCATTACCAGCCAAA 69 FBan0005315 FBgn0038984 CG5315 3 3R fatty acid oxidation; GO:0019395; hormone-mediated signaling; GO:0009755 hormone binding; GO:0042562; ; GO:0042562 integral to membrane; GO:0016021 CG5315 CG5315 CDMC26092 3 9 4 DAC06-G20 11-CG5325-RB_1 CG5325 CCGCCTCGGAGAACGACATAGCCAGCATGTTTGGTTCACTGAATCTTGAAGGGGTATGCATCCTGAAAA 69 FBan0005325 FBgn0032407 CG5325 2 2L CG5325 CG5325 "Peroxisomal farnesylated protein, BEST:GH03076" CDMC26092 3 10 4 DAC06-G20 11-CG5325-RB_1 CG5325 CCGCCTCGGAGAACGACATAGCCAGCATGTTTGGTTCACTGAATCTTGAAGGGGTATGCATCCTGAAAA 69 FBan0005325 FBgn0032407 CG5325 2 2L CG5325 CG5325 "Peroxisomal farnesylated protein, BEST:GH03076" CDMC26093 3 11 4 DAC06-K08 2-CG5360-RA_1 CG5360 CTCCGAAACGCAATCGAGTATAGTGGATCGCATCTCGGAGGATCTCTTCTGCAAGGAACGCCAACCCAT 69 FBan0005360 FBgn0034873 CG5360 2 2R CG5360 CG5360 CDMC26093 3 12 4 DAC06-K08 2-CG5360-RA_1 CG5360 CTCCGAAACGCAATCGAGTATAGTGGATCGCATCTCGGAGGATCTCTTCTGCAAGGAACGCCAACCCAT 69 FBan0005360 FBgn0034873 CG5360 2 2R CG5360 CG5360 CDMC26094 3 13 4 DAC06-K20 5-CG5376-RA_1 CG5376 GCTCACGGAGAAGAAACTAGCCATCTCCAAAGGAGTGTATGACAAGCTGCGTTCGGAGTACGACACCCA 69 FBan0005376 FBgn0038977 CG5376 3 3R CG5376 CG5376 CDMC26094 3 14 4 DAC06-K20 5-CG5376-RA_1 CG5376 GCTCACGGAGAAGAAACTAGCCATCTCCAAAGGAGTGTATGACAAGCTGCGTTCGGAGTACGACACCCA 69 FBan0005376 FBgn0038977 CG5376 3 3R CG5376 CG5376 CDMC26095 3 15 4 DAC06-O08 15-CG5406-RB_2 CG5406 AGCAGGCGAACCCAAAAGCATTTTTCAAGCTCAATTCTGCGATATGAAGATGCATTGAATCACCGGCCA 69 FBan0005406 FBgn0019652 sif 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; nervous system development; GO:0007399; regulation of axonogenesis; GO:0050770; regulation of synapse structure and function; GO:0050803; synaptic transmission; GO:0007268 Rho guanyl-nucleotide exchange factor activity; GO:0005089; guanyl-nucleotide exchange factor activity; GO:0005085; receptor signaling protein activity; GO:0005057; protein binding; GO:0005515; ; GO:0005085; ; GO:0005089; ; GO:0005057; ; GO:0005515 synapse; GO:0045202 sif still life "CG5406, CG5256, CG5406, slf, still life type 1, still life type 2, SIF, RhoGEF, Still life, still life" CDMC26095 3 16 4 DAC06-O08 15-CG5406-RB_2 CG5406 AGCAGGCGAACCCAAAAGCATTTTTCAAGCTCAATTCTGCGATATGAAGATGCATTGAATCACCGGCCA 69 FBan0005406 FBgn0019652 sif 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; nervous system development; GO:0007399; regulation of axonogenesis; GO:0050770; regulation of synapse structure and function; GO:0050803; synaptic transmission; GO:0007268 Rho guanyl-nucleotide exchange factor activity; GO:0005089; guanyl-nucleotide exchange factor activity; GO:0005085; receptor signaling protein activity; GO:0005057; protein binding; GO:0005515; ; GO:0005085; ; GO:0005089; ; GO:0005057; ; GO:0005515 synapse; GO:0045202 sif still life "CG5406, CG5256, CG5406, slf, still life type 1, still life type 2, SIF, RhoGEF, Still life, still life" CDMC26096 3 17 4 DAC06-O20 2-CG5421-RA_1 CG5421 CCATCGCAGGGCAATTGGTACCTTACGCGCATGATCTTCATGAACAACACCCACTATCCACGCGATCTC 69 FBan0005421 FBgn0032434 CG5421 2 2L CG5421 CG5421 CDMC26096 3 18 4 DAC06-O20 2-CG5421-RA_1 CG5421 CCATCGCAGGGCAATTGGTACCTTACGCGCATGATCTTCATGAACAACACCCACTATCCACGCGATCTC 69 FBan0005421 FBgn0032434 CG5421 2 2L CG5421 CG5421 CDMC26097 3 19 4 DAC07-C08 18-CG9817-RA_1 CG9817 CATGGCCAGGAGCTTTGGAGCCTACCATCAGGTGGCGTCGAGTAATTACCATCCGGGCGTTAGGC 65 FBan0009817 FBgn0030219 CG9817 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9817 CG9817 CDMC26097 3 20 4 DAC07-C08 18-CG9817-RA_1 CG9817 CATGGCCAGGAGCTTTGGAGCCTACCATCAGGTGGCGTCGAGTAATTACCATCCGGGCGTTAGGC 65 FBan0009817 FBgn0030219 CG9817 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9817 CG9817 CDMC26098 3 21 4 DAC07-C20 1-CG9867-RA_1 CG9867 CGAGGAAATTCTTTCCCACAAGGAATTCCCCCGACGGGCATCAGAAAATCCCTCCAAAACGCAGC 65 FBan0009867 FBgn0031421 CG9867 2 2L CG9867 CG9867 CDMC26098 3 22 4 DAC07-C20 1-CG9867-RA_1 CG9867 CGAGGAAATTCTTTCCCACAAGGAATTCCCCCGACGGGCATCAGAAAATCCCTCCAAAACGCAGC 65 FBan0009867 FBgn0031421 CG9867 2 2L CG9867 CG9867 CDMC26099 3 23 4 DAC07-G08 23-CG9975-RA_3 CG9975 AACAAACGCTTATCTGAAAAAGGCAGTCGTCTTTGAAAACAAAGTTAAAACACGTGCACACTTTT 65 FBan0009975 FBgn0034435 CG9975 2 2R CG9975 CG9975 CDMC26099 3 24 4 DAC07-G08 23-CG9975-RA_3 CG9975 AACAAACGCTTATCTGAAAAAGGCAGTCGTCTTTGAAAACAAAGTTAAAACACGTGCACACTTTT 65 FBan0009975 FBgn0034435 CG9975 2 2R CG9975 CG9975 CDMC26100 3 25 4 DAC07-G20 23-CR30066-RA_2 CR30066 GTTTGATGTTTTGCATTCGAAACTATTGGGTTTGTTTCCCTAGCAACTTGGAAAAACGTGCTGAA 65 FBan0030066 FBgn0050066 CR30066 2 2R CR30066 CR30066 CDMC26100 3 26 4 DAC07-G20 23-CR30066-RA_2 CR30066 GTTTGATGTTTTGCATTCGAAACTATTGGGTTTGTTTCCCTAGCAACTTGGAAAAACGTGCTGAA 65 FBan0030066 FBgn0050066 CR30066 2 2R CR30066 CR30066 CDMC26101 3 1 5 DAC07-K08 8-CR32162-RA_1 CR32162 ATGAGTAAGGAAAACCAATCAGCCTTGCTAATCGCTTGGCAGTATTGGCTTCTAGGCAGGGGGGC 65 FBan0032162 FBgn0041721 snRNA:U12:73B 3 3L "nuclear mRNA splicing via U12-type spliceosome; GO:0006375; nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U12; GO:0005693 snRNA:U12:73B snRNA:U12:73B "U12, dU12, anon-WO0172774.79, CR32162" CDMC26101 3 2 5 DAC07-K08 8-CR32162-RA_1 CR32162 ATGAGTAAGGAAAACCAATCAGCCTTGCTAATCGCTTGGCAGTATTGGCTTCTAGGCAGGGGGGC 65 FBan0032162 FBgn0041721 snRNA:U12:73B 3 3L "nuclear mRNA splicing via U12-type spliceosome; GO:0006375; nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U12; GO:0005693 snRNA:U12:73B snRNA:U12:73B "U12, dU12, anon-WO0172774.79, CR32162" CDMC26102 3 3 5 DAC07-K20 23-CR32861-RA_6 CR32861 CGGATTTCGGTAAATTATTTTCTACCCAACTTTACCGTAACCAAACAAAAGGCGTTCAGTTGCAG 65 FBan0032861 FBgn0052861 snRNA:U4atac:83A 3 3R snRNA:U4atac:83A snRNA:U4atac:83A CR32861 CDMC26102 3 4 5 DAC07-K20 23-CR32861-RA_6 CR32861 CGGATTTCGGTAAATTATTTTCTACCCAACTTTACCGTAACCAAACAAAAGGCGTTCAGTTGCAG 65 FBan0032861 FBgn0052861 snRNA:U4atac:83A 3 3R snRNA:U4atac:83A snRNA:U4atac:83A CR32861 CDMC26103 3 5 5 DAC07-O08 23-CR32999-RA_1 CR32999 ACTCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGG 65 FBan0032999 FBgn0003934 snRNA:U5:23D 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:23D small nuclear RNA U5 at 23DE "dU5, K2, snRNA[[3]], U5, U5 small nuclear RNA, U5-23D, snRNA:U5, U5snRNA, CR32999, U5snRNA23DE, snRNA3, snRNA4, snRNA:U5:23DE, small nuclear RNA U5" CDMC26103 3 6 5 DAC07-O08 23-CR32999-RA_1 CR32999 ACTCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGG 65 FBan0032999 FBgn0003934 snRNA:U5:23D 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:23D small nuclear RNA U5 at 23DE "dU5, K2, snRNA[[3]], U5, U5 small nuclear RNA, U5-23D, snRNA:U5, U5snRNA, CR32999, U5snRNA23DE, snRNA3, snRNA4, snRNA:U5:23DE, small nuclear RNA U5" CDMC26104 3 7 5 DAC07-O20 27-CR40456-RA_1 CR40456 TAGTATCTAGGACTACCACGGTTGCAACGGGTAACGGGGAATCAGGGTTCGATTCCGGAGAGGGA 65 FBgn0058456 18SrRNA:CR40456 18SrRNA:CR40456 18SrRNA:CR40456 CR40456 CDMC26104 3 8 5 DAC07-O20 27-CR40456-RA_1 CR40456 TAGTATCTAGGACTACCACGGTTGCAACGGGTAACGGGGAATCAGGGTTCGATTCCGGAGAGGGA 65 FBgn0058456 18SrRNA:CR40456 18SrRNA:CR40456 18SrRNA:CR40456 CR40456 CDMC26105 3 9 5 DAC08-C08 23-CG5619-RA_8 CG5619 AGTACTGCGCCGTAAAACTGGCTCATGCATTCGAATAAACGATAAATTGATTTTGATCACCGCAGAGAA 69 FBan0005619 FBgn0003751 trk 2 2L "determination of anterior/posterior axis, embryo; GO:0008595; maternal determination of anterior/posterior axis, embryo; GO:0008358; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" torso binding; GO:0005122; ; GO:0005122; ; GO:0005122 extracellular region; GO:0005576 trk trunk "CG5619, fs(2)trunk, trunk" CDMC26105 3 10 5 DAC08-C08 23-CG5619-RA_8 CG5619 AGTACTGCGCCGTAAAACTGGCTCATGCATTCGAATAAACGATAAATTGATTTTGATCACCGCAGAGAA 69 FBan0005619 FBgn0003751 trk 2 2L "determination of anterior/posterior axis, embryo; GO:0008595; maternal determination of anterior/posterior axis, embryo; GO:0008358; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" torso binding; GO:0005122; ; GO:0005122; ; GO:0005122 extracellular region; GO:0005576 trk trunk "CG5619, fs(2)trunk, trunk" CDMC26106 3 11 5 DAC08-C20 5-CG5632-RA_1 CG5632 ATGCTGGAGCCTTACAAGAACCCAAATCTGTTACGTCCGGATTGGGGCAAATGGATAGGAGCAGTGGCT 69 FBan0005632 FBgn0036263 thoc6 3 3L mRNA export from nucleus; GO:0006406 thoc6 thoc6 "CG5632, THOC6" CDMC26106 3 12 5 DAC08-C20 5-CG5632-RA_1 CG5632 ATGCTGGAGCCTTACAAGAACCCAAATCTGTTACGTCCGGATTGGGGCAAATGGATAGGAGCAGTGGCT 69 FBan0005632 FBgn0036263 thoc6 3 3L mRNA export from nucleus; GO:0006406 thoc6 thoc6 "CG5632, THOC6" CDMC26107 3 13 5 DAC08-G08 23-CG5670-RD_3 CG5670 AATGAAAACCCCTAGCGTAGTTACCAAGTAAGCCGTGAAAAGTAAAGCCCAATAAAAACCACAACAACA 69 FBan0005670 FBgn0002921 Atpalpha 3 3R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; embryonic development (sensu Insecta); GO:0001700; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; septate junction assembly; GO:0019991 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; septate junction; GO:0005918; sodium:potassium-exchanging ATPase complex; GO:0005890 Atpalpha Na pump alpha subunit "CG5670, CG5670, CG5670, l(3)04492, alpha-subunit of ATPase, ATPase alpha subunit, Na[+],K[+]-ATPase alpha-subunit, l(3)01164, Na,K-ATPase alpha subunit, Na,K-ATPase, Atpalpha, Na/K-ATPase alpha-subunit, Da-47, Na+,K+ ATPase alpha-subunit., Na+/K+ ATPase alpha subunit, sodium/potassium transporting ATPase alpha, Na,K ATPase, Na,K ATPase alpha subunit, Na/K-ATPase, Na/K-ATPase alpha-subunit, Na[+]/K[+]-ATPase, Na[+]-K[+]-ATPase alpha[[5]]-subunit, Na[+],K[+]-ATPase alpha subunit, Na[+],K[+]-ATPase, Na[+]/K[+]ATPase, Na+-K+-ATPase, Atp a, ATPalpha, ATPa, NaK ATPase, Na[+], K[+] -ATPase, ATPalpha, Na[+]K[+]ATPase, ATPBagr, Na[+]/K[+] ATPase, JY, Na-p, l(3)01453, l(3)j3B2, l(3)j3B7, l(3)j6A4, l(3)rM454, l(3)ry136" CDMC26107 3 14 5 DAC08-G08 23-CG5670-RD_3 CG5670 AATGAAAACCCCTAGCGTAGTTACCAAGTAAGCCGTGAAAAGTAAAGCCCAATAAAAACCACAACAACA 69 FBan0005670 FBgn0002921 Atpalpha 3 3R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; embryonic development (sensu Insecta); GO:0001700; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; septate junction assembly; GO:0019991 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; septate junction; GO:0005918; sodium:potassium-exchanging ATPase complex; GO:0005890 Atpalpha Na pump alpha subunit "CG5670, CG5670, CG5670, l(3)04492, alpha-subunit of ATPase, ATPase alpha subunit, Na[+],K[+]-ATPase alpha-subunit, l(3)01164, Na,K-ATPase alpha subunit, Na,K-ATPase, Atpalpha, Na/K-ATPase alpha-subunit, Da-47, Na+,K+ ATPase alpha-subunit., Na+/K+ ATPase alpha subunit, sodium/potassium transporting ATPase alpha, Na,K ATPase, Na,K ATPase alpha subunit, Na/K-ATPase, Na/K-ATPase alpha-subunit, Na[+]/K[+]-ATPase, Na[+]-K[+]-ATPase alpha[[5]]-subunit, Na[+],K[+]-ATPase alpha subunit, Na[+],K[+]-ATPase, Na[+]/K[+]ATPase, Na+-K+-ATPase, Atp a, ATPalpha, ATPa, NaK ATPase, Na[+], K[+] -ATPase, ATPalpha, Na[+]K[+]ATPase, ATPBagr, Na[+]/K[+] ATPase, JY, Na-p, l(3)01453, l(3)j3B2, l(3)j3B7, l(3)j6A4, l(3)rM454, l(3)ry136" CDMC26108 3 15 5 DAC08-G20 17-CG5676-RA_1 CG5676 AAGAAAGTGGCGAAATGGTACACCAAACTGATTGGCGATGAAGAGGGTCCAAAAGTCAACGATCTGCAC 69 FBan0005676 FBgn0032200 CG5676 2 2L CG5676 CG5676 "LD31953, BEST:LD31953" CDMC26108 3 16 5 DAC08-G20 17-CG5676-RA_1 CG5676 AAGAAAGTGGCGAAATGGTACACCAAACTGATTGGCGATGAAGAGGGTCCAAAAGTCAACGATCTGCAC 69 FBan0005676 FBgn0032200 CG5676 2 2L CG5676 CG5676 "LD31953, BEST:LD31953" CDMC26109 3 17 5 DAC08-K08 17-CG5711-RA_3 CG5711 ACAGCTCCAAAATGGTGGTCAATTTCAAGGTGTTCAAGAAGTGTTCCCCGAACAACATGATCACGCTCT 69 FBan0005711 FBgn0000120 Arr1 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; deactivation of rhodopsin mediated signaling; GO:0016059; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; metarhodopsin inactivation; GO:0016060; phototransduction; GO:0007602 metarhodopsin binding; GO:0016030; ; GO:0016030; ; GO:0016030 membrane fraction; GO:0005624; rhabdomere; GO:0016028 Arr1 Arrestin 1 "CG5711, Arr, 3H10, Dmarrestin, DA, Drosophila Arrestin, arr1, PRII, Phosrestin-II, ArrA: Arrestin A, arrestin, DmArr1, FBgn0000120, arrestin1, DS-Ag, Arrestin A, ArrA" CDMC26109 3 18 5 DAC08-K08 17-CG5711-RA_3 CG5711 ACAGCTCCAAAATGGTGGTCAATTTCAAGGTGTTCAAGAAGTGTTCCCCGAACAACATGATCACGCTCT 69 FBan0005711 FBgn0000120 Arr1 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; deactivation of rhodopsin mediated signaling; GO:0016059; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; metarhodopsin inactivation; GO:0016060; phototransduction; GO:0007602 metarhodopsin binding; GO:0016030; ; GO:0016030; ; GO:0016030 membrane fraction; GO:0005624; rhabdomere; GO:0016028 Arr1 Arrestin 1 "CG5711, Arr, 3H10, Dmarrestin, DA, Drosophila Arrestin, arr1, PRII, Phosrestin-II, ArrA: Arrestin A, arrestin, DmArr1, FBgn0000120, arrestin1, DS-Ag, Arrestin A, ArrA" CDMC26110 3 19 5 DAC08-K20 2-CG5721-RA_2 CG5721 GCCCTGATCACCCTGTTGGAGGAGACGCTCTCTGCTGAGTCACCCAACGAATCCGTGTTAAAAAAGTCC 69 FBan0005721 FBgn0034315 CG5721 2 2R CG5721 CG5721 CDMC26110 3 20 5 DAC08-K20 2-CG5721-RA_2 CG5721 GCCCTGATCACCCTGTTGGAGGAGACGCTCTCTGCTGAGTCACCCAACGAATCCGTGTTAAAAAAGTCC 69 FBan0005721 FBgn0034315 CG5721 2 2R CG5721 CG5721 CDMC26111 3 21 5 DAC08-O08 3-CG5756-RA_1 CG5756 GCGGACGACGATCCACACCAATCAGCAACCCTATCTTACGCCCAATATCTTTGTGCCCTACCATCAGCA 69 FBan0005756 FBgn0034301 CG5756 2 2R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG5756 CG5756 CDMC26111 3 22 5 DAC08-O08 3-CG5756-RA_1 CG5756 GCGGACGACGATCCACACCAATCAGCAACCCTATCTTACGCCCAATATCTTTGTGCCCTACCATCAGCA 69 FBan0005756 FBgn0034301 CG5756 2 2R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG5756 CG5756 CDMC26112 3 23 5 DAC08-O20 1-CG5770-RA_1 CG5770 GCCGCCCCTCAAACTACCTCTACCACAGACGGGGGTTTCCTATTTGGCCTTTGAGTAGTTAGCATTCGA 69 FBan0005770 FBgn0034291 CG5770 2 2R CG5770 CG5770 BcDNA:LP06072 CDMC26112 3 24 5 DAC08-O20 1-CG5770-RA_1 CG5770 GCCGCCCCTCAAACTACCTCTACCACAGACGGGGGTTTCCTATTTGGCCTTTGAGTAGTTAGCATTCGA 69 FBan0005770 FBgn0034291 CG5770 2 2R CG5770 CG5770 BcDNA:LP06072 CDMC26113 3 25 5 DAC09-C09 1-CG31624-RA_5 CG31624 GCTCGCCAGTCAAACGTTCTATGAGCGCGACGGCAAGCCCTATTGCAAACAGGATTACGAGAACCTC 67 FBan0031624 FBgn0051624 CG31624 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31624 CG31624 "CG17401, CG17401" CDMC26113 3 26 5 DAC09-C09 1-CG31624-RA_5 CG31624 GCTCGCCAGTCAAACGTTCTATGAGCGCGACGGCAAGCCCTATTGCAAACAGGATTACGAGAACCTC 67 FBan0031624 FBgn0051624 CG31624 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31624 CG31624 "CG17401, CG17401" CDMC26114 3 1 6 DAC09-C21 3-CG31826-RA_2 CG31826 CCAGGACTATCCCGACTATCTGCAGAGTCTCGTCGAGATGGACGACCTGATCTTCGAGTCGCTGCTG 67 FBan0031826 FBgn0051826 CG31826 2 2L double-strand break repair via nonhomologous end-joining; GO:0006303; transport; GO:0006810 DNA binding; GO:0003677; transporter activity; GO:0005215; ; GO:0005215; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003677; ; GO:0004003 intracellular; GO:0005622 CG31826 CG31826 "CG13241, CG13241, CG13241, BG:DS09217.6" CDMC26114 3 2 6 DAC09-C21 3-CG31826-RA_2 CG31826 CCAGGACTATCCCGACTATCTGCAGAGTCTCGTCGAGATGGACGACCTGATCTTCGAGTCGCTGCTG 67 FBan0031826 FBgn0051826 CG31826 2 2L double-strand break repair via nonhomologous end-joining; GO:0006303; transport; GO:0006810 DNA binding; GO:0003677; transporter activity; GO:0005215; ; GO:0005215; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003677; ; GO:0004003 intracellular; GO:0005622 CG31826 CG31826 "CG13241, CG13241, CG13241, BG:DS09217.6" CDMC26115 3 3 6 DAC09-G09 2-CG32161-RA_1 CG32161 TGGTGCGAGGAACTGGACCAACGACTAGTGGAGTACATGCTATCTGCAGTCGTATTGATGGCCAGCG 67 FBan0032161 FBgn0052161 CG32161 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32161 CG32161 CDMC26115 3 4 6 DAC09-G09 2-CG32161-RA_1 CG32161 TGGTGCGAGGAACTGGACCAACGACTAGTGGAGTACATGCTATCTGCAGTCGTATTGATGGCCAGCG 67 FBan0032161 FBgn0052161 CG32161 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32161 CG32161 CDMC26116 3 5 6 DAC09-G21 3-CG32444-RA_1 CG32444 GCGACCGACTCATGCAGTTCGAAAATCGTCAGATCAAGGGCTACGACAACTGCTTCGTGGTCAACGG 67 FBan0032444 FBgn0043783 CG32444 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG32444 CG32444 "CG14576, CG12562, CG14576, CG14576, aldose 1-epimerase, CT3430, BcDNA:GH08902" CDMC26116 3 6 6 DAC09-G21 3-CG32444-RA_1 CG32444 GCGACCGACTCATGCAGTTCGAAAATCGTCAGATCAAGGGCTACGACAACTGCTTCGTGGTCAACGG 67 FBan0032444 FBgn0043783 CG32444 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG32444 CG32444 "CG14576, CG12562, CG14576, CG14576, aldose 1-epimerase, CT3430, BcDNA:GH08902" CDMC26117 3 7 6 DAC09-K09 5-CG33007-RA_2 CG33007 GGCGATGAGGAGATGGAGAGATGCGAATTGAATACGGCAAGTCGTGGTCACGAATGGATGCTCCGCA 67 FBan0033007 FBgn0053007 CG33007 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33007 CG33007 CDMC26117 3 8 6 DAC09-K09 5-CG33007-RA_2 CG33007 GGCGATGAGGAGATGGAGAGATGCGAATTGAATACGGCAAGTCGTGGTCACGAATGGATGCTCCGCA 67 FBan0033007 FBgn0053007 CG33007 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33007 CG33007 CDMC26118 3 9 6 DAC09-K21 23-CG33206-RA_1 CG33206 TGTATGTGTATATGTGCAACACTAGCAACTTGTAAATATGTAATATGCAACTTGAACATGTCGAGGG 67 FBgn0052587 CDMC26118 3 10 6 DAC09-K21 23-CG33206-RA_1 CG33206 TGTATGTGTATATGTGCAACACTAGCAACTTGTAAATATGTAATATGCAACTTGAACATGTCGAGGG 67 FBgn0052587 CDMC26119 3 11 6 DAC09-O09 3-CG3517-RA_6 CG3517 GGGGATTCAAGGCCTTCTACTACGAGCCGAAAGTGGACTTGACCTACGATGAGCAAGGCAGACCCTC 67 FBan0003517 FBgn0038706 CG3517 3 3R CG3517 CG3517 CDMC26119 3 12 6 DAC09-O09 3-CG3517-RA_6 CG3517 GGGGATTCAAGGCCTTCTACTACGAGCCGAAAGTGGACTTGACCTACGATGAGCAAGGCAGACCCTC 67 FBan0003517 FBgn0038706 CG3517 3 3R CG3517 CG3517 CDMC26120 3 13 6 DAC09-O21 AutoBlank AutoBlank CDMC26120 3 14 6 DAC09-O21 AutoBlank AutoBlank CDMC26121 3 15 6 DAC10-C08 23-CG18358-RA_1 CG18358 CCGGAACGCAACCATTTCACATCGCTATCCATGTATATTATCTATTCTTATGGTATTTGTAGTAATCCA 69 FBan0018358 FBgn0030782 CG18358 X X CG18358 CG18358 "CG9644, CG9644, BcDNA:RE13557" CDMC26121 3 16 6 DAC10-C08 23-CG18358-RA_1 CG18358 CCGGAACGCAACCATTTCACATCGCTATCCATGTATATTATCTATTCTTATGGTATTTGTAGTAATCCA 69 FBan0018358 FBgn0030782 CG18358 X X CG18358 CG18358 "CG9644, CG9644, BcDNA:RE13557" CDMC26122 3 17 6 DAC10-C20 3-CG18371-RA_1 CG18371 CCCACCAAGGAGATCACTTCGCACAACTTTAGCCGATTCTCGATTCGCTACCACAATGTGGCAGCAACG 69 FBan0018371 FBgn0033893 CG18371 2 2R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.-; acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG18371 CG18371 CDMC26122 3 18 6 DAC10-C20 3-CG18371-RA_1 CG18371 CCCACCAAGGAGATCACTTCGCACAACTTTAGCCGATTCTCGATTCGCTACCACAATGTGGCAGCAACG 69 FBan0018371 FBgn0033893 CG18371 2 2R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.-; acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG18371 CG18371 CDMC26123 3 19 6 DAC10-G08 23-CG18428-RA_1 CG18428 ACAAGGAAAAGCACAAGTCAAAGAAATCCAAGAAACACAACCGAAAAAAGGAAGAATCTCCGCCGATAG 69 FBan0018428 FBgn0039149 CG18428 3 3R CG18428 CG18428 CDMC26123 3 20 6 DAC10-G08 23-CG18428-RA_1 CG18428 ACAAGGAAAAGCACAAGTCAAAGAAATCCAAGAAACACAACCGAAAAAAGGAAGAATCTCCGCCGATAG 69 FBan0018428 FBgn0039149 CG18428 3 3R CG18428 CG18428 CDMC26124 3 21 6 DAC10-G20 6-CG18466-RB_1 CG18466 AGCCAGGAAGCAGTTCGATGATCGCAAGTCCTCCTGAAGATTCACCAGTAACTATCGTGCTTCGCTGGC 69 FBan0018466 FBgn0010222 Nmdmc 3 3R 10-formyltetrahydrofolate metabolism; GO:0009256; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975; folic acid and derivative biosynthesis; GO:0009396 magnesium ion binding; GO:0000287; methenyltetrahydrofolate cyclohydrolase activity; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NADP+) activity; GO:0004488 ; EC:1.5.1.5; ; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NAD+) activity; GO:0004487 ; EC:1.5.1.15; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5; ; GO:0000287; ; GO:0004487 ; EC:1.5.1.15; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5; ; GO:0004477 ; EC:3.5.4.9 mitochondrion; GO:0005739 Nmdmc NAD-dependent methylenetetrahydrofolate dehydrogenase "CG18466, CG18466, DNMDMC, dNMDMC, Dnmdmc" CDMC26124 3 22 6 DAC10-G20 6-CG18466-RB_1 CG18466 AGCCAGGAAGCAGTTCGATGATCGCAAGTCCTCCTGAAGATTCACCAGTAACTATCGTGCTTCGCTGGC 69 FBan0018466 FBgn0010222 Nmdmc 3 3R 10-formyltetrahydrofolate metabolism; GO:0009256; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975; folic acid and derivative biosynthesis; GO:0009396 magnesium ion binding; GO:0000287; methenyltetrahydrofolate cyclohydrolase activity; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NADP+) activity; GO:0004488 ; EC:1.5.1.5; ; GO:0004477 ; EC:3.5.4.9; methylenetetrahydrofolate dehydrogenase (NAD+) activity; GO:0004487 ; EC:1.5.1.15; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5; ; GO:0000287; ; GO:0004487 ; EC:1.5.1.15; ; GO:0004477 ; EC:3.5.4.9; ; GO:0004488 ; EC:1.5.1.5; ; GO:0004477 ; EC:3.5.4.9 mitochondrion; GO:0005739 Nmdmc NAD-dependent methylenetetrahydrofolate dehydrogenase "CG18466, CG18466, DNMDMC, dNMDMC, Dnmdmc" CDMC26125 3 23 6 DAC10-K08 22-CG18506-RA_1 CG18506 ACCCCCGCGCCATTCAGGGCACTTTGCTACTCTAACTCTACTTTCATAACTTAACAACAGACAATCAGA 69 FBan0018506 FBgn0035079 CG18506 2 2R CG18506 CG18506 CDMC26125 3 24 6 DAC10-K08 22-CG18506-RA_1 CG18506 ACCCCCGCGCCATTCAGGGCACTTTGCTACTCTAACTCTACTTTCATAACTTAACAACAGACAATCAGA 69 FBan0018506 FBgn0035079 CG18506 2 2R CG18506 CG18506 CDMC26126 3 25 6 DAC10-K20 23-CG18536-RA_5 CG18536 CTTTTGAGTTGGTTACAACCTCAACTAGAATCGGAATAGTGTGTATATTATTTCATTTGACAGCAGCAT 69 FBan0018536 FBgn0034322 CG18536 2 2R CG18536 CG18536 CDMC26126 3 26 6 DAC10-K20 23-CG18536-RA_5 CG18536 CTTTTGAGTTGGTTACAACCTCAACTAGAATCGGAATAGTGTGTATATTATTTCATTTGACAGCAGCAT 69 FBan0018536 FBgn0034322 CG18536 2 2R CG18536 CG18536 CDMC26127 3 1 7 DAC10-O08 1-CG18586-RA_1 CG18586 CCGAGGGGATCAGTGAGGATCCAGGATGTTCTGACCACTCCAGTGATGCAGAATTTCCAACCACTTCGT 69 FBan0018586 FBgn0035642 CG18586 3 3L metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- CG18586 CG18586 CDMC26127 3 2 7 DAC10-O08 1-CG18586-RA_1 CG18586 CCGAGGGGATCAGTGAGGATCCAGGATGTTCTGACCACTCCAGTGATGCAGAATTTCCAACCACTTCGT 69 FBan0018586 FBgn0035642 CG18586 3 3L metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- CG18586 CG18586 CDMC26128 3 3 7 DAC10-O20 23-CG18604-RA_7 CG18604 AACAGGAGCAAGTAAAGTACATTCCAGTAGCCGAAATTTCATACAAAGTAAACCAACGTTCGTTCTAGC 69 FBan0018604 FBgn0034378 CG18604 2 2R CG18604 CG18604 CDMC26128 3 4 7 DAC10-O20 23-CG18604-RA_7 CG18604 AACAGGAGCAAGTAAAGTACATTCCAGTAGCCGAAATTTCATACAAAGTAAACCAACGTTCGTTCTAGC 69 FBan0018604 FBgn0034378 CG18604 2 2R CG18604 CG18604 CDMC26129 3 5 7 DAC11-C08 3-CG10459-RA_2 CG10459 GCGAGGTGTGTGCCATTGGATCCCAAGATGGCAGTATCATTCTCTGGCAAATGAACCCCAAACAGGC 67 FBan0010459 FBgn0033440 CG10459 2 2R transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase signaling protein activity; GO:0005071; ; GO:0005071 CG10459 CG10459 CDMC26129 3 6 7 DAC11-C08 3-CG10459-RA_2 CG10459 GCGAGGTGTGTGCCATTGGATCCCAAGATGGCAGTATCATTCTCTGGCAAATGAACCCCAAACAGGC 67 FBan0010459 FBgn0033440 CG10459 2 2R transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase signaling protein activity; GO:0005071; ; GO:0005071 CG10459 CG10459 CDMC26130 3 7 7 DAC11-C20 3-CG10639-RA_2 CG10639 TGGAGTACGTGCCCAAGCAATGGATCTGGATGGCAATCTGGTGGACGATTTTGTTTTCGATCGCGGA 67 FBan0010639 FBgn0032729 CG10639 2 2L electron transport; GO:0006118; lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10639 CG10639 CDMC26130 3 8 7 DAC11-C20 3-CG10639-RA_2 CG10639 TGGAGTACGTGCCCAAGCAATGGATCTGGATGGCAATCTGGTGGACGATTTTGTTTTCGATCGCGGA 67 FBan0010639 FBgn0032729 CG10639 2 2L electron transport; GO:0006118; lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10639 CG10639 CDMC26131 3 9 7 DAC11-G08 6-CG10934-RA_1 CG10934 ACGCCCTACCAAATCGCCGGACGTACAGATACTATGAGACAGATGAGAACTTAGGCGATGGTCCGCG 67 FBan0010934 FBgn0034263 CG10934 2 2R CG10934 CG10934 anon-WO0140519.130 CDMC26131 3 10 7 DAC11-G08 6-CG10934-RA_1 CG10934 ACGCCCTACCAAATCGCCGGACGTACAGATACTATGAGACAGATGAGAACTTAGGCGATGGTCCGCG 67 FBan0010934 FBgn0034263 CG10934 2 2R CG10934 CG10934 anon-WO0140519.130 CDMC26132 3 11 7 DAC11-G20 2-CG1101-RA_2 CG1101 CGTCGGTAACCTGGACTACGGCGTATCCAACACGGACATCAAGGAGCTCTTCAACGACTTTGGTCCG 67 FBan0001101 FBgn0010774 Aly 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; transcription coactivator activity; GO:0003713; ; GO:0003713 Aly Aly "CG1101, CG1101, l(3)02267, cg1101, DmREF1, dmREF1, REF1, ref1, BcDNA:LD24793" CDMC26132 3 12 7 DAC11-G20 2-CG1101-RA_2 CG1101 CGTCGGTAACCTGGACTACGGCGTATCCAACACGGACATCAAGGAGCTCTTCAACGACTTTGGTCCG 67 FBan0001101 FBgn0010774 Aly 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; transcription coactivator activity; GO:0003713; ; GO:0003713 Aly Aly "CG1101, CG1101, l(3)02267, cg1101, DmREF1, dmREF1, REF1, ref1, BcDNA:LD24793" CDMC26133 3 13 7 DAC11-K08 15-CG11384-RA_2 CG11384 GCAACACTACCGGGAACCCGATGACAAATATAACCTAACCAATCTGACGGATGATCGCAGCGTCTGG 67 FBan0011384 FBgn0040363 CG11384 X X CG11384 CG11384 EG:BACR42I17.3 CDMC26133 3 14 7 DAC11-K08 15-CG11384-RA_2 CG11384 GCAACACTACCGGGAACCCGATGACAAATATAACCTAACCAATCTGACGGATGATCGCAGCGTCTGG 67 FBan0011384 FBgn0040363 CG11384 X X CG11384 CG11384 EG:BACR42I17.3 CDMC26134 3 15 7 DAC11-K20 1-CG11538-RA_1 CG11538 TGTTGTCCATCTGCTTGACATGATGGAAGCCGTGCATTTTGTAGTGCTCAGCCCATTCCAGTGCCTG 67 FBan0011538 FBgn0017424 CG11538 3 3L larval serum protein complex; GO:0005616 CG11538 CG11538 anon-68Ed CDMC26134 3 16 7 DAC11-K20 1-CG11538-RA_1 CG11538 TGTTGTCCATCTGCTTGACATGATGGAAGCCGTGCATTTTGTAGTGCTCAGCCCATTCCAGTGCCTG 67 FBan0011538 FBgn0017424 CG11538 3 3L larval serum protein complex; GO:0005616 CG11538 CG11538 anon-68Ed CDMC26135 3 17 7 DAC11-O08 3-CG12163-RA_8 CG12163 ACCCATACAAGGCCAAAAAGAATCAGTGCCACTTCAACAGGACTTTGTCCCACGTTCAGGTTGCCGG 67 FBan0012163 FBgn0037303 CG12163 3 3R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cysteine protease inhibitor activity; GO:0004869; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004869; ; GO:0004197 ; EC:3.4.22.- CG12163 CG12163 anon-WO0118547.305 CDMC26135 3 18 7 DAC11-O08 3-CG12163-RA_8 CG12163 ACCCATACAAGGCCAAAAAGAATCAGTGCCACTTCAACAGGACTTTGTCCCACGTTCAGGTTGCCGG 67 FBan0012163 FBgn0037303 CG12163 3 3R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cysteine protease inhibitor activity; GO:0004869; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004869; ; GO:0004197 ; EC:3.4.22.- CG12163 CG12163 anon-WO0118547.305 CDMC26136 3 19 7 DAC11-O20 AutoBlank AutoBlank CDMC26136 3 20 7 DAC11-O20 AutoBlank AutoBlank CDMC26137 3 21 7 DAC12-C08 3-CG10284-RA_1 CG10284 CCATGGAAAGGGCTTTCTCCAGACGCAGAGCAATAATGAGACGCTCGATAGGTAGCCACATGCGCA 66 FBan0010284 FBgn0037441 CG10284 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG10284 CG10284 BRG-A3 CDMC26137 3 22 7 DAC12-C08 3-CG10284-RA_1 CG10284 CCATGGAAAGGGCTTTCTCCAGACGCAGAGCAATAATGAGACGCTCGATAGGTAGCCACATGCGCA 66 FBan0010284 FBgn0037441 CG10284 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG10284 CG10284 BRG-A3 CDMC26138 3 23 7 DAC12-C20 16-CG10476-RA_1 CG10476 TGAAGGAGGACGACTATCCAAGAGTGAAAACCTTCATGACGGACTACTTTCACTACGACGAGCCCA 66 FBan0010476 FBgn0034426 CG10476 2 2R CG10476 CG10476 CDMC26138 3 24 7 DAC12-C20 16-CG10476-RA_1 CG10476 TGAAGGAGGACGACTATCCAAGAGTGAAAACCTTCATGACGGACTACTTTCACTACGACGAGCCCA 66 FBan0010476 FBgn0034426 CG10476 2 2R CG10476 CG10476 CDMC26139 3 25 7 DAC12-G08 6-CG10931-RA_3 CG10931 TGGAATTGATTGAAACAGCTTCGACTCCTGGAGATTCCGAAACTGAAATCGCCATCCCGGAGGCCG 66 FBan0010931 FBgn0034274 CG10931 2 2R cell proliferation; GO:0008283 CG10931 CG10931 CDMC26139 3 26 7 DAC12-G08 6-CG10931-RA_3 CG10931 TGGAATTGATTGAAACAGCTTCGACTCCTGGAGATTCCGAAACTGAAATCGCCATCCCGGAGGCCG 66 FBan0010931 FBgn0034274 CG10931 2 2R cell proliferation; GO:0008283 CG10931 CG10931 CDMC26140 3 1 8 DAC12-G20 3-CG11029-RA_1 CG11029 GCACTGGAAGCTGTTGACAGTGTATGTGGGAAACAACGACATCTGCTCCGACCTGTGTCACTGGGA 66 FBan0011029 FBgn0031735 CG11029 2 2L lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; ; GO:0004622 ; EC:3.1.1.5 CG11029 CG11029 CDMC26140 3 2 8 DAC12-G20 3-CG11029-RA_1 CG11029 GCACTGGAAGCTGTTGACAGTGTATGTGGGAAACAACGACATCTGCTCCGACCTGTGTCACTGGGA 66 FBan0011029 FBgn0031735 CG11029 2 2L lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; ; GO:0004622 ; EC:3.1.1.5 CG11029 CG11029 CDMC26141 3 3 8 DAC12-K08 8-CG11266-RC_1 CG11266 ACTGTCCAATATGTTTGATCCGCGTACCGAGACAAATCCTACCTGGGACGTTGAGATCCGCGACGA 66 FBan0011266 FBgn0031883 CG11266 2 2L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634; spliceosome complex; GO:0005681 CG11266 CG11266 "cg11266, HCC1, CAPER, CC1.3" CDMC26141 3 4 8 DAC12-K08 8-CG11266-RC_1 CG11266 ACTGTCCAATATGTTTGATCCGCGTACCGAGACAAATCCTACCTGGGACGTTGAGATCCGCGACGA 66 FBan0011266 FBgn0031883 CG11266 2 2L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634; spliceosome complex; GO:0005681 CG11266 CG11266 "cg11266, HCC1, CAPER, CC1.3" CDMC26142 3 5 8 DAC12-K20 2-CG11438-RA_1 CG11438 CGTCATGTTCGGCTGGTACGTATCGCTGACTCGGATCATCGACTATTACCACCACTGGAGCGACGT 66 FBan0011438 FBgn0037164 CG11438 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11438 CG11438 "WUN-like, Css1alpha" CDMC26142 3 6 8 DAC12-K20 2-CG11438-RA_1 CG11438 CGTCATGTTCGGCTGGTACGTATCGCTGACTCGGATCATCGACTATTACCACCACTGGAGCGACGT 66 FBan0011438 FBgn0037164 CG11438 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11438 CG11438 "WUN-like, Css1alpha" CDMC26143 3 7 8 DAC12-O08 8-CG1214-RA_2 CG1214 GGCGTATGGTGCATATTCAGCGCCTTTGGAATCGCCTTCAACTTGGTGAATACGGTCACAGCTCAA 66 FBan0001214 FBgn0003295 ru 3 3L cone cell fate commitment (sensu Endopterygota); GO:0007466; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; female gamete generation; GO:0007292; leg disc proximal/distal pattern formation; GO:0007479; nervous system development; GO:0007399; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; tracheal epithelial cell migration (sensu Insecta); GO:0007427 serine-type peptidase activity; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; ; GO:0008236 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ru roughoid "CG1214, rho-3, roughoid/rhomboid-3, Rho-related [62A1], Rhomboid 3, rho3, Rho-3, rhomboid-3" CDMC26143 3 8 8 DAC12-O08 8-CG1214-RA_2 CG1214 GGCGTATGGTGCATATTCAGCGCCTTTGGAATCGCCTTCAACTTGGTGAATACGGTCACAGCTCAA 66 FBan0001214 FBgn0003295 ru 3 3L cone cell fate commitment (sensu Endopterygota); GO:0007466; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; female gamete generation; GO:0007292; leg disc proximal/distal pattern formation; GO:0007479; nervous system development; GO:0007399; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; tracheal epithelial cell migration (sensu Insecta); GO:0007427 serine-type peptidase activity; GO:0008236; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057; ; GO:0008236 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ru roughoid "CG1214, rho-3, roughoid/rhomboid-3, Rho-related [62A1], Rhomboid 3, rho3, Rho-3, rhomboid-3" CDMC26144 3 9 8 DAC12-O20 AutoBlank AutoBlank CDMC26144 3 10 8 DAC12-O20 AutoBlank AutoBlank CDMC26145 3 11 8 DAC13-C08 16-CG14549-RA_1 CG14549 ACAGATTACAGCTCAGAAGGTTCTGGAAATCATAGAAACCGCGTGGATAAATGAAATGTGTGCGCCGGA 69 FBan0014549 FBgn0039403 CG14549 3 3R CG14549 CG14549 anon-WO0172774.61 CDMC26145 3 12 8 DAC13-C08 16-CG14549-RA_1 CG14549 ACAGATTACAGCTCAGAAGGTTCTGGAAATCATAGAAACCGCGTGGATAAATGAAATGTGTGCGCCGGA 69 FBan0014549 FBgn0039403 CG14549 3 3R CG14549 CG14549 anon-WO0172774.61 CDMC26146 3 13 8 DAC13-C20 12-CG14562-RA_7 CG14562 ACGGAGAGTTTGAGGTGCGCTTCCTTAGCTGGCATAACGAGTTGCTTACCCTCAGCCTTAAGATACAGA 69 FBan0014562 FBgn0037142 CG14562 3 3L CG14562 CG14562 anon-WO0140519.241 CDMC26146 3 14 8 DAC13-C20 12-CG14562-RA_7 CG14562 ACGGAGAGTTTGAGGTGCGCTTCCTTAGCTGGCATAACGAGTTGCTTACCCTCAGCCTTAAGATACAGA 69 FBan0014562 FBgn0037142 CG14562 3 3L CG14562 CG14562 anon-WO0140519.241 CDMC26147 3 15 8 DAC13-G08 10-CG14608-RA_1 CG14608 TTCGGGCTTACTCTCTAATCAGACCAACGGAACCCAATCAGAAGCGGGATCGAAATACCAGCAGTACCC 69 FBan0014608 FBgn0037487 CG14608 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14608 CG14608 CDMC26147 3 16 8 DAC13-G08 10-CG14608-RA_1 CG14608 TTCGGGCTTACTCTCTAATCAGACCAACGGAACCCAATCAGAAGCGGGATCGAAATACCAGCAGTACCC 69 FBan0014608 FBgn0037487 CG14608 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14608 CG14608 CDMC26148 3 17 8 DAC13-G20 3-CG14617-RA_3 CG14617 GTGCAGCGCATTGTCCAAACCATCAGAGACACCCTGATCTTCGTGTTGAACCTGCACCTGGAAACTTGT 69 FBan0014617 FBgn0031191 CG14617 X X CG14617 CG14617 CG32501 CDMC26148 3 18 8 DAC13-G20 3-CG14617-RA_3 CG14617 GTGCAGCGCATTGTCCAAACCATCAGAGACACCCTGATCTTCGTGTTGAACCTGCACCTGGAAACTTGT 69 FBan0014617 FBgn0031191 CG14617 X X CG14617 CG14617 CG32501 CDMC26149 3 19 8 DAC13-K08 17-CG14658-RA_1 CG14658 AGCCAGCCCAAAAACCAGTAAAACACACACTCAAAATGTCCAACATGCCAATCGAAGGGTAAACTCTGT 69 FBan0014658 FBgn0037283 CG14658 3 3R CG14658 CG14658 CDMC26149 3 20 8 DAC13-K08 17-CG14658-RA_1 CG14658 AGCCAGCCCAAAAACCAGTAAAACACACACTCAAAATGTCCAACATGCCAATCGAAGGGTAAACTCTGT 69 FBan0014658 FBgn0037283 CG14658 3 3R CG14658 CG14658 CDMC26150 3 21 8 DAC13-K20 16-CG14667-RA_2 CG14667 CGACCAGTACGTTTGTTATCAAGGCACGAAAGAGGAACACCAAGACCTAGAGGAAATCGAGCTGGATGA 69 FBan0014667 FBgn0037317 CG14667 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14667 CG14667 CDMC26150 3 22 8 DAC13-K20 16-CG14667-RA_2 CG14667 CGACCAGTACGTTTGTTATCAAGGCACGAAAGAGGAACACCAAGACCTAGAGGAAATCGAGCTGGATGA 69 FBan0014667 FBgn0037317 CG14667 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14667 CG14667 CDMC26151 3 23 8 DAC13-O08 14-CG1469-RB_1 CG1469 CCTTGGCCAAGGATGATGAATATTGCCAGAACACTGTAATCACCGCATGCTCTACGTCAGCCTTTTCGG 69 FBan0001469 FBgn0015221 Fer2LCH 3 3R iron ion homeostasis; GO:0006879 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 Fer2LCH Ferritin 2 light chain homologue "CG1469, CG1469, CG1469, l(3)neo60, l(3)neo63, l(3)00035, Ferritin, l(3)07016, 2LCH, LCH, Fer-H: Ferritin-Heavy, anon-EST:ParkEST264, l(3)j2A3, l(3)s2083, Ferritin-Heavy" CDMC26151 3 24 8 DAC13-O08 14-CG1469-RB_1 CG1469 CCTTGGCCAAGGATGATGAATATTGCCAGAACACTGTAATCACCGCATGCTCTACGTCAGCCTTTTCGG 69 FBan0001469 FBgn0015221 Fer2LCH 3 3R iron ion homeostasis; GO:0006879 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 Fer2LCH Ferritin 2 light chain homologue "CG1469, CG1469, CG1469, l(3)neo60, l(3)neo63, l(3)00035, Ferritin, l(3)07016, 2LCH, LCH, Fer-H: Ferritin-Heavy, anon-EST:ParkEST264, l(3)j2A3, l(3)s2083, Ferritin-Heavy" CDMC26152 3 25 8 DAC13-O20 3-CG14713-RA_3 CG14713 CCAGTACGCGGAATAGTACGATCGTGGACACAAGTACATCGGCGACAAGTGTAGCAACACCCACGCAAA 69 FBan0014713 FBgn0037928 CG14713 3 3R CG14713 CG14713 "CG18479, anon-WO0118547.710" CDMC26152 3 26 8 DAC13-O20 3-CG14713-RA_3 CG14713 CCAGTACGCGGAATAGTACGATCGTGGACACAAGTACATCGGCGACAAGTGTAGCAACACCCACGCAAA 69 FBan0014713 FBgn0037928 CG14713 3 3R CG14713 CG14713 "CG18479, anon-WO0118547.710" CDMC26153 3 1 9 DAC14-C08 9-CG17322-RB_4 CG17322 CTGTGCCGATTGTGGGTGTCCCAATTTACGGCGACCAATCCCTCAATATTGCCGCATTGGTGCAG 65 FBan0017322 FBgn0027070 CG17322 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG17322 CG17322 "LD25345, BEST:LD25345" CDMC26153 3 2 9 DAC14-C08 9-CG17322-RB_4 CG17322 CTGTGCCGATTGTGGGTGTCCCAATTTACGGCGACCAATCCCTCAATATTGCCGCATTGGTGCAG 65 FBan0017322 FBgn0027070 CG17322 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG17322 CG17322 "LD25345, BEST:LD25345" CDMC26154 3 3 9 DAC14-C20 3-CG17362-RA_2 CG17362 ATGCAAACTGCAGATTTATGGCACGAACTTTGCGAATCTGGGTTGGTCCTCTTTCGGTCTGCCGC 65 FBan0017362 FBgn0036393 CG17362 3 3L CG17362 CG17362 CDMC26154 3 4 9 DAC14-C20 3-CG17362-RA_2 CG17362 ATGCAAACTGCAGATTTATGGCACGAACTTTGCGAATCTGGGTTGGTCCTCTTTCGGTCTGCCGC 65 FBan0017362 FBgn0036393 CG17362 3 3L CG17362 CG17362 CDMC26155 3 5 9 DAC14-G08 3-CG17564-RB_1 CG17564 CCAAACTGGAACGATCCTACAACGAGTCCAGAGTGCAGTGCCTCAGATGGGAGAAGATCCTGGCC 65 FBan0017564 FBgn0032768 CG17564 2 2L CG17564 CG17564 CDMC26155 3 6 9 DAC14-G08 3-CG17564-RB_1 CG17564 CCAAACTGGAACGATCCTACAACGAGTCCAGAGTGCAGTGCCTCAGATGGGAGAAGATCCTGGCC 65 FBan0017564 FBgn0032768 CG17564 2 2L CG17564 CG17564 CDMC26156 3 7 9 DAC14-G20 2-CG17610-RA_1 CG17610 CACACCAATCACTGATTCCGAGACAGTGACAACACCCGAAACTGTTACCCACACCGGAGAACCGC 65 FBan0017610 FBgn0001137 grk 2 2L "anterior/posterior axis determination, follicular epithelium; GO:0030714; anterior/posterior pattern formation; GO:0009952; border follicle cell migration (sensu Insecta); GO:0007298; cell fate determination; GO:0001709; cell fate specification; GO:0001708; dorsal appendage formation; GO:0046843; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; epidermal growth factor receptor signaling pathway; GO:0007173; gurken receptor signaling pathway; GO:0008314; maternal determination of dorsal/ventral axis, follicular epithelium, germ-line encoded; GO:0008070; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination (sensu Insecta); GO:0048111; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte dorsal/ventral axis determination; GO:0007310" epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; gurken receptor binding; GO:0008317; ; GO:0005154; ; GO:0008317 endoplasmic reticulum; GO:0005783; extracellular region; GO:0005576 grk gurken "CG17610, CG17610, ve: veinlet, CT32746, Grk, gurken" CDMC26156 3 8 9 DAC14-G20 2-CG17610-RA_1 CG17610 CACACCAATCACTGATTCCGAGACAGTGACAACACCCGAAACTGTTACCCACACCGGAGAACCGC 65 FBan0017610 FBgn0001137 grk 2 2L "anterior/posterior axis determination, follicular epithelium; GO:0030714; anterior/posterior pattern formation; GO:0009952; border follicle cell migration (sensu Insecta); GO:0007298; cell fate determination; GO:0001709; cell fate specification; GO:0001708; dorsal appendage formation; GO:0046843; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; epidermal growth factor receptor signaling pathway; GO:0007173; gurken receptor signaling pathway; GO:0008314; maternal determination of dorsal/ventral axis, follicular epithelium, germ-line encoded; GO:0008070; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination (sensu Insecta); GO:0048111; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte dorsal/ventral axis determination; GO:0007310" epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; gurken receptor binding; GO:0008317; ; GO:0005154; ; GO:0008317 endoplasmic reticulum; GO:0005783; extracellular region; GO:0005576 grk gurken "CG17610, CG17610, ve: veinlet, CT32746, Grk, gurken" CDMC26157 3 9 9 DAC14-K08 14-CG17734-RA_2 CG17734 CTCGAACTGCTGTCCATTGCAGAAAGTTTCGCGAACGTTGCCAAGCGATTAAACCGATCCGAACC 65 FBan0017734 FBgn0037890 CG17734 3 3R CG17734 CG17734 BcDNA:RH54117 CDMC26157 3 10 9 DAC14-K08 14-CG17734-RA_2 CG17734 CTCGAACTGCTGTCCATTGCAGAAAGTTTCGCGAACGTTGCCAAGCGATTAAACCGATCCGAACC 65 FBan0017734 FBgn0037890 CG17734 3 3R CG17734 CG17734 BcDNA:RH54117 CDMC26158 3 11 9 DAC14-K20 1-CG17776-RA_1 CG17776 TATGCCTGCATTGGAGTCACCCTGTACGGCACCTACATCCTGGGAATGCGCTACTACCACTACTG 65 FBan0017776 FBgn0040899 CG17776 X X CG17776 CG17776 CDMC26158 3 12 9 DAC14-K20 1-CG17776-RA_1 CG17776 TATGCCTGCATTGGAGTCACCCTGTACGGCACCTACATCCTGGGAATGCGCTACTACCACTACTG 65 FBan0017776 FBgn0040899 CG17776 X X CG17776 CG17776 CDMC26159 3 13 9 DAC14-O08 23-CG17945-RA_2 CG17945 GAATCGATTTGTGAAACCATACCACAATCCCACCATGGTTAAACTAACACCTGAAAGTTAAAAGC 65 FBan0017945 FBgn0004174 Mst84Dc 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Dc Male-specific RNA 84Dc "CG17945, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-3" CDMC26159 3 14 9 DAC14-O08 23-CG17945-RA_2 CG17945 GAATCGATTTGTGAAACCATACCACAATCCCACCATGGTTAAACTAACACCTGAAAGTTAAAAGC 65 FBan0017945 FBgn0004174 Mst84Dc 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Dc Male-specific RNA 84Dc "CG17945, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-3" CDMC26160 3 15 9 DAC14-O20 AutoBlank AutoBlank CDMC26160 3 16 9 DAC14-O20 AutoBlank AutoBlank CDMC26161 3 17 9 DAC15-C08 3-CG12904-RA_2 CG12904 CGCGAATCTCGTGCGAAGTCGGATGGAGTCTCTGAATCTACCCACGATCGACTACGACGATGTGAGCG 68 FBan0012904 FBgn0033510 CG12904 2 2R ion transport; GO:0006811; potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; calcium-activated potassium channel activity; GO:0015269; ; GO:0005267; ; GO:0015269 membrane; GO:0016020 CG12904 CG12904 CDMC26161 3 18 9 DAC15-C08 3-CG12904-RA_2 CG12904 CGCGAATCTCGTGCGAAGTCGGATGGAGTCTCTGAATCTACCCACGATCGACTACGACGATGTGAGCG 68 FBan0012904 FBgn0033510 CG12904 2 2R ion transport; GO:0006811; potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; calcium-activated potassium channel activity; GO:0015269; ; GO:0005267; ; GO:0015269 membrane; GO:0016020 CG12904 CG12904 CDMC26162 3 19 9 DAC15-C20 23-CG1307-RB_1 CG1307 GCTAAGATTTACGTTATTACATTAACTGTGAACCGAGCTATTAAACATTAAACGATTGACAGTCCGGC 68 FBan0001307 FBgn0026566 CG1307 3 3R tRNA metabolism; GO:0006399 aminoacyl-tRNA hydrolase activity; GO:0004045 ; EC:3.1.1.29; ; GO:0004045 ; EC:3.1.1.29; ; GO:0004045 ; EC:3.1.1.29 mitochondrion; GO:0005739 CG1307 CG1307 "hypothetical 23.1kd-like protein, BG:DS00004.12" CDMC26162 3 20 9 DAC15-C20 23-CG1307-RB_1 CG1307 GCTAAGATTTACGTTATTACATTAACTGTGAACCGAGCTATTAAACATTAAACGATTGACAGTCCGGC 68 FBan0001307 FBgn0026566 CG1307 3 3R tRNA metabolism; GO:0006399 aminoacyl-tRNA hydrolase activity; GO:0004045 ; EC:3.1.1.29; ; GO:0004045 ; EC:3.1.1.29; ; GO:0004045 ; EC:3.1.1.29 mitochondrion; GO:0005739 CG1307 CG1307 "hypothetical 23.1kd-like protein, BG:DS00004.12" CDMC26163 3 21 9 DAC15-G08 2-CG1349-RA_1 CG1349 GCACTTTTCTAAGTTTACCAAGATGTCGAAAAGCGCGCTGGTGATTTTGGCTCCCGGAGCGGAGGAGA 68 FBan0001349 FBgn0039802 dj-1beta 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 dj-1beta dj-1beta CG1349 CDMC26163 3 22 9 DAC15-G08 2-CG1349-RA_1 CG1349 GCACTTTTCTAAGTTTACCAAGATGTCGAAAAGCGCGCTGGTGATTTTGGCTCCCGGAGCGGAGGAGA 68 FBan0001349 FBgn0039802 dj-1beta 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110; vitamin metabolism; GO:0006766 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 dj-1beta dj-1beta CG1349 CDMC26164 3 23 9 DAC15-G20 3-CG13626-RA_2 CG13626 GCGTACGCGCAAACGAAGCAAAGCCAACAGATCGGATCTGAACAACTCATCCTCCAAGATGGCTCTGG 68 FBan0013626 FBgn0039212 Syx18 3 3R neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; SNAP receptor activity; GO:0005484; ; GO:0005486; ; GO:0005484 plasma membrane; GO:0005886 Syx18 Syntaxin 18 "CG13626, Dm Ufe1, Ufe1/Syntaxin 18, DmSyx18, syntaxin, Syntaxin 18" CDMC26164 3 24 9 DAC15-G20 3-CG13626-RA_2 CG13626 GCGTACGCGCAAACGAAGCAAAGCCAACAGATCGGATCTGAACAACTCATCCTCCAAGATGGCTCTGG 68 FBan0013626 FBgn0039212 Syx18 3 3R neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; SNAP receptor activity; GO:0005484; ; GO:0005486; ; GO:0005484 plasma membrane; GO:0005886 Syx18 Syntaxin 18 "CG13626, Dm Ufe1, Ufe1/Syntaxin 18, DmSyx18, syntaxin, Syntaxin 18" CDMC26165 3 25 9 DAC15-K08 1-CG13916-RA_1 CG13916 GCGATCTGTTTGTGTTGCATGGAAACCTCTGTGGCAGTTCGAATCCCTCGATACGTTCAGTGGCGCAC 68 FBgn0035220 CDMC26165 3 26 9 DAC15-K08 1-CG13916-RA_1 CG13916 GCGATCTGTTTGTGTTGCATGGAAACCTCTGTGGCAGTTCGAATCCCTCGATACGTTCAGTGGCGCAC 68 FBgn0035220 CDMC26166 3 1 10 DAC15-K20 1-CG14049-RA_1 CG14049 ACGGAATACGAACAGAGACGCATGATGTGCTCCACCGGCCTCAGCGATGTGATACAGAAGATATGCGT 68 FBgn0029612 CDMC26166 3 2 10 DAC15-K20 1-CG14049-RA_1 CG14049 ACGGAATACGAACAGAGACGCATGATGTGCTCCACCGGCCTCAGCGATGTGATACAGAAGATATGCGT 68 FBgn0029612 CDMC26167 3 3 10 DAC15-O08 2-CG14497-RA_1 CG14497 GGTCAGCCCGAGTACACCAACAATGAGTTACCATCTGGCGGTCTAGATGATGTGGACATTGAGGGCGA 68 FBan0014497 FBgn0034298 CG14497 2 2R CG14497 CG14497 CDMC26167 3 4 10 DAC15-O08 2-CG14497-RA_1 CG14497 GGTCAGCCCGAGTACACCAACAATGAGTTACCATCTGGCGGTCTAGATGATGTGGACATTGAGGGCGA 68 FBan0014497 FBgn0034298 CG14497 2 2R CG14497 CG14497 CDMC26168 3 5 10 DAC15-O20 1-CG14580-RA_1 CG14580 GAGCAGCAGAAGAAAGTGGAGGATCAGAGGAGCACTGCAATATTCAGCAACCAACTGCCACCGAGTGG 68 FBan0014580 FBgn0040646 CG14580 X X CG14580 CG14580 CDMC26168 3 6 10 DAC15-O20 1-CG14580-RA_1 CG14580 GAGCAGCAGAAGAAAGTGGAGGATCAGAGGAGCACTGCAATATTCAGCAACCAACTGCCACCGAGTGG 68 FBan0014580 FBgn0040646 CG14580 X X CG14580 CG14580 CDMC26169 3 7 10 DAC16-C08 2-CG31092-RA_1 CG31092 TACCACAAGACCACAGAGGACCACTTCAGTCTGGAGAAGAATGGGACGCCACACATTTACGCCGC 65 FBan0031092 FBgn0051092 LpR2 3 3R cholesterol metabolism; GO:0008203; female gamete generation; GO:0007292; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 calcium ion binding; GO:0005509; ; GO:0005509; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041 membrane; GO:0016020 LpR2 LpR2 "CG4823, CG31092, CG4834, CG4823, CG4823, CG31092, CG4823, LDLR-like, a2M-receptor-like" CDMC26169 3 8 10 DAC16-C08 2-CG31092-RA_1 CG31092 TACCACAAGACCACAGAGGACCACTTCAGTCTGGAGAAGAATGGGACGCCACACATTTACGCCGC 65 FBan0031092 FBgn0051092 LpR2 3 3R cholesterol metabolism; GO:0008203; female gamete generation; GO:0007292; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 calcium ion binding; GO:0005509; ; GO:0005509; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041 membrane; GO:0016020 LpR2 LpR2 "CG4823, CG31092, CG4834, CG4823, CG4823, CG31092, CG4823, LDLR-like, a2M-receptor-like" CDMC26170 3 9 10 DAC16-C20 23-CG31128-RA_1 CG31128 TCGGAATATGCGATAGTGGGGAGAGATATTCATAAGTCGAAAACCAATAGTGGCTTTTCAAAAAA 65 FBan0031128 FBgn0051128 CG31128 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31128 CG31128 BcDNA:AT04449 CDMC26170 3 10 10 DAC16-C20 23-CG31128-RA_1 CG31128 TCGGAATATGCGATAGTGGGGAGAGATATTCATAAGTCGAAAACCAATAGTGGCTTTTCAAAAAA 65 FBan0031128 FBgn0051128 CG31128 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31128 CG31128 BcDNA:AT04449 CDMC26171 3 11 10 DAC16-G08 47-CG31247-RA_1 CG31247 GAAGTTACGAGTACGTCTGATGATGTCCTACTAATTGGTGACCAAGAACAAACTGATGGCAAGCG 65 FBan0031247 FBgn0038554 tinc 3 3R regulation of eye photoreceptor cell development; GO:0042478 plasma membrane; GO:0005886 tinc tincar "CG31247, CG14319, CG14320, CG7723, Tincar, tincar" CDMC26171 3 12 10 DAC16-G08 47-CG31247-RA_1 CG31247 GAAGTTACGAGTACGTCTGATGATGTCCTACTAATTGGTGACCAAGAACAAACTGATGGCAAGCG 65 FBan0031247 FBgn0038554 tinc 3 3R regulation of eye photoreceptor cell development; GO:0042478 plasma membrane; GO:0005886 tinc tincar "CG31247, CG14319, CG14320, CG7723, Tincar, tincar" CDMC26172 3 13 10 DAC16-G20 3-CG31279-RA_4 CG31279 ATCGGTGCCATAGGTGATCCCAGTCCACAAAATGTCTCATCGGGATCGGAACCCCTCATCACGTG 65 FBan0031279 FBgn0051279 CG31279 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31279 CG31279 CDMC26172 3 14 10 DAC16-G20 3-CG31279-RA_4 CG31279 ATCGGTGCCATAGGTGATCCCAGTCCACAAAATGTCTCATCGGGATCGGAACCCCTCATCACGTG 65 FBan0031279 FBgn0051279 CG31279 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31279 CG31279 CDMC26173 3 15 10 DAC16-K08 1-CG31381-RA_1 CG31381 GAACGCTTCGGAGGAGAAATAATCAGCGCTGACTCCATGCAGGTTTACACCCACCTGGACATCGC 65 FBan0031381 FBgn0043799 CG31381 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA metabolism; GO:0006399; tRNA processing; GO:0008033" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.-; tRNA isopentenyltransferase activity; GO:0004811 ; EC:2.5.1.8; ; GO:0004811 ; EC:2.5.1.8; ; GO:0008270 nucleus; GO:0005634 CG31381 CG31381 BEST:LD10347 CDMC26173 3 16 10 DAC16-K08 1-CG31381-RA_1 CG31381 GAACGCTTCGGAGGAGAAATAATCAGCGCTGACTCCATGCAGGTTTACACCCACCTGGACATCGC 65 FBan0031381 FBgn0043799 CG31381 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA metabolism; GO:0006399; tRNA processing; GO:0008033" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.-; tRNA isopentenyltransferase activity; GO:0004811 ; EC:2.5.1.8; ; GO:0004811 ; EC:2.5.1.8; ; GO:0008270 nucleus; GO:0005634 CG31381 CG31381 BEST:LD10347 CDMC26174 3 17 10 DAC16-K20 3-CG31422-RA_1 CG31422 GATCCCAGCCAGAAGATCGATGGCAATTTGCAATTTGCTAGCTGCAACTGTGTCGCGTCGCGATC 65 FBan0031422 FBgn0051422 CG31422 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31422 CG31422 CDMC26174 3 18 10 DAC16-K20 3-CG31422-RA_1 CG31422 GATCCCAGCCAGAAGATCGATGGCAATTTGCAATTTGCTAGCTGCAACTGTGTCGCGTCGCGATC 65 FBan0031422 FBgn0051422 CG31422 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31422 CG31422 CDMC26175 3 19 10 DAC16-O08 23-CG31542-RA_2 CG31542 AACGCTCACAACATGACATGACAGTACTCCCAAATTTCAGGTTAGCCAAATTTCCAGTTTCGACC 65 FBan0031542 FBgn0051542 CG31542 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31542 CG31542 "BcDNA:AT15479, NEST:bs01d10, NEST:bs08f12, NEST:bs29h01" CDMC26175 3 20 10 DAC16-O08 23-CG31542-RA_2 CG31542 AACGCTCACAACATGACATGACAGTACTCCCAAATTTCAGGTTAGCCAAATTTCCAGTTTCGACC 65 FBan0031542 FBgn0051542 CG31542 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31542 CG31542 "BcDNA:AT15479, NEST:bs01d10, NEST:bs08f12, NEST:bs29h01" CDMC26176 3 21 10 DAC16-O20 AutoBlank AutoBlank CDMC26176 3 22 10 DAC16-O20 AutoBlank AutoBlank CDMC26177 3 23 10 DAC17-C08 1-CG32712-RA_1 CG32712 ATCTTAGCCGGCAGGAGTTATCGTATTTGCGCTGGACGGTGGTGTTCACGCTGCTCTACTCCTTC 65 FBan0032712 FBgn0052712 CG32712 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32712 CG32712 CDMC26177 3 24 10 DAC17-C08 1-CG32712-RA_1 CG32712 ATCTTAGCCGGCAGGAGTTATCGTATTTGCGCTGGACGGTGGTGTTCACGCTGCTCTACTCCTTC 65 FBan0032712 FBgn0052712 CG32712 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32712 CG32712 CDMC26178 3 25 10 DAC17-C20 23-CG32781-RB_6 CG32781 CAAGTTTCGTTTCTAGGGGGTCACCTTACTTTTGTTGATCTGTCTGCCATTCATTACTCACTCAA 65 FBan0032781 FBgn0052781 CG32781 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32781 CG32781 CDMC26178 3 26 10 DAC17-C20 23-CG32781-RB_6 CG32781 CAAGTTTCGTTTCTAGGGGGTCACCTTACTTTTGTTGATCTGTCTGCCATTCATTACTCACTCAA 65 FBan0032781 FBgn0052781 CG32781 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32781 CG32781 CDMC26179 3 1 11 DAC17-G08 17-CG32918-RC_1 CG32918 CGCACCCAGTACCTGAACGTGCTCATCAAGAAGTTCGCCAAATTCATTTCCCATCTGGCCACAAC 65 FBgn0052918 CDMC26179 3 2 11 DAC17-G08 17-CG32918-RC_1 CG32918 CGCACCCAGTACCTGAACGTGCTCATCAAGAAGTTCGCCAAATTCATTTCCCATCTGGCCACAAC 65 FBgn0052918 CDMC26180 3 3 11 DAC17-G20 2-CG32983-RA_2 CG32983 GTTTCTTCCCAATGGCCTCGTCACCGGAGTGATTGTGACCATTTTCCTGGTAGCTCTCCTTCCGC 65 FBan0032983 FBgn0052983 CG32983 2 2L CG32983 CG32983 CG18663 CDMC26180 3 4 11 DAC17-G20 2-CG32983-RA_2 CG32983 GTTTCTTCCCAATGGCCTCGTCACCGGAGTGATTGTGACCATTTTCCTGGTAGCTCTCCTTCCGC 65 FBan0032983 FBgn0052983 CG32983 2 2L CG32983 CG32983 CG18663 CDMC26181 3 5 11 DAC17-K08 3-CG3312-RA_2 CG3312 CAGCCCGTCCTCGAGAATGGCCTTATGGTGCAGGAGTTTTTTCGCCGCTATGAACGTTGCTATGG 65 FBan0003312 FBgn0014024 Rnp4F X X RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729 intracellular; GO:0005622 Rnp4F RNA-binding protein 4F "CG3312, 4f-rnp, 4F-rnp, rnp-4f, RNP-4F, RNA-binding protein 4F" CDMC26181 3 6 11 DAC17-K08 3-CG3312-RA_2 CG3312 CAGCCCGTCCTCGAGAATGGCCTTATGGTGCAGGAGTTTTTTCGCCGCTATGAACGTTGCTATGG 65 FBan0003312 FBgn0014024 Rnp4F X X RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729 intracellular; GO:0005622 Rnp4F RNA-binding protein 4F "CG3312, 4f-rnp, 4F-rnp, rnp-4f, RNP-4F, RNA-binding protein 4F" CDMC26182 3 7 11 DAC17-K20 5-CG33159-RA_1 CG33159 TAATGCGTATGCCAGGATCAGTGGTTGGGGAGTTACCCGCGAGAATAACCGTGAACCTGCCGAAC 65 FBan0033159 FBgn0053159 CG33159 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33159 CG33159 "CG11532, SP176" CDMC26182 3 8 11 DAC17-K20 5-CG33159-RA_1 CG33159 TAATGCGTATGCCAGGATCAGTGGTTGGGGAGTTACCCGCGAGAATAACCGTGAACCTGCCGAAC 65 FBan0033159 FBgn0053159 CG33159 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33159 CG33159 "CG11532, SP176" CDMC26183 3 9 11 DAC17-O08 3-CG33257-RA_1 CG33257 GTAGAGCCTCCCGAGCCAGAGAAGCCACAACATAGCACCAAAAGCTACTACACCACATCGGGAGG 65 FBan0033257 FBgn0053257 CG33257 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33257 CG33257 CG13037 CDMC26183 3 10 11 DAC17-O08 3-CG33257-RA_1 CG33257 GTAGAGCCTCCCGAGCCAGAGAAGCCACAACATAGCACCAAAAGCTACTACACCACATCGGGAGG 65 FBan0033257 FBgn0053257 CG33257 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33257 CG33257 CG13037 CDMC26184 3 11 11 DAC17-O20 AutoBlank AutoBlank CDMC26184 3 12 11 DAC17-O20 AutoBlank AutoBlank CDMC26185 3 13 11 DAC18-C08 2-CG5973-RA_1 CG5973 ATTCCGCGGCATTCAATTGACCGTACTGGGTTCTATGGTGGAGCCCTACTCACAAATTTGCGGCTCAG 68 FBan0005973 FBgn0031914 CG5973 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 Arp2/3 protein complex; GO:0005885 CG5973 CG5973 CDMC26185 3 14 11 DAC18-C08 2-CG5973-RA_1 CG5973 ATTCCGCGGCATTCAATTGACCGTACTGGGTTCTATGGTGGAGCCCTACTCACAAATTTGCGGCTCAG 68 FBan0005973 FBgn0031914 CG5973 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 Arp2/3 protein complex; GO:0005885 CG5973 CG5973 CDMC26186 3 15 11 DAC18-C20 38-CG6157-RA_1 CG6157 CCCTGTTAGAGATCAGGATCACCTTCATACTGCTGTGCAAGCTATATAGCAGCGATCACCTGGTGGGC 68 FBan0006157 FBgn0015926 dah X X "cellularization; GO:0007349; cytokinesis, contractile ring formation; GO:0000915" zinc ion binding; GO:0008270; ; GO:0008270 extrinsic to membrane; GO:0019898 dah discontinuous actin hexagon "CG6157, CG6157, fs(1)dah, Dah, Apd, Apodystrophin" CDMC26186 3 16 11 DAC18-C20 38-CG6157-RA_1 CG6157 CCCTGTTAGAGATCAGGATCACCTTCATACTGCTGTGCAAGCTATATAGCAGCGATCACCTGGTGGGC 68 FBan0006157 FBgn0015926 dah X X "cellularization; GO:0007349; cytokinesis, contractile ring formation; GO:0000915" zinc ion binding; GO:0008270; ; GO:0008270 extrinsic to membrane; GO:0019898 dah discontinuous actin hexagon "CG6157, CG6157, fs(1)dah, Dah, Apd, Apodystrophin" CDMC26187 3 17 11 DAC18-G08 3-CG6580-RA_1 CG6580 GCCTGGACTACTACGGCAGCCACTATATCACCTCCAACCACCTGTGCTATGCCACTCCCGAGAATAAG 68 FBan0006580 FBgn0035666 Jon65Aii 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Aii Jonah 65Aii "CG6580, CG6580, Jon65A, SP153, Jonah 65A" CDMC26187 3 18 11 DAC18-G08 3-CG6580-RA_1 CG6580 GCCTGGACTACTACGGCAGCCACTATATCACCTCCAACCACCTGTGCTATGCCACTCCCGAGAATAAG 68 FBan0006580 FBgn0035666 Jon65Aii 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Aii Jonah 65Aii "CG6580, CG6580, Jon65A, SP153, Jonah 65A" CDMC26188 3 19 11 DAC18-G20 3-CG6692-RA_2 CG6692 GCGTTTCCGCCTCAAGATCTTCAATGAGAACAAGCACAAGATTGCCAAGCACAACCAGCGATTCGCCG 68 FBan0006692 FBgn0013770 Cp1 2 2R "autophagic cell death; GO:0048102; protein catabolism; GO:0030163; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355; salivary gland cell autophagic cell death; GO:0035071" nucleic acid binding; GO:0003676; cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0003676; ; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 lysosome; GO:0005764 Cp1 Cysteine proteinase-1 "CG6692, CG6692, DCP1, Drosophila Cysteine proteinase-1, cathepsin L, fs(2)50Ca, CP1, Dcp1, cysteine proteinase-1, Dcp-1, CT20780, Cathepsin L, cp1, CysP-1" CDMC26188 3 20 11 DAC18-G20 3-CG6692-RA_2 CG6692 GCGTTTCCGCCTCAAGATCTTCAATGAGAACAAGCACAAGATTGCCAAGCACAACCAGCGATTCGCCG 68 FBan0006692 FBgn0013770 Cp1 2 2R "autophagic cell death; GO:0048102; protein catabolism; GO:0030163; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355; salivary gland cell autophagic cell death; GO:0035071" nucleic acid binding; GO:0003676; cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0003676; ; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 lysosome; GO:0005764 Cp1 Cysteine proteinase-1 "CG6692, CG6692, DCP1, Drosophila Cysteine proteinase-1, cathepsin L, fs(2)50Ca, CP1, Dcp1, cysteine proteinase-1, Dcp-1, CT20780, Cathepsin L, cp1, CysP-1" CDMC26189 3 21 11 DAC18-K08 2-CG7079-RA_1 CG7079 TGCACTGCTGAGAGATTTTCCAAAGGGCATTCCCGAGGTCGATCTGAAACCCTTCAATGTGCTGTCCG 68 FBan0007079 FBgn0038849 CG7079 3 3R CG7079 CG7079 CDMC26189 3 22 11 DAC18-K08 2-CG7079-RA_1 CG7079 TGCACTGCTGAGAGATTTTCCAAAGGGCATTCCCGAGGTCGATCTGAAACCCTTCAATGTGCTGTCCG 68 FBan0007079 FBgn0038849 CG7079 3 3R CG7079 CG7079 CDMC26190 3 23 11 DAC18-K20 1-CG7208-RA_1 CG7208 CCTGCCCTTGGTCAGTCCGAATAAGTCGCTCTGTGTGATCTTCGCATTACTGGAGTCACAGAACCCGG 68 FBan0007208 FBgn0038575 CG7208 3 3R CG7208 CG7208 CDMC26190 3 24 11 DAC18-K20 1-CG7208-RA_1 CG7208 CCTGCCCTTGGTCAGTCCGAATAAGTCGCTCTGTGTGATCTTCGCATTACTGGAGTCACAGAACCCGG 68 FBan0007208 FBgn0038575 CG7208 3 3R CG7208 CG7208 CDMC26191 3 25 11 DAC18-O08 3-CG7496-RA_1 CG7496 GGCTACCACTATCTGATCGGCGGTAATGGCAAGGTATACGAAGGCAGAAGTCCAAGCCAGAGAGGAGC 68 FBan0007496 FBgn0035806 PGRP-SD 3 3L defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SD PGRP-SD "CG7496, CG7496, CG7496" CDMC26191 3 26 11 DAC18-O08 3-CG7496-RA_1 CG7496 GGCTACCACTATCTGATCGGCGGTAATGGCAAGGTATACGAAGGCAGAAGTCCAAGCCAGAGAGGAGC 68 FBan0007496 FBgn0035806 PGRP-SD 3 3L defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SD PGRP-SD "CG7496, CG7496, CG7496" CDMC26192 3 1 12 DAC18-O20 15-CG7738-RA_3 CG7738 TCTGTATCAGCAACCCATTGAATCAAGCAGAAAGCAAGATGCGTCTAACACTTCTGGCCCTCATCGGT 68 FBan0007738 FBgn0033596 CG7738 2 2R CG7738 CG7738 BcDNA:RH51528 CDMC26192 3 2 12 DAC18-O20 15-CG7738-RA_3 CG7738 TCTGTATCAGCAACCCATTGAATCAAGCAGAAAGCAAGATGCGTCTAACACTTCTGGCCCTCATCGGT 68 FBan0007738 FBgn0033596 CG7738 2 2R CG7738 CG7738 BcDNA:RH51528 CDMC26193 3 3 12 DAC19-C08 12-CG17802-RA_2 CG17802 GGAGCAGGAGGTGTTGTACGAGGTGTCCTATGCGGATAATGAAGGACTGGAGGAAGACCACGACCTGTA 69 FBan0017802 FBgn0038549 CG17802 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17802 CG17802 CDMC26193 3 4 12 DAC19-C08 12-CG17802-RA_2 CG17802 GGAGCAGGAGGTGTTGTACGAGGTGTCCTATGCGGATAATGAAGGACTGGAGGAAGACCACGACCTGTA 69 FBan0017802 FBgn0038549 CG17802 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17802 CG17802 CDMC26194 3 5 12 DAC19-C20 14-CG17821-RA_1 CG17821 AGTGTCTGCAGGAGCATACATAATCAGGTGTTATTGTGTTTTGGGTCCGCATACACTGTTGCAGGTGCA 69 FBan0017821 FBgn0034383 CG17821 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG17821 CG17821 CDMC26194 3 6 12 DAC19-C20 14-CG17821-RA_1 CG17821 AGTGTCTGCAGGAGCATACATAATCAGGTGTTATTGTGTTTTGGGTCCGCATACACTGTTGCAGGTGCA 69 FBan0017821 FBgn0034383 CG17821 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG17821 CG17821 CDMC26195 3 7 12 DAC19-G08 3-CG17871-RB_2 CG17871 GTGGAGCACGTGGGATCTTTTCGAGCTGAGGAGCAAACAGGAAGTGGATATGTGGCGATTCGAGCATCG 69 FBan0017871 FBgn0036474 Or71a 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or71a Odorant receptor 71a "CG17871, 71B.1, DOR14, 71a, Or71c" CDMC26195 3 8 12 DAC19-G08 3-CG17871-RB_2 CG17871 GTGGAGCACGTGGGATCTTTTCGAGCTGAGGAGCAAACAGGAAGTGGATATGTGGCGATTCGAGCATCG 69 FBan0017871 FBgn0036474 Or71a 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or71a Odorant receptor 71a "CG17871, 71B.1, DOR14, 71a, Or71c" CDMC26196 3 9 12 DAC19-G20 23-CG17896-RA_5 CG17896 ATTCTGGAGAAGATTCAGATGAAATGTTCCACGTATTGAATTTCTGGATGCTTGCACACAGGACGTATT 69 FBan0017896 FBgn0023537 CG17896 X X amino acid catabolism; GO:0009063; pyrimidine base metabolism; GO:0006206; valine metabolism; GO:0006573 methylmalonate-semialdehyde dehydrogenase (acylating) activity; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27 mitochondrion; GO:0005739 CG17896 CG17896 EG:171D11.1 CDMC26196 3 10 12 DAC19-G20 23-CG17896-RA_5 CG17896 ATTCTGGAGAAGATTCAGATGAAATGTTCCACGTATTGAATTTCTGGATGCTTGCACACAGGACGTATT 69 FBan0017896 FBgn0023537 CG17896 X X amino acid catabolism; GO:0009063; pyrimidine base metabolism; GO:0006206; valine metabolism; GO:0006573 methylmalonate-semialdehyde dehydrogenase (acylating) activity; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27; ; GO:0004491 ; EC:1.2.1.27 mitochondrion; GO:0005739 CG17896 CG17896 EG:171D11.1 CDMC26197 3 11 12 DAC19-K08 23-CG17935-RA_5 CG17935 TCATCTTTCCCTTAACCCAAGAACATCAAAATTTGAGCTCTTTTCCAAGCTTTTTAGGTTCAGCACTTT 69 FBan0017935 FBgn0004175 Mst84Dd 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Dd Male-specific RNA 84Dd "CG17935, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-4" CDMC26197 3 12 12 DAC19-K08 23-CG17935-RA_5 CG17935 TCATCTTTCCCTTAACCCAAGAACATCAAAATTTGAGCTCTTTTCCAAGCTTTTTAGGTTCAGCACTTT 69 FBan0017935 FBgn0004175 Mst84Dd 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Dd Male-specific RNA 84Dd "CG17935, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-4" CDMC26198 3 13 12 DAC19-K20 15-CG17949-RA_1 CG17949 TCAGTGAGGGAACCAAGGCTGTCACCAAGTACACCAGCTCTAAATAATTTTCTCCTGCGAATGCGGACA 69 FBan0017949 FBgn0061209 His2B:CG17949 2 2L His2B:CG17949 His2B:CG17949 "CG17949, CG17949, CG17949" CDMC26198 3 14 12 DAC19-K20 15-CG17949-RA_1 CG17949 TCAGTGAGGGAACCAAGGCTGTCACCAAGTACACCAGCTCTAAATAATTTTCTCCTGCGAATGCGGACA 69 FBan0017949 FBgn0061209 His2B:CG17949 2 2L His2B:CG17949 His2B:CG17949 "CG17949, CG17949, CG17949" CDMC26199 3 15 12 DAC19-O08 1-CG18000-RE_1 CG18000 GGGCTTGGGAATGAAGGTACGAGGACTGAAGATGGAGCTACGTCCCCTCAACTGAAAGAGCCCAAATGT 69 FBgn0013761 CDMC26199 3 16 12 DAC19-O08 1-CG18000-RE_1 CG18000 GGGCTTGGGAATGAAGGTACGAGGACTGAAGATGGAGCTACGTCCCCTCAACTGAAAGAGCCCAAATGT 69 FBgn0013761 CDMC26200 3 17 12 DAC19-O20 1-CG18013-RA_1 CG18013 GCGCACTTCGATCGACGCCTTTATCAAGGGAGAGGGCACATATGCAAAGCTAGACAACCTCACGCTTCT 69 FBan0018013 FBgn0031599 CG18013 2 2L DNA strand elongation; GO:0006271 transcriptional elongation regulator activity; GO:0003711; ; GO:0003711 nucleus; GO:0005634 CG18013 CG18013 CDMC26200 3 18 12 DAC19-O20 1-CG18013-RA_1 CG18013 GCGCACTTCGATCGACGCCTTTATCAAGGGAGAGGGCACATATGCAAAGCTAGACAACCTCACGCTTCT 69 FBan0018013 FBgn0031599 CG18013 2 2L DNA strand elongation; GO:0006271 transcriptional elongation regulator activity; GO:0003711; ; GO:0003711 nucleus; GO:0005634 CG18013 CG18013 CDMC26201 3 19 12 DAC20-C08 1-CG10679-RA_1 CG10679 CCCTGACCGGCAAGGAAATCGAGATCGACATTGAGCCCACGGACAAGGTAGATCGCATCAAGGAG 65 FBan0010679 FBgn0032725 Nedd8 2 2L protein modification; GO:0006464; regulation of proteolysis; GO:0030162; ubiquitin-dependent protein catabolism; GO:0006511 protein binding; GO:0005515; ; GO:0005515 Nedd8 Nedd8 "CG10679, nedd8" CDMC26201 3 20 12 DAC20-C08 1-CG10679-RA_1 CG10679 CCCTGACCGGCAAGGAAATCGAGATCGACATTGAGCCCACGGACAAGGTAGATCGCATCAAGGAG 65 FBan0010679 FBgn0032725 Nedd8 2 2L protein modification; GO:0006464; regulation of proteolysis; GO:0030162; ubiquitin-dependent protein catabolism; GO:0006511 protein binding; GO:0005515; ; GO:0005515 Nedd8 Nedd8 "CG10679, nedd8" CDMC26202 3 21 12 DAC20-C20 5-CG10712-RB_3 CG10712 ACGGCACTGTTTACCAGGTAGCGGGAAAAAATGCGGAGGGACAAACTATTCTCGTTACGCAGGGC 65 FBgn0037201 CDMC26202 3 22 12 DAC20-C20 5-CG10712-RB_3 CG10712 ACGGCACTGTTTACCAGGTAGCGGGAAAAAATGCGGAGGGACAAACTATTCTCGTTACGCAGGGC 65 FBgn0037201 CDMC26203 3 23 12 DAC20-G08 3-CG10840-RB_4 CG10840 ATACGAATTGGACCCGTGGTGAAACGCGATGTGATGAAGGCCTCCACAATGTTGGAACACGAGGC 65 FBan0010840 FBgn0026259 eIF5B 3 3L translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; DEAD/H-box RNA helicase binding; GO:0017151; ; GO:0003743; ; GO:0017151; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829 eIF5B eIF5B "CG10840, CG14970, CG10840, CG10840, A1, cIF2: cytoplasmic Initiation Factor 2, cytoplasmic Initiation Factor 2, dIF2, yIF2, IF2, anon-WO0118547.362, cIF2" CDMC26203 3 24 12 DAC20-G08 3-CG10840-RB_4 CG10840 ATACGAATTGGACCCGTGGTGAAACGCGATGTGATGAAGGCCTCCACAATGTTGGAACACGAGGC 65 FBan0010840 FBgn0026259 eIF5B 3 3L translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; DEAD/H-box RNA helicase binding; GO:0017151; ; GO:0003743; ; GO:0017151; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829 eIF5B eIF5B "CG10840, CG14970, CG10840, CG10840, A1, cIF2: cytoplasmic Initiation Factor 2, cytoplasmic Initiation Factor 2, dIF2, yIF2, IF2, anon-WO0118547.362, cIF2" CDMC26204 3 25 12 DAC20-G20 2-CG1086-RA_2 CG1086 ATCAACGCCGTCTTCTACTATTCCACGTCGCTGTTCATGAGCTCGGGATTGACTGAGGAGAGCGC 65 FBan0001086 FBgn0025593 Glut1 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; glucose transport; GO:0015758; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; glucose transporter activity; GO:0005355; ; GO:0005355; protein binding; GO:0005515; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005525; ; GO:0005355; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624; nucleolus; GO:0005730; nucleus; GO:0005634 Glut1 Glucose transporter 1 "CG1086, CG1086, Dmglut1, glut1, glucose transporter 1, GLU" CDMC26204 3 26 12 DAC20-G20 2-CG1086-RA_2 CG1086 ATCAACGCCGTCTTCTACTATTCCACGTCGCTGTTCATGAGCTCGGGATTGACTGAGGAGAGCGC 65 FBan0001086 FBgn0025593 Glut1 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; glucose transport; GO:0015758; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; glucose transporter activity; GO:0005355; ; GO:0005355; protein binding; GO:0005515; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005525; ; GO:0005355; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624; nucleolus; GO:0005730; nucleus; GO:0005634 Glut1 Glucose transporter 1 "CG1086, CG1086, Dmglut1, glut1, glucose transporter 1, GLU" CDMC26205 3 1 13 DAC20-K08 23-CG10953-RA_1 CG10953 TACCGTCACCGTTTCTAAACTTACCAAAGCCCAACGAAAAACTGTTTCCTAACGAATCCCTACGG 65 FBan0010953 FBgn0034204 CG10953 2 2R CG10953 CG10953 CDMC26205 3 2 13 DAC20-K08 23-CG10953-RA_1 CG10953 TACCGTCACCGTTTCTAAACTTACCAAAGCCCAACGAAAAACTGTTTCCTAACGAATCCCTACGG 65 FBan0010953 FBgn0034204 CG10953 2 2R CG10953 CG10953 CDMC26206 3 3 13 DAC20-K20 6-CG10998-RA_1 CG10998 CATGCTCAACAAGGACTACATCACGTTGCGCAAGATGTCCCAACTGGTGACCACCAAACGGCTGC 65 FBan0010998 FBgn0031142 CG10998 X X CG10998 CG10998 CDMC26206 3 4 13 DAC20-K20 6-CG10998-RA_1 CG10998 CATGCTCAACAAGGACTACATCACGTTGCGCAAGATGTCCCAACTGGTGACCACCAAACGGCTGC 65 FBan0010998 FBgn0031142 CG10998 X X CG10998 CG10998 CDMC26207 3 5 13 DAC20-O08 14-CG11121-RA_1 CG11121 CCGATTGCTGGAAGGCTGTCATGAGTGGATATTCAGCTTCCAAATGCTTGGCAAGGGGATTCTGG 65 FBan0011121 FBgn0003460 so 2 2R Bolwig's organ morphogenesis; GO:0001746; circadian rhythm; GO:0007623; entrainment of circadian clock; GO:0009649; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; optic placode formation (sensu Endopterygota); GO:0001744; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271; spermatogenesis; GO:0007283 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 so sine oculis "CG11121, mda, medusa, Drl: Droplet, somda, So, ami, med: medusa, old: optic lobe defective, Droplet, absent minded, optic lobe defective, Drl" CDMC26207 3 6 13 DAC20-O08 14-CG11121-RA_1 CG11121 CCGATTGCTGGAAGGCTGTCATGAGTGGATATTCAGCTTCCAAATGCTTGGCAAGGGGATTCTGG 65 FBan0011121 FBgn0003460 so 2 2R Bolwig's organ morphogenesis; GO:0001746; circadian rhythm; GO:0007623; entrainment of circadian clock; GO:0009649; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; optic placode formation (sensu Endopterygota); GO:0001744; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271; spermatogenesis; GO:0007283 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 so sine oculis "CG11121, mda, medusa, Drl: Droplet, somda, So, ami, med: medusa, old: optic lobe defective, Droplet, absent minded, optic lobe defective, Drl" CDMC26208 3 7 13 DAC20-O20 AutoBlank AutoBlank CDMC26208 3 8 13 DAC20-O20 AutoBlank AutoBlank CDMC26209 3 9 13 DAC21-C08 14-CG11238-RA_2 CG11238 GGAGGCGGAAGGTACGTTGCAACTGTCGACACTGAGACAGGAGAACGAACGTCTACAGCGGGAGC 65 FBan0011238 FBgn0010830 l(3)04053 3 3L l(3)04053 lethal (3) 04053 "CG11238, l(3)j8B2" CDMC26209 3 10 13 DAC21-C08 14-CG11238-RA_2 CG11238 GGAGGCGGAAGGTACGTTGCAACTGTCGACACTGAGACAGGAGAACGAACGTCTACAGCGGGAGC 65 FBan0011238 FBgn0010830 l(3)04053 3 3L l(3)04053 lethal (3) 04053 "CG11238, l(3)j8B2" CDMC26210 3 11 13 DAC21-C20 3-CG11286-RA_1 CG11286 TGAGTTCCATCGTCTCCAGGAGCTCGACGAGTGGTATGAGCCAAGGATCAAGTTCCACGACGAGG 65 FBan0011286 FBgn0037516 CG11286 3 3R CG11286 CG11286 CDMC26210 3 12 13 DAC21-C20 3-CG11286-RA_1 CG11286 TGAGTTCCATCGTCTCCAGGAGCTCGACGAGTGGTATGAGCCAAGGATCAAGTTCCACGACGAGG 65 FBan0011286 FBgn0037516 CG11286 3 3R CG11286 CG11286 CDMC26211 3 13 13 DAC21-G08 3-CG11423-RA_1 CG11423 CACTCCTTGCCGCGAGGGTCTCCACTGGGTGAACATGATCATGCATAGATTTGTGACAGGACAGG 65 FBan0011423 FBgn0034251 CG11423 2 2R "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; oxidative phosphorylation; GO:0006119" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11423 CG11423 CDMC26211 3 14 13 DAC21-G08 3-CG11423-RA_1 CG11423 CACTCCTTGCCGCGAGGGTCTCCACTGGGTGAACATGATCATGCATAGATTTGTGACAGGACAGG 65 FBan0011423 FBgn0034251 CG11423 2 2R "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; oxidative phosphorylation; GO:0006119" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11423 CG11423 CDMC26212 3 15 13 DAC21-G20 3-CG11470-RA_1 CG11470 CGGCTTGCATCTCGGCCTATGACAATTGCACATCCCATATCAGCGAGAAGTATGCCGAGGATCGC 65 FBan0011470 FBgn0039671 CG11470 3 3R CG11470 CG11470 CDMC26212 3 16 13 DAC21-G20 3-CG11470-RA_1 CG11470 CGGCTTGCATCTCGGCCTATGACAATTGCACATCCCATATCAGCGAGAAGTATGCCGAGGATCGC 65 FBan0011470 FBgn0039671 CG11470 3 3R CG11470 CG11470 CDMC26213 3 17 13 DAC21-K08 1-CG11585-RA_1 CG11585 GGGAGGTTCCAGTGGCTCCTACTCAGCTCCAGTTGCATCATATAGCTCCTATTCCGCTCCAGCTG 65 FBan0011585 FBgn0030543 CG11585 X X CG11585 CG11585 CDMC26213 3 18 13 DAC21-K08 1-CG11585-RA_1 CG11585 GGGAGGTTCCAGTGGCTCCTACTCAGCTCCAGTTGCATCATATAGCTCCTATTCCGCTCCAGCTG 65 FBan0011585 FBgn0030543 CG11585 X X CG11585 CG11585 CDMC26214 3 19 13 DAC21-K20 2-CG11601-RA_2 CG11601 ACAATGTCTGCCTCTCGTTTTGGGTCATCTACGTGTGGGACCGTGAGCTCATCTTTCCCTCAGCG 65 FBan0011601 FBgn0031244 CG11601 2 2L CG11601 CG11601 CDMC26214 3 20 13 DAC21-K20 2-CG11601-RA_2 CG11601 ACAATGTCTGCCTCTCGTTTTGGGTCATCTACGTGTGGGACCGTGAGCTCATCTTTCCCTCAGCG 65 FBan0011601 FBgn0031244 CG11601 2 2L CG11601 CG11601 CDMC26215 3 21 13 DAC21-O08 3-CG11697-RA_3 CG11697 TGCGATCCTTTAGCTGTAACGAATCCTTCGACCAGGTCCTGGGACGTATCACCTTGGAATGGGGC 65 FBan0011697 FBgn0030313 CG11697 X X CG11697 CG11697 "a, anon-WO03040301.203" CDMC26215 3 22 13 DAC21-O08 3-CG11697-RA_3 CG11697 TGCGATCCTTTAGCTGTAACGAATCCTTCGACCAGGTCCTGGGACGTATCACCTTGGAATGGGGC 65 FBan0011697 FBgn0030313 CG11697 X X CG11697 CG11697 "a, anon-WO03040301.203" CDMC26216 3 23 13 DAC21-O20 AutoBlank AutoBlank CDMC26216 3 24 13 DAC21-O20 AutoBlank AutoBlank CDMC26217 3 25 13 DAC22-C08 3-CG3167-RA_3 CG3167 AGCAGCTGGAGAAAAACGATAGCCGTGTGCTGTTCGGAATGGTGAATCGTGACGGGAAGGCAATG 65 FBan0003167 FBgn0034962 CG3167 2 2R CG3167 CG3167 BcDNA:LD24895 CDMC26217 3 26 13 DAC22-C08 3-CG3167-RA_3 CG3167 AGCAGCTGGAGAAAAACGATAGCCGTGTGCTGTTCGGAATGGTGAATCGTGACGGGAAGGCAATG 65 FBan0003167 FBgn0034962 CG3167 2 2R CG3167 CG3167 BcDNA:LD24895 CDMC26218 3 1 14 DAC22-C20 23-CG31704-RA_1 CG31704 CGTGACCTATAGTAACCAGTGTGTTTTGGATTGTTTAATTAAAGAAGGACGCTCCATTACCGTGG 65 FBan0031704 FBgn0051704 CG31704 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG31704 CG31704 CDMC26218 3 2 14 DAC22-C20 23-CG31704-RA_1 CG31704 CGTGACCTATAGTAACCAGTGTGTTTTGGATTGTTTAATTAAAGAAGGACGCTCCATTACCGTGG 65 FBan0031704 FBgn0051704 CG31704 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG31704 CG31704 CDMC26219 3 3 14 DAC22-G08 3-CG31797-RA_1 CG31797 GTTGCCAGTGCGAGATCTGTCACTTCATGGATCGCCCTTTCAACGAACAGGAGGCTCCCTTCATG 65 FBan0031797 FBgn0051797 CG31797 2 2L CG31797 CG31797 "CG15175, CG15176, CT35089" CDMC26219 3 4 14 DAC22-G08 3-CG31797-RA_1 CG31797 GTTGCCAGTGCGAGATCTGTCACTTCATGGATCGCCCTTTCAACGAACAGGAGGCTCCCTTCATG 65 FBan0031797 FBgn0051797 CG31797 2 2L CG31797 CG31797 "CG15175, CG15176, CT35089" CDMC26220 3 5 14 DAC22-G20 18-CG31841-RA_1 CG31841 TCAGGACAAAACAGCACCCTCAAGATCAACACAAACGTGAAAGATATTGAAGCTGGGGTTGTGGC 65 FBan0031841 FBgn0051841 CG31841 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 CG31841 CG31841 "DS00180.5, BG:DS00180.5" CDMC26220 3 6 14 DAC22-G20 18-CG31841-RA_1 CG31841 TCAGGACAAAACAGCACCCTCAAGATCAACACAAACGTGAAAGATATTGAAGCTGGGGTTGTGGC 65 FBan0031841 FBgn0051841 CG31841 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 CG31841 CG31841 "DS00180.5, BG:DS00180.5" CDMC26221 3 7 14 DAC22-K08 3-CG31954-RA_1 CG31954 ACATATGGTAAAACGGCAGATCGCCTGAAAGTGCGACTCGGAACCAGCGAATTTGCTCGCAGTGG 65 FBan0031954 FBgn0051954 CG31954 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG31954 CG31954 "CG3229, CG3229, SP107" CDMC26221 3 8 14 DAC22-K08 3-CG31954-RA_1 CG31954 ACATATGGTAAAACGGCAGATCGCCTGAAAGTGCGACTCGGAACCAGCGAATTTGCTCGCAGTGG 65 FBan0031954 FBgn0051954 CG31954 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG31954 CG31954 "CG3229, CG3229, SP107" CDMC26222 3 9 14 DAC22-K20 1-CG32021-RA_2 CG32021 GAACATCTCGGCGAGAAAGTGTTCCATCAGCAAAATCAACAGGCCGGGCAGACCAGATCGTAGGG 65 FBan0032021 FBgn0052021 CG32021 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32021 CG32021 BcDNA:SD15619 CDMC26222 3 10 14 DAC22-K20 1-CG32021-RA_2 CG32021 GAACATCTCGGCGAGAAAGTGTTCCATCAGCAAAATCAACAGGCCGGGCAGACCAGATCGTAGGG 65 FBan0032021 FBgn0052021 CG32021 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32021 CG32021 BcDNA:SD15619 CDMC26223 3 11 14 DAC22-O08 3-CG32133-RA_1 CG32133 AAGCGCCCGATTCCTACATCATAGTAACCTGTCCCACGGACATGCATCTCTGTGCGGATCTCACG 65 FBan0032133 FBgn0052133 CG32133 3 3L transcription factor binding; GO:0008134; ; GO:0008134 intracellular; GO:0005622 CG32133 CG32133 "CG6532, CG8797" CDMC26223 3 12 14 DAC22-O08 3-CG32133-RA_1 CG32133 AAGCGCCCGATTCCTACATCATAGTAACCTGTCCCACGGACATGCATCTCTGTGCGGATCTCACG 65 FBan0032133 FBgn0052133 CG32133 3 3L transcription factor binding; GO:0008134; ; GO:0008134 intracellular; GO:0005622 CG32133 CG32133 "CG6532, CG8797" CDMC26224 3 13 14 DAC22-O20 AutoBlank AutoBlank CDMC26224 3 14 14 DAC22-O20 AutoBlank AutoBlank CDMC26225 3 15 14 DAC23-C08 2-CG10755-RA_2 CG10755 AGGCGTTATTCTCTCGGATTTCGCGACGTTACCGTATCTAAGCTGCGTGGTCAAAGAGTCCCTGCGTCT 69 FBan0010755 FBgn0015036 Cyp4ae1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ae1 Cytochrome P450-4ae1 "CG10755, CG10755, TcD20, transcription unit I, I: Intensifier of Bar, P450, P-450, CYP4E4, EG:152A3.6, 4ae1, Cyp4e4, anon-2Ea, I" CDMC26225 3 16 14 DAC23-C08 2-CG10755-RA_2 CG10755 AGGCGTTATTCTCTCGGATTTCGCGACGTTACCGTATCTAAGCTGCGTGGTCAAAGAGTCCCTGCGTCT 69 FBan0010755 FBgn0015036 Cyp4ae1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ae1 Cytochrome P450-4ae1 "CG10755, CG10755, TcD20, transcription unit I, I: Intensifier of Bar, P450, P-450, CYP4E4, EG:152A3.6, 4ae1, Cyp4e4, anon-2Ea, I" CDMC26226 3 17 14 DAC23-C20 2-CG10772-RA_2 CG10772 TGGCTCGATCCAACGAACTATACTCCCGAGTTTCCCTAGTTCCGGGTGACGAAAGTGACTCTGACGAGG 69 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC26226 3 18 14 DAC23-C20 2-CG10772-RA_2 CG10772 TGGCTCGATCCAACGAACTATACTCCCGAGTTTCCCTAGTTCCGGGTGACGAAAGTGACTCTGACGAGG 69 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC26227 3 19 14 DAC23-G08 23-CG10809-RA_3 CG10809 GCCAAAAACAAAAAGAAATCAAGTTATGTAATAATGATGCAATCGCAACTCAAGAGGACACCTAACAAT 69 FBan0010809 FBgn0036052 CG10809 3 3L CG10809 CG10809 CDMC26227 3 20 14 DAC23-G08 23-CG10809-RA_3 CG10809 GCCAAAAACAAAAAGAAATCAAGTTATGTAATAATGATGCAATCGCAACTCAAGAGGACACCTAACAAT 69 FBan0010809 FBgn0036052 CG10809 3 3L CG10809 CG10809 CDMC26228 3 21 14 DAC23-G20 23-CG1081-RA_5 CG1081 TTGGAAATACGGCAAATCGCTATGGCAATACGAAAATCGATTATCTCTTATCTACACAGTTGGGTCAGC 69 FBan0001081 FBgn0041191 Rheb 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; G1/S transition of mitotic cell cycle; GO:0000082; cell growth; GO:0016049; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; intracellular protein transport; GO:0006886; positive regulation of cell growth; GO:0030307; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; response to starvation; GO:0042594; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 Rheb Rheb "CG1081, CG1081, CG1081, CG1081, CG1081, DmRheb, DReb, rheb, dRheb, Dm Rheb" CDMC26228 3 22 14 DAC23-G20 23-CG1081-RA_5 CG1081 TTGGAAATACGGCAAATCGCTATGGCAATACGAAAATCGATTATCTCTTATCTACACAGTTGGGTCAGC 69 FBan0001081 FBgn0041191 Rheb 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; G1/S transition of mitotic cell cycle; GO:0000082; cell growth; GO:0016049; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; intracellular protein transport; GO:0006886; positive regulation of cell growth; GO:0030307; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; response to starvation; GO:0042594; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 Rheb Rheb "CG1081, CG1081, CG1081, CG1081, CG1081, DmRheb, DReb, rheb, dRheb, Dm Rheb" CDMC26229 3 23 14 DAC23-K08 22-CG10847-RA_7 CG10847 AGTCACCAATTCACCAGAAAACCAAACCAAACTATCCACACACCATGAAAACAACTTAAGAGCCGGGGA 69 FBan0010847 FBgn0004875 enc 3 3L cystoblast division; GO:0007282; egg chamber formation (sensu Insecta); GO:0007293; germ-line cyst formation; GO:0048134; karyosome formation; GO:0030717; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitosis; GO:0007067; oocyte axis determination (sensu Insecta); GO:0048111; oocyte dorsal/ventral axis determination; GO:0007310; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; regulation of pole plasm oskar mRNA localization; GO:0007317 nucleic acid binding; GO:0003676; ; GO:0003676 cytoplasm; GO:0005737 enc encore "CG10847, BB129, fs(3)63F-64A" CDMC26229 3 24 14 DAC23-K08 22-CG10847-RA_7 CG10847 AGTCACCAATTCACCAGAAAACCAAACCAAACTATCCACACACCATGAAAACAACTTAAGAGCCGGGGA 69 FBan0010847 FBgn0004875 enc 3 3L cystoblast division; GO:0007282; egg chamber formation (sensu Insecta); GO:0007293; germ-line cyst formation; GO:0048134; karyosome formation; GO:0030717; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitosis; GO:0007067; oocyte axis determination (sensu Insecta); GO:0048111; oocyte dorsal/ventral axis determination; GO:0007310; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; regulation of pole plasm oskar mRNA localization; GO:0007317 nucleic acid binding; GO:0003676; ; GO:0003676 cytoplasm; GO:0005737 enc encore "CG10847, BB129, fs(3)63F-64A" CDMC26230 3 25 14 DAC23-K20 3-CG10855-RA_1 CG10855 GCCCTCGCTATTGGGCCTCCCGGACGAATTGTACTTCGAGATCTTCAGATATCTGGACAAAAGCCAGCT 69 FBan0010855 FBgn0035461 CG10855 3 3L CG10855 CG10855 CDMC26230 3 26 14 DAC23-K20 3-CG10855-RA_1 CG10855 GCCCTCGCTATTGGGCCTCCCGGACGAATTGTACTTCGAGATCTTCAGATATCTGGACAAAAGCCAGCT 69 FBan0010855 FBgn0035461 CG10855 3 3L CG10855 CG10855 CDMC26231 3 1 15 DAC23-O08 2-CG10910-RB_1 CG10910 CCACTGCCAGTTGGAACACTACCACCGAGGGAAATTGGTTCGATCACCTGCTGAACGAGATTGGAAACC 69 FBan0010910 FBgn0034289 CG10910 2 2R CG10910 CG10910 CDMC26231 3 2 15 DAC23-O08 2-CG10910-RB_1 CG10910 CCACTGCCAGTTGGAACACTACCACCGAGGGAAATTGGTTCGATCACCTGCTGAACGAGATTGGAAACC 69 FBan0010910 FBgn0034289 CG10910 2 2R CG10910 CG10910 CDMC26232 3 3 15 DAC23-O20 2-CG10920-RA_1 CG10920 TGCCAATGAGCGAACTCCAGCATCAGTATAACACCGCGGTAATTCAGATGATGGCAAGCCTAGTGGCCT 69 FBan0010920 FBgn0029963 CG10920 X X transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 membrane; GO:0016020; mitochondrion; GO:0005739 CG10920 CG10920 CDMC26232 3 4 15 DAC23-O20 2-CG10920-RA_1 CG10920 TGCCAATGAGCGAACTCCAGCATCAGTATAACACCGCGGTAATTCAGATGATGGCAAGCCTAGTGGCCT 69 FBan0010920 FBgn0029963 CG10920 X X transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 membrane; GO:0016020; mitochondrion; GO:0005739 CG10920 CG10920 CDMC26233 3 5 15 DAC24-C08 23-CG14940-RA_19 CG14940 TCAAAGGGCAGTGGTAAAAGTGCTTAGCAGTAAGGTACCAAATTATCAGCTGAAATTGGGATCATAGCT 69 FBan0014940 FBgn0032379 Pde1c 2 2L cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; GO:0004117 ; EC:3.1.4.-; cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; calcium- and calmodulin-regulated cGMP-specific phosphodiesterase activity; GO:0048101; ; GO:0004117 ; EC:3.1.4.-; ; GO:0048101; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35; ; GO:0004115 ; EC:3.1.4.-" Pde1c Phosphodiesterase 1c "CG14940, CG14940, PDE1c, PDE1C, Phosphodiesterase 1c" CDMC26233 3 6 15 DAC24-C08 23-CG14940-RA_19 CG14940 TCAAAGGGCAGTGGTAAAAGTGCTTAGCAGTAAGGTACCAAATTATCAGCTGAAATTGGGATCATAGCT 69 FBan0014940 FBgn0032379 Pde1c 2 2L cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; GO:0004117 ; EC:3.1.4.-; cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; calcium- and calmodulin-regulated cGMP-specific phosphodiesterase activity; GO:0048101; ; GO:0004117 ; EC:3.1.4.-; ; GO:0048101; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35; ; GO:0004115 ; EC:3.1.4.-" Pde1c Phosphodiesterase 1c "CG14940, CG14940, PDE1c, PDE1C, Phosphodiesterase 1c" CDMC26234 3 7 15 DAC24-C20 3-CG14955-RA_2 CG14955 TTGCCACAATGCCAATGCTACAGGTACCTCCCCGTATCAGCAGAGACCAATGTGGATTATCTGGAGGGC 69 FBan0014955 FBgn0035399 CG14955 3 3L intracellular protein transport; GO:0006886 CG14955 CG14955 CDMC26234 3 8 15 DAC24-C20 3-CG14955-RA_2 CG14955 TTGCCACAATGCCAATGCTACAGGTACCTCCCCGTATCAGCAGAGACCAATGTGGATTATCTGGAGGGC 69 FBan0014955 FBgn0035399 CG14955 3 3L intracellular protein transport; GO:0006886 CG14955 CG14955 CDMC26235 3 9 15 DAC24-G08 15-CG14981-RA_1 CG14981 CCGGTGATAAGATACTTCCGTGTTCCTTCAAAGGGTTGCTTTAGAGCACAAACCCGCGATTTTCGACCG 69 FBan0014981 FBgn0035473 mge 3 3L protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 mge maggie "CG14981, l(3)SH3, l(3)63Fc, BcDNA:LP07226, maggie" CDMC26235 3 10 15 DAC24-G08 15-CG14981-RA_1 CG14981 CCGGTGATAAGATACTTCCGTGTTCCTTCAAAGGGTTGCTTTAGAGCACAAACCCGCGATTTTCGACCG 69 FBan0014981 FBgn0035473 mge 3 3L protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 mge maggie "CG14981, l(3)SH3, l(3)63Fc, BcDNA:LP07226, maggie" CDMC26236 3 11 15 DAC24-G20 14-CG14993-RA_2 CG14993 TGCAGGCCGAAACTTTGAATGAGCTTATGGGATTGGACTTTGAAGCTTGGGATGTGGTAAGAAGCCAGA 69 FBan0014993 FBgn0016013 Faa 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 fumarylacetoacetase activity; GO:0004334 ; EC:3.7.1.2; ; GO:0004334 ; EC:3.7.1.2 Faa Fumarylacetoacetase "CG14993, CG14993, l(3)SH11, l(3)64Al, dfaa, Fumarylacetoacetase" CDMC26236 3 12 15 DAC24-G20 14-CG14993-RA_2 CG14993 TGCAGGCCGAAACTTTGAATGAGCTTATGGGATTGGACTTTGAAGCTTGGGATGTGGTAAGAAGCCAGA 69 FBan0014993 FBgn0016013 Faa 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 fumarylacetoacetase activity; GO:0004334 ; EC:3.7.1.2; ; GO:0004334 ; EC:3.7.1.2 Faa Fumarylacetoacetase "CG14993, CG14993, l(3)SH11, l(3)64Al, dfaa, Fumarylacetoacetase" CDMC26237 3 13 15 DAC24-K08 10-CG15015-RA_1 CG15015 TTGGCGAGGATACCTACTATGAAACGGAAGTGGAGACCCTTAATCCAGTGGGAAAATGTCGTGCCCTGT 69 FBan0015015 FBgn0035533 Cip4 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; cell cycle; GO:0007049; mesoderm development; GO:0007498; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515; Rho GTPase binding; GO:0017048; ; GO:0017048 Cip4 Cip4 "CG15015, CG11341, CG15015, CG11341, CG15015, CG15015, DCIP4" CDMC26237 3 14 15 DAC24-K08 10-CG15015-RA_1 CG15015 TTGGCGAGGATACCTACTATGAAACGGAAGTGGAGACCCTTAATCCAGTGGGAAAATGTCGTGCCCTGT 69 FBan0015015 FBgn0035533 Cip4 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; cell cycle; GO:0007049; mesoderm development; GO:0007498; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515; Rho GTPase binding; GO:0017048; ; GO:0017048 Cip4 Cip4 "CG15015, CG11341, CG15015, CG11341, CG15015, CG15015, DCIP4" CDMC26238 3 15 15 DAC24-K20 9-CG15024-RA_1 CG15024 CCGCCCGAGCAGATGTCTCCCAGTTGGTGAGATCTGGCAATGGATTTGTTTACGATGTACCCAAAGTCA 69 FBan0015024 FBgn0040699 CG15024 3 3L CG15024 CG15024 CDMC26238 3 16 15 DAC24-K20 9-CG15024-RA_1 CG15024 CCGCCCGAGCAGATGTCTCCCAGTTGGTGAGATCTGGCAATGGATTTGTTTACGATGTACCCAAAGTCA 69 FBan0015024 FBgn0040699 CG15024 3 3L CG15024 CG15024 CDMC26239 3 17 15 DAC24-O08 23-CG1506-RA_6 CG1506 GAGTCCAAATCCCACCATATACAACTAAAACCCACGTGTCAGTCCAAATTGAGAACAAAAGATACTACA 69 FBan0001506 FBgn0023416 Ac3 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1 integral to membrane; GO:0016021 Ac3 Ac3 "CG1506, CG1506, DAC3, DAC39E, AC 3" CDMC26239 3 18 15 DAC24-O08 23-CG1506-RA_6 CG1506 GAGTCCAAATCCCACCATATACAACTAAAACCCACGTGTCAGTCCAAATTGAGAACAAAAGATACTACA 69 FBan0001506 FBgn0023416 Ac3 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1 integral to membrane; GO:0016021 Ac3 Ac3 "CG1506, CG1506, DAC3, DAC39E, AC 3" CDMC26240 3 19 15 DAC24-O20 17-CG15081-RA_4 CG15081 TTGCCAGCTCACAGAACAAGGTCTATTTGTCGGCGGATAGCTTGATGCTTAACATCCAGGACTCTGGCT 69 FBan0015081 FBgn0010551 l(2)03709 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of progression through cell cycle; GO:0000074" l(2)03709 lethal (2) 03709 "CG15081, anon-WO0118547.157, anon-WO02079478.4" CDMC26240 3 20 15 DAC24-O20 17-CG15081-RA_4 CG15081 TTGCCAGCTCACAGAACAAGGTCTATTTGTCGGCGGATAGCTTGATGCTTAACATCCAGGACTCTGGCT 69 FBan0015081 FBgn0010551 l(2)03709 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of progression through cell cycle; GO:0000074" l(2)03709 lethal (2) 03709 "CG15081, anon-WO0118547.157, anon-WO02079478.4" CDMC26241 3 21 15 DAC25-C08 17-CG14328-RA_1 CG14328 TGGAGGCTATGGGCAGCAATACAACCAGTTTAGCAACTACAACAACTACGGATCTTCTGGCTACTACGG 69 FBan0014328 FBgn0040566 CG14328 3 3R CG14328 CG14328 CDMC26241 3 22 15 DAC25-C08 17-CG14328-RA_1 CG14328 TGGAGGCTATGGGCAGCAATACAACCAGTTTAGCAACTACAACAACTACGGATCTTCTGGCTACTACGG 69 FBan0014328 FBgn0040566 CG14328 3 3R CG14328 CG14328 CDMC26242 3 23 15 DAC25-C20 16-CG14341-RA_1 CG14341 TGCCAGCAACTTTCATCCCGACACTCCAGATACTCAAAGCGATGTCCACTATAACGTTACCCAACATCA 69 FBan0014341 FBgn0031315 CG14341 2 2L CG14341 CG14341 CDMC26242 3 24 15 DAC25-C20 16-CG14341-RA_1 CG14341 TGCCAGCAACTTTCATCCCGACACTCCAGATACTCAAAGCGATGTCCACTATAACGTTACCCAACATCA 69 FBan0014341 FBgn0031315 CG14341 2 2L CG14341 CG14341 CDMC26243 3 25 15 DAC25-G08 12-CG14387-RA_5 CG14387 ACATCCAGCCAGTTTGTGAACATTGTGATCGGTTTCCAGCAGCTATATGACATGGACGTGGTGGATCGC 69 FBan0014387 FBgn0038089 CG14387 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG14387 CG14387 CDMC26243 3 26 15 DAC25-G08 12-CG14387-RA_5 CG14387 ACATCCAGCCAGTTTGTGAACATTGTGATCGGTTTCCAGCAGCTATATGACATGGACGTGGTGGATCGC 69 FBan0014387 FBgn0038089 CG14387 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG14387 CG14387 CDMC26244 3 1 16 DAC25-G20 11-CG14402-RA_1 CG14402 TGACCCCGTCAATTGAGCGTAGGATTTGCTGGATGCTAAGACAAATTGCTACTAAATTCGGGTGCCGCA 69 FBan0014402 FBgn0032894 CG14402 2 2L CG14402 CG14402 BcDNA:AT08210 CDMC26244 3 2 16 DAC25-G20 11-CG14402-RA_1 CG14402 TGACCCCGTCAATTGAGCGTAGGATTTGCTGGATGCTAAGACAAATTGCTACTAAATTCGGGTGCCGCA 69 FBan0014402 FBgn0032894 CG14402 2 2L CG14402 CG14402 BcDNA:AT08210 CDMC26245 3 3 16 DAC25-K08 23-CG1443-RA_11 CG1443 TCGTATCCATTGTAGGGCATATCTTGAACTCCCCAATCTTTCGGTCAAGCTCGTAACACTTTCGTTTCC 69 FBan0001443 FBgn0039620 CG1443 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG1443 CG1443 CDMC26245 3 4 16 DAC25-K08 23-CG1443-RA_11 CG1443 TCGTATCCATTGTAGGGCATATCTTGAACTCCCCAATCTTTCGGTCAAGCTCGTAACACTTTCGTTTCC 69 FBan0001443 FBgn0039620 CG1443 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG1443 CG1443 CDMC26246 3 5 16 DAC25-K20 23-CG14454-RA_2 CG14454 CTGCACCAACTAATCAGATTATTAGATTGATCTCTTTCTTTGGAGGTATTTTTGAGAAGGCATGCCTGC 69 FBan0014454 FBgn0037177 CG14454 3 3L CG14454 CG14454 "CT34135, BcDNA:RE01153" CDMC26246 3 6 16 DAC25-K20 23-CG14454-RA_2 CG14454 CTGCACCAACTAATCAGATTATTAGATTGATCTCTTTCTTTGGAGGTATTTTTGAGAAGGCATGCCTGC 69 FBan0014454 FBgn0037177 CG14454 3 3L CG14454 CG14454 "CT34135, BcDNA:RE01153" CDMC26247 3 7 16 DAC25-O08 16-CG14502-RB_2 CG14502 GTTACGAGTTTCCCTTTCTGGATCTCGCCATCTAATGAGTTGCACACACAAGTTGTTGGGATGCAGGGA 69 FBan0014502 FBgn0034321 CG14502 2 2R CG14502 CG14502 CDMC26247 3 8 16 DAC25-O08 16-CG14502-RB_2 CG14502 GTTACGAGTTTCCCTTTCTGGATCTCGCCATCTAATGAGTTGCACACACAAGTTGTTGGGATGCAGGGA 69 FBan0014502 FBgn0034321 CG14502 2 2R CG14502 CG14502 CDMC26248 3 9 16 DAC25-O20 3-CG14513-RA_4 CG14513 CCGCCAGTACGGTTCTGGATCTGGCATCCCCTAGCCGGAAAATTGACCTTAACACCAGCAACAATTTCT 69 FBan0014513 FBgn0005596 yemalpha 3 3R oogenesis (sensu Insecta); GO:0009993 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 yemalpha yemanuclein alpha "CG14513, CG11879, yT4.5, yG4.5: yema-gene-4.5, yem-alpha, yem-alpha, yema, yemanuclein-alpha, yemalpha, yema-gene-4.5, yG4.5" CDMC26248 3 10 16 DAC25-O20 3-CG14513-RA_4 CG14513 CCGCCAGTACGGTTCTGGATCTGGCATCCCCTAGCCGGAAAATTGACCTTAACACCAGCAACAATTTCT 69 FBan0014513 FBgn0005596 yemalpha 3 3R oogenesis (sensu Insecta); GO:0009993 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 yemalpha yemanuclein alpha "CG14513, CG11879, yT4.5, yG4.5: yema-gene-4.5, yem-alpha, yem-alpha, yema, yemanuclein-alpha, yemalpha, yema-gene-4.5, yG4.5" CDMC26249 3 11 16 DAC26-C08 9-CG4730-RA_2 CG4730 ACTTTCCCTATTCCTGTGATCTCTGTGATCGTCGTTTCGCACAGCGATCCCATTTGACTGTCCACCAGC 69 FBan0004730 FBgn0039355 CG4730 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4730 CG4730 CDMC26249 3 12 16 DAC26-C08 9-CG4730-RA_2 CG4730 ACTTTCCCTATTCCTGTGATCTCTGTGATCGTCGTTTCGCACAGCGATCCCATTTGACTGTCCACCAGC 69 FBan0004730 FBgn0039355 CG4730 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4730 CG4730 CDMC26250 3 13 16 DAC26-C20 7-CG4742-RA_1 CG4742 TGCCTGGATTTGCTGTGATAACTCAAGCAAGCTAAGATGCACAAGGTGATCCGGCAAATGTCCCAGCTG 69 FBan0004742 FBgn0030786 mRpL22 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL22 mitochondrial ribosomal protein L22 "CG4742, CG4742, CG4742, L22, mitochondrial ribosomal protein L22" CDMC26250 3 14 16 DAC26-C20 7-CG4742-RA_1 CG4742 TGCCTGGATTTGCTGTGATAACTCAAGCAAGCTAAGATGCACAAGGTGATCCGGCAAATGTCCCAGCTG 69 FBan0004742 FBgn0030786 mRpL22 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL22 mitochondrial ribosomal protein L22 "CG4742, CG4742, CG4742, L22, mitochondrial ribosomal protein L22" CDMC26251 3 15 16 DAC26-G08 17-CG4766-RA_1 CG4766 CGGTTCGCAAGTCCGGATGGAAAAATCGAAAAATCGAGAGAATGAAAAAAGAGCATTTGTCCAGGCGGC 69 FBan0004766 FBgn0027546 CG4766 X X CG4766 CG4766 "gh11415, BcDNA:GH11415" CDMC26251 3 16 16 DAC26-G08 17-CG4766-RA_1 CG4766 CGGTTCGCAAGTCCGGATGGAAAAATCGAAAAATCGAGAGAATGAAAAAAGAGCATTTGTCCAGGCGGC 69 FBan0004766 FBgn0027546 CG4766 X X CG4766 CG4766 "gh11415, BcDNA:GH11415" CDMC26252 3 17 16 DAC26-G20 2-CG4774-RB_1 CG4774 CCCAACATGCTGACCATCAGTCGTGCCGTCCTCTCACCCTACATCGGATATGTTATAGTCCAGGGCGAT 69 FBan0004774 FBgn0039360 CG4774 3 3R phospholipid biosynthesis; GO:0008654 CDP-alcohol phosphatidyltransferase activity; GO:0017169; ; GO:0017169; ; GO:0017169 integral to membrane; GO:0016021 CG4774 CG4774 CDMC26252 3 18 16 DAC26-G20 2-CG4774-RB_1 CG4774 CCCAACATGCTGACCATCAGTCGTGCCGTCCTCTCACCCTACATCGGATATGTTATAGTCCAGGGCGAT 69 FBan0004774 FBgn0039360 CG4774 3 3R phospholipid biosynthesis; GO:0008654 CDP-alcohol phosphatidyltransferase activity; GO:0017169; ; GO:0017169; ; GO:0017169 integral to membrane; GO:0016021 CG4774 CG4774 CDMC26253 3 19 16 DAC26-K08 3-CG4803-RA_1 CG4803 CCCTGCTGTTGATGGAATTCGTAGACGGTGGATCTCTGTCCAGTTTTCTGCACGCGAAAAGCAAGCCAA 69 FBan0004803 FBgn0039015 Takl2 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 Takl2 Tak1-like 2 "CG4803, CG4803, CG4803, TAK, Tak1-like 2" CDMC26253 3 20 16 DAC26-K08 3-CG4803-RA_1 CG4803 CCCTGCTGTTGATGGAATTCGTAGACGGTGGATCTCTGTCCAGTTTTCTGCACGCGAAAAGCAAGCCAA 69 FBan0004803 FBgn0039015 Takl2 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 Takl2 Tak1-like 2 "CG4803, CG4803, CG4803, TAK, Tak1-like 2" CDMC26254 3 21 16 DAC26-K20 15-CG4814-RA_1 CG4814 ACCATCCACCGGCATGTGATATCAAGGATACCGAGATATAGCATCACATACACGGACAACACGTGGCTG 69 FBan0004814 FBgn0035605 CG4814 3 3L CG4814 CG4814 CT15465 CDMC26254 3 22 16 DAC26-K20 15-CG4814-RA_1 CG4814 ACCATCCACCGGCATGTGATATCAAGGATACCGAGATATAGCATCACATACACGGACAACACGTGGCTG 69 FBan0004814 FBgn0035605 CG4814 3 3L CG4814 CG4814 CT15465 CDMC26255 3 23 16 DAC26-O08 3-CG4853-RB_4 CG4853 CCTTGGGTTCGAATTGCATCAGCCAGGTGACAATCGACAGTTACGTGCAGTGGTTCAACCAGCTAAGCT 69 FBan0004853 FBgn0034230 CG4853 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; deoxyribonuclease activity; GO:0004536; ; GO:0004536 CG4853 CG4853 CDMC26255 3 24 16 DAC26-O08 3-CG4853-RB_4 CG4853 CCTTGGGTTCGAATTGCATCAGCCAGGTGACAATCGACAGTTACGTGCAGTGGTTCAACCAGCTAAGCT 69 FBan0004853 FBgn0034230 CG4853 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; deoxyribonuclease activity; GO:0004536; ; GO:0004536 CG4853 CG4853 CDMC26256 3 25 16 DAC26-O20 3-CG4860-RA_2 CG4860 ACGGTGGACAAGAGCATGAAACACAAGGGAATCACTGCCTTTCTTACGCCCAAGGATGTTCCAGGACTC 69 FBan0004860 FBgn0037999 CG4860 3 3R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 CG4860 CG4860 CDMC26256 3 26 16 DAC26-O20 3-CG4860-RA_2 CG4860 ACGGTGGACAAGAGCATGAAACACAAGGGAATCACTGCCTTTCTTACGCCCAAGGATGTTCCAGGACTC 69 FBan0004860 FBgn0037999 CG4860 3 3R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 CG4860 CG4860 CDMC26257 3 1 17 DAC27-C08 1-CG3496-RA_1 CG3496 CCCGCTTCTCACTGACACTTCCCGTAAACTCGGCAAACGAACCAGAACTAGATCCTAAGATGCCCGCTG 69 FBan0003496 FBgn0003977 vir 2 2R "dosage compensation; GO:0007549; primary sex determination, soma; GO:0007539; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; sex determination; GO:0007530" nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676 integral to membrane; GO:0016021; nucleus; GO:0005634 vir virilizer CG3496 CDMC26257 3 2 17 DAC27-C08 1-CG3496-RA_1 CG3496 CCCGCTTCTCACTGACACTTCCCGTAAACTCGGCAAACGAACCAGAACTAGATCCTAAGATGCCCGCTG 69 FBan0003496 FBgn0003977 vir 2 2R "dosage compensation; GO:0007549; primary sex determination, soma; GO:0007539; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; sex determination; GO:0007530" nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676 integral to membrane; GO:0016021; nucleus; GO:0005634 vir virilizer CG3496 CDMC26258 3 3 17 DAC27-C20 11-CG3504-RA_1 CG3504 TCCACGTGGGATCCATGACGACACTGAAGGTCCATCAGTTATTCCACACCACATACGAGAAAGCGGTCA 69 FBan0003504 FBgn0001263 inaD 2 2R cell surface receptor linked signal transduction; GO:0007166; deactivation of rhodopsin mediated signaling; GO:0016059; phototransduction; GO:0007602; protein localization; GO:0008104; protein targeting; GO:0006605 calmodulin binding; GO:0005516; ; GO:0005516; structural molecule activity; GO:0005198; ; GO:0005198; myosin binding; GO:0017022; receptor signaling complex scaffold activity; GO:0030159; ; GO:0005198; protein binding; GO:0005515; ; GO:0017022; ; GO:0030159; ; GO:0005515 inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 inaD inactivation no afterpotential D "CG3504, CG3504, InaD, INAD, Ina-D" CDMC26258 3 4 17 DAC27-C20 11-CG3504-RA_1 CG3504 TCCACGTGGGATCCATGACGACACTGAAGGTCCATCAGTTATTCCACACCACATACGAGAAAGCGGTCA 69 FBan0003504 FBgn0001263 inaD 2 2R cell surface receptor linked signal transduction; GO:0007166; deactivation of rhodopsin mediated signaling; GO:0016059; phototransduction; GO:0007602; protein localization; GO:0008104; protein targeting; GO:0006605 calmodulin binding; GO:0005516; ; GO:0005516; structural molecule activity; GO:0005198; ; GO:0005198; myosin binding; GO:0017022; receptor signaling complex scaffold activity; GO:0030159; ; GO:0005198; protein binding; GO:0005515; ; GO:0017022; ; GO:0030159; ; GO:0005515 inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 inaD inactivation no afterpotential D "CG3504, CG3504, InaD, INAD, Ina-D" CDMC26259 3 5 17 DAC27-G08 2-CG3542-RA_1 CG3542 GGAGAGGTAGCTAGCCCTGGACTCAGTTGCTGGACAAGTTCTCTTTTCAGTCCTTGCCTTCCACTGCAC 69 FBan0003542 FBgn0031492 CG3542 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" FH1 domain binding; GO:0017058; ; GO:0017058 snRNP U1; GO:0005685 CG3542 CG3542 CDMC26259 3 6 17 DAC27-G08 2-CG3542-RA_1 CG3542 GGAGAGGTAGCTAGCCCTGGACTCAGTTGCTGGACAAGTTCTCTTTTCAGTCCTTGCCTTCCACTGCAC 69 FBan0003542 FBgn0031492 CG3542 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" FH1 domain binding; GO:0017058; ; GO:0017058 snRNP U1; GO:0005685 CG3542 CG3542 CDMC26260 3 7 17 DAC27-G20 17-CG3565-RA_1 CG3565 TGTGCGCCAATGTAATGTCTTGGTTTGACGATTCGCCCAATCCCAGGATTATGATAAAACCAGACGGCG 69 FBan0003565 FBgn0035034 CG3565 2 2R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG3565 CG3565 anon-WO0140519.176 CDMC26260 3 8 17 DAC27-G20 17-CG3565-RA_1 CG3565 TGTGCGCCAATGTAATGTCTTGGTTTGACGATTCGCCCAATCCCAGGATTATGATAAAACCAGACGGCG 69 FBan0003565 FBgn0035034 CG3565 2 2R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG3565 CG3565 anon-WO0140519.176 CDMC26261 3 9 17 DAC27-K08 15-CG3604-RA_1 CG3604 CCTCCACGGACTCAACAACCGAACAAAACAGCGAAGTGGCCACAGAAACTAGCACCTCGTCTTAAAAAA 69 FBan0003604 FBgn0031562 CG3604 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG3604 CG3604 BcDNA:LP04037 CDMC26261 3 10 17 DAC27-K08 15-CG3604-RA_1 CG3604 CCTCCACGGACTCAACAACCGAACAAAACAGCGAAGTGGCCACAGAAACTAGCACCTCGTCTTAAAAAA 69 FBan0003604 FBgn0031562 CG3604 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG3604 CG3604 BcDNA:LP04037 CDMC26262 3 11 17 DAC27-K20 10-CG3615-RA_3 CG3615 CGCACACGACAAAGGTTCGCCAGGAGTTTAGCAACTTCTTTCAGTTTAAGGCTGGCTACCTACTCAGCG 69 FBan0003615 FBgn0034110 Atg9 2 2R Atg9 Autophagy-specific gene 9 "CG3615, CG3615, CG3615, Autophagy-specific gene 9" CDMC26262 3 12 17 DAC27-K20 10-CG3615-RA_3 CG3615 CGCACACGACAAAGGTTCGCCAGGAGTTTAGCAACTTCTTTCAGTTTAAGGCTGGCTACCTACTCAGCG 69 FBan0003615 FBgn0034110 Atg9 2 2R Atg9 Autophagy-specific gene 9 "CG3615, CG3615, CG3615, Autophagy-specific gene 9" CDMC26263 3 13 17 DAC27-O08 23-CG3656-RA_1 CG3656 GGGAGCGAGTCTACTGAACCACAACATCGCATTATATCTTTACGCTTGTCAATTAAAATATATTCAAAA 69 FBan0003656 FBgn0005670 Cyp4d1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d1 Cytochrome P450-4d1 "CG3656, CG3656, CG3656, CYP4D1, P450, P-450, EG:87B1.1, 4d1, Cyp4D1, Cyt-P450-4D1: Cytochrome P450 4D1, Cytochrome P450 4D1" CDMC26263 3 14 17 DAC27-O08 23-CG3656-RA_1 CG3656 GGGAGCGAGTCTACTGAACCACAACATCGCATTATATCTTTACGCTTGTCAATTAAAATATATTCAAAA 69 FBan0003656 FBgn0005670 Cyp4d1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d1 Cytochrome P450-4d1 "CG3656, CG3656, CG3656, CYP4D1, P450, P-450, EG:87B1.1, 4d1, Cyp4D1, Cyt-P450-4D1: Cytochrome P450 4D1, Cytochrome P450 4D1" CDMC26264 3 15 17 DAC27-O20 2-CG3668-RA_1 CG3668 GCGACTAGGCGGGATTCCCACTCGCTTGAACCAATTGGCTTGTGTACAGTCCATTGAACGGTGATTTCA 69 FBan0003668 FBgn0004896 fd59A 2 2R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd59A forkhead domain 59A "CG3668, FD3, Dmfd3, fd3" CDMC26264 3 16 17 DAC27-O20 2-CG3668-RA_1 CG3668 GCGACTAGGCGGGATTCCCACTCGCTTGAACCAATTGGCTTGTGTACAGTCCATTGAACGGTGATTTCA 69 FBan0003668 FBgn0004896 fd59A 2 2R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd59A forkhead domain 59A "CG3668, FD3, Dmfd3, fd3" CDMC26265 3 17 17 DAC28-C08 18-CG14760-RA_4 CG14760 TGGCCTATGTCGCCTCCTTACTTTACGACGTCGAAGAGTCCAGAAAGTCCAGCACCACTATTTACCTTG 69 FBan0014760 FBgn0033277 CG14760 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14760 CG14760 SP120 CDMC26265 3 18 17 DAC28-C08 18-CG14760-RA_4 CG14760 TGGCCTATGTCGCCTCCTTACTTTACGACGTCGAAGAGTCCAGAAAGTCCAGCACCACTATTTACCTTG 69 FBan0014760 FBgn0033277 CG14760 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14760 CG14760 SP120 CDMC26266 3 19 17 DAC28-C20 3-CG14782-RA_1 CG14782 AGCTGCGCAAGATGACGGCATTCAAGGCTCGTCCGAATCCATTTAAATAGTGCTCGACGGAACCAATCG 69 FBan0014782 FBgn0025381 CG14782 X X cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; skeletal development; GO:0001501 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; zinc ion binding; GO:0008270; ; GO:0008270 CG14782 CG14782 EG:80H7.5 CDMC26266 3 20 17 DAC28-C20 3-CG14782-RA_1 CG14782 AGCTGCGCAAGATGACGGCATTCAAGGCTCGTCCGAATCCATTTAAATAGTGCTCGACGGAACCAATCG 69 FBan0014782 FBgn0025381 CG14782 X X cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; skeletal development; GO:0001501 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; zinc ion binding; GO:0008270; ; GO:0008270 CG14782 CG14782 EG:80H7.5 CDMC26267 3 21 17 DAC28-G08 22-CG14821-RA_1 CG14821 TGGCACTCGCGAAATTGCCCACTCATCTTGACTAATGCTCGAAACTCTTCTTTGGCATTATCCATTTGT 69 FBan0014821 FBgn0035719 CG14821 3 3L CG14821 CG14821 CDMC26267 3 22 17 DAC28-G08 22-CG14821-RA_1 CG14821 TGGCACTCGCGAAATTGCCCACTCATCTTGACTAATGCTCGAAACTCTTCTTTGGCATTATCCATTTGT 69 FBan0014821 FBgn0035719 CG14821 3 3L CG14821 CG14821 CDMC26268 3 23 17 DAC28-G20 9-CG14830-RA_2 CG14830 TCCTGGTGACGCTAGGATTCGTCATTGTGGTGCAGTTCTATGAGCCACTGTACGTGTGGATACTGGGAA 69 FBan0014830 FBgn0035755 CG14830 3 3L CG14830 CG14830 CDMC26268 3 24 17 DAC28-G20 9-CG14830-RA_2 CG14830 TCCTGGTGACGCTAGGATTCGTCATTGTGGTGCAGTTCTATGAGCCACTGTACGTGTGGATACTGGGAA 69 FBan0014830 FBgn0035755 CG14830 3 3L CG14830 CG14830 CDMC26269 3 25 17 DAC28-K08 13-CG14872-RA_1 CG14872 TCCGTTGAATTCCCCTGGAACGAAGATACGCAAACCGGCATCTTCAAACTCGATTACGATACGGTCACT 69 FBan0014872 FBgn0038346 CG14872 3 3R CG14872 CG14872 CDMC26269 3 26 17 DAC28-K08 13-CG14872-RA_1 CG14872 TCCGTTGAATTCCCCTGGAACGAAGATACGCAAACCGGCATCTTCAAACTCGATTACGATACGGTCACT 69 FBan0014872 FBgn0038346 CG14872 3 3R CG14872 CG14872 CDMC26270 3 1 18 DAC28-K20 3-CG14881-RB_2 CG14881 GCCCAGGGCATTGACCGCCGGGAGTACATTGGTCACCTGGTCGATGAGTATTATACGACAACCAACATC 69 FBan0014881 FBgn0038425 CG14881 3 3R CG14881 CG14881 CDMC26270 3 2 18 DAC28-K20 3-CG14881-RB_2 CG14881 GCCCAGGGCATTGACCGCCGGGAGTACATTGGTCACCTGGTCGATGAGTATTATACGACAACCAACATC 69 FBan0014881 FBgn0038425 CG14881 3 3R CG14881 CG14881 CDMC26271 3 3 18 DAC28-O08 23-CG14903-RA_1 CG14903 GCTCTGGTCAAGCTCAGTGAAAAGTTAAAGGAGAACGAGATTAAACACAAGTTGTGGATCGAACAGCCC 69 FBan0014903 FBgn0038446 CG14903 3 3R CG14903 CG14903 CDMC26271 3 4 18 DAC28-O08 23-CG14903-RA_1 CG14903 GCTCTGGTCAAGCTCAGTGAAAAGTTAAAGGAGAACGAGATTAAACACAAGTTGTGGATCGAACAGCCC 69 FBan0014903 FBgn0038446 CG14903 3 3R CG14903 CG14903 CDMC26272 3 5 18 DAC28-O20 2-CG14913-RA_1 CG14913 TGACGCGGATAGAGCTACCAGTTCGTGTTCACATGCGTCACTGGTTCTTGGGCTATCTAACTGCGGACT 69 FBan0014913 FBgn0032331 CG14913 2 2L CG14913 CG14913 CDMC26272 3 6 18 DAC28-O20 2-CG14913-RA_1 CG14913 TGACGCGGATAGAGCTACCAGTTCGTGTTCACATGCGTCACTGGTTCTTGGGCTATCTAACTGCGGACT 69 FBan0014913 FBgn0032331 CG14913 2 2L CG14913 CG14913 CDMC26273 3 7 18 DAC29-C08 17-CG6403-RA_1 CG6403 CGTTGCGTAACTGCGTCGACGACTGATGATGTGATGTGTGGCGTTTTAATTATAGTTCATCCATCGCCA 69 FBan0006403 FBgn0039453 CG6403 3 3R CG6403 CG6403 CDMC26273 3 8 18 DAC29-C08 17-CG6403-RA_1 CG6403 CGTTGCGTAACTGCGTCGACGACTGATGATGTGATGTGTGGCGTTTTAATTATAGTTCATCCATCGCCA 69 FBan0006403 FBgn0039453 CG6403 3 3R CG6403 CG6403 CDMC26274 3 9 18 DAC29-C20 15-CG6412-RA_5 CG6412 AGCCGAAAACTAAACTATCGACGCTTACCAGTCGTTCACCTATCGAGGCACCACACTCGCTTTGGATTT 69 FBan0006412 FBgn0032646 CG6412 2 2L translational elongation; GO:0006414 translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746 mitochondrion; GO:0005739 CG6412 CG6412 mtEF-Ts CDMC26274 3 10 18 DAC29-C20 15-CG6412-RA_5 CG6412 AGCCGAAAACTAAACTATCGACGCTTACCAGTCGTTCACCTATCGAGGCACCACACTCGCTTTGGATTT 69 FBan0006412 FBgn0032646 CG6412 2 2L translational elongation; GO:0006414 translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746 mitochondrion; GO:0005739 CG6412 CG6412 mtEF-Ts CDMC26275 3 11 18 DAC29-G08 6-CG6449-RA_1 CG6449 CGGCGGCAATGTGAATGTAAACGTTCCCAATGGAGGAAGACGACCCAGTTTCTCCTTTCCGGGATACAA 69 FBan0006449 FBgn0036101 ninA 3 3L axon guidance; GO:0007411; cell adhesion; GO:0007155; tissue regeneration; GO:0042246 integral to membrane; GO:0016021 ninA ninjurin A "CG6449, CG6449, CG6449, ninjurin A" CDMC26275 3 12 18 DAC29-G08 6-CG6449-RA_1 CG6449 CGGCGGCAATGTGAATGTAAACGTTCCCAATGGAGGAAGACGACCCAGTTTCTCCTTTCCGGGATACAA 69 FBan0006449 FBgn0036101 ninA 3 3L axon guidance; GO:0007411; cell adhesion; GO:0007155; tissue regeneration; GO:0042246 integral to membrane; GO:0016021 ninA ninjurin A "CG6449, CG6449, CG6449, ninjurin A" CDMC26276 3 13 18 DAC29-G20 2-CG6457-RA_2 CG6457 GCGATCTGCAGTACGTGGACCTTACCATCATCTCCAACTCCAAATGCCAGGAAACCTTCGGAAGCCTGA 69 FBan0006457 FBgn0040060 yip7 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 yip7 yippee interacting protein 7 "CG6457, CG6457, CG6457, mac, machete, MAC, Machete, SPH116, SP116, yippee interacting protein 7" CDMC26276 3 14 18 DAC29-G20 2-CG6457-RA_2 CG6457 GCGATCTGCAGTACGTGGACCTTACCATCATCTCCAACTCCAAATGCCAGGAAACCTTCGGAAGCCTGA 69 FBan0006457 FBgn0040060 yip7 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 yip7 yippee interacting protein 7 "CG6457, CG6457, CG6457, mac, machete, MAC, Machete, SPH116, SP116, yippee interacting protein 7" CDMC26277 3 15 18 DAC29-K08 2-CG6495-RA_1 CG6495 AGGAAACGTACACGGAGGCACCAAAAAAGAAGCAGCACAAACACAAGAAGGTCAAGACGAAGACGGCCA 69 FBan0006495 FBgn0027550 CG6495 2 2L CG6495 CG6495 "GH10711, BcDNA:GH10711" CDMC26277 3 16 18 DAC29-K08 2-CG6495-RA_1 CG6495 AGGAAACGTACACGGAGGCACCAAAAAAGAAGCAGCACAAACACAAGAAGGTCAAGACGAAGACGGCCA 69 FBan0006495 FBgn0027550 CG6495 2 2L CG6495 CG6495 "GH10711, BcDNA:GH10711" CDMC26278 3 17 18 DAC29-K20 5-CG6511-RA_1 CG6511 CGCCTCCAAAGAAGTGCTGGAATTGCTTCAGAAATCGTTGCGACTTTGTGATGTCGAACACCCTGGTGC 69 FBan0006511 FBgn0035923 CG6511 3 3L CG6511 CG6511 CDMC26278 3 18 18 DAC29-K20 5-CG6511-RA_1 CG6511 CGCCTCCAAAGAAGTGCTGGAATTGCTTCAGAAATCGTTGCGACTTTGTGATGTCGAACACCCTGGTGC 69 FBan0006511 FBgn0035923 CG6511 3 3L CG6511 CG6511 CDMC26279 3 19 18 DAC29-O08 40-CG6545-RA_1 CG6545 AGCAAGATTTGAGTGTACAAGGCTTGTCAGTATCGTCAGTACCGACTTGCAGTGTAGTGACAAAGCCGT 69 FBan0006545 FBgn0011278 lbe 3 3R "central nervous system development; GO:0007417; heart development; GO:0007507; mesodermal cell fate specification; GO:0007501; muscle development; GO:0007517; regulation of cell fate specification; GO:0042659; regulation of neuron differentiation; GO:0045664; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lbe ladybird early "CG6545, lady-bird-early, ladybird, lb, Lbe, Lb, Ladybird, NK?, Hox11-D125, ladybird early" CDMC26279 3 20 18 DAC29-O08 40-CG6545-RA_1 CG6545 AGCAAGATTTGAGTGTACAAGGCTTGTCAGTATCGTCAGTACCGACTTGCAGTGTAGTGACAAAGCCGT 69 FBan0006545 FBgn0011278 lbe 3 3R "central nervous system development; GO:0007417; heart development; GO:0007507; mesodermal cell fate specification; GO:0007501; muscle development; GO:0007517; regulation of cell fate specification; GO:0042659; regulation of neuron differentiation; GO:0045664; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lbe ladybird early "CG6545, lady-bird-early, ladybird, lb, Lbe, Lb, Ladybird, NK?, Hox11-D125, ladybird early" CDMC26280 3 21 18 DAC29-O20 23-CG6556-RA_11 CG6556 ACACGCATACCTGCAATCCCTTCGATTCGAAACCCACTTAGATGTAAATGTTTAATCTGCCTTATTTGC 69 FBan0006556 FBgn0021818 cnk 2 2R "Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; torso signaling pathway; GO:0008293; wing morphogenesis; GO:0007476" enzyme binding; GO:0019899; protein binding; GO:0005515; ; GO:0019899; ; GO:0005515 apical part of cell; GO:0045177 cnk connector enhancer of ksr "CG6556, CNK, connector enhancer of KSR, EK2-3: enhancer of KDN, anon-WO0140519.129, anon-WO0257455.27, l(2)k16314, enhancer of KDN, EK2-3, connector enhancer of ksr" CDMC26280 3 22 18 DAC29-O20 23-CG6556-RA_11 CG6556 ACACGCATACCTGCAATCCCTTCGATTCGAAACCCACTTAGATGTAAATGTTTAATCTGCCTTATTTGC 69 FBan0006556 FBgn0021818 cnk 2 2R "Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; torso signaling pathway; GO:0008293; wing morphogenesis; GO:0007476" enzyme binding; GO:0019899; protein binding; GO:0005515; ; GO:0019899; ; GO:0005515 apical part of cell; GO:0045177 cnk connector enhancer of ksr "CG6556, CNK, connector enhancer of KSR, EK2-3: enhancer of KDN, anon-WO0140519.129, anon-WO0257455.27, l(2)k16314, enhancer of KDN, EK2-3, connector enhancer of ksr" CDMC26281 3 23 18 DAC30-C08 16-CG40032-RA_1 CG40032 GGTTCTTTGTCTTAGTGATTCGTTCCATGCGCGTTCTTGGTCACTAACTCTCTACTCCTCCGCCTTC 67 FBgn0058032 CG40032 CG40032 CG40032 CDMC26281 3 24 18 DAC30-C08 16-CG40032-RA_1 CG40032 GGTTCTTTGTCTTAGTGATTCGTTCCATGCGCGTTCTTGGTCACTAACTCTCTACTCCTCCGCCTTC 67 FBgn0058032 CG40032 CG40032 CG40032 CDMC26282 3 25 18 DAC30-C20 3-CG4025-RA_2 CG4025 ACGTGTCGCTGTCGCATCCCCAGATTGCCCTGATGTCCTATTCGACCACCATCTAGAGCTTACCTTC 67 FBan0004025 FBgn0025624 CG4025 X X CG4025 CG4025 "EG:22E5.9, anon-WO0140519.169" CDMC26282 3 26 18 DAC30-C20 3-CG4025-RA_2 CG4025 ACGTGTCGCTGTCGCATCCCCAGATTGCCCTGATGTCCTATTCGACCACCATCTAGAGCTTACCTTC 67 FBan0004025 FBgn0025624 CG4025 X X CG4025 CG4025 "EG:22E5.9, anon-WO0140519.169" CDMC26283 3 1 19 DAC30-G08 3-CG4289-RA_5 CG4289 CGCCACACGACACTTATCCAGAAGCAGCAGTTCCTACGGTCCAAAGGTCTCACCGCTCACGAAATTC 67 FBan0004289 FBgn0037020 CG4289 3 3L protein targeting to peroxisome; GO:0006625 protein binding; GO:0005515; ; GO:0005515 peroxisomal membrane; GO:0005778 CG4289 CG4289 CDMC26283 3 2 19 DAC30-G08 3-CG4289-RA_5 CG4289 CGCCACACGACACTTATCCAGAAGCAGCAGTTCCTACGGTCCAAAGGTCTCACCGCTCACGAAATTC 67 FBan0004289 FBgn0037020 CG4289 3 3L protein targeting to peroxisome; GO:0006625 protein binding; GO:0005515; ; GO:0005515 peroxisomal membrane; GO:0005778 CG4289 CG4289 CDMC26284 3 3 19 DAC30-G20 3-CG4454-RB_1 CG4454 GCGCCTGTACGAGCTGAAAATGGATTCCCGCCTTATCAGCATCGATTCGCTGGAGACCAAGTTCCTC 67 FBan0004454 FBgn0032105 Borr 2 2L cytokinesis; GO:0000910; mitosis; GO:0007067 Borr Borealin-related "CG4454, CG4454, Bor, dBor, Borealin" CDMC26284 3 4 19 DAC30-G20 3-CG4454-RB_1 CG4454 GCGCCTGTACGAGCTGAAAATGGATTCCCGCCTTATCAGCATCGATTCGCTGGAGACCAAGTTCCTC 67 FBan0004454 FBgn0032105 Borr 2 2L cytokinesis; GO:0000910; mitosis; GO:0007067 Borr Borealin-related "CG4454, CG4454, Bor, dBor, Borealin" CDMC26285 3 5 19 DAC30-K08 2-CG4963-RA_2 CG4963 AGGAACAGCAGATACAGCAGAAAACAGCTCCCAGAGAACTACGTCTCCCCCAGACCTACAATGCCCC 67 FBan0004963 FBgn0039561 CG4963 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4963 CG4963 "anon-EST:fe2H5, anon-fast-evolving-2H5" CDMC26285 3 6 19 DAC30-K08 2-CG4963-RA_2 CG4963 AGGAACAGCAGATACAGCAGAAAACAGCTCCCAGAGAACTACGTCTCCCCCAGACCTACAATGCCCC 67 FBan0004963 FBgn0039561 CG4963 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4963 CG4963 "anon-EST:fe2H5, anon-fast-evolving-2H5" CDMC26286 3 7 19 DAC30-K20 1-CG5114-RA_1 CG5114 GCTGTTCTGCACTAACAACGGTCCGGTTAGCACAATCCAGTCGGAACACGGAATTGAGTGTCTGGCC 67 FBan0005114 FBgn0036460 CG5114 3 3L CG5114 CG5114 CDMC26286 3 8 19 DAC30-K20 1-CG5114-RA_1 CG5114 GCTGTTCTGCACTAACAACGGTCCGGTTAGCACAATCCAGTCGGAACACGGAATTGAGTGTCTGGCC 67 FBan0005114 FBgn0036460 CG5114 3 3L CG5114 CG5114 CDMC26287 3 9 19 DAC30-O08 2-CG5560-RA_1 CG5560 GGATCAGAACCCCCATCTGCTTCAGCTGAACATCAATTGGGCGAACACTTGCATCCGATTGTCCAGG 67 FBan0005560 FBgn0030607 CG5560 X X CG5560 CG5560 CDMC26287 3 10 19 DAC30-O08 2-CG5560-RA_1 CG5560 GGATCAGAACCCCCATCTGCTTCAGCTGAACATCAATTGGGCGAACACTTGCATCCGATTGTCCAGG 67 FBan0005560 FBgn0030607 CG5560 X X CG5560 CG5560 CDMC26288 3 11 19 DAC30-O20 AutoBlank AutoBlank CDMC26288 3 12 19 DAC30-O20 AutoBlank AutoBlank CDMC26289 3 13 19 DAC31-C08 5-CG7494-RA_1 CG7494 TGCCATCGGGAGACGCATCATCCCAGCATGTACAACGTACCCAATGCTCCCCTCAATTTGGATATTGAA 69 FBan0007494 FBgn0037566 mRpL1 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL1 mitochondrial ribosomal protein L1 "CG7494, CG7494, L1, mitochondrial ribosomal protein L1" CDMC26289 3 14 19 DAC31-C08 5-CG7494-RA_1 CG7494 TGCCATCGGGAGACGCATCATCCCAGCATGTACAACGTACCCAATGCTCCCCTCAATTTGGATATTGAA 69 FBan0007494 FBgn0037566 mRpL1 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL1 mitochondrial ribosomal protein L1 "CG7494, CG7494, L1, mitochondrial ribosomal protein L1" CDMC26290 3 15 19 DAC31-C20 10-CG7509-RA_2 CG7509 GCCCAAAGGCTCACCGTGATTAATATGTGCGACAATCAGATTCAGAACTTTCCACCCAACCTCCTGCGA 69 FBan0007509 FBgn0035575 CG7509 3 3L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG7509 CG7509 "CT1509, tartan/capricious-like" CDMC26290 3 16 19 DAC31-C20 10-CG7509-RA_2 CG7509 GCCCAAAGGCTCACCGTGATTAATATGTGCGACAATCAGATTCAGAACTTTCCACCCAACCTCCTGCGA 69 FBan0007509 FBgn0035575 CG7509 3 3L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG7509 CG7509 "CT1509, tartan/capricious-like" CDMC26291 3 17 19 DAC31-G08 2-CG7544-RA_1 CG7544 TGCCTGTGCAATCCACCCTTCTTCGACTCGAACTTACCAAATCCCTTAGGCGGCAATACCAGGAATCCA 69 FBan0007544 FBgn0033994 CG7544 2 2R CG7544 CG7544 CDMC26291 3 18 19 DAC31-G08 2-CG7544-RA_1 CG7544 TGCCTGTGCAATCCACCCTTCTTCGACTCGAACTTACCAAATCCCTTAGGCGGCAATACCAGGAATCCA 69 FBan0007544 FBgn0033994 CG7544 2 2R CG7544 CG7544 CDMC26292 3 19 19 DAC31-G20 15-CG7554-RA_5 CG7554 AGAAACCGGAGACTAAGAACGATCCACGAGATACAGATACCGATATCGCAGCAGTGAAAGTGTGCCGCA 69 FBan0007554 FBgn0041160 comm2 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 comm2 comm2 CG7554 CDMC26292 3 20 19 DAC31-G20 15-CG7554-RA_5 CG7554 AGAAACCGGAGACTAAGAACGATCCACGAGATACAGATACCGATATCGCAGCAGTGAAAGTGTGCCGCA 69 FBan0007554 FBgn0041160 comm2 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 comm2 comm2 CG7554 CDMC26293 3 21 19 DAC31-K08 2-CG7586-RA_1 CG7586 CCAGCCTTCGGACTTCATACCAAGGCAATCTTCCACGGCAGGAATCAGTCGCATATCTCCTATGTGGCT 69 FBan0007586 FBgn0020240 Mcr 2 2L cell-cell signaling; GO:0007267; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 cytokine activity; GO:0005125; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005125; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 Mcr Macroglobulin complement-related "CG7586, CG7586, alpha-2-Mrp: alpha-2-macroglobulin related, anon-28DE, alpha-2-macroglobulin related, Macroglobulin complement-related" CDMC26293 3 22 19 DAC31-K08 2-CG7586-RA_1 CG7586 CCAGCCTTCGGACTTCATACCAAGGCAATCTTCCACGGCAGGAATCAGTCGCATATCTCCTATGTGGCT 69 FBan0007586 FBgn0020240 Mcr 2 2L cell-cell signaling; GO:0007267; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 cytokine activity; GO:0005125; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005125; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 Mcr Macroglobulin complement-related "CG7586, CG7586, alpha-2-Mrp: alpha-2-macroglobulin related, anon-28DE, alpha-2-macroglobulin related, Macroglobulin complement-related" CDMC26294 3 23 19 DAC31-K20 23-CG7596-RA_6 CG7596 ACGAAAATCGAAGAAAAACCAGTATCAGAGCCTGAAATTGAATCCGAAATAAAGAACTCTACGAGCGTC 69 FBan0007596 FBgn0003375 Sgs5 3 3R puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs5 Salivary gland secretion 5 "CG7596, Sgs-5, Sgs, sgs5, SGS-5, BcDNA:LP02306" CDMC26294 3 24 19 DAC31-K20 23-CG7596-RA_6 CG7596 ACGAAAATCGAAGAAAAACCAGTATCAGAGCCTGAAATTGAATCCGAAATAAAGAACTCTACGAGCGTC 69 FBan0007596 FBgn0003375 Sgs5 3 3R puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs5 Salivary gland secretion 5 "CG7596, Sgs-5, Sgs, sgs5, SGS-5, BcDNA:LP02306" CDMC26295 3 25 19 DAC31-O08 8-CG7628-RA_1 CG7628 GGATGATGGCAGTGTCGATTGGCATCTATTCCGGAATATTGCCTATGCATGGATCGTAACGGTGCCGGT 69 FBan0007628 FBgn0036137 CG7628 3 3L phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 phosphate transporter activity; GO:0015114; inorganic phosphate transporter activity; GO:0005315; ; GO:0015114; ; GO:0005315 membrane; GO:0016020 CG7628 CG7628 CDMC26295 3 26 19 DAC31-O08 8-CG7628-RA_1 CG7628 GGATGATGGCAGTGTCGATTGGCATCTATTCCGGAATATTGCCTATGCATGGATCGTAACGGTGCCGGT 69 FBan0007628 FBgn0036137 CG7628 3 3L phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 phosphate transporter activity; GO:0015114; inorganic phosphate transporter activity; GO:0005315; ; GO:0015114; ; GO:0005315 membrane; GO:0016020 CG7628 CG7628 CDMC26296 3 1 20 DAC31-O20 23-CG7638-RA_5 CG7638 GCATTGTCTACCAATCATATTTCAACAAGACCTAGGTTCATTTAAATCCCCGTCGTAGTATATGACTTT 69 FBan0007638 FBgn0036133 CG7638 3 3L CG7638 CG7638 CDMC26296 3 2 20 DAC31-O20 23-CG7638-RA_5 CG7638 GCATTGTCTACCAATCATATTTCAACAAGACCTAGGTTCATTTAAATCCCCGTCGTAGTATATGACTTT 69 FBan0007638 FBgn0036133 CG7638 3 3L CG7638 CG7638 CDMC26297 3 3 20 DAC32-C08 22-CG14966-RA_1 CG14966 TCTTTGGACAAGGGATCTCGATCGCGAAACAAGATAATAATGATAACCAAGGGAGTGTCCACGGTGGA 68 FBan0014966 FBgn0035415 CG14966 3 3L CG14966 CG14966 CDMC26297 3 4 20 DAC32-C08 22-CG14966-RA_1 CG14966 TCTTTGGACAAGGGATCTCGATCGCGAAACAAGATAATAATGATAACCAAGGGAGTGTCCACGGTGGA 68 FBan0014966 FBgn0035415 CG14966 3 3L CG14966 CG14966 CDMC26298 3 5 20 DAC32-C20 3-CG15100-RA_3 CG15100 GCGTTGATAAACCGAGAGCTGCGTGGTTACATCAACTCCATGGAGAAGGCTAAACTTCGGGATGGCGT 68 FBan0015100 FBgn0034401 CG15100 2 2R methionyl-tRNA aminoacylation; GO:0006431; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; methionine-tRNA ligase activity; GO:0004825 ; EC:6.1.1.10; ; GO:0004825 ; EC:6.1.1.10; ; GO:0003729; ; GO:0004825 ; EC:6.1.1.10 CG15100 CG15100 "clone 2.15, p120, MRS, anon-EST:Liang-2.15" CDMC26298 3 6 20 DAC32-C20 3-CG15100-RA_3 CG15100 GCGTTGATAAACCGAGAGCTGCGTGGTTACATCAACTCCATGGAGAAGGCTAAACTTCGGGATGGCGT 68 FBan0015100 FBgn0034401 CG15100 2 2R methionyl-tRNA aminoacylation; GO:0006431; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; methionine-tRNA ligase activity; GO:0004825 ; EC:6.1.1.10; ; GO:0004825 ; EC:6.1.1.10; ; GO:0003729; ; GO:0004825 ; EC:6.1.1.10 CG15100 CG15100 "clone 2.15, p120, MRS, anon-EST:Liang-2.15" CDMC26299 3 7 20 DAC32-G08 2-CG15408-RA_1 CG15408 ACCTTCTCTGCCATGGTTATGCTATCGGTCAATGTGGGAATCCTGGTGGGCTATATCATCGGCACCCA 68 FBan0015408 FBgn0031523 CG15408 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; ; GO:0005353 integral to membrane; GO:0016021; membrane; GO:0016020 CG15408 CG15408 CDMC26299 3 8 20 DAC32-G08 2-CG15408-RA_1 CG15408 ACCTTCTCTGCCATGGTTATGCTATCGGTCAATGTGGGAATCCTGGTGGGCTATATCATCGGCACCCA 68 FBan0015408 FBgn0031523 CG15408 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; ; GO:0005353 integral to membrane; GO:0016021; membrane; GO:0016020 CG15408 CG15408 CDMC26300 3 9 20 DAC32-G20 1-CG15617-RA_1 CG15617 CGGCCCTGGAGATGACCTTCAATGAGGCCCTGCAAATGTTCCGAAAGAATTCGCGATACGTTCGTGTC 68 FBan0015617 FBgn0034151 CG15617 2 2R protein binding; GO:0005515; ; GO:0005515 CG15617 CG15617 CT35755 CDMC26300 3 10 20 DAC32-G20 1-CG15617-RA_1 CG15617 CGGCCCTGGAGATGACCTTCAATGAGGCCCTGCAAATGTTCCGAAAGAATTCGCGATACGTTCGTGTC 68 FBan0015617 FBgn0034151 CG15617 2 2R protein binding; GO:0005515; ; GO:0005515 CG15617 CG15617 CT35755 CDMC26301 3 11 20 DAC32-K08 11-CG16849-RA_1 CG16849 ATCATTCGTTTGGCCTACCAGGAGAACGAGGCTCTGATCCACCAAAAAGTTATGAGCGCGATGAAGCA 68 FBan0016849 FBgn0032526 CG16849 2 2L CG16849 CG16849 CDMC26301 3 12 20 DAC32-K08 11-CG16849-RA_1 CG16849 ATCATTCGTTTGGCCTACCAGGAGAACGAGGCTCTGATCCACCAAAAAGTTATGAGCGCGATGAAGCA 68 FBan0016849 FBgn0032526 CG16849 2 2L CG16849 CG16849 CDMC26302 3 13 20 DAC32-K20 1-CG16972-RA_1 CG16972 GCGTTAACACCGGTGATCATCTGATCATCAAGTCAGCATCGAACGACGAAGCCTGGATAAGTGCCGCC 68 FBan0016972 FBgn0032481 CG16972 2 2L CG16972 CG16972 anon-WO0140519.52 CDMC26302 3 14 20 DAC32-K20 1-CG16972-RA_1 CG16972 GCGTTAACACCGGTGATCATCTGATCATCAAGTCAGCATCGAACGACGAAGCCTGGATAAGTGCCGCC 68 FBan0016972 FBgn0032481 CG16972 2 2L CG16972 CG16972 anon-WO0140519.52 CDMC26303 3 15 20 DAC32-O08 3-CG17328-RA_1 CG17328 CGACAAGCCTTTTCAGTGTGAGATCTGCTCAAAGCAGTTTTCCGCGTTAGGCAATTTCCAGGCGCACC 68 FBan0017328 FBgn0028895 CG17328 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG17328 CG17328 "BG:DS02740.8, DS02740.8" CDMC26303 3 16 20 DAC32-O08 3-CG17328-RA_1 CG17328 CGACAAGCCTTTTCAGTGTGAGATCTGCTCAAAGCAGTTTTCCGCGTTAGGCAATTTCCAGGCGCACC 68 FBan0017328 FBgn0028895 CG17328 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 CG17328 CG17328 "BG:DS02740.8, DS02740.8" CDMC26304 3 17 20 DAC32-O20 2-CG1749-RA_1 CG1749 GGCTACAATGCCCTTAGCGACTTCTTTCCCAAGATGACGCTCAAACCGAATCCGCAGTGCGATGACAG 68 FBan0001749 FBgn0030305 CG1749 X X L-serine biosynthesis; GO:0006564; Mo-molybdopterin cofactor biosynthesis; GO:0006777 "Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG1749 CG1749 CDMC26304 3 18 20 DAC32-O20 2-CG1749-RA_1 CG1749 GGCTACAATGCCCTTAGCGACTTCTTTCCCAAGATGACGCTCAAACCGAATCCGCAGTGCGATGACAG 68 FBan0001749 FBgn0030305 CG1749 X X L-serine biosynthesis; GO:0006564; Mo-molybdopterin cofactor biosynthesis; GO:0006777 "Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG1749 CG1749 CDMC26305 3 19 20 DAC33-C08 2-CG3162-RA_1 CG3162 TCTTCAGGTACCGGGCATATCCACACTACAAGATCCTGGCTCACCTACCGAAACTCTCTGCCTGCT 66 FBan0003162 FBgn0034834 CG3162 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 snRNP U2; GO:0005686 CG3162 CG3162 cg3162 CDMC26305 3 20 20 DAC33-C08 2-CG3162-RA_1 CG3162 TCTTCAGGTACCGGGCATATCCACACTACAAGATCCTGGCTCACCTACCGAAACTCTCTGCCTGCT 66 FBan0003162 FBgn0034834 CG3162 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 snRNP U2; GO:0005686 CG3162 CG3162 cg3162 CDMC26306 3 21 20 DAC33-C20 16-CG31794-RD_1 CG31794 AGTTGGATTCTATGCTAGGCAATCTACAGGCCAATATGAGTCGCCAAGGAGTCAATACCGTGCAGA 66 FBan0031794 FBgn0041789 Pax 2 2L cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 focal adhesion; GO:0005925 Pax Paxillin "CG18576, CG31794, CG18061, CG18576, CG18576, CG31794, paxillin, CT40481, CT42454, Dpax, PDLP, paxillin-derived LIM-only protein, DPxn37, Paxillin-derived LIM-only protein, DPaxillin, DPxn, Paxillin" CDMC26306 3 22 20 DAC33-C20 16-CG31794-RD_1 CG31794 AGTTGGATTCTATGCTAGGCAATCTACAGGCCAATATGAGTCGCCAAGGAGTCAATACCGTGCAGA 66 FBan0031794 FBgn0041789 Pax 2 2L cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 focal adhesion; GO:0005925 Pax Paxillin "CG18576, CG31794, CG18061, CG18576, CG18576, CG31794, paxillin, CT40481, CT42454, Dpax, PDLP, paxillin-derived LIM-only protein, DPxn37, Paxillin-derived LIM-only protein, DPaxillin, DPxn, Paxillin" CDMC26307 3 23 20 DAC33-G08 3-CG32396-RA_1 CG32396 CCGTCGCCGAATATGTCGCAGGTGGTTGTGGAACCCTATAATGCCCTACTTAGTACTCCCGCCTTG 66 FBan0032396 FBgn0052396 CG32396 3 3L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 microtubule; GO:0005874; tubulin; GO:0045298 CG32396 CG32396 "CG8339, CT42364" CDMC26307 3 24 20 DAC33-G08 3-CG32396-RA_1 CG32396 CCGTCGCCGAATATGTCGCAGGTGGTTGTGGAACCCTATAATGCCCTACTTAGTACTCCCGCCTTG 66 FBan0032396 FBgn0052396 CG32396 3 3L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 microtubule; GO:0005874; tubulin; GO:0045298 CG32396 CG32396 "CG8339, CT42364" CDMC26308 3 25 20 DAC33-G20 5-CG32491-RP_1 CG32491 GCCGGAGTGGTCAACAGCAACTCTCCCTTCTTCATCGTCAGCAAGTACGGCACCAAGCAGATCATG 66 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC26308 3 26 20 DAC33-G20 5-CG32491-RP_1 CG32491 GCCGGAGTGGTCAACAGCAACTCTCCCTTCTTCATCGTCAGCAAGTACGGCACCAAGCAGATCATG 66 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC26309 3 1 21 DAC33-K08 14-CG32830-RA_1 CG32830 GGCCAGGACAATAGCTCTAAGCAGGTCACGAGATTTTCCGGAACTCTTTCAAAACACCATTGCCGC 66 FBan0032830 FBgn0052830 CG32830 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32830 CG32830 CDMC26309 3 2 21 DAC33-K08 14-CG32830-RA_1 CG32830 GGCCAGGACAATAGCTCTAAGCAGGTCACGAGATTTTCCGGAACTCTTTCAAAACACCATTGCCGC 66 FBan0032830 FBgn0052830 CG32830 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32830 CG32830 CDMC26310 3 3 21 DAC33-K20 2-CG33191-RA_1 CG33191 CGTGCCGTTTCGATCCCAGTCCTATTATGGACGAGGAAGGCAATGTGTTTTGTCCCGGCAACTGTG 66 FBan0033191 FBgn0053191 CG33191 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33191 CG33191 "anon-WO0140519.60, BcDNA:GH01761, BEST:GH01761" CDMC26310 3 4 21 DAC33-K20 2-CG33191-RA_1 CG33191 CGTGCCGTTTCGATCCCAGTCCTATTATGGACGAGGAAGGCAATGTGTTTTGTCCCGGCAACTGTG 66 FBan0033191 FBgn0053191 CG33191 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33191 CG33191 "anon-WO0140519.60, BcDNA:GH01761, BEST:GH01761" CDMC26311 3 5 21 DAC33-O08 3-CG3509-RA_4 CG3509 AACCCCAAGTCGATGGTCCCAAAACCAAAGGGTACGCTCATATCCCTAGCTCTTATGGCCATCGGG 66 FBan0003509 FBgn0038252 CG3509 3 3R nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3509 CG3509 CDMC26311 3 6 21 DAC33-O08 3-CG3509-RA_4 CG3509 AACCCCAAGTCGATGGTCCCAAAACCAAAGGGTACGCTCATATCCCTAGCTCTTATGGCCATCGGG 66 FBan0003509 FBgn0038252 CG3509 3 3R nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3509 CG3509 CDMC26312 3 7 21 DAC33-O20 AutoBlank AutoBlank CDMC26312 3 8 21 DAC33-O20 AutoBlank AutoBlank CDMC26313 3 9 21 DAC34-C08 22-CG1345-RA_1 CG1345 GGCTGAAGCCACATATGTTTAACCCCTACATTTGTAGCTGTACTGACCCTTTGTGTTGTGGACCCACTA 69 FBan0001345 FBgn0039580 Gfat2 3 3R carbohydrate biosynthesis; GO:0016051; monosaccharide metabolism; GO:0005996 glutamine-fructose-6-phosphate transaminase (isomerizing) activity; GO:0004360 ; EC:2.6.1.16; sugar binding; GO:0005529; ; GO:0004360 ; EC:2.6.1.16; ; GO:0005529 cytoplasm; GO:0005737 Gfat2 Glutamine:fructose-6-phosphate aminotransferase 2 "CG1345, CG1345, CG1345, CG1345, CG1345, Dmel/GFAT2, Glutamine:fructose-6-phosphate aminotransferase 2" CDMC26313 3 10 21 DAC34-C08 22-CG1345-RA_1 CG1345 GGCTGAAGCCACATATGTTTAACCCCTACATTTGTAGCTGTACTGACCCTTTGTGTTGTGGACCCACTA 69 FBan0001345 FBgn0039580 Gfat2 3 3R carbohydrate biosynthesis; GO:0016051; monosaccharide metabolism; GO:0005996 glutamine-fructose-6-phosphate transaminase (isomerizing) activity; GO:0004360 ; EC:2.6.1.16; sugar binding; GO:0005529; ; GO:0004360 ; EC:2.6.1.16; ; GO:0005529 cytoplasm; GO:0005737 Gfat2 Glutamine:fructose-6-phosphate aminotransferase 2 "CG1345, CG1345, CG1345, CG1345, CG1345, Dmel/GFAT2, Glutamine:fructose-6-phosphate aminotransferase 2" CDMC26314 3 11 21 DAC34-C20 23-CG13475-RA_5 CG13475 AGGTTTTGCCACTTTACCGTCTTCTGAAGACTTAATTTCTCCCCTCCAACTCTCTTACTTATTTCCCCA 69 FBan0013475 FBgn0040318 HGTX 3 3L "nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HGTX HGTX "CG4745, CG13475, CG4745, CG4745, dNkx6, Nk6, Nkx6" CDMC26314 3 12 21 DAC34-C20 23-CG13475-RA_5 CG13475 AGGTTTTGCCACTTTACCGTCTTCTGAAGACTTAATTTCTCCCCTCCAACTCTCTTACTTATTTCCCCA 69 FBan0013475 FBgn0040318 HGTX 3 3L "nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HGTX HGTX "CG4745, CG13475, CG4745, CG4745, dNkx6, Nk6, Nkx6" CDMC26315 3 13 21 DAC34-G08 3-CG13527-RA_3 CG13527 ATCAAGTGGACGTGGTTCTCATGGACAACGCGGTGTGTAAGACGTACTTCCGACACTACGGGGATGGAA 69 FBan0013527 FBgn0034776 CG13527 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG13527 CG13527 SPH182 CDMC26315 3 14 21 DAC34-G08 3-CG13527-RA_3 CG13527 ATCAAGTGGACGTGGTTCTCATGGACAACGCGGTGTGTAAGACGTACTTCCGACACTACGGGGATGGAA 69 FBan0013527 FBgn0034776 CG13527 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG13527 CG13527 SPH182 CDMC26316 3 15 21 DAC34-G20 16-CG13544-RA_1 CG13544 CGATGTCATCGCCAGTATGAGACGCTGGAAAATTCTGGTGGACAACGATTTGACTGTGGACAAGAACAT 69 FBan0013544 FBgn0034826 CG13544 2 2R CG13544 CG13544 CDMC26316 3 16 21 DAC34-G20 16-CG13544-RA_1 CG13544 CGATGTCATCGCCAGTATGAGACGCTGGAAAATTCTGGTGGACAACGATTTGACTGTGGACAAGAACAT 69 FBan0013544 FBgn0034826 CG13544 2 2R CG13544 CG13544 CDMC26317 3 17 21 DAC34-K08 2-CG13587-RA_2 CG13587 GGCCTTGAACTACGCTCCAGGAGGACCGAAAAGGAGGCTAAATGCATTTGATCAGAGGTCCTTTGGCAA 69 FBan0013587 FBgn0035031 CG13587 2 2R CG13587 CG13587 CDMC26317 3 18 21 DAC34-K08 2-CG13587-RA_2 CG13587 GGCCTTGAACTACGCTCCAGGAGGACCGAAAAGGAGGCTAAATGCATTTGATCAGAGGTCCTTTGGCAA 69 FBan0013587 FBgn0035031 CG13587 2 2R CG13587 CG13587 CDMC26318 3 19 21 DAC34-K20 23-CG13598-RA_1 CG13598 CGCCAGGCCATATATATAGAGTTATCCATACATATGTGACGATACGAGTATAGAGTTTAGTGTTAGGTG 69 FBan0013598 FBgn0016754 sba 3 3R sba six-banded "CG13598, CG13598, CG13598, F125, TF125, TF125 type II, Dm Sba, AAF56201, Tf125, six-banded" CDMC26318 3 20 21 DAC34-K20 23-CG13598-RA_1 CG13598 CGCCAGGCCATATATATAGAGTTATCCATACATATGTGACGATACGAGTATAGAGTTTAGTGTTAGGTG 69 FBan0013598 FBgn0016754 sba 3 3R sba six-banded "CG13598, CG13598, CG13598, F125, TF125, TF125 type II, Dm Sba, AAF56201, Tf125, six-banded" CDMC26319 3 21 21 DAC34-O08 3-CG13624-RA_2 CG13624 GCCAGGAAGCTGCACAATATTGGCAAGGAACTGGACAAGCTAAGCCGCACCATCAATGACATGACTCCT 69 FBan0013624 FBgn0039209 CG13624 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG13624 CG13624 anon-WO0153538.65 CDMC26319 3 22 21 DAC34-O08 3-CG13624-RA_2 CG13624 GCCAGGAAGCTGCACAATATTGGCAAGGAACTGGACAAGCTAAGCCGCACCATCAATGACATGACTCCT 69 FBan0013624 FBgn0039209 CG13624 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG13624 CG13624 anon-WO0153538.65 CDMC26320 3 23 21 DAC34-O20 8-CG13640-RA_2 CG13640 GGAGGCTACGGTCAGGGAAACTACGGCTATGGAAGCTATGCTGGAGGATATGGTTACAACTATCCCGCA 69 FBan0013640 FBgn0039237 CG13640 3 3R CG13640 CG13640 BcDNA:RE70528 CDMC26320 3 24 21 DAC34-O20 8-CG13640-RA_2 CG13640 GGAGGCTACGGTCAGGGAAACTACGGCTATGGAAGCTATGCTGGAGGATATGGTTACAACTATCCCGCA 69 FBan0013640 FBgn0039237 CG13640 3 3R CG13640 CG13640 BcDNA:RE70528 CDMC26321 3 25 21 DAC35-C08 3-CG17982-RA_9 CG17982 CCAAGGAGCCCCTGAACATACCCCTGCTGACAAGGTTGGAGAGCGGCATGAAGAAGCTGGATATAG 66 FBan0017982 FBgn0030006 CG17982 X X CG17982 CG17982 CDMC26321 3 26 21 DAC35-C08 3-CG17982-RA_9 CG17982 CCAAGGAGCCCCTGAACATACCCCTGCTGACAAGGTTGGAGAGCGGCATGAAGAAGCTGGATATAG 66 FBan0017982 FBgn0030006 CG17982 X X CG17982 CG17982 CDMC26322 3 1 22 DAC35-C20 3-CG18315-RB_5 CG18315 TCACCGATCCGAAGGCATGTGTGTACTTGCGCGATTTGCTTGTTGATCACATCCGGGAAAGTGCTC 66 FBan0018315 FBgn0000109 Aprt 3 3L purine base metabolism; GO:0006144; purine ribonucleoside salvage; GO:0006166 adenine phosphoribosyltransferase activity; GO:0003999 ; EC:2.4.2.7; ; GO:0003999 ; EC:2.4.2.7 cytoplasm; GO:0005737 Aprt Adenine phosphoribosyltransferase "CG18315, BcDNA:LP07986, aprt" CDMC26322 3 2 22 DAC35-C20 3-CG18315-RB_5 CG18315 TCACCGATCCGAAGGCATGTGTGTACTTGCGCGATTTGCTTGTTGATCACATCCGGGAAAGTGCTC 66 FBan0018315 FBgn0000109 Aprt 3 3L purine base metabolism; GO:0006144; purine ribonucleoside salvage; GO:0006166 adenine phosphoribosyltransferase activity; GO:0003999 ; EC:2.4.2.7; ; GO:0003999 ; EC:2.4.2.7 cytoplasm; GO:0005737 Aprt Adenine phosphoribosyltransferase "CG18315, BcDNA:LP07986, aprt" CDMC26323 3 3 22 DAC35-G08 2-CG2525-RA_2 CG2525 TTCCGTGCATTTCGGTAATAGCCTCGGTGCTTACGTCGTCTTCAACAGAAGCCCGTGAAGTGGTGC 66 FBan0002525 FBgn0026417 Hus1-like 3 3R DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 Hus1-like Hus1-like "CG2525, CG2525, Hus1" CDMC26323 3 4 22 DAC35-G08 2-CG2525-RA_2 CG2525 TTCCGTGCATTTCGGTAATAGCCTCGGTGCTTACGTCGTCTTCAACAGAAGCCCGTGAAGTGGTGC 66 FBan0002525 FBgn0026417 Hus1-like 3 3R DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 Hus1-like Hus1-like "CG2525, CG2525, Hus1" CDMC26324 3 5 22 DAC35-G20 15-CG2819-RA_1 CG2819 GTCGCCCTCTAGGCTGTCACCGAATATATTTCTCAACCTCAACATTGACCACTTGGGACTGGAGCG 66 FBan0002819 FBgn0023489 Pph13 2 2L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Pph13 PvuII-PstI homology 13 "CG2819, PPH13, Munster, Mu, 60Mun1, PvuII-PstI homology 13" CDMC26324 3 6 22 DAC35-G20 15-CG2819-RA_1 CG2819 GTCGCCCTCTAGGCTGTCACCGAATATATTTCTCAACCTCAACATTGACCACTTGGGACTGGAGCG 66 FBan0002819 FBgn0023489 Pph13 2 2L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Pph13 PvuII-PstI homology 13 "CG2819, PPH13, Munster, Mu, 60Mun1, PvuII-PstI homology 13" CDMC26325 3 7 22 DAC35-K08 9-CG30196-RA_1 CG30196 TGGCTGTTTCATTGGACGCGATATCACTCTGAGTTGGTACAAGAGGACCCTCTTTCGGCTGCAACG 66 FBan0030196 FBgn0050196 CG30196 2 2R CG30196 CG30196 "CG13514, CG13514" CDMC26325 3 8 22 DAC35-K08 9-CG30196-RA_1 CG30196 TGGCTGTTTCATTGGACGCGATATCACTCTGAGTTGGTACAAGAGGACCCTCTTTCGGCTGCAACG 66 FBan0030196 FBgn0050196 CG30196 2 2R CG30196 CG30196 "CG13514, CG13514" CDMC26326 3 9 22 DAC35-K20 1-CG30457-RA_1 CG30457 GTCCACGTTCCAAGTAACATACATCCACAATGAAATTCCTGGTTGTCGCCGTCGCCCTCTTGGCCG 66 FBan0030457 FBgn0050457 CG30457 2 2R CG30457 CG30457 CG17288 CDMC26326 3 10 22 DAC35-K20 1-CG30457-RA_1 CG30457 GTCCACGTTCCAAGTAACATACATCCACAATGAAATTCCTGGTTGTCGCCGTCGCCCTCTTGGCCG 66 FBan0030457 FBgn0050457 CG30457 2 2R CG30457 CG30457 CG17288 CDMC26327 3 11 22 DAC35-O08 3-CG31257-RA_2 CG31257 GCCATGGGAGTTTCTTTGTTGCCAAAGAGTCGGCACATCGCGGAGTGTATCAATGGGCTTCGTAGC 66 FBan0031257 FBgn0051257 CG31257 3 3R CG31257 CG31257 CDMC26327 3 12 22 DAC35-O08 3-CG31257-RA_2 CG31257 GCCATGGGAGTTTCTTTGTTGCCAAAGAGTCGGCACATCGCGGAGTGTATCAATGGGCTTCGTAGC 66 FBan0031257 FBgn0051257 CG31257 3 3R CG31257 CG31257 CDMC26328 3 13 22 DAC35-O20 AutoBlank AutoBlank CDMC26328 3 14 22 DAC35-O20 AutoBlank AutoBlank CDMC26329 3 15 22 DAC36-C08 23-CG17946-RA_4 CG17946 TTTCGGTTCCTTTCGATTCCGGTTGGGAAATATCTTTTAAGAAACAAAATCATGTACATGTACGTCA 67 FBan0017946 FBgn0004172 Mst84Da 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Da Male-specific RNA 84Da "CG17946, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-1" CDMC26329 3 16 22 DAC36-C08 23-CG17946-RA_4 CG17946 TTTCGGTTCCTTTCGATTCCGGTTGGGAAATATCTTTTAAGAAACAAAATCATGTACATGTACGTCA 67 FBan0017946 FBgn0004172 Mst84Da 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Da Male-specific RNA 84Da "CG17946, Mst87D, Mst84, Mst ORF, Mstprox, Mst, mst(3)gl-1" CDMC26330 3 17 22 DAC36-C20 1-CG18157-RA_4 CG18157 TCCAAAGCACCAAAGGCACCCAAGCCACACAAGCCGAAATCTTTTTCCGACAAAAAGGCGGAATCAG 67 FBan0018157 FBgn0030563 CG18157 X X CG18157 CG18157 CDMC26330 3 18 22 DAC36-C20 1-CG18157-RA_4 CG18157 TCCAAAGCACCAAAGGCACCCAAGCCACACAAGCCGAAATCTTTTTCCGACAAAAAGGCGGAATCAG 67 FBan0018157 FBgn0030563 CG18157 X X CG18157 CG18157 CDMC26331 3 19 22 DAC36-G08 15-CG2003-RB_8 CG2003 GGGGCCCAAAAAAATGGAGATTCCCTGGAAAGGCATTTTTACCTCTGTTCCAGTCTACGCCCTTCTC 67 FBan0002003 FBgn0039886 CG2003 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 CG2003 CG2003 CDMC26331 3 20 22 DAC36-G08 15-CG2003-RB_8 CG2003 GGGGCCCAAAAAAATGGAGATTCCCTGGAAAGGCATTTTTACCTCTGTTCCAGTCTACGCCCTTCTC 67 FBan0002003 FBgn0039886 CG2003 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 CG2003 CG2003 CDMC26332 3 21 22 DAC36-G20 6-CG2221-RA_3 CG2221 TGGCAAGTTTACGTTCAGCGTGACCCTGTACCAGAGTGGCGACATTGTTTTCGCATACATGCTGGTG 67 FBgn0030194 CDMC26332 3 22 22 DAC36-G20 6-CG2221-RA_3 CG2221 TGGCAAGTTTACGTTCAGCGTGACCCTGTACCAGAGTGGCGACATTGTTTTCGCATACATGCTGGTG 67 FBgn0030194 CDMC26333 3 23 22 DAC36-K08 3-CG30022-RA_3 CG30022 CCAAGGCGGATCGTCACCTGAATGAAGGGGATCGCATAGATTTCGGCACCCATGTGATTGATGCTCT 67 FBan0030022 FBgn0050022 CG30022 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016829 ; EC:4.-.-.- CG30022 CG30022 "CG9026, CG9026, BcDNA:RE56416" CDMC26333 3 24 22 DAC36-K08 3-CG30022-RA_3 CG30022 CCAAGGCGGATCGTCACCTGAATGAAGGGGATCGCATAGATTTCGGCACCCATGTGATTGATGCTCT 67 FBan0030022 FBgn0050022 CG30022 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016829 ; EC:4.-.-.- CG30022 CG30022 "CG9026, CG9026, BcDNA:RE56416" CDMC26334 3 25 22 DAC36-K20 3-CG30129-RA_4 CG30129 CCCTCTGAGTCGGTGAAGTGCTATCACAGCTGCGTCTACAAGAAACTGGGTCTCCTGGGTGACGATG 67 FBan0030129 FBgn0046880 Obp56b 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56b Odorant-binding protein 56b "CG15129, CG30129, CG15129, CG15129, CG15129, CG15129, OBP56b, 56b, Odorant-binding protein 56b" CDMC26334 3 26 22 DAC36-K20 3-CG30129-RA_4 CG30129 CCCTCTGAGTCGGTGAAGTGCTATCACAGCTGCGTCTACAAGAAACTGGGTCTCCTGGGTGACGATG 67 FBan0030129 FBgn0046880 Obp56b 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56b Odorant-binding protein 56b "CG15129, CG30129, CG15129, CG15129, CG15129, CG15129, OBP56b, 56b, Odorant-binding protein 56b" CDMC26335 3 1 23 DAC36-O08 15-CG3061-RA_2 CG3061 CGAAAAGCGCAAGAACTACGATCTGTATGGCATCAATGAGTCGCACAATGGTCACGGCAACAATGGT 67 FBan0003061 FBgn0038195 CG3061 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG3061 CG3061 dnaJ like2 CDMC26335 3 2 23 DAC36-O08 15-CG3061-RA_2 CG3061 CGAAAAGCGCAAGAACTACGATCTGTATGGCATCAATGAGTCGCACAATGGTCACGGCAACAATGGT 67 FBan0003061 FBgn0038195 CG3061 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG3061 CG3061 dnaJ like2 CDMC26336 3 3 23 DAC36-O20 AutoBlank AutoBlank CDMC26336 3 4 23 DAC36-O20 AutoBlank AutoBlank CDMC26337 3 5 23 DAC37-C08 3-CG7614-RA_1 CG7614 ATCGGAGGAGGGTCCACTTTTCGTATACGAGCCACTTGTTCCTTTCAGTGAGGGACCTGCCATGC 65 FBan0007614 FBgn0024956 Mat1 2 2R DNA repair; GO:0006281; protein complex assembly; GO:0006461; protein ubiquitination; GO:0016567; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; kinase activator activity; GO:0019209; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016251; ; GO:0019209; ; GO:0008270 transcription factor TFIIH complex; GO:0005675; ubiquitin ligase complex; GO:0000151 Mat1 Mat1 "CG7614, CG7614, MAT1" CDMC26337 3 6 23 DAC37-C08 3-CG7614-RA_1 CG7614 ATCGGAGGAGGGTCCACTTTTCGTATACGAGCCACTTGTTCCTTTCAGTGAGGGACCTGCCATGC 65 FBan0007614 FBgn0024956 Mat1 2 2R DNA repair; GO:0006281; protein complex assembly; GO:0006461; protein ubiquitination; GO:0016567; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; kinase activator activity; GO:0019209; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016251; ; GO:0019209; ; GO:0008270 transcription factor TFIIH complex; GO:0005675; ubiquitin ligase complex; GO:0000151 Mat1 Mat1 "CG7614, CG7614, MAT1" CDMC26338 3 7 23 DAC37-C20 3-CG7660-RA_10 CG7660 TGATTTTGGTCGTGATCTGCTGCCCTTGACAAACGACAAGAAGGCATGTCCCAGTGAGGAAGCCG 65 FBan0007660 FBgn0038538 pxt 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 pxt pxt "CG7660, CG7660, CG7660, Dpxt, anon-WO0172774.128" CDMC26338 3 8 23 DAC37-C20 3-CG7660-RA_10 CG7660 TGATTTTGGTCGTGATCTGCTGCCCTTGACAAACGACAAGAAGGCATGTCCCAGTGAGGAAGCCG 65 FBan0007660 FBgn0038538 pxt 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 pxt pxt "CG7660, CG7660, CG7660, Dpxt, anon-WO0172774.128" CDMC26339 3 9 23 DAC37-G08 3-CG7816-RC_4 CG7816 CTAGCCGAGTCATCATCGATCACGGCACATACTCCACCGAAAGTCACTGGACATGAGCAGGCAGC 65 FBan0007816 FBgn0039714 CG7816 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to membrane; GO:0016021 CG7816 CG7816 CDMC26339 3 10 23 DAC37-G08 3-CG7816-RC_4 CG7816 CTAGCCGAGTCATCATCGATCACGGCACATACTCCACCGAAAGTCACTGGACATGAGCAGGCAGC 65 FBan0007816 FBgn0039714 CG7816 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to membrane; GO:0016021 CG7816 CG7816 CDMC26340 3 11 23 DAC37-G20 2-CG7863-RA_1 CG7863 ACGATTTCAACGAGCCTGGGTATCTCGAAATCAAGCCTGACCAAGAACAAACTCAAGCCCGCCCG 65 FBan0007863 FBgn0033051 dream 2 2R apoptosis; GO:0006915; intracellular signaling cascade; GO:0007242; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 dream dream "CG7863, CG7863, CG7863, strica, STRICA/DREAM, STRICA, Strica/Dream, Strica" CDMC26340 3 12 23 DAC37-G20 2-CG7863-RA_1 CG7863 ACGATTTCAACGAGCCTGGGTATCTCGAAATCAAGCCTGACCAAGAACAAACTCAAGCCCGCCCG 65 FBan0007863 FBgn0033051 dream 2 2R apoptosis; GO:0006915; intracellular signaling cascade; GO:0007242; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 dream dream "CG7863, CG7863, CG7863, strica, STRICA/DREAM, STRICA, Strica/Dream, Strica" CDMC26341 3 13 23 DAC37-K08 3-CG7951-RA_5 CG7951 CGGGACTATCATAACAACCCGCTGATCAGTGGCACCAACTTCCAGCTGTCTCCAGTCTTCGGAGG 65 FBan0007951 FBgn0015542 sima 3 3R "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; signal transducer activity; GO:0004871; ; GO:0016563; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 sima similar "CG7951, l(3)j11B7, DMU43090, SIMA, Sima, Hif-1A, Hypoxia Inducible Factor, HIF alpha, HIF-alpha, similar" CDMC26341 3 14 23 DAC37-K08 3-CG7951-RA_5 CG7951 CGGGACTATCATAACAACCCGCTGATCAGTGGCACCAACTTCCAGCTGTCTCCAGTCTTCGGAGG 65 FBan0007951 FBgn0015542 sima 3 3R "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; signal transducer activity; GO:0004871; ; GO:0016563; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 sima similar "CG7951, l(3)j11B7, DMU43090, SIMA, Sima, Hif-1A, Hypoxia Inducible Factor, HIF alpha, HIF-alpha, similar" CDMC26342 3 15 23 DAC37-K20 23-CG7977-RA_2 CG7977 CTATAAACAAAGTAATGCTAAGCTGACACGGTAGAGCGAGGATGAACGTTTCAAAGTTGTCTGGG 65 FBan0007977 FBgn0026372 RpL23A 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL23A Ribosomal protein L23A "CG7977, CG7977, rpL25, clone 1.4, PBP-3, RpL23a, PARP-binding protein-3, Ribosomal protein L23a, rpl23a, L23a, RpL25, anon-EST:fe2D1, anon-EST:Liang-1.4, Ribosomal protein L25, anon-fast-evolving-2D1, Ribosomal protein L23A" CDMC26342 3 16 23 DAC37-K20 23-CG7977-RA_2 CG7977 CTATAAACAAAGTAATGCTAAGCTGACACGGTAGAGCGAGGATGAACGTTTCAAAGTTGTCTGGG 65 FBan0007977 FBgn0026372 RpL23A 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL23A Ribosomal protein L23A "CG7977, CG7977, rpL25, clone 1.4, PBP-3, RpL23a, PARP-binding protein-3, Ribosomal protein L23a, rpl23a, L23a, RpL25, anon-EST:fe2D1, anon-EST:Liang-1.4, Ribosomal protein L25, anon-fast-evolving-2D1, Ribosomal protein L23A" CDMC26343 3 17 23 DAC37-O08 17-CG8085-RA_1 CG8085 CAGCTACTCGCTGTACAGCAATGGATTTGTGGTGACCACTATCGATAGTGAACAAGATCCCGCCC 65 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC26343 3 18 23 DAC37-O08 17-CG8085-RA_1 CG8085 CAGCTACTCGCTGTACAGCAATGGATTTGTGGTGACCACTATCGATAGTGAACAAGATCCCGCCC 65 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC26344 3 19 23 DAC37-O20 3-CG8095-RB_4 CG8095 AGCTTCCCGTAAATCGCACCATTGTGTTCAACTGCCGGGATCCCGAAATGACCATATGTGTCCGA 65 FBan0008095 FBgn0003328 scb 2 2R axon guidance; GO:0007411; calcium-dependent cell-cell adhesion; GO:0016339; calcium-dependent cell-matrix adhesion; GO:0016340; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-matrix adhesion; GO:0007160; dorsal closure; GO:0007391; heart development; GO:0007507; heterophilic cell adhesion; GO:0007157; learning and/or memory; GO:0007611; locomotion; GO:0040011; memory; GO:0007613; midgut development; GO:0007494; olfactory learning; GO:0008355; salivary gland development; GO:0007431; short-term memory; GO:0007614; tracheal system development (sensu Insecta); GO:0007424 receptor activity; GO:0004872; ; GO:0004872; laminin receptor activity; GO:0005055; structural molecule activity; GO:0005198; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0050839; ; GO:0050839; ; GO:0005198; ; GO:0004872; ; GO:0050839; ; GO:0005055 focal adhesion; GO:0005925; integral to membrane; GO:0016021; integrin complex; GO:0008305; plasma membrane; GO:0005886 scb scab "CG8095, CG8095, CG8095, PS3, volado, alphaPS3, Volado, Vol, aVolado, aPS3, alpha[[PS3]], E(Sev-CycE)E93, Dm0620, alphaPS3, CT21280, CT36929, vol, alpha-PS3, E(sev-cycE)[e93], Complementation group 2.11, alphaInt3, l(2)01288, alpha Position-Specific antigen 3, scab" CDMC26344 3 20 23 DAC37-O20 3-CG8095-RB_4 CG8095 AGCTTCCCGTAAATCGCACCATTGTGTTCAACTGCCGGGATCCCGAAATGACCATATGTGTCCGA 65 FBan0008095 FBgn0003328 scb 2 2R axon guidance; GO:0007411; calcium-dependent cell-cell adhesion; GO:0016339; calcium-dependent cell-matrix adhesion; GO:0016340; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-matrix adhesion; GO:0007160; dorsal closure; GO:0007391; heart development; GO:0007507; heterophilic cell adhesion; GO:0007157; learning and/or memory; GO:0007611; locomotion; GO:0040011; memory; GO:0007613; midgut development; GO:0007494; olfactory learning; GO:0008355; salivary gland development; GO:0007431; short-term memory; GO:0007614; tracheal system development (sensu Insecta); GO:0007424 receptor activity; GO:0004872; ; GO:0004872; laminin receptor activity; GO:0005055; structural molecule activity; GO:0005198; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0050839; ; GO:0050839; ; GO:0005198; ; GO:0004872; ; GO:0050839; ; GO:0005055 focal adhesion; GO:0005925; integral to membrane; GO:0016021; integrin complex; GO:0008305; plasma membrane; GO:0005886 scb scab "CG8095, CG8095, CG8095, PS3, volado, alphaPS3, Volado, Vol, aVolado, aPS3, alpha[[PS3]], E(Sev-CycE)E93, Dm0620, alphaPS3, CT21280, CT36929, vol, alpha-PS3, E(sev-cycE)[e93], Complementation group 2.11, alphaInt3, l(2)01288, alpha Position-Specific antigen 3, scab" CDMC26345 3 21 23 DAC38-C08 9-CG4170-RD_4 CG4170 TCGGTCAAGGAGGCTATTGATGATGTGAACAAGAACGAAAGCGAAACCAATGTGACCAATGCCGAGGGC 69 FBan0004170 FBgn0024183 vig 2 2L RNA interference; GO:0016246 mRNA binding; GO:0003729; ; GO:0003729 RNA-induced silencing complex; GO:0016442 vig vasa intronic gene "CG4170, BG:DS00929.13, EP(2)0812, VIG, vasa intronic gene" CDMC26345 3 22 23 DAC38-C08 9-CG4170-RD_4 CG4170 TCGGTCAAGGAGGCTATTGATGATGTGAACAAGAACGAAAGCGAAACCAATGTGACCAATGCCGAGGGC 69 FBan0004170 FBgn0024183 vig 2 2L RNA interference; GO:0016246 mRNA binding; GO:0003729; ; GO:0003729 RNA-induced silencing complex; GO:0016442 vig vasa intronic gene "CG4170, BG:DS00929.13, EP(2)0812, VIG, vasa intronic gene" CDMC26346 3 23 23 DAC38-C20 3-CG4185-RA_1 CG4185 GCCAACGAGAGTCGCGAGCTGATACTCAACTGCTGCTCAGAGTTCATTCATCTGATCAGTTCGGAGGCC 69 FBan0004185 FBgn0028926 NC2beta 2 2L negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcriptional preinitiation complex formation; GO:0017055; positive regulation of transcription from RNA polymerase II promoter; GO:0045944 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; general transcriptional repressor activity; GO:0016565; transcriptional repressor activity; GO:0016564; ; GO:0003702; protein binding; GO:0005515; ; GO:0016563; ; GO:0016564; ; GO:0016565; ; GO:0003677; ; GO:0005515 negative cofactor 2 complex; GO:0017054; nucleus; GO:0005634 NC2beta NC2beta "CG4185, CG4185, BG:DS00929.3, Dr1, dNC2, NC2beta, dDr1" CDMC26346 3 24 23 DAC38-C20 3-CG4185-RA_1 CG4185 GCCAACGAGAGTCGCGAGCTGATACTCAACTGCTGCTCAGAGTTCATTCATCTGATCAGTTCGGAGGCC 69 FBan0004185 FBgn0028926 NC2beta 2 2L negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcriptional preinitiation complex formation; GO:0017055; positive regulation of transcription from RNA polymerase II promoter; GO:0045944 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; general transcriptional repressor activity; GO:0016565; transcriptional repressor activity; GO:0016564; ; GO:0003702; protein binding; GO:0005515; ; GO:0016563; ; GO:0016564; ; GO:0016565; ; GO:0003677; ; GO:0005515 negative cofactor 2 complex; GO:0017054; nucleus; GO:0005634 NC2beta NC2beta "CG4185, CG4185, BG:DS00929.3, Dr1, dNC2, NC2beta, dDr1" CDMC26347 3 25 23 DAC38-G08 23-CG4211-RA_12 CG4211 GATCTGGATCTTGGTCTGGATATCTCATCTCATTCGATGTCCACTAATGGATGATCCTTCTGTTGTGCA 69 FBan0004211 FBgn0004227 nonA X X "hemopoiesis; GO:0030097; male courtship behavior (sensu Insecta), song production; GO:0045433; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398; phototaxis; GO:0042331; visual behavior; GO:0007632; visual perception; GO:0007601" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA no on or off transient A "CG4211, CG4211, diss: dissonance, dissonance, Bj6: Bj6-monoclonal-antibody, Bj6-1, non-A, NonA, no-on-transient A, no-on transient A, nonA/diss, opm2, x14, Bj6-monoclonal-antibody, Positive spike II group, diss, Bj6" CDMC26347 3 26 23 DAC38-G08 23-CG4211-RA_12 CG4211 GATCTGGATCTTGGTCTGGATATCTCATCTCATTCGATGTCCACTAATGGATGATCCTTCTGTTGTGCA 69 FBan0004211 FBgn0004227 nonA X X "hemopoiesis; GO:0030097; male courtship behavior (sensu Insecta), song production; GO:0045433; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398; phototaxis; GO:0042331; visual behavior; GO:0007632; visual perception; GO:0007601" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA no on or off transient A "CG4211, CG4211, diss: dissonance, dissonance, Bj6: Bj6-monoclonal-antibody, Bj6-1, non-A, NonA, no-on-transient A, no-on transient A, nonA/diss, opm2, x14, Bj6-monoclonal-antibody, Positive spike II group, diss, Bj6" CDMC26348 3 1 24 DAC38-G20 3-CG4220-RB_1 CG4220 GCAAACCAGAAGCCCAAATGCAGATACCAGAGGAGCAGAGTAAACCAGCAGCTACTTGTCTGCCAAGCT 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC26348 3 2 24 DAC38-G20 3-CG4220-RB_1 CG4220 GCAAACCAGAAGCCCAAATGCAGATACCAGAGGAGCAGAGTAAACCAGCAGCTACTTGTCTGCCAAGCT 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC26349 3 3 24 DAC38-K08 9-CG4258-RA_2 CG4258 GCCACCCTTAAGTCCATTGAACTGCTCACCGATTGCTACGTTTTGGTTCAAGGAAACACAGTCTCCGCC 69 FBan0004258 FBgn0020305 dbe 2 2L rRNA processing; GO:0006364 mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; nucleoplasm; GO:0005654 dbe dribble "CG4258, l(2)k05428, l(2)k06708, dribble" CDMC26349 3 4 24 DAC38-K08 9-CG4258-RA_2 CG4258 GCCACCCTTAAGTCCATTGAACTGCTCACCGATTGCTACGTTTTGGTTCAAGGAAACACAGTCTCCGCC 69 FBan0004258 FBgn0020305 dbe 2 2L rRNA processing; GO:0006364 mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; nucleoplasm; GO:0005654 dbe dribble "CG4258, l(2)k05428, l(2)k06708, dribble" CDMC26350 3 5 24 DAC38-K20 23-CG4266-RA_2 CG4266 GGGAGCTTGTGGGGGAGTAGAAGCCCAATCATAAACAAATCAGCAATCGCAAAACTTGAAATGTTTATT 69 FBan0004266 FBgn0034598 CG4266 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG4266 CG4266 cg4266 CDMC26350 3 6 24 DAC38-K20 23-CG4266-RA_2 CG4266 GGGAGCTTGTGGGGGAGTAGAAGCCCAATCATAAACAAATCAGCAATCGCAAAACTTGAAATGTTTATT 69 FBan0004266 FBgn0034598 CG4266 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG4266 CG4266 cg4266 CDMC26351 3 7 24 DAC38-O08 23-CG4319-RA_3 CG4319 AGCCATCGCAATGAGGATTCGAGTAACTAACAAATACGGGGAAAACCAATAGTCCAGTCCAAAATCCAG 69 FBan0004319 FBgn0011706 rpr 3 3L NOT nurse cell apoptosis; GO:0045476; apoptosis; GO:0006915; apoptotic program; GO:0008632; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic development (sensu Insecta); GO:0001700; induction of apoptosis; GO:0006917; induction of apoptosis by ionic changes; GO:0008627; larval midgut cell programmed cell death; GO:0035096; negative regulation of protein biosynthesis; GO:0017148; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of proteolysis; GO:0030162; response to DNA damage stimulus; GO:0006974; salivary gland cell autophagic cell death; GO:0035071 cytoplasm; GO:0005737; mitochondrion; GO:0005739 rpr reaper "CG4319, CG4319, CG4319, Rpr, rp, Reaper L, RPR, anon-WO0162936.19, reaper" CDMC26351 3 8 24 DAC38-O08 23-CG4319-RA_3 CG4319 AGCCATCGCAATGAGGATTCGAGTAACTAACAAATACGGGGAAAACCAATAGTCCAGTCCAAAATCCAG 69 FBan0004319 FBgn0011706 rpr 3 3L NOT nurse cell apoptosis; GO:0045476; apoptosis; GO:0006915; apoptotic program; GO:0008632; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic development (sensu Insecta); GO:0001700; induction of apoptosis; GO:0006917; induction of apoptosis by ionic changes; GO:0008627; larval midgut cell programmed cell death; GO:0035096; negative regulation of protein biosynthesis; GO:0017148; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of proteolysis; GO:0030162; response to DNA damage stimulus; GO:0006974; salivary gland cell autophagic cell death; GO:0035071 cytoplasm; GO:0005737; mitochondrion; GO:0005739 rpr reaper "CG4319, CG4319, CG4319, Rpr, rp, Reaper L, RPR, anon-WO0162936.19, reaper" CDMC26352 3 9 24 DAC38-O20 2-CG4328-RA_3 CG4328 AGAGGACCCAAGCGACCGAGAACCATTCTAAACACGCAGCAAAGACGAGCTTTTAAGGCCTCCTTCGAA 69 FBan0004328 FBgn0036274 CG4328 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4328 CG4328 CDMC26352 3 10 24 DAC38-O20 2-CG4328-RA_3 CG4328 AGAGGACCCAAGCGACCGAGAACCATTCTAAACACGCAGCAAAGACGAGCTTTTAAGGCCTCCTTCGAA 69 FBan0004328 FBgn0036274 CG4328 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4328 CG4328 CDMC26353 3 11 24 DAC39-C08 23-CG6949-RA_2 CG6949 ATGAATTCTTTGCCTCTTTGAACCGAAAATGGGAAAGGATGAAATTTGAAACTTATGGGGTTGTATTTT 69 FBan0006949 FBgn0038996 mRpL45 3 3R intracellular protein transport; GO:0006886; protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; protein translocase activity; GO:0015450; ; GO:0003735; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739 mRpL45 mitochondrial ribosomal protein L45 "CG6949, MRP-L45, mitochondrial ribosomal protein L45" CDMC26353 3 12 24 DAC39-C08 23-CG6949-RA_2 CG6949 ATGAATTCTTTGCCTCTTTGAACCGAAAATGGGAAAGGATGAAATTTGAAACTTATGGGGTTGTATTTT 69 FBan0006949 FBgn0038996 mRpL45 3 3R intracellular protein transport; GO:0006886; protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; protein translocase activity; GO:0015450; ; GO:0003735; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739 mRpL45 mitochondrial ribosomal protein L45 "CG6949, MRP-L45, mitochondrial ribosomal protein L45" CDMC26354 3 13 24 DAC39-C20 23-CG6956-RA_2 CG6956 GGATACGCTAACCGAGAGCTGTTCTATGTATAATGGTTTCTAGTTGATTATTAAATAAACGCGGCAAAA 69 FBan0006956 FBgn0020642 Lcp65Ac 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ac Lcp65Ac "CG6956, Lcp-c, DMLCP65c, DCP2" CDMC26354 3 14 24 DAC39-C20 23-CG6956-RA_2 CG6956 GGATACGCTAACCGAGAGCTGTTCTATGTATAATGGTTTCTAGTTGATTATTAAATAAACGCGGCAAAA 69 FBan0006956 FBgn0020642 Lcp65Ac 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ac Lcp65Ac "CG6956, Lcp-c, DMLCP65c, DCP2" CDMC26355 3 15 24 DAC39-G08 2-CG6985-RA_1 CG6985 AGGCAGCAAGGATGTCGAGATTCAGGAGGAGATTAAAACCGTCGAGGAGTGCCTTATTCAGCGCCAGTT 69 FBan0006985 FBgn0039017 CG6985 3 3R CG6985 CG6985 CDMC26355 3 16 24 DAC39-G08 2-CG6985-RA_1 CG6985 AGGCAGCAAGGATGTCGAGATTCAGGAGGAGATTAAAACCGTCGAGGAGTGCCTTATTCAGCGCCAGTT 69 FBan0006985 FBgn0039017 CG6985 3 3R CG6985 CG6985 CDMC26356 3 17 24 DAC39-G20 8-CG6993-RA_1 CG6993 AGGGAATCGGGTATGGGTACTGCAACCTTAATCAGCACAAAGTTACGAAGCCAATCCCCGTTGATCCCA 69 FBan0006993 FBgn0003513 ss 3 3R "antennal morphogenesis; GO:0007469; cell-cell signaling; GO:0007267; defense response; GO:0006952; regulation of transcription, DNA-dependent; GO:0006355; response to toxin; GO:0009636; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; receptor activity; GO:0004872; ; GO:0003700; ; GO:0004872; ; GO:0003700 nucleus; GO:0005634 ss spineless "CG6993, SS, aristapedia, AHR, spineless-aristapedia" CDMC26356 3 18 24 DAC39-G20 8-CG6993-RA_1 CG6993 AGGGAATCGGGTATGGGTACTGCAACCTTAATCAGCACAAAGTTACGAAGCCAATCCCCGTTGATCCCA 69 FBan0006993 FBgn0003513 ss 3 3R "antennal morphogenesis; GO:0007469; cell-cell signaling; GO:0007267; defense response; GO:0006952; regulation of transcription, DNA-dependent; GO:0006355; response to toxin; GO:0009636; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; receptor activity; GO:0004872; ; GO:0003700; ; GO:0004872; ; GO:0003700 nucleus; GO:0005634 ss spineless "CG6993, SS, aristapedia, AHR, spineless-aristapedia" CDMC26357 3 19 24 DAC39-K08 2-CG7023-RA_1 CG7023 TCAAGGTCTCGCATCGCGTTGTGTTTCCACTGGAACTGAGGCTCTTTAACACCTCCGATGATGCAGTGA 69 FBan0007023 FBgn0039025 CG7023 3 3R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG7023 CG7023 CDMC26357 3 20 24 DAC39-K08 2-CG7023-RA_1 CG7023 TCAAGGTCTCGCATCGCGTTGTGTTTCCACTGGAACTGAGGCTCTTTAACACCTCCGATGATGCAGTGA 69 FBan0007023 FBgn0039025 CG7023 3 3R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG7023 CG7023 CDMC26358 3 21 24 DAC39-K20 3-CG7035-RA_1 CG7035 AGCGCATGGAGGAGAAATTGGAAGCAGCGAATGTGAACCAGAAGCGTCTGTTCCTCATCGTCTTCCAGA 69 FBan0007035 FBgn0022942 Cbp80 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 nucleus; GO:0005634; snRNA cap binding complex; GO:0005846; spliceosome complex; GO:0005681 Cbp80 cap binding protein 80 "CG7035, CG7035, CBP80, EG:84H4.3" CDMC26358 3 22 24 DAC39-K20 3-CG7035-RA_1 CG7035 AGCGCATGGAGGAGAAATTGGAAGCAGCGAATGTGAACCAGAAGCGTCTGTTCCTCATCGTCTTCCAGA 69 FBan0007035 FBgn0022942 Cbp80 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 nucleus; GO:0005634; snRNA cap binding complex; GO:0005846; spliceosome complex; GO:0005681 Cbp80 cap binding protein 80 "CG7035, CG7035, CBP80, EG:84H4.3" CDMC26359 3 23 24 DAC39-O08 13-CG7065-RA_1 CG7065 GAGAACATCATAGCCAATCTAATGGGCACTTTAAGCAAGAATGGCACTTCTGGAGGTTCACCCGTGGGT 69 FBan0007065 FBgn0030091 CG7065 X X CG7065 CG7065 CDMC26359 3 24 24 DAC39-O08 13-CG7065-RA_1 CG7065 GAGAACATCATAGCCAATCTAATGGGCACTTTAAGCAAGAATGGCACTTCTGGAGGTTCACCCGTGGGT 69 FBan0007065 FBgn0030091 CG7065 X X CG7065 CG7065 CDMC26360 3 25 24 DAC39-O20 23-CG7073-RB_4 CG7073 GCCGCCACTAGTGTTAGTTTAGCTGCGTATATTAATTGATGACGCGTAAGTCAAAAGGCTATTCAACAC 69 FBan0007073 FBgn0038947 sar1 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 COPII-coated vesicle; GO:0030138 sar1 sar1 "CG7073, CG7073, l(3)05712, 5712, clone 1.48, dsar1, Sar1, NP_732719, Dm Sar1, anon-EST:Liang-1.48" CDMC26360 3 26 24 DAC39-O20 23-CG7073-RB_4 CG7073 GCCGCCACTAGTGTTAGTTTAGCTGCGTATATTAATTGATGACGCGTAAGTCAAAAGGCTATTCAACAC 69 FBan0007073 FBgn0038947 sar1 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 COPII-coated vesicle; GO:0030138 sar1 sar1 "CG7073, CG7073, l(3)05712, 5712, clone 1.48, dsar1, Sar1, NP_732719, Dm Sar1, anon-EST:Liang-1.48" CDMC26361 3 1 25 DAC40-C08 23-CG33335-RA_2 CG33335 ACGATGCCTGTGACACAGTTAACTCATGCTCGACACCAAAACATATATCAAATGTGTGGCACGAC 65 FBan0033335 FBgn0053335 CG33335 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33335 CG33335 CDMC26361 3 2 25 DAC40-C08 23-CG33335-RA_2 CG33335 ACGATGCCTGTGACACAGTTAACTCATGCTCGACACCAAAACATATATCAAATGTGTGGCACGAC 65 FBan0033335 FBgn0053335 CG33335 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33335 CG33335 CDMC26362 3 3 25 DAC40-C20 12-CG3339-RA_4 CG3339 TGGTGACCTGACCATCTCGTCCAATGTCCTGCACAACTATCTGGAGGGTAGCAATCGGATTCCGT 65 FBan0003339 FBgn0039510 CG3339 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003774; ; GO:0004197 ; EC:3.4.22.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; integral to membrane; GO:0016021; microtubule associated complex; GO:0005875 CG3339 CG3339 CDMC26362 3 4 25 DAC40-C20 12-CG3339-RA_4 CG3339 TGGTGACCTGACCATCTCGTCCAATGTCCTGCACAACTATCTGGAGGGTAGCAATCGGATTCCGT 65 FBan0003339 FBgn0039510 CG3339 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003774; ; GO:0004197 ; EC:3.4.22.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; integral to membrane; GO:0016021; microtubule associated complex; GO:0005875 CG3339 CG3339 CDMC26363 3 5 25 DAC40-G08 3-CG3430-RA_2 CG3430 ATGAGACAAACAAGCTGGTTTCCGGCGTACTACAGTTGGCTCCCCATACGCATTTGGTGCTCGAC 65 FBan0003430 FBgn0031875 CG3430 2 2L CG3430 CG3430 CDMC26363 3 6 25 DAC40-G08 3-CG3430-RA_2 CG3430 ATGAGACAAACAAGCTGGTTTCCGGCGTACTACAGTTGGCTCCCCATACGCATTTGGTGCTCGAC 65 FBan0003430 FBgn0031875 CG3430 2 2L CG3430 CG3430 CDMC26364 3 7 25 DAC40-G20 18-CG3476-RA_5 CG3476 TGGAGGAGGTCGAAATCAGCACAGAAAAGAAATCCAATCCCGTAAAGTCATTTATTGCGGGCGGC 65 FBan0003476 FBgn0031881 CG3476 2 2L acyl carnitine transport; GO:0006844; carnitine transport; GO:0015879; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; acyl carnitine transporter activity; GO:0015227; carnitine transporter activity; GO:0015226; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015226; ; GO:0015227; carnitine:acyl carnitine antiporter activity; GO:0005476; ; GO:0005476 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG3476 CG3476 CDMC26364 3 8 25 DAC40-G20 18-CG3476-RA_5 CG3476 TGGAGGAGGTCGAAATCAGCACAGAAAAGAAATCCAATCCCGTAAAGTCATTTATTGCGGGCGGC 65 FBan0003476 FBgn0031881 CG3476 2 2L acyl carnitine transport; GO:0006844; carnitine transport; GO:0015879; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; acyl carnitine transporter activity; GO:0015227; carnitine transporter activity; GO:0015226; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015226; ; GO:0015227; carnitine:acyl carnitine antiporter activity; GO:0005476; ; GO:0005476 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG3476 CG3476 CDMC26365 3 9 25 DAC40-K08 4-CG3625-RA_1 CG3625 CTTCTGGACACTGTACGCTATCGACAGGGAGCTAGTCTTCCCCAAGGTTCTGGACCCCGTGTTCC 65 FBan0003625 FBgn0031245 CG3625 2 2L CG3625 CG3625 CDMC26365 3 10 25 DAC40-K08 4-CG3625-RA_1 CG3625 CTTCTGGACACTGTACGCTATCGACAGGGAGCTAGTCTTCCCCAAGGTTCTGGACCCCGTGTTCC 65 FBan0003625 FBgn0031245 CG3625 2 2L CG3625 CG3625 CDMC26366 3 11 25 DAC40-K20 18-CG3650-RA_1 CG3650 TATCCCGGCGTCTACACCAGCGTCCATCGGGTCCGGAGCTTCATCCTCCGCTCCATTAAGAAGTG 65 FBan0003650 FBgn0035070 CG3650 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG3650 CG3650 SP159 CDMC26366 3 12 25 DAC40-K20 18-CG3650-RA_1 CG3650 TATCCCGGCGTCTACACCAGCGTCCATCGGGTCCGGAGCTTCATCCTCCGCTCCATTAAGAAGTG 65 FBan0003650 FBgn0035070 CG3650 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG3650 CG3650 SP159 CDMC26367 3 13 25 DAC40-O08 1-CG3730-RA_1 CG3730 AAAGTGTGGTACGAATGGCAGGTGGTCAATTCTCCAGACGATTGGGAGCACCATAACACACGCGG 65 FBan0003730 FBgn0015925 csul 2 2R MAPKKK cascade; GO:0000165; mitosis; GO:0007067; pole plasm assembly; GO:0007315 protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008276 ; EC:2.1.1.- cytoplasm; GO:0005737 csul capsuleen "CG3730, JBP1, DART5, Drosophila arginine methyltransferase 5, capsuleen" CDMC26367 3 14 25 DAC40-O08 1-CG3730-RA_1 CG3730 AAAGTGTGGTACGAATGGCAGGTGGTCAATTCTCCAGACGATTGGGAGCACCATAACACACGCGG 65 FBan0003730 FBgn0015925 csul 2 2R MAPKKK cascade; GO:0000165; mitosis; GO:0007067; pole plasm assembly; GO:0007315 protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008276 ; EC:2.1.1.- cytoplasm; GO:0005737 csul capsuleen "CG3730, JBP1, DART5, Drosophila arginine methyltransferase 5, capsuleen" CDMC26368 3 15 25 DAC40-O20 AutoBlank AutoBlank CDMC26368 3 16 25 DAC40-O20 AutoBlank AutoBlank CDMC26369 3 17 25 DAC41-C08 AutoBlank AutoBlank CDMC26369 3 18 25 DAC41-C08 AutoBlank AutoBlank CDMC26370 3 19 25 DAC41-C20 AutoBlank AutoBlank CDMC26370 3 20 25 DAC41-C20 AutoBlank AutoBlank CDMC26371 3 21 25 DAC41-G08 AutoBlank AutoBlank CDMC26371 3 22 25 DAC41-G08 AutoBlank AutoBlank CDMC26372 3 23 25 DAC41-G20 AutoBlank AutoBlank CDMC26372 3 24 25 DAC41-G20 AutoBlank AutoBlank CDMC26373 3 25 25 DAC41-K08 AutoBlank AutoBlank CDMC26373 3 26 25 DAC41-K08 AutoBlank AutoBlank CDMC26374 3 1 26 DAC41-K20 AutoBlank AutoBlank CDMC26374 3 2 26 DAC41-K20 AutoBlank AutoBlank CDMC26375 3 3 26 DAC41-O08 AutoBlank AutoBlank CDMC26375 3 4 26 DAC41-O08 AutoBlank AutoBlank CDMC26376 3 5 26 DAC41-O20 AutoBlank AutoBlank CDMC26376 3 6 26 DAC41-O20 AutoBlank AutoBlank CDMC26377 3 7 26 DAC42-C08 150mM NaPO4 Blank CDMC26377 3 8 26 DAC42-C08 150mM NaPO4 Blank CDMC26378 3 9 26 DAC42-C20 150mM NaPO4 Blank CDMC26378 3 10 26 DAC42-C20 150mM NaPO4 Blank CDMC26379 3 11 26 DAC42-G08 150mM NaPO4 Blank CDMC26379 3 12 26 DAC42-G08 150mM NaPO4 Blank CDMC26380 3 13 26 DAC42-G20 150mM NaPO4 Blank CDMC26380 3 14 26 DAC42-G20 150mM NaPO4 Blank CDMC26381 3 15 26 DAC42-K08 150mM NaPO4 Blank CDMC26381 3 16 26 DAC42-K08 150mM NaPO4 Blank CDMC26382 3 17 26 DAC42-K20 5uM MSP 5uM MSP CDMC26382 3 18 26 DAC42-K20 5uM MSP 5uM MSP CDMC26383 3 19 26 DAC42-O08 10uM MSP 10uM MSP CDMC26383 3 20 26 DAC42-O08 10uM MSP 10uM MSP CDMC26384 3 21 26 DAC42-O20 20uM MSP 20uM MSP CDMC26384 3 22 26 DAC42-O20 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC26385 4 1 1 DAC01-D08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26385 4 2 1 DAC01-D08 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26386 4 3 1 DAC01-D20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26386 4 4 1 DAC01-D20 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26387 4 5 1 DAC01-H08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26387 4 6 1 DAC01-H08 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26388 4 7 1 DAC01-H20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26388 4 8 1 DAC01-H20 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26389 4 9 1 DAC01-L08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26389 4 10 1 DAC01-L08 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26390 4 11 1 DAC01-L20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26390 4 12 1 DAC01-L20 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26391 4 13 1 DAC01-P08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26391 4 14 1 DAC01-P08 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26392 4 15 1 DAC01-P20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26392 4 16 1 DAC01-P20 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26393 4 17 1 DAC02-D08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26393 4 18 1 DAC02-D08 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26394 4 19 1 DAC02-D20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26394 4 20 1 DAC02-D20 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26395 4 21 1 DAC02-H08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26395 4 22 1 DAC02-H08 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26396 4 23 1 DAC02-H20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26396 4 24 1 DAC02-H20 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26397 4 25 1 DAC02-L08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26397 4 26 1 DAC02-L08 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26398 4 1 2 DAC02-L20 N/A CG9075 (01196-01434) CDMC26398 4 2 2 DAC02-L20 N/A CG9075 (01196-01434) CDMC26399 4 3 2 DAC02-P08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26399 4 4 2 DAC02-P08 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26400 4 5 2 DAC02-P20 AutoBlank AutoBlank CDMC26400 4 6 2 DAC02-P20 AutoBlank AutoBlank CDMC26401 4 7 2 DAC03-D08 3-CG5451-RA_3 CG5451 GCGCATCATCACCGGTCAGTGTTTGCGTAAATTCGAGAAAGCCCACACCAAGGGAATAACCTGTCTGCA 69 FBan0005451 FBgn0038666 CG5451 3 3R CG5451 CG5451 CDMC26401 4 8 2 DAC03-D08 3-CG5451-RA_3 CG5451 GCGCATCATCACCGGTCAGTGTTTGCGTAAATTCGAGAAAGCCCACACCAAGGGAATAACCTGTCTGCA 69 FBan0005451 FBgn0038666 CG5451 3 3R CG5451 CG5451 CDMC26402 4 9 2 DAC03-D20 23-CG5462-RD_11 CG5462 TACCCGTATACCCCGTAACATGTTAACGCTGAAACGTGAAGTTTATAGAGTGACAACTACCACGAACCC 69 FBan0005462 FBgn0026178 scrib 3 3R antibacterial polypeptide induction; GO:0006963; asymmetric protein localization; GO:0008105; cell adhesion; GO:0007155; cell proliferation; GO:0008283; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; gonad development; GO:0008406; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of embryonic epithelium; GO:0016331; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; olfactory behavior; GO:0042048; pole cell migration; GO:0007280; positive regulation of heart contraction rate; GO:0045823; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074; regulation of synapse structure and function; GO:0050803; response to chemical stimulus; GO:0042221; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; hormone activity; GO:0005179; ; GO:0005515; ; GO:0005179 apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cytoplasm; GO:0005737; extracellular region; GO:0005576; lateral plasma membrane; GO:0016328; septate junction; GO:0005918; subapical complex; GO:0035003 scrib scribbled "CG5462, CG5462, CG5462, CG5462, l(3)j7B3, l(3)673, smi97B, smell impaired 97B, 0424/05, scribble, ird15, immune response deficient 15, l(3)S042405, vart, vartul, ird, CT17324, gp150-like, SCR, Scrib, Scribble, l(3)c00119, lethal (3) c00119, scribbled" CDMC26402 4 10 2 DAC03-D20 23-CG5462-RD_11 CG5462 TACCCGTATACCCCGTAACATGTTAACGCTGAAACGTGAAGTTTATAGAGTGACAACTACCACGAACCC 69 FBan0005462 FBgn0026178 scrib 3 3R antibacterial polypeptide induction; GO:0006963; asymmetric protein localization; GO:0008105; cell adhesion; GO:0007155; cell proliferation; GO:0008283; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; gonad development; GO:0008406; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of embryonic epithelium; GO:0016331; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; olfactory behavior; GO:0042048; pole cell migration; GO:0007280; positive regulation of heart contraction rate; GO:0045823; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074; regulation of synapse structure and function; GO:0050803; response to chemical stimulus; GO:0042221; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; hormone activity; GO:0005179; ; GO:0005515; ; GO:0005179 apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cytoplasm; GO:0005737; extracellular region; GO:0005576; lateral plasma membrane; GO:0016328; septate junction; GO:0005918; subapical complex; GO:0035003 scrib scribbled "CG5462, CG5462, CG5462, CG5462, l(3)j7B3, l(3)673, smi97B, smell impaired 97B, 0424/05, scribble, ird15, immune response deficient 15, l(3)S042405, vart, vartul, ird, CT17324, gp150-like, SCR, Scrib, Scribble, l(3)c00119, lethal (3) c00119, scribbled" CDMC26403 4 11 2 DAC03-H08 2-CG5481-RA_1 CG5481 ACGGTGGAGTGGAGAACTTTGAGTAGCCTGGTTAGGAAGGGTATTTGGAGGGGAATGTGCTGAAGGCAA 69 FBan0005481 FBgn0002543 lea 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron migration; GO:0001764; signal transduction; GO:0007165; tracheal outgrowth (sensu Insecta); GO:0007426; ventral cord development; GO:0007419 receptor activity; GO:0004872; axon guidance receptor activity; GO:0008046; ; GO:0004872; ; GO:0008046 plasma membrane; GO:0005886 lea leak "CG5481, CG14347, CG14348, CG5574, CG5481, CG5481, D-robo2, D-Robo2, clone 1.75, robo2, robo-2, dRobo-2, CT17326, Robo-2, roundabout 2, Robo2, Robo 2, Roundabout 2, anon-EST:Liang-1.75" CDMC26403 4 12 2 DAC03-H08 2-CG5481-RA_1 CG5481 ACGGTGGAGTGGAGAACTTTGAGTAGCCTGGTTAGGAAGGGTATTTGGAGGGGAATGTGCTGAAGGCAA 69 FBan0005481 FBgn0002543 lea 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron migration; GO:0001764; signal transduction; GO:0007165; tracheal outgrowth (sensu Insecta); GO:0007426; ventral cord development; GO:0007419 receptor activity; GO:0004872; axon guidance receptor activity; GO:0008046; ; GO:0004872; ; GO:0008046 plasma membrane; GO:0005886 lea leak "CG5481, CG14347, CG14348, CG5574, CG5481, CG5481, D-robo2, D-Robo2, clone 1.75, robo2, robo-2, dRobo-2, CT17326, Robo-2, roundabout 2, Robo2, Robo 2, Roundabout 2, anon-EST:Liang-1.75" CDMC26404 4 13 2 DAC03-H20 23-CG5491-RA_2 CG5491 TGCGCGGGCATAAACTTGCATTTATATTGTTATTTACTATATCTACCCGGTATTAAGATGGCCGCAAAT 69 FBan0005491 FBgn0039459 CG5491 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG5491 CG5491 CDMC26404 4 14 2 DAC03-H20 23-CG5491-RA_2 CG5491 TGCGCGGGCATAAACTTGCATTTATATTGTTATTTACTATATCTACCCGGTATTAAGATGGCCGCAAAT 69 FBan0005491 FBgn0039459 CG5491 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG5491 CG5491 CDMC26405 4 15 2 DAC03-L08 3-CG5526-RA_1 CG5526 TGCCGGAGCGTCATAACTATCTGTGTCCCATGTACAAGACTGCCGAACGTCGAGGAGTATTGTCCACCA 69 FBan0005526 FBgn0013810 Dhc36C 2 2L cell motility; GO:0006928; glycerol-3-phosphate metabolism; GO:0006072; microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004368 ; EC:1.1.99.5" axonemal dynein complex; GO:0005858; glycerol-3-phosphate dehydrogenase complex; GO:0009331; microtubule associated complex; GO:0005875 Dhc36C Dynein heavy chain at 36C "CG5526, CG5526, CG5526, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC26405 4 16 2 DAC03-L08 3-CG5526-RA_1 CG5526 TGCCGGAGCGTCATAACTATCTGTGTCCCATGTACAAGACTGCCGAACGTCGAGGAGTATTGTCCACCA 69 FBan0005526 FBgn0013810 Dhc36C 2 2L cell motility; GO:0006928; glycerol-3-phosphate metabolism; GO:0006072; microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004368 ; EC:1.1.99.5" axonemal dynein complex; GO:0005858; glycerol-3-phosphate dehydrogenase complex; GO:0009331; microtubule associated complex; GO:0005875 Dhc36C Dynein heavy chain at 36C "CG5526, CG5526, CG5526, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC26406 4 17 2 DAC03-L20 13-CG5541-RA_1 CG5541 ACTCGCAATGTTCGTCAGTTGTAAGTGGCCCATGTATATAGTCGCATGTAGGCTGGGATCTTGCCCAAA 69 FBan0005541 FBgn0030603 CG5541 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5541 CG5541 CDMC26406 4 18 2 DAC03-L20 13-CG5541-RA_1 CG5541 ACTCGCAATGTTCGTCAGTTGTAAGTGGCCCATGTATATAGTCGCATGTAGGCTGGGATCTTGCCCAAA 69 FBan0005541 FBgn0030603 CG5541 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5541 CG5541 CDMC26407 4 19 2 DAC03-P08 2-CG5576-RA_1 CG5576 GGATGTGGTGCATTCCGCCAATATTCCGGGCACTCTCAGTAACGTCCAGACAAACAACACCATGAACGT 69 FBan0005576 FBgn0013983 imd 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; humoral immune response; GO:0006959; immune response; GO:0006955; innate immune response; GO:0045087; intracellular signaling cascade; GO:0007242; response to bacteria; GO:0009617; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 imd immune deficiency "CG5576, CG5576, CG5576, Imd, Immunodeficiency, BG5, shadok, IMD, anon-WO0172774.166" CDMC26407 4 20 2 DAC03-P08 2-CG5576-RA_1 CG5576 GGATGTGGTGCATTCCGCCAATATTCCGGGCACTCTCAGTAACGTCCAGACAAACAACACCATGAACGT 69 FBan0005576 FBgn0013983 imd 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; humoral immune response; GO:0006959; immune response; GO:0006955; innate immune response; GO:0045087; intracellular signaling cascade; GO:0007242; response to bacteria; GO:0009617; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 imd immune deficiency "CG5576, CG5576, CG5576, Imd, Immunodeficiency, BG5, shadok, IMD, anon-WO0172774.166" CDMC26408 4 21 2 DAC03-P20 22-CG5590-RA_1 CG5590 CGCTCAAGTCCAAGCTGTAGGGTGCGATTGAGTGGCTGAGTTTTCTATTGTTTACAAGCGTTTCAGTTT 69 FBan0005590 FBgn0039537 CG5590 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-; sterol carrier activity; GO:0005498; ; GO:0005498" CG5590 CG5590 CDMC26408 4 22 2 DAC03-P20 22-CG5590-RA_1 CG5590 CGCTCAAGTCCAAGCTGTAGGGTGCGATTGAGTGGCTGAGTTTTCTATTGTTTACAAGCGTTTCAGTTT 69 FBan0005590 FBgn0039537 CG5590 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-; sterol carrier activity; GO:0005498; ; GO:0005498" CG5590 CG5590 CDMC26409 4 23 2 DAC04-D08 23-CG12378-RA_8 CG12378 GTACTCAAGAGCAATGCAAAAAATTAAGGAAACACAAAACCTTTCTGAAGTATCACAACCTTTCAAACA 69 FBan0012378 FBgn0038748 CG12378 3 3R CG12378 CG12378 CDMC26409 4 24 2 DAC04-D08 23-CG12378-RA_8 CG12378 GTACTCAAGAGCAATGCAAAAAATTAAGGAAACACAAAACCTTTCTGAAGTATCACAACCTTTCAAACA 69 FBan0012378 FBgn0038748 CG12378 3 3R CG12378 CG12378 CDMC26410 4 25 2 DAC04-D20 12-CG12390-RA_6 CG12390 CGCGGTCGCGTTCACAACATTAATGGTCGTATTCTTAAGGATGATGCTACGGGAGAGGTTGACCCTGGA 69 FBan0012390 FBgn0015582 dare 2 2R cholesterol catabolism; GO:0006707; courtship behavior; GO:0007619; electron transport; GO:0006118; ferredoxin metabolism; GO:0006124; molting cycle (sensu Insecta); GO:0007591; molting cycle (sensu Protostomia and Nematoda); GO:0018988; olfactory behavior; GO:0042048; oogenesis (sensu Insecta); GO:0009993; pheromone metabolism; GO:0042810; phototaxis; GO:0042331; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ferredoxin-NADP+ reductase activity; GO:0004324 ; EC:1.18.1.2; NADPH-adrenodoxin reductase activity; GO:0015039 ; EC:1.18.1.-; ; GO:0005489; ; GO:0015039 ; EC:1.18.1.-; ; GO:0004324 ; EC:1.18.1.2; ; GO:0015039 ; EC:1.18.1.-; ; GO:0015039 ; EC:1.18.1.-; ; GO:0005489 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 dare defective in the avoidance of repellents "CG12390, AR, Adrenodoxin reductase, W8, ADXRDTASE, defective in the avoidance of repellents" CDMC26410 4 26 2 DAC04-D20 12-CG12390-RA_6 CG12390 CGCGGTCGCGTTCACAACATTAATGGTCGTATTCTTAAGGATGATGCTACGGGAGAGGTTGACCCTGGA 69 FBan0012390 FBgn0015582 dare 2 2R cholesterol catabolism; GO:0006707; courtship behavior; GO:0007619; electron transport; GO:0006118; ferredoxin metabolism; GO:0006124; molting cycle (sensu Insecta); GO:0007591; molting cycle (sensu Protostomia and Nematoda); GO:0018988; olfactory behavior; GO:0042048; oogenesis (sensu Insecta); GO:0009993; pheromone metabolism; GO:0042810; phototaxis; GO:0042331; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ferredoxin-NADP+ reductase activity; GO:0004324 ; EC:1.18.1.2; NADPH-adrenodoxin reductase activity; GO:0015039 ; EC:1.18.1.-; ; GO:0005489; ; GO:0015039 ; EC:1.18.1.-; ; GO:0004324 ; EC:1.18.1.2; ; GO:0015039 ; EC:1.18.1.-; ; GO:0015039 ; EC:1.18.1.-; ; GO:0005489 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 dare defective in the avoidance of repellents "CG12390, AR, Adrenodoxin reductase, W8, ADXRDTASE, defective in the avoidance of repellents" CDMC26411 4 1 3 DAC04-H08 23-CG1242-RA_10 CG1242 GCGACCAGTCGAAACAAACAACCAAAATTCATTCTATCACTCGCATTCACATACACAATTTACTTGCGT 69 FBan0001242 FBgn0001233 Hsp83 3 3L "R7 cell fate commitment; GO:0007465; actin filament organization; GO:0007015; centrosome cycle; GO:0007098; defense response; GO:0006952; determination of anterior/posterior axis, embryo; GO:0008595; protein complex assembly; GO:0006461; protein folding; GO:0006457; regulation of cell shape; GO:0008360; regulation of circadian sleep/wake cycle, sleep; GO:0045187; response to heat; GO:0009408; spermatogenesis; GO:0007283; torso signaling pathway; GO:0008293" "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" centrosome; GO:0005813; cytoplasm; GO:0005737 Hsp83 Heat shock protein 83 "CG1242, CG1242, CG1242, hsp83, 83K HSP, hsp82, 83, Hsp82, E(sev)3A: Enhancer of sevenless 3A, hsp84, l(3)j5C2, E(sina)2, Enhancer of seven in absentia 2, HSP83, Hsp90, clone 2.53, HSP90, hsp90, DMHSP82, HSP82, ms(3)08445, ORF1, en(lz)3C/4C, anon-WO0068693, anon-WO0140519.209, Su(Raf)3A, anon-EST:Liang-2.53, stc, Enhancer of sevenless 3A, scratch, E(sev)3A" CDMC26411 4 2 3 DAC04-H08 23-CG1242-RA_10 CG1242 GCGACCAGTCGAAACAAACAACCAAAATTCATTCTATCACTCGCATTCACATACACAATTTACTTGCGT 69 FBan0001242 FBgn0001233 Hsp83 3 3L "R7 cell fate commitment; GO:0007465; actin filament organization; GO:0007015; centrosome cycle; GO:0007098; defense response; GO:0006952; determination of anterior/posterior axis, embryo; GO:0008595; protein complex assembly; GO:0006461; protein folding; GO:0006457; regulation of cell shape; GO:0008360; regulation of circadian sleep/wake cycle, sleep; GO:0045187; response to heat; GO:0009408; spermatogenesis; GO:0007283; torso signaling pathway; GO:0008293" "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" centrosome; GO:0005813; cytoplasm; GO:0005737 Hsp83 Heat shock protein 83 "CG1242, CG1242, CG1242, hsp83, 83K HSP, hsp82, 83, Hsp82, E(sev)3A: Enhancer of sevenless 3A, hsp84, l(3)j5C2, E(sina)2, Enhancer of seven in absentia 2, HSP83, Hsp90, clone 2.53, HSP90, hsp90, DMHSP82, HSP82, ms(3)08445, ORF1, en(lz)3C/4C, anon-WO0068693, anon-WO0140519.209, Su(Raf)3A, anon-EST:Liang-2.53, stc, Enhancer of sevenless 3A, scratch, E(sev)3A" CDMC26412 4 3 3 DAC04-H20 3-CG12443-RA_4 CG12443 TTGCACCGTCACTCTTCAGCGTGGACAAGAACATCAACAGCAACCTGAACAACACACTAACGGAGGCTT 69 FBan0012443 FBgn0033652 ths 2 2R fibroblast growth factor receptor signaling pathway; GO:0008543; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498 fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104 ths thisbe "CG12443, CG12443, CG12443, CG12443, CG12443, FGF8-like1, fgf8-like, Neu4, DFGF8-1, thisbe" CDMC26412 4 4 3 DAC04-H20 3-CG12443-RA_4 CG12443 TTGCACCGTCACTCTTCAGCGTGGACAAGAACATCAACAGCAACCTGAACAACACACTAACGGAGGCTT 69 FBan0012443 FBgn0033652 ths 2 2R fibroblast growth factor receptor signaling pathway; GO:0008543; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498 fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104 ths thisbe "CG12443, CG12443, CG12443, CG12443, CG12443, FGF8-like1, fgf8-like, Neu4, DFGF8-1, thisbe" CDMC26413 4 5 3 DAC04-L08 23-CG12491-RA_7 CG12491 TCGGCTTAACCCGATCGAACAATGAAATGGTCCAAATTGAAAAATAAATGCATACACAAAAGCAACAAT 69 FBan0012491 FBgn0034900 CG12491 2 2R CG12491 CG12491 CDMC26413 4 6 3 DAC04-L08 23-CG12491-RA_7 CG12491 TCGGCTTAACCCGATCGAACAATGAAATGGTCCAAATTGAAAAATAAATGCATACACAAAAGCAACAAT 69 FBan0012491 FBgn0034900 CG12491 2 2R CG12491 CG12491 CDMC26414 4 7 3 DAC04-L20 8-CG12501-RA_2 CG12501 GCCCACTCGGATATCCAGAACTTGATGCACGAAGCAGATAATCGGGAGATGGAACTTTTGGTCGCCACT 69 FBan0012501 FBgn0034473 Or56a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or56a Odorant receptor 56a "CG12501, CG12501, 56E.1, DOR59, 56a" CDMC26414 4 8 3 DAC04-L20 8-CG12501-RA_2 CG12501 GCCCACTCGGATATCCAGAACTTGATGCACGAAGCAGATAATCGGGAGATGGAACTTTTGGTCGCCACT 69 FBan0012501 FBgn0034473 Or56a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or56a Odorant receptor 56a "CG12501, CG12501, 56E.1, DOR59, 56a" CDMC26415 4 9 3 DAC04-P08 2-CG12546-RA_1 CG12546 GCAACTGGAGAATCAACGTCGACAGATCAACCAGCTGAGCGGATGAAGGTCTTCGGAAAGACTCGGCTT 69 FBan0012546 FBgn0037178 CG12546 3 3L CG12546 CG12546 BcDNA:RE45259 CDMC26415 4 10 3 DAC04-P08 2-CG12546-RA_1 CG12546 GCAACTGGAGAATCAACGTCGACAGATCAACCAGCTGAGCGGATGAAGGTCTTCGGAAAGACTCGGCTT 69 FBan0012546 FBgn0037178 CG12546 3 3L CG12546 CG12546 BcDNA:RE45259 CDMC26416 4 11 3 DAC04-P20 1-CG12564-RA_1 CG12564 CCCCCGATTTACCCCGACTTACCACGATTTTCCTCGATTTCCCTCGATTTCCCTGGATTTCCCCCCATT 69 FBan0012564 FBgn0031179 CG12564 X X CG12564 CG12564 pp-CT34320 CDMC26416 4 12 3 DAC04-P20 1-CG12564-RA_1 CG12564 CCCCCGATTTACCCCGACTTACCACGATTTTCCTCGATTTCCCTCGATTTCCCTGGATTTCCCCCCATT 69 FBan0012564 FBgn0031179 CG12564 X X CG12564 CG12564 pp-CT34320 CDMC26417 4 13 3 DAC05-D08 23-CG5058-RD_11 CG5058 TACCGAATCTATCTATTAGGTGCATCTAACGAAAGGAATCATTAGCTCTGCACGAACTCTAGCCGTAGC 69 FBan0005058 FBgn0004586 grh 2 2R embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; ganglion mother cell fate determination; GO:0007402; membrane organization and biogenesis; GO:0016044; plasma membrane organization and biogenesis; GO:0007009; primary tracheal branching (sensu Insecta); GO:0007428; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube length; GO:0035159; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704 nucleus; GO:0005634 grh grainy head "CG5058, CG5058, Elf-1/NTF-1, NTF-1, Ntf, Neurogenic element binding transcription factor, l(2)06850, grainyhead, elf1, NTF-1/Elf-1, Elf-1, Elf1: Element I binding activity, DREB, decapentaplegic repression element binding protein, elf1(CAG)[[7]], Gh, Grainyhead, EG:191D12.1, NTF1, Ntf1, hsk, l(2)IM45, l(2)s2140, Element I binding activity, head skeleton, Elf1" CDMC26417 4 14 3 DAC05-D08 23-CG5058-RD_11 CG5058 TACCGAATCTATCTATTAGGTGCATCTAACGAAAGGAATCATTAGCTCTGCACGAACTCTAGCCGTAGC 69 FBan0005058 FBgn0004586 grh 2 2R embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; ganglion mother cell fate determination; GO:0007402; membrane organization and biogenesis; GO:0016044; plasma membrane organization and biogenesis; GO:0007009; primary tracheal branching (sensu Insecta); GO:0007428; regulation of cell shape; GO:0008360; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube length; GO:0035159; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704 nucleus; GO:0005634 grh grainy head "CG5058, CG5058, Elf-1/NTF-1, NTF-1, Ntf, Neurogenic element binding transcription factor, l(2)06850, grainyhead, elf1, NTF-1/Elf-1, Elf-1, Elf1: Element I binding activity, DREB, decapentaplegic repression element binding protein, elf1(CAG)[[7]], Gh, Grainyhead, EG:191D12.1, NTF1, Ntf1, hsk, l(2)IM45, l(2)s2140, Element I binding activity, head skeleton, Elf1" CDMC26418 4 15 3 DAC05-D20 2-CG5071-RB_1 CG5071 TGCGTCAGCCCATCGTTCACTGTTACCCCATCTACTTTCTGGACATGGAAATAGCAGGAGAACTGGCCG 69 FBan0005071 FBgn0039347 CG5071 3 3R protein folding; GO:0006457; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 CG5071 CG5071 BcDNA:AT31683 CDMC26418 4 16 3 DAC05-D20 2-CG5071-RB_1 CG5071 TGCGTCAGCCCATCGTTCACTGTTACCCCATCTACTTTCTGGACATGGAAATAGCAGGAGAACTGGCCG 69 FBan0005071 FBgn0039347 CG5071 3 3R protein folding; GO:0006457; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 CG5071 CG5071 BcDNA:AT31683 CDMC26419 4 17 3 DAC05-H08 23-CG5106-RA_1 CG5106 CGATGTAGGCATGGAATGGACTTCGATTGATGGGACAATGGAATTTGATTAATATGTAACATTTTAGTT 69 FBan0005106 FBgn0037879 scpr-C 3 3R scpr-C SCP-containing protein C "CG5106, CG5106, SCPR-C, BEST:CK01680, SCP-containing protein C" CDMC26419 4 18 3 DAC05-H08 23-CG5106-RA_1 CG5106 CGATGTAGGCATGGAATGGACTTCGATTGATGGGACAATGGAATTTGATTAATATGTAACATTTTAGTT 69 FBan0005106 FBgn0037879 scpr-C 3 3R scpr-C SCP-containing protein C "CG5106, CG5106, SCPR-C, BEST:CK01680, SCP-containing protein C" CDMC26420 4 19 3 DAC05-H20 3-CG5118-RA_1 CG5118 CGCTCGCATGATGACCGACCACCTCTACGAGAACTCAAACACAGCTCTTCATCTGGCGGTGATAAACCA 69 FBan0005118 FBgn0031317 CG5118 2 2L CG5118 CG5118 anon-WO0140519.11 CDMC26420 4 20 3 DAC05-H20 3-CG5118-RA_1 CG5118 CGCTCGCATGATGACCGACCACCTCTACGAGAACTCAAACACAGCTCTTCATCTGGCGGTGATAAACCA 69 FBan0005118 FBgn0031317 CG5118 2 2L CG5118 CG5118 anon-WO0140519.11 CDMC26421 4 21 3 DAC05-L08 3-CG5154-RA_2 CG5154 GGCGTGTTTAAGAGGGTATGGGGATCGTTACGTGGCTGGTTTAGTTCCTCATCGGTGGACGAGAAGTCC 69 FBgn0034333 CDMC26421 4 22 3 DAC05-L08 3-CG5154-RA_2 CG5154 GGCGTGTTTAAGAGGGTATGGGGATCGTTACGTGGCTGGTTTAGTTCCTCATCGGTGGACGAGAAGTCC 69 FBgn0034333 CDMC26422 4 23 3 DAC05-L20 23-CG5167-RA_1 CG5167 GTCTGGAAGTGATAAGACATTTCTAGTCAAATCATTATAGTCGCATATCTGTGGACTCTGGAATGGCGG 69 FBan0005167 FBgn0038038 CG5167 3 3R CG5167 CG5167 CDMC26422 4 24 3 DAC05-L20 23-CG5167-RA_1 CG5167 GTCTGGAAGTGATAAGACATTTCTAGTCAAATCATTATAGTCGCATATCTGTGGACTCTGGAATGGCGG 69 FBan0005167 FBgn0038038 CG5167 3 3R CG5167 CG5167 CDMC26423 4 25 3 DAC05-P08 9-CG5195-RA_1 CG5195 ACCACGCCCGATATAACCACCACAACGCCTTTGATGCAGAGGATCGCCACTAGTACAACAAAAGCTTCT 69 FBan0005195 FBgn0036995 CG5195 3 3L DNA replication; GO:0006260; cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 CG5195 CG5195 "CT16609, tartan/capricious-like" CDMC26423 4 26 3 DAC05-P08 9-CG5195-RA_1 CG5195 ACCACGCCCGATATAACCACCACAACGCCTTTGATGCAGAGGATCGCCACTAGTACAACAAAAGCTTCT 69 FBan0005195 FBgn0036995 CG5195 3 3L DNA replication; GO:0006260; cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 CG5195 CG5195 "CT16609, tartan/capricious-like" CDMC26424 4 1 4 DAC05-P20 16-CG5208-RA_1 CG5208 TCTGATTGAAACACTGTATCGCTATCTGCTGAAGTTGGAGGATTTGGAAAGCCCAGAAGTGATGGCCAC 69 FBan0005208 FBgn0028470 CG5208 3 3R CG5208 CG5208 "LD27979, BcDNA:LD27979, anon-WO0118547.282" CDMC26424 4 2 4 DAC05-P20 16-CG5208-RA_1 CG5208 TCTGATTGAAACACTGTATCGCTATCTGCTGAAGTTGGAGGATTTGGAAAGCCCAGAAGTGATGGCCAC 69 FBan0005208 FBgn0028470 CG5208 3 3R CG5208 CG5208 "LD27979, BcDNA:LD27979, anon-WO0118547.282" CDMC26425 4 3 4 DAC06-D08 1-CG9392-RA_1 CG9392 TCGGGACCCATTTTCCTCCATCAAAGGCTCCTGTAAAGACCACACCTAACGTAGCACCACCTTCTGGAA 69 FBan0009392 FBgn0036895 CG9392 3 3L CG9392 CG9392 CDMC26425 4 4 4 DAC06-D08 1-CG9392-RA_1 CG9392 TCGGGACCCATTTTCCTCCATCAAAGGCTCCTGTAAAGACCACACCTAACGTAGCACCACCTTCTGGAA 69 FBan0009392 FBgn0036895 CG9392 3 3L CG9392 CG9392 CDMC26426 4 5 4 DAC06-D20 15-CG9412-RC_5 CG9412 AGTAGTTGGAGCAACATAAAACGTCAACTGTCCTTTAAATGTTCCTGAGCGCAACTCTCGGGGCGTCGA 69 FBan0009412 FBgn0015778 rin 3 3R Ras protein signal transduction; GO:0007265; ommatidial rotation; GO:0016318; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; protein import into nucleus; GO:0006606; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005515; SH3 domain binding; GO:0017124; ; GO:0017124; protein transporter activity; GO:0008565; ; GO:0008565 cytosol; GO:0005829; nucleus; GO:0005634 rin rasputin "CG9412, Nts: Next to squid, Next to squid, rasp, cg9412, Nts, rasputin" CDMC26426 4 6 4 DAC06-D20 15-CG9412-RC_5 CG9412 AGTAGTTGGAGCAACATAAAACGTCAACTGTCCTTTAAATGTTCCTGAGCGCAACTCTCGGGGCGTCGA 69 FBan0009412 FBgn0015778 rin 3 3R Ras protein signal transduction; GO:0007265; ommatidial rotation; GO:0016318; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; protein import into nucleus; GO:0006606; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005515; SH3 domain binding; GO:0017124; ; GO:0017124; protein transporter activity; GO:0008565; ; GO:0008565 cytosol; GO:0005829; nucleus; GO:0005634 rin rasputin "CG9412, Nts: Next to squid, Next to squid, rasp, cg9412, Nts, rasputin" CDMC26427 4 7 4 DAC06-H08 2-CG9437-RA_1 CG9437 AGCAACACGACTACGACGCTAAGCTGGAGTCTCATACCACACAATCGGAGACGTATTCGGTGGTCGTGG 69 FBan0009437 FBgn0034599 CG9437 2 2R DNA binding; GO:0003677; ; GO:0003677 CG9437 CG9437 CDMC26427 4 8 4 DAC06-H08 2-CG9437-RA_1 CG9437 AGCAACACGACTACGACGCTAAGCTGGAGTCTCATACCACACAATCGGAGACGTATTCGGTGGTCGTGG 69 FBan0009437 FBgn0034599 CG9437 2 2R DNA binding; GO:0003677; ; GO:0003677 CG9437 CG9437 CDMC26428 4 9 4 DAC06-H20 3-CG9450-RA_1 CG9450 CCTGCTCCAGTCGTTCATCGACACTCGCTTCTCTGAAACATTCCAGGTAGAGATTCTGGCCACCAAGGG 69 FBan0009450 FBgn0003891 tud 2 2R embryonic development; GO:0009790; germ cell development; GO:0007281; intracellular mRNA localization; GO:0008298; mitochondrial rRNA export from mitochondrion; GO:0019090; pole cell fate determination; GO:0007278; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315 nucleic acid binding; GO:0003676; ; GO:0003676 mitochondrion; GO:0005739; polar granule; GO:0018994 tud tudor "CG9450, tu, tudor" CDMC26428 4 10 4 DAC06-H20 3-CG9450-RA_1 CG9450 CCTGCTCCAGTCGTTCATCGACACTCGCTTCTCTGAAACATTCCAGGTAGAGATTCTGGCCACCAAGGG 69 FBan0009450 FBgn0003891 tud 2 2R embryonic development; GO:0009790; germ cell development; GO:0007281; intracellular mRNA localization; GO:0008298; mitochondrial rRNA export from mitochondrion; GO:0019090; pole cell fate determination; GO:0007278; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315 nucleic acid binding; GO:0003676; ; GO:0003676 mitochondrion; GO:0005739; polar granule; GO:0018994 tud tudor "CG9450, tu, tudor" CDMC26429 4 11 4 DAC06-L08 23-CG9488-RA_1 CG9488 CGAGTTTGAGACAGTTCGGAATTTAAGTGCTGTTATCATACACACCAACAACATGTTTTCCAAAGATGT 69 FBgn0031793 CDMC26429 4 12 4 DAC06-L08 23-CG9488-RA_1 CG9488 CGAGTTTGAGACAGTTCGGAATTTAAGTGCTGTTATCATACACACCAACAACATGTTTTCCAAAGATGT 69 FBgn0031793 CDMC26430 4 13 4 DAC06-L20 2-CG9497-RA_1 CG9497 GGGCGAGAACTACTGCAGTCAAATCTACAGAGTGAAGGTTTCGTTTAAGCGCCCCGATCATCCGGAGCA 69 FBan0009497 FBgn0031800 CG9497 2 2L CG9497 CG9497 CDMC26430 4 14 4 DAC06-L20 2-CG9497-RA_1 CG9497 GGGCGAGAACTACTGCAGTCAAATCTACAGAGTGAAGGTTTCGTTTAAGCGCCCCGATCATCCGGAGCA 69 FBan0009497 FBgn0031800 CG9497 2 2L CG9497 CG9497 CDMC26431 4 15 4 DAC06-P08 2-CG9526-RB_1 CG9526 TCGCACATACAGGGACTACTTTGAGATGCCTTTCAAGACCTACGCTCCAACTGTTGAAGCCACCCTGGA 69 FBan0009526 FBgn0031815 CG9526 2 2L CG9526 CG9526 CT26954 CDMC26431 4 16 4 DAC06-P08 2-CG9526-RB_1 CG9526 TCGCACATACAGGGACTACTTTGAGATGCCTTTCAAGACCTACGCTCCAACTGTTGAAGCCACCCTGGA 69 FBan0009526 FBgn0031815 CG9526 2 2L CG9526 CG9526 CT26954 CDMC26432 4 17 4 DAC06-P20 23-CG9539-RA_6 CG9539 TAACCTGCTTTGTTTTTTTCGTCGTCTGTCAAAACAACCACAGTAAGCGTAAATTGTAAGGCCTTTGGC 69 FBan0009539 FBgn0026571 Sec61alpha 2 2L "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; cell death; GO:0008219; protein secretion; GO:0009306" protein transporter activity; GO:0008565; protein translocase activity; GO:0015450; ; GO:0008565; ; GO:0008565; ; GO:0015450 translocon complex; GO:0005784 Sec61alpha Sec61alpha "CG9539, l(2)k04917, 0455, LD29847, DSec61alpha, endd2, Sec61alpha, sec61, DSec61alpha, Sec61, anon-WO0118547.195, anon-WO0118547.277, BEST:LD29847, BcDNA:LD29847" CDMC26432 4 18 4 DAC06-P20 23-CG9539-RA_6 CG9539 TAACCTGCTTTGTTTTTTTCGTCGTCTGTCAAAACAACCACAGTAAGCGTAAATTGTAAGGCCTTTGGC 69 FBan0009539 FBgn0026571 Sec61alpha 2 2L "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; cell death; GO:0008219; protein secretion; GO:0009306" protein transporter activity; GO:0008565; protein translocase activity; GO:0015450; ; GO:0008565; ; GO:0008565; ; GO:0015450 translocon complex; GO:0005784 Sec61alpha Sec61alpha "CG9539, l(2)k04917, 0455, LD29847, DSec61alpha, endd2, Sec61alpha, sec61, DSec61alpha, Sec61, anon-WO0118547.195, anon-WO0118547.277, BEST:LD29847, BcDNA:LD29847" CDMC26433 4 19 4 DAC07-D08 3-CG6585-RA_1 CG6585 GGTTCAGGCCATTCATTTAGATCCCGCATTGTATCCGGCACCCAACCAGTTTCGTCCAGAACGCTTTCT 69 FBan0006585 FBgn0030949 Cyp308a1 X X electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp308a1 Cyp308a1 "CG6585, 308a1" CDMC26433 4 20 4 DAC07-D08 3-CG6585-RA_1 CG6585 GGTTCAGGCCATTCATTTAGATCCCGCATTGTATCCGGCACCCAACCAGTTTCGTCCAGAACGCTTTCT 69 FBan0006585 FBgn0030949 Cyp308a1 X X electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp308a1 Cyp308a1 "CG6585, 308a1" CDMC26434 4 21 4 DAC07-D20 9-CG6598-RA_2 CG6598 GGCCGACAAGGGTTCGATCCAGAACTACCTGATCGATCTGACCGATGGTGGATTCGATTACACCTTCGA 69 FBan0006598 FBgn0011768 Fdh 3 3R carbohydrate metabolism; GO:0005975 "octanol dehydrogenase activity; GO:0004552 ; EC:1.1.1.73; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; formaldehyde dehydrogenase (glutathione) activity; GO:0004327 ; EC:1.2.1.1; ; GO:0004327 ; EC:1.2.1.1; zinc ion binding; GO:0008270; ; GO:0004022 ; EC:1.1.1.1; ; GO:0004327 ; EC:1.2.1.1; ; GO:0004552 ; EC:1.1.1.73; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Fdh Formaldehyde dehydrogenase "CG6598, CG6598, Odh: Octanol dehydrogenase, ODH, gfd: glutathione-dependent formaldehyde dehydrogenase, odh, ADHX, gfd/odh, glutathione-dependent formaldehyde dehydrogenase, Octanol dehydrogenase, Odh, gfd" CDMC26434 4 22 4 DAC07-D20 9-CG6598-RA_2 CG6598 GGCCGACAAGGGTTCGATCCAGAACTACCTGATCGATCTGACCGATGGTGGATTCGATTACACCTTCGA 69 FBan0006598 FBgn0011768 Fdh 3 3R carbohydrate metabolism; GO:0005975 "octanol dehydrogenase activity; GO:0004552 ; EC:1.1.1.73; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; formaldehyde dehydrogenase (glutathione) activity; GO:0004327 ; EC:1.2.1.1; ; GO:0004327 ; EC:1.2.1.1; zinc ion binding; GO:0008270; ; GO:0004022 ; EC:1.1.1.1; ; GO:0004327 ; EC:1.2.1.1; ; GO:0004552 ; EC:1.1.1.73; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Fdh Formaldehyde dehydrogenase "CG6598, CG6598, Odh: Octanol dehydrogenase, ODH, gfd: glutathione-dependent formaldehyde dehydrogenase, odh, ADHX, gfd/odh, glutathione-dependent formaldehyde dehydrogenase, Octanol dehydrogenase, Odh, gfd" CDMC26435 4 23 4 DAC07-H08 1-CG6628-RA_1 CG6628 TGGTCAGAACTTGGCTTTGGTCAACATAACCCTGCTACCTGAAGACGGAAATCACACCGACGAGTGCCT 69 FBan0006628 FBgn0036072 CG6628 3 3L defense response; GO:0006952 extracellular region; GO:0005576 CG6628 CG6628 CDMC26435 4 24 4 DAC07-H08 1-CG6628-RA_1 CG6628 TGGTCAGAACTTGGCTTTGGTCAACATAACCCTGCTACCTGAAGACGGAAATCACACCGACGAGTGCCT 69 FBan0006628 FBgn0036072 CG6628 3 3L defense response; GO:0006952 extracellular region; GO:0005576 CG6628 CG6628 CDMC26436 4 25 4 DAC07-H20 15-CG6639-RA_2 CG6639 GGCTTGCAAATGGTAGAAGGAATAACCATTGATCAAGCACGACCAGCTCAATATCCCTGGGCTGTTGCT 69 FBan0006639 FBgn0032638 CG6639 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG6639 CG6639 "c-SPH93, SPH93" CDMC26436 4 26 4 DAC07-H20 15-CG6639-RA_2 CG6639 GGCTTGCAAATGGTAGAAGGAATAACCATTGATCAAGCACGACCAGCTCAATATCCCTGGGCTGTTGCT 69 FBan0006639 FBgn0032638 CG6639 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG6639 CG6639 "c-SPH93, SPH93" CDMC26437 4 1 5 DAC07-L08 23-CG6671-RC_11 CG6671 AAAATGCAAGCAAGGCCAGATAAGTTAAGTGGGCAATGAATAACGAGAACTGCAATTTCAACAAGGGAC 69 FBan0006671 FBgn0026611 AGO1 2 2R "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, targeting of mRNA for destruction; GO:0030423; miRNA-mediated gene silencing; GO:0035195; miRNA-mediated gene silencing, mRNA cleavage; GO:0035279; miRNA-mediated gene silencing, production of miRNAs; GO:0035196; synaptogenesis; GO:0007416; translational initiation; GO:0006413" translation initiation factor activity; GO:0003743; enzyme binding; GO:0019899; ; GO:0003743; ; GO:0019899 RNA-induced silencing complex; GO:0016442; eukaryotic translation initiation factor 2 complex; GO:0005850 AGO1 Argonaute 1 "CG6671, l(2)04845, l(2)k00208, l(2)4845, l(2)k08121, dAGO1, ago1-1, ago1, Dm Ago1, Ago-1, dAgo1, Ago, Ago1, anon-WO0257455.29" CDMC26437 4 2 5 DAC07-L08 23-CG6671-RC_11 CG6671 AAAATGCAAGCAAGGCCAGATAAGTTAAGTGGGCAATGAATAACGAGAACTGCAATTTCAACAAGGGAC 69 FBan0006671 FBgn0026611 AGO1 2 2R "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, targeting of mRNA for destruction; GO:0030423; miRNA-mediated gene silencing; GO:0035195; miRNA-mediated gene silencing, mRNA cleavage; GO:0035279; miRNA-mediated gene silencing, production of miRNAs; GO:0035196; synaptogenesis; GO:0007416; translational initiation; GO:0006413" translation initiation factor activity; GO:0003743; enzyme binding; GO:0019899; ; GO:0003743; ; GO:0019899 RNA-induced silencing complex; GO:0016442; eukaryotic translation initiation factor 2 complex; GO:0005850 AGO1 Argonaute 1 "CG6671, l(2)04845, l(2)k00208, l(2)4845, l(2)k08121, dAGO1, ago1-1, ago1, Dm Ago1, Ago-1, dAgo1, Ago, Ago1, anon-WO0257455.29" CDMC26438 4 3 5 DAC07-L20 23-CG6682-RA_16 CG6682 ACGCAAGAATAACAACCCTAACCGTACATCATAATCCCCCAAACCAATTCCAGAACCCATCCCAACTTT 69 FBgn0014015 CDMC26438 4 4 5 DAC07-L20 23-CG6682-RA_16 CG6682 ACGCAAGAATAACAACCCTAACCGTACATCATAATCCCCCAAACCAATTCCAGAACCCATCCCAACTTT 69 FBgn0014015 CDMC26439 4 5 5 DAC07-P08 18-CG6707-RA_1 CG6707 ACCCCGATCTGTGTTGGCAGTCATTAGTTATTAGACCAGCGACCGATCAATCCACAGTGCATCTCATTT 69 FBan0006707 FBgn0036058 CG6707 3 3L CG6707 CG6707 CDMC26439 4 6 5 DAC07-P08 18-CG6707-RA_1 CG6707 ACCCCGATCTGTGTTGGCAGTCATTAGTTATTAGACCAGCGACCGATCAATCCACAGTGCATCTCATTT 69 FBan0006707 FBgn0036058 CG6707 3 3L CG6707 CG6707 CDMC26440 4 7 5 DAC07-P20 23-CG6720-RA_9 CG6720 GCTTAGCAACCGAAAACATTGTAACGAGTCACATTCGATGAAAAACTGCATCATGAATTGCACATTGAC 69 FBan0006720 FBgn0015320 UbcD2 2 2L protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD2 Ubiquitin conjugating enzyme 2 "CG6720, CG6720, l(2)k13206, ubcD2" CDMC26440 4 8 5 DAC07-P20 23-CG6720-RA_9 CG6720 GCTTAGCAACCGAAAACATTGTAACGAGTCACATTCGATGAAAAACTGCATCATGAATTGCACATTGAC 69 FBan0006720 FBgn0015320 UbcD2 2 2L protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD2 Ubiquitin conjugating enzyme 2 "CG6720, CG6720, l(2)k13206, ubcD2" CDMC26441 4 9 5 DAC08-D08 1-CG31873-RA_1 CG31873 GCGAGCCGGTTTTGCATTTAGCTGGATATTCGGTGGAGATCCTTCGGACGAATCACATTGGTCATGCCA 69 FBgn0051873 CDMC26441 4 10 5 DAC08-D08 1-CG31873-RA_1 CG31873 GCGAGCCGGTTTTGCATTTAGCTGGATATTCGGTGGAGATCCTTCGGACGAATCACATTGGTCATGCCA 69 FBgn0051873 CDMC26442 4 11 5 DAC08-D20 16-CG31882-RA_3 CG31882 AGCCCGACAGCTTATTTGGGATATCGTTTCCGATTGGGCAGATAGATATAGGGTCCGCTTTGTGTCAAT 69 FBan0031882 FBgn0051882 CG31882 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31882 CG31882 "bs35a07.y1, NEST:bs35a07" CDMC26442 4 12 5 DAC08-D20 16-CG31882-RA_3 CG31882 AGCCCGACAGCTTATTTGGGATATCGTTTCCGATTGGGCAGATAGATATAGGGTCCGCTTTGTGTCAAT 69 FBan0031882 FBgn0051882 CG31882 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31882 CG31882 "bs35a07.y1, NEST:bs35a07" CDMC26443 4 13 5 DAC08-H08 4-CG31916-RA_1 CG31916 GCCAGCTAGTGTGGATGCACATTTGGCTGACGATTTGTTCGATGGATTGAAACGTGTTGATGTCGCCGG 69 FBgn0047188 CDMC26443 4 14 5 DAC08-H08 4-CG31916-RA_1 CG31916 GCCAGCTAGTGTGGATGCACATTTGGCTGACGATTTGTTCGATGGATTGAAACGTGTTGATGTCGCCGG 69 FBgn0047188 CDMC26444 4 15 5 DAC08-H20 2-CG31924-RB_2 CG31924 GGCGGGTTCTAGGCAGTGCTCTTTTCAGCCAGTTACCCATTGCATTTTCGAACTCGATGGTCTGCTGAT 69 FBan0031924 FBgn0051924 CG31924 2 2L metabolism; GO:0008152 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG31924 CG31924 "CG5564, CG5564, BcDNA:AT29272" CDMC26444 4 16 5 DAC08-H20 2-CG31924-RB_2 CG31924 GGCGGGTTCTAGGCAGTGCTCTTTTCAGCCAGTTACCCATTGCATTTTCGAACTCGATGGTCTGCTGAT 69 FBan0031924 FBgn0051924 CG31924 2 2L metabolism; GO:0008152 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG31924 CG31924 "CG5564, CG5564, BcDNA:AT29272" CDMC26445 4 17 5 DAC08-L08 2-CG31975-RA_3 CG31975 GGTCCCGCCTCCTTAATTATCACACAAGCAGTCTGACGAAACCGGGCGATAACTACGGAAGCGTTCTCC 69 FBan0031975 FBgn0051975 CG31975 2 2L CG31975 CG31975 CG18501 CDMC26445 4 18 5 DAC08-L08 2-CG31975-RA_3 CG31975 GGTCCCGCCTCCTTAATTATCACACAAGCAGTCTGACGAAACCGGGCGATAACTACGGAAGCGTTCTCC 69 FBan0031975 FBgn0051975 CG31975 2 2L CG31975 CG31975 CG18501 CDMC26446 4 19 5 DAC08-L20 8-CG31991-RB_1 CG31991 GGTCCCCGAATGGGCAATATAATCGTGTGGGCTTCCATTATTCTTGGTCAGCCTCTGTGCATAATGGCC 69 FBan0031991 FBgn0004797 mdy 2 2L aspartyl-tRNA aminoacylation; GO:0006422; cholesterol metabolism; GO:0008203; lysyl-tRNA aminoacylation; GO:0006430; oogenesis (sensu Insecta); GO:0009993; regulation of nurse cell apoptosis; GO:0045477; tRNA aminoacylation for protein translation; GO:0006418; triacylglycerol biosynthesis; GO:0019432 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; diacylglycerol O-acyltransferase activity; GO:0004144 ; EC:2.3.1.20; sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; ; GO:0004144 ; EC:2.3.1.20; ; GO:0003676; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004144 ; EC:2.3.1.20; ; GO:0004772 ; EC:2.3.1.26; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0004812 ; EC:6.1.1.-; lysine-tRNA ligase activity; GO:0004824 ; EC:6.1.1.6; ; GO:0004815 ; EC:6.1.1.12; ; GO:0004824 ; EC:6.1.1.6; ; GO:0004144 ; EC:2.3.1.20 cytoplasm; GO:0005737 mdy midway "CG17938, CG31991, CG13273, CG17937, CG17938, CT39962" CDMC26446 4 20 5 DAC08-L20 8-CG31991-RB_1 CG31991 GGTCCCCGAATGGGCAATATAATCGTGTGGGCTTCCATTATTCTTGGTCAGCCTCTGTGCATAATGGCC 69 FBan0031991 FBgn0004797 mdy 2 2L aspartyl-tRNA aminoacylation; GO:0006422; cholesterol metabolism; GO:0008203; lysyl-tRNA aminoacylation; GO:0006430; oogenesis (sensu Insecta); GO:0009993; regulation of nurse cell apoptosis; GO:0045477; tRNA aminoacylation for protein translation; GO:0006418; triacylglycerol biosynthesis; GO:0019432 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; diacylglycerol O-acyltransferase activity; GO:0004144 ; EC:2.3.1.20; sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; ; GO:0004144 ; EC:2.3.1.20; ; GO:0003676; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004144 ; EC:2.3.1.20; ; GO:0004772 ; EC:2.3.1.26; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0004812 ; EC:6.1.1.-; lysine-tRNA ligase activity; GO:0004824 ; EC:6.1.1.6; ; GO:0004815 ; EC:6.1.1.12; ; GO:0004824 ; EC:6.1.1.6; ; GO:0004144 ; EC:2.3.1.20 cytoplasm; GO:0005737 mdy midway "CG17938, CG31991, CG13273, CG17937, CG17938, CT39962" CDMC26447 4 21 5 DAC08-P08 17-CG32027-RA_1 CG32027 TGAAAACGGGAACTGCTGTGCCATTTAGACCAAACTGGCAACCTGTTACATATTTCAGCCACGTTAGCC 69 FBan0032027 FBgn0052027 CG32027 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32027 CG32027 BcDNA:RE02231 CDMC26447 4 22 5 DAC08-P08 17-CG32027-RA_1 CG32027 TGAAAACGGGAACTGCTGTGCCATTTAGACCAAACTGGCAACCTGTTACATATTTCAGCCACGTTAGCC 69 FBan0032027 FBgn0052027 CG32027 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32027 CG32027 BcDNA:RE02231 CDMC26448 4 23 5 DAC08-P20 12-CG32037-RA_1 CG32037 TCCCATTCCCATGTTTGCAAGCCATTCGTATCCAGCCCATGCACCGTGAAAAAATGTGGTCACAATTGA 69 FBan0032037 FBgn0052037 CG32037 3 3L CG32037 CG32037 "CG3426, CG3426" CDMC26448 4 24 5 DAC08-P20 12-CG32037-RA_1 CG32037 TCCCATTCCCATGTTTGCAAGCCATTCGTATCCAGCCCATGCACCGTGAAAAAATGTGGTCACAATTGA 69 FBan0032037 FBgn0052037 CG32037 3 3L CG32037 CG32037 "CG3426, CG3426" CDMC26449 4 25 5 DAC09-D09 1-CG5441-RA_1 CG5441 ATACCTCCGATGGGGATTCCCTCTCCTGTCTAAGTCCCGGCTATGGAAGTCTACTCACTGGCAGC 65 FBan0005441 FBgn0008649 dei 3 3R mesoderm development; GO:0007498; muscle attachment; GO:0016203; somatic muscle development; GO:0007525 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700 nucleus; GO:0005634 dei delilah "CG5441, CG5441, del, Delilah, delilah" CDMC26449 4 26 5 DAC09-D09 1-CG5441-RA_1 CG5441 ATACCTCCGATGGGGATTCCCTCTCCTGTCTAAGTCCCGGCTATGGAAGTCTACTCACTGGCAGC 65 FBan0005441 FBgn0008649 dei 3 3R mesoderm development; GO:0007498; muscle attachment; GO:0016203; somatic muscle development; GO:0007525 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700 nucleus; GO:0005634 dei delilah "CG5441, CG5441, del, Delilah, delilah" CDMC26450 4 1 6 DAC09-D21 3-CG5507-RA_1 CG5507 CATTTGCGTGCACATTCCGACAGGCCATCATCGACTTCGACAAGCTAACTGGGAGGCCGTTTAGC 65 FBan0005507 FBgn0004359 T48 3 3R T48 Transcript 48 "CG5507, anon-97D, t48, 48, '48' transcript, Ubx-t48, transcript-48" CDMC26450 4 2 6 DAC09-D21 3-CG5507-RA_1 CG5507 CATTTGCGTGCACATTCCGACAGGCCATCATCGACTTCGACAAGCTAACTGGGAGGCCGTTTAGC 65 FBan0005507 FBgn0004359 T48 3 3R T48 Transcript 48 "CG5507, anon-97D, t48, 48, '48' transcript, Ubx-t48, transcript-48" CDMC26451 4 3 6 DAC09-H09 3-CG5629-RA_1 CG5629 ATCTTGATCGGGATCCATATTGCGTGACCAGCTCGCATTATTGCCGTGTTCTGAATCCGGGCACG 65 FBan0005629 FBgn0027595 CG5629 3 3R CG5629 CG5629 "GH03502, anon-WO0118547.401, BcDNA:GH03502" CDMC26451 4 4 6 DAC09-H09 3-CG5629-RA_1 CG5629 ATCTTGATCGGGATCCATATTGCGTGACCAGCTCGCATTATTGCCGTGTTCTGAATCCGGGCACG 65 FBan0005629 FBgn0027595 CG5629 3 3R CG5629 CG5629 "GH03502, anon-WO0118547.401, BcDNA:GH03502" CDMC26452 4 5 6 DAC09-H21 12-CG5657-RA_2 CG5657 CAGGGCATGGAGGTGATACCCGAGGTGGATTTGGTGAAGTTCTACGGTACCACGGACTTGGAGCG 65 FBan0005657 FBgn0038042 Scgbeta 3 3R cytoskeleton organization and biogenesis; GO:0007010; muscle contraction; GO:0006936 structural constituent of muscle; GO:0008307; ; GO:0008307 integral to membrane; GO:0016021; sarcoglycan complex; GO:0016012 Scgbeta Sarcoglycan beta "CG5657, CG5657, DmSCG-beta, Scgbeta, Sarcoglycan beta" CDMC26452 4 6 6 DAC09-H21 12-CG5657-RA_2 CG5657 CAGGGCATGGAGGTGATACCCGAGGTGGATTTGGTGAAGTTCTACGGTACCACGGACTTGGAGCG 65 FBan0005657 FBgn0038042 Scgbeta 3 3R cytoskeleton organization and biogenesis; GO:0007010; muscle contraction; GO:0006936 structural constituent of muscle; GO:0008307; ; GO:0008307 integral to membrane; GO:0016021; sarcoglycan complex; GO:0016012 Scgbeta Sarcoglycan beta "CG5657, CG5657, DmSCG-beta, Scgbeta, Sarcoglycan beta" CDMC26453 4 7 6 DAC09-L09 3-CG5789-RA_1 CG5789 GGGGAATCGGAAGCACTGAAGAAGACGGCCAGTGACAGCCACAAAAGAATGCAAAGAGAACGGGA 65 FBan0005789 FBgn0039207 CG5789 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0003677; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; nucleus; GO:0005634 CG5789 CG5789 CDMC26453 4 8 6 DAC09-L09 3-CG5789-RA_1 CG5789 GGGGAATCGGAAGCACTGAAGAAGACGGCCAGTGACAGCCACAAAAGAATGCAAAGAGAACGGGA 65 FBan0005789 FBgn0039207 CG5789 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0003677; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; nucleus; GO:0005634 CG5789 CG5789 CDMC26454 4 9 6 DAC09-L21 1-CG5832-RA_3 CG5832 CAATAATAACAACAGCAACACCACTGCCAGCTCGAACCAAGCCAGCAAATCGCCCTCTCACCACC 65 FBan0005832 FBgn0014858 Hmx 3 3R mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hmx H6-like-homeobox "CG5832, CG5832, CG5832" CDMC26454 4 10 6 DAC09-L21 1-CG5832-RA_3 CG5832 CAATAATAACAACAGCAACACCACTGCCAGCTCGAACCAAGCCAGCAAATCGCCCTCTCACCACC 65 FBan0005832 FBgn0014858 Hmx 3 3R mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hmx H6-like-homeobox "CG5832, CG5832, CG5832" CDMC26455 4 11 6 DAC09-P09 3-CG5953-RB_8 CG5953 ATGTGTCCCTCAAACTGCGGACCATGGATCGCACGCAACGAATCATTGCGGAGAAGCTAATCAGC 65 FBan0005953 FBgn0032587 CG5953 2 2L CG5953 CG5953 CDMC26455 4 12 6 DAC09-P09 3-CG5953-RB_8 CG5953 ATGTGTCCCTCAAACTGCGGACCATGGATCGCACGCAACGAATCATTGCGGAGAAGCTAATCAGC 65 FBan0005953 FBgn0032587 CG5953 2 2L CG5953 CG5953 CDMC26456 4 13 6 DAC09-P21 AutoBlank AutoBlank CDMC26456 4 14 6 DAC09-P21 AutoBlank AutoBlank CDMC26457 4 15 6 DAC10-D08 24-CG6544-RB_4 CG6544 ACTCTCAAAGCATCCAAATCTAAAAATCTCAACATGGTTTACGAAAGTGGATTTACGACCCGCAG 65 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC26457 4 16 6 DAC10-D08 24-CG6544-RB_4 CG6544 ACTCTCAAAGCATCCAAATCTAAAAATCTCAACATGGTTTACGAAAGTGGATTTACGACCCGCAG 65 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC26458 4 17 6 DAC10-D20 23-CG6611-RC_4 CG6611 CCCATCTGCAGCTGTAATTAGTTAGGATCTGGTGCTTAACCATTGTAATTGTGCATTTCTTACCT 65 FBan0006611 FBgn0000451 ect 3 3L ect ectodermal "CG6611, CG11965, Difl, DROECT, Ifl, Interferon-like protein" CDMC26458 4 18 6 DAC10-D20 23-CG6611-RC_4 CG6611 CCCATCTGCAGCTGTAATTAGTTAGGATCTGGTGCTTAACCATTGTAATTGTGCATTTCTTACCT 65 FBan0006611 FBgn0000451 ect 3 3L ect ectodermal "CG6611, CG11965, Difl, DROECT, Ifl, Interferon-like protein" CDMC26459 4 19 6 DAC10-H08 14-CG6721-RB_1 CG6721 CCGCGGGCCATTATCACGACCAGGTAAAGGAATACGCATCGATGTGGCAAACACAACCCCCTACC 65 FBan0006721 FBgn0004390 Gap1 3 3L "MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; negative regulation of Ras protein signal transduction; GO:0046580; sister chromatid cohesion; GO:0007062; torso signaling pathway; GO:0008293" Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099; ; GO:0005099 plasma membrane; GO:0005886 Gap1 GTPase-activating protein 1 "CG6721, CG6721, CG6721, mip: more inner photoreceptors, rI533, more inner photoreceptors, sxt: sextra, seven extra, sextra, gap1, rasGAP, Gap, gap, GAP, GAP1, Ras-GAP, mip, sxt" CDMC26459 4 20 6 DAC10-H08 14-CG6721-RB_1 CG6721 CCGCGGGCCATTATCACGACCAGGTAAAGGAATACGCATCGATGTGGCAAACACAACCCCCTACC 65 FBan0006721 FBgn0004390 Gap1 3 3L "MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; negative regulation of Ras protein signal transduction; GO:0046580; sister chromatid cohesion; GO:0007062; torso signaling pathway; GO:0008293" Ras GTPase activator activity; GO:0005099; ; GO:0005099; ; GO:0005099; ; GO:0005099 plasma membrane; GO:0005886 Gap1 GTPase-activating protein 1 "CG6721, CG6721, CG6721, mip: more inner photoreceptors, rI533, more inner photoreceptors, sxt: sextra, seven extra, sextra, gap1, rasGAP, Gap, gap, GAP, GAP1, Ras-GAP, mip, sxt" CDMC26460 4 21 6 DAC10-H20 3-CG6753-RA_1 CG6753 AAGCAGCTGATGCACTACTTCCAGGGCTATGTGTCCACCAGATTCCGGCAGTATGACTACGGTCC 65 FBan0006753 FBgn0038070 CG6753 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6753 CG6753 CDMC26460 4 22 6 DAC10-H20 3-CG6753-RA_1 CG6753 AAGCAGCTGATGCACTACTTCCAGGGCTATGTGTCCACCAGATTCCGGCAGTATGACTACGGTCC 65 FBan0006753 FBgn0038070 CG6753 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6753 CG6753 CDMC26461 4 23 6 DAC10-L08 23-CG6846-RA_1 CG6846 TTTTTACCGTAACGCTTAGTGTAAAAAACAAAACATCTGAAAAAAATCGCGTGTGAAAACGGCGC 65 FBan0006846 FBgn0036825 RpL26 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL26 Ribosomal protein L26 "CG6846, Ribosomal protein L26" CDMC26461 4 24 6 DAC10-L08 23-CG6846-RA_1 CG6846 TTTTTACCGTAACGCTTAGTGTAAAAAACAAAACATCTGAAAAAAATCGCGTGTGAAAACGGCGC 65 FBan0006846 FBgn0036825 RpL26 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL26 Ribosomal protein L26 "CG6846, Ribosomal protein L26" CDMC26462 4 25 6 DAC10-L20 2-CG6879-RA_3 CG6879 CAGCCCATTTTCCGGATCAAGTTCCGCCCAAAGACCACATCAACAGACATTCTACGGACGGAGCC 65 FBan0006879 FBgn0039222 CG6879 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6879 CG6879 CDMC26462 4 26 6 DAC10-L20 2-CG6879-RA_3 CG6879 CAGCCCATTTTCCGGATCAAGTTCCGCCCAAAGACCACATCAACAGACATTCTACGGACGGAGCC 65 FBan0006879 FBgn0039222 CG6879 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6879 CG6879 CDMC26463 4 1 7 DAC10-P08 12-CG6982-RA_2 CG6982 CCGACCACGACGATTGAGACCATCACAATCACGAGGCCGCTGAAGGTGATTGCATTTATCTGCGG 65 FBan0006982 FBgn0039014 CG6982 3 3R establishment and/or maintenance of cell polarity; GO:0007163 structural molecule activity; GO:0005198; ; GO:0005198 membrane; GO:0016020; tight junction; GO:0005923 CG6982 CG6982 CDMC26463 4 2 7 DAC10-P08 12-CG6982-RA_2 CG6982 CCGACCACGACGATTGAGACCATCACAATCACGAGGCCGCTGAAGGTGATTGCATTTATCTGCGG 65 FBan0006982 FBgn0039014 CG6982 3 3R establishment and/or maintenance of cell polarity; GO:0007163 structural molecule activity; GO:0005198; ; GO:0005198 membrane; GO:0016020; tight junction; GO:0005923 CG6982 CG6982 CDMC26464 4 3 7 DAC10-P20 AutoBlank AutoBlank CDMC26464 4 4 7 DAC10-P20 AutoBlank AutoBlank CDMC26465 4 5 7 DAC11-D08 17-CG10021-RD_1 CG10021 TGCACCACCGAGAAGAACAGGGTTCAGCATTGAGGACATAATGAGGCGTTAGAAGTAAACCGAGAAAGA 69 FBan0010021 FBgn0004893 bowl 2 2L cell proliferation; GO:0008283; hindgut morphogenesis; GO:0007442; leg joint morphogenesis (sensu Endopterygota); GO:0016348; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 bowl brother of odd with entrails limited "CG10021, Su(tor)2-1, l(2)c, bowel, 17-29-5, Bowl, org2: odd skipped-related 2, odd skipped-related 2" CDMC26465 4 6 7 DAC11-D08 17-CG10021-RD_1 CG10021 TGCACCACCGAGAAGAACAGGGTTCAGCATTGAGGACATAATGAGGCGTTAGAAGTAAACCGAGAAAGA 69 FBan0010021 FBgn0004893 bowl 2 2L cell proliferation; GO:0008283; hindgut morphogenesis; GO:0007442; leg joint morphogenesis (sensu Endopterygota); GO:0016348; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 bowl brother of odd with entrails limited "CG10021, Su(tor)2-1, l(2)c, bowel, 17-29-5, Bowl, org2: odd skipped-related 2, odd skipped-related 2" CDMC26466 4 7 7 DAC11-D20 23-CG10037-RA_3 CG10037 AGTTCCACGTTAGACAAGCTCGACTGTATGCAAATCTTTAAAGAATAGAAATAAGATGAGGTCCGTCGA 69 FBan0010037 FBgn0003995 vvl 3 3L "dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425" DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0003702 nucleus; GO:0005634 vvl ventral veins lacking "CG10037, PRD gene 3, Cf1a: Chorion factor 1a, ut, u-turn, dfr: drifter, drifter, Cf1-a, DFR, drf, Cf1a/drifter, Drifter, Cfla, dfr/vvl, dfr-vvl, VVL, Dfr/Vvl, Drifter/Ventral veinless, Vv1, U-turn, prd3, paired-like 3, dfr, Cf1a" CDMC26466 4 8 7 DAC11-D20 23-CG10037-RA_3 CG10037 AGTTCCACGTTAGACAAGCTCGACTGTATGCAAATCTTTAAAGAATAGAAATAAGATGAGGTCCGTCGA 69 FBan0010037 FBgn0003995 vvl 3 3L "dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425" DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0003702 nucleus; GO:0005634 vvl ventral veins lacking "CG10037, PRD gene 3, Cf1a: Chorion factor 1a, ut, u-turn, dfr: drifter, drifter, Cf1-a, DFR, drf, Cf1a/drifter, Drifter, Cfla, dfr/vvl, dfr-vvl, VVL, Dfr/Vvl, Drifter/Ventral veinless, Vv1, U-turn, prd3, paired-like 3, dfr, Cf1a" CDMC26467 4 9 7 DAC11-H08 23-CG10071-RB_2 CG10071 GCGTTTTTCCAATTGGCTATTTTTATTTATAATATCTTCAATTGCAGCTAGGAATTCCAGTGTGCGAAA 69 FBan0010071 FBgn0016726 RpL29 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL29 Ribosomal protein L29 "CG10071, CG10071, DL43, 60S ribosomal protein L43, anon-EST:Posey204, BcDNA:RH58777, RpL43, anon-EST:Posey73" CDMC26467 4 10 7 DAC11-H08 23-CG10071-RB_2 CG10071 GCGTTTTTCCAATTGGCTATTTTTATTTATAATATCTTCAATTGCAGCTAGGAATTCCAGTGTGCGAAA 69 FBan0010071 FBgn0016726 RpL29 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL29 Ribosomal protein L29 "CG10071, CG10071, DL43, 60S ribosomal protein L43, anon-EST:Posey204, BcDNA:RH58777, RpL43, anon-EST:Posey73" CDMC26468 4 11 7 DAC11-H20 13-CG10077-RA_1 CG10077 GCCCTGCGGTTCGATAGAGGCTACCAGATTGTAGACCAGCTCTACTGTAATTTCCTTTCCCCACACGAA 69 FBan0010077 FBgn0035720 CG10077 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10077 CG10077 "cg10077, p90, DmRH5, BcDNA:HL07910, BcDNA:HL01868" CDMC26468 4 12 7 DAC11-H20 13-CG10077-RA_1 CG10077 GCCCTGCGGTTCGATAGAGGCTACCAGATTGTAGACCAGCTCTACTGTAATTTCCTTTCCCCACACGAA 69 FBan0010077 FBgn0035720 CG10077 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG10077 CG10077 "cg10077, p90, DmRH5, BcDNA:HL07910, BcDNA:HL01868" CDMC26469 4 13 7 DAC11-L08 2-CG10107-RB_3 CG10107 CCCATCAATGAGCAGTCGCATTGGTTCCTCGCCATCATTTGCTACCCGAACTTAAAAGGACCCGTCACG 69 FBan0010107 FBgn0035713 CG10107 3 3L proteolysis; GO:0006508 cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- CG10107 CG10107 CDMC26469 4 14 7 DAC11-L08 2-CG10107-RB_3 CG10107 CCCATCAATGAGCAGTCGCATTGGTTCCTCGCCATCATTTGCTACCCGAACTTAAAAGGACCCGTCACG 69 FBan0010107 FBgn0035713 CG10107 3 3L proteolysis; GO:0006508 cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- CG10107 CG10107 CDMC26470 4 15 7 DAC11-L20 23-CG10118-RB_12 CG10118 CTGGGAAAGCAAAGTTCAGATACATCCGCACTTAGTAGGCAAAGTACCACACAAAAACCGATTGTATAC 69 FBan0010118 FBgn0005626 ple 3 3L adult locomotory behavior; GO:0008344; amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; catecholamine biosynthesis; GO:0042423; catecholamine metabolism; GO:0006584; courtship behavior; GO:0007619; pigmentation during development; GO:0048066; regulation of dopamine metabolism; GO:0042053; signal transduction; GO:0007165 tyrosine 3-monooxygenase activity; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; iron ion binding; GO:0005506; ; GO:0005506 cellular component unknown; GO:0008372 ple pale "CG10118, CG10118, DTH, Drosophila tyrosine hydroxylase, TH, DH65B, VII, XBB70 Group VII, Th: Tyrosine-3-hydroxylase, tyrosine hydroxylase, Pale, Tyrosine Hydroxylase, dTH65B, Tyrosine-3-hydroxylase, pale, Th" CDMC26470 4 16 7 DAC11-L20 23-CG10118-RB_12 CG10118 CTGGGAAAGCAAAGTTCAGATACATCCGCACTTAGTAGGCAAAGTACCACACAAAAACCGATTGTATAC 69 FBan0010118 FBgn0005626 ple 3 3L adult locomotory behavior; GO:0008344; amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; catecholamine biosynthesis; GO:0042423; catecholamine metabolism; GO:0006584; courtship behavior; GO:0007619; pigmentation during development; GO:0048066; regulation of dopamine metabolism; GO:0042053; signal transduction; GO:0007165 tyrosine 3-monooxygenase activity; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; ; GO:0004511 ; EC:1.14.16.2; iron ion binding; GO:0005506; ; GO:0005506 cellular component unknown; GO:0008372 ple pale "CG10118, CG10118, DTH, Drosophila tyrosine hydroxylase, TH, DH65B, VII, XBB70 Group VII, Th: Tyrosine-3-hydroxylase, tyrosine hydroxylase, Pale, Tyrosine Hydroxylase, dTH65B, Tyrosine-3-hydroxylase, pale, Th" CDMC26471 4 17 7 DAC11-P08 2-CG10145-RA_1 CG10145 ACAGAACCTCAGGGCGTCATCTATCGGATCACCTCGCGTTATCCTGGACATCCTGCGGGTAGCTTTTAT 69 FBan0010145 FBgn0020269 mspo 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578 mspo M-spondin "CG10145, m-spondin, CT28539, M-spondin" CDMC26471 4 18 7 DAC11-P08 2-CG10145-RA_1 CG10145 ACAGAACCTCAGGGCGTCATCTATCGGATCACCTCGCGTTATCCTGGACATCCTGCGGGTAGCTTTTAT 69 FBan0010145 FBgn0020269 mspo 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578 mspo M-spondin "CG10145, m-spondin, CT28539, M-spondin" CDMC26472 4 19 7 DAC11-P20 3-CG10165-RB_1 CG10165 AGGCGGTTTTGTCAACTATTTCCAGCCCAAGTTCGCCCTGAAAGTAATGCCTCCATCAGAGCTTCGCTT 69 FBan0010165 FBgn0032801 CG10165 2 2L CG10165 CG10165 CDMC26472 4 20 7 DAC11-P20 3-CG10165-RB_1 CG10165 AGGCGGTTTTGTCAACTATTTCCAGCCCAAGTTCGCCCTGAAAGTAATGCCTCCATCAGAGCTTCGCTT 69 FBan0010165 FBgn0032801 CG10165 2 2L CG10165 CG10165 CDMC26473 4 21 7 DAC12-D08 2-CG30115-RC_4 CG30115 ACGCAGGATCAGTATTACAGCCCAGATCACGAGACGGAACTACTGTCCCCAGCAGAGAAGTCAAAGCGA 69 FBan0030115 FBgn0050115 CG30115 2 2R signal transduction; GO:0007165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30115 CG30115 "CG18430, CG5503" CDMC26473 4 22 7 DAC12-D08 2-CG30115-RC_4 CG30115 ACGCAGGATCAGTATTACAGCCCAGATCACGAGACGGAACTACTGTCCCCAGCAGAGAAGTCAAAGCGA 69 FBan0030115 FBgn0050115 CG30115 2 2R signal transduction; GO:0007165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30115 CG30115 "CG18430, CG5503" CDMC26474 4 23 7 DAC12-D20 23-CG30122-RB_3 CG30122 ATGACAGTGACGAAGCAATTGAATGAAACGCGGTCTTTACTCTGGCACTACGTATCTAGGCAGTACAAC 69 FBan0030122 FBgn0050122 CG30122 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG30122 CG30122 "CG18610, CG5477, CG18610, LD11002" CDMC26474 4 24 7 DAC12-D20 23-CG30122-RB_3 CG30122 ATGACAGTGACGAAGCAATTGAATGAAACGCGGTCTTTACTCTGGCACTACGTATCTAGGCAGTACAAC 69 FBan0030122 FBgn0050122 CG30122 2 2R RNA elongation from RNA polymerase II promoter; GO:0006368 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG30122 CG30122 "CG18610, CG5477, CG18610, LD11002" CDMC26475 4 25 7 DAC12-H08 16-CG30161-RA_1 CG30161 CTGAGCAATCCAGAAATTAGGTATAGAGACTGGGATTCCAAGCCTGCACAAGAAATCCTTCCGAAGGCC 69 FBan0030161 FBgn0050161 CG30161 2 2R CG30161 CG30161 "CG4856, BcDNA:AT15604" CDMC26475 4 26 7 DAC12-H08 16-CG30161-RA_1 CG30161 CTGAGCAATCCAGAAATTAGGTATAGAGACTGGGATTCCAAGCCTGCACAAGAAATCCTTCCGAAGGCC 69 FBan0030161 FBgn0050161 CG30161 2 2R CG30161 CG30161 "CG4856, BcDNA:AT15604" CDMC26476 4 1 8 DAC12-H20 1-CG30172-RA_1 CG30172 ACAGGCTCAAAAAGCGCAAAAGCTGACCACATTTCTGCAAACTAGATACCCGGACGTATGGGCCATGCT 69 FBan0030172 FBgn0050172 CG30172 2 2R CG30172 CG30172 "BcDNA:RH70879, anon-AE003462.1" CDMC26476 4 2 8 DAC12-H20 1-CG30172-RA_1 CG30172 ACAGGCTCAAAAAGCGCAAAAGCTGACCACATTTCTGCAAACTAGATACCCGGACGTATGGGCCATGCT 69 FBan0030172 FBgn0050172 CG30172 2 2R CG30172 CG30172 "BcDNA:RH70879, anon-AE003462.1" CDMC26477 4 3 8 DAC12-L08 7-CG3021-RA_1 CG3021 ACCATTGGTGGACTGTCAGCTGAGCATCTCTCCCAGTAACACTTTTCTTGTCGAGTTGGACGCTCCTTT 69 FBan0003021 FBgn0040337 CG3021 X X tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 nucleic acid binding; GO:0003676; tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity; GO:0004808 ; EC:2.1.1.61; ; GO:0003676; ; GO:0004808 ; EC:2.1.1.61 cytoplasm; GO:0005737 CG3021 CG3021 "E, Transcription unit E, EG:BACR7A4.8, anon-1Ed" CDMC26477 4 4 8 DAC12-L08 7-CG3021-RA_1 CG3021 ACCATTGGTGGACTGTCAGCTGAGCATCTCTCCCAGTAACACTTTTCTTGTCGAGTTGGACGCTCCTTT 69 FBan0003021 FBgn0040337 CG3021 X X tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 nucleic acid binding; GO:0003676; tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity; GO:0004808 ; EC:2.1.1.61; ; GO:0003676; ; GO:0004808 ; EC:2.1.1.61 cytoplasm; GO:0005737 CG3021 CG3021 "E, Transcription unit E, EG:BACR7A4.8, anon-1Ed" CDMC26478 4 5 8 DAC12-L20 6-CG30268-RA_4 CG30268 GCAAGGCTCAGAACATCATATATGTGCAGCCTCATGTGCCGATAGTAATGGAGGACCTGGGCATTCCCG 69 FBan0030268 FBgn0050268 CG30268 2 2R CG30268 CG30268 CG13520 CDMC26478 4 6 8 DAC12-L20 6-CG30268-RA_4 CG30268 GCAAGGCTCAGAACATCATATATGTGCAGCCTCATGTGCCGATAGTAATGGAGGACCTGGGCATTCCCG 69 FBan0030268 FBgn0050268 CG30268 2 2R CG30268 CG30268 CG13520 CDMC26479 4 7 8 DAC12-P08 23-CG30295-RA_11 CG30295 TGAGGCTGCTAGTACGACAAGTCGCAACGTGAATCAGAATGAAAGCCAAAAACTGAATCGAAATGAGCC 69 FBan0030295 FBgn0050295 Ipk1 2 2R inositol and derivative phosphorylation; GO:0046853 inositol pentakisphosphate 2-kinase activity; GO:0035299; ; GO:0035299 Ipk1 Ipk1 "CG30295, CG15228, CG15229, CG15230, CG30295, dmIpk1" CDMC26479 4 8 8 DAC12-P08 23-CG30295-RA_11 CG30295 TGAGGCTGCTAGTACGACAAGTCGCAACGTGAATCAGAATGAAAGCCAAAAACTGAATCGAAATGAGCC 69 FBan0030295 FBgn0050295 Ipk1 2 2R inositol and derivative phosphorylation; GO:0046853 inositol pentakisphosphate 2-kinase activity; GO:0035299; ; GO:0035299 Ipk1 Ipk1 "CG30295, CG15228, CG15229, CG15230, CG30295, dmIpk1" CDMC26480 4 9 8 DAC12-P20 2-CG30329-RA_1 CG30329 TCGGAAAGCAGATCTCATTCTGGTGGTCATTCCGCAGATGATCTTCATGCTGTGCCTCTTCGGCTACCT 69 FBgn0050329 CDMC26480 4 10 8 DAC12-P20 2-CG30329-RA_1 CG30329 TCGGAAAGCAGATCTCATTCTGGTGGTCATTCCGCAGATGATCTTCATGCTGTGCCTCTTCGGCTACCT 69 FBgn0050329 CDMC26481 4 11 8 DAC13-D08 6-CG13263-RA_2 CG13263 GGCTTCCAAGATGGGTTCTGGTGATGCAGAGAACGGCAAGAAGATATTTGTGCAGAAGTGCGCCC 65 FBan0013263 FBgn0000408 Cyt-c-d 2 2L caspase activation; GO:0006919; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; sperm individualization; GO:0007291 "electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; GO:0045155; ; GO:0005489; ; GO:0045155" mitochondrial inner membrane; GO:0005743; mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Cyt-c-d Cytochrome c distal "CG13263, DC3, pDMc02, CytC1, cytochrome c, cyt.c, Cytochrome C, bs30f07.y1, Cytc, cyt-c-d, cytochrome C, Cytochrome c, Cyt-c1, CytC-1" CDMC26481 4 12 8 DAC13-D08 6-CG13263-RA_2 CG13263 GGCTTCCAAGATGGGTTCTGGTGATGCAGAGAACGGCAAGAAGATATTTGTGCAGAAGTGCGCCC 65 FBan0013263 FBgn0000408 Cyt-c-d 2 2L caspase activation; GO:0006919; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; sperm individualization; GO:0007291 "electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; GO:0045155; ; GO:0005489; ; GO:0045155" mitochondrial inner membrane; GO:0005743; mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Cyt-c-d Cytochrome c distal "CG13263, DC3, pDMc02, CytC1, cytochrome c, cyt.c, Cytochrome C, bs30f07.y1, Cytc, cyt-c-d, cytochrome C, Cytochrome c, Cyt-c1, CytC-1" CDMC26482 4 13 8 DAC13-D20 3-CG13360-RA_1 CG13360 CTTTCTGCCGATGGTGACCATGAAGAAGGAGGACTCGTACGACATCAGCATAGAGGCGCTGTCGG 65 FBan0013360 FBgn0025620 CG13360 X X CG13360 CG13360 EG:34F3.5 CDMC26482 4 14 8 DAC13-D20 3-CG13360-RA_1 CG13360 CTTTCTGCCGATGGTGACCATGAAGAAGGAGGACTCGTACGACATCAGCATAGAGGCGCTGTCGG 65 FBan0013360 FBgn0025620 CG13360 X X CG13360 CG13360 EG:34F3.5 CDMC26483 4 15 8 DAC13-H08 12-CG13479-RA_1 CG13479 CCATATTTCATCAGCACTTGGATCGACAACAGGTCATGCAAGCACAACAGCAGGATCGCCCGAGA 65 FBan0013479 FBgn0040811 CG13479 3 3L CG13479 CG13479 CDMC26483 4 16 8 DAC13-H08 12-CG13479-RA_1 CG13479 CCATATTTCATCAGCACTTGGATCGACAACAGGTCATGCAAGCACAACAGCAGGATCGCCCGAGA 65 FBan0013479 FBgn0040811 CG13479 3 3L CG13479 CG13479 CDMC26484 4 17 8 DAC13-H20 19-CG13511-RA_1 CG13511 AGTCTGGCCACGTCCCCCACCCGCAAGACCCACATGTGCGCTCTGACCTTGTATATCTGCTGCTG 65 FBan0013511 FBgn0034759 CG13511 2 2R CG13511 CG13511 CDMC26484 4 18 8 DAC13-H20 19-CG13511-RA_1 CG13511 AGTCTGGCCACGTCCCCCACCCGCAAGACCCACATGTGCGCTCTGACCTTGTATATCTGCTGCTG 65 FBan0013511 FBgn0034759 CG13511 2 2R CG13511 CG13511 CDMC26485 4 19 8 DAC13-L08 2-CG1360-RA_1 CG1360 CACCTCCAGCCACAAGAACTGATGCAGAGTGCTAAGAACCGGAGACTGATCACCAAGCTGGAAGC 65 FBan0001360 FBgn0033195 CG1360 2 2R CG1360 CG1360 CDMC26485 4 20 8 DAC13-L08 2-CG1360-RA_1 CG1360 CACCTCCAGCCACAAGAACTGATGCAGAGTGCTAAGAACCGGAGACTGATCACCAAGCTGGAAGC 65 FBan0001360 FBgn0033195 CG1360 2 2R CG1360 CG1360 CDMC26486 4 21 8 DAC13-L20 16-CG13632-RA_1 CG13632 TTTGATGGATGTGGCCTTGCAGCAGAGTGTGCGACAGGGTCTCGATGCCATGACCGAGCTGTACG 65 FBan0013632 FBgn0039221 CG13632 3 3R CG13632 CG13632 CDMC26486 4 22 8 DAC13-L20 16-CG13632-RA_1 CG13632 TTTGATGGATGTGGCCTTGCAGCAGAGTGTGCGACAGGGTCTCGATGCCATGACCGAGCTGTACG 65 FBan0013632 FBgn0039221 CG13632 3 3R CG13632 CG13632 CDMC26487 4 23 8 DAC13-P08 23-CG13711-RA_1 CG13711 GCCGACGAGTTGAAGACTGTTAACCATCAGATCGTCTTTCGGCATAAACTTCGTCGCCAGATTCA 65 FBan0013711 FBgn0035572 CG13711 3 3L CG13711 CG13711 HL5 CDMC26487 4 24 8 DAC13-P08 23-CG13711-RA_1 CG13711 GCCGACGAGTTGAAGACTGTTAACCATCAGATCGTCTTTCGGCATAAACTTCGTCGCCAGATTCA 65 FBan0013711 FBgn0035572 CG13711 3 3L CG13711 CG13711 HL5 CDMC26488 4 25 8 DAC13-P20 AutoBlank AutoBlank CDMC26488 4 26 8 DAC13-P20 AutoBlank AutoBlank CDMC26489 4 1 9 DAC14-D08 18-CG16700-RA_1 CG16700 TTGGCTTTACTTGGCTTCTTCACTGGCTCCTACGAAAGCCTAAAGCAAATTGTCAAGCATTTCGGGGAG 69 FBan0016700 FBgn0030816 CG16700 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; gamma-aminobutyric acid:hydrogen symporter activity; GO:0015495; ; GO:0015495 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG16700 CG16700 CDMC26489 4 2 9 DAC14-D08 18-CG16700-RA_1 CG16700 TTGGCTTTACTTGGCTTCTTCACTGGCTCCTACGAAAGCCTAAAGCAAATTGTCAAGCATTTCGGGGAG 69 FBan0016700 FBgn0030816 CG16700 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; gamma-aminobutyric acid:hydrogen symporter activity; GO:0015495; ; GO:0015495 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG16700 CG16700 CDMC26490 4 3 9 DAC14-D20 6-CG16713-RA_2 CG16713 CCCCATTCCCTAAACGGAGATGGCAGAATATCCTGTGAGGCCTATATACCCAGTTGGTCCTACGACGCC 69 FBan0016713 FBgn0031560 CG16713 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG16713 CG16713 CT37195 CDMC26490 4 4 9 DAC14-D20 6-CG16713-RA_2 CG16713 CCCCATTCCCTAAACGGAGATGGCAGAATATCCTGTGAGGCCTATATACCCAGTTGGTCCTACGACGCC 69 FBan0016713 FBgn0031560 CG16713 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG16713 CG16713 CT37195 CDMC26491 4 5 9 DAC14-H08 8-CG16742-RA_3 CG16742 GGCCCAACAGCTTCGACTAGAGATAGCCCAGAAGTTGAACACTCTGAGCGAAGTTCCATTAAGGCACCC 69 FBan0016742 FBgn0034529 CG16742 2 2R CG16742 CG16742 CDMC26491 4 6 9 DAC14-H08 8-CG16742-RA_3 CG16742 GGCCCAACAGCTTCGACTAGAGATAGCCCAGAAGTTGAACACTCTGAGCGAAGTTCCATTAAGGCACCC 69 FBan0016742 FBgn0034529 CG16742 2 2R CG16742 CG16742 CDMC26492 4 7 9 DAC14-H20 17-CG16752-RA_3 CG16752 GCATCATGCTGACGAACTTCTTCCTGGTATTCAGCTATCCGATCAACTTCGGCATTTACTGCGGCATGT 69 FBan0016752 FBgn0029768 CG16752 X X G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; electron transporter activity; GO:0005489; ; GO:0005489; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG16752 CG16752 "CG12731, CG12731, CG12731" CDMC26492 4 8 9 DAC14-H20 17-CG16752-RA_3 CG16752 GCATCATGCTGACGAACTTCTTCCTGGTATTCAGCTATCCGATCAACTTCGGCATTTACTGCGGCATGT 69 FBan0016752 FBgn0029768 CG16752 X X G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; electron transporter activity; GO:0005489; ; GO:0005489; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG16752 CG16752 "CG12731, CG12731, CG12731" CDMC26493 4 9 9 DAC14-L08 2-CG16798-RA_1 CG16798 CGGCGGACAAGTACACGATGAGGATCGATCACAAAGAGTGTGGAAGCTTGGTGAAACCGGAGACCAACA 69 FBan0016798 FBgn0032856 CG16798 2 2L CG16798 CG16798 38C.41 CDMC26493 4 10 9 DAC14-L08 2-CG16798-RA_1 CG16798 CGGCGGACAAGTACACGATGAGGATCGATCACAAAGAGTGTGGAAGCTTGGTGAAACCGGAGACCAACA 69 FBan0016798 FBgn0032856 CG16798 2 2L CG16798 CG16798 38C.41 CDMC26494 4 11 9 DAC14-L20 3-CG1681-RA_3 CG1681 AGCACACGCTCAACGAGTTCGAACAGCTATTCCTCAACTCCCGCAAGTTCATGATGGGCGACAACATTT 69 FBan0001681 FBgn0030484 CG1681 X X defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG1681 CG1681 CDMC26494 4 12 9 DAC14-L20 3-CG1681-RA_3 CG1681 AGCACACGCTCAACGAGTTCGAACAGCTATTCCTCAACTCCCGCAAGTTCATGATGGGCGACAACATTT 69 FBan0001681 FBgn0030484 CG1681 X X defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG1681 CG1681 CDMC26495 4 13 9 DAC14-P08 17-CG16868-RA_1 CG16868 GGCACATGGAAACTGCCGAATCGTAGTCCACAATAGCGTTGTTAAGTTTTAGAGCGTAAGATGTCCGCT 69 FBan0016868 FBgn0034498 CG16868 2 2R CG16868 CG16868 CDMC26495 4 14 9 DAC14-P08 17-CG16868-RA_1 CG16868 GGCACATGGAAACTGCCGAATCGTAGTCCACAATAGCGTTGTTAAGTTTTAGAGCGTAAGATGTCCGCT 69 FBan0016868 FBgn0034498 CG16868 2 2R CG16868 CG16868 CDMC26496 4 15 9 DAC14-P20 12-CG16885-RB_2 CG16885 TGTTGCGGGTTGGTTGAGACATACAAGCCCATCTTGATCGCAAAGTGTTGAGGAGCTAACCTAGTGCAA 69 FBan0016885 FBgn0032538 CG16885 2 2L CG16885 CG16885 CG18634 CDMC26496 4 16 9 DAC14-P20 12-CG16885-RB_2 CG16885 TGTTGCGGGTTGGTTGAGACATACAAGCCCATCTTGATCGCAAAGTGTTGAGGAGCTAACCTAGTGCAA 69 FBan0016885 FBgn0032538 CG16885 2 2L CG16885 CG16885 CG18634 CDMC26497 4 17 9 DAC15-D08 23-CG18657-RA_1 CG18657 GTCAGCCCAGTTTAAGCATTTGTGAACAATTTACGTACTAGGGCCGTCTCGAAATCAAACAGAGCGCCA 69 FBan0018657 FBgn0015773 NetA X X axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 NetA Netrin-A "CG18657, D-netrin-A, netrinA, netrin, Netrin, CT27014, Netrin A, NETRIN, netA, Netrin-A" CDMC26497 4 18 9 DAC15-D08 23-CG18657-RA_1 CG18657 GTCAGCCCAGTTTAAGCATTTGTGAACAATTTACGTACTAGGGCCGTCTCGAAATCAAACAGAGCGCCA 69 FBan0018657 FBgn0015773 NetA X X axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 NetA Netrin-A "CG18657, D-netrin-A, netrinA, netrin, Netrin, CT27014, Netrin A, NETRIN, netA, Netrin-A" CDMC26498 4 19 9 DAC15-D20 5-CG1866-RB_1 CG1866 GGGCCGAAAACGTCAGGATTCGCCGAGTAAGAAGCGTCCCAATTCAACGGAAAGAAAGTGGCGTGACTC 69 FBan0001866 FBgn0039581 Moca-cyp 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 Moca-cyp Moca-cyp "CG1866, CG1866, CG1866, anon-WO0147981.13, anon-WO0147981.4, anon-WO0147981.5, BEST:LD38313" CDMC26498 4 20 9 DAC15-D20 5-CG1866-RB_1 CG1866 GGGCCGAAAACGTCAGGATTCGCCGAGTAAGAAGCGTCCCAATTCAACGGAAAGAAAGTGGCGTGACTC 69 FBan0001866 FBgn0039581 Moca-cyp 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 Moca-cyp Moca-cyp "CG1866, CG1866, CG1866, anon-WO0147981.13, anon-WO0147981.4, anon-WO0147981.5, BEST:LD38313" CDMC26499 4 21 9 DAC15-H08 16-CG18777-RA_1 CG18777 TGCGATCGGATAGCAATGTTGGAATCGATAACTACTCATATGCAGTTGAAACCAGCGACGGTACCTCGA 69 FBan0018777 FBgn0042118 CG18777 3 3L CG18777 CG18777 BcDNA:RE62456 CDMC26499 4 22 9 DAC15-H08 16-CG18777-RA_1 CG18777 TGCGATCGGATAGCAATGTTGGAATCGATAACTACTCATATGCAGTTGAAACCAGCGACGGTACCTCGA 69 FBan0018777 FBgn0042118 CG18777 3 3L CG18777 CG18777 BcDNA:RE62456 CDMC26500 4 23 9 DAC15-H20 9-CG18787-RA_1 CG18787 CGAGGAGGTGCGGTTCATGTGTTACGAGGCCAAACGACAAAACCAATTCGAACAGTTCAGCCAACAGTT 69 FBan0018787 FBgn0042125 CG18787 2 2L CG18787 CG18787 CDMC26500 4 24 9 DAC15-H20 9-CG18787-RA_1 CG18787 CGAGGAGGTGCGGTTCATGTGTTACGAGGCCAAACGACAAAACCAATTCGAACAGTTCAGCCAACAGTT 69 FBan0018787 FBgn0042125 CG18787 2 2L CG18787 CG18787 CDMC26501 4 25 9 DAC15-L08 13-CG1885-RA_1 CG1885 GGCGGAAAACTCGACAAAGGAAAATTCAGCACACAGTTTGCGTCCGATCAAAGTGAGAAACGTGAGCCA 69 FBan0001885 FBgn0030066 CG1885 X X heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778; proteolysis; GO:0006508 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; caspase activity; GO:0030693; uroporphyrinogen-III synthase activity; GO:0004852 ; EC:4.2.1.75; ; GO:0030693; ; GO:0004852 ; EC:4.2.1.75 CG1885 CG1885 CDMC26501 4 26 9 DAC15-L08 13-CG1885-RA_1 CG1885 GGCGGAAAACTCGACAAAGGAAAATTCAGCACACAGTTTGCGTCCGATCAAAGTGAGAAACGTGAGCCA 69 FBan0001885 FBgn0030066 CG1885 X X heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778; proteolysis; GO:0006508 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; caspase activity; GO:0030693; uroporphyrinogen-III synthase activity; GO:0004852 ; EC:4.2.1.75; ; GO:0030693; ; GO:0004852 ; EC:4.2.1.75 CG1885 CG1885 CDMC26502 4 1 10 DAC15-L20 3-CG1896-RA_1 CG1896 CGGCGACGCTTATATAGACGAAGCCAACATCGGGTGATACGTGCAACCGTCAAATCTGAGGCTGCAGAA 69 FBan0001896 FBgn0039870 CG1896 3 3R CG1896 CG1896 CDMC26502 4 2 10 DAC15-L20 3-CG1896-RA_1 CG1896 CGGCGACGCTTATATAGACGAAGCCAACATCGGGTGATACGTGCAACCGTCAAATCTGAGGCTGCAGAA 69 FBan0001896 FBgn0039870 CG1896 3 3R CG1896 CG1896 CDMC26503 4 3 10 DAC15-P08 14-CG1924-RA_1 CG1924 CCGTGGGGGAGTAGGATGAGCAGAGCGAAGAAATGGAAGTTGACGATACCACCAAGAAGAGCATATAGC 69 FBan0001924 FBgn0030377 CG1924 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG1924 CG1924 CDMC26503 4 4 10 DAC15-P08 14-CG1924-RA_1 CG1924 CCGTGGGGGAGTAGGATGAGCAGAGCGAAGAAATGGAAGTTGACGATACCACCAAGAAGAGCATATAGC 69 FBan0001924 FBgn0030377 CG1924 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG1924 CG1924 CDMC26504 4 5 10 DAC15-P20 15-CG1941-RA_1 CG1941 ACGACCTGGAGAAGATGTTCGCCAAGTACAAGGATCAGTACATACCGAACTCCAAGCAGGACAAGCTGA 69 FBan0001941 FBgn0033214 CG1941 2 2R CG1941 CG1941 CDMC26504 4 6 10 DAC15-P20 15-CG1941-RA_1 CG1941 ACGACCTGGAGAAGATGTTCGCCAAGTACAAGGATCAGTACATACCGAACTCCAAGCAGGACAAGCTGA 69 FBan0001941 FBgn0033214 CG1941 2 2R CG1941 CG1941 CDMC26505 4 7 10 DAC16-D08 23-CG32763-RA_3 CG32763 AATGAACTCAGTATCGAGTGAATGTCAGTGTGAATGTGGTGAATATGGTGAATGTGTGTTCGCTTGTGT 69 FBgn0027523 CDMC26505 4 8 10 DAC16-D08 23-CG32763-RA_3 CG32763 AATGAACTCAGTATCGAGTGAATGTCAGTGTGAATGTGGTGAATATGGTGAATGTGTGTTCGCTTGTGT 69 FBgn0027523 CDMC26506 4 9 10 DAC16-D20 3-CG32776-RB_1 CG32776 GCGCAAACCGAAGTGGAGTCGAACACGGAAGTGCAGGAGTACAGGAGGGGTCAACTTATGAGGAAGTTT 69 FBan0032776 FBgn0052776 CG32776 X X small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG32776 CG32776 "CG16828, CG16829, CG16828, BcDNA:RH43809" CDMC26506 4 10 10 DAC16-D20 3-CG32776-RB_1 CG32776 GCGCAAACCGAAGTGGAGTCGAACACGGAAGTGCAGGAGTACAGGAGGGGTCAACTTATGAGGAAGTTT 69 FBan0032776 FBgn0052776 CG32776 X X small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG32776 CG32776 "CG16828, CG16829, CG16828, BcDNA:RH43809" CDMC26507 4 11 10 DAC16-H08 2-CG3280-RA_1 CG3280 GCCGGAACAAGCTCCTCTGGAACTGGCAATTTTCCCATAAAGGAGACCCATCCAAAGAGCCGCTTCAAA 69 FBan0003280 FBgn0036017 CG3280 3 3L CG3280 CG3280 CDMC26507 4 12 10 DAC16-H08 2-CG3280-RA_1 CG3280 GCCGGAACAAGCTCCTCTGGAACTGGCAATTTTCCCATAAAGGAGACCCATCCAAAGAGCCGCTTCAAA 69 FBan0003280 FBgn0036017 CG3280 3 3L CG3280 CG3280 CDMC26508 4 13 10 DAC16-H20 3-CG32816-RA_1 CG32816 GCCCGCCTGTATCGGAAACAACTCCTTTATCCTTACCCCTTCCGCTCTTGACAACTCAACAGCAACAGC 69 FBan0032816 FBgn0052816 CG32816 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32816 CG32816 CDMC26508 4 14 10 DAC16-H20 3-CG32816-RA_1 CG32816 GCCCGCCTGTATCGGAAACAACTCCTTTATCCTTACCCCTTCCGCTCTTGACAACTCAACAGCAACAGC 69 FBan0032816 FBgn0052816 CG32816 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32816 CG32816 CDMC26509 4 15 10 DAC16-L08 23-CG32850-RA_3 CG32850 GTGCCTATTATATTCAACGTGTGAACACACAAACATAACTAAAATGTACTTGTAGTACTTGGACGCATT 69 FBan0032850 FBgn0052850 CG32850 4 4 CG32850 CG32850 "BcDNA:RE41137, BEST:GH26713" CDMC26509 4 16 10 DAC16-L08 23-CG32850-RA_3 CG32850 GTGCCTATTATATTCAACGTGTGAACACACAAACATAACTAAAATGTACTTGTAGTACTTGGACGCATT 69 FBan0032850 FBgn0052850 CG32850 4 4 CG32850 CG32850 "BcDNA:RE41137, BEST:GH26713" CDMC26510 4 17 10 DAC16-L20 13-CG32859-RA_1 CG32859 GCGAACAACAATGAATATCCCACACAAGGTCCCCAAAAAGTGGAGTCACCAACTGATGTTACCCAGCCT 69 FBan0032859 FBgn0040368 CG32859 X X translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG32859 CG32859 "CG11392, CG11393, CG11392, CG11393, eIF4E, CT31794, EG:BACR42I17.1" CDMC26510 4 18 10 DAC16-L20 13-CG32859-RA_1 CG32859 GCGAACAACAATGAATATCCCACACAAGGTCCCCAAAAAGTGGAGTCACCAACTGATGTTACCCAGCCT 69 FBan0032859 FBgn0040368 CG32859 X X translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG32859 CG32859 "CG11392, CG11393, CG11392, CG11393, eIF4E, CT31794, EG:BACR42I17.1" CDMC26511 4 19 10 DAC16-P08 15-CG32952-RA_2 CG32952 TTCACCATTATCCTGTTTCTGGCTGGACTGGGTCAGCACACAACTGAAAGTGTACTTCCAGACTGCGTT 69 FBgn0052952 CDMC26511 4 20 10 DAC16-P08 15-CG32952-RA_2 CG32952 TTCACCATTATCCTGTTTCTGGCTGGACTGGGTCAGCACACAACTGAAAGTGTACTTCCAGACTGCGTT 69 FBgn0052952 CDMC26512 4 21 10 DAC16-P20 1-CG32956-RE_1 CG32956 GCCAAGGATATTCTACAGACCCTCACCGAGCTAGACTTCGAAAGCTTCGTGCCCTCTCTGACGCAGGAT 69 FBgn0052956 CDMC26512 4 22 10 DAC16-P20 1-CG32956-RE_1 CG32956 GCCAAGGATATTCTACAGACCCTCACCGAGCTAGACTTCGAAAGCTTCGTGCCCTCTCTGACGCAGGAT 69 FBgn0052956 CDMC26513 4 23 10 DAC17-D08 12-CG12393-RA_3 CG12393 GGCTGCACCATTGAGCTGTCTAACGAGGTGGACAACTACTGCTTCGAGATCGCCTTCAACGGCAA 65 FBan0012393 FBgn0031768 CG12393 2 2L CG12393 CG12393 CDMC26513 4 24 10 DAC17-D08 12-CG12393-RA_3 CG12393 GGCTGCACCATTGAGCTGTCTAACGAGGTGGACAACTACTGCTTCGAGATCGCCTTCAACGGCAA 65 FBan0012393 FBgn0031768 CG12393 2 2L CG12393 CG12393 CDMC26514 4 25 10 DAC17-D20 15-CG12452-RA_1 CG12452 ATGTTCGATGCTCTGCTCCGCGATGATCACGAACATCGGCTGAGCTTGGATGCAGTGCATCGCAT 65 FBan0012452 FBgn0037029 CG12452 3 3L CG12452 CG12452 CDMC26514 4 26 10 DAC17-D20 15-CG12452-RA_1 CG12452 ATGTTCGATGCTCTGCTCCGCGATGATCACGAACATCGGCTGAGCTTGGATGCAGTGCATCGCAT 65 FBan0012452 FBgn0037029 CG12452 3 3L CG12452 CG12452 CDMC26515 4 1 11 DAC17-H08 2-CG12524-RA_1 CG12524 CATAACCGATCCGAAGATTGTGCAGAACGTGCTGATGTGCATCGAACGGGTCATGGACCGCATGG 65 FBan0012524 FBgn0036061 CG12524 3 3L CG12524 CG12524 CDMC26515 4 2 11 DAC17-H08 2-CG12524-RA_1 CG12524 CATAACCGATCCGAAGATTGTGCAGAACGTGCTGATGTGCATCGAACGGGTCATGGACCGCATGG 65 FBan0012524 FBgn0036061 CG12524 3 3L CG12524 CG12524 CDMC26516 4 3 11 DAC17-H20 18-CG12552-RA_1 CG12552 ATATCATTGCTCCGTTTGATTGTGTCCAAAAGCATCGTTCACTCAGGAATAGGGCACCGTCGCTG 65 FBgn0040004 CG12552 CG12552 CG12552 CDMC26516 4 4 11 DAC17-H20 18-CG12552-RA_1 CG12552 ATATCATTGCTCCGTTTGATTGTGTCCAAAAGCATCGTTCACTCAGGAATAGGGCACCGTCGCTG 65 FBgn0040004 CG12552 CG12552 CG12552 CDMC26517 4 5 11 DAC17-L08 3-CG12683-RA_1 CG12683 TAATGCCATTTGCCAGTTGCAAGAGTACTCAGCTACTAAGTCCCTCGCCCCTTTCTTGCCGCAGC 65 FBan0012683 FBgn0040911 CG12683 X X CG12683 CG12683 CDMC26517 4 6 11 DAC17-L08 3-CG12683-RA_1 CG12683 TAATGCCATTTGCCAGTTGCAAGAGTACTCAGCTACTAAGTCCCTCGCCCCTTTCTTGCCGCAGC 65 FBan0012683 FBgn0040911 CG12683 X X CG12683 CG12683 CDMC26518 4 7 11 DAC17-L20 3-CG1271-RB_3 CG1271 GAAGAGCTCCATGAACTGGTTCTCGTATGCCCTGTTCCTTCTCACCCGCCAGTCACGATTCCTCG 65 FBan0001271 FBgn0035392 CG1271 3 3L ATP synthesis coupled proton transport; GO:0015986; carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG1271 CG1271 CDMC26518 4 8 11 DAC17-L20 3-CG1271-RB_3 CG1271 GAAGAGCTCCATGAACTGGTTCTCGTATGCCCTGTTCCTTCTCACCCGCCAGTCACGATTCCTCG 65 FBan0001271 FBgn0035392 CG1271 3 3L ATP synthesis coupled proton transport; GO:0015986; carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG1271 CG1271 CDMC26519 4 9 11 DAC17-P08 1-CG12835-RA_1 CG12835 GATATGACGATCTGAGGAACCTGAACCGCTGCCGCAACAGGAACGCCGTTTGGCTAAATCCCAAG 65 FBan0012835 FBgn0033142 CG12835 2 2R CG12835 CG12835 CDMC26519 4 10 11 DAC17-P08 1-CG12835-RA_1 CG12835 GATATGACGATCTGAGGAACCTGAACCGCTGCCGCAACAGGAACGCCGTTTGGCTAAATCCCAAG 65 FBan0012835 FBgn0033142 CG12835 2 2R CG12835 CG12835 CDMC26520 4 11 11 DAC17-P20 AutoBlank AutoBlank CDMC26520 4 12 11 DAC17-P20 AutoBlank AutoBlank CDMC26521 4 13 11 DAC18-D08 3-CG6098-RA_1 CG6098 GGATCTACGGATCGACCTGTTGGATGTGTGGGGCAATTGCTTCAAGGAATTCAATGCAGATGCCGCG 67 FBan0006098 FBgn0010398 Lrr47 2 2L Ras protein signal transduction; GO:0007265 Ras GTPase binding; GO:0017016; ; GO:0017016 cytoplasm; GO:0005737; extracellular region; GO:0005576; nucleus; GO:0005634; peripheral to membrane of membrane fraction; GO:0000300 Lrr47 Leucine-rich repeat 47 "CG6098, LRR47, CT19173, Lrr-47" CDMC26521 4 14 11 DAC18-D08 3-CG6098-RA_1 CG6098 GGATCTACGGATCGACCTGTTGGATGTGTGGGGCAATTGCTTCAAGGAATTCAATGCAGATGCCGCG 67 FBan0006098 FBgn0010398 Lrr47 2 2L Ras protein signal transduction; GO:0007265 Ras GTPase binding; GO:0017016; ; GO:0017016 cytoplasm; GO:0005737; extracellular region; GO:0005576; nucleus; GO:0005634; peripheral to membrane of membrane fraction; GO:0000300 Lrr47 Leucine-rich repeat 47 "CG6098, LRR47, CT19173, Lrr-47" CDMC26522 4 15 11 DAC18-D20 23-CG6290-RA_3 CG6290 AGAATCACCGAGCTCCCTGACGACCACCATCGAGTGTATTTTTTTTGTTTGTTTATAAGTGCAATAA 67 FBan0006290 FBgn0030921 CG6290 X X CG6290 CG6290 BcDNA:GH02837 CDMC26522 4 16 11 DAC18-D20 23-CG6290-RA_3 CG6290 AGAATCACCGAGCTCCCTGACGACCACCATCGAGTGTATTTTTTTTGTTTGTTTATAAGTGCAATAA 67 FBan0006290 FBgn0030921 CG6290 X X CG6290 CG6290 BcDNA:GH02837 CDMC26523 4 17 11 DAC18-H08 3-CG6741-RB_3 CG6741 TCTTTAAGGGACCTGGACTGAAATCGTTGGGCTTCAGCATAGTGGGAGGTCGAGATTCGCCAAAGGG 67 FBan0006741 FBgn0000008 a 2 2R eye development (sensu Endopterygota); GO:0007456 protein binding; GO:0005515; ; GO:0005515 adherens junction; GO:0005912; apical plasma membrane; GO:0016324 a arc "CG6741, CG13505, CG6741, CG13505, CG13505, CG6741, bran: broad angular, broad angular, Arc, bran, arc" CDMC26523 4 18 11 DAC18-H08 3-CG6741-RB_3 CG6741 TCTTTAAGGGACCTGGACTGAAATCGTTGGGCTTCAGCATAGTGGGAGGTCGAGATTCGCCAAAGGG 67 FBan0006741 FBgn0000008 a 2 2R eye development (sensu Endopterygota); GO:0007456 protein binding; GO:0005515; ; GO:0005515 adherens junction; GO:0005912; apical plasma membrane; GO:0016324 a arc "CG6741, CG13505, CG6741, CG13505, CG13505, CG6741, bran: broad angular, broad angular, Arc, bran, arc" CDMC26524 4 19 11 DAC18-H20 15-CG6932-RA_2 CG6932 GCGACAATCCCACTGCCGATGACATTAAGATCCAAAGACAGATAGCCGCCATCAACGAGTGCCCCAT 67 FBan0006932 FBgn0028837 CSN6 3 3R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 signalosome complex; GO:0008180 CSN6 COP9 complex homolog subunit 6 "CG6932, Dch6, Drosophila COP9 signalosome homolog 6, CH6, COP9 complex homolog subunit 6" CDMC26524 4 20 11 DAC18-H20 15-CG6932-RA_2 CG6932 GCGACAATCCCACTGCCGATGACATTAAGATCCAAAGACAGATAGCCGCCATCAACGAGTGCCCCAT 67 FBan0006932 FBgn0028837 CSN6 3 3R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 signalosome complex; GO:0008180 CSN6 COP9 complex homolog subunit 6 "CG6932, Dch6, Drosophila COP9 signalosome homolog 6, CH6, COP9 complex homolog subunit 6" CDMC26525 4 21 11 DAC18-L08 15-CG7427-RA_1 CG7427 AGGGCGTAATCCACTTCCTGGAGGACTTGGACCTGAAGCCAGACTCAAAACTGGTGCTGATCATAGC 67 FBan0007427 FBgn0036510 CG7427 3 3L CG7427 CG7427 CDMC26525 4 22 11 DAC18-L08 15-CG7427-RA_1 CG7427 AGGGCGTAATCCACTTCCTGGAGGACTTGGACCTGAAGCCAGACTCAAAACTGGTGCTGATCATAGC 67 FBan0007427 FBgn0036510 CG7427 3 3L CG7427 CG7427 CDMC26526 4 23 11 DAC18-L20 3-CG7707-RA_4 CG7707 GCTGCGGGAAACTTCGGAGGAACTGAAGCAAATCAGCACGGCGTACATATTGCATCATCACAAGGCC 67 FBan0007707 FBgn0036703 CG7707 3 3L CG7707 CG7707 CDMC26526 4 24 11 DAC18-L20 3-CG7707-RA_4 CG7707 GCTGCGGGAAACTTCGGAGGAACTGAAGCAAATCAGCACGGCGTACATATTGCATCATCACAAGGCC 67 FBan0007707 FBgn0036703 CG7707 3 3L CG7707 CG7707 CDMC26527 4 25 11 DAC18-P08 3-CG8051-RA_1 CG8051 GGCCAAAATCAATCTAAGCAACCGTACCTTCTTCGTTGTGGGCATTTTGGGCATGTGCATTGGCCGC 67 FBan0008051 FBgn0031012 CG8051 X X transport; GO:0006810 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8051 CG8051 "EP(X)1550, anon-WO03002137.1" CDMC26527 4 26 11 DAC18-P08 3-CG8051-RA_1 CG8051 GGCCAAAATCAATCTAAGCAACCGTACCTTCTTCGTTGTGGGCATTTTGGGCATGTGCATTGGCCGC 67 FBan0008051 FBgn0031012 CG8051 X X transport; GO:0006810 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8051 CG8051 "EP(X)1550, anon-WO03002137.1" CDMC26528 4 1 12 DAC18-P20 AutoBlank AutoBlank CDMC26528 4 2 12 DAC18-P20 AutoBlank AutoBlank CDMC26529 4 3 12 DAC19-D08 3-CG8176-RB_2 CG8176 GCTCGTGTCCCTTCCAACTTGTCAGCTACTGGAAGTGTGAGTCCAGCTACACGGCCCTTAAAGTGGAC 68 FBan0008176 FBgn0037702 CG8176 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG8176 CG8176 CG31123 CDMC26529 4 4 12 DAC19-D08 3-CG8176-RB_2 CG8176 GCTCGTGTCCCTTCCAACTTGTCAGCTACTGGAAGTGTGAGTCCAGCTACACGGCCCTTAAAGTGGAC 68 FBan0008176 FBgn0037702 CG8176 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG8176 CG8176 CG31123 CDMC26530 4 5 12 DAC19-D20 3-CG8351-RA_4 CG8351 TGCAGCTCTGCATGGAAAAGATCAACGAAATGGCCGTCCAAATTGTCGAACAGTCCAAGGACCAGCAG 68 FBan0008351 FBgn0037632 CG8351 3 3R protein amino acid phosphorylation; GO:0006468; protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ATPase activity, coupled; GO:0042623; ; GO:0004672 ; EC:2.7.1.37; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG8351 CG8351 CDMC26530 4 6 12 DAC19-D20 3-CG8351-RA_4 CG8351 TGCAGCTCTGCATGGAAAAGATCAACGAAATGGCCGTCCAAATTGTCGAACAGTCCAAGGACCAGCAG 68 FBan0008351 FBgn0037632 CG8351 3 3R protein amino acid phosphorylation; GO:0006468; protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ATPase activity, coupled; GO:0042623; ; GO:0004672 ; EC:2.7.1.37; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG8351 CG8351 CDMC26531 4 7 12 DAC19-H08 14-CG8844-RB_1 CG8844 GGAAATTATTTACTAACAGCTCTTCCGCTTACGCCAGGTGGTAGGAGAGCCAGAAAATGCCGGAACCG 68 FBan0008844 FBgn0021967 Pdsw 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 Pdsw Pdsw "CG8844, l(2)k10101, BcDNA:RE65754, anon-EST:Posey91" CDMC26531 4 8 12 DAC19-H08 14-CG8844-RB_1 CG8844 GGAAATTATTTACTAACAGCTCTTCCGCTTACGCCAGGTGGTAGGAGAGCCAGAAAATGCCGGAACCG 68 FBan0008844 FBgn0021967 Pdsw 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 Pdsw Pdsw "CG8844, l(2)k10101, BcDNA:RE65754, anon-EST:Posey91" CDMC26532 4 9 12 DAC19-H20 2-CG8963-RA_2 CG8963 GGCAAACAGAAGACCTAGACGACTGTGGAGAACTGTGTTGCATTGGACGGATTCATGAGGGCGTGGTC 68 FBan0008963 FBgn0034181 CG8963 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG8963 CG8963 CDMC26532 4 10 12 DAC19-H20 2-CG8963-RA_2 CG8963 GGCAAACAGAAGACCTAGACGACTGTGGAGAACTGTGTTGCATTGGACGGATTCATGAGGGCGTGGTC 68 FBan0008963 FBgn0034181 CG8963 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG8963 CG8963 CDMC26533 4 11 12 DAC19-L08 9-CG9396-RA_2 CG9396 CCTGGTTGGAGCTGTTGTGCCTCAGTTTGTTCAGGAGCACTACTTCCCAACTGGTTTATCGCAGTCCC 68 FBan0009396 FBgn0037714 CG9396 3 3R CG9396 CG9396 CDMC26533 4 12 12 DAC19-L08 9-CG9396-RA_2 CG9396 CCTGGTTGGAGCTGTTGTGCCTCAGTTTGTTCAGGAGCACTACTTCCCAACTGGTTTATCGCAGTCCC 68 FBan0009396 FBgn0037714 CG9396 3 3R CG9396 CG9396 CDMC26534 4 13 12 DAC19-L20 3-CG9504-RA_3 CG9504 TGGGTGTACCACGGATGAAACAGCCATTGATAGCGGGTGCTACGTTCGGTTACACTCATCATGTCCCG 68 FBan0009504 FBgn0030597 Eo X X ecdysone metabolism; GO:0008205; electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-; ecdysone oxidase activity; GO:0047875 ; EC:1.1.3.16; ; GO:0047875 ; EC:1.1.3.16" Eo Ecdysone oxidase "CG9504, DmEO, Ecdysone oxidase" CDMC26534 4 14 12 DAC19-L20 3-CG9504-RA_3 CG9504 TGGGTGTACCACGGATGAAACAGCCATTGATAGCGGGTGCTACGTTCGGTTACACTCATCATGTCCCG 68 FBan0009504 FBgn0030597 Eo X X ecdysone metabolism; GO:0008205; electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-; ecdysone oxidase activity; GO:0047875 ; EC:1.1.3.16; ; GO:0047875 ; EC:1.1.3.16" Eo Ecdysone oxidase "CG9504, DmEO, Ecdysone oxidase" CDMC26535 4 15 12 DAC19-P08 23-CR30260-RA_1 CR30260 CCAGTTGATCCATTATATCCATAGCAAAATATTAATTGGCCACCTATCAAATTGGTATGTGCTCTGAA 68 FBan0030260 FBgn0050260 CR30260 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30260 CR30260 "tRNA[Thr][[3]], AE002787.trna33-ThrTGT, tRNA:T:TGT:AE002787-d, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC26535 4 16 12 DAC19-P08 23-CR30260-RA_1 CR30260 CCAGTTGATCCATTATATCCATAGCAAAATATTAATTGGCCACCTATCAAATTGGTATGTGCTCTGAA 68 FBan0030260 FBgn0050260 CR30260 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30260 CR30260 "tRNA[Thr][[3]], AE002787.trna33-ThrTGT, tRNA:T:TGT:AE002787-d, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC26536 4 17 12 DAC19-P20 AutoBlank AutoBlank CDMC26536 4 18 12 DAC19-P20 AutoBlank AutoBlank CDMC26537 4 19 12 DAC20-D08 18-CG18081-RA_1 CG18081 AGTCGATGAGAGGAGGGCGCGTAAAGTTAGAACATAGTTTCCAAAGCTAAGGGCCCAGCTGAATTTTTT 69 FBan0018081 FBgn0036537 CG18081 3 3L CG18081 CG18081 BcDNA:RE63284 CDMC26537 4 20 12 DAC20-D08 18-CG18081-RA_1 CG18081 AGTCGATGAGAGGAGGGCGCGTAAAGTTAGAACATAGTTTCCAAAGCTAAGGGCCCAGCTGAATTTTTT 69 FBan0018081 FBgn0036537 CG18081 3 3L CG18081 CG18081 BcDNA:RE63284 CDMC26538 4 21 12 DAC20-D20 6-CG18096-RA_3 CG18096 TCGATAGGGCTGTGGAATTTGTGGTTACGGAGGTGCACCAGTCAAATGAGCCGTATGATCTGGCCATTG 69 FBan0018096 FBgn0041183 TepI 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961 endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepI Thiolester containing protein I "CG18096, BG:DS00365.2, dTEPI, Tep1, tep1, Thiolester containing protein I" CDMC26538 4 22 12 DAC20-D20 6-CG18096-RA_3 CG18096 TCGATAGGGCTGTGGAATTTGTGGTTACGGAGGTGCACCAGTCAAATGAGCCGTATGATCTGGCCATTG 69 FBan0018096 FBgn0041183 TepI 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961 endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepI Thiolester containing protein I "CG18096, BG:DS00365.2, dTEPI, Tep1, tep1, Thiolester containing protein I" CDMC26539 4 23 12 DAC20-H08 9-CG1814-RA_1 CG1814 AGGCCCGCAAACCAAAGTTCTTTACGGATGAATCTCGACCAATAAGGCTATTCGACGAGCGAACGCAGT 69 FBan0001814 FBgn0033426 CG1814 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG1814 CG1814 CDMC26539 4 24 12 DAC20-H08 9-CG1814-RA_1 CG1814 AGGCCCGCAAACCAAAGTTCTTTACGGATGAATCTCGACCAATAAGGCTATTCGACGAGCGAACGCAGT 69 FBan0001814 FBgn0033426 CG1814 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG1814 CG1814 CDMC26540 4 25 12 DAC20-H20 23-CG18177-RA_18 CG18177 AGCTGTAACCGAGTGATTTGGAATTAGCATAGCCCCCTTATCTTTTGAATGTAGCCCGTGTGTATGTTT 69 FBan0018177 FBgn0036039 CG18177 3 3L CG18177 CG18177 DmAAF50213 CDMC26540 4 26 12 DAC20-H20 23-CG18177-RA_18 CG18177 AGCTGTAACCGAGTGATTTGGAATTAGCATAGCCCCCTTATCTTTTGAATGTAGCCCGTGTGTATGTTT 69 FBan0018177 FBgn0036039 CG18177 3 3L CG18177 CG18177 DmAAF50213 CDMC26541 4 1 13 DAC20-L08 8-CG1822-RC_1 CG1822 TTCTACCGGTTTCCACCAAACTCCAAACCTTCCGAGCATAACAACCTACCACATCCTGATCGTTCCCCT 69 FBan0001822 FBgn0014133 bif X X female meiosis chromosome segregation; GO:0016321; negative regulation of axon extension; GO:0030517 actin binding; GO:0003779; ; GO:0003779; protein phosphatase 1 binding; GO:0008157; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008157 cytoplasm; GO:0005737 bif bifocal "CG1822, CG1822, bifocal" CDMC26541 4 2 13 DAC20-L08 8-CG1822-RC_1 CG1822 TTCTACCGGTTTCCACCAAACTCCAAACCTTCCGAGCATAACAACCTACCACATCCTGATCGTTCCCCT 69 FBan0001822 FBgn0014133 bif X X female meiosis chromosome segregation; GO:0016321; negative regulation of axon extension; GO:0030517 actin binding; GO:0003779; ; GO:0003779; protein phosphatase 1 binding; GO:0008157; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008157 cytoplasm; GO:0005737 bif bifocal "CG1822, CG1822, bifocal" CDMC26542 4 3 13 DAC20-L20 24-CG1824-RA_2 CG1824 GCAAGGATAGTGACGATGTTAGGCAAATTGAATGATTCCCTATACACTTAATTTAATATTCTTATAATG 69 FBan0001824 FBgn0030403 CG1824 X X defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG1824 CG1824 CDMC26542 4 4 13 DAC20-L20 24-CG1824-RA_2 CG1824 GCAAGGATAGTGACGATGTTAGGCAAATTGAATGATTCCCTATACACTTAATTTAATATTCTTATAATG 69 FBan0001824 FBgn0030403 CG1824 X X defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG1824 CG1824 CDMC26543 4 5 13 DAC20-P08 22-CG18284-RA_1 CG18284 CAGAGTCAAGGGACGTCACAATCACAAAGTCAAGCTCAAATTCAATCACAGCCTGAACCAAGGTCATGT 69 FBgn0032274 CDMC26543 4 6 13 DAC20-P08 22-CG18284-RA_1 CG18284 CAGAGTCAAGGGACGTCACAATCACAAAGTCAAGCTCAAATTCAATCACAGCCTGAACCAAGGTCATGT 69 FBgn0032274 CDMC26544 4 7 13 DAC20-P20 18-CG18301-RA_1 CG18301 CCCAATGTGGTGGAAAAGTATCTCGTTCCGAATGAAAACTTTAACCACTTCGATCTGGTCTGGGGCAGA 69 FBan0018301 FBgn0032265 CG18301 2 2L lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18301 CG18301 CDMC26544 4 8 13 DAC20-P20 18-CG18301-RA_1 CG18301 CCCAATGTGGTGGAAAAGTATCTCGTTCCGAATGAAAACTTTAACCACTTCGATCTGGTCTGGGGCAGA 69 FBan0018301 FBgn0032265 CG18301 2 2L lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18301 CG18301 CDMC26545 4 9 13 DAC21-D08 23-CG3924-RA_1 CG3924 AGGATACTTCTGTTCTTGTCTTGACTGCCTTGCAAAGTACTTAATGTGTTGTTTTAGTAAAACATAACT 69 FBan0003924 FBgn0013764 Chi 2 2R axon guidance; GO:0007411; blastoderm segmentation; GO:0007350; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350; wing morphogenesis; GO:0007476 transcription cofactor activity; GO:0003712; ; GO:0003712 nucleus; GO:0005634 Chi Chip "CG3924, l(2)04405, dLdb, Ldb, chip, dLDB/Chip, l(2)k04405, Chip" CDMC26545 4 10 13 DAC21-D08 23-CG3924-RA_1 CG3924 AGGATACTTCTGTTCTTGTCTTGACTGCCTTGCAAAGTACTTAATGTGTTGTTTTAGTAAAACATAACT 69 FBan0003924 FBgn0013764 Chi 2 2R axon guidance; GO:0007411; blastoderm segmentation; GO:0007350; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350; wing morphogenesis; GO:0007476 transcription cofactor activity; GO:0003712; ; GO:0003712 nucleus; GO:0005634 Chi Chip "CG3924, l(2)04405, dLdb, Ldb, chip, dLDB/Chip, l(2)k04405, Chip" CDMC26546 4 11 13 DAC21-D20 16-CG3936-RA_1 CG3936 AGGGTTCCGAGGCCATCTACATTTGACCGTGATCTGGATGATTTGGTATGTTGAATATCGCGCAAGGAT 69 FBan0003936 FBgn0004647 N X X "NOT anesthesia-resistant memory; GO:0007615; NOT establishment of wing hair orientation; GO:0001737; Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R7 cell differentiation; GO:0045466; R8 cell differentiation; GO:0045465; R8 development; GO:0045463; anterior/posterior pattern formation; GO:0009952; asymmetric cell division; GO:0008356; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell fate commitment; GO:0045165; cell fate specification; GO:0001708; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; crystal cell differentiation; GO:0042688; dorsal closure; GO:0007391; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; embryonic crystal cell differentiation; GO:0035165; embryonic hemopoiesis; GO:0035162; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; foregut morphogenesis; GO:0007440; glial cell fate determination; GO:0007403; hemocyte proliferation (sensu Arthropoda); GO:0035172; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; lamellocyte differentiation; GO:0035171; lateral inhibition; GO:0046331; leg disc morphogenesis; GO:0007478; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; long-term memory; GO:0007616; lymph gland crystal cell differentiation; GO:0035170; lymph gland development (sensu Arthropoda); GO:0048542; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; mesoderm development; GO:0007498; morphogenesis of follicular epithelium; GO:0016333; muscle cell fate determination; GO:0007521; negative regulation of JNK cascade; GO:0046329; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; regulation of cardioblast cell fate specification; GO:0042686; regulation of crystal cell differentiation; GO:0042689; regulation of growth; GO:0040008; regulation of progression through mitotic cell cycle; GO:0007346; response to pest, pathogen or parasite; GO:0009613; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; retinal cell programmed cell death; GO:0046666; second mitotic wave (sensu Endopterygota); GO:0016330; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360; stalk formation (sensu Insecta); GO:0030713; striated muscle development; GO:0007519; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476" transmembrane receptor activity; GO:0004888; transcriptional activator activity; GO:0016563; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004888; receptor binding; GO:0005102; calcium ion binding; GO:0005509; ; GO:0005102; protein binding; GO:0005515; ; GO:0004888; ; GO:0004872; ; GO:0016563; ; GO:0005509; ; GO:0005515 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622; nucleus; GO:0005634; plasma membrane; GO:0005886 N Notch "CG3936, CG3936, fa: facet, facet, split, spl: split, Ax: Abruptex, Abruptex, l(1)N, 16-178, 16-55, co, n[fah]: notch-Fahmy, Chp: Chopped, dNotch, Co: Confluens, clone 1.12, 1.1, nd: notchoid, shd, swb: strawberry, CT13012, EG:163A10.2, Nintra, notch, EG:140G11.1, anon-EST:Liang-1.12, l(1)3Cb, l(1)Ax, Chopped, Confluens, notchoid, strawberry, Ax, spl, Co, Chp, nd, n[fah], swb, Notch" CDMC26546 4 12 13 DAC21-D20 16-CG3936-RA_1 CG3936 AGGGTTCCGAGGCCATCTACATTTGACCGTGATCTGGATGATTTGGTATGTTGAATATCGCGCAAGGAT 69 FBan0003936 FBgn0004647 N X X "NOT anesthesia-resistant memory; GO:0007615; NOT establishment of wing hair orientation; GO:0001737; Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R7 cell differentiation; GO:0045466; R8 cell differentiation; GO:0045465; R8 development; GO:0045463; anterior/posterior pattern formation; GO:0009952; asymmetric cell division; GO:0008356; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell fate commitment; GO:0045165; cell fate specification; GO:0001708; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; crystal cell differentiation; GO:0042688; dorsal closure; GO:0007391; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; embryonic crystal cell differentiation; GO:0035165; embryonic hemopoiesis; GO:0035162; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; foregut morphogenesis; GO:0007440; glial cell fate determination; GO:0007403; hemocyte proliferation (sensu Arthropoda); GO:0035172; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; lamellocyte differentiation; GO:0035171; lateral inhibition; GO:0046331; leg disc morphogenesis; GO:0007478; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; long-term memory; GO:0007616; lymph gland crystal cell differentiation; GO:0035170; lymph gland development (sensu Arthropoda); GO:0048542; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; mesoderm development; GO:0007498; morphogenesis of follicular epithelium; GO:0016333; muscle cell fate determination; GO:0007521; negative regulation of JNK cascade; GO:0046329; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; regulation of cardioblast cell fate specification; GO:0042686; regulation of crystal cell differentiation; GO:0042689; regulation of growth; GO:0040008; regulation of progression through mitotic cell cycle; GO:0007346; response to pest, pathogen or parasite; GO:0009613; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; retinal cell programmed cell death; GO:0046666; second mitotic wave (sensu Endopterygota); GO:0016330; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360; stalk formation (sensu Insecta); GO:0030713; striated muscle development; GO:0007519; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476" transmembrane receptor activity; GO:0004888; transcriptional activator activity; GO:0016563; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004888; receptor binding; GO:0005102; calcium ion binding; GO:0005509; ; GO:0005102; protein binding; GO:0005515; ; GO:0004888; ; GO:0004872; ; GO:0016563; ; GO:0005509; ; GO:0005515 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622; nucleus; GO:0005634; plasma membrane; GO:0005886 N Notch "CG3936, CG3936, fa: facet, facet, split, spl: split, Ax: Abruptex, Abruptex, l(1)N, 16-178, 16-55, co, n[fah]: notch-Fahmy, Chp: Chopped, dNotch, Co: Confluens, clone 1.12, 1.1, nd: notchoid, shd, swb: strawberry, CT13012, EG:163A10.2, Nintra, notch, EG:140G11.1, anon-EST:Liang-1.12, l(1)3Cb, l(1)Ax, Chopped, Confluens, notchoid, strawberry, Ax, spl, Co, Chp, nd, n[fah], swb, Notch" CDMC26547 4 13 13 DAC21-H08 22-CG3967-RA_1 CG3967 TGTGGTGAAGTCGAAGTCACAAACCAGAAGGCACGCAATATTTGCTAACATCTTTTGTACGTGTGGCAT 69 FBan0003967 FBgn0035989 CG3967 3 3L CG3967 CG3967 CDMC26547 4 14 13 DAC21-H08 22-CG3967-RA_1 CG3967 TGTGGTGAAGTCGAAGTCACAAACCAGAAGGCACGCAATATTTGCTAACATCTTTTGTACGTGTGGCAT 69 FBan0003967 FBgn0035989 CG3967 3 3L CG3967 CG3967 CDMC26548 4 15 13 DAC21-H20 9-CG3980-RB_10 CG3980 GCTGTGGCCCAAAGAGTTACGGTTACGGCACTGAACCCTCAGCTGCACAAGACCAAGATCAACAAAAAT 69 FBan0003980 FBgn0031575 CG3980 2 2L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG3980 CG3980 CT13231 CDMC26548 4 16 13 DAC21-H20 9-CG3980-RB_10 CG3980 GCTGTGGCCCAAAGAGTTACGGTTACGGCACTGAACCCTCAGCTGCACAAGACCAAGATCAACAAAAAT 69 FBan0003980 FBgn0031575 CG3980 2 2L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG3980 CG3980 CT13231 CDMC26549 4 17 13 DAC21-L08 17-CG40050-RA_1 CG40050 AGCTTAAAGCTGGGGAAGCAACTTGTGTGTCATGCTTGGGCGAAGATCTAGTCATCTTTCGTTCAAAGA 69 FBgn0058050 CG40050 CG40050 CG40050 CDMC26549 4 18 13 DAC21-L08 17-CG40050-RA_1 CG40050 AGCTTAAAGCTGGGGAAGCAACTTGTGTGTCATGCTTGGGCGAAGATCTAGTCATCTTTCGTTCAAAGA 69 FBgn0058050 CG40050 CG40050 CG40050 CDMC26550 4 19 13 DAC21-L20 7-CG4006-RA_1 CG4006 AGCGACTTAGAGCGACTTAGTGCTAGGATAAAGCATGCATCATCGGATCGCATCCTCTAGGGGTCGCTT 69 FBan0004006 FBgn0010379 Akt1 3 3R anti-apoptosis; GO:0006916; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein amino acid phosphorylation; GO:0006468; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of protein import into nucleus; GO:0042306; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; phosphoinositide binding; GO:0035091; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0035091; ; GO:0004713 ; EC:2.7.1.112 plasma membrane; GO:0005886 Akt1 Akt1 "CG4006, CG4006, CG4006, RAC, related to the A and C kinases, Dakt1, l(3)04226, DRAC-PK, Related to PKA to PKC protein kinases, l(3)89Bq, PKB/AKT, DPKB, Akt, dAkt, AKT, PKB, dakt1, DAKT1, DRAC-PK66; DRAC-PK85, DAkt1, dAkt1, dPKB, Dakt, akt, AKT/PKB, Akt/PKB, D-Akt, dAkt/PKB, DAKT1/PKB, PKB/dAKT, PKB/Akt, dAKT/dPKB, RacPK" CDMC26550 4 20 13 DAC21-L20 7-CG4006-RA_1 CG4006 AGCGACTTAGAGCGACTTAGTGCTAGGATAAAGCATGCATCATCGGATCGCATCCTCTAGGGGTCGCTT 69 FBan0004006 FBgn0010379 Akt1 3 3R anti-apoptosis; GO:0006916; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein amino acid phosphorylation; GO:0006468; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of protein import into nucleus; GO:0042306; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; phosphoinositide binding; GO:0035091; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0035091; ; GO:0004713 ; EC:2.7.1.112 plasma membrane; GO:0005886 Akt1 Akt1 "CG4006, CG4006, CG4006, RAC, related to the A and C kinases, Dakt1, l(3)04226, DRAC-PK, Related to PKA to PKC protein kinases, l(3)89Bq, PKB/AKT, DPKB, Akt, dAkt, AKT, PKB, dakt1, DAKT1, DRAC-PK66; DRAC-PK85, DAkt1, dAkt1, dPKB, Dakt, akt, AKT/PKB, Akt/PKB, D-Akt, dAkt/PKB, DAKT1/PKB, PKB/dAKT, PKB/Akt, dAKT/dPKB, RacPK" CDMC26551 4 21 13 DAC21-P08 18-CG40123-RA_4 CG40123 ACGATGGCATCCATTTCAGAGGTTTTGCGATACTCTTCGTCCCCCATTGTTCCTCATGTAGCAATGGAA 69 FBgn0058123 CG40123 cholesterol metabolism; GO:0008203; lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40123 CG40123 CDMC26551 4 22 13 DAC21-P08 18-CG40123-RA_4 CG40123 ACGATGGCATCCATTTCAGAGGTTTTGCGATACTCTTCGTCCCCCATTGTTCCTCATGTAGCAATGGAA 69 FBgn0058123 CG40123 cholesterol metabolism; GO:0008203; lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40123 CG40123 CDMC26552 4 23 13 DAC21-P20 6-CG40138-RA_1 CG40138 TCCCTTTCTGCACCCTACGTCCGGAGAAACATCAGCCGACTACGAGAATATTCACCGCCTTAAATCGCA 69 FBgn0058138 CG40138 CG40138 CG40138 CDMC26552 4 24 13 DAC21-P20 6-CG40138-RA_1 CG40138 TCCCTTTCTGCACCCTACGTCCGGAGAAACATCAGCCGACTACGAGAATATTCACCGCCTTAAATCGCA 69 FBgn0058138 CG40138 CG40138 CG40138 CDMC26553 4 25 13 DAC22-D08 2-CG13792-RA_1 CG13792 GAGAAGACTCCGCTTCTGGACAGTGTGGAAATGTCCCCGATGAGTCCAACCGATCCAGAGGAACC 65 FBan0013792 FBgn0031927 CG13792 2 2L CG13792 CG13792 CDMC26553 4 26 13 DAC22-D08 2-CG13792-RA_1 CG13792 GAGAAGACTCCGCTTCTGGACAGTGTGGAAATGTCCCCGATGAGTCCAACCGATCCAGAGGAACC 65 FBan0013792 FBgn0031927 CG13792 2 2L CG13792 CG13792 CDMC26554 4 1 14 DAC22-D20 2-CG1380-RB_1 CG1380 CTTGTCCCATGTACGTGACTGAGATAGCCCAGGTCCAGTACCGCGGAACCATGGGATGCTTCTTC 65 FBan0001380 FBgn0028560 sut4 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 sut4 sugar transporter 4 CG1380 CDMC26554 4 2 14 DAC22-D20 2-CG1380-RB_1 CG1380 CTTGTCCCATGTACGTGACTGAGATAGCCCAGGTCCAGTACCGCGGAACCATGGGATGCTTCTTC 65 FBan0001380 FBgn0028560 sut4 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 sut4 sugar transporter 4 CG1380 CDMC26555 4 3 14 DAC22-H08 17-CG13890-RA_3 CG13890 TAGCTACCGGCAATCACAGTAAAATGATCCACTGATTGGACTTTGTCGCTCATTCCGCGCACAGC 65 FBan0013890 FBgn0035169 CG13890 3 3L fatty acid beta-oxidation; GO:0006635 dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004165 ; EC:5.3.3.8 CG13890 CG13890 CDMC26555 4 4 14 DAC22-H08 17-CG13890-RA_3 CG13890 TAGCTACCGGCAATCACAGTAAAATGATCCACTGATTGGACTTTGTCGCTCATTCCGCGCACAGC 65 FBan0013890 FBgn0035169 CG13890 3 3L fatty acid beta-oxidation; GO:0006635 dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004165 ; EC:5.3.3.8 CG13890 CG13890 CDMC26556 4 5 14 DAC22-H20 3-CG13925-RA_1 CG13925 ACACCATCCTCAAGGATACCAACAGCAAGCCCATTCTCAAGTTCAGTGTCAGCGCGATCCTTGGC 65 FBan0013925 FBgn0035291 CG13925 3 3L CG13925 CG13925 CDMC26556 4 6 14 DAC22-H20 3-CG13925-RA_1 CG13925 ACACCATCCTCAAGGATACCAACAGCAAGCCCATTCTCAAGTTCAGTGTCAGCGCGATCCTTGGC 65 FBan0013925 FBgn0035291 CG13925 3 3L CG13925 CG13925 CDMC26557 4 7 14 DAC22-L08 14-CG13984-RA_1 CG13984 TGCAGAATGAGCTGACCATTTTCCACTACCACCTACTCTTCGACTATGGAGCACCGATCCAGGTG 65 FBan0013984 FBgn0031796 CG13984 2 2L CG13984 CG13984 CDMC26557 4 8 14 DAC22-L08 14-CG13984-RA_1 CG13984 TGCAGAATGAGCTGACCATTTTCCACTACCACCTACTCTTCGACTATGGAGCACCGATCCAGGTG 65 FBan0013984 FBgn0031796 CG13984 2 2L CG13984 CG13984 CDMC26558 4 9 14 DAC22-L20 2-CG13997-RA_1 CG13997 TTTGGAAGCCTCGACCTGTGGAGGAAGTACAGGGTGCTTAAGGAGCCTGCCATCGAGATCATCAG 65 FBan0013997 FBgn0031754 CG13997 2 2L CG13997 CG13997 CDMC26558 4 10 14 DAC22-L20 2-CG13997-RA_1 CG13997 TTTGGAAGCCTCGACCTGTGGAGGAAGTACAGGGTGCTTAAGGAGCCTGCCATCGAGATCATCAG 65 FBan0013997 FBgn0031754 CG13997 2 2L CG13997 CG13997 CDMC26559 4 11 14 DAC22-P08 12-CG14082-RA_1 CG14082 GTGGGTCCCTACAGCCTCAGTGAGTCCATGCACAAGCTCACCTTCACGCAATCTTTGGCATTCCC 65 FBan0014082 FBgn0036851 CG14082 3 3L CG14082 CG14082 CDMC26559 4 12 14 DAC22-P08 12-CG14082-RA_1 CG14082 GTGGGTCCCTACAGCCTCAGTGAGTCCATGCACAAGCTCACCTTCACGCAATCTTTGGCATTCCC 65 FBan0014082 FBgn0036851 CG14082 3 3L CG14082 CG14082 CDMC26560 4 13 14 DAC22-P20 AutoBlank AutoBlank CDMC26560 4 14 14 DAC22-P20 AutoBlank AutoBlank CDMC26561 4 15 14 DAC23-D08 1-CG4720-RB_1 CG4720 TGCGGTACCATTGCATCAAACCCCATTGGATGTTCGCATTGGATAATCTGGTTAAGCGGGCCGTC 65 FBan0004720 FBgn0014006 Pk92B 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; programmed cell death; GO:0012501; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP/ERK kinase kinase activity; GO:0004710 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004710 ; EC:2.7.1.- Pk92B Protein kinase at 92B "CG4720, CG4720, MEKK5/ASK1, DASK1, DASK, Ask1, Apoptotic signal-regulating kinase 1, DPk92B/ASK1, ASK1" CDMC26561 4 16 14 DAC23-D08 1-CG4720-RB_1 CG4720 TGCGGTACCATTGCATCAAACCCCATTGGATGTTCGCATTGGATAATCTGGTTAAGCGGGCCGTC 65 FBan0004720 FBgn0014006 Pk92B 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; programmed cell death; GO:0012501; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP/ERK kinase kinase activity; GO:0004710 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004710 ; EC:2.7.1.- Pk92B Protein kinase at 92B "CG4720, CG4720, MEKK5/ASK1, DASK1, DASK, Ask1, Apoptotic signal-regulating kinase 1, DPk92B/ASK1, ASK1" CDMC26562 4 17 14 DAC23-D20 1-CG4784-RA_1 CG4784 GTGCCAATAGGTGCCTACTACACCCTGGTTTCTCCCAACACCAAGTACAGTGTTACCACGCCCAC 65 FBan0004784 FBgn0036619 CG4784 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG4784 CG4784 CT15377 CDMC26562 4 18 14 DAC23-D20 1-CG4784-RA_1 CG4784 GTGCCAATAGGTGCCTACTACACCCTGGTTTCTCCCAACACCAAGTACAGTGTTACCACGCCCAC 65 FBan0004784 FBgn0036619 CG4784 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG4784 CG4784 CT15377 CDMC26563 4 19 14 DAC23-H08 3-CG4969-RA_1 CG4969 GATGCAGTGACAACGTTAACTTTGGCCTTCGTCACTCGCGCGTTTTCCTTGACGCCAAGCAAAGG 65 FBan0004969 FBgn0031902 Wnt6 2 2L development; GO:0007275; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt6 Wnt6 "CG4969, DWnt6, DWnt-6" CDMC26563 4 20 14 DAC23-H08 3-CG4969-RA_1 CG4969 GATGCAGTGACAACGTTAACTTTGGCCTTCGTCACTCGCGCGTTTTCCTTGACGCCAAGCAAAGG 65 FBan0004969 FBgn0031902 Wnt6 2 2L development; GO:0007275; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt6 Wnt6 "CG4969, DWnt6, DWnt-6" CDMC26564 4 21 14 DAC23-H20 2-CG5026-RB_1 CG5026 GAACTTTCCTGTGCGATTCAGAGCGGGAGAGAAACGAACTGAATGTGCACACCAGGACGACGAGC 65 FBan0005026 FBgn0035945 CG5026 3 3L protein metabolism; GO:0019538 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG5026 CG5026 CDMC26564 4 22 14 DAC23-H20 2-CG5026-RB_1 CG5026 GAACTTTCCTGTGCGATTCAGAGCGGGAGAGAAACGAACTGAATGTGCACACCAGGACGACGAGC 65 FBan0005026 FBgn0035945 CG5026 3 3L protein metabolism; GO:0019538 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG5026 CG5026 CDMC26565 4 23 14 DAC23-L08 3-CG5188-RA_3 CG5188 GCCCGAGGAGATCAAGAAACCGGCGTACTACTTCAAGAATATGCCACCGGGTAACACGCTGGGAT 65 FBan0005188 FBgn0032247 CG5188 2 2L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG5188 CG5188 MAP1B CDMC26565 4 24 14 DAC23-L08 3-CG5188-RA_3 CG5188 GCCCGAGGAGATCAAGAAACCGGCGTACTACTTCAAGAATATGCCACCGGGTAACACGCTGGGAT 65 FBan0005188 FBgn0032247 CG5188 2 2L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG5188 CG5188 MAP1B CDMC26566 4 25 14 DAC23-L20 3-CG5205-RA_1 CG5205 TTCAGGCCCGATGGTTCGACGGTAGTGAGTTCCTAACGTTGCCAGGAGTGAACGAGGACAATCTC 65 FBan0005205 FBgn0038344 CG5205 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0008026 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG5205 CG5205 cg5205 CDMC26566 4 26 14 DAC23-L20 3-CG5205-RA_1 CG5205 TTCAGGCCCGATGGTTCGACGGTAGTGAGTTCCTAACGTTGCCAGGAGTGAACGAGGACAATCTC 65 FBan0005205 FBgn0038344 CG5205 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0008026 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG5205 CG5205 cg5205 CDMC26567 4 1 15 DAC23-P08 14-CG5330-RA_1 CG5330 AGTGCGCACCATTGTGAAGCAGGTTCCGACGGATTCCTTCTTCAATTTCTTCAGCCCACCAGAGG 65 FBan0005330 FBgn0015268 Nap1 2 2R "nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461; regulation of transcription, DNA-dependent; GO:0006355" histone binding; GO:0042393; ; GO:0042393; ; GO:0042393 NOT ACF complex; GO:0016590; cytoplasm; GO:0005737; nucleus; GO:0005634 Nap1 Nucleosome assembly protein 1 "CG5330, dNAP-1, NAP1, NAP-1, dNap1, p56/dCAF-4, dNAP1, Nap-1" CDMC26567 4 2 15 DAC23-P08 14-CG5330-RA_1 CG5330 AGTGCGCACCATTGTGAAGCAGGTTCCGACGGATTCCTTCTTCAATTTCTTCAGCCCACCAGAGG 65 FBan0005330 FBgn0015268 Nap1 2 2R "nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461; regulation of transcription, DNA-dependent; GO:0006355" histone binding; GO:0042393; ; GO:0042393; ; GO:0042393 NOT ACF complex; GO:0016590; cytoplasm; GO:0005737; nucleus; GO:0005634 Nap1 Nucleosome assembly protein 1 "CG5330, dNAP-1, NAP1, NAP-1, dNap1, p56/dCAF-4, dNAP1, Nap-1" CDMC26568 4 3 15 DAC23-P20 AutoBlank AutoBlank CDMC26568 4 4 15 DAC23-P20 AutoBlank AutoBlank CDMC26569 4 5 15 DAC24-D08 2-CG9207-RA_2 CG9207 ACCACTATGGACACTAAGAAGGGCCTGGTCTCGGAGTCGTATGAGGAAATAGTGTTCCAGGAGCCCACC 69 FBan0009207 FBgn0031873 Gas41 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Gas41 Gas41 "CG9207, CG9207, CG9207, CG9207, CG9207, GAS41, dGas41" CDMC26569 4 6 15 DAC24-D08 2-CG9207-RA_2 CG9207 ACCACTATGGACACTAAGAAGGGCCTGGTCTCGGAGTCGTATGAGGAAATAGTGTTCCAGGAGCCCACC 69 FBan0009207 FBgn0031873 Gas41 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Gas41 Gas41 "CG9207, CG9207, CG9207, CG9207, CG9207, GAS41, dGas41" CDMC26570 4 7 15 DAC24-D20 8-CG9215-RA_5 CG9215 ACCAGACGGAGCGATGGTCCTATCCCTGAATGACTTTCAAGCGCAGGATTCTATTACTCAGCAGGCAGA 69 FBan0009215 FBgn0030659 CG9215 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9215 CG9215 CDMC26570 4 8 15 DAC24-D20 8-CG9215-RA_5 CG9215 ACCAGACGGAGCGATGGTCCTATCCCTGAATGACTTTCAAGCGCAGGATTCTATTACTCAGCAGGCAGA 69 FBan0009215 FBgn0030659 CG9215 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9215 CG9215 CDMC26571 4 9 15 DAC24-H08 22-CG9258-RA_2 CG9258 GGCTGTTCCAAGGCCAATAACTATGGCTACAAGACGAACCAGCCCTGCATATTCTTGAAGCTGAATAAG 69 FBan0009258 FBgn0015776 nrv1 2 2L potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv1 nervana 1 "CG9258, nervana, Nrv1: Nirvana 1, 42kDa, Nervana, Na[+]/K[+]-ATPase, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, Nrv: Nirvana, Nirvana, Nirvana 1, Nrv1" CDMC26571 4 10 15 DAC24-H08 22-CG9258-RA_2 CG9258 GGCTGTTCCAAGGCCAATAACTATGGCTACAAGACGAACCAGCCCTGCATATTCTTGAAGCTGAATAAG 69 FBan0009258 FBgn0015776 nrv1 2 2L potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv1 nervana 1 "CG9258, nervana, Nrv1: Nirvana 1, 42kDa, Nervana, Na[+]/K[+]-ATPase, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, Nrv: Nirvana, Nirvana, Nirvana 1, Nrv1" CDMC26572 4 11 15 DAC24-H20 18-CG9267-RA_7 CG9267 CGACATGGAACCGCGCATGTATGCCAAACCCGTCGTTTTCTACGTTTTTATAATATGGTCTCTGGTCGA 69 FBan0009267 FBgn0032524 CG9267 2 2L protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG9267 CG9267 Q9VJX8 CDMC26572 4 12 15 DAC24-H20 18-CG9267-RA_7 CG9267 CGACATGGAACCGCGCATGTATGCCAAACCCGTCGTTTTCTACGTTTTTATAATATGGTCTCTGGTCGA 69 FBan0009267 FBgn0032524 CG9267 2 2L protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG9267 CG9267 Q9VJX8 CDMC26573 4 13 15 DAC24-L08 1-CG9307-RA_1 CG9307 GCGGCAGGAAGAACGGCCTAACGCAAATCCTGTACGACAACATGAAGAACTATCGGGTTCCGGAACCTA 69 FBan0009307 FBgn0038180 CG9307 3 3R chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG9307 CG9307 CDMC26573 4 14 15 DAC24-L08 1-CG9307-RA_1 CG9307 GCGGCAGGAAGAACGGCCTAACGCAAATCCTGTACGACAACATGAAGAACTATCGGGTTCCGGAACCTA 69 FBan0009307 FBgn0038180 CG9307 3 3R chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG9307 CG9307 CDMC26574 4 15 15 DAC24-L20 3-CG9316-RA_4 CG9316 TCCAGGCCATTGGATTCTGCTCGAAGGGATCAGGTCGTGATGTGGTGCTCAATGTAAAGGGAACCATGA 69 FBan0009316 FBgn0032878 CG9316 2 2L CG9316 CG9316 38E.9 CDMC26574 4 16 15 DAC24-L20 3-CG9316-RA_4 CG9316 TCCAGGCCATTGGATTCTGCTCGAAGGGATCAGGTCGTGATGTGGTGCTCAATGTAAAGGGAACCATGA 69 FBan0009316 FBgn0032878 CG9316 2 2L CG9316 CG9316 38E.9 CDMC26575 4 17 15 DAC24-P08 14-CG9350-RA_1 CG9350 GCCGATCCTCCCAAGAACTGGACCACGGAAAAGCCAAAGGAGTAAAGAAGGCGTAAAGTCTAGTTTCCT 69 FBan0009350 FBgn0034576 CG9350 2 2R CG9350 CG9350 BcDNA:RH51452 CDMC26575 4 18 15 DAC24-P08 14-CG9350-RA_1 CG9350 GCCGATCCTCCCAAGAACTGGACCACGGAAAAGCCAAAGGAGTAAAGAAGGCGTAAAGTCTAGTTTCCT 69 FBan0009350 FBgn0034576 CG9350 2 2R CG9350 CG9350 BcDNA:RH51452 CDMC26576 4 19 15 DAC24-P20 23-CG9359-RA_1 CG9359 GCTGTGATTTCTGGGTTACGAATAAATGTTGATTTATAAGCAGACAAGATTACCAACAGCATTTTGCAT 69 FBan0009359 FBgn0003889 betaTub85D 3 3R cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 betaTub85D beta-Tubulin at 85D "CG9359, CG9359, B2t, DTB4, beta85D, beta[[2]]-tubulin, beta2, beta2 tubulin, beta2-tubulin, 2t, testis-specific beta-tubulin, beta2t, beta2tub, beta-tubulin, Dmbeta2, beta tubulin, beta(2)Tu, tubulin, b2 tubulin, D.m.BETA-85D, beta2tubulin, BETA 85D, BETA2, betaTub85D, beta-Tubulin, Beta tubulin, beta-tub, beta-Tub85D, betaTub2, ms(3)KK[D]" CDMC26576 4 20 15 DAC24-P20 23-CG9359-RA_1 CG9359 GCTGTGATTTCTGGGTTACGAATAAATGTTGATTTATAAGCAGACAAGATTACCAACAGCATTTTGCAT 69 FBan0009359 FBgn0003889 betaTub85D 3 3R cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 betaTub85D beta-Tubulin at 85D "CG9359, CG9359, B2t, DTB4, beta85D, beta[[2]]-tubulin, beta2, beta2 tubulin, beta2-tubulin, 2t, testis-specific beta-tubulin, beta2t, beta2tub, beta-tubulin, Dmbeta2, beta tubulin, beta(2)Tu, tubulin, b2 tubulin, D.m.BETA-85D, beta2tubulin, BETA 85D, BETA2, betaTub85D, beta-Tubulin, Beta tubulin, beta-tub, beta-Tub85D, betaTub2, ms(3)KK[D]" CDMC26577 4 21 15 DAC25-D08 2-CG1058-RA_1 CG1058 CGGCTCCCAGATGTCCCGCTTGTCCATTTACTTCAAGCAGAGTCAGTTCATCACTTCAAAGCGGTCGGA 69 FBan0001058 FBgn0022981 rpk 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272; amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280; ; GO:0005272 membrane; GO:0016020 rpk ripped pocket "CG1058, RPK, dGNaC1: gonad-specific amiloride-sensitive sodium channel 1, GNaC1, gonad-specific amiloride-sensitive sodium channel 1, dGNaC1, ripped pocket" CDMC26577 4 22 15 DAC25-D08 2-CG1058-RA_1 CG1058 CGGCTCCCAGATGTCCCGCTTGTCCATTTACTTCAAGCAGAGTCAGTTCATCACTTCAAAGCGGTCGGA 69 FBan0001058 FBgn0022981 rpk 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272; amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280; ; GO:0005272 membrane; GO:0016020 rpk ripped pocket "CG1058, RPK, dGNaC1: gonad-specific amiloride-sensitive sodium channel 1, GNaC1, gonad-specific amiloride-sensitive sodium channel 1, dGNaC1, ripped pocket" CDMC26578 4 23 15 DAC25-D20 2-CG1059-RA_2 CG1059 CCGGCACTCGTATGCTCACTATCGTCAAACAAGTGGAATCGAATCCGGAGGTAATGGCTGCTTGTGCCA 69 FBan0001059 FBgn0011341 Karybeta3 3 3R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 cytosol; GO:0005829; nuclear pore; GO:0005643 Karybeta3 Karyopherin beta 3 "CG1059, CG1059, l(3)j3A4, l(3)j7E8, Karybeta3, Karyopherin beta 3" CDMC26578 4 24 15 DAC25-D20 2-CG1059-RA_2 CG1059 CCGGCACTCGTATGCTCACTATCGTCAAACAAGTGGAATCGAATCCGGAGGTAATGGCTGCTTGTGCCA 69 FBan0001059 FBgn0011341 Karybeta3 3 3R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 cytosol; GO:0005829; nuclear pore; GO:0005643 Karybeta3 Karyopherin beta 3 "CG1059, CG1059, l(3)j3A4, l(3)j7E8, Karybeta3, Karyopherin beta 3" CDMC26579 4 25 15 DAC25-H08 2-CG10627-RA_1 CG10627 GCAGTGCCCACCTGTAGAGCGGAATGACGAACTAACCTCTCACGGGAATCGACAATTGACACAGATCCT 69 FBan0010627 FBgn0036298 CG10627 3 3L monosaccharide metabolism; GO:0005996 phosphoacetylglucosamine mutase activity; GO:0004610 ; EC:5.4.2.3; ; GO:0004610 ; EC:5.4.2.3 CG10627 CG10627 CDMC26579 4 26 15 DAC25-H08 2-CG10627-RA_1 CG10627 GCAGTGCCCACCTGTAGAGCGGAATGACGAACTAACCTCTCACGGGAATCGACAATTGACACAGATCCT 69 FBan0010627 FBgn0036298 CG10627 3 3L monosaccharide metabolism; GO:0005996 phosphoacetylglucosamine mutase activity; GO:0004610 ; EC:5.4.2.3; ; GO:0004610 ; EC:5.4.2.3 CG10627 CG10627 CDMC26580 4 1 16 DAC25-H20 3-CG10633-RA_2 CG10633 GAGGCCGATGAAGACGAACCAGTGGATCCAAATCCAGTCTCCACAGATCCTGCCAAATCCTATCGGGAT 69 FBan0010633 FBgn0035604 CG10633 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG10633 CG10633 CT29782 CDMC26580 4 2 16 DAC25-H20 3-CG10633-RA_2 CG10633 GAGGCCGATGAAGACGAACCAGTGGATCCAAATCCAGTCTCCACAGATCCTGCCAAATCCTATCGGGAT 69 FBan0010633 FBgn0035604 CG10633 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG10633 CG10633 CT29782 CDMC26581 4 3 16 DAC25-L08 2-CG10669-RA_1 CG10669 GCAAGATTTGTGACATCCAGTTTGTCAGCGTGGCAGACTTGCGAAGGCACATATCTATGCAGGGCCACA 69 FBan0010669 FBgn0039329 CG10669 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10669 CG10669 CDMC26581 4 4 16 DAC25-L08 2-CG10669-RA_1 CG10669 GCAAGATTTGTGACATCCAGTTTGTCAGCGTGGCAGACTTGCGAAGGCACATATCTATGCAGGGCCACA 69 FBan0010669 FBgn0039329 CG10669 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10669 CG10669 CDMC26582 4 5 16 DAC25-L20 15-CG10675-RA_2 CG10675 AGCCTGTTCATCTGAAGTTTCCAGGAGAGCCGGTAAAAAGCGACTACATTCTTTTGGAGGATCTGCGGA 69 FBan0010675 FBgn0039328 CG10675 3 3R CG10675 CG10675 CDMC26582 4 6 16 DAC25-L20 15-CG10675-RA_2 CG10675 AGCCTGTTCATCTGAAGTTTCCAGGAGAGCCGGTAAAAAGCGACTACATTCTTTTGGAGGATCTGCGGA 69 FBan0010675 FBgn0039328 CG10675 3 3R CG10675 CG10675 CDMC26583 4 7 16 DAC25-P08 22-CG1070-RC_1 CG1070 CTCCAACAGAACCACCACAAATTTTGTTTAGCCAATCGAGTAGCCACACCATGAACATAGCGACAACCT 69 FBan0001070 FBgn0037471 Alh 3 3R "larval development (sensu Insecta); GO:0002168; molting cycle (sensu Insecta); GO:0007591; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Alh Alhambra "CG1070, l(3)j8C8, AF10, Dalf, anon-WO0118547.226, l(3)j13A6, Alhambra" CDMC26583 4 8 16 DAC25-P08 22-CG1070-RC_1 CG1070 CTCCAACAGAACCACCACAAATTTTGTTTAGCCAATCGAGTAGCCACACCATGAACATAGCGACAACCT 69 FBan0001070 FBgn0037471 Alh 3 3R "larval development (sensu Insecta); GO:0002168; molting cycle (sensu Insecta); GO:0007591; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Alh Alhambra "CG1070, l(3)j8C8, AF10, Dalf, anon-WO0118547.226, l(3)j13A6, Alhambra" CDMC26584 4 9 16 DAC25-P20 13-CG10728-RA_1 CG10728 GGGTGACAATCACATCTATCTCGGGGACTATGACGGCAAAGTTCATACTCTGGACATTCGAGTGCCACG 69 FBgn0032841 CDMC26584 4 10 16 DAC25-P20 13-CG10728-RA_1 CG10728 GGGTGACAATCACATCTATCTCGGGGACTATGACGGCAAAGTTCATACTCTGGACATTCGAGTGCCACG 69 FBgn0032841 CDMC26585 4 11 16 DAC26-D08 23-CG8053-RB_2 CG8053 GCAGCGGCAGTTAAATTGCGAAACCAAACCTATAGTATCAGTTCATTTATAGCCATTTTTAATGTTCTA 69 FBan0008053 FBgn0026250 eIF-1A 3 3R protein biosynthesis; GO:0006412; smoothened signaling pathway; GO:0007224; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic 43S preinitiation complex; GO:0016282 eIF-1A Eukaryotic initiation factor 1A "CG8053, CG8053, clone 2.3, anon-EST:Liang-2.3, D-eIF4c, Eukaryotic initiation factor 4c, eIF-4c, D-eIF1A, eIF1A, EP(3)0935, Group I, group I, anon-EST:Posey4, EP935, Eukaryotic initiation factor 1A" CDMC26585 4 12 16 DAC26-D08 23-CG8053-RB_2 CG8053 GCAGCGGCAGTTAAATTGCGAAACCAAACCTATAGTATCAGTTCATTTATAGCCATTTTTAATGTTCTA 69 FBan0008053 FBgn0026250 eIF-1A 3 3R protein biosynthesis; GO:0006412; smoothened signaling pathway; GO:0007224; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic 43S preinitiation complex; GO:0016282 eIF-1A Eukaryotic initiation factor 1A "CG8053, CG8053, clone 2.3, anon-EST:Liang-2.3, D-eIF4c, Eukaryotic initiation factor 4c, eIF-4c, D-eIF1A, eIF1A, EP(3)0935, Group I, group I, anon-EST:Posey4, EP935, Eukaryotic initiation factor 1A" CDMC26586 4 13 16 DAC26-D20 10-CG8065-RA_1 CG8065 TCGGTAGACCTGGGAATTTCCCCAAAGAACGGGAGCAACAAGTTTGTCATGAACGAAACTCCTTCCGGG 69 FBan0008065 FBgn0036075 CG8065 3 3L CG8065 CG8065 CDMC26586 4 14 16 DAC26-D20 10-CG8065-RA_1 CG8065 TCGGTAGACCTGGGAATTTCCCCAAAGAACGGGAGCAACAAGTTTGTCATGAACGAAACTCCTTCCGGG 69 FBan0008065 FBgn0036075 CG8065 3 3L CG8065 CG8065 CDMC26587 4 15 16 DAC26-H08 21-CG8097-RA_5 CG8097 TATGGCTACCTCCTTACCTTTCCGGAGCTAATGGAGTCCATAATGGATCAATTGGACCAGGGTCATTGC 69 FBan0008097 FBgn0030660 CG8097 X X arginyl-tRNA aminoacylation; GO:0006420 ATP binding; GO:0005524; ; GO:0005524; arginine-tRNA ligase activity; GO:0004814 ; EC:6.1.1.19; ; GO:0004814 ; EC:6.1.1.19 CG8097 CG8097 CDMC26587 4 16 16 DAC26-H08 21-CG8097-RA_5 CG8097 TATGGCTACCTCCTTACCTTTCCGGAGCTAATGGAGTCCATAATGGATCAATTGGACCAGGGTCATTGC 69 FBan0008097 FBgn0030660 CG8097 X X arginyl-tRNA aminoacylation; GO:0006420 ATP binding; GO:0005524; ; GO:0005524; arginine-tRNA ligase activity; GO:0004814 ; EC:6.1.1.19; ; GO:0004814 ; EC:6.1.1.19 CG8097 CG8097 CDMC26588 4 17 16 DAC26-H20 17-CG8108-RA_6 CG8108 GCCAGCCCAAGAATCTTCATCAGGCCTCCGAACACCACAAGACCATTAAGAAGTTCTTAATGCCCTATT 69 FBan0008108 FBgn0027567 CG8108 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8108 CG8108 BcDNA:GH07921 CDMC26588 4 18 16 DAC26-H20 17-CG8108-RA_6 CG8108 GCCAGCCCAAGAATCTTCATCAGGCCTCCGAACACCACAAGACCATTAAGAAGTTCTTAATGCCCTATT 69 FBan0008108 FBgn0027567 CG8108 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8108 CG8108 BcDNA:GH07921 CDMC26589 4 19 16 DAC26-L08 23-CG8144-RC_3 CG8144 CGTTGCGTGTTTTGTTTTTGGTACTCCCAACCAACTTATACGATACGATACGTTACATGGGGCATATAT 69 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC26589 4 20 16 DAC26-L08 23-CG8144-RC_3 CG8144 CGTTGCGTGTTTTGTTTTTGGTACTCCCAACCAACTTATACGATACGATACGTTACATGGGGCATATAT 69 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC26590 4 21 16 DAC26-L20 1-CG8165-RA_1 CG8165 AGATGTTTGTGCCACCAGACTTAGGACCCAAAATGTACAACGCATATGGCTCAGCATTGCACCCCGACA 69 FBan0008165 FBgn0037703 CG8165 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG8165 CG8165 CG31123 CDMC26590 4 22 16 DAC26-L20 1-CG8165-RA_1 CG8165 AGATGTTTGTGCCACCAGACTTAGGACCCAAAATGTACAACGCATATGGCTCAGCATTGCACCCCGACA 69 FBan0008165 FBgn0037703 CG8165 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG8165 CG8165 CG31123 CDMC26591 4 23 16 DAC26-P08 2-CG8192-RA_1 CG8192 TGCAGTGGAGTGAGCAGTAAACAGTCTTGTCGTTCCCTCGGATCCACCTCTCGTGTATATTCCCCGTCT 69 FBan0008192 FBgn0034030 CG8192 2 2R CG8192 CG8192 CDMC26591 4 24 16 DAC26-P08 2-CG8192-RA_1 CG8192 TGCAGTGGAGTGAGCAGTAAACAGTCTTGTCGTTCCCTCGGATCCACCTCTCGTGTATATTCCCCGTCT 69 FBan0008192 FBgn0034030 CG8192 2 2R CG8192 CG8192 CDMC26592 4 25 16 DAC26-P20 17-CG8205-RE_2 CG8205 GCGATTTGTGAAATGGGATTGCATTTTAATTCTAGCGGCGATCTTTTCCCGTGTCTCTCCATGGCAGCT 69 FBan0008205 FBgn0023441 fus 2 2R epidermal growth factor receptor signaling pathway; GO:0007173 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fus fusilli "CG8205, CG8205, E(cact[E10])7, Enhancer of cactus[E10], number 7, cg8205, fusilli" CDMC26592 4 26 16 DAC26-P20 17-CG8205-RE_2 CG8205 GCGATTTGTGAAATGGGATTGCATTTTAATTCTAGCGGCGATCTTTTCCCGTGTCTCTCCATGGCAGCT 69 FBan0008205 FBgn0023441 fus 2 2R epidermal growth factor receptor signaling pathway; GO:0007173 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fus fusilli "CG8205, CG8205, E(cact[E10])7, Enhancer of cactus[E10], number 7, cg8205, fusilli" CDMC26593 4 1 17 DAC27-D08 16-CG8441-RA_2 CG8441 AGCGCAGAGGACACAAATGCAGTGGAATTAGATAGCACCGAAGCTACAAAGGAATCCCAAAATGTGGAT 69 FBan0008441 FBgn0034086 CG8441 2 2R CG8441 CG8441 CDMC26593 4 2 17 DAC27-D08 16-CG8441-RA_2 CG8441 AGCGCAGAGGACACAAATGCAGTGGAATTAGATAGCACCGAAGCTACAAAGGAATCCCAAAATGTGGAT 69 FBan0008441 FBgn0034086 CG8441 2 2R CG8441 CG8441 CDMC26594 4 3 17 DAC27-D20 7-CG8451-RA_1 CG8451 CGATACATGTCTCTTCCATCGCTCAAGAAGGCTCGTGCTTCCATGGCCATTTTTACAATTGGCGTGGCT 69 FBan0008451 FBgn0031998 CG8451 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG8451 CG8451 CDMC26594 4 4 17 DAC27-D20 7-CG8451-RA_1 CG8451 CGATACATGTCTCTTCCATCGCTCAAGAAGGCTCGTGCTTCCATGGCCATTTTTACAATTGGCGTGGCT 69 FBan0008451 FBgn0031998 CG8451 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG8451 CG8451 CDMC26595 4 5 17 DAC27-H08 22-CG8495-RC_1 CG8495 TGCCCCCGGTTGAGTACGGAAATACGTGTTTAGCATCTAGAACAGTTTCCTTAATTAAGGGTGGCCAAA 69 FBan0008495 FBgn0037752 RpS29 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS29 Ribosomal protein S29 "CG8495, anon-WO0118547.360, BcDNA:AT28563, BcDNA:AT13329, BcDNA:RH06643, anon-EST:fe3B4, anon-fast-evolving-3B4, Ribosomal protein S29" CDMC26595 4 6 17 DAC27-H08 22-CG8495-RC_1 CG8495 TGCCCCCGGTTGAGTACGGAAATACGTGTTTAGCATCTAGAACAGTTTCCTTAATTAAGGGTGGCCAAA 69 FBan0008495 FBgn0037752 RpS29 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS29 Ribosomal protein S29 "CG8495, anon-WO0118547.360, BcDNA:AT28563, BcDNA:AT13329, BcDNA:RH06643, anon-EST:fe3B4, anon-fast-evolving-3B4, Ribosomal protein S29" CDMC26596 4 7 17 DAC27-H20 10-CG8505-RA_1 CG8505 AACGGATGTGAGGGACAACACGACACGAGAACCACATGACAACACCATGATACTGATAGCCCAGTCTGA 69 FBan0008505 FBgn0033728 CG8505 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8505 CG8505 CDMC26596 4 8 17 DAC27-H20 10-CG8505-RA_1 CG8505 AACGGATGTGAGGGACAACACGACACGAGAACCACATGACAACACCATGATACTGATAGCCCAGTCTGA 69 FBan0008505 FBgn0033728 CG8505 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8505 CG8505 CDMC26597 4 9 17 DAC27-L08 2-CG8546-RA_4 CG8546 TCTGGGACAAGTGGAACAACAATCCGGTTATTGTCAGTTTCGCCGAGAAATCCACTCCGGTGTGGCAAA 69 FBan0008546 FBgn0035785 CG8546 3 3L cation transport; GO:0006812; sodium ion transport; GO:0006814 amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280 membrane; GO:0016020 CG8546 CG8546 CDMC26597 4 10 17 DAC27-L08 2-CG8546-RA_4 CG8546 TCTGGGACAAGTGGAACAACAATCCGGTTATTGTCAGTTTCGCCGAGAAATCCACTCCGGTGTGGCAAA 69 FBan0008546 FBgn0035785 CG8546 3 3L cation transport; GO:0006812; sodium ion transport; GO:0006814 amiloride-sensitive sodium channel activity; GO:0015280; ; GO:0015280 membrane; GO:0016020 CG8546 CG8546 CDMC26598 4 11 17 DAC27-L20 2-CG8553-RA_1 CG8553 CGTGCGCCAATGTGCTCAGCGATTTGTATGCCATGGGAGTCACAGATTGCGATAACATGCTGATGCTGT 69 FBan0008553 FBgn0020615 SelD 2 2R cell proliferation; GO:0008283; imaginal disc development; GO:0007444; selenocysteine biosynthesis; GO:0016260 "ATP binding; GO:0005524; ; GO:0005524; NOT selenide, water dikinase activity; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3" SelD "selenide,water dikinase" "CG8553, CG8553, SeS, Selenophosphate synthetase, Dm-SelD, ptuf, patufet, ptuf1, selD-like, Dm SelD, SPS1, selD, anon-WO0172774.145, anon-WO0172774.146, l(2)k12303, ptf1: patufet" CDMC26598 4 12 17 DAC27-L20 2-CG8553-RA_1 CG8553 CGTGCGCCAATGTGCTCAGCGATTTGTATGCCATGGGAGTCACAGATTGCGATAACATGCTGATGCTGT 69 FBan0008553 FBgn0020615 SelD 2 2R cell proliferation; GO:0008283; imaginal disc development; GO:0007444; selenocysteine biosynthesis; GO:0016260 "ATP binding; GO:0005524; ; GO:0005524; NOT selenide, water dikinase activity; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3" SelD "selenide,water dikinase" "CG8553, CG8553, SeS, Selenophosphate synthetase, Dm-SelD, ptuf, patufet, ptuf1, selD-like, Dm SelD, SPS1, selD, anon-WO0172774.145, anon-WO0172774.146, l(2)k12303, ptf1: patufet" CDMC26599 4 13 17 DAC27-P08 12-CG8592-RA_3 CG8592 ACTTGGACGGTTCTGAAGAAAAGATGGAGCTGAAAAAGCATGTGCCGTACATCCTGAACGGGGAACTGT 69 FBan0008592 FBgn0003527 stil 2 2R development; GO:0007275; female sex determination; GO:0030237; female sex differentiation; GO:0046660; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 nuclear chromatin; GO:0000790 stil stand still "CG8592, STAND STILL, Y10276" CDMC26599 4 14 17 DAC27-P08 12-CG8592-RA_3 CG8592 ACTTGGACGGTTCTGAAGAAAAGATGGAGCTGAAAAAGCATGTGCCGTACATCCTGAACGGGGAACTGT 69 FBan0008592 FBgn0003527 stil 2 2R development; GO:0007275; female sex determination; GO:0030237; female sex differentiation; GO:0046660; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 nuclear chromatin; GO:0000790 stil stand still "CG8592, STAND STILL, Y10276" CDMC26600 4 15 17 DAC27-P20 2-CG8601-RA_2 CG8601 GGCAATGGATCGCAAGGTTCACATTCTCCCAACAAGAGTGCTCTTAGCAAGGAGCGTGCTGAATTCGGA 69 FBgn0035764 CDMC26600 4 16 17 DAC27-P20 2-CG8601-RA_2 CG8601 GGCAATGGATCGCAAGGTTCACATTCTCCCAACAAGAGTGCTCTTAGCAAGGAGCGTGCTGAATTCGGA 69 FBgn0035764 CDMC26601 4 17 17 DAC28-D08 17-CG3035-RA_1 CG3035 ACTGCTGCATTAAGTTATCCGGCATGCCAGATCTGACGTTATCTTTCATGAATCCTCGCCTCTTCGACG 69 FBan0003035 FBgn0000330 cm X X "intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; neurotransmitter secretion; GO:0007269; ommochrome biosynthesis; GO:0006727; pinocytosis; GO:0006907; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901" clathrin adaptor complex; GO:0030131; clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; nucleus; GO:0005634; synaptic vesicle; GO:0008021 cm carmine "CG3035, CG32731, CG3035, CG3035, AP-3, mu3, mu3, Dmu3, cg3035, Mu3, l(1)VEM119" CDMC26601 4 18 17 DAC28-D08 17-CG3035-RA_1 CG3035 ACTGCTGCATTAAGTTATCCGGCATGCCAGATCTGACGTTATCTTTCATGAATCCTCGCCTCTTCGACG 69 FBan0003035 FBgn0000330 cm X X "intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; neurotransmitter secretion; GO:0007269; ommochrome biosynthesis; GO:0006727; pinocytosis; GO:0006907; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901" clathrin adaptor complex; GO:0030131; clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; nucleus; GO:0005634; synaptic vesicle; GO:0008021 cm carmine "CG3035, CG32731, CG3035, CG3035, AP-3, mu3, mu3, Dmu3, cg3035, Mu3, l(1)VEM119" CDMC26602 4 19 17 DAC28-D20 8-CG30372-RA_1 CG30372 CGAGGAAGGGCATGTTTCCCGTCAGTTTCGTGCATATGCTGCCTGATTAATCAATCCCCTGTTTGTGCT 69 FBan0030372 FBgn0050372 CG30372 2 2R regulation of GTPase activity; GO:0043087; small GTPase mediated signal transduction; GO:0007264 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG30372 CG30372 "CG2226, CG14758, CG2226, CG2226" CDMC26602 4 20 17 DAC28-D20 8-CG30372-RA_1 CG30372 CGAGGAAGGGCATGTTTCCCGTCAGTTTCGTGCATATGCTGCCTGATTAATCAATCCCCTGTTTGTGCT 69 FBan0030372 FBgn0050372 CG30372 2 2R regulation of GTPase activity; GO:0043087; small GTPase mediated signal transduction; GO:0007264 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG30372 CG30372 "CG2226, CG14758, CG2226, CG2226" CDMC26603 4 21 17 DAC28-H08 16-CG30411-RA_1 CG30411 GGCTCATCTCGAGGTGTCCATCTATGGAGTGGACCTGTAGGCTGTCTGACCCATTGTTGTAAATATCAA 69 FBan0030411 FBgn0050411 CG30411 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30411 CG30411 BcDNA:RE06996 CDMC26603 4 22 17 DAC28-H08 16-CG30411-RA_1 CG30411 GGCTCATCTCGAGGTGTCCATCTATGGAGTGGACCTGTAGGCTGTCTGACCCATTGTTGTAAATATCAA 69 FBan0030411 FBgn0050411 CG30411 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30411 CG30411 BcDNA:RE06996 CDMC26604 4 23 17 DAC28-H20 14-CG30427-RC_1 CG30427 TGGGTTTGGAAGTTTTGCAGTTCTTTACCACGCGAAGCTGGGACTTTAAATCCACACACTTCGAGCAGA 69 FBgn0050427 CDMC26604 4 24 17 DAC28-H20 14-CG30427-RC_1 CG30427 TGGGTTTGGAAGTTTTGCAGTTCTTTACCACGCGAAGCTGGGACTTTAAATCCACACACTTCGAGCAGA 69 FBgn0050427 CDMC26605 4 25 17 DAC28-L08 8-CG30460-RC_1 CG30460 AGGAGGCGAGTCGTACAGTAGCGGATCCGAACACTCTTTTGCAACCAATCCAAAACAGGAGCAGAACAT 69 FBan0030460 FBgn0050460 CG30460 2 2R CG30460 CG30460 "CG15607, CG15608, CG15607, anon-WO0140519.237" CDMC26605 4 26 17 DAC28-L08 8-CG30460-RC_1 CG30460 AGGAGGCGAGTCGTACAGTAGCGGATCCGAACACTCTTTTGCAACCAATCCAAAACAGGAGCAGAACAT 69 FBan0030460 FBgn0050460 CG30460 2 2R CG30460 CG30460 "CG15607, CG15608, CG15607, anon-WO0140519.237" CDMC26606 4 1 18 DAC28-L20 23-CG30472-RA_1 CG30472 TGGAGGGCTATTTCACATTGATAGTCGCATCTTTAATTTGTAAATTCCAAGACAAGCAAGATGAGTGTA 69 FBan0030472 FBgn0050472 CG30472 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30472 CG30472 CDMC26606 4 2 18 DAC28-L20 23-CG30472-RA_1 CG30472 TGGAGGGCTATTTCACATTGATAGTCGCATCTTTAATTTGTAAATTCCAAGACAAGCAAGATGAGTGTA 69 FBan0030472 FBgn0050472 CG30472 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30472 CG30472 CDMC26607 4 3 18 DAC28-P08 23-CG30497-RA_5 CG30497 TATATCCACAACAAATGAAAGACAAATGGTCCACAGAGCAAAATGAGTCGAAGATGAGTGGATGTGGAT 69 FBan0030497 FBgn0050497 CG30497 2 2R CG30497 CG30497 "CG1383, CG1557, CG1383, CG1383, EP(2)2618, anon-WO0118547.176, NEST:bs36c04, BEST:LD33067" CDMC26607 4 4 18 DAC28-P08 23-CG30497-RA_5 CG30497 TATATCCACAACAAATGAAAGACAAATGGTCCACAGAGCAAAATGAGTCGAAGATGAGTGGATGTGGAT 69 FBan0030497 FBgn0050497 CG30497 2 2R CG30497 CG30497 "CG1383, CG1557, CG1383, CG1383, EP(2)2618, anon-WO0118547.176, NEST:bs36c04, BEST:LD33067" CDMC26608 4 5 18 DAC28-P20 1-CG3056-RB_1 CG3056 CGGTTCCGGTCTCTCTTCCTGTTACCATGAACAGAGCCAGTCCACAAGCTTAAAGTGAGTGCAGACGGA 69 FBan0003056 FBgn0024987 CG3056 X X "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398; sex determination; GO:0007530" mRNA binding; GO:0003729; ; GO:0003729 CG3056 CG3056 "cg3056, EG:132E8.1, anon-EST:Posey102" CDMC26608 4 6 18 DAC28-P20 1-CG3056-RB_1 CG3056 CGGTTCCGGTCTCTCTTCCTGTTACCATGAACAGAGCCAGTCCACAAGCTTAAAGTGAGTGCAGACGGA 69 FBan0003056 FBgn0024987 CG3056 X X "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398; sex determination; GO:0007530" mRNA binding; GO:0003729; ; GO:0003729 CG3056 CG3056 "cg3056, EG:132E8.1, anon-EST:Posey102" CDMC26609 4 7 18 DAC29-D08 2-CG9993-RA_2 CG9993 TGAGCGCGGTCAAAAGCAGTCTCAAGTTCAAGACGGAGATCATTCTGCTCACTGGAACTCTGCCTGGAG 69 FBan0009993 FBgn0034553 CG9993 2 2R metabolism; GO:0008152; proteolysis; GO:0006508 ligase activity; GO:0016874 ; EC:6.-.-.-; serine-type peptidase activity; GO:0008236; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008236; ; GO:0016207 ; EC:6.2.1.12 membrane; GO:0016020 CG9993 CG9993 CDMC26609 4 8 18 DAC29-D08 2-CG9993-RA_2 CG9993 TGAGCGCGGTCAAAAGCAGTCTCAAGTTCAAGACGGAGATCATTCTGCTCACTGGAACTCTGCCTGGAG 69 FBan0009993 FBgn0034553 CG9993 2 2R metabolism; GO:0008152; proteolysis; GO:0006508 ligase activity; GO:0016874 ; EC:6.-.-.-; serine-type peptidase activity; GO:0008236; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008236; ; GO:0016207 ; EC:6.2.1.12 membrane; GO:0016020 CG9993 CG9993 CDMC26610 4 9 18 DAC29-D20 2-CG9999-RA_1 CG9999 GGCCGTCTCCTTGTACCAGGCCACCTTTGACTATGCCATCAAGACAAAGCAGGAGACACGTGTACTCAA 69 FBan0009999 FBgn0003346 RanGap 2 2L meiotic chromosome segregation; GO:0045132; nucleocytoplasmic transport; GO:0006913; signal transduction; GO:0007165 Ran GTPase activator activity; GO:0005098; ; GO:0005098; ; GO:0005098 cytoplasm; GO:0005737 RanGap Ran GTPase activating protein "CG9999, CG9999, CG9999, Sd: Segregation distorter, SD, Segregation distorter, rangap, dRanGAP, CT28175, Scl, RanGAP, ranGAP, Sd" CDMC26610 4 10 18 DAC29-D20 2-CG9999-RA_1 CG9999 GGCCGTCTCCTTGTACCAGGCCACCTTTGACTATGCCATCAAGACAAAGCAGGAGACACGTGTACTCAA 69 FBan0009999 FBgn0003346 RanGap 2 2L meiotic chromosome segregation; GO:0045132; nucleocytoplasmic transport; GO:0006913; signal transduction; GO:0007165 Ran GTPase activator activity; GO:0005098; ; GO:0005098; ; GO:0005098 cytoplasm; GO:0005737 RanGap Ran GTPase activating protein "CG9999, CG9999, CG9999, Sd: Segregation distorter, SD, Segregation distorter, rangap, dRanGAP, CT28175, Scl, RanGAP, ranGAP, Sd" CDMC26611 4 11 18 DAC29-H08 8-CR31400-RC_1 CR31400 ACTGGTGTATCGACTTCTCTGCTCCACTATGGGTGAAGGATACCCTACCGAAAAGGCCTTCTGTCGCTT 69 FBan0031400 FBgn0001234 Hsromega 3 3R nuclear speck organization and biogenesis; GO:0035063; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; response to heat; GO:0009408 chromatin; GO:0000785; omega speckle; GO:0035062 Hsromega Heat shock RNA omega "er3, hsr-omega, 93D locus, hsrw, hsr omega, Hsr-omega, heat-shock RNA-omega, l(3)05241, hsromega, n(3)05241, Hsr omega, Hsr93D, Heat-shock response factor-omega, hsr-omega, Hsromega, l(3)93De, l(3)er3, CR31400" CDMC26611 4 12 18 DAC29-H08 8-CR31400-RC_1 CR31400 ACTGGTGTATCGACTTCTCTGCTCCACTATGGGTGAAGGATACCCTACCGAAAAGGCCTTCTGTCGCTT 69 FBan0031400 FBgn0001234 Hsromega 3 3R nuclear speck organization and biogenesis; GO:0035063; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; response to heat; GO:0009408 chromatin; GO:0000785; omega speckle; GO:0035062 Hsromega Heat shock RNA omega "er3, hsr-omega, 93D locus, hsrw, hsr omega, Hsr-omega, heat-shock RNA-omega, l(3)05241, hsromega, n(3)05241, Hsr omega, Hsr93D, Heat-shock response factor-omega, hsr-omega, Hsromega, l(3)93De, l(3)er3, CR31400" CDMC26612 4 13 18 DAC29-H20 23-CR31808-RA_16 CR31808 AATCCACTTATTGCGTTTATTCGGGTTTATTAGTGCTTAAGTTTCGAGAACAGCCGACTACAACACGAG 69 FBan0031808 FBgn0062978 CR31808 2 2L CR31808 CR31808 "BcDNA:RE70695, RE70695" CDMC26612 4 14 18 DAC29-H20 23-CR31808-RA_16 CR31808 AATCCACTTATTGCGTTTATTCGGGTTTATTAGTGCTTAAGTTTCGAGAACAGCCGACTACAACACGAG 69 FBan0031808 FBgn0062978 CR31808 2 2L CR31808 CR31808 "BcDNA:RE70695, RE70695" CDMC26613 4 15 18 DAC29-L08 24-CR32660-RA_2 CR32660 ACAAATCGACTTAACACTACATGCTTATATGTATACACTTGTACACGAATCTACAAATATAATATTGTT 69 FBan0032660 FBgn0052660 CR32660 X X CR32660 CR32660 CDMC26613 4 16 18 DAC29-L08 24-CR32660-RA_2 CR32660 ACAAATCGACTTAACACTACATGCTTATATGTATACACTTGTACACGAATCTACAAATATAATATTGTT 69 FBan0032660 FBgn0052660 CR32660 X X CR32660 CR32660 CDMC26614 4 17 18 DAC29-L20 12-CR32863-RA_2 CR32863 GAAATGAAACACGCGCTTTTGTCGACCCAGGAGCCAGTTAGGTCTAAGCTGTTTGTCATGGTGACGACG 69 FBan0032863 FBgn0043853 snoRNA:U85 3 3R nucleolus; GO:0005730 snoRNA:U85 snoRNA:U85 "CG31504, U85 scaRNA, CR32863" CDMC26614 4 18 18 DAC29-L20 12-CR32863-RA_2 CR32863 GAAATGAAACACGCGCTTTTGTCGACCCAGGAGCCAGTTAGGTCTAAGCTGTTTGTCATGGTGACGACG 69 FBan0032863 FBgn0043853 snoRNA:U85 3 3R nucleolus; GO:0005730 snoRNA:U85 snoRNA:U85 "CG31504, U85 scaRNA, CR32863" CDMC26615 4 19 18 DAC29-P08 8-CR33471-RA_1 CR33471 GGTTCCATGCATTCGAAAGCGGAATCGTGAATAAAATCACCTGGGATGCCTATCGGGAGTCAGTTGGCC 69 FBan0033471 FBgn0053471 CR33471 2 2R CR33471 CR33471 CDMC26615 4 20 18 DAC29-P08 8-CR33471-RA_1 CR33471 GGTTCCATGCATTCGAAAGCGGAATCGTGAATAAAATCACCTGGGATGCCTATCGGGAGTCAGTTGGCC 69 FBan0033471 FBgn0053471 CR33471 2 2R CR33471 CR33471 CDMC26616 4 21 18 DAC29-P20 2-CR41111-RA_1 CR41111 ACGTACGAGAAATACGCCGACCAGACAGAGACAATGACAAGGACGCTTACAGAAGACCACCGGACACCA 69 FBgn0069906 CR41111 CR41111 CR41111 CDMC26616 4 22 18 DAC29-P20 2-CR41111-RA_1 CR41111 ACGTACGAGAAATACGCCGACCAGACAGAGACAATGACAAGGACGCTTACAGAAGACCACCGGACACCA 69 FBgn0069906 CR41111 CR41111 CR41111 CDMC26617 4 23 18 DAC30-D08 23-CG12003-RA_3 CG12003 AAACAGTCGAAATTATAGTTCTTAGAGGGAGATTACCATCAAAATTGCCAATCGAAGCCAGCATTGTGG 69 FBan0012003 FBgn0035234 CG12003 3 3L CG12003 CG12003 CDMC26617 4 24 18 DAC30-D08 23-CG12003-RA_3 CG12003 AAACAGTCGAAATTATAGTTCTTAGAGGGAGATTACCATCAAAATTGCCAATCGAAGCCAGCATTGTGG 69 FBan0012003 FBgn0035234 CG12003 3 3L CG12003 CG12003 CDMC26618 4 25 18 DAC30-D20 8-CG12011-RA_1 CG12011 GCTCCTCCCGAATCCATTCTATGTGAACAAGAACCAGGACATTAACCAGTCTCAGGTCGTGAGCCTGCC 69 FBan0012011 FBgn0035257 CG12011 3 3L CG12011 CG12011 "clone 1.72, anon-EST:Liang-1.72" CDMC26618 4 26 18 DAC30-D20 8-CG12011-RA_1 CG12011 GCTCCTCCCGAATCCATTCTATGTGAACAAGAACCAGGACATTAACCAGTCTCAGGTCGTGAGCCTGCC 69 FBan0012011 FBgn0035257 CG12011 3 3L CG12011 CG12011 "clone 1.72, anon-EST:Liang-1.72" CDMC26619 4 1 19 DAC30-H08 3-CG12051-RA_1 CG12051 GGCGTGGTCGTTCCTCATCGAACACACCCATTGCAGACAAAGGATGGGAGTCAAAAGTATTGGGCATGA 69 FBan0012051 FBgn0000043 Act42A 2 2R cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act42A Actin 42A "CG12051, CG12051, CG12051, actin, Actin, A, act42A, act 42A, BAP47, 42A actin., C: Group C" CDMC26619 4 2 19 DAC30-H08 3-CG12051-RA_1 CG12051 GGCGTGGTCGTTCCTCATCGAACACACCCATTGCAGACAAAGGATGGGAGTCAAAAGTATTGGGCATGA 69 FBan0012051 FBgn0000043 Act42A 2 2R cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act42A Actin 42A "CG12051, CG12051, CG12051, actin, Actin, A, act42A, act 42A, BAP47, 42A actin., C: Group C" CDMC26620 4 3 19 DAC30-H20 3-CG12052-RJ_1 CG12052 TAGTGCCGGGTTTGCTTCAGTCTGAGTCCAAAGTCCTAATCACACAGAGTTCAGTCCAGTCCAGAGCGC 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC26620 4 4 19 DAC30-H20 3-CG12052-RJ_1 CG12052 TAGTGCCGGGTTTGCTTCAGTCTGAGTCCAAAGTCCTAATCACACAGAGTTCAGTCCAGTCCAGAGCGC 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC26621 4 5 19 DAC30-L08 23-CG12079-RA_1 CG12079 AGCCAAGAAGTAATCCGAAGTCGGTTTGTTAAATGGTAATTAGATCAATAAAACGTGATCACTATGAGA 69 FBan0012079 FBgn0035404 CG12079 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12079 CG12079 CDMC26621 4 6 19 DAC30-L08 23-CG12079-RA_1 CG12079 AGCCAAGAAGTAATCCGAAGTCGGTTTGTTAAATGGTAATTAGATCAATAAAACGTGATCACTATGAGA 69 FBan0012079 FBgn0035404 CG12079 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12079 CG12079 CDMC26622 4 7 19 DAC30-L20 10-CG12101-RA_1 CG12101 AGGGGGAGGGAGATGTGATGAGAACCGAAACCAGCATACTGTTTAAGTCACGATGTGGAACGATGACGT 69 FBan0012101 FBgn0015245 Hsp60 X X 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408; response to stress; GO:0006950 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Hsp60 Heat shock protein 60 "CG12101, CG12101, CG12101, l(1)BP5, 12, G62, BP5, Cpn60, hsp60, Dmhsp60, heat shock protein 60 kDa, HSP60, Mmp-P1, l(1)10Ac, l(1)G8, l(1)HM21, l(1)L12, l(1)dp025, Mitochondrial matrix protein P1, lethal(1)10Ac, Heat shock protein 60" CDMC26622 4 8 19 DAC30-L20 10-CG12101-RA_1 CG12101 AGGGGGAGGGAGATGTGATGAGAACCGAAACCAGCATACTGTTTAAGTCACGATGTGGAACGATGACGT 69 FBan0012101 FBgn0015245 Hsp60 X X 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408; response to stress; GO:0006950 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Hsp60 Heat shock protein 60 "CG12101, CG12101, CG12101, l(1)BP5, 12, G62, BP5, Cpn60, hsp60, Dmhsp60, heat shock protein 60 kDa, HSP60, Mmp-P1, l(1)10Ac, l(1)G8, l(1)HM21, l(1)L12, l(1)dp025, Mitochondrial matrix protein P1, lethal(1)10Ac, Heat shock protein 60" CDMC26623 4 9 19 DAC30-P08 23-CG12130-RA_7 CG12130 CCTTGTGGTGCATATCGCAGAGAATTCCGATCGTGGTGTATTTCTAGTTGATTTATTGAGCCGTTTGTT 69 FBan0012130 FBgn0033466 CG12130 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; copper ion binding; GO:0005507; ; GO:0005507 membrane; GO:0016020 CG12130 CG12130 anon-WO0149856.3 CDMC26623 4 10 19 DAC30-P08 23-CG12130-RA_7 CG12130 CCTTGTGGTGCATATCGCAGAGAATTCCGATCGTGGTGTATTTCTAGTTGATTTATTGAGCCGTTTGTT 69 FBan0012130 FBgn0033466 CG12130 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; copper ion binding; GO:0005507; ; GO:0005507 membrane; GO:0016020 CG12130 CG12130 anon-WO0149856.3 CDMC26624 4 11 19 DAC30-P20 2-CG12141-RB_1 CG12141 TCGGAGGCGGATTTCGAAATCGATACGTCCAAATTGCGACGTGGTGATATCATCGGCGTTGTCGGACAT 69 FBgn0030143 CDMC26624 4 12 19 DAC30-P20 2-CG12141-RB_1 CG12141 TCGGAGGCGGATTTCGAAATCGATACGTCCAAATTGCGACGTGGTGATATCATCGGCGTTGTCGGACAT 69 FBgn0030143 CDMC26625 4 13 19 DAC31-D08 2-CG3903-RC_1 CG3903 TCCCTCAAGTCAGGGATCTCGCTCAAGGAAACCAATGGCCATTTGGTGAAGCAATCTGAAAGGGCA 66 FBan0003903 FBgn0001987 Gli 2 2L defense response; GO:0006952; ectoderm development; GO:0007398; establishment of blood-nerve barrier; GO:0008065; female meiosis chromosome segregation; GO:0016321; neuromuscular synaptic transmission; GO:0007274; regulation of tracheal tube size; GO:0035151; response to toxin; GO:0009636; septate junction assembly; GO:0019991 receptor binding; GO:0005102; serine esterase activity; GO:0004759; ; GO:0005102; ; GO:0004759 plasma membrane; GO:0005886; septate junction; GO:0005918 Gli Gliotactin "CG3903, CG3903, CG3903, CG3903, CG3903, l(2)br45, l(2)35Dg, gliotactin, BG:DS09217.3, n(2)k09033, gli" CDMC26625 4 14 19 DAC31-D08 2-CG3903-RC_1 CG3903 TCCCTCAAGTCAGGGATCTCGCTCAAGGAAACCAATGGCCATTTGGTGAAGCAATCTGAAAGGGCA 66 FBan0003903 FBgn0001987 Gli 2 2L defense response; GO:0006952; ectoderm development; GO:0007398; establishment of blood-nerve barrier; GO:0008065; female meiosis chromosome segregation; GO:0016321; neuromuscular synaptic transmission; GO:0007274; regulation of tracheal tube size; GO:0035151; response to toxin; GO:0009636; septate junction assembly; GO:0019991 receptor binding; GO:0005102; serine esterase activity; GO:0004759; ; GO:0005102; ; GO:0004759 plasma membrane; GO:0005886; septate junction; GO:0005918 Gli Gliotactin "CG3903, CG3903, CG3903, CG3903, CG3903, l(2)br45, l(2)35Dg, gliotactin, BG:DS09217.3, n(2)k09033, gli" CDMC26626 4 15 19 DAC31-D20 23-CG40189-RA_9 CG40189 AAAAGAAGAGAAAGTGAAGCAGATTTACAAAGGAAGGTTGATCGAAAAGAAAAAGAGAACAGCCAG 66 FBgn0058189 CG40189 CG40189 CG40189 CDMC26626 4 16 19 DAC31-D20 23-CG40189-RA_9 CG40189 AAAAGAAGAGAAAGTGAAGCAGATTTACAAAGGAAGGTTGATCGAAAAGAAAAAGAGAACAGCCAG 66 FBgn0058189 CG40189 CG40189 CG40189 CDMC26627 4 17 19 DAC31-H08 3-CG4399-RB_1 CG4399 TCAGGAGCGGGAACTAGTGGTTCTCAGAAGCCATCTAATGTGGCGCAATTGCTTAGCTCTCCACCG 66 FBan0004399 FBgn0010110 east X X achiasmate meiosis I; GO:0000705; female meiosis chromosome segregation; GO:0016321; mitotic metaphase; GO:0000089; proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 NOT nuclear chromosome; GO:0000228; NOT nucleolus; GO:0005730; nucleus; GO:0005634 east enhanced adult sensory threshold "CG4399, CG4399, l(1)G0014, l(1)G0500, EG:133E12.4, anon-WO03040301.224, enhanced adult salt tolerance, enhanced adult sensory threshold" CDMC26627 4 18 19 DAC31-H08 3-CG4399-RB_1 CG4399 TCAGGAGCGGGAACTAGTGGTTCTCAGAAGCCATCTAATGTGGCGCAATTGCTTAGCTCTCCACCG 66 FBan0004399 FBgn0010110 east X X achiasmate meiosis I; GO:0000705; female meiosis chromosome segregation; GO:0016321; mitotic metaphase; GO:0000089; proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 NOT nuclear chromosome; GO:0000228; NOT nucleolus; GO:0005730; nucleus; GO:0005634 east enhanced adult sensory threshold "CG4399, CG4399, l(1)G0014, l(1)G0500, EG:133E12.4, anon-WO03040301.224, enhanced adult salt tolerance, enhanced adult sensory threshold" CDMC26628 4 19 19 DAC31-H20 3-CG4589-RC_1 CG4589 AGATGCTGAGACAACTCTTAAGCGTGAACCTAAGCCGAAGTGATGTGTTGGAGTAGGGGCGGTGGC 66 FBan0004589 FBgn0019886 CG4589 2 2R calcium ion binding; GO:0005509; ; GO:0005509 mitochondrion; GO:0005739 CG4589 CG4589 "B4D, anon-60Da" CDMC26628 4 20 19 DAC31-H20 3-CG4589-RC_1 CG4589 AGATGCTGAGACAACTCTTAAGCGTGAACCTAAGCCGAAGTGATGTGTTGGAGTAGGGGCGGTGGC 66 FBan0004589 FBgn0019886 CG4589 2 2R calcium ion binding; GO:0005509; ; GO:0005509 mitochondrion; GO:0005739 CG4589 CG4589 "B4D, anon-60Da" CDMC26629 4 21 19 DAC31-L08 2-CG4965-RA_1 CG4965 ACCCATACGAGTTCCTTGGCGGACACATACGGGGAGCGAAGAATTTGTACACACGTGGGCAGATAC 66 FBan0004965 FBgn0002673 twe 2 2L M phase of mitotic cell cycle; GO:0000087; cellularization; GO:0007349; embryonic development; GO:0009790; female meiotic spindle assembly (sensu Metazoa); GO:0007056; male meiosis; GO:0007140; male meiotic spindle assembly (sensu Metazoa); GO:0007053; meiotic G2/MI transition; GO:0008315; pole cell formation; GO:0007279; protein amino acid dephosphorylation; GO:0006470; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; spermatogenesis; GO:0007283 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.- microtubule cytoskeleton; GO:0015630 twe twine "CG4965, CG4965, mat(2)synHB5, mat(2)syn[HB5], twn: twain, BG:DS02740.1, l(2)35Fh, cdc25, TWINE, twine, Cdc25, mat(2)syn-A, twn" CDMC26629 4 22 19 DAC31-L08 2-CG4965-RA_1 CG4965 ACCCATACGAGTTCCTTGGCGGACACATACGGGGAGCGAAGAATTTGTACACACGTGGGCAGATAC 66 FBan0004965 FBgn0002673 twe 2 2L M phase of mitotic cell cycle; GO:0000087; cellularization; GO:0007349; embryonic development; GO:0009790; female meiotic spindle assembly (sensu Metazoa); GO:0007056; male meiosis; GO:0007140; male meiotic spindle assembly (sensu Metazoa); GO:0007053; meiotic G2/MI transition; GO:0008315; pole cell formation; GO:0007279; protein amino acid dephosphorylation; GO:0006470; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; spermatogenesis; GO:0007283 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.- microtubule cytoskeleton; GO:0015630 twe twine "CG4965, CG4965, mat(2)synHB5, mat(2)syn[HB5], twn: twain, BG:DS02740.1, l(2)35Fh, cdc25, TWINE, twine, Cdc25, mat(2)syn-A, twn" CDMC26630 4 23 19 DAC31-L20 6-CG5047-RA_5 CG5047 CCCTTAAGGAGGAAATGGGATTCAATGCCAAGGAGCTAAGTGACCTGGTGGTACGAAAGCCGCGCC 66 FBan0005047 FBgn0037008 CG5047 3 3L CG5047 CG5047 CDMC26630 4 24 19 DAC31-L20 6-CG5047-RA_5 CG5047 CCCTTAAGGAGGAAATGGGATTCAATGCCAAGGAGCTAAGTGACCTGGTGGTACGAAAGCCGCGCC 66 FBan0005047 FBgn0037008 CG5047 3 3L CG5047 CG5047 CDMC26631 4 25 19 DAC31-P08 3-CG5485-RA_7 CG5485 TCCATGGGCCTAACGTTCGCTAAGAAGCACGGATATGAGGTCAGACCAAATCAGGAGCTGTTCGCC 66 FBan0005485 FBgn0036770 Prestin 3 3L anion transport; GO:0006820; extracellular transport; GO:0006858; sulfate transport; GO:0008272; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 membrane; GO:0016020 Prestin Prestin "CG5485, CG5485, CG5485, CG5485, dpres" CDMC26631 4 26 19 DAC31-P08 3-CG5485-RA_7 CG5485 TCCATGGGCCTAACGTTCGCTAAGAAGCACGGATATGAGGTCAGACCAAATCAGGAGCTGTTCGCC 66 FBan0005485 FBgn0036770 Prestin 3 3L anion transport; GO:0006820; extracellular transport; GO:0006858; sulfate transport; GO:0008272; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 membrane; GO:0016020 Prestin Prestin "CG5485, CG5485, CG5485, CG5485, dpres" CDMC26632 4 1 20 DAC31-P20 AutoBlank AutoBlank CDMC26632 4 2 20 DAC31-P20 AutoBlank AutoBlank CDMC26633 4 3 20 DAC32-D08 16-CG11155-RA_2 CG11155 GCCAACTTAGCTGCATTTCTAACAGTTGAACGGATGATTTCCCCCATTGAAAGCGCTTCTGATTTGGCA 69 FBan0011155 FBgn0039927 CG11155 4 4 cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG11155 CG11155 CT30863 CDMC26633 4 4 20 DAC32-D08 16-CG11155-RA_2 CG11155 GCCAACTTAGCTGCATTTCTAACAGTTGAACGGATGATTTCCCCCATTGAAAGCGCTTCTGATTTGGCA 69 FBan0011155 FBgn0039927 CG11155 4 4 cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG11155 CG11155 CT30863 CDMC26634 4 5 20 DAC32-D20 3-CG11166-RB_1 CG11166 GGCACCCAAAATGGAGAATAGCACCATGCGAATCTCAACCAAGACGAAGGTTTCTACCGGCAGCCGTAG 69 FBan0011166 FBgn0033166 CG11166 2 2R CG11166 CG11166 "CG1706, CG1706, EP(2)2475, LD35207" CDMC26634 4 6 20 DAC32-D20 3-CG11166-RB_1 CG11166 GGCACCCAAAATGGAGAATAGCACCATGCGAATCTCAACCAAGACGAAGGTTTCTACCGGCAGCCGTAG 69 FBan0011166 FBgn0033166 CG11166 2 2R CG11166 CG11166 "CG1706, CG1706, EP(2)2475, LD35207" CDMC26635 4 7 20 DAC32-H08 22-CG11218-RA_2 CG11218 CCAAAGGGTTTCCAACAACATCTCTACCGAAAATGAAGTTCCTGATTGTCCTCTCCGTCATTTTGGCCA 69 FBan0011218 FBgn0034470 Obp56d 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56d Odorant-binding protein 56d "CG11218, CG11218, CG11218, CG11218, CG11218, OBP56d, 56d, CT31326, BcDNA:RE22207, BEST:GH09027, Odorant-binding protein 56d" CDMC26635 4 8 20 DAC32-H08 22-CG11218-RA_2 CG11218 CCAAAGGGTTTCCAACAACATCTCTACCGAAAATGAAGTTCCTGATTGTCCTCTCCGTCATTTTGGCCA 69 FBan0011218 FBgn0034470 Obp56d 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56d Odorant-binding protein 56d "CG11218, CG11218, CG11218, CG11218, CG11218, OBP56d, 56d, CT31326, BcDNA:RE22207, BEST:GH09027, Odorant-binding protein 56d" CDMC26636 4 9 20 DAC32-H20 23-CG11241-RA_1 CG11241 TCTAAGCAGATCTCTAAGTAGTTACTCCTAACAAAGACTTATGGACCTCTAAATCGTCAACTGTTCAAT 69 FBan0011241 FBgn0037186 CG11241 3 3L amino acid biosynthesis; GO:0008652 alanine-glyoxylate transaminase activity; GO:0008453 ; EC:2.6.1.44; ; GO:0008453 ; EC:2.6.1.44; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 CG11241 CG11241 CDMC26636 4 10 20 DAC32-H20 23-CG11241-RA_1 CG11241 TCTAAGCAGATCTCTAAGTAGTTACTCCTAACAAAGACTTATGGACCTCTAAATCGTCAACTGTTCAAT 69 FBan0011241 FBgn0037186 CG11241 3 3L amino acid biosynthesis; GO:0008652 alanine-glyoxylate transaminase activity; GO:0008453 ; EC:2.6.1.44; ; GO:0008453 ; EC:2.6.1.44; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 CG11241 CG11241 CDMC26637 4 11 20 DAC32-L08 23-CG11271-RC_1 CG11271 CCCCATCTCTCATTCTCCTTTAAATCCCACTCAGCTTTATAAAATTGAATTGAAATTTTGCTCGAAAAA 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC26637 4 12 20 DAC32-L08 23-CG11271-RC_1 CG11271 CCCCATCTCTCATTCTCCTTTAAATCCCACTCAGCTTTATAAAATTGAATTGAAATTTTGCTCGAAAAA 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC26638 4 13 20 DAC32-L20 3-CG11281-RA_2 CG11281 CAGCAGGTCAACGTCTTCCTTTGGCTACGGTTTTCATGTCCGGTCGCATTTGGTTGGATACGGCACTTT 69 FBan0011281 FBgn0036347 CG11281 3 3L CG11281 CG11281 CDMC26638 4 14 20 DAC32-L20 3-CG11281-RA_2 CG11281 CAGCAGGTCAACGTCTTCCTTTGGCTACGGTTTTCATGTCCGGTCGCATTTGGTTGGATACGGCACTTT 69 FBan0011281 FBgn0036347 CG11281 3 3L CG11281 CG11281 CDMC26639 4 15 20 DAC32-P08 23-CG11319-RA_9 CG11319 GCGAACGAAATGTTTTTCTGTAAATTGCATTCAATGTGATTTATCATGAACACACCCACGACACTCACA 69 FBan0011319 FBgn0031835 CG11319 2 2L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG11319 CG11319 CDMC26639 4 16 20 DAC32-P08 23-CG11319-RA_9 CG11319 GCGAACGAAATGTTTTTCTGTAAATTGCATTCAATGTGATTTATCATGAACACACCCACGACACTCACA 69 FBan0011319 FBgn0031835 CG11319 2 2L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG11319 CG11319 CDMC26640 4 17 20 DAC32-P20 3-CG11325-RA_1 CG11325 ACTTTCAGTGCGTCATCTTCAACTCGTTCAGGAGCGACTTTGATGAGAAGCTGTATCAGGCGGCCTCCA 69 FBan0011325 FBgn0025595 GRHR 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; gonadotropin-releasing hormone receptor activity; GO:0004968; ; GO:0008188; ; GO:0004930; ; GO:0004968; ; GO:0001653 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHR Gonadotropin-releasing hormone receptor "CG11325, CG11325, CG11325, DGRHR, gonadotropin-releasing hormone receptor, gonadotrophin-releasing hormone receptor, hormone receptor, GRHR/CG11325, DAKHR, BEST:GH19447" CDMC26640 4 18 20 DAC32-P20 3-CG11325-RA_1 CG11325 ACTTTCAGTGCGTCATCTTCAACTCGTTCAGGAGCGACTTTGATGAGAAGCTGTATCAGGCGGCCTCCA 69 FBan0011325 FBgn0025595 GRHR 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; female gamete generation; GO:0007292; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; gonadotropin-releasing hormone receptor activity; GO:0004968; ; GO:0008188; ; GO:0004930; ; GO:0004968; ; GO:0001653 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 GRHR Gonadotropin-releasing hormone receptor "CG11325, CG11325, CG11325, DGRHR, gonadotropin-releasing hormone receptor, gonadotrophin-releasing hormone receptor, hormone receptor, GRHR/CG11325, DAKHR, BEST:GH19447" CDMC26641 4 19 20 DAC33-D08 9-CG12605-RB_1 CG12605 ACCCCCTCACAAGAACCGGATACCCAGAGACACACAAACCGGACACCATTCGCCAGATAACTAACACTA 69 FBan0012605 FBgn0035481 CG12605 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12605 CG12605 anon-WO0140519.93 CDMC26641 4 20 20 DAC33-D08 9-CG12605-RB_1 CG12605 ACCCCCTCACAAGAACCGGATACCCAGAGACACACAAACCGGACACCATTCGCCAGATAACTAACACTA 69 FBan0012605 FBgn0035481 CG12605 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12605 CG12605 anon-WO0140519.93 CDMC26642 4 21 20 DAC33-D20 2-CG12623-RA_1 CG12623 CGATTCCGCCTTTGGACGATTGGTGCGTTATTACGGTTCGGAGACCCTGGATAAATTGCTCTTCCGCGA 69 FBan0012623 FBgn0030285 CG12623 X X CG12623 CG12623 CDMC26642 4 22 20 DAC33-D20 2-CG12623-RA_1 CG12623 CGATTCCGCCTTTGGACGATTGGTGCGTTATTACGGTTCGGAGACCCTGGATAAATTGCTCTTCCGCGA 69 FBan0012623 FBgn0030285 CG12623 X X CG12623 CG12623 CDMC26643 4 23 20 DAC33-H08 23-CG12672-RA_1 CG12672 CATTTGCTGCAATTCGTTTGATTTTCTTGCTTGTAACGATTTGAATAAAACGATTAAGAATACCTGCAA 69 FBan0012672 FBgn0030886 CG12672 X X CG12672 CG12672 CDMC26643 4 24 20 DAC33-H08 23-CG12672-RA_1 CG12672 CATTTGCTGCAATTCGTTTGATTTTCTTGCTTGTAACGATTTGAATAAAACGATTAAGAATACCTGCAA 69 FBan0012672 FBgn0030886 CG12672 X X CG12672 CG12672 CDMC26644 4 25 20 DAC33-H20 16-CG12681-RA_1 CG12681 GGATTCCTAAGGCCAAGAGAACGCAAAAACAAGTCCAGAACGAAGATCAAGCAAAGCCTCTCGAGATGG 69 FBan0012681 FBgn0029730 CG12681 X X CG12681 CG12681 CDMC26644 4 26 20 DAC33-H20 16-CG12681-RA_1 CG12681 GGATTCCTAAGGCCAAGAGAACGCAAAAACAAGTCCAGAACGAAGATCAAGCAAAGCCTCTCGAGATGG 69 FBan0012681 FBgn0029730 CG12681 X X CG12681 CG12681 CDMC26645 4 1 21 DAC33-L08 12-CG12737-RA_1 CG12737 AGGGCGACATTGCGCTGATAAAACCGGAATTTGTCGATGAGCACCCGATCATCTATTGGAACTTGCTCT 69 FBan0012737 FBgn0025864 Crag X X signal transduction; GO:0007165; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085 Crag Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein "CG12737, CRAG, Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein" CDMC26645 4 2 21 DAC33-L08 12-CG12737-RA_1 CG12737 AGGGCGACATTGCGCTGATAAAACCGGAATTTGTCGATGAGCACCCGATCATCTATTGGAACTTGCTCT 69 FBan0012737 FBgn0025864 Crag X X signal transduction; GO:0007165; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085 Crag Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein "CG12737, CRAG, Calmodulin-binding protein related to a Rab3 GDP/GTP exchange protein" CDMC26646 4 3 21 DAC33-L20 13-CG12749-RA_2 CG12749 GGCAGGCAATCAGTAGCATGTGTGTGTCAGACCAGGCAGACAAGATCAGAACCAAGAAATCAAGATGCA 69 FBan0012749 FBgn0004237 Hrb87F 3 3R "RNA localization; GO:0006403; mRNA processing; GO:0006397; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 chromatin; GO:0000785; heterogeneous nuclear ribonucleoprotein complex; GO:0030530; nucleoplasm; GO:0005654; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 Hrb87F Heterogeneous nuclear ribonucleoprotein at 87F "CG12749, CG12749, P11, hrp36, HRB87F/hrp36, Hrb87Fa, hrp40, P11/Hrb87F, p38, Hrp36, Q14, Q16, HRP36, Hrb87f, Hrb2: hnRNA-binding protein 2, Hrb85CD, hnRNA-binding protein 2, Heterogeneous nuclear ribonucleoprotein at 85CD" CDMC26646 4 4 21 DAC33-L20 13-CG12749-RA_2 CG12749 GGCAGGCAATCAGTAGCATGTGTGTGTCAGACCAGGCAGACAAGATCAGAACCAAGAAATCAAGATGCA 69 FBan0012749 FBgn0004237 Hrb87F 3 3R "RNA localization; GO:0006403; mRNA processing; GO:0006397; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 chromatin; GO:0000785; heterogeneous nuclear ribonucleoprotein complex; GO:0030530; nucleoplasm; GO:0005654; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 Hrb87F Heterogeneous nuclear ribonucleoprotein at 87F "CG12749, CG12749, P11, hrp36, HRB87F/hrp36, Hrb87Fa, hrp40, P11/Hrb87F, p38, Hrp36, Q14, Q16, HRP36, Hrb87f, Hrb2: hnRNA-binding protein 2, Hrb85CD, hnRNA-binding protein 2, Heterogeneous nuclear ribonucleoprotein at 85CD" CDMC26647 4 5 21 DAC33-P08 3-CG12783-RA_3 CG12783 CGCAAGAACACCGGACGTACTCTTAGCGAGGATCAAATGAAACGTTTGCTCGCCTACCAGGAGCACGTT 69 FBan0012783 FBgn0038448 CG12783 3 3R neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12783 CG12783 CDMC26647 4 6 21 DAC33-P08 3-CG12783-RA_3 CG12783 CGCAAGAACACCGGACGTACTCTTAGCGAGGATCAAATGAAACGTTTGCTCGCCTACCAGGAGCACGTT 69 FBan0012783 FBgn0038448 CG12783 3 3R neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12783 CG12783 CDMC26648 4 7 21 DAC33-P20 2-CG12797-RA_1 CG12797 CCCATAGACAACGACTGGGATTGCACAGCCACTCTTACTTCACACACAAGCACGGTTTGGGGCATTGAC 69 FBan0012797 FBgn0033972 CG12797 2 2R CG12797 CG12797 CDMC26648 4 8 21 DAC33-P20 2-CG12797-RA_1 CG12797 CCCATAGACAACGACTGGGATTGCACAGCCACTCTTACTTCACACACAAGCACGGTTTGGGGCATTGAC 69 FBan0012797 FBgn0033972 CG12797 2 2R CG12797 CG12797 CDMC26649 4 9 21 DAC34-D08 3-CG4364-RA_1 CG4364 CGCAATCTGTTCCGGAAACTCATCCGCGAGAAGCAGACTAAGGAAAAGGAGGAATGGCTGTTGCGCAAG 69 FBan0004364 FBgn0032138 CG4364 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein complex assembly; GO:0006461; protein metabolism; GO:0019538; rRNA metabolism; GO:0016072" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 intracellular; GO:0005622 CG4364 CG4364 CDMC26649 4 10 21 DAC34-D08 3-CG4364-RA_1 CG4364 CGCAATCTGTTCCGGAAACTCATCCGCGAGAAGCAGACTAAGGAAAAGGAGGAATGGCTGTTGCGCAAG 69 FBan0004364 FBgn0032138 CG4364 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein complex assembly; GO:0006461; protein metabolism; GO:0019538; rRNA metabolism; GO:0016072" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 intracellular; GO:0005622 CG4364 CG4364 CDMC26650 4 11 21 DAC34-D20 17-CG4377-RA_3 CG4377 GTGCGCAATTCAGCTGAATCGCCAAAATGTTACAGCTGTGAAGGCATAAATTGTTCGAGAACCACTCGT 69 FBan0004377 FBgn0034664 CG4377 2 2R CG4377 CG4377 CT14296 CDMC26650 4 12 21 DAC34-D20 17-CG4377-RA_3 CG4377 GTGCGCAATTCAGCTGAATCGCCAAAATGTTACAGCTGTGAAGGCATAAATTGTTCGAGAACCACTCGT 69 FBan0004377 FBgn0034664 CG4377 2 2R CG4377 CG4377 CT14296 CDMC26651 4 13 21 DAC34-H08 9-CG4421-RA_1 CG4421 ACATGGGCACCCTGTTTCAGAGTTTCGTCGAGGCCATCTATCCACAGATAAGGAATAATCATCCCGCCG 69 FBan0004421 FBgn0010044 GstD8 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18 GstD8 Glutathione S transferase D8 "CG4421, DmGST27, gstD27, GST D27, GstD27: Glutathione S transferase D27, GST, Gst, DmGSTD8, Glutathione S transferase D27, Glutathione S transferase D8, GstD27" CDMC26651 4 14 21 DAC34-H08 9-CG4421-RA_1 CG4421 ACATGGGCACCCTGTTTCAGAGTTTCGTCGAGGCCATCTATCCACAGATAAGGAATAATCATCCCGCCG 69 FBan0004421 FBgn0010044 GstD8 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18 GstD8 Glutathione S transferase D8 "CG4421, DmGST27, gstD27, GST D27, GstD27: Glutathione S transferase D27, GST, Gst, DmGSTD8, Glutathione S transferase D27, Glutathione S transferase D8, GstD27" CDMC26652 4 15 21 DAC34-H20 1-CG4429-RA_1 CG4429 CAGGCTGGCCTCTGTGTCTCTGTGTCAGTGTCCAGTGTCAGTCAGCAAGCAACTTAACAACAAGCAACA 69 FBan0004429 FBgn0010256 Rbp2 X X translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829 Rbp2 RNA-binding protein 2 "CG4429, CG4429, rrm2, RRM2, cg4429, eIF4H, anon-EST:fe1B9, anon-fast-evolving-1B9" CDMC26652 4 16 21 DAC34-H20 1-CG4429-RA_1 CG4429 CAGGCTGGCCTCTGTGTCTCTGTGTCAGTGTCCAGTGTCAGTCAGCAAGCAACTTAACAACAAGCAACA 69 FBan0004429 FBgn0010256 Rbp2 X X translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 cytosol; GO:0005829 Rbp2 RNA-binding protein 2 "CG4429, CG4429, rrm2, RRM2, cg4429, eIF4H, anon-EST:fe1B9, anon-fast-evolving-1B9" CDMC26653 4 17 21 DAC34-L08 15-CG4463-RA_1 CG4463 GGTGGAGCAGGACAATGGCAACGATAAGTAGAGGACTCGTTCCGAGAGATGCCCTGCATTATTTAACCA 69 FBan0004463 FBgn0001224 Hsp23 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408 actin binding; GO:0003779; ; GO:0003779 Hsp23 Heat shock protein 23 "CG4463, CG4463, hsp23, hsp 23, 23, Protein 23, hsp 22K, hsp 23K, hsp23/22, DmHsp23, HSP23/IAP" CDMC26653 4 18 21 DAC34-L08 15-CG4463-RA_1 CG4463 GGTGGAGCAGGACAATGGCAACGATAAGTAGAGGACTCGTTCCGAGAGATGCCCTGCATTATTTAACCA 69 FBan0004463 FBgn0001224 Hsp23 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408 actin binding; GO:0003779; ; GO:0003779 Hsp23 Heat shock protein 23 "CG4463, CG4463, hsp23, hsp 23, 23, Protein 23, hsp 22K, hsp 23K, hsp23/22, DmHsp23, HSP23/IAP" CDMC26654 4 19 21 DAC34-L20 15-CG4476-RB_1 CG4476 TCTGGTGGGATTGATTTACATCACTCCCGGAGGTCAACATATCATCACGCTTATGGACTTTCACGGCGT 69 FBan0004476 FBgn0035969 CG4476 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG4476 CG4476 anon-WO0149848.7 CDMC26654 4 20 21 DAC34-L20 15-CG4476-RB_1 CG4476 TCTGGTGGGATTGATTTACATCACTCCCGGAGGTCAACATATCATCACGCTTATGGACTTTCACGGCGT 69 FBan0004476 FBgn0035969 CG4476 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG4476 CG4476 anon-WO0149848.7 CDMC26655 4 21 21 DAC34-P08 9-CG4525-RA_1 CG4525 ACATACATTGCGGTCACCCTGAGCTAGCTTGGAATGTATTCATCACCAGGGATACGAATGCGGAGGCAT 69 FBan0004525 FBgn0038358 CG4525 3 3R CG4525 CG4525 CDMC26655 4 22 21 DAC34-P08 9-CG4525-RA_1 CG4525 ACATACATTGCGGTCACCCTGAGCTAGCTTGGAATGTATTCATCACCAGGGATACGAATGCGGAGGCAT 69 FBan0004525 FBgn0038358 CG4525 3 3R CG4525 CG4525 CDMC26656 4 23 21 DAC34-P20 27-CG4536-RA_1 CG4536 GCAGTCCACCATGTTCAATACCTACACCAGCACTTGGATGGCCCTGTTCCAAACCACACTGGGTGATTA 69 FBan0004536 FBgn0029904 CG4536 X X calcium ion transport; GO:0006816; osmosensory signaling pathway; GO:0007231; sensory perception of pain; GO:0019233; sensory perception of smell; GO:0007608 calcium channel activity; GO:0005262; ; GO:0005262; ; GO:0005262 membrane; GO:0016020 CG4536 CG4536 CT14708 CDMC26656 4 24 21 DAC34-P20 27-CG4536-RA_1 CG4536 GCAGTCCACCATGTTCAATACCTACACCAGCACTTGGATGGCCCTGTTCCAAACCACACTGGGTGATTA 69 FBan0004536 FBgn0029904 CG4536 X X calcium ion transport; GO:0006816; osmosensory signaling pathway; GO:0007231; sensory perception of pain; GO:0019233; sensory perception of smell; GO:0007608 calcium channel activity; GO:0005262; ; GO:0005262; ; GO:0005262 membrane; GO:0016020 CG4536 CG4536 CT14708 CDMC26657 4 25 21 DAC35-D08 47-CG8821-RA_5 CG8821 GCAGACCGATTGAAAAGAACCATTTTTAAAAATCAATTGAAAAAATTTGTTTTTGAACCCTAGTTGGCC 69 FBan0008821 FBgn0033748 vis 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0003700 nucleus; GO:0005634 vis vismay "CG8821, zaa, zuker-aly-like a, vismay" CDMC26657 4 26 21 DAC35-D08 47-CG8821-RA_5 CG8821 GCAGACCGATTGAAAAGAACCATTTTTAAAAATCAATTGAAAAAATTTGTTTTTGAACCCTAGTTGGCC 69 FBan0008821 FBgn0033748 vis 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; histone deacetylase binding; GO:0042826; ; GO:0042826; ; GO:0003700 nucleus; GO:0005634 vis vismay "CG8821, zaa, zuker-aly-like a, vismay" CDMC26658 4 1 22 DAC35-D20 8-CG8828-RA_3 CG8828 GCGGAGCACCTTTGCGGATATTCCCAACTCCCTGCTTCTGAACGTGGTAATGAAGATCAAAGAGGAGCA 69 FBan0008828 FBgn0033740 CG8828 2 2R CG8828 CG8828 CDMC26658 4 2 22 DAC35-D20 8-CG8828-RA_3 CG8828 GCGGAGCACCTTTGCGGATATTCCCAACTCCCTGCTTCTGAACGTGGTAATGAAGATCAAAGAGGAGCA 69 FBan0008828 FBgn0033740 CG8828 2 2R CG8828 CG8828 CDMC26659 4 3 22 DAC35-H08 14-CG8865-RA_2 CG8865 AGGTCCTACCCGATAAGGAACTGGTGATGCCGAAGAATGCGAATGTCTACTACGCGGTTAACACGAACT 69 FBan0008865 FBgn0026376 Rgl 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ral guanyl-nucleotide exchange factor activity; GO:0008321; RAL GDP-dissociation stimulator activity; GO:0016220; ; GO:0016220; ; GO:0008321; ; GO:0008321 Rgl Ral guanine nucleotide exchange factor 2 "CG8865, CG8865, dRGL, RalGDS, DRgl, Ral guanine nucleotide exchange factor 2" CDMC26659 4 4 22 DAC35-H08 14-CG8865-RA_2 CG8865 AGGTCCTACCCGATAAGGAACTGGTGATGCCGAAGAATGCGAATGTCTACTACGCGGTTAACACGAACT 69 FBan0008865 FBgn0026376 Rgl 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular signaling cascade; GO:0007242; small GTPase mediated signal transduction; GO:0007264; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ral guanyl-nucleotide exchange factor activity; GO:0008321; RAL GDP-dissociation stimulator activity; GO:0016220; ; GO:0016220; ; GO:0008321; ; GO:0008321 Rgl Ral guanine nucleotide exchange factor 2 "CG8865, CG8865, dRGL, RalGDS, DRgl, Ral guanine nucleotide exchange factor 2" CDMC26660 4 5 22 DAC35-H20 23-CG8884-RB_2 CG8884 TCGTTGTCTTCCTTCCTTCGATCCAATTATAATTTTGCCTCTTCCTTTGACACATTTCTCCACATGTTT 69 FBan0008884 FBgn0013334 Sap47 3 3R synaptic transmission; GO:0007268 molecular function unknown; GO:0005554; ; GO:0005554 synapse; GO:0045202 Sap47 Synapse-associated protein 47kD "CG8884, dsap-47, sap47, SAP47, SAP-47" CDMC26660 4 6 22 DAC35-H20 23-CG8884-RB_2 CG8884 TCGTTGTCTTCCTTCCTTCGATCCAATTATAATTTTGCCTCTTCCTTTGACACATTTCTCCACATGTTT 69 FBan0008884 FBgn0013334 Sap47 3 3R synaptic transmission; GO:0007268 molecular function unknown; GO:0005554; ; GO:0005554 synapse; GO:0045202 Sap47 Synapse-associated protein 47kD "CG8884, dsap-47, sap47, SAP47, SAP-47" CDMC26661 4 7 22 DAC35-L08 14-CG8927-RA_1 CG8927 TGGCAACAAACGTGAGTACCACTATGAGACTGGAATCAAGTGCGATCCTAACAACCGCAACAACGAGGA 69 FBan0008927 FBgn0038405 CG8927 3 3R CG8927 CG8927 CDMC26661 4 8 22 DAC35-L08 14-CG8927-RA_1 CG8927 TGGCAACAAACGTGAGTACCACTATGAGACTGGAATCAAGTGCGATCCTAACAACCGCAACAACGAGGA 69 FBan0008927 FBgn0038405 CG8927 3 3R CG8927 CG8927 CDMC26662 4 9 22 DAC35-L20 23-CG8936-RA_1 CG8936 ACCGGGAATGTAAAAGACTCACTAATATACTGCCGATCTTAGAGTATTTACCACCAAAATTTACGAATA 69 FBgn0030818 CDMC26662 4 10 22 DAC35-L20 23-CG8936-RA_1 CG8936 ACCGGGAATGTAAAAGACTCACTAATATACTGCCGATCTTAGAGTATTTACCACCAAAATTTACGAATA 69 FBgn0030818 CDMC26663 4 11 22 DAC35-P08 6-CG8972-RA_1 CG8972 GGGAGCTGAGGCAATAGAGCGGTAGCGAGTAGCACTACGCTGTGTCAATAAGAGTGACATCGTTCTGCC 69 FBan0008972 FBgn0033672 rho-7 2 2R rho-7 rhomboid-7 "CG8972, anon-WO0138581.3, rhomboid-7" CDMC26663 4 12 22 DAC35-P08 6-CG8972-RA_1 CG8972 GGGAGCTGAGGCAATAGAGCGGTAGCGAGTAGCACTACGCTGTGTCAATAAGAGTGACATCGTTCTGCC 69 FBan0008972 FBgn0033672 rho-7 2 2R rho-7 rhomboid-7 "CG8972, anon-WO0138581.3, rhomboid-7" CDMC26664 4 13 22 DAC35-P20 23-CG8986-RA_4 CG8986 TCGAGCAGTTCTAGTTTGTAGTGTCGTCTAGGTCTACAGCCCATGAATGTAAATATTATTTATGATCGC 69 FBan0008986 FBgn0033658 CG8986 2 2R CG8986 CG8986 CT25838 CDMC26664 4 14 22 DAC35-P20 23-CG8986-RA_4 CG8986 TCGAGCAGTTCTAGTTTGTAGTGTCGTCTAGGTCTACAGCCCATGAATGTAAATATTATTTATGATCGC 69 FBan0008986 FBgn0033658 CG8986 2 2R CG8986 CG8986 CT25838 CDMC26665 4 15 22 DAC36-D08 3-CG7084-RB_2 CG7084 ATCAAGTTCCTCAACGCGCTCACCTTTTTCACGGTGAACCTGCAGTGCCTGGAGATCTATCCCAC 65 FBan0007084 FBgn0038938 CG7084 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 CG7084 CG7084 CDMC26665 4 16 22 DAC36-D08 3-CG7084-RB_2 CG7084 ATCAAGTTCCTCAACGCGCTCACCTTTTTCACGGTGAACCTGCAGTGCCTGGAGATCTATCCCAC 65 FBan0007084 FBgn0038938 CG7084 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 CG7084 CG7084 CDMC26666 4 17 22 DAC36-D20 3-CG7157-RA_3 CG7157 TCAAGGTCCTTCAATTGAGCCTAAGCTGGTCCCCCAACCCGGTTCACTGGACAAATTGCCATCAG 65 FBan0007157 FBgn0011559 Acp36DE 2 2L "mating plug formation; GO:0042628; negative regulation of female receptivity, post-mating; GO:0045434; sperm competition; GO:0046692; sperm displacement; GO:0007321; sperm storage; GO:0046693" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp36DE Accessory gland peptide 36DE "CG7157, CG7157, CG7157, Accessory gland protein, 36DE accessory gland protein, CT22109, anon-WO0140519.55" CDMC26666 4 18 22 DAC36-D20 3-CG7157-RA_3 CG7157 TCAAGGTCCTTCAATTGAGCCTAAGCTGGTCCCCCAACCCGGTTCACTGGACAAATTGCCATCAG 65 FBan0007157 FBgn0011559 Acp36DE 2 2L "mating plug formation; GO:0042628; negative regulation of female receptivity, post-mating; GO:0045434; sperm competition; GO:0046692; sperm displacement; GO:0007321; sperm storage; GO:0046693" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp36DE Accessory gland peptide 36DE "CG7157, CG7157, CG7157, Accessory gland protein, 36DE accessory gland protein, CT22109, anon-WO0140519.55" CDMC26667 4 19 22 DAC36-H08 18-CG7260-RA_6 CG7260 GGATGCCAAAGAGCGACCGGATACACTGTATCCACACGATACCCACTACGGCTGGCTCATTCCAC 65 FBan0007260 FBgn0011723 byn 3 3L "Malpighian tubule morphogenesis; GO:0007443; cell fate determination; GO:0001709; embryonic development (sensu Insecta); GO:0001700; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; midgut development; GO:0007494; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 byn brachyenteron "CG7260, D-TRA, T related antigen, Trg: T-related gene, DTrg, dm-Trg, trg, Byn, Brachyenteron, byn/apro, Dm-BYN, D-Trg, Tra, apro: aproctous, T-related gene, aproctous, Trg, brachyenteron" CDMC26667 4 20 22 DAC36-H08 18-CG7260-RA_6 CG7260 GGATGCCAAAGAGCGACCGGATACACTGTATCCACACGATACCCACTACGGCTGGCTCATTCCAC 65 FBan0007260 FBgn0011723 byn 3 3L "Malpighian tubule morphogenesis; GO:0007443; cell fate determination; GO:0001709; embryonic development (sensu Insecta); GO:0001700; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; midgut development; GO:0007494; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 byn brachyenteron "CG7260, D-TRA, T related antigen, Trg: T-related gene, DTrg, dm-Trg, trg, Byn, Brachyenteron, byn/apro, Dm-BYN, D-Trg, Tra, apro: aproctous, T-related gene, aproctous, Trg, brachyenteron" CDMC26668 4 21 22 DAC36-H20 9-CG7283-RA_1 CG7283 TGGCAAGATCGAGGAGGTTAAGTCGACCATCAAGTTCCAGATGAAGAAGGTGCTCTGCCTGTCCG 65 FBan0007283 FBgn0036213 RpL10Ab 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Ab Ribosomal protein L10Ab "CG7283, BcDNA:RH06366, anon-EST:Posey188, Ribosomal protein L10Ab" CDMC26668 4 22 22 DAC36-H20 9-CG7283-RA_1 CG7283 TGGCAAGATCGAGGAGGTTAAGTCGACCATCAAGTTCCAGATGAAGAAGGTGCTCTGCCTGTCCG 65 FBan0007283 FBgn0036213 RpL10Ab 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Ab Ribosomal protein L10Ab "CG7283, BcDNA:RH06366, anon-EST:Posey188, Ribosomal protein L10Ab" CDMC26669 4 23 22 DAC36-L08 14-CG7392-RA_3 CG7392 CGCAGGAGATGTCTGGCAACACGGGGAAGTTCATTAACAAGGTGGTGTCACACCCAACGCTACCC 65 FBan0007392 FBgn0044323 Cka 2 2L JNK cascade; GO:0007254; dorsal closure; GO:0007391; eye photoreceptor development (sensu Endopterygota); GO:0042051; positive regulation of JNK cascade; GO:0046330 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Cka Connector of kinase to AP-1 "CG7392, CG7392, CG7392, CG7392, l(2)05836, 5836, WD-40-family-member, CKA, Dcka, cka, connector of kinase to AP-1, anon-WO0172774.174, anon-WO0172774.175, anon-WO0172774.177, anon-WO0172774.179, l(2)s1883, Connector of kinase to AP-1" CDMC26669 4 24 22 DAC36-L08 14-CG7392-RA_3 CG7392 CGCAGGAGATGTCTGGCAACACGGGGAAGTTCATTAACAAGGTGGTGTCACACCCAACGCTACCC 65 FBan0007392 FBgn0044323 Cka 2 2L JNK cascade; GO:0007254; dorsal closure; GO:0007391; eye photoreceptor development (sensu Endopterygota); GO:0042051; positive regulation of JNK cascade; GO:0046330 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Cka Connector of kinase to AP-1 "CG7392, CG7392, CG7392, CG7392, l(2)05836, 5836, WD-40-family-member, CKA, Dcka, cka, connector of kinase to AP-1, anon-WO0172774.174, anon-WO0172774.175, anon-WO0172774.177, anon-WO0172774.179, l(2)s1883, Connector of kinase to AP-1" CDMC26670 4 25 22 DAC36-L20 3-CG7415-RB_1 CG7415 CTTCCTGGAGAAACTTACGACACCAAGTTCGGAGCAATTGGTTCCTCGTACGAGGAATGCCGCGC 65 FBan0007415 FBgn0037580 DppIII 3 3R proteolysis; GO:0006508 dipeptidyl-peptidase III activity; GO:0017039 ; EC:3.4.14.4; ; GO:0017039 ; EC:3.4.14.4; ; GO:0017039 ; EC:3.4.14.4 cytoplasm; GO:0005737 DppIII Dipeptidyl aminopeptidase III "CG7415, CG7415, CG7415, DPP, dipeptidyl aminopeptidase, Dipeptidyl aminopeptidase III" CDMC26670 4 26 22 DAC36-L20 3-CG7415-RB_1 CG7415 CTTCCTGGAGAAACTTACGACACCAAGTTCGGAGCAATTGGTTCCTCGTACGAGGAATGCCGCGC 65 FBan0007415 FBgn0037580 DppIII 3 3R proteolysis; GO:0006508 dipeptidyl-peptidase III activity; GO:0017039 ; EC:3.4.14.4; ; GO:0017039 ; EC:3.4.14.4; ; GO:0017039 ; EC:3.4.14.4 cytoplasm; GO:0005737 DppIII Dipeptidyl aminopeptidase III "CG7415, CG7415, CG7415, DPP, dipeptidyl aminopeptidase, Dipeptidyl aminopeptidase III" CDMC26671 4 1 23 DAC36-P08 16-CG7508-RA_1 CG7508 GATGCCCAGATAGTCGGTTTTCTAGCGCCATTTTAAGCTCGCAACGAACTGAGGTATAACCGGGC 65 FBan0007508 FBgn0010433 ato 3 3R "Bolwig's organ morphogenesis; GO:0001746; R8 cell differentiation; GO:0045465; R8 cell fate commitment; GO:0007460; R8 cell fate specification; GO:0045464; activation of MAPK activity; GO:0000187; antennal morphogenesis; GO:0007469; brain development; GO:0007420; cell fate commitment; GO:0045165; compound eye morphogenesis (sensu Endopterygota); GO:0001745; epidermal growth factor receptor signaling pathway; GO:0007173; male courtship behavior (sensu Insecta), song production; GO:0045433; nervous system development; GO:0007399; neuron differentiation; GO:0030182; neuron recognition; GO:0008038; oenocyte development; GO:0007438; optic placode development (sensu Endopterygota); GO:0001748; peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355; second mitotic wave (sensu Endopterygota); GO:0016330; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360; sensory perception of sound; GO:0007605; smoothened signaling pathway; GO:0007224" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 host cell nucleus; GO:0042025; nucleus; GO:0005634 ato atonal "CG7508, ATO, ato1" CDMC26671 4 2 23 DAC36-P08 16-CG7508-RA_1 CG7508 GATGCCCAGATAGTCGGTTTTCTAGCGCCATTTTAAGCTCGCAACGAACTGAGGTATAACCGGGC 65 FBan0007508 FBgn0010433 ato 3 3R "Bolwig's organ morphogenesis; GO:0001746; R8 cell differentiation; GO:0045465; R8 cell fate commitment; GO:0007460; R8 cell fate specification; GO:0045464; activation of MAPK activity; GO:0000187; antennal morphogenesis; GO:0007469; brain development; GO:0007420; cell fate commitment; GO:0045165; compound eye morphogenesis (sensu Endopterygota); GO:0001745; epidermal growth factor receptor signaling pathway; GO:0007173; male courtship behavior (sensu Insecta), song production; GO:0045433; nervous system development; GO:0007399; neuron differentiation; GO:0030182; neuron recognition; GO:0008038; oenocyte development; GO:0007438; optic placode development (sensu Endopterygota); GO:0001748; peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355; second mitotic wave (sensu Endopterygota); GO:0016330; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360; sensory perception of sound; GO:0007605; smoothened signaling pathway; GO:0007224" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 host cell nucleus; GO:0042025; nucleus; GO:0005634 ato atonal "CG7508, ATO, ato1" CDMC26672 4 3 23 DAC36-P20 AutoBlank AutoBlank CDMC26672 4 4 23 DAC36-P20 AutoBlank AutoBlank CDMC26673 4 5 23 DAC37-D08 1-CG12933-RA_1 CG12933 GGTGGAGACCCAGAAGCAAACACTGATTGCCCGCGACGAGAGTATCAAGAAGCTGCTGGAAATGC 65 FBan0012933 FBgn0033418 CG12933 2 2R small GTPase regulator activity; GO:0005083; ; GO:0005083 CG12933 CG12933 CDMC26673 4 6 23 DAC37-D08 1-CG12933-RA_1 CG12933 GGTGGAGACCCAGAAGCAAACACTGATTGCCCGCGACGAGAGTATCAAGAAGCTGCTGGAAATGC 65 FBan0012933 FBgn0033418 CG12933 2 2R small GTPase regulator activity; GO:0005083; ; GO:0005083 CG12933 CG12933 CDMC26674 4 7 23 DAC37-D20 2-CG12954-RA_1 CG12954 CATTCACAAGCGAGGTGTACGAGACACGGGCATACTTGTCGACGGGCAGTATGTGGAGATTCCCG 65 FBan0012954 FBgn0034001 mRpL41 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL41 mitochondrial ribosomal protein L41 "CG12954, CG12954, YmL27, BcDNA:RE19416, mitochondrial ribosomal protein L41" CDMC26674 4 8 23 DAC37-D20 2-CG12954-RA_1 CG12954 CATTCACAAGCGAGGTGTACGAGACACGGGCATACTTGTCGACGGGCAGTATGTGGAGATTCCCG 65 FBan0012954 FBgn0034001 mRpL41 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL41 mitochondrial ribosomal protein L41 "CG12954, CG12954, YmL27, BcDNA:RE19416, mitochondrial ribosomal protein L41" CDMC26675 4 9 23 DAC37-H08 3-CG13042-RA_1 CG13042 ATCATCCAACCGATTGTGGCTCCGGTGGTGAAGACCTATGCCGCTCCCATCATCAAGACTTATGC 65 FBan0013042 FBgn0036602 CG13042 3 3L CG13042 CG13042 CDMC26675 4 10 23 DAC37-H08 3-CG13042-RA_1 CG13042 ATCATCCAACCGATTGTGGCTCCGGTGGTGAAGACCTATGCCGCTCCCATCATCAAGACTTATGC 65 FBan0013042 FBgn0036602 CG13042 3 3L CG13042 CG13042 CDMC26676 4 11 23 DAC37-H20 3-CG13050-RA_1 CG13050 ATTGGGCTACCATGCACCCATCATCTCCAAGACGATCATCGGCAAAAGCTACTTGGGCGGCTATG 65 FBan0013050 FBgn0036591 CG13050 3 3L CG13050 CG13050 CDMC26676 4 12 23 DAC37-H20 3-CG13050-RA_1 CG13050 ATTGGGCTACCATGCACCCATCATCTCCAAGACGATCATCGGCAAAAGCTACTTGGGCGGCTATG 65 FBan0013050 FBgn0036591 CG13050 3 3L CG13050 CG13050 CDMC26677 4 13 23 DAC37-L08 1-CG1309-RA_1 CG1309 ATCACCTACGCCTCTGACGAGGGCAAGTCATTCCCCATGAACATTGGAGCAGATTACTCGGAGGA 65 FBan0001309 FBgn0035519 CG1309 3 3L defense response; GO:0006952 catalytic activity; GO:0003824; ; GO:0003824 CG1309 CG1309 CDMC26677 4 14 23 DAC37-L08 1-CG1309-RA_1 CG1309 ATCACCTACGCCTCTGACGAGGGCAAGTCATTCCCCATGAACATTGGAGCAGATTACTCGGAGGA 65 FBan0001309 FBgn0035519 CG1309 3 3L defense response; GO:0006952 catalytic activity; GO:0003824; ; GO:0003824 CG1309 CG1309 CDMC26678 4 15 23 DAC37-L20 3-CG13129-RA_1 CG13129 GAAGAACGAGGCGATGAACGCGACTAGTGCATACCCCTTCCTCTACACCAACTATCTGCCCACCG 65 FBan0013129 FBgn0040966 CG13129 2 2L CG13129 CG13129 CDMC26678 4 16 23 DAC37-L20 3-CG13129-RA_1 CG13129 GAAGAACGAGGCGATGAACGCGACTAGTGCATACCCCTTCCTCTACACCAACTATCTGCCCACCG 65 FBan0013129 FBgn0040966 CG13129 2 2L CG13129 CG13129 CDMC26679 4 17 23 DAC37-P08 3-CG1318-RC_3 CG1318 TCAAACTGAACACCTTCCACTGGCACATCACGGACTCGCACAGCTTCCCATTGGAGGTGAAGAAG 65 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC26679 4 18 23 DAC37-P08 3-CG1318-RC_3 CG1318 TCAAACTGAACACCTTCCACTGGCACATCACGGACTCGCACAGCTTCCCATTGGAGGTGAAGAAG 65 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC26680 4 19 23 DAC37-P20 AutoBlank AutoBlank CDMC26680 4 20 23 DAC37-P20 AutoBlank AutoBlank CDMC26681 4 21 23 DAC38-D08 14-CG32589-RA_1 CG32589 GGCCTTGGGCACTTTGAACACTCGATCGGCGATTTCTGCAATTGTAATGGGATTTTCGATAGCGATTGC 69 FBgn0052589 CDMC26681 4 22 23 DAC38-D08 14-CG32589-RA_1 CG32589 GGCCTTGGGCACTTTGAACACTCGATCGGCGATTTCTGCAATTGTAATGGGATTTTCGATAGCGATTGC 69 FBgn0052589 CDMC26682 4 23 23 DAC38-D20 17-CG32595-RA_1 CG32595 ACGGATGCTTTACCGTTAGGTCGGAGGATTCAGATTTTGATCTAGACTTCTCCGATTCTGAGGACGGCT 69 FBan0032595 FBgn0052595 CG32595 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32595 CG32595 CDMC26682 4 24 23 DAC38-D20 17-CG32595-RA_1 CG32595 ACGGATGCTTTACCGTTAGGTCGGAGGATTCAGATTTTGATCTAGACTTCTCCGATTCTGAGGACGGCT 69 FBan0032595 FBgn0052595 CG32595 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32595 CG32595 CDMC26683 4 25 23 DAC38-H08 2-CG32637-RA_1 CG32637 CGCCAAGTACTGGGATCACCTGTACAGAAAGCAGCCATTCGGGAGACACGATAATCTCAGGATTGGCGA 69 FBan0032637 FBgn0052637 CG32637 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32637 CG32637 CDMC26683 4 26 23 DAC38-H08 2-CG32637-RA_1 CG32637 CGCCAAGTACTGGGATCACCTGTACAGAAAGCAGCCATTCGGGAGACACGATAATCTCAGGATTGGCGA 69 FBan0032637 FBgn0052637 CG32637 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32637 CG32637 CDMC26684 4 1 24 DAC38-H20 23-CG32645-RB_3 CG32645 ATCTGCACCCTCGACTCTTTCGGATCGTTATCTATACATGTACTTATTACTCTGCACCACATTTTTCAC 69 FBan0032645 FBgn0052645 CG32645 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG32645 CG32645 "CG15716, CG4331" CDMC26684 4 2 24 DAC38-H20 23-CG32645-RB_3 CG32645 ATCTGCACCCTCGACTCTTTCGGATCGTTATCTATACATGTACTTATTACTCTGCACCACATTTTTCAC 69 FBan0032645 FBgn0052645 CG32645 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG32645 CG32645 "CG15716, CG4331" CDMC26685 4 3 24 DAC38-L08 2-CG32680-RB_2 CG32680 AGCCGGATCAGTGCCATCCTGGTGAGCAGAACACCTGTGACCACTACGACATCAAACAGTTCTTTCACT 69 FBan0032680 FBgn0052680 CG32680 X X CG32680 CG32680 CG15301 CDMC26685 4 4 24 DAC38-L08 2-CG32680-RB_2 CG32680 AGCCGGATCAGTGCCATCCTGGTGAGCAGAACACCTGTGACCACTACGACATCAAACAGTTCTTTCACT 69 FBan0032680 FBgn0052680 CG32680 X X CG32680 CG32680 CG15301 CDMC26686 4 5 24 DAC38-L20 23-CG32690-RA_10 CG32690 TACGACACTGGATGGTAACACGATGGTAACACGAATTGATACTGCGTTGATTTGGATCGTTGAACACAG 69 FBan0032690 FBgn0052690 CG32690 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32690 CG32690 BEST:LP10814 CDMC26686 4 6 24 DAC38-L20 23-CG32690-RA_10 CG32690 TACGACACTGGATGGTAACACGATGGTAACACGAATTGATACTGCGTTGATTTGGATCGTTGAACACAG 69 FBan0032690 FBgn0052690 CG32690 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32690 CG32690 BEST:LP10814 CDMC26687 4 7 24 DAC38-P08 11-CG32715-RA_1 CG32715 TGGGCTTAAAGAGGTCAAGAGGTCACAGAACATGAGGAGCCGTCAGGAAATCTAATCGTAGCACAGCCA 69 FBan0032715 FBgn0052715 CG32715 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32715 CG32715 CDMC26687 4 8 24 DAC38-P08 11-CG32715-RA_1 CG32715 TGGGCTTAAAGAGGTCAAGAGGTCACAGAACATGAGGAGCCGTCAGGAAATCTAATCGTAGCACAGCCA 69 FBan0032715 FBgn0052715 CG32715 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32715 CG32715 CDMC26688 4 9 24 DAC38-P20 23-CG32721-RA_1 CG32721 GGCAGGCATCAATCAGTTGTCGCTGGCTATTATATATATTATATATTACTGTTACGCTAGTGTAACGAT 69 FBan0032721 FBgn0027553 CG32721 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 CG32721 CG32721 "CG12152, BcDNA:GH10333" CDMC26688 4 10 24 DAC38-P20 23-CG32721-RA_1 CG32721 GGCAGGCATCAATCAGTTGTCGCTGGCTATTATATATATTATATATTACTGTTACGCTAGTGTAACGAT 69 FBan0032721 FBgn0027553 CG32721 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 CG32721 CG32721 "CG12152, BcDNA:GH10333" CDMC26689 4 11 24 DAC39-D08 8-CG13689-RA_1 CG13689 TTCCCAAGGAAACAGGAACGTTTCACTGCCTGGACTACGTGTACGAGAGTTCTTCCGAGGATGAGGAGA 69 FBan0013689 FBgn0031270 CG13689 2 2L CG13689 CG13689 CDMC26689 4 12 24 DAC39-D08 8-CG13689-RA_1 CG13689 TTCCCAAGGAAACAGGAACGTTTCACTGCCTGGACTACGTGTACGAGAGTTCTTCCGAGGATGAGGAGA 69 FBan0013689 FBgn0031270 CG13689 2 2L CG13689 CG13689 CDMC26690 4 13 24 DAC39-D20 8-CG13699-RA_1 CG13699 TGCTGCCCAACGAAAACTGAAATTTCCTGTAGATCGCGATGAACGTTCTGAAAGTGTTCGGCGTGGCAA 69 FBan0013699 FBgn0036781 CG13699 3 3L CG13699 CG13699 CDMC26690 4 14 24 DAC39-D20 8-CG13699-RA_1 CG13699 TGCTGCCCAACGAAAACTGAAATTTCCTGTAGATCGCGATGAACGTTCTGAAAGTGTTCGGCGTGGCAA 69 FBan0013699 FBgn0036781 CG13699 3 3L CG13699 CG13699 CDMC26691 4 15 24 DAC39-H08 9-CG13743-RA_1 CG13743 ACAAAAGCCATCACCTCTTACTTTCTCTTCGGGCTGAGAGATCGGAACCAAGCTGAAGACCCCACAACT 69 FBan0013743 FBgn0033368 CG13743 2 2R CG13743 CG13743 CDMC26691 4 16 24 DAC39-H08 9-CG13743-RA_1 CG13743 ACAAAAGCCATCACCTCTTACTTTCTCTTCGGGCTGAGAGATCGGAACCAAGCTGAAGACCCCACAACT 69 FBan0013743 FBgn0033368 CG13743 2 2R CG13743 CG13743 CDMC26692 4 17 24 DAC39-H20 24-CG13759-RA_1 CG13759 TCACATTTGGAACAATAATCTCATTTATTTTCTACATATACATACATTGCATAATCGTTATTGGAATGT 69 FBan0013759 FBgn0040376 CG13759 X X N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG13759 CG13759 "EG:BACR25B3.5, CT33239, BcDNA:AT19803" CDMC26692 4 18 24 DAC39-H20 24-CG13759-RA_1 CG13759 TCACATTTGGAACAATAATCTCATTTATTTTCTACATATACATACATTGCATAATCGTTATTGGAATGT 69 FBan0013759 FBgn0040376 CG13759 X X N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG13759 CG13759 "EG:BACR25B3.5, CT33239, BcDNA:AT19803" CDMC26693 4 19 24 DAC39-L08 17-CG1378-RA_3 CG1378 GCCTCATCTCCGACATGTACAGTCAGCGCAAGATCTGAAAAGTATGTAGAGCCTAGACTAATCGCCGCA 69 FBan0001378 FBgn0003720 tll 3 3R "Bolwig's organ morphogenesis; GO:0001746; anterior/posterior axis specification; GO:0009948; cell fate commitment; GO:0045165; cell fate specification; GO:0001708; eye development (sensu Endopterygota); GO:0007456; gastrulation; GO:0007369; intracellular signaling cascade; GO:0007242; optic placode development (sensu Endopterygota); GO:0001748; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; transcription, DNA-dependent; GO:0006351" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 tll tailless "CG1378, Tll, NR2E2, TAILLESS" CDMC26693 4 20 24 DAC39-L08 17-CG1378-RA_3 CG1378 GCCTCATCTCCGACATGTACAGTCAGCGCAAGATCTGAAAAGTATGTAGAGCCTAGACTAATCGCCGCA 69 FBan0001378 FBgn0003720 tll 3 3R "Bolwig's organ morphogenesis; GO:0001746; anterior/posterior axis specification; GO:0009948; cell fate commitment; GO:0045165; cell fate specification; GO:0001708; eye development (sensu Endopterygota); GO:0007456; gastrulation; GO:0007369; intracellular signaling cascade; GO:0007242; optic placode development (sensu Endopterygota); GO:0001748; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; transcription, DNA-dependent; GO:0006351" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 tll tailless "CG1378, Tll, NR2E2, TAILLESS" CDMC26694 4 21 24 DAC39-L20 16-CG13800-RA_1 CG13800 ATTTCAAGTGAGGGAGCATTACGTATCCGAGGTTTCCATTAGTGCTTCGGAATCAACGGATGAGGAGCA 69 FBan0013800 FBgn0035338 CG13800 3 3L CG13800 CG13800 CDMC26694 4 22 24 DAC39-L20 16-CG13800-RA_1 CG13800 ATTTCAAGTGAGGGAGCATTACGTATCCGAGGTTTCCATTAGTGCTTCGGAATCAACGGATGAGGAGCA 69 FBan0013800 FBgn0035338 CG13800 3 3L CG13800 CG13800 CDMC26695 4 23 24 DAC39-P08 14-CG13867-RA_1 CG13867 TGGCCGACTTTCCTGGACAACTTTGCCATTATCTCAAGTCACTTGACGGGATTGACGAAAATCTTGGCA 69 FBan0013867 FBgn0034503 MED8 2 2R transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED8 Mediator complex subunit 8 "CG13867, CG30140, CG13867, dARC32, Med8/ARC32, Arc32, Mediator complex subunit 8" CDMC26695 4 24 24 DAC39-P08 14-CG13867-RA_1 CG13867 TGGCCGACTTTCCTGGACAACTTTGCCATTATCTCAAGTCACTTGACGGGATTGACGAAAATCTTGGCA 69 FBan0013867 FBgn0034503 MED8 2 2R transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED8 Mediator complex subunit 8 "CG13867, CG30140, CG13867, dARC32, Med8/ARC32, Arc32, Mediator complex subunit 8" CDMC26696 4 25 24 DAC39-P20 14-CG13874-RA_1 CG13874 GTTCACCCTATTCTGTATTGCTCTGGCAGCTTTTTTGTCCATGGGACAGTGTAATCCGGACTTTCGCCA 69 FBan0013874 FBgn0034475 Obp56h 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56h Odorant-binding protein 56h "CG13874, CG13874, CG13874, CG13874, OBP56h, 56h, Odorant-binding protein 56h" CDMC26696 4 26 24 DAC39-P20 14-CG13874-RA_1 CG13874 GTTCACCCTATTCTGTATTGCTCTGGCAGCTTTTTTGTCCATGGGACAGTGTAATCCGGACTTTCGCCA 69 FBan0013874 FBgn0034475 Obp56h 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56h Odorant-binding protein 56h "CG13874, CG13874, CG13874, CG13874, OBP56h, 56h, Odorant-binding protein 56h" CDMC26697 4 1 25 DAC40-D08 8-CG14166-RA_1 CG14166 CTGGAATCGGAGGCGACCAAAGACAAGCGACAAGTGAGCTCCAAGGAGACGTCTCTGTACCCCAA 65 FBan0014166 FBgn0036054 CG14166 3 3L CG14166 CG14166 CDMC26697 4 2 25 DAC40-D08 8-CG14166-RA_1 CG14166 CTGGAATCGGAGGCGACCAAAGACAAGCGACAAGTGAGCTCCAAGGAGACGTCTCTGTACCCCAA 65 FBan0014166 FBgn0036054 CG14166 3 3L CG14166 CG14166 CDMC26698 4 3 25 DAC40-D20 3-CG14190-RA_1 CG14190 ATGAGAGCATGTTTCCACCAATCATTCTGCCCGCTATCCTCAAGCGTTCATCCCAGGAGAGGCTG 65 FBan0014190 FBgn0030979 CG14190 X X CG14190 CG14190 CDMC26698 4 4 25 DAC40-D20 3-CG14190-RA_1 CG14190 ATGAGAGCATGTTTCCACCAATCATTCTGCCCGCTATCCTCAAGCGTTCATCCCAGGAGAGGCTG 65 FBan0014190 FBgn0030979 CG14190 X X CG14190 CG14190 CDMC26699 4 5 25 DAC40-H08 12-CG14260-RA_1 CG14260 GCAGCTCGTTGAGGTAACCCAGTTGTTCGGTCACGTTCTCTTCGAAGTGGATGGCACCATAGTTG 65 FBan0014260 FBgn0039504 CG14260 3 3R CG14260 CG14260 CDMC26699 4 6 25 DAC40-H08 12-CG14260-RA_1 CG14260 GCAGCTCGTTGAGGTAACCCAGTTGTTCGGTCACGTTCTCTTCGAAGTGGATGGCACCATAGTTG 65 FBan0014260 FBgn0039504 CG14260 3 3R CG14260 CG14260 CDMC26700 4 7 25 DAC40-H20 23-CG14286-RA_2 CG14286 CCTCCAGGCAAATCAAATTCACACCTACGGCTGAATCATCCAAAAAGTCTAGCTTTGTAAAGAAG 65 FBan0014286 FBgn0038673 CG14286 3 3R CG14286 CG14286 CDMC26700 4 8 25 DAC40-H20 23-CG14286-RA_2 CG14286 CCTCCAGGCAAATCAAATTCACACCTACGGCTGAATCATCCAAAAAGTCTAGCTTTGTAAAGAAG 65 FBan0014286 FBgn0038673 CG14286 3 3R CG14286 CG14286 CDMC26701 4 9 25 DAC40-L08 23-CG14384-RA_9 CG14384 ACAATTGCTAAACTGAACTGCCTATAAATTTCAAGTCTCAAAATGTCCCTCAATTGCCCGGTTCA 65 FBan0014384 FBgn0038097 CG14384 3 3R proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.- intracellular; GO:0005622 CG14384 CG14384 CDMC26701 4 10 25 DAC40-L08 23-CG14384-RA_9 CG14384 ACAATTGCTAAACTGAACTGCCTATAAATTTCAAGTCTCAAAATGTCCCTCAATTGCCCGGTTCA 65 FBan0014384 FBgn0038097 CG14384 3 3R proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.- intracellular; GO:0005622 CG14384 CG14384 CDMC26702 4 11 25 DAC40-L20 2-CG1440-RA_2 CG1440 ATCCCATGGGTACGCTAGCACAGTAGGTCCAGGTTGCCATCAAGACACACCCAACACACCTAACA 65 FBan0001440 FBgn0030038 CG1440 X X proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG1440 CG1440 CDMC26702 4 12 25 DAC40-L20 2-CG1440-RA_2 CG1440 ATCCCATGGGTACGCTAGCACAGTAGGTCCAGGTTGCCATCAAGACACACCCAACACACCTAACA 65 FBan0001440 FBgn0030038 CG1440 X X proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG1440 CG1440 CDMC26703 4 13 25 DAC40-P08 11-CG14477-RA_1 CG14477 TATTATACCGATGCCACGCCCACCCTGGTGCTGAGCAGCGACTATAACTCCAACTGCATCCCCAT 65 FBgn0015514 CDMC26703 4 14 25 DAC40-P08 11-CG14477-RA_1 CG14477 TATTATACCGATGCCACGCCCACCCTGGTGCTGAGCAGCGACTATAACTCCAACTGCATCCCCAT 65 FBgn0015514 CDMC26704 4 15 25 DAC40-P20 AutoBlank AutoBlank CDMC26704 4 16 25 DAC40-P20 AutoBlank AutoBlank CDMC26705 4 17 25 DAC41-D08 AutoBlank AutoBlank CDMC26705 4 18 25 DAC41-D08 AutoBlank AutoBlank CDMC26706 4 19 25 DAC41-D20 AutoBlank AutoBlank CDMC26706 4 20 25 DAC41-D20 AutoBlank AutoBlank CDMC26707 4 21 25 DAC41-H08 AutoBlank AutoBlank CDMC26707 4 22 25 DAC41-H08 AutoBlank AutoBlank CDMC26708 4 23 25 DAC41-H20 AutoBlank AutoBlank CDMC26708 4 24 25 DAC41-H20 AutoBlank AutoBlank CDMC26709 4 25 25 DAC41-L08 AutoBlank AutoBlank CDMC26709 4 26 25 DAC41-L08 AutoBlank AutoBlank CDMC26710 4 1 26 DAC41-L20 AutoBlank AutoBlank CDMC26710 4 2 26 DAC41-L20 AutoBlank AutoBlank CDMC26711 4 3 26 DAC41-P08 AutoBlank AutoBlank CDMC26711 4 4 26 DAC41-P08 AutoBlank AutoBlank CDMC26712 4 5 26 DAC41-P20 AutoBlank AutoBlank CDMC26712 4 6 26 DAC41-P20 AutoBlank AutoBlank CDMC26713 4 7 26 DAC42-D08 150mM NaPO4 Blank CDMC26713 4 8 26 DAC42-D08 150mM NaPO4 Blank CDMC26714 4 9 26 DAC42-D20 150mM NaPO4 Blank CDMC26714 4 10 26 DAC42-D20 150mM NaPO4 Blank CDMC26715 4 11 26 DAC42-H08 150mM NaPO4 Blank CDMC26715 4 12 26 DAC42-H08 150mM NaPO4 Blank CDMC26716 4 13 26 DAC42-H20 150mM NaPO4 Blank CDMC26716 4 14 26 DAC42-H20 150mM NaPO4 Blank CDMC26717 4 15 26 DAC42-L08 150mM NaPO4 Blank CDMC26717 4 16 26 DAC42-L08 150mM NaPO4 Blank CDMC26718 4 17 26 DAC42-L20 5uM MSP 5uM MSP CDMC26718 4 18 26 DAC42-L20 5uM MSP 5uM MSP CDMC26719 4 19 26 DAC42-P08 10uM MSP 10uM MSP CDMC26719 4 20 26 DAC42-P08 10uM MSP 10uM MSP CDMC26720 4 21 26 DAC42-P20 20uM MSP 20uM MSP CDMC26720 4 22 26 DAC42-P20 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC26721 1 1 1 DAC01-A07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26721 1 2 1 DAC01-A07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC26722 1 3 1 DAC01-A19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26722 1 4 1 DAC01-A19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC26723 1 5 1 DAC01-E07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26723 1 6 1 DAC01-E07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC26724 1 7 1 DAC01-E19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26724 1 8 1 DAC01-E19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC26725 1 9 1 DAC01-I07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26725 1 10 1 DAC01-I07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC26726 1 11 1 DAC01-I19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26726 1 12 1 DAC01-I19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC26727 1 13 1 DAC01-M07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26727 1 14 1 DAC01-M07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC26728 1 15 1 DAC01-M19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26728 1 16 1 DAC01-M19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC26729 1 17 1 DAC02-A07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26729 1 18 1 DAC02-A07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC26730 1 19 1 DAC02-A19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26730 1 20 1 DAC02-A19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC26731 1 21 1 DAC02-E07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26731 1 22 1 DAC02-E07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC26732 1 23 1 DAC02-E19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26732 1 24 1 DAC02-E19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC26733 1 25 1 DAC02-I07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26733 1 26 1 DAC02-I07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC26734 1 1 2 DAC02-I19 N/A CG9075 (01196-01434) CDMC26734 1 2 2 DAC02-I19 N/A CG9075 (01196-01434) CDMC26735 1 3 2 DAC02-M07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26735 1 4 2 DAC02-M07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC26736 1 5 2 DAC02-M19 AutoBlank AutoBlank CDMC26736 1 6 2 DAC02-M19 AutoBlank AutoBlank CDMC26737 1 7 2 DAC03-A07 12-CG17081-RA_1 CG17081 GCGCGCAAGGAGCTGTGTGATAAGTTGGATGTGGAAAGAAGCAAACTCAATGCGGAGCTGAATGATGTG 69 FBan0017081 FBgn0036480 CG17081 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; transporter activity; GO:0005215; ; GO:0008017; ; GO:0005200; ; GO:0005215 CG17081 CG17081 CDMC26737 1 8 2 DAC03-A07 12-CG17081-RA_1 CG17081 GCGCGCAAGGAGCTGTGTGATAAGTTGGATGTGGAAAGAAGCAAACTCAATGCGGAGCTGAATGATGTG 69 FBan0017081 FBgn0036480 CG17081 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; transporter activity; GO:0005215; ; GO:0008017; ; GO:0005200; ; GO:0005215 CG17081 CG17081 CDMC26738 1 9 2 DAC03-A19 10-CG17097-RA_2 CG17097 AGCTAGGAACACAGACTTTAGAGTCACAGTCTCCATCCGAGGTGCTACTACACATTCAGGGGCCTTCCA 69 FBan0017097 FBgn0032275 CG17097 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG17097 CG17097 CDMC26738 1 10 2 DAC03-A19 10-CG17097-RA_2 CG17097 AGCTAGGAACACAGACTTTAGAGTCACAGTCTCCATCCGAGGTGCTACTACACATTCAGGGGCCTTCCA 69 FBan0017097 FBgn0032275 CG17097 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG17097 CG17097 CDMC26739 1 11 2 DAC03-E07 12-CG17142-RA_1 CG17142 ACAGGCGAACAGACAAGCAACCCGACTGTGACTGATTGGAAGCAAGAGATTCTGAGTTTTTTGGGGTCA 69 FBan0017142 FBgn0035113 pyx 3 3L "DNA replication; GO:0006260; calcium ion transport; GO:0006816; cation transport; GO:0006812; protein amino acid ADP-ribosylation; GO:0006471; protein heterotetramerization; GO:0051290; response to heat; GO:0009408; transcription, RNA-dependent; GO:0006410" calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005262; cation channel activity; GO:0005261; ; GO:0005057; ; GO:0016779 ; EC:2.7.7.-; ; GO:0005261 integral to membrane; GO:0016021; membrane; GO:0016020 pyx pyrexia "CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CT33412, pyrexia" CDMC26739 1 12 2 DAC03-E07 12-CG17142-RA_1 CG17142 ACAGGCGAACAGACAAGCAACCCGACTGTGACTGATTGGAAGCAAGAGATTCTGAGTTTTTTGGGGTCA 69 FBan0017142 FBgn0035113 pyx 3 3L "DNA replication; GO:0006260; calcium ion transport; GO:0006816; cation transport; GO:0006812; protein amino acid ADP-ribosylation; GO:0006471; protein heterotetramerization; GO:0051290; response to heat; GO:0009408; transcription, RNA-dependent; GO:0006410" calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005262; cation channel activity; GO:0005261; ; GO:0005057; ; GO:0016779 ; EC:2.7.7.-; ; GO:0005261 integral to membrane; GO:0016021; membrane; GO:0016020 pyx pyrexia "CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CG17142, CT33412, pyrexia" CDMC26740 1 13 2 DAC03-E19 2-CG17152-RA_1 CG17152 GGCTATCCTCCTTCAGCTCGATGAGAACGTTCCTCATGGGTTGGATCCTCTTCAGCTACGTCCTGTCCA 69 FBan0017152 FBgn0036250 CG17152 3 3L glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG17152 CG17152 CT38092 CDMC26740 1 14 2 DAC03-E19 2-CG17152-RA_1 CG17152 GGCTATCCTCCTTCAGCTCGATGAGAACGTTCCTCATGGGTTGGATCCTCTTCAGCTACGTCCTGTCCA 69 FBan0017152 FBgn0036250 CG17152 3 3L glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG17152 CG17152 CT38092 CDMC26741 1 15 2 DAC03-I07 3-CG17189-RA_3 CG17189 CCACCCTTTCCGCCAATCTTACGGATATGCTGATCAGGGGCTTTGGCAAAATGCTGATCAAGGAGAGCA 69 FBan0017189 FBgn0039485 CG17189 3 3R CG17189 CG17189 CDMC26741 1 16 2 DAC03-I07 3-CG17189-RA_3 CG17189 CCACCCTTTCCGCCAATCTTACGGATATGCTGATCAGGGGCTTTGGCAAAATGCTGATCAAGGAGAGCA 69 FBan0017189 FBgn0039485 CG17189 3 3R CG17189 CG17189 CDMC26742 1 17 2 DAC03-I19 13-CG17200-RA_3 CG17200 TGGCTTTGTTTCCGGTTCCCTCCCATTCGCACTATTATCATGCCCTTCCATATCTCAAAAACTTGGCCT 69 FBan0017200 FBgn0040253 Ugt86Dg 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dg Ugt86Dg "CG17200, CG17200, AC 006491G" CDMC26742 1 18 2 DAC03-I19 13-CG17200-RA_3 CG17200 TGGCTTTGTTTCCGGTTCCCTCCCATTCGCACTATTATCATGCCCTTCCATATCTCAAAAACTTGGCCT 69 FBan0017200 FBgn0040253 Ugt86Dg 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dg Ugt86Dg "CG17200, CG17200, AC 006491G" CDMC26743 1 19 2 DAC03-M07 3-CG17239-RA_1 CG17239 CCGCTTCGGTGGACATTGTGGACCAGGATCAGTGTCGTAGGTCGTACGGAAGAAAAATCACCAAGGACA 69 FBan0017239 FBgn0042186 CG17239 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17239 CG17239 SP138 CDMC26743 1 20 2 DAC03-M07 3-CG17239-RA_1 CG17239 CCGCTTCGGTGGACATTGTGGACCAGGATCAGTGTCGTAGGTCGTACGGAAGAAAAATCACCAAGGACA 69 FBan0017239 FBgn0042186 CG17239 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17239 CG17239 SP138 CDMC26744 1 21 2 DAC03-M19 18-CG17255-RA_1 CG17255 GGGGAATCCCCGTCACAATCGCAAAATGGCAACTCAGCTAAATCACCGTAGCGAGGAGGAAATTAATTT 69 FBan0017255 FBgn0030205 CG17255 X X CG17255 CG17255 CDMC26744 1 22 2 DAC03-M19 18-CG17255-RA_1 CG17255 GGGGAATCCCCGTCACAATCGCAAAATGGCAACTCAGCTAAATCACCGTAGCGAGGAGGAAATTAATTT 69 FBan0017255 FBgn0030205 CG17255 X X CG17255 CG17255 CDMC26745 1 23 2 DAC04-A07 17-CG15867-RA_1 CG15867 GACGCTTGGAGGCAGACCGCTGGATAAACGGACCGCTGAACAGCTACGGCAAGGTGAGTGTCTAA 65 FBan0015867 FBgn0040961 CG15867 2 2L CG15867 CG15867 CDMC26745 1 24 2 DAC04-A07 17-CG15867-RA_1 CG15867 GACGCTTGGAGGCAGACCGCTGGATAAACGGACCGCTGAACAGCTACGGCAAGGTGAGTGTCTAA 65 FBan0015867 FBgn0040961 CG15867 2 2L CG15867 CG15867 CDMC26746 1 25 2 DAC04-A19 2-CG15884-RA_2 CG15884 GATGGCCAGTATCGTGAGGACCCCTCGGTGTACTACAAGGACCAGAAGTTCAATCGCCCCCTTTC 65 FBan0015884 FBgn0039481 CG15884 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15884 CG15884 CT33880 CDMC26746 1 26 2 DAC04-A19 2-CG15884-RA_2 CG15884 GATGGCCAGTATCGTGAGGACCCCTCGGTGTACTACAAGGACCAGAAGTTCAATCGCCCCCTTTC 65 FBan0015884 FBgn0039481 CG15884 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15884 CG15884 CT33880 CDMC26747 1 1 3 DAC04-E07 2-CG1674-RA_1 CG1674 TGCCTTAACACCAATTCCGTCTTCCCAAGCTGGTAGTAAGGACTGGACGGACGCTAATGAGCCCA 65 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC26747 1 2 3 DAC04-E07 2-CG1674-RA_1 CG1674 TGCCTTAACACCAATTCCGTCTTCCCAAGCTGGTAGTAAGGACTGGACGGACGCTAATGAGCCCA 65 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC26748 1 3 3 DAC04-E19 1-CG16778-RA_1 CG16778 TGTTGGATCGAAGCAGTCCTCTTCCGTGGACGAAGACTACTCAGGTCCTGGAATACCGCTCTCGC 65 FBan0016778 FBgn0003715 Tkr 2 2R DNA binding; GO:0003677; actin binding; GO:0003779; ; GO:0003677; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; ; GO:0003677 nucleus; GO:0005634 Tkr Tyrosine kinase-related protein "CG16778, CG2672, g2, dTKR, BTB-III, BtbIII, tkr, anon-G2, BTB-protein-III" CDMC26748 1 4 3 DAC04-E19 1-CG16778-RA_1 CG16778 TGTTGGATCGAAGCAGTCCTCTTCCGTGGACGAAGACTACTCAGGTCCTGGAATACCGCTCTCGC 65 FBan0016778 FBgn0003715 Tkr 2 2R DNA binding; GO:0003677; actin binding; GO:0003779; ; GO:0003677; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; ; GO:0003677 nucleus; GO:0005634 Tkr Tyrosine kinase-related protein "CG16778, CG2672, g2, dTKR, BTB-III, BtbIII, tkr, anon-G2, BTB-protein-III" CDMC26749 1 5 3 DAC04-I07 3-CG16896-RA_2 CG16896 CTAAAGATTTTGCCTGGCCCCTTCTGAGCACTGCCTTTTCCGAGGTCCTTGAAGAGGAGCAGTGG 65 FBan0016896 FBgn0035073 CG16896 2 2R CG16896 CG16896 CDMC26749 1 6 3 DAC04-I07 3-CG16896-RA_2 CG16896 CTAAAGATTTTGCCTGGCCCCTTCTGAGCACTGCCTTTTCCGAGGTCCTTGAAGAGGAGCAGTGG 65 FBan0016896 FBgn0035073 CG16896 2 2R CG16896 CG16896 CDMC26750 1 7 3 DAC04-I19 2-CG16937-RA_1 CG16937 CCGAGATCGTTTCTATGAGAAGTTCACAGGTGCCGATCAGAGGACATGGGACGAACACTGGCCGG 65 FBan0016937 FBgn0032991 CG16937 2 2L CG16937 CG16937 CDMC26750 1 8 3 DAC04-I19 2-CG16937-RA_1 CG16937 CCGAGATCGTTTCTATGAGAAGTTCACAGGTGCCGATCAGAGGACATGGGACGAACACTGGCCGG 65 FBan0016937 FBgn0032991 CG16937 2 2L CG16937 CG16937 CDMC26751 1 9 3 DAC04-M07 15-CG17105-RA_1 CG17105 CCACTGCCAACGCTAATGCAAACGCAAACTCAGTTGGTTACAGTCCGGGTGCTTACTACGGATAA 65 FBan0017105 FBgn0032280 CG17105 2 2L CG17105 CG17105 CDMC26751 1 10 3 DAC04-M07 15-CG17105-RA_1 CG17105 CCACTGCCAACGCTAATGCAAACGCAAACTCAGTTGGTTACAGTCCGGGTGCTTACTACGGATAA 65 FBan0017105 FBgn0032280 CG17105 2 2L CG17105 CG17105 CDMC26752 1 11 3 DAC04-M19 3-CG17146-RB_1 CG17146 CTCGAAGGGATTCCTCATCGATGGATATCCGCGTCAGAAGAACCAGGGCATTGAGTTCGAGGCGC 65 FBan0017146 FBgn0022709 Adk1 3 3L ATP metabolism; GO:0046034; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; uridine kinase activity; GO:0004849 ; EC:2.7.1.48; ; GO:0004849 ; EC:2.7.1.48; ; GO:0004017 ; EC:2.7.4.3 cytoplasm; GO:0005737 Adk1 Adenylate kinase-1 "CG17146, ADK-1, AK1, bs34e10.y1, DAK1, Adenylate kinase-1" CDMC26752 1 12 3 DAC04-M19 3-CG17146-RB_1 CG17146 CTCGAAGGGATTCCTCATCGATGGATATCCGCGTCAGAAGAACCAGGGCATTGAGTTCGAGGCGC 65 FBan0017146 FBgn0022709 Adk1 3 3L ATP metabolism; GO:0046034; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; uridine kinase activity; GO:0004849 ; EC:2.7.1.48; ; GO:0004849 ; EC:2.7.1.48; ; GO:0004017 ; EC:2.7.4.3 cytoplasm; GO:0005737 Adk1 Adenylate kinase-1 "CG17146, ADK-1, AK1, bs34e10.y1, DAK1, Adenylate kinase-1" CDMC26753 1 13 3 DAC05-A07 2-CG10222-RA_1 CG10222 GGGCGTTGTGAATCTGGATCCAGCCAACGAAAACATGTCCTACGAACCGGTGCTAAGTGTGATGGAGC 68 FBan0010222 FBgn0036356 CG10222 3 3L CG10222 CG10222 CDMC26753 1 14 3 DAC05-A07 2-CG10222-RA_1 CG10222 GGGCGTTGTGAATCTGGATCCAGCCAACGAAAACATGTCCTACGAACCGGTGCTAAGTGTGATGGAGC 68 FBan0010222 FBgn0036356 CG10222 3 3L CG10222 CG10222 CDMC26754 1 15 3 DAC05-A19 2-CG10341-RA_3 CG10341 GTGGTCCAGGGAAGTCCATCGGAAGAATCCAAAAAAGTTGCCTCTGACGCTTCTGCTACTGTGACCGC 68 FBan0010341 FBgn0032701 CG10341 2 2L CG10341 CG10341 CDMC26754 1 16 3 DAC05-A19 2-CG10341-RA_3 CG10341 GTGGTCCAGGGAAGTCCATCGGAAGAATCCAAAAAAGTTGCCTCTGACGCTTCTGCTACTGTGACCGC 68 FBan0010341 FBgn0032701 CG10341 2 2L CG10341 CG10341 CDMC26755 1 17 3 DAC05-E07 3-CG10859-RA_3 CG10859 TGTTCTGCATCGGAGACAACATGGGCAACTTGGAGTTTTGGGACCTGCTGATGTCTCACAAACGACCG 68 FBan0010859 FBgn0032520 CG10859 2 2L microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG10859 CG10859 CDMC26755 1 18 3 DAC05-E07 3-CG10859-RA_3 CG10859 TGTTCTGCATCGGAGACAACATGGGCAACTTGGAGTTTTGGGACCTGCTGATGTCTCACAAACGACCG 68 FBan0010859 FBgn0032520 CG10859 2 2L microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG10859 CG10859 CDMC26756 1 19 3 DAC05-E19 2-CG10998-RB_1 CG10998 GCACCGCTCTAAAGAGCTTCGAGAATCGCCTCGTGGTAGTCGATGAGAATCTCAAGGATTGCACGGGC 68 FBan0010998 FBgn0031142 CG10998 X X CG10998 CG10998 CDMC26756 1 20 3 DAC05-E19 2-CG10998-RB_1 CG10998 GCACCGCTCTAAAGAGCTTCGAGAATCGCCTCGTGGTAGTCGATGAGAATCTCAAGGATTGCACGGGC 68 FBan0010998 FBgn0031142 CG10998 X X CG10998 CG10998 CDMC26757 1 21 3 DAC05-I07 2-CG11231-RA_1 CG11231 GGGCTCCAGAGAGGTCACGGGACCGATGTTCTGGAACACCACGTACAATAGTGTTCTAAGCCTTGCTC 68 FBan0011231 FBgn0039939 CG11231 4 4 CG11231 CG11231 CDMC26757 1 22 3 DAC05-I07 2-CG11231-RA_1 CG11231 GGGCTCCAGAGAGGTCACGGGACCGATGTTCTGGAACACCACGTACAATAGTGTTCTAAGCCTTGCTC 68 FBan0011231 FBgn0039939 CG11231 4 4 CG11231 CG11231 CDMC26758 1 23 3 DAC05-I19 9-CG11369-RA_13 CG11369 TTCCATTGCCGCAAAGAAGCTACGACAAGCCGTGGATACTGAAACGCTCTAAAAAGAGACGCTTGGCG 68 FBan0011369 FBgn0029951 CG11369 X X CG11369 CG11369 CDMC26758 1 24 3 DAC05-I19 9-CG11369-RA_13 CG11369 TTCCATTGCCGCAAAGAAGCTACGACAAGCCGTGGATACTGAAACGCTCTAAAAAGAGACGCTTGGCG 68 FBan0011369 FBgn0029951 CG11369 X X CG11369 CG11369 CDMC26759 1 25 3 DAC05-M07 2-CG11849-RA_1 CG11849 GGCCACCCTACTCAGCTCCCTGTTCTTCCCTCCCTACGAATTTGTACATTGTGACCTCGACGATGACC 68 FBan0011849 FBgn0039286 dan 3 3R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" dan distal antenna "CG11849, CG11849, CG11849, CG11849, CG11849, fernandez, Tintin, Dan, distal antenna" CDMC26759 1 26 3 DAC05-M07 2-CG11849-RA_1 CG11849 GGCCACCCTACTCAGCTCCCTGTTCTTCCCTCCCTACGAATTTGTACATTGTGACCTCGACGATGACC 68 FBan0011849 FBgn0039286 dan 3 3R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" dan distal antenna "CG11849, CG11849, CG11849, CG11849, CG11849, fernandez, Tintin, Dan, distal antenna" CDMC26760 1 1 4 DAC05-M19 2-CG12068-RA_1 CG12068 TCGCTGCTGGCAAAGTTTAAGGATGCATTGACCAGCTCACAACCCTTGGCTCTGTACATCGAGGAACC 68 FBan0012068 FBgn0039695 CG12068 3 3R metabolism; GO:0008152; visual perception; GO:0007601 3-hydroxybutyrate dehydrogenase activity; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30 CG12068 CG12068 CDMC26760 1 2 4 DAC05-M19 2-CG12068-RA_1 CG12068 TCGCTGCTGGCAAAGTTTAAGGATGCATTGACCAGCTCACAACCCTTGGCTCTGTACATCGAGGAACC 68 FBan0012068 FBgn0039695 CG12068 3 3R metabolism; GO:0008152; visual perception; GO:0007601 3-hydroxybutyrate dehydrogenase activity; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30 CG12068 CG12068 CDMC26761 1 3 4 DAC06-A07 3-CG32982-RA_1 CG32982 AGCAATGCGAATCTCAGTCGATACTCCAATGGATATGTCTCGGCCCAGAACAGTTTCACCCAAGCCGGA 69 FBan0032982 FBgn0052982 CG32982 2 2L CG32982 CG32982 "CG18566, CG9585, CG9584, CG18566, CG9585, CG9585" CDMC26761 1 4 4 DAC06-A07 3-CG32982-RA_1 CG32982 AGCAATGCGAATCTCAGTCGATACTCCAATGGATATGTCTCGGCCCAGAACAGTTTCACCCAAGCCGGA 69 FBan0032982 FBgn0052982 CG32982 2 2L CG32982 CG32982 "CG18566, CG9585, CG9584, CG18566, CG9585, CG9585" CDMC26762 1 5 4 DAC06-A19 23-CG3299-RA_4 CG3299 TCCAAGGAATCTAGAATCGCCCCTCCATCGTATTTGTAGTGTACTAACAGAAGCATTTATCGAAGCCCT 69 FBan0003299 FBgn0004397 Vinc X X cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin cytoskeleton; GO:0015629; focal adhesion; GO:0005925 Vinc Vinculin "CG3299, CG3299, CG3299, Dmvincp, vinculin, CT11081, EG:103B4.1, vinc, Vin, Vin2EF, Vinculin at 2EF" CDMC26762 1 6 4 DAC06-A19 23-CG3299-RA_4 CG3299 TCCAAGGAATCTAGAATCGCCCCTCCATCGTATTTGTAGTGTACTAACAGAAGCATTTATCGAAGCCCT 69 FBan0003299 FBgn0004397 Vinc X X cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin cytoskeleton; GO:0015629; focal adhesion; GO:0005925 Vinc Vinculin "CG3299, CG3299, CG3299, Dmvincp, vinculin, CT11081, EG:103B4.1, vinc, Vin, Vin2EF, Vinculin at 2EF" CDMC26763 1 7 4 DAC06-E07 13-CG33051-RA_1 CG33051 GGCCGAATCTGCTGACCAAGAAGACAAACATCGAGGACAGACTGAAGGTTCTGGAGCAGAAAGAACTGA 69 FBan0033051 FBgn0053051 CG33051 3 3L CG33051 CG33051 CG3882 CDMC26763 1 8 4 DAC06-E07 13-CG33051-RA_1 CG33051 GGCCGAATCTGCTGACCAAGAAGACAAACATCGAGGACAGACTGAAGGTTCTGGAGCAGAAAGAACTGA 69 FBan0033051 FBgn0053051 CG33051 3 3L CG33051 CG33051 CG3882 CDMC26764 1 9 4 DAC06-E19 12-CG33066-RC_1 CG33066 TGGACAGGTGCGTTACCAAGTTCGCGCGCTTCAACCAGAATATGATGAAAGTTTACGTGGATGTGCAGA 69 FBgn0053066 CDMC26764 1 10 4 DAC06-E19 12-CG33066-RC_1 CG33066 TGGACAGGTGCGTTACCAAGTTCGCGCGCTTCAACCAGAATATGATGAAAGTTTACGTGGATGTGCAGA 69 FBgn0053066 CDMC26765 1 11 4 DAC06-I07 1-CG33097-RA_1 CG33097 AGGAGCTTCACAAGATCGTGTTCGACCCGCGGTATCTTCTGCTGACTTCGAAGGAACGCAAACAGGTAT 69 FBan0033097 FBgn0053097 CG33097 3 3R RNA elongation; GO:0006354; transcription from RNA polymerase II promoter; GO:0006366 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nucleus; GO:0005634 CG33097 CG33097 CG15187 CDMC26765 1 12 4 DAC06-I07 1-CG33097-RA_1 CG33097 AGGAGCTTCACAAGATCGTGTTCGACCCGCGGTATCTTCTGCTGACTTCGAAGGAACGCAAACAGGTAT 69 FBan0033097 FBgn0053097 CG33097 3 3R RNA elongation; GO:0006354; transcription from RNA polymerase II promoter; GO:0006366 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nucleus; GO:0005634 CG33097 CG33097 CG15187 CDMC26766 1 13 4 DAC06-I19 8-CG33104-RA_2 CG33104 ACCACTGGCCTCATTGTTCCGTGTGTTTCCCTCATTTGGCAGGAATTGCGAATTTCATCGATGGATCGT 69 FBgn0053104 CDMC26766 1 14 4 DAC06-I19 8-CG33104-RA_2 CG33104 ACCACTGGCCTCATTGTTCCGTGTGTTTCCCTCATTTGGCAGGAATTGCGAATTTCATCGATGGATCGT 69 FBgn0053104 CDMC26767 1 15 4 DAC06-M07 23-CG33128-RA_1 CG33128 GAGGGCAGCAGAATATCTTTCGTTAGAAAAGCTCAGAGTACTCATTAAATCATAATGCTGAAGTGGCTG 69 FBan0033128 FBgn0053128 CG33128 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG33128 CG33128 CG10872 CDMC26767 1 16 4 DAC06-M07 23-CG33128-RA_1 CG33128 GAGGGCAGCAGAATATCTTTCGTTAGAAAAGCTCAGAGTACTCATTAAATCATAATGCTGAAGTGGCTG 69 FBan0033128 FBgn0053128 CG33128 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG33128 CG33128 CG10872 CDMC26768 1 17 4 DAC06-M19 23-CG33135-RA_2 CG33135 TCGAAGAGAAGCTAGACATTCTGATTAAAGCTTACATGGAGGATCGTGATAGATTCCTGGCTCTTCCGC 69 FBan0033135 FBgn0033494 KCNQ 2 2R muscle contraction; GO:0006936; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 KCNQ KCNQ potassium channel "CG12215, CG33135, CG12915, CG12215, CG12215, CG12215, DKCNQ" CDMC26768 1 18 4 DAC06-M19 23-CG33135-RA_2 CG33135 TCGAAGAGAAGCTAGACATTCTGATTAAAGCTTACATGGAGGATCGTGATAGATTCCTGGCTCTTCCGC 69 FBan0033135 FBgn0033494 KCNQ 2 2R muscle contraction; GO:0006936; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 KCNQ KCNQ potassium channel "CG12215, CG33135, CG12915, CG12215, CG12215, CG12215, DKCNQ" CDMC26769 1 19 4 DAC07-A07 14-CG5781-RA_1 CG5781 GCCGAATCCCTGGAAGCAAACAAGGGTCACCGCTAGAAAAGATTCTCAGGCAGCCTAGAAATGAGATTG 69 FBan0005781 FBgn0032448 CG5781 2 2L CG5781 CG5781 CDMC26769 1 20 4 DAC07-A07 14-CG5781-RA_1 CG5781 GCCGAATCCCTGGAAGCAAACAAGGGTCACCGCTAGAAAAGATTCTCAGGCAGCCTAGAAATGAGATTG 69 FBan0005781 FBgn0032448 CG5781 2 2L CG5781 CG5781 CDMC26770 1 21 4 DAC07-A19 2-CG5792-RA_2 CG5792 CCGAGGAGGAACTGATTGGCATACTGGAATCCACTACTCCTGGCTCCTATCGAGTGCCCATGAGCATCT 69 FBan0005792 FBgn0032455 CG5792 2 2L CG5792 CG5792 CDMC26770 1 22 4 DAC07-A19 2-CG5792-RA_2 CG5792 CCGAGGAGGAACTGATTGGCATACTGGAATCCACTACTCCTGGCTCCTATCGAGTGCCCATGAGCATCT 69 FBan0005792 FBgn0032455 CG5792 2 2L CG5792 CG5792 CDMC26771 1 23 4 DAC07-E07 1-CG5821-RA_1 CG5821 GCCGAATCGAATGGACGCATTCAAGGTTGGTCCCAGTCGAGCCAAATGTCCTTGTTTTGTTTTGTCGCA 69 FBan0005821 FBgn0022985 qkr58E-2 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; ; GO:0003729 qkr58E-2 quaking related 58E-2 "CG5821, CG5821, qrk58E-2" CDMC26771 1 24 4 DAC07-E07 1-CG5821-RA_1 CG5821 GCCGAATCGAATGGACGCATTCAAGGTTGGTCCCAGTCGAGCCAAATGTCCTTGTTTTGTTTTGTCGCA 69 FBan0005821 FBgn0022985 qkr58E-2 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; ; GO:0003729 qkr58E-2 quaking related 58E-2 "CG5821, CG5821, qrk58E-2" CDMC26772 1 25 4 DAC07-E19 11-CG5838-RA_2 CG5838 AGCACTTCCCCTGGACACTGTACGAAACATTGAAGTTCTTTGCCGAGTCCATATCTTGGTCCGAGGACA 69 FBan0005838 FBgn0015664 Dref 2 2L "DNA replication; GO:0006260; mitochondrial DNA replication; GO:0006264; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 transcription factor complex; GO:0005667 Dref DNA replication-related element factor "CG5838, CG5838, DREF, dDREF, p80, p80/DREF, DmDREF" CDMC26772 1 26 4 DAC07-E19 11-CG5838-RA_2 CG5838 AGCACTTCCCCTGGACACTGTACGAAACATTGAAGTTCTTTGCCGAGTCCATATCTTGGTCCGAGGACA 69 FBan0005838 FBgn0015664 Dref 2 2L "DNA replication; GO:0006260; mitochondrial DNA replication; GO:0006264; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 transcription factor complex; GO:0005667 Dref DNA replication-related element factor "CG5838, CG5838, DREF, dDREF, p80, p80/DREF, DmDREF" CDMC26773 1 1 5 DAC07-I07 15-CG5869-RA_1 CG5869 TGAAAGCCAAGCTCAAGTAGAGAGGTTTCGATCTCTGGGATCAATCAATCCGGGCCGTTGTCAAAAGCA 69 FBan0005869 FBgn0028894 CG5869 2 2L ectoderm development; GO:0007398; gliogenesis; GO:0042063 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG5869 CG5869 "BG:DS02740.9, DS02740.9, BcDNA:SD03793" CDMC26773 1 2 5 DAC07-I07 15-CG5869-RA_1 CG5869 TGAAAGCCAAGCTCAAGTAGAGAGGTTTCGATCTCTGGGATCAATCAATCCGGGCCGTTGTCAAAAGCA 69 FBan0005869 FBgn0028894 CG5869 2 2L ectoderm development; GO:0007398; gliogenesis; GO:0042063 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG5869 CG5869 "BG:DS02740.9, DS02740.9, BcDNA:SD03793" CDMC26774 1 3 5 DAC07-I19 1-CG5877-RA_1 CG5877 GCCAGCTGAGATGTCTTTGGAGGAGTACTTCCAGCCCAACAAATTGCTCATCCTCTTGCGCGCTATCTG 69 FBan0005877 FBgn0030625 CG5877 X X CG5877 CG5877 CDMC26774 1 4 5 DAC07-I19 1-CG5877-RA_1 CG5877 GCCAGCTGAGATGTCTTTGGAGGAGTACTTCCAGCCCAACAAATTGCTCATCCTCTTGCGCGCTATCTG 69 FBan0005877 FBgn0030625 CG5877 X X CG5877 CG5877 CDMC26775 1 5 5 DAC07-M07 16-CG5920-RA_1 CG5920 GGAGGAGATCTACCTGTACTCGCTTCCCATCAAAGAGTTCGAGATCATCGACTTCTTCCTGGGATCCTC 69 FBan0005920 FBgn0004867 sop 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sop string of pearls "CG5920, l(2)03848, RpS2, Ribosomal protein S2, l(2)k04603, Dm01335, dS2, Ribosome RS2, S2, anon-EST:Posey202" CDMC26775 1 6 5 DAC07-M07 16-CG5920-RA_1 CG5920 GGAGGAGATCTACCTGTACTCGCTTCCCATCAAAGAGTTCGAGATCATCGACTTCTTCCTGGGATCCTC 69 FBan0005920 FBgn0004867 sop 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sop string of pearls "CG5920, l(2)03848, RpS2, Ribosomal protein S2, l(2)k04603, Dm01335, dS2, Ribosome RS2, S2, anon-EST:Posey202" CDMC26776 1 7 5 DAC07-M19 22-CG5930-RA_3 CG5930 GCGAAGACGATGTCACCGACGAAGACTCTGCCGAAATGTTTGACACAGATAACGTGATTGTTTGTCAGT 69 FBan0005930 FBgn0011289 TfIIA-L 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016986; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-L Transcription factor IIA L "CG5930, CG5930, TFIIA, TFIIA-L, dTFIIA, CT18631" CDMC26776 1 8 5 DAC07-M19 22-CG5930-RA_3 CG5930 GCGAAGACGATGTCACCGACGAAGACTCTGCCGAAATGTTTGACACAGATAACGTGATTGTTTGTCAGT 69 FBan0005930 FBgn0011289 TfIIA-L 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016986; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-L Transcription factor IIA L "CG5930, CG5930, TFIIA, TFIIA-L, dTFIIA, CT18631" CDMC26777 1 9 5 DAC08-A07 9-CG8221-RA_4 CG8221 TGTGGGTGTTCGTATCTATGTGGATGTGCTGTTGAACCACATGTCCGGAGATTTTGACGGTGTGGCTGT 69 FBan0008221 FBgn0020506 Amyrel 2 2R carbohydrate metabolism; GO:0005975 "alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; oligo-1,6-glucosidase activity; GO:0004574 ; EC:3.2.1.10; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004574 ; EC:3.2.1.10" Amyrel Amyrel "CG8221, amyrel" CDMC26777 1 10 5 DAC08-A07 9-CG8221-RA_4 CG8221 TGTGGGTGTTCGTATCTATGTGGATGTGCTGTTGAACCACATGTCCGGAGATTTTGACGGTGTGGCTGT 69 FBan0008221 FBgn0020506 Amyrel 2 2R carbohydrate metabolism; GO:0005975 "alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; oligo-1,6-glucosidase activity; GO:0004574 ; EC:3.2.1.10; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004574 ; EC:3.2.1.10" Amyrel Amyrel "CG8221, amyrel" CDMC26778 1 11 5 DAC08-A19 23-CG8229-RC_2 CG8229 TATTTGCAAACCAGAGAAACGACTAAGTAGGGAGGTATAAAACAATAATGACTTCGTTGGACTGCAGAT 69 FBan0008229 FBgn0033356 CG8229 2 2R CG8229 CG8229 CDMC26778 1 12 5 DAC08-A19 23-CG8229-RC_2 CG8229 TATTTGCAAACCAGAGAAACGACTAAGTAGGGAGGTATAAAACAATAATGACTTCGTTGGACTGCAGAT 69 FBan0008229 FBgn0033356 CG8229 2 2R CG8229 CG8229 CDMC26779 1 13 5 DAC08-E07 12-CG8270-RA_6 CG8270 TGCCCGGAGAGGTGATCAATGAAATAACCTATCATACACCCATAACTCCAGGGCGCTCCATCAAACCGT 69 FBan0008270 FBgn0035703 CG8270 3 3L CG8270 CG8270 CDMC26779 1 14 5 DAC08-E07 12-CG8270-RA_6 CG8270 TGCCCGGAGAGGTGATCAATGAAATAACCTATCATACACCCATAACTCCAGGGCGCTCCATCAAACCGT 69 FBan0008270 FBgn0035703 CG8270 3 3L CG8270 CG8270 CDMC26780 1 15 5 DAC08-E19 16-CG8284-RA_1 CG8284 CCGCGCCCCATTGAGCATGTGGTGTTATGTAATTGAACCCAGGTTCTGTTTCATTAATTTACGTGCAGT 69 FBan0008284 FBgn0015321 UbcD4 3 3L protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD4 Ubiquitin conjugating enzyme 4 "CG8284, E2" CDMC26780 1 16 5 DAC08-E19 16-CG8284-RA_1 CG8284 CCGCGCCCCATTGAGCATGTGGTGTTATGTAATTGAACCCAGGTTCTGTTTCATTAATTTACGTGCAGT 69 FBan0008284 FBgn0015321 UbcD4 3 3L protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD4 Ubiquitin conjugating enzyme 4 "CG8284, E2" CDMC26781 1 17 5 DAC08-I07 13-CG8317-RA_1 CG8317 AGGGTCCTCTAGCACTTAGCCACTTAGCCACTTTCGATGCGTCCTAGTTCTAAGTCAAATGCACTGCAG 69 FBan0008317 FBgn0034140 CG8317 2 2R CG8317 CG8317 CDMC26781 1 18 5 DAC08-I07 13-CG8317-RA_1 CG8317 AGGGTCCTCTAGCACTTAGCCACTTAGCCACTTTCGATGCGTCCTAGTTCTAAGTCAAATGCACTGCAG 69 FBan0008317 FBgn0034140 CG8317 2 2R CG8317 CG8317 CDMC26782 1 19 5 DAC08-I19 9-CG8325-RA_3 CG8325 CCGACCTCGTGAAGCTTTGGGAGTTGTTGAGGATGCTTTACACGAGTTTCCCGATAACCTGCAGCTACT 69 FBan0008325 FBgn0021847 l(2)k14710 2 2R l(2)k14710 lethal (2) k14710 "CG8325, CG8325, l(2)k15603, BcDNA:LD21719" CDMC26782 1 20 5 DAC08-I19 9-CG8325-RA_3 CG8325 CCGACCTCGTGAAGCTTTGGGAGTTGTTGAGGATGCTTTACACGAGTTTCCCGATAACCTGCAGCTACT 69 FBan0008325 FBgn0021847 l(2)k14710 2 2R l(2)k14710 lethal (2) k14710 "CG8325, CG8325, l(2)k15603, BcDNA:LD21719" CDMC26783 1 21 5 DAC08-M07 17-CG8367-RA_1 CG8367 GCCTCTCGCCTCTCCGATAGCCCGAAAAAAATCAGATAACCAGTTAACCCACATAACTCGATATCCCGT 69 FBan0008367 FBgn0000289 cg 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing morphogenesis; GO:0007476 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 cg combgap "CG8367, CG8367, l(2)07659, mig, migraine, l(2)k11504, comb gap" CDMC26783 1 22 5 DAC08-M07 17-CG8367-RA_1 CG8367 GCCTCTCGCCTCTCCGATAGCCCGAAAAAAATCAGATAACCAGTTAACCCACATAACTCGATATCCCGT 69 FBan0008367 FBgn0000289 cg 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing morphogenesis; GO:0007476 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 cg combgap "CG8367, CG8367, l(2)07659, mig, migraine, l(2)k11504, comb gap" CDMC26784 1 23 5 DAC08-M19 9-CG8378-RA_1 CG8378 CCGCTGAACCAACCCACACAACCAACACGGACGAACTTTTCCTTTGCTAACTTTAACTGGAGACAGCGT 69 FBan0008378 FBgn0027495 CG8378 2 2R CG8378 CG8378 BcDNA:LD29892 CDMC26784 1 24 5 DAC08-M19 9-CG8378-RA_1 CG8378 CCGCTGAACCAACCCACACAACCAACACGGACGAACTTTTCCTTTGCTAACTTTAACTGGAGACAGCGT 69 FBan0008378 FBgn0027495 CG8378 2 2R CG8378 CG8378 BcDNA:LD29892 CDMC26785 1 25 5 DAC09-A08 15-CG12807-RA_3 CG12807 GGCCGAGGGAAAGTCCAACTATAACACGGATGTGATCAGCCACGTATTCTACTTGGGCAATCAACAGGT 69 FBan0012807 FBgn0037772 CG12807 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG12807 CG12807 CDMC26785 1 26 5 DAC09-A08 15-CG12807-RA_3 CG12807 GGCCGAGGGAAAGTCCAACTATAACACGGATGTGATCAGCCACGTATTCTACTTGGGCAATCAACAGGT 69 FBan0012807 FBgn0037772 CG12807 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG12807 CG12807 CDMC26786 1 1 6 DAC09-A20 15-CG12817-RA_1 CG12817 CCAAGCTGAACCATTTGAGACTGTAATACCGCAAGCAAAAGAAAACCAAGCACTTGACTGCACCCCGTT 69 FBan0012817 FBgn0037798 CG12817 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG12817 CG12817 BcDNA:RE53107 CDMC26786 1 2 6 DAC09-A20 15-CG12817-RA_1 CG12817 CCAAGCTGAACCATTTGAGACTGTAATACCGCAAGCAAAAGAAAACCAAGCACTTGACTGCACCCCGTT 69 FBan0012817 FBgn0037798 CG12817 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG12817 CG12817 BcDNA:RE53107 CDMC26787 1 3 6 DAC09-E08 18-CG12854-RA_1 CG12854 GGGACATCGAAACGCACTACGATTTCTTCTTGGTCTTTGTCGCCTTGGACAGCCAGGAGGATAAGATTA 69 FBan0012854 FBgn0033965 CG12854 2 2R CG12854 CG12854 CDMC26787 1 4 6 DAC09-E08 18-CG12854-RA_1 CG12854 GGGACATCGAAACGCACTACGATTTCTTCTTGGTCTTTGTCGCCTTGGACAGCCAGGAGGATAAGATTA 69 FBan0012854 FBgn0033965 CG12854 2 2R CG12854 CG12854 CDMC26788 1 5 6 DAC09-E20 14-CG12862-RB_1 CG12862 CGCTACCTCCAATTAAGTCCCTCACCTCCTCATTAGCTTAGACCAGATAGCGGTAGACATGGACGACGG 69 FBan0012862 FBgn0033950 CG12862 2 2R CG12862 CG12862 CDMC26788 1 6 6 DAC09-E20 14-CG12862-RB_1 CG12862 CGCTACCTCCAATTAAGTCCCTCACCTCCTCATTAGCTTAGACCAGATAGCGGTAGACATGGACGACGG 69 FBan0012862 FBgn0033950 CG12862 2 2R CG12862 CG12862 CDMC26789 1 7 6 DAC09-I08 18-CG12907-RA_1 CG12907 CCCCCAAACGGACATGTCAAGGAGCAGGATGTTTTCCCCCAAAATTCTCATCGAATCCATATCGTTTCT 69 FBan0012907 FBgn0033511 CG12907 2 2R CG12907 CG12907 "anon-WO0140519.79, BcDNA:AT31822" CDMC26789 1 8 6 DAC09-I08 18-CG12907-RA_1 CG12907 CCCCCAAACGGACATGTCAAGGAGCAGGATGTTTTCCCCCAAAATTCTCATCGAATCCATATCGTTTCT 69 FBan0012907 FBgn0033511 CG12907 2 2R CG12907 CG12907 "anon-WO0140519.79, BcDNA:AT31822" CDMC26790 1 9 6 DAC09-I20 3-CG12917-RA_5 CG12917 GCAGCGCTTGGAAACAGTTCCATCCGGTGTCACTCTACTCGTGTACTGCAGTCCCTCGGTTTTCAAAGA 69 FBan0012917 FBgn0033490 CG12917 2 2R CG12917 CG12917 CDMC26790 1 10 6 DAC09-I20 3-CG12917-RA_5 CG12917 GCAGCGCTTGGAAACAGTTCCATCCGGTGTCACTCTACTCGTGTACTGCAGTCCCTCGGTTTTCAAAGA 69 FBan0012917 FBgn0033490 CG12917 2 2R CG12917 CG12917 CDMC26791 1 11 6 DAC09-M08 3-CG12960-RA_5 CG12960 AGCACCTCAAGCTGATCATCTTTGTCCTGTGCTTCGCCAGCGTTATGATCACCACCATGTATGAGGCCT 69 FBan0012960 FBgn0034023 CG12960 2 2R CG12960 CG12960 CDMC26791 1 12 6 DAC09-M08 3-CG12960-RA_5 CG12960 AGCACCTCAAGCTGATCATCTTTGTCCTGTGCTTCGCCAGCGTTATGATCACCACCATGTATGAGGCCT 69 FBan0012960 FBgn0034023 CG12960 2 2R CG12960 CG12960 CDMC26792 1 13 6 DAC09-M20 3-CG12984-RA_5 CG12984 ACGGATCAACCACTTGTACCAATGCCTCCAACGACCTCTCGCCACGATAGGCAACATTTTAAGGACCCT 69 FBan0012984 FBgn0037042 CG12984 3 3L CG12984 CG12984 CDMC26792 1 14 6 DAC09-M20 3-CG12984-RA_5 CG12984 ACGGATCAACCACTTGTACCAATGCCTCCAACGACCTCTCGCCACGATAGGCAACATTTTAAGGACCCT 69 FBan0012984 FBgn0037042 CG12984 3 3L CG12984 CG12984 CDMC26793 1 15 6 DAC10-A07 5-CG10930-RA_1 CG10930 AGCGACCCACTGATATTCCGGATGAGGGTATCATGTGCGATCTCCTTTGGGCGGATCTAAATCACACCA 69 FBan0010930 FBgn0003140 PpY-55A 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737; nucleus; GO:0005634 PpY-55A Protein phosphatase Y at 55A "CG10930, CG10930, protein phosphatase-Y, PPY, D19, PPY 55A, protein phosphatase from PCR fragment D19, PpD19, Protein phosphatase D19" CDMC26793 1 16 6 DAC10-A07 5-CG10930-RA_1 CG10930 AGCGACCCACTGATATTCCGGATGAGGGTATCATGTGCGATCTCCTTTGGGCGGATCTAAATCACACCA 69 FBan0010930 FBgn0003140 PpY-55A 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737; nucleus; GO:0005634 PpY-55A Protein phosphatase Y at 55A "CG10930, CG10930, protein phosphatase-Y, PPY, D19, PPY 55A, protein phosphatase from PCR fragment D19, PpD19, Protein phosphatase D19" CDMC26794 1 17 6 DAC10-A19 17-CG10948-RC_3 CG10948 TGCCGCTAGTCACAAGAAGGTTTGGGACCATTTCACCAAAGCCCAAAGAAAAAACATCGATCAATGGAA 69 FBan0010948 FBgn0036317 CG10948 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG10948 CG10948 "cg10948, CT30663" CDMC26794 1 18 6 DAC10-A19 17-CG10948-RC_3 CG10948 TGCCGCTAGTCACAAGAAGGTTTGGGACCATTTCACCAAAGCCCAAAGAAAAAACATCGATCAATGGAA 69 FBan0010948 FBgn0036317 CG10948 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG10948 CG10948 "cg10948, CT30663" CDMC26795 1 19 6 DAC10-E07 3-CG10984-RB_1 CG10984 GCGCCCTATTCCGTTTGCACGTATTTGAAGGACGACGAGGTCTACAACATGATCACACCGGAGCAGGAT 69 FBan0010984 FBgn0036305 CG10984 3 3L CG10984 CG10984 CDMC26795 1 20 6 DAC10-E07 3-CG10984-RB_1 CG10984 GCGCCCTATTCCGTTTGCACGTATTTGAAGGACGACGAGGTCTACAACATGATCACACCGGAGCAGGAT 69 FBan0010984 FBgn0036305 CG10984 3 3L CG10984 CG10984 CDMC26796 1 21 6 DAC10-E19 22-CG10991-RA_1 CG10991 GGAGCCGTCGACACAGAGATCATTGATGAGAAAATCAATAAGGTCATTCCAAACTTTCCCATGCTGCGC 69 FBan0010991 FBgn0037389 CG10991 3 3R CG10991 CG10991 CDMC26796 1 22 6 DAC10-E19 22-CG10991-RA_1 CG10991 GGAGCCGTCGACACAGAGATCATTGATGAGAAAATCAATAAGGTCATTCCAAACTTTCCCATGCTGCGC 69 FBan0010991 FBgn0037389 CG10991 3 3R CG10991 CG10991 CDMC26797 1 23 6 DAC10-I07 9-CG11041-RA_2 CG11041 TCCAGGCCTTTAAGATCTTGGATCCGGAGAACAAGGGCTATCTCACCAAGGAGAGCTTTGGCAAACTGA 69 FBan0011041 FBgn0034481 CG11041 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG11041 CG11041 CDMC26797 1 24 6 DAC10-I07 9-CG11041-RA_2 CG11041 TCCAGGCCTTTAAGATCTTGGATCCGGAGAACAAGGGCTATCTCACCAAGGAGAGCTTTGGCAAACTGA 69 FBan0011041 FBgn0034481 CG11041 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG11041 CG11041 CDMC26798 1 25 6 DAC10-I19 3-CG11050-RA_2 CG11050 TGGACAGACTGCCGAGAGCAAGTTCGTCAAGGATTTGGATCGTCTGGATATGGTTATGCAGGCGTTCGA 69 FBan0011050 FBgn0031836 CG11050 2 2L CG11050 CG11050 BcDNA:LD22339 CDMC26798 1 26 6 DAC10-I19 3-CG11050-RA_2 CG11050 TGGACAGACTGCCGAGAGCAAGTTCGTCAAGGATTTGGATCGTCTGGATATGGTTATGCAGGCGTTCGA 69 FBan0011050 FBgn0031836 CG11050 2 2L CG11050 CG11050 BcDNA:LD22339 CDMC26799 1 1 7 DAC10-M07 18-CG11086-RA_5 CG11086 TTCATTGTGAAATTGCCACTCAAAATTGAAACAGCGCGGACAAACGGTTGAAGAAACACAAAGCCCAGT 69 FBan0011086 FBgn0033153 CG11086 2 2R CG11086 CG11086 BcDNA:RH70774 CDMC26799 1 2 7 DAC10-M07 18-CG11086-RA_5 CG11086 TTCATTGTGAAATTGCCACTCAAAATTGAAACAGCGCGGACAAACGGTTGAAGAAACACAAAGCCCAGT 69 FBan0011086 FBgn0033153 CG11086 2 2R CG11086 CG11086 BcDNA:RH70774 CDMC26800 1 3 7 DAC10-M19 8-CG11095-RA_3 CG11095 CGATCCGCCGACCGTAATCCTACTCAGGCTAGCAACAATCTGGTACTGTGATTGGGCCAAATGTGCTTC 69 FBan0011095 FBgn0030528 CG11095 X X phosphate metabolism; GO:0006796 hydrolase activity; GO:0016787 ; EC:3.-.-.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016791 ; EC:3.1.3.- CG11095 CG11095 CDMC26800 1 4 7 DAC10-M19 8-CG11095-RA_3 CG11095 CGATCCGCCGACCGTAATCCTACTCAGGCTAGCAACAATCTGGTACTGTGATTGGGCCAAATGTGCTTC 69 FBan0011095 FBgn0030528 CG11095 X X phosphate metabolism; GO:0006796 hydrolase activity; GO:0016787 ; EC:3.-.-.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016791 ; EC:3.1.3.- CG11095 CG11095 CDMC26801 1 5 7 DAC11-A07 8-CG12165-RA_3 CG12165 CAGCTGGAGATGCCACTTTTGAGGTGCACTCCAACGACAAGAAACAACCTCTGAGTAAGCAGGACAGCC 69 FBan0012165 FBgn0033156 Incenp 2 2R histone phosphorylation; GO:0016572; metaphase plate congression; GO:0051310; protein localization; GO:0008104 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 colocalizes_with condensed chromosome; GO:0000793; colocalizes_with midbody; GO:0030496 Incenp Inner centromere protein "CG12165, CG12165, CG12165, CG12165, DmINCENP, INCENP, dIncenp, anon-WO0118547.171, Inner centromere protein" CDMC26801 1 6 7 DAC11-A07 8-CG12165-RA_3 CG12165 CAGCTGGAGATGCCACTTTTGAGGTGCACTCCAACGACAAGAAACAACCTCTGAGTAAGCAGGACAGCC 69 FBan0012165 FBgn0033156 Incenp 2 2R histone phosphorylation; GO:0016572; metaphase plate congression; GO:0051310; protein localization; GO:0008104 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 colocalizes_with condensed chromosome; GO:0000793; colocalizes_with midbody; GO:0030496 Incenp Inner centromere protein "CG12165, CG12165, CG12165, CG12165, DmINCENP, INCENP, dIncenp, anon-WO0118547.171, Inner centromere protein" CDMC26802 1 7 7 DAC11-A19 24-CG12184-RA_1 CG12184 AGCTTTGTTATTTTTCTATATATTTTAATCGATCACAATTGTTTAAGTCCAGTCCATACGTAATGTTAA 69 FBan0012184 FBgn0025387 CG12184 X X CG12184 CG12184 EG:66A1.3 CDMC26802 1 8 7 DAC11-A19 24-CG12184-RA_1 CG12184 AGCTTTGTTATTTTTCTATATATTTTAATCGATCACAATTGTTTAAGTCCAGTCCATACGTAATGTTAA 69 FBan0012184 FBgn0025387 CG12184 X X CG12184 CG12184 EG:66A1.3 CDMC26803 1 9 7 DAC11-E07 22-CG12219-RA_1 CG12219 TTTGCATATTAGCCATACCGAATGTACTTATCCGACGTTTCGTGTACTCCACAAAGTCAAGGCGTCCCG 69 FBgn0029862 CDMC26803 1 10 7 DAC11-E07 22-CG12219-RA_1 CG12219 TTTGCATATTAGCCATACCGAATGTACTTATCCGACGTTTCGTGTACTCCACAAAGTCAAGGCGTCCCG 69 FBgn0029862 CDMC26804 1 11 7 DAC11-E19 1-CG12229-RA_1 CG12229 CGCGTCTTTGAATGCCAACTATGTGGTTCTGCCCAAGATACGATGCAAGAGCTTTCTTCGTGCCGTGCG 69 FBan0012229 FBgn0036723 CG12229 3 3L glycolysis; GO:0006096 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG12229 CG12229 CDMC26804 1 12 7 DAC11-E19 1-CG12229-RA_1 CG12229 CGCGTCTTTGAATGCCAACTATGTGGTTCTGCCCAAGATACGATGCAAGAGCTTTCTTCGTGCCGTGCG 69 FBan0012229 FBgn0036723 CG12229 3 3L glycolysis; GO:0006096 pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG12229 CG12229 CDMC26805 1 13 7 DAC11-I07 5-CG12264-RA_1 CG12264 CCCGCTGGACGTTAACGCCATGAACATTGACCTGATGTCTATATCCGGCCACAAAATCTACGGCCCAAA 69 FBan0012264 FBgn0032393 CG12264 2 2L alanine biosynthesis; GO:0006523; iron-sulfur cluster assembly; GO:0016226; nitrogen utilization; GO:0019740 cystathionine gamma-lyase activity; GO:0004123 ; EC:4.4.1.1; transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; ; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG12264 CG12264 CDMC26805 1 14 7 DAC11-I07 5-CG12264-RA_1 CG12264 CCCGCTGGACGTTAACGCCATGAACATTGACCTGATGTCTATATCCGGCCACAAAATCTACGGCCCAAA 69 FBan0012264 FBgn0032393 CG12264 2 2L alanine biosynthesis; GO:0006523; iron-sulfur cluster assembly; GO:0016226; nitrogen utilization; GO:0019740 cystathionine gamma-lyase activity; GO:0004123 ; EC:4.4.1.1; transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; ; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG12264 CG12264 CDMC26806 1 15 7 DAC11-I19 23-CG12288-RA_1 CG12288 ACTCAATTCAATGAGATTCGTTTGACTTTCTGTTACGAAGTTAACCACCGGATCAGTTTCCGTAGCGGA 69 FBan0012288 FBgn0032620 CG12288 2 2L poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 CG12288 CG12288 cg12288 CDMC26806 1 16 7 DAC11-I19 23-CG12288-RA_1 CG12288 ACTCAATTCAATGAGATTCGTTTGACTTTCTGTTACGAAGTTAACCACCGGATCAGTTTCCGTAGCGGA 69 FBan0012288 FBgn0032620 CG12288 2 2L poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 CG12288 CG12288 cg12288 CDMC26807 1 17 7 DAC11-M07 1-CG12325-RA_1 CG12325 GGGCGTACAACGGGGAGACATGTCATCCAGGAGATTCCAGCAAGAGGTTAGGGTGTTCTCCGTAAAGTT 69 FBan0012325 FBgn0033557 CG12325 2 2R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 CG12325 CG12325 CDMC26807 1 18 7 DAC11-M07 1-CG12325-RA_1 CG12325 GGGCGTACAACGGGGAGACATGTCATCCAGGAGATTCCAGCAAGAGGTTAGGGTGTTCTCCGTAAAGTT 69 FBan0012325 FBgn0033557 CG12325 2 2R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 CG12325 CG12325 CDMC26808 1 19 7 DAC11-M19 6-CG12341-RA_1 CG12341 CCAACACTCCATTCTCCACATCGCGCCCAATCCAATGTTCACAGAGTTCCGACTTCCAAGCGGACATAT 69 FBan0012341 FBgn0033550 CG12341 2 2R CG12341 CG12341 BcDNA:SD17342 CDMC26808 1 20 7 DAC11-M19 6-CG12341-RA_1 CG12341 CCAACACTCCATTCTCCACATCGCGCCCAATCCAATGTTCACAGAGTTCCGACTTCCAAGCGGACATAT 69 FBan0012341 FBgn0033550 CG12341 2 2R CG12341 CG12341 BcDNA:SD17342 CDMC26809 1 21 7 DAC12-A07 2-CG7842-RA_1 CG7842 GCCCTGAAAACGGTGCGACTTCAGGACCCCGTCATTAGAGTGTACTCCAATGTGGATGGCAAACCCTAT 69 FBan0007842 FBgn0036691 CG7842 3 3L fatty acid biosynthesis; GO:0006633 [acyl-carrier protein] S-malonyltransferase activity; GO:0004314 ; EC:2.3.1.39; ; GO:0004314 ; EC:2.3.1.39; ; GO:0004314 ; EC:2.3.1.39 mitochondrion; GO:0005739 CG7842 CG7842 CDMC26809 1 22 7 DAC12-A07 2-CG7842-RA_1 CG7842 GCCCTGAAAACGGTGCGACTTCAGGACCCCGTCATTAGAGTGTACTCCAATGTGGATGGCAAACCCTAT 69 FBan0007842 FBgn0036691 CG7842 3 3L fatty acid biosynthesis; GO:0006633 [acyl-carrier protein] S-malonyltransferase activity; GO:0004314 ; EC:2.3.1.39; ; GO:0004314 ; EC:2.3.1.39; ; GO:0004314 ; EC:2.3.1.39 mitochondrion; GO:0005739 CG7842 CG7842 CDMC26810 1 23 7 DAC12-A19 2-CG7853-RA_2 CG7853 CGCCGGAACTCCGTATCCTTTGCTTTGACCTCACCTACTACAATCGCACAACTCAGTTCCTGCTCAGCT 69 FBan0007853 FBgn0036695 CG7853 3 3L CG7853 CG7853 CDMC26810 1 24 7 DAC12-A19 2-CG7853-RA_2 CG7853 CGCCGGAACTCCGTATCCTTTGCTTTGACCTCACCTACTACAATCGCACAACTCAGTTCCTGCTCAGCT 69 FBan0007853 FBgn0036695 CG7853 3 3L CG7853 CG7853 CDMC26811 1 25 7 DAC12-E07 1-CG7885-RA_1 CG7885 TGTGCTTCGAGTATGATCCGGACAACTCCATGCGACACACTCTGTATCCCAAACCTGATGAGTGGCCAA 69 FBan0007885 FBgn0026373 RpII33 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII33 RNA polymerase II 33kD subunit "CG7885, CG7885, l(2)br17, lethal 17 in the black-reduced region, br17, RNA polymerase II, l(2)34Dg, l34Dg, l(2)k05605, polII, BG:DS00941.10, RPB3, RNA polII, RNA pol II, rpII33, RNA Pol II, Pol II, Rpll33, PolII, RNAP, lethal(2)34Dg" CDMC26811 1 26 7 DAC12-E07 1-CG7885-RA_1 CG7885 TGTGCTTCGAGTATGATCCGGACAACTCCATGCGACACACTCTGTATCCCAAACCTGATGAGTGGCCAA 69 FBan0007885 FBgn0026373 RpII33 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII33 RNA polymerase II 33kD subunit "CG7885, CG7885, l(2)br17, lethal 17 in the black-reduced region, br17, RNA polymerase II, l(2)34Dg, l34Dg, l(2)k05605, polII, BG:DS00941.10, RPB3, RNA polII, RNA pol II, rpII33, RNA Pol II, Pol II, Rpll33, PolII, RNAP, lethal(2)34Dg" CDMC26812 1 1 8 DAC12-E19 14-CG7897-RA_3 CG7897 AGTGCGTGTCACCGACCTAAAGCCACATGAAATTCATATAAGCGGACTAGACAAGGCGTTGCTCAAGGT 69 FBan0007897 FBgn0033039 gp210 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 gp210 gp210 "CG7897, CG14467, GP210, gp120" CDMC26812 1 2 8 DAC12-E19 14-CG7897-RA_3 CG7897 AGTGCGTGTCACCGACCTAAAGCCACATGAAATTCATATAAGCGGACTAGACAAGGCGTTGCTCAAGGT 69 FBan0007897 FBgn0033039 gp210 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 gp210 gp210 "CG7897, CG14467, GP210, gp120" CDMC26813 1 3 8 DAC12-I07 2-CG7929-RA_1 CG7929 GGCACCTGTTTCACAATTGTTGAAGCCCCTTCGAAGGCAAAGTTCTTCGCGCGTAAACGCCCTTTTGAT 69 FBan0007929 FBgn0041102 ocn 3 3R ocn ocnus "CG7929, CG7929, BcDNA:GH02250, bs29e10.y1, ocnus" CDMC26813 1 4 8 DAC12-I07 2-CG7929-RA_1 CG7929 GGCACCTGTTTCACAATTGTTGAAGCCCCTTCGAAGGCAAAGTTCTTCGCGCGTAAACGCCCTTTTGAT 69 FBan0007929 FBgn0041102 ocn 3 3R ocn ocnus "CG7929, CG7929, BcDNA:GH02250, bs29e10.y1, ocnus" CDMC26814 1 5 8 DAC12-I19 22-CG7939-RC_2 CG7939 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC26814 1 6 8 DAC12-I19 22-CG7939-RC_2 CG7939 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC26815 1 7 8 DAC12-M07 2-CG7972-RA_2 CG7972 GCTGGCGAGAGTATCCTGATAGCCCAGAGCAAAGACAATCTGCTGGTCGGACAAATGCTTTTCTCGCCT 69 FBgn0035843 CDMC26815 1 8 8 DAC12-M07 2-CG7972-RA_2 CG7972 GCTGGCGAGAGTATCCTGATAGCCCAGAGCAAAGACAATCTGCTGGTCGGACAAATGCTTTTCTCGCCT 69 FBgn0035843 CDMC26816 1 9 8 DAC12-M19 15-CG7981-RE_2 CG7981 GGCTGCATCTCCAGGCTATACAACTTCCAAAAACCTGTCAATCTCCTAGCGGACATTAAGGATGCGGCA 69 FBan0033950 FBgn0001402 trol X X DNA methylation; GO:0006306; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; neuroblast division; GO:0045034; signal transduction; GO:0007165 DNA binding; GO:0003677; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0003677 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 trol terribly reduced optic lobes "CG12497, CG7981, CG33950, CG33675, CG12497, CG7981, CG12497, CG7981, CG12497, CG7981, CG7981, CG12497, CG7981, zw1, l(1)zw1, zw-1, ZW-1, l(1)zwl, l(1)trol, l(1)3Ac, pcan, perlecan, Perlecan, EG:BACR25B3.11, EG:BACR25B3.1, EG:BACR25B3.10, CT23996, EG:BACR25B3.2, GC7891, anon-WO0153538.72, BcDNA:GM02481, l(1)9-96, l(1)VA51, troll" CDMC26816 1 10 8 DAC12-M19 15-CG7981-RE_2 CG7981 GGCTGCATCTCCAGGCTATACAACTTCCAAAAACCTGTCAATCTCCTAGCGGACATTAAGGATGCGGCA 69 FBan0033950 FBgn0001402 trol X X DNA methylation; GO:0006306; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; neuroblast division; GO:0045034; signal transduction; GO:0007165 DNA binding; GO:0003677; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0003677 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 trol terribly reduced optic lobes "CG12497, CG7981, CG33950, CG33675, CG12497, CG7981, CG12497, CG7981, CG12497, CG7981, CG7981, CG12497, CG7981, zw1, l(1)zw1, zw-1, ZW-1, l(1)zwl, l(1)trol, l(1)3Ac, pcan, perlecan, Perlecan, EG:BACR25B3.11, EG:BACR25B3.1, EG:BACR25B3.10, CT23996, EG:BACR25B3.2, GC7891, anon-WO0153538.72, BcDNA:GM02481, l(1)9-96, l(1)VA51, troll" CDMC26817 1 11 8 DAC13-A07 8-CG13244-RA_1 CG13244 TGCACTGTCACTATTTAGGCGTCTGTCCAATCTGCGCTCTGAGCTCATTTTCAGGAAGCGGGACATCAT 69 FBan0013244 FBgn0032577 CG13244 2 2L CG13244 CG13244 BcDNA:GH27987 CDMC26817 1 12 8 DAC13-A07 8-CG13244-RA_1 CG13244 TGCACTGTCACTATTTAGGCGTCTGTCCAATCTGCGCTCTGAGCTCATTTTCAGGAAGCGGGACATCAT 69 FBan0013244 FBgn0032577 CG13244 2 2L CG13244 CG13244 BcDNA:GH27987 CDMC26818 1 13 8 DAC13-A19 5-CG13253-RA_1 CG13253 CGTGCGGCAGACAAAAGCGCATGAAAAATTCATTGGGAACCGTCGGAACCGAAAGTTTAGCGTCAGGAT 69 FBan0013253 FBgn0037015 CG13253 3 3L CG13253 CG13253 CDMC26818 1 14 8 DAC13-A19 5-CG13253-RA_1 CG13253 CGTGCGGCAGACAAAAGCGCATGAAAAATTCATTGGGAACCGTCGGAACCGAAAGTTTAGCGTCAGGAT 69 FBan0013253 FBgn0037015 CG13253 3 3L CG13253 CG13253 CDMC26819 1 15 8 DAC13-E07 1-CG13295-RA_1 CG13295 GCGGCTGGAACATTGAGCACTACCGTGGCTGTTTAAAGACCCTTGAGCGACTATCCAACACCCATTTGT 69 FBan0013295 FBgn0035674 CG13295 3 3L CG13295 CG13295 CDMC26819 1 16 8 DAC13-E07 1-CG13295-RA_1 CG13295 GCGGCTGGAACATTGAGCACTACCGTGGCTGTTTAAAGACCCTTGAGCGACTATCCAACACCCATTTGT 69 FBan0013295 FBgn0035674 CG13295 3 3L CG13295 CG13295 CDMC26820 1 17 8 DAC13-E19 18-CG13309-RA_1 CG13309 GGCCATCAAAAATGCCACCGAGTATTGTCAAACCATTCAAACAGCCGGAAAATATCCTTATGGCGGAGA 69 FBan0013309 FBgn0035933 CG13309 3 3L CG13309 CG13309 CT32604 CDMC26820 1 18 8 DAC13-E19 18-CG13309-RA_1 CG13309 GGCCATCAAAAATGCCACCGAGTATTGTCAAACCATTCAAACAGCCGGAAAATATCCTTATGGCGGAGA 69 FBan0013309 FBgn0035933 CG13309 3 3L CG13309 CG13309 CT32604 CDMC26821 1 19 8 DAC13-I07 2-CG1332-RA_3 CG1332 CCCAGCTGAATACTCAGAATAGCTATTCACCCAAGCCCTTGACGGTGCTCTATGGTCACGACGATGCCA 69 FBan0001332 FBgn0035514 CG1332 3 3L protein targeting; GO:0006605 sphingomyelin phosphodiesterase activator activity; GO:0016230; ; GO:0016230 CG1332 CG1332 CDMC26821 1 20 8 DAC13-I07 2-CG1332-RA_3 CG1332 CCCAGCTGAATACTCAGAATAGCTATTCACCCAAGCCCTTGACGGTGCTCTATGGTCACGACGATGCCA 69 FBan0001332 FBgn0035514 CG1332 3 3L protein targeting; GO:0006605 sphingomyelin phosphodiesterase activator activity; GO:0016230; ; GO:0016230 CG1332 CG1332 CDMC26822 1 21 8 DAC13-I19 23-CG13339-RA_1 CG13339 ACGAAAGATGTCTCAAAACCAAGAAAACCCTACCAAAAACGGACAGAAAAACCGAAAACAGAGGCGACC 69 FBan0013339 FBgn0033871 CG13339 2 2R CG13339 CG13339 BcDNA:RE69336 CDMC26822 1 22 8 DAC13-I19 23-CG13339-RA_1 CG13339 ACGAAAGATGTCTCAAAACCAAGAAAACCCTACCAAAAACGGACAGAAAAACCGAAAACAGAGGCGACC 69 FBan0013339 FBgn0033871 CG13339 2 2R CG13339 CG13339 BcDNA:RE69336 CDMC26823 1 23 8 DAC13-M07 17-CG13389-RA_1 CG13389 GCCCTGGTTGCCTAAGTTCTTGATTCGCTAGTTGGTAGTTTGTTTTCAAGTCTTGCGGGGTCCTACATT 69 FBan0013389 FBgn0010265 RpS13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS13 Ribosomal protein S13 "CG13389, l(2)k09614, M(2)32A, M(2)32, ribosomal protein S17, Minute(2)32A, S13, Rp17" CDMC26823 1 24 8 DAC13-M07 17-CG13389-RA_1 CG13389 GCCCTGGTTGCCTAAGTTCTTGATTCGCTAGTTGGTAGTTTGTTTTCAAGTCTTGCGGGGTCCTACATT 69 FBan0013389 FBgn0010265 RpS13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS13 Ribosomal protein S13 "CG13389, l(2)k09614, M(2)32A, M(2)32, ribosomal protein S17, Minute(2)32A, S13, Rp17" CDMC26824 1 25 8 DAC13-M19 2-CG13396-RA_3 CG13396 GCCGGTCTATTTGCCCGTGAAAAGTCCCCATATAGCCTACCGCTTTGTCAGTATTCCTGTGGCGTCGAA 69 FBan0013396 FBgn0001084 fy 2 2L establishment and/or maintenance of cell polarity; GO:0007163; establishment of planar polarity; GO:0001736; establishment of wing hair orientation; GO:0001737 fy fuzzy "CG13396, fuzzy" CDMC26824 1 26 8 DAC13-M19 2-CG13396-RA_3 CG13396 GCCGGTCTATTTGCCCGTGAAAAGTCCCCATATAGCCTACCGCTTTGTCAGTATTCCTGTGGCGTCGAA 69 FBan0013396 FBgn0001084 fy 2 2L establishment and/or maintenance of cell polarity; GO:0007163; establishment of planar polarity; GO:0001736; establishment of wing hair orientation; GO:0001737 fy fuzzy "CG13396, fuzzy" CDMC26825 1 1 9 DAC14-A07 1-CG8596-RA_1 CG8596 ATATCCCATTGGGGTGACTCTCATCCAGACCATATTCTCCAAAGTTCTGGGACCTCGGCCGCAGG 65 FBan0008596 FBgn0035767 CG8596 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8596 CG8596 CDMC26825 1 2 9 DAC14-A07 1-CG8596-RA_1 CG8596 ATATCCCATTGGGGTGACTCTCATCCAGACCATATTCTCCAAAGTTCTGGGACCTCGGCCGCAGG 65 FBan0008596 FBgn0035767 CG8596 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8596 CG8596 CDMC26826 1 3 9 DAC14-A19 23-CG8641-RA_5 CG8641 CCACCGCAAATTGTATCGCATACGGAATGAAGTCTTTCAATTGGATATTTTGGATACTTCTGGCT 65 FBan0008641 FBgn0035733 CG8641 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; nitric oxide mediated signal transduction; GO:0007263; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8641 CG8641 CDMC26826 1 4 9 DAC14-A19 23-CG8641-RA_5 CG8641 CCACCGCAAATTGTATCGCATACGGAATGAAGTCTTTCAATTGGATATTTTGGATACTTCTGGCT 65 FBan0008641 FBgn0035733 CG8641 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; nitric oxide mediated signal transduction; GO:0007263; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8641 CG8641 CDMC26827 1 5 9 DAC14-E07 2-CG8774-RB_1 CG8774 CAACATCGAATGGCTATCCAGAAACGAAGCTGACATCACCGACTGGCTAAGTGGAACGGCCTCGC 65 FBan0008774 FBgn0038136 CG8774 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0003676; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; endonuclease activity; GO:0004519; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004519 CG8774 CG8774 CDMC26827 1 6 9 DAC14-E07 2-CG8774-RB_1 CG8774 CAACATCGAATGGCTATCCAGAAACGAAGCTGACATCACCGACTGGCTAAGTGGAACGGCCTCGC 65 FBan0008774 FBgn0038136 CG8774 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0003676; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; endonuclease activity; GO:0004519; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004519 CG8774 CG8774 CDMC26828 1 7 9 DAC14-E19 3-CG8787-RA_1 CG8787 AATACCAACTCATCGGCCGTCGCGCTTATGGAAGCTGGCAACAACTACATAGTGACGACCAACGC 65 FBan0008787 FBgn0000142 Asx 2 2R chromatin silencing; GO:0006342; sex comb development; GO:0045498 chromatin binding; GO:0003682; ; GO:0003682; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; ; GO:0016563; ; GO:0016564 chromatin; GO:0000785; nucleus; GO:0005634 Asx Additional sex combs "CG8787, Additional sex combs" CDMC26828 1 8 9 DAC14-E19 3-CG8787-RA_1 CG8787 AATACCAACTCATCGGCCGTCGCGCTTATGGAAGCTGGCAACAACTACATAGTGACGACCAACGC 65 FBan0008787 FBgn0000142 Asx 2 2R chromatin silencing; GO:0006342; sex comb development; GO:0045498 chromatin binding; GO:0003682; ; GO:0003682; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; ; GO:0016563; ; GO:0016564 chromatin; GO:0000785; nucleus; GO:0005634 Asx Additional sex combs "CG8787, Additional sex combs" CDMC26829 1 9 9 DAC14-I07 23-CG8905-RA_1 CG8905 TAAAATCTGATATCGGGACTTAGCCTTATTAGCAGTCGAATAAAACGCAGATATGTTCGTGGCCC 65 FBan0008905 FBgn0010213 Sod2 2 2R defense response; GO:0006952; determination of adult life span; GO:0008340; removal of superoxide radicals; GO:0019430; superoxide metabolism; GO:0006801 antioxidant activity; GO:0016209; superoxide dismutase activity; GO:0004784 ; EC:1.15.1.1; manganese superoxide dismutase activity; GO:0008383; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0008383; ; GO:0004784 ; EC:1.15.1.1; ; GO:0008383; ; GO:0046872 mitochondrial matrix; GO:0005759 Sod2 Superoxide dismutase 2 (Mn) "CG8905, CG8905, SOD-2, Mn SOD, MnSOD, SOD, Mn-superoxide dismutase, mnSOD, Superoxide dismutase, SOD2, mitochodnrial SOD, Mn[2+]SOD, Mn-SOD, Sod-2" CDMC26829 1 10 9 DAC14-I07 23-CG8905-RA_1 CG8905 TAAAATCTGATATCGGGACTTAGCCTTATTAGCAGTCGAATAAAACGCAGATATGTTCGTGGCCC 65 FBan0008905 FBgn0010213 Sod2 2 2R defense response; GO:0006952; determination of adult life span; GO:0008340; removal of superoxide radicals; GO:0019430; superoxide metabolism; GO:0006801 antioxidant activity; GO:0016209; superoxide dismutase activity; GO:0004784 ; EC:1.15.1.1; manganese superoxide dismutase activity; GO:0008383; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0008383; ; GO:0004784 ; EC:1.15.1.1; ; GO:0008383; ; GO:0046872 mitochondrial matrix; GO:0005759 Sod2 Superoxide dismutase 2 (Mn) "CG8905, CG8905, SOD-2, Mn SOD, MnSOD, SOD, Mn-superoxide dismutase, mnSOD, Superoxide dismutase, SOD2, mitochodnrial SOD, Mn[2+]SOD, Mn-SOD, Sod-2" CDMC26830 1 11 9 DAC14-I19 3-CG8959-RA_1 CG8959 AAGGGTCGTGTGGTGAACTTCACTTGCTTCCTGAGGGAACTTAATCTGCCCCTCAACTTGCCAGC 65 FBan0008959 FBgn0030691 CG8959 X X CG8959 CG8959 CDMC26830 1 12 9 DAC14-I19 3-CG8959-RA_1 CG8959 AAGGGTCGTGTGGTGAACTTCACTTGCTTCCTGAGGGAACTTAATCTGCCCCTCAACTTGCCAGC 65 FBan0008959 FBgn0030691 CG8959 X X CG8959 CG8959 CDMC26831 1 13 9 DAC14-M07 23-CG9034-RA_1 CG9034 TGGTTTGTTCGTTGTGTAACTTAACTGAACGCGTTGAATTTTTGTGTACCAAGATGTCCGCATCC 65 FBan0009034 FBgn0040931 CG9034 X X CG9034 CG9034 "GH20078, BcDNA:RH45008" CDMC26831 1 14 9 DAC14-M07 23-CG9034-RA_1 CG9034 TGGTTTGTTCGTTGTGTAACTTAACTGAACGCGTTGAATTTTTGTGTACCAAGATGTCCGCATCC 65 FBan0009034 FBgn0040931 CG9034 X X CG9034 CG9034 "GH20078, BcDNA:RH45008" CDMC26832 1 15 9 DAC14-M19 17-CG9067-RA_2 CG9067 CAGGAACTGGAATTGCAATATCATGTTAACGCCGCCTTAGACGTCGTGGAGGAGAAGTGCCTGAT 65 FBan0009067 FBgn0033605 CG9067 2 2R CG9067 CG9067 CDMC26832 1 16 9 DAC14-M19 17-CG9067-RA_2 CG9067 CAGGAACTGGAATTGCAATATCATGTTAACGCCGCCTTAGACGTCGTGGAGGAGAAGTGCCTGAT 65 FBan0009067 FBgn0033605 CG9067 2 2R CG9067 CG9067 CDMC26833 1 17 9 DAC15-A07 3-CG8172-RA_2 CG8172 GCGCCTAAACCACGAAGAGTATGGCATCGAGCGAAAGGAAGTGCATCCCCATTACAATCCGGCAGAC 67 FBan0008172 FBgn0033362 CG8172 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8172 CG8172 "c-SP32, SP32" CDMC26833 1 18 9 DAC15-A07 3-CG8172-RA_2 CG8172 GCGCCTAAACCACGAAGAGTATGGCATCGAGCGAAAGGAAGTGCATCCCCATTACAATCCGGCAGAC 67 FBan0008172 FBgn0033362 CG8172 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8172 CG8172 "c-SP32, SP32" CDMC26834 1 19 9 DAC15-A19 13-CG8287-RA_2 CG8287 GCCAGCATTAACGTGGAAGAAGCCTTCCTCACCCTAGCCAGTGATATCAAAGCGAAAACGGAAAAGC 67 FBan0008287 FBgn0015796 Rab8 3 3L "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab8 Rab-protein 8 "CG8287, CG8287, DRAB8, DRab8, rab8, DmRab8, AAF49101, Dm Rab8, dm-Rab8, Rab-r8" CDMC26834 1 20 9 DAC15-A19 13-CG8287-RA_2 CG8287 GCCAGCATTAACGTGGAAGAAGCCTTCCTCACCCTAGCCAGTGATATCAAAGCGAAAACGGAAAAGC 67 FBan0008287 FBgn0015796 Rab8 3 3L "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab8 Rab-protein 8 "CG8287, CG8287, DRAB8, DRab8, rab8, DmRab8, AAF49101, Dm Rab8, dm-Rab8, Rab-r8" CDMC26835 1 21 9 DAC15-E07 6-CG8591-RA_4 CG8591 CCGGGACCAGGAGGAAAACGAAGAGGATGACAACCCAGAGAGCTATGACTTGGCTGAAATCGAGCCG 67 FBan0008591 FBgn0035769 CTCF 3 3L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CTCF CTCF "CG8591, dCTCF" CDMC26835 1 22 9 DAC15-E07 6-CG8591-RA_4 CG8591 CCGGGACCAGGAGGAAAACGAAGAGGATGACAACCCAGAGAGCTATGACTTGGCTGAAATCGAGCCG 67 FBan0008591 FBgn0035769 CTCF 3 3L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CTCF CTCF "CG8591, dCTCF" CDMC26836 1 23 9 DAC15-E19 12-CG8846-RA_4 CG8846 ACACGTCCAGCGGAAAGTTTTCGAAACCAATCCAATCAATCAGCTAAGATGTCCGCTTCACCCACCG 67 FBan0008846 FBgn0022073 Thor 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; immune response; GO:0006955; negative regulation of cell size; GO:0045792; negative regulation of translational initiation; GO:0045947; regulation of cell growth; GO:0001558; response to stress; GO:0006950 eukaryotic initiation factor 4E binding; GO:0008190; ; GO:0008190; ; GO:0008190; ; GO:0008190; ; GO:0008190 Thor Thor "CG8846, CG8846, l(2)k07736, 4E-BP, eIF-4E-binding protein, Dm 4E-BP, d4E-BP, Phas1, insulin-stimulated eIF-4E binding protein, pp20, BcDNA.HL08053, 4EBP, thor, CT8705, d4E-BP1, d4EBP, 4E-BP1, eIF4E-BP, BcDNA:HL08053, anon-WO0172774.158, l(2)k13517" CDMC26836 1 24 9 DAC15-E19 12-CG8846-RA_4 CG8846 ACACGTCCAGCGGAAAGTTTTCGAAACCAATCCAATCAATCAGCTAAGATGTCCGCTTCACCCACCG 67 FBan0008846 FBgn0022073 Thor 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; immune response; GO:0006955; negative regulation of cell size; GO:0045792; negative regulation of translational initiation; GO:0045947; regulation of cell growth; GO:0001558; response to stress; GO:0006950 eukaryotic initiation factor 4E binding; GO:0008190; ; GO:0008190; ; GO:0008190; ; GO:0008190; ; GO:0008190 Thor Thor "CG8846, CG8846, l(2)k07736, 4E-BP, eIF-4E-binding protein, Dm 4E-BP, d4E-BP, Phas1, insulin-stimulated eIF-4E binding protein, pp20, BcDNA.HL08053, 4EBP, thor, CT8705, d4E-BP1, d4EBP, 4E-BP1, eIF4E-BP, BcDNA:HL08053, anon-WO0172774.158, l(2)k13517" CDMC26837 1 25 9 DAC15-I07 17-CG9220-RB_1 CG9220 TGCCATCTACAAGTCGGACATACTCGATGAGGATATCAACGGATTCGATAAGGACATCACCGGCTGG 67 FBan0009220 FBgn0030662 CG9220 X X chondroitin sulfate biosynthesis; GO:0030206; protein amino acid glycosylation; GO:0006486 acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0008375 ; EC:2.4.1.-; ; GO:0015020 ; EC:2.4.1.17 CG9220 CG9220 CDMC26837 1 26 9 DAC15-I07 17-CG9220-RB_1 CG9220 TGCCATCTACAAGTCGGACATACTCGATGAGGATATCAACGGATTCGATAAGGACATCACCGGCTGG 67 FBan0009220 FBgn0030662 CG9220 X X chondroitin sulfate biosynthesis; GO:0030206; protein amino acid glycosylation; GO:0006486 acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0008375 ; EC:2.4.1.-; ; GO:0015020 ; EC:2.4.1.17 CG9220 CG9220 CDMC26838 1 1 10 DAC15-I19 1-CG9320-RA_1 CG9320 CCACTTGTTCGCCTCTGTGATTGTCCCGGTCTAGTCTTTCCCTCGAGTACTCCCAAAAGCCTGCAAG 67 FBan0009320 FBgn0032882 CG9320 2 2L "GTP binding; GO:0005525; nucleic acid binding; GO:0003676; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0003676; ; GO:0016818 ; EC:3.6.1.-" CG9320 CG9320 38E.14 CDMC26838 1 2 10 DAC15-I19 1-CG9320-RA_1 CG9320 CCACTTGTTCGCCTCTGTGATTGTCCCGGTCTAGTCTTTCCCTCGAGTACTCCCAAAAGCCTGCAAG 67 FBan0009320 FBgn0032882 CG9320 2 2L "GTP binding; GO:0005525; nucleic acid binding; GO:0003676; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0003676; ; GO:0016818 ; EC:3.6.1.-" CG9320 CG9320 38E.14 CDMC26839 1 3 10 DAC15-M07 2-CG9737-RA_1 CG9737 ACATTGCCATTATCCGGCTAAAGCATCCCGTGTCCTTCACTCACTTCGTCATGCCCATCTGTTTGCC 67 FBan0009737 FBgn0039758 CG9737 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG9737 CG9737 "c-SP5, SP5" CDMC26839 1 4 10 DAC15-M07 2-CG9737-RA_1 CG9737 ACATTGCCATTATCCGGCTAAAGCATCCCGTGTCCTTCACTCACTTCGTCATGCCCATCTGTTTGCC 67 FBan0009737 FBgn0039758 CG9737 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG9737 CG9737 "c-SP5, SP5" CDMC26840 1 5 10 DAC15-M19 3-CG9862-RA_1 CG9862 CGGCCAACAGAGGACTCATCATATACTCGCTGCAGAATAGCCCAACCGAGTACAAGCGGCAGGAGAG 67 FBan0009862 FBgn0034646 Rae1 2 2R "RNA localization; GO:0006403; cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 Rae1 Rae1 "CG9862, CG9862, dmrae1" CDMC26840 1 6 10 DAC15-M19 3-CG9862-RA_1 CG9862 CGGCCAACAGAGGACTCATCATATACTCGCTGCAGAATAGCCCAACCGAGTACAAGCGGCAGGAGAG 67 FBan0009862 FBgn0034646 Rae1 2 2R "RNA localization; GO:0006403; cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 Rae1 Rae1 "CG9862, CG9862, dmrae1" CDMC26841 1 7 10 DAC16-A07 2-CG4877-RA_4 CG4877 CGCATAAGCACAAGTCTCACAAGCATAGGAGCTCCCATAAGTCCCAGGCTGAATCTTCCGCCACCATCA 69 FBan0004877 FBgn0036624 CG4877 3 3L CG4877 CG4877 "CG4689, CG4689" CDMC26841 1 8 10 DAC16-A07 2-CG4877-RA_4 CG4877 CGCATAAGCACAAGTCTCACAAGCATAGGAGCTCCCATAAGTCCCAGGCTGAATCTTCCGCCACCATCA 69 FBan0004877 FBgn0036624 CG4877 3 3L CG4877 CG4877 "CG4689, CG4689" CDMC26842 1 9 10 DAC16-A19 2-CG4891-RA_2 CG4891 TGCTCATTTGGAATCGGGTCAAGCTATTTGGTTTCCCTGGTACTTTCAGCGCTACGGACTAGCCCCACA 69 FBan0004891 FBgn0028520 CG4891 2 2L CG4891 CG4891 "BG:DS04095.1, DS04095.1" CDMC26842 1 10 10 DAC16-A19 2-CG4891-RA_2 CG4891 TGCTCATTTGGAATCGGGTCAAGCTATTTGGTTTCCCTGGTACTTTCAGCGCTACGGACTAGCCCCACA 69 FBan0004891 FBgn0028520 CG4891 2 2L CG4891 CG4891 "BG:DS04095.1, DS04095.1" CDMC26843 1 11 10 DAC16-E07 9-CG4917-RB_5 CG4917 CGGCGATCACAACAGCGTGCTTGTTGGTCTTACCCTATATGACATCGAGTTTTAAGGATACGCCGCGCT 69 FBan0004917 FBgn0039003 wfs1 3 3R sensory perception of sound; GO:0007605; visual perception; GO:0007601 glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2 glutamate-cysteine ligase complex; GO:0017109 wfs1 wolfram syndrome 1 "CG4917, wolfram syndrome 1" CDMC26843 1 12 10 DAC16-E07 9-CG4917-RB_5 CG4917 CGGCGATCACAACAGCGTGCTTGTTGGTCTTACCCTATATGACATCGAGTTTTAAGGATACGCCGCGCT 69 FBan0004917 FBgn0039003 wfs1 3 3R sensory perception of sound; GO:0007605; visual perception; GO:0007601 glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2 glutamate-cysteine ligase complex; GO:0017109 wfs1 wolfram syndrome 1 "CG4917, wolfram syndrome 1" CDMC26844 1 13 10 DAC16-E19 3-CG4926-RA_1 CG4926 CGCTCCGGAAAACTGTCCCACTGCTGTCTACTCGCTAATGATCGAGTGCTGGCATGAGCAGTCAGTAAA 69 FBan0004926 FBgn0010407 Ror 2 2L central nervous system development; GO:0007417; ectoderm development; GO:0007398; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; neurotrophin receptor activity; GO:0005030; ; GO:0005030 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Ror Ror "CG4926, CG4926, Dror, DRor, DmHD-2, ROR, HD-2" CDMC26844 1 14 10 DAC16-E19 3-CG4926-RA_1 CG4926 CGCTCCGGAAAACTGTCCCACTGCTGTCTACTCGCTAATGATCGAGTGCTGGCATGAGCAGTCAGTAAA 69 FBan0004926 FBgn0010407 Ror 2 2L central nervous system development; GO:0007417; ectoderm development; GO:0007398; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; neurotrophin receptor activity; GO:0005030; ; GO:0005030 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Ror Ror "CG4926, CG4926, Dror, DRor, DmHD-2, ROR, HD-2" CDMC26845 1 15 10 DAC16-I07 14-CG4953-RA_1 CG4953 TGGCGAATCTGCCGAATTTCCATTGTCCGTCTGTCCATCTAAATTGGGCCTCGTGAAAATAACACCCTT 69 FBan0004953 FBgn0032204 CG4953 2 2L CG4953 CG4953 CDMC26845 1 16 10 DAC16-I07 14-CG4953-RA_1 CG4953 TGGCGAATCTGCCGAATTTCCATTGTCCGTCTGTCCATCTAAATTGGGCCTCGTGAAAATAACACCCTT 69 FBan0004953 FBgn0032204 CG4953 2 2L CG4953 CG4953 CDMC26846 1 17 10 DAC16-I19 23-CG4962-RA_10 CG4962 TTTGCATTTCGTAGTCAGAAGCGGAAATACAAATTGTGTACAAAATCCCTCAAAAACCCAGACACCCAC 69 FBan0004962 FBgn0036597 CG4962 3 3L CG4962 CG4962 CT15908 CDMC26846 1 18 10 DAC16-I19 23-CG4962-RA_10 CG4962 TTTGCATTTCGTAGTCAGAAGCGGAAATACAAATTGTGTACAAAATCCCTCAAAAACCCAGACACCCAC 69 FBan0004962 FBgn0036597 CG4962 3 3L CG4962 CG4962 CT15908 CDMC26847 1 19 10 DAC16-M07 2-CG4998-RA_1 CG4998 CCGGTTGACACCTCCTCCGATGAGTTCGTTTTCCACTTCTGACCGAAGCCATCTTTCAACACTCTCGCA 69 FBan0004998 FBgn0036612 CG4998 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4998 CG4998 SPH66 CDMC26847 1 20 10 DAC16-M07 2-CG4998-RA_1 CG4998 CCGGTTGACACCTCCTCCGATGAGTTCGTTTTCCACTTCTGACCGAAGCCATCTTTCAACACTCTCGCA 69 FBan0004998 FBgn0036612 CG4998 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4998 CG4998 SPH66 CDMC26848 1 21 10 DAC16-M19 8-CG5009-RA_2 CG5009 AGCTGGGCATGAAGGGTGTCAACAATGGCTATTTGGGACTGAAGAACGTACGGGTGCCTTTAAACAACA 69 FBan0005009 FBgn0027572 CG5009 2 2R fatty acid beta-oxidation; GO:0006635 palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 CG5009 CG5009 "GH07485, BcDNA:GH07485" CDMC26848 1 22 10 DAC16-M19 8-CG5009-RA_2 CG5009 AGCTGGGCATGAAGGGTGTCAACAATGGCTATTTGGGACTGAAGAACGTACGGGTGCCTTTAAACAACA 69 FBan0005009 FBgn0027572 CG5009 2 2R fatty acid beta-oxidation; GO:0006635 palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 CG5009 CG5009 "GH07485, BcDNA:GH07485" CDMC26849 1 23 10 DAC17-A07 14-CG7088-RA_1 CG7088 GCGTTCTGCCCCAGGATCAATAGAACCAAGTGGATCGGAAGGTAAACCACGCGTAGGCATAACAATTCA 69 FBan0007088 FBgn0001090 bnb X X development; GO:0007275; gliogenesis; GO:0042063 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 bnb bangles and beads "CG7088, Gap43" CDMC26849 1 24 10 DAC17-A07 14-CG7088-RA_1 CG7088 GCGTTCTGCCCCAGGATCAATAGAACCAAGTGGATCGGAAGGTAAACCACGCGTAGGCATAACAATTCA 69 FBan0007088 FBgn0001090 bnb X X development; GO:0007275; gliogenesis; GO:0042063 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 bnb bangles and beads "CG7088, Gap43" CDMC26850 1 25 10 DAC17-A19 14-CG7098-RA_1 CG7098 GCCAGACTGTAAATTAGCCACGCTATTCGACACGTACACGTAGCCTCTAGTGTCCGCAATCCAAGTTGT 69 FBan0007098 FBgn0030891 dik X X histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 Ada2/Gcn5/Ada3 transcription activator complex; GO:0005671; histone acetyltransferase complex; GO:0000123; polytene chromosome; GO:0005700 dik diskette "CG7098, DADA3, HL-XIV, dAda3, Ada3, diskette" CDMC26850 1 26 10 DAC17-A19 14-CG7098-RA_1 CG7098 GCCAGACTGTAAATTAGCCACGCTATTCGACACGTACACGTAGCCTCTAGTGTCCGCAATCCAAGTTGT 69 FBan0007098 FBgn0030891 dik X X histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 Ada2/Gcn5/Ada3 transcription activator complex; GO:0005671; histone acetyltransferase complex; GO:0000123; polytene chromosome; GO:0005700 dik diskette "CG7098, DADA3, HL-XIV, dAda3, Ada3, diskette" CDMC26851 1 1 11 DAC17-E07 10-CG7131-RA_1 CG7131 GCCGGCATTTGTTAGCCTGGAAATACATTATGGTTGCTCTGAAGAATCCGTCTCCCAAGCTCATCCCGA 69 FBan0007131 FBgn0038598 CG7131 3 3R CG7131 CG7131 anon-WO0140519.212 CDMC26851 1 2 11 DAC17-E07 10-CG7131-RA_1 CG7131 GCCGGCATTTGTTAGCCTGGAAATACATTATGGTTGCTCTGAAGAATCCGTCTCCCAAGCTCATCCCGA 69 FBan0007131 FBgn0038598 CG7131 3 3R CG7131 CG7131 anon-WO0140519.212 CDMC26852 1 3 11 DAC17-E19 3-CG7146-RA_2 CG7146 TGGTGATCATCTGCCGCTGATCTTTGAGTTCGCTGACTGGGTCTTAAACGATAATCCCGAGGAAGGCCT 69 FBan0007146 FBgn0038593 CG7146 3 3R CG7146 CG7146 CDMC26852 1 4 11 DAC17-E19 3-CG7146-RA_2 CG7146 TGGTGATCATCTGCCGCTGATCTTTGAGTTCGCTGACTGGGTCTTAAACGATAATCCCGAGGAAGGCCT 69 FBan0007146 FBgn0038593 CG7146 3 3R CG7146 CG7146 CDMC26853 1 5 11 DAC17-I07 18-CG7180-RA_1 CG7180 CGGAGTACAAGTACTGCTACGATCTGGTGCTCCACTATGTCCTCCACTTCCTCAACAAGAAGGAGTGAA 69 FBan0007180 FBgn0032673 CG7180 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG7180 CG7180 R-PTPk CDMC26853 1 6 11 DAC17-I07 18-CG7180-RA_1 CG7180 CGGAGTACAAGTACTGCTACGATCTGGTGCTCCACTATGTCCTCCACTTCCTCAACAAGAAGGAGTGAA 69 FBan0007180 FBgn0032673 CG7180 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG7180 CG7180 R-PTPk CDMC26854 1 7 11 DAC17-I19 9-CG7188-RB_1 CG7188 ACGTCGGCGTTTTCGTTATGGCTGCCTTCATCGTCTACGATACACAGAACATTGTGGAGAAGTGCCGAA 69 FBan0007188 FBgn0035871 CG7188 3 3L anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066 integral to membrane; GO:0016021 CG7188 CG7188 d-BI-1 CDMC26854 1 8 11 DAC17-I19 9-CG7188-RB_1 CG7188 ACGTCGGCGTTTTCGTTATGGCTGCCTTCATCGTCTACGATACACAGAACATTGTGGAGAAGTGCCGAA 69 FBan0007188 FBgn0035871 CG7188 3 3L anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066 integral to membrane; GO:0016021 CG7188 CG7188 d-BI-1 CDMC26855 1 9 11 DAC17-M07 15-CG7230-RA_1 CG7230 GGCACTCGTAGGCCATCTTTGGAAACCAGCTAGTTGTAGGCCTTAAAACAGTGTTACTCCACCATCCCA 69 FBan0007230 FBgn0003254 rib 2 2R "Malpighian tubule morphogenesis; GO:0007443; cell migration; GO:0016477; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; head involution; GO:0008258; hindgut morphogenesis; GO:0007442; membrane organization and biogenesis; GO:0016044; primary tracheal branching (sensu Insecta); GO:0007428; protein localization; GO:0008104; regulation of Malpighian tubule diameter; GO:0035297; regulation of cell shape; GO:0008360; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal lumen formation; GO:0035149; tracheal system development (sensu Insecta); GO:0007424" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 rib ribbon "CG7230, CG7230, CG7230, CG7230, gene 5" CDMC26855 1 10 11 DAC17-M07 15-CG7230-RA_1 CG7230 GGCACTCGTAGGCCATCTTTGGAAACCAGCTAGTTGTAGGCCTTAAAACAGTGTTACTCCACCATCCCA 69 FBan0007230 FBgn0003254 rib 2 2R "Malpighian tubule morphogenesis; GO:0007443; cell migration; GO:0016477; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; head involution; GO:0008258; hindgut morphogenesis; GO:0007442; membrane organization and biogenesis; GO:0016044; primary tracheal branching (sensu Insecta); GO:0007428; protein localization; GO:0008104; regulation of Malpighian tubule diameter; GO:0035297; regulation of cell shape; GO:0008360; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal lumen formation; GO:0035149; tracheal system development (sensu Insecta); GO:0007424" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 rib ribbon "CG7230, CG7230, CG7230, CG7230, gene 5" CDMC26856 1 11 11 DAC17-M19 2-CG7248-RA_1 CG7248 CAACAACCACAGAGAAGCCTTCACCGAATGGAATTTGTGCAGATAAGGCAGAGGGATCACTGGTGCCCT 69 FBan0007248 FBgn0036229 CG7248 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7248 CG7248 CDMC26856 1 12 11 DAC17-M19 2-CG7248-RA_1 CG7248 CAACAACCACAGAGAAGCCTTCACCGAATGGAATTTGTGCAGATAAGGCAGAGGGATCACTGGTGCCCT 69 FBan0007248 FBgn0036229 CG7248 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7248 CG7248 CDMC26857 1 13 11 DAC18-A07 1-CG32395-RA_1 CG32395 TGAGGGAAGTGAATCTGCTCAACCGCTTTACACGCCAGTTCCTGTTTCTCATCGTGTTGGTGACCCAGA 69 FBan0032395 FBgn0041232 Gr65a 3 3L NOT taste receptor activity; GO:0008527; ; GO:0008527 Gr65a Gr65a "CG32395, CG32395, 65C.1, Gustatory receptor 65C.1, Gr65C1, GR65C.1" CDMC26857 1 14 11 DAC18-A07 1-CG32395-RA_1 CG32395 TGAGGGAAGTGAATCTGCTCAACCGCTTTACACGCCAGTTCCTGTTTCTCATCGTGTTGGTGACCCAGA 69 FBan0032395 FBgn0041232 Gr65a 3 3L NOT taste receptor activity; GO:0008527; ; GO:0008527 Gr65a Gr65a "CG32395, CG32395, 65C.1, Gustatory receptor 65C.1, Gr65C1, GR65C.1" CDMC26858 1 15 11 DAC18-A19 3-CG32403-RA_1 CG32403 CTGCGTCACCTTCATCAGAGGTGCCATGGATATGAGCAGTTGAGATTGGAGACGAATCGCCTGGTCCAG 69 FBgn0052403 CDMC26858 1 16 11 DAC18-A19 3-CG32403-RA_1 CG32403 CTGCGTCACCTTCATCAGAGGTGCCATGGATATGAGCAGTTGAGATTGGAGACGAATCGCCTGGTCCAG 69 FBgn0052403 CDMC26859 1 17 11 DAC18-E07 2-CG32436-RA_1 CG32436 TTCACGCCCAATGGAAGCTATGCCATCTACCACGACGAGTTCTTTCACGTCTTTGATCCCTACGGCAGT 69 FBan0032436 FBgn0052436 CG32436 3 3L CG32436 CG32436 "CG6968, CG12973, CG6968" CDMC26859 1 18 11 DAC18-E07 2-CG32436-RA_1 CG32436 TTCACGCCCAATGGAAGCTATGCCATCTACCACGACGAGTTCTTTCACGTCTTTGATCCCTACGGCAGT 69 FBan0032436 FBgn0052436 CG32436 3 3L CG32436 CG32436 "CG6968, CG12973, CG6968" CDMC26860 1 19 11 DAC18-E19 2-CG32447-RA_1 CG32447 GCCCCACCTGACCCTGGGAATTTTGATATATTCCTATCGGTCGGTCAGAGGGTTCGTGGAAGTTCGTGG 69 FBan0032447 FBgn0052447 CG32447 3 3L metabotropic glutamate receptor signaling pathway; GO:0007216 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021 CG32447 CG32447 "CG7155, CG14571, CG7155, CG7155, anon-WO0170980.76, anon-WO0170980.77" CDMC26860 1 20 11 DAC18-E19 2-CG32447-RA_1 CG32447 GCCCCACCTGACCCTGGGAATTTTGATATATTCCTATCGGTCGGTCAGAGGGTTCGTGGAAGTTCGTGG 69 FBan0032447 FBgn0052447 CG32447 3 3L metabotropic glutamate receptor signaling pathway; GO:0007216 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021 CG32447 CG32447 "CG7155, CG14571, CG7155, CG7155, anon-WO0170980.76, anon-WO0170980.77" CDMC26861 1 21 11 DAC18-I07 18-CG32476-RA_4 CG32476 CACTCCGTTGTGCACATCTATGGGATCCCGAACCAAGGGTTCATTGGCTACGTCATACAGTTTTGTATT 69 FBan0032476 FBgn0052476 mthl14 3 3L mthl14 methuselah-like 14 "CG32476, BcDNA:RE31310" CDMC26861 1 22 11 DAC18-I07 18-CG32476-RA_4 CG32476 CACTCCGTTGTGCACATCTATGGGATCCCGAACCAAGGGTTCATTGGCTACGTCATACAGTTTTGTATT 69 FBan0032476 FBgn0052476 mthl14 3 3L mthl14 methuselah-like 14 "CG32476, BcDNA:RE31310" CDMC26862 1 23 11 DAC18-I19 23-CG32490-RH_9 CG32490 GCTCCATACAGAGTTAGGAACGATCAAACTAATGAATGAATGCCTTAACGTGGCTCAAATGACTAGACC 69 FBan0032490 FBgn0041605 cpx 3 3R neurotransmitter transport; GO:0006836; synaptic vesicle exocytosis; GO:0016079 syntaxin binding; GO:0019905; ; GO:0019905 cpx complexin "CG32490, BcDNA:HL04936, BcDNA:GH27718, BcDNA:RH26459, BcDNA:RH31085, complexin" CDMC26862 1 24 11 DAC18-I19 23-CG32490-RH_9 CG32490 GCTCCATACAGAGTTAGGAACGATCAAACTAATGAATGAATGCCTTAACGTGGCTCAAATGACTAGACC 69 FBan0032490 FBgn0041605 cpx 3 3R neurotransmitter transport; GO:0006836; synaptic vesicle exocytosis; GO:0016079 syntaxin binding; GO:0019905; ; GO:0019905 cpx complexin "CG32490, BcDNA:HL04936, BcDNA:GH27718, BcDNA:RH26459, BcDNA:RH31085, complexin" CDMC26863 1 25 11 DAC18-M07 17-CG32507-RA_2 CG32507 TGCGTCAGCACCACAACCTTACAACTCTGTTCAGGATGAGGCTACTCCTGGAGAAATATTTCCGAGAAT 69 FBan0032507 FBgn0052507 CG32507 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32507 CG32507 CDMC26863 1 26 11 DAC18-M07 17-CG32507-RA_2 CG32507 TGCGTCAGCACCACAACCTTACAACTCTGTTCAGGATGAGGCTACTCCTGGAGAAATATTTCCGAGAAT 69 FBan0032507 FBgn0052507 CG32507 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32507 CG32507 CDMC26864 1 1 12 DAC18-M19 17-CG32521-RB_1 CG32521 GCAGCGACTGAAGTAGCTAGCCTAGCATTCCATGTGGAGATCGACTTTGGAGTCTCCTTTCAAAACAGT 69 FBan0032521 FBgn0052521 CG32521 X X CG32521 CG32521 "CG1726, CG1735, CG1726, CG1735" CDMC26864 1 2 12 DAC18-M19 17-CG32521-RB_1 CG32521 GCAGCGACTGAAGTAGCTAGCCTAGCATTCCATGTGGAGATCGACTTTGGAGTCTCCTTTCAAAACAGT 69 FBan0032521 FBgn0052521 CG32521 X X CG32521 CG32521 "CG1726, CG1735, CG1726, CG1735" CDMC26865 1 3 12 DAC19-A07 3-CG8112-RA_1 CG8112 ATGGAGCATTACGCCCTAAAGAACTGCAACCTAAGCAACGAGAGTTGGACGTATCGCCTGCTGCC 65 FBan0008112 FBgn0037612 CG8112 3 3R cholesterol metabolism; GO:0008203 sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; ; GO:0004772 ; EC:2.3.1.26 CG8112 CG8112 CDMC26865 1 4 12 DAC19-A07 3-CG8112-RA_1 CG8112 ATGGAGCATTACGCCCTAAAGAACTGCAACCTAAGCAACGAGAGTTGGACGTATCGCCTGCTGCC 65 FBan0008112 FBgn0037612 CG8112 3 3R cholesterol metabolism; GO:0008203 sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; ; GO:0004772 ; EC:2.3.1.26 CG8112 CG8112 CDMC26866 1 5 12 DAC19-A19 3-CG8159-RA_1 CG8159 GTTCAGCTGTCACCATCCCAGTCAGCGGATCAGGTCAAATTCGTGACGGAAAAGGAGCCAGAAGC 65 FBan0008159 FBgn0037619 CG8159 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8159 CG8159 CDMC26866 1 6 12 DAC19-A19 3-CG8159-RA_1 CG8159 GTTCAGCTGTCACCATCCCAGTCAGCGGATCAGGTCAAATTCGTGACGGAAAAGGAGCCAGAAGC 65 FBan0008159 FBgn0037619 CG8159 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8159 CG8159 CDMC26867 1 7 12 DAC19-E07 2-CG8241-RA_3 CG8241 CTGTGCGCATTCAGAAGGCAATCTGCTCCGGATTCTTCCGCAATGCAGCAAAAAAGGATCCGCAG 65 FBan0008241 FBgn0033898 CG8241 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 CG8241 CG8241 "cg8241, Prp22" CDMC26867 1 8 12 DAC19-E07 2-CG8241-RA_3 CG8241 CTGTGCGCATTCAGAAGGCAATCTGCTCCGGATTCTTCCGCAATGCAGCAAAAAAGGATCCGCAG 65 FBan0008241 FBgn0033898 CG8241 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 CG8241 CG8241 "cg8241, Prp22" CDMC26868 1 9 12 DAC19-E19 2-CG8262-RA_1 CG8262 ATCCCTTCAACCCATCTCCTCCGCGAAAATCACTGCCCCAGGTTGTCTATTCCGACATCGACGTC 65 FBan0008262 FBgn0027513 CG8262 2 2R CG8262 CG8262 BcDNA:LD22033 CDMC26868 1 10 12 DAC19-E19 2-CG8262-RA_1 CG8262 ATCCCTTCAACCCATCTCCTCCGCGAAAATCACTGCCCCAGGTTGTCTATTCCGACATCGACGTC 65 FBan0008262 FBgn0027513 CG8262 2 2R CG8262 CG8262 BcDNA:LD22033 CDMC26869 1 11 12 DAC19-I07 2-CG8348-RA_1 CG8348 CAAGGAGTCGTCACAGTTACAGTTTGCGGACTCCCAGCAATCAGCATCGACTGGACCACAATCCC 65 FBan0008348 FBgn0012344 Dh 3 3R fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0005184; ; GO:0008613; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 extracellular region; GO:0005576; integral to membrane; GO:0016021 Dh Diuretic hormone "CG8348, CG8348, DH, Drm-DH, diuretic hormone, Drome-DH[[44]], CRF-like peptide, DH44, diuretic hormone 44, drome-DH44, Diuretic hormone" CDMC26869 1 12 12 DAC19-I07 2-CG8348-RA_1 CG8348 CAAGGAGTCGTCACAGTTACAGTTTGCGGACTCCCAGCAATCAGCATCGACTGGACCACAATCCC 65 FBan0008348 FBgn0012344 Dh 3 3R fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0005184; ; GO:0008613; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 extracellular region; GO:0005576; integral to membrane; GO:0016021 Dh Diuretic hormone "CG8348, CG8348, DH, Drm-DH, diuretic hormone, Drome-DH[[44]], CRF-like peptide, DH44, diuretic hormone 44, drome-DH44, Diuretic hormone" CDMC26870 1 13 12 DAC19-I19 3-CG8379-RB_1 CG8379 TACGCCAACTCCATGATGCACGACAGCAATCTTACCTTCAAAGTCATGCTGCATCGGGCGCAGAT 65 FBan0008379 FBgn0037638 CG8379 3 3R CG8379 CG8379 anon-WO0118547.250 CDMC26870 1 14 12 DAC19-I19 3-CG8379-RB_1 CG8379 TACGCCAACTCCATGATGCACGACAGCAATCTTACCTTCAAAGTCATGCTGCATCGGGCGCAGAT 65 FBan0008379 FBgn0037638 CG8379 3 3R CG8379 CG8379 anon-WO0118547.250 CDMC26871 1 15 12 DAC19-M07 3-CG8455-RA_1 CG8455 CAAGCAGTTCCAGGAATATGTGTGGCGCTACCTGAAGATGTTCCACCTACCACCGGGAATTCCGC 65 FBan0008455 FBgn0031997 CG8455 2 2L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8455 CG8455 CDMC26871 1 16 12 DAC19-M07 3-CG8455-RA_1 CG8455 CAAGCAGTTCCAGGAATATGTGTGGCGCTACCTGAAGATGTTCCACCTACCACCGGGAATTCCGC 65 FBan0008455 FBgn0031997 CG8455 2 2L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8455 CG8455 CDMC26872 1 17 12 DAC19-M19 18-CG8491-RA_1 CG8491 CGCCCAACCAGATGAATCAGATGAACATGGGAGGTCAAGGCATGTCGCAGAATCCGATGATGCAG 65 FBan0008491 FBgn0001324 kto 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 kto kohtalo "CG8491, CG8491, CG8491, SRB8, dTRAP230, Trap230, Srb8/KTO/TRAP230, khotalo, Kto, MED12, Mediator complex subunit 12, Med12, Kto/Med12" CDMC26872 1 18 12 DAC19-M19 18-CG8491-RA_1 CG8491 CGCCCAACCAGATGAATCAGATGAACATGGGAGGTCAAGGCATGTCGCAGAATCCGATGATGCAG 65 FBan0008491 FBgn0001324 kto 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 kto kohtalo "CG8491, CG8491, CG8491, SRB8, dTRAP230, Trap230, Srb8/KTO/TRAP230, khotalo, Kto, MED12, Mediator complex subunit 12, Med12, Kto/Med12" CDMC26873 1 19 12 DAC20-A07 23-CG7654-RA_2 CG7654 AGTATCGACGACCTCGAATAGTACTTGGAGATGGCTACAGAAATTGAGATATAAATTTCAACAGTAGAA 69 FBan0007654 FBgn0036928 Tom20 3 3L protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 Tom20 Translocase of outer membrane 20 "CG7654, CG7654, CG7654, dtom20, anon-WO0118547.225, Translocase of outer membrane 20" CDMC26873 1 20 12 DAC20-A07 23-CG7654-RA_2 CG7654 AGTATCGACGACCTCGAATAGTACTTGGAGATGGCTACAGAAATTGAGATATAAATTTCAACAGTAGAA 69 FBan0007654 FBgn0036928 Tom20 3 3L protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 Tom20 Translocase of outer membrane 20 "CG7654, CG7654, CG7654, dtom20, anon-WO0118547.225, Translocase of outer membrane 20" CDMC26874 1 21 12 DAC20-A19 23-CG7664-RA_16 CG7664 CCAGGACCTCCTTTTCCAAGCTTCAATCGCCAACAAACCACAATACATACATACATACAGCCACTGTAA 69 FBan0007664 FBgn0001994 crp 2 2L RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702 nucleus; GO:0005634 crp cropped "CG7664, l(2)35Fd, l(2)k00809, dAP-4, 35F(AT)[[17]], BG:DS02740.3, AP-4, AP4, l(2)SH2 1614, MS:35F.AT17, l(2)SH1614, l(2)00232, l(2)k03505" CDMC26874 1 22 12 DAC20-A19 23-CG7664-RA_16 CG7664 CCAGGACCTCCTTTTCCAAGCTTCAATCGCCAACAAACCACAATACATACATACATACAGCCACTGTAA 69 FBan0007664 FBgn0001994 crp 2 2L RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702 nucleus; GO:0005634 crp cropped "CG7664, l(2)35Fd, l(2)k00809, dAP-4, 35F(AT)[[17]], BG:DS02740.3, AP-4, AP4, l(2)SH2 1614, MS:35F.AT17, l(2)SH1614, l(2)00232, l(2)k03505" CDMC26875 1 23 12 DAC20-E07 15-CG7708-RA_5 CG7708 GGCTGCAGTTGATACCAGAGAATTATCCGATTTTATGTTGCGCTTGTTAGGGGGACACAAATGGGGGGA 69 FBan0007708 FBgn0038641 CG7708 3 3R acetylcholine biosynthesis; GO:0008292; transport; GO:0006810 proline:sodium symporter activity; GO:0005298; ; GO:0005298; choline transporter activity; GO:0015220; ; GO:0015220 integral to membrane; GO:0016021; membrane; GO:0016020 CG7708 CG7708 CDMC26875 1 24 12 DAC20-E07 15-CG7708-RA_5 CG7708 GGCTGCAGTTGATACCAGAGAATTATCCGATTTTATGTTGCGCTTGTTAGGGGGACACAAATGGGGGGA 69 FBan0007708 FBgn0038641 CG7708 3 3R acetylcholine biosynthesis; GO:0008292; transport; GO:0006810 proline:sodium symporter activity; GO:0005298; ; GO:0005298; choline transporter activity; GO:0015220; ; GO:0015220 integral to membrane; GO:0016021; membrane; GO:0016020 CG7708 CG7708 CDMC26876 1 25 12 DAC20-E19 15-CG7716-RA_5 CG7716 CGGAGGTCCTGAATCTCTACGGCTACGAGGCATTAGCTCTTGGCTATGAAACAAAATGGCCACTAAGCT 69 FBan0007716 FBgn0035800 CG7716 3 3L microtubule nucleation; GO:0007020; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 centrosome; GO:0005813 CG7716 CG7716 CDMC26876 1 26 12 DAC20-E19 15-CG7716-RA_5 CG7716 CGGAGGTCCTGAATCTCTACGGCTACGAGGCATTAGCTCTTGGCTATGAAACAAAATGGCCACTAAGCT 69 FBan0007716 FBgn0035800 CG7716 3 3L microtubule nucleation; GO:0007020; mitosis; GO:0007067 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 centrosome; GO:0005813 CG7716 CG7716 CDMC26877 1 1 13 DAC20-I07 2-CG7757-RA_2 CG7757 CCAGGATCTGGAGACGGTAGACGACGCAAGCGGTAAGATAAGCATACGCCAAACAGCCATAACCAACCT 69 FBan0007757 FBgn0036915 CG7757 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U4; GO:0005687; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG7757 CG7757 CDMC26877 1 2 13 DAC20-I07 2-CG7757-RA_2 CG7757 CCAGGATCTGGAGACGGTAGACGACGCAAGCGGTAAGATAAGCATACGCCAAACAGCCATAACCAACCT 69 FBan0007757 FBgn0036915 CG7757 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U4; GO:0005687; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG7757 CG7757 CDMC26878 1 3 13 DAC20-I19 23-CG7765-RA_1 CG7765 AAATGGATTACGTTATACATACTTAACATAACTGATAATTGCCTTCGCTTAGATGAGATGTGTCGCGAT 69 FBan0007765 FBgn0001308 Khc 2 2R "action potential propagation; GO:0019227; axon cargo transport; GO:0008088; cytoplasmic transport, nurse cell to oocyte; GO:0007303; eye photoreceptor cell differentiation; GO:0001754; microtubule-based movement; GO:0007018; neurotransmitter secretion; GO:0007269; oocyte dorsal/ventral axis determination; GO:0007310; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; protein targeting; GO:0006605; regulation of pole plasm oskar mRNA localization; GO:0007317" microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0008017; ; GO:0005524; microtubule motor activity; GO:0003777; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 Khc Kinesin heavy chain "CG7765, CG7765, kinesin, kin, khc, Dmkin, KHC, l(2)k13314, kinesin alpha subunit, DmKHC, Kin: Kinesin, DKH, l(2R)W12, kinesin alpha-chain, l(2)W12, KIF5A, KIN, DK, kinesin heavy chain I, Kinesin, kinesin I, l(2)k13219, Kin" CDMC26878 1 4 13 DAC20-I19 23-CG7765-RA_1 CG7765 AAATGGATTACGTTATACATACTTAACATAACTGATAATTGCCTTCGCTTAGATGAGATGTGTCGCGAT 69 FBan0007765 FBgn0001308 Khc 2 2R "action potential propagation; GO:0019227; axon cargo transport; GO:0008088; cytoplasmic transport, nurse cell to oocyte; GO:0007303; eye photoreceptor cell differentiation; GO:0001754; microtubule-based movement; GO:0007018; neurotransmitter secretion; GO:0007269; oocyte dorsal/ventral axis determination; GO:0007310; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; protein targeting; GO:0006605; regulation of pole plasm oskar mRNA localization; GO:0007317" microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0008017; ; GO:0005524; microtubule motor activity; GO:0003777; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 Khc Kinesin heavy chain "CG7765, CG7765, kinesin, kin, khc, Dmkin, KHC, l(2)k13314, kinesin alpha subunit, DmKHC, Kin: Kinesin, DKH, l(2R)W12, kinesin alpha-chain, l(2)W12, KIF5A, KIN, DK, kinesin heavy chain I, Kinesin, kinesin I, l(2)k13219, Kin" CDMC26879 1 5 13 DAC20-M07 3-CG7800-RA_4 CG7800 AGTCCGGACTTCACCATGAACGACCTGAATCAACTGCCGTACCTAACAAGCCTTCAATTGCGACGTGGA 69 FBan0007800 FBgn0037552 CG7800 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7800 CG7800 CT23295 CDMC26879 1 6 13 DAC20-M07 3-CG7800-RA_4 CG7800 AGTCCGGACTTCACCATGAACGACCTGAATCAACTGCCGTACCTAACAAGCCTTCAATTGCGACGTGGA 69 FBan0007800 FBgn0037552 CG7800 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7800 CG7800 CT23295 CDMC26880 1 7 13 DAC20-M19 3-CG7813-RA_3 CG7813 TGTGACGCCGAAAAGGAAACTGATCCTTGCAAGCTCATGGAAGAGGAAACCGTTTGCAAGCCAGATCCT 69 FBan0007813 FBgn0034133 CG7813 2 2R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG7813 CG7813 CDMC26880 1 8 13 DAC20-M19 3-CG7813-RA_3 CG7813 TGTGACGCCGAAAAGGAAACTGATCCTTGCAAGCTCATGGAAGAGGAAACCGTTTGCAAGCCAGATCCT 69 FBan0007813 FBgn0034133 CG7813 2 2R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 CG7813 CG7813 CDMC26881 1 9 13 DAC21-A07 2-CG2555-RA_1 CG2555 TCCAGGGATCCTACTCATACACTGGGGATGATGGCAAGCAGTACACGGTGAACTACACGGCCGATAAGA 69 FBan0002555 FBgn0030398 CG2555 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG2555 CG2555 CDMC26881 1 10 13 DAC21-A07 2-CG2555-RA_1 CG2555 TCCAGGGATCCTACTCATACACTGGGGATGATGGCAAGCAGTACACGGTGAACTACACGGCCGATAAGA 69 FBan0002555 FBgn0030398 CG2555 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG2555 CG2555 CDMC26882 1 11 13 DAC21-A19 6-CG2595-RA_2 CG2595 TGCCGTGATCTTCGCTCCAACTCTGTTCGGAGATCTGGATCTAACCCTCGAAAATGTCGTCACTTGGCA 69 FBan0002595 FBgn0045843 RacGAP84C 3 3R intracellular signaling cascade; GO:0007242; limb morphogenesis (sensu Endopterygota); GO:0035109; signal transduction; GO:0007165 diacylglycerol binding; GO:0019992; GTPase activator activity; GO:0005096; Ras GTPase activator activity; GO:0005099; ; GO:0005096; ; GO:0019992; ; GO:0005099; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RacGAP84C RacGAP84C "CG2595, CG2595, P1.7, rnprot1.7, rnRacGAP, RnRacGAP, RotundRACGAP, rnRac-GAP, rnracGAP, rnprot; racGAP, rnRacGap, RhoGAP-84C8, rnracGap, GAP84C, RotundRacGAP, rotund RacGAP" CDMC26882 1 12 13 DAC21-A19 6-CG2595-RA_2 CG2595 TGCCGTGATCTTCGCTCCAACTCTGTTCGGAGATCTGGATCTAACCCTCGAAAATGTCGTCACTTGGCA 69 FBan0002595 FBgn0045843 RacGAP84C 3 3R intracellular signaling cascade; GO:0007242; limb morphogenesis (sensu Endopterygota); GO:0035109; signal transduction; GO:0007165 diacylglycerol binding; GO:0019992; GTPase activator activity; GO:0005096; Ras GTPase activator activity; GO:0005099; ; GO:0005096; ; GO:0019992; ; GO:0005099; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RacGAP84C RacGAP84C "CG2595, CG2595, P1.7, rnprot1.7, rnRacGAP, RnRacGAP, RotundRACGAP, rnRac-GAP, rnracGAP, rnprot; racGAP, rnRacGap, RhoGAP-84C8, rnracGap, GAP84C, RotundRacGAP, rotund RacGAP" CDMC26883 1 13 13 DAC21-E07 14-CG2669-RA_1 CG2669 GCGCGTTTGCTATCAAAGAGATGAGGGATATGCTTGGAGCTAGACACCAAGTGCTCCTCACACTAGAGC 69 FBan0002669 FBgn0037316 CG2669 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2669 CG2669 CDMC26883 1 14 13 DAC21-E07 14-CG2669-RA_1 CG2669 GCGCGTTTGCTATCAAAGAGATGAGGGATATGCTTGGAGCTAGACACCAAGTGCTCCTCACACTAGAGC 69 FBan0002669 FBgn0037316 CG2669 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2669 CG2669 CDMC26884 1 15 13 DAC21-E19 11-CG2679-RA_1 CG2679 TGCCGCACGCTATAACTGCCAGTCATCAGGTGACCGACGTCTAAAATATCGTCAACTACCCACGAACAA 69 FBan0002679 FBgn0004919 gol 2 2R "mesoderm development; GO:0007498; mesoderm formation; GO:0001707; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; peptidase activity; GO:0008233 ; EC:3.4.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 gol goliath "CG2679, g1, anon-G1, meso, goliath" CDMC26884 1 16 13 DAC21-E19 11-CG2679-RA_1 CG2679 TGCCGCACGCTATAACTGCCAGTCATCAGGTGACCGACGTCTAAAATATCGTCAACTACCCACGAACAA 69 FBan0002679 FBgn0004919 gol 2 2R "mesoderm development; GO:0007498; mesoderm formation; GO:0001707; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; peptidase activity; GO:0008233 ; EC:3.4.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 gol goliath "CG2679, g1, anon-G1, meso, goliath" CDMC26885 1 17 13 DAC21-I07 2-CG2727-RC_1 CG2727 CCTGCCCTTGGTGTTTGAGAAAGAAGTAATGACTTCAAACGAGGTGCCTGGATACCGGTTCACCCCACC 69 FBan0002727 FBgn0010435 emp 2 2R apoptosis; GO:0006915; autophagic cell death; GO:0048102; carbon utilization by fixation of carbon dioxide; GO:0015977; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 integral to plasma membrane; GO:0005887; lysosome; GO:0005764; plasma membrane; GO:0005886; ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 emp epithelial membrane protein "CG2727, CG2727, epithelial membrane protein" CDMC26885 1 18 13 DAC21-I07 2-CG2727-RC_1 CG2727 CCTGCCCTTGGTGTTTGAGAAAGAAGTAATGACTTCAAACGAGGTGCCTGGATACCGGTTCACCCCACC 69 FBan0002727 FBgn0010435 emp 2 2R apoptosis; GO:0006915; autophagic cell death; GO:0048102; carbon utilization by fixation of carbon dioxide; GO:0015977; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 integral to plasma membrane; GO:0005887; lysosome; GO:0005764; plasma membrane; GO:0005886; ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 emp epithelial membrane protein "CG2727, CG2727, epithelial membrane protein" CDMC26886 1 19 13 DAC21-I19 15-CG2788-RA_8 CG2788 CGGGCCATCGAACGACATCGAAATAAGCCCTACGATCTGCTACTCACGGAATACTTCAACTCCGATTGC 69 FBan0002788 FBgn0015663 Dot 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ecdysteroid UDP-glucosyltransferase activity; GO:0050488; ecdysteroid UDP-glucuronosyltransferase activity; GO:0050489; ; GO:0050488; ; GO:0050489 Dot Dorothy "CG2788, CG2788, Dorothy" CDMC26886 1 20 13 DAC21-I19 15-CG2788-RA_8 CG2788 CGGGCCATCGAACGACATCGAAATAAGCCCTACGATCTGCTACTCACGGAATACTTCAACTCCGATTGC 69 FBan0002788 FBgn0015663 Dot 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ecdysteroid UDP-glucosyltransferase activity; GO:0050488; ecdysteroid UDP-glucuronosyltransferase activity; GO:0050489; ; GO:0050488; ; GO:0050489 Dot Dorothy "CG2788, CG2788, Dorothy" CDMC26887 1 21 13 DAC21-M07 3-CG2845-RA_2 CG2845 CGCGCCACTGCAATATCCTCCTCTTCATGGGCTGTGTATCCAAACCATCTCTAGCGATTGTGACCCAGT 69 FBan0002845 FBgn0003079 phl X X "MAPKKK cascade; GO:0000165; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; epidermal growth factor receptor signaling pathway; GO:0007173; gastrulation; GO:0007369; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemopoiesis; GO:0030097; intracellular signaling cascade; GO:0007242; lamellocyte differentiation; GO:0035171; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0005515 phl pole hole "CG2845, CG2845, CG2845, C110, l(1)ph: pole-hole, l(1)phl, Draf-1, l(1)pole hole, l(1)raf, raf, D-Raf, D-raf, l(1)polehole, 11-29, ph: polyhomeotic, Raf, Draf, raf1: raf-like-oncogene-1, D-raf1, rafl, RAF, DRaf, Raf1, Draf1, l(1)2Fe, l(1)G0475, D-RAF, EG:BACH48C10.3, raf-1, draf, l(1)polehole/draf, Pole hole, pole-hole, raf-like-oncogene-1, l(1)ph, raf1, ph" CDMC26887 1 22 13 DAC21-M07 3-CG2845-RA_2 CG2845 CGCGCCACTGCAATATCCTCCTCTTCATGGGCTGTGTATCCAAACCATCTCTAGCGATTGTGACCCAGT 69 FBan0002845 FBgn0003079 phl X X "MAPKKK cascade; GO:0000165; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; epidermal growth factor receptor signaling pathway; GO:0007173; gastrulation; GO:0007369; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemopoiesis; GO:0030097; intracellular signaling cascade; GO:0007242; lamellocyte differentiation; GO:0035171; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0005515 phl pole hole "CG2845, CG2845, CG2845, C110, l(1)ph: pole-hole, l(1)phl, Draf-1, l(1)pole hole, l(1)raf, raf, D-Raf, D-raf, l(1)polehole, 11-29, ph: polyhomeotic, Raf, Draf, raf1: raf-like-oncogene-1, D-raf1, rafl, RAF, DRaf, Raf1, Draf1, l(1)2Fe, l(1)G0475, D-RAF, EG:BACH48C10.3, raf-1, draf, l(1)polehole/draf, Pole hole, pole-hole, raf-like-oncogene-1, l(1)ph, raf1, ph" CDMC26888 1 23 13 DAC21-M19 9-CG2863-RA_1 CG2863 AGCCACTCCATATTTGTTTTTCGTGGGCGAGGATGAGATCAAGAAGAGCCTGGAGGACACGTTGGACTT 69 FBan0002863 FBgn0021874 Nle 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; Notch signaling pathway; GO:0007219 Notch binding; GO:0005112; ; GO:0005112 heterotrimeric G-protein complex; GO:0005834 Nle Notchless "CG2863, l(2)k13714, notchless, anon-WO0026364, Notchless" CDMC26888 1 24 13 DAC21-M19 9-CG2863-RA_1 CG2863 AGCCACTCCATATTTGTTTTTCGTGGGCGAGGATGAGATCAAGAAGAGCCTGGAGGACACGTTGGACTT 69 FBan0002863 FBgn0021874 Nle 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; Notch signaling pathway; GO:0007219 Notch binding; GO:0005112; ; GO:0005112 heterotrimeric G-protein complex; GO:0005834 Nle Notchless "CG2863, l(2)k13714, notchless, anon-WO0026364, Notchless" CDMC26889 1 25 13 DAC22-A07 33-CG14507-RB_1 CG14507 ACGGTCAGAGCAACTGCATCTCCTATCTGGAATACTTTGTGCCCTACGTGTGGAAGTGCTACCGC 65 FBan0014507 FBgn0039655 CG14507 3 3R lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 CG14507 CG14507 CDMC26889 1 26 13 DAC22-A07 33-CG14507-RB_1 CG14507 ACGGTCAGAGCAACTGCATCTCCTATCTGGAATACTTTGTGCCCTACGTGTGGAAGTGCTACCGC 65 FBan0014507 FBgn0039655 CG14507 3 3R lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 CG14507 CG14507 CDMC26890 1 1 14 DAC22-A19 18-CG14537-RA_1 CG14537 TCCCATTGCCTTGGGACATGCCTTCTTCGTGCTTCCACTGTTTTGCGATTTGGGTTGCAGCCTGG 65 FBan0014537 FBgn0031954 CG14537 2 2L CG14537 CG14537 BcDNA:AT11469 CDMC26890 1 2 14 DAC22-A19 18-CG14537-RA_1 CG14537 TCCCATTGCCTTGGGACATGCCTTCTTCGTGCTTCCACTGTTTTGCGATTTGGGTTGCAGCCTGG 65 FBan0014537 FBgn0031954 CG14537 2 2L CG14537 CG14537 BcDNA:AT11469 CDMC26891 1 3 14 DAC22-E07 3-CG14627-RA_1 CG14627 CATCACAAACGGATCCGGCATTCAAGCCCTCGTACAAGATGCCCGAGATGGAGACCAACTTCACG 65 FBan0014627 FBgn0040361 CG14627 X X CG14627 CG14627 EG:BACR42I17.5 CDMC26891 1 4 14 DAC22-E07 3-CG14627-RA_1 CG14627 CATCACAAACGGATCCGGCATTCAAGCCCTCGTACAAGATGCCCGAGATGGAGACCAACTTCACG 65 FBan0014627 FBgn0040361 CG14627 X X CG14627 CG14627 EG:BACR42I17.5 CDMC26892 1 5 14 DAC22-E19 2-CG14640-RA_1 CG14640 ATTACAAGGAACGTCACATCACCGTCGGCGTGCCCAAGCGCAACTACAACGTGGTGTTCATCAAG 65 FBan0014640 FBgn0037227 CG14640 3 3R CG14640 CG14640 CDMC26892 1 6 14 DAC22-E19 2-CG14640-RA_1 CG14640 ATTACAAGGAACGTCACATCACCGTCGGCGTGCCCAAGCGCAACTACAACGTGGTGTTCATCAAG 65 FBan0014640 FBgn0037227 CG14640 3 3R CG14640 CG14640 CDMC26893 1 7 14 DAC22-I07 16-CG14752-RA_1 CG14752 GAAAGTATTCATCTTCGTCGCCCTCTTCGCCGTGGCCTACTGCGCACCCAGTCCCGGCTTCTTTG 65 FBan0014752 FBgn0033307 CG14752 2 2R CG14752 CG14752 CDMC26893 1 8 14 DAC22-I07 16-CG14752-RA_1 CG14752 GAAAGTATTCATCTTCGTCGCCCTCTTCGCCGTGGCCTACTGCGCACCCAGTCCCGGCTTCTTTG 65 FBan0014752 FBgn0033307 CG14752 2 2R CG14752 CG14752 CDMC26894 1 9 14 DAC22-I19 23-CG14777-RB_1 CG14777 CGTATTTGTTACCTTTTGTGACTCCCAATTGTTAGGCCAATTGTTGAATTAGATAGCGGTAGCGT 65 FBan0014777 FBgn0026872 CG14777 X X development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG14777 CG14777 "EG:80H7.10, BcDNA:RH63812" CDMC26894 1 10 14 DAC22-I19 23-CG14777-RB_1 CG14777 CGTATTTGTTACCTTTTGTGACTCCCAATTGTTAGGCCAATTGTTGAATTAGATAGCGGTAGCGT 65 FBan0014777 FBgn0026872 CG14777 X X development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG14777 CG14777 "EG:80H7.10, BcDNA:RH63812" CDMC26895 1 11 14 DAC22-M07 6-CG14842-RA_1 CG14842 TGGCAATGGCAATGGACCCATGGATTCTGGAAAATTTAGCCTGTCCGATGTGGAGCAACCAGCAG 65 FBan0014842 FBgn0038229 CG14842 3 3R CG14842 CG14842 CDMC26895 1 12 14 DAC22-M07 6-CG14842-RA_1 CG14842 TGGCAATGGCAATGGACCCATGGATTCTGGAAAATTTAGCCTGTCCGATGTGGAGCAACCAGCAG 65 FBan0014842 FBgn0038229 CG14842 3 3R CG14842 CG14842 CDMC26896 1 13 14 DAC22-M19 2-CG14870-RA_4 CG14870 AAAAAGAAGTCCCGGAGTGCCAAAGAAAGTGTTCCCAATGCAATGGACGCGAAAGCCACTGCCAG 65 FBan0014870 FBgn0038342 CG14870 3 3R CG14870 CG14870 CDMC26896 1 14 14 DAC22-M19 2-CG14870-RA_4 CG14870 AAAAAGAAGTCCCGGAGTGCCAAAGAAAGTGTTCCCAATGCAATGGACGCGAAAGCCACTGCCAG 65 FBan0014870 FBgn0038342 CG14870 3 3R CG14870 CG14870 CDMC26897 1 15 14 DAC23-A07 22-CG6735-RA_1 CG6735 AGTGAAGCCATATCGAAGACACTCTGCAAGCATGAAAGCATCAAGGATGTTGGACAAGCGATCCATTTT 69 FBan0033957 FBgn0036472 cp309 3 3L cytoskeleton organization and biogenesis; GO:0007010; microtubule nucleation; GO:0007020 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 centrosome; GO:0005813 cp309 cp309 "CG6735, CG18648, CG13459, CG33957, CG6735, CG6735, CG18648, CG13459, AKAP450, CP309, d-plp" CDMC26897 1 16 14 DAC23-A07 22-CG6735-RA_1 CG6735 AGTGAAGCCATATCGAAGACACTCTGCAAGCATGAAAGCATCAAGGATGTTGGACAAGCGATCCATTTT 69 FBan0033957 FBgn0036472 cp309 3 3L cytoskeleton organization and biogenesis; GO:0007010; microtubule nucleation; GO:0007020 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 centrosome; GO:0005813 cp309 cp309 "CG6735, CG18648, CG13459, CG33957, CG6735, CG6735, CG18648, CG13459, AKAP450, CP309, d-plp" CDMC26898 1 17 14 DAC23-A19 2-CG6749-RA_1 CG6749 TGGAGAGCCTGAGTAGCGTACAGGAGATCCTAGTGGACAACAATCGCCTTACCTTTCTGGCCAAGGTGA 69 FBan0006749 FBgn0036040 CG6749 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 CG6749 CG6749 CDMC26898 1 18 14 DAC23-A19 2-CG6749-RA_1 CG6749 TGGAGAGCCTGAGTAGCGTACAGGAGATCCTAGTGGACAACAATCGCCTTACCTTTCTGGCCAAGGTGA 69 FBan0006749 FBgn0036040 CG6749 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 CG6749 CG6749 CDMC26899 1 19 14 DAC23-E07 5-CG6781-RA_1 CG6781 TCTGGACGAGCAGTATCCATTGCGACCACTCTATCCACGTGATCCGCTGAAGAAAGTGCAGGACAAGTT 69 FBan0006781 FBgn0035905 CG6781 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6781 CG6781 CDMC26899 1 20 14 DAC23-E07 5-CG6781-RA_1 CG6781 TCTGGACGAGCAGTATCCATTGCGACCACTCTATCCACGTGATCCGCTGAAGAAAGTGCAGGACAAGTT 69 FBan0006781 FBgn0035905 CG6781 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6781 CG6781 CDMC26900 1 21 14 DAC23-E19 17-CG6794-RA_2 CG6794 GCCCAAAAAACAGTTGAAAGCCTAAAGCGCAGTCTCATGAGCACCAATTTACATCCATCCAAGCAGGTT 69 FBan0006794 FBgn0011274 Dif 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response; GO:0006952; immune response; GO:0006955; innate immune response; GO:0045087; lamellocyte differentiation; GO:0035171; plasmatocyte differentiation; GO:0042387; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620; response to pest, pathogen or parasite; GO:0009613" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 Dif Dorsal-related immunity factor "CG6794, CG6794, CG6794, dif, DIF" CDMC26900 1 22 14 DAC23-E19 17-CG6794-RA_2 CG6794 GCCCAAAAAACAGTTGAAAGCCTAAAGCGCAGTCTCATGAGCACCAATTTACATCCATCCAAGCAGGTT 69 FBan0006794 FBgn0011274 Dif 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response; GO:0006952; immune response; GO:0006955; innate immune response; GO:0045087; lamellocyte differentiation; GO:0035171; plasmatocyte differentiation; GO:0042387; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620; response to pest, pathogen or parasite; GO:0009613" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 Dif Dorsal-related immunity factor "CG6794, CG6794, CG6794, dif, DIF" CDMC26901 1 23 14 DAC23-I07 2-CG6830-RA_2 CG6830 CGTGCTGCCATTGGTTCTCTTGGACCCCACTCAGTCGGCCACATTCGATAATTTTATGTCGGACTCTGC 69 FBan0006830 FBgn0037934 CG6830 3 3R CG6830 CG6830 CDMC26901 1 24 14 DAC23-I07 2-CG6830-RA_2 CG6830 CGTGCTGCCATTGGTTCTCTTGGACCCCACTCAGTCGGCCACATTCGATAATTTTATGTCGGACTCTGC 69 FBan0006830 FBgn0037934 CG6830 3 3R CG6830 CG6830 CDMC26902 1 25 14 DAC23-I19 15-CG6843-RA_2 CG6843 GGCGAGAAGGACGCTCATGCCGATGACCAAAATCCCGAACTAGTTTTTCTCAAATCCCTGTCCAAGAAA 69 FBan0006843 FBgn0036827 CG6843 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG6843 CG6843 CDMC26902 1 26 14 DAC23-I19 15-CG6843-RA_2 CG6843 GGCGAGAAGGACGCTCATGCCGATGACCAAAATCCCGAACTAGTTTTTCTCAAATCCCTGTCCAAGAAA 69 FBan0006843 FBgn0036827 CG6843 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG6843 CG6843 CDMC26903 1 1 15 DAC23-M07 23-CG6877-RA_1 CG6877 GGGAGTGCATTTATACTTGATCATATTCCTCAAATTCGTTCAGACCGTCATACCAACCATCGAATACGA 69 FBan0006877 FBgn0036813 Aut1 3 3L autophagy; GO:0006914; macroautophagy; GO:0016236 Aut1 Aut1 "CG6877, CG6877, CG6877, Draut1, Atg3, Autophagy-specific gene 3" CDMC26903 1 2 15 DAC23-M07 23-CG6877-RA_1 CG6877 GGGAGTGCATTTATACTTGATCATATTCCTCAAATTCGTTCAGACCGTCATACCAACCATCGAATACGA 69 FBan0006877 FBgn0036813 Aut1 3 3L autophagy; GO:0006914; macroautophagy; GO:0016236 Aut1 Aut1 "CG6877, CG6877, CG6877, Draut1, Atg3, Autophagy-specific gene 3" CDMC26904 1 3 15 DAC23-M19 23-CG6889-RA_7 CG6889 AAGGCAAAACAGCGAACTCCTAGCCAAGTAAGTTTGAAACGGAAGCAAAACAAAATTCTATATTAGCGT 69 FBan0006889 FBgn0040071 tara 3 3R chromatin-mediated maintenance of transcription; GO:0048096 tara taranis "CG6889, CG6889, CG6889, l(3)03881, 5472, EP(3)3463, l(3)jlC5, anon-WO0257455.25, l(3)j1C5, taranis" CDMC26904 1 4 15 DAC23-M19 23-CG6889-RA_7 CG6889 AAGGCAAAACAGCGAACTCCTAGCCAAGTAAGTTTGAAACGGAAGCAAAACAAAATTCTATATTAGCGT 69 FBan0006889 FBgn0040071 tara 3 3R chromatin-mediated maintenance of transcription; GO:0048096 tara taranis "CG6889, CG6889, CG6889, l(3)03881, 5472, EP(3)3463, l(3)jlC5, anon-WO0257455.25, l(3)j1C5, taranis" CDMC26905 1 5 15 DAC24-A07 16-CG2155-RA_1 CG2155 ACGAGCTTTGGTTCAAGCAGATCATCTTTGAGTTCGACTCCATACGAGACATGTTGGATGCAGAGGTCA 69 FBan0002155 FBgn0003965 v X X eye pigmentation (sensu Endopterygota); GO:0048072; ommochrome biosynthesis; GO:0006727; tryptophan catabolism; GO:0006569 "tryptophan 2,3-dioxygenase activity; GO:0004833 ; EC:1.13.11.11; ; GO:0004833 ; EC:1.13.11.11; ; GO:0004833 ; EC:1.13.11.11" v vermilion "CG2155, Ver, NP_511113, vermilion" CDMC26905 1 6 15 DAC24-A07 16-CG2155-RA_1 CG2155 ACGAGCTTTGGTTCAAGCAGATCATCTTTGAGTTCGACTCCATACGAGACATGTTGGATGCAGAGGTCA 69 FBan0002155 FBgn0003965 v X X eye pigmentation (sensu Endopterygota); GO:0048072; ommochrome biosynthesis; GO:0006727; tryptophan catabolism; GO:0006569 "tryptophan 2,3-dioxygenase activity; GO:0004833 ; EC:1.13.11.11; ; GO:0004833 ; EC:1.13.11.11; ; GO:0004833 ; EC:1.13.11.11" v vermilion "CG2155, Ver, NP_511113, vermilion" CDMC26906 1 7 15 DAC24-A19 10-CG2165-RA_1 CG2165 CCAATGGCATGTGACGGTTTGCGGACTATATCTGTAGCATATCGCGATTTTGTGCCTGGTAAAGCCGCA 69 FBan0002165 FBgn0025704 CG2165 4 4 calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; cation transport; GO:0006812; metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 plasma membrane; GO:0005886 CG2165 CG2165 "CK02288, BEST:CK01140, BEST:CK02288" CDMC26906 1 8 15 DAC24-A19 10-CG2165-RA_1 CG2165 CCAATGGCATGTGACGGTTTGCGGACTATATCTGTAGCATATCGCGATTTTGTGCCTGGTAAAGCCGCA 69 FBan0002165 FBgn0025704 CG2165 4 4 calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; cation transport; GO:0006812; metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 plasma membrane; GO:0005886 CG2165 CG2165 "CK02288, BEST:CK01140, BEST:CK02288" CDMC26907 1 9 15 DAC24-E07 8-CG2201-RB_1 CG2201 AGGAGCCCGATTGGATTTGGAATTGTATGCAGCGTTGGGTTTCCGGTTTAGAGAGCATTGTTAACGGCA 69 FBan0002201 FBgn0032955 CG2201 2 2L phospholipid metabolism; GO:0006644; phosphorylation; GO:0016310 ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; choline kinase activity; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32 CG2201 CG2201 CDMC26907 1 10 15 DAC24-E07 8-CG2201-RB_1 CG2201 AGGAGCCCGATTGGATTTGGAATTGTATGCAGCGTTGGGTTTCCGGTTTAGAGAGCATTGTTAACGGCA 69 FBan0002201 FBgn0032955 CG2201 2 2L phospholipid metabolism; GO:0006644; phosphorylation; GO:0016310 ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; choline kinase activity; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32 CG2201 CG2201 CDMC26908 1 11 15 DAC24-E19 10-CG2212-RA_1 CG2212 ACCCACAATCCTGCATCCCATCCCTCTCATTCACCTAACCAATCCACACACATTGTAATGGAAGGCACA 69 FBan0002212 FBgn0003656 sws X X brain development; GO:0007420; transmission of nerve impulse; GO:0019226 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; nutrient reservoir activity; GO:0045735; ; GO:0045735" sws swiss cheese "CG2212, olfE: olfactory E, olfactory E, olfE, swiss cheese" CDMC26908 1 12 15 DAC24-E19 10-CG2212-RA_1 CG2212 ACCCACAATCCTGCATCCCATCCCTCTCATTCACCTAACCAATCCACACACATTGTAATGGAAGGCACA 69 FBan0002212 FBgn0003656 sws X X brain development; GO:0007420; transmission of nerve impulse; GO:0019226 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; nutrient reservoir activity; GO:0045735; ; GO:0045735" sws swiss cheese "CG2212, olfE: olfactory E, olfactory E, olfE, swiss cheese" CDMC26909 1 13 15 DAC24-I07 1-CG2260-RA_1 CG2260 GCTCTGGAGAGCCCAACTTCGATGCTATGGAAGACAATCCGTATGAGACTTCGAAGCAACGACGCGAGC 69 FBan0002260 FBgn0030000 CG2260 X X CG2260 CG2260 CDMC26909 1 14 15 DAC24-I07 1-CG2260-RA_1 CG2260 GCTCTGGAGAGCCCAACTTCGATGCTATGGAAGACAATCCGTATGAGACTTCGAAGCAACGACGCGAGC 69 FBan0002260 FBgn0030000 CG2260 X X CG2260 CG2260 CDMC26910 1 15 15 DAC24-I19 3-CG2286-RA_2 CG2286 GCCTATGTGCACAACGAACTGCAGATTGCCTCGATTGGACCCAAGATCGATCTGTCCTACGACCACGAG 69 FBan0002286 FBgn0017566 ND75 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; electron carrier activity; GO:0009055; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0009055; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; iron ion binding; GO:0005506; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0005506 respiratory chain complex I (sensu Eukaryota); GO:0005747 ND75 NADH:ubiquinone reductase 75kD subunit precursor "CG2286, CG2286, CG2286, CG2286, CG2286, NADH:ubiquinone reductase 75 kDa subunit, NADH:ubiquinone reductase 75-kD subunit precursor" CDMC26910 1 16 15 DAC24-I19 3-CG2286-RA_2 CG2286 GCCTATGTGCACAACGAACTGCAGATTGCCTCGATTGGACCCAAGATCGATCTGTCCTACGACCACGAG 69 FBan0002286 FBgn0017566 ND75 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; electron carrier activity; GO:0009055; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0009055; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; iron ion binding; GO:0005506; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0005506 respiratory chain complex I (sensu Eukaryota); GO:0005747 ND75 NADH:ubiquinone reductase 75kD subunit precursor "CG2286, CG2286, CG2286, CG2286, CG2286, NADH:ubiquinone reductase 75 kDa subunit, NADH:ubiquinone reductase 75-kD subunit precursor" CDMC26911 1 17 15 DAC24-M07 14-CG2374-RA_1 CG2374 GCAGCGACGGATGGAGTTCTAGTTCTAGGCCTTCGGTAATCTCGAGCTATCCAACAGTACAAACTCGGA 69 FBan0002374 FBgn0016032 lbm 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; synaptogenesis; GO:0007416; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 extracellular region; GO:0005576; integral to membrane; GO:0016021 lbm late bloomer "CG2374, CG2374, CG2374, Late Bloomer, lbl, Lbm, Dm.Tsp42Em, latebloomer, tetraspanin 42E" CDMC26911 1 18 15 DAC24-M07 14-CG2374-RA_1 CG2374 GCAGCGACGGATGGAGTTCTAGTTCTAGGCCTTCGGTAATCTCGAGCTATCCAACAGTACAAACTCGGA 69 FBan0002374 FBgn0016032 lbm 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; synaptogenesis; GO:0007416; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 extracellular region; GO:0005576; integral to membrane; GO:0016021 lbm late bloomer "CG2374, CG2374, CG2374, Late Bloomer, lbl, Lbm, Dm.Tsp42Em, latebloomer, tetraspanin 42E" CDMC26912 1 19 15 DAC24-M19 15-CG2444-RA_1 CG2444 CCTCGCTCGATCCCAGAGTTTCCACCAGAGATTACCCAAAACGAAATCCAGTATCGAGCAGTATGTCGC 69 FBan0002444 FBgn0030326 CG2444 X X CG2444 CG2444 BcDNA:LP01642 CDMC26912 1 20 15 DAC24-M19 15-CG2444-RA_1 CG2444 CCTCGCTCGATCCCAGAGTTTCCACCAGAGATTACCCAAAACGAAATCCAGTATCGAGCAGTATGTCGC 69 FBan0002444 FBgn0030326 CG2444 X X CG2444 CG2444 BcDNA:LP01642 CDMC26913 1 21 15 DAC25-A07 2-CG10018-RA_2 CG10018 AGCACTGCAGTAAGATGCCTGAATTGGCCGGATCTAGACTCCGTGCTAACAGAAGATCGCAGCGG 65 FBan0010018 FBgn0037338 Snm1 3 3R DNA repair; GO:0006281 Snm1 Snm1 "CG10018, SNM1, mus322, mutagen-sensitive 322" CDMC26913 1 22 15 DAC25-A07 2-CG10018-RA_2 CG10018 AGCACTGCAGTAAGATGCCTGAATTGGCCGGATCTAGACTCCGTGCTAACAGAAGATCGCAGCGG 65 FBan0010018 FBgn0037338 Snm1 3 3R DNA repair; GO:0006281 Snm1 Snm1 "CG10018, SNM1, mus322, mutagen-sensitive 322" CDMC26914 1 23 15 DAC25-A19 2-CG10069-RB_1 CG10069 TGGTCGGCATCTTTGTGAACGGACCATATGCCCTGATTACAACCTCTGTAAGTGCAGAGCTGGGC 65 FBan0010069 FBgn0034611 CG10069 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; extracellular transport; GO:0006858 glycerol-3-phosphate transporter activity; GO:0015169; ; GO:0015169 integral to membrane; GO:0016021 CG10069 CG10069 CDMC26914 1 24 15 DAC25-A19 2-CG10069-RB_1 CG10069 TGGTCGGCATCTTTGTGAACGGACCATATGCCCTGATTACAACCTCTGTAAGTGCAGAGCTGGGC 65 FBan0010069 FBgn0034611 CG10069 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; extracellular transport; GO:0006858 glycerol-3-phosphate transporter activity; GO:0015169; ; GO:0015169 integral to membrane; GO:0016021 CG10069 CG10069 CDMC26915 1 25 15 DAC25-E07 3-CG10173-RA_1 CG10173 AAGTGGCTACGATCCTAACGATGTGATCACCACGATACCGGTGTCCTTGTCCATCCAGCGATCGC 65 FBan0010173 FBgn0035696 Best2 3 3L ion transport; GO:0006811; transport; GO:0006810 Best2 Bestrophin 2 "CG10173, CG10173, CG10173, dbest2, Bestrophin 2" CDMC26915 1 26 15 DAC25-E07 3-CG10173-RA_1 CG10173 AAGTGGCTACGATCCTAACGATGTGATCACCACGATACCGGTGTCCTTGTCCATCCAGCGATCGC 65 FBan0010173 FBgn0035696 Best2 3 3L ion transport; GO:0006811; transport; GO:0006810 Best2 Bestrophin 2 "CG10173, CG10173, CG10173, dbest2, Bestrophin 2" CDMC26916 1 1 16 DAC25-E19 2-CG10202-RA_2 CG10202 ATTCCCGTCGTGGAACAGAAAGAGGCCGATCCAGAGTTTCCCACCCTCGTTAAACCAAATCCGGA 65 FBan0010202 FBgn0033969 CG10202 2 2R monosaccharide metabolism; GO:0005996 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 CG10202 CG10202 anon-WO0140519.148 CDMC26916 1 2 16 DAC25-E19 2-CG10202-RA_2 CG10202 ATTCCCGTCGTGGAACAGAAAGAGGCCGATCCAGAGTTTCCCACCCTCGTTAAACCAAATCCGGA 65 FBan0010202 FBgn0033969 CG10202 2 2R monosaccharide metabolism; GO:0005996 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 CG10202 CG10202 anon-WO0140519.148 CDMC26917 1 3 16 DAC25-I07 9-CG10326-RA_1 CG10326 GTGGTGTTTGGCGTCATCAGCTGCCTGTACCTGGTGCTGTGGTACCTGGACTTGTCGCTGATTAC 65 FBan0010326 FBgn0038453 CG10326 3 3R integral to plasma membrane; GO:0005887 CG10326 CG10326 CDMC26917 1 4 16 DAC25-I07 9-CG10326-RA_1 CG10326 GTGGTGTTTGGCGTCATCAGCTGCCTGTACCTGGTGCTGTGGTACCTGGACTTGTCGCTGATTAC 65 FBan0010326 FBgn0038453 CG10326 3 3R integral to plasma membrane; GO:0005887 CG10326 CG10326 CDMC26918 1 5 16 DAC25-I19 2-CG10360-RA_4 CG10360 TTTGCGCCCTCAACGACTCCCAGTGCTGAGAATAAGAAACCAGAAGAGCAGGGTCAATCCAGTGG 65 FBan0010360 FBgn0003231 ref(2)P 2 2L proteolysis; GO:0006508; viral infectious cycle; GO:0019058 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 ref(2)P refractory to sigma P "CG10360, ref(2)p, ref, refractaire(2)Paris, refractaire, ref(2)Pn, ref(2)Po2, Ref2P, Ref(2)p, ref2p, Ref(2)P" CDMC26918 1 6 16 DAC25-I19 2-CG10360-RA_4 CG10360 TTTGCGCCCTCAACGACTCCCAGTGCTGAGAATAAGAAACCAGAAGAGCAGGGTCAATCCAGTGG 65 FBan0010360 FBgn0003231 ref(2)P 2 2L proteolysis; GO:0006508; viral infectious cycle; GO:0019058 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 ref(2)P refractory to sigma P "CG10360, ref(2)p, ref, refractaire(2)Paris, refractaire, ref(2)Pn, ref(2)Po2, Ref2P, Ref(2)p, ref2p, Ref(2)P" CDMC26919 1 7 16 DAC25-M07 3-CG10473-RA_2 CG10473 TAGCATTTTACAGCGCCTAACGTCACCTCACCCCAAAACGAAACCACAGCAACCAGAAATGCGCC 65 FBan0010473 FBgn0032745 CG10473 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 nucleus; GO:0005634 CG10473 CG10473 "CG10437, CG10437" CDMC26919 1 8 16 DAC25-M07 3-CG10473-RA_2 CG10473 TAGCATTTTACAGCGCCTAACGTCACCTCACCCCAAAACGAAACCACAGCAACCAGAAATGCGCC 65 FBan0010473 FBgn0032745 CG10473 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 nucleus; GO:0005634 CG10473 CG10473 "CG10437, CG10437" CDMC26920 1 9 16 DAC25-M19 9-CG10513-RA_2 CG10513 GCTGCTGTTCTGAACGAACGTCAACCCGGATTGCTGACCAAGTTCGATCACGGCATCTTCAATCG 65 FBan0010513 FBgn0039311 CG10513 3 3R CG10513 CG10513 CT29500 CDMC26920 1 10 16 DAC25-M19 9-CG10513-RA_2 CG10513 GCTGCTGTTCTGAACGAACGTCAACCCGGATTGCTGACCAAGTTCGATCACGGCATCTTCAATCG 65 FBan0010513 FBgn0039311 CG10513 3 3R CG10513 CG10513 CT29500 CDMC26921 1 11 16 DAC26-A07 2-CG6172-RA_3 CG6172 AGCGACGAGTCCTGTTCACCAAGGCGCAAACATATGAGCTGGAACGTCGGTTTCGACAACAACGTTACT 69 FBan0006172 FBgn0003986 vnd X X "brain development; GO:0007420; cell homeostasis; GO:0019725; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleus; GO:0005634 vnd ventral nervous system defective "CG6172, CG6172, EC6, NK2, nk-2, NK-2, ventral nervous system condensation defective, vnd/NK-2, l(1)1Bf, dNK-2, Vnd, VND, EG:118B3.1, ventral nerve cord defective, l(1)EA142, l(1)EC6, l(1)GA100, l(1)GA122, l(1)RC24, l(1)VA208, l(1)VE769" CDMC26921 1 12 16 DAC26-A07 2-CG6172-RA_3 CG6172 AGCGACGAGTCCTGTTCACCAAGGCGCAAACATATGAGCTGGAACGTCGGTTTCGACAACAACGTTACT 69 FBan0006172 FBgn0003986 vnd X X "brain development; GO:0007420; cell homeostasis; GO:0019725; central nervous system development; GO:0007417; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleus; GO:0005634 vnd ventral nervous system defective "CG6172, CG6172, EC6, NK2, nk-2, NK-2, ventral nervous system condensation defective, vnd/NK-2, l(1)1Bf, dNK-2, Vnd, VND, EG:118B3.1, ventral nerve cord defective, l(1)EA142, l(1)EC6, l(1)GA100, l(1)GA122, l(1)RC24, l(1)VA208, l(1)VE769" CDMC26922 1 13 16 DAC26-A19 23-CG6179-RA_2 CG6179 CTATTGAGTTGGCAGATTTCAGCGGATTTCCATTGCGTCTCAGCTTATTTAGTGATCAAGATACGGTCA 69 FBan0006179 FBgn0030915 CG6179 X X CG6179 CG6179 CDMC26922 1 14 16 DAC26-A19 23-CG6179-RA_2 CG6179 CTATTGAGTTGGCAGATTTCAGCGGATTTCCATTGCGTCTCAGCTTATTTAGTGATCAAGATACGGTCA 69 FBan0006179 FBgn0030915 CG6179 X X CG6179 CG6179 CDMC26923 1 15 16 DAC26-E07 2-CG6208-RA_1 CG6208 TGGCAGTCGTCTTGATTGGGGACTCCACTCATCAGGCATCGGAATTTGCATCGAAGGTTTCCCGGATAT 69 FBan0006208 FBgn0037789 CG6208 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 CG6208 CG6208 CDMC26923 1 16 16 DAC26-E07 2-CG6208-RA_1 CG6208 TGGCAGTCGTCTTGATTGGGGACTCCACTCATCAGGCATCGGAATTTGCATCGAAGGTTTCCCGGATAT 69 FBan0006208 FBgn0037789 CG6208 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 CG6208 CG6208 CDMC26924 1 17 16 DAC26-E19 12-CG6218-RA_1 CG6218 GCGGACTTCGATCTTCCGAGAAACTATGCCGACAACGTCACAGTACTGTACACGTACACCGATCCTCGA 69 FBan0006218 FBgn0038321 CG6218 3 3R carbohydrate metabolism; GO:0005975; monosaccharide metabolism; GO:0005996 kinase activity; GO:0016301; carbohydrate kinase activity; GO:0019200; ; GO:0016301; ; GO:0019200 CG6218 CG6218 CDMC26924 1 18 16 DAC26-E19 12-CG6218-RA_1 CG6218 GCGGACTTCGATCTTCCGAGAAACTATGCCGACAACGTCACAGTACTGTACACGTACACCGATCCTCGA 69 FBan0006218 FBgn0038321 CG6218 3 3R carbohydrate metabolism; GO:0005975; monosaccharide metabolism; GO:0005996 kinase activity; GO:0016301; carbohydrate kinase activity; GO:0019200; ; GO:0016301; ; GO:0019200 CG6218 CG6218 CDMC26925 1 19 16 DAC26-I07 3-CG6254-RA_2 CG6254 CCACCTCGGGAACACTGAAGCGACACATAGAAGGCATCCACAACCAAATAAAGCCCTATGTGTGCGACC 69 FBan0006254 FBgn0037794 CG6254 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6254 CG6254 CDMC26925 1 20 16 DAC26-I07 3-CG6254-RA_2 CG6254 CCACCTCGGGAACACTGAAGCGACACATAGAAGGCATCCACAACCAAATAAAGCCCTATGTGTGCGACC 69 FBan0006254 FBgn0037794 CG6254 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6254 CG6254 CDMC26926 1 21 16 DAC26-I19 2-CG6276-RA_1 CG6276 ACAGCAGCTGGACAACTATCTGGACTACTTTGACGAGGCGGAACACAACAACTCCGAGCTGGATGACAT 69 FBan0006276 FBgn0038316 CG6276 3 3R CG6276 CG6276 CDMC26926 1 22 16 DAC26-I19 2-CG6276-RA_1 CG6276 ACAGCAGCTGGACAACTATCTGGACTACTTTGACGAGGCGGAACACAACAACTCCGAGCTGGATGACAT 69 FBan0006276 FBgn0038316 CG6276 3 3R CG6276 CG6276 CDMC26927 1 23 16 DAC26-M07 15-CG6320-RA_5 CG6320 CGCCGAGAAGCTAGCCCAATGTCCACCGGATATGTTCGATGTAATCCTAGACGAGAATCAGCTGGAAGA 69 FBan0006320 FBgn0015608 Ca-beta 2 2L calcium ion transport; GO:0006816 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891 Ca-beta Ca[2+]-channel-protein-beta-subunit "CG6320, CG6320, CG6320, Calcium channel beta, DmCa1beta, dmcab1, calcium channel beta subunit, Ca[2+]-channel-protein-beta-subunit" CDMC26927 1 24 16 DAC26-M07 15-CG6320-RA_5 CG6320 CGCCGAGAAGCTAGCCCAATGTCCACCGGATATGTTCGATGTAATCCTAGACGAGAATCAGCTGGAAGA 69 FBan0006320 FBgn0015608 Ca-beta 2 2L calcium ion transport; GO:0006816 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891 Ca-beta Ca[2+]-channel-protein-beta-subunit "CG6320, CG6320, CG6320, Calcium channel beta, DmCa1beta, dmcab1, calcium channel beta subunit, Ca[2+]-channel-protein-beta-subunit" CDMC26928 1 25 16 DAC26-M19 6-CG6331-RA_1 CG6331 CGACGGAAAACCCTGCTCATCTTCTTCGATTGGTTTGTGAACAGTGGCGTTTACTACGGCCTGTCGTGG 69 FBan0006331 FBgn0019952 Orct 3 3R apoptosis; GO:0006915; cation transport; GO:0006812; extracellular transport; GO:0006858; organic cation transport; GO:0015695 cation transporter activity; GO:0008324; ; GO:0008324; organic cation transporter activity; GO:0015101; ; GO:0015101 integral to membrane; GO:0016021 Orct Organic cation transporter CG6331 CDMC26928 1 26 16 DAC26-M19 6-CG6331-RA_1 CG6331 CGACGGAAAACCCTGCTCATCTTCTTCGATTGGTTTGTGAACAGTGGCGTTTACTACGGCCTGTCGTGG 69 FBan0006331 FBgn0019952 Orct 3 3R apoptosis; GO:0006915; cation transport; GO:0006812; extracellular transport; GO:0006858; organic cation transport; GO:0015695 cation transporter activity; GO:0008324; ; GO:0008324; organic cation transporter activity; GO:0015101; ; GO:0015101 integral to membrane; GO:0016021 Orct Organic cation transporter CG6331 CDMC26929 1 1 17 DAC27-A07 8-CG3683-RA_1 CG3683 TGCCGCAAGACCCAGGGAGTGTTCGACAAGTGTATCAAAGATAACTTCGACTGGGATCGTCCCTCCTAT 69 FBan0003683 FBgn0035046 CG3683 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3683 CG3683 CDMC26929 1 2 17 DAC27-A07 8-CG3683-RA_1 CG3683 TGCCGCAAGACCCAGGGAGTGTTCGACAAGTGTATCAAAGATAACTTCGACTGGGATCGTCCCTCCTAT 69 FBan0003683 FBgn0035046 CG3683 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3683 CG3683 CDMC26930 1 3 17 DAC27-A19 16-CG3696-RA_1 CG3696 TTAGGAGCCAATTTGGAGAAAACGGATTTGGGTTTGTCTCAACGCCATAAAGTTCGACACTGCTGCAAC 69 FBan0003696 FBgn0001309 kis 2 2L blastoderm segmentation; GO:0007350; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003682; ATP-dependent helicase activity; GO:0008026; ; GO:0008026; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 kis kismet "CG3660, CG3696, CG18326, CG3660, l(2)k13631, l(2)k14112, 136/31, 2532, 5841, GM02209, EK2-4, KIS, kiss, anon-WO0172774.164, anon-WO0257455.5, BEST:GM02209, Su(Pc)21AB, l(2)07812, l(2)k08827, l(2)s3527, l(2)s4771, l(2)s4793, l(2)k11324, lethal (2) k11324, kismet" CDMC26930 1 4 17 DAC27-A19 16-CG3696-RA_1 CG3696 TTAGGAGCCAATTTGGAGAAAACGGATTTGGGTTTGTCTCAACGCCATAAAGTTCGACACTGCTGCAAC 69 FBan0003696 FBgn0001309 kis 2 2L blastoderm segmentation; GO:0007350; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003682; ATP-dependent helicase activity; GO:0008026; ; GO:0008026; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 kis kismet "CG3660, CG3696, CG18326, CG3660, l(2)k13631, l(2)k14112, 136/31, 2532, 5841, GM02209, EK2-4, KIS, kiss, anon-WO0172774.164, anon-WO0257455.5, BEST:GM02209, Su(Pc)21AB, l(2)07812, l(2)k08827, l(2)s3527, l(2)s4771, l(2)s4793, l(2)k11324, lethal (2) k11324, kismet" CDMC26931 1 5 17 DAC27-E07 15-CG3735-RA_5 CG3735 CGGAGACATCCGGAACGTTCTGACTCCAATACATCAGGTTTTCCGCCTAATCAATTGCTCCAGTGTGGA 69 FBan0003735 FBgn0034933 CG3735 2 2R CG3735 CG3735 CDMC26931 1 6 17 DAC27-E07 15-CG3735-RA_5 CG3735 CGGAGACATCCGGAACGTTCTGACTCCAATACATCAGGTTTTCCGCCTAATCAATTGCTCCAGTGTGGA 69 FBan0003735 FBgn0034933 CG3735 2 2R CG3735 CG3735 CDMC26932 1 7 17 DAC27-E19 23-CG3747-RA_3 CG3747 GCAGCGAGAACAGCAATAAGATTTAAGATGAAAACAACGTAACATTTATCGCCTAAATTAGGGATACTT 69 FBan0003747 FBgn0026439 Eaat1 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; dicarboxylic acid transport; GO:0006835 cation transporter activity; GO:0008324; L-glutamate transporter activity; GO:0005313; ; GO:0008324; sodium:dicarboxylate symporter activity; GO:0017153; glutamate:sodium symporter activity; GO:0015501; ; GO:0015501; ; GO:0005313; ; GO:0015501; ; GO:0017153 plasma membrane; GO:0005886 Eaat1 Excitatory amino acid transporter 1 "CG3747, dEAAT1, AF001784, sodium-dependent excitatory amino acid transporter 1, glutamate transporter, Dglt-1, sodium-dependent glutamate transporter, Drosophila glutamate transporter-1, EAAT, Dglut-1, sodium-excitatory-glutamate-cotransporter, Excitatory amino acid transporter 1" CDMC26932 1 8 17 DAC27-E19 23-CG3747-RA_3 CG3747 GCAGCGAGAACAGCAATAAGATTTAAGATGAAAACAACGTAACATTTATCGCCTAAATTAGGGATACTT 69 FBan0003747 FBgn0026439 Eaat1 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; dicarboxylic acid transport; GO:0006835 cation transporter activity; GO:0008324; L-glutamate transporter activity; GO:0005313; ; GO:0008324; sodium:dicarboxylate symporter activity; GO:0017153; glutamate:sodium symporter activity; GO:0015501; ; GO:0015501; ; GO:0005313; ; GO:0015501; ; GO:0017153 plasma membrane; GO:0005886 Eaat1 Excitatory amino acid transporter 1 "CG3747, dEAAT1, AF001784, sodium-dependent excitatory amino acid transporter 1, glutamate transporter, Dglt-1, sodium-dependent glutamate transporter, Drosophila glutamate transporter-1, EAAT, Dglut-1, sodium-excitatory-glutamate-cotransporter, Excitatory amino acid transporter 1" CDMC26933 1 9 17 DAC27-I07 2-CG3782-RA_1 CG3782 TGGAGAAGCCGGATGCATTAGCAGCAGAATCGTCGGTCGAACACAAGGATTCGGATATCGAAGCGCTTA 69 FBan0003782 FBgn0031660 mRpL28 2 2L RNA processing; GO:0006396; protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735; ; GO:0003735; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- mitochondrial large ribosomal subunit; GO:0005762 mRpL28 mitochondrial ribosomal protein L28 "CG3782, CG3782, CG3782, ecdysteroid regulated 16kd protein, MRP-L28, mitochondrial ribosomal protein L28" CDMC26933 1 10 17 DAC27-I07 2-CG3782-RA_1 CG3782 TGGAGAAGCCGGATGCATTAGCAGCAGAATCGTCGGTCGAACACAAGGATTCGGATATCGAAGCGCTTA 69 FBan0003782 FBgn0031660 mRpL28 2 2L RNA processing; GO:0006396; protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735; ; GO:0003735; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- mitochondrial large ribosomal subunit; GO:0005762 mRpL28 mitochondrial ribosomal protein L28 "CG3782, CG3782, CG3782, ecdysteroid regulated 16kd protein, MRP-L28, mitochondrial ribosomal protein L28" CDMC26934 1 11 17 DAC27-I19 3-CG3799-RA_3 CG3799 GGCAAGCGCCTGACGAAGATCAGCATATACGCCTTCCTCTTTTCGGATCTTCTGTTGCTGTGCAAACGT 69 FBan0003799 FBgn0027593 CG3799 3 3L CG3799 CG3799 BcDNA:GH03693 CDMC26934 1 12 17 DAC27-I19 3-CG3799-RA_3 CG3799 GGCAAGCGCCTGACGAAGATCAGCATATACGCCTTCCTCTTTTCGGATCTTCTGTTGCTGTGCAAACGT 69 FBan0003799 FBgn0027593 CG3799 3 3L CG3799 CG3799 BcDNA:GH03693 CDMC26935 1 13 17 DAC27-M07 11-CG3839-RA_1 CG3839 TCGAGGACTACAGGACATGCTTGATGATGGCACTGCTTCATCAACTCGTCACATCTACAATTCCGCCGA 69 FBan0003839 FBgn0002561 l(1)sc X X central nervous system development; GO:0007417; myoblast cell fate determination; GO:0007518; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419 transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 l(1)sc lethal of scute "CG3839, CG3839, T3, l'sc, AS-C T3, ascT3, lsc, ASC-T3, AS-T3, L'sc, EG:198A6.2, Lethal of Scute, L'Sc, l(1)1Ba, l-sc, sc/T3" CDMC26935 1 14 17 DAC27-M07 11-CG3839-RA_1 CG3839 TCGAGGACTACAGGACATGCTTGATGATGGCACTGCTTCATCAACTCGTCACATCTACAATTCCGCCGA 69 FBan0003839 FBgn0002561 l(1)sc X X central nervous system development; GO:0007417; myoblast cell fate determination; GO:0007518; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419 transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 l(1)sc lethal of scute "CG3839, CG3839, T3, l'sc, AS-C T3, ascT3, lsc, ASC-T3, AS-T3, L'sc, EG:198A6.2, Lethal of Scute, L'Sc, l(1)1Ba, l-sc, sc/T3" CDMC26936 1 15 17 DAC27-M19 24-CG3849-RA_1 CG3849 CCAACAGCCCAAAATTTAAATTTTTAGTGCATTAACTTATACTGCATCCACTACATACATAGATATATA 69 FBgn0036653 CDMC26936 1 16 17 DAC27-M19 24-CG3849-RA_1 CG3849 CCAACAGCCCAAAATTTAAATTTTTAGTGCATTAACTTATACTGCATCCACTACATACATAGATATATA 69 FBgn0036653 CDMC26937 1 17 17 DAC28-A07 2-CG10175-RB_2 CG10175 GGGTGACCCGCGAGATAAGATCCTTCTACTTGGGAAGCAAGCATGTGGGCATTGAATCAGTGGACGAGA 69 FBan0010175 FBgn0039084 CG10175 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG10175 CG10175 CDMC26937 1 18 17 DAC28-A07 2-CG10175-RB_2 CG10175 GGGTGACCCGCGAGATAAGATCCTTCTACTTGGGAAGCAAGCATGTGGGCATTGAATCAGTGGACGAGA 69 FBan0010175 FBgn0039084 CG10175 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG10175 CG10175 CDMC26938 1 19 17 DAC28-A19 3-CG10185-RA_5 CG10185 AGTGTGGAACCGTGTGTCCGAGCAGGTAGTTTTTAGGGACGACCAACCAGGAATTCAGCAAATCACCCT 69 FBan0010185 FBgn0038397 CG10185 3 3R CG10185 CG10185 CDMC26938 1 20 17 DAC28-A19 3-CG10185-RA_5 CG10185 AGTGTGGAACCGTGTGTCCGAGCAGGTAGTTTTTAGGGACGACCAACCAGGAATTCAGCAAATCACCCT 69 FBan0010185 FBgn0038397 CG10185 3 3R CG10185 CG10185 CDMC26939 1 21 17 DAC28-E07 23-CG10219-RA_1 CG10219 GGAGCAATCAGTTGATGAACCACGAAACACCAGTTATTTATTCATAGTTTCGCGATAAGCATTAAATAA 69 FBan0010219 FBgn0039112 CG10219 3 3R electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; heme binding; GO:0020037; ; GO:0008177 ; EC:1.3.5.1; ; GO:0020037; ; GO:0000104 ; EC:1.3.99.1 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; respiratory chain complex II (sensu Eukaryota); GO:0005749 CG10219 CG10219 BEST:GH27735 CDMC26939 1 22 17 DAC28-E07 23-CG10219-RA_1 CG10219 GGAGCAATCAGTTGATGAACCACGAAACACCAGTTATTTATTCATAGTTTCGCGATAAGCATTAAATAA 69 FBan0010219 FBgn0039112 CG10219 3 3R electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; heme binding; GO:0020037; ; GO:0008177 ; EC:1.3.5.1; ; GO:0020037; ; GO:0000104 ; EC:1.3.99.1 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; respiratory chain complex II (sensu Eukaryota); GO:0005749 CG10219 CG10219 BEST:GH27735 CDMC26940 1 23 17 DAC28-E19 23-CG10229-RA_9 CG10229 GCGAATGGCTAGCGATTGTAGGAGTATATTTTTGAATAGCCTTAAACACGCGCTTAAGTCATTAAGCTT 69 FBan0010229 FBgn0040208 katanin-60 3 3R intracellular protein transport; GO:0006886; microtubule severing; GO:0051013; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 katanin; GO:0008352 katanin-60 katanin 60 "CG10229, CG10229, CG10229, DmCG10229, katanin60-dm, katanin 60" CDMC26940 1 24 17 DAC28-E19 23-CG10229-RA_9 CG10229 GCGAATGGCTAGCGATTGTAGGAGTATATTTTTGAATAGCCTTAAACACGCGCTTAAGTCATTAAGCTT 69 FBan0010229 FBgn0040208 katanin-60 3 3R intracellular protein transport; GO:0006886; microtubule severing; GO:0051013; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 katanin; GO:0008352 katanin-60 katanin 60 "CG10229, CG10229, CG10229, DmCG10229, katanin60-dm, katanin 60" CDMC26941 1 25 17 DAC28-I07 7-CG10260-RB_1 CG10260 TGTCATCCGCAATTCGTACCAGAACTTCCGCACGCGTACCTACGACATGATCCAGTACTACCAGAACCA 69 FBan0010260 FBgn0040335 CG10260 X X intracellular signaling cascade; GO:0007242; phosphorylation; GO:0016310 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 CG10260 CG10260 "PI4K, EG:BACR7C10.2" CDMC26941 1 26 17 DAC28-I07 7-CG10260-RB_1 CG10260 TGTCATCCGCAATTCGTACCAGAACTTCCGCACGCGTACCTACGACATGATCCAGTACTACCAGAACCA 69 FBan0010260 FBgn0040335 CG10260 X X intracellular signaling cascade; GO:0007242; phosphorylation; GO:0016310 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 CG10260 CG10260 "PI4K, EG:BACR7C10.2" CDMC26942 1 1 18 DAC28-I19 6-CG10269-RA_1 CG10269 CCACTTCCAATGCAGCTGACACTGTCCGGAAAAGTTGTAGGCATGCCTCGAATTGCTCTCTAGCTGGAT 69 FBan0010269 FBgn0022935 D19A 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 D19A D19A "CG10269, Zinc finger AT-hook protein" CDMC26942 1 2 18 DAC28-I19 6-CG10269-RA_1 CG10269 CCACTTCCAATGCAGCTGACACTGTCCGGAAAAGTTGTAGGCATGCCTCGAATTGCTCTCTAGCTGGAT 69 FBan0010269 FBgn0022935 D19A 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 D19A D19A "CG10269, Zinc finger AT-hook protein" CDMC26943 1 3 18 DAC28-M07 23-CG10305-RB_2 CG10305 TATGCATCCAGTTCTTTTTTAATTTCAAATAAACAGCGTGCTTCATTGGGAAACAGCTACTACCTACAA 69 FBan0010305 FBgn0004413 RpS26 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS26 Ribosomal protein S26 "CG10305, l(2)04553, ribosomal protein S31., anon-EST:fe2A3, rpS26, rpS31, anon-fast-evolving-2A3" CDMC26943 1 4 18 DAC28-M07 23-CG10305-RB_2 CG10305 TATGCATCCAGTTCTTTTTTAATTTCAAATAAACAGCGTGCTTCATTGGGAAACAGCTACTACCTACAA 69 FBan0010305 FBgn0004413 RpS26 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS26 Ribosomal protein S26 "CG10305, l(2)04553, ribosomal protein S31., anon-EST:fe2A3, rpS26, rpS31, anon-fast-evolving-2A3" CDMC26944 1 5 18 DAC28-M19 4-CG10320-RA_1 CG10320 ACGCGTAGGGGTTTTCACTAAAGCTAAAGTAGTCCTCCGATCAGTTAATGCGCGGCTTGAGCTCGTCGT 69 FBan0010320 FBgn0034645 CG10320 2 2R "RNA import into nucleus; GO:0006404; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG10320 CG10320 "anon-EST:Posey47, anon-EST:Posey84" CDMC26944 1 6 18 DAC28-M19 4-CG10320-RA_1 CG10320 ACGCGTAGGGGTTTTCACTAAAGCTAAAGTAGTCCTCCGATCAGTTAATGCGCGGCTTGAGCTCGTCGT 69 FBan0010320 FBgn0034645 CG10320 2 2R "RNA import into nucleus; GO:0006404; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG10320 CG10320 "anon-EST:Posey47, anon-EST:Posey84" CDMC26945 1 7 18 DAC29-A07 16-CG13884-RA_1 CG13884 CCGACGGGATAATAACAAGCATCTCTAACACCCAACAGCCGTTAGGGAAATTCTAAGTTGGCAGACCGA 69 FBan0013884 FBgn0035138 CG13884 3 3L CG13884 CG13884 BcDNA:AT18596 CDMC26945 1 8 18 DAC29-A07 16-CG13884-RA_1 CG13884 CCGACGGGATAATAACAAGCATCTCTAACACCCAACAGCCGTTAGGGAAATTCTAAGTTGGCAGACCGA 69 FBan0013884 FBgn0035138 CG13884 3 3L CG13884 CG13884 BcDNA:AT18596 CDMC26946 1 9 18 DAC29-A19 1-CG13896-RA_1 CG13896 ACGAAGAGGCATTGAGACACCTAAGAGCGCTCCAGGAGTACGCCATGATCCATGATAATTTCAGGGCCA 69 FBan0013896 FBgn0035159 CG13896 3 3L CG13896 CG13896 CDMC26946 1 10 18 DAC29-A19 1-CG13896-RA_1 CG13896 ACGAAGAGGCATTGAGACACCTAAGAGCGCTCCAGGAGTACGCCATGATCCATGATAATTTCAGGGCCA 69 FBan0013896 FBgn0035159 CG13896 3 3L CG13896 CG13896 CDMC26947 1 11 18 DAC29-E07 8-CG13951-RA_1 CG13951 TGCCCTACGTCAAGGCCTTCAGCTTTGGACATCAAACGCAGAGGAGTTTCTACACAGGCAAAGATCAGA 69 FBan0013951 FBgn0016970 l(2)k10201 2 2R development; GO:0007275 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 l(2)k10201 lethal (2) k10201 "CG13951, CG8803, B" CDMC26947 1 12 18 DAC29-E07 8-CG13951-RA_1 CG13951 TGCCCTACGTCAAGGCCTTCAGCTTTGGACATCAAACGCAGAGGAGTTTCTACACAGGCAAAGATCAGA 69 FBan0013951 FBgn0016970 l(2)k10201 2 2R development; GO:0007275 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 l(2)k10201 lethal (2) k10201 "CG13951, CG8803, B" CDMC26948 1 13 18 DAC29-E19 1-CG13966-RA_1 CG13966 CCCGTTTCGATACACACGAGCAACTTGCGTCTGAACATGATGAACCAGGATCCCAAGGACCTCCACACA 69 FBan0013966 FBgn0032838 CG13966 2 2L CG13966 CG13966 CDMC26948 1 14 18 DAC29-E19 1-CG13966-RA_1 CG13966 CCCGTTTCGATACACACGAGCAACTTGCGTCTGAACATGATGAACCAGGATCCCAAGGACCTCCACACA 69 FBan0013966 FBgn0032838 CG13966 2 2L CG13966 CG13966 CDMC26949 1 15 18 DAC29-I07 1-CG14006-RA_4 CG14006 GGCCACGTATGAGCACTCCTGTTACGGCATCTACACATCCAAACCGTTCGTCCTCACGCTTGAAGTGAT 69 FBan0014006 FBgn0031733 CG14006 2 2L CG14006 CG14006 CDMC26949 1 16 18 DAC29-I07 1-CG14006-RA_4 CG14006 GGCCACGTATGAGCACTCCTGTTACGGCATCTACACATCCAAACCGTTCGTCCTCACGCTTGAAGTGAT 69 FBan0014006 FBgn0031733 CG14006 2 2L CG14006 CG14006 CDMC26950 1 17 18 DAC29-I19 23-CG14022-RA_2 CG14022 GGTCCGGTTTGTGTGGCCTTATAGTTTTGTGTGTTTGTTTTGTGCATTACTTGGCTAAGTTTGTAAATA 69 FBan0014022 FBgn0031700 CG14022 2 2L acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG14022 CG14022 BcDNA:RH62365 CDMC26950 1 18 18 DAC29-I19 23-CG14022-RA_2 CG14022 GGTCCGGTTTGTGTGGCCTTATAGTTTTGTGTGTTTGTTTTGTGCATTACTTGGCTAAGTTTGTAAATA 69 FBan0014022 FBgn0031700 CG14022 2 2L acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 CG14022 CG14022 BcDNA:RH62365 CDMC26951 1 19 18 DAC29-M07 7-CG14043-RA_1 CG14043 GGGACTGGAAATTCTCCTGGAGGCAGAAAAAATCTACGAGGACTTCAAAGCCAGTGGTCTGAAGCCCCT 69 FBan0014043 FBgn0031659 CG14043 2 2L CG14043 CG14043 CDMC26951 1 20 18 DAC29-M07 7-CG14043-RA_1 CG14043 GGGACTGGAAATTCTCCTGGAGGCAGAAAAAATCTACGAGGACTTCAAAGCCAGTGGTCTGAAGCCCCT 69 FBan0014043 FBgn0031659 CG14043 2 2L CG14043 CG14043 CDMC26952 1 21 18 DAC29-M19 14-CG14050-RA_2 CG14050 GCCACTCCGAGAATCTGATGCGGCATTTGAAACGTAAGCATGAGGATGCCTACAAAAGTGTTCTGGACG 69 FBan0014050 FBgn0040392 CG14050 X X CG14050 CG14050 "H48C10.1, EG:BACH48C10.1" CDMC26952 1 22 18 DAC29-M19 14-CG14050-RA_2 CG14050 GCCACTCCGAGAATCTGATGCGGCATTTGAAACGTAAGCATGAGGATGCCTACAAAAGTGTTCTGGACG 69 FBan0014050 FBgn0040392 CG14050 X X CG14050 CG14050 "H48C10.1, EG:BACH48C10.1" CDMC26953 1 23 18 DAC30-A07 23-CG15096-RA_2 CG15096 CCGAAACTACTAGTCAGCTAGTTCCGCTCTCCTTCAAATCCAAAACTATCAATCCTATTTGCAGCCAGG 69 FBan0015096 FBgn0034394 CG15096 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021; membrane; GO:0016020 CG15096 CG15096 CT42567 CDMC26953 1 24 18 DAC30-A07 23-CG15096-RA_2 CG15096 CCGAAACTACTAGTCAGCTAGTTCCGCTCTCCTTCAAATCCAAAACTATCAATCCTATTTGCAGCCAGG 69 FBan0015096 FBgn0034394 CG15096 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021; membrane; GO:0016020 CG15096 CG15096 CT42567 CDMC26954 1 25 18 DAC30-A19 2-CG15105-RB_2 CG15105 GTGGCCGATTCTGGCAATAACCGCATTCAGATCTTCAATCCGGATGGCAGTTTCCTGAAGACCTTCGGT 69 FBan0015105 FBgn0034412 CG15105 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transport; GO:0006810" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG15105 CG15105 CDMC26954 1 26 18 DAC30-A19 2-CG15105-RB_2 CG15105 GTGGCCGATTCTGGCAATAACCGCATTCAGATCTTCAATCCGGATGGCAGTTTCCTGAAGACCTTCGGT 69 FBan0015105 FBgn0034412 CG15105 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transport; GO:0006810" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG15105 CG15105 CDMC26955 1 1 19 DAC30-E07 23-CG15138-RB_4 CG15138 CCTCCACAACACACACTTTTCACCGATTTTTCCGTCTTCGCTTTGCATAGAAAATAAAGAAACTCACTG 69 FBan0015138 FBgn0032629 beat-IIIc 2 2L extracellular region; GO:0005576 beat-IIIc beat-IIIc "CG15138, CG6365, beat IIIc, BcDNA:RE14414" CDMC26955 1 2 19 DAC30-E07 23-CG15138-RB_4 CG15138 CCTCCACAACACACACTTTTCACCGATTTTTCCGTCTTCGCTTTGCATAGAAAATAAAGAAACTCACTG 69 FBan0015138 FBgn0032629 beat-IIIc 2 2L extracellular region; GO:0005576 beat-IIIc beat-IIIc "CG15138, CG6365, beat IIIc, BcDNA:RE14414" CDMC26956 1 3 19 DAC30-E19 17-CG15149-RA_1 CG15149 CGATGTATCCGGCATGATTCAGCCCGTTCGTAAAATAGTCTTGATTGTAAACGATTCAACGCCGGAGCA 69 FBan0015149 FBgn0032659 CG15149 2 2L CG15149 CG15149 CDMC26956 1 4 19 DAC30-E19 17-CG15149-RA_1 CG15149 CGATGTATCCGGCATGATTCAGCCCGTTCGTAAAATAGTCTTGATTGTAAACGATTCAACGCCGGAGCA 69 FBan0015149 FBgn0032659 CG15149 2 2L CG15149 CG15149 CDMC26957 1 5 19 DAC30-I07 3-CG15185-RA_1 CG15185 AGCACAGGCGAGGTGTTAGGCATAATGCTCAATAACGTCATTCGCGGATTTGCCATCAACGACCACCTC 69 FBan0015185 FBgn0037449 CG15185 3 3R CG15185 CG15185 CDMC26957 1 6 19 DAC30-I07 3-CG15185-RA_1 CG15185 AGCACAGGCGAGGTGTTAGGCATAATGCTCAATAACGTCATTCGCGGATTTGCCATCAACGACCACCTC 69 FBan0015185 FBgn0037449 CG15185 3 3R CG15185 CG15185 CDMC26958 1 7 19 DAC30-I19 22-CG15200-RA_2 CG15200 TCCACGATTTTTTTCGAAATAAAACATCCAGCCATGTCGAACGGTTTTTCCTTCTGGAACGGACAGCCA 69 FBan0015200 FBgn0030278 CG15200 X X CG15200 CG15200 CDMC26958 1 8 19 DAC30-I19 22-CG15200-RA_2 CG15200 TCCACGATTTTTTTCGAAATAAAACATCCAGCCATGTCGAACGGTTTTTCCTTCTGGAACGGACAGCCA 69 FBan0015200 FBgn0030278 CG15200 X X CG15200 CG15200 CDMC26959 1 9 19 DAC30-M07 23-CG15231-RA_1 CG15231 TCTAGTGAACAGAGTACAAAAGTCAAAAGTACAAAAAGTCACTTCAAAGTCAGTGCAAATTTCGTCATT 69 FBan0015231 FBgn0040653 IM4 2 2R defense response; GO:0006952; immune response; GO:0006955 extracellular region; GO:0005576 IM4 Immune induced molecule 4 "CG15231, CG15231, CG15231, DIM4, DIM-4, BcDNA:RH25931" CDMC26959 1 10 19 DAC30-M07 23-CG15231-RA_1 CG15231 TCTAGTGAACAGAGTACAAAAGTCAAAAGTACAAAAAGTCACTTCAAAGTCAGTGCAAATTTCGTCATT 69 FBan0015231 FBgn0040653 IM4 2 2R defense response; GO:0006952; immune response; GO:0006955 extracellular region; GO:0005576 IM4 Immune induced molecule 4 "CG15231, CG15231, CG15231, DIM4, DIM-4, BcDNA:RH25931" CDMC26960 1 11 19 DAC30-M19 6-CG15240-RA_1 CG15240 TGCGCACTCTTCGTTGGAGTCGATGGTGAATTTCATTGCGGTCACATCAAGTACTGTTCCCTGCACCAT 69 FBan0015240 FBgn0029684 CG15240 X X CG15240 CG15240 CDMC26960 1 12 19 DAC30-M19 6-CG15240-RA_1 CG15240 TGCGCACTCTTCGTTGGAGTCGATGGTGAATTTCATTGCGGTCACATCAAGTACTGTTCCCTGCACCAT 69 FBan0015240 FBgn0029684 CG15240 X X CG15240 CG15240 CDMC26961 1 13 19 DAC31-A07 1-CG12402-RA_1 CG12402 GGCTACTGCAACCGTCTCACTTCAGAGGGATTTGAGGCATTGACCCAAAACTGTCCATCCCTGGAGG 67 FBan0012402 FBgn0038202 CG12402 3 3R CG12402 CG12402 CDMC26961 1 14 19 DAC31-A07 1-CG12402-RA_1 CG12402 GGCTACTGCAACCGTCTCACTTCAGAGGGATTTGAGGCATTGACCCAAAACTGTCCATCCCTGGAGG 67 FBan0012402 FBgn0038202 CG12402 3 3R CG12402 CG12402 CDMC26962 1 15 19 DAC31-A19 3-CG12710-RA_1 CG12710 CGATCCTCAACCTCTGGTATGACCAATATGGAGCCGTCGTGCCCATCACAGTCACCTCCAACATTGC 67 FBan0012710 FBgn0040630 CG12710 3 3R CG12710 CG12710 CDMC26962 1 16 19 DAC31-A19 3-CG12710-RA_1 CG12710 CGATCCTCAACCTCTGGTATGACCAATATGGAGCCGTCGTGCCCATCACAGTCACCTCCAACATTGC 67 FBan0012710 FBgn0040630 CG12710 3 3R CG12710 CG12710 CDMC26963 1 17 19 DAC31-E07 2-CG13125-RA_1 CG13125 AGGGCATGAGGACTACTCACACATCGCGAGTGGATAAACGTGAAGATCGCCTAGCTCAACGCAGCAG 67 FBan0013125 FBgn0032163 CG13125 2 2L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 protein phosphatase type 1 complex; GO:0000164 CG13125 CG13125 CT32363 CDMC26963 1 18 19 DAC31-E07 2-CG13125-RA_1 CG13125 AGGGCATGAGGACTACTCACACATCGCGAGTGGATAAACGTGAAGATCGCCTAGCTCAACGCAGCAG 67 FBan0013125 FBgn0032163 CG13125 2 2L protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 protein phosphatase type 1 complex; GO:0000164 CG13125 CG13125 CT32363 CDMC26964 1 19 19 DAC31-E19 3-CG13300-RA_3 CG13300 GGAGGACTTGAGCAGCTTTGGTGACGTGACGTTCGACATCTTCGATGACGATGACGACTTGTTCGGC 67 FBan0013300 FBgn0035699 CG13300 3 3L CG13300 CG13300 CDMC26964 1 20 19 DAC31-E19 3-CG13300-RA_3 CG13300 GGAGGACTTGAGCAGCTTTGGTGACGTGACGTTCGACATCTTCGATGACGATGACGACTTGTTCGGC 67 FBan0013300 FBgn0035699 CG13300 3 3L CG13300 CG13300 CDMC26965 1 21 19 DAC31-I07 9-CG13579-RA_1 CG13579 CCATTTCACTGGGCTTCATAGTGATGGTCACTCCGTGGACGATTCAGGAAATAGTCACCGCCTGCAC 67 FBan0013579 FBgn0035010 CG13579 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG13579 CG13579 "anon-WO0170980.151, anon-WO0170980.152" CDMC26965 1 22 19 DAC31-I07 9-CG13579-RA_1 CG13579 CCATTTCACTGGGCTTCATAGTGATGGTCACTCCGTGGACGATTCAGGAAATAGTCACCGCCTGCAC 67 FBan0013579 FBgn0035010 CG13579 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG13579 CG13579 "anon-WO0170980.151, anon-WO0170980.152" CDMC26966 1 23 19 DAC31-I19 3-CG13652-RA_1 CG13652 GGCCCAGTGTCCGTTGCACAAGCAGCTAGAAGGGGGACAGTTCTACAACTACAACTACCACTTCCAC 67 FBan0013652 FBgn0039284 CG13652 3 3R CG13652 CG13652 CDMC26966 1 24 19 DAC31-I19 3-CG13652-RA_1 CG13652 GGCCCAGTGTCCGTTGCACAAGCAGCTAGAAGGGGGACAGTTCTACAACTACAACTACCACTTCCAC 67 FBan0013652 FBgn0039284 CG13652 3 3R CG13652 CG13652 CDMC26967 1 25 19 DAC31-M07 2-CG13992-RA_1 CG13992 TGAACCCATTCGGACCCTTCGGAGCCCTCAATCCTTTCAATCCTTTCAACAGAGTTCTGGGAGCACC 67 FBan0013992 FBgn0031756 CG13992 2 2L CG13992 CG13992 CDMC26967 1 26 19 DAC31-M07 2-CG13992-RA_1 CG13992 TGAACCCATTCGGACCCTTCGGAGCCCTCAATCCTTTCAATCCTTTCAACAGAGTTCTGGGAGCACC 67 FBan0013992 FBgn0031756 CG13992 2 2L CG13992 CG13992 CDMC26968 1 1 20 DAC31-M19 23-CG14235-RA_2 CG14235 ACACAAATGTTCAATTACTTGAATTCTGAACCGATCGTTTGTGTTTGTTTCTTCTTGATCCTTGATC 67 FBan0014235 FBgn0031066 CG14235 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG14235 CG14235 Cytochrome c oxidase subunitVIb CDMC26968 1 2 20 DAC31-M19 23-CG14235-RA_2 CG14235 ACACAAATGTTCAATTACTTGAATTCTGAACCGATCGTTTGTGTTTGTTTCTTCTTGATCCTTGATC 67 FBan0014235 FBgn0031066 CG14235 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG14235 CG14235 Cytochrome c oxidase subunitVIb CDMC26969 1 3 20 DAC32-A07 1-CG31703-RA_1 CG31703 TCGAAAAAACTGGCCAGCATCGGTACCAAGTCCTTAGTTCTACACGCGGGGTCCATGTGCCTACCATTT 69 FBan0031703 FBgn0051703 CG31703 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31703 CG31703 CDMC26969 1 4 20 DAC32-A07 1-CG31703-RA_1 CG31703 TCGAAAAAACTGGCCAGCATCGGTACCAAGTCCTTAGTTCTACACGCGGGGTCCATGTGCCTACCATTT 69 FBan0031703 FBgn0051703 CG31703 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31703 CG31703 CDMC26970 1 5 20 DAC32-A19 23-CG31716-RA_5 CG31716 TGCTGAACTTATGGAAAATGAGGTGGTCCAAAAACAGAGTATTAATAATGAGAACCCCTTGCCGAAGTT 69 FBan0031716 FBgn0051716 CG31716 2 2L negative regulation of transcription; GO:0016481; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 mRNA binding; GO:0003729; ; GO:0003729; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; transcriptional repressor activity; GO:0016564; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016564; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31716 CG31716 "CG5251, CG5244, CG5251, cg5251, NOT4" CDMC26970 1 6 20 DAC32-A19 23-CG31716-RA_5 CG31716 TGCTGAACTTATGGAAAATGAGGTGGTCCAAAAACAGAGTATTAATAATGAGAACCCCTTGCCGAAGTT 69 FBan0031716 FBgn0051716 CG31716 2 2L negative regulation of transcription; GO:0016481; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 mRNA binding; GO:0003729; ; GO:0003729; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; transcriptional repressor activity; GO:0016564; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016564; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31716 CG31716 "CG5251, CG5244, CG5251, cg5251, NOT4" CDMC26971 1 7 20 DAC32-E07 12-CG31742-RA_1 CG31742 CAAGGAAACTGGAGGAATGTGGCCAATAAAGACTGCCAGGAACTGCATGAACAGTACTCAGGTGTGGGA 69 FBan0031742 FBgn0051742 CG31742 2 2L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 CG31742 CG31742 "AE003657 - proteasome beta subunit, anon-AE003657.1" CDMC26971 1 8 20 DAC32-E07 12-CG31742-RA_1 CG31742 CAAGGAAACTGGAGGAATGTGGCCAATAAAGACTGCCAGGAACTGCATGAACAGTACTCAGGTGTGGGA 69 FBan0031742 FBgn0051742 CG31742 2 2L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 CG31742 CG31742 "AE003657 - proteasome beta subunit, anon-AE003657.1" CDMC26972 1 9 20 DAC32-E19 9-CG31750-RA_3 CG31750 TGGCTGAATAGCCTATCCTGGAATCGCTCATTTGTGGATCGCGTGAATGACGTAATCCGGTTGAACGGT 69 FBan0031750 FBgn0046888 Gr36d 2 2L biological process unknown; GO:0000004 NOT taste receptor activity; GO:0008527; ; GO:0008527 Gr36d Gr36d CG31750 CDMC26972 1 10 20 DAC32-E19 9-CG31750-RA_3 CG31750 TGGCTGAATAGCCTATCCTGGAATCGCTCATTTGTGGATCGCGTGAATGACGTAATCCGGTTGAACGGT 69 FBan0031750 FBgn0046888 Gr36d 2 2L biological process unknown; GO:0000004 NOT taste receptor activity; GO:0008527; ; GO:0008527 Gr36d Gr36d CG31750 CDMC26973 1 11 20 DAC32-I07 15-CG31776-RA_7 CG31776 CCCATTTTGGATGCCATCTCACGCAAGACATTTGCCTATGCCAAACAAAATACGATGACTCGCTCCGGT 69 FBan0031776 FBgn0051776 CG31776 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG31776 CG31776 "CG8845a, CG8845, CG8845a" CDMC26973 1 12 20 DAC32-I07 15-CG31776-RA_7 CG31776 CCCATTTTGGATGCCATCTCACGCAAGACATTTGCCTATGCCAAACAAAATACGATGACTCGCTCCGGT 69 FBan0031776 FBgn0051776 CG31776 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG31776 CG31776 "CG8845a, CG8845, CG8845a" CDMC26974 1 13 20 DAC32-I19 7-CG31784-RA_1 CG31784 CCCCCCTGGCACAATAAACCGAAAACCCATCAGGATGAAAACTGCCAAAAGAGCTATCCAGAATGCGGA 69 FBan0031784 FBgn0051784 CG31784 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31784 CG31784 NEST:bs05c10 CDMC26974 1 14 20 DAC32-I19 7-CG31784-RA_1 CG31784 CCCCCCTGGCACAATAAACCGAAAACCCATCAGGATGAAAACTGCCAAAAGAGCTATCCAGAATGCGGA 69 FBan0031784 FBgn0051784 CG31784 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31784 CG31784 NEST:bs05c10 CDMC26975 1 15 20 DAC32-M07 11-CG31815-RA_1 CG31815 CCGCCCAGGAGATTTCCCGGCTTTACAATGTCATTGTTCAGACACCGTCAGATGAACCAATTCCTTGGA 69 FBan0031815 FBgn0051815 CG31815 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31815 CG31815 CDMC26975 1 16 20 DAC32-M07 11-CG31815-RA_1 CG31815 CCGCCCAGGAGATTTCCCGGCTTTACAATGTCATTGTTCAGACACCGTCAGATGAACCAATTCCTTGGA 69 FBan0031815 FBgn0051815 CG31815 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31815 CG31815 CDMC26976 1 17 20 DAC32-M19 3-CG31821-RA_1 CG31821 GGCCCTGCAGATCAATGGTACTGTCTATGCGTCACAGGTTATGGAAGTGTTGTCCAGCCTTCACGGAGA 69 FBan0031821 FBgn0051821 CG31821 2 2L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG31821 CG31821 "CG7647, BG:DS00365.3" CDMC26976 1 18 20 DAC32-M19 3-CG31821-RA_1 CG31821 GGCCCTGCAGATCAATGGTACTGTCTATGCGTCACAGGTTATGGAAGTGTTGTCCAGCCTTCACGGAGA 69 FBan0031821 FBgn0051821 CG31821 2 2L proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG31821 CG31821 "CG7647, BG:DS00365.3" CDMC26977 1 19 20 DAC33-A07 23-CG15509-RA_3 CG15509 CCCAAAACGATTCAACAAAAGCTGATCAGGTAAAGCAACTCTCGCCAGTTTCCACACTAAATTCTCAGA 69 FBan0033956 FBgn0001297 kay 3 3R "JNK cascade; GO:0007254; R3/R4 cell fate commitment; GO:0007464; central nervous system development; GO:0007417; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; follicle cell migration (sensu Insecta); GO:0007297; head involution; GO:0008258; imaginal disc fusion, thorax closure; GO:0046529; midgut development; GO:0007494; regulation of transcription, DNA-dependent; GO:0006355; response to wounding; GO:0009611; wound healing; GO:0042060" DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; ; GO:0008134; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0046982; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 kay kayak "CG15507, CG15509, CG33956, CG15507, CG15509, CG15509, sro, dFRA, dFra, dAP-1, Fos, AP-1, D-fos, D-Fos, DFos, DFra, DFOS, Fra, Dfos, dFos, shroud, fos, c-Fos, AP1, d-fos, dlhD: dorsal holes D, Fos-related antigen, dorsal holes D" CDMC26977 1 20 20 DAC33-A07 23-CG15509-RA_3 CG15509 CCCAAAACGATTCAACAAAAGCTGATCAGGTAAAGCAACTCTCGCCAGTTTCCACACTAAATTCTCAGA 69 FBan0033956 FBgn0001297 kay 3 3R "JNK cascade; GO:0007254; R3/R4 cell fate commitment; GO:0007464; central nervous system development; GO:0007417; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; follicle cell migration (sensu Insecta); GO:0007297; head involution; GO:0008258; imaginal disc fusion, thorax closure; GO:0046529; midgut development; GO:0007494; regulation of transcription, DNA-dependent; GO:0006355; response to wounding; GO:0009611; wound healing; GO:0042060" DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; ; GO:0008134; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0046982; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 kay kayak "CG15507, CG15509, CG33956, CG15507, CG15509, CG15509, sro, dFRA, dFra, dAP-1, Fos, AP-1, D-fos, D-Fos, DFos, DFra, DFOS, Fra, Dfos, dFos, shroud, fos, c-Fos, AP1, d-fos, dlhD: dorsal holes D, Fos-related antigen, dorsal holes D" CDMC26978 1 21 20 DAC33-A19 10-CG15529-RA_1 CG15529 ACCTGTTCATAAGGCAAGTGGATAGGAGACAACGCTATGCCATTGGTCAGAAGAAGTCTCAGGAGCGCT 69 FBan0015529 FBgn0039748 CG15529 3 3R intracellular signaling cascade; GO:0007242 CG15529 CG15529 CDMC26978 1 22 20 DAC33-A19 10-CG15529-RA_1 CG15529 ACCTGTTCATAAGGCAAGTGGATAGGAGACAACGCTATGCCATTGGTCAGAAGAAGTCTCAGGAGCGCT 69 FBan0015529 FBgn0039748 CG15529 3 3R intracellular signaling cascade; GO:0007242 CG15529 CG15529 CDMC26979 1 23 20 DAC33-E07 14-CG15570-RA_9 CG15570 TGGTCCTTGCCGACATTCCCATTTTGAGCAGCATTACTAACCTTCTGGGAGTGACAGGACTAATCGGAA 69 FBan0015570 FBgn0029697 CG15570 X X CG15570 CG15570 CDMC26979 1 24 20 DAC33-E07 14-CG15570-RA_9 CG15570 TGGTCCTTGCCGACATTCCCATTTTGAGCAGCATTACTAACCTTCTGGGAGTGACAGGACTAATCGGAA 69 FBan0015570 FBgn0029697 CG15570 X X CG15570 CG15570 CDMC26980 1 25 20 DAC33-E19 11-CG15581-RA_3 CG15581 ACGAGACTCGGGGAGATTCCTACCACAGGACCTTGAATTCGAACATAGATCGACTCCTCGGCATCATGA 69 FBan0015581 FBgn0037399 Or83c 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or83c Odorant receptor 83c "CG15581, 83D.1, DOR116, 83c" CDMC26980 1 26 20 DAC33-E19 11-CG15581-RA_3 CG15581 ACGAGACTCGGGGAGATTCCTACCACAGGACCTTGAATTCGAACATAGATCGACTCCTCGGCATCATGA 69 FBan0015581 FBgn0037399 Or83c 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or83c Odorant receptor 83c "CG15581, 83D.1, DOR116, 83c" CDMC26981 1 1 21 DAC33-I07 14-CG15625-RA_1 CG15625 GCCTCCGCTCTGTGTGCGATGAACATCAAGAATTTCGATCACATCCGTCACATATCCTATGGCATCCGT 69 FBan0015625 FBgn0031644 CG15625 2 2L CG15625 CG15625 CDMC26981 1 2 21 DAC33-I07 14-CG15625-RA_1 CG15625 GCCTCCGCTCTGTGTGCGATGAACATCAAGAATTTCGATCACATCCGTCACATATCCTATGGCATCCGT 69 FBan0015625 FBgn0031644 CG15625 2 2L CG15625 CG15625 CDMC26982 1 3 21 DAC33-I19 22-CG15638-RA_1 CG15638 GGTCCTGGCTGAAGAATTCCTTTGCAAATGCATAATCATTCGGTTTAGGTGGTGCCAAATTCAAGTGCT 69 FBan0015638 FBgn0028943 CG15638 2 2L CG15638 CG15638 BG:BACR48E02.1 CDMC26982 1 4 21 DAC33-I19 22-CG15638-RA_1 CG15638 GGTCCTGGCTGAAGAATTCCTTTGCAAATGCATAATCATTCGGTTTAGGTGGTGCCAAATTCAAGTGCT 69 FBan0015638 FBgn0028943 CG15638 2 2L CG15638 CG15638 BG:BACR48E02.1 CDMC26983 1 5 21 DAC33-M07 3-CG1569-RA_4 CG1569 TGCTACAGAAGTGGCTCGCTCTGACTATGGAGTCTGCGGGTGATGGTACCATTTTGGAGGAGACCTTCA 69 FBan0001569 FBgn0003268 rod 3 3R mitotic sister chromatid segregation; GO:0000070; mitotic spindle checkpoint; GO:0007094 kinetochore; GO:0000776; kinetochore microtubule; GO:0005828; outer kinetochore of condensed chromosome; GO:0000940 rod rough deal "CG1569, CG1569, pNB20A, ROD, EP3408, rough deal" CDMC26983 1 6 21 DAC33-M07 3-CG1569-RA_4 CG1569 TGCTACAGAAGTGGCTCGCTCTGACTATGGAGTCTGCGGGTGATGGTACCATTTTGGAGGAGACCTTCA 69 FBan0001569 FBgn0003268 rod 3 3R mitotic sister chromatid segregation; GO:0000070; mitotic spindle checkpoint; GO:0007094 kinetochore; GO:0000776; kinetochore microtubule; GO:0005828; outer kinetochore of condensed chromosome; GO:0000940 rod rough deal "CG1569, CG1569, pNB20A, ROD, EP3408, rough deal" CDMC26984 1 7 21 DAC33-M19 15-CG15708-RA_1 CG15708 CCAGTGAACTGGTGCGACACATCCAACAGGATCATCCGGAGATATACGCAGTGACCACGGATAAAATCA 69 FBan0015708 FBgn0034099 CG15708 2 2R CG15708 CG15708 CDMC26984 1 8 21 DAC33-M19 15-CG15708-RA_1 CG15708 CCAGTGAACTGGTGCGACACATCCAACAGGATCATCCGGAGATATACGCAGTGACCACGGATAAAATCA 69 FBan0015708 FBgn0034099 CG15708 2 2R CG15708 CG15708 CDMC26985 1 9 21 DAC34-A07 23-CG31121-RA_1 CG31121 GGCACAGGCTACCGAACTGTACATTCCATAGAAACTAATTCTTGAAATAAATAGTGTTTAGTCGAGGCA 69 FBan0031121 FBgn0051121 CG31121 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG31121 CG31121 "CG18633, CG11764, CG18655, CG18633, BcDNA:GH19411" CDMC26985 1 10 21 DAC34-A07 23-CG31121-RA_1 CG31121 GGCACAGGCTACCGAACTGTACATTCCATAGAAACTAATTCTTGAAATAAATAGTGTTTAGTCGAGGCA 69 FBan0031121 FBgn0051121 CG31121 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG31121 CG31121 "CG18633, CG11764, CG18655, CG18633, BcDNA:GH19411" CDMC26986 1 11 21 DAC34-A19 16-CG31141-RA_1 CG31141 GCTCCGCGACCATCATGTTTATCATGTTCGCCAACTTTTATTTCCAGTGCTACCTGAGACCGAAGCATA 69 FBan0031141 FBgn0051141 CG31141 3 3R fatty acid elongation; GO:0030497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31141 CG31141 CDMC26986 1 12 21 DAC34-A19 16-CG31141-RA_1 CG31141 GCTCCGCGACCATCATGTTTATCATGTTCGCCAACTTTTATTTCCAGTGCTACCTGAGACCGAAGCATA 69 FBan0031141 FBgn0051141 CG31141 3 3R fatty acid elongation; GO:0030497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31141 CG31141 CDMC26987 1 13 21 DAC34-E07 23-CG31171-RA_8 CG31171 TCAAAGCATTGGCATTAGGGTCAAGAGCAATAAAGTGGCCATAACATAAACACACTAACGATTCGGACA 69 FBan0031171 FBgn0051171 CG31171 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31171 CG31171 CDMC26987 1 14 21 DAC34-E07 23-CG31171-RA_8 CG31171 TCAAAGCATTGGCATTAGGGTCAAGAGCAATAAAGTGGCCATAACATAAACACACTAACGATTCGGACA 69 FBan0031171 FBgn0051171 CG31171 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31171 CG31171 CDMC26988 1 15 21 DAC34-E19 2-CG31182-RA_1 CG31182 CAACCGCACCCGAATTACCCACCACAATCCCCAATCACAACTCCCGCTTTTGAGTTCTGTTTTCGCTTT 69 FBan0031182 FBgn0051182 CG31182 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31182 CG31182 BcDNA:LD46351 CDMC26988 1 16 21 DAC34-E19 2-CG31182-RA_1 CG31182 CAACCGCACCCGAATTACCCACCACAATCCCCAATCACAACTCCCGCTTTTGAGTTCTGTTTTCGCTTT 69 FBan0031182 FBgn0051182 CG31182 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31182 CG31182 BcDNA:LD46351 CDMC26989 1 17 21 DAC34-I07 9-CG31207-RA_1 CG31207 ACGAAGGTCAGTGGGTTTGATGAGAATCCCACATCCAGCTTGATTGAAATACACGGCCGGATACCCAGT 69 FBan0031207 FBgn0051207 CG31207 3 3R CG31207 CG31207 "CG7096, CG7096, CG7096, CG7096" CDMC26989 1 18 21 DAC34-I07 9-CG31207-RA_1 CG31207 ACGAAGGTCAGTGGGTTTGATGAGAATCCCACATCCAGCTTGATTGAAATACACGGCCGGATACCCAGT 69 FBan0031207 FBgn0051207 CG31207 3 3R CG31207 CG31207 "CG7096, CG7096, CG7096, CG7096" CDMC26990 1 19 21 DAC34-I19 18-CG31213-RA_1 CG31213 CGCTATCGATAGCGGGTCGGTACTTTGTCTTGATGATACAAATGGTAGTGTCGATCACGCGACCCAAAG 69 FBan0031213 FBgn0051213 CG31213 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0000166" membrane; GO:0016020 CG31213 CG31213 "CG4794, CG11460, CG4794" CDMC26990 1 20 21 DAC34-I19 18-CG31213-RA_1 CG31213 CGCTATCGATAGCGGGTCGGTACTTTGTCTTGATGATACAAATGGTAGTGTCGATCACGCGACCCAAAG 69 FBan0031213 FBgn0051213 CG31213 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0000166" membrane; GO:0016020 CG31213 CG31213 "CG4794, CG11460, CG4794" CDMC26991 1 21 21 DAC34-M07 20-CG31249-RA_3 CG31249 TTTTGTATAGTAATCCGTTGAAAGCATGCTGTCGCTCAAGATGAAACTCGAGGTACTGGGTCGTCCCGA 69 FBan0031249 FBgn0051249 CG31249 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31249 CG31249 "CG7477, CG7477, CG7477, Q9VEG8" CDMC26991 1 22 21 DAC34-M07 20-CG31249-RA_3 CG31249 TTTTGTATAGTAATCCGTTGAAAGCATGCTGTCGCTCAAGATGAAACTCGAGGTACTGGGTCGTCCCGA 69 FBan0031249 FBgn0051249 CG31249 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31249 CG31249 "CG7477, CG7477, CG7477, Q9VEG8" CDMC26992 1 23 21 DAC34-M19 3-CG31267-RA_1 CG31267 CCACCACCTATAATCACTGGGGATCGGAGGGCTGGATATACTCCGTGGAGGATATCGTCATGCACTGCA 69 FBan0031267 FBgn0051267 CG31267 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31267 CG31267 "CG5240, SPH146" CDMC26992 1 24 21 DAC34-M19 3-CG31267-RA_1 CG31267 CCACCACCTATAATCACTGGGGATCGGAGGGCTGGATATACTCCGTGGAGGATATCGTCATGCACTGCA 69 FBan0031267 FBgn0051267 CG31267 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31267 CG31267 "CG5240, SPH146" CDMC26993 1 25 21 DAC35-A07 12-CG7808-RC_1 CG7808 CCTTTCTTTCTCGCTTTTTACTCGAACATGGGTATTAGCCGCGATAGTGCACACAAACGCCGGGCC 66 FBan0007808 FBgn0039713 RpS8 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS8 Ribosomal protein S8 "CG7808, clone 1.56, S8, anon-EST:Liang-1.56, BcDNA:RH06886, anon-EST:fe1A2, BcDNA:SD17528, anon-fast-evolving-1A2, Ribosomal protein S8" CDMC26993 1 26 21 DAC35-A07 12-CG7808-RC_1 CG7808 CCTTTCTTTCTCGCTTTTTACTCGAACATGGGTATTAGCCGCGATAGTGCACACAAACGCCGGGCC 66 FBan0007808 FBgn0039713 RpS8 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS8 Ribosomal protein S8 "CG7808, clone 1.56, S8, anon-EST:Liang-1.56, BcDNA:RH06886, anon-EST:fe1A2, BcDNA:SD17528, anon-fast-evolving-1A2, Ribosomal protein S8" CDMC26994 1 1 22 DAC35-A19 3-CG7953-RA_1 CG7953 ACCTCGCTGAAGACCACCATCTCGTTGGAGTCTGTGACTTCGGACATCACTGGATTCATGGGCAAC 66 FBan0007953 FBgn0028533 CG7953 2 2L CG7953 CG7953 "BG:DS00941.14, DS00941.14, anon-WO0140519.73" CDMC26994 1 2 22 DAC35-A19 3-CG7953-RA_1 CG7953 ACCTCGCTGAAGACCACCATCTCGTTGGAGTCTGTGACTTCGGACATCACTGGATTCATGGGCAAC 66 FBan0007953 FBgn0028533 CG7953 2 2L CG7953 CG7953 "BG:DS00941.14, DS00941.14, anon-WO0140519.73" CDMC26995 1 3 22 DAC35-E07 3-CG8332-RA_1 CG8332 AGAAGAAGCGTACCTTCAAGAAGTTCACCTACCGCGGTGTCGACTTGGACCAGCTTCTGGACATGC 66 FBan0008332 FBgn0034138 RpS15 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15 Ribosomal protein S15 "CG8332, anon-EST:Posey137, anon-EST:Posey185, Ribosomal protein S15" CDMC26995 1 4 22 DAC35-E07 3-CG8332-RA_1 CG8332 AGAAGAAGCGTACCTTCAAGAAGTTCACCTACCGCGGTGTCGACTTGGACCAGCTTCTGGACATGC 66 FBan0008332 FBgn0034138 RpS15 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15 Ribosomal protein S15 "CG8332, anon-EST:Posey137, anon-EST:Posey185, Ribosomal protein S15" CDMC26996 1 5 22 DAC35-E19 2-CG8436-RA_1 CG8436 CCGGCGAAGTAGAAGCGCTGTAGTGTACACTTCTGCCGACGAGAAGGATCATGACGAGGCTCCTAG 66 FBan0008436 FBgn0037670 CG8436 3 3R CG8436 CG8436 CDMC26996 1 6 22 DAC35-E19 2-CG8436-RA_1 CG8436 CCGGCGAAGTAGAAGCGCTGTAGTGTACACTTCTGCCGACGAGAAGGATCATGACGAGGCTCCTAG 66 FBan0008436 FBgn0037670 CG8436 3 3R CG8436 CG8436 CDMC26997 1 7 22 DAC35-I07 17-CG9107-RA_2 CG9107 TCTACACCTTCCAAATACGCGAGAGCAAGATGCAGAATATCGTCGAGATGCGCAAGAAGTTCGAGG 66 FBan0009107 FBgn0031764 CG9107 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG9107 CG9107 CDMC26997 1 8 22 DAC35-I07 17-CG9107-RA_2 CG9107 TCTACACCTTCCAAATACGCGAGAGCAAGATGCAGAATATCGTCGAGATGCGCAAGAAGTTCGAGG 66 FBan0009107 FBgn0031764 CG9107 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG9107 CG9107 CDMC26998 1 9 22 DAC35-I19 9-CG9222-RA_4 CG9222 GGGTGGCTGTCAAGATCATATCCAAAGTGAAGGCTCCCTCCGAGTACACGCAAAAGTTCCTGCCGC 66 FBan0009222 FBgn0031784 CG9222 2 2L cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG9222 CG9222 CDMC26998 1 10 22 DAC35-I19 9-CG9222-RA_4 CG9222 GGGTGGCTGTCAAGATCATATCCAAAGTGAAGGCTCCCTCCGAGTACACGCAAAAGTTCCTGCCGC 66 FBan0009222 FBgn0031784 CG9222 2 2L cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG9222 CG9222 CDMC26999 1 11 22 DAC35-M07 3-CG9749-RA_1 CG9749 TCATGGATGGTGTTACCGGTCTGTTTCCGGGCAACTACGTAGAGCCTTGTGTCTAAGCCTCGCATC 66 FBan0009749 FBgn0020510 Abi 3 3R cell motility; GO:0006928; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; metabolism; GO:0008152; positive regulation of protein kinase activity; GO:0045860; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165 signal transducer activity; GO:0004871; transferase activity; GO:0016740 ; EC:2.-.-.-; protein binding; GO:0005515; ; GO:0004871; ; GO:0016740 ; EC:2.-.-.-; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0005515; ; GO:0005515; ; GO:0005515 Abi Abelson Interacting Protein "CG9749, CG9749, Ablphilin, dAbi, Abi-1, Abelson Interacting Protein" CDMC26999 1 12 22 DAC35-M07 3-CG9749-RA_1 CG9749 TCATGGATGGTGTTACCGGTCTGTTTCCGGGCAACTACGTAGAGCCTTGTGTCTAAGCCTCGCATC 66 FBan0009749 FBgn0020510 Abi 3 3R cell motility; GO:0006928; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; metabolism; GO:0008152; positive regulation of protein kinase activity; GO:0045860; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165 signal transducer activity; GO:0004871; transferase activity; GO:0016740 ; EC:2.-.-.-; protein binding; GO:0005515; ; GO:0004871; ; GO:0016740 ; EC:2.-.-.-; small GTPase regulator activity; GO:0005083; ; GO:0005083; ; GO:0005515; ; GO:0005515; ; GO:0005515 Abi Abelson Interacting Protein "CG9749, CG9749, Ablphilin, dAbi, Abi-1, Abelson Interacting Protein" CDMC27000 1 13 22 DAC35-M19 2-CG9879-RA_1 CG9879 TTTGGGCGTGAGATTTGCCGTCTTTCCCACAGGATTCGTTTTGGTCCTTCACTCGACCAGTCACTG 66 FBan0009879 FBgn0031444 CG9879 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 CG9879 CG9879 CDMC27000 1 14 22 DAC35-M19 2-CG9879-RA_1 CG9879 TTTGGGCGTGAGATTTGCCGTCTTTCCCACAGGATTCGTTTTGGTCCTTCACTCGACCAGTCACTG 66 FBan0009879 FBgn0031444 CG9879 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 CG9879 CG9879 CDMC27001 1 15 22 DAC36-A07 20-CG18091-RA_1 CG18091 TTCAATGCGCTGCCAGCCGTCGATAAGAACGCACGCGAGCGGGTCAAGTCATCCGGCAGACAGAG 65 FBan0018091 FBgn0024368 CG18091 X X CG18091 CG18091 EG:190E7.1 CDMC27001 1 16 22 DAC36-A07 20-CG18091-RA_1 CG18091 TTCAATGCGCTGCCAGCCGTCGATAAGAACGCACGCGAGCGGGTCAAGTCATCCGGCAGACAGAG 65 FBan0018091 FBgn0024368 CG18091 X X CG18091 CG18091 EG:190E7.1 CDMC27002 1 17 22 DAC36-A19 2-CG18135-RD_1 CG18135 TGAGGTTCAAGCAGAACGTCTTCCCAGTGATGTTCCTCACGCAGGGAGAGACGAAGAAGTGGCAG 65 FBan0018135 FBgn0036837 CG18135 3 3L CG18135 CG18135 CDMC27002 1 18 22 DAC36-A19 2-CG18135-RD_1 CG18135 TGAGGTTCAAGCAGAACGTCTTCCCAGTGATGTTCCTCACGCAGGGAGAGACGAAGAAGTGGCAG 65 FBan0018135 FBgn0036837 CG18135 3 3L CG18135 CG18135 CDMC27003 1 19 22 DAC36-E07 2-CG18345-RB_2 CG18345 TGCTCTTTCGCAATTCCGAAACCGAGAGCTTCCATTGTGTCCCAGCAAGCTGATAGCGAACTCGG 65 FBan0018345 FBgn0005614 trpl 2 2R calcium ion transport; GO:0006816; calcium-mediated signaling; GO:0019722; fluid secretion; GO:0007589; response to abiotic stimulus; GO:0009628; response to light stimulus; GO:0009416 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; ; GO:0005516; calcium channel activity; GO:0005262; ; GO:0005262; light-activated voltage-gated calcium channel activity; GO:0008086; ; GO:0005262; cation channel activity; GO:0005261; store-operated calcium channel activity; GO:0015279; ; GO:0005262; ; GO:0005261; ; GO:0008086; ; GO:0015279 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; rhabdomere; GO:0016028 trpl trp-like "CG18345, CG1694, trp-l, TrpL, TRPL, DmTRPL, dTrpL, dTRPL" CDMC27003 1 20 22 DAC36-E07 2-CG18345-RB_2 CG18345 TGCTCTTTCGCAATTCCGAAACCGAGAGCTTCCATTGTGTCCCAGCAAGCTGATAGCGAACTCGG 65 FBan0018345 FBgn0005614 trpl 2 2R calcium ion transport; GO:0006816; calcium-mediated signaling; GO:0019722; fluid secretion; GO:0007589; response to abiotic stimulus; GO:0009628; response to light stimulus; GO:0009416 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; ; GO:0005516; calcium channel activity; GO:0005262; ; GO:0005262; light-activated voltage-gated calcium channel activity; GO:0008086; ; GO:0005262; cation channel activity; GO:0005261; store-operated calcium channel activity; GO:0015279; ; GO:0005262; ; GO:0005261; ; GO:0008086; ; GO:0015279 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; rhabdomere; GO:0016028 trpl trp-like "CG18345, CG1694, trp-l, TrpL, TRPL, DmTRPL, dTrpL, dTRPL" CDMC27004 1 21 22 DAC36-E19 2-CG18377-RA_1 CG18377 TCCCCATTTGGTTGTTTCAAACGATCCCGCATATTTCCCAGAACCCAAGCGTTTTCTGCCCGAGC 65 FBan0018377 FBgn0033524 Cyp49a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; mitochondrion; GO:0005739 Cyp49a1 Cyp49a1 "CG18377, CG12894, Cyp49a1p, 49a1" CDMC27004 1 22 22 DAC36-E19 2-CG18377-RA_1 CG18377 TCCCCATTTGGTTGTTTCAAACGATCCCGCATATTTCCCAGAACCCAAGCGTTTTCTGCCCGAGC 65 FBan0018377 FBgn0033524 Cyp49a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; mitochondrion; GO:0005739 Cyp49a1 Cyp49a1 "CG18377, CG12894, Cyp49a1p, 49a1" CDMC27005 1 23 22 DAC36-I07 9-CG18563-RA_2 CG18563 CGGTGGAGGTTATGCATTGTTCTGCTCCCTCGGAGATGAGAATCCACACGTCTTCGAGCAGGCTG 65 FBan0018563 FBgn0032639 CG18563 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG18563 CG18563 SPH156 CDMC27005 1 24 22 DAC36-I07 9-CG18563-RA_2 CG18563 CGGTGGAGGTTATGCATTGTTCTGCTCCCTCGGAGATGAGAATCCACACGTCTTCGAGCAGGCTG 65 FBan0018563 FBgn0032639 CG18563 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG18563 CG18563 SPH156 CDMC27006 1 25 22 DAC36-I19 3-CG18635-RA_9 CG18635 CGGAATCCGACAAGATAATGGAGAACTTTCGAGCCCGCAAGTCATTGCCGAACTCAGGTGAGGCC 65 FBan0018635 FBgn0034279 CG18635 2 2R CG18635 CG18635 CDMC27006 1 26 22 DAC36-I19 3-CG18635-RA_9 CG18635 CGGAATCCGACAAGATAATGGAGAACTTTCGAGCCCGCAAGTCATTGCCGAACTCAGGTGAGGCC 65 FBan0018635 FBgn0034279 CG18635 2 2R CG18635 CG18635 CDMC27007 1 1 23 DAC36-M07 1-CG18766-RA_1 CG18766 GCTGGGCGTCCCTGTTACCGCACTCGAGGTTCACTTTAAAGTCAACAATCTAACGCAGCGCTACC 65 FBan0018766 FBgn0042111 CG18766 3 3R CG18766 CG18766 CG5995 CDMC27007 1 2 23 DAC36-M07 1-CG18766-RA_1 CG18766 GCTGGGCGTCCCTGTTACCGCACTCGAGGTTCACTTTAAAGTCAACAATCTAACGCAGCGCTACC 65 FBan0018766 FBgn0042111 CG18766 3 3R CG18766 CG18766 CG5995 CDMC27008 1 3 23 DAC36-M19 5-CG18817-RB_1 CG18817 CCAACTGGCTTTGGTGATCTACATGTGGGTGCAGAAGGACAAGTACCTGGAGATCATGGGCGACG 65 FBan0018817 FBgn0029508 Tsp42Ea 2 2R integral to membrane; GO:0016021 Tsp42Ea Tetraspanin 42Ea "CG3364, CG18742, CG18817, CG3364, CG18742, CG3364, CG18817, GH05668, Dm.Tsp42Ea, Q9U3V4, tetraspanin 42E, BcDNA:GM15292, BcDNA:GH05668, Tetraspanin 42Ea" CDMC27008 1 4 23 DAC36-M19 5-CG18817-RB_1 CG18817 CCAACTGGCTTTGGTGATCTACATGTGGGTGCAGAAGGACAAGTACCTGGAGATCATGGGCGACG 65 FBan0018817 FBgn0029508 Tsp42Ea 2 2R integral to membrane; GO:0016021 Tsp42Ea Tetraspanin 42Ea "CG3364, CG18742, CG18817, CG3364, CG18742, CG3364, CG18817, GH05668, Dm.Tsp42Ea, Q9U3V4, tetraspanin 42E, BcDNA:GM15292, BcDNA:GH05668, Tetraspanin 42Ea" CDMC27009 1 5 23 DAC37-A07 2-CG16894-RA_1 CG16894 ACATCTATGCCATACCCAGTTACGCTTGTGGATTGCACTGGTTCGGCGTCATCTTTGTGCACAGTGGAA 69 FBan0016894 FBgn0034483 CG16894 2 2R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG16894 CG16894 CDMC27009 1 6 23 DAC37-A07 2-CG16894-RA_1 CG16894 ACATCTATGCCATACCCAGTTACGCTTGTGGATTGCACTGGTTCGGCGTCATCTTTGTGCACAGTGGAA 69 FBan0016894 FBgn0034483 CG16894 2 2R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG16894 CG16894 CDMC27010 1 7 23 DAC37-A19 14-CG16904-RA_4 CG16904 CGCAGGATCATGAGCTAAAGTCCACGGAAAGGACACTGTCGTACATGTACCATCTGAACAAGGTGCTCG 69 FBan0016904 FBgn0037763 CG16904 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG16904 CG16904 CDMC27010 1 8 23 DAC37-A19 14-CG16904-RA_4 CG16904 CGCAGGATCATGAGCTAAAGTCCACGGAAAGGACACTGTCGTACATGTACCATCTGAACAAGGTGCTCG 69 FBan0016904 FBgn0037763 CG16904 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG16904 CG16904 CDMC27011 1 9 23 DAC37-E07 3-CG16953-RA_1 CG16953 GGCCAAAATGTGGAGTAACAAGCATCCATTGGACCGCAATCAGTTCCAGGATTTGGGAACGCAACTGCA 69 FBan0016953 FBgn0038809 CG16953 3 3R CG16953 CG16953 CDMC27011 1 10 23 DAC37-E07 3-CG16953-RA_1 CG16953 GGCCAAAATGTGGAGTAACAAGCATCCATTGGACCGCAATCAGTTCCAGGATTTGGGAACGCAACTGCA 69 FBan0016953 FBgn0038809 CG16953 3 3R CG16953 CG16953 CDMC27012 1 11 23 DAC37-E19 9-CG16961-RA_1 CG16961 ATCGATGGTGTTGGAATTATTCCCGTGCTGCTATTACGGCACCCTGATATCCGTGGAGATGAACCAGCT 69 FBan0016961 FBgn0026391 Or33b 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33b Odorant receptor 33b "CG16961, CG16961, DOR33B.2, Olfactory receptor 33B.2, dor72, AN1, 33B.2, DOR72, 33b, Or33B.2, Or72" CDMC27012 1 12 23 DAC37-E19 9-CG16961-RA_1 CG16961 ATCGATGGTGTTGGAATTATTCCCGTGCTGCTATTACGGCACCCTGATATCCGTGGAGATGAACCAGCT 69 FBan0016961 FBgn0026391 Or33b 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33b Odorant receptor 33b "CG16961, CG16961, DOR33B.2, Olfactory receptor 33B.2, dor72, AN1, 33B.2, DOR72, 33b, Or33B.2, Or72" CDMC27013 1 13 23 DAC37-I07 5-CG16984-RA_1 CG16984 GCATCTGGAAGCCGAGTGAGGTGTCTCCATGGATTCACTTGCTTTGCTCTTAGAGGCGGACACACAAAA 69 FBgn0035354 CDMC27013 1 14 23 DAC37-I07 5-CG16984-RA_1 CG16984 GCATCTGGAAGCCGAGTGAGGTGTCTCCATGGATTCACTTGCTTTGCTCTTAGAGGCGGACACACAAAA 69 FBgn0035354 CDMC27014 1 15 23 DAC37-I19 15-CG16992-RA_2 CG16992 GGGCCTGGGAGGATAGACCTGACAAACTGAATTGGATTCCCGGTGTTGGCTTATATCGATGCTGGATAA 69 FBan0016992 FBgn0035789 mthl6 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl6 methuselah-like 6 "CG16992, CG16992, CG16992, mth-like 6, Mth-like 6, anon-WO0170980.127, anon-WO0170980.128" CDMC27014 1 16 23 DAC37-I19 15-CG16992-RA_2 CG16992 GGGCCTGGGAGGATAGACCTGACAAACTGAATTGGATTCCCGGTGTTGGCTTATATCGATGCTGGATAA 69 FBan0016992 FBgn0035789 mthl6 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl6 methuselah-like 6 "CG16992, CG16992, CG16992, mth-like 6, Mth-like 6, anon-WO0170980.127, anon-WO0170980.128" CDMC27015 1 17 23 DAC37-M07 1-CG17032-RA_1 CG17032 GGGCGCCACTATCGAGGAAGTAGTGGTGGAATCAGCCTTGTACATCAAACCGAAGTCTAATCCGCAGGT 69 FBan0017032 FBgn0036547 CG17032 3 3L CG17032 CG17032 CDMC27015 1 18 23 DAC37-M07 1-CG17032-RA_1 CG17032 GGGCGCCACTATCGAGGAAGTAGTGGTGGAATCAGCCTTGTACATCAAACCGAAGTCTAATCCGCAGGT 69 FBan0017032 FBgn0036547 CG17032 3 3L CG17032 CG17032 CDMC27016 1 19 23 DAC37-M19 1-CG17045-RA_1 CG17045 GGCAATCGTTTGAACCGCGCGGAACTGTCACTTAGCAGGTTCTCATTTGATAGCCATGTTGGTCGTCCT 69 FBan0017045 FBgn0038150 yellow-e3 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e3 yellow-e3 "CG17045, CG17045" CDMC27016 1 20 23 DAC37-M19 1-CG17045-RA_1 CG17045 GGCAATCGTTTGAACCGCGCGGAACTGTCACTTAGCAGGTTCTCATTTGATAGCCATGTTGGTCGTCCT 69 FBan0017045 FBgn0038150 yellow-e3 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e3 yellow-e3 "CG17045, CG17045" CDMC27017 1 21 23 DAC38-A07 11-CG17544-RB_1 CG17544 GCCCAGTCCAAGCTTTGAGGAGGATTACCACCGAGGATTAGAACCTAGTTACCAAGTGCCTGACTTCGA 69 FBan0017544 FBgn0032775 CG17544 2 2L electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 pristanoyl-CoA oxidase activity; GO:0016402 ; EC:1.3.3.-; ; GO:0016402 ; EC:1.3.3.- peroxisome; GO:0005777 CG17544 CG17544 CDMC27017 1 22 23 DAC38-A07 11-CG17544-RB_1 CG17544 GCCCAGTCCAAGCTTTGAGGAGGATTACCACCGAGGATTAGAACCTAGTTACCAAGTGCCTGACTTCGA 69 FBan0017544 FBgn0032775 CG17544 2 2L electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 pristanoyl-CoA oxidase activity; GO:0016402 ; EC:1.3.3.-; ; GO:0016402 ; EC:1.3.3.- peroxisome; GO:0005777 CG17544 CG17544 CDMC27018 1 23 23 DAC38-A19 22-CG1756-RA_1 CG1756 ACGGAAAGGAGGGATAGAAACCAGACAGCGAGATTGAGCTTCCATCGATGAAAAAAGTGCTGCATAGTT 69 FBan0001756 FBgn0030303 CG1756 X X cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG1756 CG1756 "anon-WO0109301.51, anon-WO0109301.52, anon-WO0109301.9" CDMC27018 1 24 23 DAC38-A19 22-CG1756-RA_1 CG1756 ACGGAAAGGAGGGATAGAAACCAGACAGCGAGATTGAGCTTCCATCGATGAAAAAAGTGCTGCATAGTT 69 FBan0001756 FBgn0030303 CG1756 X X cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG1756 CG1756 "anon-WO0109301.51, anon-WO0109301.52, anon-WO0109301.9" CDMC27019 1 25 23 DAC38-E07 12-CG17612-RB_1 CG17612 CGCAGGTTTGCGTACAATTTCTCCGGAGTAAGTCTCCTGGACAAATATTCCCTTGTCCCAAATGCCCGA 69 FBan0017612 FBgn0031597 CG17612 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17612 CG17612 CDMC27019 1 26 23 DAC38-E07 12-CG17612-RB_1 CG17612 CGCAGGTTTGCGTACAATTTCTCCGGAGTAAGTCTCCTGGACAAATATTCCCTTGTCCCAAATGCCCGA 69 FBan0017612 FBgn0031597 CG17612 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17612 CG17612 CDMC27020 1 1 24 DAC38-E19 7-CG1762-RA_2 CG1762 GCTTCTTCGTCTATCAGGTCATCGACCACTCAAACTTCTTGACCATCCAGGCAGTTGATTGCGAGCCCC 69 FBan0001762 FBgn0010395 betaInt-nu 2 2L cell adhesion; GO:0007155; cell motility; GO:0006928; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; development; GO:0007275; heterophilic cell adhesion; GO:0007157; signal transduction; GO:0007165 receptor activity; GO:0004872; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 betaInt-nu beta[nu] integrin "CG1762, CG1762, CG1762, Beta[[nu]], beta[[v]], betav, integrin beta neu, betanu, CT5192, Integrin bn, beta[nu]-intergin, integrin beta v, betaInt[nu]" CDMC27020 1 2 24 DAC38-E19 7-CG1762-RA_2 CG1762 GCTTCTTCGTCTATCAGGTCATCGACCACTCAAACTTCTTGACCATCCAGGCAGTTGATTGCGAGCCCC 69 FBan0001762 FBgn0010395 betaInt-nu 2 2L cell adhesion; GO:0007155; cell motility; GO:0006928; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; development; GO:0007275; heterophilic cell adhesion; GO:0007157; signal transduction; GO:0007165 receptor activity; GO:0004872; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 betaInt-nu beta[nu] integrin "CG1762, CG1762, CG1762, Beta[[nu]], beta[[v]], betav, integrin beta neu, betanu, CT5192, Integrin bn, beta[nu]-intergin, integrin beta v, betaInt[nu]" CDMC27021 1 3 24 DAC38-I07 17-CG17681-RB_1 CG17681 GCATCAGTTAGTGCTCCCCCAAAGAGCAAGTACACTCGAACATTTGTTCACCAAATCGTTATGGGCTCA 69 FBan0017681 FBgn0032668 CG17681 2 2L CG17681 CG17681 CDMC27021 1 4 24 DAC38-I07 17-CG17681-RB_1 CG17681 GCATCAGTTAGTGCTCCCCCAAAGAGCAAGTACACTCGAACATTTGTTCACCAAATCGTTATGGGCTCA 69 FBan0017681 FBgn0032668 CG17681 2 2L CG17681 CG17681 CDMC27022 1 5 24 DAC38-I19 14-CG17691-RA_5 CG17691 AAGAAAAGTGTTTTTTGCACCTTGAAGCACCCGTTAAACGAGTGGCTGGTTGGGATACTCCGTTTCCCC 69 FBgn0039993 CG17691 acyl-CoA biosynthesis; GO:0046949; amino acid catabolism; GO:0009063; tricarboxylic acid cycle; GO:0006099 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4 3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex; GO:0017086 CG17691 CG17691 CDMC27022 1 6 24 DAC38-I19 14-CG17691-RA_5 CG17691 AAGAAAAGTGTTTTTTGCACCTTGAAGCACCCGTTAAACGAGTGGCTGGTTGGGATACTCCGTTTCCCC 69 FBgn0039993 CG17691 acyl-CoA biosynthesis; GO:0046949; amino acid catabolism; GO:0009063; tricarboxylic acid cycle; GO:0006099 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4 3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex; GO:0017086 CG17691 CG17691 CDMC27023 1 7 24 DAC38-M07 17-CG1772-RA_1 CG1772 CCGCATTTCGGCTCATTGCTGCTTTGTTTTTGCGACCTACTAACATTGTAACCAATTCGACCAGTGGAA 69 FBan0001772 FBgn0010316 dap 2 2R G1/S transition of mitotic cell cycle; GO:0000082; cell cycle arrest; GO:0007050; maintenance of oocyte identity (sensu Insecta); GO:0016350; negative regulation of progression through cell cycle; GO:0045786; negative regulation of protein amino acid dephosphorylation; GO:0035308; oogenesis (sensu Insecta); GO:0009993; regulation of cyclin dependent protein kinase activity; GO:0000079; regulation of protein kinase activity; GO:0045859; sensory organ development; GO:0007423; tracheal system development (sensu Insecta); GO:0007424 cyclin-dependent protein kinase inhibitor activity; GO:0004861; ; GO:0004861; ; GO:0004861; ; GO:0004861 nucleus; GO:0005634 dap dacapo "CG1772, CG1772, CDI4, Cdi4: Cyclin-dependent kinase interactor 4, chakra, E(Sev-CycE)2B, dacapo/cyclin-dependent kinase interactor 4, Dap, decapo, P15, CDKN2B, CIB1, Decapo, p21[dacapo], cdi4, l(2)04454, Cyclin-dependent kinase interactor 4, Cdi4, dacapo" CDMC27023 1 8 24 DAC38-M07 17-CG1772-RA_1 CG1772 CCGCATTTCGGCTCATTGCTGCTTTGTTTTTGCGACCTACTAACATTGTAACCAATTCGACCAGTGGAA 69 FBan0001772 FBgn0010316 dap 2 2R G1/S transition of mitotic cell cycle; GO:0000082; cell cycle arrest; GO:0007050; maintenance of oocyte identity (sensu Insecta); GO:0016350; negative regulation of progression through cell cycle; GO:0045786; negative regulation of protein amino acid dephosphorylation; GO:0035308; oogenesis (sensu Insecta); GO:0009993; regulation of cyclin dependent protein kinase activity; GO:0000079; regulation of protein kinase activity; GO:0045859; sensory organ development; GO:0007423; tracheal system development (sensu Insecta); GO:0007424 cyclin-dependent protein kinase inhibitor activity; GO:0004861; ; GO:0004861; ; GO:0004861; ; GO:0004861 nucleus; GO:0005634 dap dacapo "CG1772, CG1772, CDI4, Cdi4: Cyclin-dependent kinase interactor 4, chakra, E(Sev-CycE)2B, dacapo/cyclin-dependent kinase interactor 4, Dap, decapo, P15, CDKN2B, CIB1, Decapo, p21[dacapo], cdi4, l(2)04454, Cyclin-dependent kinase interactor 4, Cdi4, dacapo" CDMC27024 1 9 24 DAC38-M19 17-CG17743-RA_1 CG17743 ACCAGTATTTCGGGGAAAAGTGGTTGTTCAAACGCTGAATCAAACAGCCAGAGTGAAGATACCTCTGCA 69 FBan0017743 FBgn0002521 pho 4 4 cell proliferation; GO:0008283; chromatin silencing; GO:0006342; gene silencing; GO:0016458; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nuclear chromatin; GO:0000790; nucleus; GO:0005634 pho pleiohomeotic "CG17743, l(4)BU-2, l(4)OC-1, l(4)29, l(4)102EFc, YY1, l(4)pho, PHO, Pho" CDMC27024 1 10 24 DAC38-M19 17-CG17743-RA_1 CG17743 ACCAGTATTTCGGGGAAAAGTGGTTGTTCAAACGCTGAATCAAACAGCCAGAGTGAAGATACCTCTGCA 69 FBan0017743 FBgn0002521 pho 4 4 cell proliferation; GO:0008283; chromatin silencing; GO:0006342; gene silencing; GO:0016458; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nuclear chromatin; GO:0000790; nucleus; GO:0005634 pho pleiohomeotic "CG17743, l(4)BU-2, l(4)OC-1, l(4)29, l(4)102EFc, YY1, l(4)pho, PHO, Pho" CDMC27025 1 11 24 DAC39-A07 11-CG3216-RB_1 CG3216 GCGATGTGTACTCCTTTGGCATTATTCTGGAGGAGATCGTCAACCGTGGTGGACCCTACCAGGAG 65 FBan0003216 FBgn0034568 CG3216 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 "ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872; GABA-B receptor activity; GO:0004965; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004965; ; GO:0008528" membrane; GO:0016020 CG3216 CG3216 GYC CDMC27025 1 12 24 DAC39-A07 11-CG3216-RB_1 CG3216 GCGATGTGTACTCCTTTGGCATTATTCTGGAGGAGATCGTCAACCGTGGTGGACCCTACCAGGAG 65 FBan0003216 FBgn0034568 CG3216 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 "ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872; GABA-B receptor activity; GO:0004965; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004965; ; GO:0008528" membrane; GO:0016020 CG3216 CG3216 GYC CDMC27026 1 13 24 DAC39-A19 3-CG32185-RA_1 CG32185 GGTGACAATAGTGGCCTCCTATCGTCAACCATATCCCGAGGAGTTCCAGACCAGTCCAGAGCAGC 65 FBan0032185 FBgn0052185 CG32185 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32185 CG32185 CDMC27026 1 14 24 DAC39-A19 3-CG32185-RA_1 CG32185 GGTGACAATAGTGGCCTCCTATCGTCAACCATATCCCGAGGAGTTCCAGACCAGTCCAGAGCAGC 65 FBan0032185 FBgn0052185 CG32185 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32185 CG32185 CDMC27027 1 15 24 DAC39-E07 5-CG32271-RA_1 CG32271 AGACGGGTGTCAGAAGTGGTGTGGACAAGGTTTATACCCCAAAGGCTTACAACACCCGCACCCTC 65 FBan0032271 FBgn0052271 CG32271 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG32271 CG32271 "CG11532, SP176" CDMC27027 1 16 24 DAC39-E07 5-CG32271-RA_1 CG32271 AGACGGGTGTCAGAAGTGGTGTGGACAAGGTTTATACCCCAAAGGCTTACAACACCCGCACCCTC 65 FBan0032271 FBgn0052271 CG32271 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG32271 CG32271 "CG11532, SP176" CDMC27028 1 17 24 DAC39-E19 23-CG32334-RA_1 CG32334 TACGGCAATTGTTCAAATTTCGAGCTGCTACCGCATGCAAAATATGTGTAATTGTTTGATATAAG 65 FBan0032334 FBgn0052334 CG32334 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32334 CG32334 CDMC27028 1 18 24 DAC39-E19 23-CG32334-RA_1 CG32334 TACGGCAATTGTTCAAATTTCGAGCTGCTACCGCATGCAAAATATGTGTAATTGTTTGATATAAG 65 FBan0032334 FBgn0052334 CG32334 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32334 CG32334 CDMC27029 1 19 24 DAC39-I07 3-CG32443-RA_1 CG32443 ATACCAAAACCGTGCAACAACCTGGCTATCAACCAGAAACAGCCGCTTACTCCTCTTTCGCCGCG 65 FBan0032443 FBgn0003042 Pc 3 3L chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; gene silencing; GO:0016458 chromatin binding; GO:0003682; ; GO:0003682; methylated histone residue binding; GO:0035064; transcriptional repressor activity; GO:0016564; ; GO:0035064; ; GO:0016564 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634 Pc Polycomb "CG32443, CG7618, DmPc, Pc-G, dPC, PC" CDMC27029 1 20 24 DAC39-I07 3-CG32443-RA_1 CG32443 ATACCAAAACCGTGCAACAACCTGGCTATCAACCAGAAACAGCCGCTTACTCCTCTTTCGCCGCG 65 FBan0032443 FBgn0003042 Pc 3 3L chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; gene silencing; GO:0016458 chromatin binding; GO:0003682; ; GO:0003682; methylated histone residue binding; GO:0035064; transcriptional repressor activity; GO:0016564; ; GO:0035064; ; GO:0016564 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634 Pc Polycomb "CG32443, CG7618, DmPc, Pc-G, dPC, PC" CDMC27030 1 21 24 DAC39-I19 23-CG32490-RE_1 CG32490 CAACAAAGTTGAAAAAACGTCTTAGCGATGCGTTTAAGAATTGTCCTTTGAGAAACTTGTTCTGA 65 FBan0032490 FBgn0041605 cpx 3 3R neurotransmitter transport; GO:0006836; synaptic vesicle exocytosis; GO:0016079 syntaxin binding; GO:0019905; ; GO:0019905 cpx complexin "CG32490, BcDNA:HL04936, BcDNA:GH27718, BcDNA:RH26459, BcDNA:RH31085, complexin" CDMC27030 1 22 24 DAC39-I19 23-CG32490-RE_1 CG32490 CAACAAAGTTGAAAAAACGTCTTAGCGATGCGTTTAAGAATTGTCCTTTGAGAAACTTGTTCTGA 65 FBan0032490 FBgn0041605 cpx 3 3R neurotransmitter transport; GO:0006836; synaptic vesicle exocytosis; GO:0016079 syntaxin binding; GO:0019905; ; GO:0019905 cpx complexin "CG32490, BcDNA:HL04936, BcDNA:GH27718, BcDNA:RH26459, BcDNA:RH31085, complexin" CDMC27031 1 23 24 DAC39-M07 2-CG32538-RA_1 CG32538 CATTTCCCACACCTGTCTGACATCCTCTGCGGAGTACGAACTGGCGCTGATACTCAAGGAGCTGC 65 FBan0032538 FBgn0031014 nAcRalpha-18C X X cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-18C nicotinic Acetylcholine Receptor alpha 18C "CG32538, CG8082, CG8109, CT24218, Dalpha7, nAChR" CDMC27031 1 24 24 DAC39-M07 2-CG32538-RA_1 CG32538 CATTTCCCACACCTGTCTGACATCCTCTGCGGAGTACGAACTGGCGCTGATACTCAAGGAGCTGC 65 FBan0032538 FBgn0031014 nAcRalpha-18C X X cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-18C nicotinic Acetylcholine Receptor alpha 18C "CG32538, CG8082, CG8109, CT24218, Dalpha7, nAChR" CDMC27032 1 25 24 DAC39-M19 18-CG32552-RA_1 CG32552 GCAGCCGGAAGACCAAACGACCATTGAGCCGCCCTTTTAAGCCGTGTTAGTAGACCGCGGTCGTC 65 FBan0032552 FBgn0052552 CG32552 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32552 CG32552 CDMC27032 1 26 24 DAC39-M19 18-CG32552-RA_1 CG32552 GCAGCCGGAAGACCAAACGACCATTGAGCCGCCCTTTTAAGCCGTGTTAGTAGACCGCGGTCGTC 65 FBan0032552 FBgn0052552 CG32552 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32552 CG32552 CDMC27033 1 1 25 DAC40-A07 3-CG41041-RA_5 CG41041 GATGTGTCAAGCTGAGACGGATTGCGGCCGGTTCCCTTTGGAGATCTAGTGCAGAAAGGCAAAGG 65 FBgn0069966 CG41041 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41041 CG41041 CDMC27033 1 2 25 DAC40-A07 3-CG41041-RA_5 CG41041 GATGTGTCAAGCTGAGACGGATTGCGGCCGGTTCCCTTTGGAGATCTAGTGCAGAAAGGCAAAGG 65 FBgn0069966 CG41041 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41041 CG41041 CDMC27034 1 3 25 DAC40-A19 15-CG4109-RA_1 CG4109 CAGCAGAACGAAGGACTCGAGGTTCTATCAGCCACATTGTCCAGACAGCGCCAACTGGCCACACA 65 FBan0004109 FBgn0036643 Syx8 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx8 Syntaxin 8 "CG4109, DmSyx8, syntaxin, Dm Syx8, Syntaxin 8" CDMC27034 1 4 25 DAC40-A19 15-CG4109-RA_1 CG4109 CAGCAGAACGAAGGACTCGAGGTTCTATCAGCCACATTGTCCAGACAGCGCCAACTGGCCACACA 65 FBan0004109 FBgn0036643 Syx8 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx8 Syntaxin 8 "CG4109, DmSyx8, syntaxin, Dm Syx8, Syntaxin 8" CDMC27035 1 5 25 DAC40-E07 2-CG4166-RA_1 CG4166 GCACCAGAAGGACACGTGGGTCAAGTGCGATGATCATGTGATAACGATGGCATCGCTCAAGCAGG 65 FBan0004166 FBgn0013717 not 3 3L axon target recognition; GO:0007412; protein deubiquitination; GO:0016579; ubiquitin-dependent protein catabolism; GO:0006511 nucleic acid binding; GO:0003676; ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 nucleus; GO:0005634 not non-stop "CG4166, CG4166, l(3)02069, nonstop, i155, anon-WO0257455.9, l(3)j9A6" CDMC27035 1 6 25 DAC40-E07 2-CG4166-RA_1 CG4166 GCACCAGAAGGACACGTGGGTCAAGTGCGATGATCATGTGATAACGATGGCATCGCTCAAGCAGG 65 FBan0004166 FBgn0013717 not 3 3L axon target recognition; GO:0007412; protein deubiquitination; GO:0016579; ubiquitin-dependent protein catabolism; GO:0006511 nucleic acid binding; GO:0003676; ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0004843; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 nucleus; GO:0005634 not non-stop "CG4166, CG4166, l(3)02069, nonstop, i155, anon-WO0257455.9, l(3)j9A6" CDMC27036 1 7 25 DAC40-E19 23-CG4193-RA_3 CG4193 ATTCGATGTTATGTGTATGCTCATGTGATGTTTAGCTTGTAAGCGCGAGATGTGGGTAGCAGGAG 65 FBan0004193 FBgn0011761 dhd X X electron transport; GO:0006118; embryonic development; GO:0009790; female meiosis; GO:0007143; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 nucleus; GO:0005634 dhd deadhead "CG4193, thioredoxin-like, DmTrx-1, Trx-1, thioredoxin" CDMC27036 1 8 25 DAC40-E19 23-CG4193-RA_3 CG4193 ATTCGATGTTATGTGTATGCTCATGTGATGTTTAGCTTGTAAGCGCGAGATGTGGGTAGCAGGAG 65 FBan0004193 FBgn0011761 dhd X X electron transport; GO:0006118; embryonic development; GO:0009790; female meiosis; GO:0007143; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 nucleus; GO:0005634 dhd deadhead "CG4193, thioredoxin-like, DmTrx-1, Trx-1, thioredoxin" CDMC27037 1 9 25 DAC40-I07 3-CG4325-RA_2 CG4325 TGCCGCCTACTTTCAGCTTTATCTGGACTTTGAGGAGTTTCCGGAAAGTGCATCGGCTCAGGGTG 65 FBan0004325 FBgn0026878 CG4325 X X CG4325 CG4325 EG:22E5.12 CDMC27037 1 10 25 DAC40-I07 3-CG4325-RA_2 CG4325 TGCCGCCTACTTTCAGCTTTATCTGGACTTTGAGGAGTTTCCGGAAAGTGCATCGGCTCAGGGTG 65 FBan0004325 FBgn0026878 CG4325 X X CG4325 CG4325 EG:22E5.12 CDMC27038 1 11 25 DAC40-I19 15-CG4375-RA_1 CG4375 ACAAGACTACCAACGGAGGTCTCTGCGAAAAACCAATCTCCAAGGTCGAGCCTGAACAATCTCGG 65 FBan0004375 FBgn0031295 CG4375 2 2L CG4375 CG4375 BcDNA:AT13819 CDMC27038 1 12 25 DAC40-I19 15-CG4375-RA_1 CG4375 ACAAGACTACCAACGGAGGTCTCTGCGAAAAACCAATCTCCAAGGTCGAGCCTGAACAATCTCGG 65 FBan0004375 FBgn0031295 CG4375 2 2L CG4375 CG4375 BcDNA:AT13819 CDMC27039 1 13 25 DAC40-M07 15-CG4494-RA_1 CG4494 AAATCAACATGTCTGACGAAAAGAAGGGAGGTGAGACCGAGCACATCAACCTGAAGGTCCTCGGC 65 FBan0004494 FBgn0026170 smt3 2 2L anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein import into nucleus; GO:0006606; protein modification; GO:0006464 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 smt3 smt3 "CG4494, l(2)04493, SMT3, dSmt3, DmSmt3, Smt3, Dmsmt3, Dm0342, DmSUMO-1, SUMO, sumo, anon-EST:Posey240" CDMC27039 1 14 25 DAC40-M07 15-CG4494-RA_1 CG4494 AAATCAACATGTCTGACGAAAAGAAGGGAGGTGAGACCGAGCACATCAACCTGAAGGTCCTCGGC 65 FBan0004494 FBgn0026170 smt3 2 2L anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein import into nucleus; GO:0006606; protein modification; GO:0006464 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 smt3 smt3 "CG4494, l(2)04493, SMT3, dSmt3, DmSmt3, Smt3, Dmsmt3, Dm0342, DmSUMO-1, SUMO, sumo, anon-EST:Posey240" CDMC27040 1 15 25 DAC40-M19 1-CG4554-RA_1 CG4554 GATTTGCGGAAAGGCTACCACTGGTTCTACCCACTCTGGTGAACGTTCTGACTTTGGGGCATGCG 65 FBan0004554 FBgn0034734 CG4554 2 2R CG4554 CG4554 CDMC27040 1 16 25 DAC40-M19 1-CG4554-RA_1 CG4554 GATTTGCGGAAAGGCTACCACTGGTTCTACCCACTCTGGTGAACGTTCTGACTTTGGGGCATGCG 65 FBan0004554 FBgn0034734 CG4554 2 2R CG4554 CG4554 CDMC27041 1 17 25 DAC41-A07 2-CG4548-RB_1 CG4548 TCGACGAGCAGCAGATTTCACGGCACTACAATCAGACGGACCTTATGGAGCTGTACTCGTACGAGCTGA 69 FBan0004548 FBgn0039338 XNP 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0016251; ; GO:0003678; ; GO:0003677 nucleus; GO:0005634 XNP XNP "CG4548, xnp/atr-x, EP(3)0635, EP635" CDMC27041 1 18 25 DAC41-A07 2-CG4548-RB_1 CG4548 TCGACGAGCAGCAGATTTCACGGCACTACAATCAGACGGACCTTATGGAGCTGTACTCGTACGAGCTGA 69 FBan0004548 FBgn0039338 XNP 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0016251; ; GO:0003678; ; GO:0003677 nucleus; GO:0005634 XNP XNP "CG4548, xnp/atr-x, EP(3)0635, EP635" CDMC27042 1 19 25 DAC41-A19 1-CG4565-RA_1 CG4565 TTGAGTGCAATGACATGTGCAAATGCTGTAGAAACACGTGCTCCAATCGGCTTGTGTACTCAGGCCCGA 69 FBan0004565 FBgn0037841 CG4565 3 3R chromatin modification; GO:0016568 zinc ion binding; GO:0008270; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0008270; ; GO:0018024 ; EC:2.1.1.43 nucleus; GO:0005634 CG4565 CG4565 CDMC27042 1 20 25 DAC41-A19 1-CG4565-RA_1 CG4565 TTGAGTGCAATGACATGTGCAAATGCTGTAGAAACACGTGCTCCAATCGGCTTGTGTACTCAGGCCCGA 69 FBan0004565 FBgn0037841 CG4565 3 3R chromatin modification; GO:0016568 zinc ion binding; GO:0008270; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0008270; ; GO:0018024 ; EC:2.1.1.43 nucleus; GO:0005634 CG4565 CG4565 CDMC27043 1 21 25 DAC41-E07 15-CG4603-RA_1 CG4603 AGTGTGAAGCTCAAGTCCAAAAAAGGTCAATTCATTGTCAACGACCTGAACGAGCATACGACGCTGGGG 69 FBan0004603 FBgn0035593 CG4603 3 3L CG4603 CG4603 CDMC27043 1 22 25 DAC41-E07 15-CG4603-RA_1 CG4603 AGTGTGAAGCTCAAGTCCAAAAAAGGTCAATTCATTGTCAACGACCTGAACGAGCATACGACGCTGGGG 69 FBan0004603 FBgn0035593 CG4603 3 3L CG4603 CG4603 CDMC27044 1 23 25 DAC41-E19 23-CG4609-RA_8 CG4609 AACAAAAACGAAAAAAAACATCAAGAACACCCATTTACAAACCTAGGACAACTGTAAAGCAAAAGCAGG 69 FBan0004609 FBgn0014163 fax 3 3L axonogenesis; GO:0007409; transmission of nerve impulse; GO:0019226 fax failed axon connections "CG4609, fac, clone 1.34, Fax, anon-EST:Liang-1.34, anon-WO0172774.62, anon-WO0172774.63, anon-WO0172774.65, anon-WO0172774.66, anon-WO0172774.67, anon-WO0172774.68, anon-WO0172774.69, failed axon connections" CDMC27044 1 24 25 DAC41-E19 23-CG4609-RA_8 CG4609 AACAAAAACGAAAAAAAACATCAAGAACACCCATTTACAAACCTAGGACAACTGTAAAGCAAAAGCAGG 69 FBan0004609 FBgn0014163 fax 3 3L axonogenesis; GO:0007409; transmission of nerve impulse; GO:0019226 fax failed axon connections "CG4609, fac, clone 1.34, Fax, anon-EST:Liang-1.34, anon-WO0172774.62, anon-WO0172774.63, anon-WO0172774.65, anon-WO0172774.66, anon-WO0172774.67, anon-WO0172774.68, anon-WO0172774.69, failed axon connections" CDMC27045 1 25 25 DAC41-I07 18-CG4637-RA_2 CG4637 TGGCGCCACGATTGAGATGGAATCCTGGAAGAGCGATCCTGATCCCAACGATCCTGTATTGTATTATAT 69 FBan0004637 FBgn0004644 hh 3 3R "Bolwig's organ morphogenesis; GO:0001746; R8 cell fate specification; GO:0045464; activation of hh target transcription factor; GO:0007228; analia morphogenesis (sensu Endopterygota); GO:0007487; anterior head segmentation; GO:0035288; anterior/posterior lineage restriction, imaginal disc; GO:0048099; cell-cell signaling; GO:0007267; compartment specification; GO:0007386; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoneme biogenesis; GO:0035231; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; epidermis development; GO:0008544; foregut morphogenesis; GO:0007440; genital disc development; GO:0035215; germ cell attraction; GO:0035232; germ cell migration; GO:0008354; germ-line stem cell division; GO:0042078; glial cell migration; GO:0008347; gonadal mesoderm development; GO:0007506; growth; GO:0040007; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; intein-mediated protein splicing; GO:0016539; intracellular signaling cascade; GO:0007242; leg disc morphogenesis; GO:0007478; mesoderm development; GO:0007498; negative regulation of proteolysis; GO:0045861; ovarian follicle cell development (sensu Insecta); GO:0030707; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; pigmentation during development; GO:0048066; positive regulation of smoothened signaling pathway; GO:0045880; posterior head segmentation; GO:0035289; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein autoprocessing; GO:0016540; protein import into nucleus; GO:0006606; protein splicing; GO:0030908; regulation of cell proliferation; GO:0042127; regulation of organ size; GO:0046620; regulation of progression through mitotic cell cycle; GO:0007346; regulation of protein import into nucleus; GO:0042306; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; wing disc anterior/posterior pattern formation; GO:0048100; wing disc proximal/distal pattern formation; GO:0007473; wing vein specification; GO:0007474" patched binding; GO:0005113; ; GO:0005113; signal transducer activity; GO:0004871; morphogen activity; GO:0016015; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; endopeptidase activity; GO:0004175; ; GO:0016015; ; GO:0004871; ; GO:0004175; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005113 cytoplasm; GO:0005737; cytoplasmic membrane-bound vesicle; GO:0016023; extracellular region; GO:0005576; nucleus; GO:0005634 hh hedgehog "CG4637, l(3)hh, l(3)neo56, bar-3: bar-on-3, bar, bar3, hg, Mrt: Moonrat, Hh, anon-WO0182946.19, HH, anon-WO0134654.19, Mir, l(3)neo57, Mirabile, Moonrat, bar-on-3, bar-3, Mrt, hedgehog" CDMC27045 1 26 25 DAC41-I07 18-CG4637-RA_2 CG4637 TGGCGCCACGATTGAGATGGAATCCTGGAAGAGCGATCCTGATCCCAACGATCCTGTATTGTATTATAT 69 FBan0004637 FBgn0004644 hh 3 3R "Bolwig's organ morphogenesis; GO:0001746; R8 cell fate specification; GO:0045464; activation of hh target transcription factor; GO:0007228; analia morphogenesis (sensu Endopterygota); GO:0007487; anterior head segmentation; GO:0035288; anterior/posterior lineage restriction, imaginal disc; GO:0048099; cell-cell signaling; GO:0007267; compartment specification; GO:0007386; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoneme biogenesis; GO:0035231; determination of anterior/posterior axis, embryo; GO:0008595; ectoderm development; GO:0007398; epidermis development; GO:0008544; foregut morphogenesis; GO:0007440; genital disc development; GO:0035215; germ cell attraction; GO:0035232; germ cell migration; GO:0008354; germ-line stem cell division; GO:0042078; glial cell migration; GO:0008347; gonadal mesoderm development; GO:0007506; growth; GO:0040007; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; intein-mediated protein splicing; GO:0016539; intracellular signaling cascade; GO:0007242; leg disc morphogenesis; GO:0007478; mesoderm development; GO:0007498; negative regulation of proteolysis; GO:0045861; ovarian follicle cell development (sensu Insecta); GO:0030707; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; pigmentation during development; GO:0048066; positive regulation of smoothened signaling pathway; GO:0045880; posterior head segmentation; GO:0035289; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein autoprocessing; GO:0016540; protein import into nucleus; GO:0006606; protein splicing; GO:0030908; regulation of cell proliferation; GO:0042127; regulation of organ size; GO:0046620; regulation of progression through mitotic cell cycle; GO:0007346; regulation of protein import into nucleus; GO:0042306; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; wing disc anterior/posterior pattern formation; GO:0048100; wing disc proximal/distal pattern formation; GO:0007473; wing vein specification; GO:0007474" patched binding; GO:0005113; ; GO:0005113; signal transducer activity; GO:0004871; morphogen activity; GO:0016015; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; endopeptidase activity; GO:0004175; ; GO:0016015; ; GO:0004871; ; GO:0004175; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005113 cytoplasm; GO:0005737; cytoplasmic membrane-bound vesicle; GO:0016023; extracellular region; GO:0005576; nucleus; GO:0005634 hh hedgehog "CG4637, l(3)hh, l(3)neo56, bar-3: bar-on-3, bar, bar3, hg, Mrt: Moonrat, Hh, anon-WO0182946.19, HH, anon-WO0134654.19, Mir, l(3)neo57, Mirabile, Moonrat, bar-on-3, bar-3, Mrt, hedgehog" CDMC27046 1 1 26 DAC41-I19 2-CG4648-RA_2 CG4648 GTTCGGGGAATTGGTGGTAGATGCCATTAAGGTGCAGACGGAATCAGAACCTACTGCCCATGAGGAGCT 69 FBan0004648 FBgn0031225 CG4648 2 2L CG4648 CG4648 CDMC27046 1 2 26 DAC41-I19 2-CG4648-RA_2 CG4648 GTTCGGGGAATTGGTGGTAGATGCCATTAAGGTGCAGACGGAATCAGAACCTACTGCCCATGAGGAGCT 69 FBan0004648 FBgn0031225 CG4648 2 2L CG4648 CG4648 CDMC27047 1 3 26 DAC41-M07 12-CG4675-RB_6 CG4675 TGGTCATTGGAAAGAACTTCCCGGTCAATCAGGGCATATACGACTGTGTCTGTACACCGCCAATTGGGA 69 FBan0004675 FBgn0031899 Ndae1 2 2L anion transport; GO:0006820; bicarbonate transport; GO:0015701; chloride transport; GO:0006821; proton transport; GO:0015992; sodium ion transport; GO:0006814 anion exchanger activity; GO:0015380; cation transporter activity; GO:0008324; ; GO:0015380; sodium:bicarbonate symporter activity; GO:0008510; ; GO:0008324; ; GO:0015380; bicarbonate transporter activity; GO:0015106; ; GO:0008510; ; GO:0015106; inorganic anion exchanger activity; GO:0005452; ; GO:0005452 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Ndae1 Na[+]-driven anion exchanger 1 "CG4675, CG4675, CG4675, CG4675, l(2)k10316, NDAE1, ndae1, anon-WO0257455.13, Na[+]-driven anion exchanger 1" CDMC27047 1 4 26 DAC41-M07 12-CG4675-RB_6 CG4675 TGGTCATTGGAAAGAACTTCCCGGTCAATCAGGGCATATACGACTGTGTCTGTACACCGCCAATTGGGA 69 FBan0004675 FBgn0031899 Ndae1 2 2L anion transport; GO:0006820; bicarbonate transport; GO:0015701; chloride transport; GO:0006821; proton transport; GO:0015992; sodium ion transport; GO:0006814 anion exchanger activity; GO:0015380; cation transporter activity; GO:0008324; ; GO:0015380; sodium:bicarbonate symporter activity; GO:0008510; ; GO:0008324; ; GO:0015380; bicarbonate transporter activity; GO:0015106; ; GO:0008510; ; GO:0015106; inorganic anion exchanger activity; GO:0005452; ; GO:0005452 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Ndae1 Na[+]-driven anion exchanger 1 "CG4675, CG4675, CG4675, CG4675, l(2)k10316, NDAE1, ndae1, anon-WO0257455.13, Na[+]-driven anion exchanger 1" CDMC27048 1 5 26 DAC41-M19 23-CG4681-RA_3 CG4681 TCAATGTGTGTAGATTGTCCAGGTCTTTTATCAAATCACAATCGTTGTTGCAAGAAACTTAGCCACCGT 69 FBgn0035029 CDMC27048 1 6 26 DAC41-M19 23-CG4681-RA_3 CG4681 TCAATGTGTGTAGATTGTCCAGGTCTTTTATCAAATCACAATCGTTGTTGCAAGAAACTTAGCCACCGT 69 FBgn0035029 CDMC27049 1 7 26 DAC42-A07 150mM NaPO4 Blank CDMC27049 1 8 26 DAC42-A07 150mM NaPO4 Blank CDMC27050 1 9 26 DAC42-A19 150mM NaPO4 Blank CDMC27050 1 10 26 DAC42-A19 150mM NaPO4 Blank CDMC27051 1 11 26 DAC42-E07 150mM NaPO4 Blank CDMC27051 1 12 26 DAC42-E07 150mM NaPO4 Blank CDMC27052 1 13 26 DAC42-E19 150mM NaPO4 Blank CDMC27052 1 14 26 DAC42-E19 150mM NaPO4 Blank CDMC27053 1 15 26 DAC42-I07 150mM NaPO4 Blank CDMC27053 1 16 26 DAC42-I07 150mM NaPO4 Blank CDMC27054 1 17 26 DAC42-I19 5uM MSP 5uM MSP CDMC27054 1 18 26 DAC42-I19 5uM MSP 5uM MSP CDMC27055 1 19 26 DAC42-M07 10uM MSP 10uM MSP CDMC27055 1 20 26 DAC42-M07 10uM MSP 10uM MSP CDMC27056 1 21 26 DAC42-M19 20uM MSP 20uM MSP CDMC27056 1 22 26 DAC42-M19 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC27057 2 1 1 DAC01-B07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27057 2 2 1 DAC01-B07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27058 2 3 1 DAC01-B19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27058 2 4 1 DAC01-B19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27059 2 5 1 DAC01-F07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27059 2 6 1 DAC01-F07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27060 2 7 1 DAC01-F19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27060 2 8 1 DAC01-F19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27061 2 9 1 DAC01-J07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27061 2 10 1 DAC01-J07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27062 2 11 1 DAC01-J19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27062 2 12 1 DAC01-J19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27063 2 13 1 DAC01-N07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27063 2 14 1 DAC01-N07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27064 2 15 1 DAC01-N19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27064 2 16 1 DAC01-N19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27065 2 17 1 DAC02-B07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27065 2 18 1 DAC02-B07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27066 2 19 1 DAC02-B19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27066 2 20 1 DAC02-B19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27067 2 21 1 DAC02-F07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27067 2 22 1 DAC02-F07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27068 2 23 1 DAC02-F19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27068 2 24 1 DAC02-F19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27069 2 25 1 DAC02-J07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27069 2 26 1 DAC02-J07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27070 2 1 2 DAC02-J19 N/A CG9075 (00001-00239) CDMC27070 2 2 2 DAC02-J19 N/A CG9075 (00001-00239) CDMC27071 2 3 2 DAC02-N07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27071 2 4 2 DAC02-N07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27072 2 5 2 DAC02-N19 AutoBlank AutoBlank CDMC27072 2 6 2 DAC02-N19 AutoBlank AutoBlank CDMC27073 2 7 2 DAC03-B07 3-CG3780-RA_2 CG3780 GTACACATGCCCAAGGATCGTGTCACCCAAATGCACCAGGGCTATGGATTCGTCGAGTTCCTCAG 65 FBan0003780 FBgn0015818 Spx X X "histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" "mRNA binding; GO:0003729; ; GO:0003729; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 Spx Spliceosomal protein on the X "CG3780, CG3780, SPX, Spliceosomal protein on the X" CDMC27073 2 8 2 DAC03-B07 3-CG3780-RA_2 CG3780 GTACACATGCCCAAGGATCGTGTCACCCAAATGCACCAGGGCTATGGATTCGTCGAGTTCCTCAG 65 FBan0003780 FBgn0015818 Spx X X "histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" "mRNA binding; GO:0003729; ; GO:0003729; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 Spx Spliceosomal protein on the X "CG3780, CG3780, SPX, Spliceosomal protein on the X" CDMC27074 2 9 2 DAC03-B19 14-CG3822-RA_2 CG3822 CTCCACATATCAGCGCATGTGGTCATTCATGGAATCAGCTCGTCCTTCCGTCTTTACAGCCAGCA 65 FBan0003822 FBgn0038837 CG3822 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG3822 CG3822 CT12759 CDMC27074 2 10 2 DAC03-B19 14-CG3822-RA_2 CG3822 CTCCACATATCAGCGCATGTGGTCATTCATGGAATCAGCTCGTCCTTCCGTCTTTACAGCCAGCA 65 FBan0003822 FBgn0038837 CG3822 3 3R cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG3822 CG3822 CT12759 CDMC27075 2 11 2 DAC03-F07 3-CG3950-RA_5 CG3950 TGATCGAGGCACCACAGATGCGTCAGAATCAGAGTCACACCATGAGCACCACTCGATCCAGCAAC 65 FBan0003950 FBgn0029875 CG3950 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG3950 CG3950 CDMC27075 2 12 2 DAC03-F07 3-CG3950-RA_5 CG3950 TGATCGAGGCACCACAGATGCGTCAGAATCAGAGTCACACCATGAGCACCACTCGATCCAGCAAC 65 FBan0003950 FBgn0029875 CG3950 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG3950 CG3950 CDMC27076 2 13 2 DAC03-F19 15-CG3979-RA_2 CG3979 TTGGCAATGCTCTGATTGGATTGAAGGTTCTGCCCAACTCTGTCCTCTTACTGGTGGTCATCCTG 65 FBan0003979 FBgn0036816 Indy 3 3L cation transport; GO:0006812; determination of adult life span; GO:0008340; sodium ion transport; GO:0006814 citrate transporter activity; GO:0015137; succinate transporter activity; GO:0015141; tricarboxylic acid transporter activity; GO:0015142; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015137; ; GO:0015141; ; GO:0015142 plasma membrane; GO:0005886 Indy I'm not dead yet "CG3979, indy, drIndy, I am not dead yet, anon-WO0172774.70, anon-EST:fe3A7, BEST:LP01220, anon-fast-evolving-3A7, I'm not dead yet" CDMC27076 2 14 2 DAC03-F19 15-CG3979-RA_2 CG3979 TTGGCAATGCTCTGATTGGATTGAAGGTTCTGCCCAACTCTGTCCTCTTACTGGTGGTCATCCTG 65 FBan0003979 FBgn0036816 Indy 3 3L cation transport; GO:0006812; determination of adult life span; GO:0008340; sodium ion transport; GO:0006814 citrate transporter activity; GO:0015137; succinate transporter activity; GO:0015141; tricarboxylic acid transporter activity; GO:0015142; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015137; ; GO:0015141; ; GO:0015142 plasma membrane; GO:0005886 Indy I'm not dead yet "CG3979, indy, drIndy, I am not dead yet, anon-WO0172774.70, anon-EST:fe3A7, BEST:LP01220, anon-fast-evolving-3A7, I'm not dead yet" CDMC27077 2 15 2 DAC03-J07 23-CG40133-RA_2 CG40133 ACAATAGCGACTCGTCAGGGGAAGACATAATTCAGGAGTATAAAAATCTGCTAGCAACAAGGAGT 65 FBgn0058133 CG40133 CG40133 CG40133 CDMC27077 2 16 2 DAC03-J07 23-CG40133-RA_2 CG40133 ACAATAGCGACTCGTCAGGGGAAGACATAATTCAGGAGTATAAAAATCTGCTAGCAACAAGGAGT 65 FBgn0058133 CG40133 CG40133 CG40133 CDMC27078 2 17 2 DAC03-J19 23-CG40178-RC_2 CG40178 GCCTCGAAGTTTAACTAGGTTACGATACCTTCTAACCGCCTTTGAATTTTACGACCGAGTTGCAT 65 FBgn0058178 CG40178 CG40178 CG40178 CDMC27078 2 18 2 DAC03-J19 23-CG40178-RC_2 CG40178 GCCTCGAAGTTTAACTAGGTTACGATACCTTCTAACCGCCTTTGAATTTTACGACCGAGTTGCAT 65 FBgn0058178 CG40178 CG40178 CG40178 CDMC27079 2 19 2 DAC03-N07 6-CG40370-RA_1 CG40370 CCGATGCTGACGCTGCGATGGAGAACAATGACCGTTGCAGTGGATCTCCCCCTTTAAGATCTGCG 65 FBgn0058370 CG40370 CG40370 CG40370 CDMC27079 2 20 2 DAC03-N07 6-CG40370-RA_1 CG40370 CCGATGCTGACGCTGCGATGGAGAACAATGACCGTTGCAGTGGATCTCCCCCTTTAAGATCTGCG 65 FBgn0058370 CG40370 CG40370 CG40370 CDMC27080 2 21 2 DAC03-N19 23-CG4041-RA_1 CG4041 CTCAGCTTGTTCAAGTTCATTCCAAAGTATCTGCAATGGTTCTTTCTCAAGGATAATTCGGCGGT 65 FBan0004041 FBgn0029736 CG4041 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG4041 CG4041 CDMC27080 2 22 2 DAC03-N19 23-CG4041-RA_1 CG4041 CTCAGCTTGTTCAAGTTCATTCCAAAGTATCTGCAATGGTTCTTTCTCAAGGATAATTCGGCGGT 65 FBan0004041 FBgn0029736 CG4041 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG4041 CG4041 CDMC27081 2 23 2 DAC04-B07 15-CG31513-RA_1 CG31513 GCTGGCGAAACAGGCATGTTGTCGTGTTAAATACGGTGCATGTCACGGCATTAACTTTAAGGCCAATGT 69 FBan0031513 FBgn0051513 CG31513 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31513 CG31513 CDMC27081 2 24 2 DAC04-B07 15-CG31513-RA_1 CG31513 GCTGGCGAAACAGGCATGTTGTCGTGTTAAATACGGTGCATGTCACGGCATTAACTTTAAGGCCAATGT 69 FBan0031513 FBgn0051513 CG31513 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31513 CG31513 CDMC27082 2 25 2 DAC04-B19 16-CG31522-RC_1 CG31522 CCTCACGTTCCTCTCCGAAACATGGGGGATCAATTATTTTGACACCAGTTCTCTAATTGGCAAGAGCGG 69 FBan0031522 FBgn0051522 CG31522 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31522 CG31522 "CG9798, anon-WO0118547.381, BcDNA:GH22993, BcDNA:LD10305" CDMC27082 2 26 2 DAC04-B19 16-CG31522-RC_1 CG31522 CCTCACGTTCCTCTCCGAAACATGGGGGATCAATTATTTTGACACCAGTTCTCTAATTGGCAAGAGCGG 69 FBan0031522 FBgn0051522 CG31522 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31522 CG31522 "CG9798, anon-WO0118547.381, BcDNA:GH22993, BcDNA:LD10305" CDMC27083 2 1 3 DAC04-F07 22-CG31549-RA_1 CG31549 TCCAGTGATCGAACTTCGCTTAGCGTAAAAGAAACACCCCACGATGTCATCCTTCAAGGACAAAGTGAT 69 FBan0031549 FBgn0051549 CG31549 3 3R lipid metabolism; GO:0006629 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31549 CG31549 "CG11005, CG11005" CDMC27083 2 2 3 DAC04-F07 22-CG31549-RA_1 CG31549 TCCAGTGATCGAACTTCGCTTAGCGTAAAAGAAACACCCCACGATGTCATCCTTCAAGGACAAAGTGAT 69 FBan0031549 FBgn0051549 CG31549 3 3R lipid metabolism; GO:0006629 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31549 CG31549 "CG11005, CG11005" CDMC27084 2 3 3 DAC04-F19 3-CG31560-RA_2 CG31560 TGAGGAGACCGTCCAAGGATAAAGTGGATGACCAAATCGCAATGGGCTTCAATGGGATGATGGGCGAAA 69 FBan0031560 FBgn0051560 CG31560 3 3R CG31560 CG31560 CG10314 CDMC27084 2 4 3 DAC04-F19 3-CG31560-RA_2 CG31560 TGAGGAGACCGTCCAAGGATAAAGTGGATGACCAAATCGCAATGGGCTTCAATGGGATGATGGGCGAAA 69 FBan0031560 FBgn0051560 CG31560 3 3R CG31560 CG31560 CG10314 CDMC27085 2 5 3 DAC04-J07 1-CG31628-RA_1 CG31628 GCCGGAATACCTTCGTTGGTCATCTCCCACAAGGATTTCGCTAGCCGAGAGGTCTATGATGCGGAACTT 69 FBan0031628 FBgn0000053 ade3 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 phosphoribosylamine-glycine ligase activity; GO:0004637 ; EC:6.3.4.13; ; GO:0004637 ; EC:6.3.4.13; phosphoribosylformylglycinamidine cyclo-ligase activity; GO:0004641 ; EC:6.3.3.1; phosphoribosylglycinamide formyltransferase activity; GO:0004644 ; EC:2.1.2.2; ; GO:0004641 ; EC:6.3.3.1; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004637 ; EC:6.3.4.13; ; GO:0004641 ; EC:6.3.3.1; ; GO:0004644 ; EC:2.1.2.2 cytoplasm; GO:0005737 ade3 adenosine 3 "CG31628, CG8761, ADE8, D, Complementation group D, Gart, gart, GART, Gart/ade3, l(2)27Da" CDMC27085 2 6 3 DAC04-J07 1-CG31628-RA_1 CG31628 GCCGGAATACCTTCGTTGGTCATCTCCCACAAGGATTTCGCTAGCCGAGAGGTCTATGATGCGGAACTT 69 FBan0031628 FBgn0000053 ade3 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base biosynthesis; GO:0009113; purine base metabolism; GO:0006144 phosphoribosylamine-glycine ligase activity; GO:0004637 ; EC:6.3.4.13; ; GO:0004637 ; EC:6.3.4.13; phosphoribosylformylglycinamidine cyclo-ligase activity; GO:0004641 ; EC:6.3.3.1; phosphoribosylglycinamide formyltransferase activity; GO:0004644 ; EC:2.1.2.2; ; GO:0004641 ; EC:6.3.3.1; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004637 ; EC:6.3.4.13; ; GO:0004641 ; EC:6.3.3.1; ; GO:0004644 ; EC:2.1.2.2 cytoplasm; GO:0005737 ade3 adenosine 3 "CG31628, CG8761, ADE8, D, Complementation group D, Gart, gart, GART, Gart/ade3, l(2)27Da" CDMC27086 2 7 3 DAC04-J19 13-CG31637-RA_1 CG31637 AGCAACTGGGTGCATTGTGCATTGTGAAAAACTCATTCATAGCGGGCACATTTTTGCTACACACGCAGA 69 FBan0031637 FBgn0051637 CG31637 2 2L carbohydrate metabolism; GO:0005975 sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG31637 CG31637 "CG13765, CG9551, anon-WO0118547.107" CDMC27086 2 8 3 DAC04-J19 13-CG31637-RA_1 CG31637 AGCAACTGGGTGCATTGTGCATTGTGAAAAACTCATTCATAGCGGGCACATTTTTGCTACACACGCAGA 69 FBan0031637 FBgn0051637 CG31637 2 2L carbohydrate metabolism; GO:0005975 sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG31637 CG31637 "CG13765, CG9551, anon-WO0118547.107" CDMC27087 2 9 3 DAC04-N07 22-CG31660-RB_1 CG31660 TATCCACCAGTTGTCCATGTGACCCACTAAAATATCTCAAATTCGCAGGCTCTAAGTGCCAAACACCGC 69 FBan0031660 FBgn0051660 CG31660 2 2L metabotropic glutamate receptor signaling pathway; GO:0007216 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021 CG31660 CG31660 "CG11923, CG11925, CG11923, anon-WO0170980.181, anon-WO0170980.182" CDMC27087 2 10 3 DAC04-N07 22-CG31660-RB_1 CG31660 TATCCACCAGTTGTCCATGTGACCCACTAAAATATCTCAAATTCGCAGGCTCTAAGTGCCAAACACCGC 69 FBan0031660 FBgn0051660 CG31660 2 2L metabotropic glutamate receptor signaling pathway; GO:0007216 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" integral to membrane; GO:0016021 CG31660 CG31660 "CG11923, CG11925, CG11923, anon-WO0170980.181, anon-WO0170980.182" CDMC27088 2 11 3 DAC04-N19 3-CG31670-RA_1 CG31670 TCGCCAATACCGAAAGCCCTGAGTTCCGTGTAGACACGCTACACAGATCCTCCAGGACACGTTTCGATA 69 FBgn0051670 CDMC27088 2 12 3 DAC04-N19 3-CG31670-RA_1 CG31670 TCGCCAATACCGAAAGCCCTGAGTTCCGTGTAGACACGCTACACAGATCCTCCAGGACACGTTTCGATA 69 FBgn0051670 CDMC27089 2 13 3 DAC05-B07 23-CG5968-RA_7 CG5968 TTGATGTCTGAGATGGAGGCCCTTGACAAAGAAGAATCTCCGGAGAAGTCACTTAAAAAGAAAAAGAAA 69 FBan0005968 FBgn0032588 CG5968 2 2L CG5968 CG5968 BcDNA:AT27976 CDMC27089 2 14 3 DAC05-B07 23-CG5968-RA_7 CG5968 TTGATGTCTGAGATGGAGGCCCTTGACAAAGAAGAATCTCCGGAGAAGTCACTTAAAAAGAAAAAGAAA 69 FBan0005968 FBgn0032588 CG5968 2 2L CG5968 CG5968 BcDNA:AT27976 CDMC27090 2 15 3 DAC05-B19 1-CG5986-RA_1 CG5986 ACCGCATTTTACTTGCTCTGCACTCTGTTCGCACACTTCATTTGACGGTCAAGTTTAGCCGCTACCGGT 69 FBan0005986 FBgn0043455 CG5986 3 3R CG5986 CG5986 BEST:LP03871 CDMC27090 2 16 3 DAC05-B19 1-CG5986-RA_1 CG5986 ACCGCATTTTACTTGCTCTGCACTCTGTTCGCACACTTCATTTGACGGTCAAGTTTAGCCGCTACCGGT 69 FBan0005986 FBgn0043455 CG5986 3 3R CG5986 CG5986 BEST:LP03871 CDMC27091 2 17 3 DAC05-F07 17-CG6025-RA_3 CG6025 TCGCCGAGGTCCATCATGCGTTAGGACTGGAGAACCTAAAGAACCGCACATTTCAAATATTCAAAACGT 69 FBan0006025 FBgn0000115 Arf72A 3 3L cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Arf72A Arflike at 72A "CG6025, CG6025, arl, dARL1p, l(3)72Ae, Arf, Arl1, arf[72A], BcDNA:GM20805" CDMC27091 2 18 3 DAC05-F07 17-CG6025-RA_3 CG6025 TCGCCGAGGTCCATCATGCGTTAGGACTGGAGAACCTAAAGAACCGCACATTTCAAATATTCAAAACGT 69 FBan0006025 FBgn0000115 Arf72A 3 3L cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 Arf72A Arflike at 72A "CG6025, CG6025, arl, dARL1p, l(3)72Ae, Arf, Arl1, arf[72A], BcDNA:GM20805" CDMC27092 2 19 3 DAC05-F19 16-CG6040-RA_1 CG6040 TGCTGGCAATCTAAGGAATGTAGTCTCGGTGCAGAATCTAAGTACACTGAACGAAGAATCCTCGGCCAA 69 FBan0006040 FBgn0038679 CG6040 3 3R CG6040 CG6040 CDMC27092 2 20 3 DAC05-F19 16-CG6040-RA_1 CG6040 TGCTGGCAATCTAAGGAATGTAGTCTCGGTGCAGAATCTAAGTACACTGAACGAAGAATCCTCGGCCAA 69 FBan0006040 FBgn0038679 CG6040 3 3R CG6040 CG6040 CDMC27093 2 21 3 DAC05-J07 2-CG6067-RA_1 CG6067 CCACTCACACATCCTGCCATCAGCATCAGAGTAAATCGCCAAGGATTTGTGTCCAGCCGAAAACCAGCA 69 FBan0006067 FBgn0029828 CG6067 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG6067 CG6067 CDMC27093 2 22 3 DAC05-J07 2-CG6067-RA_1 CG6067 CCACTCACACATCCTGCCATCAGCATCAGAGTAAATCGCCAAGGATTTGTGTCCAGCCGAAAACCAGCA 69 FBan0006067 FBgn0029828 CG6067 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG6067 CG6067 CDMC27094 2 23 3 DAC05-J19 13-CG6081-RA_1 CG6081 AGCAATGGAGGTGGTATGAAAAGTTACAGAGACAGGGGTGTTTACCTAGCTTTTGGCGATGGACCTCGT 69 FBan0006081 FBgn0031688 Cyp28d2 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28d2 Cyp28d2 "CG6081, 28d2" CDMC27094 2 24 3 DAC05-J19 13-CG6081-RA_1 CG6081 AGCAATGGAGGTGGTATGAAAAGTTACAGAGACAGGGGTGTTTACCTAGCTTTTGGCGATGGACCTCGT 69 FBan0006081 FBgn0031688 Cyp28d2 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28d2 Cyp28d2 "CG6081, 28d2" CDMC27095 2 25 3 DAC05-N07 1-CG6127-RA_1 CG6127 TGGATCGGGTCACAGTCTGCTGATAGGAGTGCTATGCGGTGTCTTTATAGTCCTGGTGGGATTCTCGGT 69 FBan0006127 FBgn0004197 Ser 3 3R "Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; crystal cell differentiation; GO:0042688; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; larval salivary gland morphogenesis; GO:0007436; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; lymph gland crystal cell differentiation; GO:0035170; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; nervous system development; GO:0007399; regulation of crystal cell differentiation; GO:0042689; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; epidermal growth factor receptor binding; GO:0005154; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0005112; ; GO:0004871; ; GO:0005154; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Ser Serrate "CG6127, Bd: Beaded, Rpw: Ripped wing, dmSerrate, CT18858, serrate, Beaded, ser, mel(3)8, std, Ripped wing, serratoid, Bd, Rpw" CDMC27095 2 26 3 DAC05-N07 1-CG6127-RA_1 CG6127 TGGATCGGGTCACAGTCTGCTGATAGGAGTGCTATGCGGTGTCTTTATAGTCCTGGTGGGATTCTCGGT 69 FBan0006127 FBgn0004197 Ser 3 3R "Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; crystal cell differentiation; GO:0042688; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; larval salivary gland morphogenesis; GO:0007436; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; lymph gland crystal cell differentiation; GO:0035170; lymph gland hemopoiesis (sensu Arthropoda); GO:0035167; nervous system development; GO:0007399; regulation of crystal cell differentiation; GO:0042689; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; epidermal growth factor receptor binding; GO:0005154; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0005112; ; GO:0004871; ; GO:0005154; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Ser Serrate "CG6127, Bd: Beaded, Rpw: Ripped wing, dmSerrate, CT18858, serrate, Beaded, ser, mel(3)8, std, Ripped wing, serratoid, Bd, Rpw" CDMC27096 2 1 4 DAC05-N19 23-CG6139-RA_14 CG6139 GGAATGAACGATCCACCCCGAAAAAGATTCCAAAGTGAACCAATTGTGAAAAAGAAAGTGCAATCCAGA 69 FBgn0033852 CDMC27096 2 2 4 DAC05-N19 23-CG6139-RA_14 CG6139 GGAATGAACGATCCACCCCGAAAAAGATTCCAAAGTGAACCAATTGTGAAAAAGAAAGTGCAATCCAGA 69 FBgn0033852 CDMC27097 2 3 4 DAC06-B07 8-CG11517-RA_1 CG11517 GCTGCAAGTGCCCCACTTTATTTTGTTAAGCGCCTTCGATGGCCAACAAACGAAAAGTCCTTTGAGCCA 69 FBan0011517 FBgn0040622 CG11517 3 3R CG11517 CG11517 CDMC27097 2 4 4 DAC06-B07 8-CG11517-RA_1 CG11517 GCTGCAAGTGCCCCACTTTATTTTGTTAAGCGCCTTCGATGGCCAACAAACGAAAAGTCCTTTGAGCCA 69 FBan0011517 FBgn0040622 CG11517 3 3R CG11517 CG11517 CDMC27098 2 5 4 DAC06-B19 18-CG11537-RA_9 CG11537 AGATGGGCTTTAACTATGTGGAGGTCTCGGTCTTTATAGCCATAGTAGGCATCCTCAGCATCACGGTGC 69 FBan0011537 FBgn0035400 CG11537 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; defense response; GO:0006952; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG11537 CG11537 CDMC27098 2 6 4 DAC06-B19 18-CG11537-RA_9 CG11537 AGATGGGCTTTAACTATGTGGAGGTCTCGGTCTTTATAGCCATAGTAGGCATCCTCAGCATCACGGTGC 69 FBan0011537 FBgn0035400 CG11537 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; defense response; GO:0006952; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG11537 CG11537 CDMC27099 2 7 4 DAC06-F07 23-CG11584-RB_2 CG11584 GCATCAAGTTGGGTGTTCAACGATTTAGCTGAACTTAGTGTTACGTAGCCAATTTCTAGCACCTTATAA 69 FBan0011584 FBgn0030541 CG11584 X X CG11584 CG11584 CDMC27099 2 8 4 DAC06-F07 23-CG11584-RB_2 CG11584 GCATCAAGTTGGGTGTTCAACGATTTAGCTGAACTTAGTGTTACGTAGCCAATTTCTAGCACCTTATAA 69 FBan0011584 FBgn0030541 CG11584 X X CG11584 CG11584 CDMC27100 2 9 4 DAC06-F19 15-CG11594-RB_7 CG11594 TGCTGTGGCTGAAGAGGAATCTGTCACAGACTTTTGGAAATATTTGGAGGGTCTTTGACCTGCCCGACT 69 FBan0011594 FBgn0035484 CG11594 3 3L carbohydrate metabolism; GO:0005975 CG11594 CG11594 CDMC27100 2 10 4 DAC06-F19 15-CG11594-RB_7 CG11594 TGCTGTGGCTGAAGAGGAATCTGTCACAGACTTTTGGAAATATTTGGAGGGTCTTTGACCTGCCCGACT 69 FBan0011594 FBgn0035484 CG11594 3 3L carbohydrate metabolism; GO:0005975 CG11594 CG11594 CDMC27101 2 11 4 DAC06-J07 11-CG11639-RA_1 CG11639 CGCGAGGATCAGCATTCCTTGAAGGTCGATGTGGTCAAAATTGTGGCCTGTCTTGGAACTGACAATGGA 69 FBan0011639 FBgn0040338 TfIIA-S-2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-S-2 TfIIA-S-2 "CG11639, CG11639, CG11639, EG:BACR7A4.7, TFIIA" CDMC27101 2 12 4 DAC06-J07 11-CG11639-RA_1 CG11639 CGCGAGGATCAGCATTCCTTGAAGGTCGATGTGGTCAAAATTGTGGCCTGTCTTGGAACTGACAATGGA 69 FBan0011639 FBgn0040338 TfIIA-S-2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIIA complex; GO:0005672 TfIIA-S-2 TfIIA-S-2 "CG11639, CG11639, CG11639, EG:BACR7A4.7, TFIIA" CDMC27102 2 13 4 DAC06-J19 18-CG11655-RA_10 CG11655 GCTGGACGTGAAGATCAAGCGACCGAAACGTGTGGTGGATGACATATTCCTGGGTACGATCATACTACT 69 FBan0011655 FBgn0030638 CG11655 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 cation transporter activity; GO:0008324; ; GO:0008324; bile acid:sodium symporter activity; GO:0008508; ; GO:0008508 membrane; GO:0016020 CG11655 CG11655 CDMC27102 2 14 4 DAC06-J19 18-CG11655-RA_10 CG11655 GCTGGACGTGAAGATCAAGCGACCGAAACGTGTGGTGGATGACATATTCCTGGGTACGATCATACTACT 69 FBan0011655 FBgn0030638 CG11655 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 cation transporter activity; GO:0008324; ; GO:0008324; bile acid:sodium symporter activity; GO:0008508; ; GO:0008508 membrane; GO:0016020 CG11655 CG11655 CDMC27103 2 15 4 DAC06-N07 23-CG11699-RA_5 CG11699 GTTGTGCGATCCAATTCGGGCATTAGTAGTTACGACAACAATAAATCGCAATTGAGAAGGATGAGCGAG 69 FBan0011699 FBgn0030311 CG11699 X X CG11699 CG11699 CDMC27103 2 16 4 DAC06-N07 23-CG11699-RA_5 CG11699 GTTGTGCGATCCAATTCGGGCATTAGTAGTTACGACAACAATAAATCGCAATTGAGAAGGATGAGCGAG 69 FBan0011699 FBgn0030311 CG11699 X X CG11699 CG11699 CDMC27104 2 17 4 DAC06-N19 22-CG11719-RA_1 CG11719 TCGCCGTTCTGCTCAAACACCACCAAAAAAGTCTACAGTTCTCTATACTTTGTCAACGCATGGACGACT 69 FBan0011719 FBgn0002865 Mst98Ca 3 3R Mst98Ca Male-specific RNA 98Ca "CG11719, Mst98C, Mst, MST98Ca, Mst98CE, mst(3)gl-12, mst336" CDMC27104 2 18 4 DAC06-N19 22-CG11719-RA_1 CG11719 TCGCCGTTCTGCTCAAACACCACCAAAAAAGTCTACAGTTCTCTATACTTTGTCAACGCATGGACGACT 69 FBan0011719 FBgn0002865 Mst98Ca 3 3R Mst98Ca Male-specific RNA 98Ca "CG11719, Mst98C, Mst, MST98Ca, Mst98CE, mst(3)gl-12, mst336" CDMC27105 2 19 4 DAC07-B07 1-CG14984-RA_1 CG14984 ATCGAAGAGTCTCGTCACCGAATCTCCCCAGGCGGAAACTACAAACCCACCAACCACATCCGATG 65 FBan0014984 FBgn0035480 CG14984 3 3L CG14984 CG14984 CDMC27105 2 20 4 DAC07-B07 1-CG14984-RA_1 CG14984 ATCGAAGAGTCTCGTCACCGAATCTCCCCAGGCGGAAACTACAAACCCACCAACCACATCCGATG 65 FBan0014984 FBgn0035480 CG14984 3 3L CG14984 CG14984 CDMC27106 2 21 4 DAC07-B19 1-CG15023-RA_1 CG15023 TATGGCTATGACTACCCCAAGCCGGAGATACCATTTGTGATTACCTCGACGACGGAGCCACCACC 65 FBan0015023 FBgn0035548 CG15023 3 3L CG15023 CG15023 CDMC27106 2 22 4 DAC07-B19 1-CG15023-RA_1 CG15023 TATGGCTATGACTACCCCAAGCCGGAGATACCATTTGTGATTACCTCGACGACGGAGCCACCACC 65 FBan0015023 FBgn0035548 CG15023 3 3L CG15023 CG15023 CDMC27107 2 23 4 DAC07-F07 1-CG15094-RB_1 CG15094 TTTATGCTTTTCGGACGCACAAGGGTTCAACCGTGGAATAGTCGCCCCACAACGAGAACTCCGTC 65 FBan0015094 FBgn0034392 CG15094 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; sodium ion transport; GO:0006814 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0005316 integral to membrane; GO:0016021 CG15094 CG15094 CDMC27107 2 24 4 DAC07-F07 1-CG15094-RB_1 CG15094 TTTATGCTTTTCGGACGCACAAGGGTTCAACCGTGGAATAGTCGCCCCACAACGAGAACTCCGTC 65 FBan0015094 FBgn0034392 CG15094 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; sodium ion transport; GO:0006814 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0005316 integral to membrane; GO:0016021 CG15094 CG15094 CDMC27108 2 25 4 DAC07-F19 23-CG15130-RA_1 CG15130 CCTAATAAGTGAGTACATCATAGCTGTAGCTTCGGTCTGGACACAGTTTAATCGAATCATTGCCG 65 FBan0015130 FBgn0032860 CG15130 2 2L CG15130 CG15130 38C.48 CDMC27108 2 26 4 DAC07-F19 23-CG15130-RA_1 CG15130 CCTAATAAGTGAGTACATCATAGCTGTAGCTTCGGTCTGGACACAGTTTAATCGAATCATTGCCG 65 FBan0015130 FBgn0032860 CG15130 2 2L CG15130 CG15130 38C.48 CDMC27109 2 1 5 DAC07-J07 3-CG15198-RA_1 CG15198 GAAAACCCTCGAGTCCGACGACAAACCCTTCAATCCCTTCTACATTGGCCCACATCCCAGCAAGG 65 FBan0015198 FBgn0030283 CG15198 X X CG15198 CG15198 CDMC27109 2 2 5 DAC07-J07 3-CG15198-RA_1 CG15198 GAAAACCCTCGAGTCCGACGACAAACCCTTCAATCCCTTCTACATTGGCCCACATCCCAGCAAGG 65 FBan0015198 FBgn0030283 CG15198 X X CG15198 CG15198 CDMC27110 2 3 5 DAC07-J19 3-CG15239-RA_1 CG15239 ATGAGACTGGATTCGCCTACGAGCTCCTCAATGGCATCCTGGATTTTTTCAACTGAGCGGCCAGC 65 FBan0015239 FBgn0029681 CG15239 X X CG15239 CG15239 CDMC27110 2 4 5 DAC07-J19 3-CG15239-RA_1 CG15239 ATGAGACTGGATTCGCCTACGAGCTCCTCAATGGCATCCTGGATTTTTTCAACTGAGCGGCCAGC 65 FBan0015239 FBgn0029681 CG15239 X X CG15239 CG15239 CDMC27111 2 5 5 DAC07-N07 23-CG15323-RA_1 CG15323 AAGGACCTGAAAGATCTGATTGCCCTGAATGAGAAGGAATGTAATAGGCTGTTATTCGATCGCCT 65 FBan0015323 FBgn0040784 CG15323 X X CG15323 CG15323 CDMC27111 2 6 5 DAC07-N07 23-CG15323-RA_1 CG15323 AAGGACCTGAAAGATCTGATTGCCCTGAATGAGAAGGAATGTAATAGGCTGTTATTCGATCGCCT 65 FBan0015323 FBgn0040784 CG15323 X X CG15323 CG15323 CDMC27112 2 7 5 DAC07-N19 16-CG15358-RA_1 CG15358 TACGGAATATGCAGAAGCTCAGTATTTGGCTGTTACTTGCTCTTTTTGCCTGGAATGCGCACGCG 65 FBan0015358 FBgn0031373 CG15358 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG15358 CG15358 CDMC27112 2 8 5 DAC07-N19 16-CG15358-RA_1 CG15358 TACGGAATATGCAGAAGCTCAGTATTTGGCTGTTACTTGCTCTTTTTGCCTGGAATGCGCACGCG 65 FBan0015358 FBgn0031373 CG15358 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG15358 CG15358 CDMC27113 2 9 5 DAC08-B07 3-CG14442-RA_1 CG14442 CCTGGCAGGCACAAAAGTCCACCGGAAACCCAGAAAGCTAAATGAAATGAAACACTGTGACGCCCC 66 FBan0014442 FBgn0029893 CG14442 X X CG14442 CG14442 CDMC27113 2 10 5 DAC08-B07 3-CG14442-RA_1 CG14442 CCTGGCAGGCACAAAAGTCCACCGGAAACCCAGAAAGCTAAATGAAATGAAACACTGTGACGCCCC 66 FBan0014442 FBgn0029893 CG14442 X X CG14442 CG14442 CDMC27114 2 11 5 DAC08-B19 16-CG14505-RA_1 CG14505 GGCACTCTCCGGACCTTTTGTAGCGAAAAAAGTTAACAAGTTTTTGTGCCGTTCCACTTGACTGCC 66 FBan0014505 FBgn0034327 CG14505 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14505 CG14505 CDMC27114 2 12 5 DAC08-B19 16-CG14505-RA_1 CG14505 GGCACTCTCCGGACCTTTTGTAGCGAAAAAAGTTAACAAGTTTTTGTGCCGTTCCACTTGACTGCC 66 FBan0014505 FBgn0034327 CG14505 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14505 CG14505 CDMC27115 2 13 5 DAC08-F07 3-CG14735-RA_3 CG14735 ACTTCGTGAGCGCCACCATACGGATGTCATGTTGTTGGAGGATCACGATCAGATGTGTTCGGTGGG 66 FBan0014735 FBgn0037985 CG14735 3 3R CG14735 CG14735 anon-WO0140519.127 CDMC27115 2 14 5 DAC08-F07 3-CG14735-RA_3 CG14735 ACTTCGTGAGCGCCACCATACGGATGTCATGTTGTTGGAGGATCACGATCAGATGTGTTCGGTGGG 66 FBan0014735 FBgn0037985 CG14735 3 3R CG14735 CG14735 anon-WO0140519.127 CDMC27116 2 15 5 DAC08-F19 1-CG14810-RA_1 CG14810 ACAGGATCTAAATATGACCAGTGGCTCCATCAACCCAGCTACATCGACCTCGAAAGGCGCCATCCC 66 FBan0014810 FBgn0029589 CG14810 X X CG14810 CG14810 CDMC27116 2 16 5 DAC08-F19 1-CG14810-RA_1 CG14810 ACAGGATCTAAATATGACCAGTGGCTCCATCAACCCAGCTACATCGACCTCGAAAGGCGCCATCCC 66 FBan0014810 FBgn0029589 CG14810 X X CG14810 CG14810 CDMC27117 2 17 5 DAC08-J07 1-CG15226-RA_3 CG15226 CCTGGGGTCAGTCCTTCAGTTTTCCCGTCTACACCGTGGGAAGCATAGTCTCGGCTCTAACAGGAG 66 FBan0015226 FBgn0034550 CG15226 2 2R CG15226 CG15226 CDMC27117 2 18 5 DAC08-J07 1-CG15226-RA_3 CG15226 CCTGGGGTCAGTCCTTCAGTTTTCCCGTCTACACCGTGGGAAGCATAGTCTCGGCTCTAACAGGAG 66 FBan0015226 FBgn0034550 CG15226 2 2R CG15226 CG15226 CDMC27118 2 19 5 DAC08-J19 14-CG15385-RA_3 CG15385 CAACCAGGGCCAAACCATAGCCTATGCCTCCAGACTAGCATTCGAAGTTTACCGGAGCGACGCTCA 66 FBan0015385 FBgn0031397 CG15385 2 2L phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0016791 ; EC:3.1.3.-; ; GO:0003993 ; EC:3.1.3.2 CG15385 CG15385 CDMC27118 2 20 5 DAC08-J19 14-CG15385-RA_3 CG15385 CAACCAGGGCCAAACCATAGCCTATGCCTCCAGACTAGCATTCGAAGTTTACCGGAGCGACGCTCA 66 FBan0015385 FBgn0031397 CG15385 2 2L phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0016791 ; EC:3.1.3.-; ; GO:0003993 ; EC:3.1.3.2 CG15385 CG15385 CDMC27119 2 21 5 DAC08-N07 6-CG15880-RA_1 CG15880 ACGGACTTCCAGTCCACCACGTATACCACCTGTAATGCCTTCAACATCTTTCCCTCCACATCGGCG 66 FBan0015880 FBgn0031283 CG15880 2 2L CG15880 CG15880 CDMC27119 2 22 5 DAC08-N07 6-CG15880-RA_1 CG15880 ACGGACTTCCAGTCCACCACGTATACCACCTGTAATGCCTTCAACATCTTTCCCTCCACATCGGCG 66 FBan0015880 FBgn0031283 CG15880 2 2L CG15880 CG15880 CDMC27120 2 23 5 DAC08-N19 3-CG1671-RA_4 CG1671 CAGGAGTGCACCATACTGAGAGCCGAGTTCCTGGATCACGGCAAGTTCATTATCTCCGCTGCTTCG 66 FBan0001671 FBgn0033454 CG1671 2 2R biological process unknown; GO:0000004 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 cellular component unknown; GO:0008372 CG1671 CG1671 CDMC27120 2 24 5 DAC08-N19 3-CG1671-RA_4 CG1671 CAGGAGTGCACCATACTGAGAGCCGAGTTCCTGGATCACGGCAAGTTCATTATCTCCGCTGCTTCG 66 FBan0001671 FBgn0033454 CG1671 2 2R biological process unknown; GO:0000004 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 cellular component unknown; GO:0008372 CG1671 CG1671 CDMC27121 2 25 5 DAC09-B08 2-CG14086-RA_1 CG14086 GCGACTTTGAAAAGGTGTCGAGCTTTGTGGATACCATGGAGGATGATTTCGCGGAGATTGGTGCCACGC 69 FBan0014086 FBgn0036860 CG14086 3 3L CG14086 CG14086 CDMC27121 2 26 5 DAC09-B08 2-CG14086-RA_1 CG14086 GCGACTTTGAAAAGGTGTCGAGCTTTGTGGATACCATGGAGGATGATTTCGCGGAGATTGGTGCCACGC 69 FBan0014086 FBgn0036860 CG14086 3 3L CG14086 CG14086 CDMC27122 2 1 6 DAC09-B20 16-CG1409-RA_2 CG1409 GGTCAGAAGAGCCGATGATCCTTCGCAGCTGTATTCACATGGATTGCCTTTTAGTAGCGTGGCATAAAA 69 FBan0001409 FBgn0029964 CG1409 X X CG1409 CG1409 "D.M.BLPp, BcDNA:AT29287" CDMC27122 2 2 6 DAC09-B20 16-CG1409-RA_2 CG1409 GGTCAGAAGAGCCGATGATCCTTCGCAGCTGTATTCACATGGATTGCCTTTTAGTAGCGTGGCATAAAA 69 FBan0001409 FBgn0029964 CG1409 X X CG1409 CG1409 "D.M.BLPp, BcDNA:AT29287" CDMC27123 2 3 6 DAC09-F08 8-CG14143-RA_1 CG14143 CCGCCACGGTCACTGTTTCATCGGTCACTGTTTCATCGGTCACTATTCCATCGGTCACTATTCCTTCGG 69 FBan0014143 FBgn0036138 CG14143 3 3L CG14143 CG14143 CDMC27123 2 4 6 DAC09-F08 8-CG14143-RA_1 CG14143 CCGCCACGGTCACTGTTTCATCGGTCACTGTTTCATCGGTCACTATTCCATCGGTCACTATTCCTTCGG 69 FBan0014143 FBgn0036138 CG14143 3 3L CG14143 CG14143 CDMC27124 2 5 6 DAC09-F20 16-CG14156-RA_1 CG14156 TCTTGGGCTACGACACCTTTGATCGAAATTTTGGTTTCCTCATCTGGTTTCCCTTCGATGCAACAAGGA 69 FBan0014156 FBgn0036078 Or67c 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67c Odorant receptor 67c "CG14156, 67D.1, DOR77, 67c" CDMC27124 2 6 6 DAC09-F20 16-CG14156-RA_1 CG14156 TCTTGGGCTACGACACCTTTGATCGAAATTTTGGTTTCCTCATCTGGTTTCCCTTCGATGCAACAAGGA 69 FBan0014156 FBgn0036078 Or67c 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67c Odorant receptor 67c "CG14156, 67D.1, DOR77, 67c" CDMC27125 2 7 6 DAC09-J08 10-CG14205-RA_1 CG14205 GCATTCGGGTACTGTCCTTCATCTGGGTCGTCTATGGCCACATATACCTCGTATCTTTCTTTGGCCCCA 69 FBan0014205 FBgn0031034 CG14205 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG14205 CG14205 CDMC27125 2 8 6 DAC09-J08 10-CG14205-RA_1 CG14205 GCATTCGGGTACTGTCCTTCATCTGGGTCGTCTATGGCCACATATACCTCGTATCTTTCTTTGGCCCCA 69 FBan0014205 FBgn0031034 CG14205 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG14205 CG14205 CDMC27126 2 9 6 DAC09-J20 23-CG14214-RA_7 CG14214 AGTGGCAAGGAAACCACCAATCATCCAATCATCCATTATAGCATACATCAGATCAACGTCTTTTTTTTT 69 FBan0014214 FBgn0031049 CG14214 X X "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; protein transport; GO:0015031; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0015450 integral to endoplasmic reticulum membrane; GO:0030176; translocon complex; GO:0005784 CG14214 CG14214 CDMC27126 2 10 6 DAC09-J20 23-CG14214-RA_7 CG14214 AGTGGCAAGGAAACCACCAATCATCCAATCATCCATTATAGCATACATCAGATCAACGTCTTTTTTTTT 69 FBan0014214 FBgn0031049 CG14214 X X "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; protein transport; GO:0015031; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0015450 integral to endoplasmic reticulum membrane; GO:0030176; translocon complex; GO:0005784 CG14214 CG14214 CDMC27127 2 11 6 DAC09-N08 7-CG14253-RA_1 CG14253 GCCCTGTTGCGTCCCATCATTCACGACCACAACGTATCCCATGATACTTATCTGGAGCTCTTCCGCTTC 69 FBan0014253 FBgn0039467 CG14253 3 3R CG14253 CG14253 CDMC27127 2 12 6 DAC09-N08 7-CG14253-RA_1 CG14253 GCCCTGTTGCGTCCCATCATTCACGACCACAACGTATCCCATGATACTTATCTGGAGCTCTTCCGCTTC 69 FBan0014253 FBgn0039467 CG14253 3 3R CG14253 CG14253 CDMC27128 2 13 6 DAC09-N20 2-CG14269-RA_1 CG14269 ACAGCCTATTGGTGGTCAGTTCCGGCTATGCGATCTACACTCTCCATCCAATGGAAACACCCTATGGCT 69 FBan0014269 FBgn0029658 CG14269 X X CG14269 CG14269 CDMC27128 2 14 6 DAC09-N20 2-CG14269-RA_1 CG14269 ACAGCCTATTGGTGGTCAGTTCCGGCTATGCGATCTACACTCTCCATCCAATGGAAACACCCTATGGCT 69 FBan0014269 FBgn0029658 CG14269 X X CG14269 CG14269 CDMC27129 2 15 6 DAC10-B07 23-CG1956-RA_1 CG1956 CATTGCATAAACTTCGCGTACGAGTAGTAACCAATATGCCCTTAAATCAAAGTCTAAACACAGCCAACA 69 FBan0001956 FBgn0004636 R 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; NOT regulation of JNK cascade; GO:0046328; cell adhesion; GO:0007155; cytokinesis; GO:0000910; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; mitosis; GO:0007067; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; receptor mediated endocytosis; GO:0006898; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; stalk formation (sensu Insecta); GO:0030713 GTP binding; GO:0005525; ; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0019003; ; GO:0003924 R Roughened "CG1956, Dras3, l(3)R, Rap1, l(3)62Bf, E(faf), Enhancer of faf, Dras62B, RAP1, ras3, RasIII, rap1, ras 3, DRap, DRap1, Rap, C-ras3, Ras3, BEST:GH18528" CDMC27129 2 16 6 DAC10-B07 23-CG1956-RA_1 CG1956 CATTGCATAAACTTCGCGTACGAGTAGTAACCAATATGCCCTTAAATCAAAGTCTAAACACAGCCAACA 69 FBan0001956 FBgn0004636 R 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; NOT regulation of JNK cascade; GO:0046328; cell adhesion; GO:0007155; cytokinesis; GO:0000910; dorsal closure; GO:0007391; intracellular protein transport; GO:0006886; mitosis; GO:0007067; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; receptor mediated endocytosis; GO:0006898; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; stalk formation (sensu Insecta); GO:0030713 GTP binding; GO:0005525; ; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0019003; ; GO:0003924 R Roughened "CG1956, Dras3, l(3)R, Rap1, l(3)62Bf, E(faf), Enhancer of faf, Dras62B, RAP1, ras3, RasIII, rap1, ras 3, DRap, DRap1, Rap, C-ras3, Ras3, BEST:GH18528" CDMC27130 2 17 6 DAC10-B19 2-CG1964-RA_1 CG1964 AGAAAACCAAGTCCATGGGTAATCTGTCCAACGAGAAGGTCAAACTGCAGGTGGTTTACAAGCCGCCCT 69 FBan0001964 FBgn0039688 Kul 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 Kul Kuzbanian-like "CG1964, CT3146, ADAM10, Kuzbanian-like" CDMC27130 2 18 6 DAC10-B19 2-CG1964-RA_1 CG1964 AGAAAACCAAGTCCATGGGTAATCTGTCCAACGAGAAGGTCAAACTGCAGGTGGTTTACAAGCCGCCCT 69 FBan0001964 FBgn0039688 Kul 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 Kul Kuzbanian-like "CG1964, CT3146, ADAM10, Kuzbanian-like" CDMC27131 2 19 6 DAC10-F07 22-CG2005-RC_4 CG2005 CGGATGCAGACCGAGGATTTGGGAGCACACTTCAATATCCGATCGTATCAATCCAATCATTTGTCAGCT 69 FBan0002005 FBgn0004369 Ptp99A 3 3R axonal defasciculation; GO:0007414; defasciculation of motor neuron; GO:0007415; motor axon guidance; GO:0008045; protein amino acid dephosphorylation; GO:0006470 DNA binding; GO:0003677; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0003677 nucleus; GO:0005634; plasma membrane; GO:0005886 Ptp99A Protein tyrosine phosphatase 99A "CG2005, CG2005, DPTP[[99A]], DPTP99A, dptp99A, PTP99A, R-PTP 99A, CT6383" CDMC27131 2 20 6 DAC10-F07 22-CG2005-RC_4 CG2005 CGGATGCAGACCGAGGATTTGGGAGCACACTTCAATATCCGATCGTATCAATCCAATCATTTGTCAGCT 69 FBan0002005 FBgn0004369 Ptp99A 3 3R axonal defasciculation; GO:0007414; defasciculation of motor neuron; GO:0007415; motor axon guidance; GO:0008045; protein amino acid dephosphorylation; GO:0006470 DNA binding; GO:0003677; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0003677 nucleus; GO:0005634; plasma membrane; GO:0005886 Ptp99A Protein tyrosine phosphatase 99A "CG2005, CG2005, DPTP[[99A]], DPTP99A, dptp99A, PTP99A, R-PTP 99A, CT6383" CDMC27132 2 21 6 DAC10-F19 5-CG2019-RA_1 CG2019 AGCTGGCGGAATCATGATGGCATCCAACATATTGCCCTACATACAGATTGGCGTCTTCCTGGTCGTTGT 69 FBan0002019 FBgn0029088 disp 3 3R exocytosis; GO:0006887; response to oxidative stress; GO:0006979; smoothened signaling pathway; GO:0007224 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 integral to membrane; GO:0016021; membrane; GO:0016020 disp dispatched "CG2019, anon-WO0146227.1, dispatched" CDMC27132 2 22 6 DAC10-F19 5-CG2019-RA_1 CG2019 AGCTGGCGGAATCATGATGGCATCCAACATATTGCCCTACATACAGATTGGCGTCTTCCTGGTCGTTGT 69 FBan0002019 FBgn0029088 disp 3 3R exocytosis; GO:0006887; response to oxidative stress; GO:0006979; smoothened signaling pathway; GO:0007224 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 integral to membrane; GO:0016021; membrane; GO:0016020 disp dispatched "CG2019, anon-WO0146227.1, dispatched" CDMC27133 2 23 6 DAC10-J07 1-CG2053-RA_1 CG2053 GCACCCACATTGACAGCCTAGGACTCTTGCTATGGCATTCCTTTGGAGCTGTGAGTGGCTTGCTACAAG 69 FBan0002053 FBgn0039887 CG2053 3 3R CG2053 CG2053 CDMC27133 2 24 6 DAC10-J07 1-CG2053-RA_1 CG2053 GCACCCACATTGACAGCCTAGGACTCTTGCTATGGCATTCCTTTGGAGCTGTGAGTGGCTTGCTACAAG 69 FBan0002053 FBgn0039887 CG2053 3 3R CG2053 CG2053 CDMC27134 2 25 6 DAC10-J19 17-CG2069-RA_1 CG2069 TGAGCGGGGACTAGTGTTTTAATTACTCCAGCTGTTTTTCATTCTGCTTATCCCAGGTGGTACAGGCGT 69 FBan0002069 FBgn0035264 Oseg4 3 3L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg4 Oseg4 "CG2069, CG2069, cytC40, OSEG4" CDMC27134 2 26 6 DAC10-J19 17-CG2069-RA_1 CG2069 TGAGCGGGGACTAGTGTTTTAATTACTCCAGCTGTTTTTCATTCTGCTTATCCCAGGTGGTACAGGCGT 69 FBan0002069 FBgn0035264 Oseg4 3 3L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg4 Oseg4 "CG2069, CG2069, cytC40, OSEG4" CDMC27135 2 1 7 DAC10-N07 15-CG2103-RB_1 CG2103 CGCTTGGCCACATAACAATTTACCCCGACTCAAGCGCACATATGCAACAGAGGATGCAACAGAGAGTAT 69 FBan0002103 FBgn0035375 pgant6 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant6 polypeptide GalNAc transferase 6 "CG2103, CG2103, CG2103, CG2103, CG2103, polypeptide GalNAc transferase 6" CDMC27135 2 2 7 DAC10-N07 15-CG2103-RB_1 CG2103 CGCTTGGCCACATAACAATTTACCCCGACTCAAGCGCACATATGCAACAGAGGATGCAACAGAGAGTAT 69 FBan0002103 FBgn0035375 pgant6 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant6 polypeptide GalNAc transferase 6 "CG2103, CG2103, CG2103, CG2103, CG2103, polypeptide GalNAc transferase 6" CDMC27136 2 3 7 DAC10-N19 2-CG2114-RA_2 CG2114 CGCCTGAGTCGTGACCAACCGGATCTTATCCACTACGAGAGCTCCATATCGAACAACGGCGATGGAACT 69 FBan0002114 FBgn0035385 FR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity; GO:0001653; ; GO:0004930; ; GO:0008188; opioid receptor activity; GO:0004985; ; GO:0008188; ; GO:0004930; ; GO:0001653; ; GO:0004985; ; GO:0004930 integral to membrane; GO:0016021 FR Fmrf Receptor "CG2114, CG2114, CG2114, CG2114, CG2114, CG2114, larval-opioid-receptor, DrmFMRFa-R, FMRFaR" CDMC27136 2 4 7 DAC10-N19 2-CG2114-RA_2 CG2114 CGCCTGAGTCGTGACCAACCGGATCTTATCCACTACGAGAGCTCCATATCGAACAACGGCGATGGAACT 69 FBan0002114 FBgn0035385 FR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity; GO:0001653; ; GO:0004930; ; GO:0008188; opioid receptor activity; GO:0004985; ; GO:0008188; ; GO:0004930; ; GO:0001653; ; GO:0004985; ; GO:0004930 integral to membrane; GO:0016021 FR Fmrf Receptor "CG2114, CG2114, CG2114, CG2114, CG2114, CG2114, larval-opioid-receptor, DrmFMRFa-R, FMRFaR" CDMC27137 2 5 7 DAC11-B07 1-CG9187-RA_1 CG9187 TGCCCATTGATCTAACCAACAATCTGCGTCCGCCCAAGTCACTTTACATCGAGGTGCGCTGCATG 65 FBan0009187 FBgn0035194 CG9187 3 3L CG9187 CG9187 CDMC27137 2 6 7 DAC11-B07 1-CG9187-RA_1 CG9187 TGCCCATTGATCTAACCAACAATCTGCGTCCGCCCAAGTCACTTTACATCGAGGTGCGCTGCATG 65 FBan0009187 FBgn0035194 CG9187 3 3L CG9187 CG9187 CDMC27138 2 7 7 DAC11-B19 6-CG9214-RA_1 CG9214 GCCTCTTTGAGTCGCACTTCTCTGCGGATGTTAGCAGCATGGGTCTGTATGTGAGCGGAACAGCT 65 FBan0009214 FBgn0028397 Tob X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; negative regulation of cell proliferation; GO:0008285; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Tob Tob "CG9214, CG9214" CDMC27138 2 8 7 DAC11-B19 6-CG9214-RA_1 CG9214 GCCTCTTTGAGTCGCACTTCTCTGCGGATGTTAGCAGCATGGGTCTGTATGTGAGCGGAACAGCT 65 FBan0009214 FBgn0028397 Tob X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; negative regulation of cell proliferation; GO:0008285; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Tob Tob "CG9214, CG9214" CDMC27139 2 9 7 DAC11-F07 2-CG9330-RA_1 CG9330 CAGTGGAAAAGGAGACTGTGGTCACGCTCAAATTCCCCGAAGTGGAACCCCTTAATCCTCCCGTG 65 FBan0009330 FBgn0036888 CG9330 3 3L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9330 CG9330 CDMC27139 2 10 7 DAC11-F07 2-CG9330-RA_1 CG9330 CAGTGGAAAAGGAGACTGTGGTCACGCTCAAATTCCCCGAAGTGGAACCCCTTAATCCTCCCGTG 65 FBan0009330 FBgn0036888 CG9330 3 3L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9330 CG9330 CDMC27140 2 11 7 DAC11-F19 3-CG9363-RA_3 CG9363 TGCGATGAACCTGAAGGAGATACCCTACGACATCAAGCCGATCAGCCTGATCAAATCCGGTGGCG 65 FBan0009363 FBgn0037697 CG9363 3 3R L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 maleylacetoacetate isomerase activity; GO:0016034 ; EC:5.2.1.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2; ; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2 cytoplasm; GO:0005737 CG9363 CG9363 CDMC27140 2 12 7 DAC11-F19 3-CG9363-RA_3 CG9363 TGCGATGAACCTGAAGGAGATACCCTACGACATCAAGCCGATCAGCCTGATCAAATCCGGTGGCG 65 FBan0009363 FBgn0037697 CG9363 3 3R L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 maleylacetoacetate isomerase activity; GO:0016034 ; EC:5.2.1.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2; ; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2 cytoplasm; GO:0005737 CG9363 CG9363 CDMC27141 2 13 7 DAC11-J07 20-CG9487-RA_1 CG9487 CCGGCCAAACGGAACTCGAGTGTTAGCCATGTCTATGACAACTATCTGCTGTATGCCACCAGCGA 65 FBan0009487 FBgn0032073 CG9487 2 2L CG9487 CG9487 CDMC27141 2 14 7 DAC11-J07 20-CG9487-RA_1 CG9487 CCGGCCAAACGGAACTCGAGTGTTAGCCATGTCTATGACAACTATCTGCTGTATGCCACCAGCGA 65 FBan0009487 FBgn0032073 CG9487 2 2L CG9487 CG9487 CDMC27142 2 15 7 DAC11-J19 2-CG9533-RA_1 CG9533 GCGACAGAAGCGCCTACAAAAGTCCGAGCTCAATCACAAACGATCGGAGGTTGCAACAGAGGCAG 65 FBan0009533 FBgn0003301 rut X X G-protein coupled receptor protein signaling pathway; GO:0007186; behavioral response to ethanol; GO:0048149; cAMP biosynthesis; GO:0006171; cAMP-mediated signaling; GO:0019933; courtship behavior; GO:0007619; grooming behavior; GO:0007625; learning; GO:0007612; learning and/or memory; GO:0007611; mating behavior; GO:0007617; memory; GO:0007613; molting cycle (sensu Insecta); GO:0007591; olfactory learning; GO:0008355; synaptic transmission; GO:0007268 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; calcium- and calmodulin-responsive adenylate cyclase activity; GO:0008294; ; GO:0008294; ; GO:0008294; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to plasma membrane; GO:0005887 rut rutabaga "CG9533, CG9533, CG9533, Ac12F, AC, EP1603" CDMC27142 2 16 7 DAC11-J19 2-CG9533-RA_1 CG9533 GCGACAGAAGCGCCTACAAAAGTCCGAGCTCAATCACAAACGATCGGAGGTTGCAACAGAGGCAG 65 FBan0009533 FBgn0003301 rut X X G-protein coupled receptor protein signaling pathway; GO:0007186; behavioral response to ethanol; GO:0048149; cAMP biosynthesis; GO:0006171; cAMP-mediated signaling; GO:0019933; courtship behavior; GO:0007619; grooming behavior; GO:0007625; learning; GO:0007612; learning and/or memory; GO:0007611; mating behavior; GO:0007617; memory; GO:0007613; molting cycle (sensu Insecta); GO:0007591; olfactory learning; GO:0008355; synaptic transmission; GO:0007268 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; calcium- and calmodulin-responsive adenylate cyclase activity; GO:0008294; ; GO:0008294; ; GO:0008294; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to plasma membrane; GO:0005887 rut rutabaga "CG9533, CG9533, CG9533, Ac12F, AC, EP1603" CDMC27143 2 17 7 DAC11-N07 2-CG9602-RA_1 CG9602 CACACCGTGGAGACGATCCTTCTTTCCGTTATCTCCATGCTCACCGATCCCAATGACGAGTCGGC 65 FBan0009602 FBgn0038175 CG9602 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004840 CG9602 CG9602 BcDNA:GH25305 CDMC27143 2 18 7 DAC11-N07 2-CG9602-RA_1 CG9602 CACACCGTGGAGACGATCCTTCTTTCCGTTATCTCCATGCTCACCGATCCCAATGACGAGTCGGC 65 FBan0009602 FBgn0038175 CG9602 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004840 CG9602 CG9602 BcDNA:GH25305 CDMC27144 2 19 7 DAC11-N19 1-CG9624-RA_1 CG9624 GTAGCCCCTTCTTCGACGTGCTATGGCCATTGATCCTGGACGAGAATGTCTGTCGCATCGAGACC 65 FBan0009624 FBgn0038213 CG9624 3 3R CG9624 CG9624 CDMC27144 2 20 7 DAC11-N19 1-CG9624-RA_1 CG9624 GTAGCCCCTTCTTCGACGTGCTATGGCCATTGATCCTGGACGAGAATGTCTGTCGCATCGAGACC 65 FBan0009624 FBgn0038213 CG9624 3 3R CG9624 CG9624 CDMC27145 2 21 7 DAC12-B07 1-CG15423-RA_1 CG15423 CAATTGTAGAGGTGGACATTGTGCCGCCAAGGATTCCTCGACCAGTGATTGAGATCGGAGTGGGC 65 FBan0015423 FBgn0031580 CG15423 2 2L CG15423 CG15423 CDMC27145 2 22 7 DAC12-B07 1-CG15423-RA_1 CG15423 CAATTGTAGAGGTGGACATTGTGCCGCCAAGGATTCCTCGACCAGTGATTGAGATCGGAGTGGGC 65 FBan0015423 FBgn0031580 CG15423 2 2L CG15423 CG15423 CDMC27146 2 23 7 DAC12-B19 3-CG15437-RA_5 CG15437 GAAGACGAGGAGACCGAAAACGACGTAGACATCATGGGCTTTGAGGATCTGGAGGACCCCCAACC 65 FBan0015437 FBgn0027609 morgue 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917; induction of retinal cell programmed cell death (sensu Endopterygota); GO:0046675; protein metabolism; GO:0019538; protein ubiquitination; GO:0016567; regulation of retinal programmed cell death; GO:0046668 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ubiquitin-like conjugating enzyme activity; GO:0008640; ; GO:0008640 SCF ubiquitin ligase complex; GO:0019005 morgue "modifier of rpr and grim, ubiquitously expressed" "CG15437, CG15437, CG15437, CG15437, BcDNA:GH02435, modifier of rpr and grim, ubiquitously expressed" CDMC27146 2 24 7 DAC12-B19 3-CG15437-RA_5 CG15437 GAAGACGAGGAGACCGAAAACGACGTAGACATCATGGGCTTTGAGGATCTGGAGGACCCCCAACC 65 FBan0015437 FBgn0027609 morgue 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917; induction of retinal cell programmed cell death (sensu Endopterygota); GO:0046675; protein metabolism; GO:0019538; protein ubiquitination; GO:0016567; regulation of retinal programmed cell death; GO:0046668 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004840; ; GO:0004842 ; EC:6.3.2.19; ubiquitin-like conjugating enzyme activity; GO:0008640; ; GO:0008640 SCF ubiquitin ligase complex; GO:0019005 morgue "modifier of rpr and grim, ubiquitously expressed" "CG15437, CG15437, CG15437, CG15437, BcDNA:GH02435, modifier of rpr and grim, ubiquitously expressed" CDMC27147 2 25 7 DAC12-F07 18-CG15514-RA_8 CG15514 CTCCAACTTGACGCGCCACTTAATCCGGAACCACAAGCTCTTGGCCCGATCAATTTTTGCCGGCG 65 FBan0015514 FBgn0039712 CG15514 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG15514 CG15514 CDMC27147 2 26 7 DAC12-F07 18-CG15514-RA_8 CG15514 CTCCAACTTGACGCGCCACTTAATCCGGAACCACAAGCTCTTGGCCCGATCAATTTTTGCCGGCG 65 FBan0015514 FBgn0039712 CG15514 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG15514 CG15514 CDMC27148 2 1 8 DAC12-F19 15-CG15531-RA_7 CG15531 GAACACTCCGTTCCAGTACTTTGGGGACTCCCTAGCCACCTCCATGTTCGTGGGTTTCTGGCTGC 65 FBan0015531 FBgn0039755 CG15531 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506; ; GO:0004768 ; EC:1.14.19.1 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG15531 CG15531 CDMC27148 2 2 8 DAC12-F19 15-CG15531-RA_7 CG15531 GAACACTCCGTTCCAGTACTTTGGGGACTCCCTAGCCACCTCCATGTTCGTGGGTTTCTGGCTGC 65 FBan0015531 FBgn0039755 CG15531 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506; ; GO:0004768 ; EC:1.14.19.1 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG15531 CG15531 CDMC27149 2 3 8 DAC12-J07 23-CG15630-RA_8 CG15630 ACTTTGAACTCGTAATCAGGTCGCAAGCATATTCACGGTTTTTTGTGTAGTAACCACAGGAATTC 65 FBan0015630 FBgn0031627 CG15630 2 2L cell adhesion; GO:0007155 membrane; GO:0016020 CG15630 CG15630 "CG31970, CG31970, CT35785" CDMC27149 2 4 8 DAC12-J07 23-CG15630-RA_8 CG15630 ACTTTGAACTCGTAATCAGGTCGCAAGCATATTCACGGTTTTTTGTGTAGTAACCACAGGAATTC 65 FBan0015630 FBgn0031627 CG15630 2 2L cell adhesion; GO:0007155 membrane; GO:0016020 CG15630 CG15630 "CG31970, CG31970, CT35785" CDMC27150 2 5 8 DAC12-J19 17-CG15660-RA_1 CG15660 GGGAGTCCTGGGACCTGGGAACACGCACATCATCTTGGGGACACACGATACACGAGACGGCATAA 65 FBan0015660 FBgn0034608 CG15660 2 2R CG15660 CG15660 CDMC27150 2 6 8 DAC12-J19 17-CG15660-RA_1 CG15660 GGGAGTCCTGGGACCTGGGAACACGCACATCATCTTGGGGACACACGATACACGAGACGGCATAA 65 FBan0015660 FBgn0034608 CG15660 2 2R CG15660 CG15660 CDMC27151 2 7 8 DAC12-N07 5-CG15753-RA_1 CG15753 CAATGCATGCGACATGGGCTGTCAGACGAGGGAATCGCTGTTTGTCAACAGTCCCGGAATTGGAC 65 FBan0015753 FBgn0030491 CG15753 X X CG15753 CG15753 CDMC27151 2 8 8 DAC12-N07 5-CG15753-RA_1 CG15753 CAATGCATGCGACATGGGCTGTCAGACGAGGGAATCGCTGTTTGTCAACAGTCCCGGAATTGGAC 65 FBan0015753 FBgn0030491 CG15753 X X CG15753 CG15753 CDMC27152 2 9 8 DAC12-N19 15-CG15771-RA_1 CG15771 GCAGCTGTTGGCCCATCACACTGTTGGCAAATTGTTATTTGCAACCTGCACGAAAAACAACCTCC 65 FBan0015771 FBgn0029801 CG15771 X X CG15771 CG15771 CR33074 CDMC27152 2 10 8 DAC12-N19 15-CG15771-RA_1 CG15771 GCAGCTGTTGGCCCATCACACTGTTGGCAAATTGTTATTTGCAACCTGCACGAAAAACAACCTCC 65 FBan0015771 FBgn0029801 CG15771 X X CG15771 CG15771 CR33074 CDMC27153 2 11 8 DAC13-B07 8-CG13024-RA_1 CG13024 ACCAAAGACCTGGATACCGTATCCATCGCTAGCTCTATGCACTTCACGATGGTCAATGGAGAGGGTGGT 69 FBan0013024 FBgn0036665 CG13024 3 3L CG13024 CG13024 BcDNA:RH61817 CDMC27153 2 12 8 DAC13-B07 8-CG13024-RA_1 CG13024 ACCAAAGACCTGGATACCGTATCCATCGCTAGCTCTATGCACTTCACGATGGTCAATGGAGAGGGTGGT 69 FBan0013024 FBgn0036665 CG13024 3 3L CG13024 CG13024 BcDNA:RH61817 CDMC27154 2 13 8 DAC13-B19 11-CG13033-RA_1 CG13033 ACGCAACCACAGCTCCAATCGATTGAGCAGGTCAGATCCAGATCGCAGAGCAAGTGAAGCAAACATTTA 69 FBan0013033 FBgn0036638 CG13033 3 3L CG13033 CG13033 BcDNA:RE50345 CDMC27154 2 14 8 DAC13-B19 11-CG13033-RA_1 CG13033 ACGCAACCACAGCTCCAATCGATTGAGCAGGTCAGATCCAGATCGCAGAGCAAGTGAAGCAAACATTTA 69 FBan0013033 FBgn0036638 CG13033 3 3L CG13033 CG13033 BcDNA:RE50345 CDMC27155 2 15 8 DAC13-F07 3-CG13074-RA_1 CG13074 GGCAACATCATCTTTTGCCCAGCCAATGATGGGTCACTGGAATACTATAGGGTGAGCGATGGAGCCCAT 69 FBan0013074 FBgn0036567 CG13074 3 3L CG13074 CG13074 CDMC27155 2 16 8 DAC13-F07 3-CG13074-RA_1 CG13074 GGCAACATCATCTTTTGCCCAGCCAATGATGGGTCACTGGAATACTATAGGGTGAGCGATGGAGCCCAT 69 FBan0013074 FBgn0036567 CG13074 3 3L CG13074 CG13074 CDMC27156 2 17 8 DAC13-F19 3-CG13084-RA_1 CG13084 GCCACATGACCAGCCTGAATCCTACAAGCTTCCTGTGGATTACAGTCCCAAACCTAACCACGAGCAACC 69 FBan0013084 FBgn0032788 CG13084 2 2L CG13084 CG13084 CDMC27156 2 18 8 DAC13-F19 3-CG13084-RA_1 CG13084 GCCACATGACCAGCCTGAATCCTACAAGCTTCCTGTGGATTACAGTCCCAAACCTAACCACGAGCAACC 69 FBan0013084 FBgn0032788 CG13084 2 2L CG13084 CG13084 CDMC27157 2 19 8 DAC13-J07 16-CG13121-RA_2 CG13121 CCTGTTCCGAGAGTTTCTGCGTCAGAGTTACATCAATGGTCTGCATCCGTTTCTCTATCATACACCCGT 69 FBan0013121 FBgn0032145 CG13121 2 2L CG13121 CG13121 CDMC27157 2 20 8 DAC13-J07 16-CG13121-RA_2 CG13121 CCTGTTCCGAGAGTTTCTGCGTCAGAGTTACATCAATGGTCTGCATCCGTTTCTCTATCATACACCCGT 69 FBan0013121 FBgn0032145 CG13121 2 2L CG13121 CG13121 CDMC27158 2 21 8 DAC13-J19 18-CG13137-RA_3 CG13137 GGAGCCGGACTGTCAGCAAAAGATACGTTTGATACCGAATCCGAAGAGTTTAGGCTCCTTCTCCCTACT 69 FBan0013137 FBgn0032188 CG13137 2 2L CG13137 CG13137 CDMC27158 2 22 8 DAC13-J19 18-CG13137-RA_3 CG13137 GGAGCCGGACTGTCAGCAAAAGATACGTTTGATACCGAATCCGAAGAGTTTAGGCTCCTTCTCCCTACT 69 FBan0013137 FBgn0032188 CG13137 2 2L CG13137 CG13137 CDMC27159 2 23 8 DAC13-N07 16-CG1318-RD_1 CG1318 GAGTGTCCCATTGACGCGTACGATGCACAAGTTTGACCAGCTATTAAACCATTTCTCTTAACGGTCGCT 69 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC27159 2 24 8 DAC13-N07 16-CG1318-RD_1 CG1318 GAGTGTCCCATTGACGCGTACGATGCACAAGTTTGACCAGCTATTAAACCATTTCTCTTAACGGTCGCT 69 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC27160 2 25 8 DAC13-N19 22-CG13197-RA_6 CG13197 AATTGGCGTCCATTGCACACATGGAGTAAATCGAACTGGATACCTGATCTGCTACTTCATGATCTCCGT 69 FBgn0033647 CDMC27160 2 26 8 DAC13-N19 22-CG13197-RA_6 CG13197 AATTGGCGTCCATTGCACACATGGAGTAAATCGAACTGGATACCTGATCTGCTACTTCATGATCTCCGT 69 FBgn0033647 CDMC27161 2 1 9 DAC14-B07 18-CG40156-RA_1 CG40156 TCTGCTCCTCTCCACCAGTTCGATATTTGAAAATTCCCGCCTTCCACTCATTAATTTTCGGCAACACCG 69 FBgn0058156 CG40156 CG40156 CG40156 CDMC27161 2 2 9 DAC14-B07 18-CG40156-RA_1 CG40156 TCTGCTCCTCTCCACCAGTTCGATATTTGAAAATTCCCGCCTTCCACTCATTAATTTTCGGCAACACCG 69 FBgn0058156 CG40156 CG40156 CG40156 CDMC27162 2 3 9 DAC14-B19 22-CG40163-RA_1 CG40163 ACACTGGCGTGCTCAGGATTTTCAGATCCCGAACTATATACACTGCCTTCAGCAATAACCGTTTCGATT 69 FBgn0058163 CG40163 CG40163 CG40163 CDMC27162 2 4 9 DAC14-B19 22-CG40163-RA_1 CG40163 ACACTGGCGTGCTCAGGATTTTCAGATCCCGAACTATATACACTGCCTTCAGCAATAACCGTTTCGATT 69 FBgn0058163 CG40163 CG40163 CG40163 CDMC27163 2 5 9 DAC14-F07 15-CG40207-RA_1 CG40207 CGTGGACGTTGTCTCGCCACAGAGTCTAGACTTTGGAATTCGGACTTTTGCACTTTGCTTGTGCCTAAA 69 FBgn0058207 CG40207 CG40207 CG40207 CDMC27163 2 6 9 DAC14-F07 15-CG40207-RA_1 CG40207 CGTGGACGTTGTCTCGCCACAGAGTCTAGACTTTGGAATTCGGACTTTTGCACTTTGCTTGTGCCTAAA 69 FBgn0058207 CG40207 CG40207 CG40207 CDMC27164 2 7 9 DAC14-F19 23-CG40224-RA_10 CG40224 AATTACCAGCGCTAACGATCCCTATCACTTTTTGAAGATTTAGGTAGATCAATTTTGGGTCAATTTTCG 69 FBgn0058224 CG40224 CG40224 CG40224 CDMC27164 2 8 9 DAC14-F19 23-CG40224-RA_10 CG40224 AATTACCAGCGCTAACGATCCCTATCACTTTTTGAAGATTTAGGTAGATCAATTTTGGGTCAATTTTCG 69 FBgn0058224 CG40224 CG40224 CG40224 CDMC27165 2 9 9 DAC14-J07 1-CG40290-RA_1 CG40290 CCATCGCCGGAATCGCCACAAGTAGGACCAAGTGGAATGGTTAAACAACCTTATACAATGCCACGGCCA 69 FBgn0058290 CG40290 CG40290 CG40290 CDMC27165 2 10 9 DAC14-J07 1-CG40290-RA_1 CG40290 CCATCGCCGGAATCGCCACAAGTAGGACCAAGTGGAATGGTTAAACAACCTTATACAATGCCACGGCCA 69 FBgn0058290 CG40290 CG40290 CG40290 CDMC27166 2 11 9 DAC14-J19 17-CG40303-RA_1 CG40303 AGAAAGTAAGCATCTGCGTTTAAAAAACAAGCAGTTTGCATGCCTACCGGTTGCTCCCAACTTAAGGCA 69 FBgn0058303 CG40303 CG40303 CG40303 CDMC27166 2 12 9 DAC14-J19 17-CG40303-RA_1 CG40303 AGAAAGTAAGCATCTGCGTTTAAAAAACAAGCAGTTTGCATGCCTACCGGTTGCTCCCAACTTAAGGCA 69 FBgn0058303 CG40303 CG40303 CG40303 CDMC27167 2 13 9 DAC14-N07 23-CG4035-RC_5 CG4035 GCTCCTTATTCGGTCCGATCCCACACTGATTATTTTGTCTTTCATTTATTTATCGTTATAAGCAACAGT 69 FBan0004035 FBgn0015218 eIF-4E 3 3L RNA metabolism; GO:0016070; autophagic cell death; GO:0048102; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; positive regulation of cell growth; GO:0030307; protein biosynthesis; GO:0006412; regulation of cell growth; GO:0001558; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743; ; GO:0000339 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4E Eukaryotic initiation factor 4E "CG4035, CG4035, CG4035, CG4035, CG4035, l(3)67Af, CBP, cap binding protein, l(3)07238, Eif4e, eIF4E, 1004/13, 0589/11, 0260/09, 0587/11, 0919/12, 7238, IF4E, eIF-4e, D-eIF4E, eukaryotic initiation factor 4E, CT13384, CT39424, CT39426, deIF4E, eIF-4E1,2, eIF4e, eIF-4EII, eif-4E, l(3)S091912, l(3)S058711, l(3)S026009, l(3)S025007, Eif4E, lethal(3)67Af, Eukaryotic initiation factor 4E" CDMC27167 2 14 9 DAC14-N07 23-CG4035-RC_5 CG4035 GCTCCTTATTCGGTCCGATCCCACACTGATTATTTTGTCTTTCATTTATTTATCGTTATAAGCAACAGT 69 FBan0004035 FBgn0015218 eIF-4E 3 3L RNA metabolism; GO:0016070; autophagic cell death; GO:0048102; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; positive regulation of cell growth; GO:0030307; protein biosynthesis; GO:0006412; regulation of cell growth; GO:0001558; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; ; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743; ; GO:0000339 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4E Eukaryotic initiation factor 4E "CG4035, CG4035, CG4035, CG4035, CG4035, l(3)67Af, CBP, cap binding protein, l(3)07238, Eif4e, eIF4E, 1004/13, 0589/11, 0260/09, 0587/11, 0919/12, 7238, IF4E, eIF-4e, D-eIF4E, eukaryotic initiation factor 4E, CT13384, CT39424, CT39426, deIF4E, eIF-4E1,2, eIF4e, eIF-4EII, eif-4E, l(3)S091912, l(3)S058711, l(3)S026009, l(3)S025007, Eif4E, lethal(3)67Af, Eukaryotic initiation factor 4E" CDMC27168 2 15 9 DAC14-N19 8-CG40380-RA_1 CG40380 ACCCTGCGCCTATGGTTCTCACCAAGACAGTTTCAGCCTACTTTATGCTGTCATCCTTGCTCCTGATGC 69 FBgn0058380 CG40380 CG40380 CG40380 CDMC27168 2 16 9 DAC14-N19 8-CG40380-RA_1 CG40380 ACCCTGCGCCTATGGTTCTCACCAAGACAGTTTCAGCCTACTTTATGCTGTCATCCTTGCTCCTGATGC 69 FBgn0058380 CG40380 CG40380 CG40380 CDMC27169 2 17 9 DAC15-B07 2-CG7287-RA_1 CG7287 GCTGCCGCTCCGGATGCAGAGATTGTTGACCTGGTGTCCGATGTCAATGCCGATAGCTATAGCTACAAA 69 FBan0007287 FBgn0020645 Lcp65Aa 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Aa Lcp65Aa "CG7287, Lcp-a, DMLCP65a, DCP4" CDMC27169 2 18 9 DAC15-B07 2-CG7287-RA_1 CG7287 GCTGCCGCTCCGGATGCAGAGATTGTTGACCTGGTGTCCGATGTCAATGCCGATAGCTATAGCTACAAA 69 FBan0007287 FBgn0020645 Lcp65Aa 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Aa Lcp65Aa "CG7287, Lcp-a, DMLCP65a, DCP4" CDMC27170 2 19 9 DAC15-B19 21-CG7294-RA_1 CG7294 GGCGGCTTTGGCGGTGGTCCTTATGGCGGCGGTTTCGGAGGTGGTCCATACGGCGGGGGATTCGGTAAT 69 FBan0007294 FBgn0032284 CG7294 2 2L CG7294 CG7294 BcDNA:RE28280 CDMC27170 2 20 9 DAC15-B19 21-CG7294-RA_1 CG7294 GGCGGCTTTGGCGGTGGTCCTTATGGCGGCGGTTTCGGAGGTGGTCCATACGGCGGGGGATTCGGTAAT 69 FBan0007294 FBgn0032284 CG7294 2 2L CG7294 CG7294 BcDNA:RE28280 CDMC27171 2 21 9 DAC15-F07 8-CG7328-RA_2 CG7328 CCCGCAGACCACCTATGAGGACTTCAGCAAGATAAACCTTTCGCAGTATGGATGGGTACACTTCGAGGC 69 FBan0007328 FBgn0036942 CG7328 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7328 CG7328 CDMC27171 2 22 9 DAC15-F07 8-CG7328-RA_2 CG7328 CCCGCAGACCACCTATGAGGACTTCAGCAAGATAAACCTTTCGCAGTATGGATGGGTACACTTCGAGGC 69 FBan0007328 FBgn0036942 CG7328 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7328 CG7328 CDMC27172 2 23 9 DAC15-F19 6-CG7337-RA_1 CG7337 GCCACCAAGGCCTAGGAACCTGGCATTTGATCACAAGAGCAAACTGATGATCAACAATAGTGGCAGCCC 69 FBan0007337 FBgn0031374 CG7337 2 2L CG7337 CG7337 CDMC27172 2 24 9 DAC15-F19 6-CG7337-RA_1 CG7337 GCCACCAAGGCCTAGGAACCTGGCATTTGATCACAAGAGCAAACTGATGATCAACAATAGTGGCAGCCC 69 FBan0007337 FBgn0031374 CG7337 2 2L CG7337 CG7337 CDMC27173 2 25 9 DAC15-J07 1-CG7364-RA_1 CG7364 CGGAAACTAAGCGAAAACTCGACGACTCAGCCATGTGAGCTAACTTCCCCTTCTTGTCCCCAGCTGCAG 69 FBan0007364 FBgn0028541 CG7364 2 2L intracellular protein transport; GO:0006886; phagocytosis; GO:0006909 transporter activity; GO:0005215; ; GO:0005215; ; GO:0005215 endosome; GO:0005768; integral to membrane; GO:0016021 CG7364 CG7364 "CG16861, BG:DS00797.1, n(2)k07245" CDMC27173 2 26 9 DAC15-J07 1-CG7364-RA_1 CG7364 CGGAAACTAAGCGAAAACTCGACGACTCAGCCATGTGAGCTAACTTCCCCTTCTTGTCCCCAGCTGCAG 69 FBan0007364 FBgn0028541 CG7364 2 2L intracellular protein transport; GO:0006886; phagocytosis; GO:0006909 transporter activity; GO:0005215; ; GO:0005215; ; GO:0005215 endosome; GO:0005768; integral to membrane; GO:0016021 CG7364 CG7364 "CG16861, BG:DS00797.1, n(2)k07245" CDMC27174 2 1 10 DAC15-J19 2-CG7375-RA_2 CG7375 CGAACTGAACCTGCCAAACACTTGCGCCACAGACTTTCCCGATCCCAATGACTTGCTCAACTTCAAGCT 69 FBan0007375 FBgn0035853 CG7375 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG7375 CG7375 anon-WO0118547.309 CDMC27174 2 2 10 DAC15-J19 2-CG7375-RA_2 CG7375 CGAACTGAACCTGCCAAACACTTGCGCCACAGACTTTCCCGATCCCAATGACTTGCTCAACTTCAAGCT 69 FBan0007375 FBgn0035853 CG7375 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG7375 CG7375 anon-WO0118547.309 CDMC27175 2 3 10 DAC15-N07 12-CG7405-RA_1 CG7405 TGCCTGCAAAGTTGAGGAGTTCAACGTGTCCATCAACCAGTTCGTAAACAACATCAAGGGCGACAGGAA 69 FBan0007405 FBgn0022936 CycH 3 3L protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; cyclin-dependent protein kinase activating kinase regulator activity; GO:0019914 ; EC:2.7.1.-; ; GO:0016251; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0019914 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- transcription factor TFIIH complex; GO:0005675 CycH Cyclin H "CG7405, CG7405, cyclin H" CDMC27175 2 4 10 DAC15-N07 12-CG7405-RA_1 CG7405 TGCCTGCAAAGTTGAGGAGTTCAACGTGTCCATCAACCAGTTCGTAAACAACATCAAGGGCGACAGGAA 69 FBan0007405 FBgn0022936 CycH 3 3L protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; cyclin-dependent protein kinase activating kinase regulator activity; GO:0019914 ; EC:2.7.1.-; ; GO:0016251; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0019914 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- transcription factor TFIIH complex; GO:0005675 CycH Cyclin H "CG7405, CG7405, cyclin H" CDMC27176 2 5 10 DAC15-N19 1-CG7428-RA_1 CG7428 GCTGCATCTCACGGACAACCTCATCCTGCAGACGATCAAGAACATCCGGCAGTATGACACCATCGAGAT 69 FBgn0031346 CDMC27176 2 6 10 DAC15-N19 1-CG7428-RA_1 CG7428 GCTGCATCTCACGGACAACCTCATCCTGCAGACGATCAAGAACATCCGGCAGTATGACACCATCGAGAT 69 FBgn0031346 CDMC27177 2 7 10 DAC16-B07 2-CG12237-RA_1 CG12237 TCATGCGGTTCTACGATGCCAGGAGTACTCGTGAGGGTCTCAAATGCGAAACCATCCATCCCGATC 66 FBan0012237 FBgn0031048 CG12237 X X CG12237 CG12237 CDMC27177 2 8 10 DAC16-B07 2-CG12237-RA_1 CG12237 TCATGCGGTTCTACGATGCCAGGAGTACTCGTGAGGGTCTCAAATGCGAAACCATCCATCCCGATC 66 FBan0012237 FBgn0031048 CG12237 X X CG12237 CG12237 CDMC27178 2 9 10 DAC16-B19 2-CG12314-RA_1 CG12314 GCATTATCACAGCTGACGACAAACTCACAGCCACGTTTCAGGCGGAATTCCAACGAATGTGGCGGG 66 FBan0012314 FBgn0032389 CG12314 2 2L CG12314 CG12314 CDMC27178 2 10 10 DAC16-B19 2-CG12314-RA_1 CG12314 GCATTATCACAGCTGACGACAAACTCACAGCCACGTTTCAGGCGGAATTCCAACGAATGTGGCGGG 66 FBan0012314 FBgn0032389 CG12314 2 2L CG12314 CG12314 CDMC27179 2 11 10 DAC16-F07 6-CG12913-RA_1 CG12913 GGTCTACTACCCCGTCGTATTTAGCCTGTACAATCCGCATGTGGTGTACTCACTGCAGGGCAAGCC 66 FBan0012913 FBgn0033500 CG12913 2 2R chondroitin sulfate biosynthesis; GO:0030206; protein amino acid glycosylation; GO:0006486 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; ; GO:0008376 ; EC:2.4.1.- CG12913 CG12913 CDMC27179 2 12 10 DAC16-F07 6-CG12913-RA_1 CG12913 GGTCTACTACCCCGTCGTATTTAGCCTGTACAATCCGCATGTGGTGTACTCACTGCAGGGCAAGCC 66 FBan0012913 FBgn0033500 CG12913 2 2R chondroitin sulfate biosynthesis; GO:0030206; protein amino acid glycosylation; GO:0006486 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; ; GO:0008376 ; EC:2.4.1.- CG12913 CG12913 CDMC27180 2 13 10 DAC16-F19 2-CG13157-RA_1 CG13157 ACCAGAATCCTGCCTATTCCCGACCAGTCAGTCGTGAAAGTTCAGCAGAGAAATATGGACGCCGGC 66 FBan0013157 FBgn0033732 CG13157 2 2R CG13157 CG13157 CDMC27180 2 14 10 DAC16-F19 2-CG13157-RA_1 CG13157 ACCAGAATCCTGCCTATTCCCGACCAGTCAGTCGTGAAAGTTCAGCAGAGAAATATGGACGCCGGC 66 FBan0013157 FBgn0033732 CG13157 2 2R CG13157 CG13157 CDMC27181 2 15 10 DAC16-J07 13-CG13460-RA_1 CG13460 ACTACTACCACTGTTTCTGGTGAGGATTCGCCATCTGTGACTACCGATGTCGTTCCCGATCAGTCG 66 FBan0013460 FBgn0036471 CG13460 3 3L CG13460 CG13460 CDMC27181 2 16 10 DAC16-J07 13-CG13460-RA_1 CG13460 ACTACTACCACTGTTTCTGGTGAGGATTCGCCATCTGTGACTACCGATGTCGTTCCCGATCAGTCG 66 FBan0013460 FBgn0036471 CG13460 3 3L CG13460 CG13460 CDMC27182 2 17 10 DAC16-J19 1-CG13590-RA_1 CG13590 GGCCAAGATCATCTGGTACATGATCCGGAACGTGTCCACCATCAACCACACCTGTCCCTATGAGGG 66 FBan0013590 FBgn0035012 CG13590 2 2R CG13590 CG13590 CDMC27182 2 18 10 DAC16-J19 1-CG13590-RA_1 CG13590 GGCCAAGATCATCTGGTACATGATCCGGAACGTGTCCACCATCAACCACACCTGTCCCTATGAGGG 66 FBan0013590 FBgn0035012 CG13590 2 2R CG13590 CG13590 CDMC27183 2 19 10 DAC16-N07 8-CG14118-RA_2 CG14118 TGATGCTTCAGTTTATCGGCCTAATTTTGGCGGTCGTGATTCTGCGAGAGATTCGGGCACGTGAGG 66 FBan0014118 FBgn0036323 CG14118 3 3L CG14118 CG14118 CDMC27183 2 20 10 DAC16-N07 8-CG14118-RA_2 CG14118 TGATGCTTCAGTTTATCGGCCTAATTTTGGCGGTCGTGATTCTGCGAGAGATTCGGGCACGTGAGG 66 FBan0014118 FBgn0036323 CG14118 3 3L CG14118 CG14118 CDMC27184 2 21 10 DAC16-N19 3-CG1420-RA_2 CG1420 GCAGCGGCTACTACAGAACCTGCAGCTCAAAGCCAATTCAAGGTACCAGAAGTGCCACCTGAAAGG 66 FBan0001420 FBgn0039626 CG1420 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG1420 CG1420 CDMC27184 2 22 10 DAC16-N19 3-CG1420-RA_2 CG1420 GCAGCGGCTACTACAGAACCTGCAGCTCAAAGCCAATTCAAGGTACCAGAAGTGCCACCTGAAAGG 66 FBan0001420 FBgn0039626 CG1420 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG1420 CG1420 CDMC27185 2 23 10 DAC17-B07 3-CG17283-RA_5 CG17283 GCCATGACCACCAAGGAACCGGGAACCACTTTCGTGACCTCAAATTTCGATGGTATACTAGGGCTGGGA 69 FBan0017283 FBgn0038505 CG17283 3 3R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin E activity; GO:0004193 ; EC:3.4.23.34; ; GO:0004193 ; EC:3.4.23.34; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG17283 CG17283 CDMC27185 2 24 10 DAC17-B07 3-CG17283-RA_5 CG17283 GCCATGACCACCAAGGAACCGGGAACCACTTTCGTGACCTCAAATTTCGATGGTATACTAGGGCTGGGA 69 FBan0017283 FBgn0038505 CG17283 3 3R autophagic cell death; GO:0048102; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cathepsin E activity; GO:0004193 ; EC:3.4.23.34; ; GO:0004193 ; EC:3.4.23.34; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG17283 CG17283 CDMC27186 2 25 10 DAC17-B19 47-CG17292-RA_4 CG17292 TTCAATCACCATTGAATTAGTCCTCAAGTGCATAATGGGATTAGCGTTCGATTAAACTTGTTCAGCCGA 69 FBan0017292 FBgn0032029 CG17292 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG17292 CG17292 CDMC27186 2 26 10 DAC17-B19 47-CG17292-RA_4 CG17292 TTCAATCACCATTGAATTAGTCCTCAAGTGCATAATGGGATTAGCGTTCGATTAAACTTGTTCAGCCGA 69 FBan0017292 FBgn0032029 CG17292 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG17292 CG17292 CDMC27187 2 1 11 DAC17-F07 16-CG17332-RB_1 CG17332 TCCGCTTCTCCATCACACTTGCAATGATGTTTGTTCTTGCTATCTTTAAGCGCATGTTTGTTCCCCGTT 69 FBan0017332 FBgn0027779 VhaSFD 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; determination of adult life span; GO:0008340 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 VhaSFD Vacuolar H[+]-ATPase SFD subunit "CG17332, CG17332, CG17332, vhaSFD, V-ATPase" CDMC27187 2 2 11 DAC17-F07 16-CG17332-RB_1 CG17332 TCCGCTTCTCCATCACACTTGCAATGATGTTTGTTCTTGCTATCTTTAAGCGCATGTTTGTTCCCCGTT 69 FBan0017332 FBgn0027779 VhaSFD 2 2L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; determination of adult life span; GO:0008340 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 VhaSFD Vacuolar H[+]-ATPase SFD subunit "CG17332, CG17332, CG17332, vhaSFD, V-ATPase" CDMC27188 2 3 11 DAC17-F19 24-CG17350-RA_1 CG17350 TTTTTCGCTGACAATAACATATTCCTAATTGCCATCAAACTGTTAGAAAAGAATTGTATTTAGGTAAAG 69 FBan0017350 FBgn0032772 CG17350 2 2L CG17350 CG17350 CDMC27188 2 4 11 DAC17-F19 24-CG17350-RA_1 CG17350 TTTTTCGCTGACAATAACATATTCCTAATTGCCATCAAACTGTTAGAAAAGAATTGTATTTAGGTAAAG 69 FBan0017350 FBgn0032772 CG17350 2 2L CG17350 CG17350 CDMC27189 2 5 11 DAC17-J07 23-CG1738-RA_5 CG1738 AGATGGACCGAGGCGTTACGTGGGAATTAGTACATTTTGGCACTGTACATGTGCATTCAATATTTTGAT 69 FBan0001738 FBgn0030291 CG1738 X X CG1738 CG1738 BcDNA:RE11532 CDMC27189 2 6 11 DAC17-J07 23-CG1738-RA_5 CG1738 AGATGGACCGAGGCGTTACGTGGGAATTAGTACATTTTGGCACTGTACATGTGCATTCAATATTTTGAT 69 FBan0001738 FBgn0030291 CG1738 X X CG1738 CG1738 BcDNA:RE11532 CDMC27190 2 7 11 DAC17-J19 14-CG17436-RA_1 CG17436 TTTTTGGACCATGTCCCCGATTCAGTTGTTCAAAGTTTGGAAGCTCCGGAAGTCCTGAGAGCGAATCAT 69 CDMC27190 2 8 11 DAC17-J19 14-CG17436-RA_1 CG17436 TTTTTGGACCATGTCCCCGATTCAGTTGTTCAAAGTTTGGAAGCTCCGGAAGTCCTGAGAGCGAATCAT 69 CDMC27191 2 9 11 DAC17-N07 23-CG1748-RA_12 CG1748 CGTAAACAACTGTATTGATTATTTAGAAGACAACGGGTTACAACAGGTTGGACTCTTTCGGGTGAGCAC 69 FBan0001748 FBgn0039898 RhoGAP102A 4 4 intracellular signaling cascade; GO:0007242 Rho GTPase activator activity; GO:0005100; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005100 RhoGAP102A RhoGAP102A "CG1748, CG1748, CG1748" CDMC27191 2 10 11 DAC17-N07 23-CG1748-RA_12 CG1748 CGTAAACAACTGTATTGATTATTTAGAAGACAACGGGTTACAACAGGTTGGACTCTTTCGGGTGAGCAC 69 FBan0001748 FBgn0039898 RhoGAP102A 4 4 intracellular signaling cascade; GO:0007242 Rho GTPase activator activity; GO:0005100; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005100 RhoGAP102A RhoGAP102A "CG1748, CG1748, CG1748" CDMC27192 2 11 11 DAC17-N19 2-CG17498-RA_2 CG17498 ACGGCATCAATTCGATCCTCTTCCAACGCGGAATTTACCCAGCCGAAGACTTTAACAACACGCAGCAGT 69 FBan0017498 FBgn0035640 mad2 3 3L cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitotic checkpoint; GO:0007093; mitotic spindle checkpoint; GO:0007094 nucleus; GO:0005634 mad2 mad2 "CG17498, CG17498, CG17498, CG17498, CG17498, CG17498, Mad2" CDMC27192 2 12 11 DAC17-N19 2-CG17498-RA_2 CG17498 ACGGCATCAATTCGATCCTCTTCCAACGCGGAATTTACCCAGCCGAAGACTTTAACAACACGCAGCAGT 69 FBan0017498 FBgn0035640 mad2 3 3L cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitotic checkpoint; GO:0007093; mitotic spindle checkpoint; GO:0007094 nucleus; GO:0005634 mad2 mad2 "CG17498, CG17498, CG17498, CG17498, CG17498, CG17498, Mad2" CDMC27193 2 13 11 DAC18-B07 23-CG31294-RA_11 CG31294 AAATGGATGCTGATGAAAGCTTTTTGAATCAACGGTCTCTACTAATGGATGTTATGAAGCAGCTTGAAG 69 FBan0031294 FBgn0051294 CG31294 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31294 CG31294 "BcDNA:AT21457, NEST:bs15e12, NEST:bs25d10" CDMC27193 2 14 11 DAC18-B07 23-CG31294-RA_11 CG31294 AAATGGATGCTGATGAAAGCTTTTTGAATCAACGGTCTCTACTAATGGATGTTATGAAGCAGCTTGAAG 69 FBan0031294 FBgn0051294 CG31294 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31294 CG31294 "BcDNA:AT21457, NEST:bs15e12, NEST:bs25d10" CDMC27194 2 15 11 DAC18-B19 23-CG31305-RI_5 CG31305 CAGTGAACATCTTGTGCAGAACACAGACCAAATATTCCAAAAATGTCTTTCGTTGGCAAGAAGTACAAG 69 FBgn0051305 CDMC27194 2 16 11 DAC18-B19 23-CG31305-RI_5 CG31305 CAGTGAACATCTTGTGCAGAACACAGACCAAATATTCCAAAAATGTCTTTCGTTGGCAAGAAGTACAAG 69 FBgn0051305 CDMC27195 2 17 11 DAC18-F07 2-CG31344-RA_1 CG31344 GCTGGTGGACATATTCACCTATTACTTGCCCTACGTCGCCATTTGGAAGTTTGGCCCGAAGTCCGCGTA 69 FBan0031344 FBgn0051344 CG31344 3 3R CG31344 CG31344 "CG6572, CG6572, anon-WO0118547.636" CDMC27195 2 18 11 DAC18-F07 2-CG31344-RA_1 CG31344 GCTGGTGGACATATTCACCTATTACTTGCCCTACGTCGCCATTTGGAAGTTTGGCCCGAAGTCCGCGTA 69 FBan0031344 FBgn0051344 CG31344 3 3R CG31344 CG31344 "CG6572, CG6572, anon-WO0118547.636" CDMC27196 2 19 11 DAC18-F19 23-CG31352-RA_2 CG31352 GGGAAACTATGCTAATTTCACAGCCAGTTTTGAAACACGCTTTAAATAGTTGATGCAAGTGAAACCAAC 69 FBan0031352 FBgn0051352 CG31352 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31352 CG31352 "CG9489, anon-WO0140519.21" CDMC27196 2 20 11 DAC18-F19 23-CG31352-RA_2 CG31352 GGGAAACTATGCTAATTTCACAGCCAGTTTTGAAACACGCTTTAAATAGTTGATGCAAGTGAAACCAAC 69 FBan0031352 FBgn0051352 CG31352 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31352 CG31352 "CG9489, anon-WO0140519.21" CDMC27197 2 21 11 DAC18-J07 13-CG31386-RA_3 CG31386 CGTTACGTGCCCTCAAAGTGCCATTTTGTCACTGGGTCCTTTTTCTGCTACTTCCACTTCTTCTCGCAC 69 FBan0031386 FBgn0051386 CG31386 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31386 CG31386 BcDNA:RE39877 CDMC27197 2 22 11 DAC18-J07 13-CG31386-RA_3 CG31386 CGTTACGTGCCCTCAAAGTGCCATTTTGTCACTGGGTCCTTTTTCTGCTACTTCCACTTCTTCTCGCAC 69 FBan0031386 FBgn0051386 CG31386 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31386 CG31386 BcDNA:RE39877 CDMC27198 2 23 11 DAC18-J19 23-CG3139-RA_6 CG3139 TGTATCCCCTGTACACCCACTTACACAGTTGTAGTTATGTTCACTGAAGCAGAAGAGTTATGCGTAGGA 69 FBan0003139 FBgn0004242 syt 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; larval locomotory behavior; GO:0008345; neurotransmitter secretion; GO:0007269; regulation of pole plasm oskar mRNA localization; GO:0007317; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle transport; GO:0048489; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005515; transporter activity; GO:0005215; ; GO:0005515; ; GO:0005509; ; GO:0005215 integral to synaptic vesicle membrane; GO:0030285; membrane; GO:0016020; synaptic vesicle; GO:0008021 syt synaptotagmin "CG3139, CG3139, DSYT, l(2)23Ba, Syt, Synaptotagmin, D. Syt I, SYT I, l(2)k05909, SYT1, Synaptotagmin I, Syt1, SYT, synaptotagmin I, Dsyt2, sytI, syt-1, synaptotagmin 1, DSYT2, SytI, dsytI, l(2)23AB1, synaptotagmin" CDMC27198 2 24 11 DAC18-J19 23-CG3139-RA_6 CG3139 TGTATCCCCTGTACACCCACTTACACAGTTGTAGTTATGTTCACTGAAGCAGAAGAGTTATGCGTAGGA 69 FBan0003139 FBgn0004242 syt 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; larval locomotory behavior; GO:0008345; neurotransmitter secretion; GO:0007269; regulation of pole plasm oskar mRNA localization; GO:0007317; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle transport; GO:0048489; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005515; transporter activity; GO:0005215; ; GO:0005515; ; GO:0005509; ; GO:0005215 integral to synaptic vesicle membrane; GO:0030285; membrane; GO:0016020; synaptic vesicle; GO:0008021 syt synaptotagmin "CG3139, CG3139, DSYT, l(2)23Ba, Syt, Synaptotagmin, D. Syt I, SYT I, l(2)k05909, SYT1, Synaptotagmin I, Syt1, SYT, synaptotagmin I, Dsyt2, sytI, syt-1, synaptotagmin 1, DSYT2, SytI, dsytI, l(2)23AB1, synaptotagmin" CDMC27199 2 25 11 DAC18-N07 13-CG3143-RA_1 CG3143 CCACTGTGGGTCGATCGTAATCCAAATCGCAAGGATGATCGTTATAGCCGGTAGTCGTCGTTGTTGTGT 69 FBan0003143 FBgn0038197 foxo 3 3R "determination of adult life span; GO:0008340; induction of apoptosis; GO:0006917; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; regulation of cell growth; GO:0001558; regulation of insulin receptor signaling pathway; GO:0046626; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 foxo "forkhead box, sub-group O" "CG3143, Dfoxo, FKHR, Afx, dFOXO, DmQ95V5, Q95V55, cg3143, Foxo, FOXO, dFoxo, anon-WO0118547.374, forkhead box, sub-group O" CDMC27199 2 26 11 DAC18-N07 13-CG3143-RA_1 CG3143 CCACTGTGGGTCGATCGTAATCCAAATCGCAAGGATGATCGTTATAGCCGGTAGTCGTCGTTGTTGTGT 69 FBan0003143 FBgn0038197 foxo 3 3R "determination of adult life span; GO:0008340; induction of apoptosis; GO:0006917; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; regulation of cell growth; GO:0001558; regulation of insulin receptor signaling pathway; GO:0046626; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 foxo "forkhead box, sub-group O" "CG3143, Dfoxo, FKHR, Afx, dFOXO, DmQ95V5, Q95V55, cg3143, Foxo, FOXO, dFoxo, anon-WO0118547.374, forkhead box, sub-group O" CDMC27200 2 1 12 DAC18-N19 2-CG31453-RA_2 CG31453 CCCAGCTGGATTCCCTTAAGACTTGTCCCAACGTACTGATCCTGGCCACATCTAACCTGGCTCAAAGCA 69 FBan0031453 FBgn0051453 CG31453 3 3R transcription from RNA polymerase II promoter; GO:0006366 ATP binding; GO:0005524; ; GO:0005524; transcription cofactor activity; GO:0003712; ; GO:0003712; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG31453 CG31453 "CG11743, CG11744, CG11743, CG11744, CG11744" CDMC27200 2 2 12 DAC18-N19 2-CG31453-RA_2 CG31453 CCCAGCTGGATTCCCTTAAGACTTGTCCCAACGTACTGATCCTGGCCACATCTAACCTGGCTCAAAGCA 69 FBan0031453 FBgn0051453 CG31453 3 3R transcription from RNA polymerase II promoter; GO:0006366 ATP binding; GO:0005524; ; GO:0005524; transcription cofactor activity; GO:0003712; ; GO:0003712; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG31453 CG31453 "CG11743, CG11744, CG11743, CG11744, CG11744" CDMC27201 2 3 12 DAC19-B07 2-CG6007-RA_1 CG6007 CTGTGGACTCCCTGTACGGGCCGACTAAGAACATCTGGAGCGAGGACCTTAACAAGGATCACTGG 65 FBan0006007 FBgn0027658 gatA 3 3R tRNA aminoacylation for protein translation; GO:0006418 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0017068 ; EC:6.3.5.-; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 gatA gatA CG6007 CDMC27201 2 4 12 DAC19-B07 2-CG6007-RA_1 CG6007 CTGTGGACTCCCTGTACGGGCCGACTAAGAACATCTGGAGCGAGGACCTTAACAAGGATCACTGG 65 FBan0006007 FBgn0027658 gatA 3 3R tRNA aminoacylation for protein translation; GO:0006418 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0017068 ; EC:6.3.5.-; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 gatA gatA CG6007 CDMC27202 2 5 12 DAC19-B19 8-CG6030-RA_1 CG6030 GTCGATAGCTTCCAGAAGCAGTACGAAGCCCTGAAGGTGCCCTATCCCCAGGACAAGGTGTCGTC 65 FBan0006030 FBgn0016120 ATPsyn-d 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-d "ATP synthase, subunit d" "CG6030, ATP synthase chain D, ATPase synthase, subunit d" CDMC27202 2 6 12 DAC19-B19 8-CG6030-RA_1 CG6030 GTCGATAGCTTCCAGAAGCAGTACGAAGCCCTGAAGGTGCCCTATCCCCAGGACAAGGTGTCGTC 65 FBan0006030 FBgn0016120 ATPsyn-d 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-d "ATP synthase, subunit d" "CG6030, ATP synthase chain D, ATPase synthase, subunit d" CDMC27203 2 7 12 DAC19-F07 23-CG6132-RA_1 CG6132 GACCTTTTATCTGCTGGCATTTAAAACTGCTGTCTAATAAAACTATTATCATTCCTGCACGACCC 65 FBan0006132 FBgn0003378 Sgs8 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs8 Salivary gland secretion 8 "CG6132, 68C GII, Gene II, group II, sgs-8, Sgs-8, Sgs, sgs8" CDMC27203 2 8 12 DAC19-F07 23-CG6132-RA_1 CG6132 GACCTTTTATCTGCTGGCATTTAAAACTGCTGTCTAATAAAACTATTATCATTCCTGCACGACCC 65 FBan0006132 FBgn0003378 Sgs8 3 3L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs8 Salivary gland secretion 8 "CG6132, 68C GII, Gene II, group II, sgs-8, Sgs-8, Sgs, sgs8" CDMC27204 2 9 12 DAC19-F19 15-CG6184-RA_5 CG6184 GACACCTGTCGTCTGCGTTACAACGAGTCCACGATGCTGAAGCTCTACGGGATTGCCAGGCACAT 65 FBan0006184 FBgn0038725 CG6184 3 3R CG6184 CG6184 CDMC27204 2 10 12 DAC19-F19 15-CG6184-RA_5 CG6184 GACACCTGTCGTCTGCGTTACAACGAGTCCACGATGCTGAAGCTCTACGGGATTGCCAGGCACAT 65 FBan0006184 FBgn0038725 CG6184 3 3R CG6184 CG6184 CDMC27205 2 11 12 DAC19-J07 3-CG6295-RA_2 CG6295 CACCTTCTACCTGTACACCAACTCGAACCGCAACTCTCCCCAGGAGATCAAGGCTACGTCAGCAT 65 FBan0006295 FBgn0039471 CG6295 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6295 CG6295 CDMC27205 2 12 12 DAC19-J07 3-CG6295-RA_2 CG6295 CACCTTCTACCTGTACACCAACTCGAACCGCAACTCTCCCCAGGAGATCAAGGCTACGTCAGCAT 65 FBan0006295 FBgn0039471 CG6295 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6295 CG6295 CDMC27206 2 13 12 DAC19-J19 23-CG6329-RA_1 CG6329 AAATCACCTTTCAGCGTGAATCATATCATTGAGCTTTGCTTCACAAGAAGACGGGAAGACATTCT 65 FBan0006329 FBgn0033872 CG6329 2 2R CG6329 CG6329 CDMC27206 2 14 12 DAC19-J19 23-CG6329-RA_1 CG6329 AAATCACCTTTCAGCGTGAATCATATCATTGAGCTTTGCTTCACAAGAAGACGGGAAGACATTCT 65 FBan0006329 FBgn0033872 CG6329 2 2R CG6329 CG6329 CDMC27207 2 15 12 DAC19-N07 1-CG6416-RG_1 CG6416 AAATACCCTTTCCCAAGACCCCTGCTAAAAGTCCTTCCCGTCCACACTTCTTTCCGACCCACCAC 65 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC27207 2 16 12 DAC19-N07 1-CG6416-RG_1 CG6416 AAATACCCTTTCCCAAGACCCCTGCTAAAAGTCCTTCCCGTCCACACTTCTTTCCGACCCACCAC 65 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC27208 2 17 12 DAC19-N19 2-CG6440-RA_1 CG6440 TTTTTTGCAAGGACATCCCGAACACCACTTGGTCCCGACATGAGACAACGACACTGGACCCTGAC 65 FBan0006440 FBgn0011581 Dms 3 3R negative regulation of heart contraction rate; GO:0045822; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184 Dms Dromyosuppressin "CG6440, CG6440, TDVDHVFLRFamide, dromyosuppressin, Nems, DMS, Drm-MS, FLRFa, myosuppressin, Drome-MS, Neomyosuppressin" CDMC27208 2 18 12 DAC19-N19 2-CG6440-RA_1 CG6440 TTTTTTGCAAGGACATCCCGAACACCACTTGGTCCCGACATGAGACAACGACACTGGACCCTGAC 65 FBan0006440 FBgn0011581 Dms 3 3R negative regulation of heart contraction rate; GO:0045822; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184 Dms Dromyosuppressin "CG6440, CG6440, TDVDHVFLRFamide, dromyosuppressin, Nems, DMS, Drm-MS, FLRFa, myosuppressin, Drome-MS, Neomyosuppressin" CDMC27209 2 19 12 DAC20-B07 3-CG30037-RA_1 CG30037 CACCGTGCAAAGGATAACGTGATGTGGGAGGCATGGTACCGAGTCACCAACTTCAGCAGCAAGTG 65 FBan0030037 FBgn0050037 CG30037 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG30037 CG30037 CG8976 CDMC27209 2 20 12 DAC20-B07 3-CG30037-RA_1 CG30037 CACCGTGCAAAGGATAACGTGATGTGGGAGGCATGGTACCGAGTCACCAACTTCAGCAGCAAGTG 65 FBan0030037 FBgn0050037 CG30037 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG30037 CG30037 CG8976 CDMC27210 2 21 12 DAC20-B19 3-CG30061-RA_1 CG30061 CAGACCATGGATCTGTGGACGATCCCGATGGATGTTTGCGGAACCATTTGGGATCATCGGCTAGC 65 FBan0030061 FBgn0050061 CG30061 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30061 CG30061 CDMC27210 2 22 12 DAC20-B19 3-CG30061-RA_1 CG30061 CAGACCATGGATCTGTGGACGATCCCGATGGATGTTTGCGGAACCATTTGGGATCATCGGCTAGC 65 FBan0030061 FBgn0050061 CG30061 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30061 CG30061 CDMC27211 2 23 12 DAC20-F07 3-CG30175-RA_6 CG30175 CCTCCACCACAAGCTCAAGTCAAGGAGGTTACTCCAGTGAAGGTAGTGTCTTCCCCACCACCTCC 65 FBgn0050175 CDMC27211 2 24 12 DAC20-F07 3-CG30175-RA_6 CG30175 CCTCCACCACAAGCTCAAGTCAAGGAGGTTACTCCAGTGAAGGTAGTGTCTTCCCCACCACCTCC 65 FBgn0050175 CDMC27212 2 25 12 DAC20-F19 3-CG3024-RA_2 CG3024 GAATTAGAAAGATCCCTGGAACGCACCCTCATTGGCCAGCACATCGTGAGGCAGCATATCGTCCC 65 FBan0003024 FBgn0025615 torp4a X X cytokine and chemokine mediated signaling pathway; GO:0019221; protein folding; GO:0006457; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0005524; ; GO:0051082 endoplasmic reticulum lumen; GO:0005788 torp4a torp4a "CG3024, DmTorp4a, EG:84H4.1" CDMC27212 2 26 12 DAC20-F19 3-CG3024-RA_2 CG3024 GAATTAGAAAGATCCCTGGAACGCACCCTCATTGGCCAGCACATCGTGAGGCAGCATATCGTCCC 65 FBan0003024 FBgn0025615 torp4a X X cytokine and chemokine mediated signaling pathway; GO:0019221; protein folding; GO:0006457; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0005524; ; GO:0051082 endoplasmic reticulum lumen; GO:0005788 torp4a torp4a "CG3024, DmTorp4a, EG:84H4.1" CDMC27213 2 1 13 DAC20-J07 15-CG30361-RA_6 CG30361 CCCCCGGAGATTCGAGATTCTCGCAACCATACGTAAGTAGAGGAAAGTGTCTGTTGACCCAAGCG 65 FBan0030361 FBgn0050361 mXr 2 2R "G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0007200; transmission of nerve impulse; GO:0019226" "G-protein coupled receptor activity; GO:0004930; ; GO:0004930; NOT glutamate binding; GO:0016595; NOT glutamate receptor activity; GO:0008066; ; GO:0016595; ; GO:0016595; ; GO:0008066; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0008067" integral to membrane; GO:0016021 mXr mXr "CG8692, CG30361, CG18447, CG8692, CG30361, CG30361, DmGluRB, GluRB, DmXR, DmGluBR, anon-WO0170980.4, anon-WO0170980.5, Glu-RB" CDMC27213 2 2 13 DAC20-J07 15-CG30361-RA_6 CG30361 CCCCCGGAGATTCGAGATTCTCGCAACCATACGTAAGTAGAGGAAAGTGTCTGTTGACCCAAGCG 65 FBan0030361 FBgn0050361 mXr 2 2R "G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0007200; transmission of nerve impulse; GO:0019226" "G-protein coupled receptor activity; GO:0004930; ; GO:0004930; NOT glutamate binding; GO:0016595; NOT glutamate receptor activity; GO:0008066; ; GO:0016595; ; GO:0016595; ; GO:0008066; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0008067" integral to membrane; GO:0016021 mXr mXr "CG8692, CG30361, CG18447, CG8692, CG30361, CG30361, DmGluRB, GluRB, DmXR, DmGluBR, anon-WO0170980.4, anon-WO0170980.5, Glu-RB" CDMC27214 2 3 13 DAC20-J19 1-CG30382-RA_1 CG30382 CCGTGGATGTGCTGTGTCGTCGAATTGCGGATATCAACCAGGTGTACACGCAGAATGCCGAGATG 65 FBan0030382 FBgn0050382 CG30382 2 2R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG30382 CG30382 CDMC27214 2 4 13 DAC20-J19 1-CG30382-RA_1 CG30382 CCGTGGATGTGCTGTGTCGTCGAATTGCGGATATCAACCAGGTGTACACGCAGAATGCCGAGATG 65 FBan0030382 FBgn0050382 CG30382 2 2R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG30382 CG30382 CDMC27215 2 5 13 DAC20-N07 23-CG30473-RA_1 CG30473 TATCACCGGAGAGCTATGATAAGTATGGTGTAAAGGTAAAACCATGCCTCAAACTATCGCATCGC 65 FBan0030473 FBgn0043530 Obp51a 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp51a Odorant-binding protein 51a "CG30473, 51a, anon-AE003812.1, Obp-c, Odorant-binding protein 51a" CDMC27215 2 6 13 DAC20-N07 23-CG30473-RA_1 CG30473 TATCACCGGAGAGCTATGATAAGTATGGTGTAAAGGTAAAACCATGCCTCAAACTATCGCATCGC 65 FBan0030473 FBgn0043530 Obp51a 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp51a Odorant-binding protein 51a "CG30473, 51a, anon-AE003812.1, Obp-c, Odorant-binding protein 51a" CDMC27216 2 7 13 DAC20-N19 23-CG30499-RA_3 CG30499 CGAAATGTTTTGACCAAATTGCATTGCAAGTAATGGGGAAAATTCCTCGGGAAATGGTACCATTA 65 FBan0030499 FBgn0050499 CG30499 2 2R carbohydrate metabolism; GO:0005975; pentose-phosphate shunt; GO:0006098 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; ribulose-phosphate 3-epimerase activity; GO:0004750 ; EC:5.1.3.1; ; GO:0004750 ; EC:5.1.3.1 CG30499 CG30499 "CG1364, CG1364, CG1364" CDMC27216 2 8 13 DAC20-N19 23-CG30499-RA_3 CG30499 CGAAATGTTTTGACCAAATTGCATTGCAAGTAATGGGGAAAATTCCTCGGGAAATGGTACCATTA 65 FBan0030499 FBgn0050499 CG30499 2 2R carbohydrate metabolism; GO:0005975; pentose-phosphate shunt; GO:0006098 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; ribulose-phosphate 3-epimerase activity; GO:0004750 ; EC:5.1.3.1; ; GO:0004750 ; EC:5.1.3.1 CG30499 CG30499 "CG1364, CG1364, CG1364" CDMC27217 2 9 13 DAC21-B07 3-CG3869-RA_1 CG3869 CCGCAGTAGTGGAACAGTAGTGGGTTGGCTGACCGTGGGGCAAAACACTAACCAGAATGTGGATGATC 68 FBan0003869 FBgn0029870 Marf X X mitochondrial fusion; GO:0008053; mitochondrion organization and biogenesis; GO:0007005; protein targeting to mitochondrion; GO:0006626 GTP binding; GO:0005525; ; GO:0005525; nucleotide phosphatase activity; GO:0019204; GTPase activity; GO:0003924; ; GO:0019204; ; GO:0003924 mitochondrial membrane; GO:0005740; plasma membrane; GO:0005886 Marf Mitochondrial assembly regulatory factor "CG3869, CG3869, dmfn, Drosophila mitofusin, anon-WO0125274.3" CDMC27217 2 10 13 DAC21-B07 3-CG3869-RA_1 CG3869 CCGCAGTAGTGGAACAGTAGTGGGTTGGCTGACCGTGGGGCAAAACACTAACCAGAATGTGGATGATC 68 FBan0003869 FBgn0029870 Marf X X mitochondrial fusion; GO:0008053; mitochondrion organization and biogenesis; GO:0007005; protein targeting to mitochondrion; GO:0006626 GTP binding; GO:0005525; ; GO:0005525; nucleotide phosphatase activity; GO:0019204; GTPase activity; GO:0003924; ; GO:0019204; ; GO:0003924 mitochondrial membrane; GO:0005740; plasma membrane; GO:0005886 Marf Mitochondrial assembly regulatory factor "CG3869, CG3869, dmfn, Drosophila mitofusin, anon-WO0125274.3" CDMC27218 2 11 13 DAC21-B19 3-CG3962-RA_1 CG3962 CACACCCGGATGGAAGTAACAACGGGGAAAGGAATGCTCATACACCACAAAACACGTACGGCAGTGGG 68 FBan0003962 FBgn0038475 Keap1 3 3R actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Keap1 Keap1 "CG3962, CG3962, CG3962, CG3962, dKEAP1" CDMC27218 2 12 13 DAC21-B19 3-CG3962-RA_1 CG3962 CACACCCGGATGGAAGTAACAACGGGGAAAGGAATGCTCATACACCACAAAACACGTACGGCAGTGGG 68 FBan0003962 FBgn0038475 Keap1 3 3R actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Keap1 Keap1 "CG3962, CG3962, CG3962, CG3962, dKEAP1" CDMC27219 2 13 13 DAC21-F07 23-CG4216-RA_6 CG4216 CGGAGCAAACTGAAAGAGTAATCATCTATTTGTGCCTGAAATTGGTAAATCGTCCAACAAAGCTATAT 68 FBan0004216 FBgn0003683 term 3 3L DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 term terminus "CG4216, ter, Bsg75C, Term" CDMC27219 2 14 13 DAC21-F07 23-CG4216-RA_6 CG4216 CGGAGCAAACTGAAAGAGTAATCATCTATTTGTGCCTGAAATTGGTAAATCGTCCAACAAAGCTATAT 68 FBan0004216 FBgn0003683 term 3 3L DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 term terminus "CG4216, ter, Bsg75C, Term" CDMC27220 2 15 13 DAC21-F19 3-CG4370-RA_1 CG4370 CGCTGGACAGTGTGATCAGCAATCCTCAATCCTATCCCATCACAATTGTGCCGAATAGGCCGACCAGC 68 FBan0004370 FBgn0039081 Irk2 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; G-protein activated inward rectifier potassium channel activity; GO:0015467; ; GO:0005242; ; GO:0015467 membrane; GO:0016020 Irk2 Inwardly rectifying potassium channel 2 "CG4370, CG10180, irk2, dKirII" CDMC27220 2 16 13 DAC21-F19 3-CG4370-RA_1 CG4370 CGCTGGACAGTGTGATCAGCAATCCTCAATCCTATCCCATCACAATTGTGCCGAATAGGCCGACCAGC 68 FBan0004370 FBgn0039081 Irk2 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; G-protein activated inward rectifier potassium channel activity; GO:0015467; ; GO:0005242; ; GO:0015467 membrane; GO:0016020 Irk2 Inwardly rectifying potassium channel 2 "CG4370, CG10180, irk2, dKirII" CDMC27221 2 17 13 DAC21-J07 3-CG4928-RA_1 CG4928 GGACGATCTCGAGGAGGACATTGTGGTCACGCGCCTGTAAATGTTTTTTTCTCACCCAAGGACACCCC 68 FBan0004928 FBgn0027556 CG4928 X X muscle contraction; GO:0006936 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG4928 CG4928 BcDNA:GH10120 CDMC27221 2 18 13 DAC21-J07 3-CG4928-RA_1 CG4928 GGACGATCTCGAGGAGGACATTGTGGTCACGCGCCTGTAAATGTTTTTTTCTCACCCAAGGACACCCC 68 FBan0004928 FBgn0027556 CG4928 X X muscle contraction; GO:0006936 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG4928 CG4928 BcDNA:GH10120 CDMC27222 2 19 13 DAC21-J19 1-CG5038-RA_1 CG5038 TGGAGCCCCACAACACATTGTACCACACGAATCTCGGAGTTCTCTATCATCGCTGGGACAAGACGCAG 68 FBan0005038 FBgn0038324 CG5038 3 3R protein amino acid glycosylation; GO:0006486 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase complex; GO:0017122 CG5038 CG5038 CDMC27222 2 20 13 DAC21-J19 1-CG5038-RA_1 CG5038 TGGAGCCCCACAACACATTGTACCACACGAATCTCGGAGTTCTCTATCATCGCTGGGACAAGACGCAG 68 FBan0005038 FBgn0038324 CG5038 3 3R protein amino acid glycosylation; GO:0006486 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase complex; GO:0017122 CG5038 CG5038 CDMC27223 2 21 13 DAC21-N07 3-CG5366-RA_5 CG5366 GACGGTCTCGACATTCGCAAAGCGGCATTTGAATGCATGTACACACTTCTCGAGCAGGGCTTGGATCG 68 FBan0005366 FBgn0027568 CG5366 2 2L transcription from RNA polymerase II promoter; GO:0006366 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528 CG5366 CG5366 BcDNA:GH07774 CDMC27223 2 22 13 DAC21-N07 3-CG5366-RA_5 CG5366 GACGGTCTCGACATTCGCAAAGCGGCATTTGAATGCATGTACACACTTCTCGAGCAGGGCTTGGATCG 68 FBan0005366 FBgn0027568 CG5366 2 2L transcription from RNA polymerase II promoter; GO:0006366 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528 CG5366 CG5366 BcDNA:GH07774 CDMC27224 2 23 13 DAC21-N19 2-CG5522-RB_2 CG5522 GCTCACTCACTCCCTGAAACGAGGCAACCACAGAACATTCCCGCAACCACAACGAACGAACAAATTGC 68 FBan0005522 FBgn0034158 CG5522 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165; small GTPase mediated signal transduction; GO:0007264; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG5522 CG5522 CDMC27224 2 24 13 DAC21-N19 2-CG5522-RB_2 CG5522 GCTCACTCACTCCCTGAAACGAGGCAACCACAGAACATTCCCGCAACCACAACGAACGAACAAATTGC 68 FBan0005522 FBgn0034158 CG5522 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165; small GTPase mediated signal transduction; GO:0007264; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG5522 CG5522 CDMC27225 2 25 13 DAC22-B07 9-CG40445-RA_1 CG40445 AGCGGTACCAAAGAAAACAGTTTGTTACATCTTGCGCCCAACGTGATTGTCGTCATCAAGGAGCCAGCA 69 FBgn0058445 CG40445 CG40445 CG40445 CDMC27225 2 26 13 DAC22-B07 9-CG40445-RA_1 CG40445 AGCGGTACCAAAGAAAACAGTTTGTTACATCTTGCGCCCAACGTGATTGTCGTCATCAAGGAGCCAGCA 69 FBgn0058445 CG40445 CG40445 CG40445 CDMC27226 2 1 14 DAC22-B19 11-CG4045-RA_1 CG4045 GGGTCTGTTGTACACCATGACGGACGTTGAGGACTTGCACAAGTGGATAGTGACACATATGGAGGAGCA 69 FBan0004045 FBgn0025629 CG4045 X X tRNA modification; GO:0006400 tRNA (guanine-N7-)-methyltransferase activity; GO:0008176 ; EC:2.1.1.33; ; GO:0008176 ; EC:2.1.1.33 cellular component unknown; GO:0008372 CG4045 CG4045 EG:22E5.4 CDMC27226 2 2 14 DAC22-B19 11-CG4045-RA_1 CG4045 GGGTCTGTTGTACACCATGACGGACGTTGAGGACTTGCACAAGTGGATAGTGACACATATGGAGGAGCA 69 FBan0004045 FBgn0025629 CG4045 X X tRNA modification; GO:0006400 tRNA (guanine-N7-)-methyltransferase activity; GO:0008176 ; EC:2.1.1.33; ; GO:0008176 ; EC:2.1.1.33 cellular component unknown; GO:0008372 CG4045 CG4045 EG:22E5.4 CDMC27227 2 3 14 DAC22-F07 23-CG4057-RA_2 CG4057 TTGTTGTATTTTTTGTACACCTCTGTTGACGTTTCGAGTTCCAAACGCCTTTCTCTATATGCCATGGCC 69 FBan0004057 FBgn0041582 tamo 2 2R development; GO:0007275; negative regulation of protein import into nucleus; GO:0042308; protein transport; GO:0015031 nuclear localization sequence binding; GO:0008139; ; GO:0008139; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; Ran GTPase binding; GO:0008536; ; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737 tamo tamo "CG4057, CG4057, 60B" CDMC27227 2 4 14 DAC22-F07 23-CG4057-RA_2 CG4057 TTGTTGTATTTTTTGTACACCTCTGTTGACGTTTCGAGTTCCAAACGCCTTTCTCTATATGCCATGGCC 69 FBan0004057 FBgn0041582 tamo 2 2R development; GO:0007275; negative regulation of protein import into nucleus; GO:0042308; protein transport; GO:0015031 nuclear localization sequence binding; GO:0008139; ; GO:0008139; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; Ran GTPase binding; GO:0008536; ; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737 tamo tamo "CG4057, CG4057, 60B" CDMC27228 2 5 14 DAC22-F19 18-CG4064-RA_3 CG4064 CGCACCCTAGATCGGTATATGCAAAAGAGGGCGGATAGATACTACAACAATTGCACCCAAACTGAGCCA 69 FBan0004064 FBgn0029808 CG4064 X X CG4064 CG4064 CDMC27228 2 6 14 DAC22-F19 18-CG4064-RA_3 CG4064 CGCACCCTAGATCGGTATATGCAAAAGAGGGCGGATAGATACTACAACAATTGCACCCAAACTGAGCCA 69 FBan0004064 FBgn0029808 CG4064 X X CG4064 CG4064 CDMC27229 2 7 14 DAC22-J07 2-CG4103-RA_1 CG4103 GCCGGCAATGTACAGAAAGGGAACGATTCTGCTGAGAAAACGCGTGATATTGGGTGAGAAGAGCAGGCA 69 FBan0004103 FBgn0028925 CG4103 2 2L CG4103 CG4103 BG:DS00929.4 CDMC27229 2 8 14 DAC22-J07 2-CG4103-RA_1 CG4103 GCCGGCAATGTACAGAAAGGGAACGATTCTGCTGAGAAAACGCGTGATATTGGGTGAGAAGAGCAGGCA 69 FBan0004103 FBgn0028925 CG4103 2 2L CG4103 CG4103 BG:DS00929.4 CDMC27230 2 9 14 DAC22-J19 23-CG41061-RA_1 CG41061 GGTATTTAAAACCGAAACAGTTATTGATAATGGCAGTTTATATAGTTCGGGATCTGAAAATCCTGAGCA 69 FBgn0069957 CG41061 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41061 CG41061 CDMC27230 2 10 14 DAC22-J19 23-CG41061-RA_1 CG41061 GGTATTTAAAACCGAAACAGTTATTGATAATGGCAGTTTATATAGTTCGGGATCTGAAAATCCTGAGCA 69 FBgn0069957 CG41061 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41061 CG41061 CDMC27231 2 11 14 DAC22-N07 8-CG41119-RA_1 CG41119 GCTTCTGCGTCTGGACATATACGACACAACCCACACCAATTTACTCGCATTTCGGAGTCGGGTCACACC 69 FBgn0069932 CG41119 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41119 CG41119 CDMC27231 2 12 14 DAC22-N07 8-CG41119-RA_1 CG41119 GCTTCTGCGTCTGGACATATACGACACAACCCACACCAATTTACTCGCATTTCGGAGTCGGGTCACACC 69 FBgn0069932 CG41119 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41119 CG41119 CDMC27232 2 13 14 DAC22-N19 16-CG41130-RA_1 CG41130 GGCGAAGAACCTCCTACGACATCTTTTGCCGATAACATAGATAAAGCGTGTCCTTTACCAGTGCTGCGA 69 FBan0041130 FBgn0069921 CG41130 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41130 CG41130 CDMC27232 2 14 14 DAC22-N19 16-CG41130-RA_1 CG41130 GGCGAAGAACCTCCTACGACATCTTTTGCCGATAACATAGATAAAGCGTGTCCTTTACCAGTGCTGCGA 69 FBan0041130 FBgn0069921 CG41130 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41130 CG41130 CDMC27233 2 15 14 DAC23-B07 8-CG33338-RA_1 CG33338 GGCCAGGTGGCTAAGGTGAGACTACGAGGCACTGAAAATTACTTCGCTATGAAAAGGCTTATGCGCCCA 69 FBgn0053338 CDMC27233 2 16 14 DAC23-B07 8-CG33338-RA_1 CG33338 GGCCAGGTGGCTAAGGTGAGACTACGAGGCACTGAAAATTACTTCGCTATGAAAAGGCTTATGCGCCCA 69 FBgn0053338 CDMC27234 2 17 14 DAC23-B19 17-CG33348-RA_1 CG33348 GTACAAAGACTACGAACTGGACTTGAAGACCAGCTTGAATGTTCCGAATCTGGATGGGCGCTACAAGCT 69 CDMC27234 2 18 14 DAC23-B19 17-CG33348-RA_1 CG33348 GTACAAAGACTACGAACTGGACTTGAAGACCAGCTTGAATGTTCCGAATCTGGATGGGCGCTACAAGCT 69 CDMC27235 2 19 14 DAC23-F07 17-CG33468-RA_3 CG33468 TCGCCGAAAACTGTGGTACATGTACTATGCGACAACAGATCAGGTGGACAAAACTGTGGATCAGATCCA 69 FBan0033468 FBgn0053468 CG33468 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33468 CG33468 CDMC27235 2 20 14 DAC23-F07 17-CG33468-RA_3 CG33468 TCGCCGAAAACTGTGGTACATGTACTATGCGACAACAGATCAGGTGGACAAAACTGTGGATCAGATCCA 69 FBan0033468 FBgn0053468 CG33468 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33468 CG33468 CDMC27236 2 21 14 DAC23-F19 15-CG33476-RA_1 CG33476 CGCGTCAGGATGCGAGAAAGTAGGGACCCCTTTGTGATGGAAATGCTGTGGGTATACAGTGTAGTACGA 69 FBan0033476 FBgn0053476 CG33476 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33476 CG33476 CDMC27236 2 22 14 DAC23-F19 15-CG33476-RA_1 CG33476 CGCGTCAGGATGCGAGAAAGTAGGGACCCCTTTGTGATGGAAATGCTGTGGGTATACAGTGTAGTACGA 69 FBan0033476 FBgn0053476 CG33476 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33476 CG33476 CDMC27237 2 23 14 DAC23-J07 13-CG33494-RA_1 CG33494 TCCTGGGACATCTTTCTGCTCAAATTACCGTGAGTCCAAGCACGTTCAATCCTCTTATGGTCGACAGCA 69 FBan0033494 FBgn0053494 CG33494 3 3R CG33494 CG33494 BcDNA:LP10657 CDMC27237 2 24 14 DAC23-J07 13-CG33494-RA_1 CG33494 TCCTGGGACATCTTTCTGCTCAAATTACCGTGAGTCCAAGCACGTTCAATCCTCTTATGGTCGACAGCA 69 FBan0033494 FBgn0053494 CG33494 3 3R CG33494 CG33494 BcDNA:LP10657 CDMC27238 2 25 14 DAC23-J19 9-CG3351-RA_1 CG3351 AGGTTGCCGGCATGATCACTCTCAAGCATTTGTACGAGATTGCAGCTATTAAGATTCAGGACCCGCCCA 69 FBan0003351 FBgn0038234 mRpL11 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL11 mitochondrial ribosomal protein L11 "CG3351, CG3351, CG3351, L11, BcDNA:RE67638, mitochondrial ribosomal protein L11" CDMC27238 2 26 14 DAC23-J19 9-CG3351-RA_1 CG3351 AGGTTGCCGGCATGATCACTCTCAAGCATTTGTACGAGATTGCAGCTATTAAGATTCAGGACCCGCCCA 69 FBan0003351 FBgn0038234 mRpL11 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL11 mitochondrial ribosomal protein L11 "CG3351, CG3351, CG3351, L11, BcDNA:RE67638, mitochondrial ribosomal protein L11" CDMC27239 2 1 15 DAC23-N07 23-CG3401-RA_10 CG3401 CACTTACGTTTAGGGCTATACGATAAACGAGCTCATCCAAAGATAATCGAACGACAACTCTCATGAGAT 69 FBan0003401 FBgn0003888 betaTub60D 2 2R axon guidance; GO:0007411; axonogenesis; GO:0007409; chromosome segregation; GO:0007059; heart development; GO:0007507; intracellular protein transport; GO:0006886; larval behavior; GO:0030537; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; response to light stimulus; GO:0009416 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 betaTub60D beta-Tubulin at 60D "CG3401, CG3401, beta3 tubulin, DTB3, beta60C, beta[[3]]-tubulin, beta3, beta3-tubulin, beta-tub, 3t, B3t, beta[[3]] tubulin, Beta3 tubulin, beta3t: beta3 tubulin, T, betaTub60C, beta-3tubulin, B3-tubulin, 60C beta tubulin, beta-tubulin, beta3-Tubulin, Dmbeta3, beta[[3]]-Tub, beta 3 tubulin, tubulin, beta tubulin, beta3-Tub, 60C beta tubulin, D.m.BETA-60D, BETA 60D, beta3 TU, beta-Tub6D, p53, p50, tubulin b-3, p53/tubulin, p50/tubulin, betaTub60D, beta-3 Tubulin, beta3tubulin, beta-Tubulin, Beta tubulin, beta-Tub60D, betaTub3, beta3t" CDMC27239 2 2 15 DAC23-N07 23-CG3401-RA_10 CG3401 CACTTACGTTTAGGGCTATACGATAAACGAGCTCATCCAAAGATAATCGAACGACAACTCTCATGAGAT 69 FBan0003401 FBgn0003888 betaTub60D 2 2R axon guidance; GO:0007411; axonogenesis; GO:0007409; chromosome segregation; GO:0007059; heart development; GO:0007507; intracellular protein transport; GO:0006886; larval behavior; GO:0030537; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067; response to light stimulus; GO:0009416 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 betaTub60D beta-Tubulin at 60D "CG3401, CG3401, beta3 tubulin, DTB3, beta60C, beta[[3]]-tubulin, beta3, beta3-tubulin, beta-tub, 3t, B3t, beta[[3]] tubulin, Beta3 tubulin, beta3t: beta3 tubulin, T, betaTub60C, beta-3tubulin, B3-tubulin, 60C beta tubulin, beta-tubulin, beta3-Tubulin, Dmbeta3, beta[[3]]-Tub, beta 3 tubulin, tubulin, beta tubulin, beta3-Tub, 60C beta tubulin, D.m.BETA-60D, BETA 60D, beta3 TU, beta-Tub6D, p53, p50, tubulin b-3, p53/tubulin, p50/tubulin, betaTub60D, beta-3 Tubulin, beta3tubulin, beta-Tubulin, Beta tubulin, beta-Tub60D, betaTub3, beta3t" CDMC27240 2 3 15 DAC23-N19 17-CG3412-RA_1 CG3412 TAGGCGCTGTAATACTAATCGAGGGTCAGTCTTTGAATCGCCCTTCGGATCAGTGGATCGATCGATTGG 69 FBan0003412 FBgn0023423 slmb 3 3R circadian rhythm; GO:0007623; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; olfactory learning; GO:0008355; proteolysis; GO:0006508; regulation of frizzled signaling pathway; GO:0008590; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; release of cytoplasmic sequestered NF-kappaB; GO:0008588; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 SCF ubiquitin ligase complex; GO:0019005; ubiquitin ligase complex; GO:0000151 slmb supernumerary limbs "CG3412, CG3412, shv, shiva, ica, icare, slimb, Slimb, pingiel, BcDNA:GM02031, crd: centrosome replication defective, l(3)00295, centrosome replication defective" CDMC27240 2 4 15 DAC23-N19 17-CG3412-RA_1 CG3412 TAGGCGCTGTAATACTAATCGAGGGTCAGTCTTTGAATCGCCCTTCGGATCAGTGGATCGATCGATTGG 69 FBan0003412 FBgn0023423 slmb 3 3R circadian rhythm; GO:0007623; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; olfactory learning; GO:0008355; proteolysis; GO:0006508; regulation of frizzled signaling pathway; GO:0008590; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; release of cytoplasmic sequestered NF-kappaB; GO:0008588; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 SCF ubiquitin ligase complex; GO:0019005; ubiquitin ligase complex; GO:0000151 slmb supernumerary limbs "CG3412, CG3412, shv, shiva, ica, icare, slimb, Slimb, pingiel, BcDNA:GM02031, crd: centrosome replication defective, l(3)00295, centrosome replication defective" CDMC27241 2 5 15 DAC24-B07 12-CG33158-RB_4 CG33158 CAGGGCGTTTGTTTTGCGGTTCTCGAGTGGTCTATCCAATCTGAAGGAGAGGATTTGAATTCCCGTGGC 69 FBan0033158 FBgn0053158 CG33158 3 3L translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 eukaryotic translation initiation factor 2 complex; GO:0005850 CG33158 CG33158 "CG4638, CG10162" CDMC27241 2 6 15 DAC24-B07 12-CG33158-RB_4 CG33158 CAGGGCGTTTGTTTTGCGGTTCTCGAGTGGTCTATCCAATCTGAAGGAGAGGATTTGAATTCCCGTGGC 69 FBan0033158 FBgn0053158 CG33158 3 3L translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 eukaryotic translation initiation factor 2 complex; GO:0005850 CG33158 CG33158 "CG4638, CG10162" CDMC27242 2 7 15 DAC24-B19 17-CG33171-RE_1 CG33171 CGGCGAAAGTGAAAGTAGGGAGTTCAAGACGGCCGATGAGTATGCAGCGCATTTAGAAAATTTACTGCT 69 FBan0033171 FBgn0053171 CG33171 3 3L cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817; protein amino acid prenylation; GO:0018346; signal transduction; GO:0007165 extracellular matrix structural constituent; GO:0005201; ; GO:0005201; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- collagen; GO:0005581; cytoplasm; GO:0005737 CG33171 CG33171 "CG8645, CG14822, CT14872" CDMC27242 2 8 15 DAC24-B19 17-CG33171-RE_1 CG33171 CGGCGAAAGTGAAAGTAGGGAGTTCAAGACGGCCGATGAGTATGCAGCGCATTTAGAAAATTTACTGCT 69 FBan0033171 FBgn0053171 CG33171 3 3L cell-matrix adhesion; GO:0007160; cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817; protein amino acid prenylation; GO:0018346; signal transduction; GO:0007165 extracellular matrix structural constituent; GO:0005201; ; GO:0005201; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- collagen; GO:0005581; cytoplasm; GO:0005737 CG33171 CG33171 "CG8645, CG14822, CT14872" CDMC27243 2 9 15 DAC24-F07 2-CG33196-RB_1 CG33196 GCGGCTCAAAGGGTTGAGGATATCTGCGTATCTATGGTGGGGCTGATTATAGCACTGGTCATCACGGCA 69 FBan0033196 FBgn0053196 dp 2 2L "apposition of dorsal and ventral wing surfaces; GO:0007475; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; electron transport; GO:0006118; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; regulation of transcription, DNA-dependent; GO:0006355; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; ; GO:0003676; receptor binding; GO:0005102; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; serine-type endopeptidase inhibitor activity; GO:0004867; transcription factor activity; GO:0003700; ; GO:0005102; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; ; GO:0004867; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003700; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 extracellular matrix (sensu Metazoa); GO:0005578; nucleus; GO:0005634 dp dumpy "CG15637, CG33196, CG31724, CG31726, CG31964, CG31965, CG33086, CG31727, CG31725, CG33000, CG31967, CG31968, CG31966, CG15637, DP, SP460, CT35799, fibrillin-like, Dp, Dumpy, BcDNA:SD02173, CR33195, l(2)24Fd, olv[D], dumpy" CDMC27243 2 10 15 DAC24-F07 2-CG33196-RB_1 CG33196 GCGGCTCAAAGGGTTGAGGATATCTGCGTATCTATGGTGGGGCTGATTATAGCACTGGTCATCACGGCA 69 FBan0033196 FBgn0053196 dp 2 2L "apposition of dorsal and ventral wing surfaces; GO:0007475; cell-matrix adhesion; GO:0007160; ectoderm development; GO:0007398; electron transport; GO:0006118; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; regulation of transcription, DNA-dependent; GO:0006355; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; ; GO:0003676; receptor binding; GO:0005102; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; serine-type endopeptidase inhibitor activity; GO:0004867; transcription factor activity; GO:0003700; ; GO:0005102; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; ; GO:0004867; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003700; ; GO:0008270; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 extracellular matrix (sensu Metazoa); GO:0005578; nucleus; GO:0005634 dp dumpy "CG15637, CG33196, CG31724, CG31726, CG31964, CG31965, CG33086, CG31727, CG31725, CG33000, CG31967, CG31968, CG31966, CG15637, DP, SP460, CT35799, fibrillin-like, Dp, Dumpy, BcDNA:SD02173, CR33195, l(2)24Fd, olv[D], dumpy" CDMC27244 2 11 15 DAC24-F19 1-CG33201-RB_1 CG33201 ACGGAGCAACAAGAGATTTCCACACGTGATCTGGGAGCAGGAAAGCCGTCTCACCTTATAAGGCAAGCC 69 FBan0033201 FBgn0053201 CG33201 3 3R CG33201 CG33201 CDMC27244 2 12 15 DAC24-F19 1-CG33201-RB_1 CG33201 ACGGAGCAACAAGAGATTTCCACACGTGATCTGGGAGCAGGAAAGCCGTCTCACCTTATAAGGCAAGCC 69 FBan0033201 FBgn0053201 CG33201 3 3R CG33201 CG33201 CDMC27245 2 13 15 DAC24-J07 16-CG33226-RA_1 CG33226 GGGCAAAACGGAATCTCAACTGACGAGCACAATACTCCAGACAACTAGTTTGTTCCATCTGGATCGCAA 69 FBan0033226 FBgn0069056 CG33226 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33226 CG33226 "CG10450, CG10450, SPH37, SP37" CDMC27245 2 14 15 DAC24-J07 16-CG33226-RA_1 CG33226 GGGCAAAACGGAATCTCAACTGACGAGCACAATACTCCAGACAACTAGTTTGTTCCATCTGGATCGCAA 69 FBan0033226 FBgn0069056 CG33226 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33226 CG33226 "CG10450, CG10450, SPH37, SP37" CDMC27246 2 15 15 DAC24-J19 11-CG33233-RA_7 CG33233 GGCACTCGTAGGAGCGCTGTCCTTCTCGGTGATTTCTGCTTTAATGCCGGATCTCTATTCGCTTTCTGT 69 FBan0033233 FBgn0053233 CG33233 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33233 CG33233 CG12036 CDMC27246 2 16 15 DAC24-J19 11-CG33233-RA_7 CG33233 GGCACTCGTAGGAGCGCTGTCCTTCTCGGTGATTTCTGCTTTAATGCCGGATCTCTATTCGCTTTCTGT 69 FBan0033233 FBgn0053233 CG33233 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33233 CG33233 CG12036 CDMC27247 2 17 15 DAC24-N07 9-CG33286-RA_1 CG33286 GGGCCCAAGGGCTTTGGTCAAGCGTCCAGATGCAGAGGAAGTCGTTACTCAGGTTAAGACTTTAGACTT 69 FBan0033286 FBgn0053286 CG33286 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33286 CG33286 "CG12982, CG12982" CDMC27247 2 18 15 DAC24-N07 9-CG33286-RA_1 CG33286 GGGCCCAAGGGCTTTGGTCAAGCGTCCAGATGCAGAGGAAGTCGTTACTCAGGTTAAGACTTTAGACTT 69 FBan0033286 FBgn0053286 CG33286 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33286 CG33286 "CG12982, CG12982" CDMC27248 2 19 15 DAC24-N19 23-CG33296-RA_12 CG33296 CTTTGATCGGCCTTTTTACTCTATCTTGGGCCTTAATTGCAATAATTTTTTACCATTTCTCGGAGCCTG 69 FBan0033296 FBgn0053296 CG33296 2 2L CG33296 CG33296 CDMC27248 2 20 15 DAC24-N19 23-CG33296-RA_12 CG33296 CTTTGATCGGCCTTTTTACTCTATCTTGGGCCTTAATTGCAATAATTTTTTACCATTTCTCGGAGCCTG 69 FBan0033296 FBgn0053296 CG33296 2 2L CG33296 CG33296 CDMC27249 2 21 15 DAC25-B07 3-CG10349-RB_2 CG10349 CGACCGAATACCAGCAAATGCCCAAAGTAAATCTCTTTCGAGTGGCTGCAATCCCCGTGGACGTTCAGT 69 FBan0010349 FBgn0015350 CG10349 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10349 CG10349 "domain II, II, candidate gene 5, CT29078, CG-CG10349, anon-89Ea" CDMC27249 2 22 15 DAC25-B07 3-CG10349-RB_2 CG10349 CGACCGAATACCAGCAAATGCCCAAAGTAAATCTCTTTCGAGTGGCTGCAATCCCCGTGGACGTTCAGT 69 FBan0010349 FBgn0015350 CG10349 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10349 CG10349 "domain II, II, candidate gene 5, CT29078, CG-CG10349, anon-89Ea" CDMC27250 2 23 15 DAC25-B19 9-CG10363-RA_5 CG10363 TGCATTGGACACTCGCATCAAGAGGAATCTGCAGGACGGATACCAACATATGTTGCACTATCGCCACGA 69 FBan0010363 FBgn0041180 TepIV 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; protease inhibitor activity; GO:0030414; ; GO:0030414; endopeptidase inhibitor activity; GO:0004866; ; GO:0005351; ; GO:0004866 TepIV Thiolester containing protein IV "CG10363, CG10363, CG10363, dTEPIV, Tep4, CT29102, Thiolester containing protein IV" CDMC27250 2 24 15 DAC25-B19 9-CG10363-RA_5 CG10363 TGCATTGGACACTCGCATCAAGAGGAATCTGCAGGACGGATACCAACATATGTTGCACTATCGCCACGA 69 FBan0010363 FBgn0041180 TepIV 2 2L antibacterial humoral response (sensu Protostomia); GO:0006961; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; protease inhibitor activity; GO:0030414; ; GO:0030414; endopeptidase inhibitor activity; GO:0004866; ; GO:0005351; ; GO:0004866 TepIV Thiolester containing protein IV "CG10363, CG10363, CG10363, dTEPIV, Tep4, CT29102, Thiolester containing protein IV" CDMC27251 2 25 15 DAC25-F07 2-CG10396-RA_1 CG10396 ACACCCGAATGGAAGATGTGTCTGGGCGTCGCTTTGTGGCTTGTGTCAATCGGAATCGCGATATCGATA 69 FBan0010396 FBgn0033020 CG10396 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG10396 CG10396 "IV: transcript group IV, BcDNA:AT07685, IV" CDMC27251 2 26 15 DAC25-F07 2-CG10396-RA_1 CG10396 ACACCCGAATGGAAGATGTGTCTGGGCGTCGCTTTGTGGCTTGTGTCAATCGGAATCGCGATATCGATA 69 FBan0010396 FBgn0033020 CG10396 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG10396 CG10396 "IV: transcript group IV, BcDNA:AT07685, IV" CDMC27252 2 1 16 DAC25-F19 3-CG10418-RA_1 CG10418 CGGATATCAGTGTCACAGATCCGGACAAGTACCCCCACATGCTGAGCGTCAAGAACTGCTTCATCCGTG 69 FBan0010418 FBgn0036277 CG10418 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG10418 CG10418 BcDNA:GM14851 CDMC27252 2 2 16 DAC25-F19 3-CG10418-RA_1 CG10418 CGGATATCAGTGTCACAGATCCGGACAAGTACCCCCACATGCTGAGCGTCAAGAACTGCTTCATCCGTG 69 FBan0010418 FBgn0036277 CG10418 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG10418 CG10418 BcDNA:GM14851 CDMC27253 2 3 16 DAC25-J07 8-CG10469-RA_1 CG10469 ACCGGAGCTACACCATCGTCCACAAGAAGTTCGACCGTAAGACCGTGACAAACGATATAGCCCTGATCA 69 FBan0010469 FBgn0035678 CG10469 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10469 CG10469 SP123 CDMC27253 2 4 16 DAC25-J07 8-CG10469-RA_1 CG10469 ACCGGAGCTACACCATCGTCCACAAGAAGTTCGACCGTAAGACCGTGACAAACGATATAGCCCTGATCA 69 FBan0010469 FBgn0035678 CG10469 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10469 CG10469 SP123 CDMC27254 2 5 16 DAC25-J19 3-CG10480-RA_1 CG10480 CCGTTGGATGTGGCGAAGTCTGTTCCTATGCCGTTACAATTGATGGCAAACTGTATTCCTGGGGCTCCG 69 FBan0010480 FBgn0002638 Bj1 3 3L "central nervous system development; GO:0007417; chromosome condensation; GO:0030261; mRNA processing; GO:0006397; mitotic chromosome condensation; GO:0007076; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of neurogenesis; GO:0050767; regulation of nucleocytoplasmic transport; GO:0046822" chromatin binding; GO:0003682; ; GO:0003682; Ran guanyl-nucleotide exchange factor activity; GO:0005087; ; GO:0005087 cytoplasm; GO:0005737; nucleus; GO:0005634 Bj1 Bj1 protein "CG18640 (Bj1), RCC protein, CG18640 (Bj1), CG10480 (Bj1), CG18640, BJ1, inxs, in excess, sdt, side-out, RanGEF (Bj1), RCC1 (Bj1), inxs (Bj1)" CDMC27254 2 6 16 DAC25-J19 3-CG10480-RA_1 CG10480 CCGTTGGATGTGGCGAAGTCTGTTCCTATGCCGTTACAATTGATGGCAAACTGTATTCCTGGGGCTCCG 69 FBan0010480 FBgn0002638 Bj1 3 3L "central nervous system development; GO:0007417; chromosome condensation; GO:0030261; mRNA processing; GO:0006397; mitotic chromosome condensation; GO:0007076; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of neurogenesis; GO:0050767; regulation of nucleocytoplasmic transport; GO:0046822" chromatin binding; GO:0003682; ; GO:0003682; Ran guanyl-nucleotide exchange factor activity; GO:0005087; ; GO:0005087 cytoplasm; GO:0005737; nucleus; GO:0005634 Bj1 Bj1 protein "CG18640 (Bj1), RCC protein, CG18640 (Bj1), CG10480 (Bj1), CG18640, BJ1, inxs, in excess, sdt, side-out, RanGEF (Bj1), RCC1 (Bj1), inxs (Bj1)" CDMC27255 2 7 16 DAC25-N07 3-CG10523-RB_2 CG10523 CGGAGTGTTGGGATGATGTCTTGAAGTCGCGTAGAATTCCCGGTCATTGTGAAAGTCTGGAGGTGGCCT 69 FBan0010523 FBgn0041100 park 3 3L DNA methylation; GO:0006306; mitochondrion organization and biogenesis; GO:0007005; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 DNA binding; GO:0003677; ligase activity; GO:0016874 ; EC:6.-.-.-; carrier activity; GO:0005386; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- park parkin "CG10523, CG10523, D-parkin, Parkin, dParkin, SD01679, dpk, dparkin, parkin" CDMC27255 2 8 16 DAC25-N07 3-CG10523-RB_2 CG10523 CGGAGTGTTGGGATGATGTCTTGAAGTCGCGTAGAATTCCCGGTCATTGTGAAAGTCTGGAGGTGGCCT 69 FBan0010523 FBgn0041100 park 3 3L DNA methylation; GO:0006306; mitochondrion organization and biogenesis; GO:0007005; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 DNA binding; GO:0003677; ligase activity; GO:0016874 ; EC:6.-.-.-; carrier activity; GO:0005386; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- park parkin "CG10523, CG10523, D-parkin, Parkin, dParkin, SD01679, dpk, dparkin, parkin" CDMC27256 2 9 16 DAC25-N19 3-CG10531-RA_4 CG10531 TGGCAAGTTCGATGTGTCCAATATCGATGCCGGTCTGTGCACCCATCTGAGCTACTCCTTCTTCGGAAT 69 FBan0010531 FBgn0034582 CG10531 2 2R cell-cell signaling; GO:0007267; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG10531 CG10531 CDMC27256 2 10 16 DAC25-N19 3-CG10531-RA_4 CG10531 TGGCAAGTTCGATGTGTCCAATATCGATGCCGGTCTGTGCACCCATCTGAGCTACTCCTTCTTCGGAAT 69 FBan0010531 FBgn0034582 CG10531 2 2R cell-cell signaling; GO:0007267; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG10531 CG10531 CDMC27257 2 11 16 DAC26-B07 1-CG15279-RA_1 CG15279 GGGCACAATGTACACAGGGATGCAGCAATTGTAACGGGTCTGGACACTATGACCTCTCTGCTAGCTGGA 69 FBan0015279 FBgn0028886 CG15279 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation:amino acid symporter activity; GO:0005416; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005416; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15279 CG15279 "BG:DS03431.1, DS03431.1, anon-WO0149848.9" CDMC27257 2 12 16 DAC26-B07 1-CG15279-RA_1 CG15279 GGGCACAATGTACACAGGGATGCAGCAATTGTAACGGGTCTGGACACTATGACCTCTCTGCTAGCTGGA 69 FBan0015279 FBgn0028886 CG15279 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation:amino acid symporter activity; GO:0005416; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005416; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15279 CG15279 "BG:DS03431.1, DS03431.1, anon-WO0149848.9" CDMC27258 2 13 16 DAC26-B19 3-CG15287-RA_1 CG15287 CGGCCGATCCGGATGAATGGACAAAGCCCGAAGTTCGCCCATCAACTAAAAGTCAGCGATCAGATCGAT 69 FBan0015287 FBgn0028918 CG15287 2 2L CG15287 CG15287 BG:DS01068.1 CDMC27258 2 14 16 DAC26-B19 3-CG15287-RA_1 CG15287 CGGCCGATCCGGATGAATGGACAAAGCCCGAAGTTCGCCCATCAACTAAAAGTCAGCGATCAGATCGAT 69 FBan0015287 FBgn0028918 CG15287 2 2L CG15287 CG15287 BG:DS01068.1 CDMC27259 2 15 16 DAC26-F07 19-CG15336-RA_1 CG15336 CGACTGCAACGTGGGTTTCTCCAGTTCGCGGGCCCTGTACCATCACCGGACGCTCCACGAGGATGGGAA 69 FBan0015336 FBgn0030009 CG15336 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15336 CG15336 CDMC27259 2 16 16 DAC26-F07 19-CG15336-RA_1 CG15336 CGACTGCAACGTGGGTTTCTCCAGTTCGCGGGCCCTGTACCATCACCGGACGCTCCACGAGGATGGGAA 69 FBan0015336 FBgn0030009 CG15336 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15336 CG15336 CDMC27260 2 17 16 DAC26-F19 18-CG15354-RA_2 CG15354 AGCACAGCGATGAGAATTCCTTCCGGATGTCAGGGTCAAGTAGCTGGGAAATGCAAATTATTGATGCAA 69 FBgn0031383 CDMC27260 2 18 16 DAC26-F19 18-CG15354-RA_2 CG15354 AGCACAGCGATGAGAATTCCTTCCGGATGTCAGGGTCAAGTAGCTGGGAAATGCAAATTATTGATGCAA 69 FBgn0031383 CDMC27261 2 19 16 DAC26-J07 3-CG15400-RA_2 CG15400 GCTGCATAATGTACCTGCTGATCATTGGAATGGTGGTCTGTATGTGGCTGAGTCGCCTCTACCTGGCCA 69 FBan0015400 FBgn0031463 CG15400 2 2L glucose-6-phosphatase activity; GO:0004346 ; EC:3.1.3.9; ; GO:0004346 ; EC:3.1.3.9 CG15400 CG15400 CDMC27261 2 20 16 DAC26-J07 3-CG15400-RA_2 CG15400 GCTGCATAATGTACCTGCTGATCATTGGAATGGTGGTCTGTATGTGGCTGAGTCGCCTCTACCTGGCCA 69 FBan0015400 FBgn0031463 CG15400 2 2L glucose-6-phosphatase activity; GO:0004346 ; EC:3.1.3.9; ; GO:0004346 ; EC:3.1.3.9 CG15400 CG15400 CDMC27262 2 21 16 DAC26-J19 16-CG15427-RA_2 CG15427 TGAATGAGAGGCTGACCATACGTGTAAGTCCCAACTGAAAATCGCTCCTTGCATTTTGCATTCCGGACT 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC27262 2 22 16 DAC26-J19 16-CG15427-RA_2 CG15427 TGAATGAGAGGCTGACCATACGTGTAAGTCCCAACTGAAAATCGCTCCTTGCATTTTGCATTCCGGACT 69 FBan0015427 FBgn0010473 tutl 2 2L adult locomotory behavior; GO:0008344; cell-cell adhesion; GO:0016337; flight behavior; GO:0007629; larval behavior; GO:0030537; peripheral nervous system development; GO:0007422; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 tutl turtle "CG15427, CG15426, CG15428, jf4, l(2)01085, CT35489, CT35490, l(2)24Df, l(2)jf4, lethal(2)24Df, turtle" CDMC27263 2 23 16 DAC26-N07 11-CG15460-RA_1 CG15460 GCAGCCTCAGTTTACGCGTGGATTCAATCAGTGGATGGGCAATCAGTCTACGATGACTAAGGGTTTGCC 69 FBan0015460 FBgn0031104 CG15460 X X CG15460 CG15460 CDMC27263 2 24 16 DAC26-N07 11-CG15460-RA_1 CG15460 GCAGCCTCAGTTTACGCGTGGATTCAATCAGTGGATGGGCAATCAGTCTACGATGACTAAGGGTTTGCC 69 FBan0015460 FBgn0031104 CG15460 X X CG15460 CG15460 CDMC27264 2 25 16 DAC26-N19 15-CG1546-RB_7 CG1546 AGTTGGGCAATCCAAAGAAAGCCGCAAGACTACTGAGTCAGATCCTTGAATCGCAACCAACACATTCCG 69 FBan0001546 FBgn0039779 PH4alphaSG2 3 3R protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaSG2 prolyl-4-hydroxylase-alpha SG2 "CG1546, CG1546, prolyl-4-hydroxylase-alpha SG2" CDMC27264 2 26 16 DAC26-N19 15-CG1546-RB_7 CG1546 AGTTGGGCAATCCAAAGAAAGCCGCAAGACTACTGAGTCAGATCCTTGAATCGCAACCAACACATTCCG 69 FBan0001546 FBgn0039779 PH4alphaSG2 3 3R protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaSG2 prolyl-4-hydroxylase-alpha SG2 "CG1546, CG1546, prolyl-4-hydroxylase-alpha SG2" CDMC27265 2 1 17 DAC27-B07 16-CG9745-RB_1 CG9745 GCTGAGAAATCGGACAAACCGTTTACAACTGCACTGCACTGTAATGACGACACATAGCTCGGAAAACGA 69 FBan0009745 FBgn0000412 D1 3 3R "regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; satellite DNA binding; GO:0003696; ; GO:0003680; double-stranded DNA binding; GO:0003690; ; GO:0003696; ; GO:0003690 nucleus; GO:0005634 D1 D1 chromosomal protein "CG9745, CG9745, Chromosomal protein D1, dD1, EP(3)0473, RE69409" CDMC27265 2 2 17 DAC27-B07 16-CG9745-RB_1 CG9745 GCTGAGAAATCGGACAAACCGTTTACAACTGCACTGCACTGTAATGACGACACATAGCTCGGAAAACGA 69 FBan0009745 FBgn0000412 D1 3 3R "regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; satellite DNA binding; GO:0003696; ; GO:0003680; double-stranded DNA binding; GO:0003690; ; GO:0003696; ; GO:0003690 nucleus; GO:0005634 D1 D1 chromosomal protein "CG9745, CG9745, Chromosomal protein D1, dD1, EP(3)0473, RE69409" CDMC27266 2 3 17 DAC27-B19 15-CG9759-RA_1 CG9759 ACACACAGGGTAGATAGACGACCAGACCTAGAGACAGACGGCTACTCGTACTACAGCTACAGCCACAAA 69 FBan0009759 FBgn0038160 CG9759 3 3R CG9759 CG9759 BcDNA:GH02603 CDMC27266 2 4 17 DAC27-B19 15-CG9759-RA_1 CG9759 ACACACAGGGTAGATAGACGACCAGACCTAGAGACAGACGGCTACTCGTACTACAGCTACAGCCACAAA 69 FBan0009759 FBgn0038160 CG9759 3 3R CG9759 CG9759 BcDNA:GH02603 CDMC27267 2 5 17 DAC27-F07 6-CG9795-RA_1 CG9795 AAAGGAGACTAACAAACGCCTCTCACATCTGGAATCCGAAAACAAGTGCCTTCGTCAAGCTCTGGCCGG 69 FBan0009795 FBgn0037234 CG9795 3 3R CG9795 CG9795 CDMC27267 2 6 17 DAC27-F07 6-CG9795-RA_1 CG9795 AAAGGAGACTAACAAACGCCTCTCACATCTGGAATCCGAAAACAAGTGCCTTCGTCAAGCTCTGGCCGG 69 FBan0009795 FBgn0037234 CG9795 3 3R CG9795 CG9795 CDMC27268 2 7 17 DAC27-F19 23-CG9811-RA_3 CG9811 CTTTCGTTTTCCTCTAAGCATGAGTTGGGATAATTTTGAATGCTCGTTGTAATACGGCGACTGGAATAA 69 FBan0009811 FBgn0034434 Rgk1 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rgk1 Rgk1 "CG9811, CG9811, CG9811, CT27512" CDMC27268 2 8 17 DAC27-F19 23-CG9811-RA_3 CG9811 CTTTCGTTTTCCTCTAAGCATGAGTTGGGATAATTTTGAATGCTCGTTGTAATACGGCGACTGGAATAA 69 FBan0009811 FBgn0034434 Rgk1 2 2R small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rgk1 Rgk1 "CG9811, CG9811, CG9811, CT27512" CDMC27269 2 9 17 DAC27-J07 7-CG9854-RA_1 CG9854 TCCCCACAGCTGGTTTGAGGAGTGCGTAGAAGAGAGAAGTGTGGAGAGGAGGATGTGGATAAAGATGGA 69 FBan0009854 FBgn0015949 hrg 2 2R mRNA polyadenylylation; GO:0006378; transcription; GO:0006350 poly(A) binding; GO:0008143; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19; ; GO:0008143; ; GO:0004652 ; EC:2.7.7.19 nucleoplasm; GO:0005654 hrg hiiragi "CG9854, CG9854, l(2)k07619, Pap, Poly(A) polymerase, PAP: Pelle associated protein, poly(A) polymerase, l(2)07619, PAP, hiiragi" CDMC27269 2 10 17 DAC27-J07 7-CG9854-RA_1 CG9854 TCCCCACAGCTGGTTTGAGGAGTGCGTAGAAGAGAGAAGTGTGGAGAGGAGGATGTGGATAAAGATGGA 69 FBan0009854 FBgn0015949 hrg 2 2R mRNA polyadenylylation; GO:0006378; transcription; GO:0006350 poly(A) binding; GO:0008143; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19; ; GO:0008143; ; GO:0004652 ; EC:2.7.7.19 nucleoplasm; GO:0005654 hrg hiiragi "CG9854, CG9854, l(2)k07619, Pap, Poly(A) polymerase, PAP: Pelle associated protein, poly(A) polymerase, l(2)07619, PAP, hiiragi" CDMC27270 2 11 17 DAC27-J19 3-CG9874-RA_1 CG9874 CGCTGATCCCGGTATTGTGCCACAACTTCAGAACATCGTGTCCACGGTTAATCTGTGCTGCAAACTGGA 69 FBan0009874 FBgn0003687 Tbp 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; snRNA transcription from RNA polymerase III promoter; GO:0042796; tRNA transcription from RNA polymerase III promoter; GO:0042797; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0008134 DNA-directed RNA polymerase III complex; GO:0005666; colocalizes_with transcription factor TFIIIB complex; GO:0000126; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Tbp TATA binding protein "CG9874, CG9874, TFIID, dTFIID, 42kDa polypeptide, dTBP, TBP, TFIIDtau, dTbp, TfIID, TBP38, RBP" CDMC27270 2 12 17 DAC27-J19 3-CG9874-RA_1 CG9874 CGCTGATCCCGGTATTGTGCCACAACTTCAGAACATCGTGTCCACGGTTAATCTGTGCTGCAAACTGGA 69 FBan0009874 FBgn0003687 Tbp 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; snRNA transcription from RNA polymerase III promoter; GO:0042796; tRNA transcription from RNA polymerase III promoter; GO:0042797; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0008134 DNA-directed RNA polymerase III complex; GO:0005666; colocalizes_with transcription factor TFIIIB complex; GO:0000126; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Tbp TATA binding protein "CG9874, CG9874, TFIID, dTFIID, 42kDa polypeptide, dTBP, TBP, TFIIDtau, dTbp, TfIID, TBP38, RBP" CDMC27271 2 13 17 DAC27-N07 23-CG9908-RA_14 CG9908 ACTGTAGTGCGACATCTAAGTGTATAGTATTCAATCCGTTCCTCAGTGTGAATGTGCAGATGCATGAAT 69 FBan0009908 FBgn0000459 disco X X brain development; GO:0007420; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; photoreceptor maintenance; GO:0045494 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 disco disconnected "CG9908, disc" CDMC27271 2 14 17 DAC27-N07 23-CG9908-RA_14 CG9908 ACTGTAGTGCGACATCTAAGTGTATAGTATTCAATCCGTTCCTCAGTGTGAATGTGCAGATGCATGAAT 69 FBan0009908 FBgn0000459 disco X X brain development; GO:0007420; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; photoreceptor maintenance; GO:0045494 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 disco disconnected "CG9908, disc" CDMC27272 2 15 17 DAC27-N19 12-CG9920-RA_1 CG9920 TCGCGCCTGCTCTTATAGCTACCACTCACACTGCCATATCGTGTAAGGACAGGCCAAATAAACCACTGT 69 FBan0009920 FBgn0038200 CG9920 3 3R 'de novo' protein folding; GO:0006458; protein folding; GO:0006457 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrial matrix; GO:0005759 CG9920 CG9920 "anon-WO0140519.48, BEST:GH20473" CDMC27272 2 16 17 DAC27-N19 12-CG9920-RA_1 CG9920 TCGCGCCTGCTCTTATAGCTACCACTCACACTGCCATATCGTGTAAGGACAGGCCAAATAAACCACTGT 69 FBan0009920 FBgn0038200 CG9920 3 3R 'de novo' protein folding; GO:0006458; protein folding; GO:0006457 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrial matrix; GO:0005759 CG9920 CG9920 "anon-WO0140519.48, BEST:GH20473" CDMC27273 2 17 17 DAC28-B07 18-CG11779-RB_1 CG11779 TGTACAAAGGTTTCGCTTTCGATTGCTTTGAAAGTTTTGTCCGCCACTAGTCAACTGCGTCCGCC 65 FBan0011779 FBgn0038683 CG11779 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG11779 CG11779 "BEST:GM03811, BcDNA:GM03811" CDMC27273 2 18 17 DAC28-B07 18-CG11779-RB_1 CG11779 TGTACAAAGGTTTCGCTTTCGATTGCTTTGAAAGTTTTGTCCGCCACTAGTCAACTGCGTCCGCC 65 FBan0011779 FBgn0038683 CG11779 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG11779 CG11779 "BEST:GM03811, BcDNA:GM03811" CDMC27274 2 19 17 DAC28-B19 10-CG11822-RB_1 CG11822 CGGCCTACTGCGAACTCAACATGCTCAACTGGCCCCACGACAAGCAGAGCTGCAAGTTGAAGATC 65 FBan0011822 FBgn0031261 nAcRbeta-21C 2 2L ion transport; GO:0006811; transport; GO:0006810 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; neurotransmitter receptor activity; GO:0030594; ; GO:0030594 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-21C nicotinic acetylcholine receptor beta 21C "CG11822, CG11822, CG11822, CT33131, Dbeta3, nAChR, nAcR-21Beta, nicotinic acetylcholine receptor beta 21C" CDMC27274 2 20 17 DAC28-B19 10-CG11822-RB_1 CG11822 CGGCCTACTGCGAACTCAACATGCTCAACTGGCCCCACGACAAGCAGAGCTGCAAGTTGAAGATC 65 FBan0011822 FBgn0031261 nAcRbeta-21C 2 2L ion transport; GO:0006811; transport; GO:0006810 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; neurotransmitter receptor activity; GO:0030594; ; GO:0030594 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-21C nicotinic acetylcholine receptor beta 21C "CG11822, CG11822, CG11822, CT33131, Dbeta3, nAChR, nAcR-21Beta, nicotinic acetylcholine receptor beta 21C" CDMC27275 2 21 17 DAC28-F07 1-CG11921-RA_1 CG11921 CGAGGAGCTGACTGCCCTGGCGAACCTCAATAGATTCTTCTTTACCACCCGTAACGGAGGCAGTG 65 FBan0011921 FBgn0004897 fd96Ca 3 3R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd96Ca forkhead domain 96Ca "CG11921, FD4, Dmfd4, fd4" CDMC27275 2 22 17 DAC28-F07 1-CG11921-RA_1 CG11921 CGAGGAGCTGACTGCCCTGGCGAACCTCAATAGATTCTTCTTTACCACCCGTAACGGAGGCAGTG 65 FBan0011921 FBgn0004897 fd96Ca 3 3R embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd96Ca forkhead domain 96Ca "CG11921, FD4, Dmfd4, fd4" CDMC27276 2 23 17 DAC28-F19 15-CG11975-RA_4 CG11975 GGCTTCCAGCATCCCCGGAGAGTGCAATGAACCTCACAGAGCAAAACCCATATGGAAACGGGCTG 65 FBan0011975 FBgn0037648 CG11975 3 3R CG11975 CG11975 CDMC27276 2 24 17 DAC28-F19 15-CG11975-RA_4 CG11975 GGCTTCCAGCATCCCCGGAGAGTGCAATGAACCTCACAGAGCAAAACCCATATGGAAACGGGCTG 65 FBan0011975 FBgn0037648 CG11975 3 3R CG11975 CG11975 CDMC27277 2 25 17 DAC28-J07 3-CG12082-RA_3 CG12082 GGGAAAGTACAGCAGTATTGCCGAGAACACTTTGGACACCGATCACAGCACCGGAATATCGCCGG 65 FBan0012082 FBgn0035402 CG12082 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ubiquitin-specific protease 5 activity; GO:0008581; ; GO:0008581; ; GO:0004197 ; EC:3.4.22.- CG12082 CG12082 CDMC27277 2 26 17 DAC28-J07 3-CG12082-RA_3 CG12082 GGGAAAGTACAGCAGTATTGCCGAGAACACTTTGGACACCGATCACAGCACCGGAATATCGCCGG 65 FBan0012082 FBgn0035402 CG12082 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ubiquitin-specific protease 5 activity; GO:0008581; ; GO:0008581; ; GO:0004197 ; EC:3.4.22.- CG12082 CG12082 CDMC27278 2 1 18 DAC28-J19 6-CG12102-RA_3 CG12102 CTGGCCAGGACACCTTGGATCCGCTAAGGGAGCTTTGCTATCCGGATAGCGATGTTTTCCTGCTC 65 FBan0012102 FBgn0030180 CG12102 X X small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG12102 CG12102 CDMC27278 2 2 18 DAC28-J19 6-CG12102-RA_3 CG12102 CTGGCCAGGACACCTTGGATCCGCTAAGGGAGCTTTGCTATCCGGATAGCGATGTTTTCCTGCTC 65 FBan0012102 FBgn0030180 CG12102 X X small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG12102 CG12102 CDMC27279 2 3 18 DAC28-N07 2-CG12169-RA_1 CG12169 AATCGTGACGGCCTATCCCGACGTGGAGGTTCTTGACATCACCGAAGACTTGGAGTTTGTCCTGC 65 FBan0012169 FBgn0035143 CG12169 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG12169 CG12169 PP2C CDMC27279 2 4 18 DAC28-N07 2-CG12169-RA_1 CG12169 AATCGTGACGGCCTATCCCGACGTGGAGGTTCTTGACATCACCGAAGACTTGGAGTTTGTCCTGC 65 FBan0012169 FBgn0035143 CG12169 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG12169 CG12169 PP2C CDMC27280 2 5 18 DAC28-N19 3-CG12189-RA_1 CG12189 AATCCATATGTCACCACCAATGTGAGCCCGCTAAAGGCCACCGATCTTAAGCCATCGACTTCCCG 65 FBan0012189 FBgn0035150 Rev1 3 3L DNA repair; GO:0006281; bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; ; GO:0003676; deoxycytidyl transferase activity; GO:0017125; ; GO:0017125; ; GO:0017125 intracellular; GO:0005622 Rev1 Rev1 "CG12189, CG12189, dREV1, DmRev1, drev1, AAF47401, REV1" CDMC27280 2 6 18 DAC28-N19 3-CG12189-RA_1 CG12189 AATCCATATGTCACCACCAATGTGAGCCCGCTAAAGGCCACCGATCTTAAGCCATCGACTTCCCG 65 FBan0012189 FBgn0035150 Rev1 3 3L DNA repair; GO:0006281; bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; ; GO:0003676; deoxycytidyl transferase activity; GO:0017125; ; GO:0017125; ; GO:0017125 intracellular; GO:0005622 Rev1 Rev1 "CG12189, CG12189, dREV1, DmRev1, drev1, AAF47401, REV1" CDMC27281 2 7 18 DAC29-B07 23-CG3069-RA_1 CG3069 CCGACTACGGTATTAATGTTAGGAAAGTGGACTATAGTCAGTAGATAATGGCATGCATTGTAGTAGTTT 69 FBan0003069 FBgn0026324 Taf10b 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016251; ; GO:0003700; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf10b TBP-associated factor 10b "CG3069, CG3069, TAFII16, dtafII16, TAF[[II]]16, dTAF[[II]]16, TFIID, TAF10b, TAF[[II]], dmTAF10b, TAF, Taf16: TBP-associated factor 16kD, TafII16, TBP-associated factor 16kD" CDMC27281 2 8 18 DAC29-B07 23-CG3069-RA_1 CG3069 CCGACTACGGTATTAATGTTAGGAAAGTGGACTATAGTCAGTAGATAATGGCATGCATTGTAGTAGTTT 69 FBan0003069 FBgn0026324 Taf10b 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0016251; ; GO:0003700; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf10b TBP-associated factor 10b "CG3069, CG3069, TAFII16, dtafII16, TAF[[II]]16, dTAF[[II]]16, TFIID, TAF10b, TAF[[II]], dmTAF10b, TAF, Taf16: TBP-associated factor 16kD, TafII16, TBP-associated factor 16kD" CDMC27282 2 9 18 DAC29-B19 3-CG3083-RA_1 CG3083 GGCAAGTGCATGGTCTTGCCCACCGTCAAAGCCGAAGATGTTCCTAAGCTCTTTCCTGATGGTATCGAA 69 FBan0003083 FBgn0031479 Prx6005 2 2L cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0016209; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 Prx6005 Peroxiredoxin 6005 "CG3083, CG3083, DPx6005, Peroxiredoxin 6005" CDMC27282 2 10 18 DAC29-B19 3-CG3083-RA_1 CG3083 GGCAAGTGCATGGTCTTGCCCACCGTCAAAGCCGAAGATGTTCCTAAGCTCTTTCCTGATGGTATCGAA 69 FBan0003083 FBgn0031479 Prx6005 2 2L cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0016209; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 Prx6005 Peroxiredoxin 6005 "CG3083, CG3083, DPx6005, Peroxiredoxin 6005" CDMC27283 2 11 18 DAC29-F07 2-CG31013-RA_1 CG31013 GCAACCAGTGGGGATATGGCAATTGAAAGCATTCTACAGCTGGAAGGATGAGCTTCCCACCGAACGTGA 69 FBan0031013 FBgn0051013 CG31013 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31013 CG31013 CG9713 CDMC27283 2 12 18 DAC29-F07 2-CG31013-RA_1 CG31013 GCAACCAGTGGGGATATGGCAATTGAAAGCATTCTACAGCTGGAAGGATGAGCTTCCCACCGAACGTGA 69 FBan0031013 FBgn0051013 CG31013 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31013 CG31013 CG9713 CDMC27284 2 13 18 DAC29-F19 2-CG31019-RA_3 CG31019 TCGCTGCAATCTGATGGGACAGGATATGAATCGCAACTGGCACATAGGATCCGAGTTCACGCAACCAGA 69 FBan0031019 FBgn0051019 CG31019 3 3R proteolysis; GO:0006508 GTPase activity; GO:0003924; ; GO:0003924; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG31019 CG31019 CDMC27284 2 14 18 DAC29-F19 2-CG31019-RA_3 CG31019 TCGCTGCAATCTGATGGGACAGGATATGAATCGCAACTGGCACATAGGATCCGAGTTCACGCAACCAGA 69 FBan0031019 FBgn0051019 CG31019 3 3R proteolysis; GO:0006508 GTPase activity; GO:0003924; ; GO:0003924; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG31019 CG31019 CDMC27285 2 15 18 DAC29-J07 13-CG31052-RA_1 CG31052 TGGCGGAAATCTGTCGAGAAAGGAACGTGCCTACATTACAATTTCCGGTTTTCCCAAAGCAACTGTCCA 69 FBan0031052 FBgn0051052 CG31052 3 3R regulation of pH; GO:0006885 solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 CG31052 CG31052 "CG4682, CG4693" CDMC27285 2 16 18 DAC29-J07 13-CG31052-RA_1 CG31052 TGGCGGAAATCTGTCGAGAAAGGAACGTGCCTACATTACAATTTCCGGTTTTCCCAAAGCAACTGTCCA 69 FBan0031052 FBgn0051052 CG31052 3 3R regulation of pH; GO:0006885 solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 CG31052 CG31052 "CG4682, CG4693" CDMC27286 2 17 18 DAC29-J19 1-CG3105-RA_1 CG3105 GCTGAGGGTCTCGTTACCTGACTCAAGCCACACAGAAATCGGCGGTTCAATATGCTCCTCGAAATCCGA 69 FBan0003105 FBgn0034950 CG3105 2 2R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG3105 CG3105 CDMC27286 2 18 18 DAC29-J19 1-CG3105-RA_1 CG3105 GCTGAGGGTCTCGTTACCTGACTCAAGCCACACAGAAATCGGCGGTTCAATATGCTCCTCGAAATCCGA 69 FBan0003105 FBgn0034950 CG3105 2 2R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG3105 CG3105 CDMC27287 2 19 18 DAC29-N07 16-CG31088-RA_2 CG31088 TGCCCCAAAATCAGTGAAATTACGATCAAATCGCTTGACTGGGAGCTTCAGGGTCTTATTCAGCCAAGT 69 FBan0031088 FBgn0051088 CG31088 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31088 CG31088 CDMC27287 2 20 18 DAC29-N07 16-CG31088-RA_2 CG31088 TGCCCCAAAATCAGTGAAATTACGATCAAATCGCTTGACTGGGAGCTTCAGGGTCTTATTCAGCCAAGT 69 FBan0031088 FBgn0051088 CG31088 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31088 CG31088 CDMC27288 2 21 18 DAC29-N19 3-CG31096-RA_2 CG31096 CGGCGGTTAATCCTCTCTTGTACACCTTCACCACGCCCAAGTACCGAAATCAAATCTTCCTTCGCGGCT 69 FBan0031096 FBgn0039354 Lgr3 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021 Lgr3 Lgr3 "CG5042, CG5046, CG31096, CG5042, CG5042, CG5042, CG5042, CG5046, CT16193, anon-WO0170980.25, anon-WO0170980.26" CDMC27288 2 22 18 DAC29-N19 3-CG31096-RA_2 CG31096 CGGCGGTTAATCCTCTCTTGTACACCTTCACCACGCCCAAGTACCGAAATCAAATCTTCCTTCGCGGCT 69 FBan0031096 FBgn0039354 Lgr3 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021 Lgr3 Lgr3 "CG5042, CG5046, CG31096, CG5042, CG5042, CG5042, CG5042, CG5046, CT16193, anon-WO0170980.25, anon-WO0170980.26" CDMC27289 2 23 18 DAC30-B07 5-CG1965-RA_1 CG1965 ACTGACATGTCGTCATACCAGGACGCATTTGTTAGCCTGTGCCTTCCAAAAGTCTTGGCTCCGCT 65 FBan0001965 FBgn0037466 CG1965 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 CG1965 CG1965 CDMC27289 2 24 18 DAC30-B07 5-CG1965-RA_1 CG1965 ACTGACATGTCGTCATACCAGGACGCATTTGTTAGCCTGTGCCTTCCAAAAGTCTTGGCTCCGCT 65 FBan0001965 FBgn0037466 CG1965 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 CG1965 CG1965 CDMC27290 2 25 18 DAC30-B19 23-CG1987-RA_1 CG1987 AATGGCTCAACAGATTTCTGAAGTTTGACTCAATAAATTCGTCCCCCTCCATATAATAACCCCCC 65 FBan0001987 FBgn0030479 Rbp1-like X X "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 Rbp1-like Rbp1-like "CG1987, CG1987, RBP1-like, i159, BcDNA:RE47308, BEST:HL02433" CDMC27290 2 26 18 DAC30-B19 23-CG1987-RA_1 CG1987 AATGGCTCAACAGATTTCTGAAGTTTGACTCAATAAATTCGTCCCCCTCCATATAATAACCCCCC 65 FBan0001987 FBgn0030479 Rbp1-like X X "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 Rbp1-like Rbp1-like "CG1987, CG1987, RBP1-like, i159, BcDNA:RE47308, BEST:HL02433" CDMC27291 2 1 19 DAC30-F07 2-CG2150-RA_1 CG2150 GAGATCGCTTCCCCTTCTCAAGCCCTCTTCCCGAACTCAGCGACTGTACCCCAACACTCTGAAAC 65 FBan0002150 FBgn0003065 CG2150 3 3R CG2150 CG2150 "GCR1, GCR 1, Pen100DE, anon-Pen100DE, pen100DE" CDMC27291 2 2 19 DAC30-F07 2-CG2150-RA_1 CG2150 GAGATCGCTTCCCCTTCTCAAGCCCTCTTCCCGAACTCAGCGACTGTACCCCAACACTCTGAAAC 65 FBan0002150 FBgn0003065 CG2150 3 3R CG2150 CG2150 "GCR1, GCR 1, Pen100DE, anon-Pen100DE, pen100DE" CDMC27292 2 3 19 DAC30-F19 3-CG2196-RA_2 CG2196 ATTCCCATGAGCTATGTGTGGCCCTTGGACAAGGAAGAAAAGCAGAACCCCAAGCTCTACTCGCC 65 FBan0002196 FBgn0039872 CG2196 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG2196 CG2196 CDMC27292 2 4 19 DAC30-F19 3-CG2196-RA_2 CG2196 ATTCCCATGAGCTATGTGTGGCCCTTGGACAAGGAAGAAAAGCAGAACCCCAAGCTCTACTCGCC 65 FBan0002196 FBgn0039872 CG2196 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG2196 CG2196 CDMC27293 2 5 19 DAC30-J07 23-CG2345-RA_2 CG2345 CTCATCCGCAGTACTCATTTAACTATGATGTTCAGGATCCAGAGACAGGAGATGTTAAGTCCCAG 65 FBan0002345 FBgn0000552 Edg84A 3 3R structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011; ; GO:0008011 Edg84A Ecdysone-dependent gene 84A "CG2345, CG2345, EDG84, cuticle-like cluster, EDG-84, Edg84, EDG84A, cc1, EDG-84A, DM-EDG84, ecdysone-dependent gene-84A-1, BG:DS00004.8, cuticle cluster 1" CDMC27293 2 6 19 DAC30-J07 23-CG2345-RA_2 CG2345 CTCATCCGCAGTACTCATTTAACTATGATGTTCAGGATCCAGAGACAGGAGATGTTAAGTCCCAG 65 FBan0002345 FBgn0000552 Edg84A 3 3R structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011; ; GO:0008011 Edg84A Ecdysone-dependent gene 84A "CG2345, CG2345, EDG84, cuticle-like cluster, EDG-84, Edg84, EDG84A, cc1, EDG-84A, DM-EDG84, ecdysone-dependent gene-84A-1, BG:DS00004.8, cuticle cluster 1" CDMC27294 2 7 19 DAC30-J19 6-CG2604-RA_4 CG2604 CCCAGAGACTGCCAAGATTCTATCCCTTTCTCAAGCCACGACCGCTGGTCTTCCGCTCTACCGAG 65 FBan0002604 FBgn0037298 CG2604 3 3R CG2604 CG2604 CT40966 CDMC27294 2 8 19 DAC30-J19 6-CG2604-RA_4 CG2604 CCCAGAGACTGCCAAGATTCTATCCCTTTCTCAAGCCACGACCGCTGGTCTTCCGCTCTACCGAG 65 FBan0002604 FBgn0037298 CG2604 3 3R CG2604 CG2604 CT40966 CDMC27295 2 9 19 DAC30-N07 19-CG2879-RA_1 CG2879 GCGCTGAATACGATGGTGCGGCAGGCGAATAAACCGGGGCGGCAGGAGCAGAATATCCTTGGTCC 65 FBan0002879 FBgn0025834 CG2879 X X CG2879 CG2879 EG:25E8.6 CDMC27295 2 10 19 DAC30-N07 19-CG2879-RA_1 CG2879 GCGCTGAATACGATGGTGCGGCAGGCGAATAAACCGGGGCGGCAGGAGCAGAATATCCTTGGTCC 65 FBan0002879 FBgn0025834 CG2879 X X CG2879 CG2879 EG:25E8.6 CDMC27296 2 11 19 DAC30-N19 2-CG2918-RA_3 CG2918 CGACCAGAGGCTATCAAAGCACTCAAGGGCATGATTGATGGCGCCGAAAAGTTCCTGGTCACTGG 65 FBan0002918 FBgn0023529 CG2918 X X defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524 CG2918 CG2918 "EG:25E8.1, CT9894" CDMC27296 2 12 19 DAC30-N19 2-CG2918-RA_3 CG2918 CGACCAGAGGCTATCAAAGCACTCAAGGGCATGATTGATGGCGCCGAAAAGTTCCTGGTCACTGG 65 FBan0002918 FBgn0023529 CG2918 X X defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524 CG2918 CG2918 "EG:25E8.1, CT9894" CDMC27297 2 13 19 DAC31-B07 2-CG31722-RA_1 CG31722 GCCTTCGATGGAGTAGATCCCATTGGTGGAGCCCATAGGATTGGCGTTTCCTGGGGTTTTCACTGTTG 68 FBgn0051722 CDMC27297 2 14 19 DAC31-B07 2-CG31722-RA_1 CG31722 GCCTTCGATGGAGTAGATCCCATTGGTGGAGCCCATAGGATTGGCGTTTCCTGGGGTTTTCACTGTTG 68 FBgn0051722 CDMC27298 2 15 19 DAC31-B19 2-CG3178-RA_1 CG3178 CCCAAGAAACGCGCCAAGAAAACAACCAATGGTGAGACTGCGGTAGAACTTGAGCCAAAGACCAAGGC 68 FBan0003178 FBgn0004584 Rrp1 2 2L DNA repair; GO:0006281 nucleic acid binding; GO:0003676; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; ; GO:0008311; ; GO:0003906 ; EC:4.2.99.18 nucleus; GO:0005634 Rrp1 Recombination repair protein 1 "CG3178, strand transferase, rrp, RRP1" CDMC27298 2 16 19 DAC31-B19 2-CG3178-RA_1 CG3178 CCCAAGAAACGCGCCAAGAAAACAACCAATGGTGAGACTGCGGTAGAACTTGAGCCAAAGACCAAGGC 68 FBan0003178 FBgn0004584 Rrp1 2 2L DNA repair; GO:0006281 nucleic acid binding; GO:0003676; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; ; GO:0008311; ; GO:0003906 ; EC:4.2.99.18 nucleus; GO:0005634 Rrp1 Recombination repair protein 1 "CG3178, strand transferase, rrp, RRP1" CDMC27299 2 17 19 DAC31-F07 6-CG32234-RA_2 CG32234 GCCACTCGAGGAGTACATGCTATTCACAAAGTCCGGTGCCGACAACATAACGGTCATCAATCCGCAGG 68 FBan0032234 FBgn0052234 CG32234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32234 CG32234 CDMC27299 2 18 19 DAC31-F07 6-CG32234-RA_2 CG32234 GCCACTCGAGGAGTACATGCTATTCACAAAGTCCGGTGCCGACAACATAACGGTCATCAATCCGCAGG 68 FBan0032234 FBgn0052234 CG32234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32234 CG32234 CDMC27300 2 19 19 DAC31-F19 2-CG32335-RA_2 CG32335 AGGGTGCTCTGGATGAGAACTTTCGGACCGTAGATGTCAGTGTGGAAGCTTGCCCGGATTTAAGGGAC 68 FBan0032335 FBgn0063667 CG32335 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32335 CG32335 BcDNA:RE72485 CDMC27300 2 20 19 DAC31-F19 2-CG32335-RA_2 CG32335 AGGGTGCTCTGGATGAGAACTTTCGGACCGTAGATGTCAGTGTGGAAGCTTGCCCGGATTTAAGGGAC 68 FBan0032335 FBgn0063667 CG32335 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32335 CG32335 BcDNA:RE72485 CDMC27301 2 21 19 DAC31-J07 2-CG32775-RA_1 CG32775 CCACTCCGCTGGTCAGAAACCTTTTGGATAGAGCCGGATTGGAGAAGCGTTCCACGTTGCTGAACATC 68 FBgn0047321 CDMC27301 2 22 19 DAC31-J07 2-CG32775-RA_1 CG32775 CCACTCCGCTGGTCAGAAACCTTTTGGATAGAGCCGGATTGGAGAAGCGTTCCACGTTGCTGAACATC 68 FBgn0047321 CDMC27302 2 23 19 DAC31-J19 3-CG33092-RA_6 CG33092 GCCGAGGAGACAACGTTTGCATCCGTAGTGACGCAACATCCGAAATTGGCGGGGATTAACTTCACTGG 68 FBan0033092 FBgn0053092 CG33092 3 3R glutamate biosynthesis; GO:0006537; proline catabolism; GO:0006562 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG33092 CG33092 "CG6670, CG6670" CDMC27302 2 24 19 DAC31-J19 3-CG33092-RA_6 CG33092 GCCGAGGAGACAACGTTTGCATCCGTAGTGACGCAACATCCGAAATTGGCGGGGATTAACTTCACTGG 68 FBan0033092 FBgn0053092 CG33092 3 3R glutamate biosynthesis; GO:0006537; proline catabolism; GO:0006562 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG33092 CG33092 "CG6670, CG6670" CDMC27303 2 25 19 DAC31-N07 1-CG3436-RA_1 CG3436 GGCGCCCATAATGCAATTAGAAGGACATGAGGGAGAGATTTTCACAGCGGAATTCCATCCCGAGGGGG 68 FBan0003436 FBgn0031229 CG3436 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3436 CG3436 CDMC27303 2 26 19 DAC31-N07 1-CG3436-RA_1 CG3436 GGCGCCCATAATGCAATTAGAAGGACATGAGGGAGAGATTTTCACAGCGGAATTCCATCCCGAGGGGG 68 FBan0003436 FBgn0031229 CG3436 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3436 CG3436 CDMC27304 2 1 20 DAC31-N19 3-CG3544-RA_5 CG3544 GATGTGCCATCCGACAAGAAGGGACGAATACATGGGCCTCCTATGCTTCCAAAACGGAGGATTGACGC 68 FBan0003544 FBgn0031279 CG3544 2 2L carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3544 CG3544 CDMC27304 2 2 20 DAC31-N19 3-CG3544-RA_5 CG3544 GATGTGCCATCCGACAAGAAGGGACGAATACATGGGCCTCCTATGCTTCCAAAACGGAGGATTGACGC 68 FBan0003544 FBgn0031279 CG3544 2 2L carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3544 CG3544 CDMC27305 2 3 20 DAC32-B07 13-CG15741-RA_1 CG15741 ACCTACTTCGTCCACTTCTCCAACTTCGTCCACTTCTCCAACTTCGTCCACTTCTCCAACTTCGTCGTC 69 FBan0015741 FBgn0030338 CG15741 X X CG15741 CG15741 CDMC27305 2 4 20 DAC32-B07 13-CG15741-RA_1 CG15741 ACCTACTTCGTCCACTTCTCCAACTTCGTCCACTTCTCCAACTTCGTCCACTTCTCCAACTTCGTCGTC 69 FBan0015741 FBgn0030338 CG15741 X X CG15741 CG15741 CDMC27306 2 5 20 DAC32-B19 9-CG15758-RB_1 CG15758 GGTCGAGTGCCGAAAGTCGAGTGTCGATAGTCGAGTGGCAAACATTCAAAGTTGCACGATACCAGCGAA 69 FBan0015758 FBgn0040865 CG15758 X X CG15758 CG15758 CDMC27306 2 6 20 DAC32-B19 9-CG15758-RB_1 CG15758 GGTCGAGTGCCGAAAGTCGAGTGTCGATAGTCGAGTGGCAAACATTCAAAGTTGCACGATACCAGCGAA 69 FBan0015758 FBgn0040865 CG15758 X X CG15758 CG15758 CDMC27307 2 7 20 DAC32-F07 1-CG15829-RA_1 CG15829 GTCTGACCGCCGATGATGCCAAGGCCTACTACATCGAGGTCTACAAGAAGTACGCTCCCCAGTACGAAT 69 FBan0015829 FBgn0035743 CG15829 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; carrier activity; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0005386; ; GO:0050809; ; GO:0004857; ; GO:0000062 CG15829 CG15829 CDMC27307 2 8 20 DAC32-F07 1-CG15829-RA_1 CG15829 GTCTGACCGCCGATGATGCCAAGGCCTACTACATCGAGGTCTACAAGAAGTACGCTCCCCAGTACGAAT 69 FBan0015829 FBgn0035743 CG15829 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; carrier activity; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0005386; ; GO:0050809; ; GO:0004857; ; GO:0000062 CG15829 CG15829 CDMC27308 2 9 20 DAC32-F19 23-CG15848-RA_18 CG15848 TTTCTGGACCAAAATGATTTTCTGTGCATGGCAGTAAGAGCATGTGTCGTAGAAGGAAAAGGTGATTGC 69 CDMC27308 2 10 20 DAC32-F19 23-CG15848-RA_18 CG15848 TTTCTGGACCAAAATGATTTTCTGTGCATGGCAGTAAGAGCATGTGTCGTAGAAGGAAAAGGTGATTGC 69 CDMC27309 2 11 20 DAC32-J07 33-CG15899-RB_2 CG15899 TGGAGACGAACACGCACCAGATTATACCCATCAATCCGACGATTATACGGGTGATGAGGGTACTGCGGA 69 FBan0015899 FBgn0029846 Ca-alpha1T X X calcium ion transport; GO:0006816; cation transport; GO:0006812; glycolysis; GO:0006096; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269 ATP binding; GO:0005524; ; GO:0005524; calcium channel activity; GO:0005262; low voltage-gated calcium channel activity; GO:0008332; ; GO:0005262; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0008332; ; GO:0004365 ; EC:1.2.1.12 integral to membrane; GO:0016021; membrane; GO:0016020 Ca-alpha1T Ca-alpha1T "CG15899, CG4222, CG12544, CG15899, CG4222, CG12544, CG15899, CG15899, Caalpha1T, Ca-alpha1T" CDMC27309 2 12 20 DAC32-J07 33-CG15899-RB_2 CG15899 TGGAGACGAACACGCACCAGATTATACCCATCAATCCGACGATTATACGGGTGATGAGGGTACTGCGGA 69 FBan0015899 FBgn0029846 Ca-alpha1T X X calcium ion transport; GO:0006816; cation transport; GO:0006812; glycolysis; GO:0006096; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269 ATP binding; GO:0005524; ; GO:0005524; calcium channel activity; GO:0005262; low voltage-gated calcium channel activity; GO:0008332; ; GO:0005262; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0008332; ; GO:0004365 ; EC:1.2.1.12 integral to membrane; GO:0016021; membrane; GO:0016020 Ca-alpha1T Ca-alpha1T "CG15899, CG4222, CG12544, CG15899, CG4222, CG12544, CG15899, CG15899, Caalpha1T, Ca-alpha1T" CDMC27310 2 13 20 DAC32-J19 2-CG15914-RA_1 CG15914 TGCGCCCAACAAATTGGTCTACCCGGAAATCTACCCAAAGGAAAACCTCTACAACACCTCCAATGCGCT 69 FBan0015914 FBgn0030700 CG15914 X X CG15914 CG15914 PIG CDMC27310 2 14 20 DAC32-J19 2-CG15914-RA_1 CG15914 TGCGCCCAACAAATTGGTCTACCCGGAAATCTACCCAAAGGAAAACCTCTACAACACCTCCAATGCGCT 69 FBan0015914 FBgn0030700 CG15914 X X CG15914 CG15914 PIG CDMC27311 2 15 20 DAC32-N07 23-CG1620-RA_2 CG1620 TCTCTCATAACCCGTAAAGAATTTCTCTATTGTTAAGTGTGCGATTCGTCTATTTGTTACATGTGCGTG 69 FBan0001620 FBgn0033183 CG1620 2 2R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG1620 CG1620 CDMC27311 2 16 20 DAC32-N07 23-CG1620-RA_2 CG1620 TCTCTCATAACCCGTAAAGAATTTCTCTATTGTTAAGTGTGCGATTCGTCTATTTGTTACATGTGCGTG 69 FBan0001620 FBgn0033183 CG1620 2 2R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG1620 CG1620 CDMC27312 2 17 20 DAC32-N19 18-CG1629-RA_6 CG1629 TTTAGGCATTGATGTCCATAATAACCGCCTGTTTGTGACAACTCCTCGTTGGAAGAATGGTGTGCCTGC 69 FBan0001629 FBgn0039896 yellow-h 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-h yellow-h "CG1629, CG1629" CDMC27312 2 18 20 DAC32-N19 18-CG1629-RA_6 CG1629 TTTAGGCATTGATGTCCATAATAACCGCCTGTTTGTGACAACTCCTCGTTGGAAGAATGGTGTGCCTGC 69 FBan0001629 FBgn0039896 yellow-h 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-h yellow-h "CG1629, CG1629" CDMC27313 2 19 20 DAC33-B07 2-CG1132-RA_1 CG1132 GCGGGACAAGAACACAATCGAGGATAACGACAGTGCTGGGAAGGGAAGCTACTGGATGCTGGACTCATC 69 FBan0001132 FBgn0004895 fd64A 3 3L "embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd64A forkhead domain 64A "CG1132, FD2, Dmfd2, fd2" CDMC27313 2 20 20 DAC33-B07 2-CG1132-RA_1 CG1132 GCGGGACAAGAACACAATCGAGGATAACGACAGTGCTGGGAAGGGAAGCTACTGGATGCTGGACTCATC 69 FBan0001132 FBgn0004895 fd64A 3 3L "embryonic development; GO:0009790; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd64A forkhead domain 64A "CG1132, FD2, Dmfd2, fd2" CDMC27314 2 21 20 DAC33-B19 16-CG1133-RA_1 CG1133 ACATCGAAGGGATTGGAAGCTTCGTCGCATATACGTACATACACTTTCGGCCTTAGATTTCCTCCAGCT 69 FBan0001133 FBgn0003002 opa 3 3R cell proliferation; GO:0008283; germ cell migration; GO:0008354; midgut development; GO:0007494; periodic partitioning; GO:0007365; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003704 nucleus; GO:0005634 opa odd paired "CG1133, GLI-Kr zinc finger pair-rule protein, odd-paired" CDMC27314 2 22 20 DAC33-B19 16-CG1133-RA_1 CG1133 ACATCGAAGGGATTGGAAGCTTCGTCGCATATACGTACATACACTTTCGGCCTTAGATTTCCTCCAGCT 69 FBan0001133 FBgn0003002 opa 3 3R cell proliferation; GO:0008283; germ cell migration; GO:0008354; midgut development; GO:0007494; periodic partitioning; GO:0007365; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003704 nucleus; GO:0005634 opa odd paired "CG1133, GLI-Kr zinc finger pair-rule protein, odd-paired" CDMC27315 2 23 20 DAC33-F07 7-CG11374-RA_1 CG11374 ACGCCTAACACACTCATTGCCTCGACCCATTCCACATTCAAACAAACTTCCCCGAGATGGAGAGAACGT 69 FBan0011374 FBgn0031214 CG11374 2 2L galactoside binding; GO:0016936; urate transporter activity; GO:0015143; ; GO:0016936; ; GO:0015143 CG11374 CG11374 CDMC27315 2 24 20 DAC33-F07 7-CG11374-RA_1 CG11374 ACGCCTAACACACTCATTGCCTCGACCCATTCCACATTCAAACAAACTTCCCCGAGATGGAGAGAACGT 69 FBan0011374 FBgn0031214 CG11374 2 2L galactoside binding; GO:0016936; urate transporter activity; GO:0015143; ; GO:0016936; ; GO:0015143 CG11374 CG11374 CDMC27316 2 25 20 DAC33-F19 18-CG11380-RA_3 CG11380 GGGCTGAGGTCTGGATAAATGTTCAGATGTTCGAAGGCATGGAAACTCATTTGACCGAACGCACTATCT 69 FBan0011380 FBgn0040359 CG11380 X X CG11380 CG11380 EG:BACR42I17.7 CDMC27316 2 26 20 DAC33-F19 18-CG11380-RA_3 CG11380 GGGCTGAGGTCTGGATAAATGTTCAGATGTTCGAAGGCATGGAAACTCATTTGACCGAACGCACTATCT 69 FBan0011380 FBgn0040359 CG11380 X X CG11380 CG11380 EG:BACR42I17.7 CDMC27317 2 1 21 DAC33-J07 3-CG11417-RA_2 CG11417 TGCTCAAAAGGCGGTTTCAGAGGACCCACAGAAGAGCAAGCCCAAAAAGACTTCTAAGCAGGAACGCAT 69 FBan0011417 FBgn0024364 CG11417 X X CG11417 CG11417 EG:8D8.4 CDMC27317 2 2 21 DAC33-J07 3-CG11417-RA_2 CG11417 TGCTCAAAAGGCGGTTTCAGAGGACCCACAGAAGAGCAAGCCCAAAAAGACTTCTAAGCAGGAACGCAT 69 FBan0011417 FBgn0024364 CG11417 X X CG11417 CG11417 EG:8D8.4 CDMC27318 2 3 21 DAC33-J19 23-CG11427-RA_17 CG11427 TCGAGAGATTATATGTAAATGTGCAGTGTAACAGATGCAACTTAAGTGTTCAAGTGGGATCGAAATCCA 69 FBan0011427 FBgn0003210 rb X X eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; ommochrome biosynthesis; GO:0006727; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 rb ruby "CG11427, CG11427, CG11427, CG11427, beta3, beta3, AP-3beta, cg11427" CDMC27318 2 4 21 DAC33-J19 23-CG11427-RA_17 CG11427 TCGAGAGATTATATGTAAATGTGCAGTGTAACAGATGCAACTTAAGTGTTCAAGTGGGATCGAAATCCA 69 FBan0011427 FBgn0003210 rb X X eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular protein transport; GO:0006886; intracellular transport; GO:0046907; lysosome organization and biogenesis; GO:0007040; ommochrome biosynthesis; GO:0006727; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 rb ruby "CG11427, CG11427, CG11427, CG11427, beta3, beta3, AP-3beta, cg11427" CDMC27319 2 5 21 DAC33-N07 2-CG11474-RA_1 CG11474 CAAGTTCGAGCTTTCGCCACTGGAACACTTTTGGACGAGTCCCTACGAGTTCTATCGCATGCCAGAGGT 69 FBan0011474 FBgn0034688 CG11474 2 2R CG11474 CG11474 CDMC27319 2 6 21 DAC33-N07 2-CG11474-RA_1 CG11474 CAAGTTCGAGCTTTCGCCACTGGAACACTTTTGGACGAGTCCCTACGAGTTCTATCGCATGCCAGAGGT 69 FBan0011474 FBgn0034688 CG11474 2 2R CG11474 CG11474 CDMC27320 2 7 21 DAC33-N19 16-CG1148-RA_1 CG1148 GGGACCGCTAAGCCATGTGAAAAGTGTGTCAGTTTTAAGTGGAGAGTCGATCCGTTAAGCCAATAAGCA 69 FBan0001148 FBgn0037410 Osi2 3 3R Osi2 Osiris 2 "CG1148, CG1148, CG1148, Osiris, Osiris 2" CDMC27320 2 8 21 DAC33-N19 16-CG1148-RA_1 CG1148 GGGACCGCTAAGCCATGTGAAAAGTGTGTCAGTTTTAAGTGGAGAGTCGATCCGTTAAGCCAATAAGCA 69 FBan0001148 FBgn0037410 Osi2 3 3R Osi2 Osiris 2 "CG1148, CG1148, CG1148, Osiris, Osiris 2" CDMC27321 2 9 21 DAC34-B07 1-CG14476-RA_1 CG14476 GCGCCTCAACCTTGATGTTGCACGATCCGTACACACTGATAATCTGCTTAGACCGTCAGGGCAAGGC 67 FBan0014476 FBgn0027588 CG14476 X X polysaccharide metabolism; GO:0005976 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG14476 CG14476 "glucosidase II, clot#312, BcDNA:GH04962" CDMC27321 2 10 21 DAC34-B07 1-CG14476-RA_1 CG14476 GCGCCTCAACCTTGATGTTGCACGATCCGTACACACTGATAATCTGCTTAGACCGTCAGGGCAAGGC 67 FBan0014476 FBgn0027588 CG14476 X X polysaccharide metabolism; GO:0005976 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG14476 CG14476 "glucosidase II, clot#312, BcDNA:GH04962" CDMC27322 2 11 21 DAC34-B19 10-CG14616-RC_2 CG14616 ACTCTAACCGCCTCAAATCAGACAGAGGTTGTCGAACATGAGCCGATATCAACGACCGTAACGCCCA 67 FBgn0031192 CDMC27322 2 12 21 DAC34-B19 10-CG14616-RC_2 CG14616 ACTCTAACCGCCTCAAATCAGACAGAGGTTGTCGAACATGAGCCGATATCAACGACCGTAACGCCCA 67 FBgn0031192 CDMC27323 2 13 21 DAC34-F07 1-CG14983-RA_1 CG14983 CCAGAACAGCGACTAGCCCAACTGGAATCGGTCACATCACGGATGCATCTATACCATTCAAGGCGCG 67 FBan0014983 FBgn0035479 CG14983 3 3L CG14983 CG14983 CDMC27323 2 14 21 DAC34-F07 1-CG14983-RA_1 CG14983 CCAGAACAGCGACTAGCCCAACTGGAATCGGTCACATCACGGATGCATCTATACCATTCAAGGCGCG 67 FBan0014983 FBgn0035479 CG14983 3 3L CG14983 CG14983 CDMC27324 2 15 21 DAC34-F19 27-CG15050-RA_1 CG15050 CACGGTCATCTTTCCCTGCATCTACGCCTCGCAGATATTGCCCAGAGATGAACAGGAGCGTTTGAGG 67 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC27324 2 16 21 DAC34-F19 27-CG15050-RA_1 CG15050 CACGGTCATCTTTCCCTGCATCTACGCCTCGCAGATATTGCCCAGAGATGAACAGGAGCGTTTGAGG 67 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC27325 2 17 21 DAC34-J07 3-CG15596-RA_1 CG15596 GCTGCGGACAGTGCGTCATATCTATGGGCAGTGTGCATATAGCGAGGACGTTTTCTGGTGCTGCAAG 67 FBan0015596 FBgn0037418 Osi11 3 3R Osi11 Osiris 11 "CG15596, CG15596, CG15596, Osiris, Osiris 11" CDMC27325 2 18 21 DAC34-J07 3-CG15596-RA_1 CG15596 GCTGCGGACAGTGCGTCATATCTATGGGCAGTGTGCATATAGCGAGGACGTTTTCTGGTGCTGCAAG 67 FBan0015596 FBgn0037418 Osi11 3 3R Osi11 Osiris 11 "CG15596, CG15596, CG15596, Osiris, Osiris 11" CDMC27326 2 19 21 DAC34-J19 2-CG15655-RA_1 CG15655 CCCTGACCTCCATGTTCATCAATGTGGTGCAGATCAAGCTGAGCGATCACTTCAAAATGGCCAGCGC 67 FBan0015655 FBgn0034587 CG15655 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG15655 CG15655 "anon-WO0109301.16, anon-WO0109301.17, anon-WO0109301.1" CDMC27326 2 20 21 DAC34-J19 2-CG15655-RA_1 CG15655 CCCTGACCTCCATGTTCATCAATGTGGTGCAGATCAAGCTGAGCGATCACTTCAAAATGGCCAGCGC 67 FBan0015655 FBgn0034587 CG15655 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 CG15655 CG15655 "anon-WO0109301.16, anon-WO0109301.17, anon-WO0109301.1" CDMC27327 2 21 21 DAC34-N07 13-CG16755-RA_1 CG16755 TCTTCATCGGGACTTCTGTGATGCAGGTCTACCTGGTGTGCTATTACGGTCAGCAAGTTCTCGACTT 67 FBan0016755 FBgn0037685 Or85f 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85f Odorant receptor 85f "CG16755, 85D.1, DOR32, 85f" CDMC27327 2 22 21 DAC34-N07 13-CG16755-RA_1 CG16755 TCTTCATCGGGACTTCTGTGATGCAGGTCTACCTGGTGTGCTATTACGGTCAGCAAGTTCTCGACTT 67 FBan0016755 FBgn0037685 Or85f 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85f Odorant receptor 85f "CG16755, 85D.1, DOR32, 85f" CDMC27328 2 23 21 DAC34-N19 3-CG17029-RA_4 CG17029 TGATGCAGGAGGGCTATCAGAAGGCAAAGACGGAATACAAGGTCAAGGCGGACTTCTACGACCTGGT 67 FBan0017029 FBgn0036551 CG17029 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17029 CG17029 IMP CDMC27328 2 24 21 DAC34-N19 3-CG17029-RA_4 CG17029 TGATGCAGGAGGGCTATCAGAAGGCAAAGACGGAATACAAGGTCAAGGCGGACTTCTACGACCTGGT 67 FBan0017029 FBgn0036551 CG17029 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17029 CG17029 IMP CDMC27329 2 25 21 DAC35-B07 24-CG11756-RA_2 CG11756 CGTCGCTTGCAATTATTTTAAATTCTTAGTAAACTTTCTTGGAAAATGCTTAAATATTTGGCTGGAATT 69 FBan0011756 FBgn0030290 CG11756 X X CG11756 CG11756 BcDNA:AT06648 CDMC27329 2 26 21 DAC35-B07 24-CG11756-RA_2 CG11756 CGTCGCTTGCAATTATTTTAAATTCTTAGTAAACTTTCTTGGAAAATGCTTAAATATTTGGCTGGAATT 69 FBan0011756 FBgn0030290 CG11756 X X CG11756 CG11756 BcDNA:AT06648 CDMC27330 2 1 22 DAC35-B19 17-CG11765-RA_1 CG11765 TCCGCACCACTGACAACTACTGACACAAAACCGTTCCCCATTTGTGATCCATTCAATAATGTGCCGTAT 69 FBan0011765 FBgn0033518 Prx2540-2 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 Prx2540-2 Peroxiredoxin 2540 "CG11765, CG11765, DPx2540, Prx2540, DPx-2540-2, Peroxiredoxin 2540" CDMC27330 2 2 22 DAC35-B19 17-CG11765-RA_1 CG11765 TCCGCACCACTGACAACTACTGACACAAAACCGTTCCCCATTTGTGATCCATTCAATAATGTGCCGTAT 69 FBan0011765 FBgn0033518 Prx2540-2 2 2R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0016209; ; GO:0004601 ; EC:1.11.1.7; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004602 ; EC:1.11.1.9 Prx2540-2 Peroxiredoxin 2540 "CG11765, CG11765, DPx2540, Prx2540, DPx-2540-2, Peroxiredoxin 2540" CDMC27331 2 3 22 DAC35-F07 1-CG1179-RA_1 CG1179 TGGCACTACTGCAGCGGATGGTTGCCGTCCATCGATGACTGCTTCTAAACCGATTTCGACCCTGAATAA 69 FBan0001179 FBgn0004425 LysB 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysB Lysozyme B "CG1179, lysB" CDMC27331 2 4 22 DAC35-F07 1-CG1179-RA_1 CG1179 TGGCACTACTGCAGCGGATGGTTGCCGTCCATCGATGACTGCTTCTAAACCGATTTCGACCCTGAATAA 69 FBan0001179 FBgn0004425 LysB 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysB Lysozyme B "CG1179, lysB" CDMC27332 2 5 22 DAC35-F19 8-CG11820-RA_2 CG11820 GCTGCAAGGCGTTTTACTTCTATAACTCGACCACACAGACTGTTTCGTGGCTACCTCCTTCGCATCCCA 69 FBan0011820 FBgn0039270 CG11820 3 3R CG11820 CG11820 CDMC27332 2 6 22 DAC35-F19 8-CG11820-RA_2 CG11820 GCTGCAAGGCGTTTTACTTCTATAACTCGACCACACAGACTGTTTCGTGGCTACCTCCTTCGCATCCCA 69 FBan0011820 FBgn0039270 CG11820 3 3R CG11820 CG11820 CDMC27333 2 7 22 DAC35-J07 22-CG11864-RA_5 CG11864 GCTGCTTGCCGGATTTTATCAGGGGGACATAAAAGCTCATCCAATTCGTACTCGAAACGGAATTGTCAA 69 FBan0011864 FBgn0028944 CG11864 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG11864 CG11864 "BG:BACR44L22.8, BACR44L22.8" CDMC27333 2 8 22 DAC35-J07 22-CG11864-RA_5 CG11864 GCTGCTTGCCGGATTTTATCAGGGGGACATAAAAGCTCATCCAATTCGTACTCGAAACGGAATTGTCAA 69 FBan0011864 FBgn0028944 CG11864 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG11864 CG11864 "BG:BACR44L22.8, BACR44L22.8" CDMC27334 2 9 22 DAC35-J19 2-CG11878-RA_1 CG11878 GGCTCACCTCGGAATATGTGCAGGATAAGTTGCGCACCTACTTCAAGGATAGCTCACTGAAGCTGGCGA 69 FBan0011878 FBgn0039310 CG11878 3 3R CG11878 CG11878 CT33083 CDMC27334 2 10 22 DAC35-J19 2-CG11878-RA_1 CG11878 GGCTCACCTCGGAATATGTGCAGGATAAGTTGCGCACCTACTTCAAGGATAGCTCACTGAAGCTGGCGA 69 FBan0011878 FBgn0039310 CG11878 3 3R CG11878 CG11878 CT33083 CDMC27335 2 11 22 DAC35-N07 17-CG11908-RA_4 CG11908 GCTTACACCCTCCGAGGAACCTTCTTCGCAGTCTGAATCTCGAGGGACTGATAATGCAAATCCTATCAC 69 FBan0011908 FBgn0027376 rha 3 3R chromosome; GO:0005694 rha rha "CG11908, RADHA, anon-WO0140519.50" CDMC27335 2 12 22 DAC35-N07 17-CG11908-RA_4 CG11908 GCTTACACCCTCCGAGGAACCTTCTTCGCAGTCTGAATCTCGAGGGACTGATAATGCAAATCCTATCAC 69 FBan0011908 FBgn0027376 rha 3 3R chromosome; GO:0005694 rha rha "CG11908, RADHA, anon-WO0140519.50" CDMC27336 2 13 22 DAC35-N19 14-CG11920-RA_3 CG11920 ACATATCCGATGTGGTTATGCGACATGATATACCCGACATTGGACACATGAGCGAGCAGAAGCCACACT 69 FBan0011920 FBgn0039274 CG11920 3 3R rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532 CG11920 CG11920 CDMC27336 2 14 22 DAC35-N19 14-CG11920-RA_3 CG11920 ACATATCCGATGTGGTTATGCGACATGATATACCCGACATTGGACACATGAGCGAGCAGAAGCCACACT 69 FBan0011920 FBgn0039274 CG11920 3 3R rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532 CG11920 CG11920 CDMC27337 2 15 22 DAC36-B07 3-CG8610-RA_2 CG8610 TGGGCCACCGACCTAGATCCCAAAGGTGCCAACAATCAAATCAAAGATGCCTTCGACTCAATGGCTCAT 69 FBan0008610 FBgn0012058 Cdc27 3 3L cell cycle; GO:0007049; cellular physiological process; GO:0050875; mitosis; GO:0007067 Cdc27 Cdc27 "CG8610, l(3)L7123, Dmcdc27, mks, makos, CDC27Dm, cdc27" CDMC27337 2 16 22 DAC36-B07 3-CG8610-RA_2 CG8610 TGGGCCACCGACCTAGATCCCAAAGGTGCCAACAATCAAATCAAAGATGCCTTCGACTCAATGGCTCAT 69 FBan0008610 FBgn0012058 Cdc27 3 3L cell cycle; GO:0007049; cellular physiological process; GO:0050875; mitosis; GO:0007067 Cdc27 Cdc27 "CG8610, l(3)L7123, Dmcdc27, mks, makos, CDC27Dm, cdc27" CDMC27338 2 17 22 DAC36-B19 3-CG8624-RA_4 CG8624 GTTCGAGGTCTCCAAGACAGACAAGTCCAACCCAAACTGCAATGAGTTGGAATACCAGTGGGGCTGCTT 69 FBan0008624 FBgn0023001 melt 3 3L ectoderm development; GO:0007398; peripheral nervous system development; GO:0007422 molecular function unknown; GO:0005554; ; GO:0005554 melt melted "CG8624, 1441/14, anon-WO03014152.10, melted" CDMC27338 2 18 22 DAC36-B19 3-CG8624-RA_4 CG8624 GTTCGAGGTCTCCAAGACAGACAAGTCCAACCCAAACTGCAATGAGTTGGAATACCAGTGGGGCTGCTT 69 FBan0008624 FBgn0023001 melt 3 3L ectoderm development; GO:0007398; peripheral nervous system development; GO:0007422 molecular function unknown; GO:0005554; ; GO:0005554 melt melted "CG8624, 1441/14, anon-WO03014152.10, melted" CDMC27339 2 19 22 DAC36-F07 13-CG8657-RA_1 CG8657 TGTGGATGCGTACATCACTTACAACTTCCACAAGACGCGCGAATCTCGATTCTATCTGCTCAGCAGTCG 69 FBan0008657 FBgn0020930 Dgkepsilon 2 2R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107 Dgkepsilon Diacyl glycerol kinase epsilon "CG8657, CG8657, CG8657, CG8657, DGKe, DGKepsilon" CDMC27339 2 20 22 DAC36-F07 13-CG8657-RA_1 CG8657 TGTGGATGCGTACATCACTTACAACTTCCACAAGACGCGCGAATCTCGATTCTATCTGCTCAGCAGTCG 69 FBan0008657 FBgn0020930 Dgkepsilon 2 2R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107 Dgkepsilon Diacyl glycerol kinase epsilon "CG8657, CG8657, CG8657, CG8657, DGKe, DGKepsilon" CDMC27340 2 21 22 DAC36-F19 9-CG8669-RA_4 CG8669 GGCAGCGAAATTGCCCGAGAGAACCAACTGGTCGATGATATCGTCAATATGCGTGCTAAGGAGCTCGAA 69 FBan0008669 FBgn0000370 crc 2 2L "metamorphosis (sensu Insecta); GO:0046698; molting cycle (sensu Insecta); GO:0007591; pupariation; GO:0035073; pupation; GO:0035074; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; ; GO:0003700; ; GO:0046982 nucleus; GO:0005634 crc cryptocephal "CG8669, CG8669, l(2)crc: lethal(2)cryptocephal, 929, ATF-4, dATF-4, l(2)crc" CDMC27340 2 22 22 DAC36-F19 9-CG8669-RA_4 CG8669 GGCAGCGAAATTGCCCGAGAGAACCAACTGGTCGATGATATCGTCAATATGCGTGCTAAGGAGCTCGAA 69 FBan0008669 FBgn0000370 crc 2 2L "metamorphosis (sensu Insecta); GO:0046698; molting cycle (sensu Insecta); GO:0007591; pupariation; GO:0035073; pupation; GO:0035074; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; ; GO:0003700; ; GO:0046982 nucleus; GO:0005634 crc cryptocephal "CG8669, CG8669, l(2)crc: lethal(2)cryptocephal, 929, ATF-4, dATF-4, l(2)crc" CDMC27341 2 23 22 DAC36-J07 15-CG8705-RA_8 CG8705 GCAGCACGGACAATGTGGATGGCAAGAAGGAGAAGAAAAAGAAGGGTCTGTTCTAAGTCAACACGCTCA 69 FBan0008705 FBgn0013726 pnut 2 2R "apoptosis; GO:0006915; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; eye photoreceptor development (sensu Endopterygota); GO:0042051; mitosis; GO:0007067; vesicle docking during exocytosis; GO:0006904; vesicle targeting; GO:0006903" actin binding; GO:0003779; ; GO:0003779; GTP binding; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0016787 ; EC:3.-.-.-; ; GO:0003924; ; GO:0005525 apical plasma membrane; GO:0016324; intercellular bridge; GO:0045171; ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 pnut peanut "CG8705, CG8705, CG8705, E(sina)8, Enhancer of seven in absentia 8, Pnut, clone 2.18, Peanut, septin, E(sina)44C, anon-EST:Liang-2.18, l(2)02502, peanut" CDMC27341 2 24 22 DAC36-J07 15-CG8705-RA_8 CG8705 GCAGCACGGACAATGTGGATGGCAAGAAGGAGAAGAAAAAGAAGGGTCTGTTCTAAGTCAACACGCTCA 69 FBan0008705 FBgn0013726 pnut 2 2R "apoptosis; GO:0006915; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; eye photoreceptor development (sensu Endopterygota); GO:0042051; mitosis; GO:0007067; vesicle docking during exocytosis; GO:0006904; vesicle targeting; GO:0006903" actin binding; GO:0003779; ; GO:0003779; GTP binding; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0016787 ; EC:3.-.-.-; ; GO:0003924; ; GO:0005525 apical plasma membrane; GO:0016324; intercellular bridge; GO:0045171; ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 pnut peanut "CG8705, CG8705, CG8705, E(sina)8, Enhancer of seven in absentia 8, Pnut, clone 2.18, Peanut, septin, E(sina)44C, anon-EST:Liang-2.18, l(2)02502, peanut" CDMC27342 2 25 22 DAC36-J19 2-CG8714-RA_1 CG8714 CCCTGACTGCCTACATGTTCCTTATCCTGGTCTGCTACCTGCCATCATACCTCTTTCCCGAGAGTCCCA 69 FBan0008714 FBgn0028563 sut1 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut1 sugar transporter 1 CG8714 CDMC27342 2 26 22 DAC36-J19 2-CG8714-RA_1 CG8714 CCCTGACTGCCTACATGTTCCTTATCCTGGTCTGCTACCTGCCATCATACCTCTTTCCCGAGAGTCCCA 69 FBan0008714 FBgn0028563 sut1 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut1 sugar transporter 1 CG8714 CDMC27343 2 1 23 DAC36-N07 14-CG8746-RA_3 CG8746 GGAGTTCCGTATTCCGAAGCGGATCAAGGGATTGAAGGATCGTGAAAGAAAGAAGCTGGAACGGAAGGT 69 FBan0008746 FBgn0033330 CG8746 2 2R CG8746 CG8746 CDMC27343 2 2 23 DAC36-N07 14-CG8746-RA_3 CG8746 GGAGTTCCGTATTCCGAAGCGGATCAAGGGATTGAAGGATCGTGAAAGAAAGAAGCTGGAACGGAAGGT 69 FBan0008746 FBgn0033330 CG8746 2 2R CG8746 CG8746 CDMC27344 2 3 23 DAC36-N19 2-CG8765-RA_1 CG8765 TCAACTGCGGAGTTCCAGAAGATCGAGATACAGACTCCAACCACGCCTAGGTACCAGAATGCTGCCACT 69 FBan0008765 FBgn0036900 CG8765 3 3L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG8765 CG8765 CDMC27344 2 4 23 DAC36-N19 2-CG8765-RA_1 CG8765 TCAACTGCGGAGTTCCAGAAGATCGAGATACAGACTCCAACCACGCCTAGGTACCAGAATGCTGCCACT 69 FBan0008765 FBgn0036900 CG8765 3 3L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG8765 CG8765 CDMC27345 2 5 23 DAC37-B07 16-CG8995-RA_3 CG8995 TCGATCATCAGCGACACCATAAGGGACCTTATGAACTCGATCAACAGCATTCAGACTTTGGGCAACGTT 69 FBan0008995 FBgn0030695 PGRP-LE X X defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253; response to bacteria; GO:0009617; signal transduction; GO:0007165 receptor activity; GO:0004872; protein binding; GO:0005515; ; GO:0004872; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0016019; ; GO:0016019; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-LE Peptidoglycan recognition protein LE "CG8995, CG8995, anon-WO0153538.66" CDMC27345 2 6 23 DAC37-B07 16-CG8995-RA_3 CG8995 TCGATCATCAGCGACACCATAAGGGACCTTATGAACTCGATCAACAGCATTCAGACTTTGGGCAACGTT 69 FBan0008995 FBgn0030695 PGRP-LE X X defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253; response to bacteria; GO:0009617; signal transduction; GO:0007165 receptor activity; GO:0004872; protein binding; GO:0005515; ; GO:0004872; peptidoglycan receptor activity; GO:0016019; ; GO:0016019; ; GO:0016019; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0016019; ; GO:0016019; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-LE Peptidoglycan recognition protein LE "CG8995, CG8995, anon-WO0153538.66" CDMC27346 2 7 23 DAC37-B19 6-CG9004-RA_3 CG9004 GCGTTTGAAGGCCATGCTGAAGAATGATCGCTACGTGGTGACTCTGAACATAACCCTGGAGGACCTCCT 69 FBan0009004 FBgn0035336 CG9004 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG9004 CG9004 CDMC27346 2 8 23 DAC37-B19 6-CG9004-RA_3 CG9004 GCGTTTGAAGGCCATGCTGAAGAATGATCGCTACGTGGTGACTCTGAACATAACCCTGGAGGACCTCCT 69 FBan0009004 FBgn0035336 CG9004 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG9004 CG9004 CDMC27347 2 9 23 DAC37-F07 3-CG9036-RA_3 CG9036 GCAGGGCAAATTCAACGGCTACTAAGATGGGGAAGTGAGGATACCCGATTTAGGTCGACCCCGCAACTA 69 FBan0009036 FBgn0034499 CG9036 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG9036 CG9036 CDMC27347 2 10 23 DAC37-F07 3-CG9036-RA_3 CG9036 GCAGGGCAAATTCAACGGCTACTAAGATGGGGAAGTGAGGATACCCGATTTAGGTCGACCCCGCAACTA 69 FBan0009036 FBgn0034499 CG9036 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG9036 CG9036 CDMC27348 2 11 23 DAC37-F19 8-CG9045-RE_4 CG9045 CGTCGAACGCAGATCGGTTAATGCATCTGGTAGCGATTTGAAGAGTTCGCGAACCCATCTCATCACGCT 69 FBan0009045 FBgn0002914 Myb X X "anti-apoptosis; GO:0006916; cell cycle; GO:0007049; cell proliferation; GO:0008283; centrosome cycle; GO:0007098; chorion gene amplification; GO:0007307; cytokinesis; GO:0000910; mitosis; GO:0007067; regulation of mitosis; GO:0007088; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; spindle organization and biogenesis; GO:0007051" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0003677; ; GO:0016563 Myb complex; GO:0031523; nucleus; GO:0005634 Myb Myb oncogene-like "CG9045, CG9045, CG9045, CG9045, D-myb, c-myb, myb, Dm-myb, Dm-Myb, c-Myb, DmMYB, Dm myb, Dm Myb, dMyb, DMyb, p85, dmMYB, MYB, dmyb, DmMyb, l(1)XVI" CDMC27348 2 12 23 DAC37-F19 8-CG9045-RE_4 CG9045 CGTCGAACGCAGATCGGTTAATGCATCTGGTAGCGATTTGAAGAGTTCGCGAACCCATCTCATCACGCT 69 FBan0009045 FBgn0002914 Myb X X "anti-apoptosis; GO:0006916; cell cycle; GO:0007049; cell proliferation; GO:0008283; centrosome cycle; GO:0007098; chorion gene amplification; GO:0007307; cytokinesis; GO:0000910; mitosis; GO:0007067; regulation of mitosis; GO:0007088; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; spindle organization and biogenesis; GO:0007051" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0003677; ; GO:0016563 Myb complex; GO:0031523; nucleus; GO:0005634 Myb Myb oncogene-like "CG9045, CG9045, CG9045, CG9045, D-myb, c-myb, myb, Dm-myb, Dm-Myb, c-Myb, DmMYB, Dm myb, Dm Myb, dMyb, DMyb, p85, dmMYB, MYB, dmyb, DmMyb, l(1)XVI" CDMC27349 2 13 23 DAC37-J07 17-CG9084-RB_2 CG9084 AGGACAACTAACATTCTGTGTAGAGGGTCCTGTCGGTTTAGGATTCTGCTGCTTCAGTTTGCCCAAAGA 69 FBan0009084 FBgn0033582 CG9084 2 2R CG9084 CG9084 CDMC27349 2 14 23 DAC37-J07 17-CG9084-RB_2 CG9084 AGGACAACTAACATTCTGTGTAGAGGGTCCTGTCGGTTTAGGATTCTGCTGCTTCAGTTTGCCCAAAGA 69 FBan0009084 FBgn0033582 CG9084 2 2R CG9084 CG9084 CDMC27350 2 15 23 DAC37-J19 3-CG9094-RB_2 CG9094 TGGGATGGAATCCACTGGATGCTGATGTCCAAAAAAGCGACGAAAGCCTCTGCGAAAGGCCAAAAATGG 69 FBan0009094 FBgn0035184 CG9094 3 3L CG9094 CG9094 CDMC27350 2 16 23 DAC37-J19 3-CG9094-RB_2 CG9094 TGGGATGGAATCCACTGGATGCTGATGTCCAAAAAAGCGACGAAAGCCTCTGCGAAAGGCCAAAAATGG 69 FBan0009094 FBgn0035184 CG9094 3 3L CG9094 CG9094 CDMC27351 2 17 23 DAC37-N07 9-CG9131-RA_4 CG9131 TCGGAGCCACTGTCATCTCTAGCAGCACAGCACGAGTAAAGGTCAGCTCTCGTAACTTGTCTCGGAAAT 69 FBan0009131 FBgn0029161 slmo 2 2L "larval behavior; GO:0030537; larval locomotory behavior; GO:0008345; peristalsis; GO:0030432; regulation of transcription, DNA-dependent; GO:0006355; spermatogenesis; GO:0007283" transcription factor activity; GO:0003700; ; GO:0003700 mitochondrion; GO:0005739 slmo slowmo "CG9131, kisir, Kisir, CT26166, slowmo" CDMC27351 2 18 23 DAC37-N07 9-CG9131-RA_4 CG9131 TCGGAGCCACTGTCATCTCTAGCAGCACAGCACGAGTAAAGGTCAGCTCTCGTAACTTGTCTCGGAAAT 69 FBan0009131 FBgn0029161 slmo 2 2L "larval behavior; GO:0030537; larval locomotory behavior; GO:0008345; peristalsis; GO:0030432; regulation of transcription, DNA-dependent; GO:0006355; spermatogenesis; GO:0007283" transcription factor activity; GO:0003700; ; GO:0003700 mitochondrion; GO:0005739 slmo slowmo "CG9131, kisir, Kisir, CT26166, slowmo" CDMC27352 2 19 23 DAC37-N19 9-CG9147-RA_4 CG9147 CGACCTTGTAGAGCAGTTGGAACAGGGCTTTGCAGGTCAATACCGTCTGGAGAAGGTTTACATCGACCG 69 FBan0009147 FBgn0031774 CG9147 2 2L CG9147 CG9147 CDMC27352 2 20 23 DAC37-N19 9-CG9147-RA_4 CG9147 CGACCTTGTAGAGCAGTTGGAACAGGGCTTTGCAGGTCAATACCGTCTGGAGAAGGTTTACATCGACCG 69 FBan0009147 FBgn0031774 CG9147 2 2L CG9147 CG9147 CDMC27353 2 21 23 DAC38-B07 3-CG5545-RA_1 CG5545 TGCAGGCTCTTCTTCAAGGACCTCACAACGAACCACCGACTAGCAGCAGTTAAATAGGAGTGGGGG 66 FBan0005545 FBgn0032651 Oli 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transmission of nerve impulse; GO:0019226 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Oli Olig family "CG5545, CG5545, CG5545, CG5545, Doli, Olig family" CDMC27353 2 22 23 DAC38-B07 3-CG5545-RA_1 CG5545 TGCAGGCTCTTCTTCAAGGACCTCACAACGAACCACCGACTAGCAGCAGTTAAATAGGAGTGGGGG 66 FBan0005545 FBgn0032651 Oli 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transmission of nerve impulse; GO:0019226 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Oli Olig family "CG5545, CG5545, CG5545, CG5545, Doli, Olig family" CDMC27354 2 23 23 DAC38-B19 14-CG5802-RA_1 CG5802 TCTACGCCGTCGGTATCTTCGTATGCTACTTCTTGTACGGAATTGTCCAGGAGAAGTTGACGCGGG 66 FBan0005802 FBgn0038863 CG5802 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 UDP-galactose transporter activity; GO:0005459; ; GO:0005459 CG5802 CG5802 "anon-EST:fe1H6, anon-fast-evolving-1H6" CDMC27354 2 24 23 DAC38-B19 14-CG5802-RA_1 CG5802 TCTACGCCGTCGGTATCTTCGTATGCTACTTCTTGTACGGAATTGTCCAGGAGAAGTTGACGCGGG 66 FBan0005802 FBgn0038863 CG5802 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 UDP-galactose transporter activity; GO:0005459; ; GO:0005459 CG5802 CG5802 "anon-EST:fe1H6, anon-fast-evolving-1H6" CDMC27355 2 25 23 DAC38-F07 9-CG6232-RA_7 CG6232 ACCGCCTGTCTGGTCCTTCGGAATCCTCATCGAATAGCAGCCAAGTGAAGAGGAGCAAAATCGATG 66 FBan0006232 FBgn0032252 CG6232 2 2L CG6232 CG6232 CT19510 CDMC27355 2 26 23 DAC38-F07 9-CG6232-RA_7 CG6232 ACCGCCTGTCTGGTCCTTCGGAATCCTCATCGAATAGCAGCCAAGTGAAGAGGAGCAAAATCGATG 66 FBan0006232 FBgn0032252 CG6232 2 2L CG6232 CG6232 CT19510 CDMC27356 2 1 24 DAC38-F19 15-CG6348-RB_2 CG6348 CGGGCATCAAAAGGAGTGACAGCTTAGATCCCATAGCGAACACTACGATTCTATCCGTGCCGCAAC 66 FBan0006348 FBgn0003267 ro 3 3R "R2/R5 cell differentiation (sensu Endopterygota); GO:0048054; R8 cell fate specification; GO:0045464; eye development (sensu Endopterygota); GO:0007456; negative regulation of R8 differentiation; GO:0045680; regulation of transcription, DNA-dependent; GO:0006355; restriction of R8 fate; GO:0007461" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 ro rough CG6348 CDMC27356 2 2 24 DAC38-F19 15-CG6348-RB_2 CG6348 CGGGCATCAAAAGGAGTGACAGCTTAGATCCCATAGCGAACACTACGATTCTATCCGTGCCGCAAC 66 FBan0006348 FBgn0003267 ro 3 3R "R2/R5 cell differentiation (sensu Endopterygota); GO:0048054; R8 cell fate specification; GO:0045464; eye development (sensu Endopterygota); GO:0007456; negative regulation of R8 differentiation; GO:0045680; regulation of transcription, DNA-dependent; GO:0006355; restriction of R8 fate; GO:0007461" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 ro rough CG6348 CDMC27357 2 3 24 DAC38-J07 2-CG6742-RA_3 CG6742 GCTGCATACGACCTCTCCTCCAGTGACGGAAAGAAGGCTCTGGACATTGCAGTGGACCAGGAAAAC 66 FBan0006742 FBgn0039056 cenB1A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; carbohydrate metabolism; GO:0005975; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 "ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" cenB1A centaurin beta 1A "CG6742, CenB1A, centaurin beta 1A" CDMC27357 2 4 24 DAC38-J07 2-CG6742-RA_3 CG6742 GCTGCATACGACCTCTCCTCCAGTGACGGAAAGAAGGCTCTGGACATTGCAGTGGACCAGGAAAAC 66 FBan0006742 FBgn0039056 cenB1A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; carbohydrate metabolism; GO:0005975; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 "ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" cenB1A centaurin beta 1A "CG6742, CenB1A, centaurin beta 1A" CDMC27358 2 5 24 DAC38-J19 1-CG6930-RA_1 CG6930 CGGCTCCTGAGGATCGTACAAGGACTTCTGGTAAACTCCCAGCCGAATTTCAAGCCATAAGGGGCG 66 FBan0006930 FBgn0037947 CG6930 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6930 CG6930 CDMC27358 2 6 24 DAC38-J19 1-CG6930-RA_1 CG6930 CGGCTCCTGAGGATCGTACAAGGACTTCTGGTAAACTCCCAGCCGAATTTCAAGCCATAAGGGGCG 66 FBan0006930 FBgn0037947 CG6930 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6930 CG6930 CDMC27359 2 7 24 DAC38-N07 3-CG7460-RB_2 CG7460 GCAGCGGATCACCTGTTTGAAGTATCCGGAAAGGGTCACTTGGAGTACTGGCTATGCGAAGGCGAG 66 FBan0007460 FBgn0036749 CG7460 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7460 CG7460 CDMC27359 2 8 24 DAC38-N07 3-CG7460-RB_2 CG7460 GCAGCGGATCACCTGTTTGAAGTATCCGGAAAGGGTCACTTGGAGTACTGGCTATGCGAAGGCGAG 66 FBan0007460 FBgn0036749 CG7460 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7460 CG7460 CDMC27360 2 9 24 DAC38-N19 3-CG7635-RA_1 CG7635 GCGACAGTTTCGAATCCATAGCCGATCGGAGAGCAACGAACGTAGGCCAGAACGGAGCAGAGAAAC 66 FBan0007635 FBgn0030993 Mec2 X X cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 Mec2 Mec2 "CG7635, DMec2" CDMC27360 2 10 24 DAC38-N19 3-CG7635-RA_1 CG7635 GCGACAGTTTCGAATCCATAGCCGATCGGAGAGCAACGAACGTAGGCCAGAACGGAGCAGAGAAAC 66 FBan0007635 FBgn0030993 Mec2 X X cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 Mec2 Mec2 "CG7635, DMec2" CDMC27361 2 11 24 DAC39-B07 23-CG32041-RC_1 CG32041 AAGAAGCTTTTGTTGGAAAAACCAAGTTACCTTATTAACTACAATGCGTTCCTTACCGATGTTTTGGCG 69 FBgn0052041 CDMC27361 2 12 24 DAC39-B07 23-CG32041-RC_1 CG32041 AAGAAGCTTTTGTTGGAAAAACCAAGTTACCTTATTAACTACAATGCGTTCCTTACCGATGTTTTGGCG 69 FBgn0052041 CDMC27362 2 13 24 DAC39-B19 14-CG3204-RA_1 CG3204 GCCTTGGCACAACTGTGGGACTGTCCATTTATCGAGGCATCTGCAAAGGATCGGATAAACGTAAACGAA 69 FBan0003204 FBgn0025806 Rap2l 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rap2l Ras-associated protein 2-like "CG3204, Rap21, Dm Rap21" CDMC27362 2 14 24 DAC39-B19 14-CG3204-RA_1 CG3204 GCCTTGGCACAACTGTGGGACTGTCCATTTATCGAGGCATCTGCAAAGGATCGGATAAACGTAAACGAA 69 FBan0003204 FBgn0025806 Rap2l 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rap2l Ras-associated protein 2-like "CG3204, Rap21, Dm Rap21" CDMC27363 2 15 24 DAC39-F07 3-CG32077-RA_1 CG32077 GCAGCGACCGCAAGAAGAGATCCCGACGAAACTAAAGTAGAGACCCCATTGCGAATACCCCAGGCATAA 69 FBan0032077 FBgn0014368 nol 3 3L neuroblast proliferation; GO:0007405 extracellular region; GO:0005576 nol no optic lobe "CG32077, no optic lobe" CDMC27363 2 16 24 DAC39-F07 3-CG32077-RA_1 CG32077 GCAGCGACCGCAAGAAGAGATCCCGACGAAACTAAAGTAGAGACCCCATTGCGAATACCCCAGGCATAA 69 FBan0032077 FBgn0014368 nol 3 3L neuroblast proliferation; GO:0007405 extracellular region; GO:0005576 nol no optic lobe "CG32077, no optic lobe" CDMC27364 2 17 24 DAC39-F19 3-CG32090-RA_1 CG32090 GGTCTCCGTTCTGATTGCCGGATCTCTGTCGGATTCGTATACCATTCGCAAGGGATACATCCACCTGGC 69 FBgn0052090 CDMC27364 2 18 24 DAC39-F19 3-CG32090-RA_1 CG32090 GGTCTCCGTTCTGATTGCCGGATCTCTGTCGGATTCGTATACCATTCGCAAGGGATACATCCACCTGGC 69 FBgn0052090 CDMC27365 2 19 24 DAC39-J07 9-CG32120-RA_1 CG32120 AGGCTAGGCGGCAATCTCTGATCCAGGAGATCCCAGTATTAGCTAAGCAGGACGAGACACACACTCAAA 69 FBan0032120 FBgn0002573 sens 3 3L NOT R8 cell fate specification; GO:0045464; R8 cell differentiation; GO:0045465; cell proliferation; GO:0008283; eye photoreceptor development (sensu Endopterygota); GO:0042051; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; peripheral nervous system development; GO:0007422; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sens senseless "CG10714, CG32120, CG10714, Ly, 1228/04, Ly-1, Senseless, Sens, sense, Sen, l(3)70Ad, Lyra" CDMC27365 2 20 24 DAC39-J07 9-CG32120-RA_1 CG32120 AGGCTAGGCGGCAATCTCTGATCCAGGAGATCCCAGTATTAGCTAAGCAGGACGAGACACACACTCAAA 69 FBan0032120 FBgn0002573 sens 3 3L NOT R8 cell fate specification; GO:0045464; R8 cell differentiation; GO:0045465; cell proliferation; GO:0008283; eye photoreceptor development (sensu Endopterygota); GO:0042051; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; peripheral nervous system development; GO:0007422; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sens senseless "CG10714, CG32120, CG10714, Ly, 1228/04, Ly-1, Senseless, Sens, sense, Sen, l(3)70Ad, Lyra" CDMC27366 2 21 24 DAC39-J19 18-CG32138-RA_7 CG32138 GCGTGTGGAGCGTATCTCGTCCAAGCTAGCCATTATGAACTATATGGGCAATTTTGTCGACAGCGTTCA 69 FBan0032138 FBgn0052138 CG32138 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; cell organization and biogenesis; GO:0016043; intracellular signaling cascade; GO:0007242 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; Rho GTPase binding; GO:0017048; ; GO:0017048 CG32138 CG32138 "CG6807, CG13485, CG6807, CG6807, anon-WO0172774.98" CDMC27366 2 22 24 DAC39-J19 18-CG32138-RA_7 CG32138 GCGTGTGGAGCGTATCTCGTCCAAGCTAGCCATTATGAACTATATGGGCAATTTTGTCGACAGCGTTCA 69 FBan0032138 FBgn0052138 CG32138 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; cell organization and biogenesis; GO:0016043; intracellular signaling cascade; GO:0007242 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; Rho GTPase binding; GO:0017048; ; GO:0017048 CG32138 CG32138 "CG6807, CG13485, CG6807, CG6807, anon-WO0172774.98" CDMC27367 2 23 24 DAC39-N07 3-CG32168-RA_3 CG32168 ACAAAGCGAGCGATTAACAAATGCATTGAACGCCTTCTATTCCGCACCCTCACACGATCGTCCAAGGGA 69 FBgn0052168 CDMC27367 2 24 24 DAC39-N07 3-CG32168-RA_3 CG32168 ACAAAGCGAGCGATTAACAAATGCATTGAACGCCTTCTATTCCGCACCCTCACACGATCGTCCAAGGGA 69 FBgn0052168 CDMC27368 2 25 24 DAC39-N19 16-CG32178-RA_1 CG32178 ACCGCCGTTTCTCAAACATCTGAACATCATCGATACGAATCTTTATGCGGCACTTAAGAGCATGCCCAA 69 FBan0032178 FBgn0043025 Msi 3 3L purine ribonucleoside monophosphate biosynthesis; GO:0009168; spermatid development; GO:0007286 growth factor activity; GO:0008083; ; GO:0008083; ; GO:0008083; deaminase activity; GO:0019239; ; GO:0008083; ; GO:0019239 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624 Msi Male-specific insect derived growth factor "CG32178, MSI, male-specific IDGF, ADGF-A2, BcDNA:AT05468, male-specific-imaginal-disc-growth-factor, Male-specific insect derived growth factor" CDMC27368 2 26 24 DAC39-N19 16-CG32178-RA_1 CG32178 ACCGCCGTTTCTCAAACATCTGAACATCATCGATACGAATCTTTATGCGGCACTTAAGAGCATGCCCAA 69 FBan0032178 FBgn0043025 Msi 3 3L purine ribonucleoside monophosphate biosynthesis; GO:0009168; spermatid development; GO:0007286 growth factor activity; GO:0008083; ; GO:0008083; ; GO:0008083; deaminase activity; GO:0019239; ; GO:0008083; ; GO:0019239 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624 Msi Male-specific insect derived growth factor "CG32178, MSI, male-specific IDGF, ADGF-A2, BcDNA:AT05468, male-specific-imaginal-disc-growth-factor, Male-specific insect derived growth factor" CDMC27369 2 1 25 DAC40-B07 3-CG9559-RA_1 CG9559 GCCACCACAGAGACAGTTGCTACATCGGGCCAGGTTAATGAAATCAGCTTGACAGCAACGTCAGCATCA 69 FBan0009559 FBgn0000719 fog X X "gastrulation; GO:0007369; mesoderm development; GO:0007498; posterior midgut invagination; GO:0007374; regulation of cell shape; GO:0008360; regulation of development, heterochronic; GO:0040034; salivary gland morphogenesis; GO:0007435; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; ventral furrow formation; GO:0007370" extracellular region; GO:0005576 fog folded gastrulation "CG9559, l114, M67, l(1)114, 114, l(1)16-3-190, CR41108, CR41109, CR41110, l(1)20Ba" CDMC27369 2 2 25 DAC40-B07 3-CG9559-RA_1 CG9559 GCCACCACAGAGACAGTTGCTACATCGGGCCAGGTTAATGAAATCAGCTTGACAGCAACGTCAGCATCA 69 FBan0009559 FBgn0000719 fog X X "gastrulation; GO:0007369; mesoderm development; GO:0007498; posterior midgut invagination; GO:0007374; regulation of cell shape; GO:0008360; regulation of development, heterochronic; GO:0040034; salivary gland morphogenesis; GO:0007435; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; ventral furrow formation; GO:0007370" extracellular region; GO:0005576 fog folded gastrulation "CG9559, l114, M67, l(1)114, 114, l(1)16-3-190, CR41108, CR41109, CR41110, l(1)20Ba" CDMC27370 2 3 25 DAC40-B19 18-CG9575-RA_4 CG9575 AGCGGTTTGCGAAACAAATGGACATCGAGCTATTCGAGACATCTGCCAAAGACAACATAAACGTGGAGA 69 FBan0009575 FBgn0031090 Rab35 X X "cytokinesis; GO:0000910; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab35 Rab35 "CG9575, DmRab35, DRab35" CDMC27370 2 4 25 DAC40-B19 18-CG9575-RA_4 CG9575 AGCGGTTTGCGAAACAAATGGACATCGAGCTATTCGAGACATCTGCCAAAGACAACATAAACGTGGAGA 69 FBan0009575 FBgn0031090 Rab35 X X "cytokinesis; GO:0000910; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab35 Rab35 "CG9575, DmRab35, DRab35" CDMC27371 2 5 25 DAC40-F07 5-CG9613-RA_1 CG9613 TGGGCACCCTTCTGAAATCAGACGAAAGCAAGAAACAGCGACAATCCTCACTAACAACATCGACGGCCA 69 FBan0009613 FBgn0037574 CG9613 3 3R biosynthesis; GO:0009058; ubiquinone metabolism; GO:0006743 4-hydroxybenzoate octaprenyltransferase activity; GO:0008412 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008412 ; EC:2.5.1.- integral to membrane; GO:0016021; membrane; GO:0016020 CG9613 CG9613 CDMC27371 2 6 25 DAC40-F07 5-CG9613-RA_1 CG9613 TGGGCACCCTTCTGAAATCAGACGAAAGCAAGAAACAGCGACAATCCTCACTAACAACATCGACGGCCA 69 FBan0009613 FBgn0037574 CG9613 3 3R biosynthesis; GO:0009058; ubiquinone metabolism; GO:0006743 4-hydroxybenzoate octaprenyltransferase activity; GO:0008412 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008412 ; EC:2.5.1.- integral to membrane; GO:0016021; membrane; GO:0016020 CG9613 CG9613 CDMC27372 2 7 25 DAC40-F19 16-CG9616-RA_1 CG9616 TGCCCCAGCACTACTGCGATGAGCACTTCAGATATGCCATGAAAGACAAACAACAGACCTATATAGGCA 69 FBan0009616 FBgn0038214 CG9616 3 3R CG9616 CG9616 CDMC27372 2 8 25 DAC40-F19 16-CG9616-RA_1 CG9616 TGCCCCAGCACTACTGCGATGAGCACTTCAGATATGCCATGAAAGACAAACAACAGACCTATATAGGCA 69 FBan0009616 FBgn0038214 CG9616 3 3R CG9616 CG9616 CDMC27373 2 9 25 DAC40-J07 3-CG9655-RA_1 CG9655 ACAAGCTGCTTTATTTCATCACCCTCAAGTCGTACAACGTTGTGTACATGGGCTGGTGCCTGACCGCAT 69 FBan0009655 FBgn0026630 nes 3 3L plasma membrane; GO:0005886 nes nessy "CG9655, nessy" CDMC27373 2 10 25 DAC40-J07 3-CG9655-RA_1 CG9655 ACAAGCTGCTTTATTTCATCACCCTCAAGTCGTACAACGTTGTGTACATGGGCTGGTGCCTGACCGCAT 69 FBan0009655 FBgn0026630 nes 3 3L plasma membrane; GO:0005886 nes nessy "CG9655, nessy" CDMC27374 2 11 25 DAC40-J19 3-CG9664-RA_1 CG9664 GGAGCAGTTCCTCAAGGACTTCCAGATGGAGGGCAATGAGTTCGATTGGGATATGGCTGTCCTGGGAAT 69 FBan0009664 FBgn0031515 CG9664 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9664 CG9664 CDMC27374 2 12 25 DAC40-J19 3-CG9664-RA_1 CG9664 GGAGCAGTTCCTCAAGGACTTCCAGATGGAGGGCAATGAGTTCGATTGGGATATGGCTGTCCTGGGAAT 69 FBan0009664 FBgn0031515 CG9664 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9664 CG9664 CDMC27375 2 13 25 DAC40-N07 16-CG9699-RA_1 CG9699 TCCCCCCCCAAAAAGCACAAAGAATCCGACGAACCAAAAACTTCAGACATCACACAGCCTTTTTCAATT 69 FBan0009699 FBgn0030772 CG9699 X X cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 septin ring; GO:0005940 CG9699 CG9699 CDMC27375 2 14 25 DAC40-N07 16-CG9699-RA_1 CG9699 TCCCCCCCCAAAAAGCACAAAGAATCCGACGAACCAAAAACTTCAGACATCACACAGCCTTTTTCAATT 69 FBan0009699 FBgn0030772 CG9699 X X cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 septin ring; GO:0005940 CG9699 CG9699 CDMC27376 2 15 25 DAC40-N19 18-CG9709-RA_1 CG9709 CCCCGCACTGAACAAGATATTGGAGAACGTGCTGGAACTATTTCTGGTCCAAACGGTGCTTAATAACCT 69 FBan0009709 FBgn0034629 Acox57D-d 2 2R electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0003997 ; EC:1.3.3.6; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 Acox57D-d acyl-Coenzyme A oxidase at 57D distal "CG9709, acyl co-enzyme A oxidase, D-acox, acox, Acox57Dd, acyl-Coenzyme A oxidase at 57D distal" CDMC27376 2 16 25 DAC40-N19 18-CG9709-RA_1 CG9709 CCCCGCACTGAACAAGATATTGGAGAACGTGCTGGAACTATTTCTGGTCCAAACGGTGCTTAATAACCT 69 FBan0009709 FBgn0034629 Acox57D-d 2 2R electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0003997 ; EC:1.3.3.6; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 Acox57D-d acyl-Coenzyme A oxidase at 57D distal "CG9709, acyl co-enzyme A oxidase, D-acox, acox, Acox57Dd, acyl-Coenzyme A oxidase at 57D distal" CDMC27377 2 17 25 DAC41-B07 AutoBlank AutoBlank CDMC27377 2 18 25 DAC41-B07 AutoBlank AutoBlank CDMC27378 2 19 25 DAC41-B19 AutoBlank AutoBlank CDMC27378 2 20 25 DAC41-B19 AutoBlank AutoBlank CDMC27379 2 21 25 DAC41-F07 AutoBlank AutoBlank CDMC27379 2 22 25 DAC41-F07 AutoBlank AutoBlank CDMC27380 2 23 25 DAC41-F19 AutoBlank AutoBlank CDMC27380 2 24 25 DAC41-F19 AutoBlank AutoBlank CDMC27381 2 25 25 DAC41-J07 AutoBlank AutoBlank CDMC27381 2 26 25 DAC41-J07 AutoBlank AutoBlank CDMC27382 2 1 26 DAC41-J19 AutoBlank AutoBlank CDMC27382 2 2 26 DAC41-J19 AutoBlank AutoBlank CDMC27383 2 3 26 DAC41-N07 AutoBlank AutoBlank CDMC27383 2 4 26 DAC41-N07 AutoBlank AutoBlank CDMC27384 2 5 26 DAC41-N19 AutoBlank AutoBlank CDMC27384 2 6 26 DAC41-N19 AutoBlank AutoBlank CDMC27385 2 7 26 DAC42-B07 150mM NaPO4 Blank CDMC27385 2 8 26 DAC42-B07 150mM NaPO4 Blank CDMC27386 2 9 26 DAC42-B19 150mM NaPO4 Blank CDMC27386 2 10 26 DAC42-B19 150mM NaPO4 Blank CDMC27387 2 11 26 DAC42-F07 150mM NaPO4 Blank CDMC27387 2 12 26 DAC42-F07 150mM NaPO4 Blank CDMC27388 2 13 26 DAC42-F19 150mM NaPO4 Blank CDMC27388 2 14 26 DAC42-F19 150mM NaPO4 Blank CDMC27389 2 15 26 DAC42-J07 150mM NaPO4 Blank CDMC27389 2 16 26 DAC42-J07 150mM NaPO4 Blank CDMC27390 2 17 26 DAC42-J19 5uM MSP 5uM MSP CDMC27390 2 18 26 DAC42-J19 5uM MSP 5uM MSP CDMC27391 2 19 26 DAC42-N07 10uM MSP 10uM MSP CDMC27391 2 20 26 DAC42-N07 10uM MSP 10uM MSP CDMC27392 2 21 26 DAC42-N19 20uM MSP 20uM MSP CDMC27392 2 22 26 DAC42-N19 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC27393 3 1 1 DAC01-C07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27393 3 2 1 DAC01-C07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27394 3 3 1 DAC01-C19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27394 3 4 1 DAC01-C19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27395 3 5 1 DAC01-G07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27395 3 6 1 DAC01-G07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27396 3 7 1 DAC01-G19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27396 3 8 1 DAC01-G19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27397 3 9 1 DAC01-K07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27397 3 10 1 DAC01-K07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27398 3 11 1 DAC01-K19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27398 3 12 1 DAC01-K19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27399 3 13 1 DAC01-O07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27399 3 14 1 DAC01-O07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27400 3 15 1 DAC01-O19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27400 3 16 1 DAC01-O19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27401 3 17 1 DAC02-C07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27401 3 18 1 DAC02-C07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27402 3 19 1 DAC02-C19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27402 3 20 1 DAC02-C19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27403 3 21 1 DAC02-G07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27403 3 22 1 DAC02-G07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27404 3 23 1 DAC02-G19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27404 3 24 1 DAC02-G19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27405 3 25 1 DAC02-K07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27405 3 26 1 DAC02-K07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27406 3 1 2 DAC02-K19 N/A CG9075 (00001-00239) CDMC27406 3 2 2 DAC02-K19 N/A CG9075 (00001-00239) CDMC27407 3 3 2 DAC02-O07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27407 3 4 2 DAC02-O07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27408 3 5 2 DAC02-O19 AutoBlank AutoBlank CDMC27408 3 6 2 DAC02-O19 AutoBlank AutoBlank CDMC27409 3 7 2 DAC03-C07 9-CG17116-RA_1 CG17116 GTCGGTGAAGAGTGTGCGGAGGATCAACTCCAAGAAGTTCAATCACTTGGACTTCCTGATTTCCGGCGA 69 FBan0017116 FBgn0024740 Lip2 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 Lip2 Lipase 2 "CG17116, Dmlip2, lip2, Lipase 2" CDMC27409 3 8 2 DAC03-C07 9-CG17116-RA_1 CG17116 GTCGGTGAAGAGTGTGCGGAGGATCAACTCCAAGAAGTTCAATCACTTGGACTTCCTGATTTCCGGCGA 69 FBan0017116 FBgn0024740 Lip2 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 Lip2 Lipase 2 "CG17116, Dmlip2, lip2, Lipase 2" CDMC27410 3 9 2 DAC03-C19 15-CG1712-RA_7 CG1712 CCATTGTATCCGGTGTTTACTGTGGCCTTTTCAGCCTGAACGACACTCTCGAGCTCAACGATCGACTAA 69 FBan0001712 FBgn0041243 Gr43a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr43a Gustatory receptor 43a "CG1712, CG1712, CG1712, 43C.1, Gustatory receptor 43C.1, Gr43C1, 43C1, DmGr43a, GR43C.1, Gustatory receptor 43a" CDMC27410 3 10 2 DAC03-C19 15-CG1712-RA_7 CG1712 CCATTGTATCCGGTGTTTACTGTGGCCTTTTCAGCCTGAACGACACTCTCGAGCTCAACGATCGACTAA 69 FBan0001712 FBgn0041243 Gr43a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr43a Gustatory receptor 43a "CG1712, CG1712, CG1712, 43C.1, Gustatory receptor 43C.1, Gr43C1, 43C1, DmGr43a, GR43C.1, Gustatory receptor 43a" CDMC27411 3 11 2 DAC03-G07 22-CG17169-RA_1 CG17169 AGCCGGGCCTTTTAAGGAACTGCAAGACGAGAGATCAAATGCGACCTCTGATTAATAAAGTCAAGCAGT 69 FBgn0040514 CG17169 CG17169 CG17169 CDMC27411 3 12 2 DAC03-G07 22-CG17169-RA_1 CG17169 AGCCGGGCCTTTTAAGGAACTGCAAGACGAGAGATCAAATGCGACCTCTGATTAATAAAGTCAAGCAGT 69 FBgn0040514 CG17169 CG17169 CG17169 CDMC27412 3 13 2 DAC03-G19 8-CG17178-RA_2 CG17178 AGAGCAATGAGGCGTACCAGAGTATTGCTGGTGATCGCAATATTACGGATGGAACAATCGCCATCGGCA 69 FBan0017178 FBgn0040506 ACXE 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXE ACXE "CG17178, CG17178, DACXE, AC" CDMC27412 3 14 2 DAC03-G19 8-CG17178-RA_2 CG17178 AGAGCAATGAGGCGTACCAGAGTATTGCTGGTGATCGCAATATTACGGATGGAACAATCGCCATCGGCA 69 FBan0017178 FBgn0040506 ACXE 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXE ACXE "CG17178, CG17178, DACXE, AC" CDMC27413 3 15 2 DAC03-K07 16-CG17211-RA_1 CG17211 GCCCAATCTCGATGAACTAATCGTTGACAAGGCGAACAAAAAGCCGATTGAAGAGCATATCGAGACCGT 69 FBan0017211 FBgn0032414 CG17211 2 2L CG17211 CG17211 CDMC27413 3 16 2 DAC03-K07 16-CG17211-RA_1 CG17211 GCCCAATCTCGATGAACTAATCGTTGACAAGGCGAACAAAAAGCCGATTGAAGAGCATATCGAGACCGT 69 FBan0017211 FBgn0032414 CG17211 2 2L CG17211 CG17211 CDMC27414 3 17 2 DAC03-K19 9-CG17221-RA_1 CG17221 GGGACTGGGAGTAGGAGCGCTTAAGAATGTGTTCGATCTGTTCCAGACCAACGTAAGATCCGTCACGCA 69 FBan0017221 FBgn0031500 CG17221 2 2L "zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG17221 CG17221 DM_7295851 CDMC27414 3 18 2 DAC03-K19 9-CG17221-RA_1 CG17221 GGGACTGGGAGTAGGAGCGCTTAAGAATGTGTTCGATCTGTTCCAGACCAACGTAAGATCCGTCACGCA 69 FBan0017221 FBgn0031500 CG17221 2 2L "zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG17221 CG17221 DM_7295851 CDMC27415 3 19 2 DAC03-O07 3-CG17262-RA_1 CG17262 CGCGATAGTCTGGGTGTCTACGATCCGGTGGACATACACAGTCGGGGATTGCTAAAGGTCCATCTGAGA 69 FBan0017262 FBgn0031499 CG17262 2 2L intracellular signaling cascade; GO:0007242 membrane; GO:0016020 CG17262 CG17262 CDMC27415 3 20 2 DAC03-O07 3-CG17262-RA_1 CG17262 CGCGATAGTCTGGGTGTCTACGATCCGGTGGACATACACAGTCGGGGATTGCTAAAGGTCCATCTGAGA 69 FBan0017262 FBgn0031499 CG17262 2 2L intracellular signaling cascade; GO:0007242 membrane; GO:0016020 CG17262 CG17262 CDMC27416 3 21 2 DAC03-O19 13-CG17272-RA_1 CG17272 GCCGACGATCCAAGAACTGGTTTCCTATCTGAAGCAAAAGAATGGGAAAATGAGCTTCGCCGACTTCCT 69 FBan0017272 FBgn0038830 CG17272 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17272 CG17272 BEST:GH27755 CDMC27416 3 22 2 DAC03-O19 13-CG17272-RA_1 CG17272 GCCGACGATCCAAGAACTGGTTTCCTATCTGAAGCAAAAGAATGGGAAAATGAGCTTCGCCGACTTCCT 69 FBan0017272 FBgn0038830 CG17272 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17272 CG17272 BEST:GH27755 CDMC27417 3 23 2 DAC04-C07 3-CG15929-RA_1 CG15929 AGAAGGCTTCAGCGTCCAGCAGTAGTACGTTATTGGCCGAAAAGGATGTCCCGGAGGTCAAGGAG 65 FBan0015929 FBgn0029800 lin-52 X X negative regulation of transcription from RNA polymerase II promoter; GO:0000122 Myb complex; GO:0031523 lin-52 lin-52 "CG15929, CG15929, dLin-52, dLIN-52" CDMC27417 3 24 2 DAC04-C07 3-CG15929-RA_1 CG15929 AGAAGGCTTCAGCGTCCAGCAGTAGTACGTTATTGGCCGAAAAGGATGTCCCGGAGGTCAAGGAG 65 FBan0015929 FBgn0029800 lin-52 X X negative regulation of transcription from RNA polymerase II promoter; GO:0000122 Myb complex; GO:0031523 lin-52 lin-52 "CG15929, CG15929, dLin-52, dLIN-52" CDMC27418 3 25 2 DAC04-C19 23-CG1637-RA_1 CG1637 TGCACTTCATCGGTTTTAGCACAGAAGTCTATTATTTCACTAAGTTCGGGATCAAGCAGATCGTG 65 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC27418 3 26 2 DAC04-C19 23-CG1637-RA_1 CG1637 TGCACTTCATCGGTTTTAGCACAGAAGTCTATTATTTCACTAAGTTCGGGATCAAGCAGATCGTG 65 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC27419 3 1 3 DAC04-G07 7-CG16813-RA_1 CG16813 CATGGATGCGGACTCTGATGACGATGTGGTCTTCATTATGGAACAGCCGGGCCAACGCACTCCAG 65 FBan0016813 FBgn0032490 CG16813 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG16813 CG16813 CDMC27419 3 2 3 DAC04-G07 7-CG16813-RA_1 CG16813 CATGGATGCGGACTCTGATGACGATGTGGTCTTCATTATGGAACAGCCGGGCCAACGCACTCCAG 65 FBan0016813 FBgn0032490 CG16813 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG16813 CG16813 CDMC27420 3 3 3 DAC04-G19 2-CG16857-RA_1 CG16857 TTGGCCAGTGAAACTAAGAGGCGATAGATGAGGAAATGGGTGGGTTGTTCACCGTGCACCAGTCC 65 FBan0016857 FBgn0028482 CG16857 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG16857 CG16857 "CT35491, BcDNA:GH11322, GH11322" CDMC27420 3 4 3 DAC04-G19 2-CG16857-RA_1 CG16857 TTGGCCAGTGAAACTAAGAGGCGATAGATGAGGAAATGGGTGGGTTGTTCACCGTGCACCAGTCC 65 FBan0016857 FBgn0028482 CG16857 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG16857 CG16857 "CT35491, BcDNA:GH11322, GH11322" CDMC27421 3 5 3 DAC04-K07 3-CG16995-RA_1 CG16995 ATTCTCCGTCGTTTCAAGGTAACACCGGCCATTTCACTCAGGTGGTCTGGAAGAGCTCCACCGAG 65 FBan0016995 FBgn0031412 CG16995 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG16995 CG16995 CDMC27421 3 6 3 DAC04-K07 3-CG16995-RA_1 CG16995 ATTCTCCGTCGTTTCAAGGTAACACCGGCCATTTCACTCAGGTGGTCTGGAAGAGCTCCACCGAG 65 FBan0016995 FBgn0031412 CG16995 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG16995 CG16995 CDMC27422 3 7 3 DAC04-K19 3-CG17054-RD_4 CG17054 GAACGATGTGACGCAATCTGCTGCCATAACCGCAGTAGACGCTACTGAAACTCCAAAGGCAGCCG 65 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC27422 3 8 3 DAC04-K19 3-CG17054-RD_4 CG17054 GAACGATGTGACGCAATCTGCTGCCATAACCGCAGTAGACGCTACTGAAACTCCAAAGGCAGCCG 65 FBan0017054 FBgn0033795 Cap-G 2 2R cytokinesis; GO:0000910; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070 condensin complex; GO:0000796 Cap-G Cap-G "CG17054, CG13327, CG13328, CG30057, CG17054, CG13327, CG13328, DCAP-G, dcap-g, CapG, cap-G, dCAP-G, BcDNA:RH49308, l(2)c00093, lethal (2) c00093" CDMC27423 3 9 3 DAC04-O07 3-CG1718-RA_1 CG1718 TACGCGCGCCAATCAGTGAGCTAGCCCCCAAAAAGATCCAACACCCAGTTGATAACACCACATGG 65 FBan0001718 FBgn0031170 CG1718 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1718 CG1718 CDMC27423 3 10 3 DAC04-O07 3-CG1718-RA_1 CG1718 TACGCGCGCCAATCAGTGAGCTAGCCCCCAAAAAGATCCAACACCCAGTTGATAACACCACATGG 65 FBan0001718 FBgn0031170 CG1718 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1718 CG1718 CDMC27424 3 11 3 DAC04-O19 AutoBlank AutoBlank CDMC27424 3 12 3 DAC04-O19 AutoBlank AutoBlank CDMC27425 3 13 3 DAC05-C07 14-CG10492-RA_5 CG10492 CGCCTTTGCCACGTCTCTTAGTTCCGTAAGCCTCTCAATTCGCGTTAATTCAATTCGAGGATCGGCAG 68 FBan0010492 FBgn0032748 CG10492 2 2L CG10492 CG10492 "B1, TU37B1, transcription unit 37B1, TuB1, anon-37B-1" CDMC27425 3 14 3 DAC05-C07 14-CG10492-RA_5 CG10492 CGCCTTTGCCACGTCTCTTAGTTCCGTAAGCCTCTCAATTCGCGTTAATTCAATTCGAGGATCGGCAG 68 FBan0010492 FBgn0032748 CG10492 2 2L CG10492 CG10492 "B1, TU37B1, transcription unit 37B1, TuB1, anon-37B-1" CDMC27426 3 15 3 DAC05-C19 2-CG10583-RA_4 CG10583 CGTCTAGACCACCTCCATTGGGAACAACTAGTCACCGTGCAGGAATTCTCCCGCGTCAAATCACTGCA 68 FBan0010583 FBgn0035627 Sse 3 3L meiosis I; GO:0007127; mitotic sister chromatid segregation; GO:0000070; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- nucleus; GO:0005634 Sse Separase "CG10583, l(3)13m-281, l(3)SG14, SSE, sse, separase, lethal(3)SG14, Separase" CDMC27426 3 16 3 DAC05-C19 2-CG10583-RA_4 CG10583 CGTCTAGACCACCTCCATTGGGAACAACTAGTCACCGTGCAGGAATTCTCCCGCGTCAAATCACTGCA 68 FBan0010583 FBgn0035627 Sse 3 3L meiosis I; GO:0007127; mitotic sister chromatid segregation; GO:0000070; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- nucleus; GO:0005634 Sse Separase "CG10583, l(3)13m-281, l(3)SG14, SSE, sse, separase, lethal(3)SG14, Separase" CDMC27427 3 17 3 DAC05-G07 2-CG11163-RB_1 CG11163 TGTTAATAGGGAGGTGGTGACAATTGGGTCAAATGTCGTCCGGGTTCCAGAGGAGCAAACCTGGGAAG 68 FBan0011163 FBgn0025693 CG11163 2 2R cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG11163 CG11163 "CK02137, BEST:CK02137" CDMC27427 3 18 3 DAC05-G07 2-CG11163-RB_1 CG11163 TGTTAATAGGGAGGTGGTGACAATTGGGTCAAATGTCGTCCGGGTTCCAGAGGAGCAAACCTGGGAAG 68 FBan0011163 FBgn0025693 CG11163 2 2R cation transport; GO:0006812 zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG11163 CG11163 "CK02137, BEST:CK02137" CDMC27428 3 19 3 DAC05-G19 14-CG11202-RA_3 CG11202 GACGCATGTTTCCCACGTTTCAGGTGAGGATCGGTGGTTTGGATCCACATGCCACCTACATTTGCATG 68 FBan0011202 FBgn0021767 org-1 X X mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 org-1 optomotor-blind-related-gene-1 "CG11202, omb-related gene-1, optomotor-blind-related gene-1, Org-1, Dm-ORG-1, optomotor-blind-related-protein-1" CDMC27428 3 20 3 DAC05-G19 14-CG11202-RA_3 CG11202 GACGCATGTTTCCCACGTTTCAGGTGAGGATCGGTGGTTTGGATCCACATGCCACCTACATTTGCATG 68 FBan0011202 FBgn0021767 org-1 X X mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 org-1 optomotor-blind-related-gene-1 "CG11202, omb-related gene-1, optomotor-blind-related gene-1, Org-1, Dm-ORG-1, optomotor-blind-related-protein-1" CDMC27429 3 21 3 DAC05-K07 2-CG11450-RA_1 CG11450 GCCGATCAATCCGTACCGTCCATTGCCACGTGCTTAGAAGCTGTAACATCAACCATCCAAACGGAGGG 68 FBan0011450 FBgn0002931 net 2 2L regulation of transcription; GO:0045449; wing vein morphogenesis; GO:0008586 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 net net "CG11450, CG11450, CG11450, CG11450, CG11450, Group IId, Shout, shout" CDMC27429 3 22 3 DAC05-K07 2-CG11450-RA_1 CG11450 GCCGATCAATCCGTACCGTCCATTGCCACGTGCTTAGAAGCTGTAACATCAACCATCCAAACGGAGGG 68 FBan0011450 FBgn0002931 net 2 2L regulation of transcription; GO:0045449; wing vein morphogenesis; GO:0008586 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 net net "CG11450, CG11450, CG11450, CG11450, CG11450, Group IId, Shout, shout" CDMC27430 3 23 3 DAC05-K19 2-CG11718-RA_1 CG11718 GGCTCCACAGTTAGTAAGTCCTTTGTGCAGCATCTGAGAAAGCCCTCTCACAAGCAGAAACGAGCGCC 68 FBan0011718 FBgn0037585 CG11718 3 3R CG11718 CG11718 CDMC27430 3 24 3 DAC05-K19 2-CG11718-RA_1 CG11718 GGCTCCACAGTTAGTAAGTCCTTTGTGCAGCATCTGAGAAAGCCCTCTCACAAGCAGAAACGAGCGCC 68 FBan0011718 FBgn0037585 CG11718 3 3R CG11718 CG11718 CDMC27431 3 25 3 DAC05-O07 2-CG12178-RA_1 CG12178 GCAATCGACTCTGAACACTTGTCTGAACTCACCGAGGAAGAGGACGTCACCTTTACTCAAGCGCGCGA 68 FBan0012178 FBgn0026787 Nhe1 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe1 Nhe1 "CG12178, NHE1, DmNHE1" CDMC27431 3 26 3 DAC05-O07 2-CG12178-RA_1 CG12178 GCAATCGACTCTGAACACTTGTCTGAACTCACCGAGGAAGAGGACGTCACCTTTACTCAAGCGCGCGA 68 FBan0012178 FBgn0026787 Nhe1 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe1 Nhe1 "CG12178, NHE1, DmNHE1" CDMC27432 3 1 4 DAC05-O19 2-CG12287-RA_1 CG12287 CGCCAAACTCGATGACTGCCAATTCTCTGGGAATGAGTAGTGCCGTGATGACTCCAAATACGCCCAGC 68 FBan0012287 FBgn0004394 pdm2 2 2L "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 pdm2 POU domain protein 2 "CG12287, CG15486, CG15487, pdm-2, dPOU-28, dPOU28, dOct2, dim: didymous, dPOU28/pdm-2, miti, miti-mere, dpou28, Miti-mere, Pdm-2, pdm, Pdm2, didymous, dim" CDMC27432 3 2 4 DAC05-O19 2-CG12287-RA_1 CG12287 CGCCAAACTCGATGACTGCCAATTCTCTGGGAATGAGTAGTGCCGTGATGACTCCAAATACGCCCAGC 68 FBan0012287 FBgn0004394 pdm2 2 2L "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 pdm2 POU domain protein 2 "CG12287, CG15486, CG15487, pdm-2, dPOU-28, dPOU28, dOct2, dim: didymous, dPOU28/pdm-2, miti, miti-mere, dpou28, Miti-mere, Pdm-2, pdm, Pdm2, didymous, dim" CDMC27433 3 3 4 DAC06-C07 12-CG33013-RB_2 CG33013 TGGCACGTTGACTCACAGTGATTCGGGATACTACTTCATATACCAGGATAGACGCGGTCTGAGTCCGCT 69 FBan0033013 FBgn0053013 CG33013 2 2R CG33013 CG33013 "CG13161, CG30041" CDMC27433 3 4 4 DAC06-C07 12-CG33013-RB_2 CG33013 TGGCACGTTGACTCACAGTGATTCGGGATACTACTTCATATACCAGGATAGACGCGGTCTGAGTCCGCT 69 FBan0033013 FBgn0053013 CG33013 2 2R CG33013 CG33013 "CG13161, CG30041" CDMC27434 3 5 4 DAC06-C19 23-CG33045-RF_1 CG33045 CCTCCCCAGATTCCTTTCTAAAACGATGTATGTACACATGGATGCCTTCTTCATTATAGACATCCGGAA 69 FBgn0026414 CDMC27434 3 6 4 DAC06-C19 23-CG33045-RF_1 CG33045 CCTCCCCAGATTCCTTTCTAAAACGATGTATGTACACATGGATGCCTTCTTCATTATAGACATCCGGAA 69 FBgn0026414 CDMC27435 3 7 4 DAC06-G07 3-CG33071-RB_3 CG33071 TTCCATTGAGTCGGTCCCACTGGAGGACCAACGTTTGGACAGTGAAAAGACCCTGTTTGACCACGTGAA 69 FBgn0053071 CDMC27435 3 8 4 DAC06-G07 3-CG33071-RB_3 CG33071 TTCCATTGAGTCGGTCCCACTGGAGGACCAACGTTTGGACAGTGAAAAGACCCTGTTTGACCACGTGAA 69 FBgn0053071 CDMC27436 3 9 4 DAC06-G19 3-CG33091-RA_2 CG33091 GCCGGATCTGTGTCAGCGTTACCAGGCAAAGATCGATCGACTGGTGGAGAACGTAATGGAGTACGGAGA 69 FBgn0053091 CDMC27436 3 10 4 DAC06-G19 3-CG33091-RA_2 CG33091 GCCGGATCTGTGTCAGCGTTACCAGGCAAAGATCGATCGACTGGTGGAGAACGTAATGGAGTACGGAGA 69 FBgn0053091 CDMC27437 3 11 4 DAC06-K07 16-CG33113-RA_1 CG33113 TTCTTGTTGAGGATATCATCGATTCGATCAAGTTCGGCGTCATTCTGTGGGTCTTCACCTACGTGGGTG 69 FBan0033113 FBgn0053113 Rtnl1 2 2L intracellular protein transport; GO:0006886 receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005057 endoplasmic reticulum; GO:0005783 Rtnl1 Rtnl1 "CG18623, CG8895, CG33113, CG18623, CG33113, G9" CDMC27437 3 12 4 DAC06-K07 16-CG33113-RA_1 CG33113 TTCTTGTTGAGGATATCATCGATTCGATCAAGTTCGGCGTCATTCTGTGGGTCTTCACCTACGTGGGTG 69 FBan0033113 FBgn0053113 Rtnl1 2 2L intracellular protein transport; GO:0006886 receptor signaling protein activity; GO:0005057; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005057 endoplasmic reticulum; GO:0005783 Rtnl1 Rtnl1 "CG18623, CG8895, CG33113, CG18623, CG33113, G9" CDMC27438 3 13 4 DAC06-K19 9-CG33120-RA_1 CG33120 CCGGCCACCACAATCGAAGACCTGCCTTTCCTTAAATCTTCATCGCTTTGGGGACAAATACAGACTGGC 69 FBan0033120 FBgn0053120 CG33120 2 2L CG33120 CG33120 CG10599 CDMC27438 3 14 4 DAC06-K19 9-CG33120-RA_1 CG33120 CCGGCCACCACAATCGAAGACCTGCCTTTCCTTAAATCTTCATCGCTTTGGGGACAAATACAGACTGGC 69 FBan0033120 FBgn0053120 CG33120 2 2L CG33120 CG33120 CG10599 CDMC27439 3 15 4 DAC06-O07 3-CG33142-RA_4 CG33142 AGTGGGGCCGATTAGTAAACCGAATCCCCATGATTCTCAAAAGGAGGCAACCTCGTTTCTGGAGCGACA 69 FBgn0053142 CDMC27439 3 16 4 DAC06-O07 3-CG33142-RA_4 CG33142 AGTGGGGCCGATTAGTAAACCGAATCCCCATGATTCTCAAAAGGAGGCAACCTCGTTTCTGGAGCGACA 69 FBgn0053142 CDMC27440 3 17 4 DAC06-O19 16-CG33147-RA_1 CG33147 ACCTAGGCTAATGCTTTCCGTGACGATCCATCCAATTTCGGTTTACACCAACTTGAGCACACTCTTTCA 69 FBan0033147 FBgn0053147 CG33147 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG33147 CG33147 "CG30124, CG15074, CG30123, CG15075, CG15076" CDMC27440 3 18 4 DAC06-O19 16-CG33147-RA_1 CG33147 ACCTAGGCTAATGCTTTCCGTGACGATCCATCCAATTTCGGTTTACACCAACTTGAGCACACTCTTTCA 69 FBan0033147 FBgn0053147 CG33147 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG33147 CG33147 "CG30124, CG15074, CG30123, CG15075, CG15076" CDMC27441 3 19 4 DAC07-C07 6-CG5800-RA_4 CG5800 TCAGGATCGTCGCATTGCCATCTACGAGGATTTCCTTCGCAAGAGCCACGTCGTTATGTTCTCCACTGA 69 FBan0005800 FBgn0030855 CG5800 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG5800 CG5800 "cg5800, DmRH14" CDMC27441 3 20 4 DAC07-C07 6-CG5800-RA_4 CG5800 TCAGGATCGTCGCATTGCCATCTACGAGGATTTCCTTCGCAAGAGCCACGTCGTTATGTTCTCCACTGA 69 FBan0005800 FBgn0030855 CG5800 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 CG5800 CG5800 "cg5800, DmRH14" CDMC27442 3 21 4 DAC07-C19 23-CG5809-RA_1 CG5809 ACGAATCGAAACCAACGATCATATAAACTATGTACCACAAAATGAATAAACTGTGCAACAAAACGTGTA 69 FBan0005809 FBgn0025678 CaBP1 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CaBP1 CaBP1 "CG5809, CG5809, DmCaBP1, BG:DS09218.4, AAL28897" CDMC27442 3 22 4 DAC07-C19 23-CG5809-RA_1 CG5809 ACGAATCGAAACCAACGATCATATAAACTATGTACCACAAAATGAATAAACTGTGCAACAAAACGTGTA 69 FBan0005809 FBgn0025678 CaBP1 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CaBP1 CaBP1 "CG5809, CG5809, DmCaBP1, BG:DS09218.4, AAL28897" CDMC27443 3 23 4 DAC07-G07 17-CG5848-RB_1 CG5848 CTAGACACACACGTTCTCAAAATGCATCCAGGAAATGGAACCTTATGTACTTACTGTCCCGGCACGTGG 69 FBan0005848 FBgn0000250 cact 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cellular defense response; GO:0006968; cytoplasmic sequestering of transcription factor; GO:0042994; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal/ventral axis specification; GO:0009950; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; negative regulation of protein import into nucleus; GO:0042308; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 cact cactus "CG5848, CG5848, CG5848, cac, fs(2)ltoRN48, female-sterile-(2)-ltoRN48, BG:DS02740.15, n(2)k17003, dip6, CACT, cactus" CDMC27443 3 24 4 DAC07-G07 17-CG5848-RB_1 CG5848 CTAGACACACACGTTCTCAAAATGCATCCAGGAAATGGAACCTTATGTACTTACTGTCCCGGCACGTGG 69 FBan0005848 FBgn0000250 cact 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anti-apoptosis; GO:0006916; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cellular defense response; GO:0006968; cytoplasmic sequestering of transcription factor; GO:0042994; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal/ventral axis specification; GO:0009950; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; negative regulation of protein import into nucleus; GO:0042308; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to fungi; GO:0009620 transcription factor binding; GO:0008134; ; GO:0008134; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 cact cactus "CG5848, CG5848, CG5848, cac, fs(2)ltoRN48, female-sterile-(2)-ltoRN48, BG:DS02740.15, n(2)k17003, dip6, CACT, cactus" CDMC27444 3 25 4 DAC07-G19 3-CG5855-RB_2 CG5855 CCGGACTTTATGATCCCACCACGGTCCTGAAAACCGATACTTTGTACCGGAACATGCGTGAGGGTTGGA 69 FBan0005855 FBgn0000339 cni 2 2L "ER to Golgi transport; GO:0006888; anterior/posterior pattern formation; GO:0009952; bicoid mRNA localization; GO:0045450; blastoderm segmentation; GO:0007350; dorsal appendage formation; GO:0046843; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; establishment of oocyte nucleus localization during oocyte axis determination (sensu Insecta); GO:0048126; establishment of oocyte nucleus localization during oocyte axis determination; GO:0030722; gurken receptor signaling pathway; GO:0008314; intracellular mRNA localization; GO:0008298; intracellular signaling cascade; GO:0007242; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; transport; GO:0006810" protein binding; GO:0005515; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005515 integral to plasma membrane; GO:0005887 cni cornichon "CG5855, IV: transcript group IV, BG:DS02740.13, anon-35Fe, spnG: spindle-G, spindle-G, IV" CDMC27444 3 26 4 DAC07-G19 3-CG5855-RB_2 CG5855 CCGGACTTTATGATCCCACCACGGTCCTGAAAACCGATACTTTGTACCGGAACATGCGTGAGGGTTGGA 69 FBan0005855 FBgn0000339 cni 2 2L "ER to Golgi transport; GO:0006888; anterior/posterior pattern formation; GO:0009952; bicoid mRNA localization; GO:0045450; blastoderm segmentation; GO:0007350; dorsal appendage formation; GO:0046843; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; establishment of oocyte nucleus localization during oocyte axis determination (sensu Insecta); GO:0048126; establishment of oocyte nucleus localization during oocyte axis determination; GO:0030722; gurken receptor signaling pathway; GO:0008314; intracellular mRNA localization; GO:0008298; intracellular signaling cascade; GO:0007242; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; transport; GO:0006810" protein binding; GO:0005515; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005515 integral to plasma membrane; GO:0005887 cni cornichon "CG5855, IV: transcript group IV, BG:DS02740.13, anon-35Fe, spnG: spindle-G, spindle-G, IV" CDMC27445 3 1 5 DAC07-K07 9-CG5885-RA_1 CG5885 CGAACTGAAAAATGGGATCCGGCAAACAACAGAAAGTCCAGTCCTCTGGCTTCACCAAGGAAGAGGAGC 69 FBan0005885 FBgn0025700 CG5885 2 2L cotranslational protein targeting to membrane; GO:0006613; intracellular protein transport; GO:0006886 integral to endoplasmic reticulum membrane; GO:0030176; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; translocon complex; GO:0005784 CG5885 CG5885 "CK01296, AI945207, BEST:CK01296" CDMC27445 3 2 5 DAC07-K07 9-CG5885-RA_1 CG5885 CGAACTGAAAAATGGGATCCGGCAAACAACAGAAAGTCCAGTCCTCTGGCTTCACCAAGGAAGAGGAGC 69 FBan0005885 FBgn0025700 CG5885 2 2L cotranslational protein targeting to membrane; GO:0006613; intracellular protein transport; GO:0006886 integral to endoplasmic reticulum membrane; GO:0030176; integral to membrane; GO:0016021; signal recognition particle (sensu Eukaryota); GO:0005786; translocon complex; GO:0005784 CG5885 CG5885 "CK01296, AI945207, BEST:CK01296" CDMC27446 3 3 5 DAC07-K19 3-CG5906-RA_1 CG5906 GGGCCTGGTGTGCCACTATTGGTACCAACATCTGGACTACTTGTTTCCGAAGCGCACCTATAAGGTGGT 69 FBan0005906 FBgn0036217 CG5906 3 3L development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG5906 CG5906 BcDNA:AT16953 CDMC27446 3 4 5 DAC07-K19 3-CG5906-RA_1 CG5906 GGGCCTGGTGTGCCACTATTGGTACCAACATCTGGACTACTTGTTTCCGAAGCGCACCTATAAGGTGGT 69 FBan0005906 FBgn0036217 CG5906 3 3L development; GO:0007275 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 CG5906 CG5906 BcDNA:AT16953 CDMC27447 3 5 5 DAC07-O07 2-CG5937-RA_1 CG5937 CCTCGCAGTGCAAGTTGTCAGACGACCGGAGCTACTCGTTTCTCTTGTACCCGCTTAACAATGGCTTCA 69 FBan0005937 FBgn0029834 CG5937 X X CG5937 CG5937 CDMC27447 3 6 5 DAC07-O07 2-CG5937-RA_1 CG5937 CCTCGCAGTGCAAGTTGTCAGACGACCGGAGCTACTCGTTTCTCTTGTACCCGCTTAACAATGGCTTCA 69 FBan0005937 FBgn0029834 CG5937 X X CG5937 CG5937 CDMC27448 3 7 5 DAC07-O19 3-CG5945-RA_1 CG5945 GGTGTCCGTCAAACTCAATGGCGACAAGGTGAAACTCCGTCTGGTCACCCAAATGCCCAAGTTGAACAT 69 FBan0005945 FBgn0032494 CG5945 2 2L CG5945 CG5945 CT18564 CDMC27448 3 8 5 DAC07-O19 3-CG5945-RA_1 CG5945 GGTGTCCGTCAAACTCAATGGCGACAAGGTGAAACTCCGTCTGGTCACCCAAATGCCCAAGTTGAACAT 69 FBan0005945 FBgn0032494 CG5945 2 2L CG5945 CG5945 CT18564 CDMC27449 3 9 5 DAC08-C07 18-CG8243-RA_1 CG8243 CCACCACCTCCTCAGTACCGTCAAATCTGAACCAGCAGTTTGGGAATCTTAATATCGGTAATGTGTGGC 69 FBan0008243 FBgn0033349 CG8243 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG8243 CG8243 CDMC27449 3 10 5 DAC08-C07 18-CG8243-RA_1 CG8243 CCACCACCTCCTCAGTACCGTCAAATCTGAACCAGCAGTTTGGGAATCTTAATATCGGTAATGTGTGGC 69 FBan0008243 FBgn0033349 CG8243 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG8243 CG8243 CDMC27450 3 11 5 DAC08-C19 16-CG8254-RA_1 CG8254 ACACCCTGTATTCTTGCCCCCAGTTTCATTCGCGCAATCGGTCTAAATCTTTTTTGGGTTTTTTGCACT 69 FBan0008254 FBgn0041156 exex 3 3L "axon target recognition; GO:0007412; central nervous system development; GO:0007417; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 exex extra-extra "CG8254, CG8254, CG8254, CG8254, DHB9, dHb9, HB9, Hb9, hb9, extra-extra" CDMC27450 3 12 5 DAC08-C19 16-CG8254-RA_1 CG8254 ACACCCTGTATTCTTGCCCCCAGTTTCATTCGCGCAATCGGTCTAAATCTTTTTTGGGTTTTTTGCACT 69 FBan0008254 FBgn0041156 exex 3 3L "axon target recognition; GO:0007412; central nervous system development; GO:0007417; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 exex extra-extra "CG8254, CG8254, CG8254, CG8254, DHB9, dHb9, HB9, Hb9, hb9, extra-extra" CDMC27451 3 13 5 DAC08-G07 14-CG8291-RB_1 CG8291 ACGTATTGGTCCAGGAAGATGGGCAGTCTTATCCAAATTGGAGTGCTGTTAGTCATTCCCGTGACTGCT 69 FBan0008291 FBgn0034049 CG8291 2 2R extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; neurotransmitter transporter activity; GO:0005326; ; GO:0005328; ; GO:0005326 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8291 CG8291 CDMC27451 3 14 5 DAC08-G07 14-CG8291-RB_1 CG8291 ACGTATTGGTCCAGGAAGATGGGCAGTCTTATCCAAATTGGAGTGCTGTTAGTCATTCCCGTGACTGCT 69 FBan0008291 FBgn0034049 CG8291 2 2R extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; neurotransmitter transporter activity; GO:0005326; ; GO:0005328; ; GO:0005326 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8291 CG8291 CDMC27452 3 15 5 DAC08-G19 2-CG8303-RA_2 CG8303 TGCGATTGGTCGGAGTTCATCGATCGGTGTCTGATAGGAATCCGGCGTTTCTACTTCAAGGAGTCGGCA 69 FBan0008303 FBgn0034143 CG8303 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8303 CG8303 CDMC27452 3 16 5 DAC08-G19 2-CG8303-RA_2 CG8303 TGCGATTGGTCGGAGTTCATCGATCGGTGTCTGATAGGAATCCGGCGTTTCTACTTCAAGGAGTCGGCA 69 FBan0008303 FBgn0034143 CG8303 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8303 CG8303 CDMC27453 3 17 5 DAC08-K07 3-CG8332-RB_1 CG8332 GGCATCCGTGCGGGTATCGAACAAAATGCCATACGAAACACCATTAGAAGACTTCGTTGCACGGCTGCT 69 FBan0008332 FBgn0034138 RpS15 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15 Ribosomal protein S15 "CG8332, anon-EST:Posey137, anon-EST:Posey185, Ribosomal protein S15" CDMC27453 3 18 5 DAC08-K07 3-CG8332-RB_1 CG8332 GGCATCCGTGCGGGTATCGAACAAAATGCCATACGAAACACCATTAGAAGACTTCGTTGCACGGCTGCT 69 FBan0008332 FBgn0034138 RpS15 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS15 Ribosomal protein S15 "CG8332, anon-EST:Posey137, anon-EST:Posey185, Ribosomal protein S15" CDMC27454 3 19 5 DAC08-K19 10-CG8346-RA_1 CG8346 AGCGTGGCTGTCATATAAAAGTAGGGCTGGGAACTAGTTTGCCACTCATTTCGTAAAAGTGCCGCCACT 69 FBan0008346 FBgn0002609 HLHm3 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; ; GO:0016566 nucleus; GO:0005634 HLHm3 E(spl) region transcript m3 "CG8346, m3, HLH-m3, E(spl)m3, E(spl)M3, split locus enhancer protein m3, E(Spl)-HLH-m3, HLHM3, E(spl)m3/m4" CDMC27454 3 20 5 DAC08-K19 10-CG8346-RA_1 CG8346 AGCGTGGCTGTCATATAAAAGTAGGGCTGGGAACTAGTTTGCCACTCATTTCGTAAAAGTGCCGCCACT 69 FBan0008346 FBgn0002609 HLHm3 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; ; GO:0016566 nucleus; GO:0005634 HLHm3 E(spl) region transcript m3 "CG8346, m3, HLH-m3, E(spl)m3, E(spl)M3, split locus enhancer protein m3, E(Spl)-HLH-m3, HLHM3, E(spl)m3/m4" CDMC27455 3 21 5 DAC08-O07 15-CG8396-RA_1 CG8396 GCAAGCAAGAAGGCGAAGGAATCTGATGCTCCAAATTCAGATCCAAAAGATTCGGGCGAAAATGGTGCT 69 FBan0008396 FBgn0015299 Ssb-c31a 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; ; GO:0003697; transcription coactivator activity; GO:0003713; ; GO:0003697; ; GO:0003713 transcription factor complex; GO:0005667 Ssb-c31a Single stranded-binding protein c31A "CG8396, p11, C31A" CDMC27455 3 22 5 DAC08-O07 15-CG8396-RA_1 CG8396 GCAAGCAAGAAGGCGAAGGAATCTGATGCTCCAAATTCAGATCCAAAAGATTCGGGCGAAAATGGTGCT 69 FBan0008396 FBgn0015299 Ssb-c31a 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; ; GO:0003697; transcription coactivator activity; GO:0003713; ; GO:0003697; ; GO:0003713 transcription factor complex; GO:0005667 Ssb-c31a Single stranded-binding protein c31A "CG8396, p11, C31A" CDMC27456 3 23 5 DAC08-O19 17-CG8409-RA_2 CG8409 AGTGGCCAATGAAAAAATCCCACGAATGGTAATCCACTTCTACGAAGAGCGCCTATCCTGGTACTCTGA 69 FBan0008409 FBgn0003607 Su(var)205 2 2L "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; establishment of chromatin silencing; GO:0006343; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; telomere maintenance; GO:0000723" chromatin binding; GO:0003682; mRNA binding; GO:0003729; ; GO:0003729; histone binding; GO:0042393; transcriptional repressor activity; GO:0016564; transcriptional activator activity; GO:0016563; methylated histone residue binding; GO:0035064; ; GO:0016563; ; GO:0016564; ; GO:0003682; ; GO:0042393; ; GO:0035064 "centric heterochromatin; GO:0005721; chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; heterochromatin; GO:0000792; nuclear heterochromatin; GO:0005720; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701; polytene chromosome puff; GO:0005703; polytene chromosome, telomeric region; GO:0035012" Su(var)205 Suppressor of variegation 205 "CG8409, Su(var)29A, E(var)29, HP1, Su-var(2)5, Suvar(2)5, HP-1, Su(var)2-5, heterochromatin-protein-1, Suvar2-5, Su(var)2-501, Su(var)2-05, Su(Var)2-5, su(var)205, dHP1, HP1-VS, heterochromatin protein 1, Su(var), Su(var)[205], HP1a, DmHP-1, Heterochromatin Protein 1, Hp1, HP1alpha, heterochromatin-binding protein, DmHP1, HP1A, E(var)29A, C1A9-nuclear-antigen" CDMC27456 3 24 5 DAC08-O19 17-CG8409-RA_2 CG8409 AGTGGCCAATGAAAAAATCCCACGAATGGTAATCCACTTCTACGAAGAGCGCCTATCCTGGTACTCTGA 69 FBan0008409 FBgn0003607 Su(var)205 2 2L "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; establishment of chromatin silencing; GO:0006343; negative regulation of transcription, DNA-dependent; GO:0045892; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; telomere maintenance; GO:0000723" chromatin binding; GO:0003682; mRNA binding; GO:0003729; ; GO:0003729; histone binding; GO:0042393; transcriptional repressor activity; GO:0016564; transcriptional activator activity; GO:0016563; methylated histone residue binding; GO:0035064; ; GO:0016563; ; GO:0016564; ; GO:0003682; ; GO:0042393; ; GO:0035064 "centric heterochromatin; GO:0005721; chromosome, pericentric region; GO:0000775; chromosome, telomeric region; GO:0000781; heterochromatin; GO:0000792; nuclear heterochromatin; GO:0005720; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701; polytene chromosome puff; GO:0005703; polytene chromosome, telomeric region; GO:0035012" Su(var)205 Suppressor of variegation 205 "CG8409, Su(var)29A, E(var)29, HP1, Su-var(2)5, Suvar(2)5, HP-1, Su(var)2-5, heterochromatin-protein-1, Suvar2-5, Su(var)2-501, Su(var)2-05, Su(Var)2-5, su(var)205, dHP1, HP1-VS, heterochromatin protein 1, Su(var), Su(var)[205], HP1a, DmHP-1, Heterochromatin Protein 1, Hp1, HP1alpha, heterochromatin-binding protein, DmHP1, HP1A, E(var)29A, C1A9-nuclear-antigen" CDMC27457 3 25 5 DAC09-C08 3-CG12831-RA_1 CG12831 GCGTTTTCCTGCACAATCTCTTCGAGGCGATGGTCAACGACTTTAGGTTCTTTAGCCGCCACATGAGCA 69 FBan0012831 FBgn0033141 CG12831 2 2R CG12831 CG12831 CDMC27457 3 26 5 DAC09-C08 3-CG12831-RA_1 CG12831 GCGTTTTCCTGCACAATCTCTTCGAGGCGATGGTCAACGACTTTAGGTTCTTTAGCCGCCACATGAGCA 69 FBan0012831 FBgn0033141 CG12831 2 2R CG12831 CG12831 CDMC27458 3 1 6 DAC09-C20 17-CG12843-RA_3 CG12843 GGCCGCATTCGTGAAGTATCTGGACGATAAGTTACTGGTGTTCAAAATCGTCTGCTGGTTGCTTGTCAT 69 FBan0012843 FBgn0033130 Tsp42Ei 2 2R integral to membrane; GO:0016021 Tsp42Ei Tetraspanin 42Ei "CG12843, CG12843, CG12843, Dm.Tsp42Ei, Tsp42EI, tetraspanin 42E, Tetraspanin 42Ei" CDMC27458 3 2 6 DAC09-C20 17-CG12843-RA_3 CG12843 GGCCGCATTCGTGAAGTATCTGGACGATAAGTTACTGGTGTTCAAAATCGTCTGCTGGTTGCTTGTCAT 69 FBan0012843 FBgn0033130 Tsp42Ei 2 2R integral to membrane; GO:0016021 Tsp42Ei Tetraspanin 42Ei "CG12843, CG12843, CG12843, Dm.Tsp42Ei, Tsp42EI, tetraspanin 42E, Tetraspanin 42Ei" CDMC27459 3 3 6 DAC09-G08 3-CG12877-RA_2 CG12877 AGGCTGCACCTATGCCAACTACCACGTCAGCGACTATTACGATCCGGAAAAGCTCACCTGTTTCGTGAA 69 FBan0012877 FBgn0039544 CG12877 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG12877 CG12877 BcDNA:LD30051 CDMC27459 3 4 6 DAC09-G08 3-CG12877-RA_2 CG12877 AGGCTGCACCTATGCCAACTACCACGTCAGCGACTATTACGATCCGGAAAAGCTCACCTGTTTCGTGAA 69 FBan0012877 FBgn0039544 CG12877 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 intracellular; GO:0005622 CG12877 CG12877 BcDNA:LD30051 CDMC27460 3 5 6 DAC09-G20 3-CG1288-RA_1 CG1288 GCGCAGCAGATCCCATTAGATGCCGTTCAAACTTATCGCCCTGCCATAGAACCTATATCGCTGCGCTCT 69 FBan0001288 FBgn0037484 CG1288 3 3R CG1288 CG1288 "BcDNA:AT26093, BEST:LP10010" CDMC27460 3 6 6 DAC09-G20 3-CG1288-RA_1 CG1288 GCGCAGCAGATCCCATTAGATGCCGTTCAAACTTATCGCCCTGCCATAGAACCTATATCGCTGCGCTCT 69 FBan0001288 FBgn0037484 CG1288 3 3R CG1288 CG1288 "BcDNA:AT26093, BEST:LP10010" CDMC27461 3 7 6 DAC09-K08 18-CG12932-RA_1 CG12932 CCACCATCTGCCATACTCGAAACTAGACTTAGATTACCCGAAACTGCCGCAAGAGCATAAGCGACAAGT 69 FBan0012932 FBgn0033419 CG12932 2 2R CG12932 CG12932 CDMC27461 3 8 6 DAC09-K08 18-CG12932-RA_1 CG12932 CCACCATCTGCCATACTCGAAACTAGACTTAGATTACCCGAAACTGCCGCAAGAGCATAAGCGACAAGT 69 FBan0012932 FBgn0033419 CG12932 2 2R CG12932 CG12932 CDMC27462 3 9 6 DAC09-K20 2-CG12945-RA_1 CG12945 GGTCGGACCTGGTTAACGATATCAATCAGCCCGGTGAATTGTGCCAGTGTCCTACGTGTCCAGATGTGT 69 FBan0012945 FBgn0037755 CG12945 3 3R CG12945 CG12945 CDMC27462 3 10 6 DAC09-K20 2-CG12945-RA_1 CG12945 GGTCGGACCTGGTTAACGATATCAATCAGCCCGGTGAATTGTGCCAGTGTCCTACGTGTCCAGATGTGT 69 FBan0012945 FBgn0037755 CG12945 3 3R CG12945 CG12945 CDMC27463 3 11 6 DAC09-O08 14-CG12995-RB_1 CG12995 CGCCGCGTCGGTTAAAACACTTCTACCACATCCAACCATGTTCACCTATCGCCTGAAACTGATGATCCT 69 FBan0012995 FBgn0030826 CG12995 X X CG12995 CG12995 CDMC27463 3 12 6 DAC09-O08 14-CG12995-RB_1 CG12995 CGCCGCGTCGGTTAAAACACTTCTACCACATCCAACCATGTTCACCTATCGCCTGAAACTGATGATCCT 69 FBan0012995 FBgn0030826 CG12995 X X CG12995 CG12995 CDMC27464 3 13 6 DAC09-O20 23-CG13004-RA_1 CG13004 CAAAAAAAACTGTAACAACGACATCGATAAGTGGTGTTCTGGAAACTCTGGTGTTTTCGAAAGTTCCCA 69 FBan0013004 FBgn0030797 CG13004 X X CG13004 CG13004 CDMC27464 3 14 6 DAC09-O20 23-CG13004-RA_1 CG13004 CAAAAAAAACTGTAACAACGACATCGATAAGTGGTGTTCTGGAAACTCTGGTGTTTTCGAAAGTTCCCA 69 FBan0013004 FBgn0030797 CG13004 X X CG13004 CG13004 CDMC27465 3 15 6 DAC10-C07 3-CG10959-RA_1 CG10959 GCGGAACCCATCGAGATGCTTTTCACCTACTGACCGAACTGAGTGGAAACCTCCTGTCGCCTTAAGCTC 69 FBan0010959 FBgn0030010 CG10959 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10959 CG10959 CDMC27465 3 16 6 DAC10-C07 3-CG10959-RA_1 CG10959 GCGGAACCCATCGAGATGCTTTTCACCTACTGACCGAACTGAGTGGAAACCTCCTGTCGCCTTAAGCTC 69 FBan0010959 FBgn0030010 CG10959 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10959 CG10959 CDMC27466 3 17 6 DAC10-C19 12-CG10969-RA_8 CG10969 TGCCAATGGTTTCAATCCGACGTCCCCAATTGCGGAAATATCGTGACCATATGCGATGAGGAACACCAA 69 FBan0010969 FBgn0036310 CG10969 3 3L CG10969 CG10969 CDMC27466 3 18 6 DAC10-C19 12-CG10969-RA_8 CG10969 TGCCAATGGTTTCAATCCGACGTCCCCAATTGCGGAAATATCGTGACCATATGCGATGAGGAACACCAA 69 FBan0010969 FBgn0036310 CG10969 3 3L CG10969 CG10969 CDMC27467 3 19 6 DAC10-G07 3-CG1100-RA_1 CG1100 TGACGGAAAAGCTGGTTTGTGCCGTGCTTTATTGCGTTTTAGCTCCCTTCGACAACGAACAGAGCGACA 69 FBan0001100 FBgn0028690 Rpn5 3 3R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn5 Rpn5 "CG1100, p55" CDMC27467 3 20 6 DAC10-G07 3-CG1100-RA_1 CG1100 TGACGGAAAAGCTGGTTTGTGCCGTGCTTTATTGCGTTTTAGCTCCCTTCGACAACGAACAGAGCGACA 69 FBan0001100 FBgn0028690 Rpn5 3 3R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn5 Rpn5 "CG1100, p55" CDMC27468 3 21 6 DAC10-G19 1-CG11025-RA_1 CG11025 AGCTGGCCCTTATGCTCCACGCCTGATAGCTATGCTAAAGCAACGTTTGATCAATCGCCGAAATCAGCA 69 FBan0011025 FBgn0028372 isopeptidase-T-3 2 2R ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 isopeptidase-T-3 isopeptidase-T-3 "CG11025, ISOT-3, isopeptidase T-3" CDMC27468 3 22 6 DAC10-G19 1-CG11025-RA_1 CG11025 AGCTGGCCCTTATGCTCCACGCCTGATAGCTATGCTAAAGCAACGTTTGATCAATCGCCGAAATCAGCA 69 FBan0011025 FBgn0028372 isopeptidase-T-3 2 2R ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 isopeptidase-T-3 isopeptidase-T-3 "CG11025, ISOT-3, isopeptidase T-3" CDMC27469 3 23 6 DAC10-K07 2-CG11060-RA_1 CG11060 GGCCAAGAAGCCTCGCGATAGACCCTGGGATTTAAGTATCGAGACCCTGCGTCACTTTATTGGCAAGCA 69 FBan0011060 FBgn0033149 CG11060 2 2R CG11060 CG11060 CDMC27469 3 24 6 DAC10-K07 2-CG11060-RA_1 CG11060 GGCCAAGAAGCCTCGCGATAGACCCTGGGATTTAAGTATCGAGACCCTGCGTCACTTTATTGGCAAGCA 69 FBan0011060 FBgn0033149 CG11060 2 2R CG11060 CG11060 CDMC27470 3 25 6 DAC10-K19 2-CG1106-RD_2 CG1106 ACGTTGCAAAGCCTGGTTCCGATGAGATCGTGGTCAGCACCGTTCCCTTCGATGAGAAACTTCCTCTTT 69 FBan0001106 FBgn0010225 Gel 3 3R cytoskeleton organization and biogenesis; GO:0007010; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0003779; ; GO:0005351 actin filament; GO:0005884; cytosol; GO:0005829; extracellular region; GO:0005576 Gel Gelsolin "CG1106, CG1106, CG1106, DGS, Drosophila Gelsolin, gelsolin, gel: gelded, gel" CDMC27470 3 26 6 DAC10-K19 2-CG1106-RD_2 CG1106 ACGTTGCAAAGCCTGGTTCCGATGAGATCGTGGTCAGCACCGTTCCCTTCGATGAGAAACTTCCTCTTT 69 FBan0001106 FBgn0010225 Gel 3 3R cytoskeleton organization and biogenesis; GO:0007010; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0003779; ; GO:0005351 actin filament; GO:0005884; cytosol; GO:0005829; extracellular region; GO:0005576 Gel Gelsolin "CG1106, CG1106, CG1106, DGS, Drosophila Gelsolin, gelsolin, gel: gelded, gel" CDMC27471 3 1 7 DAC10-O07 14-CG11112-RA_1 CG11112 CCCAGAACGGGGTTGCAAGAAAGGACTAAGAAAGGATTGAGTGCGGGCATTAAGAAGTGCGTCCTTATG 69 FBan0011112 FBgn0033164 CG11112 2 2R CG11112 CG11112 CT8227 CDMC27471 3 2 7 DAC10-O07 14-CG11112-RA_1 CG11112 CCCAGAACGGGGTTGCAAGAAAGGACTAAGAAAGGATTGAGTGCGGGCATTAAGAAGTGCGTCCTTATG 69 FBan0011112 FBgn0033164 CG11112 2 2R CG11112 CG11112 CT8227 CDMC27472 3 3 7 DAC10-O19 23-CG11124-RB_1 CG11124 GCTGACATGATATCAACGATTTGTAGACAAGATGATTACATTACCTGATGCGCACATCACATTAATTAT 69 FBan0011124 FBgn0033170 sPLA2 2 2R lipid catabolism; GO:0016042; phospholipid metabolism; GO:0006644 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; calcium-dependent phospholipase A2 activity; GO:0047498; ; GO:0005509; ; GO:0047498; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 sPLA2 secretory Phospholipase A2 "CG11124, CG11124, CG11124, CG11124, CG11124, sPLA[[2]], secretory phospholipase A[[2]], secretory Phospholipase A2" CDMC27472 3 4 7 DAC10-O19 23-CG11124-RB_1 CG11124 GCTGACATGATATCAACGATTTGTAGACAAGATGATTACATTACCTGATGCGCACATCACATTAATTAT 69 FBan0011124 FBgn0033170 sPLA2 2 2R lipid catabolism; GO:0016042; phospholipid metabolism; GO:0006644 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; calcium-dependent phospholipase A2 activity; GO:0047498; ; GO:0005509; ; GO:0047498; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 sPLA2 secretory Phospholipase A2 "CG11124, CG11124, CG11124, CG11124, CG11124, sPLA[[2]], secretory phospholipase A[[2]], secretory Phospholipase A2" CDMC27473 3 5 7 DAC11-C07 12-CG12194-RA_3 CG12194 TGGTGGAGAATTGGCCAAACTAAGCGATATAGTCACCTTCAAGCTGGACTTCTGGATGGTGTCCGTGGT 69 FBan0012194 FBgn0031636 CG12194 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12194 CG12194 anon-EST:Posey105 CDMC27473 3 6 7 DAC11-C07 12-CG12194-RA_3 CG12194 TGGTGGAGAATTGGCCAAACTAAGCGATATAGTCACCTTCAAGCTGGACTTCTGGATGGTGTCCGTGGT 69 FBan0012194 FBgn0031636 CG12194 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12194 CG12194 anon-EST:Posey105 CDMC27474 3 7 7 DAC11-C19 16-CG12210-RA_1 CG12210 CCTCCTAGGGAGTGAGGTAAACACATGGATACGAAATGGAAAAGGACCAAACAAACACAACTGGGACGG 69 FBan0012210 FBgn0003660 Syb 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle transport; GO:0048489; tracheal lumen formation; GO:0035149; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Syb Synaptobrevin "CG12210, CG12210, Vamp, syb, 21.15, J, Complementation group J, synaptobrevin, VAMP, c-Syb, l(2)46El, l(2)46CFq, Vesicle-associated membrane protein" CDMC27474 3 8 7 DAC11-C19 16-CG12210-RA_1 CG12210 CCTCCTAGGGAGTGAGGTAAACACATGGATACGAAATGGAAAAGGACCAAACAAACACAACTGGGACGG 69 FBan0012210 FBgn0003660 Syb 2 2R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle transport; GO:0048489; tracheal lumen formation; GO:0035149; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Syb Synaptobrevin "CG12210, CG12210, Vamp, syb, 21.15, J, Complementation group J, synaptobrevin, VAMP, c-Syb, l(2)46El, l(2)46CFq, Vesicle-associated membrane protein" CDMC27475 3 9 7 DAC11-G07 12-CG12236-RB_1 CG12236 CCCAACCAGCCCATTCCCTCGTGTTTCGATCAAAGGCCCCAAAACGAAAACTAGCCAAATTTGTCAACT 69 FBan0012236 FBgn0029822 CG12236 X X "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG12236 CG12236 CDMC27475 3 10 7 DAC11-G07 12-CG12236-RB_1 CG12236 CCCAACCAGCCCATTCCCTCGTGTTTCGATCAAAGGCCCCAAAACGAAAACTAGCCAAATTTGTCAACT 69 FBan0012236 FBgn0029822 CG12236 X X "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG12236 CG12236 CDMC27476 3 11 7 DAC11-G19 2-CG12255-RA_1 CG12255 TGCTCGCCGAGAAGAAAGTTCTGGTGATACCGAATCCAACTCCCATCGCTGTTCGTTCACAGCCGATAT 69 FBan0012255 FBgn0036618 CG12255 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12255 CG12255 CDMC27476 3 12 7 DAC11-G19 2-CG12255-RA_1 CG12255 TGCTCGCCGAGAAGAAAGTTCTGGTGATACCGAATCCAACTCCCATCGCTGTTCGTTCACAGCCGATAT 69 FBan0012255 FBgn0036618 CG12255 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12255 CG12255 CDMC27477 3 13 7 DAC11-K07 18-CG12299-RA_1 CG12299 TGGAGCCACAACGACTCCAACTATTCCACGTCGCGTATTTCCCAGAATCGCCTGAAGAGATTACATTAA 69 FBan0012299 FBgn0032295 CG12299 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12299 CG12299 CDMC27477 3 14 7 DAC11-K07 18-CG12299-RA_1 CG12299 TGGAGCCACAACGACTCCAACTATTCCACGTCGCGTATTTCCCAGAATCGCCTGAAGAGATTACATTAA 69 FBan0012299 FBgn0032295 CG12299 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12299 CG12299 CDMC27478 3 15 7 DAC11-K19 1-CG12310-RA_1 CG12310 CCAGGTTCGGAGGTCATGGTCCAGTTGTGATCAGGCGTCACCCTAGTCTTGTCTAGGTCAAAGCCCTAT 69 FBan0012310 FBgn0036467 CG12310 3 3L CG12310 CG12310 BcDNA:RE02926 CDMC27478 3 16 7 DAC11-K19 1-CG12310-RA_1 CG12310 CCAGGTTCGGAGGTCATGGTCCAGTTGTGATCAGGCGTCACCCTAGTCTTGTCTAGGTCAAAGCCCTAT 69 FBan0012310 FBgn0036467 CG12310 3 3L CG12310 CG12310 BcDNA:RE02926 CDMC27479 3 17 7 DAC11-O07 2-CG12346-RA_1 CG12346 TCGAGGCGATTCTGGTGAAAAGCGAACCCATCTCGAATAAGGACGATTGTGATGAGCCATACCCCGTGA 69 FBan0012346 FBgn0017414 cag 2 2R cag cag CG12346 CDMC27479 3 18 7 DAC11-O07 2-CG12346-RA_1 CG12346 TCGAGGCGATTCTGGTGAAAAGCGAACCCATCTCGAATAAGGACGATTGTGATGAGCCATACCCCGTGA 69 FBan0012346 FBgn0017414 cag 2 2R cag cag CG12346 CDMC27480 3 19 7 DAC11-O19 15-CG12350-RA_2 CG12350 ATCATTCATCCCAAGTATCGCACTCTGAACAACGACTACGATGCGGCAATTCTGATCCTGGATGGGGAT 69 FBan0012350 FBgn0043470 lambdaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 lambdaTry lambdaTry "CG12350, SP76, lambdaTry" CDMC27480 3 20 7 DAC11-O19 15-CG12350-RA_2 CG12350 ATCATTCATCCCAAGTATCGCACTCTGAACAACGACTACGATGCGGCAATTCTGATCCTGGATGGGGAT 69 FBan0012350 FBgn0043470 lambdaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 lambdaTry lambdaTry "CG12350, SP76, lambdaTry" CDMC27481 3 21 7 DAC12-C07 8-CG7865-RB_3 CG7865 GGCCGCACTCTGATTCCTGTGGAAGAGCTCACCGAAATGGCAAGCGAGAAACTGATAGACATCCAAGAT 69 FBan0007865 FBgn0033050 PNGase 2 2R proteolysis; GO:0006508 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; GO:0000224 ; EC:3.5.1.52; ; GO:0000224 ; EC:3.5.1.52 PNGase PNGase CG7865 CDMC27481 3 22 7 DAC12-C07 8-CG7865-RB_3 CG7865 GGCCGCACTCTGATTCCTGTGGAAGAGCTCACCGAAATGGCAAGCGAGAAACTGATAGACATCCAAGAT 69 FBan0007865 FBgn0033050 PNGase 2 2R proteolysis; GO:0006508 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; GO:0000224 ; EC:3.5.1.52; ; GO:0000224 ; EC:3.5.1.52 PNGase PNGase CG7865 CDMC27482 3 23 7 DAC12-C19 42-CG7875-RA_15 CG7875 GGGCACTGCTAATGTTCGGCTCCTATTCGGTTATCAACATCATTGTGCTTCTCAACATGCTGATTGCCA 69 FBan0007875 FBgn0003861 trp 3 3R calcium ion transport; GO:0006816; calcium-mediated signaling; GO:0019722; light-induced release of internally sequestered calcium ion; GO:0008377; phototransduction; GO:0007602; response to light stimulus; GO:0009416 calmodulin binding; GO:0005516; ; GO:0005516; calcium channel activity; GO:0005262; ; GO:0005262; light-activated voltage-gated calcium channel activity; GO:0008086; ; GO:0005262; intracellular ligand-gated calcium channel activity; GO:0005218; store-operated calcium channel activity; GO:0015279; ; GO:0015279; ; GO:0005262; ; GO:0008086; ; GO:0015279; ; GO:0005218 inaD signaling complex; GO:0016027; integral to plasma membrane; GO:0005887; light-activated voltage-gated calcium channel complex; GO:0008087; rhabdomere; GO:0016028 trp transient receptor potential "CG7875, 559, TRP, dTrp, DmTRP, dTRP, Cosens-Manning mutant" CDMC27482 3 24 7 DAC12-C19 42-CG7875-RA_15 CG7875 GGGCACTGCTAATGTTCGGCTCCTATTCGGTTATCAACATCATTGTGCTTCTCAACATGCTGATTGCCA 69 FBan0007875 FBgn0003861 trp 3 3R calcium ion transport; GO:0006816; calcium-mediated signaling; GO:0019722; light-induced release of internally sequestered calcium ion; GO:0008377; phototransduction; GO:0007602; response to light stimulus; GO:0009416 calmodulin binding; GO:0005516; ; GO:0005516; calcium channel activity; GO:0005262; ; GO:0005262; light-activated voltage-gated calcium channel activity; GO:0008086; ; GO:0005262; intracellular ligand-gated calcium channel activity; GO:0005218; store-operated calcium channel activity; GO:0015279; ; GO:0015279; ; GO:0005262; ; GO:0008086; ; GO:0015279; ; GO:0005218 inaD signaling complex; GO:0016027; integral to plasma membrane; GO:0005887; light-activated voltage-gated calcium channel complex; GO:0008087; rhabdomere; GO:0016028 trp transient receptor potential "CG7875, 559, TRP, dTrp, DmTRP, dTRP, Cosens-Manning mutant" CDMC27483 3 25 7 DAC12-G07 13-CG7910-RA_1 CG7910 GCGTTTGCTGATGGTGGAACTCTTCAACAGCATCATAGGTCACTCAATCTTCACCAAAGAGGCCATGGT 69 FBan0007910 FBgn0037547 CG7910 3 3R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG7910 CG7910 CDMC27483 3 26 7 DAC12-G07 13-CG7910-RA_1 CG7910 GCGTTTGCTGATGGTGGAACTCTTCAACAGCATCATAGGTCACTCAATCTTCACCAAAGAGGCCATGGT 69 FBan0007910 FBgn0037547 CG7910 3 3R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG7910 CG7910 CDMC27484 3 1 8 DAC12-G19 2-CG7920-RA_1 CG7920 GCCGACGGTCGTGGCGATAATGTGCCGATCTTCCTTCACGAGATCCCGAATCTGTTCTACAAGCAGATC 69 FBan0007920 FBgn0039737 CG7920 3 3R acetyl-CoA metabolism; GO:0006084 4-hydroxybutyrate CoA-transferase activity; GO:0008411; ; GO:0008411 CG7920 CG7920 "GH02390.5prime, i130, BEST:GH02390, anon-WO0153538.36, anon-WO0153538.37" CDMC27484 3 2 8 DAC12-G19 2-CG7920-RA_1 CG7920 GCCGACGGTCGTGGCGATAATGTGCCGATCTTCCTTCACGAGATCCCGAATCTGTTCTACAAGCAGATC 69 FBan0007920 FBgn0039737 CG7920 3 3R acetyl-CoA metabolism; GO:0006084 4-hydroxybutyrate CoA-transferase activity; GO:0008411; ; GO:0008411 CG7920 CG7920 "GH02390.5prime, i130, BEST:GH02390, anon-WO0153538.36, anon-WO0153538.37" CDMC27485 3 3 8 DAC12-K07 17-CG7945-RC_1 CG7945 GAGAACTCTGCTTACGTTGTAAGTGCCCGTTCAAGAAGTCCACCAAAGTGTCTACATCAGCAGTTGGGA 69 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC27485 3 4 8 DAC12-K07 17-CG7945-RC_1 CG7945 GAGAACTCTGCTTACGTTGTAAGTGCCCGTTCAAGAAGTCCACCAAAGTGTCTACATCAGCAGTTGGGA 69 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC27486 3 5 8 DAC12-K19 23-CG7959-RA_5 CG7959 CACCAGCAGTTAGAGACTCAATTCGCGAATACTCAATATTTCATGGACAACTGAGAATGCTCCGAACCC 69 FBan0007959 FBgn0013753 Bgb 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor binding; GO:0008134; ; GO:0008134; transcription coactivator activity; GO:0003713; protein heterodimerization activity; GO:0046982; ; GO:0003713; ; GO:0003713; ; GO:0046982; ; GO:0003713; ; GO:0003713 core-binding factor complex; GO:0016513; nucleus; GO:0005634 Bgb Big brother "CG7959, Big-brother, bgb, rpbeta2, runt domain partner beta2, en(lz)D/9, Big brother" CDMC27486 3 6 8 DAC12-K19 23-CG7959-RA_5 CG7959 CACCAGCAGTTAGAGACTCAATTCGCGAATACTCAATATTTCATGGACAACTGAGAATGCTCCGAACCC 69 FBan0007959 FBgn0013753 Bgb 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor binding; GO:0008134; ; GO:0008134; transcription coactivator activity; GO:0003713; protein heterodimerization activity; GO:0046982; ; GO:0003713; ; GO:0003713; ; GO:0046982; ; GO:0003713; ; GO:0003713 core-binding factor complex; GO:0016513; nucleus; GO:0005634 Bgb Big brother "CG7959, Big-brother, bgb, rpbeta2, runt domain partner beta2, en(lz)D/9, Big brother" CDMC27487 3 7 8 DAC12-O07 12-CG7996-RA_2 CG7996 CCCAGCAGGACATCAAGATCCTCATCATCGTGCTGCATCCGAAGTACAGATCCTCGGCATATTACCACG 69 FBan0007996 FBgn0003450 snk 3 3R "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 snk snake "CG7996, CG7996, c-SP26, SP26, l(3)87Dg, me(3)4" CDMC27487 3 8 8 DAC12-O07 12-CG7996-RA_2 CG7996 CCCAGCAGGACATCAAGATCCTCATCATCGTGCTGCATCCGAAGTACAGATCCTCGGCATATTACCACG 69 FBan0007996 FBgn0003450 snk 3 3R "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; protein processing; GO:0016485; proteolysis; GO:0006508" serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 snk snake "CG7996, CG7996, c-SP26, SP26, l(3)87Dg, me(3)4" CDMC27488 3 9 8 DAC12-O19 22-CG8010-RA_2 CG8010 AGGGTTCAAGTGCAAGTTCCTAGCTGTGTTGCTTCACAATCAACAAACAAAATATCGTGTGGGCTCTCA 69 FBan0008010 FBgn0031008 CG8010 X X CG8010 CG8010 CDMC27488 3 10 8 DAC12-O19 22-CG8010-RA_2 CG8010 AGGGTTCAAGTGCAAGTTCCTAGCTGTGTTGCTTCACAATCAACAAACAAAATATCGTGTGGGCTCTCA 69 FBan0008010 FBgn0031008 CG8010 X X CG8010 CG8010 CDMC27489 3 11 8 DAC13-C07 3-CG13277-RA_1 CG13277 GGAGTCGAGAGCATCGCCAATCCGTTTATAACGCAATAGTCCAAGGTTTTGTGGCTGGGATGCGTTCCA 69 FBan0013277 FBgn0032599 CG13277 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688 CG13277 CG13277 BcDNA:RH73529 CDMC27489 3 12 8 DAC13-C07 3-CG13277-RA_1 CG13277 GGAGTCGAGAGCATCGCCAATCCGTTTATAACGCAATAGTCCAAGGTTTTGTGGCTGGGATGCGTTCCA 69 FBan0013277 FBgn0032599 CG13277 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688 CG13277 CG13277 BcDNA:RH73529 CDMC27490 3 13 8 DAC13-C19 2-CG13284-RB_1 CG13284 GCGGCCATCTACCTCGTAGGACTGCTCACCATCGGTGTGTTTCTGTACGACAACCTGAAGTCATTGGTC 69 FBan0013284 FBgn0032614 CG13284 2 2L steroid metabolism; GO:0008202 steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.- CG13284 CG13284 CDMC27490 3 14 8 DAC13-C19 2-CG13284-RB_1 CG13284 GCGGCCATCTACCTCGTAGGACTGCTCACCATCGGTGTGTTTCTGTACGACAACCTGAAGTCATTGGTC 69 FBan0013284 FBgn0032614 CG13284 2 2L steroid metabolism; GO:0008202 steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.- CG13284 CG13284 CDMC27491 3 15 8 DAC13-G07 2-CG13316-RA_1 CG13316 GGCGGAGGTTCAGTGAATGGGTTCCATCAGGCCGATAAGGATCGCAATTACACTTTCCTGAGGCTCAGT 69 FBan0013316 FBgn0023215 Mnt X X regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Mnt Mnt "CG2856, CG13316, CG2856, CG2856, dMad, Mad-3E, DmMnt, dMnt, Mad, EG:114E2.2" CDMC27491 3 16 8 DAC13-G07 2-CG13316-RA_1 CG13316 GGCGGAGGTTCAGTGAATGGGTTCCATCAGGCCGATAAGGATCGCAATTACACTTTCCTGAGGCTCAGT 69 FBan0013316 FBgn0023215 Mnt X X regulation of transcription; GO:0045449 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Mnt Mnt "CG2856, CG13316, CG2856, CG2856, dMad, Mad-3E, DmMnt, dMnt, Mad, EG:114E2.2" CDMC27492 3 17 8 DAC13-G19 23-CG13321-RA_2 CG13321 GCGAGTATATAACATCACGTTCCAGACCTAAATCAACATACAAAAAAAGCACACAAATACAACATGGGA 69 FBan0013321 FBgn0033787 CG13321 2 2R CG13321 CG13321 CDMC27492 3 18 8 DAC13-G19 23-CG13321-RA_2 CG13321 GCGAGTATATAACATCACGTTCCAGACCTAAATCAACATACAAAAAAAGCACACAAATACAACATGGGA 69 FBan0013321 FBgn0033787 CG13321 2 2R CG13321 CG13321 CDMC27493 3 19 8 DAC13-K07 19-CG13348-RA_4 CG13348 TGCTAATTCCCGCCGATCATGTGAGTCGACAGAAATCCGATTGCTATTACATCAATCAGCAGCATCTGC 69 FBan0013348 FBgn0020766 Aats-phe 2 2R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 mitochondrion; GO:0005739 Aats-phe Phenylalanyl-tRNA synthetase "CG13348, Pts, FRS, PheRS, Phenylalanyl-tRNA synthetase" CDMC27493 3 20 8 DAC13-K07 19-CG13348-RA_4 CG13348 TGCTAATTCCCGCCGATCATGTGAGTCGACAGAAATCCGATTGCTATTACATCAATCAGCAGCATCTGC 69 FBan0013348 FBgn0020766 Aats-phe 2 2R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 mitochondrion; GO:0005739 Aats-phe Phenylalanyl-tRNA synthetase "CG13348, Pts, FRS, PheRS, Phenylalanyl-tRNA synthetase" CDMC27494 3 21 8 DAC13-K19 3-CG13369-RA_2 CG13369 CCCTCCTCCACCGAGGTCAAGTAATCTCGAGTGATAAGCGGCAGTGAACTCTCGTCTCTGCTTCTCCAT 69 FBan0013369 FBgn0025640 CG13369 X X D-ribose metabolism; GO:0006014; pentose-phosphate shunt; GO:0006098 ribokinase activity; GO:0004747 ; EC:2.7.1.15; ; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG13369 CG13369 EG:115C2.1 CDMC27494 3 22 8 DAC13-K19 3-CG13369-RA_2 CG13369 CCCTCCTCCACCGAGGTCAAGTAATCTCGAGTGATAAGCGGCAGTGAACTCTCGTCTCTGCTTCTCCAT 69 FBan0013369 FBgn0025640 CG13369 X X D-ribose metabolism; GO:0006014; pentose-phosphate shunt; GO:0006098 ribokinase activity; GO:0004747 ; EC:2.7.1.15; ; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG13369 CG13369 EG:115C2.1 CDMC27495 3 23 8 DAC13-O07 3-CG13409-RA_2 CG13409 GCCATTCTGCAAGCGACGTTCCTTTGTGCTCTACTCATGTTTTGGCTGTGCATCTACCATGGACTGCGA 69 FBan0013409 FBgn0038926 CG13409 3 3R CG13409 CG13409 CDMC27495 3 24 8 DAC13-O07 3-CG13409-RA_2 CG13409 GCCATTCTGCAAGCGACGTTCCTTTGTGCTCTACTCATGTTTTGGCTGTGCATCTACCATGGACTGCGA 69 FBan0013409 FBgn0038926 CG13409 3 3R CG13409 CG13409 CDMC27496 3 25 8 DAC13-O19 17-CG13420-RA_1 CG13420 TGCAATCAGCTGCACGAGAGACTACGAAACCCATTACCACAAGATGATCATCTCTGGTACGGAAAGTGT 69 FBan0013420 FBgn0038900 CG13420 3 3R CG13420 CG13420 CDMC27496 3 26 8 DAC13-O19 17-CG13420-RA_1 CG13420 TGCAATCAGCTGCACGAGAGACTACGAAACCCATTACCACAAGATGATCATCTCTGGTACGGAAAGTGT 69 FBan0013420 FBgn0038900 CG13420 3 3R CG13420 CG13420 CDMC27497 3 1 9 DAC14-C07 2-CG8671-RA_2 CG8671 GGAGCGAATGCGTTTTCAACAGCACCATCAATTGCGGAAGAACTCCAACGCATCAAACGGGTCGG 65 FBan0008671 FBgn0032938 CG8671 2 2L CG8671 CG8671 anon-WO0118547.182 CDMC27497 3 2 9 DAC14-C07 2-CG8671-RA_2 CG8671 GGAGCGAATGCGTTTTCAACAGCACCATCAATTGCGGAAGAACTCCAACGCATCAAACGGGTCGG 65 FBan0008671 FBgn0032938 CG8671 2 2L CG8671 CG8671 anon-WO0118547.182 CDMC27498 3 3 9 DAC14-C19 2-CG8721-RA_1 CG8721 AGGCCAAGAACCTCTTCAAGTTCGGCGCACTACTGGGCTATGACATGGACTTTCTGGACATTGGC 65 FBan0008721 FBgn0013307 Odc1 2 2R amino acid biosynthesis; GO:0008652; polyamine biosynthesis; GO:0006596 ornithine decarboxylase activity; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17 Odc1 Ornithine decarboxylase 1 "CG8721, dodc1, ornithine decarboxylase" CDMC27498 3 4 9 DAC14-C19 2-CG8721-RA_1 CG8721 AGGCCAAGAACCTCTTCAAGTTCGGCGCACTACTGGGCTATGACATGGACTTTCTGGACATTGGC 65 FBan0008721 FBgn0013307 Odc1 2 2R amino acid biosynthesis; GO:0008652; polyamine biosynthesis; GO:0006596 ornithine decarboxylase activity; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17 Odc1 Ornithine decarboxylase 1 "CG8721, dodc1, ornithine decarboxylase" CDMC27499 3 5 9 DAC14-G07 3-CG8837-RA_3 CG8837 GTTCACCATGACGTTCCCCTTCGTCCAAGAGAGCCCCCACTACTATCTGCGCAAGAACAACATGG 65 FBan0008837 FBgn0031520 CG8837 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG8837 CG8837 CDMC27499 3 6 9 DAC14-G07 3-CG8837-RA_3 CG8837 GTTCACCATGACGTTCCCCTTCGTCCAAGAGAGCCCCCACTACTATCTGCGCAAGAACAACATGG 65 FBan0008837 FBgn0031520 CG8837 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG8837 CG8837 CDMC27500 3 7 9 DAC14-G19 1-CG8882-RA_1 CG8882 GTTCGATTCGGAGTCCCTGATGTGCCTCAAGACCTACAAAACGGAGCGTCCAGTAAACTCGGCGG 65 FBan0008882 FBgn0015834 Trip1 2 2L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 Trip1 Trip1 "CG8882, CG8882, DmTRIP, eIF3-S2, Trip1" CDMC27500 3 8 9 DAC14-G19 1-CG8882-RA_1 CG8882 GTTCGATTCGGAGTCCCTGATGTGCCTCAAGACCTACAAAACGGAGCGTCCAGTAAACTCGGCGG 65 FBan0008882 FBgn0015834 Trip1 2 2L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 Trip1 Trip1 "CG8882, CG8882, DmTRIP, eIF3-S2, Trip1" CDMC27501 3 9 9 DAC14-K07 3-CG8981-RA_1 CG8981 AGAAACCAAAGGGCAAATCACGTACACGGATTCGCACGCTAGTCCACACCAACATGCACCAGGAG 65 FBan0008981 FBgn0033664 MCPH1 2 2R intracellular; GO:0005622 MCPH1 MCPH1 "CG8981, CG13184, CG8981, CG8981, CG8981" CDMC27501 3 10 9 DAC14-K07 3-CG8981-RA_1 CG8981 AGAAACCAAAGGGCAAATCACGTACACGGATTCGCACGCTAGTCCACACCAACATGCACCAGGAG 65 FBan0008981 FBgn0033664 MCPH1 2 2R intracellular; GO:0005622 MCPH1 MCPH1 "CG8981, CG13184, CG8981, CG8981, CG8981" CDMC27502 3 11 9 DAC14-K19 2-CG9010-RA_1 CG9010 AGTGCTCCGGTAGGTTTACCACCCTGAAAGCCTGTCAAGGTCACTTGGATAGTGGGGCCAAAAAG 65 FBan0009010 FBgn0034173 CG9010 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 CG9010 CG9010 anon-WO0140519.132 CDMC27502 3 12 9 DAC14-K19 2-CG9010-RA_1 CG9010 AGTGCTCCGGTAGGTTTACCACCCTGAAAGCCTGTCAAGGTCACTTGGATAGTGGGGCCAAAAAG 65 FBan0009010 FBgn0034173 CG9010 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 CG9010 CG9010 anon-WO0140519.132 CDMC27503 3 13 9 DAC14-O07 1-CG9101-RA_2 CG9101 GACGCCTCATAAGATCGCGCAGCTTCACCACCGATATCCAACGAATGCCAACGGAGGCCATTTAC 65 FBan0009101 FBgn0030622 CG9101 X X CG9101 CG9101 CDMC27503 3 14 9 DAC14-O07 1-CG9101-RA_2 CG9101 GACGCCTCATAAGATCGCGCAGCTTCACCACCGATATCCAACGAATGCCAACGGAGGCCATTTAC 65 FBan0009101 FBgn0030622 CG9101 X X CG9101 CG9101 CDMC27504 3 15 9 DAC14-O19 18-CG9138-RA_2 CG9138 GTGCGATGGCTTCTGCGAGAACTCTGGTGCGTGTGTCAAGGACTTGAAGGGCACACCATCTTGCC 65 FBan0009138 FBgn0031879 SP1070 2 2L cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; nervous system development; GO:0007399 Notch binding; GO:0005112; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005112; ; GO:0004872; ; GO:0005509 SP1070 SP1070 "CG9138, CT26172, poly-EGF" CDMC27504 3 16 9 DAC14-O19 18-CG9138-RA_2 CG9138 GTGCGATGGCTTCTGCGAGAACTCTGGTGCGTGTGTCAAGGACTTGAAGGGCACACCATCTTGCC 65 FBan0009138 FBgn0031879 SP1070 2 2L cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; nervous system development; GO:0007399 Notch binding; GO:0005112; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005112; ; GO:0004872; ; GO:0005509 SP1070 SP1070 "CG9138, CT26172, poly-EGF" CDMC27505 3 17 9 DAC15-C07 2-CG8386-RA_1 CG8386 ACGGCAAGACAGCGAAGATGTACCGTGGTGGCAAGATCTGTCTGACGGATCACTTTAAGCCACTGTG 67 FBan0008386 FBgn0034061 CG8386 2 2R CG8386 CG8386 CDMC27505 3 18 9 DAC15-C07 2-CG8386-RA_1 CG8386 ACGGCAAGACAGCGAAGATGTACCGTGGTGGCAAGATCTGTCTGACGGATCACTTTAAGCCACTGTG 67 FBan0008386 FBgn0034061 CG8386 2 2R CG8386 CG8386 CDMC27506 3 19 9 DAC15-C19 14-CG8519-RA_1 CG8519 TCAACTATATACGCCGTGCCAAATCCGATCTTCAGTCCGATACACCCGTCCAACTTTGTGCCAACAA 67 FBan0008519 FBgn0035711 CG8519 3 3L small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8519 CG8519 CDMC27506 3 20 9 DAC15-C19 14-CG8519-RA_1 CG8519 TCAACTATATACGCCGTGCCAAATCCGATCTTCAGTCCGATACACCCGTCCAACTTTGTGCCAACAA 67 FBan0008519 FBgn0035711 CG8519 3 3L small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG8519 CG8519 CDMC27507 3 21 9 DAC15-G07 2-CG9021-RA_1 CG9021 AGCTGCTCCATGACTATGTCTGTCGGCGACTTAAATTGGATCCCACCTACTACGCGGAGTACGTGCG 67 FBan0009021 FBgn0031747 CG9021 2 2L CG9021 CG9021 CDMC27507 3 22 9 DAC15-G07 2-CG9021-RA_1 CG9021 AGCTGCTCCATGACTATGTCTGTCGGCGACTTAAATTGGATCCCACCTACTACGCGGAGTACGTGCG 67 FBan0009021 FBgn0031747 CG9021 2 2L CG9021 CG9021 CDMC27508 3 23 9 DAC15-G19 1-CG9094-RA_1 CG9094 GGTGACCAAACGTACACATAAGGGGTAAAATGGGTACTGGGGAGGGGAAAGAGTATGGGGATGGGGC 67 FBan0009094 FBgn0035184 CG9094 3 3L CG9094 CG9094 CDMC27508 3 24 9 DAC15-G19 1-CG9094-RA_1 CG9094 GGTGACCAAACGTACACATAAGGGGTAAAATGGGTACTGGGGAGGGGAAAGAGTATGGGGATGGGGC 67 FBan0009094 FBgn0035184 CG9094 3 3L CG9094 CG9094 CDMC27509 3 25 9 DAC15-K07 2-CG9446-RA_1 CG9446 TGCGCACCATACAAGACGAGATCCGCAAACTTAAGGCGATCATCGTCAAGCAAGAGAACCGCATCCG 67 FBan0009446 FBgn0033109 coro 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; catalytic activity; GO:0003824; ; GO:0005200; ; GO:0003824; ; GO:0003779 actin cytoskeleton; GO:0015629 coro coro "CG9446, CG9446, coronin" CDMC27509 3 26 9 DAC15-K07 2-CG9446-RA_1 CG9446 TGCGCACCATACAAGACGAGATCCGCAAACTTAAGGCGATCATCGTCAAGCAAGAGAACCGCATCCG 67 FBan0009446 FBgn0033109 coro 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; catalytic activity; GO:0003824; ; GO:0005200; ; GO:0003824; ; GO:0003779 actin cytoskeleton; GO:0015629 coro coro "CG9446, CG9446, coronin" CDMC27510 3 1 10 DAC15-K19 3-CG9486-RA_3 CG9486 GTGGATTTCCCGTCGTCACATCTACCTGCAGCAACCAGAACTCCAAACGCCTTATGACCGCCCTAAA 67 FBan0009486 FBgn0031791 CG9486 2 2L N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG9486 CG9486 CDMC27510 3 2 10 DAC15-K19 3-CG9486-RA_3 CG9486 GTGGATTTCCCGTCGTCACATCTACCTGCAGCAACCAGAACTCCAAACGCCTTATGACCGCCCTAAA 67 FBan0009486 FBgn0031791 CG9486 2 2L N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG9486 CG9486 CDMC27511 3 3 10 DAC15-O07 23-CG9978-RA_7 CG9978 GAAACCCGTACAACTTGACCGTTGACATGACTCCCTTCATTAAGATCAACGAAAGCTACTATGTTTT 67 FBgn0032778 CDMC27511 3 4 10 DAC15-O07 23-CG9978-RA_7 CG9978 GAAACCCGTACAACTTGACCGTTGACATGACTCCCTTCATTAAGATCAACGAAAGCTACTATGTTTT 67 FBgn0032778 CDMC27512 3 5 10 DAC15-O19 AutoBlank AutoBlank CDMC27512 3 6 10 DAC15-O19 AutoBlank AutoBlank CDMC27513 3 7 10 DAC16-C07 23-CG4898-RB_7 CG4898 AGTAGCCTGCACTTTTGATTTGTGTGTTCGTAGATGGATAGTTTGTAGATTGATTTTGATCGCGGACCA 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC27513 3 8 10 DAC16-C07 23-CG4898-RB_7 CG4898 AGTAGCCTGCACTTTTGATTTGTGTGTTCGTAGATGGATAGTTTGTAGATTGATTTTGATCGCGGACCA 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC27514 3 9 10 DAC16-C19 3-CG4901-RA_1 CG4901 TCGAGCGTTCTGCACGGAAAGTACAAGCCGAGCTACATACTCTTCACCGAAATTGTGCAGACGGAGCAA 69 FBan0004901 FBgn0032194 CG4901 2 2L U2-type spliceosome disassembly; GO:0000391 "ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG4901 CG4901 cg4901 CDMC27514 3 10 10 DAC16-C19 3-CG4901-RA_1 CG4901 TCGAGCGTTCTGCACGGAAAGTACAAGCCGAGCTACATACTCTTCACCGAAATTGTGCAGACGGAGCAA 69 FBan0004901 FBgn0032194 CG4901 2 2L U2-type spliceosome disassembly; GO:0000391 "ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG4901 CG4901 cg4901 CDMC27515 3 11 10 DAC16-G07 9-CG4937-RA_2 CG4937 CCCACCCATCAGTTGACCCTGTACGAGGTTATCCTGAACGACAGCTTAGAGCGTCCTCTTCACCATGAC 69 FBan0004937 FBgn0030808 RhoGAP15B X X small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP15B RhoGAP15B "CG4937, CG4937, CG4937" CDMC27515 3 12 10 DAC16-G07 9-CG4937-RA_2 CG4937 CCCACCCATCAGTTGACCCTGTACGAGGTTATCCTGAACGACAGCTTAGAGCGTCCTCTTCACCATGAC 69 FBan0004937 FBgn0030808 RhoGAP15B X X small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP15B RhoGAP15B "CG4937, CG4937, CG4937" CDMC27516 3 13 10 DAC16-G19 23-CG4946-RA_3 CG4946 ACGTGAATGCCTGCTACAAACATTTTTACTACTTTGTGCAAGAATTTGACATGATTTCGGCCAAGGAAT 69 FBan0004946 FBgn0032203 CG4946 2 2L cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 CG4946 CG4946 CDMC27516 3 14 10 DAC16-G19 23-CG4946-RA_3 CG4946 ACGTGAATGCCTGCTACAAACATTTTTACTACTTTGTGCAAGAATTTGACATGATTTCGGCCAAGGAAT 69 FBan0004946 FBgn0032203 CG4946 2 2L cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 CG4946 CG4946 CDMC27517 3 15 10 DAC16-K07 8-CG4976-RA_1 CG4976 GCCGTTCGTATCCATGTGAAGCCTAAGAAGACTCCCAAGGTGAAACACATAAGTGCGGACGATGAGCCA 69 FBan0004976 FBgn0039559 Mes-4 3 3R gene silencing; GO:0016458; germ-line sex determination; GO:0018992; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003712; ; GO:0042054; ; GO:0008270; ; GO:0003677 nuclear chromosome; GO:0000228; ubiquitin ligase complex; GO:0000151 Mes-4 Mes-4 "CG4976, CG4976, CG4976, CG4976, CG4976, dMes-4, dMES-4" CDMC27517 3 16 10 DAC16-K07 8-CG4976-RA_1 CG4976 GCCGTTCGTATCCATGTGAAGCCTAAGAAGACTCCCAAGGTGAAACACATAAGTGCGGACGATGAGCCA 69 FBan0004976 FBgn0039559 Mes-4 3 3R gene silencing; GO:0016458; germ-line sex determination; GO:0018992; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0008134; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003712; ; GO:0042054; ; GO:0008270; ; GO:0003677 nuclear chromosome; GO:0000228; ubiquitin ligase complex; GO:0000151 Mes-4 Mes-4 "CG4976, CG4976, CG4976, CG4976, CG4976, dMes-4, dMES-4" CDMC27518 3 17 10 DAC16-K19 6-CG4986-RA_2 CG4986 GGAACGCACTTTTTGATCCTGCTTCTGTTGTGTGGAGTCCTGGGATCTAACGGTGTGACGCCCGACATT 69 FBan0004986 FBgn0011670 Mst57Dc 3 3R oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Dc Male-specific RNA 57Dc "CG4986, mst-1, Acp57Dc, Mst57dc for male accessory gland protein, male-specific RNA 57dc, male specific transcript 57D, mst(2)ag-1" CDMC27518 3 18 10 DAC16-K19 6-CG4986-RA_2 CG4986 GGAACGCACTTTTTGATCCTGCTTCTGTTGTGTGGAGTCCTGGGATCTAACGGTGTGACGCCCGACATT 69 FBan0004986 FBgn0011670 Mst57Dc 3 3R oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Dc Male-specific RNA 57Dc "CG4986, mst-1, Acp57Dc, Mst57dc for male accessory gland protein, male-specific RNA 57dc, male specific transcript 57D, mst(2)ag-1" CDMC27519 3 19 10 DAC16-O07 18-CG5018-RA_2 CG5018 ACATTTGTCGCAGCATGCTCCCTTTCTGAAAGGTTCCGTAGCTTCCATGGCAATCAGTAAAAAGCTTTT 69 FBan0005018 FBgn0036578 CG5018 3 3L CG5018 CG5018 CDMC27519 3 20 10 DAC16-O07 18-CG5018-RA_2 CG5018 ACATTTGTCGCAGCATGCTCCCTTTCTGAAAGGTTCCGTAGCTTCCATGGCAATCAGTAAAAAGCTTTT 69 FBan0005018 FBgn0036578 CG5018 3 3L CG5018 CG5018 CDMC27520 3 21 10 DAC16-O19 13-CG5029-RA_1 CG5029 TGGACTCAATTTTTCCCAACGGAAGATCCTATTGTCTGGGCTCCATGAACCTGGAGTGTTGGTACCTCT 69 FBan0005029 FBgn0019932 SamDC 2 2L spermidine biosynthesis; GO:0008295; spermine biosynthesis; GO:0006597 adenosylmethionine decarboxylase activity; GO:0004014 ; EC:4.1.1.50; ; GO:0004014 ; EC:4.1.1.50; ; GO:0004014 ; EC:4.1.1.50 SamDC S-adenosylmethionine decarboxylase "CG5029, CG5029, l(2)31Dc, l(2)31Dd, l(2)31De, S-adenosylmethionine decarboxylase" CDMC27520 3 22 10 DAC16-O19 13-CG5029-RA_1 CG5029 TGGACTCAATTTTTCCCAACGGAAGATCCTATTGTCTGGGCTCCATGAACCTGGAGTGTTGGTACCTCT 69 FBan0005029 FBgn0019932 SamDC 2 2L spermidine biosynthesis; GO:0008295; spermine biosynthesis; GO:0006597 adenosylmethionine decarboxylase activity; GO:0004014 ; EC:4.1.1.50; ; GO:0004014 ; EC:4.1.1.50; ; GO:0004014 ; EC:4.1.1.50 SamDC S-adenosylmethionine decarboxylase "CG5029, CG5029, l(2)31Dc, l(2)31Dd, l(2)31De, S-adenosylmethionine decarboxylase" CDMC27521 3 23 10 DAC17-C07 12-CG7106-RA_1 CG7106 TCGCAATAGTTATAAATGCATCACCTTCAGGATGCGAGGAGACAGATCGTGTCGAAGCCTCGAAGCGCT 69 FBan0007106 FBgn0040099 lectin-28C 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-28C lectin-28C "CG7106, CG7106, CG7106, AC 004723A, AC004723a, Lectin28C" CDMC27521 3 24 10 DAC17-C07 12-CG7106-RA_1 CG7106 TCGCAATAGTTATAAATGCATCACCTTCAGGATGCGAGGAGACAGATCGTGTCGAAGCCTCGAAGCGCT 69 FBan0007106 FBgn0040099 lectin-28C 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-28C lectin-28C "CG7106, CG7106, CG7106, AC 004723A, AC004723a, Lectin28C" CDMC27522 3 25 10 DAC17-C19 2-CG7120-RA_1 CG7120 GCACAGCCACAGTGACATTTCGCAGACCAGCAGTATGGACAGCTATATGGAGGAGTATCTGCGGAAGCT 69 FBan0007120 FBgn0035888 CG7120 3 3L CG7120 CG7120 BcDNA:AT15424 CDMC27522 3 26 10 DAC17-C19 2-CG7120-RA_1 CG7120 GCACAGCCACAGTGACATTTCGCAGACCAGCAGTATGGACAGCTATATGGAGGAGTATCTGCGGAAGCT 69 FBan0007120 FBgn0035888 CG7120 3 3L CG7120 CG7120 BcDNA:AT15424 CDMC27523 3 1 11 DAC17-G07 17-CG7161-RA_1 CG7161 CAAGTGCTGCAAAAAGGTCACTGTCCCTTTTGTCACACATCCTCCGAAAAGCTGATGGAAGACTTTTGA 69 FBan0007161 FBgn0035891 Oseg1 3 3L sensory cilium biogenesis; GO:0035058 Oseg1 Oseg1 "CG7161, CG7161, OSEG1" CDMC27523 3 2 11 DAC17-G07 17-CG7161-RA_1 CG7161 CAAGTGCTGCAAAAAGGTCACTGTCCCTTTTGTCACACATCCTCCGAAAAGCTGATGGAAGACTTTTGA 69 FBan0007161 FBgn0035891 Oseg1 3 3L sensory cilium biogenesis; GO:0035058 Oseg1 Oseg1 "CG7161, CG7161, OSEG1" CDMC27524 3 3 11 DAC17-G19 6-CG7171-RA_1 CG7171 TGGACAAGCCACATGGCACCATCTATGCCCAATTGGCCCGGAAGAACATCAATAGTCACCTGTAGATCG 69 FBan0007171 FBgn0003961 Uro 2 2L allantoin biosynthesis; GO:0019428; purine base metabolism; GO:0006144 urate oxidase activity; GO:0004846 ; EC:1.7.3.3; ; GO:0004846 ; EC:1.7.3.3; ; GO:0004846 ; EC:1.7.3.3 peroxisome; GO:0005777 Uro Urate oxidase "CG7171, OU, UO, Dm UO, uro, UOX, anon-WO0140519.210, Uo" CDMC27524 3 4 11 DAC17-G19 6-CG7171-RA_1 CG7171 TGGACAAGCCACATGGCACCATCTATGCCCAATTGGCCCGGAAGAACATCAATAGTCACCTGTAGATCG 69 FBan0007171 FBgn0003961 Uro 2 2L allantoin biosynthesis; GO:0019428; purine base metabolism; GO:0006144 urate oxidase activity; GO:0004846 ; EC:1.7.3.3; ; GO:0004846 ; EC:1.7.3.3; ; GO:0004846 ; EC:1.7.3.3 peroxisome; GO:0005777 Uro Urate oxidase "CG7171, OU, UO, Dm UO, uro, UOX, anon-WO0140519.210, Uo" CDMC27525 3 5 11 DAC17-K07 13-CG7201-RA_1 CG7201 CCAACTCCCATGCGAACCCCTATTGTTGACCTCGTCTAGATGTTAGGATTACGATTGAGTTGAGCGCGT 69 FBan0007201 FBgn0035865 CG7201 3 3L CG7201 CG7201 CDMC27525 3 6 11 DAC17-K07 13-CG7201-RA_1 CG7201 CCAACTCCCATGCGAACCCCTATTGTTGACCTCGTCTAGATGTTAGGATTACGATTGAGTTGAGCGCGT 69 FBan0007201 FBgn0035865 CG7201 3 3L CG7201 CG7201 CDMC27526 3 7 11 DAC17-K19 18-CG7219-RA_11 CG7219 CCAGGATGATTCTGGCCAACGCATTGTACTTTAAGGCATTCTGGGAAACGGACTTTATAGAGTCAGCCA 69 FBan0007219 FBgn0031973 CG7219 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG7219 CG7219 CDMC27526 3 8 11 DAC17-K19 18-CG7219-RA_11 CG7219 CCAGGATGATTCTGGCCAACGCATTGTACTTTAAGGCATTCTGGGAAACGGACTTTATAGAGTCAGCCA 69 FBan0007219 FBgn0031973 CG7219 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG7219 CG7219 CDMC27527 3 9 11 DAC17-O07 5-CG7263-RB_1 CG7263 GCTCCCTGGCACACTATTCCAGAGAGAACAATGGCGGTAAAGTGTACCAGGTGTTCCAGGAAAATGCCA 69 FBan0007263 FBgn0031392 CG7263 2 2L DNA fragmentation during apoptosis; GO:0006309; defense response; GO:0006952; ferredoxin metabolism; GO:0006124; induction of apoptosis; GO:0006917; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 mitochondrial intermembrane space; GO:0005758; nucleus; GO:0005634 CG7263 CG7263 CDMC27527 3 10 11 DAC17-O07 5-CG7263-RB_1 CG7263 GCTCCCTGGCACACTATTCCAGAGAGAACAATGGCGGTAAAGTGTACCAGGTGTTCCAGGAAAATGCCA 69 FBan0007263 FBgn0031392 CG7263 2 2L DNA fragmentation during apoptosis; GO:0006309; defense response; GO:0006952; ferredoxin metabolism; GO:0006124; induction of apoptosis; GO:0006917; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 mitochondrial intermembrane space; GO:0005758; nucleus; GO:0005634 CG7263 CG7263 CDMC27528 3 11 11 DAC17-O19 17-CG7272-RA_2 CG7272 CCTCCCGTTCCCACATAACCCGTTTGAAAGGCATCAACTGAGAGTCATTGAAATCATGGAGGCACTGGG 69 FBan0007272 FBgn0036501 CG7272 3 3L CG7272 CG7272 CDMC27528 3 12 11 DAC17-O19 17-CG7272-RA_2 CG7272 CCTCCCGTTCCCACATAACCCGTTTGAAAGGCATCAACTGAGAGTCATTGAAATCATGGAGGCACTGGG 69 FBan0007272 FBgn0036501 CG7272 3 3L CG7272 CG7272 CDMC27529 3 13 11 DAC18-C07 23-CG3240-RA_2 CG3240 ATAGCCAGGAGGAGATATTCATTCAGTTCTTCATAATTCCTTTGCTCAACACTGATTAAACCGAAACTA 69 FBan0003240 FBgn0026778 Rad1 2 2L DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 damaged DNA binding; GO:0003684; ; GO:0003684; exonuclease activity; GO:0004527; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004527 nucleus; GO:0005634 Rad1 Rad1 "CG3240, Rad1[Dm]" CDMC27529 3 14 11 DAC18-C07 23-CG3240-RA_2 CG3240 ATAGCCAGGAGGAGATATTCATTCAGTTCTTCATAATTCCTTTGCTCAACACTGATTAAACCGAAACTA 69 FBan0003240 FBgn0026778 Rad1 2 2L DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074 damaged DNA binding; GO:0003684; ; GO:0003684; exonuclease activity; GO:0004527; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004527 nucleus; GO:0005634 Rad1 Rad1 "CG3240, Rad1[Dm]" CDMC27530 3 15 11 DAC18-C19 23-CG3241-RA_19 CG3241 TCGGATGACTTGTAAGCAAGACGACTCATCCCTATATGTTTGTTTTTTTATGTGCTCAGTGATGTCCAG 69 FBan0003241 FBgn0005616 msl-2 2 2L "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047; protein ubiquitination; GO:0016567" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003682; ; GO:0003677; protein binding; GO:0005515; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 X chromosome; GO:0000805; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 msl-2 male-specific lethal 2 "CG3241, msl, km(2)A, msl2, MSL-2, MSL2, MSL, Msl2, male specifc lethal, kmA: killer of males, killer-of-males-A, male-specific lethal 2" CDMC27530 3 16 11 DAC18-C19 23-CG3241-RA_19 CG3241 TCGGATGACTTGTAAGCAAGACGACTCATCCCTATATGTTTGTTTTTTTATGTGCTCAGTGATGTCCAG 69 FBan0003241 FBgn0005616 msl-2 2 2L "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047; protein ubiquitination; GO:0016567" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003682; ; GO:0003677; protein binding; GO:0005515; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 X chromosome; GO:0000805; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 msl-2 male-specific lethal 2 "CG3241, msl, km(2)A, msl2, MSL-2, MSL2, MSL, Msl2, male specifc lethal, kmA: killer of males, killer-of-males-A, male-specific lethal 2" CDMC27531 3 17 11 DAC18-G07 3-CG32454-RA_2 CG32454 TCGCCCGAGCTATGGCACTTCTACGACCCATCGAGTCCTGTCAGTTGTATAGTGCAAGAGGTGGCTAAT 69 FBan0032454 FBgn0052454 CG32454 3 3L proteolysis; GO:0006508 metalloexopeptidase activity; GO:0008235; ; GO:0008235 CG32454 CG32454 CG11367 CDMC27531 3 18 11 DAC18-G07 3-CG32454-RA_2 CG32454 TCGCCCGAGCTATGGCACTTCTACGACCCATCGAGTCCTGTCAGTTGTATAGTGCAAGAGGTGGCTAAT 69 FBan0032454 FBgn0052454 CG32454 3 3L proteolysis; GO:0006508 metalloexopeptidase activity; GO:0008235; ; GO:0008235 CG32454 CG32454 CG11367 CDMC27532 3 19 11 DAC18-G19 9-CG32465-RB_1 CG32465 GGCTTTGCGGCGTACTCCACAGCTTTGAGTGTGACCATCGCAATAGGATGTTCGCTTTTGATCCTGAAT 69 FBan0032465 FBgn0052465 CG32465 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG32465 CG32465 "CG18291, CG1062, CG18291" CDMC27532 3 20 11 DAC18-G19 9-CG32465-RB_1 CG32465 GGCTTTGCGGCGTACTCCACAGCTTTGAGTGTGACCATCGCAATAGGATGTTCGCTTTTGATCCTGAAT 69 FBan0032465 FBgn0052465 CG32465 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG32465 CG32465 "CG18291, CG1062, CG18291" CDMC27533 3 21 11 DAC18-K07 23-CG32491-RJ_1 CG32491 CCGAAAACTTAAGATCGGAGAGTTCTCCTTCACTCGAAACAAGACCTCGGGATTGAAAACTTATTGGTC 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC27533 3 22 11 DAC18-K07 23-CG32491-RJ_1 CG32491 CCGAAAACTTAAGATCGGAGAGTTCTCCTTCACTCGAAACAAGACCTCGGGATTGAAAACTTATTGGTC 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC27534 3 23 11 DAC18-K19 23-CG32491-RV_1 CG32491 AGAGCCGAACAGTTTTGATGAATTTAAAAAGGCTAAGCACAACCACTAGCCAATAAATACAATTTTTAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC27534 3 24 11 DAC18-K19 23-CG32491-RV_1 CG32491 AGAGCCGAACAGTTTTGATGAATTTAAAAAGGCTAAGCACAACCACTAGCCAATAAATACAATTTTTAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC27535 3 25 11 DAC18-O07 24-CG32530-RA_1 CG32530 TGAAAGCCTTTAAATCATTGGATTGGTAGTTATCTGTATACGCAATGTGGTACAATAATTTTTAAGCGG 69 FBgn0052530 CDMC27535 3 26 11 DAC18-O07 24-CG32530-RA_1 CG32530 TGAAAGCCTTTAAATCATTGGATTGGTAGTTATCTGTATACGCAATGTGGTACAATAATTTTTAAGCGG 69 FBgn0052530 CDMC27536 3 1 12 DAC18-O19 3-CG3254-RB_3 CG3254 GCACTGGGAACGCAGAGATGGTCCTTCGGGAAGTATGCGTGAGGAAGAGGACTTGGTTTCGAGTAAACT 69 FBan0003254 FBgn0031530 pgant2 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant2 polypeptide GalNAc transferase 2 "CG3254, CG3254, CG3254, CG3254, polypeptide GalNAc transferase 2" CDMC27536 3 2 12 DAC18-O19 3-CG3254-RB_3 CG3254 GCACTGGGAACGCAGAGATGGTCCTTCGGGAAGTATGCGTGAGGAAGAGGACTTGGTTTCGAGTAAACT 69 FBan0003254 FBgn0031530 pgant2 2 2L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant2 polypeptide GalNAc transferase 2 "CG3254, CG3254, CG3254, CG3254, polypeptide GalNAc transferase 2" CDMC27537 3 3 12 DAC19-C07 23-CG8193-RA_1 CG8193 CAACTCTTAGCAATCTATTGCATCTTTATTGAGCCGCTTAATAAACAAGACATCATGGCATTCCA 65 FBan0008193 FBgn0033367 CG8193 2 2R defense response; GO:0006952; metabolism; GO:0008152; transport; GO:0006810 monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 CG8193 CG8193 CDMC27537 3 4 12 DAC19-C07 23-CG8193-RA_1 CG8193 CAACTCTTAGCAATCTATTGCATCTTTATTGAGCCGCTTAATAAACAAGACATCATGGCATTCCA 65 FBan0008193 FBgn0033367 CG8193 2 2R defense response; GO:0006952; metabolism; GO:0008152; transport; GO:0006810 monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 CG8193 CG8193 CDMC27538 3 5 12 DAC19-C19 9-CG8214-RA_1 CG8214 AGCCACCCTGCATCGATACAACGACCAATTCGCCAAGGAGAATGACCAACTACGCAAGGACAGCG 65 FBan0008214 FBgn0034037 CG8214 2 2R CG8214 CG8214 CDMC27538 3 6 12 DAC19-C19 9-CG8214-RA_1 CG8214 AGCCACCCTGCATCGATACAACGACCAATTCGCCAAGGAGAATGACCAACTACGCAAGGACAGCG 65 FBan0008214 FBgn0034037 CG8214 2 2R CG8214 CG8214 CDMC27539 3 7 12 DAC19-G07 6-CG8289-RA_1 CG8289 AAGACAGCGATTGCCAGACCTCTACCTCCAACGTGGATGTACCAGCTGCAAGGAACAAGCGCAAG 65 FBan0008289 FBgn0030854 CG8289 X X CG8289 CG8289 CDMC27539 3 8 12 DAC19-G07 6-CG8289-RA_1 CG8289 AAGACAGCGATTGCCAGACCTCTACCTCCAACGTGGATGTACCAGCTGCAAGGAACAAGCGCAAG 65 FBan0008289 FBgn0030854 CG8289 X X CG8289 CG8289 CDMC27540 3 9 12 DAC19-G19 1-CG8320-RA_2 CG8320 ATAGCTGACACACAACTTGCAATCCCACCATGGCTCCCCAGCAAAAGGGTAAACAAGGCACGAAG 65 FBan0008320 FBgn0034059 CG8320 2 2R CG8320 CG8320 CDMC27540 3 10 12 DAC19-G19 1-CG8320-RA_2 CG8320 ATAGCTGACACACAACTTGCAATCCCACCATGGCTCCCCAGCAAAAGGGTAAACAAGGCACGAAG 65 FBan0008320 FBgn0034059 CG8320 2 2R CG8320 CG8320 CDMC27541 3 11 12 DAC19-K07 17-CG8401-RA_4 CG8401 CTGCACAGGATGGAACACATCAGAAGGGGATCGGGTCTGGTTTCCAGGGAGCATGGTGTCCAGGG 65 FBan0008401 FBgn0034069 CG8401 2 2R CG8401 CG8401 CDMC27541 3 12 12 DAC19-K07 17-CG8401-RA_4 CG8401 CTGCACAGGATGGAACACATCAGAAGGGGATCGGGTCTGGTTTCCAGGGAGCATGGTGTCCAGGG 65 FBan0008401 FBgn0034069 CG8401 2 2R CG8401 CG8401 CDMC27542 3 13 12 DAC19-K19 15-CG8428-RB_3 CG8428 GCTCAGTTGGGCGGACAAGTTCCCGATGTTCATGTTCCTATTGGAAGGGATCGGAGGAAGGAGGA 65 FBan0008428 FBgn0004571 spin 2 2R central nervous system remodeling (sensu Insecta); GO:0035193; courtship behavior; GO:0007619; programmed cell death; GO:0012501; regulation of female receptivity; GO:0045924; regulation of nurse cell apoptosis; GO:0045477; regulation of programmed cell death; GO:0043067; regulation of synaptic growth at neuromuscular junction; GO:0008582; tetracycline transport; GO:0015904; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520 integral to membrane; GO:0016021; plasma membrane; GO:0005886 spin spinster "CG8428, CG8428, l(2)10403, l(2)k09905, Spin, diphthong, spinster" CDMC27542 3 14 12 DAC19-K19 15-CG8428-RB_3 CG8428 GCTCAGTTGGGCGGACAAGTTCCCGATGTTCATGTTCCTATTGGAAGGGATCGGAGGAAGGAGGA 65 FBan0008428 FBgn0004571 spin 2 2R central nervous system remodeling (sensu Insecta); GO:0035193; courtship behavior; GO:0007619; programmed cell death; GO:0012501; regulation of female receptivity; GO:0045924; regulation of nurse cell apoptosis; GO:0045477; regulation of programmed cell death; GO:0043067; regulation of synaptic growth at neuromuscular junction; GO:0008582; tetracycline transport; GO:0015904; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520 integral to membrane; GO:0016021; plasma membrane; GO:0005886 spin spinster "CG8428, CG8428, l(2)10403, l(2)k09905, Spin, diphthong, spinster" CDMC27543 3 15 12 DAC19-O07 3-CG8524-RA_3 CG8524 TCGATCAGCCGCTAAATCTGTGTGTGGTCAAAAAGTCTCGCGACAGCAACAACTCACCCATGCCG 65 FBan0008524 FBgn0024321 NK7.1 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 NK7.1 NK7.1 CG8524 CDMC27543 3 16 12 DAC19-O07 3-CG8524-RA_3 CG8524 TCGATCAGCCGCTAAATCTGTGTGTGGTCAAAAAGTCTCGCGACAGCAACAACTCACCCATGCCG 65 FBan0008524 FBgn0024321 NK7.1 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 NK7.1 NK7.1 CG8524 CDMC27544 3 17 12 DAC19-O19 6-CG8567-RA_4 CG8567 GCGTGGTGGACGAGAACAACATGTTCCTGTCGGAAGAGAACATCACGTCCAAGGATGAGCCGTGG 65 FBan0008567 FBgn0013799 Deaf1 3 3L cell cycle; GO:0007049; embryonic development (sensu Metazoa); GO:0009792; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634; polytene chromosome; GO:0005700 Deaf1 Deformed epidermal autoregulatory factor-1 "CG8567, DEAF-1, Deaf-1, deaf-1, Deformed epidermal autoregulatory factor-1" CDMC27544 3 18 12 DAC19-O19 6-CG8567-RA_4 CG8567 GCGTGGTGGACGAGAACAACATGTTCCTGTCGGAAGAGAACATCACGTCCAAGGATGAGCCGTGG 65 FBan0008567 FBgn0013799 Deaf1 3 3L cell cycle; GO:0007049; embryonic development (sensu Metazoa); GO:0009792; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634; polytene chromosome; GO:0005700 Deaf1 Deformed epidermal autoregulatory factor-1 "CG8567, DEAF-1, Deaf-1, deaf-1, Deformed epidermal autoregulatory factor-1" CDMC27545 3 19 12 DAC20-C07 23-CG7675-RB_1 CG7675 ACGCACAATTTACTGATTTACTTTTCTTGTTTTTAAGGGGGAGTTTACTGTAGCCTAAGTTTTCTCAAT 69 FBan0007675 FBgn0038610 CG7675 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7675 CG7675 CDMC27545 3 20 12 DAC20-C07 23-CG7675-RB_1 CG7675 ACGCACAATTTACTGATTTACTTTTCTTGTTTTTAAGGGGGAGTTTACTGTAGCCTAAGTTTTCTCAAT 69 FBan0007675 FBgn0038610 CG7675 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG7675 CG7675 CDMC27546 3 21 12 DAC20-C19 12-CG7695-RA_2 CG7695 ACCAAGGAATGCCCGGATATCTATGACCCAGTCTGTGCGCAGATCTTCCAGGAGGAGTACTTGACATTT 69 FBan0007695 FBgn0038631 CG7695 3 3R CG7695 CG7695 CDMC27546 3 22 12 DAC20-C19 12-CG7695-RA_2 CG7695 ACCAAGGAATGCCCGGATATCTATGACCCAGTCTGTGCGCAGATCTTCCAGGAGGAGTACTTGACATTT 69 FBan0007695 FBgn0038631 CG7695 3 3R CG7695 CG7695 CDMC27547 3 23 12 DAC20-G07 22-CG7734-RD_2 CG7734 AGATCCGAGAGCGAGAGAAGTGTGTTATTTTTAAGGCCTAGCCCCGAAAATGAACCTCCAAACCGAACC 69 FBan0007734 FBgn0003396 shn 2 2R cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; ectoderm development; GO:0007398; learning and/or memory; GO:0007611; midgut development; GO:0007494; negative regulation of cell proliferation; GO:0008285; negative regulation of salivary gland determination; GO:0045705; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; olfactory learning; GO:0008355; peripheral nervous system development; GO:0007422; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; ; GO:0008270; ; GO:0005351 nucleus; GO:0005634 shn schnurri "CG7734, CG7734, CG7734, CG7734, quo: quo vadis, l(2)04738, EP2359, EP(2)2359, SD06302, Shn, BEST:SD06302, quo vadis, quo" CDMC27547 3 24 12 DAC20-G07 22-CG7734-RD_2 CG7734 AGATCCGAGAGCGAGAGAAGTGTGTTATTTTTAAGGCCTAGCCCCGAAAATGAACCTCCAAACCGAACC 69 FBan0007734 FBgn0003396 shn 2 2R cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; ectoderm development; GO:0007398; learning and/or memory; GO:0007611; midgut development; GO:0007494; negative regulation of cell proliferation; GO:0008285; negative regulation of salivary gland determination; GO:0045705; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; olfactory learning; GO:0008355; peripheral nervous system development; GO:0007422; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; ; GO:0008270; ; GO:0005351 nucleus; GO:0005634 shn schnurri "CG7734, CG7734, CG7734, CG7734, quo: quo vadis, l(2)04738, EP2359, EP(2)2359, SD06302, Shn, BEST:SD06302, quo vadis, quo" CDMC27548 3 25 12 DAC20-G19 16-CG7745-RA_1 CG7745 TGGGAGAATTAGTCACCACGGAACTGCTGAAAATGAACAAGGAACGGAAGAAAAGTGCACAGAAACGGA 69 FBan0007745 FBgn0033616 CG7745 2 2R CG7745 CG7745 CDMC27548 3 26 12 DAC20-G19 16-CG7745-RA_1 CG7745 TGGGAGAATTAGTCACCACGGAACTGCTGAAAATGAACAAGGAACGGAAGAAAAGTGCACAGAAACGGA 69 FBan0007745 FBgn0033616 CG7745 2 2R CG7745 CG7745 CDMC27549 3 1 13 DAC20-K07 11-CG7777-RA_1 CG7777 CGCAGGACGAATTAGCTTGATCAGAGCCTTTTTCTATGTGGTTTTCCAGTGCTTGGGTGCAATTGCCGG 69 FBan0007777 FBgn0033635 CG7777 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water transporter activity; GO:0005372; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005372 membrane; GO:0016020 CG7777 CG7777 CDMC27549 3 2 13 DAC20-K07 11-CG7777-RA_1 CG7777 CGCAGGACGAATTAGCTTGATCAGAGCCTTTTTCTATGTGGTTTTCCAGTGCTTGGGTGCAATTGCCGG 69 FBan0007777 FBgn0033635 CG7777 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water transporter activity; GO:0005372; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005372 membrane; GO:0016020 CG7777 CG7777 CDMC27550 3 3 13 DAC20-K19 18-CG7787-RA_1 CG7787 GCAGCGATGCCAAACACGTGTGTCCAGTCTCTTGCAATCCATTTTATCATGCCACTTATCCGCTAATCT 69 FBan0007787 FBgn0032020 CG7787 2 2L intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 guanyl-nucleotide exchange factor activity; GO:0005085; zinc ion binding; GO:0008270; ; GO:0005085; ; GO:0008270 cellular component unknown; GO:0008372 CG7787 CG7787 BcDNA:RE45155 CDMC27550 3 4 13 DAC20-K19 18-CG7787-RA_1 CG7787 GCAGCGATGCCAAACACGTGTGTCCAGTCTCTTGCAATCCATTTTATCATGCCACTTATCCGCTAATCT 69 FBan0007787 FBgn0032020 CG7787 2 2L intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 guanyl-nucleotide exchange factor activity; GO:0005085; zinc ion binding; GO:0008270; ; GO:0005085; ; GO:0008270 cellular component unknown; GO:0008372 CG7787 CG7787 BcDNA:RE45155 CDMC27551 3 5 13 DAC20-O07 22-CG7823-RA_1 CG7823 AGCATTTTTCGCCTAAGTCCTCCTCAATGAGAGTCAAGTCAAAACCAAGTCAAGTCACTAGGCCAGTCA 69 FBan0007823 FBgn0036921 RhoGDI 3 3L Rho GDP-dissociation inhibitor activity; GO:0005094; ; GO:0005094 cytoplasm; GO:0005737 RhoGDI RhoGDI "CG7823, CG7823, CG7823, CG7823" CDMC27551 3 6 13 DAC20-O07 22-CG7823-RA_1 CG7823 AGCATTTTTCGCCTAAGTCCTCCTCAATGAGAGTCAAGTCAAAACCAAGTCAAGTCACTAGGCCAGTCA 69 FBan0007823 FBgn0036921 RhoGDI 3 3L Rho GDP-dissociation inhibitor activity; GO:0005094; ; GO:0005094 cytoplasm; GO:0005737 RhoGDI RhoGDI "CG7823, CG7823, CG7823, CG7823" CDMC27552 3 7 13 DAC20-O19 15-CG7831-RA_2 CG7831 TGAGCAACGAGCAGAAGGACATGGAGATTCGAATGGCCAAGAACAACAAGAACGACATCTACGTGTCCA 69 FBan0007831 FBgn0002924 ncd 3 3R chromosome segregation; GO:0007059; female meiotic spindle assembly (sensu Metazoa); GO:0007056; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; minus-end-directed microtubule motor activity; GO:0008569 ; EC:3.6.4.5; ; GO:0005200; ; GO:0003777; ; GO:0008569 ; EC:3.6.4.5 kinesin complex; GO:0005871; minus-end kinesin complex; GO:0005872; spindle; GO:0005819 ncd non-claret disjunctional "CG7831, CG7831, CG7831, ca, l(3)05884, Ncd, DmNcd, DmNCD, KIFC1, ndc, ca[nd]" CDMC27552 3 8 13 DAC20-O19 15-CG7831-RA_2 CG7831 TGAGCAACGAGCAGAAGGACATGGAGATTCGAATGGCCAAGAACAACAAGAACGACATCTACGTGTCCA 69 FBan0007831 FBgn0002924 ncd 3 3R chromosome segregation; GO:0007059; female meiotic spindle assembly (sensu Metazoa); GO:0007056; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; minus-end-directed microtubule motor activity; GO:0008569 ; EC:3.6.4.5; ; GO:0005200; ; GO:0003777; ; GO:0008569 ; EC:3.6.4.5 kinesin complex; GO:0005871; minus-end kinesin complex; GO:0005872; spindle; GO:0005819 ncd non-claret disjunctional "CG7831, CG7831, CG7831, ca, l(3)05884, Ncd, DmNcd, DmNCD, KIFC1, ndc, ca[nd]" CDMC27553 3 9 13 DAC21-C07 23-CG2621-RC_3 CG2621 CGAGCTAAGATCTAACTAACTAAGAGTTTGCGTAGGTTAAACAAGGCATGGTCTTGCAACAACGTGCAG 69 FBan0002621 FBgn0003371 sgg X X "Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; circadian rhythm; GO:0007623; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; mitosis; GO:0007067; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; regulation of hemocyte differentiation; GO:0045610; regulation of protein import into nucleus; GO:0042306; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; glycogen synthase kinase 3 activity; GO:0004696 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004696 ; EC:2.7.1.- sgg shaggy "CG2621, CG2621, CG2621, CG2621, CG2621, CG2621, zw3, l(1)zw3, zw-3, ZW-3, l(1)3Ba, zw3[sgg], zw3(sgg), zw[3], sgg/zw3, sgg-zw3, shaggy-zeste white 3, zest-white 3, Zw3, zeste white 3, zw3/sgg, GSK3, Zw3[sgg], zeste white-3, Zw-3, DMZ3K25Z, zeste-white 3, l(1)G0055, l(1)G0263, l(1)G0335, ZW3, sgg10, sgg39, sgg46, Zw3/GSK3, Zeste white-3, l(1)G0183, zeste-white3, DMSGG3, GSK3beta, GSK-3, Zeste-white 3, SGG/GSK3b, EG:155E2.3, Sgg, Zw3-sh, Zw3 kinase, GSK-3beta, GSKbeta, Gsk3, GSK, glycogen synthase kinase 3Beta, Glycogen Synthase Kinase 3, anon-WO03040301.254, EG:BACR7C10.8" CDMC27553 3 10 13 DAC21-C07 23-CG2621-RC_3 CG2621 CGAGCTAAGATCTAACTAACTAAGAGTTTGCGTAGGTTAAACAAGGCATGGTCTTGCAACAACGTGCAG 69 FBan0002621 FBgn0003371 sgg X X "Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; circadian rhythm; GO:0007623; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; mitosis; GO:0007067; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; regulation of hemocyte differentiation; GO:0045610; regulation of protein import into nucleus; GO:0042306; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; glycogen synthase kinase 3 activity; GO:0004696 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004696 ; EC:2.7.1.- sgg shaggy "CG2621, CG2621, CG2621, CG2621, CG2621, CG2621, zw3, l(1)zw3, zw-3, ZW-3, l(1)3Ba, zw3[sgg], zw3(sgg), zw[3], sgg/zw3, sgg-zw3, shaggy-zeste white 3, zest-white 3, Zw3, zeste white 3, zw3/sgg, GSK3, Zw3[sgg], zeste white-3, Zw-3, DMZ3K25Z, zeste-white 3, l(1)G0055, l(1)G0263, l(1)G0335, ZW3, sgg10, sgg39, sgg46, Zw3/GSK3, Zeste white-3, l(1)G0183, zeste-white3, DMSGG3, GSK3beta, GSK-3, Zeste-white 3, SGG/GSK3b, EG:155E2.3, Sgg, Zw3-sh, Zw3 kinase, GSK-3beta, GSKbeta, Gsk3, GSK, glycogen synthase kinase 3Beta, Glycogen Synthase Kinase 3, anon-WO03040301.254, EG:BACR7C10.8" CDMC27554 3 11 13 DAC21-C19 2-CG2658-RB_1 CG2658 CGACGGGAGCTCAAAACGATCTGGAAAAGGTGACGAAGATCGCGTACTCGCAGATCAAGAAGTTCGGCA 69 FBan0002658 FBgn0024992 CG2658 X X ATP-dependent proteolysis; GO:0006510; mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008237; ; GO:0016887; ; GO:0008237; ; GO:0000166; ; GO:0004222 ; EC:3.4.24.- membrane; GO:0016020; mitochondrion; GO:0005739 CG2658 CG2658 "anon-3Ba, EG:100G10.7, Dm100G10.aj, paraplegin_DROME" CDMC27554 3 12 13 DAC21-C19 2-CG2658-RB_1 CG2658 CGACGGGAGCTCAAAACGATCTGGAAAAGGTGACGAAGATCGCGTACTCGCAGATCAAGAAGTTCGGCA 69 FBan0002658 FBgn0024992 CG2658 X X ATP-dependent proteolysis; GO:0006510; mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008237; ; GO:0016887; ; GO:0008237; ; GO:0000166; ; GO:0004222 ; EC:3.4.24.- membrane; GO:0016020; mitochondrion; GO:0005739 CG2658 CG2658 "anon-3Ba, EG:100G10.7, Dm100G10.aj, paraplegin_DROME" CDMC27555 3 13 13 DAC21-G07 17-CG2699-RA_1 CG2699 ACTGCCCTCCGCTATCCCCTCAAGAATTAGACGGCTCCAGAAACAAAAGAAAAACAAAGGGAAAACGTT 69 FBan0002699 FBgn0020622 Pi3K21B 2 2L insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphoinositide phosphorylation; GO:0046854; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620 phosphoinositide 3-kinase regulator activity; GO:0035014; ; GO:0035014; ; GO:0035014; ; GO:0035014; ; GO:0035014; kinase binding; GO:0019900; phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0035014; ; GO:0035014; ; GO:0019900; ; GO:0016303 ; EC:2.7.1.137 "phosphoinositide 3-kinase complex; GO:0005942; phosphoinositide 3-kinase complex, class IA; GO:0035030" Pi3K21B Pi3K21B "CG2699, CG2699, p60, droPIK57, PI3K, PI(3)K, PI 3-kinase, PI3-kinase, dPI3K, Pi3Kp60, dPI 3-kinase" CDMC27555 3 14 13 DAC21-G07 17-CG2699-RA_1 CG2699 ACTGCCCTCCGCTATCCCCTCAAGAATTAGACGGCTCCAGAAACAAAAGAAAAACAAAGGGAAAACGTT 69 FBan0002699 FBgn0020622 Pi3K21B 2 2L insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphoinositide phosphorylation; GO:0046854; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620 phosphoinositide 3-kinase regulator activity; GO:0035014; ; GO:0035014; ; GO:0035014; ; GO:0035014; ; GO:0035014; kinase binding; GO:0019900; phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0035014; ; GO:0035014; ; GO:0019900; ; GO:0016303 ; EC:2.7.1.137 "phosphoinositide 3-kinase complex; GO:0005942; phosphoinositide 3-kinase complex, class IA; GO:0035030" Pi3K21B Pi3K21B "CG2699, CG2699, p60, droPIK57, PI3K, PI(3)K, PI 3-kinase, PI3-kinase, dPI3K, Pi3Kp60, dPI 3-kinase" CDMC27556 3 15 13 DAC21-G19 23-CG2712-RA_2 CG2712 AATGTGGAGACCTGAAGCTAGATCGCTTATACTATCGGCTTAATGTACAAATCGGGACATTTAGTTTTA 69 FBan0002712 FBgn0024975 CG2712 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2712 CG2712 "III, Coding Region III, EG:95B7.7, anon-3Be" CDMC27556 3 16 13 DAC21-G19 23-CG2712-RA_2 CG2712 AATGTGGAGACCTGAAGCTAGATCGCTTATACTATCGGCTTAATGTACAAATCGGGACATTTAGTTTTA 69 FBan0002712 FBgn0024975 CG2712 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2712 CG2712 "III, Coding Region III, EG:95B7.7, anon-3Be" CDMC27557 3 17 13 DAC21-K07 17-CG2811-RA_2 CG2811 AGACCATGCTCTCCAAACTGGACATACTAGAAGACTACCCGGACTACTATGATCGCGAGCAACAAACCA 69 FBan0002811 FBgn0035082 CG2811 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2811 CG2811 BcDNA:RE67445 CDMC27557 3 18 13 DAC21-K07 17-CG2811-RA_2 CG2811 AGACCATGCTCTCCAAACTGGACATACTAGAAGACTACCCGGACTACTATGATCGCGAGCAACAAACCA 69 FBan0002811 FBgn0035082 CG2811 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG2811 CG2811 BcDNA:RE67445 CDMC27558 3 19 13 DAC21-K19 3-CG2830-RA_1 CG2830 TGCAGGGCAAACCCAAGACAGGACTTTTGGAAATGCGCATCCAGCAAATTCAAGATGAACTGGCGGAAA 69 FBan0002830 FBgn0011244 Hsp60B 2 2L 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408; spermatid development; GO:0007286 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Hsp60B Heat shock protein 60 related "CG2830, ms(2)21D: male sterile(2)21D, hsp60B, anon-WO0140519.61, ms(2)06619, male sterile(2)21D, ms(2)21D, Heat shock protein 60 related" CDMC27558 3 20 13 DAC21-K19 3-CG2830-RA_1 CG2830 TGCAGGGCAAACCCAAGACAGGACTTTTGGAAATGCGCATCCAGCAAATTCAAGATGAACTGGCGGAAA 69 FBan0002830 FBgn0011244 Hsp60B 2 2L 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408; spermatid development; GO:0007286 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Hsp60B Heat shock protein 60 related "CG2830, ms(2)21D: male sterile(2)21D, hsp60B, anon-WO0140519.61, ms(2)06619, male sterile(2)21D, ms(2)21D, Heat shock protein 60 related" CDMC27559 3 21 13 DAC21-O07 15-CG2893-RA_9 CG2893 CCTGGTCTCCCTGTATGCCGTCTATCTTGCGGTCATGTATTTCGACAAAACTTTCCAAAAGTGCGCCAA 69 FBgn0040030 CG2893 calcium ion transport; GO:0006816; cation transport; GO:0006812; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 "calcium, potassium:sodium antiporter activity; GO:0008273; alpha-type channel activity; GO:0015268; sugar porter activity; GO:0005351; calcium:sodium antiporter activity; GO:0005432; ; GO:0015268; ; GO:0008273; ; GO:0005351; ; GO:0005432" integral to membrane; GO:0016021; membrane; GO:0016020 CG2893 CG2893 "CG40147, CG40147, CK02262, BEST:CK02262" CDMC27559 3 22 13 DAC21-O07 15-CG2893-RA_9 CG2893 CCTGGTCTCCCTGTATGCCGTCTATCTTGCGGTCATGTATTTCGACAAAACTTTCCAAAAGTGCGCCAA 69 FBgn0040030 CG2893 calcium ion transport; GO:0006816; cation transport; GO:0006812; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 "calcium, potassium:sodium antiporter activity; GO:0008273; alpha-type channel activity; GO:0015268; sugar porter activity; GO:0005351; calcium:sodium antiporter activity; GO:0005432; ; GO:0015268; ; GO:0008273; ; GO:0005351; ; GO:0005432" integral to membrane; GO:0016021; membrane; GO:0016020 CG2893 CG2893 "CG40147, CG40147, CK02262, BEST:CK02262" CDMC27560 3 23 13 DAC21-O19 3-CG2910-RB_3 CG2910 AGCGCCTTTCAAGAGCTCAAAGCCGCCATATGATGAAAGTGCGTTGGAGTACAGACGTCCGGAATACGA 69 FBan0002910 FBgn0027548 nito 2 2R mRNA binding; GO:0003729; ; GO:0003729 nito spenito "CG2910, CG2910, DmSSp, cg2910, Dm44A/spenito, BcDNA:GH11110, dOTT, One Twenty Two, spenito" CDMC27560 3 24 13 DAC21-O19 3-CG2910-RB_3 CG2910 AGCGCCTTTCAAGAGCTCAAAGCCGCCATATGATGAAAGTGCGTTGGAGTACAGACGTCCGGAATACGA 69 FBan0002910 FBgn0027548 nito 2 2R mRNA binding; GO:0003729; ; GO:0003729 nito spenito "CG2910, CG2910, DmSSp, cg2910, Dm44A/spenito, BcDNA:GH11110, dOTT, One Twenty Two, spenito" CDMC27561 3 25 13 DAC22-C07 18-CG14565-RA_2 CG14565 CGGAGGTTCCGGAAACCACAACTAGTGCGGTTATCCGGGATCAAGAGGGGAATGTCACCACCGCG 65 FBan0014565 FBgn0037129 CG14565 3 3L CG14565 CG14565 CDMC27561 3 26 13 DAC22-C07 18-CG14565-RA_2 CG14565 CGGAGGTTCCGGAAACCACAACTAGTGCGGTTATCCGGGATCAAGAGGGGAATGTCACCACCGCG 65 FBan0014565 FBgn0037129 CG14565 3 3L CG14565 CG14565 CDMC27562 3 1 14 DAC22-C19 1-CG14612-RA_1 CG14612 CCCGATCCTGGATATAAGCCTACGTTACGCAGTCAAGATAAGGCCGCCCTGAAGGAACTGCTGCA 65 FBan0014612 FBgn0040670 CG14612 3 3R CG14612 CG14612 CDMC27562 3 2 14 DAC22-C19 1-CG14612-RA_1 CG14612 CCCGATCCTGGATATAAGCCTACGTTACGCAGTCAAGATAAGGCCGCCCTGAAGGAACTGCTGCA 65 FBan0014612 FBgn0040670 CG14612 3 3R CG14612 CG14612 CDMC27563 3 3 14 DAC22-G07 3-CG14656-RA_2 CG14656 GTTGTTGACTACAGCATTATGCCGCACCTCACAACGGTCGCAACAACCACACCACATGCCTTGAC 65 FBan0014656 FBgn0037278 CG14656 3 3R CG14656 CG14656 CDMC27563 3 4 14 DAC22-G07 3-CG14656-RA_2 CG14656 GTTGTTGACTACAGCATTATGCCGCACCTCACAACGGTCGCAACAACCACACCACATGCCTTGAC 65 FBan0014656 FBgn0037278 CG14656 3 3R CG14656 CG14656 CDMC27564 3 5 14 DAC22-G19 17-CG14707-RA_1 CG14707 CATTACTGGGAAACCCCGTACTCGCAGCCGTACTTCGACAACTCCTCGAGGCGTGAGGTCACCGC 65 FBgn0040548 CDMC27564 3 6 14 DAC22-G19 17-CG14707-RA_1 CG14707 CATTACTGGGAAACCCCGTACTCGCAGCCGTACTTCGACAACTCCTCGAGGCGTGAGGTCACCGC 65 FBgn0040548 CDMC27565 3 7 14 DAC22-K07 23-CG14793-RA_4 CG14793 AACTAAAAGCTTTCGAAAGTTAGGGACGAGATAGCGAAAGAGAAATTGAACCCAAAGCGCCTCAC 65 FBgn0014432 CDMC27565 3 8 14 DAC22-K07 23-CG14793-RA_4 CG14793 AACTAAAAGCTTTCGAAAGTTAGGGACGAGATAGCGAAAGAGAAATTGAACCCAAAGCGCCTCAC 65 FBgn0014432 CDMC27566 3 9 14 DAC22-K19 2-CG14809-RA_1 CG14809 CATCCTTTGTCAGAGCGACAACAATGACATTGCGAGTGCGAGCCGATGGACTCATCCGATGGAGC 65 FBan0014809 FBgn0040898 CG14809 X X CG14809 CG14809 CDMC27566 3 10 14 DAC22-K19 2-CG14809-RA_1 CG14809 CATCCTTTGTCAGAGCGACAACAATGACATTGCGAGTGCGAGCCGATGGACTCATCCGATGGAGC 65 FBan0014809 FBgn0040898 CG14809 X X CG14809 CG14809 CDMC27567 3 11 14 DAC22-O07 23-CG14898-RA_1 CG14898 ATTGACCCCAAGACTGTAGAAATGTTGAAAGACGACCAAGTAGTCCAACTATACGAGCTGATGCT 65 FBan0014898 FBgn0038437 CG14898 3 3R CG14898 CG14898 BcDNA:RE23580 CDMC27567 3 12 14 DAC22-O07 23-CG14898-RA_1 CG14898 ATTGACCCCAAGACTGTAGAAATGTTGAAAGACGACCAAGTAGTCCAACTATACGAGCTGATGCT 65 FBan0014898 FBgn0038437 CG14898 3 3R CG14898 CG14898 BcDNA:RE23580 CDMC27568 3 13 14 DAC22-O19 AutoBlank AutoBlank CDMC27568 3 14 14 DAC22-O19 AutoBlank AutoBlank CDMC27569 3 15 14 DAC23-C07 10-CG6758-RA_1 CG6758 CGCGGATAGCACTTTGTTGCTGGTAACCCCACTTCCCAAATCCTTCAAAGTTCGGCGTAAGAGGTTCAT 69 FBan0006758 FBgn0034704 CG6758 2 2R CG6758 CG6758 CDMC27569 3 16 14 DAC23-C07 10-CG6758-RA_1 CG6758 CGCGGATAGCACTTTGTTGCTGGTAACCCCACTTCCCAAATCCTTCAAAGTTCGGCGTAAGAGGTTCAT 69 FBan0006758 FBgn0034704 CG6758 2 2R CG6758 CG6758 CDMC27570 3 17 14 DAC23-C19 5-CG6768-RA_1 CG6768 GCCGCGAAAAGTTTGAATCCCTGCTGACCCTCTTCATGCAATCTTTGGCTGAAAAGAAGACCACCGAGC 69 FBan0006768 FBgn0020756 DNApol-epsilon 3 3R DNA repair; GO:0006281; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; epsilon DNA polymerase activity; GO:0003893; ; GO:0003893; ; GO:0003893; 3'-5'-exodeoxyribonuclease activity; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003893; ; GO:0008296; ; GO:0003677; ; GO:0000166 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 DNApol-epsilon DNA polymerase epsilon "CG6768, CG6768, pol-epsilon, BAB17608, DNApol-epsilon, DNA polymerase epsilon" CDMC27570 3 18 14 DAC23-C19 5-CG6768-RA_1 CG6768 GCCGCGAAAAGTTTGAATCCCTGCTGACCCTCTTCATGCAATCTTTGGCTGAAAAGAAGACCACCGAGC 69 FBan0006768 FBgn0020756 DNApol-epsilon 3 3R DNA repair; GO:0006281; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; epsilon DNA polymerase activity; GO:0003893; ; GO:0003893; ; GO:0003893; 3'-5'-exodeoxyribonuclease activity; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003893; ; GO:0008296; ; GO:0003677; ; GO:0000166 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 DNApol-epsilon DNA polymerase epsilon "CG6768, CG6768, pol-epsilon, BAB17608, DNApol-epsilon, DNA polymerase epsilon" CDMC27571 3 19 14 DAC23-G07 17-CG6805-RA_1 CG6805 CTGAAGGAGCGCATCGAAGACTATCACCAAATCGTGGACAATCACAAGTACAATGCGCAGGGATATCGC 69 FBan0006805 FBgn0034179 CG6805 2 2R calcium-mediated signaling; GO:0019722; cytoskeleton organization and biogenesis; GO:0007010; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG6805 CG6805 "CK01299, IPP, BEST:CK01299" CDMC27571 3 20 14 DAC23-G07 17-CG6805-RA_1 CG6805 CTGAAGGAGCGCATCGAAGACTATCACCAAATCGTGGACAATCACAAGTACAATGCGCAGGGATATCGC 69 FBan0006805 FBgn0034179 CG6805 2 2R calcium-mediated signaling; GO:0019722; cytoskeleton organization and biogenesis; GO:0007010; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 inositol trisphosphate phosphatase activity; GO:0046030; ; GO:0046030 CG6805 CG6805 "CK01299, IPP, BEST:CK01299" CDMC27572 3 21 14 DAC23-G19 3-CG6817-RA_1 CG6817 GGGCATGTCGGTAAAGTCGGCCGTCTACTACAACCTGTTGACTGGAGTCCTGAGTTTCATCGGCATGAT 69 FBan0006817 FBgn0024236 foi 3 3L cell migration; GO:0016477; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; ion transport; GO:0006811; metal ion transport; GO:0030001; pole cell migration; GO:0007280; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 metal ion transporter activity; GO:0046873; zinc ion transporter activity; GO:0005385; ; GO:0046873; ; GO:0005385 plasma membrane; GO:0005886 foi fear-of-intimacy "CG6817, l(3)neo13, fear of intimacy, l(3)j8E8, dFOI, fear-of-intimacy" CDMC27572 3 22 14 DAC23-G19 3-CG6817-RA_1 CG6817 GGGCATGTCGGTAAAGTCGGCCGTCTACTACAACCTGTTGACTGGAGTCCTGAGTTTCATCGGCATGAT 69 FBan0006817 FBgn0024236 foi 3 3L cell migration; GO:0016477; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; ion transport; GO:0006811; metal ion transport; GO:0030001; pole cell migration; GO:0007280; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 metal ion transporter activity; GO:0046873; zinc ion transporter activity; GO:0005385; ; GO:0046873; ; GO:0005385 plasma membrane; GO:0005886 foi fear-of-intimacy "CG6817, l(3)neo13, fear of intimacy, l(3)j8E8, dFOI, fear-of-intimacy" CDMC27573 3 23 14 DAC23-K07 15-CG6856-RA_1 CG6856 AGCCCAACTGCAAAACAGCTCACAGGTTCTTAATTCCCTGGAGGAAATGGGTAAGCAGTTGGAGATTGA 69 FBan0006856 FBgn0036819 CG6856 3 3L CG6856 CG6856 CDMC27573 3 24 14 DAC23-K07 15-CG6856-RA_1 CG6856 AGCCCAACTGCAAAACAGCTCACAGGTTCTTAATTCCCTGGAGGAAATGGGTAAGCAGTTGGAGATTGA 69 FBan0006856 FBgn0036819 CG6856 3 3L CG6856 CG6856 CDMC27574 3 25 14 DAC23-K19 3-CG6867-RA_1 CG6867 GCCCGTTTTCCACAAGGTGGTCAATGAAAAGTTCGGCTCCTGGCTTAGAGATCCATCTCCGGACAGTGA 69 FBan0006867 FBgn0030887 CG6867 X X cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 cytoplasm; GO:0005737 CG6867 CG6867 CT21241 CDMC27574 3 26 14 DAC23-K19 3-CG6867-RA_1 CG6867 GCCCGTTTTCCACAAGGTGGTCAATGAAAAGTTCGGCTCCTGGCTTAGAGATCCATCTCCGGACAGTGA 69 FBan0006867 FBgn0030887 CG6867 X X cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 cytoplasm; GO:0005737 CG6867 CG6867 CT21241 CDMC27575 3 1 15 DAC23-O07 2-CG6895-RA_1 CG6895 GGCTGAGCAAGCGAAAGATATCCCATTTCGGCGATGACTTTCACACCTACAGCTTGGATTGGAGCAGCA 69 FBan0006895 FBgn0040323 GNBP1 3 3L "NOT defense response to Gram-negative bacteria; GO:0050829; NOT defense response to fungi; GO:0050832; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; innate immune response; GO:0045087; polysaccharide metabolism; GO:0005976; response to pest, pathogen or parasite; GO:0009613" Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; polysaccharide binding; GO:0030247; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0030247; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.-; lipopolysaccharide binding; GO:0001530; ; GO:0001530 membrane fraction; GO:0005624 GNBP1 Gram-negative bacteria binding protein 1 "CG6895, DGNBP-1, DGNBP1, GNBP, osiris, Gram-negative bacteria binding protein 1" CDMC27575 3 2 15 DAC23-O07 2-CG6895-RA_1 CG6895 GGCTGAGCAAGCGAAAGATATCCCATTTCGGCGATGACTTTCACACCTACAGCTTGGATTGGAGCAGCA 69 FBan0006895 FBgn0040323 GNBP1 3 3L "NOT defense response to Gram-negative bacteria; GO:0050829; NOT defense response to fungi; GO:0050832; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; immune response; GO:0006955; innate immune response; GO:0045087; polysaccharide metabolism; GO:0005976; response to pest, pathogen or parasite; GO:0009613" Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; polysaccharide binding; GO:0030247; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0030247; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.-; lipopolysaccharide binding; GO:0001530; ; GO:0001530 membrane fraction; GO:0005624 GNBP1 Gram-negative bacteria binding protein 1 "CG6895, DGNBP-1, DGNBP1, GNBP, osiris, Gram-negative bacteria binding protein 1" CDMC27576 3 3 15 DAC23-O19 12-CG6908-RA_4 CG6908 TCGCCAGCTGGAAAGTGTTCTATAAGGAGCGCAACACCTACGGACAATACATTCCCGAGTTTGAGCAGA 69 FBan0006908 FBgn0037936 CG6908 3 3R CG6908 CG6908 CDMC27576 3 4 15 DAC23-O19 12-CG6908-RA_4 CG6908 TCGCCAGCTGGAAAGTGTTCTATAAGGAGCGCAACACCTACGGACAATACATTCCCGAGTTTGAGCAGA 69 FBan0006908 FBgn0037936 CG6908 3 3R CG6908 CG6908 CDMC27577 3 5 15 DAC24-C07 13-CG2175-RA_1 CG2175 TGACACCCGGCATGTTGGAGAGACTTCTTCGGATCAAGATGGATTTCCAGCGTAGATTTCCCCATTTGT 69 FBan0002175 FBgn0000427 1-Dec X X eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600; extracellular region; GO:0005576 1-Dec defective chorion 1 "CG2175, fs(1)384, fs(1)1501, fs(1)A384, dec[[1]], fs(1)C1, fs(1)M102, Fc1, Fc, dec1, dec, Fcp7C: Follicle cell protein 7C, fs(1)11-549, fs(1)12-1873, fs(1)12-2514, fs(1)12-3512, fs(1)12-365, fs(1)12-3907, fs(1)12-403, fs(1)12-4860, fs(1)13-453, fs(1)13C-57, fs(1)13C-73, fs(1)14-963, fs(1)14A-114, fs(1)14E19, fs(1)5, fs(1)A257, fs(1)M1021, Follicle cell protein 7C" CDMC27577 3 6 15 DAC24-C07 13-CG2175-RA_1 CG2175 TGACACCCGGCATGTTGGAGAGACTTCTTCGGATCAAGATGGATTTCCAGCGTAGATTTCCCCATTTGT 69 FBan0002175 FBgn0000427 1-Dec X X eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600; extracellular region; GO:0005576 1-Dec defective chorion 1 "CG2175, fs(1)384, fs(1)1501, fs(1)A384, dec[[1]], fs(1)C1, fs(1)M102, Fc1, Fc, dec1, dec, Fcp7C: Follicle cell protein 7C, fs(1)11-549, fs(1)12-1873, fs(1)12-2514, fs(1)12-3512, fs(1)12-365, fs(1)12-3907, fs(1)12-403, fs(1)12-4860, fs(1)13-453, fs(1)13C-57, fs(1)13C-73, fs(1)14-963, fs(1)14A-114, fs(1)14E19, fs(1)5, fs(1)A257, fs(1)M1021, Follicle cell protein 7C" CDMC27578 3 7 15 DAC24-C19 16-CG2189-RA_1 CG2189 TCAACAGCAACAATCCGATCTCATGACCAATCTTCAGCTACACATCAAGCAGGACTACGATCTGACGGC 69 FBan0002189 FBgn0000439 Dfd 3 3R "anterior/posterior axis specification; GO:0009948; brain development; GO:0007420; embryonic development; GO:0009790; embryonic morphogenesis; GO:0048598; induction of apoptosis; GO:0006917; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 Dfd Deformed "CG2189, EbR11, DmDfd, deformed, dfd, BG:DS00276.5, l(3)84Ae, Deformed" CDMC27578 3 8 15 DAC24-C19 16-CG2189-RA_1 CG2189 TCAACAGCAACAATCCGATCTCATGACCAATCTTCAGCTACACATCAAGCAGGACTACGATCTGACGGC 69 FBan0002189 FBgn0000439 Dfd 3 3R "anterior/posterior axis specification; GO:0009948; brain development; GO:0007420; embryonic development; GO:0009790; embryonic morphogenesis; GO:0048598; induction of apoptosis; GO:0006917; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 Dfd Deformed "CG2189, EbR11, DmDfd, deformed, dfd, BG:DS00276.5, l(3)84Ae, Deformed" CDMC27579 3 9 15 DAC24-G07 2-CG2233-RA_2 CG2233 ATGCGTACTTGGCAAAGGAGAAGCAGTTGTTCACGGAGGACACTTTTCAGGTTGGCAGTTTGGTCCAGG 69 FBan0002233 FBgn0029990 CG2233 X X CG2233 CG2233 CDMC27579 3 10 15 DAC24-G07 2-CG2233-RA_2 CG2233 ATGCGTACTTGGCAAAGGAGAAGCAGTTGTTCACGGAGGACACTTTTCAGGTTGGCAGTTTGGTCCAGG 69 FBan0002233 FBgn0029990 CG2233 X X CG2233 CG2233 CDMC27580 3 11 15 DAC24-G19 13-CG2249-RA_1 CG2249 GCTCGCAAATAACATGGACTTGGTAGAACGACGTCAGAAACCGATGTACACGCAAAGTTGCCAACTGGA 69 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC27580 3 12 15 DAC24-G19 13-CG2249-RA_1 CG2249 GCTCGCAAATAACATGGACTTGGTAGAACGACGTCAGAAACCGATGTACACGCAAAGTTGCCAACTGGA 69 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC27581 3 13 15 DAC24-K07 7-CG2316-RB_1 CG2316 GCAGGGGAGTTGCACATACCAAGGCCTGTGAAAGACGTTCCATGTATGTTTTACATTCCCCAACGTCCA 69 FBan0002316 FBgn0039890 CG2316 4 4 lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG2316 CG2316 CDMC27581 3 14 15 DAC24-K07 7-CG2316-RB_1 CG2316 GCAGGGGAGTTGCACATACCAAGGCCTGTGAAAGACGTTCCATGTATGTTTTACATTCCCCAACGTCCA 69 FBan0002316 FBgn0039890 CG2316 4 4 lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG2316 CG2316 CDMC27582 3 15 15 DAC24-K19 8-CG2342-RA_1 CG2342 GCTTCGCCTCTTATCTCGTACGCCTATTGAAATGCTCAGGAATAGGCCACCACGACCCGATAATTGCCG 69 FBan0002342 FBgn0004777 Ccp84Ag 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ag Ccp84Ag "CG2342, BcDNA:RE04513, BG:DS00004.7, cc2: cuticle cluster 2, cuticle cluster 2" CDMC27582 3 16 15 DAC24-K19 8-CG2342-RA_1 CG2342 GCTTCGCCTCTTATCTCGTACGCCTATTGAAATGCTCAGGAATAGGCCACCACGACCCGATAATTGCCG 69 FBan0002342 FBgn0004777 Ccp84Ag 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ag Ccp84Ag "CG2342, BcDNA:RE04513, BG:DS00004.7, cc2: cuticle cluster 2, cuticle cluster 2" CDMC27583 3 17 15 DAC24-O07 14-CG2478-RA_7 CG2478 TGCGGTGTCCTTTAATCTAGAACTTTTGCCTAGCGTACAGATTACAAGCTGGGATGTGCTTCCCGCAGA 69 FBan0002478 FBgn0032872 CG2478 2 2L CG2478 CG2478 38D.28 CDMC27583 3 18 15 DAC24-O07 14-CG2478-RA_7 CG2478 TGCGGTGTCCTTTAATCTAGAACTTTTGCCTAGCGTACAGATTACAAGCTGGGATGTGCTTCCCGCAGA 69 FBan0002478 FBgn0032872 CG2478 2 2L CG2478 CG2478 38D.28 CDMC27584 3 19 15 DAC24-O19 23-CG2520-RA_10 CG2520 ATTTGGCCGACAATTTGCAGAGAAGCTTGCTTAGAGGGTTGGCTTACCAAATCGAATGTATCTTGTAGA 69 FBan0002520 FBgn0026210 lap 3 3R intracellular protein transport; GO:0006886; nerve-nerve synaptic transmission; GO:0007270; neurotransmitter secretion; GO:0007269; phototactic behavior; GO:0046953; receptor mediated endocytosis; GO:0006898; synaptic transmission; GO:0007268; synaptic vesicle coating; GO:0016183; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle transport; GO:0048489 phosphatidylinositol binding; GO:0005545; clathrin binding; GO:0030276; ; GO:0030276; ; GO:0030276; ; GO:0005545 clathrin adaptor complex; GO:0030131; coated pit; GO:0005905; synaptic vesicle; GO:0008021 lap like-AP180 "CG2520, l(3)neo34, dAP-3, AP180, LAP, sig, saisoog, Lap, complementation group 12, lap/AP180, BcDNA:GM10787, like-AP180" CDMC27584 3 20 15 DAC24-O19 23-CG2520-RA_10 CG2520 ATTTGGCCGACAATTTGCAGAGAAGCTTGCTTAGAGGGTTGGCTTACCAAATCGAATGTATCTTGTAGA 69 FBan0002520 FBgn0026210 lap 3 3R intracellular protein transport; GO:0006886; nerve-nerve synaptic transmission; GO:0007270; neurotransmitter secretion; GO:0007269; phototactic behavior; GO:0046953; receptor mediated endocytosis; GO:0006898; synaptic transmission; GO:0007268; synaptic vesicle coating; GO:0016183; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle transport; GO:0048489 phosphatidylinositol binding; GO:0005545; clathrin binding; GO:0030276; ; GO:0030276; ; GO:0030276; ; GO:0005545 clathrin adaptor complex; GO:0030131; coated pit; GO:0005905; synaptic vesicle; GO:0008021 lap like-AP180 "CG2520, l(3)neo34, dAP-3, AP180, LAP, sig, saisoog, Lap, complementation group 12, lap/AP180, BcDNA:GM10787, like-AP180" CDMC27585 3 21 15 DAC25-C07 2-CG10105-RA_1 CG10105 ATGGAAGACTTCCCACCGTTGGACAATCGCGAACCCTGCTCTAAGTTTGGCTTCTCCCAACTGAC 65 FBan0010105 FBgn0033935 CG10105 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10105 CG10105 CDMC27585 3 22 15 DAC25-C07 2-CG10105-RA_1 CG10105 ATGGAAGACTTCCCACCGTTGGACAATCGCGAACCCTGCTCTAAGTTTGGCTTCTCCCAACTGAC 65 FBan0010105 FBgn0033935 CG10105 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10105 CG10105 CDMC27586 3 23 15 DAC25-C19 16-CG10151-RB_1 CG10151 ATACATCCACTTTGGCTGACATGTTACAGGGTAACAAACCGTCGAATCTGCTTCCTTTCACCGGG 65 FBan0010151 FBgn0033960 CG10151 2 2R CG10151 CG10151 CDMC27586 3 24 15 DAC25-C19 16-CG10151-RB_1 CG10151 ATACATCCACTTTGGCTGACATGTTACAGGGTAACAAACCGTCGAATCTGCTTCCTTTCACCGGG 65 FBan0010151 FBgn0033960 CG10151 2 2R CG10151 CG10151 CDMC27587 3 25 15 DAC25-G07 2-CG10262-RA_1 CG10262 GATGCGGTCACCATTAAGGCCGTTGACAGACCGGAGAAGATTACGCTCAGCTTCGAGTCGGATGG 65 FBan0010262 FBgn0032813 CG10262 2 2L DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of DNA replication; GO:0006275 DNA binding; GO:0003677; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 delta-DNA polymerase cofactor complex; GO:0005660; nucleus; GO:0005634 CG10262 CG10262 CDMC27587 3 26 15 DAC25-G07 2-CG10262-RA_1 CG10262 GATGCGGTCACCATTAAGGCCGTTGACAGACCGGAGAAGATTACGCTCAGCTTCGAGTCGGATGG 65 FBan0010262 FBgn0032813 CG10262 2 2L DNA repair; GO:0006281; DNA replication; GO:0006260; regulation of DNA replication; GO:0006275 DNA binding; GO:0003677; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 delta-DNA polymerase cofactor complex; GO:0005660; nucleus; GO:0005634 CG10262 CG10262 CDMC27588 3 1 16 DAC25-G19 3-CG10289-RA_1 CG10289 TTGCTGATTTCGATGCGCACTTTAGCACATTTGGCAGCGATCTTGGTATGCCCATAAGTGCGCCG 65 FBan0010289 FBgn0035688 CG10289 3 3L CG10289 CG10289 CDMC27588 3 2 16 DAC25-G19 3-CG10289-RA_1 CG10289 TTGCTGATTTCGATGCGCACTTTAGCACATTTGGCAGCGATCTTGGTATGCCCATAAGTGCGCCG 65 FBan0010289 FBgn0035688 CG10289 3 3L CG10289 CG10289 CDMC27589 3 3 16 DAC25-K07 3-CG10373-RA_1 CG10373 TTCGCAACGTCGCACGGAGCCTACGTCAACCGAGTTATCAGAAGCTCTTTCAGCAGGACAAGAGC 65 FBan0010373 FBgn0032704 CG10373 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171 CG10373 CG10373 CDMC27589 3 4 16 DAC25-K07 3-CG10373-RA_1 CG10373 TTCGCAACGTCGCACGGAGCCTACGTCAACCGAGTTATCAGAAGCTCTTTCAGCAGGACAAGAGC 65 FBan0010373 FBgn0032704 CG10373 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; transport; GO:0006810 transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171 CG10373 CG10373 CDMC27590 3 5 16 DAC25-K19 2-CG10425-RA_3 CG10425 GTGCTGGTTCATGTTCTGGTCTACGTGTTCGTCATGGCCAAGAAACCGAGGAGCATTGTGGGTCG 65 FBan0010425 FBgn0039304 CG10425 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10425 CG10425 CDMC27590 3 6 16 DAC25-K19 2-CG10425-RA_3 CG10425 GTGCTGGTTCATGTTCTGGTCTACGTGTTCGTCATGGCCAAGAAACCGAGGAGCATTGTGGGTCG 65 FBan0010425 FBgn0039304 CG10425 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10425 CG10425 CDMC27591 3 7 16 DAC25-O07 3-CG10559-RA_4 CG10559 CATCTCAAGGGTCCGTACCCCCAGAACTACTTGCAACCCACGTACGCCGATACCATGAAGGAGAG 65 FBan0010559 FBgn0039323 CG10559 3 3R CG10559 CG10559 CDMC27591 3 8 16 DAC25-O07 3-CG10559-RA_4 CG10559 CATCTCAAGGGTCCGTACCCCCAGAACTACTTGCAACCCACGTACGCCGATACCATGAAGGAGAG 65 FBan0010559 FBgn0039323 CG10559 3 3R CG10559 CG10559 CDMC27592 3 9 16 DAC25-O19 AutoBlank AutoBlank CDMC27592 3 10 16 DAC25-O19 AutoBlank AutoBlank CDMC27593 3 11 16 DAC26-C07 17-CG6189-RA_2 CG6189 CCGCAGACAGCAAACTACAATCCTTGCGAGAAGCCAGTTTGAAGTTGCTCAAAAAGATACTCGCTAGGA 69 FBan0006189 FBgn0001341 l(1)1Bi X X transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003677 nucleolus; GO:0005730 l(1)1Bi lethal (1) 1Bi "CG6189, CG6189, HM-419, HM-52, l(1)Bi, EG:115C2.2, l(1)lBi" CDMC27593 3 12 16 DAC26-C07 17-CG6189-RA_2 CG6189 CCGCAGACAGCAAACTACAATCCTTGCGAGAAGCCAGTTTGAAGTTGCTCAAAAAGATACTCGCTAGGA 69 FBan0006189 FBgn0001341 l(1)1Bi X X transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003677 nucleolus; GO:0005730 l(1)1Bi lethal (1) 1Bi "CG6189, CG6189, HM-419, HM-52, l(1)Bi, EG:115C2.2, l(1)lBi" CDMC27594 3 13 16 DAC26-C19 3-CG6201-RA_2 CG6201 GCGAAGAGCCCAAGCACCTAGACTCTACAAGACGGGACCCATCTGGCAGTACAACAGCGAGCTAGTTAT 69 FBan0006201 FBgn0032343 CG6201 2 2L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; L-iduronidase activity; GO:0003940 ; EC:3.2.1.76; ; GO:0003940 ; EC:3.2.1.76" CG6201 CG6201 CDMC27594 3 14 16 DAC26-C19 3-CG6201-RA_2 CG6201 GCGAAGAGCCCAAGCACCTAGACTCTACAAGACGGGACCCATCTGGCAGTACAACAGCGAGCTAGTTAT 69 FBan0006201 FBgn0032343 CG6201 2 2L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; L-iduronidase activity; GO:0003940 ; EC:3.2.1.76; ; GO:0003940 ; EC:3.2.1.76" CG6201 CG6201 CDMC27595 3 15 16 DAC26-G07 27-CG6227-RA_2 CG6227 CGCGCGGTTTGGATGTTAAGGATCTCATACTGGTGGTCAACTACGATGTGCCCAACCACTACGAGGACT 69 FBan0006227 FBgn0030631 CG6227 X X "homoiothermy; GO:0042309; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; response to freezing; GO:0050826" "mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004004; ice binding; GO:0050825; ; GO:0050825; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0003729; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 CG6227 CG6227 "cg6227, DmRH29, Prp5" CDMC27595 3 16 16 DAC26-G07 27-CG6227-RA_2 CG6227 CGCGCGGTTTGGATGTTAAGGATCTCATACTGGTGGTCAACTACGATGTGCCCAACCACTACGAGGACT 69 FBan0006227 FBgn0030631 CG6227 X X "homoiothermy; GO:0042309; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; response to freezing; GO:0050826" "mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004004; ice binding; GO:0050825; ; GO:0050825; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0003729; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 CG6227 CG6227 "cg6227, DmRH29, Prp5" CDMC27596 3 17 16 DAC26-G19 23-CG6236-RA_11 CG6236 TGTCGCGATTGATTTGTGCACAAAATGACAAGTCCAAAACATAGAAACTGCTAAGCAATCAACTGGAAT 69 FBan0006236 FBgn0038318 CG6236 3 3R CG6236 CG6236 CDMC27596 3 18 16 DAC26-G19 23-CG6236-RA_11 CG6236 TGTCGCGATTGATTTGTGCACAAAATGACAAGTCCAAAACATAGAAACTGCTAAGCAATCAACTGGAAT 69 FBan0006236 FBgn0038318 CG6236 3 3R CG6236 CG6236 CDMC27597 3 19 16 DAC26-K07 1-CG6293-RA_1 CG6293 TGGATGCAGAAGAACCCTGGAGCTATTGACACCGGAAACAAGACCGTGGACTCAACGTTATCGGTGCTA 69 FBan0006293 FBgn0037807 CG6293 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" L-ascorbate:sodium symporter activity; GO:0008520; ; GO:0008520 membrane; GO:0016020 CG6293 CG6293 CDMC27597 3 20 16 DAC26-K07 1-CG6293-RA_1 CG6293 TGGATGCAGAAGAACCCTGGAGCTATTGACACCGGAAACAAGACCGTGGACTCAACGTTATCGGTGCTA 69 FBan0006293 FBgn0037807 CG6293 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" L-ascorbate:sodium symporter activity; GO:0008520; ; GO:0008520 membrane; GO:0016020 CG6293 CG6293 CDMC27598 3 21 16 DAC26-K19 18-CG6302-RA_3 CG6302 AGGCGGAGAACCGTAATGTCCTGGTGTTCAACTGAGAGCGATTGATTACCTCACCACACCGTATTTATT 69 FBan0006302 FBgn0010741 l(3)01239 3 3L 'de novo' protein folding; GO:0006458; oogenesis (sensu Insecta); GO:0009993 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 l(3)01239 lethal (3) 01239 "CG6302, CG6302, CG6302, l(3)j9B4, P01239" CDMC27598 3 22 16 DAC26-K19 18-CG6302-RA_3 CG6302 AGGCGGAGAACCGTAATGTCCTGGTGTTCAACTGAGAGCGATTGATTACCTCACCACACCGTATTTATT 69 FBan0006302 FBgn0010741 l(3)01239 3 3L 'de novo' protein folding; GO:0006458; oogenesis (sensu Insecta); GO:0009993 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 l(3)01239 lethal (3) 01239 "CG6302, CG6302, CG6302, l(3)j9B4, P01239" CDMC27599 3 23 16 DAC26-O07 2-CG6343-RB_1 CG6343 TGGTGCGAAGCCCGTATCAAGTACTGCCATGAGAAGCCCGATCTGATGAATTACTTCAATGTGCCGCGT 69 FBan0006343 FBgn0019957 ND42 3 3R "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "ATP binding; GO:0005524; ; GO:0005524; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; phosphotransferase activity, alcohol group as acceptor; GO:0016773 ; EC:2.7.1.-; ; GO:0016773 ; EC:2.7.1.-" mitochondrial matrix; GO:0005759; respiratory chain complex I (sensu Eukaryota); GO:0005747 ND42 NADH:ubiquinone reductase 42kD subunit precursor "CG6343, CG6343, NADH-ubiquinone oxidoreductase subunit" CDMC27599 3 24 16 DAC26-O07 2-CG6343-RB_1 CG6343 TGGTGCGAAGCCCGTATCAAGTACTGCCATGAGAAGCCCGATCTGATGAATTACTTCAATGTGCCGCGT 69 FBan0006343 FBgn0019957 ND42 3 3R "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "ATP binding; GO:0005524; ; GO:0005524; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; phosphotransferase activity, alcohol group as acceptor; GO:0016773 ; EC:2.7.1.-; ; GO:0016773 ; EC:2.7.1.-" mitochondrial matrix; GO:0005759; respiratory chain complex I (sensu Eukaryota); GO:0005747 ND42 NADH:ubiquinone reductase 42kD subunit precursor "CG6343, CG6343, NADH-ubiquinone oxidoreductase subunit" CDMC27600 3 25 16 DAC26-O19 3-CG6357-RA_1 CG6357 ACGCTGACTCATCGACACCCACAATTGAACACACCTCTGGCTTATCTGAGTTCGAGGAGGAATGCCAGT 69 FBan0006357 FBgn0033875 CG6357 2 2R cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG6357 CG6357 CDMC27600 3 26 16 DAC26-O19 3-CG6357-RA_1 CG6357 ACGCTGACTCATCGACACCCACAATTGAACACACCTCTGGCTTATCTGAGTTCGAGGAGGAATGCCAGT 69 FBan0006357 FBgn0033875 CG6357 2 2R cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG6357 CG6357 CDMC27601 3 1 17 DAC27-C07 11-CG3709-RA_1 CG3709 CCGCCAAGGTGCATCGTGGAAATCCAAAAGCCTTGATCATCGATATTGTCACTCAAGCGGGGACTTACA 69 FBan0003709 FBgn0031227 CG3709 2 2L CG3709 CG3709 anon-WO0257455.7 CDMC27601 3 2 17 DAC27-C07 11-CG3709-RA_1 CG3709 CCGCCAAGGTGCATCGTGGAAATCCAAAAGCCTTGATCATCGATATTGTCACTCAAGCGGGGACTTACA 69 FBan0003709 FBgn0031227 CG3709 2 2L CG3709 CG3709 anon-WO0257455.7 CDMC27602 3 3 17 DAC27-C19 2-CG3723-RA_2 CG3723 ACTTCACCCAGGAAACACTCGAGATGTCAGGCAAGGAGGCAGAGTTCAAAGCCATTCTCTTCTCCCTCT 69 FBan0003723 FBgn0013812 Dhc93AB 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc93AB Dynein heavy chain at 93AB "CG3723, CG3723, CG3723, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC27602 3 4 17 DAC27-C19 2-CG3723-RA_2 CG3723 ACTTCACCCAGGAAACACTCGAGATGTCAGGCAAGGAGGCAGAGTTCAAAGCCATTCTCTTCTCCCTCT 69 FBan0003723 FBgn0013812 Dhc93AB 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc93AB Dynein heavy chain at 93AB "CG3723, CG3723, CG3723, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC27603 3 5 17 DAC27-G07 2-CG3757-RA_2 CG3757 TGGGCATCGGCAATACCACCACTAATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCACGGATA 69 FBan0003757 FBgn0004034 y X X "adult cuticle biosynthesis (sensu Insecta); GO:0008365; carbon utilization by fixation of carbon dioxide; GO:0015977; courtship behavior; GO:0007619; cuticle pigmentation; GO:0048067; ectoderm development; GO:0007398; larval or pupal development (sensu Insecta); GO:0002165; male courtship behavior (sensu Insecta), wing extension; GO:0048065; melanin biosynthesis; GO:0042438; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066" receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 extracellular region; GO:0005576; ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 y yellow "CG3757, CG3757, T6, EG:125H10.2, yellow" CDMC27603 3 6 17 DAC27-G07 2-CG3757-RA_2 CG3757 TGGGCATCGGCAATACCACCACTAATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCACGGATA 69 FBan0003757 FBgn0004034 y X X "adult cuticle biosynthesis (sensu Insecta); GO:0008365; carbon utilization by fixation of carbon dioxide; GO:0015977; courtship behavior; GO:0007619; cuticle pigmentation; GO:0048067; ectoderm development; GO:0007398; larval or pupal development (sensu Insecta); GO:0002165; male courtship behavior (sensu Insecta), wing extension; GO:0048065; melanin biosynthesis; GO:0042438; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066" receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198; ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 extracellular region; GO:0005576; ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 y yellow "CG3757, CG3757, T6, EG:125H10.2, yellow" CDMC27604 3 7 17 DAC27-G19 8-CG3766-RA_1 CG3766 TGGCCCTCAAAGTCCAAGCCTCCCGATATGCTCAACGATTCCATTCTGAACGAAAGCAGAAGTTGTCCT 69 FBan0003766 FBgn0011232 scat 2 2L "Golgi to vacuole transport; GO:0006896; proteolysis; GO:0006508; retrograde transport, endosome to Golgi; GO:0042147; sperm individualization; GO:0007291; spermatid development; GO:0007286" nucleic acid binding; GO:0003676; ; GO:0003676; carrier activity; GO:0005386; ; GO:0005386; zinc ion binding; GO:0008270; ; GO:0008270 Golgi apparatus; GO:0005794; mitochondrion; GO:0005739; nucleus; GO:0005634 scat scattered "CG3766, CG3766, ms(2)30B, ms(2)05289" CDMC27604 3 8 17 DAC27-G19 8-CG3766-RA_1 CG3766 TGGCCCTCAAAGTCCAAGCCTCCCGATATGCTCAACGATTCCATTCTGAACGAAAGCAGAAGTTGTCCT 69 FBan0003766 FBgn0011232 scat 2 2L "Golgi to vacuole transport; GO:0006896; proteolysis; GO:0006508; retrograde transport, endosome to Golgi; GO:0042147; sperm individualization; GO:0007291; spermatid development; GO:0007286" nucleic acid binding; GO:0003676; ; GO:0003676; carrier activity; GO:0005386; ; GO:0005386; zinc ion binding; GO:0008270; ; GO:0008270 Golgi apparatus; GO:0005794; mitochondrion; GO:0005739; nucleus; GO:0005634 scat scattered "CG3766, CG3766, ms(2)30B, ms(2)05289" CDMC27605 3 9 17 DAC27-K07 2-CG3812-RB_1 CG3812 GCCGGAAGTCCCATACAGGATAGCAAATCGGGCGAAGATAGCAGAAGGCATCTGGATCCAGGATCTGAA 69 FBan0003812 FBgn0030421 CG3812 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 membrane; GO:0016020 CG3812 CG3812 CDMC27605 3 10 17 DAC27-K07 2-CG3812-RB_1 CG3812 GCCGGAAGTCCCATACAGGATAGCAAATCGGGCGAAGATAGCAGAAGGCATCTGGATCCAGGATCTGAA 69 FBan0003812 FBgn0030421 CG3812 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 membrane; GO:0016020 CG3812 CG3812 CDMC27606 3 11 17 DAC27-K19 3-CG3827-RA_2 CG3827 GGCACCTACGAAGGAGTTCCCCAACAAATATCCACCCACCTGGATCGTCTGGATCATCTGGACAACGAA 69 FBan0003827 FBgn0004170 sc X X "bristle morphogenesis; GO:0008407; central nervous system development; GO:0007417; dosage compensation; GO:0007549; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0003704 nucleus; GO:0005634 sc scute "CG3827, CG3827, T4, scute alpha, T4 AS-C, AS-C T4, Hw: Hairy-wing, sis-b: sisterless b, ascT4, sisb, AS-C T4sc, sis b, sisB, DROACS2, scute/sisterlessB, Hairy-wing, scalpha, achaete-scute, sisterless-b, EG:198A6.1, Sc, l(1)1Ba, sc/T4: scute-T4-transcript, scute-T4-transcript, sis-b, Hw, scute" CDMC27606 3 12 17 DAC27-K19 3-CG3827-RA_2 CG3827 GGCACCTACGAAGGAGTTCCCCAACAAATATCCACCCACCTGGATCGTCTGGATCATCTGGACAACGAA 69 FBan0003827 FBgn0004170 sc X X "bristle morphogenesis; GO:0008407; central nervous system development; GO:0007417; dosage compensation; GO:0007549; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0003704 nucleus; GO:0005634 sc scute "CG3827, CG3827, T4, scute alpha, T4 AS-C, AS-C T4, Hw: Hairy-wing, sis-b: sisterless b, ascT4, sisb, AS-C T4sc, sis b, sisB, DROACS2, scute/sisterlessB, Hairy-wing, scalpha, achaete-scute, sisterless-b, EG:198A6.1, Sc, l(1)1Ba, sc/T4: scute-T4-transcript, scute-T4-transcript, sis-b, Hw, scute" CDMC27607 3 13 17 DAC27-O07 3-CG3860-RA_6 CG3860 GCCGAGTCCTACGTCCAGTTTTTGAAGCAGGGAACCAGGAAGAACGATGACTACGATGGCTCTCCGAAC 69 FBan0003860 FBgn0034951 CG3860 2 2R cholesterol metabolism; GO:0008203; lipid transport; GO:0006869 oxysterol binding; GO:0008142; nucleic acid binding; GO:0003676; ; GO:0008142; ; GO:0003676 CG3860 CG3860 CDMC27607 3 14 17 DAC27-O07 3-CG3860-RA_6 CG3860 GCCGAGTCCTACGTCCAGTTTTTGAAGCAGGGAACCAGGAAGAACGATGACTACGATGGCTCTCCGAAC 69 FBan0003860 FBgn0034951 CG3860 2 2R cholesterol metabolism; GO:0008203; lipid transport; GO:0006869 oxysterol binding; GO:0008142; nucleic acid binding; GO:0003676; ; GO:0008142; ; GO:0003676 CG3860 CG3860 CDMC27608 3 15 17 DAC27-O19 2-CG3876-RA_1 CG3876 GCCCTCTTCTGCTTGTCGTTTTGGACCTCTGCGGATCATTACGAGACCCACAGAAACGCATTTGTGGTG 69 FBan0003876 FBgn0031284 CG3876 2 2L cell proliferation; GO:0008283; signal transduction; GO:0007165 CG3876 CG3876 CDMC27608 3 16 17 DAC27-O19 2-CG3876-RA_1 CG3876 GCCCTCTTCTGCTTGTCGTTTTGGACCTCTGCGGATCATTACGAGACCCACAGAAACGCATTTGTGGTG 69 FBan0003876 FBgn0031284 CG3876 2 2L cell proliferation; GO:0008283; signal transduction; GO:0007165 CG3876 CG3876 CDMC27609 3 17 17 DAC28-C07 23-CG1019-RA_6 CG1019 TCCATGTCTGTGAACCGTTCCGATGCATCTGTCTAATGACCAATCTGTTTTAACTAACTATCCCTGAAA 69 FBan0001019 FBgn0014863 Mlp84B 3 3R cell differentiation; GO:0030154; cell proliferation; GO:0008283; mesoderm development; GO:0007498; striated muscle development; GO:0007519 protein binding; GO:0005515; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 Mlp84B Muscle LIM protein at 84B "CG1019, DmLIM-3, Muscle-specific LIM protein at 84B, Mlmu84B, mlp84B, dMlp84B, DLim-3" CDMC27609 3 18 17 DAC28-C07 23-CG1019-RA_6 CG1019 TCCATGTCTGTGAACCGTTCCGATGCATCTGTCTAATGACCAATCTGTTTTAACTAACTATCCCTGAAA 69 FBan0001019 FBgn0014863 Mlp84B 3 3R cell differentiation; GO:0030154; cell proliferation; GO:0008283; mesoderm development; GO:0007498; striated muscle development; GO:0007519 protein binding; GO:0005515; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 Mlp84B Muscle LIM protein at 84B "CG1019, DmLIM-3, Muscle-specific LIM protein at 84B, Mlmu84B, mlp84B, dMlp84B, DLim-3" CDMC27610 3 19 17 DAC28-C19 23-CG10208-RA_1 CG10208 CCATTTATGTAAACAGTGCCATAGAGATGTGCAAGATCATCTTCCGTATTGATGACGAATTATCAATAC 69 FBan0010208 FBgn0039118 CG10208 3 3R CG10208 CG10208 CT28701 CDMC27610 3 20 17 DAC28-C19 23-CG10208-RA_1 CG10208 CCATTTATGTAAACAGTGCCATAGAGATGTGCAAGATCATCTTCCGTATTGATGACGAATTATCAATAC 69 FBan0010208 FBgn0039118 CG10208 3 3R CG10208 CG10208 CT28701 CDMC27611 3 21 17 DAC28-G07 12-CG10241-RA_1 CG10241 TCACCGAGCATCGCTACGGGAATATGCTGGATATATTCCTCTTTGGATTTCCCAAGTTATCGCGCCGCT 69 FBan0010241 FBgn0015714 Cyp6a17 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a17 Cyp6a17 "CG10241, 61D6S, cyp6a17, 6a17, ESTS:61D6S" CDMC27611 3 22 17 DAC28-G07 12-CG10241-RA_1 CG10241 TCACCGAGCATCGCTACGGGAATATGCTGGATATATTCCTCTTTGGATTTCCCAAGTTATCGCGCCGCT 69 FBan0010241 FBgn0015714 Cyp6a17 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a17 Cyp6a17 "CG10241, 61D6S, cyp6a17, 6a17, ESTS:61D6S" CDMC27612 3 23 17 DAC28-G19 15-CG10248-RA_1 CG10248 CGTGCTCGAAGACGCCCAATCCTTTGGTCTACGATCCCAAATCATTCGTACTTGGTGTGAAAGACGGAA 69 FBan0010248 FBgn0013772 Cyp6a8 2 2R electron transport; GO:0006118; insecticide metabolism; GO:0017143; lauric acid metabolism; GO:0048252; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497; fatty acid (omega-1)-hydroxylase activity; GO:0008393; ; GO:0008393 membrane; GO:0016020; microsome; GO:0005792 Cyp6a8 Cytochrome P450-6a8 "CG10248, CG10248, P450, P-450, CYP6A8, 6a8, Cyt-P450-rAF5: cytochrome P450 related AF5, cytochrome P450 related AF5" CDMC27612 3 24 17 DAC28-G19 15-CG10248-RA_1 CG10248 CGTGCTCGAAGACGCCCAATCCTTTGGTCTACGATCCCAAATCATTCGTACTTGGTGTGAAAGACGGAA 69 FBan0010248 FBgn0013772 Cyp6a8 2 2R electron transport; GO:0006118; insecticide metabolism; GO:0017143; lauric acid metabolism; GO:0048252; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497; fatty acid (omega-1)-hydroxylase activity; GO:0008393; ; GO:0008393 membrane; GO:0016020; microsome; GO:0005792 Cyp6a8 Cytochrome P450-6a8 "CG10248, CG10248, P450, P-450, CYP6A8, 6a8, Cyt-P450-rAF5: cytochrome P450 related AF5, cytochrome P450 related AF5" CDMC27613 3 25 17 DAC28-K07 3-CG10281-RA_1 CG10281 ACCGTTTGGTCGAGACCATGACGAAAATCCTGAAGAAGATCAATCCCGTCAAGCACACCATCCAGGGGA 69 FBan0010281 FBgn0010282 TfIIFalpha 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368; positive regulation of transcription; GO:0045941; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016251; ; GO:0016251; transcriptional activator activity; GO:0016563; ; GO:0016251; ; GO:0016986; ; GO:0003677; ; GO:0016563 nucleus; GO:0005634; transcription factor TFIIF complex; GO:0005674 TfIIFalpha Transcription factor IIFalpha "CG10281, CG10281, CG10281, TFIIF, factor 5, factor 5a, TfIIF, F5a, TFIIFalpha, large subunit of transcription factor 5, TFIIF-L, TfIIFalpha" CDMC27613 3 26 17 DAC28-K07 3-CG10281-RA_1 CG10281 ACCGTTTGGTCGAGACCATGACGAAAATCCTGAAGAAGATCAATCCCGTCAAGCACACCATCCAGGGGA 69 FBan0010281 FBgn0010282 TfIIFalpha 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368; positive regulation of transcription; GO:0045941; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016251; ; GO:0016251; transcriptional activator activity; GO:0016563; ; GO:0016251; ; GO:0016986; ; GO:0003677; ; GO:0016563 nucleus; GO:0005634; transcription factor TFIIF complex; GO:0005674 TfIIFalpha Transcription factor IIFalpha "CG10281, CG10281, CG10281, TFIIF, factor 5, factor 5a, TfIIF, F5a, TFIIFalpha, large subunit of transcription factor 5, TFIIF-L, TfIIFalpha" CDMC27614 3 1 18 DAC28-K19 15-CG10296-RA_1 CG10296 CCGACGTCCTGGAACTCAACTTTATGGAGTCCCTAATCCTGTGCAGAAAAGAATTGGCCATCAATGCGG 69 FBan0010296 FBgn0037436 CG10296 3 3R lipid metabolism; GO:0006629; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003707; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG10296 CG10296 "FAX-1, NR2E5" CDMC27614 3 2 18 DAC28-K19 15-CG10296-RA_1 CG10296 CCGACGTCCTGGAACTCAACTTTATGGAGTCCCTAATCCTGTGCAGAAAAGAATTGGCCATCAATGCGG 69 FBan0010296 FBgn0037436 CG10296 3 3R lipid metabolism; GO:0006629; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003707; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG10296 CG10296 "FAX-1, NR2E5" CDMC27615 3 3 18 DAC28-O07 1-CG10334-RA_2 CG10334 CCTTCGATGCCTGGTACTGTTTGAACGATGCCCATTGCTTTGCGGTGAAGATAGCCGATCTACCGGTTT 69 FBan0010334 FBgn0005672 spi 2 2L G2/M transition of mitotic cell cycle; GO:0000086; R8-mediated photoreceptor organization; GO:0045470; anti-apoptosis; GO:0006916; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; oenocyte development; GO:0007438; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; salivary gland determination; GO:0007432; second mitotic wave (sensu Endopterygota); GO:0016330; tracheal system development (sensu Insecta); GO:0007424 epidermal growth factor receptor activating ligand activity; GO:0005155; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; gurken receptor binding; GO:0008317; ; GO:0005154; ; GO:0005155; ; GO:0008317 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; extracellular region; GO:0005576; integral to membrane; GO:0016021; plasma membrane; GO:0005886 spi spitz "CG10334, CG10334, CG10334, CG10334, l(2)s3547, Spi, l(2)01068, Spitz, CT29014, EP(2)2378, anon-WO0118547.158, l(2)37Fa, spitz" CDMC27615 3 4 18 DAC28-O07 1-CG10334-RA_2 CG10334 CCTTCGATGCCTGGTACTGTTTGAACGATGCCCATTGCTTTGCGGTGAAGATAGCCGATCTACCGGTTT 69 FBan0010334 FBgn0005672 spi 2 2L G2/M transition of mitotic cell cycle; GO:0000086; R8-mediated photoreceptor organization; GO:0045470; anti-apoptosis; GO:0006916; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; oenocyte development; GO:0007438; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; salivary gland determination; GO:0007432; second mitotic wave (sensu Endopterygota); GO:0016330; tracheal system development (sensu Insecta); GO:0007424 epidermal growth factor receptor activating ligand activity; GO:0005155; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; gurken receptor binding; GO:0008317; ; GO:0005154; ; GO:0005155; ; GO:0008317 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; extracellular region; GO:0005576; integral to membrane; GO:0016021; plasma membrane; GO:0005886 spi spitz "CG10334, CG10334, CG10334, CG10334, l(2)s3547, Spi, l(2)01068, Spitz, CT29014, EP(2)2378, anon-WO0118547.158, l(2)37Fa, spitz" CDMC27616 3 5 18 DAC28-O19 3-CG10344-RB_2 CG10344 TGCCTTCCATGAACCGGGTGGCTTCTTCCACACCTTCACCTTTCTTATGGCCATGTTCCTGGTGTTTAA 69 FBan0010344 FBgn0034729 CG10344 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG10344 CG10344 CDMC27616 3 6 18 DAC28-O19 3-CG10344-RB_2 CG10344 TGCCTTCCATGAACCGGGTGGCTTCTTCCACACCTTCACCTTTCTTATGGCCATGTTCCTGGTGTTTAA 69 FBan0010344 FBgn0034729 CG10344 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG10344 CG10344 CDMC27617 3 7 18 DAC29-C07 15-CG13907-RA_1 CG13907 AGCCTAGGCAACAGCGGAGGATGAAGTGCGGAAAATTCACTTTTCTACCAGGAGAACTCAGCTTAGCTT 69 FBan0013907 FBgn0035173 CG13907 3 3L cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG13907 CG13907 CDMC27617 3 8 18 DAC29-C07 15-CG13907-RA_1 CG13907 AGCCTAGGCAACAGCGGAGGATGAAGTGCGGAAAATTCACTTTTCTACCAGGAGAACTCAGCTTAGCTT 69 FBan0013907 FBgn0035173 CG13907 3 3L cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG13907 CG13907 CDMC27618 3 9 18 DAC29-C19 16-CG13933-RA_1 CG13933 GCAGTTCGTTTCGCACCAACTCGTGCTACCTGCTTTTCTACTACATCATCCTGATCACGAAGAAGGAGT 69 FBan0013933 FBgn0035270 CG13933 3 3L intracellular signaling cascade; GO:0007242 CG13933 CG13933 dmASBa CDMC27618 3 10 18 DAC29-C19 16-CG13933-RA_1 CG13933 GCAGTTCGTTTCGCACCAACTCGTGCTACCTGCTTTTCTACTACATCATCCTGATCACGAAGAAGGAGT 69 FBan0013933 FBgn0035270 CG13933 3 3L intracellular signaling cascade; GO:0007242 CG13933 CG13933 dmASBa CDMC27619 3 11 18 DAC29-G07 23-CG1397-RA_3 CG1397 TTCTTGCTCTGCTTAAGATTTTATTGCCGTTTACTCGTGCATTTTTTCGTATCATTTTTCCGATCGCAA 69 FBan0001397 FBgn0030275 CG1397 X X CG1397 CG1397 CDMC27619 3 12 18 DAC29-G07 23-CG1397-RA_3 CG1397 TTCTTGCTCTGCTTAAGATTTTATTGCCGTTTACTCGTGCATTTTTTCGTATCATTTTTCCGATCGCAA 69 FBan0001397 FBgn0030275 CG1397 X X CG1397 CG1397 CDMC27620 3 13 18 DAC29-G19 2-CG13995-RA_1 CG13995 AGCCACCCAAAGGATCGGACTCTGGATCGGGTTTCATTTCACTCCATTCAGTGGCGACCGTTTCCTAAT 69 FBan0013995 FBgn0031770 CG13995 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity, unknown ligand; GO:0016526; G-protein coupled receptor activity; GO:0004930; ; GO:0008188; ; GO:0004930; ; GO:0016526" integral to membrane; GO:0016021 CG13995 CG13995 "anon-WO0170980.169, anon-WO0170980.170" CDMC27620 3 14 18 DAC29-G19 2-CG13995-RA_1 CG13995 AGCCACCCAAAGGATCGGACTCTGGATCGGGTTTCATTTCACTCCATTCAGTGGCGACCGTTTCCTAAT 69 FBan0013995 FBgn0031770 CG13995 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity, unknown ligand; GO:0016526; G-protein coupled receptor activity; GO:0004930; ; GO:0008188; ; GO:0004930; ; GO:0016526" integral to membrane; GO:0016021 CG13995 CG13995 "anon-WO0170980.169, anon-WO0170980.170" CDMC27621 3 15 18 DAC29-K07 3-CG1402-RA_1 CG1402 CGACTGATGCAAGGCTCCGAGAGTACACCCAAAGCTCCACTAGGTAATAATGCGCGACCAGTGCAAAGT 69 FBan0001402 FBgn0029962 CG1402 X X one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG1402 CG1402 CDMC27621 3 16 18 DAC29-K07 3-CG1402-RA_1 CG1402 CGACTGATGCAAGGCTCCGAGAGTACACCCAAAGCTCCACTAGGTAATAATGCGCGACCAGTGCAAAGT 69 FBan0001402 FBgn0029962 CG1402 X X one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG1402 CG1402 CDMC27622 3 17 18 DAC29-K19 3-CG14036-RA_2 CG14036 AGACCTGCAAGTACAACGCCACACACCGAGTCCAGGACATGGAGAAGCATCTGAAGGAGTGTGACTACT 69 FBan0014036 FBgn0031677 CG14036 2 2L CG14036 CG14036 CDMC27622 3 18 18 DAC29-K19 3-CG14036-RA_2 CG14036 AGACCTGCAAGTACAACGCCACACACCGAGTCCAGGACATGGAGAAGCATCTGAAGGAGTGTGACTACT 69 FBan0014036 FBgn0031677 CG14036 2 2L CG14036 CG14036 CDMC27623 3 19 18 DAC29-O07 2-CG14061-RA_1 CG14061 GGGGATGACGTAAAGATGGCCTACTATGGTCCACCCAAGTTCCAGATCAGACTGTACAACACGCGGGTT 69 FBan0014061 FBgn0039598 CG14061 3 3R CG14061 CG14061 CDMC27623 3 20 18 DAC29-O07 2-CG14061-RA_1 CG14061 GGGGATGACGTAAAGATGGCCTACTATGGTCCACCCAAGTTCCAGATCAGACTGTACAACACGCGGGTT 69 FBan0014061 FBgn0039598 CG14061 3 3R CG14061 CG14061 CDMC27624 3 21 18 DAC29-O19 7-CG14076-RA_1 CG14076 GCGACAACCAAATGGATCATTCGATGGTCTCATGGGACGTTTTCAACGCTATGAACTGGACTTGGCCCA 69 FBan0014076 FBgn0036829 CG14076 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG14076 CG14076 CT33663 CDMC27624 3 22 18 DAC29-O19 7-CG14076-RA_1 CG14076 GCGACAACCAAATGGATCATTCGATGGTCTCATGGGACGTTTTCAACGCTATGAACTGGACTTGGCCCA 69 FBan0014076 FBgn0036829 CG14076 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG14076 CG14076 CT33663 CDMC27625 3 23 18 DAC30-C07 23-CG15113-RA_8 CG15113 AAAGAAACCCAAGAGTAGTACGCTTAGATACCCTAGAAACCCTAAGTAGGTGGTATGAACAGTGATCGG 69 FBan0015113 FBgn0004572 5-HT1B 2 2R "serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase inhibiting pathway; GO:0007198; serotonin receptor, phospholipase C activating pathway; GO:0007208; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT1 receptor activity; GO:0001586; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001586 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 5-HT1B Serotonin receptor 1B "CG15113, CG15113, 5HT-dro2B, 5HT-dro[[2B]], 5-HT1BDro, 5-HT[[dro2B]], 5htdro2b, DRO2B, 5-HT-dro2B, 5-HT[[1BDro]], Dm5HTdro2B, 5HT-R2B: Serotonin receptor 2B, Serotonin receptor 2B" CDMC27625 3 24 18 DAC30-C07 23-CG15113-RA_8 CG15113 AAAGAAACCCAAGAGTAGTACGCTTAGATACCCTAGAAACCCTAAGTAGGTGGTATGAACAGTGATCGG 69 FBan0015113 FBgn0004572 5-HT1B 2 2R "serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase inhibiting pathway; GO:0007198; serotonin receptor, phospholipase C activating pathway; GO:0007208; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT1 receptor activity; GO:0001586; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001586 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 5-HT1B Serotonin receptor 1B "CG15113, CG15113, 5HT-dro2B, 5HT-dro[[2B]], 5-HT1BDro, 5-HT[[dro2B]], 5htdro2b, DRO2B, 5-HT-dro2B, 5-HT[[1BDro]], Dm5HTdro2B, 5HT-R2B: Serotonin receptor 2B, Serotonin receptor 2B" CDMC27626 3 25 18 DAC30-C19 14-CG15120-RA_1 CG15120 ACGCATTGAGCACACGAAACCTGGAGGTAATGTGCACGACATTGAAGATAATCCAACAGCTGGTCATGT 69 FBan0015120 FBgn0034454 CG15120 2 2R CG15120 CG15120 CDMC27626 3 26 18 DAC30-C19 14-CG15120-RA_1 CG15120 ACGCATTGAGCACACGAAACCTGGAGGTAATGTGCACGACATTGAAGATAATCCAACAGCTGGTCATGT 69 FBan0015120 FBgn0034454 CG15120 2 2R CG15120 CG15120 CDMC27627 3 1 19 DAC30-G07 2-CG1515-RA_1 CG1515 AGCACGCTATCAAAATCCCGTCGAAGCAGATCCGCTGACGAAAATGCAAAACGACCTGGACGAAACGAA 69 FBgn0029978 CDMC27627 3 2 19 DAC30-G07 2-CG1515-RA_1 CG1515 AGCACGCTATCAAAATCCCGTCGAAGCAGATCCGCTGACGAAAATGCAAAACGACCTGGACGAAACGAA 69 FBgn0029978 CDMC27628 3 3 19 DAC30-G19 23-CG15172-RA_1 CG15172 AGTGGTCGAGTAAATGAAAGTAAAACGTAGCCACTAATTGTTCGACAATAAAAAAGAGTAAATTCAGCA 69 FBan0015172 FBgn0032740 CG15172 2 2L CG15172 CG15172 CDMC27628 3 4 19 DAC30-G19 23-CG15172-RA_1 CG15172 AGTGGTCGAGTAAATGAAAGTAAAACGTAGCCACTAATTGTTCGACAATAAAAAAGAGTAAATTCAGCA 69 FBan0015172 FBgn0032740 CG15172 2 2L CG15172 CG15172 CDMC27629 3 5 19 DAC30-K07 23-CG15211-RA_3 CG15211 TAAGCCAAGCCAAACTATAAACAGCAACAATATGGTCGAGACCGTTGTCAATATCGAGCGCACAACAAC 69 FBan0015211 FBgn0030234 CG15211 X X membrane; GO:0016020 CG15211 CG15211 CDMC27629 3 6 19 DAC30-K07 23-CG15211-RA_3 CG15211 TAAGCCAAGCCAAACTATAAACAGCAACAATATGGTCGAGACCGTTGTCAATATCGAGCGCACAACAAC 69 FBan0015211 FBgn0030234 CG15211 X X membrane; GO:0016020 CG15211 CG15211 CDMC27630 3 7 19 DAC30-K19 23-CG15220-RA_2 CG15220 TCTGCTGAAATTGGCTGTTTTTTGAACGTTATTAACTGAGGAGTTATTATGGATGCCTTTGATCCACGC 69 FBan0015220 FBgn0030322 CG15220 X X DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677 DNA replication factor A complex; GO:0005662 CG15220 CG15220 BcDNA:RH55360 CDMC27630 3 8 19 DAC30-K19 23-CG15220-RA_2 CG15220 TCTGCTGAAATTGGCTGTTTTTTGAACGTTATTAACTGAGGAGTTATTATGGATGCCTTTGATCCACGC 69 FBan0015220 FBgn0030322 CG15220 X X DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677 DNA replication factor A complex; GO:0005662 CG15220 CG15220 BcDNA:RH55360 CDMC27631 3 9 19 DAC30-O07 2-CG15258-RA_1 CG15258 ACTCGGCGGAAATCAGTTTCAACTTTTGGCAGGAGTTCGAACACATCCGGTCGATCCAGCAAAATCGCA 69 FBan0015258 FBgn0032563 CG15258 2 2L CG15258 CG15258 CDMC27631 3 10 19 DAC30-O07 2-CG15258-RA_1 CG15258 ACTCGGCGGAAATCAGTTTCAACTTTTGGCAGGAGTTCGAACACATCCGGTCGATCCAGCAAAATCGCA 69 FBan0015258 FBgn0032563 CG15258 2 2L CG15258 CG15258 CDMC27632 3 11 19 DAC30-O19 23-CG15270-RA_8 CG15270 ACAACGACACGCATAACTGTGAGATAATATCGTCCATTGTTCCTTCCATATAAAGGATAACGCCTTCGC 69 FBan0015270 FBgn0028879 CG15270 2 2L CG15270 CG15270 "BG:DS04929.1, Axs-like" CDMC27632 3 12 19 DAC30-O19 23-CG15270-RA_8 CG15270 ACAACGACACGCATAACTGTGAGATAATATCGTCCATTGTTCCTTCCATATAAAGGATAACGCCTTCGC 69 FBan0015270 FBgn0028879 CG15270 2 2L CG15270 CG15270 "BG:DS04929.1, Axs-like" CDMC27633 3 13 19 DAC31-C07 2-CG12861-RA_1 CG12861 GGATCCCATGCCCTGTGATGACGTGAAGAAAAAGCCCGAGATACTGATTGAAGTGCCGCGTATCGGG 67 FBan0012861 FBgn0033953 CG12861 2 2R CG12861 CG12861 CDMC27633 3 14 19 DAC31-C07 2-CG12861-RA_1 CG12861 GGATCCCATGCCCTGTGATGACGTGAAGAAAAAGCCCGAGATACTGATTGAAGTGCCGCGTATCGGG 67 FBan0012861 FBgn0033953 CG12861 2 2R CG12861 CG12861 CDMC27634 3 15 19 DAC31-C19 3-CG12964-RA_2 CG12964 ACAATACAACCGCTACCTCCCTCTGAAGATCAACGGAGCACAGTTCCCGATTCCCGATAGCGAGGAG 67 FBan0012964 FBgn0034022 CG12964 2 2R CG12964 CG12964 CDMC27634 3 16 19 DAC31-C19 3-CG12964-RA_2 CG12964 ACAATACAACCGCTACCTCCCTCTGAAGATCAACGGAGCACAGTTCCCGATTCCCGATAGCGAGGAG 67 FBan0012964 FBgn0034022 CG12964 2 2R CG12964 CG12964 CDMC27635 3 17 19 DAC31-G07 2-CG13391-RA_1 CG13391 GGCCATTGCCAAGGGTATCCGAAGAATTGTGGCTCTTACAGGACCCGAAGCTCTGAAGGCACTGAAG 67 FBan0013391 FBgn0027094 Aats-ala 2 2L alanyl-tRNA aminoacylation; GO:0006419 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7; ; GO:0003729; ; GO:0004813 ; EC:6.1.1.7 Aats-ala Alanyl-tRNA synthetase "CG13391, ARS, AlaRS, alaS, Alanyl-tRNA synthetase" CDMC27635 3 18 19 DAC31-G07 2-CG13391-RA_1 CG13391 GGCCATTGCCAAGGGTATCCGAAGAATTGTGGCTCTTACAGGACCCGAAGCTCTGAAGGCACTGAAG 67 FBan0013391 FBgn0027094 Aats-ala 2 2L alanyl-tRNA aminoacylation; GO:0006419 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; alanine-tRNA ligase activity; GO:0004813 ; EC:6.1.1.7; ; GO:0004813 ; EC:6.1.1.7; ; GO:0003729; ; GO:0004813 ; EC:6.1.1.7 Aats-ala Alanyl-tRNA synthetase "CG13391, ARS, AlaRS, alaS, Alanyl-tRNA synthetase" CDMC27636 3 19 19 DAC31-G19 14-CG13494-RA_1 CG13494 TCATGGATGACACATTATCAACGGTAGAAGGCGGGATGACGGAAACATCCTCATGGAGCACCACGAT 67 FBan0013494 FBgn0034671 CG13494 2 2R CG13494 CG13494 BcDNA:AT17606 CDMC27636 3 20 19 DAC31-G19 14-CG13494-RA_1 CG13494 TCATGGATGACACATTATCAACGGTAGAAGGCGGGATGACGGAAACATCCTCATGGAGCACCACGAT 67 FBan0013494 FBgn0034671 CG13494 2 2R CG13494 CG13494 BcDNA:AT17606 CDMC27637 3 21 19 DAC31-K07 9-CG13723-RA_4 CG13723 ACCACGCGATCTACTTCTACGTGTCACTCTTTTCGATGTCCTACTGCGTTGTACTGTGGCAGGTGCG 67 FBan0013723 FBgn0036705 CG13723 3 3L CG13723 CG13723 CDMC27637 3 22 19 DAC31-K07 9-CG13723-RA_4 CG13723 ACCACGCGATCTACTTCTACGTGTCACTCTTTTCGATGTCCTACTGCGTTGTACTGTGGCAGGTGCG 67 FBan0013723 FBgn0036705 CG13723 3 3L CG13723 CG13723 CDMC27638 3 23 19 DAC31-K19 1-CG13897-RA_2 CG13897 TCAAGATTGAAGCCGAGCATATGCCCATGTTGTCGACCTTTAAGAGCGAGCAAGTCTCAGCTGCGGA 67 FBan0013897 FBgn0035160 CG13897 3 3L DNA binding; GO:0003677; ; GO:0003677 CG13897 CG13897 anon-WO0118547.557 CDMC27638 3 24 19 DAC31-K19 1-CG13897-RA_2 CG13897 TCAAGATTGAAGCCGAGCATATGCCCATGTTGTCGACCTTTAAGAGCGAGCAAGTCTCAGCTGCGGA 67 FBan0013897 FBgn0035160 CG13897 3 3L DNA binding; GO:0003677; ; GO:0003677 CG13897 CG13897 anon-WO0118547.557 CDMC27639 3 25 19 DAC31-O07 3-CG14354-RA_1 CG14354 CGAAGCAAGGAACAAGGCTGTAAGGGACCGAAGATCCTACGAGGAGGACATCGGTGGAACTTTTGGG 67 FBan0014354 FBgn0039376 CG14354 3 3R CG14354 CG14354 CDMC27639 3 26 19 DAC31-O07 3-CG14354-RA_1 CG14354 CGAAGCAAGGAACAAGGCTGTAAGGGACCGAAGATCCTACGAGGAGGACATCGGTGGAACTTTTGGG 67 FBan0014354 FBgn0039376 CG14354 3 3R CG14354 CG14354 CDMC27640 3 1 20 DAC31-O19 AutoBlank AutoBlank CDMC27640 3 2 20 DAC31-O19 AutoBlank AutoBlank CDMC27641 3 3 20 DAC32-C07 9-CG31728-RA_1 CG31728 AGGCGACCCACTTATCCTAGTTATCCCTCGCCAGTTACAACCACGACAACTACGAGACGTCCTGTGAGC 69 FBan0031728 FBgn0051728 CG31728 2 2L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31728 CG31728 "CG16821, CG16821, CG16821, CG16821, c-SP36, SP36" CDMC27641 3 4 20 DAC32-C07 9-CG31728-RA_1 CG31728 AGGCGACCCACTTATCCTAGTTATCCCTCGCCAGTTACAACCACGACAACTACGAGACGTCCTGTGAGC 69 FBan0031728 FBgn0051728 CG31728 2 2L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31728 CG31728 "CG16821, CG16821, CG16821, CG16821, c-SP36, SP36" CDMC27642 3 5 20 DAC32-C19 14-CG31735-RA_1 CG31735 GGCACTTTAGGGACGCCAGATTCGTTACCCATATTCCCTATTCCGGACCCAACTTCGATGGACTATGTT 69 FBan0031735 FBgn0051735 CG31735 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31735 CG31735 BcDNA:AT20140 CDMC27642 3 6 20 DAC32-C19 14-CG31735-RA_1 CG31735 GGCACTTTAGGGACGCCAGATTCGTTACCCATATTCCCTATTCCGGACCCAACTTCGATGGACTATGTT 69 FBan0031735 FBgn0051735 CG31735 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31735 CG31735 BcDNA:AT20140 CDMC27643 3 7 20 DAC32-G07 18-CG31760-RA_4 CG31760 GCACCCCAATCGTCGTCTGATGGCTTCCATCTCCAATCCCGTTCTGCTTAACTTGTGATTATGTTTACA 69 FBan0031760 FBgn0051760 CG31760 2 2L gamma-aminobutyric acid signaling pathway; GO:0007214 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" membrane; GO:0016020 CG31760 CG31760 "CG17215, CG17214, CG17215, BcDNA:RE52162" CDMC27643 3 8 20 DAC32-G07 18-CG31760-RA_4 CG31760 GCACCCCAATCGTCGTCTGATGGCTTCCATCTCCAATCCCGTTCTGCTTAACTTGTGATTATGTTTACA 69 FBan0031760 FBgn0051760 CG31760 2 2L gamma-aminobutyric acid signaling pathway; GO:0007214 "metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067" membrane; GO:0016020 CG31760 CG31760 "CG17215, CG17214, CG17215, BcDNA:RE52162" CDMC27644 3 9 20 DAC32-G19 4-CG31765-RA_1 CG31765 TCCCAGCAACAACTCCTCAATTAAAACCCCACCTTACGCCTATGCCAGGAAGGAGTCACTCTACTCGGT 69 FBan0031765 FBgn0051765 CG31765 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 CG31765 CG31765 "CG8855, DS00180.5, BG:DS00180.5, CT25428" CDMC27644 3 10 20 DAC32-G19 4-CG31765-RA_1 CG31765 TCCCAGCAACAACTCCTCAATTAAAACCCCACCTTACGCCTATGCCAGGAAGGAGTCACTCTACTCGGT 69 FBan0031765 FBgn0051765 CG31765 2 2L proteolysis; GO:0006508 peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 CG31765 CG31765 "CG8855, DS00180.5, BG:DS00180.5, CT25428" CDMC27645 3 11 20 DAC32-K07 18-CG31795-RB_2 CG31795 ACTTTGATTTGGCGTGAGCACTTGGAAGGTTCGAAAAAGGCTTCACGAGATTGTCAGTAGGAGGACATT 69 FBan0031795 FBgn0031294 ia2 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001 plasma membrane; GO:0005886 ia2 ia2 "CG31795, CG11344, CG4355, R-PTPX/1A2, anon-WO0153538.69" CDMC27645 3 12 20 DAC32-K07 18-CG31795-RB_2 CG31795 ACTTTGATTTGGCGTGAGCACTTGGAAGGTTCGAAAAAGGCTTCACGAGATTGTCAGTAGGAGGACATT 69 FBan0031795 FBgn0031294 ia2 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001 plasma membrane; GO:0005886 ia2 ia2 "CG31795, CG11344, CG4355, R-PTPX/1A2, anon-WO0153538.69" CDMC27646 3 13 20 DAC32-K19 2-CG31807-RA_1 CG31807 AGCCCAGACTCGCTCGTTGATGAGGATGCTGAAGAAGGATGTTGTTGAGCAGCTCTTAGCGGAAAGGAA 69 FBan0031807 FBgn0051807 CG31807 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31807 CG31807 CDMC27646 3 14 20 DAC32-K19 2-CG31807-RA_1 CG31807 AGCCCAGACTCGCTCGTTGATGAGGATGCTGAAGAAGGATGTTGTTGAGCAGCTCTTAGCGGAAAGGAA 69 FBan0031807 FBgn0051807 CG31807 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG31807 CG31807 CDMC27647 3 15 20 DAC32-O07 3-CG31832-RA_1 CG31832 GGCCAGAGTTCACCACACACGTGTCCTAGTGGCAGTCCAAATGGAATTCACCAGCTAATGTTGCCAGAA 69 FBan0031832 FBgn0051832 CG31832 2 2L defense response; GO:0006952; defense response to bacteria; GO:0042742 CG31832 CG31832 "BG:DS00929.7, DS00929.7" CDMC27647 3 16 20 DAC32-O07 3-CG31832-RA_1 CG31832 GGCCAGAGTTCACCACACACGTGTCCTAGTGGCAGTCCAAATGGAATTCACCAGCTAATGTTGCCAGAA 69 FBan0031832 FBgn0051832 CG31832 2 2L defense response; GO:0006952; defense response to bacteria; GO:0042742 CG31832 CG31832 "BG:DS00929.7, DS00929.7" CDMC27648 3 17 20 DAC32-O19 23-CG31847-RA_14 CG31847 GTCTAATCGAGTATATTTCCCGAGGCTTAACTCCTCTATTCTTCGCAAGCCACTTGATTTCCCTGCCCA 69 FBan0031847 FBgn0051847 CG31847 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31847 CG31847 "CG16851, CG16851, BcDNA:HL01958" CDMC27648 3 18 20 DAC32-O19 23-CG31847-RA_14 CG31847 GTCTAATCGAGTATATTTCCCGAGGCTTAACTCCTCTATTCTTCGCAAGCCACTTGATTTCCCTGCCCA 69 FBan0031847 FBgn0051847 CG31847 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31847 CG31847 "CG16851, CG16851, BcDNA:HL01958" CDMC27649 3 19 20 DAC33-C07 2-CG15543-RA_1 CG15543 CAAGTGCGGGATCATCTCGGAGCTCACCAAAACTCCCTATGTGCTGGGTAAAAAATACGGCGAGGCAAA 69 FBan0015543 FBgn0039799 CG15543 3 3R CG15543 CG15543 CDMC27649 3 20 20 DAC33-C07 2-CG15543-RA_1 CG15543 CAAGTGCGGGATCATCTCGGAGCTCACCAAAACTCCCTATGTGCTGGGTAAAAAATACGGCGAGGCAAA 69 FBan0015543 FBgn0039799 CG15543 3 3R CG15543 CG15543 CDMC27650 3 21 20 DAC33-C19 23-CG15552-RA_3 CG15552 CACAGAGAGAAAGAAAGCATCGGTATTCCTAAACTTATTTGGGGATTCAATCGGAGAAATACAATGGCA 69 FBan0015552 FBgn0024288 Sox100B 3 3R ATP synthesis coupled proton transport; GO:0015986; male gonad development; GO:0008584; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530 "ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; DNA bending activity; GO:0008301; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0008301; ; GO:0003700" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 Sox100B Sox100B "CG12098, CG15552, CG18674, CG12098, CG12098, CG12098, SoxB, SOX100B, SOXE, Sox9, CT6009" CDMC27650 3 22 20 DAC33-C19 23-CG15552-RA_3 CG15552 CACAGAGAGAAAGAAAGCATCGGTATTCCTAAACTTATTTGGGGATTCAATCGGAGAAATACAATGGCA 69 FBan0015552 FBgn0024288 Sox100B 3 3R ATP synthesis coupled proton transport; GO:0015986; male gonad development; GO:0008584; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530 "ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; DNA bending activity; GO:0008301; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0008301; ; GO:0003700" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 Sox100B Sox100B "CG12098, CG15552, CG18674, CG12098, CG12098, CG12098, SoxB, SOX100B, SOXE, Sox9, CT6009" CDMC27651 3 23 20 DAC33-G07 8-CG15595-RA_1 CG15595 CGCTTTGGTCACATCCGGTATTTTGGCTCTGAAATGGATTTTGTCTGGAGGACATGCACACGATCGCCT 69 FBan0015595 FBgn0037422 Osi13 3 3R Osi13 Osiris 13 "CG15595, CG15595, Osiris, Osiris 13" CDMC27651 3 24 20 DAC33-G07 8-CG15595-RA_1 CG15595 CGCTTTGGTCACATCCGGTATTTTGGCTCTGAAATGGATTTTGTCTGGAGGACATGCACACGATCGCCT 69 FBan0015595 FBgn0037422 Osi13 3 3R Osi13 Osiris 13 "CG15595, CG15595, Osiris, Osiris 13" CDMC27652 3 25 20 DAC33-G19 3-CG15603-RA_1 CG15603 TCGACTCGACTGCCACGAGACACCAGATAGCGAGAGAGAACCCTTCAGTTCAGGAGCTCTTCCATTTGA 69 FBan0015603 FBgn0030712 CG15603 X X CG15603 CG15603 CDMC27652 3 26 20 DAC33-G19 3-CG15603-RA_1 CG15603 TCGACTCGACTGCCACGAGACACCAGATAGCGAGAGAGAACCCTTCAGTTCAGGAGCTCTTCCATTTGA 69 FBan0015603 FBgn0030712 CG15603 X X CG15603 CG15603 CDMC27653 3 1 21 DAC33-K07 2-CG15653-RA_1 CG15653 CGAACCGAACACTGGGCAATATTTGTGTCTACGGTGCGGTGGCCTCCATATCCGCTGTGATGTACATGA 69 FBan0015653 FBgn0034578 CG15653 2 2R CG15653 CG15653 CDMC27653 3 2 21 DAC33-K07 2-CG15653-RA_1 CG15653 CGAACCGAACACTGGGCAATATTTGTGTCTACGGTGCGGTGGCCTCCATATCCGCTGTGATGTACATGA 69 FBan0015653 FBgn0034578 CG15653 2 2R CG15653 CG15653 CDMC27654 3 3 21 DAC33-K19 11-CG15675-RA_1 CG15675 GCCGGCTGTCTTGGAAGCACCCAAAGTGAATCCGCACACATTTCCAGCGATATTAAGCAGGATTCTACT 69 FBan0015675 FBgn0034648 CG15675 2 2R CG15675 CG15675 BcDNA:GM01014 CDMC27654 3 4 21 DAC33-K19 11-CG15675-RA_1 CG15675 GCCGGCTGTCTTGGAAGCACCCAAAGTGAATCCGCACACATTTCCAGCGATATTAAGCAGGATTCTACT 69 FBan0015675 FBgn0034648 CG15675 2 2R CG15675 CG15675 BcDNA:GM01014 CDMC27655 3 5 21 DAC33-O07 18-CG15721-RA_1 CG15721 TGCAGTCTCCGATCCAGAAACCATTCAAAATACAACGTTTGCAACGACACCTTTCCCGGAAACCACTAA 69 FBan0015721 FBgn0030438 CG15721 X X CG15721 CG15721 CDMC27655 3 6 21 DAC33-O07 18-CG15721-RA_1 CG15721 TGCAGTCTCCGATCCAGAAACCATTCAAAATACAACGTTTGCAACGACACCTTTCCCGGAAACCACTAA 69 FBan0015721 FBgn0030438 CG15721 X X CG15721 CG15721 CDMC27656 3 7 21 DAC33-O19 18-CG15734-RA_2 CG15734 GCAGCGAGAATGCATTGATTTTGGATAACGAAAGTCGCATCGGATGTGTAGCCGTAAATGGGACAAGGA 69 FBan0015734 FBgn0030374 CG15734 X X CG15734 CG15734 CDMC27656 3 8 21 DAC33-O19 18-CG15734-RA_2 CG15734 GCAGCGAGAATGCATTGATTTTGGATAACGAAAGTCGCATCGGATGTGTAGCCGTAAATGGGACAAGGA 69 FBan0015734 FBgn0030374 CG15734 X X CG15734 CG15734 CDMC27657 3 9 21 DAC34-C07 12-CG31150-RA_5 CG31150 CGCTTCCCACGAGCTTACCTTCGACTCAGGACTTAAGCGCTCCTGCTCAGTAATCAATGGCATAGTCAA 69 FBan0031150 FBgn0051150 CG31150 3 3R lipid transport; GO:0006869 lipid transporter activity; GO:0005319; ; GO:0005319 CG31150 CG31150 "CG9625, CG9627, CG9622, CG9625, CG9627, CG9625, CG9625" CDMC27657 3 10 21 DAC34-C07 12-CG31150-RA_5 CG31150 CGCTTCCCACGAGCTTACCTTCGACTCAGGACTTAAGCGCTCCTGCTCAGTAATCAATGGCATAGTCAA 69 FBan0031150 FBgn0051150 CG31150 3 3R lipid transport; GO:0006869 lipid transporter activity; GO:0005319; ; GO:0005319 CG31150 CG31150 "CG9625, CG9627, CG9622, CG9625, CG9627, CG9625, CG9625" CDMC27658 3 11 21 DAC34-C19 17-CG31158-RB_1 CG31158 AGGTCGTTCATCAGAAGACATCGGCATAATCTCGGCAACCAGAGGATTATCTCGAATTCGTGCAGTTGA 69 FBan0031158 FBgn0051158 CG31158 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; protein binding; GO:0005515; ; GO:0005086; ; GO:0005515 CG31158 CG31158 "CG18185, CG6941, EFA6" CDMC27658 3 12 21 DAC34-C19 17-CG31158-RB_1 CG31158 AGGTCGTTCATCAGAAGACATCGGCATAATCTCGGCAACCAGAGGATTATCTCGAATTCGTGCAGTTGA 69 FBan0031158 FBgn0051158 CG31158 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; protein binding; GO:0005515; ; GO:0005086; ; GO:0005515 CG31158 CG31158 "CG18185, CG6941, EFA6" CDMC27659 3 13 21 DAC34-G07 17-CG31191-RA_1 CG31191 GGCCGGTCGGTAGGTAGTCCTACAAGCCCAAACTTCGTACAATTTTACCTTTTCAACGTCTCAGTGTCT 69 FBan0031191 FBgn0051191 CG31191 3 3R CG31191 CG31191 "CG17276, CG17277" CDMC27659 3 14 21 DAC34-G07 17-CG31191-RA_1 CG31191 GGCCGGTCGGTAGGTAGTCCTACAAGCCCAAACTTCGTACAATTTTACCTTTTCAACGTCTCAGTGTCT 69 FBan0031191 FBgn0051191 CG31191 3 3R CG31191 CG31191 "CG17276, CG17277" CDMC27660 3 15 21 DAC34-G19 24-CG31200-RA_1 CG31200 TGGATAATGGAAAATTTGAAGTAGAAAGTACAACTTGTTATGTGAATACTCAATAAACTATTCAACATG 69 FBan0031200 FBgn0051200 CG31200 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31200 CG31200 "CG17837, SPH169" CDMC27660 3 16 21 DAC34-G19 24-CG31200-RA_1 CG31200 TGGATAATGGAAAATTTGAAGTAGAAAGTACAACTTGTTATGTGAATACTCAATAAACTATTCAACATG 69 FBan0031200 FBgn0051200 CG31200 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31200 CG31200 "CG17837, SPH169" CDMC27661 3 17 21 DAC34-K07 16-CG31223-RA_1 CG31223 GCGGATGAAGTTTGGAGCCGGTTAACTACAGAGGAGCAAGATGAGTTCCAGAAATTGATCACCAATGGA 69 FBan0031223 FBgn0051223 CG31223 3 3R CG31223 CG31223 "CG15694, CG15694" CDMC27661 3 18 21 DAC34-K07 16-CG31223-RA_1 CG31223 GCGGATGAAGTTTGGAGCCGGTTAACTACAGAGGAGCAAGATGAGTTCCAGAAATTGATCACCAATGGA 69 FBan0031223 FBgn0051223 CG31223 3 3R CG31223 CG31223 "CG15694, CG15694" CDMC27662 3 19 21 DAC34-K19 1-CG3123-RA_2 CG3123 CGCGTCGCCTTGAACACCTATCCCAACTTGATCCCTCTGGTAAGCGGACTTAGTGTTTCGGAGATGGAG 69 FBan0003123 FBgn0031465 CG3123 2 2L CG3123 CG3123 CDMC27662 3 20 21 DAC34-K19 1-CG3123-RA_2 CG3123 CGCGTCGCCTTGAACACCTATCCCAACTTGATCCCTCTGGTAAGCGGACTTAGTGTTTCGGAGATGGAG 69 FBan0003123 FBgn0031465 CG3123 2 2L CG3123 CG3123 CDMC27663 3 21 21 DAC34-O07 23-CG31275-RB_3 CG31275 CTAATGCTACAAACGATTCATGCGAGTTGAACGATTCCGGAAGAAATACAAAGTTATTGCTGCAAAACC 69 FBgn0051275 CDMC27663 3 22 21 DAC34-O07 23-CG31275-RB_3 CG31275 CTAATGCTACAAACGATTCATGCGAGTTGAACGATTCCGGAAGAAATACAAAGTTATTGCTGCAAAACC 69 FBgn0051275 CDMC27664 3 23 21 DAC34-O19 17-CG31286-RC_3 CG31286 AGATCGCCATGGAGTCCCAAAATTGACATTGGACAACGTGCTCAGTAAGGGATGCCAAAGTTATGCTTG 69 FBan0031286 FBgn0051286 CG31286 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31286 CG31286 "BcDNA:AT25568, NEST:bs36b12" CDMC27664 3 24 21 DAC34-O19 17-CG31286-RC_3 CG31286 AGATCGCCATGGAGTCCCAAAATTGACATTGGACAACGTGCTCAGTAAGGGATGCCAAAGTTATGCTTG 69 FBan0031286 FBgn0051286 CG31286 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31286 CG31286 "BcDNA:AT25568, NEST:bs36b12" CDMC27665 3 25 21 DAC35-C07 2-CG8080-RA_2 CG8080 GATGCCCTTCTGACAATCGCTTTAGACTGAATCCAGTGATGCGCCCCTAGTGCCTGGTCATCTCGC 66 FBan0008080 FBgn0033373 CG8080 2 2R CG8080 CG8080 CG30346 CDMC27665 3 26 21 DAC35-C07 2-CG8080-RA_2 CG8080 GATGCCCTTCTGACAATCGCTTTAGACTGAATCCAGTGATGCGCCCCTAGTGCCTGGTCATCTCGC 66 FBan0008080 FBgn0033373 CG8080 2 2R CG8080 CG8080 CG30346 CDMC27666 3 1 22 DAC35-C19 3-CG8260-RB_3 CG8260 TGATGGCGAGGTTAATCCGTGCGATATGGGCGAAATTTTGAGGGCCGCATACTTCCTGGACATTCC 66 FBan0008260 FBgn0030684 CG8260 X X CG8260 CG8260 CDMC27666 3 2 22 DAC35-C19 3-CG8260-RB_3 CG8260 TGATGGCGAGGTTAATCCGTGCGATATGGGCGAAATTTTGAGGGCCGCATACTTCCTGGACATTCC 66 FBan0008260 FBgn0030684 CG8260 X X CG8260 CG8260 CDMC27667 3 3 22 DAC35-G07 15-CG8719-RA_1 CG8719 ACCTGAATGATGGAATCTTCGGAGCGTTCGCAGGAATGTTTTACTACCCTGAAGAGGTGGCTCCCG 66 FBan0008719 FBgn0013308 Odc2 2 2R amino acid biosynthesis; GO:0008652; polyamine biosynthesis; GO:0006596 ornithine decarboxylase activity; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17 Odc2 Ornithine decarboxylase 2 "CG8719, dodc2" CDMC27667 3 4 22 DAC35-G07 15-CG8719-RA_1 CG8719 ACCTGAATGATGGAATCTTCGGAGCGTTCGCAGGAATGTTTTACTACCCTGAAGAGGTGGCTCCCG 66 FBan0008719 FBgn0013308 Odc2 2 2R amino acid biosynthesis; GO:0008652; polyamine biosynthesis; GO:0006596 ornithine decarboxylase activity; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17; ; GO:0004586 ; EC:4.1.1.17 Odc2 Ornithine decarboxylase 2 "CG8719, dodc2" CDMC27668 3 5 22 DAC35-G19 2-CG8909-RB_1 CG8909 GCCTGTCCGGATGTGATGGATCCCAAGGATGTGGCATGCTCCATTAAGCCAAAAGTTTTGGTGCAC 66 FBan0008909 FBgn0030706 CG8909 X X "cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of transcription, DNA-dependent; GO:0006355" low-density lipoprotein receptor activity; GO:0005041; calcium ion binding; GO:0005509; transcription factor activity; GO:0003700; ; GO:0005509; ; GO:0005041; ; GO:0003700 intracellular; GO:0005622; membrane; GO:0016020 CG8909 CG8909 "CT25574, yolkless-like" CDMC27668 3 6 22 DAC35-G19 2-CG8909-RB_1 CG8909 GCCTGTCCGGATGTGATGGATCCCAAGGATGTGGCATGCTCCATTAAGCCAAAAGTTTTGGTGCAC 66 FBan0008909 FBgn0030706 CG8909 X X "cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of transcription, DNA-dependent; GO:0006355" low-density lipoprotein receptor activity; GO:0005041; calcium ion binding; GO:0005509; transcription factor activity; GO:0003700; ; GO:0005509; ; GO:0005041; ; GO:0003700 intracellular; GO:0005622; membrane; GO:0016020 CG8909 CG8909 "CT25574, yolkless-like" CDMC27669 3 7 22 DAC35-K07 8-CG9395-RA_4 CG9395 GCGGCCCTAAACGACTGCCTCTACCGCACCATGTATCGCTACAAGTATCTGGCACTGGTGGATCTG 66 FBan0009395 FBgn0032506 CG9395 2 2L CG9395 CG9395 CDMC27669 3 8 22 DAC35-K07 8-CG9395-RA_4 CG9395 GCGGCCCTAAACGACTGCCTCTACCGCACCATGTATCGCTACAAGTATCTGGCACTGGTGGATCTG 66 FBan0009395 FBgn0032506 CG9395 2 2L CG9395 CG9395 CDMC27670 3 9 22 DAC35-K19 1-CG9580-RA_1 CG9580 ACTGGACCATCAAGCTCTGGTCGCTAAAGGACACCAAGCCGCTGTACTCCTTTGAGCAGTACATCG 66 FBgn0025801 Sdic RNA localization; GO:0006403; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; mitosis; GO:0007067; vesicle-mediated transport; GO:0016192 "microtubule binding; GO:0008017; ; GO:0008017; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286 Sdic Sperm-specific dynein intermediate chain Sperm-specific dynein intermediate chain CDMC27670 3 10 22 DAC35-K19 1-CG9580-RA_1 CG9580 ACTGGACCATCAAGCTCTGGTCGCTAAAGGACACCAAGCCGCTGTACTCCTTTGAGCAGTACATCG 66 FBgn0025801 Sdic RNA localization; GO:0006403; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; mitosis; GO:0007067; vesicle-mediated transport; GO:0016192 "microtubule binding; GO:0008017; ; GO:0008017; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286 Sdic Sperm-specific dynein intermediate chain Sperm-specific dynein intermediate chain CDMC27671 3 11 22 DAC35-O07 3-CR30367-RA_1 CR30367 CGTGAGTAACGGCAGGATACGAACTTTTTGGATTGAGTGGCTCATCCCCCATCCCCCATCCGTAGG 66 FBan0030367 FBgn0011812 Lcp1Psi 2 2R Lcp1Psi Larval cuticle protein 1 pseudogene "CG30367, Psigene I, Psi1, PsiI, LcpPsi, Lcp1Psi, PsiLcp, CR30367" CDMC27671 3 12 22 DAC35-O07 3-CR30367-RA_1 CR30367 CGTGAGTAACGGCAGGATACGAACTTTTTGGATTGAGTGGCTCATCCCCCATCCCCCATCCGTAGG 66 FBan0030367 FBgn0011812 Lcp1Psi 2 2R Lcp1Psi Larval cuticle protein 1 pseudogene "CG30367, Psigene I, Psi1, PsiI, LcpPsi, Lcp1Psi, PsiLcp, CR30367" CDMC27672 3 13 22 DAC35-O19 AutoBlank AutoBlank CDMC27672 3 14 22 DAC35-O19 AutoBlank AutoBlank CDMC27673 3 15 22 DAC36-C07 12-CG18180-RA_1 CG18180 CCCATGTCGACTTCAACGGACTGATCAACAAGATCCCTCTGCCAAGCATGAACGAGCAGAACGAC 65 FBan0018180 FBgn0036024 CG18180 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG18180 CG18180 SP151 CDMC27673 3 16 22 DAC36-C07 12-CG18180-RA_1 CG18180 CCCATGTCGACTTCAACGGACTGATCAACAAGATCCCTCTGCCAAGCATGAACGAGCAGAACGAC 65 FBan0018180 FBgn0036024 CG18180 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG18180 CG18180 SP151 CDMC27674 3 17 22 DAC36-C19 1-CG18278-RA_2 CG18278 CTCAACAAAAGGCGAAGGGTTCCATTTTTCGAGCGTTCCCTGTTGATCGAGTACTGGGGCGAGGG 65 FBan0018278 FBgn0033836 CG18278 2 2R N-acetylglucosamine metabolism; GO:0006044; carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14 lysosome; GO:0005764 CG18278 CG18278 CDMC27674 3 18 22 DAC36-C19 1-CG18278-RA_2 CG18278 CTCAACAAAAGGCGAAGGGTTCCATTTTTCGAGCGTTCCCTGTTGATCGAGTACTGGGGCGAGGG 65 FBan0018278 FBgn0033836 CG18278 2 2R N-acetylglucosamine metabolism; GO:0006044; carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14 lysosome; GO:0005764 CG18278 CG18278 CDMC27675 3 19 22 DAC36-G07 3-CG18471-RA_2 CG18471 TCATATCCCCACGGCTATGGCTATCCACCGGAACCTCAGAGAAGTCCATACGGTGATCCCAGTCG 65 FBan0018471 FBgn0024232 gprs 2 2R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 gprs gprs "CG18471, CG5967, Gprs" CDMC27675 3 20 22 DAC36-G07 3-CG18471-RA_2 CG18471 TCATATCCCCACGGCTATGGCTATCCACCGGAACCTCAGAGAAGTCCATACGGTGATCCCAGTCG 65 FBan0018471 FBgn0024232 gprs 2 2R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 gprs gprs "CG18471, CG5967, Gprs" CDMC27676 3 21 22 DAC36-G19 6-CG18531-RA_1 CG18531 GTGGGCAACGACTTCCTGGCTATCACCTCCAACTGCTACTGGATGTTCCTCAACTTCCGCCAGTC 65 FBan0018531 FBgn0027796 Gr2a X X sensory perception of smell; GO:0007608; sensory perception of taste; GO:0050909 odorant binding; GO:0005549; taste receptor activity; GO:0008527; ; GO:0008527; olfactory receptor activity; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Gr2a Gustatory receptor 2a "CG18531, CG18531, CG18531, EG:BACN32G11.1, GR2B1, Gr2B1, Gustatory receptor 2B1, Gustatory receptor 2a" CDMC27676 3 22 22 DAC36-G19 6-CG18531-RA_1 CG18531 GTGGGCAACGACTTCCTGGCTATCACCTCCAACTGCTACTGGATGTTCCTCAACTTCCGCCAGTC 65 FBan0018531 FBgn0027796 Gr2a X X sensory perception of smell; GO:0007608; sensory perception of taste; GO:0050909 odorant binding; GO:0005549; taste receptor activity; GO:0008527; ; GO:0008527; olfactory receptor activity; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Gr2a Gustatory receptor 2a "CG18531, CG18531, CG18531, EG:BACN32G11.1, GR2B1, Gr2B1, Gustatory receptor 2B1, Gustatory receptor 2a" CDMC27677 3 23 22 DAC36-K07 5-CG18666-RA_1 CG18666 CTGATATTTCAAGTGCCCCCTCGGTTGTCATTGCGTTGCCAAGTAGCGAGACCCTCGTCGTGACC 65 FBan0018666 FBgn0040967 CG18666 2 2L CG18666 CG18666 CDMC27677 3 24 22 DAC36-K07 5-CG18666-RA_1 CG18666 CTGATATTTCAAGTGCCCCCTCGGTTGTCATTGCGTTGCCAAGTAGCGAGACCCTCGTCGTGACC 65 FBan0018666 FBgn0040967 CG18666 2 2L CG18666 CG18666 CDMC27678 3 25 22 DAC36-K19 1-CG1869-RA_1 CG1869 TGGTGCTGAAGATCGTGTGGCCTACGTCAGTCTGCTAAAGGAATTGCGAGTGGCTTTTGAGGGTG 65 FBan0001869 FBgn0035398 CG1869 3 3L chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; heparin binding; GO:0008201; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061; ; GO:0008201" extracellular region; GO:0005576 CG1869 CG1869 CDMC27678 3 26 22 DAC36-K19 1-CG1869-RA_1 CG1869 TGGTGCTGAAGATCGTGTGGCCTACGTCAGTCTGCTAAAGGAATTGCGAGTGGCTTTTGAGGGTG 65 FBan0001869 FBgn0035398 CG1869 3 3L chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; heparin binding; GO:0008201; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061; ; GO:0008201" extracellular region; GO:0005576 CG1869 CG1869 CDMC27679 3 1 23 DAC36-O07 9-CG1900-RB_1 CG1900 CTGACCACGTCCCAGTGCTTCAATTCACTGACCCAGAGCTCCAAGAGCAAGAACCGCTGCAAGAC 65 FBan0001900 FBgn0030391 Rab40 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab40 Rab40 "CG1900, CG1900, DmRab40" CDMC27679 3 2 23 DAC36-O07 9-CG1900-RB_1 CG1900 CTGACCACGTCCCAGTGCTTCAATTCACTGACCCAGAGCTCCAAGAGCAAGAACCGCTGCAAGAC 65 FBan0001900 FBgn0030391 Rab40 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; regulation of cell shape; GO:0008360; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab40 Rab40 "CG1900, CG1900, DmRab40" CDMC27680 3 3 23 DAC36-O19 AutoBlank AutoBlank CDMC27680 3 4 23 DAC36-O19 AutoBlank AutoBlank CDMC27681 3 5 23 DAC37-C07 9-CG16926-RA_1 CG16926 CGCCCAACAAGTACAACGACAAGCTGATGAACTCCATCTGGGGATTGTACAATCGCTATTCCCCCCACA 69 FBan0016926 FBgn0040732 CG16926 2 2R CG16926 CG16926 CDMC27681 3 6 23 DAC37-C07 9-CG16926-RA_1 CG16926 CGCCCAACAAGTACAACGACAAGCTGATGAACTCCATCTGGGGATTGTACAATCGCTATTCCCCCCACA 69 FBan0016926 FBgn0040732 CG16926 2 2R CG16926 CG16926 CDMC27682 3 7 23 DAC37-C19 23-CG1693-RA_2 CG1693 GAATCCTGCTTTTCGACTCTTGTACATATTATATACCGAACTATACCCGAACTTTCCGAGCAAGTCGAC 69 FBan0001693 FBgn0015558 tty X X tty tweety "CG1693, CG1693, twe, tweety" CDMC27682 3 8 23 DAC37-C19 23-CG1693-RA_2 CG1693 GAATCCTGCTTTTCGACTCTTGTACATATTATATACCGAACTATACCCGAACTTTCCGAGCAAGTCGAC 69 FBan0001693 FBgn0015558 tty X X tty tweety "CG1693, CG1693, twe, tweety" CDMC27683 3 9 23 DAC37-G07 3-CG16970-RA_1 CG16970 TGTGCCACTGTCTATGCGTTCATCGTCACCATGTGCTATTGGCTACTGGTCCACAATCCCGGTAAGTGA 69 FBan0016970 FBgn0032504 CG16970 2 2L CG16970 CG16970 CDMC27683 3 10 23 DAC37-G07 3-CG16970-RA_1 CG16970 TGTGCCACTGTCTATGCGTTCATCGTCACCATGTGCTATTGGCTACTGGTCCACAATCCCGGTAAGTGA 69 FBan0016970 FBgn0032504 CG16970 2 2L CG16970 CG16970 CDMC27684 3 11 23 DAC37-G19 3-CG16979-RA_5 CG16979 TCAGCATTGCTGTGACCAATGAGGAACAGATCCGAGTCCAGGTACCATTAGAGATCGAAGCCATGGCCA 69 FBan0016979 FBgn0036512 CG16979 3 3L CG16979 CG16979 CDMC27684 3 12 23 DAC37-G19 3-CG16979-RA_5 CG16979 TCAGCATTGCTGTGACCAATGAGGAACAGATCCGAGTCCAGGTACCATTAGAGATCGAAGCCATGGCCA 69 FBan0016979 FBgn0036512 CG16979 3 3L CG16979 CG16979 CDMC27685 3 13 23 DAC37-K07 2-CG17018-RD_1 CG17018 AGTCACATTGGCGAGCATAATGGACTTCCAATCAGTCAGCCCCCCCTGAAACGAAGCGCAACAATCAAT 69 FBan0017018 FBgn0039972 CG17018 2 2L CG17018 CG17018 "CG17410, BcDNA:RE40762" CDMC27685 3 14 23 DAC37-K07 2-CG17018-RD_1 CG17018 AGTCACATTGGCGAGCATAATGGACTTCCAATCAGTCAGCCCCCCCTGAAACGAAGCGCAACAATCAAT 69 FBan0017018 FBgn0039972 CG17018 2 2L CG17018 CG17018 "CG17410, BcDNA:RE40762" CDMC27686 3 15 23 DAC37-K19 14-CG17026-RA_2 CG17026 TGGCGCGCTACCCGGATCACAAATTCATTGGGGAAGAGGATACCCACAAGAATGACAATGTAACGAAAG 69 FBan0017026 FBgn0036550 CG17026 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17026 CG17026 CDMC27686 3 16 23 DAC37-K19 14-CG17026-RA_2 CG17026 TGGCGCGCTACCCGGATCACAAATTCATTGGGGAAGAGGATACCCACAAGAATGACAATGTAACGAAAG 69 FBan0017026 FBgn0036550 CG17026 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG17026 CG17026 CDMC27687 3 17 23 DAC37-O07 23-CG17052-RA_10 CG17052 ACACAGATTCGCGTCTTAGTCACTTAAATTTAGTAGTTCTAGCCCATTTCCTATAGAGCGTATGTGTAG 69 FBan0017052 FBgn0031097 CG17052 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17052 CG17052 CDMC27687 3 18 23 DAC37-O07 23-CG17052-RA_10 CG17052 ACACAGATTCGCGTCTTAGTCACTTAAATTTAGTAGTTCTAGCCCATTTCCTATAGAGCGTATGTGTAG 69 FBan0017052 FBgn0031097 CG17052 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17052 CG17052 CDMC27688 3 19 23 DAC37-O19 23-CG17065-RA_2 CG17065 ATTCTCCAAATAAATTGTTAAACTTATACATTCCAATTGAAGGAGCTTGAGATTCTTGTGAGTGCAGCC 69 FBan0017065 FBgn0031099 CG17065 X X N-acetylglucosamine metabolism; GO:0006044; polysaccharide metabolism; GO:0005976 N-acetylglucosamine-6-phosphate deacetylase activity; GO:0008448 ; EC:3.5.1.25; ; GO:0008448 ; EC:3.5.1.25 CG17065 CG17065 CDMC27688 3 20 23 DAC37-O19 23-CG17065-RA_2 CG17065 ATTCTCCAAATAAATTGTTAAACTTATACATTCCAATTGAAGGAGCTTGAGATTCTTGTGAGTGCAGCC 69 FBan0017065 FBgn0031099 CG17065 X X N-acetylglucosamine metabolism; GO:0006044; polysaccharide metabolism; GO:0005976 N-acetylglucosamine-6-phosphate deacetylase activity; GO:0008448 ; EC:3.5.1.25; ; GO:0008448 ; EC:3.5.1.25 CG17065 CG17065 CDMC27689 3 21 23 DAC38-C07 9-CG17592-RA_1 CG17592 TCCCCATTTTGGAGCGGTTCTTTTTCGCCACTATCTCGTGCAATATGAGCTGGACTCTCGAATGTCCCT 69 FBan0017592 FBgn0029711 Usf X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Usf Usf "CG17592, CG17592, CG17592, CG17592, Dm Usf, DmUsf" CDMC27689 3 22 23 DAC38-C07 9-CG17592-RA_1 CG17592 TCCCCATTTTGGAGCGGTTCTTTTTCGCCACTATCTCGTGCAATATGAGCTGGACTCTCGAATGTCCCT 69 FBan0017592 FBgn0029711 Usf X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Usf Usf "CG17592, CG17592, CG17592, CG17592, Dm Usf, DmUsf" CDMC27690 3 23 23 DAC38-C19 22-CG1759-RA_1 CG1759 GCCGTTGCACCTGGAATATTGCACGTTGTTAATTTTTGTGATTGTATATTCCTGGTTTCGACACGCGCC 69 FBan0001759 FBgn0000251 cad 2 2L Malpighian tubule morphogenesis; GO:0007443; analia morphogenesis (sensu Endopterygota); GO:0007487; anterior/posterior axis specification; GO:0009948; gastrulation (sensu Insecta); GO:0010004; germ-band extension; GO:0007377; gut mesoderm development; GO:0007502; hindgut morphogenesis; GO:0007442; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 cad caudal "CG1759, S67, cd, Cad, 38E.19, anon-WO2004063362.83" CDMC27690 3 24 23 DAC38-C19 22-CG1759-RA_1 CG1759 GCCGTTGCACCTGGAATATTGCACGTTGTTAATTTTTGTGATTGTATATTCCTGGTTTCGACACGCGCC 69 FBan0001759 FBgn0000251 cad 2 2L Malpighian tubule morphogenesis; GO:0007443; analia morphogenesis (sensu Endopterygota); GO:0007487; anterior/posterior axis specification; GO:0009948; gastrulation (sensu Insecta); GO:0010004; germ-band extension; GO:0007377; gut mesoderm development; GO:0007502; hindgut morphogenesis; GO:0007442; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 cad caudal "CG1759, S67, cd, Cad, 38E.19, anon-WO2004063362.83" CDMC27691 3 25 23 DAC38-G07 15-CG1763-RA_5 CG1763 GCTGGAGCTCTCGTCTATACACATTCAGGACAGCAGTCTGAGTCTGTTGGGTTTCCATAGCGATAGCGA 69 FBan0001763 FBgn0002948 nod X X female meiotic spindle assembly (sensu Metazoa); GO:0007056; meiotic chromosome segregation; GO:0045132; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003677 kinesin complex; GO:0005871 nod no distributive disjunction "CG1763, CG1763, CG1763, l(1)TW6, Nod, DmNod, DnMod, KIF22" CDMC27691 3 26 23 DAC38-G07 15-CG1763-RA_5 CG1763 GCTGGAGCTCTCGTCTATACACATTCAGGACAGCAGTCTGAGTCTGTTGGGTTTCCATAGCGATAGCGA 69 FBan0001763 FBgn0002948 nod X X female meiotic spindle assembly (sensu Metazoa); GO:0007056; meiotic chromosome segregation; GO:0045132; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003677 kinesin complex; GO:0005871 nod no distributive disjunction "CG1763, CG1763, CG1763, l(1)TW6, Nod, DmNod, DnMod, KIF22" CDMC27692 3 1 24 DAC38-G19 16-CG17660-RA_1 CG17660 ACCAAGTTCGAGGTGTCGAAAATGCAATAAGCTGTGACTTTCGCTGGACCGAAGAGACTTTTTACGCAT 69 FBan0017660 FBgn0031356 CG17660 2 2L CG17660 CG17660 CDMC27692 3 2 24 DAC38-G19 16-CG17660-RA_1 CG17660 ACCAAGTTCGAGGTGTCGAAAATGCAATAAGCTGTGACTTTCGCTGGACCGAAGAGACTTTTTACGCAT 69 FBan0017660 FBgn0031356 CG17660 2 2L CG17660 CG17660 CDMC27693 3 3 24 DAC38-K07 13-CG17707-RA_1 CG17707 TGCCAACCGTAAATGCAATACTGTCGTATCGCGTTATGTGGCCACTTTCACGACTCACATACTGTGCCT 69 FBgn0025835 CG17707 CG17707 CG17707 EG:23E12.3 CDMC27693 3 4 24 DAC38-K07 13-CG17707-RA_1 CG17707 TGCCAACCGTAAATGCAATACTGTCGTATCGCGTTATGTGGCCACTTTCACGACTCACATACTGTGCCT 69 FBgn0025835 CG17707 CG17707 CG17707 EG:23E12.3 CDMC27694 3 5 24 DAC38-K19 12-CG1771-RB_1 CG1771 ACATGTGATCAAATGGGTCACCGTGGATCAAGTGGGTCATGTGGGTTGTGGTTCAATGTGCCATTTCAC 69 FBan0001771 FBgn0004456 mew X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell differentiation; GO:0030154; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectodermal gut morphogenesis; GO:0048567; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 mew multiple edematous wings "CG1771, CG1771, CG1771, PS1alpha: Position-specific-antigen-1alpha, PS1, alpha[[PS1]], PS1 integrin, Position-specific-1 antigen, alphaPS1, alpha-PS1-integrin, alpha integrin, aPS1, l(1)G0429, alpha-PS1, l(1)G0443, CT5254, alphaPS1 integrin, alphaPS1, Position-specific-antigen-1alpha, PS1alpha" CDMC27694 3 6 24 DAC38-K19 12-CG1771-RB_1 CG1771 ACATGTGATCAAATGGGTCACCGTGGATCAAGTGGGTCATGTGGGTTGTGGTTCAATGTGCCATTTCAC 69 FBan0001771 FBgn0004456 mew X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell differentiation; GO:0030154; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectodermal gut morphogenesis; GO:0048567; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 mew multiple edematous wings "CG1771, CG1771, CG1771, PS1alpha: Position-specific-antigen-1alpha, PS1, alpha[[PS1]], PS1 integrin, Position-specific-1 antigen, alphaPS1, alpha-PS1-integrin, alpha integrin, aPS1, l(1)G0429, alpha-PS1, l(1)G0443, CT5254, alphaPS1 integrin, alphaPS1, Position-specific-antigen-1alpha, PS1alpha" CDMC27695 3 7 24 DAC38-O07 23-CG17759-RA_14 CG17759 CCTCAGCGAGATGCAATAACGGCCCGAGAGTTTATACTGCGAATGTTTGTAGATTTAAATCCAGATTCC 69 FBan0017759 FBgn0004435 Galpha49B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; axon midline choice point recognition; GO:0016199; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; protein amino acid ADP-ribosylation; GO:0006471; rhodopsin mediated signaling; GO:0016056; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 Galpha49B G protein alpha49B "CG17759, CG17759, CG17759, dgq, DGqalpha, DGq, dgqalpha, Dgq, DGalphaq, dGqalpha, dG[[q]]alpha, G[[qalpha]], Galphaq, dGqalpha-3, Gqalpha, Galpha[[q]]: G-protein-alpha[[q]], DmGalpha[[q]], G[[q]], Galpha, Galpha49B, Gqa-3, G[[q]]alpha, dGqa-49b, dGqalpha-49b, dGaalpha, G alpha 49B, Gaq, G[[a]]q, G[q], G[[alphaq]], Gq, Galpha49b, DGalpha[[q]], G-protein-alpha[[q]], Galpha[[q]]" CDMC27695 3 8 24 DAC38-O07 23-CG17759-RA_14 CG17759 CCTCAGCGAGATGCAATAACGGCCCGAGAGTTTATACTGCGAATGTTTGTAGATTTAAATCCAGATTCC 69 FBan0017759 FBgn0004435 Galpha49B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; axon midline choice point recognition; GO:0016199; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; protein amino acid ADP-ribosylation; GO:0006471; rhodopsin mediated signaling; GO:0016056; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834; inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 Galpha49B G protein alpha49B "CG17759, CG17759, CG17759, dgq, DGqalpha, DGq, dgqalpha, Dgq, DGalphaq, dGqalpha, dG[[q]]alpha, G[[qalpha]], Galphaq, dGqalpha-3, Gqalpha, Galpha[[q]]: G-protein-alpha[[q]], DmGalpha[[q]], G[[q]], Galpha, Galpha49B, Gqa-3, G[[q]]alpha, dGqa-49b, dGqalpha-49b, dGaalpha, G alpha 49B, Gaq, G[[a]]q, G[q], G[[alphaq]], Gq, Galpha49b, DGalpha[[q]], G-protein-alpha[[q]], Galpha[[q]]" CDMC27696 3 9 24 DAC38-O19 1-CG17763-RA_1 CG17763 AGGCGCACTTTAACGAAATGACCGACTGCTTGCATAAGCTTTTGACTCCAGTGACGCCCAGTAGCATGA 69 FBan0017763 FBgn0029777 CG17763 X X CG17763 CG17763 CDMC27696 3 10 24 DAC38-O19 1-CG17763-RA_1 CG17763 AGGCGCACTTTAACGAAATGACCGACTGCTTGCATAAGCTTTTGACTCCAGTGACGCCCAGTAGCATGA 69 FBan0017763 FBgn0029777 CG17763 X X CG17763 CG17763 CDMC27697 3 11 24 DAC39-C07 1-CG32212-RA_4 CG32212 CTTACTCTGCTCCTCTAGACTACTCTGCTCTCGCTGCCGTGGTAACTGCTCCCACTCCACCTGTG 65 FBan0032212 FBgn0052212 CG32212 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32212 CG32212 CDMC27697 3 12 24 DAC39-C07 1-CG32212-RA_4 CG32212 CTTACTCTGCTCCTCTAGACTACTCTGCTCTCGCTGCCGTGGTAACTGCTCCCACTCCACCTGTG 65 FBan0032212 FBgn0052212 CG32212 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32212 CG32212 CDMC27698 3 13 24 DAC39-C19 2-CG32245-RB_1 CG32245 CGGGTATCAAATGCGACCGTCTCTATCGCGAACGTGGAGAATGCTCACCATTCGACCAGGCTACT 65 FBan0032245 FBgn0052245 CG32245 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG32245 CG32245 "CG7468, CG13718, CG7468" CDMC27698 3 14 24 DAC39-C19 2-CG32245-RB_1 CG32245 CGGGTATCAAATGCGACCGTCTCTATCGCGAACGTGGAGAATGCTCACCATTCGACCAGGCTACT 65 FBan0032245 FBgn0052245 CG32245 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG32245 CG32245 "CG7468, CG13718, CG7468" CDMC27699 3 15 24 DAC39-G07 3-CG32379-RA_1 CG32379 CAACATCCGGCGATACGACAGACTTTGCGTTTGGAGTGGTGAATGCCACAGTTGCCATGACCATG 65 FBan0032379 FBgn0052379 CG32379 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; carboxypeptidase activity; GO:0004180; ; GO:0004180; ; GO:0004182 ; EC:3.4.17.1 CG32379 CG32379 "CG18415, CG18415, CG18415" CDMC27699 3 16 24 DAC39-G07 3-CG32379-RA_1 CG32379 CAACATCCGGCGATACGACAGACTTTGCGTTTGGAGTGGTGAATGCCACAGTTGCCATGACCATG 65 FBan0032379 FBgn0052379 CG32379 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; carboxypeptidase activity; GO:0004180; ; GO:0004180; ; GO:0004182 ; EC:3.4.17.1 CG32379 CG32379 "CG18415, CG18415, CG18415" CDMC27700 3 17 24 DAC39-G19 3-CG32422-RA_1 CG32422 TTATGTGGTGAATGCCATGATAGCAACCGCCTGGGATATCGCTCGAAGGTTAGTCCTCCAGCGCA 65 FBan0032422 FBgn0052422 CG32422 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32422 CG32422 CDMC27700 3 18 24 DAC39-G19 3-CG32422-RA_1 CG32422 TTATGTGGTGAATGCCATGATAGCAACCGCCTGGGATATCGCTCGAAGGTTAGTCCTCCAGCGCA 65 FBan0032422 FBgn0052422 CG32422 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32422 CG32422 CDMC27701 3 19 24 DAC39-K07 3-CG32495-RB_3 CG32495 GATTCACCCAGGCATATAGCATCGGTCTGTTGCGATCCGACTATATGGCACACGTGTCCGAGGGC 65 FBan0032495 FBgn0052495 CG32495 X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 ATP binding; GO:0005524; ; GO:0005524; ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 CG32495 CG32495 CDMC27701 3 20 24 DAC39-K07 3-CG32495-RB_3 CG32495 GATTCACCCAGGCATATAGCATCGGTCTGTTGCGATCCGACTATATGGCACACGTGTCCGAGGGC 65 FBan0032495 FBgn0052495 CG32495 X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 ATP binding; GO:0005524; ; GO:0005524; ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 CG32495 CG32495 CDMC27702 3 21 24 DAC39-K19 17-CG32516-RA_5 CG32516 TCAGTCATTTCGATTTTCCCTTTGCAGACGACAAAAATGCCCGAGTGATCAAGCCAACACAGCGA 65 FBan0032516 FBgn0052516 CG32516 X X transport; GO:0006810 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG32516 CG32516 BcDNA:AT04622 CDMC27702 3 22 24 DAC39-K19 17-CG32516-RA_5 CG32516 TCAGTCATTTCGATTTTCCCTTTGCAGACGACAAAAATGCCCGAGTGATCAAGCCAACACAGCGA 65 FBan0032516 FBgn0052516 CG32516 X X transport; GO:0006810 "ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG32516 CG32516 BcDNA:AT04622 CDMC27703 3 23 24 DAC39-O07 23-CG32577-RA_3 CG32577 CCAACGACGAAACGCTTGATATGAGGAAACGAACAAAATTTGATTACAGATTGCCGTTTACCGAA 65 FBan0032577 FBgn0042650 disco-r X X malate metabolism; GO:0006108; regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; malate dehydrogenase activity; GO:0016615; ; GO:0016615 nucleus; GO:0005634 disco-r disco-related "CG9223, CG32577, CG9219, CG9223, disconnected-related, disco-related, disco-r" CDMC27703 3 24 24 DAC39-O07 23-CG32577-RA_3 CG32577 CCAACGACGAAACGCTTGATATGAGGAAACGAACAAAATTTGATTACAGATTGCCGTTTACCGAA 65 FBan0032577 FBgn0042650 disco-r X X malate metabolism; GO:0006108; regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; malate dehydrogenase activity; GO:0016615; ; GO:0016615 nucleus; GO:0005634 disco-r disco-related "CG9223, CG32577, CG9219, CG9223, disconnected-related, disco-related, disco-r" CDMC27704 3 25 24 DAC39-O19 AutoBlank AutoBlank CDMC27704 3 26 24 DAC39-O19 AutoBlank AutoBlank CDMC27705 3 1 25 DAC40-C07 5-CG41129-RA_1 CG41129 CAAGGATTTTTGCGGGCATGGATCATGGCACCAGCAGTTGACAGCCTTTGTAAGCAATCGTGGCG 65 FBgn0069922 CG41129 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41129 CG41129 CDMC27705 3 2 25 DAC40-C07 5-CG41129-RA_1 CG41129 CAAGGATTTTTGCGGGCATGGATCATGGCACCAGCAGTTGACAGCCTTTGTAAGCAATCGTGGCG 65 FBgn0069922 CG41129 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41129 CG41129 CDMC27706 3 3 25 DAC40-C19 3-CG4135-RA_1 CG4135 CAAGCTGGAAAACGCGGAAATGCACAGTCACATGTTGCCATCAGCAGAGATTGCGACAACGGCAG 65 FBan0004135 FBgn0038494 beat-IIb 3 3R extracellular region; GO:0005576 beat-IIb beat-IIb "CG4135, CG14337, CT13620, beat IIb" CDMC27706 3 4 25 DAC40-C19 3-CG4135-RA_1 CG4135 CAAGCTGGAAAACGCGGAAATGCACAGTCACATGTTGCCATCAGCAGAGATTGCGACAACGGCAG 65 FBan0004135 FBgn0038494 beat-IIb 3 3R extracellular region; GO:0005576 beat-IIb beat-IIb "CG4135, CG14337, CT13620, beat IIb" CDMC27707 3 5 25 DAC40-G07 2-CG4267-RA_3 CG4267 TCGGACGCACTACACTCGATCGGTCAGAAGCCCCGAGGGAGATATCTTGGAACAGCCATGATCTC 65 FBan0004267 FBgn0031405 CG4267 2 2L lipid metabolism; GO:0006629 phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG4267 CG4267 CDMC27707 3 6 25 DAC40-G07 2-CG4267-RA_3 CG4267 TCGGACGCACTACACTCGATCGGTCAGAAGCCCCGAGGGAGATATCTTGGAACAGCCATGATCTC 65 FBan0004267 FBgn0031405 CG4267 2 2L lipid metabolism; GO:0006629 phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG4267 CG4267 CDMC27708 3 7 25 DAC40-G19 2-CG4286-RA_1 CG4286 GAAGGGTAAACGTGACAGTGACAGTGGGCCACATGGTAGTGGTTTGGGATCCAATGTGCCCGAAC 65 FBan0004286 FBgn0034601 CG4286 2 2R CG4286 CG4286 CDMC27708 3 8 25 DAC40-G19 2-CG4286-RA_1 CG4286 GAAGGGTAAACGTGACAGTGACAGTGGGCCACATGGTAGTGGTTTGGGATCCAATGTGCCCGAAC 65 FBan0004286 FBgn0034601 CG4286 2 2R CG4286 CG4286 CDMC27709 3 9 25 DAC40-K07 23-CG4404-RA_1 CG4404 TCTCCGTGAAGAAAAAAAGCCACAAGAATCGAAGAAAACACACCCAGTTGATAGAAAACGCCAAC 65 FBan0004404 FBgn0030432 CG4404 X X DNA binding; GO:0003677; ; GO:0003677 CG4404 CG4404 CDMC27709 3 10 25 DAC40-K07 23-CG4404-RA_1 CG4404 TCTCCGTGAAGAAAAAAAGCCACAAGAATCGAAGAAAACACACCCAGTTGATAGAAAACGCCAAC 65 FBan0004404 FBgn0030432 CG4404 X X DNA binding; GO:0003677; ; GO:0003677 CG4404 CG4404 CDMC27710 3 11 25 DAC40-K19 23-CG4457-RA_2 CG4457 TTTTTGTTAATTACACAGGAATTGCAATAAACCAACCAAGAATTCACTGAAAGAATGGCGACAGC 65 FBan0004457 FBgn0015298 Srp19 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614; protein biosynthesis; GO:0006412; protein complex assembly; GO:0006461; protein targeting; GO:0006605 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0008312; ; GO:0008312; ; GO:0003729 signal recognition particle (sensu Eukaryota); GO:0005786 Srp19 Signal recognition particle protein 19 "CG4457, SRP19, srp19" CDMC27710 3 12 25 DAC40-K19 23-CG4457-RA_2 CG4457 TTTTTGTTAATTACACAGGAATTGCAATAAACCAACCAAGAATTCACTGAAAGAATGGCGACAGC 65 FBan0004457 FBgn0015298 Srp19 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614; protein biosynthesis; GO:0006412; protein complex assembly; GO:0006461; protein targeting; GO:0006605 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0008312; ; GO:0008312; ; GO:0003729 signal recognition particle (sensu Eukaryota); GO:0005786 Srp19 Signal recognition particle protein 19 "CG4457, SRP19, srp19" CDMC27711 3 13 25 DAC40-O07 9-CG4581-RA_1 CG4581 GTGGCGAATCCACAACCGAAGCAGAAGAACAGCCAGAATATCGTGCTCGTGGATGGAGTCCGCAC 65 FBan0004581 FBgn0025352 Thiolase 2 2R fatty acid beta-oxidation; GO:0006635 acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 Thiolase Thiolase "CG4581, CG4581, thiolase" CDMC27711 3 14 25 DAC40-O07 9-CG4581-RA_1 CG4581 GTGGCGAATCCACAACCGAAGCAGAAGAACAGCCAGAATATCGTGCTCGTGGATGGAGTCCGCAC 65 FBan0004581 FBgn0025352 Thiolase 2 2R fatty acid beta-oxidation; GO:0006635 acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 Thiolase Thiolase "CG4581, CG4581, thiolase" CDMC27712 3 15 25 DAC40-O19 AutoBlank AutoBlank CDMC27712 3 16 25 DAC40-O19 AutoBlank AutoBlank CDMC27713 3 17 25 DAC41-C07 8-CG4579-RA_2 CG4579 ACGGCTAAAGCGTCCGATGCAAAAAACGGTGCTACGCAAACGATTCCAAAAATAGTGGCCCATACCCTA 69 FBan0004579 FBgn0021761 Nup154 2 2L cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643; nucleus; GO:0005634 Nup154 Nup154 "CG4579, zk, zonder kloten, tlp: tulipano, tulipano, l(2)01501, l(2)10432, nup154, Nup32D, nup32D, BcDNA:LD21772, ms(2)zk, tlp" CDMC27713 3 18 25 DAC41-C07 8-CG4579-RA_2 CG4579 ACGGCTAAAGCGTCCGATGCAAAAAACGGTGCTACGCAAACGATTCCAAAAATAGTGGCCCATACCCTA 69 FBan0004579 FBgn0021761 Nup154 2 2L cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643; nucleus; GO:0005634 Nup154 Nup154 "CG4579, zk, zonder kloten, tlp: tulipano, tulipano, l(2)01501, l(2)10432, nup154, Nup32D, nup32D, BcDNA:LD21772, ms(2)zk, tlp" CDMC27714 3 19 25 DAC41-C19 3-CG4594-RA_2 CG4594 ACAGACGTGGAGCGACTCCGAACCGTTTGGACCGAATTGCAGAATGTATGGATTGCCCTCTATGGAACA 69 FBan0004594 FBgn0032161 CG4594 2 2L fatty acid beta-oxidation; GO:0006635 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4594 CG4594 CDMC27714 3 20 25 DAC41-C19 3-CG4594-RA_2 CG4594 ACAGACGTGGAGCGACTCCGAACCGTTTGGACCGAATTGCAGAATGTATGGATTGCCCTCTATGGAACA 69 FBan0004594 FBgn0032161 CG4594 2 2L fatty acid beta-oxidation; GO:0006635 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4594 CG4594 CDMC27715 3 21 25 DAC41-G07 23-CG4618-RA_3 CG4618 CTTAGTTTAAGATCGCACCAAATCCCAAAATGTTCAACAATATTTTCGGAAAGAAACCCACCGTGAAGG 69 FBan0004618 FBgn0035589 CG4618 3 3L CG4618 CG4618 CDMC27715 3 22 25 DAC41-G07 23-CG4618-RA_3 CG4618 CTTAGTTTAAGATCGCACCAAATCCCAAAATGTTCAACAATATTTTCGGAAAGAAACCCACCGTGAAGG 69 FBan0004618 FBgn0035589 CG4618 3 3L CG4618 CG4618 CDMC27716 3 23 25 DAC41-G19 23-CG4625-RA_3 CG4625 GTCCAGTTCGCTATGAAGCAAATGAAATTCACGAAACCGCCAAAAACATACACTTGCAAAAAAGTGGAT 69 FBan0004625 FBgn0040212 Dhap-at 3 3R phospholipid metabolism; GO:0006644 glycerol-3-phosphate O-acyltransferase activity; GO:0004366 ; EC:2.3.1.15; glycerone-phosphate O-acyltransferase activity; GO:0016287 ; EC:2.3.1.42; ; GO:0016287 ; EC:2.3.1.42; ; GO:0004366 ; EC:2.3.1.15; ; GO:0016287 ; EC:2.3.1.42 mitochondrion; GO:0005739; peroxisome; GO:0005777 Dhap-at Dihydroxyacetone phosphate acyltransferase "CG4625, CG4625, CG4625, glycerol-3-phosphate acyltransferase, 8-1, GPAT, Glycerol 3-phosphate acyltransferase, DHAP-AT, Gpat, glycerol-3-phosphate-acyltransferase, Dihydroxyacetone phosphate acyltransferase" CDMC27716 3 24 25 DAC41-G19 23-CG4625-RA_3 CG4625 GTCCAGTTCGCTATGAAGCAAATGAAATTCACGAAACCGCCAAAAACATACACTTGCAAAAAAGTGGAT 69 FBan0004625 FBgn0040212 Dhap-at 3 3R phospholipid metabolism; GO:0006644 glycerol-3-phosphate O-acyltransferase activity; GO:0004366 ; EC:2.3.1.15; glycerone-phosphate O-acyltransferase activity; GO:0016287 ; EC:2.3.1.42; ; GO:0016287 ; EC:2.3.1.42; ; GO:0004366 ; EC:2.3.1.15; ; GO:0016287 ; EC:2.3.1.42 mitochondrion; GO:0005739; peroxisome; GO:0005777 Dhap-at Dihydroxyacetone phosphate acyltransferase "CG4625, CG4625, CG4625, glycerol-3-phosphate acyltransferase, 8-1, GPAT, Glycerol 3-phosphate acyltransferase, DHAP-AT, Gpat, glycerol-3-phosphate-acyltransferase, Dihydroxyacetone phosphate acyltransferase" CDMC27717 3 25 25 DAC41-K07 23-CG4655-RB_5 CG4655 ACTGAAGTTCCCACAGTTGACCTTTCTAATTGCCTCTAGATGTGACTGATGGGTCTCAGATAATTCTCT 69 FBan0004655 FBgn0037839 CG4655 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 CG4655 CG4655 "CT15041, DCad86C, BcDNA:LP07955" CDMC27717 3 26 25 DAC41-K07 23-CG4655-RB_5 CG4655 ACTGAAGTTCCCACAGTTGACCTTTCTAATTGCCTCTAGATGTGACTGATGGGTCTCAGATAATTCTCT 69 FBan0004655 FBgn0037839 CG4655 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 CG4655 CG4655 "CT15041, DCad86C, BcDNA:LP07955" CDMC27718 3 1 26 DAC41-K19 2-CG4666-RA_2 CG4666 ACCCATCTTCCATCCGTACAAGATTCAGACCAAGCTGATCTGGTGGGACGACAAGGCCATTTACCTGGA 69 FBan0004666 FBgn0029838 CG4666 X X CG4666 CG4666 CDMC27718 3 2 26 DAC41-K19 2-CG4666-RA_2 CG4666 ACCCATCTTCCATCCGTACAAGATTCAGACCAAGCTGATCTGGTGGGACGACAAGGCCATTTACCTGGA 69 FBan0004666 FBgn0029838 CG4666 X X CG4666 CG4666 CDMC27719 3 3 26 DAC41-O07 15-CG4695-RA_3 CG4695 ACAAAATCTCATTGCCATTGAGTCACTCCGAGGAGATGTACGACGAGAAGAATCCCGATGTTGTGCCCT 69 FBan0004695 FBgn0037859 CG4695 3 3R CG4695 CG4695 CDMC27719 3 4 26 DAC41-O07 15-CG4695-RA_3 CG4695 ACAAAATCTCATTGCCATTGAGTCACTCCGAGGAGATGTACGACGAGAAGAATCCCGATGTTGTGCCCT 69 FBan0004695 FBgn0037859 CG4695 3 3R CG4695 CG4695 CDMC27720 3 5 26 DAC41-O19 11-CG4701-RA_1 CG4701 TGGGAGCACTTGGAAATTCAAATGGAAGACCTTCTCAAGTCGCTGTCCGTCATGAAGGCGTCGAAACAT 69 FBan0004701 FBgn0028868 CG4701 2 2L intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0005524 mitochondrial outer membrane; GO:0005741 CG4701 CG4701 "BG:DS06874.3, DmDM19DC4Z" CDMC27720 3 6 26 DAC41-O19 11-CG4701-RA_1 CG4701 TGGGAGCACTTGGAAATTCAAATGGAAGACCTTCTCAAGTCGCTGTCCGTCATGAAGGCGTCGAAACAT 69 FBan0004701 FBgn0028868 CG4701 2 2L intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0005524 mitochondrial outer membrane; GO:0005741 CG4701 CG4701 "BG:DS06874.3, DmDM19DC4Z" CDMC27721 3 7 26 DAC42-C07 150mM NaPO4 Blank CDMC27721 3 8 26 DAC42-C07 150mM NaPO4 Blank CDMC27722 3 9 26 DAC42-C19 150mM NaPO4 Blank CDMC27722 3 10 26 DAC42-C19 150mM NaPO4 Blank CDMC27723 3 11 26 DAC42-G07 150mM NaPO4 Blank CDMC27723 3 12 26 DAC42-G07 150mM NaPO4 Blank CDMC27724 3 13 26 DAC42-G19 150mM NaPO4 Blank CDMC27724 3 14 26 DAC42-G19 150mM NaPO4 Blank CDMC27725 3 15 26 DAC42-K07 150mM NaPO4 Blank CDMC27725 3 16 26 DAC42-K07 150mM NaPO4 Blank CDMC27726 3 17 26 DAC42-K19 5uM MSP 5uM MSP CDMC27726 3 18 26 DAC42-K19 5uM MSP 5uM MSP CDMC27727 3 19 26 DAC42-O07 10uM MSP 10uM MSP CDMC27727 3 20 26 DAC42-O07 10uM MSP 10uM MSP CDMC27728 3 21 26 DAC42-O19 20uM MSP 20uM MSP CDMC27728 3 22 26 DAC42-O19 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC27729 4 1 1 DAC01-D07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27729 4 2 1 DAC01-D07 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC27730 4 3 1 DAC01-D19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27730 4 4 1 DAC01-D19 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC27731 4 5 1 DAC01-H07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27731 4 6 1 DAC01-H07 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC27732 4 7 1 DAC01-H19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27732 4 8 1 DAC01-H19 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC27733 4 9 1 DAC01-L07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27733 4 10 1 DAC01-L07 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC27734 4 11 1 DAC01-L19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27734 4 12 1 DAC01-L19 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC27735 4 13 1 DAC01-P07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27735 4 14 1 DAC01-P07 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC27736 4 15 1 DAC01-P19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27736 4 16 1 DAC01-P19 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC27737 4 17 1 DAC02-D07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27737 4 18 1 DAC02-D07 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC27738 4 19 1 DAC02-D19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27738 4 20 1 DAC02-D19 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC27739 4 21 1 DAC02-H07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27739 4 22 1 DAC02-H07 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC27740 4 23 1 DAC02-H19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27740 4 24 1 DAC02-H19 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC27741 4 25 1 DAC02-L07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27741 4 26 1 DAC02-L07 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC27742 4 1 2 DAC02-L19 N/A CG9075 (01674-01910) CDMC27742 4 2 2 DAC02-L19 N/A CG9075 (01674-01910) CDMC27743 4 3 2 DAC02-P07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27743 4 4 2 DAC02-P07 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC27744 4 5 2 DAC02-P19 AutoBlank AutoBlank CDMC27744 4 6 2 DAC02-P19 AutoBlank AutoBlank CDMC27745 4 7 2 DAC03-D07 6-CG3884-RA_1 CG3884 CAGCTTGACACCCGGTGTAATTGAGACCTACAACCGATGCCTCCAGATCCCATTCGGTGGCCAAG 65 FBan0003884 FBgn0033786 CG3884 2 2R CG3884 CG3884 CDMC27745 4 8 2 DAC03-D07 6-CG3884-RA_1 CG3884 CAGCTTGACACCCGGTGTAATTGAGACCTACAACCGATGCCTCCAGATCCCATTCGGTGGCCAAG 65 FBan0003884 FBgn0033786 CG3884 2 2R CG3884 CG3884 CDMC27746 4 9 2 DAC03-D19 23-CG3906-RA_2 CG3906 CGGAGTGGAGTATTCAATGTGTCTCCATTGTATGTATGTAAGCCCAATAAAGCAACAAGTGAAAG 65 FBan0003906 FBgn0034871 CG3906 2 2R CG3906 CG3906 CDMC27746 4 10 2 DAC03-D19 23-CG3906-RA_2 CG3906 CGGAGTGGAGTATTCAATGTGTCTCCATTGTATGTATGTAAGCCCAATAAAGCAACAAGTGAAAG 65 FBan0003906 FBgn0034871 CG3906 2 2R CG3906 CG3906 CDMC27747 4 11 2 DAC03-H07 23-CG4000-RA_6 CG4000 GCCTTAACCCCCTTTGATGGTCATTTAAGTTAGTCCTAAAGCTAGTCAATGTTTTTGGAGCTCAC 65 FBan0004000 FBgn0038820 CG4000 3 3R CG4000 CG4000 CDMC27747 4 12 2 DAC03-H07 23-CG4000-RA_6 CG4000 GCCTTAACCCCCTTTGATGGTCATTTAAGTTAGTCCTAAAGCTAGTCAATGTTTTTGGAGCTCAC 65 FBan0004000 FBgn0038820 CG4000 3 3R CG4000 CG4000 CDMC27748 4 13 2 DAC03-H19 23-CG40108-RA_6 CG40108 AATTTAATCAGTCACCATATATTAGACAGCATGATCACGTCTCACCAAATGGTACTAGTTCCGTG 65 FBgn0058108 CG40108 CG40108 CG40108 CDMC27748 4 14 2 DAC03-H19 23-CG40108-RA_6 CG40108 AATTTAATCAGTCACCATATATTAGACAGCATGATCACGTCTCACCAAATGGTACTAGTTCCGTG 65 FBgn0058108 CG40108 CG40108 CG40108 CDMC27749 4 15 2 DAC03-L07 23-CG40244-RA_1 CG40244 TTTGACTATAAGTTACCTGTTAACGACGATTAATACGTGTGCAAGGGAATGGAAGGTATGCAAGT 65 FBgn0058244 CG40244 CG40244 CG40244 CDMC27749 4 16 2 DAC03-L07 23-CG40244-RA_1 CG40244 TTTGACTATAAGTTACCTGTTAACGACGATTAATACGTGTGCAAGGGAATGGAAGGTATGCAAGT 65 FBgn0058244 CG40244 CG40244 CG40244 CDMC27750 4 17 2 DAC03-L19 1-CG40322-RA_2 CG40322 GTACTCGATTTCGTACTGGGTCCCGTACTGGTTCCGTACTCGGTTCCGTACTCGGTCCCGTACTG 65 FBgn0058322 CG40322 CG40322 CG40322 CDMC27750 4 18 2 DAC03-L19 1-CG40322-RA_2 CG40322 GTACTCGATTTCGTACTGGGTCCCGTACTGGTTCCGTACTCGGTTCCGTACTCGGTCCCGTACTG 65 FBgn0058322 CG40322 CG40322 CG40322 CDMC27751 4 19 2 DAC03-P07 16-CG40497-RB_1 CG40497 GTCCCAGGACGAGCGTTGCCTCGCCCCAAAACGATACACCCTGTCCCATACCATCCTAATCCTGG 65 FBgn0069970 CG40497 CG40497 CG40497 CDMC27751 4 20 2 DAC03-P07 16-CG40497-RB_1 CG40497 GTCCCAGGACGAGCGTTGCCTCGCCCCAAAACGATACACCCTGTCCCATACCATCCTAATCCTGG 65 FBgn0069970 CG40497 CG40497 CG40497 CDMC27752 4 21 2 DAC03-P19 AutoBlank AutoBlank CDMC27752 4 22 2 DAC03-P19 AutoBlank AutoBlank CDMC27753 4 23 2 DAC04-D07 17-CG31529-RA_3 CG31529 GGCCAGGGTTGTCATACTGTCGTGTAGTTGACAAACATTTGTACATAAGCGTCTGACAGAGTTGCCCTC 69 FBan0031529 FBgn0051529 CG31529 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31529 CG31529 BcDNA:LD01463 CDMC27753 4 24 2 DAC04-D07 17-CG31529-RA_3 CG31529 GGCCAGGGTTGTCATACTGTCGTGTAGTTGACAAACATTTGTACATAAGCGTCTGACAGAGTTGCCCTC 69 FBan0031529 FBgn0051529 CG31529 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31529 CG31529 BcDNA:LD01463 CDMC27754 4 25 2 DAC04-D19 23-CG31536-RC_2 CG31536 ATTTTCCAAAGCAAAACCAAAAACCAATTTCGCCTCAAAATTCTAATCCAGTCTTGTACGAGCATTGAA 69 FBan0031536 FBgn0051536 Cdep 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; Rho guanyl-nucleotide exchange factor activity; GO:0005089; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005089; ; GO:0003779 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Cdep Cdep "CG1283, CG31536, CG2008, CG1283, CG1283, CG31536, CG2008, i23, CDEP, BcDNA:AT26639, BcDNA:RH50880" CDMC27754 4 26 2 DAC04-D19 23-CG31536-RC_2 CG31536 ATTTTCCAAAGCAAAACCAAAAACCAATTTCGCCTCAAAATTCTAATCCAGTCTTGTACGAGCATTGAA 69 FBan0031536 FBgn0051536 Cdep 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; Rho guanyl-nucleotide exchange factor activity; GO:0005089; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005089; ; GO:0003779 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Cdep Cdep "CG1283, CG31536, CG2008, CG1283, CG1283, CG31536, CG2008, i23, CDEP, BcDNA:AT26639, BcDNA:RH50880" CDMC27755 4 1 3 DAC04-H07 12-CG31609-RA_2 CG31609 TTTGCCATTTTCCATCTGCTTCAGCCGTATTTTGGGTGTGGAATTTGGCATTTTTCCGCAGGCTGCAAT 69 FBan0031609 FBgn0051609 CG31609 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG31609 CG31609 anon-AE003623.1 CDMC27755 4 2 3 DAC04-H07 12-CG31609-RA_2 CG31609 TTTGCCATTTTCCATCTGCTTCAGCCGTATTTTGGGTGTGGAATTTGGCATTTTTCCGCAGGCTGCAAT 69 FBan0031609 FBgn0051609 CG31609 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG31609 CG31609 anon-AE003623.1 CDMC27756 4 3 3 DAC04-H19 13-CG31622-RA_1 CG31622 AGGGAAAATTTCGACCCGACGAATGCTTGATCATGCTTTTGACCTCCTCTACTTGGGATACTCCGTGGA 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC27756 4 4 3 DAC04-H19 13-CG31622-RA_1 CG31622 AGGGAAAATTTCGACCCGACGAATGCTTGATCATGCTTTTGACCTCCTCTACTTGGGATACTCCGTGGA 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC27757 4 5 3 DAC04-L07 18-CG31644-RA_1 CG31644 ACTTTGGCCCTGTTAGCTCCACTTCTTTTCTACACTTTACACAACAATCCGCGCAAGAGGAAGTACAGG 69 FBan0031644 FBgn0051644 CG31644 2 2L electron transport; GO:0006118 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 cellular component unknown; GO:0008372 CG31644 CG31644 BcDNA:AT20031 CDMC27757 4 6 3 DAC04-L07 18-CG31644-RA_1 CG31644 ACTTTGGCCCTGTTAGCTCCACTTCTTTTCTACACTTTACACAACAATCCGCGCAAGAGGAAGTACAGG 69 FBan0031644 FBgn0051644 CG31644 2 2L electron transport; GO:0006118 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 cellular component unknown; GO:0008372 CG31644 CG31644 BcDNA:AT20031 CDMC27758 4 7 3 DAC04-L19 3-CG31650-RA_1 CG31650 AGGTGGACCATCTCTTTGTCTCCACCGATGAGGATCACGACGATCGCCTGTCCTACCTGGAAATACTCA 69 FBgn0051650 CDMC27758 4 8 3 DAC04-L19 3-CG31650-RA_1 CG31650 AGGTGGACCATCTCTTTGTCTCCACCGATGAGGATCACGACGATCGCCTGTCCTACCTGGAAATACTCA 69 FBgn0051650 CDMC27759 4 9 3 DAC04-P07 2-CG31679-RA_1 CG31679 GGCCCGTTTGTGGAATCGTCCTACTTCATGGGCCGACAAATTCAGGGAGCTGGTATTATCACCGATCCT 69 FBan0031679 FBgn0051679 CG31679 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG31679 CG31679 CG17006 CDMC27759 4 10 3 DAC04-P07 2-CG31679-RA_1 CG31679 GGCCCGTTTGTGGAATCGTCCTACTTCATGGGCCGACAAATTCAGGGAGCTGGTATTATCACCGATCCT 69 FBan0031679 FBgn0051679 CG31679 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG31679 CG31679 CG17006 CDMC27760 4 11 3 DAC04-P19 22-CG31688-RA_1 CG31688 AGCCAAGGGGAATCGGGATGTTTTCGGAATTCACAATCATGGTTCGATTTAGTGGGTCATGTGAAAGTT 69 FBan0031688 FBgn0051688 CG31688 2 2L CG31688 CG31688 "CG18597, CG11016, CG11017, CG18597, CG18597, 38C.49, 38C.52" CDMC27760 4 12 3 DAC04-P19 22-CG31688-RA_1 CG31688 AGCCAAGGGGAATCGGGATGTTTTCGGAATTCACAATCATGGTTCGATTTAGTGGGTCATGTGAAAGTT 69 FBan0031688 FBgn0051688 CG31688 2 2L CG31688 CG31688 "CG18597, CG11016, CG11017, CG18597, CG18597, 38C.49, 38C.52" CDMC27761 4 13 3 DAC05-D07 17-CG5999-RA_2 CG5999 AATCATCTATTGAACCCCCTGATCGGTAATCCCCTGGAGGTTTCCTATGCCGGAATCAGTAATCCTGCA 69 FBan0005999 FBgn0038083 CG5999 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG5999 CG5999 CDMC27761 4 14 3 DAC05-D07 17-CG5999-RA_2 CG5999 AATCATCTATTGAACCCCCTGATCGGTAATCCCCTGGAGGTTTCCTATGCCGGAATCAGTAATCCTGCA 69 FBan0005999 FBgn0038083 CG5999 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG5999 CG5999 CDMC27762 4 15 3 DAC05-D19 23-CG6013-RA_4 CG6013 AACATTTTAGGATCGGAATTCATTCATAAAGGACACAATGCCAAAGAAAATGGGAATCAACTCGAAGGC 69 FBan0006013 FBgn0038675 CG6013 3 3R CG6013 CG6013 CDMC27762 4 16 3 DAC05-D19 23-CG6013-RA_4 CG6013 AACATTTTAGGATCGGAATTCATTCATAAAGGACACAATGCCAAAGAAAATGGGAATCAACTCGAAGGC 69 FBan0006013 FBgn0038675 CG6013 3 3R CG6013 CG6013 CDMC27763 4 17 3 DAC05-H07 8-CG6044-RC_1 CG6044 AGCCCACGCAAAAGAGCTCAGAACTCACAAAAAACCCTGGTGACAAAACAAAGTTCAGTGTCTCGGCCG 69 FBan0006044 FBgn0034725 CG6044 2 2R CG6044 CG6044 BcDNA:RH44966 CDMC27763 4 18 3 DAC05-H07 8-CG6044-RC_1 CG6044 AGCCCACGCAAAAGAGCTCAGAACTCACAAAAAACCCTGGTGACAAAACAAAGTTCAGTGTCTCGGCCG 69 FBan0006044 FBgn0034725 CG6044 2 2R CG6044 CG6044 BcDNA:RH44966 CDMC27764 4 19 3 DAC05-H19 17-CG6055-RA_2 CG6055 TCTGTGCTGTTCGCTTATCGAGTTTTGAGCCCCGCTTTGTGTCGTTCGTTTCAATCTAAAGCTATCCAA 69 FBan0006055 FBgn0031918 CG6055 2 2L sugar binding; GO:0005529; ; GO:0005529 CG6055 CG6055 CDMC27764 4 20 3 DAC05-H19 17-CG6055-RA_2 CG6055 TCTGTGCTGTTCGCTTATCGAGTTTTGAGCCCCGCTTTGTGTCGTTCGTTTCAATCTAAAGCTATCCAA 69 FBan0006055 FBgn0031918 CG6055 2 2L sugar binding; GO:0005529; ; GO:0005529 CG6055 CG6055 CDMC27765 4 21 3 DAC05-L07 12-CG6097-RA_5 CG6097 TGGCGGATCGTGAAAAGGCAATACATGAGGATGCCATTTGGAATGTTGAGGAGCACCGCTATACACAGA 69 FBan0006097 FBgn0003292 rt 3 3L protein amino acid O-linked mannosylation; GO:0035269; protein amino acid glycosylation; GO:0006486 "dolichyl-phosphate-mannose-protein mannosyltransferase activity; GO:0004169 ; EC:2.4.1.109; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0016757 ; EC:2.4.-.-; mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0000030 ; EC:2.4.1.-" integral to membrane; GO:0016021; membrane; GO:0016020 rt rotated abdomen "CG6097, pomt, dPOMT1, Drosophila Protein O-mannosyltransferase 1, Rot_abd, POMT1, fs(3)neo1" CDMC27765 4 22 3 DAC05-L07 12-CG6097-RA_5 CG6097 TGGCGGATCGTGAAAAGGCAATACATGAGGATGCCATTTGGAATGTTGAGGAGCACCGCTATACACAGA 69 FBan0006097 FBgn0003292 rt 3 3L protein amino acid O-linked mannosylation; GO:0035269; protein amino acid glycosylation; GO:0006486 "dolichyl-phosphate-mannose-protein mannosyltransferase activity; GO:0004169 ; EC:2.4.1.109; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0016757 ; EC:2.4.-.-; mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0004169 ; EC:2.4.1.109; ; GO:0000030 ; EC:2.4.1.-" integral to membrane; GO:0016021; membrane; GO:0016020 rt rotated abdomen "CG6097, pomt, dPOMT1, Drosophila Protein O-mannosyltransferase 1, Rot_abd, POMT1, fs(3)neo1" CDMC27766 4 23 3 DAC05-L19 10-CG6115-RA_1 CG6115 GGCCCTGTACTCGCTGAAGAAGTACCGAAGTGTCAAGCAGCGCTATAGTTACAATGACTAAGTGGGCGG 69 FBan0006115 FBgn0040985 CG6115 2 2L CG6115 CG6115 BcDNA:GH16758 CDMC27766 4 24 3 DAC05-L19 10-CG6115-RA_1 CG6115 GGCCCTGTACTCGCTGAAGAAGTACCGAAGTGTCAAGCAGCGCTATAGTTACAATGACTAAGTGGGCGG 69 FBan0006115 FBgn0040985 CG6115 2 2L CG6115 CG6115 BcDNA:GH16758 CDMC27767 4 25 3 DAC05-P07 6-CG6146-RA_5 CG6146 TGGCCTCCTGGATCGAGAATGTGCAGGGACAGGTCAAGTACATCATGTTGAATCCCTCCTCGAAACTCA 69 FBan0006146 FBgn0004924 Top1 X X DNA replication; GO:0006260; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268; embryonic development; GO:0009790; larval development (sensu Insecta); GO:0002168; mRNA transcription; GO:0009299; oogenesis (sensu Insecta); GO:0009993; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2 cytoplasm; GO:0005737; nucleus; GO:0005634 Top1 Topoisomerase 1 "CG6146, Topoisomerase I, topoisomerase I, type I topoisomerase, top1, l(1)top1, TOP1, topoI, l(1)G0278, l(1)G0229, l(1)G0201, topo I, l(1)G0134, topi, topoisomerase1, Topo I, TopI, dTopoI" CDMC27767 4 26 3 DAC05-P07 6-CG6146-RA_5 CG6146 TGGCCTCCTGGATCGAGAATGTGCAGGGACAGGTCAAGTACATCATGTTGAATCCCTCCTCGAAACTCA 69 FBan0006146 FBgn0004924 Top1 X X DNA replication; GO:0006260; DNA topological change; GO:0006265; DNA unwinding during replication; GO:0006268; embryonic development; GO:0009790; larval development (sensu Insecta); GO:0002168; mRNA transcription; GO:0009299; oogenesis (sensu Insecta); GO:0009993; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA topoisomerase type I activity; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003676; ; GO:0003917 ; EC:5.99.1.2; ; GO:0003917 ; EC:5.99.1.2 cytoplasm; GO:0005737; nucleus; GO:0005634 Top1 Topoisomerase 1 "CG6146, Topoisomerase I, topoisomerase I, type I topoisomerase, top1, l(1)top1, TOP1, topoI, l(1)G0278, l(1)G0229, l(1)G0201, topo I, l(1)G0134, topi, topoisomerase1, Topo I, TopI, dTopoI" CDMC27768 4 1 4 DAC05-P19 2-CG6156-RB_1 CG6156 CCAAGCTGAAGGGACGTCGTTCCAATGTCCAGCATACCATTGTCAGTTTGGAATCACCCTTCAGCGACA 69 FBan0006156 FBgn0038328 CG6156 3 3R CG6156 CG6156 anon-FF CDMC27768 4 2 4 DAC05-P19 2-CG6156-RB_1 CG6156 CCAAGCTGAAGGGACGTCGTTCCAATGTCCAGCATACCATTGTCAGTTTGGAATCACCCTTCAGCGACA 69 FBan0006156 FBgn0038328 CG6156 3 3R CG6156 CG6156 anon-FF CDMC27769 4 3 4 DAC06-D07 23-CG11556-RA_20 CG11556 ATGTTTTTCCTGTAGGACACATTTGAACGAACTGATTTCTCAGCGCAGTCAAGGAAATATGAACCATAT 69 FBan0011556 FBgn0030230 Rph X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 zinc ion binding; GO:0008270; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008270 membrane; GO:0016020; synaptic vesicle; GO:0008021 Rph Rabphilin "CG11556, CG11556, rabphilin-3A, dm-rabphilin, Rabphilin" CDMC27769 4 4 4 DAC06-D07 23-CG11556-RA_20 CG11556 ATGTTTTTCCTGTAGGACACATTTGAACGAACTGATTTCTCAGCGCAGTCAAGGAAATATGAACCATAT 69 FBan0011556 FBgn0030230 Rph X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle exocytosis; GO:0016079; vesicle-mediated transport; GO:0016192 zinc ion binding; GO:0008270; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008270 membrane; GO:0016020; synaptic vesicle; GO:0008021 Rph Rabphilin "CG11556, CG11556, rabphilin-3A, dm-rabphilin, Rabphilin" CDMC27770 4 5 4 DAC06-D19 2-CG11570-RA_1 CG11570 CCTTCGCTGTGAGCAAAACCTCCAGTGGAGTTCAGTATACCAGAGATGCGTTGTCCCACAGTATGGCGA 69 FBan0011570 FBgn0036230 CG11570 3 3L CG11570 CG11570 CDMC27770 4 6 4 DAC06-D19 2-CG11570-RA_1 CG11570 CCTTCGCTGTGAGCAAAACCTCCAGTGGAGTTCAGTATACCAGAGATGCGTTGTCCCACAGTATGGCGA 69 FBan0011570 FBgn0036230 CG11570 3 3L CG11570 CG11570 CDMC27771 4 7 4 DAC06-H07 18-CG11617-RA_3 CG11617 TCTGACCGAGCGGATATCAGCACAAACAGGGGGTAAGACCAAGTACAAGCATCAGATGATGGAAAAGTA 69 FBan0011617 FBgn0031232 CG11617 2 2L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11617 CG11617 CDMC27771 4 8 4 DAC06-H07 18-CG11617-RA_3 CG11617 TCTGACCGAGCGGATATCAGCACAAACAGGGGGTAAGACCAAGTACAAGCATCAGATGATGGAAAAGTA 69 FBan0011617 FBgn0031232 CG11617 2 2L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11617 CG11617 CDMC27772 4 9 4 DAC06-H19 22-CG11628-RA_3 CG11628 AGCGCTACTGTCAACTAAATCCAGATATATTCACCAACACGGACACATGCTATGTGCTCAGCTTCGCAA 69 FBan0011628 FBgn0032960 Grp1 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; ; GO:0005086 Grp1 General receptor for phosphoinositides 1 "CG11628, CG11633, CG11628, CG11628, CG11628, CG11628, CG11628, CG11628, GRP1/cytohesin 1, cytohesin/GRP1, CYH1, General receptor for phosphoinositides 1" CDMC27772 4 10 4 DAC06-H19 22-CG11628-RA_3 CG11628 AGCGCTACTGTCAACTAAATCCAGATATATTCACCAACACGGACACATGCTATGTGCTCAGCTTCGCAA 69 FBan0011628 FBgn0032960 Grp1 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886 ARF guanyl-nucleotide exchange factor activity; GO:0005086; ; GO:0005086 Grp1 General receptor for phosphoinositides 1 "CG11628, CG11633, CG11628, CG11628, CG11628, CG11628, CG11628, CG11628, GRP1/cytohesin 1, cytohesin/GRP1, CYH1, General receptor for phosphoinositides 1" CDMC27773 4 11 4 DAC06-L07 3-CG11664-RA_1 CG11664 CCTGGCAATAGCCTTTCGAAAATGCGGAGATAAGCGATATCCCGCCCTCTTTACGGACGTCCACTACCA 69 FBan0011664 FBgn0040341 CG11664 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11664 CG11664 "EG:BACR7A4.3, SP193" CDMC27773 4 12 4 DAC06-L07 3-CG11664-RA_1 CG11664 CCTGGCAATAGCCTTTCGAAAATGCGGAGATAAGCGATATCCCGCCCTCTTTACGGACGTCCACTACCA 69 FBan0011664 FBgn0040341 CG11664 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11664 CG11664 "EG:BACR7A4.3, SP193" CDMC27774 4 13 4 DAC06-L19 23-CG11672-RA_1 CG11672 CCTGTTCACTTATTGCTTATGCATGACATTTATTTGACAAGTTTTTGATTGATTTTACAGCTGCTGCAG 69 FBan0011672 FBgn0037563 CG11672 3 3R CG11672 CG11672 BcDNA:RE26525 CDMC27774 4 14 4 DAC06-L19 23-CG11672-RA_1 CG11672 CCTGTTCACTTATTGCTTATGCATGACATTTATTTGACAAGTTTTTGATTGATTTTACAGCTGCTGCAG 69 FBan0011672 FBgn0037563 CG11672 3 3R CG11672 CG11672 BcDNA:RE26525 CDMC27775 4 15 4 DAC06-P07 22-CG11727-RB_1 CG11727 TCTGGAATCTCGCATGAAGGATGAGCTGATGAATGTGAAAATCAAATTCACCGAGCAAAGCCAAACGGT 69 FBan0011727 FBgn0030299 CG11727 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG11727 CG11727 "BcDNA:LD11130, BcDNA:GH08923" CDMC27775 4 16 4 DAC06-P07 22-CG11727-RB_1 CG11727 TCTGGAATCTCGCATGAAGGATGAGCTGATGAATGTGAAAATCAAATTCACCGAGCAAAGCCAAACGGT 69 FBan0011727 FBgn0030299 CG11727 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG11727 CG11727 "BcDNA:LD11130, BcDNA:GH08923" CDMC27776 4 17 4 DAC06-P19 3-CG11748-RB_1 CG11748 GCTCAGCTGCCTGAAGAACAACATCAAGGTATTCGTGTTTCCCTAGGCTTTCCATCCGAGGCTGCCAAT 69 FBan0011748 FBgn0031109 Obp19a X X olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp19a Odorant-binding protein 19a "CG11748, CG11748, CG11748, OBP19a, 19a, Odorant-binding protein 19a" CDMC27776 4 18 4 DAC06-P19 3-CG11748-RB_1 CG11748 GCTCAGCTGCCTGAAGAACAACATCAAGGTATTCGTGTTTCCCTAGGCTTTCCATCCGAGGCTGCCAAT 69 FBan0011748 FBgn0031109 Obp19a X X olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp19a Odorant-binding protein 19a "CG11748, CG11748, CG11748, OBP19a, 19a, Odorant-binding protein 19a" CDMC27777 4 19 4 DAC07-D07 4-CG15047-RA_1 CG15047 GTCGCAAGTTGAGCAATTGCATCTGAAATCTCCGCCAGAAACGGCTGCAGCAGGAGCAGGATCTC 65 FBan0015047 FBgn0030938 CG15047 X X CG15047 CG15047 CDMC27777 4 20 4 DAC07-D07 4-CG15047-RA_1 CG15047 GTCGCAAGTTGAGCAATTGCATCTGAAATCTCCGCCAGAAACGGCTGCAGCAGGAGCAGGATCTC 65 FBan0015047 FBgn0030938 CG15047 X X CG15047 CG15047 CDMC27778 4 21 4 DAC07-D19 3-CG15062-RA_2 CG15062 GAAATTGAATGCCAGCAGTACGCATCTGGACTGGGAGAACACCTGCAATCTGAAGCCCACGGGTC 65 FBgn0030909 CDMC27778 4 22 4 DAC07-D19 3-CG15062-RA_2 CG15062 GAAATTGAATGCCAGCAGTACGCATCTGGACTGGGAGAACACCTGCAATCTGAAGCCCACGGGTC 65 FBgn0030909 CDMC27779 4 23 4 DAC07-H07 15-CG15157-RA_1 CG15157 GTCCACATTTACGCTCACATCCTTCGACAGTGATATCGGACACGGCCTGAAAGAACGCGAGTCGC 65 FBan0015157 FBgn0032675 CG15157 2 2L CG15157 CG15157 CDMC27779 4 24 4 DAC07-H07 15-CG15157-RA_1 CG15157 GTCCACATTTACGCTCACATCCTTCGACAGTGATATCGGACACGGCCTGAAAGAACGCGAGTCGC 65 FBan0015157 FBgn0032675 CG15157 2 2L CG15157 CG15157 CDMC27780 4 25 4 DAC07-H19 4-CG15171-RA_1 CG15171 CACTGGTGATTCTGGCCCGATCCATGGTGCAGGATTTGGAGAATGGGGACGAGCTGAGTTACGTG 65 FBan0015171 FBgn0028569 robl37BC 2 2L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 robl37BC robl37BC "CG15171, CG15171" CDMC27780 4 26 4 DAC07-H19 4-CG15171-RA_1 CG15171 CACTGGTGATTCTGGCCCGATCCATGGTGCAGGATTTGGAGAATGGGGACGAGCTGAGTTACGTG 65 FBan0015171 FBgn0028569 robl37BC 2 2L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 robl37BC robl37BC "CG15171, CG15171" CDMC27781 4 1 5 DAC07-L07 3-CG15254-RA_1 CG15254 AAAACGGAGAGATGACCATTGTGCCGCTACAGGAAGGTGCCGAAGAACTTATGGGGCAGCGATTG 65 FBan0015254 FBgn0028949 CG15254 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15254 CG15254 "BG:BACR44L22.2, BACcr44L22.2" CDMC27781 4 2 5 DAC07-L07 3-CG15254-RA_1 CG15254 AAAACGGAGAGATGACCATTGTGCCGCTACAGGAAGGTGCCGAAGAACTTATGGGGCAGCGATTG 65 FBan0015254 FBgn0028949 CG15254 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15254 CG15254 "BG:BACR44L22.2, BACcr44L22.2" CDMC27782 4 3 5 DAC07-L19 3-CG15308-RA_1 CG15308 GACAGGCCCCCATCTACGATGCTCCACTGGTGCAGTCCTATGGTGGATGGTTGAAGCAGAAGTAG 65 FBan0015308 FBgn0040941 CG15308 X X CG15308 CG15308 CDMC27782 4 4 5 DAC07-L19 3-CG15308-RA_1 CG15308 GACAGGCCCCCATCTACGATGCTCCACTGGTGCAGTCCTATGGTGGATGGTTGAAGCAGAAGTAG 65 FBan0015308 FBgn0040941 CG15308 X X CG15308 CG15308 CDMC27783 4 5 5 DAC07-P07 23-CG15375-RA_5 CG15375 CGCGAAAACTAAAGTTCTCCGGTATTTGTAAGCTAACCGATGAGGAACTGTCGCATCTCTACAAG 65 FBan0015375 FBgn0029694 CG15375 X X CG15375 CG15375 CDMC27783 4 6 5 DAC07-P07 23-CG15375-RA_5 CG15375 CGCGAAAACTAAAGTTCTCCGGTATTTGTAAGCTAACCGATGAGGAACTGTCGCATCTCTACAAG 65 FBan0015375 FBgn0029694 CG15375 X X CG15375 CG15375 CDMC27784 4 7 5 DAC07-P19 AutoBlank AutoBlank CDMC27784 4 8 5 DAC07-P19 AutoBlank AutoBlank CDMC27785 4 9 5 DAC08-D07 7-CG14650-RA_1 CG14650 GGAGAATCGACTAATTTACGACCAAAGCATTGCCGAAACTCTGCACACCGAGAAGGCGTGGACGGA 66 FBan0014650 FBgn0037252 CG14650 3 3R protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG14650 CG14650 CDMC27785 4 10 5 DAC08-D07 7-CG14650-RA_1 CG14650 GGAGAATCGACTAATTTACGACCAAAGCATTGCCGAAACTCTGCACACCGAGAAGGCGTGGACGGA 66 FBan0014650 FBgn0037252 CG14650 3 3R protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG14650 CG14650 CDMC27786 4 11 5 DAC08-D19 17-CG14698-RA_1 CG14698 GGAGCTTATAAACCAATTTGCCGGCCCGATCAAAAGAAAATCTATGGAGTAGCGCGAAACGAGGCC 66 FBan0014698 FBgn0037858 CG14698 3 3R CG14698 CG14698 CDMC27786 4 12 5 DAC08-D19 17-CG14698-RA_1 CG14698 GGAGCTTATAAACCAATTTGCCGGCCCGATCAAAAGAAAATCTATGGAGTAGCGCGAAACGAGGCC 66 FBan0014698 FBgn0037858 CG14698 3 3R CG14698 CG14698 CDMC27787 4 13 5 DAC08-H07 9-CG14945-RA_5 CG14945 TGTCCATCGTCTGCTGATCAGCTACTTGCGGGATCAGTTAAAGGACCTGATAGCCCATCCTTCGCT 66 FBan0014945 FBgn0032402 CG14945 2 2L CG14945 CG14945 CDMC27787 4 14 5 DAC08-H07 9-CG14945-RA_5 CG14945 TGTCCATCGTCTGCTGATCAGCTACTTGCGGGATCAGTTAAAGGACCTGATAGCCCATCCTTCGCT 66 FBan0014945 FBgn0032402 CG14945 2 2L CG14945 CG14945 CDMC27788 4 15 5 DAC08-H19 21-CG15004-RA_5 CG15004 CGGTACTCGTGGGAGAACAATCTGTACCACCTAATCCTTTCGCTGATCATACCGAACGTGCTCTTT 66 FBan0015004 FBgn0035505 CG15004 3 3L sodium channel auxiliary protein activity; GO:0016974; ; GO:0016974 CG15004 CG15004 CDMC27788 4 16 5 DAC08-H19 21-CG15004-RA_5 CG15004 CGGTACTCGTGGGAGAACAATCTGTACCACCTAATCCTTTCGCTGATCATACCGAACGTGCTCTTT 66 FBan0015004 FBgn0035505 CG15004 3 3L sodium channel auxiliary protein activity; GO:0016974; ; GO:0016974 CG15004 CG15004 CDMC27789 4 17 5 DAC08-L07 24-CG1552-RA_1 CG1552 TGTAGGCTATAATTTAGATTGTAACATATATAAGCTGGTATTCATCAAACTGAGCACAAAAAAAAA 66 FBan0001552 FBgn0030258 CG1552 X X CG1552 CG1552 anon-EST:Posey230 CDMC27789 4 18 5 DAC08-L07 24-CG1552-RA_1 CG1552 TGTAGGCTATAATTTAGATTGTAACATATATAAGCTGGTATTCATCAAACTGAGCACAAAAAAAAA 66 FBan0001552 FBgn0030258 CG1552 X X CG1552 CG1552 anon-EST:Posey230 CDMC27790 4 19 5 DAC08-L19 1-CG15696-RA_1 CG15696 GCCAACAAACTAGCCGACTCCTTGGAGCTGACCAATACGCGGGTGAAGATCTGGTTCCAGAATCGA 66 FBan0015696 FBgn0038833 CG15696 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG15696 CG15696 CDMC27790 4 20 5 DAC08-L19 1-CG15696-RA_1 CG15696 GCCAACAAACTAGCCGACTCCTTGGAGCTGACCAATACGCGGGTGAAGATCTGGTTCCAGAATCGA 66 FBan0015696 FBgn0038833 CG15696 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG15696 CG15696 CDMC27791 4 21 5 DAC08-P07 16-CG17181-RA_4 CG17181 GCTCCGTGTGTGATAAAGCATTGACTTCCCATCGGCAACTGAATCATCCGTCTATATTCGAGGCGG 66 FBan0017181 FBgn0035144 CG17181 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17181 CG17181 CDMC27791 4 22 5 DAC08-P07 16-CG17181-RA_4 CG17181 GCTCCGTGTGTGATAAAGCATTGACTTCCCATCGGCAACTGAATCATCCGTCTATATTCGAGGCGG 66 FBan0017181 FBgn0035144 CG17181 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17181 CG17181 CDMC27792 4 23 5 DAC08-P19 AutoBlank AutoBlank CDMC27792 4 24 5 DAC08-P19 AutoBlank AutoBlank CDMC27793 4 25 5 DAC09-D08 12-CG14115-RA_5 CG14115 TGGGTGGAGTTTTCGTTCTTGGCTTGAGCTTAGCACATTGTTTTCTGGTGTTTCCTCGTCAGGGATCCT 69 FBan0014115 FBgn0036343 CG14115 3 3L CG14115 CG14115 CDMC27793 4 26 5 DAC09-D08 12-CG14115-RA_5 CG14115 TGGGTGGAGTTTTCGTTCTTGGCTTGAGCTTAGCACATTGTTTTCTGGTGTTTCCTCGTCAGGGATCCT 69 FBan0014115 FBgn0036343 CG14115 3 3L CG14115 CG14115 CDMC27794 4 1 6 DAC09-D20 23-CG1411-RD_5 CG1411 CGATCCTAAGGTGAGAAGTGTAGGGTGTATATTGTTTTAAACACAAGCAAATCCAAGTATCAGGGAGTA 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC27794 4 2 6 DAC09-D20 23-CG1411-RD_5 CG1411 CGATCCTAAGGTGAGAAGTGTAGGGTGTATATTGTTTTAAACACAAGCAAATCCAAGTATCAGGGAGTA 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC27795 4 3 6 DAC09-H08 22-CG1417-RC_1 CG1417 GGCCATCCGATCTAAAATAGTCAAATAATACTGTTCATAGGAGCCTGGGATAGCCAACCGCGCATACCT 69 FBan0001417 FBgn0003423 slgA X X glutamate biosynthesis; GO:0006537; locomotory behavior; GO:0007626; phototactic behavior; GO:0046953; proline catabolism; GO:0006562 proline dehydrogenase activity; GO:0004657 ; EC:1.5.99.8; ; GO:0004657 ; EC:1.5.99.8; ; GO:0004657 ; EC:1.5.99.8 mitochondrial matrix; GO:0005759 slgA sluggish A "CG1417, slg, sluggish, sl, tu3, proline dehydrogenase, sluggish-A, PRODH, EE85" CDMC27795 4 4 6 DAC09-H08 22-CG1417-RC_1 CG1417 GGCCATCCGATCTAAAATAGTCAAATAATACTGTTCATAGGAGCCTGGGATAGCCAACCGCGCATACCT 69 FBan0001417 FBgn0003423 slgA X X glutamate biosynthesis; GO:0006537; locomotory behavior; GO:0007626; phototactic behavior; GO:0046953; proline catabolism; GO:0006562 proline dehydrogenase activity; GO:0004657 ; EC:1.5.99.8; ; GO:0004657 ; EC:1.5.99.8; ; GO:0004657 ; EC:1.5.99.8 mitochondrial matrix; GO:0005759 slgA sluggish A "CG1417, slg, sluggish, sl, tu3, proline dehydrogenase, sluggish-A, PRODH, EE85" CDMC27796 4 5 6 DAC09-H20 18-CG1418-RA_1 CG1418 GCAGCGAAGACGTGTATCTAAGATAAGTGTTAGGACGAGGTTGGGAAAGCACAAGCAAAATGGCACACA 69 FBan0001418 FBgn0033468 CG1418 2 2R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 Rab GTPase binding; GO:0017137; ; GO:0017137 CG1418 CG1418 CDMC27796 4 6 6 DAC09-H20 18-CG1418-RA_1 CG1418 GCAGCGAAGACGTGTATCTAAGATAAGTGTTAGGACGAGGTTGGGAAAGCACAAGCAAAATGGCACACA 69 FBan0001418 FBgn0033468 CG1418 2 2R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 Rab GTPase binding; GO:0017137; ; GO:0017137 CG1418 CG1418 CDMC27797 4 7 6 DAC09-L08 2-CG14224-RA_1 CG14224 CCCATCAAGCCGGAAATGTCAGGAATCCATCATAGCCACATGCCAACATACCAACACCCCCAAGACACA 69 FBan0014224 FBgn0031057 CG14224 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 CG14224 CG14224 "clone 5.42, anon-18DEa, BEST:LD26923" CDMC27797 4 8 6 DAC09-L08 2-CG14224-RA_1 CG14224 CCCATCAAGCCGGAAATGTCAGGAATCCATCATAGCCACATGCCAACATACCAACACCCCCAAGACACA 69 FBan0014224 FBgn0031057 CG14224 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 CG14224 CG14224 "clone 5.42, anon-18DEa, BEST:LD26923" CDMC27798 4 9 6 DAC09-L20 23-CG14234-RA_9 CG14234 AAGTACGGACGTATTTCTCAATCCACAGTACGGATTAAGCCCTTTTAGCTGGACACACCTACAACCAAT 69 FBan0014234 FBgn0031065 CG14234 X X CG14234 CG14234 CDMC27798 4 10 6 DAC09-L20 23-CG14234-RA_9 CG14234 AAGTACGGACGTATTTCTCAATCCACAGTACGGATTAAGCCCTTTTAGCTGGACACACCTACAACCAAT 69 FBan0014234 FBgn0031065 CG14234 X X CG14234 CG14234 CDMC27799 4 11 6 DAC09-P08 14-CG14285-RA_1 CG14285 CTCTGGGATGGGTTTGCAACTGGTCAACAATCTTTCGCAGCAACAGTACTCCAAAATTTGGCACTTGCC 69 FBan0014285 FBgn0038674 CG14285 3 3R CG14285 CG14285 CDMC27799 4 12 6 DAC09-P08 14-CG14285-RA_1 CG14285 CTCTGGGATGGGTTTGCAACTGGTCAACAATCTTTCGCAGCAACAGTACTCCAAAATTTGGCACTTGCC 69 FBan0014285 FBgn0038674 CG14285 3 3R CG14285 CG14285 CDMC27800 4 13 6 DAC09-P20 16-CG1429-RD_1 CG1429 GGAACCAAAAACGTTTTTTGATGGTTGGCCTAATTGATTTGAGCCGAGATCACAGCCTTGTGCAAGCAA 69 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC27800 4 14 6 DAC09-P20 16-CG1429-RD_1 CG1429 GGAACCAAAAACGTTTTTTGATGGTTGGCCTAATTGATTTGAGCCGAGATCACAGCCTTGTGCAAGCAA 69 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC27801 4 15 6 DAC10-D07 23-CG1976-RA_8 CG1976 ATTTTTGCCCACCTTAATAACATTTTGACGCTTTACGGGGATTTTTGTCATGGTTTTTCGAGCGGTTTG 69 FBan0001976 FBgn0039883 RhoGAP100F 3 3R intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; protein binding; GO:0005515; ; GO:0005085; ; GO:0005096; ; GO:0005515 RhoGAP100F RhoGAP100F "CG1976, CG1976, CG1976" CDMC27801 4 16 6 DAC10-D07 23-CG1976-RA_8 CG1976 ATTTTTGCCCACCTTAATAACATTTTGACGCTTTACGGGGATTTTTGTCATGGTTTTTCGAGCGGTTTG 69 FBan0001976 FBgn0039883 RhoGAP100F 3 3R intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; protein binding; GO:0005515; ; GO:0005085; ; GO:0005096; ; GO:0005515 RhoGAP100F RhoGAP100F "CG1976, CG1976, CG1976" CDMC27802 4 17 6 DAC10-D19 16-CG1982-RA_1 CG1982 TCCTATCGCTGGTCCTACGTCACGCTGATAACTGATAACCGCGAATTCAGAAGTCCACTAGTGTAAGGT 69 FBan0001982 FBgn0024289 Sodh-1 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Sodh-1 Sorbitol dehydrogenase 1 "CG1982, Sorbitol dehydrogenase like, Sdh-1, DM_7298873, Sodh, BG:DS00464.2" CDMC27802 4 18 6 DAC10-D19 16-CG1982-RA_1 CG1982 TCCTATCGCTGGTCCTACGTCACGCTGATAACTGATAACCGCGAATTCAGAAGTCCACTAGTGTAAGGT 69 FBan0001982 FBgn0024289 Sodh-1 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" Sodh-1 Sorbitol dehydrogenase 1 "CG1982, Sorbitol dehydrogenase like, Sdh-1, DM_7298873, Sodh, BG:DS00464.2" CDMC27803 4 19 6 DAC10-H07 23-CG2040-RA_4 CG2040 GCAGTTGTTGGACGAGTGTTGATTAGTTAGGAGCTAAGAAATGCCAAGCTAAGTGGCCCTTTAAAGTCA 69 FBan0002040 FBgn0010114 hig 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 extracellular region; GO:0005576; membrane; GO:0016020 hig hikaru genki "CG2040, HIG, CT6282, hikaru genki" CDMC27803 4 20 6 DAC10-H07 23-CG2040-RA_4 CG2040 GCAGTTGTTGGACGAGTGTTGATTAGTTAGGAGCTAAGAAATGCCAAGCTAAGTGGCCCTTTAAAGTCA 69 FBan0002040 FBgn0010114 hig 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 extracellular region; GO:0005576; membrane; GO:0016020 hig hikaru genki "CG2040, HIG, CT6282, hikaru genki" CDMC27804 4 21 6 DAC10-H19 42-CG2047-RA_16 CG2047 TCGCAGAGTTAGAGAAGAAATCTAGCAATACACATCCGATATGGCCACCACAAACAGCCAGAGCCACTA 69 FBan0002047 FBgn0001077 ftz 3 3R "anterior/posterior axis specification; GO:0009948; blastoderm segmentation; GO:0007350; cell fate specification; GO:0001708; central nervous system development; GO:0007417; germ cell migration; GO:0008354; gonadal mesoderm development; GO:0007506; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; trunk segmentation; GO:0035290" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 ftz fushi tarazu "CG2047, Dm-Ftz, fushi-tarazu, BG:DS07876.1, Ual: Ultra-abdominal-like, l(3)84Ag, Ultra-abdominal-like, fushi tarazu" CDMC27804 4 22 6 DAC10-H19 42-CG2047-RA_16 CG2047 TCGCAGAGTTAGAGAAGAAATCTAGCAATACACATCCGATATGGCCACCACAAACAGCCAGAGCCACTA 69 FBan0002047 FBgn0001077 ftz 3 3R "anterior/posterior axis specification; GO:0009948; blastoderm segmentation; GO:0007350; cell fate specification; GO:0001708; central nervous system development; GO:0007417; germ cell migration; GO:0008354; gonadal mesoderm development; GO:0007506; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; trunk segmentation; GO:0035290" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 ftz fushi tarazu "CG2047, Dm-Ftz, fushi-tarazu, BG:DS07876.1, Ual: Ultra-abdominal-like, l(3)84Ag, Ultra-abdominal-like, fushi tarazu" CDMC27805 4 23 6 DAC10-L07 6-CG2081-RB_1 CG2081 GCTGCCCACTGTATGAGTGCAAGAGCTACGAGTCGAATTCGGGGGGAACTCTGGAGCAGACCAACATAT 69 FBan0002081 FBgn0030262 CG2081 X X CG2081 CG2081 BcDNA:RH70969 CDMC27805 4 24 6 DAC10-L07 6-CG2081-RB_1 CG2081 GCTGCCCACTGTATGAGTGCAAGAGCTACGAGTCGAATTCGGGGGGAACTCTGGAGCAGACCAACATAT 69 FBan0002081 FBgn0030262 CG2081 X X CG2081 CG2081 BcDNA:RH70969 CDMC27806 4 25 6 DAC10-L19 2-CG2091-RA_1 CG2091 AGCTGCGCATGTACTTTCATTACCAGCCGTCCTTCTATCACCTCCACGTGCACATCAATCCAGTACGGA 69 FBan0002091 FBgn0037372 CG2091 3 3R CG2091 CG2091 CDMC27806 4 26 6 DAC10-L19 2-CG2091-RA_1 CG2091 AGCTGCGCATGTACTTTCATTACCAGCCGTCCTTCTATCACCTCCACGTGCACATCAATCCAGTACGGA 69 FBan0002091 FBgn0037372 CG2091 3 3R CG2091 CG2091 CDMC27807 4 1 7 DAC10-P07 9-CG2127-RA_1 CG2127 AGCTCCGGGGATGTCTCTCGCTTATGGCCCTCCCACATTTTCATTCCATAAGACTGAGGACTCTGTACT 69 FBan0002127 FBgn0033286 CG2127 2 2R CG2127 CG2127 "bs19a07.y1, anon-WO0140519.25, NEST:bs19a07" CDMC27807 4 2 7 DAC10-P07 9-CG2127-RA_1 CG2127 AGCTCCGGGGATGTCTCTCGCTTATGGCCCTCCCACATTTTCATTCCATAAGACTGAGGACTCTGTACT 69 FBan0002127 FBgn0033286 CG2127 2 2R CG2127 CG2127 "bs19a07.y1, anon-WO0140519.25, NEST:bs19a07" CDMC27808 4 3 7 DAC10-P19 8-CG2140-RB_1 CG2140 AACGCGCAGTAGAAATCAACAAGTGATCACCATGTCGAGCGAGGAAACAAAGACTTTCACGCGGGCCGA 69 FBan0002140 FBgn0033189 Cyt-b5 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489 membrane; GO:0016020; microsome; GO:0005792 Cyt-b5 Cyt-b5 "CG2140, CG2140, CG2140, CG2140, 1857, l(2)01857, CYTB5, BcDNA:GH02503, BcDNA:RE66521" CDMC27808 4 4 7 DAC10-P19 8-CG2140-RB_1 CG2140 AACGCGCAGTAGAAATCAACAAGTGATCACCATGTCGAGCGAGGAAACAAAGACTTTCACGCGGGCCGA 69 FBan0002140 FBgn0033189 Cyt-b5 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489 membrane; GO:0016020; microsome; GO:0005792 Cyt-b5 Cyt-b5 "CG2140, CG2140, CG2140, CG2140, 1857, l(2)01857, CYTB5, BcDNA:GH02503, BcDNA:RE66521" CDMC27809 4 5 7 DAC11-D07 14-CG9271-RA_1 CG9271 GCCCATCCAGTGGTAGGATGATCCACAGACTTCACTAACCCCTGATCAACGACAAAAGCAATGCA 65 FBan0009271 FBgn0003983 Vm34Ca 2 2L vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm34Ca Vitelline membrane 34Ca "CG9271, Vm34C, VM34C.1, VM34C, VM26A.1" CDMC27809 4 6 7 DAC11-D07 14-CG9271-RA_1 CG9271 GCCCATCCAGTGGTAGGATGATCCACAGACTTCACTAACCCCTGATCAACGACAAAAGCAATGCA 65 FBan0009271 FBgn0003983 Vm34Ca 2 2L vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm34Ca Vitelline membrane 34Ca "CG9271, Vm34C, VM34C.1, VM34C, VM26A.1" CDMC27810 4 7 7 DAC11-D19 3-CG9293-RA_1 CG9293 ATACGGCGACTGGACAACGATTTAGCACGCTTCGAGGGTGAGATTCAGGAGAAGGCCTCATCCAC 65 FBan0009293 FBgn0032516 CG9293 2 2L "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; protein biosynthesis; GO:0006412; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 CG9293 CG9293 CDMC27810 4 8 7 DAC11-D19 3-CG9293-RA_1 CG9293 ATACGGCGACTGGACAACGATTTAGCACGCTTCGAGGGTGAGATTCAGGAGAAGGCCTCATCCAC 65 FBan0009293 FBgn0032516 CG9293 2 2L "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; protein biosynthesis; GO:0006412; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0003677 CG9293 CG9293 CDMC27811 4 9 7 DAC11-H07 3-CG9388-RA_1 CG9388 CTTCAGCGAGTCATCCTGCAACAGGTAGCTTCATCTCCACCCGCGTTTTTGTCTGCGATGCGTTG 65 FBan0009388 FBgn0024833 AP-47 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-47 AP-47 "CG9388, CG9388, CG9388, AP47, mu1, Dmu1, cg9388" CDMC27811 4 10 7 DAC11-H07 3-CG9388-RA_1 CG9388 CTTCAGCGAGTCATCCTGCAACAGGTAGCTTCATCTCCACCCGCGTTTTTGTCTGCGATGCGTTG 65 FBan0009388 FBgn0024833 AP-47 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-47 AP-47 "CG9388, CG9388, CG9388, AP47, mu1, Dmu1, cg9388" CDMC27812 4 11 7 DAC11-H19 2-CG9441-RA_1 CG9441 AGTCCGGATAGTGATGGTACACAACCGAAAACACCACTGACACCGCGTACATCGACAACGCCAGG 65 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC27812 4 12 7 DAC11-H19 2-CG9441-RA_1 CG9441 AGTCCGGATAGTGATGGTACACAACCGAAAACACCACTGACACCGCGTACATCGACAACGCCAGG 65 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC27813 4 13 7 DAC11-L07 12-CG9554-RA_1 CG9554 TATGCCAACCGATACACCAAAGACCACAGCTCCCTGATGACCATCGCCTTCCGCATGGAGGAGAT 65 FBan0009554 FBgn0000320 eya 2 2L Bolwig's organ morphogenesis; GO:0001746; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor development (sensu Endopterygota); GO:0042051; eye-antennal disc morphogenesis; GO:0007455; gonad development; GO:0008406; male gonad development; GO:0008584; mesoderm development; GO:0007498; negative regulation of cell fate specification; GO:0009996; optic placode formation (sensu Endopterygota); GO:0001744; pole cell migration; GO:0007280; protein amino acid dephosphorylation; GO:0006470; spermatogenesis; GO:0007283; transcription; GO:0006350; visual perception; GO:0007601 hydrolase activity; GO:0016787 ; EC:3.-.-.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; NOT lipid phosphatase activity; GO:0042577; NOT nucleotide phosphatase activity; GO:0019204; NOT protein serine/threonine phosphatase activity; GO:0004722; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004725 ; EC:3.1.3.48; ; GO:0042577; ; GO:0019204; ; GO:0004722 nucleus; GO:0005634 eya eyes absent "CG9554, cli: clift, clift, EY2-1, Eyes-Absent, Eyes absent, Eya, CLIFT, cli/eya, BcDNA:LD16029, cli" CDMC27813 4 14 7 DAC11-L07 12-CG9554-RA_1 CG9554 TATGCCAACCGATACACCAAAGACCACAGCTCCCTGATGACCATCGCCTTCCGCATGGAGGAGAT 65 FBan0009554 FBgn0000320 eya 2 2L Bolwig's organ morphogenesis; GO:0001746; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor development (sensu Endopterygota); GO:0042051; eye-antennal disc morphogenesis; GO:0007455; gonad development; GO:0008406; male gonad development; GO:0008584; mesoderm development; GO:0007498; negative regulation of cell fate specification; GO:0009996; optic placode formation (sensu Endopterygota); GO:0001744; pole cell migration; GO:0007280; protein amino acid dephosphorylation; GO:0006470; spermatogenesis; GO:0007283; transcription; GO:0006350; visual perception; GO:0007601 hydrolase activity; GO:0016787 ; EC:3.-.-.-; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; NOT lipid phosphatase activity; GO:0042577; NOT nucleotide phosphatase activity; GO:0019204; NOT protein serine/threonine phosphatase activity; GO:0004722; ; GO:0016787 ; EC:3.-.-.-; ; GO:0004725 ; EC:3.1.3.48; ; GO:0042577; ; GO:0019204; ; GO:0004722 nucleus; GO:0005634 eya eyes absent "CG9554, cli: clift, clift, EY2-1, Eyes-Absent, Eyes absent, Eya, CLIFT, cli/eya, BcDNA:LD16029, cli" CDMC27814 4 15 7 DAC11-L19 23-CG9581-RA_4 CG9581 GCGGAGGCGTTTTAAGAGCTCACAACGAAAACCAAATTCCTAGTCATAAGCCTTTCATTCTCCCG 65 FBan0009581 FBgn0031093 CG9581 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235; ; GO:0004239 ; EC:3.4.11.18 CG9581 CG9581 CDMC27814 4 16 7 DAC11-L19 23-CG9581-RA_4 CG9581 GCGGAGGCGTTTTAAGAGCTCACAACGAAAACCAAATTCCTAGTCATAAGCCTTTCATTCTCCCG 65 FBan0009581 FBgn0031093 CG9581 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235; ; GO:0004239 ; EC:3.4.11.18 CG9581 CG9581 CDMC27815 4 17 7 DAC11-P07 18-CG9675-RA_1 CG9675 AAATACAGGAACAAAATGATGCAGCCGAGACTAGTGATTTTGGGTCTGATCGGATTGACGGCGGT 65 FBan0009675 FBgn0030774 CG9675 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9675 CG9675 "SPH114, anon-EST:ParkEST153, anon-WO0140519.154" CDMC27815 4 18 7 DAC11-P07 18-CG9675-RA_1 CG9675 AAATACAGGAACAAAATGATGCAGCCGAGACTAGTGATTTTGGGTCTGATCGGATTGACGGCGGT 65 FBan0009675 FBgn0030774 CG9675 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9675 CG9675 "SPH114, anon-EST:ParkEST153, anon-WO0140519.154" CDMC27816 4 19 7 DAC11-P19 2-CG9702-RA_1 CG9702 CAGTGTAGTGAGTGTCTTCGAGGGATTGAACACGAGGCTGGTGCTTTGCTACAACACCCATGCCC 65 FBan0009702 FBgn0039787 CG9702 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG9702 CG9702 CDMC27816 4 20 7 DAC11-P19 2-CG9702-RA_1 CG9702 CAGTGTAGTGAGTGTCTTCGAGGGATTGAACACGAGGCTGGTGCTTTGCTACAACACCCATGCCC 65 FBan0009702 FBgn0039787 CG9702 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG9702 CG9702 CDMC27817 4 21 7 DAC12-D07 1-CG15454-RA_1 CG15454 CAGCAGTCACATTGATGCGGGTTTCGAAAGCGACAGCATTTCGGTAACAGGATCGCCGCGAAAAA 65 FBan0015454 FBgn0031122 CG15454 X X CG15454 CG15454 CDMC27817 4 22 7 DAC12-D07 1-CG15454-RA_1 CG15454 CAGCAGTCACATTGATGCGGGTTTCGAAAGCGACAGCATTTCGGTAACAGGATCGCCGCGAAAAA 65 FBan0015454 FBgn0031122 CG15454 X X CG15454 CG15454 CDMC27818 4 23 7 DAC12-D19 3-CG15480-RA_1 CG15480 CAAAACCGCCGGCTATACGCACAAAAAGTTTGGCAAGAAGAGCTCCAAGGATATCGCCCCCAACC 65 FBan0015480 FBgn0032489 CG15480 2 2L CG15480 CG15480 CDMC27818 4 24 7 DAC12-D19 3-CG15480-RA_1 CG15480 CAAAACCGCCGGCTATACGCACAAAAAGTTTGGCAAGAAGAGCTCCAAGGATATCGCCCCCAACC 65 FBan0015480 FBgn0032489 CG15480 2 2L CG15480 CG15480 CDMC27819 4 25 7 DAC12-H07 23-CG15566-RA_1 CG15566 AATTTCGATAATTGCAATGCGAATGTCTACTGTGGTCAGAAGGCAAAGCAACTAGGGCCAATTAC 65 FBan0015566 FBgn0039842 CG15566 3 3R CG15566 CG15566 CDMC27819 4 26 7 DAC12-H07 23-CG15566-RA_1 CG15566 AATTTCGATAATTGCAATGCGAATGTCTACTGTGGTCAGAAGGCAAAGCAACTAGGGCCAATTAC 65 FBan0015566 FBgn0039842 CG15566 3 3R CG15566 CG15566 CDMC27820 4 1 8 DAC12-H19 16-CG15593-RB_1 CG15593 TTCTGCTAACGCGTCTACATCCCCATGGAGTCCTAGAAGTCTAGGCAGAATTATAGCCCACTGCA 65 FBan0015593 FBgn0037417 Osi10 3 3R Osi10 Osiris 10 "CG15593, CG15593, CG15593, CG15593, Osiris, Osiris 10" CDMC27820 4 2 8 DAC12-H19 16-CG15593-RB_1 CG15593 TTCTGCTAACGCGTCTACATCCCCATGGAGTCCTAGAAGTCTAGGCAGAATTATAGCCCACTGCA 65 FBan0015593 FBgn0037417 Osi10 3 3R Osi10 Osiris 10 "CG15593, CG15593, CG15593, CG15593, Osiris, Osiris 10" CDMC27821 4 3 8 DAC12-L07 3-CG15673-RA_1 CG15673 GAAGATCCATTCCTCGTGCTGCGTAGACGGCCAGTCCTATCTCTTCAGCGTGGAGAACGTTCTCC 65 FBan0015673 FBgn0034639 CG15673 2 2R CG15673 CG15673 CDMC27821 4 4 8 DAC12-L07 3-CG15673-RA_1 CG15673 GAAGATCCATTCCTCGTGCTGCGTAGACGGCCAGTCCTATCTCTTCAGCGTGGAGAACGTTCTCC 65 FBan0015673 FBgn0034639 CG15673 2 2R CG15673 CG15673 CDMC27822 4 5 8 DAC12-L19 9-CG15719-RA_1 CG15719 CGATACGGTGAAAAGGCTTCGTACCATGATGCAACGATGTTCTCAGCTGCTTCCCGTCCTGGTCA 65 FBan0015719 FBgn0030440 CG15719 X X CG15719 CG15719 CDMC27822 4 6 8 DAC12-L19 9-CG15719-RA_1 CG15719 CGATACGGTGAAAAGGCTTCGTACCATGATGCAACGATGTTCTCAGCTGCTTCCCGTCCTGGTCA 65 FBan0015719 FBgn0030440 CG15719 X X CG15719 CG15719 CDMC27823 4 7 8 DAC12-P07 11-CG15793-RA_1 CG15793 ACTGAAAGTCCTGCACGAATGTAATTTCCCGCACATTGTCGGTTTCTACGGCGCCTTCTACAGCG 65 FBan0015793 FBgn0010269 Dsor1 X X "MAPKKK cascade; GO:0000165; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; hemocyte differentiation (sensu Arthropoda); GO:0042386; protein amino acid phosphorylation; GO:0006468; regulation of Toll signaling pathway; GO:0008592; sevenless signaling pathway; GO:0045500; signal transduction; GO:0007165; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.- Dsor1 Downstream of raf1 "CG15793, CG15793, Dsor, D-mek, MEK, MAPKK, DMEK-1, D-sor-1, DSor, D-Mek, dsor1, DRODSOR1, D-MEK, Dmek, Su(Raf)34B, D-MEK/Dsor, D-sor, DSOR1, D-SOR, Mek, sor, EK1-1, mek, SOR, sor/MEK1, DSORT, MEK1/2, DSor1" CDMC27823 4 8 8 DAC12-P07 11-CG15793-RA_1 CG15793 ACTGAAAGTCCTGCACGAATGTAATTTCCCGCACATTGTCGGTTTCTACGGCGCCTTCTACAGCG 65 FBan0015793 FBgn0010269 Dsor1 X X "MAPKKK cascade; GO:0000165; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; hemocyte differentiation (sensu Arthropoda); GO:0042386; protein amino acid phosphorylation; GO:0006468; regulation of Toll signaling pathway; GO:0008592; sevenless signaling pathway; GO:0045500; signal transduction; GO:0007165; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.- Dsor1 Downstream of raf1 "CG15793, CG15793, Dsor, D-mek, MEK, MAPKK, DMEK-1, D-sor-1, DSor, D-Mek, dsor1, DRODSOR1, D-MEK, Dmek, Su(Raf)34B, D-MEK/Dsor, D-sor, DSOR1, D-SOR, Mek, sor, EK1-1, mek, SOR, sor/MEK1, DSORT, MEK1/2, DSor1" CDMC27824 4 9 8 DAC12-P19 AutoBlank AutoBlank CDMC27824 4 10 8 DAC12-P19 AutoBlank AutoBlank CDMC27825 4 11 8 DAC13-D07 5-CG13048-RA_1 CG13048 TGGGTGGTGAGGCAAAGCCCTCTCATCTTCACTACAATCACTTCGATCCCCACCATGTCAACCACTTTG 69 FBan0013048 FBgn0036593 CG13048 3 3L CG13048 CG13048 CDMC27825 4 12 8 DAC13-D07 5-CG13048-RA_1 CG13048 TGGGTGGTGAGGCAAAGCCCTCTCATCTTCACTACAATCACTTCGATCCCCACCATGTCAACCACTTTG 69 FBan0013048 FBgn0036593 CG13048 3 3L CG13048 CG13048 CDMC27826 4 13 8 DAC13-D19 13-CG13065-RA_1 CG13065 TGGTAAACGAGGTCCATACCACCCATCATCGTTTTCCGCATGCATTTCGTTTTGTTTGGATCGGTCAGA 69 FBan0013065 FBgn0036590 CG13065 3 3L CG13065 CG13065 BcDNA:RH56745 CDMC27826 4 14 8 DAC13-D19 13-CG13065-RA_1 CG13065 TGGTAAACGAGGTCCATACCACCCATCATCGTTTTCCGCATGCATTTCGTTTTGTTTGGATCGGTCAGA 69 FBan0013065 FBgn0036590 CG13065 3 3L CG13065 CG13065 BcDNA:RH56745 CDMC27827 4 15 8 DAC13-H07 14-CG13097-RA_3 CG13097 TGCGACCGGTGAACACCCCGCAAGAGTACAGAAAACAACTTGTGCTTGACCAGGAGAAATCAAAACAAT 69 FBan0013097 FBgn0032051 CG13097 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG13097 CG13097 CDMC27827 4 16 8 DAC13-H07 14-CG13097-RA_3 CG13097 TGCGACCGGTGAACACCCCGCAAGAGTACAGAAAACAACTTGTGCTTGACCAGGAGAAATCAAAACAAT 69 FBan0013097 FBgn0032051 CG13097 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG13097 CG13097 CDMC27828 4 17 8 DAC13-H19 12-CG13109-RA_2 CG13109 GCAGCGCTACGAGGTGACCCTAAGGTGCCTAGTTCAGAACCAAGGATCACGTACAACCAAAACTTCTCT 69 FBan0013109 FBgn0041092 tai 2 2L border follicle cell migration (sensu Insecta); GO:0007298; regulation of transcription; GO:0045449; signal transduction; GO:0007165 transcription coactivator activity; GO:0003713; ; GO:0003713; signal transducer activity; GO:0004871; ; GO:0003713; ; GO:0004871 nucleus; GO:0005634 tai taiman "CG13109, CG18494, CG13109, CG13109, CG13109, l(2)01351, l(2)k05802, l(2)k05809, 58/2, bs13g05.y1, EP(2)2630, DAIB1, Drosophila Amplified in breast cancer-1, Taiman, DmTaiman, NEST:bs13g05, taiman" CDMC27828 4 18 8 DAC13-H19 12-CG13109-RA_2 CG13109 GCAGCGCTACGAGGTGACCCTAAGGTGCCTAGTTCAGAACCAAGGATCACGTACAACCAAAACTTCTCT 69 FBan0013109 FBgn0041092 tai 2 2L border follicle cell migration (sensu Insecta); GO:0007298; regulation of transcription; GO:0045449; signal transduction; GO:0007165 transcription coactivator activity; GO:0003713; ; GO:0003713; signal transducer activity; GO:0004871; ; GO:0003713; ; GO:0004871 nucleus; GO:0005634 tai taiman "CG13109, CG18494, CG13109, CG13109, CG13109, l(2)01351, l(2)k05802, l(2)k05809, 58/2, bs13g05.y1, EP(2)2630, DAIB1, Drosophila Amplified in breast cancer-1, Taiman, DmTaiman, NEST:bs13g05, taiman" CDMC27829 4 19 8 DAC13-L07 9-CG13158-RA_1 CG13158 CCAATATGTTGGCCTCCATTCGACCAAGTCCAGAAACGGAACAACAAGACTGTGACTTCTTGGCCAGCA 69 FBan0013158 FBgn0033727 Or49a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or49a Odorant receptor 49a "CG13158, CG13158, 49A.1, DOR10, 49a" CDMC27829 4 20 8 DAC13-L07 9-CG13158-RA_1 CG13158 CCAATATGTTGGCCTCCATTCGACCAAGTCCAGAAACGGAACAACAAGACTGTGACTTCTTGGCCAGCA 69 FBan0013158 FBgn0033727 Or49a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or49a Odorant receptor 49a "CG13158, CG13158, 49A.1, DOR10, 49a" CDMC27830 4 21 8 DAC13-L19 12-CG13178-RA_2 CG13178 GGGCTTTCAGGCCATGGACGGTAGTTTCATCAGGGACGTGGATCAAGATTACTACGCGGAATACGTTGA 69 FBan0013178 FBgn0033685 CG13178 2 2R CG13178 CG13178 CDMC27830 4 22 8 DAC13-L19 12-CG13178-RA_2 CG13178 GGGCTTTCAGGCCATGGACGGTAGTTTCATCAGGGACGTGGATCAAGATTACTACGCGGAATACGTTGA 69 FBan0013178 FBgn0033685 CG13178 2 2R CG13178 CG13178 CDMC27831 4 23 8 DAC13-P07 14-CG13209-RA_1 CG13209 GTCAACTGGACAGCGGATACATGAGCACCGATTCAACGGAACTGTACAAGCGAAATGTCTACGATCGGT 69 FBgn0033618 CDMC27831 4 24 8 DAC13-P07 14-CG13209-RA_1 CG13209 GTCAACTGGACAGCGGATACATGAGCACCGATTCAACGGAACTGTACAAGCGAAATGTCTACGATCGGT 69 FBgn0033618 CDMC27832 4 25 8 DAC13-P19 23-CG13220-RA_2 CG13220 TGGATAAGCTGCAGAAGAACTAGATGATCTGATCGATACGATATAGGACTGAGGTATTCGAACCCAAAA 69 FBan0013220 FBgn0033608 CG13220 2 2R CG13220 CG13220 CDMC27832 4 26 8 DAC13-P19 23-CG13220-RA_2 CG13220 TGGATAAGCTGCAGAAGAACTAGATGATCTGATCGATACGATATAGGACTGAGGTATTCGAACCCAAAA 69 FBan0013220 FBgn0033608 CG13220 2 2R CG13220 CG13220 CDMC27833 4 1 9 DAC14-D07 11-CG40178-RB_2 CG40178 TCCGCCATCTCTGATCGCTCAAACGGTAAGAGCAGACAACGAAGGAGGAATCCCTCAATCAAATGGGAA 69 FBgn0058178 CG40178 CG40178 CG40178 CDMC27833 4 2 9 DAC14-D07 11-CG40178-RB_2 CG40178 TCCGCCATCTCTGATCGCTCAAACGGTAAGAGCAGACAACGAAGGAGGAATCCCTCAATCAAATGGGAA 69 FBgn0058178 CG40178 CG40178 CG40178 CDMC27834 4 3 9 DAC14-D19 15-CG40195-RA_1 CG40195 TTGGAGCTAATCAACAGAACGGCAGAGAATGTCTCCGTGTCCATTTCAAGTATGCAACGGTACCGAGCT 69 FBgn0058195 CG40195 CG40195 CG40195 CDMC27834 4 4 9 DAC14-D19 15-CG40195-RA_1 CG40195 TTGGAGCTAATCAACAGAACGGCAGAGAATGTCTCCGTGTCCATTTCAAGTATGCAACGGTACCGAGCT 69 FBgn0058195 CG40195 CG40195 CG40195 CDMC27835 4 5 9 DAC14-H07 17-CG40245-RA_1 CG40245 CCGGACCCCCAATGGTTAGGAAATCTGAACACCGTTCAGCTATATGTTGTTTGGCTCTTCTAAAAGCCA 69 FBgn0058245 CG40245 CG40245 CG40245 CDMC27835 4 6 9 DAC14-H07 17-CG40245-RA_1 CG40245 CCGGACCCCCAATGGTTAGGAAATCTGAACACCGTTCAGCTATATGTTGTTTGGCTCTTCTAAAAGCCA 69 FBgn0058245 CG40245 CG40245 CG40245 CDMC27836 4 7 9 DAC14-H19 18-CG40267-RA_1 CG40267 GCGACCATACGCTGAAGTGGGTGTCTTAGATTGGATAGTAATGGGACTGTTAGATACTGGAGCGGCACA 69 FBgn0058267 CG40267 CG40267 CG40267 CDMC27836 4 8 9 DAC14-H19 18-CG40267-RA_1 CG40267 GCGACCATACGCTGAAGTGGGTGTCTTAGATTGGATAGTAATGGGACTGTTAGATACTGGAGCGGCACA 69 FBgn0058267 CG40267 CG40267 CG40267 CDMC27837 4 9 9 DAC14-L07 23-CG40317-RA_1 CG40317 GCCATGACATTACAGCACGTGTGTTCAGACAAAAGTTGAAGTCTTTAATAAGTTTCATTACTAAATCAC 69 FBgn0058317 CG40317 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; ; GO:0004386; ; GO:0003678 CG40317 CG40317 CDMC27837 4 10 9 DAC14-L07 23-CG40317-RA_1 CG40317 GCCATGACATTACAGCACGTGTGTTCAGACAAAAGTTGAAGTCTTTAATAAGTTTCATTACTAAATCAC 69 FBgn0058317 CG40317 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; ; GO:0004386; ; GO:0003678 CG40317 CG40317 CDMC27838 4 11 9 DAC14-L19 11-CG40342-RA_1 CG40342 GGAGGAGGGTTAGTACAAGCTGCGATGGAAAGCGAGAAGTTCATGTCGTTAAGAGGAGAAGCTGCGACA 69 FBgn0058342 CG40342 CG40342 CG40342 CDMC27838 4 12 9 DAC14-L19 11-CG40342-RA_1 CG40342 GGAGGAGGGTTAGTACAAGCTGCGATGGAAAGCGAGAAGTTCATGTCGTTAAGAGGAGAAGCTGCGACA 69 FBgn0058342 CG40342 CG40342 CG40342 CDMC27839 4 13 9 DAC14-P07 2-CG4039-RA_1 CG4039 CGTGGACGAATGCAATGAGGTGGTGGACTATGCCATTGCTCGCAAGATCGTTGATCTGCACTCGAACAT 69 FBan0004039 FBgn0025815 Mcm6 X X DNA replication; GO:0006260; DNA replication initiation; GO:0006270; chorion gene amplification; GO:0007307; oogenesis (sensu Insecta); GO:0009993; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; ; GO:0003682; ; GO:0008094 pre-replicative complex; GO:0005656 Mcm6 Minichromosome maintenance 6 "CG4039, fs(1)K1214, DmMCM6, MCM6, mcm6, female sterile(1)K1214, Minichromosome maintenance 6" CDMC27839 4 14 9 DAC14-P07 2-CG4039-RA_1 CG4039 CGTGGACGAATGCAATGAGGTGGTGGACTATGCCATTGCTCGCAAGATCGTTGATCTGCACTCGAACAT 69 FBan0004039 FBgn0025815 Mcm6 X X DNA replication; GO:0006260; DNA replication initiation; GO:0006270; chorion gene amplification; GO:0007307; oogenesis (sensu Insecta); GO:0009993; pre-replicative complex formation and maintenance; GO:0006267 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; ; GO:0003682; ; GO:0008094 pre-replicative complex; GO:0005656 Mcm6 Minichromosome maintenance 6 "CG4039, fs(1)K1214, DmMCM6, MCM6, mcm6, female sterile(1)K1214, Minichromosome maintenance 6" CDMC27840 4 15 9 DAC14-P19 23-CG40411-RC_15 CG40411 CGCACCATGCCAGATCCTACTAAGAGCTATATAAGAAGTGATGGGGTTGAAATTCCTTACGGAGAAACC 69 CDMC27840 4 16 9 DAC14-P19 23-CG40411-RC_15 CG40411 CGCACCATGCCAGATCCTACTAAGAGCTATATAAGAAGTGATGGGGTTGAAATTCCTTACGGAGAAACC 69 CDMC27841 4 17 9 DAC15-D07 18-CG7304-RA_3 CG7304 GCCGAAAACTTGGTGTTCGTGGATGCACAAGTGGAGTTTACAAATGGCTGGTTATCCCCATTACTTGAT 69 FBan0007304 FBgn0036527 CG7304 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7304 CG7304 CDMC27841 4 18 9 DAC15-D07 18-CG7304-RA_3 CG7304 GCCGAAAACTTGGTGTTCGTGGATGCACAAGTGGAGTTTACAAATGGCTGGTTATCCCCATTACTTGAT 69 FBan0007304 FBgn0036527 CG7304 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7304 CG7304 CDMC27842 4 19 9 DAC15-D19 17-CG7320-RA_1 CG7320 TCGGCAGGAAAACGAACTTAATTGTGACTTTAGCCAGGGTGTCAGTCGATGGGATGAACTGCCCTTGGG 69 FBan0007320 FBgn0036782 CG7320 3 3L CG7320 CG7320 CDMC27842 4 20 9 DAC15-D19 17-CG7320-RA_1 CG7320 TCGGCAGGAAAACGAACTTAATTGTGACTTTAGCCAGGGTGTCAGTCGATGGGATGAACTGCCCTTGGG 69 FBan0007320 FBgn0036782 CG7320 3 3L CG7320 CG7320 CDMC27843 4 21 9 DAC15-H07 8-CG7344-RA_1 CG7344 CCGAGCGCATGTTCCTCCAGGTTGTCGGAATCTTACGCGATGAGAATGAGGTTTGTGTACTGGCTAACA 69 FBan0007344 FBgn0038713 CG7344 3 3R CG7344 CG7344 CDMC27843 4 22 9 DAC15-H07 8-CG7344-RA_1 CG7344 CCGAGCGCATGTTCCTCCAGGTTGTCGGAATCTTACGCGATGAGAATGAGGTTTGTGTACTGGCTAACA 69 FBan0007344 FBgn0038713 CG7344 3 3R CG7344 CG7344 CDMC27844 4 23 9 DAC15-H19 23-CG7355-RA_2 CG7355 GTGAGTCAAGGGTCGTGAGAAATGGCAGAAACAACGATATTTCGAATATTTTCAATGAGAACTGTCGGC 69 FBan0007355 FBgn0004589 Eig71Eb 3 3L Eig71Eb Ecdysone-induced gene 71Eb "CG7355, CG7355, gene II, II, Gene II, 71E-Gene-II, L71-2, L71, gene-II" CDMC27844 4 24 9 DAC15-H19 23-CG7355-RA_2 CG7355 GTGAGTCAAGGGTCGTGAGAAATGGCAGAAACAACGATATTTCGAATATTTTCAATGAGAACTGTCGGC 69 FBan0007355 FBgn0004589 Eig71Eb 3 3L Eig71Eb Ecdysone-induced gene 71Eb "CG7355, CG7355, gene II, II, Gene II, 71E-Gene-II, L71-2, L71, gene-II" CDMC27845 4 25 9 DAC15-L07 12-CG7384-RA_1 CG7384 TCCAGCAGGGGGTATGTCCGTACAGAATCTGTGATAGTGCTAACCTGCAATGGCGTCCATAGCATAGTT 69 FBan0007384 FBgn0032262 CG7384 2 2L CG7384 CG7384 CDMC27845 4 26 9 DAC15-L07 12-CG7384-RA_1 CG7384 TCCAGCAGGGGGTATGTCCGTACAGAATCTGTGATAGTGCTAACCTGCAATGGCGTCCATAGCATAGTT 69 FBan0007384 FBgn0032262 CG7384 2 2L CG7384 CG7384 CDMC27846 4 1 10 DAC15-L19 9-CG7395-RA_7 CG7395 CGAGTGGCGCTTCTACATCCTATTCTTCTTTGTGGCCCACTCTATTGCCATGAGCTCCACCTGCTACAA 69 FBan0007395 FBgn0036934 NPFR76F 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0008188; ; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0004995; ; GO:0004983; ; GO:0004930 integral to membrane; GO:0016021 NPFR76F Neuropeptide F-like Receptor 76F "CG18639, CG7395, CG7395/CG18639, CG18639, CG7395, CG7395, CG18639, CG7395, CG7395/CG18639, CG7395, Drm-sNPF-R, GPCR60, CT22771, anon-WO0131005.1, neuropeptide-Y-receptor, Neuropeptide F-like Receptor 76F" CDMC27846 4 2 10 DAC15-L19 9-CG7395-RA_7 CG7395 CGAGTGGCGCTTCTACATCCTATTCTTCTTTGTGGCCCACTCTATTGCCATGAGCTCCACCTGCTACAA 69 FBan0007395 FBgn0036934 NPFR76F 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0008188; ; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0004995; ; GO:0004983; ; GO:0004930 integral to membrane; GO:0016021 NPFR76F Neuropeptide F-like Receptor 76F "CG18639, CG7395, CG7395/CG18639, CG18639, CG7395, CG7395, CG18639, CG7395, CG7395/CG18639, CG7395, Drm-sNPF-R, GPCR60, CT22771, anon-WO0131005.1, neuropeptide-Y-receptor, Neuropeptide F-like Receptor 76F" CDMC27847 4 3 10 DAC15-P07 23-CG7443-RA_3 CG7443 GGTGGTTAGATTATCTTATCCTTACCCACACCTTATAACACCTCTCTAACACTAGCTATTAAATGGGAT 69 FBan0007443 FBgn0037577 CG7443 3 3R CG7443 CG7443 CDMC27847 4 4 10 DAC15-P07 23-CG7443-RA_3 CG7443 GGTGGTTAGATTATCTTATCCTTACCCACACCTTATAACACCTCTCTAACACTAGCTATTAAATGGGAT 69 FBan0007443 FBgn0037577 CG7443 3 3R CG7443 CG7443 CDMC27848 4 5 10 DAC15-P19 23-CG7453-RA_3 CG7453 GGCCAAATTGAATTTAAAGCCAACTGATTTTCAACACTAAATTCGAGTGGACTCTTAAGTTTAAGCATT 69 FBan0007453 FBgn0030991 CG7453 X X CG7453 CG7453 CDMC27848 4 6 10 DAC15-P19 23-CG7453-RA_3 CG7453 GGCCAAATTGAATTTAAAGCCAACTGATTTTCAACACTAAATTCGAGTGGACTCTTAAGTTTAAGCATT 69 FBan0007453 FBgn0030991 CG7453 X X CG7453 CG7453 CDMC27849 4 7 10 DAC16-D07 2-CG12441-RB_1 CG12441 CGACTGGCAAAGATAGCCGGCCTAAACCGCCTAAAGACAGATGGTGATCCAGGACAAACGGGATCG 66 FBan0012441 FBgn0032185 CG12441 2 2L CG12441 CG12441 CDMC27849 4 8 10 DAC16-D07 2-CG12441-RB_1 CG12441 CGACTGGCAAAGATAGCCGGCCTAAACCGCCTAAAGACAGATGGTGATCCAGGACAAACGGGATCG 66 FBan0012441 FBgn0032185 CG12441 2 2L CG12441 CG12441 CDMC27850 4 9 10 DAC16-D19 18-CG12743-RA_2 CG12743 AATGGCAGTCAGTTTAGTTTCTATACTACTCCATCGCCGCATCATCACCTGATAACACCGCCGAGG 66 FBan0012743 FBgn0003023 otu X X chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; female germ-line sex determination; GO:0019099; germ cell development; GO:0007281; germ-line cyst formation; GO:0048134; germ-line sex determination; GO:0018992; oogenesis (sensu Insecta); GO:0009993 nucleic acid binding; GO:0003676; ; GO:0003676 cytoplasm; GO:0005737 otu ovarian tumor "CG12743, fs(1)231, fs(1)M101, K, fs(1)23l, fs(1)otu, DROOTUA, OTU, fs(1)jA265" CDMC27850 4 10 10 DAC16-D19 18-CG12743-RA_2 CG12743 AATGGCAGTCAGTTTAGTTTCTATACTACTCCATCGCCGCATCATCACCTGATAACACCGCCGAGG 66 FBan0012743 FBgn0003023 otu X X chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; female germ-line sex determination; GO:0019099; germ cell development; GO:0007281; germ-line cyst formation; GO:0048134; germ-line sex determination; GO:0018992; oogenesis (sensu Insecta); GO:0009993 nucleic acid binding; GO:0003676; ; GO:0003676 cytoplasm; GO:0005737 otu ovarian tumor "CG12743, fs(1)231, fs(1)M101, K, fs(1)23l, fs(1)otu, DROOTUA, OTU, fs(1)jA265" CDMC27851 4 11 10 DAC16-H07 3-CG13296-RA_2 CG13296 ACTCTCCGAGGATGTGTATAGCTTCAATGCCATCTTCGAACTGCATGGTGGACAAGTGCGCGTCCG 66 FBan0013296 FBgn0035687 CG13296 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13296 CG13296 CDMC27851 4 12 10 DAC16-H07 3-CG13296-RA_2 CG13296 ACTCTCCGAGGATGTGTATAGCTTCAATGCCATCTTCGAACTGCATGGTGGACAAGTGCGCGTCCG 66 FBan0013296 FBgn0035687 CG13296 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13296 CG13296 CDMC27852 4 13 10 DAC16-H19 6-CG13425-RD_2 CG13425 ATGCCGCGACAAATGTGCCTCAGGGTCATGATCCCAACAACAGCACACAGGTCACCATTCCAAAAG 66 FBan0013425 FBgn0015907 bl 2 2R "appendage morphogenesis; GO:0035107; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; induction of apoptosis; GO:0006917; mRNA processing; GO:0006397; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; transcription factor binding; GO:0008134; ; GO:0003729; ; GO:0008134; ; GO:0003729 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; ribonucleoprotein complex; GO:0030529 bl bancal "CG13425, Hrb57A, Heterogeneous nuclear ribonucleoprotein at 57A, Q18, l(2)k08305, bancal" CDMC27852 4 14 10 DAC16-H19 6-CG13425-RD_2 CG13425 ATGCCGCGACAAATGTGCCTCAGGGTCATGATCCCAACAACAGCACACAGGTCACCATTCCAAAAG 66 FBan0013425 FBgn0015907 bl 2 2R "appendage morphogenesis; GO:0035107; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; induction of apoptosis; GO:0006917; mRNA processing; GO:0006397; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; transcription factor binding; GO:0008134; ; GO:0003729; ; GO:0008134; ; GO:0003729 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; ribonucleoprotein complex; GO:0030529 bl bancal "CG13425, Hrb57A, Heterogeneous nuclear ribonucleoprotein at 57A, Q18, l(2)k08305, bancal" CDMC27853 4 15 10 DAC16-L07 10-CG13835-RA_1 CG13835 AGGCAACTCGAAACAGTTTTGGTGGACCAAAGTCCTCGGGAAATCAGAAGAAAGAGTCAGCAGGGG 66 FBan0013835 FBgn0039036 CG13835 3 3R CG13835 CG13835 CDMC27853 4 16 10 DAC16-L07 10-CG13835-RA_1 CG13835 AGGCAACTCGAAACAGTTTTGGTGGACCAAAGTCCTCGGGAAATCAGAAGAAAGAGTCAGCAGGGG 66 FBan0013835 FBgn0039036 CG13835 3 3R CG13835 CG13835 CDMC27854 4 17 10 DAC16-L19 1-CG13991-RA_1 CG13991 GCCCAACTACAACTTCAGGACCAACGTTGATATGCGCGACGGTCCCGAGTTTAGTCGACTCAAGGT 66 FBan0013991 FBgn0031785 CG13991 2 2L proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG13991 CG13991 CDMC27854 4 18 10 DAC16-L19 1-CG13991-RA_1 CG13991 GCCCAACTACAACTTCAGGACCAACGTTGATATGCGCGACGGTCCCGAGTTTAGTCGACTCAAGGT 66 FBan0013991 FBgn0031785 CG13991 2 2L proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 membrane; GO:0016020 CG13991 CG13991 CDMC27855 4 19 10 DAC16-P07 2-CG14318-RA_2 CG14318 TGCCCACCATATCTGTGAGTCGTTCCTCGGAAGAAGGGGATGAACTGGCTAAGATCGAGGACGAGC 66 FBan0014318 FBgn0038544 CG14318 3 3R CG14318 CG14318 CDMC27855 4 20 10 DAC16-P07 2-CG14318-RA_2 CG14318 TGCCCACCATATCTGTGAGTCGTTCCTCGGAAGAAGGGGATGAACTGGCTAAGATCGAGGACGAGC 66 FBan0014318 FBgn0038544 CG14318 3 3R CG14318 CG14318 CDMC27856 4 21 10 DAC16-P19 AutoBlank AutoBlank CDMC27856 4 22 10 DAC16-P19 AutoBlank AutoBlank CDMC27857 4 23 10 DAC17-D07 13-CG17302-RA_2 CG17302 TCAGCTGCCCATTTTACCAGGAAAACACTGGCGGATTATATAAGGACCAACACCAGATACCAGGTGGCA 69 FBan0017302 FBgn0031443 CG17302 2 2L ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17302 CG17302 anon-WO0140519.122 CDMC27857 4 24 10 DAC17-D07 13-CG17302-RA_2 CG17302 TCAGCTGCCCATTTTACCAGGAAAACACTGGCGGATTATATAAGGACCAACACCAGATACCAGGTGGCA 69 FBan0017302 FBgn0031443 CG17302 2 2L ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17302 CG17302 anon-WO0140519.122 CDMC27858 4 25 10 DAC17-D19 2-CG17324-RA_2 CG17324 GCCGTGGCACTACAAACGCATGGGAAGTCCGTTCATTAACCCCATTATGCCCATGAATTTCCTGCCCTA 69 FBan0017324 FBgn0027074 CG17324 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-; ; GO:0008194" CG17324 CG17324 "GH06505, BEST:GH06505" CDMC27858 4 26 10 DAC17-D19 2-CG17324-RA_2 CG17324 GCCGTGGCACTACAAACGCATGGGAAGTCCGTTCATTAACCCCATTATGCCCATGAATTTCCTGCCCTA 69 FBan0017324 FBgn0027074 CG17324 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring hexosyl groups; GO:0016758 ; EC:2.4.1.-; ; GO:0016758 ; EC:2.4.1.-; ; GO:0008194" CG17324 CG17324 "GH06505, BEST:GH06505" CDMC27859 4 1 11 DAC17-H07 2-CG17370-RA_1 CG17370 CACTGGACGGTCTCAAGCGTAATGGACTCGTCTCGGGTCTCTACCTGCCTCATATCGATGCTGCTGATA 69 FBan0017370 FBgn0039381 CG17370 3 3R CG17370 CG17370 CG5901 CDMC27859 4 2 11 DAC17-H07 2-CG17370-RA_1 CG17370 CACTGGACGGTCTCAAGCGTAATGGACTCGTCTCGGGTCTCTACCTGCCTCATATCGATGCTGCTGATA 69 FBan0017370 FBgn0039381 CG17370 3 3R CG17370 CG17370 CG5901 CDMC27860 4 3 11 DAC17-H19 2-CG17379-RA_1 CG17379 ACCGCACCGCGTATGATTGCCTATCGCAACAAGAAGGGTAATGTGGTCTATGATGGAACCGTGGGTCAT 69 FBan0017379 FBgn0039076 CG17379 3 3R CG17379 CG17379 CDMC27860 4 4 11 DAC17-H19 2-CG17379-RA_1 CG17379 ACCGCACCGCGTATGATTGCCTATCGCAACAAGAAGGGTAATGTGGTCTATGATGGAACCGTGGGTCAT 69 FBan0017379 FBgn0039076 CG17379 3 3R CG17379 CG17379 CDMC27861 4 5 11 DAC17-L07 12-CG1745-RA_3 CG1745 ACCATCTCGACGAGTCATTGGCCAAGAGGAAGCGTAAGAGCGTGGCTAACTCAAAACCAAACAAAAGCA 69 FBan0001745 FBgn0030301 CG1745 X X CG1745 CG1745 CDMC27861 4 6 11 DAC17-L07 12-CG1745-RA_3 CG1745 ACCATCTCGACGAGTCATTGGCCAAGAGGAAGCGTAAGAGCGTGGCTAACTCAAAACCAAACAAAAGCA 69 FBan0001745 FBgn0030301 CG1745 X X CG1745 CG1745 CDMC27862 4 7 11 DAC17-L19 3-CG17477-RA_4 CG17477 ACGGCTGGTCACTGTGTCAAAGGATACCCGACTAGCAGACTTCAAGTGGCCACTGGTACAATTCGCTAT 69 FBan0017477 FBgn0038479 CG17477 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4 CG17477 CG17477 SPH174 CDMC27862 4 8 11 DAC17-L19 3-CG17477-RA_4 CG17477 ACGGCTGGTCACTGTGTCAAAGGATACCCGACTAGCAGACTTCAAGTGGCCACTGGTACAATTCGCTAT 69 FBan0017477 FBgn0038479 CG17477 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4 CG17477 CG17477 SPH174 CDMC27863 4 9 11 DAC17-P07 22-CG17514-RA_1 CG17514 GTCAGAGAGACAATGCTCCATGCACTTCGAAGTATTGTCAGTCGATCTGGAGACAAAATGTCGGAACCA 69 FBgn0039959 CG17514 regulation of translation; GO:0006445 translation activator activity; GO:0008494; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0008494 CG17514 CG17514 CDMC27863 4 10 11 DAC17-P07 22-CG17514-RA_1 CG17514 GTCAGAGAGACAATGCTCCATGCACTTCGAAGTATTGTCAGTCGATCTGGAGACAAAATGTCGGAACCA 69 FBgn0039959 CG17514 regulation of translation; GO:0006445 translation activator activity; GO:0008494; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0008494 CG17514 CG17514 CDMC27864 4 11 11 DAC17-P19 15-CG17523-RA_1 CG17523 CGCTGCGAAATGTCAGTATACCCTATTTTCTTCGCCAAGTAAGCCTGGTACCCAAGGAGAAGGTGGACA 69 FBgn0034336 CDMC27864 4 12 11 DAC17-P19 15-CG17523-RA_1 CG17523 CGCTGCGAAATGTCAGTATACCCTATTTTCTTCGCCAAGTAAGCCTGGTACCCAAGGAGAAGGTGGACA 69 FBgn0034336 CDMC27865 4 13 11 DAC18-D07 16-CG31317-RA_1 CG31317 GGCAGAGGAGGAAACGCCAAACTACATGAACTGCTAGGCCATCCCAACGACACATATTGTAATCGAAAG 69 FBan0031317 FBgn0020299 stumps 3 3R branching morphogenesis; GO:0001763; fibroblast growth factor receptor signaling pathway; GO:0008543; gastrulation; GO:0007369; heart development; GO:0007507; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; mesodermal cell migration; GO:0008078; oogenesis (sensu Insecta); GO:0009993; primary tracheal branching (sensu Insecta); GO:0007428; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 cytoplasm; GO:0005737; intracellular; GO:0005622 stumps stumps "CG18485, CG3375, CG31317, CG18485, CG3375, CG18485, C: Group C, l(3)09904, hbr: heartbroken, heartbroken, 0837/10, dof, downstream of FGFR, downstream of FGF receptor, P1740, gene C, Dof, sms, heartbroken/dof, Downstream of FGF, Downstream of FGFR, dof/hbr, Dof/stumps/heartbroken, stumps/dof, Hbr/Dof, Stumps, Downstream of FGF receptor, Heartbroken, i28, i21, DOF, dof/hbr/sms, anon-EST:CL47, anon-estC, l(3)S083710, hbr" CDMC27865 4 14 11 DAC18-D07 16-CG31317-RA_1 CG31317 GGCAGAGGAGGAAACGCCAAACTACATGAACTGCTAGGCCATCCCAACGACACATATTGTAATCGAAAG 69 FBan0031317 FBgn0020299 stumps 3 3R branching morphogenesis; GO:0001763; fibroblast growth factor receptor signaling pathway; GO:0008543; gastrulation; GO:0007369; heart development; GO:0007507; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; mesodermal cell migration; GO:0008078; oogenesis (sensu Insecta); GO:0009993; primary tracheal branching (sensu Insecta); GO:0007428; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 cytoplasm; GO:0005737; intracellular; GO:0005622 stumps stumps "CG18485, CG3375, CG31317, CG18485, CG3375, CG18485, C: Group C, l(3)09904, hbr: heartbroken, heartbroken, 0837/10, dof, downstream of FGFR, downstream of FGF receptor, P1740, gene C, Dof, sms, heartbroken/dof, Downstream of FGF, Downstream of FGFR, dof/hbr, Dof/stumps/heartbroken, stumps/dof, Hbr/Dof, Stumps, Downstream of FGF receptor, Heartbroken, i28, i21, DOF, dof/hbr/sms, anon-EST:CL47, anon-estC, l(3)S083710, hbr" CDMC27866 4 15 11 DAC18-D19 1-CG31330-RA_1 CG31330 CCAGCCGCCTTAAGACTGTGATCAAAACGACAATGGTGAAGCGAAGTCCTAGCCATGACTCAACGGCAA 69 FBan0031330 FBgn0051330 CG31330 3 3R CG31330 CG31330 "CG14848, CG14849, CG14848" CDMC27866 4 16 11 DAC18-D19 1-CG31330-RA_1 CG31330 CCAGCCGCCTTAAGACTGTGATCAAAACGACAATGGTGAAGCGAAGTCCTAGCCATGACTCAACGGCAA 69 FBan0031330 FBgn0051330 CG31330 3 3R CG31330 CG31330 "CG14848, CG14849, CG14848" CDMC27867 4 17 11 DAC18-H07 14-CG31363-RE_3 CG31363 AACCCTACACTCCCGTATCCAGGTCAGAAAATCGAAAGGCACGAAAGTAGGACATGATGGCCAACGAAT 69 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC27867 4 18 11 DAC18-H07 14-CG31363-RE_3 CG31363 AACCCTACACTCCCGTATCCAGGTCAGAAAATCGAAAGGCACGAAAGTAGGACATGATGGCCAACGAAT 69 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC27868 4 19 11 DAC18-H19 22-CG3136-RC_2 CG3136 TGAGATTGAGCCTGTCGGAAAACAATTAAGCATGTCCAATCGACGGTTACTATGGGCTGATTCAGAGGA 69 FBan0003136 FBgn0033010 CG3136 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG3136 CG3136 CDMC27868 4 20 11 DAC18-H19 22-CG3136-RC_2 CG3136 TGAGATTGAGCCTGTCGGAAAACAATTAAGCATGTCCAATCGACGGTTACTATGGGCTGATTCAGAGGA 69 FBan0003136 FBgn0033010 CG3136 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG3136 CG3136 CDMC27869 4 21 11 DAC18-L07 9-CG31413-RA_3 CG31413 GGCTGCCATTAAGCAATTCTTGATCTTTGTCGACCTTAAGCCCCAGAAACCGTTGCCAAAAACCCCACC 69 FBan0031413 FBgn0051413 CG31413 3 3R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG31413 CG31413 "CG10299, CG10299, CG10299" CDMC27869 4 22 11 DAC18-L07 9-CG31413-RA_3 CG31413 GGCTGCCATTAAGCAATTCTTGATCTTTGTCGACCTTAAGCCCCAGAAACCGTTGCCAAAAACCCCACC 69 FBan0031413 FBgn0051413 CG31413 3 3R electron transport; GO:0006118; protein modification; GO:0006464 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971; glucosidase activity; GO:0015926 ; EC:3.2.1.-; electron transporter activity; GO:0005489; ; GO:0015926 ; EC:3.2.1.-; ; GO:0016971; ; GO:0005489 CG31413 CG31413 "CG10299, CG10299, CG10299" CDMC27870 4 23 11 DAC18-L19 8-CG31424-RA_1 CG31424 TCAACTCAGCCCATAGACTCCGGAATTCCAATGGTTTTCTCGTCGCTATTGATTGTGGTTCCCTGCGGA 69 FBan0031424 FBgn0051424 CG31424 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31424 CG31424 CDMC27870 4 24 11 DAC18-L19 8-CG31424-RA_1 CG31424 TCAACTCAGCCCATAGACTCCGGAATTCCAATGGTTTTCTCGTCGCTATTGATTGTGGTTCCCTGCGGA 69 FBan0031424 FBgn0051424 CG31424 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31424 CG31424 CDMC27871 4 25 11 DAC18-P07 3-CG31472-RB_2 CG31472 TCCACGATCGCATCCGCTTTAGACGAGGTGGAGGAGTAGAATCCGAAGTCGACAGCAAACTGGTTCACA 69 FBan0031472 FBgn0051472 CG31472 3 3R coenzyme metabolism; GO:0006732; pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 CG31472 CG31472 "CG2649, CG2649" CDMC27871 4 26 11 DAC18-P07 3-CG31472-RB_2 CG31472 TCCACGATCGCATCCGCTTTAGACGAGGTGGAGGAGTAGAATCCGAAGTCGACAGCAAACTGGTTCACA 69 FBan0031472 FBgn0051472 CG31472 3 3R coenzyme metabolism; GO:0006732; pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 CG31472 CG31472 "CG2649, CG2649" CDMC27872 4 1 12 DAC18-P19 1-CG31498-RA_1 CG31498 CGCATAGAGCCACTCATCTGACGTCACCTCGAGTCCCCGATAATTATCGATGGGAGTTATGGCGCTGCT 69 FBan0031498 FBgn0051498 CG31498 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31498 CG31498 CDMC27872 4 2 12 DAC18-P19 1-CG31498-RA_1 CG31498 CGCATAGAGCCACTCATCTGACGTCACCTCGAGTCCCCGATAATTATCGATGGGAGTTATGGCGCTGCT 69 FBan0031498 FBgn0051498 CG31498 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31498 CG31498 CDMC27873 4 3 12 DAC19-D07 6-CG6058-RA_3 CG6058 GTTGCGTCCTGAAGATCGGCAAGAACACCCCATCCTACCAGTCGATCCTGGAGAACGCCAATGTC 65 FBan0006058 FBgn0000064 Ald 3 3R glycolysis; GO:0006096; mesoderm development; GO:0007498 fructose-bisphosphate aldolase activity; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13 Ald Aldolase "CG6058, CG6058, CG6058, ALD, ald, aldolase, FBA, fructose 1,6 biphosphate-aldolase A, T4, T6, T7, T12, BcDNA:LP07735, Aldolase" CDMC27873 4 4 12 DAC19-D07 6-CG6058-RA_3 CG6058 GTTGCGTCCTGAAGATCGGCAAGAACACCCCATCCTACCAGTCGATCCTGGAGAACGCCAATGTC 65 FBan0006058 FBgn0000064 Ald 3 3R glycolysis; GO:0006096; mesoderm development; GO:0007498 fructose-bisphosphate aldolase activity; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13; ; GO:0004332 ; EC:4.1.2.13 Ald Aldolase "CG6058, CG6058, CG6058, ALD, ald, aldolase, FBA, fructose 1,6 biphosphate-aldolase A, T4, T6, T7, T12, BcDNA:LP07735, Aldolase" CDMC27874 4 5 12 DAC19-D19 12-CG6108-RA_5 CG6108 AGCGAGGTGCTGCCACTCCAACCAATATGGAGCCACAACTACCAGAGGTCTATGTGGAACCCGAG 65 FBan0006108 FBgn0032498 CG6108 2 2L CG6108 CG6108 CDMC27874 4 6 12 DAC19-D19 12-CG6108-RA_5 CG6108 AGCGAGGTGCTGCCACTCCAACCAATATGGAGCCACAACTACCAGAGGTCTATGTGGAACCCGAG 65 FBan0006108 FBgn0032498 CG6108 2 2L CG6108 CG6108 CDMC27875 4 7 12 DAC19-H07 2-CG6202-RA_1 CG6202 TCTGTGGGACTTCCAGTTCTTACTGCGAAACTTTGCACTCATCGGAGCCCTACTGCTCGTCCTGG 65 FBan0006202 FBgn0019925 Surf4 3 3R asymmetric protein localization; GO:0008105; protein targeting; GO:0006605 receptor signaling protein activity; GO:0005057; ; GO:0005057 endoplasmic reticulum membrane; GO:0005789 Surf4 Surfeit 4 "CG6202, Surf-4, SURF-4, Surfeit 4" CDMC27875 4 8 12 DAC19-H07 2-CG6202-RA_1 CG6202 TCTGTGGGACTTCCAGTTCTTACTGCGAAACTTTGCACTCATCGGAGCCCTACTGCTCGTCCTGG 65 FBan0006202 FBgn0019925 Surf4 3 3R asymmetric protein localization; GO:0008105; protein targeting; GO:0006605 receptor signaling protein activity; GO:0005057; ; GO:0005057 endoplasmic reticulum membrane; GO:0005789 Surf4 Surfeit 4 "CG6202, Surf-4, SURF-4, Surfeit 4" CDMC27876 4 9 12 DAC19-H19 15-CG6262-RB_4 CG6262 AATCGCAACAGCAGAGAACCCTGGGGATACAGCACGATCCAGATTGTCCATGTGCCGGACCACAG 65 FBan0006262 FBgn0034121 CG6262 2 2R disaccharide metabolism; GO:0005984; trehalose metabolism; GO:0005991 "trehalase activity; GO:0015927 ; EC:3.2.1.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; ; GO:0015927 ; EC:3.2.1.-; ; GO:0004555 ; EC:3.2.1.28" CG6262 CG6262 CDMC27876 4 10 12 DAC19-H19 15-CG6262-RB_4 CG6262 AATCGCAACAGCAGAGAACCCTGGGGATACAGCACGATCCAGATTGTCCATGTGCCGGACCACAG 65 FBan0006262 FBgn0034121 CG6262 2 2R disaccharide metabolism; GO:0005984; trehalose metabolism; GO:0005991 "trehalase activity; GO:0015927 ; EC:3.2.1.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; ; GO:0015927 ; EC:3.2.1.-; ; GO:0004555 ; EC:3.2.1.28" CG6262 CG6262 CDMC27877 4 11 12 DAC19-L07 3-CG6345-RA_1 CG6345 TTTGGAGTAGGTGACTTTTTGGCCGTCCGCATTGAGGAATCCAACTCACAGGTGCTGAAGGGCAC 65 FBan0006345 FBgn0037816 CG6345 3 3R regulation of cyclin dependent protein kinase activity; GO:0000079 catalytic activity; GO:0003824; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0005506 cellular component unknown; GO:0008372 CG6345 CG6345 CDMC27877 4 12 12 DAC19-L07 3-CG6345-RA_1 CG6345 TTTGGAGTAGGTGACTTTTTGGCCGTCCGCATTGAGGAATCCAACTCACAGGTGCTGAAGGGCAC 65 FBan0006345 FBgn0037816 CG6345 3 3R regulation of cyclin dependent protein kinase activity; GO:0000079 catalytic activity; GO:0003824; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0005506 cellular component unknown; GO:0008372 CG6345 CG6345 CDMC27878 4 13 12 DAC19-L19 3-CG6367-RA_3 CG6367 AAGGTGACGGATACCATGCCCGGTATCTGCAGAACATCCTCCGATTGTGAGCCCCTAATCGATGG 65 FBan0006367 FBgn0030926 psh X X antifungal polypeptide induction; GO:0006967; defense response to fungi; GO:0050832; proteolysis; GO:0006508; regulation of Toll signaling pathway; GO:0008592 peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 psh persephone "CG6367, CG6367, c-SP28, SP28, persephone" CDMC27878 4 14 12 DAC19-L19 3-CG6367-RA_3 CG6367 AAGGTGACGGATACCATGCCCGGTATCTGCAGAACATCCTCCGATTGTGAGCCCCTAATCGATGG 65 FBan0006367 FBgn0030926 psh X X antifungal polypeptide induction; GO:0006967; defense response to fungi; GO:0050832; proteolysis; GO:0006508; regulation of Toll signaling pathway; GO:0008592 peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 psh persephone "CG6367, CG6367, c-SP28, SP28, persephone" CDMC27879 4 15 12 DAC19-P07 23-CG6462-RA_1 CG6462 GCTTTAATACGACTGCCAAGAAAAGTCAGAACTTCAGAACAAGTGCAACCCATTGAGTTGGCTGG 65 FBan0006462 FBgn0035663 CG6462 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG6462 CG6462 SP127 CDMC27879 4 16 12 DAC19-P07 23-CG6462-RA_1 CG6462 GCTTTAATACGACTGCCAAGAAAAGTCAGAACTTCAGAACAAGTGCAACCCATTGAGTTGGCTGG 65 FBan0006462 FBgn0035663 CG6462 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG6462 CG6462 SP127 CDMC27880 4 17 12 DAC19-P19 AutoBlank AutoBlank CDMC27880 4 18 12 DAC19-P19 AutoBlank AutoBlank CDMC27881 4 19 12 DAC20-D07 23-CG30108-RA_1 CG30108 ATAGATCCGATCTTCGAAACCGGGCTTGAGGAGAATAATGCGAATAGATCTGATGCAAAACAGCA 65 FBan0030108 FBgn0050108 CG30108 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30108 CG30108 CDMC27881 4 20 12 DAC20-D07 23-CG30108-RA_1 CG30108 ATAGATCCGATCTTCGAAACCGGGCTTGAGGAGAATAATGCGAATAGATCTGATGCAAAACAGCA 65 FBan0030108 FBgn0050108 CG30108 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30108 CG30108 CDMC27882 4 21 12 DAC20-D19 1-CG3014-RA_2 CG3014 AGGTCGTACGGATCGCTTAACACGGATCACACAGGTCGGAGTCTGGACACTTTCGGATCCCTCTG 65 FBan0003014 FBgn0037519 CG3014 3 3R CG3014 CG3014 CDMC27882 4 22 12 DAC20-D19 1-CG3014-RA_2 CG3014 AGGTCGTACGGATCGCTTAACACGGATCACACAGGTCGGAGTCTGGACACTTTCGGATCCCTCTG 65 FBan0003014 FBgn0037519 CG3014 3 3R CG3014 CG3014 CDMC27883 4 23 12 DAC20-H07 3-CG30272-RA_4 CG30272 CTTCAGTTCCCTTCTGGGCCTTGATGGTCACTAGGTGCTGTCAGTCCTGGGGATATTCCACGCTC 65 FBan0030272 FBgn0050272 CG30272 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG30272 CG30272 "CG11682, CG11682" CDMC27883 4 24 12 DAC20-H07 3-CG30272-RA_4 CG30272 CTTCAGTTCCCTTCTGGGCCTTGATGGTCACTAGGTGCTGTCAGTCCTGGGGATATTCCACGCTC 65 FBan0030272 FBgn0050272 CG30272 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG30272 CG30272 "CG11682, CG11682" CDMC27884 4 25 12 DAC20-H19 6-CG30330-RA_2 CG30330 GTGTGCGAGGACGATATGCGCTCCTGAACAAGGATCTTCAGGCGATTGTGACCGAATCCCAGTCG 65 FBan0030330 FBgn0041236 Gr59d 2 2R protein amino acid prenylation; GO:0018346; sensory perception of taste; GO:0050909 mRNA binding; GO:0003729; taste receptor activity; GO:0008527; ; GO:0003729; ; GO:0008527; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- Gr59d Gustatory receptor 59d "CG30330, CG13543, CG30330, 59D.1, Gustatory receptor 59D.1, 59D1, Gr59D1, GR59D.1, Gustatory receptor 59d" CDMC27884 4 26 12 DAC20-H19 6-CG30330-RA_2 CG30330 GTGTGCGAGGACGATATGCGCTCCTGAACAAGGATCTTCAGGCGATTGTGACCGAATCCCAGTCG 65 FBan0030330 FBgn0041236 Gr59d 2 2R protein amino acid prenylation; GO:0018346; sensory perception of taste; GO:0050909 mRNA binding; GO:0003729; taste receptor activity; GO:0008527; ; GO:0003729; ; GO:0008527; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- Gr59d Gustatory receptor 59d "CG30330, CG13543, CG30330, 59D.1, Gustatory receptor 59D.1, 59D1, Gr59D1, GR59D.1, Gustatory receptor 59d" CDMC27885 4 1 13 DAC20-L07 2-CG30412-RA_1 CG30412 GTGGAGCGATGCAGTACGCCTATGGGTTTCAAGCAGATCAAGCACGATCTGTTGGATGATCCGCC 65 FBan0030412 FBgn0050412 CG30412 2 2R CG30412 CG30412 "CG9803, CG9803, CG9803, anon-WO0140519.195" CDMC27885 4 2 13 DAC20-L07 2-CG30412-RA_1 CG30412 GTGGAGCGATGCAGTACGCCTATGGGTTTCAAGCAGATCAAGCACGATCTGTTGGATGATCCGCC 65 FBan0030412 FBgn0050412 CG30412 2 2R CG30412 CG30412 "CG9803, CG9803, CG9803, anon-WO0140519.195" CDMC27886 4 3 13 DAC20-L19 48-CG30427-RA_3 CG30427 TGTGCGAGAGTTTGATACCAATATTGCAAGTGTTTTAATTGAGGAGAATACCAAGCAATACTCAA 65 FBgn0050427 CDMC27886 4 4 13 DAC20-L19 48-CG30427-RA_3 CG30427 TGTGCGAGAGTTTGATACCAATATTGCAAGTGTTTTAATTGAGGAGAATACCAAGCAATACTCAA 65 FBgn0050427 CDMC27887 4 5 13 DAC20-P07 21-CG3081-RA_1 CG3081 GCACGCTTGGTGAGGCCGATTTCTTCGACAAGGACATCCTGAGGAAGCGAACGGATTTTGGCGGT 65 FBan0003081 FBgn0025613 CG3081 X X CG3081 CG3081 EG:84H4.4 CDMC27887 4 6 13 DAC20-P07 21-CG3081-RA_1 CG3081 GCACGCTTGGTGAGGCCGATTTCTTCGACAAGGACATCCTGAGGAAGCGAACGGATTTTGGCGGT 65 FBan0003081 FBgn0025613 CG3081 X X CG3081 CG3081 EG:84H4.4 CDMC27888 4 7 13 DAC20-P19 AutoBlank AutoBlank CDMC27888 4 8 13 DAC20-P19 AutoBlank AutoBlank CDMC27889 4 9 13 DAC21-D07 18-CG4013-RC_1 CG4013 TGTCATTTGTTATTTGTCCTTTGTCTTTCGGTCGTTGATTCCCTCTGCTCCTCACACAGCTCCAGCCT 68 FBan0004013 FBgn0024308 Smr X X "negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; protein binding; GO:0005515; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; ; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003714; ; GO:0003677 nucleus; GO:0005634; polytene chromosome; GO:0005700 Smr Smrter "CG4013, CG4013, CG4013, SMRTER, l(1)G0361, E52, SMRT-related ecdysone receptor-interacting factor, anon-WO0153538.73, SANT domain protein, Smrter" CDMC27889 4 10 13 DAC21-D07 18-CG4013-RC_1 CG4013 TGTCATTTGTTATTTGTCCTTTGTCTTTCGGTCGTTGATTCCCTCTGCTCCTCACACAGCTCCAGCCT 68 FBan0004013 FBgn0024308 Smr X X "negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; protein binding; GO:0005515; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; ; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003714; ; GO:0003677 nucleus; GO:0005634; polytene chromosome; GO:0005700 Smr Smrter "CG4013, CG4013, CG4013, SMRTER, l(1)G0361, E52, SMRT-related ecdysone receptor-interacting factor, anon-WO0153538.73, SANT domain protein, Smrter" CDMC27890 4 11 13 DAC21-D19 15-CG4096-RA_2 CG4096 GGTGAGTCCAACGAACCGTTCCAACGAATCGTGTCCATTAAACGCAATCTTCTCATAGCCTTGGGTGA 68 FBan0004096 FBgn0029791 CG4096 X X cell-cell adhesion; GO:0016337; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 CG4096 CG4096 CT13580 CDMC27890 4 12 13 DAC21-D19 15-CG4096-RA_2 CG4096 GGTGAGTCCAACGAACCGTTCCAACGAATCGTGTCCATTAAACGCAATCTTCTCATAGCCTTGGGTGA 68 FBan0004096 FBgn0029791 CG4096 X X cell-cell adhesion; GO:0016337; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 CG4096 CG4096 CT13580 CDMC27891 4 13 13 DAC21-H07 2-CG4461-RA_1 CG4461 TCGACTCCGTCCGCTCTACCATCCGCCGTATGATTTCCAGCTATATCCGTATCTGTGGGACGATTCGC 68 FBan0004461 FBgn0035982 CG4461 3 3L response to heat; GO:0009408 CG4461 CG4461 "gh12586, Hsp20, BEST:GH12586" CDMC27891 4 14 13 DAC21-H07 2-CG4461-RA_1 CG4461 TCGACTCCGTCCGCTCTACCATCCGCCGTATGATTTCCAGCTATATCCGTATCTGTGGGACGATTCGC 68 FBan0004461 FBgn0035982 CG4461 3 3L response to heat; GO:0009408 CG4461 CG4461 "gh12586, Hsp20, BEST:GH12586" CDMC27892 4 15 13 DAC21-H19 3-CG4656-RA_1 CG4656 AGCTGAAACGTCGGTGCTCTATCAATGGTCACTACTACAATCGGGAGACGTCGTTTTTCACGCCGCCC 68 FBan0004656 FBgn0039055 CG4656 3 3R signal transduction; GO:0007165 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 CG4656 CG4656 CDMC27892 4 16 13 DAC21-H19 3-CG4656-RA_1 CG4656 AGCTGAAACGTCGGTGCTCTATCAATGGTCACTACTACAATCGGGAGACGTCGTTTTTCACGCCGCCC 68 FBan0004656 FBgn0039055 CG4656 3 3R signal transduction; GO:0007165 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 CG4656 CG4656 CDMC27893 4 17 13 DAC21-L07 6-CG5148-RA_2 CG5148 GTGGTGATGGGGCATCAAACTCGGAGGATGATCTGCAAATAGCCCTGGCTATGTCGAAGGCCACCTAC 68 FBan0005148 FBgn0038478 CG5148 3 3R CG5148 CG5148 CDMC27893 4 18 13 DAC21-L07 6-CG5148-RA_2 CG5148 GTGGTGATGGGGCATCAAACTCGGAGGATGATCTGCAAATAGCCCTGGCTATGTCGAAGGCCACCTAC 68 FBan0005148 FBgn0038478 CG5148 3 3R CG5148 CG5148 CDMC27894 4 19 13 DAC21-L19 11-CG5214-RA_1 CG5214 GATACGTCCTATGATGTACATCGCCCTGACCTACGATCACCGAATCATTGATGGACGTGAGGCGGTCC 68 FBan0005214 FBgn0037891 CG5214 3 3R tricarboxylic acid cycle; GO:0006099 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoyllysine-residue succinyltransferase activity; GO:0004149 ; EC:2.3.1.61; ; GO:0004149 ; EC:2.3.1.61; ; GO:0004149 ; EC:2.3.1.61 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5214 CG5214 CDMC27894 4 20 13 DAC21-L19 11-CG5214-RA_1 CG5214 GATACGTCCTATGATGTACATCGCCCTGACCTACGATCACCGAATCATTGATGGACGTGAGGCGGTCC 68 FBan0005214 FBgn0037891 CG5214 3 3R tricarboxylic acid cycle; GO:0006099 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoyllysine-residue succinyltransferase activity; GO:0004149 ; EC:2.3.1.61; ; GO:0004149 ; EC:2.3.1.61; ; GO:0004149 ; EC:2.3.1.61 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5214 CG5214 CDMC27895 4 21 13 DAC21-P07 23-CG5655-RA_1 CG5655 GACTCGAACAACGTCAAACCAAAATCTAGAAGTACGCAATTTTAATAAAGGAAATGCGGAACAGTTTC 68 FBan0005655 FBgn0011305 Rsf1 2 2L "negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 Rsf1 Repressor splicing factor 1 "CG5655, CG5655, ROX21, Rox21, rox21, RSF1, Repressor splicing factor 1" CDMC27895 4 22 13 DAC21-P07 23-CG5655-RA_1 CG5655 GACTCGAACAACGTCAAACCAAAATCTAGAAGTACGCAATTTTAATAAAGGAAATGCGGAACAGTTTC 68 FBan0005655 FBgn0011305 Rsf1 2 2L "negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 Rsf1 Repressor splicing factor 1 "CG5655, CG5655, ROX21, Rox21, rox21, RSF1, Repressor splicing factor 1" CDMC27896 4 23 13 DAC21-P19 3-CG5753-RA_2 CG5753 AAGCATAAGCATCGGCGAATGTCGGAAAGCCGTATACCGTACCCCATGACCGGTCGATTTGCCAAAAC 68 FBan0005753 FBgn0003520 stau 2 2R RNA localization; GO:0006403; asymmetric protein localization during cell fate commitment; GO:0045167; bicoid mRNA localization; GO:0045450; embryonic development; GO:0009790; intracellular mRNA localization; GO:0008298; long-term memory; GO:0007616; microtubule-based process; GO:0007017; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318; positive regulation of oskar mRNA translation; GO:0046012; protein localization; GO:0008104; regulation of oskar mRNA translation; GO:0046011; regulation of pole plasm oskar mRNA localization; GO:0007317 double-stranded RNA binding; GO:0003725; mRNA binding; GO:0003729; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003725; ; GO:0008017; ; GO:0003729; ; GO:0003725; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 apical cortex; GO:0045179; basal cortex; GO:0045180; cell cortex; GO:0005938; microtubule associated complex; GO:0005875 stau staufen "CG5753, CG5753, dStau, Stauffen, Dmstau, STAU" CDMC27896 4 24 13 DAC21-P19 3-CG5753-RA_2 CG5753 AAGCATAAGCATCGGCGAATGTCGGAAAGCCGTATACCGTACCCCATGACCGGTCGATTTGCCAAAAC 68 FBan0005753 FBgn0003520 stau 2 2R RNA localization; GO:0006403; asymmetric protein localization during cell fate commitment; GO:0045167; bicoid mRNA localization; GO:0045450; embryonic development; GO:0009790; intracellular mRNA localization; GO:0008298; long-term memory; GO:0007616; microtubule-based process; GO:0007017; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly; GO:0007315; pole plasm mRNA localization; GO:0019094; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318; positive regulation of oskar mRNA translation; GO:0046012; protein localization; GO:0008104; regulation of oskar mRNA translation; GO:0046011; regulation of pole plasm oskar mRNA localization; GO:0007317 double-stranded RNA binding; GO:0003725; mRNA binding; GO:0003729; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003725; ; GO:0008017; ; GO:0003729; ; GO:0003725; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 apical cortex; GO:0045179; basal cortex; GO:0045180; cell cortex; GO:0005938; microtubule associated complex; GO:0005875 stau staufen "CG5753, CG5753, dStau, Stauffen, Dmstau, STAU" CDMC27897 4 25 13 DAC22-D07 22-CG40470-RA_1 CG40470 GGTTCGCCTGCCTAAGGAAGTTTTGCCTCTAAGCTATGAAGTCCTCATTGAACCGCATATGGATAACCA 69 FBgn0058470 CG40470 CG40470 CG40470 CDMC27897 4 26 13 DAC22-D07 22-CG40470-RA_1 CG40470 GGTTCGCCTGCCTAAGGAAGTTTTGCCTCTAAGCTATGAAGTCCTCATTGAACCGCATATGGATAACCA 69 FBgn0058470 CG40470 CG40470 CG40470 CDMC27898 4 1 14 DAC22-D19 2-CG4049-RA_4 CG4049 TGGACCCACGAAGCCACTAGACGATCAAAATACGCCTAAATCACCAAACGGTGCCTCTCACTCGCCAAT 69 FBan0004049 FBgn0034976 CG4049 2 2R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003677 CG4049 CG4049 "R-gene, BEST:LD04705" CDMC27898 4 2 14 DAC22-D19 2-CG4049-RA_4 CG4049 TGGACCCACGAAGCCACTAGACGATCAAAATACGCCTAAATCACCAAACGGTGCCTCTCACTCGCCAAT 69 FBan0004049 FBgn0034976 CG4049 2 2R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003677 CG4049 CG4049 "R-gene, BEST:LD04705" CDMC27899 4 3 14 DAC22-H07 14-CG4079-RA_1 CG4079 TCTCGTTTCCAACTTTACGGAAGAACAGCTGGATCGCTACGAAATGTATCGTCGCTCTGCCTTTCCCAA 69 FBan0004079 FBgn0011291 Taf11 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf11 TBP-associated factor 11 "CG4079, CG4079, Taf30beta: TBP-associated factor 30kD subunit beta, dTAF[[II]]30beta, Taf[[II]]30beta, TAF[[II]]30beta, TAF30b, dTAF[[II]]30, dTAFII30, TFIID 28 beta, dTAFII30 beta, TAF30beta, d30beta, TFIID, dTAFII30beta, TAF11, TAF[II]30beta, TAF[[II]], TAF, TFIID-p28beta, TBP-associated factor 30kD subunit beta, Taf30beta" CDMC27899 4 4 14 DAC22-H07 14-CG4079-RA_1 CG4079 TCTCGTTTCCAACTTTACGGAAGAACAGCTGGATCGCTACGAAATGTATCGTCGCTCTGCCTTTCCCAA 69 FBan0004079 FBgn0011291 Taf11 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf11 TBP-associated factor 11 "CG4079, CG4079, Taf30beta: TBP-associated factor 30kD subunit beta, dTAF[[II]]30beta, Taf[[II]]30beta, TAF[[II]]30beta, TAF30b, dTAF[[II]]30, dTAFII30, TFIID 28 beta, dTAFII30 beta, TAF30beta, d30beta, TFIID, dTAFII30beta, TAF11, TAF[II]30beta, TAF[[II]], TAF, TFIID-p28beta, TBP-associated factor 30kD subunit beta, Taf30beta" CDMC27900 4 5 14 DAC22-H19 11-CG4091-RC_1 CG4091 GCCACCCATCTCACCTGCAGTCGTTAGTCGATGCTAAGTTGGTTATGCTAAGTCGTCACCAGAACCTGT 69 FBan0004091 FBgn0034894 CG4091 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG4091 CG4091 CDMC27900 4 6 14 DAC22-H19 11-CG4091-RC_1 CG4091 GCCACCCATCTCACCTGCAGTCGTTAGTCGATGCTAAGTTGGTTATGCTAAGTCGTCACCAGAACCTGT 69 FBan0004091 FBgn0034894 CG4091 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG4091 CG4091 CDMC27901 4 7 14 DAC22-L07 22-CG41087-RA_2 CG41087 TGCTTGTCAAAGTCCTGCCAGAGCTTATCTGTTAGACGTTTGTTTACCAGAAGATCAAGCAAGAGGCCT 69 FBgn0069947 CG41087 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41087 CG41087 CDMC27901 4 8 14 DAC22-L07 22-CG41087-RA_2 CG41087 TGCTTGTCAAAGTCCTGCCAGAGCTTATCTGTTAGACGTTTGTTTACCAGAAGATCAAGCAAGAGGCCT 69 FBgn0069947 CG41087 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41087 CG41087 CDMC27902 4 9 14 DAC22-L19 18-CG41103-RA_3 CG41103 TGGGATCCCGAAACAAAGCCGAAAGACAGAAACTCAAAATTCAGAGCCCTAACACTCAAACACTCAGCA 69 FBgn0069941 CG41103 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41103 CG41103 CDMC27902 4 10 14 DAC22-L19 18-CG41103-RA_3 CG41103 TGGGATCCCGAAACAAAGCCGAAAGACAGAAACTCAAAATTCAGAGCCCTAACACTCAAACACTCAGCA 69 FBgn0069941 CG41103 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41103 CG41103 CDMC27903 4 11 14 DAC22-P07 23-CG4119-RA_1 CG4119 GCGAGCCAATCGTGAAGAACAGCTTCATTGATTTCTAAATCCACCTTGTTAGCGTTAATTAATAAATAT 69 FBan0004119 FBgn0028474 CG4119 X X "mRNA processing; GO:0006397; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG4119 CG4119 "cg4119, BcDNA:LD23634" CDMC27903 4 12 14 DAC22-P07 23-CG4119-RA_1 CG4119 GCGAGCCAATCGTGAAGAACAGCTTCATTGATTTCTAAATCCACCTTGTTAGCGTTAATTAATAAATAT 69 FBan0004119 FBgn0028474 CG4119 X X "mRNA processing; GO:0006397; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG4119 CG4119 "cg4119, BcDNA:LD23634" CDMC27904 4 13 14 DAC22-P19 23-CG4125-RA_8 CG4125 AATATAGAAGCTAGATCTTGACAGTCGCCTTAACTTATGACACGCCCATACATCTCAAAACGCCCATGC 69 FBan0004125 FBgn0003285 rst X X apoptotic program; GO:0008632; axonogenesis; GO:0007409; cell adhesion; GO:0007155; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; homophilic cell adhesion; GO:0007156; myoblast fusion; GO:0007520; regulation of striated muscle development; GO:0016202; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; retinal cell programmed cell death; GO:0046666; signal transduction; GO:0007165 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rst roughest "CG4125, irreC: irregular optic chiasma C, irreC-rst, irreC-roughest, IrreC-rst, irrecC-rst, rst-irrecC, IREE-C, CT13684, irregular chiasm C-roughest, rst-irreC, IrreC-Rst, ChiasmC-roughest, IrreC, rst/irrecC, IRREC/RST, irregular chiasm-C-roughest, IrrecC, UB883, irregular optic chiasma C, irreC" CDMC27904 4 14 14 DAC22-P19 23-CG4125-RA_8 CG4125 AATATAGAAGCTAGATCTTGACAGTCGCCTTAACTTATGACACGCCCATACATCTCAAAACGCCCATGC 69 FBan0004125 FBgn0003285 rst X X apoptotic program; GO:0008632; axonogenesis; GO:0007409; cell adhesion; GO:0007155; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; homophilic cell adhesion; GO:0007156; myoblast fusion; GO:0007520; regulation of striated muscle development; GO:0016202; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; retinal cell programmed cell death; GO:0046666; signal transduction; GO:0007165 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rst roughest "CG4125, irreC: irregular optic chiasma C, irreC-rst, irreC-roughest, IrreC-rst, irrecC-rst, rst-irrecC, IREE-C, CT13684, irregular chiasm C-roughest, rst-irreC, IrreC-Rst, ChiasmC-roughest, IrreC, rst/irrecC, IRREC/RST, irregular chiasm-C-roughest, IrrecC, UB883, irregular optic chiasma C, irreC" CDMC27905 4 15 14 DAC23-D07 23-CG3342-RA_1 CG3342 GCGATTCGACAAGGAACCGGATGAGAAGGAATTCATAACGTTTATGGTCAAAAACAAACTGCCAGTGGA 69 FBan0003342 FBgn0029874 CG3342 X X CG3342 CG3342 CDMC27905 4 16 14 DAC23-D07 23-CG3342-RA_1 CG3342 GCGATTCGACAAGGAACCGGATGAGAAGGAATTCATAACGTTTATGGTCAAAAACAAACTGCCAGTGGA 69 FBan0003342 FBgn0029874 CG3342 X X CG3342 CG3342 CDMC27906 4 17 14 DAC23-D19 15-CG33458-RA_1 CG33458 TCGATCGATTCACCTGTCGCTACTGGTTTGGATACATGGTTGATCGTACTCACATTTGTGCGGGCGAAA 69 FBan0033458 FBgn0053458 CG33458 2 2R CG33458 CG33458 CDMC27906 4 18 14 DAC23-D19 15-CG33458-RA_1 CG33458 TCGATCGATTCACCTGTCGCTACTGGTTTGGATACATGGTTGATCGTACTCACATTTGTGCGGGCGAAA 69 FBan0033458 FBgn0053458 CG33458 2 2R CG33458 CG33458 CDMC27907 4 19 14 DAC23-H07 1-CG33480-RA_1 CG33480 GCTGCCTGCTCCACATGTCCAAGGATCAGATTGCGATTGCCAGAGTTTCGGCGTTGTTTTGTTTTCGTT 69 FBgn0053480 CG33480 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33480 CG33480 CDMC27907 4 20 14 DAC23-H07 1-CG33480-RA_1 CG33480 GCTGCCTGCTCCACATGTCCAAGGATCAGATTGCGATTGCCAGAGTTTCGGCGTTGTTTTGTTTTCGTT 69 FBgn0053480 CG33480 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33480 CG33480 CDMC27908 4 21 14 DAC23-H19 14-CG33485-RA_1 CG33485 AGCAGAACGAACCCTTCGGAAGGCTGCTCAACACTGCATTAAAGACACAAACAAAAGGCAAAGGGAAAA 69 FBan0033485 FBgn0038282 dpr9 3 3R dpr9 dpr9 "CG12601, CG31114, CG33485, CG14862, CG14863, CG12601, CG12601, CG31114, CT34680, Dpr-9, BcDNA:GH01517" CDMC27908 4 22 14 DAC23-H19 14-CG33485-RA_1 CG33485 AGCAGAACGAACCCTTCGGAAGGCTGCTCAACACTGCATTAAAGACACAAACAAAAGGCAAAGGGAAAA 69 FBan0033485 FBgn0038282 dpr9 3 3R dpr9 dpr9 "CG12601, CG31114, CG33485, CG14862, CG14863, CG12601, CG12601, CG31114, CT34680, Dpr-9, BcDNA:GH01517" CDMC27909 4 23 14 DAC23-L07 23-CG3365-RB_2 CG3365 GTTTCCATTGCTAATCATCTGCTTTTCGTGTGCTAATTTTATACACTAGTACGTGCGATATCGGCCGTG 69 FBan0003365 FBgn0020304 drongo 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of GTPase activity; GO:0043087; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 drongo drongo "CG3365, drongo" CDMC27909 4 24 14 DAC23-L07 23-CG3365-RB_2 CG3365 GTTTCCATTGCTAATCATCTGCTTTTCGTGTGCTAATTTTATACACTAGTACGTGCGATATCGGCCGTG 69 FBan0003365 FBgn0020304 drongo 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931; regulation of GTPase activity; GO:0043087; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 drongo drongo "CG3365, drongo" CDMC27910 4 25 14 DAC23-L19 2-CG3382-RA_2 CG3382 GCGCCAGGTCTCTCGTACATGGATGATAACTCCGCAAGTTCCAAGACCCCAGCAATGCTAAGTATGGGA 69 FBan0003382 FBgn0034715 Oatp58Db 2 2R anion transport; GO:0006820; organic anion transport; GO:0015711; rRNA processing; GO:0006364 organic anion transporter activity; GO:0008514; ; GO:0008514; ; GO:0008514 membrane; GO:0016020 Oatp58Db Organic anion transporting polypeptide 58Db "CG3382, oatp 58Db, 58Db, Organic anion transporting polypeptide 58Db" CDMC27910 4 26 14 DAC23-L19 2-CG3382-RA_2 CG3382 GCGCCAGGTCTCTCGTACATGGATGATAACTCCGCAAGTTCCAAGACCCCAGCAATGCTAAGTATGGGA 69 FBan0003382 FBgn0034715 Oatp58Db 2 2R anion transport; GO:0006820; organic anion transport; GO:0015711; rRNA processing; GO:0006364 organic anion transporter activity; GO:0008514; ; GO:0008514; ; GO:0008514 membrane; GO:0016020 Oatp58Db Organic anion transporting polypeptide 58Db "CG3382, oatp 58Db, 58Db, Organic anion transporting polypeptide 58Db" CDMC27911 4 1 15 DAC23-P07 23-CG3422-RA_2 CG3422 TGAACCGAATGCATACTTTTTTTAATTACCACTTTCTATTCTTCGGAACCCTGTAAAACGGTATGAAAA 69 FBan0003422 FBgn0004066 Pros28.1 X X ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1 Proteasome 28kD subunit 1 "CG3422, PROS-28.1, PROS-Dm28.1, Pros28, alpha4_dm, PROSA-28.1, 20S proteasome, pros28.1, a4, 20s proteasome, alpha4, Pros-Dm28.1" CDMC27911 4 2 15 DAC23-P07 23-CG3422-RA_2 CG3422 TGAACCGAATGCATACTTTTTTTAATTACCACTTTCTATTCTTCGGAACCCTGTAAAACGGTATGAAAA 69 FBan0003422 FBgn0004066 Pros28.1 X X ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1 Proteasome 28kD subunit 1 "CG3422, PROS-28.1, PROS-Dm28.1, Pros28, alpha4_dm, PROSA-28.1, 20S proteasome, pros28.1, a4, 20s proteasome, alpha4, Pros-Dm28.1" CDMC27912 4 3 15 DAC23-P19 23-CG3443-RB_19 CG3443 TAAAGAGTACACAAATGAAACAAATCCCGCATTACATAAGCCTAAGCGATAAGCGAACTTCGGACAGGA 69 FBan0003443 FBgn0003048 pcx X X ectoderm development; GO:0007398; nervous system development; GO:0007399 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 pcx pecanex "CG3443, CG3443, fs(1)M10, mel(1)R1, fs(1)pcx, DMPCX, EG:30B8.4, fs(1)12-1012, fs(1)12-1743, fs(1)12-2135, fs(1)12-3014, fs(1)12-3102, fs(1)12-4169, fs(1)14-1153, fs(1)14-567, fs(1)A387, mel(1)R, pecanex" CDMC27912 4 4 15 DAC23-P19 23-CG3443-RB_19 CG3443 TAAAGAGTACACAAATGAAACAAATCCCGCATTACATAAGCCTAAGCGATAAGCGAACTTCGGACAGGA 69 FBan0003443 FBgn0003048 pcx X X ectoderm development; GO:0007398; nervous system development; GO:0007399 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 pcx pecanex "CG3443, CG3443, fs(1)M10, mel(1)R1, fs(1)pcx, DMPCX, EG:30B8.4, fs(1)12-1012, fs(1)12-1743, fs(1)12-2135, fs(1)12-3014, fs(1)12-3102, fs(1)12-4169, fs(1)14-1153, fs(1)14-567, fs(1)A387, mel(1)R, pecanex" CDMC27913 4 5 15 DAC24-D07 10-CG33178-RA_1 CG33178 GCCCGGCGATATGTTTACCCTGGAGAATCCTGTCTTTTGCTGCTATCTTTTTTGGTCCACAGTCCTGGT 69 FBan0033178 FBgn0053178 CG33178 X X defense response; GO:0006952; protein metabolism; GO:0019538; protein modification; GO:0006464; response to toxin; GO:0009636 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- CG33178 CG33178 "CG5579, BcDNA:RH14671" CDMC27913 4 6 15 DAC24-D07 10-CG33178-RA_1 CG33178 GCCCGGCGATATGTTTACCCTGGAGAATCCTGTCTTTTGCTGCTATCTTTTTTGGTCCACAGTCCTGGT 69 FBan0033178 FBgn0053178 CG33178 X X defense response; GO:0006952; protein metabolism; GO:0019538; protein modification; GO:0006464; response to toxin; GO:0009636 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- CG33178 CG33178 "CG5579, BcDNA:RH14671" CDMC27914 4 7 15 DAC24-D19 12-CG33189-RA_1 CG33189 TCGAAGAGCAGAAGATCGAGTGTAAAGTGGTCCAACAAGGATGAAGTGTGTCCCGATTGCCAGGAACCT 69 FBan0033189 FBgn0053189 CG33189 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33189 CG33189 CDMC27914 4 8 15 DAC24-D19 12-CG33189-RA_1 CG33189 TCGAAGAGCAGAAGATCGAGTGTAAAGTGGTCCAACAAGGATGAAGTGTGTCCCGATTGCCAGGAACCT 69 FBan0033189 FBgn0053189 CG33189 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33189 CG33189 CDMC27915 4 9 15 DAC24-H07 2-CG33208-RA_2 CG33208 GCTGCGGAGTTCTCCACCCAATACCAAATGCCAAACCTGGAGTTCGCTGTTAATCACTACGGCAAACCA 69 FBan0033208 FBgn0053208 MICAL 3 3R axon guidance; GO:0007411; chromosome segregation; GO:0007059; mitosis; GO:0007067 actin binding; GO:0003779; centromeric DNA binding; GO:0019237; zinc ion binding; GO:0008270; ; GO:0019237; ; GO:0008270; ; GO:0003779 cytosol; GO:0005829 MICAL MICAL "CG33208, CG11685, CG11687, CG18484, CG18667, CG18668, CG33186, CG33190" CDMC27915 4 10 15 DAC24-H07 2-CG33208-RA_2 CG33208 GCTGCGGAGTTCTCCACCCAATACCAAATGCCAAACCTGGAGTTCGCTGTTAATCACTACGGCAAACCA 69 FBan0033208 FBgn0053208 MICAL 3 3R axon guidance; GO:0007411; chromosome segregation; GO:0007059; mitosis; GO:0007067 actin binding; GO:0003779; centromeric DNA binding; GO:0019237; zinc ion binding; GO:0008270; ; GO:0019237; ; GO:0008270; ; GO:0003779 cytosol; GO:0005829 MICAL MICAL "CG33208, CG11685, CG11687, CG18484, CG18667, CG18668, CG33186, CG33190" CDMC27916 4 11 15 DAC24-H19 17-CG33218-RA_3 CG33218 TCCAATAATTCCACCCATCGAAGCTAACAAAATGATACCGAGGCCTCAAAATGGATTCGTCAGCCGAGC 69 FBan0033218 FBgn0053218 CG33218 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33218 CG33218 "CG2854, CT9762" CDMC27916 4 12 15 DAC24-H19 17-CG33218-RA_3 CG33218 TCCAATAATTCCACCCATCGAAGCTAACAAAATGATACCGAGGCCTCAAAATGGATTCGTCAGCCGAGC 69 FBan0033218 FBgn0053218 CG33218 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33218 CG33218 "CG2854, CT9762" CDMC27917 4 13 15 DAC24-L07 17-CG3325-RA_3 CG3325 GCCTGCGAGAAGAGGCATCCCGAAATGGAGCTGAATTTTCTGGGAAACATCTTTGTGGAAAATCACATT 69 FBan0003325 FBgn0003480 spn-B 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome condensation; GO:0030261; double-strand break repair; GO:0006302; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; meiosis; GO:0007126; meiotic recombination; GO:0007131; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; regulation of translation; GO:0006445 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; recombinase activity; GO:0000150; DNA strand annealing activity; GO:0000739; ; GO:0003684; ; GO:0000739; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 spn-B spindle B "CG3325, spnB, SpnB, spindle-B, Spindle-B" CDMC27917 4 14 15 DAC24-L07 17-CG3325-RA_3 CG3325 GCCTGCGAGAAGAGGCATCCCGAAATGGAGCTGAATTTTCTGGGAAACATCTTTGTGGAAAATCACATT 69 FBan0003325 FBgn0003480 spn-B 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome condensation; GO:0030261; double-strand break repair; GO:0006302; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; meiosis; GO:0007126; meiotic recombination; GO:0007131; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; regulation of translation; GO:0006445 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; recombinase activity; GO:0000150; DNA strand annealing activity; GO:0000739; ; GO:0003684; ; GO:0000739; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 spn-B spindle B "CG3325, spnB, SpnB, spindle-B, Spindle-B" CDMC27918 4 15 15 DAC24-L19 15-CG33264-RA_4 CG33264 ACGCCCTACTGAAAGACAGTTCTACGCTTCGGAGCAAAGGATAGTGTTCCTTCTTGGAACCATTTGCCA 69 FBgn0036326 CDMC27918 4 16 15 DAC24-L19 15-CG33264-RA_4 CG33264 ACGCCCTACTGAAAGACAGTTCTACGCTTCGGAGCAAAGGATAGTGTTCCTTCTTGGAACCATTTGCCA 69 FBgn0036326 CDMC27919 4 17 15 DAC24-P07 13-CG33309-RA_1 CG33309 GGTACGACAAGCATATGTGACCATTTTGCAAATTGCTACCCCTCGTTGGACTCACTTGGATGCCTCACT 69 FBan0033309 FBgn0053309 CG33309 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33309 CG33309 "BG:DS06874.7, DS06874.7, NEST:bs22a11" CDMC27919 4 18 15 DAC24-P07 13-CG33309-RA_1 CG33309 GGTACGACAAGCATATGTGACCATTTTGCAAATTGCTACCCCTCGTTGGACTCACTTGGATGCCTCACT 69 FBan0033309 FBgn0053309 CG33309 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33309 CG33309 "BG:DS06874.7, DS06874.7, NEST:bs22a11" CDMC27920 4 19 15 DAC24-P19 2-CG33321-RA_1 CG33321 GGTTCAGCGTGATGCACTATGAACGTGGTAGTTGGCAACCCACAATGTTCAACCTTCACTCCCCGAACT 69 FBgn0053321 CDMC27920 4 20 15 DAC24-P19 2-CG33321-RA_1 CG33321 GGTTCAGCGTGATGCACTATGAACGTGGTAGTTGGCAACCCACAATGTTCAACCTTCACTCCCCGAACT 69 FBgn0053321 CDMC27921 4 21 15 DAC25-D07 10-CG10376-RA_1 CG10376 TGCCCGAGTCGCTCATAATCGAAACCGTTTACGATTCCCTAGCGGATACCACAATGAAGTTGGACGACA 69 FBan0010376 FBgn0032702 CG10376 2 2L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470; protein amino acid phosphorylation; GO:0006468 protein serine/threonine phosphatase activity; GO:0004722; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004722; ; GO:0016791 ; EC:3.1.3.- CG10376 CG10376 PP2C CDMC27921 4 22 15 DAC25-D07 10-CG10376-RA_1 CG10376 TGCCCGAGTCGCTCATAATCGAAACCGTTTACGATTCCCTAGCGGATACCACAATGAAGTTGGACGACA 69 FBan0010376 FBgn0032702 CG10376 2 2L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470; protein amino acid phosphorylation; GO:0006468 protein serine/threonine phosphatase activity; GO:0004722; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004722; ; GO:0016791 ; EC:3.1.3.- CG10376 CG10376 PP2C CDMC27922 4 23 15 DAC25-D19 8-CG10388-RA_1 CG10388 TGCCATTGCGATTTTCCGTTCTCCCAGTGTAATTAGAGCCTGAGTTGTTTGAGAGAGTCTTCGCGGGCT 69 FBan0010388 FBgn0003944 Ubx 3 3R "anterior/posterior axis specification; GO:0009948; aortic cell fate commitment (sensu Insecta); GO:0035052; endoderm formation; GO:0001706; haltere development; GO:0007482; heart development; GO:0007507; leg morphogenesis (sensu Endopterygota); GO:0007480; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; specification of organ identity; GO:0010092; specification of segmental identity, abdomen; GO:0007385; specification of segmental identity, thorax; GO:0007384" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 Ubx Ultrabithorax "CG10388, bx: bithorax, Cbx: Contrabithorax, abx: anterobithorax, pbx: postbithorax, UBx, Hm: Haltere mimic, bxd, Contrabithorax, Haltere mimic, anterobithorax, bithorax, bithoraxoid, postbithorax, ubx, DmUbx, DUbx, Ultraabdominal, Ubx1b, BX-C, Bxl, bx[D], bxd[D], bxl, l(3)89Eb, bx, pbx, Cbx, abx, Hm" CDMC27922 4 24 15 DAC25-D19 8-CG10388-RA_1 CG10388 TGCCATTGCGATTTTCCGTTCTCCCAGTGTAATTAGAGCCTGAGTTGTTTGAGAGAGTCTTCGCGGGCT 69 FBan0010388 FBgn0003944 Ubx 3 3R "anterior/posterior axis specification; GO:0009948; aortic cell fate commitment (sensu Insecta); GO:0035052; endoderm formation; GO:0001706; haltere development; GO:0007482; heart development; GO:0007507; leg morphogenesis (sensu Endopterygota); GO:0007480; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; specification of organ identity; GO:0010092; specification of segmental identity, abdomen; GO:0007385; specification of segmental identity, thorax; GO:0007384" DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 Ubx Ultrabithorax "CG10388, bx: bithorax, Cbx: Contrabithorax, abx: anterobithorax, pbx: postbithorax, UBx, Hm: Haltere mimic, bxd, Contrabithorax, Haltere mimic, anterobithorax, bithorax, bithoraxoid, postbithorax, ubx, DmUbx, DUbx, Ultraabdominal, Ubx1b, BX-C, Bxl, bx[D], bxd[D], bxl, l(3)89Eb, bx, pbx, Cbx, abx, Hm" CDMC27923 4 25 15 DAC25-H07 23-CG10423-RA_2 CG10423 ACAGTTCTTGTCGTATTTGTTTATAGAAAGTGGATAATTGCCAACAGGATAGATAGTGGAGCTCAATCG 69 FBan0010423 FBgn0039300 RpS27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS27 Ribosomal protein S27 "CG10423, anon-EST:Posey295, Ribosomal protein S27" CDMC27923 4 26 15 DAC25-H07 23-CG10423-RA_2 CG10423 ACAGTTCTTGTCGTATTTGTTTATAGAAAGTGGATAATTGCCAACAGGATAGATAGTGGAGCTCAATCG 69 FBan0010423 FBgn0039300 RpS27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS27 Ribosomal protein S27 "CG10423, anon-EST:Posey295, Ribosomal protein S27" CDMC27924 4 1 16 DAC25-H19 7-CG10445-RA_1 CG10445 TGCAAGCTAGAAATTGCGAAAGTTGTGCTTCCAGAGGAAGGAGGAGAAGTGACCAAATGTGTTGGCGGT 69 FBan0010445 FBgn0037531 CG10445 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003677; RNA polymerase II transcription termination factor activity; GO:0003717; ; GO:0003717 nucleus; GO:0005634 CG10445 CG10445 CDMC27924 4 2 16 DAC25-H19 7-CG10445-RA_1 CG10445 TGCAAGCTAGAAATTGCGAAAGTTGTGCTTCCAGAGGAAGGAGGAGAAGTGACCAAATGTGTTGGCGGT 69 FBan0010445 FBgn0037531 CG10445 3 3R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003677; RNA polymerase II transcription termination factor activity; GO:0003717; ; GO:0003717 nucleus; GO:0005634 CG10445 CG10445 CDMC27925 4 3 16 DAC25-L07 3-CG10495-RA_3 CG10495 CGCCCAGCTCATCTACCCATATGTCGATGGCATCGATCTAAATTGCGGATGTCCACAAAGCTGGGCAAT 69 FBan0010495 FBgn0032750 CG10495 2 2L CG10495 CG10495 anon-WO0118547.200 CDMC27925 4 4 16 DAC25-L07 3-CG10495-RA_3 CG10495 CGCCCAGCTCATCTACCCATATGTCGATGGCATCGATCTAAATTGCGGATGTCCACAAAGCTGGGCAAT 69 FBan0010495 FBgn0032750 CG10495 2 2L CG10495 CG10495 anon-WO0118547.200 CDMC27926 4 5 16 DAC25-L19 2-CG10508-RC_3 CG10508 CGCCAACATCAAATGCAACTAGGCGGGAGTATCTCATCTGGAACCTCCCCCAGAGTGCCAAAGAAGTGA 69 FBan0010508 FBgn0037060 CG10508 3 3L CG10508 CG10508 CDMC27926 4 6 16 DAC25-L19 2-CG10508-RC_3 CG10508 CGCCAACATCAAATGCAACTAGGCGGGAGTATCTCATCTGGAACCTCCCCCAGAGTGCCAAAGAAGTGA 69 FBan0010508 FBgn0037060 CG10508 3 3L CG10508 CG10508 CDMC27927 4 7 16 DAC25-P07 23-CG10539-RA_19 CG10539 TATGAATATGATTATGTTTATGAGGCAGACGGAGAAGATGATTGTGCTACGAGAAGGAAAGCGTTCGTT 69 FBan0010539 FBgn0015806 S6k 3 3L MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; autophagy; GO:0006914; cell cycle; GO:0007049; determination of adult life span; GO:0008340; oogenesis (sensu Insecta); GO:0009993; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; positive regulation of organ size; GO:0046622; protein amino acid phosphorylation; GO:0006468; regulation of cell size; GO:0008361; response to nutrient; GO:0007584 ATP binding; GO:0005524; ; GO:0005524; ribosomal protein S6 kinase activity; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.- ribosome; GO:0005840 S6k RPS6-p70-protein kinase "CG10539, CG10539, CG10539, fs(3)07084, dp70[S6k], Dp70[s6k], Dp70S6k, p70S6K, Dp70s6k, p70[S6k], 7084, dp70s6k, dps6k, dS6K, p70s6K, DS6K, p70[S6 kinase], dS6k, p70[S6kinase], S6K, S6 kinase, S6kinase, p70 S6K, s6k11, dS6 kinase, ds6k, l(3)07084, RPS6-p70-protein kinase" CDMC27927 4 8 16 DAC25-P07 23-CG10539-RA_19 CG10539 TATGAATATGATTATGTTTATGAGGCAGACGGAGAAGATGATTGTGCTACGAGAAGGAAAGCGTTCGTT 69 FBan0010539 FBgn0015806 S6k 3 3L MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; autophagy; GO:0006914; cell cycle; GO:0007049; determination of adult life span; GO:0008340; oogenesis (sensu Insecta); GO:0009993; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of growth; GO:0045927; positive regulation of organ size; GO:0046622; protein amino acid phosphorylation; GO:0006468; regulation of cell size; GO:0008361; response to nutrient; GO:0007584 ATP binding; GO:0005524; ; GO:0005524; ribosomal protein S6 kinase activity; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.- ribosome; GO:0005840 S6k RPS6-p70-protein kinase "CG10539, CG10539, CG10539, fs(3)07084, dp70[S6k], Dp70[s6k], Dp70S6k, p70S6K, Dp70s6k, p70[S6k], 7084, dp70s6k, dps6k, dS6K, p70s6K, DS6K, p70[S6 kinase], dS6k, p70[S6kinase], S6K, S6 kinase, S6kinase, p70 S6K, s6k11, dS6 kinase, ds6k, l(3)07084, RPS6-p70-protein kinase" CDMC27928 4 9 16 DAC25-P19 9-CG10553-RA_2 CG10553 TGCATCCCCAGACAAAGGATGAGGATGTTAGCCAAAAACAGGTCACCATTCCGGATTGGGTTAAGCCAA 69 FBan0010553 FBgn0039324 CG10553 3 3R CG10553 CG10553 CT29612 CDMC27928 4 10 16 DAC25-P19 9-CG10553-RA_2 CG10553 TGCATCCCCAGACAAAGGATGAGGATGTTAGCCAAAAACAGGTCACCATTCCGGATTGGGTTAAGCCAA 69 FBan0010553 FBgn0039324 CG10553 3 3R CG10553 CG10553 CT29612 CDMC27929 4 11 16 DAC26-D07 1-CG15307-RA_1 CG15307 ACCGCCAGAGGAGTCAGGAATTCAGTGGGAAAATCAGCCGAGAGCCGTACTAAGGAATCAACAGGGAAA 69 FBan0015307 FBgn0030192 CG15307 X X CG15307 CG15307 CDMC27929 4 12 16 DAC26-D07 1-CG15307-RA_1 CG15307 ACCGCCAGAGGAGTCAGGAATTCAGTGGGAAAATCAGCCGAGAGCCGTACTAAGGAATCAACAGGGAAA 69 FBan0015307 FBgn0030192 CG15307 X X CG15307 CG15307 CDMC27930 4 13 16 DAC26-D19 1-CG15324-RA_1 CG15324 GCGGTGCTCTCACTTGAGGAGTCACTGTACCGACTACGTGATGAGGATGACCCAGGTATTACAGTGGCT 69 FBan0015324 FBgn0029966 CG15324 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15324 CG15324 CT35324 CDMC27930 4 14 16 DAC26-D19 1-CG15324-RA_1 CG15324 GCGGTGCTCTCACTTGAGGAGTCACTGTACCGACTACGTGATGAGGATGACCCAGGTATTACAGTGGCT 69 FBan0015324 FBgn0029966 CG15324 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15324 CG15324 CT35324 CDMC27931 4 15 16 DAC26-H07 17-CG15373-RA_1 CG15373 CGCGATGTCCACGATACCAAGTTCAATGAGGACAAGCTATCCATACAGTTTCGAACAGGCAGATTGGGT 69 FBan0015373 FBgn0030889 CG15373 X X CG15373 CG15373 CDMC27931 4 16 16 DAC26-H07 17-CG15373-RA_1 CG15373 CGCGATGTCCACGATACCAAGTTCAATGAGGACAAGCTATCCATACAGTTTCGAACAGGCAGATTGGGT 69 FBan0015373 FBgn0030889 CG15373 X X CG15373 CG15373 CDMC27932 4 17 16 DAC26-H19 3-CG15389-RA_1 CG15389 GCAAAAATGTGTTTGTCGTTTCGACCGCCAAGGACCTCTTTGCGAGCTGCCCATTATCATCCGGAATGC 69 FBgn0031415 CDMC27932 4 18 16 DAC26-H19 3-CG15389-RA_1 CG15389 GCAAAAATGTGTTTGTCGTTTCGACCGCCAAGGACCTCTTTGCGAGCTGCCCATTATCATCCGGAATGC 69 FBgn0031415 CDMC27933 4 19 16 DAC26-L07 6-CG15439-RA_7 CG15439 TGCAAGAGGAGCAAGGATCAGCATCTGTTGGTCAAATGTGACACTTGCAATTTGCACTACCACCTGGGC 69 FBan0015439 FBgn0031606 CG15439 2 2L "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG15439 CG15439 CDMC27933 4 20 16 DAC26-L07 6-CG15439-RA_7 CG15439 TGCAAGAGGAGCAAGGATCAGCATCTGTTGGTCAAATGTGACACTTGCAATTTGCACTACCACCTGGGC 69 FBan0015439 FBgn0031606 CG15439 2 2L "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG15439 CG15439 CDMC27934 4 21 16 DAC26-L19 22-CG1544-RA_5 CG1544 GGACACTGGCTTGGATTACTCACTACTTCATTACATTGGTCAGCAGAGTGTGACTTTCCCCGAAGACTT 69 FBan0001544 FBgn0039827 CG1544 3 3R tricarboxylic acid cycle; GO:0006099 oxoglutarate dehydrogenase (succinyl-transferring) activity; GO:0004591 ; EC:1.2.4.2; ; GO:0004591 ; EC:1.2.4.2 CG1544 CG1544 CDMC27934 4 22 16 DAC26-L19 22-CG1544-RA_5 CG1544 GGACACTGGCTTGGATTACTCACTACTTCATTACATTGGTCAGCAGAGTGTGACTTTCCCCGAAGACTT 69 FBan0001544 FBgn0039827 CG1544 3 3R tricarboxylic acid cycle; GO:0006099 oxoglutarate dehydrogenase (succinyl-transferring) activity; GO:0004591 ; EC:1.2.4.2; ; GO:0004591 ; EC:1.2.4.2 CG1544 CG1544 CDMC27935 4 23 16 DAC26-P07 23-CG15481-RA_1 CG15481 TGCGAAAGTTGGTTGAAATAAAGTAATCTTTTCTATTCCAATCTTGTCGTTTTTTACAATTGAAGGGCA 69 FBan0015481 FBgn0032487 Ski6 2 2L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Ski6 Ski6 "CG15481, CG15481, CG15481, dSki6" CDMC27935 4 24 16 DAC26-P07 23-CG15481-RA_1 CG15481 TGCGAAAGTTGGTTGAAATAAAGTAATCTTTTCTATTCCAATCTTGTCGTTTTTTACAATTGAAGGGCA 69 FBan0015481 FBgn0032487 Ski6 2 2L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Ski6 Ski6 "CG15481, CG15481, CG15481, dSki6" CDMC27936 4 25 16 DAC26-P19 3-CG15498-RA_2 CG15498 TTTGGTTATGGCTCGGTACCTGCTGTGGCATCCAAACGACCCAATCAAATGAGCTGTTGCAAGTTTGCC 69 FBan0015498 FBgn0038892 CG15498 3 3R CG15498 CG15498 CDMC27936 4 26 16 DAC26-P19 3-CG15498-RA_2 CG15498 TTTGGTTATGGCTCGGTACCTGCTGTGGCATCCAAACGACCCAATCAAATGAGCTGTTGCAAGTTTGCC 69 FBan0015498 FBgn0038892 CG15498 3 3R CG15498 CG15498 CDMC27937 4 1 17 DAC27-D07 23-CG9771-RA_8 CG9771 TGCAGGCCGAGTTAGAGCAGAACCCGACAATATAGATACTACTGAAGTGTCTGTGTTCAACTTCAAGGG 69 FBan0009771 FBgn0040466 Dip2 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Dip2 Dorsal interacting protein 2 "CG9771, dip2, sip4, septin interacting protein 4, dmDIP2, DIP2, dorsal interacting protein 2, Dorsal interacting protein 2" CDMC27937 4 2 17 DAC27-D07 23-CG9771-RA_8 CG9771 TGCAGGCCGAGTTAGAGCAGAACCCGACAATATAGATACTACTGAAGTGTCTGTGTTCAACTTCAAGGG 69 FBan0009771 FBgn0040466 Dip2 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Dip2 Dorsal interacting protein 2 "CG9771, dip2, sip4, septin interacting protein 4, dmDIP2, DIP2, dorsal interacting protein 2, Dorsal interacting protein 2" CDMC27938 4 3 17 DAC27-D19 8-CG9781-RA_1 CG9781 CGCGTCCTACAACCCTTGACAAAATGTGTGCTGGCAAGAAGGATGGAGTGATGCTTACAAAGAACGGGT 69 FBan0009781 FBgn0036228 CG9781 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG9781 CG9781 CDMC27938 4 4 17 DAC27-D19 8-CG9781-RA_1 CG9781 CGCGTCCTACAACCCTTGACAAAATGTGTGCTGGCAAGAAGGATGGAGTGATGCTTACAAAGAACGGGT 69 FBan0009781 FBgn0036228 CG9781 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG9781 CG9781 CDMC27939 4 5 17 DAC27-H07 9-CG9825-RA_1 CG9825 CGAGGACTATCTGCAGACACAGAACCCGGAACTTGCCAATAGACCACCTATGCAGGCGTTATCCTTTCC 69 FBan0009825 FBgn0034783 CG9825 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9825 CG9825 CDMC27939 4 6 17 DAC27-H07 9-CG9825-RA_1 CG9825 CGAGGACTATCTGCAGACACAGAACCCGGAACTTGCCAATAGACCACCTATGCAGGCGTTATCCTTTCC 69 FBan0009825 FBgn0034783 CG9825 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9825 CG9825 CDMC27940 4 7 17 DAC27-H19 15-CG9842-RA_1 CG9842 CCTCCCCCTGCGATAATGCGATAATTTAAGATGAAAAACCCCAGCAGAATCCCCATAATCCCCAGAGGC 69 FBan0009842 FBgn0011826 Pp2B-14D X X protein amino acid dephosphorylation; GO:0006470 calmodulin binding; GO:0005516; ; GO:0005516; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004723 calcineurin complex; GO:0005955 Pp2B-14D Protein phosphatase 2B at 14D "CG9842, CG9842, CG9842, D33, CnnA14D, PP2B 14D, PP2B, Calcineurin, calcium/calmodulin regulated protein phosphatase 2B, protein phosphatase from PCR fragment D33, calcineurin, Pp12-14D, canA, CanA14D, Pp2B-14DF, PpD33, Protein phosphatase D33" CDMC27940 4 8 17 DAC27-H19 15-CG9842-RA_1 CG9842 CCTCCCCCTGCGATAATGCGATAATTTAAGATGAAAAACCCCAGCAGAATCCCCATAATCCCCAGAGGC 69 FBan0009842 FBgn0011826 Pp2B-14D X X protein amino acid dephosphorylation; GO:0006470 calmodulin binding; GO:0005516; ; GO:0005516; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004723 calcineurin complex; GO:0005955 Pp2B-14D Protein phosphatase 2B at 14D "CG9842, CG9842, CG9842, D33, CnnA14D, PP2B 14D, PP2B, Calcineurin, calcium/calmodulin regulated protein phosphatase 2B, protein phosphatase from PCR fragment D33, calcineurin, Pp12-14D, canA, CanA14D, Pp2B-14DF, PpD33, Protein phosphatase D33" CDMC27941 4 9 17 DAC27-L07 23-CG9883-RA_1 CG9883 CCACGAAAGGCGCAGAAAGACATTGTATATATTCGTAGTAGGTCCTGCTAAAAGTAAAAGTAAAGTTAT 69 FBan0009883 FBgn0031435 CG9883 2 2L CG9883 CG9883 CDMC27941 4 10 17 DAC27-L07 23-CG9883-RA_1 CG9883 CCACGAAAGGCGCAGAAAGACATTGTATATATTCGTAGTAGGTCCTGCTAAAAGTAAAAGTAAAGTTAT 69 FBan0009883 FBgn0031435 CG9883 2 2L CG9883 CG9883 CDMC27942 4 11 17 DAC27-L19 9-CG9889-RA_3 CG9889 AGGCGAGAGCTTCTACCTGATGGACGGCATGTTTGCACTGAACAACGACAAGCGCAATCTTTACTTCCA 69 FBan0009889 FBgn0041712 yellow-d 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-d yellow-d "CG9889, BcDNA:GH20107, yellow-d" CDMC27942 4 12 17 DAC27-L19 9-CG9889-RA_3 CG9889 AGGCGAGAGCTTCTACCTGATGGACGGCATGTTTGCACTGAACAACGACAAGCGCAATCTTTACTTCCA 69 FBan0009889 FBgn0041712 yellow-d 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-d yellow-d "CG9889, BcDNA:GH20107, yellow-d" CDMC27943 4 13 17 DAC27-P07 16-CG9935-RA_3 CG9935 GGGATCCTCGAAAGCGAAAGAAACTATACCCCACCTGACCGTTCATTTTGGATCGAAATTGCTGAGGAA 69 FBan0009935 FBgn0039916 CG9935 4 4 cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813; proteolysis; GO:0006508 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG9935 CG9935 CT36399 CDMC27943 4 14 17 DAC27-P07 16-CG9935-RA_3 CG9935 GGGATCCTCGAAAGCGAAAGAAACTATACCCCACCTGACCGTTCATTTTGGATCGAAATTGCTGAGGAA 69 FBan0009935 FBgn0039916 CG9935 4 4 cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813; proteolysis; GO:0006508 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 CG9935 CG9935 CT36399 CDMC27944 4 15 17 DAC27-P19 23-CG9949-RA_12 CG9949 ATATTTTTGGTGAGATTTCGCAGATTTGTATAACACACTTTCCTGTCGAATGCGAAAATCGTGGCTGAC 69 FBan0009949 FBgn0003410 sina 3 3L R7 cell fate commitment; GO:0007465; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of R7 differentiation; GO:0045676; sensory organ development; GO:0007423; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; ligase activity; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005515; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 sina seven in absentia "CG9949, CG9949, CG9949, sia, anon-EST:fe2H7, anon-fast-evolving-2H7" CDMC27944 4 16 17 DAC27-P19 23-CG9949-RA_12 CG9949 ATATTTTTGGTGAGATTTCGCAGATTTGTATAACACACTTTCCTGTCGAATGCGAAAATCGTGGCTGAC 69 FBan0009949 FBgn0003410 sina 3 3L R7 cell fate commitment; GO:0007465; protein ubiquitination; GO:0016567; proteolysis; GO:0006508; regulation of R7 differentiation; GO:0045676; sensory organ development; GO:0007423; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; ligase activity; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005515; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 sina seven in absentia "CG9949, CG9949, CG9949, sia, anon-EST:fe2H7, anon-fast-evolving-2H7" CDMC27945 4 17 17 DAC28-D07 3-CG11852-RA_3 CG11852 GCGCTGATCCTGCAACCAGCAAGTTTGAGATGTACGGATCCTTTCCCAAGATCGTGCTGAAGGGC 65 FBan0011852 FBgn0039297 CG11852 3 3R CG11852 CG11852 CT33073 CDMC27945 4 18 17 DAC28-D07 3-CG11852-RA_3 CG11852 GCGCTGATCCTGCAACCAGCAAGTTTGAGATGTACGGATCCTTTCCCAAGATCGTGCTGAAGGGC 65 FBan0011852 FBgn0039297 CG11852 3 3R CG11852 CG11852 CT33073 CDMC27946 4 19 17 DAC28-D19 3-CG11881-RA_1 CG11881 TTAATCTTAGCACCTCGCCATCTGGACGCCTAGATGCACTGGTTCCACATACCGAGAGCCACCAG 65 FBan0011881 FBgn0039638 CG11881 3 3R CG11881 CG11881 CDMC27946 4 20 17 DAC28-D19 3-CG11881-RA_1 CG11881 TTAATCTTAGCACCTCGCCATCTGGACGCCTAGATGCACTGGTTCCACATACCGAGAGCCACCAG 65 FBan0011881 FBgn0039638 CG11881 3 3R CG11881 CG11881 CDMC27947 4 21 17 DAC28-H07 2-CG1200-RB_1 CG1200 TGCATCGACTACTTCTACTCCCTGAAGAACGTCTCCTTCTGCGCATTTCACCCTCGCGATCACCG 65 FBan0001200 FBgn0040281 Aplip1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of JNK cascade; GO:0046328 kinesin binding; GO:0019894; NOT JUN kinase binding; GO:0008432; protein binding; GO:0005515; protein kinase binding; GO:0019901; ; GO:0008432; ; GO:0019894; ; GO:0019901; kinase activator activity; GO:0019209; ; GO:0005515; ; GO:0019894; ; GO:0019209; ; GO:0008432; ; GO:0019901; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 cytoplasm; GO:0005737; integral to membrane; GO:0016021 Aplip1 APP-like protein interacting protein 1 "CG1200, CG1200, Ek4, EK4, E(Khc)ek4, dp1, ek4, APLIP1, SP512, aplip1, Jip1/2, APP-like protein interacting protein 1" CDMC27947 4 22 17 DAC28-H07 2-CG1200-RB_1 CG1200 TGCATCGACTACTTCTACTCCCTGAAGAACGTCTCCTTCTGCGCATTTCACCCTCGCGATCACCG 65 FBan0001200 FBgn0040281 Aplip1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of JNK cascade; GO:0046328 kinesin binding; GO:0019894; NOT JUN kinase binding; GO:0008432; protein binding; GO:0005515; protein kinase binding; GO:0019901; ; GO:0008432; ; GO:0019894; ; GO:0019901; kinase activator activity; GO:0019209; ; GO:0005515; ; GO:0019894; ; GO:0019209; ; GO:0008432; ; GO:0019901; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 cytoplasm; GO:0005737; integral to membrane; GO:0016021 Aplip1 APP-like protein interacting protein 1 "CG1200, CG1200, Ek4, EK4, E(Khc)ek4, dp1, ek4, APLIP1, SP512, aplip1, Jip1/2, APP-like protein interacting protein 1" CDMC27948 4 23 17 DAC28-H19 14-CG12035-RA_1 CG12035 CCGACTCCGAGAGCGACATATGCAGTCAGCAGAACAGAGCGAAATTGCCTGAATCCCGTTGGCGT 65 FBan0012035 FBgn0035263 CG12035 3 3L CG12035 CG12035 CDMC27948 4 24 17 DAC28-H19 14-CG12035-RA_1 CG12035 CCGACTCCGAGAGCGACATATGCAGTCAGCAGAACAGAGCGAAATTGCCTGAATCCCGTTGGCGT 65 FBan0012035 FBgn0035263 CG12035 3 3L CG12035 CG12035 CDMC27949 4 25 17 DAC28-L07 2-CG12123-RA_1 CG12123 TGGTCTGGCTGCAATTCGAGGAACCGGAGAAGCACACCATTGACTACAAATTCGCCGACATGCTG 65 FBan0012123 FBgn0030039 CG12123 X X CG12123 CG12123 CDMC27949 4 26 17 DAC28-L07 2-CG12123-RA_1 CG12123 TGGTCTGGCTGCAATTCGAGGAACCGGAGAAGCACACCATTGACTACAAATTCGCCGACATGCTG 65 FBan0012123 FBgn0030039 CG12123 X X CG12123 CG12123 CDMC27950 4 1 18 DAC28-L19 3-CG12147-RA_1 CG12147 TTCCGGAACCAGTACAAGGTGTGTGACTTCCTCTTCGACTGGGTCGTTTTGAAGCGAGAGTCGCC 65 FBan0012147 FBgn0037325 CG12147 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG12147 CG12147 CKIa-like CDMC27950 4 2 18 DAC28-L19 3-CG12147-RA_1 CG12147 TTCCGGAACCAGTACAAGGTGTGTGACTTCCTCTTCGACTGGGTCGTTTTGAAGCGAGAGTCGCC 65 FBan0012147 FBgn0037325 CG12147 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG12147 CG12147 CKIa-like CDMC27951 4 3 18 DAC28-P07 3-CG12239-RA_3 CG12239 ATGGATTTGTCCCGACGCATGGAACGTGAACAGACTGAGCGAGACTCTGAGGAACGCATCGAGAG 65 FBan0012239 FBgn0029810 CG12239 X X CG12239 CG12239 CDMC27951 4 4 18 DAC28-P07 3-CG12239-RA_3 CG12239 ATGGATTTGTCCCGACGCATGGAACGTGAACAGACTGAGCGAGACTCTGAGGAACGCATCGAGAG 65 FBan0012239 FBgn0029810 CG12239 X X CG12239 CG12239 CDMC27952 4 5 18 DAC28-P19 AutoBlank AutoBlank CDMC27952 4 6 18 DAC28-P19 AutoBlank AutoBlank CDMC27953 4 7 18 DAC29-D07 12-CG3097-RA_2 CG3097 GGTGGCAATATCTGGAAGGAGAACTCCAAGTTTCTGGACATCTCCATTGCCAGGGATCAACTGAAGGCC 69 FBan0003097 FBgn0029804 CG3097 X X proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG3097 CG3097 CDMC27953 4 8 18 DAC29-D07 12-CG3097-RA_2 CG3097 GGTGGCAATATCTGGAAGGAGAACTCCAAGTTTCTGGACATCTCCATTGCCAGGGATCAACTGAAGGCC 69 FBan0003097 FBgn0029804 CG3097 X X proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG3097 CG3097 CDMC27954 4 9 18 DAC29-D19 23-CG31008-RA_1 CG31008 CCGCCAGTACAATATTTAGGAAGCTAGAAAGGGGAAGGGATTTTAATTTGTCAAATTATAAGACGTTAA 69 FBan0031008 FBgn0051008 CG31008 3 3R CG31008 CG31008 "bs08f11.y1, BEST:GH26101" CDMC27954 4 10 18 DAC29-D19 23-CG31008-RA_1 CG31008 CCGCCAGTACAATATTTAGGAAGCTAGAAAGGGGAAGGGATTTTAATTTGTCAAATTATAAGACGTTAA 69 FBan0031008 FBgn0051008 CG31008 3 3R CG31008 CG31008 "bs08f11.y1, BEST:GH26101" CDMC27955 4 11 18 DAC29-H07 3-CG31030-RA_3 CG31030 GGTGAGTCTCTCGGGACACGGAGAAGAGGATGACTCTGAGATTCTGTTGGCCTACAACGAAGCCGTGAA 69 FBan0031030 FBgn0051030 CG31030 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG31030 CG31030 "CG2176, BcDNA:RH09162, anon-EST:Posey81" CDMC27955 4 12 18 DAC29-H07 3-CG31030-RA_3 CG31030 GGTGAGTCTCTCGGGACACGGAGAAGAGGATGACTCTGAGATTCTGTTGGCCTACAACGAAGCCGTGAA 69 FBan0031030 FBgn0051030 CG31030 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG31030 CG31030 "CG2176, BcDNA:RH09162, anon-EST:Posey81" CDMC27956 4 13 18 DAC29-H19 9-CG31040-RA_1 CG31040 CCTGTCCAACGTTCTTGAAGAGTTGGGCTTGTCCATCAACCTTCAGTTGTCTCAGATCCTCACGCTGCT 69 FBan0031040 FBgn0051040 Cog7 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 colocalizes_with Golgi apparatus; GO:0005794 Cog7 Cog7 "CG31040, CG7880" CDMC27956 4 14 18 DAC29-H19 9-CG31040-RA_1 CG31040 CCTGTCCAACGTTCTTGAAGAGTTGGGCTTGTCCATCAACCTTCAGTTGTCTCAGATCCTCACGCTGCT 69 FBan0031040 FBgn0051040 Cog7 3 3R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 colocalizes_with Golgi apparatus; GO:0005794 Cog7 Cog7 "CG31040, CG7880" CDMC27957 4 15 18 DAC29-L07 13-CG31067-RA_1 CG31067 ACCTGTCCCAAGTGACGTGCGTTCTAAACTTAGCAGGATTTTTATCGCAAACCGCAAATTTCGGGGGAT 69 FBan0031067 FBgn0051067 CG31067 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31067 CG31067 CDMC27957 4 16 18 DAC29-L07 13-CG31067-RA_1 CG31067 ACCTGTCCCAAGTGACGTGCGTTCTAAACTTAGCAGGATTTTTATCGCAAACCGCAAATTTCGGGGGAT 69 FBan0031067 FBgn0051067 CG31067 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31067 CG31067 CDMC27958 4 17 18 DAC29-L19 15-CG3107-RB_1 CG3107 TGTTCACAGTCCCATATCTCCACCAAGACCATCCAACACTGCGAGTTTTGGCAAAATTGCTATCAGCCA 69 FBan0003107 FBgn0033005 CG3107 2 2R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.- CG3107 CG3107 CDMC27958 4 18 18 DAC29-L19 15-CG3107-RB_1 CG3107 TGTTCACAGTCCCATATCTCCACCAAGACCATCCAACACTGCGAGTTTTGGCAAAATTGCTATCAGCCA 69 FBan0003107 FBgn0033005 CG3107 2 2R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.- CG3107 CG3107 CDMC27959 4 19 18 DAC29-P07 3-CG31102-RA_2 CG31102 GGGCTGAGTGTAAAGTTTGCACCAAAGTGCCACCATGCGGAGGATATCAAAGGAAGGATCTGCCTGGTT 69 FBan0031102 FBgn0051102 CG31102 3 3R CG31102 CG31102 CG10634 CDMC27959 4 20 18 DAC29-P07 3-CG31102-RA_2 CG31102 GGGCTGAGTGTAAAGTTTGCACCAAAGTGCCACCATGCGGAGGATATCAAAGGAAGGATCTGCCTGGTT 69 FBan0031102 FBgn0051102 CG31102 3 3R CG31102 CG31102 CG10634 CDMC27960 4 21 18 DAC29-P19 1-CG31109-RA_1 CG31109 ACGGGTAGCACTACTCGGGAAGGAACCCATGCAGATTAATAACTGCTAACCTCGTCTCTGGTCGGTGGA 69 FBan0031109 FBgn0051109 CG31109 3 3R CG31109 CG31109 "CG13649, BcDNA:RE17222" CDMC27960 4 22 18 DAC29-P19 1-CG31109-RA_1 CG31109 ACGGGTAGCACTACTCGGGAAGGAACCCATGCAGATTAATAACTGCTAACCTCGTCTCTGGTCGGTGGA 69 FBan0031109 FBgn0051109 CG31109 3 3R CG31109 CG31109 "CG13649, BcDNA:RE17222" CDMC27961 4 23 18 DAC30-D07 2-CG2045-RA_2 CG2045 GCATTTTGGCAACTGCAACTCGGTGGAATTCGGTAGGGGCACCTGTATCGAGAAGAAGGACTGCG 65 FBan0002045 FBgn0019929 Ser7 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004263 ; EC:3.4.21.1 Ser7 Ser7 "CG2045, CG2045, CG2045, SP#2, c-SP3, SP3: Serine Protease 3, SP2: Serine Protease 2, Serine Protease 2, SP3" CDMC27961 4 24 18 DAC30-D07 2-CG2045-RA_2 CG2045 GCATTTTGGCAACTGCAACTCGGTGGAATTCGGTAGGGGCACCTGTATCGAGAAGAAGGACTGCG 65 FBan0002045 FBgn0019929 Ser7 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004263 ; EC:3.4.21.1 Ser7 Ser7 "CG2045, CG2045, CG2045, SP#2, c-SP3, SP3: Serine Protease 3, SP2: Serine Protease 2, Serine Protease 2, SP3" CDMC27962 4 25 18 DAC30-D19 23-CG2099-RA_1 CG2099 ATTAAAACGCAACTTGGCTTTTTTATTAAGGCGAGATACCGATTGAAAGTTGACGGTAATCTGTA 65 FBan0002099 FBgn0037328 RpL35A 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL35A Ribosomal protein L35A "CG2099, L35a, anon-EST:Posey39, Ribosomal protein L35A" CDMC27962 4 26 18 DAC30-D19 23-CG2099-RA_1 CG2099 ATTAAAACGCAACTTGGCTTTTTTATTAAGGCGAGATACCGATTGAAAGTTGACGGTAATCTGTA 65 FBan0002099 FBgn0037328 RpL35A 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL35A Ribosomal protein L35A "CG2099, L35a, anon-EST:Posey39, Ribosomal protein L35A" CDMC27963 4 1 19 DAC30-H07 1-CG2238-RA_1 CG2238 AGACCACGCTTGTATCCCACTGAAGAAGTCTGATCCCGTCGTCTCCTACCGTGAGACTGTGTCGG 65 FBan0002238 FBgn0000559 Ef2b 2 2L protein biosynthesis; GO:0006412; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829 Ef2b Elongation factor 2b "CG2238, CG2238, CG2238, EF2, EF-2, EF-2b, clone 1.44, eEF2, Ef2, anon-EST:Liang-1.44" CDMC27963 4 2 19 DAC30-H07 1-CG2238-RA_1 CG2238 AGACCACGCTTGTATCCCACTGAAGAAGTCTGATCCCGTCGTCTCCTACCGTGAGACTGTGTCGG 65 FBan0002238 FBgn0000559 Ef2b 2 2L protein biosynthesis; GO:0006412; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829 Ef2b Elongation factor 2b "CG2238, CG2238, CG2238, EF2, EF-2, EF-2b, clone 1.44, eEF2, Ef2, anon-EST:Liang-1.44" CDMC27964 4 3 19 DAC30-H19 3-CG2263-RA_1 CG2263 CCACTCTCACCAAGTTGGAGACGGATCTCACGGTGGAAATGCTCGCAAATGGATTGTGGGACCAG 65 FBan0002263 FBgn0030007 CG2263 X X phenylalanyl-tRNA aminoacylation; GO:0006432; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG2263 CG2263 CDMC27964 4 4 19 DAC30-H19 3-CG2263-RA_1 CG2263 CCACTCTCACCAAGTTGGAGACGGATCTCACGGTGGAAATGCTCGCAAATGGATTGTGGGACCAG 65 FBan0002263 FBgn0030007 CG2263 X X phenylalanyl-tRNA aminoacylation; GO:0006432; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG2263 CG2263 CDMC27965 4 5 19 DAC30-L07 24-CG2711-RA_1 CG2711 AGGCTAAGGATTAGACACTTAGTTCAATAAAACTGATTTTTGTTCCAGAAAAAACTGAAAGAAAA 65 FBan0002711 FBgn0000520 dwg X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; chromatin insulator sequence binding; GO:0043035; ; GO:0043035; ; GO:0005515 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 dwg deformed wings "CG2711, CG2711, zw5, l(1)zw5, zw-5, ZW-5, ves: vestigium, vestigium, SBP, scs-binding protein, EG:95B7.6, Zw5, Zw-5, zeste-white 5, scs binding protein, Sbp, l(1)3Be, ves" CDMC27965 4 6 19 DAC30-L07 24-CG2711-RA_1 CG2711 AGGCTAAGGATTAGACACTTAGTTCAATAAAACTGATTTTTGTTCCAGAAAAAACTGAAAGAAAA 65 FBan0002711 FBgn0000520 dwg X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; chromatin insulator sequence binding; GO:0043035; ; GO:0043035; ; GO:0005515 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 dwg deformed wings "CG2711, CG2711, zw5, l(1)zw5, zw-5, ZW-5, ves: vestigium, vestigium, SBP, scs-binding protein, EG:95B7.6, Zw5, Zw-5, zeste-white 5, scs binding protein, Sbp, l(1)3Be, ves" CDMC27966 4 7 19 DAC30-L19 3-CG2822-RA_1 CG2822 CAGCATCGCGACACCCAGGAAACCCTAGCCGTACTCGATCGTCTCGATCTGGATACGGAAAAACC 65 FBan0002822 FBgn0003386 Shaw 2 2L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shaw Shaker cognate w "CG2822, CG15419, dShaw2, dShaw, Shaw2" CDMC27966 4 8 19 DAC30-L19 3-CG2822-RA_1 CG2822 CAGCATCGCGACACCCAGGAAACCCTAGCCGTACTCGATCGTCTCGATCTGGATACGGAAAAACC 65 FBan0002822 FBgn0003386 Shaw 2 2L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shaw Shaker cognate w "CG2822, CG15419, dShaw2, dShaw, Shaw2" CDMC27967 4 9 19 DAC30-P07 24-CG2960-RA_1 CG2960 GGTTAACCATCTAAGTAAATATATGTACATTTTGTGAAACCACATCTAATCGAAATGTATTGCAT 65 FBan0002960 FBgn0003941 RpL40 2 2L "ATP-dependent proteolysis; GO:0006510; establishment and/or maintenance of chromatin architecture; GO:0006325; protein biosynthesis; GO:0006412; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; protein binding; GO:0005515; ; GO:0003735; ; GO:0003676; ; GO:0005515; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; nucleus; GO:0005634; ribosome; GO:0005840 RpL40 Ribosomal protein L40 "CG2960, DUb52, CEP52, Ub52, ubiquitin 52-AA extension protein, BcDNA:RE10554, Dub52, Ubi-f, Ubi-f52: Ubiquitin fusion 52, Ubiquitin fusion 52" CDMC27967 4 10 19 DAC30-P07 24-CG2960-RA_1 CG2960 GGTTAACCATCTAAGTAAATATATGTACATTTTGTGAAACCACATCTAATCGAAATGTATTGCAT 65 FBan0002960 FBgn0003941 RpL40 2 2L "ATP-dependent proteolysis; GO:0006510; establishment and/or maintenance of chromatin architecture; GO:0006325; protein biosynthesis; GO:0006412; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; protein binding; GO:0005515; ; GO:0003735; ; GO:0003676; ; GO:0005515; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; nucleus; GO:0005634; ribosome; GO:0005840 RpL40 Ribosomal protein L40 "CG2960, DUb52, CEP52, Ub52, ubiquitin 52-AA extension protein, BcDNA:RE10554, Dub52, Ubi-f, Ubi-f52: Ubiquitin fusion 52, Ubiquitin fusion 52" CDMC27968 4 11 19 DAC30-P19 AutoBlank AutoBlank CDMC27968 4 12 19 DAC30-P19 AutoBlank AutoBlank CDMC27969 4 13 19 DAC31-D07 3-CG31957-RA_2 CG31957 AGCCACCAGCCAAAACAAAGACGACTCCGATTTCGAGGATGATCTCCTGCCCAATACAAATCGGCCTG 68 FBan0031957 FBgn0051957 CG31957 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676 cellular component unknown; GO:0008372 CG31957 CG31957 CDMC27969 4 14 19 DAC31-D07 3-CG31957-RA_2 CG31957 AGCCACCAGCCAAAACAAAGACGACTCCGATTTCGAGGATGATCTCCTGCCCAATACAAATCGGCCTG 68 FBan0031957 FBgn0051957 CG31957 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676 cellular component unknown; GO:0008372 CG31957 CG31957 CDMC27970 4 15 19 DAC31-D19 1-CG32087-RA_1 CG32087 AATTCCCTGGCCTATCTAAGCCATCTGGTTCGTGCTTTCGAGCTGTGTGCCTTCATCATGGTCACCTG 68 FBan0032087 FBgn0052087 CG32087 3 3L CG32087 CG32087 CG7308 CDMC27970 4 16 19 DAC31-D19 1-CG32087-RA_1 CG32087 AATTCCCTGGCCTATCTAAGCCATCTGGTTCGTGCTTTCGAGCTGTGTGCCTTCATCATGGTCACCTG 68 FBan0032087 FBgn0052087 CG32087 3 3L CG32087 CG32087 CG7308 CDMC27971 4 17 19 DAC31-H07 2-CG32387-RB_3 CG32387 AGCTGTCAGGTTGACAACGGCATTGGAACTGATCGACTGACGCACACCTTAATCGTTCAAGTGCCACC 68 FBan0032387 FBgn0052387 CG32387 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399 CG32387 CG32387 "CG14828, CG8618, CG8619, CT14580, CT34644, CT14584, Dscam-like, BcDNA:AT03867" CDMC27971 4 18 19 DAC31-H07 2-CG32387-RB_3 CG32387 AGCTGTCAGGTTGACAACGGCATTGGAACTGATCGACTGACGCACACCTTAATCGTTCAAGTGCCACC 68 FBan0032387 FBgn0052387 CG32387 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399 CG32387 CG32387 "CG14828, CG8618, CG8619, CT14580, CT34644, CT14584, Dscam-like, BcDNA:AT03867" CDMC27972 4 19 19 DAC31-H19 19-CG32511-RA_1 CG32511 ATCGGCCAGAACGATTAACGCTCCTCTGATAAAACACATTATTGATTTGGGTGGTTCCTACGGCGGAG 68 FBan0032511 FBgn0052511 CG32511 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32511 CG32511 CDMC27972 4 20 19 DAC31-H19 19-CG32511-RA_1 CG32511 ATCGGCCAGAACGATTAACGCTCCTCTGATAAAACACATTATTGATTTGGGTGGTTCCTACGGCGGAG 68 FBan0032511 FBgn0052511 CG32511 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32511 CG32511 CDMC27973 4 21 19 DAC31-L07 16-CG33263-RA_1 CG33263 TGACCATTGTGAGATGTCCTTACAAGTATGGCTGGGACTTTCCTACAAAGCAATGCAAGCCTAGCAGC 68 FBan0033263 FBgn0053263 CG33263 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33263 CG33263 CG14106 CDMC27973 4 22 19 DAC31-L07 16-CG33263-RA_1 CG33263 TGACCATTGTGAGATGTCCTTACAAGTATGGCTGGGACTTTCCTACAAAGCAATGCAAGCCTAGCAGC 68 FBan0033263 FBgn0053263 CG33263 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33263 CG33263 CG14106 CDMC27974 4 23 19 DAC31-L19 3-CG33342-RA_1 CG33342 GCTCATCTGTCATCGCCTTTTACTGGTTTATTCGTGTTGCAGGCTCGGAGATCGGAATGCAGGTGCCT 68 FBan0033342 FBgn0053342 CG33342 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33342 CG33342 CDMC27974 4 24 19 DAC31-L19 3-CG33342-RA_1 CG33342 GCTCATCTGTCATCGCCTTTTACTGGTTTATTCGTGTTGCAGGCTCGGAGATCGGAATGCAGGTGCCT 68 FBan0033342 FBgn0053342 CG33342 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33342 CG33342 CDMC27975 4 25 19 DAC31-P07 1-CG3634-RA_1 CG3634 CCGTAGCCGACAAGTTTTCGCCAGACATAGCATCCAAGCGAGGTCTAAGTCAAGCTGAAATGAGCGCC 68 FBan0003634 FBgn0037026 CG3634 3 3L CG3634 CG3634 CDMC27975 4 26 19 DAC31-P07 1-CG3634-RA_1 CG3634 CCGTAGCCGACAAGTTTTCGCCAGACATAGCATCCAAGCGAGGTCTAAGTCAAGCTGAAATGAGCGCC 68 FBan0003634 FBgn0037026 CG3634 3 3L CG3634 CG3634 CDMC27976 4 1 20 DAC31-P19 2-CG3759-RA_1 CG3759 AGGAACTACAGAAGATTCGGGATCCAGCAAGCCGATAACAGCTACTCCCCCAAATACAGGAGGCGGTG 68 FBan0003759 FBgn0032116 CG3759 2 2L defense response; GO:0006952; response to toxin; GO:0009636 ferroxidase activity; GO:0004322 ; EC:1.16.3.1; iron ion transporter activity; GO:0005381; ; GO:0005381; copper ion binding; GO:0005507; ; GO:0004322 ; EC:1.16.3.1; ; GO:0005507 CG3759 CG3759 laccase-like CDMC27976 4 2 20 DAC31-P19 2-CG3759-RA_1 CG3759 AGGAACTACAGAAGATTCGGGATCCAGCAAGCCGATAACAGCTACTCCCCCAAATACAGGAGGCGGTG 68 FBan0003759 FBgn0032116 CG3759 2 2L defense response; GO:0006952; response to toxin; GO:0009636 ferroxidase activity; GO:0004322 ; EC:1.16.3.1; iron ion transporter activity; GO:0005381; ; GO:0005381; copper ion binding; GO:0005507; ; GO:0004322 ; EC:1.16.3.1; ; GO:0005507 CG3759 CG3759 laccase-like CDMC27977 4 3 20 DAC32-D07 3-CG15785-RA_2 CG15785 GCGAGTATGCTGGACAGGATGGTGCCGACACCTACTGCATGGACAAGTGTCTCAACTATGAATCGGAGT 69 FBan0015785 FBgn0040913 CG15785 X X CG15785 CG15785 CDMC27977 4 4 20 DAC32-D07 3-CG15785-RA_2 CG15785 GCGAGTATGCTGGACAGGATGGTGCCGACACCTACTGCATGGACAAGTGTCTCAACTATGAATCGGAGT 69 FBan0015785 FBgn0040913 CG15785 X X CG15785 CG15785 CDMC27978 4 5 20 DAC32-D19 23-CG15817-RB_3 CG15817 AGAAACGTTTTCATGTAACAAGCTGCAACAGAACTTCATTCACTCACAAATCACACACGTTTGTAATGT 69 FBan0015817 FBgn0028476 CG15817 3 3R protein deubiquitination; GO:0016579; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG15817 CG15817 "LD22910, BcDNA:LD22910" CDMC27978 4 6 20 DAC32-D19 23-CG15817-RB_3 CG15817 AGAAACGTTTTCATGTAACAAGCTGCAACAGAACTTCATTCACTCACAAATCACACACGTTTGTAATGT 69 FBan0015817 FBgn0028476 CG15817 3 3R protein deubiquitination; GO:0016579; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG15817 CG15817 "LD22910, BcDNA:LD22910" CDMC27979 4 7 20 DAC32-H07 23-CG15871-RA_3 CG15871 CGCGTGCAGGACTACTAGAACTACTCAATGGGGTGCTGTTAAGTTTTGTGTGTAATAGTGGTTAACAAG 69 FBan0015871 FBgn0030552 mRpL38 X X protein biosynthesis; GO:0006412 phosphatidylethanolamine binding; GO:0008429; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0008429 mitochondrial large ribosomal subunit; GO:0005762 mRpL38 mitochondrial ribosomal protein L38 "CG15871, MRP-L3, mitochondrial ribosomal protein L3a, mRpL3a, mitochondrial ribosomal protein L38" CDMC27979 4 8 20 DAC32-H07 23-CG15871-RA_3 CG15871 CGCGTGCAGGACTACTAGAACTACTCAATGGGGTGCTGTTAAGTTTTGTGTGTAATAGTGGTTAACAAG 69 FBan0015871 FBgn0030552 mRpL38 X X protein biosynthesis; GO:0006412 phosphatidylethanolamine binding; GO:0008429; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0008429 mitochondrial large ribosomal subunit; GO:0005762 mRpL38 mitochondrial ribosomal protein L38 "CG15871, MRP-L3, mitochondrial ribosomal protein L3a, mRpL3a, mitochondrial ribosomal protein L38" CDMC27980 4 9 20 DAC32-H19 11-CG15887-RA_1 CG15887 TGGTAGATGATTTGTTTCGGTTTTGGCTGACCAGGATGACAATGCAAGACCAGGGATAACGGCGAGCTG 69 FBan0015887 FBgn0038132 CG15887 3 3R CG15887 CG15887 BcDNA:RE53127 CDMC27980 4 10 20 DAC32-H19 11-CG15887-RA_1 CG15887 TGGTAGATGATTTGTTTCGGTTTTGGCTGACCAGGATGACAATGCAAGACCAGGGATAACGGCGAGCTG 69 FBan0015887 FBgn0038132 CG15887 3 3R CG15887 CG15887 BcDNA:RE53127 CDMC27981 4 11 20 DAC32-L07 12-CG15924-RA_2 CG15924 GGCCAGTTCGCCAAGTATTCTAATTGGAAGCGTTAACAGGCAGGAAGCGATTGGCAGTGCAAATGGAAA 69 FBan0015924 FBgn0034111 CG15924 2 2R CG15924 CG15924 CDMC27981 4 12 20 DAC32-L07 12-CG15924-RA_2 CG15924 GGCCAGTTCGCCAAGTATTCTAATTGGAAGCGTTAACAGGCAGGAAGCGATTGGCAGTGCAAATGGAAA 69 FBan0015924 FBgn0034111 CG15924 2 2R CG15924 CG15924 CDMC27982 4 13 20 DAC32-L19 3-CG1599-RA_1 CG1599 TGCATTCCGTAAGGCCTCCCGAAATTTGGCTCGTCAAATGTTTTGGAAGAACATCCGCGTCTACGTGGT 69 FBan0001599 FBgn0033452 CG1599 2 2R intracellular protein transport; GO:0006886 v-SNARE activity; GO:0005485; SNAP receptor activity; GO:0005484; ; GO:0005485; ; GO:0005484 plasma membrane; GO:0005886 CG1599 CG1599 CDMC27982 4 14 20 DAC32-L19 3-CG1599-RA_1 CG1599 TGCATTCCGTAAGGCCTCCCGAAATTTGGCTCGTCAAATGTTTTGGAAGAACATCCGCGTCTACGTGGT 69 FBan0001599 FBgn0033452 CG1599 2 2R intracellular protein transport; GO:0006886 v-SNARE activity; GO:0005485; SNAP receptor activity; GO:0005484; ; GO:0005485; ; GO:0005484 plasma membrane; GO:0005886 CG1599 CG1599 CDMC27983 4 15 20 DAC32-P07 14-CG1637-RC_1 CG1637 GCGATTCGTCGATGGTGGAAAGAAGGCTCGCACTCAGTACATACACAATGTGGAACTGAAGGATCTGGA 69 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC27983 4 16 20 DAC32-P07 14-CG1637-RC_1 CG1637 GCGATTCGTCGATGGTGGAAAGAAGGCTCGCACTCAGTACATACACAATGTGGAACTGAAGGATCTGGA 69 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC27984 4 17 20 DAC32-P19 1-CG1644-RA_1 CG1644 GCACGCCTGTCTACATATCGGTGTTGGGAATCCATCGTGATGCACAGTACTGGCCAAATCCCGAAGTCT 69 FBan0001644 FBgn0031182 Cyp6t1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t1 Cyp6t1 "CG1644, 6t1" CDMC27984 4 18 20 DAC32-P19 1-CG1644-RA_1 CG1644 GCACGCCTGTCTACATATCGGTGTTGGGAATCCATCGTGATGCACAGTACTGGCCAAATCCCGAAGTCT 69 FBan0001644 FBgn0031182 Cyp6t1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t1 Cyp6t1 "CG1644, 6t1" CDMC27985 4 19 20 DAC33-D07 6-CG1134-RA_4 CG1134 TGGTCTACGACAACTACGAGCCCTCCAATCTGTCCCTCTTCGACCATGTGTTTGGTTTCTTCTCTGGCG 69 FBan0001134 FBgn0035483 CG1134 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG1134 CG1134 CDMC27985 4 20 20 DAC33-D07 6-CG1134-RA_4 CG1134 TGGTCTACGACAACTACGAGCCCTCCAATCTGTCCCTCTTCGACCATGTGTTTGGTTTCTTCTCTGGCG 69 FBan0001134 FBgn0035483 CG1134 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG1134 CG1134 CDMC27986 4 21 20 DAC33-D19 23-CG11362-RA_6 CG11362 TCATTACAAATGTGGACAGGGATATCCCGGGAAAGAGAAAACCGAAGATTACTCAGTACTTCAAGCTGA 69 FBan0011362 FBgn0034737 CG11362 2 2R CG11362 CG11362 CDMC27986 4 22 20 DAC33-D19 23-CG11362-RA_6 CG11362 TCATTACAAATGTGGACAGGGATATCCCGGGAAAGAGAAAACCGAAGATTACTCAGTACTTCAAGCTGA 69 FBan0011362 FBgn0034737 CG11362 2 2R CG11362 CG11362 CDMC27987 4 23 20 DAC33-H07 2-CG11391-RA_4 CG11391 CGGCGGACTACGAAAAGATTAAGGACATAGGAGCCTCGCTGGGAGCTCTGATCATCACCGTTAACGGGA 69 FBan0011391 FBgn0038732 CG11391 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11391 CG11391 CDMC27987 4 24 20 DAC33-H07 2-CG11391-RA_4 CG11391 CGGCGGACTACGAAAAGATTAAGGACATAGGAGCCTCGCTGGGAGCTCTGATCATCACCGTTAACGGGA 69 FBan0011391 FBgn0038732 CG11391 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11391 CG11391 CDMC27988 4 25 20 DAC33-H19 3-CG11405-RA_1 CG11405 ACGAAATCGATACCCGAACTCAGCTGCAGGCAGAAACGGGAAACACAATCCAATCCCCATGAAAACCCA 69 FBan0011405 FBgn0028550 A3-3 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 A3-3 A3-3 "CG11405, CG11405, EG:33C11.1" CDMC27988 4 26 20 DAC33-H19 3-CG11405-RA_1 CG11405 ACGAAATCGATACCCGAACTCAGCTGCAGGCAGAAACGGGAAACACAATCCAATCCCCATGAAAACCCA 69 FBan0011405 FBgn0028550 A3-3 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 A3-3 A3-3 "CG11405, CG11405, EG:33C11.1" CDMC27989 4 1 21 DAC33-L07 2-CG11440-RA_1 CG11440 TCGGCCTTCAACGGCTTATTGCTCGATGGCGATTACGAGAATTTCGGCTATGGGTGAGTATCTCGCCAA 69 FBan0011440 FBgn0037163 CG11440 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11440 CG11440 WUN-like CDMC27989 4 2 21 DAC33-L07 2-CG11440-RA_1 CG11440 TCGGCCTTCAACGGCTTATTGCTCGATGGCGATTACGAGAATTTCGGCTATGGGTGAGTATCTCGCCAA 69 FBan0011440 FBgn0037163 CG11440 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11440 CG11440 WUN-like CDMC27990 4 3 21 DAC33-L19 23-CG11458-RA_1 CG11458 ACCTGTCTCGCCTCTTTTCCATTCTCAATTGTTTTAACGATGTGTTTTCATTACTTCCTTGTTTAATTT 69 FBan0011458 FBgn0040637 CG11458 3 3L CG11458 CG11458 CDMC27990 4 4 21 DAC33-L19 23-CG11458-RA_1 CG11458 ACCTGTCTCGCCTCTTTTCCATTCTCAATTGTTTTAACGATGTGTTTTCATTACTTCCTTGTTTAATTT 69 FBan0011458 FBgn0040637 CG11458 3 3L CG11458 CG11458 CDMC27991 4 5 21 DAC33-P07 2-CG11495-RA_1 CG11495 GCTCTGAGTTGCTCCTGACCAAGTCGGATGGTCGCTCCAAGACCAAAACTTTTTGACCTCGCCAAAAGT 69 FBan0011495 FBgn0024194 rasp 3 3L N-terminal peptidyl-L-cysteine N-palmitoylation; GO:0018009; patched ligand processing; GO:0007225; protein amino acid palmitoylation; GO:0018318; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 rasp rasp "CG11495, CG11495, CG11495, CG11495, l(3)m47, l(3)SG3, rsp, sit, sightless, ski, skinny hedgehog, sig/ski, ski/sit, cmn, central missing, l(3)63Bg, Rasp, 7F21, l(3)M47, lethal(3)63Bg, lethal(3)SG3, rasp" CDMC27991 4 6 21 DAC33-P07 2-CG11495-RA_1 CG11495 GCTCTGAGTTGCTCCTGACCAAGTCGGATGGTCGCTCCAAGACCAAAACTTTTTGACCTCGCCAAAAGT 69 FBan0011495 FBgn0024194 rasp 3 3L N-terminal peptidyl-L-cysteine N-palmitoylation; GO:0018009; patched ligand processing; GO:0007225; protein amino acid palmitoylation; GO:0018318; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 rasp rasp "CG11495, CG11495, CG11495, CG11495, l(3)m47, l(3)SG3, rsp, sit, sightless, ski, skinny hedgehog, sig/ski, ski/sit, cmn, central missing, l(3)63Bg, Rasp, 7F21, l(3)M47, lethal(3)63Bg, lethal(3)SG3, rasp" CDMC27992 4 7 21 DAC33-P19 15-CG11505-RB_1 CG11505 GGGCGCTGAGTATGGGATCCAGATTCAGGAGGGCAACAATACTAAGAACGTTACTAAGCAGAGCTCCAG 69 FBan0011505 FBgn0035424 CG11505 3 3L CG11505 CG11505 CDMC27992 4 8 21 DAC33-P19 15-CG11505-RB_1 CG11505 GGGCGCTGAGTATGGGATCCAGATTCAGGAGGGCAACAATACTAAGAACGTTACTAAGCAGAGCTCCAG 69 FBan0011505 FBgn0035424 CG11505 3 3L CG11505 CG11505 CDMC27993 4 9 21 DAC34-D07 2-CG1471-RB_1 CG1471 TGATGTGATGCTATCGCTGAACACCGGGGTTCTCTTCGACGGACATCCCATAAACACCGACTTTGGC 67 FBan0001471 FBgn0039774 CDase 3 3R lipid metabolism; GO:0006629 ceramidase activity; GO:0017040 ; EC:3.5.1.23; ; GO:0017040 ; EC:3.5.1.23; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0017040 ; EC:3.5.1.23; ; GO:0016298 ; EC:3.1.1.- CDase Ceramidase "CG1471, CG1471, CG1471, CG1471, CG1471, ceramidase, fcd, anon-WO0118547.407, Ceramidase" CDMC27993 4 10 21 DAC34-D07 2-CG1471-RB_1 CG1471 TGATGTGATGCTATCGCTGAACACCGGGGTTCTCTTCGACGGACATCCCATAAACACCGACTTTGGC 67 FBan0001471 FBgn0039774 CDase 3 3R lipid metabolism; GO:0006629 ceramidase activity; GO:0017040 ; EC:3.5.1.23; ; GO:0017040 ; EC:3.5.1.23; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0017040 ; EC:3.5.1.23; ; GO:0016298 ; EC:3.1.1.- CDase Ceramidase "CG1471, CG1471, CG1471, CG1471, CG1471, ceramidase, fcd, anon-WO0118547.407, Ceramidase" CDMC27994 4 11 21 DAC34-D19 3-CG14892-RA_2 CG14892 GGATGGGGCAAGGCCAACATTAGTGGTGATCTCTCCAATCAGCTGCTGAAAACACAGGTGCCATTGC 67 FBan0014892 FBgn0038447 CG14892 3 3R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14892 CG14892 SP175 CDMC27994 4 12 21 DAC34-D19 3-CG14892-RA_2 CG14892 GGATGGGGCAAGGCCAACATTAGTGGTGATCTCTCCAATCAGCTGCTGAAAACACAGGTGCCATTGC 67 FBan0014892 FBgn0038447 CG14892 3 3R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14892 CG14892 SP175 CDMC27995 4 13 21 DAC34-H07 3-CG15284-RA_3 CG15284 CGACGTCATCGTCAACAAATGCGAAGGATTGTGCAACAGTCAGGTGCAACCATCGGTGATAACGCCC 67 FBan0015284 FBgn0032546 pburs 2 2L contributes_to neuropeptide hormone activity; GO:0005184; ; GO:0005184 bursicon neuropeptide hormone complex; GO:0031395 pburs partner of burs "CG15284, CG15284, CG15284, CG15284, CG15284, bursbeta, bursicon beta, burs-beta" CDMC27995 4 14 21 DAC34-H07 3-CG15284-RA_3 CG15284 CGACGTCATCGTCAACAAATGCGAAGGATTGTGCAACAGTCAGGTGCAACCATCGGTGATAACGCCC 67 FBan0015284 FBgn0032546 pburs 2 2L contributes_to neuropeptide hormone activity; GO:0005184; ; GO:0005184 bursicon neuropeptide hormone complex; GO:0031395 pburs partner of burs "CG15284, CG15284, CG15284, CG15284, CG15284, bursbeta, bursicon beta, burs-beta" CDMC27996 4 15 21 DAC34-H19 3-CG15429-RA_7 CG15429 CGACCTCGTGTCCTATTCCCTCCCATATTGGAAGTGGCCATATCGGAGTTTTGCAAAACACCGGGGG 67 FBan0015429 FBgn0031596 CG15429 2 2L CG15429 CG15429 BcDNA:AT23465 CDMC27996 4 16 21 DAC34-H19 3-CG15429-RA_7 CG15429 CGACCTCGTGTCCTATTCCCTCCCATATTGGAAGTGGCCATATCGGAGTTTTGCAAAACACCGGGGG 67 FBan0015429 FBgn0031596 CG15429 2 2L CG15429 CG15429 BcDNA:AT23465 CDMC27997 4 17 21 DAC34-L07 18-CG15769-RA_1 CG15769 ACCGTGGCTACGACAGTGTCAGTGGTTGTTATGGTGTAAATTTGGATCGAAACTTCGACTACGGCTG 67 FBan0015769 FBgn0029805 CG15769 X X proteolysis; GO:0006508 NOT carboxypeptidase activity; GO:0004180; ; GO:0004180; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- CG15769 CG15769 CDMC27997 4 18 21 DAC34-L07 18-CG15769-RA_1 CG15769 ACCGTGGCTACGACAGTGTCAGTGGTTGTTATGGTGTAAATTTGGATCGAAACTTCGACTACGGCTG 67 FBan0015769 FBgn0029805 CG15769 X X proteolysis; GO:0006508 NOT carboxypeptidase activity; GO:0004180; ; GO:0004180; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- CG15769 CG15769 CDMC27998 4 19 21 DAC34-L19 2-CG15916-RA_2 CG15916 GCCAAAGATCAAGTTTGTCCGGGACAAAACGAGCACTGGTCTCCATCAGGTCCACGAGGTTCTGTCC 67 FBan0015916 FBgn0030704 CG15916 X X CG15916 CG15916 BcDNA:RH08992 CDMC27998 4 20 21 DAC34-L19 2-CG15916-RA_2 CG15916 GCCAAAGATCAAGTTTGTCCGGGACAAAACGAGCACTGGTCTCCATCAGGTCCACGAGGTTCTGTCC 67 FBan0015916 FBgn0030704 CG15916 X X CG15916 CG15916 BcDNA:RH08992 CDMC27999 4 21 21 DAC34-P07 3-CG17129-RA_4 CG17129 GACCTGGTTCCCTACGCAGAGAATATGATTCGGGTTCGCACTGACCTGTTGCAGGAGCAAGTTGACC 67 FBan0017129 FBgn0035151 CG17129 3 3L CG17129 CG17129 CDMC27999 4 22 21 DAC34-P07 3-CG17129-RA_4 CG17129 GACCTGGTTCCCTACGCAGAGAATATGATTCGGGTTCGCACTGACCTGTTGCAGGAGCAAGTTGACC 67 FBan0017129 FBgn0035151 CG17129 3 3L CG17129 CG17129 CDMC28000 4 23 21 DAC34-P19 AutoBlank AutoBlank CDMC28000 4 24 21 DAC34-P19 AutoBlank AutoBlank CDMC28001 4 25 21 DAC35-D07 22-CG11777-RA_1 CG11777 TCCGAAACATCAAGGGATTTATTGTCCAAACTGGAGATCCTACGAACACCGGAAAGAATGGACAGTCCA 69 FBan0011777 FBgn0033527 CG11777 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG11777 CG11777 BcDNA:RE61564 CDMC28001 4 26 21 DAC35-D07 22-CG11777-RA_1 CG11777 TCCGAAACATCAAGGGATTTATTGTCCAAACTGGAGATCCTACGAACACCGGAAAGAATGGACAGTCCA 69 FBan0011777 FBgn0033527 CG11777 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG11777 CG11777 BcDNA:RE61564 CDMC28002 4 1 22 DAC35-D19 2-CG11790-RA_1 CG11790 AGCCAAGCAATACAGTCCCGAAGCCTTTGTCCAGTTTGCTGAGAAGGGATATACCCAGAGCCATCCTCA 69 FBan0011790 FBgn0039265 CG11790 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG11790 CG11790 CDMC28002 4 2 22 DAC35-D19 2-CG11790-RA_1 CG11790 AGCCAAGCAATACAGTCCCGAAGCCTTTGTCCAGTTTGCTGAGAAGGGATATACCCAGAGCCATCCTCA 69 FBan0011790 FBgn0039265 CG11790 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG11790 CG11790 CDMC28003 4 3 22 DAC35-H07 2-CG11842-RA_1 CG11842 CGCACCCCGAATTTAGCTACCCGGCGATTTACAACGACATTTCCGTGGTACGATTGAGTCGACCCGTAA 69 FBan0011842 FBgn0039629 CG11842 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11842 CG11842 SP68 CDMC28003 4 4 22 DAC35-H07 2-CG11842-RA_1 CG11842 CGCACCCCGAATTTAGCTACCCGGCGATTTACAACGACATTTCCGTGGTACGATTGAGTCGACCCGTAA 69 FBan0011842 FBgn0039629 CG11842 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11842 CG11842 SP68 CDMC28004 4 5 22 DAC35-H19 3-CG11854-RA_2 CG11854 CGCGTCTCCAAGGGCGATCATCAAACCTACGCCGAGGTGATGAACATAAAGGTTGAGCTGGATCCATCC 69 FBan0011854 FBgn0039299 CG11854 3 3R CG11854 CG11854 CDMC28004 4 6 22 DAC35-H19 3-CG11854-RA_2 CG11854 CGCGTCTCCAAGGGCGATCATCAAACCTACGCCGAGGTGATGAACATAAAGGTTGAGCTGGATCCATCC 69 FBan0011854 FBgn0039299 CG11854 3 3R CG11854 CG11854 CDMC28005 4 7 22 DAC35-L07 18-CG11888-RA_1 CG11888 GCCCCCAGAGCCCTTTGAGTACATCGAGGACTAAATGGGCATGCTGTTTGTCATTATCTAAGTGAATCC 69 FBan0011888 FBgn0028692 Rpn2 3 3R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpn2 Rpn2 "CG11888, p110, dRpn2" CDMC28005 4 8 22 DAC35-L07 18-CG11888-RA_1 CG11888 GCCCCCAGAGCCCTTTGAGTACATCGAGGACTAAATGGGCATGCTGTTTGTCATTATCTAAGTGAATCC 69 FBan0011888 FBgn0028692 Rpn2 3 3R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpn2 Rpn2 "CG11888, p110, dRpn2" CDMC28006 4 9 22 DAC35-L19 9-CG11900-RA_3 CG11900 AGGATCCTCAGGAAACCCCCTATGTGAACCATGTGATCAATGTGAGCACTATTCTCTCCGTGGAGGCCT 69 FBan0011900 FBgn0039650 CG11900 3 3R CG11900 CG11900 CDMC28006 4 10 22 DAC35-L19 9-CG11900-RA_3 CG11900 AGGATCCTCAGGAAACCCCCTATGTGAACCATGTGATCAATGTGAGCACTATTCTCTCCGTGGAGGCCT 69 FBan0011900 FBgn0039650 CG11900 3 3R CG11900 CG11900 CDMC28007 4 11 22 DAC35-P07 5-CG11943-RB_1 CG11943 AGCAGCAGACCAACCCCACCGATGACTCGAAGAGGCTACGTGTCAAGTATTTTCTGGATATAGCAGCCA 69 FBan0011943 FBgn0031078 CG11943 X X CG11943 CG11943 anon-EST:Posey281 CDMC28007 4 12 22 DAC35-P07 5-CG11943-RB_1 CG11943 AGCAGCAGACCAACCCCACCGATGACTCGAAGAGGCTACGTGTCAAGTATTTTCTGGATATAGCAGCCA 69 FBan0011943 FBgn0031078 CG11943 X X CG11943 CG11943 anon-EST:Posey281 CDMC28008 4 13 22 DAC35-P19 1-CG11968-RA_1 CG11968 CGCACCGCTTTGAAAAGGTGTCCAACATCATCAAGCAGTTCAAGCTGAGCTGTTCGAAGTTGGGCGCTA 69 FBan0011968 FBgn0037647 CG11968 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cellular physiological process; GO:0050875 GTPase activity; GO:0003924; ; GO:0003924 cytoplasm; GO:0005737; nucleus; GO:0005634 CG11968 CG11968 CDMC28008 4 14 22 DAC35-P19 1-CG11968-RA_1 CG11968 CGCACCGCTTTGAAAAGGTGTCCAACATCATCAAGCAGTTCAAGCTGAGCTGTTCGAAGTTGGGCGCTA 69 FBan0011968 FBgn0037647 CG11968 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cellular physiological process; GO:0050875 GTPase activity; GO:0003924; ; GO:0003924 cytoplasm; GO:0005737; nucleus; GO:0005634 CG11968 CG11968 CDMC28009 4 15 22 DAC36-D07 11-CG8631-RA_1 CG8631 TCCACGTGGATGACCACTTGCTGTATACGGAGGAGAAGGAGTATGTCCACAACTACCTCACAGACGACA 69 FBan0008631 FBgn0002775 msl-3 3 3L "chromatin assembly or disassembly; GO:0006333; dosage compensation; GO:0007549; dosage compensation, by hyperactivation of X chromosome; GO:0009047; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; ; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; protein binding; GO:0005515; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 X chromosome; GO:0000805; chromatin; GO:0000785; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 msl-3 male-specific lethal 3 "CG8631, mle(3)132, msl, msl3, mle3, gene 2, MSL-3, MSL3, mls3, MSL, DmMsl-3, male specifc lethal" CDMC28009 4 16 22 DAC36-D07 11-CG8631-RA_1 CG8631 TCCACGTGGATGACCACTTGCTGTATACGGAGGAGAAGGAGTATGTCCACAACTACCTCACAGACGACA 69 FBan0008631 FBgn0002775 msl-3 3 3L "chromatin assembly or disassembly; GO:0006333; dosage compensation; GO:0007549; dosage compensation, by hyperactivation of X chromosome; GO:0009047; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; ; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; protein binding; GO:0005515; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 X chromosome; GO:0000805; chromatin; GO:0000785; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 msl-3 male-specific lethal 3 "CG8631, mle(3)132, msl, msl3, mle3, gene 2, MSL-3, MSL3, mls3, MSL, DmMsl-3, male specifc lethal" CDMC28010 4 17 22 DAC36-D19 16-CG8643-RA_3 CG8643 TGCACCCAATGACTTGTGTGCGAAACAAACAAAATGTCTAGGGCGATATGCAGTCAACTGTAACGTGGT 69 FBan0008643 FBgn0033310 rgr 2 2R cell proliferation; GO:0008283; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 rgr regular "CG14751, CG8643, CG14751, CG8643, CG8643, CG8643, regular" CDMC28010 4 18 22 DAC36-D19 16-CG8643-RA_3 CG8643 TGCACCCAATGACTTGTGTGCGAAACAAACAAAATGTCTAGGGCGATATGCAGTCAACTGTAACGTGGT 69 FBan0008643 FBgn0033310 rgr 2 2R cell proliferation; GO:0008283; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 rgr regular "CG14751, CG8643, CG14751, CG8643, CG8643, CG8643, regular" CDMC28011 4 19 22 DAC36-H07 24-CG8677-RA_1 CG8677 CCTTTGATCTTACGTATTAACATTAAGAAACGTTAATTTTCAAGTTTTGAATATGGTTTAGGGAGAATT 69 FBan0008677 FBgn0026577 CG8677 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG8677 CG8677 "LD14959, BEST:LD14959, BEST:LD19244" CDMC28011 4 20 22 DAC36-H07 24-CG8677-RA_1 CG8677 CCTTTGATCTTACGTATTAACATTAAGAAACGTTAATTTTCAAGTTTTGAATATGGTTTAGGGAGAATT 69 FBan0008677 FBgn0026577 CG8677 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG8677 CG8677 "LD14959, BEST:LD14959, BEST:LD19244" CDMC28012 4 21 22 DAC36-H19 13-CG8690-RA_1 CG8690 AACTTCGGATCGGTAGCTAAAACCGTTGACTTGAGTCAGTTTGACAAGAGCCGTACCGAAAGCCTGCAG 69 FBan0008690 FBgn0033297 CG8690 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; ; GO:0005215; alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20 CG8690 CG8690 CT6532 CDMC28012 4 22 22 DAC36-H19 13-CG8690-RA_1 CG8690 AACTTCGGATCGGTAGCTAAAACCGTTGACTTGAGTCAGTTTGACAAGAGCCGTACCGAAAGCCTGCAG 69 FBan0008690 FBgn0033297 CG8690 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; ; GO:0005215; alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20 CG8690 CG8690 CT6532 CDMC28013 4 23 22 DAC36-L07 4-CG8728-RA_1 CG8728 TGCGCTCGAAGATCCAGCTTCAGTCCATGTTACTAATGAACCTGGAGTCGAGACCCGTTGTGTTCGAGG 69 FBan0008728 FBgn0033235 CG8728 2 2R electron transport; GO:0006118; protein processing; GO:0016485; proteolysis; GO:0006508 mitochondrial processing peptidase activity; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64 mitochondrial matrix; GO:0005759 CG8728 CG8728 CDMC28013 4 24 22 DAC36-L07 4-CG8728-RA_1 CG8728 TGCGCTCGAAGATCCAGCTTCAGTCCATGTTACTAATGAACCTGGAGTCGAGACCCGTTGTGTTCGAGG 69 FBan0008728 FBgn0033235 CG8728 2 2R electron transport; GO:0006118; protein processing; GO:0016485; proteolysis; GO:0006508 mitochondrial processing peptidase activity; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64; ; GO:0004240 ; EC:3.4.24.64 mitochondrial matrix; GO:0005759 CG8728 CG8728 CDMC28014 4 25 22 DAC36-L19 38-CG8738-RA_6 CG8738 TGAATTGCGCATTGATCCGGCTGAAATCGTAGGGGTTATTCGGATTCCAAACAAATTCCCAGCGAGTGT 69 FBan0008738 FBgn0033321 CG8738 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8738 CG8738 "c-SPH121, SPH121" CDMC28014 4 26 22 DAC36-L19 38-CG8738-RA_6 CG8738 TGAATTGCGCATTGATCCGGCTGAAATCGTAGGGGTTATTCGGATTCCAAACAAATTCCCAGCGAGTGT 69 FBan0008738 FBgn0033321 CG8738 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8738 CG8738 "c-SPH121, SPH121" CDMC28015 4 1 23 DAC36-P07 17-CG8776-RA_1 CG8776 TGCCCACTTTCAATCTCTCAGTAGGTGTGTAGGATTAGGAATCTCAGCAGATGAGCAGAAGACCAAGCA 69 FBan0008776 FBgn0033764 CG8776 2 2R electron transport; GO:0006118 carbon-monoxide oxygenase activity; GO:0008805 ; EC:1.2.2.4; ; GO:0008805 ; EC:1.2.2.4 integral to membrane; GO:0016021; transport vesicle; GO:0030133 CG8776 CG8776 CG13147 CDMC28015 4 2 23 DAC36-P07 17-CG8776-RA_1 CG8776 TGCCCACTTTCAATCTCTCAGTAGGTGTGTAGGATTAGGAATCTCAGCAGATGAGCAGAAGACCAAGCA 69 FBan0008776 FBgn0033764 CG8776 2 2R electron transport; GO:0006118 carbon-monoxide oxygenase activity; GO:0008805 ; EC:1.2.2.4; ; GO:0008805 ; EC:1.2.2.4 integral to membrane; GO:0016021; transport vesicle; GO:0030133 CG8776 CG8776 CG13147 CDMC28016 4 3 23 DAC36-P19 2-CG8790-RB_1 CG8790 CCCGTGGAATCCTGATGACGATTGGCCAAATTGCATTTTACGACCAGACGAAGATCTACCTGCTGGCCA 69 FBan0008790 FBgn0027610 CG8790 3 3R transport; GO:0006810 carrier activity; GO:0005386; dicarboxylic acid transporter activity; GO:0005310; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 CG8790 CG8790 BcDNA:GH02431 CDMC28016 4 4 23 DAC36-P19 2-CG8790-RB_1 CG8790 CCCGTGGAATCCTGATGACGATTGGCCAAATTGCATTTTACGACCAGACGAAGATCTACCTGCTGGCCA 69 FBan0008790 FBgn0027610 CG8790 3 3R transport; GO:0006810 carrier activity; GO:0005386; dicarboxylic acid transporter activity; GO:0005310; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005310 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 CG8790 CG8790 BcDNA:GH02431 CDMC28017 4 5 23 DAC37-D07 23-CG9015-RA_6 CG9015 CGTGCAATATTCGAGGGCGTACAAATGGTTTTCATGTGATATAATTGTAGCGTACATATGTTTTTGTAT 69 FBan0009015 FBgn0000577 en 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; anterior head segmentation; GO:0035288; anterior/posterior lineage restriction, imaginal disc; GO:0048099; anterior/posterior pattern formation, imaginal disc; GO:0007448; central nervous system development; GO:0007417; compartment specification; GO:0007386; ectoderm development; GO:0007398; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; genital disc anterior/posterior pattern formation; GO:0035224; imaginal disc pattern formation; GO:0007447; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; negative regulation of transcription; GO:0016481; neuroblast fate determination; GO:0007400; posterior compartment specification; GO:0007388; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; trunk segmentation; GO:0035290; wing disc anterior/posterior pattern formation; GO:0048100" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcriptional repressor activity; GO:0016564; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0030528; ; GO:0016564; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 en engrailed "CG9015, spt: spermatheca, spermatheca, Engrailed/Invected, Eng, Apa, Es: Erased, V: transcript group V, Apigmented abdomen, Erased, transcript group V, spt" CDMC28017 4 6 23 DAC37-D07 23-CG9015-RA_6 CG9015 CGTGCAATATTCGAGGGCGTACAAATGGTTTTCATGTGATATAATTGTAGCGTACATATGTTTTTGTAT 69 FBan0009015 FBgn0000577 en 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; anterior head segmentation; GO:0035288; anterior/posterior lineage restriction, imaginal disc; GO:0048099; anterior/posterior pattern formation, imaginal disc; GO:0007448; central nervous system development; GO:0007417; compartment specification; GO:0007386; ectoderm development; GO:0007398; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; genital disc anterior/posterior pattern formation; GO:0035224; imaginal disc pattern formation; GO:0007447; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; negative regulation of transcription; GO:0016481; neuroblast fate determination; GO:0007400; posterior compartment specification; GO:0007388; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; trunk segmentation; GO:0035290; wing disc anterior/posterior pattern formation; GO:0048100" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcriptional repressor activity; GO:0016564; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0030528; ; GO:0016564; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 en engrailed "CG9015, spt: spermatheca, spermatheca, Engrailed/Invected, Eng, Apa, Es: Erased, V: transcript group V, Apigmented abdomen, Erased, transcript group V, spt" CDMC28018 4 7 23 DAC37-D19 22-CG9027-RB_1 CG9027 GCCTGTGGTGTTATTGGCATCAAGTAAATATCCCTTCCAACGTGTCAGCCAAATCAATATGCTGCTCGA 69 FBan0009027 FBgn0033631 CG9027 2 2R defense response; GO:0006952; superoxide metabolism; GO:0006801 "superoxide dismutase activity; GO:0004784 ; EC:1.15.1.1; metal ion binding; GO:0046872; ; GO:0004784 ; EC:1.15.1.1; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG9027 CG9027 CT25938 CDMC28018 4 8 23 DAC37-D19 22-CG9027-RB_1 CG9027 GCCTGTGGTGTTATTGGCATCAAGTAAATATCCCTTCCAACGTGTCAGCCAAATCAATATGCTGCTCGA 69 FBan0009027 FBgn0033631 CG9027 2 2R defense response; GO:0006952; superoxide metabolism; GO:0006801 "superoxide dismutase activity; GO:0004784 ; EC:1.15.1.1; metal ion binding; GO:0046872; ; GO:0004784 ; EC:1.15.1.1; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG9027 CG9027 CT25938 CDMC28019 4 9 23 DAC37-H07 9-CG9060-RA_2 CG9060 ACAACACCCTTTCAAGTGCTTCTCGAGGACATATCCGGCAATAGTTTCATCGAGAATCCCCTGGCACCT 69 FBan0009060 FBgn0030096 Zpr1 X X transcription from RNA polymerase I promoter; GO:0006360 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleolus; GO:0005730 Zpr1 Zpr1 "CG9060, CG9060, CG9060" CDMC28019 4 10 23 DAC37-H07 9-CG9060-RA_2 CG9060 ACAACACCCTTTCAAGTGCTTCTCGAGGACATATCCGGCAATAGTTTCATCGAGAATCCCCTGGCACCT 69 FBan0009060 FBgn0030096 Zpr1 X X transcription from RNA polymerase I promoter; GO:0006360 protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleolus; GO:0005730 Zpr1 Zpr1 "CG9060, CG9060, CG9060" CDMC28020 4 11 23 DAC37-H19 23-CG9075-RB_1 CG9075 GAAAGAATTCTAAACAAAAAGTGAGTGAGCAAAACAGCAAACAAGAACTGCGAAATCGATAACCGAGCG 69 FBan0009075 FBgn0001942 eIF-4a 2 2L "DNA unwinding during replication; GO:0006268; imaginal disc growth; GO:0007446; larval development (sensu Insecta); GO:0002168; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; translational initiation; GO:0006413" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0000339; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281; nucleus; GO:0005634 eIF-4a Eukaryotic initiation factor 4a "CG9075, CG9075, CG9075, CG9075, CG9075, l(2)gdh-4, l(2L)162, l(2)k01501, eIF4A, 2439, eif-4a, eif4A, EiF4A, eIF-4A, DmRH2, EIF-4A, Eif-4a, Dm-eIF4A, Eif4a, anon-26Aa, anon26A, l(2)02439, l(2)162, l(2)26Ac" CDMC28020 4 12 23 DAC37-H19 23-CG9075-RB_1 CG9075 GAAAGAATTCTAAACAAAAAGTGAGTGAGCAAAACAGCAAACAAGAACTGCGAAATCGATAACCGAGCG 69 FBan0009075 FBgn0001942 eIF-4a 2 2L "DNA unwinding during replication; GO:0006268; imaginal disc growth; GO:0007446; larval development (sensu Insecta); GO:0002168; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; translational initiation; GO:0006413" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0000339; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281; nucleus; GO:0005634 eIF-4a Eukaryotic initiation factor 4a "CG9075, CG9075, CG9075, CG9075, CG9075, l(2)gdh-4, l(2L)162, l(2)k01501, eIF4A, 2439, eif-4a, eif4A, EiF4A, eIF-4A, DmRH2, EIF-4A, Eif-4a, Dm-eIF4A, Eif4a, anon-26Aa, anon26A, l(2)02439, l(2)162, l(2)26Ac" CDMC28021 4 13 23 DAC37-L07 17-CG9109-RA_1 CG9109 CGCATATATACTTCGCCATCAAAACCTGTGCGAAATTCCACAAGGAACGCATACCAATCATCGAGCGCA 69 FBan0009109 FBgn0031765 CG9109 2 2L CG9109 CG9109 CDMC28021 4 14 23 DAC37-L07 17-CG9109-RA_1 CG9109 CGCATATATACTTCGCCATCAAAACCTGTGCGAAATTCCACAAGGAACGCATACCAATCATCGAGCGCA 69 FBan0009109 FBgn0031765 CG9109 2 2L CG9109 CG9109 CDMC28022 4 15 23 DAC37-L19 3-CG9122-RA_1 CG9122 GGAGTGCGCTACAACCCGTACACGATGAGTGTTGAAGTCCTGTCGAATGCCAAGAAGATCACAGCGGTG 69 FBan0009122 FBgn0035187 Trh 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; serotonin biosynthesis; GO:0042427; signal transduction; GO:0007165; tryptophan metabolism; GO:0006568 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004510 ; EC:1.14.16.4; ; GO:0004510 ; EC:1.14.16.4 Trh Tryptophan hydroxylase "CG9122, DTRH, Tryptophan hydroxylase" CDMC28022 4 16 23 DAC37-L19 3-CG9122-RA_1 CG9122 GGAGTGCGCTACAACCCGTACACGATGAGTGTTGAAGTCCTGTCGAATGCCAAGAAGATCACAGCGGTG 69 FBan0009122 FBgn0035187 Trh 3 3L amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072; serotonin biosynthesis; GO:0042427; signal transduction; GO:0007165; tryptophan metabolism; GO:0006568 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004510 ; EC:1.14.16.4; ; GO:0004510 ; EC:1.14.16.4 Trh Tryptophan hydroxylase "CG9122, DTRH, Tryptophan hydroxylase" CDMC28023 4 17 23 DAC37-P07 14-CG9155-RC_1 CG9155 AGGGCGACTTGATTCTGATCATTCCGCGCATAATCGAGTTCAGCACGTATATCATTGACACCGTGGGAA 69 FBan0009155 FBgn0010246 Myo61F 3 3L intracellular protein transport; GO:0006886; mesoderm development; GO:0007498; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasm; GO:0005737; myosin; GO:0016459 Myo61F Myosin 61F "CG9155, CG9155, CG9155, myosin I, myosin 61F, DroMIB, myosin-IB, myosin 1b, IB, Myosin IB, myosin IB, MYO61F, Myo1B, MYOIB, DmIB, Dm IB, Myo-IB, MIB, myosin61F, Myosin-IB" CDMC28023 4 18 23 DAC37-P07 14-CG9155-RC_1 CG9155 AGGGCGACTTGATTCTGATCATTCCGCGCATAATCGAGTTCAGCACGTATATCATTGACACCGTGGGAA 69 FBan0009155 FBgn0010246 Myo61F 3 3L intracellular protein transport; GO:0006886; mesoderm development; GO:0007498; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasm; GO:0005737; myosin; GO:0016459 Myo61F Myosin 61F "CG9155, CG9155, CG9155, myosin I, myosin 61F, DroMIB, myosin-IB, myosin 1b, IB, Myosin IB, myosin IB, MYO61F, Myo1B, MYOIB, DmIB, Dm IB, Myo-IB, MIB, myosin61F, Myosin-IB" CDMC28024 4 19 23 DAC37-P19 3-CG9168-RA_4 CG9168 GCGAACCCACTGAAACGGTAACCAACCAAAGGCTCCTCAGAAAAGTGGCTCAAGAGGTGGTGCATCATA 69 FBan0009168 FBgn0035216 CG9168 3 3L CG9168 CG9168 CDMC28024 4 20 23 DAC37-P19 3-CG9168-RA_4 CG9168 GCGAACCCACTGAAACGGTAACCAACCAAAGGCTCCTCAGAAAAGTGGCTCAAGAGGTGGTGCATCATA 69 FBan0009168 FBgn0035216 CG9168 3 3L CG9168 CG9168 CDMC28025 4 21 23 DAC38-D07 3-CG5902-RA_1 CG5902 CGTGGCTGCATTGGTACTTTTAGTGCAATGGAACTGCACCATGGTCTTCGGGAGTACGCCTTGACC 66 FBan0005902 FBgn0039136 CG5902 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5902 CG5902 anon-WO0118547.372 CDMC28025 4 22 23 DAC38-D07 3-CG5902-RA_1 CG5902 CGTGGCTGCATTGGTACTTTTAGTGCAATGGAACTGCACCATGGTCTTCGGGAGTACGCCTTGACC 66 FBan0005902 FBgn0039136 CG5902 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5902 CG5902 anon-WO0118547.372 CDMC28026 4 23 23 DAC38-D19 3-CG6125-RB_2 CG6125 CCCTTCGCCTTCGAGTATCAGAATCGCACCTATGTGTTCACGGATATCCTCCATGAGCTGGGCAGC 66 FBan0006125 FBgn0038337 CG6125 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG6125 CG6125 CDMC28026 4 24 23 DAC38-D19 3-CG6125-RB_2 CG6125 CCCTTCGCCTTCGAGTATCAGAATCGCACCTATGTGTTCACGGATATCCTCCATGAGCTGGGCAGC 66 FBan0006125 FBgn0038337 CG6125 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG6125 CG6125 CDMC28027 4 25 23 DAC38-H07 9-CG6470-RA_3 CG6470 ACCAACCAGCAGGATCAGATGACCCAGCAGGAAAAACTTCAGAAGATTATCATGCGCGAGTCGGCA 66 FBan0006470 FBgn0030933 CG6470 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6470 CG6470 anon-WO0140519.137 CDMC28027 4 26 23 DAC38-H07 9-CG6470-RA_3 CG6470 ACCAACCAGCAGGATCAGATGACCCAGCAGGAAAAACTTCAGAAGATTATCATGCGCGAGTCGGCA 66 FBan0006470 FBgn0030933 CG6470 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6470 CG6470 anon-WO0140519.137 CDMC28028 4 1 24 DAC38-H19 2-CG6641-RA_1 CG6641 AGACACACCGACCTAGCATCATGCAGTCTACTCCAATCATTCTGGTGGCAATCGTCCTTCTCGGCG 66 FBan0006641 FBgn0011283 Pbprp5 2 2L metabolism; GO:0008152; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- extracellular region; GO:0005576 Pbprp5 Pheromone-binding protein-related protein 5 "CG6641, pbprp-5, PB-PRP5, pbprp5, PBPRP5, 28a, PBP5, PBPRP-5, Obp28a" CDMC28028 4 2 24 DAC38-H19 2-CG6641-RA_1 CG6641 AGACACACCGACCTAGCATCATGCAGTCTACTCCAATCATTCTGGTGGCAATCGTCCTTCTCGGCG 66 FBan0006641 FBgn0011283 Pbprp5 2 2L metabolism; GO:0008152; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- extracellular region; GO:0005576 Pbprp5 Pheromone-binding protein-related protein 5 "CG6641, pbprp-5, PB-PRP5, pbprp5, PBPRP5, 28a, PBP5, PBPRP-5, Obp28a" CDMC28029 4 3 24 DAC38-L07 3-CG7115-RA_2 CG7115 TGCGTTGGAGCATCTGAAAGAGCCGGACTTTGGCGCCAAATCACTTGCCATGGAGTCGTATAAACG 66 FBan0007115 FBgn0027515 CG7115 2 2L cell adhesion; GO:0007155; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG7115 CG7115 "PP2C, BcDNA:LD21794" CDMC28029 4 4 24 DAC38-L07 3-CG7115-RA_2 CG7115 TGCGTTGGAGCATCTGAAAGAGCCGGACTTTGGCGCCAAATCACTTGCCATGGAGTCGTATAAACG 66 FBan0007115 FBgn0027515 CG7115 2 2L cell adhesion; GO:0007155; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG7115 CG7115 "PP2C, BcDNA:LD21794" CDMC28030 4 5 24 DAC38-L19 24-CG7182-RA_1 CG7182 GACTATTTATTGTTGCTAGCCTAATGATTACAATACAAAAACTTAATAAAGATAAATACGCAAGCG 66 FBan0007182 FBgn0035878 CG7182 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524 CG7182 CG7182 CDMC28030 4 6 24 DAC38-L19 24-CG7182-RA_1 CG7182 GACTATTTATTGTTGCTAGCCTAATGATTACAATACAAAAACTTAATAAAGATAAATACGCAAGCG 66 FBan0007182 FBgn0035878 CG7182 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524 CG7182 CG7182 CDMC28031 4 7 24 DAC38-P07 3-CG7754-RA_1 CG7754 CGAGAGCCATCAATTTAGCCAGTACGAGTCCATCGGGTGGAACAACAGTCACTGTCACGGGTTGGG 66 FBan0007754 FBgn0015001 iotaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 iotaTry iotaTrypsin "CG7754, trypsin iota, SP129" CDMC28031 4 8 24 DAC38-P07 3-CG7754-RA_1 CG7754 CGAGAGCCATCAATTTAGCCAGTACGAGTCCATCGGGTGGAACAACAGTCACTGTCACGGGTTGGG 66 FBan0007754 FBgn0015001 iotaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 iotaTry iotaTrypsin "CG7754, trypsin iota, SP129" CDMC28032 4 9 24 DAC38-P19 AutoBlank AutoBlank CDMC28032 4 10 24 DAC38-P19 AutoBlank AutoBlank CDMC28033 4 11 24 DAC39-D07 23-CG32056-RA_4 CG32056 AATGAAACTCCTTGTTAATTTTGATGAACATACTGAACTCAGGCTTCCTTCGAGAGGACATTGCCAGAA 69 FBan0032056 FBgn0052056 CG32056 3 3L lipid metabolism; GO:0006629; lipid transport; GO:0006869; phospholipid scrambling; GO:0017121; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; carrier activity; GO:0005386; binding; GO:0005488; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0005488; ; GO:0005386; phospholipid scramblase activity; GO:0017128; ; GO:0004812 ; EC:6.1.1.-; ; GO:0017128 CG32056 CG32056 "CG6590, CT20492" CDMC28033 4 12 24 DAC39-D07 23-CG32056-RA_4 CG32056 AATGAAACTCCTTGTTAATTTTGATGAACATACTGAACTCAGGCTTCCTTCGAGAGGACATTGCCAGAA 69 FBan0032056 FBgn0052056 CG32056 3 3L lipid metabolism; GO:0006629; lipid transport; GO:0006869; phospholipid scrambling; GO:0017121; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; carrier activity; GO:0005386; binding; GO:0005488; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0005488; ; GO:0005386; phospholipid scramblase activity; GO:0017128; ; GO:0004812 ; EC:6.1.1.-; ; GO:0017128 CG32056 CG32056 "CG6590, CT20492" CDMC28034 4 13 24 DAC39-D19 16-CG32066-RB_1 CG32066 AGCCTCCGCGTAACGTAGCAAAGAAGTCGGACAAAAAGTGGGACGCATATATCAGCAGCAACAATATTT 69 FBan0032066 FBgn0052066 CG32066 3 3L CG32066 CG32066 "CG6487, CG6491, CG6487, CG6491" CDMC28034 4 14 24 DAC39-D19 16-CG32066-RB_1 CG32066 AGCCTCCGCGTAACGTAGCAAAGAAGTCGGACAAAAAGTGGGACGCATATATCAGCAGCAACAATATTT 69 FBan0032066 FBgn0052066 CG32066 3 3L CG32066 CG32066 "CG6487, CG6491, CG6487, CG6491" CDMC28035 4 15 24 DAC39-H07 3-CG32104-RB_3 CG32104 GCTCCGGATTTGCATGAGCTGCTTCGTGATTGCCTGATGGATTTCTACAGGGAGAATGCAGCCCATGAA 69 FBan0032104 FBgn0052104 CG32104 3 3L ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; ; GO:0016887 CG32104 CG32104 "CG14124, CG14123, CG14124, anon-69Ag" CDMC28035 4 16 24 DAC39-H07 3-CG32104-RB_3 CG32104 GCTCCGGATTTGCATGAGCTGCTTCGTGATTGCCTGATGGATTTCTACAGGGAGAATGCAGCCCATGAA 69 FBan0032104 FBgn0052104 CG32104 3 3L ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; ; GO:0016887 CG32104 CG32104 "CG14124, CG14123, CG14124, anon-69Ag" CDMC28036 4 17 24 DAC39-H19 14-CG32110-RA_1 CG32110 ACGCTGGACTAGAAAGGTGGATCTGTTTAGCATGGACCTCATACTTGTGCCTGTTCACCAAATGCTCGT 69 FBan0032110 FBgn0052110 CG32110 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; protein targeting; GO:0006605; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- CG32110 CG32110 anon-AE003540.1 CDMC28036 4 18 24 DAC39-H19 14-CG32110-RA_1 CG32110 ACGCTGGACTAGAAAGGTGGATCTGTTTAGCATGGACCTCATACTTGTGCCTGTTCACCAAATGCTCGT 69 FBan0032110 FBgn0052110 CG32110 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; protein targeting; GO:0006605; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- CG32110 CG32110 anon-AE003540.1 CDMC28037 4 19 24 DAC39-L07 8-CG32147-RA_1 CG32147 GCGTCGTCAGATCGAAAGCTCATTGTAGTCTCCGGATTTGGTCCATTTCTCGGTCACGAAGCGGTCAAC 69 FBan0032147 FBgn0047178 CG32147 3 3L proteolysis; GO:0006508 pyroglutamyl-peptidase I activity; GO:0004219 ; EC:3.4.19.3; ; GO:0004219 ; EC:3.4.19.3 CG32147 CG32147 BcDNA:RE07960 CDMC28037 4 20 24 DAC39-L07 8-CG32147-RA_1 CG32147 GCGTCGTCAGATCGAAAGCTCATTGTAGTCTCCGGATTTGGTCCATTTCTCGGTCACGAAGCGGTCAAC 69 FBan0032147 FBgn0047178 CG32147 3 3L proteolysis; GO:0006508 pyroglutamyl-peptidase I activity; GO:0004219 ; EC:3.4.19.3; ; GO:0004219 ; EC:3.4.19.3 CG32147 CG32147 BcDNA:RE07960 CDMC28038 4 21 24 DAC39-L19 16-CG32156-RE_2 CG32156 GGCGGGATCTTCGTACTCCACAAGCGATCGATATGTCAGCCCCTATTCGAGTAGTTATGATAAGGGTGT 69 FBan0032156 FBgn0005536 Mbs 3 3L dorsal closure; GO:0007391; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; regulation of eye photoreceptor development (sensu Endopterygota); GO:0045314; wing hair organization and biogenesis; GO:0035317 myosin binding; GO:0017022; ; GO:0017022; structural constituent of cytoskeleton; GO:0005200; myosin phosphatase activity; GO:0017018; ; GO:0017018; ; GO:0017018; ; GO:0005200; ; GO:0017022; ; GO:0017018; ; GO:0017018 myosin phosphatase complex; GO:0017023 Mbs Myosin binding subunit "CG5891, CG32156, CG5600, CG5891, l(3)72Dd: lethal(3)72Dd, l(3)03802, 0953/04, 0573/06, DMBS, DMYPT, Myosin phosphatase, MLC-phosphatase, DMbs, Mypt, l(3)j3B4, l(3)j7A1, l(3)S057306b, l(3)S057306, l(3)S005331b, l(3)S095304, lethal(3)72Dd, lethal (3) S057306b, lethal (3) S095304, l(3)72Dd, Myosin binding subunit" CDMC28038 4 22 24 DAC39-L19 16-CG32156-RE_2 CG32156 GGCGGGATCTTCGTACTCCACAAGCGATCGATATGTCAGCCCCTATTCGAGTAGTTATGATAAGGGTGT 69 FBan0032156 FBgn0005536 Mbs 3 3L dorsal closure; GO:0007391; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; regulation of eye photoreceptor development (sensu Endopterygota); GO:0045314; wing hair organization and biogenesis; GO:0035317 myosin binding; GO:0017022; ; GO:0017022; structural constituent of cytoskeleton; GO:0005200; myosin phosphatase activity; GO:0017018; ; GO:0017018; ; GO:0017018; ; GO:0005200; ; GO:0017022; ; GO:0017018; ; GO:0017018 myosin phosphatase complex; GO:0017023 Mbs Myosin binding subunit "CG5891, CG32156, CG5600, CG5891, l(3)72Dd: lethal(3)72Dd, l(3)03802, 0953/04, 0573/06, DMBS, DMYPT, Myosin phosphatase, MLC-phosphatase, DMbs, Mypt, l(3)j3B4, l(3)j7A1, l(3)S057306b, l(3)S057306, l(3)S005331b, l(3)S095304, lethal(3)72Dd, lethal (3) S057306b, lethal (3) S095304, l(3)72Dd, Myosin binding subunit" CDMC28039 4 23 24 DAC39-P07 3-CG32186-RA_1 CG32186 GGGCAATCGCAGTTCCTGGCACCTGGAAGACTATTCCCTATCACAGCCATCCTTGGAAGATGCATTTGA 69 FBan0032186 FBgn0052186 CG32186 3 3L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021 CG32186 CG32186 "CG5587, CG5944, CG5587, CG5944" CDMC28039 4 24 24 DAC39-P07 3-CG32186-RA_1 CG32186 GGGCAATCGCAGTTCCTGGCACCTGGAAGACTATTCCCTATCACAGCCATCCTTGGAAGATGCATTTGA 69 FBan0032186 FBgn0052186 CG32186 3 3L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021 CG32186 CG32186 "CG5587, CG5944, CG5587, CG5944" CDMC28040 4 25 24 DAC39-P19 2-CG32194-RB_2 CG32194 TGAACAGAGCTCCCTTTGCAATTCCCAAACTCCCACTGTCTGTGTCTGCAAGTGACAGAGATGGAGCGA 69 FBan0032194 FBgn0052194 CG32194 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32194 CG32194 BcDNA:RE06388 CDMC28040 4 26 24 DAC39-P19 2-CG32194-RB_2 CG32194 TGAACAGAGCTCCCTTTGCAATTCCCAAACTCCCACTGTCTGTGTCTGCAAGTGACAGAGATGGAGCGA 69 FBan0032194 FBgn0052194 CG32194 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32194 CG32194 BcDNA:RE06388 CDMC28041 4 1 25 DAC40-D07 12-CG9588-RA_3 CG9588 CCGAGGCGATGGATCACTGATGTAGCTTTGTGTTTAAGCTTTTTTCGAGTTGCCTGTGCACTCCTGCCC 69 FBan0009588 FBgn0038166 CG9588 3 3R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; protein binding; GO:0005515; ; GO:0008233 ; EC:3.4.-.-; ; GO:0005515 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG9588 CG9588 CDMC28041 4 2 25 DAC40-D07 12-CG9588-RA_3 CG9588 CCGAGGCGATGGATCACTGATGTAGCTTTGTGTTTAAGCTTTTTTCGAGTTGCCTGTGCACTCCTGCCC 69 FBan0009588 FBgn0038166 CG9588 3 3R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; protein binding; GO:0005515; ; GO:0008233 ; EC:3.4.-.-; ; GO:0005515 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG9588 CG9588 CDMC28042 4 3 25 DAC40-D19 1-CG9596-RA_2 CG9596 GGGCAAAGAAACACTGGAGCTGAAGTCTCTTTTGGACCAACCCTATGGCTCCACGTTCAAGATGTGCGT 69 FBan0009596 FBgn0031832 CG9596 2 2L protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of translational initiation; GO:0006446 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0008135" CG9596 CG9596 CDMC28042 4 4 25 DAC40-D19 1-CG9596-RA_2 CG9596 GGGCAAAGAAACACTGGAGCTGAAGTCTCTTTTGGACCAACCCTATGGCTCCACGTTCAAGATGTGCGT 69 FBan0009596 FBgn0031832 CG9596 2 2L protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of translational initiation; GO:0006446 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0008135" CG9596 CG9596 CDMC28043 4 5 25 DAC40-H07 6-CG9629-RA_3 CG9629 TGCCAGCGTTGTCCATCGCGAAACCTTTGCACCAATTGTGTACATCCTCAAAGCCAAAAACGTGGACCA 69 FBan0009629 FBgn0036857 CG9629 3 3L metabolism; GO:0008152 aldehyde dehydrogenase (NAD) activity; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3 CG9629 CG9629 CDMC28043 4 6 25 DAC40-H07 6-CG9629-RA_3 CG9629 TGCCAGCGTTGTCCATCGCGAAACCTTTGCACCAATTGTGTACATCCTCAAAGCCAAAAACGTGGACCA 69 FBan0009629 FBgn0036857 CG9629 3 3L metabolism; GO:0008152 aldehyde dehydrogenase (NAD) activity; GO:0004029 ; EC:1.2.1.3; ; GO:0004029 ; EC:1.2.1.3 CG9629 CG9629 CDMC28044 4 7 25 DAC40-H19 6-CG9641-RA_1 CG9641 GCGGTAGAGCCCATGAGGATGTAAAGAAGCAGAGGGTCCCAGAGCCGTCATGGACCTCGAAACAGAATA 69 FBan0009641 FBgn0031483 CG9641 2 2L CG9641 CG9641 CDMC28044 4 8 25 DAC40-H19 6-CG9641-RA_1 CG9641 GCGGTAGAGCCCATGAGGATGTAAAGAAGCAGAGGGTCCCAGAGCCGTCATGGACCTCGAAACAGAATA 69 FBan0009641 FBgn0031483 CG9641 2 2L CG9641 CG9641 CDMC28045 4 9 25 DAC40-L07 23-CG9674-RB_6 CG9674 AGAGCAGCTAATATCAAGTTTTGTGTGCGTGCATCGTCCTTAGCCTATAGTGCGAAATTCTTTAACGAT 69 FBan0009674 FBgn0036663 CG9674 3 3L amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; glutamate biosynthesis; GO:0006537; nitrogen compound metabolism; GO:0006807 monooxygenase activity; GO:0004497; ; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; glutamate synthase (NADPH) activity; GO:0004355 ; EC:1.4.1.13; ; GO:0004355 ; EC:1.4.1.13 CG9674 CG9674 CDMC28045 4 10 25 DAC40-L07 23-CG9674-RB_6 CG9674 AGAGCAGCTAATATCAAGTTTTGTGTGCGTGCATCGTCCTTAGCCTATAGTGCGAAATTCTTTAACGAT 69 FBan0009674 FBgn0036663 CG9674 3 3L amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; glutamate biosynthesis; GO:0006537; nitrogen compound metabolism; GO:0006807 monooxygenase activity; GO:0004497; ; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; glutamate synthase (NADPH) activity; GO:0004355 ; EC:1.4.1.13; ; GO:0004355 ; EC:1.4.1.13 CG9674 CG9674 CDMC28046 4 11 25 DAC40-L19 17-CG9691-RB_1 CG9691 ACAGCCCATTAATCTTATGATTACAGGGATTTTGCAATCGCTTGAAGGTCCCCTCCGTCTCGTTGCATA 69 FBan0009691 FBgn0030160 CG9691 X X CG9691 CG9691 "CT27394, BcDNA:RH12290" CDMC28046 4 12 25 DAC40-L19 17-CG9691-RB_1 CG9691 ACAGCCCATTAATCTTATGATTACAGGGATTTTGCAATCGCTTGAAGGTCCCCTCCGTCTCGTTGCATA 69 FBan0009691 FBgn0030160 CG9691 X X CG9691 CG9691 "CT27394, BcDNA:RH12290" CDMC28047 4 13 25 DAC40-P07 2-CG9720-RA_1 CG9720 AGCCAGGATCGGCCCTCTTTTGGTATAACTTGGACACGAAGGGTAACGATCATATGGGTTCCCTGCACA 69 FBan0009720 FBgn0039783 PH4alphaNE2 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE2 prolyl-4-hydroxylase-alpha NE2 "CG9720, CG9720, PH4alphaNE2, prolyl-4-hydroxylase-alpha NE2" CDMC28047 4 14 25 DAC40-P07 2-CG9720-RA_1 CG9720 AGCCAGGATCGGCCCTCTTTTGGTATAACTTGGACACGAAGGGTAACGATCATATGGGTTCCCTGCACA 69 FBan0009720 FBgn0039783 PH4alphaNE2 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE2 prolyl-4-hydroxylase-alpha NE2 "CG9720, CG9720, PH4alphaNE2, prolyl-4-hydroxylase-alpha NE2" CDMC28048 4 15 25 DAC40-P19 2-CG9734-RA_1 CG9734 AACGGAGCATAAACATGAACAGCGATGAGGTGCAACTGATCAAGAAGACCTGGGAAATCCCCGTGGCAA 69 FBan0009734 FBgn0027657 glob1 3 3R oxygen transport; GO:0015671 oxygen transporter activity; GO:0005344; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005344 glob1 globin 1 "CG9734, dmeglob1, Hb, Hemoglobin, DmeGlob1, Glob1" CDMC28048 4 16 25 DAC40-P19 2-CG9734-RA_1 CG9734 AACGGAGCATAAACATGAACAGCGATGAGGTGCAACTGATCAAGAAGACCTGGGAAATCCCCGTGGCAA 69 FBan0009734 FBgn0027657 glob1 3 3R oxygen transport; GO:0015671 oxygen transporter activity; GO:0005344; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005344 glob1 globin 1 "CG9734, dmeglob1, Hb, Hemoglobin, DmeGlob1, Glob1" CDMC28049 4 17 25 DAC41-D07 AutoBlank AutoBlank CDMC28049 4 18 25 DAC41-D07 AutoBlank AutoBlank CDMC28050 4 19 25 DAC41-D19 AutoBlank AutoBlank CDMC28050 4 20 25 DAC41-D19 AutoBlank AutoBlank CDMC28051 4 21 25 DAC41-H07 AutoBlank AutoBlank CDMC28051 4 22 25 DAC41-H07 AutoBlank AutoBlank CDMC28052 4 23 25 DAC41-H19 AutoBlank AutoBlank CDMC28052 4 24 25 DAC41-H19 AutoBlank AutoBlank CDMC28053 4 25 25 DAC41-L07 AutoBlank AutoBlank CDMC28053 4 26 25 DAC41-L07 AutoBlank AutoBlank CDMC28054 4 1 26 DAC41-L19 AutoBlank AutoBlank CDMC28054 4 2 26 DAC41-L19 AutoBlank AutoBlank CDMC28055 4 3 26 DAC41-P07 AutoBlank AutoBlank CDMC28055 4 4 26 DAC41-P07 AutoBlank AutoBlank CDMC28056 4 5 26 DAC41-P19 AutoBlank AutoBlank CDMC28056 4 6 26 DAC41-P19 AutoBlank AutoBlank CDMC28057 4 7 26 DAC42-D07 150mM NaPO4 Blank CDMC28057 4 8 26 DAC42-D07 150mM NaPO4 Blank CDMC28058 4 9 26 DAC42-D19 150mM NaPO4 Blank CDMC28058 4 10 26 DAC42-D19 150mM NaPO4 Blank CDMC28059 4 11 26 DAC42-H07 150mM NaPO4 Blank CDMC28059 4 12 26 DAC42-H07 150mM NaPO4 Blank CDMC28060 4 13 26 DAC42-H19 150mM NaPO4 Blank CDMC28060 4 14 26 DAC42-H19 150mM NaPO4 Blank CDMC28061 4 15 26 DAC42-L07 150mM NaPO4 Blank CDMC28061 4 16 26 DAC42-L07 150mM NaPO4 Blank CDMC28062 4 17 26 DAC42-L19 5uM MSP 5uM MSP CDMC28062 4 18 26 DAC42-L19 5uM MSP 5uM MSP CDMC28063 4 19 26 DAC42-P07 10uM MSP 10uM MSP CDMC28063 4 20 26 DAC42-P07 10uM MSP 10uM MSP CDMC28064 4 21 26 DAC42-P19 20uM MSP 20uM MSP CDMC28064 4 22 26 DAC42-P19 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC28065 1 1 1 DAC01-A06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28065 1 2 1 DAC01-A06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28066 1 3 1 DAC01-A18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28066 1 4 1 DAC01-A18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28067 1 5 1 DAC01-E06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28067 1 6 1 DAC01-E06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28068 1 7 1 DAC01-E18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28068 1 8 1 DAC01-E18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28069 1 9 1 DAC01-I06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28069 1 10 1 DAC01-I06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28070 1 11 1 DAC01-I18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28070 1 12 1 DAC01-I18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28071 1 13 1 DAC01-M06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28071 1 14 1 DAC01-M06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28072 1 15 1 DAC01-M18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28072 1 16 1 DAC01-M18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28073 1 17 1 DAC02-A06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28073 1 18 1 DAC02-A06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28074 1 19 1 DAC02-A18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28074 1 20 1 DAC02-A18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28075 1 21 1 DAC02-E06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28075 1 22 1 DAC02-E06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28076 1 23 1 DAC02-E18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28076 1 24 1 DAC02-E18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28077 1 25 1 DAC02-I06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28077 1 26 1 DAC02-I06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28078 1 1 2 DAC02-I18 AutoBlank AutoBlank CDMC28078 1 2 2 DAC02-I18 AutoBlank AutoBlank CDMC28079 1 3 2 DAC02-M06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28079 1 4 2 DAC02-M06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28080 1 5 2 DAC02-M18 AutoBlank AutoBlank CDMC28080 1 6 2 DAC02-M18 AutoBlank AutoBlank CDMC28081 1 7 2 DAC03-A06 8-CG32203-RA_1 CG32203 CAAGTGCGCGGTGTTATGGTTCCATTCAAGAACAGCGATATGGGAATGCTGGTATTACTGCCAAGGCCA 69 FBan0032203 FBgn0052203 CG32203 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG32203 CG32203 CDMC28081 1 8 2 DAC03-A06 8-CG32203-RA_1 CG32203 CAAGTGCGCGGTGTTATGGTTCCATTCAAGAACAGCGATATGGGAATGCTGGTATTACTGCCAAGGCCA 69 FBan0032203 FBgn0052203 CG32203 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG32203 CG32203 CDMC28082 1 9 2 DAC03-A18 10-CG32211-RA_2 CG32211 TGCCTCCCGACTGATGGCTCAAATCTGCAAGAACTTCAATACCCTAACCAACAATCTGCAAACCCGTGT 69 FBan0032211 FBgn0010417 Taf6 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003677; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf6 TBP-associated factor 6 "CG9348, CG32211, CG9348, TAFII60, TBP associated factor 60, Taf60, TBP-associated factor 60, p62, dTAF[[II]]60, Taf[[II]]60, TAF[[II]]60, dme-TAFII60, SR3-4B, Suppressor of Ras85D 3-4B, dTAF[[II]]62, dTAF62, TAF60, dTAF[[II]]262, TAF[[II]]60/62, TAF[[II]]62, TAF60/62, TAFII60(62), TFIID 62, d60, TFIID, dTAFII62, TAF6, TAF[[II]], taf60, dmTAF6, TAF, Taf62, TBP-associated factor 60kD" CDMC28082 1 10 2 DAC03-A18 10-CG32211-RA_2 CG32211 TGCCTCCCGACTGATGGCTCAAATCTGCAAGAACTTCAATACCCTAACCAACAATCTGCAAACCCGTGT 69 FBan0032211 FBgn0010417 Taf6 3 3L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0003677; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf6 TBP-associated factor 6 "CG9348, CG32211, CG9348, TAFII60, TBP associated factor 60, Taf60, TBP-associated factor 60, p62, dTAF[[II]]60, Taf[[II]]60, TAF[[II]]60, dme-TAFII60, SR3-4B, Suppressor of Ras85D 3-4B, dTAF[[II]]62, dTAF62, TAF60, dTAF[[II]]262, TAF[[II]]60/62, TAF[[II]]62, TAF60/62, TAFII60(62), TFIID 62, d60, TFIID, dTAFII62, TAF6, TAF[[II]], taf60, dmTAF6, TAF, Taf62, TBP-associated factor 60kD" CDMC28083 1 11 2 DAC03-E06 23-CG32245-RA_7 CG32245 CTGAACCCACGCTAACAGATGAAATCAACTAGTCAGCAACGTTCGTAGGTCCAAAATACGAATGCCAAA 69 FBan0032245 FBgn0052245 CG32245 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG32245 CG32245 "CG7468, CG13718, CG7468" CDMC28083 1 12 2 DAC03-E06 23-CG32245-RA_7 CG32245 CTGAACCCACGCTAACAGATGAAATCAACTAGTCAGCAACGTTCGTAGGTCCAAAATACGAATGCCAAA 69 FBan0032245 FBgn0052245 CG32245 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG32245 CG32245 "CG7468, CG13718, CG7468" CDMC28084 1 13 2 DAC03-E18 14-CG32251-RA_1 CG32251 CGACGAGGAAAGTGACGCAGAGCCAGTAGAGGAAATTCCGGAAACCTTTGTAGACTACGATTCCGAGGA 69 FBan0032251 FBgn0052251 CG32251 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32251 CG32251 "CG1326, CG1326" CDMC28084 1 14 2 DAC03-E18 14-CG32251-RA_1 CG32251 CGACGAGGAAAGTGACGCAGAGCCAGTAGAGGAAATTCCGGAAACCTTTGTAGACTACGATTCCGAGGA 69 FBan0032251 FBgn0052251 CG32251 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32251 CG32251 "CG1326, CG1326" CDMC28085 1 15 2 DAC03-I06 2-CG3227-RA_2 CG3227 CCCGCGGCAGAACATAAAACTACCAGCCAAACCCCAAGTCAAAGCCCGTAATGGCAGTTTTACCGATCT 69 FBan0003227 FBgn0031434 insv 2 2L sensory organ development; GO:0007423 insv insensitive "CG3227, BcDNA:RE55538, insensitive" CDMC28085 1 16 2 DAC03-I06 2-CG3227-RA_2 CG3227 CCCGCGGCAGAACATAAAACTACCAGCCAAACCCCAAGTCAAAGCCCGTAATGGCAGTTTTACCGATCT 69 FBan0003227 FBgn0031434 insv 2 2L sensory organ development; GO:0007423 insv insensitive "CG3227, BcDNA:RE55538, insensitive" CDMC28086 1 17 2 DAC03-I18 3-CG32301-RA_4 CG32301 CCACCATCGAGAACTACGAGGCGGATAAGTCGGGTCTGCGAGCTCTTCACGAGATGATCTGCTACTTCG 69 FBan0032301 FBgn0052301 CG32301 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32301 CG32301 "CG8970, CG8970, AC" CDMC28086 1 18 2 DAC03-I18 3-CG32301-RA_4 CG32301 CCACCATCGAGAACTACGAGGCGGATAAGTCGGGTCTGCGAGCTCTTCACGAGATGATCTGCTACTTCG 69 FBan0032301 FBgn0052301 CG32301 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cAMP biosynthesis; GO:0006171; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32301 CG32301 "CG8970, CG8970, AC" CDMC28087 1 19 2 DAC03-M06 23-CG32345-RA_13 CG32345 GGTGCAACAATACAACAACTGAGGAGAAGACTGCGAGAACAACAAAAAAGAATTCTTTACGAGCCTCGC 69 FBan0032345 FBgn0052345 CG32345 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32345 CG32345 "SD03580, BcDNA:SD03580" CDMC28087 1 20 2 DAC03-M06 23-CG32345-RA_13 CG32345 GGTGCAACAATACAACAACTGAGGAGAAGACTGCGAGAACAACAAAAAAGAATTCTTTACGAGCCTCGC 69 FBan0032345 FBgn0052345 CG32345 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32345 CG32345 "SD03580, BcDNA:SD03580" CDMC28088 1 21 2 DAC03-M18 2-CG32354-RA_2 CG32354 GCTCATCGGATGGCAATGTATACAACTCCACGTGCGAGATGAAGCTGAAGACGTGTGGACAGGGTGTGG 69 FBan0032354 FBgn0052354 CG32354 3 3L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 extracellular region; GO:0005576 CG32354 CG32354 "CG17355, CG7027, CG7159, CG17355, CK01670, BEST:CK01670" CDMC28088 1 22 2 DAC03-M18 2-CG32354-RA_2 CG32354 GCTCATCGGATGGCAATGTATACAACTCCACGTGCGAGATGAAGCTGAAGACGTGTGGACAGGGTGTGG 69 FBan0032354 FBgn0052354 CG32354 3 3L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 extracellular region; GO:0005576 CG32354 CG32354 "CG17355, CG7027, CG7159, CG17355, CK01670, BEST:CK01670" CDMC28089 1 23 2 DAC04-A06 3-CG2919-RA_2 CG2919 CCCAGTCCGAAATCAAACTCAGTTTCCCCGTCTGATCCATCGCCCAAAGAGCTCACCCAGAATCGGATA 69 FBan0002919 FBgn0037348 CG2919 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG2919 CG2919 CDMC28089 1 24 2 DAC04-A06 3-CG2919-RA_2 CG2919 CCCAGTCCGAAATCAAACTCAGTTTCCCCGTCTGATCCATCGCCCAAAGAGCTCACCCAGAATCGGATA 69 FBan0002919 FBgn0037348 CG2919 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG2919 CG2919 CDMC28090 1 25 2 DAC04-A18 17-CG2934-RA_1 CG2934 GCATCTCCGAGCAGGATCTGGATGAGATGAACATCGAGATCATTCGTAACACCCTTTACAAGGCCTACC 69 FBan0002934 FBgn0028665 VhaAC39 X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 VhaAC39 VhaAC39 "CG2934, CG2934, vhaAC39, V-ATPase, anon-EST:GressD5" CDMC28090 1 26 2 DAC04-A18 17-CG2934-RA_1 CG2934 GCATCTCCGAGCAGGATCTGGATGAGATGAACATCGAGATCATTCGTAACACCCTTTACAAGGCCTACC 69 FBan0002934 FBgn0028665 VhaAC39 X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 VhaAC39 VhaAC39 "CG2934, CG2934, vhaAC39, V-ATPase, anon-EST:GressD5" CDMC28091 1 1 3 DAC04-E06 1-CG2980-RA_2 CG2980 CCTCAAGGCCAAGGACTACGGAAAACCCTTCTGTTGGCTGCAAAGTATGTGCTCGATTGCAACCGTCAA 69 FBan0002980 FBgn0034939 thoc5 2 2R mRNA export from nucleus; GO:0006406 thoc5 thoc5 "CG2980, THOC5" CDMC28091 1 2 3 DAC04-E06 1-CG2980-RA_2 CG2980 CCTCAAGGCCAAGGACTACGGAAAACCCTTCTGTTGGCTGCAAAGTATGTGCTCGATTGCAACCGTCAA 69 FBan0002980 FBgn0034939 thoc5 2 2R mRNA export from nucleus; GO:0006406 thoc5 thoc5 "CG2980, THOC5" CDMC28092 1 3 3 DAC04-E18 12-CG2988-RA_1 CG2988 AGAGACCCTTTCTCTCCATCCACACTTCTCTCTCAAGATCCGTGCCAAATCCTTGCGAAGTTTCGAGGT 69 FBan0002988 FBgn0000576 ems 3 3R "anterior head segmentation; GO:0035288; axonogenesis; GO:0007409; brain development; GO:0007420; brain segmentation; GO:0035284; embryonic development (sensu Insecta); GO:0001700; pattern specification; GO:0007389; regulation of transcription, DNA-dependent; GO:0006355; specification of segmental identity, antennal segment; GO:0007383; specification of segmental identity, mandibular segment; GO:0042305; spiracle morphogenesis; GO:0035277; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 ems empty spiracles "CG2988, E4, W13, ant, antenna, empty spiracles" CDMC28092 1 4 3 DAC04-E18 12-CG2988-RA_1 CG2988 AGAGACCCTTTCTCTCCATCCACACTTCTCTCTCAAGATCCGTGCCAAATCCTTGCGAAGTTTCGAGGT 69 FBan0002988 FBgn0000576 ems 3 3R "anterior head segmentation; GO:0035288; axonogenesis; GO:0007409; brain development; GO:0007420; brain segmentation; GO:0035284; embryonic development (sensu Insecta); GO:0001700; pattern specification; GO:0007389; regulation of transcription, DNA-dependent; GO:0006355; specification of segmental identity, antennal segment; GO:0007383; specification of segmental identity, mandibular segment; GO:0042305; spiracle morphogenesis; GO:0035277; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 ems empty spiracles "CG2988, E4, W13, ant, antenna, empty spiracles" CDMC28093 1 5 3 DAC04-I06 22-CG30016-RA_1 CG30016 CGGAGCGCAATGTGAGGACACTTTATCCAGCAATTGACTTGATTGTGGATTGCAGTGAGAATCAGAACT 69 FBan0030016 FBgn0050016 CG30016 2 2R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; steroid binding; GO:0005496; ; GO:0005496 CG30016 CG30016 anon-AE003828.1 CDMC28093 1 6 3 DAC04-I06 22-CG30016-RA_1 CG30016 CGGAGCGCAATGTGAGGACACTTTATCCAGCAATTGACTTGATTGTGGATTGCAGTGAGAATCAGAACT 69 FBan0030016 FBgn0050016 CG30016 2 2R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; steroid binding; GO:0005496; ; GO:0005496 CG30016 CG30016 anon-AE003828.1 CDMC28094 1 7 3 DAC04-I18 15-CG30021-RA_2 CG30021 CCATGTGGGTGCAGTAGATCGGTTGCCAAATGTGGACAAGCATTTCATGCAGTTTGTTGATGAACACCA 69 FBan0030021 FBgn0050021 skf 2 2R asymmetric protein localization; GO:0008105; protein targeting; GO:0006605; signal transduction; GO:0007165 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 plasma membrane; GO:0005886 skf skiff "CG13219, CG18338, CG30021, CG13219, CG18338" CDMC28094 1 8 3 DAC04-I18 15-CG30021-RA_2 CG30021 CCATGTGGGTGCAGTAGATCGGTTGCCAAATGTGGACAAGCATTTCATGCAGTTTGTTGATGAACACCA 69 FBan0030021 FBgn0050021 skf 2 2R asymmetric protein localization; GO:0008105; protein targeting; GO:0006605; signal transduction; GO:0007165 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 plasma membrane; GO:0005886 skf skiff "CG13219, CG18338, CG30021, CG13219, CG18338" CDMC28095 1 9 3 DAC04-M06 14-CG30054-RB_1 CG30054 TGGGTACGTGGAGTGGGATGTATTGGGATGTATCAAGGATACAATGTGCGTATATCCACAGGCGCATGC 69 FBan0030054 FBgn0050054 CG30054 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; protein amino acid ADP-ribosylation; GO:0006471; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; ; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 CG30054 CG30054 CDMC28095 1 10 3 DAC04-M06 14-CG30054-RB_1 CG30054 TGGGTACGTGGAGTGGGATGTATTGGGATGTATCAAGGATACAATGTGCGTATATCCACAGGCGCATGC 69 FBan0030054 FBgn0050054 CG30054 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; protein amino acid ADP-ribosylation; GO:0006471; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; ; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 CG30054 CG30054 CDMC28096 1 11 3 DAC04-M18 2-CG30069-RA_1 CG30069 AGCCGGGTTCTGTCTGGAAGCACAGTTGGACATAACATCAGCGAAGATTCAACATCGCGAACCGTCTCA 69 FBan0030069 FBgn0050069 CG30069 2 2R cell cycle; GO:0007049; cell proliferation; GO:0008283; metabolism; GO:0008152; regulation of progression through cell cycle; GO:0000074 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30069 CG30069 "CG8381, CG13017, CG8381" CDMC28096 1 12 3 DAC04-M18 2-CG30069-RA_1 CG30069 AGCCGGGTTCTGTCTGGAAGCACAGTTGGACATAACATCAGCGAAGATTCAACATCGCGAACCGTCTCA 69 FBan0030069 FBgn0050069 CG30069 2 2R cell cycle; GO:0007049; cell proliferation; GO:0008283; metabolism; GO:0008152; regulation of progression through cell cycle; GO:0000074 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30069 CG30069 "CG8381, CG13017, CG8381" CDMC28097 1 13 3 DAC05-A06 2-CG17579-RA_1 CG17579 CGCTACAGTGAACCACCAGAGCCATGCCTACTATAGTTGGGAGTCCACTGTTTGTCTGTGGGAGGTGG 68 FBan0017579 FBgn0003326 sca 2 2R bristle morphogenesis; GO:0008407; defense response; GO:0006952; defense response to bacteria; GO:0042742; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; female meiosis chromosome segregation; GO:0016321; lateral inhibition; GO:0046331; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461 signal transducer activity; GO:0004871; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576; fibrinogen complex; GO:0005577 sca scabrous "CG17579, CG17579, clone 38, Sca1b, Sca, mAb sca1, anon-EST:Liang-38" CDMC28097 1 14 3 DAC05-A06 2-CG17579-RA_1 CG17579 CGCTACAGTGAACCACCAGAGCCATGCCTACTATAGTTGGGAGTCCACTGTTTGTCTGTGGGAGGTGG 68 FBan0017579 FBgn0003326 sca 2 2R bristle morphogenesis; GO:0008407; defense response; GO:0006952; defense response to bacteria; GO:0042742; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; female meiosis chromosome segregation; GO:0016321; lateral inhibition; GO:0046331; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461 signal transducer activity; GO:0004871; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576; fibrinogen complex; GO:0005577 sca scabrous "CG17579, CG17579, clone 38, Sca1b, Sca, mAb sca1, anon-EST:Liang-38" CDMC28098 1 15 3 DAC05-A18 3-CG17999-RA_3 CG17999 CACAAGGTGACCTTTCTGTTCCTGGCCTCCCATCAGATTGCCCTGCTATCCAAGCATGACAGTGATGT 68 FBan0017999 FBgn0034552 CG17999 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- CG17999 CG17999 CDMC28098 1 16 3 DAC05-A18 3-CG17999-RA_3 CG17999 CACAAGGTGACCTTTCTGTTCCTGGCCTCCCATCAGATTGCCCTGCTATCCAAGCATGACAGTGATGT 68 FBan0017999 FBgn0034552 CG17999 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- CG17999 CG17999 CDMC28099 1 17 3 DAC05-E06 16-CG2021-RA_1 CG2021 GACGGACGGAACTTCATCGGGACACTCAAGGGATTCGACCAGACCATCAATATCATCATAGACGAGTG 68 FBan0002021 FBgn0035271 CG2021 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG2021 CG2021 CDMC28099 1 18 3 DAC05-E06 16-CG2021-RA_1 CG2021 GACGGACGGAACTTCATCGGGACACTCAAGGGATTCGACCAGACCATCAATATCATCATAGACGAGTG 68 FBan0002021 FBgn0035271 CG2021 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG2021 CG2021 CDMC28100 1 19 3 DAC05-E18 2-CG2113-RA_1 CG2113 CGACAAGTTGCTTGCCACTCTGTTGGGTGCCCGAAAGTATGGGTTCGTAGACTTTAGCGGAGAAACCC 68 FBan0002113 FBgn0035384 CG2113 3 3L CG2113 CG2113 BcDNA:AT18037 CDMC28100 1 20 3 DAC05-E18 2-CG2113-RA_1 CG2113 CGACAAGTTGCTTGCCACTCTGTTGGGTGCCCGAAAGTATGGGTTCGTAGACTTTAGCGGAGAAACCC 68 FBan0002113 FBgn0035384 CG2113 3 3L CG2113 CG2113 BcDNA:AT18037 CDMC28101 1 21 3 DAC05-I06 3-CG30072-RA_1 CG30072 ACCAACACAGTTGTGGACGGAGCTATTCATCCTGACAATGCCCGACTCATGCTGGAGAAGCTTTTCGG 68 FBan0030072 FBgn0050072 Obp50c 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50c Odorant-binding protein 50c "CG30072, CG30072, Odorant-binding protein 50c" CDMC28101 1 22 3 DAC05-I06 3-CG30072-RA_1 CG30072 ACCAACACAGTTGTGGACGGAGCTATTCATCCTGACAATGCCCGACTCATGCTGGAGAAGCTTTTCGG 68 FBan0030072 FBgn0050072 Obp50c 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50c Odorant-binding protein 50c "CG30072, CG30072, Odorant-binding protein 50c" CDMC28102 1 23 3 DAC05-I18 15-CG30280-RA_1 CG30280 ACGGATACAGGGTAACCCAAATGATGATAAGACCCAAGTGCCGAATGATACCAGTGACTCAGCGGTGA 68 FBan0030280 FBgn0050280 CG30280 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30280 CG30280 CG6676 CDMC28102 1 24 3 DAC05-I18 15-CG30280-RA_1 CG30280 ACGGATACAGGGTAACCCAAATGATGATAAGACCCAAGTGCCGAATGATACCAGTGACTCAGCGGTGA 68 FBan0030280 FBgn0050280 CG30280 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30280 CG30280 CG6676 CDMC28103 1 25 3 DAC05-M06 3-CG31247-RC_2 CG31247 GCCTCCAACTCCAAGATCATTGCCATCAAAGCGAAGAACCAAAAGCGCAGGATATCCAAACGGGCTGC 68 FBan0031247 FBgn0038554 tinc 3 3R regulation of eye photoreceptor cell development; GO:0042478 plasma membrane; GO:0005886 tinc tincar "CG31247, CG14319, CG14320, CG7723, Tincar, tincar" CDMC28103 1 26 3 DAC05-M06 3-CG31247-RC_2 CG31247 GCCTCCAACTCCAAGATCATTGCCATCAAAGCGAAGAACCAAAAGCGCAGGATATCCAAACGGGCTGC 68 FBan0031247 FBgn0038554 tinc 3 3R regulation of eye photoreceptor cell development; GO:0042478 plasma membrane; GO:0005886 tinc tincar "CG31247, CG14319, CG14320, CG7723, Tincar, tincar" CDMC28104 1 1 4 DAC05-M18 2-CG31313-RA_2 CG31313 GCTGGATGGAGATGACTTATCCAAGGCTAAGGAGCTCTTGGACACAACGCTCGCCAAACTTGCCACAG 68 FBan0031313 FBgn0051313 CG31313 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG31313 CG31313 BcDNA:RH02566 CDMC28104 1 2 4 DAC05-M18 2-CG31313-RA_2 CG31313 GCTGGATGGAGATGACTTATCCAAGGCTAAGGAGCTCTTGGACACAACGCTCGCCAAACTTGCCACAG 68 FBan0031313 FBgn0051313 CG31313 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG31313 CG31313 BcDNA:RH02566 CDMC28105 1 3 4 DAC06-A06 5-CG5222-RA_2 CG5222 TCCTTCGGGCGTTGTCTATGACCTCTTTGAGTGCCTCACCCAGAATTTGGAAAACGCTGGCCTAAACAA 69 FBan0005222 FBgn0036570 CG5222 3 3L mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG5222 CG5222 CDMC28105 1 4 4 DAC06-A06 5-CG5222-RA_2 CG5222 TCCTTCGGGCGTTGTCTATGACCTCTTTGAGTGCCTCACCCAGAATTTGGAAAACGCTGGCCTAAACAA 69 FBan0005222 FBgn0036570 CG5222 3 3L mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG5222 CG5222 CDMC28106 1 5 4 DAC06-A18 15-CG5235-RA_2 CG5235 CCGGAACGTTGCACTCACATCAAGCTGGTCGCACAATTAGTCTTCGACATGTTCGATCTGGTAAGGAGT 69 FBan0005235 FBgn0036565 CG5235 3 3L catecholamine metabolism; GO:0006584; metabolism; GO:0008152; synaptic transmission; GO:0007268 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1; copper ion binding; GO:0005507; ; GO:0005507 CG5235 CG5235 CDMC28106 1 6 4 DAC06-A18 15-CG5235-RA_2 CG5235 CCGGAACGTTGCACTCACATCAAGCTGGTCGCACAATTAGTCTTCGACATGTTCGATCTGGTAAGGAGT 69 FBan0005235 FBgn0036565 CG5235 3 3L catecholamine metabolism; GO:0006584; metabolism; GO:0008152; synaptic transmission; GO:0007268 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1; copper ion binding; GO:0005507; ; GO:0005507 CG5235 CG5235 CDMC28107 1 7 4 DAC06-E06 3-CG5272-RA_2 CG5272 CGCACGCGTTCCGTATTTTCGCCCACAAGTCAAAGTACCCTTATAAATGGGGAGACCAGGCTACTGGGA 69 FBgn0036453 CDMC28107 1 8 4 DAC06-E06 3-CG5272-RA_2 CG5272 CGCACGCGTTCCGTATTTTCGCCCACAAGTCAAAGTACCCTTATAAATGGGGAGACCAGGCTACTGGGA 69 FBgn0036453 CDMC28108 1 9 4 DAC06-E18 2-CG5287-RA_1 CG5287 TGCTGATGGGATTCCAGGTGCTGTGTACACTGATTGCCCTGACCATACGATATCCACTGGCCAACTACT 69 FBan0005287 FBgn0032477 CG5287 2 2L lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 "UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; GO:0003975 ; EC:2.7.8.15; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0003975 ; EC:2.7.8.15" membrane; GO:0016020 CG5287 CG5287 CDMC28108 1 10 4 DAC06-E18 2-CG5287-RA_1 CG5287 TGCTGATGGGATTCCAGGTGCTGTGTACACTGATTGCCCTGACCATACGATATCCACTGGCCAACTACT 69 FBan0005287 FBgn0032477 CG5287 2 2L lipid metabolism; GO:0006629; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 "UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; GO:0003975 ; EC:2.7.8.15; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0003975 ; EC:2.7.8.15" membrane; GO:0016020 CG5287 CG5287 CDMC28109 1 11 4 DAC06-I06 23-CG5334-RA_1 CG5334 TCTTCTCGGCAAAATCTTCATAAAATCTGTCGCTATCGATTGCGTGGAAATTGTCGTTTCGATGATTTA 69 FBan0005334 FBgn0030577 CG5334 X X CG5334 CG5334 CDMC28109 1 12 4 DAC06-I06 23-CG5334-RA_1 CG5334 TCTTCTCGGCAAAATCTTCATAAAATCTGTCGCTATCGATTGCGTGGAAATTGTCGTTTCGATGATTTA 69 FBan0005334 FBgn0030577 CG5334 X X CG5334 CG5334 CDMC28110 1 13 4 DAC06-I18 2-CG5347-RA_1 CG5347 TGCACCAGAGTTTGTTCCCAGGTACAAAGCCAATTCTGCCGATTTCCAAGCAACTGAAGGTGTCCAGGA 69 FBan0005347 FBgn0030578 CG5347 X X CG5347 CG5347 CDMC28110 1 14 4 DAC06-I18 2-CG5347-RA_1 CG5347 TGCACCAGAGTTTGTTCCCAGGTACAAAGCCAATTCTGCCGATTTCCAAGCAACTGAAGGTGTCCAGGA 69 FBan0005347 FBgn0030578 CG5347 X X CG5347 CG5347 CDMC28111 1 15 4 DAC06-M06 14-CG5384-RA_1 CG5384 AATTCCCCATTGACTTCGATGCCTTTGAGTTGTGTACCCCCGAATTGCAAAACAAGCTCTGCCCAATGC 69 FBan0005384 FBgn0032216 CG5384 2 2L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 "ubiquitin-specific protease activity; GO:0004843; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15" CG5384 CG5384 CDMC28111 1 16 4 DAC06-M06 14-CG5384-RA_1 CG5384 AATTCCCCATTGACTTCGATGCCTTTGAGTTGTGTACCCCCGAATTGCAAAACAAGCTCTGCCCAATGC 69 FBan0005384 FBgn0032216 CG5384 2 2L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 "ubiquitin-specific protease activity; GO:0004843; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15" CG5384 CG5384 CDMC28112 1 17 4 DAC06-M18 2-CG5397-RA_1 CG5397 TCCCCTGCTGACTGGAGTCACCAAGCACGAGACAGCAAATTCCGTCACTGTGGAAACGATAGAAAAGGT 69 FBan0005397 FBgn0031327 CG5397 2 2L defense response; GO:0006952; ectoderm development; GO:0007398 "sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004772 ; EC:2.3.1.26" CG5397 CG5397 CT16527 CDMC28112 1 18 4 DAC06-M18 2-CG5397-RA_1 CG5397 TCCCCTGCTGACTGGAGTCACCAAGCACGAGACAGCAAATTCCGTCACTGTGGAAACGATAGAAAAGGT 69 FBan0005397 FBgn0031327 CG5397 2 2L defense response; GO:0006952; ectoderm development; GO:0007398 "sterol O-acyltransferase activity; GO:0004772 ; EC:2.3.1.26; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004772 ; EC:2.3.1.26" CG5397 CG5397 CT16527 CDMC28113 1 19 4 DAC07-A06 2-CG9743-RA_1 CG9743 AGAGAGATGCCTACACGTGGGCCCTTGATCACAGGATACATCACAAGTTCTCGGAGACAGACGCC 65 FBan0009743 FBgn0039756 CG9743 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG9743 CG9743 anon-WO0118547.264 CDMC28113 1 20 4 DAC07-A06 2-CG9743-RA_1 CG9743 AGAGAGATGCCTACACGTGGGCCCTTGATCACAGGATACATCACAAGTTCTCGGAGACAGACGCC 65 FBan0009743 FBgn0039756 CG9743 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG9743 CG9743 anon-WO0118547.264 CDMC28114 1 21 4 DAC07-A18 3-CG9777-RA_1 CG9777 AATGGGAAGAGCAGCGTCGTCTTAAAGCCGAAAACTCGCAAACCACAGTGGACCAGATGACTCCG 65 FBan0009777 FBgn0030764 CG9777 X X CG9777 CG9777 CDMC28114 1 22 4 DAC07-A18 3-CG9777-RA_1 CG9777 AATGGGAAGAGCAGCGTCGTCTTAAAGCCGAAAACTCGCAAACCACAGTGGACCAGATGACTCCG 65 FBan0009777 FBgn0030764 CG9777 X X CG9777 CG9777 CDMC28115 1 23 4 DAC07-E06 3-CG9891-RA_2 CG9891 CATACTCTCTGGCCTACGTCACAAACGAAATGCGACCGAACGGGACTCTCCTGCAGGCTTATCCC 65 FBan0009891 FBgn0034856 yellow-d2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-d2 yellow-d2 "CG9891, CG9891, CT27880" CDMC28115 1 24 4 DAC07-E06 3-CG9891-RA_2 CG9891 CATACTCTCTGGCCTACGTCACAAACGAAATGCGACCGAACGGGACTCTCCTGCAGGCTTATCCC 65 FBan0009891 FBgn0034856 yellow-d2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-d2 yellow-d2 "CG9891, CG9891, CT27880" CDMC28116 1 25 4 DAC07-E18 12-CG9929-RA_4 CG9929 GTCGAGGTGGCCAAATGTGAGCTGGTAATCGGAGAGCTTGGGATGTACTACAAGCCGGATGAGCA 65 FBan0009929 FBgn0038188 Art9 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art9 Arginine methyltransferase 9 "CG9929, CG9929, DART9, Arginine methyltransferase 9" CDMC28116 1 26 4 DAC07-E18 12-CG9929-RA_4 CG9929 GTCGAGGTGGCCAAATGTGAGCTGGTAATCGGAGAGCTTGGGATGTACTACAAGCCGGATGAGCA 65 FBan0009929 FBgn0038188 Art9 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art9 Arginine methyltransferase 9 "CG9929, CG9929, DART9, Arginine methyltransferase 9" CDMC28117 1 1 5 DAC07-I06 23-CR30505-RA_1 CR30505 CTTTGATTACTTAAGGAAACATTTGCCAGGTTGCAATAGATCGTTGAACAGGTTGAAGAAAAAAC 65 FBan0030505 FBgn0050505 CR30505 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30505 CR30505 "tRNA[Thr][[3]], AE002787.trna24-ThrTGT, CR30261, tRNA:T:TGT:AE002787-a, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC28117 1 2 5 DAC07-I06 23-CR30505-RA_1 CR30505 CTTTGATTACTTAAGGAAACATTTGCCAGGTTGCAATAGATCGTTGAACAGGTTGAAGAAAAAAC 65 FBan0030505 FBgn0050505 CR30505 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30505 CR30505 "tRNA[Thr][[3]], AE002787.trna24-ThrTGT, CR30261, tRNA:T:TGT:AE002787-a, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC28118 1 3 5 DAC07-I18 5-CR31396-RA_1 CR31396 AGAGGTTAAGGCGTTGGACTGCTAATCCAATGTGCTCTGCACGCGTGGGTTCGAATCCCATCCTC 65 FBan0031396 FBgn0011970 tRNA:S2b:86A 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:S2b:86A transfer RNA:ser2b:86A "tRNA[Ser][[2b]], AE002708.trna56-SerGCT, tRNA:ser2b:86A, tRNA:S2b, tRNA:ser2b, tRNA:S, tRNA:ser, CR31396, tRNA:S:GCT:AE002708-f, transfer RNA:ser2b, transfer RNA:ser" CDMC28118 1 4 5 DAC07-I18 5-CR31396-RA_1 CR31396 AGAGGTTAAGGCGTTGGACTGCTAATCCAATGTGCTCTGCACGCGTGGGTTCGAATCCCATCCTC 65 FBan0031396 FBgn0011970 tRNA:S2b:86A 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:S2b:86A transfer RNA:ser2b:86A "tRNA[Ser][[2b]], AE002708.trna56-SerGCT, tRNA:ser2b:86A, tRNA:S2b, tRNA:ser2b, tRNA:S, tRNA:ser, CR31396, tRNA:S:GCT:AE002708-f, transfer RNA:ser2b, transfer RNA:ser" CDMC28119 1 5 5 DAC07-M06 23-CR32887-RA_1 CR32887 CATGATGATTTTATTCGTACCGCCCCAGTCTGAAGAGACGTGTTGATTGGTTATTTATACTGATA 65 FBan0032887 FBgn0063381 snoRNA:U31:54Ea 2 2R snoRNA:U31:54Ea snoRNA:U31:54Ea "U31snoRNA, CR32887" CDMC28119 1 6 5 DAC07-M06 23-CR32887-RA_1 CR32887 CATGATGATTTTATTCGTACCGCCCCAGTCTGAAGAGACGTGTTGATTGGTTATTTATACTGATA 65 FBan0032887 FBgn0063381 snoRNA:U31:54Ea 2 2R snoRNA:U31:54Ea snoRNA:U31:54Ea "U31snoRNA, CR32887" CDMC28120 1 7 5 DAC07-M18 23-CR32899-RA_1 CR32899 ATTATGATGATTAAGGATACCGCCCCAGTCGGAGAAATTATGTCGATTGGTTAAACATACTGACT 65 FBan0032899 FBgn0063378 snoRNA:U31:54Ed 2 2R snoRNA:U31:54Ed snoRNA:U31:54Ed "U31snoRNA, CR32899" CDMC28120 1 8 5 DAC07-M18 23-CR32899-RA_1 CR32899 ATTATGATGATTAAGGATACCGCCCCAGTCGGAGAAATTATGTCGATTGGTTAAACATACTGACT 65 FBan0032899 FBgn0063378 snoRNA:U31:54Ed 2 2R snoRNA:U31:54Ed snoRNA:U31:54Ed "U31snoRNA, CR32899" CDMC28121 1 9 5 DAC08-A06 23-CG5596-RB_1 CG5596 CAACACCAACAAACTTTTAGCGACAACCATTCTCCATAGATGTTATATTCATCGCTAACTCTCTCTATC 69 FBan0005596 FBgn0002772 Mlc1 3 3R mesoderm development; GO:0007498; muscle contraction; GO:0006936; proteolysis; GO:0006508 "NOT calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; microfilament motor activity; GO:0000146; ; GO:0042623; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0000146; ; GO:0005509; ; GO:0004197 ; EC:3.4.22.-" muscle myosin; GO:0005859; myosin; GO:0016459 Mlc1 Myosin alkali light chain 1 "CG5596, CG5596, MLC-ALK, MLC1, Myosin Light Chain-1, LC1, mlc-alk, Mlc-1, mlcl, Mlci, MlcI, ELC, DmMLC1, myosin light chain, mlc1, mlc, FBgn0002772" CDMC28121 1 10 5 DAC08-A06 23-CG5596-RB_1 CG5596 CAACACCAACAAACTTTTAGCGACAACCATTCTCCATAGATGTTATATTCATCGCTAACTCTCTCTATC 69 FBan0005596 FBgn0002772 Mlc1 3 3R mesoderm development; GO:0007498; muscle contraction; GO:0006936; proteolysis; GO:0006508 "NOT calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; microfilament motor activity; GO:0000146; ; GO:0042623; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0000146; ; GO:0005509; ; GO:0004197 ; EC:3.4.22.-" muscle myosin; GO:0005859; myosin; GO:0016459 Mlc1 Myosin alkali light chain 1 "CG5596, CG5596, MLC-ALK, MLC1, Myosin Light Chain-1, LC1, mlc-alk, Mlc-1, mlcl, Mlci, MlcI, ELC, DmMLC1, myosin light chain, mlc1, mlc, FBgn0002772" CDMC28122 1 11 5 DAC08-A18 16-CG5609-RA_1 CG5609 CGCATGGCTCCTAGCTTAAGACCAGATGAAAGGGCGAGAATGGACAGATTCATAAGTGGATATACGGGA 69 FBan0005609 FBgn0038838 TotB 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotB Turandot B "CG5609, tot, BcDNA:LP06769" CDMC28122 1 12 5 DAC08-A18 16-CG5609-RA_1 CG5609 CGCATGGCTCCTAGCTTAAGACCAGATGAAAGGGCGAGAATGGACAGATTCATAAGTGGATATACGGGA 69 FBan0005609 FBgn0038838 TotB 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotB Turandot B "CG5609, tot, BcDNA:LP06769" CDMC28123 1 13 5 DAC08-E06 2-CG5644-RA_4 CG5644 GGCTATCGGCATGTGGATCCTTCCAGCTGTTACCTTCGATCCGAATAACCTACCCAACCTGGACGTGAT 69 FBan0005644 FBgn0035948 CG5644 3 3L CG5644 CG5644 anon-EST:Posey104 CDMC28123 1 14 5 DAC08-E06 2-CG5644-RA_4 CG5644 GGCTATCGGCATGTGGATCCTTCCAGCTGTTACCTTCGATCCGAATAACCTACCCAACCTGGACGTGAT 69 FBan0005644 FBgn0035948 CG5644 3 3L CG5644 CG5644 anon-EST:Posey104 CDMC28124 1 15 5 DAC08-E18 2-CG5658-RA_1 CG5658 AGGTTCGCATCGCTCTACCCGATGGCAAGTTAAACATTCTGCGTCGATACAGTCGCTTCAGGGAACTGC 69 FBan0005658 FBgn0004387 Klp98A 3 3R intracellular signaling cascade; GO:0007242; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Klp98A Kinesin-like protein at 98A "CG5658, CG5658, KLP6, KLP98A, DmKlp98A, KIF16A, Klp6" CDMC28124 1 16 5 DAC08-E18 2-CG5658-RA_1 CG5658 AGGTTCGCATCGCTCTACCCGATGGCAAGTTAAACATTCTGCGTCGATACAGTCGCTTCAGGGAACTGC 69 FBan0005658 FBgn0004387 Klp98A 3 3R intracellular signaling cascade; GO:0007242; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Klp98A Kinesin-like protein at 98A "CG5658, CG5658, KLP6, KLP98A, DmKlp98A, KIF16A, Klp6" CDMC28125 1 17 5 DAC08-I06 6-CG5686-RA_1 CG5686 CCCAGTTCGAATTGCCTGCCAATGAAAGTGGAGAAACTCAAGCTATCCGACTATCAGACAGCACCGCCA 69 FBan0005686 FBgn0024248 chico 2 2L aging; GO:0007568; cell glucose homeostasis; GO:0001678; cellular morphogenesis; GO:0000902; cytokine and chemokine mediated signaling pathway; GO:0019221; determination of adult life span; GO:0008340; egg chamber growth (sensu Insecta); GO:0007295; insulin receptor signaling pathway; GO:0008286; metabolism; GO:0008152; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; regulation of body size; GO:0040014; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of tracheal tube length; GO:0035159; response to starvation; GO:0042594; vitellogenesis; GO:0007296 insulin-like growth factor receptor binding; GO:0005159; ; GO:0005159; ; GO:0005159; ; GO:0005159; insulin receptor binding; GO:0005158; ; GO:0005159; ; GO:0005159; ; GO:0005158 chico chico "CG5686, flipper, fs(2)4, IRS, BcDNA.GH11263, dIRS, CHICO, anon-WO0078940.4, BcDNA:GH11263, chic, fs(2)ry4, anon-WO0078940.1" CDMC28125 1 18 5 DAC08-I06 6-CG5686-RA_1 CG5686 CCCAGTTCGAATTGCCTGCCAATGAAAGTGGAGAAACTCAAGCTATCCGACTATCAGACAGCACCGCCA 69 FBan0005686 FBgn0024248 chico 2 2L aging; GO:0007568; cell glucose homeostasis; GO:0001678; cellular morphogenesis; GO:0000902; cytokine and chemokine mediated signaling pathway; GO:0019221; determination of adult life span; GO:0008340; egg chamber growth (sensu Insecta); GO:0007295; insulin receptor signaling pathway; GO:0008286; metabolism; GO:0008152; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; regulation of body size; GO:0040014; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of tracheal tube length; GO:0035159; response to starvation; GO:0042594; vitellogenesis; GO:0007296 insulin-like growth factor receptor binding; GO:0005159; ; GO:0005159; ; GO:0005159; ; GO:0005159; insulin receptor binding; GO:0005158; ; GO:0005159; ; GO:0005159; ; GO:0005158 chico chico "CG5686, flipper, fs(2)4, IRS, BcDNA.GH11263, dIRS, CHICO, anon-WO0078940.4, BcDNA:GH11263, chic, fs(2)ry4, anon-WO0078940.1" CDMC28126 1 19 5 DAC08-I18 23-CG5695-RA_2 CG5695 CCGTTTCGATGGTCAATAGGTCAAAATTGGTAACTAACGAAACTCGAAAATAAGTTTTTGTCAGTCAAA 69 FBan0005695 FBgn0011225 jar 3 3R asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; border follicle cell migration (sensu Insecta); GO:0007298; dorsal closure; GO:0007391; establishment of mitotic spindle localization; GO:0040001; intercellular junction maintenance; GO:0045217; intracellular protein transport; GO:0006886; membrane organization and biogenesis; GO:0016044; neuroblast division; GO:0045034; oogenesis (sensu Insecta); GO:0009993; pseudocleavage (sensu Insecta); GO:0030589; sensory perception of sound; GO:0007605; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0005515" cytoplasm; GO:0005737; endocytic vesicle; GO:0030139; microtubule associated complex; GO:0005875; myosin; GO:0016459; unconventional myosin; GO:0016461 jar jaguar "CG5695, CG5695, Mhc95F, 95F MHC, Dro95F, myosin-VI, 95F unconventional myosin, 95F myosin, 95F, myosin 95F, 95F Myosin, myosin VI, myosin heavy chain, JAG, MHC95F, MYOVI, Dm95F, Dm 95F, Myosin VI, MyoVI, Jaguar, ms(3)06746, Myosin heavy chain at 95F, jaguar" CDMC28126 1 20 5 DAC08-I18 23-CG5695-RA_2 CG5695 CCGTTTCGATGGTCAATAGGTCAAAATTGGTAACTAACGAAACTCGAAAATAAGTTTTTGTCAGTCAAA 69 FBan0005695 FBgn0011225 jar 3 3R asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; border follicle cell migration (sensu Insecta); GO:0007298; dorsal closure; GO:0007391; establishment of mitotic spindle localization; GO:0040001; intercellular junction maintenance; GO:0045217; intracellular protein transport; GO:0006886; membrane organization and biogenesis; GO:0016044; neuroblast division; GO:0045034; oogenesis (sensu Insecta); GO:0009993; pseudocleavage (sensu Insecta); GO:0030589; sensory perception of sound; GO:0007605; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0005515" cytoplasm; GO:0005737; endocytic vesicle; GO:0030139; microtubule associated complex; GO:0005875; myosin; GO:0016459; unconventional myosin; GO:0016461 jar jaguar "CG5695, CG5695, Mhc95F, 95F MHC, Dro95F, myosin-VI, 95F unconventional myosin, 95F myosin, 95F, myosin 95F, 95F Myosin, myosin VI, myosin heavy chain, JAG, MHC95F, MYOVI, Dm95F, Dm 95F, Myosin VI, MyoVI, Jaguar, ms(3)06746, Myosin heavy chain at 95F, jaguar" CDMC28127 1 21 5 DAC08-M06 6-CG5727-RA_2 CG5727 AGTGGCGAGAAAATCGGACGTTCCAATCTATCCACCATTTCAAGTGGAACCCCAGCTATCGTGCAGCAA 69 FBan0005727 FBgn0032193 CG5727 2 2L CG5727 CG5727 BcDNA:LD02427 CDMC28127 1 22 5 DAC08-M06 6-CG5727-RA_2 CG5727 AGTGGCGAGAAAATCGGACGTTCCAATCTATCCACCATTTCAAGTGGAACCCCAGCTATCGTGCAGCAA 69 FBan0005727 FBgn0032193 CG5727 2 2L CG5727 CG5727 BcDNA:LD02427 CDMC28128 1 23 5 DAC08-M18 14-CG5739-RA_1 CG5739 GGGTCCACCTGTGCTGTACTGCAACGAATCCGACAATCAGCTGAAGAACTTTAAGCCATTCGATTTGGA 69 FBan0005739 FBgn0032190 CG5739 2 2L CG5739 CG5739 CDMC28128 1 24 5 DAC08-M18 14-CG5739-RA_1 CG5739 GGGTCCACCTGTGCTGTACTGCAACGAATCCGACAATCAGCTGAAGAACTTTAAGCCATTCGATTTGGA 69 FBan0005739 FBgn0032190 CG5739 2 2L CG5739 CG5739 CDMC28129 1 25 5 DAC09-A07 3-CG31136-RA_3 CG31136 GCATTGAGTACCATGTGGAGCACGCTATGGACTATGTGCAGACGGCAACTCAGGACACCAAGAAGGC 67 FBan0031136 FBgn0013343 Syx1A 3 3R cellularization; GO:0007349; cuticle biosynthesis; GO:0042335; cytokinesis; GO:0000910; exocytosis; GO:0006887; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; regulation of exocytosis; GO:0017157; regulation of pole plasm oskar mRNA localization; GO:0007317; synaptic transmission; GO:0007268; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486; SNAP receptor activity; GO:0005484; protein transporter activity; GO:0008565; ; GO:0005484; ; GO:0008565 integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 Syx1A Syntaxin 1A "CG5448, CG10716, CG31136, CG18615, CG5448, CG10716, syx1A, syt-1A, syx-1A, syx-1, syntaxin, syx, synt, syntaxin-1A, Syntx 1, syntaxin1, SYX1A, Syx, Dm Syx1, syx1, CT30033, DmSyx1A, syntaxin 1, dSyx1, syntaxin-1, Syntaxin, Syntaxin-1A, Syntaxin1A, anon-WO02059370.54, Syt1A, l(3)06737, anon-EST:Gibbs4" CDMC28129 1 26 5 DAC09-A07 3-CG31136-RA_3 CG31136 GCATTGAGTACCATGTGGAGCACGCTATGGACTATGTGCAGACGGCAACTCAGGACACCAAGAAGGC 67 FBan0031136 FBgn0013343 Syx1A 3 3R cellularization; GO:0007349; cuticle biosynthesis; GO:0042335; cytokinesis; GO:0000910; exocytosis; GO:0006887; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; regulation of exocytosis; GO:0017157; regulation of pole plasm oskar mRNA localization; GO:0007317; synaptic transmission; GO:0007268; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486; SNAP receptor activity; GO:0005484; protein transporter activity; GO:0008565; ; GO:0005484; ; GO:0008565 integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 Syx1A Syntaxin 1A "CG5448, CG10716, CG31136, CG18615, CG5448, CG10716, syx1A, syt-1A, syx-1A, syx-1, syntaxin, syx, synt, syntaxin-1A, Syntx 1, syntaxin1, SYX1A, Syx, Dm Syx1, syx1, CT30033, DmSyx1A, syntaxin 1, dSyx1, syntaxin-1, Syntaxin, Syntaxin-1A, Syntaxin1A, anon-WO02059370.54, Syt1A, l(3)06737, anon-EST:Gibbs4" CDMC28130 1 1 6 DAC09-A19 2-CG31326-RA_1 CG31326 GCCGGAGATACCAAGTCCCGTCCCACAACGACCGACACCAAATCCTAGTCGATCTAATGCTCCTCAG 67 FBan0031326 FBgn0051326 CG31326 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31326 CG31326 "CG9645, CG9645, CG9645, CG9645, CG9645, CG9645, CG9645, SPH144" CDMC28130 1 2 6 DAC09-A19 2-CG31326-RA_1 CG31326 GCCGGAGATACCAAGTCCCGTCCCACAACGACCGACACCAAATCCTAGTCGATCTAATGCTCCTCAG 67 FBan0031326 FBgn0051326 CG31326 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31326 CG31326 "CG9645, CG9645, CG9645, CG9645, CG9645, CG9645, CG9645, SPH144" CDMC28131 1 3 6 DAC09-E07 2-CG31883-RA_4 CG31883 AAAACCTGGAGGTGATAGCGATGGCTCGACAGGACGTCCCGAAGAGAAACCGATTGTAAGTCCTGGG 67 FBgn0051883 CDMC28131 1 4 6 DAC09-E07 2-CG31883-RA_4 CG31883 AAAACCTGGAGGTGATAGCGATGGCTCGACAGGACGTCCCGAAGAGAAACCGATTGTAAGTCCTGGG 67 FBgn0051883 CDMC28132 1 5 6 DAC09-E19 3-CG32067-RA_1 CG32067 GGGCGGATTGAATATCAATAGCTTGGCCAGTCTAGGCAACCTTGGCAATTTGGGCAACCTCAGCCAG 67 FBgn0052067 CDMC28132 1 6 6 DAC09-E19 3-CG32067-RA_1 CG32067 GGGCGGATTGAATATCAATAGCTTGGCCAGTCTAGGCAACCTTGGCAATTTGGGCAACCTCAGCCAG 67 FBgn0052067 CDMC28133 1 7 6 DAC09-I07 13-CG32498-RB_1 CG32498 GCCCAGGATATACTCGACACGCTTGAAGAGAACAGAGACTACTACCAGAGCATGATACCGCCTTCGC 67 FBan0032498 FBgn0000479 dnc X X associative learning; GO:0008306; behavior; GO:0007610; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; circadian rhythm; GO:0007623; courtship behavior; GO:0007619; cyclic nucleotide metabolism; GO:0009187; learning; GO:0007612; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; memory; GO:0007613; nonassociative learning; GO:0046958; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; reproduction; GO:0000003; synaptic transmission; GO:0007268 "cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; 3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; ; GO:0004114 ; EC:3.1.4.17; ; GO:0004115 ; EC:3.1.4.-" dnc dunce "CG10791, CG10797, CG32498, CG10792, CG14268, CG14267, CG10791, CG10791, CG10797, fs(1)M42, EG:96G10.7, EG:140G11.4, PDE4, EG:BACN5I9.2, EG:BACN05I09.3, dunce" CDMC28133 1 8 6 DAC09-I07 13-CG32498-RB_1 CG32498 GCCCAGGATATACTCGACACGCTTGAAGAGAACAGAGACTACTACCAGAGCATGATACCGCCTTCGC 67 FBan0032498 FBgn0000479 dnc X X associative learning; GO:0008306; behavior; GO:0007610; behavioral response to ethanol; GO:0048149; cAMP-mediated signaling; GO:0019933; circadian rhythm; GO:0007623; courtship behavior; GO:0007619; cyclic nucleotide metabolism; GO:0009187; learning; GO:0007612; learning and/or memory; GO:0007611; locomotor rhythm; GO:0045475; mating behavior; GO:0007617; memory; GO:0007613; nonassociative learning; GO:0046958; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; reproduction; GO:0000003; synaptic transmission; GO:0007268 "cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; 3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; ; GO:0004114 ; EC:3.1.4.17; ; GO:0004115 ; EC:3.1.4.-" dnc dunce "CG10791, CG10797, CG32498, CG10792, CG14268, CG14267, CG10791, CG10791, CG10797, fs(1)M42, EG:96G10.7, EG:140G11.4, PDE4, EG:BACN5I9.2, EG:BACN05I09.3, dunce" CDMC28134 1 9 6 DAC09-I19 17-CG3260-RA_1 CG3260 CCCTTAACACAAATCGTTTTCCCAGAATTTGAGATTGTAATGGACAGCAACCCCGTGGAGTCTGGCG 67 FBan0003260 FBgn0021875 Zfrp8 2 2R apoptosis; GO:0006915; electron transport; GO:0006118; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 cytoplasm; GO:0005737; nucleus; GO:0005634 Zfrp8 Zinc finger protein RP-8 "CG3260, CG3260, l(2)k13705, 137/5, zfrp8, Zinc finger protein RP-8" CDMC28134 1 10 6 DAC09-I19 17-CG3260-RA_1 CG3260 CCCTTAACACAAATCGTTTTCCCAGAATTTGAGATTGTAATGGACAGCAACCCCGTGGAGTCTGGCG 67 FBan0003260 FBgn0021875 Zfrp8 2 2R apoptosis; GO:0006915; electron transport; GO:0006118; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 cytoplasm; GO:0005737; nucleus; GO:0005634 Zfrp8 Zinc finger protein RP-8 "CG3260, CG3260, l(2)k13705, 137/5, zfrp8, Zinc finger protein RP-8" CDMC28135 1 11 6 DAC09-M07 2-CG3328-RA_2 CG3328 TCATCCCATTCGCAAATTCAATCCTGGAACCGTCTACACCCACGTTTACAAGACCGTATCGCCCCCA 67 FBan0003328 FBgn0034985 CG3328 2 2R proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693 CG3328 CG3328 CDMC28135 1 12 6 DAC09-M07 2-CG3328-RA_2 CG3328 TCATCCCATTCGCAAATTCAATCCTGGAACCGTCTACACCCACGTTTACAAGACCGTATCGCCCCCA 67 FBan0003328 FBgn0034985 CG3328 2 2R proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693 CG3328 CG3328 CDMC28136 1 13 6 DAC09-M19 2-CG33497-RA_1 CG33497 AGCTCTGGTCGCTAAAGGACACAAAGCCGCTGTACTCCTTTGAGGACAACTCCGACTACGTGATGGA 67 FBan0033497 FBgn0053497 Sdic:CG33497 X X Sdic:CG33497 Sdic:CG33497 CG33497 CDMC28136 1 14 6 DAC09-M19 2-CG33497-RA_1 CG33497 AGCTCTGGTCGCTAAAGGACACAAAGCCGCTGTACTCCTTTGAGGACAACTCCGACTACGTGATGGA 67 FBan0033497 FBgn0053497 Sdic:CG33497 X X Sdic:CG33497 Sdic:CG33497 CG33497 CDMC28137 1 15 6 DAC10-A06 1-CG18313-RA_1 CG18313 AGCGGAATCCATGAGTTGACCATCGAGTTCACCGATTCCAGTGAGGTTGTGGTAGTCATGCCCAAGGTT 69 FBan0018313 FBgn0030566 CG18313 X X CG18313 CG18313 CDMC28137 1 16 6 DAC10-A06 1-CG18313-RA_1 CG18313 AGCGGAATCCATGAGTTGACCATCGAGTTCACCGATTCCAGTGAGGTTGTGGTAGTCATGCCCAAGGTT 69 FBan0018313 FBgn0030566 CG18313 X X CG18313 CG18313 CDMC28138 1 17 6 DAC10-A18 15-CG18327-RA_1 CG18327 GTGGCATTTACTACAGGGGCTGGTTGGATTGTGTGCTTACGATCCTAAGATCGGAGGGTGTATATGGGT 69 FBan0018327 FBgn0033904 CG18327 2 2R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18327 CG18327 CDMC28138 1 18 6 DAC10-A18 15-CG18327-RA_1 CG18327 GTGGCATTTACTACAGGGGCTGGTTGGATTGTGTGCTTACGATCCTAAGATCGGAGGGTGTATATGGGT 69 FBan0018327 FBgn0033904 CG18327 2 2R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18327 CG18327 CDMC28139 1 19 6 DAC10-E06 9-CG1838-RA_1 CG1838 TCACCAGCTTTGGATGGCATTTCGTTGTAGCACCAACGTCCTTTGACGCATACTTCTGCAGTGGTGACT 69 FBan0001838 FBgn0026199 myoglianin 4 4 cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0005160; ; GO:0008083 myoglianin myoglianin "CG1838, CG1838, Myoglianin, BcDNA:LD02307" CDMC28139 1 20 6 DAC10-E06 9-CG1838-RA_1 CG1838 TCACCAGCTTTGGATGGCATTTCGTTGTAGCACCAACGTCCTTTGACGCATACTTCTGCAGTGGTGACT 69 FBan0001838 FBgn0026199 myoglianin 4 4 cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0005160; ; GO:0008083 myoglianin myoglianin "CG1838, CG1838, Myoglianin, BcDNA:LD02307" CDMC28140 1 21 6 DAC10-E18 14-CG18405-RA_3 CG18405 TGCAGCTACATCTACCGTGATTGATTGATATGCAACACCAAATCGATGCCACTCATCCAGGCCCAGTCT 69 FBan0018405 FBgn0011259 Sema-1a 2 2L axon guidance; GO:0007411; ectoderm development; GO:0007398; signal transduction; GO:0007165 semaphorin receptor binding; GO:0030215; receptor activity; GO:0004872; ; GO:0004872; ; GO:0030215 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Sema-1a Sema-1a "CG18405, CG18405, Fasciclin-IV, Sema1a, D-Sema I, D-semaI, FasIV, D-SemaI, d-sema I, d-semaI, SemaI, Sema-I, D-Sema 1a, sema-I: semaphorin I, semaphorin, Sema 1a, Dsema-I, CT26404, sema-1a, Sema1A, semaphorin 1, sema1a, semiphorin, Semaphorin-1, BcDNA:RE36155, D-Sema-I, Fas-IV: Fasciclin-IV, l(2)k13702, semaphorin I, sema-I" CDMC28140 1 22 6 DAC10-E18 14-CG18405-RA_3 CG18405 TGCAGCTACATCTACCGTGATTGATTGATATGCAACACCAAATCGATGCCACTCATCCAGGCCCAGTCT 69 FBan0018405 FBgn0011259 Sema-1a 2 2L axon guidance; GO:0007411; ectoderm development; GO:0007398; signal transduction; GO:0007165 semaphorin receptor binding; GO:0030215; receptor activity; GO:0004872; ; GO:0004872; ; GO:0030215 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Sema-1a Sema-1a "CG18405, CG18405, Fasciclin-IV, Sema1a, D-Sema I, D-semaI, FasIV, D-SemaI, d-sema I, d-semaI, SemaI, Sema-I, D-Sema 1a, sema-I: semaphorin I, semaphorin, Sema 1a, Dsema-I, CT26404, sema-1a, Sema1A, semaphorin 1, sema1a, semiphorin, Semaphorin-1, BcDNA:RE36155, D-Sema-I, Fas-IV: Fasciclin-IV, l(2)k13702, semaphorin I, sema-I" CDMC28141 1 23 6 DAC10-I06 9-CG18477-RA_1 CG18477 AGGAGGTTCCTTACGCAAGTCCAACACTTTCTGCAGGCCCGTATCTTAACCAGTGGAATCAACCGAACT 69 FBan0018477 FBgn0028864 CG18477 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18477 CG18477 "BG:DS07108.1, SPH69" CDMC28141 1 24 6 DAC10-I06 9-CG18477-RA_1 CG18477 AGGAGGTTCCTTACGCAAGTCCAACACTTTCTGCAGGCCCGTATCTTAACCAGTGGAATCAACCGAACT 69 FBan0018477 FBgn0028864 CG18477 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18477 CG18477 "BG:DS07108.1, SPH69" CDMC28142 1 25 6 DAC10-I18 23-CG18492-RA_8 CG18492 AGCAATATCAAAAACAACGACTAGCTCAATGACCGAAAATACCTCATCAACATCATCGGACATCACGCC 69 FBan0018492 FBgn0026323 Tak1 X X I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of JNKK activity; GO:0007256; antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; defense response; GO:0006952; dorsal closure; GO:0007391; eye development (sensu Endopterygota); GO:0007456; immune response; GO:0006955; innate immune response; GO:0045087; notum morphogenesis; GO:0007477; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; JUN kinase kinase kinase activity; GO:0004706 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004706 ; EC:2.7.1.- cellular component unknown; GO:0008372 Tak1 TGF-beta activated kinase 1 "CG1388, CG18492, CG1388, CG18492, DTAK1, Tak 1, TAK1, TGF-beta activated-kinase 1, dTAK1, DTak, DTak1, TAK, DmTak1, dTak1, D-tak, D10, tak1, dTAK, tak, TAK-1, TGF-beta activated kinase 1" CDMC28142 1 26 6 DAC10-I18 23-CG18492-RA_8 CG18492 AGCAATATCAAAAACAACGACTAGCTCAATGACCGAAAATACCTCATCAACATCATCGGACATCACGCC 69 FBan0018492 FBgn0026323 Tak1 X X I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of JNKK activity; GO:0007256; antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; defense response; GO:0006952; dorsal closure; GO:0007391; eye development (sensu Endopterygota); GO:0007456; immune response; GO:0006955; innate immune response; GO:0045087; notum morphogenesis; GO:0007477; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; JUN kinase kinase kinase activity; GO:0004706 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004706 ; EC:2.7.1.- cellular component unknown; GO:0008372 Tak1 TGF-beta activated kinase 1 "CG1388, CG18492, CG1388, CG18492, DTAK1, Tak 1, TAK1, TGF-beta activated-kinase 1, dTAK1, DTak, DTak1, TAK, DmTak1, dTak1, D-tak, D10, tak1, dTAK, tak, TAK-1, TGF-beta activated kinase 1" CDMC28143 1 1 7 DAC10-M06 23-CG18542-RA_3 CG18542 GTTTAGCCAATATATAGTAAGCTAATACTCCACAAACATTCCTGCATGTCGACAGACTTTAGCCGTTGT 69 FBan0018542 FBgn0037731 CG18542 3 3R CG18542 CG18542 CDMC28143 1 2 7 DAC10-M06 23-CG18542-RA_3 CG18542 GTTTAGCCAATATATAGTAAGCTAATACTCCACAAACATTCCTGCATGTCGACAGACTTTAGCCGTTGT 69 FBan0018542 FBgn0037731 CG18542 3 3R CG18542 CG18542 CDMC28144 1 3 7 DAC10-M18 3-CG18559-RA_4 CG18559 TCATGCCCTGACCGTGATGCTGGATGGCTACGATACTTCGGGAACAGCTCTTCTCCATGCTCTGTACTA 69 FBan0018559 FBgn0041337 Cyp309a2 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a2 Cyp309a2 "CG18559, 309a2" CDMC28144 1 4 7 DAC10-M18 3-CG18559-RA_4 CG18559 TCATGCCCTGACCGTGATGCTGGATGGCTACGATACTTCGGGAACAGCTCTTCTCCATGCTCTGTACTA 69 FBan0018559 FBgn0041337 Cyp309a2 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a2 Cyp309a2 "CG18559, 309a2" CDMC28145 1 5 7 DAC11-A06 2-CG10104-RA_1 CG10104 GGGTCCCATCTTCCTGGCAGCAAAATTCGACGGCATCTTTGGATTGGCCTATCGCAGCATCTCTATG 67 FBan0010104 FBgn0033933 CG10104 2 2R proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG10104 CG10104 CDMC28145 1 6 7 DAC11-A06 2-CG10104-RA_1 CG10104 GGGTCCCATCTTCCTGGCAGCAAAATTCGACGGCATCTTTGGATTGGCCTATCGCAGCATCTCTATG 67 FBan0010104 FBgn0033933 CG10104 2 2R proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG10104 CG10104 CDMC28146 1 7 7 DAC11-A18 2-CG10234-RA_1 CG10234 TGCGTGGTGCAGAAACAACCCGACTGTGATCCCAAAAACATGTGGCTGCAGATACCCTTCTTCTGTG 67 FBan0010234 FBgn0024230 Hs2st 2 2L meiosis; GO:0007126; signal transduction; GO:0007165 heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Hs2st Hs2st "CG10234, HS2ST, dHS2ST, DmHs2st, heparan-sulfate-2-sulfotransferase" CDMC28146 1 8 7 DAC11-A18 2-CG10234-RA_1 CG10234 TGCGTGGTGCAGAAACAACCCGACTGTGATCCCAAAAACATGTGGCTGCAGATACCCTTCTTCTGTG 67 FBan0010234 FBgn0024230 Hs2st 2 2L meiosis; GO:0007126; signal transduction; GO:0007165 heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Hs2st Hs2st "CG10234, HS2ST, dHS2ST, DmHs2st, heparan-sulfate-2-sulfotransferase" CDMC28147 1 9 7 DAC11-E06 1-CG10711-RA_1 CG10711 CACGCGGGACAACTTTACCAGCAATTCTGCCTACTTCAGTAGCCTGGCCCGACAGATTTGCGAAATG 67 FBan0010711 FBgn0036375 CG10711 3 3L CG10711 CG10711 CDMC28147 1 10 7 DAC11-E06 1-CG10711-RA_1 CG10711 CACGCGGGACAACTTTACCAGCAATTCTGCCTACTTCAGTAGCCTGGCCCGACAGATTTGCGAAATG 67 FBan0010711 FBgn0036375 CG10711 3 3L CG10711 CG10711 CDMC28148 1 11 7 DAC11-E18 2-CG10805-RA_1 CG10805 GGTACATAAGTGGGCACTGGAGAGTACCTCTCGGGAAACGCGTCTCACCTACTTCCTGCTGACCAAC 67 FBan0010805 FBgn0031864 CG10805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10805 CG10805 anon-WO0118547.160 CDMC28148 1 12 7 DAC11-E18 2-CG10805-RA_1 CG10805 GGTACATAAGTGGGCACTGGAGAGTACCTCTCGGGAAACGCGTCTCACCTACTTCCTGCTGACCAAC 67 FBan0010805 FBgn0031864 CG10805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10805 CG10805 anon-WO0118547.160 CDMC28149 1 13 7 DAC11-I06 23-CG11142-RA_2 CG11142 GGTTGCTCGAGTTTTCTAGTCTGTAGTTAAAGAATTTGGCAAACTGATTGTTGACATTTTGCGCGTC 67 FBan0011142 FBgn0031737 CG11142 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG11142 CG11142 CDMC28149 1 14 7 DAC11-I06 23-CG11142-RA_2 CG11142 GGTTGCTCGAGTTTTCTAGTCTGTAGTTAAAGAATTTGGCAAACTGATTGTTGACATTTTGCGCGTC 67 FBan0011142 FBgn0031737 CG11142 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG11142 CG11142 CDMC28150 1 15 7 DAC11-I18 1-CG1124-RA_1 CG1124 TCCATGCTAACTTCGAGGGTGTGAGTGCCGATCTCACAGGAAAGACATCCATTCACGCCTTCAAGGG 67 FBan0001124 FBgn0037290 CG1124 3 3R CG1124 CG1124 CT1789 CDMC28150 1 16 7 DAC11-I18 1-CG1124-RA_1 CG1124 TCCATGCTAACTTCGAGGGTGTGAGTGCCGATCTCACAGGAAAGACATCCATTCACGCCTTCAAGGG 67 FBan0001124 FBgn0037290 CG1124 3 3R CG1124 CG1124 CT1789 CDMC28151 1 17 7 DAC11-M06 3-CG11899-RA_3 CG11899 TCGCTCCAGCAACTATGCCAAGATCCATGATGCGACCATCAGCGATCTTCGCGAACTCCTCAATGTG 67 FBan0011899 FBgn0014427 CG11899 3 3R L-serine biosynthesis; GO:0006564; pyridoxine biosynthesis; GO:0008615 phosphoserine transaminase activity; GO:0004648 ; EC:2.6.1.52; ; GO:0004648 ; EC:2.6.1.52; ; GO:0004648 ; EC:2.6.1.52 CG11899 CG11899 "39C10S, ESTS:39C10S, anon-sts29" CDMC28151 1 18 7 DAC11-M06 3-CG11899-RA_3 CG11899 TCGCTCCAGCAACTATGCCAAGATCCATGATGCGACCATCAGCGATCTTCGCGAACTCCTCAATGTG 67 FBan0011899 FBgn0014427 CG11899 3 3R L-serine biosynthesis; GO:0006564; pyridoxine biosynthesis; GO:0008615 phosphoserine transaminase activity; GO:0004648 ; EC:2.6.1.52; ; GO:0004648 ; EC:2.6.1.52; ; GO:0004648 ; EC:2.6.1.52 CG11899 CG11899 "39C10S, ESTS:39C10S, anon-sts29" CDMC28152 1 19 7 DAC11-M18 1-CG12042-RA_3 CG12042 GCCGGAGAACATTTTCACGGAACCCTTGAACTTGCGGAATGTGACAACCATCACCCAGCGACATAGC 67 FBan0012042 FBgn0033206 CG12042 2 2R intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 dynactin complex; GO:0005869 CG12042 CG12042 P62 DYNACTIN CDMC28152 1 20 7 DAC11-M18 1-CG12042-RA_3 CG12042 GCCGGAGAACATTTTCACGGAACCCTTGAACTTGCGGAATGTGACAACCATCACCCAGCGACATAGC 67 FBan0012042 FBgn0033206 CG12042 2 2R intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 dynactin complex; GO:0005869 CG12042 CG12042 P62 DYNACTIN CDMC28153 1 21 7 DAC12-A06 1-CG1009-RB_1 CG1009 CTGGCCCTGGTTGATTCGTACAGAAACGAGACGAACTACACGGTGTGGACTGCCATCACCAACTCG 66 FBan0001009 FBgn0035226 Psa 3 3L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; proteolysis; GO:0006508 cytosol alanyl aminopeptidase activity; GO:0016285 ; EC:3.4.11.14; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0016285 ; EC:3.4.11.14; ; GO:0008270; ; GO:0005351; ; GO:0004179 ; EC:3.4.11.2 Psa Puromycin sensitive aminopeptidase "CG1009, CG1009, dPsa, puromycin-sensitive-aminopeptidase, Puromycin sensitive aminopeptidase" CDMC28153 1 22 7 DAC12-A06 1-CG1009-RB_1 CG1009 CTGGCCCTGGTTGATTCGTACAGAAACGAGACGAACTACACGGTGTGGACTGCCATCACCAACTCG 66 FBan0001009 FBgn0035226 Psa 3 3L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; proteolysis; GO:0006508 cytosol alanyl aminopeptidase activity; GO:0016285 ; EC:3.4.11.14; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0016285 ; EC:3.4.11.14; ; GO:0008270; ; GO:0005351; ; GO:0004179 ; EC:3.4.11.2 Psa Puromycin sensitive aminopeptidase "CG1009, CG1009, dPsa, puromycin-sensitive-aminopeptidase, Puromycin sensitive aminopeptidase" CDMC28154 1 23 7 DAC12-A18 3-CG10159-RA_1 CG10159 TGATGGATGATGAGGGCCTGGATCAGCCTGAGAAGCAAGTGACCGTGCTAACCCATTCGACTTCAC 66 FBan0010159 FBgn0015602 BEAF-32 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; chromatin insulator sequence binding; GO:0043035; ; GO:0043035; ; GO:0005515 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 BEAF-32 Boundary element-associated factor of 32kD "CG10159, CG10159, BEAF, BEAF-32A, BEAF-32B, bs04c01.y1, boundary element associated factor, BEAF32A, BEAF32, BEAF32B, Beaf-32, Boundary element-associated factor of 32kD" CDMC28154 1 24 7 DAC12-A18 3-CG10159-RA_1 CG10159 TGATGGATGATGAGGGCCTGGATCAGCCTGAGAAGCAAGTGACCGTGCTAACCCATTCGACTTCAC 66 FBan0010159 FBgn0015602 BEAF-32 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; chromatin insulator sequence binding; GO:0043035; ; GO:0043035; ; GO:0005515 colocalizes_with nuclear chromatin; GO:0000790; nucleus; GO:0005634 BEAF-32 Boundary element-associated factor of 32kD "CG10159, CG10159, BEAF, BEAF-32A, BEAF-32B, bs04c01.y1, boundary element associated factor, BEAF32A, BEAF32, BEAF32B, Beaf-32, Boundary element-associated factor of 32kD" CDMC28155 1 25 7 DAC12-E06 15-CG10576-RA_1 CG10576 AGAGAAGACGGCAACAATTTGAGGATACATTTCCCCAGAAATCCTCCATCCATCAACAAGGCGGGC 66 FBan0010576 FBgn0035630 CG10576 3 3L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG10576 CG10576 BEST:CK00496 CDMC28155 1 26 7 DAC12-E06 15-CG10576-RA_1 CG10576 AGAGAAGACGGCAACAATTTGAGGATACATTTCCCCAGAAATCCTCCATCCATCAACAAGGCGGGC 66 FBan0010576 FBgn0035630 CG10576 3 3L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG10576 CG10576 BEST:CK00496 CDMC28156 1 1 8 DAC12-E18 1-CG10710-RA_1 CG10710 GGGCAATTACCGGTATTACAACGGCACAGGAGACAAGACCATGCGAGGCTACGAGTTCATCTCCCG 66 FBan0010710 FBgn0036377 CG10710 3 3L CG10710 CG10710 CDMC28156 1 2 8 DAC12-E18 1-CG10710-RA_1 CG10710 GGGCAATTACCGGTATTACAACGGCACAGGAGACAAGACCATGCGAGGCTACGAGTTCATCTCCCG 66 FBan0010710 FBgn0036377 CG10710 3 3L CG10710 CG10710 CDMC28157 1 3 8 DAC12-I06 6-CG11127-RA_4 CG11127 TTCCCTTCCAGCAGTCCAATGGCACACGTTCGCGAATCCATCAACTATTACTCACGGACTGCTTGC 66 FBan0011127 FBgn0033178 CG11127 2 2R CG11127 CG11127 CDMC28157 1 4 8 DAC12-I06 6-CG11127-RA_4 CG11127 TTCCCTTCCAGCAGTCCAATGGCACACGTTCGCGAATCCATCAACTATTACTCACGGACTGCTTGC 66 FBan0011127 FBgn0033178 CG11127 2 2R CG11127 CG11127 CDMC28158 1 5 8 DAC12-I18 2-CG11140-RB_1 CG11140 CGGCATGGGCAGATATCATGGAAAGTACGGCTTCGAGACCTTCACGCACAAGAAATCTTGCCTGGG 66 FBan0011140 FBgn0010548 Aldh-III 2 2R defense response; GO:0006952; metabolism; GO:0008152; response to toxin; GO:0009636 aldehyde dehydrogenase activity; GO:0004028 ; EC:1.2.1.-; ; GO:0004028 ; EC:1.2.1.- Aldh-III Aldehyde dehydrogenase type III "CG11140, CG11140, l(2)03610, Dhap, FALDH, Fatty Aldehyde Dehydrogenase, CT41571, Fatty aldehyde dehydrogenase, ALDH-III, Aldehyde dehydrogenase type III" CDMC28158 1 6 8 DAC12-I18 2-CG11140-RB_1 CG11140 CGGCATGGGCAGATATCATGGAAAGTACGGCTTCGAGACCTTCACGCACAAGAAATCTTGCCTGGG 66 FBan0011140 FBgn0010548 Aldh-III 2 2R defense response; GO:0006952; metabolism; GO:0008152; response to toxin; GO:0009636 aldehyde dehydrogenase activity; GO:0004028 ; EC:1.2.1.-; ; GO:0004028 ; EC:1.2.1.- Aldh-III Aldehyde dehydrogenase type III "CG11140, CG11140, l(2)03610, Dhap, FALDH, Fatty Aldehyde Dehydrogenase, CT41571, Fatty aldehyde dehydrogenase, ALDH-III, Aldehyde dehydrogenase type III" CDMC28159 1 7 8 DAC12-M06 1-CG11783-RA_1 CG11783 GGAGATGTCCTACGGCACTCAGTCTACGTACGGTGGATGCAATTCGGCTGCAAACAATAGCCAGCC 66 FBan0011783 FBgn0015240 Hr96 3 3R hormone secretion; GO:0046879; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; skeletal development; GO:0001501 DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003707 nucleus; GO:0005634 Hr96 Hormone receptor-like in 96 "CG11783, DHR96, Dhr96, NR1J1" CDMC28159 1 8 8 DAC12-M06 1-CG11783-RA_1 CG11783 GGAGATGTCCTACGGCACTCAGTCTACGTACGGTGGATGCAATTCGGCTGCAAACAATAGCCAGCC 66 FBan0011783 FBgn0015240 Hr96 3 3R hormone secretion; GO:0046879; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; skeletal development; GO:0001501 DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003707 nucleus; GO:0005634 Hr96 Hormone receptor-like in 96 "CG11783, DHR96, Dhr96, NR1J1" CDMC28160 1 9 8 DAC12-M18 1-CG12015-RA_1 CG12015 GGATTAATCGAGCGATCACAGCCATGGCCACGATGCGCATACCCAAACAAAAGGTGATCCTGTGCG 66 FBan0012015 FBgn0035155 RabX6 3 3L intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0005525; ; GO:0003924 RabX6 RabX6 "CG12015, CG12015, CG12015, DmRabX6" CDMC28160 1 10 8 DAC12-M18 1-CG12015-RA_1 CG12015 GGATTAATCGAGCGATCACAGCCATGGCCACGATGCGCATACCCAAACAAAAGGTGATCCTGTGCG 66 FBan0012015 FBgn0035155 RabX6 3 3L intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0005525; ; GO:0003924 RabX6 RabX6 "CG12015, CG12015, CG12015, DmRabX6" CDMC28161 1 11 8 DAC13-A06 47-CG14521-RA_3 CG14521 AAGAAAAGCACAAAAAAACAGCAACTAAAATACCCATAAAATAATAGGAAAACAAAGAGTGCCAGCAGA 69 FBan0014521 FBgn0039617 CG14521 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG14521 CG14521 "CT34248, anon-WO0140519.196" CDMC28161 1 12 8 DAC13-A06 47-CG14521-RA_3 CG14521 AAGAAAAGCACAAAAAAACAGCAACTAAAATACCCATAAAATAATAGGAAAACAAAGAGTGCCAGCAGA 69 FBan0014521 FBgn0039617 CG14521 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG14521 CG14521 "CT34248, anon-WO0140519.196" CDMC28162 1 13 8 DAC13-A18 1-CG1453-RC_2 CG1453 GCAAGCGTTAGTTCATTCCCGCATTCGACCCGTTCATCCACAATCACCAACAATCATCCACCACACCCA 69 FBan0001453 FBgn0030268 Klp10A X X microtubule-based movement; GO:0007018; mitotic sister chromatid segregation; GO:0000070; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871; kinetochore microtubule; GO:0005828 Klp10A Klp10A "CG1453, CG1453, DmKlp10A, DmCG1453, KIF2A, KLP10A, DmKLP10A, Kif2A, KLP10a, anon-WO03040301.142" CDMC28162 1 14 8 DAC13-A18 1-CG1453-RC_2 CG1453 GCAAGCGTTAGTTCATTCCCGCATTCGACCCGTTCATCCACAATCACCAACAATCATCCACCACACCCA 69 FBan0001453 FBgn0030268 Klp10A X X microtubule-based movement; GO:0007018; mitotic sister chromatid segregation; GO:0000070; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871; kinetochore microtubule; GO:0005828 Klp10A Klp10A "CG1453, CG1453, DmKlp10A, DmCG1453, KIF2A, KLP10A, DmKLP10A, Kif2A, KLP10a, anon-WO03040301.142" CDMC28163 1 15 8 DAC13-E06 12-CG14575-RA_3 CG14575 GCTGGAAAACAGCCACACAGTTTGCGAGGAGCCCAAAGTTGAGAACGATATTTGGATCGAGAACGAGGA 69 FBan0014575 FBgn0037100 capaR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; fluid secretion; GO:0007589 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; ; GO:0008188; ; GO:0004930; ; GO:0004930; neuromedin U receptor activity; GO:0001607; ; GO:0001607 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 capaR capa receptor "CG14575, CG14575, CG14575, CG14575, CG14575, CG14575, capa receptor" CDMC28163 1 16 8 DAC13-E06 12-CG14575-RA_3 CG14575 GCTGGAAAACAGCCACACAGTTTGCGAGGAGCCCAAAGTTGAGAACGATATTTGGATCGAGAACGAGGA 69 FBan0014575 FBgn0037100 capaR 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; fluid secretion; GO:0007589 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; ; GO:0008188; ; GO:0004930; ; GO:0004930; neuromedin U receptor activity; GO:0001607; ; GO:0001607 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 capaR capa receptor "CG14575, CG14575, CG14575, CG14575, CG14575, CG14575, capa receptor" CDMC28164 1 17 8 DAC13-E18 8-CG14589-RA_3 CG14589 GTGCGTGACCTTCTTGTGGATATTTCTGTGCATCTACGTCCTGTCCAAGCTAACCCAACTCGTGGAGCT 69 FBan0014589 FBgn0033063 CG14589 2 2R CG14589 CG14589 CDMC28164 1 18 8 DAC13-E18 8-CG14589-RA_3 CG14589 GTGCGTGACCTTCTTGTGGATATTTCTGTGCATCTACGTCCTGTCCAAGCTAACCCAACTCGTGGAGCT 69 FBan0014589 FBgn0033063 CG14589 2 2R CG14589 CG14589 CDMC28165 1 19 8 DAC13-I06 15-CG14628-RA_1 CG14628 TGAGGATGACGTCGATGAATACGATGATTACTCCGAAAGTGATGACGAAGATGGCCCGGGAGACATGCA 69 FBan0014628 FBgn0040365 CG14628 X X mRNA binding; GO:0003729; ; GO:0003729 CG14628 CG14628 "cg14628, EG:BACR42I17.12" CDMC28165 1 20 8 DAC13-I06 15-CG14628-RA_1 CG14628 TGAGGATGACGTCGATGAATACGATGATTACTCCGAAAGTGATGACGAAGATGGCCCGGGAGACATGCA 69 FBan0014628 FBgn0040365 CG14628 X X mRNA binding; GO:0003729; ; GO:0003729 CG14628 CG14628 "cg14628, EG:BACR42I17.12" CDMC28166 1 21 8 DAC13-I18 3-CG14644-RA_5 CG14644 AACTTGTGCGGAGAAAACGTTGTTTGTGCTGTCCATGATTCTGATAGTCCTTTGCCTGCCGTGGTCCCT 69 FBan0014644 FBgn0037226 CG14644 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG14644 CG14644 CDMC28166 1 22 8 DAC13-I18 3-CG14644-RA_5 CG14644 AACTTGTGCGGAGAAAACGTTGTTTGTGCTGTCCATGATTCTGATAGTCCTTTGCCTGCCGTGGTCCCT 69 FBan0014644 FBgn0037226 CG14644 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG14644 CG14644 CDMC28167 1 23 8 DAC13-M06 3-CG14677-RA_2 CG14677 GGCAGCTTCCCCATTTCGACTACTCACGCATGGAGTATAGTTTCAGCAACGGCGTAGTCACCCAGAGTT 69 FBan0014677 FBgn0037393 CG14677 3 3R CG14677 CG14677 CDMC28167 1 24 8 DAC13-M06 3-CG14677-RA_2 CG14677 GGCAGCTTCCCCATTTCGACTACTCACGCATGGAGTATAGTTTCAGCAACGGCGTAGTCACCCAGAGTT 69 FBan0014677 FBgn0037393 CG14677 3 3R CG14677 CG14677 CDMC28168 1 25 8 DAC13-M18 9-CG1468-RA_1 CG1468 AGGTTGACCCCTATGGCACTTACGATAGCCAAATCCACTCAATTGGGGCTAATGATGACGGCAACTGGA 69 FBan0001468 FBgn0030157 CG1468 X X CG1468 CG1468 BcDNA:GH18955 CDMC28168 1 26 8 DAC13-M18 9-CG1468-RA_1 CG1468 AGGTTGACCCCTATGGCACTTACGATAGCCAAATCCACTCAATTGGGGCTAATGATGACGGCAACTGGA 69 FBan0001468 FBgn0030157 CG1468 X X CG1468 CG1468 BcDNA:GH18955 CDMC28169 1 1 9 DAC14-A06 2-CG17227-RB_1 CG17227 TTGGGCGTTTGTGGAAGACAGTGACCAAAGTGCACTCTGGCTTGGATGATGCTACCAACGCAGAG 65 FBan0017227 FBgn0038035 CG17227 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003676; ; GO:0003910 ; EC:6.5.1.1 intracellular; GO:0005622 CG17227 CG17227 CDMC28169 1 2 9 DAC14-A06 2-CG17227-RB_1 CG17227 TTGGGCGTTTGTGGAAGACAGTGACCAAAGTGCACTCTGGCTTGGATGATGCTACCAACGCAGAG 65 FBan0017227 FBgn0038035 CG17227 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003676; ; GO:0003910 ; EC:6.5.1.1 intracellular; GO:0005622 CG17227 CG17227 CDMC28170 1 3 9 DAC14-A18 11-CG17259-RA_1 CG17259 GTACGCCCGTGACTACGTTCCCCTGTACACGCCCTTCTTCATGCGAAAGGAGGTAATGCAGGAGG 65 FBan0017259 FBgn0031497 CG17259 2 2L seryl-tRNA aminoacylation; GO:0006434 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 CG17259 CG17259 CDMC28170 1 4 9 DAC14-A18 11-CG17259-RA_1 CG17259 GTACGCCCGTGACTACGTTCCCCTGTACACGCCCTTCTTCATGCGAAAGGAGGTAATGCAGGAGG 65 FBan0017259 FBgn0031497 CG17259 2 2L seryl-tRNA aminoacylation; GO:0006434 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003729; serine-tRNA ligase activity; GO:0004828 ; EC:6.1.1.11; ; GO:0004828 ; EC:6.1.1.11 CG17259 CG17259 CDMC28171 1 5 9 DAC14-E06 7-CG17388-RA_1 CG17388 TGTACGCATTCTTTGCAGTTGGCGAGAAGGAGGATGAGGAAAACACCGGACTGCTGGAGCCCAAG 65 FBan0017388 FBgn0033937 CG17388 2 2R CG17388 CG17388 CDMC28171 1 6 9 DAC14-E06 7-CG17388-RA_1 CG17388 TGTACGCATTCTTTGCAGTTGGCGAGAAGGAGGATGAGGAAAACACCGGACTGCTGGAGCCCAAG 65 FBan0017388 FBgn0033937 CG17388 2 2R CG17388 CG17388 CDMC28172 1 7 9 DAC14-E18 17-CG1745-RB_1 CG1745 TCTTTAGAAAAACCAACGAACGAAGACAGGGTTGAGAAAGTAGAGGACGAGGTCGAGCATGCCGA 65 FBan0001745 FBgn0030301 CG1745 X X CG1745 CG1745 CDMC28172 1 8 9 DAC14-E18 17-CG1745-RB_1 CG1745 TCTTTAGAAAAACCAACGAACGAAGACAGGGTTGAGAAAGTAGAGGACGAGGTCGAGCATGCCGA 65 FBan0001745 FBgn0030301 CG1745 X X CG1745 CG1745 CDMC28173 1 9 9 DAC14-I06 3-CG17642-RA_1 CG17642 GTCCCTCAAGCCGAAATTCCCGCAGTACGAGAGCCTGAATGTGCAGATCAAGGGCTACGACTACC 65 FBan0017642 FBgn0031357 mRpL48 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL48 mitochondrial ribosomal protein L48 "CG17642, CG17642, MRP-L48, mitochondrial ribosomal protein L48" CDMC28173 1 10 9 DAC14-I06 3-CG17642-RA_1 CG17642 GTCCCTCAAGCCGAAATTCCCGCAGTACGAGAGCCTGAATGTGCAGATCAAGGGCTACGACTACC 65 FBan0017642 FBgn0031357 mRpL48 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL48 mitochondrial ribosomal protein L48 "CG17642, CG17642, MRP-L48, mitochondrial ribosomal protein L48" CDMC28174 1 11 9 DAC14-I18 3-CG17669-RA_1 CG17669 TTTTCCGGAATATGAGCATTGCAAGCCGAACAAGACACTGGCCGTTGGATTGGTGCGCAATGGAC 65 FBan0017669 FBgn0034352 CG17669 2 2R CG17669 CG17669 CDMC28174 1 12 9 DAC14-I18 3-CG17669-RA_1 CG17669 TTTTCCGGAATATGAGCATTGCAAGCCGAACAAGACACTGGCCGTTGGATTGGTGCGCAATGGAC 65 FBan0017669 FBgn0034352 CG17669 2 2R CG17669 CG17669 CDMC28175 1 13 9 DAC14-M06 1-CG17793-RA_1 CG17793 GAAATGGACAATCGCAGCAGGCAGTGACCAACAGCAAGCAGTCGCATTTCTGGCTAGATTGCTCC 65 FBan0017793 FBgn0038030 CG17793 3 3R CG17793 CG17793 CDMC28175 1 14 9 DAC14-M06 1-CG17793-RA_1 CG17793 GAAATGGACAATCGCAGCAGGCAGTGACCAACAGCAAGCAGTCGCATTTCTGGCTAGATTGCTCC 65 FBan0017793 FBgn0038030 CG17793 3 3R CG17793 CG17793 CDMC28176 1 15 9 DAC14-M18 17-CG17834-RA_1 CG17834 ACACGCCCACTATTGAGAAGTACCGGGTATCGCAGAGTCTCTATTCCATTCAAACGGCGAATGCT 65 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC28176 1 16 9 DAC14-M18 17-CG17834-RA_1 CG17834 ACACGCCCACTATTGAGAAGTACCGGGTATCGCAGAGTCTCTATTCCATTCAAACGGCGAATGCT 65 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC28177 1 17 9 DAC15-A06 1-CG12338-RA_1 CG12338 GCTTTCTACGGCGATTACGACACCTACGTTCTTCCCGGATTTGAGACTGTGACCCTGGGAGGATGTCG 68 FBan0012338 FBgn0033543 CG12338 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 D-aspartate oxidase activity; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; D-amino-acid oxidase activity; GO:0003884 ; EC:1.4.3.3; ; GO:0003884 ; EC:1.4.3.3 CG12338 CG12338 CDMC28177 1 18 9 DAC15-A06 1-CG12338-RA_1 CG12338 GCTTTCTACGGCGATTACGACACCTACGTTCTTCCCGGATTTGAGACTGTGACCCTGGGAGGATGTCG 68 FBan0012338 FBgn0033543 CG12338 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 D-aspartate oxidase activity; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; D-amino-acid oxidase activity; GO:0003884 ; EC:1.4.3.3; ; GO:0003884 ; EC:1.4.3.3 CG12338 CG12338 CDMC28178 1 19 9 DAC15-A18 24-CG12708-RA_4 CG12708 TTCTTAAAATAAATCCGCGAACCATTTATTTTATTTTTTTGCTGTTGGAAATAAATATCAGTGCCGAA 68 FBan0012708 FBgn0030666 CG12708 X X CG12708 CG12708 CDMC28178 1 20 9 DAC15-A18 24-CG12708-RA_4 CG12708 TTCTTAAAATAAATCCGCGAACCATTTATTTTATTTTTTTGCTGTTGGAAATAAATATCAGTGCCGAA 68 FBan0012708 FBgn0030666 CG12708 X X CG12708 CG12708 CDMC28179 1 21 9 DAC15-E06 2-CG13326-RA_1 CG13326 AGAGCATCCTTTCCAAGTGTCCCACTATGAAGTTCGCCATTCGCAACTGCCTCACCTTCACGGACATC 68 FBan0013326 FBgn0033794 CG13326 2 2R CG13326 CG13326 CDMC28179 1 22 9 DAC15-E06 2-CG13326-RA_1 CG13326 AGAGCATCCTTTCCAAGTGTCCCACTATGAAGTTCGCCATTCGCAACTGCCTCACCTTCACGGACATC 68 FBan0013326 FBgn0033794 CG13326 2 2R CG13326 CG13326 CDMC28180 1 23 9 DAC15-E18 16-CG1338-RA_4 CG1338 CCACATTCAAAATAGAACACGATCGAACACGAATCCAGGAAATGTGGCAAAGGTCCAGAATAGGGGCC 68 FBan0001338 FBgn0031128 hydra X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hydra hydra CG1338 CDMC28180 1 24 9 DAC15-E18 16-CG1338-RA_4 CG1338 CCACATTCAAAATAGAACACGATCGAACACGAATCCAGGAAATGTGGCAAAGGTCCAGAATAGGGGCC 68 FBan0001338 FBgn0031128 hydra X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hydra hydra CG1338 CDMC28181 1 25 9 DAC15-I06 3-CG13760-RB_1 CG13760 GGCCCAAGCTGTTAGACCAAAACATTCCCAGTTCAGTTTCCAATTGGACGCCAGGATCAAAGGAGCGC 68 FBan0013760 FBgn0040375 CG13760 X X CG13760 CG13760 EG:BACR25B3.6 CDMC28181 1 26 9 DAC15-I06 3-CG13760-RB_1 CG13760 GGCCCAAGCTGTTAGACCAAAACATTCCCAGTTCAGTTTCCAATTGGACGCCAGGATCAAAGGAGCGC 68 FBan0013760 FBgn0040375 CG13760 X X CG13760 CG13760 EG:BACR25B3.6 CDMC28182 1 1 10 DAC15-I18 16-CG13837-RA_1 CG13837 TGGATGGTCATTACTACGACGAAAAATTGGAACGCTGTTTGGATCGAAAGTTGGTGTCGAGATGCCGG 68 FBan0013837 FBgn0039042 CG13837 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13837 CG13837 CDMC28182 1 2 10 DAC15-I18 16-CG13837-RA_1 CG13837 TGGATGGTCATTACTACGACGAAAAATTGGAACGCTGTTTGGATCGAAAGTTGGTGTCGAGATGCCGG 68 FBan0013837 FBgn0039042 CG13837 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13837 CG13837 CDMC28183 1 3 10 DAC15-M06 2-CG14219-RA_2 CG14219 TCTATGCGGTGGACTCATTTTTCTTCCTGAGCGGTCTGTTGCTCGTGGTGATTGCCCTGCGATCAATG 68 FBan0014219 FBgn0031033 CG14219 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG14219 CG14219 CDMC28183 1 4 10 DAC15-M06 2-CG14219-RA_2 CG14219 TCTATGCGGTGGACTCATTTTTCTTCCTGAGCGGTCTGTTGCTCGTGGTGATTGCCCTGCGATCAATG 68 FBan0014219 FBgn0031033 CG14219 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG14219 CG14219 CDMC28184 1 5 10 DAC15-M18 2-CG14332-RA_1 CG14332 CTGCTGGAGCTCATGGACGTCCAAATGTAGGTGGATCTGCCCATGGAAATTCCTACCAGAATCGCCAA 68 FBan0014332 FBgn0038509 CG14332 3 3R CG14332 CG14332 CDMC28184 1 6 10 DAC15-M18 2-CG14332-RA_1 CG14332 CTGCTGGAGCTCATGGACGTCCAAATGTAGGTGGATCTGCCCATGGAAATTCCTACCAGAATCGCCAA 68 FBan0014332 FBgn0038509 CG14332 3 3R CG14332 CG14332 CDMC28185 1 7 10 DAC16-A06 11-CG31043-RA_1 CG31043 CCAGTTTGGATCGCCCTCCAAGACCTTTGCTCCAAAGATGCGAGGACCCGTGAATATGGTGGCTG 65 FBan0031043 FBgn0026239 gukh 3 3R protein localization; GO:0008104 protein binding; GO:0005515; ; GO:0005515 colocalizes_with presynaptic membrane; GO:0042734 gukh GUK-holder "CG31043, CG14287, CG14288, CG5456, CG6003, gukholder, Gukh, GUKholder, anon-WO0118547.205, GUKh, GUK-holder" CDMC28185 1 8 10 DAC16-A06 11-CG31043-RA_1 CG31043 CCAGTTTGGATCGCCCTCCAAGACCTTTGCTCCAAAGATGCGAGGACCCGTGAATATGGTGGCTG 65 FBan0031043 FBgn0026239 gukh 3 3R protein localization; GO:0008104 protein binding; GO:0005515; ; GO:0005515 colocalizes_with presynaptic membrane; GO:0042734 gukh GUK-holder "CG31043, CG14287, CG14288, CG5456, CG6003, gukholder, Gukh, GUKholder, anon-WO0118547.205, GUKh, GUK-holder" CDMC28186 1 9 10 DAC16-A18 15-CG31066-RA_1 CG31066 GACAAGCGCGACAAGGTAATGTTCCCACGAAACAGGTTGTCCGCACTTCAGGCCACGACTTTGCC 65 FBan0031066 FBgn0051066 CG31066 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31066 CG31066 CDMC28186 1 10 10 DAC16-A18 15-CG31066-RA_1 CG31066 GACAAGCGCGACAAGGTAATGTTCCCACGAAACAGGTTGTCCGCACTTCAGGCCACGACTTTGCC 65 FBan0031066 FBgn0051066 CG31066 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31066 CG31066 CDMC28187 1 11 10 DAC16-E06 1-CG31173-RA_1 CG31173 AGGATCCTGGGAGTGATTTGCTTTGACATAGGCCAAAGGACATCGGATGATTCCCTGGTGGTCCG 65 FBan0031173 FBgn0045469 Gr93c 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0008527 extracellular region; GO:0005576; integral to membrane; GO:0016021 Gr93c Gustatory receptor 93c "CG13411, CG31173, CG13411, 93F.3, Gustatory receptor 93F.3, Gr93F3, GR93F.3, Gustatory receptor 93c" CDMC28187 1 12 10 DAC16-E06 1-CG31173-RA_1 CG31173 AGGATCCTGGGAGTGATTTGCTTTGACATAGGCCAAAGGACATCGGATGATTCCCTGGTGGTCCG 65 FBan0031173 FBgn0045469 Gr93c 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0008527 extracellular region; GO:0005576; integral to membrane; GO:0016021 Gr93c Gustatory receptor 93c "CG13411, CG31173, CG13411, 93F.3, Gustatory receptor 93F.3, Gr93F3, GR93F.3, Gustatory receptor 93c" CDMC28188 1 13 10 DAC16-E18 6-CG31222-RA_1 CG31222 AGCGAATGTCCGCAGTCCTGGACCACAGATGAGAACTCTGACAGCGATAGAGACACCCAGCACAG 65 FBan0031222 FBgn0051222 CG31222 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31222 CG31222 CDMC28188 1 14 10 DAC16-E18 6-CG31222-RA_1 CG31222 AGCGAATGTCCGCAGTCCTGGACCACAGATGAGAACTCTGACAGCGATAGAGACACCCAGCACAG 65 FBan0031222 FBgn0051222 CG31222 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31222 CG31222 CDMC28189 1 15 10 DAC16-I06 17-CG31302-RC_3 CG31302 GACGGGCGAAATCATACTCGTCTACGGTGATATGGATGAAGACGGTTTCTACATGGGCGAACTGG 65 FBan0031302 FBgn0051302 CG31302 3 3R ciliary or flagellar motility; GO:0001539; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226 motor activity; GO:0003774; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288 CG31302 CG31302 "CG5143, CG5152, CG5143" CDMC28189 1 16 10 DAC16-I06 17-CG31302-RC_3 CG31302 GACGGGCGAAATCATACTCGTCTACGGTGATATGGATGAAGACGGTTTCTACATGGGCGAACTGG 65 FBan0031302 FBgn0051302 CG31302 3 3R ciliary or flagellar motility; GO:0001539; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226 motor activity; GO:0003774; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288 CG31302 CG31302 "CG5143, CG5152, CG5143" CDMC28190 1 17 10 DAC16-I18 18-CG31323-RA_3 CG31323 CGCAAGTCCCGCAGACCTGGAGTCACTGATGAGGCACCTGCTCAGTCTGGTCGTGTTCCTATTGG 65 FBan0031323 FBgn0051323 CG31323 3 3R CG31323 CG31323 "CG14558, CG14558" CDMC28190 1 18 10 DAC16-I18 18-CG31323-RA_3 CG31323 CGCAAGTCCCGCAGACCTGGAGTCACTGATGAGGCACCTGCTCAGTCTGGTCGTGTTCCTATTGG 65 FBan0031323 FBgn0051323 CG31323 3 3R CG31323 CG31323 "CG14558, CG14558" CDMC28191 1 19 10 DAC16-M06 23-CG31461-RA_4 CG31461 TTGATGGGGGAAATCCTTAAAGTTCTCACACTGAAAGTATTGCTAAAACAGAAGCCTGAAGTCCG 65 FBan0031461 FBgn0051461 CG31461 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31461 CG31461 CDMC28191 1 20 10 DAC16-M06 23-CG31461-RA_4 CG31461 TTGATGGGGGAAATCCTTAAAGTTCTCACACTGAAAGTATTGCTAAAACAGAAGCCTGAAGTCCG 65 FBan0031461 FBgn0051461 CG31461 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31461 CG31461 CDMC28192 1 21 10 DAC16-M18 12-CG31493-RA_2 CG31493 GTACATGGAACTTTGGGATGCTGTCGATGCGAGCTTTAATGTCAACGAGCACTGCCAGGTGGACA 65 FBan0031493 FBgn0051493 CG31493 3 3R CG31493 CG31493 CG2640 CDMC28192 1 22 10 DAC16-M18 12-CG31493-RA_2 CG31493 GTACATGGAACTTTGGGATGCTGTCGATGCGAGCTTTAATGTCAACGAGCACTGCCAGGTGGACA 65 FBan0031493 FBgn0051493 CG31493 3 3R CG31493 CG31493 CG2640 CDMC28193 1 23 10 DAC17-A06 1-CG32638-RA_1 CG32638 TTGCCCCCGGCTAGCTAATAGTTGTTGACATCACTCGTTATTCGCCGTTCATTGTTGACGCCCCC 65 FBan0032638 FBgn0052638 CG32638 X X CG32638 CG32638 CDMC28193 1 24 10 DAC17-A06 1-CG32638-RA_1 CG32638 TTGCCCCCGGCTAGCTAATAGTTGTTGACATCACTCGTTATTCGCCGTTCATTGTTGACGCCCCC 65 FBan0032638 FBgn0052638 CG32638 X X CG32638 CG32638 CDMC28194 1 25 10 DAC17-A18 23-CG32677-RA_3 CG32677 TTGAACCGCGACATTAGTCAGAGAGTACAGCAGCTATAGTAACAGAACCCCCATATATGCTTACC 65 FBan0032677 FBgn0052677 CG32677 X X protein targeting; GO:0006605 beta-amyloid binding; GO:0001540; ; GO:0001540 CG32677 CG32677 "CG1861, CG1852, CG1861" CDMC28194 1 26 10 DAC17-A18 23-CG32677-RA_3 CG32677 TTGAACCGCGACATTAGTCAGAGAGTACAGCAGCTATAGTAACAGAACCCCCATATATGCTTACC 65 FBan0032677 FBgn0052677 CG32677 X X protein targeting; GO:0006605 beta-amyloid binding; GO:0001540; ; GO:0001540 CG32677 CG32677 "CG1861, CG1852, CG1861" CDMC28195 1 1 11 DAC17-E06 2-CG32805-RA_1 CG32805 CTGCGCATGTGCTGAAAACAGCGGTGACCTTAGCCAGTCTAAGTGAGATAGCCACAGCACGTCAG 65 FBgn0052805 CDMC28195 1 2 11 DAC17-E06 2-CG32805-RA_1 CG32805 CTGCGCATGTGCTGAAAACAGCGGTGACCTTAGCCAGTCTAAGTGAGATAGCCACAGCACGTCAG 65 FBgn0052805 CDMC28196 1 3 11 DAC17-E18 3-CG32828-RA_1 CG32828 GGTTGCTGTTCCGATTCCACTTGGACATTATTCCGCCGTTCCAATTGGAACCAGCCGTCGTCTCG 65 FBan0032828 FBgn0052828 CG32828 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32828 CG32828 CDMC28196 1 4 11 DAC17-E18 3-CG32828-RA_1 CG32828 GGTTGCTGTTCCGATTCCACTTGGACATTATTCCGCCGTTCCAATTGGAACCAGCCGTCGTCTCG 65 FBan0032828 FBgn0052828 CG32828 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32828 CG32828 CDMC28197 1 5 11 DAC17-I06 2-CG33052-RA_1 CG33052 GAGGCTCAGTTCTTGCGGGCCAAGATAGAGCTGCACAATGCATCCGAAAAGAAGGAGCTGCTCAC 65 FBan0033052 FBgn0053052 CG33052 3 3L CG33052 CG33052 CG3882 CDMC28197 1 6 11 DAC17-I06 2-CG33052-RA_1 CG33052 GAGGCTCAGTTCTTGCGGGCCAAGATAGAGCTGCACAATGCATCCGAAAAGAAGGAGCTGCTCAC 65 FBan0033052 FBgn0053052 CG33052 3 3L CG33052 CG33052 CG3882 CDMC28198 1 7 11 DAC17-I18 3-CG33090-RB_2 CG33090 CATGTCCGCCATGGCTACCATTCTGGACCAGCCGAACGATTGCCTGCGCTATCAGGATATTTTGG 65 FBan0033090 FBgn0028916 CG33090 2 2L CG33090 CG33090 "CG15287, CG31837, CG7469, BG:DS01068.2" CDMC28198 1 8 11 DAC17-I18 3-CG33090-RB_2 CG33090 CATGTCCGCCATGGCTACCATTCTGGACCAGCCGAACGATTGCCTGCGCTATCAGGATATTTTGG 65 FBan0033090 FBgn0028916 CG33090 2 2L CG33090 CG33090 "CG15287, CG31837, CG7469, BG:DS01068.2" CDMC28199 1 9 11 DAC17-M06 2-CG33180-RB_2 CG33180 GATGGACCTGTGGGCTCACGATCCTGCCGTTACGACACCAATTCTCAAATTGTTTGCCGAGCTGG 65 FBan0033180 FBgn0053180 Ranbp16 X X "protein export from nucleus; GO:0006611; protein import into nucleus, docking; GO:0000059" nuclear export signal receptor activity; GO:0005049; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005049; protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp16 Ranbp16 "CG9126, CG33180, CG9136, CG9126, RanBP16" CDMC28199 1 10 11 DAC17-M06 2-CG33180-RB_2 CG33180 GATGGACCTGTGGGCTCACGATCCTGCCGTTACGACACCAATTCTCAAATTGTTTGCCGAGCTGG 65 FBan0033180 FBgn0053180 Ranbp16 X X "protein export from nucleus; GO:0006611; protein import into nucleus, docking; GO:0000059" nuclear export signal receptor activity; GO:0005049; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005049; protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp16 Ranbp16 "CG9126, CG33180, CG9136, CG9126, RanBP16" CDMC28200 1 11 11 DAC17-M18 11-CG33231-RA_1 CG33231 CGCCGAAGCACGATGATGCCGTGAGCCTAGTGCGGAATCTCTCTACTTTGGGACAACCTCGATCG 65 FBan0033231 FBgn0053231 CG33231 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33231 CG33231 CDMC28200 1 12 11 DAC17-M18 11-CG33231-RA_1 CG33231 CGCCGAAGCACGATGATGCCGTGAGCCTAGTGCGGAATCTCTCTACTTTGGGACAACCTCGATCG 65 FBan0033231 FBgn0053231 CG33231 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33231 CG33231 CDMC28201 1 13 11 DAC18-A06 2-CG5826-RA_2 CG5826 GCCAGCTGAAGTACCCGCTCCTCTCCGATTTGACCAAGAAGATCTCTGCCGACTACGATGTGTTGCTG 68 FBan0005826 FBgn0038519 Prx5037 3 3R cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0016209 mitochondrion; GO:0005739 Prx5037 Peroxiredoxin 5037 "CG5826, CG5826, CG5826, DPx5037, DPx-5037, Thioredoxin peroxidase 3, thioredoxin-peroxidase-3, Peroxiredoxin 5037" CDMC28201 1 14 11 DAC18-A06 2-CG5826-RA_2 CG5826 GCCAGCTGAAGTACCCGCTCCTCTCCGATTTGACCAAGAAGATCTCTGCCGACTACGATGTGTTGCTG 68 FBan0005826 FBgn0038519 Prx5037 3 3R cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0016209 mitochondrion; GO:0005739 Prx5037 Peroxiredoxin 5037 "CG5826, CG5826, CG5826, DPx5037, DPx-5037, Thioredoxin peroxidase 3, thioredoxin-peroxidase-3, Peroxiredoxin 5037" CDMC28202 1 15 11 DAC18-A18 3-CG5893-RA_2 CG5893 CCTCACACCATCTGGATCAGGGTTATCCAGTGCCGTACTTCGGTGGATTTGACCCACTGGCTCTATCG 68 FBan0005893 FBgn0000411 D 3 3L "blastoderm segmentation; GO:0007350; brain development; GO:0007420; central nervous system development; GO:0007417; ectoderm development; GO:0007398; hindgut morphogenesis; GO:0007442; larval development (sensu Insecta); GO:0002168; nervous system development; GO:0007399; positive regulation of transcription, DNA-dependent; GO:0045893; post-embryonic appendage morphogenesis; GO:0035120; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; DNA bending activity; GO:0008301; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016563; ; GO:0008301; ; GO:0008301 cytoplasm; GO:0005737; nucleus; GO:0005634 D Dichaete "CG5893, l(3)LG9, Sox70D, Sox box protein 70D, fish, fish-hook, SOXDP, SOX70, SOX70D, SOXB2.1, fish hook, loD, lethal of Dichaete, Dichaete" CDMC28202 1 16 11 DAC18-A18 3-CG5893-RA_2 CG5893 CCTCACACCATCTGGATCAGGGTTATCCAGTGCCGTACTTCGGTGGATTTGACCCACTGGCTCTATCG 68 FBan0005893 FBgn0000411 D 3 3L "blastoderm segmentation; GO:0007350; brain development; GO:0007420; central nervous system development; GO:0007417; ectoderm development; GO:0007398; hindgut morphogenesis; GO:0007442; larval development (sensu Insecta); GO:0002168; nervous system development; GO:0007399; positive regulation of transcription, DNA-dependent; GO:0045893; post-embryonic appendage morphogenesis; GO:0035120; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; DNA bending activity; GO:0008301; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016563; ; GO:0008301; ; GO:0008301 cytoplasm; GO:0005737; nucleus; GO:0005634 D Dichaete "CG5893, l(3)LG9, Sox70D, Sox box protein 70D, fish, fish-hook, SOXDP, SOX70, SOX70D, SOXB2.1, fish hook, loD, lethal of Dichaete, Dichaete" CDMC28203 1 17 11 DAC18-E06 2-CG6220-RA_2 CG6220 ACGACTGCTCAGGAATACCTCAAACTGGCTCACCATTCCATGATGCGTAGCTTGGACTCTACGGTGCC 68 FBan0006220 FBgn0033865 CG6220 2 2R CG6220 CG6220 CDMC28203 1 18 11 DAC18-E06 2-CG6220-RA_2 CG6220 ACGACTGCTCAGGAATACCTCAAACTGGCTCACCATTCCATGATGCGTAGCTTGGACTCTACGGTGCC 68 FBan0006220 FBgn0033865 CG6220 2 2R CG6220 CG6220 CDMC28204 1 19 11 DAC18-E18 3-CG6312-RA_2 CG6312 TGGCTGGCATGGAGCGGCATATTCGTAGTGTTTATGTAACCAGTAACCGTTGACCCCATCAGTGTGCA 68 FBan0006312 FBgn0020379 Rfx 3 3R dendrite morphogenesis; GO:0016358; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 Rfx Rfx "CG6312, dRFX, rfx, dRfx, RFX, Regulatory factor X" CDMC28204 1 20 11 DAC18-E18 3-CG6312-RA_2 CG6312 TGGCTGGCATGGAGCGGCATATTCGTAGTGTTTATGTAACCAGTAACCGTTGACCCCATCAGTGTGCA 68 FBan0006312 FBgn0020379 Rfx 3 3R dendrite morphogenesis; GO:0016358; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 Rfx Rfx "CG6312, dRFX, rfx, dRfx, RFX, Regulatory factor X" CDMC28205 1 21 11 DAC18-I06 1-CG6725-RA_1 CG6725 GTCTGACGCCTGGAGAGAGATCCCACATGCACGATGCTTTAGATCAGTTGAAGAGCTGTCGAGGACGC 68 FBan0006725 FBgn0040271 Sulf1 3 3R metabolism; GO:0008152; pattern specification; GO:0007389; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14; alkyl sulfatase activity; GO:0018741 ; EC:3.1.6.-; ; GO:0018741 ; EC:3.1.6.- Golgi stack; GO:0005795; cell surface; GO:0009986; endoplasmic reticulum; GO:0005783 Sulf1 Sulfated "CG6725, CG6725, DSulf, Neu5, Sulfated" CDMC28205 1 22 11 DAC18-I06 1-CG6725-RA_1 CG6725 GTCTGACGCCTGGAGAGAGATCCCACATGCACGATGCTTTAGATCAGTTGAAGAGCTGTCGAGGACGC 68 FBan0006725 FBgn0040271 Sulf1 3 3R metabolism; GO:0008152; pattern specification; GO:0007389; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14; alkyl sulfatase activity; GO:0018741 ; EC:3.1.6.-; ; GO:0018741 ; EC:3.1.6.- Golgi stack; GO:0005795; cell surface; GO:0009986; endoplasmic reticulum; GO:0005783 Sulf1 Sulfated "CG6725, CG6725, DSulf, Neu5, Sulfated" CDMC28206 1 23 11 DAC18-I18 1-CG6857-RA_1 CG6857 TGCTAGTGCTATTCCGGGATCACAAACGAGCATCCTTCTTCGGCCTCACGATTGACGCCTTCTACCAC 68 FBan0006857 FBgn0030950 CCKLR-17D1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; cholecystokinin receptor activity; GO:0004951; ; GO:0008188; ; GO:0004930; neuropeptide Y receptor activity; GO:0004983; ; GO:0004951; ; GO:0004983 integral to membrane; GO:0016021 CCKLR-17D1 CCK-like receptor at 17D1 "CG6857, CG6857, CG6857, CG6857, CG6857, anon-WO0170980.61, anon-WO0170980.62, CCK-like receptor at 17D1" CDMC28206 1 24 11 DAC18-I18 1-CG6857-RA_1 CG6857 TGCTAGTGCTATTCCGGGATCACAAACGAGCATCCTTCTTCGGCCTCACGATTGACGCCTTCTACCAC 68 FBan0006857 FBgn0030950 CCKLR-17D1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; cholecystokinin receptor activity; GO:0004951; ; GO:0008188; ; GO:0004930; neuropeptide Y receptor activity; GO:0004983; ; GO:0004951; ; GO:0004983 integral to membrane; GO:0016021 CCKLR-17D1 CCK-like receptor at 17D1 "CG6857, CG6857, CG6857, CG6857, CG6857, anon-WO0170980.61, anon-WO0170980.62, CCK-like receptor at 17D1" CDMC28207 1 25 11 DAC18-M06 2-CG7332-RA_2 CG7332 GGCATCTGTGAGCAGAGCGACATCGGCTTTATAACACTGATGGAGGAAATGCGTTACTGCACGGTGGG 68 FBan0007332 FBgn0030973 CG7332 X X calcium ion binding; GO:0005509; ; GO:0005509 CG7332 CG7332 CDMC28207 1 26 11 DAC18-M06 2-CG7332-RA_2 CG7332 GGCATCTGTGAGCAGAGCGACATCGGCTTTATAACACTGATGGAGGAAATGCGTTACTGCACGGTGGG 68 FBan0007332 FBgn0030973 CG7332 X X calcium ion binding; GO:0005509; ; GO:0005509 CG7332 CG7332 CDMC28208 1 1 12 DAC18-M18 2-CG7435-RA_3 CG7435 GGCCAGAAGTCTCTGCGATCCTACTGGAGAAACTACTTCGAGTCCACTGATGGTCTGGTCTGGGTGGT 68 FBan0007435 FBgn0004908 Arf84F 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; ; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 Arf84F ADP ribosylation factor 84F "CG7435, CG7435, Arl84F, Arf84D, Q06849, Arf, Dm Arf84F, arl2: arflike-2, arflike-2" CDMC28208 1 2 12 DAC18-M18 2-CG7435-RA_3 CG7435 GGCCAGAAGTCTCTGCGATCCTACTGGAGAAACTACTTCGAGTCCACTGATGGTCTGGTCTGGGTGGT 68 FBan0007435 FBgn0004908 Arf84F 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; ; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 Arf84F ADP ribosylation factor 84F "CG7435, CG7435, Arl84F, Arf84D, Q06849, Arf, Dm Arf84F, arl2: arflike-2, arflike-2" CDMC28209 1 3 12 DAC19-A06 18-CG17769-RA_1 CG17769 CGCGAGGCTGATTTTGATGGGGATGGCATGATCAACTACGAGGAATTCGTATGGATGATAAGCCAGAAG 69 FBan0017769 FBgn0011273 And 3 3R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; detection of calcium ion; GO:0005513 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 cytoplasm; GO:0005737; flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 And Androcam "CG17769, ACaM, Camr97A: Calmodulin-related 97A, Acam, Calmodulin-related 97A, Camr97A" CDMC28209 1 4 12 DAC19-A06 18-CG17769-RA_1 CG17769 CGCGAGGCTGATTTTGATGGGGATGGCATGATCAACTACGAGGAATTCGTATGGATGATAAGCCAGAAG 69 FBan0017769 FBgn0011273 And 3 3R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; detection of calcium ion; GO:0005513 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 cytoplasm; GO:0005737; flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 And Androcam "CG17769, ACaM, Camr97A: Calmodulin-related 97A, Acam, Calmodulin-related 97A, Camr97A" CDMC28210 1 5 12 DAC19-A18 2-CG17785-RA_5 CG17785 CGGCCAGTTTCTCCAACAGTCCCGACATATCCGCCAACTCAATGGACACAAATGAATTGGCTGCCTTCA 69 FBan0017785 FBgn0039188 Golgin84 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Golgin84 Golgin84 CG17785 CDMC28210 1 6 12 DAC19-A18 2-CG17785-RA_5 CG17785 CGGCCAGTTTCTCCAACAGTCCCGACATATCCGCCAACTCAATGGACACAAATGAATTGGCTGCCTTCA 69 FBan0017785 FBgn0039188 Golgin84 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Golgin84 Golgin84 CG17785 CDMC28211 1 7 12 DAC19-E06 3-CG17838-RA_2 CG17838 AGGACGAACTGATTCCGCTATTCGAGAACTGCGGCATAATCTGGGACCTACGACTCATGATGGACCCGA 69 FBan0017838 FBgn0038826 CG17838 3 3R mRNA binding; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG17838 CG17838 "l(3)03806, cg17838, AI945337, anon-WO0118547.613" CDMC28211 1 8 12 DAC19-E06 3-CG17838-RA_2 CG17838 AGGACGAACTGATTCCGCTATTCGAGAACTGCGGCATAATCTGGGACCTACGACTCATGATGGACCCGA 69 FBan0017838 FBgn0038826 CG17838 3 3R mRNA binding; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG17838 CG17838 "l(3)03806, cg17838, AI945337, anon-WO0118547.613" CDMC28212 1 9 12 DAC19-E18 15-CG17855-RA_1 CG17855 GGAGAAAGTGAAACGTTGTCGTGCTTTGGAGGAGATGTTTAAACGGCAGAAGACGCTTACAGGCTTGGT 69 FBan0017855 FBgn0032124 CG17855 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17855 CG17855 CDMC28212 1 10 12 DAC19-E18 15-CG17855-RA_1 CG17855 GGAGAAAGTGAAACGTTGTCGTGCTTTGGAGGAGATGTTTAAACGGCAGAAGACGCTTACAGGCTTGGT 69 FBan0017855 FBgn0032124 CG17855 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17855 CG17855 CDMC28213 1 11 12 DAC19-I06 3-CG17911-RA_1 CG17911 AGGACATACTTCGGCATCGGGACAGATCTCTACGGATCTTTTGCTTTGTGCTGTTGCTACCCAGGTGGT 69 FBan0017911 FBgn0037591 Or85c 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85c Odorant receptor 85c "CG17911, 85A.3, DOR78, 85c" CDMC28213 1 12 12 DAC19-I06 3-CG17911-RA_1 CG17911 AGGACATACTTCGGCATCGGGACAGATCTCTACGGATCTTTTGCTTTGTGCTGTTGCTACCCAGGTGGT 69 FBan0017911 FBgn0037591 Or85c 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85c Odorant receptor 85c "CG17911, 85A.3, DOR78, 85c" CDMC28214 1 13 12 DAC19-I18 13-CG17927-RK_1 CG17927 ACTCCCAATATTGTTTGTCATGCAGACCAGACAAGACTTACGGACGACACGAGCTACACACTGCGCTTA 69 FBan0017927 FBgn0002741 Mhc 2 2L cytokinesis; GO:0000910; mitosis; GO:0007067; myofibril assembly; GO:0030239; striated muscle contraction; GO:0006941 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; structural constituent of muscle; GO:0008307; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0008307; microfilament motor activity; GO:0000146; ; GO:0000146" muscle myosin; GO:0005859; myosin; GO:0016459; striated muscle thick filament; GO:0005863 Mhc Myosin heavy chain "CG17927, CG17927, CG17927, Sht: Shrunken-thorax, MHC, Mhc36B, Ifm(2)2, Bsh: Bashed, myosin heavy-chain, l(2)k10423, sMHC, sarcomeric myosin heavy-chain, mMHC, DroMII, muscle myosin-II, muscle specific myosin II, myosin, mhc, muscle myosin II heavy chain, Myosin, muscle myosin, myosin heavy chain, muscle myosin heavy chain, DROMHC, ifm(2)2, DmMHC, Dm II, Myo, FBgn0002741, Nup: Not-upheld, Stp: Stuckup, l(2)36Ae, l(2)M66, Not-upheld, Shrunken-thorax, Stuckup, Bsh, Sht, Myosin heavy chain" CDMC28214 1 14 12 DAC19-I18 13-CG17927-RK_1 CG17927 ACTCCCAATATTGTTTGTCATGCAGACCAGACAAGACTTACGGACGACACGAGCTACACACTGCGCTTA 69 FBan0017927 FBgn0002741 Mhc 2 2L cytokinesis; GO:0000910; mitosis; GO:0007067; myofibril assembly; GO:0030239; striated muscle contraction; GO:0006941 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; structural constituent of muscle; GO:0008307; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0008307; microfilament motor activity; GO:0000146; ; GO:0000146" muscle myosin; GO:0005859; myosin; GO:0016459; striated muscle thick filament; GO:0005863 Mhc Myosin heavy chain "CG17927, CG17927, CG17927, Sht: Shrunken-thorax, MHC, Mhc36B, Ifm(2)2, Bsh: Bashed, myosin heavy-chain, l(2)k10423, sMHC, sarcomeric myosin heavy-chain, mMHC, DroMII, muscle myosin-II, muscle specific myosin II, myosin, mhc, muscle myosin II heavy chain, Myosin, muscle myosin, myosin heavy chain, muscle myosin heavy chain, DROMHC, ifm(2)2, DmMHC, Dm II, Myo, FBgn0002741, Nup: Not-upheld, Stp: Stuckup, l(2)36Ae, l(2)M66, Not-upheld, Shrunken-thorax, Stuckup, Bsh, Sht, Myosin heavy chain" CDMC28215 1 15 12 DAC19-M06 1-CG17964-RB_1 CG17964 CGGTCCGTGTCTCGGTTCATCTCAGGAACGAGCCATGATGCTTGGAAATCGGTTCAGTCACTTGGGAAT 69 FBan0017964 FBgn0019664 pan 4 4 "Wnt receptor signaling pathway; GO:0016055; embryonic pattern specification; GO:0009880; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; mesodermal cell fate determination; GO:0007500; negative regulation of frizzled signaling pathway; GO:0045810; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" transcription regulator activity; GO:0030528; ; GO:0030528 transcription factor complex; GO:0005667 pan pangolin "CG17964, lethal 13, l(4)13, dTCF, TCF/LEF, TCF/LEF1, TCF, DTcf, lef1, LEF-1, dTcf, Tcf, Tcf-1, DTCF, IA5, Pan, cTCF, LEF/TCF-1, LEF/TCF, Tcf/LEF, l(4)102ABb, pangolin" CDMC28215 1 16 12 DAC19-M06 1-CG17964-RB_1 CG17964 CGGTCCGTGTCTCGGTTCATCTCAGGAACGAGCCATGATGCTTGGAAATCGGTTCAGTCACTTGGGAAT 69 FBan0017964 FBgn0019664 pan 4 4 "Wnt receptor signaling pathway; GO:0016055; embryonic pattern specification; GO:0009880; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; mesodermal cell fate determination; GO:0007500; negative regulation of frizzled signaling pathway; GO:0045810; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" transcription regulator activity; GO:0030528; ; GO:0030528 transcription factor complex; GO:0005667 pan pangolin "CG17964, lethal 13, l(4)13, dTCF, TCF/LEF, TCF/LEF1, TCF, DTcf, lef1, LEF-1, dTcf, Tcf, Tcf-1, DTCF, IA5, Pan, cTCF, LEF/TCF-1, LEF/TCF, Tcf/LEF, l(4)102ABb, pangolin" CDMC28216 1 17 12 DAC19-M18 22-CG17977-RA_1 CG17977 ACCGCATCCTGAGGCCAGAAGGTCGAATAGAACCGCTGAAAAACAATTTGTCAAAGATGTTCAACTACG 69 FBan0017977 FBgn0040778 CG17977 2 2R CG17977 CG17977 CDMC28216 1 18 12 DAC19-M18 22-CG17977-RA_1 CG17977 ACCGCATCCTGAGGCCAGAAGGTCGAATAGAACCGCTGAAAAACAATTTGTCAAAGATGTTCAACTACG 69 FBan0017977 FBgn0040778 CG17977 2 2R CG17977 CG17977 CDMC28217 1 19 12 DAC20-A06 15-CG10590-RA_5 CG10590 TACCATGGTGGCGGTCACTTGCATCTGCCTGTTTGTCATCCTGCCCTTGACTCTGGTGGGTACTG 65 FBan0010590 FBgn0035622 CG10590 3 3L intracellular protein transport; GO:0006886; phagocytosis; GO:0006909 transporter activity; GO:0005215; ; GO:0005215 endosome; GO:0005768; integral to membrane; GO:0016021 CG10590 CG10590 CDMC28217 1 20 12 DAC20-A06 15-CG10590-RA_5 CG10590 TACCATGGTGGCGGTCACTTGCATCTGCCTGTTTGTCATCCTGCCCTTGACTCTGGTGGGTACTG 65 FBan0010590 FBgn0035622 CG10590 3 3L intracellular protein transport; GO:0006886; phagocytosis; GO:0006909 transporter activity; GO:0005215; ; GO:0005215 endosome; GO:0005768; integral to membrane; GO:0016021 CG10590 CG10590 CDMC28218 1 21 12 DAC20-A18 3-CG10635-RA_1 CG10635 GCACGAACAAAGTGTTCCAGAACCACGATGACGTGCACATCTCCTTCGAGGATCAGCAGCGGATC 65 FBan0010635 FBgn0035603 CG10635 3 3L 'de novo' protein folding; GO:0006458 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG10635 CG10635 BcDNA:SD11994 CDMC28218 1 22 12 DAC20-A18 3-CG10635-RA_1 CG10635 GCACGAACAAAGTGTTCCAGAACCACGATGACGTGCACATCTCCTTCGAGGATCAGCAGCGGATC 65 FBan0010635 FBgn0035603 CG10635 3 3L 'de novo' protein folding; GO:0006458 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG10635 CG10635 BcDNA:SD11994 CDMC28219 1 23 12 DAC20-E06 23-CG10737-RB_1 CG10737 GAACACACACATGTGCAATAAGTTCTTTGGATTCGTTTTTAACCCATTTCTCCGTGTCAACGTGC 65 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC28219 1 24 12 DAC20-E06 23-CG10737-RB_1 CG10737 GAACACACACATGTGCAATAAGTTCTTTGGATTCGTTTTTAACCCATTTCTCCGTGTCAACGTGC 65 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC28220 1 25 12 DAC20-E18 15-CG10761-RA_6 CG10761 GCCATCGCCCAAAACATCACCATCACTATGAGCCGACAATTTATGCATTTACCGCTTCACAGCCG 65 FBan0010761 FBgn0030015 CG10761 X X CG10761 CG10761 CDMC28220 1 26 12 DAC20-E18 15-CG10761-RA_6 CG10761 GCCATCGCCCAAAACATCACCATCACTATGAGCCGACAATTTATGCATTTACCGCTTCACAGCCG 65 FBan0010761 FBgn0030015 CG10761 X X CG10761 CG10761 CDMC28221 1 1 13 DAC20-I06 15-CG10897-RA_1 CG10897 CAAGTTCTTCGAGTCCCGCTGGGGTGAACTGACTGACAAGCACTCCTGATCCTGCACCACTAGCC 65 FBan0010897 FBgn0033636 tou 2 2R "ATP synthesis coupled proton transport; GO:0015986; chromatin remodeling; GO:0006338; regulation of transcription, DNA-dependent; GO:0006355" "chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 tou toutatis "CG10897, CG10897, CG10897, CG10897, VI, transcript group VI, gene VI, EP622, EP(2)0622, Dm Tou, EP0622, anon-48Ad, toutatis" CDMC28221 1 2 13 DAC20-I06 15-CG10897-RA_1 CG10897 CAAGTTCTTCGAGTCCCGCTGGGGTGAACTGACTGACAAGCACTCCTGATCCTGCACCACTAGCC 65 FBan0010897 FBgn0033636 tou 2 2R "ATP synthesis coupled proton transport; GO:0015986; chromatin remodeling; GO:0006338; regulation of transcription, DNA-dependent; GO:0006355" "chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 tou toutatis "CG10897, CG10897, CG10897, CG10897, VI, transcript group VI, gene VI, EP622, EP(2)0622, Dm Tou, EP0622, anon-48Ad, toutatis" CDMC28222 1 3 13 DAC20-I18 3-CG10918-RA_1 CG10918 ACCGATAGCTCCACCGATAGCTCTACCGATAGCTCCACCGATAGCTCCACTGATAGCAGCTCCAC 65 FBan0010918 FBgn0031178 CG10918 X X CG10918 CG10918 CDMC28222 1 4 13 DAC20-I18 3-CG10918-RA_1 CG10918 ACCGATAGCTCCACCGATAGCTCTACCGATAGCTCCACCGATAGCTCCACTGATAGCAGCTCCAC 65 FBan0010918 FBgn0031178 CG10918 X X CG10918 CG10918 CDMC28223 1 5 13 DAC20-M06 1-CG11072-RA_1 CG11072 TACTACAAGACGGGAGCCTGGTGGACGTCACACTAGTTTGTTCAGAGGGCACATCCATCAGAGCC 65 FBan0011072 FBgn0030535 CG11072 X X protein binding; GO:0005515; ; GO:0005515 CG11072 CG11072 CDMC28223 1 6 13 DAC20-M06 1-CG11072-RA_1 CG11072 TACTACAAGACGGGAGCCTGGTGGACGTCACACTAGTTTGTTCAGAGGGCACATCCATCAGAGCC 65 FBan0011072 FBgn0030535 CG11072 X X protein binding; GO:0005515; ; GO:0005515 CG11072 CG11072 CDMC28224 1 7 13 DAC20-M18 23-CG11089-RA_3 CG11089 AAACACCCTGTTAATCAAACCCCATCAAACTGCCTTATGACCATTCCAAGCTCAATAAAACCACT 65 FBan0011089 FBgn0039241 CG11089 3 3R purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 IMP cyclohydrolase activity; GO:0003937 ; EC:3.5.4.10; ; GO:0003937 ; EC:3.5.4.10; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; GO:0004643 ; EC:2.1.2.3; ; GO:0004643 ; EC:2.1.2.3 CG11089 CG11089 "CT30991, BEST:GH11240" CDMC28224 1 8 13 DAC20-M18 23-CG11089-RA_3 CG11089 AAACACCCTGTTAATCAAACCCCATCAAACTGCCTTATGACCATTCCAAGCTCAATAAAACCACT 65 FBan0011089 FBgn0039241 CG11089 3 3R purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 IMP cyclohydrolase activity; GO:0003937 ; EC:3.5.4.10; ; GO:0003937 ; EC:3.5.4.10; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; GO:0004643 ; EC:2.1.2.3; ; GO:0004643 ; EC:2.1.2.3 CG11089 CG11089 "CT30991, BEST:GH11240" CDMC28225 1 9 13 DAC21-A06 6-CG11172-RA_1 CG11172 AGACGGCATCGGATCCATTGGTTGACCTGCTATTGAACCACTCAAACACACCAGAAACAGCGGCT 65 FBan0011172 FBgn0030505 NFAT X X "cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; mesoderm development; GO:0007498; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700 nucleoplasm; GO:0005654; nucleus; GO:0005634 NFAT NFAT "CG11172, CG11172, CG11172, CG11172, CG11172, EP1335, MESR1, dNFAT, Rel domain protein, NFAT5, Drosophila TonEBP, NF-AT5, Misexpression Suppressor of Ras 1" CDMC28225 1 10 13 DAC21-A06 6-CG11172-RA_1 CG11172 AGACGGCATCGGATCCATTGGTTGACCTGCTATTGAACCACTCAAACACACCAGAAACAGCGGCT 65 FBan0011172 FBgn0030505 NFAT X X "cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; mesoderm development; GO:0007498; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700 nucleoplasm; GO:0005654; nucleus; GO:0005634 NFAT NFAT "CG11172, CG11172, CG11172, CG11172, CG11172, EP1335, MESR1, dNFAT, Rel domain protein, NFAT5, Drosophila TonEBP, NF-AT5, Misexpression Suppressor of Ras 1" CDMC28226 1 11 13 DAC21-A18 3-CG11198-RA_5 CG11198 CAGGCAGGTCAGGTGTGGTACCCCGACTCCTCGTACAAAACGGCACAAGCGATCAAAGATTTTGG 65 FBan0011198 FBgn0033246 CG11198 2 2R fatty acid biosynthesis; GO:0006633 ATP binding; GO:0005524; ; GO:0005524; acetyl-CoA carboxylase activity; GO:0003989 ; EC:6.4.1.2; biotin carboxylase activity; GO:0004075 ; EC:6.3.4.14; ; GO:0004075 ; EC:6.3.4.14; biotin binding; GO:0009374; ; GO:0009374; ; GO:0003989 ; EC:6.4.1.2 biotin carboxylase complex; GO:0009343 CG11198 CG11198 "CG8723, CG8723, Acetyl CoA carboxylase, Acetyl-CoA carboxylase, DmACC, FBgn0043811" CDMC28226 1 12 13 DAC21-A18 3-CG11198-RA_5 CG11198 CAGGCAGGTCAGGTGTGGTACCCCGACTCCTCGTACAAAACGGCACAAGCGATCAAAGATTTTGG 65 FBan0011198 FBgn0033246 CG11198 2 2R fatty acid biosynthesis; GO:0006633 ATP binding; GO:0005524; ; GO:0005524; acetyl-CoA carboxylase activity; GO:0003989 ; EC:6.4.1.2; biotin carboxylase activity; GO:0004075 ; EC:6.3.4.14; ; GO:0004075 ; EC:6.3.4.14; biotin binding; GO:0009374; ; GO:0009374; ; GO:0003989 ; EC:6.4.1.2 biotin carboxylase complex; GO:0009343 CG11198 CG11198 "CG8723, CG8723, Acetyl CoA carboxylase, Acetyl-CoA carboxylase, DmACC, FBgn0043811" CDMC28227 1 13 13 DAC21-E06 2-CG11307-RA_3 CG11307 TTCGTCACCATATCATCCATGGACCAGACCTCCAGTACCGACTTGGATCAAAAGCGGCTCAGGGA 65 FBan0011307 FBgn0037106 CG11307 3 3L "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-" CG11307 CG11307 CDMC28227 1 14 13 DAC21-E06 2-CG11307-RA_3 CG11307 TTCGTCACCATATCATCCATGGACCAGACCTCCAGTACCGACTTGGATCAAAAGCGGCTCAGGGA 65 FBan0011307 FBgn0037106 CG11307 3 3L "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-" CG11307 CG11307 CDMC28228 1 15 13 DAC21-E18 24-CG11373-RA_1 CG11373 GGTCCCCAAATTGGATCCACGTTTTAAATCCTGATATTCTTTTTTTATAAAATGTACGGATTCTT 65 FBan0011373 FBgn0040679 CG11373 3 3R CG11373 CG11373 CDMC28228 1 16 13 DAC21-E18 24-CG11373-RA_1 CG11373 GGTCCCCAAATTGGATCCACGTTTTAAATCCTGATATTCTTTTTTTATAAAATGTACGGATTCTT 65 FBan0011373 FBgn0040679 CG11373 3 3R CG11373 CG11373 CDMC28229 1 17 13 DAC21-I06 5-CG1151-RA_1 CG1151 CCCTCAGATCGAGCTTTTCGGTGGTGTTTCTCTGGTGAAGTCCAATGAAGGTCGTCAGGGCAAGT 65 FBan0001151 FBgn0027527 Osi6 3 3R Osi6 Osiris 6 "CG1151, CG1151, BcDNA:LD21503, Osiris, Osiris 6" CDMC28229 1 18 13 DAC21-I06 5-CG1151-RA_1 CG1151 CCCTCAGATCGAGCTTTTCGGTGGTGTTTCTCTGGTGAAGTCCAATGAAGGTCGTCAGGGCAAGT 65 FBan0001151 FBgn0027527 Osi6 3 3R Osi6 Osiris 6 "CG1151, CG1151, BcDNA:LD21503, Osiris, Osiris 6" CDMC28230 1 19 13 DAC21-I18 6-CG11539-RA_4 CG11539 GATGAGCAACGAGACCCTGAGGGAGTTGACCGCATCCGAGGAACTGACCTTAGAAGAGGAGCACG 65 FBan0011539 FBgn0039859 CG11539 3 3R CG11539 CG11539 CDMC28230 1 20 13 DAC21-I18 6-CG11539-RA_4 CG11539 GATGAGCAACGAGACCCTGAGGGAGTTGACCGCATCCGAGGAACTGACCTTAGAAGAGGAGCACG 65 FBan0011539 FBgn0039859 CG11539 3 3R CG11539 CG11539 CDMC28231 1 21 13 DAC21-M06 3-CG11629-RA_4 CG11629 GAAACTCCCCGAAGAACCCATACAAGCAGCTGAACAATGACTCGGTGGAGGAGAAACGCCTGTCG 65 FBan0011629 FBgn0032965 CG11629 2 2L CG11629 CG11629 CDMC28231 1 22 13 DAC21-M06 3-CG11629-RA_4 CG11629 GAAACTCCCCGAAGAACCCATACAAGCAGCTGAACAATGACTCGGTGGAGGAGAAACGCCTGTCG 65 FBan0011629 FBgn0032965 CG11629 2 2L CG11629 CG11629 CDMC28232 1 23 13 DAC21-M18 1-CG11674-RA_1 CG11674 AAAACTTTGTGCACAACCACAACATGACCAAGTGCATCAAGGGCTCCGCTTACGGTGACACGTGC 65 FBan0011674 FBgn0030551 CG11674 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP-dependent RNA helicase activity; GO:0004004; sugar binding; GO:0005529; ; GO:0004004; ; GO:0005529 spliceosome complex; GO:0005681 CG11674 CG11674 CDMC28232 1 24 13 DAC21-M18 1-CG11674-RA_1 CG11674 AAAACTTTGTGCACAACCACAACATGACCAAGTGCATCAAGGGCTCCGCTTACGGTGACACGTGC 65 FBan0011674 FBgn0030551 CG11674 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP-dependent RNA helicase activity; GO:0004004; sugar binding; GO:0005529; ; GO:0004004; ; GO:0005529 spliceosome complex; GO:0005681 CG11674 CG11674 CDMC28233 1 25 13 DAC22-A06 3-CG31611-RA_1 CG31611 GAACACGCCAAGAGGAAGACAGTTACAGCCATGGATGTTGTGTACGCTCTGAAGAGGCAAGGCCG 65 FBan0031611 FBgn0051611 His4:CG31611 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His4:CG31611 His4:CG31611 "CG31611, CG31611, CG31611" CDMC28233 1 26 13 DAC22-A06 3-CG31611-RA_1 CG31611 GAACACGCCAAGAGGAAGACAGTTACAGCCATGGATGTTGTGTACGCTCTGAAGAGGCAAGGCCG 65 FBan0031611 FBgn0051611 His4:CG31611 2 2L chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 His4:CG31611 His4:CG31611 "CG31611, CG31611, CG31611" CDMC28234 1 1 14 DAC22-A18 2-CG31633-RA_3 CG31633 AGTGCATTCGCTTCACGGTGACGGAACTTACACTCCAATACCTAGCCATGGATCACCTGGAGCGG 65 FBan0031633 FBgn0051633 CG31633 2 2L CG31633 CG31633 "CG13770, CG13770" CDMC28234 1 2 14 DAC22-A18 2-CG31633-RA_3 CG31633 AGTGCATTCGCTTCACGGTGACGGAACTTACACTCCAATACCTAGCCATGGATCACCTGGAGCGG 65 FBan0031633 FBgn0051633 CG31633 2 2L CG31633 CG31633 "CG13770, CG13770" CDMC28235 1 3 14 DAC22-E06 15-CG31714-RA_1 CG31714 CAGTGGGGGCAATGATGCAACGCTGGATCGGATCACGCTCGATCTGGACTACTTGCTGAACAGGG 65 FBan0031714 FBgn0032180 CG31714 2 2L G-protein coupled receptor activity; GO:0004930; ; GO:0004930 membrane; GO:0016020 CG31714 CG31714 "CG5833, CG13132, CG5833" CDMC28235 1 4 14 DAC22-E06 15-CG31714-RA_1 CG31714 CAGTGGGGGCAATGATGCAACGCTGGATCGGATCACGCTCGATCTGGACTACTTGCTGAACAGGG 65 FBan0031714 FBgn0032180 CG31714 2 2L G-protein coupled receptor activity; GO:0004930; ; GO:0004930 membrane; GO:0016020 CG31714 CG31714 "CG5833, CG13132, CG5833" CDMC28236 1 5 14 DAC22-E18 6-CG31757-RA_1 CG31757 ACGGCTCACTGACGATTATCCGACGCACCAATAGCCGCAACTTTACCCAATTCGACGGCCAACTG 65 FBan0031757 FBgn0051757 CG31757 2 2L cyclic nucleotide metabolism; GO:0009187 "3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; ; GO:0004114 ; EC:3.1.4.17" CG31757 CG31757 CG14942 CDMC28236 1 6 14 DAC22-E18 6-CG31757-RA_1 CG31757 ACGGCTCACTGACGATTATCCGACGCACCAATAGCCGCAACTTTACCCAATTCGACGGCCAACTG 65 FBan0031757 FBgn0051757 CG31757 2 2L cyclic nucleotide metabolism; GO:0009187 "3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; ; GO:0004114 ; EC:3.1.4.17" CG31757 CG31757 CG14942 CDMC28237 1 7 14 DAC22-I06 3-CG31893-RA_1 CG31893 GAGCTAGTTGCCTGCGAGCAGAACACTGGATTCGATCCGAAAACTGGAAGCTGCGTCGATTGGAG 65 FBan0031893 FBgn0040958 Peritrophin-15b 2 2L biological process unknown; GO:0000004 chitin binding; GO:0008061; ; GO:0008061 extracellular space; GO:0005615 Peritrophin-15b Peritrophin-15b "CG31893, CG13395, Dm15b, Dm-peritrophin-15b, Peritrophin-15b" CDMC28237 1 8 14 DAC22-I06 3-CG31893-RA_1 CG31893 GAGCTAGTTGCCTGCGAGCAGAACACTGGATTCGATCCGAAAACTGGAAGCTGCGTCGATTGGAG 65 FBan0031893 FBgn0040958 Peritrophin-15b 2 2L biological process unknown; GO:0000004 chitin binding; GO:0008061; ; GO:0008061 extracellular space; GO:0005615 Peritrophin-15b Peritrophin-15b "CG31893, CG13395, Dm15b, Dm-peritrophin-15b, Peritrophin-15b" CDMC28238 1 9 14 DAC22-I18 2-CG3191-RA_1 CG3191 CTTCTACCAGTGCATGTTTGGAGACGTGGAGGAGACTCGGAAGCTCATCGAGGTGAACTACGCCC 65 FBan0003191 FBgn0023525 CG3191 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 intracellular; GO:0005622 CG3191 CG3191 "CG18842, EG:30B8.3, 62D9.a, BEST:GM01072" CDMC28238 1 10 14 DAC22-I18 2-CG3191-RA_1 CG3191 CTTCTACCAGTGCATGTTTGGAGACGTGGAGGAGACTCGGAAGCTCATCGAGGTGAACTACGCCC 65 FBan0003191 FBgn0023525 CG3191 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 intracellular; GO:0005622 CG3191 CG3191 "CG18842, EG:30B8.3, 62D9.a, BEST:GM01072" CDMC28239 1 11 14 DAC22-M06 24-CG32069-RA_1 CG32069 TGGCCAAAATTCCCCTGATATTCCTTAACATAATTGCGATTATATTTAAACTATTACTTGGTTGA 65 FBan0032069 FBgn0052069 CG32069 3 3L CG32069 CG32069 "CG6316, CG6316, CG6316" CDMC28239 1 12 14 DAC22-M06 24-CG32069-RA_1 CG32069 TGGCCAAAATTCCCCTGATATTCCTTAACATAATTGCGATTATATTTAAACTATTACTTGGTTGA 65 FBan0032069 FBgn0052069 CG32069 3 3L CG32069 CG32069 "CG6316, CG6316, CG6316" CDMC28240 1 13 14 DAC22-M18 23-CG32098-RA_1 CG32098 AGACGGTCCGACAAGTAATCGCCTTAAAATGCAATTTGTTTTGTTGCAATCAACGATTTTTGATG 65 FBan0032098 FBgn0052098 CG32098 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32098 CG32098 CDMC28240 1 14 14 DAC22-M18 23-CG32098-RA_1 CG32098 AGACGGTCCGACAAGTAATCGCCTTAAAATGCAATTTGTTTTGTTGCAATCAACGATTTTTGATG 65 FBan0032098 FBgn0052098 CG32098 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32098 CG32098 CDMC28241 1 15 14 DAC23-A06 11-CG10732-RB_1 CG10732 CGCCGCCTACTTACCGCTCAAGTCCAGGTCCCATCTTCATGAACCACCATAACAACACGATACATCAGA 69 FBan0010732 FBgn0036365 CG10732 3 3L CG10732 CG10732 NEST:bs28e06 CDMC28241 1 16 14 DAC23-A06 11-CG10732-RB_1 CG10732 CGCCGCCTACTTACCGCTCAAGTCCAGGTCCCATCTTCATGAACCACCATAACAACACGATACATCAGA 69 FBan0010732 FBgn0036365 CG10732 3 3L CG10732 CG10732 NEST:bs28e06 CDMC28242 1 17 14 DAC23-A18 2-CG10747-RA_1 CG10747 GGAGATTTTTGAGCCACTTCTGGAGATTCGCCAGTTCGTGGACACCCATCCAGAGGAGGTGGTAATCCT 69 FBan0010747 FBgn0032845 CG10747 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 phospholipase C activity; GO:0004629 ; EC:3.1.4.3; ; GO:0004629 ; EC:3.1.4.3 CG10747 CG10747 38B.13 CDMC28242 1 18 14 DAC23-A18 2-CG10747-RA_1 CG10747 GGAGATTTTTGAGCCACTTCTGGAGATTCGCCAGTTCGTGGACACCCATCCAGAGGAGGTGGTAATCCT 69 FBan0010747 FBgn0032845 CG10747 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 phospholipase C activity; GO:0004629 ; EC:3.1.4.3; ; GO:0004629 ; EC:3.1.4.3 CG10747 CG10747 38B.13 CDMC28243 1 19 14 DAC23-E06 23-CG10788-RB_1 CG10788 TGACGCCTTTGAAAATGTAGTTTTTCTTTTTGGTTTTCTTTTTTCCGTTCAAAACACTTAAGGCAAATA 69 FBan0010788 FBgn0010295 ng3 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng3 new glue 3 "CG10788, ng-3, ng, BcDNA:LP03924, EG:96G10.3" CDMC28243 1 20 14 DAC23-E06 23-CG10788-RB_1 CG10788 TGACGCCTTTGAAAATGTAGTTTTTCTTTTTGGTTTTCTTTTTTCCGTTCAAAACACTTAAGGCAAATA 69 FBan0010788 FBgn0010295 ng3 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng3 new glue 3 "CG10788, ng-3, ng, BcDNA:LP03924, EG:96G10.3" CDMC28244 1 21 14 DAC23-E18 22-CG1079-RA_1 CG1079 GCAAGTGGTATGTGATGCATAGCTTCTACCAGAGTCTACGCACCATGAATAAGCTTCGAGAGATTGCCA 69 FBan0001079 FBgn0026592 CG1079 3 3L CG1079 CG1079 "HL04053, BEST:HL04053" CDMC28244 1 22 14 DAC23-E18 22-CG1079-RA_1 CG1079 GCAAGTGGTATGTGATGCATAGCTTCTACCAGAGTCTACGCACCATGAATAAGCTTCGAGAGATTGCCA 69 FBan0001079 FBgn0026592 CG1079 3 3L CG1079 CG1079 "HL04053, BEST:HL04053" CDMC28245 1 23 14 DAC23-I06 1-CG1082-RA_1 CG1082 CCACCTCGGACCCAAATGCTCCACTCACTAAATCTCTGGTGGATTGGAAGCCCGTAACTCGATTCGGAA 69 FBan0001082 FBgn0015572 alpha-Est4 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est4 alpha-Esterase-4 "CG1082, alphaE4, C: Group C, fragment C, aE4" CDMC28245 1 24 14 DAC23-I06 1-CG1082-RA_1 CG1082 CCACCTCGGACCCAAATGCTCCACTCACTAAATCTCTGGTGGATTGGAAGCCCGTAACTCGATTCGGAA 69 FBan0001082 FBgn0015572 alpha-Est4 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est4 alpha-Esterase-4 "CG1082, alphaE4, C: Group C, fragment C, aE4" CDMC28246 1 25 14 DAC23-I18 11-CG10839-RA_1 CG10839 AAGAACCTGAAAGTCCTGAGCCTGGCACGTAACAATCTTAAAACGCTCAACGGCATAGAACCACTGGCC 69 FBan0010839 FBgn0028858 CG10839 2 2L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG10839 CG10839 BG:DS07486.2 CDMC28246 1 26 14 DAC23-I18 11-CG10839-RA_1 CG10839 AAGAACCTGAAAGTCCTGAGCCTGGCACGTAACAATCTTAAAACGCTCAACGGCATAGAACCACTGGCC 69 FBan0010839 FBgn0028858 CG10839 2 2L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG10839 CG10839 BG:DS07486.2 CDMC28247 1 1 15 DAC23-M06 9-CG1086-RB_2 CG1086 ACTACACGTTCTTGCCGTTCAGCGTATTCCTGGCCATCTTCTGGATATTCACGTACAAGAAGGTGCCCG 69 FBan0001086 FBgn0025593 Glut1 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; glucose transport; GO:0015758; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; glucose transporter activity; GO:0005355; ; GO:0005355; protein binding; GO:0005515; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005525; ; GO:0005355; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624; nucleolus; GO:0005730; nucleus; GO:0005634 Glut1 Glucose transporter 1 "CG1086, CG1086, Dmglut1, glut1, glucose transporter 1, GLU" CDMC28247 1 2 15 DAC23-M06 9-CG1086-RB_2 CG1086 ACTACACGTTCTTGCCGTTCAGCGTATTCCTGGCCATCTTCTGGATATTCACGTACAAGAAGGTGCCCG 69 FBan0001086 FBgn0025593 Glut1 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; glucose transport; GO:0015758; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; glucose transporter activity; GO:0005355; ; GO:0005355; protein binding; GO:0005515; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351; ; GO:0005525; ; GO:0005355; ; GO:0005515 integral to membrane; GO:0016021; membrane; GO:0016020; membrane fraction; GO:0005624; nucleolus; GO:0005730; nucleus; GO:0005634 Glut1 Glucose transporter 1 "CG1086, CG1086, Dmglut1, glut1, glucose transporter 1, GLU" CDMC28248 1 3 15 DAC23-M18 16-CG1089-RA_1 CG1089 GGCACGGCTTTAATCGCACCTTTAACGCCAGACTTACCTATGCAAAAGCACCCACATATTACTATCGCT 69 FBan0001089 FBgn0015573 alpha-Est5 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est5 alpha-Esterase-5 "CG1089, alphaE5, D, fragment D, aE5" CDMC28248 1 4 15 DAC23-M18 16-CG1089-RA_1 CG1089 GGCACGGCTTTAATCGCACCTTTAACGCCAGACTTACCTATGCAAAAGCACCCACATATTACTATCGCT 69 FBan0001089 FBgn0015573 alpha-Est5 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est5 alpha-Esterase-5 "CG1089, alphaE5, D, fragment D, aE5" CDMC28249 1 5 15 DAC24-A06 9-CG14920-RA_5 CG14920 GGCACTCCGTTGTGCAGAACCTATCACCTACCAGCCATGTTGATTATCCTGCTCGTCCTCATCCAGAAC 69 FBan0014920 FBgn0032337 CG14920 2 2L CG14920 CG14920 CDMC28249 1 6 15 DAC24-A06 9-CG14920-RA_5 CG14920 GGCACTCCGTTGTGCAGAACCTATCACCTACCAGCCATGTTGATTATCCTGCTCGTCCTCATCCAGAAC 69 FBan0014920 FBgn0032337 CG14920 2 2L CG14920 CG14920 CDMC28250 1 7 15 DAC24-A18 8-CG14931-RA_1 CG14931 CGAGAGCGAGTCTGATTTTTTGACTTCGCATCCCAGTGCTTTGCACAACTCCACGATGATCATGTCGCC 69 FBan0014931 FBgn0032374 CG14931 2 2L CG14931 CG14931 CDMC28250 1 8 15 DAC24-A18 8-CG14931-RA_1 CG14931 CGAGAGCGAGTCTGATTTTTTGACTTCGCATCCCAGTGCTTTGCACAACTCCACGATGATCATGTCGCC 69 FBan0014931 FBgn0032374 CG14931 2 2L CG14931 CG14931 CDMC28251 1 9 15 DAC24-E06 9-CG14960-RA_1 CG14960 TCGGCTATGGTTGCCTTTCTGGTCGCCATTGGTATGAAGTCTCTGTTCCTGCTCAAGGTCTTAGTGGTT 69 FBan0014960 FBgn0035428 CG14960 3 3L CG14960 CG14960 CDMC28251 1 10 15 DAC24-E06 9-CG14960-RA_1 CG14960 TCGGCTATGGTTGCCTTTCTGGTCGCCATTGGTATGAAGTCTCTGTTCCTGCTCAAGGTCTTAGTGGTT 69 FBan0014960 FBgn0035428 CG14960 3 3L CG14960 CG14960 CDMC28252 1 11 15 DAC24-E18 2-CG14968-RE_1 CG14968 GCCAGCATCAATCACTGGAGCTATCCCATCGACACGATCTCGTATGGCGTTCAGGACCTGGTCTACACA 69 FBan0014968 FBgn0035431 CG14968 3 3L CG14968 CG14968 "anon-WO0107627.1, anon-WO0107627.2, anon-WO0107627.3" CDMC28252 1 12 15 DAC24-E18 2-CG14968-RE_1 CG14968 GCCAGCATCAATCACTGGAGCTATCCCATCGACACGATCTCGTATGGCGTTCAGGACCTGGTCTACACA 69 FBan0014968 FBgn0035431 CG14968 3 3L CG14968 CG14968 "anon-WO0107627.1, anon-WO0107627.2, anon-WO0107627.3" CDMC28253 1 13 15 DAC24-I06 2-CG14998-RD_2 CG14998 TCCACATACCATTAACCCATCCACATTTACAGCGCCTCACTGCTAGGAGGGCATATTCGAACCCCCTCT 69 FBan0014998 FBgn0035500 CG14998 3 3L CG14998 CG14998 Dm-308 CDMC28253 1 14 15 DAC24-I06 2-CG14998-RD_2 CG14998 TCCACATACCATTAACCCATCCACATTTACAGCGCCTCACTGCTAGGAGGGCATATTCGAACCCCCTCT 69 FBan0014998 FBgn0035500 CG14998 3 3L CG14998 CG14998 Dm-308 CDMC28254 1 15 15 DAC24-I18 16-CG15009-RA_1 CG15009 ACTGCAGCCTGAGTTTTAGTCCAAGTGAAATCGAAAGCCCACCTTAACGTATTCCATTTCCACCGGAAA 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC28254 1 16 15 DAC24-I18 16-CG15009-RA_1 CG15009 ACTGCAGCCTGAGTTTTAGTCCAAGTGAAATCGAAAGCCCACCTTAACGTATTCCATTTCCACCGGAAA 69 FBan0015009 FBgn0001257 ImpL2 3 3L cell adhesion; GO:0007155 extracellular region; GO:0005576 ImpL2 Ecdysone-inducible gene L2 "CG15009, Imp-L2, IMP-L2, neural and ectodermal development factor, CT34862, Imp-12, IMPL2, ImpL-2" CDMC28255 1 17 15 DAC24-M06 3-CG15035-RA_3 CG15035 ATGCAGCAAATATCGGAGACAGTGGTTTTTTGGTGGTGCGATCTGGTAAAGTGGTTTGCCGGTCCCAGG 69 FBan0015035 FBgn0029949 CG15035 X X CG15035 CG15035 CDMC28255 1 18 15 DAC24-M06 3-CG15035-RA_3 CG15035 ATGCAGCAAATATCGGAGACAGTGGTTTTTTGGTGGTGCGATCTGGTAAAGTGGTTTGCCGGTCCCAGG 69 FBan0015035 FBgn0029949 CG15035 X X CG15035 CG15035 CDMC28256 1 19 15 DAC24-M18 2-CG15056-RA_1 CG15056 ACGCGGAGGTCCACATACCCCAATGTTTTCACATTTCGAGGATTTCATACGCCTGATGTCGATCCGGCT 69 FBan0015056 FBgn0030918 CG15056 X X CG15056 CG15056 CDMC28256 1 20 15 DAC24-M18 2-CG15056-RA_1 CG15056 ACGCGGAGGTCCACATACCCCAATGTTTTCACATTTCGAGGATTTCATACGCCTGATGTCGATCCGGCT 69 FBan0015056 FBgn0030918 CG15056 X X CG15056 CG15056 CDMC28257 1 21 15 DAC25-A06 2-CG14304-RA_4 CG14304 AGCGCCCTCCATTAACGCCTGCATACGTACCAGAGGATCAGGATCAGCTACCAGATATTCGCACCTCAT 69 FBan0014304 FBgn0038629 CG14304 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14304 CG14304 CDMC28257 1 22 15 DAC25-A06 2-CG14304-RA_4 CG14304 AGCGCCCTCCATTAACGCCTGCATACGTACCAGAGGATCAGGATCAGCTACCAGATATTCGCACCTCAT 69 FBan0014304 FBgn0038629 CG14304 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG14304 CG14304 CDMC28258 1 23 15 DAC25-A18 1-CG1430-RA_1 CG1430 GTGCGCGATGTGTTGAAACGCTATCGCAGTGGCAAGATCCCTAAGGCCTTCAAGATCATACCCAAGCTG 69 FBan0001430 FBgn0010292 bys X X cell adhesion; GO:0007155 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 bys by S6 "CG1430, bystin" CDMC28258 1 24 15 DAC25-A18 1-CG1430-RA_1 CG1430 GTGCGCGATGTGTTGAAACGCTATCGCAGTGGCAAGATCCCTAAGGCCTTCAAGATCATACCCAAGCTG 69 FBan0001430 FBgn0010292 bys X X cell adhesion; GO:0007155 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 bys by S6 "CG1430, bystin" CDMC28259 1 25 15 DAC25-E06 6-CG14352-RA_2 CG14352 GCCTCAGAAGCGCCTCTACCGAAGTCAAGCTCGTGCCGAATAACTCAAGCTACTCAGTTGACAGACCAA 69 FBan0014352 FBgn0031351 CG14352 2 2L CG14352 CG14352 CDMC28259 1 26 15 DAC25-E06 6-CG14352-RA_2 CG14352 GCCTCAGAAGCGCCTCTACCGAAGTCAAGCTCGTGCCGAATAACTCAAGCTACTCAGTTGACAGACCAA 69 FBan0014352 FBgn0031351 CG14352 2 2L CG14352 CG14352 CDMC28260 1 1 16 DAC25-E18 22-CG14362-RA_1 CG14362 ACGGACTCGAACCAAATAATGTTCCAAGACTTCTGCAAAGCATTCGCAGTCTTCGACATGACCGAAATG 69 FBan0014362 FBgn0038186 CG14362 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG14362 CG14362 CDMC28260 1 2 16 DAC25-E18 22-CG14362-RA_1 CG14362 ACGGACTCGAACCAAATAATGTTCCAAGACTTCTGCAAAGCATTCGCAGTCTTCGACATGACCGAAATG 69 FBan0014362 FBgn0038186 CG14362 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG14362 CG14362 CDMC28261 1 3 16 DAC25-I06 13-CG14417-RA_1 CG14417 GGCGACAAGTACCTACGTCATTCCGATGTCTTGGAACGATCTGATTGGGACGTTCAATTTCCCAGAGCC 69 FBan0014417 FBgn0040353 CG14417 X X CG14417 CG14417 EG:BACR43E12.6 CDMC28261 1 4 16 DAC25-I06 13-CG14417-RA_1 CG14417 GGCGACAAGTACCTACGTCATTCCGATGTCTTGGAACGATCTGATTGGGACGTTCAATTTCCCAGAGCC 69 FBan0014417 FBgn0040353 CG14417 X X CG14417 CG14417 EG:BACR43E12.6 CDMC28262 1 5 16 DAC25-I18 9-CG14427-RA_2 CG14427 CGTCGCCGATTTGCCAAAGAAGGGATAATGCTCAGATGCCTCCCTCATCGTACCAGAAGTGGAGAAACT 69 FBan0014427 FBgn0029931 CG14427 X X CG14427 CG14427 CDMC28262 1 6 16 DAC25-I18 9-CG14427-RA_2 CG14427 CGTCGCCGATTTGCCAAAGAAGGGATAATGCTCAGATGCCTCCCTCATCGTACCAGAAGTGGAGAAACT 69 FBan0014427 FBgn0029931 CG14427 X X CG14427 CG14427 CDMC28263 1 7 16 DAC25-M06 2-CG14470-RA_1 CG14470 TCCCGCGTCCCGAATTTGATGGATTGGTCCGATACGAGATTGATGTGCAGCAAACGATTGCATTTGCCA 69 FBan0014470 FBgn0033046 CG14470 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG14470 CG14470 CDMC28263 1 8 16 DAC25-M06 2-CG14470-RA_1 CG14470 TCCCGCGTCCCGAATTTGATGGATTGGTCCGATACGAGATTGATGTGCAGCAAACGATTGCATTTGCCA 69 FBan0014470 FBgn0033046 CG14470 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG14470 CG14470 CDMC28264 1 9 16 DAC25-M18 14-CG14488-RA_1 CG14488 GCCACCGAAAAACGAAGAGACCGAGGAAGTTCTGGTCAACAAGTATCCACTTTACTGCACTACTGCCGT 69 FBan0014488 FBgn0034278 CG14488 2 2R CG14488 CG14488 CDMC28264 1 10 16 DAC25-M18 14-CG14488-RA_1 CG14488 GCCACCGAAAAACGAAGAGACCGAGGAAGTTCTGGTCAACAAGTATCCACTTTACTGCACTACTGCCGT 69 FBan0014488 FBgn0034278 CG14488 2 2R CG14488 CG14488 CDMC28265 1 11 16 DAC26-A06 2-CG4707-RA_1 CG4707 GCCGGACATAGAGCCTGAGGAACGTTACGCTGAGATTCCCAAGCGGGTTGTGGTGAAACCTAAGAAGTA 69 FBan0004707 FBgn0035036 CG4707 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4707 CG4707 CDMC28265 1 12 16 DAC26-A06 2-CG4707-RA_1 CG4707 GCCGGACATAGAGCCTGAGGAACGTTACGCTGAGATTCCCAAGCGGGTTGTGGTGAAACCTAAGAAGTA 69 FBan0004707 FBgn0035036 CG4707 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4707 CG4707 CDMC28266 1 13 16 DAC26-A18 23-CG4719-RA_4 CG4719 TTGGGTTAATCAAAAGTGAAGCACAGTTTTTGAGTGATTTTAATTCGAAATACGGAAAATGCGATTCGA 69 FBan0004719 FBgn0027508 tankyrase 3 3R "DNA replication; GO:0006260; cytoskeletal anchoring; GO:0007016; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005200; ; GO:0016779 ; EC:2.7.7.- tankyrase tankyrase "CG4719, CG17487, BcDNA:LD22548" CDMC28266 1 14 16 DAC26-A18 23-CG4719-RA_4 CG4719 TTGGGTTAATCAAAAGTGAAGCACAGTTTTTGAGTGATTTTAATTCGAAATACGGAAAATGCGATTCGA 69 FBan0004719 FBgn0027508 tankyrase 3 3R "DNA replication; GO:0006260; cytoskeletal anchoring; GO:0007016; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005200; ; GO:0016779 ; EC:2.7.7.- tankyrase tankyrase "CG4719, CG17487, BcDNA:LD22548" CDMC28267 1 15 16 DAC26-E06 23-CG4750-RA_5 CG4750 TTGATGCTTTGGTACAGTGTTTGCACAGAAAAAACATTCTGGTCTGGAGAAGCCATCCTCGTAAAGGTT 69 FBan0004750 FBgn0034134 CG4750 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG4750 CG4750 anon-WO0140519.81 CDMC28267 1 16 16 DAC26-E06 23-CG4750-RA_5 CG4750 TTGATGCTTTGGTACAGTGTTTGCACAGAAAAAACATTCTGGTCTGGAGAAGCCATCCTCGTAAAGGTT 69 FBan0004750 FBgn0034134 CG4750 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG4750 CG4750 anon-WO0140519.81 CDMC28268 1 17 16 DAC26-E18 17-CG4756-RA_1 CG4756 ACCCATCAAGGAGAAGGAGATCATCACATTCTTCGTGTACATGGTGAAGATGGGCTCGAATAAGCTGGA 69 FBan0004756 FBgn0030788 CG4756 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 CG4756 CG4756 CDMC28268 1 18 16 DAC26-E18 17-CG4756-RA_1 CG4756 ACCCATCAAGGAGAAGGAGATCATCACATTCTTCGTGTACATGGTGAAGATGGGCTCGAATAAGCTGGA 69 FBan0004756 FBgn0030788 CG4756 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 CG4756 CG4756 CDMC28269 1 19 16 DAC26-I06 15-CG4783-RA_4 CG4783 TGGCAGACCCAAGGTGGTTACTCAGAATGTACAGAATGCATATTGGTCTGCTCGGACAAAAGGAGGTGT 69 FBan0004783 FBgn0038756 CG4783 3 3R CG4783 CG4783 GH26202 CDMC28269 1 20 16 DAC26-I06 15-CG4783-RA_4 CG4783 TGGCAGACCCAAGGTGGTTACTCAGAATGTACAGAATGCATATTGGTCTGCTCGGACAAAAGGAGGTGT 69 FBan0004783 FBgn0038756 CG4783 3 3R CG4783 CG4783 GH26202 CDMC28270 1 21 16 DAC26-I18 1-CG4790-RA_1 CG4790 GGGCGCCTTATGAAGTTGGTTCGAATGGGGGTAGAGTCCCGACAGGATCTAATACTCACCAGTGGCATG 69 FBan0004790 FBgn0005390 fs(1)M3 X X eggshell formation (sensu Insecta); GO:0007304; terminal region determination; GO:0007362; vitelline membrane formation (sensu Insecta); GO:0007305 external side of plasma membrane; GO:0009897; extracellular region; GO:0005576 fs(1)M3 female sterile (1) M3 "CG4790, fs(1)K646, Fs(1)K646, fs(1)ph, fs(1)pole hole, fs(1)polehole, fs(1)phl" CDMC28270 1 22 16 DAC26-I18 1-CG4790-RA_1 CG4790 GGGCGCCTTATGAAGTTGGTTCGAATGGGGGTAGAGTCCCGACAGGATCTAATACTCACCAGTGGCATG 69 FBan0004790 FBgn0005390 fs(1)M3 X X eggshell formation (sensu Insecta); GO:0007304; terminal region determination; GO:0007362; vitelline membrane formation (sensu Insecta); GO:0007305 external side of plasma membrane; GO:0009897; extracellular region; GO:0005576 fs(1)M3 female sterile (1) M3 "CG4790, fs(1)K646, Fs(1)K646, fs(1)ph, fs(1)pole hole, fs(1)polehole, fs(1)phl" CDMC28271 1 23 16 DAC26-M06 3-CG4822-RA_2 CG4822 ACCCGGCTGACTTCATTATCGAAGTTGCTTGCCTTGAGTATGGCGGGTCCTATCACGAGCCAATGGTAG 69 FBan0004822 FBgn0031220 CG4822 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG4822 CG4822 CDMC28271 1 24 16 DAC26-M06 3-CG4822-RA_2 CG4822 ACCCGGCTGACTTCATTATCGAAGTTGCTTGCCTTGAGTATGGCGGGTCCTATCACGAGCCAATGGTAG 69 FBan0004822 FBgn0031220 CG4822 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG4822 CG4822 CDMC28272 1 25 16 DAC26-M18 24-CG4843-RA_2 CG4843 AGTAGCAGAATGTATAAAGTAAACAAAACGAAAACAAGAACACGAATTTTGTATTTTTAAAATCAATGT 69 FBan0004843 FBgn0004117 Tm2 3 3R muscle contraction; GO:0006936 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 muscle thin filament tropomyosin; GO:0005862 Tm2 Tropomyosin 2 "CG4843, CG4843, CG4843, mTmI, Ifm(3)3, dro Tm, TmI, Tropomyosin-2, tropomyosin, Ifm-TmI, Tn-H, Tm1, DROTROPI1, Tropomyosin, tropomyosin I, l(3)nc99Eb, Tropomyosin I, Troponin H, Tm, Ifm(3)5: Indirect flight muscle, lethal(3)nc99Eb" CDMC28272 1 26 16 DAC26-M18 24-CG4843-RA_2 CG4843 AGTAGCAGAATGTATAAAGTAAACAAAACGAAAACAAGAACACGAATTTTGTATTTTTAAAATCAATGT 69 FBan0004843 FBgn0004117 Tm2 3 3R muscle contraction; GO:0006936 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 muscle thin filament tropomyosin; GO:0005862 Tm2 Tropomyosin 2 "CG4843, CG4843, CG4843, mTmI, Ifm(3)3, dro Tm, TmI, Tropomyosin-2, tropomyosin, Ifm-TmI, Tn-H, Tm1, DROTROPI1, Tropomyosin, tropomyosin I, l(3)nc99Eb, Tropomyosin I, Troponin H, Tm, Ifm(3)5: Indirect flight muscle, lethal(3)nc99Eb" CDMC28273 1 1 17 DAC27-A06 3-CG3455-RA_1 CG3455 CCGATGCCGGACAATCTGCGGGTGAAAGCCTTATCCGAGTACCGAAAGAAGTTGCTAGAGCACAAGGAA 69 FBan0003455 FBgn0028685 Rpt4 X X proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0003676; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt4 Rpt4 "CG3455, p42D, Dmp42D, Dm_Rpt4a, Dm_Rpt4b, l(1)G0114, l(1)G0227, l(1)G0345" CDMC28273 1 2 17 DAC27-A06 3-CG3455-RA_1 CG3455 CCGATGCCGGACAATCTGCGGGTGAAAGCCTTATCCGAGTACCGAAAGAAGTTGCTAGAGCACAAGGAA 69 FBan0003455 FBgn0028685 Rpt4 X X proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0003676; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt4 Rpt4 "CG3455, p42D, Dmp42D, Dm_Rpt4a, Dm_Rpt4b, l(1)G0114, l(1)G0227, l(1)G0345" CDMC28274 1 3 17 DAC27-A18 2-CG3478-RA_4 CG3478 CATGGCGATGAGGTCCTGGTCAGTGTGCTGCCAGCATATGTCGTGTCCACTGACAATTTGCACGAAATT 69 FBan0003478 FBgn0020258 ppk 2 2L cation transport; GO:0006812; larval locomotory behavior; GO:0008345; sodium ion transport; GO:0006814; thermosensory behavior; GO:0040040 sodium channel activity; GO:0005272; ; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk pickpocket "CG3478, PPK, dmdNaC1, BG:DS06238.1, dmdNaCl, ppk1, pickpocket1, PPK1, mdNaC1: multidendritic neurons sodium channel 1, pkt, multidendritic neurons sodium channel 1, pickpocket" CDMC28274 1 4 17 DAC27-A18 2-CG3478-RA_4 CG3478 CATGGCGATGAGGTCCTGGTCAGTGTGCTGCCAGCATATGTCGTGTCCACTGACAATTTGCACGAAATT 69 FBan0003478 FBgn0020258 ppk 2 2L cation transport; GO:0006812; larval locomotory behavior; GO:0008345; sodium ion transport; GO:0006814; thermosensory behavior; GO:0040040 sodium channel activity; GO:0005272; ; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk pickpocket "CG3478, PPK, dmdNaC1, BG:DS06238.1, dmdNaCl, ppk1, pickpocket1, PPK1, mdNaC1: multidendritic neurons sodium channel 1, pkt, multidendritic neurons sodium channel 1, pickpocket" CDMC28275 1 5 17 DAC27-E06 13-CG3520-RA_1 CG3520 ACCATCATTCGGTGCTACTTGGTTTTGTACAACGAGAAGCTTCCAAATCCTCTCAAGTGGCTTACGCCC 69 FBan0003520 FBgn0034859 CG3520 2 2R CG3520 CG3520 CDMC28275 1 6 17 DAC27-E06 13-CG3520-RA_1 CG3520 ACCATCATTCGGTGCTACTTGGTTTTGTACAACGAGAAGCTTCCAAATCCTCTCAAGTGGCTTACGCCC 69 FBan0003520 FBgn0034859 CG3520 2 2R CG3520 CG3520 CDMC28276 1 7 17 DAC27-E18 14-CG3530-RA_2 CG3530 GGGGCTATATGGCCAATCACCTGAACGAGTATATCAACCCGCTGTACAAACCAAATGTAGACGAGGCCA 69 FBan0003530 FBgn0028497 CG3530 2 2R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; zinc ion binding; GO:0008270; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008270; ; GO:0004725 ; EC:3.1.3.48 CG3530 CG3530 "CG18093, BcDNA, MYOTUBULARIN-like, BcDNA:GH04637" CDMC28276 1 8 17 DAC27-E18 14-CG3530-RA_2 CG3530 GGGGCTATATGGCCAATCACCTGAACGAGTATATCAACCCGCTGTACAAACCAAATGTAGACGAGGCCA 69 FBan0003530 FBgn0028497 CG3530 2 2R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; zinc ion binding; GO:0008270; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008270; ; GO:0004725 ; EC:3.1.3.48 CG3530 CG3530 "CG18093, BcDNA, MYOTUBULARIN-like, BcDNA:GH04637" CDMC28277 1 9 17 DAC27-I06 9-CG3571-RB_4 CG3571 GCCAGCACTGGGGAATCTGTGAGCACGGTCGAGATTTACGATCCGCTCACCAAAAAATGGAAAATGGGC 69 FBan0003571 FBgn0037978 CG3571 3 3R apoptosis; GO:0006915 actin binding; GO:0003779; ; GO:0003779 CG3571 CG3571 anon-WO0118547.179 CDMC28277 1 10 17 DAC27-I06 9-CG3571-RB_4 CG3571 GCCAGCACTGGGGAATCTGTGAGCACGGTCGAGATTTACGATCCGCTCACCAAAAAATGGAAAATGGGC 69 FBan0003571 FBgn0037978 CG3571 3 3R apoptosis; GO:0006915 actin binding; GO:0003779; ; GO:0003779 CG3571 CG3571 anon-WO0118547.179 CDMC28278 1 11 17 DAC27-I18 18-CG3587-RA_1 CG3587 ACGATCGGCTGCTAGCACTGTGATTGCGACAAGACAAATGCTAAAATAAAGTTCTTACCTCGGGCAGCA 69 FBan0003587 FBgn0023521 CG3587 X X CG3587 CG3587 EG:39E1.2 CDMC28278 1 12 17 DAC27-I18 18-CG3587-RA_1 CG3587 ACGATCGGCTGCTAGCACTGTGATTGCGACAAGACAAATGCTAAAATAAAGTTCTTACCTCGGGCAGCA 69 FBan0003587 FBgn0023521 CG3587 X X CG3587 CG3587 EG:39E1.2 CDMC28279 1 13 17 DAC27-M06 23-CG3622-RA_4 CG3622 ACGGAAAAGGAGCTCGATCTCCAATGATTTGTTCAACATAACGGAGATATTCATTAAACCATCACATTC 69 FBan0003622 FBgn0034778 CG3622 2 2R cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- CG3622 CG3622 BcDNA:GM08694 CDMC28279 1 14 17 DAC27-M06 23-CG3622-RA_4 CG3622 ACGGAAAAGGAGCTCGATCTCCAATGATTTGTTCAACATAACGGAGATATTCATTAAACCATCACATTC 69 FBan0003622 FBgn0034778 CG3622 2 2R cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- CG3622 CG3622 BcDNA:GM08694 CDMC28280 1 15 17 DAC27-M18 15-CG3638-RB_1 CG3638 CGGTGGAAAAGCGAAGACACAGTCGGCGAAAGATGACTAGGTGCTCCTGAACATTTCCAAACGAGTTTT 69 FBan0003638 FBgn0026875 CG3638 X X CG3638 CG3638 EG:33C11.3 CDMC28280 1 16 17 DAC27-M18 15-CG3638-RB_1 CG3638 CGGTGGAAAAGCGAAGACACAGTCGGCGAAAGATGACTAGGTGCTCCTGAACATTTCCAAACGAGTTTT 69 FBan0003638 FBgn0026875 CG3638 X X CG3638 CG3638 EG:33C11.3 CDMC28281 1 17 17 DAC28-A06 2-CG14721-RA_1 CG14721 CCACGACACCACTTGAACCGCTCGATGTGATAACGGGTGACTTTGACTCGATCACTGAGGAAACGGTCG 69 FBan0014721 FBgn0037942 CG14721 3 3R thiamin diphosphate biosynthesis; GO:0009229; thiamin metabolism; GO:0006772 ATP binding; GO:0005524; ; GO:0005524; thiamin diphosphokinase activity; GO:0004788 ; EC:2.7.6.2; ; GO:0004788 ; EC:2.7.6.2 CG14721 CG14721 CDMC28281 1 18 17 DAC28-A06 2-CG14721-RA_1 CG14721 CCACGACACCACTTGAACCGCTCGATGTGATAACGGGTGACTTTGACTCGATCACTGAGGAAACGGTCG 69 FBan0014721 FBgn0037942 CG14721 3 3R thiamin diphosphate biosynthesis; GO:0009229; thiamin metabolism; GO:0006772 ATP binding; GO:0005524; ; GO:0005524; thiamin diphosphokinase activity; GO:0004788 ; EC:2.7.6.2; ; GO:0004788 ; EC:2.7.6.2 CG14721 CG14721 CDMC28282 1 19 17 DAC28-A18 2-CG14741-RA_1 CG14741 GGTCCTGTTCCTGATTCCTTATGGCGTCTACAAGGATGGCGTTTCGGCAAACGGATTTGTTGTGAGCGA 69 FBan0014741 FBgn0037989 CG14741 3 3R cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG14741 CG14741 CDMC28282 1 20 17 DAC28-A18 2-CG14741-RA_1 CG14741 GGTCCTGTTCCTGATTCCTTATGGCGTCTACAAGGATGGCGTTTCGGCAAACGGATTTGTTGTGAGCGA 69 FBan0014741 FBgn0037989 CG14741 3 3R cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ; GO:0015662" integral to membrane; GO:0016021; membrane; GO:0016020 CG14741 CG14741 CDMC28283 1 21 17 DAC28-E06 10-CG14792-RD_1 CG14792 GTCCACTAACCATATGCCTGTCTCGTTCACAGGTCCGTAACTCTTTCCACGTTAACATGTCGGGAGGCT 69 FBan0014792 FBgn0003517 sta X X protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sta stubarista "CG14792, CG14792, CG14792, 37LRP/p40, Rp40, clone 2.56, P40, l(1)G0130, k14, Stubarista, l(1)G0448, EG:80H7.6, Sa, Laminin receptor, RpSA, Ribosomal protein SA, Lam-r: Laminin-receptor, anon-EST:Liang-2.56, l(1)2Af, Laminin-receptor" CDMC28283 1 22 17 DAC28-E06 10-CG14792-RD_1 CG14792 GTCCACTAACCATATGCCTGTCTCGTTCACAGGTCCGTAACTCTTTCCACGTTAACATGTCGGGAGGCT 69 FBan0014792 FBgn0003517 sta X X protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sta stubarista "CG14792, CG14792, CG14792, 37LRP/p40, Rp40, clone 2.56, P40, l(1)G0130, k14, Stubarista, l(1)G0448, EG:80H7.6, Sa, Laminin receptor, RpSA, Ribosomal protein SA, Lam-r: Laminin-receptor, anon-EST:Liang-2.56, l(1)2Af, Laminin-receptor" CDMC28284 1 23 17 DAC28-E18 17-CG14804-RA_3 CG14804 ACCATGCGGGACATTAACAAGAAGTTCTCAGTCAAGTATTTCCTCAACCTTGTGCTGATGGACACCGAG 69 FBan0014804 FBgn0014411 CG14804 X X intracellular protein transport; GO:0006886; lysosome organization and biogenesis; GO:0007040; protein targeting; GO:0006605 CG14804 CG14804 "EG:63B12.8, 131F2S, ESTS:131F2S, anon-sts13" CDMC28284 1 24 17 DAC28-E18 17-CG14804-RA_3 CG14804 ACCATGCGGGACATTAACAAGAAGTTCTCAGTCAAGTATTTCCTCAACCTTGTGCTGATGGACACCGAG 69 FBan0014804 FBgn0014411 CG14804 X X intracellular protein transport; GO:0006886; lysosome organization and biogenesis; GO:0007040; protein targeting; GO:0006605 CG14804 CG14804 "EG:63B12.8, 131F2S, ESTS:131F2S, anon-sts13" CDMC28285 1 25 17 DAC28-I06 2-CG1483-RB_1 CG1483 GGCGGGGAAGGGGTAGCACCATCAAATGAATGTGTCCCAACACCTAATGGTCAGATCAATGCGGAAGAA 69 FBan0001483 FBgn0002645 Map205 3 3R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017 cytoplasmic microtubule; GO:0005881; microtubule associated complex; GO:0005875; spindle microtubule; GO:0005876 Map205 Microtubule-associated protein 205 "CG1483, CG1483, 205K MAP, 205kD MAP, 205kDa MAP, MAP205, 205-kDa MAP, MAP4" CDMC28285 1 26 17 DAC28-I06 2-CG1483-RB_1 CG1483 GGCGGGGAAGGGGTAGCACCATCAAATGAATGTGTCCCAACACCTAATGGTCAGATCAATGCGGAAGAA 69 FBan0001483 FBgn0002645 Map205 3 3R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017 cytoplasmic microtubule; GO:0005881; microtubule associated complex; GO:0005875; spindle microtubule; GO:0005876 Map205 Microtubule-associated protein 205 "CG1483, CG1483, 205K MAP, 205kD MAP, 205kDa MAP, MAP205, 205-kDa MAP, MAP4" CDMC28286 1 1 18 DAC28-I18 2-CG14857-RA_1 CG14857 TGAAGCCTTCAGGAGGAACTGCATCGTCAAGAGGAAGCTTTCAAACCAACCGGAACAAACGGCAGGAAT 69 FBan0014857 FBgn0038262 CG14857 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14857 CG14857 CDMC28286 1 2 18 DAC28-I18 2-CG14857-RA_1 CG14857 TGAAGCCTTCAGGAGGAACTGCATCGTCAAGAGGAAGCTTTCAAACCAACCGGAACAAACGGCAGGAAT 69 FBan0014857 FBgn0038262 CG14857 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14857 CG14857 CDMC28287 1 3 18 DAC28-M06 15-CG14887-RA_3 CG14887 AGGTGTCACCGGCTGTACATTACCAAAATAATGCAGAAGTTCGATTGCGACACCTTTTTCCCCGCGATC 69 FBan0014887 FBgn0004087 Dhfr 3 3R "'de novo' IMP biosynthesis; GO:0006189; DNA metabolism; GO:0006259; folic acid and derivative metabolism; GO:0006760; glycine biosynthesis; GO:0006545; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; pyrimidine base metabolism; GO:0006206; pyrimidine deoxyribonucleotide interconversion; GO:0015955" dihydrofolate reductase activity; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3 Dhfr Dihydrofolate reductase "CG14887, DHFR, dhfr" CDMC28287 1 4 18 DAC28-M06 15-CG14887-RA_3 CG14887 AGGTGTCACCGGCTGTACATTACCAAAATAATGCAGAAGTTCGATTGCGACACCTTTTTCCCCGCGATC 69 FBan0014887 FBgn0004087 Dhfr 3 3R "'de novo' IMP biosynthesis; GO:0006189; DNA metabolism; GO:0006259; folic acid and derivative metabolism; GO:0006760; glycine biosynthesis; GO:0006545; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; pyrimidine base metabolism; GO:0006206; pyrimidine deoxyribonucleotide interconversion; GO:0015955" dihydrofolate reductase activity; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3; ; GO:0004146 ; EC:1.5.1.3 Dhfr Dihydrofolate reductase "CG14887, DHFR, dhfr" CDMC28288 1 5 18 DAC28-M18 1-CG14897-RA_1 CG14897 AGGCTTCCGTCAGTGACCTCAGAAGAGCCTGCACCTATCCAAGACAAAGTTGAGTCGATCGGGTCAGAA 69 FBan0014897 FBgn0038434 CG14897 3 3R CG14897 CG14897 CDMC28288 1 6 18 DAC28-M18 1-CG14897-RA_1 CG14897 AGGCTTCCGTCAGTGACCTCAGAAGAGCCTGCACCTATCCAAGACAAAGTTGAGTCGATCGGGTCAGAA 69 FBan0014897 FBgn0038434 CG14897 3 3R CG14897 CG14897 CDMC28289 1 7 18 DAC29-A06 23-CG6372-RA_2 CG6372 TCGTCAGCGTCCCCTAAAAATTTCCAACGACATTGTTCCCAGGGAAAAAATGTTTGTTCGTTTTAAGTA 69 FBan0006372 FBgn0035915 CG6372 3 3L proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1 intracellular; GO:0005622 CG6372 CG6372 "bs33g03.y1, bs34e01.y1, anon-WO0140519.89" CDMC28289 1 8 18 DAC29-A06 23-CG6372-RA_2 CG6372 TCGTCAGCGTCCCCTAAAAATTTCCAACGACATTGTTCCCAGGGAAAAAATGTTTGTTCGTTTTAAGTA 69 FBan0006372 FBgn0035915 CG6372 3 3L proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1 intracellular; GO:0005622 CG6372 CG6372 "bs33g03.y1, bs34e01.y1, anon-WO0140519.89" CDMC28290 1 9 18 DAC29-A18 2-CG6388-RA_4 CG6388 CCCAATGCAAGCTGTCGATGAGCAAGCAGTCTTGGATATACCAATGCACCGGATGTGAGACCTTCACGC 69 FBan0006388 FBgn0032430 CG6388 2 2L tRNA modification; GO:0006400; tRNA processing; GO:0008033 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; tRNA (guanine-N2-)-methyltransferase activity; GO:0004809 ; EC:2.1.1.32; ; GO:0003729; ; GO:0004809 ; EC:2.1.1.32 CG6388 CG6388 CDMC28290 1 10 18 DAC29-A18 2-CG6388-RA_4 CG6388 CCCAATGCAAGCTGTCGATGAGCAAGCAGTCTTGGATATACCAATGCACCGGATGTGAGACCTTCACGC 69 FBan0006388 FBgn0032430 CG6388 2 2L tRNA modification; GO:0006400; tRNA processing; GO:0008033 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; tRNA (guanine-N2-)-methyltransferase activity; GO:0004809 ; EC:2.1.1.32; ; GO:0003729; ; GO:0004809 ; EC:2.1.1.32 CG6388 CG6388 CDMC28291 1 11 18 DAC29-E06 14-CG6422-RB_1 CG6422 CGATGGCCCGGACTTTGACAGAGAAAATGACTTTGGGTCCCACTACGGGTCCAATAACCGAAAAAATGA 69 FBan0006422 FBgn0039261 CG6422 3 3R CG6422 CG6422 CDMC28291 1 12 18 DAC29-E06 14-CG6422-RB_1 CG6422 CGATGGCCCGGACTTTGACAGAGAAAATGACTTTGGGTCCCACTACGGGTCCAATAACCGAAAAAATGA 69 FBan0006422 FBgn0039261 CG6422 3 3R CG6422 CG6422 CDMC28292 1 13 18 DAC29-E18 8-CG6433-RA_1 CG6433 TGGTCAGGCAGTTTCAGGAGCCAAATGTTTTCAAGGGATTCTTCGAGTCCTGGCAAAACGATTACGGCA 69 FBan0006433 FBgn0003187 qua 2 2L "actin filament bundle formation; GO:0051017; actin filament organization; GO:0007015; cytoplasmic transport, nurse cell to oocyte; GO:0007303; nurse cell to oocyte transport (sensu Insecta); GO:0007300" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 qua quail "CG6433, CG6433, quail, fs(2)A12, anon-WO0140519.71, female sterile(2)A12" CDMC28292 1 14 18 DAC29-E18 8-CG6433-RA_1 CG6433 TGGTCAGGCAGTTTCAGGAGCCAAATGTTTTCAAGGGATTCTTCGAGTCCTGGCAAAACGATTACGGCA 69 FBan0006433 FBgn0003187 qua 2 2L "actin filament bundle formation; GO:0051017; actin filament organization; GO:0007015; cytoplasmic transport, nurse cell to oocyte; GO:0007303; nurse cell to oocyte transport (sensu Insecta); GO:0007300" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 qua quail "CG6433, CG6433, quail, fs(2)A12, anon-WO0140519.71, female sterile(2)A12" CDMC28293 1 15 18 DAC29-I06 9-CG6465-RA_1 CG6465 TGTGGTGCCTCCCTTGCTAATGGTCTGCTTCGATTGTCGTTTGGCTCTAGATGTGGACTTTGAGGAGTT 69 FBan0006465 FBgn0037818 CG6465 3 3R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; ; GO:0008237; aminoacylase activity; GO:0004046 ; EC:3.5.1.14; ; GO:0004046 ; EC:3.5.1.14 CG6465 CG6465 CDMC28293 1 16 18 DAC29-I06 9-CG6465-RA_1 CG6465 TGTGGTGCCTCCCTTGCTAATGGTCTGCTTCGATTGTCGTTTGGCTCTAGATGTGGACTTTGAGGAGTT 69 FBan0006465 FBgn0037818 CG6465 3 3R amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; ; GO:0008237; aminoacylase activity; GO:0004046 ; EC:3.5.1.14; ; GO:0004046 ; EC:3.5.1.14 CG6465 CG6465 CDMC28294 1 17 18 DAC29-I18 3-CG6483-RA_1 CG6483 ACCAGCGTCGCTAACACTCTGCAGTACGAAGTCTTCGAGGTTGTGTCCGTCTCTCAATGCCAGAACACT 69 FBan0006483 FBgn0035665 Jon65Aiii 3 3L proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Aiii Jonah 65Aiii "CG6483, CG6483, CG6483, CG6483, CG6483, Jon65A, SP98, Jonah 65A, anon-WO0140519.59, anon-EST:GressD16" CDMC28294 1 18 18 DAC29-I18 3-CG6483-RA_1 CG6483 ACCAGCGTCGCTAACACTCTGCAGTACGAAGTCTTCGAGGTTGTGTCCGTCTCTCAATGCCAGAACACT 69 FBan0006483 FBgn0035665 Jon65Aiii 3 3L proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon65Aiii Jonah 65Aiii "CG6483, CG6483, CG6483, CG6483, CG6483, Jon65A, SP98, Jonah 65A, anon-WO0140519.59, anon-EST:GressD16" CDMC28295 1 19 18 DAC29-M06 22-CG6520-RA_1 CG6520 GGAGCGAGTTGGAAAACCAAACGATTGCAGCTTAAGTCTAGTAGATCATCCTCTAAGCATGTCGGGCAA 69 FBan0006520 FBgn0034224 CG6520 2 2R CG6520 CG6520 CDMC28295 1 20 18 DAC29-M06 22-CG6520-RA_1 CG6520 GGAGCGAGTTGGAAAACCAAACGATTGCAGCTTAAGTCTAGTAGATCATCCTCTAAGCATGTCGGGCAA 69 FBan0006520 FBgn0034224 CG6520 2 2R CG6520 CG6520 CDMC28296 1 21 18 DAC29-M18 17-CG6534-RA_1 CG6534 GCCTTCACGTACGAACAACTAGTTTCCCTGGAGAACAAGTTCAAGACCACCAGATATCTCAGCGTCTGC 69 FBan0006534 FBgn0002941 slou 3 3R "ectoderm development; GO:0007398; gut mesoderm development; GO:0007502; mesodermal cell fate specification; GO:0007501; muscle cell fate determination; GO:0007521; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; somatic muscle development; GO:0007525; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 slou slouch "CG6534, PRD gene 9, Nk1, S59, S59/NK-1, NK-1, NK1/S59, NK1, S-59, slou/NK1, s59, prd9: paired-like 9, paired-like 9, slouch" CDMC28296 1 22 18 DAC29-M18 17-CG6534-RA_1 CG6534 GCCTTCACGTACGAACAACTAGTTTCCCTGGAGAACAAGTTCAAGACCACCAGATATCTCAGCGTCTGC 69 FBan0006534 FBgn0002941 slou 3 3R "ectoderm development; GO:0007398; gut mesoderm development; GO:0007502; mesodermal cell fate specification; GO:0007501; muscle cell fate determination; GO:0007521; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; somatic muscle development; GO:0007525; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 slou slouch "CG6534, PRD gene 9, Nk1, S59, S59/NK-1, NK-1, NK1/S59, NK1, S-59, slou/NK1, s59, prd9: paired-like 9, paired-like 9, slouch" CDMC28297 1 23 18 DAC30-A06 3-CG3675-RA_2 CG3675 CTGGTGGCCTACTTTGATGTCGGATTCAGCAAGAGTACGCAAAGGATCAGCTTCAGCACATCGCCCT 67 FBan0003675 FBgn0031592 Art2 2 2L protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art2 Arginine methyltransferase 2 "CG3675, DART2, Arginine methyltransferase 2" CDMC28297 1 24 18 DAC30-A06 3-CG3675-RA_2 CG3675 CTGGTGGCCTACTTTGATGTCGGATTCAGCAAGAGTACGCAAAGGATCAGCTTCAGCACATCGCCCT 67 FBan0003675 FBgn0031592 Art2 2 2L protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art2 Arginine methyltransferase 2 "CG3675, DART2, Arginine methyltransferase 2" CDMC28298 1 25 18 DAC30-A18 1-CG3821-RA_2 CG3821 GTTCCGCGATATTCTCACTGAGCAGGGCTTCACAGAGATTCACACGCCGAAGATCATTTCAGCGGCC 67 FBan0003821 FBgn0002069 Aats-asp 2 2R aspartyl-tRNA aminoacylation; GO:0006422; growth; GO:0040007 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0003729; ; GO:0004815 ; EC:6.1.1.12 cytoplasm; GO:0005737 Aats-asp Aspartyl-tRNA synthetase "CG3821, CG3821, CG3821, l(2)vr1, vr1, clone 2.49, cDNA1, DRS, poney, AspRS, l(2)k04508, l(2)49Db: lethal(2)49Db, aats-asp, l(2)v27, anon-EST:Liang-2.49, lethal(2)49Db, l(2)49Db" CDMC28298 1 26 18 DAC30-A18 1-CG3821-RA_2 CG3821 GTTCCGCGATATTCTCACTGAGCAGGGCTTCACAGAGATTCACACGCCGAAGATCATTTCAGCGGCC 67 FBan0003821 FBgn0002069 Aats-asp 2 2R aspartyl-tRNA aminoacylation; GO:0006422; growth; GO:0040007 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0003729; ; GO:0004815 ; EC:6.1.1.12 cytoplasm; GO:0005737 Aats-asp Aspartyl-tRNA synthetase "CG3821, CG3821, CG3821, l(2)vr1, vr1, clone 2.49, cDNA1, DRS, poney, AspRS, l(2)k04508, l(2)49Db: lethal(2)49Db, aats-asp, l(2)v27, anon-EST:Liang-2.49, lethal(2)49Db, l(2)49Db" CDMC28299 1 1 19 DAC30-E06 17-CG4065-RA_1 CG4065 TGCTGTGCATGAGTTCCTCTACATCTACTGGTATCCATACGAGTTCCTCATTGGCTTCCTGGTCTCC 67 FBan0004065 FBgn0034982 CG4065 2 2R CG4065 CG4065 anon-EST:Nelson1 CDMC28299 1 2 19 DAC30-E06 17-CG4065-RA_1 CG4065 TGCTGTGCATGAGTTCCTCTACATCTACTGGTATCCATACGAGTTCCTCATTGGCTTCCTGGTCTCC 67 FBan0004065 FBgn0034982 CG4065 2 2R CG4065 CG4065 anon-EST:Nelson1 CDMC28300 1 3 19 DAC30-E18 17-CG41136-RA_2 CG41136 AGCATCAGCTTGGCGTTTTGGATTTCAAACACCACCAGACTATAATGACCATGAACTCAACTGCGGA 67 FBgn0069916 CG41136 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41136 CG41136 CDMC28300 1 4 19 DAC30-E18 17-CG41136-RA_2 CG41136 AGCATCAGCTTGGCGTTTTGGATTTCAAACACCACCAGACTATAATGACCATGAACTCAACTGCGGA 67 FBgn0069916 CG41136 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41136 CG41136 CDMC28301 1 5 19 DAC30-I06 1-CG4586-RA_1 CG4586 GGCTTGCAATCATTTGTGGTGAGGATCAGGGACGAGAGGACACACGAACCGTTGACTGGAGTCGATG 67 FBan0004586 FBgn0029924 CG4586 X X fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; ; GO:0003997 ; EC:1.3.3.6 peroxisome; GO:0005777 CG4586 CG4586 CDMC28301 1 6 19 DAC30-I06 1-CG4586-RA_1 CG4586 GGCTTGCAATCATTTGTGGTGAGGATCAGGGACGAGAGGACACACGAACCGTTGACTGGAGTCGATG 67 FBan0004586 FBgn0029924 CG4586 X X fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; ; GO:0003997 ; EC:1.3.3.6 peroxisome; GO:0005777 CG4586 CG4586 CDMC28302 1 7 19 DAC30-I18 3-CG4816-RA_2 CG4816 ACCAAGAGAGTGTGCCAAATGTTTGTAGGAAGGGATTCGGAGGGAGTGGATGGCAATGGACGGATCC 67 FBan0004816 FBgn0022987 qkr54B 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" RNA binding; GO:0003723; ; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737 qkr54B quaking related 54B "CG4816, SAM, SAM50, QKR54B, p62GAP, Sam50, qrk54B" CDMC28302 1 8 19 DAC30-I18 3-CG4816-RA_2 CG4816 ACCAAGAGAGTGTGCCAAATGTTTGTAGGAAGGGATTCGGAGGGAGTGGATGGCAATGGACGGATCC 67 FBan0004816 FBgn0022987 qkr54B 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" RNA binding; GO:0003723; ; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737 qkr54B quaking related 54B "CG4816, SAM, SAM50, QKR54B, p62GAP, Sam50, qrk54B" CDMC28303 1 9 19 DAC30-M06 16-CG5207-RA_1 CG5207 AACTAGCATCATGGCGTTCACCAAGGTTCTCCAATTGATTCTCCTAGCTGTGGTTGCCATTTCCTCT 67 FBan0005207 FBgn0037889 scpr-A 3 3R scpr-A SCP-containing protein A "CG5207, bs03f04.y1, SCPR-A, SCP-containing protein A" CDMC28303 1 10 19 DAC30-M06 16-CG5207-RA_1 CG5207 AACTAGCATCATGGCGTTCACCAAGGTTCTCCAATTGATTCTCCTAGCTGTGGTTGCCATTTCCTCT 67 FBan0005207 FBgn0037889 scpr-A 3 3R scpr-A SCP-containing protein A "CG5207, bs03f04.y1, SCPR-A, SCP-containing protein A" CDMC28304 1 11 19 DAC30-M18 1-CG5358-RA_1 CG5358 GGATCAGCGTGAACGGAATAGGCGAAGGCATGGACATCACTCATGGACTTATGCATCCGCACTAGGG 67 FBan0005358 FBgn0037770 Art4 3 3R "histone methylation; GO:0016571; induction of programmed cell death by ecdysone; GO:0035078; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919; protein amino acid methylation; GO:0006479" histone methyltransferase activity; GO:0042054; ; GO:0042054; histone-arginine N-methyltransferase activity; GO:0008469 ; EC:2.1.1.125; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; ; GO:0008469 ; EC:2.1.1.125; protein-arginine omega-N asymmetric methyltransferase activity; GO:0035242; protein-arginine omega-N monomethyltransferase activity; GO:0035241; ; GO:0035242; ; GO:0035241 histone methyltransferase complex; GO:0035097 Art4 Arginine methyltransferase 4 "CG5358, CG5358, CG5358, DART4, CARMER, Coactivator Arg methyltransferase for Ecr/Usp, Carmer, Arginine methyltransferase 4" CDMC28304 1 12 19 DAC30-M18 1-CG5358-RA_1 CG5358 GGATCAGCGTGAACGGAATAGGCGAAGGCATGGACATCACTCATGGACTTATGCATCCGCACTAGGG 67 FBan0005358 FBgn0037770 Art4 3 3R "histone methylation; GO:0016571; induction of programmed cell death by ecdysone; GO:0035078; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919; protein amino acid methylation; GO:0006479" histone methyltransferase activity; GO:0042054; ; GO:0042054; histone-arginine N-methyltransferase activity; GO:0008469 ; EC:2.1.1.125; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; ; GO:0008469 ; EC:2.1.1.125; protein-arginine omega-N asymmetric methyltransferase activity; GO:0035242; protein-arginine omega-N monomethyltransferase activity; GO:0035241; ; GO:0035242; ; GO:0035241 histone methyltransferase complex; GO:0035097 Art4 Arginine methyltransferase 4 "CG5358, CG5358, CG5358, DART4, CARMER, Coactivator Arg methyltransferase for Ecr/Usp, Carmer, Arginine methyltransferase 4" CDMC28305 1 13 19 DAC31-A06 23-CG7462-RC_3 CG7462 AGTTCGATTATAGTGGTAGTATAGGTAGCAATTTCCCCAACCTAAAACCACTGTAACCGATCTTTGGGG 69 FBan0007462 FBgn0017645 Ank2 3 3L cytoskeletal anchoring; GO:0007016; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; receptor binding; GO:0005102; ; GO:0003779; ; GO:0005200; ; GO:0005102 plasma membrane; GO:0005886 Ank2 Ank2 "CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, ESTS:149B10S, Dank2" CDMC28305 1 14 19 DAC31-A06 23-CG7462-RC_3 CG7462 AGTTCGATTATAGTGGTAGTATAGGTAGCAATTTCCCCAACCTAAAACCACTGTAACCGATCTTTGGGG 69 FBan0007462 FBgn0017645 Ank2 3 3L cytoskeletal anchoring; GO:0007016; ectoderm development; GO:0007398; nervous system development; GO:0007399 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; receptor binding; GO:0005102; ; GO:0003779; ; GO:0005200; ; GO:0005102 plasma membrane; GO:0005886 Ank2 Ank2 "CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, CG7462, ESTS:149B10S, Dank2" CDMC28306 1 15 19 DAC31-A18 2-CG7479-RA_2 CG7479 GGAAACCAAAGAGCCCGTGGTCATGACCTGGGAAAAGATGTCTAAGTCAAAGCTGAATGGGGTGGAGCC 69 FBgn0035576 CDMC28306 1 16 19 DAC31-A18 2-CG7479-RA_2 CG7479 GGAAACCAAAGAGCCCGTGGTCATGACCTGGGAAAAGATGTCTAAGTCAAAGCTGAATGGGGTGGAGCC 69 FBgn0035576 CDMC28307 1 17 19 DAC31-E06 23-CG7519-RA_3 CG7519 GCCAGAAAGGTACCCGAAGAGGAACAGTAATCCCTCGCTCTAGCTTAGATTAAGTTGTAAAGACTGGAT 69 FBan0007519 FBgn0037087 CG7519 3 3L CG7519 CG7519 CDMC28307 1 18 19 DAC31-E06 23-CG7519-RA_3 CG7519 GCCAGAAAGGTACCCGAAGAGGAACAGTAATCCCTCGCTCTAGCTTAGATTAAGTTGTAAAGACTGGAT 69 FBan0007519 FBgn0037087 CG7519 3 3L CG7519 CG7519 CDMC28308 1 19 19 DAC31-E18 3-CG7529-RA_3 CG7529 GTTCCTTGCTGCTGAGTCCCAAAACCGGCGACAATATGTTCAAGAGAGCGATTGTGCAGTCAGGTTCGA 69 FBan0007529 FBgn0037090 CG7529 3 3L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG7529 CG7529 CDMC28308 1 20 19 DAC31-E18 3-CG7529-RA_3 CG7529 GTTCCTTGCTGCTGAGTCCCAAAACCGGCGACAATATGTTCAAGAGAGCGATTGTGCAGTCAGGTTCGA 69 FBan0007529 FBgn0037090 CG7529 3 3L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG7529 CG7529 CDMC28309 1 21 19 DAC31-I06 5-CG7563-RA_1 CG7563 GCGAACTGGAAAACCGTCCCCAGGGTCTGAACTTTTTCAGATACAAGTCTTCTGTGGGAAGATCGCCGC 69 FBan0007563 FBgn0012051 CalpA 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; protein autoprocessing; GO:0016540; protein metabolism; GO:0019538; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737 CalpA Calpain-A "CG7563, CG18152, CG7563, calpain, Calpain lacking calmodulin-like domain., Calpain, EST C, Calpain A" CDMC28309 1 22 19 DAC31-I06 5-CG7563-RA_1 CG7563 GCGAACTGGAAAACCGTCCCCAGGGTCTGAACTTTTTCAGATACAAGTCTTCTGTGGGAAGATCGCCGC 69 FBan0007563 FBgn0012051 CalpA 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; protein autoprocessing; GO:0016540; protein metabolism; GO:0019538; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737 CalpA Calpain-A "CG7563, CG18152, CG7563, calpain, Calpain lacking calmodulin-like domain., Calpain, EST C, Calpain A" CDMC28310 1 23 19 DAC31-I18 6-CG7576-RA_5 CG7576 CGCCCACTTCATCCACACTTTGCTTTCCCCTACGAGACTGTTGCGAACTGAATCCGGATTGCGAGTTAC 69 FBan0007576 FBgn0005586 Rab3 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein transport; GO:0015031; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 synaptic vesicle; GO:0008021 Rab3 Rab-protein 3 "CG7576, rab3, drab3, DRAB3, Drab3, Rab3A, DmRab3, AAF58762, DRab3, dm-Rab3" CDMC28310 1 24 19 DAC31-I18 6-CG7576-RA_5 CG7576 CGCCCACTTCATCCACACTTTGCTTTCCCCTACGAGACTGTTGCGAACTGAATCCGGATTGCGAGTTAC 69 FBan0007576 FBgn0005586 Rab3 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein transport; GO:0015031; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 synaptic vesicle; GO:0008021 Rab3 Rab-protein 3 "CG7576, rab3, drab3, DRAB3, Drab3, Rab3A, DmRab3, AAF58762, DRab3, dm-Rab3" CDMC28311 1 25 19 DAC31-M06 3-CG7604-RA_2 CG7604 GCAGAATGCGGATTCGATCCACAATGCCCACAAGGCTGGAATCCCGATAGTCCTCTATTACCCGATCCC 69 FBan0007604 FBgn0004592 Eig71Ee 3 3L hemolymph coagulation; GO:0042381; puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Eig71Ee Ecdysone-induced gene 71Ee "CG7604, CG7604, gene VII, VII, Gene VII, 71E-Gene-VII, I71-7, L71, eig71Ee, gp150, L71-7, gene-VII" CDMC28311 1 26 19 DAC31-M06 3-CG7604-RA_2 CG7604 GCAGAATGCGGATTCGATCCACAATGCCCACAAGGCTGGAATCCCGATAGTCCTCTATTACCCGATCCC 69 FBan0007604 FBgn0004592 Eig71Ee 3 3L hemolymph coagulation; GO:0042381; puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Eig71Ee Ecdysone-induced gene 71Ee "CG7604, CG7604, gene VII, VII, Gene VII, 71E-Gene-VII, I71-7, L71, eig71Ee, gp150, L71-7, gene-VII" CDMC28312 1 1 20 DAC31-M18 2-CG7619-RA_1 CG7619 ACCCGAGGACAACTTGCCGGACTTTGCTAACATGACTGAGGAGGAACAGATTGCCTTCGCTATGCAGAT 69 FBan0007619 FBgn0015283 Pros54 3 3L chromosome segregation; GO:0007059; protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros54 Proteasome 54kD subunit "CG7619, mu-54, 54 kda mu particle subunit of 26S protease, S5a, p54, dRpn10, S5A" CDMC28312 1 2 20 DAC31-M18 2-CG7619-RA_1 CG7619 ACCCGAGGACAACTTGCCGGACTTTGCTAACATGACTGAGGAGGAACAGATTGCCTTCGCTATGCAGAT 69 FBan0007619 FBgn0015283 Pros54 3 3L chromosome segregation; GO:0007059; protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros54 Proteasome 54kD subunit "CG7619, mu-54, 54 kda mu particle subunit of 26S protease, S5a, p54, dRpn10, S5A" CDMC28313 1 3 20 DAC32-A06 2-CG1462-RA_2 CG1462 CGAATGACTCCAGACCTCAGAACAGCTCCAACATGTGGATGCCCCTGAAGCATTTTACCGCTGAGGAG 68 FBan0001462 FBgn0016123 Aph-4 3 3R epithelial fluid transport; GO:0042045; mesoderm development; GO:0007498; metabolism; GO:0008152; nervous system development; GO:0007399; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 anchored to plasma membrane; GO:0046658 Aph-4 Alkaline phosphatase 4 "CG1462, Aph, l(3)07028, Alkaline phosphatase, AP, alkaline phosphatase, pMY51, Alkaline phosphatase-4" CDMC28313 1 4 20 DAC32-A06 2-CG1462-RA_2 CG1462 CGAATGACTCCAGACCTCAGAACAGCTCCAACATGTGGATGCCCCTGAAGCATTTTACCGCTGAGGAG 68 FBan0001462 FBgn0016123 Aph-4 3 3R epithelial fluid transport; GO:0042045; mesoderm development; GO:0007498; metabolism; GO:0008152; nervous system development; GO:0007399; skeletal development; GO:0001501 alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 anchored to plasma membrane; GO:0046658 Aph-4 Alkaline phosphatase 4 "CG1462, Aph, l(3)07028, Alkaline phosphatase, AP, alkaline phosphatase, pMY51, Alkaline phosphatase-4" CDMC28314 1 5 20 DAC32-A18 3-CG14778-RA_2 CG14778 GCTCCGGTTCAGCATGTACGGTGGTCTGTTTGTTGCTCCTACCCTCTACGGATGGGTCAAGATTTCCA 68 FBan0014778 FBgn0029580 CG14778 X X receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG14778 CG14778 CDMC28314 1 6 20 DAC32-A18 3-CG14778-RA_2 CG14778 GCTCCGGTTCAGCATGTACGGTGGTCTGTTTGTTGCTCCTACCCTCTACGGATGGGTCAAGATTTCCA 68 FBan0014778 FBgn0029580 CG14778 X X receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG14778 CG14778 CDMC28315 1 7 20 DAC32-E06 11-CG15263-RA_1 CG15263 TGGATACTACAACGAGAACTATCGCGATAGGGACACCTGTAGGGAGGCCTTTGAACTGGTCACCGTCA 68 FBan0015263 FBgn0028853 CG15263 2 2L CG15263 CG15263 BG:DS07851.4 CDMC28315 1 8 20 DAC32-E06 11-CG15263-RA_1 CG15263 TGGATACTACAACGAGAACTATCGCGATAGGGACACCTGTAGGGAGGCCTTTGAACTGGTCACCGTCA 68 FBan0015263 FBgn0028853 CG15263 2 2L CG15263 CG15263 BG:DS07851.4 CDMC28316 1 9 20 DAC32-E18 3-CG15333-RA_2 CG15333 ACAGCCACAGTATAATGGTTCCATCACACCACCGCTATTCGTTGGCAAGATTTGTCGCGAAGAGCCGG 68 FBan0015333 FBgn0029989 CG15333 X X CG15333 CG15333 "CG18293, CG18293" CDMC28316 1 10 20 DAC32-E18 3-CG15333-RA_2 CG15333 ACAGCCACAGTATAATGGTTCCATCACACCACCGCTATTCGTTGGCAAGATTTGTCGCGAAGAGCCGG 68 FBan0015333 FBgn0029989 CG15333 X X CG15333 CG15333 "CG18293, CG18293" CDMC28317 1 11 20 DAC32-I06 23-CG15712-RA_1 CG15712 AGGCGCCCATAAAAAAGTTGAGTCAGAAGAGCATCAACGTGGATGAAATACTTCAAATCGTATTTGAG 68 FBan0015712 FBgn0034131 CG15712 2 2R CG15712 CG15712 CDMC28317 1 12 20 DAC32-I06 23-CG15712-RA_1 CG15712 AGGCGCCCATAAAAAAGTTGAGTCAGAAGAGCATCAACGTGGATGAAATACTTCAAATCGTATTTGAG 68 FBan0015712 FBgn0034131 CG15712 2 2R CG15712 CG15712 CDMC28318 1 13 20 DAC32-I18 3-CG1597-RA_5 CG1597 GGCCGAGCAATTCTAGATCTCGCCTACACGGTTTTCAGCCTGCCAAAACTGCTGTGAGTTCCTCAACG 68 FBan0001597 FBgn0030289 CG1597 X X oligosaccharide metabolism; GO:0009311; protein amino acid glycosylation; GO:0006486 mannosyl-oligosaccharide glucosidase activity; GO:0004573 ; EC:3.2.1.106; ; GO:0004573 ; EC:3.2.1.106 CG1597 CG1597 CDMC28318 1 14 20 DAC32-I18 3-CG1597-RA_5 CG1597 GGCCGAGCAATTCTAGATCTCGCCTACACGGTTTTCAGCCTGCCAAAACTGCTGTGAGTTCCTCAACG 68 FBan0001597 FBgn0030289 CG1597 X X oligosaccharide metabolism; GO:0009311; protein amino acid glycosylation; GO:0006486 mannosyl-oligosaccharide glucosidase activity; GO:0004573 ; EC:3.2.1.106; ; GO:0004573 ; EC:3.2.1.106 CG1597 CG1597 CDMC28319 1 15 20 DAC32-M06 2-CG17012-RA_1 CG17012 GGCAGTACATTTGCTGATTTCTCCGGTGGTACCTGTCCTTTTGGAGCCATCTGAACGCATCATCGGCG 68 FBan0017012 FBgn0031406 CG17012 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17012 CG17012 SP163 CDMC28319 1 16 20 DAC32-M06 2-CG17012-RA_1 CG17012 GGCAGTACATTTGCTGATTTCTCCGGTGGTACCTGTCCTTTTGGAGCCATCTGAACGCATCATCGGCG 68 FBan0017012 FBgn0031406 CG17012 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG17012 CG17012 SP163 CDMC28320 1 17 20 DAC32-M18 3-CG17144-RA_1 CG17144 GCAAACCGAATGCCACTTCCGTGACCACAAACGTGGCCATAGTCTAAGCGGTCCTCTTTGTCCTGTAC 68 FBan0017144 FBgn0036267 CG17144 3 3L CG17144 CG17144 CDMC28320 1 18 20 DAC32-M18 3-CG17144-RA_1 CG17144 GCAAACCGAATGCCACTTCCGTGACCACAAACGTGGCCATAGTCTAAGCGGTCCTCTTTGTCCTGTAC 68 FBan0017144 FBgn0036267 CG17144 3 3L CG17144 CG17144 CDMC28321 1 19 20 DAC33-A06 1-CG31329-RA_2 CG31329 GGCCAACACTTGTCACGTCCGCATTACCCTAGACCCGGTTGAAAACGGACCAGTAGTGCTTCGAAT 66 FBgn0051329 CDMC28321 1 20 20 DAC33-A06 1-CG31329-RA_2 CG31329 GGCCAACACTTGTCACGTCCGCATTACCCTAGACCCGGTTGAAAACGGACCAGTAGTGCTTCGAAT 66 FBgn0051329 CDMC28322 1 21 20 DAC33-A18 3-CG3149-RA_6 CG3149 CCAAATGGAAAGCATTTCAACCGGGAACTGCAAACGCTAACCCTCAGCTTTGTGAAGCAGGGCGTG 66 FBan0003149 FBgn0027564 CG3149 X X nuclear division; GO:0000280 integral to membrane; GO:0016021 CG3149 CG3149 BcDNA:GH08388 CDMC28322 1 22 20 DAC33-A18 3-CG3149-RA_6 CG3149 CCAAATGGAAAGCATTTCAACCGGGAACTGCAAACGCTAACCCTCAGCTTTGTGAAGCAGGGCGTG 66 FBan0003149 FBgn0027564 CG3149 X X nuclear division; GO:0000280 integral to membrane; GO:0016021 CG3149 CG3149 BcDNA:GH08388 CDMC28323 1 23 20 DAC33-E06 2-CG3194-RA_1 CG3194 GCCTTGGCTTCTTCGACAATATCACCTTGTCCACCAGTGACCATCTGGCTCACTTCTACGACGCGG 66 FBan0003194 FBgn0033087 CG3194 2 2R CG3194 CG3194 CDMC28323 1 24 20 DAC33-E06 2-CG3194-RA_1 CG3194 GCCTTGGCTTCTTCGACAATATCACCTTGTCCACCAGTGACCATCTGGCTCACTTCTACGACGCGG 66 FBan0003194 FBgn0033087 CG3194 2 2R CG3194 CG3194 CDMC28324 1 25 20 DAC33-E18 15-CG32221-RA_8 CG32221 GCACCAGCAAGGATCTAATAAAAGCCATTGGGATACACCTTCCGCGGGTCAACAGTCTGAGCCTGG 66 FBan0032221 FBgn0052221 CG32221 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32221 CG32221 anon-WO0118547.270 CDMC28324 1 26 20 DAC33-E18 15-CG32221-RA_8 CG32221 GCACCAGCAAGGATCTAATAAAAGCCATTGGGATACACCTTCCGCGGGTCAACAGTCTGAGCCTGG 66 FBan0032221 FBgn0052221 CG32221 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32221 CG32221 anon-WO0118547.270 CDMC28325 1 1 21 DAC33-I06 9-CG32635-RA_3 CG32635 CAGGAGCAGGACCATCATGTGGAGGATCAGGAGTACGACGATGGCATTGGTTTCAGTTGTGACAGC 66 FBan0032635 FBgn0052635 CG32635 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; proteolysis; GO:0006508; transport; GO:0006810 procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; receptor activity; GO:0004872; ; GO:0004872; ; GO:0017026 ; EC:3.4.24.19 CG32635 CG32635 "CG12727, CG15751, CG15752, CT36003, tld-like" CDMC28325 1 2 21 DAC33-I06 9-CG32635-RA_3 CG32635 CAGGAGCAGGACCATCATGTGGAGGATCAGGAGTACGACGATGGCATTGGTTTCAGTTGTGACAGC 66 FBan0032635 FBgn0052635 CG32635 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; proteolysis; GO:0006508; transport; GO:0006810 procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; receptor activity; GO:0004872; ; GO:0004872; ; GO:0017026 ; EC:3.4.24.19 CG32635 CG32635 "CG12727, CG15751, CG15752, CT36003, tld-like" CDMC28326 1 3 21 DAC33-I18 2-CG32707-RA_1 CG32707 CGGCGAGGATCATAGGGACAGGGATCTCGTCACCTGCACCTATTACGTTAACGAAGCGTCCAGGAC 66 FBan0032707 FBgn0052707 APC4 X X mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 mRNA binding; GO:0003729; ; GO:0003729; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC4 Anaphase Promoting Complex 4 "CG32707, CG4350, CG32707, CG4350, Anaphase Promoting Complex 4" CDMC28326 1 4 21 DAC33-I18 2-CG32707-RA_1 CG32707 CGGCGAGGATCATAGGGACAGGGATCTCGTCACCTGCACCTATTACGTTAACGAAGCGTCCAGGAC 66 FBan0032707 FBgn0052707 APC4 X X mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 mRNA binding; GO:0003729; ; GO:0003729; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC4 Anaphase Promoting Complex 4 "CG32707, CG4350, CG32707, CG4350, Anaphase Promoting Complex 4" CDMC28327 1 5 21 DAC33-M06 2-CG33251-RA_1 CG33251 CGATGCATTTGAGCGTCTAGAACCGGACCTACTGCGAGATCGCTTAGATCCACTGCGAGAGCGACG 66 FBan0033251 FBgn0053251 CG33251 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33251 CG33251 CDMC28327 1 6 21 DAC33-M06 2-CG33251-RA_1 CG33251 CGATGCATTTGAGCGTCTAGAACCGGACCTACTGCGAGATCGCTTAGATCCACTGCGAGAGCGACG 66 FBan0033251 FBgn0053251 CG33251 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33251 CG33251 CDMC28328 1 7 21 DAC33-M18 2-CG33334-RA_1 CG33334 CATCGAGAGCATCAGTCTGCCGGATGTGGTTGTCGAGTCAACGACCGTCAATGCATCCACATCAGG 66 FBan0033334 FBgn0053334 CG33334 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33334 CG33334 CG5740 CDMC28328 1 8 21 DAC33-M18 2-CG33334-RA_1 CG33334 CATCGAGAGCATCAGTCTGCCGGATGTGGTTGTCGAGTCAACGACCGTCAATGCATCCACATCAGG 66 FBan0033334 FBgn0053334 CG33334 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33334 CG33334 CG5740 CDMC28329 1 9 21 DAC34-A06 17-CG13425-RC_1 CG13425 GGGCGATACATAACTATGATCCTATGAACTTTGACCGCGTATATGCCGATGAGTACGGTGGCTATGGCA 69 FBan0013425 FBgn0015907 bl 2 2R "appendage morphogenesis; GO:0035107; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; induction of apoptosis; GO:0006917; mRNA processing; GO:0006397; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; transcription factor binding; GO:0008134; ; GO:0003729; ; GO:0008134; ; GO:0003729 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; ribonucleoprotein complex; GO:0030529 bl bancal "CG13425, Hrb57A, Heterogeneous nuclear ribonucleoprotein at 57A, Q18, l(2)k08305, bancal" CDMC28329 1 10 21 DAC34-A06 17-CG13425-RC_1 CG13425 GGGCGATACATAACTATGATCCTATGAACTTTGACCGCGTATATGCCGATGAGTACGGTGGCTATGGCA 69 FBan0013425 FBgn0015907 bl 2 2R "appendage morphogenesis; GO:0035107; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; imaginal disc growth; GO:0007446; induction of apoptosis; GO:0006917; mRNA processing; GO:0006397; protein targeting; GO:0006605; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of translation; GO:0006445; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; transcription factor binding; GO:0008134; ; GO:0003729; ; GO:0008134; ; GO:0003729 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; ribonucleoprotein complex; GO:0030529 bl bancal "CG13425, Hrb57A, Heterogeneous nuclear ribonucleoprotein at 57A, Q18, l(2)k08305, bancal" CDMC28330 1 11 21 DAC34-A18 2-CG13443-RA_2 CG13443 GAGCCGCTTAAGGTGAAGCTGACACTGCCAGAGCTGACCGAGAACAATGCAGAAGAAACAGAAGTCCCT 69 FBan0013443 FBgn0034548 CG13443 2 2R CG13443 CG13443 CDMC28330 1 12 21 DAC34-A18 2-CG13443-RA_2 CG13443 GAGCCGCTTAAGGTGAAGCTGACACTGCCAGAGCTGACCGAGAACAATGCAGAAGAAACAGAAGTCCCT 69 FBan0013443 FBgn0034548 CG13443 2 2R CG13443 CG13443 CDMC28331 1 13 21 DAC34-E06 17-CG13481-RA_1 CG13481 AGCTCGGAGTCCCTAAACAAGATGAAGTCTCTTGTGGGGAAGATGATCTTCATGCAAGTCACCGAACAT 69 FBan0013481 FBgn0036421 CG13481 3 3L CG13481 CG13481 CDMC28331 1 14 21 DAC34-E06 17-CG13481-RA_1 CG13481 AGCTCGGAGTCCCTAAACAAGATGAAGTCTCTTGTGGGGAAGATGATCTTCATGCAAGTCACCGAACAT 69 FBan0013481 FBgn0036421 CG13481 3 3L CG13481 CG13481 CDMC28332 1 15 21 DAC34-E18 13-CG13499-RD_1 CG13499 GCGCTCAGTTCGTCTGCAGAAGTCAGCAGTAGCGGTTCGTAGTGCTCCGTAATTTCAATGTGTACAGAG 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC28332 1 16 21 DAC34-E18 13-CG13499-RD_1 CG13499 GCGCTCAGTTCGTCTGCAGAAGTCAGCAGTAGCGGTTCGTAGTGCTCCGTAATTTCAATGTGTACAGAG 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC28333 1 17 21 DAC34-I06 2-CG13561-RA_1 CG13561 GGACTACGGACTCTTCACCACCTTCACTTTCCACCGATCGGAGTTGGCCCAGGTTAAGGTGTACTTCAC 69 FBan0013561 FBgn0034906 CG13561 2 2R CG13561 CG13561 CDMC28333 1 18 21 DAC34-I06 2-CG13561-RA_1 CG13561 GGACTACGGACTCTTCACCACCTTCACTTTCCACCGATCGGAGTTGGCCCAGGTTAAGGTGTACTTCAC 69 FBan0013561 FBgn0034906 CG13561 2 2R CG13561 CG13561 CDMC28334 1 19 21 DAC34-I18 3-CG13568-RA_3 CG13568 CCGAGGATCTGCCCTTCTTCAATTCCTTGACCTATACCATCTCCACCGACCCCACAACATACGCCTTCA 69 FBan0013568 FBgn0034965 CG13568 2 2R CG13568 CG13568 CDMC28334 1 20 21 DAC34-I18 3-CG13568-RA_3 CG13568 CCGAGGATCTGCCCTTCTTCAATTCCTTGACCTATACCATCTCCACCGACCCCACAACATACGCCTTCA 69 FBan0013568 FBgn0034965 CG13568 2 2R CG13568 CG13568 CDMC28335 1 21 21 DAC34-M06 3-CG13604-RA_1 CG13604 AGTTTCTCTGCAAGCATTGAGACTGAGACTCAACTCGATTGGGACGGACCTGGAGGTGAATCACACGCT 69 FBan0013604 FBgn0039137 CG13604 3 3R CG13604 CG13604 UBASH3A CDMC28335 1 22 21 DAC34-M06 3-CG13604-RA_1 CG13604 AGTTTCTCTGCAAGCATTGAGACTGAGACTCAACTCGATTGGGACGGACCTGGAGGTGAATCACACGCT 69 FBan0013604 FBgn0039137 CG13604 3 3R CG13604 CG13604 UBASH3A CDMC28336 1 23 21 DAC34-M18 14-CG13611-RA_1 CG13611 GCCGTCAGATTAGAGCACTTTAAGAACTATGTCCAGGTGACGGATGATCAGGGTAACAAGCACACGGCT 69 FBan0013611 FBgn0039177 CG13611 3 3R CG13611 CG13611 CDMC28336 1 24 21 DAC34-M18 14-CG13611-RA_1 CG13611 GCCGTCAGATTAGAGCACTTTAAGAACTATGTCCAGGTGACGGATGATCAGGGTAACAAGCACACGGCT 69 FBan0013611 FBgn0039177 CG13611 3 3R CG13611 CG13611 CDMC28337 1 25 21 DAC35-A06 18-CG17299-RA_6 CG17299 GCGTACATGCAAAAAAGTTTGCGCGAACTGAAGATTGGCACCTATAACAACATCGAGACCGCCGAC 66 FBan0017299 FBgn0025803 SNF4Agamma 3 3R cholesterol homeostasis; GO:0042632; defense response; GO:0006952; fatty acid metabolism; GO:0006631; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of phosphate metabolism; GO:0019220; response to stress; GO:0006950 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- SNF4Agamma SNF4/AMP-activated protein kinase gamma subunit "CG17299, CG5806, CG17299, SNF4A, SNF4/AMP-activated protein kinase gamma, SNF4, EP3015b, loe, lochrig, SNF4a, FBgn0025803, loechrig, SNF4Ag, anon-WO0118547.338, anon-WO0118547.575, anon-WO0257455.21" CDMC28337 1 26 21 DAC35-A06 18-CG17299-RA_6 CG17299 GCGTACATGCAAAAAAGTTTGCGCGAACTGAAGATTGGCACCTATAACAACATCGAGACCGCCGAC 66 FBan0017299 FBgn0025803 SNF4Agamma 3 3R cholesterol homeostasis; GO:0042632; defense response; GO:0006952; fatty acid metabolism; GO:0006631; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of phosphate metabolism; GO:0019220; response to stress; GO:0006950 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; AMP-activated protein kinase activity; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.-; ; GO:0004679 ; EC:2.7.1.- SNF4Agamma SNF4/AMP-activated protein kinase gamma subunit "CG17299, CG5806, CG17299, SNF4A, SNF4/AMP-activated protein kinase gamma, SNF4, EP3015b, loe, lochrig, SNF4a, FBgn0025803, loechrig, SNF4Ag, anon-WO0118547.338, anon-WO0118547.575, anon-WO0257455.21" CDMC28338 1 1 22 DAC35-A18 3-CG17603-RB_6 CG17603 AGTTTGATGAAGCCTGGGGCAATGATGATTACAACTTTGACCGTGGCAGTAGGGCCAGTTCACCCG 66 FBan0017603 FBgn0010355 Taf1 3 3R "protein complex assembly; GO:0006461; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016563; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf1 TBP-associated factor 1 "CG17603, CG17603, EfW1, cel, TAF200, TAFII250, TATA-associated factor 250, TBP-associated factor 250, p230, dTAF[[II]]250, Taf250: TBP-associated factor 250kD, l(3)84Ab, Taf[[II]]250, TAF[[II]]250, Taf230, SR3-5, Suppressor of Ras85D 3-5, TAF230, dTAF[[II]]230, cell, TAF[[II]]250/230, TAF250, dTAF250, TFIID 230 kda subunit, TAF250/230, TAFII-250, d230, TFIID TAF250, dTAF230, TFIID, dTAFII250, TAF[[II]]230, TAF1, TAF[II]250, TAF[[II]], dmTAF1, dmTAF[[II]]230, TAF, BG:DS00004.13, Taf200, TBP-associated factor 250kD, cell lethal, Taf250" CDMC28338 1 2 22 DAC35-A18 3-CG17603-RB_6 CG17603 AGTTTGATGAAGCCTGGGGCAATGATGATTACAACTTTGACCGTGGCAGTAGGGCCAGTTCACCCG 66 FBan0017603 FBgn0010355 Taf1 3 3R "protein complex assembly; GO:0006461; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016563; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf1 TBP-associated factor 1 "CG17603, CG17603, EfW1, cel, TAF200, TAFII250, TATA-associated factor 250, TBP-associated factor 250, p230, dTAF[[II]]250, Taf250: TBP-associated factor 250kD, l(3)84Ab, Taf[[II]]250, TAF[[II]]250, Taf230, SR3-5, Suppressor of Ras85D 3-5, TAF230, dTAF[[II]]230, cell, TAF[[II]]250/230, TAF250, dTAF250, TFIID 230 kda subunit, TAF250/230, TAFII-250, d230, TFIID TAF250, dTAF230, TFIID, dTAFII250, TAF[[II]]230, TAF1, TAF[II]250, TAF[[II]], dmTAF1, dmTAF[[II]]230, TAF, BG:DS00004.13, Taf200, TBP-associated factor 250kD, cell lethal, Taf250" CDMC28339 1 3 22 DAC35-E06 1-CG18480-RA_1 CG18480 AGTCGGGAGAAACTGTGCCTAAGATACCGCATTTGCTTGGAGCGTGTGAGTCATGAACTCCTGGCT 66 FBan0018480 FBgn0028518 CG18480 2 2L CG18480 CG18480 "BG:DS07108.4, CT42128, BcDNA:LP11031" CDMC28339 1 4 22 DAC35-E06 1-CG18480-RA_1 CG18480 AGTCGGGAGAAACTGTGCCTAAGATACCGCATTTGCTTGGAGCGTGTGAGTCATGAACTCCTGGCT 66 FBan0018480 FBgn0028518 CG18480 2 2L CG18480 CG18480 "BG:DS07108.4, CT42128, BcDNA:LP11031" CDMC28340 1 5 22 DAC35-E18 2-CG18746-RA_1 CG18746 GGAAGTGTCCCGCTAACGAAGCAACTCCAAAAAGAACCAAGGACTTGGGGTGAAGTTCTGCCACCC 66 FBan0018746 FBgn0042103 CG18746 3 3R CG18746 CG18746 CDMC28340 1 6 22 DAC35-E18 2-CG18746-RA_1 CG18746 GGAAGTGTCCCGCTAACGAAGCAACTCCAAAAAGAACCAAGGACTTGGGGTGAAGTTCTGCCACCC 66 FBan0018746 FBgn0042103 CG18746 3 3R CG18746 CG18746 CDMC28341 1 7 22 DAC35-I06 14-CG2915-RA_1 CG2915 TCAAAGCGGAGAACGGTAGGGATTACGTGAGTGGTAGTCTGTTTGAGACCATCTATCCGTCGAGCG 66 FBan0002915 FBgn0033241 CG2915 2 2R proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG2915 CG2915 CDMC28341 1 8 22 DAC35-I06 14-CG2915-RA_1 CG2915 TCAAAGCGGAGAACGGTAGGGATTACGTGAGTGGTAGTCTGTTTGAGACCATCTATCCGTCGAGCG 66 FBan0002915 FBgn0033241 CG2915 2 2R proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG2915 CG2915 CDMC28342 1 9 22 DAC35-I18 3-CG30047-RA_5 CG30047 TGTCCATATGGTTCGCCATAATCCTGGTCCTTCATGTGCTGGGAATGATCCTCAGTCTCGGGCTGC 66 FBan0030047 FBgn0050047 CG30047 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30047 CG30047 CDMC28342 1 10 22 DAC35-I18 3-CG30047-RA_5 CG30047 TGTCCATATGGTTCGCCATAATCCTGGTCCTTCATGTGCTGGGAATGATCCTCAGTCTCGGGCTGC 66 FBan0030047 FBgn0050047 CG30047 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30047 CG30047 CDMC28343 1 11 22 DAC35-M06 3-CG3086-RD_3 CG3086 GCATCCAGGACGTCATTAGCAACAAGTGGATTGCCCAGTACAATGCTGTTCCACAGACACCGCTCT 66 FBan0003086 FBgn0013987 MAPk-Ak2 X X MAPKKK cascade; GO:0000165; cell adhesion; GO:0007155; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 MAPk-Ak2 MAP kinase activated protein-kinase-2 "CG3086, CG3086, DmMAPKAPK-2, MAP kinase activated protein kinase-2, MAPKAP" CDMC28343 1 12 22 DAC35-M06 3-CG3086-RD_3 CG3086 GCATCCAGGACGTCATTAGCAACAAGTGGATTGCCCAGTACAATGCTGTTCCACAGACACCGCTCT 66 FBan0003086 FBgn0013987 MAPk-Ak2 X X MAPKKK cascade; GO:0000165; cell adhesion; GO:0007155; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 MAPk-Ak2 MAP kinase activated protein-kinase-2 "CG3086, CG3086, DmMAPKAPK-2, MAP kinase activated protein kinase-2, MAPKAP" CDMC28344 1 13 22 DAC35-M18 2-CG31120-RB_1 CG31120 CCGCAACCAGCCTACGATGTGATTGTCTCTGTCCTGAATCCGAAACCGAGACTCACCCATGCCAAG 66 FBan0031120 FBgn0051120 CG31120 3 3R protein metabolism; GO:0019538 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31120 CG31120 "CG13644, CG6031, CG18761" CDMC28344 1 14 22 DAC35-M18 2-CG31120-RB_1 CG31120 CCGCAACCAGCCTACGATGTGATTGTCTCTGTCCTGAATCCGAAACCGAGACTCACCCATGCCAAG 66 FBan0031120 FBgn0051120 CG31120 3 3R protein metabolism; GO:0019538 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31120 CG31120 "CG13644, CG6031, CG18761" CDMC28345 1 15 22 DAC36-A06 3-CG17347-RA_1 CG17347 CCAAGATTGGCGATAAGAACGTCTTCGAGAGCAAGTGCTATGTGGGCCCCGGTGTCACTGTTTCCAG 67 FBan0017347 FBgn0032761 CG17347 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 CG17347 CG17347 "P27 DYNACTIN, dynactin, p27 subunit" CDMC28345 1 16 22 DAC36-A06 3-CG17347-RA_1 CG17347 CCAAGATTGGCGATAAGAACGTCTTCGAGAGCAAGTGCTATGTGGGCCCCGGTGTCACTGTTTCCAG 67 FBan0017347 FBgn0032761 CG17347 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 CG17347 CG17347 "P27 DYNACTIN, dynactin, p27 subunit" CDMC28346 1 17 22 DAC36-A18 3-CG17654-RA_1 CG17654 CAAGGCCAATCTGGATGTGGTTGACCAGGCGTCCATTGACAACTTCATGATCAAGTTGGACGGCACC 67 FBan0017654 FBgn0000579 Eno 2 2L glycolysis; GO:0006096 phosphopyruvate hydratase activity; GO:0004634 ; EC:4.2.1.11; ; GO:0004634 ; EC:4.2.1.11; ; GO:0004634 ; EC:4.2.1.11 phosphopyruvate hydratase complex; GO:0000015 Eno Enolase "CG17654, CG17654, CG17654, CG17654, CG17654, ENOA, Eno2, CT32526, T18, phosphopyruvate hydratase, anon-WO0153538.76, BEST:LD15491" CDMC28346 1 18 22 DAC36-A18 3-CG17654-RA_1 CG17654 CAAGGCCAATCTGGATGTGGTTGACCAGGCGTCCATTGACAACTTCATGATCAAGTTGGACGGCACC 67 FBan0017654 FBgn0000579 Eno 2 2L glycolysis; GO:0006096 phosphopyruvate hydratase activity; GO:0004634 ; EC:4.2.1.11; ; GO:0004634 ; EC:4.2.1.11; ; GO:0004634 ; EC:4.2.1.11 phosphopyruvate hydratase complex; GO:0000015 Eno Enolase "CG17654, CG17654, CG17654, CG17654, CG17654, ENOA, Eno2, CT32526, T18, phosphopyruvate hydratase, anon-WO0153538.76, BEST:LD15491" CDMC28347 1 19 22 DAC36-E06 24-CG18467-RA_1 CG18467 AGTGTAATTTTTTTTGATGGATGTTGAATATTAAATATTTCCATGTCTTGATGTAAATTGGAGCAAA 67 FBan0018467 FBgn0034218 CG18467 2 2R CG18467 CG18467 CDMC28347 1 20 22 DAC36-E06 24-CG18467-RA_1 CG18467 AGTGTAATTTTTTTTGATGGATGTTGAATATTAAATATTTCCATGTCTTGATGTAAATTGGAGCAAA 67 FBan0018467 FBgn0034218 CG18467 2 2R CG18467 CG18467 CDMC28348 1 21 22 DAC36-E18 23-CG1857-RA_1 CG1857 GCGTCTAAAATGAACCAAATTCGGACAAATTGATTTATTAGAATTCCATTTCTGAGTAGAGCCTTGC 67 FBan0001857 FBgn0002930 nec 2 2R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; immune response; GO:0006955; negative regulation of Toll signaling pathway; GO:0045751; proteolysis; GO:0006508; regulation of proteolysis; GO:0030162 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 nec necrotic "CG1857, CG1857, CG1857, CG1857, Ser3, SER3, Serine protease inhibitor 3, Spn43Ac, serpin43Ac, anon-WO0118057.3" CDMC28348 1 22 22 DAC36-E18 23-CG1857-RA_1 CG1857 GCGTCTAAAATGAACCAAATTCGGACAAATTGATTTATTAGAATTCCATTTCTGAGTAGAGCCTTGC 67 FBan0001857 FBgn0002930 nec 2 2R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; immune response; GO:0006955; negative regulation of Toll signaling pathway; GO:0045751; proteolysis; GO:0006508; regulation of proteolysis; GO:0030162 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 nec necrotic "CG1857, CG1857, CG1857, CG1857, Ser3, SER3, Serine protease inhibitor 3, Spn43Ac, serpin43Ac, anon-WO0118057.3" CDMC28349 1 23 22 DAC36-I06 3-CG2503-RA_1 CG2503 GGTTACAACGTCAAGAAGTCGCTTCGGGAGGAGACTCTCTACCTGGACCGCGAAGCCCAGATCAAAG 67 FBgn0037274 CDMC28349 1 24 22 DAC36-I06 3-CG2503-RA_1 CG2503 GGTTACAACGTCAAGAAGTCGCTTCGGGAGGAGACTCTCTACCTGGACCGCGAAGCCCAGATCAAAG 67 FBgn0037274 CDMC28350 1 25 22 DAC36-I18 3-CG2861-RB_2 CG2861 ACCCAGGGTACCAAAAGCTCCAAAGGAACCAAAAGTACCCAAGATTCCGAAGAACCCCAGGGTACCG 67 FBan0002861 FBgn0029728 CG2861 X X CG2861 CG2861 CDMC28350 1 26 22 DAC36-I18 3-CG2861-RB_2 CG2861 ACCCAGGGTACCAAAAGCTCCAAAGGAACCAAAAGTACCCAAGATTCCGAAGAACCCCAGGGTACCG 67 FBan0002861 FBgn0029728 CG2861 X X CG2861 CG2861 CDMC28351 1 1 23 DAC36-M06 3-CG3027-RA_6 CG3027 GCCCACAAGTGCGAAAGATATTGCCGAACAGAATGGATTCGACATCAAGGGCTATCGCTTCACGGCG 67 FBan0003027 FBgn0037513 pyd3 3 3R nitrogen compound metabolism; GO:0006807; pyrimidine base metabolism; GO:0006206 beta-ureidopropionase activity; GO:0003837 ; EC:3.5.1.6; ; GO:0003837 ; EC:3.5.1.6; ; GO:0003837 ; EC:3.5.1.6 pyd3 pyd3 CG3027 CDMC28351 1 2 23 DAC36-M06 3-CG3027-RA_6 CG3027 GCCCACAAGTGCGAAAGATATTGCCGAACAGAATGGATTCGACATCAAGGGCTATCGCTTCACGGCG 67 FBan0003027 FBgn0037513 pyd3 3 3R nitrogen compound metabolism; GO:0006807; pyrimidine base metabolism; GO:0006206 beta-ureidopropionase activity; GO:0003837 ; EC:3.5.1.6; ; GO:0003837 ; EC:3.5.1.6; ; GO:0003837 ; EC:3.5.1.6 pyd3 pyd3 CG3027 CDMC28352 1 3 23 DAC36-M18 13-CG30388-RA_1 CG30388 GCACGGCGATGTAGTGAATCTCATCAAGGAGTCTGGTCTTCATGTGCGTCTCACTATCGGCGTTCCG 67 FBan0030388 FBgn0034590 Magi 2 2R asymmetric protein localization; GO:0008105; intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 membrane; GO:0016020 Magi Magi "CG30388, CG15656, CG4117, D-MAGI, Ima, ima" CDMC28352 1 4 23 DAC36-M18 13-CG30388-RA_1 CG30388 GCACGGCGATGTAGTGAATCTCATCAAGGAGTCTGGTCTTCATGTGCGTCTCACTATCGGCGTTCCG 67 FBan0030388 FBgn0034590 Magi 2 2R asymmetric protein localization; GO:0008105; intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 membrane; GO:0016020 Magi Magi "CG30388, CG15656, CG4117, D-MAGI, Ima, ima" CDMC28353 1 5 23 DAC37-A06 13-CG7556-RA_1 CG7556 TACTTTGCATTAAAGACTCTCTGGCATAGCATTTTGGACCTTGCCAATCCTAATCCGCGGCCCGA 65 FBan0007556 FBgn0030990 CG7556 X X protein folding; GO:0006457 DNA binding; GO:0003677; unfolded protein binding; GO:0051082; ; GO:0003677; ; GO:0051082 nucleus; GO:0005634 CG7556 CG7556 CDMC28353 1 6 23 DAC37-A06 13-CG7556-RA_1 CG7556 TACTTTGCATTAAAGACTCTCTGGCATAGCATTTTGGACCTTGCCAATCCTAATCCGCGGCCCGA 65 FBan0007556 FBgn0030990 CG7556 X X protein folding; GO:0006457 DNA binding; GO:0003677; unfolded protein binding; GO:0051082; ; GO:0003677; ; GO:0051082 nucleus; GO:0005634 CG7556 CG7556 CDMC28354 1 7 23 DAC37-A18 23-CG7592-RA_1 CG7592 CAGAACCATCTGATCGCTTGTCTAAAGTTCAAGTCGTAAATAAAGTATTTGTTTAACGGCCCAAA 65 FBan0007592 FBgn0039685 Obp99b 3 3R autophagic cell death; GO:0048102; olfactory behavior; GO:0042048; response to pheromone; GO:0019236; salivary gland cell autophagic cell death; GO:0035071; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp99b Odorant-binding protein 99b "CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, 99b, Obp99d, tsx, turn on sex-specificity, BcDNA:LP06572, Odorant-binding protein 99b" CDMC28354 1 8 23 DAC37-A18 23-CG7592-RA_1 CG7592 CAGAACCATCTGATCGCTTGTCTAAAGTTCAAGTCGTAAATAAAGTATTTGTTTAACGGCCCAAA 65 FBan0007592 FBgn0039685 Obp99b 3 3R autophagic cell death; GO:0048102; olfactory behavior; GO:0042048; response to pheromone; GO:0019236; salivary gland cell autophagic cell death; GO:0035071; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp99b Odorant-binding protein 99b "CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, CG7592, 99b, Obp99d, tsx, turn on sex-specificity, BcDNA:LP06572, Odorant-binding protein 99b" CDMC28355 1 9 23 DAC37-E06 1-CG7702-RB_1 CG7702 AAATTCCGAGCTAGCTGCACAAGTTTCGAGCCAAAGATGTCCACGACAGTGACGCGATCCCAACC 65 FBan0007702 FBgn0038638 CG7702 3 3R CG7702 CG7702 "CT23351, connectin-like" CDMC28355 1 10 23 DAC37-E06 1-CG7702-RB_1 CG7702 AAATTCCGAGCTAGCTGCACAAGTTTCGAGCCAAAGATGTCCACGACAGTGACGCGATCCCAACC 65 FBan0007702 FBgn0038638 CG7702 3 3R CG7702 CG7702 "CT23351, connectin-like" CDMC28356 1 11 23 DAC37-E18 2-CG7735-RA_2 CG7735 CAGGTGTTTCCATTAAGGCAATCGACATGTCCGGTGCGACGCGATACAGGAATCTGTGGGAGCAC 65 FBan0007735 FBgn0034446 CG7735 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7735 CG7735 CDMC28356 1 12 23 DAC37-E18 2-CG7735-RA_2 CG7735 CAGGTGTTTCCATTAAGGCAATCGACATGTCCGGTGCGACGCGATACAGGAATCTGTGGGAGCAC 65 FBan0007735 FBgn0034446 CG7735 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7735 CG7735 CDMC28357 1 13 23 DAC37-I06 16-CG7895-RA_1 CG7895 CGCCTCATGGAGACCGCTAGCAACTCGTCCTCCCTAAGGAGCATCTACGGTTCAGATGAGGGCGC 65 FBan0007895 FBgn0004110 tin 3 3R "cardiac cell differentiation; GO:0035051; cardioblast cell fate determination; GO:0007510; cardioblast differentiation; GO:0010002; cell fate specification; GO:0001708; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; metamorphosis; GO:0007552; negative regulation of transcription, DNA-dependent; GO:0045892; nervous system development; GO:0007399; pericardial cell differentiation; GO:0007513; pole cell migration; GO:0007280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; somatic muscle development; GO:0007525; visceral muscle development; GO:0007522" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 tin tinman "CG7895, msh-2, NK-4, msh2: muscle-specific-homeodomain-2, NK4/msh-2, NK-4/msh-2, DmNK-4, DROHOXHK4, HOX, NK4, tin/NK4, Tin, muscle-specific-homeodomain-2, msh2" CDMC28357 1 14 23 DAC37-I06 16-CG7895-RA_1 CG7895 CGCCTCATGGAGACCGCTAGCAACTCGTCCTCCCTAAGGAGCATCTACGGTTCAGATGAGGGCGC 65 FBan0007895 FBgn0004110 tin 3 3R "cardiac cell differentiation; GO:0035051; cardioblast cell fate determination; GO:0007510; cardioblast differentiation; GO:0010002; cell fate specification; GO:0001708; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; metamorphosis; GO:0007552; negative regulation of transcription, DNA-dependent; GO:0045892; nervous system development; GO:0007399; pericardial cell differentiation; GO:0007513; pole cell migration; GO:0007280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; somatic muscle development; GO:0007525; visceral muscle development; GO:0007522" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 tin tinman "CG7895, msh-2, NK-4, msh2: muscle-specific-homeodomain-2, NK4/msh-2, NK-4/msh-2, DmNK-4, DROHOXHK4, HOX, NK4, tin/NK4, Tin, muscle-specific-homeodomain-2, msh2" CDMC28358 1 15 23 DAC37-I18 23-CG7925-RB_2 CG7925 TGGTACTACAAACTGAACAAAAAACTACTGAACAAAACTCCAAGAGCATGAATTTTCTGCGGCAA 65 FBan0007925 FBgn0003714 tko X X behavior; GO:0007610; courtship behavior; GO:0007619; detection of mechanical stimulus during sensory perception of sound; GO:0050910; male courtship behavior; GO:0008049; mechanosensory behavior; GO:0007638; protein biosynthesis; GO:0006412; response to mechanical stimulus; GO:0009612; sensory perception of sound; GO:0007605 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 tko technical knockout "CG7925, CG7925, l(1)tko, mt-rps12, rps12, mitoribosomal protein S12, EG:BACH59J11.1, MRP-S12, S12, mitochondrial ribosomal protein S12, MRPS12, l(1)3Ab, mRpS12" CDMC28358 1 16 23 DAC37-I18 23-CG7925-RB_2 CG7925 TGGTACTACAAACTGAACAAAAAACTACTGAACAAAACTCCAAGAGCATGAATTTTCTGCGGCAA 65 FBan0007925 FBgn0003714 tko X X behavior; GO:0007610; courtship behavior; GO:0007619; detection of mechanical stimulus during sensory perception of sound; GO:0050910; male courtship behavior; GO:0008049; mechanosensory behavior; GO:0007638; protein biosynthesis; GO:0006412; response to mechanical stimulus; GO:0009612; sensory perception of sound; GO:0007605 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761; mitochondrial small ribosomal subunit; GO:0005763 tko technical knockout "CG7925, CG7925, l(1)tko, mt-rps12, rps12, mitoribosomal protein S12, EG:BACH59J11.1, MRP-S12, S12, mitochondrial ribosomal protein S12, MRPS12, l(1)3Ab, mRpS12" CDMC28359 1 17 23 DAC37-M06 17-CG8007-RB_1 CG8007 AGCGAGATGGAGCTACTCATGTGCAGTAGTGGCAATAAAAAGTCATTGACCTCCAGTGTGAGTGC 65 FBan0008007 FBgn0037600 CG8007 3 3R serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609 integral to membrane; GO:0016021 CG8007 CG8007 "anon-WO0170980.97, anon-WO0170980.98" CDMC28359 1 18 23 DAC37-M06 17-CG8007-RB_1 CG8007 AGCGAGATGGAGCTACTCATGTGCAGTAGTGGCAATAAAAAGTCATTGACCTCCAGTGTGAGTGC 65 FBan0008007 FBgn0037600 CG8007 3 3R serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609 integral to membrane; GO:0016021 CG8007 CG8007 "anon-WO0170980.97, anon-WO0170980.98" CDMC28360 1 19 23 DAC37-M18 5-CG8025-RA_1 CG8025 ACACCCTGGCCATTAACAAGTCCCTGAGAGAACTAGTCAAAGGCGTGCTCACGAAGCGGGTGAAG 65 FBan0008025 FBgn0036916 Mtr3 3 3L RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Mtr3 Mtr3 "CG8025, CG8025, CG8025, dMtr3" CDMC28360 1 20 23 DAC37-M18 5-CG8025-RA_1 CG8025 ACACCCTGGCCATTAACAAGTCCCTGAGAGAACTAGTCAAAGGCGTGCTCACGAAGCGGGTGAAG 65 FBan0008025 FBgn0036916 Mtr3 3 3L RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Mtr3 Mtr3 "CG8025, CG8025, CG8025, dMtr3" CDMC28361 1 21 23 DAC38-A06 24-CG4140-RA_1 CG4140 CGAAACGGGACTGATAGATTAATCACTTAATAGTCAAACTATGCGCATACTTATAGAATAACTAATATA 69 FBan0004140 FBgn0028535 CG4140 2 2L CG4140 CG4140 BG:DS00929.2 CDMC28361 1 22 23 DAC38-A06 24-CG4140-RA_1 CG4140 CGAAACGGGACTGATAGATTAATCACTTAATAGTCAAACTATGCGCATACTTATAGAATAACTAATATA 69 FBan0004140 FBgn0028535 CG4140 2 2L CG4140 CG4140 BG:DS00929.2 CDMC28362 1 23 23 DAC38-A18 23-CG4157-RA_4 CG4157 TCGCTTTACCCTACAACAATTGCCATCTCTAAAAAAAAGCGAAAATCATCTTGGGAATTTGCAGAAAAC 69 FBan0004157 FBgn0028693 Rpn12 3 3L cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn12 Rpn12 "CG4157, p30, dRpn12" CDMC28362 1 24 23 DAC38-A18 23-CG4157-RA_4 CG4157 TCGCTTTACCCTACAACAATTGCCATCTCTAAAAAAAAGCGAAAATCATCTTGGGAATTTGCAGAAAAC 69 FBan0004157 FBgn0028693 Rpn12 3 3L cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn12 Rpn12 "CG4157, p30, dRpn12" CDMC28363 1 25 23 DAC38-E06 3-CG4196-RB_2 CG4196 ACGGCTACAAAATGAAACCAACCGACGCTCAGGAAGAACTGGAAGAGGTGCAAACTGATCTGCGCAAGC 69 FBan0004196 FBgn0038297 CG4196 3 3R receptor signaling protein activity; GO:0005057; ; GO:0005057 CG4196 CG4196 CDMC28363 1 26 23 DAC38-E06 3-CG4196-RB_2 CG4196 ACGGCTACAAAATGAAACCAACCGACGCTCAGGAAGAACTGGAAGAGGTGCAAACTGATCTGCGCAAGC 69 FBan0004196 FBgn0038297 CG4196 3 3R receptor signaling protein activity; GO:0005057; ; GO:0005057 CG4196 CG4196 CDMC28364 1 1 24 DAC38-E18 23-CG4204-RA_2 CG4204 CGACACAAAATTGAACTTTGGAATGGGATTGATAATATTCGGCTTTAATTTTACCCTAACCCCTTGATT 69 FBan0004204 FBgn0023212 Elongin-B 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368 transcriptional elongation regulator activity; GO:0003711; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0003711 transcription elongation factor complex; GO:0008023 Elongin-B Elongin B "CG4204, d-elongin B, Elongin B" CDMC28364 1 2 24 DAC38-E18 23-CG4204-RA_2 CG4204 CGACACAAAATTGAACTTTGGAATGGGATTGATAATATTCGGCTTTAATTTTACCCTAACCCCTTGATT 69 FBan0004204 FBgn0023212 Elongin-B 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368 transcriptional elongation regulator activity; GO:0003711; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0003711 transcription elongation factor complex; GO:0008023 Elongin-B Elongin B "CG4204, d-elongin B, Elongin B" CDMC28365 1 3 24 DAC38-I06 15-CG4230-RA_13 CG4230 GCGCGTGACACGAGCTCATCACTTCAAATTTTCAGTTGTCAGCTGTGCAGTTGTCAGTTTTTCGACGGT 69 FBan0004230 FBgn0031683 CG4230 2 2L CG4230 CG4230 CDMC28365 1 4 24 DAC38-I06 15-CG4230-RA_13 CG4230 GCGCGTGACACGAGCTCATCACTTCAAATTTTCAGTTGTCAGCTGTGCAGTTGTCAGTTTTTCGACGGT 69 FBan0004230 FBgn0031683 CG4230 2 2L CG4230 CG4230 CDMC28366 1 5 24 DAC38-I18 22-CG4244-RB_1 CG4244 ACGCTCCACTGTAAATAGTTTACTCGACCGAATTCGAATTGTTGACGAGCTGAGTTTGGTGTACTGGCA 69 FBan0004244 FBgn0003557 Su(dx) 2 2L Notch signaling pathway; GO:0007219; leg joint morphogenesis (sensu Endopterygota); GO:0016348; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512; wing margin morphogenesis; GO:0008587; wing vein morphogenesis; GO:0008586 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 Su(dx) Suppressor of deltex "CG4244, Su(Dx), Su(deltex), anon-WO0073329.1, anon-WO0073329.2, anon-WO0073329.4" CDMC28366 1 6 24 DAC38-I18 22-CG4244-RB_1 CG4244 ACGCTCCACTGTAAATAGTTTACTCGACCGAATTCGAATTGTTGACGAGCTGAGTTTGGTGTACTGGCA 69 FBan0004244 FBgn0003557 Su(dx) 2 2L Notch signaling pathway; GO:0007219; leg joint morphogenesis (sensu Endopterygota); GO:0016348; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512; wing margin morphogenesis; GO:0008587; wing vein morphogenesis; GO:0008586 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 Su(dx) Suppressor of deltex "CG4244, Su(Dx), Su(deltex), anon-WO0073329.1, anon-WO0073329.2, anon-WO0073329.4" CDMC28367 1 7 24 DAC38-M06 12-CG4280-RA_4 CG4280 GCGTGCCGAGACAAAGCACCCATTTACTCCTCCTTCCCTCACTTTTACCTAGCGGATCAGTCGTATGTT 69 FBan0004280 FBgn0015924 crq 2 2L "apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; defense response; GO:0006952; immune response; GO:0006955; macrophage activation; GO:0042116; phagocytosis; GO:0006909; phagocytosis, engulfment; GO:0006911; regulation of phagocytosis; GO:0050764; salivary gland cell autophagic cell death; GO:0035071" scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 crq croquemort "CG4280, CG31655, CG4280, cqm, Cd36, anon-WO0140519.8, D-CD36, CD36-like, croquemort" CDMC28367 1 8 24 DAC38-M06 12-CG4280-RA_4 CG4280 GCGTGCCGAGACAAAGCACCCATTTACTCCTCCTTCCCTCACTTTTACCTAGCGGATCAGTCGTATGTT 69 FBan0004280 FBgn0015924 crq 2 2L "apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; defense response; GO:0006952; immune response; GO:0006955; macrophage activation; GO:0042116; phagocytosis; GO:0006909; phagocytosis, engulfment; GO:0006911; regulation of phagocytosis; GO:0050764; salivary gland cell autophagic cell death; GO:0035071" scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 crq croquemort "CG4280, CG31655, CG4280, cqm, Cd36, anon-WO0140519.8, D-CD36, CD36-like, croquemort" CDMC28368 1 9 24 DAC38-M18 16-CG4301-RA_1 CG4301 GGCCGTACTTCCTGATGTGGGTCCTATTTGCGATCTACCACAGTGTCATCATATTCTACTTCGCCTTCT 69 FBan0004301 FBgn0030747 CG4301 X X cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 ATP binding; GO:0005524; ; GO:0005524; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 integral to membrane; GO:0016021; membrane; GO:0016020 CG4301 CG4301 CDMC28368 1 10 24 DAC38-M18 16-CG4301-RA_1 CG4301 GGCCGTACTTCCTGATGTGGGTCCTATTTGCGATCTACCACAGTGTCATCATATTCTACTTCGCCTTCT 69 FBan0004301 FBgn0030747 CG4301 X X cation transport; GO:0006812; lipid metabolism; GO:0006629; lipid transport; GO:0006869 ATP binding; GO:0005524; ; GO:0005524; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 integral to membrane; GO:0016021; membrane; GO:0016020 CG4301 CG4301 CDMC28369 1 11 24 DAC39-A06 8-CG6915-RA_5 CG6915 GTGAGCATTCCCTGTCGGATGGCTATGTCACTCAACCTGGCTTTGGATTATCCAATCCTCGACTTGGCT 69 FBan0006915 FBgn0035898 CG6915 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transport; GO:0006810 guanyl-nucleotide exchange factor activity; GO:0005085; transporter activity; GO:0005215; ; GO:0005085; ; GO:0005215; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG6915 CG6915 CDMC28369 1 12 24 DAC39-A06 8-CG6915-RA_5 CG6915 GTGAGCATTCCCTGTCGGATGGCTATGTCACTCAACCTGGCTTTGGATTATCCAATCCTCGACTTGGCT 69 FBan0006915 FBgn0035898 CG6915 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transport; GO:0006810 guanyl-nucleotide exchange factor activity; GO:0005085; transporter activity; GO:0005215; ; GO:0005085; ; GO:0005215; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG6915 CG6915 CDMC28370 1 13 24 DAC39-A18 3-CG6928-RA_9 CG6928 CGGTCTGCCCAACGTTTCACTGCCAAAGTTTGAGACCACCATACTGGACAGGAATGGCACTGAGATCAG 69 FBan0006928 FBgn0036240 CG6928 3 3L anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG6928 CG6928 CDMC28370 1 14 24 DAC39-A18 3-CG6928-RA_9 CG6928 CGGTCTGCCCAACGTTTCACTGCCAAAGTTTGAGACCACCATACTGGACAGGAATGGCACTGAGATCAG 69 FBan0006928 FBgn0036240 CG6928 3 3L anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 CG6928 CG6928 CDMC28371 1 15 24 DAC39-E06 22-CG6963-RB_1 CG6963 TGGACATCCGGAAGAGTTTGCGACATATTTGCGTTATGTACGGCGGTTAGATTTTTTCGAAACTCCCGA 69 FBan0006963 FBgn0011253 gish 3 3R glial cell migration; GO:0008347; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- gish gilgamesh "CG6963, CG6963, CG6963, CG6963, CG6963, ms(3)89B, Hrr25, CKIg-like, CKIgamma, anon-WO0118547.425, CKI-related, gilgamesh" CDMC28371 1 16 24 DAC39-E06 22-CG6963-RB_1 CG6963 TGGACATCCGGAAGAGTTTGCGACATATTTGCGTTATGTACGGCGGTTAGATTTTTTCGAAACTCCCGA 69 FBan0006963 FBgn0011253 gish 3 3R glial cell migration; GO:0008347; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- gish gilgamesh "CG6963, CG6963, CG6963, CG6963, CG6963, ms(3)89B, Hrr25, CKIg-like, CKIgamma, anon-WO0118547.425, CKI-related, gilgamesh" CDMC28372 1 17 24 DAC39-E18 11-CG6975-RA_1 CG6975 CGTCGCTAGTCTACCAAAGTGTGCAGAAAAAGCATCCGTACGCATCGAATTGGCTAGAACGATTGCGCA 69 FBan0006975 FBgn0005198 gig 3 3L determination of adult life span; GO:0008340; endocytosis; GO:0006897; insulin receptor signaling pathway; GO:0008286; intracellular protein transport; GO:0006886; negative regulation of cell growth; GO:0030308; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; oogenesis (sensu Insecta); GO:0009993; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; response to nutrient; GO:0007584; signal transduction; GO:0007165 kinase binding; GO:0019900; GTPase activator activity; GO:0005096; ; GO:0019900; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 gig gigas "CG6975, ME 109, l(3)109: lethal(3)109, C1, dTSC2, TSC2, Tsc2, dTsc2, tsc2, lethal(3)109, l(3)109, gigas" CDMC28372 1 18 24 DAC39-E18 11-CG6975-RA_1 CG6975 CGTCGCTAGTCTACCAAAGTGTGCAGAAAAAGCATCCGTACGCATCGAATTGGCTAGAACGATTGCGCA 69 FBan0006975 FBgn0005198 gig 3 3L determination of adult life span; GO:0008340; endocytosis; GO:0006897; insulin receptor signaling pathway; GO:0008286; intracellular protein transport; GO:0006886; negative regulation of cell growth; GO:0030308; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; oogenesis (sensu Insecta); GO:0009993; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; response to nutrient; GO:0007584; signal transduction; GO:0007165 kinase binding; GO:0019900; GTPase activator activity; GO:0005096; ; GO:0019900; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 gig gigas "CG6975, ME 109, l(3)109: lethal(3)109, C1, dTSC2, TSC2, Tsc2, dTsc2, tsc2, lethal(3)109, l(3)109, gigas" CDMC28373 1 19 24 DAC39-I06 11-CG7001-RA_1 CG7001 GACTCAGTGGCACCGACCTCTGACCAACTCAATCTTCAACTCGCACTTTAAGGAGACCAGCAAGAACGA 69 FBan0007001 FBgn0004462 Pk17E X X MAPKKK cascade; GO:0000165; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- Pk17E Protein kinase-like 17E "CG7001, CG7001, CG7001, 3-10, Bin4, Bicoid interacting protein 4, bin4, BIN4, Pk?4" CDMC28373 1 20 24 DAC39-I06 11-CG7001-RA_1 CG7001 GACTCAGTGGCACCGACCTCTGACCAACTCAATCTTCAACTCGCACTTTAAGGAGACCAGCAAGAACGA 69 FBan0007001 FBgn0004462 Pk17E X X MAPKKK cascade; GO:0000165; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- Pk17E Protein kinase-like 17E "CG7001, CG7001, CG7001, 3-10, Bin4, Bicoid interacting protein 4, bin4, BIN4, Pk?4" CDMC28374 1 21 24 DAC39-I18 5-CG7011-RA_3 CG7011 CCTCGAGGTCCTCAACTACATGCAGCCAACCCTAAATGAAGAGCTCTTCGTGGACACCACTCGTGATCA 69 FBan0007011 FBgn0036489 CG7011 3 3L COPII-coated vesicle; GO:0030138 CG7011 CG7011 CDMC28374 1 22 24 DAC39-I18 5-CG7011-RA_3 CG7011 CCTCGAGGTCCTCAACTACATGCAGCCAACCCTAAATGAAGAGCTCTTCGTGGACACCACTCGTGATCA 69 FBan0007011 FBgn0036489 CG7011 3 3L COPII-coated vesicle; GO:0030138 CG7011 CG7011 CDMC28375 1 23 24 DAC39-M06 3-CG7041-RA_2 CG7041 AGCCGGTGGAGAATCTCGACTGTCCAGACCTGATAGCCAACTTCGAGGAGTCGCTGAAGAACAACAAGA 69 FBan0007041 FBgn0030082 HP1b X X chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1b HP1b "CG7041, Hp1b, HP1" CDMC28375 1 24 24 DAC39-M06 3-CG7041-RA_2 CG7041 AGCCGGTGGAGAATCTCGACTGTCCAGACCTGATAGCCAACTTCGAGGAGTCGCTGAAGAACAACAAGA 69 FBan0007041 FBgn0030082 HP1b X X chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1b HP1b "CG7041, Hp1b, HP1" CDMC28376 1 25 24 DAC39-M18 3-CG7048-RA_2 CG7048 CGCCAAGTCCGAGATGATCGACCTGACCAAGTTGAGTCCGGAACAGCTGATTCAGATCAAGCAGGAGTT 69 FBan0007048 FBgn0038976 CG7048 3 3R protein folding; GO:0006457 protein binding; GO:0005515; ; GO:0005515 prefoldin complex; GO:0016272 CG7048 CG7048 CDMC28376 1 26 24 DAC39-M18 3-CG7048-RA_2 CG7048 CGCCAAGTCCGAGATGATCGACCTGACCAAGTTGAGTCCGGAACAGCTGATTCAGATCAAGCAGGAGTT 69 FBan0007048 FBgn0038976 CG7048 3 3R protein folding; GO:0006457 protein binding; GO:0005515; ; GO:0005515 prefoldin complex; GO:0016272 CG7048 CG7048 CDMC28377 1 1 25 DAC40-A06 2-CG33289-RA_1 CG33289 AATCGGGCAGAGTCCCAGATCTTCGACCTACAGAGCTCTCAGTGCAAGGAGTTTTGCCTGACCAG 65 FBan0033289 FBgn0053289 CG33289 3 3L CG33289 CG33289 CDMC28377 1 2 25 DAC40-A06 2-CG33289-RA_1 CG33289 AATCGGGCAGAGTCCCAGATCTTCGACCTACAGAGCTCTCAGTGCAAGGAGTTTTGCCTGACCAG 65 FBan0033289 FBgn0053289 CG33289 3 3L CG33289 CG33289 CDMC28378 1 3 25 DAC40-A18 3-CG33306-RA_4 CG33306 GATTGGAGGCATTCAGGGTCGTCCTGCAAAATGGTAGCCCGAGATTTGGAATCCCCGTTATGGCA 65 FBgn0028921 CDMC28378 1 4 25 DAC40-A18 3-CG33306-RA_4 CG33306 GATTGGAGGCATTCAGGGTCGTCCTGCAAAATGGTAGCCCGAGATTTGGAATCCCCGTTATGGCA 65 FBgn0028921 CDMC28379 1 5 25 DAC40-E06 1-CG3353-RA_1 CG3353 TGCCAAGGTGTCCGATCTACCACTAACGGATTCGGAAAAGGAACAGCTCGACACGGTCATCGACG 65 FBan0003353 FBgn0038869 CG3353 3 3R CG3353 CG3353 CDMC28379 1 6 25 DAC40-E06 1-CG3353-RA_1 CG3353 TGCCAAGGTGTCCGATCTACCACTAACGGATTCGGAAAAGGAACAGCTCGACACGGTCATCGACG 65 FBan0003353 FBgn0038869 CG3353 3 3R CG3353 CG3353 CDMC28380 1 7 25 DAC40-E18 2-CG3396-RA_3 CG3396 TTAGTGACAGCATCACACAGCATCCGAACGTCGAAGCGAGAACATCCCAGCACGCATTCTACGCA 65 FBan0003396 FBgn0040296 Ocho 3 3L Notch signaling pathway; GO:0007219; sensory organ development; GO:0007423 Ocho Ocho "CG5138, CG3396, CG5138, CG5138, CG5138, Ocho" CDMC28380 1 8 25 DAC40-E18 2-CG3396-RA_3 CG3396 TTAGTGACAGCATCACACAGCATCCGAACGTCGAAGCGAGAACATCCCAGCACGCATTCTACGCA 65 FBan0003396 FBgn0040296 Ocho 3 3L Notch signaling pathway; GO:0007219; sensory organ development; GO:0007423 Ocho Ocho "CG5138, CG3396, CG5138, CG5138, CG5138, Ocho" CDMC28381 1 9 25 DAC40-I06 2-CG3552-RA_3 CG3552 AGGAGGTAAAGCGACCGGTCCGTAGGCGAACCATGAGCAAGGTTAAGTACGAGACGAGTCTGGAG 65 FBan0003552 FBgn0035999 CG3552 3 3L CG3552 CG3552 CDMC28381 1 10 25 DAC40-I06 2-CG3552-RA_3 CG3552 AGGAGGTAAAGCGACCGGTCCGTAGGCGAACCATGAGCAAGGTTAAGTACGAGACGAGTCTGGAG 65 FBan0003552 FBgn0035999 CG3552 3 3L CG3552 CG3552 CDMC28382 1 11 25 DAC40-I18 3-CG3595-RA_1 CG3595 TAGCTCCATTAACCGCATCAGAACCACCAATCCAACAGCAACCATGTCATCCCGTAAGACCGCCG 65 FBan0003595 FBgn0003514 sqh X X border follicle cell migration (sensu Insecta); GO:0007298; calcium-mediated signaling; GO:0019722; cellularization; GO:0007349; cytokinesis; GO:0000910; establishment of planar polarity; GO:0001736; muscle contraction; GO:0006936; nuclear axial expansion; GO:0035191; nurse cell to oocyte transport (sensu Insecta); GO:0007300; ovarian follicle cell development (sensu Insecta); GO:0030707 "calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; ; GO:0005516; ; GO:0042623; ; GO:0005509" unconventional myosin; GO:0016461 sqh spaghetti squash "CG3595, CG3595, CG3595, ssq, spg, myosin regulatory light chain, myosin II, Sqh, DmMRLC_C, Myosin II, Myosin, RLC, MRLC, myoII, sgh" CDMC28382 1 12 25 DAC40-I18 3-CG3595-RA_1 CG3595 TAGCTCCATTAACCGCATCAGAACCACCAATCCAACAGCAACCATGTCATCCCGTAAGACCGCCG 65 FBan0003595 FBgn0003514 sqh X X border follicle cell migration (sensu Insecta); GO:0007298; calcium-mediated signaling; GO:0019722; cellularization; GO:0007349; cytokinesis; GO:0000910; establishment of planar polarity; GO:0001736; muscle contraction; GO:0006936; nuclear axial expansion; GO:0035191; nurse cell to oocyte transport (sensu Insecta); GO:0007300; ovarian follicle cell development (sensu Insecta); GO:0030707 "calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; ; GO:0005516; ; GO:0042623; ; GO:0005509" unconventional myosin; GO:0016461 sqh spaghetti squash "CG3595, CG3595, CG3595, ssq, spg, myosin regulatory light chain, myosin II, Sqh, DmMRLC_C, Myosin II, Myosin, RLC, MRLC, myoII, sgh" CDMC28383 1 13 25 DAC40-M06 6-CG3662-RA_1 CG3662 TGTATTAGCCTCGAGGGCGGATTGAAAGGATACGGAGAGATTGGATCGGTACACGCGCACAGACA 65 FBan0003662 FBgn0031285 CG3662 2 2L CG3662 CG3662 CDMC28383 1 14 25 DAC40-M06 6-CG3662-RA_1 CG3662 TGTATTAGCCTCGAGGGCGGATTGAAAGGATACGGAGAGATTGGATCGGTACACGCGCACAGACA 65 FBan0003662 FBgn0031285 CG3662 2 2L CG3662 CG3662 CDMC28384 1 15 25 DAC40-M18 3-CG3701-RA_3 CG3701 CTAGCGGTGGATACCTACTCGTTGAGGTTCCTGGGCATGATTGCTACCTACAATCCGCCGCGAAG 65 FBan0003701 FBgn0034732 CG3701 2 2R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812 ATP binding; GO:0005524; ; GO:0005524; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 sodium:potassium-exchanging ATPase complex; GO:0005890 CG3701 CG3701 CDMC28384 1 16 25 DAC40-M18 3-CG3701-RA_3 CG3701 CTAGCGGTGGATACCTACTCGTTGAGGTTCCTGGGCATGATTGCTACCTACAATCCGCCGCGAAG 65 FBan0003701 FBgn0034732 CG3701 2 2R calcium ion homeostasis; GO:0006874; cation transport; GO:0006812 ATP binding; GO:0005524; ; GO:0005524; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 sodium:potassium-exchanging ATPase complex; GO:0005890 CG3701 CG3701 CDMC28385 1 17 25 DAC41-A06 AutoBlank AutoBlank CDMC28385 1 18 25 DAC41-A06 AutoBlank AutoBlank CDMC28386 1 19 25 DAC41-A18 AutoBlank AutoBlank CDMC28386 1 20 25 DAC41-A18 AutoBlank AutoBlank CDMC28387 1 21 25 DAC41-E06 AutoBlank AutoBlank CDMC28387 1 22 25 DAC41-E06 AutoBlank AutoBlank CDMC28388 1 23 25 DAC41-E18 AutoBlank AutoBlank CDMC28388 1 24 25 DAC41-E18 AutoBlank AutoBlank CDMC28389 1 25 25 DAC41-I06 AutoBlank AutoBlank CDMC28389 1 26 25 DAC41-I06 AutoBlank AutoBlank CDMC28390 1 1 26 DAC41-I18 AutoBlank AutoBlank CDMC28390 1 2 26 DAC41-I18 AutoBlank AutoBlank CDMC28391 1 3 26 DAC41-M06 AutoBlank AutoBlank CDMC28391 1 4 26 DAC41-M06 AutoBlank AutoBlank CDMC28392 1 5 26 DAC41-M18 AutoBlank AutoBlank CDMC28392 1 6 26 DAC41-M18 AutoBlank AutoBlank CDMC28393 1 7 26 DAC42-A06 150mM NaPO4 Blank CDMC28393 1 8 26 DAC42-A06 150mM NaPO4 Blank CDMC28394 1 9 26 DAC42-A18 150mM NaPO4 Blank CDMC28394 1 10 26 DAC42-A18 150mM NaPO4 Blank CDMC28395 1 11 26 DAC42-E06 150mM NaPO4 Blank CDMC28395 1 12 26 DAC42-E06 150mM NaPO4 Blank CDMC28396 1 13 26 DAC42-E18 150mM NaPO4 Blank CDMC28396 1 14 26 DAC42-E18 150mM NaPO4 Blank CDMC28397 1 15 26 DAC42-I06 150mM NaPO4 Blank CDMC28397 1 16 26 DAC42-I06 150mM NaPO4 Blank CDMC28398 1 17 26 DAC42-I18 5uM MSP 5uM MSP CDMC28398 1 18 26 DAC42-I18 5uM MSP 5uM MSP CDMC28399 1 19 26 DAC42-M06 10uM MSP 10uM MSP CDMC28399 1 20 26 DAC42-M06 10uM MSP 10uM MSP CDMC28400 1 21 26 DAC42-M18 20uM MSP 20uM MSP CDMC28400 1 22 26 DAC42-M18 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC28401 2 1 1 DAC01-B06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28401 2 2 1 DAC01-B06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28402 2 3 1 DAC01-B18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28402 2 4 1 DAC01-B18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28403 2 5 1 DAC01-F06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28403 2 6 1 DAC01-F06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28404 2 7 1 DAC01-F18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28404 2 8 1 DAC01-F18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28405 2 9 1 DAC01-J06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28405 2 10 1 DAC01-J06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28406 2 11 1 DAC01-J18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28406 2 12 1 DAC01-J18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28407 2 13 1 DAC01-N06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28407 2 14 1 DAC01-N06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28408 2 15 1 DAC01-N18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28408 2 16 1 DAC01-N18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28409 2 17 1 DAC02-B06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28409 2 18 1 DAC02-B06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28410 2 19 1 DAC02-B18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28410 2 20 1 DAC02-B18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28411 2 21 1 DAC02-F06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28411 2 22 1 DAC02-F06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28412 2 23 1 DAC02-F18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28412 2 24 1 DAC02-F18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28413 2 25 1 DAC02-J06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28413 2 26 1 DAC02-J06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28414 2 1 2 DAC02-J18 N/A CG9075 (01674-01910) CDMC28414 2 2 2 DAC02-J18 N/A CG9075 (01674-01910) CDMC28415 2 3 2 DAC02-N06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28415 2 4 2 DAC02-N06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28416 2 5 2 DAC02-N18 AutoBlank AutoBlank CDMC28416 2 6 2 DAC02-N18 AutoBlank AutoBlank CDMC28417 2 7 2 DAC03-B06 3-CG5430-RA_2 CG5430 AGTACGACAACACCATTGACATAGAGGAGGGCAAGACCTATACTCCGACGGAGCTCAAGTTCCAGCCGA 69 FBan0005430 FBgn0011294 a5 2 2L signal transduction; GO:0007165 phosphatidylethanolamine binding; GO:0008429; kinase inhibitor activity; GO:0019210; ; GO:0019210; ; GO:0008429; ; GO:0008429 a5 antennal protein 5 "CG5430, A5" CDMC28417 2 8 2 DAC03-B06 3-CG5430-RA_2 CG5430 AGTACGACAACACCATTGACATAGAGGAGGGCAAGACCTATACTCCGACGGAGCTCAAGTTCCAGCCGA 69 FBan0005430 FBgn0011294 a5 2 2L signal transduction; GO:0007165 phosphatidylethanolamine binding; GO:0008429; kinase inhibitor activity; GO:0019210; ; GO:0019210; ; GO:0008429; ; GO:0008429 a5 antennal protein 5 "CG5430, A5" CDMC28418 2 9 2 DAC03-B18 1-CG5440-RA_5 CG5440 TCTCGAAGATTCTGCTATCAATTTGCTCCCTACTCACCGACTGCAATCCCAAGGATCCGCTGATGGCCA 69 FBan0005440 FBgn0031331 CG5440 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG5440 CG5440 CDMC28418 2 10 2 DAC03-B18 1-CG5440-RA_5 CG5440 TCTCGAAGATTCTGCTATCAATTTGCTCCCTACTCACCGACTGCAATCCCAAGGATCCGCTGATGGCCA 69 FBan0005440 FBgn0031331 CG5440 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG5440 CG5440 CDMC28419 2 11 2 DAC03-F06 23-CG5469-RC_1 CG5469 GCTATGTAGAAGTGCTTTAACCCATATATTCAGCGGTATTTGTCCCTTATATTATAACAGAGCTGTTGT 69 FBan0005469 FBgn0034372 Gint3 2 2R protein binding; GO:0005515; ; GO:0005515 Gint3 GDI interacting protein 3 "CG5469, GDI interacting protein 3" CDMC28419 2 12 2 DAC03-F06 23-CG5469-RC_1 CG5469 GCTATGTAGAAGTGCTTTAACCCATATATTCAGCGGTATTTGTCCCTTATATTATAACAGAGCTGTTGT 69 FBan0005469 FBgn0034372 Gint3 2 2R protein binding; GO:0005515; ; GO:0005515 Gint3 GDI interacting protein 3 "CG5469, GDI interacting protein 3" CDMC28420 2 13 2 DAC03-F18 23-CG5473-RB_1 CG5473 GCCGATGGCTTTGTGAAAATCAGTGAAGATAACAATCCTTAAGCTAAAGTCTATATACATAGATCTCCT 69 FBan0005473 FBgn0034371 SP2637 2 2R asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1; protein N-terminal asparagine amidohydrolase activity; GO:0008418 ; EC:3.5.1.-; ; GO:0008418 ; EC:3.5.1.- SP2637 SP2637 "CG5473, dm-ntan1, BEST:GH24992" CDMC28420 2 14 2 DAC03-F18 23-CG5473-RB_1 CG5473 GCCGATGGCTTTGTGAAAATCAGTGAAGATAACAATCCTTAAGCTAAAGTCTATATACATAGATCTCCT 69 FBan0005473 FBgn0034371 SP2637 2 2R asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1; protein N-terminal asparagine amidohydrolase activity; GO:0008418 ; EC:3.5.1.-; ; GO:0008418 ; EC:3.5.1.- SP2637 SP2637 "CG5473, dm-ntan1, BEST:GH24992" CDMC28421 2 15 2 DAC03-J06 9-CG5497-RA_2 CG5497 TCTGGTGTACCGATGGCTTCATTAACCTGTCGTTCCCGAATGCCAATGGTCATTCGACTTATCAGCGGT 69 FBan0005497 FBgn0034361 mRpS28 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS28 mitochondrial ribosomal protein S28 "CG5497, MRP-S35, BcDNA:RH13070, mitochondrial ribosomal protein S28" CDMC28421 2 16 2 DAC03-J06 9-CG5497-RA_2 CG5497 TCTGGTGTACCGATGGCTTCATTAACCTGTCGTTCCCGAATGCCAATGGTCATTCGACTTATCAGCGGT 69 FBan0005497 FBgn0034361 mRpS28 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS28 mitochondrial ribosomal protein S28 "CG5497, MRP-S35, BcDNA:RH13070, mitochondrial ribosomal protein S28" CDMC28422 2 17 2 DAC03-J18 16-CG5505-RA_2 CG5505 AGCTAGAACATAATTGTTGCCTCCCAAAATCATCCCCAACCTTCACCGAAGCACACAGTCCCATTAGAA 69 FBan0005505 FBgn0035633 mule 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 mule mule "CG5505, CG5505, CG5505, CG5505, anon-WO0118547.247" CDMC28422 2 18 2 DAC03-J18 16-CG5505-RA_2 CG5505 AGCTAGAACATAATTGTTGCCTCCCAAAATCATCCCCAACCTTCACCGAAGCACACAGTCCCATTAGAA 69 FBan0005505 FBgn0035633 mule 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 mule mule "CG5505, CG5505, CG5505, CG5505, anon-WO0118547.247" CDMC28423 2 19 2 DAC03-N06 3-CG5550-RA_1 CG5550 TGGTCGTCCAGCGAAGAGTCAGTGTGGAGGAGAACTTCTACCGCAATTGGACCTCTTATCAGACGGGTT 69 FBan0005550 FBgn0034160 CG5550 2 2R defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 extracellular matrix (sensu Metazoa); GO:0005578 CG5550 CG5550 Fibrinogen-like CDMC28423 2 20 2 DAC03-N06 3-CG5550-RA_1 CG5550 TGGTCGTCCAGCGAAGAGTCAGTGTGGAGGAGAACTTCTACCGCAATTGGACCTCTTATCAGACGGGTT 69 FBan0005550 FBgn0034160 CG5550 2 2R defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 extracellular matrix (sensu Metazoa); GO:0005578 CG5550 CG5550 Fibrinogen-like CDMC28424 2 21 2 DAC03-N18 8-CG5559-RA_1 CG5559 CCGGCACGTTTGCATCGGAGGAAGTAAGCTACATTTGGCCAACTTGGATCTCAGCGAGCAATTGAAGTT 69 FBan0005559 FBgn0032653 CG5559 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544 CG5559 CG5559 CDMC28424 2 22 2 DAC03-N18 8-CG5559-RA_1 CG5559 CCGGCACGTTTGCATCGGAGGAAGTAAGCTACATTTGGCCAACTTGGATCTCAGCGAGCAATTGAAGTT 69 FBan0005559 FBgn0032653 CG5559 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544 CG5559 CG5559 CDMC28425 2 23 2 DAC04-B06 3-CG12358-RA_1 CG12358 CCCGCCACAGAATCACAAACTACCCCGAACCCGTACCACGTGGACCTCATACGCGAAAAACCTTAGATA 69 FBan0012358 FBgn0038100 Paip2 3 3R negative regulation of translation; GO:0016478; regulation of cell growth; GO:0001558 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Paip2 polyA-binding protein interacting protein 2 "CG12358, dPaip2, polyA-binding protein interacting protein 2" CDMC28425 2 24 2 DAC04-B06 3-CG12358-RA_1 CG12358 CCCGCCACAGAATCACAAACTACCCCGAACCCGTACCACGTGGACCTCATACGCGAAAAACCTTAGATA 69 FBan0012358 FBgn0038100 Paip2 3 3R negative regulation of translation; GO:0016478; regulation of cell growth; GO:0001558 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Paip2 polyA-binding protein interacting protein 2 "CG12358, dPaip2, polyA-binding protein interacting protein 2" CDMC28426 2 25 2 DAC04-B18 23-CG1236-RA_4 CG1236 AAACTTATTGATTCAGGGACACATAATTCGAAGGATGAGCTCCCAACACAAGGTGTACGTAACCAGGCC 69 FBan0001236 FBgn0037370 CG1236 3 3R L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 phosphoglycerate dehydrogenase activity; GO:0004617 ; EC:1.1.1.95; ; GO:0004617 ; EC:1.1.1.95 CG1236 CG1236 CDMC28426 2 26 2 DAC04-B18 23-CG1236-RA_4 CG1236 AAACTTATTGATTCAGGGACACATAATTCGAAGGATGAGCTCCCAACACAAGGTGTACGTAACCAGGCC 69 FBan0001236 FBgn0037370 CG1236 3 3R L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 phosphoglycerate dehydrogenase activity; GO:0004617 ; EC:1.1.1.95; ; GO:0004617 ; EC:1.1.1.95 CG1236 CG1236 CDMC28427 2 1 3 DAC04-F06 14-CG12403-RA_1 CG12403 GGCCCGCTTCAGGTCTAGTCAGGTCAGAATCGAATCACCAGAAGATACGCAAAACGAAAGGAAAGACGA 69 FBan0012403 FBgn0020368 Vha68-1 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha68-1 Vha68-1 "CG12403, CG12403, CG12403, vha68-1, vha67-2, Vha, V-ATPase, Vha68" CDMC28427 2 2 3 DAC04-F06 14-CG12403-RA_1 CG12403 GGCCCGCTTCAGGTCTAGTCAGGTCAGAATCGAATCACCAGAAGATACGCAAAACGAAAGGAAAGACGA 69 FBan0012403 FBgn0020368 Vha68-1 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha68-1 Vha68-1 "CG12403, CG12403, CG12403, vha68-1, vha67-2, Vha, V-ATPase, Vha68" CDMC28428 2 3 3 DAC04-F18 1-CG12418-RA_1 CG12418 TCATCAAGAAACTGCCCAGTCTTGGCCAATTTCACGTTTACCGGCTGACCAAGAACGTCTGCCAGACTT 69 FBan0012418 FBgn0040536 CG12418 3 3R CG12418 CG12418 CDMC28428 2 4 3 DAC04-F18 1-CG12418-RA_1 CG12418 TCATCAAGAAACTGCCCAGTCTTGGCCAATTTCACGTTTACCGGCTGACCAAGAACGTCTGCCAGACTT 69 FBan0012418 FBgn0040536 CG12418 3 3R CG12418 CG12418 CDMC28429 2 5 3 DAC04-J06 23-CG1244-RC_2 CG1244 GAGATACTAGTTACGGATTTTAGTTACATACGTTTTGGAGTGTGCACATAAGTTGAAGTTGTAGCTACT 69 FBan0001244 FBgn0035357 CG1244 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1244 CG1244 "clone 1.37, anon-EST:Liang-1.37, anon-WO0118547.584" CDMC28429 2 6 3 DAC04-J06 23-CG1244-RC_2 CG1244 GAGATACTAGTTACGGATTTTAGTTACATACGTTTTGGAGTGTGCACATAAGTTGAAGTTGTAGCTACT 69 FBan0001244 FBgn0035357 CG1244 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1244 CG1244 "clone 1.37, anon-EST:Liang-1.37, anon-WO0118547.584" CDMC28430 2 7 3 DAC04-J18 2-CG12477-RA_1 CG12477 GTGGGATTGCCGACCCATGCTCTAGGGCTACCGATTCCATCAGATTTTTCGGGACTTGGCAATTGTCTT 69 FBan0012477 FBgn0036809 CG12477 3 3L CG12477 CG12477 CDMC28430 2 8 3 DAC04-J18 2-CG12477-RA_1 CG12477 GTGGGATTGCCGACCCATGCTCTAGGGCTACCGATTCCATCAGATTTTTCGGGACTTGGCAATTGTCTT 69 FBan0012477 FBgn0036809 CG12477 3 3L CG12477 CG12477 CDMC28431 2 9 3 DAC04-N06 1-CG12519-RA_1 CG12519 CGCCTTTGGCTTACTCCGCACCACTGAGCTACGCCGTTCCATCTGCACCGCTCCTTATCTAAATTACTA 69 FBan0012519 FBgn0036872 CG12519 3 3L CG12519 CG12519 CDMC28431 2 10 3 DAC04-N06 1-CG12519-RA_1 CG12519 CGCCTTTGGCTTACTCCGCACCACTGAGCTACGCCGTTCCATCTGCACCGCTCCTTATCTAAATTACTA 69 FBan0012519 FBgn0036872 CG12519 3 3L CG12519 CG12519 CDMC28432 2 11 3 DAC04-N18 3-CG12530-RB_2 CG12530 GCCTCCAGAGCTCTAATCCCTACCCGGTATTTTGGTCGGTTTCTATGTTTGGTCCACTGTGACCAGGCG 69 FBan0012530 FBgn0010341 Cdc42 X X "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; axon guidance; GO:0007411; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; cellularization; GO:0007349; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264; suture of dorsal opening; GO:0007396; transforming growth factor beta receptor signaling pathway; GO:0007179; wing hair outgrowth; GO:0035318; wound healing; GO:0042060" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Cdc42 Cdc42 "CG12530, CDC42, Dcdc42, cdc42, DCDC42, Dmcdc42, DCdc42, D-Cdc42, D-CDC42, Cdc42Dm, Dm Cdc42, DmCDC42, Cdc42-like" CDMC28432 2 12 3 DAC04-N18 3-CG12530-RB_2 CG12530 GCCTCCAGAGCTCTAATCCCTACCCGGTATTTTGGTCGGTTTCTATGTTTGGTCCACTGTGACCAGGCG 69 FBan0012530 FBgn0010341 Cdc42 X X "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; axon guidance; GO:0007411; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; cellularization; GO:0007349; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264; suture of dorsal opening; GO:0007396; transforming growth factor beta receptor signaling pathway; GO:0007179; wing hair outgrowth; GO:0035318; wound healing; GO:0042060" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Cdc42 Cdc42 "CG12530, CDC42, Dcdc42, cdc42, DCDC42, Dmcdc42, DCdc42, D-Cdc42, D-CDC42, Cdc42Dm, Dm Cdc42, DmCDC42, Cdc42-like" CDMC28433 2 13 3 DAC05-B06 23-CG5036-RA_8 CG5036 AGATTCCTAAACTCTCAAAAGTTCAAGACACTAGCTCAACTGCAAGACAACTCGAATGCCGGTTCCAAA 69 FBan0005036 FBgn0028743 CG5036 2 2R regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG5036 CG5036 EG:52C10.2 CDMC28433 2 14 3 DAC05-B06 23-CG5036-RA_8 CG5036 AGATTCCTAAACTCTCAAAAGTTCAAGACACTAGCTCAACTGCAAGACAACTCGAATGCCGGTTCCAAA 69 FBan0005036 FBgn0028743 CG5036 2 2R regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG5036 CG5036 EG:52C10.2 CDMC28434 2 15 3 DAC05-B18 6-CG5048-RA_1 CG5048 TGGGTACATGTTTGTACCGCTTACGCTTACCGCTTCCCCATCCCGTCAATGTTGATCGTTGTCATGCAA 69 FBan0005048 FBgn0036437 CG5048 3 3L CG5048 CG5048 anon-WO0140519.238 CDMC28434 2 16 3 DAC05-B18 6-CG5048-RA_1 CG5048 TGGGTACATGTTTGTACCGCTTACGCTTACCGCTTCCCCATCCCGTCAATGTTGATCGTTGTCATGCAA 69 FBan0005048 FBgn0036437 CG5048 3 3L CG5048 CG5048 anon-WO0140519.238 CDMC28435 2 17 3 DAC05-F06 6-CG5077-RA_1 CG5077 TCCCAGCAATCCAAGTCTCTCCCGCAGACAAAGTCCATATGCAAATCTCTTCCCTTTTAGCCTTGGGCA 69 FBan0005077 FBgn0038786 CG5077 3 3R cholesterol metabolism; GO:0008203; proteolysis; GO:0006508 oxysterol binding; GO:0008142; ; GO:0008142; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG5077 CG5077 CDMC28435 2 18 3 DAC05-F06 6-CG5077-RA_1 CG5077 TCCCAGCAATCCAAGTCTCTCCCGCAGACAAAGTCCATATGCAAATCTCTTCCCTTTTAGCCTTGGGCA 69 FBan0005077 FBgn0038786 CG5077 3 3R cholesterol metabolism; GO:0008203; proteolysis; GO:0006508 oxysterol binding; GO:0008142; ; GO:0008142; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG5077 CG5077 CDMC28436 2 19 3 DAC05-F18 3-CG5089-RA_3 CG5089 GCCAAAATCGTCGCTACGCAGACCGATATACCTTCGACGACCAGACTCAAGCACAAATCCAGGGCATCA 69 FBan0005089 FBgn0034144 CG5089 2 2R CG5089 CG5089 anon-WO0140519.170 CDMC28436 2 20 3 DAC05-F18 3-CG5089-RA_3 CG5089 GCCAAAATCGTCGCTACGCAGACCGATATACCTTCGACGACCAGACTCAAGCACAAATCCAGGGCATCA 69 FBan0005089 FBgn0034144 CG5089 2 2R CG5089 CG5089 anon-WO0140519.170 CDMC28437 2 21 3 DAC05-J06 22-CG5125-RA_1 CG5125 TGTGTTCTCCATCTGATGCAACCAATCGGCTTATAGCTGTCTGAGACATAACACTTAACATCGACGGCC 69 FBan0005125 FBgn0002938 ninaC 2 2L "adaptation of rhodopsin mediated signaling; GO:0016062; cytoskeleton organization and biogenesis; GO:0007010; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular protein transport; GO:0006886; phototransduction, UV; GO:0007604; phototransduction, visible light; GO:0007603; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104" "calmodulin binding; GO:0005516; ; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; phosphoinositide binding; GO:0035091; ; GO:0004713 ; EC:2.7.1.112; ; GO:0003774; ; GO:0035091" cytoplasm; GO:0005737; cytoskeleton; GO:0005856; inaD signaling complex; GO:0016027; myosin; GO:0016459; myosin III; GO:0042385; rhabdomere; GO:0016028; unconventional myosin; GO:0016461 ninaC neither inactivation nor afterpotential C "CG54125, CG5125, CG54125, CG5125, myosin-III, myosin III, DRONINAC, 2.2, NINAC, CT16120, CT42491, NINA C, Dm NinaC, NinaC, Droninac, Nina C" CDMC28437 2 22 3 DAC05-J06 22-CG5125-RA_1 CG5125 TGTGTTCTCCATCTGATGCAACCAATCGGCTTATAGCTGTCTGAGACATAACACTTAACATCGACGGCC 69 FBan0005125 FBgn0002938 ninaC 2 2L "adaptation of rhodopsin mediated signaling; GO:0016062; cytoskeleton organization and biogenesis; GO:0007010; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular protein transport; GO:0006886; phototransduction, UV; GO:0007604; phototransduction, visible light; GO:0007603; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104" "calmodulin binding; GO:0005516; ; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; phosphoinositide binding; GO:0035091; ; GO:0004713 ; EC:2.7.1.112; ; GO:0003774; ; GO:0035091" cytoplasm; GO:0005737; cytoskeleton; GO:0005856; inaD signaling complex; GO:0016027; myosin; GO:0016459; myosin III; GO:0042385; rhabdomere; GO:0016028; unconventional myosin; GO:0016461 ninaC neither inactivation nor afterpotential C "CG54125, CG5125, CG54125, CG5125, myosin-III, myosin III, DRONINAC, 2.2, NINAC, CT16120, CT42491, NINA C, Dm NinaC, NinaC, Droninac, Nina C" CDMC28438 2 23 3 DAC05-J18 22-CG5134-RC_2 CG5134 CGTGTTTTTTATGATGGATTTGTCGCCAAACAATCAGATCGAGGACAGAAAACCCATCCTAACCGCCGA 69 FBan0005134 FBgn0034311 MED9 2 2R mediator complex; GO:0000119 MED9 Mediator complex subunit 9 "CG5134, CG30113, CG30112, BcDNA:RH42446, BcDNA:LD07740, Mediator complex subunit 9" CDMC28438 2 24 3 DAC05-J18 22-CG5134-RC_2 CG5134 CGTGTTTTTTATGATGGATTTGTCGCCAAACAATCAGATCGAGGACAGAAAACCCATCCTAACCGCCGA 69 FBan0005134 FBgn0034311 MED9 2 2R mediator complex; GO:0000119 MED9 Mediator complex subunit 9 "CG5134, CG30113, CG30112, BcDNA:RH42446, BcDNA:LD07740, Mediator complex subunit 9" CDMC28439 2 25 3 DAC05-N06 23-CG5172-RB_3 CG5172 ATGCTGACTTGTGTTCCATGGCATAGAGATAGAGACAATCCCTAGATTCTTCTATTTTTCTTCTATCGA 69 FBan0005172 FBgn0030830 CG5172 X X CG5172 CG5172 "CT16557, BcDNA:RH06401" CDMC28439 2 26 3 DAC05-N06 23-CG5172-RB_3 CG5172 ATGCTGACTTGTGTTCCATGGCATAGAGATAGAGACAATCCCTAGATTCTTCTATTTTTCTTCTATCGA 69 FBan0005172 FBgn0030830 CG5172 X X CG5172 CG5172 "CT16557, BcDNA:RH06401" CDMC28440 2 1 4 DAC05-N18 1-CG5181-RA_1 CG5181 AGGTGGCCTTAAGGGGGAACGGCGTTAAATGGTCTACAGACGCGGGATAGCACTTAGCGATCAAGAATT 69 FBan0005181 FBgn0031909 CG5181 2 2L CG5181 CG5181 CDMC28440 2 2 4 DAC05-N18 1-CG5181-RA_1 CG5181 AGGTGGCCTTAAGGGGGAACGGCGTTAAATGGTCTACAGACGCGGGATAGCACTTAGCGATCAAGAATT 69 FBan0005181 FBgn0031909 CG5181 2 2L CG5181 CG5181 CDMC28441 2 3 4 DAC06-B06 13-CG9366-RA_1 CG9366 ACTGCTTCCTGTTGTGCTATTCGATCAGCAGTAGGACCTCATTCGAAAACGTGAAAAGCAAGTGGTGGC 69 FBan0009366 FBgn0014380 RhoL 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; calcium ion binding; GO:0005509; GTPase activity; GO:0003924; ; GO:0005509; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 RhoL rho-like "CG9366, CG9366, CG9366, CG9366, CG9366, rol, Rho-like, G: Complementation group G, Drac3, DRhoL, RhoL/Rac3, Mes1, DmRHO-L, Rac3, Rhol, anon-EST:CL1c2, rhoL, rho-like, G" CDMC28441 2 4 4 DAC06-B06 13-CG9366-RA_1 CG9366 ACTGCTTCCTGTTGTGCTATTCGATCAGCAGTAGGACCTCATTCGAAAACGTGAAAAGCAAGTGGTGGC 69 FBan0009366 FBgn0014380 RhoL 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; calcium ion binding; GO:0005509; GTPase activity; GO:0003924; ; GO:0005509; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 RhoL rho-like "CG9366, CG9366, CG9366, CG9366, CG9366, rol, Rho-like, G: Complementation group G, Drac3, DRhoL, RhoL/Rac3, Mes1, DmRHO-L, Rac3, Rhol, anon-EST:CL1c2, rhoL, rho-like, G" CDMC28442 2 5 4 DAC06-B18 4-CG9380-RB_1 CG9380 GCGGTTTTCAAGCTTTGTCCGAGATCCCACTCAAGACCTTTTCTCCCTAACGTTGGGAAGTACACCGGC 69 FBan0009380 FBgn0035094 CG9380 2 2R CG9380 CG9380 CDMC28442 2 6 4 DAC06-B18 4-CG9380-RB_1 CG9380 GCGGTTTTCAAGCTTTGTCCGAGATCCCACTCAAGACCTTTTCTCCCTAACGTTGGGAAGTACACCGGC 69 FBan0009380 FBgn0035094 CG9380 2 2R CG9380 CG9380 CDMC28443 2 7 4 DAC06-F06 23-CG9418-RA_1 CG9418 CAATTTTTAAATGCAATAGAGTGTACGGTTAAACAGAAATGACGGAACCAACGAGCAAGACACCGGATG 69 FBan0009418 FBgn0026582 CG9418 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 CG9418 CG9418 "LD07122, BEST:LD07122" CDMC28443 2 8 4 DAC06-F06 23-CG9418-RA_1 CG9418 CAATTTTTAAATGCAATAGAGTGTACGGTTAAACAGAAATGACGGAACCAACGAGCAAGACACCGGATG 69 FBan0009418 FBgn0026582 CG9418 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 CG9418 CG9418 "LD07122, BEST:LD07122" CDMC28444 2 9 4 DAC06-F18 3-CG9430-RA_1 CG9430 GCCGGCATACGCATTTTACTCTCGTCGATGGTGGGATTCGTCCTGATGTTTGGCCTCCAGATAGCAAGT 69 FBan0009430 FBgn0033097 CG9430 2 2R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG9430 CG9430 CDMC28444 2 10 4 DAC06-F18 3-CG9430-RA_1 CG9430 GCCGGCATACGCATTTTACTCTCGTCGATGGTGGGATTCGTCCTGATGTTTGGCCTCCAGATAGCAAGT 69 FBan0009430 FBgn0033097 CG9430 2 2R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG9430 CG9430 CDMC28445 2 11 4 DAC06-J06 14-CG9458-RA_1 CG9458 GCTCATCCAGTTTGGAATCGTTCTGGGGCATAGTATCTACACCCTAAAGCAACCGGACTGTCCATCAGC 69 FBan0009458 FBgn0037765 CG9458 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG9458 CG9458 CT26802 CDMC28445 2 12 4 DAC06-J06 14-CG9458-RA_1 CG9458 GCTCATCCAGTTTGGAATCGTTCTGGGGCATAGTATCTACACCCTAAAGCAACCGGACTGTCCATCAGC 69 FBan0009458 FBgn0037765 CG9458 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG9458 CG9458 CT26802 CDMC28446 2 13 4 DAC06-J18 8-CG9471-RA_2 CG9471 CCTGGAGCACAGGTGAGACTGCACTTTTGCAAACCAACAACTGGACTAAACGCATTTCAATCGACGGGA 69 FBan0009471 FBgn0037749 CG9471 3 3R coenzyme metabolism; GO:0006732; electron transport; GO:0006118 NADPH dehydrogenase activity; GO:0003959 ; EC:1.6.99.1; biliverdin reductase activity; GO:0004074 ; EC:1.3.1.24; ; GO:0003959 ; EC:1.6.99.1; ; GO:0004074 ; EC:1.3.1.24 CG9471 CG9471 "BVR, Biliverdin IX-beta reductase, biliverdin reductase" CDMC28446 2 14 4 DAC06-J18 8-CG9471-RA_2 CG9471 CCTGGAGCACAGGTGAGACTGCACTTTTGCAAACCAACAACTGGACTAAACGCATTTCAATCGACGGGA 69 FBan0009471 FBgn0037749 CG9471 3 3R coenzyme metabolism; GO:0006732; electron transport; GO:0006118 NADPH dehydrogenase activity; GO:0003959 ; EC:1.6.99.1; biliverdin reductase activity; GO:0004074 ; EC:1.3.1.24; ; GO:0003959 ; EC:1.6.99.1; ; GO:0004074 ; EC:1.3.1.24 CG9471 CG9471 "BVR, Biliverdin IX-beta reductase, biliverdin reductase" CDMC28447 2 15 4 DAC06-N06 12-CG9507-RA_3 CG9507 CGATCCGGAATCCGAATCCTACGTAAGCTCACTGTTCCAGCGTTTGAAGGTGCGATTTGGCCAAATCTT 69 FBan0009507 FBgn0031808 CG9507 2 2L proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG9507 CG9507 CDMC28447 2 16 4 DAC06-N06 12-CG9507-RA_3 CG9507 CGATCCGGAATCCGAATCCTACGTAAGCTCACTGTTCCAGCGTTTGAAGGTGCGATTTGGCCAAATCTT 69 FBan0009507 FBgn0031808 CG9507 2 2L proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG9507 CG9507 CDMC28448 2 17 4 DAC06-N18 3-CG9517-RB_2 CG9517 AGGGGTGGCCGCAAGAATGTGGTTTTCGTGAGAAGAGAAGTGATAGCCAGTGCTGGAGCTCTGAATACT 69 FBan0009517 FBgn0030591 CG9517 X X electron transport; GO:0006118 glucose dehydrogenase activity; GO:0008708 ; EC:1.1.-.-; ; GO:0008708 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660 CG9517 CG9517 CDMC28448 2 18 4 DAC06-N18 3-CG9517-RB_2 CG9517 AGGGGTGGCCGCAAGAATGTGGTTTTCGTGAGAAGAGAAGTGATAGCCAGTGCTGGAGCTCTGAATACT 69 FBan0009517 FBgn0030591 CG9517 X X electron transport; GO:0006118 glucose dehydrogenase activity; GO:0008708 ; EC:1.1.-.-; ; GO:0008708 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660 CG9517 CG9517 CDMC28449 2 19 4 DAC07-B06 2-CG6567-RA_1 CG6567 GGGTGTCAAGGGCACATTTCATCCATTGAGGAACACACTGCACGAACTGAAAACTGCCTCCATCACGGA 69 FBan0006567 FBgn0037842 CG6567 3 3R lipid metabolism; GO:0006629 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; ; GO:0004622 ; EC:3.1.1.5 CG6567 CG6567 CDMC28449 2 20 4 DAC07-B06 2-CG6567-RA_1 CG6567 GGGTGTCAAGGGCACATTTCATCCATTGAGGAACACACTGCACGAACTGAAAACTGCCTCCATCACGGA 69 FBan0006567 FBgn0037842 CG6567 3 3R lipid metabolism; GO:0006629 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; ; GO:0004622 ; EC:3.1.1.5 CG6567 CG6567 CDMC28450 2 21 4 DAC07-B18 9-CG6576-RA_2 CG6576 CGACGTCCACGATGTAAGGTGAATCCCTCGATAGCGCTGAGAAAGAAGAAACAGGAGACTGCACCCAGT 69 FBan0006576 FBgn0035924 CG6576 3 3L CG6576 CG6576 CDMC28450 2 22 4 DAC07-B18 9-CG6576-RA_2 CG6576 CGACGTCCACGATGTAAGGTGAATCCCTCGATAGCGCTGAGAAAGAAGAAACAGGAGACTGCACCCAGT 69 FBan0006576 FBgn0035924 CG6576 3 3L CG6576 CG6576 CDMC28451 2 23 4 DAC07-F06 23-CG6605-RA_10 CG6605 ACACAAATTGATGTTGAACAGATGGTATTGATATTGGCAACTGAAACATGCATTAATTGGCCAACCCGA 69 FBan0006605 FBgn0000183 BicD 2 2L NOT female germ-line cyst formation (sensu Insecta); GO:0030727; cell differentiation; GO:0030154; egg chamber formation (sensu Insecta); GO:0007293; intracellular mRNA localization; GO:0008298; mitosis; GO:0007067; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte microtubule cytoskeleton polarization; GO:0008103; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993 chromatin binding; GO:0003682; dynein binding; GO:0045502; ; GO:0003682; ; GO:0045502; NOT mRNA binding; GO:0003729; ; GO:0003729 microtubule cytoskeleton; GO:0015630 BicD Bicaudal D "CG6605, Bic-D, Bic[D], BIC-D, Bicaudal-D, anon-EST:fe2A11, anon-fast-evolving-2A11" CDMC28451 2 24 4 DAC07-F06 23-CG6605-RA_10 CG6605 ACACAAATTGATGTTGAACAGATGGTATTGATATTGGCAACTGAAACATGCATTAATTGGCCAACCCGA 69 FBan0006605 FBgn0000183 BicD 2 2L NOT female germ-line cyst formation (sensu Insecta); GO:0030727; cell differentiation; GO:0030154; egg chamber formation (sensu Insecta); GO:0007293; intracellular mRNA localization; GO:0008298; mitosis; GO:0007067; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte microtubule cytoskeleton polarization; GO:0008103; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993 chromatin binding; GO:0003682; dynein binding; GO:0045502; ; GO:0003682; ; GO:0045502; NOT mRNA binding; GO:0003729; ; GO:0003729 microtubule cytoskeleton; GO:0015630 BicD Bicaudal D "CG6605, Bic-D, Bic[D], BIC-D, Bicaudal-D, anon-EST:fe2A11, anon-fast-evolving-2A11" CDMC28452 2 25 4 DAC07-F18 23-CG6615-RA_7 CG6615 TCCCTGTAATGGAAGTGACTTCCCTCTTGAAATTGTTTCTTATGAAACTAATCCACGAATTCCTCAGAA 69 FBgn0036694 CDMC28452 2 26 4 DAC07-F18 23-CG6615-RA_7 CG6615 TCCCTGTAATGGAAGTGACTTCCCTCTTGAAATTGTTTCTTATGAAACTAATCCACGAATTCCTCAGAA 69 FBgn0036694 CDMC28453 2 1 5 DAC07-J06 7-CG6650-RA_2 CG6650 GCTGCTTCAACAGCTTCGACACTTTGTACTGCCCTACGTAGACTCCCTGGGAATGAACGAACAAGAGCT 69 FBan0006650 FBgn0036402 CG6650 3 3L glycolysis; GO:0006096 phosphofructokinase activity; GO:0008443 ; EC:2.7.1.-; ; GO:0008443 ; EC:2.7.1.- CG6650 CG6650 "0670/06, l(3)S067006, l(3)067006, anon-WO0172774.121, anon-WO0172774.122, anon-WO0172774.123" CDMC28453 2 2 5 DAC07-J06 7-CG6650-RA_2 CG6650 GCTGCTTCAACAGCTTCGACACTTTGTACTGCCCTACGTAGACTCCCTGGGAATGAACGAACAAGAGCT 69 FBan0006650 FBgn0036402 CG6650 3 3L glycolysis; GO:0006096 phosphofructokinase activity; GO:0008443 ; EC:2.7.1.-; ; GO:0008443 ; EC:2.7.1.- CG6650 CG6650 "0670/06, l(3)S067006, l(3)067006, anon-WO0172774.121, anon-WO0172774.122, anon-WO0172774.123" CDMC28454 2 3 5 DAC07-J18 9-CG6659-RB_1 CG6659 CGGCGCGATGATGGAATGCTGGAATCGTGTTGTGTTGTACGTAGCTGTGTGAGCTGTGTGACTAGGATT 69 FBan0006659 FBgn0030946 CG6659 X X CG6659 CG6659 CDMC28454 2 4 5 DAC07-J18 9-CG6659-RB_1 CG6659 CGGCGCGATGATGGAATGCTGGAATCGTGTTGTGTTGTACGTAGCTGTGTGAGCTGTGTGACTAGGATT 69 FBan0006659 FBgn0030946 CG6659 X X CG6659 CG6659 CDMC28455 2 5 5 DAC07-N06 3-CG6688-RA_3 CG6688 ACCCGGCGATTGCGTTCTGGAGGTAAATGGCAACGATGTTTTAGGCTTGAGAGTGTCTGAAATCGCCAA 69 FBan0006688 FBgn0039038 CG6688 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515 ubiquitin ligase complex; GO:0000151 CG6688 CG6688 CDMC28455 2 6 5 DAC07-N06 3-CG6688-RA_3 CG6688 ACCCGGCGATTGCGTTCTGGAGGTAAATGGCAACGATGTTTTAGGCTTGAGAGTGTCTGAAATCGCCAA 69 FBan0006688 FBgn0039038 CG6688 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515 ubiquitin ligase complex; GO:0000151 CG6688 CG6688 CDMC28456 2 7 5 DAC07-N18 3-CG6695-RA_2 CG6695 CGCCCATGATCAGCTATCCAATACCTGCGCGAATGCTCAATGTAAACCAAGCACTCACAGCTACCGCAC 69 FBan0006695 FBgn0039215 CG6695 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6695 CG6695 CDMC28456 2 8 5 DAC07-N18 3-CG6695-RA_2 CG6695 CGCCCATGATCAGCTATCCAATACCTGCGCGAATGCTCAATGTAAACCAAGCACTCACAGCTACCGCAC 69 FBan0006695 FBgn0039215 CG6695 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6695 CG6695 CDMC28457 2 9 5 DAC08-B06 15-CG31857-RA_4 CG31857 CAGTACGGATGAGGACTATGAGGAGGCCATAGATCAGTTCTCGCCAACGATATACACCACTCGATCGGC 69 FBan0031857 FBgn0051857 CG31857 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31857 CG31857 CDMC28457 2 10 5 DAC08-B06 15-CG31857-RA_4 CG31857 CAGTACGGATGAGGACTATGAGGAGGCCATAGATCAGTTCTCGCCAACGATATACACCACTCGATCGGC 69 FBan0031857 FBgn0051857 CG31857 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31857 CG31857 CDMC28458 2 11 5 DAC08-B18 17-CG31865-RA_1 CG31865 GGCCGTGCAAGTTCTGCTCAAGGATCTACTATCGGCAATCATCAAGAAACGAAAGCACTACAAGACCAG 69 FBan0031865 FBgn0051865 CG31865 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31865 CG31865 BcDNA:RE30472 CDMC28458 2 12 5 DAC08-B18 17-CG31865-RA_1 CG31865 GGCCGTGCAAGTTCTGCTCAAGGATCTACTATCGGCAATCATCAAGAAACGAAAGCACTACAAGACCAG 69 FBan0031865 FBgn0051865 CG31865 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31865 CG31865 BcDNA:RE30472 CDMC28459 2 13 5 DAC08-F06 2-CG31897-RA_1 CG31897 TTGGGAACGATATCTAGGATGAAGCCCTCGGATCAGGCAAATGCGGTTTGGAACGATTTGCAGGGGAAA 69 FBan0031897 FBgn0051897 CG31897 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31897 CG31897 NEST:bs30d08 CDMC28459 2 14 5 DAC08-F06 2-CG31897-RA_1 CG31897 TTGGGAACGATATCTAGGATGAAGCCCTCGGATCAGGCAAATGCGGTTTGGAACGATTTGCAGGGGAAA 69 FBan0031897 FBgn0051897 CG31897 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31897 CG31897 NEST:bs30d08 CDMC28460 2 15 5 DAC08-F18 1-CG31904-RD_3 CG31904 ACACATGCCTTCAGTTCGCTGATCTTTTCGGAGCTCTCCACCTTTGGAATACTTCATGGCGGTTGGCTT 69 FBan0031904 FBgn0051904 CG31904 2 2L CG31904 CG31904 anon-WO0149848.5 CDMC28460 2 16 5 DAC08-F18 1-CG31904-RD_3 CG31904 ACACATGCCTTCAGTTCGCTGATCTTTTCGGAGCTCTCCACCTTTGGAATACTTCATGGCGGTTGGCTT 69 FBan0031904 FBgn0051904 CG31904 2 2L CG31904 CG31904 anon-WO0149848.5 CDMC28461 2 17 5 DAC08-J06 14-CG31932-RA_1 CG31932 CCTCGAAGATTCACACCATCTAAGCTCCTCAAGAATTCACGCACTAGCATCCTTGTACGATCGCCTGCT 69 FBan0031932 FBgn0041249 Gr22f 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr22f Gustatory receptor 22f "CG31932, 22B.1, GR22B.1, Gustatory receptor 22B.1, Gr22B1, GR22b1, Gustatory receptor 22f" CDMC28461 2 18 5 DAC08-J06 14-CG31932-RA_1 CG31932 CCTCGAAGATTCACACCATCTAAGCTCCTCAAGAATTCACGCACTAGCATCCTTGTACGATCGCCTGCT 69 FBan0031932 FBgn0041249 Gr22f 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr22f Gustatory receptor 22f "CG31932, 22B.1, GR22B.1, Gustatory receptor 22B.1, Gr22B1, GR22b1, Gustatory receptor 22f" CDMC28462 2 19 5 DAC08-J18 13-CG31955-RA_1 CG31955 CCGCGGTGTCATAAGTCCATTTCGTCCACCAAAGTTGTGAAAAGCTTTGCATAGTGACGAATGCAAGCC 69 FBan0031955 FBgn0051955 CG31955 2 2L CG31955 CG31955 CDMC28462 2 20 5 DAC08-J18 13-CG31955-RA_1 CG31955 CCGCGGTGTCATAAGTCCATTTCGTCCACCAAAGTTGTGAAAAGCTTTGCATAGTGACGAATGCAAGCC 69 FBan0031955 FBgn0051955 CG31955 2 2L CG31955 CG31955 CDMC28463 2 21 5 DAC08-N06 15-CG32000-RD_5 CG32000 TGCTTGGGTTGTTGATCATAAAGGACTGTCTAAAGAGCTTCCAACGCGAGCGATAGTACCTGGGGACAT 69 FBan0032000 FBgn0052000 CG32000 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; metabolism; GO:0008152; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ATPase activity, coupled to transmembrane movement of ions; GO:0042625; ; GO:0042625; ; GO:0015662" integral to membrane; GO:0016021 CG32000 CG32000 "BcDNA:LD05303, BcDNA:LD19039, BcDNA:SD17880" CDMC28463 2 22 5 DAC08-N06 15-CG32000-RD_5 CG32000 TGCTTGGGTTGTTGATCATAAAGGACTGTCTAAAGAGCTTCCAACGCGAGCGATAGTACCTGGGGACAT 69 FBan0032000 FBgn0052000 CG32000 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; metabolism; GO:0008152; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; GO:0015662; ATPase activity, coupled to transmembrane movement of ions; GO:0042625; ; GO:0042625; ; GO:0015662" integral to membrane; GO:0016021 CG32000 CG32000 "BcDNA:LD05303, BcDNA:LD19039, BcDNA:SD17880" CDMC28464 2 23 5 DAC08-N18 23-CG32017-RA_3 CG32017 TATAAGTCAGCAAGTAAACATCATCACAAAAGTTCTGAAGTTGTCTACGCATGGTTGGGGTTTTTGATA 69 FBan0032017 FBgn0052017 CG32017 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32017 CG32017 CDMC28464 2 24 5 DAC08-N18 23-CG32017-RA_3 CG32017 TATAAGTCAGCAAGTAAACATCATCACAAAAGTTCTGAAGTTGTCTACGCATGGTTGGGGTTTTTGATA 69 FBan0032017 FBgn0052017 CG32017 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32017 CG32017 CDMC28465 2 25 5 DAC09-B07 2-CG5380-RA_1 CG5380 ACTGGCCTTCAAGCAGATGTCTTGCTGCACGGTGAACGAGGTTCAGAAGTTCATCTCGGACTTGG 65 FBan0005380 FBgn0038951 CG5380 3 3R rRNA metabolism; GO:0016072; tRNA metabolism; GO:0006399; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666; nucleus; GO:0005634 CG5380 CG5380 CDMC28465 2 26 5 DAC09-B07 2-CG5380-RA_1 CG5380 ACTGGCCTTCAAGCAGATGTCTTGCTGCACGGTGAACGAGGTTCAGAAGTTCATCTCGGACTTGG 65 FBan0005380 FBgn0038951 CG5380 3 3R rRNA metabolism; GO:0016072; tRNA metabolism; GO:0006399; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666; nucleus; GO:0005634 CG5380 CG5380 CDMC28466 2 1 6 DAC09-B19 3-CG5411-RA_1 CG5411 GATGGCCAACTCCAAATAGCATACGGCCTTCCGGAGATTGTTCTCGGGTCTACTGAAGCCACTGC 65 FBan0005411 FBgn0034886 Pde8 2 2R cyclic nucleotide metabolism; GO:0009187; mesoderm development; GO:0007498; signal transduction; GO:0007165 cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; signal transducer activity; GO:0004871; ; GO:0004115 ; EC:3.1.4.-; ; GO:0004871; ; GO:0004115 ; EC:3.1.4.- Pde8 Phosphodiesterase 8 "CG5411, CG5411, CG5411, CG5411, CG5411, PDE8, Phosphodiesterase 8" CDMC28466 2 2 6 DAC09-B19 3-CG5411-RA_1 CG5411 GATGGCCAACTCCAAATAGCATACGGCCTTCCGGAGATTGTTCTCGGGTCTACTGAAGCCACTGC 65 FBan0005411 FBgn0034886 Pde8 2 2R cyclic nucleotide metabolism; GO:0009187; mesoderm development; GO:0007498; signal transduction; GO:0007165 cAMP-specific phosphodiesterase activity; GO:0004115 ; EC:3.1.4.-; ; GO:0004115 ; EC:3.1.4.-; signal transducer activity; GO:0004871; ; GO:0004115 ; EC:3.1.4.-; ; GO:0004871; ; GO:0004115 ; EC:3.1.4.- Pde8 Phosphodiesterase 8 "CG5411, CG5411, CG5411, CG5411, CG5411, PDE8, Phosphodiesterase 8" CDMC28467 2 3 6 DAC09-F07 23-CG5540-RA_14 CG5540 ACCCGCACAATTTTCGTTCAATTCCTCTTGATCGGAATTTGCCTTGGCCTTTCAATGATCAATCT 65 FBan0005540 FBgn0039551 Or98a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98a Odorant receptor 98a "CG5540, CG5540, 98B.1, DOR110, 98a" CDMC28467 2 4 6 DAC09-F07 23-CG5540-RA_14 CG5540 ACCCGCACAATTTTCGTTCAATTCCTCTTGATCGGAATTTGCCTTGGCCTTTCAATGATCAATCT 65 FBan0005540 FBgn0039551 Or98a 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98a Odorant receptor 98a "CG5540, CG5540, 98B.1, DOR110, 98a" CDMC28468 2 5 6 DAC09-F19 2-CG5580-RB_1 CG5580 GTAGTTCGGGTCATCGGCGTGAGAAGACCAAGGACAAGAACGCACATTCCAATCGCATGTCCGTG 65 FBan0005580 FBgn0010575 sbb 2 2R axon guidance; GO:0007411; axon target recognition; GO:0007412; larval locomotory behavior; GO:0008345; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; photoreceptor cell development; GO:0042461 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sbb scribbler "CG5580, CG5580, CG5580, CG5580, scribble, l(2)04440, mtv, master of thickveins, bks, brakeless, Bks, Brakeless, GM04742, Group IIa, Scrib, Scribble, disc6" CDMC28468 2 6 6 DAC09-F19 2-CG5580-RB_1 CG5580 GTAGTTCGGGTCATCGGCGTGAGAAGACCAAGGACAAGAACGCACATTCCAATCGCATGTCCGTG 65 FBan0005580 FBgn0010575 sbb 2 2R axon guidance; GO:0007411; axon target recognition; GO:0007412; larval locomotory behavior; GO:0008345; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; photoreceptor cell development; GO:0042461 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sbb scribbler "CG5580, CG5580, CG5580, CG5580, scribble, l(2)04440, mtv, master of thickveins, bks, brakeless, Bks, Brakeless, GM04742, Group IIa, Scrib, Scribble, disc6" CDMC28469 2 7 6 DAC09-J07 14-CG5701-RA_2 CG5701 ACATAACAAACCTCAAGGGCACGATTTAGAGTGGTCGGGGAGATAAGGGTTGGAAATGGAGGGGG 65 FBan0005701 FBgn0036980 RhoBTB 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cytoskeleton organization and biogenesis; GO:0007010; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 RhoBTB RhoBTB "CG5701, CG5701, RhoX, RhoGTPase" CDMC28469 2 8 6 DAC09-J07 14-CG5701-RA_2 CG5701 ACATAACAAACCTCAAGGGCACGATTTAGAGTGGTCGGGGAGATAAGGGTTGGAAATGGAGGGGG 65 FBan0005701 FBgn0036980 RhoBTB 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cytoskeleton organization and biogenesis; GO:0007010; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 RhoBTB RhoBTB "CG5701, CG5701, RhoX, RhoGTPase" CDMC28470 2 9 6 DAC09-J19 2-CG5732-RA_2 CG5732 TGGGCTGCAAGAACAAGTGGGACCCCTTATCCCTGTCCGTTTGGAAGAAGTTCCTCGAGTCTCAG 65 FBan0005732 FBgn0038934 CG5732 3 3R nucleic acid binding; GO:0003676; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0003676; ; GO:0004652 ; EC:2.7.7.19 CG5732 CG5732 DmCG5732 CDMC28470 2 10 6 DAC09-J19 2-CG5732-RA_2 CG5732 TGGGCTGCAAGAACAAGTGGGACCCCTTATCCCTGTCCGTTTGGAAGAAGTTCCTCGAGTCTCAG 65 FBan0005732 FBgn0038934 CG5732 3 3R nucleic acid binding; GO:0003676; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0003676; ; GO:0004652 ; EC:2.7.7.19 CG5732 CG5732 DmCG5732 CDMC28471 2 11 6 DAC09-N07 14-CG5870-RA_1 CG5870 GAGCTGCTGATGAACAACCACCAGAGCCTTAAGGCCGAGATCGACACACGGGAGGACAACTTCGG 65 FBan0005870 FBgn0003471 beta-Spec X X cytoskeleton organization and biogenesis; GO:0007010; fusome organization and biogenesis; GO:0045478; neuromuscular synaptic transmission; GO:0007274; plasma membrane organization and biogenesis; GO:0007009; spectrosome organization and biogenesis; GO:0030721 actin binding; GO:0003779; calmodulin binding; GO:0005516; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0005516; ; GO:0008017; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; actin filament binding; GO:0051015; ; GO:0051015; ; GO:0005516 apicolateral plasma membrane; GO:0016327; fusome; GO:0045169; plasma membrane; GO:0005886; spectrin; GO:0008091; spectrosome; GO:0045170 beta-Spec beta Spectrin "CG5870, CG5870, CG5870, CG5870, beta-spectrin, spectrin, Specbeta, Spec-beta, beta, SPEC8, beta spectrin, l(1)G0108, l(1)G0074, l(1)G0198, betaSpec, Spectrin, betaspec, beta-spec, i6, i168, beta-spectrin, beta-Spec, b-Spec, anon-EST:fe1B3, anon-fast-evolving-1B3" CDMC28471 2 12 6 DAC09-N07 14-CG5870-RA_1 CG5870 GAGCTGCTGATGAACAACCACCAGAGCCTTAAGGCCGAGATCGACACACGGGAGGACAACTTCGG 65 FBan0005870 FBgn0003471 beta-Spec X X cytoskeleton organization and biogenesis; GO:0007010; fusome organization and biogenesis; GO:0045478; neuromuscular synaptic transmission; GO:0007274; plasma membrane organization and biogenesis; GO:0007009; spectrosome organization and biogenesis; GO:0030721 actin binding; GO:0003779; calmodulin binding; GO:0005516; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0005516; ; GO:0008017; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; actin filament binding; GO:0051015; ; GO:0051015; ; GO:0005516 apicolateral plasma membrane; GO:0016327; fusome; GO:0045169; plasma membrane; GO:0005886; spectrin; GO:0008091; spectrosome; GO:0045170 beta-Spec beta Spectrin "CG5870, CG5870, CG5870, CG5870, beta-spectrin, spectrin, Specbeta, Spec-beta, beta, SPEC8, beta spectrin, l(1)G0108, l(1)G0074, l(1)G0198, betaSpec, Spectrin, betaspec, beta-spec, i6, i168, beta-spectrin, beta-Spec, b-Spec, anon-EST:fe1B3, anon-fast-evolving-1B3" CDMC28472 2 13 6 DAC09-N19 9-CG5911-RA_5 CG5911 GCAGGGCGATTACTGCTGGAATTGGTGACATTGGGAAGAAGGAAGGAAGACTCTTCTCGCGGGCG 65 FBan0005911 FBgn0038874 ETHR 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; amine receptor activity; GO:0008227; ecdysis-triggering hormone receptor activity; GO:0042654; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008528; ; GO:0042654; ; GO:0008188; ; GO:0008227; ; GO:0042654; ; GO:0008528" integral to membrane; GO:0016021 ETHR ETHR "CG5911, CG5911a, CG5911b, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911a, CG5911b, CG5911, anon-WO0170980.37, anon-WO0170980.38" CDMC28472 2 14 6 DAC09-N19 9-CG5911-RA_5 CG5911 GCAGGGCGATTACTGCTGGAATTGGTGACATTGGGAAGAAGGAAGGAAGACTCTTCTCGCGGGCG 65 FBan0005911 FBgn0038874 ETHR 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; amine receptor activity; GO:0008227; ecdysis-triggering hormone receptor activity; GO:0042654; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008528; ; GO:0042654; ; GO:0008188; ; GO:0008227; ; GO:0042654; ; GO:0008528" integral to membrane; GO:0016021 ETHR ETHR "CG5911, CG5911a, CG5911b, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911, CG5911a, CG5911b, CG5911, anon-WO0170980.37, anon-WO0170980.38" CDMC28473 2 15 6 DAC10-B06 2-CG6488-RA_4 CG6488 TTCTGCAGACTCTGGAACGTGATCTACAGCTAGGAGTTGGCTCCGTCGAAACAGTGCTTGGGCAG 65 FBan0006488 FBgn0032361 CG6488 2 2L CG6488 CG6488 CDMC28473 2 16 6 DAC10-B06 2-CG6488-RA_4 CG6488 TTCTGCAGACTCTGGAACGTGATCTACAGCTAGGAGTTGGCTCCGTCGAAACAGTGCTTGGGCAG 65 FBan0006488 FBgn0032361 CG6488 2 2L CG6488 CG6488 CDMC28474 2 17 6 DAC10-B18 17-CG6510-RA_4 CG6510 AGTGTCATACCGATTTGACAAGCTCTTTCCGTTTCCTTTTCGCGTGAACGTCCAACATGAGAGCC 65 FBan0006510 FBgn0010409 RpL18A 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL18A Ribosomal protein L18A "CG6510, L18a, ribosomal protein L18a, L18, L18A, RpL18a, anon-EST:Posey75" CDMC28474 2 18 6 DAC10-B18 17-CG6510-RA_4 CG6510 AGTGTCATACCGATTTGACAAGCTCTTTCCGTTTCCTTTTCGCGTGAACGTCCAACATGAGAGCC 65 FBan0006510 FBgn0010409 RpL18A 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL18A Ribosomal protein L18A "CG6510, L18a, ribosomal protein L18a, L18, L18A, RpL18a, anon-EST:Posey75" CDMC28475 2 19 6 DAC10-F06 11-CG6638-RA_1 CG6638 GTGGCCTTGTCGTACGGAGCACACTCCAATCTGTGCATCAATCAGCTGACAAAGAACGGCACCCC 65 FBan0006638 FBgn0035911 CG6638 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; leucine catabolism; GO:0006552 isovaleryl-CoA dehydrogenase activity; GO:0008470 ; EC:1.3.99.10; ; GO:0008470 ; EC:1.3.99.10; ; GO:0008470 ; EC:1.3.99.10 mitochondrial matrix; GO:0005759 CG6638 CG6638 CDMC28475 2 20 6 DAC10-F06 11-CG6638-RA_1 CG6638 GTGGCCTTGTCGTACGGAGCACACTCCAATCTGTGCATCAATCAGCTGACAAAGAACGGCACCCC 65 FBan0006638 FBgn0035911 CG6638 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; leucine catabolism; GO:0006552 isovaleryl-CoA dehydrogenase activity; GO:0008470 ; EC:1.3.99.10; ; GO:0008470 ; EC:1.3.99.10; ; GO:0008470 ; EC:1.3.99.10 mitochondrial matrix; GO:0005759 CG6638 CG6638 CDMC28476 2 21 6 DAC10-F18 2-CG6677-RA_1 CG6677 TACGGCAACTTGCAGGCTCCATTGGGATACGACAAGTTCGGTTACTCCTGGAGATCTCGCAAGGG 65 FBan0006677 FBgn0000139 ash2 3 3R chromatin-mediated maintenance of transcription; GO:0048096; transcription from RNA polymerase II promoter; GO:0006366; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 ash2 "absent, small, or homeotic discs 2" "CG6677, CG6677, CG6677, ash-2, 291.8, 1124/11, ASH2, l(3)112411, 703, l(3)SG65, mad: many abnormal discs, l(3)S112411, many abnormal discs" CDMC28476 2 22 6 DAC10-F18 2-CG6677-RA_1 CG6677 TACGGCAACTTGCAGGCTCCATTGGGATACGACAAGTTCGGTTACTCCTGGAGATCTCGCAAGGG 65 FBan0006677 FBgn0000139 ash2 3 3R chromatin-mediated maintenance of transcription; GO:0048096; transcription from RNA polymerase II promoter; GO:0006366; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 ash2 "absent, small, or homeotic discs 2" "CG6677, CG6677, CG6677, ash-2, 291.8, 1124/11, ASH2, l(3)112411, 703, l(3)SG65, mad: many abnormal discs, l(3)S112411, many abnormal discs" CDMC28477 2 23 6 DAC10-J06 18-CG6776-RA_1 CG6776 TCGTCCTGAACGCCAAGAATGTGCCCTATCACAGTGTCTACATCAATCTCACCGAGAAACCAGAG 65 FBan0006776 FBgn0035904 CG6776 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6776 CG6776 T14 CDMC28477 2 24 6 DAC10-J06 18-CG6776-RA_1 CG6776 TCGTCCTGAACGCCAAGAATGTGCCCTATCACAGTGTCTACATCAATCTCACCGAGAAACCAGAG 65 FBan0006776 FBgn0035904 CG6776 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6776 CG6776 T14 CDMC28478 2 25 6 DAC10-J18 2-CG6798-RA_3 CG6798 ATACTCGTGTCGTTGACCGTGTTTTTCCTGCTCTTGGCCGAAATTATCCCCCCAACCTCGTTGGC 65 FBan0006798 FBgn0004118 nAcRbeta-96A 3 3R cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-96A nicotinic Acetylcholine Receptor beta 96A "CG6798, SBD: second beta-like subunit of Drosophila, second beta-like subunit of Drosophila, beta[[2]], sbd: stubbloid, Acr96Ac, nAcRs, nAcr96Ac, nAChR, Dbeta2, AcrF, SBD, sbd" CDMC28478 2 26 6 DAC10-J18 2-CG6798-RA_3 CG6798 ATACTCGTGTCGTTGACCGTGTTTTTCCTGCTCTTGGCCGAAATTATCCCCCCAACCTCGTTGGC 65 FBan0006798 FBgn0004118 nAcRbeta-96A 3 3R cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-96A nicotinic Acetylcholine Receptor beta 96A "CG6798, SBD: second beta-like subunit of Drosophila, second beta-like subunit of Drosophila, beta[[2]], sbd: stubbloid, Acr96Ac, nAcRs, nAcr96Ac, nAChR, Dbeta2, AcrF, SBD, sbd" CDMC28479 2 1 7 DAC10-N06 6-CG6903-RA_2 CG6903 GTCTTCCCCTCGTTCCTCTGGATCATGGGCGTGTGCATACCGCTCTCCGTCAAATCGCAATTGTC 65 FBan0006903 FBgn0029737 CG6903 X X CG6903 CG6903 CDMC28479 2 2 7 DAC10-N06 6-CG6903-RA_2 CG6903 GTCTTCCCCTCGTTCCTCTGGATCATGGGCGTGTGCATACCGCTCTCCGTCAAATCGCAATTGTC 65 FBan0006903 FBgn0029737 CG6903 X X CG6903 CG6903 CDMC28480 2 3 7 DAC10-N18 3-CG6936-RA_1 CG6936 TTGGCTTTCCGTCATCAGTCTGCACCTTTGGAACACGTTCAGAGGCTCCTCCCACAAAGCGAATC 65 FBan0006936 FBgn0023000 mth 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; aging; GO:0007568; determination of adult life span; GO:0008340; response to heat; GO:0009408; response to oxidative stress; GO:0006979; response to starvation; GO:0042594; response to stress; GO:0006950; synaptic vesicle exocytosis; GO:0016079 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mth methuselah "CG6936, CG6936, Mth, MTH, methuselah" CDMC28480 2 4 7 DAC10-N18 3-CG6936-RA_1 CG6936 TTGGCTTTCCGTCATCAGTCTGCACCTTTGGAACACGTTCAGAGGCTCCTCCCACAAAGCGAATC 65 FBan0006936 FBgn0023000 mth 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; aging; GO:0007568; determination of adult life span; GO:0008340; response to heat; GO:0009408; response to oxidative stress; GO:0006979; response to starvation; GO:0042594; response to stress; GO:0006950; synaptic vesicle exocytosis; GO:0016079 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mth methuselah "CG6936, CG6936, Mth, MTH, methuselah" CDMC28481 2 5 7 DAC11B6 3-modified_GFP_1 modified_GFP_1 TCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGA 69 CDMC28481 2 6 7 DAC11B6 3-modified_GFP_1 modified_GFP_1 TCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGA 69 CDMC28482 2 7 7 DAC11-B18 2-CG10007-RA_2 CG10007 CCGAGCATTGATCCATTTAGCTGTAGTTCGCGTGCAGTTTTCGACGATTGGGGTGATCTCTTTGCGGCT 69 FBan0010007 FBgn0037971 CG10007 3 3R CG10007 CG10007 CDMC28482 2 8 7 DAC11-B18 2-CG10007-RA_2 CG10007 CCGAGCATTGATCCATTTAGCTGTAGTTCGCGTGCAGTTTTCGACGATTGGGGTGATCTCTTTGCGGCT 69 FBan0010007 FBgn0037971 CG10007 3 3R CG10007 CG10007 CDMC28483 2 9 7 DAC11-F06 23-CG10045-RA_4 CG10045 CCTGGAGTTCAAGAAGTACTTCGAATAAGCCTGATATTCACGTTTTTATACCCGTACATATGATGTAGT 69 FBan0010045 FBgn0001149 GstD1 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD1 Glutathione S transferase D1 "CG10045 Glutathione S-transferase, CG10045, CG10045 Glutathione S-transferase, CG10045, GSTase, GST, GST1-1, DmGst1, Gst1, DmGST-1, Gst, DmGST1, gstD1, GSt1-1, Gst1-1, G-S-T, Glutathione S-transferase 1, gst-D1-1, GSTD1, GST1, DmGSTD1-1, GST-1, DmGSTD1, T5, Gst1.1" CDMC28483 2 10 7 DAC11-F06 23-CG10045-RA_4 CG10045 CCTGGAGTTCAAGAAGTACTTCGAATAAGCCTGATATTCACGTTTTTATACCCGTACATATGATGTAGT 69 FBan0010045 FBgn0001149 GstD1 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD1 Glutathione S transferase D1 "CG10045 Glutathione S-transferase, CG10045, CG10045 Glutathione S-transferase, CG10045, GSTase, GST, GST1-1, DmGst1, Gst1, DmGST-1, Gst, DmGST1, gstD1, GSt1-1, Gst1-1, G-S-T, Glutathione S-transferase 1, gst-D1-1, GSTD1, GST1, DmGSTD1-1, GST-1, DmGSTD1, T5, Gst1.1" CDMC28484 2 11 7 DAC11-F18 17-CG10055-RA_2 CG10055 TGGCGATGATGACTTGGACCTTGATAACGATACTTCTGGACAGGAGGACGAGACTACCACTGATGATGA 69 FBan0010055 FBgn0037482 CG10055 3 3R CG10055 CG10055 RE52393 CDMC28484 2 12 7 DAC11-F18 17-CG10055-RA_2 CG10055 TGGCGATGATGACTTGGACCTTGATAACGATACTTCTGGACAGGAGGACGAGACTACCACTGATGATGA 69 FBan0010055 FBgn0037482 CG10055 3 3R CG10055 CG10055 RE52393 CDMC28485 2 13 7 DAC11-J06 23-CG10082-RA_1 CG10082 TGTGATTCAAGCAAACCTATTTAACAACCGGATATAGACCTTAACTTTTAACTTTTAACCGACGCGTAA 69 FBan0010082 FBgn0034644 CG10082 2 2R inositol and derivative phosphorylation; GO:0046853; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 kinase activity; GO:0016301; ; GO:0016301; inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; inositol hexakisphosphate kinase activity; GO:0050517 ; EC:2.7.4.21; ; GO:0050517 ; EC:2.7.4.21; ; GO:0050517 ; EC:2.7.4.21 CG10082 CG10082 anon-WO0172774.149 CDMC28485 2 14 7 DAC11-J06 23-CG10082-RA_1 CG10082 TGTGATTCAAGCAAACCTATTTAACAACCGGATATAGACCTTAACTTTTAACTTTTAACCGACGCGTAA 69 FBan0010082 FBgn0034644 CG10082 2 2R inositol and derivative phosphorylation; GO:0046853; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 kinase activity; GO:0016301; ; GO:0016301; inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; inositol hexakisphosphate kinase activity; GO:0050517 ; EC:2.7.4.21; ; GO:0050517 ; EC:2.7.4.21; ; GO:0050517 ; EC:2.7.4.21 CG10082 CG10082 anon-WO0172774.149 CDMC28486 2 15 7 DAC11-J18 16-CG10093-RA_1 CG10093 AAGATTGCCGAGGAAATCTTTTTGTCCCCAGAGTGCCTAAATAGGAGCTCGATATTTTCCAAGCCGGTT 69 FBan0010093 FBgn0038007 Cyp313a3 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a3 Cyp313a3 "CG10093, 313a3" CDMC28486 2 16 7 DAC11-J18 16-CG10093-RA_1 CG10093 AAGATTGCCGAGGAAATCTTTTTGTCCCCAGAGTGCCTAAATAGGAGCTCGATATTTTCCAAGCCGGTT 69 FBan0010093 FBgn0038007 Cyp313a3 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a3 Cyp313a3 "CG10093, 313a3" CDMC28487 2 17 7 DAC11-N06 23-CG10128-RD_2 CG10128 CGGGCTGTAAAGGAGCATACGACTGAAATATTGTTTTGGTGAATCCTATCCCATCTAATGCATTTGGTT 69 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC28487 2 18 7 DAC11-N06 23-CG10128-RD_2 CG10128 CGGGCTGTAAAGGAGCATACGACTGAAATATTGTTTTGGTGAATCCTATCCCATCTAATGCATTTGGTT 69 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC28488 2 19 7 DAC11-N18 9-CG10134-RA_1 CG10134 TCGATGTATCGCATGGAGGAATACCTTAAAGCCACCTGCATATCGGATTTTTCCAGCCTGCCCACTCGA 69 FBan0010134 FBgn0038087 beat-Va 3 3R extracellular region; GO:0005576 beat-Va beat-Va "CG10134, beat Va" CDMC28488 2 20 7 DAC11-N18 9-CG10134-RA_1 CG10134 TCGATGTATCGCATGGAGGAATACCTTAAAGCCACCTGCATATCGGATTTTTCCAGCCTGCCCACTCGA 69 FBan0010134 FBgn0038087 beat-Va 3 3R extracellular region; GO:0005576 beat-Va beat-Va "CG10134, beat Va" CDMC28489 2 21 7 DAC12-B06 13-CG30092-RC_1 CG30092 GCTAACAGTCCGAACCACAAAATAACCCCAGACTGAGTCTTCGAATGAGCGAGACTCTATGCCAGCACA 69 FBan0030092 FBgn0028371 jbug 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 jbug jitterbug "CG11605, CG13525, CG3550, CG30092, CG11605, CG13525, CG3550, CG11605, CG11605, Filamin, filamin, shi kong, AAF46896, jitterbug" CDMC28489 2 22 7 DAC12-B06 13-CG30092-RC_1 CG30092 GCTAACAGTCCGAACCACAAAATAACCCCAGACTGAGTCTTCGAATGAGCGAGACTCTATGCCAGCACA 69 FBan0030092 FBgn0028371 jbug 2 2R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 jbug jitterbug "CG11605, CG13525, CG3550, CG30092, CG11605, CG13525, CG3550, CG11605, CG11605, Filamin, filamin, shi kong, AAF46896, jitterbug" CDMC28490 2 23 7 DAC12-B18 18-CG3009-RA_1 CG3009 AGGGAGTCGCAATCCTAGCTAACTTAGCTGCATGTGTGATTGCCATTAACGTTATGCATGTACCGTGTT 69 FBan0003009 FBgn0029720 CG3009 X X lipid catabolism; GO:0016042; phospholipid metabolism; GO:0006644 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 CG3009 CG3009 CDMC28490 2 24 7 DAC12-B18 18-CG3009-RA_1 CG3009 AGGGAGTCGCAATCCTAGCTAACTTAGCTGCATGTGTGATTGCCATTAACGTTATGCATGTACCGTGTT 69 FBan0003009 FBgn0029720 CG3009 X X lipid catabolism; GO:0016042; phospholipid metabolism; GO:0006644 phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 CG3009 CG3009 CDMC28491 2 25 7 DAC12-F06 14-CG30141-RA_1 CG30141 AACCAAATGGCTAAATGCTCGGGGTGAAGTCGATCTGAAATCAATGAAAGCAACCAGTGAGACAGCGGT 69 FBan0030141 FBgn0043535 Obp57a 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57a Odorant-binding protein 57a "CG30141, OBP57a, 57a, Obp57c, anon-AE003792.1, Obp-f, Odorant-binding protein 57a" CDMC28491 2 26 7 DAC12-F06 14-CG30141-RA_1 CG30141 AACCAAATGGCTAAATGCTCGGGGTGAAGTCGATCTGAAATCAATGAAAGCAACCAGTGAGACAGCGGT 69 FBan0030141 FBgn0043535 Obp57a 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57a Odorant-binding protein 57a "CG30141, OBP57a, 57a, Obp57c, anon-AE003792.1, Obp-f, Odorant-binding protein 57a" CDMC28492 2 1 8 DAC12-F18 13-CG30150-RA_1 CG30150 GCCGAATCAATTCTAGGTGACTGGCCTGCAAATGTGGATTTGACTAGCGTGAAAAGGTCCCACAAGTGT 69 FBan0030150 FBgn0043536 Obp57d 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57d Odorant-binding protein 57d "CG30150, OBP57d, 57d, Obp57e, anon-AE003791.1, Obp-g, Odorant-binding protein 57d" CDMC28492 2 2 8 DAC12-F18 13-CG30150-RA_1 CG30150 GCCGAATCAATTCTAGGTGACTGGCCTGCAAATGTGGATTTGACTAGCGTGAAAAGGTCCCACAAGTGT 69 FBan0030150 FBgn0043536 Obp57d 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57d Odorant-binding protein 57d "CG30150, OBP57d, 57d, Obp57e, anon-AE003791.1, Obp-g, Odorant-binding protein 57d" CDMC28493 2 3 8 DAC12-J06 15-CG3017-RA_1 CG3017 CCCTCGCCTGGAGATCTCGCTTGCAGCATAGTTGCCTCTTGGAAACACGACTATAAATGAAGCATTCGA 69 FBan0003017 FBgn0020764 Alas 2 2R amino acid metabolism; GO:0006520; heme biosynthesis; GO:0006783 5-aminolevulinate synthase activity; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37; transaminase activity; GO:0008483 ; EC:2.6.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008483 ; EC:2.6.1.-; ; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37 mitochondrial matrix; GO:0005759 Alas Aminolevulinate synthase "CG3017, CG3017, alas" CDMC28493 2 4 8 DAC12-J06 15-CG3017-RA_1 CG3017 CCCTCGCCTGGAGATCTCGCTTGCAGCATAGTTGCCTCTTGGAAACACGACTATAAATGAAGCATTCGA 69 FBan0003017 FBgn0020764 Alas 2 2R amino acid metabolism; GO:0006520; heme biosynthesis; GO:0006783 5-aminolevulinate synthase activity; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37; transaminase activity; GO:0008483 ; EC:2.6.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008483 ; EC:2.6.1.-; ; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37; ; GO:0003870 ; EC:2.3.1.37 mitochondrial matrix; GO:0005759 Alas Aminolevulinate synthase "CG3017, CG3017, alas" CDMC28494 2 5 8 DAC12-J18 1-CG30189-RA_1 CG30189 TGCCATCTTCTTGACTTTGCTACCGAGTGCTTTCTGGAAATCGGCCAAGCTTTTGAGTACGGCGGACTG 69 FBan0030189 FBgn0045483 Gr59a 2 2R Gr59a Gustatory receptor 59a "CG13537, CG30189, CG13537, CG30189, GR59C.1, Gustatory receptor 59a" CDMC28494 2 6 8 DAC12-J18 1-CG30189-RA_1 CG30189 TGCCATCTTCTTGACTTTGCTACCGAGTGCTTTCTGGAAATCGGCCAAGCTTTTGAGTACGGCGGACTG 69 FBan0030189 FBgn0045483 Gr59a 2 2R Gr59a Gustatory receptor 59a "CG13537, CG30189, CG13537, CG30189, GR59C.1, Gustatory receptor 59a" CDMC28495 2 7 8 DAC12-N06 21-CG30277-RA_5 CG30277 TTCTGGGTGTAATGTGCTTCCTTAAACTCGTGGGAGCATCTAGTAAATCGACGAATCTGCTCCTAGCCC 69 FBan0030277 FBgn0050277 Oatp58Da 2 2R anion transport; GO:0006820; ion transport; GO:0006811; organic anion transport; GO:0015711; transport; GO:0006810 transporter activity; GO:0005215; organic anion transporter activity; GO:0008514; ; GO:0005215; ; GO:0008514 membrane; GO:0016020 Oatp58Da Organic anion transporting polypeptide 58Da "CG30277, CG3387, oatp 58Da, Organic anion transporting polypeptide 58Da" CDMC28495 2 8 8 DAC12-N06 21-CG30277-RA_5 CG30277 TTCTGGGTGTAATGTGCTTCCTTAAACTCGTGGGAGCATCTAGTAAATCGACGAATCTGCTCCTAGCCC 69 FBan0030277 FBgn0050277 Oatp58Da 2 2R anion transport; GO:0006820; ion transport; GO:0006811; organic anion transport; GO:0015711; transport; GO:0006810 transporter activity; GO:0005215; organic anion transporter activity; GO:0008514; ; GO:0005215; ; GO:0008514 membrane; GO:0016020 Oatp58Da Organic anion transporting polypeptide 58Da "CG30277, CG3387, oatp 58Da, Organic anion transporting polypeptide 58Da" CDMC28496 2 9 8 DAC12-N18 2-CG30284-RA_3 CG30284 GCCACCTACGACGACAAGGCAGTCAAATTTTACCCAGACCGAACGAAGACGGACACATCGCAAGCTGAG 69 FBan0030284 FBgn0050284 CG30284 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30284 CG30284 "BcDNA:AT22714, BcDNA:AT12437, NEST:bs16b04" CDMC28496 2 10 8 DAC12-N18 2-CG30284-RA_3 CG30284 GCCACCTACGACGACAAGGCAGTCAAATTTTACCCAGACCGAACGAAGACGGACACATCGCAAGCTGAG 69 FBan0030284 FBgn0050284 CG30284 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30284 CG30284 "BcDNA:AT22714, BcDNA:AT12437, NEST:bs16b04" CDMC28497 2 11 8 DAC13-B06 14-CG13224-RA_1 CG13224 CCATCTCTCTCACCCCACAAGAATAGCCAACGAAATGTTCAAGATCGCCATCTGCTTGTTGGCCC 65 FBan0013224 FBgn0033598 CG13224 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13224 CG13224 CDMC28497 2 12 8 DAC13-B06 14-CG13224-RA_1 CG13224 CCATCTCTCTCACCCCACAAGAATAGCCAACGAAATGTTCAAGATCGCCATCTGCTTGTTGGCCC 65 FBan0013224 FBgn0033598 CG13224 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13224 CG13224 CDMC28498 2 13 8 DAC13-B18 20-CG13235-RA_1 CG13235 TCGTCGCAGCTCGACATAGACAAATGTTGCTCTTGTCACAAGTGGAGGAGGCAGCAACAGCAGCA 65 FBan0013235 FBgn0040766 CG13235 2 2R CG13235 CG13235 CDMC28498 2 14 8 DAC13-B18 20-CG13235-RA_1 CG13235 TCGTCGCAGCTCGACATAGACAAATGTTGCTCTTGTCACAAGTGGAGGAGGCAGCAACAGCAGCA 65 FBan0013235 FBgn0040766 CG13235 2 2R CG13235 CG13235 CDMC28499 2 15 8 DAC13-F06 1-CG13386-RA_1 CG13386 ATGGCCATTATTCACCGCCCGAATATGCGTATCCGTATCCTCTGGATCACCACGAGATAGCCGCG 65 FBan0013386 FBgn0032040 CG13386 2 2L CG13386 CG13386 CDMC28499 2 16 8 DAC13-F06 1-CG13386-RA_1 CG13386 ATGGCCATTATTCACCGCCCGAATATGCGTATCCGTATCCTCTGGATCACCACGAGATAGCCGCG 65 FBan0013386 FBgn0032040 CG13386 2 2L CG13386 CG13386 CDMC28500 2 17 8 DAC13-F18 3-CG1342-RA_6 CG1342 ATTCCAGGTAGCAGATCTTCCACAGGTCAAAGCCCGAGTTCTAAGCCTGCCCTACGAAACCTCCC 65 FBan0001342 FBgn0039795 CG1342 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG1342 CG1342 CDMC28500 2 18 8 DAC13-F18 3-CG1342-RA_6 CG1342 ATTCCAGGTAGCAGATCTTCCACAGGTCAAAGCCCGAGTTCTAAGCCTGCCCTACGAAACCTCCC 65 FBan0001342 FBgn0039795 CG1342 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG1342 CG1342 CDMC28501 2 19 8 DAC13-J06 18-CG13535-RA_1 CG13535 GCACTTGAATACTTAAGTGACGCTCAATTTGATGGACAAGGACGTCGAGAATCAGCGGGCAAGCC 65 FBan0013535 FBgn0034787 CG13535 2 2R CG13535 CG13535 CDMC28501 2 20 8 DAC13-J06 18-CG13535-RA_1 CG13535 GCACTTGAATACTTAAGTGACGCTCAATTTGATGGACAAGGACGTCGAGAATCAGCGGGCAAGCC 65 FBan0013535 FBgn0034787 CG13535 2 2R CG13535 CG13535 CDMC28502 2 21 8 DAC13-J18 1-CG13557-RA_1 CG13557 CACTCCCGAATCGGATGAAGCCAGATTGGTGTATCCCTGCTACTGCTACAAGCCAACTCCCGAGG 65 FBan0013557 FBgn0034867 CG13557 2 2R CG13557 CG13557 CDMC28502 2 22 8 DAC13-J18 1-CG13557-RA_1 CG13557 CACTCCCGAATCGGATGAAGCCAGATTGGTGTATCCCTGCTACTGCTACAAGCCAACTCCCGAGG 65 FBan0013557 FBgn0034867 CG13557 2 2R CG13557 CG13557 CDMC28503 2 23 8 DAC13-N06 3-CG13651-RA_3 CG13651 TCAACTCCAAACTCACCCCACAGACTGCCGATGTCCTGGTAGATGCACAGCCGAAATCAGAGGAC 65 FBan0013651 FBgn0039283 danr 3 3R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" danr distal antenna-related "CG13651, CG13651, CG13651, CG13651, CG13651, hernandez, Tintin, Distal antenna related, distal antenna-related" CDMC28503 2 24 8 DAC13-N06 3-CG13651-RA_3 CG13651 TCAACTCCAAACTCACCCCACAGACTGCCGATGTCCTGGTAGATGCACAGCCGAAATCAGAGGAC 65 FBan0013651 FBgn0039283 danr 3 3R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" danr distal antenna-related "CG13651, CG13651, CG13651, CG13651, CG13651, hernandez, Tintin, Distal antenna related, distal antenna-related" CDMC28504 2 25 8 DAC13-N18 23-CG13678-RA_2 CG13678 CATCTACCAAGTGACAATCCAAAAAGAAAACCAATACATCAACATGTTCAAATTCGCTGCTATCT 65 FBan0013678 FBgn0035859 CG13678 3 3L CG13678 CG13678 BcDNA:RE24439 CDMC28504 2 26 8 DAC13-N18 23-CG13678-RA_2 CG13678 CATCTACCAAGTGACAATCCAAAAAGAAAACCAATACATCAACATGTTCAAATTCGCTGCTATCT 65 FBan0013678 FBgn0035859 CG13678 3 3L CG13678 CG13678 BcDNA:RE24439 CDMC28505 2 1 9 DAC14-B06 2-CG1651-RB_1 CG1651 TGGCTAGAACATGGAGGCATATTGACGGGCAATGTACTAGCTGAAGCCCTCTACAAAATCGGCCGCTCA 69 FBan0001651 FBgn0011747 Ank 4 4 cytoskeletal anchoring; GO:0007016; signal transduction; GO:0007165 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; receptor binding; GO:0005102; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005102; ; GO:0005200 NOT fusome; GO:0045169; fusome; GO:0045169; plasma membrane; GO:0005886; spectrosome; GO:0045170 Ank Ankyrin "CG1651, CG32008, CG1651, CG1651, CG1651, ankyrin, ANK, Dank1, ank" CDMC28505 2 2 9 DAC14-B06 2-CG1651-RB_1 CG1651 TGGCTAGAACATGGAGGCATATTGACGGGCAATGTACTAGCTGAAGCCCTCTACAAAATCGGCCGCTCA 69 FBan0001651 FBgn0011747 Ank 4 4 cytoskeletal anchoring; GO:0007016; signal transduction; GO:0007165 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; receptor binding; GO:0005102; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005102; ; GO:0005200 NOT fusome; GO:0045169; fusome; GO:0045169; plasma membrane; GO:0005886; spectrosome; GO:0045170 Ank Ankyrin "CG1651, CG32008, CG1651, CG1651, CG1651, ankyrin, ANK, Dank1, ank" CDMC28506 2 3 9 DAC14-B18 16-CG1659-RA_4 CG1659 CGGCTTTTGCTTTCCATTTTCGAAGAATACGGTTGAGCACATCTACGAGTTTCCTAACCTTCCACCCGA 69 FBan0001659 FBgn0025549 unc-119 X X sensory perception; GO:0007600; sensory perception of chemical stimulus; GO:0007606; visual perception; GO:0007601 receptor activity; GO:0004872; ; GO:0004872 cellular component unknown; GO:0008372 unc-119 unc-119 "CG1659, Unc-119, dm unc-119, Unc119, anon-EST:Posey123" CDMC28506 2 4 9 DAC14-B18 16-CG1659-RA_4 CG1659 CGGCTTTTGCTTTCCATTTTCGAAGAATACGGTTGAGCACATCTACGAGTTTCCTAACCTTCCACCCGA 69 FBan0001659 FBgn0025549 unc-119 X X sensory perception; GO:0007600; sensory perception of chemical stimulus; GO:0007606; visual perception; GO:0007601 receptor activity; GO:0004872; ; GO:0004872 cellular component unknown; GO:0008372 unc-119 unc-119 "CG1659, Unc-119, dm unc-119, Unc119, anon-EST:Posey123" CDMC28507 2 5 9 DAC14-F06 9-CG16724-RA_2 CG16724 AGAGGGACAGCAGAAAGAAGGAGCACAAGATTCCGTACTTTGCAGACGAGGTTCGAGAACAGGATCGGT 69 FBan0016724 FBgn0003741 tra 3 3L "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; negative regulation of translation; GO:0016478; nuclear mRNA splicing, via spliceosome; GO:0000398; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; sex differentiation; GO:0007548; somatic sex determination; GO:0018993; spliceosome assembly; GO:0000245" spliceosome complex; GO:0005681 tra transformer "CG16724, Dmtra, TRA" CDMC28507 2 6 9 DAC14-F06 9-CG16724-RA_2 CG16724 AGAGGGACAGCAGAAAGAAGGAGCACAAGATTCCGTACTTTGCAGACGAGGTTCGAGAACAGGATCGGT 69 FBan0016724 FBgn0003741 tra 3 3L "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; negative regulation of translation; GO:0016478; nuclear mRNA splicing, via spliceosome; GO:0000398; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; sex differentiation; GO:0007548; somatic sex determination; GO:0018993; spliceosome assembly; GO:0000245" spliceosome complex; GO:0005681 tra transformer "CG16724, Dmtra, TRA" CDMC28508 2 7 9 DAC14-F18 3-CG16735-RA_2 CG16735 ACCGGTAACTATTCCTTTGCAGGCACACTTATTCATCCGCGGGTGGTTATGACTGTCACCTACCGGGTT 69 FBan0016735 FBgn0037666 CG16735 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG16735 CG16735 CDMC28508 2 8 9 DAC14-F18 3-CG16735-RA_2 CG16735 ACCGGTAACTATTCCTTTGCAGGCACACTTATTCATCCGCGGGTGGTTATGACTGTCACCTACCGGGTT 69 FBan0016735 FBgn0037666 CG16735 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG16735 CG16735 CDMC28509 2 9 9 DAC14-J06 38-CG16771-RA_4 CG16771 TGGAACGCCGATAAATAGCCAAAAGTTTCGAAAACTCAGCGATGTGGACATGACGGAAGTGCAGCTGAA 69 FBan0016771 FBgn0032779 CG16771 2 2L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG16771 CG16771 CDMC28509 2 10 9 DAC14-J06 38-CG16771-RA_4 CG16771 TGGAACGCCGATAAATAGCCAAAAGTTTCGAAAACTCAGCGATGTGGACATGACGGAAGTGCAGCTGAA 69 FBan0016771 FBgn0032779 CG16771 2 2L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG16771 CG16771 CDMC28510 2 11 9 DAC14-J18 10-CG16784-RB_2 CG16784 TCGCCTAACGAATTTTTTGATTGGACCAATGATCAGCGAAGACTCAGCCAACCTCTTAAGCACGCGCGT 69 FBan0016784 FBgn0003141 pr 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; tetrahydrobiopterin biosynthesis; GO:0006729 6-pyruvoyltetrahydropterin synthase activity; GO:0003874 ; EC:4.2.3.12; ; GO:0003874 ; EC:4.2.3.12; ; GO:0003874 ; EC:4.2.3.12 pr purple "CG16784, 38B.9, anon-38Bb" CDMC28510 2 12 9 DAC14-J18 10-CG16784-RB_2 CG16784 TCGCCTAACGAATTTTTTGATTGGACCAATGATCAGCGAAGACTCAGCCAACCTCTTAAGCACGCGCGT 69 FBan0016784 FBgn0003141 pr 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; pteridine biosynthesis; GO:0006728; tetrahydrobiopterin biosynthesis; GO:0006729 6-pyruvoyltetrahydropterin synthase activity; GO:0003874 ; EC:4.2.3.12; ; GO:0003874 ; EC:4.2.3.12; ; GO:0003874 ; EC:4.2.3.12 pr purple "CG16784, 38B.9, anon-38Bb" CDMC28511 2 13 9 DAC14-N06 15-CG16833-RA_1 CG16833 GGTGATCACACTGCATATTCCTTACACCTGAGTCCAGAACAAGACTTTCTTCCAGCGTCAGGTGGGTCT 69 FBan0016833 FBgn0026147 CG16833 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG16833 CG16833 "LD13681, BEST:LD13681" CDMC28511 2 14 9 DAC14-N06 15-CG16833-RA_1 CG16833 GGTGATCACACTGCATATTCCTTACACCTGAGTCCAGAACAAGACTTTCTTCCAGCGTCAGGTGGGTCT 69 FBan0016833 FBgn0026147 CG16833 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG16833 CG16833 "LD13681, BEST:LD13681" CDMC28512 2 15 9 DAC14-N18 7-CG16840-RA_1 CG16840 TGCCCGAGGAATCCTGCGAAAATCTGGAGGAGAAGTCACCCATTGCATTTCAAATCACAATGAAGCGCA 69 FBan0016840 FBgn0032329 Art8 2 2L protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art8 Arginine methyltransferase 8 "CG16840, DART8, Arginine methyltransferase 8" CDMC28512 2 16 9 DAC14-N18 7-CG16840-RA_1 CG16840 TGCCCGAGGAATCCTGCGAAAATCTGGAGGAGAAGTCACCCATTGCATTTCAAATCACAATGAAGCGCA 69 FBan0016840 FBgn0032329 Art8 2 2L protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art8 Arginine methyltransferase 8 "CG16840, DART8, Arginine methyltransferase 8" CDMC28513 2 17 9 DAC15-B06 3-CG18617-RA_3 CG18617 CGTGTGCATGTCGGTCGTTAACTTCACCCACTTCAAGCGTTATGCCTCCATTTTCCTGGAGTTCGTGCC 69 FBan0018617 FBgn0028670 Vha100-2 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; copper ion binding; GO:0005507; ; GO:0005507" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-2 Vha100-2 "CG7679, CG18617, CG7679, vha100-2, V-ATPase, anon-WO0118547.296, BcDNA:LD21735" CDMC28513 2 18 9 DAC15-B06 3-CG18617-RA_3 CG18617 CGTGTGCATGTCGGTCGTTAACTTCACCCACTTCAAGCGTTATGCCTCCATTTTCCTGGAGTTCGTGCC 69 FBan0018617 FBgn0028670 Vha100-2 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; copper ion binding; GO:0005507; ; GO:0005507" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-2 Vha100-2 "CG7679, CG18617, CG7679, vha100-2, V-ATPase, anon-WO0118547.296, BcDNA:LD21735" CDMC28514 2 19 9 DAC15-B18 14-CG18636-RA_3 CG18636 GAACGAGGAGTGAAGAATGCACCGGATATTACTGCAATTTTCGAGAGGAGCACATGGTAGATGCGGGCT 69 FBan0018636 FBgn0032551 CG18636 2 2L NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG18636 CG18636 SPH130 CDMC28514 2 20 9 DAC15-B18 14-CG18636-RA_3 CG18636 GAACGAGGAGTGAAGAATGCACCGGATATTACTGCAATTTTCGAGAGGAGCACATGGTAGATGCGGGCT 69 FBan0018636 FBgn0032551 CG18636 2 2L NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG18636 CG18636 SPH130 CDMC28515 2 21 9 DAC15-F06 14-CG1871-RA_1 CG1871 TCATCGACACAATGGTGGACATTAGCTGCATGGTTTACCAGAAGAGCACCAATACCTATGCGCCCTACA 69 FBan0001871 FBgn0011586 e(r) X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 e(r) enhancer of rudimentary "CG1871, CG1871, ER" CDMC28515 2 22 9 DAC15-F06 14-CG1871-RA_1 CG1871 TCATCGACACAATGGTGGACATTAGCTGCATGGTTTACCAGAAGAGCACCAATACCTATGCGCCCTACA 69 FBan0001871 FBgn0011586 e(r) X X regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 e(r) enhancer of rudimentary "CG1871, CG1871, ER" CDMC28516 2 23 9 DAC15-F18 3-CG1874-RA_2 CG1874 AGCGTCAGCTTCACAGTTCATCGTTTGTGTCCAACATCTGCTACGCTTTTGACCAGTTCTTCGCCAGCA 69 FBan0001874 FBgn0033425 CG1874 2 2R CG1874 CG1874 CDMC28516 2 24 9 DAC15-F18 3-CG1874-RA_2 CG1874 AGCGTCAGCTTCACAGTTCATCGTTTGTGTCCAACATCTGCTACGCTTTTGACCAGTTCTTCGCCAGCA 69 FBan0001874 FBgn0033425 CG1874 2 2R CG1874 CG1874 CDMC28517 2 25 9 DAC15-J06 9-CG18810-RA_3 CG18810 GTGGCGTCTGTGTCCTGATGCGAGATCATCACTGCTTCTTTACTGGTTGCTGCATCGGTCATGAGAACT 69 FBan0018810 FBgn0042133 CG18810 2 2L CG18810 CG18810 CDMC28517 2 26 9 DAC15-J06 9-CG18810-RA_3 CG18810 GTGGCGTCTGTGTCCTGATGCGAGATCATCACTGCTTCTTTACTGGTTGCTGCATCGGTCATGAGAACT 69 FBan0018810 FBgn0042133 CG18810 2 2L CG18810 CG18810 CDMC28518 2 1 10 DAC15-J18 3-CG18823-RA_1 CG18823 ATAGACGCGCTCGACCAAATTGTCTTCAAATCGAAGGTTCTCCAGGTCTCGAACGCCACCTTTCCTCCA 69 FBan0018823 FBgn0042146 CG18823 X X CG18823 CG18823 CDMC28518 2 2 10 DAC15-J18 3-CG18823-RA_1 CG18823 ATAGACGCGCTCGACCAAATTGTCTTCAAATCGAAGGTTCTCCAGGTCTCGAACGCCACCTTTCCTCCA 69 FBan0018823 FBgn0042146 CG18823 X X CG18823 CG18823 CDMC28519 2 3 10 DAC15-N06 22-CG1903-RA_2 CG1903 ACAACAAGAACCATCGGAGGGACGAACATCAAGAACAACCACCGTTAGCAGTAAGCAGGAGAATCAAAA 69 FBan0001903 FBgn0005410 sno X X Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; embryonic development; GO:0009790; epidermal growth factor receptor signaling pathway; GO:0007173; imaginal disc morphogenesis; GO:0007560; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of proteolysis; GO:0030162; wing margin morphogenesis; GO:0008587 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; helicase activity; GO:0004386; ; GO:0004386 nucleus; GO:0005634 sno strawberry notch "CG1903, g-l: glossy-like, glossy-like, Strawberry Notch, Sno, l(1)11Ea, g-l" CDMC28519 2 4 10 DAC15-N06 22-CG1903-RA_2 CG1903 ACAACAAGAACCATCGGAGGGACGAACATCAAGAACAACCACCGTTAGCAGTAAGCAGGAGAATCAAAA 69 FBan0001903 FBgn0005410 sno X X Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; embryonic development; GO:0009790; epidermal growth factor receptor signaling pathway; GO:0007173; imaginal disc morphogenesis; GO:0007560; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of proteolysis; GO:0030162; wing margin morphogenesis; GO:0008587 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; helicase activity; GO:0004386; ; GO:0004386 nucleus; GO:0005634 sno strawberry notch "CG1903, g-l: glossy-like, glossy-like, Strawberry Notch, Sno, l(1)11Ea, g-l" CDMC28520 2 5 10 DAC15-N18 8-CG1910-RA_1 CG1910 GCCGCTGCACCTAAAGAACCTGCTTCTGTTATGGATGTGGACGAAGATGAGACGCTCGTCGAAAACACA 69 FBan0001910 FBgn0022349 CG1910 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1910 CG1910 "1A3, anon1A3, Anon1A3, anon-EST:fe1A3: anon-fast-evolving-1A3, anon-WO0118547.398, anon-WO0118547.745, anon-fast-evolving-1A3" CDMC28520 2 6 10 DAC15-N18 8-CG1910-RA_1 CG1910 GCCGCTGCACCTAAAGAACCTGCTTCTGTTATGGATGTGGACGAAGATGAGACGCTCGTCGAAAACACA 69 FBan0001910 FBgn0022349 CG1910 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1910 CG1910 "1A3, anon1A3, Anon1A3, anon-EST:fe1A3: anon-fast-evolving-1A3, anon-WO0118547.398, anon-WO0118547.745, anon-fast-evolving-1A3" CDMC28521 2 7 10 DAC16-B06 23-CG32737-RB_2 CG32737 CAAAACAAACACACAGAGAGAACAATTAGTTTTCGTTTCTTGATTCGTTCGGAATTAATTTTCGTGGTT 69 FBgn0052737 CDMC28521 2 8 10 DAC16-B06 23-CG32737-RB_2 CG32737 CAAAACAAACACACAGAGAGAACAATTAGTTTTCGTTTCTTGATTCGTTCGGAATTAATTTTCGTGGTT 69 FBgn0052737 CDMC28522 2 9 10 DAC16-B18 9-CG3274-RA_6 CG3274 GGAACTGTCCCCGCAAGAAATTCAAGTCTCTTAACGAGCTGCAGTACCACGTGTGCAGTGTCCACTGTC 69 FBgn0027541 CDMC28522 2 10 10 DAC16-B18 9-CG3274-RA_6 CG3274 GGAACTGTCCCCGCAAGAAATTCAAGTCTCTTAACGAGCTGCAGTACCACGTGTGCAGTGTCCACTGTC 69 FBgn0027541 CDMC28523 2 11 10 DAC16-F06 12-CG3278-RA_5 CG3278 CGGAGCACGTGCGAAATGAGTTGAAACCCATCCATAAAGTACTGGATCGCATCTTAACTGCCGTGCCAA 69 FBan0003278 FBgn0032988 Tif-IA 2 2L regulation of transcription from RNA polymerase I promoter; GO:0006356; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase I transcription factor activity; GO:0003701; ; GO:0003701; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003701 DNA-directed RNA polymerase I complex; GO:0005736 Tif-IA Tif-IA "CG5951, CG3278, CG16938, CG5951, CG3278, CG5951, CG3278, TIF-IA, dTIF-IA, Tif-1A" CDMC28523 2 12 10 DAC16-F06 12-CG3278-RA_5 CG3278 CGGAGCACGTGCGAAATGAGTTGAAACCCATCCATAAAGTACTGGATCGCATCTTAACTGCCGTGCCAA 69 FBan0003278 FBgn0032988 Tif-IA 2 2L regulation of transcription from RNA polymerase I promoter; GO:0006356; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase I transcription factor activity; GO:0003701; ; GO:0003701; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003701 DNA-directed RNA polymerase I complex; GO:0005736 Tif-IA Tif-IA "CG5951, CG3278, CG16938, CG5951, CG3278, CG5951, CG3278, TIF-IA, dTIF-IA, Tif-1A" CDMC28524 2 13 10 DAC16-F18 1-CG32798-RA_2 CG32798 GCCGGAGCTGAGTAAGATGGAGCAGCAGGTGCCGAATAAGATGAAGATGCAGGAGCTGAGTAAGATGGA 69 FBan0032798 FBgn0052798 CG32798 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32798 CG32798 CDMC28524 2 14 10 DAC16-F18 1-CG32798-RA_2 CG32798 GCCGGAGCTGAGTAAGATGGAGCAGCAGGTGCCGAATAAGATGAAGATGCAGGAGCTGAGTAAGATGGA 69 FBan0032798 FBgn0052798 CG32798 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32798 CG32798 CDMC28525 2 15 10 DAC16-J06 12-CG32824-RA_1 CG32824 CCGACTGGGTGGTGAAATCAAAAATCAGTATCAAAACCCGGTCCTCTAGTTTCTCATGGAGGCGCTGGG 69 FBan0032824 FBgn0052824 CG32824 X X CG32824 CG32824 "CG18859, CG18859" CDMC28525 2 16 10 DAC16-J06 12-CG32824-RA_1 CG32824 CCGACTGGGTGGTGAAATCAAAAATCAGTATCAAAACCCGGTCCTCTAGTTTCTCATGGAGGCGCTGGG 69 FBan0032824 FBgn0052824 CG32824 X X CG32824 CG32824 "CG18859, CG18859" CDMC28526 2 17 10 DAC16-J18 10-CG32843-RA_1 CG32843 GGTCAAGAACCCAAAAATCAAACCCCACCAAAAGCTACAGCCCATTGAACCCAGTTAGTATCGCCAGGC 69 FBan0032843 FBgn0052843 CG32843 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; ; GO:0008188; ; GO:0001633; ; GO:0004948; ; GO:0004948 integral to membrane; GO:0016021 CG32843 CG32843 "CG17415, CG17043, CG17415, anon-WO0170980.136, anon-WO0170980.137" CDMC28526 2 18 10 DAC16-J18 10-CG32843-RA_1 CG32843 GGTCAAGAACCCAAAAATCAAACCCCACCAAAAGCTACAGCCCATTGAACCCAGTTAGTATCGCCAGGC 69 FBan0032843 FBgn0052843 CG32843 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; ; GO:0008188; ; GO:0001633; ; GO:0004948; ; GO:0004948 integral to membrane; GO:0016021 CG32843 CG32843 "CG17415, CG17043, CG17415, anon-WO0170980.136, anon-WO0170980.137" CDMC28527 2 19 10 DAC16-N06 3-CG32919-RB_2 CG32919 CGACAACCTGTACGGACCCATTGCAGTTCTCTACGGAGCAGCCTTCGGAATACTGCATATCACACTGCT 69 FBgn0052919 CDMC28527 2 20 10 DAC16-N06 3-CG32919-RB_2 CG32919 CGACAACCTGTACGGACCCATTGCAGTTCTCTACGGAGCAGCCTTCGGAATACTGCATATCACACTGCT 69 FBgn0052919 CDMC28528 2 21 10 DAC16-N18 1-CG32939-RA_2 CG32939 TCACCACGCCGTATACAATGCTGCATGGATCTATCGCTTTGCCATCGATCCCCATTACCCGTGTCAGAC 69 FBan0032939 FBgn0052939 CG32939 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32939 CG32939 CDMC28528 2 22 10 DAC16-N18 1-CG32939-RA_2 CG32939 TCACCACGCCGTATACAATGCTGCATGGATCTATCGCTTTGCCATCGATCCCCATTACCCGTGTCAGAC 69 FBan0032939 FBgn0052939 CG32939 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32939 CG32939 CDMC28529 2 23 10 DAC17-B06 15-CG12274-RA_1 CG12274 CTACTCCTGTGTGGCGGAAAATCAGCTGGGAAAGGCACGCAAGACCCTCCAGTTGAGCGGAAAAC 65 FBan0012274 FBgn0039546 CG12274 3 3R CG12274 CG12274 CDMC28529 2 24 10 DAC17-B06 15-CG12274-RA_1 CG12274 CTACTCCTGTGTGGCGGAAAATCAGCTGGGAAAGGCACGCAAGACCCTCCAGTTGAGCGGAAAAC 65 FBan0012274 FBgn0039546 CG12274 3 3R CG12274 CG12274 CDMC28530 2 25 10 DAC17-B18 3-CG12320-RA_7 CG12320 TTCACAATGAACAAGGACAACTCCAGCATGAAAATGGATCCGCAGCTAGCCCTACGCCTCCTGGC 65 FBan0012320 FBgn0038590 CG12320 3 3R CG12320 CG12320 CDMC28530 2 26 10 DAC17-B18 3-CG12320-RA_7 CG12320 TTCACAATGAACAAGGACAACTCCAGCATGAAAATGGATCCGCAGCTAGCCCTACGCCTCCTGGC 65 FBan0012320 FBgn0038590 CG12320 3 3R CG12320 CG12320 CDMC28531 2 1 11 DAC17-F06 3-CG12470-RA_1 CG12470 ATGTCCTTCGGGCTCAACCGAATCATTACCCGGCTCTTCTTCGTATTCCGGAAACAATGGCGGTG 65 FBan0012470 FBgn0040371 CG12470 X X CG12470 CG12470 "EG:BACR37P7.5, NEST:bs07e10, NEST:bs17h08" CDMC28531 2 2 11 DAC17-F06 3-CG12470-RA_1 CG12470 ATGTCCTTCGGGCTCAACCGAATCATTACCCGGCTCTTCTTCGTATTCCGGAAACAATGGCGGTG 65 FBan0012470 FBgn0040371 CG12470 X X CG12470 CG12470 "EG:BACR37P7.5, NEST:bs07e10, NEST:bs17h08" CDMC28532 2 3 11 DAC17-F18 24-CG12506-RA_1 CG12506 TCAGTTCCTTACCATTCCCTTTATCAATACAAGTTCTTGAAATAAATTGATATCAGTACTCTAAT 65 FBan0012506 FBgn0031276 CG12506 2 2L CG12506 CG12506 CDMC28532 2 4 11 DAC17-F18 24-CG12506-RA_1 CG12506 TCAGTTCCTTACCATTCCCTTTATCAATACAAGTTCTTGAAATAAATTGATATCAGTACTCTAAT 65 FBan0012506 FBgn0031276 CG12506 2 2L CG12506 CG12506 CDMC28533 2 5 11 DAC17-J06 3-CG12600-RA_2 CG12600 TCGTCGGATGAGTCCACCATTACATCCTCCCAGACATCCACACTGACCAGAAACCAAGCACCCTG 65 FBgn0038254 CDMC28533 2 6 11 DAC17-J06 3-CG12600-RA_2 CG12600 TCGTCGGATGAGTCCACCATTACATCCTCCCAGACATCCACACTGACCAGAAACCAAGCACCCTG 65 FBgn0038254 CDMC28534 2 7 11 DAC17-J18 12-CG12653-RA_1 CG12653 CTCCAGTTGCCACATGAAGTCCGAGTATGCGGCCAGTTATCCGGCTGATTTTGGTGCGGGAACAG 65 FBan0012653 FBgn0000233 btd X X "anterior head segmentation; GO:0035288; cephalic furrow formation; GO:0007376; head segmentation; GO:0035287; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" nucleic acid binding; GO:0003676; transcription factor binding; GO:0008134; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270; ; GO:0008134; ; GO:0008134 nucleus; GO:0005634 btd buttonhead "CG12653, BTD" CDMC28534 2 8 11 DAC17-J18 12-CG12653-RA_1 CG12653 CTCCAGTTGCCACATGAAGTCCGAGTATGCGGCCAGTTATCCGGCTGATTTTGGTGCGGGAACAG 65 FBan0012653 FBgn0000233 btd X X "anterior head segmentation; GO:0035288; cephalic furrow formation; GO:0007376; head segmentation; GO:0035287; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; posterior head segmentation; GO:0035289; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" nucleic acid binding; GO:0003676; transcription factor binding; GO:0008134; RNA polymerase II transcription factor activity; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270; ; GO:0008134; ; GO:0008134 nucleus; GO:0005634 btd buttonhead "CG12653, BTD" CDMC28535 2 9 11 DAC17-N06 5-CG12734-RA_2 CG12734 AACCGTCGATCTTGGGTAGATGACGCCCGTACCAATTCCCAGTTCGTGATCGGTTCCGAGTCAGG 65 FBan0012734 FBgn0035411 CG12734 3 3L CG12734 CG12734 CDMC28535 2 10 11 DAC17-N06 5-CG12734-RA_2 CG12734 AACCGTCGATCTTGGGTAGATGACGCCCGTACCAATTCCCAGTTCGTGATCGGTTCCGAGTCAGG 65 FBan0012734 FBgn0035411 CG12734 3 3L CG12734 CG12734 CDMC28536 2 11 11 DAC17-N18 23-CG12795-RA_1 CG12795 CTTAGTGTAGAGGAAAACAGTAACCGGAGAAGTACAATCATGGAATTTCCACACTTGGGACAGCA 65 FBan0012795 FBgn0031535 CG12795 2 2L CG12795 CG12795 CDMC28536 2 12 11 DAC17-N18 23-CG12795-RA_1 CG12795 CTTAGTGTAGAGGAAAACAGTAACCGGAGAAGTACAATCATGGAATTTCCACACTTGGGACAGCA 65 FBan0012795 FBgn0031535 CG12795 2 2L CG12795 CG12795 CDMC28537 2 13 11 DAC18-B06 23-CG5703-RA_1 CG5703 AGCAAATTTTCAGCCTTTTCATTATTTTGGAAACGCCAGAATGCTGACAAACTGTGCCTCCAAAACA 67 FBan0005703 FBgn0030853 CG5703 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG5703 CG5703 BEST:LP01573 CDMC28537 2 14 11 DAC18-B06 23-CG5703-RA_1 CG5703 AGCAAATTTTCAGCCTTTTCATTATTTTGGAAACGCCAGAATGCTGACAAACTGTGCCTCCAAAACA 67 FBan0005703 FBgn0030853 CG5703 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG5703 CG5703 BEST:LP01573 CDMC28538 2 15 11 DAC18-B18 1-CG5863-RA_1 CG5863 GCCACAGAAACGCTCGATAACCGATTGAACTTGGAGTACGCTGGACCCATTAGCATTGGATCGCCGG 67 FBan0005863 FBgn0038507 CG5863 3 3R proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG5863 CG5863 CDMC28538 2 16 11 DAC18-B18 1-CG5863-RA_1 CG5863 GCCACAGAAACGCTCGATAACCGATTGAACTTGGAGTACGCTGGACCCATTAGCATTGGATCGCCGG 67 FBan0005863 FBgn0038507 CG5863 3 3R proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG5863 CG5863 CDMC28539 2 17 11 DAC18-F06 2-CG6417-RA_1 CG6417 CCAAGCTGTGCTTCCGATAACCAGAGACCTTCATCCAAACCATCAACCGCAACCTGAGAGTCCGAGG 67 FBan0006417 FBgn0032435 Oatp33Eb 2 2L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 Oatp33Eb Organic anion transporting polypeptide 33Eb "CG6417, oatp 33Eb, Organic anion transporting polypeptide 33Eb" CDMC28539 2 18 11 DAC18-F06 2-CG6417-RA_1 CG6417 CCAAGCTGTGCTTCCGATAACCAGAGACCTTCATCCAAACCATCAACCGCAACCTGAGAGTCCGAGG 67 FBan0006417 FBgn0032435 Oatp33Eb 2 2L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 Oatp33Eb Organic anion transporting polypeptide 33Eb "CG6417, oatp 33Eb, Organic anion transporting polypeptide 33Eb" CDMC28540 2 19 11 DAC18-F18 2-CG6568-RA_6 CG6568 GCACTTTGAGCTGAGCGAATCAGATGTCGAGGACACATTTAAGCGCACCCTTATCAAGCTGGCCCGT 67 FBan0006568 FBgn0034210 CG6568 2 2R CG6568 CG6568 CDMC28540 2 20 11 DAC18-F18 2-CG6568-RA_6 CG6568 GCACTTTGAGCTGAGCGAATCAGATGTCGAGGACACATTTAAGCGCACCCTTATCAAGCTGGCCCGT 67 FBan0006568 FBgn0034210 CG6568 2 2R CG6568 CG6568 CDMC28541 2 21 11 DAC18-J06 13-CG7125-RA_1 CG7125 ACCAAGTTCCTGATCACCCAGATCCTGATTGCCCTCAAGTACCTGCATTCGCAAAACATAGTCCACT 67 FBan0007125 FBgn0038603 PKD 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 PKD Protein Kinase D "CG7125, PKCm, Protein Kinase D" CDMC28541 2 22 11 DAC18-J06 13-CG7125-RA_1 CG7125 ACCAAGTTCCTGATCACCCAGATCCTGATTGCCCTCAAGTACCTGCATTCGCAAAACATAGTCCACT 67 FBan0007125 FBgn0038603 PKD 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 PKD Protein Kinase D "CG7125, PKCm, Protein Kinase D" CDMC28542 2 23 11 DAC18-J18 3-CG7212-RA_2 CG7212 GCCGCATGAAGAACTCCGATTCGGTGAGGCTTATGTTCAGCATCGGTAAGCTAATGAGCCTGCTGCG 67 FBan0007212 FBgn0038574 cdm 3 3R "protein import into nucleus, docking; GO:0000059" transporter activity; GO:0005215; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 cdm cadmus "CG7212, CG7212, cadmus" CDMC28542 2 24 11 DAC18-J18 3-CG7212-RA_2 CG7212 GCCGCATGAAGAACTCCGATTCGGTGAGGCTTATGTTCAGCATCGGTAAGCTAATGAGCCTGCTGCG 67 FBan0007212 FBgn0038574 cdm 3 3R "protein import into nucleus, docking; GO:0000059" transporter activity; GO:0005215; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 cdm cadmus "CG7212, CG7212, cadmus" CDMC28543 2 25 11 DAC18-N06 2-CG7824-RA_2 CG7824 CCGGTGCGAAGACGGATTTTCAAAGGTATTCCTGTCGGACTGTGTTGCCGCGATTAGCAACTCGTGG 67 FBan0007824 FBgn0039711 CG7824 3 3R CG7824 CG7824 CDMC28543 2 26 11 DAC18-N06 2-CG7824-RA_2 CG7824 CCGGTGCGAAGACGGATTTTCAAAGGTATTCCTGTCGGACTGTGTTGCCGCGATTAGCAACTCGTGG 67 FBan0007824 FBgn0039711 CG7824 3 3R CG7824 CG7824 CDMC28544 2 1 12 DAC18-N18 1-CG7957-RA_1 CG7957 GGAACTTCGCGACCTGATCCTCTGCCAGATCAACTCTCACCAGATCTCCTGCCTGATCAGTCTAGCG 67 FBan0007957 FBgn0038578 MED17 3 3R cellular physiological process; GO:0050875; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex comb development; GO:0045498; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED17 Mediator complex subunit 17 "CG7957, l(3)s2956, Trap80, dTrap80, dTRAP80/SRB4, p70, Mediator, dTRAP80, TRAP80, Med17, Mediator complex subunit 17" CDMC28544 2 2 12 DAC18-N18 1-CG7957-RA_1 CG7957 GGAACTTCGCGACCTGATCCTCTGCCAGATCAACTCTCACCAGATCTCCTGCCTGATCAGTCTAGCG 67 FBan0007957 FBgn0038578 MED17 3 3R cellular physiological process; GO:0050875; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex comb development; GO:0045498; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED17 Mediator complex subunit 17 "CG7957, l(3)s2956, Trap80, dTrap80, dTRAP80/SRB4, p70, Mediator, dTRAP80, TRAP80, Med17, Mediator complex subunit 17" CDMC28545 2 3 12 DAC19-B06 3-CG7837-RA_8 CG7837 AGGATCTCGAGGAACTGAGCTCGGATGTACCACCGAAACTAGCCCCGTTCCGCAATACAACATGCAAC 68 FBan0007837 FBgn0039696 CG7837 3 3R CG7837 CG7837 CDMC28545 2 4 12 DAC19-B06 3-CG7837-RA_8 CG7837 AGGATCTCGAGGAACTGAGCTCGGATGTACCACCGAAACTAGCCCCGTTCCGCAATACAACATGCAAC 68 FBan0007837 FBgn0039696 CG7837 3 3R CG7837 CG7837 CDMC28546 2 5 12 DAC19-B18 2-CG7955-RC_1 CG7955 TGCCATCGCTAGGGCCATACTGAAGAACACCCCCATTCTGATCTTTGACGAGGCTACAAGCAGTCTGG 68 FBan0007955 FBgn0035244 CG7955 3 3L defense response; GO:0006952; extracellular transport; GO:0006858; heme transport; GO:0015886; iron-sulfur cluster assembly; GO:0016226; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; heme transporter activity; GO:0015232; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0015232; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG7955 CG7955 CDMC28546 2 6 12 DAC19-B18 2-CG7955-RC_1 CG7955 TGCCATCGCTAGGGCCATACTGAAGAACACCCCCATTCTGATCTTTGACGAGGCTACAAGCAGTCTGG 68 FBan0007955 FBgn0035244 CG7955 3 3L defense response; GO:0006952; extracellular transport; GO:0006858; heme transport; GO:0015886; iron-sulfur cluster assembly; GO:0016226; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; heme transporter activity; GO:0015232; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0015232; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG7955 CG7955 CDMC28547 2 7 12 DAC19-F06 3-CG8506-RA_1 CG8506 GGCCATGGAAGCCTACGAACGAAATAACATGGCAGCTAACCAATCCAACGTTGGAGTTCCTGGTCCGG 68 FBan0008506 FBgn0031991 CG8506 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8506 CG8506 CDMC28547 2 8 12 DAC19-F06 3-CG8506-RA_1 CG8506 GGCCATGGAAGCCTACGAACGAAATAACATGGCAGCTAACCAATCCAACGTTGGAGTTCCTGGTCCGG 68 FBan0008506 FBgn0031991 CG8506 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8506 CG8506 CDMC28548 2 9 12 DAC19-F18 1-CG8695-RA_1 CG8695 TCTGCGTGATGAGCCTACTTTGAAGCAGGGTGATGTCTCCGTAACAGCCATTGGTCCAAATGTGCTGG 68 FBan0008695 FBgn0002571 LvpL 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpL Larval visceral protein L "CG8695, V: transcript group V, gene V, L, maltase, hdl cuticle gene cluster." CDMC28548 2 10 12 DAC19-F18 1-CG8695-RA_1 CG8695 TCTGCGTGATGAGCCTACTTTGAAGCAGGGTGATGTCTCCGTAACAGCCATTGGTCCAAATGTGCTGG 68 FBan0008695 FBgn0002571 LvpL 2 2R glucose metabolism; GO:0006006 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 LvpL Larval visceral protein L "CG8695, V: transcript group V, gene V, L, maltase, hdl cuticle gene cluster." CDMC28549 2 11 12 DAC19-J06 2-CG9102-RA_1 CG9102 GCCCGAAAAGTCCAATGATTACTTGCCCCAAAGATTCTTGGCCCCAATTGGATAACCACCCTGAGCCC 68 FBan0009102 FBgn0025525 bab2 3 3L chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 NOT polytene chromosome chromocenter; GO:0005701; nucleus; GO:0005634; polytene chromosome; GO:0005700 bab2 bab2 "CG9102, CG13911, BTB-II, bab-II, bric a brac II, bab, BAB2, bric a brac, bric-a-brac2, bric-a-brac, BtbII, BTB-protein-II" CDMC28549 2 12 12 DAC19-J06 2-CG9102-RA_1 CG9102 GCCCGAAAAGTCCAATGATTACTTGCCCCAAAGATTCTTGGCCCCAATTGGATAACCACCCTGAGCCC 68 FBan0009102 FBgn0025525 bab2 3 3L chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; leg morphogenesis (sensu Endopterygota); GO:0007480; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 NOT polytene chromosome chromocenter; GO:0005701; nucleus; GO:0005634; polytene chromosome; GO:0005700 bab2 bab2 "CG9102, CG13911, BTB-II, bab-II, bric a brac II, bab, BAB2, bric a brac, bric-a-brac2, bric-a-brac, BtbII, BTB-protein-II" CDMC28550 2 13 12 DAC19-J18 2-CG9253-RA_2 CG9253 GGCTTTGTGTCAAGCATGTGACGAATTGAAGTGGAAGGCGCCTTCGAAGATCCAACGTGAGGCCATTC 68 FBan0009253 FBgn0032919 CG9253 2 2L "metal ion transport; GO:0030001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; metal ion binding; GO:0046872; ; GO:0004004; ; GO:0046872 CG9253 CG9253 "cg9253, DmRH24, anon-EST:GressD10" CDMC28550 2 14 12 DAC19-J18 2-CG9253-RA_2 CG9253 GGCTTTGTGTCAAGCATGTGACGAATTGAAGTGGAAGGCGCCTTCGAAGATCCAACGTGAGGCCATTC 68 FBan0009253 FBgn0032919 CG9253 2 2L "metal ion transport; GO:0030001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; metal ion binding; GO:0046872; ; GO:0004004; ; GO:0046872 CG9253 CG9253 "cg9253, DmRH24, anon-EST:GressD10" CDMC28551 2 15 12 DAC19-N06 1-CG9748-RA_2 CG9748 CGGTCGCCTAGAGGACATGATCACACGCGGAAAGGTGGGACTGGAGAACATTCGATTCCTTGTACTGG 68 FBan0009748 FBgn0000171 bel 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatid development; GO:0007286" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0008026; ; GO:0004004 bel belle "CG9748, L3, l(3)85Ac, cap, ms(3)neo30, cg9748, BEL: BEL element, DmRH6, l(3)L3, ms(3)Pneo85A, anon-85Ab, capon, BEL" CDMC28551 2 16 12 DAC19-N06 1-CG9748-RA_2 CG9748 CGGTCGCCTAGAGGACATGATCACACGCGGAAAGGTGGGACTGGAGAACATTCGATTCCTTGTACTGG 68 FBan0009748 FBgn0000171 bel 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatid development; GO:0007286" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0008026; ; GO:0004004 bel belle "CG9748, L3, l(3)85Ac, cap, ms(3)neo30, cg9748, BEL: BEL element, DmRH6, l(3)L3, ms(3)Pneo85A, anon-85Ab, capon, BEL" CDMC28552 2 17 12 DAC19-N18 2-CG9913-RB_2 CG9913 CAAGACCGAACTCCGTTACCTGCGCGAACAGATTGTTCTCACCTTCAAGCAGCAGATGAAACTGCGCA 68 FBan0009913 FBgn0038205 Kif19A 3 3R microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 kinesin complex; GO:0005871 Kif19A Kif19A "CG9913, CG9913, CG9913, CG9913, KIF19A, DmKIF19A" CDMC28552 2 18 12 DAC19-N18 2-CG9913-RB_2 CG9913 CAAGACCGAACTCCGTTACCTGCGCGAACAGATTGTTCTCACCTTCAAGCAGCAGATGAAACTGCGCA 68 FBan0009913 FBgn0038205 Kif19A 3 3R microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 kinesin complex; GO:0005871 Kif19A Kif19A "CG9913, CG9913, CG9913, CG9913, KIF19A, DmKIF19A" CDMC28553 2 19 12 DAC20-B06 15-CG18028-RC_3 CG18028 TCGGAGATAGTCACCACGCAAAGACGAGGTCAGCAGGTTTCCTACGAACAACTATGCTCATTGTGCCAC 69 CDMC28553 2 20 12 DAC20-B06 15-CG18028-RC_3 CG18028 TCGGAGATAGTCACCACGCAAAGACGAGGTCAGCAGGTTTCCTACGAACAACTATGCTCATTGTGCCAC 69 CDMC28554 2 21 12 DAC20-B18 12-CG18063-RA_1 CG18063 TCTCTCTCTGGACACCATCAAACACAACATACCTCGATCGAACACACCTTGATGGCCAAGCTGGACTCT 69 FBan0018063 FBgn0028856 CG18063 2 2L CG18063 CG18063 "BG:DS07486.5, DS07486.5" CDMC28554 2 22 12 DAC20-B18 12-CG18063-RA_1 CG18063 TCTCTCTCTGGACACCATCAAACACAACATACCTCGATCGAACACACCTTGATGGCCAAGCTGGACTCT 69 FBan0018063 FBgn0028856 CG18063 2 2L CG18063 CG18063 "BG:DS07486.5, DS07486.5" CDMC28555 2 23 12 DAC20-F06 23-CG18106-RA_1 CG18106 GGGCCAAAACTTACCTCAAATCCAAAGCACCATATTTATACTCTCACTCTTGTACTAAAATGAAAACTA 69 FBan0018106 FBgn0025583 IM2 2 2R defense response; GO:0006952 extracellular region; GO:0005576 IM2 Immune induced molecule 2 "CG18106, CG18106, DIM2, Im2, anon-WO0140519.2, BcDNA:RH08291" CDMC28555 2 24 12 DAC20-F06 23-CG18106-RA_1 CG18106 GGGCCAAAACTTACCTCAAATCCAAAGCACCATATTTATACTCTCACTCTTGTACTAAAATGAAAACTA 69 FBan0018106 FBgn0025583 IM2 2 2R defense response; GO:0006952 extracellular region; GO:0005576 IM2 Immune induced molecule 2 "CG18106, CG18106, DIM2, Im2, anon-WO0140519.2, BcDNA:RH08291" CDMC28556 2 25 12 DAC20-F18 7-CG18131-RD_1 CG18131 CCACCCGGGATACGAACGATCCGTCAAGTCGGTGCCTCTATATGAAAGAAGACAAGCTACTCCGGAACA 69 FBan0018131 FBgn0031343 CG18131 2 2L CG18131 CG18131 BcDNA:AT12853 CDMC28556 2 26 12 DAC20-F18 7-CG18131-RD_1 CG18131 CCACCCGGGATACGAACGATCCGTCAAGTCGGTGCCTCTATATGAAAGAAGACAAGCTACTCCGGAACA 69 FBan0018131 FBgn0031343 CG18131 2 2L CG18131 CG18131 BcDNA:AT12853 CDMC28557 2 1 13 DAC20-J06 23-CG1818-RA_5 CG1818 AGTGGAAATAACTTCGTTAGCCCTCTACTACCTTTTTAACAGCCAAAAGTCACTATGAAAGACGCAAAG 69 FBan0001818 FBgn0033428 Updo 2 2R heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779 uroporphyrinogen decarboxylase activity; GO:0004853 ; EC:4.1.1.37; ; GO:0004853 ; EC:4.1.1.37 cytoplasm; GO:0005737 Updo Updo "CG1818, CG1818" CDMC28557 2 2 13 DAC20-J06 23-CG1818-RA_5 CG1818 AGTGGAAATAACTTCGTTAGCCCTCTACTACCTTTTTAACAGCCAAAAGTCACTATGAAAGACGCAAAG 69 FBan0001818 FBgn0033428 Updo 2 2R heme biosynthesis; GO:0006783; porphyrin biosynthesis; GO:0006779 uroporphyrinogen decarboxylase activity; GO:0004853 ; EC:4.1.1.37; ; GO:0004853 ; EC:4.1.1.37 cytoplasm; GO:0005737 Updo Updo "CG1818, CG1818" CDMC28558 2 3 13 DAC20-J18 22-CG18212-RG_1 CG18212 AGAGAAGAAATGCTAGCAAAGGAAAAGTCCGACTCTGATTACAGAAACAGGCAATTTCCACCCAAGCCC 69 FBan0018212 FBgn0038535 CG18212 3 3R CG18212 CG18212 CDMC28558 2 4 13 DAC20-J18 22-CG18212-RG_1 CG18212 AGAGAAGAAATGCTAGCAAAGGAAAAGTCCGACTCTGATTACAGAAACAGGCAATTTCCACCCAAGCCC 69 FBan0018212 FBgn0038535 CG18212 3 3R CG18212 CG18212 CDMC28559 2 5 13 DAC20-N06 8-CG18258-RA_1 CG18258 GCGGAGCAGTTATGGAACACTACCGGATTTTATCAGGATCGACCCACTGTCTTGTTCATCACCGGCTGG 69 FBan0018258 FBgn0030827 CG18258 X X development; GO:0007275; female gamete generation; GO:0007292; gametogenesis; GO:0007276; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18258 CG18258 CT41369 CDMC28559 2 6 13 DAC20-N06 8-CG18258-RA_1 CG18258 GCGGAGCAGTTATGGAACACTACCGGATTTTATCAGGATCGACCCACTGTCTTGTTCATCACCGGCTGG 69 FBan0018258 FBgn0030827 CG18258 X X development; GO:0007275; female gamete generation; GO:0007292; gametogenesis; GO:0007276; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG18258 CG18258 CT41369 CDMC28560 2 7 13 DAC20-N18 3-CG18269-RA_4 CG18269 GGCCACATCCAAGTTGGTACTCACCGAAGAGCTGCTCAAATTGCAAAGGCAACGACTGGCAGATACCAA 69 FBan0018269 FBgn0031719 CG18269 2 2L CG18269 CG18269 CDMC28560 2 8 13 DAC20-N18 3-CG18269-RA_4 CG18269 GGCCACATCCAAGTTGGTACTCACCGAAGAGCTGCTCAAATTGCAAAGGCAACGACTGGCAGATACCAA 69 FBan0018269 FBgn0031719 CG18269 2 2L CG18269 CG18269 CDMC28561 2 9 13 DAC21-B06 23-CG3891-RA_3 CG3891 AGTCGCTCTGTGTCCATTTGTCCTCAATCACACCACTTTAGTCGGCTCACATAGTTTTCATTTTTTTTT 69 FBan0003891 FBgn0035993 CG3891 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3891 CG3891 CDMC28561 2 10 13 DAC21-B06 23-CG3891-RA_3 CG3891 AGTCGCTCTGTGTCCATTTGTCCTCAATCACACCACTTTAGTCGGCTCACATAGTTTTCATTTTTTTTT 69 FBan0003891 FBgn0035993 CG3891 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3891 CG3891 CDMC28562 2 11 13 DAC21-B18 9-CG3915-RA_12 CG3915 TCAAAGGACAGGGGGAATAATCTCCGCTTCTGGCAGGATACGCCATGAAAAATGCAATATGCAGCTGGC 69 FBan0003915 FBgn0033791 Drl-2 2 2R cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.- Drl-2 Derailed 2 "CG3915, CG12463, DNT-like, dnl: doughnut-like, doughnut-like, Derailed 2, dnl" CDMC28562 2 12 13 DAC21-B18 9-CG3915-RA_12 CG3915 TCAAAGGACAGGGGGAATAATCTCCGCTTCTGGCAGGATACGCCATGAAAAATGCAATATGCAGCTGGC 69 FBan0003915 FBgn0033791 Drl-2 2 2R cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.- Drl-2 Derailed 2 "CG3915, CG12463, DNT-like, dnl: doughnut-like, doughnut-like, Derailed 2, dnl" CDMC28563 2 13 13 DAC21-F06 9-CG3944-RA_5 CG3944 GGATGGCAGCAGACGTACCACACGCTACGATATCGACATGACCAAGTGCATCTACTGCGGATTCTGTCA 69 FBan0003944 FBgn0017567 ND23 3 3R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; iron ion binding; GO:0005506; ; GO:0003954 ; EC:1.6.99.3; ; GO:0005506 respiratory chain complex I (sensu Eukaryota); GO:0005747 ND23 NADH:ubiquinone reductase 23kD subunit precursor CG3944 CDMC28563 2 14 13 DAC21-F06 9-CG3944-RA_5 CG3944 GGATGGCAGCAGACGTACCACACGCTACGATATCGACATGACCAAGTGCATCTACTGCGGATTCTGTCA 69 FBan0003944 FBgn0017567 ND23 3 3R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; iron ion binding; GO:0005506; ; GO:0003954 ; EC:1.6.99.3; ; GO:0005506 respiratory chain complex I (sensu Eukaryota); GO:0005747 ND23 NADH:ubiquinone reductase 23kD subunit precursor CG3944 CDMC28564 2 15 13 DAC21-F18 1-CG3955-RA_1 CG3955 GGCCTTCGGGTCACCTCACAGAATTTACGGACACTCAGCGCTCTCAAAGATGCTCCACACTGAACTCAA 69 FBan0003955 FBgn0033793 CG3955 2 2R CG3955 CG3955 CDMC28564 2 16 13 DAC21-F18 1-CG3955-RA_1 CG3955 GGCCTTCGGGTCACCTCACAGAATTTACGGACACTCAGCGCTCTCAAAGATGCTCCACACTGAACTCAA 69 FBan0003955 FBgn0033793 CG3955 2 2R CG3955 CG3955 CDMC28565 2 17 13 DAC21-J06 23-CG3988-RA_1 CG3988 GTTGAGTACGCTATTCTATCTAAAAACATTCCACTACCTCAGGGTATACAGATGGAGAAGAAGGCTGGC 69 FBan0003988 FBgn0028552 gammaSnap 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 cytoplasm; GO:0005737 gammaSnap gamma-soluble NSF attachment protein "CG3988, CG3988, gSnap, gammaSNAP-2, gamma-SNAP, gammaSnap, gamma SNAP" CDMC28565 2 18 13 DAC21-J06 23-CG3988-RA_1 CG3988 GTTGAGTACGCTATTCTATCTAAAAACATTCCACTACCTCAGGGTATACAGATGGAGAAGAAGGCTGGC 69 FBan0003988 FBgn0028552 gammaSnap 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 cytoplasm; GO:0005737 gammaSnap gamma-soluble NSF attachment protein "CG3988, CG3988, gSnap, gammaSNAP-2, gamma-SNAP, gammaSnap, gamma SNAP" CDMC28566 2 19 13 DAC21-J18 2-CG40040-RA_1 CG40040 GCCCTTATGCCCAAGTTATGGTTGGGTTAATGGACACCAGAGCTTTGGTTACTTGTATAGGGGGCCGCT 69 FBgn0058040 CG40040 CG40040 CG40040 CDMC28566 2 20 13 DAC21-J18 2-CG40040-RA_1 CG40040 GCCCTTATGCCCAAGTTATGGTTGGGTTAATGGACACCAGAGCTTTGGTTACTTGTATAGGGGGCCGCT 69 FBgn0058040 CG40040 CG40040 CG40040 CDMC28567 2 21 13 DAC21-N06 15-CG40090-RA_1 CG40090 TCGGTAAAAGCATGGATTCAAGGCGGAATTGTAAAAGTTCTGGAATGGCCACCTTACTCCCAGGACCTT 69 FBgn0058090 CG40090 CG40090 CG40090 CDMC28567 2 22 13 DAC21-N06 15-CG40090-RA_1 CG40090 TCGGTAAAAGCATGGATTCAAGGCGGAATTGTAAAAGTTCTGGAATGGCCACCTTACTCCCAGGACCTT 69 FBgn0058090 CG40090 CG40090 CG40090 CDMC28568 2 23 13 DAC21-N18 17-CG40109-RA_3 CG40109 TCGTGGTACGACGTATTGGTTTTTAAAGGTATACTGCGATCAAGAAACGACGGATGGAGGTTGGACGGT 69 FBgn0058109 CG40109 CG40109 CG40109 CDMC28568 2 24 13 DAC21-N18 17-CG40109-RA_3 CG40109 TCGTGGTACGACGTATTGGTTTTTAAAGGTATACTGCGATCAAGAAACGACGGATGGAGGTTGGACGGT 69 FBgn0058109 CG40109 CG40109 CG40109 CDMC28569 2 25 13 DAC22-B06 18-CG13731-RA_1 CG13731 CACCGTTCGCACCACCGTTCGTACCACTCCTCGTCCAACTTTGCCTCCTACCAAGCCACCAACTC 65 FBan0013731 FBgn0036717 CG13731 3 3L CG13731 CG13731 CDMC28569 2 26 13 DAC22-B06 18-CG13731-RA_1 CG13731 CACCGTTCGCACCACCGTTCGTACCACTCCTCGTCCAACTTTGCCTCCTACCAAGCCACCAACTC 65 FBan0013731 FBgn0036717 CG13731 3 3L CG13731 CG13731 CDMC28570 2 1 14 DAC22-B18 3-CG13772-RA_2 CG13772 TCGTTTGTGGACACCACCCTGCAATTCAACAGTCCGCAGCAATTCGACTATGCTGTGCAGTCCTC 65 FBan0013772 FBgn0031866 neuroligin 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 neuroligin neuroligin "CG13772, neuroligin" CDMC28570 2 2 14 DAC22-B18 3-CG13772-RA_2 CG13772 TCGTTTGTGGACACCACCCTGCAATTCAACAGTCCGCAGCAATTCGACTATGCTGTGCAGTCCTC 65 FBan0013772 FBgn0031866 neuroligin 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399 NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; neurexin binding; GO:0042043; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 neuroligin neuroligin "CG13772, neuroligin" CDMC28571 2 3 14 DAC22-F06 1-CG13828-RA_1 CG13828 GAACGTGAAGTTGGCTTTTGTTGACGGTTACGACGTGTATCCCAAGGGCGAGCCATGTCTCTGGC 65 FBan0013828 FBgn0040591 CG13828 3 3R CG13828 CG13828 CDMC28571 2 4 14 DAC22-F06 1-CG13828-RA_1 CG13828 GAACGTGAAGTTGGCTTTTGTTGACGGTTACGACGTGTATCCCAAGGGCGAGCCATGTCTCTGGC 65 FBan0013828 FBgn0040591 CG13828 3 3R CG13828 CG13828 CDMC28572 2 5 14 DAC22-F18 3-CG13859-RA_1 CG13859 ATCTGGATGCCATCGGTGTCGATAATCCCTCGCATCGTGGCAAACTTCTGAAGAGTGTGCGCATG 65 FBan0013859 FBgn0038940 CG13859 3 3R CG13859 CG13859 CDMC28572 2 6 14 DAC22-F18 3-CG13859-RA_1 CG13859 ATCTGGATGCCATCGGTGTCGATAATCCCTCGCATCGTGGCAAACTTCTGAAGAGTGTGCGCATG 65 FBan0013859 FBgn0038940 CG13859 3 3R CG13859 CG13859 CDMC28573 2 7 14 DAC22-J06 14-CG13932-RA_1 CG13932 CACCGCACAGCTGTCAGTCTCTGGATGGAGCAAGAACCCGGGTCTCCAGACTACAGACTCCAGTG 65 FBan0013932 FBgn0035259 CG13932 3 3L CG13932 CG13932 CDMC28573 2 8 14 DAC22-J06 14-CG13932-RA_1 CG13932 CACCGCACAGCTGTCAGTCTCTGGATGGAGCAAGAACCCGGGTCTCCAGACTACAGACTCCAGTG 65 FBan0013932 FBgn0035259 CG13932 3 3L CG13932 CG13932 CDMC28574 2 9 14 DAC22-J18 14-CG13949-RA_1 CG13949 TCCGTTTGCAAGGACGCACAATGGACCTCATCAAGGAGATCAACGACAAATACATGGCCCTCGAG 65 FBan0013949 FBgn0031288 CG13949 2 2L CG13949 CG13949 BcDNA:AT06839 CDMC28574 2 10 14 DAC22-J18 14-CG13949-RA_1 CG13949 TCCGTTTGCAAGGACGCACAATGGACCTCATCAAGGAGATCAACGACAAATACATGGCCCTCGAG 65 FBan0013949 FBgn0031288 CG13949 2 2L CG13949 CG13949 BcDNA:AT06839 CDMC28575 2 11 14 DAC22-N06 3-CG14020-RA_1 CG14020 TATTGGACAGAGGATGTGGACTACGATGGCGTAACAGATCGGGCGCACTTTCAGCTGGAACTGCA 65 FBan0014020 FBgn0031707 CG14020 2 2L CG14020 CG14020 CDMC28575 2 12 14 DAC22-N06 3-CG14020-RA_1 CG14020 TATTGGACAGAGGATGTGGACTACGATGGCGTAACAGATCGGGCGCACTTTCAGCTGGAACTGCA 65 FBan0014020 FBgn0031707 CG14020 2 2L CG14020 CG14020 CDMC28576 2 13 14 DAC22-N18 3-CG14065-RA_1 CG14065 ACACCGCCGAGAACTCATCGGAATTGGACGACAACAACGACTTCGTGCCGGTACTATCGCATCAC 65 FBan0014065 FBgn0039579 CG14065 3 3R CG14065 CG14065 CDMC28576 2 14 14 DAC22-N18 3-CG14065-RA_1 CG14065 ACACCGCCGAGAACTCATCGGAATTGGACGACAACAACGACTTCGTGCCGGTACTATCGCATCAC 65 FBan0014065 FBgn0039579 CG14065 3 3R CG14065 CG14065 CDMC28577 2 15 14 DAC23-B06 3-CG4619-RA_3 CG4619 TGTCGTCGTAAAACGACTCATGACTCTTCTCAAGCCTGGAGACCTGCGCTCCAAAGACTTGGCCA 65 FBan0004619 FBgn0032166 CG4619 2 2L CG4619 CG4619 CG31879 CDMC28577 2 16 14 DAC23-B06 3-CG4619-RA_3 CG4619 TGTCGTCGTAAAACGACTCATGACTCTTCTCAAGCCTGGAGACCTGCGCTCCAAAGACTTGGCCA 65 FBan0004619 FBgn0032166 CG4619 2 2L CG4619 CG4619 CG31879 CDMC28578 2 17 14 DAC23-B18 3-CG4686-RA_2 CG4686 TCAGTCGCTGACACCATTGAATACGTGACCCTGGGCAATCCTGTCAGCAAGATGGTAGCCTCGTC 65 FBan0004686 FBgn0038739 CG4686 3 3R CG4686 CG4686 BcDNA:AT09463 CDMC28578 2 18 14 DAC23-B18 3-CG4686-RA_2 CG4686 TCAGTCGCTGACACCATTGAATACGTGACCCTGGGCAATCCTGTCAGCAAGATGGTAGCCTCGTC 65 FBan0004686 FBgn0038739 CG4686 3 3R CG4686 CG4686 BcDNA:AT09463 CDMC28579 2 19 14 DAC23-F06 2-CG4852-RA_1 CG4852 GGCTTCTATTCGGCCTTTCTATTTGCCCGTACAGGTCATGTGATGGCTCCCATCTTGGTGCACGC 65 FBan0004852 FBgn0029121 Sras 3 3L proteolysis; GO:0006508 prenyl protein specific endopeptidase activity; GO:0008319 ; EC:3.4.24.-; ; GO:0008319 ; EC:3.4.24.-; ; GO:0008319 ; EC:3.4.24.- integral to endoplasmic reticulum membrane; GO:0030176 Sras severas "CG4852, CG4852, severas" CDMC28579 2 20 14 DAC23-F06 2-CG4852-RA_1 CG4852 GGCTTCTATTCGGCCTTTCTATTTGCCCGTACAGGTCATGTGATGGCTCCCATCTTGGTGCACGC 65 FBan0004852 FBgn0029121 Sras 3 3L proteolysis; GO:0006508 prenyl protein specific endopeptidase activity; GO:0008319 ; EC:3.4.24.-; ; GO:0008319 ; EC:3.4.24.-; ; GO:0008319 ; EC:3.4.24.- integral to endoplasmic reticulum membrane; GO:0030176 Sras severas "CG4852, CG4852, severas" CDMC28580 2 21 14 DAC23-F18 2-CG4904-RA_2 CG4904 ATCATCCGTCACGGAATTCGCGCTATACTCGGTACCCTGCCTACGGATGAGCAAGGCAAAGATGC 65 FBan0004904 FBgn0003151 Pros35 2 2L ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros35 Proteasome 35kD subunit "CG4904, PROS-35, PROS-Dm35, alpha_dm, 20S proteasome, 20s proteasome, Pros-Dm35, pros35" CDMC28580 2 22 14 DAC23-F18 2-CG4904-RA_2 CG4904 ATCATCCGTCACGGAATTCGCGCTATACTCGGTACCCTGCCTACGGATGAGCAAGGCAAAGATGC 65 FBan0004904 FBgn0003151 Pros35 2 2L ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros35 Proteasome 35kD subunit "CG4904, PROS-35, PROS-Dm35, alpha_dm, 20S proteasome, 20s proteasome, Pros-Dm35, pros35" CDMC28581 2 23 14 DAC23-J06 2-CG5105-RA_2 CG5105 ATGGAAGAGTGGGAGAGGAGGTCTTGTTGGCCGTAATCAAACTCGCCGATCAATCGCCTGAGCTC 65 FBan0005105 FBgn0024314 Plap 2 2L biological process unknown; GO:0000004 phospholipase A2 activator activity; GO:0016005; ; GO:0016005; ; GO:0016005 fusome; GO:0045169 Plap Phospholipase A2 activator protein "CG5105, CG5105, CG5105, dmPLAP, dPLAP, Phospholipase A2 activator protein" CDMC28581 2 24 14 DAC23-J06 2-CG5105-RA_2 CG5105 ATGGAAGAGTGGGAGAGGAGGTCTTGTTGGCCGTAATCAAACTCGCCGATCAATCGCCTGAGCTC 65 FBan0005105 FBgn0024314 Plap 2 2L biological process unknown; GO:0000004 phospholipase A2 activator activity; GO:0016005; ; GO:0016005; ; GO:0016005 fusome; GO:0045169 Plap Phospholipase A2 activator protein "CG5105, CG5105, CG5105, dmPLAP, dPLAP, Phospholipase A2 activator protein" CDMC28582 2 25 14 DAC23-J18 18-CG5150-RA_4 CG5150 GGCCTGCGGTGAGTTGTCAGATGGACTCCAGGACATAGCTGTCCAGTTGATTCACGGCGAGGTGG 65 FBan0005150 FBgn0035620 CG5150 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5150 CG5150 CDMC28582 2 26 14 DAC23-J18 18-CG5150-RA_4 CG5150 GGCCTGCGGTGAGTTGTCAGATGGACTCCAGGACATAGCTGTCCAGTTGATTCACGGCGAGGTGG 65 FBan0005150 FBgn0035620 CG5150 3 3L mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG5150 CG5150 CDMC28583 2 1 15 DAC23-N06 14-CG5231-RA_1 CG5231 GGCTGGATGTTTATGCGCACAACATAGAGACGGTTGAGAAGCTCACTCCCTATGTGCGCGACCGG 65 FBan0005231 FBgn0029158 Las 3 3L coenzyme metabolism; GO:0006732; lipoate biosynthesis; GO:0009107; lipoic acid biosynthesis; GO:0009105; prosthetic group metabolism; GO:0051189 lipoic acid synthase activity; GO:0017140; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0017140; ; GO:0005506; lipoate synthase activity; GO:0016992; ; GO:0016992 mitochondrion; GO:0005739 Las Lipoic acid synthase "CG5231, CG5231, Lipoic acid synthase" CDMC28583 2 2 15 DAC23-N06 14-CG5231-RA_1 CG5231 GGCTGGATGTTTATGCGCACAACATAGAGACGGTTGAGAAGCTCACTCCCTATGTGCGCGACCGG 65 FBan0005231 FBgn0029158 Las 3 3L coenzyme metabolism; GO:0006732; lipoate biosynthesis; GO:0009107; lipoic acid biosynthesis; GO:0009105; prosthetic group metabolism; GO:0051189 lipoic acid synthase activity; GO:0017140; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0017140; ; GO:0005506; lipoate synthase activity; GO:0016992; ; GO:0016992 mitochondrion; GO:0005739 Las Lipoic acid synthase "CG5231, CG5231, Lipoic acid synthase" CDMC28584 2 3 15 DAC23-N18 23-CG5278-RA_3 CG5278 GCTAAGCAGATTTTTGAATTTCACATCGAAACGATCGTCGCTATATAATCGTATTTGTGGGAGCA 65 FBan0005278 FBgn0038986 CG5278 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5278 CG5278 CDMC28584 2 4 15 DAC23-N18 23-CG5278-RA_3 CG5278 GCTAAGCAGATTTTTGAATTTCACATCGAAACGATCGTCGCTATATAATCGTATTTGTGGGAGCA 65 FBan0005278 FBgn0038986 CG5278 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5278 CG5278 CDMC28585 2 5 15 DAC24-B06 24-CG9183-RA_1 CG9183 TCCTCCCACTTTTATTAGCAATCGTCTGCGTTAATGTATTGTCATTTTGTAATAATTTATTAATTTTAA 69 FBan0009183 FBgn0003114 plu 2 2R egg activation; GO:0007343; fertilization (sensu Metazoa); GO:0007338; negative regulation of DNA replication; GO:0008156; regulation of progression through mitotic cell cycle; GO:0007346 DNA binding; GO:0003677; ; GO:0003677 plu plutonium "CG9183, PLU, Plu" CDMC28585 2 6 15 DAC24-B06 24-CG9183-RA_1 CG9183 TCCTCCCACTTTTATTAGCAATCGTCTGCGTTAATGTATTGTCATTTTGTAATAATTTATTAATTTTAA 69 FBan0009183 FBgn0003114 plu 2 2R egg activation; GO:0007343; fertilization (sensu Metazoa); GO:0007338; negative regulation of DNA replication; GO:0008156; regulation of progression through mitotic cell cycle; GO:0007346 DNA binding; GO:0003677; ; GO:0003677 plu plutonium "CG9183, PLU, Plu" CDMC28586 2 7 15 DAC24-B18 23-CG9195-RA_14 CG9195 GACACTCTGCTTTCCGGGGATCTAATCAAATCAAAAGGAGAATCAATCAATCAACCACGAACTCAAGCA 69 FBan0009195 FBgn0040285 Scamp X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; synaptic vesicle exocytosis; GO:0016079 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Scamp Scamp "CG9195, CG9195, dmSCAMP, SCAMP, dmSC, BcDNA:GM04934, anon-EST:fe1F7, anon-fast-evolving-1F7" CDMC28586 2 8 15 DAC24-B18 23-CG9195-RA_14 CG9195 GACACTCTGCTTTCCGGGGATCTAATCAAATCAAAAGGAGAATCAATCAATCAACCACGAACTCAAGCA 69 FBan0009195 FBgn0040285 Scamp X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; synaptic vesicle exocytosis; GO:0016079 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Scamp Scamp "CG9195, CG9195, dmSCAMP, SCAMP, dmSC, BcDNA:GM04934, anon-EST:fe1F7, anon-fast-evolving-1F7" CDMC28587 2 9 15 DAC24-F06 22-CG9236-RA_1 CG9236 TTTACGGAACAGGAATTGGATGACTACCAGGTGAGCGATCAATCAGATGAAGTTCACTTCCACACAGCT 69 FBan0009236 FBgn0034558 CG9236 2 2R intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597 CG9236 CG9236 CDMC28587 2 10 15 DAC24-F06 22-CG9236-RA_1 CG9236 TTTACGGAACAGGAATTGGATGACTACCAGGTGAGCGATCAATCAGATGAAGTTCACTTCCACACAGCT 69 FBan0009236 FBgn0034558 CG9236 2 2R intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597 CG9236 CG9236 CDMC28588 2 11 15 DAC24-F18 2-CG9245-RB_2 CG9245 ACACCTGTCTCCTCCGTACTGGTTATCTGCCGATATTGTGGAATTGTAGGCACGCCCTAAAGAGCCCGA 69 FBan0009245 FBgn0030670 CG9245 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity; GO:0003881 ; EC:2.7.8.11; ; GO:0003881 ; EC:2.7.8.11 CG9245 CG9245 anon-WO02059370.38 CDMC28588 2 12 15 DAC24-F18 2-CG9245-RB_2 CG9245 ACACCTGTCTCCTCCGTACTGGTTATCTGCCGATATTGTGGAATTGTAGGCACGCCCTAAAGAGCCCGA 69 FBan0009245 FBgn0030670 CG9245 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity; GO:0003881 ; EC:2.7.8.11; ; GO:0003881 ; EC:2.7.8.11 CG9245 CG9245 anon-WO02059370.38 CDMC28589 2 13 15 DAC24-J06 9-CG9284-RB_1 CG9284 AGAGGAGGCGTCAGAGAAACGAGCAGAGGACATAAGGCTATCCGTGTATTTTTGGATCACCACGGTGGT 69 FBan0009284 FBgn0046297 CG9284 2 2R CG9284 CG9284 "bs30g10.y1, anon-WO0140519.157, BEST:GH11908" CDMC28589 2 14 15 DAC24-J06 9-CG9284-RB_1 CG9284 AGAGGAGGCGTCAGAGAAACGAGCAGAGGACATAAGGCTATCCGTGTATTTTTGGATCACCACGGTGGT 69 FBan0009284 FBgn0046297 CG9284 2 2R CG9284 CG9284 "bs30g10.y1, anon-WO0140519.157, BEST:GH11908" CDMC28590 2 15 15 DAC24-J18 23-CG9296-RA_11 CG9296 ACTTCGCTTTTGAGTACTTCAGCATTTCAATGCAATTGTTTGCGCGTTTATGAACTAGTTGTAGTCCAA 69 FBan0009296 FBgn0032059 CG9296 2 2L cyclic nucleotide metabolism; GO:0009187; visual perception; GO:0007601 cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.- CG9296 CG9296 CDMC28590 2 16 15 DAC24-J18 23-CG9296-RA_11 CG9296 ACTTCGCTTTTGAGTACTTCAGCATTTCAATGCAATTGTTTGCGCGTTTATGAACTAGTTGTAGTCCAA 69 FBan0009296 FBgn0032059 CG9296 2 2L cyclic nucleotide metabolism; GO:0009187; visual perception; GO:0007601 cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004116 ; EC:3.1.4.- CG9296 CG9296 CDMC28591 2 17 15 DAC24-N06 9-CG9325-RD_3 CG9325 ACGCCAGTGAGGATAGAAGATCCACTCCAGTTTGTGCCTGCAGGAACCAATCCAAGGGAATTTAAGCGT 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC28591 2 18 15 DAC24-N06 9-CG9325-RD_3 CG9325 ACGCCAGTGAGGATAGAAGATCCACTCCAGTTTGTGCCTGCAGGAACCAATCCAAGGGAATTTAAGCGT 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC28592 2 19 15 DAC24-N18 23-CG9334-RA_1 CG9334 AAAAAGATGGTAGGATTCACTCCAAAACTTATCAATATAAATGTGCATCTAAGGCTTCCCAAGTTCAAA 69 FBan0009334 FBgn0028986 Spn3 2 2L negative regulation of proteolysis; GO:0045861; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn3 Serine protease inhibitor 3 "CG9334, CG9334, CG9334, sp3: serpin 3, serpin 3" CDMC28592 2 20 15 DAC24-N18 23-CG9334-RA_1 CG9334 AAAAAGATGGTAGGATTCACTCCAAAACTTATCAATATAAATGTGCATCTAAGGCTTCCCAAGTTCAAA 69 FBan0009334 FBgn0028986 Spn3 2 2L negative regulation of proteolysis; GO:0045861; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn3 Serine protease inhibitor 3 "CG9334, CG9334, CG9334, sp3: serpin 3, serpin 3" CDMC28593 2 21 15 DAC25-B06 8-CG10565-RA_1 CG10565 AGGCGTTAAGGAGGTCAAGAAGAATGAGCTCTGGAGCAATGAGAACGTGCAGTTGCTTATCAAGGCGGT 69 FBan0010565 FBgn0037051 CG10565 3 3L protein folding; GO:0006457 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0003677 nucleus; GO:0005634 CG10565 CG10565 CDMC28593 2 22 15 DAC25-B06 8-CG10565-RA_1 CG10565 AGGCGTTAAGGAGGTCAAGAAGAATGAGCTCTGGAGCAATGAGAACGTGCAGTTGCTTATCAAGGCGGT 69 FBan0010565 FBgn0037051 CG10565 3 3L protein folding; GO:0006457 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0003677 nucleus; GO:0005634 CG10565 CG10565 CDMC28594 2 23 15 DAC25-B18 3-CG10575-RA_1 CG10575 CCTGGTGGACATAGATGATACGCTGCAGTACGAAATTGTGCCCATCGATGATCCCTTTGGTCCCACGCA 69 FBan0010575 FBgn0035632 CG10575 3 3L CG10575 CG10575 CDMC28594 2 24 15 DAC25-B18 3-CG10575-RA_1 CG10575 CCTGGTGGACATAGATGATACGCTGCAGTACGAAATTGTGCCCATCGATGATCCCTTTGGTCCCACGCA 69 FBan0010575 FBgn0035632 CG10575 3 3L CG10575 CG10575 CDMC28595 2 25 15 DAC25-F06 15-CG10604-RA_2 CG10604 CCGCCCCTGAATGGAGGTAGTGGTGCATCCAATGGAGTACTCTATCCGAATGCACCCTACACCGATCAC 69 FBan0010604 FBgn0000529 bsh 2 2L brain development; GO:0007420; ectoderm development; GO:0007398; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 bsh brain-specific homeobox "CG10604, E86, lambdaE86, Bsh: Bashed, Hox11-310, Bsh" CDMC28595 2 26 15 DAC25-F06 15-CG10604-RA_2 CG10604 CCGCCCCTGAATGGAGGTAGTGGTGCATCCAATGGAGTACTCTATCCGAATGCACCCTACACCGATCAC 69 FBan0010604 FBgn0000529 bsh 2 2L brain development; GO:0007420; ectoderm development; GO:0007398; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003702 nucleus; GO:0005634 bsh brain-specific homeobox "CG10604, E86, lambdaE86, Bsh: Bashed, Hox11-310, Bsh" CDMC28596 2 1 16 DAC25-F18 11-CG10619-RB_1 CG10619 GCAGGGCAGTCCGTAGACAATCGAACCGAATCTAATCCAGCTTCTTTTGTTGCTCCCAGAATCCAAGCT 69 FBan0010619 FBgn0003896 tup 2 2L amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; ectoderm development; GO:0007398; germ-band shortening; GO:0007390; head involution; GO:0008258; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 tup tailup "CG10619, isl, islet, Islet, Isl, Islet 1, l(2)37Aa, l(2)E41, lethal(2)37Aa" CDMC28596 2 2 16 DAC25-F18 11-CG10619-RB_1 CG10619 GCAGGGCAGTCCGTAGACAATCGAACCGAATCTAATCCAGCTTCTTTTGTTGCTCCCAGAATCCAAGCT 69 FBan0010619 FBgn0003896 tup 2 2L amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; ectoderm development; GO:0007398; germ-band shortening; GO:0007390; head involution; GO:0008258; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 tup tailup "CG10619, isl, islet, Islet, Isl, Islet 1, l(2)37Aa, l(2)E41, lethal(2)37Aa" CDMC28597 2 3 16 DAC25-J06 9-CG10642-RA_2 CG10642 CGGACATCGGTGTCTTTGTTAAGGATCTCAGTGGCTATGTGGTGCACAACGCCGATGATCTGGAGAACA 69 FBan0010642 FBgn0004380 Klp64D 3 3L NOT sperm axoneme assembly; GO:0007288; microtubule-based movement; GO:0007018; protein targeting; GO:0006605; sensory cilium biogenesis; GO:0035058 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Klp64D Kinesin-like protein at 64D "CG10642, CG10642, KLP4, KLP64D, DmKlp64D, KIF3A, klp64D, Klp4" CDMC28597 2 4 16 DAC25-J06 9-CG10642-RA_2 CG10642 CGGACATCGGTGTCTTTGTTAAGGATCTCAGTGGCTATGTGGTGCACAACGCCGATGATCTGGAGAACA 69 FBan0010642 FBgn0004380 Klp64D 3 3L NOT sperm axoneme assembly; GO:0007288; microtubule-based movement; GO:0007018; protein targeting; GO:0006605; sensory cilium biogenesis; GO:0035058 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 Klp64D Kinesin-like protein at 64D "CG10642, CG10642, KLP4, KLP64D, DmKlp64D, KIF3A, klp64D, Klp4" CDMC28598 2 5 16 DAC25-J18 7-CG10654-RA_1 CG10654 AGCGAACCGAAGTCTCAAATATCACATGAGAAGGACGCACGAAAGGTATCACGAGTCAGAGTCCCCGGA 69 FBan0010654 FBgn0036294 CG10654 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10654 CG10654 CDMC28598 2 6 16 DAC25-J18 7-CG10654-RA_1 CG10654 AGCGAACCGAAGTCTCAAATATCACATGAGAAGGACGCACGAAAGGTATCACGAGTCAGAGTCCCCGGA 69 FBan0010654 FBgn0036294 CG10654 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10654 CG10654 CDMC28599 2 7 16 DAC25-N06 15-CG10685-RA_1 CG10685 GCACTTCCGCATTCAATCCCGTCGAGACAGAGCCATAGATATACTTAAACGGGGACTGGAGGATCTGGA 69 FBan0010685 FBgn0032762 CG10685 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase I promoter; GO:0006360; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677; ; GO:0046983 DNA-directed RNA polymerase I complex; GO:0005736 CG10685 CG10685 CDMC28599 2 8 16 DAC25-N06 15-CG10685-RA_1 CG10685 GCACTTCCGCATTCAATCCCGTCGAGACAGAGCCATAGATATACTTAAACGGGGACTGGAGGATCTGGA 69 FBan0010685 FBgn0032762 CG10685 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase I promoter; GO:0006360; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677; ; GO:0046983 DNA-directed RNA polymerase I complex; GO:0005736 CG10685 CG10685 CDMC28600 2 9 16 DAC25-N18 2-CG10694-RA_1 CG10694 TGGGATTCCTCAGGAGGTTGTTTCAGAGCAGGGATTAGCTGCAATCCCGAGCGTACAGACAAGTGATCA 69 FBan0010694 FBgn0039147 CG10694 3 3R base-excision repair; GO:0006284; nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 CG10694 CG10694 CDMC28600 2 10 16 DAC25-N18 2-CG10694-RA_1 CG10694 TGGGATTCCTCAGGAGGTTGTTTCAGAGCAGGGATTAGCTGCAATCCCGAGCGTACAGACAAGTGATCA 69 FBan0010694 FBgn0039147 CG10694 3 3R base-excision repair; GO:0006284; nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 CG10694 CG10694 CDMC28601 2 11 16 DAC26-B06 9-CG8026-RA_3 CG8026 AGCGCAAAAGAAATCACCAGAGATTGCACAATATGAATCCGATCAAGGCACAGTCAACGGGCAGTCCCA 69 FBan0008026 FBgn0033391 CG8026 2 2R folic acid transport; GO:0015884; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; folic acid transporter activity; GO:0008517; ; GO:0008517 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8026 CG8026 "anon-WO0242455.53, anon-WO0242455.6, anon-WO0242455.7" CDMC28601 2 12 16 DAC26-B06 9-CG8026-RA_3 CG8026 AGCGCAAAAGAAATCACCAGAGATTGCACAATATGAATCCGATCAAGGCACAGTCAACGGGCAGTCCCA 69 FBan0008026 FBgn0033391 CG8026 2 2R folic acid transport; GO:0015884; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; folic acid transporter activity; GO:0008517; ; GO:0008517 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8026 CG8026 "anon-WO0242455.53, anon-WO0242455.6, anon-WO0242455.7" CDMC28602 2 13 16 DAC26-B18 24-CG8038-RA_2 CG8038 TGGAAAGTTAGCATCGCTTTTCAATAGAAATTTAATAATTGCCCTCAAAGATCCTCTAAAACTTTACTT 69 FBan0008038 FBgn0035831 CG8038 3 3L tRNA processing; GO:0008033 ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 CG8038 CG8038 "anon-WO0172774.38, BcDNA:LD45688" CDMC28602 2 14 16 DAC26-B18 24-CG8038-RA_2 CG8038 TGGAAAGTTAGCATCGCTTTTCAATAGAAATTTAATAATTGCCCTCAAAGATCCTCTAAAACTTTACTT 69 FBan0008038 FBgn0035831 CG8038 3 3L tRNA processing; GO:0008033 ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 CG8038 CG8038 "anon-WO0172774.38, BcDNA:LD45688" CDMC28603 2 15 16 DAC26-F06 6-CG8073-RA_2 CG8073 TCCAGTTCTTCGAAACGCTGACTGGATTCAAGTGGATGGGTAACAAGGCAATCGAGCTACAGCAGGCGG 69 FBan0008073 FBgn0033377 Pmm45A 2 2R monosaccharide metabolism; GO:0005996 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 Pmm45A Phosphomannomutase 45A CG8073 CDMC28603 2 16 16 DAC26-F06 6-CG8073-RA_2 CG8073 TCCAGTTCTTCGAAACGCTGACTGGATTCAAGTGGATGGGTAACAAGGCAATCGAGCTACAGCAGGCGG 69 FBan0008073 FBgn0033377 Pmm45A 2 2R monosaccharide metabolism; GO:0005996 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 Pmm45A Phosphomannomutase 45A CG8073 CDMC28604 2 17 16 DAC26-F18 16-CG8086-RA_1 CG8086 TCGCGACTAATCCTGGCAAGGACTGTATGCACTACGCGCTATTAGCACCGCAATAAAGTGAAGTTTTTT 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC28604 2 18 16 DAC26-F18 16-CG8086-RA_1 CG8086 TCGCGACTAATCCTGGCAAGGACTGTATGCACTACGCGCTATTAGCACCGCAATAAAGTGAAGTTTTTT 69 FBan0008086 FBgn0032010 CG8086 2 2L nuclear pore; GO:0005643 CG8086 CG8086 CG8113 CDMC28605 2 19 16 DAC26-J06 23-CG8120-RA_10 CG8120 TGGGCCAATTACAATACTTGGTCAAATGGCTGGATTATAGCGATGAAGATAATACCTGGGAATCGGCAG 69 FBan0008120 FBgn0037675 HP1e 3 3R "chromatin assembly or disassembly; GO:0006333; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1e HP1e "CG8120, CG8120, CG8120" CDMC28605 2 20 16 DAC26-J06 23-CG8120-RA_10 CG8120 TGGGCCAATTACAATACTTGGTCAAATGGCTGGATTATAGCGATGAAGATAATACCTGGGAATCGGCAG 69 FBan0008120 FBgn0037675 HP1e 3 3R "chromatin assembly or disassembly; GO:0006333; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1e HP1e "CG8120, CG8120, CG8120" CDMC28606 2 21 16 DAC26-J18 23-CG8129-RB_2 CG8129 AAATCCACATCATCGGATCTATATGGCATGGAGTTATATCTGAAAAAGGATTTCCTACAATATACAGGC 69 FBan0008129 FBgn0037684 CG8129 3 3R amino acid biosynthesis; GO:0008652; amino acid catabolism; GO:0009063 threonine ammonia-lyase activity; GO:0004794 ; EC:4.3.1.19; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004794 ; EC:4.3.1.19; amino acid binding; GO:0016597; ; GO:0016597 CG8129 CG8129 CT24308 CDMC28606 2 22 16 DAC26-J18 23-CG8129-RB_2 CG8129 AAATCCACATCATCGGATCTATATGGCATGGAGTTATATCTGAAAAAGGATTTCCTACAATATACAGGC 69 FBan0008129 FBgn0037684 CG8129 3 3R amino acid biosynthesis; GO:0008652; amino acid catabolism; GO:0009063 threonine ammonia-lyase activity; GO:0004794 ; EC:4.3.1.19; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004794 ; EC:4.3.1.19; amino acid binding; GO:0016597; ; GO:0016597 CG8129 CG8129 CT24308 CDMC28607 2 23 16 DAC26-N06 23-CG8174-RA_9 CG8174 ACTAGAGCCACACGAAATTTATGAAATTATTCTTGACCACTCTTAACACAAGCATTAACACCTAGAGGC 69 FBan0008174 FBgn0026370 SRPK 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 SRPK SRPK "CG8174, CG8174, CG8174, CG8174, dSRPK, dSRPK1, BcDNA:SD03158" CDMC28607 2 24 16 DAC26-N06 23-CG8174-RA_9 CG8174 ACTAGAGCCACACGAAATTTATGAAATTATTCTTGACCACTCTTAACACAAGCATTAACACCTAGAGGC 69 FBan0008174 FBgn0026370 SRPK 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 SRPK SRPK "CG8174, CG8174, CG8174, CG8174, dSRPK, dSRPK1, BcDNA:SD03158" CDMC28608 2 25 16 DAC26-N18 12-CG8182-RB_4 CG8182 ACGCTGTGAATTCGAACATATGTCTGGACGATTTGCTGCAGAACAACGAAAAGCCCTATAACGCCGGCT 69 FBan0008182 FBgn0034025 GalNAc-T1 2 2R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 GalNAc-T1 GalNAc-T1 "CG8182, CG8182, CG8182, pgant1, polypeptide GalNAc transferase 1, N-acetylgalactosaminyltransferase" CDMC28608 2 26 16 DAC26-N18 12-CG8182-RB_4 CG8182 ACGCTGTGAATTCGAACATATGTCTGGACGATTTGCTGCAGAACAACGAAAAGCCCTATAACGCCGGCT 69 FBan0008182 FBgn0034025 GalNAc-T1 2 2R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 GalNAc-T1 GalNAc-T1 "CG8182, CG8182, CG8182, pgant1, polypeptide GalNAc transferase 1, N-acetylgalactosaminyltransferase" CDMC28609 2 1 17 DAC27-B06 23-CG8416-RB_1 CG8416 CCAAGGAGGTCGTAGGCGTCAAGATGAGAGTTATGTTCCCATTAAATCTATCAAATACAGAGAGACCAG 69 FBan0008416 FBgn0014020 Rho1 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; NOT muscle attachment; GO:0016203; NOT myofibril assembly; GO:0030239; actin cable formation; GO:0045011; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; axon guidance; GO:0007411; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; endocytosis; GO:0006897; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; germ-band extension; GO:0007377; glial cell migration; GO:0008347; motor axon guidance; GO:0008045; neuroblast proliferation; GO:0007405; ommatidial rotation; GO:0016318; peripheral nervous system development; GO:0007422; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; small GTPase mediated signal transduction; GO:0007264; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; ventral furrow formation; GO:0007370; wound healing; GO:0042060" GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 Rho1 Rho1 "CG8416, l(2)k02107b, DrhoA, Rho: Rhombotin, RhoA, DRhoA, rhoA, rho, E3.10/J3.8, rho1, Drho1, DRho1, n(2)k07236, dRho1, dRhoA, DRho, dnRho, RHO, Rho GTPase, Rho kinase, AAF01186, Dm Rho1, DmRHO-A, l(2)52Fa, Rho" CDMC28609 2 2 17 DAC27-B06 23-CG8416-RB_1 CG8416 CCAAGGAGGTCGTAGGCGTCAAGATGAGAGTTATGTTCCCATTAAATCTATCAAATACAGAGAGACCAG 69 FBan0008416 FBgn0014020 Rho1 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; NOT muscle attachment; GO:0016203; NOT myofibril assembly; GO:0030239; actin cable formation; GO:0045011; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; axon guidance; GO:0007411; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; endocytosis; GO:0006897; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; germ-band extension; GO:0007377; glial cell migration; GO:0008347; motor axon guidance; GO:0008045; neuroblast proliferation; GO:0007405; ommatidial rotation; GO:0016318; peripheral nervous system development; GO:0007422; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; small GTPase mediated signal transduction; GO:0007264; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; ventral furrow formation; GO:0007370; wound healing; GO:0042060" GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 Rho1 Rho1 "CG8416, l(2)k02107b, DrhoA, Rho: Rhombotin, RhoA, DRhoA, rhoA, rho, E3.10/J3.8, rho1, Drho1, DRho1, n(2)k07236, dRho1, dRhoA, DRho, dnRho, RHO, Rho GTPase, Rho kinase, AAF01186, Dm Rho1, DmRHO-A, l(2)52Fa, Rho" CDMC28610 2 3 17 DAC27-B18 3-CG8424-RA_1 CG8424 GGTCTGCACACCATACGCATTCCGGTTAGCTTCGATGATTTTCCCAAGGACTCGGAAGATGCCAAGGTT 69 FBan0008424 FBgn0034076 CG8424 2 2R cell-cell signaling; GO:0007267; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG8424 CG8424 CDMC28610 2 4 17 DAC27-B18 3-CG8424-RA_1 CG8424 GGTCTGCACACCATACGCATTCCGGTTAGCTTCGATGATTTTCCCAAGGACTCGGAAGATGCCAAGGTT 69 FBan0008424 FBgn0034076 CG8424 2 2R cell-cell signaling; GO:0007267; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG8424 CG8424 CDMC28611 2 5 17 DAC27-F06 23-CG8468-RB_5 CG8468 GTTTCTATAAGCTTTAGTGGAGGAGCCCATATGTGGACTAGAATTTAGCAGCTAGACTAAGCGGAGGAT 69 FBan0008468 FBgn0033913 CG8468 2 2R cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG8468 CG8468 CDMC28611 2 6 17 DAC27-F06 23-CG8468-RB_5 CG8468 GTTTCTATAAGCTTTAGTGGAGGAGCCCATATGTGGACTAGAATTTAGCAGCTAGACTAAGCGGAGGAT 69 FBan0008468 FBgn0033913 CG8468 2 2R cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG8468 CG8468 CDMC28612 2 7 17 DAC27-F18 2-CG8484-RA_1 CG8484 GCGTCCATATCTTTGTCTGGTGTGTGGAAAGCGCTTTCTCACCGGATCCGTCTTCTATCAGCACCGTCT 69 FBan0008484 FBgn0037751 topi 3 3R "cell proliferation; GO:0008283; male meiosis; GO:0007140; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; spermatogenesis; GO:0007283" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 topi matotopetli "CG8484, CG8484, matotopetli" CDMC28612 2 8 17 DAC27-F18 2-CG8484-RA_1 CG8484 GCGTCCATATCTTTGTCTGGTGTGTGGAAAGCGCTTTCTCACCGGATCCGTCTTCTATCAGCACCGTCT 69 FBan0008484 FBgn0037751 topi 3 3R "cell proliferation; GO:0008283; male meiosis; GO:0007140; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; spermatogenesis; GO:0007283" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 topi matotopetli "CG8484, CG8484, matotopetli" CDMC28613 2 9 17 DAC27-J06 2-CG8522-RB_1 CG8522 GGCTTCTACCAAGTGCCAGGTGAAGTGCTCGAGAAGTTCCAGACCGATTTGAACTCGTTGCGCAACATT 69 FBan0008522 FBgn0015234 HLH106 3 3L fatty acid biosynthesis; GO:0006633; lipid metabolism; GO:0006629; positive regulation of transcription; GO:0045941; regulation of fatty acid biosynthesis; GO:0042304; transcription from RNA polymerase II promoter; GO:0006366 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH106 Helix loop helix protein 106 "CG8522, CG8522, CG8522, dSREBP, Sterol regulatory element-binding protein, SREBP, Srebp, Helix loop helix protein 106" CDMC28613 2 10 17 DAC27-J06 2-CG8522-RB_1 CG8522 GGCTTCTACCAAGTGCCAGGTGAAGTGCTCGAGAAGTTCCAGACCGATTTGAACTCGTTGCGCAACATT 69 FBan0008522 FBgn0015234 HLH106 3 3L fatty acid biosynthesis; GO:0006633; lipid metabolism; GO:0006629; positive regulation of transcription; GO:0045941; regulation of fatty acid biosynthesis; GO:0042304; transcription from RNA polymerase II promoter; GO:0006366 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH106 Helix loop helix protein 106 "CG8522, CG8522, CG8522, dSREBP, Sterol regulatory element-binding protein, SREBP, Srebp, Helix loop helix protein 106" CDMC28614 2 11 17 DAC27-J18 10-CG8536-RA_3 CG8536 TGCCTTATCGATCAATATTTGGAGGTGTTTCCGCAATGACGCGTGAGCACTTTCAGGCCGTAAATGGGT 69 FBan0008536 FBgn0027538 beta4GalNAcTA 2 2R N-acetylglucosamine metabolism; GO:0006044; adult locomotory behavior; GO:0008344; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; sperm individualization; GO:0007291 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; xylose isomerase activity; GO:0009045 ; EC:5.3.1.5; ; GO:0009045 ; EC:5.3.1.5; ; GO:0008376 ; EC:2.4.1.- beta4GalNAcTA beta4GalNAcTA "CG8536, CG8536, CG8536, CG8536, dbeta4GalTA, BcDNA:GH13356, anon-WO0118547.128, beta4GalTA" CDMC28614 2 12 17 DAC27-J18 10-CG8536-RA_3 CG8536 TGCCTTATCGATCAATATTTGGAGGTGTTTCCGCAATGACGCGTGAGCACTTTCAGGCCGTAAATGGGT 69 FBan0008536 FBgn0027538 beta4GalNAcTA 2 2R N-acetylglucosamine metabolism; GO:0006044; adult locomotory behavior; GO:0008344; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; sperm individualization; GO:0007291 acetylgalactosaminyltransferase activity; GO:0008376 ; EC:2.4.1.-; xylose isomerase activity; GO:0009045 ; EC:5.3.1.5; ; GO:0009045 ; EC:5.3.1.5; ; GO:0008376 ; EC:2.4.1.- beta4GalNAcTA beta4GalNAcTA "CG8536, CG8536, CG8536, CG8536, dbeta4GalTA, BcDNA:GH13356, anon-WO0118547.128, beta4GalTA" CDMC28615 2 13 17 DAC27-N06 2-CG8566-RD_1 CG8566 GCCATCGGTTGATGCACGAGCTTAGGTCAGGTTAATGGATCAATTGGAGCTTCACTTGTGCCCGGATCA 69 FBan0008566 FBgn0034155 unc-104 2 2R cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 unc-104 unc-104 "CG8566, CG8566, CG8566, Dunc104, DmKlp53D, DmCG8566, KIF1B, Klp53D" CDMC28615 2 14 17 DAC27-N06 2-CG8566-RD_1 CG8566 GCCATCGGTTGATGCACGAGCTTAGGTCAGGTTAATGGATCAATTGGAGCTTCACTTGTGCCCGGATCA 69 FBan0008566 FBgn0034155 unc-104 2 2R cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 unc-104 unc-104 "CG8566, CG8566, CG8566, Dunc104, DmKlp53D, DmCG8566, KIF1B, Klp53D" CDMC28616 2 15 17 DAC27-N18 16-CG8580-RA_1 CG8580 AGGACGAACAACTATTGACAGTGCATTTCAGTGGCCTTTGGAATACTGCTCAAACAACCAGCAAGCAAT 69 FBgn0035773 CDMC28616 2 16 17 DAC27-N18 16-CG8580-RA_1 CG8580 AGGACGAACAACTATTGACAGTGCATTTCAGTGGCCTTTGGAATACTGCTCAAACAACCAGCAAGCAAT 69 FBgn0035773 CDMC28617 2 17 17 DAC28-B06 12-CG30337-RB_1 CG30337 ACAGTGCCCTCGCAAAGCCACAGATACACACATCTTGGGATGCAGATGAGGCAAAAGGATTTTACACGT 69 FBan0030337 FBgn0050337 CG30337 2 2R "DNA metabolism; GO:0006259; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein targeting; GO:0006605" nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; damaged DNA binding; GO:0003684; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003684; ; GO:0008017; ; GO:0005200 CG30337 CG30337 "CG1931, CG1931" CDMC28617 2 18 17 DAC28-B06 12-CG30337-RB_1 CG30337 ACAGTGCCCTCGCAAAGCCACAGATACACACATCTTGGGATGCAGATGAGGCAAAAGGATTTTACACGT 69 FBan0030337 FBgn0050337 CG30337 2 2R "DNA metabolism; GO:0006259; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein targeting; GO:0006605" nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; damaged DNA binding; GO:0003684; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003684; ; GO:0008017; ; GO:0005200 CG30337 CG30337 "CG1931, CG1931" CDMC28618 2 19 17 DAC28-B18 23-CG30350-RA_7 CG30350 TTTATTTATTGATAAAGGTCTTTTCGCCCAATTTAAATGGCTGATTTTCCGATGTGTGTGACCCCGTCG 69 FBan0030350 FBgn0050350 CG30350 2 2R CG30350 CG30350 "CG8278, CG8278, CG8278" CDMC28618 2 20 17 DAC28-B18 23-CG30350-RA_7 CG30350 TTTATTTATTGATAAAGGTCTTTTCGCCCAATTTAAATGGCTGATTTTCCGATGTGTGTGACCCCGTCG 69 FBan0030350 FBgn0050350 CG30350 2 2R CG30350 CG30350 "CG8278, CG8278, CG8278" CDMC28619 2 21 17 DAC28-F06 15-CG30379-RA_6 CG30379 ACGAGTCCCAGGACACGAATTCCGATCCAAAAGATGGCGAACACTTGGTCGAAAATGGGATGATTTCCC 69 FBan0030379 FBgn0050379 CG30379 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 CG30379 CG30379 CDMC28619 2 22 17 DAC28-F06 15-CG30379-RA_6 CG30379 ACGAGTCCCAGGACACGAATTCCGATCCAAAAGATGGCGAACACTTGGTCGAAAATGGGATGATTTCCC 69 FBan0030379 FBgn0050379 CG30379 2 2R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 CG30379 CG30379 CDMC28620 2 23 17 DAC28-F18 6-CG30392-RA_1 CG30392 ACTTTGTCTACGAGTTTCTCAATCGGATCCAGGCGATACCCGACGACCAAAAGACTGTGGACGTGTGCA 69 FBan0030392 FBgn0050392 CG30392 2 2R CG30392 CG30392 "CG10509, CG10509, anon-WO0153538.80" CDMC28620 2 24 17 DAC28-F18 6-CG30392-RA_1 CG30392 ACTTTGTCTACGAGTTTCTCAATCGGATCCAGGCGATACCCGACGACCAAAAGACTGTGGACGTGTGCA 69 FBan0030392 FBgn0050392 CG30392 2 2R CG30392 CG30392 "CG10509, CG10509, anon-WO0153538.80" CDMC28621 2 25 17 DAC28-J06 22-CG30436-RA_1 CG30436 CGGCAAAGTGGATTTTTCCGTGAAACATAAAAGCAAAGTTCGCTCTGTCAATTAATGCAAGCCCGACGT 69 FBan0030436 FBgn0050436 CG30436 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30436 CG30436 CDMC28621 2 26 17 DAC28-J06 22-CG30436-RA_1 CG30436 CGGCAAAGTGGATTTTTCCGTGAAACATAAAAGCAAAGTTCGCTCTGTCAATTAATGCAAGCCCGACGT 69 FBan0030436 FBgn0050436 CG30436 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30436 CG30436 CDMC28622 2 1 18 DAC28-J18 2-CG30445-RA_1 CG30445 CGCCACTGAGAAGGACATCCTGGAAGCTTGGACCCAGATAAAGTGCTTTGCTGAGGAAATACTGCGGGA 69 FBan0030445 FBgn0050445 Tdc1 2 2R amino acid metabolism; GO:0006520; transmission of nerve impulse; GO:0019226 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Tdc1 Tdc1 "CG3686, CG30445, CG3686" CDMC28622 2 2 18 DAC28-J18 2-CG30445-RA_1 CG30445 CGCCACTGAGAAGGACATCCTGGAAGCTTGGACCCAGATAAAGTGCTTTGCTGAGGAAATACTGCGGGA 69 FBan0030445 FBgn0050445 Tdc1 2 2R amino acid metabolism; GO:0006520; transmission of nerve impulse; GO:0019226 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Tdc1 Tdc1 "CG3686, CG30445, CG3686" CDMC28623 2 3 18 DAC28-N06 8-CG30484-RA_1 CG30484 ACTGATGAAGGAGGTTGCCATTCGCGAAGACTTTCGACCCAAAAAGAAACCACGCGATTTTGTGACGGA 69 FBan0030484 FBgn0050484 CG30484 2 2R CG30484 CG30484 CG13342 CDMC28623 2 4 18 DAC28-N06 8-CG30484-RA_1 CG30484 ACTGATGAAGGAGGTTGCCATTCGCGAAGACTTTCGACCCAAAAAGAAACCACGCGATTTTGTGACGGA 69 FBan0030484 FBgn0050484 CG30484 2 2R CG30484 CG30484 CG13342 CDMC28624 2 5 18 DAC28-N18 13-CG30491-RA_1 CG30491 GCCTTTGTTTTGGCCCTTTGTTAAGACTCCGAGAAATGGTGCTCAGACCTCGTTGTATGTTGCTCTGGA 69 FBan0030491 FBgn0050491 CG30491 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30491 CG30491 "CG17986, CG2074" CDMC28624 2 6 18 DAC28-N18 13-CG30491-RA_1 CG30491 GCCTTTGTTTTGGCCCTTTGTTAAGACTCCGAGAAATGGTGCTCAGACCTCGTTGTATGTTGCTCTGGA 69 FBan0030491 FBgn0050491 CG30491 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30491 CG30491 "CG17986, CG2074" CDMC28625 2 7 18 DAC29-B06 23-CG9967-RA_2 CG9967 TTAATTGTGCAATTGTTTGTTTAAAGTGCATGTGAACAAGATACGCTAATAAAAGTCTTCGGATCGGTG 69 FBan0009967 FBgn0031413 CG9967 2 2L CG9967 CG9967 CDMC28625 2 8 18 DAC29-B06 23-CG9967-RA_2 CG9967 TTAATTGTGCAATTGTTTGTTTAAAGTGCATGTGAACAAGATACGCTAATAAAAGTCTTCGGATCGGTG 69 FBan0009967 FBgn0031413 CG9967 2 2L CG9967 CG9967 CDMC28626 2 9 18 DAC29-B18 22-CG9983-RB_1 CG9983 TCGCACCTGAGGATGGAATGGATGTTGAACGGTTTCCCCTCTGCACCATCGTAAATATACGACTTTTAT 69 FBan0009983 FBgn0001215 Hrb98DE 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530; ribonucleoprotein complex; GO:0030529 Hrb98DE Heterogeneous nuclear ribonucleoprotein at 98DE "CG9983, CG9983, CG9983, p9, E7Delta6, HDP(P9), hrp38, HRB98DE/hrp38, hrb98DE, Hrb1: hnRNA-binding protein 1, Pen9, anon-E7Delta6, hnRNA-binding protein 1" CDMC28626 2 10 18 DAC29-B18 22-CG9983-RB_1 CG9983 TCGCACCTGAGGATGGAATGGATGTTGAACGGTTTCCCCTCTGCACCATCGTAAATATACGACTTTTAT 69 FBan0009983 FBgn0001215 Hrb98DE 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530; ribonucleoprotein complex; GO:0030529 Hrb98DE Heterogeneous nuclear ribonucleoprotein at 98DE "CG9983, CG9983, CG9983, p9, E7Delta6, HDP(P9), hrp38, HRB98DE/hrp38, hrb98DE, Hrb1: hnRNA-binding protein 1, Pen9, anon-E7Delta6, hnRNA-binding protein 1" CDMC28627 2 11 18 DAC29-F06 23-CR30009-RA_3 CR30009 GCCAATAGCAAGGCGTGTTTTTGTTGCTAAATGATTATTTATGTATACGCGAGGACCCTTGAGTTTTAA 69 FBan0030009 FBgn0050009 CR30009 2 2R CR30009 CR30009 BcDNA:RE30084 CDMC28627 2 12 18 DAC29-F06 23-CR30009-RA_3 CR30009 GCCAATAGCAAGGCGTGTTTTTGTTGCTAAATGATTATTTATGTATACGCGAGGACCCTTGAGTTTTAA 69 FBan0030009 FBgn0050009 CR30009 2 2R CR30009 CR30009 BcDNA:RE30084 CDMC28628 2 13 18 DAC29-F18 8-CR30478-RA_1 CR30478 ACGCACAAAACTGTGTTGGTAAACAAGCGCTAGCACGGTGCGAAAAGTGTAAGGTGGTGTAAACAGCCA 69 FBan0030478 FBgn0050478 CR30478 2 2R CR30478 CR30478 CDMC28628 2 14 18 DAC29-F18 8-CR30478-RA_1 CR30478 ACGCACAAAACTGTGTTGGTAAACAAGCGCTAGCACGGTGCGAAAAGTGTAAGGTGGTGTAAACAGCCA 69 FBan0030478 FBgn0050478 CR30478 2 2R CR30478 CR30478 CDMC28629 2 15 18 DAC29-J06 7-CR31969-RA_1 CR31969 AGAGAAGAGGATCCCCAATCCCAACCGAGATCAACAATGAGAAGTAGTTTCCTGGGTTCCCGAGAGCGA 69 FBan0031969 FBgn0051969 CR31969 2 2L CR31969 CR31969 BcDNA:LP03459 CDMC28629 2 16 18 DAC29-J06 7-CR31969-RA_1 CR31969 AGAGAAGAGGATCCCCAATCCCAACCGAGATCAACAATGAGAAGTAGTTTCCTGGGTTCCCGAGAGCGA 69 FBan0031969 FBgn0051969 CR31969 2 2L CR31969 CR31969 BcDNA:LP03459 CDMC28630 2 17 18 DAC29-J18 18-CR32385-RA_9 CR32385 CCTGCACCTTTTAGCGGGCATTTTCCAAACCGGTTTACGAGGTTTTTCATTGAGGCAAACAGTTTTCCT 69 FBan0032385 FBgn0047205 CR32385 3 3L CR32385 CR32385 "LD18889, anon-WO0118547.23, BcDNA:LD18889" CDMC28630 2 18 18 DAC29-J18 18-CR32385-RA_9 CR32385 CCTGCACCTTTTAGCGGGCATTTTCCAAACCGGTTTACGAGGTTTTTCATTGAGGCAAACAGTTTTCCT 69 FBan0032385 FBgn0047205 CR32385 3 3L CR32385 CR32385 "LD18889, anon-WO0118547.23, BcDNA:LD18889" CDMC28631 2 19 18 DAC29-N06 23-CR32910-RA_1 CR32910 CACATGATGATAATTGAAAGTTCTTGATAGGAATTGCCGGCTGACACATATATGAAGCTAATTCTAGTT 69 FBan0032910 FBgn0060291 snoRNA:U49:66Db 3 3L snoRNA:U49:66Db snoRNA:U49:66Db "U49b, Dmel\U49b, CR32910" CDMC28631 2 20 18 DAC29-N06 23-CR32910-RA_1 CR32910 CACATGATGATAATTGAAAGTTCTTGATAGGAATTGCCGGCTGACACATATATGAAGCTAATTCTAGTT 69 FBan0032910 FBgn0060291 snoRNA:U49:66Db 3 3L snoRNA:U49:66Db snoRNA:U49:66Db "U49b, Dmel\U49b, CR32910" CDMC28632 2 21 18 DAC29-N18 2-CR33294-RA_4 CR33294 GCAGGACCTGGCGTTTTCTCAAGCAGCATACCCGCTAGCAAATGACTTTGTAGCTTCTGTGTGCGTTGA 69 FBan0033294 FBgn0053294 CG33294 3 3R CG33294 CG33294 "BP1027, CR33294" CDMC28632 2 22 18 DAC29-N18 2-CR33294-RA_4 CR33294 GCAGGACCTGGCGTTTTCTCAAGCAGCATACCCGCTAGCAAATGACTTTGTAGCTTCTGTGTGCGTTGA 69 FBan0033294 FBgn0053294 CG33294 3 3R CG33294 CG33294 "BP1027, CR33294" CDMC28633 2 23 18 DAC30-B06 16-CG11983-RA_1 CG11983 GATCATGACCCCAGAGAATAAGCCCCTAGCCAATCAAGAATCTCTCTACTCCGAAACCGAAGATGCTGT 69 FBan0011983 FBgn0037654 CG11983 3 3R CG11983 CG11983 CDMC28633 2 24 18 DAC30-B06 16-CG11983-RA_1 CG11983 GATCATGACCCCAGAGAATAAGCCCCTAGCCAATCAAGAATCTCTCTACTCCGAAACCGAAGATGCTGT 69 FBan0011983 FBgn0037654 CG11983 3 3R CG11983 CG11983 CDMC28634 2 25 18 DAC30-B18 2-CG11992-RC_5 CG11992 TGCGTGGAAAGCTTCCTTAATGGAGTGCCAACCGTACAATTGGACCTCTCGCTAACGAACGACGATGGT 69 FBan0011992 FBgn0014018 Rel 3 3R I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to bacteria; GO:0009617; signal transduction; GO:0007165 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0003704; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Rel Relish "CG11992, CG11992, CG11992, CG11992, CG11992, l(3)neo36, ird4, immune response deficient 4, relish, ird, rel, REL, Relish" CDMC28634 2 26 18 DAC30-B18 2-CG11992-RC_5 CG11992 TGCGTGGAAAGCTTCCTTAATGGAGTGCCAACCGTACAATTGGACCTCTCGCTAACGAACGACGATGGT 69 FBan0011992 FBgn0014018 Rel 3 3R I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to bacteria; GO:0009617; signal transduction; GO:0007165 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0003704; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Rel Relish "CG11992, CG11992, CG11992, CG11992, CG11992, l(3)neo36, ird4, immune response deficient 4, relish, ird, rel, REL, Relish" CDMC28635 2 1 19 DAC30-F06 9-CG12022-RA_1 CG12022 CGGCGAACGCATGTCCAAGGACCAAAAGGAGCTGTACGTTAAGTTTTTCGAGGACAATCCATGCATGCT 69 FBan0012022 FBgn0035276 CG12022 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG12022 CG12022 "CG32317, CG32317, CG32317" CDMC28635 2 2 19 DAC30-F06 9-CG12022-RA_1 CG12022 CGGCGAACGCATGTCCAAGGACCAAAAGGAGCTGTACGTTAAGTTTTTCGAGGACAATCCATGCATGCT 69 FBan0012022 FBgn0035276 CG12022 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG12022 CG12022 "CG32317, CG32317, CG32317" CDMC28636 2 3 19 DAC30-F18 18-CG12026-RB_1 CG12026 AGGACGCCAACCAATTAAGCTTAGCACGTGCAAGAACCAGGGGTGAAACTCAGCTTAAAGTTTTCCATA 69 FBan0012026 FBgn0035289 CG12026 3 3L CG12026 CG12026 CDMC28636 2 4 19 DAC30-F18 18-CG12026-RB_1 CG12026 AGGACGCCAACCAATTAAGCTTAGCACGTGCAAGAACCAGGGGTGAAACTCAGCTTAAAGTTTTCCATA 69 FBan0012026 FBgn0035289 CG12026 3 3L CG12026 CG12026 CDMC28637 2 5 19 DAC30-J06 23-CG12055-RA_2 CG12055 GCGCAATTGAGGATGCTTTTTTTTCAAATGCACAAAATAGCCATAATTACGCAAAGCTACATATTTATT 69 FBan0012055 FBgn0001091 Gapdh1 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 cytoplasm; GO:0005737 Gapdh1 Glyceraldehyde 3 phosphate dehydrogenase 1 "CG12055, CG12055, CG12055, CG12055, Gapdh-1, GA3PDH, Gapdh, GAPDH, GADPH, Gapd, G3-P dehydrogenase, gapdh-1, gh12586, GAPDH-1, Glyceraldehyde-3-phosphate dehydrogenase1, GAPDH I, Gapdh43E, BEST:GH12586" CDMC28637 2 6 19 DAC30-J06 23-CG12055-RA_2 CG12055 GCGCAATTGAGGATGCTTTTTTTTCAAATGCACAAAATAGCCATAATTACGCAAAGCTACATATTTATT 69 FBan0012055 FBgn0001091 Gapdh1 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 cytoplasm; GO:0005737 Gapdh1 Glyceraldehyde 3 phosphate dehydrogenase 1 "CG12055, CG12055, CG12055, CG12055, Gapdh-1, GA3PDH, Gapdh, GAPDH, GADPH, Gapd, G3-P dehydrogenase, gapdh-1, gh12586, GAPDH-1, Glyceraldehyde-3-phosphate dehydrogenase1, GAPDH I, Gapdh43E, BEST:GH12586" CDMC28638 2 7 19 DAC30-J18 3-CG12070-RA_4 CG12070 CCCACCAGAGACAGCATCAAGCATATCCTGGAGGAGTCTTGCGACCGAATGAGGAAGCCAATGAACACT 69 FBan0012070 FBgn0000416 Sap-r 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; sphingolipid metabolism; GO:0006665; transport; GO:0006810 lysosome; GO:0005764 Sap-r Saposin-related "CG12070, DAPA: Drosophila Aggregation promoting activity, Sapr, P110: 110kD protein, sap-r, Apa, BcDNA:GH08312, anon-EST:ParkEST270, Aggregation promoting activity, Drosophila Aggregation promoting activity, 110kD protein, P110, DAPA" CDMC28638 2 8 19 DAC30-J18 3-CG12070-RA_4 CG12070 CCCACCAGAGACAGCATCAAGCATATCCTGGAGGAGTCTTGCGACCGAATGAGGAAGCCAATGAACACT 69 FBan0012070 FBgn0000416 Sap-r 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; sphingolipid metabolism; GO:0006665; transport; GO:0006810 lysosome; GO:0005764 Sap-r Saposin-related "CG12070, DAPA: Drosophila Aggregation promoting activity, Sapr, P110: 110kD protein, sap-r, Apa, BcDNA:GH08312, anon-EST:ParkEST270, Aggregation promoting activity, Drosophila Aggregation promoting activity, 110kD protein, P110, DAPA" CDMC28639 2 9 19 DAC30-N06 23-CG1210-RA_9 CG1210 TGTAAACAGTGTAACTATGTACAGAACTATGTGAGCTATATGCACACGGCAAAAAGACCCTAAGTCGTG 69 FBan0001210 FBgn0020386 Pk61C 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; anti-apoptosis; GO:0006916; cell surface receptor linked signal transduction; GO:0007166; glycogen metabolism; GO:0005977; insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242; oogenesis (sensu Insecta); GO:0009993; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; potassium ion transport; GO:0006813; protein amino acid phosphorylation; GO:0006468; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; sex differentiation; GO:0007548; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; voltage-gated potassium channel activity; GO:0005249; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005249 cytoplasm; GO:0005737; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Pk61C Protein kinase 61C "CG1210, CG1201, CG1210, CG1210, CG1210, CG1201, CG1210, Dstpk61, DSTPK61, serine/threonine protein kinase., PDK1, Phosphoinositide dependent kinase 1, dPDK1, dPDK-1, PDK, PDK-1, dSTPK61, Pdk1" CDMC28639 2 10 19 DAC30-N06 23-CG1210-RA_9 CG1210 TGTAAACAGTGTAACTATGTACAGAACTATGTGAGCTATATGCACACGGCAAAAAGACCCTAAGTCGTG 69 FBan0001210 FBgn0020386 Pk61C 3 3L actin cytoskeleton organization and biogenesis; GO:0030036; anti-apoptosis; GO:0006916; cell surface receptor linked signal transduction; GO:0007166; glycogen metabolism; GO:0005977; insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242; oogenesis (sensu Insecta); GO:0009993; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; potassium ion transport; GO:0006813; protein amino acid phosphorylation; GO:0006468; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; sex differentiation; GO:0007548; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; voltage-gated potassium channel activity; GO:0005249; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005249 cytoplasm; GO:0005737; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Pk61C Protein kinase 61C "CG1210, CG1201, CG1210, CG1210, CG1210, CG1201, CG1210, Dstpk61, DSTPK61, serine/threonine protein kinase., PDK1, Phosphoinositide dependent kinase 1, dPDK1, dPDK-1, PDK, PDK-1, dSTPK61, Pdk1" CDMC28640 2 11 19 DAC30-N18 23-CG12117-RA_5 CG12117 GTCCGGCGATCATGTGGATTACAGGGATGAGCAGTTCTAGCTAGTTAATCAGTATGTTGCTATCTGTGG 69 FBan0012117 FBgn0014032 Sptr X X metabolism; GO:0008152; tetrahydrobiopterin biosynthesis; GO:0006729 sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 Sptr Sepiapterin reductase "CG12117, SR, sepiapterin reductase, sptr" CDMC28640 2 12 19 DAC30-N18 23-CG12117-RA_5 CG12117 GTCCGGCGATCATGTGGATTACAGGGATGAGCAGTTCTAGCTAGTTAATCAGTATGTTGCTATCTGTGG 69 FBan0012117 FBgn0014032 Sptr X X metabolism; GO:0008152; tetrahydrobiopterin biosynthesis; GO:0006729 sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 Sptr Sepiapterin reductase "CG12117, SR, sepiapterin reductase, sptr" CDMC28641 2 13 19 DAC31-B06 3-CG3624-RA_1 CG3624 AGACGTGGTGGTCTTGTGGTACTTCGGCGATAATGTCATTTCCAATGGCAAGAACCTGGTGCAGCC 66 FBan0003624 FBgn0034724 CG3624 2 2R CG3624 CG3624 CT12183 CDMC28641 2 14 19 DAC31-B06 3-CG3624-RA_1 CG3624 AGACGTGGTGGTCTTGTGGTACTTCGGCGATAATGTCATTTCCAATGGCAAGAACCTGGTGCAGCC 66 FBan0003624 FBgn0034724 CG3624 2 2R CG3624 CG3624 CT12183 CDMC28642 2 15 19 DAC31-B18 8-CG3775-RA_1 CG3775 TGTCACTTAGCCAAGCCAAATTGGAATATCGTCAGGTTTTTGGTGAGCCCGTGACTTCGGTGCCAG 66 FBan0003775 FBgn0030425 CG3775 X X proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG3775 CG3775 "zinc metalloprotease, BEST:GH06882" CDMC28642 2 16 19 DAC31-B18 8-CG3775-RA_1 CG3775 TGTCACTTAGCCAAGCCAAATTGGAATATCGTCAGGTTTTTGGTGAGCCCGTGACTTCGGTGCCAG 66 FBan0003775 FBgn0030425 CG3775 X X proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG3775 CG3775 "zinc metalloprotease, BEST:GH06882" CDMC28643 2 17 19 DAC31-F06 9-CG40486-RA_1 CG40486 GGCCATGTGATCCTCATTAACAGCCTAACGGGCCGTAACATCATCAATCCACCTGGTGACGAGCTG 66 FBgn0069972 CG40486 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40486 CG40486 CDMC28643 2 18 19 DAC31-F06 9-CG40486-RA_1 CG40486 GGCCATGTGATCCTCATTAACAGCCTAACGGGCCGTAACATCATCAATCCACCTGGTGACGAGCTG 66 FBgn0069972 CG40486 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40486 CG40486 CDMC28644 2 19 19 DAC31-F18 2-CG4268-RA_1 CG4268 CCCAGCCGTGAAGAACATGTTGTCGCAGAACTCTCAGTTTACCGAGTATCCCGTCTCGCAACTGCG 66 FBan0004268 FBgn0016696 Pitslre 3 3L cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- nucleus; GO:0005634 Pitslre Pitslre "CG4268, CG4268, group 3, PITSLRE, Gat: Gat-like, Gta, Gat-like, Galactosyltransferase-associated kinase-like" CDMC28644 2 20 19 DAC31-F18 2-CG4268-RA_1 CG4268 CCCAGCCGTGAAGAACATGTTGTCGCAGAACTCTCAGTTTACCGAGTATCCCGTCTCGCAACTGCG 66 FBan0004268 FBgn0016696 Pitslre 3 3L cell adhesion; GO:0007155; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- nucleus; GO:0005634 Pitslre Pitslre "CG4268, CG4268, group 3, PITSLRE, Gat: Gat-like, Gta, Gat-like, Galactosyltransferase-associated kinase-like" CDMC28645 2 21 19 DAC31-J06 2-CG4735-RA_1 CG4735 AGTTTTGTGTGGTCTATCCGAAGGCTGTCGACTTGCACCTACATGGCAAGGACTCGGTGAAGCTCG 66 FBan0004735 FBgn0003401 shu 2 2R oogenesis (sensu Insecta); GO:0009993; protein folding; GO:0006457 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- cytoplasm; GO:0005737 shu shutdown "CG4735, CG4735, CG4735, Shutdown, shutdown" CDMC28645 2 22 19 DAC31-J06 2-CG4735-RA_1 CG4735 AGTTTTGTGTGGTCTATCCGAAGGCTGTCGACTTGCACCTACATGGCAAGGACTCGGTGAAGCTCG 66 FBan0004735 FBgn0003401 shu 2 2R oogenesis (sensu Insecta); GO:0009993; protein folding; GO:0006457 isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- cytoplasm; GO:0005737 shu shutdown "CG4735, CG4735, CG4735, Shutdown, shutdown" CDMC28646 2 23 19 DAC31-J18 14-CG4841-RA_1 CG4841 GGGCAAGTCCATTGAGCCATATGGCGTTGATTACATCCTAAACAAACTGGGCTTCAGCCATGCACG 66 FBan0004841 FBgn0032622 CG4841 2 2L CG4841 CG4841 CDMC28646 2 24 19 DAC31-J18 14-CG4841-RA_1 CG4841 GGGCAAGTCCATTGAGCCATATGGCGTTGATTACATCCTAAACAAACTGGGCTTCAGCCATGCACG 66 FBan0004841 FBgn0032622 CG4841 2 2L CG4841 CG4841 CDMC28647 2 25 19 DAC31-N06 9-CG5102-RA_1 CG5102 TCCACGTCCTTGCCTAAGCAAACGAAAAAGCGGAAAGAGCACACAGCCATTAGCAATTCGGTTCCG 66 FBan0005102 FBgn0000413 da 2 2L "R8 cell fate specification; GO:0045464; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to oxidative stress; GO:0006979; second mitotic wave (sensu Endopterygota); GO:0016330; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0004601 ; EC:1.11.1.7; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0003704 nucleus; GO:0005634 da daughterless "CG5102, CG5102, CG5102, CG5102, l(2)31Ea, Da, daughter-less" CDMC28647 2 26 19 DAC31-N06 9-CG5102-RA_1 CG5102 TCCACGTCCTTGCCTAAGCAAACGAAAAAGCGGAAAGAGCACACAGCCATTAGCAATTCGGTTCCG 66 FBan0005102 FBgn0000413 da 2 2L "R8 cell fate specification; GO:0045464; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to oxidative stress; GO:0006979; second mitotic wave (sensu Endopterygota); GO:0016330; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0004601 ; EC:1.11.1.7; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0003704 nucleus; GO:0005634 da daughterless "CG5102, CG5102, CG5102, CG5102, l(2)31Ea, Da, daughter-less" CDMC28648 2 1 20 DAC31-N18 3-CG5320-RA_6 CG5320 TGAGCGCGAGATGTCCTGGATTGCCGATACTTATGCCAAGACCATCGGTCACCTGGACATCAATGC 66 FBan0005320 FBgn0001098 Gdh 3 3R NOT sperm storage; GO:0046693; glutamate catabolism to 2-oxoglutarate; GO:0019551; sperm storage; GO:0046693 glutamate dehydrogenase [NAD(P)+] activity; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3 mitochondrial matrix; GO:0005759 Gdh Glutamate dehydrogenase "CG5320, CG5320, CG5320, GDH, Glud, GLU-D, DHE3, GLUD, GLUD pre-mRNA, gdh" CDMC28648 2 2 20 DAC31-N18 3-CG5320-RA_6 CG5320 TGAGCGCGAGATGTCCTGGATTGCCGATACTTATGCCAAGACCATCGGTCACCTGGACATCAATGC 66 FBan0005320 FBgn0001098 Gdh 3 3R NOT sperm storage; GO:0046693; glutamate catabolism to 2-oxoglutarate; GO:0019551; sperm storage; GO:0046693 glutamate dehydrogenase [NAD(P)+] activity; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3 mitochondrial matrix; GO:0005759 Gdh Glutamate dehydrogenase "CG5320, CG5320, CG5320, GDH, Glud, GLU-D, DHE3, GLUD, GLUD pre-mRNA, gdh" CDMC28649 2 3 20 DAC32-B06 14-CG11133-RA_1 CG11133 CCTAGCAAGGCGTCTTGTTGAAGCAACCTTAGTCAAAAGAAGTGAGAATGCTGCCGAAATGATCCGGGA 69 FBan0011133 FBgn0037205 CG11133 3 3L CG11133 CG11133 CDMC28649 2 4 20 DAC32-B06 14-CG11133-RA_1 CG11133 CCTAGCAAGGCGTCTTGTTGAAGCAACCTTAGTCAAAAGAAGTGAGAATGCTGCCGAAATGATCCGGGA 69 FBan0011133 FBgn0037205 CG11133 3 3L CG11133 CG11133 CDMC28650 2 5 20 DAC32-B18 3-CG11144-RA_1 CG11144 AGGAACAAATGCGTCTTCAAGTACCCTTCCGACACAAAATAGCCCCCACCTTGATGAAGCATCAGCCCA 69 FBan0011144 FBgn0019985 Glu-RA 4 4 metabotropic glutamate receptor signaling pathway; GO:0007216; transmission of nerve impulse; GO:0019226 "G-protein coupled receptor activity; GO:0004930; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067; ; GO:0004930; ; GO:0008067" integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Glu-RA Metabotropic glutamate receptor "CG11144, DmGluRA, metabotropic glutamate receptor, DmGluR, DmGluR[[A]], DmGlu-A, DmGluAR, CAA67993.1_Dr" CDMC28650 2 6 20 DAC32-B18 3-CG11144-RA_1 CG11144 AGGAACAAATGCGTCTTCAAGTACCCTTCCGACACAAAATAGCCCCCACCTTGATGAAGCATCAGCCCA 69 FBan0011144 FBgn0019985 Glu-RA 4 4 metabotropic glutamate receptor signaling pathway; GO:0007216; transmission of nerve impulse; GO:0019226 "G-protein coupled receptor activity; GO:0004930; metabotropic glutamate, GABA-B-like receptor activity; GO:0008067; ; GO:0008067; ; GO:0004930; ; GO:0008067" integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Glu-RA Metabotropic glutamate receptor "CG11144, DmGluRA, metabotropic glutamate receptor, DmGluR, DmGluR[[A]], DmGlu-A, DmGluAR, CAA67993.1_Dr" CDMC28651 2 7 20 DAC32-F06 11-CG11176-RA_1 CG11176 AGTTCCACTGCCACAAAGTAACAAAGAGAAGACTGAGCCGAACAACCTGCCATTTTGATACCGACGCCC 69 FBan0011176 FBgn0030503 CG11176 X X CG11176 CG11176 CDMC28651 2 8 20 DAC32-F06 11-CG11176-RA_1 CG11176 AGTTCCACTGCCACAAAGTAACAAAGAGAAGACTGAGCCGAACAACCTGCCATTTTGATACCGACGCCC 69 FBan0011176 FBgn0030503 CG11176 X X CG11176 CG11176 CDMC28652 2 9 20 DAC32-F18 23-CG11194-RA_3 CG11194 AGCAGACCAAGTGTGATAGTCTTAAGTTTCGCATCCTACACAGAGAGAAAAAAATGGAGAAACAACGCA 69 FBan0011194 FBgn0027788 Hey 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hey Hairy/E(spl)-related with YRPW motif "CG11194, CG11194, hesr-1, hairy and enhancer of split related-1, dHey, Hesr-1, d-hey, Hairy and enhancer of split related protein, Hairy/E(spl)-related with YRPW motif" CDMC28652 2 10 20 DAC32-F18 23-CG11194-RA_3 CG11194 AGCAGACCAAGTGTGATAGTCTTAAGTTTCGCATCCTACACAGAGAGAAAAAAATGGAGAAACAACGCA 69 FBan0011194 FBgn0027788 Hey 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hey Hairy/E(spl)-related with YRPW motif "CG11194, CG11194, hesr-1, hairy and enhancer of split related-1, dHey, Hesr-1, d-hey, Hairy and enhancer of split related protein, Hairy/E(spl)-related with YRPW motif" CDMC28653 2 11 20 DAC32-J06 22-CG11253-RA_2 CG11253 AAATGGTAAACTTTGTGCACCCCGAGGAAATGTATCTCTTTGTGGAGAGCATTCGTCCATTTGAGGTGC 69 FBan0011253 FBgn0036338 CG11253 3 3L CG11253 CG11253 CDMC28653 2 12 20 DAC32-J06 22-CG11253-RA_2 CG11253 AAATGGTAAACTTTGTGCACCCCGAGGAAATGTATCTCTTTGTGGAGAGCATTCGTCCATTTGAGGTGC 69 FBan0011253 FBgn0036338 CG11253 3 3L CG11253 CG11253 CDMC28654 2 13 20 DAC32-J18 14-CG11261-RA_1 CG11261 CGAGGTAAGCACTTTGCAAATGGCCGTTCTGATGCTATTCAATCGGCATGAACGATTTACGGAGCAGGA 69 FBan0011261 FBgn0036332 CG11261 3 3L induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nuclear ubiquitin ligase complex; GO:0000152 CG11261 CG11261 CUL6 CDMC28654 2 14 20 DAC32-J18 14-CG11261-RA_1 CG11261 CGAGGTAAGCACTTTGCAAATGGCCGTTCTGATGCTATTCAATCGGCATGAACGATTTACGGAGCAGGA 69 FBan0011261 FBgn0036332 CG11261 3 3L induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nuclear ubiquitin ligase complex; GO:0000152 CG11261 CG11261 CUL6 CDMC28655 2 15 20 DAC32-N06 3-CG11291-RA_1 CG11291 TGGTGACGGTATCCGCAAAGATCTGAAAGAGGCCGGATTCTGTTCCGTGGTAAACGATCTGCAGCCAAA 69 FBan0011291 FBgn0034713 CG11291 2 2R metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG11291 CG11291 CDMC28655 2 16 20 DAC32-N06 3-CG11291-RA_1 CG11291 TGGTGACGGTATCCGCAAAGATCTGAAAGAGGCCGGATTCTGTTCCGTGGTAAACGATCTGCAGCCAAA 69 FBan0011291 FBgn0034713 CG11291 2 2R metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG11291 CG11291 CDMC28656 2 17 20 DAC32-N18 2-CG11308-RA_1 CG11308 TCGCCATGCCGAGAATGAGCTGAACACCCAAAACGCCTTAAATCAATACTACCTGAGGTGCAACCCCAA 69 FBgn0037080 CDMC28656 2 18 20 DAC32-N18 2-CG11308-RA_1 CG11308 TCGCCATGCCGAGAATGAGCTGAACACCCAAAACGCCTTAAATCAATACTACCTGAGGTGCAACCCCAA 69 FBgn0037080 CDMC28657 2 19 20 DAC33-B06 2-CG1257-RA_1 CG1257 GCTGCTGGCAATGGAATGGATCAAGGAAAACGCAGAACGATTTAATGGCGATCCCAAGAACGTGACCGC 69 FBan0001257 FBgn0015571 alpha-Est3 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est3 alpha-Esterase-3 "CG1257, alphaE3, B, fragment B, aE3, alpha-Est3, alpha-Ests" CDMC28657 2 20 20 DAC33-B06 2-CG1257-RA_1 CG1257 GCTGCTGGCAATGGAATGGATCAAGGAAAACGCAGAACGATTTAATGGCGATCCCAAGAACGTGACCGC 69 FBan0001257 FBgn0015571 alpha-Est3 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est3 alpha-Esterase-3 "CG1257, alphaE3, B, fragment B, aE3, alpha-Est3, alpha-Ests" CDMC28658 2 21 20 DAC33-B18 3-CG12591-RA_1 CG12591 CCCACAGACTGGGTCACGGGTACACTAGTCTACACCAGTGGCTAATCTTTCTTTTGGTGGCCCTGAACA 69 FBan0012591 FBgn0037295 dpr16 3 3R dpr16 dpr16 "CG12591, CG12591, CG12591, CT34444, Dpr-16" CDMC28658 2 22 20 DAC33-B18 3-CG12591-RA_1 CG12591 CCCACAGACTGGGTCACGGGTACACTAGTCTACACCAGTGGCTAATCTTTCTTTTGGTGGCCCTGAACA 69 FBan0012591 FBgn0037295 dpr16 3 3R dpr16 dpr16 "CG12591, CG12591, CG12591, CT34444, Dpr-16" CDMC28659 2 23 20 DAC33-F06 3-CG12636-RA_3 CG12636 GGGGAACAGGACGCACGATGGCTCGGAGACACCAGAGGTGAGACAAAAAGCGGACTTTATTGACTATGA 69 FBan0012636 FBgn0028854 CG12636 2 2L CG12636 CG12636 BG:DS07721.6 CDMC28659 2 24 20 DAC33-F06 3-CG12636-RA_3 CG12636 GGGGAACAGGACGCACGATGGCTCGGAGACACCAGAGGTGAGACAAAAAGCGGACTTTATTGACTATGA 69 FBan0012636 FBgn0028854 CG12636 2 2L CG12636 CG12636 BG:DS07721.6 CDMC28660 2 25 20 DAC33-F18 14-CG12656-RA_1 CG12656 GGCCAGTGCAAGAAGGACATCTGTCAGTGCTTTTCCTAGGTCTACTTCGACTGTAAGCCAAAACAGCGT 69 FBan0012656 FBgn0031087 CG12656 X X CG12656 CG12656 "BcDNA:RE41492, BcDNA:RH47776" CDMC28660 2 26 20 DAC33-F18 14-CG12656-RA_1 CG12656 GGCCAGTGCAAGAAGGACATCTGTCAGTGCTTTTCCTAGGTCTACTTCGACTGTAAGCCAAAACAGCGT 69 FBan0012656 FBgn0031087 CG12656 X X CG12656 CG12656 "BcDNA:RE41492, BcDNA:RH47776" CDMC28661 2 1 21 DAC33-J06 3-CG12691-RA_1 CG12691 AGGGTCGCGATGAAGAACTCACACCAAAAAGCACTCAGGCGCTAAAGAGGTTAAATGCTGAGCCGCAAG 69 FBan0012691 FBgn0029701 CG12691 X X CG12691 CG12691 CDMC28661 2 2 21 DAC33-J06 3-CG12691-RA_1 CG12691 AGGGTCGCGATGAAGAACTCACACCAAAAAGCACTCAGGCGCTAAAGAGGTTAAATGCTGAGCCGCAAG 69 FBan0012691 FBgn0029701 CG12691 X X CG12691 CG12691 CDMC28662 2 3 21 DAC33-J18 8-CG12702-RA_1 CG12702 TGCAGACCCGGTGCAAGGATCTCAAACAGCAGAAGGTCGAACTGAAGAGCAATATGACAATCCTGCTCA 69 FBan0012702 FBgn0031070 CG12702 X X CG12702 CG12702 CDMC28662 2 4 21 DAC33-J18 8-CG12702-RA_1 CG12702 TGCAGACCCGGTGCAAGGATCTCAAACAGCAGAAGGTCGAACTGAAGAGCAATATGACAATCCTGCTCA 69 FBan0012702 FBgn0031070 CG12702 X X CG12702 CG12702 CDMC28663 2 5 21 DAC33-N06 24-CG12756-RA_1 CG12756 CGCATCTGATAAAGCACTATTTACCTTCAAAGTTTTTAAATTAAAATTTGTACATGAAATAAAGCGAAT 69 FBan0012756 FBgn0035624 Eaf6 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 Eaf6 Eaf6 "CG12756, CG12756, CG12756, dEaf6" CDMC28663 2 6 21 DAC33-N06 24-CG12756-RA_1 CG12756 CGCATCTGATAAAGCACTATTTACCTTCAAAGTTTTTAAATTAAAATTTGTACATGAAATAAAGCGAAT 69 FBan0012756 FBgn0035624 Eaf6 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 Eaf6 Eaf6 "CG12756, CG12756, CG12756, dEaf6" CDMC28664 2 7 21 DAC33-N18 3-CG12767-RA_2 CG12767 TTAGGACGAAATGAGCCGAAAGAACGGAAACCAGGACACCTTTCCCAAGACGGAGAAGATGCAGCGCTA 69 FBan0012767 FBgn0040465 Dip3 2 2R positive regulation of transcription; GO:0045941 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515; ; GO:0003677 nucleus; GO:0005634 Dip3 Dorsal interacting protein 3 "CG12767, CG12767, dip3, anon-WO0118547.169, Dorsal interacting protein 3" CDMC28664 2 8 21 DAC33-N18 3-CG12767-RA_2 CG12767 TTAGGACGAAATGAGCCGAAAGAACGGAAACCAGGACACCTTTCCCAAGACGGAGAAGATGCAGCGCTA 69 FBan0012767 FBgn0040465 Dip3 2 2R positive regulation of transcription; GO:0045941 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515; ; GO:0003677 nucleus; GO:0005634 Dip3 Dorsal interacting protein 3 "CG12767, CG12767, dip3, anon-WO0118547.169, Dorsal interacting protein 3" CDMC28665 2 9 21 DAC34-B06 23-CG4341-RA_3 CG4341 ATGAATTGGCTTCTCGAGATTGTTTTGTCCGTTGTGTGTACATTTTAGTTAAGCGAATAAAGATACCGA 69 FBan0004341 FBgn0028481 CG4341 2 2L CG4341 CG4341 BcDNA:GH12144 CDMC28665 2 10 21 DAC34-B06 23-CG4341-RA_3 CG4341 ATGAATTGGCTTCTCGAGATTGTTTTGTCCGTTGTGTGTACATTTTAGTTAAGCGAATAAAGATACCGA 69 FBan0004341 FBgn0028481 CG4341 2 2L CG4341 CG4341 BcDNA:GH12144 CDMC28666 2 11 21 DAC34-B18 13-CG4353-RA_1 CG4353 CCCAGAGACGCATCTACCGTACGATAGATCAATGAGTAGCGCTGCAAATCATGGTCATGTGATGCTGGT 69 FBan0004353 FBgn0010303 hep X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cable formation; GO:0045011; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, spreading of leading edge cells; GO:0007395; eggshell pattern formation (sensu Insecta); GO:0030381; establishment of planar polarity; GO:0001736; filopodium formation; GO:0046847; imaginal disc fusion, thorax closure; GO:0046529; lamellipodium biogenesis; GO:0030032; micropyle formation; GO:0046844; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; wound healing; GO:0042060" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0005515 hep hemipterous "CG4353, CG2190, CG4353, CG2190, hp, DMKK7, JNKK, l(1)G0107, l(1)G0208, HEP, HEP/MKK7, DHEP/MKK7, MKK7, hem, l(1)7P1" CDMC28666 2 12 21 DAC34-B18 13-CG4353-RA_1 CG4353 CCCAGAGACGCATCTACCGTACGATAGATCAATGAGTAGCGCTGCAAATCATGGTCATGTGATGCTGGT 69 FBan0004353 FBgn0010303 hep X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cable formation; GO:0045011; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, spreading of leading edge cells; GO:0007395; eggshell pattern formation (sensu Insecta); GO:0030381; establishment of planar polarity; GO:0001736; filopodium formation; GO:0046847; imaginal disc fusion, thorax closure; GO:0046529; lamellipodium biogenesis; GO:0030032; micropyle formation; GO:0046844; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357; wound healing; GO:0042060" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase activity; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; ; GO:0004708 ; EC:2.7.1.-; JUN kinase kinase activity; GO:0008545 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004708 ; EC:2.7.1.-; ; GO:0008545 ; EC:2.7.1.-; ; GO:0005515 hep hemipterous "CG4353, CG2190, CG4353, CG2190, hp, DMKK7, JNKK, l(1)G0107, l(1)G0208, HEP, HEP/MKK7, DHEP/MKK7, MKK7, hem, l(1)7P1" CDMC28667 2 13 21 DAC34-F06 38-CG4383-RA_1 CG4383 GCCGAAATCACATAAGGGTTATCCAGCCGATGAACTTCAATGGCCAGAAGCTATATGTTTGCGGGACCA 69 FBgn0034125 CDMC28667 2 14 21 DAC34-F06 38-CG4383-RA_1 CG4383 GCCGAAATCACATAAGGGTTATCCAGCCGATGAACTTCAATGGCCAGAAGCTATATGTTTGCGGGACCA 69 FBgn0034125 CDMC28668 2 15 21 DAC34-F18 23-CG4405-RA_13 CG4405 TGGGCTCTGTTTTTGGTTTACCAGTTGAACATTTTCGAAACGAAATTGAATACGGAAAGGTTTAAGGAG 69 FBan0004405 FBgn0032129 jp 2 2L jp junctophilin "CG4405, CG13115, JP" CDMC28668 2 16 21 DAC34-F18 23-CG4405-RA_13 CG4405 TGGGCTCTGTTTTTGGTTTACCAGTTGAACATTTTCGAAACGAAATTGAATACGGAAAGGTTTAAGGAG 69 FBan0004405 FBgn0032129 jp 2 2L jp junctophilin "CG4405, CG13115, JP" CDMC28669 2 17 21 DAC34-J06 17-CG4437-RA_1 CG4437 GGGCGTACGTCTCCATAGATTGCAACCGGATTATCATATATATGCCCATCGACAATTAAGCCCCACCGA 69 FBan0004437 FBgn0035977 PGRP-LF 3 3L defense response; GO:0006952; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28 integral to plasma membrane; GO:0005887 PGRP-LF Peptidoglycan recognition protein LF "CG4437, CG4437, PGRP-like, PRGP-like, PGRP-LCa, anon-WO0118547.581, Peptidoglycan recognition protein LF" CDMC28669 2 18 21 DAC34-J06 17-CG4437-RA_1 CG4437 GGGCGTACGTCTCCATAGATTGCAACCGGATTATCATATATATGCCCATCGACAATTAAGCCCCACCGA 69 FBan0004437 FBgn0035977 PGRP-LF 3 3L defense response; GO:0006952; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 protein binding; GO:0005515; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0005515; ; GO:0008745 ; EC:3.5.1.28 integral to plasma membrane; GO:0005887 PGRP-LF Peptidoglycan recognition protein LF "CG4437, CG4437, PGRP-like, PRGP-like, PGRP-LCa, anon-WO0118547.581, Peptidoglycan recognition protein LF" CDMC28670 2 19 21 DAC34-J18 23-CG4448-RA_5 CG4448 TTCTTGTGGAATAAAACGAGTTGGTTACAGTGTAATGCCTTTACCTGCATCGTCTACTGGTCACAGCTA 69 FBan0004448 FBgn0039067 CG4448 3 3R transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 CG4448 CG4448 CDMC28670 2 20 21 DAC34-J18 23-CG4448-RA_5 CG4448 TTCTTGTGGAATAAAACGAGTTGGTTACAGTGTAATGCCTTTACCTGCATCGTCTACTGGTCACAGCTA 69 FBan0004448 FBgn0039067 CG4448 3 3R transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 CG4448 CG4448 CDMC28671 2 21 21 DAC34-N06 2-CG4484-RA_2 CG4484 CCCAGGATTTGGAGACCCAGTCGGATTACGATGCTCCCGTCTCCCTTAAGGCCTATCTCAAGAGCATCT 69 FBan0004484 FBgn0035968 CG4484 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 sucrose:hydrogen symporter activity; GO:0008506; ; GO:0008506 CG4484 CG4484 CDMC28671 2 22 21 DAC34-N06 2-CG4484-RA_2 CG4484 CCCAGGATTTGGAGACCCAGTCGGATTACGATGCTCCCGTCTCCCTTAAGGCCTATCTCAAGAGCATCT 69 FBan0004484 FBgn0035968 CG4484 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 sucrose:hydrogen symporter activity; GO:0008506; ; GO:0008506 CG4484 CG4484 CDMC28672 2 23 21 DAC34-N18 5-CG4496-RA_5 CG4496 AGGCACTCACACGATCCACAATTCATTTGCATGATCTGTCACTTGGGAGCACCTTTGGAGCAGGACTCT 69 FBan0004496 FBgn0031894 CG4496 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4496 CG4496 CDMC28672 2 24 21 DAC34-N18 5-CG4496-RA_5 CG4496 AGGCACTCACACGATCCACAATTCATTTGCATGATCTGTCACTTGGGAGCACCTTTGGAGCAGGACTCT 69 FBan0004496 FBgn0031894 CG4496 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4496 CG4496 CDMC28673 2 25 21 DAC35-B06 1-CG8804-RA_1 CG8804 CCCGTTCCACGATTCTACGGTCCGGAATTGGATGCTATACTTCATCGGAGCTGTGATACCAGTCGGCGT 69 FBan0008804 FBgn0016078 wun 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; embryonic pattern specification; GO:0009880; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; germ cell repulsion; GO:0035233; lipid metabolism; GO:0006629; pole cell migration; GO:0007280 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; protein homodimerization activity; GO:0042803; ; GO:0042803 integral to membrane; GO:0016021; plasma membrane; GO:0005886 wun wunen "CG8804, CG8804, CG8804, CG8804, l(2)k16806, Wunen, wunen" CDMC28673 2 26 21 DAC35-B06 1-CG8804-RA_1 CG8804 CCCGTTCCACGATTCTACGGTCCGGAATTGGATGCTATACTTCATCGGAGCTGTGATACCAGTCGGCGT 69 FBan0008804 FBgn0016078 wun 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; embryonic pattern specification; GO:0009880; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; germ cell repulsion; GO:0035233; lipid metabolism; GO:0006629; pole cell migration; GO:0007280 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; protein homodimerization activity; GO:0042803; ; GO:0042803 integral to membrane; GO:0016021; plasma membrane; GO:0005886 wun wunen "CG8804, CG8804, CG8804, CG8804, l(2)k16806, Wunen, wunen" CDMC28674 2 1 22 DAC35-B18 8-CG8811-RB_1 CG8811 TGCACACCCGAGCTGAAGAATAAGCGAGCTTTCCTGTTCAATAAACTGGTGCAATTGATGCCACCGAGC 69 FBan0008811 FBgn0033757 muskelin 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010 muskelin muskelin "CG8811, CG8811, CG8811, DmMK, muskelin" CDMC28674 2 2 22 DAC35-B18 8-CG8811-RB_1 CG8811 TGCACACCCGAGCTGAAGAATAAGCGAGCTTTCCTGTTCAATAAACTGGTGCAATTGATGCCACCGAGC 69 FBan0008811 FBgn0033757 muskelin 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010 muskelin muskelin "CG8811, CG8811, CG8811, DmMK, muskelin" CDMC28675 2 3 22 DAC35-F06 23-CG8840-RA_1 CG8840 GTAAGATTTCTATTTGAACTCTGATCAAGTTCCGTACTTGCAGCTGAATTCTTTGATGGCTTCCATGGA 69 FBan0008840 FBgn0031531 CG8840 2 2L CG8840 CG8840 CDMC28675 2 4 22 DAC35-F06 23-CG8840-RA_1 CG8840 GTAAGATTTCTATTTGAACTCTGATCAAGTTCCGTACTTGCAGCTGAATTCTTTGATGGCTTCCATGGA 69 FBan0008840 FBgn0031531 CG8840 2 2L CG8840 CG8840 CDMC28676 2 5 22 DAC35-F18 17-CG8854-RA_1 CG8854 GATTTGGGTGCTTGGGTTAGGCTAACTACCAACACGTTTGCACCAATCGCGAACAGAAACCTTATTGTT 69 FBan0008854 FBgn0033702 CG8854 2 2R CG8854 CG8854 CDMC28676 2 6 22 DAC35-F18 17-CG8854-RA_1 CG8854 GATTTGGGTGCTTGGGTTAGGCTAACTACCAACACGTTTGCACCAATCGCGAACAGAAACCTTATTGTT 69 FBan0008854 FBgn0033702 CG8854 2 2R CG8854 CG8854 CDMC28677 2 7 22 DAC35-J06 23-CG8893-RA_3 CG8893 GCATCACCTACATACATATGCGCTATGCTCTGAAATGCTACTGTTTTCGCTCTTCAATTACCAGCCACA 69 FBan0008893 FBgn0001092 Gapdh2 X X glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 cytoplasm; GO:0005737 Gapdh2 Glyceraldehyde 3 phosphate dehydrogenase 2 "CG8893, CG8893, CG8893, Gapdh-2, GAPDH, GA3PDH, Gapdh, Gapd, G3-P dehydrogenase, GADPH, GAPDH II, Gapdh13F" CDMC28677 2 8 22 DAC35-J06 23-CG8893-RA_3 CG8893 GCATCACCTACATACATATGCGCTATGCTCTGAAATGCTACTGTTTTCGCTCTTCAATTACCAGCCACA 69 FBan0008893 FBgn0001092 Gapdh2 X X glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 cytoplasm; GO:0005737 Gapdh2 Glyceraldehyde 3 phosphate dehydrogenase 2 "CG8893, CG8893, CG8893, Gapdh-2, GAPDH, GA3PDH, Gapdh, Gapd, G3-P dehydrogenase, GADPH, GAPDH II, Gapdh13F" CDMC28678 2 9 22 DAC35-J18 8-CG8912-RA_3 CG8912 GCAGCAGAAATCGCACAAAAACGACAATCACTGAGGACGTTCGGATGTATCGGAATCGTCGGTAGGGGG 69 FBan0008912 FBgn0014870 Psi 2 2R "mRNA processing; GO:0006397; negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of translation; GO:0006445; spermatogenesis; GO:0007283" single-stranded DNA binding; GO:0003697; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003697 colocalizes_with snRNP U1; GO:0005685 Psi P-element somatic inhibitor "CG8912, PSI, EG:EG0003.2, P-element somatic inhibitor" CDMC28678 2 10 22 DAC35-J18 8-CG8912-RA_3 CG8912 GCAGCAGAAATCGCACAAAAACGACAATCACTGAGGACGTTCGGATGTATCGGAATCGTCGGTAGGGGG 69 FBan0008912 FBgn0014870 Psi 2 2R "mRNA processing; GO:0006397; negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of translation; GO:0006445; spermatogenesis; GO:0007283" single-stranded DNA binding; GO:0003697; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003697 colocalizes_with snRNP U1; GO:0005685 Psi P-element somatic inhibitor "CG8912, PSI, EG:EG0003.2, P-element somatic inhibitor" CDMC28679 2 11 22 DAC35-N06 2-CG8947-RA_1 CG8947 GCACCGGTCACTATGCCACCTTCAATCCCATGCAGGAGTTTATATCCGGAACCGATGAGCATGTGGACA 69 FBan0008947 FBgn0028967 26-29-p 3 3L proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; ; GO:0004216 ; EC:3.4.22.38 26-29-p 26-29kD-proteinase "CG8947, l(3)s3635, 26,29kDa proteinase, 26/29kD-proteinase, 26-29kD-proteinase" CDMC28679 2 12 22 DAC35-N06 2-CG8947-RA_1 CG8947 GCACCGGTCACTATGCCACCTTCAATCCCATGCAGGAGTTTATATCCGGAACCGATGAGCATGTGGACA 69 FBan0008947 FBgn0028967 26-29-p 3 3L proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; ; GO:0004216 ; EC:3.4.22.38 26-29-p 26-29kD-proteinase "CG8947, l(3)s3635, 26,29kDa proteinase, 26/29kD-proteinase, 26-29kD-proteinase" CDMC28680 2 13 22 DAC35-N18 9-CG8960-RA_3 CG8960 ACCAAAGGGAACCACTGACATCCCAGCATGTCAATGACAATGTGCCAATTGAGCCCAGCAAAGCAAAAT 69 FBan0008960 FBgn0035315 CG8960 3 3L CG8960 CG8960 CDMC28680 2 14 22 DAC35-N18 9-CG8960-RA_3 CG8960 ACCAAAGGGAACCACTGACATCCCAGCATGTCAATGACAATGTGCCAATTGAGCCCAGCAAAGCAAAAT 69 FBan0008960 FBgn0035315 CG8960 3 3L CG8960 CG8960 CDMC28681 2 15 22 DAC36-B06 2-CG7037-RA_1 CG7037 TCTTTGACCGGAAGTCGCTCATCAACCATCGTTGGCTATCGCTTCCTCTGTTTTCTCTCCGCCGG 65 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC28681 2 16 22 DAC36-B06 2-CG7037-RA_1 CG7037 TCTTTGACCGGAAGTCGCTCATCAACCATCGTTGGCTATCGCTTCCTCTGTTTTCTCTCCGCCGG 65 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC28682 2 17 22 DAC36-B18 1-CG7066-RA_1 CG7066 CCGTCCTCGCCTCAAGGAGTTGTCCACTCAGTTGTTAAGGGACCTGGATCGATTTCAGAAGCGCG 65 FBan0007066 FBgn0035869 CG7066 3 3L CG7066 CG7066 CDMC28682 2 18 22 DAC36-B18 1-CG7066-RA_1 CG7066 CCGTCCTCGCCTCAAGGAGTTGTCCACTCAGTTGTTAAGGGACCTGGATCGATTTCAGAAGCGCG 65 FBan0007066 FBgn0035869 CG7066 3 3L CG7066 CG7066 CDMC28683 2 19 22 DAC36-F06 23-CG7202-RA_1 CG7202 TTATCAGCACACAACAAAATTTCGGGAATCATGTTCGAATGCATAAGTTTCTTGTTCCTGGCTGC 65 FBan0007202 FBgn0037086 CG7202 3 3L CG7202 CG7202 CDMC28683 2 20 22 DAC36-F06 23-CG7202-RA_1 CG7202 TTATCAGCACACAACAAAATTTCGGGAATCATGTTCGAATGCATAAGTTTCTTGTTCCTGGCTGC 65 FBan0007202 FBgn0037086 CG7202 3 3L CG7202 CG7202 CDMC28684 2 21 22 DAC36-F18 17-CG7231-RC_3 CG7231 TATTCCTCAAACAGTCGGATATGATGAAGGTATGGGGCACAAATCTCACTGCCATTACCTGGGCC 65 FBan0007231 FBgn0031968 CG7231 2 2L CG7231 CG7231 CDMC28684 2 22 22 DAC36-F18 17-CG7231-RC_3 CG7231 TATTCCTCAAACAGTCGGATATGATGAAGGTATGGGGCACAAATCTCACTGCCATTACCTGGGCC 65 FBan0007231 FBgn0031968 CG7231 2 2L CG7231 CG7231 CDMC28685 2 23 22 DAC36-J06 3-CG7311-RA_4 CG7311 GTGACCTCCAGTTGGACACAGGACTTGAAGTTAGACGGAGCCGAATCATGGTGTTGCATGCTGCC 65 FBan0007311 FBgn0028848 CG7311 2 2L electron transport; GO:0006118; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; mitochondrion; GO:0005739 CG7311 CG7311 BG:DS08249.2 CDMC28685 2 24 22 DAC36-J06 3-CG7311-RA_4 CG7311 GTGACCTCCAGTTGGACACAGGACTTGAAGTTAGACGGAGCCGAATCATGGTGTTGCATGCTGCC 65 FBan0007311 FBgn0028848 CG7311 2 2L electron transport; GO:0006118; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; mitochondrion; GO:0005739 CG7311 CG7311 BG:DS08249.2 CDMC28686 2 25 22 DAC36-J18 3-CG7357-RA_4 CG7357 CACTGCTCCGATTGCACATTCGAGTCCATCACAAGGGCGAGAAACCGTACGTCTGCAAGTTCTGC 65 FBan0007357 FBgn0038551 CG7357 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7357 CG7357 CDMC28686 2 26 22 DAC36-J18 3-CG7357-RA_4 CG7357 CACTGCTCCGATTGCACATTCGAGTCCATCACAAGGGCGAGAAACCGTACGTCTGCAAGTTCTGC 65 FBan0007357 FBgn0038551 CG7357 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7357 CG7357 CDMC28687 2 1 23 DAC36-N06 2-CG7431-RA_2 CG7431 ACATCGCGAACGTTCTCCAACCAGACGATAGCCAAGGAGCTCCAAGACATGATGCTCAGCGACAG 65 FBan0007431 FBgn0038542 CG7431 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; tyramine receptor activity; GO:0008226; ; GO:0008227; ; GO:0008226 integral to membrane; GO:0016021 CG7431 CG7431 "DmCG7431, anon-WO0170980.82, anon-WO0170980.83" CDMC28687 2 2 23 DAC36-N06 2-CG7431-RA_2 CG7431 ACATCGCGAACGTTCTCCAACCAGACGATAGCCAAGGAGCTCCAAGACATGATGCTCAGCGACAG 65 FBan0007431 FBgn0038542 CG7431 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; tyramine receptor activity; GO:0008226; ; GO:0008227; ; GO:0008226 integral to membrane; GO:0016021 CG7431 CG7431 "DmCG7431, anon-WO0170980.82, anon-WO0170980.83" CDMC28688 2 3 23 DAC36-N18 4-CG7456-RA_2 CG7456 ATTCGCAGGGCTCTGACAACCCAATCGATAAACGGAACCTGTGCTGTGATCAACAACGTGGCTGC 65 FBan0007456 FBgn0032258 CG7456 2 2L CG7456 CG7456 CDMC28688 2 4 23 DAC36-N18 4-CG7456-RA_2 CG7456 ATTCGCAGGGCTCTGACAACCCAATCGATAAACGGAACCTGTGCTGTGATCAACAACGTGGCTGC 65 FBan0007456 FBgn0032258 CG7456 2 2L CG7456 CG7456 CDMC28689 2 5 23 DAC37-B06 4-CG12874-RA_1 CG12874 AGCCCGCTTCCAGCCAGGTCGTGCTCCATGTCCTGTGTAAGTATGCCACCCACAACCATATTTAA 65 FBan0012874 FBgn0039547 CG12874 3 3R CG12874 CG12874 CDMC28689 2 6 23 DAC37-B06 4-CG12874-RA_1 CG12874 AGCCCGCTTCCAGCCAGGTCGTGCTCCATGTCCTGTGTAAGTATGCCACCCACAACCATATTTAA 65 FBan0012874 FBgn0039547 CG12874 3 3R CG12874 CG12874 CDMC28690 2 7 23 DAC37-B18 5-CG12900-RA_1 CG12900 ACGCACTGGCCTTGCAGGACTACACCCTAAAGGCTTTTAGTGCCGGTCTTGTCTATTACTGGGCG 65 FBan0012900 FBgn0033515 CG12900 2 2R CG12900 CG12900 CDMC28690 2 8 23 DAC37-B18 5-CG12900-RA_1 CG12900 ACGCACTGGCCTTGCAGGACTACACCCTAAAGGCTTTTAGTGCCGGTCTTGTCTATTACTGGGCG 65 FBan0012900 FBgn0033515 CG12900 2 2R CG12900 CG12900 CDMC28691 2 9 23 DAC37-F06 18-CG12986-RA_1 CG12986 GATGTCGGGTGGCCTGTTCGTACCATCGCCTGAGGATATTCCACTTCACCCAGGACGCGACTGCC 65 FBan0012986 FBgn0030868 CG12986 X X CG12986 CG12986 CDMC28691 2 10 23 DAC37-F06 18-CG12986-RA_1 CG12986 GATGTCGGGTGGCCTGTTCGTACCATCGCCTGAGGATATTCCACTTCACCCAGGACGCGACTGCC 65 FBan0012986 FBgn0030868 CG12986 X X CG12986 CG12986 CDMC28692 2 11 23 DAC37-F18 14-CG13018-RA_1 CG13018 CTCCAGGACAACAACGTTCCAGCTGAGTGCCAGGTGCTCCGCAATACCTTCTACGAGTGCAAGCG 65 FBan0013018 FBgn0040751 CG13018 2 2R CG13018 CG13018 CDMC28692 2 12 23 DAC37-F18 14-CG13018-RA_1 CG13018 CTCCAGGACAACAACGTTCCAGCTGAGTGCCAGGTGCTCCGCAATACCTTCTACGAGTGCAAGCG 65 FBan0013018 FBgn0040751 CG13018 2 2R CG13018 CG13018 CDMC28693 2 13 23 DAC37-J06 6-CG13058-RA_4 CG13058 CAGATGCTGCCAAGGATTAAGCCAGTGCGAAACATTAGCTACGCCTCCCTGATCCCAGGACCTCG 65 FBan0013058 FBgn0036610 CG13058 3 3L CG13058 CG13058 CDMC28693 2 14 23 DAC37-J06 6-CG13058-RA_4 CG13058 CAGATGCTGCCAAGGATTAAGCCAGTGCGAAACATTAGCTACGCCTCCCTGATCCCAGGACCTCG 65 FBan0013058 FBgn0036610 CG13058 3 3L CG13058 CG13058 CDMC28694 2 15 23 DAC37-J18 6-CG13069-RA_2 CG13069 GAATACCACGGAAATTTTGCGGCTCCCTACGTGGCATCTCCCTATGTGGCTTCTCCCTACGTGGC 65 FBan0013069 FBgn0040798 CG13069 3 3L CG13069 CG13069 CDMC28694 2 16 23 DAC37-J18 6-CG13069-RA_2 CG13069 GAATACCACGGAAATTTTGCGGCTCCCTACGTGGCATCTCCCTATGTGGCTTCTCCCTACGTGGC 65 FBan0013069 FBgn0040798 CG13069 3 3L CG13069 CG13069 CDMC28695 2 17 23 DAC37-N06 12-CG13144-RA_1 CG13144 ACCGCCCTCGATCTTCACAAAGTCGTTGTCGCCACCAAAGATGACCAAGCTTCAGGAGTTGCAGC 65 FBan0013144 FBgn0032260 CG13144 2 2L CG13144 CG13144 CDMC28695 2 18 23 DAC37-N06 12-CG13144-RA_1 CG13144 ACCGCCCTCGATCTTCACAAAGTCGTTGTCGCCACCAAAGATGACCAAGCTTCAGGAGTTGCAGC 65 FBan0013144 FBgn0032260 CG13144 2 2L CG13144 CG13144 CDMC28696 2 19 23 DAC37-N18 17-CG13165-RA_1 CG13165 AGTTCCCCTTCATCTCGTACTACCTGATCAATACGCTGCAAACGGATCCTTCCAGCTTCTATGCT 65 FBan0013165 FBgn0033707 CG13165 2 2R cellular physiological process; GO:0050875 CG13165 CG13165 CDMC28696 2 20 23 DAC37-N18 17-CG13165-RA_1 CG13165 AGTTCCCCTTCATCTCGTACTACCTGATCAATACGCTGCAAACGGATCCTTCCAGCTTCTATGCT 65 FBan0013165 FBgn0033707 CG13165 2 2R cellular physiological process; GO:0050875 CG13165 CG13165 CDMC28697 2 21 23 DAC38-B06 3-CG32563-RA_1 CG32563 GCCGGCGCATATAAAAGCTGTGATCCCCTCGAAGAATCGGCCAAACAAAATGCAGGTGCTTAATGTGCA 69 FBan0032563 FBgn0052563 CG32563 X X CG32563 CG32563 CG5095 CDMC28697 2 22 23 DAC38-B06 3-CG32563-RA_1 CG32563 GCCGGCGCATATAAAAGCTGTGATCCCCTCGAAGAATCGGCCAAACAAAATGCAGGTGCTTAATGTGCA 69 FBan0032563 FBgn0052563 CG32563 X X CG32563 CG32563 CG5095 CDMC28698 2 23 23 DAC38-B18 2-CG32576-RA_1 CG32576 ACGTTGGAGATGGGTCTCTCGATAGCTATCGCACCCCGTTATCGATCAACGAGCACTACGGTTGCGTTT 69 FBan0032576 FBgn0052576 CG32576 X X vesicle-mediated transport; GO:0016192 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32576 CG32576 "BcDNA:RE29988, anon-AE003501.1, NEST:bs01h05" CDMC28698 2 24 23 DAC38-B18 2-CG32576-RA_1 CG32576 ACGTTGGAGATGGGTCTCTCGATAGCTATCGCACCCCGTTATCGATCAACGAGCACTACGGTTGCGTTT 69 FBan0032576 FBgn0052576 CG32576 X X vesicle-mediated transport; GO:0016192 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32576 CG32576 "BcDNA:RE29988, anon-AE003501.1, NEST:bs01h05" CDMC28699 2 25 23 DAC38-F06 2-CG32602-RA_2 CG32602 GCCAACTGACGGAACAACGCCAGAACGGACTTCTCAGAAGACGACAACCTTGAAGCCAACATCGGAGAA 69 FBan0032602 FBgn0052602 CG32602 X X cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872 CG32602 CG32602 "CG5228, CG5228" CDMC28699 2 26 23 DAC38-F06 2-CG32602-RA_2 CG32602 GCCAACTGACGGAACAACGCCAGAACGGACTTCTCAGAAGACGACAACCTTGAAGCCAACATCGGAGAA 69 FBan0032602 FBgn0052602 CG32602 X X cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872 CG32602 CG32602 "CG5228, CG5228" CDMC28700 2 1 24 DAC38-F18 17-CG32627-RA_1 CG32627 ACATGGGACGAGCATTTTGTGAGACACTTCTGGACTACTGCGATGAGAATCCGAACAAAGTAAAGCGGC 69 FBan0032627 FBgn0052627 CG32627 X X proteolysis; GO:0006508 purine nucleotide binding; GO:0017076; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0017076; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG32627 CG32627 "CG11428, CG11428" CDMC28700 2 2 24 DAC38-F18 17-CG32627-RA_1 CG32627 ACATGGGACGAGCATTTTGTGAGACACTTCTGGACTACTGCGATGAGAATCCGAACAAAGTAAAGCGGC 69 FBan0032627 FBgn0052627 CG32627 X X proteolysis; GO:0006508 purine nucleotide binding; GO:0017076; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0017076; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG32627 CG32627 "CG11428, CG11428" CDMC28701 2 3 24 DAC38-J06 16-CG32651-RA_1 CG32651 CGGCCAATCAAGTTAATGCACTTACTCAAAAAGGCAAGGAAAAGGTGGGCATTACGTTTATCGCCAGGA 69 FBan0032651 FBgn0052651 CG32651 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32651 CG32651 CDMC28701 2 4 24 DAC38-J06 16-CG32651-RA_1 CG32651 CGGCCAATCAAGTTAATGCACTTACTCAAAAAGGCAAGGAAAAGGTGGGCATTACGTTTATCGCCAGGA 69 FBan0032651 FBgn0052651 CG32651 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32651 CG32651 CDMC28702 2 5 24 DAC38-J18 23-CG3265-RB_5 CG3265 TTTTCACTAGCTGACTTTTGTCGTTTTGAGTGTTGTATGTAGTGGATCACAAGAGCCGAACCAACGGTA 69 FBan0003265 FBgn0027066 Eb1 2 2R chromosome segregation; GO:0007059; establishment of mitotic spindle localization; GO:0040001; microtubule-based process; GO:0007017; mitotic spindle assembly; GO:0051227; mitotic spindle elongation; GO:0000022; mitotic spindle organization and biogenesis; GO:0007052; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; receptor binding; GO:0005102; ; GO:0005102 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Eb1 Eb1 "CG3265, CG3265, CG3265, CG3265, CG3265, l(2)04524, clone 2.33, clone 2.52, EB1, l(2)4524, BcDNA.LD08743, dEB-1, dEB1, Dm EB1, dEb1, EB-1, S(DmcycE[JP])2.5, BcDNA:LD08743, anon-EST:Liang-2.33, anon-EST:Liang-2.52" CDMC28702 2 6 24 DAC38-J18 23-CG3265-RB_5 CG3265 TTTTCACTAGCTGACTTTTGTCGTTTTGAGTGTTGTATGTAGTGGATCACAAGAGCCGAACCAACGGTA 69 FBan0003265 FBgn0027066 Eb1 2 2R chromosome segregation; GO:0007059; establishment of mitotic spindle localization; GO:0040001; microtubule-based process; GO:0007017; mitotic spindle assembly; GO:0051227; mitotic spindle elongation; GO:0000022; mitotic spindle organization and biogenesis; GO:0007052; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; receptor binding; GO:0005102; ; GO:0005102 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Eb1 Eb1 "CG3265, CG3265, CG3265, CG3265, CG3265, l(2)04524, clone 2.33, clone 2.52, EB1, l(2)4524, BcDNA.LD08743, dEB-1, dEB1, Dm EB1, dEb1, EB-1, S(DmcycE[JP])2.5, BcDNA:LD08743, anon-EST:Liang-2.33, anon-EST:Liang-2.52" CDMC28703 2 7 24 DAC38-N06 2-CG32698-RA_4 CG32698 GGCGGACCGTTGTCGTATCGCTACCGTTTCCACGAGATCCACATGCACTACGGATTGAACGACCAATTT 69 FBan0032698 FBgn0052698 CG32698 X X one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG32698 CG32698 "CG9678, CG9683" CDMC28703 2 8 24 DAC38-N06 2-CG32698-RA_4 CG32698 GGCGGACCGTTGTCGTATCGCTACCGTTTCCACGAGATCCACATGCACTACGGATTGAACGACCAATTT 69 FBan0032698 FBgn0052698 CG32698 X X one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG32698 CG32698 "CG9678, CG9683" CDMC28704 2 9 24 DAC38-N18 2-CG32703-RA_2 CG32703 TGCGGATGTGCTTAACTATGCGAACGTTAGCACCCACTTGAAAAAGCTGCAGCGGTCAAAGGAGAGTGA 69 FBan0032703 FBgn0052703 CG32703 X X MAPKKK cascade; GO:0000165; anti-apoptosis; GO:0006916; cell proliferation; GO:0008283; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- CG32703 CG32703 "CG17441, CG2309, ERK7" CDMC28704 2 10 24 DAC38-N18 2-CG32703-RA_2 CG32703 TGCGGATGTGCTTAACTATGCGAACGTTAGCACCCACTTGAAAAAGCTGCAGCGGTCAAAGGAGAGTGA 69 FBan0032703 FBgn0052703 CG32703 X X MAPKKK cascade; GO:0000165; anti-apoptosis; GO:0006916; cell proliferation; GO:0008283; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- CG32703 CG32703 "CG17441, CG2309, ERK7" CDMC28705 2 11 24 DAC39-B06 14-CG13656-RA_2 CG13656 TGTGTATCATGCTGACCACATCCGAGAAAAAATGCTACTCACTCTGCCGTTTCTGGATCAGCAGGGGTT 69 FBan0013656 FBgn0039307 CG13656 3 3R CG13656 CG13656 CDMC28705 2 12 24 DAC39-B06 14-CG13656-RA_2 CG13656 TGTGTATCATGCTGACCACATCCGAGAAAAAATGCTACTCACTCTGCCGTTTCTGGATCAGCAGGGGTT 69 FBan0013656 FBgn0039307 CG13656 3 3R CG13656 CG13656 CDMC28706 2 13 24 DAC39-B18 11-CG13664-RA_3 CG13664 GCCGAAACAGGCGACATCAATCTTTCATTGAGGGAAAAGAATGCACCAGTTGAGATTCATCCCGGCACC 69 FBan0013664 FBgn0039295 CG13664 3 3R CG13664 CG13664 CDMC28706 2 14 24 DAC39-B18 11-CG13664-RA_3 CG13664 GCCGAAACAGGCGACATCAATCTTTCATTGAGGGAAAAGAATGCACCAGTTGAGATTCATCCCGGCACC 69 FBan0013664 FBgn0039295 CG13664 3 3R CG13664 CG13664 CDMC28707 2 15 24 DAC39-F06 1-CG13715-RA_1 CG13715 ACGGCAATGGGAATGGAAATGGAAATCGCAAAGCGGGCGGCAAACAAAATGGATACCATGGCGTCAATA 69 FBan0013715 FBgn0035564 CG13715 3 3L CG13715 CG13715 CDMC28707 2 16 24 DAC39-F06 1-CG13715-RA_1 CG13715 ACGGCAATGGGAATGGAAATGGAAATCGCAAAGCGGGCGGCAAACAAAATGGATACCATGGCGTCAATA 69 FBan0013715 FBgn0035564 CG13715 3 3L CG13715 CG13715 CDMC28708 2 17 24 DAC39-F18 15-CG13737-RA_1 CG13737 TCGAGCGTGAGGTTGAAAACCCAGTCATCAGAGGAAAATAAACGTTAACACCGATTTGTGCGGCCAACA 69 FBan0013737 FBgn0036382 CG13737 3 3L CG13737 CG13737 CDMC28708 2 18 24 DAC39-F18 15-CG13737-RA_1 CG13737 TCGAGCGTGAGGTTGAAAACCCAGTCATCAGAGGAAAATAAACGTTAACACCGATTTGTGCGGCCAACA 69 FBan0013737 FBgn0036382 CG13737 3 3L CG13737 CG13737 CDMC28709 2 19 24 DAC39-J06 18-CG13776-RA_4 CG13776 CGGCAGCCACTTTCGGAAACATGCTATTAAGACCAAGTACGGTATTGATCGTGTGGTCGAGGATCTCAT 69 FBan0013776 FBgn0031880 CG13776 2 2L CG13776 CG13776 CDMC28709 2 20 24 DAC39-J06 18-CG13776-RA_4 CG13776 CGGCAGCCACTTTCGGAAACATGCTATTAAGACCAAGTACGGTATTGATCGTGTGGTCGAGGATCTCAT 69 FBan0013776 FBgn0031880 CG13776 2 2L CG13776 CG13776 CDMC28710 2 21 24 DAC39-J18 23-CG13784-RB_2 CG13784 CACAGCTGACTTCCTTTCTTTCCTTCCTGCATTACACTGTTCAACAAACAATAGTTATAACCGCAAACG 69 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC28710 2 22 24 DAC39-J18 23-CG13784-RB_2 CG13784 CACAGCTGACTTCCTTTCTTTCCTTCCTGCATTACACTGTTCAACAAACAATAGTTATAACCGCAAACG 69 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC28711 2 23 24 DAC39-N06 23-CG13826-RA_4 CG13826 TGAAAGGCTTCGGTGTTAATTACTTTATCCAAATGCCAGCACAAATGTTCCCAGTTCAGAACGCAATAT 69 FBan0013826 FBgn0040590 CG13826 3 3R CG13826 CG13826 BcDNA:RE05559 CDMC28711 2 24 24 DAC39-N06 23-CG13826-RA_4 CG13826 TGAAAGGCTTCGGTGTTAATTACTTTATCCAAATGCCAGCACAAATGTTCCCAGTTCAGAACGCAATAT 69 FBan0013826 FBgn0040590 CG13826 3 3R CG13826 CG13826 BcDNA:RE05559 CDMC28712 2 25 24 DAC39-N18 11-CG13843-RA_2 CG13843 GGGGATCGACCATTCCCATCCATTTGCTGAAGCCAACCTTCAAGCATTGTGAGAATATCTACTCCCGCT 69 FBan0013843 FBgn0038993 CG13843 3 3R CG13843 CG13843 CDMC28712 2 26 24 DAC39-N18 11-CG13843-RA_2 CG13843 GGGGATCGACCATTCCCATCCATTTGCTGAAGCCAACCTTCAAGCATTGTGAGAATATCTACTCCCGCT 69 FBan0013843 FBgn0038993 CG13843 3 3R CG13843 CG13843 CDMC28713 2 1 25 DAC40-B06 2-CG14126-RA_2 CG14126 ACAGCCCAAGAGAGCGATAACAGCAAAGTTAATGCCATTAGCCCCAGTCCACAGAACAGTCCCGC 65 FBan0014126 FBgn0036223 CG14126 3 3L CG14126 CG14126 CDMC28713 2 2 25 DAC40-B06 2-CG14126-RA_2 CG14126 ACAGCCCAAGAGAGCGATAACAGCAAAGTTAATGCCATTAGCCCCAGTCCACAGAACAGTCCCGC 65 FBan0014126 FBgn0036223 CG14126 3 3L CG14126 CG14126 CDMC28714 2 3 25 DAC40-B18 14-CG14141-RA_1 CG14141 CAGAGTGGTGCAGACTCTGGCCGAGTGGATCAGTCACCGATCAAACGAGATTCGCACAGCAACGC 65 FBan0014141 FBgn0036146 CG14141 3 3L CG14141 CG14141 "CT33742, BcDNA:RH33338" CDMC28714 2 4 25 DAC40-B18 14-CG14141-RA_1 CG14141 CAGAGTGGTGCAGACTCTGGCCGAGTGGATCAGTCACCGATCAAACGAGATTCGCACAGCAACGC 65 FBan0014141 FBgn0036146 CG14141 3 3L CG14141 CG14141 "CT33742, BcDNA:RH33338" CDMC28715 2 5 25 DAC40-F06 1-CG14218-RA_1 CG14218 CTTCTCCCCCACCAAGTGCTTCGCGATTTTTGGTCAACTACGAGAGCGATGACGACTTTGGGCAG 65 FBan0014218 FBgn0031031 CG14218 X X NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG14218 CG14218 SPH211 CDMC28715 2 6 25 DAC40-F06 1-CG14218-RA_1 CG14218 CTTCTCCCCCACCAAGTGCTTCGCGATTTTTGGTCAACTACGAGAGCGATGACGACTTTGGGCAG 65 FBan0014218 FBgn0031031 CG14218 X X NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG14218 CG14218 SPH211 CDMC28716 2 7 25 DAC40-F18 3-CG14243-RA_1 CG14243 ATGTGTCCAACCTGGCTAAGCAACTGAATGCCCTGAAGACGAGCTCCACCAACAAACCAGAGGTG 65 FBan0014243 FBgn0039444 CG14243 3 3R CG14243 CG14243 CDMC28716 2 8 25 DAC40-F18 3-CG14243-RA_1 CG14243 ATGTGTCCAACCTGGCTAAGCAACTGAATGCCCTGAAGACGAGCTCCACCAACAAACCAGAGGTG 65 FBan0014243 FBgn0039444 CG14243 3 3R CG14243 CG14243 CDMC28717 2 9 25 DAC40-J06 6-CG14307-RC_2 CG14307 ACGATCCAGGCGTTATCGAGGAGGTCGTTGTGGATCACGTTCGTGAGATGGAAGCGGGGAATGAG 65 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC28717 2 10 25 DAC40-J06 6-CG14307-RC_2 CG14307 ACGATCCAGGCGTTATCGAGGAGGTCGTTGTGGATCACGTTCGTGAGATGGAAGCGGGGAATGAG 65 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC28718 2 11 25 DAC40-J18 3-CG14340-RA_2 CG14340 CTACCACCTCACGTTGCAGTTCCAGCACGAGTTGATCAAGAGCCATCGCTTGATCCAACTGGTGC 65 FBan0014340 FBgn0031302 CG14340 2 2L CG14340 CG14340 CDMC28718 2 12 25 DAC40-J18 3-CG14340-RA_2 CG14340 CTACCACCTCACGTTGCAGTTCCAGCACGAGTTGATCAAGAGCCATCGCTTGATCCAACTGGTGC 65 FBan0014340 FBgn0031302 CG14340 2 2L CG14340 CG14340 CDMC28719 2 13 25 DAC40-N06 12-CG14419-RA_1 CG14419 TTGTCTAGTCGAGGGAAACCAAATCAGACGAGAATGCGCGCTTCCATACTGTTTTTCGGCCTGCT 65 FBan0014419 FBgn0029639 CG14419 X X CG14419 CG14419 CDMC28719 2 14 25 DAC40-N06 12-CG14419-RA_1 CG14419 TTGTCTAGTCGAGGGAAACCAAATCAGACGAGAATGCGCGCTTCCATACTGTTTTTCGGCCTGCT 65 FBan0014419 FBgn0029639 CG14419 X X CG14419 CG14419 CDMC28720 2 15 25 DAC40-N18 2-CG14451-RA_2 CG14451 ATCCAGCCATCAGGGATAGTCAGTCCGCCATCACTTTGGGGAGGCATGTGTGCAAAAAAGGCTAC 65 FBan0014451 FBgn0037183 CG14451 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14451 CG14451 CDMC28720 2 16 25 DAC40-N18 2-CG14451-RA_2 CG14451 ATCCAGCCATCAGGGATAGTCAGTCCGCCATCACTTTGGGGAGGCATGTGTGCAAAAAAGGCTAC 65 FBan0014451 FBgn0037183 CG14451 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14451 CG14451 CDMC28721 2 17 25 DAC41-B06 AutoBlank AutoBlank CDMC28721 2 18 25 DAC41-B06 AutoBlank AutoBlank CDMC28722 2 19 25 DAC41-B18 AutoBlank AutoBlank CDMC28722 2 20 25 DAC41-B18 AutoBlank AutoBlank CDMC28723 2 21 25 DAC41-F06 AutoBlank AutoBlank CDMC28723 2 22 25 DAC41-F06 AutoBlank AutoBlank CDMC28724 2 23 25 DAC41-F18 AutoBlank AutoBlank CDMC28724 2 24 25 DAC41-F18 AutoBlank AutoBlank CDMC28725 2 25 25 DAC41-J06 AutoBlank AutoBlank CDMC28725 2 26 25 DAC41-J06 AutoBlank AutoBlank CDMC28726 2 1 26 DAC41-J18 AutoBlank AutoBlank CDMC28726 2 2 26 DAC41-J18 AutoBlank AutoBlank CDMC28727 2 3 26 DAC41-N06 AutoBlank AutoBlank CDMC28727 2 4 26 DAC41-N06 AutoBlank AutoBlank CDMC28728 2 5 26 DAC41-N18 AutoBlank AutoBlank CDMC28728 2 6 26 DAC41-N18 AutoBlank AutoBlank CDMC28729 2 7 26 DAC42-B06 150mM NaPO4 Blank CDMC28729 2 8 26 DAC42-B06 150mM NaPO4 Blank CDMC28730 2 9 26 DAC42-B18 150mM NaPO4 Blank CDMC28730 2 10 26 DAC42-B18 150mM NaPO4 Blank CDMC28731 2 11 26 DAC42-F06 150mM NaPO4 Blank CDMC28731 2 12 26 DAC42-F06 150mM NaPO4 Blank CDMC28732 2 13 26 DAC42-F18 150mM NaPO4 Blank CDMC28732 2 14 26 DAC42-F18 150mM NaPO4 Blank CDMC28733 2 15 26 DAC42-J06 150mM NaPO4 Blank CDMC28733 2 16 26 DAC42-J06 150mM NaPO4 Blank CDMC28734 2 17 26 DAC42-J18 5uM MSP 5uM MSP CDMC28734 2 18 26 DAC42-J18 5uM MSP 5uM MSP CDMC28735 2 19 26 DAC42-N06 10uM MSP 10uM MSP CDMC28735 2 20 26 DAC42-N06 10uM MSP 10uM MSP CDMC28736 2 21 26 DAC42-N18 20uM MSP 20uM MSP CDMC28736 2 22 26 DAC42-N18 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC28737 3 1 1 DAC01-C06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28737 3 2 1 DAC01-C06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC28738 3 3 1 DAC01-C18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28738 3 4 1 DAC01-C18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC28739 3 5 1 DAC01-G06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28739 3 6 1 DAC01-G06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC28740 3 7 1 DAC01-G18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28740 3 8 1 DAC01-G18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC28741 3 9 1 DAC01-K06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28741 3 10 1 DAC01-K06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC28742 3 11 1 DAC01-K18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28742 3 12 1 DAC01-K18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC28743 3 13 1 DAC01-O06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28743 3 14 1 DAC01-O06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC28744 3 15 1 DAC01-O18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28744 3 16 1 DAC01-O18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC28745 3 17 1 DAC02-C06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28745 3 18 1 DAC02-C06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC28746 3 19 1 DAC02-C18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28746 3 20 1 DAC02-C18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC28747 3 21 1 DAC02-G06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28747 3 22 1 DAC02-G06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC28748 3 23 1 DAC02-G18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28748 3 24 1 DAC02-G18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC28749 3 25 1 DAC02-K06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28749 3 26 1 DAC02-K06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC28750 3 1 2 DAC02-K18 N/A CG9075 (01435-01673) CDMC28750 3 2 2 DAC02-K18 N/A CG9075 (01435-01673) CDMC28751 3 3 2 DAC02-O06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28751 3 4 2 DAC02-O06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC28752 3 5 2 DAC02-O18 AutoBlank AutoBlank CDMC28752 3 6 2 DAC02-O18 AutoBlank AutoBlank CDMC28753 3 7 2 DAC03-C06 5-CG32227-RA_1 CG32227 AGCCAGGATGATGCTCGATCCAAAATCTTGCGAAGAAAGGAGCCGAAGTCAAAGGAAGTGGCCGTGTAA 69 FBan0032227 FBgn0052227 CG32227 3 3L CG32227 CG32227 "CG13815, CG13817, CT33316" CDMC28753 3 8 2 DAC03-C06 5-CG32227-RA_1 CG32227 AGCCAGGATGATGCTCGATCCAAAATCTTGCGAAGAAAGGAGCCGAAGTCAAAGGAAGTGGCCGTGTAA 69 FBan0032227 FBgn0052227 CG32227 3 3L CG32227 CG32227 "CG13815, CG13817, CT33316" CDMC28754 3 9 2 DAC03-C18 17-CG32235-RA_2 CG32235 AGCTGAAGGGGAGAATCGCATACATAATGCTACGAGGCAGCATAATCATGAGCCGATTTCACAAGGAGA 69 FBan0032235 FBgn0047330 CG32235 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32235 CG32235 BcDNA:AT25643 CDMC28754 3 10 2 DAC03-C18 17-CG32235-RA_2 CG32235 AGCTGAAGGGGAGAATCGCATACATAATGCTACGAGGCAGCATAATCATGAGCCGATTTCACAAGGAGA 69 FBan0032235 FBgn0047330 CG32235 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32235 CG32235 BcDNA:AT25643 CDMC28755 3 11 2 DAC03-G06 2-CG32261-RA_2 CG32261 GGAACACGAGGAGGTCTGTGAATCGGTGTTCATCCAAATCAGGGAGCACTACGTCAAGATGTGCGAGCT 69 FBan0032261 FBgn0045479 Gr64a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64a Gustatory receptor 64a "CG14986, CG32261, CG14986, LU.3, Gustatory receptor LU.3, Gr64A1, GrLU3, GRLU.3, Gustatory receptor 64a" CDMC28755 3 12 2 DAC03-G06 2-CG32261-RA_2 CG32261 GGAACACGAGGAGGTCTGTGAATCGGTGTTCATCCAAATCAGGGAGCACTACGTCAAGATGTGCGAGCT 69 FBan0032261 FBgn0045479 Gr64a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64a Gustatory receptor 64a "CG14986, CG32261, CG14986, LU.3, Gustatory receptor LU.3, Gr64A1, GrLU3, GRLU.3, Gustatory receptor 64a" CDMC28756 3 13 2 DAC03-G18 23-CG32275-RA_1 CG32275 GGCCACAGAATTTAGAATCAGCAGGTGAAACTTCTTTCGGAATTCCAGCGATTATTGACCGCATTCTGA 69 FBan0032275 FBgn0052275 CG32275 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32275 CG32275 CDMC28756 3 14 2 DAC03-G18 23-CG32275-RA_1 CG32275 GGCCACAGAATTTAGAATCAGCAGGTGAAACTTCTTTCGGAATTCCAGCGATTATTGACCGCATTCTGA 69 FBan0032275 FBgn0052275 CG32275 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32275 CG32275 CDMC28757 3 15 2 DAC03-K06 3-CG32310-RA_1 CG32310 CCCGGTATTCGCAAGCAGCCACAACTGACCACCATGGAGACTTCCTTTAAGTCCAGTGGCTATACAGCT 69 FBan0032310 FBgn0052310 CG32310 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32310 CG32310 CDMC28757 3 16 2 DAC03-K06 3-CG32310-RA_1 CG32310 CCCGGTATTCGCAAGCAGCCACAACTGACCACCATGGAGACTTCCTTTAAGTCCAGTGGCTATACAGCT 69 FBan0032310 FBgn0052310 CG32310 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32310 CG32310 CDMC28758 3 17 2 DAC03-K18 9-CG32320-RA_2 CG32320 CCCGAGGATCCTGAGCCAGAAGACGACCCTGAAGATCGATGCCAAAAATCACCTACAGAATGTCGATGC 69 FBan0032320 FBgn0052320 CG32320 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32320 CG32320 CDMC28758 3 18 2 DAC03-K18 9-CG32320-RA_2 CG32320 CCCGAGGATCCTGAGCCAGAAGACGACCCTGAAGATCGATGCCAAAAATCACCTACAGAATGTCGATGC 69 FBan0032320 FBgn0052320 CG32320 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32320 CG32320 CDMC28759 3 19 2 DAC03-O06 22-CG32372-RA_1 CG32372 GCATTCGGGACAAACGTACGAGGACAGTCTTATGATTTAAGCTTATTTGTTGGGGGCTCAATTTCGCGT 69 FBan0032372 FBgn0052372 CG32372 3 3L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG32372 CG32372 "CG14836, CG7545, F, CT15760, anon-EST:CL1a11" CDMC28759 3 20 2 DAC03-O06 22-CG32372-RA_1 CG32372 GCATTCGGGACAAACGTACGAGGACAGTCTTATGATTTAAGCTTATTTGTTGGGGGCTCAATTTCGCGT 69 FBan0032372 FBgn0052372 CG32372 3 3L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG32372 CG32372 "CG14836, CG7545, F, CT15760, anon-EST:CL1a11" CDMC28760 3 21 2 DAC03-O18 3-CG32388-RA_1 CG32388 TGCCGGAGATCCCAGATGAATCGGGTCCATTTTACGGGCAGCTCATAAAACGGATCGTGCACAGACATT 69 FBan0032388 FBgn0045806 CG32388 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32388 CG32388 "anon-WO0140519.36, BEST:GH26265, BcDNA:GH26265, BcDNA:AT03632" CDMC28760 3 22 2 DAC03-O18 3-CG32388-RA_1 CG32388 TGCCGGAGATCCCAGATGAATCGGGTCCATTTTACGGGCAGCTCATAAAACGGATCGTGCACAGACATT 69 FBan0032388 FBgn0045806 CG32388 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32388 CG32388 "anon-WO0140519.36, BEST:GH26265, BcDNA:GH26265, BcDNA:AT03632" CDMC28761 3 23 2 DAC04-C06 17-CG2947-RA_1 CG2947 GCCGACTTCGTCGATGACGGTTTGGACTAAGGTTTAGAAATGGGGCAGTAGTAAGACTGAAACATGCGT 69 FBan0002947 FBgn0029676 CG2947 X X protein folding; GO:0006457 Hsc70 protein regulator activity; GO:0017078; ; GO:0017078 CG2947 CG2947 "anon-EST:fe1A9, anon-fast-evolving-1A9" CDMC28761 3 24 2 DAC04-C06 17-CG2947-RA_1 CG2947 GCCGACTTCGTCGATGACGGTTTGGACTAAGGTTTAGAAATGGGGCAGTAGTAAGACTGAAACATGCGT 69 FBan0002947 FBgn0029676 CG2947 X X protein folding; GO:0006457 Hsc70 protein regulator activity; GO:0017078; ; GO:0017078 CG2947 CG2947 "anon-EST:fe1A9, anon-fast-evolving-1A9" CDMC28762 3 25 2 DAC04-C18 6-CG2962-RA_1 CG2962 CGGCCCACCGGGATACTAGAACAATTCGCCAATCTATCGGAGGACCTTCCTGCTAACTACATCGACAGC 69 FBan0002962 FBgn0030186 CG2962 X X CG2962 CG2962 CDMC28762 3 26 2 DAC04-C18 6-CG2962-RA_1 CG2962 CGGCCCACCGGGATACTAGAACAATTCGCCAATCTATCGGAGGACCTTCCTGCTAACTACATCGACAGC 69 FBan0002962 FBgn0030186 CG2962 X X CG2962 CG2962 CDMC28763 3 1 3 DAC04-G06 23-CG2998-RA_6 CG2998 CATCTTGCACGTGAATTCTCTGCGAATTTAGCATTTTTAGCGATCTAACATGGACAAACCAGTTGTGTG 69 FBan0002998 FBgn0030136 RpS28b X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS28b Ribosomal protein S28b "CG2998, Ribosomal protein S28b" CDMC28763 3 2 3 DAC04-G06 23-CG2998-RA_6 CG2998 CATCTTGCACGTGAATTCTCTGCGAATTTAGCATTTTTAGCGATCTAACATGGACAAACCAGTTGTGTG 69 FBan0002998 FBgn0030136 RpS28b X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS28b Ribosomal protein S28b "CG2998, Ribosomal protein S28b" CDMC28764 3 3 3 DAC04-G18 2-CG30007-RA_1 CG30007 TGGGGTACCTGCATCGAAGCCAATGTGGGTGATAAGTCATTGGACCAACGAGACACTACCTTCAACGCA 69 FBan0030007 FBgn0050007 CG30007 2 2R CG30007 CG30007 CG12138 CDMC28764 3 4 3 DAC04-G18 2-CG30007-RA_1 CG30007 TGGGGTACCTGCATCGAAGCCAATGTGGGTGATAAGTCATTGGACCAACGAGACACTACCTTCAACGCA 69 FBan0030007 FBgn0050007 CG30007 2 2R CG30007 CG30007 CG12138 CDMC28765 3 5 3 DAC04-K06 1-CG30034-RA_1 CG30034 GGAGTGAAAAGTAGTGCCCCTTTTGATTTGGAGACTACGGACACGTGTCTGCACCCCCATAGCTCCACA 69 FBan0030034 FBgn0050034 CG30034 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30034 CG30034 CDMC28765 3 6 3 DAC04-K06 1-CG30034-RA_1 CG30034 GGAGTGAAAAGTAGTGCCCCTTTTGATTTGGAGACTACGGACACGTGTCTGCACCCCCATAGCTCCACA 69 FBan0030034 FBgn0050034 CG30034 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30034 CG30034 CDMC28766 3 7 3 DAC04-K18 18-CG30044-RA_1 CG30044 GGAGTCCAGTGGTTATGTGTGAGCCTAACAAGCAGTTCACATTAGTTGTATGGCTGCAAACCGAAACCT 69 FBan0030044 FBgn0050044 CG30044 2 2R CG30044 CG30044 "CG13152, CG13153" CDMC28766 3 8 3 DAC04-K18 18-CG30044-RA_1 CG30044 GGAGTCCAGTGGTTATGTGTGAGCCTAACAAGCAGTTCACATTAGTTGTATGGCTGCAAACCGAAACCT 69 FBan0030044 FBgn0050044 CG30044 2 2R CG30044 CG30044 "CG13152, CG13153" CDMC28767 3 9 3 DAC04-O06 3-CG30075-RA_2 CG30075 CGCTCTGTCAGCACGGTCGTGCCCTAAGCGACTTGGGTAAATACCATCCATCCCGTTTGTGCTACATAA 69 FBan0030075 FBgn0050075 CG30075 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30075 CG30075 CDMC28767 3 10 3 DAC04-O06 3-CG30075-RA_2 CG30075 CGCTCTGTCAGCACGGTCGTGCCCTAAGCGACTTGGGTAAATACCATCCATCCCGTTTGTGCTACATAA 69 FBan0030075 FBgn0050075 CG30075 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30075 CG30075 CDMC28768 3 11 3 DAC04-O18 3-CG30083-RA_1 CG30083 TCAGGCCCATTTGCATTATCACGGATCCCACAAAAGTGCCAAATGTCAAAACCTTCAAGGCTGCAGGCT 69 FBan0030083 FBgn0050083 CG30083 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30083 CG30083 CDMC28768 3 12 3 DAC04-O18 3-CG30083-RA_1 CG30083 TCAGGCCCATTTGCATTATCACGGATCCCACAAAAGTGCCAAATGTCAAAACCTTCAAGGCTGCAGGCT 69 FBan0030083 FBgn0050083 CG30083 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30083 CG30083 CDMC28769 3 13 3 DAC05-C06 8-CG18340-RA_1 CG18340 GCAACTGCCAGCGTACTAACGAATCCCACCGAGCTGATTAAGATCCAAATGCAAATGGAGGGACAGCG 68 FBan0018340 FBgn0031758 Ucp4B 2 2L mitochondrial transport; GO:0006839; proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4B Ucp4B "CG18340, CG18340, DmUCP4B, dmUCP4b" CDMC28769 3 14 3 DAC05-C06 8-CG18340-RA_1 CG18340 GCAACTGCCAGCGTACTAACGAATCCCACCGAGCTGATTAAGATCCAAATGCAAATGGAGGGACAGCG 68 FBan0018340 FBgn0031758 Ucp4B 2 2L mitochondrial transport; GO:0006839; proton transport; GO:0015992 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ucp4B Ucp4B "CG18340, CG18340, DmUCP4B, dmUCP4b" CDMC28770 3 15 3 DAC05-C18 3-CG18808-RA_2 CG18808 ACAAAGAAGTGGCGGAAAGGCTGTGCGTAAAACCCATCGAGCTGGCTTTTGATAGGTGTCAGTCCAGG 68 FBan0018808 FBgn0042131 CG18808 3 3L carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18808 CG18808 CDMC28770 3 16 3 DAC05-C18 3-CG18808-RA_2 CG18808 ACAAAGAAGTGGCGGAAAGGCTGTGCGTAAAACCCATCGAGCTGGCTTTTGATAGGTGTCAGTCCAGG 68 FBan0018808 FBgn0042131 CG18808 3 3L carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18808 CG18808 CDMC28771 3 17 3 DAC05-G06 8-CG2656-RA_3 CG2656 GCTGACCATCGGGACTGGTTTTGGCGAGAAATACGCAAAGCTTACGCAGGCTATTGGCGCGCTAATTG 68 FBan0002656 FBgn0037478 CG2656 3 3R ATP binding; GO:0005524; purine nucleotide binding; GO:0017076; ; GO:0005524; ; GO:0017076 CG2656 CG2656 NEST:bs33f03 CDMC28771 3 18 3 DAC05-G06 8-CG2656-RA_3 CG2656 GCTGACCATCGGGACTGGTTTTGGCGAGAAATACGCAAAGCTTACGCAGGCTATTGGCGCGCTAATTG 68 FBan0002656 FBgn0037478 CG2656 3 3R ATP binding; GO:0005524; purine nucleotide binding; GO:0017076; ; GO:0005524; ; GO:0017076 CG2656 CG2656 NEST:bs33f03 CDMC28772 3 19 3 DAC05-G18 2-CG2913-RA_1 CG2913 AGAGCCCGATATGACCCACCTGCGAATATACAATGGCATGCCCTGTCGCTATGAGATCTCGAGTGCAG 68 FBan0002913 FBgn0015565 yin X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427; ; GO:0005427; ; GO:0005427 integral to plasma membrane; GO:0005887 yin yin "CG2913, CG2913, opt1, oligopeptide transporter 1, opt, EG:EG0002.1" CDMC28772 3 20 3 DAC05-G18 2-CG2913-RA_1 CG2913 AGAGCCCGATATGACCCACCTGCGAATATACAATGGCATGCCCTGTCGCTATGAGATCTCGAGTGCAG 68 FBan0002913 FBgn0015565 yin X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427; ; GO:0005427; ; GO:0005427 integral to plasma membrane; GO:0005887 yin yin "CG2913, CG2913, opt1, oligopeptide transporter 1, opt, EG:EG0002.1" CDMC28773 3 21 3 DAC05-K06 2-CG30467-RA_1 CG30467 CCGCCATGTTGATACAGCTGATGCGACTCTTTCAGTACATCATGGCCCATGTGCTTAGCGGCAAGGAG 68 FBan0030467 FBgn0050467 CG30467 2 2R CG30467 CG30467 "CG8185, CG8185" CDMC28773 3 22 3 DAC05-K06 2-CG30467-RA_1 CG30467 CCGCCATGTTGATACAGCTGATGCGACTCTTTCAGTACATCATGGCCCATGTGCTTAGCGGCAAGGAG 68 FBan0030467 FBgn0050467 CG30467 2 2R CG30467 CG30467 "CG8185, CG8185" CDMC28774 3 23 3 DAC05-K18 2-CG31038-RA_1 CG31038 GCAGCAGTTCTCGAAGTGCCCCCACAAAGAATCCCGTTGCGAAGCCTAGATTATCTGCTGCTTACCTC 68 FBan0031038 FBgn0051038 CG31038 3 3R CG31038 CG31038 "CG15512, CG7854" CDMC28774 3 24 3 DAC05-K18 2-CG31038-RA_1 CG31038 GCAGCAGTTCTCGAAGTGCCCCCACAAAGAATCCCGTTGCGAAGCCTAGATTATCTGCTGCTTACCTC 68 FBan0031038 FBgn0051038 CG31038 3 3R CG31038 CG31038 "CG15512, CG7854" CDMC28775 3 25 3 DAC05-O06 13-CG31446-RA_3 CG31446 TGCTGATCGATACCACATATGCCGTATCTCCCGATTACCCGTGGGTGAATCAAACCATGAACGCAACC 68 FBan0031446 FBgn0051446 CG31446 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31446 CG31446 BcDNA:RE40372 CDMC28775 3 26 3 DAC05-O06 13-CG31446-RA_3 CG31446 TGCTGATCGATACCACATATGCCGTATCTCCCGATTACCCGTGGGTGAATCAAACCATGAACGCAACC 68 FBan0031446 FBgn0051446 CG31446 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31446 CG31446 BcDNA:RE40372 CDMC28776 3 1 4 DAC05-O18 3-CG31663-RA_1 CG31663 GCAGCAGGATGATGAAAAATCCGATGCCACTTGATGGACTGCCAACCCAATTCTCTGACCTGCCACAC 68 FBan0031663 FBgn0051663 CG31663 2 2L CG31663 CG31663 "CG15359, CG15360, BcDNA:GH27779" CDMC28776 3 2 4 DAC05-O18 3-CG31663-RA_1 CG31663 GCAGCAGGATGATGAAAAATCCGATGCCACTTGATGGACTGCCAACCCAATTCTCTGACCTGCCACAC 68 FBan0031663 FBgn0051663 CG31663 2 2L CG31663 CG31663 "CG15359, CG15360, BcDNA:GH27779" CDMC28777 3 3 4 DAC06-C06 2-CG5250-RA_1 CG5250 CAGGCGCATCATCAGTGTTCGGTTGAGCAACATTCCGATCAACGAGGACATCCAAATCCACTGCAAGGC 69 FBan0005250 FBgn0038691 CG5250 3 3R potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" sodium:potassium-exchanging ATPase complex; GO:0005890 CG5250 CG5250 CDMC28777 3 4 4 DAC06-C06 2-CG5250-RA_1 CG5250 CAGGCGCATCATCAGTGTTCGGTTGAGCAACATTCCGATCAACGAGGACATCCAAATCCACTGCAAGGC 69 FBan0005250 FBgn0038691 CG5250 3 3R potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" sodium:potassium-exchanging ATPase complex; GO:0005890 CG5250 CG5250 CDMC28778 3 5 4 DAC06-C18 3-CG5266-RA_1 CG5266 ACGACGCTGTTCACACCGCCATCCTTACGCTGAAAGAAGGTTTTGAGGGAAAAATGACTGCCGACAACA 69 FBan0005266 FBgn0010405 Pros25 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros25 Proteasome 25kD subunit "CG5266, CG5266, PROS Dm25, alpha2_dm, PRC3, PROS-Dm25g, 20S proteasome, Proteosome, dalpha2, 20s proteasome, Proteasome subunit alpha-type 2" CDMC28778 3 6 4 DAC06-C18 3-CG5266-RA_1 CG5266 ACGACGCTGTTCACACCGCCATCCTTACGCTGAAAGAAGGTTTTGAGGGAAAAATGACTGCCGACAACA 69 FBan0005266 FBgn0010405 Pros25 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros25 Proteasome 25kD subunit "CG5266, CG5266, PROS Dm25, alpha2_dm, PRC3, PROS-Dm25g, 20S proteasome, Proteosome, dalpha2, 20s proteasome, Proteasome subunit alpha-type 2" CDMC28779 3 7 4 DAC06-G06 8-CG5313-RA_1 CG5313 TGGGCTATCCGTTGAGGCAGGATATTGAACAGATATTGAAGGCCTTGCTATCCGGCAGTAGCTTGGAGG 69 FBan0005313 FBgn0032244 RfC3 2 2L DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663 RfC3 RfC3 CG5313 CDMC28779 3 8 4 DAC06-G06 8-CG5313-RA_1 CG5313 TGGGCTATCCGTTGAGGCAGGATATTGAACAGATATTGAAGGCCTTGCTATCCGGCAGTAGCTTGGAGG 69 FBan0005313 FBgn0032244 RfC3 2 2L DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663 RfC3 RfC3 CG5313 CDMC28780 3 9 4 DAC06-G18 2-CG5322-RA_1 CG5322 GGCACCGGTTCCATTCCTTCCTCCGTTGAATATTACCATGCTCCTCACAATCCCTTGACGGCCAATTCA 69 FBan0005322 FBgn0032253 CG5322 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG5322 CG5322 CDMC28780 3 10 4 DAC06-G18 2-CG5322-RA_1 CG5322 GGCACCGGTTCCATTCCTTCCTCCGTTGAATATTACCATGCTCCTCACAATCCCTTGACGGCCAATTCA 69 FBan0005322 FBgn0032253 CG5322 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG5322 CG5322 CDMC28781 3 11 4 DAC06-K06 16-CG5359-RA_3 CG5359 CCAAGTCGCGATCGACGATGAAAAACAGAAACGGATGATTCACAGAGATCTGAATGGGCTTCGATTGGG 69 FBan0005359 FBgn0037773 CG5359 3 3R CG5359 CG5359 BcDNA:RE37471 CDMC28781 3 12 4 DAC06-K06 16-CG5359-RA_3 CG5359 CCAAGTCGCGATCGACGATGAAAAACAGAAACGGATGATTCACAGAGATCTGAATGGGCTTCGATTGGG 69 FBan0005359 FBgn0037773 CG5359 3 3R CG5359 CG5359 BcDNA:RE37471 CDMC28782 3 13 4 DAC06-K18 15-CG5375-RA_3 CG5375 AGTCCGAACCTAAATCAGGCTGAAATACCCAACATGAGCAGCTTGGAAATCGGTGGAAGTGGAAGCCAG 69 FBan0005375 FBgn0032221 CG5375 2 2L CG5375 CG5375 CDMC28782 3 14 4 DAC06-K18 15-CG5375-RA_3 CG5375 AGTCCGAACCTAAATCAGGCTGAAATACCCAACATGAGCAGCTTGGAAATCGGTGGAAGTGGAAGCCAG 69 FBan0005375 FBgn0032221 CG5375 2 2L CG5375 CG5375 CDMC28783 3 15 4 DAC06-O06 9-CG5405-RA_4 CG5405 TCTGCCACAGCATGCACAGCAATTGGGTGATATGTTCAATGGACTGACTGTTAGTTTCGCCACCAAGGA 69 FBan0005405 FBgn0020647 KrT95D 3 3R protein targeting to Golgi; GO:0000042 KrT95D Krueppel target at 95D "CG5405, CG5405" CDMC28783 3 16 4 DAC06-O06 9-CG5405-RA_4 CG5405 TCTGCCACAGCATGCACAGCAATTGGGTGATATGTTCAATGGACTGACTGTTAGTTTCGCCACCAAGGA 69 FBan0005405 FBgn0020647 KrT95D 3 3R protein targeting to Golgi; GO:0000042 KrT95D Krueppel target at 95D "CG5405, CG5405" CDMC28784 3 17 4 DAC06-O18 16-CG5418-RA_1 CG5418 GCCGTGAATGCCATGTATCGGCTAGTGTGTCAATATCCAAAACAAGTTGACTTTCTACTTTGCGGGCCA 69 FBan0005418 FBgn0032436 CG5418 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5418 CG5418 CDMC28784 3 18 4 DAC06-O18 16-CG5418-RA_1 CG5418 GCCGTGAATGCCATGTATCGGCTAGTGTGTCAATATCCAAAACAAGTTGACTTTCTACTTTGCGGGCCA 69 FBan0005418 FBgn0032436 CG5418 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5418 CG5418 CDMC28785 3 19 4 DAC07-C06 1-CG9807-RA_1 CG9807 ATGGCGCAGGGGTTCAACTATGCCCATCGTCAGTCAATCTGCTTTGAAGAGGTTTCCGCCAAGAG 65 FBan0009807 FBgn0030221 CG9807 X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160; vesicle-mediated transport; GO:0016192" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG9807 CG9807 CDMC28785 3 20 4 DAC07-C06 1-CG9807-RA_1 CG9807 ATGGCGCAGGGGTTCAACTATGCCCATCGTCAGTCAATCTGCTTTGAAGAGGTTTCCGCCAAGAG 65 FBan0009807 FBgn0030221 CG9807 X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160; vesicle-mediated transport; GO:0016192" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG9807 CG9807 CDMC28786 3 21 4 DAC07-C18 6-CG9861-RA_2 CG9861 CCAGATGGACAAGTTGCTAAAGGATGGCATGCGAGTACTCAGGAAGGAGCCCCGCTATGTGCTGG 65 FBan0009861 FBgn0034844 CG9861 2 2R CG9861 CG9861 CDMC28786 3 22 4 DAC07-C18 6-CG9861-RA_2 CG9861 CCAGATGGACAAGTTGCTAAAGGATGGCATGCGAGTACTCAGGAAGGAGCCCCGCTATGTGCTGG 65 FBan0009861 FBgn0034844 CG9861 2 2R CG9861 CG9861 CDMC28787 3 23 4 DAC07-G06 13-CG9972-RA_1 CG9972 ATCTTCTGGCGGTCACTTGTACATCAATCAGAGTGACAAGTCGACTCCCTACAATGCCACGCTCT 65 FBan0009972 FBgn0035379 CG9972 3 3L CG9972 CG9972 CDMC28787 3 24 4 DAC07-G06 13-CG9972-RA_1 CG9972 ATCTTCTGGCGGTCACTTGTACATCAATCAGAGTGACAAGTCGACTCCCTACAATGCCACGCTCT 65 FBan0009972 FBgn0035379 CG9972 3 3L CG9972 CG9972 CDMC28788 3 25 4 DAC07-G18 20-CR30024-RA_1 CR30024 CGGGGTGCGGACTTCAAATCCGTAGTCGATTTGCGTCGAAGTGGTTCGATTCCACCTGGGGGGCG 65 FBan0030024 FBgn0011987 tRNA:SeC 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:SeC transfer RNA:SeCys "tRNA[[Ser]Sec], Selenocysteine tRNA, Sec tRNA[[Ser]Sec], SeCys-tRNA, AE002787.trna26-SeC(e)TCA, tRNA:SeCys, CR30024, CR30256, tRNA:SeC:TCA:AE002787" CDMC28788 3 26 4 DAC07-G18 20-CR30024-RA_1 CR30024 CGGGGTGCGGACTTCAAATCCGTAGTCGATTTGCGTCGAAGTGGTTCGATTCCACCTGGGGGGCG 65 FBan0030024 FBgn0011987 tRNA:SeC 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:SeC transfer RNA:SeCys "tRNA[[Ser]Sec], Selenocysteine tRNA, Sec tRNA[[Ser]Sec], SeCys-tRNA, AE002787.trna26-SeC(e)TCA, tRNA:SeCys, CR30024, CR30256, tRNA:SeC:TCA:AE002787" CDMC28789 3 1 5 DAC07-K06 22-CR31940-RA_1 CR31940 TGGTGTAATGGTTAGCACTCAGGACTCTGAATCCTGCGATCCGAGTTCAAATCTCGGTAGAACCT 65 FBan0031940 FBgn0051940 CR31940 2 2L CR31940 CR31940 "AE002638.trna5-GlnCTG, tRNA:Q:CTG:AE002638-b" CDMC28789 3 2 5 DAC07-K06 22-CR31940-RA_1 CR31940 TGGTGTAATGGTTAGCACTCAGGACTCTGAATCCTGCGATCCGAGTTCAAATCTCGGTAGAACCT 65 FBan0031940 FBgn0051940 CR31940 2 2L CR31940 CR31940 "AE002638.trna5-GlnCTG, tRNA:Q:CTG:AE002638-b" CDMC28790 3 3 5 DAC07-K18 3-CR32777-RA_2 CR32777 CAGGTGTAACAAAGCCTATGAAATCCGGTCCAACCCCACATCAGGCCATAGCCAAGAAGCTCCGC 65 FBan0032777 FBgn0019661 roX1 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX1 RNA on the X 1 "yang, roX, rox1, BcDNA:GH10432, CR32777, EG:EG0002.2, RNA on the X 1" CDMC28790 3 4 5 DAC07-K18 3-CR32777-RA_2 CR32777 CAGGTGTAACAAAGCCTATGAAATCCGGTCCAACCCCACATCAGGCCATAGCCAAGAAGCTCCGC 65 FBan0032777 FBgn0019661 roX1 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX1 RNA on the X 1 "yang, roX, rox1, BcDNA:GH10432, CR32777, EG:EG0002.2, RNA on the X 1" CDMC28791 3 5 5 DAC07-O06 23-CR32998-RA_1 CR32998 CAAGCAATGAAGTTCCAACTGAGCTGCGATTATTGCTAGTTGAAAACTAAAACCAATATCTCGCC 65 FBan0032998 FBgn0041719 snRNA:U4:25F 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U4; GO:0005687 snRNA:U4:25F snRNA:U4:25F "dU4, U4-2, U4, K3, U4 small nuclear RNA, U4-25F, snRNA:U4, U4snRNA, CR32998, small nuclear RNA U4" CDMC28791 3 6 5 DAC07-O06 23-CR32998-RA_1 CR32998 CAAGCAATGAAGTTCCAACTGAGCTGCGATTATTGCTAGTTGAAAACTAAAACCAATATCTCGCC 65 FBan0032998 FBgn0041719 snRNA:U4:25F 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U4; GO:0005687 snRNA:U4:25F snRNA:U4:25F "dU4, U4-2, U4, K3, U4 small nuclear RNA, U4-25F, snRNA:U4, U4snRNA, CR32998, small nuclear RNA U4" CDMC28792 3 7 5 DAC07-O18 3-CR33363-RA_1 CR33363 GTTCTCGTCCGATCACCGAAATTAAGCAGCGTCGGGCGCGGTTAGTACTTAGATGGGGGGCTTAG 65 FBan0033363 FBgn0053363 5SrRNA-Psi:CR33363 2 2R 5SrRNA-Psi:CR33363 5SrRNA-Psi:CR33363 CR33363 CDMC28792 3 8 5 DAC07-O18 3-CR33363-RA_1 CR33363 GTTCTCGTCCGATCACCGAAATTAAGCAGCGTCGGGCGCGGTTAGTACTTAGATGGGGGGCTTAG 65 FBan0033363 FBgn0053363 5SrRNA-Psi:CR33363 2 2R 5SrRNA-Psi:CR33363 5SrRNA-Psi:CR33363 CR33363 CDMC28793 3 9 5 DAC08-C06 7-CG5618-RA_1 CG5618 CCGTGTTTAGCTTGATCGAAACTGAGGTGATCGCGACCATCTGCAAGTTAGCGGGATACAAGGAAGGCG 69 FBan0005618 FBgn0036975 CG5618 3 3L amino acid metabolism; GO:0006520; proteolysis; GO:0006508; sulfur metabolism; GO:0006790; synaptic transmission; GO:0007268 sulfinoalanine decarboxylase activity; GO:0004782 ; EC:4.1.1.29; dipeptidyl-peptidase III activity; GO:0017039 ; EC:3.4.14.4; ; GO:0004782 ; EC:4.1.1.29; ; GO:0017039 ; EC:3.4.14.4 cytoplasm; GO:0005737 CG5618 CG5618 CDMC28793 3 10 5 DAC08-C06 7-CG5618-RA_1 CG5618 CCGTGTTTAGCTTGATCGAAACTGAGGTGATCGCGACCATCTGCAAGTTAGCGGGATACAAGGAAGGCG 69 FBan0005618 FBgn0036975 CG5618 3 3L amino acid metabolism; GO:0006520; proteolysis; GO:0006508; sulfur metabolism; GO:0006790; synaptic transmission; GO:0007268 sulfinoalanine decarboxylase activity; GO:0004782 ; EC:4.1.1.29; dipeptidyl-peptidase III activity; GO:0017039 ; EC:3.4.14.4; ; GO:0004782 ; EC:4.1.1.29; ; GO:0017039 ; EC:3.4.14.4 cytoplasm; GO:0005737 CG5618 CG5618 CDMC28794 3 11 5 DAC08-C18 23-CG5630-RA_7 CG5630 TTAAAATAGTGAACGGTGTCATGCAAGAAGATCATCCGGTTATCATGTACAAGGAGGACTTCGTCAGCG 69 FBan0005630 FBgn0038842 CG5630 3 3R CG5630 CG5630 CDMC28794 3 12 5 DAC08-C18 23-CG5630-RA_7 CG5630 TTAAAATAGTGAACGGTGTCATGCAAGAAGATCATCCGGTTATCATGTACAAGGAGGACTTCGTCAGCG 69 FBan0005630 FBgn0038842 CG5630 3 3R CG5630 CG5630 CDMC28795 3 13 5 DAC08-G06 8-CG5669-RA_1 CG5669 ATGACGAGGATCCAGAACTAGACAGTGGCGATGAAGTGAAGATGACAATTGCGGTCAGTGAGCCTGGCG 69 FBan0005669 FBgn0039169 CG5669 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5669 CG5669 CDMC28795 3 14 5 DAC08-G06 8-CG5669-RA_1 CG5669 ATGACGAGGATCCAGAACTAGACAGTGGCGATGAAGTGAAGATGACAATTGCGGTCAGTGAGCCTGGCG 69 FBan0005669 FBgn0039169 CG5669 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5669 CG5669 CDMC28796 3 15 5 DAC08-G18 22-CG5675-RA_1 CG5675 ACGCATTGTCCCGAAAATACCAACCTTCCCAAATTCCCTCGCATCCATTAGCTTAAGCATTCGATTGAA 69 FBan0005675 FBgn0026313 X11L X X establishment and/or maintenance of cell polarity; GO:0007163; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; protein binding; GO:0005515; ; GO:0004812 ; EC:6.1.1.-; ; GO:0005515 X11L X11L "CG5675, CG5678, CG5675, CG5678, dX11L, MINT, Mint, X11, Dmint" CDMC28796 3 16 5 DAC08-G18 22-CG5675-RA_1 CG5675 ACGCATTGTCCCGAAAATACCAACCTTCCCAAATTCCCTCGCATCCATTAGCTTAAGCATTCGATTGAA 69 FBan0005675 FBgn0026313 X11L X X establishment and/or maintenance of cell polarity; GO:0007163; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; protein binding; GO:0005515; ; GO:0004812 ; EC:6.1.1.-; ; GO:0005515 X11L X11L "CG5675, CG5678, CG5675, CG5678, dX11L, MINT, Mint, X11, Dmint" CDMC28797 3 17 5 DAC08-K06 12-CG5709-RA_1 CG5709 ACCGCCTAAGCAGATCGGCTCATCGGTTAGACCCTAAGTTTTAAACCTTGTATTAGCCCCGCGTGAACA 69 FBan0005709 FBgn0025186 ari-2 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 ari-2 ariadne 2 "CG5709, CG5709, l(2)07768, ari2, ariadne-2" CDMC28797 3 18 5 DAC08-K06 12-CG5709-RA_1 CG5709 ACCGCCTAAGCAGATCGGCTCATCGGTTAGACCCTAAGTTTTAAACCTTGTATTAGCCCCGCGTGAACA 69 FBan0005709 FBgn0025186 ari-2 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 ari-2 ariadne 2 "CG5709, CG5709, l(2)07768, ari2, ariadne-2" CDMC28798 3 19 5 DAC08-K18 16-CG5719-RA_1 CG5719 TGGACGAGGATCCTTGACAGCTGAGAACTTCGTATCCTATGTACGTTACGAATTCATGGCCCGTGAGAT 69 FBgn0034316 CDMC28798 3 20 5 DAC08-K18 16-CG5719-RA_1 CG5719 TGGACGAGGATCCTTGACAGCTGAGAACTTCGTATCCTATGTACGTTACGAATTCATGGCCCGTGAGAT 69 FBgn0034316 CDMC28799 3 21 5 DAC08-O06 1-CG5755-RA_1 CG5755 TCCCGCACAGTACAGCCCTACAATTTCGATTCCCTCTCCTGCAACAAGAGCTCTACGACAAAATCGCCA 69 FBan0005755 FBgn0032664 CG5755 2 2L transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG5755 CG5755 anon-WO0140519.163 CDMC28799 3 22 5 DAC08-O06 1-CG5755-RA_1 CG5755 TCCCGCACAGTACAGCCCTACAATTTCGATTCCCTCTCCTGCAACAAGAGCTCTACGACAAAATCGCCA 69 FBan0005755 FBgn0032664 CG5755 2 2L transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG5755 CG5755 anon-WO0140519.163 CDMC28800 3 23 5 DAC08-O18 8-CG5768-RA_2 CG5768 AGCATGGGCTATAATGGACGTGACTGCATCTTGAGAACCCTCTGCGAAAGTCGTCAATACTTCCAGCGC 69 FBan0005768 FBgn0039198 CG5768 3 3R CG5768 CG5768 CDMC28800 3 24 5 DAC08-O18 8-CG5768-RA_2 CG5768 AGCATGGGCTATAATGGACGTGACTGCATCTTGAGAACCCTCTGCGAAAGTCGTCAATACTTCCAGCGC 69 FBan0005768 FBgn0039198 CG5768 3 3R CG5768 CG5768 CDMC28801 3 25 5 DAC09-C07 1-CG31495-RA_1 CG31495 TCTCCATTGGCATCAAACGGTTGCTTGACTTGATTGCGTGGGTGAATTCCCTAAATCCCGACCGTCG 67 FBan0031495 FBgn0051495 CG31495 3 3R CG31495 CG31495 CG9931 CDMC28801 3 26 5 DAC09-C07 1-CG31495-RA_1 CG31495 TCTCCATTGGCATCAAACGGTTGCTTGACTTGATTGCGTGGGTGAATTCCCTAAATCCCGACCGTCG 67 FBan0031495 FBgn0051495 CG31495 3 3R CG31495 CG31495 CG9931 CDMC28802 3 1 6 DAC09-C19 3-CG31796-RA_1 CG31796 GCACATCAAAGGCAATTCCCAAGGCGGTAAAGAGTTTTCGGCTGACTCTCGCTCATTTGCGTGCGAT 67 FBan0031796 FBgn0051796 CG31796 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31796 CG31796 CDMC28802 3 2 6 DAC09-C19 3-CG31796-RA_1 CG31796 GCACATCAAAGGCAATTCCCAAGGCGGTAAAGAGTTTTCGGCTGACTCTCGCTCATTTGCGTGCGAT 67 FBan0031796 FBgn0051796 CG31796 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31796 CG31796 CDMC28803 3 3 6 DAC09-G07 3-CG32154-RA_1 CG32154 TGGCGCATTCTCGCATGGGTATCGATTTGTCCCAAATCTTTGGCAGTCGGTTTGTTGACTTCTGCCG 67 FBan0032154 FBgn0052154 CG32154 3 3L proteolysis; GO:0006508 gamma-glutamyl hydrolase activity; GO:0008464 ; EC:3.4.19.9; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0008464 ; EC:3.4.19.9 CG32154 CG32154 CG5082 CDMC28803 3 4 6 DAC09-G07 3-CG32154-RA_1 CG32154 TGGCGCATTCTCGCATGGGTATCGATTTGTCCCAAATCTTTGGCAGTCGGTTTGTTGACTTCTGCCG 67 FBan0032154 FBgn0052154 CG32154 3 3L proteolysis; GO:0006508 gamma-glutamyl hydrolase activity; GO:0008464 ; EC:3.4.19.9; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0008464 ; EC:3.4.19.9 CG32154 CG32154 CG5082 CDMC28804 3 5 6 DAC09-G19 3-CG32425-RA_1 CG32425 TCGACTCCGCATTGGACAGTTGGCAACAGGAGGGAGATGACGATGATTTAGCGGAGGACTTTGAACG 67 FBan0032425 FBgn0052425 CG32425 3 3L CG32425 CG32425 "CG5100, CG15869, CG5100, CG5100, CG5100, CG15869" CDMC28804 3 6 6 DAC09-G19 3-CG32425-RA_1 CG32425 TCGACTCCGCATTGGACAGTTGGCAACAGGAGGGAGATGACGATGATTTAGCGGAGGACTTTGAACG 67 FBan0032425 FBgn0052425 CG32425 3 3L CG32425 CG32425 "CG5100, CG15869, CG5100, CG5100, CG5100, CG15869" CDMC28805 3 7 6 DAC09-K07 2-CG3289-RA_1 CG3289 TCTCTCCAAGTTTCCCGTGATCCAGCACGTCTACTTCGGAGAACTGATGACATTCGAGCCCGTCTCC 67 FBan0003289 FBgn0016698 Ptpa 2 2L regulation of enzyme activity; GO:0050790 protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160; ; GO:0008160 Ptpa Phosphotyrosyl phosphatase activator "CG3289, DPTPA, PTPA" CDMC28805 3 8 6 DAC09-K07 2-CG3289-RA_1 CG3289 TCTCTCCAAGTTTCCCGTGATCCAGCACGTCTACTTCGGAGAACTGATGACATTCGAGCCCGTCTCC 67 FBan0003289 FBgn0016698 Ptpa 2 2L regulation of enzyme activity; GO:0050790 protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160; ; GO:0008160 Ptpa Phosphotyrosyl phosphatase activator "CG3289, DPTPA, PTPA" CDMC28806 3 9 6 DAC09-K19 2-CG33150-RA_3 CG33150 CTGGGCTCCTACTGGGAATTCGTGCTCGTCACCACACAGAGGGTATCCTTGGACCGCTACCTAAATG 67 FBan0033150 FBgn0041234 Gr59f 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr59f Gustatory receptor 59f "CG5365, CG33150, CG5365, 59E.1, Gustatory receptor 59E.1, Gr59E1, GR59E.1, Gustatory receptor 59f" CDMC28806 3 10 6 DAC09-K19 2-CG33150-RA_3 CG33150 CTGGGCTCCTACTGGGAATTCGTGCTCGTCACCACACAGAGGGTATCCTTGGACCGCTACCTAAATG 67 FBan0033150 FBgn0041234 Gr59f 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr59f Gustatory receptor 59f "CG5365, CG33150, CG5365, 59E.1, Gustatory receptor 59E.1, Gr59E1, GR59E.1, Gustatory receptor 59f" CDMC28807 3 11 6 DAC09-O07 2-CG3508-RB_1 CG3508 GGAGCTGCACAAAGATGACTCCGACGACAACTGTTTTGGCTCCCAGACCGAAGATCAGGTGCTCTTC 67 FBan0003508 FBgn0038251 CG3508 3 3R CG3508 CG3508 CDMC28807 3 12 6 DAC09-O07 2-CG3508-RB_1 CG3508 GGAGCTGCACAAAGATGACTCCGACGACAACTGTTTTGGCTCCCAGACCGAAGATCAGGTGCTCTTC 67 FBan0003508 FBgn0038251 CG3508 3 3R CG3508 CG3508 CDMC28808 3 13 6 DAC09-O19 AutoBlank AutoBlank CDMC28808 3 14 6 DAC09-O19 AutoBlank AutoBlank CDMC28809 3 15 6 DAC10-C06 23-CG18349-RA_2 CG18349 AGAAGGTCTTTGGTTAATCGAAATCGGGACTAGAATGTGCCAACATACATATGAAAAGCTTTATTACGA 69 FBan0018349 FBgn0036109 CG18349 3 3L CG18349 CG18349 BcDNA:LP01241 CDMC28809 3 16 6 DAC10-C06 23-CG18349-RA_2 CG18349 AGAAGGTCTTTGGTTAATCGAAATCGGGACTAGAATGTGCCAACATACATATGAAAAGCTTTATTACGA 69 FBan0018349 FBgn0036109 CG18349 3 3L CG18349 CG18349 BcDNA:LP01241 CDMC28810 3 17 6 DAC10-C18 3-CG18368-RA_1 CG18368 GCCCTATCAAGACCCAGGAGAAGACCACAACGAGGATTGGAAGACGACCACTGTACGCGTGACAGAAAC 69 FBan0018368 FBgn0033864 CG18368 2 2R CG18368 CG18368 CDMC28810 3 18 6 DAC10-C18 3-CG18368-RA_1 CG18368 GCCCTATCAAGACCCAGGAGAAGACCACAACGAGGATTGGAAGACGACCACTGTACGCGTGACAGAAAC 69 FBan0018368 FBgn0033864 CG18368 2 2R CG18368 CG18368 CDMC28811 3 19 6 DAC10-G06 15-CG18420-RA_1 CG18420 CCTTTCAACATCGCTTTTACGATCCAAACACGCATGCCAATGATATAGCCCTACTGCGACTGGTGTCCA 69 FBan0018420 FBgn0028866 CG18420 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18420 CG18420 "BG:DS06874.6, DS06874.6, SPH111" CDMC28811 3 20 6 DAC10-G06 15-CG18420-RA_1 CG18420 CCTTTCAACATCGCTTTTACGATCCAAACACGCATGCCAATGATATAGCCCTACTGCGACTGGTGTCCA 69 FBan0018420 FBgn0028866 CG18420 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18420 CG18420 "BG:DS06874.6, DS06874.6, SPH111" CDMC28812 3 21 6 DAC10-G18 23-CG18455-RA_8 CG18455 ATCCTCACAAGCTCCGAAGCACTAAGGCCCAGCTATTCAGATTGTTTCAATTGTATTTCTAAGTTAGCC 69 FBan0018455 FBgn0025360 Optix 2 2R eye development (sensu Endopterygota); GO:0007456; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Optix Optix "CG18455, CG18455, CG18455, optix, D-Six3, Six3, Dsix3, opt, anon-WO0153538.79" CDMC28812 3 22 6 DAC10-G18 23-CG18455-RA_8 CG18455 ATCCTCACAAGCTCCGAAGCACTAAGGCCCAGCTATTCAGATTGTTTCAATTGTATTTCTAAGTTAGCC 69 FBan0018455 FBgn0025360 Optix 2 2R eye development (sensu Endopterygota); GO:0007456; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Optix Optix "CG18455, CG18455, CG18455, optix, D-Six3, Six3, Dsix3, opt, anon-WO0153538.79" CDMC28813 3 23 6 DAC10-K06 23-CG18505-RA_5 CG18505 CCCAACGCTAAGGTCTCAAAGGCTGAATTTTCGCAAATCCAGGAAATCGAGGACTATACGTTCACTTCC 69 FBan0018505 FBgn0038363 Acyp2 3 3R acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 Acyp2 Acylphosphatase 2 "CG18505, CG18505, CG18505, AcPDro2, Acylphosphatase 2" CDMC28813 3 24 6 DAC10-K06 23-CG18505-RA_5 CG18505 CCCAACGCTAAGGTCTCAAAGGCTGAATTTTCGCAAATCCAGGAAATCGAGGACTATACGTTCACTTCC 69 FBan0018505 FBgn0038363 Acyp2 3 3R acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 Acyp2 Acylphosphatase 2 "CG18505, CG18505, CG18505, AcPDro2, Acylphosphatase 2" CDMC28814 3 25 6 DAC10-K18 8-CG18528-RA_1 CG18528 GCATCGAACGCATCACCGGACACATCAGCTGCGAAGATATACTCGACGTGGTCTTCAAGGACTTTTGCA 69 FBan0018528 FBgn0039189 CG18528 3 3R defense response; GO:0006952; response to toxin; GO:0009636; tRNA modification; GO:0006400 GTP binding; GO:0005525; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; GTPase activity; GO:0003924; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003924; ; GO:0005525 CG18528 CG18528 CDMC28814 3 26 6 DAC10-K18 8-CG18528-RA_1 CG18528 GCATCGAACGCATCACCGGACACATCAGCTGCGAAGATATACTCGACGTGGTCTTCAAGGACTTTTGCA 69 FBan0018528 FBgn0039189 CG18528 3 3R defense response; GO:0006952; response to toxin; GO:0009636; tRNA modification; GO:0006400 GTP binding; GO:0005525; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; GTPase activity; GO:0003924; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003924; ; GO:0005525 CG18528 CG18528 CDMC28815 3 1 7 DAC10-O06 9-CG18585-RA_8 CG18585 AGTTCATTGTTGGCAAGTCCTACGAGGGGAGAACCATTAGAGGCATTAAGATCTCCCACAAGGCTGGCA 69 FBan0018585 FBgn0031929 CG18585 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; carboxypeptidase activity; GO:0004180; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004180 CG18585 CG18585 CDMC28815 3 2 7 DAC10-O06 9-CG18585-RA_8 CG18585 AGTTCATTGTTGGCAAGTCCTACGAGGGGAGAACCATTAGAGGCATTAAGATCTCCCACAAGGCTGGCA 69 FBan0018585 FBgn0031929 CG18585 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; carboxypeptidase activity; GO:0004180; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004180 CG18585 CG18585 CDMC28816 3 3 7 DAC10-O18 3-CG18600-RA_3 CG18600 GCGGATCCCAATGTGGCAAAGAAGGGAACTCGCACCAATTTCAGCAGTGAAAAGGCACTGACACACTTT 69 FBan0018600 FBgn0038601 CG18600 3 3R CG18600 CG18600 "CK01205, BEST:CK01205" CDMC28816 3 4 7 DAC10-O18 3-CG18600-RA_3 CG18600 GCGGATCCCAATGTGGCAAAGAAGGGAACTCGCACCAATTTCAGCAGTGAAAAGGCACTGACACACTTT 69 FBan0018600 FBgn0038601 CG18600 3 3R CG18600 CG18600 "CK01205, BEST:CK01205" CDMC28817 3 5 7 DAC11-C06 6-CG10447-RA_1 CG10447 TCGGATCGTAATCTCTTTCTGGACGCCAGTTATCCGCACAACGAAGATGGGTCCTCCGCAAACGATG 67 FBan0010447 FBgn0032816 CG10447 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 CCAAT-binding factor complex; GO:0016602 CG10447 CG10447 BcDNA:RH50436 CDMC28817 3 6 7 DAC11-C06 6-CG10447-RA_1 CG10447 TCGGATCGTAATCTCTTTCTGGACGCCAGTTATCCGCACAACGAAGATGGGTCCTCCGCAAACGATG 67 FBan0010447 FBgn0032816 CG10447 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 CCAAT-binding factor complex; GO:0016602 CG10447 CG10447 BcDNA:RH50436 CDMC28818 3 7 7 DAC11-C18 2-CG10622-RA_1 CG10622 CCAAAGCCTTCGAGATCCTCACTGCTGACCCGAAAGTCAAGGGAATCCTGGTCAATGTCTTTGGCGG 67 FBan0010622 FBgn0029118 Sucb 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Sucb Sucb "CG10622, sucb, sucB" CDMC28818 3 8 7 DAC11-C18 2-CG10622-RA_1 CG10622 CCAAAGCCTTCGAGATCCTCACTGCTGACCCGAAAGTCAAGGGAATCCTGGTCAATGTCTTTGGCGG 67 FBan0010622 FBgn0029118 Sucb 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Sucb Sucb "CG10622, sucb, sucB" CDMC28819 3 9 7 DAC11-G06 3-CG10932-RA_2 CG10932 GGAATTGCGAAGACCGATGTCCAGGAGGTGATTATGGGCAATGTGGTATCTGCTGGTCTGGGACAGG 67 FBan0010932 FBgn0029969 CG10932 X X fatty acid biosynthesis; GO:0006633; pyruvate metabolism; GO:0006090 acetyl-CoA C-acetyltransferase activity; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9 mitochondrion; GO:0005739 CG10932 CG10932 CDMC28819 3 10 7 DAC11-G06 3-CG10932-RA_2 CG10932 GGAATTGCGAAGACCGATGTCCAGGAGGTGATTATGGGCAATGTGGTATCTGCTGGTCTGGGACAGG 67 FBan0010932 FBgn0029969 CG10932 X X fatty acid biosynthesis; GO:0006633; pyruvate metabolism; GO:0006090 acetyl-CoA C-acetyltransferase activity; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9; ; GO:0003985 ; EC:2.3.1.9 mitochondrion; GO:0005739 CG10932 CG10932 CDMC28820 3 11 7 DAC11-G18 2-CG11008-RA_1 CG11008 CCACAGCGTCAGAAGATCCTGAGGCAGTTGAAGGAGATTCTGTGGAGGTCCCCATCAAACGAAAGGC 67 FBan0011008 FBgn0036315 CG11008 3 3L CG11008 CG11008 CDMC28820 3 12 7 DAC11-G18 2-CG11008-RA_1 CG11008 CCACAGCGTCAGAAGATCCTGAGGCAGTTGAAGGAGATTCTGTGGAGGTCCCCATCAAACGAAAGGC 67 FBan0011008 FBgn0036315 CG11008 3 3L CG11008 CG11008 CDMC28821 3 13 7 DAC11-K06 23-CG11354-RA_1 CG11354 AGGCATGTACTAGCTCCTAAGTCTACATAAACCAGATATTATATATACAAGAGCTACATACGGCAGC 67 FBan0011354 FBgn0026411 Lim1 X X "ectoderm development; GO:0007398; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis (sensu Endopterygota); GO:0007480; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700 nucleus; GO:0005634 Lim1 Lim kinase "CG11354, CG10760, dlim-1, dLim1, dlim1, Dlim1, BcDNA:GH04929, lim1, Lim kinase" CDMC28821 3 14 7 DAC11-K06 23-CG11354-RA_1 CG11354 AGGCATGTACTAGCTCCTAAGTCTACATAAACCAGATATTATATATACAAGAGCTACATACGGCAGC 67 FBan0011354 FBgn0026411 Lim1 X X "ectoderm development; GO:0007398; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis (sensu Endopterygota); GO:0007480; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003700 nucleus; GO:0005634 Lim1 Lim kinase "CG11354, CG10760, dlim-1, dLim1, dlim1, Dlim1, BcDNA:GH04929, lim1, Lim kinase" CDMC28822 3 15 7 DAC11-K18 3-CG1150-RA_1 CG1150 CTGCTGGCGGTGATCATCTCACTGAAGAAGCTGCTCTCTAGCAAGAAAACCATCGTGGAGGTGCCAT 67 FBan0001150 FBgn0037411 Osi3 3 3R Osi3 Osiris 3 "CG1150, CG1150, CG1150, Osiris, Osiris 3" CDMC28822 3 16 7 DAC11-K18 3-CG1150-RA_1 CG1150 CTGCTGGCGGTGATCATCTCACTGAAGAAGCTGCTCTCTAGCAAGAAAACCATCGTGGAGGTGCCAT 67 FBan0001150 FBgn0037411 Osi3 3 3R Osi3 Osiris 3 "CG1150, CG1150, CG1150, Osiris, Osiris 3" CDMC28823 3 17 7 DAC11-O06 14-CG12162-RB_1 CG12162 AGTGGGGTCCTGAATCCTCCTGAAAATTGCATAACACGTCATTTGTACAGACTGGCTGAGGTGGGTC 67 FBan0012162 FBgn0037329 CG12162 3 3R metabolism; GO:0008152 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG12162 CG12162 CDMC28823 3 18 7 DAC11-O06 14-CG12162-RB_1 CG12162 AGTGGGGTCCTGAATCCTCCTGAAAATTGCATAACACGTCATTTGTACAGACTGGCTGAGGTGGGTC 67 FBan0012162 FBgn0037329 CG12162 3 3R metabolism; GO:0008152 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG12162 CG12162 CDMC28824 3 19 7 DAC11-O18 AutoBlank AutoBlank CDMC28824 3 20 7 DAC11-O18 AutoBlank AutoBlank CDMC28825 3 21 7 DAC12-C06 3-CG10283-RA_1 CG10283 ACACATGCAGCAACACGCCGATGATATTGAGCTCTATGTGGATCCGTGCGACTATGCGAGTCTGCG 66 FBan0010283 FBgn0032681 CG10283 2 2L CG10283 CG10283 CDMC28825 3 22 7 DAC12-C06 3-CG10283-RA_1 CG10283 ACACATGCAGCAACACGCCGATGATATTGAGCTCTATGTGGATCCGTGCGACTATGCGAGTCTGCG 66 FBan0010283 FBgn0032681 CG10283 2 2L CG10283 CG10283 CDMC28826 3 23 7 DAC12-C18 1-CG10431-RA_1 CG10431 CGCGCTCATGCAAGCCCATTGTGACCAATGTAAGCCAGATACCTAACCCAATGATCTGCGAGCTGC 66 FBan0010431 FBgn0032730 CG10431 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10431 CG10431 dmCG10431 CDMC28826 3 24 7 DAC12-C18 1-CG10431-RA_1 CG10431 CGCGCTCATGCAAGCCCATTGTGACCAATGTAAGCCAGATACCTAACCCAATGATCTGCGAGCTGC 66 FBan0010431 FBgn0032730 CG10431 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10431 CG10431 dmCG10431 CDMC28827 3 25 7 DAC12-G06 11-CG10874-RA_1 CG10874 TCATTCCTTTGTCTCCGAAGTTCCCGATGTTAAGCACATGGAAAGAGCTCTCCTCGGACTGCTGGA 66 FBan0010874 FBgn0031395 CG10874 2 2L CG10874 CG10874 CDMC28827 3 26 7 DAC12-G06 11-CG10874-RA_1 CG10874 TCATTCCTTTGTCTCCGAAGTTCCCGATGTTAAGCACATGGAAAGAGCTCTCCTCGGACTGCTGGA 66 FBan0010874 FBgn0031395 CG10874 2 2L CG10874 CG10874 CDMC28828 3 1 8 DAC12-G18 14-CG11020-RA_3 CG11020 CGCCTTCTAGTGTAGTACAGTGCAGAGTAGCTTTAGTGGATTAGCCGCCTTGAAGTGTGCCCTGCT 66 FBan0011020 FBgn0016920 nompC 2 2L calcium ion transport; GO:0006816; detection of mechanical stimulus during sensory perception; GO:0050974; detection of mechanical stimulus during sensory perception of sound; GO:0050910; folic acid and derivative biosynthesis; GO:0009396; mechanosensory behavior; GO:0007638; sensory perception of mechanical stimulus; GO:0050954; sensory perception of sound; GO:0007605 cytoskeletal protein binding; GO:0008092; ; GO:0008092; calcium channel activity; GO:0005262; ion channel activity; GO:0005216; mechanically-gated ion channel activity; GO:0008381; ; GO:0008381; ankyrin binding; GO:0030506; ; GO:0005262; ; GO:0005216; ; GO:0030506; ; GO:0008381; 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity; GO:0003848 ; EC:2.7.6.3; ; GO:0003848 ; EC:2.7.6.3 membrane; GO:0016020 nompC no mechanoreceptor potential C "CG11020, CG17468, CG11020, CG11020, jf24, nomp, l(2)jf24, CT30855, NOMPC, l(2)25Dc, lethal(2)25Dc, no mechanoreceptor potential C" CDMC28828 3 2 8 DAC12-G18 14-CG11020-RA_3 CG11020 CGCCTTCTAGTGTAGTACAGTGCAGAGTAGCTTTAGTGGATTAGCCGCCTTGAAGTGTGCCCTGCT 66 FBan0011020 FBgn0016920 nompC 2 2L calcium ion transport; GO:0006816; detection of mechanical stimulus during sensory perception; GO:0050974; detection of mechanical stimulus during sensory perception of sound; GO:0050910; folic acid and derivative biosynthesis; GO:0009396; mechanosensory behavior; GO:0007638; sensory perception of mechanical stimulus; GO:0050954; sensory perception of sound; GO:0007605 cytoskeletal protein binding; GO:0008092; ; GO:0008092; calcium channel activity; GO:0005262; ion channel activity; GO:0005216; mechanically-gated ion channel activity; GO:0008381; ; GO:0008381; ankyrin binding; GO:0030506; ; GO:0005262; ; GO:0005216; ; GO:0030506; ; GO:0008381; 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity; GO:0003848 ; EC:2.7.6.3; ; GO:0003848 ; EC:2.7.6.3 membrane; GO:0016020 nompC no mechanoreceptor potential C "CG11020, CG17468, CG11020, CG11020, jf24, nomp, l(2)jf24, CT30855, NOMPC, l(2)25Dc, lethal(2)25Dc, no mechanoreceptor potential C" CDMC28829 3 3 8 DAC12-K06 3-CG11211-RA_1 CG11211 GGTGGATCGGAGCTATTTCTGGACCTGGATGAGCACTGGCATTCCCGTTACCTACGCACAATGGAG 66 FBan0011211 FBgn0033067 CG11211 2 2R mannose binding; GO:0005537; ; GO:0005537 CG11211 CG11211 BcDNA:RH26557 CDMC28829 3 4 8 DAC12-K06 3-CG11211-RA_1 CG11211 GGTGGATCGGAGCTATTTCTGGACCTGGATGAGCACTGGCATTCCCGTTACCTACGCACAATGGAG 66 FBan0011211 FBgn0033067 CG11211 2 2R mannose binding; GO:0005537; ; GO:0005537 CG11211 CG11211 BcDNA:RH26557 CDMC28830 3 5 8 DAC12-K18 21-CG11345-RA_2 CG11345 CCAAGAACGTTCCAACAGAAAAATGAAAGTCCTTATGCTGGCTGTTTGCAGCTTGGCTCTGGTAGC 66 FBan0011345 FBgn0035546 CG11345 3 3L CG11345 CG11345 CDMC28830 3 6 8 DAC12-K18 21-CG11345-RA_2 CG11345 CCAAGAACGTTCCAACAGAAAAATGAAAGTCCTTATGCTGGCTGTTTGCAGCTTGGCTCTGGTAGC 66 FBan0011345 FBgn0035546 CG11345 3 3L CG11345 CG11345 CDMC28831 3 7 8 DAC12-O06 3-CG12127-RA_6 CG12127 GGCGTATTCCCCGCTCTATCTGACCAAAATGAGGCTCCAACGACAGTGCATTGTGGTCAACATGCG 66 FBan0012127 FBgn0000077 amx X X DNA replication; GO:0006260; ectoderm development; GO:0007398; mesoderm development; GO:0007498 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; endoribonuclease activity; GO:0004521; ; GO:0004520; ; GO:0004521; sugar binding; GO:0005529; ; GO:0005529 plasma membrane; GO:0005886 amx almondex "CG12127, fs(1)amx, BcDNA:GH02974" CDMC28831 3 8 8 DAC12-O06 3-CG12127-RA_6 CG12127 GGCGTATTCCCCGCTCTATCTGACCAAAATGAGGCTCCAACGACAGTGCATTGTGGTCAACATGCG 66 FBan0012127 FBgn0000077 amx X X DNA replication; GO:0006260; ectoderm development; GO:0007398; mesoderm development; GO:0007498 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; endoribonuclease activity; GO:0004521; ; GO:0004520; ; GO:0004521; sugar binding; GO:0005529; ; GO:0005529 plasma membrane; GO:0005886 amx almondex "CG12127, fs(1)amx, BcDNA:GH02974" CDMC28832 3 9 8 DAC12-O18 AutoBlank AutoBlank CDMC28832 3 10 8 DAC12-O18 AutoBlank AutoBlank CDMC28833 3 11 8 DAC13-C06 1-CG14548-RA_1 CG14548 TGCGTGCACACAGAGTCTCCGAGTCCGAATCTAGTGGAACGTTGCGACTGTGGATTACGCGAGTTTACT 69 FBan0014548 FBgn0002733 HLHmbeta 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 HLHmbeta E(spl) region transcript mbeta "CG14548, mA, HLH-mbeta, mbeta, E(spl)mbeta, E(spl), E(spl)beta, E(spl)-Mbeta, E(spl)Mbeta, E(spl) mbeta, Mbeta, split locus enhancer protein mA, E(Spl) HLH-Mbeta, E(spl)mbeta, Dm-mA, E(spl)mA, mbeta, HLHmbeta, E(spl)-mbeta, HLHmA: Enhancer of split region transcript HLHmA, Enhancer of split region transcript HLHmA" CDMC28833 3 12 8 DAC13-C06 1-CG14548-RA_1 CG14548 TGCGTGCACACAGAGTCTCCGAGTCCGAATCTAGTGGAACGTTGCGACTGTGGATTACGCGAGTTTACT 69 FBan0014548 FBgn0002733 HLHmbeta 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 HLHmbeta E(spl) region transcript mbeta "CG14548, mA, HLH-mbeta, mbeta, E(spl)mbeta, E(spl), E(spl)beta, E(spl)-Mbeta, E(spl)Mbeta, E(spl) mbeta, Mbeta, split locus enhancer protein mA, E(Spl) HLH-Mbeta, E(spl)mbeta, Dm-mA, E(spl)mA, mbeta, HLHmbeta, E(spl)-mbeta, HLHmA: Enhancer of split region transcript HLHmA, Enhancer of split region transcript HLHmA" CDMC28834 3 13 8 DAC13-C18 23-CG14560-RA_3 CG14560 CAGCGGGTGGTTCCGGTAGAAAGAAAAATGTCAATCACAACGTCATAACCATTGGATAAAATTCTTCGA 69 FBan0014560 FBgn0004414 msopa 3 3L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 msopa male-specific opa containing gene "CG14560, CG14560, CG14560, Dromsopa: Drosophila male specific opa containing gene, Drosophila male specific opa containing gene, Dromsopa" CDMC28834 3 14 8 DAC13-C18 23-CG14560-RA_3 CG14560 CAGCGGGTGGTTCCGGTAGAAAGAAAAATGTCAATCACAACGTCATAACCATTGGATAAAATTCTTCGA 69 FBan0014560 FBgn0004414 msopa 3 3L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 msopa male-specific opa containing gene "CG14560, CG14560, CG14560, Dromsopa: Drosophila male specific opa containing gene, Drosophila male specific opa containing gene, Dromsopa" CDMC28835 3 15 8 DAC13-G06 2-CG14606-RA_1 CG14606 CGGGGAGCGTTATCGTCCATGGCCATGATGTACGTTAGCATCGGCATGATGGTTGGCTTTACATTAGCC 69 FBan0014606 FBgn0037485 CG14606 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 hexose transporter activity; GO:0015149; ; GO:0015149 integral to membrane; GO:0016021; membrane; GO:0016020 CG14606 CG14606 CDMC28835 3 16 8 DAC13-G06 2-CG14606-RA_1 CG14606 CGGGGAGCGTTATCGTCCATGGCCATGATGTACGTTAGCATCGGCATGATGGTTGGCTTTACATTAGCC 69 FBan0014606 FBgn0037485 CG14606 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 hexose transporter activity; GO:0015149; ; GO:0015149 integral to membrane; GO:0016021; membrane; GO:0016020 CG14606 CG14606 CDMC28836 3 17 8 DAC13-G18 13-CG14615-RA_2 CG14615 GGCTCAAATACCGCGCAATGATCTGAACCACATTTCTCTGAGAAAGCAGTTCTACACCCATCGAAGGGG 69 FBan0014615 FBgn0031184 CG14615 X X CG14615 CG14615 CDMC28836 3 18 8 DAC13-G18 13-CG14615-RA_2 CG14615 GGCTCAAATACCGCGCAATGATCTGAACCACATTTCTCTGAGAAAGCAGTTCTACACCCATCGAAGGGG 69 FBan0014615 FBgn0031184 CG14615 X X CG14615 CG14615 CDMC28837 3 19 8 DAC13-K06 17-CG14657-RB_1 CG14657 CGTCAGCAGATCTCCGCAAGCACCTAAGGTCTAAAAAACTTCAATACTCGCTCATTGGAACGTAAGCCC 69 FBan0014657 FBgn0037282 CG14657 3 3R CG14657 CG14657 CDMC28837 3 20 8 DAC13-K06 17-CG14657-RB_1 CG14657 CGTCAGCAGATCTCCGCAAGCACCTAAGGTCTAAAAAACTTCAATACTCGCTCATTGGAACGTAAGCCC 69 FBan0014657 FBgn0037282 CG14657 3 3R CG14657 CG14657 CDMC28838 3 21 8 DAC13-K18 23-CG14666-RA_3 CG14666 AAAGCTTTTAAGGTTTTAAGTCAACCTCCCATGCTTCTTCCAAATTAAGTGTTAATTCGATATTCAGCG 69 FBan0014666 FBgn0037307 Tim17a2 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a2 Tim17a2 "CG14666, BcDNA:RH03914" CDMC28838 3 22 8 DAC13-K18 23-CG14666-RA_3 CG14666 AAAGCTTTTAAGGTTTTAAGTCAACCTCCCATGCTTCTTCCAAATTAAGTGTTAATTCGATATTCAGCG 69 FBan0014666 FBgn0037307 Tim17a2 3 3R protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a2 Tim17a2 "CG14666, BcDNA:RH03914" CDMC28839 3 23 8 DAC13-O06 2-CG14695-RA_1 CG14695 AGCGATATGCTGGTGATGCTATATGATCCTGCCTGCTACTACTGGCCCATTCAGAAGAGGATGCTGCGC 69 FBan0014695 FBgn0037850 CG14695 3 3R CG14695 CG14695 CDMC28839 3 24 8 DAC13-O06 2-CG14695-RA_1 CG14695 AGCGATATGCTGGTGATGCTATATGATCCTGCCTGCTACTACTGGCCCATTCAGAAGAGGATGCTGCGC 69 FBan0014695 FBgn0037850 CG14695 3 3R CG14695 CG14695 CDMC28840 3 25 8 DAC13-O18 3-CG14712-RA_1 CG14712 ACCGGAGAGTCGTCCGATACGAAAGGCCACTAGGCGTCTGCAGAAATAAGTCCGCTTCAGAAGTAGCTT 69 FBan0014712 FBgn0037924 CG14712 3 3R tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004812 ; EC:6.1.1.- CG14712 CG14712 CDMC28840 3 26 8 DAC13-O18 3-CG14712-RA_1 CG14712 ACCGGAGAGTCGTCCGATACGAAAGGCCACTAGGCGTCTGCAGAAATAAGTCCGCTTCAGAAGTAGCTT 69 FBan0014712 FBgn0037924 CG14712 3 3R tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004812 ; EC:6.1.1.- CG14712 CG14712 CDMC28841 3 1 9 DAC14-C06 3-CG17286-RA_2 CG17286 CAACAAGGGCCCTCTCACCGCTTTCGTTGGTATATCAGTGGACTCCACCGTGCTCATGAAACTGC 65 FBan0017286 FBgn0027500 CG17286 3 3L CG17286 CG17286 "BcDNA:LD24702, anon-73Ba" CDMC28841 3 2 9 DAC14-C06 3-CG17286-RA_2 CG17286 CAACAAGGGCCCTCTCACCGCTTTCGTTGGTATATCAGTGGACTCCACCGTGCTCATGAAACTGC 65 FBan0017286 FBgn0027500 CG17286 3 3L CG17286 CG17286 "BcDNA:LD24702, anon-73Ba" CDMC28842 3 3 9 DAC14-C18 17-CG17344-RA_1 CG17344 CGAGCTCCTTTCGCAAAGTAGTTCGTATGCCAGCAGACAAAATCCCTACGCGTATCCGCCAGCGG 65 FBan0017344 FBgn0032755 CG17344 2 2L CG17344 CG17344 BcDNA:AT10305 CDMC28842 3 4 9 DAC14-C18 17-CG17344-RA_1 CG17344 CGAGCTCCTTTCGCAAAGTAGTTCGTATGCCAGCAGACAAAATCCCTACGCGTATCCGCCAGCGG 65 FBan0017344 FBgn0032755 CG17344 2 2L CG17344 CG17344 BcDNA:AT10305 CDMC28843 3 5 9 DAC14-G06 3-CG17560-RA_2 CG17560 ATTTCAAGGCCGCCATGTATGGAATGCGTCTCTATATTGGCAAGGAGAAACCCACCGCGGAGTCC 65 FBan0017560 FBgn0038450 CG17560 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17560 CG17560 CT38785 CDMC28843 3 6 9 DAC14-G06 3-CG17560-RA_2 CG17560 ATTTCAAGGCCGCCATGTATGGAATGCGTCTCTATATTGGCAAGGAGAAACCCACCGCGGAGTCC 65 FBan0017560 FBgn0038450 CG17560 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17560 CG17560 CT38785 CDMC28844 3 7 9 DAC14-G18 3-CG17599-RA_7 CG17599 GGCAGAGCTACAGAAGGTTACCCGACTCTTGACATCCCCAGGACAAAACGAAGCGGACAACGACG 65 FBan0017599 FBgn0031196 CG17599 X X CG17599 CG17599 CDMC28844 3 8 9 DAC14-G18 3-CG17599-RA_7 CG17599 GGCAGAGCTACAGAAGGTTACCCGACTCTTGACATCCCCAGGACAAAACGAAGCGGACAACGACG 65 FBan0017599 FBgn0031196 CG17599 X X CG17599 CG17599 CDMC28845 3 9 9 DAC14-K06 2-CG1771-RA_2 CG1771 CTGTGGAACTCGACGCTGGTCAGTGAGTATCCTCGGGTGGAAAGGGTCAGGATTTTCTCGACAGC 65 FBan0001771 FBgn0004456 mew X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell differentiation; GO:0030154; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectodermal gut morphogenesis; GO:0048567; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 mew multiple edematous wings "CG1771, CG1771, CG1771, PS1alpha: Position-specific-antigen-1alpha, PS1, alpha[[PS1]], PS1 integrin, Position-specific-1 antigen, alphaPS1, alpha-PS1-integrin, alpha integrin, aPS1, l(1)G0429, alpha-PS1, l(1)G0443, CT5254, alphaPS1 integrin, alphaPS1, Position-specific-antigen-1alpha, PS1alpha" CDMC28845 3 10 9 DAC14-K06 2-CG1771-RA_2 CG1771 CTGTGGAACTCGACGCTGGTCAGTGAGTATCCTCGGGTGGAAAGGGTCAGGATTTTCTCGACAGC 65 FBan0001771 FBgn0004456 mew X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell differentiation; GO:0030154; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; ectodermal gut morphogenesis; GO:0048567; heterophilic cell adhesion; GO:0007157; midgut development; GO:0007494; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 mew multiple edematous wings "CG1771, CG1771, CG1771, PS1alpha: Position-specific-antigen-1alpha, PS1, alpha[[PS1]], PS1 integrin, Position-specific-1 antigen, alphaPS1, alpha-PS1-integrin, alpha integrin, aPS1, l(1)G0429, alpha-PS1, l(1)G0443, CT5254, alphaPS1 integrin, alphaPS1, Position-specific-antigen-1alpha, PS1alpha" CDMC28846 3 11 9 DAC14-K18 12-CG17758-RA_7 CG17758 GCACGCTGAGGATTTCGCACAGGATACCGGGACACTCTAGAGGTCATGCCATAATCCAGCACGAT 65 FBan0017758 FBgn0029780 CG17758 X X CG17758 CG17758 CDMC28846 3 12 9 DAC14-K18 12-CG17758-RA_7 CG17758 GCACGCTGAGGATTTCGCACAGGATACCGGGACACTCTAGAGGTCATGCCATAATCCAGCACGAT 65 FBan0017758 FBgn0029780 CG17758 X X CG17758 CG17758 CDMC28847 3 13 9 DAC14-O06 23-CG17934-RA_1 CG17934 TTTTCGTCCTAAGTTATTTCTTTGTTAGGTTCAAAAACTTTACGGAACCATCATGTGTTGCGGAC 65 FBan0017934 FBgn0004173 Mst84Db 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Db Male-specific RNA 84Db "CG17934, Mst87D, Mst84, Mst ORF, Mstprox, Mst, bs22c06.y1, mst(3)gl-2, BcDNA:AT08471, NEST:bs22c06" CDMC28847 3 14 9 DAC14-O06 23-CG17934-RA_1 CG17934 TTTTCGTCCTAAGTTATTTCTTTGTTAGGTTCAAAAACTTTACGGAACCATCATGTGTTGCGGAC 65 FBan0017934 FBgn0004173 Mst84Db 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst84Db Male-specific RNA 84Db "CG17934, Mst87D, Mst84, Mst ORF, Mstprox, Mst, bs22c06.y1, mst(3)gl-2, BcDNA:AT08471, NEST:bs22c06" CDMC28848 3 15 9 DAC14-O18 3-CG18012-RA_4 CG18012 ATGCCCAGAGTCTTCTCGAGGAGAACTACCACGTGGACATGATTGGGTATCTGGAGACGAGGCCG 65 FBan0018012 FBgn0038552 CG18012 3 3R protein amino acid glycosylation; GO:0006486 "DNA binding; GO:0003677; beta-1,4-mannosyltransferase activity; GO:0019187 ; EC:2.4.1.-; ; GO:0019187 ; EC:2.4.1.-; ; GO:0003677" nucleus; GO:0005634 CG18012 CG18012 CDMC28848 3 16 9 DAC14-O18 3-CG18012-RA_4 CG18012 ATGCCCAGAGTCTTCTCGAGGAGAACTACCACGTGGACATGATTGGGTATCTGGAGACGAGGCCG 65 FBan0018012 FBgn0038552 CG18012 3 3R protein amino acid glycosylation; GO:0006486 "DNA binding; GO:0003677; beta-1,4-mannosyltransferase activity; GO:0019187 ; EC:2.4.1.-; ; GO:0019187 ; EC:2.4.1.-; ; GO:0003677" nucleus; GO:0005634 CG18012 CG18012 CDMC28849 3 17 9 DAC15-C06 3-CG12899-RA_1 CG12899 GCCAAAACCTCCAAGTGAGCTACACCGCTTTGGCCATGTCGGACGATAATCAAACCTGCAGCTACTCG 68 FBan0012899 FBgn0040771 CG12899 2 2R CG12899 CG12899 CDMC28849 3 18 9 DAC15-C06 3-CG12899-RA_1 CG12899 GCCAAAACCTCCAAGTGAGCTACACCGCTTTGGCCATGTCGGACGATAATCAAACCTGCAGCTACTCG 68 FBan0012899 FBgn0040771 CG12899 2 2R CG12899 CG12899 CDMC28850 3 19 9 DAC15-C18 3-CG12992-RA_1 CG12992 TCCTATTACAACGCTCAATCGACATCCGCTTACGGCTATCCTCCGACTGGTTTTCCGATGTCCCAGCA 68 FBan0012992 FBgn0030846 CG12992 X X CG12992 CG12992 CDMC28850 3 20 9 DAC15-C18 3-CG12992-RA_1 CG12992 TCCTATTACAACGCTCAATCGACATCCGCTTACGGCTATCCTCCGACTGGTTTTCCGATGTCCCAGCA 68 FBan0012992 FBgn0030846 CG12992 X X CG12992 CG12992 CDMC28851 3 21 9 DAC15-G06 3-CG13495-RA_4 CG13495 CCGTTGTCTTCGCCCTAATGAGCACTACCCTAAGGATACGCTCCTGCAGGAAATGCCTACGCTTGGAA 68 FBan0013495 FBgn0041238 Gr58b 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58b Gustatory receptor 58b "CG13495, 58A.2, Gustatory receptor 58A.2, 58A2, Gr58A2, GR58A.2, Gustatory receptor 58b" CDMC28851 3 22 9 DAC15-G06 3-CG13495-RA_4 CG13495 CCGTTGTCTTCGCCCTAATGAGCACTACCCTAAGGATACGCTCCTGCAGGAAATGCCTACGCTTGGAA 68 FBan0013495 FBgn0041238 Gr58b 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58b Gustatory receptor 58b "CG13495, 58A.2, Gustatory receptor 58A.2, 58A2, Gr58A2, GR58A.2, Gustatory receptor 58b" CDMC28852 3 23 9 DAC15-G18 2-CG13614-RA_1 CG13614 GCCACCCCTCTAAAGAAACCCATGCCAATGAAACTACACCAACGCATCGATGTGAGGCCACAAAAGCC 68 FBan0013614 FBgn0039194 CG13614 3 3R CG13614 CG13614 CDMC28852 3 24 9 DAC15-G18 2-CG13614-RA_1 CG13614 GCCACCCCTCTAAAGAAACCCATGCCAATGAAACTACACCAACGCATCGATGTGAGGCCACAAAAGCC 68 FBan0013614 FBgn0039194 CG13614 3 3R CG13614 CG13614 CDMC28853 3 25 9 DAC15-K06 8-CG13901-RA_1 CG13901 CGTGTGCCTAGGTAATCCCATCAATCCCCAGAGATGTCCTACCAGAACTGGCTAAACTACCTGCAGGC 68 FBan0013901 FBgn0035164 CG13901 3 3L CG13901 CG13901 CDMC28853 3 26 9 DAC15-K06 8-CG13901-RA_1 CG13901 CGTGTGCCTAGGTAATCCCATCAATCCCCAGAGATGTCCTACCAGAACTGGCTAAACTACCTGCAGGC 68 FBan0013901 FBgn0035164 CG13901 3 3L CG13901 CG13901 CDMC28854 3 1 10 DAC15-K18 3-CG14017-RA_1 CG14017 TGCATTCCAACGACTCGGATAACTACAAGGTTATTCCGGATGCCGTCAAGGGTTTGTGCTTCGCGCAC 68 FBan0014017 FBgn0031721 CG14017 2 2L CG14017 CG14017 CDMC28854 3 2 10 DAC15-K18 3-CG14017-RA_1 CG14017 TGCATTCCAACGACTCGGATAACTACAAGGTTATTCCGGATGCCGTCAAGGGTTTGTGCTTCGCGCAC 68 FBan0014017 FBgn0031721 CG14017 2 2L CG14017 CG14017 CDMC28855 3 3 10 DAC15-O06 17-CG14483-RA_1 CG14483 ACATGGCCTTTCCGGTGACGCTATTCCACTTGTTTAACCAGCCGGAATACTTTGAAGAATGGGTGACC 68 FBan0014483 FBgn0034248 CG14483 2 2R CG14483 CG14483 CDMC28855 3 4 10 DAC15-O06 17-CG14483-RA_1 CG14483 ACATGGCCTTTCCGGTGACGCTATTCCACTTGTTTAACCAGCCGGAATACTTTGAAGAATGGGTGACC 68 FBan0014483 FBgn0034248 CG14483 2 2R CG14483 CG14483 CDMC28856 3 5 10 DAC15-O18 2-CG14550-RA_2 CG14550 GGCGGTCTATGGTTTCGCCTTCTATATGCTGTTCACGGTCCTCTTCCTCGTATACGTGACTTGGGCGC 68 FBan0014550 FBgn0039405 CG14550 3 3R CG14550 CG14550 BcDNA:GM30016 CDMC28856 3 6 10 DAC15-O18 2-CG14550-RA_2 CG14550 GGCGGTCTATGGTTTCGCCTTCTATATGCTGTTCACGGTCCTCTTCCTCGTATACGTGACTTGGGCGC 68 FBan0014550 FBgn0039405 CG14550 3 3R CG14550 CG14550 BcDNA:GM30016 CDMC28857 3 7 10 DAC16-C06 3-CG31086-RA_1 CG31086 CATTCAAGCAGCTCAATCGAAATGGACGGTCACAGCTGGCTTCACTTCAGCAACGGAGCAATCCC 65 FBan0031086 FBgn0051086 CG31086 3 3R CG31086 CG31086 "CG14558, CG14558" CDMC28857 3 8 10 DAC16-C06 3-CG31086-RA_1 CG31086 CATTCAAGCAGCTCAATCGAAATGGACGGTCACAGCTGGCTTCACTTCAGCAACGGAGCAATCCC 65 FBan0031086 FBgn0051086 CG31086 3 3R CG31086 CG31086 "CG14558, CG14558" CDMC28858 3 9 10 DAC16-C18 3-CG31127-RA_1 CG31127 TCTTCGAGCAGCAACGCATGAGTCTAAAGAGAAAACTGGTGGAGAGTCGCCTGATGGCACCGTCG 65 FBgn0051127 CDMC28858 3 10 10 DAC16-C18 3-CG31127-RA_1 CG31127 TCTTCGAGCAGCAACGCATGAGTCTAAAGAGAAAACTGGTGGAGAGTCGCCTGATGGCACCGTCG 65 FBgn0051127 CDMC28859 3 11 10 DAC16-G06 1-CG31240-RA_1 CG31240 GCCCCCAGAATGCATTCCAAATGTGCCTTACCAAAACGGGTGACGAGTGACCTCCCTCCAAATTG 65 FBan0031240 FBgn0011701 repo 3 3R glial cell differentiation; GO:0010001; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 repo reversed polarity "CG8045(CT24072), CG31240, CG8045(CT24072), rk2, RK2, 3702, REPO, CT24072, reverse polarity, AbRK2, l(3)03702, Antibody RK2" CDMC28859 3 12 10 DAC16-G06 1-CG31240-RA_1 CG31240 GCCCCCAGAATGCATTCCAAATGTGCCTTACCAAAACGGGTGACGAGTGACCTCCCTCCAAATTG 65 FBan0031240 FBgn0011701 repo 3 3R glial cell differentiation; GO:0010001; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 repo reversed polarity "CG8045(CT24072), CG31240, CG8045(CT24072), rk2, RK2, 3702, REPO, CT24072, reverse polarity, AbRK2, l(3)03702, Antibody RK2" CDMC28860 3 13 10 DAC16-G18 2-CG31278-RA_2 CG31278 CTTGCCGCCATACAACCATTTCACCCAGATTGGTGACCCTGTTCTTAGGCAACAAGCGGCTTTGG 65 FBan0031278 FBgn0051278 CG31278 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464 peptide deformylase activity; GO:0042586 ; EC:3.5.1.88; ; GO:0042586 ; EC:3.5.1.88; formylmethionine deformylase activity; GO:0008463 ; EC:3.5.1.31; ; GO:0008463 ; EC:3.5.1.31 CG31278 CG31278 "CG6482, PDF" CDMC28860 3 14 10 DAC16-G18 2-CG31278-RA_2 CG31278 CTTGCCGCCATACAACCATTTCACCCAGATTGGTGACCCTGTTCTTAGGCAACAAGCGGCTTTGG 65 FBan0031278 FBgn0051278 CG31278 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464 peptide deformylase activity; GO:0042586 ; EC:3.5.1.88; ; GO:0042586 ; EC:3.5.1.88; formylmethionine deformylase activity; GO:0008463 ; EC:3.5.1.31; ; GO:0008463 ; EC:3.5.1.31 CG31278 CG31278 "CG6482, PDF" CDMC28861 3 15 10 DAC16-K06 15-CG31373-RA_2 CG31373 ACATGGATAGGATGGATCTCTCCACCTTCAACTGCATCCTCTGGGAGCAAATCAACGCAGCTGAA 65 FBan0031373 FBgn0051373 CG31373 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464 peptide deformylase activity; GO:0042586 ; EC:3.5.1.88; ; GO:0042586 ; EC:3.5.1.88; formylmethionine deformylase activity; GO:0008463 ; EC:3.5.1.31; ; GO:0008463 ; EC:3.5.1.31 CG31373 CG31373 "CG6482, PDF" CDMC28861 3 16 10 DAC16-K06 15-CG31373-RA_2 CG31373 ACATGGATAGGATGGATCTCTCCACCTTCAACTGCATCCTCTGGGAGCAAATCAACGCAGCTGAA 65 FBan0031373 FBgn0051373 CG31373 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464 peptide deformylase activity; GO:0042586 ; EC:3.5.1.88; ; GO:0042586 ; EC:3.5.1.88; formylmethionine deformylase activity; GO:0008463 ; EC:3.5.1.31; ; GO:0008463 ; EC:3.5.1.31 CG31373 CG31373 "CG6482, PDF" CDMC28862 3 17 10 DAC16-K18 24-CG31415-RA_1 CG31415 AAAATGTAACAGATCAGATATAAAGTTGTTTCGAGACTAACTTTCAGTACTCCCAATACTCCAAC 65 FBan0031415 FBgn0051415 CG31415 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31415 CG31415 NEST:bs07c11 CDMC28862 3 18 10 DAC16-K18 24-CG31415-RA_1 CG31415 AAAATGTAACAGATCAGATATAAAGTTGTTTCGAGACTAACTTTCAGTACTCCCAATACTCCAAC 65 FBan0031415 FBgn0051415 CG31415 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31415 CG31415 NEST:bs07c11 CDMC28863 3 19 10 DAC16-O06 3-CG3153-RA_1 CG3153 CACCTACAAGAACAGCTTCAAGATCCTGCCCGTCTACCCGACCGTCAGTTTGGAGATCCACTGGG 65 FBan0003153 FBgn0038198 CG3153 3 3R receptor binding; GO:0005102; ; GO:0005102 CG3153 CG3153 "CT10556, DmML2" CDMC28863 3 20 10 DAC16-O06 3-CG3153-RA_1 CG3153 CACCTACAAGAACAGCTTCAAGATCCTGCCCGTCTACCCGACCGTCAGTTTGGAGATCCACTGGG 65 FBan0003153 FBgn0038198 CG3153 3 3R receptor binding; GO:0005102; ; GO:0005102 CG3153 CG3153 "CT10556, DmML2" CDMC28864 3 21 10 DAC16-O18 23-CG31563-RA_1 CG31563 GCTATAAGGCCATAAAACATTTCTATTCAGTTAGCATCCAATCCACCTAAGTTATGCCGATTCGC 65 FBan0031563 FBgn0051563 CG31563 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31563 CG31563 CDMC28864 3 22 10 DAC16-O18 23-CG31563-RA_1 CG31563 GCTATAAGGCCATAAAACATTTCTATTCAGTTAGCATCCAATCCACCTAAGTTATGCCGATTCGC 65 FBan0031563 FBgn0051563 CG31563 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31563 CG31563 CDMC28865 3 23 10 DAC17-C06 1-CG32710-RA_1 CG32710 CAACATTCAAAACAGCAGCAACTACAGCACCACCGTGGCGTATGCAGTTTTGGCCAGCAGTCGTC 65 FBan0032710 FBgn0052710 CG32710 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32710 CG32710 CDMC28865 3 24 10 DAC17-C06 1-CG32710-RA_1 CG32710 CAACATTCAAAACAGCAGCAACTACAGCACCACCGTGGCGTATGCAGTTTTGGCCAGCAGTCGTC 65 FBan0032710 FBgn0052710 CG32710 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32710 CG32710 CDMC28866 3 25 10 DAC17-C18 41-CG32778-RA_5 CG32778 GCAGCAATATGAGCAAATGCGTTATGCCCAAAGTCATGTTAGCGTTGGTCCAAGCGGAGAACTAA 65 FBan0032778 FBgn0052778 CG32778 X X "ATP synthesis coupled proton transport; GO:0015986; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" "ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 CG32778 CG32778 "CG4985, CG4985" CDMC28866 3 26 10 DAC17-C18 41-CG32778-RA_5 CG32778 GCAGCAATATGAGCAAATGCGTTATGCCCAAAGTCATGTTAGCGTTGGTCCAAGCGGAGAACTAA 65 FBan0032778 FBgn0052778 CG32778 X X "ATP synthesis coupled proton transport; GO:0015986; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" "ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleus; GO:0005634; proton-transporting two-sector ATPase complex; GO:0016469 CG32778 CG32778 "CG4985, CG4985" CDMC28867 3 1 11 DAC17-G06 3-CG3287-RB_4 CG3287 TTGCTGCGCTACCTGTATGTTTTCATCGGATCGGTGCTGAGTTTGGACACGTGGTTGCTGCGATC 65 FBan0003287 FBgn0028954 CG3287 2 2R CG3287 CG3287 "BEST:LD11166, n(2)09967" CDMC28867 3 2 11 DAC17-G06 3-CG3287-RB_4 CG3287 TTGCTGCGCTACCTGTATGTTTTCATCGGATCGGTGCTGAGTTTGGACACGTGGTTGCTGCGATC 65 FBan0003287 FBgn0028954 CG3287 2 2R CG3287 CG3287 "BEST:LD11166, n(2)09967" CDMC28868 3 3 11 DAC17-G18 23-CG32973-RA_1 CG32973 CTGCTGCATTTTTCACTCGCATTGTCGTTTCTTCATTTTTTTTAAGCTCTGCGCAAATATATTGA 65 FBan0032973 FBgn0052973 CG32973 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32973 CG32973 CDMC28868 3 4 11 DAC17-G18 23-CG32973-RA_1 CG32973 CTGCTGCATTTTTCACTCGCATTGTCGTTTCTTCATTTTTTTTAAGCTCTGCGCAAATATATTGA 65 FBan0032973 FBgn0052973 CG32973 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32973 CG32973 CDMC28869 3 5 11 DAC17-K06 23-CG33129-RC_1 CG33129 GAAACTCATTGAAATTAAGTTAGAAAATGGCTCAGGTTAAACCGAAAAGTAACAAACAGAGCGGC 65 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC28869 3 6 11 DAC17-K06 23-CG33129-RC_1 CG33129 GAAACTCATTGAAATTAAGTTAGAAAATGGCTCAGGTTAAACCGAAAAGTAACAAACAGAGCGGC 65 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC28870 3 7 11 DAC17-K18 3-CG33157-RD_4 CG33157 GCCCGGATTTTTGGCGTACTACCCCTGGCCGGAATAAATCCTAATGGCAAGCCGGAAAATGTTCG 65 FBgn0053157 CDMC28870 3 8 11 DAC17-K18 3-CG33157-RD_4 CG33157 GCCCGGATTTTTGGCGTACTACCCCTGGCCGGAATAAATCCTAATGGCAAGCCGGAAAATGTTCG 65 FBgn0053157 CDMC28871 3 9 11 DAC17-O06 1-CG33256-RA_2 CG33256 AGGATCGGGACCCTTTTCACCTAGGAGCAGTCTTGCCTTTGTGGGAGAATCCTTGGAGGGCATAG 65 FBan0033256 FBgn0053256 CG33256 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33256 CG33256 CDMC28871 3 10 11 DAC17-O06 1-CG33256-RA_2 CG33256 AGGATCGGGACCCTTTTCACCTAGGAGCAGTCTTGCCTTTGTGGGAGAATCCTTGGAGGGCATAG 65 FBan0033256 FBgn0053256 CG33256 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33256 CG33256 CDMC28872 3 11 11 DAC17-O18 23-CG33276-RA_1 CG33276 AAACAAAAATGGACTATTGCTAATCTGCTTAAGTGGATGCATGCGAATATTTTAACGGAGCGTCC 65 FBan0033276 FBgn0053276 CG33276 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 extracellular region; GO:0005576 CG33276 CG33276 anon-AE003558.1 CDMC28872 3 12 11 DAC17-O18 23-CG33276-RA_1 CG33276 AAACAAAAATGGACTATTGCTAATCTGCTTAAGTGGATGCATGCGAATATTTTAACGGAGCGTCC 65 FBan0033276 FBgn0053276 CG33276 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 extracellular region; GO:0005576 CG33276 CG33276 anon-AE003558.1 CDMC28873 3 13 11 DAC18-C06 3-CG5962-RA_2 CG5962 TGGTCAGCAAGGGATTCACCTTCTCGAATGGCAAGATCAGTCTGGAGGTTACGCTGGACAGGGAGATC 68 FBan0005962 FBgn0000121 Arr2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; adaptation of rhodopsin mediated signaling; GO:0016062; deactivation of rhodopsin mediated signaling; GO:0016059; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; metarhodopsin inactivation; GO:0016060; phototransduction; GO:0007602 metarhodopsin binding; GO:0016030; ; GO:0016030 membrane fraction; GO:0005624; rhabdomere; GO:0016028; soluble fraction; GO:0005625 Arr2 Arrestin 2 "CG5962, arr2, arrestin-like protein, phosrestin-1, 49, 49kD Arrestin homolog, ArrB: Arrestin B, PRI, Phosrestin I, ArrB-ml, phosrestin I, arrestin2, arrestin, arrestin-2, Beta-Arrestin, AH, Arrestin B, ArrB" CDMC28873 3 14 11 DAC18-C06 3-CG5962-RA_2 CG5962 TGGTCAGCAAGGGATTCACCTTCTCGAATGGCAAGATCAGTCTGGAGGTTACGCTGGACAGGGAGATC 68 FBan0005962 FBgn0000121 Arr2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; adaptation of rhodopsin mediated signaling; GO:0016062; deactivation of rhodopsin mediated signaling; GO:0016059; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; metarhodopsin inactivation; GO:0016060; phototransduction; GO:0007602 metarhodopsin binding; GO:0016030; ; GO:0016030 membrane fraction; GO:0005624; rhabdomere; GO:0016028; soluble fraction; GO:0005625 Arr2 Arrestin 2 "CG5962, arr2, arrestin-like protein, phosrestin-1, 49, 49kD Arrestin homolog, ArrB: Arrestin B, PRI, Phosrestin I, ArrB-ml, phosrestin I, arrestin2, arrestin, arrestin-2, Beta-Arrestin, AH, Arrestin B, ArrB" CDMC28874 3 15 11 DAC18-C18 2-CG6026-RA_1 CG6026 AGCCAGATCCATCCTTTTCAGAGCTCCACCCTGAATCTCAGACTTCTGTTTCGGGAGTACTCGTGGCG 68 FBan0006026 FBgn0038676 CG6026 3 3R CG6026 CG6026 CDMC28874 3 16 11 DAC18-C18 2-CG6026-RA_1 CG6026 AGCCAGATCCATCCTTTTCAGAGCTCCACCCTGAATCTCAGACTTCTGTTTCGGGAGTACTCGTGGCG 68 FBan0006026 FBgn0038676 CG6026 3 3R CG6026 CG6026 CDMC28875 3 17 11 DAC18-G06 3-CG6571-RD_1 CG6571 GGACCTCAACGGAGATGGCAAAGTGGACTTGAACGAATTCCTGGAAGCGTTCAGGCTGAGTGATCTGC 68 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC28875 3 18 11 DAC18-G06 3-CG6571-RD_1 CG6571 GGACCTCAACGGAGATGGCAAAGTGGACTTGAACGAATTCCTGGAAGCGTTCAGGCTGAGTGATCTGC 68 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC28876 3 19 11 DAC18-G18 2-CG6666-RA_2 CG6666 ACACCGCCAATGGTATTAGGCATCTCCTCTGGGACACCGGACGGTTCCTGAAGATCAAGGAGGTTTAC 68 FBan0006666 FBgn0037873 CG6666 3 3R "mitochondrial electron transport, succinate to ubiquinone; GO:0006121; succinate metabolism; GO:0006105; tricarboxylic acid cycle; GO:0006099" succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0000104 ; EC:1.3.99.1; ; GO:0008177 ; EC:1.3.5.1 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG6666 CG6666 BcDNA:RH04289 CDMC28876 3 20 11 DAC18-G18 2-CG6666-RA_2 CG6666 ACACCGCCAATGGTATTAGGCATCTCCTCTGGGACACCGGACGGTTCCTGAAGATCAAGGAGGTTTAC 68 FBan0006666 FBgn0037873 CG6666 3 3R "mitochondrial electron transport, succinate to ubiquinone; GO:0006121; succinate metabolism; GO:0006105; tricarboxylic acid cycle; GO:0006099" succinate dehydrogenase activity; GO:0000104 ; EC:1.3.99.1; succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0000104 ; EC:1.3.99.1; ; GO:0008177 ; EC:1.3.5.1 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG6666 CG6666 BcDNA:RH04289 CDMC28877 3 21 11 DAC18-K06 47-CG7050-RA_3 CG7050 GCGACCCCCATATCACCATCCGTGGAGATGTTCAATTGGTAACTGGAGTATTAGATAGAAATGATCTG 68 FBan0007050 FBgn0038975 Nrx-1 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 plasma membrane; GO:0005886 Nrx-1 Neurexin 1 "CG7050, CG7050, CG7050, CT21808, Neurexin-like, dnrx-1, Neurexin 1" CDMC28877 3 22 11 DAC18-K06 47-CG7050-RA_3 CG7050 GCGACCCCCATATCACCATCCGTGGAGATGTTCAATTGGTAACTGGAGTATTAGATAGAAATGATCTG 68 FBan0007050 FBgn0038975 Nrx-1 3 3R cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 plasma membrane; GO:0005886 Nrx-1 Neurexin 1 "CG7050, CG7050, CG7050, CT21808, Neurexin-like, dnrx-1, Neurexin 1" CDMC28878 3 23 11 DAC18-K18 3-CG7156-RA_1 CG7156 TCCGGAGCTACGTTTGGACTACGACCAATTGCAGGCTCATCCATTCTTCAAAGGCATCGATTGGCAGG 68 FBan0007156 FBgn0038588 CG7156 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG7156 CG7156 CDMC28878 3 24 11 DAC18-K18 3-CG7156-RA_1 CG7156 TCCGGAGCTACGTTTGGACTACGACCAATTGCAGGCTCATCCATTCTTCAAAGGCATCGATTGGCAGG 68 FBan0007156 FBgn0038588 CG7156 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG7156 CG7156 CDMC28879 3 25 11 DAC18-O06 6-CG7488-RA_2 CG7488 TGGTGCACGATGCCTCAAATGCCTGGACTAGGAAGGAACTGCATCCCACTGTCTTGGATACGCTGAAG 68 FBan0007488 FBgn0038106 CG7488 3 3R regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 CG7488 CG7488 CDMC28879 3 26 11 DAC18-O06 6-CG7488-RA_2 CG7488 TGGTGCACGATGCCTCAAATGCCTGGACTAGGAAGGAACTGCATCCCACTGTCTTGGATACGCTGAAG 68 FBan0007488 FBgn0038106 CG7488 3 3R regulation of progression through cell cycle; GO:0000074 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 CG7488 CG7488 CDMC28880 3 1 12 DAC18-O18 3-CG7724-RA_1 CG7724 GCCTCCTACACGTCCTCGATGCTGATGTACAATCGTCTAAGGGCCTCCATCCACATGGACTACATGCC 68 FBan0007724 FBgn0036698 CG7724 3 3L cholesterol metabolism; GO:0008203; steroid biosynthesis; GO:0006694 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-; 3-beta-hydroxy-delta5-steroid dehydrogenase activity; GO:0003854 ; EC:1.1.1.145; ; GO:0003854 ; EC:1.1.1.145" CG7724 CG7724 CDMC28880 3 2 12 DAC18-O18 3-CG7724-RA_1 CG7724 GCCTCCTACACGTCCTCGATGCTGATGTACAATCGTCTAAGGGCCTCCATCCACATGGACTACATGCC 68 FBan0007724 FBgn0036698 CG7724 3 3L cholesterol metabolism; GO:0008203; steroid biosynthesis; GO:0006694 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-; 3-beta-hydroxy-delta5-steroid dehydrogenase activity; GO:0003854 ; EC:1.1.1.145; ; GO:0003854 ; EC:1.1.1.145" CG7724 CG7724 CDMC28881 3 3 12 DAC19-C06 15-CG17801-RA_1 CG17801 GCGACCAGTGCACCAAGAGATTCAATACCAAGACCTGCTTGAATAAGCACAAGTTCCTGCACTCAGGTC 69 FBan0017801 FBgn0038550 CG17801 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17801 CG17801 CDMC28881 3 4 12 DAC19-C06 15-CG17801-RA_1 CG17801 GCGACCAGTGCACCAAGAGATTCAATACCAAGACCTGCTTGAATAAGCACAAGTTCCTGCACTCAGGTC 69 FBan0017801 FBgn0038550 CG17801 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17801 CG17801 CDMC28882 3 5 12 DAC19-C18 3-CG17819-RA_2 CG17819 TGGGCCTATATCGCCTAACTGGTCGAGATTGGACTTTTGAGGAATGTTCCATGCGGACAGGGTCTGGTG 69 FBan0017819 FBgn0038915 CG17819 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein amino acid ADP-ribosylation; GO:0006471; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG17819 CG17819 BcDNA:LP07781 CDMC28882 3 6 12 DAC19-C18 3-CG17819-RA_2 CG17819 TGGGCCTATATCGCCTAACTGGTCGAGATTGGACTTTTGAGGAATGTTCCATGCGGACAGGGTCTGGTG 69 FBan0017819 FBgn0038915 CG17819 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein amino acid ADP-ribosylation; GO:0006471; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG17819 CG17819 BcDNA:LP07781 CDMC28883 3 7 12 DAC19-G06 16-CG17870-RB_1 CG17870 GTGCGGAAATCGGTTCAAATCCCATGAATCAGGAACCATATCTGTTAGAGGAATGTGGCGAGAACGGAA 69 FBan0017870 FBgn0004907 14-3-3zeta 2 2R "Ras protein signal transduction; GO:0007265; cell proliferation; GO:0008283; chromosome segregation; GO:0007059; learning and/or memory; GO:0007611; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic cell cycle, embryonic; GO:0045448; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of progression through cell cycle; GO:0000074; tryptophan hydroxylase activation; GO:0006588" protein kinase C inhibitor activity; GO:0008426; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0008426; tryptophan hydroxylase activator activity; GO:0016483; ; GO:0004863; ; GO:0016483; protein domain specific binding; GO:0019904; ; GO:0019904 nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3zeta 14-3-3zeta "CG17870, CG17870, 549, 2G1, 5.11, leonardo, leo: leonardo, D14-3-3zeta, K, Complementation group K, 14-3-3, 14-3-3zeta, Leonardo-13-3-3, leonardo 14-3-3, 4-3-3 zeta, par-5, Par-5, PAR5, d14-3-3zeta, l(2)46CFe, l(2)46Ee, D14-3-3: D14 3 3 protein, l(2)07103, BEST:GH05075, D14 3 3 protein, leo" CDMC28883 3 8 12 DAC19-G06 16-CG17870-RB_1 CG17870 GTGCGGAAATCGGTTCAAATCCCATGAATCAGGAACCATATCTGTTAGAGGAATGTGGCGAGAACGGAA 69 FBan0017870 FBgn0004907 14-3-3zeta 2 2R "Ras protein signal transduction; GO:0007265; cell proliferation; GO:0008283; chromosome segregation; GO:0007059; learning and/or memory; GO:0007611; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic cell cycle, embryonic; GO:0045448; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of progression through cell cycle; GO:0000074; tryptophan hydroxylase activation; GO:0006588" protein kinase C inhibitor activity; GO:0008426; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0008426; tryptophan hydroxylase activator activity; GO:0016483; ; GO:0004863; ; GO:0016483; protein domain specific binding; GO:0019904; ; GO:0019904 nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3zeta 14-3-3zeta "CG17870, CG17870, 549, 2G1, 5.11, leonardo, leo: leonardo, D14-3-3zeta, K, Complementation group K, 14-3-3, 14-3-3zeta, Leonardo-13-3-3, leonardo 14-3-3, 4-3-3 zeta, par-5, Par-5, PAR5, d14-3-3zeta, l(2)46CFe, l(2)46Ee, D14-3-3: D14 3 3 protein, l(2)07103, BEST:GH05075, D14 3 3 protein, leo" CDMC28884 3 9 12 DAC19-G18 23-CG17894-RC_10 CG17894 ATGCTATCAAAAGCTTCCAAGGATCTCTGACCACCTTTGACCAATCCCTGTACTTGTATGTCGCTATAT 69 FBan0017894 FBgn0000338 cnc 3 3R bicoid mRNA localization; GO:0045450; blastoderm segmentation; GO:0007350; defense response; GO:0006952; hemopoiesis; GO:0030097; maintenance of oocyte nucleus localization during oocyte axis determination; GO:0042070; mesoderm development; GO:0007498; oocyte dorsal/ventral axis determination; GO:0007310; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to stress; GO:0006950 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0046982; ; GO:0016563 nucleus; GO:0005634 cnc cap-n-collar "CG4578, CG4566, CG17894, CG4578, CG4566, cap 'n' collar, l(3)03921, 5134, CNC_DROME, CNC, cap'n'collar, Cap 'n' collar, Cnc, cap and collar, anon-WO0153538.6, anon-WO0153538.7" CDMC28884 3 10 12 DAC19-G18 23-CG17894-RC_10 CG17894 ATGCTATCAAAAGCTTCCAAGGATCTCTGACCACCTTTGACCAATCCCTGTACTTGTATGTCGCTATAT 69 FBan0017894 FBgn0000338 cnc 3 3R bicoid mRNA localization; GO:0045450; blastoderm segmentation; GO:0007350; defense response; GO:0006952; hemopoiesis; GO:0030097; maintenance of oocyte nucleus localization during oocyte axis determination; GO:0042070; mesoderm development; GO:0007498; oocyte dorsal/ventral axis determination; GO:0007310; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; regulation of pole plasm oskar mRNA localization; GO:0007317; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to stress; GO:0006950 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; ; GO:0046982; ; GO:0016563 nucleus; GO:0005634 cnc cap-n-collar "CG4578, CG4566, CG17894, CG4578, CG4566, cap 'n' collar, l(3)03921, 5134, CNC_DROME, CNC, cap'n'collar, Cap 'n' collar, Cnc, cap and collar, anon-WO0153538.6, anon-WO0153538.7" CDMC28885 3 11 12 DAC19-K06 2-CG17932-RB_1 CG17932 GGTGCCAATGAGTGCCGAAGATGAGAAAGTGCTCAACGATGGTATGGCTGGAATGGTGAAGGAGAAGCC 69 FBan0017932 FBgn0040260 Ugt36Bc 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Bc Ugt36Bc "CG17932, CG17932, AC 005121C" CDMC28885 3 12 12 DAC19-K06 2-CG17932-RB_1 CG17932 GGTGCCAATGAGTGCCGAAGATGAGAAAGTGCTCAACGATGGTATGGCTGGAATGGTGAAGGAGAAGCC 69 FBan0017932 FBgn0040260 Ugt36Bc 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Bc Ugt36Bc "CG17932, CG17932, AC 005121C" CDMC28886 3 13 12 DAC19-K18 23-CG17947-RA_17 CG17947 AAGCAATGCGAAAAATGACGGAAGAAGACAAACAAAAAATTGCTCAGCAAGTGGAGTTATTCCGTAGGG 69 FBan0017947 FBgn0010215 alpha-Cat 3 3L cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; establishment and/or maintenance of cell polarity; GO:0007163; oocyte localization during oogenesis; GO:0030720; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; cadherin binding; GO:0045296; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0045296; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0008965 ; EC:2.7.3.9 actin cytoskeleton; GO:0015629; adherens junction; GO:0005912; catenin complex; GO:0016342; cell-matrix junction; GO:0030055; cytoplasm; GO:0005737; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 alpha-Cat alpha Catenin "CG17947, CG17947, CG17947, CG17947, Dalpha-catenin, alpha-catenin, Dalpha-cadherin, Dmcatp, D-alpha-catenin, alphacat, alpha-catenin, alpha-Catenin, CT39986, alpha-CAT, a-cat, alpha-cat, Dalpha-cat, alpha-ctn, DalphaC, catenin, alpha-Cat, DalphaCatenin, Dalpha-Catenin" CDMC28886 3 14 12 DAC19-K18 23-CG17947-RA_17 CG17947 AAGCAATGCGAAAAATGACGGAAGAAGACAAACAAAAAATTGCTCAGCAAGTGGAGTTATTCCGTAGGG 69 FBan0017947 FBgn0010215 alpha-Cat 3 3L cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; establishment and/or maintenance of cell polarity; GO:0007163; oocyte localization during oogenesis; GO:0030720; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; cadherin binding; GO:0045296; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; sugar porter activity; GO:0005351; ; GO:0045296; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0008965 ; EC:2.7.3.9 actin cytoskeleton; GO:0015629; adherens junction; GO:0005912; catenin complex; GO:0016342; cell-matrix junction; GO:0030055; cytoplasm; GO:0005737; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 alpha-Cat alpha Catenin "CG17947, CG17947, CG17947, CG17947, Dalpha-catenin, alpha-catenin, Dalpha-cadherin, Dmcatp, D-alpha-catenin, alphacat, alpha-catenin, alpha-Catenin, CT39986, alpha-CAT, a-cat, alpha-cat, Dalpha-cat, alpha-ctn, DalphaC, catenin, alpha-Cat, DalphaCatenin, Dalpha-Catenin" CDMC28887 3 15 12 DAC19-O06 8-CG1799-RA_1 CG1799 CCCACTGCTCGACTACACCCGCCTATTCGATCGCAAGTGAGAGAAGAAAAGAGAATCGAGCGCTCGAAT 69 FBan0001799 FBgn0003204 ras X X GMP biosynthesis; GO:0006177; oogenesis (sensu Insecta); GO:0009993; purine base metabolism; GO:0006144 IMP dehydrogenase activity; GO:0003938 ; EC:1.1.1.205; ; GO:0003938 ; EC:1.1.1.205; ; GO:0003938 ; EC:1.1.1.205 ras raspberry "CG11485, CG1799, CG11485, CG11485, IMPDH, IMP dehydrogenase, l(1)G0127, l(1)G0056, l(1)G0238, l(1)G0436, l(1)G0391, l(1)G0388, l(1)G0351, l(1)G0098, raspberry/impd, inosine monophosphate dehydrogenase, l(1)G0482, l(1)G0002, raspberry-lethal, EP(X)1093, LD02673, LD06825, IMPdH, l(1)9Eb, ras-l: raspberry-lethal, l(1)G0380, raspberry" CDMC28887 3 16 12 DAC19-O06 8-CG1799-RA_1 CG1799 CCCACTGCTCGACTACACCCGCCTATTCGATCGCAAGTGAGAGAAGAAAAGAGAATCGAGCGCTCGAAT 69 FBan0001799 FBgn0003204 ras X X GMP biosynthesis; GO:0006177; oogenesis (sensu Insecta); GO:0009993; purine base metabolism; GO:0006144 IMP dehydrogenase activity; GO:0003938 ; EC:1.1.1.205; ; GO:0003938 ; EC:1.1.1.205; ; GO:0003938 ; EC:1.1.1.205 ras raspberry "CG11485, CG1799, CG11485, CG11485, IMPDH, IMP dehydrogenase, l(1)G0127, l(1)G0056, l(1)G0238, l(1)G0436, l(1)G0391, l(1)G0388, l(1)G0351, l(1)G0098, raspberry/impd, inosine monophosphate dehydrogenase, l(1)G0482, l(1)G0002, raspberry-lethal, EP(X)1093, LD02673, LD06825, IMPdH, l(1)9Eb, ras-l: raspberry-lethal, l(1)G0380, raspberry" CDMC28888 3 17 12 DAC19-O18 13-CG18011-RA_1 CG18011 CGGCTGTGGACGGACTTTTGTAAACAGTTCCCAGTTGAATGTGCATGTCCGAAAGATTCACGATGGCAT 69 FBan0018011 FBgn0033491 CG18011 2 2R electron transport; GO:0006118 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0008270; ; GO:0005489; ; GO:0005506 nucleus; GO:0005634 CG18011 CG18011 CG17847 CDMC28888 3 18 12 DAC19-O18 13-CG18011-RA_1 CG18011 CGGCTGTGGACGGACTTTTGTAAACAGTTCCCAGTTGAATGTGCATGTCCGAAAGATTCACGATGGCAT 69 FBan0018011 FBgn0033491 CG18011 2 2R electron transport; GO:0006118 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0008270; ; GO:0005489; ; GO:0005506 nucleus; GO:0005634 CG18011 CG18011 CG17847 CDMC28889 3 19 12 DAC20-C06 1-CG10674-RA_1 CG10674 AACAGGTGCTCTCCTCCTTTATGTTGAGCGTCAGTGCGGTGGTGATGTCCTACCTCCAGAATCCC 65 FBan0010674 FBgn0035592 CG10674 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10674 CG10674 CDMC28889 3 20 12 DAC20-C06 1-CG10674-RA_1 CG10674 AACAGGTGCTCTCCTCCTTTATGTTGAGCGTCAGTGCGGTGGTGATGTCCTACCTCCAGAATCCC 65 FBan0010674 FBgn0035592 CG10674 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10674 CG10674 CDMC28890 3 21 12 DAC20-C18 23-CG10706-RA_2 CG10706 TGCCCCCTTCATTATTAGACTCATCATTGTGCCCATCAATAAACGTAGAAAAGCTTTGGGAAAGC 65 FBan0010706 FBgn0029761 SK X X cation transport; GO:0006812; lipid catabolism; GO:0016042; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; small conductance calcium-activated potassium channel activity; GO:0016286; calcium-activated potassium channel activity; GO:0015269; ; GO:0005516; calcium ion binding; GO:0005509; voltage-gated potassium channel activity; GO:0005249; ; GO:0005509; ; GO:0015269; ; GO:0005249; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0016286; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004623 ; EC:3.1.1.4 integral to membrane; GO:0016021; membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 SK small conductance calcium-activated potassium channel "CG10706, CG12733, CG4179, dSK, BcDNA:GM01744, small conductance calcium-activated potassium channel" CDMC28890 3 22 12 DAC20-C18 23-CG10706-RA_2 CG10706 TGCCCCCTTCATTATTAGACTCATCATTGTGCCCATCAATAAACGTAGAAAAGCTTTGGGAAAGC 65 FBan0010706 FBgn0029761 SK X X cation transport; GO:0006812; lipid catabolism; GO:0016042; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; small conductance calcium-activated potassium channel activity; GO:0016286; calcium-activated potassium channel activity; GO:0015269; ; GO:0005516; calcium ion binding; GO:0005509; voltage-gated potassium channel activity; GO:0005249; ; GO:0005509; ; GO:0015269; ; GO:0005249; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0016286; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004623 ; EC:3.1.1.4 integral to membrane; GO:0016021; membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 SK small conductance calcium-activated potassium channel "CG10706, CG12733, CG4179, dSK, BcDNA:GM01744, small conductance calcium-activated potassium channel" CDMC28891 3 23 12 DAC20-G06 1-CG10838-RA_1 CG10838 TTCCGATCAAAACGACCCTGGACTACACTCTGACACTCCACTACGCGGCACTGATGCAAACGGTG 65 FBan0010838 FBgn0028570 robl22E 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 robl22E robl22E "CG10838, CG10838" CDMC28891 3 24 12 DAC20-G06 1-CG10838-RA_1 CG10838 TTCCGATCAAAACGACCCTGGACTACACTCTGACACTCCACTACGCGGCACTGATGCAAACGGTG 65 FBan0010838 FBgn0028570 robl22E 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 robl22E robl22E "CG10838, CG10838" CDMC28892 3 25 12 DAC20-G18 18-CG10864-RA_9 CG10864 TGGGCGCTCTGATCGTGATCTATGCCATCTGTGGAGCATTCGCCTTCATGCACATCGAGCGCCAG 65 FBan0010864 FBgn0038621 CG10864 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 outward rectifier potassium channel activity; GO:0015271; ; GO:0015271 membrane; GO:0016020 CG10864 CG10864 CDMC28892 3 26 12 DAC20-G18 18-CG10864-RA_9 CG10864 TGGGCGCTCTGATCGTGATCTATGCCATCTGTGGAGCATTCGCCTTCATGCACATCGAGCGCCAG 65 FBan0010864 FBgn0038621 CG10864 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 outward rectifier potassium channel activity; GO:0015271; ; GO:0015271 membrane; GO:0016020 CG10864 CG10864 CDMC28893 3 1 13 DAC20-K06 2-CG10952-RA_1 CG10952 CAACACAGGCTCCCCCAACATCTGCGGTAACCAGCCCAGTGGACACTGTGATAACCATTTCATCG 65 FBan0010952 FBgn0000535 eag X X "behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; regulation of heart contraction rate; GO:0008016; regulation of transcription, DNA-dependent; GO:0006355; sensory perception of smell; GO:0007608; signal transduction; GO:0007165; two-component signal transduction system (phosphorelay); GO:0000160" voltage-gated potassium channel activity; GO:0005249; signal transducer activity; GO:0004871; ; GO:0005249; ; GO:0004871; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- integral to plasma membrane; GO:0005887; voltage-gated potassium channel complex; GO:0008076 eag ether a go-go "CG10952, Eag, CIKE, ether-a-go-go" CDMC28893 3 2 13 DAC20-K06 2-CG10952-RA_1 CG10952 CAACACAGGCTCCCCCAACATCTGCGGTAACCAGCCCAGTGGACACTGTGATAACCATTTCATCG 65 FBan0010952 FBgn0000535 eag X X "behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; regulation of heart contraction rate; GO:0008016; regulation of transcription, DNA-dependent; GO:0006355; sensory perception of smell; GO:0007608; signal transduction; GO:0007165; two-component signal transduction system (phosphorelay); GO:0000160" voltage-gated potassium channel activity; GO:0005249; signal transducer activity; GO:0004871; ; GO:0005249; ; GO:0004871; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- integral to plasma membrane; GO:0005887; voltage-gated potassium channel complex; GO:0008076 eag ether a go-go "CG10952, Eag, CIKE, ether-a-go-go" CDMC28894 3 3 13 DAC20-K18 13-CG10989-RA_1 CG10989 AACATGTGCGATGACAAGGACAAACACCTGGGCATGGATGTGACGGTGACTGCGCCCTTGGAAAC 65 FBan0010989 FBgn0037392 CG10989 3 3R CG10989 CG10989 CDMC28894 3 4 13 DAC20-K18 13-CG10989-RA_1 CG10989 AACATGTGCGATGACAAGGACAAACACCTGGGCATGGATGTGACGGTGACTGCGCCCTTGGAAAC 65 FBan0010989 FBgn0037392 CG10989 3 3R CG10989 CG10989 CDMC28895 3 5 13 DAC20-O06 1-CG11115-RA_1 CG11115 TCGGGGCTGTTTTGGATGATGCACATTTTCGGGATCAACTCATGTCTCAGGTAGATCCACCGCCC 65 FBan0011115 FBgn0037202 Ssl1 3 3L DNA repair; GO:0006281; regulation of transcription; GO:0045449; transcription initiation from RNA polymerase II promoter; GO:0006367 nucleic acid binding; GO:0003676; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0016251; ; GO:0003700; ; GO:0008270 transcription factor TFIIH complex; GO:0005675 Ssl1 Ssl1 "CG11115, CG11115, SSL1" CDMC28895 3 6 13 DAC20-O06 1-CG11115-RA_1 CG11115 TCGGGGCTGTTTTGGATGATGCACATTTTCGGGATCAACTCATGTCTCAGGTAGATCCACCGCCC 65 FBan0011115 FBgn0037202 Ssl1 3 3L DNA repair; GO:0006281; regulation of transcription; GO:0045449; transcription initiation from RNA polymerase II promoter; GO:0006367 nucleic acid binding; GO:0003676; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0016251; ; GO:0003700; ; GO:0008270 transcription factor TFIIH complex; GO:0005675 Ssl1 Ssl1 "CG11115, CG11115, SSL1" CDMC28896 3 7 13 DAC20-O18 1-CG11153-RA_2 CG11153 CACCGAACAGCTCTTCCCAAAGGGATCACTGCGAAAACCTTACTCCTGTTGTGTCCAGTCCTCCC 65 FBan0011153 FBgn0039938 Sox102F 4 4 regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox102F Sox102F "CG11153, CG11153, CG11153, SOX102D, SOXD, Sox D, Sox102D, SoxD" CDMC28896 3 8 13 DAC20-O18 1-CG11153-RA_2 CG11153 CACCGAACAGCTCTTCCCAAAGGGATCACTGCGAAAACCTTACTCCTGTTGTGTCCAGTCCTCCC 65 FBan0011153 FBgn0039938 Sox102F 4 4 regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox102F Sox102F "CG11153, CG11153, CG11153, SOX102D, SOXD, Sox D, Sox102D, SoxD" CDMC28897 3 9 13 DAC21-C06 2-CG11235-RA_1 CG11235 AGGATTTTCATGGCTGGTAGCTAAAGCCTTCCCCGTTTCTCCAACGTTCCCTCTTGCCGTTGCTG 65 FBan0011235 FBgn0031135 CG11235 X X CG11235 CG11235 CDMC28897 3 10 13 DAC21-C06 2-CG11235-RA_1 CG11235 AGGATTTTCATGGCTGGTAGCTAAAGCCTTCCCCGTTTCTCCAACGTTCCCTCTTGCCGTTGCTG 65 FBan0011235 FBgn0031135 CG11235 X X CG11235 CG11235 CDMC28898 3 11 13 DAC21-C18 9-CG11284-RA_2 CG11284 ATTCGAGGAGGAATCTGGGAAAGCGCAATGCCCGTACAATCCCCAATTGAGATCAGCAACCGTGC 65 FBan0011284 FBgn0030056 CG11284 X X one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG11284 CG11284 CDMC28898 3 12 13 DAC21-C18 9-CG11284-RA_2 CG11284 ATTCGAGGAGGAATCTGGGAAAGCGCAATGCCCGTACAATCCCCAATTGAGATCAGCAACCGTGC 65 FBan0011284 FBgn0030056 CG11284 X X one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG11284 CG11284 CDMC28899 3 13 13 DAC21-G06 23-CG11421-RA_1 CG11421 TGTGGTAGTTTAGTTTCTGCTAGTTTTCAATAGCTGTCGAGTAATAAACGTAGGCGAGTTGTGCA 65 FBan0011421 FBgn0011281 Pbprp3 3 3R response to pheromone; GO:0019236; sensory perception; GO:0007600; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Pbprp3 Pheromone-binding protein-related protein 3 "CG11421, OS-F, PBP-H2, Pheromone-binding protein Homolog 2, Olfactory-specific-F, pbprp-3, Os-F, PB-PRP3, pbprp3(OS-F), 83a, OS-F/PBP3, PBPRP3, PBPRP-3, Obp83a" CDMC28899 3 14 13 DAC21-G06 23-CG11421-RA_1 CG11421 TGTGGTAGTTTAGTTTCTGCTAGTTTTCAATAGCTGTCGAGTAATAAACGTAGGCGAGTTGTGCA 65 FBan0011421 FBgn0011281 Pbprp3 3 3R response to pheromone; GO:0019236; sensory perception; GO:0007600; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Pbprp3 Pheromone-binding protein-related protein 3 "CG11421, OS-F, PBP-H2, Pheromone-binding protein Homolog 2, Olfactory-specific-F, pbprp-3, Os-F, PB-PRP3, pbprp3(OS-F), 83a, OS-F/PBP3, PBPRP3, PBPRP-3, Obp83a" CDMC28900 3 15 13 DAC21-G18 18-CG1146-RA_11 CG1146 GCCTGGAAGTATGCGGAATGGCTACCTTACCTCCTCGTCTCCTACGTGGTAGTCACCCTGCTGCC 65 FBan0001146 FBgn0035346 CG1146 3 3L CG1146 CG1146 CDMC28900 3 16 13 DAC21-G18 18-CG1146-RA_11 CG1146 GCCTGGAAGTATGCGGAATGGCTACCTTACCTCCTCGTCTCCTACGTGGTAGTCACCCTGCTGCC 65 FBan0001146 FBgn0035346 CG1146 3 3L CG1146 CG1146 CDMC28901 3 17 13 DAC21-K06 3-CG11581-RA_1 CG11581 CTACTTCTGCCCCTGATCAACGGAGATGTGAGTCACCTGCCCAGGGAATATATACCGCCCAGTGC 65 FBan0011581 FBgn0030540 CG11581 X X CG11581 CG11581 CDMC28901 3 18 13 DAC21-K06 3-CG11581-RA_1 CG11581 CTACTTCTGCCCCTGATCAACGGAGATGTGAGTCACCTGCCCAGGGAATATATACCGCCCAGTGC 65 FBan0011581 FBgn0030540 CG11581 X X CG11581 CG11581 CDMC28902 3 19 13 DAC21-K18 24-CG11598-RA_4 CG11598 AGATCTAACGTTAAACCGATAAATATTATTCATATATCAGCGTTTTTTTCACTTATTCCTCCTCG 65 FBan0011598 FBgn0038067 CG11598 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG11598 CG11598 CDMC28902 3 20 13 DAC21-K18 24-CG11598-RA_4 CG11598 AGATCTAACGTTAAACCGATAAATATTATTCATATATCAGCGTTTTTTTCACTTATTCCTCCTCG 65 FBan0011598 FBgn0038067 CG11598 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG11598 CG11598 CDMC28903 3 21 13 DAC21-O06 18-CG11695-RA_5 CG11695 CAACTGGTCAGCCGGATTAGCTACGATGTACACATGCTACGCTTCCATCCCAACAAGGACGACCT 65 FBan0011695 FBgn0030316 CG11695 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11695 CG11695 c CDMC28903 3 22 13 DAC21-O06 18-CG11695-RA_5 CG11695 CAACTGGTCAGCCGGATTAGCTACGATGTACACATGCTACGCTTCCATCCCAACAAGGACGACCT 65 FBan0011695 FBgn0030316 CG11695 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11695 CG11695 c CDMC28904 3 23 13 DAC21-O18 3-CG1172-RA_3 CG1172 CAAGGTGCCAATCGACGAGTGCAGCATACACCAGGGATATGTGGTGCAGGTGATTGTCAACACGG 65 FBan0001172 FBgn0037321 CG1172 3 3R CG1172 CG1172 CDMC28904 3 24 13 DAC21-O18 3-CG1172-RA_3 CG1172 CAAGGTGCCAATCGACGAGTGCAGCATACACCAGGGATATGTGGTGCAGGTGATTGTCAACACGG 65 FBan0001172 FBgn0037321 CG1172 3 3R CG1172 CG1172 CDMC28905 3 25 13 DAC22-C06 16-CG31676-RA_1 CG31676 TCAACAAGTTTTAGTCACTTTGCCCTCACGAATCTGCACAAATCACAGACGAACAGGATGCCCCG 65 FBan0031676 FBgn0051676 CG31676 2 2L CG31676 CG31676 "CG14403, CG14404, BcDNA:RH34376" CDMC28905 3 26 13 DAC22-C06 16-CG31676-RA_1 CG31676 TCAACAAGTTTTAGTCACTTTGCCCTCACGAATCTGCACAAATCACAGACGAACAGGATGCCCCG 65 FBan0031676 FBgn0051676 CG31676 2 2L CG31676 CG31676 "CG14403, CG14404, BcDNA:RH34376" CDMC28906 3 1 14 DAC22-C18 15-CG3169-RA_1 CG3169 CGGACCTTCGCATCCCAACGCCGACAATGAACATTTTGGCCTATCTGGCGCATGAGACCATTGCC 65 FBan0003169 FBgn0037981 Spt3 3 3R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016251 SAGA complex; GO:0000124; histone acetyltransferase complex; GO:0000123; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Spt3 Spt3 "CG3169, CG3169, SPT3, dSpt3, TFIID" CDMC28906 3 2 14 DAC22-C18 15-CG3169-RA_1 CG3169 CGGACCTTCGCATCCCAACGCCGACAATGAACATTTTGGCCTATCTGGCGCATGAGACCATTGCC 65 FBan0003169 FBgn0037981 Spt3 3 3R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016251 SAGA complex; GO:0000124; histone acetyltransferase complex; GO:0000123; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Spt3 Spt3 "CG3169, CG3169, SPT3, dSpt3, TFIID" CDMC28907 3 3 14 DAC22-G06 3-CG31794-RA_1 CG31794 GATTCTTATACGCCCAATCATGCTGTTCCGGGACAACAGGTGCATCAGGCCTATACGTCGCAGGC 65 FBan0031794 FBgn0041789 Pax 2 2L cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 focal adhesion; GO:0005925 Pax Paxillin "CG18576, CG31794, CG18061, CG18576, CG18576, CG31794, paxillin, CT40481, CT42454, Dpax, PDLP, paxillin-derived LIM-only protein, DPxn37, Paxillin-derived LIM-only protein, DPaxillin, DPxn, Paxillin" CDMC28907 3 4 14 DAC22-G06 3-CG31794-RA_1 CG31794 GATTCTTATACGCCCAATCATGCTGTTCCGGGACAACAGGTGCATCAGGCCTATACGTCGCAGGC 65 FBan0031794 FBgn0041789 Pax 2 2L cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 focal adhesion; GO:0005925 Pax Paxillin "CG18576, CG31794, CG18061, CG18576, CG18576, CG31794, paxillin, CT40481, CT42454, Dpax, PDLP, paxillin-derived LIM-only protein, DPxn37, Paxillin-derived LIM-only protein, DPaxillin, DPxn, Paxillin" CDMC28908 3 5 14 DAC22-G18 3-CG31824-RA_1 CG31824 CTATTCCCCGACCTGAGCAGCCCATGTATACCAAAGGTGCTCCTCTAGTTTGTCCCACCGAGAGC 65 FBan0031824 FBgn0051824 CG31824 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31824 CG31824 CG18629 CDMC28908 3 6 14 DAC22-G18 3-CG31824-RA_1 CG31824 CTATTCCCCGACCTGAGCAGCCCATGTATACCAAAGGTGCTCCTCTAGTTTGTCCCACCGAGAGC 65 FBan0031824 FBgn0051824 CG31824 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31824 CG31824 CG18629 CDMC28909 3 7 14 DAC22-K06 23-CG31952-RA_1 CG31952 TGAAATAATACGAAACTCAATATCTTTTTTGCTGTGTAAATCGACACCAGCAATTCAGCGAACGC 65 FBan0031952 FBgn0051952 CG31952 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31952 CG31952 "CG15413, CG15413, BcDNA:AT14709" CDMC28909 3 8 14 DAC22-K06 23-CG31952-RA_1 CG31952 TGAAATAATACGAAACTCAATATCTTTTTTGCTGTGTAAATCGACACCAGCAATTCAGCGAACGC 65 FBan0031952 FBgn0051952 CG31952 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31952 CG31952 "CG15413, CG15413, BcDNA:AT14709" CDMC28910 3 9 14 DAC22-K18 16-CG32013-RA_1 CG32013 GATAGCCTCAGCCGCGCCCTCCGTATTCGCTATCGGTTGGTCGTCGGTTTTTTTCTGCCCGTACC 65 FBan0032013 FBgn0052013 CG32013 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32013 CG32013 CDMC28910 3 10 14 DAC22-K18 16-CG32013-RA_1 CG32013 GATAGCCTCAGCCGCGCCCTCCGTATTCGCTATCGGTTGGTCGTCGGTTTTTTTCTGCCCGTACC 65 FBan0032013 FBgn0052013 CG32013 4 4 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32013 CG32013 CDMC28911 3 11 14 DAC22-O06 14-CG32130-RA_1 CG32130 GAGCCAGTGACTCCACAGCCACAGGATGCTACAAAGATGCAGGAACCCATCCCTCTACCAGCACC 65 FBan0032130 FBgn0052130 CG32130 3 3L apoptosis; GO:0006915; proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; protein binding; GO:0005515; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0005515; ; GO:0004263 ; EC:3.4.21.1 CG32130 CG32130 "CG10745, CG14108, GH04349" CDMC28911 3 12 14 DAC22-O06 14-CG32130-RA_1 CG32130 GAGCCAGTGACTCCACAGCCACAGGATGCTACAAAGATGCAGGAACCCATCCCTCTACCAGCACC 65 FBan0032130 FBgn0052130 CG32130 3 3L apoptosis; GO:0006915; proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; protein binding; GO:0005515; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0005515; ; GO:0004263 ; EC:3.4.21.1 CG32130 CG32130 "CG10745, CG14108, GH04349" CDMC28912 3 13 14 DAC22-O18 3-CG32156-RC_1 CG32156 AATATCATCGAGGATCCAGACCGCCAGTTCATGAGACTCCGGAGATGTGTCGAAACCAGCCCACG 65 FBan0032156 FBgn0005536 Mbs 3 3L dorsal closure; GO:0007391; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; regulation of eye photoreceptor development (sensu Endopterygota); GO:0045314; wing hair organization and biogenesis; GO:0035317 myosin binding; GO:0017022; ; GO:0017022; structural constituent of cytoskeleton; GO:0005200; myosin phosphatase activity; GO:0017018; ; GO:0017018; ; GO:0017018; ; GO:0005200; ; GO:0017022; ; GO:0017018; ; GO:0017018 myosin phosphatase complex; GO:0017023 Mbs Myosin binding subunit "CG5891, CG32156, CG5600, CG5891, l(3)72Dd: lethal(3)72Dd, l(3)03802, 0953/04, 0573/06, DMBS, DMYPT, Myosin phosphatase, MLC-phosphatase, DMbs, Mypt, l(3)j3B4, l(3)j7A1, l(3)S057306b, l(3)S057306, l(3)S005331b, l(3)S095304, lethal(3)72Dd, lethal (3) S057306b, lethal (3) S095304, l(3)72Dd, Myosin binding subunit" CDMC28912 3 14 14 DAC22-O18 3-CG32156-RC_1 CG32156 AATATCATCGAGGATCCAGACCGCCAGTTCATGAGACTCCGGAGATGTGTCGAAACCAGCCCACG 65 FBan0032156 FBgn0005536 Mbs 3 3L dorsal closure; GO:0007391; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; regulation of eye photoreceptor development (sensu Endopterygota); GO:0045314; wing hair organization and biogenesis; GO:0035317 myosin binding; GO:0017022; ; GO:0017022; structural constituent of cytoskeleton; GO:0005200; myosin phosphatase activity; GO:0017018; ; GO:0017018; ; GO:0017018; ; GO:0005200; ; GO:0017022; ; GO:0017018; ; GO:0017018 myosin phosphatase complex; GO:0017023 Mbs Myosin binding subunit "CG5891, CG32156, CG5600, CG5891, l(3)72Dd: lethal(3)72Dd, l(3)03802, 0953/04, 0573/06, DMBS, DMYPT, Myosin phosphatase, MLC-phosphatase, DMbs, Mypt, l(3)j3B4, l(3)j7A1, l(3)S057306b, l(3)S057306, l(3)S005331b, l(3)S095304, lethal(3)72Dd, lethal (3) S057306b, lethal (3) S095304, l(3)72Dd, Myosin binding subunit" CDMC28913 3 15 14 DAC23-C06 23-CG10753-RA_1 CG10753 AAAAATCACTCTGTGTAGTAGCTCAGGAAAAATGTGTTTACTTGGCAACAAATTGAAAGAAGACTCCCG 69 FBan0010753 FBgn0016940 snRNP69D 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 snRNP69D small nuclear ribonucleoprotein at 69D "CG10753, CG10753, snRNP, snRNP-69D, BcDNA:RE39488, small nuclear ribonucleoprotein at 69D" CDMC28913 3 16 14 DAC23-C06 23-CG10753-RA_1 CG10753 AAAAATCACTCTGTGTAGTAGCTCAGGAAAAATGTGTTTACTTGGCAACAAATTGAAAGAAGACTCCCG 69 FBan0010753 FBgn0016940 snRNP69D 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 snRNP69D small nuclear ribonucleoprotein at 69D "CG10753, CG10753, snRNP, snRNP-69D, BcDNA:RE39488, small nuclear ribonucleoprotein at 69D" CDMC28914 3 17 14 DAC23-C18 23-CG10764-RA_9 CG10764 CGTAGTGCTCGAAGGAATAAGCGCAATCAACCAAATTGAATCGGTTTCAAAGCACCCAAATTTTACTAC 69 FBan0010764 FBgn0034221 CG10764 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10764 CG10764 "GENE 2, gene 2, SP77, anon-54Ba" CDMC28914 3 18 14 DAC23-C18 23-CG10764-RA_9 CG10764 CGTAGTGCTCGAAGGAATAAGCGCAATCAACCAAATTGAATCGGTTTCAAAGCACCCAAATTTTACTAC 69 FBan0010764 FBgn0034221 CG10764 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10764 CG10764 "GENE 2, gene 2, SP77, anon-54Ba" CDMC28915 3 19 14 DAC23-G06 10-CG10808-RA_1 CG10808 CCCTGGTCCCCCCGATGATCAGCTTGTTAGCAATGGCAATAGCTCGAGACAGAGGAAAACATGATGTTT 69 FBan0010808 FBgn0033876 synaptogyrin 2 2R regulation of calcium ion-dependent exocytosis; GO:0017158; synaptic vesicle exocytosis; GO:0016079 membrane; GO:0016020 synaptogyrin synaptogyrin "CG10808, sng-1" CDMC28915 3 20 14 DAC23-G06 10-CG10808-RA_1 CG10808 CCCTGGTCCCCCCGATGATCAGCTTGTTAGCAATGGCAATAGCTCGAGACAGAGGAAAACATGATGTTT 69 FBan0010808 FBgn0033876 synaptogyrin 2 2R regulation of calcium ion-dependent exocytosis; GO:0017158; synaptic vesicle exocytosis; GO:0016079 membrane; GO:0016020 synaptogyrin synaptogyrin "CG10808, sng-1" CDMC28916 3 21 14 DAC23-G18 23-CG10816-RA_11 CG10816 AACCACAAAAGTCACGTTTGAGAGAAAAAAAGCCTAAACGAATTTAATTCGCGACTCATATGAATCACA 69 FBan0010816 FBgn0010388 Dro 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 Dro Drosocin "CG10816, CG10816, CG10816, drosocin, Drc, Drosocin, DIM 15, DIM 9, DIM 11, Drosophila Immune induced molecule 15, Drosophila Immune induced molecule 9, Drosophila Immune induced molecule 11, dro, DROC, drc, Dros, DIM-15, IM15, BcDNA:RH31634" CDMC28916 3 22 14 DAC23-G18 23-CG10816-RA_11 CG10816 AACCACAAAAGTCACGTTTGAGAGAAAAAAAGCCTAAACGAATTTAATTCGCGACTCATATGAATCACA 69 FBan0010816 FBgn0010388 Dro 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 Dro Drosocin "CG10816, CG10816, CG10816, drosocin, Drc, Drosocin, DIM 15, DIM 9, DIM 11, Drosophila Immune induced molecule 15, Drosophila Immune induced molecule 9, Drosophila Immune induced molecule 11, dro, DROC, drc, Dros, DIM-15, IM15, BcDNA:RH31634" CDMC28917 3 23 14 DAC23-K06 3-CG10846-RA_1 CG10846 CCGCCATGCAGGACGAGATGATCAACTACACTAAGTCATTCTACGAGCATTTCGTGAGGGCTCCAGCGC 69 FBan0010846 FBgn0040228 dyn-p25 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 dyn-p25 dynactin-subunit-p25 "CG10846, CG10846, C4, lethal group C4, l(2)br2, lethal 2 in the black-reduced region, br2, l(2)35Bf, BG:DS00929.1, DS00929.1, dynactin, p25 subunit, p25, lethal(2)35Bf, dynactin-subunit-p25" CDMC28917 3 24 14 DAC23-K06 3-CG10846-RA_1 CG10846 CCGCCATGCAGGACGAGATGATCAACTACACTAAGTCATTCTACGAGCATTTCGTGAGGGCTCCAGCGC 69 FBan0010846 FBgn0040228 dyn-p25 2 2L microtubule-based movement; GO:0007018 dynactin complex; GO:0005869; microtubule associated complex; GO:0005875 dyn-p25 dynactin-subunit-p25 "CG10846, CG10846, C4, lethal group C4, l(2)br2, lethal 2 in the black-reduced region, br2, l(2)35Bf, BG:DS00929.1, DS00929.1, dynactin, p25 subunit, p25, lethal(2)35Bf, dynactin-subunit-p25" CDMC28918 3 25 14 DAC23-K18 23-CG10852-RA_8 CG10852 GTGCATGCTATGAGCAAATGCAACCAAGCAATTTATCTAAATCTTGATCCTCACTGCGGAATACTTCCC 69 FBan0010852 FBgn0015585 Acp63F 3 3L physiological process; GO:0007582; post-mating behavior; GO:0045297 Acp63F Accessory gland peptide 63F "CG10852, CG10852, CG10852, Accessory gland protein 63F, Acp63F/64A, acp63F, Acp63f, Acp63" CDMC28918 3 26 14 DAC23-K18 23-CG10852-RA_8 CG10852 GTGCATGCTATGAGCAAATGCAACCAAGCAATTTATCTAAATCTTGATCCTCACTGCGGAATACTTCCC 69 FBan0010852 FBgn0015585 Acp63F 3 3L physiological process; GO:0007582; post-mating behavior; GO:0045297 Acp63F Accessory gland peptide 63F "CG10852, CG10852, CG10852, Accessory gland protein 63F, Acp63F/64A, acp63F, Acp63f, Acp63" CDMC28919 3 1 15 DAC23-O06 3-CG10909-RA_2 CG10909 TGGGCGATCGGTATCCCACATCTCGGATATAGTGGGTGACTCCGGAATGGTTTATGCTGTGGAGCAGAT 69 FBan0010909 FBgn0038090 CG10909 3 3R 35S primary transcript processing; GO:0006365; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532 CG10909 CG10909 CDMC28919 3 2 15 DAC23-O06 3-CG10909-RA_2 CG10909 TGGGCGATCGGTATCCCACATCTCGGATATAGTGGGTGACTCCGGAATGGTTTATGCTGTGGAGCAGAT 69 FBan0010909 FBgn0038090 CG10909 3 3R 35S primary transcript processing; GO:0006365; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532 CG10909 CG10909 CDMC28920 3 3 15 DAC23-O18 3-CG1091-RB_1 CG1091 GGCGACCGTCCCCGTCATCAAGGGCTTCCTTCGAAACTTCTTTGCGTATTTCGCCAAATTTGACTACGA 69 FBan0001091 FBgn0037470 CG1091 3 3R CG1091 CG1091 anon-WO0118547.222 CDMC28920 3 4 15 DAC23-O18 3-CG1091-RB_1 CG1091 GGCGACCGTCCCCGTCATCAAGGGCTTCCTTCGAAACTTCTTTGCGTATTTCGCCAAATTTGACTACGA 69 FBan0001091 FBgn0037470 CG1091 3 3R CG1091 CG1091 anon-WO0118547.222 CDMC28921 3 5 15 DAC24-C06 23-CG14938-RA_15 CG14938 TTAGTTGAACTACTAAAAGTAATGATTGAAAGCACGGATCGAAGGAATGGAGATAGGAGTTCCCGCGTG 69 FBan0014938 FBgn0020309 crol 2 2L cell adhesion; GO:0007155; cell proliferation; GO:0008283; homoiothermy; GO:0042309; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to freezing; GO:0050826; skeletal development; GO:0001501; wing morphogenesis; GO:0007476 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270; ice binding; GO:0050825; ; GO:0050825 nucleus; GO:0005634 crol crooked legs "CG14938, CG14938, CG14938, CG14938, CG14938, clone 1.74, clone 2.48, crol alpha, crol beta, crol gamma, l(2)04418, l(2)s2346, anon-EST:Liang-1.74, anon-EST:Liang-2.48, crooked legs" CDMC28921 3 6 15 DAC24-C06 23-CG14938-RA_15 CG14938 TTAGTTGAACTACTAAAAGTAATGATTGAAAGCACGGATCGAAGGAATGGAGATAGGAGTTCCCGCGTG 69 FBan0014938 FBgn0020309 crol 2 2L cell adhesion; GO:0007155; cell proliferation; GO:0008283; homoiothermy; GO:0042309; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to freezing; GO:0050826; skeletal development; GO:0001501; wing morphogenesis; GO:0007476 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270; ice binding; GO:0050825; ; GO:0050825 nucleus; GO:0005634 crol crooked legs "CG14938, CG14938, CG14938, CG14938, CG14938, clone 1.74, clone 2.48, crol alpha, crol beta, crol gamma, l(2)04418, l(2)s2346, anon-EST:Liang-1.74, anon-EST:Liang-2.48, crooked legs" CDMC28922 3 7 15 DAC24-C18 2-CG14952-RA_1 CG14952 AGCAGCAACATGAAACACCAAGGGGACTCCTACGTGCGATGGCGATACAAGAGCTTACAAACAGCTCGT 69 FBan0014952 FBgn0035377 CG14952 3 3L CG14952 CG14952 CDMC28922 3 8 15 DAC24-C18 2-CG14952-RA_1 CG14952 AGCAGCAACATGAAACACCAAGGGGACTCCTACGTGCGATGGCGATACAAGAGCTTACAAACAGCTCGT 69 FBan0014952 FBgn0035377 CG14952 3 3L CG14952 CG14952 CDMC28923 3 9 15 DAC24-G06 3-CG14980-RB_1 CG14980 ACGGATGTTTCTCCTCCTGCGGAAGTGAAGAACCTAATCCGGATAAGCGTAGGGAACTGCTCTGCCAGA 69 FBan0014980 FBgn0035470 CG14980 3 3L CG14980 CG14980 CDMC28923 3 10 15 DAC24-G06 3-CG14980-RB_1 CG14980 ACGGATGTTTCTCCTCCTGCGGAAGTGAAGAACCTAATCCGGATAAGCGTAGGGAACTGCTCTGCCAGA 69 FBan0014980 FBgn0035470 CG14980 3 3L CG14980 CG14980 CDMC28924 3 11 15 DAC24-G18 3-CG14991-RA_2 CG14991 CCGTCTGGAAGTTCCGTCAGAGATCAGAAATGGTCCGAACAGTGAGGTCTGGGTGAGATGCGACAACGA 69 FBan0014991 FBgn0035498 Fit1 3 3L cell-matrix adhesion; GO:0007160 cell adhesion molecule binding; GO:0050839; ; GO:0050839 cytoplasm; GO:0005737; cytoskeleton; GO:0005856 Fit1 Fermitin 1 "CG14991, anon-WO0118547.421, Fermitin 1" CDMC28924 3 12 15 DAC24-G18 3-CG14991-RA_2 CG14991 CCGTCTGGAAGTTCCGTCAGAGATCAGAAATGGTCCGAACAGTGAGGTCTGGGTGAGATGCGACAACGA 69 FBan0014991 FBgn0035498 Fit1 3 3L cell-matrix adhesion; GO:0007160 cell adhesion molecule binding; GO:0050839; ; GO:0050839 cytoplasm; GO:0005737; cytoskeleton; GO:0005856 Fit1 Fermitin 1 "CG14991, anon-WO0118547.421, Fermitin 1" CDMC28925 3 13 15 DAC24-K06 14-CG15014-RA_1 CG15014 TCGGAGACTTCAGAGGTCGCCAATGGCAACGATAAGGAGCAAGCTGAATCTTCAGAAGAGTCCAAGTCT 69 FBan0015014 FBgn0035532 CG15014 3 3L CG15014 CG15014 CDMC28925 3 14 15 DAC24-K06 14-CG15014-RA_1 CG15014 TCGGAGACTTCAGAGGTCGCCAATGGCAACGATAAGGAGCAAGCTGAATCTTCAGAAGAGTCCAAGTCT 69 FBan0015014 FBgn0035532 CG15014 3 3L CG15014 CG15014 CDMC28926 3 15 15 DAC24-K18 17-CG15021-RA_1 CG15021 TGTGTGTTGTGTTGTTAGGAAAACTCGGAAAAACCGCGCTCGTTTAGCATCGAGTAGAAATGCGCTGTT 69 FBan0015021 FBgn0035544 CG15021 3 3L CG15021 CG15021 CT34875 CDMC28926 3 16 15 DAC24-K18 17-CG15021-RA_1 CG15021 TGTGTGTTGTGTTGTTAGGAAAACTCGGAAAAACCGCGCTCGTTTAGCATCGAGTAGAAATGCGCTGTT 69 FBan0015021 FBgn0035544 CG15021 3 3L CG15021 CG15021 CT34875 CDMC28927 3 17 15 DAC24-O06 23-CG15068-RA_2 CG15068 GCAAAGTTTGCAATATACGCGGCGATTAGAATGTGGAAATCAGAATATGAAATAAACTAAAGTCACTGA 69 FBan0015068 FBgn0040733 CG15068 2 2R CG15068 CG15068 CT34939 CDMC28927 3 18 15 DAC24-O06 23-CG15068-RA_2 CG15068 GCAAAGTTTGCAATATACGCGGCGATTAGAATGTGGAAATCAGAATATGAAATAAACTAAAGTCACTGA 69 FBan0015068 FBgn0040733 CG15068 2 2R CG15068 CG15068 CT34939 CDMC28928 3 19 15 DAC24-O18 12-CG15080-RA_4 CG15080 TCGGAAAATTTCGAGACGGCTGAGTCCCAGAATCTAGGACCTCAGCTCTACAATGCTCTTCAAGCAGCC 69 FBan0015080 FBgn0034391 CG15080 2 2R CG15080 CG15080 CDMC28928 3 20 15 DAC24-O18 12-CG15080-RA_4 CG15080 TCGGAAAATTTCGAGACGGCTGAGTCCCAGAATCTAGGACCTCAGCTCTACAATGCTCTTCAAGCAGCC 69 FBan0015080 FBgn0034391 CG15080 2 2R CG15080 CG15080 CDMC28929 3 21 15 DAC25-C06 3-CG14324-RA_1 CG14324 CCCCAACCAGTAGTTATTCCCATCAAACACGGATGGAAGGGTGGTCTAGGTCTAGGTGGATTTGGCGGA 69 FBan0014324 FBgn0038527 CG14324 3 3R CG14324 CG14324 BcDNA:RE34075 CDMC28929 3 22 15 DAC25-C06 3-CG14324-RA_1 CG14324 CCCCAACCAGTAGTTATTCCCATCAAACACGGATGGAAGGGTGGTCTAGGTCTAGGTGGATTTGGCGGA 69 FBan0014324 FBgn0038527 CG14324 3 3R CG14324 CG14324 BcDNA:RE34075 CDMC28930 3 23 15 DAC25-C18 3-CG1433-RA_1 CG1433 GGTCACGCATCCGTTTGATCCGGAAACCTACGAAGACGAGATCGACGAAGAGGAGACAATGGACGAGGA 69 FBan0001433 FBgn0019637 Atu 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Atu Another transcription unit "CG1433, l(3)s1938" CDMC28930 3 24 15 DAC25-C18 3-CG1433-RA_1 CG1433 GGTCACGCATCCGTTTGATCCGGAAACCTACGAAGACGAGATCGACGAAGAGGAGACAATGGACGAGGA 69 FBan0001433 FBgn0019637 Atu 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Atu Another transcription unit "CG1433, l(3)s1938" CDMC28931 3 25 15 DAC25-G06 2-CG14383-RA_1 CG14383 CCCTCAGTGCCATGAGATATCTAGCCGTCCTGCGAAAATTGTTCAAGGCCACCTTTAAGGGCAAAGCGA 69 FBan0014383 FBgn0038102 CG14383 3 3R CG14383 CG14383 CDMC28931 3 26 15 DAC25-G06 2-CG14383-RA_1 CG14383 CCCTCAGTGCCATGAGATATCTAGCCGTCCTGCGAAAATTGTTCAAGGCCACCTTTAAGGGCAAAGCGA 69 FBan0014383 FBgn0038102 CG14383 3 3R CG14383 CG14383 CDMC28932 3 1 16 DAC25-G18 3-CG14401-RA_1 CG14401 GCTGGATTATCCACACTACCCTTGGTCATTGCCCTTTCGATACTCGGACTGCTTGTCCTACTGGCGACC 69 FBan0014401 FBgn0032900 CG14401 2 2L CG14401 CG14401 CDMC28932 3 2 16 DAC25-G18 3-CG14401-RA_1 CG14401 GCTGGATTATCCACACTACCCTTGGTCATTGCCCTTTCGATACTCGGACTGCTTGTCCTACTGGCGACC 69 FBan0014401 FBgn0032900 CG14401 2 2L CG14401 CG14401 CDMC28933 3 3 16 DAC25-K06 11-CG14438-RA_1 CG14438 GCTTCCGGCAGCTAGTGTCGCCAGTGATATACCATTGTTCCTTCTGCATGTTCAACTCGACCGATGAGC 69 FBan0014438 FBgn0029899 CG14438 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14438 CG14438 CDMC28933 3 4 16 DAC25-K06 11-CG14438-RA_1 CG14438 GCTTCCGGCAGCTAGTGTCGCCAGTGATATACCATTGTTCCTTCTGCATGTTCAACTCGACCGATGAGC 69 FBan0014438 FBgn0029899 CG14438 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14438 CG14438 CDMC28934 3 5 16 DAC25-K18 23-CG14453-RA_2 CG14453 GCTGCAGCTAGAAACCTGTCGAGTCAGACAGCTAATACAAGCCAAAGATTGATGTTTTAACTAAATTGC 69 FBan0014453 FBgn0037179 CG14453 3 3L CG14453 CG14453 BcDNA:RE13473 CDMC28934 3 6 16 DAC25-K18 23-CG14453-RA_2 CG14453 GCTGCAGCTAGAAACCTGTCGAGTCAGACAGCTAATACAAGCCAAAGATTGATGTTTTAACTAAATTGC 69 FBan0014453 FBgn0037179 CG14453 3 3L CG14453 CG14453 BcDNA:RE13473 CDMC28935 3 7 16 DAC25-O06 23-CG14502-RA_2 CG14502 AAAATGACTACAAGATTATGCCGTTTAGCATCCCGAAACAGCCATATGTTGAGTTCATGAACAGCCACT 69 FBan0014502 FBgn0034321 CG14502 2 2R CG14502 CG14502 CDMC28935 3 8 16 DAC25-O06 23-CG14502-RA_2 CG14502 AAAATGACTACAAGATTATGCCGTTTAGCATCCCGAAACAGCCATATGTTGAGTTCATGAACAGCCACT 69 FBan0014502 FBgn0034321 CG14502 2 2R CG14502 CG14502 CDMC28936 3 9 16 DAC25-O18 18-CG14512-RA_2 CG14512 GTGGATGCCCAGCTAGCTACTCTGGACTTTGAAGCCTTAAAGCCCTATGAAACGAAACCGGAAAATCTT 69 FBan0014512 FBgn0039639 CG14512 3 3R CG14512 CG14512 CDMC28936 3 10 16 DAC25-O18 18-CG14512-RA_2 CG14512 GTGGATGCCCAGCTAGCTACTCTGGACTTTGAAGCCTTAAAGCCCTATGAAACGAAACCGGAAAATCTT 69 FBan0014512 FBgn0039639 CG14512 3 3R CG14512 CG14512 CDMC28937 3 11 16 DAC26-C06 23-CG4729-RD_9 CG4729 CTTTGTAAAAGGCAGTCCTCTCACAAATCTCTCTGCTAAATGGATCAATTCGTGATTCCTATCCGGACG 69 FBan0004729 FBgn0036623 CG4729 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4729 CG4729 CDMC28937 3 12 16 DAC26-C06 23-CG4729-RD_9 CG4729 CTTTGTAAAAGGCAGTCCTCTCACAAATCTCTCTGCTAAATGGATCAATTCGTGATTCCTATCCGGACG 69 FBan0004729 FBgn0036623 CG4729 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4729 CG4729 CDMC28938 3 13 16 DAC26-C18 16-CG4741-RA_2 CG4741 AGAACTGCTGTCTTCGAGACATTTTTCAGTTCCAATCAGGAATTAACACCCGAGTTCAACATGGCCCCT 69 FBan0004741 FBgn0035040 CG4741 2 2R CG4741 CG4741 CDMC28938 3 14 16 DAC26-C18 16-CG4741-RA_2 CG4741 AGAACTGCTGTCTTCGAGACATTTTTCAGTTCCAATCAGGAATTAACACCCGAGTTCAACATGGCCCCT 69 FBan0004741 FBgn0035040 CG4741 2 2R CG4741 CG4741 CDMC28939 3 15 16 DAC26-G06 23-CG4764-RA_1 CG4764 CGGACGAAAGTGAAGTTTTAGATTTAATGCAATAATAAACGATTACAAAGTAAGGAAAAACACCCCCAG 69 FBan0004764 FBgn0031310 CG4764 2 2L intracellular protein transport; GO:0006886 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG4764 CG4764 CDMC28939 3 16 16 DAC26-G06 23-CG4764-RA_1 CG4764 CGGACGAAAGTGAAGTTTTAGATTTAATGCAATAATAAACGATTACAAAGTAAGGAAAAACACCCCCAG 69 FBan0004764 FBgn0031310 CG4764 2 2L intracellular protein transport; GO:0006886 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG4764 CG4764 CDMC28940 3 17 16 DAC26-G18 14-CG4772-RA_1 CG4772 ACCAGTATTCATGACCTTCGTCGGAGATTCTCACTGGTCCTGATCAATCAGCATTTTACCATGGGCCGA 69 FBan0004772 FBgn0040252 Ugt86Dh 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dh Ugt86Dh "CG4772, CG4772, AC 006491H" CDMC28940 3 18 16 DAC26-G18 14-CG4772-RA_1 CG4772 ACCAGTATTCATGACCTTCGTCGGAGATTCTCACTGGTCCTGATCAATCAGCATTTTACCATGGGCCGA 69 FBan0004772 FBgn0040252 Ugt86Dh 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dh Ugt86Dh "CG4772, CG4772, AC 006491H" CDMC28941 3 19 16 DAC26-K06 6-CG4802-RA_5 CG4802 GCCGGGCAACCTGGTTGTTCCACACGACTTTATCGACAGGACTACTAAACGCCTTCAGACCTTCTACGA 69 FBan0004802 FBgn0034215 CG4802 2 2R amino acid metabolism; GO:0006520; phosphorylation; GO:0016310; purine base metabolism; GO:0006144 S-methyl-5-thioadenosine phosphorylase activity; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28 cellular component unknown; GO:0008372 CG4802 CG4802 CDMC28941 3 20 16 DAC26-K06 6-CG4802-RA_5 CG4802 GCCGGGCAACCTGGTTGTTCCACACGACTTTATCGACAGGACTACTAAACGCCTTCAGACCTTCTACGA 69 FBan0004802 FBgn0034215 CG4802 2 2R amino acid metabolism; GO:0006520; phosphorylation; GO:0016310; purine base metabolism; GO:0006144 S-methyl-5-thioadenosine phosphorylase activity; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28 cellular component unknown; GO:0008372 CG4802 CG4802 CDMC28942 3 21 16 DAC26-K18 23-CG4813-RA_2 CG4813 AGATTATCGAACAAAACAAAATCCGACTACAGAATCTTTTAACTTCGTTTACCCTTAAGAGTCCGCGGT 69 FBan0004813 FBgn0039013 CG4813 3 3R CG4813 CG4813 CDMC28942 3 22 16 DAC26-K18 23-CG4813-RA_2 CG4813 AGATTATCGAACAAAACAAAATCCGACTACAGAATCTTTTAACTTCGTTTACCCTTAAGAGTCCGCGGT 69 FBan0004813 FBgn0039013 CG4813 3 3R CG4813 CG4813 CDMC28943 3 23 16 DAC26-O06 12-CG4851-RA_3 CG4851 TTCATCCTGGCACTATCGTCTACAACTGCGACAAGTTCAATGGATGGTACAGCTTGGAGAACGCCTGGC 69 FBan0004851 FBgn0032358 CG4851 2 2L protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-; palmitoyl-(protein) hydrolase activity; GO:0008474 ; EC:3.1.2.22; ; GO:0008474 ; EC:3.1.2.22" lysosome; GO:0005764 CG4851 CG4851 PPT-2 CDMC28943 3 24 16 DAC26-O06 12-CG4851-RA_3 CG4851 TTCATCCTGGCACTATCGTCTACAACTGCGACAAGTTCAATGGATGGTACAGCTTGGAGAACGCCTGGC 69 FBan0004851 FBgn0032358 CG4851 2 2L protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-; palmitoyl-(protein) hydrolase activity; GO:0008474 ; EC:3.1.2.22; ; GO:0008474 ; EC:3.1.2.22" lysosome; GO:0005764 CG4851 CG4851 PPT-2 CDMC28944 3 25 16 DAC26-O18 18-CG4859-RB_1 CG4859 ACCGACTCAGCGGTAGTTTTGTTTGAGCTCGAATCGATCTACTGGATCCACGAATATCGAATCCCGAAC 69 FBan0004859 FBgn0035049 Mmp1 2 2R anti-apoptosis; GO:0006916; autophagic cell death; GO:0048102; dorsal trunk growth; GO:0035001; larval development (sensu Insecta); GO:0002168; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071; tracheal system development (sensu Insecta); GO:0007424 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578 Mmp1 Matrix metalloproteinase 1 "CG4859, CG4859, CG4859, CG4859, CG4859, CG4859, l(2)k04809, Dm1-MMP, dm1-MMP, Matrix metalloproteinase 1" CDMC28944 3 26 16 DAC26-O18 18-CG4859-RB_1 CG4859 ACCGACTCAGCGGTAGTTTTGTTTGAGCTCGAATCGATCTACTGGATCCACGAATATCGAATCCCGAAC 69 FBan0004859 FBgn0035049 Mmp1 2 2R anti-apoptosis; GO:0006916; autophagic cell death; GO:0048102; dorsal trunk growth; GO:0035001; larval development (sensu Insecta); GO:0002168; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071; tracheal system development (sensu Insecta); GO:0007424 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578 Mmp1 Matrix metalloproteinase 1 "CG4859, CG4859, CG4859, CG4859, CG4859, CG4859, l(2)k04809, Dm1-MMP, dm1-MMP, Matrix metalloproteinase 1" CDMC28945 3 1 17 DAC27-C06 14-CG3493-RA_3 CG3493 TGCAGGACGTGACGAATCGAAACCTGTTCCTGGAGCAAAAATGCGAGAACTTCCTCATACTCGAACAGT 69 FBan0003493 FBgn0034854 CG3493 2 2R intracellular protein transport; GO:0006886 CG3493 CG3493 CDMC28945 3 2 17 DAC27-C06 14-CG3493-RA_3 CG3493 TGCAGGACGTGACGAATCGAAACCTGTTCCTGGAGCAAAAATGCGAGAACTTCCTCATACTCGAACAGT 69 FBan0003493 FBgn0034854 CG3493 2 2R intracellular protein transport; GO:0006886 CG3493 CG3493 CDMC28946 3 3 17 DAC27-C18 9-CG3502-RA_2 CG3502 GGCCTGTCGTTACCATGTGGCTGATTGCACGGATCAGGCCAAGATTCTCGCTATAACCCATAGAACTGA 69 FBgn0034847 CDMC28946 3 4 17 DAC27-C18 9-CG3502-RA_2 CG3502 GGCCTGTCGTTACCATGTGGCTGATTGCACGGATCAGGCCAAGATTCTCGCTATAACCCATAGAACTGA 69 FBgn0034847 CDMC28947 3 5 17 DAC27-G06 9-CG3541-RC_2 CG3541 ACACATCCACAGCGCTCAACGAACCTCTATCCCATCGATCCCATCGCTTCGATTTCGATTGCTATTCCG 69 FBgn0035030 CDMC28947 3 6 17 DAC27-G06 9-CG3541-RC_2 CG3541 ACACATCCACAGCGCTCAACGAACCTCTATCCCATCGATCCCATCGCTTCGATTTCGATTGCTATTCCG 69 FBgn0035030 CDMC28948 3 7 17 DAC27-G18 23-CG3564-RA_5 CG3564 AATGGAAACAGAACAGCAAATATTTTCAGACACACATTCAAGGGGGGAAGAGACACTTGTGAACTTTCG 69 FBan0003564 FBgn0029709 CG3564 X X intracellular protein transport; GO:0006886 protein carrier activity; GO:0008320; ; GO:0008320 COPI vesicle coat; GO:0030126 CG3564 CG3564 CDMC28948 3 8 17 DAC27-G18 23-CG3564-RA_5 CG3564 AATGGAAACAGAACAGCAAATATTTTCAGACACACATTCAAGGGGGGAAGAGACACTTGTGAACTTTCG 69 FBan0003564 FBgn0029709 CG3564 X X intracellular protein transport; GO:0006886 protein carrier activity; GO:0008320; ; GO:0008320 COPI vesicle coat; GO:0030126 CG3564 CG3564 CDMC28949 3 9 17 DAC27-K06 9-CG3603-RA_8 CG3603 CAGCAGGCACCCACTATTGTGGTCAATTCGGCTGGAATAACCCGAGATGGTTATCTGCTCAAGATGCCC 69 FBan0003603 FBgn0029648 CG3603 X X G-protein coupled receptor protein signaling pathway; GO:0007186; fatty acid biosynthesis; GO:0006633 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG3603 CG3603 BcDNA:RH09070 CDMC28949 3 10 17 DAC27-K06 9-CG3603-RA_8 CG3603 CAGCAGGCACCCACTATTGTGGTCAATTCGGCTGGAATAACCCGAGATGGTTATCTGCTCAAGATGCCC 69 FBan0003603 FBgn0029648 CG3603 X X G-protein coupled receptor protein signaling pathway; GO:0007186; fatty acid biosynthesis; GO:0006633 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584" integral to membrane; GO:0016021 CG3603 CG3603 BcDNA:RH09070 CDMC28950 3 11 17 DAC27-K18 22-CG3613-RA_1 CG3613 GCTCGGCTCCATATCCGAAAATACGTTAACCCATCGATTTTCCAAAACCCCAAGAAACCAACCTCAACA 69 FBan0003613 FBgn0022986 qkr58E-1 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; ; GO:0003729 qkr58E-1 quaking related 58E-1 "CG3613, CG3613, CG3613, KH-domain, qkr-58-E, qrk58E-1" CDMC28950 3 12 17 DAC27-K18 22-CG3613-RA_1 CG3613 GCTCGGCTCCATATCCGAAAATACGTTAACCCATCGATTTTCCAAAACCCCAAGAAACCAACCTCAACA 69 FBan0003613 FBgn0022986 qkr58E-1 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; ; GO:0003729 qkr58E-1 quaking related 58E-1 "CG3613, CG3613, CG3613, KH-domain, qkr-58-E, qrk58E-1" CDMC28951 3 13 17 DAC27-O06 17-CG3653-RB_2 CG3653 TCGACAGTGTCACATTAAGAATCTAAAGAATCAACAGGAGACCGCCTACAAGGGTAGTCCACAGGCCAA 69 FBan0003653 FBgn0028369 kirre X X apoptotic program; GO:0008632; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; larval visceral muscle development; GO:0007523; myoblast fusion; GO:0007520; nervous system development; GO:0007399; regulation of striated muscle development; GO:0016202; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 kirre kin of irre "CG3653, duf, dumbfounded, Duf, Dumbfounded, CT12279, kin-of-irreC, DUF, DUF/KIRRE, Duf/Kirre, EG:163A10.1, kin of irre" CDMC28951 3 14 17 DAC27-O06 17-CG3653-RB_2 CG3653 TCGACAGTGTCACATTAAGAATCTAAAGAATCAACAGGAGACCGCCTACAAGGGTAGTCCACAGGCCAA 69 FBan0003653 FBgn0028369 kirre X X apoptotic program; GO:0008632; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; larval visceral muscle development; GO:0007523; myoblast fusion; GO:0007520; nervous system development; GO:0007399; regulation of striated muscle development; GO:0016202; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 kirre kin of irre "CG3653, duf, dumbfounded, Duf, Dumbfounded, CT12279, kin-of-irreC, DUF, DUF/KIRRE, Duf/Kirre, EG:163A10.1, kin of irre" CDMC28952 3 15 17 DAC27-O18 3-CG3666-RA_1 CG3666 AGATGTGGTGTTGGTGGATCAGGAAATGCGCGTGAAAGCTCAGCGGGATTACAATCTAGTGCCATTGCT 69 FBan0003666 FBgn0034094 Tsf3 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826; response to bacteria; GO:0009617 ferric iron binding; GO:0008199; iron ion transporter activity; GO:0005381; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005381; ; GO:0008199 extracellular region; GO:0005576 Tsf3 Transferrin 3 "CG3666, CG3666, CG3666, CG3666, Transferrin 3" CDMC28952 3 16 17 DAC27-O18 3-CG3666-RA_1 CG3666 AGATGTGGTGTTGGTGGATCAGGAAATGCGCGTGAAAGCTCAGCGGGATTACAATCTAGTGCCATTGCT 69 FBan0003666 FBgn0034094 Tsf3 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826; response to bacteria; GO:0009617 ferric iron binding; GO:0008199; iron ion transporter activity; GO:0005381; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005381; ; GO:0008199 extracellular region; GO:0005576 Tsf3 Transferrin 3 "CG3666, CG3666, CG3666, CG3666, Transferrin 3" CDMC28953 3 17 17 DAC28-C06 23-CG14757-RA_1 CG14757 CCGGCAGTTGTCAAAATATTTTGATTTTTCAAATTTTCCGATAGCTCAATACAAATCCAAAAATACCCA 69 FBan0014757 FBgn0033274 CG14757 2 2R CG14757 CG14757 CDMC28953 3 18 17 DAC28-C06 23-CG14757-RA_1 CG14757 CCGGCAGTTGTCAAAATATTTTGATTTTTCAAATTTTCCGATAGCTCAATACAAATCCAAAAATACCCA 69 FBan0014757 FBgn0033274 CG14757 2 2R CG14757 CG14757 CDMC28954 3 19 17 DAC28-C18 18-CG14772-RA_1 CG14772 TCTGCTCAAGGGTTTGTTGATCCTCGATATTCAAGCAGAAAATTCGTGCCGCTTGTTTGCCAGTGAAAT 69 FBan0014772 FBgn0029577 CG14772 X X CG14772 CG14772 CDMC28954 3 20 17 DAC28-C18 18-CG14772-RA_1 CG14772 TCTGCTCAAGGGTTTGTTGATCCTCGATATTCAAGCAGAAAATTCGTGCCGCTTGTTTGCCAGTGAAAT 69 FBan0014772 FBgn0029577 CG14772 X X CG14772 CG14772 CDMC28955 3 21 17 DAC28-G06 9-CG14820-RA_4 CG14820 ACACGGGCATTCCCATAGAGCGGTATGTTGCTTAAGATTCTCCTAGTCGTAGGACTCTTTGGGCTGGCT 69 FBan0014820 FBgn0035718 CG14820 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.-; ; GO:0004182 ; EC:3.4.17.1 CG14820 CG14820 CDMC28955 3 22 17 DAC28-G06 9-CG14820-RA_4 CG14820 ACACGGGCATTCCCATAGAGCGGTATGTTGCTTAAGATTCTCCTAGTCGTAGGACTCTTTGGGCTGGCT 69 FBan0014820 FBgn0035718 CG14820 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.-; ; GO:0004182 ; EC:3.4.17.1 CG14820 CG14820 CDMC28956 3 23 17 DAC28-G18 3-CG14829-RA_1 CG14829 GCTGGAATCGATTGCCTAGCTCGCTATTCGGATTGTCCAAGGGGTGAAAGTGTGCTGGATGCATATGCT 69 FBan0014829 FBgn0035751 CG14829 3 3L CG14829 CG14829 CDMC28956 3 24 17 DAC28-G18 3-CG14829-RA_1 CG14829 GCTGGAATCGATTGCCTAGCTCGCTATTCGGATTGTCCAAGGGGTGAAAGTGTGCTGGATGCATATGCT 69 FBan0014829 FBgn0035751 CG14829 3 3L CG14829 CG14829 CDMC28957 3 25 17 DAC28-K06 23-CG1486-RB_3 CG1486 TTCATTTCCACTTTCCCTACTTAAACGAAAAGAATTCCAAAGAGGATGATTGTTCGCCCGAAAAGATGA 69 FBan0001486 FBgn0031174 CG1486 X X amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG1486 CG1486 CDMC28957 3 26 17 DAC28-K06 23-CG1486-RB_3 CG1486 TTCATTTCCACTTTCCCTACTTAAACGAAAAGAATTCCAAAGAGGATGATTGTTCGCCCGAAAAGATGA 69 FBan0001486 FBgn0031174 CG1486 X X amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG1486 CG1486 CDMC28958 3 1 18 DAC28-K18 7-CG14880-RB_1 CG14880 CGCCGTCCAAGATCTATGAGCCACCCTTTGTGTACCCCATCTACAATCTAGAAGAGTCCCAGACCCAGA 69 FBan0014880 FBgn0038422 CG14880 3 3R CG14880 CG14880 CDMC28958 3 2 18 DAC28-K18 7-CG14880-RB_1 CG14880 CGCCGTCCAAGATCTATGAGCCACCCTTTGTGTACCCCATCTACAATCTAGAAGAGTCCCAGACCCAGA 69 FBan0014880 FBgn0038422 CG14880 3 3R CG14880 CG14880 CDMC28959 3 3 18 DAC28-O06 3-CG14902-RA_6 CG14902 GCAGGGATTCGGATTCGATGTACGCACCTTCGACGATCTGACCTTCTCCGAGATCAACGACACGCTCAA 69 FBan0014902 FBgn0028381 decay 3 3R apoptosis; GO:0006915; apoptotic program; GO:0008632; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 cytoplasm; GO:0005737 decay death executioner caspase related to Apopain/Yama "CG14902, CG14902, DECAY, Drosophila executioner caspase related to Apopain/Yama, Decay, caspase-3 protein, caspase-3, death executioner caspase related to Apopain/Yama" CDMC28959 3 4 18 DAC28-O06 3-CG14902-RA_6 CG14902 GCAGGGATTCGGATTCGATGTACGCACCTTCGACGATCTGACCTTCTCCGAGATCAACGACACGCTCAA 69 FBan0014902 FBgn0028381 decay 3 3R apoptosis; GO:0006915; apoptotic program; GO:0008632; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 cytoplasm; GO:0005737 decay death executioner caspase related to Apopain/Yama "CG14902, CG14902, DECAY, Drosophila executioner caspase related to Apopain/Yama, Decay, caspase-3 protein, caspase-3, death executioner caspase related to Apopain/Yama" CDMC28960 3 5 18 DAC28-O18 9-CG14911-RA_1 CG14911 CCGCCAATCCCTCATATCAGAATACGGCCTACAGTCAGTGTGGCGAGAAATACAATTACCAGGGCCACG 69 FBan0014911 FBgn0035701 CG14911 3 3L CG14911 CG14911 CDMC28960 3 6 18 DAC28-O18 9-CG14911-RA_1 CG14911 CCGCCAATCCCTCATATCAGAATACGGCCTACAGTCAGTGTGGCGAGAAATACAATTACCAGGGCCACG 69 FBan0014911 FBgn0035701 CG14911 3 3L CG14911 CG14911 CDMC28961 3 7 18 DAC29-C06 2-CG6398-RA_1 CG6398 GCAGATCTACCCAGGACCTTACTATCATGGCTCGCAGTACGGACCCTACAACTACTAGAGGCACACCCG 69 FBan0006398 FBgn0030870 CG6398 X X CG6398 CG6398 CDMC28961 3 8 18 DAC29-C06 2-CG6398-RA_1 CG6398 GCAGATCTACCCAGGACCTTACTATCATGGCTCGCAGTACGGACCCTACAACTACTAGAGGCACACCCG 69 FBan0006398 FBgn0030870 CG6398 X X CG6398 CG6398 CDMC28962 3 9 18 DAC29-C18 3-CG6409-RA_2 CG6409 GCCGAGCTCTTCGAGAAGAACAAGCACGCGGATAAGTCCACTTCCAGTTCCGAGGAAAGCAAGGAGAAA 69 FBan0006409 FBgn0036106 CG6409 3 3L GPI anchor biosynthesis; GO:0006506 endoplasmic reticulum; GO:0005783 CG6409 CG6409 CDMC28962 3 10 18 DAC29-C18 3-CG6409-RA_2 CG6409 GCCGAGCTCTTCGAGAAGAACAAGCACGCGGATAAGTCCACTTCCAGTTCCGAGGAAAGCAAGGAGAAA 69 FBan0006409 FBgn0036106 CG6409 3 3L GPI anchor biosynthesis; GO:0006506 endoplasmic reticulum; GO:0005783 CG6409 CG6409 CDMC28963 3 11 18 DAC29-G06 23-CG6448-RA_17 CG6448 AATGAAACCCGCACCTTACATTCTGTATCGACAGAGATTCAAAGCTCCATTAAGGAAGTCACATCCGCC 69 FBan0006448 FBgn0032976 CG6448 2 2L CG6448 CG6448 "CG15217, CG15217, CG15217, anon-WO0140519.28" CDMC28963 3 12 18 DAC29-G06 23-CG6448-RA_17 CG6448 AATGAAACCCGCACCTTACATTCTGTATCGACAGAGATTCAAAGCTCCATTAAGGAAGTCACATCCGCC 69 FBan0006448 FBgn0032976 CG6448 2 2L CG6448 CG6448 "CG15217, CG15217, CG15217, anon-WO0140519.28" CDMC28964 3 13 18 DAC29-G18 6-CG6456-RA_1 CG6456 CCACGCTCCTCGAAATCTGTTTCACACCGGTCAAGTGAGAGCGCTATAATTGAATTGCACTCGTGCCCG 69 FBan0006456 FBgn0036713 Mip 3 3L neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005179; ; GO:0005179; ecdysiostatic hormone activity; GO:0016087; myoinhibitory hormone activity; GO:0016085; ; GO:0005184; ; GO:0005179; ; GO:0016087; ; GO:0016085 cellular component unknown; GO:0008372 Mip Myoinhibiting peptide precursor "CG6456, CG6456, DAP-B, Drm-MIP, Drm-MIP-1, Drm-MIP-2, Drm-MIP-3, Drm-MIP-4, Drm-MIP-5, allatostatin (B-type), Drm-MIP-2 (B-type), Drm-MIP-5 (B-type), drostatin-B2, AstB-1, MIP, allatostatin, Myoinhibiting peptide precursor" CDMC28964 3 14 18 DAC29-G18 6-CG6456-RA_1 CG6456 CCACGCTCCTCGAAATCTGTTTCACACCGGTCAAGTGAGAGCGCTATAATTGAATTGCACTCGTGCCCG 69 FBan0006456 FBgn0036713 Mip 3 3L neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; ; GO:0005179; ; GO:0005179; ecdysiostatic hormone activity; GO:0016087; myoinhibitory hormone activity; GO:0016085; ; GO:0005184; ; GO:0005179; ; GO:0016087; ; GO:0016085 cellular component unknown; GO:0008372 Mip Myoinhibiting peptide precursor "CG6456, CG6456, DAP-B, Drm-MIP, Drm-MIP-1, Drm-MIP-2, Drm-MIP-3, Drm-MIP-4, Drm-MIP-5, allatostatin (B-type), Drm-MIP-2 (B-type), Drm-MIP-5 (B-type), drostatin-B2, AstB-1, MIP, allatostatin, Myoinhibiting peptide precursor" CDMC28965 3 15 18 DAC29-K06 16-CG6494-RA_2 CG6494 TGCGCAAATGTTGCTTTGAAGTGTTGCAAACATGCGAATCCTAAACTCGGTTCACAACTTCGTTGGCTT 69 FBan0006494 FBgn0001168 h 3 3L "bristle morphogenesis; GO:0008407; cell proliferation; GO:0008283; membrane organization and biogenesis; GO:0016044; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; restriction of R8 fate; GO:0007461; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; trunk segmentation; GO:0035290" DNA binding; GO:0003677; specific transcriptional repressor activity; GO:0016566; general transcriptional repressor activity; GO:0016565; protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016565; ; GO:0003677; ; GO:0016564; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 h hairy "CG6494, CG6494, CG6494, CG6494, brr, barrel, l(3)08247, 8247, dDr1, Hairy, l(3)rM384, hairy" CDMC28965 3 16 18 DAC29-K06 16-CG6494-RA_2 CG6494 TGCGCAAATGTTGCTTTGAAGTGTTGCAAACATGCGAATCCTAAACTCGGTTCACAACTTCGTTGGCTT 69 FBan0006494 FBgn0001168 h 3 3L "bristle morphogenesis; GO:0008407; cell proliferation; GO:0008283; membrane organization and biogenesis; GO:0016044; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; posterior head segmentation; GO:0035289; restriction of R8 fate; GO:0007461; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; trunk segmentation; GO:0035290" DNA binding; GO:0003677; specific transcriptional repressor activity; GO:0016566; general transcriptional repressor activity; GO:0016565; protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016565; ; GO:0003677; ; GO:0016564; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 h hairy "CG6494, CG6494, CG6494, CG6494, brr, barrel, l(3)08247, 8247, dDr1, Hairy, l(3)rM384, hairy" CDMC28966 3 17 18 DAC29-K18 7-CG6509-RB_1 CG6509 ACCGTTGTCCGAGTGTCTGATGGTTCGCCTTACAATTGACTTCTCCAACCTCTTCAAACTGTGCGAGGT 69 FBan0006509 FBgn0032363 CG6509 2 2L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198; protein binding; GO:0005515; ; GO:0005515 CG6509 CG6509 LD32687 CDMC28966 3 18 18 DAC29-K18 7-CG6509-RB_1 CG6509 ACCGTTGTCCGAGTGTCTGATGGTTCGCCTTACAATTGACTTCTCCAACCTCTTCAAACTGTGCGAGGT 69 FBan0006509 FBgn0032363 CG6509 2 2L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198; protein binding; GO:0005515; ; GO:0005515 CG6509 CG6509 LD32687 CDMC28967 3 19 18 DAC29-O06 23-CG6544-RD_5 CG6544 AACTCGTGTAAGTATTTGGTTTTCATCCTTATCGCCTACATCGCTTGTCATCATCCATCTTTCTATGGA 69 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC28967 3 20 18 DAC29-O06 23-CG6544-RD_5 CG6544 AACTCGTGTAAGTATTTGGTTTTCATCCTTATCGCCTACATCGCTTGTCATCATCCATCTTTCTATGGA 69 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC28968 3 21 18 DAC29-O18 2-CG6554-RA_2 CG6554 GCGTCTTGGGTTCAGTACGTCACCAGACTCCACATACACGCATTGGAAGCAAACCGTGTTCTACCTCGA 69 FBan0006554 FBgn0037834 Art1 3 3R "histone methylation; GO:0016571; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919; protein amino acid methylation; GO:0006479" histone methyltransferase activity; GO:0042054; ; GO:0042054; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; protein-arginine omega-N asymmetric methyltransferase activity; GO:0035242; protein-arginine omega-N monomethyltransferase activity; GO:0035241; ; GO:0035242; ; GO:0035241 Art1 Arginine methyltransferase 1 "CG6554, DART1, Arginine methyltransferase 1" CDMC28968 3 22 18 DAC29-O18 2-CG6554-RA_2 CG6554 GCGTCTTGGGTTCAGTACGTCACCAGACTCCACATACACGCATTGGAAGCAAACCGTGTTCTACCTCGA 69 FBan0006554 FBgn0037834 Art1 3 3R "histone methylation; GO:0016571; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919; protein amino acid methylation; GO:0006479" histone methyltransferase activity; GO:0042054; ; GO:0042054; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; protein-arginine omega-N asymmetric methyltransferase activity; GO:0035242; protein-arginine omega-N monomethyltransferase activity; GO:0035241; ; GO:0035242; ; GO:0035241 Art1 Arginine methyltransferase 1 "CG6554, DART1, Arginine methyltransferase 1" CDMC28969 3 23 18 DAC30-C06 3-CG3998-RA_3 CG3998 CGAAGATGGCAAGCTGACTTTCAAGTGCCCATGCTACTGCAACCTCTTCTTCGCCACCAAGGAACAG 67 FBan0003998 FBgn0022720 zf30C 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 zf30C Zinc finger protein 30C "CG3998, CG3998, l(2)k02506, clone 1.52, anon-EST:Liang-1.52" CDMC28969 3 24 18 DAC30-C06 3-CG3998-RA_3 CG3998 CGAAGATGGCAAGCTGACTTTCAAGTGCCCATGCTACTGCAACCTCTTCTTCGCCACCAAGGAACAG 67 FBan0003998 FBgn0022720 zf30C 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 zf30C Zinc finger protein 30C "CG3998, CG3998, l(2)k02506, clone 1.52, anon-EST:Liang-1.52" CDMC28970 3 25 18 DAC30-C18 3-CG40235-RA_1 CG40235 CGGGGATTTGCATGCCACAGCGTCAACCCAATACATGGCCATTATACTGGCTAACAAGGTTGGCGAG 67 FBgn0058235 CG40235 CG40235 CG40235 CDMC28970 3 26 18 DAC30-C18 3-CG40235-RA_1 CG40235 CGGGGATTTGCATGCCACAGCGTCAACCCAATACATGGCCATTATACTGGCTAACAAGGTTGGCGAG 67 FBgn0058235 CG40235 CG40235 CG40235 CDMC28971 3 1 19 DAC30-G06 3-CG4288-RA_3 CG4288 TCAAAGCTGGACCCGAGCTGGATCGCTTCTGTTCGAAGGAGGAATGCGACTACATCCAGAAGACCAT 67 FBan0004288 FBgn0038799 CG4288 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4288 CG4288 CDMC28971 3 2 19 DAC30-G06 3-CG4288-RA_3 CG4288 TCAAAGCTGGACCCGAGCTGGATCGCTTCTGTTCGAAGGAGGAATGCGACTACATCCAGAAGACCAT 67 FBan0004288 FBgn0038799 CG4288 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4288 CG4288 CDMC28972 3 3 19 DAC30-G18 2-CG4402-RA_1 CG4402 GGTGGTGGATTATCTGGAAATCGAACAGACGGCCCATCTGGAGGATAGACCCATGCTGCTGATGCAG 67 FBan0004402 FBgn0034660 lox2 2 2R amino acid metabolism; GO:0006520; cell adhesion; GO:0007155; protein modification; GO:0006464 protein-lysine 6-oxidase activity; GO:0004720 ; EC:1.4.3.13; receptor activity; GO:0004872; ; GO:0004872; scavenger receptor activity; GO:0005044; ; GO:0004720 ; EC:1.4.3.13; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0005044; ; GO:0004720 ; EC:1.4.3.13 membrane; GO:0016020 lox2 lysyl oxidase-like 2 "CG4402, Dmloxl-2, dmlox-2, lysyl oxidase-like 2" CDMC28972 3 4 19 DAC30-G18 2-CG4402-RA_1 CG4402 GGTGGTGGATTATCTGGAAATCGAACAGACGGCCCATCTGGAGGATAGACCCATGCTGCTGATGCAG 67 FBan0004402 FBgn0034660 lox2 2 2R amino acid metabolism; GO:0006520; cell adhesion; GO:0007155; protein modification; GO:0006464 protein-lysine 6-oxidase activity; GO:0004720 ; EC:1.4.3.13; receptor activity; GO:0004872; ; GO:0004872; scavenger receptor activity; GO:0005044; ; GO:0004720 ; EC:1.4.3.13; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0005044; ; GO:0004720 ; EC:1.4.3.13 membrane; GO:0016020 lox2 lysyl oxidase-like 2 "CG4402, Dmloxl-2, dmlox-2, lysyl oxidase-like 2" CDMC28973 3 5 19 DAC30-K06 3-CG4920-RA_1 CG4920 TGGAGCGTACTATACCCCATCCCGACTATATACCGGCCTCCAAGAACCAGGTCAACGACATAGCCCT 67 FBan0004920 FBgn0000533 ea 3 3R "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576; nucleus; GO:0005634 ea easter "CG4920, CG4920, c-SP24, SP24" CDMC28973 3 6 19 DAC30-K06 3-CG4920-RA_1 CG4920 TGGAGCGTACTATACCCCATCCCGACTATATACCGGCCTCCAAGAACCAGGTCAACGACATAGCCCT 67 FBan0004920 FBgn0000533 ea 3 3R "Toll signaling pathway; GO:0008063; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576; nucleus; GO:0005634 ea easter "CG4920, CG4920, c-SP24, SP24" CDMC28974 3 7 19 DAC30-K18 2-CG5103-RA_1 CG5103 GAAGCCCCTCGATGTCGGACTAATCGTGAAGCATGGAAAGCTGTGTCGTGGAAGAATCGTCGTGGTG 67 FBan0005103 FBgn0036784 CG5103 3 3L pentose-phosphate shunt; GO:0006098 transketolase activity; GO:0004802 ; EC:2.2.1.1; ; GO:0004802 ; EC:2.2.1.1 CG5103 CG5103 CDMC28974 3 8 19 DAC30-K18 2-CG5103-RA_1 CG5103 GAAGCCCCTCGATGTCGGACTAATCGTGAAGCATGGAAAGCTGTGTCGTGGAAGAATCGTCGTGGTG 67 FBan0005103 FBgn0036784 CG5103 3 3L pentose-phosphate shunt; GO:0006098 transketolase activity; GO:0004802 ; EC:2.2.1.1; ; GO:0004802 ; EC:2.2.1.1 CG5103 CG5103 CDMC28975 3 9 19 DAC30-O06 9-CG5553-RA_6 CG5553 GCTGTCCGTATAAGAACATGGATCAGGGCTCGTTGAAAACCAAGCTGTCCTCCTATGGCCTGTCAGC 67 FBan0005553 FBgn0011425 DNAprim 3 3L "DNA replication; GO:0006260; DNA replication, synthesis of RNA primer; GO:0006269; S phase of mitotic cell cycle; GO:0000084; compound eye morphogenesis (sensu Endopterygota); GO:0001745" nucleic acid binding; GO:0003676; DNA primase activity; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.- alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNAprim DNAprim "CG5553, l(3)j10B2, l(3)77ABe, S(faf)240, DNA primase, BcDNA:GM13640" CDMC28975 3 10 19 DAC30-O06 9-CG5553-RA_6 CG5553 GCTGTCCGTATAAGAACATGGATCAGGGCTCGTTGAAAACCAAGCTGTCCTCCTATGGCCTGTCAGC 67 FBan0005553 FBgn0011425 DNAprim 3 3L "DNA replication; GO:0006260; DNA replication, synthesis of RNA primer; GO:0006269; S phase of mitotic cell cycle; GO:0000084; compound eye morphogenesis (sensu Endopterygota); GO:0001745" nucleic acid binding; GO:0003676; DNA primase activity; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.-; ; GO:0003896 ; EC:2.7.7.- alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNAprim DNAprim "CG5553, l(3)j10B2, l(3)77ABe, S(faf)240, DNA primase, BcDNA:GM13640" CDMC28976 3 11 19 DAC30-O18 AutoBlank AutoBlank CDMC28976 3 12 19 DAC30-O18 AutoBlank AutoBlank CDMC28977 3 13 19 DAC31-C06 18-CG7492-RA_4 CG7492 GCGCATTATCTACTGCATACCATTACGACTACGACTATGTTCACGTTCGTTCCATCTGCGTTCCGTGCT 69 FBan0007492 FBgn0035807 CG7492 3 3L CG7492 CG7492 "anon-EST:fe1A11, anon-fast-evolving-1A11" CDMC28977 3 14 19 DAC31-C06 18-CG7492-RA_4 CG7492 GCGCATTATCTACTGCATACCATTACGACTACGACTATGTTCACGTTCGTTCCATCTGCGTTCCGTGCT 69 FBan0007492 FBgn0035807 CG7492 3 3L CG7492 CG7492 "anon-EST:fe1A11, anon-fast-evolving-1A11" CDMC28978 3 15 19 DAC31-C18 18-CG7506-RA_2 CG7506 TGTGGATCCAGCGCTTTTCGATGATCCCGAGCACTATGTTAAGATAATGGGTTACGACAAACCGATCGA 69 FBan0007506 FBgn0035805 CG7506 3 3L CG7506 CG7506 CDMC28978 3 16 19 DAC31-C18 18-CG7506-RA_2 CG7506 TGTGGATCCAGCGCTTTTCGATGATCCCGAGCACTATGTTAAGATAATGGGTTACGACAAACCGATCGA 69 FBan0007506 FBgn0035805 CG7506 3 3L CG7506 CG7506 CDMC28979 3 17 19 DAC31-G06 3-CG7542-RA_2 CG7542 GCAACTCCAGCTACCTGATCGGATCCACCTCTTTTGGAACCTCTATGGGATGTCAAGTGGGATTCCCGG 69 FBan0007542 FBgn0036738 CG7542 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG7542 CG7542 SP71 CDMC28979 3 18 19 DAC31-G06 3-CG7542-RA_2 CG7542 GCAACTCCAGCTACCTGATCGGATCCACCTCTTTTGGAACCTCTATGGGATGTCAAGTGGGATTCCCGG 69 FBan0007542 FBgn0036738 CG7542 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG7542 CG7542 SP71 CDMC28980 3 19 19 DAC31-G18 14-CG7552-RA_2 CG7552 CGCCGGAGCAAAAGAAACGGAATTGAAATGTCTTTGCTAATGTAAACAGCGCAAAGAGAAACCCCCCGA 69 FBgn0038255 CDMC28980 3 20 19 DAC31-G18 14-CG7552-RA_2 CG7552 CGCCGGAGCAAAAGAAACGGAATTGAAATGTCTTTGCTAATGTAAACAGCGCAAAGAGAAACCCCCCGA 69 FBgn0038255 CDMC28981 3 21 19 DAC31-K06 17-CG7583-RB_1 CG7583 GGGAGCTCTGATGTGGCACACCATCATCTTGACAAAGGAGGATCTTGAGAAGTTCAAAGCTTTACGCAT 69 FBan0007583 FBgn0020496 CtBP 3 3R L-serine biosynthesis; GO:0006564; embryonic development (sensu Insecta); GO:0001700; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 "protein C-terminus binding; GO:0008022; ; GO:0008022; transcription corepressor activity; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0005515; ; GO:0016616 ; EC:1.1.1.-" nucleus; GO:0005634 CtBP C-terminal Binding Protein "CG7583, l(3)G9, G9, dCtBP, 0256/16, 256/16, EP(3)3528, RE01030, RE61183, ctbp, BcDNA:GH07572, l(3)03463, l(3)03464, l(3)87De, lethal(3)87De, C-terminal Binding Protein" CDMC28981 3 22 19 DAC31-K06 17-CG7583-RB_1 CG7583 GGGAGCTCTGATGTGGCACACCATCATCTTGACAAAGGAGGATCTTGAGAAGTTCAAAGCTTTACGCAT 69 FBan0007583 FBgn0020496 CtBP 3 3R L-serine biosynthesis; GO:0006564; embryonic development (sensu Insecta); GO:0001700; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 "protein C-terminus binding; GO:0008022; ; GO:0008022; transcription corepressor activity; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0005515; ; GO:0016616 ; EC:1.1.1.-" nucleus; GO:0005634 CtBP C-terminal Binding Protein "CG7583, l(3)G9, G9, dCtBP, 0256/16, 256/16, EP(3)3528, RE01030, RE61183, ctbp, BcDNA:GH07572, l(3)03463, l(3)03464, l(3)87De, lethal(3)87De, C-terminal Binding Protein" CDMC28982 3 23 19 DAC31-K18 17-CG7594-RA_1 CG7594 GCCGATGTTGCCAAAATGCGCAGAGTGACTCCAAGACCTCCAGGATAATAAATGTAGCATATGGCCAAA 69 FBan0007594 FBgn0014848 Eig71Eh 3 3L Eig71Eh Eig71Eh "CG7594, CG7594, L71-8, L71" CDMC28982 3 24 19 DAC31-K18 17-CG7594-RA_1 CG7594 GCCGATGTTGCCAAAATGCGCAGAGTGACTCCAAGACCTCCAGGATAATAAATGTAGCATATGGCCAAA 69 FBan0007594 FBgn0014848 Eig71Eh 3 3L Eig71Eh Eig71Eh "CG7594, CG7594, L71-8, L71" CDMC28983 3 25 19 DAC31-O06 23-CG7627-RA_3 CG7627 GGCAGAATCACAGTCTTTCCTCGTGAGAATCAGCTATTATGTGTTTGTCACCGAATCTTTAGCTGGCTA 69 FBan0007627 FBgn0032026 CG7627 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG7627 CG7627 CDMC28983 3 26 19 DAC31-O06 23-CG7627-RA_3 CG7627 GGCAGAATCACAGTCTTTCCTCGTGAGAATCAGCTATTATGTGTTTGTCACCGAATCTTTAGCTGGCTA 69 FBan0007627 FBgn0032026 CG7627 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG7627 CG7627 CDMC28984 3 1 20 DAC31-O18 2-CG7637-RA_1 CG7637 TCAAGAAGCGCTTTGGACTGCTGCTCACCCAGAAGCCGGAGCCCATTTACTAAGCCGCATTTTAGTTTT 69 FBan0007637 FBgn0033548 CG7637 2 2R CG7637 CG7637 CDMC28984 3 2 20 DAC31-O18 2-CG7637-RA_1 CG7637 TCAAGAAGCGCTTTGGACTGCTGCTCACCCAGAAGCCGGAGCCCATTTACTAAGCCGCATTTTAGTTTT 69 FBan0007637 FBgn0033548 CG7637 2 2R CG7637 CG7637 CDMC28985 3 3 20 DAC32-C06 9-CG14947-RA_12 CG14947 TCGAATCGTCTTGGAGAGGATTACCGCATCTACCAGCAGAACGTCGACCTAGATGCCTTCTTCGGCGA 68 FBan0014947 FBgn0032406 CG14947 2 2L CG14947 CG14947 CDMC28985 3 4 20 DAC32-C06 9-CG14947-RA_12 CG14947 TCGAATCGTCTTGGAGAGGATTACCGCATCTACCAGCAGAACGTCGACCTAGATGCCTTCTTCGGCGA 68 FBan0014947 FBgn0032406 CG14947 2 2L CG14947 CG14947 CDMC28986 3 5 20 DAC32-C18 16-CG15082-RA_1 CG15082 CCAGTGAAACGGAAATGGATAACCAATTCGGAGATAGCTATCTCGACCCGTATCCTACGCTGTTCGGT 68 FBan0015082 FBgn0034397 CG15082 2 2R CG15082 CG15082 CDMC28986 3 6 20 DAC32-C18 16-CG15082-RA_1 CG15082 CCAGTGAAACGGAAATGGATAACCAATTCGGAGATAGCTATCTCGACCCGTATCCTACGCTGTTCGGT 68 FBan0015082 FBgn0034397 CG15082 2 2R CG15082 CG15082 CDMC28987 3 7 20 DAC32-G06 3-CG15404-RA_2 CG15404 TGGTCACGAACTCGAATCCCCGGTGCAAGGGAAAACTTCAGTATCAATGCGTTTGCGACTACACCTGC 68 FBan0015404 FBgn0031512 CG15404 2 2L CG15404 CG15404 CDMC28987 3 8 20 DAC32-G06 3-CG15404-RA_2 CG15404 TGGTCACGAACTCGAATCCCCGGTGCAAGGGAAAACTTCAGTATCAATGCGTTTGCGACTACACCTGC 68 FBan0015404 FBgn0031512 CG15404 2 2L CG15404 CG15404 CDMC28988 3 9 20 DAC32-G18 3-CG15563-RA_1 CG15563 CCGTCGATCCGTCTCCGTTTCCAAGCAACTGGACAGGGATCTGTGCAACCAACATTTCGACACATTCG 68 FBan0015563 FBgn0039832 CG15563 3 3R CG15563 CG15563 CDMC28988 3 10 20 DAC32-G18 3-CG15563-RA_1 CG15563 CCGTCGATCCGTCTCCGTTTCCAAGCAACTGGACAGGGATCTGTGCAACCAACATTTCGACACATTCG 68 FBan0015563 FBgn0039832 CG15563 3 3R CG15563 CG15563 CDMC28989 3 11 20 DAC32-K06 16-CG16766-RA_1 CG16766 GGGATCGTTCTTCATTCCCCTCACCGTGATGCTCTACGTTTACGTGAAGATTGGTTATGTCCTCACGT 68 FBan0016766 FBgn0038541 CG16766 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021 CG16766 CG16766 "DmCG16766, anon-WO0170980.124, anon-WO0170980.125" CDMC28989 3 12 20 DAC32-K06 16-CG16766-RA_1 CG16766 GGGATCGTTCTTCATTCCCCTCACCGTGATGCTCTACGTTTACGTGAAGATTGGTTATGTCCTCACGT 68 FBan0016766 FBgn0038541 CG16766 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021 CG16766 CG16766 "DmCG16766, anon-WO0170980.124, anon-WO0170980.125" CDMC28990 3 13 20 DAC32-K18 17-CG16914-RA_1 CG16914 AGCGACTCCGAGGTTAACTTGCTGGACTTTAACTACGCTTATGAGCTATCCAACCATATTCGCGCCGT 68 FBan0016914 FBgn0025578 Lcp9 2 2R larval cuticle biosynthesis (sensu Insecta); GO:0008363 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 extracellular region; GO:0005576 Lcp9 Larval cuticle protein 9 "CG16914, LCP9, Larval cuticle protein 9" CDMC28990 3 14 20 DAC32-K18 17-CG16914-RA_1 CG16914 AGCGACTCCGAGGTTAACTTGCTGGACTTTAACTACGCTTATGAGCTATCCAACCATATTCGCGCCGT 68 FBan0016914 FBgn0025578 Lcp9 2 2R larval cuticle biosynthesis (sensu Insecta); GO:0008363 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 extracellular region; GO:0005576 Lcp9 Larval cuticle protein 9 "CG16914, LCP9, Larval cuticle protein 9" CDMC28991 3 15 20 DAC32-O06 3-CG17327-RB_2 CG17327 CGACGGACCAGGATCCCGTGGAACTAATGCTGAAGAAGACCGGCTGCATAGAGCTTCACTACAAGGTG 68 FBan0017327 FBgn0038107 CG17327 3 3R CG17327 CG17327 CDMC28991 3 16 20 DAC32-O06 3-CG17327-RB_2 CG17327 CGACGGACCAGGATCCCGTGGAACTAATGCTGAAGAAGACCGGCTGCATAGAGCTTCACTACAAGGTG 68 FBan0017327 FBgn0038107 CG17327 3 3R CG17327 CG17327 CDMC28992 3 17 20 DAC32-O18 2-CG17453-RA_1 CG17453 TTGCGGGGAGAGAGCTGGAAGGAGATGCGTCAGAAATTGGATCCAAGTCTCGAAGGTGATCGCATGTC 68 FBan0017453 FBgn0033982 Cyp317a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp317a1 Cyp317a1 "CG17453, 317a1" CDMC28992 3 18 20 DAC32-O18 2-CG17453-RA_1 CG17453 TTGCGGGGAGAGAGCTGGAAGGAGATGCGTCAGAAATTGGATCCAAGTCTCGAAGGTGATCGCATGTC 68 FBan0017453 FBgn0033982 Cyp317a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp317a1 Cyp317a1 "CG17453, 317a1" CDMC28993 3 19 20 DAC33-C06 2-CG31627-RA_4 CG31627 TTCCAGCACGGATTTCTTTTCACTCTCCGACAAGCCATCGTTGGGAAGAAGACGAGCCCTACTGGC 66 FBan0031627 FBgn0051627 CG31627 2 2L CG31627 CG31627 NEST:bs05g10 CDMC28993 3 20 20 DAC33-C06 2-CG31627-RA_4 CG31627 TTCCAGCACGGATTTCTTTTCACTCTCCGACAAGCCATCGTTGGGAAGAAGACGAGCCCTACTGGC 66 FBan0031627 FBgn0051627 CG31627 2 2L CG31627 CG31627 NEST:bs05g10 CDMC28994 3 21 20 DAC33-C18 3-CG31793-RA_2 CG31793 GGACGTCCACCTCAAGGAGGAAATTTCGGAGTTGCCTTCGGGTCTGCAGAGCATCATATCTGAGGG 66 FBan0031793 FBgn0051793 CG31793 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG31793 CG31793 "CG10441, CG17338, CG10441, CG17338" CDMC28994 3 22 20 DAC33-C18 3-CG31793-RA_2 CG31793 GGACGTCCACCTCAAGGAGGAAATTTCGGAGTTGCCTTCGGGTCTGCAGAGCATCATATCTGAGGG 66 FBan0031793 FBgn0051793 CG31793 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG31793 CG31793 "CG10441, CG17338, CG10441, CG17338" CDMC28995 3 23 20 DAC33-G06 3-CG32313-RA_6 CG32313 GTGCAACCAGACAATCGGCATAGGTCTTCGCTCCTTAATCCTGGAGGCTCACAATCGAAGGAGGGC 66 FBan0032313 FBgn0052313 CG32313 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG32313 CG32313 CDMC28995 3 24 20 DAC33-G06 3-CG32313-RA_6 CG32313 GTGCAACCAGACAATCGGCATAGGTCTTCGCTCCTTAATCCTGGAGGCTCACAATCGAAGGAGGGC 66 FBan0032313 FBgn0052313 CG32313 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG32313 CG32313 CDMC28996 3 25 20 DAC33-G18 2-CG3246-RA_1 CG3246 CACGGACCGCATCAAGATCGACATCACATTCTCGGACATGACAATGGACTTCCAGAACCTCGGCCT 66 FBan0003246 FBgn0031538 CG3246 2 2L CG3246 CG3246 CDMC28996 3 26 20 DAC33-G18 2-CG3246-RA_1 CG3246 CACGGACCGCATCAAGATCGACATCACATTCTCGGACATGACAATGGACTTCCAGAACCTCGGCCT 66 FBan0003246 FBgn0031538 CG3246 2 2L CG3246 CG3246 CDMC28997 3 1 21 DAC33-K06 2-CG32809-RD_1 CG32809 CAGCGAGACAAACATCCAGCAGAAGATAGCCGCATTGAGTCTAGCCTGTGAGACTAGTGGAGCCGC 66 FBan0032809 FBgn0023531 CG32809 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32809 CG32809 "CG3783, CG3737, CG3791, CG3783, EG:171E4.3, EG:73D1.1, EG:9D2.2" CDMC28997 3 2 21 DAC33-K06 2-CG32809-RD_1 CG32809 CAGCGAGACAAACATCCAGCAGAAGATAGCCGCATTGAGTCTAGCCTGTGAGACTAGTGGAGCCGC 66 FBan0032809 FBgn0023531 CG32809 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32809 CG32809 "CG3783, CG3737, CG3791, CG3783, EG:171E4.3, EG:73D1.1, EG:9D2.2" CDMC28998 3 3 21 DAC33-K18 12-CG33187-RB_6 CG33187 AGCTCTCATTTGGTGGATAGTAGGGCTGGCTTAGAGGGGAGGAAGAAATCAGTAGTAACGGCGGCA 66 FBgn0053187 CDMC28998 3 4 21 DAC33-K18 12-CG33187-RB_6 CG33187 AGCTCTCATTTGGTGGATAGTAGGGCTGGCTTAGAGGGGAGGAAGAAATCAGTAGTAACGGCGGCA 66 FBgn0053187 CDMC28999 3 5 21 DAC33-O06 2-CG3506-RA_1 CG3506 AGGCACCTCGTTCAGACATCAAAACGAGTGCATTACCAGAGGCTGCCATGTAGTGATCGCCACTCC 66 FBan0003506 FBgn0003970 vas 2 2L dorsal appendage formation; GO:0046843; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; mRNA polyadenylylation; GO:0006378; oocyte anterior/posterior axis determination; GO:0007314; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; pole cell fate determination; GO:0007278; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; positive regulation of oskar mRNA translation; GO:0046012; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 polar granule; GO:0018994; pole plasm; GO:0045495 vas vasa "CG3506, VASA, cgt, courgette, Vasa, BG:DS00929.14, no-relish, DmRH25, VAS, EP(2)0812, pf7, fs(2)ltoRJ36: female sterile(2)ltoRJ36, female sterile(2)ltoRJ36, vasa" CDMC28999 3 6 21 DAC33-O06 2-CG3506-RA_1 CG3506 AGGCACCTCGTTCAGACATCAAAACGAGTGCATTACCAGAGGCTGCCATGTAGTGATCGCCACTCC 66 FBan0003506 FBgn0003970 vas 2 2L dorsal appendage formation; GO:0046843; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; mRNA polyadenylylation; GO:0006378; oocyte anterior/posterior axis determination; GO:0007314; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; pole cell fate determination; GO:0007278; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; positive regulation of oskar mRNA translation; GO:0046012; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0008026 polar granule; GO:0018994; pole plasm; GO:0045495 vas vasa "CG3506, VASA, cgt, courgette, Vasa, BG:DS00929.14, no-relish, DmRH25, VAS, EP(2)0812, pf7, fs(2)ltoRJ36: female sterile(2)ltoRJ36, female sterile(2)ltoRJ36, vasa" CDMC29000 3 7 21 DAC33-O18 AutoBlank AutoBlank CDMC29000 3 8 21 DAC33-O18 AutoBlank AutoBlank CDMC29001 3 9 21 DAC34-C06 2-CG13459-RA_1 CG13459 CCCGGAGTGGACACCGACATTTAGCAAGCAGATCGAACAGTTCCACACATATCTGTTGCCCACCGAACA 69 FBgn0036475 CDMC29001 3 10 21 DAC34-C06 2-CG13459-RA_1 CG13459 CCCGGAGTGGACACCGACATTTAGCAAGCAGATCGAACAGTTCCACACATATCTGTTGCCCACCGAACA 69 FBgn0036475 CDMC29002 3 11 21 DAC34-C18 13-CG13472-RA_1 CG13472 GCGATGATTTCAACGCCCGTTTGAGTAAGATAACCGAGGAAACAGCTAATCTCAAGGTGAGCAGTGCGC 69 FBan0013472 FBgn0036450 CG13472 3 3L CG13472 CG13472 CDMC29002 3 12 21 DAC34-C18 13-CG13472-RA_1 CG13472 GCGATGATTTCAACGCCCGTTTGAGTAAGATAACCGAGGAAACAGCTAATCTCAAGGTGAGCAGTGCGC 69 FBan0013472 FBgn0036450 CG13472 3 3L CG13472 CG13472 CDMC29003 3 13 21 DAC34-G06 17-CG13519-RA_4 CG13519 GGACGTTCCTAATTCTGGTGGCCGTTTCAAAGGCTCAGGATAATGAGGAAACTACTGCAGTTGCCATAT 69 FBan0013519 FBgn0034770 Obp58d 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp58d Odorant-binding protein 58d "CG13519, Odorant-binding protein 58d" CDMC29003 3 14 21 DAC34-G06 17-CG13519-RA_4 CG13519 GGACGTTCCTAATTCTGGTGGCCGTTTCAAAGGCTCAGGATAATGAGGAAACTACTGCAGTTGCCATAT 69 FBan0013519 FBgn0034770 Obp58d 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp58d Odorant-binding protein 58d "CG13519, Odorant-binding protein 58d" CDMC29004 3 15 21 DAC34-G18 1-CG13540-RA_1 CG13540 GCACTGCTCGGAAAAGAGTTTTGCGCCCTCTGGTGACGAAATACCCACACCACGTGATTTGAAGGACAA 69 FBan0013540 FBgn0034839 CG13540 2 2R CG13540 CG13540 CDMC29004 3 16 21 DAC34-G18 1-CG13540-RA_1 CG13540 GCACTGCTCGGAAAAGAGTTTTGCGCCCTCTGGTGACGAAATACCCACACCACGTGATTTGAAGGACAA 69 FBan0013540 FBgn0034839 CG13540 2 2R CG13540 CG13540 CDMC29005 3 17 21 DAC34-K06 17-CG13585-RA_1 CG13585 AGGACCCCTGCTTCTACGAAACCTGAGCATCCACAACACAATTTTCAGACCGCAATTCCTTGTTTTGTT 69 FBan0013585 FBgn0035020 CG13585 2 2R CG13585 CG13585 BcDNA:AT28250 CDMC29005 3 18 21 DAC34-K06 17-CG13585-RA_1 CG13585 AGGACCCCTGCTTCTACGAAACCTGAGCATCCACAACACAATTTTCAGACCGCAATTCCTTGTTTTGTT 69 FBan0013585 FBgn0035020 CG13585 2 2R CG13585 CG13585 BcDNA:AT28250 CDMC29006 3 19 21 DAC34-K18 2-CG13597-RA_1 CG13597 GGCAGGGAAGCTTCTAATGGAGGCCTTTTACATGCGAATGGAGTCCATTGATTTGAGCACGGAGGTGGA 69 FBan0013597 FBgn0039124 CG13597 3 3R MAPKKK cascade; GO:0000165; development; GO:0007275; gametogenesis; GO:0007276; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; spermatogenesis; GO:0007283 single-stranded DNA binding; GO:0003697; nucleic acid binding; GO:0003676; ; GO:0003676; kinase activity; GO:0016301; ; GO:0003697; ; GO:0016301 CG13597 CG13597 CDMC29006 3 20 21 DAC34-K18 2-CG13597-RA_1 CG13597 GGCAGGGAAGCTTCTAATGGAGGCCTTTTACATGCGAATGGAGTCCATTGATTTGAGCACGGAGGTGGA 69 FBan0013597 FBgn0039124 CG13597 3 3R MAPKKK cascade; GO:0000165; development; GO:0007275; gametogenesis; GO:0007276; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; spermatogenesis; GO:0007283 single-stranded DNA binding; GO:0003697; nucleic acid binding; GO:0003676; ; GO:0003676; kinase activity; GO:0016301; ; GO:0003697; ; GO:0016301 CG13597 CG13597 CDMC29007 3 21 21 DAC34-O06 23-CG13623-RA_3 CG13623 AGTTGGGATGTATCGAACTATCGACACCTATCGTTATCGTGCGAAATCAGCTGAAATTGTTTGGATTAC 69 FBan0013623 FBgn0039205 CG13623 3 3R CG13623 CG13623 BcDNA:GH27470 CDMC29007 3 22 21 DAC34-O06 23-CG13623-RA_3 CG13623 AGTTGGGATGTATCGAACTATCGACACCTATCGTTATCGTGCGAAATCAGCTGAAATTGTTTGGATTAC 69 FBan0013623 FBgn0039205 CG13623 3 3R CG13623 CG13623 BcDNA:GH27470 CDMC29008 3 23 21 DAC34-O18 16-CG13636-RA_2 CG13636 CCCCAGTGATCCATCAAATGTGCCTCAGTGAAACCAACAGAAACAAAAGATCATCCTACCCCTACCACT 69 FBan0013636 FBgn0039232 CG13636 3 3R CG13636 CG13636 "BcDNA:RE05274, BcDNA:RE20019" CDMC29008 3 24 21 DAC34-O18 16-CG13636-RA_2 CG13636 CCCCAGTGATCCATCAAATGTGCCTCAGTGAAACCAACAGAAACAAAAGATCATCCTACCCCTACCACT 69 FBan0013636 FBgn0039232 CG13636 3 3R CG13636 CG13636 "BcDNA:RE05274, BcDNA:RE20019" CDMC29009 3 25 21 DAC35-C06 2-CG17975-RA_1 CG17975 GGCAGCCTTTTCTCGTGGATCGGAAACTTCCTAGTGGGCATGTGCTTTCCATTGCTGCAGAGTGTC 66 FBan0017975 FBgn0028562 sut2 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut2 sugar transporter 2 "CG17975, CG17975" CDMC29009 3 26 21 DAC35-C06 2-CG17975-RA_1 CG17975 GGCAGCCTTTTCTCGTGGATCGGAAACTTCCTAGTGGGCATGTGCTTTCCATTGCTGCAGAGTGTC 66 FBan0017975 FBgn0028562 sut2 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut2 sugar transporter 2 "CG17975, CG17975" CDMC29010 3 1 22 DAC35-C18 12-CG18304-RA_1 CG18304 GCCCTTTTGCAGACCGTTGATGAGCTTGTGAAGATAGCTCCTGACCTGAAAATAGTTGGCAGCGGC 66 FBan0018304 FBgn0031869 CG18304 2 2L structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG18304 CG18304 CG13774 CDMC29010 3 2 22 DAC35-C18 12-CG18304-RA_1 CG18304 GCCCTTTTGCAGACCGTTGATGAGCTTGTGAAGATAGCTCCTGACCTGAAAATAGTTGGCAGCGGC 66 FBan0018304 FBgn0031869 CG18304 2 2L structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG18304 CG18304 CG13774 CDMC29011 3 3 22 DAC35-G06 2-CG2253-RA_2 CG2253 TAACAGGTGCTCAGACCATCGGCCCTGGGATCAACAATATGTCACAGATCTCAAAGTCGGTCCCCA 66 FBan0002253 FBgn0029992 Upf2 X X protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 Upf2 Upf2 "CG2253, CG2253, CG2253, UPF2" CDMC29011 3 4 22 DAC35-G06 2-CG2253-RA_2 CG2253 TAACAGGTGCTCAGACCATCGGCCCTGGGATCAACAATATGTCACAGATCTCAAAGTCGGTCCCCA 66 FBan0002253 FBgn0029992 Upf2 X X protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 Upf2 Upf2 "CG2253, CG2253, CG2253, UPF2" CDMC29012 3 5 22 DAC35-G18 23-CG2746-RA_1 CG2746 ACTGTTTATCGTCTGAATAAAACACCTTTAGTTTGGCCGAAATGATTTTGTACAAACGTGAAACTC 66 FBan0002746 FBgn0002607 RpL19 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL19 Ribosomal protein L19 "CG2746, M(2)c, E(Dl)KP135, L19, rpL19, l(2)k03704, M(2)60E: Minute(2)60E, ribosomal protein L19, rpl19, M(2)a, anon-EST:Posey33, Enhancer of Delta KP135, lethal (2) k03704, Minute(2)60E, M(2)60E" CDMC29012 3 6 22 DAC35-G18 23-CG2746-RA_1 CG2746 ACTGTTTATCGTCTGAATAAAACACCTTTAGTTTGGCCGAAATGATTTTGTACAAACGTGAAACTC 66 FBan0002746 FBgn0002607 RpL19 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL19 Ribosomal protein L19 "CG2746, M(2)c, E(Dl)KP135, L19, rpL19, l(2)k03704, M(2)60E: Minute(2)60E, ribosomal protein L19, rpl19, M(2)a, anon-EST:Posey33, Enhancer of Delta KP135, lethal (2) k03704, Minute(2)60E, M(2)60E" CDMC29013 3 7 22 DAC35-K06 1-CG30188-RA_1 CG30188 GGTGAGCTCCTGAGAGTTAGCCAAAGAGGACATCAAGTGTCAGATCGTGTGCATTGGGGGGAGCAG 66 FBan0030188 FBgn0050188 CG30188 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG30188 CG30188 "CG13546, CG13547, CT32922, CT32921" CDMC29013 3 8 22 DAC35-K06 1-CG30188-RA_1 CG30188 GGTGAGCTCCTGAGAGTTAGCCAAAGAGGACATCAAGTGTCAGATCGTGTGCATTGGGGGGAGCAG 66 FBan0030188 FBgn0050188 CG30188 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG30188 CG30188 "CG13546, CG13547, CT32922, CT32921" CDMC29014 3 9 22 DAC35-K18 6-CG30426-RA_4 CG30426 GCAGCCCGAACTGCCTCTTTAAGATCGTTCACCGTCTGGACAGCTACAGTCCGTTAGCGAAGCCTC 66 FBan0030426 FBgn0050426 CG30426 2 2R CG30426 CG30426 "CG12196, AAF47268 Dm, Dm Set1, BcDNA:AT13877" CDMC29014 3 10 22 DAC35-K18 6-CG30426-RA_4 CG30426 GCAGCCCGAACTGCCTCTTTAAGATCGTTCACCGTCTGGACAGCTACAGTCCGTTAGCGAAGCCTC 66 FBan0030426 FBgn0050426 CG30426 2 2R CG30426 CG30426 "CG12196, AAF47268 Dm, Dm Set1, BcDNA:AT13877" CDMC29015 3 11 22 DAC35-O06 24-CG31239-RA_2 CG31239 CGAATACCTGCAGATATATATCTTGTATCTACGATATTTTCCAATACTTTGCATACCACATACCAC 66 FBan0031239 FBgn0051239 CG31239 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31239 CG31239 CDMC29015 3 12 22 DAC35-O06 24-CG31239-RA_2 CG31239 CGAATACCTGCAGATATATATCTTGTATCTACGATATTTTCCAATACTTTGCATACCACATACCAC 66 FBan0031239 FBgn0051239 CG31239 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31239 CG31239 CDMC29016 3 13 22 DAC35-O18 AutoBlank AutoBlank CDMC29016 3 14 22 DAC35-O18 AutoBlank AutoBlank CDMC29017 3 15 22 DAC36-C06 3-CG1791-RA_1 CG1791 AGTCGAAGTACGGACAGGAGATTGGCTATTTCAAGGGCATCCTGTGGAAATCCTTCCTGCCAGGACC 67 FBan0001791 FBgn0030163 CG1791 X X receptor binding; GO:0005102; ; GO:0005102 CG1791 CG1791 CDMC29017 3 16 22 DAC36-C06 3-CG1791-RA_1 CG1791 AGTCGAAGTACGGACAGGAGATTGGCTATTTCAAGGGCATCCTGTGGAAATCCTTCCTGCCAGGACC 67 FBan0001791 FBgn0030163 CG1791 X X receptor binding; GO:0005102; ; GO:0005102 CG1791 CG1791 CDMC29018 3 17 22 DAC36-C18 3-CG18146-RA_5 CG18146 CCCTTCTCTCGTTCTACTGCATACCAGTTTGCTCGAAAACCTGCATTCATGGCAGTTGTGTGGCGCC 67 FBan0018146 FBgn0028939 CG18146 2 2L cell communication; GO:0007154; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG18146 CG18146 "BG:DS00180.14, DS00180.14, CT40902" CDMC29018 3 18 22 DAC36-C18 3-CG18146-RA_5 CG18146 CCCTTCTCTCGTTCTACTGCATACCAGTTTGCTCGAAAACCTGCATTCATGGCAGTTGTGTGGCGCC 67 FBan0018146 FBgn0028939 CG18146 2 2L cell communication; GO:0007154; cell-matrix adhesion; GO:0007160; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG18146 CG18146 "BG:DS00180.14, DS00180.14, CT40902" CDMC29019 3 19 22 DAC36-G06 2-CG1994-RA_2 CG1994 GGGCCATTCAGCTGCTCAAGGACTACTATGCAAGGAAGCACACTAATCTGGAGGACGGTCCAGTTGC 67 FBgn0030062 CDMC29019 3 20 22 DAC36-G06 2-CG1994-RA_2 CG1994 GGGCCATTCAGCTGCTCAAGGACTACTATGCAAGGAAGCACACTAATCTGGAGGACGGTCCAGTTGC 67 FBgn0030062 CDMC29020 3 21 22 DAC36-G18 3-CG2210-RA_1 CG2210 ACCTTGCCGGCATTTCGTATTCGGGATTTTTTTGCAACGGCGAACACATGAAGCTCCTGATGCTCGG 67 FBan0002210 FBgn0000150 awd 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228; microtubule-based process; GO:0007017; mitosis; GO:0007067; nucleoside diphosphate phosphorylation; GO:0006165; peptidyl-serine phosphorylation; GO:0018105; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468; pyrimidine base metabolism; GO:0006206; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 GTP binding; GO:0005525; ; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; nucleotide kinase activity; GO:0019201; ; GO:0019201; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 microtubule; GO:0005874 awd abnormal wing discs "CG2210, CG2210, CG2210, CG2210, K-pn: Killer of prune, l(3)L8700, l(3)j2A4, NDPK, nucleoside diphosphate kinase, NDP kinase, 1084/08, NDKB, clone 2.28, clone 2.27, e(shi)A, eshiA, Nucleoside diphosphate kinase, killer of prune, Kpn, Killer of prune, anon-WO0172774.80, anon-WO0172774.82, BcDNA:GM19775, BcDNA:RH27794, anon-EST:Liang-2.27, anon-EST:Liang-2.28, Killer-of-prune, K-pn" CDMC29020 3 22 22 DAC36-G18 3-CG2210-RA_1 CG2210 ACCTTGCCGGCATTTCGTATTCGGGATTTTTTTGCAACGGCGAACACATGAAGCTCCTGATGCTCGG 67 FBan0002210 FBgn0000150 awd 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228; microtubule-based process; GO:0007017; mitosis; GO:0007067; nucleoside diphosphate phosphorylation; GO:0006165; peptidyl-serine phosphorylation; GO:0018105; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468; pyrimidine base metabolism; GO:0006206; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 GTP binding; GO:0005525; ; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; nucleotide kinase activity; GO:0019201; ; GO:0019201; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 microtubule; GO:0005874 awd abnormal wing discs "CG2210, CG2210, CG2210, CG2210, K-pn: Killer of prune, l(3)L8700, l(3)j2A4, NDPK, nucleoside diphosphate kinase, NDP kinase, 1084/08, NDKB, clone 2.28, clone 2.27, e(shi)A, eshiA, Nucleoside diphosphate kinase, killer of prune, Kpn, Killer of prune, anon-WO0172774.80, anon-WO0172774.82, BcDNA:GM19775, BcDNA:RH27794, anon-EST:Liang-2.27, anon-EST:Liang-2.28, Killer-of-prune, K-pn" CDMC29021 3 23 22 DAC36-K06 2-CG30020-RA_2 CG30020 GCCGGAAGACTTTTGCCTTCAAACACCATTTGATACGCCATCAGAAGGCCTCTCATCTGAGCACGCG 67 FBan0030020 FBgn0050020 CG30020 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG30020 CG30020 "CG12941, CG18353, CG12941, CG18353, p190, BEST:LD40262" CDMC29021 3 24 22 DAC36-K06 2-CG30020-RA_2 CG30020 GCCGGAAGACTTTTGCCTTCAAACACCATTTGATACGCCATCAGAAGGCCTCTCATCTGAGCACGCG 67 FBan0030020 FBgn0050020 CG30020 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG30020 CG30020 "CG12941, CG18353, CG12941, CG18353, p190, BEST:LD40262" CDMC29022 3 25 22 DAC36-K18 1-CG30091-RA_2 CG30091 GTTGAACAGCTGGGATAGAAGTGGTCCCGATGCGATCAGGTCCTTCGAGTGGTTGGCTGAGGTCTAC 67 FBan0030091 FBgn0050091 CG30091 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- CG30091 CG30091 CG8212 CDMC29022 3 26 22 DAC36-K18 1-CG30091-RA_2 CG30091 GTTGAACAGCTGGGATAGAAGTGGTCCCGATGCGATCAGGTCCTTCGAGTGGTTGGCTGAGGTCTAC 67 FBan0030091 FBgn0050091 CG30091 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- CG30091 CG30091 CG8212 CDMC29023 3 1 23 DAC36-O06 3-CG30427-RB_3 CG30427 GCACCGTTGTGGAGATGAGCAAACGCATCAACAAGCAGTTCCCATTTAACGCGGGTCTATGGTACCC 67 FBgn0050427 CDMC29023 3 2 23 DAC36-O06 3-CG30427-RB_3 CG30427 GCACCGTTGTGGAGATGAGCAAACGCATCAACAAGCAGTTCCCATTTAACGCGGGTCTATGGTACCC 67 FBgn0050427 CDMC29024 3 3 23 DAC36-O18 AutoBlank AutoBlank CDMC29024 3 4 23 DAC36-O18 AutoBlank AutoBlank CDMC29025 3 5 23 DAC37-C06 23-CG7610-RA_2 CG7610 CCGCCCTCACATAAGCGAATGGAATGTGTTCGAACAGCTCTAACGATTCATACAGCTAATTGCAT 65 FBan0007610 FBgn0020235 ATPsyn-gamma 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-gamma ATP synthase-gamma chain "CG7610, ATP synthase subunit gamma., ATPsyn-gamma, F1ATP synthase" CDMC29025 3 6 23 DAC37-C06 23-CG7610-RA_2 CG7610 CCGCCCTCACATAAGCGAATGGAATGTGTTCGAACAGCTCTAACGATTCATACAGCTAATTGCAT 65 FBan0007610 FBgn0020235 ATPsyn-gamma 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-gamma ATP synthase-gamma chain "CG7610, ATP synthase subunit gamma., ATPsyn-gamma, F1ATP synthase" CDMC29026 3 7 23 DAC37-C18 24-CG7650-RA_1 CG7650 AATCCAAACCCGACTAATTAAATTGTAAATTAAAAGTAAAAACTCGTTAATTACCAATCATGGCC 65 FBan0007650 FBgn0036519 CG7650 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118; phototransduction; GO:0007602; visual perception; GO:0007601 electron transporter activity; GO:0005489; ; GO:0005489; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7650 CG7650 BcDNA:AT27057 CDMC29026 3 8 23 DAC37-C18 24-CG7650-RA_1 CG7650 AATCCAAACCCGACTAATTAAATTGTAAATTAAAAGTAAAAACTCGTTAATTACCAATCATGGCC 65 FBan0007650 FBgn0036519 CG7650 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118; phototransduction; GO:0007602; visual perception; GO:0007601 electron transporter activity; GO:0005489; ; GO:0005489; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7650 CG7650 BcDNA:AT27057 CDMC29027 3 9 23 DAC37-G06 2-CG7795-RB_1 CG7795 ATCGTCCGCGAGATGTGAGGTCGTACACGAATCCATTTAGCGCGATCGGAAAAGAGGTTACCCGG 65 FBan0007795 FBgn0032019 CG7795 2 2L CG7795 CG7795 CDMC29027 3 10 23 DAC37-G06 2-CG7795-RB_1 CG7795 ATCGTCCGCGAGATGTGAGGTCGTACACGAATCCATTTAGCGCGATCGGAAAAGAGGTTACCCGG 65 FBan0007795 FBgn0032019 CG7795 2 2L CG7795 CG7795 CDMC29028 3 11 23 DAC37-G18 2-CG7852-RC_3 CG7852 GGCCAACGTGTTTTGACGAACGCGAAGAATGCAGAGTTAGTTCCTGGATCTGATACGCGCACCCC 65 FBan0007852 FBgn0035229 CG7852 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG7852 CG7852 CDMC29028 3 12 23 DAC37-G18 2-CG7852-RC_3 CG7852 GGCCAACGTGTTTTGACGAACGCGAAGAATGCAGAGTTAGTTCCTGGATCTGATACGCGCACCCC 65 FBan0007852 FBgn0035229 CG7852 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG7852 CG7852 CDMC29029 3 13 23 DAC37-K06 1-CG7950-RB_1 CG7950 TAATCGCCAGAAAACTCCGTGATCCAGACTCCGTGACTCTGACGCCCGTATTCTTCTGTGGCTGC 65 FBan0007950 FBgn0039745 CG7950 3 3R CG7950 CG7950 CDMC29029 3 14 23 DAC37-K06 1-CG7950-RB_1 CG7950 TAATCGCCAGAAAACTCCGTGATCCAGACTCCGTGACTCTGACGCCCGTATTCTTCTGTGGCTGC 65 FBan0007950 FBgn0039745 CG7950 3 3R CG7950 CG7950 CDMC29030 3 15 23 DAC37-K18 3-CG7974-RA_1 CG7974 CGACCACCTGAGGCAGTCTTCCTCGCACAGATCGGAGGAGATGTTGTCCAACCAGATGCTCAATG 65 FBan0007974 FBgn0035254 CG7974 3 3L CG7974 CG7974 CDMC29030 3 16 23 DAC37-K18 3-CG7974-RA_1 CG7974 CGACCACCTGAGGCAGTCTTCCTCGCACAGATCGGAGGAGATGTTGTCCAACCAGATGCTCAATG 65 FBan0007974 FBgn0035254 CG7974 3 3L CG7974 CG7974 CDMC29031 3 17 23 DAC37-O06 2-CG8069-RB_1 CG8069 CAGTCCCCTTACCACCTGCCATCAGATCCAGACTGCGTTAGAGGACGAGTCACAAAGCAACAGCG 65 FBan0008069 FBgn0033380 Phax 2 2R nervous system development; GO:0007399; snRNA export from nucleus; GO:0006408 Phax Phosphorylated adaptor for RNA export "CG8069, CG8069, CG8069, dPHAX, PHosphorylated Adaptor for RNA Export, BEST:GH22533, Phosphorylated adaptor for RNA export" CDMC29031 3 18 23 DAC37-O06 2-CG8069-RB_1 CG8069 CAGTCCCCTTACCACCTGCCATCAGATCCAGACTGCGTTAGAGGACGAGTCACAAAGCAACAGCG 65 FBan0008069 FBgn0033380 Phax 2 2R nervous system development; GO:0007399; snRNA export from nucleus; GO:0006408 Phax Phosphorylated adaptor for RNA export "CG8069, CG8069, CG8069, dPHAX, PHosphorylated Adaptor for RNA Export, BEST:GH22533, Phosphorylated adaptor for RNA export" CDMC29032 3 19 23 DAC37-O18 2-CG8093-RA_1 CG8093 ATACTTCCGGCAATTCGACTACGGATCTACGCGCAACAAGAAGGAGTACAGCAGCAAGACCCCGC 65 FBan0008093 FBgn0033999 CG8093 2 2R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG8093 CG8093 CT22063 CDMC29032 3 20 23 DAC37-O18 2-CG8093-RA_1 CG8093 ATACTTCCGGCAATTCGACTACGGATCTACGCGCAACAAGAAGGAGTACAGCAGCAAGACCCCGC 65 FBan0008093 FBgn0033999 CG8093 2 2R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3; ; GO:0016298 ; EC:3.1.1.- CG8093 CG8093 CT22063 CDMC29033 3 21 23 DAC38-C06 6-CG4164-RA_2 CG4164 TGCAGCTTATCAAGTGCTTGGTTATAATTCAGCTGTCCCTCTTGCTGGTGGAGGAGTCATTTGCCGGCC 69 FBan0004164 FBgn0031256 CG4164 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG4164 CG4164 CDMC29033 3 22 23 DAC38-C06 6-CG4164-RA_2 CG4164 TGCAGCTTATCAAGTGCTTGGTTATAATTCAGCTGTCCCTCTTGCTGGTGGAGGAGTCATTTGCCGGCC 69 FBan0004164 FBgn0031256 CG4164 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG4164 CG4164 CDMC29034 3 23 23 DAC38-C18 17-CG4183-RA_1 CG4183 CGCTTGACGAACAGAGCACAGATCGAATTCAAAAATCGAGCAGTGAACAACTCAAAGCAACTTTGCGCA 69 FBan0004183 FBgn0001225 Hsp26 3 3L defense response; GO:0006952; determination of adult life span; GO:0008340; protein folding; GO:0006457; response to heat; GO:0009408 Hsp26 Heat shock protein 26 "CG4183, CG4183, hsp26, 26, Protein 26, 26K, hsp 26, HSP26, heat shock protein hsp26, DmHsp26" CDMC29034 3 24 23 DAC38-C18 17-CG4183-RA_1 CG4183 CGCTTGACGAACAGAGCACAGATCGAATTCAAAAATCGAGCAGTGAACAACTCAAAGCAACTTTGCGCA 69 FBan0004183 FBgn0001225 Hsp26 3 3L defense response; GO:0006952; determination of adult life span; GO:0008340; protein folding; GO:0006457; response to heat; GO:0009408 Hsp26 Heat shock protein 26 "CG4183, CG4183, hsp26, 26, Protein 26, 26K, hsp 26, HSP26, heat shock protein hsp26, DmHsp26" CDMC29035 3 25 23 DAC38-G06 23-CG4210-RB_7 CG4210 AAGCTCTTTTGACCATAATCAGAAAAACACAGGTTATAAAGATTTCCCACTATGTCGAAATCCGGAGAG 69 FBan0004210 FBgn0038302 CG4210 3 3R N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG4210 CG4210 "BcDNA:SD13446, BcDNA:SD26038" CDMC29035 3 26 23 DAC38-G06 23-CG4210-RB_7 CG4210 AAGCTCTTTTGACCATAATCAGAAAAACACAGGTTATAAAGATTTCCCACTATGTCGAAATCCGGAGAG 69 FBan0004210 FBgn0038302 CG4210 3 3R N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG4210 CG4210 "BcDNA:SD13446, BcDNA:SD26038" CDMC29036 3 1 24 DAC38-G18 19-CG4220-RA_1 CG4220 GGGTTAAATCGTGCTGCAACTGTTTCTAAAACGAATTTTCCCCACAATTCCGTTGCAGGTTACGGCAGC 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC29036 3 2 24 DAC38-G18 19-CG4220-RA_1 CG4220 GGGTTAAATCGTGCTGCAACTGTTTCTAAAACGAATTTTCCCCACAATTCCGTTGCAGGTTACGGCAGC 69 FBan0004220 FBgn0004858 elB 2 2L tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 elB elbow B "CG4220, el: elbow, elbow, BG:DS06238.3, elb, P10, el" CDMC29037 3 3 24 DAC38-K06 23-CG4257-RC_11 CG4257 ACAACATCAACATCAATAAGATCTAGCCGATCAATGCATGCAAATTGAGCACCTCAACACAAACACCTT 69 FBan0004257 FBgn0016917 Stat92E 3 3R JAK-STAT cascade; GO:0007259; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; cellular defense response; GO:0006968; defense response; GO:0006952; eye development (sensu Endopterygota); GO:0007456; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; hindgut morphogenesis; GO:0007442; humoral immune response; GO:0006959; lamellocyte differentiation; GO:0035171; mesoderm development; GO:0007498; nervous system development; GO:0007399; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; primary sex determination; GO:0007538; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; signal transduction; GO:0007165; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713; stem cell division; GO:0017145; stem cell maintenance; GO:0019827; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003702; ; GO:0004871; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Stat92E Signal-transducer and activator of transcription protein at 92E "CG4257, Stat1alpha-like, marelle, D-Stat, mrl: marelle, Stat, stat, d-STAT, D-STAT, l(3)06346, dSTAT, stat92E, D-stat, STAT, Dstat92E, Dstat 92E, Dstat, DSTAT, mrl stat92E, DRODSRC, DSRC, SD-stat, STAT 92E, dSTAT92E/marelle, STAT92E, Stat92E/marelle, D-stat/stat92E, mrL, DmSTAT, l(3)j6C8, Signal-transducer and activator of transcription protein, mrl" CDMC29037 3 4 24 DAC38-K06 23-CG4257-RC_11 CG4257 ACAACATCAACATCAATAAGATCTAGCCGATCAATGCATGCAAATTGAGCACCTCAACACAAACACCTT 69 FBan0004257 FBgn0016917 Stat92E 3 3R JAK-STAT cascade; GO:0007259; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; cellular defense response; GO:0006968; defense response; GO:0006952; eye development (sensu Endopterygota); GO:0007456; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; hindgut morphogenesis; GO:0007442; humoral immune response; GO:0006959; lamellocyte differentiation; GO:0035171; mesoderm development; GO:0007498; nervous system development; GO:0007399; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; primary sex determination; GO:0007538; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; signal transduction; GO:0007165; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713; stem cell division; GO:0017145; stem cell maintenance; GO:0019827; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003702; ; GO:0004871; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Stat92E Signal-transducer and activator of transcription protein at 92E "CG4257, Stat1alpha-like, marelle, D-Stat, mrl: marelle, Stat, stat, d-STAT, D-STAT, l(3)06346, dSTAT, stat92E, D-stat, STAT, Dstat92E, Dstat 92E, Dstat, DSTAT, mrl stat92E, DRODSRC, DSRC, SD-stat, STAT 92E, dSTAT92E/marelle, STAT92E, Stat92E/marelle, D-stat/stat92E, mrL, DmSTAT, l(3)j6C8, Signal-transducer and activator of transcription protein, mrl" CDMC29038 3 5 24 DAC38-K18 3-CG4265-RA_1 CG4265 CGCGGCACAACAATAGGGTGGAACTAATCCCATAACTGAGAACCACCAAGATCCCGGATCTGCCAGACT 69 FBan0004265 FBgn0010288 Uch 2 2L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 Uch Ubiquitin carboxy-terminal hydrolase "CG4265, uch-D, UCH-D, uch, ubiquitin carboxyl terminal hydrolase, UBL, UCH" CDMC29038 3 6 24 DAC38-K18 3-CG4265-RA_1 CG4265 CGCGGCACAACAATAGGGTGGAACTAATCCCATAACTGAGAACCACCAAGATCCCGGATCTGCCAGACT 69 FBan0004265 FBgn0010288 Uch 2 2L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 Uch Ubiquitin carboxy-terminal hydrolase "CG4265, uch-D, UCH-D, uch, ubiquitin carboxyl terminal hydrolase, UBL, UCH" CDMC29039 3 7 24 DAC38-O06 9-CG4318-RA_7 CG4318 CAGCCAGGAGATGGAGACAATTGACTTGACAATCGATTCACCGGGGGACAACGTGGAGAATATGTGCCC 69 FBan0004318 FBgn0030455 CG4318 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4318 CG4318 CDMC29039 3 8 24 DAC38-O06 9-CG4318-RA_7 CG4318 CAGCCAGGAGATGGAGACAATTGACTTGACAATCGATTCACCGGGGGACAACGTGGAGAATATGTGCCC 69 FBan0004318 FBgn0030455 CG4318 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4318 CG4318 CDMC29040 3 9 24 DAC38-O18 23-CG4326-RA_2 CG4326 AGTGCATTAATATGACGTACATATGTTTCTCGGTTTTCTTATAAAATGGTTAGGCCGACGAAAGAAGAT 69 FBan0004326 FBgn0034986 mRpS17 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS17 mitochondrial ribosomal protein S17 "CG4326, MRP-S17, mitochondrial ribosomal protein S17" CDMC29040 3 10 24 DAC38-O18 23-CG4326-RA_2 CG4326 AGTGCATTAATATGACGTACATATGTTTCTCGGTTTTCTTATAAAATGGTTAGGCCGACGAAAGAAGAT 69 FBan0004326 FBgn0034986 mRpS17 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS17 mitochondrial ribosomal protein S17 "CG4326, MRP-S17, mitochondrial ribosomal protein S17" CDMC29041 3 11 24 DAC39-C06 23-CG6948-RA_4 CG6948 TGAATGCAATAAAGAATGTGCACACAGTTGTCATGCTTTCCTTGACTATCATATACCCCATCACACAAA 69 FBan0006948 FBgn0024814 Clc 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; neurotransmitter transport; GO:0006836; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183 neurotransmitter transporter activity; GO:0005326; ; GO:0005326 clathrin coat of coated pit; GO:0030132; clathrin vesicle coat; GO:0030125; coated pit; GO:0005905; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 Clc Clathrin light chain "CG6948, CG6948, clathrin, clathrin light chain, CLC, Clathrin" CDMC29041 3 12 24 DAC39-C06 23-CG6948-RA_4 CG6948 TGAATGCAATAAAGAATGTGCACACAGTTGTCATGCTTTCCTTGACTATCATATACCCCATCACACAAA 69 FBan0006948 FBgn0024814 Clc 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; neurotransmitter transport; GO:0006836; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183 neurotransmitter transporter activity; GO:0005326; ; GO:0005326 clathrin coat of coated pit; GO:0030132; clathrin vesicle coat; GO:0030125; coated pit; GO:0005905; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 Clc Clathrin light chain "CG6948, CG6948, clathrin, clathrin light chain, CLC, Clathrin" CDMC29042 3 13 24 DAC39-C18 2-CG6955-RA_1 CG6955 AGGCCCGTTCAGTGAATCCCAGGGAATCCGATTGAAAGTCATTCGCCAATCAAGTTCCAATTCAGCGCA 69 FBan0006955 FBgn0020641 Lcp65Ad 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ad Lcp65Ad "CG6955, Lcp-d, DMCLP65d, BcDNA:LP05231, DCP1" CDMC29042 3 14 24 DAC39-C18 2-CG6955-RA_1 CG6955 AGGCCCGTTCAGTGAATCCCAGGGAATCCGATTGAAAGTCATTCGCCAATCAAGTTCCAATTCAGCGCA 69 FBan0006955 FBgn0020641 Lcp65Ad 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010 Lcp65Ad Lcp65Ad "CG6955, Lcp-d, DMCLP65d, BcDNA:LP05231, DCP1" CDMC29043 3 15 24 DAC39-G06 23-CG6983-RA_2 CG6983 TGGACCTTTTGCAAATGTGTATAGAAATGTAACGCAATCCAGGCAATTAAATAACCCTAAAATATGCAA 69 FBan0006983 FBgn0035896 CG6983 3 3L CG6983 CG6983 CDMC29043 3 16 24 DAC39-G06 23-CG6983-RA_2 CG6983 TGGACCTTTTGCAAATGTGTATAGAAATGTAACGCAATCCAGGCAATTAAATAACCCTAAAATATGCAA 69 FBan0006983 FBgn0035896 CG6983 3 3L CG6983 CG6983 CDMC29044 3 17 24 DAC39-G18 24-CG6990-RA_3 CG6990 CACTGGCACTAGTGAAAAAAACCAAGCCGATTTTAAATATTGTAAACAATCTTGTAAAAACACAATAAA 69 FBan0006990 FBgn0039019 HP1c 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1c HP1c "CG6990, HP1, Hp1c" CDMC29044 3 18 24 DAC39-G18 24-CG6990-RA_3 CG6990 CACTGGCACTAGTGAAAAAAACCAAGCCGATTTTAAATATTGTAAACAATCTTGTAAAAACACAATAAA 69 FBan0006990 FBgn0039019 HP1c 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 HP1c HP1c "CG6990, HP1, Hp1c" CDMC29045 3 19 24 DAC39-K06 16-CG7020-RA_1 CG7020 GCCATTTGTGTCCAAGGGGCTAGTTCTGCAGAGAGTGCTCAAGTGTATGTAGATATGAGAGCATTGCGA 69 FBan0007020 FBgn0024806 DIP2 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 DIP2 DISCO Interacting Protein 2 "CG7020, CG7020, CG7020, Ddip2, DISCO Interacting Protein 2" CDMC29045 3 20 24 DAC39-K06 16-CG7020-RA_1 CG7020 GCCATTTGTGTCCAAGGGGCTAGTTCTGCAGAGAGTGCTCAAGTGTATGTAGATATGAGAGCATTGCGA 69 FBan0007020 FBgn0024806 DIP2 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 DIP2 DISCO Interacting Protein 2 "CG7020, CG7020, CG7020, Ddip2, DISCO Interacting Protein 2" CDMC29046 3 21 24 DAC39-K18 23-CG7033-RB_5 CG7033 ACTAATAATCCACACACAACACATTAGCAATTATATCACACGTCCCACTCTCAAAGTCGCACAATTTCT 69 FBan0007033 FBgn0030086 CG7033 X X protein folding; GO:0006457 "nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATPase activity, coupled; GO:0042623; ; GO:0042623; ATP-dependent helicase activity; GO:0008026; unfolded protein binding; GO:0051082; ; GO:0008026; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG7033 CG7033 SD02216p CDMC29046 3 22 24 DAC39-K18 23-CG7033-RB_5 CG7033 ACTAATAATCCACACACAACACATTAGCAATTATATCACACGTCCCACTCTCAAAGTCGCACAATTTCT 69 FBan0007033 FBgn0030086 CG7033 X X protein folding; GO:0006457 "nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATPase activity, coupled; GO:0042623; ; GO:0042623; ATP-dependent helicase activity; GO:0008026; unfolded protein binding; GO:0051082; ; GO:0008026; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG7033 CG7033 SD02216p CDMC29047 3 23 24 DAC39-O06 3-CG7059-RC_1 CG7059 CGGTTGTACGGCGCTCGGCAGTTCTAGTGGAAACATCGGTACCCTTATCATCCGCTGTCTGACATTAGC 69 FBan0007059 FBgn0038957 CG7059 3 3R glycolysis; GO:0006096; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 microtubule; GO:0005874 CG7059 CG7059 CDMC29047 3 24 24 DAC39-O06 3-CG7059-RC_1 CG7059 CGGTTGTACGGCGCTCGGCAGTTCTAGTGGAAACATCGGTACCCTTATCATCCGCTGTCTGACATTAGC 69 FBan0007059 FBgn0038957 CG7059 3 3R glycolysis; GO:0006096; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 microtubule; GO:0005874 CG7059 CG7059 CDMC29048 3 25 24 DAC39-O18 3-CG7072-RA_1 CG7072 TGCTCCTTCAAATATCACCTGGGATCCAAAGAGCCATCTCAACGTGACCGTCTCTCATGTGGCGGATCA 69 FBan0007072 FBgn0035874 CG7072 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7072 CG7072 CDMC29048 3 26 24 DAC39-O18 3-CG7072-RA_1 CG7072 TGCTCCTTCAAATATCACCTGGGATCCAAAGAGCCATCTCAACGTGACCGTCTCTCATGTGGCGGATCA 69 FBan0007072 FBgn0035874 CG7072 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7072 CG7072 CDMC29049 3 1 25 DAC40-C06 3-CG33333-RA_1 CG33333 TCCCTGTCCCAGCCGTTGTAGGAGCTAGTCAAGGAAATGTGTACCATGGTCGCCATCATGGCTAA 65 FBan0033333 FBgn0053333 CG33333 3 3R CG33333 CG33333 CDMC29049 3 2 25 DAC40-C06 3-CG33333-RA_1 CG33333 TCCCTGTCCCAGCCGTTGTAGGAGCTAGTCAAGGAAATGTGTACCATGGTCGCCATCATGGCTAA 65 FBan0033333 FBgn0053333 CG33333 3 3R CG33333 CG33333 CDMC29050 3 3 25 DAC40-C18 1-CG3335-RA_1 CG3335 TGGCAGGATTGTGCTTCCTCCCAGTGGGGTTACGGCACTTATCGAGTACTGTGATCCTTTGGAGG 65 FBan0003335 FBgn0036018 CG3335 3 3L mRNA binding; GO:0003729; ; GO:0003729; helicase activity; GO:0004386; ; GO:0004386 CG3335 CG3335 "cg3335, Q9VT19, Dm-RBD-1" CDMC29050 3 4 25 DAC40-C18 1-CG3335-RA_1 CG3335 TGGCAGGATTGTGCTTCCTCCCAGTGGGGTTACGGCACTTATCGAGTACTGTGATCCTTTGGAGG 65 FBan0003335 FBgn0036018 CG3335 3 3L mRNA binding; GO:0003729; ; GO:0003729; helicase activity; GO:0004386; ; GO:0004386 CG3335 CG3335 "cg3335, Q9VT19, Dm-RBD-1" CDMC29051 3 5 25 DAC40-G06 3-CG3428-RA_1 CG3428 TATCCAGCATCACCGAACTGACCACCCAAGTGTCCGAACTTAAGCGCCAAATGGAGGATGTGGTG 65 FBan0003428 FBgn0036005 CG3428 3 3L CG3428 CG3428 CDMC29051 3 6 25 DAC40-G06 3-CG3428-RA_1 CG3428 TATCCAGCATCACCGAACTGACCACCCAAGTGTCCGAACTTAAGCGCCAAATGGAGGATGTGGTG 65 FBan0003428 FBgn0036005 CG3428 3 3L CG3428 CG3428 CDMC29052 3 7 25 DAC40-G18 3-CG3473-RA_1 CG3473 GTACCGTTCTTCTTTCGATCCAGGCCCTGTTGAGTGCTCCAAACCCAGATGATCCACTGGCCAAC 65 FBan0003473 FBgn0028913 CG3473 2 2L regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG3473 CG3473 "BG:DS01486.1, BcDNA:AT16033" CDMC29052 3 8 25 DAC40-G18 3-CG3473-RA_1 CG3473 GTACCGTTCTTCTTTCGATCCAGGCCCTGTTGAGTGCTCCAAACCCAGATGATCCACTGGCCAAC 65 FBan0003473 FBgn0028913 CG3473 2 2L regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG3473 CG3473 "BG:DS01486.1, BcDNA:AT16033" CDMC29053 3 9 25 DAC40-K06 23-CG3621-RA_1 CG3621 TCGCCTTTTTTTGAGTTGTAGTACGAGCCGGTTAAAGCTAATATAGAATCAAATTGAAGCAGAAA 65 FBan0003621 FBgn0025839 CG3621 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3621 CG3621 "RNAA, EG:152A3.7, 152A3.7, anon-2Db, BcDNA:RE75088, anon-2D" CDMC29053 3 10 25 DAC40-K06 23-CG3621-RA_1 CG3621 TCGCCTTTTTTTGAGTTGTAGTACGAGCCGGTTAAAGCTAATATAGAATCAAATTGAAGCAGAAA 65 FBan0003621 FBgn0025839 CG3621 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3621 CG3621 "RNAA, EG:152A3.7, 152A3.7, anon-2Db, BcDNA:RE75088, anon-2D" CDMC29054 3 11 25 DAC40-K18 2-CG3649-RA_4 CG3649 GCCCTGCTCTCAGCTCTGCCCTTTGTGGTCATGCTGATGTCATCCTACGGATTCATTTTCCTGGC 65 FBan0003649 FBgn0034785 CG3649 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG3649 CG3649 CDMC29054 3 12 25 DAC40-K18 2-CG3649-RA_4 CG3649 GCCCTGCTCTCAGCTCTGCCCTTTGTGGTCATGCTGATGTCATCCTACGGATTCATTTTCCTGGC 65 FBan0003649 FBgn0034785 CG3649 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG3649 CG3649 CDMC29055 3 13 25 DAC40-O06 3-CG3726-RA_4 CG3726 GGCAAGCTGAAGAAGGATCTGAGCGAGCTATGGACACGTCCGCAGATTTGAGGACCAACCAATGC 65 FBan0003726 FBgn0029824 CG3726 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 CG3726 CG3726 CDMC29055 3 14 25 DAC40-O06 3-CG3726-RA_4 CG3726 GGCAAGCTGAAGAAGGATCTGAGCGAGCTATGGACACGTCCGCAGATTTGAGGACCAACCAATGC 65 FBan0003726 FBgn0029824 CG3726 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 CG3726 CG3726 CDMC29056 3 15 25 DAC40-O18 3-CG3771-RA_1 CG3771 TACGAACTCTCGCTGAGCAAACTACGCGAAGGCCTGGCTTTTAGTGGAGTGCCGGAATACACGAA 65 FBan0003771 FBgn0023130 a6 X X embryonic development (sensu Insecta); GO:0001700 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 a6 a6 "CG3771, CG3771, CG3771, EG:9D2.3" CDMC29056 3 16 25 DAC40-O18 3-CG3771-RA_1 CG3771 TACGAACTCTCGCTGAGCAAACTACGCGAAGGCCTGGCTTTTAGTGGAGTGCCGGAATACACGAA 65 FBan0003771 FBgn0023130 a6 X X embryonic development (sensu Insecta); GO:0001700 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 a6 a6 "CG3771, CG3771, CG3771, EG:9D2.3" CDMC29057 3 17 25 DAC41-C06 AutoBlank AutoBlank CDMC29057 3 18 25 DAC41-C06 AutoBlank AutoBlank CDMC29058 3 19 25 DAC41-C18 AutoBlank AutoBlank CDMC29058 3 20 25 DAC41-C18 AutoBlank AutoBlank CDMC29059 3 21 25 DAC41-G06 AutoBlank AutoBlank CDMC29059 3 22 25 DAC41-G06 AutoBlank AutoBlank CDMC29060 3 23 25 DAC41-G18 AutoBlank AutoBlank CDMC29060 3 24 25 DAC41-G18 AutoBlank AutoBlank CDMC29061 3 25 25 DAC41-K06 AutoBlank AutoBlank CDMC29061 3 26 25 DAC41-K06 AutoBlank AutoBlank CDMC29062 3 1 26 DAC41-K18 AutoBlank AutoBlank CDMC29062 3 2 26 DAC41-K18 AutoBlank AutoBlank CDMC29063 3 3 26 DAC41-O06 AutoBlank AutoBlank CDMC29063 3 4 26 DAC41-O06 AutoBlank AutoBlank CDMC29064 3 5 26 DAC41-O18 AutoBlank AutoBlank CDMC29064 3 6 26 DAC41-O18 AutoBlank AutoBlank CDMC29065 3 7 26 DAC42-C06 150mM NaPO4 Blank CDMC29065 3 8 26 DAC42-C06 150mM NaPO4 Blank CDMC29066 3 9 26 DAC42-C18 150mM NaPO4 Blank CDMC29066 3 10 26 DAC42-C18 150mM NaPO4 Blank CDMC29067 3 11 26 DAC42-G06 150mM NaPO4 Blank CDMC29067 3 12 26 DAC42-G06 150mM NaPO4 Blank CDMC29068 3 13 26 DAC42-G18 150mM NaPO4 Blank CDMC29068 3 14 26 DAC42-G18 150mM NaPO4 Blank CDMC29069 3 15 26 DAC42-K06 150mM NaPO4 Blank CDMC29069 3 16 26 DAC42-K06 150mM NaPO4 Blank CDMC29070 3 17 26 DAC42-K18 5uM MSP 5uM MSP CDMC29070 3 18 26 DAC42-K18 5uM MSP 5uM MSP CDMC29071 3 19 26 DAC42-O06 10uM MSP 10uM MSP CDMC29071 3 20 26 DAC42-O06 10uM MSP 10uM MSP CDMC29072 3 21 26 DAC42-O18 20uM MSP 20uM MSP CDMC29072 3 22 26 DAC42-O18 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC29073 4 1 1 DAC01-D06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29073 4 2 1 DAC01-D06 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29074 4 3 1 DAC01-D18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29074 4 4 1 DAC01-D18 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29075 4 5 1 DAC01-H06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29075 4 6 1 DAC01-H06 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29076 4 7 1 DAC01-H18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29076 4 8 1 DAC01-H18 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29077 4 9 1 DAC01-L06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29077 4 10 1 DAC01-L06 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29078 4 11 1 DAC01-L18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29078 4 12 1 DAC01-L18 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29079 4 13 1 DAC01-P06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29079 4 14 1 DAC01-P06 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29080 4 15 1 DAC01-P18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29080 4 16 1 DAC01-P18 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29081 4 17 1 DAC02-D06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29081 4 18 1 DAC02-D06 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29082 4 19 1 DAC02-D18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29082 4 20 1 DAC02-D18 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29083 4 21 1 DAC02-H06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29083 4 22 1 DAC02-H06 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29084 4 23 1 DAC02-H18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29084 4 24 1 DAC02-H18 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29085 4 25 1 DAC02-L06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29085 4 26 1 DAC02-L06 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29086 4 1 2 DAC02-L18 N/A CG9075 (00718-00956) CDMC29086 4 2 2 DAC02-L18 N/A CG9075 (00718-00956) CDMC29087 4 3 2 DAC02-P06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29087 4 4 2 DAC02-P06 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29088 4 5 2 DAC02-P18 AutoBlank AutoBlank CDMC29088 4 6 2 DAC02-P18 AutoBlank AutoBlank CDMC29089 4 7 2 DAC03-D06 12-CG5450-RA_1 CG5450 CCTCGCGTTGATTCGTTTTTTCCCAAATTCCAAAAACTTCGCTGTGCTGACTTAGCCACTCTGCTGCCA 69 FBan0005450 FBgn0026141 Cdlc2 2 2L RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777" cytoplasm; GO:0005737; cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 Cdlc2 Cytoplasmic dynein light chain 2 "CG5450, CG5450, dlc, 8kd dynein light chain, cytoplasmic dynein, Cytoplasmic dynein, dynein, anon-WO0140519.117" CDMC29089 4 8 2 DAC03-D06 12-CG5450-RA_1 CG5450 CCTCGCGTTGATTCGTTTTTTCCCAAATTCCAAAAACTTCGCTGTGCTGACTTAGCCACTCTGCTGCCA 69 FBan0005450 FBgn0026141 Cdlc2 2 2L RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777" cytoplasm; GO:0005737; cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 Cdlc2 Cytoplasmic dynein light chain 2 "CG5450, CG5450, dlc, 8kd dynein light chain, cytoplasmic dynein, Cytoplasmic dynein, dynein, anon-WO0140519.117" CDMC29090 4 9 2 DAC03-D18 23-CG5461-RC_6 CG5461 CTCACCCAAACATGTTAAGTTCGTGTTAGGTAGACTAGCCTGCTGTTAAGAATTGTTATGTTGTTGCTG 69 FBan0005461 FBgn0010460 bun 2 2L autophagic cell death; GO:0048102; cell fate determination; GO:0001709; decapentaplegic receptor signaling pathway; GO:0008101; dorsal appendage formation; GO:0046843; eggshell formation (sensu Insecta); GO:0007304; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; negative regulation of cell fate specification; GO:0009996; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; segmentation; GO:0035282 RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 bun bunched "CG5461, CG5461, CG5461, TSC-22, shs, l(2)00255, 1550, shortsighted, l(2)02687, l(2)05479, l(2)06475, l(2)k02903, EP(2)0488, short-sighted, Tsc22, l(2)rI043, short sighted, bunched" CDMC29090 4 10 2 DAC03-D18 23-CG5461-RC_6 CG5461 CTCACCCAAACATGTTAAGTTCGTGTTAGGTAGACTAGCCTGCTGTTAAGAATTGTTATGTTGTTGCTG 69 FBan0005461 FBgn0010460 bun 2 2L autophagic cell death; GO:0048102; cell fate determination; GO:0001709; decapentaplegic receptor signaling pathway; GO:0008101; dorsal appendage formation; GO:0046843; eggshell formation (sensu Insecta); GO:0007304; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; negative regulation of cell fate specification; GO:0009996; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; segmentation; GO:0035282 RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 bun bunched "CG5461, CG5461, CG5461, TSC-22, shs, l(2)00255, 1550, shortsighted, l(2)02687, l(2)05479, l(2)06475, l(2)k02903, EP(2)0488, short-sighted, Tsc22, l(2)rI043, short sighted, bunched" CDMC29091 4 11 2 DAC03-H06 7-CG5480-RA_1 CG5480 AGCGCCTAGTGCCACGTACCTGCCTGTGAACAAGGTCAAGTAGGAAACCTGCAAGACCACATTCTTATT 69 FBan0005480 FBgn0039446 CG5480 3 3R CG5480 CG5480 CDMC29091 4 12 2 DAC03-H06 7-CG5480-RA_1 CG5480 AGCGCCTAGTGCCACGTACCTGCCTGTGAACAAGGTCAAGTAGGAAACCTGCAAGACCACATTCTTATT 69 FBan0005480 FBgn0039446 CG5480 3 3R CG5480 CG5480 CDMC29092 4 13 2 DAC03-H18 18-CG5490-RA_2 CG5490 GCTGTTTCAGTTCGATCCCGACGATGAGCTATTGTTCCGTTAAAGAGAAGCCTCCAAGAAGAACACTGC 69 FBan0005490 FBgn0003717 Tl 3 3R Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; cytokinesis; GO:0000910; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832; dorsal/ventral axis specification; GO:0009950; embryonic pattern specification; GO:0009880; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; regulation of hemocyte differentiation; GO:0045610; regulation of melanization defense response; GO:0035007; response to bacteria; GO:0009617; response to fungi; GO:0009620; synaptogenesis; GO:0007416; zygotic determination of dorsal/ventral axis; GO:0007352 transmembrane receptor activity; GO:0004888; cytokine binding; GO:0019955; ; GO:0004888; ; GO:0019955 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Tl Toll "CG5490, CG5490, CG5490, CG5490, Fs(1)Tl, toll, tl, dToll, CT17414, Toll-1, T1, toll-1, dToll1, Fs(3)Tl, mat(3)9, mel(3)10, mel(3)9, Toll" CDMC29092 4 14 2 DAC03-H18 18-CG5490-RA_2 CG5490 GCTGTTTCAGTTCGATCCCGACGATGAGCTATTGTTCCGTTAAAGAGAAGCCTCCAAGAAGAACACTGC 69 FBan0005490 FBgn0003717 Tl 3 3R Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; antimicrobial humoral response (sensu Protostomia); GO:0006960; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; cytokinesis; GO:0000910; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832; dorsal/ventral axis specification; GO:0009950; embryonic pattern specification; GO:0009880; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; immune response; GO:0006955; innate immune response; GO:0045087; regulation of hemocyte differentiation; GO:0045610; regulation of melanization defense response; GO:0035007; response to bacteria; GO:0009617; response to fungi; GO:0009620; synaptogenesis; GO:0007416; zygotic determination of dorsal/ventral axis; GO:0007352 transmembrane receptor activity; GO:0004888; cytokine binding; GO:0019955; ; GO:0004888; ; GO:0019955 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Tl Toll "CG5490, CG5490, CG5490, CG5490, Fs(1)Tl, toll, tl, dToll, CT17414, Toll-1, T1, toll-1, dToll1, Fs(3)Tl, mat(3)9, mel(3)10, mel(3)9, Toll" CDMC29093 4 15 2 DAC03-L06 1-CG5521-RA_3 CG5521 AGCGAACACAATCGGGATTACAGGCGGGACATATTGCCCACTGAGTTTTGCGATGTGCTGATTGTGGTT 69 FBan0005521 FBgn0039466 CG5521 3 3R CG5521 CG5521 EP3527 CDMC29093 4 16 2 DAC03-L06 1-CG5521-RA_3 CG5521 AGCGAACACAATCGGGATTACAGGCGGGACATATTGCCCACTGAGTTTTGCGATGTGCTGATTGTGGTT 69 FBan0005521 FBgn0039466 CG5521 3 3R CG5521 CG5521 EP3527 CDMC29094 4 17 2 DAC03-L18 16-CG5537-RA_1 CG5537 CCCGTGGCACCTAATCACTTTGGCCAGAAATACTTCGGTACAGACTAGATACTTGGGTCTATCTCGCAG 69 FBan0005537 FBgn0035639 CG5537 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" uracil phosphoribosyltransferase activity; GO:0004845 ; EC:2.4.2.9; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004845 ; EC:2.4.2.9 CG5537 CG5537 anon-EST:Posey275 CDMC29094 4 18 2 DAC03-L18 16-CG5537-RA_1 CG5537 CCCGTGGCACCTAATCACTTTGGCCAGAAATACTTCGGTACAGACTAGATACTTGGGTCTATCTCGCAG 69 FBan0005537 FBgn0035639 CG5537 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" uracil phosphoribosyltransferase activity; GO:0004845 ; EC:2.4.2.9; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004845 ; EC:2.4.2.9 CG5537 CG5537 anon-EST:Posey275 CDMC29095 4 19 2 DAC03-P06 15-CG5575-RA_1 CG5575 CCTACTTACACCCCCCTTGCTCTAGAAGCCCAATCCAATACTTTTTAAGCGGCTGGTCCATTCAGTGGA 69 FBan0005575 FBgn0011236 ken 2 2R copulation; GO:0007620; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; insemination; GO:0007320; male analia morphogenesis (sensu Endopterygota); GO:0045496; male genitalia morphogenesis (sensu Endopterygota); GO:0007485 nucleic acid binding; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003676; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 ken ken and barbie "CG5575, okina, ok, 2970, 3907, 5029, 8253, P420, l(2)00628, ken & barbie, l(2)02970, l(2)05029" CDMC29095 4 20 2 DAC03-P06 15-CG5575-RA_1 CG5575 CCTACTTACACCCCCCTTGCTCTAGAAGCCCAATCCAATACTTTTTAAGCGGCTGGTCCATTCAGTGGA 69 FBan0005575 FBgn0011236 ken 2 2R copulation; GO:0007620; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; insemination; GO:0007320; male analia morphogenesis (sensu Endopterygota); GO:0045496; male genitalia morphogenesis (sensu Endopterygota); GO:0007485 nucleic acid binding; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003676; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 ken ken and barbie "CG5575, okina, ok, 2970, 3907, 5029, 8253, P420, l(2)00628, ken & barbie, l(2)02970, l(2)05029" CDMC29096 4 21 2 DAC03-P18 23-CG5589-RA_1 CG5589 GGTTATGAAAAGGACTTAAATTCAAAGCAGAAGAAGCTAGGCAATATTAAAACAGAACTTAAGCCAGCC 69 FBan0005589 FBgn0036754 CG5589 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0003729 CG5589 CG5589 "cg5589, DmRH17" CDMC29096 4 22 2 DAC03-P18 23-CG5589-RA_1 CG5589 GGTTATGAAAAGGACTTAAATTCAAAGCAGAAGAAGCTAGGCAATATTAAAACAGAACTTAAGCCAGCC 69 FBan0005589 FBgn0036754 CG5589 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0003729 CG5589 CG5589 "cg5589, DmRH17" CDMC29097 4 23 2 DAC04-D06 2-CG12377-RA_4 CG12377 CGGTCTGCGCTATACGAATGAGCTAAAAAGGCACTGTCTGGGCCAAGACATAAGTGAGGGAGGTGTCCT 69 FBan0012377 FBgn0037168 CG12377 3 3L CG12377 CG12377 CDMC29097 4 24 2 DAC04-D06 2-CG12377-RA_4 CG12377 CGGTCTGCGCTATACGAATGAGCTAAAAAGGCACTGTCTGGGCCAAGACATAAGTGAGGGAGGTGTCCT 69 FBan0012377 FBgn0037168 CG12377 3 3L CG12377 CG12377 CDMC29098 4 25 2 DAC04-D18 6-CG12389-RA_6 CG12389 AGCCACTTGGACTGCTATGTCGCCCTAATGGAGCTCTTCCACGAAATCACATACATCACTACCTGCGGA 69 FBan0012389 FBgn0025373 Fpps 2 2R cholesterol metabolism; GO:0008203; farnesyl diphosphate biosynthesis; GO:0045337; germ cell migration; GO:0008354 geranyltranstransferase activity; GO:0004337 ; EC:2.5.1.10; ; GO:0004337 ; EC:2.5.1.10; dimethylallyltranstransferase activity; GO:0004161 ; EC:2.5.1.1; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0004161 ; EC:2.5.1.1; ; GO:0004337 ; EC:2.5.1.10 Fpps Farnesyl pyrophosphate synthase "CG12389, CG12389, l(2)k06103, v(2)k03514, FPS, Farnesyl diphosphate synthase, fpps, fps" CDMC29098 4 26 2 DAC04-D18 6-CG12389-RA_6 CG12389 AGCCACTTGGACTGCTATGTCGCCCTAATGGAGCTCTTCCACGAAATCACATACATCACTACCTGCGGA 69 FBan0012389 FBgn0025373 Fpps 2 2R cholesterol metabolism; GO:0008203; farnesyl diphosphate biosynthesis; GO:0045337; germ cell migration; GO:0008354 geranyltranstransferase activity; GO:0004337 ; EC:2.5.1.10; ; GO:0004337 ; EC:2.5.1.10; dimethylallyltranstransferase activity; GO:0004161 ; EC:2.5.1.1; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0004161 ; EC:2.5.1.1; ; GO:0004337 ; EC:2.5.1.10 Fpps Farnesyl pyrophosphate synthase "CG12389, CG12389, l(2)k06103, v(2)k03514, FPS, Farnesyl diphosphate synthase, fpps, fps" CDMC29099 4 1 3 DAC04-H06 23-CG12425-RA_2 CG12425 GCGCTTGAGTTCGTGTATTTCCGGTTGAACAAACACATAAGCGAAACATAAAAGAAAGGCGAAAAAAAT 69 FBan0012425 FBgn0039571 CG12425 3 3R CG12425 CG12425 CDMC29099 4 2 3 DAC04-H06 23-CG12425-RA_2 CG12425 GCGCTTGAGTTCGTGTATTTCCGGTTGAACAAACACATAAGCGAAACATAAAAGAAAGGCGAAAAAAAT 69 FBan0012425 FBgn0039571 CG12425 3 3R CG12425 CG12425 CDMC29100 4 3 3 DAC04-H18 3-CG12439-RA_4 CG12439 GCCGTTGGATCACTGTGCATTGTGCTCGAGGTGTTGACACAGCGGAAGATGAAGAATTTGGTGGGACAG 69 FBan0012439 FBgn0032094 CG12439 2 2L CG12439 CG12439 BcDNA:AT16114 CDMC29100 4 4 3 DAC04-H18 3-CG12439-RA_4 CG12439 GCCGTTGGATCACTGTGCATTGTGCTCGAGGTGTTGACACAGCGGAAGATGAAGAATTTGGTGGGACAG 69 FBan0012439 FBgn0032094 CG12439 2 2L CG12439 CG12439 BcDNA:AT16114 CDMC29101 4 5 3 DAC04-L06 17-CG12489-RA_2 CG12489 GCGTGCCGATTGTCTGAGAACCAACATGATTCACTAGTGCTCTATGACCACAACCTAAAAGGGGAACAA 69 FBan0012489 FBgn0034738 Dnr1 2 2R immune response; GO:0006955; protein ubiquitination; GO:0016567; transmission of nerve impulse; GO:0019226 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoskeleton; GO:0005856; ubiquitin ligase complex; GO:0000151 Dnr1 Defense repressor 1 "CG12489, CG12489, CG12489, Defense repressor 1" CDMC29101 4 6 3 DAC04-L06 17-CG12489-RA_2 CG12489 GCGTGCCGATTGTCTGAGAACCAACATGATTCACTAGTGCTCTATGACCACAACCTAAAAGGGGAACAA 69 FBan0012489 FBgn0034738 Dnr1 2 2R immune response; GO:0006955; protein ubiquitination; GO:0016567; transmission of nerve impulse; GO:0019226 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoskeleton; GO:0005856; ubiquitin ligase complex; GO:0000151 Dnr1 Defense repressor 1 "CG12489, CG12489, CG12489, Defense repressor 1" CDMC29102 4 7 3 DAC04-L18 16-CG1249-RA_1 CG1249 ACGAAGCCGCGCTGAATACTTTTGCCAACAATAAACGCAGAAAACCAACTGAGAAGCGAAACAAGAAGA 69 FBan0001249 FBgn0037434 CG1249 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG1249 CG1249 BcDNA:LD03002 CDMC29102 4 8 3 DAC04-L18 16-CG1249-RA_1 CG1249 ACGAAGCCGCGCTGAATACTTTTGCCAACAATAAACGCAGAAAACCAACTGAGAAGCGAAACAAGAAGA 69 FBan0001249 FBgn0037434 CG1249 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG1249 CG1249 BcDNA:LD03002 CDMC29103 4 9 3 DAC04-P06 14-CG12541-RA_2 CG12541 GGGCATGGTGCACAATCTCAATATGCCGACGTGTCAATTTGCGGCCTATAATCCCAACATTTATGCCAA 69 FBan0012541 FBgn0029930 CG12541 X X CG12541 CG12541 CDMC29103 4 10 3 DAC04-P06 14-CG12541-RA_2 CG12541 GGGCATGGTGCACAATCTCAATATGCCGACGTGTCAATTTGCGGCCTATAATCCCAACATTTATGCCAA 69 FBan0012541 FBgn0029930 CG12541 X X CG12541 CG12541 CDMC29104 4 11 3 DAC04-P18 16-CG12559-RD_1 CG12559 TCATTCCGCAAACGTCTTGCATCGGGACCTTAAGCCAAGTAATTTACTGTTGAACAAGACGTGCGACTT 69 CDMC29104 4 12 3 DAC04-P18 16-CG12559-RD_1 CG12559 TCATTCCGCAAACGTCTTGCATCGGGACCTTAAGCCAAGTAATTTACTGTTGAACAAGACGTGCGACTT 69 CDMC29105 4 13 3 DAC05-D06 7-CG5057-RA_1 CG5057 TGTCTGCACCGCTAGAGAACCTTGAGACCCAGCTAGAGATGTTCATCGAGAATGTTCGTCAGATCCGCA 69 FBan0005057 FBgn0036581 MED10 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0016455 mediator complex; GO:0000119 MED10 Mediator complex subunit 10 "CG5057, CG5057, CG5057, Nut2, dTRAP15, dMED10, Mediator, Med10, BcDNA:SD24044, Mediator complex subunit 10" CDMC29105 4 14 3 DAC05-D06 7-CG5057-RA_1 CG5057 TGTCTGCACCGCTAGAGAACCTTGAGACCCAGCTAGAGATGTTCATCGAGAATGTTCGTCAGATCCGCA 69 FBan0005057 FBgn0036581 MED10 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0016455 mediator complex; GO:0000119 MED10 Mediator complex subunit 10 "CG5057, CG5057, CG5057, Nut2, dTRAP15, dMED10, Mediator, Med10, BcDNA:SD24044, Mediator complex subunit 10" CDMC29106 4 15 3 DAC05-D18 3-CG5067-RA_1 CG5067 TGCAGCAACGCAGACTCACAAAACGAAACGGATGTGCAACAAAGCTCACACTTAGCAAACGCTCATGCA 69 FBan0005067 FBgn0028386 cic 3 3R "embryonic development (sensu Insecta); GO:0001700; negative regulation of transcription; GO:0016481; regulation of transcription, DNA-dependent; GO:0006355; transport; GO:0006810" RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; transporter activity; GO:0005215; ; GO:0003702; ; GO:0003700; ; GO:0030528; ; GO:0005215; ; GO:0003712 nucleus; GO:0005634 cic capicua "CG5067, CG5067, CG5067, E(Dl)D49, fettucine, fet, Enhancer of Delta D49, capicua" CDMC29106 4 16 3 DAC05-D18 3-CG5067-RA_1 CG5067 TGCAGCAACGCAGACTCACAAAACGAAACGGATGTGCAACAAAGCTCACACTTAGCAAACGCTCATGCA 69 FBan0005067 FBgn0028386 cic 3 3R "embryonic development (sensu Insecta); GO:0001700; negative regulation of transcription; GO:0016481; regulation of transcription, DNA-dependent; GO:0006355; transport; GO:0006810" RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; transcription factor activity; GO:0003700; transporter activity; GO:0005215; ; GO:0003702; ; GO:0003700; ; GO:0030528; ; GO:0005215; ; GO:0003712 nucleus; GO:0005634 cic capicua "CG5067, CG5067, CG5067, E(Dl)D49, fettucine, fet, Enhancer of Delta D49, capicua" CDMC29107 4 17 3 DAC05-H06 3-CG5104-RB_5 CG5104 TGTGCAAAACCCCCCGAGAGGAGTGCCGGTAATTCCAAGTCAGCCACCTGTTGAACATTATTCAATCGC 69 FBan0005104 FBgn0037009 CG5104 3 3L CG5104 CG5104 BcDNA:RH26504 CDMC29107 4 18 3 DAC05-H06 3-CG5104-RB_5 CG5104 TGTGCAAAACCCCCCGAGAGGAGTGCCGGTAATTCCAAGTCAGCCACCTGTTGAACATTATTCAATCGC 69 FBan0005104 FBgn0037009 CG5104 3 3L CG5104 CG5104 BcDNA:RH26504 CDMC29108 4 19 3 DAC05-H18 2-CG5116-RA_1 CG5116 GCCTCATGATGCACGTGGTTATCAGCCAACGCACACTGGATCAGTTCAAGCGACAGTTTTGCCGATGAA 69 FBan0005116 FBgn0039339 CG5116 3 3R "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG5116 CG5116 CDMC29108 4 20 3 DAC05-H18 2-CG5116-RA_1 CG5116 GCCTCATGATGCACGTGGTTATCAGCCAACGCACACTGGATCAGTTCAAGCGACAGTTTTGCCGATGAA 69 FBan0005116 FBgn0039339 CG5116 3 3R "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG5116 CG5116 CDMC29109 4 21 3 DAC05-L06 23-CG5151-RB_4 CG5151 AAAAACCAAGAAAGCAACAAACTTGAAAGAGACAGACACAATACCATAAAAACTGAAGAAAGGGAATGA 69 FBan0005151 FBgn0036576 CG5151 3 3L CG5151 CG5151 CDMC29109 4 22 3 DAC05-L06 23-CG5151-RB_4 CG5151 AAAAACCAAGAAAGCAACAAACTTGAAAGAGACAGACACAATACCATAAAAACTGAAGAAAGGGAATGA 69 FBan0005151 FBgn0036576 CG5151 3 3L CG5151 CG5151 CDMC29110 4 23 3 DAC05-L18 23-CG5166-RB_12 CG5166 AGCAAGAGCTTGAGTCAGGCTTCCTTTGGGTTTTAGTGCCTCCGTTGTCTCCGAATTAATGAAAAATTA 69 FBgn0038338 CDMC29110 4 24 3 DAC05-L18 23-CG5166-RB_12 CG5166 AGCAAGAGCTTGAGTCAGGCTTCCTTTGGGTTTTAGTGCCTCCGTTGTCTCCGAATTAATGAAAAATTA 69 FBgn0038338 CDMC29111 4 25 3 DAC05-P06 3-CG5194-RA_10 CG5194 ACCAGTGCCCTTGTGTCCCAGAGATGTTCCGGGACTTTCCTCGAGCCAGATACCATGCATAAAACACTT 69 FBan0005194 FBgn0035955 CG5194 3 3L CG5194 CG5194 anon-WO0140519.239 CDMC29111 4 26 3 DAC05-P06 3-CG5194-RA_10 CG5194 ACCAGTGCCCTTGTGTCCCAGAGATGTTCCGGGACTTTCCTCGAGCCAGATACCATGCATAAAACACTT 69 FBan0005194 FBgn0035955 CG5194 3 3L CG5194 CG5194 anon-WO0140519.239 CDMC29112 4 1 4 DAC05-P18 16-CG5206-RA_2 CG5206 TCCCTTACTCCGCTAACATAGAGTTCGTTGTTTCAATGAGAAATCGATCCGTAGGCTTGCCCCCACAAT 69 FBan0005206 FBgn0023097 bon 3 3R "peripheral nervous system development; GO:0007422; protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription coactivator activity; GO:0003713; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0003713; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 bon bonus "CG5206, CG15687, CG5206, 0241/08, 0249/12, 0487/06, 0434/20, Bonus, anon-WO0118547.418, l(3)S043420, bonus" CDMC29112 4 2 4 DAC05-P18 16-CG5206-RA_2 CG5206 TCCCTTACTCCGCTAACATAGAGTTCGTTGTTTCAATGAGAAATCGATCCGTAGGCTTGCCCCCACAAT 69 FBan0005206 FBgn0023097 bon 3 3R "peripheral nervous system development; GO:0007422; protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription coactivator activity; GO:0003713; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0003713; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 bon bonus "CG5206, CG15687, CG5206, 0241/08, 0249/12, 0487/06, 0434/20, Bonus, anon-WO0118547.418, l(3)S043420, bonus" CDMC29113 4 3 4 DAC06-D06 23-CG9391-RB_4 CG9391 CTAACCAAAAGCATTTTAAATATACCGACCATGTACCTAACAAACAAATTGACTACGCCTAGTCACGGA 69 FBan0009391 FBgn0037063 CG9391 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG9391 CG9391 IMP CDMC29113 4 4 4 DAC06-D06 23-CG9391-RB_4 CG9391 CTAACCAAAAGCATTTTAAATATACCGACCATGTACCTAACAAACAAATTGACTACGCCTAGTCACGGA 69 FBan0009391 FBgn0037063 CG9391 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG9391 CG9391 IMP CDMC29114 4 5 4 DAC06-D18 3-CG9410-RB_1 CG9410 ACTCCATGCAGGACATGTACAGCGTGGTTTCCGACGTCAGCAATTACCACAAGTTCGTGCCGTATGTGA 69 FBan0009410 FBgn0033086 CG9410 2 2R CG9410 CG9410 CDMC29114 4 6 4 DAC06-D18 3-CG9410-RB_1 CG9410 ACTCCATGCAGGACATGTACAGCGTGGTTTCCGACGTCAGCAATTACCACAAGTTCGTGCCGTATGTGA 69 FBan0009410 FBgn0033086 CG9410 2 2R CG9410 CG9410 CDMC29115 4 7 4 DAC06-H06 16-CG9436-RA_1 CG9436 GAGATTTGATCGCGAGAAAGGCGTAGTAGCACTGGTTTAGACTTAGAAGCGTCCAATTTGCACAGCGTT 69 FBan0009436 FBgn0033101 CG9436 2 2R aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG9436 CG9436 CDMC29115 4 8 4 DAC06-H06 16-CG9436-RA_1 CG9436 GAGATTTGATCGCGAGAAAGGCGTAGTAGCACTGGTTTAGACTTAGAAGCGTCCAATTTGCACAGCGTT 69 FBan0009436 FBgn0033101 CG9436 2 2R aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG9436 CG9436 CDMC29116 4 9 4 DAC06-H18 15-CG9447-RA_7 CG9447 GTTATGAGCGGCTTCCTTCTCTACGTGAAATTCACCAAACGCCAACAGATTCAACCCAAGACTGGCACG 69 FBan0009447 FBgn0033110 CG9447 2 2R "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG9447 CG9447 CDMC29116 4 10 4 DAC06-H18 15-CG9447-RA_7 CG9447 GTTATGAGCGGCTTCCTTCTCTACGTGAAATTCACCAAACGCCAACAGATTCAACCCAAGACTGGCACG 69 FBan0009447 FBgn0033110 CG9447 2 2R "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG9447 CG9447 CDMC29117 4 11 4 DAC06-L06 3-CG9483-RA_1 CG9483 CCGTCTGCATGGTGATGTACACGGCTACCATAATCCATGATCGCCAGTTCGATGTGCCCAAGAACGAGT 69 FBan0009483 FBgn0032072 CG9483 2 2L CG9483 CG9483 anon-WO0140519.161 CDMC29117 4 12 4 DAC06-L06 3-CG9483-RA_1 CG9483 CCGTCTGCATGGTGATGTACACGGCTACCATAATCCATGATCGCCAGTTCGATGTGCCCAAGAACGAGT 69 FBan0009483 FBgn0032072 CG9483 2 2L CG9483 CG9483 anon-WO0140519.161 CDMC29118 4 13 4 DAC06-L18 23-CG9496-RA_1 CG9496 GCGACATCGATCGAAGCCATATTTATACAGTATAGCATTCCTTAAAAGATCCCCTTGTATATGTAACTT 69 FBan0009496 FBgn0032075 Tsp29Fb 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp29Fb Tetraspanin 29Fb "CG9496, CG9496, CG9496, CG9496, Dm.Tsp29Fb, anon-EST:ParkEST130, Tetraspanin 29Fb" CDMC29118 4 14 4 DAC06-L18 23-CG9496-RA_1 CG9496 GCGACATCGATCGAAGCCATATTTATACAGTATAGCATTCCTTAAAAGATCCCCTTGTATATGTAACTT 69 FBan0009496 FBgn0032075 Tsp29Fb 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp29Fb Tetraspanin 29Fb "CG9496, CG9496, CG9496, CG9496, Dm.Tsp29Fb, anon-EST:ParkEST130, Tetraspanin 29Fb" CDMC29119 4 15 4 DAC06-P06 16-CG9525-RA_2 CG9525 CTCCTGTTCCCGAAAATCGAACCTGTTCAGATGCTGGCATAGGAGAATCCCAATGTCCATGTGATAGCT 69 FBan0009525 FBgn0032080 CG9525 2 2L CG9525 CG9525 CDMC29119 4 16 4 DAC06-P06 16-CG9525-RA_2 CG9525 CTCCTGTTCCCGAAAATCGAACCTGTTCAGATGCTGGCATAGGAGAATCCCAATGTCCATGTGATAGCT 69 FBan0009525 FBgn0032080 CG9525 2 2L CG9525 CG9525 CDMC29120 4 17 4 DAC06-P18 22-CG9537-RA_1 CG9537 CGCTCTCGGCTTTTGTGAACAGGATGCAAGATTTTCCCGATTACCACGATGTGCTTCAAATACTGGAAA 69 FBan0009537 FBgn0031820 DLP 2 2L JNK cascade; GO:0007254; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; ; GO:0005057 DLP Daxx-like protein "CG9537, Daxx" CDMC29120 4 18 4 DAC06-P18 22-CG9537-RA_1 CG9537 CGCTCTCGGCTTTTGTGAACAGGATGCAAGATTTTCCCGATTACCACGATGTGCTTCAAATACTGGAAA 69 FBan0009537 FBgn0031820 DLP 2 2L JNK cascade; GO:0007254; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 receptor signaling protein activity; GO:0005057; ; GO:0005057 DLP Daxx-like protein "CG9537, Daxx" CDMC29121 4 19 4 DAC07-D06 17-CG6584-RE_2 CG6584 GCCAAGCGTTCAAAAGCAGAAAAGCGCACGAAAATAGAACGGAAAATGTGGGAAATGTGGTAGACGGAA 69 FBan0006584 FBgn0037847 SelR 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; peptidyl-methionine modification; GO:0018206 zinc ion binding; GO:0008270; ; GO:0008270; protein-methionine-R-oxide reductase activity; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.-; ; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.- SelR SelR "CG6584, MsrB, methionine-R-sulfoxide reductase, BcDNA:RE36040, BcDNA:RH61230" CDMC29121 4 20 4 DAC07-D06 17-CG6584-RE_2 CG6584 GCCAAGCGTTCAAAAGCAGAAAAGCGCACGAAAATAGAACGGAAAATGTGGGAAATGTGGTAGACGGAA 69 FBan0006584 FBgn0037847 SelR 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; peptidyl-methionine modification; GO:0018206 zinc ion binding; GO:0008270; ; GO:0008270; protein-methionine-R-oxide reductase activity; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.-; ; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.- SelR SelR "CG6584, MsrB, methionine-R-sulfoxide reductase, BcDNA:RE36040, BcDNA:RH61230" CDMC29122 4 21 4 DAC07-D18 8-CG6596-RA_1 CG6596 TCGGGGAGTTTGGCCGATATCAGAAGCTACTGTTCATCTGCATGATCCCATTCTCGTTTTTCGTGGCCT 69 FBan0006596 FBgn0035671 CG6596 3 3L CG6596 CG6596 CDMC29122 4 22 4 DAC07-D18 8-CG6596-RA_1 CG6596 TCGGGGAGTTTGGCCGATATCAGAAGCTACTGTTCATCTGCATGATCCCATTCTCGTTTTTCGTGGCCT 69 FBan0006596 FBgn0035671 CG6596 3 3L CG6596 CG6596 CDMC29123 4 23 4 DAC07-H06 18-CG6627-RA_1 CG6627 TGCTTGCTTTAGAATGCCAGCGAATGTTGCGTTGATTATTTGTACACCGATGCATTCTTTGGCCACCCG 69 FBan0006627 FBgn0027453 Dnz1 2 2L metal ion binding; GO:0046872; ; GO:0046872 Dnz1 DNZDHHC/NEW1 zinc finger protein 11 "CG6627, DNZ1" CDMC29123 4 24 4 DAC07-H06 18-CG6627-RA_1 CG6627 TGCTTGCTTTAGAATGCCAGCGAATGTTGCGTTGATTATTTGTACACCGATGCATTCTTTGGCCACCCG 69 FBan0006627 FBgn0027453 Dnz1 2 2L metal ion binding; GO:0046872; ; GO:0046872 Dnz1 DNZDHHC/NEW1 zinc finger protein 11 "CG6627, DNZ1" CDMC29124 4 25 4 DAC07-H18 23-CG6634-RA_1 CG6634 AGATCGTTTCTGGCAAATATTACTGCTGAGTTTCTTTTCAGTCAATGAAATTGCTTAAACTTTAGCTTT 69 FBgn0031706 CDMC29124 4 26 4 DAC07-H18 23-CG6634-RA_1 CG6634 AGATCGTTTCTGGCAAATATTACTGCTGAGTTTCTTTTCAGTCAATGAAATTGCTTAAACTTTAGCTTT 69 FBgn0031706 CDMC29125 4 1 5 DAC07-L06 18-CG6667-RC_7 CG6667 AATTGCAGAATGACCACCAGGATGGCAGTAAGTTGACTGTTGAGATTTTTCCCAAACTGGTGTCGGTCT 69 FBan0006667 FBgn0000462 dl 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; cellular defense response; GO:0006968; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; heart development; GO:0007507; immune response; GO:0006955; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; plasmatocyte differentiation; GO:0042387; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; morphogen activity; GO:0016015; transcriptional repressor activity; GO:0016564; protein binding; GO:0005515; ; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0016015; ; GO:0016563; ; GO:0016564; ; GO:0005515; ; GO:0005515; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 dl dorsal "CG6667, CG6667, CG6667, fs(2)k10816, dL, mat(2)dorsal, anon-EST:GressD7" CDMC29125 4 2 5 DAC07-L06 18-CG6667-RC_7 CG6667 AATTGCAGAATGACCACCAGGATGGCAGTAAGTTGACTGTTGAGATTTTTCCCAAACTGGTGTCGGTCT 69 FBan0006667 FBgn0000462 dl 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; cellular defense response; GO:0006968; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; heart development; GO:0007507; immune response; GO:0006955; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; plasmatocyte differentiation; GO:0042387; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; morphogen activity; GO:0016015; transcriptional repressor activity; GO:0016564; protein binding; GO:0005515; ; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0016015; ; GO:0016563; ; GO:0016564; ; GO:0005515; ; GO:0005515; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 dl dorsal "CG6667, CG6667, CG6667, fs(2)k10816, dL, mat(2)dorsal, anon-EST:GressD7" CDMC29126 4 3 5 DAC07-L18 13-CG6679-RA_1 CG6679 GCCGTCATGATCGTCCAGATTTTCTTGCCCTGTTACTACGGCAATGAGTTGACCTTTCATGCCAATGCA 69 FBan0006679 FBgn0039034 Or94b 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; proteolysis; GO:0006508; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004984; ; GO:0008270; ; GO:0005549 integral to membrane; GO:0016021 Or94b Odorant receptor 94b "CG6679, 94D.2, DOR109, 94b, anon-JP2002534971-A.31, anon-JP2002534971-A.32" CDMC29126 4 4 5 DAC07-L18 13-CG6679-RA_1 CG6679 GCCGTCATGATCGTCCAGATTTTCTTGCCCTGTTACTACGGCAATGAGTTGACCTTTCATGCCAATGCA 69 FBan0006679 FBgn0039034 Or94b 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; proteolysis; GO:0006508; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004984; ; GO:0008270; ; GO:0005549 integral to membrane; GO:0016021 Or94b Odorant receptor 94b "CG6679, 94D.2, DOR109, 94b, anon-JP2002534971-A.31, anon-JP2002534971-A.32" CDMC29127 4 5 5 DAC07-P06 3-CG6704-RA_2 CG6704 AGCATGCCCATTTGTCCAATGTACTCTTTCTGCGCTACGAAGACATGTTGGCTGATCTGCCAGGTGCAA 69 FBan0006704 FBgn0033887 CG6704 2 2R sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; retinol dehydratase activity; GO:0017051; ; GO:0017051; ; GO:0008146 ; EC:2.8.2.- CG6704 CG6704 CDMC29127 4 6 5 DAC07-P06 3-CG6704-RA_2 CG6704 AGCATGCCCATTTGTCCAATGTACTCTTTCTGCGCTACGAAGACATGTTGGCTGATCTGCCAGGTGCAA 69 FBan0006704 FBgn0033887 CG6704 2 2R sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; retinol dehydratase activity; GO:0017051; ; GO:0017051; ; GO:0008146 ; EC:2.8.2.- CG6704 CG6704 CDMC29128 4 7 5 DAC07-P18 13-CG6719-RA_1 CG6719 AGGCAACAGGATGACAGGAATAATGGACTCGGTGGAAATGCCCAAATTACCGGAAAACCAGAAGACCTT 69 FBan0006719 FBgn0037893 CG6719 3 3R 'de novo' protein folding; GO:0006458; protein complex assembly; GO:0006461 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG6719 CG6719 BcDNA:LD34406 CDMC29128 4 8 5 DAC07-P18 13-CG6719-RA_1 CG6719 AGGCAACAGGATGACAGGAATAATGGACTCGGTGGAAATGCCCAAATTACCGGAAAACCAGAAGACCTT 69 FBan0006719 FBgn0037893 CG6719 3 3R 'de novo' protein folding; GO:0006458; protein complex assembly; GO:0006461 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG6719 CG6719 BcDNA:LD34406 CDMC29129 4 9 5 DAC08-D06 23-CG31872-RA_1 CG31872 GCTTGGCACATATGTGAAATTGCCTTTTCCTAAGGGCTCGGAAATAAATATAATTTTTATTAAGGGAAA 69 FBan0031872 FBgn0051872 CG31872 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31872 CG31872 "CG17093, CG17101" CDMC29129 4 10 5 DAC08-D06 23-CG31872-RA_1 CG31872 GCTTGGCACATATGTGAAATTGCCTTTTCCTAAGGGCTCGGAAATAAATATAATTTTTATTAAGGGAAA 69 FBan0031872 FBgn0051872 CG31872 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31872 CG31872 "CG17093, CG17101" CDMC29130 4 11 5 DAC08-D18 16-CG31880-RA_3 CG31880 TCATTCGCATGGCAATCTTTCCAGTCATTTGTCTGCTCATCCAAATTGCGAACAGATTCCTCGGGATGG 69 FBan0031880 FBgn0051880 CG31880 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31880 CG31880 CDMC29130 4 12 5 DAC08-D18 16-CG31880-RA_3 CG31880 TCATTCGCATGGCAATCTTTCCAGTCATTTGTCTGCTCATCCAAATTGCGAACAGATTCCTCGGGATGG 69 FBan0031880 FBgn0051880 CG31880 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31880 CG31880 CDMC29131 4 13 5 DAC08-H06 1-CG31911-RA_1 CG31911 CCGCTCCGACCCAAATTTCGTAGTAGGCCCGGACTACTTTACACTGGTCACTTGCTTCGCGACCTTTAA 69 FBan0031911 FBgn0026585 Ent2 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "equilibrative nucleoside transporter, nitrobenzyl-thioinosine-insensitive activity; GO:0015397; ; GO:0015397" membrane; GO:0016020 Ent2 Equilibrative nucleoside transporter 2 "CG11045, CG31911, CG11045, CG11045, CG11045, LD04971, DmENT2, BEST:LD04971, Equilibrative nucleoside transporter 2" CDMC29131 4 14 5 DAC08-H06 1-CG31911-RA_1 CG31911 CCGCTCCGACCCAAATTTCGTAGTAGGCCCGGACTACTTTACACTGGTCACTTGCTTCGCGACCTTTAA 69 FBan0031911 FBgn0026585 Ent2 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "equilibrative nucleoside transporter, nitrobenzyl-thioinosine-insensitive activity; GO:0015397; ; GO:0015397" membrane; GO:0016020 Ent2 Equilibrative nucleoside transporter 2 "CG11045, CG31911, CG11045, CG11045, CG11045, LD04971, DmENT2, BEST:LD04971, Equilibrative nucleoside transporter 2" CDMC29132 4 15 5 DAC08-H18 16-CG31922-RA_1 CG31922 CCTTCCTTGCAACCCATTAACCCGGAAAAACTCAAGCAAACCGACTTTGAACTCAGTTGGGGCTAAATA 69 FBan0031922 FBgn0051922 CG31922 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532 CG31922 CG31922 "20K, anon-AE003587.1" CDMC29132 4 16 5 DAC08-H18 16-CG31922-RA_1 CG31922 CCTTCCTTGCAACCCATTAACCCGGAAAAACTCAAGCAAACCGACTTTGAACTCAGTTGGGGCTAAATA 69 FBan0031922 FBgn0051922 CG31922 2 2L biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532 CG31922 CG31922 "20K, anon-AE003587.1" CDMC29133 4 17 5 DAC08-L06 3-CG31973-RB_2 CG31973 GGCGTCCGGTACATGAAAACGTGTCAACCATGCCCCGACATTTACCCCTGGACTGGAAAATCTGGAATT 69 FBan0031973 FBgn0051973 CG31973 2 2L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030; metabolism; GO:0008152 "chitin binding; GO:0008061; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG31973 CG31973 "CG2761, CG2776, CG2761, BcDNA:RH43162" CDMC29133 4 18 5 DAC08-L06 3-CG31973-RB_2 CG31973 GGCGTCCGGTACATGAAAACGTGTCAACCATGCCCCGACATTTACCCCTGGACTGGAAAATCTGGAATT 69 FBan0031973 FBgn0051973 CG31973 2 2L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030; metabolism; GO:0008152 "chitin binding; GO:0008061; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG31973 CG31973 "CG2761, CG2776, CG2761, BcDNA:RH43162" CDMC29134 4 19 5 DAC08-L18 23-CG31990-RA_17 CG31990 CCTCCACTTCAAGCTCCAAAATAAGGAATATCGAACTTTAGAATTGCCACTGTCCATGTTTCAACAAGT 69 FBgn0051990 CDMC29134 4 20 5 DAC08-L18 23-CG31990-RA_17 CG31990 CCTCCACTTCAAGCTCCAAAATAAGGAATATCGAACTTTAGAATTGCCACTGTCCATGTTTCAACAAGT 69 FBgn0051990 CDMC29135 4 21 5 DAC08-P06 22-CG32025-RA_1 CG32025 TCTGTGTTCTCACCTTTTGAACCCACAATGAGTCGCCTACCAAAAATAGCAAATGGCATTGATGCGTGA 69 FBan0032025 FBgn0040229 desert 3 3L desert desert CG32025 CDMC29135 4 22 5 DAC08-P06 22-CG32025-RA_1 CG32025 TCTGTGTTCTCACCTTTTGAACCCACAATGAGTCGCCTACCAAAAATAGCAAATGGCATTGATGCGTGA 69 FBan0032025 FBgn0040229 desert 3 3L desert desert CG32025 CDMC29136 4 23 5 DAC08-P18 18-CG32036-RB_7 CG32036 TTTGTAACCGACATAATGATGCCAAAGCTGGGCTGTTTCTCATTTTGGCTAATGTTCGTTGTCGGAGCC 69 FBan0032036 FBgn0052036 CG32036 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32036 CG32036 "CG3426, CG3426" CDMC29136 4 24 5 DAC08-P18 18-CG32036-RB_7 CG32036 TTTGTAACCGACATAATGATGCCAAAGCTGGGCTGTTTCTCATTTTGGCTAATGTTCGTTGTCGGAGCC 69 FBan0032036 FBgn0052036 CG32036 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32036 CG32036 "CG3426, CG3426" CDMC29137 4 25 5 DAC09-D07 15-CG5434-RA_4 CG5434 CGCTAGCTCCCTGGAGGAACTACTTAAGCTGAACCCCAACGACACCAAGGTCTTGGCCCAGTTGG 65 FBan0005434 FBgn0038810 CG5434 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614; regulation of translation; GO:0006445 "7S RNA binding; GO:0008312; ; GO:0008312; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0008135" signal recognition particle (sensu Eukaryota); GO:0005786 CG5434 CG5434 CDMC29137 4 26 5 DAC09-D07 15-CG5434-RA_4 CG5434 CGCTAGCTCCCTGGAGGAACTACTTAAGCTGAACCCCAACGACACCAAGGTCTTGGCCCAGTTGG 65 FBan0005434 FBgn0038810 CG5434 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614; regulation of translation; GO:0006445 "7S RNA binding; GO:0008312; ; GO:0008312; translation factor activity, nucleic acid binding; GO:0008135; ; GO:0008135" signal recognition particle (sensu Eukaryota); GO:0005786 CG5434 CG5434 CDMC29138 4 1 6 DAC09-D19 11-CG5486-RA_1 CG5486 AACTCGTTGGTACATCTCATAGAAGGCGAAACACTGACGGTGGAGTTGGGTAAGACGCTGGAGCC 65 FBan0005486 FBgn0016756 Ubp64E 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004843; ; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 Ubp64E Ubiquitin-specific protease 64E "CG5486, E-var(3)64E, D-UBP-64E, E(var)3-64E, D-Ubp-64E, UBP, Ubp64, BcDNA:LD12764, E(var)1" CDMC29138 4 2 6 DAC09-D19 11-CG5486-RA_1 CG5486 AACTCGTTGGTACATCTCATAGAAGGCGAAACACTGACGGTGGAGTTGGGTAAGACGCTGGAGCC 65 FBan0005486 FBgn0016756 Ubp64E 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004843; ; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 Ubp64E Ubiquitin-specific protease 64E "CG5486, E-var(3)64E, D-UBP-64E, E(var)3-64E, D-Ubp-64E, UBP, Ubp64, BcDNA:LD12764, E(var)1" CDMC29139 4 3 6 DAC09-H07 6-CG5620-RA_2 CG5620 GTCCACGCACCCAAAATCCCTATTCGCGGGGTAACATTTGCCTGAACTGCTGTCACATCCTGTGC 65 FBan0005620 FBgn0036268 CG5620 3 3L metal ion binding; GO:0046872; ; GO:0046872 CG5620 CG5620 CR32097 CDMC29139 4 4 6 DAC09-H07 6-CG5620-RA_2 CG5620 GTCCACGCACCCAAAATCCCTATTCGCGGGGTAACATTTGCCTGAACTGCTGTCACATCCTGTGC 65 FBan0005620 FBgn0036268 CG5620 3 3L metal ion binding; GO:0046872; ; GO:0046872 CG5620 CG5620 CR32097 CDMC29140 4 5 6 DAC09-H19 2-CG5651-RA_1 CG5651 CAGTCGCTGCTAAATGGCATGAACCGCTTCCTCGAACTGCTTGGTATTACGTTCCGTCGCGATCC 65 FBan0005651 FBgn0035946 CG5651 3 3L electron transport; GO:0006118; mRNA metabolism; GO:0016071 ATP binding; GO:0005524; ; GO:0005524; ribonuclease inhibitor activity; GO:0008428; transporter activity; GO:0005215; electron transporter activity; GO:0005489; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; iron ion binding; GO:0005506; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008428; ; GO:0008428; ; GO:0000166; ; GO:0005489; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0005506 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG5651 CG5651 BEST:GH18088 CDMC29140 4 6 6 DAC09-H19 2-CG5651-RA_1 CG5651 CAGTCGCTGCTAAATGGCATGAACCGCTTCCTCGAACTGCTTGGTATTACGTTCCGTCGCGATCC 65 FBan0005651 FBgn0035946 CG5651 3 3L electron transport; GO:0006118; mRNA metabolism; GO:0016071 ATP binding; GO:0005524; ; GO:0005524; ribonuclease inhibitor activity; GO:0008428; transporter activity; GO:0005215; electron transporter activity; GO:0005489; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; iron ion binding; GO:0005506; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008428; ; GO:0008428; ; GO:0000166; ; GO:0005489; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0005506 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG5651 CG5651 BEST:GH18088 CDMC29141 4 7 6 DAC09-L07 2-CG5783-RA_1 CG5783 GTTCAGCAAACTGGGATTCCAGGTCATCGATCAATGCTACTGGCTAAGGACGGAACCCACCGGTG 65 FBan0005783 FBgn0032670 CG5783 2 2L CG5783 CG5783 CDMC29141 4 8 6 DAC09-L07 2-CG5783-RA_1 CG5783 GTTCAGCAAACTGGGATTCCAGGTCATCGATCAATGCTACTGGCTAAGGACGGAACCCACCGGTG 65 FBan0005783 FBgn0032670 CG5783 2 2L CG5783 CG5783 CDMC29142 4 9 6 DAC09-L19 13-CG5829-RA_1 CG5829 CAACGGATTCACCAGCTTCTCCATCTCCAGCATCCTGAGTCGCAGTGAGCCGGCCAAGAAGAACG 65 FBan0005829 FBgn0038520 CG5829 3 3R CG5829 CG5829 CDMC29142 4 10 6 DAC09-L19 13-CG5829-RA_1 CG5829 CAACGGATTCACCAGCTTCTCCATCTCCAGCATCCTGAGTCGCAGTGAGCCGGCCAAGAAGAACG 65 FBan0005829 FBgn0038520 CG5829 3 3R CG5829 CG5829 CDMC29143 4 11 6 DAC09-P07 12-CG5932-RA_2 CG5932 ATCCGGCTGGATCCTCTAGCAACCAGGGCATCCACTACCTGCAGCTATGGAAGTCCCTCAAGTTC 65 FBan0005932 FBgn0036996 CG5932 3 3L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG5932 CG5932 CDMC29143 4 12 6 DAC09-P07 12-CG5932-RA_2 CG5932 ATCCGGCTGGATCCTCTAGCAACCAGGGCATCCACTACCTGCAGCTATGGAAGTCCCTCAAGTTC 65 FBan0005932 FBgn0036996 CG5932 3 3L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG5932 CG5932 CDMC29144 4 13 6 DAC09-P19 11-CG5983-RA_1 CG5983 CATGCAACCGGGCGTACTCAAGCTCATTTTTCGAGCGGTCCTTGTCCCAGGGGAAGATCTGCATC 65 FBan0005983 FBgn0040508 ACXC 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXC ACXC "CG5983, CG5983, DACXC, AC" CDMC29144 4 14 6 DAC09-P19 11-CG5983-RA_1 CG5983 CATGCAACCGGGCGTACTCAAGCTCATTTTTCGAGCGGTCCTTGTCCCAGGGGAAGATCTGCATC 65 FBan0005983 FBgn0040508 ACXC 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXC ACXC "CG5983, CG5983, DACXC, AC" CDMC29145 4 15 6 DAC10-D06 16-CG6533-RA_1 CG6533 GACTGGAATTCCCTCAACCGTTATGGATGGGAGCAGGGTCGCCCACTTTTGGCCAAGCCCTACGG 65 FBan0006533 FBgn0000356 Cp16 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp16 Chorion protein 16 "CG6533, s16-1, s16, cp16, Dms16, CP16, X16715, S16" CDMC29145 4 16 6 DAC10-D06 16-CG6533-RA_1 CG6533 GACTGGAATTCCCTCAACCGTTATGGATGGGAGCAGGGTCGCCCACTTTTGGCCAAGCCCTACGG 65 FBan0006533 FBgn0000356 Cp16 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp16 Chorion protein 16 "CG6533, s16-1, s16, cp16, Dms16, CP16, X16715, S16" CDMC29146 4 17 6 DAC10-D18 3-CG6586-RA_1 CG6586 GAGGCCGTCAACATCCCCAAGACATCCATGACCATGGAAGACATACAGCTGCCGACAATGAGCAG 65 FBan0006586 FBgn0028980 tan 3 3L dopamine biosynthesis; GO:0042416; histamine metabolism; GO:0001692; phosphoinositide metabolism; GO:0030384; pigmentation during development; GO:0048066; sensory organ development; GO:0007423 hydrolase activity; GO:0016787 ; EC:3.-.-.-; beta-alanyl-dopamine hydrolase activity; GO:0003832; ; GO:0003832; ; GO:0016787 ; EC:3.-.-.- cytoplasm; GO:0005737; nucleus; GO:0005634 tan tantalus "CG6586, tantalus" CDMC29146 4 18 6 DAC10-D18 3-CG6586-RA_1 CG6586 GAGGCCGTCAACATCCCCAAGACATCCATGACCATGGAAGACATACAGCTGCCGACAATGAGCAG 65 FBan0006586 FBgn0028980 tan 3 3L dopamine biosynthesis; GO:0042416; histamine metabolism; GO:0001692; phosphoinositide metabolism; GO:0030384; pigmentation during development; GO:0048066; sensory organ development; GO:0007423 hydrolase activity; GO:0016787 ; EC:3.-.-.-; beta-alanyl-dopamine hydrolase activity; GO:0003832; ; GO:0003832; ; GO:0016787 ; EC:3.-.-.- cytoplasm; GO:0005737; nucleus; GO:0005634 tan tantalus "CG6586, tantalus" CDMC29147 4 19 6 DAC10-H06 3-CG6718-RC_1 CG6718 TGCCAACAACCCGACTCTAGACGCCATGACCGAGATTCACGAGTACAATATGGCCTTGCGTAGCG 65 FBan0006718 FBgn0036053 CG6718 3 3L phospholipid metabolism; GO:0006644 calcium-independent phospholipase A2 activity; GO:0047499; nutrient reservoir activity; GO:0045735; ; GO:0047499; ; GO:0045735 cytosol; GO:0005829 CG6718 CG6718 CDMC29147 4 20 6 DAC10-H06 3-CG6718-RC_1 CG6718 TGCCAACAACCCGACTCTAGACGCCATGACCGAGATTCACGAGTACAATATGGCCTTGCGTAGCG 65 FBan0006718 FBgn0036053 CG6718 3 3L phospholipid metabolism; GO:0006644 calcium-independent phospholipase A2 activity; GO:0047499; nutrient reservoir activity; GO:0045735; ; GO:0047499; ; GO:0045735 cytosol; GO:0005829 CG6718 CG6718 CDMC29148 4 21 6 DAC10-H18 23-CG6750-RA_1 CG6750 GTAGATTTTGTTTCGAGTCAGAGAGGGTTAAAATAAAGCAAGTTGTGTGACTACAATGGGAAACC 65 FBan0006750 FBgn0032292 CG6750 2 2L CG6750 CG6750 CDMC29148 4 22 6 DAC10-H18 23-CG6750-RA_1 CG6750 GTAGATTTTGTTTCGAGTCAGAGAGGGTTAAAATAAAGCAAGTTGTGTGACTACAATGGGAAACC 65 FBan0006750 FBgn0032292 CG6750 2 2L CG6750 CG6750 CDMC29149 4 23 6 DAC10-L06 3-CG6842-RA_2 CG6842 CTTGTCCCGCACGAAACCGACCGTCAACGAAGACGATCTGAAGAAGCTGCGCAAATTCACAGAGG 65 FBan0006842 FBgn0027605 CG6842 X X intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 CG6842 CG6842 "DmBcDNA.GH02678, vps4, BcDNA:GH02678" CDMC29149 4 24 6 DAC10-L06 3-CG6842-RA_2 CG6842 CTTGTCCCGCACGAAACCGACCGTCAACGAAGACGATCTGAAGAAGCTGCGCAAATTCACAGAGG 65 FBan0006842 FBgn0027605 CG6842 X X intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 CG6842 CG6842 "DmBcDNA.GH02678, vps4, BcDNA:GH02678" CDMC29150 4 25 6 DAC10-L18 2-CG6875-RA_1 CG6875 CACGACTATATGACCAACCCAGAGGCCATTTACATGGTGCGCGAAACTAAGAAGCTCGTGGCCCG 65 FBan0006875 FBgn0000140 asp 3 3R actin filament reorganization during cell cycle; GO:0030037; cystoblast division; GO:0007282; establishment of meiotic spindle localization; GO:0051295; female germ-line stem cell division; GO:0048132; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; oocyte differentiation (sensu Insecta); GO:0030706; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; ; GO:0008017; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 microtubule associated complex; GO:0005875; microtubule organizing center; GO:0005815 asp abnormal spindle "CG6875, CG6875, CG6875, Asp, anon-WO0118547.279, anon-96Aa" CDMC29150 4 26 6 DAC10-L18 2-CG6875-RA_1 CG6875 CACGACTATATGACCAACCCAGAGGCCATTTACATGGTGCGCGAAACTAAGAAGCTCGTGGCCCG 65 FBan0006875 FBgn0000140 asp 3 3R actin filament reorganization during cell cycle; GO:0030037; cystoblast division; GO:0007282; establishment of meiotic spindle localization; GO:0051295; female germ-line stem cell division; GO:0048132; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; oocyte differentiation (sensu Insecta); GO:0030706; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; ; GO:0008017; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 microtubule associated complex; GO:0005875; microtubule organizing center; GO:0005815 asp abnormal spindle "CG6875, CG6875, CG6875, Asp, anon-WO0118547.279, anon-96Aa" CDMC29151 4 1 7 DAC10-P06 18-CG6972-RA_1 CG6972 ATGATGTGATCATCATTCTGCACCAGGATCGAAGGGATCACACACTGATGAACTACGCCCAGGAC 65 FBan0006972 FBgn0039008 CG6972 3 3R CG6972 CG6972 CDMC29151 4 2 7 DAC10-P06 18-CG6972-RA_1 CG6972 ATGATGTGATCATCATTCTGCACCAGGATCGAAGGGATCACACACTGATGAACTACGCCCAGGAC 65 FBan0006972 FBgn0039008 CG6972 3 3R CG6972 CG6972 CDMC29152 4 3 7 DAC10-P18 1-CG7012-RA_1 CG7012 TTCCGGCATGTATTCCACTTGGACTGAATCCACCTGGTCACAGTTCAGTGCACGCATCTTCCTGC 65 FBan0007012 FBgn0039234 nct 3 3R Notch receptor processing; GO:0007220; Notch signaling pathway; GO:0007219; cytoskeleton organization and biogenesis; GO:0007010; membrane protein ectodomain proteolysis; GO:0006509; protein processing; GO:0016485 integral to membrane; GO:0016021; plasma membrane; GO:0005886 nct nicastrin "CG7012, CG7012, agro, agoraphobic, Nic, Nicastrin, S5A, dNicastrin, Nct, nicastrin" CDMC29152 4 4 7 DAC10-P18 1-CG7012-RA_1 CG7012 TTCCGGCATGTATTCCACTTGGACTGAATCCACCTGGTCACAGTTCAGTGCACGCATCTTCCTGC 65 FBan0007012 FBgn0039234 nct 3 3R Notch receptor processing; GO:0007220; Notch signaling pathway; GO:0007219; cytoskeleton organization and biogenesis; GO:0007010; membrane protein ectodomain proteolysis; GO:0006509; protein processing; GO:0016485 integral to membrane; GO:0016021; plasma membrane; GO:0005886 nct nicastrin "CG7012, CG7012, agro, agoraphobic, Nic, Nicastrin, S5A, dNicastrin, Nct, nicastrin" CDMC29153 4 5 7 DAC11-D06 2-CG10019-RA_1 CG10019 TCGGAGCTGCATTAGTCTCAATCAAATGGAGCCCTATCTGCAGGCGAACTTCTGCCAAAGGCACATGTT 69 FBan0010019 FBgn0031568 CG10019 2 2L transport; GO:0006810 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG10019 CG10019 "GH25970, BEST:GH25970" CDMC29153 4 6 7 DAC11-D06 2-CG10019-RA_1 CG10019 TCGGAGCTGCATTAGTCTCAATCAAATGGAGCCCTATCTGCAGGCGAACTTCTGCCAAAGGCACATGTT 69 FBan0010019 FBgn0031568 CG10019 2 2L transport; GO:0006810 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG10019 CG10019 "GH25970, BEST:GH25970" CDMC29154 4 7 7 DAC11-D18 2-CG10036-RB_1 CG10036 CCACCCGTTCAGGTCAATCCTCTCATTATCCTTTCACCTCTGGTCGTGTCTGTCTTCCAGCACCTGGAC 69 FBan0010036 FBgn0015524 otp 2 2R central nervous system development; GO:0007417; ectoderm development; GO:0007398; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700 nucleus; GO:0005634 otp orthopedia "CG10036, CG2965, bk24, W26, Orthopedia, w26, Otp, BcDNA:RE58095" CDMC29154 4 8 7 DAC11-D18 2-CG10036-RB_1 CG10036 CCACCCGTTCAGGTCAATCCTCTCATTATCCTTTCACCTCTGGTCGTGTCTGTCTTCCAGCACCTGGAC 69 FBan0010036 FBgn0015524 otp 2 2R central nervous system development; GO:0007417; ectoderm development; GO:0007398; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700 nucleus; GO:0005634 otp orthopedia "CG10036, CG2965, bk24, W26, Orthopedia, w26, Otp, BcDNA:RE58095" CDMC29155 4 9 7 DAC11-H06 15-CG10068-RA_1 CG10068 TGACCGCTTTTGGATGGAGAGCGACCCACGAAACATTATGGACTTCCGCGAGATTTACCAGTCATTTGA 69 FBan0010068 FBgn0037473 CG10068 3 3R cytokinesis; GO:0000910 CG10068 CG10068 CDMC29155 4 10 7 DAC11-H06 15-CG10068-RA_1 CG10068 TGACCGCTTTTGGATGGAGAGCGACCCACGAAACATTATGGACTTCCGCGAGATTTACCAGTCATTTGA 69 FBan0010068 FBgn0037473 CG10068 3 3R cytokinesis; GO:0000910 CG10068 CG10068 CDMC29156 4 11 7 DAC11-H18 23-CG10076-RD_1 CG10076 GCAAAGCCCTAGAAAAATCGAGTGAACGAAAAGTTACCAATTATCGCACTAAGATCAAAAAAATCAAAT 69 FBan0010076 FBgn0003475 spir 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; eggshell formation (sensu Insecta); GO:0007304; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 spir spire "CG10076, CG18621, CG10076, CG10076, p150-Spir, 38C.34, 38C.37, l(2)08327, p150Spir, Spir, spire" CDMC29156 4 12 7 DAC11-H18 23-CG10076-RD_1 CG10076 GCAAAGCCCTAGAAAAATCGAGTGAACGAAAAGTTACCAATTATCGCACTAAGATCAAAAAAATCAAAT 69 FBan0010076 FBgn0003475 spir 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; eggshell formation (sensu Insecta); GO:0007304; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 spir spire "CG10076, CG18621, CG10076, CG10076, p150-Spir, 38C.34, 38C.37, l(2)08327, p150Spir, Spir, spire" CDMC29157 4 13 7 DAC11-L06 18-CG10106-RA_12 CG10106 CGGCATCTTGGGCATTGTTTATGGCGTGCTGATTCTGAAGAGCATCGGTGTAGTTGAAGTTAATGGACA 69 FBan0010106 FBgn0029506 Tsp42Ee 2 2R integral to membrane; GO:0016021 Tsp42Ee Tetraspanin 42Ee "CG10106, CG10106, CG10106, CG10106, BcDNA:LD16071, Dm.Tsp42Ee, tetraspanin 42E, anon-WO0118547.151, Tetraspanin 42Ee" CDMC29157 4 14 7 DAC11-L06 18-CG10106-RA_12 CG10106 CGGCATCTTGGGCATTGTTTATGGCGTGCTGATTCTGAAGAGCATCGGTGTAGTTGAAGTTAATGGACA 69 FBan0010106 FBgn0029506 Tsp42Ee 2 2R integral to membrane; GO:0016021 Tsp42Ee Tetraspanin 42Ee "CG10106, CG10106, CG10106, CG10106, BcDNA:LD16071, Dm.Tsp42Ee, tetraspanin 42E, anon-WO0118547.151, Tetraspanin 42Ee" CDMC29158 4 15 7 DAC11-L18 23-CG10117-RA_4 CG10117 CAGTAATTGCCACTGAAAAGGAATACGAACTCTTTTCGGGCCATTCAGAAATAAATGCACAAATCCGCC 69 FBan0010117 FBgn0020245 ttv 2 2R "N-acetylglucosamine metabolism; GO:0006044; Wnt receptor signaling pathway; GO:0016055; cellular physiological process; GO:0050875; decapentaplegic receptor signaling pathway; GO:0008101; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; heparin biosynthesis; GO:0030210; regulation of smoothened signaling pathway; GO:0008589; smoothened signaling pathway; GO:0007224" acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; protein binding; GO:0005515; ; GO:0008375 ; EC:2.4.1.-; ; GO:0015020 ; EC:2.4.1.17; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; GO:0050509 ; EC:2.4.1.225; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; GO:0050508 ; EC:2.4.1.224; ; GO:0005515; ; GO:0050509 ; EC:2.4.1.225; ; GO:0050508 ; EC:2.4.1.224 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020 ttv tout-velu "CG10117, CG10117, CG10117, CG10117, CG10117, l(2)05282, l(2)k03617, P1.15, tout velu, l(2)00681, tout-velu, DEXT1, l(2)k00115" CDMC29158 4 16 7 DAC11-L18 23-CG10117-RA_4 CG10117 CAGTAATTGCCACTGAAAAGGAATACGAACTCTTTTCGGGCCATTCAGAAATAAATGCACAAATCCGCC 69 FBan0010117 FBgn0020245 ttv 2 2R "N-acetylglucosamine metabolism; GO:0006044; Wnt receptor signaling pathway; GO:0016055; cellular physiological process; GO:0050875; decapentaplegic receptor signaling pathway; GO:0008101; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; heparin biosynthesis; GO:0030210; regulation of smoothened signaling pathway; GO:0008589; smoothened signaling pathway; GO:0007224" acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; protein binding; GO:0005515; ; GO:0008375 ; EC:2.4.1.-; ; GO:0015020 ; EC:2.4.1.17; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; GO:0050509 ; EC:2.4.1.225; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; GO:0050508 ; EC:2.4.1.224; ; GO:0005515; ; GO:0050509 ; EC:2.4.1.225; ; GO:0050508 ; EC:2.4.1.224 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020 ttv tout-velu "CG10117, CG10117, CG10117, CG10117, CG10117, l(2)05282, l(2)k03617, P1.15, tout velu, l(2)00681, tout-velu, DEXT1, l(2)k00115" CDMC29159 4 17 7 DAC11-P06 11-CG10144-RA_1 CG10144 AGACTCAGTTTGAAGAATGTCCACGGTGCTTTACGGCCATTCCAGATCAAAGTATTGGTTTGCCGCGGC 69 FBan0010144 FBgn0035704 CG10144 3 3L CG10144 CG10144 anon-WO0118547.365 CDMC29159 4 18 7 DAC11-P06 11-CG10144-RA_1 CG10144 AGACTCAGTTTGAAGAATGTCCACGGTGCTTTACGGCCATTCCAGATCAAAGTATTGGTTTGCCGCGGC 69 FBan0010144 FBgn0035704 CG10144 3 3L CG10144 CG10144 anon-WO0118547.365 CDMC29160 4 19 7 DAC11-P18 2-CG10164-RA_1 CG10164 AGAACAACCTGAACCATCGAGAGTTGTCAACACGGAGCCTATTCGACTGAACGTGGAACCCCAATCCCA 69 FBan0010164 FBgn0039088 CG10164 3 3R CG10164 CG10164 NEST:bs02f09 CDMC29160 4 20 7 DAC11-P18 2-CG10164-RA_1 CG10164 AGAACAACCTGAACCATCGAGAGTTGTCAACACGGAGCCTATTCGACTGAACGTGGAACCCCAATCCCA 69 FBan0010164 FBgn0039088 CG10164 3 3R CG10164 CG10164 NEST:bs02f09 CDMC29161 4 21 7 DAC12-D06 12-CG30110-RA_1 CG30110 AGAGCGATCCCGATGTACCATTCATGATTGAGATGAAGAGGCGTCAGGATCGTGAGCAGTTGAAGCAGT 69 FBan0030110 FBgn0050110 CG30110 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30110 CG30110 NEST:bs09e07 CDMC29161 4 22 7 DAC12-D06 12-CG30110-RA_1 CG30110 AGAGCGATCCCGATGTACCATTCATGATTGAGATGAAGAGGCGTCAGGATCGTGAGCAGTTGAAGCAGT 69 FBan0030110 FBgn0050110 CG30110 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30110 CG30110 NEST:bs09e07 CDMC29162 4 23 7 DAC12-D18 2-CG30121-RA_4 CG30121 ACCCTCCAGTTGCGATTGACAGTCCTTGAGATGTTTCCACTCAGTTTCCCATGTCTGTGGCCTCTGACA 69 FBan0030121 FBgn0050121 CG30121 2 2R CG30121 CG30121 BcDNA:GH12850 CDMC29162 4 24 7 DAC12-D18 2-CG30121-RA_4 CG30121 ACCCTCCAGTTGCGATTGACAGTCCTTGAGATGTTTCCACTCAGTTTCCCATGTCTGTGGCCTCTGACA 69 FBan0030121 FBgn0050121 CG30121 2 2R CG30121 CG30121 BcDNA:GH12850 CDMC29163 4 25 7 DAC12-H06 15-CG30159-RA_1 CG30159 CGCACTCCAGTGAGGCAAATGTCAAAGTCTGGTCAGTAGCAAAACAGAATTGCAGCCAAGAAAAGCGGA 69 FBan0030159 FBgn0050159 CG30159 2 2R CG30159 CG30159 "CG3364, CG3364, CG3364, CG3364" CDMC29163 4 26 7 DAC12-H06 15-CG30159-RA_1 CG30159 CGCACTCCAGTGAGGCAAATGTCAAAGTCTGGTCAGTAGCAAAACAGAATTGCAGCCAAGAAAAGCGGA 69 FBan0030159 FBgn0050159 CG30159 2 2R CG30159 CG30159 "CG3364, CG3364, CG3364, CG3364" CDMC29164 4 1 8 DAC12-H18 23-CG30171-RA_1 CG30171 TGCTCACCACATTTTAGTCAATTAGCTGCGAAGTAGTGTTAAGAGGAATGTTGTTTTTATTTCTTGTAT 69 FBgn0050171 CDMC29164 4 2 8 DAC12-H18 23-CG30171-RA_1 CG30171 TGCTCACCACATTTTAGTCAATTAGCTGCGAAGTAGTGTTAAGAGGAATGTTGTTTTTATTTCTTGTAT 69 FBgn0050171 CDMC29165 4 3 8 DAC12-L06 5-CG30217-RA_2 CG30217 TGCTTTGACGTTCGTCTATTCCTGTCTGCAAAGTCGCCTGAAATCGAAGCGTGTCTTCTGCAGCCGATG 69 FBan0030217 FBgn0050217 CG30217 2 2R CG30217 CG30217 "CG13514, CG13514, CG13514" CDMC29165 4 4 8 DAC12-L06 5-CG30217-RA_2 CG30217 TGCTTTGACGTTCGTCTATTCCTGTCTGCAAAGTCGCCTGAAATCGAAGCGTGTCTTCTGCAGCCGATG 69 FBan0030217 FBgn0050217 CG30217 2 2R CG30217 CG30217 "CG13514, CG13514, CG13514" CDMC29166 4 5 8 DAC12-L18 23-CG30265-RA_2 CG30265 GATGGACCTTCTCAGAAGTCGATGATATTAAAGTTCCACTAGATCGATAGCACTTAAGTCTCCAGTGTA 69 FBan0030265 FBgn0050265 CG30265 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG30265 CG30265 "CG11682, CG11682, CG11682" CDMC29166 4 6 8 DAC12-L18 23-CG30265-RA_2 CG30265 GATGGACCTTCTCAGAAGTCGATGATATTAAAGTTCCACTAGATCGATAGCACTTAAGTCTCCAGTGTA 69 FBan0030265 FBgn0050265 CG30265 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG30265 CG30265 "CG11682, CG11682, CG11682" CDMC29167 4 7 8 DAC12-P06 14-CG30293-RA_1 CG30293 TGGTGGCATCTCCGAAGAAGCGGGACAATTTCTATAGCTCTATGTTGGAGTTCATGTTCAGGTGGGGAT 69 FBan0030293 FBgn0050293 CG30293 2 2R carbohydrate metabolism; GO:0005975; cell communication; GO:0007154; cell-cell signaling; GO:0007267; chitin metabolism; GO:0006030; development; GO:0007275; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "chitin binding; GO:0008061; receptor binding; GO:0005102; hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0005102; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0008061; ; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 CG30293 CG30293 "BcDNA:AT18578, NEST:bs09g08, NEST:bs33a06, NEST:bs28h08" CDMC29167 4 8 8 DAC12-P06 14-CG30293-RA_1 CG30293 TGGTGGCATCTCCGAAGAAGCGGGACAATTTCTATAGCTCTATGTTGGAGTTCATGTTCAGGTGGGGAT 69 FBan0030293 FBgn0050293 CG30293 2 2R carbohydrate metabolism; GO:0005975; cell communication; GO:0007154; cell-cell signaling; GO:0007267; chitin metabolism; GO:0006030; development; GO:0007275; polysaccharide metabolism; GO:0005976; signal transduction; GO:0007165 "chitin binding; GO:0008061; receptor binding; GO:0005102; hydrolase activity; GO:0016787 ; EC:3.-.-.-; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0005102; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0008061; ; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 CG30293 CG30293 "BcDNA:AT18578, NEST:bs09g08, NEST:bs33a06, NEST:bs28h08" CDMC29168 4 9 8 DAC12-P18 2-CG30327-RA_1 CG30327 GCTGAGGGAGCTGTATGCCAAGTACACGGCAGCAAGTAAATTGGACATTAAGGTCATGCACCAGGGTCG 69 FBan0030327 FBgn0050327 CG30327 2 2R mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U12; GO:0005693 CG30327 CG30327 "CG11478, cg11478, 65K" CDMC29168 4 10 8 DAC12-P18 2-CG30327-RA_1 CG30327 GCTGAGGGAGCTGTATGCCAAGTACACGGCAGCAAGTAAATTGGACATTAAGGTCATGCACCAGGGTCG 69 FBan0030327 FBgn0050327 CG30327 2 2R mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U12; GO:0005693 CG30327 CG30327 "CG11478, cg11478, 65K" CDMC29169 4 11 8 DAC13-D06 3-CG13258-RA_1 CG13258 AGGATCCTGTCGAGAGATCCCTTCGAGTGCCTGCAATCGTTGATATGCCAACTGATGTCCGGAGC 65 FBan0013258 FBgn0032582 CG13258 2 2L CG13258 CG13258 CDMC29169 4 12 8 DAC13-D06 3-CG13258-RA_1 CG13258 AGGATCCTGTCGAGAGATCCCTTCGAGTGCCTGCAATCGTTGATATGCCAACTGATGTCCGGAGC 65 FBan0013258 FBgn0032582 CG13258 2 2L CG13258 CG13258 CDMC29170 4 13 8 DAC13-D18 2-CG13358-RA_1 CG13358 AACCGGACTTGGACTTGAGGCAGGGACCCAACTATATGGACTACCTGTGGTACTTGGCGATGGAG 65 FBan0013358 FBgn0026874 CG13358 X X CG13358 CG13358 EG:34F3.10 CDMC29170 4 14 8 DAC13-D18 2-CG13358-RA_1 CG13358 AACCGGACTTGGACTTGAGGCAGGGACCCAACTATATGGACTACCTGTGGTACTTGGCGATGGAG 65 FBan0013358 FBgn0026874 CG13358 X X CG13358 CG13358 EG:34F3.10 CDMC29171 4 15 8 DAC13-H06 3-CG13474-RA_1 CG13474 TATAGGAAGTTGTGACTCCGAGCTGGACATGCTAAGCCAACTCTACGGAGCCAGAAGTGCCCAGG 65 FBan0013474 FBgn0036439 CG13474 3 3L CG13474 CG13474 BcDNA:AT29351 CDMC29171 4 16 8 DAC13-H06 3-CG13474-RA_1 CG13474 TATAGGAAGTTGTGACTCCGAGCTGGACATGCTAAGCCAACTCTACGGAGCCAGAAGTGCCCAGG 65 FBan0013474 FBgn0036439 CG13474 3 3L CG13474 CG13474 BcDNA:AT29351 CDMC29172 4 17 8 DAC13-H18 23-CG13510-RA_1 CG13510 ACGCCACACATTAAACTCATGAGACTCACACAGGAAACAGAAATGCGACAAGATATCTTGGGACA 65 FBan0013510 FBgn0034758 CG13510 2 2R CG13510 CG13510 CDMC29172 4 18 8 DAC13-H18 23-CG13510-RA_1 CG13510 ACGCCACACATTAAACTCATGAGACTCACACAGGAAACAGAAATGCGACAAGATATCTTGGGACA 65 FBan0013510 FBgn0034758 CG13510 2 2R CG13510 CG13510 CDMC29173 4 19 8 DAC13-L06 2-CG13608-RA_1 CG13608 CAATCCGGGCGATACCGCATAACCACAAAGCGAAACAGGCCTCTTACCTACGAGATGGCCAATCC 65 FBan0013608 FBgn0039159 mRpS24 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS24 mitochondrial ribosomal protein S24 "CG13608, CG13608, MRP-S24, Mitochondrial ribosomal protein S24, MrpS24, mitochondrial ribosomal protein S24" CDMC29173 4 20 8 DAC13-L06 2-CG13608-RA_1 CG13608 CAATCCGGGCGATACCGCATAACCACAAAGCGAAACAGGCCTCTTACCTACGAGATGGCCAATCC 65 FBan0013608 FBgn0039159 mRpS24 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS24 mitochondrial ribosomal protein S24 "CG13608, CG13608, MRP-S24, Mitochondrial ribosomal protein S24, MrpS24, mitochondrial ribosomal protein S24" CDMC29174 4 21 8 DAC13-L18 2-CG13630-RA_1 CG13630 TTCCCACAGACTCCCAAGCGAACAGTTCCGAACGCCATACAACGTCCAGATTACGCCGATCATCC 65 FBan0013630 FBgn0039219 CG13630 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG13630 CG13630 MAP1A CDMC29174 4 22 8 DAC13-L18 2-CG13630-RA_1 CG13630 TTCCCACAGACTCCCAAGCGAACAGTTCCGAACGCCATACAACGTCCAGATTACGCCGATCATCC 65 FBan0013630 FBgn0039219 CG13630 3 3R protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 CG13630 CG13630 MAP1A CDMC29175 4 23 8 DAC13-P06 9-CG13693-RA_4 CG13693 AACGTTACTGGTCTCATGATGAGCACGTCAGGACACAGCCTTAAAACCGACACGCAGAGCAGACG 65 FBan0013693 FBgn0031235 CG13693 2 2L CG13693 CG13693 CDMC29175 4 24 8 DAC13-P06 9-CG13693-RA_4 CG13693 AACGTTACTGGTCTCATGATGAGCACGTCAGGACACAGCCTTAAAACCGACACGCAGAGCAGACG 65 FBan0013693 FBgn0031235 CG13693 2 2L CG13693 CG13693 CDMC29176 4 25 8 DAC13-P18 15-CG13722-RA_2 CG13722 ACCACCGGTAATTCCCACTTCACCACCAGTACCAAAATATCTGCCACCTACAAACCCACCAACGC 65 FBan0013722 FBgn0035553 CG13722 3 3L CG13722 CG13722 CDMC29176 4 26 8 DAC13-P18 15-CG13722-RA_2 CG13722 ACCACCGGTAATTCCCACTTCACCACCAGTACCAAAATATCTGCCACCTACAAACCCACCAACGC 65 FBan0013722 FBgn0035553 CG13722 3 3L CG13722 CG13722 CDMC29177 4 1 9 DAC14-D06 9-CG1668-RB_3 CG1668 CGCCTGCGTGATGAAAAAGCTGCAGATAATGGATGAATCCGGTAAGCTGAACAAGGAACACGCCATCGA 69 FBan0001668 FBgn0011280 Pbprp2 X X transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp2 Pheromone-binding protein-related protein 2 "CG1668, CG1668, pbprp-2, PB-PRP2, PBPRP2, pbprp2, 19d, PBP2, PBPRP-2, Obp19d, BcDNA:RH68082, BcDNA:HL07789" CDMC29177 4 2 9 DAC14-D06 9-CG1668-RB_3 CG1668 CGCCTGCGTGATGAAAAAGCTGCAGATAATGGATGAATCCGGTAAGCTGAACAAGGAACACGCCATCGA 69 FBan0001668 FBgn0011280 Pbprp2 X X transport; GO:0006810 pheromone binding; GO:0005550; phenylalkylamine binding; GO:0008145; ; GO:0005550; ; GO:0005550; ; GO:0008145 extracellular region; GO:0005576 Pbprp2 Pheromone-binding protein-related protein 2 "CG1668, CG1668, pbprp-2, PB-PRP2, PBPRP2, pbprp2, 19d, PBP2, PBPRP-2, Obp19d, BcDNA:RH68082, BcDNA:HL07789" CDMC29178 4 3 9 DAC14-D18 15-CG16712-RA_1 CG16712 CCGCTGGTATTGATGGCAATGGTCTCATCAAGTGTGCCGCTTTTATACCCAGCTTCAGTTATCATCCCG 69 FBan0016712 FBgn0031561 CG16712 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG16712 CG16712 "CT37183, BcDNA:RH05411, BcDNA:RH38008" CDMC29178 4 4 9 DAC14-D18 15-CG16712-RA_1 CG16712 CCGCTGGTATTGATGGCAATGGTCTCATCAAGTGTGCCGCTTTTATACCCAGCTTCAGTTATCATCCCG 69 FBan0016712 FBgn0031561 CG16712 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG16712 CG16712 "CT37183, BcDNA:RH05411, BcDNA:RH38008" CDMC29179 4 5 9 DAC14-H06 17-CG16741-RA_1 CG16741 TGCGGTTACCGAAATTAACGCAAATGGGTATGAAACGCTTTGTATCCTCTTTGATTCGCAAGTCCCCGA 69 FBan0016741 FBgn0042198 CG16741 2 2R CG16741 CG16741 CG18463 CDMC29179 4 6 9 DAC14-H06 17-CG16741-RA_1 CG16741 TGCGGTTACCGAAATTAACGCAAATGGGTATGAAACGCTTTGTATCCTCTTTGATTCGCAAGTCCCCGA 69 FBan0016741 FBgn0042198 CG16741 2 2R CG16741 CG16741 CG18463 CDMC29180 4 7 9 DAC14-H18 23-CG1674-RD_1 CG1674 AAAATTAATGTATTAGTATGTTCCCCAGTAATAAACACGTACAGTGCAGTCTTGATAGTTTTCCGGTGC 69 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC29180 4 8 9 DAC14-H18 23-CG1674-RD_1 CG1674 AAAATTAATGTATTAGTATGTTCCCCAGTAATAAACACGTACAGTGCAGTCTTGATAGTTTTCCGGTGC 69 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC29181 4 9 9 DAC14-L06 2-CG16793-RA_1 CG16793 AGGGATCTTGCTCTACCTAGCACTGGTCTTCCTCCTGGCGATTATCTTGATGAACGTCTTCGCCTCCGT 69 FBan0016793 FBgn0036712 CG16793 3 3L calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG16793 CG16793 CT33194 CDMC29181 4 10 9 DAC14-L06 2-CG16793-RA_1 CG16793 AGGGATCTTGCTCTACCTAGCACTGGTCTTCCTCCTGGCGATTATCTTGATGAACGTCTTCGCCTCCGT 69 FBan0016793 FBgn0036712 CG16793 3 3L calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG16793 CG16793 CT33194 CDMC29182 4 11 9 DAC14-L18 17-CG16812-RA_1 CG16812 GCATGGACGATTTCGAAAGTGACGAAGAGGATTACATGTCCAGCGGAGAAGATTTTGATATGGGAGCCG 69 FBan0016812 FBgn0032488 CG16812 2 2L CG16812 CG16812 CDMC29182 4 12 9 DAC14-L18 17-CG16812-RA_1 CG16812 GCATGGACGATTTCGAAAGTGACGAAGAGGATTACATGTCCAGCGGAGAAGATTTTGATATGGGAGCCG 69 FBan0016812 FBgn0032488 CG16812 2 2L CG16812 CG16812 CDMC29183 4 13 9 DAC14-P06 12-CG16863-RA_1 CG16863 CGGGGAGCAAGCTGTTGCAAAGCATCCGGAGAACCGTGATCACTACGATATCTGGGCGGCATTCAAATC 69 FBan0016863 FBgn0028931 CG16863 2 2L DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG16863 CG16863 "BG:DS00797.6, DS00797.6" CDMC29183 4 14 9 DAC14-P06 12-CG16863-RA_1 CG16863 CGGGGAGCAAGCTGTTGCAAAGCATCCGGAGAACCGTGATCACTACGATATCTGGGCGGCATTCAAATC 69 FBan0016863 FBgn0028931 CG16863 2 2L DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG16863 CG16863 "BG:DS00797.6, DS00797.6" CDMC29184 4 15 9 DAC14-P18 16-CG16885-RA_1 CG16885 ATCGGAACCAGGAGAAAATCACACAACTGACGCAATCCATTATAGAAAGCTTGCCAAAACCCATCCGGG 69 FBan0016885 FBgn0032538 CG16885 2 2L CG16885 CG16885 CG18634 CDMC29184 4 16 9 DAC14-P18 16-CG16885-RA_1 CG16885 ATCGGAACCAGGAGAAAATCACACAACTGACGCAATCCATTATAGAAAGCTTGCCAAAACCCATCCGGG 69 FBan0016885 FBgn0032538 CG16885 2 2L CG16885 CG16885 CG18634 CDMC29185 4 17 9 DAC15-D06 16-CG1864-RC_1 CG1864 TCCCATCTCACTTGAACCCACCCAATCAACAAATACAAATCCTAGGGAAGTTGAGAGGTTCAGCAACCA 69 FBan0001864 FBgn0014859 Hr38 2 2L epidermis development; GO:0008544; intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 Hr38 Hormone receptor-like in 38 "CG1864, DHR38, Dhr38, NR4A4, HR38, 38E.3, 38E.7, l(2)02306" CDMC29185 4 18 9 DAC15-D06 16-CG1864-RC_1 CG1864 TCCCATCTCACTTGAACCCACCCAATCAACAAATACAAATCCTAGGGAAGTTGAGAGGTTCAGCAACCA 69 FBan0001864 FBgn0014859 Hr38 2 2L epidermis development; GO:0008544; intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 Hr38 Hormone receptor-like in 38 "CG1864, DHR38, Dhr38, NR4A4, HR38, 38E.3, 38E.7, l(2)02306" CDMC29186 4 19 9 DAC15-D18 3-CG18669-RA_5 CG18669 TGGAATGAGACCGCAAAGTATCTGCCAGAAGGTGTGTCCACAATGCATCCGAGTGACTTTACAGCCGGA 69 FBan0018669 FBgn0040599 CG18669 3 3R CG18669 CG18669 CDMC29186 4 20 9 DAC15-D18 3-CG18669-RA_5 CG18669 TGGAATGAGACCGCAAAGTATCTGCCAGAAGGTGTGTCCACAATGCATCCGAGTGACTTTACAGCCGGA 69 FBan0018669 FBgn0040599 CG18669 3 3R CG18669 CG18669 CDMC29187 4 21 9 DAC15-H06 23-CG18773-RA_1 CG18773 AGAGCATCAAACAGTTCCAAGTTTTCTAACAAACACCACACAGCTCCAACATGAAATTCCTCATCGTCT 69 FBan0018773 FBgn0020643 Lcp65Ab2 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp65Ab2 Lcp65Ab2 "CG18773, LCP5, CP5, L[[3]]CP5, LCP-5, Lcp-b2, Lcp65Ab, Lcp65A-b, Lcp-b, BcDNA:RE39879, DCP-beta, Lcp5" CDMC29187 4 22 9 DAC15-H06 23-CG18773-RA_1 CG18773 AGAGCATCAAACAGTTCCAAGTTTTCTAACAAACACCACACAGCTCCAACATGAAATTCCTCATCGTCT 69 FBan0018773 FBgn0020643 Lcp65Ab2 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp65Ab2 Lcp65Ab2 "CG18773, LCP5, CP5, L[[3]]CP5, LCP-5, Lcp-b2, Lcp65Ab, Lcp65A-b, Lcp-b, BcDNA:RE39879, DCP-beta, Lcp5" CDMC29188 4 23 9 DAC15-H18 8-CG18783-RA_1 CG18783 TCTGCTCGCCAAACTTCTTCCTTCCCCTCCACGATTAGTGTCAACGGCATCTTTGACATCATGTACCCA 69 FBan0018783 FBgn0028420 Kr-h1 2 2L cell proliferation; GO:0008283; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to ecdysone; GO:0035075 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Kr-h1 Kruppel homolog 1 "CG9167, CG18783, CG9167, CG9167, CG9167, CG9167, CG9167, Kr h, Pow, 44/11, Passion of white, P381, l(2)10642, Kr-h, Krueppel-homolog alpha-isoform, l(2)05208" CDMC29188 4 24 9 DAC15-H18 8-CG18783-RA_1 CG18783 TCTGCTCGCCAAACTTCTTCCTTCCCCTCCACGATTAGTGTCAACGGCATCTTTGACATCATGTACCCA 69 FBan0018783 FBgn0028420 Kr-h1 2 2L cell proliferation; GO:0008283; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to ecdysone; GO:0035075 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Kr-h1 Kruppel homolog 1 "CG9167, CG18783, CG9167, CG9167, CG9167, CG9167, CG9167, Kr h, Pow, 44/11, Passion of white, P381, l(2)10642, Kr-h, Krueppel-homolog alpha-isoform, l(2)05208" CDMC29189 4 25 9 DAC15-L06 24-CG18854-RA_1 CG18854 GGAACAATGCTGCAAAATAAGAATAATAGTAGCAGTTAGTAAATTGACTAATAAAATGTTTGTTTTCAA 69 FBan0018854 FBgn0042174 CG18854 2 2L inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 CG18854 CG18854 "CG13122, CG13122, CG13122" CDMC29189 4 26 9 DAC15-L06 24-CG18854-RA_1 CG18854 GGAACAATGCTGCAAAATAAGAATAATAGTAGCAGTTAGTAAATTGACTAATAAAATGTTTGTTTTCAA 69 FBan0018854 FBgn0042174 CG18854 2 2L inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 CG18854 CG18854 "CG13122, CG13122, CG13122" CDMC29190 4 1 10 DAC15-L18 1-CG1895-RA_1 CG1895 TGGAACCACGCCTTGTGTACGAGATCTATGTGAGCGCGTTCAGTCATTTCGAGAACAACGATGCCTCCA 69 FBan0001895 FBgn0030339 Cyp28c1 X X electron transport; GO:0006118; proteolysis; GO:0006508; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28c1 Cyp28c1 "CG1895, 28c1" CDMC29190 4 2 10 DAC15-L18 1-CG1895-RA_1 CG1895 TGGAACCACGCCTTGTGTACGAGATCTATGTGAGCGCGTTCAGTCATTTCGAGAACAACGATGCCTCCA 69 FBan0001895 FBgn0030339 Cyp28c1 X X electron transport; GO:0006118; proteolysis; GO:0006508; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28c1 Cyp28c1 "CG1895, 28c1" CDMC29191 4 3 10 DAC15-P06 16-CG1922-RA_1 CG1922 ACCTTATTGGAACGGAATGCAATTGGCCTTAGGCAAAAAGATAAGACGTCCTTGGTAAAGCGGACAGGT 69 FBan0001922 FBgn0028996 onecut 4 4 "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleoplasm; GO:0005654; nucleus; GO:0005634 onecut onecut "CG1922, D-onecut, A1, onecut" CDMC29191 4 4 10 DAC15-P06 16-CG1922-RA_1 CG1922 ACCTTATTGGAACGGAATGCAATTGGCCTTAGGCAAAAAGATAAGACGTCCTTGGTAAAGCGGACAGGT 69 FBan0001922 FBgn0028996 onecut 4 4 "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700 nucleoplasm; GO:0005654; nucleus; GO:0005634 onecut onecut "CG1922, D-onecut, A1, onecut" CDMC29192 4 5 10 DAC15-P18 1-CG1938-RB_1 CG1938 AGCAGTGCTCGATCATTCAATGGTCCGGTAGTTGGTGTACGGGCTTTTTTATCAGTTTCGCAAGGGGCT 69 FBan0001938 FBgn0030276 Dlic2 X X RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlic2 Dlic2 "CG1938, CG1938, CG1938, l(1)G0065, l(1)G0190, DLIC2" CDMC29192 4 6 10 DAC15-P18 1-CG1938-RB_1 CG1938 AGCAGTGCTCGATCATTCAATGGTCCGGTAGTTGGTGTACGGGCTTTTTTATCAGTTTCGCAAGGGGCT 69 FBan0001938 FBgn0030276 Dlic2 X X RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlic2 Dlic2 "CG1938, CG1938, CG1938, l(1)G0065, l(1)G0190, DLIC2" CDMC29193 4 7 10 DAC16-D06 1-CG32762-RA_1 CG32762 TGCCAGCAATCAAGCAAAATGCACAGCCAACAACTGACTTTGATTTTCGGCATGACCCTCCTGTGGTCA 69 FBan0032762 FBgn0052762 CG32762 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32762 CG32762 CDMC29193 4 8 10 DAC16-D06 1-CG32762-RA_1 CG32762 TGCCAGCAATCAAGCAAAATGCACAGCCAACAACTGACTTTGATTTTCGGCATGACCCTCCTGTGGTCA 69 FBan0032762 FBgn0052762 CG32762 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32762 CG32762 CDMC29194 4 9 10 DAC16-D18 3-CG32774-RA_1 CG32774 GCAGGTATCACCACATCCACAGAGACATCCACAAGTGCACAGTCGACCTCTACCATTCTGGCAGACACA 69 FBan0032774 FBgn0052774 CG32774 X X CG32774 CG32774 "CG15574, CG15575" CDMC29194 4 10 10 DAC16-D18 3-CG32774-RA_1 CG32774 GCAGGTATCACCACATCCACAGAGACATCCACAAGTGCACAGTCGACCTCTACCATTCTGGCAGACACA 69 FBan0032774 FBgn0052774 CG32774 X X CG32774 CG32774 "CG15574, CG15575" CDMC29195 4 11 10 DAC16-H06 18-CG32806-RB_1 CG32806 TCCAGTGGAATGCATGCTATTGGATTGGCTTGGCACACTTGCTAATGATAATTTCTTGCATGCGCGGAC 69 FBan0032806 FBgn0052806 CG32806 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32806 CG32806 NEST:bs06b11 CDMC29195 4 12 10 DAC16-H06 18-CG32806-RB_1 CG32806 TCCAGTGGAATGCATGCTATTGGATTGGCTTGGCACACTTGCTAATGATAATTTCTTGCATGCGCGGAC 69 FBan0032806 FBgn0052806 CG32806 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32806 CG32806 NEST:bs06b11 CDMC29196 4 13 10 DAC16-H18 9-CG32814-RA_2 CG32814 TGCAATCAGGGGATGCGACAAAACTCCGTTCGACGAACATCACGAAAGATCCGAAACCACCGACTACAT 69 FBan0032814 FBgn0052814 CG32814 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32814 CG32814 CDMC29196 4 14 10 DAC16-H18 9-CG32814-RA_2 CG32814 TGCAATCAGGGGATGCGACAAAACTCCGTTCGACGAACATCACGAAAGATCCGAAACCACCGACTACAT 69 FBan0032814 FBgn0052814 CG32814 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32814 CG32814 CDMC29197 4 15 10 DAC16-L06 23-CG3284-RA_1 CG3284 CCGCATGACTTTGAATCACTTGCAAGAACTTCGATTTGGTTTGTATAAATGTTTAAATAGCTCAGTCTT 69 FBan0003284 FBgn0004855 RpII15 3 3R "RNA elongation; GO:0006354; mRNA transcription; GO:0009299; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003700; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII15 RNA polymerase II 15kD subunit "CG3284, CG3284, RNA polymerase II, l(3)Z23, RPII15, RNApolII, RpII215, RNAP II, polII, H5, RNA polII, PolII, RNA pol II, Pol II, 8WG16, Pol IIa, dRPB9, RNA Pol II, RNAP, l(3)88Be" CDMC29197 4 16 10 DAC16-L06 23-CG3284-RA_1 CG3284 CCGCATGACTTTGAATCACTTGCAAGAACTTCGATTTGGTTTGTATAAATGTTTAAATAGCTCAGTCTT 69 FBan0003284 FBgn0004855 RpII15 3 3R "RNA elongation; GO:0006354; mRNA transcription; GO:0009299; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003700; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII15 RNA polymerase II 15kD subunit "CG3284, CG3284, RNA polymerase II, l(3)Z23, RPII15, RNApolII, RpII215, RNAP II, polII, H5, RNA polII, PolII, RNA pol II, Pol II, 8WG16, Pol IIa, dRPB9, RNA Pol II, RNAP, l(3)88Be" CDMC29198 4 17 10 DAC16-L18 11-CG32858-RB_1 CG32858 GGTTGCTGCACGCGTCATCAGTATCACAATCACACACATACTTCCCAACCAAGCGGGGATTCCCTAATT 69 FBan0032858 FBgn0003447 sn X X actin filament bundle formation; GO:0051017; actin filament organization; GO:0007015; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; female gamete generation; GO:0007292; oogenesis (sensu Insecta); GO:0009993; visual perception; GO:0007601 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 sn singed "CG1536, CG32858, CG15331, CG1536, fs(1)M45, fs(1)K418, fascin, Sn, fs(1)A1057, fs(1)K1421, fs(1)K473, fs(1)K743, singed" CDMC29198 4 18 10 DAC16-L18 11-CG32858-RB_1 CG32858 GGTTGCTGCACGCGTCATCAGTATCACAATCACACACATACTTCCCAACCAAGCGGGGATTCCCTAATT 69 FBan0032858 FBgn0003447 sn X X actin filament bundle formation; GO:0051017; actin filament organization; GO:0007015; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; female gamete generation; GO:0007292; oogenesis (sensu Insecta); GO:0009993; visual perception; GO:0007601 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 sn singed "CG1536, CG32858, CG15331, CG1536, fs(1)M45, fs(1)K418, fascin, Sn, fs(1)A1057, fs(1)K1421, fs(1)K473, fs(1)K743, singed" CDMC29199 4 19 10 DAC16-P06 24-CG32951-RA_1 CG32951 ACTCGTGCAATAGCATCAAATTAAAGTTGTATTTTAATTAAAAGATAAACTTTTTTAGGCGTTTATTCT 69 FBgn0052951 CDMC29199 4 20 10 DAC16-P06 24-CG32951-RA_1 CG32951 ACTCGTGCAATAGCATCAAATTAAAGTTGTATTTTAATTAAAAGATAAACTTTTTTAGGCGTTTATTCT 69 FBgn0052951 CDMC29200 4 21 10 DAC16-P18 3-CG32956-RA_2 CG32956 GCACGTCAGCAAACGTGTCCAATTGGCAATTGACAAGATGTCCGGAAAGATCGATGAGACGCCGGAGAA 69 FBgn0052956 CDMC29200 4 22 10 DAC16-P18 3-CG32956-RA_2 CG32956 GCACGTCAGCAAACGTGTCCAATTGGCAATTGACAAGATGTCCGGAAAGATCGATGAGACGCCGGAGAA 69 FBgn0052956 CDMC29201 4 23 10 DAC17-D06 23-CG12386-RA_1 CG12386 GGTGCGAGTTTCAAAATTGATTCCCCACGAGTTGTACAACTCTTCCACTATGGATAACGACATTG 65 FBan0012386 FBgn0011554 etaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 etaTry etaTrypsin "CG12386, 169C4S, DmEtaTry, SP57, etaTry, ESTS:169C4S, anon-sts17" CDMC29201 4 24 10 DAC17-D06 23-CG12386-RA_1 CG12386 GGTGCGAGTTTCAAAATTGATTCCCCACGAGTTGTACAACTCTTCCACTATGGATAACGACATTG 65 FBan0012386 FBgn0011554 etaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 etaTry etaTrypsin "CG12386, 169C4S, DmEtaTry, SP57, etaTry, ESTS:169C4S, anon-sts17" CDMC29202 4 25 10 DAC17-D18 3-CG12446-RA_3 CG12446 CATTCCCGTCTCTGGCCACATAAACCACCCAGTGCTATGAGCATCCAAGGCCTGATCTTTGGTGC 65 FBan0012446 FBgn0031201 CG12446 X X CG12446 CG12446 CDMC29202 4 26 10 DAC17-D18 3-CG12446-RA_3 CG12446 CATTCCCGTCTCTGGCCACATAAACCACCCAGTGCTATGAGCATCCAAGGCCTGATCTTTGGTGC 65 FBan0012446 FBgn0031201 CG12446 X X CG12446 CG12446 CDMC29203 4 1 11 DAC17-H06 10-CG12522-RA_1 CG12522 CAGGCAACCTCAACATCGCCCACGAGTAGCTCTTCCACTTCGCCGACGAGTAGCTCTTCCACTTC 65 FBan0012522 FBgn0036131 CG12522 3 3L CG12522 CG12522 CDMC29203 4 2 11 DAC17-H06 10-CG12522-RA_1 CG12522 CAGGCAACCTCAACATCGCCCACGAGTAGCTCTTCCACTTCGCCGACGAGTAGCTCTTCCACTTC 65 FBan0012522 FBgn0036131 CG12522 3 3L CG12522 CG12522 CDMC29204 4 3 11 DAC17-H18 12-CG12551-RA_1 CG12551 GTCCGCACCTACAGCCCGCATTCGTCTATGAGTCACCCCTTCCGGAAGAGGAAGAAGGTTCCAAG 65 FBan0012551 FBgn0033045 CG12551 2 2R CG12551 CG12551 CDMC29204 4 4 11 DAC17-H18 12-CG12551-RA_1 CG12551 GTCCGCACCTACAGCCCGCATTCGTCTATGAGTCACCCCTTCCGGAAGAGGAAGAAGGTTCCAAG 65 FBan0012551 FBgn0033045 CG12551 2 2R CG12551 CG12551 CDMC29205 4 5 11 DAC17-L06 9-CG12678-RA_1 CG12678 GAAGGTACGGGCCCAACGCCTCGATTCGCCACGGAGAAAGAAAGATTGTCCAGCCAAAACGGTAG 65 FBan0012678 FBgn0031133 CG12678 X X CG12678 CG12678 CDMC29205 4 6 11 DAC17-L06 9-CG12678-RA_1 CG12678 GAAGGTACGGGCCCAACGCCTCGATTCGCCACGGAGAAAGAAAGATTGTCCAGCCAAAACGGTAG 65 FBan0012678 FBgn0031133 CG12678 X X CG12678 CG12678 CDMC29206 4 7 11 DAC17-L18 23-CG12716-RA_4 CG12716 CAACAAGAAAAAGCGACCAACACTCAACGCCTCAATTTCAAAGTTTGCTACCATTCCGAAGAAAG 65 FBan0012716 FBgn0030439 CG12716 X X CG12716 CG12716 CDMC29206 4 8 11 DAC17-L18 23-CG12716-RA_4 CG12716 CAACAAGAAAAAGCGACCAACACTCAACGCCTCAATTTCAAAGTTTGCTACCATTCCGAAGAAAG 65 FBan0012716 FBgn0030439 CG12716 X X CG12716 CG12716 CDMC29207 4 9 11 DAC17-P06 15-CG12832-RA_2 CG12832 CTGGCCCTGGTTTTCAGTCAGATCACCGTCATCTTGGCCCAACCCATCAACTATGAGCTGCTGGC 65 FBan0012832 FBgn0033138 Tsp42Eq 2 2R integral to membrane; GO:0016021 Tsp42Eq Tetraspanin 42Eq "CG12832, CG12832, CG12832, Dm.Tsp42Eq, tetraspanin 42E, Tetraspanin 42Eq" CDMC29207 4 10 11 DAC17-P06 15-CG12832-RA_2 CG12832 CTGGCCCTGGTTTTCAGTCAGATCACCGTCATCTTGGCCCAACCCATCAACTATGAGCTGCTGGC 65 FBan0012832 FBgn0033138 Tsp42Eq 2 2R integral to membrane; GO:0016021 Tsp42Eq Tetraspanin 42Eq "CG12832, CG12832, CG12832, Dm.Tsp42Eq, tetraspanin 42E, Tetraspanin 42Eq" CDMC29208 4 11 11 DAC17-P18 1-CG12856-RA_1 CG12856 CGGCTACGTCTCCTCCTAATCCTGCGCTGGAAATTGTGGCTGCCGTTTTGAAGGCTCTTTGCTAG 65 FBan0012856 FBgn0033966 CG12856 2 2R CG12856 CG12856 CT31996 CDMC29208 4 12 11 DAC17-P18 1-CG12856-RA_1 CG12856 CGGCTACGTCTCCTCCTAATCCTGCGCTGGAAATTGTGGCTGCCGTTTTGAAGGCTCTTTGCTAG 65 FBan0012856 FBgn0033966 CG12856 2 2R CG12856 CG12856 CT31996 CDMC29209 4 13 11 DAC18-D06 3-CG5992-RA_2 CG5992 TCCCTCCTTCTGGAAAGCCACTCCCCTGACGCATGACTTCTATATCGCCTTCTTAGGAATCGCCTCG 67 FBan0005992 FBgn0036752 Adgf-A 3 3L cell proliferation; GO:0008283; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular space; GO:0005615 Adgf-A Adenosine deaminase-related growth factor A "CG5992, CG5992, CG5992, ADGF-A, adgfa, ADGDF-A, Adenosine deaminase-related growth factor A" CDMC29209 4 14 11 DAC18-D06 3-CG5992-RA_2 CG5992 TCCCTCCTTCTGGAAAGCCACTCCCCTGACGCATGACTTCTATATCGCCTTCTTAGGAATCGCCTCG 67 FBan0005992 FBgn0036752 Adgf-A 3 3L cell proliferation; GO:0008283; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular space; GO:0005615 Adgf-A Adenosine deaminase-related growth factor A "CG5992, CG5992, CG5992, ADGF-A, adgfa, ADGDF-A, Adenosine deaminase-related growth factor A" CDMC29210 4 15 11 DAC18-D18 3-CG6258-RA_1 CG6258 GGAGAACCTACGCAACCTTTGCAAGCAGAGCGATTTTCCTCATCTGATGTTCTACGGACCCTCGGGT 67 FBgn0027894 CDMC29210 4 16 11 DAC18-D18 3-CG6258-RA_1 CG6258 GGAGAACCTACGCAACCTTTGCAAGCAGAGCGATTTTCCTCATCTGATGTTCTACGGACCCTCGGGT 67 FBgn0027894 CDMC29211 4 17 11 DAC18-H06 2-CG6724-RA_2 CG6724 TGTTGCGTCAAAAAGATGGCTCTTCCGACACGGACTTCGACTTCCTGGTGTTCGATGAGTACCTGCG 67 FBan0006724 FBgn0032298 CG6724 2 2L CG6724 CG6724 CDMC29211 4 18 11 DAC18-H06 2-CG6724-RA_2 CG6724 TGTTGCGTCAAAAAGATGGCTCTTCCGACACGGACTTCGACTTCCTGGTGTTCGATGAGTACCTGCG 67 FBan0006724 FBgn0032298 CG6724 2 2L CG6724 CG6724 CDMC29212 4 19 11 DAC18-H18 2-CG6822-RB_1 CG6822 GGCAGGGTCAGAGCCAAATTGCCGATCACCTACGCGAACTTTCCCGCAAAGTGGATGAGATTATTGG 67 FBan0006831 FBgn0020254 rhea 3 3L apposition of dorsal and ventral wing surfaces; GO:0007475; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; defense response; GO:0006952; intracellular protein transport; GO:0006886; muscle attachment; GO:0016203; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856; focal adhesion; GO:0005925 rhea rhea "CG6831, CG6831, CG6831, CG6831, Talin, talin, CT21159, tendrils, rhea" CDMC29212 4 20 11 DAC18-H18 2-CG6822-RB_1 CG6822 GGCAGGGTCAGAGCCAAATTGCCGATCACCTACGCGAACTTTCCCGCAAAGTGGATGAGATTATTGG 67 FBan0006831 FBgn0020254 rhea 3 3L apposition of dorsal and ventral wing surfaces; GO:0007475; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; defense response; GO:0006952; intracellular protein transport; GO:0006886; muscle attachment; GO:0016203; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856; focal adhesion; GO:0005925 rhea rhea "CG6831, CG6831, CG6831, CG6831, Talin, talin, CT21159, tendrils, rhea" CDMC29213 4 21 11 DAC18-L06 2-CG7411-RA_2 CG7411 GGCCCTCATCCGAAATGAAACGGCGGACTGTACCCAAGTTTATTCCACTGGCAACTTCACATGCCTG 67 FBan0007411 FBgn0003011 ort 3 3R adult behavior; GO:0030534; anion transport; GO:0006820; cell-cell signaling; GO:0007267; nerve-nerve synaptic transmission; GO:0007270; response to ether; GO:0045472; response to toxin; GO:0009636; signal transduction; GO:0007165; synaptic transmission; GO:0007268 histamine-gated chloride channel activity; GO:0019182; receptor activity; GO:0004872; ligand-gated ion channel activity; GO:0015276; ; GO:0004872; ; GO:0019182; ; GO:0015276; GABA-A receptor activity; GO:0004890; neurotransmitter receptor activity; GO:0030594; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0019182; ; GO:0004890; ; GO:0005230; ; GO:0030594 histamine-gated chloride channel complex; GO:0019183; postsynaptic membrane; GO:0045211 ort ora transientless "CG7411, CG7411, CG7411, ora: outer-rhabdomeres-absent, outer rhabdomeres absent, GluCI, Hist1, histamine-gated chloride channel subunit 1, DmHisCl2, hisCl2, HisCl2, Histamine-gated chloride channel subunit 2, hclA, indefinite, outer-rhabdomeres-absent, ora" CDMC29213 4 22 11 DAC18-L06 2-CG7411-RA_2 CG7411 GGCCCTCATCCGAAATGAAACGGCGGACTGTACCCAAGTTTATTCCACTGGCAACTTCACATGCCTG 67 FBan0007411 FBgn0003011 ort 3 3R adult behavior; GO:0030534; anion transport; GO:0006820; cell-cell signaling; GO:0007267; nerve-nerve synaptic transmission; GO:0007270; response to ether; GO:0045472; response to toxin; GO:0009636; signal transduction; GO:0007165; synaptic transmission; GO:0007268 histamine-gated chloride channel activity; GO:0019182; receptor activity; GO:0004872; ligand-gated ion channel activity; GO:0015276; ; GO:0004872; ; GO:0019182; ; GO:0015276; GABA-A receptor activity; GO:0004890; neurotransmitter receptor activity; GO:0030594; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0019182; ; GO:0004890; ; GO:0005230; ; GO:0030594 histamine-gated chloride channel complex; GO:0019183; postsynaptic membrane; GO:0045211 ort ora transientless "CG7411, CG7411, CG7411, ora: outer-rhabdomeres-absent, outer rhabdomeres absent, GluCI, Hist1, histamine-gated chloride channel subunit 1, DmHisCl2, hisCl2, HisCl2, Histamine-gated chloride channel subunit 2, hclA, indefinite, outer-rhabdomeres-absent, ora" CDMC29214 4 23 11 DAC18-L18 3-CG7686-RA_7 CG7686 CCAGCGTAATTCGGCGCAATGAGCAGCTGTCCCTATTGGACGATCGCTTCGAGAAGTTTTACGCCAC 67 FBan0007686 FBgn0027525 CG7686 2 2R CG7686 CG7686 BcDNA:LD21529 CDMC29214 4 24 11 DAC18-L18 3-CG7686-RA_7 CG7686 CCAGCGTAATTCGGCGCAATGAGCAGCTGTCCCTATTGGACGATCGCTTCGAGAAGTTTTACGCCAC 67 FBan0007686 FBgn0027525 CG7686 2 2R CG7686 CG7686 BcDNA:LD21529 CDMC29215 4 25 11 DAC18-P06 16-CG8039-RA_1 CG8039 CCTTCTCCACCAAAACTGCGGAACATGTAATTGAAAATCAGGAGGAACAGAAGAAAGAGGCTCCGCC 67 FBan0008039 FBgn0037608 mRpL19 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL19 mitochondrial ribosomal protein L19 "CG8039, CG8039, L19, mitochondrial ribosomal protein L19" CDMC29215 4 26 11 DAC18-P06 16-CG8039-RA_1 CG8039 CCTTCTCCACCAAAACTGCGGAACATGTAATTGAAAATCAGGAGGAACAGAAGAAAGAGGCTCCGCC 67 FBan0008039 FBgn0037608 mRpL19 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL19 mitochondrial ribosomal protein L19 "CG8039, CG8039, L19, mitochondrial ribosomal protein L19" CDMC29216 4 1 12 DAC18-P18 AutoBlank AutoBlank CDMC29216 4 2 12 DAC18-P18 AutoBlank AutoBlank CDMC29217 4 3 12 DAC19-D06 3-CG8153-RB_2 CG8153 GCCTGGGAAGAGGATCAACAGGTACAAGTTCTCAAGGAGCAGGAGAAGTACGAAACCCGCGTGTACGG 68 FBan0008153 FBgn0004698 mus210 2 2R nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 mus210 mutagen-sensitive 210 "CG8153, mus(2)201, XPC[DM], DmXPC, Xpcc, DhR4, DhXPC, mus(2)201G1, xeroderma pigmentosum group C complementing factor, mus(2)201[GI], mus201[G1], mus212, Xeroderma pigmentosum group C-like" CDMC29217 4 4 12 DAC19-D06 3-CG8153-RB_2 CG8153 GCCTGGGAAGAGGATCAACAGGTACAAGTTCTCAAGGAGCAGGAGAAGTACGAAACCCGCGTGTACGG 68 FBan0008153 FBgn0004698 mus210 2 2R nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 mus210 mutagen-sensitive 210 "CG8153, mus(2)201, XPC[DM], DmXPC, Xpcc, DhR4, DhXPC, mus(2)201G1, xeroderma pigmentosum group C complementing factor, mus(2)201[GI], mus201[G1], mus212, Xeroderma pigmentosum group C-like" CDMC29218 4 5 12 DAC19-D18 1-CG8298-RB_1 CG8298 AGGGGCATAATCTTGGGACTTACCAGCCAGACTACAGCGGAAAACATTACCCAAGCTGCTTACGAGGC 68 FBan0008298 FBgn0033673 CG8298 2 2R carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629; transport; GO:0006810 carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30 CG8298 CG8298 CDMC29218 4 6 12 DAC19-D18 1-CG8298-RB_1 CG8298 AGGGGCATAATCTTGGGACTTACCAGCCAGACTACAGCGGAAAACATTACCCAAGCTGCTTACGAGGC 68 FBan0008298 FBgn0033673 CG8298 2 2R carbohydrate metabolism; GO:0005975; lipid metabolism; GO:0006629; transport; GO:0006810 carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30 CG8298 CG8298 CDMC29219 4 7 12 DAC19-H06 1-CG8839-RC_1 CG8839 AGCACACATTCATTGGCCTGTCGACAGCTATCATGGATAGTGCACAGTGCAAGCACGGATCTCCCAAG 68 FBan0008839 FBgn0033717 CG8839 2 2R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064 CG8839 CG8839 CDMC29219 4 8 12 DAC19-H06 1-CG8839-RC_1 CG8839 AGCACACATTCATTGGCCTGTCGACAGCTATCATGGATAGTGCACAGTGCAAGCACGGATCTCCCAAG 68 FBan0008839 FBgn0033717 CG8839 2 2R nitrogen compound metabolism; GO:0006807 fatty acid amide hydrolase activity; GO:0017064; ; GO:0017064 CG8839 CG8839 CDMC29220 4 9 12 DAC19-H18 5-CG8956-RD_1 CG8956 GCCGAGGGAAGACTGGTGAATTTGTCCTGTTCCACCATTTCGTCCTTTGTCGTATCCGTGGCCTCATC 68 FBan0008956 FBgn0015011 Ahcy89E 3 3R one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 Ahcy89E Adenosylhomocysteinase 89E "CG8956, pH200, AHCY, S-adenosyl homocysteine hydrolase-like, AdoHcyase-like, S-AHCY" CDMC29220 4 10 12 DAC19-H18 5-CG8956-RD_1 CG8956 GCCGAGGGAAGACTGGTGAATTTGTCCTGTTCCACCATTTCGTCCTTTGTCGTATCCGTGGCCTCATC 68 FBan0008956 FBgn0015011 Ahcy89E 3 3R one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 Ahcy89E Adenosylhomocysteinase 89E "CG8956, pH200, AHCY, S-adenosyl homocysteine hydrolase-like, AdoHcyase-like, S-AHCY" CDMC29221 4 11 12 DAC19-L06 1-CG9379-RA_1 CG9379 GCTCACGGACAATACGCGCAAGAAGTTCTTCCGGAAGCACTACAAGGCGGATGTTATCTCGCACTGTG 68 FBgn0037704 CDMC29221 4 12 12 DAC19-L06 1-CG9379-RA_1 CG9379 GCTCACGGACAATACGCGCAAGAAGTTCTTCCGGAAGCACTACAAGGCGGATGTTATCTCGCACTGTG 68 FBgn0037704 CDMC29222 4 13 12 DAC19-L18 2-CG9492-RA_1 CG9492 GCATACTCCTGCCAATGAACATTTTCCTCAGGCAAAGGGTCATTAAACGCGTCCACACCTGCCTCTGC 68 FBan0009492 FBgn0037726 CG9492 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG9492 CG9492 CDMC29222 4 14 12 DAC19-L18 2-CG9492-RA_1 CG9492 GCATACTCCTGCCAATGAACATTTTCCTCAGGCAAAGGGTCATTAAACGCGTCCACACCTGCCTCTGC 68 FBan0009492 FBgn0037726 CG9492 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG9492 CG9492 CDMC29223 4 15 12 DAC19-P06 16-CR18748-RA_1 CR18748 TGAAGGGCATGCATATCAATGGAACTCTGATAATGCCGGTGACTATTTGTGGTGTTCCGATATCGCCG 68 FBan0018748 FBgn0042105 CR18748 3 3R CR18748 CR18748 CG18748 CDMC29223 4 16 12 DAC19-P06 16-CR18748-RA_1 CR18748 TGAAGGGCATGCATATCAATGGAACTCTGATAATGCCGGTGACTATTTGTGGTGTTCCGATATCGCCG 68 FBan0018748 FBgn0042105 CR18748 3 3R CR18748 CR18748 CG18748 CDMC29224 4 17 12 DAC19-P18 AutoBlank AutoBlank CDMC29224 4 18 12 DAC19-P18 AutoBlank AutoBlank CDMC29225 4 19 12 DAC20-D06 18-CG18076-RH_1 CG18076 CAGCAGGAACAGCACACAGTTCTACAAAAGAGACTAACTTTGAAGTGCCCTAATGGATTGGTGGAGCGA 69 FBan0018076 FBgn0013733 shot 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; apposition of dorsal and ventral wing surfaces; GO:0007475; axonogenesis; GO:0007409; cell cycle arrest; GO:0007050; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; determination of muscle attachment site; GO:0016204; ectoderm development; GO:0007398; mesoderm development; GO:0007498; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; muscle attachment; GO:0016203; muscle development; GO:0007517; mushroom body development; GO:0016319; negative regulation of microtubule depolymerization; GO:0007026; oocyte fate determination; GO:0030716; regulation of axon extension; GO:0030516; sensory organ development; GO:0007423; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0003779; ; GO:0008017; cytoskeletal protein binding; GO:0008092; ; GO:0008092; ; GO:0008017; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; intermediate filament binding; GO:0019215; ; GO:0005200; ; GO:0005509; ; GO:0019215 adherens junction; GO:0005912; cytoskeleton; GO:0005856; fusome; GO:0045169; microtubule; GO:0005874; microtubule cytoskeleton; GO:0015630 shot short stop "CG18076, CG18637, CG18076, CG18076, CG18076, l(2)k04204, l(2)k05434, l(2)k05821, l(2)k10821, groovin, grv, kak, kakapo, Grv, 42/4, kop, kopupu, l(2)k03010, Kakapo, Shot, shortstop/kakapo, short-stop, kakapoo, shortstop, l(2)CA4, l(2)k15606, short stop" CDMC29225 4 20 12 DAC20-D06 18-CG18076-RH_1 CG18076 CAGCAGGAACAGCACACAGTTCTACAAAAGAGACTAACTTTGAAGTGCCCTAATGGATTGGTGGAGCGA 69 FBan0018076 FBgn0013733 shot 2 2R actin cytoskeleton organization and biogenesis; GO:0030036; apposition of dorsal and ventral wing surfaces; GO:0007475; axonogenesis; GO:0007409; cell cycle arrest; GO:0007050; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; determination of muscle attachment site; GO:0016204; ectoderm development; GO:0007398; mesoderm development; GO:0007498; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; muscle attachment; GO:0016203; muscle development; GO:0007517; mushroom body development; GO:0016319; negative regulation of microtubule depolymerization; GO:0007026; oocyte fate determination; GO:0030716; regulation of axon extension; GO:0030516; sensory organ development; GO:0007423; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0003779; ; GO:0008017; cytoskeletal protein binding; GO:0008092; ; GO:0008092; ; GO:0008017; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; intermediate filament binding; GO:0019215; ; GO:0005200; ; GO:0005509; ; GO:0019215 adherens junction; GO:0005912; cytoskeleton; GO:0005856; fusome; GO:0045169; microtubule; GO:0005874; microtubule cytoskeleton; GO:0015630 shot short stop "CG18076, CG18637, CG18076, CG18076, CG18076, l(2)k04204, l(2)k05434, l(2)k05821, l(2)k10821, groovin, grv, kak, kakapo, Grv, 42/4, kop, kopupu, l(2)k03010, Kakapo, Shot, shortstop/kakapo, short-stop, kakapoo, shortstop, l(2)CA4, l(2)k15606, short stop" CDMC29226 4 21 12 DAC20-D18 3-CG18095-RA_1 CG18095 ACGGCTGGACCAAAATCTCCTGAGCAGTCTTCAGTTTCTCAGTCAACGAGGTTTGGCTCGACTGGTTCA 69 FBan0018095 FBgn0028872 CG18095 2 2L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG18095 CG18095 "BG:DS05899.7, DS05899.7, gp150-like" CDMC29226 4 22 12 DAC20-D18 3-CG18095-RA_1 CG18095 ACGGCTGGACCAAAATCTCCTGAGCAGTCTTCAGTTTCTCAGTCAACGAGGTTTGGCTCGACTGGTTCA 69 FBan0018095 FBgn0028872 CG18095 2 2L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG18095 CG18095 "BG:DS05899.7, DS05899.7, gp150-like" CDMC29227 4 23 12 DAC20-H06 2-CG18145-RA_1 CG18145 AGCTGCGACTACTTCTCCTCCGTCTAGGTCGTTTATGGAGCTGGTTTCTACCGCTGACTGCTGATAGCT 69 FBan0018145 FBgn0032189 Ripalpha 2 2L Ripalpha RPA-interacting protein alpha "CG18145, dRIPalpha, RPA-interacting protein alpha" CDMC29227 4 24 12 DAC20-H06 2-CG18145-RA_1 CG18145 AGCTGCGACTACTTCTCCTCCGTCTAGGTCGTTTATGGAGCTGGTTTCTACCGCTGACTGCTGATAGCT 69 FBan0018145 FBgn0032189 Ripalpha 2 2L Ripalpha RPA-interacting protein alpha "CG18145, dRIPalpha, RPA-interacting protein alpha" CDMC29228 4 25 12 DAC20-H18 3-CG18173-RA_7 CG18173 GGACTGTTCCTGCTGTCCATTTACGTCAACCGTTGGATGGTGGCGAAAAGTCTGCTCACCTACTCCGAG 69 FBan0018173 FBgn0035265 CG18173 3 3L CG18173 CG18173 CDMC29228 4 26 12 DAC20-H18 3-CG18173-RA_7 CG18173 GGACTGTTCCTGCTGTCCATTTACGTCAACCGTTGGATGGTGGCGAAAAGTCTGCTCACCTACTCCGAG 69 FBan0018173 FBgn0035265 CG18173 3 3L CG18173 CG18173 CDMC29229 4 1 13 DAC20-L06 12-CG18228-RA_2 CG18228 ACGGCCAGATTCAAACAGGCCTGGTATACCTTATCTCTGGGTTTGAGGTGGAGAAGGCGATAAGTTCCT 69 FBan0018228 FBgn0037560 CG18228 3 3R CG18228 CG18228 CDMC29229 4 2 13 DAC20-L06 12-CG18228-RA_2 CG18228 ACGGCCAGATTCAAACAGGCCTGGTATACCTTATCTCTGGGTTTGAGGTGGAGAAGGCGATAAGTTCCT 69 FBan0018228 FBgn0037560 CG18228 3 3R CG18228 CG18228 CDMC29230 4 3 13 DAC20-L18 3-CG18249-RA_1 CG18249 TCCGCCGGGAGTGACTGGCATACACCCCTACTGGACTCTTAGAGATATCCTTGCATTTGTTACGCTCCT 69 FBan0018249 FBgn0037553 CG18249 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG18249 CG18249 CT41336 CDMC29230 4 4 13 DAC20-L18 3-CG18249-RA_1 CG18249 TCCGCCGGGAGTGACTGGCATACACCCCTACTGGACTCTTAGAGATATCCTTGCATTTGTTACGCTCCT 69 FBan0018249 FBgn0037553 CG18249 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG18249 CG18249 CT41336 CDMC29231 4 5 13 DAC20-P06 23-CG18281-RA_1 CG18281 AGGTTTTATTAAAAAGGAGACTGTCGAAAAGGCACCATTGATCTATAAGATCATAGACGACGCTAGCGA 69 FBan0018281 FBgn0037003 CG18281 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520 integral to membrane; GO:0016021 CG18281 CG18281 CDMC29231 4 6 13 DAC20-P06 23-CG18281-RA_1 CG18281 AGGTTTTATTAAAAAGGAGACTGTCGAAAAGGCACCATTGATCTATAAGATCATAGACGACGCTAGCGA 69 FBan0018281 FBgn0037003 CG18281 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520 integral to membrane; GO:0016021 CG18281 CG18281 CDMC29232 4 7 13 DAC20-P18 3-CG1829-RA_2 CG1829 GGGGCGATTGTGAGCATCAAGGACGTGTGTGATCTGTACAACACCGACATGATAGCCAGCATCGCATTC 69 FBan0001829 FBgn0031126 Cyp6v1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6v1 Cyp6v1 "CG1829, 6v1" CDMC29232 4 8 13 DAC20-P18 3-CG1829-RA_2 CG1829 GGGGCGATTGTGAGCATCAAGGACGTGTGTGATCTGTACAACACCGACATGATAGCCAGCATCGCATTC 69 FBan0001829 FBgn0031126 Cyp6v1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6v1 Cyp6v1 "CG1829, 6v1" CDMC29233 4 9 13 DAC21-D06 2-CG3923-RA_1 CG3923 CGTGTCCCCAAAGCCCTATGTTCTAACACCATCCCACCAGATTGCGTTTGGTTCTTCCTTGTGCGATGT 69 FBan0003923 FBgn0001337 Exp6 X X "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Exp6 Exportin 6 "CG3923, CG3923, EC4, l(1)1Bb: lethal(1)1Bb, l(1)EC4, EG:165H7.3, l(1)Bb, Exp1, l(1)C84, l(1)G4, lethal(1)1Bb, l(1)1Bb, Exportin 6" CDMC29233 4 10 13 DAC21-D06 2-CG3923-RA_1 CG3923 CGTGTCCCCAAAGCCCTATGTTCTAACACCATCCCACCAGATTGCGTTTGGTTCTTCCTTGTGCGATGT 69 FBan0003923 FBgn0001337 Exp6 X X "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Exp6 Exportin 6 "CG3923, CG3923, EC4, l(1)1Bb: lethal(1)1Bb, l(1)EC4, EG:165H7.3, l(1)Bb, Exp1, l(1)C84, l(1)G4, lethal(1)1Bb, l(1)1Bb, Exportin 6" CDMC29234 4 11 13 DAC21-D18 3-CG3935-RA_6 CG3935 CCCTCCTGGATTATGGGCATATCGGAGGAAATCAAGCTGGAGGAACTACCGCAAGAAGCCAAGCTAGCG 69 FBan0003935 FBgn0000061 al 2 2L "antennal morphogenesis; GO:0007469; elongation of arista core; GO:0035015; leg disc development; GO:0035218; positive regulation of Notch signaling pathway; GO:0045747; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 al aristaless "CG3935, CG3935, L13-4, AL, A1, lambda13-4, aristaless" CDMC29234 4 12 13 DAC21-D18 3-CG3935-RA_6 CG3935 CCCTCCTGGATTATGGGCATATCGGAGGAAATCAAGCTGGAGGAACTACCGCAAGAAGCCAAGCTAGCG 69 FBan0003935 FBgn0000061 al 2 2L "antennal morphogenesis; GO:0007469; elongation of arista core; GO:0035015; leg disc development; GO:0035218; positive regulation of Notch signaling pathway; GO:0045747; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 al aristaless "CG3935, CG3935, L13-4, AL, A1, lambda13-4, aristaless" CDMC29235 4 13 13 DAC21-H06 3-CG3964-RA_3 CG3964 GCAGAGGAGGTCCGCAAACATAACCAGTACACCAATCGGAGCATCGAATTCCGGGAGGAGTACGTTGAT 69 FBan0003964 FBgn0031574 CG3964 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004835 ; EC:6.3.2.25 CG3964 CG3964 CDMC29235 4 14 13 DAC21-H06 3-CG3964-RA_3 CG3964 GCAGAGGAGGTCCGCAAACATAACCAGTACACCAATCGGAGCATCGAATTCCGGGAGGAGTACGTTGAT 69 FBan0003964 FBgn0031574 CG3964 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004835 ; EC:6.3.2.25 CG3964 CG3964 CDMC29236 4 15 13 DAC21-H18 23-CG3978-RA_14 CG3978 ACCCTCACTTGAAGCCTTCCTTGGAATCATGGCATTGAAAAGACTTTAGACATTAGTACTACTCGGCCT 69 FBan0003978 FBgn0003117 pnr 3 3R "blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; cardioblast cell fate determination; GO:0007510; cardioblast differentiation; GO:0010002; cell differentiation; GO:0030154; dorsal closure; GO:0007391; ectoderm development; GO:0007398; embryonic heart tube development; GO:0035050; heart development; GO:0007507; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of transcription, DNA-dependent; GO:0045892; pattern specification; GO:0007389; pericardial cell differentiation; GO:0007513; pigment metabolism; GO:0042440; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transforming growth factor beta receptor signaling pathway; GO:0007179" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 pnr pannier "CG3978, CG3978, dGATAa, dGATAa/pannier, GATAa, GATAa/Pannier, prn, Pnr, GATA, l(3)89B3, pannier" CDMC29236 4 16 13 DAC21-H18 23-CG3978-RA_14 CG3978 ACCCTCACTTGAAGCCTTCCTTGGAATCATGGCATTGAAAAGACTTTAGACATTAGTACTACTCGGCCT 69 FBan0003978 FBgn0003117 pnr 3 3R "blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; cardioblast cell fate determination; GO:0007510; cardioblast differentiation; GO:0010002; cell differentiation; GO:0030154; dorsal closure; GO:0007391; ectoderm development; GO:0007398; embryonic heart tube development; GO:0035050; heart development; GO:0007507; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of transcription, DNA-dependent; GO:0045892; pattern specification; GO:0007389; pericardial cell differentiation; GO:0007513; pigment metabolism; GO:0042440; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; transforming growth factor beta receptor signaling pathway; GO:0007179" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 pnr pannier "CG3978, CG3978, dGATAa, dGATAa/pannier, GATAa, GATAa/Pannier, prn, Pnr, GATA, l(3)89B3, pannier" CDMC29237 4 17 13 DAC21-L06 16-CG4004-RA_2 CG4004 CGCCATTCACCAAGTTTTCACACGTTAATCACCATAAGAAGTTTTCGCACTGTGTAGCCACATTGCCGT 69 FBan0004004 FBgn0030418 CG4004 X X CG4004 CG4004 "CG18137, CG18137" CDMC29237 4 18 13 DAC21-L06 16-CG4004-RA_2 CG4004 CGCCATTCACCAAGTTTTCACACGTTAATCACCATAAGAAGTTTTCGCACTGTGTAGCCACATTGCCGT 69 FBan0004004 FBgn0030418 CG4004 X X CG4004 CG4004 "CG18137, CG18137" CDMC29238 4 19 13 DAC21-L18 6-CG40067-RA_1 CG40067 GTGGTACCTCGCGAACTGTAGCAGGAAATGGAAACGTAAACCATCGTTTGCCTCGTACAAGTGCCAGCT 69 FBgn0058067 CG40067 CG40067 CG40067 CDMC29238 4 20 13 DAC21-L18 6-CG40067-RA_1 CG40067 GTGGTACCTCGCGAACTGTAGCAGGAAATGGAAACGTAAACCATCGTTTGCCTCGTACAAGTGCCAGCT 69 FBgn0058067 CG40067 CG40067 CG40067 CDMC29239 4 21 13 DAC21-P06 23-CG40119-RA_2 CG40119 CACTTGGCTAAAAATGGTCATATAGATTTCGTTGGAAATTTAGTTACGAGTTCAGGTATGACATTCCAT 69 FBgn0058119 CG40119 CG40119 CG40119 CDMC29239 4 22 13 DAC21-P06 23-CG40119-RA_2 CG40119 CACTTGGCTAAAAATGGTCATATAGATTTCGTTGGAAATTTAGTTACGAGTTCAGGTATGACATTCCAT 69 FBgn0058119 CG40119 CG40119 CG40119 CDMC29240 4 23 13 DAC21-P18 15-CG40130-RA_7 CG40130 GGTGACGGCGTTCAGAACACAATCAACACTGAACCATGTGGAACCGTCCATAAGATACAGGTCACTGGT 69 FBgn0058130 CG40130 CG40130 CG40130 CDMC29240 4 24 13 DAC21-P18 15-CG40130-RA_7 CG40130 GGTGACGGCGTTCAGAACACAATCAACACTGAACCATGTGGAACCGTCCATAAGATACAGGTCACTGGT 69 FBgn0058130 CG40130 CG40130 CG40130 CDMC29241 4 25 13 DAC22-D06 1-CG13790-RA_1 CG13790 CAGGTCGTCAACACGGAAAATGTCTGCGAGAATGCCCAGGAGCTATCACCAAAGCGCAAATTGGC 65 FBan0013790 FBgn0040955 CG13790 2 2L CG13790 CG13790 CDMC29241 4 26 13 DAC22-D06 1-CG13790-RA_1 CG13790 CAGGTCGTCAACACGGAAAATGTCTGCGAGAATGCCCAGGAGCTATCACCAAAGCGCAAATTGGC 65 FBan0013790 FBgn0040955 CG13790 2 2L CG13790 CG13790 CDMC29242 4 1 14 DAC22-D18 2-CG13806-RA_2 CG13806 CTCCAACGGATGGGTGAACATTCCCGTGGAATCGTGCGACGTGGCTAATGGATACTACTGCAACG 65 FBan0013806 FBgn0035325 CG13806 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13806 CG13806 CDMC29242 4 2 14 DAC22-D18 2-CG13806-RA_2 CG13806 CTCCAACGGATGGGTGAACATTCCCGTGGAATCGTGCGACGTGGCTAATGGATACTACTGCAACG 65 FBan0013806 FBgn0035325 CG13806 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13806 CG13806 CDMC29243 4 3 14 DAC22-H06 6-CG13881-RA_5 CG13881 CGCATCGAAGACAAATACAAACGCTCCCTGTTCCAGCCTACGCAGGAAAGACATTCCGGCTCCAC 65 FBan0013881 FBgn0035125 CG13881 3 3L CG13881 CG13881 CDMC29243 4 4 14 DAC22-H06 6-CG13881-RA_5 CG13881 CGCATCGAAGACAAATACAAACGCTCCCTGTTCCAGCCTACGCAGGAAAGACATTCCGGCTCCAC 65 FBan0013881 FBgn0035125 CG13881 3 3L CG13881 CG13881 CDMC29244 4 5 14 DAC22-H18 1-CG13919-RA_1 CG13919 AAGTGATGATCTGCCTAACGCTGGAGTACCCGCAACAGATTCCCATATACGTGACCGTTGCCCCG 65 FBan0013919 FBgn0035248 CG13919 3 3L CG13919 CG13919 CDMC29244 4 6 14 DAC22-H18 1-CG13919-RA_1 CG13919 AAGTGATGATCTGCCTAACGCTGGAGTACCCGCAACAGATTCCCATATACGTGACCGTTGCCCCG 65 FBan0013919 FBgn0035248 CG13919 3 3L CG13919 CG13919 CDMC29245 4 7 14 DAC22-L06 3-CG13972-RA_1 CG13972 GAACTCGAAAAGCGTGTCACCAAGGAAAAGCTACAGGACCTGGAGGAACGCATTGCCGACACCAA 65 FBan0013972 FBgn0039522 CG13972 3 3R CG13972 CG13972 CDMC29245 4 8 14 DAC22-L06 3-CG13972-RA_1 CG13972 GAACTCGAAAAGCGTGTCACCAAGGAAAAGCTACAGGACCTGGAGGAACGCATTGCCGACACCAA 65 FBan0013972 FBgn0039522 CG13972 3 3R CG13972 CG13972 CDMC29246 4 9 14 DAC22-L18 17-CG13996-RA_1 CG13996 CCGAGTACGAGCAAACTTTTCGGGAGAACTACATTGATGGACACAAGCTGCTGAATCTGGACGCA 65 FBan0013996 FBgn0031763 CG13996 2 2L CG13996 CG13996 CDMC29246 4 10 14 DAC22-L18 17-CG13996-RA_1 CG13996 CCGAGTACGAGCAAACTTTTCGGGAGAACTACATTGATGGACACAAGCTGCTGAATCTGGACGCA 65 FBan0013996 FBgn0031763 CG13996 2 2L CG13996 CG13996 CDMC29247 4 11 14 DAC22-P06 23-CG14072-RA_2 CG14072 GATTCGCCCGATTATTACACCCAAAAGGAGGAATTAATCTTCAAGGTCGTGTGTGAATTGCGGGG 65 FBan0014072 FBgn0032318 CG14072 2 2L CG14072 CG14072 CDMC29247 4 12 14 DAC22-P06 23-CG14072-RA_2 CG14072 GATTCGCCCGATTATTACACCCAAAAGGAGGAATTAATCTTCAAGGTCGTGTGTGAATTGCGGGG 65 FBan0014072 FBgn0032318 CG14072 2 2L CG14072 CG14072 CDMC29248 4 13 14 DAC22-P18 1-CG14105-RA_1 CG14105 GGGCTTCCGTGCTTAATAATCGGGCACAAACTTTACGCCTAGCCAAACGTGATGAGGAGGCCCTC 65 FBan0014105 FBgn0036359 CG14105 3 3L CG14105 CG14105 CDMC29248 4 14 14 DAC22-P18 1-CG14105-RA_1 CG14105 GGGCTTCCGTGCTTAATAATCGGGCACAAACTTTACGCCTAGCCAAACGTGATGAGGAGGCCCTC 65 FBan0014105 FBgn0036359 CG14105 3 3L CG14105 CG14105 CDMC29249 4 15 14 DAC23-D06 21-CG4716-RB_1 CG4716 GCAGAAGCACGGAGGATACGATGCTTTTGTAAGCAAAGGGAGTCTAGACGAAGACGCCAGGCTGC 65 FBan0004716 FBgn0033820 CG4716 2 2R methylenetetrahydrofolate dehydrogenase activity; GO:0004486 ; EC:1.5.1.-; ; GO:0004486 ; EC:1.5.1.- CG4716 CG4716 "gh18008, BEST:GH18008" CDMC29249 4 16 14 DAC23-D06 21-CG4716-RB_1 CG4716 GCAGAAGCACGGAGGATACGATGCTTTTGTAAGCAAAGGGAGTCTAGACGAAGACGCCAGGCTGC 65 FBan0004716 FBgn0033820 CG4716 2 2R methylenetetrahydrofolate dehydrogenase activity; GO:0004486 ; EC:1.5.1.-; ; GO:0004486 ; EC:1.5.1.- CG4716 CG4716 "gh18008, BEST:GH18008" CDMC29250 4 17 14 DAC23-D18 18-CG4775-RA_1 CG4775 ATGCACCCGCGTCTCAAGTGACTGAACAGGTAGCGAAGTGACCCTGGATGAGCGTGGGTAGGCAG 65 FBan0004775 FBgn0031312 l(2)k00619 2 2L l(2)k00619 lethal (2) k00619 "CG4775, BcDNA:SD10843" CDMC29250 4 18 14 DAC23-D18 18-CG4775-RA_1 CG4775 ATGCACCCGCGTCTCAAGTGACTGAACAGGTAGCGAAGTGACCCTGGATGAGCGTGGGTAGGCAG 65 FBan0004775 FBgn0031312 l(2)k00619 2 2L l(2)k00619 lethal (2) k00619 "CG4775, BcDNA:SD10843" CDMC29251 4 19 14 DAC23-H06 2-CG4955-RA_3 CG4955 AGGGATTCGGACAGTACGCGGATATCGGAGGAAATGGTGGAAGTGTTCCAAACCTCTTCGGCGAG 65 FBan0004955 FBgn0030814 CG4955 X X CG4955 CG4955 anon-WO0140519.97 CDMC29251 4 20 14 DAC23-H06 2-CG4955-RA_3 CG4955 AGGGATTCGGACAGTACGCGGATATCGGAGGAAATGGTGGAAGTGTTCCAAACCTCTTCGGCGAG 65 FBan0004955 FBgn0030814 CG4955 X X CG4955 CG4955 anon-WO0140519.97 CDMC29252 4 21 14 DAC23-H18 1-CG5023-RA_1 CG5023 TAATTCACAATGGCTCCACGCAACAAGGAACAGGAACAGGAAGTGCTCAACTGGGTGTTCGCCGT 65 FBan0005023 FBgn0038774 CG5023 3 3R muscle contraction; GO:0006936; smooth muscle contraction; GO:0006939 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 CG5023 CG5023 CDMC29252 4 22 14 DAC23-H18 1-CG5023-RA_1 CG5023 TAATTCACAATGGCTCCACGCAACAAGGAACAGGAACAGGAAGTGCTCAACTGGGTGTTCGCCGT 65 FBan0005023 FBgn0038774 CG5023 3 3R muscle contraction; GO:0006936; smooth muscle contraction; GO:0006939 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 CG5023 CG5023 CDMC29253 4 23 14 DAC23-L06 2-CG5183-RB_1 CG5183 CCTGGATCTGTTCACCACCTACGTGAGCCTGTACAACTCGGTGATGAAGGTGTTGTTCCTGGCCA 65 FBan0005183 FBgn0022268 KdelR 2 2L "exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; protein retention in ER; GO:0006621; protein transport; GO:0015031; retrograde transport, Golgi to ER; GO:0006890" KDEL sequence binding; GO:0005046; ; GO:0005046; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005046; ; GO:0005046 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; trans-Golgi network transport vesicle; GO:0030140 KdelR KDEL receptor "CG5183, l(2)k00311, CK00230, ERD2, Erd2, dmErd2, BEST:CK00230, ER lumen protein retaining receptor 2, KDEL receptor" CDMC29253 4 24 14 DAC23-L06 2-CG5183-RB_1 CG5183 CCTGGATCTGTTCACCACCTACGTGAGCCTGTACAACTCGGTGATGAAGGTGTTGTTCCTGGCCA 65 FBan0005183 FBgn0022268 KdelR 2 2L "exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; protein retention in ER; GO:0006621; protein transport; GO:0015031; retrograde transport, Golgi to ER; GO:0006890" KDEL sequence binding; GO:0005046; ; GO:0005046; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005046; ; GO:0005046 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; trans-Golgi network transport vesicle; GO:0030140 KdelR KDEL receptor "CG5183, l(2)k00311, CK00230, ERD2, Erd2, dmErd2, BEST:CK00230, ER lumen protein retaining receptor 2, KDEL receptor" CDMC29254 4 25 14 DAC23-L18 3-CG5204-RA_1 CG5204 ATAGTGCTCATTCGACCTCGGCACTGGATTTACGAAAGCCCAGGGATGACCAGACGGAGGACTTG 65 FBan0005204 FBgn0032473 CG5204 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5204 CG5204 anon-WO0118547.212 CDMC29254 4 26 14 DAC23-L18 3-CG5204-RA_1 CG5204 ATAGTGCTCATTCGACCTCGGCACTGGATTTACGAAAGCCCAGGGATGACCAGACGGAGGACTTG 65 FBan0005204 FBgn0032473 CG5204 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5204 CG5204 anon-WO0118547.212 CDMC29255 4 1 15 DAC23-P06 15-CG5323-RA_2 CG5323 CTGTGCCATCCAGTGTGTGGACAAGCATGTGGGCCTCATTCCCGGCATGATGAAGACCATGAAGG 65 FBan0005323 FBgn0034362 CG5323 2 2R CG5323 CG5323 CDMC29255 4 2 15 DAC23-P06 15-CG5323-RA_2 CG5323 CTGTGCCATCCAGTGTGTGGACAAGCATGTGGGCCTCATTCCCGGCATGATGAAGACCATGAAGG 65 FBan0005323 FBgn0034362 CG5323 2 2R CG5323 CG5323 CDMC29256 4 3 15 DAC23-P18 2-CG5371-RA_2 CG5371 GTGGGACAAGGTGCCAACGAACCTGTGGGACTGGCAGAAATTGAAGGAGTCCATTAGGATGCACG 65 FBan0005371 FBgn0011703 RnrL 2 2L DNA replication; GO:0006260; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrL Ribonucleoside diphosphate reductase large subunit "CG5371, CG5371, CG5371, l(2)k06709, DmRNR1, RNR1, ribonucleoside-diphosphate reductase large subunit, RntL, RnrM1, Ribonucleoside diphosphate reductase M1 subunit" CDMC29256 4 4 15 DAC23-P18 2-CG5371-RA_2 CG5371 GTGGGACAAGGTGCCAACGAACCTGTGGGACTGGCAGAAATTGAAGGAGTCCATTAGGATGCACG 65 FBan0005371 FBgn0011703 RnrL 2 2L DNA replication; GO:0006260; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrL Ribonucleoside diphosphate reductase large subunit "CG5371, CG5371, CG5371, l(2)k06709, DmRNR1, RNR1, ribonucleoside-diphosphate reductase large subunit, RntL, RnrM1, Ribonucleoside diphosphate reductase M1 subunit" CDMC29257 4 5 15 DAC24-D06 15-CG9206-RA_5 CG9206 GCAAACTCCGATCTTCAGCTCATTGCCCAACATCTTCTGGACAAGGAGTACGACATCATTTCTGCAGCC 69 FBan0009206 FBgn0001108 Gl 3 3L cell fate determination; GO:0001709; eye photoreceptor cell differentiation; GO:0001754; eye photoreceptor development (sensu Endopterygota); GO:0042051; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; retrograde axon cargo transport; GO:0008090; rhabdomere development; GO:0042052; second mitotic wave (sensu Endopterygota); GO:0016330; vesicle-mediated transport; GO:0016192 microtubule motor activity; GO:0003777; dynein binding; GO:0045502; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003777; ; GO:0045502 cytoplasm; GO:0005737; dynactin complex; GO:0005869 Gl Glued "CG9206, CG9206, CG9206, Glu, p150[Glued], p150, p150glued, dynactin, p150/glued, p150/Glued, t1, Glued" CDMC29257 4 6 15 DAC24-D06 15-CG9206-RA_5 CG9206 GCAAACTCCGATCTTCAGCTCATTGCCCAACATCTTCTGGACAAGGAGTACGACATCATTTCTGCAGCC 69 FBan0009206 FBgn0001108 Gl 3 3L cell fate determination; GO:0001709; eye photoreceptor cell differentiation; GO:0001754; eye photoreceptor development (sensu Endopterygota); GO:0042051; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; retrograde axon cargo transport; GO:0008090; rhabdomere development; GO:0042052; second mitotic wave (sensu Endopterygota); GO:0016330; vesicle-mediated transport; GO:0016192 microtubule motor activity; GO:0003777; dynein binding; GO:0045502; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003777; ; GO:0045502 cytoplasm; GO:0005737; dynactin complex; GO:0005869 Gl Glued "CG9206, CG9206, CG9206, Glu, p150[Glued], p150, p150glued, dynactin, p150/glued, p150/Glued, t1, Glued" CDMC29258 4 7 15 DAC24-D18 15-CG9213-RA_1 CG9213 CCGACATTGTGTCCAAGCACAAGAATCCCAACGATGACTTGGATGACATATTCGCTGATAAGGTGCGCA 69 FBan0009213 FBgn0030655 CG9213 X X CG9213 CG9213 CG32585 CDMC29258 4 8 15 DAC24-D18 15-CG9213-RA_1 CG9213 CCGACATTGTGTCCAAGCACAAGAATCCCAACGATGACTTGGATGACATATTCGCTGATAAGGTGCGCA 69 FBan0009213 FBgn0030655 CG9213 X X CG9213 CG9213 CG32585 CDMC29259 4 9 15 DAC24-H06 3-CG9257-RA_3 CG9257 CGGGTACAGGAACATGACGAGGTGCTCTACAGGACCGAGCGGTATCACACCACTACATTTGGGTACGAT 69 FBan0009257 FBgn0032916 CG9257 2 2L CG9257 CG9257 CDMC29259 4 10 15 DAC24-H06 3-CG9257-RA_3 CG9257 CGGGTACAGGAACATGACGAGGTGCTCTACAGGACCGAGCGGTATCACACCACTACATTTGGGTACGAT 69 FBan0009257 FBgn0032916 CG9257 2 2L CG9257 CG9257 CDMC29260 4 11 15 DAC24-H18 1-CG9265-RA_1 CG9265 GGCTGCACCTTTTGGATACACCTGACCATCTGATCGAGCGGTCGTTCAATGTGAATGTCATGGCACACT 69 FBan0009265 FBgn0032910 CG9265 2 2L metabolism; GO:0008152; visual perception; GO:0007601 nucleic acid binding; GO:0003676; ; GO:0003676; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; endonuclease activity; GO:0004519; ; GO:0004519; ; GO:0016491 ; EC:1.-.-.- CG9265 CG9265 CDMC29260 4 12 15 DAC24-H18 1-CG9265-RA_1 CG9265 GGCTGCACCTTTTGGATACACCTGACCATCTGATCGAGCGGTCGTTCAATGTGAATGTCATGGCACACT 69 FBan0009265 FBgn0032910 CG9265 2 2L metabolism; GO:0008152; visual perception; GO:0007601 nucleic acid binding; GO:0003676; ; GO:0003676; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; endonuclease activity; GO:0004519; ; GO:0004519; ; GO:0016491 ; EC:1.-.-.- CG9265 CG9265 CDMC29261 4 13 15 DAC24-L06 23-CG9306-RA_1 CG9306 ACCTGGGACACCACTAATCTTAGAGTACCGTAATCAAATCACATCCAATCTTTGTCTTTAAAAGTAAAT 69 FBan0009306 FBgn0032511 CG9306 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9306 CG9306 CDMC29261 4 14 15 DAC24-L06 23-CG9306-RA_1 CG9306 ACCTGGGACACCACTAATCTTAGAGTACCGTAATCAAATCACATCCAATCTTTGTCTTTAAAAGTAAAT 69 FBan0009306 FBgn0032511 CG9306 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9306 CG9306 CDMC29262 4 15 15 DAC24-L18 2-CG9314-RA_3 CG9314 AGGAGCTGATGTCCCACGATCCGGACTATGCCATCAGGGATCTGTACAACTCGATCAAGAAGGGCAACT 69 FBan0009314 FBgn0032061 CG9314 2 2L defense response; GO:0006952; electron transport; GO:0006118; oxygen and reactive oxygen species metabolism; GO:0006800; response to oxidative stress; GO:0006979 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; catalase activity; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6 CG9314 CG9314 "CT26521, anon-WO0140519.249" CDMC29262 4 16 15 DAC24-L18 2-CG9314-RA_3 CG9314 AGGAGCTGATGTCCCACGATCCGGACTATGCCATCAGGGATCTGTACAACTCGATCAAGAAGGGCAACT 69 FBan0009314 FBgn0032061 CG9314 2 2L defense response; GO:0006952; electron transport; GO:0006118; oxygen and reactive oxygen species metabolism; GO:0006800; response to oxidative stress; GO:0006979 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; catalase activity; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6 CG9314 CG9314 "CT26521, anon-WO0140519.249" CDMC29263 4 17 15 DAC24-P06 8-CG9342-RA_6 CG9342 ATGATCGCCAGTTTGAGATCAAAACATACGTGCTGCAGAAGCTAAGAATGCTGGCTGAGAAGTGCCCGC 69 FBan0009342 FBgn0032904 CG9342 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869; triacylglycerol metabolism; GO:0006641 DNA binding; GO:0003677; carrier activity; GO:0005386; ; GO:0005386; lipid transporter activity; GO:0005319; triglyceride binding; GO:0017129; ; GO:0003677; ; GO:0005319; ; GO:0017129 nucleus; GO:0005634 CG9342 CG9342 CT3751 CDMC29263 4 18 15 DAC24-P06 8-CG9342-RA_6 CG9342 ATGATCGCCAGTTTGAGATCAAAACATACGTGCTGCAGAAGCTAAGAATGCTGGCTGAGAAGTGCCCGC 69 FBan0009342 FBgn0032904 CG9342 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869; triacylglycerol metabolism; GO:0006641 DNA binding; GO:0003677; carrier activity; GO:0005386; ; GO:0005386; lipid transporter activity; GO:0005319; triglyceride binding; GO:0017129; ; GO:0003677; ; GO:0005319; ; GO:0017129 nucleus; GO:0005634 CG9342 CG9342 CT3751 CDMC29264 4 19 15 DAC24-P18 8-CG9358-RA_1 CG9358 CCGACGCCCTTCATTCCGACTGCTCAAAGTGCACGGAAGTCCAACGCAAAAACTCACAAAAGGTAATCA 69 FBan0009358 FBgn0035089 Phk-3 2 2R "Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; gastrulation; GO:0007369; metamorphosis (sensu Insecta); GO:0046698; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; response to bacteria; GO:0009617; sensory perception; GO:0007600; signal transduction; GO:0007165; spermatogenesis; GO:0007283; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" diacylglycerol binding; GO:0019992; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; carrier activity; GO:0005386; ; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005386 cytoplasm; GO:0005737; extrinsic to plasma membrane; GO:0019897 Phk-3 Pherokine 3 "CG9358, CG9358, CG9358, CG9358, CG9358, CG9358, CG9358, BcDNA:RE09339, Pherokine 3" CDMC29264 4 20 15 DAC24-P18 8-CG9358-RA_1 CG9358 CCGACGCCCTTCATTCCGACTGCTCAAAGTGCACGGAAGTCCAACGCAAAAACTCACAAAAGGTAATCA 69 FBan0009358 FBgn0035089 Phk-3 2 2R "Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; gastrulation; GO:0007369; metamorphosis (sensu Insecta); GO:0046698; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid phosphorylation; GO:0006468; response to bacteria; GO:0009617; sensory perception; GO:0007600; signal transduction; GO:0007165; spermatogenesis; GO:0007283; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293" diacylglycerol binding; GO:0019992; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; carrier activity; GO:0005386; ; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005386 cytoplasm; GO:0005737; extrinsic to plasma membrane; GO:0019897 Phk-3 Pherokine 3 "CG9358, CG9358, CG9358, CG9358, CG9358, CG9358, CG9358, BcDNA:RE09339, Pherokine 3" CDMC29265 4 21 15 DAC25-D06 2-CG10589-RA_1 CG10589 CCTACCCTAATGGTGCGAGTAAACAACCTTGATCTGAGTGTCCTCTCCCAACGTCTTGCTCGTCCTGCC 69 FBan0010589 FBgn0037035 CG10589 3 3L CG10589 CG10589 anon-WO0140519.139 CDMC29265 4 22 15 DAC25-D06 2-CG10589-RA_1 CG10589 CCTACCCTAATGGTGCGAGTAAACAACCTTGATCTGAGTGTCCTCTCCCAACGTCTTGCTCGTCCTGCC 69 FBan0010589 FBgn0037035 CG10589 3 3L CG10589 CG10589 anon-WO0140519.139 CDMC29266 4 23 15 DAC25-D18 22-CG10598-RB_1 CG10598 CGTCAGCGGTTGGAATTAGTTTGGTCAGCTGTTTGATACCGATTGTATCCCATTCGCTACTCGAGATGA 69 FBan0010598 FBgn0003057 CG10598 X X CG10598 CG10598 "GCR-11, GCR 17, anon-Pen15EF, GCR11, GCR17, Pen15EF, pen15EF" CDMC29266 4 24 15 DAC25-D18 22-CG10598-RB_1 CG10598 CGTCAGCGGTTGGAATTAGTTTGGTCAGCTGTTTGATACCGATTGTATCCCATTCGCTACTCGAGATGA 69 FBan0010598 FBgn0003057 CG10598 X X CG10598 CG10598 "GCR-11, GCR 17, anon-Pen15EF, GCR11, GCR17, Pen15EF, pen15EF" CDMC29267 4 25 15 DAC25-H06 23-CG10626-RA_15 CG10626 TGGCAACCACTTTAATTTAAACTAGAGCGATCTAAGTTATAGCCGTGTTCCAATGACACATTCCGCAGC 69 FBan0010626 FBgn0035610 Lkr 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; leucokinin receptor activity; GO:0042071; neuropeptide Y receptor activity; GO:0004983; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; ; GO:0004983; ; GO:0042071 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021 Lkr Leucokinin receptor "CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, DLKR, Drosokinin receptor, anon-WO0131005.17, anon-WO0170980.118, anon-WO0170980.119, Leucokinin receptor" CDMC29267 4 26 15 DAC25-H06 23-CG10626-RA_15 CG10626 TGGCAACCACTTTAATTTAAACTAGAGCGATCTAAGTTATAGCCGTGTTCCAATGACACATTCCGCAGC 69 FBan0010626 FBgn0035610 Lkr 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; leucokinin receptor activity; GO:0042071; neuropeptide Y receptor activity; GO:0004983; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; ; GO:0004983; ; GO:0042071 basolateral plasma membrane; GO:0016323; integral to membrane; GO:0016021 Lkr Leucokinin receptor "CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, CG10626, DLKR, Drosokinin receptor, anon-WO0131005.17, anon-WO0170980.118, anon-WO0170980.119, Leucokinin receptor" CDMC29268 4 1 16 DAC25-H18 9-CG10632-RA_1 CG10632 TCGAAAAAGATTTGGGCTTCCTACGGATTGGTTCTCTGAATGTCCGGGTAAAGAAGACCACCGAGGCGT 69 FBan0010632 FBgn0036302 CG10632 3 3L CG10632 CG10632 BcDNA:GM09162 CDMC29268 4 2 16 DAC25-H18 9-CG10632-RA_1 CG10632 TCGAAAAAGATTTGGGCTTCCTACGGATTGGTTCTCTGAATGTCCGGGTAAAGAAGACCACCGAGGCGT 69 FBan0010632 FBgn0036302 CG10632 3 3L CG10632 CG10632 BcDNA:GM09162 CDMC29269 4 3 16 DAC25-L06 3-CG10664-RA_1 CG10664 CCGTCACCGGATTGACCTCCAAGTGGGACTACGAGAACAAGAAGTGGAAGAACTAAGTGCGCTGTCGTT 69 FBan0010664 FBgn0032833 CG10664 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG10664 CG10664 "IV: transcript group IV, IV" CDMC29269 4 4 16 DAC25-L06 3-CG10664-RA_1 CG10664 CCGTCACCGGATTGACCTCCAAGTGGGACTACGAGAACAAGAAGTGGAAGAACTAAGTGCGCTGTCGTT 69 FBan0010664 FBgn0032833 CG10664 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG10664 CG10664 "IV: transcript group IV, IV" CDMC29270 4 5 16 DAC25-L18 3-CG10673-RA_3 CG10673 TGCCAAGCAGTTCATCCAGGAAACAGTGTCCACTCAGACGGAGGATGAAGCCAAGAAATGTCTGCTGGA 69 FBan0010673 FBgn0035590 CG10673 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG10673 CG10673 CDMC29270 4 6 16 DAC25-L18 3-CG10673-RA_3 CG10673 TGCCAAGCAGTTCATCCAGGAAACAGTGTCCACTCAGACGGAGGATGAAGCCAAGAAATGTCTGCTGGA 69 FBan0010673 FBgn0035590 CG10673 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG10673 CG10673 CDMC29271 4 7 16 DAC25-P06 11-CG10706-RE_1 CG10706 GCCAACCAACTGCAAAACATCCACGAACATGGCAAATTCTCGTGTCCGTCTGTCTCGAATTTGTGTGCA 69 FBan0010706 FBgn0029761 SK X X cation transport; GO:0006812; lipid catabolism; GO:0016042; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; small conductance calcium-activated potassium channel activity; GO:0016286; calcium-activated potassium channel activity; GO:0015269; ; GO:0005516; calcium ion binding; GO:0005509; voltage-gated potassium channel activity; GO:0005249; ; GO:0005509; ; GO:0015269; ; GO:0005249; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0016286; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004623 ; EC:3.1.1.4 integral to membrane; GO:0016021; membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 SK small conductance calcium-activated potassium channel "CG10706, CG12733, CG4179, dSK, BcDNA:GM01744, small conductance calcium-activated potassium channel" CDMC29271 4 8 16 DAC25-P06 11-CG10706-RE_1 CG10706 GCCAACCAACTGCAAAACATCCACGAACATGGCAAATTCTCGTGTCCGTCTGTCTCGAATTTGTGTGCA 69 FBan0010706 FBgn0029761 SK X X cation transport; GO:0006812; lipid catabolism; GO:0016042; potassium ion transport; GO:0006813; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; small conductance calcium-activated potassium channel activity; GO:0016286; calcium-activated potassium channel activity; GO:0015269; ; GO:0005516; calcium ion binding; GO:0005509; voltage-gated potassium channel activity; GO:0005249; ; GO:0005509; ; GO:0015269; ; GO:0005249; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0016286; GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004623 ; EC:3.1.1.4 integral to membrane; GO:0016021; membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 SK small conductance calcium-activated potassium channel "CG10706, CG12733, CG4179, dSK, BcDNA:GM01744, small conductance calcium-activated potassium channel" CDMC29272 4 9 16 DAC25-P18 4-CG10725-RB_1 CG10725 GGCTCGCTGTGACAAGTACTACATTTGCATGGATGGTCTTCCTCAAGTCCAGAACTGCACAAGTGGCCT 69 FBan0010725 FBgn0036362 CG10725 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG10725 CG10725 CDMC29272 4 10 16 DAC25-P18 4-CG10725-RB_1 CG10725 GGCTCGCTGTGACAAGTACTACATTTGCATGGATGGTCTTCCTCAAGTCCAGAACTGCACAAGTGGCCT 69 FBan0010725 FBgn0036362 CG10725 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG10725 CG10725 CDMC29273 4 11 16 DAC26-D06 24-CG8050-RA_3 CG8050 CAAGATACACGTGATTTAAAAAATGATTTTTGATTAATTTTCGGGGAACTATTGTTGCAAAGTATCCAA 69 FBan0008050 FBgn0004629 Cys 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869; ; GO:0004869 Cys Cystatin-like "CG8050, CG8050, CG8050, cystatin, clone 2.34, BcDNA:RH72992, anon-EST:Liang-2.34" CDMC29273 4 12 16 DAC26-D06 24-CG8050-RA_3 CG8050 CAAGATACACGTGATTTAAAAAATGATTTTTGATTAATTTTCGGGGAACTATTGTTGCAAAGTATCCAA 69 FBan0008050 FBgn0004629 Cys 3 3R cysteine protease inhibitor activity; GO:0004869; ; GO:0004869; ; GO:0004869 Cys Cystatin-like "CG8050, CG8050, CG8050, cystatin, clone 2.34, BcDNA:RH72992, anon-EST:Liang-2.34" CDMC29274 4 13 16 DAC26-D18 2-CG8064-RA_1 CG8064 CCAGGACGCACATGTTCTTCACGTGTGGAAAGGATGGAAAGGTGAAGCAGTGGGATGGCGATAACTTCG 69 FBan0008064 FBgn0038597 CG8064 3 3R CG8064 CG8064 CDMC29274 4 14 16 DAC26-D18 2-CG8064-RA_1 CG8064 CCAGGACGCACATGTTCTTCACGTGTGGAAAGGATGGAAAGGTGAAGCAGTGGGATGGCGATAACTTCG 69 FBan0008064 FBgn0038597 CG8064 3 3R CG8064 CG8064 CDMC29275 4 15 16 DAC26-H06 2-CG8094-RA_1 CG8094 GCGGAGGTGCGAGAACTTATGCAACCCTTTGTGTTGAGTGATTACCAGGTGCAGGAAGTGTACAGTCGC 69 FBan0008094 FBgn0001187 Hex-C 2 2R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-C Hexokinase C "CG8094, CG8094, Hexokinase-3, HEX, HK, Hex, HEX-3, Hex-c, HEX-C, Hk, hexokinase, Hexokinase, DM2, CT22069, Fk: Fructokinase, Hex-3, Fructokinase" CDMC29275 4 16 16 DAC26-H06 2-CG8094-RA_1 CG8094 GCGGAGGTGCGAGAACTTATGCAACCCTTTGTGTTGAGTGATTACCAGGTGCAGGAAGTGTACAGTCGC 69 FBan0008094 FBgn0001187 Hex-C 2 2R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-C Hexokinase C "CG8094, CG8094, Hexokinase-3, HEX, HK, Hex, HEX-3, Hex-c, HEX-C, Hk, hexokinase, Hexokinase, DM2, CT22069, Fk: Fructokinase, Hex-3, Fructokinase" CDMC29276 4 17 16 DAC26-H18 1-CG8107-RA_1 CG8107 GCAACTGGAGGGATGACTAAGAGCAAGCATCAATAGCAAATCCACTCCATGCACCTCGTCAAGAGCCGG 69 FBan0008107 FBgn0025866 CalpB 3 3L protein autoprocessing; GO:0016540; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; ; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622; membrane; GO:0016020 CalpB Calpain-B "CG8107, CALPB, Calpain B" CDMC29276 4 18 16 DAC26-H18 1-CG8107-RA_1 CG8107 GCAACTGGAGGGATGACTAAGAGCAAGCATCAATAGCAAATCCACTCCATGCACCTCGTCAAGAGCCGG 69 FBan0008107 FBgn0025866 CalpB 3 3L protein autoprocessing; GO:0016540; proteolysis; GO:0006508 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; ; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622; membrane; GO:0016020 CalpB Calpain-B "CG8107, CALPB, Calpain B" CDMC29277 4 19 16 DAC26-L06 3-CG8142-RA_1 CG8142 AGGGCCCGAGCACATCATCAACACTGCTGATCTGTTCGAGATGTCGGGCGTTATACCGGAGTACTATCT 69 FBan0008142 FBgn0030871 CG8142 X X DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663 CG8142 CG8142 CDMC29277 4 20 16 DAC26-L06 3-CG8142-RA_1 CG8142 AGGGCCCGAGCACATCATCAACACTGCTGATCTGTTCGAGATGTCGGGCGTTATACCGGAGTACTATCT 69 FBan0008142 FBgn0030871 CG8142 X X DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663 CG8142 CG8142 CDMC29278 4 21 16 DAC26-L18 23-CG8160-RA_3 CG8160 TATTGAACTTCCGCAATAATTATCAATCTTCGATTTCCCGAACTAATCTCAGTACCAGTCGATTAAAGC 69 FBan0008160 FBgn0034011 CG8160 2 2R CG8160 CG8160 CDMC29278 4 22 16 DAC26-L18 23-CG8160-RA_3 CG8160 TATTGAACTTCCGCAATAATTATCAATCTTCGATTTCCCGAACTAATCTCAGTACCAGTCGATTAAAGC 69 FBan0008160 FBgn0034011 CG8160 2 2R CG8160 CG8160 CDMC29279 4 23 16 DAC26-P06 2-CG8191-RA_1 CG8191 GCGTGCCCAACTACCCCCCAATTCCTGGACACATTTGCTGGAGCTGCTAAATAAAGTGGCATTCGTTTT 69 FBan0008191 FBgn0030675 CG8191 X X CG8191 CG8191 CDMC29279 4 24 16 DAC26-P06 2-CG8191-RA_1 CG8191 GCGTGCCCAACTACCCCCCAATTCCTGGACACATTTGCTGGAGCTGCTAAATAAAGTGGCATTCGTTTT 69 FBan0008191 FBgn0030675 CG8191 X X CG8191 CG8191 CDMC29280 4 25 16 DAC26-P18 8-CG8202-RA_1 CG8202 CGCTGATCTGGAGAGGGAAACTATCGCTCAATTGGCAGTCAATCTGTGGCTCCTAGCTAACAAGGCACA 69 FBan0008202 FBgn0037622 CG8202 3 3R CG8202 CG8202 CDMC29280 4 26 16 DAC26-P18 8-CG8202-RA_1 CG8202 CGCTGATCTGGAGAGGGAAACTATCGCTCAATTGGCAGTCAATCTGTGGCTCCTAGCTAACAAGGCACA 69 FBan0008202 FBgn0037622 CG8202 3 3R CG8202 CG8202 CDMC29281 4 1 17 DAC27-D06 15-CG8440-RE_1 CG8440 TCGACGGCTAATACCATGTGTACCATGTGGCGCAGAAATGTTTTTCCATCCACAAATGTACCCGAGCAC 69 FBan0008440 FBgn0015754 Lis-1 2 2R cell motility; GO:0006928; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; fusome organization and biogenesis; GO:0045478; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mushroom body development; GO:0016319; nuclear migration; GO:0007097; oocyte differentiation (sensu Insecta); GO:0030706; oocyte fate determination (sensu Insecta); GO:0007294; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; regulation of enzyme activity; GO:0050790 "dynein binding; GO:0045502; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0045502; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0030234" dynein complex; GO:0030286 Lis-1 Lissencephaly-1 "CG8440, CG8440, l(2)k13209, Dlis-1, DLIS-1, D-Lis1, DLis-1, DLIS1, l(2R)W8, Paf-AHbeta, n(2)k11702, DLis1, Lis1, LIS-1, lis1, Lis 1" CDMC29281 4 2 17 DAC27-D06 15-CG8440-RE_1 CG8440 TCGACGGCTAATACCATGTGTACCATGTGGCGCAGAAATGTTTTTCCATCCACAAATGTACCCGAGCAC 69 FBan0008440 FBgn0015754 Lis-1 2 2R cell motility; GO:0006928; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; fusome organization and biogenesis; GO:0045478; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mushroom body development; GO:0016319; nuclear migration; GO:0007097; oocyte differentiation (sensu Insecta); GO:0030706; oocyte fate determination (sensu Insecta); GO:0007294; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993; regulation of enzyme activity; GO:0050790 "dynein binding; GO:0045502; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0045502; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0030234" dynein complex; GO:0030286 Lis-1 Lissencephaly-1 "CG8440, CG8440, l(2)k13209, Dlis-1, DLIS-1, D-Lis1, DLis-1, DLIS1, l(2R)W8, Paf-AHbeta, n(2)k11702, DLis1, Lis1, LIS-1, lis1, Lis 1" CDMC29282 4 3 17 DAC27-D18 23-CG8449-RA_1 CG8449 TCTTAGTGACTACACCACATCGTTGACATATCTAATGCGCTACCCAAACAATGTTGATGTCCATCTGGT 69 FBan0008449 FBgn0038129 CG8449 3 3R CG8449 CG8449 CDMC29282 4 4 17 DAC27-D18 23-CG8449-RA_1 CG8449 TCTTAGTGACTACACCACATCGTTGACATATCTAATGCGCTACCCAAACAATGTTGATGTCCATCTGGT 69 FBan0008449 FBgn0038129 CG8449 3 3R CG8449 CG8449 CDMC29283 4 5 17 DAC27-H06 2-CG8492-RA_4 CG8492 CCCAAAACCCATTCCTCAGTTTACTTGGCAAACCAATTGTACCTGCTCAAGCACCCATCAAGCCCCAGT 69 FBan0008492 FBgn0035813 CG8492 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG8492 CG8492 CDMC29283 4 6 17 DAC27-H06 2-CG8492-RA_4 CG8492 CCCAAAACCCATTCCTCAGTTTACTTGGCAAACCAATTGTACCTGCTCAAGCACCCATCAAGCCCCAGT 69 FBan0008492 FBgn0035813 CG8492 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG8492 CG8492 CDMC29284 4 7 17 DAC27-H18 11-CG8503-RA_1 CG8503 ACAAGTGCGTCAACTATCTGAAATACGAGTCGGACATCTTCATCGAGGGTCACGTGCTTAAGCAGGCCA 69 FBan0008503 FBgn0033917 CG8503 2 2R biosynthesis; GO:0009058 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; iron ion binding; GO:0005506; ; GO:0005506 CG8503 CG8503 CDMC29284 4 8 17 DAC27-H18 11-CG8503-RA_1 CG8503 ACAAGTGCGTCAACTATCTGAAATACGAGTCGGACATCTTCATCGAGGGTCACGTGCTTAAGCAGGCCA 69 FBan0008503 FBgn0033917 CG8503 2 2R biosynthesis; GO:0009058 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; iron ion binding; GO:0005506; ; GO:0005506 CG8503 CG8503 CDMC29285 4 9 17 DAC27-L06 2-CG8545-RA_1 CG8545 GCCCGAGGAGAACGAATGGGTCATCGACTATGCACTGAAGAAGCGAAATGTCAAACTTGTGCCCACTGG 69 FBan0008545 FBgn0033741 CG8545 2 2R rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleic acid binding; GO:0003676; ; GO:0003676 nucleolus; GO:0005730 CG8545 CG8545 CDMC29285 4 10 17 DAC27-L06 2-CG8545-RA_1 CG8545 GCCCGAGGAGAACGAATGGGTCATCGACTATGCACTGAAGAAGCGAAATGTCAAACTTGTGCCCACTGG 69 FBan0008545 FBgn0033741 CG8545 2 2R rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleic acid binding; GO:0003676; ; GO:0003676 nucleolus; GO:0005730 CG8545 CG8545 CDMC29286 4 11 17 DAC27-L18 1-CG8552-RA_1 CG8552 GCCGATGTGAGTCCACAAAACCACACGAGAGCTCTGTTGGATCCAACGATCCCACGTACCGTATACACC 69 FBan0008552 FBgn0031990 CG8552 2 2L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; metal ion binding; GO:0046872; ; GO:0008970 ; EC:3.1.1.32; ; GO:0046872 CG8552 CG8552 CG14278 CDMC29286 4 12 17 DAC27-L18 1-CG8552-RA_1 CG8552 GCCGATGTGAGTCCACAAAACCACACGAGAGCTCTGTTGGATCCAACGATCCCACGTACCGTATACACC 69 FBan0008552 FBgn0031990 CG8552 2 2L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; metal ion binding; GO:0046872; ; GO:0008970 ; EC:3.1.1.32; ; GO:0046872 CG8552 CG8552 CG14278 CDMC29287 4 13 17 DAC27-P06 14-CG8589-RA_2 CG8589 GCCTGCTCGCGATATTGAATCCATTATCGAATTACAGCAGCGCATTAGGGTGCAGTTGGTGAGTTTGGT 69 FBan0008589 FBgn0033921 CG8589 2 2R CG8589 CG8589 "anon-EST:fe1D11, anon-fast-evolving-1D11" CDMC29287 4 14 17 DAC27-P06 14-CG8589-RA_2 CG8589 GCCTGCTCGCGATATTGAATCCATTATCGAATTACAGCAGCGCATTAGGGTGCAGTTGGTGAGTTTGGT 69 FBan0008589 FBgn0033921 CG8589 2 2R CG8589 CG8589 "anon-EST:fe1D11, anon-fast-evolving-1D11" CDMC29288 4 15 17 DAC27-P18 11-CG8600-RA_3 CG8600 TCTGCGGGGAAAGACGTATGAGCATGAGATTAGCTATGCCTAATATTGGGGTGTTCAGGGGTGTCCCAT 69 FBan0008600 FBgn0035765 CG8600 3 3L CG8600 CG8600 CDMC29288 4 16 17 DAC27-P18 11-CG8600-RA_3 CG8600 TCTGCGGGGAAAGACGTATGAGCATGAGATTAGCTATGCCTAATATTGGGGTGTTCAGGGGTGTCCCAT 69 FBan0008600 FBgn0035765 CG8600 3 3L CG8600 CG8600 CDMC29289 4 17 17 DAC28-D06 23-CG30358-RA_10 CG30358 ATGATCAGCATATACGAGTGGAGTACTTAGCAGGCTGGTTAGATCAATTATAGAACTGAAGGCCTTATT 69 FBan0030358 FBgn0050358 CG30358 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30358 CG30358 CDMC29289 4 18 17 DAC28-D06 23-CG30358-RA_10 CG30358 ATGATCAGCATATACGAGTGGAGTACTTAGCAGGCTGGTTAGATCAATTATAGAACTGAAGGCCTTATT 69 FBan0030358 FBgn0050358 CG30358 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30358 CG30358 CDMC29290 4 19 17 DAC28-D18 23-CG30369-RA_4 CG30369 GCTCCTCGTGATCTTAGAGACTATTTTATGTCAAGCTGGAAAAACGAGAGAAAATGATATCCCCCCTTG 69 FBan0030369 FBgn0050369 CG30369 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30369 CG30369 NEST:bs06h11 CDMC29290 4 20 17 DAC28-D18 23-CG30369-RA_4 CG30369 GCTCCTCGTGATCTTAGAGACTATTTTATGTCAAGCTGGAAAAACGAGAGAAAATGATATCCCCCCTTG 69 FBan0030369 FBgn0050369 CG30369 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30369 CG30369 NEST:bs06h11 CDMC29291 4 21 17 DAC28-H06 15-CG30409-RA_1 CG30409 GCCGCTTGCAAGGGAAGGCTCTACAAATGCAACACCATCGAGTCCGAAAGTTTATAATCTTTGTGGGGA 69 FBan0030409 FBgn0050409 CG30409 2 2R CG30409 CG30409 CG9872 CDMC29291 4 22 17 DAC28-H06 15-CG30409-RA_1 CG30409 GCCGCTTGCAAGGGAAGGCTCTACAAATGCAACACCATCGAGTCCGAAAGTTTATAATCTTTGTGGGGA 69 FBan0030409 FBgn0050409 CG30409 2 2R CG30409 CG30409 CG9872 CDMC29292 4 23 17 DAC28-H18 12-CG30423-RB_1 CG30423 GCCATACGGATCCATGTTCTAGAGGGGATTTGTAGTTCACAAGCTCACTAGGCTAGTAACCGGCGCAGG 69 FBan0030423 FBgn0050423 CG30423 2 2R CG30423 CG30423 BcDNA:RH04491 CDMC29292 4 24 17 DAC28-H18 12-CG30423-RB_1 CG30423 GCCATACGGATCCATGTTCTAGAGGGGATTTGTAGTTCACAAGCTCACTAGGCTAGTAACCGGCGCAGG 69 FBan0030423 FBgn0050423 CG30423 2 2R CG30423 CG30423 BcDNA:RH04491 CDMC29293 4 25 17 DAC28-L06 12-CG30459-RA_5 CG30459 AGTCAACTTAAGCCGGAAGAGCAGGTGGTCATTGCAGCCTCTGAGAATCTATCAATGGGTCCTTTCCCA 69 FBan0030459 FBgn0050459 CG30459 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30459 CG30459 "bs21e09.y1, NEST:bs21e09" CDMC29293 4 26 17 DAC28-L06 12-CG30459-RA_5 CG30459 AGTCAACTTAAGCCGGAAGAGCAGGTGGTCATTGCAGCCTCTGAGAATCTATCAATGGGTCCTTTCCCA 69 FBan0030459 FBgn0050459 CG30459 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30459 CG30459 "bs21e09.y1, NEST:bs21e09" CDMC29294 4 1 18 DAC28-L18 10-CG30469-RA_1 CG30469 TGCCACCCCGAGTCATGCTGTATCAGGATGCAAATGACGGTGAACTAAAGATGATTGGCTATGTGGCAA 69 FBan0030469 FBgn0050469 CG30469 2 2R CG30469 CG30469 CG12961 CDMC29294 4 2 18 DAC28-L18 10-CG30469-RA_1 CG30469 TGCCACCCCGAGTCATGCTGTATCAGGATGCAAATGACGGTGAACTAAAGATGATTGGCTATGTGGCAA 69 FBan0030469 FBgn0050469 CG30469 2 2R CG30469 CG30469 CG12961 CDMC29295 4 3 18 DAC28-P06 3-CG30496-RA_4 CG30496 GCCTCGAGAGGCGTCTACGAGATGAGTTGCCAGAATGTTTTCCTCATCGAGGAGAAACTTCCGCTGCAT 69 FBan0030496 FBgn0050496 CG30496 2 2R CG30496 CG30496 "CG1952, CG1952, anon-WO0118547.218, BcDNA:RE73310" CDMC29295 4 4 18 DAC28-P06 3-CG30496-RA_4 CG30496 GCCTCGAGAGGCGTCTACGAGATGAGTTGCCAGAATGTTTTCCTCATCGAGGAGAAACTTCCGCTGCAT 69 FBan0030496 FBgn0050496 CG30496 2 2R CG30496 CG30496 "CG1952, CG1952, anon-WO0118547.218, BcDNA:RE73310" CDMC29296 4 5 18 DAC28-P18 17-CG3052-RA_1 CG3052 GGGGAAAACATTGCGAATATTCCACATCCGATAAACGCATTTCACCATGCTCTGTAATCCGCACATCGC 69 FBan0003052 FBgn0011277 HLH4C X X regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH4C Helix loop helix protein 4C "CG3052, DroNHLH, EG:84H4.2" CDMC29296 4 6 18 DAC28-P18 17-CG3052-RA_1 CG3052 GGGGAAAACATTGCGAATATTCCACATCCGATAAACGCATTTCACCATGCTCTGTAATCCGCACATCGC 69 FBan0003052 FBgn0011277 HLH4C X X regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH4C Helix loop helix protein 4C "CG3052, DroNHLH, EG:84H4.2" CDMC29297 4 7 18 DAC29-D06 3-CG9992-RC_6 CG9992 GGCCGAAAGTCCCATTCCAAGGGTCGTTTTAATGCCACCAACAAGCATATCTCGTACTCGGGTCCACAG 69 FBan0009992 FBgn0030744 CG9992 X X CG9992 CG9992 CDMC29297 4 8 18 DAC29-D06 3-CG9992-RC_6 CG9992 GGCCGAAAGTCCCATTCCAAGGGTCGTTTTAATGCCACCAACAAGCATATCTCGTACTCGGGTCCACAG 69 FBan0009992 FBgn0030744 CG9992 X X CG9992 CG9992 CDMC29298 4 9 18 DAC29-D18 3-CG9998-RA_1 CG9998 TTAAGGAACTGCTTTTGTCGTTTGGCAAGCTACGAGCCTTCAACCTGGTTAAGGATGCCGCTACTGGGT 69 FBan0009998 FBgn0005411 U2af50 X X "nuclear export; GO:0051168; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; spliceosome assembly; GO:0000245" "poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187; protein heterodimerization activity; GO:0046982; ; GO:0046982; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af50 U2 small nuclear riboprotein auxiliary factor 50 "CG9998, CG9998, 9-21, dU2AF[50], l(1)14Cc, l(1)9-21, l(1)14Ca, U2AF, dU2AF50, U2AF50, DmU2AF[50], U2af, DU2AF50, dUTAf[50]" CDMC29298 4 10 18 DAC29-D18 3-CG9998-RA_1 CG9998 TTAAGGAACTGCTTTTGTCGTTTGGCAAGCTACGAGCCTTCAACCTGGTTAAGGATGCCGCTACTGGGT 69 FBan0009998 FBgn0005411 U2af50 X X "nuclear export; GO:0051168; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; spliceosome assembly; GO:0000245" "poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187; protein heterodimerization activity; GO:0046982; ; GO:0046982; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af50 U2 small nuclear riboprotein auxiliary factor 50 "CG9998, CG9998, 9-21, dU2AF[50], l(1)14Cc, l(1)9-21, l(1)14Ca, U2AF, dU2AF50, U2AF50, DmU2AF[50], U2af, DU2AF50, dUTAf[50]" CDMC29299 4 11 18 DAC29-H06 23-CR31400-RB_5 CR31400 GCAACTTAAAAGGTGTGATTTTTGAGACATGCTAATTTAATATCCGTCGAAAAGGAATATGCTCTTGGT 69 FBan0031400 FBgn0001234 Hsromega 3 3R nuclear speck organization and biogenesis; GO:0035063; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; response to heat; GO:0009408 chromatin; GO:0000785; omega speckle; GO:0035062 Hsromega Heat shock RNA omega "er3, hsr-omega, 93D locus, hsrw, hsr omega, Hsr-omega, heat-shock RNA-omega, l(3)05241, hsromega, n(3)05241, Hsr omega, Hsr93D, Heat-shock response factor-omega, hsr-omega, Hsromega, l(3)93De, l(3)er3, CR31400" CDMC29299 4 12 18 DAC29-H06 23-CR31400-RB_5 CR31400 GCAACTTAAAAGGTGTGATTTTTGAGACATGCTAATTTAATATCCGTCGAAAAGGAATATGCTCTTGGT 69 FBan0031400 FBgn0001234 Hsromega 3 3R nuclear speck organization and biogenesis; GO:0035063; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; response to heat; GO:0009408 chromatin; GO:0000785; omega speckle; GO:0035062 Hsromega Heat shock RNA omega "er3, hsr-omega, 93D locus, hsrw, hsr omega, Hsr-omega, heat-shock RNA-omega, l(3)05241, hsromega, n(3)05241, Hsr omega, Hsr93D, Heat-shock response factor-omega, hsr-omega, Hsromega, l(3)93De, l(3)er3, CR31400" CDMC29300 4 13 18 DAC29-H18 23-CR31696-RA_3 CR31696 TTTGCAATTCATAGACCATGATGTACAGTATAAGCAAATTAAGAACAACATCAGCAATCAATGTGCACC 69 FBan0031696 FBgn0047133 pncr003:2L 2 2L pncr003:2L putative noncoding RNA 003:2L "BcDNA:RE28911, CR31696, BEST:LP06756, putative noncoding RNA 003:2L" CDMC29300 4 14 18 DAC29-H18 23-CR31696-RA_3 CR31696 TTTGCAATTCATAGACCATGATGTACAGTATAAGCAAATTAAGAACAACATCAGCAATCAATGTGCACC 69 FBan0031696 FBgn0047133 pncr003:2L 2 2L pncr003:2L putative noncoding RNA 003:2L "BcDNA:RE28911, CR31696, BEST:LP06756, putative noncoding RNA 003:2L" CDMC29301 4 15 18 DAC29-L06 17-CR32658-RA_1 CR32658 TCTAGCGCCAACTGACCTAGTGAATCCCGTTCACCATTCCCGGATGTTAATTGATTGCTTAGTCTAGGA 69 FBan0032658 FBgn0040859 CR32658 X X CR32658 CR32658 CG11358 CDMC29301 4 16 18 DAC29-L06 17-CR32658-RA_1 CR32658 TCTAGCGCCAACTGACCTAGTGAATCCCGTTCACCATTCCCGGATGTTAATTGATTGCTTAGTCTAGGA 69 FBan0032658 FBgn0040859 CR32658 X X CR32658 CR32658 CG11358 CDMC29302 4 17 18 DAC29-L18 2-CR32862-RA_1 CR32862 TTCCTCCGGAGTGAGGCTTGGCCATTGTACCTCGGCTGAGTTGACCTCTGCGATTATTCCTAATGTGAA 69 FBan0032862 FBgn0004183 snRNA:U1:82Eb 3 3R nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U1; GO:0005685 snRNA:U1:82Eb small nuclear RNA U1 at 82Eb "K5, U1, U1-82.3, U1snRNA, U1 snRNA, U1a-82Eb, snRNA:U1, CR32862, U1snRNA82Eb, snRNA-U1-82.3, small nuclear RNA U1" CDMC29302 4 18 18 DAC29-L18 2-CR32862-RA_1 CR32862 TTCCTCCGGAGTGAGGCTTGGCCATTGTACCTCGGCTGAGTTGACCTCTGCGATTATTCCTAATGTGAA 69 FBan0032862 FBgn0004183 snRNA:U1:82Eb 3 3R nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U1; GO:0005685 snRNA:U1:82Eb small nuclear RNA U1 at 82Eb "K5, U1, U1-82.3, U1snRNA, U1 snRNA, U1a-82Eb, snRNA:U1, CR32862, U1snRNA82Eb, snRNA-U1-82.3, small nuclear RNA U1" CDMC29303 4 19 18 DAC29-P06 15-CR33465-RA_2 CR33465 GGCGGTTGCTTTGCAACATTCCAATTTCCGCCCAAACAATGGCGTCAACGATATAGGCCTTTTAAGACT 69 FBan0033465 FBgn0053465 CG33465 2 2R CG33465 CG33465 "BP1080, HDC06631, CR33465" CDMC29303 4 20 18 DAC29-P06 15-CR33465-RA_2 CR33465 GGCGGTTGCTTTGCAACATTCCAATTTCCGCCCAAACAATGGCGTCAACGATATAGGCCTTTTAAGACT 69 FBan0033465 FBgn0053465 CG33465 2 2R CG33465 CG33465 "BP1080, HDC06631, CR33465" CDMC29304 4 21 18 DAC29-P18 23-CR41110-RA_13 CR41110 AAGAGACATGTGCAATCGGTCAAAACGTGGCGCATATAACTTAAAAGCAAATAGTAACATGGGAATATA 69 FBgn0069907 CDMC29304 4 22 18 DAC29-P18 23-CR41110-RA_13 CR41110 AAGAGACATGTGCAATCGGTCAAAACGTGGCGCATATAACTTAAAAGCAAATAGTAACATGGGAATATA 69 FBgn0069907 CDMC29305 4 23 18 DAC30-D06 1-CG12002-RE_1 CG12002 CGGTGTCTTCTCACCCGAACAACTGACCCAAATCAAGCAAGCCAACTTTGGTCGAGTGCTTTGCGATGT 69 FBan0012002 FBgn0011828 Pxn 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 extracellular matrix (sensu Metazoa); GO:0005578 Pxn Peroxidasin "CG12002, CG12002, Protein X, peroxidasin, CT1239, pxn, Dpxn" CDMC29305 4 24 18 DAC30-D06 1-CG12002-RE_1 CG12002 CGGTGTCTTCTCACCCGAACAACTGACCCAAATCAAGCAAGCCAACTTTGGTCGAGTGCTTTGCGATGT 69 FBan0012002 FBgn0011828 Pxn 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 extracellular matrix (sensu Metazoa); GO:0005578 Pxn Peroxidasin "CG12002, CG12002, Protein X, peroxidasin, CT1239, pxn, Dpxn" CDMC29306 4 25 18 DAC30-D18 14-CG12009-RA_1 CG12009 GGACTCTCCGATCATCAATATAATGCAGGTGCAACATATGCCCATGGACTACAGAATCCCAGTCCGGGT 69 FBan0012009 FBgn0035430 CG12009 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG12009 CG12009 CDMC29306 4 26 18 DAC30-D18 14-CG12009-RA_1 CG12009 GGACTCTCCGATCATCAATATAATGCAGGTGCAACATATGCCCATGGACTACAGAATCCCAGTCCGGGT 69 FBan0012009 FBgn0035430 CG12009 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG12009 CG12009 CDMC29307 4 1 19 DAC30-H06 3-CG12047-RB_1 CG12047 GCAACAATTTGAGCACGAAAACTGTGTCACCTGGGCAATGCATGGTGGCGAAAGTGTGATGATGGAGGA 69 FBan0012047 FBgn0002873 mud X X mushroom body development; GO:0016319 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mud mushroom body defect "CG12047, CG12047, CG12047, CG12047, CG12047, Mud, KS63" CDMC29307 4 2 19 DAC30-H06 3-CG12047-RB_1 CG12047 GCAACAATTTGAGCACGAAAACTGTGTCACCTGGGCAATGCATGGTGGCGAAAGTGTGATGATGGAGGA 69 FBan0012047 FBgn0002873 mud X X mushroom body development; GO:0016319 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mud mushroom body defect "CG12047, CG12047, CG12047, CG12047, CG12047, Mud, KS63" CDMC29308 4 3 19 DAC30-H18 17-CG12052-RI_1 CG12052 CCGCAAGGTCTAGGCGAAAGTTGGGAGGATTGTGAGTACACAACTGTTGGGTGTAAAGAAGTAACCATT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC29308 4 4 19 DAC30-H18 17-CG12052-RI_1 CG12052 CCGCAAGGTCTAGGCGAAAGTTGGGAGGATTGTGAGTACACAACTGTTGGGTGTAAAGAAGTAACCATT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC29309 4 5 19 DAC30-L06 5-CG12078-RA_2 CG12078 ATGGAGCCACCATCTATGTCTACAAGCGCCCCTATTTGGATCACTTCCTCGATCGCGTATCCAAGTGGT 69 FBan0012078 FBgn0035426 CG12078 3 3L development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG12078 CG12078 CDMC29309 4 6 19 DAC30-L06 5-CG12078-RA_2 CG12078 ATGGAGCCACCATCTATGTCTACAAGCGCCCCTATTTGGATCACTTCCTCGATCGCGTATCCAAGTGGT 69 FBan0012078 FBgn0035426 CG12078 3 3L development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG12078 CG12078 CDMC29310 4 7 19 DAC30-L18 23-CG12094-RA_6 CG12094 GTAAACTCTATAAAGAGCGCTTACCCTTCGTCACTCTCCTGAGCATCATTCAAATCATTTTCGCCTGCG 69 FBan0012094 FBgn0030179 CG12094 X X CG12094 CG12094 CDMC29310 4 8 19 DAC30-L18 23-CG12094-RA_6 CG12094 GTAAACTCTATAAAGAGCGCTTACCCTTCGTCACTCTCCTGAGCATCATTCAAATCATTTTCGCCTGCG 69 FBan0012094 FBgn0030179 CG12094 X X CG12094 CG12094 CDMC29311 4 9 19 DAC30-P06 2-CG12129-RA_2 CG12129 GCGCCGCATAGAGGAAGAGACCCGTACAGAGATCTTTGTTCCGCGTCCGAACGATAGGTCAAACGAAGT 69 FBan0012129 FBgn0033475 CG12129 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG12129 CG12129 cg12129 CDMC29311 4 10 19 DAC30-P06 2-CG12129-RA_2 CG12129 GCGCCGCATAGAGGAAGAGACCCGTACAGAGATCTTTGTTCCGCGTCCGAACGATAGGTCAAACGAAGT 69 FBan0012129 FBgn0033475 CG12129 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG12129 CG12129 cg12129 CDMC29312 4 11 19 DAC30-P18 22-CG12139-RB_1 CG12139 GGGACTGGGGACGCCAATAAGCAAACATATCCAAAAATTGATAAACATATGCAACCCCCCACAGGAGAA 69 FBan0012139 FBgn0030130 CG12139 X X cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 low-density lipoprotein receptor activity; GO:0005041; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005041 membrane; GO:0016020 CG12139 CG12139 "CT7830, LDLR-like, anon-WO0140519.108" CDMC29312 4 12 19 DAC30-P18 22-CG12139-RB_1 CG12139 GGGACTGGGGACGCCAATAAGCAAACATATCCAAAAATTGATAAACATATGCAACCCCCCACAGGAGAA 69 FBan0012139 FBgn0030130 CG12139 X X cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 low-density lipoprotein receptor activity; GO:0005041; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005041 membrane; GO:0016020 CG12139 CG12139 "CT7830, LDLR-like, anon-WO0140519.108" CDMC29313 4 13 19 DAC31-D06 2-CG3893-RA_1 CG3893 GACGAGAGTGTGCCCGATTACGATCCTCAGGTCTACTGTTCCAGGGCCAACATAGTGAGAGAGCCC 66 FBan0003893 FBgn0036826 CG3893 3 3L CG3893 CG3893 BcDNA:LD18018 CDMC29313 4 14 19 DAC31-D06 2-CG3893-RA_1 CG3893 GACGAGAGTGTGCCCGATTACGATCCTCAGGTCTACTGTTCCAGGGCCAACATAGTGAGAGAGCCC 66 FBan0003893 FBgn0036826 CG3893 3 3L CG3893 CG3893 BcDNA:LD18018 CDMC29314 4 15 19 DAC31-D18 1-CG40166-RA_1 CG40166 TCGGACCCGTGCCTTGTCCCGTAATCGATCCCGTACTAGGTCCTGTACTAGTTCCCGTACTAGGTC 66 FBgn0058166 CG40166 CG40166 CG40166 CDMC29314 4 16 19 DAC31-D18 1-CG40166-RA_1 CG40166 TCGGACCCGTGCCTTGTCCCGTAATCGATCCCGTACTAGGTCCTGTACTAGTTCCCGTACTAGGTC 66 FBgn0058166 CG40166 CG40166 CG40166 CDMC29315 4 17 19 DAC31-H06 14-CG4367-RA_1 CG4367 ACTGGCGATATCCCAGTAACCGTGAAACTGCCCAGTGATCTCAACTGCATTCATTGCGTTTTGCGC 66 FBan0004367 FBgn0038783 CG4367 3 3R CG4367 CG4367 CDMC29315 4 18 19 DAC31-H06 14-CG4367-RA_1 CG4367 ACTGGCGATATCCCAGTAACCGTGAAACTGCCCAGTGATCTCAACTGCATTCATTGCGTTTTGCGC 66 FBan0004367 FBgn0038783 CG4367 3 3R CG4367 CG4367 CDMC29316 4 19 19 DAC31-H18 14-CG4580-RA_1 CG4580 TGCAATATTTCTATTGGATGAAACCATGGGTGGCAGAGAATCCACGGAGTGTGTGTCACAGGTGCG 66 FBan0004580 FBgn0032585 CG4580 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4580 CG4580 CDMC29316 4 20 19 DAC31-H18 14-CG4580-RA_1 CG4580 TGCAATATTTCTATTGGATGAAACCATGGGTGGCAGAGAATCCACGGAGTGTGTGTCACAGGTGCG 66 FBan0004580 FBgn0032585 CG4580 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4580 CG4580 CDMC29317 4 21 19 DAC31-L06 8-CG4936-RA_1 CG4936 AGGATGATGCGGAAGTCGATCTGAACTCAACCGAAGAGGAGTTCGTTCCCTCAAAAAGCGTTCGCG 66 FBan0004936 FBgn0038768 CG4936 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4936 CG4936 CDMC29317 4 22 19 DAC31-L06 8-CG4936-RA_1 CG4936 AGGATGATGCGGAAGTCGATCTGAACTCAACCGAAGAGGAGTTCGTTCCCTCAAAAAGCGTTCGCG 66 FBan0004936 FBgn0038768 CG4936 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4936 CG4936 CDMC29318 4 23 19 DAC31-L18 3-CG5024-RA_1 CG5024 CGGAGGTACGAACAGTTCATACCCACACGCTGAATGATGAACAGCTCAAGGATTGTGAGGCGGCCT 66 FBan0005024 FBgn0039373 CG5024 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG5024 CG5024 BcDNA:AT16150 CDMC29318 4 24 19 DAC31-L18 3-CG5024-RA_1 CG5024 CGGAGGTACGAACAGTTCATACCCACACGCTGAATGATGAACAGCTCAAGGATTGTGAGGCGGCCT 66 FBan0005024 FBgn0039373 CG5024 3 3R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG5024 CG5024 BcDNA:AT16150 CDMC29319 4 25 19 DAC31-P06 18-CG5404-RA_3 CG5404 GCGCATTAGTGGCATGGATTATACGGCTGCACAGGGTATATCGAAGTTATCCAGTGATCTGTGCCG 66 FBan0005404 FBgn0038354 CG5404 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG5404 CG5404 CDMC29319 4 26 19 DAC31-P06 18-CG5404-RA_3 CG5404 GCGCATTAGTGGCATGGATTATACGGCTGCACAGGGTATATCGAAGTTATCCAGTGATCTGTGCCG 66 FBan0005404 FBgn0038354 CG5404 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG5404 CG5404 CDMC29320 4 1 20 DAC31-P18 AutoBlank AutoBlank CDMC29320 4 2 20 DAC31-P18 AutoBlank AutoBlank CDMC29321 4 3 20 DAC32-D06 8-CG11154-RA_1 CG11154 CCCGTGTTGCTCTAACTGGACTGACCGTTGCAGAGTACTTCCGTGATCAAGAAGGACAGGATGTGTTGC 69 FBan0011154 FBgn0010217 ATPsyn-beta 4 4 ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-beta ATP synthase-beta "CG11154, CG11154, beta-ATPase, ATPsyn-beta, ATPB, ATP synthase beta subunit, H+-ATPase beta subunit, ATPsyn b, ATPsyn-b, ATP, ATP synthase beta, F1ATP synthase" CDMC29321 4 4 20 DAC32-D06 8-CG11154-RA_1 CG11154 CCCGTGTTGCTCTAACTGGACTGACCGTTGCAGAGTACTTCCGTGATCAAGAAGGACAGGATGTGTTGC 69 FBan0011154 FBgn0010217 ATPsyn-beta 4 4 ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-beta ATP synthase-beta "CG11154, CG11154, beta-ATPase, ATPsyn-beta, ATPB, ATP synthase beta subunit, H+-ATPase beta subunit, ATPsyn b, ATPsyn-b, ATP, ATP synthase beta, F1ATP synthase" CDMC29322 4 5 20 DAC32-D18 23-CG11165-RA_1 CG11165 AGAGCAATATACAACTCTTCCGAGAAACTATAATATACCAGTTAAGATGGAGGATATTTCGCATGAGGA 69 FBan0011165 FBgn0033238 CG11165 2 2R calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG11165 CG11165 "BcDNA:AT23738, BcDNA:AT10229" CDMC29322 4 6 20 DAC32-D18 23-CG11165-RA_1 CG11165 AGAGCAATATACAACTCTTCCGAGAAACTATAATATACCAGTTAAGATGGAGGATATTTCGCATGAGGA 69 FBan0011165 FBgn0033238 CG11165 2 2R calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG11165 CG11165 "BcDNA:AT23738, BcDNA:AT10229" CDMC29323 4 7 20 DAC32-H06 18-CG11217-RA_1 CG11217 AGCCAGTCAGTCAGTACAGCGATCGAAGGCTTAGGGAGAAATCGCGAATGCAATGTTGTTATCCTAAGT 69 FBan0011217 FBgn0015614 CanB2 2 2R calcium-mediated signaling; GO:0019722; cell homeostasis; GO:0019725; neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanB2 Calcineurin B2 "CG11217, CG11217, CG11217, CG11217, dCnB2, dCNB2, canB2, CS2-1, Calcineurin suppressor, chromosome 2, group 1" CDMC29323 4 8 20 DAC32-H06 18-CG11217-RA_1 CG11217 AGCCAGTCAGTCAGTACAGCGATCGAAGGCTTAGGGAGAAATCGCGAATGCAATGTTGTTATCCTAAGT 69 FBan0011217 FBgn0015614 CanB2 2 2R calcium-mediated signaling; GO:0019722; cell homeostasis; GO:0019725; neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanB2 Calcineurin B2 "CG11217, CG11217, CG11217, CG11217, dCnB2, dCNB2, canB2, CS2-1, Calcineurin suppressor, chromosome 2, group 1" CDMC29324 4 9 20 DAC32-H18 5-CG11236-RA_1 CG11236 GGACACGGTCGAAGATTTTTGGCGTGACATTGTCTATGGAGCAGTGGATCTGTCCAAGGAACAGCTGGC 69 FBan0011236 FBgn0031860 CG11236 2 2L amino acid metabolism; GO:0006520; electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; D-aspartate oxidase activity; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; D-amino-acid oxidase activity; GO:0003884 ; EC:1.4.3.3; ; GO:0003884 ; EC:1.4.3.3 CG11236 CG11236 CDMC29324 4 10 20 DAC32-H18 5-CG11236-RA_1 CG11236 GGACACGGTCGAAGATTTTTGGCGTGACATTGTCTATGGAGCAGTGGATCTGTCCAAGGAACAGCTGGC 69 FBan0011236 FBgn0031860 CG11236 2 2L amino acid metabolism; GO:0006520; electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; D-aspartate oxidase activity; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; ; GO:0008445 ; EC:1.4.3.1; D-amino-acid oxidase activity; GO:0003884 ; EC:1.4.3.3; ; GO:0003884 ; EC:1.4.3.3 CG11236 CG11236 CDMC29325 4 11 20 DAC32-L06 24-CG11271-RA_3 CG11271 AGCTATTCGCTAATTGAAAATAAAACGTATTGAACCTGAATCCAGATGAAAAAATAAAAGAAAGTCGAC 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC29325 4 12 20 DAC32-L06 24-CG11271-RA_3 CG11271 AGCTATTCGCTAATTGAAAATAAAACGTATTGAACCTGAATCCAGATGAAAAAATAAAAGAAAGTCGAC 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC29326 4 13 20 DAC32-L18 23-CG11280-RA_1 CG11280 AACCTATAGAACACTGAAGGATCTCCAATTCTATCAGCACTTTGCCAACACTACTGTTTTCCTCGTCCC 69 FBan0011280 FBgn0010452 trn 3 3L apoptosis; GO:0006915; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 trn tartan "CG11280, 0024/05, 0641/17, CT31487, anon-EST:fe2B1, anon-fast-evolving-2B1" CDMC29326 4 14 20 DAC32-L18 23-CG11280-RA_1 CG11280 AACCTATAGAACACTGAAGGATCTCCAATTCTATCAGCACTTTGCCAACACTACTGTTTTCCTCGTCCC 69 FBan0011280 FBgn0010452 trn 3 3L apoptosis; GO:0006915; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 trn tartan "CG11280, 0024/05, 0641/17, CT31487, anon-EST:fe2B1, anon-fast-evolving-2B1" CDMC29327 4 15 20 DAC32-P06 3-CG11317-RA_1 CG11317 CGGCGCCAAGTGAAAGGGATGAACTTGGGAGGACATCCAACTTGGAATTGGGCGCTCATCTTTTGATGA 69 FBan0011317 FBgn0039816 CG11317 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11317 CG11317 CDMC29327 4 16 20 DAC32-P06 3-CG11317-RA_1 CG11317 CGGCGCCAAGTGAAAGGGATGAACTTGGGAGGACATCCAACTTGGAATTGGGCGCTCATCTTTTGATGA 69 FBan0011317 FBgn0039816 CG11317 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11317 CG11317 CDMC29328 4 17 20 DAC32-P18 18-CG11324-RA_12 CG11324 GCCAATGCCAAGAAATGGGAAATCGAGCTGGCTACCTTGAAGAACAACAATATACGGCTGACTAGTGCT 69 FBan0011324 FBgn0025777 homer 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; adult behavior; GO:0030534; regulation of locomotion; GO:0040012; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 homer homer "CG11324, LD03829, d-Homer, Dhom, Dhomer, dhom, Dm Homer, BEST:LD03829, Dvh: Drosophila Ves-1 homolog, Drosophila Ves-1 homolog" CDMC29328 4 18 20 DAC32-P18 18-CG11324-RA_12 CG11324 GCCAATGCCAAGAAATGGGAAATCGAGCTGGCTACCTTGAAGAACAACAATATACGGCTGACTAGTGCT 69 FBan0011324 FBgn0025777 homer 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; adult behavior; GO:0030534; regulation of locomotion; GO:0040012; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 homer homer "CG11324, LD03829, d-Homer, Dhom, Dhomer, dhom, Dm Homer, BEST:LD03829, Dvh: Drosophila Ves-1 homolog, Drosophila Ves-1 homolog" CDMC29329 4 19 20 DAC33-D06 17-CG12602-RA_1 CG12602 CCGAAGTACTGTGGAACATGGTGTTTTCCATGGGATTCAAGTACGACAGCTATATTGGCGGCATTCTCA 69 FBan0012602 FBgn0032373 CG12602 2 2L cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; copper ion binding; GO:0005507; ; GO:0005507" hydrogen-transporting ATPase V0 domain; GO:0000220 CG12602 CG12602 CDMC29329 4 20 20 DAC33-D06 17-CG12602-RA_1 CG12602 CCGAAGTACTGTGGAACATGGTGTTTTCCATGGGATTCAAGTACGACAGCTATATTGGCGGCATTCTCA 69 FBan0012602 FBgn0032373 CG12602 2 2L cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; copper ion binding; GO:0005507; ; GO:0005507" hydrogen-transporting ATPase V0 domain; GO:0000220 CG12602 CG12602 CDMC29330 4 21 20 DAC33-D18 3-CG12622-RA_1 CG12622 ACGAGTTGTCCAGAATTTTGAAGCATGACCTGAAGCTCAAGGAGCACAGTCGCTTCTACTGCCTGGCCT 69 FBan0012622 FBgn0030297 Gr10b X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr10b Gustatory receptor 10b "CG12622, Gr10B2, Gustatory receptor 10B2, Gustatory receptor 10b" CDMC29330 4 22 20 DAC33-D18 3-CG12622-RA_1 CG12622 ACGAGTTGTCCAGAATTTTGAAGCATGACCTGAAGCTCAAGGAGCACAGTCGCTTCTACTGCCTGGCCT 69 FBan0012622 FBgn0030297 Gr10b X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr10b Gustatory receptor 10b "CG12622, Gr10B2, Gustatory receptor 10B2, Gustatory receptor 10b" CDMC29331 4 23 20 DAC33-H06 17-CG12664-RB_2 CG12664 AGCCGAAGCGAAAAGAGAGGTAGAGAGTAGGATTTACAGCTTCTTCGCTTCACTAAATGCAGTCGACGC 69 FBan0012664 FBgn0030090 ld14 X X plasma membrane; GO:0005886 ld14 ld14 "CG12664, CG12664, LD14, fend, forked end, BcDNA:RH56795" CDMC29331 4 24 20 DAC33-H06 17-CG12664-RB_2 CG12664 AGCCGAAGCGAAAAGAGAGGTAGAGAGTAGGATTTACAGCTTCTTCGCTTCACTAAATGCAGTCGACGC 69 FBan0012664 FBgn0030090 ld14 X X plasma membrane; GO:0005886 ld14 ld14 "CG12664, CG12664, LD14, fend, forked end, BcDNA:RH56795" CDMC29332 4 25 20 DAC33-H18 17-CG12679-RA_1 CG12679 CCTGGCCCTTATGACCTACGCACTCACTGAGGGCTAATTGCTAAAACTTAAATTTGATCGGTTCGCGAA 69 FBan0012679 FBgn0031103 CG12679 X X CG12679 CG12679 CDMC29332 4 26 20 DAC33-H18 17-CG12679-RA_1 CG12679 CCTGGCCCTTATGACCTACGCACTCACTGAGGGCTAATTGCTAAAACTTAAATTTGATCGGTTCGCGAA 69 FBan0012679 FBgn0031103 CG12679 X X CG12679 CG12679 CDMC29333 4 1 21 DAC33-L06 10-CG12730-RA_1 CG12730 CGGCGCTTCGCTACATTTGCTACATTGGCTTTAATCGCTCGTTTCTGAGGCATCTATTCGGCTGGACAA 69 FBan0012730 FBgn0029771 CG12730 X X CG12730 CG12730 BcDNA:RE01432 CDMC29333 4 2 21 DAC33-L06 10-CG12730-RA_1 CG12730 CGGCGCTTCGCTACATTTGCTACATTGGCTTTAATCGCTCGTTTCTGAGGCATCTATTCGGCTGGACAA 69 FBan0012730 FBgn0029771 CG12730 X X CG12730 CG12730 BcDNA:RE01432 CDMC29334 4 3 21 DAC33-L18 2-CG12746-RD_2 CG12746 AGCACCAGGCCTAAGCTGACAACCGAATATACCCAACGGACTAACGAAATGACTGCGAGCAAGGAAGGT 69 FBan0012746 FBgn0037341 CG12746 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG12746 CG12746 WUN-like CDMC29334 4 4 21 DAC33-L18 2-CG12746-RD_2 CG12746 AGCACCAGGCCTAAGCTGACAACCGAATATACCCAACGGACTAACGAAATGACTGCGAGCAAGGAAGGT 69 FBan0012746 FBgn0037341 CG12746 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG12746 CG12746 WUN-like CDMC29335 4 5 21 DAC33-P06 1-CG12782-RA_1 CG12782 ACCAAGCTGGTAATCGTGGACCGGAGTTGTACAACTACTCCTCCAGTCATGAATCAATTCGGCCAGCCA 69 FBan0012782 FBgn0034838 CG12782 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG12782 CG12782 CDMC29335 4 6 21 DAC33-P06 1-CG12782-RA_1 CG12782 ACCAAGCTGGTAATCGTGGACCGGAGTTGTACAACTACTCCTCCAGTCATGAATCAATTCGGCCAGCCA 69 FBan0012782 FBgn0034838 CG12782 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 CG12782 CG12782 CDMC29336 4 7 21 DAC33-P18 12-CG12796-RA_2 CG12796 GCTGCGTGTCCATGTTGACTCTGATCTCGATTGCGGTGGATCGGTATATAGCAGTCGTCTATGCTCTGC 69 FBan0012796 FBgn0029909 CG12796 X X G-protein coupled receptor protein signaling pathway; GO:0007186 amine receptor activity; GO:0008227; G-protein coupled receptor activity; GO:0004930; ; GO:0008227; ; GO:0004930 integral to membrane; GO:0016021 CG12796 CG12796 CDMC29336 4 8 21 DAC33-P18 12-CG12796-RA_2 CG12796 GCTGCGTGTCCATGTTGACTCTGATCTCGATTGCGGTGGATCGGTATATAGCAGTCGTCTATGCTCTGC 69 FBan0012796 FBgn0029909 CG12796 X X G-protein coupled receptor protein signaling pathway; GO:0007186 amine receptor activity; GO:0008227; G-protein coupled receptor activity; GO:0004930; ; GO:0008227; ; GO:0004930 integral to membrane; GO:0016021 CG12796 CG12796 CDMC29337 4 9 21 DAC34-D06 3-CG4363-RA_1 CG4363 ACCTGGCGACATAAGGAACTGCAATGCTGCCAACATCGTCGAGAGCTCAAATTTAGGGAACCGCTTCAT 69 FBan0004363 FBgn0034663 CG4363 2 2R CG4363 CG4363 "CT14230, BcDNA:LP06375" CDMC29337 4 10 21 DAC34-D06 3-CG4363-RA_1 CG4363 ACCTGGCGACATAAGGAACTGCAATGCTGCCAACATCGTCGAGAGCTCAAATTTAGGGAACCGCTTCAT 69 FBan0004363 FBgn0034663 CG4363 2 2R CG4363 CG4363 "CT14230, BcDNA:LP06375" CDMC29338 4 11 21 DAC34-D18 23-CG4376-RC_2 CG4376 AGATTTATTATACCTACACTCGTAACAGTAGCTGCAGAAGAACTTCAGATCATCATGTGAGGATGAATA 69 FBan0004376 FBgn0000667 Actn X X actin filament bundle formation; GO:0051017; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; flight behavior; GO:0007629 actin binding; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509; actin filament binding; GO:0051015; ; GO:0051015 focal adhesion; GO:0005925 Actn alpha actinin "CG4376, CG4376, CG4376, CG4376, fliA: flightless-A, l(1)EA82, GA17, Alpha-actinin, HM-29, l(1)2Cb, a-actinin, lethal(1)2cb, CT14163, CT14232, EG:133E12.1, actn, alpha-Actinin, flightless A, alpha-actinin, alpha-actinin, y, flightless-A, fliA" CDMC29338 4 12 21 DAC34-D18 23-CG4376-RC_2 CG4376 AGATTTATTATACCTACACTCGTAACAGTAGCTGCAGAAGAACTTCAGATCATCATGTGAGGATGAATA 69 FBan0004376 FBgn0000667 Actn X X actin filament bundle formation; GO:0051017; cell motility; GO:0006928; cytoskeletal anchoring; GO:0007016; flight behavior; GO:0007629 actin binding; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509; actin filament binding; GO:0051015; ; GO:0051015 focal adhesion; GO:0005925 Actn alpha actinin "CG4376, CG4376, CG4376, CG4376, fliA: flightless-A, l(1)EA82, GA17, Alpha-actinin, HM-29, l(1)2Cb, a-actinin, lethal(1)2cb, CT14163, CT14232, EG:133E12.1, actn, alpha-Actinin, flightless A, alpha-actinin, alpha-actinin, y, flightless-A, fliA" CDMC29339 4 13 21 DAC34-H06 7-CG4420-RA_1 CG4420 AGCCAGAAACCGGATTGCAATAGGATGATGAACAGACTGGACCCCATTAACTGGAAGCCGTTCCAACGA 69 FBan0004420 FBgn0030753 CG4420 X X proteolysis; GO:0006508 aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.- CG4420 CG4420 CDMC29339 4 14 21 DAC34-H06 7-CG4420-RA_1 CG4420 AGCCAGAAACCGGATTGCAATAGGATGATGAACAGACTGGACCCCATTAACTGGAAGCCGTTCCAACGA 69 FBan0004420 FBgn0030753 CG4420 X X proteolysis; GO:0006508 aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.- CG4420 CG4420 CDMC29340 4 15 21 DAC34-H18 17-CG4428-RA_3 CG4428 CTGCCGTGATGCCACCTACCTCAAGATCGTGAACCGTTTTGAAGACGTAAGGAATAGCTTCTACTCCAT 69 FBan0004428 FBgn0031298 Atg4 2 2L cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- Atg4 Autophagy-specific gene 4 "CG4428, CG4428, CG4428, Autophagy-specific gene 4" CDMC29340 4 16 21 DAC34-H18 17-CG4428-RA_3 CG4428 CTGCCGTGATGCCACCTACCTCAAGATCGTGAACCGTTTTGAAGACGTAAGGAATAGCTTCTACTCCAT 69 FBan0004428 FBgn0031298 Atg4 2 2L cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- Atg4 Autophagy-specific gene 4 "CG4428, CG4428, CG4428, Autophagy-specific gene 4" CDMC29341 4 17 21 DAC34-L06 3-CG4459-RA_3 CG4459 TCGATGTGCAGCTCACGATGTACGCCAATGACCTGGACCAGAAATCCAAACAGAAGCACAGCTATTGCC 69 FBan0004459 FBgn0038753 CG4459 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 CG4459 CG4459 CDMC29341 4 18 21 DAC34-L06 3-CG4459-RA_3 CG4459 TCGATGTGCAGCTCACGATGTACGCCAATGACCTGGACCAGAAATCCAAACAGAAGCACAGCTATTGCC 69 FBan0004459 FBgn0038753 CG4459 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 CG4459 CG4459 CDMC29342 4 19 21 DAC34-L18 3-CG4475-RA_5 CG4475 TCAGTTCTCCGAGGTTACCTCCCTCAAGAGGAAGTATCCCCACCTGAAAGTTTTGTTGAGTGTGGGCGG 69 FBan0004475 FBgn0020415 Idgf2 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; nutrient reservoir activity; GO:0045735; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14; ; GO:0045735" extracellular region; GO:0005576 Idgf2 Imaginal disc growth factor 2 "CG4475, CG4475, CG4475, IDGF, BG:DS02780.4, IDGF2, idgf2, IDGF-2, Imaginal disc growth factor 2" CDMC29342 4 20 21 DAC34-L18 3-CG4475-RA_5 CG4475 TCAGTTCTCCGAGGTTACCTCCCTCAAGAGGAAGTATCCCCACCTGAAAGTTTTGTTGAGTGTGGGCGG 69 FBan0004475 FBgn0020415 Idgf2 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; nutrient reservoir activity; GO:0045735; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14; ; GO:0045735" extracellular region; GO:0005576 Idgf2 Imaginal disc growth factor 2 "CG4475, CG4475, CG4475, IDGF, BG:DS02780.4, IDGF2, idgf2, IDGF-2, Imaginal disc growth factor 2" CDMC29343 4 21 21 DAC34-P06 23-CG4523-RA_1 CG4523 GGAGAAAAGCCTTCTACTTGTTACTCTGAGAAAATCAAATGGAAAAGCGTGTGATACCTATATTTTACA 69 FBan0004523 FBgn0029891 CG4523 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 CG4523 CG4523 BEST:GH23468 CDMC29343 4 22 21 DAC34-P06 23-CG4523-RA_1 CG4523 GGAGAAAAGCCTTCTACTTGTTACTCTGAGAAAATCAAATGGAAAAGCGTGTGATACCTATATTTTACA 69 FBan0004523 FBgn0029891 CG4523 X X protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 CG4523 CG4523 BEST:GH23468 CDMC29344 4 23 21 DAC34-P18 17-CG4535-RA_1 CG4535 CGGCTGCCAACCAAGTGATCATCTGCAAGCAGAAACTCAAAGAGAGCAAGAACAAGGAGAAGAAACTCT 69 FBan0004535 FBgn0029174 FKBP59 2 2L calcium ion transport; GO:0006816; detection of light stimulus during visual perception; GO:0050908; peripheral nervous system development; GO:0007422; protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; protein binding; GO:0005515; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 FKBP59 FK506-binding protein FKBP59 "CG4535, l(2)k00424, dFKBP59, FKBP59-bp1, anon-WO0118547.161, l(2)k09010" CDMC29344 4 24 21 DAC34-P18 17-CG4535-RA_1 CG4535 CGGCTGCCAACCAAGTGATCATCTGCAAGCAGAAACTCAAAGAGAGCAAGAACAAGGAGAAGAAACTCT 69 FBan0004535 FBgn0029174 FKBP59 2 2L calcium ion transport; GO:0006816; detection of light stimulus during visual perception; GO:0050908; peripheral nervous system development; GO:0007422; protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; protein binding; GO:0005515; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 FKBP59 FK506-binding protein FKBP59 "CG4535, l(2)k00424, dFKBP59, FKBP59-bp1, anon-WO0118547.161, l(2)k09010" CDMC29345 4 25 21 DAC35-D06 24-CG8819-RC_3 CG8819 CATTTTTTTAAGGTATCTAGTAATTATGTACACATACATACATAAAATGAGAACGTTTGTGGAAGGACA 69 FBan0008819 FBgn0033749 achi 2 2R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; ; GO:0003700 nucleus; GO:0005634 achi achintya "CG8819, CG8819, zaa, zuker-aly-like a, achintya" CDMC29345 4 26 21 DAC35-D06 24-CG8819-RC_3 CG8819 CATTTTTTTAAGGTATCTAGTAATTATGTACACATACATACATAAAATGAGAACGTTTGTGGAAGGACA 69 FBan0008819 FBgn0033749 achi 2 2R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; spermatogenesis; GO:0007283 transcription corepressor activity; GO:0003714; transcription factor activity; GO:0003700; ; GO:0003714; ; GO:0003700 nucleus; GO:0005634 achi achintya "CG8819, CG8819, zaa, zuker-aly-like a, achintya" CDMC29346 4 1 22 DAC35-D18 3-CG8827-RA_1 CG8827 CCGCCTGCATCAAGGCTGGCCAATATGATCCCGACAATGTGGAGTTGCCTCTGGATAATTGCGATATCT 69 FBan0008827 FBgn0012037 Ance 2 2L metamorphosis (sensu Insecta); GO:0046698; proteolysis; GO:0006508; sperm individualization; GO:0007291; spermatid nuclear differentiation; GO:0007289 zinc ion binding; GO:0008270; peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0008241 ; EC:3.4.15.- extracellular region; GO:0005576; membrane; GO:0016020 Ance Angiotensin converting enzyme "CG8827, CG8827, CG8827, l(2)br31, br31, l(2)34Eb, l34Eb, Race, AnCE, race, ACE, BG:DS08220.3, RACE, anon-EST:fe3D10, Related to angiotensin converting enzyme, anon-fast-evolving-3D10" CDMC29346 4 2 22 DAC35-D18 3-CG8827-RA_1 CG8827 CCGCCTGCATCAAGGCTGGCCAATATGATCCCGACAATGTGGAGTTGCCTCTGGATAATTGCGATATCT 69 FBan0008827 FBgn0012037 Ance 2 2L metamorphosis (sensu Insecta); GO:0046698; proteolysis; GO:0006508; sperm individualization; GO:0007291; spermatid nuclear differentiation; GO:0007289 zinc ion binding; GO:0008270; peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008270; ; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0008241 ; EC:3.4.15.- extracellular region; GO:0005576; membrane; GO:0016020 Ance Angiotensin converting enzyme "CG8827, CG8827, CG8827, l(2)br31, br31, l(2)34Eb, l34Eb, Race, AnCE, race, ACE, BG:DS08220.3, RACE, anon-EST:fe3D10, Related to angiotensin converting enzyme, anon-fast-evolving-3D10" CDMC29347 4 3 22 DAC35-H06 12-CG8864-RA_4 CG8864 GGCCACAGTCTTGGCTCACATACTGCTCAATCTGGGTCGTAATAAGGAGGCACAGAATCTTCTGCGAGA 69 FBan0008864 FBgn0028940 Cyp28a5 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28a5 Cyp28a5 "CG8864, BG:DS00180.11, DS00180.11, gh10483, cyp28a5, 28a5, BEST:GH10483" CDMC29347 4 4 22 DAC35-H06 12-CG8864-RA_4 CG8864 GGCCACAGTCTTGGCTCACATACTGCTCAATCTGGGTCGTAATAAGGAGGCACAGAATCTTCTGCGAGA 69 FBan0008864 FBgn0028940 Cyp28a5 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp28a5 Cyp28a5 "CG8864, BG:DS00180.11, DS00180.11, gh10483, cyp28a5, 28a5, BEST:GH10483" CDMC29348 4 5 22 DAC35-H18 23-CG8884-RA_2 CG8884 TTCTTTCCATTCCTTTCCAACCTTGTTTCCTCCTTAATTGATTAACCTAATATTGTTAACCCAAAACCC 69 FBan0008884 FBgn0013334 Sap47 3 3R synaptic transmission; GO:0007268 molecular function unknown; GO:0005554; ; GO:0005554 synapse; GO:0045202 Sap47 Synapse-associated protein 47kD "CG8884, dsap-47, sap47, SAP47, SAP-47" CDMC29348 4 6 22 DAC35-H18 23-CG8884-RA_2 CG8884 TTCTTTCCATTCCTTTCCAACCTTGTTTCCTCCTTAATTGATTAACCTAATATTGTTAACCCAAAACCC 69 FBan0008884 FBgn0013334 Sap47 3 3R synaptic transmission; GO:0007268 molecular function unknown; GO:0005554; ; GO:0005554 synapse; GO:0045202 Sap47 Synapse-associated protein 47kD "CG8884, dsap-47, sap47, SAP47, SAP-47" CDMC29349 4 7 22 DAC35-L06 18-CG8924-RA_4 CG8924 TCCCATGCCGGAAACATAATAATCACAACAAACTCAGGAAAACTCTCAACCGTCCCAGCGAGCATAACT 69 FBan0008924 FBgn0030710 CG8924 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG8924 CG8924 CDMC29349 4 8 22 DAC35-L06 18-CG8924-RA_4 CG8924 TCCCATGCCGGAAACATAATAATCACAACAAACTCAGGAAAACTCTCAACCGTCCCAGCGAGCATAACT 69 FBan0008924 FBgn0030710 CG8924 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG8924 CG8924 CDMC29350 4 9 22 DAC35-L18 9-CG8933-RC_1 CG8933 CGCCGCAATTTCAGCAAGCAGGCATCCGAGATTCTCAACGAGTACTTCTACAGTCACTTGAGCAACCCA 69 FBan0008933 FBgn0000611 exd X X "brain development; GO:0007420; hemopoiesis; GO:0030097; leg disc proximal/distal pattern formation; GO:0007479; mesoderm development; GO:0007498; oenocyte development; GO:0007438; regulation of transcription, DNA-dependent; GO:0006355; salivary gland determination; GO:0007432" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 exd extradenticle "CG8933, Dpbx, td48, EXD, DExd, Exd, Dm-EXD, Pbx1: Pbx1-oncogene-like, anon-EST:fe1H3, l(1)IV, Pbx1-oncogene-like, anon-fast-evolving-1H3, extradenticle" CDMC29350 4 10 22 DAC35-L18 9-CG8933-RC_1 CG8933 CGCCGCAATTTCAGCAAGCAGGCATCCGAGATTCTCAACGAGTACTTCTACAGTCACTTGAGCAACCCA 69 FBan0008933 FBgn0000611 exd X X "brain development; GO:0007420; hemopoiesis; GO:0030097; leg disc proximal/distal pattern formation; GO:0007479; mesoderm development; GO:0007498; oenocyte development; GO:0007438; regulation of transcription, DNA-dependent; GO:0006355; salivary gland determination; GO:0007432" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 cytoplasm; GO:0005737; nucleus; GO:0005634 exd extradenticle "CG8933, Dpbx, td48, EXD, DExd, Exd, Dm-EXD, Pbx1: Pbx1-oncogene-like, anon-EST:fe1H3, l(1)IV, Pbx1-oncogene-like, anon-fast-evolving-1H3, extradenticle" CDMC29351 4 11 22 DAC35-P06 3-CG8971-RA_1 CG8971 AGCAGGAGATACCCGGCATACTGAAGTCACAGTCCGTGGACTTCCTACGCCTGCCCTACTGTAGTTAAT 69 FBan0008971 FBgn0030092 fh X X iron ion homeostasis; GO:0006879 mitochondrion; GO:0005739 fh frataxin-like "CG8971, CG8971, X25, dfh, DFH, BcDNA:AT09528, frataxin-like" CDMC29351 4 12 22 DAC35-P06 3-CG8971-RA_1 CG8971 AGCAGGAGATACCCGGCATACTGAAGTCACAGTCCGTGGACTTCCTACGCCTGCCCTACTGTAGTTAAT 69 FBan0008971 FBgn0030092 fh X X iron ion homeostasis; GO:0006879 mitochondrion; GO:0005739 fh frataxin-like "CG8971, CG8971, X25, dfh, DFH, BcDNA:AT09528, frataxin-like" CDMC29352 4 13 22 DAC35-P18 3-CG8983-RA_7 CG8983 AGGAAACGTGTAGCAAGTACTCCGTCAGCGGCTACCCAACGTTGAAGATTTTCCGTCAGGATGAGGTGT 69 FBan0008983 FBgn0033663 ERp60 2 2R electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 endoplasmic reticulum; GO:0005783 ERp60 ERp60 "CG8983, CG8983, CG8983, D-ERp60, Erp60, anon-EST:fe3D9, anon-fast-evolving-3D9" CDMC29352 4 14 22 DAC35-P18 3-CG8983-RA_7 CG8983 AGGAAACGTGTAGCAAGTACTCCGTCAGCGGCTACCCAACGTTGAAGATTTTCCGTCAGGATGAGGTGT 69 FBan0008983 FBgn0033663 ERp60 2 2R electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 endoplasmic reticulum; GO:0005783 ERp60 ERp60 "CG8983, CG8983, CG8983, D-ERp60, Erp60, anon-EST:fe3D9, anon-fast-evolving-3D9" CDMC29353 4 15 22 DAC36-D06 2-CG7083-RA_2 CG7083 TTGGAGCCACACATCCTGGGGTTTACGATGCAGCCAAACAATTGTTTGCTCTACACTTTCGCGGG 65 FBan0007083 FBgn0035877 CG7083 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7083 CG7083 CDMC29353 4 16 22 DAC36-D06 2-CG7083-RA_2 CG7083 TTGGAGCCACACATCCTGGGGTTTACGATGCAGCCAAACAATTGTTTGCTCTACACTTTCGCGGG 65 FBan0007083 FBgn0035877 CG7083 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7083 CG7083 CDMC29354 4 17 22 DAC36-D18 2-CG7142-RA_1 CG7142 GACACGAGCTCTATCTCGGCGGAGTGAATCCCTACGACATCGCGCTAATTTACACCAAGGAGCCC 65 FBan0007142 FBgn0038595 CG7142 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG7142 CG7142 SP132 CDMC29354 4 18 22 DAC36-D18 2-CG7142-RA_1 CG7142 GACACGAGCTCTATCTCGGCGGAGTGAATCCCTACGACATCGCGCTAATTTACACCAAGGAGCCC 65 FBan0007142 FBgn0038595 CG7142 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG7142 CG7142 SP132 CDMC29355 4 19 22 DAC36-H06 3-CG7254-RA_1 CG7254 ACGATCCCATTGTGGGCGATAAGCTCAAGGTTATCTTCCTGGAGAACTACCGTGTCACCCTGGCC 65 FBan0007254 FBgn0004507 GlyP 2 2L carbohydrate metabolism; GO:0005975; glycogen metabolism; GO:0005977 phosphorylase activity; GO:0004645 ; EC:2.4.1.1; glycogen phosphorylase activity; GO:0008184; ; GO:0008184; ; GO:0008184; ; GO:0008184; ; GO:0004645 ; EC:2.4.1.1; ; GO:0008184 GlyP Glycogen phosphorylase "CG7254, glycogen phosphorylase b, GP, DGPH, Glp1, l(2)k07918, anon-WO0257455.33, BcDNA:LD24485" CDMC29355 4 20 22 DAC36-H06 3-CG7254-RA_1 CG7254 ACGATCCCATTGTGGGCGATAAGCTCAAGGTTATCTTCCTGGAGAACTACCGTGTCACCCTGGCC 65 FBan0007254 FBgn0004507 GlyP 2 2L carbohydrate metabolism; GO:0005975; glycogen metabolism; GO:0005977 phosphorylase activity; GO:0004645 ; EC:2.4.1.1; glycogen phosphorylase activity; GO:0008184; ; GO:0008184; ; GO:0008184; ; GO:0008184; ; GO:0004645 ; EC:2.4.1.1; ; GO:0008184 GlyP Glycogen phosphorylase "CG7254, glycogen phosphorylase b, GP, DGPH, Glp1, l(2)k07918, anon-WO0257455.33, BcDNA:LD24485" CDMC29356 4 21 22 DAC36-H18 9-CG7279-RA_6 CG7279 GACTTGCCAGCGATGATTGATCACGTGCTAAAGGTGACCGGATTCCCGAAACTGCACTACGCCGG 65 FBan0007279 FBgn0023496 Lip1 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.-; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 Lip1 Lipase 1 "CG7279, CG7279, Dmlip1, lip1, Lipase 1" CDMC29356 4 22 22 DAC36-H18 9-CG7279-RA_6 CG7279 GACTTGCCAGCGATGATTGATCACGTGCTAAAGGTGACCGGATTCCCGAAACTGCACTACGCCGG 65 FBan0007279 FBgn0023496 Lip1 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.-; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 Lip1 Lipase 1 "CG7279, CG7279, Dmlip1, lip1, Lipase 1" CDMC29357 4 23 22 DAC36-L06 3-CG7391-RA_5 CG7391 ATCAGAGCAGCTCCTCCTATCCCGCTACACATATCTGCAGCCCATGATGTCGATGGGATTCGCAC 65 FBan0007391 FBgn0023076 Clk 3 3L "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of circadian sleep/wake cycle, sleep; GO:0045187; rhythmic behavior; GO:0007622; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein heterodimerization activity; GO:0046982; ; GO:0003702; transcription factor activity; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 Clk Clock "CG7391, jrk, Jrk, dClock, dclock, dCLOCK, dCLK, dClk, clk, Jerk, dClck, CLOCK, clock, dCLK/JRK, PAS1" CDMC29357 4 24 22 DAC36-L06 3-CG7391-RA_5 CG7391 ATCAGAGCAGCTCCTCCTATCCCGCTACACATATCTGCAGCCCATGATGTCGATGGGATTCGCAC 65 FBan0007391 FBgn0023076 Clk 3 3L "behavioral response to cocaine; GO:0048148; circadian rhythm; GO:0007623; eclosion rhythm; GO:0008062; locomotor rhythm; GO:0045475; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of circadian sleep/wake cycle, sleep; GO:0045187; rhythmic behavior; GO:0007622; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein heterodimerization activity; GO:0046982; ; GO:0003702; transcription factor activity; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0003700; ; GO:0004871 nucleus; GO:0005634 Clk Clock "CG7391, jrk, Jrk, dClock, dclock, dCLOCK, dCLK, dClk, clk, Jerk, dClck, CLOCK, clock, dCLK/JRK, PAS1" CDMC29358 4 25 22 DAC36-L18 1-CG7414-RA_1 CG7414 AGAAGCTGGCTAACCTCAAGTGTGCTGATACCACGGTTTTTGAGTGGCATCCCAATGGCGAGTGG 65 FBan0007414 FBgn0037135 CG7414 3 3L CG7414 CG7414 anon-WO0118547.243 CDMC29358 4 26 22 DAC36-L18 1-CG7414-RA_1 CG7414 AGAAGCTGGCTAACCTCAAGTGTGCTGATACCACGGTTTTTGAGTGGCATCCCAATGGCGAGTGG 65 FBan0007414 FBgn0037135 CG7414 3 3L CG7414 CG7414 anon-WO0118547.243 CDMC29359 4 1 23 DAC36-P06 2-CG7486-RC_2 CG7486 CAGCAGGCAGGAGATCCACTTCGCTTCTACGATCCCGCGTACCTGGAGATCTTTTTGCTGGACTG 65 FBan0007486 FBgn0020381 Dredd X X antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; apoptotic program; GO:0008632; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; proteolysis; GO:0006508; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0005515; ; GO:0030693; apoptotic protease activator activity; GO:0016505; ; GO:0016505; ; GO:0005515 cytoplasm; GO:0005737 Dredd Death related ced-3/Nedd2-like protein "CG7486, CG7486, CG7486, DCP2, Drosophila caspase, dredd, caspase, DCP-2/DREDD, dcp-2/dredd, Dcp2, Dcp-2/Dredd, EG:115C2.9, DCP-2, Dcp-2, DREDD, Dedd, Redd: Ced-3-like/Nedd2-like protein, anon-1BCa, Death caspase-2, Ced-3-like/Nedd2-like protein" CDMC29359 4 2 23 DAC36-P06 2-CG7486-RC_2 CG7486 CAGCAGGCAGGAGATCCACTTCGCTTCTACGATCCCGCGTACCTGGAGATCTTTTTGCTGGACTG 65 FBan0007486 FBgn0020381 Dredd X X antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; apoptotic program; GO:0008632; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; proteolysis; GO:0006508; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0005515; ; GO:0030693; apoptotic protease activator activity; GO:0016505; ; GO:0016505; ; GO:0005515 cytoplasm; GO:0005737 Dredd Death related ced-3/Nedd2-like protein "CG7486, CG7486, CG7486, DCP2, Drosophila caspase, dredd, caspase, DCP-2/DREDD, dcp-2/dredd, Dcp2, Dcp-2/Dredd, EG:115C2.9, DCP-2, Dcp-2, DREDD, Dedd, Redd: Ced-3-like/Nedd2-like protein, anon-1BCa, Death caspase-2, Ced-3-like/Nedd2-like protein" CDMC29360 4 3 23 DAC36-P18 2-CG7538-RA_2 CG7538 TGCCACCATTCAGAAGTTGAGCAAGGATCCGCGTATCGTAGAGCGTGTAGTAGCATCCATGGCGC 65 FBan0007538 FBgn0014861 Mcm2 3 3R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; cell proliferation; GO:0008283; chromosome condensation; GO:0030261; pre-replicative complex formation and maintenance; GO:0006267 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003682; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 nucleus; GO:0005634; pre-replicative complex; GO:0005656 Mcm2 Minichromosome maintenance 2 "CG7538, DmMCM2, PCR3, MCM2, DmMcm2, dMCM2, l(3)rL074" CDMC29360 4 4 23 DAC36-P18 2-CG7538-RA_2 CG7538 TGCCACCATTCAGAAGTTGAGCAAGGATCCGCGTATCGTAGAGCGTGTAGTAGCATCCATGGCGC 65 FBan0007538 FBgn0014861 Mcm2 3 3R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; cell proliferation; GO:0008283; chromosome condensation; GO:0030261; pre-replicative complex formation and maintenance; GO:0006267 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003682; DNA replication origin binding; GO:0003688; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003688; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 nucleus; GO:0005634; pre-replicative complex; GO:0005656 Mcm2 Minichromosome maintenance 2 "CG7538, DmMCM2, PCR3, MCM2, DmMcm2, dMCM2, l(3)rL074" CDMC29361 4 5 23 DAC37-D06 3-CG12931-RA_1 CG12931 CTGAGAGCCTTTCCTTGGGAGAAGCAGCCTACAGCAGTGCCTGGTATACTTGGGATCGAGAGACC 65 FBan0012931 FBgn0033422 Or45b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or45b Odorant receptor 45b "CG12931, CG12931, 45F.1, DOR107, 45b" CDMC29361 4 6 23 DAC37-D06 3-CG12931-RA_1 CG12931 CTGAGAGCCTTTCCTTGGGAGAAGCAGCCTACAGCAGTGCCTGGTATACTTGGGATCGAGAGACC 65 FBan0012931 FBgn0033422 Or45b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or45b Odorant receptor 45b "CG12931, CG12931, 45F.1, DOR107, 45b" CDMC29362 4 7 23 DAC37-D18 3-CG12951-RA_1 CG12951 AGTGTGCAGGACACCCTACAGGAGGTTTCCCTGAAGATTTACTCGGATGAAGAGTGCACCAGCCG 65 FBan0012951 FBgn0037677 CG12951 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12951 CG12951 SP87 CDMC29362 4 8 23 DAC37-D18 3-CG12951-RA_1 CG12951 AGTGTGCAGGACACCCTACAGGAGGTTTCCCTGAAGATTTACTCGGATGAAGAGTGCACCAGCCG 65 FBan0012951 FBgn0037677 CG12951 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12951 CG12951 SP87 CDMC29363 4 9 23 DAC37-H06 7-CG13040-RA_1 CG13040 TGAAGCATGTGGTGCCAGCTGTTCCCGTGATTAAGACTGTGGCTCCAGTGGTTCCTGTGGTCAAG 65 FBan0013040 FBgn0036608 CG13040 3 3L CG13040 CG13040 CDMC29363 4 10 23 DAC37-H06 7-CG13040-RA_1 CG13040 TGAAGCATGTGGTGCCAGCTGTTCCCGTGATTAAGACTGTGGCTCCAGTGGTTCCTGTGGTCAAG 65 FBan0013040 FBgn0036608 CG13040 3 3L CG13040 CG13040 CDMC29364 4 11 23 DAC37-H18 16-CG13047-RA_1 CG13047 GAGTTGTAGCTCCACTGGCTGCTCCTCTGGCTGCTCCCCTGGCCTACGCTAATGCTCCTCTGTAC 65 FBan0013047 FBgn0036594 CG13047 3 3L CG13047 CG13047 CDMC29364 4 12 23 DAC37-H18 16-CG13047-RA_1 CG13047 GAGTTGTAGCTCCACTGGCTGCTCCTCTGGCTGCTCCCCTGGCCTACGCTAATGCTCCTCTGTAC 65 FBan0013047 FBgn0036594 CG13047 3 3L CG13047 CG13047 CDMC29365 4 13 23 DAC37-L06 3-CG13096-RA_1 CG13096 AAGCGCAAGTTCCTCAACAGCTACGACTACCTGTTGTGCGACGGTCGTTTGTCAGGACAGGCTAC 65 FBan0013096 FBgn0032050 CG13096 2 2L CG13096 CG13096 CDMC29365 4 14 23 DAC37-L06 3-CG13096-RA_1 CG13096 AAGCGCAAGTTCCTCAACAGCTACGACTACCTGTTGTGCGACGGTCGTTTGTCAGGACAGGCTAC 65 FBan0013096 FBgn0032050 CG13096 2 2L CG13096 CG13096 CDMC29366 4 15 23 DAC37-L18 15-CG13128-RA_1 CG13128 TTGAGCACGTTACTTGGACGACCAGCAAGAAGGGATATTTCCATCACGTCGTTTTTCCGCTGCAG 65 FBan0013128 FBgn0032183 CG13128 2 2L CG13128 CG13128 CDMC29366 4 16 23 DAC37-L18 15-CG13128-RA_1 CG13128 TTGAGCACGTTACTTGGACGACCAGCAAGAAGGGATATTTCCATCACGTCGTTTTTCCGCTGCAG 65 FBan0013128 FBgn0032183 CG13128 2 2L CG13128 CG13128 CDMC29367 4 17 23 DAC37-P06 6-CG1318-RB_1 CG1318 CACCGGCCAGACTCACCCTGGATACGGATGAGAGCTATACGCTGGACATTGATACGGATGCCTCG 65 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC29367 4 18 23 DAC37-P06 6-CG1318-RB_1 CG1318 CACCGGCCAGACTCACCCTGGATACGGATGAGAGCTATACGCTGGACATTGATACGGATGCCTCG 65 FBan0001318 FBgn0041630 Hexo1 3 3L polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" Hexo1 Hexosaminidase 1 "CG1318, DmHex1, HEX 1, HEX1, Hexosaminidase 1" CDMC29368 4 19 23 DAC37-P18 3-CG13211-RB_2 CG13211 AAACATGAGTTGGTCGGGTTCCAGTGACGAGCTCGGGGTTATTGAGCAGCTGAAAAAGTCCGTGG 65 FBan0013211 FBgn0033613 CG13211 2 2R CG13211 CG13211 BcDNA:AT13707 CDMC29368 4 20 23 DAC37-P18 3-CG13211-RB_2 CG13211 AAACATGAGTTGGTCGGGTTCCAGTGACGAGCTCGGGGTTATTGAGCAGCTGAAAAAGTCCGTGG 65 FBan0013211 FBgn0033613 CG13211 2 2R CG13211 CG13211 BcDNA:AT13707 CDMC29369 4 21 23 DAC38-D06 23-CG32588-RA_2 CG32588 GGCAATGGCTGCTCAAGTATTTGATCTTTCATTAGCGTACGGATTTCATTGTAATGTTTTGTTCGCCTT 69 FBan0032588 FBgn0052588 CG32588 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32588 CG32588 "bs07c08.y1, BcDNA:AT31812, NEST:bs07c08" CDMC29369 4 22 23 DAC38-D06 23-CG32588-RA_2 CG32588 GGCAATGGCTGCTCAAGTATTTGATCTTTCATTAGCGTACGGATTTCATTGTAATGTTTTGTTCGCCTT 69 FBan0032588 FBgn0052588 CG32588 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32588 CG32588 "bs07c08.y1, BcDNA:AT31812, NEST:bs07c08" CDMC29370 4 23 23 DAC38-D18 23-CG32594-RB_4 CG32594 GCGATGAACTGAGGAGACCTACGCATATACCTAATTAGCTAGGGAGAAGCGAACTAGGAGATATAAACC 69 FBan0032594 FBgn0052594 CG32594 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32594 CG32594 "CG5530, CG15026, CG5530, E, E protein, Gene A, BEST:LD10566, anon-EST:CL1a5" CDMC29370 4 24 23 DAC38-D18 23-CG32594-RB_4 CG32594 GCGATGAACTGAGGAGACCTACGCATATACCTAATTAGCTAGGGAGAAGCGAACTAGGAGATATAAACC 69 FBan0032594 FBgn0052594 CG32594 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32594 CG32594 "CG5530, CG15026, CG5530, E, E protein, Gene A, BEST:LD10566, anon-EST:CL1a5" CDMC29371 4 25 23 DAC38-H06 11-CG32636-RA_1 CG32636 GCGCAAGCGAGAGTCCTCTAGTCGACGTGGATGTCTCGCATATTAAACGGGTCTTGACTCTACCGGTAT 69 FBan0032636 FBgn0052636 CG32636 X X CG32636 CG32636 CG15746 CDMC29371 4 26 23 DAC38-H06 11-CG32636-RA_1 CG32636 GCGCAAGCGAGAGTCCTCTAGTCGACGTGGATGTCTCGCATATTAAACGGGTCTTGACTCTACCGGTAT 69 FBan0032636 FBgn0052636 CG32636 X X CG32636 CG32636 CG15746 CDMC29372 4 1 24 DAC38-H18 2-CG32644-RB_1 CG32644 ACCCTGTGGTCCCCGAGTCTGTGGCAAAAGTGGACATTGTTATCGCAGCTTTGAGAGCATTTGTGACTT 69 FBan0032644 FBgn0052644 CG32644 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32644 CG32644 CDMC29372 4 2 24 DAC38-H18 2-CG32644-RB_1 CG32644 ACCCTGTGGTCCCCGAGTCTGTGGCAAAAGTGGACATTGTTATCGCAGCTTTGAGAGCATTTGTGACTT 69 FBan0032644 FBgn0052644 CG32644 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32644 CG32644 CDMC29373 4 3 24 DAC38-L06 23-CG3267-RA_7 CG3267 CCAAGTTTGGAGTCTTCCGCATGTAAATCCAATTTGTATGCTGGAGAAATTTAATCGGAGCGCATTTAC 69 FBan0003267 FBgn0042083 CG3267 2 2R fatty acid biosynthesis; GO:0006633; fatty acid catabolism; GO:0009062; isoleucine catabolism; GO:0006550; leucine metabolism; GO:0006551; methionine catabolism; GO:0009087; regulation of eclosion; GO:0007563; threonine catabolism; GO:0006567; valine catabolism; GO:0006574 CoA carboxylase activity; GO:0016421 ; EC:6.4.1.-; propionyl-CoA carboxylase activity; GO:0004658 ; EC:6.4.1.3; ; GO:0016421 ; EC:6.4.1.-; methylcrotonoyl-CoA carboxylase activity; GO:0004485 ; EC:6.4.1.4; ; GO:0004658 ; EC:6.4.1.3; ; GO:0004485 ; EC:6.4.1.4; biotin carboxylase activity; GO:0004075 ; EC:6.3.4.14; ; GO:0004075 ; EC:6.3.4.14 biotin carboxylase complex; GO:0009343; mitochondrial matrix; GO:0005759 CG3267 CG3267 "l(2)4524, FBgn0042083" CDMC29373 4 4 24 DAC38-L06 23-CG3267-RA_7 CG3267 CCAAGTTTGGAGTCTTCCGCATGTAAATCCAATTTGTATGCTGGAGAAATTTAATCGGAGCGCATTTAC 69 FBan0003267 FBgn0042083 CG3267 2 2R fatty acid biosynthesis; GO:0006633; fatty acid catabolism; GO:0009062; isoleucine catabolism; GO:0006550; leucine metabolism; GO:0006551; methionine catabolism; GO:0009087; regulation of eclosion; GO:0007563; threonine catabolism; GO:0006567; valine catabolism; GO:0006574 CoA carboxylase activity; GO:0016421 ; EC:6.4.1.-; propionyl-CoA carboxylase activity; GO:0004658 ; EC:6.4.1.3; ; GO:0016421 ; EC:6.4.1.-; methylcrotonoyl-CoA carboxylase activity; GO:0004485 ; EC:6.4.1.4; ; GO:0004658 ; EC:6.4.1.3; ; GO:0004485 ; EC:6.4.1.4; biotin carboxylase activity; GO:0004075 ; EC:6.3.4.14; ; GO:0004075 ; EC:6.3.4.14 biotin carboxylase complex; GO:0009343; mitochondrial matrix; GO:0005759 CG3267 CG3267 "l(2)4524, FBgn0042083" CDMC29374 4 5 24 DAC38-L18 23-CG32688-RA_1 CG32688 TTTTTGAAAGTGATTAGCAGTAAAACTAGCCTAAGTAGCAATACCATGACGACAACAATAAGCAAGCAG 69 FBan0032688 FBgn0001203 Hk X X flight behavior; GO:0007629; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 cytoplasm; GO:0005737; voltage-gated potassium channel complex; GO:0008076 Hk Hyperkinetic "CG17779, CG32688, CG2287, CG17779" CDMC29374 4 6 24 DAC38-L18 23-CG32688-RA_1 CG32688 TTTTTGAAAGTGATTAGCAGTAAAACTAGCCTAAGTAGCAATACCATGACGACAACAATAAGCAAGCAG 69 FBan0032688 FBgn0001203 Hk X X flight behavior; GO:0007629; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 cytoplasm; GO:0005737; voltage-gated potassium channel complex; GO:0008076 Hk Hyperkinetic "CG17779, CG32688, CG2287, CG17779" CDMC29375 4 7 24 DAC38-P06 23-CG32714-RA_3 CG32714 ACCAAACGATTCTCCGGATTCTTTCAATTCTTGTTCCGATTTGTATTCTTCATTCATTCCTTAAACAAA 69 FBan0032714 FBgn0052714 CG32714 X X CG32714 CG32714 "CG1521, BcDNA:RE56803" CDMC29375 4 8 24 DAC38-P06 23-CG32714-RA_3 CG32714 ACCAAACGATTCTCCGGATTCTTTCAATTCTTGTTCCGATTTGTATTCTTCATTCATTCCTTAAACAAA 69 FBan0032714 FBgn0052714 CG32714 X X CG32714 CG32714 "CG1521, BcDNA:RE56803" CDMC29376 4 9 24 DAC38-P18 8-CG32720-RA_2 CG32720 AGTAAGCCACGCAATTTTTCACCCACATGGACCAATACTAGCTTGGTGTCCTGGATAGATGGGCGTCGT 69 FBan0032720 FBgn0052720 CG32720 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32720 CG32720 NEST:bs01f06 CDMC29376 4 10 24 DAC38-P18 8-CG32720-RA_2 CG32720 AGTAAGCCACGCAATTTTTCACCCACATGGACCAATACTAGCTTGGTGTCCTGGATAGATGGGCGTCGT 69 FBan0032720 FBgn0052720 CG32720 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32720 CG32720 NEST:bs01f06 CDMC29377 4 11 24 DAC39-D06 22-CG13686-RA_1 CG13686 CTTGCAGAAGGCAATAAATTCCCTGCAATGCTCGCTCAAAAACACAAAGGTCATGTCAACTGGGAAACC 69 FBan0013686 FBgn0040106 lectin-21Cb 2 2L spermatogenesis; GO:0007283 mannose binding; GO:0005537; ; GO:0005537 lectin-21Cb lectin-21Cb "CG13686, AC 004573B, AC004573b, Lectin21Cb" CDMC29377 4 12 24 DAC39-D06 22-CG13686-RA_1 CG13686 CTTGCAGAAGGCAATAAATTCCCTGCAATGCTCGCTCAAAAACACAAAGGTCATGTCAACTGGGAAACC 69 FBan0013686 FBgn0040106 lectin-21Cb 2 2L spermatogenesis; GO:0007283 mannose binding; GO:0005537; ; GO:0005537 lectin-21Cb lectin-21Cb "CG13686, AC 004573B, AC004573b, Lectin21Cb" CDMC29378 4 13 24 DAC39-D18 3-CG13698-RB_4 CG13698 TGCTGGGCATCTTCTGCATTCTGTCGGTCATTCAACACGCGATGATCTCATCCAGGGAGAAGGTGGTTA 69 FBan0013698 FBgn0036773 CG13698 3 3L CG13698 CG13698 CDMC29378 4 14 24 DAC39-D18 3-CG13698-RB_4 CG13698 TGCTGGGCATCTTCTGCATTCTGTCGGTCATTCAACACGCGATGATCTCATCCAGGGAGAAGGTGGTTA 69 FBan0013698 FBgn0036773 CG13698 3 3L CG13698 CG13698 CDMC29379 4 15 24 DAC39-H06 12-CG13742-RA_10 CG13742 GGAACTTCCTGTCATAAGCATTCAAAACTTCCGGCACCTGTCTGTCGTCGCAAAATCAGATGGCCACGT 69 FBan0013742 FBgn0033372 CG13742 2 2R CG13742 CG13742 BcDNA:LD16446 CDMC29379 4 16 24 DAC39-H06 12-CG13742-RA_10 CG13742 GGAACTTCCTGTCATAAGCATTCAAAACTTCCGGCACCTGTCTGTCGTCGCAAAATCAGATGGCCACGT 69 FBan0013742 FBgn0033372 CG13742 2 2R CG13742 CG13742 BcDNA:LD16446 CDMC29380 4 17 24 DAC39-H18 11-CG13758-RA_1 CG13758 GCAGGCCAGCGATATAGAACAGACTCGCAAGGCAGTTAGAGCGGCTATAGTCCTACTACCACTTTTGGG 69 FBan0013758 FBgn0040378 CG13758 X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; ; GO:0008188; ; GO:0004930; ; GO:0001633; ; GO:0004948 integral to membrane; GO:0016021 CG13758 CG13758 "EG:BACR25B3.3, BACR25B3.3, anon-WO0170980.157, anon-WO0170980.158" CDMC29380 4 18 24 DAC39-H18 11-CG13758-RA_1 CG13758 GCAGGCCAGCGATATAGAACAGACTCGCAAGGCAGTTAGAGCGGCTATAGTCCTACTACCACTTTTGGG 69 FBan0013758 FBgn0040378 CG13758 X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; ; GO:0008188; ; GO:0004930; ; GO:0001633; ; GO:0004948 integral to membrane; GO:0016021 CG13758 CG13758 "EG:BACR25B3.3, BACR25B3.3, anon-WO0170980.157, anon-WO0170980.158" CDMC29381 4 19 24 DAC39-L06 14-CG13788-RE_1 CG13788 TCCATTGTCGAGGGAAGTAATCGAGCCATCAAAAAGAGCGAGAAAACTGGAGGCATAGTGCACTCCCTA 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC29381 4 20 24 DAC39-L06 14-CG13788-RE_1 CG13788 TCCATTGTCGAGGGAAGTAATCGAGCCATCAAAAAGAGCGAGAAAACTGGAGGCATAGTGCACTCCCTA 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC29382 4 21 24 DAC39-L18 3-CG1379-RA_1 CG1379 GCTCCCATCACTTCCTTCTGGTGGTCCCATCTCGAGGAGATTGATGACCTAATCGGATGCGGAAACCTG 69 FBan0001379 FBgn0031124 CG1379 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG1379 CG1379 CDMC29382 4 22 24 DAC39-L18 3-CG1379-RA_1 CG1379 GCTCCCATCACTTCCTTCTGGTGGTCCCATCTCGAGGAGATTGATGACCTAATCGGATGCGGAAACCTG 69 FBan0001379 FBgn0031124 CG1379 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG1379 CG1379 CDMC29383 4 23 24 DAC39-P06 17-CG13865-RA_4 CG13865 AGTCGACTTGCGACGACTATGGTTACGCAAAGTCCTGCTACAAATACGGCAACTACAGTTTCCTTGGAA 69 FBgn0039965 CG13865 CG13865 CG13865 "CG40301, CG40301" CDMC29383 4 24 24 DAC39-P06 17-CG13865-RA_4 CG13865 AGTCGACTTGCGACGACTATGGTTACGCAAAGTCCTGCTACAAATACGGCAACTACAGTTTCCTTGGAA 69 FBgn0039965 CG13865 CG13865 CG13865 "CG40301, CG40301" CDMC29384 4 25 24 DAC39-P18 1-CG13872-RA_1 CG13872 CCGTGGAAGCAGTGTCGAAAGGATAGCCCGACTAAAGGCAAAGGAACAGCTTTTGGAAGTGGAAGAGCA 69 FBan0013872 FBgn0034477 CG13872 2 2R CG13872 CG13872 CDMC29384 4 26 24 DAC39-P18 1-CG13872-RA_1 CG13872 CCGTGGAAGCAGTGTCGAAAGGATAGCCCGACTAAAGGCAAAGGAACAGCTTTTGGAAGTGGAAGAGCA 69 FBan0013872 FBgn0034477 CG13872 2 2R CG13872 CG13872 CDMC29385 4 1 25 DAC40-D06 3-CG14165-RA_1 CG14165 GCTGCACGCTGAATATCCCTCACCGTCTCCATCGCAGTCCAGTATCTATGTGTCCCAGGGAACTG 65 FBan0014165 FBgn0036055 CG14165 3 3L CG14165 CG14165 CDMC29385 4 2 25 DAC40-D06 3-CG14165-RA_1 CG14165 GCTGCACGCTGAATATCCCTCACCGTCTCCATCGCAGTCCAGTATCTATGTGTCCCAGGGAACTG 65 FBan0014165 FBgn0036055 CG14165 3 3L CG14165 CG14165 CDMC29386 4 3 25 DAC40-D18 6-CG14189-RA_1 CG14189 TCTGCGCCTGATTCGCCGAAACAGGACACCCAGACAACAAGGATGAGTAGCACTGACACCGAAAC 65 FBan0014189 FBgn0040885 CG14189 X X CG14189 CG14189 CDMC29386 4 4 25 DAC40-D18 6-CG14189-RA_1 CG14189 TCTGCGCCTGATTCGCCGAAACAGGACACCCAGACAACAAGGATGAGTAGCACTGACACCGAAAC 65 FBan0014189 FBgn0040885 CG14189 X X CG14189 CG14189 CDMC29387 4 5 25 DAC40-H06 7-CG14257-RA_2 CG14257 AGGAGATCCTCAGCTTGTTGCCCAACGGGAAAACTGAGTACACGGCCTCCAAGACAGTGGCTTTG 65 FBan0014257 FBgn0039479 CG14257 3 3R CG14257 CG14257 CDMC29387 4 6 25 DAC40-H06 7-CG14257-RA_2 CG14257 AGGAGATCCTCAGCTTGTTGCCCAACGGGAAAACTGAGTACACGGCCTCCAAGACAGTGGCTTTG 65 FBan0014257 FBgn0039479 CG14257 3 3R CG14257 CG14257 CDMC29388 4 7 25 DAC40-H18 3-CG14282-RA_1 CG14282 ATCAATAGCCTGGAAGAGGTGACAGCGCACTTCACCCAGCGTAGTGAGGAGATTCGAAAGAGGCG 65 FBan0014282 FBgn0038685 CG14282 3 3R CG14282 CG14282 CDMC29388 4 8 25 DAC40-H18 3-CG14282-RA_1 CG14282 ATCAATAGCCTGGAAGAGGTGACAGCGCACTTCACCCAGCGTAGTGAGGAGATTCGAAAGAGGCG 65 FBan0014282 FBgn0038685 CG14282 3 3R CG14282 CG14282 CDMC29389 4 9 25 DAC40-L06 1-CG14377-RA_1 CG14377 CTTAAGTGCTCCTGCTTACACTGCTCCTGTGACCACATATGCCGCTGGAACTGCCTATGCTGCTC 65 FBan0014377 FBgn0038148 CG14377 3 3R CG14377 CG14377 CDMC29389 4 10 25 DAC40-L06 1-CG14377-RA_1 CG14377 CTTAAGTGCTCCTGCTTACACTGCTCCTGTGACCACATATGCCGCTGGAACTGCCTATGCTGCTC 65 FBan0014377 FBgn0038148 CG14377 3 3R CG14377 CG14377 CDMC29390 4 11 25 DAC40-L18 6-CG14407-RA_1 CG14407 CCGTCAAGATGAACCGAATTTGCCAGAGTCTCCGCCATCCGAGATACCAGATTCTCGCCACCACA 65 FBan0014407 FBgn0030584 CG14407 X X CG14407 CG14407 BcDNA:RH03087 CDMC29390 4 12 25 DAC40-L18 6-CG14407-RA_1 CG14407 CCGTCAAGATGAACCGAATTTGCCAGAGTCTCCGCCATCCGAGATACCAGATTCTCGCCACCACA 65 FBan0014407 FBgn0030584 CG14407 X X CG14407 CG14407 BcDNA:RH03087 CDMC29391 4 13 25 DAC40-P06 1-CG14472-RA_1 CG14472 TGGCAGGGATGAATGGGAGCGTGCTAGTTTGCAAAATGCCAACACCAGATGTAATGGACTGCTGC 65 FBan0014472 FBgn0011230 poe 2 2L sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 calmodulin binding; GO:0005516; ; GO:0005516; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 poe purity of essence "CG14472, CG14472, CG14472, 3420, ms(2)5970, Calo, Calossin, push, calo, pushover, ms(2)01659, ms(2)27C, ms(2)3420, male sterile(2)27C, male sterile(2)3420" CDMC29391 4 14 25 DAC40-P06 1-CG14472-RA_1 CG14472 TGGCAGGGATGAATGGGAGCGTGCTAGTTTGCAAAATGCCAACACCAGATGTAATGGACTGCTGC 65 FBan0014472 FBgn0011230 poe 2 2L sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 calmodulin binding; GO:0005516; ; GO:0005516; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 poe purity of essence "CG14472, CG14472, CG14472, 3420, ms(2)5970, Calo, Calossin, push, calo, pushover, ms(2)01659, ms(2)27C, ms(2)3420, male sterile(2)27C, male sterile(2)3420" CDMC29392 4 15 25 DAC40-P18 1-CG14493-RA_1 CG14493 AATTTAATTATGTCACAGTCGAAGGAGGGTGAACCGGTGCCCGTGCCACAGCCGTATGCCCAAAG 65 FBgn0034287 CDMC29392 4 16 25 DAC40-P18 1-CG14493-RA_1 CG14493 AATTTAATTATGTCACAGTCGAAGGAGGGTGAACCGGTGCCCGTGCCACAGCCGTATGCCCAAAG 65 FBgn0034287 CDMC29393 4 17 25 DAC41-D06 AutoBlank AutoBlank CDMC29393 4 18 25 DAC41-D06 AutoBlank AutoBlank CDMC29394 4 19 25 DAC41-D18 AutoBlank AutoBlank CDMC29394 4 20 25 DAC41-D18 AutoBlank AutoBlank CDMC29395 4 21 25 DAC41-H06 AutoBlank AutoBlank CDMC29395 4 22 25 DAC41-H06 AutoBlank AutoBlank CDMC29396 4 23 25 DAC41-H18 AutoBlank AutoBlank CDMC29396 4 24 25 DAC41-H18 AutoBlank AutoBlank CDMC29397 4 25 25 DAC41-L06 AutoBlank AutoBlank CDMC29397 4 26 25 DAC41-L06 AutoBlank AutoBlank CDMC29398 4 1 26 DAC41-L18 AutoBlank AutoBlank CDMC29398 4 2 26 DAC41-L18 AutoBlank AutoBlank CDMC29399 4 3 26 DAC41-P06 AutoBlank AutoBlank CDMC29399 4 4 26 DAC41-P06 AutoBlank AutoBlank CDMC29400 4 5 26 DAC41-P18 AutoBlank AutoBlank CDMC29400 4 6 26 DAC41-P18 AutoBlank AutoBlank CDMC29401 4 7 26 DAC42-D06 150mM NaPO4 Blank CDMC29401 4 8 26 DAC42-D06 150mM NaPO4 Blank CDMC29402 4 9 26 DAC42-D18 150mM NaPO4 Blank CDMC29402 4 10 26 DAC42-D18 150mM NaPO4 Blank CDMC29403 4 11 26 DAC42-H06 150mM NaPO4 Blank CDMC29403 4 12 26 DAC42-H06 150mM NaPO4 Blank CDMC29404 4 13 26 DAC42-H18 150mM NaPO4 Blank CDMC29404 4 14 26 DAC42-H18 150mM NaPO4 Blank CDMC29405 4 15 26 DAC42-L06 150mM NaPO4 Blank CDMC29405 4 16 26 DAC42-L06 150mM NaPO4 Blank CDMC29406 4 17 26 DAC42-L18 5uM MSP 5uM MSP CDMC29406 4 18 26 DAC42-L18 5uM MSP 5uM MSP CDMC29407 4 19 26 DAC42-P06 10uM MSP 10uM MSP CDMC29407 4 20 26 DAC42-P06 10uM MSP 10uM MSP CDMC29408 4 21 26 DAC42-P18 20uM MSP 20uM MSP CDMC29408 4 22 26 DAC42-P18 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC29409 1 1 1 DAC01-A05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29409 1 2 1 DAC01-A05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29410 1 3 1 DAC01-A17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29410 1 4 1 DAC01-A17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29411 1 5 1 DAC01-E05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29411 1 6 1 DAC01-E05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29412 1 7 1 DAC01-E17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29412 1 8 1 DAC01-E17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29413 1 9 1 DAC01-I05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29413 1 10 1 DAC01-I05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29414 1 11 1 DAC01-I17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29414 1 12 1 DAC01-I17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29415 1 13 1 DAC01-M05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29415 1 14 1 DAC01-M05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29416 1 15 1 DAC01-M17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29416 1 16 1 DAC01-M17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29417 1 17 1 DAC02-A05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29417 1 18 1 DAC02-A05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29418 1 19 1 DAC02-A17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29418 1 20 1 DAC02-A17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29419 1 21 1 DAC02-E05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29419 1 22 1 DAC02-E05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29420 1 23 1 DAC02-E17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29420 1 24 1 DAC02-E17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29421 1 25 1 DAC02-I05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29421 1 26 1 DAC02-I05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29422 1 1 2 DAC02-I17 AutoBlank AutoBlank CDMC29422 1 2 2 DAC02-I17 AutoBlank AutoBlank CDMC29423 1 3 2 DAC02-M05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29423 1 4 2 DAC02-M05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29424 1 5 2 DAC02-M17 AutoBlank AutoBlank CDMC29424 1 6 2 DAC02-M17 AutoBlank AutoBlank CDMC29425 1 7 2 DAC03-A05 13-CG1707-RA_1 CG1707 CACTGGCAATTCCCTCGCGGATTTTATCAACAGGTGGTTGGTTAATTGCCTTAAAGCATCGGAATGGGC 69 FBan0001707 FBgn0033162 CG1707 2 2R carbohydrate metabolism; GO:0005975 lactoylglutathione lyase activity; GO:0004462 ; EC:4.4.1.5; ; GO:0004462 ; EC:4.4.1.5 CG1707 CG1707 CDMC29425 1 8 2 DAC03-A05 13-CG1707-RA_1 CG1707 CACTGGCAATTCCCTCGCGGATTTTATCAACAGGTGGTTGGTTAATTGCCTTAAAGCATCGGAATGGGC 69 FBan0001707 FBgn0033162 CG1707 2 2R carbohydrate metabolism; GO:0005975 lactoylglutathione lyase activity; GO:0004462 ; EC:4.4.1.5; ; GO:0004462 ; EC:4.4.1.5 CG1707 CG1707 CDMC29426 1 9 2 DAC03-A17 22-CG17090-RB_4 CG17090 ACATTAAGCAAAGTCCAAGTCCCCTAACTCATTGCCACTTCTTAGCTTATTTTTTTTCGGGGTCCCGCG 69 FBan0017090 FBgn0035142 CG17090 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG17090 CG17090 HIPK CDMC29426 1 10 2 DAC03-A17 22-CG17090-RB_4 CG17090 ACATTAAGCAAAGTCCAAGTCCCCTAACTCATTGCCACTTCTTAGCTTATTTTTTTTCGGGGTCCCGCG 69 FBan0017090 FBgn0035142 CG17090 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG17090 CG17090 HIPK CDMC29427 1 11 2 DAC03-E05 17-CG17141-RA_1 CG17141 TGCGGCAAATTCAGCAAAAACTACGAAATGTAGACTGCATAGTCGAGATTCACGATGCACGCATCCCAT 69 FBan0017141 FBgn0039020 CG17141 3 3R CG17141 CG17141 CDMC29427 1 12 2 DAC03-E05 17-CG17141-RA_1 CG17141 TGCGGCAAATTCAGCAAAAACTACGAAATGTAGACTGCATAGTCGAGATTCACGATGCACGCATCCCAT 69 FBan0017141 FBgn0039020 CG17141 3 3R CG17141 CG17141 CDMC29428 1 13 2 DAC03-E17 22-CG17150-RB_4 CG17150 CGCCAATGGACTTGGTCATGTTCCGTTTTGCTATCGAACATGTGAGCAGGTAAGTGTGAGGAATTTTGA 69 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC29428 1 14 2 DAC03-E17 22-CG17150-RB_4 CG17150 CGCCAATGGACTTGGTCATGTTCCGTTTTGCTATCGAACATGTGAGCAGGTAAGTGTGAGGAATTTTGA 69 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC29429 1 15 2 DAC03-I05 23-CG17187-RA_3 CG17187 AACTGCAAAACAAACCCATGTTCCAGTTGTTGAATAAGGAGTAAAATAAGACTAAATGGCTAGCAAAAA 69 FBan0017187 FBgn0037882 CG17187 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG17187 CG17187 BcDNA:RE47242 CDMC29429 1 16 2 DAC03-I05 23-CG17187-RA_3 CG17187 AACTGCAAAACAAACCCATGTTCCAGTTGTTGAATAAGGAGTAAAATAAGACTAAATGGCTAGCAAAAA 69 FBan0017187 FBgn0037882 CG17187 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG17187 CG17187 BcDNA:RE47242 CDMC29430 1 17 2 DAC03-I17 2-CG17199-RA_1 CG17199 TGTTCGGTGGATGAACTGGAGCTCTCCTATTGCAATGGCTGGTCAAAGGAAGTGCCCAAATTAGTGGCT 69 FBan0017199 FBgn0038775 CG17199 3 3R carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17199 CG17199 CDMC29430 1 18 2 DAC03-I17 2-CG17199-RA_1 CG17199 TGTTCGGTGGATGAACTGGAGCTCTCCTATTGCAATGGCTGGTCAAAGGAAGTGCCCAAATTAGTGGCT 69 FBan0017199 FBgn0038775 CG17199 3 3R carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17199 CG17199 CDMC29431 1 19 2 DAC03-M05 8-CG17234-RA_1 CG17234 GCGGCCCATTGTTTTTTTGATGAGGAAGGCAATCGGCTAGATGACCAAGGATATCAAGTTCGCGCAGGA 69 FBan0017234 FBgn0042187 CG17234 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG17234 CG17234 SP113 CDMC29431 1 20 2 DAC03-M05 8-CG17234-RA_1 CG17234 GCGGCCCATTGTTTTTTTGATGAGGAAGGCAATCGGCTAGATGACCAAGGATATCAAGTTCGCGCAGGA 69 FBan0017234 FBgn0042187 CG17234 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG17234 CG17234 SP113 CDMC29432 1 21 2 DAC03-M17 2-CG17252-RA_2 CG17252 ACAGCACCGGACGACGAGAGAGTATCTGCCTCAGCCCAAGACTTAAGCACTTCCCTTACACTAGCAGTT 69 FBan0017252 FBgn0026149 BCL7-like X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BCL7-like BCL7-like CG17252 CDMC29432 1 22 2 DAC03-M17 2-CG17252-RA_2 CG17252 ACAGCACCGGACGACGAGAGAGTATCTGCCTCAGCCCAAGACTTAAGCACTTCCCTTACACTAGCAGTT 69 FBan0017252 FBgn0026149 BCL7-like X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BCL7-like BCL7-like CG17252 CDMC29433 1 23 2 DAC04-A05 11-CG15865-RA_1 CG15865 CGGGGCAAGTTCTCGCGTCCACGTCAGGGATTTCCCGCTCTGCAGAACTGTGAAGAAAACAATGG 65 FBan0015865 FBgn0015336 CG15865 X X CG15865 CG15865 anon-15Ab CDMC29433 1 24 2 DAC04-A05 11-CG15865-RA_1 CG15865 CGGGGCAAGTTCTCGCGTCCACGTCAGGGATTTCCCGCTCTGCAGAACTGTGAAGAAAACAATGG 65 FBan0015865 FBgn0015336 CG15865 X X CG15865 CG15865 anon-15Ab CDMC29434 1 25 2 DAC04-A17 1-CG15881-RB_1 CG15881 CTGAGTTTGCGGTACTCAAGGGACCAGGTCTGTGCATAAACATTGGACTCCTCGACCCCACTTGC 65 FBan0015881 FBgn0036909 CG15881 3 3L CG15881 CG15881 BcDNA:HL01254 CDMC29434 1 26 2 DAC04-A17 1-CG15881-RB_1 CG15881 CTGAGTTTGCGGTACTCAAGGGACCAGGTCTGTGCATAAACATTGGACTCCTCGACCCCACTTGC 65 FBan0015881 FBgn0036909 CG15881 3 3L CG15881 CG15881 BcDNA:HL01254 CDMC29435 1 1 3 DAC04-E05 23-CG16723-RA_8 CG16723 TTCCTACTCCATGTATATTTGGCACATGTTTGTACAAGAGGTGAATAGCAGGAACGTGCGGACTA 65 FBan0016723 FBgn0039092 CG16723 3 3R CG16723 CG16723 CDMC29435 1 2 3 DAC04-E05 23-CG16723-RA_8 CG16723 TTCCTACTCCATGTATATTTGGCACATGTTTGTACAAGAGGTGAATAGCAGGAACGTGCGGACTA 65 FBan0016723 FBgn0039092 CG16723 3 3R CG16723 CG16723 CDMC29436 1 3 3 DAC04-E17 2-CG16772-RA_1 CG16772 GTCTGGATATCCCTCCTATCCGACCTTCAGATCACCGTACTCGCCCTACCAACCCCAGGTGTTCC 65 FBan0016772 FBgn0032835 CG16772 2 2L CG16772 CG16772 anon-WO0138581.5 CDMC29436 1 4 3 DAC04-E17 2-CG16772-RA_1 CG16772 GTCTGGATATCCCTCCTATCCGACCTTCAGATCACCGTACTCGCCCTACCAACCCCAGGTGTTCC 65 FBan0016772 FBgn0032835 CG16772 2 2L CG16772 CG16772 anon-WO0138581.5 CDMC29437 1 5 3 DAC04-I05 2-CG1688-RA_2 CG1688 GAAGCATCGAGTGTTGGCTTCTGGACTTCAGGATGCAACAGCCGTGAATCTCGTGACAGCATCCG 65 FBan0001688 FBgn0027589 CG1688 2 2R potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG1688 CG1688 "anon-WO0109301.12, anon-WO0109301.49, anon-WO0109301.47, anon-WO0109301.48, anon-WO0109301.50, BcDNA:GH04802" CDMC29437 1 6 3 DAC04-I05 2-CG1688-RA_2 CG1688 GAAGCATCGAGTGTTGGCTTCTGGACTTCAGGATGCAACAGCCGTGAATCTCGTGACAGCATCCG 65 FBan0001688 FBgn0027589 CG1688 2 2R potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG1688 CG1688 "anon-WO0109301.12, anon-WO0109301.49, anon-WO0109301.47, anon-WO0109301.48, anon-WO0109301.50, BcDNA:GH04802" CDMC29438 1 7 3 DAC04-I17 18-CG16931-RA_2 CG16931 CGATCGCGATTTACCCCTCTTCAATAGAGAGTGCAGACAAAGGACCGAATTATCTTGGCGCTGGA 65 FBan0016931 FBgn0004588 Eig71Ea 3 3L Eig71Ea Ecdysone-induced gene 71Ea "CG16931, gene I, I: Intensifier of Bar, Gene I, 71E-Gene-I, L71-1, L71, gene-I, I" CDMC29438 1 8 3 DAC04-I17 18-CG16931-RA_2 CG16931 CGATCGCGATTTACCCCTCTTCAATAGAGAGTGCAGACAAAGGACCGAATTATCTTGGCGCTGGA 65 FBan0016931 FBgn0004588 Eig71Ea 3 3L Eig71Ea Ecdysone-induced gene 71Ea "CG16931, gene I, I: Intensifier of Bar, Gene I, 71E-Gene-I, L71-1, L71, gene-I, I" CDMC29439 1 9 3 DAC04-M05 2-CG17104-RA_1 CG17104 GAGATCACCACTATTCTGCCACAGGACGGAGCCACGACTCCTAATGCTGAGACCGAGGAAACCAC 65 FBgn0032279 CDMC29439 1 10 3 DAC04-M05 2-CG17104-RA_1 CG17104 GAGATCACCACTATTCTGCCACAGGACGGAGCCACGACTCCTAATGCTGAGACCGAGGAAACCAC 65 FBgn0032279 CDMC29440 1 11 3 DAC04-M17 6-CG17145-RA_2 CG17145 CGTTGCGACGGTCGGACTGCTAGTTTTGTCGTTAGTGCCACCAAGGGCTGTCGCAACTATCTGAG 65 FBan0017145 FBgn0036953 CG17145 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17145 CG17145 CDMC29440 1 12 3 DAC04-M17 6-CG17145-RA_2 CG17145 CGTTGCGACGGTCGGACTGCTAGTTTTGTCGTTAGTGCCACCAAGGGCTGTCGCAACTATCTGAG 65 FBan0017145 FBgn0036953 CG17145 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG17145 CG17145 CDMC29441 1 13 3 DAC05-A05 2-CG10148-RA_1 CG10148 GCTCTGCAAGGAATTCCGGATTTGGTCAGCCTTTCCATCGCTTACAATCCAGATGTGGGAGTGGCGAT 68 FBan0010148 FBgn0038120 CG10148 3 3R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG10148 CG10148 CT28541 CDMC29441 1 14 3 DAC05-A05 2-CG10148-RA_1 CG10148 GCTCTGCAAGGAATTCCGGATTTGGTCAGCCTTTCCATCGCTTACAATCCAGATGTGGGAGTGGCGAT 68 FBan0010148 FBgn0038120 CG10148 3 3R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG10148 CG10148 CT28541 CDMC29442 1 15 3 DAC05-A17 3-CG10318-RA_1 CG10318 CCCCGATCTGCAACTACGAACTCAACAAGCCCATTGTCAAGATCGACTACAGCCACGTGCAAATGCCG 68 FBan0010318 FBgn0034650 NC2alpha 2 2R negative regulation of transcriptional preinitiation complex formation; GO:0017055 DNA binding; GO:0003677; general transcriptional repressor activity; GO:0016565; ; GO:0016565; ; GO:0003677 negative cofactor 2 complex; GO:0017054 NC2alpha NC2alpha "CG10318, CG10318, Drap1, dNC2, dDrap, dDrap1/dNC2a, NC2alpha, dDrap1" CDMC29442 1 16 3 DAC05-A17 3-CG10318-RA_1 CG10318 CCCCGATCTGCAACTACGAACTCAACAAGCCCATTGTCAAGATCGACTACAGCCACGTGCAAATGCCG 68 FBan0010318 FBgn0034650 NC2alpha 2 2R negative regulation of transcriptional preinitiation complex formation; GO:0017055 DNA binding; GO:0003677; general transcriptional repressor activity; GO:0016565; ; GO:0016565; ; GO:0003677 negative cofactor 2 complex; GO:0017054 NC2alpha NC2alpha "CG10318, CG10318, Drap1, dNC2, dDrap, dDrap1/dNC2a, NC2alpha, dDrap1" CDMC29443 1 17 3 DAC05-E05 2-CG10849-RA_1 CG10849 CGCTCCATCTTCCCCTTCGTCCTGTAGGTTGGATGTGGGTATCCCCATGACGCATTCGCTGTATTACC 68 FBan0010849 FBgn0035471 Sc2 3 3L Sc2 Sc2 "CG10849, l(3)63Eb, l(3)05634, l(3)SH4, Ubiquitin-63E, dSc2, lethal(3)63Eb" CDMC29443 1 18 3 DAC05-E05 2-CG10849-RA_1 CG10849 CGCTCCATCTTCCCCTTCGTCCTGTAGGTTGGATGTGGGTATCCCCATGACGCATTCGCTGTATTACC 68 FBan0010849 FBgn0035471 Sc2 3 3L Sc2 Sc2 "CG10849, l(3)63Eb, l(3)05634, l(3)SH4, Ubiquitin-63E, dSc2, lethal(3)63Eb" CDMC29444 1 19 3 DAC05-E17 5-CG10981-RA_1 CG10981 CGCGAATGCATCGAAACAGCCATCAGAGCTACGCACAAGTGCCCAATATGCAACAAGAAGCTGACCGC 68 FBan0010981 FBgn0037384 CG10981 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG10981 CG10981 CDMC29444 1 20 3 DAC05-E17 5-CG10981-RA_1 CG10981 CGCGAATGCATCGAAACAGCCATCAGAGCTACGCACAAGTGCCCAATATGCAACAAGAAGCTGACCGC 68 FBan0010981 FBgn0037384 CG10981 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG10981 CG10981 CDMC29445 1 21 3 DAC05-I05 1-CG11227-RB_1 CG11227 GGCGATGACTGTACTCAGCCGACGACTAGATATCACTAGGAGCTCCATCATGAAGGTCCGCGGTCTCC 68 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC29445 1 22 3 DAC05-I05 1-CG11227-RB_1 CG11227 GGCGATGACTGTACTCAGCCGACGACTAGATATCACTAGGAGCTCCATCATGAAGGTCCGCGGTCTCC 68 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC29446 1 23 3 DAC05-I17 23-CG11368-RA_2 CG11368 ATTCCCGACTCCAATTTCCCTCATAAGGCTTACTGAAATGTCACCTAGAAAATCCTTTTGTTAAGTCC 68 FBan0011368 FBgn0040923 CG11368 X X CG11368 CG11368 BcDNA:RH67809 CDMC29446 1 24 3 DAC05-I17 23-CG11368-RA_2 CG11368 ATTCCCGACTCCAATTTCCCTCATAAGGCTTACTGAAATGTCACCTAGAAAATCCTTTTGTTAAGTCC 68 FBan0011368 FBgn0040923 CG11368 X X CG11368 CG11368 BcDNA:RH67809 CDMC29447 1 25 3 DAC05-M05 3-CG11840-RA_2 CG11840 AGTAGAGCCGGGAGGACGCAACATCCGAACAACATCCCCACTCGTTCCATCGTAAATGTCTTCTGCAG 68 FBan0011840 FBgn0031260 Spp 2 2L "regulation of transcription, DNA-dependent; GO:0006355; tracheal system development (sensu Insecta); GO:0007424" signal peptide peptidase activity; GO:0042499 ; EC:3.4.23.-; ; GO:0042499 ; EC:3.4.23.-; D-alanyl-D-alanine endopeptidase activity; GO:0008717 ; EC:3.4.99.-; ; GO:0008717 ; EC:3.4.99.-; ; GO:0042499 ; EC:3.4.23.- endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 Spp Signal peptide protease "CG11840, CG11840, shanti, spp, Signal peptide protease" CDMC29447 1 26 3 DAC05-M05 3-CG11840-RA_2 CG11840 AGTAGAGCCGGGAGGACGCAACATCCGAACAACATCCCCACTCGTTCCATCGTAAATGTCTTCTGCAG 68 FBan0011840 FBgn0031260 Spp 2 2L "regulation of transcription, DNA-dependent; GO:0006355; tracheal system development (sensu Insecta); GO:0007424" signal peptide peptidase activity; GO:0042499 ; EC:3.4.23.-; ; GO:0042499 ; EC:3.4.23.-; D-alanyl-D-alanine endopeptidase activity; GO:0008717 ; EC:3.4.99.-; ; GO:0008717 ; EC:3.4.99.-; ; GO:0042499 ; EC:3.4.23.- endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 Spp Signal peptide protease "CG11840, CG11840, shanti, spp, Signal peptide protease" CDMC29448 1 1 4 DAC05-M17 2-CG12063-RA_1 CG12063 TGCAGTCTGGGACAATATGCAGAAGCGAGCGTTACACAAGCGGTAAGAACGTCAACGCCAGTGAATGG 68 FBan0012063 FBgn0039851 CG12063 3 3R CG12063 CG12063 CDMC29448 1 2 4 DAC05-M17 2-CG12063-RA_1 CG12063 TGCAGTCTGGGACAATATGCAGAAGCGAGCGTTACACAAGCGGTAAGAACGTCAACGCCAGTGAATGG 68 FBan0012063 FBgn0039851 CG12063 3 3R CG12063 CG12063 CDMC29449 1 3 4 DAC06-A05 8-CG3297-RA_4 CG3297 GCAGGCGATCAACCTGTGGTGCTCCAAATTCTTCATCTGTATGCCCAACCAGGAGAAGTTCGACTAGGA 69 FBan0003297 FBgn0002778 mnd 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; ; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 mnd minidiscs "CG3297, l(3)o52, l(3)ds-5, SG29, l(3)B5, l(3)SG29, l(3)ds5, md" CDMC29449 1 4 4 DAC06-A05 8-CG3297-RA_4 CG3297 GCAGGCGATCAACCTGTGGTGCTCCAAATTCTTCATCTGTATGCCCAACCAGGAGAAGTTCGACTAGGA 69 FBan0003297 FBgn0002778 mnd 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; ; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 mnd minidiscs "CG3297, l(3)o52, l(3)ds-5, SG29, l(3)B5, l(3)SG29, l(3)ds5, md" CDMC29450 1 5 4 DAC06-A17 11-CG3298-RB_5 CG3298 ACGCGAAACGTGAGCTCCATTCTGATCAGGACTGCAATTGATGCCTACGTGTTGTTGGATTGTGGAGAA 69 FBan0003298 FBgn0028426 JhI-1 2 2R tRNA splicing; GO:0006388 "endoribonuclease activity, producing 5'-phosphomonoesters; GO:0016891 ; EC:3.1.26.-; ; GO:0016891 ; EC:3.1.26.-" mitochondrion; GO:0005739; nucleus; GO:0005634 JhI-1 Juvenile hormone-inducible protein 1 "CG3298, CG3298, Juvenile hormone-inducible protein 1" CDMC29450 1 6 4 DAC06-A17 11-CG3298-RB_5 CG3298 ACGCGAAACGTGAGCTCCATTCTGATCAGGACTGCAATTGATGCCTACGTGTTGTTGGATTGTGGAGAA 69 FBan0003298 FBgn0028426 JhI-1 2 2R tRNA splicing; GO:0006388 "endoribonuclease activity, producing 5'-phosphomonoesters; GO:0016891 ; EC:3.1.26.-; ; GO:0016891 ; EC:3.1.26.-" mitochondrion; GO:0005739; nucleus; GO:0005634 JhI-1 Juvenile hormone-inducible protein 1 "CG3298, CG3298, Juvenile hormone-inducible protein 1" CDMC29451 1 7 4 DAC06-E05 23-CG3304-RC_14 CG3304 CCAATCGAAACAATTGTGAGCAATGTTTTCGTTCTTTTGTATAACTCCTCCCAACTCTTTACCCTTTTT 69 FBan0003304 FBgn0031527 CG3304 2 2L CG3304 CG3304 BcDNA:RE58243 CDMC29451 1 8 4 DAC06-E05 23-CG3304-RC_14 CG3304 CCAATCGAAACAATTGTGAGCAATGTTTTCGTTCTTTTGTATAACTCCTCCCAACTCTTTACCCTTTTT 69 FBan0003304 FBgn0031527 CG3304 2 2L CG3304 CG3304 BcDNA:RE58243 CDMC29452 1 9 4 DAC06-E17 24-CG33062-RA_5 CG33062 TTTATGGTGGCTGAGTCCTTAATATTTATTGAAAAAGGCGACATTCCATTTTATTTCCAAGTAAGAAAG 69 FBan0033062 FBgn0053062 CG33062 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33062 CG33062 BcDNA:SD02058 CDMC29452 1 10 4 DAC06-E17 24-CG33062-RA_5 CG33062 TTTATGGTGGCTGAGTCCTTAATATTTATTGAAAAAGGCGACATTCCATTTTATTTCCAAGTAAGAAAG 69 FBan0033062 FBgn0053062 CG33062 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33062 CG33062 BcDNA:SD02058 CDMC29453 1 11 4 DAC06-I05 12-CG33096-RB_1 CG33096 GGTTCTGGTTATCCACGGCACCGATGATGAGGTCATTGACTTTTCCCATGGCATCGGAATCTACGAGCG 69 FBan0033096 FBgn0053096 CG33096 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG33096 CG33096 CG11935 CDMC29453 1 12 4 DAC06-I05 12-CG33096-RB_1 CG33096 GGTTCTGGTTATCCACGGCACCGATGATGAGGTCATTGACTTTTCCCATGGCATCGGAATCTACGAGCG 69 FBan0033096 FBgn0053096 CG33096 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG33096 CG33096 CG11935 CDMC29454 1 13 4 DAC06-I17 13-CG33103-RA_1 CG33103 AGTGCGTTGACAATCCGTACTTCGCTAACTGCAAGCTTATCGTCAAGGGCAGATACTGTTCCAATCCGT 69 FBan0033103 FBgn0003137 Ppn 3 3R cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 metallopeptidase activity; GO:0008237; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0008237 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 Ppn Papilin "CG18436, CG33103, CG1540, CG18436, papilin, ppl, lacunin, CT3186, CT41988, lacunin-like, Papilin" CDMC29454 1 14 4 DAC06-I17 13-CG33103-RA_1 CG33103 AGTGCGTTGACAATCCGTACTTCGCTAACTGCAAGCTTATCGTCAAGGGCAGATACTGTTCCAATCCGT 69 FBan0033103 FBgn0003137 Ppn 3 3R cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 metallopeptidase activity; GO:0008237; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0008237 basement membrane; GO:0005604; extracellular matrix (sensu Metazoa); GO:0005578 Ppn Papilin "CG18436, CG33103, CG1540, CG18436, papilin, ppl, lacunin, CT3186, CT41988, lacunin-like, Papilin" CDMC29455 1 15 4 DAC06-M05 9-CG33127-RA_3 CG33127 ACTTCCGCACATTCAACACCTGACATTGAGGGATACAGAACAAGTTCACGCAGAGATCCAGCCCCTGAT 69 FBan0033127 FBgn0053127 CG33127 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33127 CG33127 CDMC29455 1 16 4 DAC06-M05 9-CG33127-RA_3 CG33127 ACTTCCGCACATTCAACACCTGACATTGAGGGATACAGAACAAGTTCACGCAGAGATCCAGCCCCTGAT 69 FBan0033127 FBgn0053127 CG33127 2 2L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG33127 CG33127 CDMC29456 1 17 4 DAC06-M17 23-CG33134-RA_4 CG33134 GGATCGCGTCGTTAAGAAATACAATCGTACCATTTAGTCAATGAGAGCTTCAAATCATTCCTGCTTCCA 69 FBan0033134 FBgn0029131 debcl 2 2R "DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; anti-apoptosis; GO:0006916; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; regulation of mitochondrial membrane permeability; GO:0046902" mitochondrial membrane; GO:0005740; mitochondrial outer membrane; GO:0005741 debcl death executioner Bcl-2 homologue "CG12397, CG33134, CG12397, CG12397, CG12397, Drob-1, Debcl, death inducing Bcl-2-like protein, dBorg-1, dborg1, BG1, BOK, dbok, drob-1, DBok, Dbok, Drob-1/Debcl/dBorg-1/DBok, Bok, Drob-1/Debcl/dBORG-1, DEBCL, dBorg1, dBORG-1/DROB-1/DEBCL/dBOK, debok, deborg, dBorg01, Debcl/dBorg-1/dRob-1, dBOK, Drob-1/Debcl/dBorg-1/dBok, Debcl/Drob-1/dBorg-1/dBok, Bok(Debcl), debcl/Borg1, borg1/debcl, death executioner Bcl-2 homologue" CDMC29456 1 18 4 DAC06-M17 23-CG33134-RA_4 CG33134 GGATCGCGTCGTTAAGAAATACAATCGTACCATTTAGTCAATGAGAGCTTCAAATCATTCCTGCTTCCA 69 FBan0033134 FBgn0029131 debcl 2 2R "DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; anti-apoptosis; GO:0006916; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; regulation of mitochondrial membrane permeability; GO:0046902" mitochondrial membrane; GO:0005740; mitochondrial outer membrane; GO:0005741 debcl death executioner Bcl-2 homologue "CG12397, CG33134, CG12397, CG12397, CG12397, Drob-1, Debcl, death inducing Bcl-2-like protein, dBorg-1, dborg1, BG1, BOK, dbok, drob-1, DBok, Dbok, Drob-1/Debcl/dBorg-1/DBok, Bok, Drob-1/Debcl/dBORG-1, DEBCL, dBorg1, dBORG-1/DROB-1/DEBCL/dBOK, debok, deborg, dBorg01, Debcl/dBorg-1/dRob-1, dBOK, Drob-1/Debcl/dBorg-1/dBok, Debcl/Drob-1/dBorg-1/dBok, Bok(Debcl), debcl/Borg1, borg1/debcl, death executioner Bcl-2 homologue" CDMC29457 1 19 4 DAC07-A05 1-CG5780-RA_1 CG5780 GGCACCTCACGATCTGCTGTTTTGAAGGAGGCCAATTCCGATTTGCTTTCCCAGTACGCCTTTTCAGCT 69 FBan0005780 FBgn0032446 CG5780 2 2L CG5780 CG5780 CDMC29457 1 20 4 DAC07-A05 1-CG5780-RA_1 CG5780 GGCACCTCACGATCTGCTGTTTTGAAGGAGGCCAATTCCGATTTGCTTTCCCAGTACGCCTTTTCAGCT 69 FBan0005780 FBgn0032446 CG5780 2 2L CG5780 CG5780 CDMC29458 1 21 4 DAC07-A17 3-CG5790-RA_5 CG5790 CGGATTGGCTCAAAGGATAGCCGATGATGGTAGTGTAGTGCAGTCGAGTGATCTCAGCTCCCGGGAAGT 69 FBan0005790 FBgn0032677 CG5790 2 2L protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG5790 CG5790 CDC 7-related CDMC29458 1 22 4 DAC07-A17 3-CG5790-RA_5 CG5790 CGGATTGGCTCAAAGGATAGCCGATGATGGTAGTGTAGTGCAGTCGAGTGATCTCAGCTCCCGGGAAGT 69 FBan0005790 FBgn0032677 CG5790 2 2L protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG5790 CG5790 CDC 7-related CDMC29459 1 23 4 DAC07-E05 23-CG5815-RB_2 CG5815 TTACGATGCAATAAGATGAAATGCAGAGTAGATTGACGGAAAGGAGAACAGGAAAACCAGAGAAGTGCA 69 FBan0005815 FBgn0027574 CG5815 3 3R CG5815 CG5815 "BcDNA:GH07089, BcDNA:GH07346" CDMC29459 1 24 4 DAC07-E05 23-CG5815-RB_2 CG5815 TTACGATGCAATAAGATGAAATGCAGAGTAGATTGACGGAAAGGAGAACAGGAAAACCAGAGAAGTGCA 69 FBan0005815 FBgn0027574 CG5815 3 3R CG5815 CG5815 "BcDNA:GH07089, BcDNA:GH07346" CDMC29460 1 25 4 DAC07-E17 3-CG5836-RA_3 CG5836 AGGGCCATAATGATCTCCGCAGAATGCAGTTGCGAGAACTGGCTCAGCTGAATGGAACACTTCGAGAGA 69 FBan0005836 FBgn0025571 SF1 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" transcription cofactor activity; GO:0003712; ; GO:0003712 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF1 Splicing factor 1 "CG5836, CG5836, p70, dSF1, cg5836, Splicing factor 1" CDMC29460 1 26 4 DAC07-E17 3-CG5836-RA_3 CG5836 AGGGCCATAATGATCTCCGCAGAATGCAGTTGCGAGAACTGGCTCAGCTGAATGGAACACTTCGAGAGA 69 FBan0005836 FBgn0025571 SF1 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" transcription cofactor activity; GO:0003712; ; GO:0003712 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF1 Splicing factor 1 "CG5836, CG5836, p70, dSF1, cg5836, Splicing factor 1" CDMC29461 1 1 5 DAC07-I05 3-CG5867-RA_1 CG5867 TGATGGCCGGCTTATGTTTGGCAGCGGAAATAGAATTGCCACCAGTTGAGTTCAAGCCGGTTCGAGAAA 69 FBan0005867 FBgn0027586 CG5867 2 2L CG5867 CG5867 "CT18390, BcDNA:GH05536" CDMC29461 1 2 5 DAC07-I05 3-CG5867-RA_1 CG5867 TGATGGCCGGCTTATGTTTGGCAGCGGAAATAGAATTGCCACCAGTTGAGTTCAAGCCGGTTCGAGAAA 69 FBan0005867 FBgn0027586 CG5867 2 2L CG5867 CG5867 "CT18390, BcDNA:GH05536" CDMC29462 1 3 5 DAC07-I17 23-CG5876-RA_19 CG5876 AGTCGCCCGTTTGATTCTAAACTTTTGAACTGAACATATCCTAGCCCTAATGGGTCGATTAACTTGAGA 69 FBan0005876 FBgn0028375 heix 2 2L coenzyme metabolism; GO:0006732; lipid metabolism; GO:0006629; menaquinone biosynthesis; GO:0009234; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- integral to membrane; GO:0016021 heix heixuedian "CG5876, l(2)35Fc, 124/1, BG:DS02740.7, ipa-6d, l(2)k12401, lethal(2)35Fc, heixuedian" CDMC29462 1 4 5 DAC07-I17 23-CG5876-RA_19 CG5876 AGTCGCCCGTTTGATTCTAAACTTTTGAACTGAACATATCCTAGCCCTAATGGGTCGATTAACTTGAGA 69 FBan0005876 FBgn0028375 heix 2 2L coenzyme metabolism; GO:0006732; lipid metabolism; GO:0006629; menaquinone biosynthesis; GO:0009234; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- integral to membrane; GO:0016021 heix heixuedian "CG5876, l(2)35Fc, 124/1, BG:DS02740.7, ipa-6d, l(2)k12401, lethal(2)35Fc, heixuedian" CDMC29463 1 5 5 DAC07-M05 3-CG5919-RA_2 CG5919 GGGCGAGCACGAGATAGACTACATCCTGTTCCTGCAAAAAGACGTGACGCTGCGTCCAAATAGCAACGA 69 FBan0005919 FBgn0038876 CG5919 3 3R isoprenoid biosynthesis; GO:0008299 isopentenyl-diphosphate delta-isomerase activity; GO:0004452 ; EC:5.3.3.2; ; GO:0004452 ; EC:5.3.3.2 CG5919 CG5919 CDMC29463 1 6 5 DAC07-M05 3-CG5919-RA_2 CG5919 GGGCGAGCACGAGATAGACTACATCCTGTTCCTGCAAAAAGACGTGACGCTGCGTCCAAATAGCAACGA 69 FBan0005919 FBgn0038876 CG5919 3 3R isoprenoid biosynthesis; GO:0008299 isopentenyl-diphosphate delta-isomerase activity; GO:0004452 ; EC:5.3.3.2; ; GO:0004452 ; EC:5.3.3.2 CG5919 CG5919 CDMC29464 1 7 5 DAC07-M17 12-CG5927-RA_1 CG5927 AGCGCCTACATCCGGAGTATATCAGAGCCCAATTGATTGCTATTGGAGTGGCTTTCGAGAATGCGTCCT 69 FBan0005927 FBgn0030899 Her X X negative regulation of transcription from RNA polymerase II promoter; GO:0000122 transcriptional repressor activity; GO:0016564; ; GO:0016564 nucleus; GO:0005634 Her HES-related "CG5927, CG5927, CG5927, HES-related" CDMC29464 1 8 5 DAC07-M17 12-CG5927-RA_1 CG5927 AGCGCCTACATCCGGAGTATATCAGAGCCCAATTGATTGCTATTGGAGTGGCTTTCGAGAATGCGTCCT 69 FBan0005927 FBgn0030899 Her X X negative regulation of transcription from RNA polymerase II promoter; GO:0000122 transcriptional repressor activity; GO:0016564; ; GO:0016564 nucleus; GO:0005634 Her HES-related "CG5927, CG5927, CG5927, HES-related" CDMC29465 1 9 5 DAC08-A05 23-CG8219-RA_4 CG8219 CTAATCGAACTGTACGACATCGAATACTAATCCGAAGCTATCCAGCCAATTATGTATTGCTTCAATCAT 69 FBan0008219 FBgn0035693 CG8219 3 3L "protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear pore; GO:0005643 CG8219 CG8219 EP(3)3072 CDMC29465 1 10 5 DAC08-A05 23-CG8219-RA_4 CG8219 CTAATCGAACTGTACGACATCGAATACTAATCCGAAGCTATCCAGCCAATTATGTATTGCTTCAATCAT 69 FBan0008219 FBgn0035693 CG8219 3 3L "protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" protein carrier activity; GO:0008320; ; GO:0008320 cytoplasm; GO:0005737; nuclear pore; GO:0005643 CG8219 CG8219 EP(3)3072 CDMC29466 1 11 5 DAC08-A17 9-CG8228-RA_2 CG8228 GCCCCAATGTGCCGAAAGACTTCAAGGAGCTGGTCTTATCCGGTGATCAGGATGACTTCTATGGCAACA 69 FBan0008228 FBgn0037711 CG8228 3 3R "electron transport; GO:0006118; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; lysosome organization and biogenesis; GO:0007040; protein targeting; GO:0006605; regulation of transcription, DNA-dependent; GO:0006355; vesicle docking during exocytosis; GO:0006904" transcription factor activity; GO:0003700; ; GO:0003700 intracellular; GO:0005622 CG8228 CG8228 CDMC29466 1 12 5 DAC08-A17 9-CG8228-RA_2 CG8228 GCCCCAATGTGCCGAAAGACTTCAAGGAGCTGGTCTTATCCGGTGATCAGGATGACTTCTATGGCAACA 69 FBan0008228 FBgn0037711 CG8228 3 3R "electron transport; GO:0006118; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; lysosome organization and biogenesis; GO:0007040; protein targeting; GO:0006605; regulation of transcription, DNA-dependent; GO:0006355; vesicle docking during exocytosis; GO:0006904" transcription factor activity; GO:0003700; ; GO:0003700 intracellular; GO:0005622 CG8228 CG8228 CDMC29467 1 13 5 DAC08-E05 23-CG8269-RA_1 CG8269 TTGATTGTTGTAAAAAAGGATTTTTGAAGGTTTATAATTATTTCGTTGCCAAAGGATTCCAAACACCGC 69 FBan0008269 FBgn0021825 Dmn 2 2R microtubule-based movement; GO:0007018; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 dynactin complex; GO:0005869 Dmn Dynamitin "CG8269, CG8269, l(2)k16109, l(2)k16218, dynamitin, p50/Dmn, p50-dynamitin, Dynactin, dmn, p50 dynamitin, p50/dynamitin, P50, Dynamitin" CDMC29467 1 14 5 DAC08-E05 23-CG8269-RA_1 CG8269 TTGATTGTTGTAAAAAAGGATTTTTGAAGGTTTATAATTATTTCGTTGCCAAAGGATTCCAAACACCGC 69 FBan0008269 FBgn0021825 Dmn 2 2R microtubule-based movement; GO:0007018; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 dynactin complex; GO:0005869 Dmn Dynamitin "CG8269, CG8269, l(2)k16109, l(2)k16218, dynamitin, p50/Dmn, p50-dynamitin, Dynactin, dmn, p50 dynamitin, p50/dynamitin, P50, Dynamitin" CDMC29468 1 15 5 DAC08-E17 1-CG8282-RA_1 CG8282 CCCGCACATTGTTTACACACCCCATTGAAACGCAAGCCTCATCGATTACACACATCCGGGAGACGAAGT 69 FBan0008282 FBgn0032005 Snx6 2 2L intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 Snx6 Snx6 "CG8282, Dsnx6" CDMC29468 1 16 5 DAC08-E17 1-CG8282-RA_1 CG8282 CCCGCACATTGTTTACACACCCCATTGAAACGCAAGCCTCATCGATTACACACATCCGGGAGACGAAGT 69 FBan0008282 FBgn0032005 Snx6 2 2L intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 Snx6 Snx6 "CG8282, Dsnx6" CDMC29469 1 17 5 DAC08-I05 8-CG8316-RA_1 CG8316 ACCGATTGGCTTTCTCCTTCAGAAGAGGCAGGTGTCCCAAATGCGGAATTAGAAGAGGACAGTGACGAA 69 FBan0008316 FBgn0030852 CG8316 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8316 CG8316 CDMC29469 1 18 5 DAC08-I05 8-CG8316-RA_1 CG8316 ACCGATTGGCTTTCTCCTTCAGAAGAGGCAGGTGTCCCAAATGCGGAATTAGAAGAGGACAGTGACGAA 69 FBan0008316 FBgn0030852 CG8316 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8316 CG8316 CDMC29470 1 19 5 DAC08-I17 12-CG8323-RA_1 CG8323 CGCGGTCTTCTTTATCGCGGTTGGCTTGACTGCTTTGTGAAAATCCTACGATCAGAGGGCGTTTATGGT 69 FBan0008323 FBgn0033903 CG8323 2 2R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8323 CG8323 CDMC29470 1 20 5 DAC08-I17 12-CG8323-RA_1 CG8323 CGCGGTCTTCTTTATCGCGGTTGGCTTGACTGCTTTGTGAAAATCCTACGATCAGAGGGCGTTTATGGT 69 FBan0008323 FBgn0033903 CG8323 2 2R transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG8323 CG8323 CDMC29471 1 21 5 DAC08-M05 2-CG8366-RA_2 CG8366 CGGAGCACTACACTACGTTTGGGTACAAGCGGATCCGGAATTCGTTAGCAGTTTGCTGAGCATGGCTGA 69 FBan0008366 FBgn0034054 CG8366 2 2R CG8366 CG8366 CDMC29471 1 22 5 DAC08-M05 2-CG8366-RA_2 CG8366 CGGAGCACTACACTACGTTTGGGTACAAGCGGATCCGGAATTCGTTAGCAGTTTGCTGAGCATGGCTGA 69 FBan0008366 FBgn0034054 CG8366 2 2R CG8366 CG8366 CDMC29472 1 23 5 DAC08-M17 11-CG8376-RA_1 CG8376 GGGAGCGTGTCACTTCCTTTCGGTATGAACATAGGTGAGGAAAAGTTTGAGGCCAATCTTACGGCGCAC 69 FBan0008376 FBgn0000099 ap 2 2R "axon guidance; GO:0007411; cell fate commitment; GO:0045165; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; haltere disc morphogenesis; GO:0007481; histolysis; GO:0007559; leg disc development; GO:0035218; leg disc proximal/distal pattern formation; GO:0007479; leg segmentation; GO:0035286; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350; wing disc dorsal/ventral pattern formation; GO:0048190; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; zinc ion binding; GO:0008270; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0008270; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleoplasm; GO:0005654; nucleus; GO:0005634 ap apterous "CG8376, Xasta, Xa: Xasta, blt, LIM, trw: tornwing, no-wings, tornwing, Xa" CDMC29472 1 24 5 DAC08-M17 11-CG8376-RA_1 CG8376 GGGAGCGTGTCACTTCCTTTCGGTATGAACATAGGTGAGGAAAAGTTTGAGGCCAATCTTACGGCGCAC 69 FBan0008376 FBgn0000099 ap 2 2R "axon guidance; GO:0007411; cell fate commitment; GO:0045165; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; haltere disc morphogenesis; GO:0007481; histolysis; GO:0007559; leg disc development; GO:0035218; leg disc proximal/distal pattern formation; GO:0007479; leg segmentation; GO:0035286; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350; wing disc dorsal/ventral pattern formation; GO:0048190; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; zinc ion binding; GO:0008270; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0008270; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleoplasm; GO:0005654; nucleus; GO:0005634 ap apterous "CG8376, Xasta, Xa: Xasta, blt, LIM, trw: tornwing, no-wings, tornwing, Xa" CDMC29473 1 25 5 DAC09-A06 16-CG12806-RA_1 CG12806 GGGTGATGGCCAAAAAGAAGTGAAGATACGACGAGCGAAACTATCAGTGGTTTTAGTGCACCTAGCCGA 69 FBan0012806 FBgn0037766 CG12806 3 3R sodium channel auxiliary protein activity; GO:0016974; ; GO:0016974 CG12806 CG12806 CDMC29473 1 26 5 DAC09-A06 16-CG12806-RA_1 CG12806 GGGTGATGGCCAAAAAGAAGTGAAGATACGACGAGCGAAACTATCAGTGGTTTTAGTGCACCTAGCCGA 69 FBan0012806 FBgn0037766 CG12806 3 3R sodium channel auxiliary protein activity; GO:0016974; ; GO:0016974 CG12806 CG12806 CDMC29474 1 1 6 DAC09-A18 2-CG12816-RA_1 CG12816 CAGGAGGTCCTGTGCGAGTTCGTCACTGCTGTGCTCATCGTGGAGAGTGGTGAGTTTTGGACTATTGAT 69 FBan0012816 FBgn0037799 CG12816 3 3R CG12816 CG12816 CDMC29474 1 2 6 DAC09-A18 2-CG12816-RA_1 CG12816 CAGGAGGTCCTGTGCGAGTTCGTCACTGCTGTGCTCATCGTGGAGAGTGGTGAGTTTTGGACTATTGAT 69 FBan0012816 FBgn0037799 CG12816 3 3R CG12816 CG12816 CDMC29475 1 3 6 DAC09-E06 23-CG12853-RA_2 CG12853 CCAACTAGTTTGGTGGAACTAACTTAAAAAGAGGAATTCAATGTTTCCGTAGAACAATAAACCAATGGT 69 FBan0012853 FBgn0040747 CG12853 2 2R CG12853 CG12853 "bs26d12.y1, NEST:bs26d12" CDMC29475 1 4 6 DAC09-E06 23-CG12853-RA_2 CG12853 CCAACTAGTTTGGTGGAACTAACTTAAAAAGAGGAATTCAATGTTTCCGTAGAACAATAAACCAATGGT 69 FBan0012853 FBgn0040747 CG12853 2 2R CG12853 CG12853 "bs26d12.y1, NEST:bs26d12" CDMC29476 1 5 6 DAC09-E18 2-CG12862-RA_1 CG12862 CCAGGTGTTCGAGTACAAGGACTTCCTGAGCTACCTGGGCATACTGCAAACTCTGCCTTTGGACACCTT 69 FBan0012862 FBgn0033950 CG12862 2 2R CG12862 CG12862 CDMC29476 1 6 6 DAC09-E18 2-CG12862-RA_1 CG12862 CCAGGTGTTCGAGTACAAGGACTTCCTGAGCTACCTGGGCATACTGCAAACTCTGCCTTTGGACACCTT 69 FBan0012862 FBgn0033950 CG12862 2 2R CG12862 CG12862 CDMC29477 1 7 6 DAC09-I06 9-CG12902-RA_1 CG12902 TGCAGCGTTAGCCAGGGAAGACAAAATGCCATTCGATAAGTTTGTCCGCCGATGAATGGAATGGAGAGG 69 FBan0012902 FBgn0033512 CG12902 2 2R CG12902 CG12902 BcDNA:AT11401 CDMC29477 1 8 6 DAC09-I06 9-CG12902-RA_1 CG12902 TGCAGCGTTAGCCAGGGAAGACAAAATGCCATTCGATAAGTTTGTCCGCCGATGAATGGAATGGAGAGG 69 FBan0012902 FBgn0033512 CG12902 2 2R CG12902 CG12902 BcDNA:AT11401 CDMC29478 1 9 6 DAC09-I18 10-CG12914-RA_1 CG12914 TCGCAGATCGCTACTACCTCAGTCTCGTGCAATTTGTCGTCAGCTTCCTATCCATCCAGCTCTACGGAT 69 FBan0012914 FBgn0033499 CG12914 2 2R CG12914 CG12914 CDMC29478 1 10 6 DAC09-I18 10-CG12914-RA_1 CG12914 TCGCAGATCGCTACTACCTCAGTCTCGTGCAATTTGTCGTCAGCTTCCTATCCATCCAGCTCTACGGAT 69 FBan0012914 FBgn0033499 CG12914 2 2R CG12914 CG12914 CDMC29479 1 11 6 DAC09-M06 2-CG1295-RA_1 CG1295 AGAGTGAAGCCTCTGTACGATCGCTACCAACGCGACATCGAACTACATCTGTGGGAGCCCATCAATCGA 69 FBan0001295 FBgn0035509 CG1295 3 3L CG1295 CG1295 CDMC29479 1 12 6 DAC09-M06 2-CG1295-RA_1 CG1295 AGAGTGAAGCCTCTGTACGATCGCTACCAACGCGACATCGAACTACATCTGTGGGAGCCCATCAATCGA 69 FBan0001295 FBgn0035509 CG1295 3 3L CG1295 CG1295 CDMC29480 1 13 6 DAC09-M18 9-CG12977-RA_4 CG12977 GGCTGTGGAGCCAATTGTTAGGGAACAAATTAGGGACATCAAACCTTTACCGGGATTCCTGCAGGCCTT 69 FBan0012977 FBgn0037052 CG12977 3 3L CG12977 CG12977 CDMC29480 1 14 6 DAC09-M18 9-CG12977-RA_4 CG12977 GGCTGTGGAGCCAATTGTTAGGGAACAAATTAGGGACATCAAACCTTTACCGGGATTCCTGCAGGCCTT 69 FBan0012977 FBgn0037052 CG12977 3 3L CG12977 CG12977 CDMC29481 1 15 6 DAC10-A05 1-CG10928-RA_1 CG10928 CCTTCCGCCGTAACCTACTTTTCTCTGCACGCACTCAACCGACGGGGCAATCACTTATGGAAATTGCTT 69 FBan0010928 FBgn0040522 CG10928 3 3R CG10928 CG10928 CDMC29481 1 16 6 DAC10-A05 1-CG10928-RA_1 CG10928 CCTTCCGCCGTAACCTACTTTTCTCTGCACGCACTCAACCGACGGGGCAATCACTTATGGAAATTGCTT 69 FBan0010928 FBgn0040522 CG10928 3 3R CG10928 CG10928 CDMC29482 1 17 6 DAC10-A17 23-CG10944-RA_2 CG10944 GCGCGGTGATCAAACAAATTGCAAGCGAAAATGTCCAGTGATTGCGTTAAAATAAGTGGATGATATTAT 69 FBan0010944 FBgn0004922 RpS6 X X immune response; GO:0006955; protein biosynthesis; GO:0006412; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS6 Ribosomal protein S6 "CG10944, CG10944, CG10944, CG10944, l(1)air8: lethal-aberrant-immune-response-8, S6, hen: hemocytes enlarged, rpS6, air8, l(1)air[8], air[8], pp30, ribosomal protein S6, rps6, DS6, lethal(1)abberant immune response[8], anon-WO02059370.61, l(1)hen: lethal-(1)-haemocytes enlarged, hemocytes enlarged, lethal-aberrant-immune-response-8, lethal-(1)-haemocytes enlarged, l(1)air8, hen" CDMC29482 1 18 6 DAC10-A17 23-CG10944-RA_2 CG10944 GCGCGGTGATCAAACAAATTGCAAGCGAAAATGTCCAGTGATTGCGTTAAAATAAGTGGATGATATTAT 69 FBan0010944 FBgn0004922 RpS6 X X immune response; GO:0006955; protein biosynthesis; GO:0006412; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS6 Ribosomal protein S6 "CG10944, CG10944, CG10944, CG10944, l(1)air8: lethal-aberrant-immune-response-8, S6, hen: hemocytes enlarged, rpS6, air8, l(1)air[8], air[8], pp30, ribosomal protein S6, rps6, DS6, lethal(1)abberant immune response[8], anon-WO02059370.61, l(1)hen: lethal-(1)-haemocytes enlarged, hemocytes enlarged, lethal-aberrant-immune-response-8, lethal-(1)-haemocytes enlarged, l(1)air8, hen" CDMC29483 1 19 6 DAC10-E05 22-CG10978-RA_2 CG10978 GCAGCTGTTAAGGTATCGCACACTTAGTCATACAGGAAGGGAAACATATGGTCGAAACTGAGCGAAGCG 69 FBan0010978 FBgn0037374 jagn 3 3R "cytoplasmic transport, nurse cell to oocyte; GO:0007303; microtubule-based movement; GO:0007018; oogenesis (sensu Insecta); GO:0009993" jagn jagunal "CG10978, jagunal" CDMC29483 1 20 6 DAC10-E05 22-CG10978-RA_2 CG10978 GCAGCTGTTAAGGTATCGCACACTTAGTCATACAGGAAGGGAAACATATGGTCGAAACTGAGCGAAGCG 69 FBan0010978 FBgn0037374 jagn 3 3R "cytoplasmic transport, nurse cell to oocyte; GO:0007303; microtubule-based movement; GO:0007018; oogenesis (sensu Insecta); GO:0009993" jagn jagunal "CG10978, jagunal" CDMC29484 1 21 6 DAC10-E17 3-CG10990-RA_2 CG10990 GCGCGAGATGACCTCGGTGCTGATCTCCGATCTCTACGGACGCGTTATTACCGGCAAGGATATTGAGAA 69 FBan0010990 FBgn0030520 CG10990 X X apoptosis; GO:0006915; induction of apoptosis; GO:0006917; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0008135" CG10990 CG10990 CDMC29484 1 22 6 DAC10-E17 3-CG10990-RA_2 CG10990 GCGCGAGATGACCTCGGTGCTGATCTCCGATCTCTACGGACGCGTTATTACCGGCAAGGATATTGAGAA 69 FBan0010990 FBgn0030520 CG10990 X X apoptosis; GO:0006915; induction of apoptosis; GO:0006917; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0008135" CG10990 CG10990 CDMC29485 1 23 6 DAC10-I05 2-CG1103-RA_2 CG1103 ACCTTTGTTCGGACAGAAAATGACGACACTAGCTTCTGGCTCTGGCTACTTACTACCTTGGGCACCGGT 69 FBan0001103 FBgn0037235 CG1103 3 3R CG1103 CG1103 anon-WO0118547.152 CDMC29485 1 24 6 DAC10-I05 2-CG1103-RA_2 CG1103 ACCTTTGTTCGGACAGAAAATGACGACACTAGCTTCTGGCTCTGGCTACTTACTACCTTGGGCACCGGT 69 FBan0001103 FBgn0037235 CG1103 3 3R CG1103 CG1103 anon-WO0118547.152 CDMC29486 1 25 6 DAC10-I17 2-CG1104-RA_2 CG1104 GCGTCCGGAAAATTCGTTTCTGCCATACTGCAGCATATTCGCGGCTCACTAAACGAGGACCAGAATGCT 69 FBan0001104 FBgn0037467 CG1104 3 3R CG1104 CG1104 CDMC29486 1 26 6 DAC10-I17 2-CG1104-RA_2 CG1104 GCGTCCGGAAAATTCGTTTCTGCCATACTGCAGCATATTCGCGGCTCACTAAACGAGGACCAGAATGCT 69 FBan0001104 FBgn0037467 CG1104 3 3R CG1104 CG1104 CDMC29487 1 1 7 DAC10-M05 23-CG11084-RA_8 CG11084 CTGCCTCTCCACAAAGCAAAATAAAGTTCAACTTGACATTAAGGCGCCTAGTTAAGGTACACTCACAAA 69 FBan0011084 FBgn0003090 pk 2 2R establishment and/or maintenance of cell polarity; GO:0007163; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of protein localization; GO:0045184; establishment of wing hair orientation; GO:0001737; gametogenesis; GO:0007276; maintenance of protein localization; GO:0045185; protein localization; GO:0008104 nucleic acid binding; GO:0003676; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0005200; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 pk prickle "CG12830, CG11084, CG12830, sple, pk-sple, prickle-spiny-legs, prickle-spiny legs, Pk, Pk-Sple, spiny legs" CDMC29487 1 2 7 DAC10-M05 23-CG11084-RA_8 CG11084 CTGCCTCTCCACAAAGCAAAATAAAGTTCAACTTGACATTAAGGCGCCTAGTTAAGGTACACTCACAAA 69 FBan0011084 FBgn0003090 pk 2 2R establishment and/or maintenance of cell polarity; GO:0007163; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of protein localization; GO:0045184; establishment of wing hair orientation; GO:0001737; gametogenesis; GO:0007276; maintenance of protein localization; GO:0045185; protein localization; GO:0008104 nucleic acid binding; GO:0003676; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0005200; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270 cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 pk prickle "CG12830, CG11084, CG12830, sple, pk-sple, prickle-spiny-legs, prickle-spiny legs, Pk, Pk-Sple, spiny legs" CDMC29488 1 3 7 DAC10-M17 2-CG11094-RB_1 CG11094 TGTGACAGCCGTTCTACGCGTCAGCTTTCTTCAATCAACATTACCCCGTGCTGAGATGTCTGGCCTCAA 69 FBan0011094 FBgn0000504 dsx 3 3R "behavior; GO:0007610; central nervous system development; GO:0007417; courtship behavior; GO:0007619; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; female sex differentiation; GO:0046660; female somatic sex determination; GO:0019101; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; male analia morphogenesis (sensu Endopterygota); GO:0045496; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), song production; GO:0045433; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; male sex differentiation; GO:0046661; male somatic sex determination; GO:0019102; negative regulation of pigmentation; GO:0048086; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nuclear mRNA splicing, via spliceosome; GO:0000398; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of imaginal disc growth; GO:0045570; regulation of transcription; GO:0045449; sex comb development; GO:0045498; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; somatic sex determination; GO:0018993; spermatogenesis; GO:0007283; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; zinc ion binding; GO:0008270; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003704; ; GO:0003702; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0008270 nucleus; GO:0005634 dsx doublesex "CG11094, Dmdsx, Dsx, Hr: Hermaphrodite, ix-62c: intersex-62c, Hermaphrodite, intersex-62c" CDMC29488 1 4 7 DAC10-M17 2-CG11094-RB_1 CG11094 TGTGACAGCCGTTCTACGCGTCAGCTTTCTTCAATCAACATTACCCCGTGCTGAGATGTCTGGCCTCAA 69 FBan0011094 FBgn0000504 dsx 3 3R "behavior; GO:0007610; central nervous system development; GO:0007417; courtship behavior; GO:0007619; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; female sex differentiation; GO:0046660; female somatic sex determination; GO:0019101; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; male analia morphogenesis (sensu Endopterygota); GO:0045496; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), song production; GO:0045433; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; male sex differentiation; GO:0046661; male somatic sex determination; GO:0019102; negative regulation of pigmentation; GO:0048086; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nuclear mRNA splicing, via spliceosome; GO:0000398; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of imaginal disc growth; GO:0045570; regulation of transcription; GO:0045449; sex comb development; GO:0045498; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; somatic sex determination; GO:0018993; spermatogenesis; GO:0007283; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; zinc ion binding; GO:0008270; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003704; ; GO:0003702; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0008270 nucleus; GO:0005634 dsx doublesex "CG11094, Dmdsx, Dsx, Hr: Hermaphrodite, ix-62c: intersex-62c, Hermaphrodite, intersex-62c" CDMC29489 1 5 7 DAC11-A05 12-CG12164-RA_5 CG12164 CTGGAAGGAGGAGAAGGTTCCCGACTGGAAGATCGTAAAGAAGCCGAAAATTGAGGAGAGAGAGGTGCC 69 FBan0012164 FBgn0033158 CG12164 2 2R CG12164 CG12164 CDMC29489 1 6 7 DAC11-A05 12-CG12164-RA_5 CG12164 CTGGAAGGAGGAGAAGGTTCCCGACTGGAAGATCGTAAAGAAGCCGAAAATTGAGGAGAGAGAGGTGCC 69 FBan0012164 FBgn0033158 CG12164 2 2R CG12164 CG12164 CDMC29490 1 7 7 DAC11-A17 23-CG12179-RA_1 CG12179 GCTAGGCTTTGTATTTTTCTATAGCTTTTAATTGATCACAATTGTTTAAATCCCGAAGCACGTATGGTT 69 FBan0012179 FBgn0025388 CG12179 X X CG12179 CG12179 EG:66A1.2 CDMC29490 1 8 7 DAC11-A17 23-CG12179-RA_1 CG12179 GCTAGGCTTTGTATTTTTCTATAGCTTTTAATTGATCACAATTGTTTAAATCCCGAAGCACGTATGGTT 69 FBan0012179 FBgn0025388 CG12179 X X CG12179 CG12179 EG:66A1.2 CDMC29491 1 9 7 DAC11-E05 18-CG12218-RA_2 CG12218 TCCTGAACACCCTCTATGTTCACTGATTGCAAATCAAAGCGCGCAACAATCGTCCATCAGTCGATATGA 69 FBan0012218 FBgn0026206 mei-P26 X X gametogenesis; GO:0007276; germ cell development; GO:0007281; meiosis; GO:0007126; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 mei-P26 mei-P26 "CG12218, CG12218, AF145661, BcDNA:GH10646" CDMC29491 1 10 7 DAC11-E05 18-CG12218-RA_2 CG12218 TCCTGAACACCCTCTATGTTCACTGATTGCAAATCAAAGCGCGCAACAATCGTCCATCAGTCGATATGA 69 FBan0012218 FBgn0026206 mei-P26 X X gametogenesis; GO:0007276; germ cell development; GO:0007281; meiosis; GO:0007126; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 mei-P26 mei-P26 "CG12218, CG12218, AF145661, BcDNA:GH10646" CDMC29492 1 11 7 DAC11-E17 23-CG12225-RA_4 CG12225 CAGGTTTGTGACGACGGAAGAATGAAAAATAAATTTCAATTTTTTCTGACCAGAAATATACCGCCAGCT 69 FBan0012225 FBgn0028982 Spt6 X X RNA elongation; GO:0006354; RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; intracellular signaling cascade; GO:0007242; transcription initiation from RNA polymerase II promoter; GO:0006367 "chromatin binding; GO:0003682; ; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; transcriptional elongation regulator activity; GO:0003711; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016251; ; GO:0003711" nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Spt6 Spt6 "CG12225, CG12225, l(1)G0063, Dspt6, SPT6, spt 6, dSpt6, spt6" CDMC29492 1 12 7 DAC11-E17 23-CG12225-RA_4 CG12225 CAGGTTTGTGACGACGGAAGAATGAAAAATAAATTTCAATTTTTTCTGACCAGAAATATACCGCCAGCT 69 FBan0012225 FBgn0028982 Spt6 X X RNA elongation; GO:0006354; RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; intracellular signaling cascade; GO:0007242; transcription initiation from RNA polymerase II promoter; GO:0006367 "chromatin binding; GO:0003682; ; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; transcriptional elongation regulator activity; GO:0003711; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016251; ; GO:0003711" nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Spt6 Spt6 "CG12225, CG12225, l(1)G0063, Dspt6, SPT6, spt 6, dSpt6, spt6" CDMC29493 1 13 7 DAC11-I05 12-CG12263-RA_7 CG12263 GTCACATCCCGGTGGTCTACGGACTAGCAACCGTTTACTCCTCCATTGTCATTGCATTTGGCGTTTTCT 69 FBan0012263 FBgn0034346 CG12263 2 2R nucleotide metabolism; GO:0009117; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12263 CG12263 anon-WO0140519.205 CDMC29493 1 14 7 DAC11-I05 12-CG12263-RA_7 CG12263 GTCACATCCCGGTGGTCTACGGACTAGCAACCGTTTACTCCTCCATTGTCATTGCATTTGGCGTTTTCT 69 FBan0012263 FBgn0034346 CG12263 2 2R nucleotide metabolism; GO:0009117; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12263 CG12263 anon-WO0140519.205 CDMC29494 1 15 7 DAC11-I17 24-CG12284-RA_1 CG12284 AGTTATCGTAAGCCTACATTGTAATATTAGTTTAGTACAGCACTTCTATGCGTTATTTATAATAAAACT 69 FBan0012284 FBgn0003691 th 3 3L antennal morphogenesis; GO:0007469; anti-apoptosis; GO:0006916; apoptosis; GO:0006915; border follicle cell migration (sensu Insecta); GO:0007298; cellular physiological process; GO:0050875; development; GO:0007275; germ cell migration; GO:0008354; inhibition of caspase activation; GO:0001719; negative regulation of apoptosis; GO:0043066; protein monoubiquitination; GO:0006513; protein ubiquitination during ubiquitin-dependent protein catabolism; GO:0042787; spermatid nuclear differentiation; GO:0007289 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 th thread "CG12284, CG12284, DIAP1, l(3)j5C8, D-IAP1, diap1, 1065/03, 0736/01, dIAP-1, D-iap1, Diap1, dIAP1, DIAP-1, IAP, l(3)S030605b, DIAP, dIAP, diap-1, Diap-1/Th, Diap-1, diap1/thread, DIAP I, DIAP1,, Inhibitors of Apoptosis protein, l(3)S106503, l(3)S030605, E(rpr)3-1, Iap1: Inhibitor of apoptosis 1, l(3)72Dc, Inhibitor of apoptosis 1" CDMC29494 1 16 7 DAC11-I17 24-CG12284-RA_1 CG12284 AGTTATCGTAAGCCTACATTGTAATATTAGTTTAGTACAGCACTTCTATGCGTTATTTATAATAAAACT 69 FBan0012284 FBgn0003691 th 3 3L antennal morphogenesis; GO:0007469; anti-apoptosis; GO:0006916; apoptosis; GO:0006915; border follicle cell migration (sensu Insecta); GO:0007298; cellular physiological process; GO:0050875; development; GO:0007275; germ cell migration; GO:0008354; inhibition of caspase activation; GO:0001719; negative regulation of apoptosis; GO:0043066; protein monoubiquitination; GO:0006513; protein ubiquitination during ubiquitin-dependent protein catabolism; GO:0042787; spermatid nuclear differentiation; GO:0007289 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 th thread "CG12284, CG12284, DIAP1, l(3)j5C8, D-IAP1, diap1, 1065/03, 0736/01, dIAP-1, D-iap1, Diap1, dIAP1, DIAP-1, IAP, l(3)S030605b, DIAP, dIAP, diap-1, Diap-1/Th, Diap-1, diap1/thread, DIAP I, DIAP1,, Inhibitors of Apoptosis protein, l(3)S106503, l(3)S030605, E(rpr)3-1, Iap1: Inhibitor of apoptosis 1, l(3)72Dc, Inhibitor of apoptosis 1" CDMC29495 1 17 7 DAC11-M05 9-CG12323-RA_3 CG12323 GGTGGATCGTACATTGGCTCCCAGTCGATGAAGAAGATCGTGGAGATCAATCAGTTCATGCTGGGCACC 69 FBan0012323 FBgn0029134 Prosbeta5 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta5 Prosbeta5 "CG12323, CG12323, 20S proteasome, dbeta5, LD08717, Prosbeta5, anon-WO0118547.116" CDMC29495 1 18 7 DAC11-M05 9-CG12323-RA_3 CG12323 GGTGGATCGTACATTGGCTCCCAGTCGATGAAGAAGATCGTGGAGATCAATCAGTTCATGCTGGGCACC 69 FBan0012323 FBgn0029134 Prosbeta5 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta5 Prosbeta5 "CG12323, CG12323, 20S proteasome, dbeta5, LD08717, Prosbeta5, anon-WO0118547.116" CDMC29496 1 19 7 DAC11-M17 1-CG1233-RA_1 CG1233 GGCAAGTGCCTTGTGGAGGGCTGTATGTTCCGTTTCAAATCACCCGTAACTTTGGAGTATCACGGCAGA 69 FBan0001233 FBgn0035137 CG1233 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1233 CG1233 CDMC29496 1 20 7 DAC11-M17 1-CG1233-RA_1 CG1233 GGCAAGTGCCTTGTGGAGGGCTGTATGTTCCGTTTCAAATCACCCGTAACTTTGGAGTATCACGGCAGA 69 FBan0001233 FBgn0035137 CG1233 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1233 CG1233 CDMC29497 1 21 7 DAC12-A05 1-CG7840-RA_1 CG7840 GCCCAATAGCATACGCCAGTCCTTTCGGTATGGCAAGCACAGTTTCAAGGGTGAAACGGATCCTTTGGT 69 FBan0007840 FBgn0032014 CG7840 2 2L 3-oxo-5-alpha-steroid 4-dehydrogenase activity; GO:0003865 ; EC:1.3.99.5; ; GO:0003865 ; EC:1.3.99.5 integral to membrane; GO:0016021 CG7840 CG7840 cg7840 CDMC29497 1 22 7 DAC12-A05 1-CG7840-RA_1 CG7840 GCCCAATAGCATACGCCAGTCCTTTCGGTATGGCAAGCACAGTTTCAAGGGTGAAACGGATCCTTTGGT 69 FBan0007840 FBgn0032014 CG7840 2 2L 3-oxo-5-alpha-steroid 4-dehydrogenase activity; GO:0003865 ; EC:1.3.99.5; ; GO:0003865 ; EC:1.3.99.5 integral to membrane; GO:0016021 CG7840 CG7840 cg7840 CDMC29498 1 23 7 DAC12-A17 2-CG7851-RA_1 CG7851 ATGGAGTGGACATTTGACAAACATCTCCCCGAGTGCTCTACTGCTGAGGAGTGTTGGATTCGAGCGCAT 69 FBan0007851 FBgn0032013 Scgalpha 2 2L structural constituent of muscle; GO:0008307; ; GO:0008307; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005509; ; GO:0008307; ; GO:0005515 sarcoglycan complex; GO:0016012 Scgalpha Sarcoglycan alpha "CG7851, CG7851, DmSCG-alphaepsilon, Scgalpha, Sarcoglycan alpha" CDMC29498 1 24 7 DAC12-A17 2-CG7851-RA_1 CG7851 ATGGAGTGGACATTTGACAAACATCTCCCCGAGTGCTCTACTGCTGAGGAGTGTTGGATTCGAGCGCAT 69 FBan0007851 FBgn0032013 Scgalpha 2 2L structural constituent of muscle; GO:0008307; ; GO:0008307; calcium ion binding; GO:0005509; protein binding; GO:0005515; ; GO:0005509; ; GO:0008307; ; GO:0005515 sarcoglycan complex; GO:0016012 Scgalpha Sarcoglycan alpha "CG7851, CG7851, DmSCG-alphaepsilon, Scgalpha, Sarcoglycan alpha" CDMC29499 1 25 7 DAC12-E05 22-CG7884-RA_1 CG7884 TCGCAACTCACCTCGTCTAGACATGTAATCGAGCTTCTCTCTTGTCTTCACCACACACTGAACACTGAT 69 FBan0007884 FBgn0031001 CG7884 X X CG7884 CG7884 CDMC29499 1 26 7 DAC12-E05 22-CG7884-RA_1 CG7884 TCGCAACTCACCTCGTCTAGACATGTAATCGAGCTTCTCTCTTGTCTTCACCACACACTGAACACTGAT 69 FBan0007884 FBgn0031001 CG7884 X X CG7884 CG7884 CDMC29500 1 1 8 DAC12-E17 22-CG7893-RB_1 CG7893 AGCCAACGAATCACCTTGCGAACTTGATGGATGATGAGTCGAAAATGTGTAGTTAGCAAACGCAACGAT 69 FBan0007893 FBgn0040068 vav X X Rho protein signal transduction; GO:0007266; actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0019992; ; GO:0005085; ; GO:0005100; ; GO:0005085 cellular component unknown; GO:0008372 vav vav "CG7893, DroVav, Vav, BcDNA:GH01128" CDMC29500 1 2 8 DAC12-E17 22-CG7893-RB_1 CG7893 AGCCAACGAATCACCTTGCGAACTTGATGGATGATGAGTCGAAAATGTGTAGTTAGCAAACGCAACGAT 69 FBan0007893 FBgn0040068 vav X X Rho protein signal transduction; GO:0007266; actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0019992; ; GO:0005085; ; GO:0005100; ; GO:0005085 cellular component unknown; GO:0008372 vav vav "CG7893, DroVav, Vav, BcDNA:GH01128" CDMC29501 1 3 8 DAC12-I05 9-CG7926-RA_1 CG7926 CGAGGACCCGGACAGTCCAGTGATTCAGGAAGAGATTGTTAACGACTCCGACATACTGCCGCTATTCGG 69 FBan0007926 FBgn0026597 Axn 3 3R Wnt receptor signaling pathway; GO:0016055; eye-antennal disc morphogenesis; GO:0007455; frizzled signaling pathway; GO:0007222; negative regulation of Wnt receptor signaling pathway; GO:0030178; oogenesis (sensu Insecta); GO:0009993 beta-catenin binding; GO:0008013; signal transducer activity; GO:0004871; ; GO:0008013; ; GO:0004871 cytoplasm; GO:0005737 Axn Axin "CG7926, 0442/30, din, daxin, d-axin, l(3)S044230, D-Axin, Daxin, axin, D-axin, DAxin, axn, dAxin, Axin" CDMC29501 1 4 8 DAC12-I05 9-CG7926-RA_1 CG7926 CGAGGACCCGGACAGTCCAGTGATTCAGGAAGAGATTGTTAACGACTCCGACATACTGCCGCTATTCGG 69 FBan0007926 FBgn0026597 Axn 3 3R Wnt receptor signaling pathway; GO:0016055; eye-antennal disc morphogenesis; GO:0007455; frizzled signaling pathway; GO:0007222; negative regulation of Wnt receptor signaling pathway; GO:0030178; oogenesis (sensu Insecta); GO:0009993 beta-catenin binding; GO:0008013; signal transducer activity; GO:0004871; ; GO:0008013; ; GO:0004871 cytoplasm; GO:0005737 Axn Axin "CG7926, 0442/30, din, daxin, d-axin, l(3)S044230, D-Axin, Daxin, axin, D-axin, DAxin, axn, dAxin, Axin" CDMC29502 1 5 8 DAC12-I17 17-CG7936-RA_1 CG7936 CGTGGTGATCGGCTTGATTGTCTACTTCACGGTCTTCTATCACAAGGATAAGAACACGGATGAGGTGCA 69 FBan0007936 FBgn0004228 mex1 3 3L embryonic development; GO:0009790; midgut development; GO:0007494 mex1 midgut expression 1 CG7936 CDMC29502 1 6 8 DAC12-I17 17-CG7936-RA_1 CG7936 CGTGGTGATCGGCTTGATTGTCTACTTCACGGTCTTCTATCACAAGGATAAGAACACGGATGAGGTGCA 69 FBan0007936 FBgn0004228 mex1 3 3L embryonic development; GO:0009790; midgut development; GO:0007494 mex1 midgut expression 1 CG7936 CDMC29503 1 7 8 DAC12-M05 23-CG7971-RC_8 CG7971 AAGATAGTTGTTATGCGCATTTAACTTGTTTTACACTGCATTCCGTAGCCCTAAGTTAGTCATCTGCCC 69 FBan0007971 FBgn0035253 CG7971 3 3L RNA splicing; GO:0008380 spliceosome complex; GO:0005681 CG7971 CG7971 "BcDNA:GH04236, anon-EST:fe1A7, anon-fast-evolving-1A7" CDMC29503 1 8 8 DAC12-M05 23-CG7971-RC_8 CG7971 AAGATAGTTGTTATGCGCATTTAACTTGTTTTACACTGCATTCCGTAGCCCTAAGTTAGTCATCTGCCC 69 FBan0007971 FBgn0035253 CG7971 3 3L RNA splicing; GO:0008380 spliceosome complex; GO:0005681 CG7971 CG7971 "BcDNA:GH04236, anon-EST:fe1A7, anon-fast-evolving-1A7" CDMC29504 1 9 8 DAC12-M17 18-CG7980-RA_1 CG7980 GCCCTGGCCTTTGAAGAGGCTGTAATGCAGGAAATTAGGTCTATTAAGAATAAGCCTCAGGAACAGGCC 69 FBan0007980 FBgn0035255 RabX5 3 3L intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 RabX5 RabX5 "CG7980, DmRabX5" CDMC29504 1 10 8 DAC12-M17 18-CG7980-RA_1 CG7980 GCCCTGGCCTTTGAAGAGGCTGTAATGCAGGAAATTAGGTCTATTAAGAATAAGCCTCAGGAACAGGCC 69 FBan0007980 FBgn0035255 RabX5 3 3L intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 RabX5 RabX5 "CG7980, DmRabX5" CDMC29505 1 11 8 DAC13-A05 14-CG13226-RA_1 CG13226 GCTACGGCTATGGGCAGAACTACTACAGACCCAGCTACTACAATTATGGTGGATACCAGAGACCGCAGC 69 FBan0013226 FBgn0033594 CG13226 2 2R CG13226 CG13226 CDMC29505 1 12 8 DAC13-A05 14-CG13226-RA_1 CG13226 GCTACGGCTATGGGCAGAACTACTACAGACCCAGCTACTACAATTATGGTGGATACCAGAGACCGCAGC 69 FBan0013226 FBgn0033594 CG13226 2 2R CG13226 CG13226 CDMC29506 1 13 8 DAC13-A17 3-CG13252-RA_1 CG13252 CCGCCACCGTAAATTGCAACAACGCCTTTGACCAACCGAAAGTCGTAGAGGTGGTAAACCAGACCAACT 69 FBan0013252 FBgn0037016 CG13252 3 3L CG13252 CG13252 CDMC29506 1 14 8 DAC13-A17 3-CG13252-RA_1 CG13252 CCGCCACCGTAAATTGCAACAACGCCTTTGACCAACCGAAAGTCGTAGAGGTGGTAAACCAGACCAACT 69 FBan0013252 FBgn0037016 CG13252 3 3L CG13252 CG13252 CDMC29507 1 15 8 DAC13-E05 2-CG13293-RA_1 CG13293 GCCGAGGAAAATCGTACAAGGAGAACCACTGCCTATATCCGGGTGATCTATATCCGTTCACACGCCGGC 69 FBan0013293 FBgn0035677 CG13293 3 3L CG13293 CG13293 CDMC29507 1 16 8 DAC13-E05 2-CG13293-RA_1 CG13293 GCCGAGGAAAATCGTACAAGGAGAACCACTGCCTATATCCGGGTGATCTATATCCGTTCACACGCCGGC 69 FBan0013293 FBgn0035677 CG13293 3 3L CG13293 CG13293 CDMC29508 1 17 8 DAC13-E17 10-CG13307-RA_2 CG13307 GGTGTCCGGGACCAGACTATCAACTACACTTGCCCCGAATCAAAACCCATTTGCACAACCTACGGAATT 69 FBan0013307 FBgn0035930 CG13307 3 3L CG13307 CG13307 CDMC29508 1 18 8 DAC13-E17 10-CG13307-RA_2 CG13307 GGTGTCCGGGACCAGACTATCAACTACACTTGCCCCGAATCAAAACCCATTTGCACAACCTACGGAATT 69 FBan0013307 FBgn0035930 CG13307 3 3L CG13307 CG13307 CDMC29509 1 19 8 DAC13-I05 23-CG13329-RA_2 CG13329 GGGGTCGGCAATTTTAGTCCAAAAGAGAAGTTTAGGCTTAGTTTAGTTATTTGTTTGAATAGTTGTGTA 69 FBan0013329 FBgn0040477 cid 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; inner kinetochore of condensed nuclear chromosome; GO:0000941; nucleosome; GO:0000786" cid centromere identifier "CG13329, CG13329, CENP-A/Cid, CENP-A, CENP-A/CID, CID, CID/CENP-A, Cid, cenpA, cenH3, BcDNA:RE21270, centromere identifier" CDMC29509 1 20 8 DAC13-I05 23-CG13329-RA_2 CG13329 GGGGTCGGCAATTTTAGTCCAAAAGAGAAGTTTAGGCTTAGTTTAGTTATTTGTTTGAATAGTTGTGTA 69 FBan0013329 FBgn0040477 cid 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; inner kinetochore of condensed nuclear chromosome; GO:0000941; nucleosome; GO:0000786" cid centromere identifier "CG13329, CG13329, CENP-A/Cid, CENP-A, CENP-A/CID, CID, CID/CENP-A, Cid, cenpA, cenH3, BcDNA:RE21270, centromere identifier" CDMC29510 1 21 8 DAC13-I17 23-CG13338-RA_7 CG13338 AAAAAGGAGCCTTACTCATTAACTCATCGAAATGCTCTTAACTTGGCTAAAGATTCTCGCAGGTTATGC 69 FBan0013338 FBgn0033867 CG13338 2 2R CG13338 CG13338 CDMC29510 1 22 8 DAC13-I17 23-CG13338-RA_7 CG13338 AAAAAGGAGCCTTACTCATTAACTCATCGAAATGCTCTTAACTTGGCTAAAGATTCTCGCAGGTTATGC 69 FBan0013338 FBgn0033867 CG13338 2 2R CG13338 CG13338 CDMC29511 1 23 8 DAC13-M05 8-CG13388-RA_3 CG13388 GCCTCTCAATTCCAGATCGGGTTAAGTCCCCAAAAACACATCCATCACCCATCAAGCACACACCATCCA 69 FBan0013388 FBgn0027932 Akap200 2 2L autophagic cell death; GO:0048102; negative regulation of Ras protein signal transduction; GO:0046580; protein localization; GO:0008104; salivary gland cell autophagic cell death; GO:0035071 protein kinase A binding; GO:0051018; ; GO:0051018; ; GO:0051018 Akap200 A kinase anchor protein 200 "CG13388, DAKAP200, MESR2, dpo, EP(2)2254, akap200, AKAP200, anon-WO0118547.134, anon-WO0118547.213, BcDNA:LP02734" CDMC29511 1 24 8 DAC13-M05 8-CG13388-RA_3 CG13388 GCCTCTCAATTCCAGATCGGGTTAAGTCCCCAAAAACACATCCATCACCCATCAAGCACACACCATCCA 69 FBan0013388 FBgn0027932 Akap200 2 2L autophagic cell death; GO:0048102; negative regulation of Ras protein signal transduction; GO:0046580; protein localization; GO:0008104; salivary gland cell autophagic cell death; GO:0035071 protein kinase A binding; GO:0051018; ; GO:0051018; ; GO:0051018 Akap200 A kinase anchor protein 200 "CG13388, DAKAP200, MESR2, dpo, EP(2)2254, akap200, AKAP200, anon-WO0118547.134, anon-WO0118547.213, BcDNA:LP02734" CDMC29512 1 25 8 DAC13-M17 16-CG13394-RB_1 CG13394 TCCGGAAGTACGGGAATGGATTTGTAGGAGATATGGTAAGCGATATGGTCCACAAAGCCATGCGGATTT 69 FBan0013394 FBgn0032037 CG13394 2 2L CG13394 CG13394 CDMC29512 1 26 8 DAC13-M17 16-CG13394-RB_1 CG13394 TCCGGAAGTACGGGAATGGATTTGTAGGAGATATGGTAAGCGATATGGTCCACAAAGCCATGCGGATTT 69 FBan0013394 FBgn0032037 CG13394 2 2L CG13394 CG13394 CDMC29513 1 1 9 DAC14-A05 2-CG8594-RA_1 CG8594 GCTGTCCTGTGCTACGTTTGGTCTCAATGTGTCCTTGGGTGTCTTCATCCCAACTGCTCTGGTCG 65 FBan0008594 FBgn0033755 CG8594 2 2R anion transport; GO:0006820; chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG8594 CG8594 CDMC29513 1 2 9 DAC14-A05 2-CG8594-RA_1 CG8594 GCTGTCCTGTGCTACGTTTGGTCTCAATGTGTCCTTGGGTGTCTTCATCCCAACTGCTCTGGTCG 65 FBan0008594 FBgn0033755 CG8594 2 2R anion transport; GO:0006820; chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG8594 CG8594 CDMC29514 1 3 9 DAC14-A17 1-CG8640-RA_2 CG8640 TACCATCACCAAGTTCTTGGCCAACCAGGATACGGACGGCACCTACGCCTATGATATCGAGCAGG 65 FBan0008640 FBgn0035735 CG8640 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8640 CG8640 CDMC29514 1 4 9 DAC14-A17 1-CG8640-RA_2 CG8640 TACCATCACCAAGTTCTTGGCCAACCAGGATACGGACGGCACCTACGCCTATGATATCGAGCAGG 65 FBan0008640 FBgn0035735 CG8640 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8640 CG8640 CDMC29515 1 5 9 DAC14-E05 3-CG8768-RA_1 CG8768 CTTCATCGCCCGTGTATCTTCGGCGTTCCAGAGTTTGTTGTCCAAGCCATCTTTGGACCAGAGCG 65 FBan0008768 FBgn0033769 CG8768 2 2R carbohydrate metabolism; GO:0005975; monosaccharide metabolism; GO:0005996 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0016854 ; EC:5.1.-.- CG8768 CG8768 CDMC29515 1 6 9 DAC14-E05 3-CG8768-RA_1 CG8768 CTTCATCGCCCGTGTATCTTCGGCGTTCCAGAGTTTGTTGTCCAAGCCATCTTTGGACCAGAGCG 65 FBan0008768 FBgn0033769 CG8768 2 2R carbohydrate metabolism; GO:0005975; monosaccharide metabolism; GO:0005996 isomerase activity; GO:0016853 ; EC:5.-.-.-; lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0016854 ; EC:5.1.-.- CG8768 CG8768 CDMC29516 1 7 9 DAC14-E17 18-CG8786-RB_6 CG8786 GCGACAAATCCTGTACAATTTTGGTAGCCGGCTACGTCTACATTGTGGACTTGGAGCAGCTAGTC 65 FBan0008786 FBgn0036897 CG8786 3 3L CG8786 CG8786 BcDNA:GM01527 CDMC29516 1 8 9 DAC14-E17 18-CG8786-RB_6 CG8786 GCGACAAATCCTGTACAATTTTGGTAGCCGGCTACGTCTACATTGTGGACTTGGAGCAGCTAGTC 65 FBan0008786 FBgn0036897 CG8786 3 3L CG8786 CG8786 BcDNA:GM01527 CDMC29517 1 9 9 DAC14-I05 12-CG8900-RB_1 CG8900 GGCAGCTGACCTCCTCCAACTTGGACTCGAAGCTGCGTGACGATCTGGAGCGTCTGAAGAAGATC 65 FBan0008900 FBgn0010411 RpS18 2 2R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS18 Ribosomal protein S18 "CG8900, rpS18, S18: Shell-18, BcDNA:RH43343, anon-EST:Posey27, anon-EST:fe2D3, anon-fast-evolving-2D3, S18" CDMC29517 1 10 9 DAC14-I05 12-CG8900-RB_1 CG8900 GGCAGCTGACCTCCTCCAACTTGGACTCGAAGCTGCGTGACGATCTGGAGCGTCTGAAGAAGATC 65 FBan0008900 FBgn0010411 RpS18 2 2R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS18 Ribosomal protein S18 "CG8900, rpS18, S18: Shell-18, BcDNA:RH43343, anon-EST:Posey27, anon-EST:fe2D3, anon-fast-evolving-2D3, S18" CDMC29518 1 11 9 DAC14-I17 1-CG8949-RA_1 CG8949 TCGGTTGGTTCGGTGTCAGATGGGACCAATCACGCCTACAATTCGGTCAATAACTCGGTCTCCGG 65 FBan0008949 FBgn0030812 CG8949 X X CG8949 CG8949 CDMC29518 1 12 9 DAC14-I17 1-CG8949-RA_1 CG8949 TCGGTTGGTTCGGTGTCAGATGGGACCAATCACGCCTACAATTCGGTCAATAACTCGGTCTCCGG 65 FBan0008949 FBgn0030812 CG8949 X X CG8949 CG8949 CDMC29519 1 13 9 DAC14-M05 15-CG9028-RA_5 CG9028 GCGTTCCTTGTCCAGGCCTCGCTACATCAGTGGTCTTCAGAAGTTTACTACGGTGAGCAAGGCAA 65 FBan0009028 FBgn0036389 CG9028 3 3L CG9028 CG9028 CDMC29519 1 14 9 DAC14-M05 15-CG9028-RA_5 CG9028 GCGTTCCTTGTCCAGGCCTCGCTACATCAGTGGTCTTCAGAAGTTTACTACGGTGAGCAAGGCAA 65 FBan0009028 FBgn0036389 CG9028 3 3L CG9028 CG9028 CDMC29520 1 15 9 DAC14-M17 3-CG9063-RA_11 CG9063 CGGCTGTACTCGCTACCGACATCAGAGGACGACCTAGCCGTGGATATTCTGCCTCAGAAGCTGTC 65 FBan0009063 FBgn0028500 CG9063 3 3L CG9063 CG9063 BcDNA:GH03694 CDMC29520 1 16 9 DAC14-M17 3-CG9063-RA_11 CG9063 CGGCTGTACTCGCTACCGACATCAGAGGACGACCTAGCCGTGGATATTCTGCCTCAGAAGCTGTC 65 FBan0009063 FBgn0028500 CG9063 3 3L CG9063 CG9063 BcDNA:GH03694 CDMC29521 1 17 9 DAC15-A05 2-CG8151-RA_3 CG8151 CGGCGAGAAAGCCAAGTCTAAGCACTTCGAACTGTCCAAAGTGGAGCGTTACCTCAATGGCCCTGTC 67 FBan0008151 FBgn0033929 Tfb1 2 2R DNA repair; GO:0006281; RNA elongation from RNA polymerase II promoter; GO:0006368; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIH complex; GO:0005675 Tfb1 Tfb1 "CG8151, CG8151, CG8151, CG8151, CG8151, CG8151, l(2)06949, TFB1, Dmp62, l(2)06950" CDMC29521 1 18 9 DAC15-A05 2-CG8151-RA_3 CG8151 CGGCGAGAAAGCCAAGTCTAAGCACTTCGAACTGTCCAAAGTGGAGCGTTACCTCAATGGCCCTGTC 67 FBan0008151 FBgn0033929 Tfb1 2 2R DNA repair; GO:0006281; RNA elongation from RNA polymerase II promoter; GO:0006368; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIH complex; GO:0005675 Tfb1 Tfb1 "CG8151, CG8151, CG8151, CG8151, CG8151, CG8151, l(2)06949, TFB1, Dmp62, l(2)06950" CDMC29522 1 19 9 DAC15-A17 3-CG8261-RA_1 CG8261 GCCGCCCTATCAATCGAAACTGCAGTCGGTTACGGGAGTCCTCCCAGTTTCTGCTTAAACATTCCGC 67 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC29522 1 20 9 DAC15-A17 3-CG8261-RA_1 CG8261 GCCGCCCTATCAATCGAAACTGCAGTCGGTTACGGGAGTCCTCCCAGTTTCTGCTTAAACATTCCGC 67 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC29523 1 21 9 DAC15-E05 3-CG8587-RA_4 CG8587 TGTTCCGCATGTACAGCACGGTGATTGGAAACGGACGAACTCTCATGGAGGACAGTGTCATCTGTGG 67 FBan0008587 FBgn0033753 Cyp301a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp301a1 Cyp301a1 "CG8587, 301a1" CDMC29523 1 22 9 DAC15-E05 3-CG8587-RA_4 CG8587 TGTTCCGCATGTACAGCACGGTGATTGGAAACGGACGAACTCTCATGGAGGACAGTGTCATCTGTGG 67 FBan0008587 FBgn0033753 Cyp301a1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp301a1 Cyp301a1 "CG8587, 301a1" CDMC29524 1 23 9 DAC15-E17 3-CG8814-RA_1 CG8814 GGAGAGCCTGCAGGAGATCATTGAGACCATGTCGTTCACGGAGAATGTGCAGAACTTTGTGGGCAGC 67 FBan0008814 FBgn0031478 CG8814 2 2L cell acyl-CoA homeostasis; GO:0042049 acyl-CoA binding; GO:0000062; ; GO:0000062; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8814 CG8814 CDMC29524 1 24 9 DAC15-E17 3-CG8814-RA_1 CG8814 GGAGAGCCTGCAGGAGATCATTGAGACCATGTCGTTCACGGAGAATGTGCAGAACTTTGTGGGCAGC 67 FBan0008814 FBgn0031478 CG8814 2 2L cell acyl-CoA homeostasis; GO:0042049 acyl-CoA binding; GO:0000062; ; GO:0000062; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8814 CG8814 CDMC29525 1 25 9 DAC15-I05 17-CG9166-RA_3 CG9166 CGGCGTGCAAGACAAGTACAAAATATTCCGCGATGAGGAAGCCACGGAGATTTTTGATGTGGAAGAG 67 FBan0009166 FBgn0029514 312 3 3L 312 312 "CG9166, BEST:CK01660" CDMC29525 1 26 9 DAC15-I05 17-CG9166-RA_3 CG9166 CGGCGTGCAAGACAAGTACAAAATATTCCGCGATGAGGAAGCCACGGAGATTTTTGATGTGGAAGAG 67 FBan0009166 FBgn0029514 312 3 3L 312 312 "CG9166, BEST:CK01660" CDMC29526 1 1 10 DAC15-I17 2-CG9272-RA_5 CG9272 TCGCATGGTAACCAGAGTTCAAATGGGTTCGGCTACTGTGGTCATATGCAAGGTGGTCCCTGATGCT 67 FBan0009272 FBgn0032907 CG9272 2 2L DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; iron ion binding; GO:0005506; pyrimidine-specific oxidized base lesion DNA N-glycosylase activity; GO:0000703; ; GO:0003677; ; GO:0005506; ; GO:0000703 CG9272 CG9272 CDMC29526 1 2 10 DAC15-I17 2-CG9272-RA_5 CG9272 TCGCATGGTAACCAGAGTTCAAATGGGTTCGGCTACTGTGGTCATATGCAAGGTGGTCCCTGATGCT 67 FBan0009272 FBgn0032907 CG9272 2 2L DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; iron ion binding; GO:0005506; pyrimidine-specific oxidized base lesion DNA N-glycosylase activity; GO:0000703; ; GO:0003677; ; GO:0005506; ; GO:0000703 CG9272 CG9272 CDMC29527 1 3 10 DAC15-M05 1-CG9663-RA_1 CG9663 GACATGGCCAACGGAAACTATACACTTGCCCTCATCTTTCTGTTCGGCGTTTTGGTCTTCCTGCGCA 67 FBan0009663 FBgn0031516 CG9663 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9663 CG9663 CDMC29527 1 4 10 DAC15-M05 1-CG9663-RA_1 CG9663 GACATGGCCAACGGAAACTATACACTTGCCCTCATCTTTCTGTTCGGCGTTTTGGTCTTCCTGCGCA 67 FBan0009663 FBgn0031516 CG9663 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9663 CG9663 CDMC29528 1 5 10 DAC15-M17 3-CG9847-RA_1 CG9847 CGACGAGCTGTAGTGCTCAATAATGGGGGTTCTTGGTTTGCCGTCAACATCGAAGGGACACGAGTGC 67 FBan0009847 FBgn0010470 Fkbp13 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003755 ; EC:5.2.1.8 Fkbp13 Fkbp13 "CG9847, l(2)00734, GM07659, BcDNA.GM07659, FKB13, BcDNA:GM07659, BcDNA:GH08925" CDMC29528 1 6 10 DAC15-M17 3-CG9847-RA_1 CG9847 CGACGAGCTGTAGTGCTCAATAATGGGGGTTCTTGGTTTGCCGTCAACATCGAAGGGACACGAGTGC 67 FBan0009847 FBgn0010470 Fkbp13 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003755 ; EC:5.2.1.8 Fkbp13 Fkbp13 "CG9847, l(2)00734, GM07659, BcDNA.GM07659, FKB13, BcDNA:GM07659, BcDNA:GH08925" CDMC29529 1 7 10 DAC16-A05 23-CG4869-RA_1 CG4869 CGGCAATGGCGAGTAAAGTCCTAGAAACTATCACAACTGTAGCTGTTTTCTGTATACTATTTTGTAAAT 69 FBgn0039567 CDMC29529 1 8 10 DAC16-A05 23-CG4869-RA_1 CG4869 CGGCAATGGCGAGTAAAGTCCTAGAAACTATCACAACTGTAGCTGTTTTCTGTATACTATTTTGTAAAT 69 FBgn0039567 CDMC29530 1 9 10 DAC16-A17 18-CG4889-RA_1 CG4889 GGGCAGGACCAAAACGTATGCGAAGTGGACAGTATAATAGTTCGAGAAAATCGGTAACCAGGGCTGGAA 69 FBan0004889 FBgn0004009 wg 2 2L "Wnt receptor signaling pathway; GO:0016055; actin cable formation; GO:0045011; anterior head segmentation; GO:0035288; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; cardioblast differentiation; GO:0010002; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; determination of anterior/posterior axis, embryo; GO:0008595; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; epidermis development; GO:0008544; eye development (sensu Endopterygota); GO:0007456; filopodium formation; GO:0046847; foregut morphogenesis; GO:0007440; frizzled-2 signaling pathway; GO:0007223; genital disc development; GO:0035215; genital disc sexually dimorphic development; GO:0035263; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; lamellipodium biogenesis; GO:0030032; larval development (sensu Insecta); GO:0002168; larval visceral muscle development; GO:0007523; leg disc proximal/distal pattern formation; GO:0007479; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of phosphorylation; GO:0042326; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; posterior head segmentation; GO:0035289; regulation of cell proliferation; GO:0042127; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; sensory organ development; GO:0007423; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; wing cell fate specification; GO:0035311; wing disc anterior/posterior pattern formation; GO:0048100; wing disc dorsal/ventral pattern formation; GO:0048190; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" frizzled-2 binding; GO:0005110; ; GO:0005110; ; GO:0005110; receptor binding; GO:0005102; Notch binding; GO:0005112; signal transducer activity; GO:0004871; morphogen activity; GO:0016015; ; GO:0005102; ; GO:0005112; ; GO:0005110; ; GO:0016015; ; GO:0004871 cytoplasmic membrane-bound vesicle; GO:0016023; extracellular region; GO:0005576; lipid raft; GO:0045121 wg wingless "CG4889, Sp, l(2)wg, int-1, I: Intensifier of Bar, Complementation group I, Dm-1, Wnt-1, l(2)02657, Sternopleural, Wnt, Wg, WNT, Wnt1, DWint-1, Wingless, DWnt-1, Br, Dint-1, Gla, fg: flag, l(2)rO727, spd, Bristled, Glazed, flag, spade, I" CDMC29530 1 10 10 DAC16-A17 18-CG4889-RA_1 CG4889 GGGCAGGACCAAAACGTATGCGAAGTGGACAGTATAATAGTTCGAGAAAATCGGTAACCAGGGCTGGAA 69 FBan0004889 FBgn0004009 wg 2 2L "Wnt receptor signaling pathway; GO:0016055; actin cable formation; GO:0045011; anterior head segmentation; GO:0035288; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; cardioblast differentiation; GO:0010002; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; determination of anterior/posterior axis, embryo; GO:0008595; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; epidermis development; GO:0008544; eye development (sensu Endopterygota); GO:0007456; filopodium formation; GO:0046847; foregut morphogenesis; GO:0007440; frizzled-2 signaling pathway; GO:0007223; genital disc development; GO:0035215; genital disc sexually dimorphic development; GO:0035263; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; imaginal disc growth; GO:0007446; imaginal disc pattern formation; GO:0007447; lamellipodium biogenesis; GO:0030032; larval development (sensu Insecta); GO:0002168; larval visceral muscle development; GO:0007523; leg disc proximal/distal pattern formation; GO:0007479; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; negative regulation of phosphorylation; GO:0042326; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; posterior head segmentation; GO:0035289; regulation of cell proliferation; GO:0042127; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; sensory organ development; GO:0007423; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; wing cell fate specification; GO:0035311; wing disc anterior/posterior pattern formation; GO:0048100; wing disc dorsal/ventral pattern formation; GO:0048190; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" frizzled-2 binding; GO:0005110; ; GO:0005110; ; GO:0005110; receptor binding; GO:0005102; Notch binding; GO:0005112; signal transducer activity; GO:0004871; morphogen activity; GO:0016015; ; GO:0005102; ; GO:0005112; ; GO:0005110; ; GO:0016015; ; GO:0004871 cytoplasmic membrane-bound vesicle; GO:0016023; extracellular region; GO:0005576; lipid raft; GO:0045121 wg wingless "CG4889, Sp, l(2)wg, int-1, I: Intensifier of Bar, Complementation group I, Dm-1, Wnt-1, l(2)02657, Sternopleural, Wnt, Wg, WNT, Wnt1, DWint-1, Wingless, DWnt-1, Br, Dint-1, Gla, fg: flag, l(2)rO727, spd, Bristled, Glazed, flag, spade, I" CDMC29531 1 11 10 DAC16-E05 9-CG4914-RA_1 CG4914 ACCCGAGTCACGAAATATCTGGACTGGATTGTGGAGAACTCGCGAGACGGTTGTTTCTGCGATGAGGAT 69 FBan0004914 FBgn0036436 CG4914 3 3L "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG4914 CG4914 SP39 CDMC29531 1 12 10 DAC16-E05 9-CG4914-RA_1 CG4914 ACCCGAGTCACGAAATATCTGGACTGGATTGTGGAGAACTCGCGAGACGGTTGTTTCTGCGATGAGGAT 69 FBan0004914 FBgn0036436 CG4914 3 3L "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG4914 CG4914 SP39 CDMC29532 1 13 10 DAC16-E17 8-CG4925-RA_1 CG4925 TCCATCGCGAGCTGAACAAGTACAAAAGGGGAATTACGGAACCGAAGACACCAATCAGCTACTGCAGCA 69 FBan0004925 FBgn0036614 CG4925 3 3L signal transducer activity; GO:0004871; ; GO:0004871 CG4925 CG4925 CDMC29532 1 14 10 DAC16-E17 8-CG4925-RA_1 CG4925 TCCATCGCGAGCTGAACAAGTACAAAAGGGGAATTACGGAACCGAAGACACCAATCAGCTACTGCAGCA 69 FBan0004925 FBgn0036614 CG4925 3 3L signal transducer activity; GO:0004871; ; GO:0004871 CG4925 CG4925 CDMC29533 1 15 10 DAC16-I05 22-CG4952-RE_2 CG4952 ACGATAAGCTGAATACCCGTGTAGGCAGAGTTGGCATACCTAGCATTTAACTTCCCCGAAAAGAAACCA 69 FBan0004952 FBgn0005677 dac 2 2L antennal joint morphogenesis; GO:0048098; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye photoreceptor development (sensu Endopterygota); GO:0042051; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; mushroom body development; GO:0016319; spermathecum morphogenesis; GO:0035211; transcription; GO:0006350 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702 nucleoplasm; GO:0005654; nucleus; GO:0005634 dac dachshund "CG4952, l(2)36Ae, dachsund, BG:DS02780.3, Dac, dach, Dm-DAC, dacshund, l(2)rK364, spn: spinosus, spinosus, dachshund" CDMC29533 1 16 10 DAC16-I05 22-CG4952-RE_2 CG4952 ACGATAAGCTGAATACCCGTGTAGGCAGAGTTGGCATACCTAGCATTTAACTTCCCCGAAAAGAAACCA 69 FBan0004952 FBgn0005677 dac 2 2L antennal joint morphogenesis; GO:0048098; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye photoreceptor development (sensu Endopterygota); GO:0042051; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; mushroom body development; GO:0016319; spermathecum morphogenesis; GO:0035211; transcription; GO:0006350 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702 nucleoplasm; GO:0005654; nucleus; GO:0005634 dac dachshund "CG4952, l(2)36Ae, dachsund, BG:DS02780.3, Dac, dach, Dm-DAC, dacshund, l(2)rK364, spn: spinosus, spinosus, dachshund" CDMC29534 1 17 10 DAC16-I17 13-CG4960-RA_1 CG4960 GCTGGAGTGCCAAAGGACGACTAGGACAAACATTTGCGTTAACTCCATGCATTTGGTTTACGGTCTGCA 69 FBan0004960 FBgn0039371 CG4960 3 3R cell proliferation; GO:0008283 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG4960 CG4960 BcDNA:AT31258 CDMC29534 1 18 10 DAC16-I17 13-CG4960-RA_1 CG4960 GCTGGAGTGCCAAAGGACGACTAGGACAAACATTTGCGTTAACTCCATGCATTTGGTTTACGGTCTGCA 69 FBan0004960 FBgn0039371 CG4960 3 3R cell proliferation; GO:0008283 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG4960 CG4960 BcDNA:AT31258 CDMC29535 1 19 10 DAC16-M05 3-CG4996-RA_1 CG4996 CCTAGACTGGAGCAACGTTTACGCTCGGTCGAGGTTAACGTTCTGCCACAAATCAAGCTATGGCCCCTT 69 FBan0004996 FBgn0034271 CG4996 2 2R CG4996 CG4996 CDMC29535 1 20 10 DAC16-M05 3-CG4996-RA_1 CG4996 CCTAGACTGGAGCAACGTTTACGCTCGGTCGAGGTTAACGTTCTGCCACAAATCAAGCTATGGCCCCTT 69 FBan0004996 FBgn0034271 CG4996 2 2R CG4996 CG4996 CDMC29536 1 21 10 DAC16-M17 3-CG5005-RA_1 CG5005 CCAGTTCCGAAGGCCTGGACACAAGTCACATGGCAGATTCGTCCGGTGGAGGCAATTATAATTTCCACA 69 FBan0005005 FBgn0022740 HLH54F 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH54F HLH54F "CG5005, bHLH54F, HLH102C" CDMC29536 1 22 10 DAC16-M17 3-CG5005-RA_1 CG5005 CCAGTTCCGAAGGCCTGGACACAAGTCACATGGCAGATTCGTCCGGTGGAGGCAATTATAATTTCCACA 69 FBan0005005 FBgn0022740 HLH54F 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH54F HLH54F "CG5005, bHLH54F, HLH102C" CDMC29537 1 23 10 DAC17-A05 17-CG7085-RA_6 CG7085 AGAAGGGTGTGCTCACGACGGAAAAGCAAAATTTTCTACTCTTCGATATGACGACACATCCGCTGAGCG 69 FBgn0031402 CDMC29537 1 24 10 DAC17-A05 17-CG7085-RA_6 CG7085 AGAAGGGTGTGCTCACGACGGAAAAGCAAAATTTTCTACTCTTCGATATGACGACACATCCGCTGAGCG 69 FBgn0031402 CDMC29538 1 25 10 DAC17-A17 23-CG7097-RA_6 CG7097 GCAGGAGAATCCAAGTATACATACACTTAAACACGCAATTATCCACACGATTCGAGACCGACTAAGGCA 69 FBan0007097 FBgn0034421 CG7097 2 2R JNK cascade; GO:0007254; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7097 CG7097 "GLK/KHS1, Gene 2, anon-WO0153538.68" CDMC29538 1 26 10 DAC17-A17 23-CG7097-RA_6 CG7097 GCAGGAGAATCCAAGTATACATACACTTAAACACGCAATTATCCACACGATTCGAGACCGACTAAGGCA 69 FBan0007097 FBgn0034421 CG7097 2 2R JNK cascade; GO:0007254; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG7097 CG7097 "GLK/KHS1, Gene 2, anon-WO0153538.68" CDMC29539 1 1 11 DAC17-E05 23-CG7129-RA_15 CG7129 CGCCAATCTGCCTACGTTGTAACCATAATTAGCCCCCGATCTTTAACGATCTATAAATTGTATACCCGA 69 FBan0007129 FBgn0010877 l(3)05822 3 3R l(3)05822 lethal (3) 05822 "CG7129, CG7129, CG7129, 5822, LD12970, clot 3142, l(3)5822" CDMC29539 1 2 11 DAC17-E05 23-CG7129-RA_15 CG7129 CGCCAATCTGCCTACGTTGTAACCATAATTAGCCCCCGATCTTTAACGATCTATAAATTGTATACCCGA 69 FBan0007129 FBgn0010877 l(3)05822 3 3R l(3)05822 lethal (3) 05822 "CG7129, CG7129, CG7129, 5822, LD12970, clot 3142, l(3)5822" CDMC29540 1 3 11 DAC17-E17 3-CG7144-RA_5 CG7144 CCACCAAATACGGCAACCTTTACGGCTTAGGCAGGGATGTGCACACTTTGCTTCGTGGAACCATACGTT 69 FBan0007144 FBgn0025687 CG7144 2 2L amino acid catabolism; GO:0009063; electron transport; GO:0006118 "saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; GO:0004754 ; EC:1.5.1.7; ; GO:0004754 ; EC:1.5.1.7" CG7144 CG7144 "CK02318, BEST:CK02318, anon-WO0149856.1" CDMC29540 1 4 11 DAC17-E17 3-CG7144-RA_5 CG7144 CCACCAAATACGGCAACCTTTACGGCTTAGGCAGGGATGTGCACACTTTGCTTCGTGGAACCATACGTT 69 FBan0007144 FBgn0025687 CG7144 2 2L amino acid catabolism; GO:0009063; electron transport; GO:0006118 "saccharopine dehydrogenase (NAD+, L-lysine-forming) activity; GO:0004754 ; EC:1.5.1.7; ; GO:0004754 ; EC:1.5.1.7" CG7144 CG7144 "CK02318, BEST:CK02318, anon-WO0149856.1" CDMC29541 1 5 11 DAC17-I05 9-CG7178-RG_2 CG7178 GCCGTGGATCGTCGGACCGTTCAGTCTTTTTGTGTCGTTCAGTATCATCCGATTCGTGTGATCGACAGC 69 FBan0007178 FBgn0004028 wupA X X muscle contraction; GO:0006936; muscle development; GO:0007517; myofibril assembly; GO:0030239; nervous system development; GO:0007399; sarcomere organization; GO:0045214 tropomyosin binding; GO:0005523; actin binding; GO:0003779; ; GO:0005523; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 troponin complex; GO:0005861 wupA wings up A "CG7178, CG7178, CG7178, CG7178, CG7178, hdp: heldup, HLI, heldup, troponin-I, HDP, haplo-lethal region I, troponin, TnI, Troponin I, DROTROPONI, HL-I, troponin I, held-up, wup-A, HL08042, TpnI, wings-up A, hdp" CDMC29541 1 6 11 DAC17-I05 9-CG7178-RG_2 CG7178 GCCGTGGATCGTCGGACCGTTCAGTCTTTTTGTGTCGTTCAGTATCATCCGATTCGTGTGATCGACAGC 69 FBan0007178 FBgn0004028 wupA X X muscle contraction; GO:0006936; muscle development; GO:0007517; myofibril assembly; GO:0030239; nervous system development; GO:0007399; sarcomere organization; GO:0045214 tropomyosin binding; GO:0005523; actin binding; GO:0003779; ; GO:0005523; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 troponin complex; GO:0005861 wupA wings up A "CG7178, CG7178, CG7178, CG7178, CG7178, hdp: heldup, HLI, heldup, troponin-I, HDP, haplo-lethal region I, troponin, TnI, Troponin I, DROTROPONI, HL-I, troponin I, held-up, wup-A, HL08042, TpnI, wings-up A, hdp" CDMC29542 1 7 11 DAC17-I17 12-CG7187-RA_1 CG7187 TGAAGGCGATGACCACACGCAACACCACAACACGCAGCAAATAAGAACGCGGTAGTAGAAATCCTTGAT 69 FBgn0038580 CDMC29542 1 8 11 DAC17-I17 12-CG7187-RA_1 CG7187 TGAAGGCGATGACCACACGCAACACCACAACACGCAGCAAATAAGAACGCGGTAGTAGAAATCCTTGAT 69 FBgn0038580 CDMC29543 1 9 11 DAC17-M05 2-CG7229-RA_1 CG7229 TCACTGACGCGGATCGATGTGCCACACAGAAATTATTTGCCAAGCTTCCGACAAACGCCATGAAGGAGA 69 FBan0007229 FBgn0034423 CG7229 2 2R MAPKKK cascade; GO:0000165; spermatogenesis; GO:0007283 single-stranded DNA binding; GO:0003697; ; GO:0003697 nucleus; GO:0005634 CG7229 CG7229 "Gene 4, 7229" CDMC29543 1 10 11 DAC17-M05 2-CG7229-RA_1 CG7229 TCACTGACGCGGATCGATGTGCCACACAGAAATTATTTGCCAAGCTTCCGACAAACGCCATGAAGGAGA 69 FBan0007229 FBgn0034423 CG7229 2 2R MAPKKK cascade; GO:0000165; spermatogenesis; GO:0007283 single-stranded DNA binding; GO:0003697; ; GO:0003697 nucleus; GO:0005634 CG7229 CG7229 "Gene 4, 7229" CDMC29544 1 11 11 DAC17-M17 3-CG7239-RA_4 CG7239 CGAGCTATGCTACGCGCTGGAAGAAGTACGACATTATCAATCGCATCCTGAAGAACCTGCACAGGCCCA 69 FBan0007239 FBgn0031740 CG7239 2 2L CG7239 CG7239 anon-EST:Posey250 CDMC29544 1 12 11 DAC17-M17 3-CG7239-RA_4 CG7239 CGAGCTATGCTACGCGCTGGAAGAAGTACGACATTATCAATCGCATCCTGAAGAACCTGCACAGGCCCA 69 FBan0007239 FBgn0031740 CG7239 2 2L CG7239 CG7239 anon-EST:Posey250 CDMC29545 1 13 11 DAC18-A05 3-CG32394-RA_1 CG32394 TCCCAACTCGCAGTTGTACCAGCAGTATCTAAGGCGCGATGACTTTCACACGCGGATGATCTTCAACCA 69 FBan0032394 FBgn0052394 CG32394 3 3L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG32394 CG32394 CG10115 CDMC29545 1 14 11 DAC18-A05 3-CG32394-RA_1 CG32394 TCCCAACTCGCAGTTGTACCAGCAGTATCTAAGGCGCGATGACTTTCACACGCGGATGATCTTCAACCA 69 FBan0032394 FBgn0052394 CG32394 3 3L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG32394 CG32394 CG10115 CDMC29546 1 15 11 DAC18-A17 11-CG32402-RA_1 CG32402 AGCAATGGCCTTATTTACAACCACAGAAGAACGTCTGCTGCCCTACCGATCTAAATGGCACACCTTGGT 69 FBgn0052402 CDMC29546 1 16 11 DAC18-A17 11-CG32402-RA_1 CG32402 AGCAATGGCCTTATTTACAACCACAGAAGAACGTCTGCTGCCCTACCGATCTAAATGGCACACCTTGGT 69 FBgn0052402 CDMC29547 1 17 11 DAC18-E05 2-CG32435-RA_1 CG32435 CGAAGCTGTCAGTGCTAAATCCCAGCAAGGTTAGGCTCCTCAACGTGTACATCGAGAAGCAGCGGAACT 69 FBan0032435 FBgn0021760 chb 3 3L axon guidance; GO:0007411; centrosome cycle; GO:0007098; cystoblast division; GO:0007282; establishment of mitotic spindle localization; GO:0040001; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; mitotic sister chromatid segregation; GO:0000070; mitotic spindle elongation; GO:0000022; mitotic spindle organization and biogenesis; GO:0007052; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723; regulation of mitotic centrosome separation; GO:0046602; spindle organization and biogenesis; GO:0007051; stem cell maintenance; GO:0019827 GTP binding; GO:0005525; ; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017 "centrosome; GO:0005813; chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; fusome; GO:0045169; microtubule; GO:0005874; microtubule associated complex; GO:0005875; microtubule organizing center; GO:0005815; nucleus; GO:0005634; polar microtubule; GO:0005827; ring canal (sensu Insecta); GO:0045172; spindle; GO:0005819; spindle microtubule; GO:0005876; spindle pole; GO:0000922" chb chromosome bows "CG32435, 0686/07, chb(v40), v40, DMAP160, orbit, mast, multiple asters, MESR7, Misexpression suppressor of ras 7, Mast, MAST, Orbit/Mast, mast/orbit, orbit/mast, orbit/MAST, Orbit/MAST, MAST/Orbit, CLASP, BcDNA:LD31673, anon-WO0104295, NEST:bs28g05, NEST:bs17d05, NEST:bs13a06" CDMC29547 1 18 11 DAC18-E05 2-CG32435-RA_1 CG32435 CGAAGCTGTCAGTGCTAAATCCCAGCAAGGTTAGGCTCCTCAACGTGTACATCGAGAAGCAGCGGAACT 69 FBan0032435 FBgn0021760 chb 3 3L axon guidance; GO:0007411; centrosome cycle; GO:0007098; cystoblast division; GO:0007282; establishment of mitotic spindle localization; GO:0040001; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; mitotic sister chromatid segregation; GO:0000070; mitotic spindle elongation; GO:0000022; mitotic spindle organization and biogenesis; GO:0007052; oocyte microtubule cytoskeleton organization (sensu Insecta); GO:0048130; oogenesis (sensu Insecta); GO:0009993; ovarian fusome organization and biogenesis; GO:0030723; regulation of mitotic centrosome separation; GO:0046602; spindle organization and biogenesis; GO:0007051; stem cell maintenance; GO:0019827 GTP binding; GO:0005525; ; GO:0005525; microtubule binding; GO:0008017; ; GO:0008017 "centrosome; GO:0005813; chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; fusome; GO:0045169; microtubule; GO:0005874; microtubule associated complex; GO:0005875; microtubule organizing center; GO:0005815; nucleus; GO:0005634; polar microtubule; GO:0005827; ring canal (sensu Insecta); GO:0045172; spindle; GO:0005819; spindle microtubule; GO:0005876; spindle pole; GO:0000922" chb chromosome bows "CG32435, 0686/07, chb(v40), v40, DMAP160, orbit, mast, multiple asters, MESR7, Misexpression suppressor of ras 7, Mast, MAST, Orbit/Mast, mast/orbit, orbit/mast, orbit/MAST, Orbit/MAST, MAST/Orbit, CLASP, BcDNA:LD31673, anon-WO0104295, NEST:bs28g05, NEST:bs17d05, NEST:bs13a06" CDMC29548 1 19 11 DAC18-E17 2-CG32446-RA_1 CG32446 ACCACCTACGTCGGGGTGAAGAAATGAGACGAGTTCCTCAGCAAGTTTCAGAAGTACGGCAGGCTGAAA 69 FBan0032446 FBgn0052446 CG32446 3 3L cation transport; GO:0006812; defense response; GO:0006952; ion transport; GO:0006811; metal ion transport; GO:0030001; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; metal ion binding; GO:0046872; ; GO:0046872 CG32446 CG32446 CG12562 CDMC29548 1 20 11 DAC18-E17 2-CG32446-RA_1 CG32446 ACCACCTACGTCGGGGTGAAGAAATGAGACGAGTTCCTCAGCAAGTTTCAGAAGTACGGCAGGCTGAAA 69 FBan0032446 FBgn0052446 CG32446 3 3L cation transport; GO:0006812; defense response; GO:0006952; ion transport; GO:0006811; metal ion transport; GO:0030001; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; metal ion binding; GO:0046872; ; GO:0046872 CG32446 CG32446 CG12562 CDMC29549 1 21 11 DAC18-I05 14-CG32475-RA_1 CG32475 GGCATCTCAGAGCCTGTGTCTGTAAGACCAAACCCTGTGTACGGATTTGCTGTTTACGGGGAGAAATCT 69 FBan0032475 FBgn0052475 mthl8 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl8 methuselah-like 8 "CG11869, CG13406, CG32475, CG11869, CG13406, CG13406, CG32475, CG32475, mth-like 8, Mth-like 8, anon-WO0170980.145, anon-WO0170980.146" CDMC29549 1 22 11 DAC18-I05 14-CG32475-RA_1 CG32475 GGCATCTCAGAGCCTGTGTCTGTAAGACCAAACCCTGTGTACGGATTTGCTGTTTACGGGGAGAAATCT 69 FBan0032475 FBgn0052475 mthl8 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl8 methuselah-like 8 "CG11869, CG13406, CG32475, CG11869, CG13406, CG13406, CG32475, CG32475, mth-like 8, Mth-like 8, anon-WO0170980.145, anon-WO0170980.146" CDMC29550 1 23 11 DAC18-I17 15-CG32488-RA_6 CG32488 CCGATCCGATCGGGAAGCTATGTTCAAGCATACTTTCACAGATTTGACCAAGTTGCCGAAACAACGGGT 69 FBan0032488 FBgn0052488 CG32488 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG32488 CG32488 CG2077 CDMC29550 1 24 11 DAC18-I17 15-CG32488-RA_6 CG32488 CCGATCCGATCGGGAAGCTATGTTCAAGCATACTTTCACAGATTTGACCAAGTTGCCGAAACAACGGGT 69 FBan0032488 FBgn0052488 CG32488 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG32488 CG32488 CG2077 CDMC29551 1 25 11 DAC18-M05 18-CG32504-RA_3 CG32504 GCCGCCGATTACACACATGGGAGCTGTAAACCGCGTTTTATGATTTCCCTTCATTTTTTTATGGACCCA 69 FBan0032504 FBgn0052504 CG32504 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32504 CG32504 CDMC29551 1 26 11 DAC18-M05 18-CG32504-RA_3 CG32504 GCCGCCGATTACACACATGGGAGCTGTAAACCGCGTTTTATGATTTCCCTTCATTTTTTTATGGACCCA 69 FBan0032504 FBgn0052504 CG32504 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32504 CG32504 CDMC29552 1 1 12 DAC18-M17 12-CG3251-RA_4 CG3251 CGCCTGCCAGATGTTGATCTCGCTGTGGAATGGATGCTGTATCCAGATACCTTCAAAATGGGCACTGAA 69 FBan0003251 FBgn0031622 CG3251 2 2L CG3251 CG3251 CDMC29552 1 2 12 DAC18-M17 12-CG3251-RA_4 CG3251 CGCCTGCCAGATGTTGATCTCGCTGTGGAATGGATGCTGTATCCAGATACCTTCAAAATGGGCACTGAA 69 FBan0003251 FBgn0031622 CG3251 2 2L CG3251 CG3251 CDMC29553 1 3 12 DAC19-A05 23-CG8111-RA_2 CG8111 TTCATTGTTGAGCCAAATTGATCGCATTTGCCATTTATCCCTCGGCCAATAAAAACTTAACACTT 65 FBan0008111 FBgn0035825 CG8111 3 3L CG8111 CG8111 CDMC29553 1 4 12 DAC19-A05 23-CG8111-RA_2 CG8111 TTCATTGTTGAGCCAAATTGATCGCATTTGCCATTTATCCCTCGGCCAATAAAAACTTAACACTT 65 FBan0008111 FBgn0035825 CG8111 3 3L CG8111 CG8111 CDMC29554 1 5 12 DAC19-A17 23-CG8157-RA_1 CG8157 ACCTGCTGTTTTCGTGAACCAAATATTAAGGAGACCACGGATCCTGGAGATAACTCGCAAACGAA 65 FBan0008157 FBgn0034010 CG8157 2 2R CG8157 CG8157 BcDNA:RE07473 CDMC29554 1 6 12 DAC19-A17 23-CG8157-RA_1 CG8157 ACCTGCTGTTTTCGTGAACCAAATATTAAGGAGACCACGGATCCTGGAGATAACTCGCAAACGAA 65 FBan0008157 FBgn0034010 CG8157 2 2R CG8157 CG8157 BcDNA:RE07473 CDMC29555 1 7 12 DAC19-E05 11-CG8239-RA_1 CG8239 CTGCCTGGTGTACTCCCTGTCCCGACTCTACGATATACCGCTGAATGAGGAGCTGACGACGGTGG 65 FBan0008239 FBgn0030683 CG8239 X X cholesterol metabolism; GO:0008203; isoprenoid biosynthesis; GO:0008299; phosphorylation; GO:0016310 ATP binding; GO:0005524; ; GO:0005524; kinase activity; GO:0016301; ; GO:0016301; diphosphomevalonate decarboxylase activity; GO:0004163 ; EC:4.1.1.33; ; GO:0004163 ; EC:4.1.1.33 CG8239 CG8239 CDMC29555 1 8 12 DAC19-E05 11-CG8239-RA_1 CG8239 CTGCCTGGTGTACTCCCTGTCCCGACTCTACGATATACCGCTGAATGAGGAGCTGACGACGGTGG 65 FBan0008239 FBgn0030683 CG8239 X X cholesterol metabolism; GO:0008203; isoprenoid biosynthesis; GO:0008299; phosphorylation; GO:0016310 ATP binding; GO:0005524; ; GO:0005524; kinase activity; GO:0016301; ; GO:0016301; diphosphomevalonate decarboxylase activity; GO:0004163 ; EC:4.1.1.33; ; GO:0004163 ; EC:4.1.1.33 CG8239 CG8239 CDMC29556 1 9 12 DAC19-E17 3-CG8258-RA_1 CG8258 GGAGTTGGGCTACTGCGACAAAGTTTGCATCGAGGAACTGGGAGACACCACAATTGTGGCCTTCA 65 FBan0008258 FBgn0033342 CG8258 2 2R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG8258 CG8258 CDMC29556 1 10 12 DAC19-E17 3-CG8258-RA_1 CG8258 GGAGTTGGGCTACTGCGACAAAGTTTGCATCGAGGAACTGGGAGACACCACAATTGTGGCCTTCA 65 FBan0008258 FBgn0033342 CG8258 2 2R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG8258 CG8258 CDMC29557 1 11 12 DAC19-I05 1-CG8340-RA_1 CG8340 ATGCGGACATCACCCTGAGATACGACGCCACTAGTGACGACCTCATTGACGTTATCGAGGGCAAC 65 FBan0008340 FBgn0010339 128up 2 2R "GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" 128up upstream of RpIII128 "CG8340, CG8340, GTP-bp, X71866" CDMC29557 1 12 12 DAC19-I05 1-CG8340-RA_1 CG8340 ATGCGGACATCACCCTGAGATACGACGCCACTAGTGACGACCTCATTGACGTTATCGAGGGCAAC 65 FBan0008340 FBgn0010339 128up 2 2R "GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" 128up upstream of RpIII128 "CG8340, CG8340, GTP-bp, X71866" CDMC29558 1 13 12 DAC19-I17 3-CG8370-RA_2 CG8370 CAGAAAGCCAGAGCGAAAACAGCGCCAGAAGTTGAATTTTGGGCAGACCACGAATAGCACGTCGC 65 FBan0008370 FBgn0034060 CG8370 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8370 CG8370 CDMC29558 1 14 12 DAC19-I17 3-CG8370-RA_2 CG8370 CAGAAAGCCAGAGCGAAAACAGCGCCAGAAGTTGAATTTTGGGCAGACCACGAATAGCACGTCGC 65 FBan0008370 FBgn0034060 CG8370 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8370 CG8370 CDMC29559 1 15 12 DAC19-M05 27-CG8453-RA_1 CG8453 TAACCTGTTCTTCGTCAGGGATGCCCATTGGAAGGGAATTCGCACCAAGCTGACTCCCGTTTTCA 65 FBan0008453 FBgn0025454 Cyp6g1 2 2R electron transport; GO:0006118; response to DDT; GO:0046680; response to insecticide; GO:0017085; response to organophosphorus; GO:0046683 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g1 Cyp6g1 "CG8453, CG8453, CG8453, RI, RDDT, CYP6-like, cyp6g1, 6g1, Rst(2)DDT: Resistance to DDT, Cyp6gl, anon-WO03025223.16, anon-WO03025223.17, Cyp6-like, RI[DDT]: Resistance to Insecticide-DDT, RI[II]: Resistance to Insecticide on chromosome 2, Resistance to DDT, Resistance to Insecticide-DDT, Resistance to Insecticide on chromosome 2, Rst(2)DDT" CDMC29559 1 16 12 DAC19-M05 27-CG8453-RA_1 CG8453 TAACCTGTTCTTCGTCAGGGATGCCCATTGGAAGGGAATTCGCACCAAGCTGACTCCCGTTTTCA 65 FBan0008453 FBgn0025454 Cyp6g1 2 2R electron transport; GO:0006118; response to DDT; GO:0046680; response to insecticide; GO:0017085; response to organophosphorus; GO:0046683 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g1 Cyp6g1 "CG8453, CG8453, CG8453, RI, RDDT, CYP6-like, cyp6g1, 6g1, Rst(2)DDT: Resistance to DDT, Cyp6gl, anon-WO03025223.16, anon-WO03025223.17, Cyp6-like, RI[DDT]: Resistance to Insecticide-DDT, RI[II]: Resistance to Insecticide on chromosome 2, Resistance to DDT, Resistance to Insecticide-DDT, Resistance to Insecticide on chromosome 2, Rst(2)DDT" CDMC29560 1 17 12 DAC19-M17 2-CG8483-RA_1 CG8483 ACGGTGATTTCCCCTCTCGCATCCAGAGTTGGTTTAACGAGGTGCAGAAGTACTCCTTCGGGGAC 65 FBan0008483 FBgn0038126 CG8483 3 3R defense response; GO:0006952 extracellular region; GO:0005576 CG8483 CG8483 CDMC29560 1 18 12 DAC19-M17 2-CG8483-RA_1 CG8483 ACGGTGATTTCCCCTCTCGCATCCAGAGTTGGTTTAACGAGGTGCAGAAGTACTCCTTCGGGGAC 65 FBan0008483 FBgn0038126 CG8483 3 3R defense response; GO:0006952 extracellular region; GO:0005576 CG8483 CG8483 CDMC29561 1 19 12 DAC20-A05 7-CG7653-RA_1 CG7653 TCCTTGGTGCCTCTTTCATCGAACGCCAGTTTAAATGCAGAGACGCAACTGTATCAGAAGGCCACCTCT 69 FBan0007653 FBgn0028935 CG7653 2 2L proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; zinc ion binding; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 plasma membrane; GO:0005886 CG7653 CG7653 BG:DS00365.1 CDMC29561 1 20 12 DAC20-A05 7-CG7653-RA_1 CG7653 TCCTTGGTGCCTCTTTCATCGAACGCCAGTTTAAATGCAGAGACGCAACTGTATCAGAAGGCCACCTCT 69 FBan0007653 FBgn0028935 CG7653 2 2L proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; zinc ion binding; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 plasma membrane; GO:0005886 CG7653 CG7653 BG:DS00365.1 CDMC29562 1 21 12 DAC20-A17 14-CG7662-RB_1 CG7662 ACGCTACACACCAAAGGTTCTCGAGGAAATGGAAATGCGATTTGATAAGCAACGCAACACACGTCGTCG 69 FBan0007662 FBgn0039269 veli 3 3R cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; ; GO:0005515 postsynaptic membrane; GO:0045211; subapical complex; GO:0035003 veli veli "CG7662, CG7662, D-veli, Flin-7, Dveli, Lin-7, DLin-7, d-Veli, lin-7" CDMC29562 1 22 12 DAC20-A17 14-CG7662-RB_1 CG7662 ACGCTACACACCAAAGGTTCTCGAGGAAATGGAAATGCGATTTGATAAGCAACGCAACACACGTCGTCG 69 FBan0007662 FBgn0039269 veli 3 3R cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; ; GO:0005515 postsynaptic membrane; GO:0045211; subapical complex; GO:0035003 veli veli "CG7662, CG7662, D-veli, Flin-7, Dveli, Lin-7, DLin-7, d-Veli, lin-7" CDMC29563 1 23 12 DAC20-E05 2-CG7706-RA_2 CG7706 AGGAGGCCCAAAAAAGGAAGCAGCTCAAAAATCGGGACTCTGATGACGAAGATGAGTTTTGGGACCGCA 69 FBan0007706 FBgn0038640 CG7706 3 3R anion exchanger adaptor activity; GO:0017107; ; GO:0017107 CG7706 CG7706 CDMC29563 1 24 12 DAC20-E05 2-CG7706-RA_2 CG7706 AGGAGGCCCAAAAAAGGAAGCAGCTCAAAAATCGGGACTCTGATGACGAAGATGAGTTTTGGGACCGCA 69 FBan0007706 FBgn0038640 CG7706 3 3R anion exchanger adaptor activity; GO:0017107; ; GO:0017107 CG7706 CG7706 CDMC29564 1 25 12 DAC20-E17 23-CG7715-RA_1 CG7715 AGTTCAATGCCCATCTTTCAGCAAGCGGAATTTCATTCACTACTCTAAATAGCAATCTAAAGTAATTAA 69 FBan0007715 FBgn0038646 CG7715 3 3R CG7715 CG7715 CDMC29564 1 26 12 DAC20-E17 23-CG7715-RA_1 CG7715 AGTTCAATGCCCATCTTTCAGCAAGCGGAATTTCATTCACTACTCTAAATAGCAATCTAAAGTAATTAA 69 FBan0007715 FBgn0038646 CG7715 3 3R CG7715 CG7715 CDMC29565 1 1 13 DAC20-I05 13-CG7755-RA_1 CG7755 TGCCGTTTTCAAACCGCTCCAGACGAAACTATCGCTGACCAATTATGCCAATCTAAGTGCATACGGCAT 69 FBan0007755 FBgn0034105 CG7755 2 2R isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759 CG7755 CG7755 CDMC29565 1 2 13 DAC20-I05 13-CG7755-RA_1 CG7755 TGCCGTTTTCAAACCGCTCCAGACGAAACTATCGCTGACCAATTATGCCAATCTAAGTGCATACGGCAT 69 FBan0007755 FBgn0034105 CG7755 2 2R isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759 CG7755 CG7755 CDMC29566 1 3 13 DAC20-I17 3-CG7764-RA_3 CG7764 TCAGGACTGTGGCTACATTGTGGTGGAGACGAACTACCGAGTGTATGCCTACACTGATTCTCCGCTCCA 69 FBan0007764 FBgn0036513 Tfb2 3 3L "DNA repair; GO:0006281; RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 transcription factor TFIIH complex; GO:0005675 Tfb2 Tfb2 "CG7764, CG7764, TFB2, anon-WO0118547.648" CDMC29566 1 4 13 DAC20-I17 3-CG7764-RA_3 CG7764 TCAGGACTGTGGCTACATTGTGGTGGAGACGAACTACCGAGTGTATGCCTACACTGATTCTCCGCTCCA 69 FBan0007764 FBgn0036513 Tfb2 3 3L "DNA repair; GO:0006281; RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 transcription factor TFIIH complex; GO:0005675 Tfb2 Tfb2 "CG7764, CG7764, TFB2, anon-WO0118547.648" CDMC29567 1 5 13 DAC20-M05 2-CG7798-RA_1 CG7798 TGAGCGACGATATCCGGTATTCCATTGCCTGTGCGAAGTACATCAGGAAACAGCAAGGATTCTCCGCCT 69 FBan0007798 FBgn0034092 CG7798 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG7798 CG7798 CDMC29567 1 6 13 DAC20-M05 2-CG7798-RA_1 CG7798 TGAGCGACGATATCCGGTATTCCATTGCCTGTGCGAAGTACATCAGGAAACAGCAAGGATTCTCCGCCT 69 FBan0007798 FBgn0034092 CG7798 2 2R antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG7798 CG7798 CDMC29568 1 7 13 DAC20-M17 16-CG7810-RA_1 CG7810 CCGGTCGAAGAGAAGCAACAAATAGCACGAGATGCCTTCGATAAGAACCGTGAGAACTTTCTCATCCGA 69 FBan0007810 FBgn0032017 CG7810 2 2L CG7810 CG7810 CDMC29568 1 8 13 DAC20-M17 16-CG7810-RA_1 CG7810 CCGGTCGAAGAGAAGCAACAAATAGCACGAGATGCCTTCGATAAGAACCGTGAGAACTTTCTCATCCGA 69 FBan0007810 FBgn0032017 CG7810 2 2L CG7810 CG7810 CDMC29569 1 9 13 DAC21-A05 18-CG2533-RA_1 CG2533 CCCCAAGAGCCAAAATTCCACTTTCTTTGACCTTCCCTTAGACTCCGAATGAATCTCATTCACCCGAGG 69 FBan0002533 FBgn0030319 CG2533 X X CG2533 CG2533 BcDNA:AT28768 CDMC29569 1 10 13 DAC21-A05 18-CG2533-RA_1 CG2533 CCCCAAGAGCCAAAATTCCACTTTCTTTGACCTTCCCTTAGACTCCGAATGAATCTCATTCACCCGAGG 69 FBan0002533 FBgn0030319 CG2533 X X CG2533 CG2533 BcDNA:AT28768 CDMC29570 1 11 13 DAC21-A17 18-CG2577-RA_2 CG2577 CGATTTCGGGCTATCCAAGAAGTATCTGGACATAACCACTGGTGTCCATATACCATATCGCGAGGAGCG 69 FBan0002577 FBgn0030384 CG2577 X X intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG2577 CG2577 CKIa-like CDMC29570 1 12 13 DAC21-A17 18-CG2577-RA_2 CG2577 CGATTTCGGGCTATCCAAGAAGTATCTGGACATAACCACTGGTGTCCATATACCATATCGCGAGGAGCG 69 FBan0002577 FBgn0030384 CG2577 X X intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG2577 CG2577 CKIa-like CDMC29571 1 13 13 DAC21-E05 22-CG2668-RA_2 CG2668 CCTGGTGGTATCCTTCCTGGTCATTTAGACGGTTCGGTAGTTCCAAATAGTGTGCTAAATGTTGCTGGC 69 FBan0002668 FBgn0004181 Peb 2 2R mating plug formation; GO:0042628; post-mating behavior; GO:0045297 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Peb Protein ejaculatory bulb "CG2668, CG2668, CG2668, peb, PEB, PEB-me, P38, anon-WO0140519.140, BcDNA:GH06048" CDMC29571 1 14 13 DAC21-E05 22-CG2668-RA_2 CG2668 CCTGGTGGTATCCTTCCTGGTCATTTAGACGGTTCGGTAGTTCCAAATAGTGTGCTAAATGTTGCTGGC 69 FBan0002668 FBgn0004181 Peb 2 2R mating plug formation; GO:0042628; post-mating behavior; GO:0045297 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Peb Protein ejaculatory bulb "CG2668, CG2668, CG2668, peb, PEB, PEB-me, P38, anon-WO0140519.140, BcDNA:GH06048" CDMC29572 1 15 13 DAC21-E17 3-CG2677-RA_2 CG2677 GCGAAGCCAAGGTATACAGTCCCATGTTCGACTACGTGCCTCCGGAACTGGTCACCCTTTTCATATCCA 69 FBan0002677 FBgn0024996 eIF2B-beta X X translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-beta eIF2B-beta "CG2677, CG2677, CG2677, DMC100G10.3, eIF2Bbeta, EG:100G10.3, eIF2B-beta" CDMC29572 1 16 13 DAC21-E17 3-CG2677-RA_2 CG2677 GCGAAGCCAAGGTATACAGTCCCATGTTCGACTACGTGCCTCCGGAACTGGTCACCCTTTTCATATCCA 69 FBan0002677 FBgn0024996 eIF2B-beta X X translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-beta eIF2B-beta "CG2677, CG2677, CG2677, DMC100G10.3, eIF2Bbeta, EG:100G10.3, eIF2B-beta" CDMC29573 1 17 13 DAC21-I05 8-CG2720-RA_1 CG2720 TCTGGGCCTCAAGGACTGCGACACTTGCATCAAGCTAGACGAAAAGTTCATAAAGGGCTACATCCGCAA 69 FBan0002720 FBgn0024352 Hop 2 2L defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 Hop Hsp70/Hsp90 organizing protein homolog "CG2720, l(2)k00616, dSTI1, dhop, Hsp70/Hsp90 organizing protein homolog, EP(2)0418, dmSTI1, dHop, Sti1" CDMC29573 1 18 13 DAC21-I05 8-CG2720-RA_1 CG2720 TCTGGGCCTCAAGGACTGCGACACTTGCATCAAGCTAGACGAAAAGTTCATAAAGGGCTACATCCGCAA 69 FBan0002720 FBgn0024352 Hop 2 2L defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 Hop Hsp70/Hsp90 organizing protein homolog "CG2720, l(2)k00616, dSTI1, dhop, Hsp70/Hsp90 organizing protein homolog, EP(2)0418, dmSTI1, dHop, Sti1" CDMC29574 1 19 13 DAC21-I17 15-CG2781-RA_1 CG2781 GCCCATGCGGTTATGTTCTACTTCCTGTTCTCAAACTTCTACAAGCGTGCCTATGTGAAACGCGATGGC 69 FBan0002781 FBgn0037534 CG2781 3 3R fatty acid elongation; GO:0030497; fatty acid metabolism; GO:0006631; very-long-chain fatty acid biosynthesis; GO:0042761 "1,3-beta-glucan synthase activity; GO:0003843 ; EC:2.4.1.34; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003843 ; EC:2.4.1.34; fatty acid elongase activity; GO:0009922; ; GO:0009922" integral to membrane; GO:0016021 CG2781 CG2781 CDMC29574 1 20 13 DAC21-I17 15-CG2781-RA_1 CG2781 GCCCATGCGGTTATGTTCTACTTCCTGTTCTCAAACTTCTACAAGCGTGCCTATGTGAAACGCGATGGC 69 FBan0002781 FBgn0037534 CG2781 3 3R fatty acid elongation; GO:0030497; fatty acid metabolism; GO:0006631; very-long-chain fatty acid biosynthesis; GO:0042761 "1,3-beta-glucan synthase activity; GO:0003843 ; EC:2.4.1.34; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003843 ; EC:2.4.1.34; fatty acid elongase activity; GO:0009922; ; GO:0009922" integral to membrane; GO:0016021 CG2781 CG2781 CDMC29575 1 21 13 DAC21-M05 3-CG2843-RA_6 CG2843 GCGAAATGGAATCCCGTCGAAAGCTGCTTGAGAACCCCGTCAAGCTGAAGGAAATCCATCGCATTCTCA 69 FBan0002843 FBgn0031452 CG2843 2 2L CG2843 CG2843 CDMC29575 1 22 13 DAC21-M05 3-CG2843-RA_6 CG2843 GCGAAATGGAATCCCGTCGAAAGCTGCTTGAGAACCCCGTCAAGCTGAAGGAAATCCATCGCATTCTCA 69 FBan0002843 FBgn0031452 CG2843 2 2L CG2843 CG2843 CDMC29576 1 23 13 DAC21-M17 5-CG2862-RB_1 CG2862 AGCCGCCAGTGAAGACACCATTTTCGGCAAGATTTTGCGCAAGGAGATCCCATGCAAATTTATCCACGA 69 FBan0002862 FBgn0031459 CG2862 2 2L nucleotide phosphatase activity; GO:0019204; ; GO:0019204; nucleotidase activity; GO:0008252 ; EC:3.1.3.31; ; GO:0008252 ; EC:3.1.3.31 CG2862 CG2862 CDMC29576 1 24 13 DAC21-M17 5-CG2862-RB_1 CG2862 AGCCGCCAGTGAAGACACCATTTTCGGCAAGATTTTGCGCAAGGAGATCCCATGCAAATTTATCCACGA 69 FBan0002862 FBgn0031459 CG2862 2 2L nucleotide phosphatase activity; GO:0019204; ; GO:0019204; nucleotidase activity; GO:0008252 ; EC:3.1.3.31; ; GO:0008252 ; EC:3.1.3.31 CG2862 CG2862 CDMC29577 1 25 13 DAC22-A05 16-CG14503-RA_1 CG14503 AGCAGCAACAGCAACATCAGCAGATAAAAGGCAGACAAAAGGCACGAGATGTGAGAGACGTCTAG 65 FBan0014503 FBgn0040737 CG14503 2 2R CG14503 CG14503 CDMC29577 1 26 13 DAC22-A05 16-CG14503-RA_1 CG14503 AGCAGCAACAGCAACATCAGCAGATAAAAGGCAGACAAAAGGCACGAGATGTGAGAGACGTCTAG 65 FBan0014503 FBgn0040737 CG14503 2 2R CG14503 CG14503 CDMC29578 1 1 14 DAC22-A17 9-CG14532-RA_5 CG14532 GACGCCACTGCATGCAGTATCCACTTTCGTACTATCCACTATCCAGTGTCCCGAACCCCAAGCCC 65 FBan0014532 FBgn0031966 CG14532 2 2L CG14532 CG14532 CDMC29578 1 2 14 DAC22-A17 9-CG14532-RA_5 CG14532 GACGCCACTGCATGCAGTATCCACTTTCGTACTATCCACTATCCAGTGTCCCGAACCCCAAGCCC 65 FBan0014532 FBgn0031966 CG14532 2 2L CG14532 CG14532 CDMC29579 1 3 14 DAC22-E05 2-CG14625-RB_1 CG14625 CATCCCAGACAAGAGGCGATTAAGAAGCAACTGCGCTCATCGGAGGTCAAGGACTTGGAAGCCAG 65 FBan0014625 FBgn0040358 CG14625 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14625 CG14625 EG:BACR42I17.8 CDMC29579 1 4 14 DAC22-E05 2-CG14625-RB_1 CG14625 CATCCCAGACAAGAGGCGATTAAGAAGCAACTGCGCTCATCGGAGGTCAAGGACTTGGAAGCCAG 65 FBan0014625 FBgn0040358 CG14625 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14625 CG14625 EG:BACR42I17.8 CDMC29580 1 5 14 DAC22-E17 2-CG1463-RA_1 CG1463 AGGCAAGCCTTCCCCGGAATGTAACTCGATTTGTGGACAAGGAATGCAATGAGGAGCTCACGCTG 65 FBan0001463 FBgn0030406 CG1463 X X CG1463 CG1463 CDMC29580 1 6 14 DAC22-E17 2-CG1463-RA_1 CG1463 AGGCAAGCCTTCCCCGGAATGTAACTCGATTTGTGGACAAGGAATGCAATGAGGAGCTCACGCTG 65 FBan0001463 FBgn0030406 CG1463 X X CG1463 CG1463 CDMC29581 1 7 14 DAC22-I05 1-CG14745-RA_3 CG14745 TATCGGCATCTCCTTCCTGGGCAACTACAATACCAACACCCTCACCTCTGCTCAGATCACCGCTG 65 FBan0014745 FBgn0043575 PGRP-SC2 2 2R defense response; GO:0006952; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SC2 PGRP-SC2 "CG14745, CG14745, CG14745, CG14745, PGRP-SC" CDMC29581 1 8 14 DAC22-I05 1-CG14745-RA_3 CG14745 TATCGGCATCTCCTTCCTGGGCAACTACAATACCAACACCCTCACCTCTGCTCAGATCACCGCTG 65 FBan0014745 FBgn0043575 PGRP-SC2 2 2R defense response; GO:0006952; immune response; GO:0006955; innate immune response; GO:0045087; peptidoglycan catabolism; GO:0009253 N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28; ; GO:0042834 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SC2 PGRP-SC2 "CG14745, CG14745, CG14745, CG14745, PGRP-SC" CDMC29582 1 9 14 DAC22-I17 1-CG14773-RA_1 CG14773 AAGCCGGCCCAAAAGCAGCTGCCAAACAAGAGGCTGTATTTTCATTTGTCCAAGTGCAACAGCAG 65 FBan0014773 FBgn0040895 CG14773 X X CG14773 CG14773 CDMC29582 1 10 14 DAC22-I17 1-CG14773-RA_1 CG14773 AAGCCGGCCCAAAAGCAGCTGCCAAACAAGAGGCTGTATTTTCATTTGTCCAAGTGCAACAGCAG 65 FBan0014773 FBgn0040895 CG14773 X X CG14773 CG14773 CDMC29583 1 11 14 DAC22-M05 6-CG14839-RA_1 CG14839 CAGCGCAAGAGGCCAAACAGCGTATAGATCAATCGGAGTGTGAAGGCGGTTCTCGTGGCAGAAGG 65 FBan0014839 FBgn0038219 CG14839 3 3R CG14839 CG14839 CDMC29583 1 12 14 DAC22-M05 6-CG14839-RA_1 CG14839 CAGCGCAAGAGGCCAAACAGCGTATAGATCAATCGGAGTGTGAAGGCGGTTCTCGTGGCAGAAGG 65 FBan0014839 FBgn0038219 CG14839 3 3R CG14839 CG14839 CDMC29584 1 13 14 DAC22-M17 3-CG14865-RA_1 CG14865 GTACGACAAAGTCAAGTCCGTGGACATAGAGAACTGGGAGAACAAACGCGGTCCACGTCCCTGGG 65 FBgn0038314 CDMC29584 1 14 14 DAC22-M17 3-CG14865-RA_1 CG14865 GTACGACAAAGTCAAGTCCGTGGACATAGAGAACTGGGAGAACAAACGCGGTCCACGTCCCTGGG 65 FBgn0038314 CDMC29585 1 15 14 DAC23-A05 2-CG6734-RA_4 CG6734 GCGATTCGGGCATTCATCTGTGGGATCCGTTTATAGGAAGACCGCTTTCCGTACTGGATGCTCCTCGTC 69 FBan0006734 FBgn0032395 CG6734 2 2L sphingomyelin phosphodiesterase activator activity; GO:0016230; ; GO:0016230 CG6734 CG6734 CDMC29585 1 16 14 DAC23-A05 2-CG6734-RA_4 CG6734 GCGATTCGGGCATTCATCTGTGGGATCCGTTTATAGGAAGACCGCTTTCCGTACTGGATGCTCCTCGTC 69 FBan0006734 FBgn0032395 CG6734 2 2L sphingomyelin phosphodiesterase activator activity; GO:0016230; ; GO:0016230 CG6734 CG6734 CDMC29586 1 17 14 DAC23-A17 15-CG6747-RA_2 CG6747 TGTTCATCTGGCCCACTACCATAGTGCACAAAATTGATAGGAACAGTCCACTGTACATGCTCTCCGCCT 69 FBan0006747 FBgn0039061 Ir 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; ; GO:0005242; ATP-activated inward rectifier potassium channel activity; GO:0015272; ; GO:0015272 membrane; GO:0016020 Ir Inwardly rectifying potassium channel "CG6747, irk1, DIR, dKirI, Dir, Drosophila inward rectifier" CDMC29586 1 18 14 DAC23-A17 15-CG6747-RA_2 CG6747 TGTTCATCTGGCCCACTACCATAGTGCACAAAATTGATAGGAACAGTCCACTGTACATGCTCTCCGCCT 69 FBan0006747 FBgn0039061 Ir 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; ; GO:0005242; ATP-activated inward rectifier potassium channel activity; GO:0015272; ; GO:0015272 membrane; GO:0016020 Ir Inwardly rectifying potassium channel "CG6747, irk1, DIR, dKirI, Dir, Drosophila inward rectifier" CDMC29587 1 19 14 DAC23-E05 3-CG6778-RB_8 CG6778 CCGATCGGGATTGATCCGTGTGCGAGAGTTCACCATGGCAGAGATTGAACATTTCTGTGATCCCGTGCT 69 FBgn0036477 CDMC29587 1 20 14 DAC23-E05 3-CG6778-RB_8 CG6778 CCGATCGGGATTGATCCGTGTGCGAGAGTTCACCATGGCAGAGATTGAACATTTCTGTGATCCCGTGCT 69 FBgn0036477 CDMC29588 1 21 14 DAC23-E17 8-CG6792-RA_1 CG6792 GGAAACGGTGGACAGTAGCTTTCCCGATGACTTTGAGCTTCCCGTGATCGAAACGTCACCCAAGAAGAA 69 FBan0006792 FBgn0032401 CG6792 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG6792 CG6792 CDMC29588 1 22 14 DAC23-E17 8-CG6792-RA_1 CG6792 GGAAACGGTGGACAGTAGCTTTCCCGATGACTTTGAGCTTCCCGTGATCGAAACGTCACCCAAGAAGAA 69 FBan0006792 FBgn0032401 CG6792 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG6792 CG6792 CDMC29589 1 23 14 DAC23-I05 12-CG6829-RB_6 CG6829 AGGCCAAGATCAGCTATTTGGTAGCCACGGATGATGGTACCATGTTGGCTATGGGTTTCGAAAATGGCA 69 FBan0006829 FBgn0024252 Ark 2 2R apoptosis; GO:0006915; caspase activation; GO:0006919; caspase activation via cytochrome c; GO:0008635; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of retinal programmed cell death; GO:0046668; response to DNA damage stimulus; GO:0006974; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activator activity; GO:0008656; ; GO:0008656; ; GO:0005515; ; GO:0008656 Ark Apaf-1-related-killer "CG6829, CG6829, T1, Transcription unit 1, dark, Dark, Drosophila Apaf-1-related killer, dapaf-1L, dapaf-1S, DARK, Apaf-1 related killer, Hac1, dapaf-1, hac-1, Hac-1/Dark, ark, dark/hac-1/dapaf-1, dark/dapaf-1/hac-1, dApaf-1/DARK/HAC-1, arc, Hac-1, dApaf-1, Dapaf-1, ARK, dArk, Dark/Hac-1/dApaf-1, dapaf, D-Apaf-1, Dark/Dapaf-1/HAC1, anon-53Fa" CDMC29589 1 24 14 DAC23-I05 12-CG6829-RB_6 CG6829 AGGCCAAGATCAGCTATTTGGTAGCCACGGATGATGGTACCATGTTGGCTATGGGTTTCGAAAATGGCA 69 FBan0006829 FBgn0024252 Ark 2 2R apoptosis; GO:0006915; caspase activation; GO:0006919; caspase activation via cytochrome c; GO:0008635; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of retinal programmed cell death; GO:0046668; response to DNA damage stimulus; GO:0006974; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activator activity; GO:0008656; ; GO:0008656; ; GO:0005515; ; GO:0008656 Ark Apaf-1-related-killer "CG6829, CG6829, T1, Transcription unit 1, dark, Dark, Drosophila Apaf-1-related killer, dapaf-1L, dapaf-1S, DARK, Apaf-1 related killer, Hac1, dapaf-1, hac-1, Hac-1/Dark, ark, dark/hac-1/dapaf-1, dark/dapaf-1/hac-1, dApaf-1/DARK/HAC-1, arc, Hac-1, dApaf-1, Dapaf-1, ARK, dArk, Dark/Hac-1/dApaf-1, dapaf, D-Apaf-1, Dark/Dapaf-1/HAC1, anon-53Fa" CDMC29590 1 25 14 DAC23-I17 15-CG6836-RA_1 CG6836 CCAACTGGTGGTGATGCTTTGCAAACTGCAGTACCTGGTACTCTATGATCAGCTGGACGGCATCAAAAT 69 FBan0006836 FBgn0036834 CG6836 3 3L CG6836 CG6836 CDMC29590 1 26 14 DAC23-I17 15-CG6836-RA_1 CG6836 CCAACTGGTGGTGATGCTTTGCAAACTGCAGTACCTGGTACTCTATGATCAGCTGGACGGCATCAAAAT 69 FBan0006836 FBgn0036834 CG6836 3 3L CG6836 CG6836 CDMC29591 1 1 15 DAC23-M05 23-CG6874-RA_2 CG6874 GGAGCCACAGAAAGATAGCCGCCATTTGGAGATTTCCTTGAAGTTTATAATTTTAACATGTTTAATGAT 69 FBan0006874 FBgn0036815 l(3)neo26 3 3L l(3)neo26 lethal (3) neo26 "CG6874, CG6874, CG6874, CG6874, BcDNA:RE10558" CDMC29591 1 2 15 DAC23-M05 23-CG6874-RA_2 CG6874 GGAGCCACAGAAAGATAGCCGCCATTTGGAGATTTCCTTGAAGTTTATAATTTTAACATGTTTAATGAT 69 FBan0006874 FBgn0036815 l(3)neo26 3 3L l(3)neo26 lethal (3) neo26 "CG6874, CG6874, CG6874, CG6874, BcDNA:RE10558" CDMC29592 1 3 15 DAC23-M17 23-CG6888-RA_1 CG6888 AATACAAAACCGTCAAGATGCGTATGCTCAATATTAACCAAGTGGCTCCTAATTTTACTACCAATGCGG 69 FBan0006888 FBgn0036490 CG6888 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0008379 ; EC:1.11.1.- CG6888 CG6888 BcDNA:AT16346 CDMC29592 1 4 15 DAC23-M17 23-CG6888-RA_1 CG6888 AATACAAAACCGTCAAGATGCGTATGCTCAATATTAACCAAGTGGCTCCTAATTTTACTACCAATGCGG 69 FBan0006888 FBgn0036490 CG6888 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; ; GO:0008379 ; EC:1.11.1.- CG6888 CG6888 BcDNA:AT16346 CDMC29593 1 5 15 DAC24-A05 23-CG2152-RA_1 CG2152 GGTACAATATTATAACAAACTAAACAAAACAACAAGACGGTGGAAAAAGGGAATCTTGTGGTGCGGATT 69 FBan0002152 FBgn0015276 Pcmt 3 3R protein modification; GO:0006464; protein repair; GO:0030091 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; GO:0004719 ; EC:2.1.1.77; ; GO:0004719 ; EC:2.1.1.77; ; GO:0004719 ; EC:2.1.1.77 cytoplasm; GO:0005737 Pcmt Protein-L-isoaspartate (D-aspartate) O-methyltransferase "CG2152, protein D-aspartyl, L-isoaspartyl O-methyltransferase" CDMC29593 1 6 15 DAC24-A05 23-CG2152-RA_1 CG2152 GGTACAATATTATAACAAACTAAACAAAACAACAAGACGGTGGAAAAAGGGAATCTTGTGGTGCGGATT 69 FBan0002152 FBgn0015276 Pcmt 3 3R protein modification; GO:0006464; protein repair; GO:0030091 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; GO:0004719 ; EC:2.1.1.77; ; GO:0004719 ; EC:2.1.1.77; ; GO:0004719 ; EC:2.1.1.77 cytoplasm; GO:0005737 Pcmt Protein-L-isoaspartate (D-aspartate) O-methyltransferase "CG2152, protein D-aspartyl, L-isoaspartyl O-methyltransferase" CDMC29594 1 7 15 DAC24-A17 9-CG2163-RB_1 CG2163 CGCCGGAAGCTTTTGCGCCAACAAAACCGAGCTTTTGTAGCAGACGTAAACAAACCCAAATCCAAAGCA 69 FBan0002163 FBgn0005648 Pabp2 2 2R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143 nucleus; GO:0005634 Pabp2 Pabp2 "CG2163, CG2163, ROX2, dpabII, polyA-binding protein II, rox2, pAbp2, pabp2, Rox2" CDMC29594 1 8 15 DAC24-A17 9-CG2163-RB_1 CG2163 CGCCGGAAGCTTTTGCGCCAACAAAACCGAGCTTTTGTAGCAGACGTAAACAAACCCAAATCCAAAGCA 69 FBan0002163 FBgn0005648 Pabp2 2 2R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143 nucleus; GO:0005634 Pabp2 Pabp2 "CG2163, CG2163, ROX2, dpabII, polyA-binding protein II, rox2, pAbp2, pabp2, Rox2" CDMC29595 1 9 15 DAC24-E05 23-CG2200-RA_2 CG2200 GCTGCAGAAATAACCAAGCAAAACGATCGAATTAAAGAGAACATTGATGTTTATTGTACATATGCACAT 69 FBan0002200 FBgn0030447 CG2200 X X proteolysis; GO:0006508 dipeptidase E activity; GO:0017165 ; EC:3.4.13.21; serine-type peptidase activity; GO:0008236; ; GO:0008236; dipeptidyl-peptidase activity; GO:0008239; ; GO:0017165 ; EC:3.4.13.21; ; GO:0008239 cytoplasm; GO:0005737 CG2200 CG2200 CDMC29595 1 10 15 DAC24-E05 23-CG2200-RA_2 CG2200 GCTGCAGAAATAACCAAGCAAAACGATCGAATTAAAGAGAACATTGATGTTTATTGTACATATGCACAT 69 FBan0002200 FBgn0030447 CG2200 X X proteolysis; GO:0006508 dipeptidase E activity; GO:0017165 ; EC:3.4.13.21; serine-type peptidase activity; GO:0008236; ; GO:0008236; dipeptidyl-peptidase activity; GO:0008239; ; GO:0017165 ; EC:3.4.13.21; ; GO:0008239 cytoplasm; GO:0005737 CG2200 CG2200 CDMC29596 1 11 15 DAC24-E17 17-CG2209-RA_1 CG2209 TGGCAACGACGACATGACAGCCCTTATTTGCGATAGGCCACTATGCTGAACGGACTTTGATTATCGATT 69 FBan0002209 FBgn0030441 CG2209 X X CG2209 CG2209 anon-WO0140519.110 CDMC29596 1 12 15 DAC24-E17 17-CG2209-RA_1 CG2209 TGGCAACGACGACATGACAGCCCTTATTTGCGATAGGCCACTATGCTGAACGGACTTTGATTATCGATT 69 FBan0002209 FBgn0030441 CG2209 X X CG2209 CG2209 anon-WO0140519.110 CDMC29597 1 13 15 DAC24-I05 3-CG2259-RA_1 CG2259 GCCAGCCACGATATCCTCCAGGAAGTCACCATGCTCTCGTCATCGTTTCGATGGAACTTCGAGTTCCTC 69 FBan0002259 FBgn0040319 Gclc X X amino acid metabolism; GO:0006520; glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2; ; GO:0003676; protein binding; GO:0005515; ; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2; ; GO:0005515 glutamate-cysteine ligase complex; GO:0017109 Gclc Glutamate-cysteine ligase catalytic subunit "CG2259, DmGCS, gamma-Glutamylcysteine synthetase, DmGCSh, DmGCLC, GCSh, Gcs, Gcsh: gamma-Glutamylcysteine synthetase catalytic subunit, gamma-Glutamylcysteine synthetase catalytic subunit, Glutamate-cysteine ligase catalytic subunit" CDMC29597 1 14 15 DAC24-I05 3-CG2259-RA_1 CG2259 GCCAGCCACGATATCCTCCAGGAAGTCACCATGCTCTCGTCATCGTTTCGATGGAACTTCGAGTTCCTC 69 FBan0002259 FBgn0040319 Gclc X X amino acid metabolism; GO:0006520; glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; glutamate-cysteine ligase activity; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2; ; GO:0003676; protein binding; GO:0005515; ; GO:0004357 ; EC:6.3.2.2; ; GO:0004357 ; EC:6.3.2.2; ; GO:0005515 glutamate-cysteine ligase complex; GO:0017109 Gclc Glutamate-cysteine ligase catalytic subunit "CG2259, DmGCS, gamma-Glutamylcysteine synthetase, DmGCSh, DmGCLC, GCSh, Gcs, Gcsh: gamma-Glutamylcysteine synthetase catalytic subunit, gamma-Glutamylcysteine synthetase catalytic subunit, Glutamate-cysteine ligase catalytic subunit" CDMC29598 1 15 15 DAC24-I17 3-CG2278-RA_1 CG2278 CGCCAGCCGATTACCTGAGAAACGGACCCAGTTACTCCAACGATGGGGGAAACTACCGAAATGGTTACT 69 FBan0002278 FBgn0030017 CG2278 X X CG2278 CG2278 CDMC29598 1 16 15 DAC24-I17 3-CG2278-RA_1 CG2278 CGCCAGCCGATTACCTGAGAAACGGACCCAGTTACTCCAACGATGGGGGAAACTACCGAAATGGTTACT 69 FBan0002278 FBgn0030017 CG2278 X X CG2278 CG2278 CDMC29599 1 17 15 DAC24-M05 23-CG2371-RC_10 CG2371 TCCAGTGCCAATTTTATTGTTGATTCACACAAAACTCTGTGCAAAAAGATGGACCTAAAAGTATGCAAT 69 FBan0002371 FBgn0030323 CG2371 X X CG2371 CG2371 "CG2442, CG2443" CDMC29599 1 18 15 DAC24-M05 23-CG2371-RC_10 CG2371 TCCAGTGCCAATTTTATTGTTGATTCACACAAAACTCTGTGCAAAAAGATGGACCTAAAAGTATGCAAT 69 FBan0002371 FBgn0030323 CG2371 X X CG2371 CG2371 "CG2442, CG2443" CDMC29600 1 19 15 DAC24-M17 6-CG2412-RA_1 CG2412 CGTAGGCAAGACCCAGCTGTTGTACACGTTGGCCCTAAATTTCGTCTGGAAGCATAGCCAGGCAGTATT 69 FBan0002412 FBgn0033389 Rad51C 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281 recombinase activity; GO:0000150; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 Rad51C Rad51C "CG2412, CG2412, Dm CG2412" CDMC29600 1 20 15 DAC24-M17 6-CG2412-RA_1 CG2412 CGTAGGCAAGACCCAGCTGTTGTACACGTTGGCCCTAAATTTCGTCTGGAAGCATAGCCAGGCAGTATT 69 FBan0002412 FBgn0033389 Rad51C 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281 recombinase activity; GO:0000150; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 Rad51C Rad51C "CG2412, CG2412, Dm CG2412" CDMC29601 1 21 15 DAC25-A05 2-CG10014-RA_2 CG10014 TTGATGGGCCAGGTTCTAGAGGACTGTTTCCGTAACTTCCTCGAGAAACGACGCTGCGAGATGCG 65 FBan0010014 FBgn0038000 CG10014 3 3R CG10014 CG10014 CDMC29601 1 22 15 DAC25-A05 2-CG10014-RA_2 CG10014 TTGATGGGCCAGGTTCTAGAGGACTGTTTCCGTAACTTCCTCGAGAAACGACGCTGCGAGATGCG 65 FBan0010014 FBgn0038000 CG10014 3 3R CG10014 CG10014 CDMC29602 1 23 15 DAC25-A17 11-CG10064-RA_3 CG10064 GTGCGCTTTACCCACGATGGCACTAGCATAGTCTCCGTTTGGAACGATGGCATCATTCGCGCCTT 65 FBan0010064 FBgn0035724 CG10064 3 3L CG10064 CG10064 CDMC29602 1 24 15 DAC25-A17 11-CG10064-RA_3 CG10064 GTGCGCTTTACCCACGATGGCACTAGCATAGTCTCCGTTTGGAACGATGGCATCATTCGCGCCTT 65 FBan0010064 FBgn0035724 CG10064 3 3L CG10064 CG10064 CDMC29603 1 25 15 DAC25-E05 9-CG10161-RB_1 CG10161 TACAAGTTCGAGGAAAGCAACCCTTTCATCAGCGAGGACGAAGATATCCAAGTCGCCAGCGTGGG 65 FBan0010161 FBgn0040227 eIF-3p66 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF-3p66 Eukaryotic initiation factor 3 p66 subunit "CG10161, CG10161, CG10161, GM10514, eIF3-S7, GM04979, eiF3p66, BEST:GM10514, Eukaryotic initiation factor 3 p66 subunit" CDMC29603 1 26 15 DAC25-E05 9-CG10161-RB_1 CG10161 TACAAGTTCGAGGAAAGCAACCCTTTCATCAGCGAGGACGAAGATATCCAAGTCGCCAGCGTGGG 65 FBan0010161 FBgn0040227 eIF-3p66 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF-3p66 Eukaryotic initiation factor 3 p66 subunit "CG10161, CG10161, CG10161, GM10514, eIF3-S7, GM04979, eiF3p66, BEST:GM10514, Eukaryotic initiation factor 3 p66 subunit" CDMC29604 1 1 16 DAC25-E17 15-CG10194-RA_4 CG10194 AGGGACAGCAAATCATTGACCTCCACTAGCGATTATGGAGCGTTCTATGACCAGTTTGACCGCGC 65 FBan0010194 FBgn0032790 CG10194 2 2L CG10194 CG10194 CDMC29604 1 2 16 DAC25-E17 15-CG10194-RA_4 CG10194 AGGGACAGCAAATCATTGACCTCCACTAGCGATTATGGAGCGTTCTATGACCAGTTTGACCGCGC 65 FBan0010194 FBgn0032790 CG10194 2 2L CG10194 CG10194 CDMC29605 1 3 16 DAC25-I05 2-CG10311-RA_2 CG10311 TAAATTCGTGCTGTCTGTGCCAATCGACCCGGAATGGCTCCGTTATCTCGGGCATACTGGCGATA 65 FBan0010311 FBgn0038420 CG10311 3 3R CG10311 CG10311 "gh22794, BEST:GH22794" CDMC29605 1 4 16 DAC25-I05 2-CG10311-RA_2 CG10311 TAAATTCGTGCTGTCTGTGCCAATCGACCCGGAATGGCTCCGTTATCTCGGGCATACTGGCGATA 65 FBan0010311 FBgn0038420 CG10311 3 3R CG10311 CG10311 "gh22794, BEST:GH22794" CDMC29606 1 5 16 DAC25-I17 2-CG10345-RA_4 CG10345 AGCCCATGCTGGAAATGAGCGTTCACGACTACATGTGGGGCTATGAGGATCACCTGGTAGAGCTG 65 FBan0010345 FBgn0027562 CG10345 3 3R apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG10345 CG10345 "BcDNA, BcDNA:GH08773" CDMC29606 1 6 16 DAC25-I17 2-CG10345-RA_4 CG10345 AGCCCATGCTGGAAATGAGCGTTCACGACTACATGTGGGGCTATGAGGATCACCTGGTAGAGCTG 65 FBan0010345 FBgn0027562 CG10345 3 3R apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG10345 CG10345 "BcDNA, BcDNA:GH08773" CDMC29607 1 7 16 DAC25-M05 2-CG1046-RA_1 CG1046 TCGGGCCACTATTCCTACAACGTGGATTTGGTTCTGCAGAGCATCAAGCAGGATTTGGAGGCAGC 65 FBan0001046 FBgn0004053 zen 3 3R "amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; ; GO:0003677 nucleus; GO:0005634 zen zerknullt "CG1046, z1, zen1, zerknullt 1, ZEN VRE, zerknult, BG:DS00276.9, l(3)84Ad" CDMC29607 1 8 16 DAC25-M05 2-CG1046-RA_1 CG1046 TCGGGCCACTATTCCTACAACGTGGATTTGGTTCTGCAGAGCATCAAGCAGGATTTGGAGGCAGC 65 FBan0001046 FBgn0004053 zen 3 3R "amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; ; GO:0003677 nucleus; GO:0005634 zen zerknullt "CG1046, z1, zen1, zerknullt 1, ZEN VRE, zerknult, BG:DS00276.9, l(3)84Ad" CDMC29608 1 9 16 DAC25-M17 3-CG10501-RA_3 CG10501 CTACCTGAAGCACAAGCACGAGGGTCAGTCGCAAATTCCTGACTTCCGTCATTGGCAAATCCCCC 65 FBan0010501 FBgn0000075 amd 2 2L amino acid metabolism; GO:0006520; catecholamine metabolism; GO:0006584; cuticle biosynthesis (sensu Insecta); GO:0040003; dopamine metabolism; GO:0042417 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0016831 ; EC:4.1.1.- amd alpha methyl dopa-resistant "CG10501, CG17345, l(2)amd, transcription unit No. 1, fAMD, l(2)amd alpha-methyldopa hypersensitive, dopa decarboxylase, X04695, l(2)37Bk, l(2)amd[H]" CDMC29608 1 10 16 DAC25-M17 3-CG10501-RA_3 CG10501 CTACCTGAAGCACAAGCACGAGGGTCAGTCGCAAATTCCTGACTTCCGTCATTGGCAAATCCCCC 65 FBan0010501 FBgn0000075 amd 2 2L amino acid metabolism; GO:0006520; catecholamine metabolism; GO:0006584; cuticle biosynthesis (sensu Insecta); GO:0040003; dopamine metabolism; GO:0042417 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0016831 ; EC:4.1.1.- amd alpha methyl dopa-resistant "CG10501, CG17345, l(2)amd, transcription unit No. 1, fAMD, l(2)amd alpha-methyldopa hypersensitive, dopa decarboxylase, X04695, l(2)37Bk, l(2)amd[H]" CDMC29609 1 11 16 DAC26-A05 15-CG6168-RB_3 CG6168 TGTGCGCTCAGAACGTCCACTATTCAAGTTTGAGCCCGGTATAGATGTAGATGATGACCACCTGCCTTT 69 FBan0006168 FBgn0036154 CG6168 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; transferase activity; GO:0016740 ; EC:2.-.-.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0016740 ; EC:2.-.-.- CG6168 CG6168 CDMC29609 1 12 16 DAC26-A05 15-CG6168-RB_3 CG6168 TGTGCGCTCAGAACGTCCACTATTCAAGTTTGAGCCCGGTATAGATGTAGATGATGACCACCTGCCTTT 69 FBan0006168 FBgn0036154 CG6168 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; transferase activity; GO:0016740 ; EC:2.-.-.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0016740 ; EC:2.-.-.- CG6168 CG6168 CDMC29610 1 13 16 DAC26-A17 16-CG6177-RA_1 CG6177 TCGAGCTGACAAACATGGTGGAGGACAGTATCAAGCTAAAGGATAACAGCGCTTAGTCACCAACAACGA 69 FBan0006177 FBgn0026634 ldlCp 3 3R Golgi organization and biogenesis; GO:0007030; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; protein transport; GO:0015031 Golgi trans face; GO:0005802; membrane; GO:0016020 ldlCp ldlCp-related protein "CG6177, CG6177, ldl-Cp" CDMC29610 1 14 16 DAC26-A17 16-CG6177-RA_1 CG6177 TCGAGCTGACAAACATGGTGGAGGACAGTATCAAGCTAAAGGATAACAGCGCTTAGTCACCAACAACGA 69 FBan0006177 FBgn0026634 ldlCp 3 3R Golgi organization and biogenesis; GO:0007030; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; protein transport; GO:0015031 Golgi trans face; GO:0005802; membrane; GO:0016020 ldlCp ldlCp-related protein "CG6177, CG6177, ldl-Cp" CDMC29611 1 15 16 DAC26-E05 17-CG6207-RB_1 CG6207 GCCCTGCTCTAATGGGACTGAATGGCTTGAAAGTTTGGCATAATCAATTTCATCCTAAACGCTGCACGA 69 FBan0006207 FBgn0036144 GlcAT-P 3 3L glycoprotein biosynthesis; GO:0009101; glycosphingolipid biosynthesis; GO:0006688; proteoglycan biosynthesis; GO:0030166 "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; GO:0015018 ; EC:2.4.1.135; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity; GO:0046987; asioloorosomucoid beta-1,3-glucuronosyltransferase activity; GO:0046988; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity; GO:0046989; ; GO:0015018 ; EC:2.4.1.135; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0046987; ; GO:0046988; ; GO:0046989; ; GO:0015018 ; EC:2.4.1.135" membrane; GO:0016020 GlcAT-P GlcAT-P "CG6207, CG6207, CG6207, DGlcAT-P, DmGlcAT-BSII" CDMC29611 1 16 16 DAC26-E05 17-CG6207-RB_1 CG6207 GCCCTGCTCTAATGGGACTGAATGGCTTGAAAGTTTGGCATAATCAATTTCATCCTAAACGCTGCACGA 69 FBan0006207 FBgn0036144 GlcAT-P 3 3L glycoprotein biosynthesis; GO:0009101; glycosphingolipid biosynthesis; GO:0006688; proteoglycan biosynthesis; GO:0030166 "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; GO:0015018 ; EC:2.4.1.135; N-acetyllactosamine beta-1,3-glucuronosyltransferase activity; GO:0046987; asioloorosomucoid beta-1,3-glucuronosyltransferase activity; GO:0046988; galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity; GO:0046989; ; GO:0015018 ; EC:2.4.1.135; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0046987; ; GO:0046988; ; GO:0046989; ; GO:0015018 ; EC:2.4.1.135" membrane; GO:0016020 GlcAT-P GlcAT-P "CG6207, CG6207, CG6207, DGlcAT-P, DmGlcAT-BSII" CDMC29612 1 17 16 DAC26-E17 6-CG6215-RA_3 CG6215 CCGCCACGAGAACAGCGTTCACAATGTATCCGATTTCATCTGCGTGGAGTGCAACATGTCCTTCGCTAA 69 FBan0006215 FBgn0015025 CkIIalpha-i1 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CkIIalpha-i1 CKII-alpha subunit interactor-1 "CG6215, CKIIalpha-I1, CkIIalpha-i1" CDMC29612 1 18 16 DAC26-E17 6-CG6215-RA_3 CG6215 CCGCCACGAGAACAGCGTTCACAATGTATCCGATTTCATCTGCGTGGAGTGCAACATGTCCTTCGCTAA 69 FBan0006215 FBgn0015025 CkIIalpha-i1 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CkIIalpha-i1 CKII-alpha subunit interactor-1 "CG6215, CKIIalpha-I1, CkIIalpha-i1" CDMC29613 1 19 16 DAC26-I05 3-CG6251-RA_1 CG6251 GGAACGCAGCCAAACCTACCTGATGGTGGAGAATCTGGACACACAACTGAAGCAGATGTCCGAGGATCT 69 FBan0006251 FBgn0034118 Nup62 2 2R protein targeting; GO:0006605 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup62 Nup62 "CG6251, CG6251, p62, Nucleoporin" CDMC29613 1 20 16 DAC26-I05 3-CG6251-RA_1 CG6251 GGAACGCAGCCAAACCTACCTGATGGTGGAGAATCTGGACACACAACTGAAGCAGATGTCCGAGGATCT 69 FBan0006251 FBgn0034118 Nup62 2 2R protein targeting; GO:0006605 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup62 Nup62 "CG6251, CG6251, p62, Nucleoporin" CDMC29614 1 21 16 DAC26-I17 23-CG6272-RA_1 CG6272 AGATCGAGACGAGTGAAAAACATATATCTACGCTTAGAGATCTGATCATTCAGGGTGAGAAAACGGAGG 69 FBan0006272 FBgn0036126 CG6272 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003677 nucleus; GO:0005634 CG6272 CG6272 "CT19628, BcDNA:GH10915" CDMC29614 1 22 16 DAC26-I17 23-CG6272-RA_1 CG6272 AGATCGAGACGAGTGAAAAACATATATCTACGCTTAGAGATCTGATCATTCAGGGTGAGAAAACGGAGG 69 FBan0006272 FBgn0036126 CG6272 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003677 nucleus; GO:0005634 CG6272 CG6272 "CT19628, BcDNA:GH10915" CDMC29615 1 23 16 DAC26-M05 3-CG6315-RA_5 CG6315 GGGCATGCAGAGCACCATTCTGTTTTTGCAGCAAGAACTAAAGACCACACGCGATCGCATACAAACGCT 69 FBan0006315 FBgn0000662 fl(2)d 2 2R "female germ-line sex determination; GO:0019099; primary sex determination, soma; GO:0007539; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; sex determination; GO:0007530" nucleus; GO:0005634 fl(2)d female lethal d "CG6315, v(2)k16105" CDMC29615 1 24 16 DAC26-M05 3-CG6315-RA_5 CG6315 GGGCATGCAGAGCACCATTCTGTTTTTGCAGCAAGAACTAAAGACCACACGCGATCGCATACAAACGCT 69 FBan0006315 FBgn0000662 fl(2)d 2 2R "female germ-line sex determination; GO:0019099; primary sex determination, soma; GO:0007539; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; sex determination; GO:0007530" nucleus; GO:0005634 fl(2)d female lethal d "CG6315, v(2)k16105" CDMC29616 1 25 16 DAC26-M17 13-CG6330-RA_1 CG6330 TCCGATGGAACCGTCAAATTGCGCAACTCGAACATTGAGCTCATGGACCAGGATATCCTCTATCACCTG 69 FBan0006330 FBgn0039464 CG6330 3 3R nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG6330 CG6330 CDMC29616 1 26 16 DAC26-M17 13-CG6330-RA_1 CG6330 TCCGATGGAACCGTCAAATTGCGCAACTCGAACATTGAGCTCATGGACCAGGATATCCTCTATCACCTG 69 FBan0006330 FBgn0039464 CG6330 3 3R nucleoside metabolism; GO:0009116; nucleotide catabolism; GO:0009166; pyrimidine base metabolism; GO:0006206 uridine phosphorylase activity; GO:0004850 ; EC:2.4.2.3; ; GO:0004850 ; EC:2.4.2.3 cytoplasm; GO:0005737 CG6330 CG6330 CDMC29617 1 1 17 DAC27-A05 23-CG3682-RB_5 CG3682 AGGGGAATCACAGAAAATTTCGTACCTTGGTGACCAGCTATATAGGTAAACAAACGAATGGTCGATGTC 69 FBan0003682 FBgn0034789 PIP5K59B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphorylation; GO:0016310 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 PIP5K59B PIP5K59B "CG3682, CG17281, CG3682, CG3682, PIP5K 59B" CDMC29617 1 2 17 DAC27-A05 23-CG3682-RB_5 CG3682 AGGGGAATCACAGAAAATTTCGTACCTTGGTGACCAGCTATATAGGTAAACAAACGAATGGTCGATGTC 69 FBan0003682 FBgn0034789 PIP5K59B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphorylation; GO:0016310 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 PIP5K59B PIP5K59B "CG3682, CG17281, CG3682, CG3682, PIP5K 59B" CDMC29618 1 3 17 DAC27-A17 3-CG3694-RA_6 CG3694 GGGGTGGTATGTGGATAAATTTTAGCCGCCATGGATCCCAGTGCTCTACAAAACATGGATCGGGACGCA 69 FBan0003694 FBgn0028433 Ggamma30A 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 cytoplasm; GO:0005737; heterotrimeric G-protein complex; GO:0005834; rhabdomere; GO:0016028 Ggamma30A G protein gamma30A "CG18511, CG3694, CG18511, Ggamma, Ggamma[[e]], Ggamma, G[[gamma]], Ggamma30A, Ggammae, G protein gamma30A" CDMC29618 1 4 17 DAC27-A17 3-CG3694-RA_6 CG3694 GGGGTGGTATGTGGATAAATTTTAGCCGCCATGGATCCCAGTGCTCTACAAAACATGGATCGGGACGCA 69 FBan0003694 FBgn0028433 Ggamma30A 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 cytoplasm; GO:0005737; heterotrimeric G-protein complex; GO:0005834; rhabdomere; GO:0016028 Ggamma30A G protein gamma30A "CG18511, CG3694, CG18511, Ggamma, Ggamma[[e]], Ggamma, G[[gamma]], Ggamma30A, Ggammae, G protein gamma30A" CDMC29619 1 5 17 DAC27-E05 2-CG3734-RA_1 CG3734 AGCTCGAGTGACACTGCTGAAATGAGAGCTTCCAAAGAACGTATTGCCGAACTGGTACGCGAGTGGGTT 69 FBan0003734 FBgn0038700 CG3734 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 CG3734 CG3734 CDMC29619 1 6 17 DAC27-E05 2-CG3734-RA_1 CG3734 AGCTCGAGTGACACTGCTGAAATGAGAGCTTCCAAAGAACGTATTGCCGAACTGGTACGCGAGTGGGTT 69 FBan0003734 FBgn0038700 CG3734 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 CG3734 CG3734 CDMC29620 1 7 17 DAC27-E17 23-CG3746-RA_1 CG3746 ATCCCGCGGACCAATTAAATCGAAATTAATGCCAAATATTTATCTGTTCTATAATTCTATTACGCGTCT 69 FBan0003746 FBgn0034755 CG3746 2 2R CG3746 CG3746 CDMC29620 1 8 17 DAC27-E17 23-CG3746-RA_1 CG3746 ATCCCGCGGACCAATTAAATCGAAATTAATGCCAAATATTTATCTGTTCTATAATTCTATTACGCGTCT 69 FBan0003746 FBgn0034755 CG3746 2 2R CG3746 CG3746 CDMC29621 1 9 17 DAC27-I05 9-CG3781-RA_1 CG3781 GGCGGGATCCACACTGTCTCAATCTGAGCGTCATTTTCGGCTTCATTCTCAATGTACCGGCTCAGATGA 69 FBan0003781 FBgn0029853 CG3781 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3781 CG3781 CDMC29621 1 10 17 DAC27-I05 9-CG3781-RA_1 CG3781 GGCGGGATCCACACTGTCTCAATCTGAGCGTCATTTTCGGCTTCATTCTCAATGTACCGGCTCAGATGA 69 FBan0003781 FBgn0029853 CG3781 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3781 CG3781 CDMC29622 1 11 17 DAC27-I17 16-CG3798-RA_2 CG3798 CCGACGAACTTCATATTCTTGGGTCTGTTTACAGCAGCTCAGTCGTTCTTAATGGGAGTTTCCGCAACC 69 FBan0003798 FBgn0013305 Nmda1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 Nmda1 N-methyl-D-aspartate receptor-associated protein "CG3798, NMDARA1-like, cDNA2, dNMDARA1, DRONMDA, NMDARA1, N-methyl-D-aspartate receptor-associated protein" CDMC29622 1 12 17 DAC27-I17 16-CG3798-RA_2 CG3798 CCGACGAACTTCATATTCTTGGGTCTGTTTACAGCAGCTCAGTCGTTCTTAATGGGAGTTTCCGCAACC 69 FBan0003798 FBgn0013305 Nmda1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 Nmda1 N-methyl-D-aspartate receptor-associated protein "CG3798, NMDARA1-like, cDNA2, dNMDARA1, DRONMDA, NMDARA1, N-methyl-D-aspartate receptor-associated protein" CDMC29623 1 13 17 DAC27-M05 14-CG3837-RA_2 CG3837 AGAGTCGACGTCATGTGATAAGCGGTCTGAAGCCCTACACACAGTATGCGTATTTCGTGAAGACCCTCA 69 FBan0003837 FBgn0038279 CG3837 3 3R insulin-like growth factor receptor activity; GO:0005010; epidermal growth factor receptor activity; GO:0005006; ; GO:0005010; ; GO:0005006 membrane; GO:0016020 CG3837 CG3837 CDMC29623 1 14 17 DAC27-M05 14-CG3837-RA_2 CG3837 AGAGTCGACGTCATGTGATAAGCGGTCTGAAGCCCTACACACAGTATGCGTATTTCGTGAAGACCCTCA 69 FBan0003837 FBgn0038279 CG3837 3 3R insulin-like growth factor receptor activity; GO:0005010; epidermal growth factor receptor activity; GO:0005006; ; GO:0005010; ; GO:0005006 membrane; GO:0016020 CG3837 CG3837 CDMC29624 1 15 17 DAC27-M17 22-CG3847-RA_1 CG3847 AGCTCACGATCACCCGCTATTGTGTAATAACCCGAAACTCCAAATACTGACACACAAAACGAGCGTCAA 69 FBan0003847 FBgn0029867 CG3847 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3847 CG3847 CDMC29624 1 16 17 DAC27-M17 22-CG3847-RA_1 CG3847 AGCTCACGATCACCCGCTATTGTGTAATAACCCGAAACTCCAAATACTGACACACAAAACGAGCGTCAA 69 FBan0003847 FBgn0029867 CG3847 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3847 CG3847 CDMC29625 1 17 17 DAC28-A05 22-CG10171-RB_1 CG10171 GCCCGTGCGCTAATGCTGTTTTGGATTAGGATTAGCTGCATTCAATAGCTAAAAATGTCAAAGGCTGCC 69 FBan0010171 FBgn0036353 CG10171 3 3L CG10171 CG10171 CDMC29625 1 18 17 DAC28-A05 22-CG10171-RB_1 CG10171 GCCCGTGCGCTAATGCTGTTTTGGATTAGGATTAGCTGCATTCAATAGCTAAAAATGTCAAAGGCTGCC 69 FBan0010171 FBgn0036353 CG10171 3 3L CG10171 CG10171 CDMC29626 1 19 17 DAC28-A17 4-CG10183-RA_1 CG10183 AGGCGGTCTGCATTCACTTTGGAGTCGAACTGGATGTACAAAGTCGCCAGAGGTAGTACGGCCTGTATT 69 FBan0010183 FBgn0039093 CG10183 3 3R CG10183 CG10183 CDMC29626 1 20 17 DAC28-A17 4-CG10183-RA_1 CG10183 AGGCGGTCTGCATTCACTTTGGAGTCGAACTGGATGTACAAAGTCGCCAGAGGTAGTACGGCCTGTATT 69 FBan0010183 FBgn0039093 CG10183 3 3R CG10183 CG10183 CDMC29627 1 21 17 DAC28-E05 2-CG10217-RA_1 CG10217 CCCCAATTCGGAGGCATGGAAATATGATCTGTTTCTTGCTCGAAATCCTGTGCCTGTTCGTTGCCCCGT 69 FBan0010217 FBgn0039113 CG10217 3 3R CG10217 CG10217 CDMC29627 1 22 17 DAC28-E05 2-CG10217-RA_1 CG10217 CCCCAATTCGGAGGCATGGAAATATGATCTGTTTCTTGCTCGAAATCCTGTGCCTGTTCGTTGCCCCGT 69 FBan0010217 FBgn0039113 CG10217 3 3R CG10217 CG10217 CDMC29628 1 23 17 DAC28-E17 7-CG10226-RA_1 CG10226 GGCAAATCCCTTATGTTCTTCGGCTACGCAGTGACCTTGACATATGGTGGACACATGTGTGCTGATGGC 69 FBan0010226 FBgn0035695 CG10226 3 3L defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; multidrug transporter activity; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0042623; ; GO:0015239" integral to membrane; GO:0016021 CG10226 CG10226 CDMC29628 1 24 17 DAC28-E17 7-CG10226-RA_1 CG10226 GGCAAATCCCTTATGTTCTTCGGCTACGCAGTGACCTTGACATATGGTGGACACATGTGTGCTGATGGC 69 FBan0010226 FBgn0035695 CG10226 3 3L defense response; GO:0006952; drug transport; GO:0015893; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled; GO:0042623; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; multidrug transporter activity; GO:0015239; ; GO:0000166; ; GO:0042626; ; GO:0042623; ; GO:0015239" integral to membrane; GO:0016021 CG10226 CG10226 CDMC29629 1 25 17 DAC28-I05 22-CG10255-RA_5 CG10255 TGCGGCACGGTCATGAACATAATGTTGTCGAGAAAATGATGGACCATCTATTTACCGACCTAAGCCGAT 69 FBan0010255 FBgn0033984 Lap1 2 2R cell adhesion; GO:0007155; cyclic nucleotide metabolism; GO:0009187; defense response; GO:0006952; establishment and/or maintenance of cell polarity; GO:0007163; nerve-nerve synaptic transmission; GO:0007270; protein amino acid phosphorylation; GO:0006468; protein transport; GO:0015031; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; protein binding; GO:0005515; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515; Ras GTPase binding; GO:0017016; ; GO:0017016 adherens junction; GO:0005912 Lap1 Lap1 "CG10255, CG10255, dLAP1, CT28815, dlap1" CDMC29629 1 26 17 DAC28-I05 22-CG10255-RA_5 CG10255 TGCGGCACGGTCATGAACATAATGTTGTCGAGAAAATGATGGACCATCTATTTACCGACCTAAGCCGAT 69 FBan0010255 FBgn0033984 Lap1 2 2R cell adhesion; GO:0007155; cyclic nucleotide metabolism; GO:0009187; defense response; GO:0006952; establishment and/or maintenance of cell polarity; GO:0007163; nerve-nerve synaptic transmission; GO:0007270; protein amino acid phosphorylation; GO:0006468; protein transport; GO:0015031; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; protein binding; GO:0005515; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515; Ras GTPase binding; GO:0017016; ; GO:0017016 adherens junction; GO:0005912 Lap1 Lap1 "CG10255, CG10255, dLAP1, CT28815, dlap1" CDMC29630 1 1 18 DAC28-I17 3-CG10268-RA_1 CG10268 GGCCCAGGGTGAACACAACCACATCCAGTATCTGATGAGCACAGCGTAGAACTTAGGAAATCGAGGCCA 69 FBan0010268 FBgn0032811 CG10268 2 2L cholesterol biosynthesis; GO:0006695; cholesterol metabolism; GO:0008203 phosphomevalonate kinase activity; GO:0004631 ; EC:2.7.4.2; ; GO:0004631 ; EC:2.7.4.2; ; GO:0004631 ; EC:2.7.4.2 cytoplasm; GO:0005737 CG10268 CG10268 BcDNA:SD12705 CDMC29630 1 2 18 DAC28-I17 3-CG10268-RA_1 CG10268 GGCCCAGGGTGAACACAACCACATCCAGTATCTGATGAGCACAGCGTAGAACTTAGGAAATCGAGGCCA 69 FBan0010268 FBgn0032811 CG10268 2 2L cholesterol biosynthesis; GO:0006695; cholesterol metabolism; GO:0008203 phosphomevalonate kinase activity; GO:0004631 ; EC:2.7.4.2; ; GO:0004631 ; EC:2.7.4.2; ; GO:0004631 ; EC:2.7.4.2 cytoplasm; GO:0005737 CG10268 CG10268 BcDNA:SD12705 CDMC29631 1 3 18 DAC28-M05 15-CG10303-RA_4 CG10303 CTGATCCTGTCCAAAATTGCCTTCGTGGTAGCCGCAATAGTGTTGATCAAGAAGCTCATGGACAACGCC 69 FBan0010303 FBgn0037412 Osi4 3 3R Osi4 Osiris 4 "CG10303, CG10303, CG10303, Osiris, Osiris 4" CDMC29631 1 4 18 DAC28-M05 15-CG10303-RA_4 CG10303 CTGATCCTGTCCAAAATTGCCTTCGTGGTAGCCGCAATAGTGTTGATCAAGAAGCTCATGGACAACGCC 69 FBan0010303 FBgn0037412 Osi4 3 3R Osi4 Osiris 4 "CG10303, CG10303, CG10303, Osiris, Osiris 4" CDMC29632 1 5 18 DAC28-M17 2-CG1031-RA_4 CG1031 GCAACTCCTTTGAAGGTCTGTTCTCCTACCAGAGTACCCTGCACGACGAGGAACACATGCTGAGTGCTT 69 FBan0001031 FBgn0015568 alpha-Est1 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est1 alpha-Esterase-1 "CG1031, alphaE1, A, fragment A, aE1" CDMC29632 1 6 18 DAC28-M17 2-CG1031-RA_4 CG1031 GCAACTCCTTTGAAGGTCTGTTCTCCTACCAGAGTACCCTGCACGACGAGGAACACATGCTGAGTGCTT 69 FBan0001031 FBgn0015568 alpha-Est1 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est1 alpha-Esterase-1 "CG1031, alphaE1, A, fragment A, aE1" CDMC29633 1 7 18 DAC29-A05 2-CG13882-RA_2 CG13882 CCGAAGCCTGGAAAAATCCAATCCGTCATGGACCTTCCTTTGTAGCGGAATTGCCAGCATTTGCCAACC 69 FBan0013882 FBgn0035126 CG13882 3 3L CG13882 CG13882 CDMC29633 1 8 18 DAC29-A05 2-CG13882-RA_2 CG13882 CCGAAGCCTGGAAAAATCCAATCCGTCATGGACCTTCCTTTGTAGCGGAATTGCCAGCATTTGCCAACC 69 FBan0013882 FBgn0035126 CG13882 3 3L CG13882 CG13882 CDMC29634 1 9 18 DAC29-A17 2-CG13895-RA_1 CG13895 CGGGATCTCATGCAACTCGATGGTTTTGTGCCGAACAAACCGTGGATCAATCACTTCAAGGCCGCCTAT 69 FBan0013895 FBgn0035158 CG13895 3 3L DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG13895 CG13895 CDMC29634 1 10 18 DAC29-A17 2-CG13895-RA_1 CG13895 CGGGATCTCATGCAACTCGATGGTTTTGTGCCGAACAAACCGTGGATCAATCACTTCAAGGCCGCCTAT 69 FBan0013895 FBgn0035158 CG13895 3 3L DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG13895 CG13895 CDMC29635 1 11 18 DAC29-E05 23-CG13946-RA_1 CG13946 GCACCACTGACGTTTCCTCATCATAGGAAGCTAATCAAAAACTCTTGTATTAATCGATCCTGTATATAA 69 FBan0013946 FBgn0040725 CG13946 2 2L CG13946 CG13946 CDMC29635 1 12 18 DAC29-E05 23-CG13946-RA_1 CG13946 GCACCACTGACGTTTCCTCATCATAGGAAGCTAATCAAAAACTCTTGTATTAATCGATCCTGTATATAA 69 FBan0013946 FBgn0040725 CG13946 2 2L CG13946 CG13946 CDMC29636 1 13 18 DAC29-E17 12-CG13965-RA_5 CG13965 TCCCCAACAGATGGCGAAACGTCTCCAGTTACAGAAGCCAGTTCCATCGGAGAATTAACTCAGACCACA 69 FBan0013965 FBgn0032834 CG13965 2 2L CG13965 CG13965 CDMC29636 1 14 18 DAC29-E17 12-CG13965-RA_5 CG13965 TCCCCAACAGATGGCGAAACGTCTCCAGTTACAGAAGCCAGTTCCATCGGAGAATTAACTCAGACCACA 69 FBan0013965 FBgn0032834 CG13965 2 2L CG13965 CG13965 CDMC29637 1 15 18 DAC29-I05 6-CG14005-RA_1 CG14005 GTGCTGGCGTTAATAAAGCAAACGACCATCAAGCTGGAACCATGATCCCGACTACTAGCACCACGTGGT 69 FBan0014005 FBgn0031739 CG14005 2 2L CG14005 CG14005 CDMC29637 1 16 18 DAC29-I05 6-CG14005-RA_1 CG14005 GTGCTGGCGTTAATAAAGCAAACGACCATCAAGCTGGAACCATGATCCCGACTACTAGCACCACGTGGT 69 FBan0014005 FBgn0031739 CG14005 2 2L CG14005 CG14005 CDMC29638 1 17 18 DAC29-I17 12-CG14021-RA_4 CG14021 CGGAGCAGCTCCCTACACCGTTACCATGGATCACAAGAGTGACTACTTTGAGGTGGACACCATGTTCAA 69 FBan0014021 FBgn0031702 CG14021 2 2L CG14021 CG14021 CDMC29638 1 18 18 DAC29-I17 12-CG14021-RA_4 CG14021 CGGAGCAGCTCCCTACACCGTTACCATGGATCACAAGAGTGACTACTTTGAGGTGGACACCATGTTCAA 69 FBan0014021 FBgn0031702 CG14021 2 2L CG14021 CG14021 CDMC29639 1 19 18 DAC29-M05 13-CG14041-RB_1 CG14041 CAGTGGCTCCTCTGGGACGTGTGCATTTCTCGTAGTAGCTTTAGAGCGTGCTAAGTTTAAGCATTCGGA 69 FBan0014041 FBgn0040280 SP555 2 2L SP555 SP555 "CG14042, CG14041, CG14042, CG14042, bs13e02.y1, dmSSBa, BcDNA:AT09933, NEST:bs13e02" CDMC29639 1 20 18 DAC29-M05 13-CG14041-RB_1 CG14041 CAGTGGCTCCTCTGGGACGTGTGCATTTCTCGTAGTAGCTTTAGAGCGTGCTAAGTTTAAGCATTCGGA 69 FBan0014041 FBgn0040280 SP555 2 2L SP555 SP555 "CG14042, CG14041, CG14042, CG14042, bs13e02.y1, dmSSBa, BcDNA:AT09933, NEST:bs13e02" CDMC29640 1 21 18 DAC29-M17 17-CG1404-RA_1 CG1404 CAGCTCACCGTTCCAGAAATTTTGCATTAACGAAGATACCGAGTGCTTAGAAGGATGGCTCAGGAAGGT 69 FBan0001404 FBgn0020255 ran X X RNA localization; GO:0006403; actin filament organization; GO:0007015; cell adhesion; GO:0007155; cell cycle; GO:0007049; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005515; ; GO:0005525 cytoplasm; GO:0005737 ran ran "CG1404, CG1404, CG1404, CG1404, dran, l(1)G0075, ran10A, Ran, AAF30287" CDMC29640 1 22 18 DAC29-M17 17-CG1404-RA_1 CG1404 CAGCTCACCGTTCCAGAAATTTTGCATTAACGAAGATACCGAGTGCTTAGAAGGATGGCTCAGGAAGGT 69 FBan0001404 FBgn0020255 ran X X RNA localization; GO:0006403; actin filament organization; GO:0007015; cell adhesion; GO:0007155; cell cycle; GO:0007049; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005515; ; GO:0005525 cytoplasm; GO:0005737 ran ran "CG1404, CG1404, CG1404, CG1404, dran, l(1)G0075, ran10A, Ran, AAF30287" CDMC29641 1 23 18 DAC30-A05 17-CG15093-RB_1 CG15093 TGTACGACCTGATGAAGAAGGAGAAGTTCAGCGTTTAGGTTACTCACAGACTACAGGTTGTGGTGGCCA 69 FBan0015093 FBgn0034390 CG15093 2 2R amino acid metabolism; GO:0006520; pentose-phosphate shunt; GO:0006098; valine metabolism; GO:0006573 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0008442 ; EC:1.1.1.31; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 mitochondrion; GO:0005739 CG15093 CG15093 CT34968 CDMC29641 1 24 18 DAC30-A05 17-CG15093-RB_1 CG15093 TGTACGACCTGATGAAGAAGGAGAAGTTCAGCGTTTAGGTTACTCACAGACTACAGGTTGTGGTGGCCA 69 FBan0015093 FBgn0034390 CG15093 2 2R amino acid metabolism; GO:0006520; pentose-phosphate shunt; GO:0006098; valine metabolism; GO:0006573 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0008442 ; EC:1.1.1.31; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 mitochondrion; GO:0005739 CG15093 CG15093 CT34968 CDMC29642 1 25 18 DAC30-A17 2-CG15104-RA_1 CG15104 GGCGATGGAAGAGCACGACATAGCCAACTCCCTAATCGAACTGTCCACTCTAACGCAGCCTGTGAACAT 69 FBan0015104 FBgn0034410 Topors 2 2R protein ubiquitination; GO:0016567 DNA topoisomerase I binding; GO:0017033; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0017033; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Topors Topoisomerase I-interacting protein "CG15104, CG15104, dTopors, Topoisomerase I-interacting protein" CDMC29642 1 26 18 DAC30-A17 2-CG15104-RA_1 CG15104 GGCGATGGAAGAGCACGACATAGCCAACTCCCTAATCGAACTGTCCACTCTAACGCAGCCTGTGAACAT 69 FBan0015104 FBgn0034410 Topors 2 2R protein ubiquitination; GO:0016567 DNA topoisomerase I binding; GO:0017033; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0017033; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Topors Topoisomerase I-interacting protein "CG15104, CG15104, dTopors, Topoisomerase I-interacting protein" CDMC29643 1 1 19 DAC30-E05 22-CG15138-RA_1 CG15138 CCCGTCCAAGGTACGTCTTACCGGGAATTATTTGTGACCAAAATCTTATCGCTCTTGTTCGTCCAACCA 69 FBan0015138 FBgn0032629 beat-IIIc 2 2L extracellular region; GO:0005576 beat-IIIc beat-IIIc "CG15138, CG6365, beat IIIc, BcDNA:RE14414" CDMC29643 1 2 19 DAC30-E05 22-CG15138-RA_1 CG15138 CCCGTCCAAGGTACGTCTTACCGGGAATTATTTGTGACCAAAATCTTATCGCTCTTGTTCGTCCAACCA 69 FBan0015138 FBgn0032629 beat-IIIc 2 2L extracellular region; GO:0005576 beat-IIIc beat-IIIc "CG15138, CG6365, beat IIIc, BcDNA:RE14414" CDMC29644 1 3 19 DAC30-E17 3-CG15148-RA_3 CG15148 CCAACTAGCGGTCAACTGCAGGACTACTACGCTGCATTGGAGAAACTTCCTGACACAGATGAGCCCAGT 69 FBgn0032657 CDMC29644 1 4 19 DAC30-E17 3-CG15148-RA_3 CG15148 CCAACTAGCGGTCAACTGCAGGACTACTACGCTGCATTGGAGAAACTTCCTGACACAGATGAGCCCAGT 69 FBgn0032657 CDMC29645 1 5 19 DAC30-I05 1-CG15184-RA_1 CG15184 GGCGGGGATGGCGATGGCGACTTTGTCAACAATAACAAGCAACGTAATTACGCTGGATCCAAGACTGGA 69 FBan0015184 FBgn0037459 CG15184 3 3R CG15184 CG15184 CDMC29645 1 6 19 DAC30-I05 1-CG15184-RA_1 CG15184 GGCGGGGATGGCGATGGCGACTTTGTCAACAATAACAAGCAACGTAATTACGCTGGATCCAAGACTGGA 69 FBan0015184 FBgn0037459 CG15184 3 3R CG15184 CG15184 CDMC29646 1 7 19 DAC30-I17 15-CG1519-RA_1 CG1519 GGACGAAGACAGCGACAATGAGACGCACTAGTTCGTTTGTGTGCCAGTGAATCTAATTCTGGGCCTCAT 69 FBan0001519 FBgn0023175 Prosalpha7 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha7 Proteasome alpha7 subunit "CG1519, alpha7_dm, 20S proteasome, Proteasome alpha3 subunit, Prosalpha7, 20s proteasome, alpha7" CDMC29646 1 8 19 DAC30-I17 15-CG1519-RA_1 CG1519 GGACGAAGACAGCGACAATGAGACGCACTAGTTCGTTTGTGTGCCAGTGAATCTAATTCTGGGCCTCAT 69 FBan0001519 FBgn0023175 Prosalpha7 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha7 Proteasome alpha7 subunit "CG1519, alpha7_dm, 20S proteasome, Proteasome alpha3 subunit, Prosalpha7, 20s proteasome, alpha7" CDMC29647 1 9 19 DAC30-M05 23-CG1522-RF_7 CG1522 TAATGCGTTTCGTATGCTGAAATTAGCTCCTCGCAAACTTTCCGATCAGTTGAAAGAACTCGATGTCCA 69 FBan0001522 FBgn0005563 cac X X "adult locomotory behavior; GO:0008344; calcium ion transport; GO:0006816; cation transport; GO:0006812; courtship behavior; GO:0007619; epithelial fluid transport; GO:0042045; male courtship behavior (sensu Insecta), song production; GO:0045433; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; phototransduction; GO:0007602; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; visual behavior; GO:0007632" voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005245; ; GO:0005245 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891 cac cacophony "CG1522, nbA, nonB: no-on-transient B, 13, l(1)L13, L13, Dmca1A, l(1)13, Dmcalpha1A, alpha1A, Cacophony, nightblind, Ca-alpha1A, EE171, H18, H47, P18, l(1)11Aa, ldg: lamina-degeneration, opm18, opm47, Calcium channel alpha1 subunit, type A, lethal(1)11Aa, lamina-degeneration, nightblind A, no-on-transient B, nonB" CDMC29647 1 10 19 DAC30-M05 23-CG1522-RF_7 CG1522 TAATGCGTTTCGTATGCTGAAATTAGCTCCTCGCAAACTTTCCGATCAGTTGAAAGAACTCGATGTCCA 69 FBan0001522 FBgn0005563 cac X X "adult locomotory behavior; GO:0008344; calcium ion transport; GO:0006816; cation transport; GO:0006812; courtship behavior; GO:0007619; epithelial fluid transport; GO:0042045; male courtship behavior (sensu Insecta), song production; GO:0045433; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; phototransduction; GO:0007602; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; visual behavior; GO:0007632" voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005245; ; GO:0005245 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891 cac cacophony "CG1522, nbA, nonB: no-on-transient B, 13, l(1)L13, L13, Dmca1A, l(1)13, Dmcalpha1A, alpha1A, Cacophony, nightblind, Ca-alpha1A, EE171, H18, H47, P18, l(1)11Aa, ldg: lamina-degeneration, opm18, opm47, Calcium channel alpha1 subunit, type A, lethal(1)11Aa, lamina-degeneration, nightblind A, no-on-transient B, nonB" CDMC29648 1 11 19 DAC30-M17 2-CG1523-RA_2 CG1523 CGTACGGCAATGGGGTAAGACTCTTTGGTTACAGTGAGGACTGCTGCGACTATCCGAAATGTCAGGCGT 69 FBan0001523 FBgn0039601 CG1523 3 3R CG1523 CG1523 CDMC29648 1 12 19 DAC30-M17 2-CG1523-RA_2 CG1523 CGTACGGCAATGGGGTAAGACTCTTTGGTTACAGTGAGGACTGCTGCGACTATCCGAAATGTCAGGCGT 69 FBan0001523 FBgn0039601 CG1523 3 3R CG1523 CG1523 CDMC29649 1 13 19 DAC31-A05 3-CG12340-RA_2 CG12340 GCGCCAATGCTTATGAATCAGTCCAGCGTTCAACGTCTGCAGTCCTCACCGCCTATAGCTCAAAGGA 67 FBan0012340 FBgn0027499 CG12340 2 2R CG12340 CG12340 "i119, i10, LD26050, BcDNA:LD26050" CDMC29649 1 14 19 DAC31-A05 3-CG12340-RA_2 CG12340 GCGCCAATGCTTATGAATCAGTCCAGCGTTCAACGTCTGCAGTCCTCACCGCCTATAGCTCAAAGGA 67 FBan0012340 FBgn0027499 CG12340 2 2R CG12340 CG12340 "i119, i10, LD26050, BcDNA:LD26050" CDMC29650 1 15 19 DAC31-A17 3-CG12692-RB_3 CG12692 GGCTTGCTGGTCGATATGCCCAGGGAGTGGATATACGATGAGCAGTGCCATTATCATTTGCCGCGAC 67 FBan0012692 FBgn0029703 CG12692 X X CG12692 CG12692 CDMC29650 1 16 19 DAC31-A17 3-CG12692-RB_3 CG12692 GGCTTGCTGGTCGATATGCCCAGGGAGTGGATATACGATGAGCAGTGCCATTATCATTTGCCGCGAC 67 FBan0012692 FBgn0029703 CG12692 X X CG12692 CG12692 CDMC29651 1 17 19 DAC31-E05 3-CG13090-RA_2 CG13090 TGTCCGTGGAGGACTACCAACAGAAGATCCAGGCTCAACCACATTTGCTTATCGATGTGCGGCCAAC 67 FBan0013090 FBgn0032054 CG13090 2 2L Mo-molybdopterin cofactor biosynthesis; GO:0006777 Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265 CG13090 CG13090 CDMC29651 1 18 19 DAC31-E05 3-CG13090-RA_2 CG13090 TGTCCGTGGAGGACTACCAACAGAAGATCCAGGCTCAACCACATTTGCTTATCGATGTGCGGCCAAC 67 FBan0013090 FBgn0032054 CG13090 2 2L Mo-molybdopterin cofactor biosynthesis; GO:0006777 Mo-molybdopterin cofactor sulfurase activity; GO:0008265; ; GO:0008265 CG13090 CG13090 CDMC29652 1 19 19 DAC31-E17 1-CG13230-RA_1 CG13230 GCCATCCAGAAGATAATCGACGCTTACAATCGGATTCCGGGTCCTTCAGTTGTTCACCCCTGGGAGG 67 FBan0013230 FBgn0040764 CG13230 2 2R CG13230 CG13230 CDMC29652 1 20 19 DAC31-E17 1-CG13230-RA_1 CG13230 GCCATCCAGAAGATAATCGACGCTTACAATCGGATTCCGGGTCCTTCAGTTGTTCACCCCTGGGAGG 67 FBan0013230 FBgn0040764 CG13230 2 2R CG13230 CG13230 CDMC29653 1 21 19 DAC31-I05 1-CG13578-RA_2 CG13578 CGTAGAAGACACCAAATCATCGAAGCCCTGCTCCTGCTCAGCCAAGTCCAGTACAACGAGAATGGCC 67 FBan0013578 FBgn0035000 CG13578 2 2R CG13578 CG13578 CDMC29653 1 22 19 DAC31-I05 1-CG13578-RA_2 CG13578 CGTAGAAGACACCAAATCATCGAAGCCCTGCTCCTGCTCAGCCAAGTCCAGTACAACGAGAATGGCC 67 FBan0013578 FBgn0035000 CG13578 2 2R CG13578 CG13578 CDMC29654 1 23 19 DAC31-I17 23-CG13645-RA_4 CG13645 TGGATCTTTTAAAAGACGCTCAAAATCGAAGAAAATGTCAGCATTCATCGAGGAAACAAAAAGCCTG 67 FBan0013645 FBgn0039254 CG13645 3 3R NAD biosynthesis; GO:0009435; biosynthesis; GO:0009058; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG13645 CG13645 AAL90149 CDMC29654 1 24 19 DAC31-I17 23-CG13645-RA_4 CG13645 TGGATCTTTTAAAAGACGCTCAAAATCGAAGAAAATGTCAGCATTCATCGAGGAAACAAAAAGCCTG 67 FBan0013645 FBgn0039254 CG13645 3 3R NAD biosynthesis; GO:0009435; biosynthesis; GO:0009058; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG13645 CG13645 AAL90149 CDMC29655 1 25 19 DAC31-M05 15-CG13983-RA_3 CG13983 AGTCATCTCCAGCAGCTATCGATTGACATACCATGAGAACCCTGAGCGTCTTGATTCTCCTCGCCAC 67 FBan0013983 FBgn0031792 CG13983 2 2L CG13983 CG13983 CDMC29655 1 26 19 DAC31-M05 15-CG13983-RA_3 CG13983 AGTCATCTCCAGCAGCTATCGATTGACATACCATGAGAACCCTGAGCGTCTTGATTCTCCTCGCCAC 67 FBan0013983 FBgn0031792 CG13983 2 2L CG13983 CG13983 CDMC29656 1 1 20 DAC31-M17 3-CG1416-RA_2 CG1416 AACTCTGGCATCGGCTGTAAACTGGACGTTCGCACTCTCTCGATGACCGAAGAATTTCACTGCAGCG 67 FBan0001416 FBgn0032961 CG1416 2 2L CG1416 CG1416 CDMC29656 1 2 20 DAC31-M17 3-CG1416-RA_2 CG1416 AACTCTGGCATCGGCTGTAAACTGGACGTTCGCACTCTCTCGATGACCGAAGAATTTCACTGCAGCG 67 FBan0001416 FBgn0032961 CG1416 2 2L CG1416 CG1416 CDMC29657 1 3 20 DAC32-A05 18-CG31700-RA_2 CG31700 GGCACACAAAACAAATCGGTTAAGCTCGAAACGCGTGATATCCAAAAGGATGCCATTAAGGACAACGGT 69 FBan0031700 FBgn0051700 CG31700 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31700 CG31700 CDMC29657 1 4 20 DAC32-A05 18-CG31700-RA_2 CG31700 GGCACACAAAACAAATCGGTTAAGCTCGAAACGCGTGATATCCAAAAGGATGCCATTAAGGACAACGGT 69 FBan0031700 FBgn0051700 CG31700 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31700 CG31700 CDMC29658 1 5 20 DAC32-A17 17-CG31715-RA_1 CG31715 TGAGGAAATCAAGGGCCGTTTTCCAGTACACTATGCAGCAGATTTTGGACAACTGAATGTCCTGGAGTT 69 FBan0031715 FBgn0051715 CG31715 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31715 CG31715 BcDNA:RE44624 CDMC29658 1 6 20 DAC32-A17 17-CG31715-RA_1 CG31715 TGAGGAAATCAAGGGCCGTTTTCCAGTACACTATGCAGCAGATTTTGGACAACTGAATGTCCTGGAGTT 69 FBan0031715 FBgn0051715 CG31715 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31715 CG31715 BcDNA:RE44624 CDMC29659 1 7 20 DAC32-E05 2-CG31741-RA_1 CG31741 GCCCCAGGTGACCTACTTCGGCAAACGTACCTGGCATTTTCTACCGGAAAAGTCAAATGGATCGCTTGA 69 FBan0031741 FBgn0051741 CG31741 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG31741 CG31741 "CG5750, CG5750, CG5750" CDMC29659 1 8 20 DAC32-E05 2-CG31741-RA_1 CG31741 GCCCCAGGTGACCTACTTCGGCAAACGTACCTGGCATTTTCTACCGGAAAAGTCAAATGGATCGCTTGA 69 FBan0031741 FBgn0051741 CG31741 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG31741 CG31741 "CG5750, CG5750, CG5750" CDMC29660 1 9 20 DAC32-E17 3-CG3174-RA_5 CG3174 CCACAGCACGGATACCTGTGACCCAGTCTACTACGACTTCGTTTATGTCTGCAACGGGCACTACACGGA 69 FBan0003174 FBgn0033079 Fmo-2 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 dimethylaniline monooxygenase (N-oxide-forming) activity; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; monooxygenase activity; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; ; GO:0004497 cytosol; GO:0005829; microsome; GO:0005792; mitochondrion; GO:0005739 Fmo-2 Flavin-containing monooxygenase 2 "CG3174, CG3174, DmFMO-2, Flavin-containing monooxygenase 2" CDMC29660 1 10 20 DAC32-E17 3-CG3174-RA_5 CG3174 CCACAGCACGGATACCTGTGACCCAGTCTACTACGACTTCGTTTATGTCTGCAACGGGCACTACACGGA 69 FBan0003174 FBgn0033079 Fmo-2 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 dimethylaniline monooxygenase (N-oxide-forming) activity; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; ; GO:0004499 ; EC:1.14.13.8; monooxygenase activity; GO:0004497; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036; ; GO:0004497 cytosol; GO:0005829; microsome; GO:0005792; mitochondrion; GO:0005739 Fmo-2 Flavin-containing monooxygenase 2 "CG3174, CG3174, DmFMO-2, Flavin-containing monooxygenase 2" CDMC29661 1 11 20 DAC32-I05 23-CG31775-RA_3 CG31775 AGCAACAAGGCTGGTAAAAACCAATTCATAGCACCGTCTTAACGCAGATACCTCAATAAAAATATGACA 69 FBgn0051775 CDMC29661 1 12 20 DAC32-I05 23-CG31775-RA_3 CG31775 AGCAACAAGGCTGGTAAAAACCAATTCATAGCACCGTCTTAACGCAGATACCTCAATAAAAATATGACA 69 FBgn0051775 CDMC29662 1 13 20 DAC32-I17 2-CG31783-RA_1 CG31783 CCGGACAGAGCGAAACAATTCAGGGCATCACGGGTTGGAAGTACGAGATAACGCCGAATACCTTCGACA 69 FBgn0051783 CDMC29662 1 14 20 DAC32-I17 2-CG31783-RA_1 CG31783 CCGGACAGAGCGAAACAATTCAGGGCATCACGGGTTGGAAGTACGAGATAACGCCGAATACCTTCGACA 69 FBgn0051783 CDMC29663 1 15 20 DAC32-M05 12-CG31813-RA_1 CG31813 ACCACTTCCGGCCTTCCACAAGCAACAGTTCGACTGCAACCAACGATATGTCAGCCAAATATACACTGA 69 FBan0031813 FBgn0051813 CG31813 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31813 CG31813 "BG:DS08249.4, BcDNA:RE62259" CDMC29663 1 16 20 DAC32-M05 12-CG31813-RA_1 CG31813 ACCACTTCCGGCCTTCCACAAGCAACAGTTCGACTGCAACCAACGATATGTCAGCCAAATATACACTGA 69 FBan0031813 FBgn0051813 CG31813 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31813 CG31813 "BG:DS08249.4, BcDNA:RE62259" CDMC29664 1 17 20 DAC32-M17 23-CG31820-RA_3 CG31820 GAAAACGACGTGAAATTTTTTTGTGCTTTTGGTTTGAACCACATTTTCACTTACACAATGGTTCGAGCT 69 FBan0031820 FBgn0051820 CG31820 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31820 CG31820 "NEST:bs10d03, NEST:bs36g10" CDMC29664 1 18 20 DAC32-M17 23-CG31820-RA_3 CG31820 GAAAACGACGTGAAATTTTTTTGTGCTTTTGGTTTGAACCACATTTTCACTTACACAATGGTTCGAGCT 69 FBan0031820 FBgn0051820 CG31820 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31820 CG31820 "NEST:bs10d03, NEST:bs36g10" CDMC29665 1 19 20 DAC33-A05 18-CG15507-RA_1 CG15507 TCAGCGACAGGATTATGCATCCCTTCAAATGGGCAGACAAGTGAGTGGACTAGTTAAGTGCGTACGATA 69 FBgn0039693 CDMC29665 1 20 20 DAC33-A05 18-CG15507-RA_1 CG15507 TCAGCGACAGGATTATGCATCCCTTCAAATGGGCAGACAAGTGAGTGGACTAGTTAAGTGCGTACGATA 69 FBgn0039693 CDMC29666 1 21 20 DAC33-A17 2-CG15525-RA_1 CG15525 TGCTGAACTCATCCGTGAGCGACTGAAACTGAACCAAATGGAGGATATCAGCCAAGCGGTGAATGTGGC 69 FBan0015525 FBgn0039732 CG15525 3 3R CG15525 CG15525 BcDNA:SD23244 CDMC29666 1 22 20 DAC33-A17 2-CG15525-RA_1 CG15525 TGCTGAACTCATCCGTGAGCGACTGAAACTGAACCAAATGGAGGATATCAGCCAAGCGGTGAATGTGGC 69 FBan0015525 FBgn0039732 CG15525 3 3R CG15525 CG15525 BcDNA:SD23244 CDMC29667 1 23 20 DAC33-E05 16-CG15561-RA_1 CG15561 TCCGAGGCATGTGAGGTTTCCCAACTGGAAGAGCCCATAAAATCCAAGAAAAAGAAGAAAGACAAGGCT 69 FBan0015561 FBgn0039829 CG15561 3 3R CG15561 CG15561 CDMC29667 1 24 20 DAC33-E05 16-CG15561-RA_1 CG15561 TCCGAGGCATGTGAGGTTTCCCAACTGGAAGAGCCCATAAAATCCAAGAAAAAGAAGAAAGACAAGGCT 69 FBan0015561 FBgn0039829 CG15561 3 3R CG15561 CG15561 CDMC29668 1 25 20 DAC33-E17 2-CG15580-RA_1 CG15580 GCGCCTGAAGTGAGGGAATCGCACACTTCAAAGGATTCGCACCCCTCTCAAAATGGAAAGACAGAACCA 69 FBan0015580 FBgn0037398 CG15580 3 3R CG15580 CG15580 CDMC29668 1 26 20 DAC33-E17 2-CG15580-RA_1 CG15580 GCGCCTGAAGTGAGGGAATCGCACACTTCAAAGGATTCGCACCCCTCTCAAAATGGAAAGACAGAACCA 69 FBan0015580 FBgn0037398 CG15580 3 3R CG15580 CG15580 CDMC29669 1 1 21 DAC33-I05 23-CG1561-RB_1 CG1561 GCAAGAAGTTGCAGTCAATATTTATAGTAGTCACTAAGTCGCTAATCAATAAAGGCTTGAACCCAAATG 69 FBan0001561 FBgn0030317 CG1561 X X CG1561 CG1561 e CDMC29669 1 2 21 DAC33-I05 23-CG1561-RB_1 CG1561 GCAAGAAGTTGCAGTCAATATTTATAGTAGTCACTAAGTCGCTAATCAATAAAGGCTTGAACCCAAATG 69 FBan0001561 FBgn0030317 CG1561 X X CG1561 CG1561 e CDMC29670 1 3 21 DAC33-I17 3-CG15636-RA_1 CG15636 AGGGCGATGAAGAAGACTTGGAGTCGGACAATGGGTATGAGACCACTCCGAGTCCCAGGAAGAAACGAT 69 FBan0015636 FBgn0031613 CG15636 2 2L chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 CG15636 CG15636 CDMC29670 1 4 21 DAC33-I17 3-CG15636-RA_1 CG15636 AGGGCGATGAAGAAGACTTGGAGTCGGACAATGGGTATGAGACCACTCCGAGTCCCAGGAAGAAACGAT 69 FBan0015636 FBgn0031613 CG15636 2 2L chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 CG15636 CG15636 CDMC29671 1 5 21 DAC33-M05 23-CG15697-RA_2 CG15697 CCCAACGCCAACTCCACATAGAAGGATTTTGGATGAACAAGTGTCTACCTTTTACTCCAGATTGATATG 69 FBan0015697 FBgn0038834 RpS30 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS30 Ribosomal protein S30 "CG15697, S30, anon-EST:Posey127, Ribosomal protein S30" CDMC29671 1 6 21 DAC33-M05 23-CG15697-RA_2 CG15697 CCCAACGCCAACTCCACATAGAAGGATTTTGGATGAACAAGTGTCTACCTTTTACTCCAGATTGATATG 69 FBan0015697 FBgn0038834 RpS30 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS30 Ribosomal protein S30 "CG15697, S30, anon-EST:Posey127, Ribosomal protein S30" CDMC29672 1 7 21 DAC33-M17 3-CG15707-RA_1 CG15707 TGGTGTGGGACAAAAAGGATGTGCCAGAGAACAAACGGACCTTCAAGTCGAAACCGCGTCTTCTTGACA 69 FBan0015707 FBgn0034098 CG15707 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG15707 CG15707 CDMC29672 1 8 21 DAC33-M17 3-CG15707-RA_1 CG15707 TGGTGTGGGACAAAAAGGATGTGCCAGAGAACAAACGGACCTTCAAGTCGAAACCGCGTCTTCTTGACA 69 FBan0015707 FBgn0034098 CG15707 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG15707 CG15707 CDMC29673 1 9 21 DAC34-A05 2-CG31120-RA_2 CG31120 GGCGGATGCCTAGAGATCTTCGGTAGCGACGATCAGTGCTTTCCACAGTTTCCAGTGCAGCGAAAGATC 69 FBan0031120 FBgn0051120 CG31120 3 3R protein metabolism; GO:0019538 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31120 CG31120 "CG13644, CG6031, CG18761" CDMC29673 1 10 21 DAC34-A05 2-CG31120-RA_2 CG31120 GGCGGATGCCTAGAGATCTTCGGTAGCGACGATCAGTGCTTTCCACAGTTTCCAGTGCAGCGAAAGATC 69 FBan0031120 FBgn0051120 CG31120 3 3R protein metabolism; GO:0019538 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG31120 CG31120 "CG13644, CG6031, CG18761" CDMC29674 1 11 21 DAC34-A17 8-CG31140-RA_1 CG31140 GCGGGCCTAGCTCGTCCTGTGTGCCATTGAATTAAATGCGGAAAAACACCTTTGGATTGTGCAATTGGT 69 FBan0031140 FBgn0051140 CG31140 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31140 CG31140 "CG5875, CG13600, CG31452, CG5875, DGKt" CDMC29674 1 12 21 DAC34-A17 8-CG31140-RA_1 CG31140 GCGGGCCTAGCTCGTCCTGTGTGCCATTGAATTAAATGCGGAAAAACACCTTTGGATTGTGCAATTGGT 69 FBan0031140 FBgn0051140 CG31140 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31140 CG31140 "CG5875, CG13600, CG31452, CG5875, DGKt" CDMC29675 1 13 21 DAC34-E05 10-CG31170-RA_1 CG31170 ACCCCCGATGCAATTTTCCGGATCAAACCCATTAATTCCACATCCGTCCTGATCGTCCACTCGGAATTT 69 FBgn0051170 CDMC29675 1 14 21 DAC34-E05 10-CG31170-RA_1 CG31170 ACCCCCGATGCAATTTTCCGGATCAAACCCATTAATTCCACATCCGTCCTGATCGTCCACTCGGAATTT 69 FBgn0051170 CDMC29676 1 15 21 DAC34-E17 2-CG3117-RA_1 CG3117 GCCAACATCCAGACCATTCGCTTACCCATTCCGGACAAGACTTTCGATCGAAGGATATGCACGGTCGCA 69 FBan0003117 FBgn0031471 CG3117 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG3117 CG3117 "c-SPH94, SPH94" CDMC29676 1 16 21 DAC34-E17 2-CG3117-RA_1 CG3117 GCCAACATCCAGACCATTCGCTTACCCATTCCGGACAAGACTTTCGATCGAAGGATATGCACGGTCGCA 69 FBan0003117 FBgn0031471 CG3117 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG3117 CG3117 "c-SPH94, SPH94" CDMC29677 1 17 21 DAC34-I05 18-CG31206-RA_1 CG31206 GGGCCGTGCATAGAGGCTGTGGTGACCACTATAGTTATTCGGCAAATTTGCAGAACTCTAAACCTGAAT 69 FBan0031206 FBgn0051206 CG31206 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31206 CG31206 NEST:bs16c12 CDMC29677 1 18 21 DAC34-I05 18-CG31206-RA_1 CG31206 GGGCCGTGCATAGAGGCTGTGGTGACCACTATAGTTATTCGGCAAATTTGCAGAACTCTAAACCTGAAT 69 FBan0031206 FBgn0051206 CG31206 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31206 CG31206 NEST:bs16c12 CDMC29678 1 19 21 DAC34-I17 3-CG31212-RA_1 CG31212 GGCCAAACTGCAGTCTTCTTCACCAATTCCAGCGGCTACTCAAAGCGAACGAAAAAGACGACATCCCCA 69 FBan0031212 FBgn0051212 CG31212 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; ; GO:0003678; ; GO:0004386; ; GO:0003677 CG31212 CG31212 "CG14279, CG18491, CG3602" CDMC29678 1 20 21 DAC34-I17 3-CG31212-RA_1 CG31212 GGCCAAACTGCAGTCTTCTTCACCAATTCCAGCGGCTACTCAAAGCGAACGAAAAAGACGACATCCCCA 69 FBan0031212 FBgn0051212 CG31212 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; ; GO:0003678; ; GO:0004386; ; GO:0003677 CG31212 CG31212 "CG14279, CG18491, CG3602" CDMC29679 1 21 21 DAC34-M05 2-CG31248-RA_1 CG31248 CGGCAAGCTCGTTTGGACTTGCGAGAGTTGTGCAGAAAAACCGCTCTGGATGGTGTCTCATTGTTGGTT 69 FBan0031248 FBgn0051248 CG31248 3 3R CG31248 CG31248 CG2640 CDMC29679 1 22 21 DAC34-M05 2-CG31248-RA_1 CG31248 CGGCAAGCTCGTTTGGACTTGCGAGAGTTGTGCAGAAAAACCGCTCTGGATGGTGTCTCATTGTTGGTT 69 FBan0031248 FBgn0051248 CG31248 3 3R CG31248 CG31248 CG2640 CDMC29680 1 23 21 DAC34-M17 9-CG31264-RA_2 CG31264 TCGGTGGGCACCTCTGAGCAATTGTCGGTGCAGTTGGATGTGAAATATCCCCCCAAAATTATTTCAGCT 69 FBgn0051264 CDMC29680 1 24 21 DAC34-M17 9-CG31264-RA_2 CG31264 TCGGTGGGCACCTCTGAGCAATTGTCGGTGCAGTTGGATGTGAAATATCCCCCCAAAATTATTTCAGCT 69 FBgn0051264 CDMC29681 1 25 21 DAC35-A05 2-CG7808-RB_1 CG7808 GAGGACGAGAACGACGTGCTGACCAAGAAGCGCAGCGAAAAGGTTATGAAGAAGTACCTGGAGCGC 66 FBan0007808 FBgn0039713 RpS8 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS8 Ribosomal protein S8 "CG7808, clone 1.56, S8, anon-EST:Liang-1.56, BcDNA:RH06886, anon-EST:fe1A2, BcDNA:SD17528, anon-fast-evolving-1A2, Ribosomal protein S8" CDMC29681 1 26 21 DAC35-A05 2-CG7808-RB_1 CG7808 GAGGACGAGAACGACGTGCTGACCAAGAAGCGCAGCGAAAAGGTTATGAAGAAGTACCTGGAGCGC 66 FBan0007808 FBgn0039713 RpS8 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS8 Ribosomal protein S8 "CG7808, clone 1.56, S8, anon-EST:Liang-1.56, BcDNA:RH06886, anon-EST:fe1A2, BcDNA:SD17528, anon-fast-evolving-1A2, Ribosomal protein S8" CDMC29682 1 1 22 DAC35-A17 3-CG7902-RA_4 CG7902 AGGATGTTGACGAGAATGTGGAGATCGACTAGGTTGGGAGTGACCATGTCTCGGAGGAGAACCGGG 66 FBan0007902 FBgn0004862 bap 3 3R cell fate commitment; GO:0045165; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; visceral muscle development; GO:0007522 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bap bagpipe "CG7902, nk-3, NK-3, NK3, bgp, dNK-3, bagpipe" CDMC29682 1 2 22 DAC35-A17 3-CG7902-RA_4 CG7902 AGGATGTTGACGAGAATGTGGAGATCGACTAGGTTGGGAGTGACCATGTCTCGGAGGAGAACCGGG 66 FBan0007902 FBgn0004862 bap 3 3R cell fate commitment; GO:0045165; cell homeostasis; GO:0019725; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate specification; GO:0007501; midgut development; GO:0007494; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; visceral muscle development; GO:0007522 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bap bagpipe "CG7902, nk-3, NK-3, NK3, bgp, dNK-3, bagpipe" CDMC29683 1 3 22 DAC35-E05 11-CG8315-RA_1 CG8315 TGCAGTCCTACGTGCTGATGCAGGGACACAAAGACATAGTTGTGGACACGGTGAAGAATGCGTGCG 66 FBan0008315 FBgn0034058 CG8315 2 2R peroxisome fission; GO:0016559; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisomal membrane; GO:0005778 CG8315 CG8315 CDMC29683 1 4 22 DAC35-E05 11-CG8315-RA_1 CG8315 TGCAGTCCTACGTGCTGATGCAGGGACACAAAGACATAGTTGTGGACACGGTGAAGAATGCGTGCG 66 FBan0008315 FBgn0034058 CG8315 2 2R peroxisome fission; GO:0016559; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisomal membrane; GO:0005778 CG8315 CG8315 CDMC29684 1 5 22 DAC35-E17 9-CG8425-RA_3 CG8425 GCCGGCGATGGTCTCAAGTACTGGGATGTGGATCACATGACCAATTTCCGTCCAGTGGTCGAGGAG 66 FBan0008425 FBgn0010052 Jhe 2 2R cell-cell signaling; GO:0007267; juvenile hormone catabolism; GO:0006719; signal transduction; GO:0007165 juvenile-hormone esterase activity; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59 Jhe Juvenile hormone esterase "CG8425, CG8425, CG8425, CG8425, CG8425, JH, JH esterase, JHE, JH-esterase" CDMC29684 1 6 22 DAC35-E17 9-CG8425-RA_3 CG8425 GCCGGCGATGGTCTCAAGTACTGGGATGTGGATCACATGACCAATTTCCGTCCAGTGGTCGAGGAG 66 FBan0008425 FBgn0010052 Jhe 2 2R cell-cell signaling; GO:0007267; juvenile hormone catabolism; GO:0006719; signal transduction; GO:0007165 juvenile-hormone esterase activity; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59; ; GO:0004453 ; EC:3.1.1.59 Jhe Juvenile hormone esterase "CG8425, CG8425, CG8425, CG8425, CG8425, JH, JH esterase, JHE, JH-esterase" CDMC29685 1 7 22 DAC35-I05 2-CG9078-RA_1 CG9078 GCCAAGGGCTTTGAGACGTACTCCTACTACGGTCCGCTCAACTGGATCACCTTCAATGTGGGCTAC 66 FBan0009078 FBgn0001941 ifc 2 2L proteolysis; GO:0006508; spermatogenesis; GO:0007283 sphingolipid delta-4 desaturase activity; GO:0042284; stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0042284; ; GO:0004768 ; EC:1.14.19.1; ; GO:0008237; ; GO:0008270 mitochondrion; GO:0005739; plasma membrane; GO:0005886 ifc infertile crescent "CG9078, l(2)gdh-2, l(2)26Ab, des, degenerative spermatocyte, des-1, des1, degenerating spermatocyte, DES-1, sphingolipid delta 4 desaturase, ms(2)04875" CDMC29685 1 8 22 DAC35-I05 2-CG9078-RA_1 CG9078 GCCAAGGGCTTTGAGACGTACTCCTACTACGGTCCGCTCAACTGGATCACCTTCAATGTGGGCTAC 66 FBan0009078 FBgn0001941 ifc 2 2L proteolysis; GO:0006508; spermatogenesis; GO:0007283 sphingolipid delta-4 desaturase activity; GO:0042284; stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0042284; ; GO:0004768 ; EC:1.14.19.1; ; GO:0008237; ; GO:0008270 mitochondrion; GO:0005739; plasma membrane; GO:0005886 ifc infertile crescent "CG9078, l(2)gdh-2, l(2)26Ab, des, degenerative spermatocyte, des-1, des1, degenerating spermatocyte, DES-1, sphingolipid delta 4 desaturase, ms(2)04875" CDMC29686 1 9 22 DAC35-I17 9-CG9218-RA_1 CG9218 AGGCACCAAGTTCCCATTCATCATGAAGCTGTGCTTTTCCTCATCCAAGAGCATGAACGGCGCCTG 66 FBan0009218 FBgn0003435 sm 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 sm smooth "CG9218, CG9218, smo, l(2)05338, BcDNA:GH10856, smooth" CDMC29686 1 10 22 DAC35-I17 9-CG9218-RA_1 CG9218 AGGCACCAAGTTCCCATTCATCATGAAGCTGTGCTTTTCCTCATCCAAGAGCATGAACGGCGCCTG 66 FBan0009218 FBgn0003435 sm 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 sm smooth "CG9218, CG9218, smo, l(2)05338, BcDNA:GH10856, smooth" CDMC29687 1 11 22 DAC35-M05 5-CG9672-RA_1 CG9672 TCTGCAGGAGGAGATTACTTTCAGTGAGACAGTCAATGCCATTCCACTCTCCCAGGACGTTCCGCC 66 FBan0009672 FBgn0030777 CG9672 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9672 CG9672 "SPH161, BcDNA:GH16384" CDMC29687 1 12 22 DAC35-M05 5-CG9672-RA_1 CG9672 TCTGCAGGAGGAGATTACTTTCAGTGAGACAGTCAATGCCATTCCACTCTCCCAGGACGTTCCGCC 66 FBan0009672 FBgn0030777 CG9672 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9672 CG9672 "SPH161, BcDNA:GH16384" CDMC29688 1 13 22 DAC35-M17 2-CG9863-RA_2 CG9863 CCAGCGGATTCAGAGCGTTCTGGTGAACTCCCAGATCGATGATAAGTTCGAACCGAGCAACTGCCG 66 FBan0009863 FBgn0034846 CG9863 2 2R CG9863 CG9863 BcDNA:AT26616 CDMC29688 1 14 22 DAC35-M17 2-CG9863-RA_2 CG9863 CCAGCGGATTCAGAGCGTTCTGGTGAACTCCCAGATCGATGATAAGTTCGAACCGAGCAACTGCCG 66 FBan0009863 FBgn0034846 CG9863 2 2R CG9863 CG9863 BcDNA:AT26616 CDMC29689 1 15 22 DAC36-A05 3-CG18085-RA_1 CG18085 TGCCTGGTGGGAATCTGCTTCGACACCGAGTCCATATCTCTGATTATGGAGCACATGGAAGCGGG 65 FBan0018085 FBgn0003366 sev X X "R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; determination of anterior/posterior axis, embryo; GO:0008595; protein amino acid phosphorylation; GO:0006468; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; boss receptor activity; GO:0008288; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004714 ; EC:2.7.1.-; ; GO:0008288; ; GO:0005515; ; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 sev sevenless "CG18085, CG18085, CG18085, Sev, DROSEV1, 7LES, 7less, DmHD-265, DROSEV, sev(AC)[[14]], CT3980, HD-265, sevenless" CDMC29689 1 16 22 DAC36-A05 3-CG18085-RA_1 CG18085 TGCCTGGTGGGAATCTGCTTCGACACCGAGTCCATATCTCTGATTATGGAGCACATGGAAGCGGG 65 FBan0018085 FBgn0003366 sev X X "R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; R7 development; GO:0045467; determination of anterior/posterior axis, embryo; GO:0008595; protein amino acid phosphorylation; GO:0006468; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; boss receptor activity; GO:0008288; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004714 ; EC:2.7.1.-; ; GO:0008288; ; GO:0005515; ; GO:0005515; ; GO:0005515 plasma membrane; GO:0005886 sev sevenless "CG18085, CG18085, CG18085, Sev, DROSEV1, 7LES, 7less, DmHD-265, DROSEV, sev(AC)[[14]], CT3980, HD-265, sevenless" CDMC29690 1 17 22 DAC36-A17 18-CG18130-RA_5 CG18130 GACAAGATCGTGCTGAAGGTCAACAAGGTCCAGTCCAACATGATGTTATCCCTGGTCTCGTACGG 65 FBan0018130 FBgn0030359 CG18130 X X CG18130 CG18130 CDMC29690 1 18 22 DAC36-A17 18-CG18130-RA_5 CG18130 GACAAGATCGTGCTGAAGGTCAACAAGGTCCAGTCCAACATGATGTTATCCCTGGTCTCGTACGG 65 FBan0018130 FBgn0030359 CG18130 X X CG18130 CG18130 CDMC29691 1 19 22 DAC36-E05 23-CG18341-RA_1 CG18341 CCATTGTTTCCGACAAGAATTGCTCAAAAATTCACCACCTTCAGGATCACATATACTGTTGTGGC 65 FBan0018341 FBgn0029812 CG18341 X X CG18341 CG18341 CDMC29691 1 20 22 DAC36-E05 23-CG18341-RA_1 CG18341 CCATTGTTTCCGACAAGAATTGCTCAAAAATTCACCACCTTCAGGATCACATATACTGTTGTGGC 65 FBan0018341 FBgn0029812 CG18341 X X CG18341 CG18341 CDMC29692 1 21 22 DAC36-E17 2-CG1836-RB_2 CG1836 GAAGTAGCTACTTCAGCACAAAGATCAGCCGCGGGTACAAGTGCAGCACATCAAAGCGGTAGCGC 65 FBan0001836 FBgn0026777 Rad23 4 4 nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 Rad23 Rad23 "CG1836, rad23, DHR23" CDMC29692 1 22 22 DAC36-E17 2-CG1836-RB_2 CG1836 GAAGTAGCTACTTCAGCACAAAGATCAGCCGCGGGTACAAGTGCAGCACATCAAAGCGGTAGCGC 65 FBan0001836 FBgn0026777 Rad23 4 4 nucleotide-excision repair; GO:0006289 damaged DNA binding; GO:0003684; ; GO:0003684 nucleus; GO:0005634 Rad23 Rad23 "CG1836, rad23, DHR23" CDMC29693 1 23 22 DAC36-I05 1-CG18561-RA_1 CG18561 CTGCTGATGGCCAGATGAAGATGGCAACCTGCGGACATGGCTCCATAAACACAAAGACATCCAGC 65 FBan0018561 FBgn0032301 CG18561 2 2L CG18561 CG18561 CDMC29693 1 24 22 DAC36-I05 1-CG18561-RA_1 CG18561 CTGCTGATGGCCAGATGAAGATGGCAACCTGCGGACATGGCTCCATAAACACAAAGACATCCAGC 65 FBan0018561 FBgn0032301 CG18561 2 2L CG18561 CG18561 CDMC29694 1 25 22 DAC36-I17 1-CG18624-RB_5 CG18624 ATCTCGCCATCTCCTGTGCTTGTCTTGCAGACCTATGGGCAGTGGGATTGTGGTTCAATTGGCTC 65 FBan0018624 FBgn0029971 CG18624 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG18624 CG18624 CG15328 CDMC29694 1 26 22 DAC36-I17 1-CG18624-RB_5 CG18624 ATCTCGCCATCTCCTGTGCTTGTCTTGCAGACCTATGGGCAGTGGGATTGTGGTTCAATTGGCTC 65 FBan0018624 FBgn0029971 CG18624 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG18624 CG18624 CG15328 CDMC29695 1 1 23 DAC36-M05 1-CG18743-RA_1 CG18743 CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC29695 1 2 23 DAC36-M05 1-CG18743-RA_1 CG18743 CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC29696 1 3 23 DAC36-M17 23-CG18816-RB_3 CG18816 TAGAGCCGAAGTCAGATACAATCCTTAGACGTAGCCCAGTTCATAGCATAAATCCAACACACGAA 65 FBan0018816 FBgn0042086 Tsp42Eb 2 2R integral to membrane; GO:0016021 Tsp42Eb Tetraspanin 42Eb "CG18816, CG18816, LP06288, Dm.Tsp42Eb, tetraspanin 42E, BEST:LP06288, Tetraspanin 42Eb" CDMC29696 1 4 23 DAC36-M17 23-CG18816-RB_3 CG18816 TAGAGCCGAAGTCAGATACAATCCTTAGACGTAGCCCAGTTCATAGCATAAATCCAACACACGAA 65 FBan0018816 FBgn0042086 Tsp42Eb 2 2R integral to membrane; GO:0016021 Tsp42Eb Tetraspanin 42Eb "CG18816, CG18816, LP06288, Dm.Tsp42Eb, tetraspanin 42E, BEST:LP06288, Tetraspanin 42Eb" CDMC29697 1 5 23 DAC37-A05 24-CG16892-RA_3 CG16892 TTCGACTGATCTTAAAGCTTAGTGATTTTCATAGTAATACATTTTTTGATTTGGTTTTTGTAAGCGTTA 69 FBan0016892 FBgn0030122 CG16892 X X CG16892 CG16892 CDMC29697 1 6 23 DAC37-A05 24-CG16892-RA_3 CG16892 TTCGACTGATCTTAAAGCTTAGTGATTTTCATAGTAATACATTTTTTGATTTGGTTTTTGTAAGCGTTA 69 FBan0016892 FBgn0030122 CG16892 X X CG16892 CG16892 CDMC29698 1 7 23 DAC37-A17 18-CG16902-RA_1 CG16902 TCCGGCGAATCAAGCTCAAGATGGAGGAGTACGTCTGCCTGAAGGTTTACATACTGCTAAACAAAGGTA 69 FBan0016902 FBgn0023546 Hr4 X X growth; GO:0040007; metamorphosis (sensu Insecta); GO:0046698; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; steroid hormone receptor signaling pathway; GO:0030518 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; ; GO:0004879; ; GO:0004879 nucleus; GO:0005634 Hr4 Hr4 "CG16902, CG16902, CG16902, CG16902, DHR4, EG:133E12.2, GRF, NR6A2" CDMC29698 1 8 23 DAC37-A17 18-CG16902-RA_1 CG16902 TCCGGCGAATCAAGCTCAAGATGGAGGAGTACGTCTGCCTGAAGGTTTACATACTGCTAAACAAAGGTA 69 FBan0016902 FBgn0023546 Hr4 X X growth; GO:0040007; metamorphosis (sensu Insecta); GO:0046698; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; steroid hormone receptor signaling pathway; GO:0030518 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; ; GO:0004879; ; GO:0004879 nucleus; GO:0005634 Hr4 Hr4 "CG16902, CG16902, CG16902, CG16902, DHR4, EG:133E12.2, GRF, NR6A2" CDMC29699 1 9 23 DAC37-E05 2-CG16952-RC_1 CG16952 GGCAAGGACAACCATCGCCAACATCACATCCACAACATTCCGGGACATACAATTCTGGACCACCAAGGT 69 FBan0016952 FBgn0030701 CG16952 X X CG16952 CG16952 CDMC29699 1 10 23 DAC37-E05 2-CG16952-RC_1 CG16952 GGCAAGGACAACCATCGCCAACATCACATCCACAACATTCCGGGACATACAATTCTGGACCACCAAGGT 69 FBan0016952 FBgn0030701 CG16952 X X CG16952 CG16952 CDMC29700 1 11 23 DAC37-E17 22-CG16960-RA_1 CG16960 TCGTGTGGCTCGAATGCTTTCGAAAAGTTACTTGGTAGCTGCTATATCGGCCATAATCACTGCAACTGT 69 FBan0016960 FBgn0026392 Or33a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33a Odorant receptor 33a "CG16960, CG16960, DOR33B.1, Olfactory receptor 33B.1, dor73, AN3, 33B.1, DOR73, 33a, Or33B.1, Or73" CDMC29700 1 12 23 DAC37-E17 22-CG16960-RA_1 CG16960 TCGTGTGGCTCGAATGCTTTCGAAAAGTTACTTGGTAGCTGCTATATCGGCCATAATCACTGCAACTGT 69 FBan0016960 FBgn0026392 Or33a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33a Odorant receptor 33a "CG16960, CG16960, DOR33B.1, Olfactory receptor 33B.1, dor73, AN3, 33B.1, DOR73, 33a, Or33B.1, Or73" CDMC29701 1 13 23 DAC37-I05 23-CG16983-RD_10 CG16983 GTGGGTGAGCATTTCTGGAAAGTGCCGTTCTCTATGTTTCGATTCTACTTATCCCTTCATCACCATTTC 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC29701 1 14 23 DAC37-I05 23-CG16983-RD_10 CG16983 GTGGGTGAGCATTTCTGGAAAGTGCCGTTCTCTATGTTTCGATTCTACTTATCCCTTCATCACCATTTC 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC29702 1 15 23 DAC37-I17 22-CG16991-RB_1 CG16991 ACCTGACGACTACAAGTTGGGCGATCTGAATATCCCAAAATCCTGTTACAAGAATGGCAGTGAAAGGGA 69 FBan0016991 FBgn0035786 Tsp66A 3 3L integral to membrane; GO:0016021 Tsp66A Tetraspanin 66A "CG16991, CG1699, CG16991, CG1699, Dm.Tsp66A, Tetraspanin 66A" CDMC29702 1 16 23 DAC37-I17 22-CG16991-RB_1 CG16991 ACCTGACGACTACAAGTTGGGCGATCTGAATATCCCAAAATCCTGTTACAAGAATGGCAGTGAAAGGGA 69 FBan0016991 FBgn0035786 Tsp66A 3 3L integral to membrane; GO:0016021 Tsp66A Tetraspanin 66A "CG16991, CG1699, CG16991, CG1699, Dm.Tsp66A, Tetraspanin 66A" CDMC29703 1 17 23 DAC37-M05 16-CG17031-RA_2 CG17031 GTGTTCAAGGAGGATCGATCAGAAAGCGAAATTCAGAAGGCGGACTTAGAGGAATTCAAAGGTCCCGCA 69 FBan0017031 FBgn0032439 ref2 2 2L mRNA export from nucleus; GO:0006406; transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; ; GO:0003729 ref2 ref2 "CG17031, CG17031, cg17031, REF2" CDMC29703 1 18 23 DAC37-M05 16-CG17031-RA_2 CG17031 GTGTTCAAGGAGGATCGATCAGAAAGCGAAATTCAGAAGGCGGACTTAGAGGAATTCAAAGGTCCCGCA 69 FBan0017031 FBgn0032439 ref2 2 2L mRNA export from nucleus; GO:0006406; transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; ; GO:0003729 ref2 ref2 "CG17031, CG17031, cg17031, REF2" CDMC29704 1 19 23 DAC37-M17 18-CG17041-RB_1 CG17041 GCAGAAGCTGTCGCATCCCTACACCTGCACTGAGAAAAAATGCCAGTCAAAAGTTTTTATTACCCACCA 69 FBan0017041 FBgn0033822 CG17041 2 2R CG17041 CG17041 CDMC29704 1 20 23 DAC37-M17 18-CG17041-RB_1 CG17041 GCAGAAGCTGTCGCATCCCTACACCTGCACTGAGAAAAAATGCCAGTCAAAAGTTTTTATTACCCACCA 69 FBan0017041 FBgn0033822 CG17041 2 2R CG17041 CG17041 CDMC29705 1 21 23 DAC38-A05 14-CG17534-RA_1 CG17534 TGCGCTTATCTGGTTAGACGCTATGCCAAGAGTGATGACCTGTATCCCAAGGATTACTTCAAACGCGCA 69 FBgn0034343 CDMC29705 1 22 23 DAC38-A05 14-CG17534-RA_1 CG17534 TGCGCTTATCTGGTTAGACGCTATGCCAAGAGTGATGACCTGTATCCCAAGGATTACTTCAAACGCGCA 69 FBgn0034343 CDMC29706 1 23 23 DAC38-A17 2-CG17569-RA_2 CG17569 CGCCAGCCGGAATTAGTGCCTACATGAGCAAGAGTCTGGTGACCAAGATACCCACTACCATGACCATCA 69 FBan0017569 FBgn0035416 gry 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 gry gryzun "CG17569, gryzun" CDMC29706 1 24 23 DAC38-A17 2-CG17569-RA_2 CG17569 CGCCAGCCGGAATTAGTGCCTACATGAGCAAGAGTCTGGTGACCAAGATACCCACTACCATGACCATCA 69 FBan0017569 FBgn0035416 gry 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 gry gryzun "CG17569, gryzun" CDMC29707 1 25 23 DAC38-E05 18-CG17611-RA_1 CG17611 AGCAGGCTCAGTCAGGCCAGTAAATCCGAAAAGAGAGTAACCAGCAGGAAAAGAGGATCCACGTAAATA 69 FBan0017611 FBgn0034915 eIF6 2 2R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829 eIF6 eIF6 "CG17611, CG17611, CG17611, l(2)k13214, eif6, anon-WO0172774.153, anon-WO0172774.155" CDMC29707 1 26 23 DAC38-E05 18-CG17611-RA_1 CG17611 AGCAGGCTCAGTCAGGCCAGTAAATCCGAAAAGAGAGTAACCAGCAGGAAAAGAGGATCCACGTAAATA 69 FBan0017611 FBgn0034915 eIF6 2 2R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829 eIF6 eIF6 "CG17611, CG17611, CG17611, l(2)k13214, eif6, anon-WO0172774.153, anon-WO0172774.155" CDMC29708 1 1 24 DAC38-E17 8-CG17629-RD_1 CG17629 TTGAGCGACAGGGAAAAGATGCAGCCGTCAACCCAAATTTTCGAATATGGATCACAACAGAGCCGCACC 69 CDMC29708 1 2 24 DAC38-E17 8-CG17629-RD_1 CG17629 TTGAGCGACAGGGAAAAGATGCAGCCGTCAACCCAAATTTTCGAATATGGATCACAACAGAGCCGCACC 69 CDMC29709 1 3 24 DAC38-I05 3-CG17678-RA_1 CG17678 TGGACGCTCGCGAAAAATTAAACATTGCGTGGGGAAGTGACGGCAGAGAACAGGATGCTTATGATGCCA 69 CDMC29709 1 4 24 DAC38-I05 3-CG17678-RA_1 CG17678 TGGACGCTCGCGAAAAATTAAACATTGCGTGGGGAAGTGACGGCAGAGAACAGGATGCTTATGATGCCA 69 CDMC29710 1 5 24 DAC38-I17 8-CG17687-RA_1 CG17687 CGAGCGTATCAAGGTAGACGTCACTTTCCAAAACACTTTGCGCGATACGATGATGGAGGACAAGCGGGA 69 FBan0017687 FBgn0036348 CG17687 3 3L CG17687 CG17687 CDMC29710 1 6 24 DAC38-I17 8-CG17687-RA_1 CG17687 CGAGCGTATCAAGGTAGACGTCACTTTCCAAAACACTTTGCGCGATACGATGATGGAGGACAAGCGGGA 69 FBan0017687 FBgn0036348 CG17687 3 3L CG17687 CG17687 CDMC29711 1 7 24 DAC38-M05 11-CG17726-RA_1 CG17726 GGCGCACAAGAAGCTAGCTTCCGATATGTGCTCTCACGTAGCCAAACACCCGTTTCGAGTCTTTATCGA 69 FBan0017726 FBgn0037880 CG17726 3 3R CG17726 CG17726 CDMC29711 1 8 24 DAC38-M05 11-CG17726-RA_1 CG17726 GGCGCACAAGAAGCTAGCTTCCGATATGTGCTCTCACGTAGCCAAACACCCGTTTCGAGTCTTTATCGA 69 FBan0017726 FBgn0037880 CG17726 3 3R CG17726 CG17726 CDMC29712 1 9 24 DAC38-M17 2-CG17742-RA_2 CG17742 TGAGGTCGATGTGGATACGATTAAGAAGCTAAAGCTGGGTCAGAGGTCATCGCTCTGGTCCCGACCCTC 69 FBan0017742 FBgn0035746 CG17742 3 3L CG17742 CG17742 CDMC29712 1 10 24 DAC38-M17 2-CG17742-RA_2 CG17742 TGAGGTCGATGTGGATACGATTAAGAAGCTAAAGCTGGGTCAGAGGTCATCGCTCTGGTCCCGACCCTC 69 FBan0017742 FBgn0035746 CG17742 3 3L CG17742 CG17742 CDMC29713 1 11 24 DAC39-A05 11-CG32160-RA_1 CG32160 CATATCTCTCTTGGGATCTCGAGTGGTACTGCTCTGGGGGTAATGTACGCCTTATGGCCAGCAGG 65 FBan0032160 FBgn0052160 CG32160 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32160 CG32160 BcDNA:RH34065 CDMC29713 1 12 24 DAC39-A05 11-CG32160-RA_1 CG32160 CATATCTCTCTTGGGATCTCGAGTGGTACTGCTCTGGGGGTAATGTACGCCTTATGGCCAGCAGG 65 FBan0032160 FBgn0052160 CG32160 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32160 CG32160 BcDNA:RH34065 CDMC29714 1 13 24 DAC39-A17 23-CG32184-RA_1 CG32184 CTTAGTAGTATGACATCAATATTGGGAGCCAGTTATAGGTTTCTAATCCTAAGATGCCCACTGCC 65 FBan0032184 FBgn0052184 CG32184 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32184 CG32184 CDMC29714 1 14 24 DAC39-A17 23-CG32184-RA_1 CG32184 CTTAGTAGTATGACATCAATATTGGGAGCCAGTTATAGGTTTCTAATCCTAAGATGCCCACTGCC 65 FBan0032184 FBgn0052184 CG32184 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32184 CG32184 CDMC29715 1 15 24 DAC39-E05 1-CG32268-RA_1 CG32268 CAAATCAAGTTCCTGTTCACCTTCCTCGCTCTGCTGATGATGGTCATCCTGGGCGCCAAGGAAGC 65 FBan0032268 FBgn0052268 dro6 3 3L defense response; GO:0006952 dro6 drosomycin-6 "CG11520, CG32268, CG10815, CG11520, CG11520, CG11520, Dro-I, drosomycin-I" CDMC29715 1 16 24 DAC39-E05 1-CG32268-RA_1 CG32268 CAAATCAAGTTCCTGTTCACCTTCCTCGCTCTGCTGATGATGGTCATCCTGGGCGCCAAGGAAGC 65 FBan0032268 FBgn0052268 dro6 3 3L defense response; GO:0006952 dro6 drosomycin-6 "CG11520, CG32268, CG10815, CG11520, CG11520, CG11520, Dro-I, drosomycin-I" CDMC29716 1 17 24 DAC39-E17 2-CG32333-RA_5 CG32333 CTCCGAACTGCCATACTTCTACATCAGCGACGAGTACCGCGCATTCTCGCCTAACGGCATGCATC 65 FBan0032333 FBgn0052333 CG32333 3 3L catalytic activity; GO:0003824; ; GO:0003824 CG32333 CG32333 "CG9137, CG9146" CDMC29716 1 18 24 DAC39-E17 2-CG32333-RA_5 CG32333 CTCCGAACTGCCATACTTCTACATCAGCGACGAGTACCGCGCATTCTCGCCTAACGGCATGCATC 65 FBan0032333 FBgn0052333 CG32333 3 3L catalytic activity; GO:0003824; ; GO:0003824 CG32333 CG32333 "CG9137, CG9146" CDMC29717 1 19 24 DAC39-I05 12-CG32441-RA_1 CG32441 TGCACCCAGGAAGACGTGAATAAGCTACTGGAAACGCAATTCAGCACCGATGTCCTCATCCGCCA 65 FBan0032441 FBgn0052441 CG32441 3 3L CG32441 CG32441 CG7783 CDMC29717 1 20 24 DAC39-I05 12-CG32441-RA_1 CG32441 TGCACCCAGGAAGACGTGAATAAGCTACTGGAAACGCAATTCAGCACCGATGTCCTCATCCGCCA 65 FBan0032441 FBgn0052441 CG32441 3 3L CG32441 CG32441 CG7783 CDMC29718 1 21 24 DAC39-I17 6-CG3248-RA_2 CG3248 AGCGCAAACAGCTCTTTTCGATGGGTAGCAATAATGCGCTGTTGGAATTCCTTCTGGAGGGCACG 65 FBan0003248 FBgn0031536 CG3248 2 2L CG3248 CG3248 CDMC29718 1 22 24 DAC39-I17 6-CG3248-RA_2 CG3248 AGCGCAAACAGCTCTTTTCGATGGGTAGCAATAATGCGCTGTTGGAATTCCTTCTGGAGGGCACG 65 FBan0003248 FBgn0031536 CG3248 2 2L CG3248 CG3248 CDMC29719 1 23 24 DAC39-M05 7-CG32537-RA_1 CG32537 CAGGTCAAACGGAAGGATGGCCAGCTGTGCGAGATCTGTCGCCAGTTGAAGAACAACGAGGTGTC 65 FBan0032537 FBgn0052537 CG32537 X X CG32537 CG32537 CG8020 CDMC29719 1 24 24 DAC39-M05 7-CG32537-RA_1 CG32537 CAGGTCAAACGGAAGGATGGCCAGCTGTGCGAGATCTGTCGCCAGTTGAAGAACAACGAGGTGTC 65 FBan0032537 FBgn0052537 CG32537 X X CG32537 CG32537 CG8020 CDMC29720 1 25 24 DAC39-M17 19-CG32550-RA_1 CG32550 GCCTATGCTGCCCCCGCCTACGCTGCTCCTGCATACGCTACGCATCTAGCTGGGCCCGTGGTGAA 65 FBan0032550 FBgn0052550 CG32550 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32550 CG32550 CDMC29720 1 26 24 DAC39-M17 19-CG32550-RA_1 CG32550 GCCTATGCTGCCCCCGCCTACGCTGCTCCTGCATACGCTACGCATCTAGCTGGGCCCGTGGTGAA 65 FBan0032550 FBgn0052550 CG32550 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32550 CG32550 CDMC29721 1 1 25 DAC40-A05 12-CG4098-RA_1 CG4098 GCGACACATTCTGGCCACAGTGGAATCAGCTGGATGGACAGGTAAACCGCGAATCCTTTCACGGT 65 FBan0004098 FBgn0036648 CG4098 3 3L CG4098 CG4098 CDMC29721 1 2 25 DAC40-A05 12-CG4098-RA_1 CG4098 GCGACACATTCTGGCCACAGTGGAATCAGCTGGATGGACAGGTAAACCGCGAATCCTTTCACGGT 65 FBan0004098 FBgn0036648 CG4098 3 3L CG4098 CG4098 CDMC29722 1 3 25 DAC40-A17 3-CG41098-RA_1 CG41098 AATCGACATAGTTCGGATGCTGCTCGGCAAAGACAGTCGCAATGGTGATGTTCGAAGCTGCACCG 65 FBgn0069943 CG41098 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41098 CG41098 CDMC29722 1 4 25 DAC40-A17 3-CG41098-RA_1 CG41098 AATCGACATAGTTCGGATGCTGCTCGGCAAAGACAGTCGCAATGGTGATGTTCGAAGCTGCACCG 65 FBgn0069943 CG41098 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41098 CG41098 CDMC29723 1 5 25 DAC40-E05 17-CG4154-RC_1 CG4154 AGTTTCTCGAGGATCTGCAAATCTCACGTTCCTCCCTGGCAAACAATAACAACAATCAGAGCCCC 65 FBan0004154 FBgn0038295 Gyc88E 3 3R ATP synthesis coupled proton transport; GO:0015986; DNA methylation; GO:0006306; G-protein coupled receptor protein signaling pathway; GO:0007186; cGMP biosynthesis; GO:0006182; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0003677; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "guanylate cyclase complex, soluble; GO:0008074; proton-transporting two-sector ATPase complex; GO:0016469" Gyc88E Guanylyl cyclase at 88E "CG4154, CG4154, CG4154, GYC, Gyc-88E, Guanylyl cyclase at 88E" CDMC29723 1 6 25 DAC40-E05 17-CG4154-RC_1 CG4154 AGTTTCTCGAGGATCTGCAAATCTCACGTTCCTCCCTGGCAAACAATAACAACAATCAGAGCCCC 65 FBan0004154 FBgn0038295 Gyc88E 3 3R ATP synthesis coupled proton transport; GO:0015986; DNA methylation; GO:0006306; G-protein coupled receptor protein signaling pathway; GO:0007186; cGMP biosynthesis; GO:0006182; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 "DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0003677; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "guanylate cyclase complex, soluble; GO:0008074; proton-transporting two-sector ATPase complex; GO:0016469" Gyc88E Guanylyl cyclase at 88E "CG4154, CG4154, CG4154, GYC, Gyc-88E, Guanylyl cyclase at 88E" CDMC29724 1 7 25 DAC40-E17 3-CG4192-RA_3 CG4192 CCCGCAAACTAAAGACCAGTGGAAAGTACTTCCGCAACTCCTCGGATAGCCAATCACCCCTGCTG 65 FBan0004192 FBgn0028370 kek3 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 plasma membrane; GO:0005886 kek3 kekkon-3 "CG4192, BG:DS04862.1, CT12629, kekkon, Kekkon-3, kekkon-3" CDMC29724 1 8 25 DAC40-E17 3-CG4192-RA_3 CG4192 CCCGCAAACTAAAGACCAGTGGAAAGTACTTCCGCAACTCCTCGGATAGCCAATCACCCCTGCTG 65 FBan0004192 FBgn0028370 kek3 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 plasma membrane; GO:0005886 kek3 kekkon-3 "CG4192, BG:DS04862.1, CT12629, kekkon, Kekkon-3, kekkon-3" CDMC29725 1 9 25 DAC40-I05 2-CG4313-RA_2 CG4313 CGGCTCGTGTTCCATCATGCATGATCGGTATGGTAGATCCCCCAAGGAGTTCCTCTTCATCGCCG 65 FBan0004313 FBgn0025632 CG4313 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; mu-opioid receptor activity; GO:0004988; ; GO:0016526; ; GO:0004988" integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG4313 CG4313 EG:22E5.10 CDMC29725 1 10 25 DAC40-I05 2-CG4313-RA_2 CG4313 CGGCTCGTGTTCCATCATGCATGATCGGTATGGTAGATCCCCCAAGGAGTTCCTCTTCATCGCCG 65 FBan0004313 FBgn0025632 CG4313 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity, unknown ligand; GO:0016526; mu-opioid receptor activity; GO:0004988; ; GO:0016526; ; GO:0004988" integral to membrane; GO:0016021; plasma membrane; GO:0005886 CG4313 CG4313 EG:22E5.10 CDMC29726 1 11 25 DAC40-I17 2-CG4374-RA_1 CG4374 TACATCGGCCGGTCAATTGCAACCACCGCAACCTTTGAAACCGGAAGTCAGTACCTCCACATCAC 65 FBan0004374 FBgn0039078 CG4374 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4374 CG4374 CDMC29726 1 12 25 DAC40-I17 2-CG4374-RA_1 CG4374 TACATCGGCCGGTCAATTGCAACCACCGCAACCTTTGAAACCGGAAGTCAGTACCTCCACATCAC 65 FBan0004374 FBgn0039078 CG4374 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4374 CG4374 CDMC29727 1 13 25 DAC40-M05 18-CG4481-RA_6 CG4481 GGTGAGCGTCATCTTCAGTTACATCGGCGTTAGCATCGTGCTATTCTTTGTGTCGCGCTTCTCGC 65 FBan0004481 FBgn0028431 Glu-RIB 3 3L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ionotropic glutamate receptor activity; GO:0004970; ; GO:0004970; ; GO:0004971; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 ionotropic glutamate receptor complex; GO:0008328 Glu-RIB Glutamate receptor IB "CG4481, CG4481, DGluR-IB, GluRIb, dglur-IB, glutamate receptor, Glutamate receptor IB" CDMC29727 1 14 25 DAC40-M05 18-CG4481-RA_6 CG4481 GGTGAGCGTCATCTTCAGTTACATCGGCGTTAGCATCGTGCTATTCTTTGTGTCGCGCTTCTCGC 65 FBan0004481 FBgn0028431 Glu-RIB 3 3L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ionotropic glutamate receptor activity; GO:0004970; ; GO:0004970; ; GO:0004971; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 ionotropic glutamate receptor complex; GO:0008328 Glu-RIB Glutamate receptor IB "CG4481, CG4481, DGluR-IB, GluRIb, dglur-IB, glutamate receptor, Glutamate receptor IB" CDMC29728 1 15 25 DAC40-M17 2-CG4553-RA_1 CG4553 GGACGGGAAAGGGTGACTTCAGTATCCCACCGTCTCTTCTCCAGCATCTGCAGAAATTCGCCGAG 65 FBan0004553 FBgn0039336 CG4553 3 3R CG4553 CG4553 CDMC29728 1 16 25 DAC40-M17 2-CG4553-RA_1 CG4553 GGACGGGAAAGGGTGACTTCAGTATCCCACCGTCTCTTCTCCAGCATCTGCAGAAATTCGCCGAG 65 FBan0004553 FBgn0039336 CG4553 3 3R CG4553 CG4553 CDMC29729 1 17 25 DAC41-A05 11-CG4546-RA_1 CG4546 GGATGGCGTTGTGACCCTGATTAACGCAGAGGAAGAGCTCGAAATATCCGGACAGGAGGGTTAGAAACA 69 FBan0004546 FBgn0038373 CG4546 3 3R amino acid kinase activity; GO:0019202; arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0019202; ; GO:0004054 ; EC:2.7.3.3 CG4546 CG4546 CDMC29729 1 18 25 DAC41-A05 11-CG4546-RA_1 CG4546 GGATGGCGTTGTGACCCTGATTAACGCAGAGGAAGAGCTCGAAATATCCGGACAGGAGGGTTAGAAACA 69 FBan0004546 FBgn0038373 CG4546 3 3R amino acid kinase activity; GO:0019202; arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0019202; ; GO:0004054 ; EC:2.7.3.3 CG4546 CG4546 CDMC29730 1 19 25 DAC41-A17 13-CG4562-RA_1 CG4562 CGACTGCGTTTGTGTTGTCTACATCGCTGTAATCACATTGAGCTTCTTCCTCTTCTCCCCGGAGAACGG 69 FBan0004562 FBgn0038740 CG4562 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG4562 CG4562 CT14766 CDMC29730 1 20 25 DAC41-A17 13-CG4562-RA_1 CG4562 CGACTGCGTTTGTGTTGTCTACATCGCTGTAATCACATTGAGCTTCTTCCTCTTCTCCCCGGAGAACGG 69 FBan0004562 FBgn0038740 CG4562 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG4562 CG4562 CT14766 CDMC29731 1 21 25 DAC41-E05 5-CG4602-RA_1 CG4602 CCGCTCCCGTACTCCCGAAACTCGCAAACTCAAATCCATCTCTGAGGACACTGAGGTTAAGAGCTCACG 69 FBan0004602 FBgn0024285 Srp54 2 2L "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729 nucleus; GO:0005634; spliceosome complex; GO:0005681 Srp54 Srp54 "CG4602, CG4602, CG4602, dSRp54, p75, clone 2.16, SRp54, anon-EST:Liang-2.16" CDMC29731 1 22 25 DAC41-E05 5-CG4602-RA_1 CG4602 CCGCTCCCGTACTCCCGAAACTCGCAAACTCAAATCCATCTCTGAGGACACTGAGGTTAAGAGCTCACG 69 FBan0004602 FBgn0024285 Srp54 2 2L "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0003729 nucleus; GO:0005634; spliceosome complex; GO:0005681 Srp54 Srp54 "CG4602, CG4602, CG4602, dSRp54, p75, clone 2.16, SRp54, anon-EST:Liang-2.16" CDMC29732 1 23 25 DAC41-E17 18-CG4608-RB_2 CG4608 CCCGGCGATGATGCACAGTGCAACCAAGATCCCCACTAAAGACGATGAATATCAATGTATTACGACGGA 69 FBan0004608 FBgn0014135 bnl 3 3R "branching morphogenesis; GO:0001763; chemotaxis; GO:0006935; cytoneme biogenesis; GO:0035231; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; positive chemotaxis; GO:0050918; primary tracheal branching (sensu Insecta); GO:0007428; regulation of tracheal tube architecture; GO:0035152; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104; growth factor activity; GO:0008083; ; GO:0005104; ; GO:0008083 extracellular region; GO:0005576 bnl branchless "CG4608, DFGF, l(3)06916, fibroblast growth factor, Bnl, FGF, l(3)neo52, branchless" CDMC29732 1 24 25 DAC41-E17 18-CG4608-RB_2 CG4608 CCCGGCGATGATGCACAGTGCAACCAAGATCCCCACTAAAGACGATGAATATCAATGTATTACGACGGA 69 FBan0004608 FBgn0014135 bnl 3 3R "branching morphogenesis; GO:0001763; chemotaxis; GO:0006935; cytoneme biogenesis; GO:0035231; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; positive chemotaxis; GO:0050918; primary tracheal branching (sensu Insecta); GO:0007428; regulation of tracheal tube architecture; GO:0035152; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104; growth factor activity; GO:0008083; ; GO:0005104; ; GO:0008083 extracellular region; GO:0005576 bnl branchless "CG4608, DFGF, l(3)06916, fibroblast growth factor, Bnl, FGF, l(3)neo52, branchless" CDMC29733 1 25 25 DAC41-I05 3-CG4634-RA_2 CG4634 GCACGAAATCACACGAGATGGCTCTGTACGAAACCGTTGAGAAGGGCGCTAAGAATTCGCCGAGCTACA 69 FBan0004634 FBgn0016687 Nurf-38 2 2R chromatin remodeling; GO:0006338; nucleosome mobilization; GO:0042766; polyphosphate catabolism; GO:0006798; transcription; GO:0006350 inorganic diphosphatase activity; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; magnesium ion binding; GO:0000287; ; GO:0000287 NURF complex; GO:0016589; cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 Nurf-38 Nucleosome remodeling factor - 38kD "CG4634, l(2)k16102, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, NURF-38, dNURF, NURF38, p38, p38/NURF-38, 38, pyrophosphatase, NURF, Nucleosome remodeling factor - 38kD" CDMC29733 1 26 25 DAC41-I05 3-CG4634-RA_2 CG4634 GCACGAAATCACACGAGATGGCTCTGTACGAAACCGTTGAGAAGGGCGCTAAGAATTCGCCGAGCTACA 69 FBan0004634 FBgn0016687 Nurf-38 2 2R chromatin remodeling; GO:0006338; nucleosome mobilization; GO:0042766; polyphosphate catabolism; GO:0006798; transcription; GO:0006350 inorganic diphosphatase activity; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; ; GO:0004427 ; EC:3.6.1.1; magnesium ion binding; GO:0000287; ; GO:0000287 NURF complex; GO:0016589; cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 Nurf-38 Nucleosome remodeling factor - 38kD "CG4634, l(2)k16102, NURF: Nucleosome remodeling factor, Nucleosome remodeling factor, NURF-38, dNURF, NURF38, p38, p38/NURF-38, 38, pyrophosphatase, NURF, Nucleosome remodeling factor - 38kD" CDMC29734 1 1 26 DAC41-I17 23-CG4647-RA_2 CG4647 CGCATCACTAACCAGCCAGTGCATATGTAACAACTATTTTTTGTATTTCTTGGGAAATCTGTTAGTTTT 69 FBan0004647 FBgn0030433 mRpL49 X X protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; structural constituent of ribosome; GO:0003735; ; GO:0003743; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL49 mitochondrial ribosomal protein L49 "CG4647, MRP-L49, BcDNA:RE35556, mitochondrial ribosomal protein L49" CDMC29734 1 2 26 DAC41-I17 23-CG4647-RA_2 CG4647 CGCATCACTAACCAGCCAGTGCATATGTAACAACTATTTTTTGTATTTCTTGGGAAATCTGTTAGTTTT 69 FBan0004647 FBgn0030433 mRpL49 X X protein biosynthesis; GO:0006412; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; structural constituent of ribosome; GO:0003735; ; GO:0003743; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL49 mitochondrial ribosomal protein L49 "CG4647, MRP-L49, BcDNA:RE35556, mitochondrial ribosomal protein L49" CDMC29735 1 3 26 DAC41-M05 23-CG4674-RA_19 CG4674 CCAGTTACGTCCAAGCTTTGCCTAGACATAGAGCTTCAGGTTTACTTTATAGTGTTATTGAGCATCAGA 69 FBan0004674 FBgn0037856 CG4674 3 3R CG4674 CG4674 CG32471 CDMC29735 1 4 26 DAC41-M05 23-CG4674-RA_19 CG4674 CCAGTTACGTCCAAGCTTTGCCTAGACATAGAGCTTCAGGTTTACTTTATAGTGTTATTGAGCATCAGA 69 FBan0004674 FBgn0037856 CG4674 3 3R CG4674 CG4674 CG32471 CDMC29736 1 5 26 DAC41-M17 2-CG4680-RA_3 CG4680 CGCCGGCAAGAATCATCCGATGTTCAAGAGCATTGGCAACCCCACCTTTAAGTCCAGCTTCAGCTACAA 69 FBan0004680 FBgn0036627 CG4680 3 3L CG4680 CG4680 CDMC29736 1 6 26 DAC41-M17 2-CG4680-RA_3 CG4680 CGCCGGCAAGAATCATCCGATGTTCAAGAGCATTGGCAACCCCACCTTTAAGTCCAGCTTCAGCTACAA 69 FBan0004680 FBgn0036627 CG4680 3 3L CG4680 CG4680 CDMC29737 1 7 26 DAC42-A05 150mM NaPO4 Blank CDMC29737 1 8 26 DAC42-A05 150mM NaPO4 Blank CDMC29738 1 9 26 DAC42-A17 150mM NaPO4 Blank CDMC29738 1 10 26 DAC42-A17 150mM NaPO4 Blank CDMC29739 1 11 26 DAC42-E05 150mM NaPO4 Blank CDMC29739 1 12 26 DAC42-E05 150mM NaPO4 Blank CDMC29740 1 13 26 DAC42-E17 150mM NaPO4 Blank CDMC29740 1 14 26 DAC42-E17 150mM NaPO4 Blank CDMC29741 1 15 26 DAC42-I05 150mM NaPO4 Blank CDMC29741 1 16 26 DAC42-I05 150mM NaPO4 Blank CDMC29742 1 17 26 DAC42-I17 5uM MSP 5uM MSP CDMC29742 1 18 26 DAC42-I17 5uM MSP 5uM MSP CDMC29743 1 19 26 DAC42-M05 10uM MSP 10uM MSP CDMC29743 1 20 26 DAC42-M05 10uM MSP 10uM MSP CDMC29744 1 21 26 DAC42-M17 20uM MSP 20uM MSP CDMC29744 1 22 26 DAC42-M17 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC29745 2 1 1 DAC01-B05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29745 2 2 1 DAC01-B05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC29746 2 3 1 DAC01-B17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29746 2 4 1 DAC01-B17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC29747 2 5 1 DAC01-F05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29747 2 6 1 DAC01-F05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC29748 2 7 1 DAC01-F17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29748 2 8 1 DAC01-F17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC29749 2 9 1 DAC01-J05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29749 2 10 1 DAC01-J05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC29750 2 11 1 DAC01-J17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29750 2 12 1 DAC01-J17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC29751 2 13 1 DAC01-N05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29751 2 14 1 DAC01-N05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC29752 2 15 1 DAC01-N17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29752 2 16 1 DAC01-N17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC29753 2 17 1 DAC02-B05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29753 2 18 1 DAC02-B05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC29754 2 19 1 DAC02-B17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29754 2 20 1 DAC02-B17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC29755 2 21 1 DAC02-F05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29755 2 22 1 DAC02-F05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC29756 2 23 1 DAC02-F17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29756 2 24 1 DAC02-F17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC29757 2 25 1 DAC02-J05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29757 2 26 1 DAC02-J05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC29758 2 1 2 DAC02-J17 N/A CG9075 (00240-00478) CDMC29758 2 2 2 DAC02-J17 N/A CG9075 (00240-00478) CDMC29759 2 3 2 DAC02-N05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29759 2 4 2 DAC02-N05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC29760 2 5 2 DAC02-N17 AutoBlank AutoBlank CDMC29760 2 6 2 DAC02-N17 AutoBlank AutoBlank CDMC29761 2 7 2 DAC03-B05 23-CG3776-RA_4 CG3776 CAGTTCATAATTCGACCCTACTTCGACAGCGAGTTTCAACTCAAGGACTTCATATACGGCGCCAA 65 FBan0003776 FBgn0035088 CG3776 2 2R CG3776 CG3776 EP(2)0835 CDMC29761 2 8 2 DAC03-B05 23-CG3776-RA_4 CG3776 CAGTTCATAATTCGACCCTACTTCGACAGCGAGTTTCAACTCAAGGACTTCATATACGGCGCCAA 65 FBan0003776 FBgn0035088 CG3776 2 2R CG3776 CG3776 EP(2)0835 CDMC29762 2 9 2 DAC03-B17 2-CG3818-RA_1 CG3818 CAAGGCGGATGATCACAACGGTTTCGAGGCAATTGTCCAGCGTGAGCCCACGGACATCAAGATAC 65 FBan0003818 FBgn0032125 CG3818 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 CG3818 CG3818 CDMC29762 2 10 2 DAC03-B17 2-CG3818-RA_1 CG3818 CAAGGCGGATGATCACAACGGTTTCGAGGCAATTGTCCAGCGTGAGCCCACGGACATCAAGATAC 65 FBan0003818 FBgn0032125 CG3818 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 CG3818 CG3818 CDMC29763 2 11 2 DAC03-F05 23-CG3948-RB_2 CG3948 TAACTCAATGGTAGCCGTTTGTACTTTAATTTTGTCTGGTTTCGTTTCGCAATTTGATACCCTGC 65 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC29763 2 12 2 DAC03-F05 23-CG3948-RB_2 CG3948 TAACTCAATGGTAGCCGTTTGTACTTTAATTTTGTCTGGTTTCGTTTCGCAATTTGATACCCTGC 65 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC29764 2 13 2 DAC03-F17 3-CG3972-RA_1 CG3972 CATCGTGCTGCAGTACTGCGTGCACAGACGTCCAGACATCTACCCCAATCCCACCAAATTCGATC 65 FBan0003972 FBgn0010019 Cyp4g1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g1 Cytochrome P450-4g1 "CG3972, CG3972, T1, P-450-A, P450-A, P450, ASC-T1, P-450, scgamma, EG:165H7.1, 4g1, anon-WO0140519.102, Cyt-P450-A1: Cytochrome P450 A1, Achaete-scute Complex transcript 1, Cytochrome P450 A1" CDMC29764 2 14 2 DAC03-F17 3-CG3972-RA_1 CG3972 CATCGTGCTGCAGTACTGCGTGCACAGACGTCCAGACATCTACCCCAATCCCACCAAATTCGATC 65 FBan0003972 FBgn0010019 Cyp4g1 X X electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g1 Cytochrome P450-4g1 "CG3972, CG3972, T1, P-450-A, P450-A, P450, ASC-T1, P-450, scgamma, EG:165H7.1, 4g1, anon-WO0140519.102, Cyt-P450-A1: Cytochrome P450 A1, Achaete-scute Complex transcript 1, Cytochrome P450 A1" CDMC29765 2 15 2 DAC03-J05 24-CG40131-RA_3 CG40131 ATTATATCCGTTCTAATAGATACAATGGAAGTAGAATTTCACATGATTCAAGATCAGGATATGGG 65 FBgn0058131 CG40131 CG40131 CG40131 CDMC29765 2 16 2 DAC03-J05 24-CG40131-RA_3 CG40131 ATTATATCCGTTCTAATAGATACAATGGAAGTAGAATTTCACATGATTCAAGATCAGGATATGGG 65 FBgn0058131 CG40131 CG40131 CG40131 CDMC29766 2 17 2 DAC03-J17 3-CG40177-RA_1 CG40177 GAACGGAGAACGGAGAAGGATATGTGAAGGGTCAAGATGCCCCGTCGAGATGCCTAACGACAGGC 65 FBgn0058177 CG40177 CG40177 CG40177 CDMC29766 2 18 2 DAC03-J17 3-CG40177-RA_1 CG40177 GAACGGAGAACGGAGAAGGATATGTGAAGGGTCAAGATGCCCCGTCGAGATGCCTAACGACAGGC 65 FBgn0058177 CG40177 CG40177 CG40177 CDMC29767 2 19 2 DAC03-N05 1-CG4036-RA_2 CG4036 GAATATGTGCAACGGCGCTTCGAAGACGTTCCCCTGCTTCGTGGCTTTCAGACCATCGAACAGTG 65 FBan0004036 FBgn0032149 CG4036 2 2L CG4036 CG4036 CDMC29767 2 20 2 DAC03-N05 1-CG4036-RA_2 CG4036 GAATATGTGCAACGGCGCTTCGAAGACGTTCCCCTGCTTCGTGGCTTTCAGACCATCGAACAGTG 65 FBan0004036 FBgn0032149 CG4036 2 2L CG4036 CG4036 CDMC29768 2 21 2 DAC03-N17 23-CG40392-RA_1 CG40392 TTGTAAGTGTATTTACTGACAAACCAACACCAAAACTAGAATCGCCTTTTACAGTAACACAAGCC 65 FBgn0058392 CG40392 CG40392 CG40392 CDMC29768 2 22 2 DAC03-N17 23-CG40392-RA_1 CG40392 TTGTAAGTGTATTTACTGACAAACCAACACCAAAACTAGAATCGCCTTTTACAGTAACACAAGCC 65 FBgn0058392 CG40392 CG40392 CG40392 CDMC29769 2 23 2 DAC04-B05 3-CG31510-RA_1 CG31510 GCAGACCGGAATCTAGCATTGAACCGCAGAAAGTGTCTGTTGATGTAGAGACTCCGGTTGAGGAGCCGC 69 FBan0031510 FBgn0051510 CG31510 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31510 CG31510 CG10057 CDMC29769 2 24 2 DAC04-B05 3-CG31510-RA_1 CG31510 GCAGACCGGAATCTAGCATTGAACCGCAGAAAGTGTCTGTTGATGTAGAGACTCCGGTTGAGGAGCCGC 69 FBan0031510 FBgn0051510 CG31510 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31510 CG31510 CG10057 CDMC29770 2 25 2 DAC04-B17 14-CG31522-RA_1 CG31522 GTCCATGGGTAGCTGGGGAAATATGCTATGTAAGCGCGTGAAAACATTGTTAATCCTGACTGCCGAGGG 69 FBan0031522 FBgn0051522 CG31522 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31522 CG31522 "CG9798, anon-WO0118547.381, BcDNA:GH22993, BcDNA:LD10305" CDMC29770 2 26 2 DAC04-B17 14-CG31522-RA_1 CG31522 GTCCATGGGTAGCTGGGGAAATATGCTATGTAAGCGCGTGAAAACATTGTTAATCCTGACTGCCGAGGG 69 FBan0031522 FBgn0051522 CG31522 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG31522 CG31522 "CG9798, anon-WO0118547.381, BcDNA:GH22993, BcDNA:LD10305" CDMC29771 2 1 3 DAC04-F05 2-CG31548-RA_1 CG31548 CCAGTGTCAATGGGATTCGCTCCTTCCCTGGCGTTCTGGCCTACAACATATCCAAAATGGGAGTGGATC 69 FBan0031548 FBgn0051548 CG31548 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31548 CG31548 "CG2907, BcDNA:RH24570" CDMC29771 2 2 3 DAC04-F05 2-CG31548-RA_1 CG31548 CCAGTGTCAATGGGATTCGCTCCTTCCCTGGCGTTCTGGCCTACAACATATCCAAAATGGGAGTGGATC 69 FBan0031548 FBgn0051548 CG31548 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31548 CG31548 "CG2907, BcDNA:RH24570" CDMC29772 2 3 3 DAC04-F17 23-CG31558-RA_1 CG31558 TCTTCGCCTGACCTGAATGTGATATAATACACTGTACGCCTTACAGGATAATGTAGAAATAAACATTTT 69 FBan0031558 FBgn0046875 Obp83g 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83g Odorant-binding protein 83g "CG15583, CG31558, CG15583, CG15583, CG15583, CG15583, CG15583, 83g, Obp83f, BcDNA:RE27306, Odorant-binding protein 83g" CDMC29772 2 4 3 DAC04-F17 23-CG31558-RA_1 CG31558 TCTTCGCCTGACCTGAATGTGATATAATACACTGTACGCCTTACAGGATAATGTAGAAATAAACATTTT 69 FBan0031558 FBgn0046875 Obp83g 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83g Odorant-binding protein 83g "CG15583, CG31558, CG15583, CG15583, CG15583, CG15583, CG15583, 83g, Obp83f, BcDNA:RE27306, Odorant-binding protein 83g" CDMC29773 2 5 3 DAC04-J05 24-CG31626-RA_2 CG31626 TGACCTCTAGGAAATAACTAATTACCCACATTCTTCAAGAAGTGTTTTCAATTTGTTCTATAATTAAAT 69 FBan0031626 FBgn0051626 CG31626 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31626 CG31626 BcDNA:RE20756 CDMC29773 2 6 3 DAC04-J05 24-CG31626-RA_2 CG31626 TGACCTCTAGGAAATAACTAATTACCCACATTCTTCAAGAAGTGTTTTCAATTTGTTCTATAATTAAAT 69 FBan0031626 FBgn0051626 CG31626 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31626 CG31626 BcDNA:RE20756 CDMC29774 2 7 3 DAC04-J17 2-CG31636-RA_2 CG31636 TGCAGGATATAAGCCACACCATGGAAGCGAAATTGTCCAGCTATGGGCCCTACTTTCGCGAAAGCCAAA 69 FBan0031636 FBgn0051636 CG31636 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386 intracellular; GO:0005622 CG31636 CG31636 "CG13770, CG13770" CDMC29774 2 8 3 DAC04-J17 2-CG31636-RA_2 CG31636 TGCAGGATATAAGCCACACCATGGAAGCGAAATTGTCCAGCTATGGGCCCTACTTTCGCGAAAGCCAAA 69 FBan0031636 FBgn0051636 CG31636 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386 intracellular; GO:0005622 CG31636 CG31636 "CG13770, CG13770" CDMC29775 2 9 3 DAC04-N05 11-CG3165-RA_3 CG3165 GAGGCAGGCATTTGAGAAACTAAACATAGAGCTTCCCCAATCCCTGACTTGTGTTGACTCACTGCGCGC 69 FBan0003165 FBgn0031484 CG3165 2 2L CG3165 CG3165 CDMC29775 2 10 3 DAC04-N05 11-CG3165-RA_3 CG3165 GAGGCAGGCATTTGAGAAACTAAACATAGAGCTTCCCCAATCCCTGACTTGTGTTGACTCACTGCGCGC 69 FBan0003165 FBgn0031484 CG3165 2 2L CG3165 CG3165 CDMC29776 2 11 3 DAC04-N17 23-CG3166-RB_3 CG3166 GGTCTGCTCTTGCTTCAAGATCAGCCTGGAAAAAGAGCTTTCAAAATTCAATTTCAATTGAGCCCCTAG 69 FBan0003166 FBgn0000097 aop 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; R7 development; GO:0045467; cell fate determination; GO:0001709; cellular physiological process; GO:0050875; dorsal closure; GO:0007391; hemopoiesis; GO:0030097; induction of apoptosis; GO:0006917; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of cell differentiation; GO:0045596; negative regulation of eye photoreceptor development (sensu Endopterygota); GO:0045316; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; negative regulation of transcription; GO:0016481; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0016564; ; GO:0005515 nucleus; GO:0005634 aop anterior open "CG3166, CG3166, yan: yan, pok: pokkuri, pokkuri, yan/pok, Aop, Yan, aop/yan, DROYANET, DROYANETSB, SK2-1, Aop/Yan, YAN, pok" CDMC29776 2 12 3 DAC04-N17 23-CG3166-RB_3 CG3166 GGTCTGCTCTTGCTTCAAGATCAGCCTGGAAAAAGAGCTTTCAAAATTCAATTTCAATTGAGCCCCTAG 69 FBan0003166 FBgn0000097 aop 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; R7 development; GO:0045467; cell fate determination; GO:0001709; cellular physiological process; GO:0050875; dorsal closure; GO:0007391; hemopoiesis; GO:0030097; induction of apoptosis; GO:0006917; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of cell differentiation; GO:0045596; negative regulation of eye photoreceptor development (sensu Endopterygota); GO:0045316; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; negative regulation of transcription; GO:0016481; regulation of hemocyte differentiation; GO:0045610; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0016564; ; GO:0005515 nucleus; GO:0005634 aop anterior open "CG3166, CG3166, yan: yan, pok: pokkuri, pokkuri, yan/pok, Aop, Yan, aop/yan, DROYANET, DROYANETSB, SK2-1, Aop/Yan, YAN, pok" CDMC29777 2 13 3 DAC05-B05 5-CG5965-RA_1 CG5965 TCGGCTTGGTGCTTAGCACATGTTTGTTTGCGGGCAAAACCAAATTGGACTAACCAAGGAGCGAGAGTT 69 FBan0005965 FBgn0010328 woc 3 3R "ecdysone biosynthesis; GO:0006697; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 woc without children CG5965 CDMC29777 2 14 3 DAC05-B05 5-CG5965-RA_1 CG5965 TCGGCTTGGTGCTTAGCACATGTTTGTTTGCGGGCAAAACCAAATTGGACTAACCAAGGAGCGAGAGTT 69 FBan0005965 FBgn0010328 woc 3 3R "ecdysone biosynthesis; GO:0006697; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 woc without children CG5965 CDMC29778 2 15 3 DAC05-B17 11-CG5977-RA_2 CG5977 GCCAATGATCCTGCCCTCCTTCATCAATCCAATTTGGAGAAGCTGTGATGTGAGTCTCAGAGCGCAACC 69 FBan0005977 FBgn0039141 spas 3 3R intracellular protein transport; GO:0006886; locomotory behavior; GO:0007626; microtubule cytoskeleton organization and biogenesis; GO:0000226; positive regulation of microtubule depolymerization; GO:0031117; regulation of synaptic plasticity; GO:0048167; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 spas spastin "CG5977, CG5977, CG5977, D-spastin, Dspastin, spastin" CDMC29778 2 16 3 DAC05-B17 11-CG5977-RA_2 CG5977 GCCAATGATCCTGCCCTCCTTCATCAATCCAATTTGGAGAAGCTGTGATGTGAGTCTCAGAGCGCAACC 69 FBan0005977 FBgn0039141 spas 3 3R intracellular protein transport; GO:0006886; locomotory behavior; GO:0007626; microtubule cytoskeleton organization and biogenesis; GO:0000226; positive regulation of microtubule depolymerization; GO:0031117; regulation of synaptic plasticity; GO:0048167; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 spas spastin "CG5977, CG5977, CG5977, D-spastin, Dspastin, spastin" CDMC29779 2 17 3 DAC05-F05 22-CG6024-RA_1 CG6024 TGGCATCAAACACACAGATCATCCACAGAACACATCAGACATCAGAACCATGCAGAAAACAGAACCCAA 69 FBan0006024 FBgn0036202 CG6024 3 3L CG6024 CG6024 CT18912 CDMC29779 2 18 3 DAC05-F05 22-CG6024-RA_1 CG6024 TGGCATCAAACACACAGATCATCCACAGAACACATCAGACATCAGAACCATGCAGAAAACAGAACCCAA 69 FBan0006024 FBgn0036202 CG6024 3 3L CG6024 CG6024 CT18912 CDMC29780 2 19 3 DAC05-F17 18-CG6038-RA_1 CG6038 CTGCCCTGCTTCTACGCTAGAATCTCCTCTTGAGTGCAGTATTTAAGTGCCTTACTAACTCGCTCTGCA 69 FBan0006038 FBgn0036198 CG6038 3 3L CG6038 CG6038 CDMC29780 2 20 3 DAC05-F17 18-CG6038-RA_1 CG6038 CTGCCCTGCTTCTACGCTAGAATCTCCTCTTGAGTGCAGTATTTAAGTGCCTTACTAACTCGCTCTGCA 69 FBan0006038 FBgn0036198 CG6038 3 3L CG6038 CG6038 CDMC29781 2 21 3 DAC05-J05 23-CG6066-RA_6 CG6066 TAGGACCCAAGAAGAAAAAGAAAAAGGGCAAGAGAAAGCACAAGAAATCTGAAAAGAAGTCGAAGAAAA 69 FBan0006066 FBgn0039488 CG6066 3 3R CG6066 CG6066 CDMC29781 2 22 3 DAC05-J05 23-CG6066-RA_6 CG6066 TAGGACCCAAGAAGAAAAAGAAAAAGGGCAAGAGAAAGCACAAGAAATCTGAAAAGAAGTCGAAGAAAA 69 FBan0006066 FBgn0039488 CG6066 3 3R CG6066 CG6066 CDMC29782 2 23 3 DAC05-J17 3-CG6074-RA_2 CG6074 GCCGCTCGTCAGGAGTTAAGAACTTGGAAGAACGGAACCAACATGAAACTGACCGCTTTCCTCGAGGCT 69 FBan0006074 FBgn0039486 CG6074 3 3R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG6074 CG6074 CT19053 CDMC29782 2 24 3 DAC05-J17 3-CG6074-RA_2 CG6074 GCCGCTCGTCAGGAGTTAAGAACTTGGAAGAACGGAACCAACATGAAACTGACCGCTTTCCTCGAGGCT 69 FBan0006074 FBgn0039486 CG6074 3 3R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG6074 CG6074 CT19053 CDMC29783 2 25 3 DAC05-N05 16-CG6123-RA_1 CG6123 ACAAATCGGTCCTTGTATATCGAGTAGCAAACAATCGGGCGAATCAGTGCAAAATACGATGCTCCAGCG 69 FBan0006123 FBgn0030913 CG6123 X X CG6123 CG6123 CDMC29783 2 26 3 DAC05-N05 16-CG6123-RA_1 CG6123 ACAAATCGGTCCTTGTATATCGAGTAGCAAACAATCGGGCGAATCAGTGCAAAATACGATGCTCCAGCG 69 FBan0006123 FBgn0030913 CG6123 X X CG6123 CG6123 CDMC29784 2 1 4 DAC05-N17 1-CG6138-RB_2 CG6138 TGTTGAGCCAAACTAATTTCCCGGACAAACATGGTTGCATCCCCTTTGGACAAACGCACCCCTTGGAAA 69 FBan0006138 FBgn0032268 CG6138 2 2L CG6138 CG6138 BcDNA:AT25107 CDMC29784 2 2 4 DAC05-N17 1-CG6138-RB_2 CG6138 TGTTGAGCCAAACTAATTTCCCGGACAAACATGGTTGCATCCCCTTTGGACAAACGCACCCCTTGGAAA 69 FBan0006138 FBgn0032268 CG6138 2 2L CG6138 CG6138 BcDNA:AT25107 CDMC29785 2 3 4 DAC06-B05 23-CG11516-RA_2 CG11516 CGGTAAAAACACGCAGAAAAAAATTCAAATTCCAATTTCTGAGAAGACTTCTCTTGATGTGACCAAAAA 69 FBan0011516 FBgn0039661 CG11516 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG11516 CG11516 CDMC29785 2 4 4 DAC06-B05 23-CG11516-RA_2 CG11516 CGGTAAAAACACGCAGAAAAAAATTCAAATTCCAATTTCTGAGAAGACTTCTCTTGATGTGACCAAAAA 69 FBan0011516 FBgn0039661 CG11516 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG11516 CG11516 CDMC29786 2 5 4 DAC06-B17 23-CG11534-RA_1 CG11534 CAAGCTGTTTGTGTTCGTAGAAAAATTGTGTGCGGTAAAGAAACTTCGCCAAAATCTGGTGCATATGCG 69 FBan0011534 FBgn0046296 CG11534 3 3L "intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; diacylglycerol binding; GO:0019992; ; GO:0019992; receptor activity; GO:0004872; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004872; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG11534 CG11534 BEST:GH12489 CDMC29786 2 6 4 DAC06-B17 23-CG11534-RA_1 CG11534 CAAGCTGTTTGTGTTCGTAGAAAAATTGTGTGCGGTAAAGAAACTTCGCCAAAATCTGGTGCATATGCG 69 FBan0011534 FBgn0046296 CG11534 3 3L "intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; diacylglycerol binding; GO:0019992; ; GO:0019992; receptor activity; GO:0004872; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004872; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG11534 CG11534 BEST:GH12489 CDMC29787 2 7 4 DAC06-F05 17-CG11582-RA_2 CG11582 GCCATGTCCTCATCTCCAAACGATGGATACACATACAATTGGAGCGTGGTCTCGTTTTCAACGAATGGA 69 FBan0011582 FBgn0035525 CG11582 3 3L embryonic development; GO:0009790 protein binding; GO:0005515; ; GO:0005515 CG11582 CG11582 CDMC29787 2 8 4 DAC06-F05 17-CG11582-RA_2 CG11582 GCCATGTCCTCATCTCCAAACGATGGATACACATACAATTGGAGCGTGGTCTCGTTTTCAACGAATGGA 69 FBan0011582 FBgn0035525 CG11582 3 3L embryonic development; GO:0009790 protein binding; GO:0005515; ; GO:0005515 CG11582 CG11582 CDMC29788 2 9 4 DAC06-F17 2-CG11593-RA_6 CG11593 GGTCGAGGGCCGACTACAGCTACGTGATGGACAATTTGTTTCTGTACGTGGTCAAGACCCTGGAACAGT 69 FBan0011593 FBgn0035488 CG11593 3 3L apoptosis; GO:0006915; apoptotic program; GO:0008632; induction of apoptosis; GO:0006917 CG11593 CG11593 anon-EST:Posey64 CDMC29788 2 10 4 DAC06-F17 2-CG11593-RA_6 CG11593 GGTCGAGGGCCGACTACAGCTACGTGATGGACAATTTGTTTCTGTACGTGGTCAAGACCCTGGAACAGT 69 FBan0011593 FBgn0035488 CG11593 3 3L apoptosis; GO:0006915; apoptotic program; GO:0008632; induction of apoptosis; GO:0006917 CG11593 CG11593 anon-EST:Posey64 CDMC29789 2 11 4 DAC06-J05 12-CG11638-RA_1 CG11638 CGGCCATTTCCCTAAGCTACGATTGAGGCTACCCGAGTTCGCTCTATGTGCATGTTGATTGTCGAGAGA 69 FBan0011638 FBgn0040351 CG11638 X X calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG11638 CG11638 EG:BACR7A4.12 CDMC29789 2 12 4 DAC06-J05 12-CG11638-RA_1 CG11638 CGGCCATTTCCCTAAGCTACGATTGAGGCTACCCGAGTTCGCTCTATGTGCATGTTGATTGTCGAGAGA 69 FBan0011638 FBgn0040351 CG11638 X X calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG11638 CG11638 EG:BACR7A4.12 CDMC29790 2 13 4 DAC06-J17 3-CG11652-RA_7 CG11652 GGCCTGCTGATGTACGCCATGGTTATCAGCGACATTGTGGAGCGATTCACCAGCGCAGATACTGTGATA 69 FBan0011652 FBgn0036194 CG11652 3 3L defense response; GO:0006952 CG11652 CG11652 CDMC29790 2 14 4 DAC06-J17 3-CG11652-RA_7 CG11652 GGCCTGCTGATGTACGCCATGGTTATCAGCGACATTGTGGAGCGATTCACCAGCGCAGATACTGTGATA 69 FBan0011652 FBgn0036194 CG11652 3 3L defense response; GO:0006952 CG11652 CG11652 CDMC29791 2 15 4 DAC06-N05 3-CG11698-RA_1 CG11698 CGCCAAGGAAGCACAGCAACGGATCGAAGCTTTGCAAAAACTGGTGAGCAGGATTAAGATGCTGAAGCG 69 FBan0011698 FBgn0037572 CG11698 3 3R CG11698 CG11698 CDMC29791 2 16 4 DAC06-N05 3-CG11698-RA_1 CG11698 CGCCAAGGAAGCACAGCAACGGATCGAAGCTTTGCAAAAACTGGTGAGCAGGATTAAGATGCTGAAGCG 69 FBan0011698 FBgn0037572 CG11698 3 3R CG11698 CG11698 CDMC29792 2 17 4 DAC06-N17 15-CG11715-RB_1 CG11715 TCTCCTCGCATCCGATCTCGATCGCAATCTGCTCTTCAAATCCAGATACGAGTCTCTGCACTGAAAGGA 69 FBan0011715 FBgn0030304 Cyp4g15 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694; transport; GO:0006810 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g15 Cyp4g15 "CG11715, 4g15" CDMC29792 2 18 4 DAC06-N17 15-CG11715-RB_1 CG11715 TCTCCTCGCATCCGATCTCGATCGCAATCTGCTCTTCAAATCCAGATACGAGTCTCTGCACTGAAAGGA 69 FBan0011715 FBgn0030304 Cyp4g15 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694; transport; GO:0006810 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g15 Cyp4g15 "CG11715, 4g15" CDMC29793 2 19 4 DAC07-B05 13-CG14975-RA_1 CG14975 GTCGTCGCTTCTGTCGCAGCCGTTGCCAAAGTTGTCATTGTCATCCGTACCAGCAAACGCAGCAG 65 FBan0014975 FBgn0064227 Rdh 3 3L Rdh Rdh "CG14975, CG14975, Red-herring" CDMC29793 2 20 4 DAC07-B05 13-CG14975-RA_1 CG14975 GTCGTCGCTTCTGTCGCAGCCGTTGCCAAAGTTGTCATTGTCATCCGTACCAGCAAACGCAGCAG 65 FBan0014975 FBgn0064227 Rdh 3 3L Rdh Rdh "CG14975, CG14975, Red-herring" CDMC29794 2 21 4 DAC07-B17 12-CG15022-RA_1 CG15022 CAGGCTTTGCCATCTGTATTCGGGCAGACGTGTCCCACCTGTACGGAGGAGGTTACCACGATCAC 65 FBan0015022 FBgn0035547 CG15022 3 3L CG15022 CG15022 BcDNA:RE24507 CDMC29794 2 22 4 DAC07-B17 12-CG15022-RA_1 CG15022 CAGGCTTTGCCATCTGTATTCGGGCAGACGTGTCCCACCTGTACGGAGGAGGTTACCACGATCAC 65 FBan0015022 FBgn0035547 CG15022 3 3L CG15022 CG15022 BcDNA:RE24507 CDMC29795 2 23 4 DAC07-F05 24-CG15088-RB_1 CG15088 TTCAATTTTATTGAAGGGTTTATATTGTATCCGTGTTCTCTTCTCTCCCCACTAACAGTTTTTGG 65 FBan0015088 FBgn0034381 CG15088 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15088 CG15088 CDMC29795 2 24 4 DAC07-F05 24-CG15088-RB_1 CG15088 TTCAATTTTATTGAAGGGTTTATATTGTATCCGTGTTCTCTTCTCTCCCCACTAACAGTTTTTGG 65 FBan0015088 FBgn0034381 CG15088 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15088 CG15088 CDMC29796 2 25 4 DAC07-F17 1-CG15127-RA_1 CG15127 CTACCAGGTGGACGTGATCGATCCCTACTATCAGCCGCCCGTGGAGGTGGTGAATGTTATTGGAC 65 FBan0015127 FBgn0040730 CG15127 2 2R CG15127 CG15127 "CG18365, CG18365" CDMC29796 2 26 4 DAC07-F17 1-CG15127-RA_1 CG15127 CTACCAGGTGGACGTGATCGATCCCTACTATCAGCCGCCCGTGGAGGTGGTGAATGTTATTGGAC 65 FBan0015127 FBgn0040730 CG15127 2 2R CG15127 CG15127 "CG18365, CG18365" CDMC29797 2 1 5 DAC07-J05 3-CG15196-RA_3 CG15196 CACGCAGAGTCCCTGGAGACACCTGATGCGATTGACCAGGAATAACTCGAGCAGTACTTCCGGTG 65 FBan0015196 FBgn0030296 CG15196 X X CG15196 CG15196 CDMC29797 2 2 5 DAC07-J05 3-CG15196-RA_3 CG15196 CACGCAGAGTCCCTGGAGACACCTGATGCGATTGACCAGGAATAACTCGAGCAGTACTTCCGGTG 65 FBan0015196 FBgn0030296 CG15196 X X CG15196 CG15196 CDMC29798 2 3 5 DAC07-J17 1-CG15237-RA_1 CG15237 GTCATCCCGGTAACCCAGGACTTTTACTCCGCCGACGACATTCAGATGAACGACGAGACCTCACC 65 FBan0015237 FBgn0033104 CG15237 2 2R CG15237 CG15237 CDMC29798 2 4 5 DAC07-J17 1-CG15237-RA_1 CG15237 GTCATCCCGGTAACCCAGGACTTTTACTCCGCCGACGACATTCAGATGAACGACGAGACCTCACC 65 FBan0015237 FBgn0033104 CG15237 2 2R CG15237 CG15237 CDMC29799 2 5 5 DAC07-N05 18-CG15322-RA_1 CG15322 CAGCAGCATCAATTTGCCATATTGCCACGTTTTAGCAATGGTAACCCCAAGGCCGTTTACAGCCT 65 FBan0015322 FBgn0031088 CG15322 X X CG15322 CG15322 CDMC29799 2 6 5 DAC07-N05 18-CG15322-RA_1 CG15322 CAGCAGCATCAATTTGCCATATTGCCACGTTTTAGCAATGGTAACCCCAAGGCCGTTTACAGCCT 65 FBan0015322 FBgn0031088 CG15322 X X CG15322 CG15322 CDMC29800 2 7 5 DAC07-N17 23-CG15356-RA_1 CG15356 CCGTCAACATTATCAAGAATATACCAGCTAGTAGTTTAAACAACACATTGATCACACCGCTTCCC 65 FBan0015356 FBgn0031377 CG15356 2 2L CG15356 CG15356 CDMC29800 2 8 5 DAC07-N17 23-CG15356-RA_1 CG15356 CCGTCAACATTATCAAGAATATACCAGCTAGTAGTTTAAACAACACATTGATCACACCGCTTCCC 65 FBan0015356 FBgn0031377 CG15356 2 2L CG15356 CG15356 CDMC29801 2 9 5 DAC08-B05 2-CG14439-RA_1 CG14439 GGTGGCATGACCTTTGCCTACAACGCCGATCTCTACTACAACACGTACTTCCCCGACGTGGACTTG 66 FBan0014439 FBgn0029898 CG14439 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG14439 CG14439 CDMC29801 2 10 5 DAC08-B05 2-CG14439-RA_1 CG14439 GGTGGCATGACCTTTGCCTACAACGCCGATCTCTACTACAACACGTACTTCCCCGACGTGGACTTG 66 FBan0014439 FBgn0029898 CG14439 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG14439 CG14439 CDMC29802 2 11 5 DAC08-B17 2-CG14496-RA_1 CG14496 CTGCAATTGTCCGACTTAAATGCGGCCGTTCAAGGTATGGGCAGGTTTGCTGTTACCCAGGACCAG 66 FBan0014496 FBgn0034297 CG14496 2 2R CG14496 CG14496 CDMC29802 2 12 5 DAC08-B17 2-CG14496-RA_1 CG14496 CTGCAATTGTCCGACTTAAATGCGGCCGTTCAAGGTATGGGCAGGTTTGCTGTTACCCAGGACCAG 66 FBan0014496 FBgn0034297 CG14496 2 2R CG14496 CG14496 CDMC29803 2 13 5 DAC08-F05 2-CG14718-RA_1 CG14718 GCCGAACCAGTCTTTGTCCCCAGAGCAGAGATCCTCAGATTGCGGGACAATGCAACTTGCTGAATG 66 FBan0014718 FBgn0037939 CG14718 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG14718 CG14718 cg14718 CDMC29803 2 14 5 DAC08-F05 2-CG14718-RA_1 CG14718 GCCGAACCAGTCTTTGTCCCCAGAGCAGAGATCCTCAGATTGCGGGACAATGCAACTTGCTGAATG 66 FBan0014718 FBgn0037939 CG14718 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG14718 CG14718 cg14718 CDMC29804 2 15 5 DAC08-F17 15-CG14806-RA_2 CG14806 GGCGCATCCACATCATGTACAACATCTCCTGGTACCTGAAGAACTTCGACATACTCACCCTGGCTG 66 FBan0014806 FBgn0029594 CG14806 X X CG14806 CG14806 CDMC29804 2 16 5 DAC08-F17 15-CG14806-RA_2 CG14806 GGCGCATCCACATCATGTACAACATCTCCTGGTACCTGAAGAACTTCGACATACTCACCCTGGCTG 66 FBan0014806 FBgn0029594 CG14806 X X CG14806 CG14806 CDMC29805 2 17 5 DAC08-J05 14-CG15202-RA_1 CG15202 TCTACTGCAGACCAGACTATGTCCTCGAAATTAGCTATTGCGGTCGCCATAATTTGGTGCCCACGG 66 FBan0015202 FBgn0030271 CG15202 X X CG15202 CG15202 BcDNA:GH13342 CDMC29805 2 18 5 DAC08-J05 14-CG15202-RA_1 CG15202 TCTACTGCAGACCAGACTATGTCCTCGAAATTAGCTATTGCGGTCGCCATAATTTGGTGCCCACGG 66 FBan0015202 FBgn0030271 CG15202 X X CG15202 CG15202 BcDNA:GH13342 CDMC29806 2 19 5 DAC08-J17 1-CG15365-RA_3 CG15365 ACAGCAACAAGTCCTGTGACACAAACACAAGCCAAAGTCAACCAAAGCAGCAGGCGAAAGAGGAGC 66 FBan0015365 FBgn0030077 CG15365 X X CG15365 CG15365 CDMC29806 2 20 5 DAC08-J17 1-CG15365-RA_3 CG15365 ACAGCAACAAGTCCTGTGACACAAACACAAGCCAAAGTCAACCAAAGCAGCAGGCGAAAGAGGAGC 66 FBan0015365 FBgn0030077 CG15365 X X CG15365 CG15365 CDMC29807 2 21 5 DAC08-N05 3-CG1584-RA_4 CG1584 CTGCGCTCCACGAATGTCCCTCTGCAGATCAACGAGTACGGAAAGATAGTGCTGTGTGCGGATCTC 66 FBan0001584 FBgn0023180 Orc6 2 2R DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342 DNA binding; GO:0003677; ; GO:0003677 nuclear origin of replication recognition complex; GO:0005664 Orc6 Origin recognition complex subunit 6 "CG1584, DmORC6, ORC, ORC6, DmORC 6, rDmORC, Origin recognition complex subunit 6" CDMC29807 2 22 5 DAC08-N05 3-CG1584-RA_4 CG1584 CTGCGCTCCACGAATGTCCCTCTGCAGATCAACGAGTACGGAAAGATAGTGCTGTGTGCGGATCTC 66 FBan0001584 FBgn0023180 Orc6 2 2R DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342 DNA binding; GO:0003677; ; GO:0003677 nuclear origin of replication recognition complex; GO:0005664 Orc6 Origin recognition complex subunit 6 "CG1584, DmORC6, ORC, ORC6, DmORC 6, rDmORC, Origin recognition complex subunit 6" CDMC29808 2 23 5 DAC08-N17 2-CG16704-RA_1 CG16704 CCTGCAACCCATGTGGACCTATCGCCCAGATACGAACGAGTGCTTCACCTTCAATTACTCCGGCTG 66 FBan0016704 FBgn0031558 CG16704 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG16704 CG16704 "CT37177, BcDNA:RH31195" CDMC29808 2 24 5 DAC08-N17 2-CG16704-RA_1 CG16704 CCTGCAACCCATGTGGACCTATCGCCCAGATACGAACGAGTGCTTCACCTTCAATTACTCCGGCTG 66 FBan0016704 FBgn0031558 CG16704 2 2L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 extracellular region; GO:0005576 CG16704 CG16704 "CT37177, BcDNA:RH31195" CDMC29809 2 25 5 DAC09-B06 16-CG14084-RB_1 CG14084 AGGCATTAGTCAACCGATTCTGGAAATCACAACACGAGGTCAAGGGTCAATGCACAGTCAACCACAAAG 69 FBan0014084 FBgn0036855 CG14084 3 3L CG14084 CG14084 "bs16e01.y1, BcDNA:RH40423" CDMC29809 2 26 5 DAC09-B06 16-CG14084-RB_1 CG14084 AGGCATTAGTCAACCGATTCTGGAAATCACAACACGAGGTCAAGGGTCAATGCACAGTCAACCACAAAG 69 FBan0014084 FBgn0036855 CG14084 3 3L CG14084 CG14084 "bs16e01.y1, BcDNA:RH40423" CDMC29810 2 1 6 DAC09-B18 3-CG14098-RA_1 CG14098 ACCTCTCGCCTCGTCATATAGCGGCTCTAGAGAACCAGATGAAACCCAAACCTCCGGTAGAAGCCATGT 69 FBan0014098 FBgn0036884 CG14098 3 3L CG14098 CG14098 CDMC29810 2 2 6 DAC09-B18 3-CG14098-RA_1 CG14098 ACCTCTCGCCTCGTCATATAGCGGCTCTAGAGAACCAGATGAAACCCAAACCTCCGGTAGAAGCCATGT 69 FBan0014098 FBgn0036884 CG14098 3 3L CG14098 CG14098 CDMC29811 2 3 6 DAC09-F06 2-CG14142-RA_1 CG14142 GCGGTTCCTCAATACGGCGTCCTTAAACGATGCATGATTGGTCTTCTGCTCTGGGACATCGAGTCAGCT 69 FBan0014142 FBgn0036143 CG14142 3 3L CG14142 CG14142 CDMC29811 2 4 6 DAC09-F06 2-CG14142-RA_1 CG14142 GCGGTTCCTCAATACGGCGTCCTTAAACGATGCATGATTGGTCTTCTGCTCTGGGACATCGAGTCAGCT 69 FBan0014142 FBgn0036143 CG14142 3 3L CG14142 CG14142 CDMC29812 2 5 6 DAC09-F18 23-CG14154-RA_1 CG14154 GGGCATTCTTTATCTATTACATGCAACCAAATTTGTAGAAGTGAATTGGATTTTAAAGTAACGCCAGCT 69 FBan0014154 FBgn0036093 CG14154 3 3L CG14154 CG14154 CDMC29812 2 6 6 DAC09-F18 23-CG14154-RA_1 CG14154 GGGCATTCTTTATCTATTACATGCAACCAAATTTGTAGAAGTGAATTGGATTTTAAAGTAACGCCAGCT 69 FBan0014154 FBgn0036093 CG14154 3 3L CG14154 CG14154 CDMC29813 2 7 6 DAC09-J06 1-CG14204-RA_1 CG14204 ACGGCGCCTACATCTGGCACATCTTTGTCGTGGAAGTCGCCAATAGAAGCGTTCAGACCAATACGTACT 69 FBan0014204 FBgn0031032 CG14204 X X CG14204 CG14204 CDMC29813 2 8 6 DAC09-J06 1-CG14204-RA_1 CG14204 ACGGCGCCTACATCTGGCACATCTTTGTCGTGGAAGTCGCCAATAGAAGCGTTCAGACCAATACGTACT 69 FBan0014204 FBgn0031032 CG14204 X X CG14204 CG14204 CDMC29814 2 9 6 DAC09-J18 13-CG14213-RA_1 CG14213 CCGGCGACAGTTCTTACCCAGATCTTGTCAAGTTAACACGATGAGTGCTCAACCGAGTCCGCATATGAA 69 FBan0014213 FBgn0031047 CG14213 X X CG14213 CG14213 CAF40 CDMC29814 2 10 6 DAC09-J18 13-CG14213-RA_1 CG14213 CCGGCGACAGTTCTTACCCAGATCTTGTCAAGTTAACACGATGAGTGCTCAACCGAGTCCGCATATGAA 69 FBan0014213 FBgn0031047 CG14213 X X CG14213 CG14213 CAF40 CDMC29815 2 11 6 DAC09-N06 2-CG14252-RA_2 CG14252 GGGACGCTTCCGAAGAGGACAGATTCATCGACATCTGGATCCACAACTTGCATCTGTTTGAGCCTGGCA 69 FBan0014252 FBgn0039462 CG14252 3 3R CG14252 CG14252 CDMC29815 2 12 6 DAC09-N06 2-CG14252-RA_2 CG14252 GGGACGCTTCCGAAGAGGACAGATTCATCGACATCTGGATCCACAACTTGCATCTGTTTGAGCCTGGCA 69 FBan0014252 FBgn0039462 CG14252 3 3R CG14252 CG14252 CDMC29816 2 13 6 DAC09-N18 19-CG14265-RB_1 CG14265 CACGGAAACCAGCACCAGCACCGAGTCGACCACCGCTACGGGCTCAAGCACTTCGACAACCTCGGCCAG 69 FBan0014265 FBgn0040393 CG14265 X X CG14265 CG14265 "EG:96G10.8, BcDNA:RE43371" CDMC29816 2 14 6 DAC09-N18 19-CG14265-RB_1 CG14265 CACGGAAACCAGCACCAGCACCGAGTCGACCACCGCTACGGGCTCAAGCACTTCGACAACCTCGGCCAG 69 FBan0014265 FBgn0040393 CG14265 X X CG14265 CG14265 "EG:96G10.8, BcDNA:RE43371" CDMC29817 2 15 6 DAC10-B05 11-CG1954-RA_1 CG1954 GGCACTTGCTCCAAGCGAATCTCAAGGGAATTCCTAACACAATAGCCGAAATGTGCCGTCTGTACCACA 69 FBan0001954 FBgn0003093 Pkc98E 3 3R MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- Pkc98E Protein C kinase 98E "CG1954, CG1954, dPKC98F, PKC-brain, PKC d98F, Dpkc3, 98F, PKC 98F, protein kinase C, PKC, Nc98F, Pkc3, nPKC, Neural-conserved-at-98F" CDMC29817 2 16 6 DAC10-B05 11-CG1954-RA_1 CG1954 GGCACTTGCTCCAAGCGAATCTCAAGGGAATTCCTAACACAATAGCCGAAATGTGCCGTCTGTACCACA 69 FBan0001954 FBgn0003093 Pkc98E 3 3R MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- Pkc98E Protein C kinase 98E "CG1954, CG1954, dPKC98F, PKC-brain, PKC d98F, Dpkc3, 98F, PKC 98F, protein kinase C, PKC, Nc98F, Pkc3, nPKC, Neural-conserved-at-98F" CDMC29818 2 17 6 DAC10-B17 23-CG1963-RA_3 CG1963 CAACAAAAACAGCAGCTAAGAACAAACGAGTTTTGGATCGAAAATGTTGTTAACAATTAAATGCGCTCA 69 FBan0001963 FBgn0024841 Pcd 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; protein biosynthesis; GO:0006412; pteridine and derivative metabolism; GO:0042558; tetrahydrobiopterin biosynthesis; GO:0006729; transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity; GO:0008124 ; EC:4.2.1.96; ; GO:0003729; ; GO:0003735; ; GO:0008124 ; EC:4.2.1.96; ; GO:0008124 ; EC:4.2.1.96 intracellular; GO:0005622; ribosome; GO:0005840 Pcd pterin-4a-carbinolamine dehydratase "CG1963, PCD, pterin-4a-carbinolamine dehydratase, BcDNA:LP07248" CDMC29818 2 18 6 DAC10-B17 23-CG1963-RA_3 CG1963 CAACAAAAACAGCAGCTAAGAACAAACGAGTTTTGGATCGAAAATGTTGTTAACAATTAAATGCGCTCA 69 FBan0001963 FBgn0024841 Pcd 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; protein biosynthesis; GO:0006412; pteridine and derivative metabolism; GO:0042558; tetrahydrobiopterin biosynthesis; GO:0006729; transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity; GO:0008124 ; EC:4.2.1.96; ; GO:0003729; ; GO:0003735; ; GO:0008124 ; EC:4.2.1.96; ; GO:0008124 ; EC:4.2.1.96 intracellular; GO:0005622; ribosome; GO:0005840 Pcd pterin-4a-carbinolamine dehydratase "CG1963, PCD, pterin-4a-carbinolamine dehydratase, BcDNA:LP07248" CDMC29819 2 19 6 DAC10-F05 3-CG1999-RA_3 CG1999 GCGCAGTCCGGATGAAATATCCCGTGAGGTGATGGGTCGTGATTGGGAGGAAACGGTCAGGACATATAA 69 FBan0001999 FBgn0029947 CG1999 X X CG1999 CG1999 anon-WO0140519.160 CDMC29819 2 20 6 DAC10-F05 3-CG1999-RA_3 CG1999 GCGCAGTCCGGATGAAATATCCCGTGAGGTGATGGGTCGTGATTGGGAGGAAACGGTCAGGACATATAA 69 FBan0001999 FBgn0029947 CG1999 X X CG1999 CG1999 anon-WO0140519.160 CDMC29820 2 21 6 DAC10-F17 6-CG2017-RB_3 CG2017 GCGTGCTGACCGAGAATATGGCAATGAAGATTGGTCCGCTTCCCGATGGTAGCTTTCATCCCGTTACTG 69 FBan0002017 FBgn0037391 CG2017 3 3R protein biosynthesis; GO:0006412 GTP binding; GO:0005525; ; GO:0005525 CG2017 CG2017 "CG 2017, GP-1 related" CDMC29820 2 22 6 DAC10-F17 6-CG2017-RB_3 CG2017 GCGTGCTGACCGAGAATATGGCAATGAAGATTGGTCCGCTTCCCGATGGTAGCTTTCATCCCGTTACTG 69 FBan0002017 FBgn0037391 CG2017 3 3R protein biosynthesis; GO:0006412 GTP binding; GO:0005525; ; GO:0005525 CG2017 CG2017 "CG 2017, GP-1 related" CDMC29821 2 23 6 DAC10-J05 15-CG2052-RA_1 CG2052 TCAACGACCATCGGACTCATGAAGTTCGGCGATTCATTCCTCTAGGGATGACTGAGGACTGAGGATTGA 69 FBan0002052 FBgn0039905 CG2052 4 4 "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2052 CG2052 CG10204 CDMC29821 2 24 6 DAC10-J05 15-CG2052-RA_1 CG2052 TCAACGACCATCGGACTCATGAAGTTCGGCGATTCATTCCTCTAGGGATGACTGAGGACTGAGGATTGA 69 FBan0002052 FBgn0039905 CG2052 4 4 "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2052 CG2052 CG10204 CDMC29822 2 25 6 DAC10-J17 24-CG2065-RA_1 CG2065 AGCTTATCATAATGAAGACTAACGCAAAATGTAATAATTTATGTTTGAATTGTAGAATTCTTACGGATT 69 FBan0002065 FBgn0033204 CG2065 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2065 CG2065 CDMC29822 2 26 6 DAC10-J17 24-CG2065-RA_1 CG2065 AGCTTATCATAATGAAGACTAACGCAAAATGTAATAATTTATGTTTGAATTGTAGAATTCTTACGGATT 69 FBan0002065 FBgn0033204 CG2065 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2065 CG2065 CDMC29823 2 1 7 DAC10-N05 9-CG2101-RA_1 CG2101 GGTGCTCCAAAAGTGGTTCCCAGCAAGTCATTCGCTGAATGCGTGGAGAAACTGATAAACGAAGGCGAA 69 FBan0002101 FBgn0035374 mRpS35 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS35 mitochondrial ribosomal protein S35 "CG2101, MRP-S28, mitochondrial ribosomal protein S35" CDMC29823 2 2 7 DAC10-N05 9-CG2101-RA_1 CG2101 GGTGCTCCAAAAGTGGTTCCCAGCAAGTCATTCGCTGAATGCGTGGAGAAACTGATAAACGAAGGCGAA 69 FBan0002101 FBgn0035374 mRpS35 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS35 mitochondrial ribosomal protein S35 "CG2101, MRP-S28, mitochondrial ribosomal protein S35" CDMC29824 2 3 7 DAC10-N17 12-CG2112-RA_1 CG2112 CGAGGAGGATCAGGACCCTCAGACTGACCGGAACCAAAACGAAGAAAATGTGCAAGACCAGGATATCGA 69 FBan0002112 FBgn0039880 CG2112 3 3R CG2112 CG2112 CDMC29824 2 4 7 DAC10-N17 12-CG2112-RA_1 CG2112 CGAGGAGGATCAGGACCCTCAGACTGACCGGAACCAAAACGAAGAAAATGTGCAAGACCAGGATATCGA 69 FBan0002112 FBgn0039880 CG2112 3 3R CG2112 CG2112 CDMC29825 2 5 7 DAC11-B05 12-CG9177-RC_6 CG9177 TGACGGACATCTTCTATCGCTACAAGATGCCACGTCTGCAGGCAAAGGTCGAGGGCAAAGGAAAC 65 FBan0009177 FBgn0030719 eIF5 X X regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003743; ; GO:0003743; ; GO:0003743; small GTPase regulator activity; GO:0005083; ; GO:0005083 cytosol; GO:0005829 eIF5 eIF5 "CG9177, CG9177, anon-EST:fe3C6, anon-fast-evolving-3C6" CDMC29825 2 6 7 DAC11-B05 12-CG9177-RC_6 CG9177 TGACGGACATCTTCTATCGCTACAAGATGCCACGTCTGCAGGCAAAGGTCGAGGGCAAAGGAAAC 65 FBan0009177 FBgn0030719 eIF5 X X regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003743; ; GO:0003743; ; GO:0003743; small GTPase regulator activity; GO:0005083; ; GO:0005083 cytosol; GO:0005829 eIF5 eIF5 "CG9177, CG9177, anon-EST:fe3C6, anon-fast-evolving-3C6" CDMC29826 2 7 7 DAC11-B17 2-CG9200-RA_3 CG9200 TAATTACATCACCACGACCGTTCTACCGGACTTGCCAACTCTGTCGCCCAATGACGAGGAAGGGG 65 FBan0009200 FBgn0031876 CG9200 2 2L CG9200 CG9200 CDMC29826 2 8 7 DAC11-B17 2-CG9200-RA_3 CG9200 TAATTACATCACCACGACCGTTCTACCGGACTTGCCAACTCTGTCGCCCAATGACGAGGAAGGGG 65 FBan0009200 FBgn0031876 CG9200 2 2L CG9200 CG9200 CDMC29827 2 9 7 DAC11-F05 12-CG9328-RA_5 CG9328 CTGATCCTGCCTAAGAAGCTCATCAATCCCTGCATGGAGAACATCGATCGCAAGGAGTTGCACCG 65 FBan0009328 FBgn0032886 CG9328 2 2L CG9328 CG9328 "LD01639, 38E.22, BcDNA:SD01241, BEST:LD01639" CDMC29827 2 10 7 DAC11-F05 12-CG9328-RA_5 CG9328 CTGATCCTGCCTAAGAAGCTCATCAATCCCTGCATGGAGAACATCGATCGCAAGGAGTTGCACCG 65 FBan0009328 FBgn0032886 CG9328 2 2L CG9328 CG9328 "LD01639, 38E.22, BcDNA:SD01241, BEST:LD01639" CDMC29828 2 11 7 DAC11-F17 3-CG9357-RA_1 CG9357 TATCCCTTGCTGCACGAAATCAACCGTGTGCTCTTCGGTGGCAATACACCATCTGGCTTGACCAC 65 FBan0009357 FBgn0034580 CG9357 2 2R chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG9357 CG9357 CDMC29828 2 12 7 DAC11-F17 3-CG9357-RA_1 CG9357 TATCCCTTGCTGCACGAAATCAACCGTGTGCTCTTCGGTGGCAATACACCATCTGGCTTGACCAC 65 FBan0009357 FBgn0034580 CG9357 2 2R chitin metabolism; GO:0006030; polysaccharide metabolism; GO:0005976 "chitin binding; GO:0008061; chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14; ; GO:0008061" extracellular region; GO:0005576 CG9357 CG9357 CDMC29829 2 13 7 DAC11-J05 23-CG9485-RB_4 CG9485 TGTACGGATACAAGATGGAATGAGATTCGATGCCTGAGGTCCCTTGAAATTTTGCTATTCCTATT 65 FBan0009485 FBgn0034618 CG9485 2 2R glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; 4-alpha-glucanotransferase activity; GO:0004134 ; EC:2.4.1.25; amylo-alpha-1,6-glucosidase activity; GO:0004135 ; EC:3.2.1.33; ; GO:0004134 ; EC:2.4.1.25; ; GO:0004135 ; EC:3.2.1.33" CG9485 CG9485 "FBgn0034618, BEST:GH22856" CDMC29829 2 14 7 DAC11-J05 23-CG9485-RB_4 CG9485 TGTACGGATACAAGATGGAATGAGATTCGATGCCTGAGGTCCCTTGAAATTTTGCTATTCCTATT 65 FBan0009485 FBgn0034618 CG9485 2 2R glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; 4-alpha-glucanotransferase activity; GO:0004134 ; EC:2.4.1.25; amylo-alpha-1,6-glucosidase activity; GO:0004135 ; EC:3.2.1.33; ; GO:0004134 ; EC:2.4.1.25; ; GO:0004135 ; EC:3.2.1.33" CG9485 CG9485 "FBgn0034618, BEST:GH22856" CDMC29830 2 15 7 DAC11-J17 12-CG9527-RA_4 CG9527 GCGGTGGTTACTTCCGCGAAAACTCTAACCAACTGGAGCTGTACGAACAGGGCATTCTGGCTCTG 65 FBan0009527 FBgn0031813 CG9527 2 2L electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 pristanoyl-CoA oxidase activity; GO:0016402 ; EC:1.3.3.-; ; GO:0016402 ; EC:1.3.3.- peroxisome; GO:0005777 CG9527 CG9527 CDMC29830 2 16 7 DAC11-J17 12-CG9527-RA_4 CG9527 GCGGTGGTTACTTCCGCGAAAACTCTAACCAACTGGAGCTGTACGAACAGGGCATTCTGGCTCTG 65 FBan0009527 FBgn0031813 CG9527 2 2L electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 pristanoyl-CoA oxidase activity; GO:0016402 ; EC:1.3.3.-; ; GO:0016402 ; EC:1.3.3.- peroxisome; GO:0005777 CG9527 CG9527 CDMC29831 2 17 7 DAC11-N05 1-CG9601-RA_1 CG9601 CACGGAGACTTGGTGGAGATCGTTTACGGCAGGCATCAGTTCGAGGTCGTCTTTAACCCTCCACC 65 FBan0009601 FBgn0037578 CG9601 3 3R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" kinase activity; GO:0016301; nucleotide kinase activity; GO:0019201; ; GO:0016301; ; GO:0019201 CG9601 CG9601 CDMC29831 2 18 7 DAC11-N05 1-CG9601-RA_1 CG9601 CACGGAGACTTGGTGGAGATCGTTTACGGCAGGCATCAGTTCGAGGTCGTCTTTAACCCTCCACC 65 FBan0009601 FBgn0037578 CG9601 3 3R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" kinase activity; GO:0016301; nucleotide kinase activity; GO:0019201; ; GO:0016301; ; GO:0019201 CG9601 CG9601 CDMC29832 2 19 7 DAC11-N17 3-CG9620-RA_4 CG9620 CTGATGATTGGGGCCAACAACCTGTCGCTGTCCTACGTCACAGTGGCCTTCTACTACATCGGTCG 65 FBan0009620 FBgn0037567 Gfr 3 3R GDP-fucose transport; GO:0015783; Golgi vesicle transport; GO:0048193; carbohydrate metabolism; GO:0005975 GDP-fucose transporter activity; GO:0005457; ; GO:0005457; ; GO:0005457; ; GO:0005457 Golgi apparatus; GO:0005794; Golgi vesicle; GO:0005798 Gfr Gfr "CG9620, CG9620, CG9620, CG9620, gfr, Golgi GDP-fucose transporter" CDMC29832 2 20 7 DAC11-N17 3-CG9620-RA_4 CG9620 CTGATGATTGGGGCCAACAACCTGTCGCTGTCCTACGTCACAGTGGCCTTCTACTACATCGGTCG 65 FBan0009620 FBgn0037567 Gfr 3 3R GDP-fucose transport; GO:0015783; Golgi vesicle transport; GO:0048193; carbohydrate metabolism; GO:0005975 GDP-fucose transporter activity; GO:0005457; ; GO:0005457; ; GO:0005457; ; GO:0005457 Golgi apparatus; GO:0005794; Golgi vesicle; GO:0005798 Gfr Gfr "CG9620, CG9620, CG9620, CG9620, gfr, Golgi GDP-fucose transporter" CDMC29833 2 21 7 DAC12-B05 18-CG15414-RA_3 CG15414 CAGGCAGCTGAAGCAATATGCCGTCATCGAGATTATTGACAACGACATAGACGAGACCCCGGCTC 65 FBan0015414 FBgn0031542 CG15414 2 2L CG15414 CG15414 CDMC29833 2 22 7 DAC12-B05 18-CG15414-RA_3 CG15414 CAGGCAGCTGAAGCAATATGCCGTCATCGAGATTATTGACAACGACATAGACGAGACCCCGGCTC 65 FBan0015414 FBgn0031542 CG15414 2 2L CG15414 CG15414 CDMC29834 2 23 7 DAC12-B17 15-CG15435-RA_6 CG15435 GGAGCTCTACCAGCAGAAGAGGGTCAACGTTTCGGATGCGAACAAGATGGACAAGGAGAGCGCCC 65 FBan0015435 FBgn0031608 CG15435 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15435 CG15435 CDMC29834 2 24 7 DAC12-B17 15-CG15435-RA_6 CG15435 GGAGCTCTACCAGCAGAAGAGGGTCAACGTTTCGGATGCGAACAAGATGGACAAGGAGAGCGCCC 65 FBan0015435 FBgn0031608 CG15435 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15435 CG15435 CDMC29835 2 25 7 DAC12-F05 3-CG15510-RA_4 CG15510 CTTTCGGACACATCCTTACATCGGCGACCAGAAGAAGGATGGCAAACGTGAAGATCCAAGCGCCC 65 FBan0015510 FBgn0039707 CG15510 3 3R CG15510 CG15510 BcDNA:AT14346 CDMC29835 2 26 7 DAC12-F05 3-CG15510-RA_4 CG15510 CTTTCGGACACATCCTTACATCGGCGACCAGAAGAAGGATGGCAAACGTGAAGATCCAAGCGCCC 65 FBan0015510 FBgn0039707 CG15510 3 3R CG15510 CG15510 BcDNA:AT14346 CDMC29836 2 1 8 DAC12-F17 2-CG15528-RA_1 CG15528 TTGGCAGAGCCCCCCAGAACTTTGTAGCTATTCAGCTGAGTGCATCCACGCTAGAGGATCACACG 65 FBan0015528 FBgn0039742 CG15528 3 3R intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210 CG15528 CG15528 MKP-like CDMC29836 2 2 8 DAC12-F17 2-CG15528-RA_1 CG15528 TTGGCAGAGCCCCCCAGAACTTTGTAGCTATTCAGCTGAGTGCATCCACGCTAGAGGATCACACG 65 FBan0015528 FBgn0039742 CG15528 3 3R intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210 CG15528 CG15528 MKP-like CDMC29837 2 3 8 DAC12-J05 3-CG15624-RA_2 CG15624 GTTCGTGATGATGGAATGCGTGGAGAGATTGGGAATCTTCGCCTGCATCAGTGAGCTCACCGAGC 65 FBan0015624 FBgn0031649 hoe2 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746 L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021; membrane; GO:0016020 hoe2 hoepel2 CG15624 CDMC29837 2 4 8 DAC12-J05 3-CG15624-RA_2 CG15624 GTTCGTGATGATGGAATGCGTGGAGAGATTGGGAATCTTCGCCTGCATCAGTGAGCTCACCGAGC 65 FBan0015624 FBgn0031649 hoe2 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746 L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137 integral to membrane; GO:0016021; membrane; GO:0016020 hoe2 hoepel2 CG15624 CDMC29838 2 5 8 DAC12-J17 17-CG15649-RA_1 CG15649 AGTCCACCTGCAGATGGCTTTATCATTCGACTGATTACGGAGACACTGCAGAATAACGTGGCTGG 65 FBan0015649 FBgn0034563 CG15649 2 2R CG15649 CG15649 BcDNA:GH08880 CDMC29838 2 6 8 DAC12-J17 17-CG15649-RA_1 CG15649 AGTCCACCTGCAGATGGCTTTATCATTCGACTGATTACGGAGACACTGCAGAATAACGTGGCTGG 65 FBan0015649 FBgn0034563 CG15649 2 2R CG15649 CG15649 BcDNA:GH08880 CDMC29839 2 7 8 DAC12-N05 2-CG15743-RA_2 CG15743 CCTCCACGAGACCGCACAGATACCGGATGTGACCGTAAATGCCCAGGATGTCACTGTTTGGGTAG 65 FBan0015743 FBgn0030465 CG15743 X X "3'(2'),5'-bisphosphate nucleotidase activity; GO:0008441 ; EC:3.1.3.7; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0008441 ; EC:3.1.3.7; ; GO:0004437" CG15743 CG15743 CDMC29839 2 8 8 DAC12-N05 2-CG15743-RA_2 CG15743 CCTCCACGAGACCGCACAGATACCGGATGTGACCGTAAATGCCCAGGATGTCACTGTTTGGGTAG 65 FBan0015743 FBgn0030465 CG15743 X X "3'(2'),5'-bisphosphate nucleotidase activity; GO:0008441 ; EC:3.1.3.7; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0008441 ; EC:3.1.3.7; ; GO:0004437" CG15743 CG15743 CDMC29840 2 9 8 DAC12-N17 23-CG15770-RA_3 CG15770 TCCCCAATTTATGGTTAAACCACGGTGTGTTTTGTTAATTGCTGGGACATTCTCAGGGAATTGCT 65 FBan0015770 FBgn0029803 CG15770 X X CG15770 CG15770 CDMC29840 2 10 8 DAC12-N17 23-CG15770-RA_3 CG15770 TCCCCAATTTATGGTTAAACCACGGTGTGTTTTGTTAATTGCTGGGACATTCTCAGGGAATTGCT 65 FBan0015770 FBgn0029803 CG15770 X X CG15770 CG15770 CDMC29841 2 11 8 DAC13-B05 2-CG13022-RA_1 CG13022 AGGCGGGAAATGTTTTGGGCAAGTACTCCTACTACGATGAGGCTGGCTACCATGAGCTGAGCTACAAGG 69 FBan0013022 FBgn0036679 CG13022 3 3L CG13022 CG13022 CDMC29841 2 12 8 DAC13-B05 2-CG13022-RA_1 CG13022 AGGCGGGAAATGTTTTGGGCAAGTACTCCTACTACGATGAGGCTGGCTACCATGAGCTGAGCTACAAGG 69 FBan0013022 FBgn0036679 CG13022 3 3L CG13022 CG13022 CDMC29842 2 13 8 DAC13-B17 17-CG13029-RB_1 CG13029 TACGCCAAAGGATTATAGATACAATCAAGGGCTACTGGGCAACTTCATGGCCTTCATGGGAAAACGAGG 69 FBan0013029 FBgn0036670 CG13029 3 3L CG13029 CG13029 "anon-WO0118547.38, BcDNA:AT31918" CDMC29842 2 14 8 DAC13-B17 17-CG13029-RB_1 CG13029 TACGCCAAAGGATTATAGATACAATCAAGGGCTACTGGGCAACTTCATGGCCTTCATGGGAAAACGAGG 69 FBan0013029 FBgn0036670 CG13029 3 3L CG13029 CG13029 "anon-WO0118547.38, BcDNA:AT31918" CDMC29843 2 15 8 DAC13-F05 13-CG13073-RA_1 CG13073 GCAGATCGCGACTCGAATTCATACTGTACACGGAAGTCTACCAAGTCGACGAGGATTCGGTTTCCTCCA 69 FBan0013073 FBgn0036577 CG13073 3 3L CG13073 CG13073 CDMC29843 2 16 8 DAC13-F05 13-CG13073-RA_1 CG13073 GCAGATCGCGACTCGAATTCATACTGTACACGGAAGTCTACCAAGTCGACGAGGATTCGGTTTCCTCCA 69 FBan0013073 FBgn0036577 CG13073 3 3L CG13073 CG13073 CDMC29844 2 17 8 DAC13-F17 2-CG13081-RA_2 CG13081 GCGCGAGGACATTCTATACGACCAACGGCAAAAGGGTGGGGAGAACTATCAGTTCAAAGTGGATGGGGT 69 FBan0013081 FBgn0032804 CG13081 2 2L CG13081 CG13081 CDMC29844 2 18 8 DAC13-F17 2-CG13081-RA_2 CG13081 GCGCGAGGACATTCTATACGACCAACGGCAAAAGGGTGGGGAGAACTATCAGTTCAAAGTGGATGGGGT 69 FBan0013081 FBgn0032804 CG13081 2 2L CG13081 CG13081 CDMC29845 2 19 8 DAC13-J05 3-CG13120-RA_4 CG13120 GATCATTGCGGCTGTGTATCTCCGCCCTTGACCGGCAGTTCCATGGATCTCGACTATTGTATGCTTCCC 69 FBan0013120 FBgn0032142 CG13120 2 2L CG13120 CG13120 CDMC29845 2 20 8 DAC13-J05 3-CG13120-RA_4 CG13120 GATCATTGCGGCTGTGTATCTCCGCCCTTGACCGGCAGTTCCATGGATCTCGACTATTGTATGCTTCCC 69 FBan0013120 FBgn0032142 CG13120 2 2L CG13120 CG13120 CDMC29846 2 21 8 DAC13-J17 8-CG13131-RA_1 CG13131 TGTCCATCGCGTGCCAAACTTCTTGCCAAGCTCACAGTCTACGATCCATTCGATCAAATTGGACGGAGT 69 FBan0013131 FBgn0032175 CG13131 2 2L CG13131 CG13131 CDMC29846 2 22 8 DAC13-J17 8-CG13131-RA_1 CG13131 TGTCCATCGCGTGCCAAACTTCTTGCCAAGCTCACAGTCTACGATCCATTCGATCAAATTGGACGGAGT 69 FBan0013131 FBgn0032175 CG13131 2 2L CG13131 CG13131 CDMC29847 2 23 8 DAC13-N05 11-CG13189-RA_1 CG13189 TGATGTCATACCTGGGCCTTAACAGCACCAACATGATGATCCAGATGACGCAATCAAAAGCCAAGGCGG 69 FBan0013189 FBgn0033665 CG13189 2 2R metal ion transport; GO:0030001 receptor signaling protein activity; GO:0005057; ; GO:0005057; metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG13189 CG13189 CDMC29847 2 24 8 DAC13-N05 11-CG13189-RA_1 CG13189 TGATGTCATACCTGGGCCTTAACAGCACCAACATGATGATCCAGATGACGCAATCAAAAGCCAAGGCGG 69 FBan0013189 FBgn0033665 CG13189 2 2R metal ion transport; GO:0030001 receptor signaling protein activity; GO:0005057; ; GO:0005057; metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG13189 CG13189 CDMC29848 2 25 8 DAC13-N17 3-CG13195-RA_1 CG13195 TGCGAAACCCCTACACTCCTACCGCTATCTTACCGCTCCTTTTCAATGGAGTGTATGGGCCTGTTTGGT 69 FBan0013195 FBgn0033648 CG13195 2 2R CG13195 CG13195 CDMC29848 2 26 8 DAC13-N17 3-CG13195-RA_1 CG13195 TGCGAAACCCCTACACTCCTACCGCTATCTTACCGCTCCTTTTCAATGGAGTGTATGGGCCTGTTTGGT 69 FBan0013195 FBgn0033648 CG13195 2 2R CG13195 CG13195 CDMC29849 2 1 9 DAC14-B05 23-CG40155-RA_1 CG40155 GCTGTTCTGAGAATACAGCATGCATATAGAGGCTGGAGATTAAGAATTCGTTTTATGAGAATGCGGCGT 69 FBgn0058155 CG40155 CG40155 CG40155 CDMC29849 2 2 9 DAC14-B05 23-CG40155-RA_1 CG40155 GCTGTTCTGAGAATACAGCATGCATATAGAGGCTGGAGATTAAGAATTCGTTTTATGAGAATGCGGCGT 69 FBgn0058155 CG40155 CG40155 CG40155 CDMC29850 2 3 9 DAC14-B17 12-CG40162-RA_1 CG40162 GCGCCGCGAAGTAGCGAAAACAACACCAACGCTGCAAACGTAAATGTTTCTGACGATTTCAGGCCTTTA 69 FBgn0058162 CG40162 CG40162 CG40162 CDMC29850 2 4 9 DAC14-B17 12-CG40162-RA_1 CG40162 GCGCCGCGAAGTAGCGAAAACAACACCAACGCTGCAAACGTAAATGTTTCTGACGATTTCAGGCCTTTA 69 FBgn0058162 CG40162 CG40162 CG40162 CDMC29851 2 5 9 DAC14-F05 23-CG40204-RA_6 CG40204 ATCATGGGAAATGAAACAAGCTACATATGCAGGCACAAAAAAAACAACAAATGGATCTTCGTCAGGTGA 69 FBgn0058204 CG40204 CG40204 CG40204 CDMC29851 2 6 9 DAC14-F05 23-CG40204-RA_6 CG40204 ATCATGGGAAATGAAACAAGCTACATATGCAGGCACAAAAAAAACAACAAATGGATCTTCGTCAGGTGA 69 FBgn0058204 CG40204 CG40204 CG40204 CDMC29852 2 7 9 DAC14-F17 23-CG40221-RA_9 CG40221 TGAGCATATTCCTGTGATTGTTCACTCGTTCACCAAATTAACCGTAGTACGAGCGTTGAAAAGGTCAGC 69 FBgn0058221 CG40221 CG40221 CG40221 CDMC29852 2 8 9 DAC14-F17 23-CG40221-RA_9 CG40221 TGAGCATATTCCTGTGATTGTTCACTCGTTCACCAAATTAACCGTAGTACGAGCGTTGAAAAGGTCAGC 69 FBgn0058221 CG40221 CG40221 CG40221 CDMC29853 2 9 9 DAC14-J05 23-CG40287-RA_1 CG40287 GTAAGGGTAACATATTTAAATTGATCCTTTGCACAAATTAAAACGAATCCAATTCGCTTTGCGTGTTCC 69 FBgn0058287 CG40287 CG40287 CG40287 CDMC29853 2 10 9 DAC14-J05 23-CG40287-RA_1 CG40287 GTAAGGGTAACATATTTAAATTGATCCTTTGCACAAATTAAAACGAATCCAATTCGCTTTGCGTGTTCC 69 FBgn0058287 CG40287 CG40287 CG40287 CDMC29854 2 11 9 DAC14-J17 15-CG40300-RA_2 CG40300 TTTGGCCTGGCTATGTTACAGCCGTTGACGAATACAAAGGTGGTTTAATGCTATGCTGCGACGTTTCGC 69 FBgn0058300 CG40300 "development; GO:0007275; female gamete generation; GO:0007292; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG40300 CG40300 CDMC29854 2 12 9 DAC14-J17 15-CG40300-RA_2 CG40300 TTTGGCCTGGCTATGTTACAGCCGTTGACGAATACAAAGGTGGTTTAATGCTATGCTGCGACGTTTCGC 69 FBgn0058300 CG40300 "development; GO:0007275; female gamete generation; GO:0007292; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG40300 CG40300 CDMC29855 2 13 9 DAC14-N05 2-CG40359-RA_1 CG40359 GCGCAGTCGAGAGTCCGAAGCTCCGCAGAAGAACAGCGAAACCTTTAGAGGCGACAAATCTGCTATCAA 69 FBgn0058359 CG40359 CG40359 CG40359 CDMC29855 2 14 9 DAC14-N05 2-CG40359-RA_1 CG40359 GCGCAGTCGAGAGTCCGAAGCTCCGCAGAAGAACAGCGAAACCTTTAGAGGCGACAAATCTGCTATCAA 69 FBgn0058359 CG40359 CG40359 CG40359 CDMC29856 2 15 9 DAC14-N17 23-CG40378-RA_4 CG40378 ATCTGTAACACATAACGGCCACAATACTTGGAAACTCCATATATCTCGTGTACAGATAAACGACTCCGG 69 FBgn0058378 CG40378 cell adhesion; GO:0007155 CG40378 CG40378 CDMC29856 2 16 9 DAC14-N17 23-CG40378-RA_4 CG40378 ATCTGTAACACATAACGGCCACAATACTTGGAAACTCCATATATCTCGTGTACAGATAAACGACTCCGG 69 FBgn0058378 CG40378 cell adhesion; GO:0007155 CG40378 CG40378 CDMC29857 2 17 9 DAC15-B05 18-CG7285-RA_2 CG7285 TCCGGAAGAGCTTCTTCAAGGCCTTTACCTGTATGAATAAGCAGGATATCAACGCTCAACTCCAGCTGG 69 FBan0007285 FBgn0036790 star1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994 integral to membrane; GO:0016021 star1 allatostatin C receptor 1 "CG7285, CG7285, CG7285, CG7285, CG7285, CG7285, CG7285, Drostar1, Drosophila allatostatin C receptor 1, anon-WO0131005.19, anon-WO0170980.79, anon-WO0170980.80, allatostatin C receptor 1" CDMC29857 2 18 9 DAC15-B05 18-CG7285-RA_2 CG7285 TCCGGAAGAGCTTCTTCAAGGCCTTTACCTGTATGAATAAGCAGGATATCAACGCTCAACTCCAGCTGG 69 FBan0007285 FBgn0036790 star1 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994 integral to membrane; GO:0016021 star1 allatostatin C receptor 1 "CG7285, CG7285, CG7285, CG7285, CG7285, CG7285, CG7285, Drostar1, Drosophila allatostatin C receptor 1, anon-WO0131005.19, anon-WO0170980.79, anon-WO0170980.80, allatostatin C receptor 1" CDMC29858 2 19 9 DAC15-B17 2-CG7292-RA_3 CG7292 ACGAGAGTTACGGCTATGTGCTGCCCAATCACATGATGCTGCAAATCGCTGAGAGTCTTCCAAGGGAGA 69 FBan0007292 FBgn0038269 Rrp6 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 nuclear exosome (RNase complex); GO:0000176 Rrp6 Rrp6 "CG7292, CG7292, dRrp6" CDMC29858 2 20 9 DAC15-B17 2-CG7292-RA_3 CG7292 ACGAGAGTTACGGCTATGTGCTGCCCAATCACATGATGCTGCAAATCGCTGAGAGTCTTCCAAGGGAGA 69 FBan0007292 FBgn0038269 Rrp6 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 nuclear exosome (RNase complex); GO:0000176 Rrp6 Rrp6 "CG7292, CG7292, dRrp6" CDMC29859 2 21 9 DAC15-F05 17-CG7327-RA_2 CG7327 GGCTCACATACAAGCCAATCCCGAAGAAGCTAACAGGCGTCATAAAATCTGCATTCGCACCTACGATAA 69 FBan0007327 FBgn0014849 Eig71Ei 3 3L Eig71Ei Eig71Ei "CG7327, CG7327, L71-9, L71" CDMC29859 2 22 9 DAC15-F05 17-CG7327-RA_2 CG7327 GGCTCACATACAAGCCAATCCCGAAGAAGCTAACAGGCGTCATAAAATCTGCATTCGCACCTACGATAA 69 FBan0007327 FBgn0014849 Eig71Ei 3 3L Eig71Ei Eig71Ei "CG7327, CG7327, L71-9, L71" CDMC29860 2 23 9 DAC15-F17 23-CG7336-RA_6 CG7336 TGGATCTATTCAATTCATATTGCGGACGAAATAACCGAAACTGGAGGAAATTAACCCGTTGTGAGCTGG 69 FBan0007336 FBgn0004594 Eig71Eg 3 3L Eig71Eg Ecdysone-induced gene 71Eg "CG7336, gene VI, VI, Gene VI, 71E-Gene-VI, L71-6, L71, gene-VI" CDMC29860 2 24 9 DAC15-F17 23-CG7336-RA_6 CG7336 TGGATCTATTCAATTCATATTGCGGACGAAATAACCGAAACTGGAGGAAATTAACCCGTTGTGAGCTGG 69 FBan0007336 FBgn0004594 Eig71Eg 3 3L Eig71Eg Ecdysone-induced gene 71Eg "CG7336, gene VI, VI, Gene VI, 71E-Gene-VI, L71-6, L71, gene-VI" CDMC29861 2 25 9 DAC15-J05 13-CG7363-RA_1 CG7363 GCCGAAAGGGGGATTCAATGGGACTGTACCTCTTGCATTCATTGTGTGCACTTGCTTCTTTGCATCTTG 69 FBan0007363 FBgn0032269 CG7363 2 2L CG7363 CG7363 BcDNA:AT31112 CDMC29861 2 26 9 DAC15-J05 13-CG7363-RA_1 CG7363 GCCGAAAGGGGGATTCAATGGGACTGTACCTCTTGCATTCATTGTGTGCACTTGCTTCTTTGCATCTTG 69 FBan0007363 FBgn0032269 CG7363 2 2L CG7363 CG7363 BcDNA:AT31112 CDMC29862 2 1 10 DAC15-J17 23-CG7372-RA_15 CG7372 TTCAGGGTCAGCAACACTTCTTACTCATTACATTTTAAGATGCCACTGTACTTGGAAATGATGGAGACA 69 FBan0007372 FBgn0036522 CG7372 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7372 CG7372 CDMC29862 2 2 10 DAC15-J17 23-CG7372-RA_15 CG7372 TTCAGGGTCAGCAACACTTCTTACTCATTACATTTTAAGATGCCACTGTACTTGGAAATGATGGAGACA 69 FBan0007372 FBgn0036522 CG7372 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7372 CG7372 CDMC29863 2 3 10 DAC15-N05 9-CG7404-RA_6 CG7404 GCTGGGCCAAGCAGATACCTGGCTTTATAGATCTGCCACTTAACGACCAGATGAAGCTTCTCCAGGTGT 69 FBan0007404 FBgn0035849 ERR 3 3L "female gamete generation; GO:0007292; hormone secretion; GO:0046879; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 ERR estrogen-related receptor "CG7404, CG7404, dERR" CDMC29863 2 4 10 DAC15-N05 9-CG7404-RA_6 CG7404 GCTGGGCCAAGCAGATACCTGGCTTTATAGATCTGCCACTTAACGACCAGATGAAGCTTCTCCAGGTGT 69 FBan0007404 FBgn0035849 ERR 3 3L "female gamete generation; GO:0007292; hormone secretion; GO:0046879; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 ERR estrogen-related receptor "CG7404, CG7404, dERR" CDMC29864 2 5 10 DAC15-N17 23-CG7425-RA_4 CG7425 TCTGTGATCCCAATCCAGACGATCCTCTTGTTCCAGAGATTGCCAGAATATATAAAACCGATCGGGAAA 69 FBan0007425 FBgn0011217 eff 3 3R chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; compound eye morphogenesis (sensu Endopterygota); GO:0001745; male meiosis; GO:0007140; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; protein ubiquitination; GO:0016567; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0005515; ; GO:0004840 eff effete "CG7425, CG7425, ms(3)88D, UbcD1: Ubiquitin conjugating enzyme 1, E(Pc)88D, UBC4, Ubiquitin conjugating enzyme 1, fs(3)01295, Ubc-D1, SS3-3, Suppressor of GMR-sina 3-3, UBCD1, 3527, 6535, ms(3)ry1, ms(3)ry3, UbcD, ubcD1, UBCD-1, anon-WO0118547.343, l(3)01462, l(3)j2C8, l(3)s1782, mei68, ms(3)01295, ms(3)1, ms(3)3, ms(3)neo2, meiotic 68, UbcD1" CDMC29864 2 6 10 DAC15-N17 23-CG7425-RA_4 CG7425 TCTGTGATCCCAATCCAGACGATCCTCTTGTTCCAGAGATTGCCAGAATATATAAAACCGATCGGGAAA 69 FBan0007425 FBgn0011217 eff 3 3R chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; compound eye morphogenesis (sensu Endopterygota); GO:0001745; male meiosis; GO:0007140; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; protein ubiquitination; GO:0016567; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0005515; ; GO:0004840 eff effete "CG7425, CG7425, ms(3)88D, UbcD1: Ubiquitin conjugating enzyme 1, E(Pc)88D, UBC4, Ubiquitin conjugating enzyme 1, fs(3)01295, Ubc-D1, SS3-3, Suppressor of GMR-sina 3-3, UBCD1, 3527, 6535, ms(3)ry1, ms(3)ry3, UbcD, ubcD1, UBCD-1, anon-WO0118547.343, l(3)01462, l(3)j2C8, l(3)s1782, mei68, ms(3)01295, ms(3)1, ms(3)3, ms(3)neo2, meiotic 68, UbcD1" CDMC29865 2 7 10 DAC16-B05 23-CG12235-RA_1 CG12235 ATTTCCGCACACCGATAACTTCTTGTTTTGGCCAAAAATTAAGCGAACTGAACAATATACCATTCC 66 FBan0012235 FBgn0031050 Arp11 X X cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 actin filament; GO:0005884 Arp11 Arp11 "CG12235, CG12235, CG12235, CG12235, CG12235, ARP11" CDMC29865 2 8 10 DAC16-B05 23-CG12235-RA_1 CG12235 ATTTCCGCACACCGATAACTTCTTGTTTTGGCCAAAAATTAAGCGAACTGAACAATATACCATTCC 66 FBan0012235 FBgn0031050 Arp11 X X cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 actin filament; GO:0005884 Arp11 Arp11 "CG12235, CG12235, CG12235, CG12235, CG12235, ARP11" CDMC29866 2 9 10 DAC16-B17 2-CG12289-RA_2 CG12289 GCCATGTGCGACTATGTGTTCGTCACCAAGTATATAGCCGAGTCCAGAGGCTGGAAGTCACCGCTG 66 FBan0012289 FBgn0036160 CG12289 3 3L electron transport; GO:0006118; monosaccharide metabolism; GO:0005996 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3; ; GO:0005489; ; GO:0005506 CG12289 CG12289 BcDNA:AT04143 CDMC29866 2 10 10 DAC16-B17 2-CG12289-RA_2 CG12289 GCCATGTGCGACTATGTGTTCGTCACCAAGTATATAGCCGAGTCCAGAGGCTGGAAGTCACCGCTG 66 FBan0012289 FBgn0036160 CG12289 3 3L electron transport; GO:0006118; monosaccharide metabolism; GO:0005996 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3; ; GO:0005489; ; GO:0005506 CG12289 CG12289 BcDNA:AT04143 CDMC29867 2 11 10 DAC16-F05 1-CG12848-RA_1 CG12848 ACAAGTGCTACATGGACCGTAAGTTTGAGGCGAAGAAGACCGTGAACCAGGGAATCGTCCAACCGG 66 FBan0012848 FBgn0040666 CG12848 2 2R CG12848 CG12848 CDMC29867 2 12 10 DAC16-F05 1-CG12848-RA_1 CG12848 ACAAGTGCTACATGGACCGTAAGTTTGAGGCGAAGAAGACCGTGAACCAGGGAATCGTCCAACCGG 66 FBan0012848 FBgn0040666 CG12848 2 2R CG12848 CG12848 CDMC29868 2 13 10 DAC16-F17 1-CG13134-RA_1 CG13134 GCGGCAGGATAGGAAACTTCACACTGGTGGCGAATTTCCATCACTTCGACGAGAATCCTCCGCTCG 66 FBan0013134 FBgn0032182 CG13134 2 2L CG13134 CG13134 CDMC29868 2 14 10 DAC16-F17 1-CG13134-RA_1 CG13134 GCGGCAGGATAGGAAACTTCACACTGGTGGCGAATTTCCATCACTTCGACGAGAATCCTCCGCTCG 66 FBan0013134 FBgn0032182 CG13134 2 2L CG13134 CG13134 CDMC29869 2 15 10 DAC16-J05 17-CG13458-RA_3 CG13458 CGCCAAGTGGTGTGGAGCCTATCAGATTTTCAAGGCCTTCATCATGTTTCAGGAACAGTTCGGCCG 66 FBan0013458 FBgn0036479 CG13458 3 3L CG13458 CG13458 CDMC29869 2 16 10 DAC16-J05 17-CG13458-RA_3 CG13458 CGCCAAGTGGTGTGGAGCCTATCAGATTTTCAAGGCCTTCATCATGTTTCAGGAACAGTTCGGCCG 66 FBan0013458 FBgn0036479 CG13458 3 3L CG13458 CG13458 CDMC29870 2 17 10 DAC16-J17 3-CG13575-RA_2 CG13575 GGATCCGAGTAGCCTACGGCGGTTCCTCAGCTACAAGCAGGAGGTGTTCACCATTTACAAGCAGTG 66 FBan0013575 FBgn0034996 CG13575 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0008528" integral to membrane; GO:0016021 CG13575 CG13575 "anon-WO0170980.148, anon-WO0170980.149" CDMC29870 2 18 10 DAC16-J17 3-CG13575-RA_2 CG13575 GGATCCGAGTAGCCTACGGCGGTTCCTCAGCTACAAGCAGGAGGTGTTCACCATTTACAAGCAGTG 66 FBan0013575 FBgn0034996 CG13575 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0008528" integral to membrane; GO:0016021 CG13575 CG13575 "anon-WO0170980.148, anon-WO0170980.149" CDMC29871 2 19 10 DAC16-N05 2-CG14085-RA_1 CG14085 AGTCCTGCCTTATCAAAACACTGGAGGAACACGCGATTGCAGGATGGAGTGATTGCCTGGACAAGC 66 FBan0014085 FBgn0036859 CG14085 3 3L CG14085 CG14085 CDMC29871 2 20 10 DAC16-N05 2-CG14085-RA_1 CG14085 AGTCCTGCCTTATCAAAACACTGGAGGAACACGCGATTGCAGGATGGAGTGATTGCCTGGACAAGC 66 FBan0014085 FBgn0036859 CG14085 3 3L CG14085 CG14085 CDMC29872 2 21 10 DAC16-N17 16-CG14180-RA_2 CG14180 GGAGTTTCGCTTCCTGAGTGTGTTGGTATTCCGATTCTCTCTTGTAGACCTCAAGAACATGGCGGC 66 FBan0014180 FBgn0036003 CG14180 3 3L CG14180 CG14180 CDMC29872 2 22 10 DAC16-N17 16-CG14180-RA_2 CG14180 GGAGTTTCGCTTCCTGAGTGTGTTGGTATTCCGATTCTCTCTTGTAGACCTCAAGAACATGGCGGC 66 FBan0014180 FBgn0036003 CG14180 3 3L CG14180 CG14180 CDMC29873 2 23 10 DAC17-B05 6-CG17279-RA_1 CG17279 TCTGGAGGATCTCCGAGACGATGGCAAGCTATATGCCGGAATATCCAAGGTCAAGTGCTTGCTGGATGT 69 FBan0017279 FBgn0038850 CG17279 3 3R CG17279 CG17279 CDMC29873 2 24 10 DAC17-B05 6-CG17279-RA_1 CG17279 TCTGGAGGATCTCCGAGACGATGGCAAGCTATATGCCGGAATATCCAAGGTCAAGTGCTTGCTGGATGT 69 FBan0017279 FBgn0038850 CG17279 3 3R CG17279 CG17279 CDMC29874 2 25 10 DAC17-B17 23-CG17290-RA_3 CG17290 TCTATCTGTGAAAAATTATTCGTTGTCTTGTCCTTCTTTGGTTGCTATCAAAGTTGAGTTCGCAGGAAA 69 FBan0017290 FBgn0034201 CG17290 2 2R CG17290 CG17290 BcDNA:RE15976 CDMC29874 2 26 10 DAC17-B17 23-CG17290-RA_3 CG17290 TCTATCTGTGAAAAATTATTCGTTGTCTTGTCCTTCTTTGGTTGCTATCAAAGTTGAGTTCGCAGGAAA 69 FBan0017290 FBgn0034201 CG17290 2 2R CG17290 CG17290 BcDNA:RE15976 CDMC29875 2 1 11 DAC17-F05 14-CG17331-RA_1 CG17331 CAAGATGCGCAATGGCTACGATTTAAGTCCACGTGAATCGGCTCATTTTACTCGCAAGAATCTGGCCGA 69 FBan0017331 FBgn0032596 CG17331 2 2L cellular physiological process; GO:0050875; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17331 CG17331 GC17331 CDMC29875 2 2 11 DAC17-F05 14-CG17331-RA_1 CG17331 CAAGATGCGCAATGGCTACGATTTAAGTCCACGTGAATCGGCTCATTTTACTCGCAAGAATCTGGCCGA 69 FBan0017331 FBgn0032596 CG17331 2 2L cellular physiological process; GO:0050875; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17331 CG17331 GC17331 CDMC29876 2 3 11 DAC17-F17 15-CG17349-RA_2 CG17349 TGGCCGTGTGCAATCTTTACAAGAACATCAACGTGAATCTGGGAGAGGGTATCGATCCCGATCGAAACT 69 FBan0017349 FBgn0032771 CG17349 2 2L CG17349 CG17349 anon-WO0140519.204 CDMC29876 2 4 11 DAC17-F17 15-CG17349-RA_2 CG17349 TGGCCGTGTGCAATCTTTACAAGAACATCAACGTGAATCTGGGAGAGGGTATCGATCCCGATCGAAACT 69 FBan0017349 FBgn0032771 CG17349 2 2L CG17349 CG17349 anon-WO0140519.204 CDMC29877 2 5 11 DAC17-J05 3-CG17387-RA_1 CG17387 ACTGCGCCAGATTCGATACGAGAATTCCGAGCTCATAGTCGACCTCAACATGGTCAAGATGCGCTGCAG 69 FBan0017387 FBgn0037276 CG17387 3 3R CG17387 CG17387 CDMC29877 2 6 11 DAC17-J05 3-CG17387-RA_1 CG17387 ACTGCGCCAGATTCGATACGAGAATTCCGAGCTCATAGTCGACCTCAACATGGTCAAGATGCGCTGCAG 69 FBan0017387 FBgn0037276 CG17387 3 3R CG17387 CG17387 CDMC29878 2 7 11 DAC17-J17 15-CG1742-RB_1 CG1742 CCGATGCTACCTGGGATGGTCGGCTATATTGATACTCAAGATCTTCGCCGCTGGTATTTACACGGGTCT 69 FBan0001742 FBgn0025814 Mgstl X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 microsome; GO:0005792; mitochondrial outer membrane; GO:0005741 Mgstl Microsomal glutathione S-transferase-like "CG1742, Mgst1, BcDNA:RE10696, BcDNA:RH59553" CDMC29878 2 8 11 DAC17-J17 15-CG1742-RB_1 CG1742 CCGATGCTACCTGGGATGGTCGGCTATATTGATACTCAAGATCTTCGCCGCTGGTATTTACACGGGTCT 69 FBan0001742 FBgn0025814 Mgstl X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 microsome; GO:0005792; mitochondrial outer membrane; GO:0005741 Mgstl Microsomal glutathione S-transferase-like "CG1742, Mgst1, BcDNA:RE10696, BcDNA:RH59553" CDMC29879 2 9 11 DAC17-N05 1-CG17489-RC_1 CG17489 CCCACCAGGCAATTCGTAACGACCCTACACACAAGGTCACCGCTAAGAAGTCTTCTGCCGTTACGAAGA 69 CDMC29879 2 10 11 DAC17-N05 1-CG17489-RC_1 CG17489 CCCACCAGGCAATTCGTAACGACCCTACACACAAGGTCACCGCTAAGAAGTCTTCTGCCGTTACGAAGA 69 CDMC29880 2 11 11 DAC17-N17 14-CG17494-RA_1 CG17494 GGATTCGGCTGCAACGAAATTGTCAGCCCCTAATGCGGAAAGTAAGGAAAAGCTTGTAGACGTTGAGGA 69 FBgn0040011 CG17494 CG17494 CG17494 CDMC29880 2 12 11 DAC17-N17 14-CG17494-RA_1 CG17494 GGATTCGGCTGCAACGAAATTGTCAGCCCCTAATGCGGAAAGTAAGGAAAAGCTTGTAGACGTTGAGGA 69 FBgn0040011 CG17494 CG17494 CG17494 CDMC29881 2 13 11 DAC18-B05 23-CG31293-RA_2 CG31293 CTCGGAGAATCGCTCTTGCAATTCGTTTCAATGACAAACGCACATTCCACAATTGGTTTCATATAATAC 69 FBan0031293 FBgn0003227 rec 3 3R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; meiotic recombination; GO:0007131 ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003688; ; GO:0004003; DNA-dependent ATPase activity; GO:0008094; ; GO:0004003; ; GO:0008094 nucleus; GO:0005634; pre-replicative complex; GO:0005656; replication fork; GO:0005657 rec recombination-defective "CG31293, CG14875, CG4828, CG31293, rec-1, rec1" CDMC29881 2 14 11 DAC18-B05 23-CG31293-RA_2 CG31293 CTCGGAGAATCGCTCTTGCAATTCGTTTCAATGACAAACGCACATTCCACAATTGGTTTCATATAATAC 69 FBan0031293 FBgn0003227 rec 3 3R DNA replication; GO:0006260; DNA replication initiation; GO:0006270; meiotic recombination; GO:0007131 ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003688; ; GO:0004003; DNA-dependent ATPase activity; GO:0008094; ; GO:0004003; ; GO:0008094 nucleus; GO:0005634; pre-replicative complex; GO:0005656; replication fork; GO:0005657 rec recombination-defective "CG31293, CG14875, CG4828, CG31293, rec-1, rec1" CDMC29882 2 15 11 DAC18-B17 6-CG31304-RA_1 CG31304 CCGCGTCAGAGAATCGATGGTCTGATGGCTCTTTAGGCTTAGCCAGGCTTTATCCTCACCTGCGACTAA 69 FBan0031304 FBgn0051304 CG31304 3 3R signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 cytoskeleton; GO:0005856 CG31304 CG31304 "CG18442, CG6960" CDMC29882 2 16 11 DAC18-B17 6-CG31304-RA_1 CG31304 CCGCGTCAGAGAATCGATGGTCTGATGGCTCTTTAGGCTTAGCCAGGCTTTATCCTCACCTGCGACTAA 69 FBan0031304 FBgn0051304 CG31304 3 3R signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 cytoskeleton; GO:0005856 CG31304 CG31304 "CG18442, CG6960" CDMC29883 2 17 11 DAC18-F05 1-CG31343-RA_1 CG31343 GCTGGTTATCCCCTGCTCACAGTGACCCGTAATTACAATGCCGGCACTATAACGATCACCCAGAAGCGT 69 FBan0031343 FBgn0051343 CG31343 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG31343 CG31343 "CG5839, CG5839, anon-WO0140519.86, BEST:GH20248" CDMC29883 2 18 11 DAC18-F05 1-CG31343-RA_1 CG31343 GCTGGTTATCCCCTGCTCACAGTGACCCGTAATTACAATGCCGGCACTATAACGATCACCCAGAAGCGT 69 FBan0031343 FBgn0051343 CG31343 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 CG31343 CG31343 "CG5839, CG5839, anon-WO0140519.86, BEST:GH20248" CDMC29884 2 19 11 DAC18-F17 2-CG31351-RA_1 CG31351 CCGGCGGAAAGTGGATGTTCGGACCGTTCATGTGCAACGTGTACAACAGCCTGGATGTTTACTTTTCCA 69 FBgn0051351 CDMC29884 2 20 11 DAC18-F17 2-CG31351-RA_1 CG31351 CCGGCGGAAAGTGGATGTTCGGACCGTTCATGTGCAACGTGTACAACAGCCTGGATGTTTACTTTTCCA 69 FBgn0051351 CDMC29885 2 21 11 DAC18-J05 16-CG31385-RA_1 CG31385 CCACCCAAACTGGATTCTAGTACATTAACTATGGTACCACTCAAGGACAGCACAGAGGATCTCTCGCCC 69 FBgn0051385 CDMC29885 2 22 11 DAC18-J05 16-CG31385-RA_1 CG31385 CCACCCAAACTGGATTCTAGTACATTAACTATGGTACCACTCAAGGACAGCACAGAGGATCTCTCGCCC 69 FBgn0051385 CDMC29886 2 23 11 DAC18-J17 3-CG31397-RA_2 CG31397 CGGATGAGGGCCCTTTTCCCAGTTTCAGTGCCTATGTATATGCGAGGAGTATATCTCCCGAGTCCCCGT 69 FBan0031397 FBgn0051397 CG31397 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31397 CG31397 CDMC29886 2 24 11 DAC18-J17 3-CG31397-RA_2 CG31397 CGGATGAGGGCCCTTTTCCCAGTTTCAGTGCCTATGTATATGCGAGGAGTATATCTCCCGAGTCCCCGT 69 FBan0031397 FBgn0051397 CG31397 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31397 CG31397 CDMC29887 2 25 11 DAC18-N05 16-CG31438-RA_1 CG31438 GATGGGGCCATGAATATATCTGGAAACATAACCATGTTATGGGACGTCGAACCTTCAAATCGCGTCGCG 69 FBan0031438 FBgn0051438 CheB93b 3 3R CheB93b CheB93b CG31438 CDMC29887 2 26 11 DAC18-N05 16-CG31438-RA_1 CG31438 GATGGGGCCATGAATATATCTGGAAACATAACCATGTTATGGGACGTCGAACCTTCAAATCGCGTCGCG 69 FBan0031438 FBgn0051438 CheB93b 3 3R CheB93b CheB93b CG31438 CDMC29888 2 1 12 DAC18-N17 18-CG31451-RA_1 CG31451 CGCCTCATTTCGTACAAAGAGAAACCGCAACAAGGAAACACTGCACATCGTTTTTTACACCCTTGCGTT 69 FBan0031451 FBgn0051451 CG31451 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31451 CG31451 "gh16531, BcDNA:GH16531, anon-EST:Posey277" CDMC29888 2 2 12 DAC18-N17 18-CG31451-RA_1 CG31451 CGCCTCATTTCGTACAAAGAGAAACCGCAACAAGGAAACACTGCACATCGTTTTTTACACCCTTGCGTT 69 FBan0031451 FBgn0051451 CG31451 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31451 CG31451 "gh16531, BcDNA:GH16531, anon-EST:Posey277" CDMC29889 2 3 12 DAC19-B05 2-CG5991-RA_3 CG5991 TAGTCTGGCTGAGTTCTTTACCAGGCCACTTAAGGAGGGCGTTCGTGTCATCGATCAGCAGGCTC 65 FBgn0039143 CDMC29889 2 4 12 DAC19-B05 2-CG5991-RA_3 CG5991 TAGTCTGGCTGAGTTCTTTACCAGGCCACTTAAGGAGGGCGTTCGTGTCATCGATCAGCAGGCTC 65 FBgn0039143 CDMC29890 2 5 12 DAC19-B17 5-CG6022-RA_1 CG6022 ATGGCAGCGTTCAATTCTGGCAGTATCCCAGCCAACAGATGTTCTGGAACGCCATGCTACGCAAG 65 FBan0006022 FBgn0038925 CG6022 3 3R coenzyme metabolism; GO:0006732; cytochrome c-heme linkage; GO:0018063 holocytochrome-c synthase activity; GO:0004408 ; EC:4.4.1.17; ; GO:0004408 ; EC:4.4.1.17; ; GO:0004408 ; EC:4.4.1.17 mitochondrial inner membrane; GO:0005743 CG6022 CG6022 CDMC29890 2 6 12 DAC19-B17 5-CG6022-RA_1 CG6022 ATGGCAGCGTTCAATTCTGGCAGTATCCCAGCCAACAGATGTTCTGGAACGCCATGCTACGCAAG 65 FBan0006022 FBgn0038925 CG6022 3 3R coenzyme metabolism; GO:0006732; cytochrome c-heme linkage; GO:0018063 holocytochrome-c synthase activity; GO:0004408 ; EC:4.4.1.17; ; GO:0004408 ; EC:4.4.1.17; ; GO:0004408 ; EC:4.4.1.17 mitochondrial inner membrane; GO:0005743 CG6022 CG6022 CDMC29891 2 7 12 DAC19-F05 3-CG6130-RA_1 CG6130 GAGAAGCCCGAGGAGTAGACCTACAACATGGACGAATAGGCACAACACACGTTCCTGCCCCACTG 65 FBan0006130 FBgn0038334 CG6130 3 3R CG6130 CG6130 anon-WO0140519.172 CDMC29891 2 8 12 DAC19-F05 3-CG6130-RA_1 CG6130 GAGAAGCCCGAGGAGTAGACCTACAACATGGACGAATAGGCACAACACACGTTCCTGCCCCACTG 65 FBan0006130 FBgn0038334 CG6130 3 3R CG6130 CG6130 anon-WO0140519.172 CDMC29892 2 9 12 DAC19-F17 26-CG6178-RA_1 CG6178 AATGACTTCAAAGCTACTGCCCGGAAACATTGTGTACGGAGGTCCTGTGACTGAACGACAGGCCC 65 FBan0006178 FBgn0039156 CG6178 3 3R acyl-CoA biosynthesis; GO:0046949; acyl-CoA metabolism; GO:0006637; fatty acid metabolism; GO:0006631; long-chain fatty acid metabolism; GO:0001676 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; NOT luciferin monooxygenase activity; GO:0045289; ; GO:0045289; ; GO:0004467 ; EC:6.2.1.3; fatty-acyl-CoA synthase activity; GO:0004321 ; EC:2.3.1.86; ; GO:0004321 ; EC:2.3.1.86 CG6178 CG6178 CDMC29892 2 10 12 DAC19-F17 26-CG6178-RA_1 CG6178 AATGACTTCAAAGCTACTGCCCGGAAACATTGTGTACGGAGGTCCTGTGACTGAACGACAGGCCC 65 FBan0006178 FBgn0039156 CG6178 3 3R acyl-CoA biosynthesis; GO:0046949; acyl-CoA metabolism; GO:0006637; fatty acid metabolism; GO:0006631; long-chain fatty acid metabolism; GO:0001676 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; NOT luciferin monooxygenase activity; GO:0045289; ; GO:0045289; ; GO:0004467 ; EC:6.2.1.3; fatty-acyl-CoA synthase activity; GO:0004321 ; EC:2.3.1.86; ; GO:0004321 ; EC:2.3.1.86 CG6178 CG6178 CDMC29893 2 11 12 DAC19-J05 3-CG6292-RA_1 CG6292 ACCAGCGACAATCAAGAAAGAACAGGGAATAACTCCGATGACCAGTTTGGCTAGTGGGCCCGCAC 65 FBan0006292 FBgn0025455 CycT 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368; actin filament organization; GO:0007015; cell cycle; GO:0007049; regulation of cell shape; GO:0008360; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to heat; GO:0009408; transcription; GO:0006350 transcriptional elongation regulator activity; GO:0003711; positive transcription elongation factor activity; GO:0008159; kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0003711; ; GO:0008159; ; GO:0016538 ; EC:2.7.1.-; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome puff; GO:0005703; transcription elongation factor complex b; GO:0008024 CycT Cyclin T "CG6292, P-TEFb, Dmcyclin T, p124, cyclin T, dT, cyclin T1, cyclin T2, CyclinT, anon-74EFc, Cyclin T" CDMC29893 2 12 12 DAC19-J05 3-CG6292-RA_1 CG6292 ACCAGCGACAATCAAGAAAGAACAGGGAATAACTCCGATGACCAGTTTGGCTAGTGGGCCCGCAC 65 FBan0006292 FBgn0025455 CycT 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368; actin filament organization; GO:0007015; cell cycle; GO:0007049; regulation of cell shape; GO:0008360; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to heat; GO:0009408; transcription; GO:0006350 transcriptional elongation regulator activity; GO:0003711; positive transcription elongation factor activity; GO:0008159; kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0003711; ; GO:0008159; ; GO:0016538 ; EC:2.7.1.-; RNA polymerase subunit kinase activity; GO:0008353 ; EC:2.7.1.141; ; GO:0008353 ; EC:2.7.1.141 nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome puff; GO:0005703; transcription elongation factor complex b; GO:0008024 CycT Cyclin T "CG6292, P-TEFb, Dmcyclin T, p124, cyclin T, dT, cyclin T1, cyclin T2, CyclinT, anon-74EFc, Cyclin T" CDMC29894 2 13 12 DAC19-J17 3-CG6327-RA_1 CG6327 TATGTCCCTGGAGAACGACATGAAGAACCCCAGCCACTTCATCGGTTGCCCATCTGTCCTGAACT 65 FBan0006327 FBgn0036115 CG6327 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG6327 CG6327 CDMC29894 2 14 12 DAC19-J17 3-CG6327-RA_1 CG6327 TATGTCCCTGGAGAACGACATGAAGAACCCCAGCCACTTCATCGGTTGCCCATCTGTCCTGAACT 65 FBan0006327 FBgn0036115 CG6327 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG6327 CG6327 CDMC29895 2 15 12 DAC19-N05 3-CG6416-RB_1 CG6416 TATGAGGTGCCATCGACTGTGTTCTCACCCAAGCCAACCAGGGACCATCAACAAGACGTCGATGA 65 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC29895 2 16 12 DAC19-N05 3-CG6416-RB_1 CG6416 TATGAGGTGCCATCGACTGTGTTCTCACCCAAGCCAACCAGGGACCATCAACAAGACGTCGATGA 65 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC29896 2 17 12 DAC19-N17 3-CG6439-RA_1 CG6439 CAACCAGTTCGACGTGATGGTCACCCCCAATCTCTATGGTGCCATTGTGGACAATCTGGCCAGTG 65 FBan0006439 FBgn0038922 CG6439 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrion; GO:0005739 CG6439 CG6439 "Isocitrate dehydrogenase, FBgn0038922" CDMC29896 2 18 12 DAC19-N17 3-CG6439-RA_1 CG6439 CAACCAGTTCGACGTGATGGTCACCCCCAATCTCTATGGTGCCATTGTGGACAATCTGGCCAGTG 65 FBan0006439 FBgn0038922 CG6439 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrion; GO:0005739 CG6439 CG6439 "Isocitrate dehydrogenase, FBgn0038922" CDMC29897 2 19 12 DAC20-B05 1-CG30033-RB_2 CG30033 AAGATGCAGGTGCTAGGCGGCAATCCACTCAGCTTGTGTCTCTTGGTGATCATCACTCCGTCACT 65 FBan0030033 FBgn0050033 CG30033 2 2R CG30033 CG30033 "BcDNA:RH07028, BcDNA:RH63918" CDMC29897 2 20 12 DAC20-B05 1-CG30033-RB_2 CG30033 AAGATGCAGGTGCTAGGCGGCAATCCACTCAGCTTGTGTCTCTTGGTGATCATCACTCCGTCACT 65 FBan0030033 FBgn0050033 CG30033 2 2R CG30033 CG30033 "BcDNA:RH07028, BcDNA:RH63918" CDMC29898 2 21 12 DAC20-B17 1-CG30059-RA_5 CG30059 ATACAACACCTTCTTTGGCGGGAAGTACTTGAATCAGTACTGGGGCGCTGGGGATGTGCCAAAGG 65 FBan0030059 FBgn0050059 CG30059 2 2R N-acetylglucosamine metabolism; GO:0006044; carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14 lysosome; GO:0005764 CG30059 CG30059 anon-WO0140519.22 CDMC29898 2 22 12 DAC20-B17 1-CG30059-RA_5 CG30059 ATACAACACCTTCTTTGGCGGGAAGTACTTGAATCAGTACTGGGGCGCTGGGGATGTGCCAAAGG 65 FBan0030059 FBgn0050059 CG30059 2 2R N-acetylglucosamine metabolism; GO:0006044; carbohydrate metabolism; GO:0005975; polysaccharide metabolism; GO:0005976; sulfur metabolism; GO:0006790 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; N-acetylglucosamine-6-sulfatase activity; GO:0008449 ; EC:3.1.6.14; ; GO:0008449 ; EC:3.1.6.14 lysosome; GO:0005764 CG30059 CG30059 anon-WO0140519.22 CDMC29899 2 23 12 DAC20-F05 3-CG30166-RA_1 CG30166 TAGTGAATTTTTATCGCTTATCACGCCCGAGGAATTGCCGCTGGGTAAGTCCCTCCATGTCCGCC 65 FBan0030166 FBgn0050166 CG30166 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30166 CG30166 CDMC29899 2 24 12 DAC20-F05 3-CG30166-RA_1 CG30166 TAGTGAATTTTTATCGCTTATCACGCCCGAGGAATTGCCGCTGGGTAAGTCCCTCCATGTCCGCC 65 FBan0030166 FBgn0050166 CG30166 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30166 CG30166 CDMC29900 2 25 12 DAC20-F17 14-CG30219-RA_1 CG30219 AAGCAGTCAACATCTTTCGGTGCGAAATGGCTCAGGATCCGAAACCACTTTACTTTGCCGTGGGC 65 FBan0030219 FBgn0050219 CG30219 2 2R CG30219 CG30219 "CG13513, CG13513, CG13513" CDMC29900 2 26 12 DAC20-F17 14-CG30219-RA_1 CG30219 AAGCAGTCAACATCTTTCGGTGCGAAATGGCTCAGGATCCGAAACCACTTTACTTTGCCGTGGGC 65 FBan0030219 FBgn0050219 CG30219 2 2R CG30219 CG30219 "CG13513, CG13513, CG13513" CDMC29901 2 1 13 DAC20-J05 1-CG30352-RA_1 CG30352 CAAGACCCGGGCGGAACTGGCCATTCTCGTAAACCCCGAAACACCGAAAGCCATGGAATAGTATG 65 FBan0030352 FBgn0050352 CG30352 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30352 CG30352 CDMC29901 2 2 13 DAC20-J05 1-CG30352-RA_1 CG30352 CAAGACCCGGGCGGAACTGGCCATTCTCGTAAACCCCGAAACACCGAAAGCCATGGAATAGTATG 65 FBan0030352 FBgn0050352 CG30352 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30352 CG30352 CDMC29902 2 3 13 DAC20-J17 1-CG30381-RA_2 CG30381 GAAAGCCGTTTCGACGAGAACCATATCAAGGATGGCCAACCCACGACCATGGCTAATCTGGAGCG 65 FBan0030381 FBgn0050381 CG30381 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30381 CG30381 CDMC29902 2 4 13 DAC20-J17 1-CG30381-RA_2 CG30381 GAAAGCCGTTTCGACGAGAACCATATCAAGGATGGCCAACCCACGACCATGGCTAATCTGGAGCG 65 FBan0030381 FBgn0050381 CG30381 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30381 CG30381 CDMC29903 2 5 13 DAC20-N05 23-CG30465-RA_1 CG30465 TCATTTGCTGTTCGTTTTGAGTTCGAGTGTCCAATGGGTTAACCTTTTTGTTTTATGTTTTTTTT 65 FBan0030465 FBgn0050465 CG30465 2 2R CG30465 CG30465 BcDNA:RH63320 CDMC29903 2 6 13 DAC20-N05 23-CG30465-RA_1 CG30465 TCATTTGCTGTTCGTTTTGAGTTCGAGTGTCCAATGGGTTAACCTTTTTGTTTTATGTTTTTTTT 65 FBan0030465 FBgn0050465 CG30465 2 2R CG30465 CG30465 BcDNA:RH63320 CDMC29904 2 7 13 DAC20-N17 3-CG3048-RA_1 CG3048 GAGAACTTCCAGAGGCCGTCCAACGAACCAGATCAGCTAGGATTCGGCTTCCCACGCTTCATCTC 65 FBan0003048 FBgn0026319 Traf1 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; Toll signaling pathway; GO:0008063; autophagic cell death; GO:0048102; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; dorsal closure; GO:0007391; embryonic development; GO:0009790; induction of apoptosis; GO:0006917; larval development (sensu Insecta); GO:0002168; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0008270 Traf1 TNF-receptor-associated factor 1 "CG3048, DTRAF1, TRAF, TRAF1, dTraf1, dTRAF, dTRAF1, dtraf1, DTRAF" CDMC29904 2 8 13 DAC20-N17 3-CG3048-RA_1 CG3048 GAGAACTTCCAGAGGCCGTCCAACGAACCAGATCAGCTAGGATTCGGCTTCCCACGCTTCATCTC 65 FBan0003048 FBgn0026319 Traf1 2 2L I-kappaB kinase/NF-kappaB cascade; GO:0007249; JNK cascade; GO:0007254; Toll signaling pathway; GO:0008063; autophagic cell death; GO:0048102; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; dorsal closure; GO:0007391; embryonic development; GO:0009790; induction of apoptosis; GO:0006917; larval development (sensu Insecta); GO:0002168; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0008270 Traf1 TNF-receptor-associated factor 1 "CG3048, DTRAF1, TRAF, TRAF1, dTraf1, dTRAF, dTRAF1, dtraf1, DTRAF" CDMC29905 2 9 13 DAC21-B05 3-CG3853-RA_1 CG3853 TTCTCGCTGATCTACATTCCGGAGACCAAGAAACTCTCCTCGGCCAAGATCCAACAAAGACTGGGCGG 68 FBan0003853 FBgn0015230 Glut3 3 3R carbohydrate metabolism; GO:0005975; glucose transport; GO:0015758 glucose transporter activity; GO:0005355; ; GO:0005355; ; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021 Glut3 Glucose transporter type 3 "CG3853, GLU, Glucose transporter-like, glut-l" CDMC29905 2 10 13 DAC21-B05 3-CG3853-RA_1 CG3853 TTCTCGCTGATCTACATTCCGGAGACCAAGAAACTCTCCTCGGCCAAGATCCAACAAAGACTGGGCGG 68 FBan0003853 FBgn0015230 Glut3 3 3R carbohydrate metabolism; GO:0005975; glucose transport; GO:0015758 glucose transporter activity; GO:0005355; ; GO:0005355; ; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021 Glut3 Glucose transporter type 3 "CG3853, GLU, Glucose transporter-like, glut-l" CDMC29906 2 11 13 DAC21-B17 3-CG3941-RA_2 CG3941 GCGCCAAACTCGCAGTCGGGATGCTCAAAGAATCACTCAGAAGACAGGAAAGAACGAAGGCAAGCCTC 68 FBan0003941 FBgn0034878 pita 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 pita pita "CG3941, CG3941, CG3941, CG3941" CDMC29906 2 12 13 DAC21-B17 3-CG3941-RA_2 CG3941 GCGCCAAACTCGCAGTCGGGATGCTCAAAGAATCACTCAGAAGACAGGAAAGAACGAAGGCAAGCCTC 68 FBan0003941 FBgn0034878 pita 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 pita pita "CG3941, CG3941, CG3941, CG3941" CDMC29907 2 13 13 DAC21-F05 6-CG4212-RA_4 CG4212 TGTGATCTTTCTCATTGGCAACAAATCGGATCTGGAGAGCACTCGGGAGGTTACCTACGAGGAGGCCA 68 FBan0004212 FBgn0015791 Rab14 2 2L intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; receptor mediated endocytosis; GO:0006898; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 Rab14 Rab-protein 14 "CG4212, CG4212, DRAB14, DRab14, 57H4T, BG:DS01068.7, ESTS:57H4T, rab14, DmRab14, AAF53390, Rab-r14, anon-sts33" CDMC29907 2 14 13 DAC21-F05 6-CG4212-RA_4 CG4212 TGTGATCTTTCTCATTGGCAACAAATCGGATCTGGAGAGCACTCGGGAGGTTACCTACGAGGAGGCCA 68 FBan0004212 FBgn0015791 Rab14 2 2L intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; receptor mediated endocytosis; GO:0006898; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 Rab14 Rab-protein 14 "CG4212, CG4212, DRAB14, DRab14, 57H4T, BG:DS01068.7, ESTS:57H4T, rab14, DmRab14, AAF53390, Rab-r14, anon-sts33" CDMC29908 2 15 13 DAC21-F17 1-CG4365-RC_1 CG4365 TGTGCCCGTCATCTGTCCAAGTCTCGTCAAGCTGCAAAAACTACGAAAAGTCGGCTTCAGAGGCATGC 68 FBan0004365 FBgn0037024 CG4365 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydroxyacylglutathione hydrolase activity; GO:0004416 ; EC:3.1.2.6; ; GO:0004416 ; EC:3.1.2.6 CG4365 CG4365 CDMC29908 2 16 13 DAC21-F17 1-CG4365-RC_1 CG4365 TGTGCCCGTCATCTGTCCAAGTCTCGTCAAGCTGCAAAAACTACGAAAAGTCGGCTTCAGAGGCATGC 68 FBan0004365 FBgn0037024 CG4365 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 hydroxyacylglutathione hydrolase activity; GO:0004416 ; EC:3.1.2.6; ; GO:0004416 ; EC:3.1.2.6 CG4365 CG4365 CDMC29909 2 17 13 DAC21-J05 7-CG4916-RA_1 CG4916 ACTTGGAACCGAAATAAAGCCTATTCCGAAGGTCATAGACCCCGCCCTTTATGTCGCAAACGTTGGCG 68 FBan0004916 FBgn0004419 me31B 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 me31B maternal expression at 31B "CG4916, ME31B, l(2)k06607, Me31B, DmRH3" CDMC29909 2 18 13 DAC21-J05 7-CG4916-RA_1 CG4916 ACTTGGAACCGAAATAAAGCCTATTCCGAAGGTCATAGACCCCGCCCTTTATGTCGCAAACGTTGGCG 68 FBan0004916 FBgn0004419 me31B 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 me31B maternal expression at 31B "CG4916, ME31B, l(2)k06607, Me31B, DmRH3" CDMC29910 2 19 13 DAC21-J17 1-CG5037-RA_2 CG5037 GCACCCGTACTGGACGTCACGAACTACTGGTTTGCCTTGGAAACACTACCTCTGAACGCGTACTTCGC 68 FBan0005037 FBgn0032222 CG5037 2 2L coenzyme metabolism; GO:0006732; heme o biosynthesis; GO:0048034 protoheme IX farnesyltransferase activity; GO:0008495 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008495 ; EC:2.5.1.-; ; GO:0008495 ; EC:2.5.1.- integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740 CG5037 CG5037 CDMC29910 2 20 13 DAC21-J17 1-CG5037-RA_2 CG5037 GCACCCGTACTGGACGTCACGAACTACTGGTTTGCCTTGGAAACACTACCTCTGAACGCGTACTTCGC 68 FBan0005037 FBgn0032222 CG5037 2 2L coenzyme metabolism; GO:0006732; heme o biosynthesis; GO:0048034 protoheme IX farnesyltransferase activity; GO:0008495 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0008495 ; EC:2.5.1.-; ; GO:0008495 ; EC:2.5.1.- integral to membrane; GO:0016021; mitochondrial membrane; GO:0005740 CG5037 CG5037 CDMC29911 2 21 13 DAC21-N05 2-CG5343-RA_1 CG5343 CGGCGAAGGTTTAGGGCCAGTAACTACCAGTCGACAACTCGTGTCAAGCCTTTCATTTGCACCATGCC 68 FBan0005343 FBgn0032248 CG5343 2 2L regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG5343 CG5343 CDMC29911 2 22 13 DAC21-N05 2-CG5343-RA_1 CG5343 CGGCGAAGGTTTAGGGCCAGTAACTACCAGTCGACAACTCGTGTCAAGCCTTTCATTTGCACCATGCC 68 FBan0005343 FBgn0032248 CG5343 2 2L regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG5343 CG5343 CDMC29912 2 23 13 DAC21-N17 6-CG5506-RA_1 CG5506 TGAGCGGGATGTAAATTACGTGTGGGTCAGGAGCTTCGATGGATTCTATGAAAAGGGAGCCGTTGCCG 68 FBan0005506 FBgn0036766 CG5506 3 3L CG5506 CG5506 BcDNA:LP12049 CDMC29912 2 24 13 DAC21-N17 6-CG5506-RA_1 CG5506 TGAGCGGGATGTAAATTACGTGTGGGTCAGGAGCTTCGATGGATTCTATGAAAAGGGAGCCGTTGCCG 68 FBan0005506 FBgn0036766 CG5506 3 3L CG5506 CG5506 BcDNA:LP12049 CDMC29913 2 25 13 DAC22-B05 18-CG40444-RA_1 CG40444 TCTTGAAGACGATTTGCTTGCTCGCTTATCTTCTGCTGGAGACAACGTCCTTGAAGATGTCACTCTGGT 69 CDMC29913 2 26 13 DAC22-B05 18-CG40444-RA_1 CG40444 TCTTGAAGACGATTTGCTTGCTCGCTTATCTTCTGCTGGAGACAACGTCCTTGAAGATGTCACTCTGGT 69 CDMC29914 2 1 14 DAC22-B17 23-CG40452-RA_12 CG40452 GGAAAGTAGCATCCCAAGTCAACGTAAATATACCCTTACAAGCAAAACGGTCCTCATGGTTTTAAGCTT 69 CDMC29914 2 2 14 DAC22-B17 23-CG40452-RA_12 CG40452 GGAAAGTAGCATCCCAAGTCAACGTAAATATACCCTTACAAGCAAAACGGTCCTCATGGTTTTAAGCTT 69 CDMC29915 2 3 14 DAC22-F05 2-CG4054-RA_1 CG4054 TGCCCTCAAGAGCCTGGATATGTCCTTGAATCTGGTCGAGTTTGTGCGGAATGACAGTTTCGAGGGCTT 69 FBan0004054 FBgn0034668 Fili 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 Fili Fish-lips "CG4054, CT13464, Fish-lips" CDMC29915 2 4 14 DAC22-F05 2-CG4054-RA_1 CG4054 TGCCCTCAAGAGCCTGGATATGTCCTTGAATCTGGTCGAGTTTGTGCGGAATGACAGTTTCGAGGGCTT 69 FBan0004054 FBgn0034668 Fili 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 Fili Fish-lips "CG4054, CT13464, Fish-lips" CDMC29916 2 5 14 DAC22-F17 9-CG4063-RA_1 CG4063 GCCCTCCCCACCAAAAGTCCTTTACCCAATTCCACAGTTGTCCTCCAAAAAAGGGATGCCAAGAGATCA 69 FBan0004063 FBgn0023444 ebi 2 2L Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; epidermal growth factor receptor signaling pathway; GO:0007173; regulation of epidermal growth factor receptor signaling pathway; GO:0042058; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162; sensory perception of sound; GO:0007605; visual perception; GO:0007601 DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; protein binding; GO:0005515; ; GO:0005515; ; GO:0003677 nucleus; GO:0005634 ebi ebi "CG4063, Tb11, Tbl1, beta transducin-like 1 protein, Ebi, l(2)k16213, ebi" CDMC29916 2 6 14 DAC22-F17 9-CG4063-RA_1 CG4063 GCCCTCCCCACCAAAAGTCCTTTACCCAATTCCACAGTTGTCCTCCAAAAAAGGGATGCCAAGAGATCA 69 FBan0004063 FBgn0023444 ebi 2 2L Notch signaling pathway; GO:0007219; cone cell fate commitment (sensu Endopterygota); GO:0007466; epidermal growth factor receptor signaling pathway; GO:0007173; regulation of epidermal growth factor receptor signaling pathway; GO:0042058; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162; sensory perception of sound; GO:0007605; visual perception; GO:0007601 DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; protein binding; GO:0005515; ; GO:0005515; ; GO:0003677 nucleus; GO:0005634 ebi ebi "CG4063, Tb11, Tbl1, beta transducin-like 1 protein, Ebi, l(2)k16213, ebi" CDMC29917 2 7 14 DAC22-J05 2-CG4101-RA_1 CG4101 CTTCAGCTTGCTAATCCGATACGGGCTTTATGTGGGTGCTCTCTTCCAGTTCGTTTGCATTTCGGCCGC 69 FBan0004101 FBgn0025558 CG4101 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG4101 CG4101 "anon73B1, anon-73B1" CDMC29917 2 8 14 DAC22-J05 2-CG4101-RA_1 CG4101 CTTCAGCTTGCTAATCCGATACGGGCTTTATGTGGGTGCTCTCTTCCAGTTCGTTTGCATTTCGGCCGC 69 FBan0004101 FBgn0025558 CG4101 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG4101 CG4101 "anon73B1, anon-73B1" CDMC29918 2 9 14 DAC22-J17 23-CG41056-RA_5 CG41056 TGGATACAGATTTTCCTGTTCTACGAGGAGAACCAAAAGCTTTGTATTCGAAACTTCTAATTGGTGGAA 69 FBgn0058232 CG41056 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41056 CG41056 "CG40232, CG40328" CDMC29918 2 10 14 DAC22-J17 23-CG41056-RA_5 CG41056 TGGATACAGATTTTCCTGTTCTACGAGGAGAACCAAAAGCTTTGTATTCGAAACTTCTAATTGGTGGAA 69 FBgn0058232 CG41056 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41056 CG41056 "CG40232, CG40328" CDMC29919 2 11 14 DAC22-N05 15-CG41113-RA_1 CG41113 TGGCTATACAGCTTGAAGAAAGATGACTTTCCCGCCATAGCAAGTGCTCTCGGGATAAAGCTGGAAGGT 69 FBgn0069936 CG41113 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41113 CG41113 CDMC29919 2 12 14 DAC22-N05 15-CG41113-RA_1 CG41113 TGGCTATACAGCTTGAAGAAAGATGACTTTCCCGCCATAGCAAGTGCTCTCGGGATAAAGCTGGAAGGT 69 FBgn0069936 CG41113 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41113 CG41113 CDMC29920 2 13 14 DAC22-N17 24-CG41128-RA_4 CG41128 AATGACTTCTCGCGATAATATTTTCGAGGAAAAAATATGCAATAGATTAGATCATTGCGTTTCTGATGT 69 FBgn0069923 CG41128 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41128 CG41128 BcDNA:RH61753 CDMC29920 2 14 14 DAC22-N17 24-CG41128-RA_4 CG41128 AATGACTTCTCGCGATAATATTTTCGAGGAAAAAATATGCAATAGATTAGATCATTGCGTTTCTGATGT 69 FBgn0069923 CG41128 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41128 CG41128 BcDNA:RH61753 CDMC29921 2 15 14 DAC23-B05 17-CG33331-RA_1 CG33331 CCCAGTGCTGGCATTCTCAAGTCATTGGCGTATAGCTATCGCAAGGCTCAAAAGACATTCGCTGTTTAG 69 FBan0033331 FBgn0067628 CG33331 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33331 CG33331 "CG3641, CG3641, BcDNA:SD17447" CDMC29921 2 16 14 DAC23-B05 17-CG33331-RA_1 CG33331 CCCAGTGCTGGCATTCTCAAGTCATTGGCGTATAGCTATCGCAAGGCTCAAAAGACATTCGCTGTTTAG 69 FBan0033331 FBgn0067628 CG33331 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33331 CG33331 "CG3641, CG3641, BcDNA:SD17447" CDMC29922 2 17 14 DAC23-B17 16-CG33346-RA_1 CG33346 CGGTTGCCGACTACAGCTTCCCAAAAATCCTAAGACAAACCAACAAGTACTTGAATGTCGTTCCCCAGT 69 FBan0033346 FBgn0053346 CG33346 3 3R CG33346 CG33346 CDMC29922 2 18 14 DAC23-B17 16-CG33346-RA_1 CG33346 CGGTTGCCGACTACAGCTTCCCAAAAATCCTAAGACAAACCAACAAGTACTTGAATGTCGTTCCCCAGT 69 FBan0033346 FBgn0053346 CG33346 3 3R CG33346 CG33346 CDMC29923 2 19 14 DAC23-F05 15-CG33467-RA_5 CG33467 GCGCGGGTGAAAAATGTTTCCTGCAATGTGAAGCCGATCAATTGGAATACGGCGTTGGTTAACTTGGAT 69 FBan0033467 FBgn0053467 CG33467 2 2R CG33467 CG33467 CDMC29923 2 20 14 DAC23-F05 15-CG33467-RA_5 CG33467 GCGCGGGTGAAAAATGTTTCCTGCAATGTGAAGCCGATCAATTGGAATACGGCGTTGGTTAACTTGGAT 69 FBan0033467 FBgn0053467 CG33467 2 2R CG33467 CG33467 CDMC29924 2 21 14 DAC23-F17 16-CG33475-RA_1 CG33475 CCAGCCAAGTGTCTACTACCTGAGCAACAGTGTCAGAGAATTCGAAGTGCCCATTTTTCATCAACCTGG 69 FBan0033475 FBgn0053475 CG33475 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33475 CG33475 CDMC29924 2 22 14 DAC23-F17 16-CG33475-RA_1 CG33475 CCAGCCAAGTGTCTACTACCTGAGCAACAGTGTCAGAGAATTCGAAGTGCCCATTTTTCATCAACCTGG 69 FBan0033475 FBgn0053475 CG33475 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33475 CG33475 CDMC29925 2 23 14 DAC23-J05 12-CG33493-RA_1 CG33493 GGGCAGCACCAGATACCAGGCCAAACTGCATCTACACCATGACTATAAGACCAATGCGTATCCCTCGTA 69 FBan0033493 FBgn0053493 CG33493 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33493 CG33493 CG6463 CDMC29925 2 24 14 DAC23-J05 12-CG33493-RA_1 CG33493 GGGCAGCACCAGATACCAGGCCAAACTGCATCTACACCATGACTATAAGACCAATGCGTATCCCTCGTA 69 FBan0033493 FBgn0053493 CG33493 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33493 CG33493 CG6463 CDMC29926 2 25 14 DAC23-J17 3-CG3350-RA_2 CG3350 GACTCCTCCGGCTACAAGCTCAGCAAGGCTCTGATCCTGCAGAAGTCCATCGAATACATTGGCTACCTT 69 FBan0003350 FBgn0039509 bigmax 3 3R autophagic cell death; GO:0048102; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bigmax bigmax "CG3350, CG3350, CG3350, CG3350, BIGMAX, DmMlx" CDMC29926 2 26 14 DAC23-J17 3-CG3350-RA_2 CG3350 GACTCCTCCGGCTACAAGCTCAGCAAGGCTCTGATCCTGCAGAAGTCCATCGAATACATTGGCTACCTT 69 FBan0003350 FBgn0039509 bigmax 3 3R autophagic cell death; GO:0048102; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bigmax bigmax "CG3350, CG3350, CG3350, CG3350, BIGMAX, DmMlx" CDMC29927 2 1 15 DAC23-N05 18-CG3397-RA_2 CG3397 TCTGCGCGAAAACGTTTTTACCAAGTCCTACAGTTGGGGCTCCACTTTATCCACGGTTAACATGTTCAA 69 FBan0003397 FBgn0037975 CG3397 3 3R potassium ion transport; GO:0006813 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- voltage-gated potassium channel complex; GO:0008076 CG3397 CG3397 CDMC29927 2 2 15 DAC23-N05 18-CG3397-RA_2 CG3397 TCTGCGCGAAAACGTTTTTACCAAGTCCTACAGTTGGGGCTCCACTTTATCCACGGTTAACATGTTCAA 69 FBan0003397 FBgn0037975 CG3397 3 3R potassium ion transport; GO:0006813 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- voltage-gated potassium channel complex; GO:0008076 CG3397 CG3397 CDMC29928 2 3 15 DAC23-N17 22-CG3411-RA_1 CG3411 GCCAACGGCAAAAAGACAAAGGGACGTGTCAAAATCAAAATGGAATACATCGACAATAAGCTGCGTCGC 69 FBan0003411 FBgn0004101 bs 2 2R "apposition of dorsal and ventral wing surfaces; GO:0007475; cell fate commitment; GO:0045165; regulation of transcription from RNA polymerase II promoter; GO:0006357; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; terminal cell fate specification; GO:0035154; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bs blistered "CG3411, ba: balloon, balloon, px, DSRF, pruned, dSRF, pruned/DSRF, SRF, DSrf, Srf, dsrf, D-SRF, Serum Response Factor, serum response factor, DSrf/bs, Group IIc, DmSRF, BS, Serf, l(2)03267, Serum response factor, ba" CDMC29928 2 4 15 DAC23-N17 22-CG3411-RA_1 CG3411 GCCAACGGCAAAAAGACAAAGGGACGTGTCAAAATCAAAATGGAATACATCGACAATAAGCTGCGTCGC 69 FBan0003411 FBgn0004101 bs 2 2R "apposition of dorsal and ventral wing surfaces; GO:0007475; cell fate commitment; GO:0045165; regulation of transcription from RNA polymerase II promoter; GO:0006357; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; terminal cell fate specification; GO:0035154; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 bs blistered "CG3411, ba: balloon, balloon, px, DSRF, pruned, dSRF, pruned/DSRF, SRF, DSrf, Srf, dsrf, D-SRF, Serum Response Factor, serum response factor, DSrf/bs, Group IIc, DmSRF, BS, Serf, l(2)03267, Serum response factor, ba" CDMC29929 2 5 15 DAC24-B05 23-CG33156-RC_3 CG33156 CTTATAAAACATTGTCAAGTTGTGCTGTAGATTAAGCCTGATTGCAAACTGATTGAAATGTGTTCTCCT 69 FBan0033156 FBgn0053156 CG33156 2 2R CG33156 CG33156 "CG6152, CG30063" CDMC29929 2 6 15 DAC24-B05 23-CG33156-RC_3 CG33156 CTTATAAAACATTGTCAAGTTGTGCTGTAGATTAAGCCTGATTGCAAACTGATTGAAATGTGTTCTCCT 69 FBan0033156 FBgn0053156 CG33156 2 2R CG33156 CG33156 "CG6152, CG30063" CDMC29930 2 7 15 DAC24-B17 14-CG33170-RA_2 CG33170 GGTCCCCCGAGTGGATGATCCCCAGAAGTTGATGCAGCGTTTCAACGAGAAACTCAAAGAACTAATGGA 69 FBan0033170 FBgn0053170 CG33170 3 3L CG33170 CG33170 "CG8244, CG8244, BcDNA:AT30788" CDMC29930 2 8 15 DAC24-B17 14-CG33170-RA_2 CG33170 GGTCCCCCGAGTGGATGATCCCCAGAAGTTGATGCAGCGTTTCAACGAGAAACTCAAAGAACTAATGGA 69 FBan0033170 FBgn0053170 CG33170 3 3L CG33170 CG33170 "CG8244, CG8244, BcDNA:AT30788" CDMC29931 2 9 15 DAC24-F05 23-CG33194-RA_5 CG33194 TAAGAGATGGCAAAAGTACTGGCGGGATTCAATTTGTCATTGACTTGGAAGATTCCACATTATAGCCAA 69 FBan0033194 FBgn0053194 CheA29a 2 2L response to pheromone; GO:0019236 CheA29a CheA29a "CG33194, CG33194" CDMC29931 2 10 15 DAC24-F05 23-CG33194-RA_5 CG33194 TAAGAGATGGCAAAAGTACTGGCGGGATTCAATTTGTCATTGACTTGGAAGATTCCACATTATAGCCAA 69 FBan0033194 FBgn0053194 CheA29a 2 2L response to pheromone; GO:0019236 CheA29a CheA29a "CG33194, CG33194" CDMC29932 2 11 15 DAC24-F17 16-CG33200-RA_1 CG33200 CCCAAACTGCGTATGAGGTCTATCAGAGAATCCTGCTAAGATTACAAGCCCAGGAACATACACGCTCCA 69 FBan0033200 FBgn0053200 ventrally-expressed-protein-D 2 2R development; GO:0007275 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ventrally-expressed-protein-D ventrally-expressed-protein-D "CG33200, CG33200, D, anon-EST:CL57" CDMC29932 2 12 15 DAC24-F17 16-CG33200-RA_1 CG33200 CCCAAACTGCGTATGAGGTCTATCAGAGAATCCTGCTAAGATTACAAGCCCAGGAACATACACGCTCCA 69 FBan0033200 FBgn0053200 ventrally-expressed-protein-D 2 2R development; GO:0007275 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ventrally-expressed-protein-D ventrally-expressed-protein-D "CG33200, CG33200, D, anon-EST:CL57" CDMC29933 2 13 15 DAC24-J05 23-CG33225-RA_9 CG33225 AATCTCGGGCTTTTCTCATCGGCATTGTCAGCTATGGTAGTTCATCTTGTAGTGGTATCGGTGTTTACA 69 FBan0033225 FBgn0053225 CG33225 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33225 CG33225 CDMC29933 2 14 15 DAC24-J05 23-CG33225-RA_9 CG33225 AATCTCGGGCTTTTCTCATCGGCATTGTCAGCTATGGTAGTTCATCTTGTAGTGGTATCGGTGTTTACA 69 FBan0033225 FBgn0053225 CG33225 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33225 CG33225 CDMC29934 2 15 15 DAC24-J17 1-CG33232-RC_1 CG33232 TCGAAGAGTGCTCCTCATACGCGTAATGTGGCTGTAGGAGTTGCTCAGGATCTGATCAAGACGGTGCCT 69 FBgn0035345 CDMC29934 2 16 15 DAC24-J17 1-CG33232-RC_1 CG33232 TCGAAGAGTGCTCCTCATACGCGTAATGTGGCTGTAGGAGTTGCTCAGGATCTGATCAAGACGGTGCCT 69 FBgn0035345 CDMC29935 2 17 15 DAC24-N05 1-CG33285-RA_1 CG33285 AGGACGTCTACAGATGATGCCTCACGAGGTGGAAGGGATGTCTGATGGGGAGCTCAACCTTAGGTTTGA 69 FBan0033285 FBgn0053285 CG33285 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33285 CG33285 "NEST:bs33a07, NEST:bs33a04" CDMC29935 2 18 15 DAC24-N05 1-CG33285-RA_1 CG33285 AGGACGTCTACAGATGATGCCTCACGAGGTGGAAGGGATGTCTGATGGGGAGCTCAACCTTAGGTTTGA 69 FBan0033285 FBgn0053285 CG33285 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33285 CG33285 "NEST:bs33a07, NEST:bs33a04" CDMC29936 2 19 15 DAC24-N17 16-CG33295-RA_1 CG33295 GGCAACATAAAGCTGTACACCCATCGAAAAGTGGGCGTCATTCTACCAATTAAAGGTAACAATGGCCGC 69 FBan0033295 FBgn0053295 CG33295 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33295 CG33295 CDMC29936 2 20 15 DAC24-N17 16-CG33295-RA_1 CG33295 GGCAACATAAAGCTGTACACCCATCGAAAAGTGGGCGTCATTCTACCAATTAAAGGTAACAATGGCCGC 69 FBan0033295 FBgn0053295 CG33295 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33295 CG33295 CDMC29937 2 21 15 DAC25-B05 3-CG10349-RA_1 CG10349 ACTCCGAGTATGGCTGTGTGAGTGCATATAAAGAAATACGGGCTCTGAGGCCAGGTCTGAATGAGCGGC 69 FBan0010349 FBgn0015350 CG10349 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10349 CG10349 "domain II, II, candidate gene 5, CT29078, CG-CG10349, anon-89Ea" CDMC29937 2 22 15 DAC25-B05 3-CG10349-RA_1 CG10349 ACTCCGAGTATGGCTGTGTGAGTGCATATAAAGAAATACGGGCTCTGAGGCCAGGTCTGAATGAGCGGC 69 FBan0010349 FBgn0015350 CG10349 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10349 CG10349 "domain II, II, candidate gene 5, CT29078, CG-CG10349, anon-89Ea" CDMC29938 2 23 15 DAC25-B17 23-CG10362-RA_12 CG10362 CTGGGATCATGGGCTACATGTCAATGGTTAAATACTTGTGTATTCGCGTGAACTCGTACATAATCTTAA 69 FBan0010362 FBgn0030358 CG10362 X X intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992; protein binding; GO:0005515; ; GO:0005515 CG10362 CG10362 CDMC29938 2 24 15 DAC25-B17 23-CG10362-RA_12 CG10362 CTGGGATCATGGGCTACATGTCAATGGTTAAATACTTGTGTATTCGCGTGAACTCGTACATAATCTTAA 69 FBan0010362 FBgn0030358 CG10362 X X intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992; protein binding; GO:0005515; ; GO:0005515 CG10362 CG10362 CDMC29939 2 25 15 DAC25-F05 13-CG10395-RA_1 CG10395 TGGCACATGATGACAGTTTGCCTCACACGGGTGCTAAAAAAGGTAAAAGACGACGCAACAGTGATACGT 69 FBan0010395 FBgn0033019 CG10395 2 2R CG10395 CG10395 CDMC29939 2 26 15 DAC25-F05 13-CG10395-RA_1 CG10395 TGGCACATGATGACAGTTTGCCTCACACGGGTGCTAAAAAAGGTAAAAGACGACGCAACAGTGATACGT 69 FBan0010395 FBgn0033019 CG10395 2 2R CG10395 CG10395 CDMC29940 2 1 16 DAC25-F17 15-CG10417-RA_1 CG10417 AGCCCTTGGAGACCATGCCTATAAAACGAACGTAACCCTACCAGCTGAGGAACAAATGATATCTGCCCT 69 FBan0010417 FBgn0033021 CG10417 2 2R MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 CG10417 CG10417 PP2Cg CDMC29940 2 2 16 DAC25-F17 15-CG10417-RA_1 CG10417 AGCCCTTGGAGACCATGCCTATAAAACGAACGTAACCCTACCAGCTGAGGAACAAATGATATCTGCCCT 69 FBan0010417 FBgn0033021 CG10417 2 2R MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 CG10417 CG10417 PP2Cg CDMC29941 2 3 16 DAC25-J05 2-CG10465-RA_1 CG10465 ACCAGACCAAGAGCTCATGCAGGCAACGTCTTCAGCACGAGTAGGAAGTGCAAGTGGAACCAGCATTAA 69 FBan0010465 FBgn0033017 CG10465 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10465 CG10465 CDMC29941 2 4 16 DAC25-J05 2-CG10465-RA_1 CG10465 ACCAGACCAAGAGCTCATGCAGGCAACGTCTTCAGCACGAGTAGGAAGTGCAAGTGGAACCAGCATTAA 69 FBan0010465 FBgn0033017 CG10465 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10465 CG10465 CDMC29942 2 5 16 DAC25-J17 13-CG10478-RA_2 CG10478 CCGTGCCACGATTGATTCGCCTTCTTCAGTCACCCGATCCTGAAGTCTGCGAAAAGGGTATATTGAGTT 69 FBan0010478 FBgn0035657 CG10478 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 CG10478 CG10478 "CG11040, CG11040, g7295403" CDMC29942 2 6 16 DAC25-J17 13-CG10478-RA_2 CG10478 CCGTGCCACGATTGATTCGCCTTCTTCAGTCACCCGATCCTGAAGTCTGCGAAAAGGGTATATTGAGTT 69 FBan0010478 FBgn0035657 CG10478 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 CG10478 CG10478 "CG11040, CG11040, g7295403" CDMC29943 2 7 16 DAC25-N05 2-CG10522-RA_3 CG10522 CCGAGCAGCAAATACTCCTATTGGGCTGTAACACGGGACTGTATGCGTATCACTTGGACTCGCAGCGAT 69 FBgn0036295 CDMC29943 2 8 16 DAC25-N05 2-CG10522-RA_3 CG10522 CCGAGCAGCAAATACTCCTATTGGGCTGTAACACGGGACTGTATGCGTATCACTTGGACTCGCAGCGAT 69 FBgn0036295 CDMC29944 2 9 16 DAC25-N17 24-CG10530-RA_5 CG10530 CTAGTTCCTTTTTAATGTCGGTTAACAGGAAATAGAAAACCTTTATTACCGTTCTTATCAAGGAGAACA 69 FBan0010530 FBgn0020638 Lcp65Ag1 3 3L larval cuticle biosynthesis (sensu Insecta); GO:0008363 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010; ; GO:0008010 extracellular region; GO:0005576 Lcp65Ag1 Lcp65Ag1 "CG10530, LCP8, L[[3]]CP8, Lcp-g1, DCP8-alpha, Lcp8" CDMC29944 2 10 16 DAC25-N17 24-CG10530-RA_5 CG10530 CTAGTTCCTTTTTAATGTCGGTTAACAGGAAATAGAAAACCTTTATTACCGTTCTTATCAAGGAGAACA 69 FBan0010530 FBgn0020638 Lcp65Ag1 3 3L larval cuticle biosynthesis (sensu Insecta); GO:0008363 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010; ; GO:0008010; ; GO:0008010 extracellular region; GO:0005576 Lcp65Ag1 Lcp65Ag1 "CG10530, LCP8, L[[3]]CP8, Lcp-g1, DCP8-alpha, Lcp8" CDMC29945 2 11 16 DAC26-B05 8-CG15278-RA_1 CG15278 GCTGCAAGTTGGCCTTCATTAGCACACTGGTTCTCTTGTCGAACTTTGTGCTGTTCGTCTGTTTCGCCT 69 FBan0015278 FBgn0032554 CG15278 2 2L CG15278 CG15278 "bs32h08.y1, NEST:bs32h08" CDMC29945 2 12 16 DAC26-B05 8-CG15278-RA_1 CG15278 GCTGCAAGTTGGCCTTCATTAGCACACTGGTTCTCTTGTCGAACTTTGTGCTGTTCGTCTGTTTCGCCT 69 FBan0015278 FBgn0032554 CG15278 2 2L CG15278 CG15278 "bs32h08.y1, NEST:bs32h08" CDMC29946 2 13 16 DAC26-B17 2-CG15286-RA_2 CG15286 CGGCCAACATCGGTAACAATACACGGAGCATAAATGTTTACGGACCCACATCCGCTTTTACCCAGGCGT 69 FBan0015286 FBgn0028531 CG15286 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15286 CG15286 BG:DS01068.11 CDMC29946 2 14 16 DAC26-B17 2-CG15286-RA_2 CG15286 CGGCCAACATCGGTAACAATACACGGAGCATAAATGTTTACGGACCCACATCCGCTTTTACCCAGGCGT 69 FBan0015286 FBgn0028531 CG15286 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15286 CG15286 BG:DS01068.11 CDMC29947 2 15 16 DAC26-F05 23-CG15335-RB_2 CG15335 AACTTTAGCAATATTATGCGTAGTTCTGTAACTTTTCGGTTGGTTGGAAAGGATCTTGAAAGCGTTTTG 69 FBan0015335 FBgn0030001 CG15335 X X CG15335 CG15335 "CG15338, CG15338" CDMC29947 2 16 16 DAC26-F05 23-CG15335-RB_2 CG15335 AACTTTAGCAATATTATGCGTAGTTCTGTAACTTTTCGGTTGGTTGGAAAGGATCTTGAAAGCGTTTTG 69 FBan0015335 FBgn0030001 CG15335 X X CG15335 CG15335 "CG15338, CG15338" CDMC29948 2 17 16 DAC26-F17 24-CG15353-RA_1 CG15353 ACATGGACAAGCAGTTTGATTTACTTTATACAAAAACTTTGGTATATATTTCATTTCTGAAGAACAATA 69 FBan0015353 FBgn0040718 CG15353 2 2L CG15353 CG15353 BcDNA:RH63135 CDMC29948 2 18 16 DAC26-F17 24-CG15353-RA_1 CG15353 ACATGGACAAGCAGTTTGATTTACTTTATACAAAAACTTTGGTATATATTTCATTTCTGAAGAACAATA 69 FBan0015353 FBgn0040718 CG15353 2 2L CG15353 CG15353 BcDNA:RH63135 CDMC29949 2 19 16 DAC26-J05 15-CG1539-RB_13 CG1539 CGCGGCCATAGAGAAGAGCAAAACCCTGAGAGTATTAAATGTCGAGACCAACTTTATCAGTCCGCCCGT 69 FBan0031020 FBgn0011716 spdo 3 3R Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; peripheral nervous system development; GO:0007422 protein binding; GO:0005515; Notch binding; GO:0005112; ; GO:0005515; ; GO:0005112 cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886 spdo sanpodo "CG31020, CG31020, CG31020, CG31020, CG31020, 0970/02, 1309/10, l(3)00848, Tmod, BcDNA:RE23355" CDMC29949 2 20 16 DAC26-J05 15-CG1539-RB_13 CG1539 CGCGGCCATAGAGAAGAGCAAAACCCTGAGAGTATTAAATGTCGAGACCAACTTTATCAGTCCGCCCGT 69 FBan0031020 FBgn0011716 spdo 3 3R Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; peripheral nervous system development; GO:0007422 protein binding; GO:0005515; Notch binding; GO:0005112; ; GO:0005515; ; GO:0005112 cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886 spdo sanpodo "CG31020, CG31020, CG31020, CG31020, CG31020, 0970/02, 1309/10, l(3)00848, Tmod, BcDNA:RE23355" CDMC29950 2 21 16 DAC26-J17 2-CG15418-RA_1 CG15418 GGTCACCAGTTGCGATATGCCTACAACAAGAAGACCGGAAACTGCGAGAGCTTCATCTACACGGGCTGT 69 FBan0015418 FBgn0031554 CG15418 2 2L endopeptidase inhibitor activity; GO:0004866; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004866 CG15418 CG15418 CDMC29950 2 22 16 DAC26-J17 2-CG15418-RA_1 CG15418 GGTCACCAGTTGCGATATGCCTACAACAAGAAGACCGGAAACTGCGAGAGCTTCATCTACACGGGCTGT 69 FBan0015418 FBgn0031554 CG15418 2 2L endopeptidase inhibitor activity; GO:0004866; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004866 CG15418 CG15418 CDMC29951 2 23 16 DAC26-N05 2-CG1545-RA_3 CG1545 GCATCGCAATGCTGGAAAAAGCACAATTCCGGCTCGATCCAAACGCCAGATGGAGAATTTAAGCGACCC 69 FBan0001545 FBgn0030259 CG1545 X X CG1545 CG1545 "BcDNA:GH01560, anon-EST:Posey256" CDMC29951 2 24 16 DAC26-N05 2-CG1545-RA_3 CG1545 GCATCGCAATGCTGGAAAAAGCACAATTCCGGCTCGATCCAAACGCCAGATGGAGAATTTAAGCGACCC 69 FBan0001545 FBgn0030259 CG1545 X X CG1545 CG1545 "BcDNA:GH01560, anon-EST:Posey256" CDMC29952 2 25 16 DAC26-N17 2-CG15468-RA_3 CG15468 GGGAGGAGAGCAGATGATTTCGCCAGGCTATCAGAGGTTAGGCCCTTCCTTGGATCGAGTACCAGATGA 69 FBgn0029739 CDMC29952 2 26 16 DAC26-N17 2-CG15468-RA_3 CG15468 GGGAGGAGAGCAGATGATTTCGCCAGGCTATCAGAGGTTAGGCCCTTCCTTGGATCGAGTACCAGATGA 69 FBgn0029739 CDMC29953 2 1 17 DAC27-B05 23-CG9742-RA_3 CG9742 CGTTAGCCGTAGTGCTTAGTCTTAAGGCTCCGTAACATTCATAGTCAGAAGAAACACACAAACTCTTGA 69 FBan0009742 FBgn0030765 CG9742 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; spliceosome assembly; GO:0000245" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG9742 CG9742 "BcDNA:RE61341, BcDNA:RH35475" CDMC29953 2 2 17 DAC27-B05 23-CG9742-RA_3 CG9742 CGTTAGCCGTAGTGCTTAGTCTTAAGGCTCCGTAACATTCATAGTCAGAAGAAACACACAAACTCTTGA 69 FBan0009742 FBgn0030765 CG9742 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; spliceosome assembly; GO:0000245" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG9742 CG9742 "BcDNA:RE61341, BcDNA:RH35475" CDMC29954 2 3 17 DAC27-B17 2-CG9755-RC_1 CG9755 ACGCACACTCGGTTGCATACACCCACACAATGAACGACTCTTCAGCCCATTCACGTTGCTTTTGCACTA 69 FBan0009755 FBgn0003165 pum 3 3R "cell fate determination; GO:0001709; cell migration; GO:0016477; dendrite morphogenesis; GO:0016358; determination of anterior/posterior axis, embryo; GO:0008595; germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; head involution; GO:0008258; long-term memory; GO:0007616; mRNA catabolism, deadenylylation-dependent decay; GO:0000288; mitosis; GO:0007067; negative regulation of progression through cell cycle; GO:0045786; negative regulation of transcription, DNA-dependent; GO:0045892; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole cell migration; GO:0007280; positive regulation of translation; GO:0045946; synaptic transmission; GO:0007268" "mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0000900; ; GO:0003729; ; GO:0003729" cytoplasm; GO:0005737 pum pumilio "CG9755, CG9763, CG9755, CG9755, CG9763, ova, ovarette, bem, bemused, pkl, pumuckel, ovt, l(3)01688, EP(3)0883, anon-WO0172774.19, fs(3)02003, pumilio" CDMC29954 2 4 17 DAC27-B17 2-CG9755-RC_1 CG9755 ACGCACACTCGGTTGCATACACCCACACAATGAACGACTCTTCAGCCCATTCACGTTGCTTTTGCACTA 69 FBan0009755 FBgn0003165 pum 3 3R "cell fate determination; GO:0001709; cell migration; GO:0016477; dendrite morphogenesis; GO:0016358; determination of anterior/posterior axis, embryo; GO:0008595; germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; head involution; GO:0008258; long-term memory; GO:0007616; mRNA catabolism, deadenylylation-dependent decay; GO:0000288; mitosis; GO:0007067; negative regulation of progression through cell cycle; GO:0045786; negative regulation of transcription, DNA-dependent; GO:0045892; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole cell migration; GO:0007280; positive regulation of translation; GO:0045946; synaptic transmission; GO:0007268" "mRNA binding; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0000900; ; GO:0003729; ; GO:0003729" cytoplasm; GO:0005737 pum pumilio "CG9755, CG9763, CG9755, CG9755, CG9763, ova, ovarette, bem, bemused, pkl, pumuckel, ovt, l(3)01688, EP(3)0883, anon-WO0172774.19, fs(3)02003, pumilio" CDMC29955 2 5 17 DAC27-F05 8-CG9793-RA_1 CG9793 TGCGTCCTGCCAAACTTGTTTGCAACAAGCCATATCCTTTAGGGAACGCTGTTTGGAAGTCCAAAGGGA 69 FBan0009793 FBgn0037620 CG9793 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9793 CG9793 CDMC29955 2 6 17 DAC27-F05 8-CG9793-RA_1 CG9793 TGCGTCCTGCCAAACTTGTTTGCAACAAGCCATATCCTTTAGGGAACGCTGTTTGGAAGTCCAAAGGGA 69 FBan0009793 FBgn0037620 CG9793 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9793 CG9793 CDMC29956 2 7 17 DAC27-F17 6-CG9805-RA_1 CG9805 CCGGACCGGGATGAATTCCTTGAGGCCCTTAAAAAAGAACGTGCCTCCCTCTACGTCGAAAAGCTCAAA 69 FBan0009805 FBgn0037249 eIF3-S10 3 3R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S10 eIF3-S10 "CG9805, CG9805, CG9805, MMAP140, anon-WO0118547.261" CDMC29956 2 8 17 DAC27-F17 6-CG9805-RA_1 CG9805 CCGGACCGGGATGAATTCCTTGAGGCCCTTAAAAAAGAACGTGCCTCCCTCTACGTCGAAAAGCTCAAA 69 FBan0009805 FBgn0037249 eIF3-S10 3 3R regulation of translation; GO:0006445; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 3 complex; GO:0005852 eIF3-S10 eIF3-S10 "CG9805, CG9805, CG9805, MMAP140, anon-WO0118547.261" CDMC29957 2 9 17 DAC27-J05 3-CG9853-RA_1 CG9853 CGCGACACGTCTTTTCTAAAGTACGTAGCCAAGATTGGGGTGCTGTATTTCGACGAGCATCCGGAGGCT 69 FBan0009853 FBgn0037243 CG9853 3 3R CG9853 CG9853 BEST:LD21829 CDMC29957 2 10 17 DAC27-J05 3-CG9853-RA_1 CG9853 CGCGACACGTCTTTTCTAAAGTACGTAGCCAAGATTGGGGTGCTGTATTTCGACGAGCATCCGGAGGCT 69 FBan0009853 FBgn0037243 CG9853 3 3R CG9853 CG9853 BEST:LD21829 CDMC29958 2 11 17 DAC27-J17 2-CG9870-RA_1 CG9870 GCAGCTGTCATGGATATGGGAATTGGGCTTTTTGTGGTGACCATGGGATTGGTTTCACATCGAGCACGG 69 FBan0009870 FBgn0031422 CG9870 2 2L CG9870 CG9870 CDMC29958 2 12 17 DAC27-J17 2-CG9870-RA_1 CG9870 GCAGCTGTCATGGATATGGGAATTGGGCTTTTTGTGGTGACCATGGGATTGGTTTCACATCGAGCACGG 69 FBan0009870 FBgn0031422 CG9870 2 2L CG9870 CG9870 CDMC29959 2 13 17 DAC27-N05 11-CG9902-RA_1 CG9902 GCAAGGAAGAGCTAGAGAATGTGGTTAGCGGGCCCAACGACATGATAGAGTGCAGCTCGATTATAGCCA 69 FBan0009902 FBgn0030757 CG9902 X X CG9902 CG9902 CDMC29959 2 14 17 DAC27-N05 11-CG9902-RA_1 CG9902 GCAAGGAAGAGCTAGAGAATGTGGTTAGCGGGCCCAACGACATGATAGAGTGCAGCTCGATTATAGCCA 69 FBan0009902 FBgn0030757 CG9902 X X CG9902 CG9902 CDMC29960 2 15 17 DAC27-N17 14-CG9919-RA_1 CG9919 ACCCGGGCTAACAGGATTACAACTGCTTGAATCGTAGCTCATTTTAAGCCCACTATGGATTGCATCCGC 69 FBan0009919 FBgn0030742 CG9919 X X CG9919 CG9919 CDMC29960 2 16 17 DAC27-N17 14-CG9919-RA_1 CG9919 ACCCGGGCTAACAGGATTACAACTGCTTGAATCGTAGCTCATTTTAAGCCCACTATGGATTGCATCCGC 69 FBan0009919 FBgn0030742 CG9919 X X CG9919 CG9919 CDMC29961 2 17 17 DAC28-B05 2-CG11768-RA_1 CG11768 GACTGATCACTGGGAGCACGTTACATGGGACCGCAACAGCCTTGATCGCTACTCCAATCGATCGG 65 FBan0011768 FBgn0037625 CG11768 3 3R CG11768 CG11768 CDMC29961 2 18 17 DAC28-B05 2-CG11768-RA_1 CG11768 GACTGATCACTGGGAGCACGTTACATGGGACCGCAACAGCCTTGATCGCTACTCCAATCGATCGG 65 FBan0011768 FBgn0037625 CG11768 3 3R CG11768 CG11768 CDMC29962 2 19 17 DAC28-B17 23-CG11816-RA_5 CG11816 TTGGGACACCTATTGAGCAAATATGGCCATTGTACGAGGATCAATTGGTTGTATTTCCGCAAATG 65 FBan0011816 FBgn0030495 CG11816 X X CG11816 CG11816 CDMC29962 2 20 17 DAC28-B17 23-CG11816-RA_5 CG11816 TTGGGACACCTATTGAGCAAATATGGCCATTGTACGAGGATCAATTGGTTGTATTTCCGCAAATG 65 FBan0011816 FBgn0030495 CG11816 X X CG11816 CG11816 CDMC29963 2 21 17 DAC28-F05 3-CG11911-RA_1 CG11911 AACAAGTCCATGAGGGAGAGACCCACCTGTACGGTTGGGGACAGCCAAAGTCCTACATCTTCTCG 65 FBan0011911 FBgn0031249 CG11911 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG11911 CG11911 SP103 CDMC29963 2 22 17 DAC28-F05 3-CG11911-RA_1 CG11911 AACAAGTCCATGAGGGAGAGACCCACCTGTACGGTTGGGGACAGCCAAAGTCCTACATCTTCTCG 65 FBan0011911 FBgn0031249 CG11911 2 2L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG11911 CG11911 SP103 CDMC29964 2 23 17 DAC28-F17 2-CG11970-RA_2 CG11970 CCAGACGACCAAGCAGTTACCCACGATGACACGAATTGTGAGTGCCACCAGTACTACTCCGGCAA 65 FBan0011970 FBgn0027503 CG11970 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11970 CG11970 BcDNA:LD23876 CDMC29964 2 24 17 DAC28-F17 2-CG11970-RA_2 CG11970 CCAGACGACCAAGCAGTTACCCACGATGACACGAATTGTGAGTGCCACCAGTACTACTCCGGCAA 65 FBan0011970 FBgn0027503 CG11970 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11970 CG11970 BcDNA:LD23876 CDMC29965 2 25 17 DAC28-J05 2-CG12058-RA_1 CG12058 ATCGTCAGTGAGGCAAAGAGCAAGCTGTGGCGAGAAAATCACCCACAAAATCAGCAGCACCCTCA 65 FBan0012058 FBgn0005639 mxc X X RNA export from nucleus; GO:0006405; RNA processing; GO:0006396; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097 mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 mxc multi sex combs "CG12058, CG12058, l(1)mbn: lethal(1)malignant blood neoplasm, lethal(1)malignant blood neoplasm, l(1)mbn" CDMC29965 2 26 17 DAC28-J05 2-CG12058-RA_1 CG12058 ATCGTCAGTGAGGCAAAGAGCAAGCTGTGGCGAGAAAATCACCCACAAAATCAGCAGCACCCTCA 65 FBan0012058 FBgn0005639 mxc X X RNA export from nucleus; GO:0006405; RNA processing; GO:0006396; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097 mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634; ribonucleoprotein complex; GO:0030529 mxc multi sex combs "CG12058, CG12058, l(1)mbn: lethal(1)malignant blood neoplasm, lethal(1)malignant blood neoplasm, l(1)mbn" CDMC29966 2 1 18 DAC28-J17 3-CG12099-RB_4 CG12099 GAGCGTAACGAACTGCTAGCCGAATCGGATGTCTCCTGTCCCGAGGATGTGTTCATCCAGCAAGC 65 FBan0012099 FBgn0035232 CG12099 3 3L CG12099 CG12099 CDMC29966 2 2 18 DAC28-J17 3-CG12099-RB_4 CG12099 GAGCGTAACGAACTGCTAGCCGAATCGGATGTCTCCTGTCCCGAGGATGTGTTCATCCAGCAAGC 65 FBan0012099 FBgn0035232 CG12099 3 3L CG12099 CG12099 CDMC29967 2 3 18 DAC28-N05 4-CG12159-RA_1 CG12159 GAGGTCTTCCCGTGGATGATGTTCATGTTGAACGCTCTCCCATGTCCCCCGATGTGGACTTTCCG 65 FBan0012159 FBgn0033232 CG12159 2 2R CG12159 CG12159 CDMC29967 2 4 18 DAC28-N05 4-CG12159-RA_1 CG12159 GAGGTCTTCCCGTGGATGATGTTCATGTTGAACGCTCTCCCATGTCCCCCGATGTGGACTTTCCG 65 FBan0012159 FBgn0033232 CG12159 2 2R CG12159 CG12159 CDMC29968 2 5 18 DAC28-N17 3-CG12182-RA_5 CG12182 TTAGCCTGCAGATGCAATCGATAGCCATGGGTGTCCTTCAGGATTTCCAGGTGATGGGACTGTGC 65 FBan0012182 FBgn0028504 CG12182 3 3L CG12182 CG12182 BcDNA:GH02340 CDMC29968 2 6 18 DAC28-N17 3-CG12182-RA_5 CG12182 TTAGCCTGCAGATGCAATCGATAGCCATGGGTGTCCTTCAGGATTTCCAGGTGATGGGACTGTGC 65 FBan0012182 FBgn0028504 CG12182 3 3L CG12182 CG12182 BcDNA:GH02340 CDMC29969 2 7 18 DAC29-B05 23-CG3068-RA_1 CG3068 CCAATATCGGCTTTCATTGTTAACTGACCAAAATTGTAATCTGTTCTGTTAGTTGTCGAGTGCCTGTGC 69 FBan0003068 FBgn0000147 aur 3 3R asymmetric protein localization during cell fate commitment; GO:0045167; centrosome cycle; GO:0007098; chromosome segregation; GO:0007059; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 centrosome; GO:0005813 aur aurora "CG3068, CG3068, CG3068, l(3)ck10, ck10, 87A7-9/2, l(3)87Ac, ck[10], aurA, auroraA, Aurora A kinase, AuroraA, aurora-A, Aurora-A, A-type Aurora kinase, aurora A, early-A, fruhe2" CDMC29969 2 8 18 DAC29-B05 23-CG3068-RA_1 CG3068 CCAATATCGGCTTTCATTGTTAACTGACCAAAATTGTAATCTGTTCTGTTAGTTGTCGAGTGCCTGTGC 69 FBan0003068 FBgn0000147 aur 3 3R asymmetric protein localization during cell fate commitment; GO:0045167; centrosome cycle; GO:0007098; chromosome segregation; GO:0007059; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067; mitotic centrosome separation; GO:0007100; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 centrosome; GO:0005813 aur aurora "CG3068, CG3068, CG3068, l(3)ck10, ck10, 87A7-9/2, l(3)87Ac, ck[10], aurA, auroraA, Aurora A kinase, AuroraA, aurora-A, Aurora-A, A-type Aurora kinase, aurora A, early-A, fruhe2" CDMC29970 2 9 18 DAC29-B17 9-CG3082-RC_1 CG3082 CGCCGAGACTATTCGATTCCTGGAGAACAACAAGTCGTACGAACCCATTGTGATGCATGGCTTCTCCGT 69 FBan0003082 FBgn0021979 l(2)k09913 2 2R l(2)k09913 lethal (2) k09913 CG3082 CDMC29970 2 10 18 DAC29-B17 9-CG3082-RC_1 CG3082 CGCCGAGACTATTCGATTCCTGGAGAACAACAAGTCGTACGAACCCATTGTGATGCATGGCTTCTCCGT 69 FBan0003082 FBgn0021979 l(2)k09913 2 2R l(2)k09913 lethal (2) k09913 CG3082 CDMC29971 2 11 18 DAC29-F05 23-CG31012-RB_18 CG31012 GTTTGAGCCTAGTTGAATCGCCTTTTAGCTAGCTTTTGAATACTTGATTTTTAGCGTCTGCTGAACTCT 69 FBan0031012 FBgn0027598 CG31012 3 3R receptor binding; GO:0005102; ; GO:0005102; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31012 CG31012 "CG11316, CG1408, CG11316, BcDNA:GH03163" CDMC29971 2 12 18 DAC29-F05 23-CG31012-RB_18 CG31012 GTTTGAGCCTAGTTGAATCGCCTTTTAGCTAGCTTTTGAATACTTGATTTTTAGCGTCTGCTGAACTCT 69 FBan0031012 FBgn0027598 CG31012 3 3R receptor binding; GO:0005102; ; GO:0005102; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31012 CG31012 "CG11316, CG1408, CG11316, BcDNA:GH03163" CDMC29972 2 13 18 DAC29-F17 14-CG31018-RA_1 CG31018 TGGCGCTTGAAACTGTTGAGTTTGCTCTGAAGTCAAATCCACGCAATGCACAGTTGATCAGGATGCAAA 69 FBgn0051018 CG31018 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31018 CG31018 CDMC29972 2 14 18 DAC29-F17 14-CG31018-RA_1 CG31018 TGGCGCTTGAAACTGTTGAGTTTGCTCTGAAGTCAAATCCACGCAATGCACAGTTGATCAGGATGCAAA 69 FBgn0051018 CG31018 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31018 CG31018 CDMC29973 2 15 18 DAC29-J05 12-CG31051-RA_1 CG31051 CCAGCAGAACCACGAACTGACTGACACCTTCAGCATACAGGAGATGACCATTGACTCGGATCTGGAGTC 69 FBan0031051 FBgn0051051 CG31051 3 3R CG31051 CG31051 "CG1540, CT3186" CDMC29973 2 16 18 DAC29-J05 12-CG31051-RA_1 CG31051 CCAGCAGAACCACGAACTGACTGACACCTTCAGCATACAGGAGATGACCATTGACTCGGATCTGGAGTC 69 FBan0031051 FBgn0051051 CG31051 3 3R CG31051 CG31051 "CG1540, CT3186" CDMC29974 2 17 18 DAC29-J17 13-CG31059-RA_1 CG31059 GGCCATGGGTCCTTTTGTCAGCACGCTATTGAAGATCTTAACCGAGTTCGTCATGATAATGCAGCAGCT 69 FBan0031059 FBgn0046887 Gr98b 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98b Gustatory receptor 98b "CG12884, CG31059, CG12884, 98B.2, Gustatory receptor 98B.2, Gr98A1, Gr98B2, GR98B.2, Gustatory receptor 98b" CDMC29974 2 18 18 DAC29-J17 13-CG31059-RA_1 CG31059 GGCCATGGGTCCTTTTGTCAGCACGCTATTGAAGATCTTAACCGAGTTCGTCATGATAATGCAGCAGCT 69 FBan0031059 FBgn0046887 Gr98b 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr98b Gustatory receptor 98b "CG12884, CG31059, CG12884, 98B.2, Gustatory receptor 98B.2, Gr98A1, Gr98B2, GR98B.2, Gustatory receptor 98b" CDMC29975 2 19 18 DAC29-N05 17-CG31087-RA_3 CG31087 GGCCAAGTTGAAGCTCTTCCAAAAGGAGGAACAGATGTACCATAGCATTCTGCCCAAATTCGAGAAGCT 69 FBan0031087 FBgn0051087 CG31087 3 3R CG31087 CG31087 CG10551 CDMC29975 2 20 18 DAC29-N05 17-CG31087-RA_3 CG31087 GGCCAAGTTGAAGCTCTTCCAAAAGGAGGAACAGATGTACCATAGCATTCTGCCCAAATTCGAGAAGCT 69 FBan0031087 FBgn0051087 CG31087 3 3R CG31087 CG31087 CG10551 CDMC29976 2 21 18 DAC29-N17 23-CG31094-RB_1 CG31094 ACACGCCTGAAGACTGAGCAACTCTGTGTATTGTGTAAATTAATTATTTTAAAATTTTAAGGCACGGCA 69 FBgn0039363 CDMC29976 2 22 18 DAC29-N17 23-CG31094-RB_1 CG31094 ACACGCCTGAAGACTGAGCAACTCTGTGTATTGTGTAAATTAATTATTTTAAAATTTTAAGGCACGGCA 69 FBgn0039363 CDMC29977 2 23 18 DAC30-B05 2-CG1961-RA_1 CG1961 AAGTACGACTACACGAAGCCGGTGGGATCGCGTGTCATATCCGTAACGATTCGTTGTGCGGACTG 65 FBan0001961 FBgn0030264 CG1961 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; nucleotide phosphatase activity; GO:0019204; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0019204; ; GO:0008253 ; EC:3.1.3.5; ; GO:0008081 ; EC:3.1.4.- CG1961 CG1961 CDMC29977 2 24 18 DAC30-B05 2-CG1961-RA_1 CG1961 AAGTACGACTACACGAAGCCGGTGGGATCGCGTGTCATATCCGTAACGATTCGTTGTGCGGACTG 65 FBan0001961 FBgn0030264 CG1961 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; nucleotide phosphatase activity; GO:0019204; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0019204; ; GO:0008253 ; EC:3.1.3.5; ; GO:0008081 ; EC:3.1.4.- CG1961 CG1961 CDMC29978 2 25 18 DAC30-B17 2-CG1983-RA_1 CG1983 CAATGGACCCAATCCGGATTTCGTGTCCCTAATGCAGGTGCACAGATCCATATGTGAGGCGCACT 65 FBan0001983 FBgn0039751 CG1983 3 3R CG1983 CG1983 CDMC29978 2 26 18 DAC30-B17 2-CG1983-RA_1 CG1983 CAATGGACCCAATCCGGATTTCGTGTCCCTAATGCAGGTGCACAGATCCATATGTGAGGCGCACT 65 FBan0001983 FBgn0039751 CG1983 3 3R CG1983 CG1983 CDMC29979 2 1 19 DAC30-F05 8-CG2147-RA_1 CG2147 TCGGCGGATTCTCAGAGCTGCAAATTAAACAATAGTCGTCCACGCCTAGATCTTCGCAAGCGCGT 65 FBan0002147 FBgn0030025 CG2147 X X CG2147 CG2147 BcDNA:LP02728 CDMC29979 2 2 19 DAC30-F05 8-CG2147-RA_1 CG2147 TCGGCGGATTCTCAGAGCTGCAAATTAAACAATAGTCGTCCACGCCTAGATCTTCGCAAGCGCGT 65 FBan0002147 FBgn0030025 CG2147 X X CG2147 CG2147 BcDNA:LP02728 CDMC29980 2 3 19 DAC30-F17 3-CG2187-RA_2 CG2187 GAAGTTCCTCTCCCTGCCTGTTACGGATCAGGATCTTGAGGAGGTGCCACTTCGAGGATCCAAGG 65 FBan0002187 FBgn0017448 CG2187 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG2187 CG2187 "D3-100EF, anon-100EF-D3" CDMC29980 2 4 19 DAC30-F17 3-CG2187-RA_2 CG2187 GAAGTTCCTCTCCCTGCCTGTTACGGATCAGGATCTTGAGGAGGTGCCACTTCGAGGATCCAAGG 65 FBan0002187 FBgn0017448 CG2187 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG2187 CG2187 "D3-100EF, anon-100EF-D3" CDMC29981 2 5 19 DAC30-J05 2-CG2341-RA_1 CG2341 GATCCCCATCCCCAGTACAAGTACGCCTACGATGTTCAGGACTCCCTCTCCGGAGACTCCAAGAG 65 FBan0002341 FBgn0004780 Ccp84Ad 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ad Ccp84Ad "CG2341, BG:DS00004.4, cc5: cuticle cluster 5, cuticle cluster 5" CDMC29981 2 6 19 DAC30-J05 2-CG2341-RA_1 CG2341 GATCCCCATCCCCAGTACAAGTACGCCTACGATGTTCAGGACTCCCTCTCCGGAGACTCCAAGAG 65 FBan0002341 FBgn0004780 Ccp84Ad 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ad Ccp84Ad "CG2341, BG:DS00004.4, cc5: cuticle cluster 5, cuticle cluster 5" CDMC29982 2 7 19 DAC30-J17 1-CG2543-RA_3 CG2543 CTTGACGGAATCTCTGCTTCGCCATCAAGGTTTCCGCACGGGATTCTTCAGTTCTCCCCACATCC 65 FBan0002543 FBgn0030407 CG2543 X X tetrahydrofolylpolyglutamate biosynthesis; GO:0046901 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG2543 CG2543 CDMC29982 2 8 19 DAC30-J17 1-CG2543-RA_3 CG2543 CTTGACGGAATCTCTGCTTCGCCATCAAGGTTTCCGCACGGGATTCTTCAGTTCTCCCCACATCC 65 FBan0002543 FBgn0030407 CG2543 X X tetrahydrofolylpolyglutamate biosynthesis; GO:0046901 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG2543 CG2543 CDMC29983 2 9 19 DAC30-N05 18-CG2864-RA_1 CG2864 GCAACAGCAGCACAACGTCCAAAACGAGCAGTACAGCCACGAAATCAATGGGTTCAGGTGGCCGC 65 FBan0002864 FBgn0023216 Parg X X carbohydrate metabolism; GO:0005975; glycolysis; GO:0006096 "poly(ADP-ribose) glycohydrolase activity; GO:0004649 ; EC:3.2.1.143; ; GO:0004649 ; EC:3.2.1.143; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004649 ; EC:3.2.1.143; ; GO:0004649 ; EC:3.2.1.143" cellular component unknown; GO:0008372 Parg Poly(ADP-ribose) glycohydrolase "CG2864, PARG, Poly(ADPribose) glyco-hydrolase, poly(ADP-ribose) glycohydrolase, EG:114E2.1" CDMC29983 2 10 19 DAC30-N05 18-CG2864-RA_1 CG2864 GCAACAGCAGCACAACGTCCAAAACGAGCAGTACAGCCACGAAATCAATGGGTTCAGGTGGCCGC 65 FBan0002864 FBgn0023216 Parg X X carbohydrate metabolism; GO:0005975; glycolysis; GO:0006096 "poly(ADP-ribose) glycohydrolase activity; GO:0004649 ; EC:3.2.1.143; ; GO:0004649 ; EC:3.2.1.143; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004649 ; EC:3.2.1.143; ; GO:0004649 ; EC:3.2.1.143" cellular component unknown; GO:0008372 Parg Poly(ADP-ribose) glycohydrolase "CG2864, PARG, Poly(ADPribose) glyco-hydrolase, poly(ADP-ribose) glycohydrolase, EG:114E2.1" CDMC29984 2 11 19 DAC30-N17 3-CG2914-RA_2 CG2914 CAGTGCTTGGTGCCAACAGAGGCCGATTAATGCCATGCATCAGGATGTCCGGCAAAAAAGCATCG 65 FBan0002914 FBgn0005660 Ets21C 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Ets21C Ets at 21C "CG2914, D-Ets-6, ETS6, D-ets-6, Ets, ets21c, Ets6, ets21C" CDMC29984 2 12 19 DAC30-N17 3-CG2914-RA_2 CG2914 CAGTGCTTGGTGCCAACAGAGGCCGATTAATGCCATGCATCAGGATGTCCGGCAAAAAAGCATCG 65 FBan0002914 FBgn0005660 Ets21C 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Ets21C Ets at 21C "CG2914, D-Ets-6, ETS6, D-ets-6, Ets, ets21c, Ets6, ets21C" CDMC29985 2 13 19 DAC31-B05 2-CG31697-RA_1 CG31697 TTGGTGGATGAAAATCTGAACGAAGGTGGTCGCGAGTCGCTAAGGGAGACGATATACACCACGACCGC 68 FBan0031697 FBgn0051697 CG31697 2 2L CG31697 CG31697 "CG10355, CG10355" CDMC29985 2 14 19 DAC31-B05 2-CG31697-RA_1 CG31697 TTGGTGGATGAAAATCTGAACGAAGGTGGTCGCGAGTCGCTAAGGGAGACGATATACACCACGACCGC 68 FBan0031697 FBgn0051697 CG31697 2 2L CG31697 CG31697 "CG10355, CG10355" CDMC29986 2 15 19 DAC31-B17 2-CG31785-RA_1 CG31785 TTCCAGCTCTTCGTCTTCTACAGACAGCTCATCAGACTTCGCCACGCATTCGACTGCTTGGTCAGGTC 68 FBan0031785 FBgn0051785 CG31785 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31785 CG31785 CDMC29986 2 16 19 DAC31-B17 2-CG31785-RA_1 CG31785 TTCCAGCTCTTCGTCTTCTACAGACAGCTCATCAGACTTCGCCACGCATTCGACTGCTTGGTCAGGTC 68 FBan0031785 FBgn0051785 CG31785 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31785 CG31785 CDMC29987 2 17 19 DAC31-F05 2-CG32158-RC_1 CG32158 TGCCTGGTTCCTTCAGTGGGAGAACATTTCTGCCCACGTTTTCCCCATTATTCTGGCCCTTTTTCTGG 68 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC29987 2 18 19 DAC31-F05 2-CG32158-RC_1 CG32158 TGCCTGGTTCCTTCAGTGGGAGAACATTTCTGCCCACGTTTTCCCCATTATTCTGGCCCTTTTTCTGG 68 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC29988 2 19 19 DAC31-F17 2-CG32302-RA_2 CG32302 AGTCCCACACGTGCATGAACAACGATAGGTACCAATGCCCCTTCCGAACCTCTGAGATCGAGTACTGC 68 FBan0032302 FBgn0052302 CG32302 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32302 CG32302 "CG13805, CG13805, CG13805" CDMC29988 2 20 19 DAC31-F17 2-CG32302-RA_2 CG32302 AGTCCCACACGTGCATGAACAACGATAGGTACCAATGCCCCTTCCGAACCTCTGAGATCGAGTACTGC 68 FBan0032302 FBgn0052302 CG32302 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32302 CG32302 "CG13805, CG13805, CG13805" CDMC29989 2 21 19 DAC31-J05 17-CG32694-RB_1 CG32694 AGCAGGAGCAGATGAAACGAAAGGTGATGAAAGCCCAATCAACAATCAAGCATCTTCATCCCCAACAA 68 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC29989 2 22 19 DAC31-J05 17-CG32694-RB_1 CG32694 AGCAGGAGCAGATGAAACGAAAGGTGATGAAAGCCCAATCAACAATCAAGCATCTTCATCCCCAACAA 68 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC29990 2 23 19 DAC31-J17 3-CG33083-RA_4 CG33083 GGCCAATATGCTGCAGTCACCTGTCCAGATGAATCTCCATAAGCCCTACTACCGGATGCGTCGCTTCT 68 FBan0033083 FBgn0041224 Gr97a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr97a Gustatory receptor 97a "CG33083, CG31073, CG31074, CG33083, 97D.1, Gustatory receptor 97D.1, Gr97D1, GR97D.1, Gustatory receptor 97a" CDMC29990 2 24 19 DAC31-J17 3-CG33083-RA_4 CG33083 GGCCAATATGCTGCAGTCACCTGTCCAGATGAATCTCCATAAGCCCTACTACCGGATGCGTCGCTTCT 68 FBan0033083 FBgn0041224 Gr97a 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr97a Gustatory receptor 97a "CG33083, CG31073, CG31074, CG33083, 97D.1, Gustatory receptor 97D.1, Gr97D1, GR97D.1, Gustatory receptor 97a" CDMC29991 2 25 19 DAC31-N05 9-CG3415-RA_1 CG3415 GCGCCTATGTCGACCTGAAGAGCTCACAGGCCAAGCTGTAAGCGCGGATCACCTAGAGACACATAGTC 68 FBan0003415 FBgn0030731 CG3415 X X fatty acid biosynthesis; GO:0006633; proteolysis; GO:0006508; steroid metabolism; GO:0008202 estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004303 ; EC:1.1.1.62; ; GO:0004197 ; EC:3.4.22.- CG3415 CG3415 CDMC29991 2 26 19 DAC31-N05 9-CG3415-RA_1 CG3415 GCGCCTATGTCGACCTGAAGAGCTCACAGGCCAAGCTGTAAGCGCGGATCACCTAGAGACACATAGTC 68 FBan0003415 FBgn0030731 CG3415 X X fatty acid biosynthesis; GO:0006633; proteolysis; GO:0006508; steroid metabolism; GO:0008202 estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004303 ; EC:1.1.1.62; ; GO:0004197 ; EC:3.4.22.- CG3415 CG3415 CDMC29992 2 1 20 DAC31-N17 8-CG3536-RA_1 CG3536 TCTGCAGGTGAAGGTCATCAAATGGTTCGATTACCTGTGGCTTACGCAAAAATGCTCGGACGAGGAGC 68 FBan0003536 FBgn0034775 CG3536 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception of smell; GO:0007608; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 membrane; GO:0016020 CG3536 CG3536 CDMC29992 2 2 20 DAC31-N17 8-CG3536-RA_1 CG3536 TCTGCAGGTGAAGGTCATCAAATGGTTCGATTACCTGTGGCTTACGCAAAAATGCTCGGACGAGGAGC 68 FBan0003536 FBgn0034775 CG3536 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception of smell; GO:0007608; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 membrane; GO:0016020 CG3536 CG3536 CDMC29993 2 3 20 DAC32-B05 23-CG15740-RA_4 CG15740 TGCGTTCCAATTCTGTTGTCAATGTTTCCAACTCATTTCGCATGAAATTTCTGTGCACAAAAACAAGCG 69 FBan0015740 FBgn0030340 CG15740 X X CG15740 CG15740 i175 CDMC29993 2 4 20 DAC32-B05 23-CG15740-RA_4 CG15740 TGCGTTCCAATTCTGTTGTCAATGTTTCCAACTCATTTCGCATGAAATTTCTGTGCACAAAAACAAGCG 69 FBan0015740 FBgn0030340 CG15740 X X CG15740 CG15740 i175 CDMC29994 2 5 20 DAC32-B17 8-CG15749-RA_1 CG15749 GCCCAAAAGAGGATCTACAAGCAGAGACTACGCAGTTTGCAGCAATCCACATTGCATATCACAGCCGCC 69 FBan0015749 FBgn0030477 dmrt11E X X "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt11E doublesex-Mab related 11E "CG15749, doublesex-Mab related 11E" CDMC29994 2 6 20 DAC32-B17 8-CG15749-RA_1 CG15749 GCCCAAAAGAGGATCTACAAGCAGAGACTACGCAGTTTGCAGCAATCCACATTGCATATCACAGCCGCC 69 FBan0015749 FBgn0030477 dmrt11E X X "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt11E doublesex-Mab related 11E "CG15749, doublesex-Mab related 11E" CDMC29995 2 7 20 DAC32-F05 15-CG15825-RB_1 CG15825 TCGATGACAACGGCAAGATTGGCACCCACAGTGTTCACTCGTAAAGCGTCTACATCAATCAGTACCCAT 69 FBan0015825 FBgn0032773 CG15825 2 2L CG15825 CG15825 CDMC29995 2 8 20 DAC32-F05 15-CG15825-RB_1 CG15825 TCGATGACAACGGCAAGATTGGCACCCACAGTGTTCACTCGTAAAGCGTCTACATCAATCAGTACCCAT 69 FBan0015825 FBgn0032773 CG15825 2 2L CG15825 CG15825 CDMC29996 2 9 20 DAC32-F17 23-CG15845-RB_16 CG15845 AACTACAGAATAACATTAGACGTAACATCCCACAGCGTAAACCATAACGCGTAATGATACTTCCCCACG 69 FBan0015845 FBgn0000054 Adf1 2 2R larval locomotory behavior; GO:0008345; learning and/or memory; GO:0007611; long-term memory; GO:0007616; memory; GO:0007613; olfactory learning; GO:0008355; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; synaptogenesis; GO:0007416 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251 nucleus; GO:0005634 Adf1 Adh transcription factor 1 "CG15845, CG15845, CG15845, Adf-1, l(2)01349, l(2)04065, nal, nalyot, adf1, Adf 1, naylot" CDMC29996 2 10 20 DAC32-F17 23-CG15845-RB_16 CG15845 AACTACAGAATAACATTAGACGTAACATCCCACAGCGTAAACCATAACGCGTAATGATACTTCCCCACG 69 FBan0015845 FBgn0000054 Adf1 2 2R larval locomotory behavior; GO:0008345; learning and/or memory; GO:0007611; long-term memory; GO:0007616; memory; GO:0007613; olfactory learning; GO:0008355; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; synaptogenesis; GO:0007416 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251 nucleus; GO:0005634 Adf1 Adh transcription factor 1 "CG15845, CG15845, CG15845, Adf-1, l(2)01349, l(2)04065, nal, nalyot, adf1, Adf 1, naylot" CDMC29997 2 11 20 DAC32-J05 12-CG15897-RA_1 CG15897 CACCGCCATTCATTCCCGAGGACTTGTCCGTTTGGTTTAAGAAGCGCTTCGACAACGTTAGCGACTATT 69 FBan0015897 FBgn0029857 CG15897 X X CG15897 CG15897 CDMC29997 2 12 20 DAC32-J05 12-CG15897-RA_1 CG15897 CACCGCCATTCATTCCCGAGGACTTGTCCGTTTGGTTTAAGAAGCGCTTCGACAACGTTAGCGACTATT 69 FBan0015897 FBgn0029857 CG15897 X X CG15897 CG15897 CDMC29998 2 13 20 DAC32-J17 3-CG15912-RA_4 CG15912 GCTTTGCCGGCAAATTCGATTTCATTCTGACTTCCTACGAAGCCGGTGTTATGAAGCCCGAACGCGGTA 69 FBan0015912 FBgn0029712 CG15912 X X CG15912 CG15912 CDMC29998 2 14 20 DAC32-J17 3-CG15912-RA_4 CG15912 GCTTTGCCGGCAAATTCGATTTCATTCTGACTTCCTACGAAGCCGGTGTTATGAAGCCCGAACGCGGTA 69 FBan0015912 FBgn0029712 CG15912 X X CG15912 CG15912 CDMC29999 2 15 20 DAC32-N05 2-CG1618-RA_1 CG1618 ACGATCCAGGCTTCGCGATGTTTGTTCGGTCCCAAAGCCCAGATAAAAATCACAATCCACATCCCGGAG 69 FBan0001618 FBgn0000346 comt X X ER to Golgi transport; GO:0006888; Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887 cytoplasm; GO:0005737 comt comatose "CG1618, CG1618, com, dNSF, Nsf: NEM-sensitive fusion protein, dNSF-1, NSF, dNSF1, N-ethylmaleimide-sensitive fusion protein, dNsf1, DmNSF, NSF1, dnsf1, NEM-sensitive fusion protein, Nsf" CDMC29999 2 16 20 DAC32-N05 2-CG1618-RA_1 CG1618 ACGATCCAGGCTTCGCGATGTTTGTTCGGTCCCAAAGCCCAGATAAAAATCACAATCCACATCCCGGAG 69 FBan0001618 FBgn0000346 comt X X ER to Golgi transport; GO:0006888; Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887 cytoplasm; GO:0005737 comt comatose "CG1618, CG1618, com, dNSF, Nsf: NEM-sensitive fusion protein, dNSF-1, NSF, dNSF1, N-ethylmaleimide-sensitive fusion protein, dNsf1, DmNSF, NSF1, dnsf1, NEM-sensitive fusion protein, Nsf" CDMC30000 2 17 20 DAC32-N17 23-CG1628-RB_1 CG1628 CCCGCAGTCTAAGAAGAAATACACAATTGGTACATTTAAATAGGTGCGTTTCGTATAAAAAGAGAAAGA 69 FBan0001628 FBgn0030218 CG1628 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial ornithine transport; GO:0000066 carrier activity; GO:0005386; ; GO:0005386; L-ornithine transporter activity; GO:0000064; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0000064; ; GO:0000064 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG1628 CG1628 CDMC30000 2 18 20 DAC32-N17 23-CG1628-RB_1 CG1628 CCCGCAGTCTAAGAAGAAATACACAATTGGTACATTTAAATAGGTGCGTTTCGTATAAAAAGAGAAAGA 69 FBan0001628 FBgn0030218 CG1628 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial ornithine transport; GO:0000066 carrier activity; GO:0005386; ; GO:0005386; L-ornithine transporter activity; GO:0000064; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0000064; ; GO:0000064 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG1628 CG1628 CDMC30001 2 19 20 DAC33-B05 17-CG11328-RA_3 CG11328 AGCCAATCACCTTGCAAACGAACTCAGCCTGGTTGCTAACAATTTCATGTAATCCAAAGAGTGGACCCT 69 FBan0011328 FBgn0028703 Nhe3 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe3 Nhe3 "CG11328, NHE3, DmNHE3" CDMC30001 2 20 20 DAC33-B05 17-CG11328-RA_3 CG11328 AGCCAATCACCTTGCAAACGAACTCAGCCTGGTTGCTAACAATTTCATGTAATCCAAAGAGTGGACCCT 69 FBan0011328 FBgn0028703 Nhe3 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe3 Nhe3 "CG11328, NHE3, DmNHE3" CDMC30002 2 21 20 DAC33-B17 21-CG11339-RA_1 CG11339 GCTAATCGCCTGCTCCACTACACGACCTTTGAGAACAACCAGTACAAGTTCAGTCTGAACAATGCGCTG 69 FBan0011339 FBgn0039841 CG11339 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 cytoskeleton; GO:0005856 CG11339 CG11339 CDMC30002 2 22 20 DAC33-B17 21-CG11339-RA_1 CG11339 GCTAATCGCCTGCTCCACTACACGACCTTTGAGAACAACCAGTACAAGTTCAGTCTGAACAATGCGCTG 69 FBan0011339 FBgn0039841 CG11339 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 cytoskeleton; GO:0005856 CG11339 CG11339 CDMC30003 2 23 20 DAC33-F05 3-CG11372-RA_1 CG11372 TGGTGTGTAGGAATGCCTGGCTTAATGGAGCTTGGGCACAAGAAGAGCGTTCGGAGTTTGACACAAACT 69 FBan0011372 FBgn0031213 galectin 2 2L induction of apoptosis; GO:0006917 galactoside binding; GO:0016936; receptor binding; GO:0005102; ; GO:0005102; ; GO:0016936; urate transporter activity; GO:0015143; ; GO:0015143; ; GO:0016936 cytosol; GO:0005829 galectin galectin "CG11372, CG11372, Dmgal" CDMC30003 2 24 20 DAC33-F05 3-CG11372-RA_1 CG11372 TGGTGTGTAGGAATGCCTGGCTTAATGGAGCTTGGGCACAAGAAGAGCGTTCGGAGTTTGACACAAACT 69 FBan0011372 FBgn0031213 galectin 2 2L induction of apoptosis; GO:0006917 galactoside binding; GO:0016936; receptor binding; GO:0005102; ; GO:0005102; ; GO:0016936; urate transporter activity; GO:0015143; ; GO:0015143; ; GO:0016936 cytosol; GO:0005829 galectin galectin "CG11372, CG11372, Dmgal" CDMC30004 2 25 20 DAC33-F17 2-CG1137-RA_1 CG1137 GCCCTCGACGAATACATGATTGGGTTCCTGAAGGTTGAGCGGGTCTACAAGCAGATCGTCGTAAAGCGA 69 FBan0001137 FBgn0037454 CG1137 3 3R peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- CG1137 CG1137 anon-WO0118547.86 CDMC30004 2 26 20 DAC33-F17 2-CG1137-RA_1 CG1137 GCCCTCGACGAATACATGATTGGGTTCCTGAAGGTTGAGCGGGTCTACAAGCAGATCGTCGTAAAGCGA 69 FBan0001137 FBgn0037454 CG1137 3 3R peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- CG1137 CG1137 anon-WO0118547.86 CDMC30005 2 1 21 DAC33-J05 1-CG11414-RA_1 CG11414 GGCGAGTCGTATGACATTGTACCCAGCCCCTATACGTACACCGATCCACCAGATACCGAGGTCAGGAAT 69 FBan0011414 FBgn0035024 CG11414 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG11414 CG11414 CDMC30005 2 2 21 DAC33-J05 1-CG11414-RA_1 CG11414 GGCGAGTCGTATGACATTGTACCCAGCCCCTATACGTACACCGATCCACCAGATACCGAGGTCAGGAAT 69 FBan0011414 FBgn0035024 CG11414 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG11414 CG11414 CDMC30006 2 3 21 DAC33-J17 22-CG11426-RA_1 CG11426 ACAGCTTCAGCGAGGATCAGTACTGCTCTAAGGTTTAGTGAGACGGATAAGATGCTTTCGTAGCGATGT 69 FBan0011426 FBgn0037166 CG11426 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11426 CG11426 "WUN-like, Css1beta" CDMC30006 2 4 21 DAC33-J17 22-CG11426-RA_1 CG11426 ACAGCTTCAGCGAGGATCAGTACTGCTCTAAGGTTTAGTGAGACGGATAAGATGCTTTCGTAGCGATGT 69 FBan0011426 FBgn0037166 CG11426 3 3L dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11426 CG11426 "WUN-like, Css1beta" CDMC30007 2 5 21 DAC33-N05 23-CG11473-RA_11 CG11473 GGGAAATCCCCGTGACTATACACTGAAACACAAAACAGGGACACACAATGATGCAATGCCATGAAGAAC 69 FBan0011473 FBgn0029779 CG11473 X X CG11473 CG11473 anon-WO0140519.181 CDMC30007 2 6 21 DAC33-N05 23-CG11473-RA_11 CG11473 GGGAAATCCCCGTGACTATACACTGAAACACAAAACAGGGACACACAATGATGCAATGCCATGAAGAAC 69 FBan0011473 FBgn0029779 CG11473 X X CG11473 CG11473 anon-WO0140519.181 CDMC30008 2 7 21 DAC33-N17 17-CG11489-RB_1 CG11489 GCCATAAAGAGGAGGTAGCAGGAAAATGGGATGAGGAGCTAGCATTAAAGGACTCGATCGAAGCACACA 69 FBan0011489 FBgn0025702 CG11489 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 CG11489 CG11489 "CG9085, CG9085, CG9085, CG9085, CG9085, CK01209, SRPK1, BEST:CK01209, SRPK" CDMC30008 2 8 21 DAC33-N17 17-CG11489-RB_1 CG11489 GCCATAAAGAGGAGGTAGCAGGAAAATGGGATGAGGAGCTAGCATTAAAGGACTCGATCGAAGCACACA 69 FBan0011489 FBgn0025702 CG11489 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 CG11489 CG11489 "CG9085, CG9085, CG9085, CG9085, CG9085, CK01209, SRPK1, BEST:CK01209, SRPK" CDMC30009 2 9 21 DAC34-B05 5-CG14468-RA_1 CG14468 GTGCGCGCTTTGACAATGGTTGCCTACATTTTGAACGCTGTTCTTGGGATTCACATGGCCCGACAAC 67 FBan0014468 FBgn0033042 Tsp42A 2 2R integral to membrane; GO:0016021 Tsp42A Tetraspanin 42A "CG14468, CG14468, CG14468, Dm.Tsp42A, Tetraspanin 42A" CDMC30009 2 10 21 DAC34-B05 5-CG14468-RA_1 CG14468 GTGCGCGCTTTGACAATGGTTGCCTACATTTTGAACGCTGTTCTTGGGATTCACATGGCCCGACAAC 67 FBan0014468 FBgn0033042 Tsp42A 2 2R integral to membrane; GO:0016021 Tsp42A Tetraspanin 42A "CG14468, CG14468, CG14468, Dm.Tsp42A, Tetraspanin 42A" CDMC30010 2 11 21 DAC34-B17 3-CG14607-RA_2 CG14607 ACCCACCGAGAAGAACTTCATCTGGCGGATTATCTACCCCATCATCTCGCAGTGGACCCTATGGACC 67 FBan0014607 FBgn0037488 CG14607 3 3R CG14607 CG14607 CDMC30010 2 12 21 DAC34-B17 3-CG14607-RA_2 CG14607 ACCCACCGAGAAGAACTTCATCTGGCGGATTATCTACCCCATCATCTCGCAGTGGACCCTATGGACC 67 FBan0014607 FBgn0037488 CG14607 3 3R CG14607 CG14607 CDMC30011 2 13 21 DAC34-F05 18-CG14974-RA_5 CG14974 TTGTGCATCTGGCAGATAATTGCTCCATAGAGAAACTGACGGTGAACGACTCCCTGGAGTATCTGCA 67 FBan0014974 FBgn0040694 CG14974 3 3L CG14974 CG14974 CDMC30011 2 14 21 DAC34-F05 18-CG14974-RA_5 CG14974 TTGTGCATCTGGCAGATAATTGCTCCATAGAGAAACTGACGGTGAACGACTCCCTGGAGTATCTGCA 67 FBan0014974 FBgn0040694 CG14974 3 3L CG14974 CG14974 CDMC30012 2 15 21 DAC34-F17 8-CG15036-RA_1 CG15036 TGAGGCAATCCATAAAGCACATATTCGCACTGTTGGTTGCCCTGGAGTGTTTAAGCCTTGGCGACAC 67 FBan0015036 FBgn0040922 CG15036 X X CG15036 CG15036 CDMC30012 2 16 21 DAC34-F17 8-CG15036-RA_1 CG15036 TGAGGCAATCCATAAAGCACATATTCGCACTGTTGGTTGCCCTGGAGTGTTTAAGCCTTGGCGACAC 67 FBan0015036 FBgn0040922 CG15036 X X CG15036 CG15036 CDMC30013 2 17 21 DAC34-J05 11-CG15579-RA_1 CG15579 TGGCGCGTTACCTGTACGCTGACCACATTTTGGAGGCCTTCAACGTATTCCATCGTCCACTCAACCT 67 FBan0015579 FBgn0040906 CG15579 X X CG15579 CG15579 CDMC30013 2 18 21 DAC34-J05 11-CG15579-RA_1 CG15579 TGGCGCGTTACCTGTACGCTGACCACATTTTGGAGGCCTTCAACGTATTCCATCGTCCACTCAACCT 67 FBan0015579 FBgn0040906 CG15579 X X CG15579 CG15579 CDMC30014 2 19 21 DAC34-J17 3-CG15635-RA_1 CG15635 GCCTGCTAGTTCCAAAATACGTCCTCCACCACCTTCTGAACCTCAAAACCCGGACAATGTGCCCAAG 67 FBan0015635 FBgn0031617 CG15635 2 2L DNA methylation; GO:0006306 DNA binding; GO:0003677; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG15635 CG15635 CDMC30014 2 20 21 DAC34-J17 3-CG15635-RA_1 CG15635 GCCTGCTAGTTCCAAAATACGTCCTCCACCACCTTCTGAACCTCAAAACCCGGACAATGTGCCCAAG 67 FBan0015635 FBgn0031617 CG15635 2 2L DNA methylation; GO:0006306 DNA binding; GO:0003677; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG15635 CG15635 CDMC30015 2 21 21 DAC34-N05 6-CG16725-RA_1 CG16725 CGCCTGGTACATGTCCGGCTATTATACGGGCCTCTACCAGGGAAAGAAAGAAGCCAGCACCACTAGC 67 FBan0016725 FBgn0036641 Smn 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 Smn survival motor neuron "CG16725, CG16725, l(3)73Ao, DmSMN, smn, dSMN, survival motor neuron" CDMC30015 2 22 21 DAC34-N05 6-CG16725-RA_1 CG16725 CGCCTGGTACATGTCCGGCTATTATACGGGCCTCTACCAGGGAAAGAAAGAAGCCAGCACCACTAGC 67 FBan0016725 FBgn0036641 Smn 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 Smn survival motor neuron "CG16725, CG16725, l(3)73Ao, DmSMN, smn, dSMN, survival motor neuron" CDMC30016 2 23 21 DAC34-N17 23-CG17023-RA_1 CG17023 TTTCTAAGCTGGTCGACAAACTTAACCTAGACTCTAAATCTGGAGAAGAAACCGATTTCGACGTCGC 67 CDMC30016 2 24 21 DAC34-N17 23-CG17023-RA_1 CG17023 TTTCTAAGCTGGTCGACAAACTTAACCTAGACTCTAAATCTGGAGAAGAAACCGATTTCGACGTCGC 67 CDMC30017 2 25 21 DAC35-B05 8-CG11755-RA_1 CG11755 CCGCCCTTTGCTCTAGGAGTCATATACCCAGAGGACAACTACGTGATGCGAGATCCTTTCCAACCACCT 69 FBan0011755 FBgn0037611 CG11755 3 3R CG11755 CG11755 CDMC30017 2 26 21 DAC35-B05 8-CG11755-RA_1 CG11755 CCGCCCTTTGCTCTAGGAGTCATATACCCAGAGGACAACTACGTGATGCGAGATCCTTTCCAACCACCT 69 FBan0011755 FBgn0037611 CG11755 3 3R CG11755 CG11755 CDMC30018 2 1 22 DAC35-B17 23-CG11763-RA_12 CG11763 GCGCCTATTTAAAACTAATCGCCGTTCTTTTAATTGTTCGATTATGCTAAAGATGCTATGCGTTTGGCG 69 FBan0011763 FBgn0033522 micr 2 2R germ-line stem cell maintenance; GO:0030718; oogenesis; GO:0048477; protein targeting; GO:0006605 carrier activity; GO:0005386; ; GO:0005386; Ran GTPase binding; GO:0008536; ; GO:0008536 centrosome; GO:0005813 micr midlife-crisis "CG11763, CG11763, CG11763, midlife-crisis" CDMC30018 2 2 22 DAC35-B17 23-CG11763-RA_12 CG11763 GCGCCTATTTAAAACTAATCGCCGTTCTTTTAATTGTTCGATTATGCTAAAGATGCTATGCGTTTGGCG 69 FBan0011763 FBgn0033522 micr 2 2R germ-line stem cell maintenance; GO:0030718; oogenesis; GO:0048477; protein targeting; GO:0006605 carrier activity; GO:0005386; ; GO:0005386; Ran GTPase binding; GO:0008536; ; GO:0008536 centrosome; GO:0005813 micr midlife-crisis "CG11763, CG11763, CG11763, midlife-crisis" CDMC30019 2 3 22 DAC35-F05 23-CG11799-RB_7 CG11799 ATTCGAAAACCCGATTCGAAGTAACGACTTTATCCCCTAGATCTGACGAATTCAATATGCTCGATGACG 69 FBan0011799 FBgn0036134 Mnf 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Mnf Mnf "CG11799, CG11799, DmLD16137, DmMNF, MNF" CDMC30019 2 4 22 DAC35-F05 23-CG11799-RB_7 CG11799 ATTCGAAAACCCGATTCGAAGTAACGACTTTATCCCCTAGATCTGACGAATTCAATATGCTCGATGACG 69 FBan0011799 FBgn0036134 Mnf 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Mnf Mnf "CG11799, CG11799, DmLD16137, DmMNF, MNF" CDMC30020 2 5 22 DAC35-F17 16-CG11819-RA_6 CG11819 TCCCCAAATCGGTGTATGGTTGGCTACACACAAACGACACTGATGAAACGTGCAATATTGATACTGCCA 69 FBan0011819 FBgn0039268 CG11819 3 3R CG11819 CG11819 CDMC30020 2 6 22 DAC35-F17 16-CG11819-RA_6 CG11819 TCCCCAAATCGGTGTATGGTTGGCTACACACAAACGACACTGATGAAACGTGCAATATTGATACTGCCA 69 FBan0011819 FBgn0039268 CG11819 3 3R CG11819 CG11819 CDMC30021 2 7 22 DAC35-J05 23-CG11861-RA_8 CG11861 GGCTGTCAATTCACCTCGAAGCTAGAGGGCATGTTTAAAGATATGTCAGTCTCCAATACGATCATGGAT 69 FBan0011861 FBgn0001980 gft 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; induction of apoptosis; GO:0006917; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 gft guftagu "CG11861, CG11861, l(2)br34, br34, l35Cd, l(2)35Cd, BG:DS07851.2, DMcul-3, dCul-3, dCul3, Cullin3, Cul3, Cul-3, Cullin-3, gft/dCul-3, CUL3, l(2)06430, guftagu" CDMC30021 2 8 22 DAC35-J05 23-CG11861-RA_8 CG11861 GGCTGTCAATTCACCTCGAAGCTAGAGGGCATGTTTAAAGATATGTCAGTCTCCAATACGATCATGGAT 69 FBan0011861 FBgn0001980 gft 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; induction of apoptosis; GO:0006917; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 gft guftagu "CG11861, CG11861, l(2)br34, br34, l35Cd, l(2)35Cd, BG:DS07851.2, DMcul-3, dCul-3, dCul3, Cullin3, Cul3, Cul-3, Cullin-3, gft/dCul-3, CUL3, l(2)06430, guftagu" CDMC30022 2 9 22 DAC35-J17 12-CG11877-RA_1 CG11877 GCGCTGGATCAAATGATCGCAGACCAACAGACGTCCGATCTTTCGGCTATATCATCATGAGACACGCGT 69 FBan0011877 FBgn0039636 CG11877 3 3R CG11877 CG11877 CDMC30022 2 10 22 DAC35-J17 12-CG11877-RA_1 CG11877 GCGCTGGATCAAATGATCGCAGACCAACAGACGTCCGATCTTTCGGCTATATCATCATGAGACACGCGT 69 FBan0011877 FBgn0039636 CG11877 3 3R CG11877 CG11877 CDMC30023 2 11 22 DAC35-N05 3-CG11907-RA_4 CG11907 TGCGTCAGGTCATGTCGAAGATCTATCTGCATGCCATTTCCCTAGCGCTCCTCTATACCACGACCCTGT 69 FBan0011907 FBgn0031250 Ent1 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "equilibrative nucleoside transporter, nitrobenzyl-thioinosine-insensitive activity; GO:0015397; ; GO:0015397" membrane; GO:0016020 Ent1 Equilibrative nucleoside transporter 1 "CG11907, CG11907, CG11907, CG11907, DmENT1, anon-EST:fe2G2, anon-fast-evolving-2G2, Equilibrative nucleoside transporter 1" CDMC30023 2 12 22 DAC35-N05 3-CG11907-RA_4 CG11907 TGCGTCAGGTCATGTCGAAGATCTATCTGCATGCCATTTCCCTAGCGCTCCTCTATACCACGACCCTGT 69 FBan0011907 FBgn0031250 Ent1 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleobase, nucleoside, nucleotide and nucleic acid transport; GO:0015931" "equilibrative nucleoside transporter, nitrobenzyl-thioinosine-insensitive activity; GO:0015397; ; GO:0015397" membrane; GO:0016020 Ent1 Equilibrative nucleoside transporter 1 "CG11907, CG11907, CG11907, CG11907, DmENT1, anon-EST:fe2G2, anon-fast-evolving-2G2, Equilibrative nucleoside transporter 1" CDMC30024 2 13 22 DAC35-N17 2-CG11915-RA_3 CG11915 AGTGGTCCTGAAGACGCCTACTCAGCAAAGTCAAAAACACTCACCTTCCCTGGCGTATCGGATGAAGGA 69 FBan0011915 FBgn0036673 CG11915 3 3L CG11915 CG11915 CDMC30024 2 14 22 DAC35-N17 2-CG11915-RA_3 CG11915 AGTGGTCCTGAAGACGCCTACTCAGCAAAGTCAAAAACACTCACCTTCCCTGGCGTATCGGATGAAGGA 69 FBan0011915 FBgn0036673 CG11915 3 3L CG11915 CG11915 CDMC30025 2 15 22 DAC36-B05 3-CG8609-RA_1 CG8609 GCCAGCATCAATCAGGCCAACAAACGACCGGTTTCATCCGAGGAGCTCATCAAATACGCACATCGGATT 69 FBan0008609 FBgn0035754 MED4 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED4 Mediator complex subunit 4 "CG8609, dTRAP36, p34, Mediator, dp34, Med4/TRAP36, Trap36, Med4, Mediator complex subunit 4" CDMC30025 2 16 22 DAC36-B05 3-CG8609-RA_1 CG8609 GCCAGCATCAATCAGGCCAACAAACGACCGGTTTCATCCGAGGAGCTCATCAAATACGCACATCGGATT 69 FBan0008609 FBgn0035754 MED4 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED4 Mediator complex subunit 4 "CG8609, dTRAP36, p34, Mediator, dp34, Med4/TRAP36, Trap36, Med4, Mediator complex subunit 4" CDMC30026 2 17 22 DAC36-B17 14-CG8622-RA_1 CG8622 CGGAGGCGCAAAATCCAATATGGGAGAATTGGTTGGCATGCAATAGAATTGGTACTAAAGCGCTTGCCA 69 FBan0008622 FBgn0015584 Acp53Ea 2 2R physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321 hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp53Ea Accessory gland-specific peptide 53Ea "CG8622, Acp53E, Accessory gland protein 53Ea, BcDNA:AT09943" CDMC30026 2 18 22 DAC36-B17 14-CG8622-RA_1 CG8622 CGGAGGCGCAAAATCCAATATGGGAGAATTGGTTGGCATGCAATAGAATTGGTACTAAAGCGCTTGCCA 69 FBan0008622 FBgn0015584 Acp53Ea 2 2R physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321 hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp53Ea Accessory gland-specific peptide 53Ea "CG8622, Acp53E, Accessory gland protein 53Ea, BcDNA:AT09943" CDMC30027 2 19 22 DAC36-F05 2-CG8652-RA_1 CG8652 TGGCCTGGATGTGATGGTCACTTCACAGGCTGATCTGCTAAAGGATCCGAGATTCCAACGCGTTTTCGA 69 FBan0008652 FBgn0026754 Ugt37c1 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ecdysteroid UDP-glucosyltransferase activity; GO:0050488; ; GO:0015020 ; EC:2.4.1.17; ; GO:0050488 Ugt37c1 UDP-glycosyltransferase 37c1 "CG8652, DmeUgt37c1, LD15335, AC 004641A, EG:EG0003.4, UDP-glycosyltransferase 37c1" CDMC30027 2 20 22 DAC36-F05 2-CG8652-RA_1 CG8652 TGGCCTGGATGTGATGGTCACTTCACAGGCTGATCTGCTAAAGGATCCGAGATTCCAACGCGTTTTCGA 69 FBan0008652 FBgn0026754 Ugt37c1 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ecdysteroid UDP-glucosyltransferase activity; GO:0050488; ; GO:0015020 ; EC:2.4.1.17; ; GO:0050488 Ugt37c1 UDP-glycosyltransferase 37c1 "CG8652, DmeUgt37c1, LD15335, AC 004641A, EG:EG0003.4, UDP-glycosyltransferase 37c1" CDMC30028 2 21 22 DAC36-F17 23-CG8666-RA_15 CG8666 GCTACGATCATGTTTAAAATGCGAAGTAGCCGATTTTGAAAGGAAACAACAGTTTTTGGCATACCATGC 69 FBan0008666 FBgn0032943 Tsp39D 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp39D Tetraspanin 39D "CG8666, CG8666, CG8666, Dm.Tsp39D, Tetraspanin 39D" CDMC30028 2 22 22 DAC36-F17 23-CG8666-RA_15 CG8666 GCTACGATCATGTTTAAAATGCGAAGTAGCCGATTTTGAAAGGAAACAACAGTTTTTGGCATACCATGC 69 FBan0008666 FBgn0032943 Tsp39D 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp39D Tetraspanin 39D "CG8666, CG8666, CG8666, Dm.Tsp39D, Tetraspanin 39D" CDMC30029 2 23 22 DAC36-J05 2-CG8704-RA_2 CG8704 GCCAATAGTCTGGAGCAGATCGGTTCGATGAGCAACTTCAGCAATGGATACCGTGGTGGCTTGTTTCCC 69 FBan0008704 FBgn0010109 dpn 2 2R "adult locomotory behavior; GO:0008344; cell proliferation; GO:0008283; dosage compensation; GO:0007549; larval locomotory behavior; GO:0008345; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 dpn deadpan "CG3161, CG8704, CG3161, CG8704, 44C, Dpn, anon-EST:fe1B12, anon-fast-evolving-1B12, deadpan" CDMC30029 2 24 22 DAC36-J05 2-CG8704-RA_2 CG8704 GCCAATAGTCTGGAGCAGATCGGTTCGATGAGCAACTTCAGCAATGGATACCGTGGTGGCTTGTTTCCC 69 FBan0008704 FBgn0010109 dpn 2 2R "adult locomotory behavior; GO:0008344; cell proliferation; GO:0008283; dosage compensation; GO:0007549; larval locomotory behavior; GO:0008345; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 dpn deadpan "CG3161, CG8704, CG3161, CG8704, 44C, Dpn, anon-EST:fe1B12, anon-fast-evolving-1B12, deadpan" CDMC30030 2 25 22 DAC36-J17 23-CG8713-RA_2 CG8713 AGTCCAAATACAAAGATGTCGTCGTACAAAGTCATATTTTTACTCGCTGTTAGTGTAGGCTCTCCTAGG 69 FBan0008713 FBgn0033257 CG8713 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 A-type (transient outward) potassium channel activity; GO:0005250; ; GO:0005250 membrane; GO:0016020 CG8713 CG8713 "anon-WO0109301.5, anon-WO0109301.39, anon-WO0109301.40, anon-WO0109301.41, anon-WO0109301.42, anon-WO0109301.43, anon-WO0109301.44, anon-WO0109301.45, anon-WO0109301.46" CDMC30030 2 26 22 DAC36-J17 23-CG8713-RA_2 CG8713 AGTCCAAATACAAAGATGTCGTCGTACAAAGTCATATTTTTACTCGCTGTTAGTGTAGGCTCTCCTAGG 69 FBan0008713 FBgn0033257 CG8713 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 A-type (transient outward) potassium channel activity; GO:0005250; ; GO:0005250 membrane; GO:0016020 CG8713 CG8713 "anon-WO0109301.5, anon-WO0109301.39, anon-WO0109301.40, anon-WO0109301.41, anon-WO0109301.42, anon-WO0109301.43, anon-WO0109301.44, anon-WO0109301.45, anon-WO0109301.46" CDMC30031 2 1 23 DAC36-N05 12-CG8745-RA_4 CG8745 GGAGGGTCTGCAACAGAAGGCTCTTGTTTTGGGCGATTATCTTTTGGAGGAGTGCAATCGTCTGAAGCA 69 FBan0008745 FBgn0036381 CG8745 3 3L amino acid metabolism; GO:0006520 ornithine-oxo-acid transaminase activity; GO:0004587 ; EC:2.6.1.13; ; GO:0004587 ; EC:2.6.1.13; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 CG8745 CG8745 CDMC30031 2 2 23 DAC36-N05 12-CG8745-RA_4 CG8745 GGAGGGTCTGCAACAGAAGGCTCTTGTTTTGGGCGATTATCTTTTGGAGGAGTGCAATCGTCTGAAGCA 69 FBan0008745 FBgn0036381 CG8745 3 3L amino acid metabolism; GO:0006520 ornithine-oxo-acid transaminase activity; GO:0004587 ; EC:2.6.1.13; ; GO:0004587 ; EC:2.6.1.13; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 CG8745 CG8745 CDMC30032 2 3 23 DAC36-N17 23-CG8764-RA_7 CG8764 AACTCAACCTAACAAATCAGCTGTGAGTTTGGCGTGTGGAAAAAGTTTGATTGGGAACAAATCGGACGT 69 FBan0008764 FBgn0011227 ox 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; spermatid development; GO:0007286" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 ox oxen "CG8764, Qcr9, QCR9, BcDNA:RH44662, Qcr10, ms(2)00815, Ubiquinol-cytochrome C reductase" CDMC30032 2 4 23 DAC36-N17 23-CG8764-RA_7 CG8764 AACTCAACCTAACAAATCAGCTGTGAGTTTGGCGTGTGGAAAAAGTTTGATTGGGAACAAATCGGACGT 69 FBan0008764 FBgn0011227 ox 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; spermatid development; GO:0007286" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 ox oxen "CG8764, Qcr9, QCR9, BcDNA:RH44662, Qcr10, ms(2)00815, Ubiquinol-cytochrome C reductase" CDMC30033 2 5 23 DAC37-B05 12-CG8994-RC_1 CG8994 CCGCGCACAACTCACGAGCACGTTGGTGTATCGATAGTGTGAGTAAACCGTGACTGTGACGTAAACAGT 69 FBan0008994 FBgn0000615 exu 2 2R bicoid mRNA localization; GO:0045450; embryonic development (sensu Insecta); GO:0001700; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; spermatogenesis; GO:0007283 cytoplasm; GO:0005737 exu exuperantia "CG8994, CG8994, Exu, bs30h09.y1" CDMC30033 2 6 23 DAC37-B05 12-CG8994-RC_1 CG8994 CCGCGCACAACTCACGAGCACGTTGGTGTATCGATAGTGTGAGTAAACCGTGACTGTGACGTAAACAGT 69 FBan0008994 FBgn0000615 exu 2 2R bicoid mRNA localization; GO:0045450; embryonic development (sensu Insecta); GO:0001700; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; spermatogenesis; GO:0007283 cytoplasm; GO:0005737 exu exuperantia "CG8994, CG8994, Exu, bs30h09.y1" CDMC30034 2 7 23 DAC37-B17 9-CG9001-RA_1 CG9001 ACTCCATACATGACACTGGCGAACTTCAGTATGCTTAGCATGACGCGTTGCTTTGAGTACCAGGCGGAT 69 FBan0009001 FBgn0034175 CG9001 2 2R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 membrane; GO:0016020 CG9001 CG9001 CDMC30034 2 8 23 DAC37-B17 9-CG9001-RA_1 CG9001 ACTCCATACATGACACTGGCGAACTTCAGTATGCTTAGCATGACGCGTTGCTTTGAGTACCAGGCGGAT 69 FBan0009001 FBgn0034175 CG9001 2 2R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 membrane; GO:0016020 CG9001 CG9001 CDMC30035 2 9 23 DAC37-F05 1-CG9033-RB_2 CG9033 GGAGTCCATCAAGCGATCGAACAGCGAAGACACCATGGCATGGGACAACATCCAGCAGAAGTTGATGTG 69 FBan0009033 FBgn0033629 Tsp47F 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp47F Tetraspanin 47F "CG9033, CG9033, CG9033, Dm.Tsp47F, Tetraspanin 47F" CDMC30035 2 10 23 DAC37-F05 1-CG9033-RB_2 CG9033 GGAGTCCATCAAGCGATCGAACAGCGAAGACACCATGGCATGGGACAACATCCAGCAGAAGTTGATGTG 69 FBan0009033 FBgn0033629 Tsp47F 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp47F Tetraspanin 47F "CG9033, CG9033, CG9033, Dm.Tsp47F, Tetraspanin 47F" CDMC30036 2 11 23 DAC37-F17 2-CG9044-RA_3 CG9044 CGTTTGGTGGCCATTGATCTGTTGCCCTGGAAACTTGGCTTGTCCTTCACCTTAAAGGATTGGGGAGGA 69 FBan0009044 FBgn0031752 CG9044 2 2L CG9044 CG9044 CT25972 CDMC30036 2 12 23 DAC37-F17 2-CG9044-RA_3 CG9044 CGTTTGGTGGCCATTGATCTGTTGCCCTGGAAACTTGGCTTGTCCTTCACCTTAAAGGATTGGGGAGGA 69 FBan0009044 FBgn0031752 CG9044 2 2L CG9044 CG9044 CT25972 CDMC30037 2 13 23 DAC37-J05 15-CG9083-RA_1 CG9083 TCCAGAGGCGAGCAATCATTCGAGAGTCCTTCGTAACGAATCCAGAGAAATGGCAGCCCGTTTCATAAT 69 FBan0009083 FBgn0035077 CG9083 2 2R CG9083 CG9083 CDMC30037 2 14 23 DAC37-J05 15-CG9083-RA_1 CG9083 TCCAGAGGCGAGCAATCATTCGAGAGTCCTTCGTAACGAATCCAGAGAAATGGCAGCCCGTTTCATAAT 69 FBan0009083 FBgn0035077 CG9083 2 2R CG9083 CG9083 CDMC30038 2 15 23 DAC37-J17 1-CG9093-RA_1 CG9093 CGCGAGACCAGTGAAATCAGCTGCTGTCTGAAGTACCTTTTGTTCGCCAGCAATGTGATCCTGTGGCTC 69 FBan0009093 FBgn0031760 Tsp26A 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp26A Tetraspanin 26A "CG9093, CG9093, CG9093, CG9093, Dm.Tsp26A, Tetraspanin 26A" CDMC30038 2 16 23 DAC37-J17 1-CG9093-RA_1 CG9093 CGCGAGACCAGTGAAATCAGCTGCTGTCTGAAGTACCTTTTGTTCGCCAGCAATGTGATCCTGTGGCTC 69 FBan0009093 FBgn0031760 Tsp26A 2 2L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp26A Tetraspanin 26A "CG9093, CG9093, CG9093, CG9093, Dm.Tsp26A, Tetraspanin 26A" CDMC30039 2 17 23 DAC37-N05 22-CG9129-RA_1 CG9129 AGGGTGAAGAAGGAGTTCTATTCACAGAACATAAACTGGGAGAGTAACGTCGAGTCCCATTTGTCGCGA 69 FBan0009129 FBgn0035196 CG9129 3 3L CG9129 CG9129 CDMC30039 2 18 23 DAC37-N05 22-CG9129-RA_1 CG9129 AGGGTGAAGAAGGAGTTCTATTCACAGAACATAAACTGGGAGAGTAACGTCGAGTCCCATTTGTCGCGA 69 FBan0009129 FBgn0035196 CG9129 3 3L CG9129 CG9129 CDMC30040 2 19 23 DAC37-N17 3-CG9144-RA_3 CG9144 AGCATACTACGCACAAGAAGCTCAACACCCGAAGAAAACTACTTGCCGGACATCAGTGAGCGCCGTTCT 69 FBan0009144 FBgn0031773 CG9144 2 2L CG9144 CG9144 CDMC30040 2 20 23 DAC37-N17 3-CG9144-RA_3 CG9144 AGCATACTACGCACAAGAAGCTCAACACCCGAAGAAAACTACTTGCCGGACATCAGTGAGCGCCGTTCT 69 FBan0009144 FBgn0031773 CG9144 2 2L CG9144 CG9144 CDMC30041 2 21 23 DAC38-B05 2-CG5539-RA_1 CG5539 CTGCTCCCCTTAGGACTTCCGATCTGTTGCAGGACTCCACTGGAGAAGGAATTGGAGGCAGAACTT 66 FBan0005539 FBgn0034907 CG5539 2 2R CG5539 CG5539 CDMC30041 2 22 23 DAC38-B05 2-CG5539-RA_1 CG5539 CTGCTCCCCTTAGGACTTCCGATCTGTTGCAGGACTCCACTGGAGAAGGAATTGGAGGCAGAACTT 66 FBan0005539 FBgn0034907 CG5539 2 2R CG5539 CG5539 CDMC30042 2 23 23 DAC38-B17 1-CG5779-RA_1 CG5779 GGTGGCACGGATTCATCGACACGGTGTTCAACAAATTCAAGACTCGCCTGAACCCGTACAATGCCG 66 FBan0005779 FBgn0000165 Bc 2 2R "defense response; GO:0006952; melanization defense response; GO:0035006; response to pest, pathogen or parasite; GO:0009613; response to wounding; GO:0009611; scab formation; GO:0035314; transport; GO:0006810" monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 Bc Black cells "CG5779, Dox-A1: Diphenol oxidase A1 subunit, Diphenol oxidase, Monophenol oxidase, DPO, MPO, phenol oxidase, PHOX, Mox: Monophenol oxidase, Phox: Phenol oxidase, pro-POA[[1]], A[[1]], PO, prophenoloxidase A[[1]], pro-PO, pro-phenol oxidase A1., prophenoloxidase, proPO, phenoloxidase, DmePPOA1, pro-A, bc, i12, Prophenoloxidase A1, PO A1, Black Cell, ProPO A1, Diphenol oxidase A1 subunit, Phenol oxidase, Mox, Dox-A1, Phox" CDMC30042 2 24 23 DAC38-B17 1-CG5779-RA_1 CG5779 GGTGGCACGGATTCATCGACACGGTGTTCAACAAATTCAAGACTCGCCTGAACCCGTACAATGCCG 66 FBan0005779 FBgn0000165 Bc 2 2R "defense response; GO:0006952; melanization defense response; GO:0035006; response to pest, pathogen or parasite; GO:0009613; response to wounding; GO:0009611; scab formation; GO:0035314; transport; GO:0006810" monophenol monooxygenase activity; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; oxygen transporter activity; GO:0005344; ; GO:0004503 ; EC:1.14.18.1; ; GO:0004503 ; EC:1.14.18.1; ; GO:0005344 Bc Black cells "CG5779, Dox-A1: Diphenol oxidase A1 subunit, Diphenol oxidase, Monophenol oxidase, DPO, MPO, phenol oxidase, PHOX, Mox: Monophenol oxidase, Phox: Phenol oxidase, pro-POA[[1]], A[[1]], PO, prophenoloxidase A[[1]], pro-PO, pro-phenol oxidase A1., prophenoloxidase, proPO, phenoloxidase, DmePPOA1, pro-A, bc, i12, Prophenoloxidase A1, PO A1, Black Cell, ProPO A1, Diphenol oxidase A1 subunit, Phenol oxidase, Mox, Dox-A1, Phox" CDMC30043 2 25 23 DAC38-F05 2-CG6226-RA_1 CG6226 CGCCTGCAGTCGAACAACAAGACCTTCGACAGCCTCCTGAAGGGAAAACCATTTAAGTTCGCCCTG 66 FBan0006226 FBgn0013269 FK506-bp1 3 3R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005528; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 FK506-bp1 FK506-binding protein 1 "CG6226, CG6226, FKBP39, FK506bp1, FKbp39" CDMC30043 2 26 23 DAC38-F05 2-CG6226-RA_1 CG6226 CGCCTGCAGTCGAACAACAAGACCTTCGACAGCCTCCTGAAGGGAAAACCATTTAAGTTCGCCCTG 66 FBan0006226 FBgn0013269 FK506-bp1 3 3R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005528; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 FK506-bp1 FK506-binding protein 1 "CG6226, CG6226, FKBP39, FK506bp1, FKbp39" CDMC30044 2 1 24 DAC38-F17 3-CG6341-RA_2 CG6341 GGGATGACGAGACCGACATGAAGGAGATGGAGAACAATGTCCGCACCATCGAAATGGACGGTCTGC 66 FBan0006341 FBgn0028737 Ef1beta 2 2R translational elongation; GO:0006414 guanyl-nucleotide exchange factor activity; GO:0005085; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005085; translation release factor activity; GO:0003747; ; GO:0003747 cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1beta Elongation factor 1 beta "CG6341, CG6341, CG6341, BcDNA.LD24492, Elf 1 beta, Ef1beta, BcDNA:LD24492, EG:EG0003.7, Elongation factor 1 beta" CDMC30044 2 2 24 DAC38-F17 3-CG6341-RA_2 CG6341 GGGATGACGAGACCGACATGAAGGAGATGGAGAACAATGTCCGCACCATCGAAATGGACGGTCTGC 66 FBan0006341 FBgn0028737 Ef1beta 2 2R translational elongation; GO:0006414 guanyl-nucleotide exchange factor activity; GO:0005085; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005085; translation release factor activity; GO:0003747; ; GO:0003747 cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1beta Elongation factor 1 beta "CG6341, CG6341, CG6341, BcDNA.LD24492, Elf 1 beta, Ef1beta, BcDNA:LD24492, EG:EG0003.7, Elongation factor 1 beta" CDMC30045 2 3 24 DAC38-J05 18-CG6736-RA_2 CG6736 GCGGAGCAGTGCGTCTAAGGATGCTAGAGTGCGAGACCTTATCCGTAAGCTACAGCAGCCGGATGA 66 FBgn0036048 CDMC30045 2 4 24 DAC38-J05 18-CG6736-RA_2 CG6736 GCGGAGCAGTGCGTCTAAGGATGCTAGAGTGCGAGACCTTATCCGTAAGCTACAGCAGCCGGATGA 66 FBgn0036048 CDMC30046 2 5 24 DAC38-J17 2-CG6876-RA_2 CG6876 GCCTGCAATGTTCAGGTGTTGGGTGCACAAAAGAAAACCCTCTCGGGCTTCTCACAAACGCAGATG 66 FBan0006876 FBgn0036487 CG6876 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6876 CG6876 "clone 2.38, anon-EST:Liang-2.38" CDMC30046 2 6 24 DAC38-J17 2-CG6876-RA_2 CG6876 GCCTGCAATGTTCAGGTGTTGGGTGCACAAAAGAAAACCCTCTCGGGCTTCTCACAAACGCAGATG 66 FBan0006876 FBgn0036487 CG6876 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6876 CG6876 "clone 2.38, anon-EST:Liang-2.38" CDMC30047 2 7 24 DAC38-N05 8-CG7369-RA_2 CG7369 TCAAAACAGCGCAGTACTCAATGAGAACACTCTTTCCATGGCATCCTTCGAGTGTGAGCCACCGGA 66 FBan0007369 FBgn0037188 CG7369 3 3L intracellular signaling cascade; GO:0007242; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088 CG7369 CG7369 CDMC30047 2 8 24 DAC38-N05 8-CG7369-RA_2 CG7369 TCAAAACAGCGCAGTACTCAATGAGAACACTCTTTCCATGGCATCCTTCGAGTGTGAGCCACCGGA 66 FBan0007369 FBgn0037188 CG7369 3 3L intracellular signaling cascade; GO:0007242; regulation of cell shape; GO:0008360; small GTPase mediated signal transduction; GO:0007264 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088 CG7369 CG7369 CDMC30048 2 9 24 DAC38-N17 3-CG7587-RA_1 CG7587 GCTCTTGAAGATTGTGTGTGCCGGGTCTTCCAGAACGGCTGTCTTCTGAACGAGGAGAGCAATCGG 66 FBan0007587 FBgn0038523 CG7587 3 3R CG7587 CG7587 CDMC30048 2 10 24 DAC38-N17 3-CG7587-RA_1 CG7587 GCTCTTGAAGATTGTGTGTGCCGGGTCTTCCAGAACGGCTGTCTTCTGAACGAGGAGAGCAATCGG 66 FBan0007587 FBgn0038523 CG7587 3 3R CG7587 CG7587 CDMC30049 2 11 24 DAC39-B05 23-CG32041-RB_1 CG32041 GAGAGAGTGCCGGTATTTTCTAGATTATATGGATTTCCTCTCTGCCAAGAGTATAAATAGCCACCGGTT 69 FBgn0052041 CDMC30049 2 12 24 DAC39-B05 23-CG32041-RB_1 CG32041 GAGAGAGTGCCGGTATTTTCTAGATTATATGGATTTCCTCTCTGCCAAGAGTATAAATAGCCACCGGTT 69 FBgn0052041 CDMC30050 2 13 24 DAC39-B17 15-CG32047-RA_1 CG32047 TCGCAGCTCAAGGTAACCAAAATGCTGCTAATTGTCTCGACGGTTTTTGTTTGCCTCAATTTGCCCAGC 69 FBgn0052047 CDMC30050 2 14 24 DAC39-B17 15-CG32047-RA_1 CG32047 TCGCAGCTCAAGGTAACCAAAATGCTGCTAATTGTCTCGACGGTTTTTGTTTGCCTCAATTTGCCCAGC 69 FBgn0052047 CDMC30051 2 15 24 DAC39-F05 12-CG32076-RA_3 CG32076 GGCCAAGTGCTGTTTCTACGCTTCGATCATTCTGCCGTTCGTGGGATTCCTCTTCATCAATGGTTCCAT 69 FBan0032076 FBgn0052076 Alg10 3 3L protein amino acid N-linked glycosylation; GO:0006487 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; glucosyltransferase activity; GO:0046527 ; EC:2.4.1.-; ; GO:0046527 ; EC:2.4.1.- endoplasmic reticulum; GO:0005783 Alg10 Alpha 3 glucosyltransferase "CG32076, CG7624, Alpha 3 glucosyltransferase" CDMC30051 2 16 24 DAC39-F05 12-CG32076-RA_3 CG32076 GGCCAAGTGCTGTTTCTACGCTTCGATCATTCTGCCGTTCGTGGGATTCCTCTTCATCAATGGTTCCAT 69 FBan0032076 FBgn0052076 Alg10 3 3L protein amino acid N-linked glycosylation; GO:0006487 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.-; glucosyltransferase activity; GO:0046527 ; EC:2.4.1.-; ; GO:0046527 ; EC:2.4.1.- endoplasmic reticulum; GO:0005783 Alg10 Alpha 3 glucosyltransferase "CG32076, CG7624, Alpha 3 glucosyltransferase" CDMC30052 2 17 24 DAC39-F17 5-CG32088-RA_1 CG32088 TTATGGCTCCGAAAGTTTGGCTAACATGCTGGTTCTTTTGCACGGAGATCTCAAGGATTCCGACGGCGA 69 FBan0032088 FBgn0052088 CG32088 3 3L CG32088 CG32088 CG7308 CDMC30052 2 18 24 DAC39-F17 5-CG32088-RA_1 CG32088 TTATGGCTCCGAAAGTTTGGCTAACATGCTGGTTCTTTTGCACGGAGATCTCAAGGATTCCGACGGCGA 69 FBan0032088 FBgn0052088 CG32088 3 3L CG32088 CG32088 CG7308 CDMC30053 2 19 24 DAC39-J05 2-CG32117-RA_1 CG32117 ACCGGCCACGAACTTTTACTGCCATCCAAACCGAAGATCTCTGCCATCCAACCAGCTAAGACCAATTGT 69 FBan0032117 FBgn0052117 CG32117 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32117 CG32117 CDMC30053 2 20 24 DAC39-J05 2-CG32117-RA_1 CG32117 ACCGGCCACGAACTTTTACTGCCATCCAAACCGAAGATCTCTGCCATCCAACCAGCTAAGACCAATTGT 69 FBan0032117 FBgn0052117 CG32117 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32117 CG32117 CDMC30054 2 21 24 DAC39-J17 23-CG32137-RA_3 CG32137 ACAAATCGGAGAGCCTAGGCATCATAGGTATTGTACTTAATTGTTATTTGTATACGGGAAGCATTGCCC 69 FBan0032137 FBgn0052137 CG32137 3 3L cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG32137 CG32137 "CG17365, CG17366" CDMC30054 2 22 24 DAC39-J17 23-CG32137-RA_3 CG32137 ACAAATCGGAGAGCCTAGGCATCATAGGTATTGTACTTAATTGTTATTTGTATACGGGAAGCATTGCCC 69 FBan0032137 FBgn0052137 CG32137 3 3L cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG32137 CG32137 "CG17365, CG17366" CDMC30055 2 23 24 DAC39-N05 23-CG32167-RA_1 CG32167 ACTGGATTTATTTGTGTGTGCATAACTGCTTATAATGAGCCCAGTGATAATGATAGTCAATTTGCTGGG 69 FBan0032167 FBgn0052167 CG32167 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32167 CG32167 CDMC30055 2 24 24 DAC39-N05 23-CG32167-RA_1 CG32167 ACTGGATTTATTTGTGTGTGCATAACTGCTTATAATGAGCCCAGTGATAATGATAGTCAATTTGCTGGG 69 FBan0032167 FBgn0052167 CG32167 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32167 CG32167 CDMC30056 2 25 24 DAC39-N17 16-CG32176-RA_1 CG32176 CCAGTGGAGAAAGTACAGCGAAAGGAAAAGGATAAACGCAGCACTAAAAAAACGGATTCGAGCAAGCGC 69 FBan0032176 FBgn0052176 CG32176 3 3L CG32176 CG32176 "CG13729, CG13730" CDMC30056 2 26 24 DAC39-N17 16-CG32176-RA_1 CG32176 CCAGTGGAGAAAGTACAGCGAAAGGAAAAGGATAAACGCAGCACTAAAAAAACGGATTCGAGCAAGCGC 69 FBan0032176 FBgn0052176 CG32176 3 3L CG32176 CG32176 "CG13729, CG13730" CDMC30057 2 1 25 DAC40-B05 3-CG9556-RB_2 CG9556 CGAGAAGGCGAGTTCGAAAAGGCACACACGGACTTCTTTGAGGCGTTCAAGAACTACGATGAGAGCGGT 69 FBan0009556 FBgn0013746 alien 2 2L "cell cycle; GO:0007049; development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; protein targeting; GO:0006605; proteolysis; GO:0006508; signal transduction; GO:0007165" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003714; ; GO:0004871 cytoplasm; GO:0005737; signalosome complex; GO:0008180 alien alien "CG9556, Alien, d-Alien, Dch2, Drosophila COP9 signalosome homolog 2, DCH2, COP9 complex homolog subunit 2, CSN2, BcDNA:LD10463, CH2" CDMC30057 2 2 25 DAC40-B05 3-CG9556-RB_2 CG9556 CGAGAAGGCGAGTTCGAAAAGGCACACACGGACTTCTTTGAGGCGTTCAAGAACTACGATGAGAGCGGT 69 FBan0009556 FBgn0013746 alien 2 2L "cell cycle; GO:0007049; development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; protein targeting; GO:0006605; proteolysis; GO:0006508; signal transduction; GO:0007165" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; signal transducer activity; GO:0004871; ; GO:0003714; ; GO:0004871 cytoplasm; GO:0005737; signalosome complex; GO:0008180 alien alien "CG9556, Alien, d-Alien, Dch2, Drosophila COP9 signalosome homolog 2, DCH2, COP9 complex homolog subunit 2, CSN2, BcDNA:LD10463, CH2" CDMC30058 2 3 25 DAC40-B17 1-CG9573-RA_1 CG9573 CTCCTCCTAGAGAAGCGCCCAACAACTTTCGTCACTCCACCGTCCATTCAAGCGCCATCGATTAGTGAT 69 FBan0009573 FBgn0032089 CG9573 2 2L CG9573 CG9573 CDMC30058 2 4 25 DAC40-B17 1-CG9573-RA_1 CG9573 CTCCTCCTAGAGAAGCGCCCAACAACTTTCGTCACTCCACCGTCCATTCAAGCGCCATCGATTAGTGAT 69 FBan0009573 FBgn0032089 CG9573 2 2L CG9573 CG9573 CDMC30059 2 5 25 DAC40-F05 3-CG9611-RA_2 CG9611 ACGACATACTGGAACTGCCCGAGTTCGAGGGAAACGAGGCCTTGAACGAGCTACATGCCAGCAATAATT 69 FBan0009611 FBgn0028487 CG9611 3 3R Ras protein signal transduction; GO:0007265 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG9611 CG9611 "gp150-like, BcDNA:GH09045" CDMC30059 2 6 25 DAC40-F05 3-CG9611-RA_2 CG9611 ACGACATACTGGAACTGCCCGAGTTCGAGGGAAACGAGGCCTTGAACGAGCTACATGCCAGCAATAATT 69 FBan0009611 FBgn0028487 CG9611 3 3R Ras protein signal transduction; GO:0007265 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG9611 CG9611 "gp150-like, BcDNA:GH09045" CDMC30060 2 7 25 DAC40-F17 16-CG9614-RI_1 CG9614 CCCAAACCATGGCTCCCTACAATAACATGACAGTGGTTACCAAAGGACCAATGGATATTAAGTCCCGCA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC30060 2 8 25 DAC40-F17 16-CG9614-RI_1 CG9614 CCCAAACCATGGCTCCCTACAATAACATGACAGTGGTTACCAAAGGACCAATGGATATTAAGTCCCGCA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC30061 2 9 25 DAC40-J05 23-CG9654-RA_2 CG9654 TGTAGTAAATCAGGCTATTTTAATTTTGACATCTCTTCGAAAATGGATGCGGGAAATTGTGCCTCGTCG 69 FBan0009654 FBgn0010258 Rbp4 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 single-stranded RNA binding; GO:0003727; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003727 cytoplasm; GO:0005737 Rbp4 RNA-binding protein 4 "CG9654, rrm4, Tsr: Testis specific RRM protein, TSR, RRM4, Testis specific RRM protein, Tsr" CDMC30061 2 10 25 DAC40-J05 23-CG9654-RA_2 CG9654 TGTAGTAAATCAGGCTATTTTAATTTTGACATCTCTTCGAAAATGGATGCGGGAAATTGTGCCTCGTCG 69 FBan0009654 FBgn0010258 Rbp4 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 single-stranded RNA binding; GO:0003727; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003727 cytoplasm; GO:0005737 Rbp4 RNA-binding protein 4 "CG9654, rrm4, Tsr: Testis specific RRM protein, TSR, RRM4, Testis specific RRM protein, Tsr" CDMC30062 2 11 25 DAC40-J17 18-CG9662-RA_1 CG9662 TGCCGTCACCGATGGCCGTTTTCAGTGTGATTTTGTTTTCCTATTTTCTGGTGACAGGCGGTATCATAT 69 FBan0009662 FBgn0031529 CG9662 2 2L CG9662 CG9662 BcDNA:AT03617 CDMC30062 2 12 25 DAC40-J17 18-CG9662-RA_1 CG9662 TGCCGTCACCGATGGCCGTTTTCAGTGTGATTTTGTTTTCCTATTTTCTGGTGACAGGCGGTATCATAT 69 FBan0009662 FBgn0031529 CG9662 2 2L CG9662 CG9662 BcDNA:AT03617 CDMC30063 2 13 25 DAC40-N05 3-CG9698-RA_4 CG9698 TGGCTCTTCTTGTGCAGGCCAAGAAGGAATTGGAGGACTTCCGTGGTCTGAATGATACCTACCAGGAGT 69 FBan0009698 FBgn0039784 CG9698 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG9698 CG9698 "CG9698-E, CG9698-E" CDMC30063 2 14 25 DAC40-N05 3-CG9698-RA_4 CG9698 TGGCTCTTCTTGTGCAGGCCAAGAAGGAATTGGAGGACTTCCGTGGTCTGAATGATACCTACCAGGAGT 69 FBan0009698 FBgn0039784 CG9698 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG9698 CG9698 "CG9698-E, CG9698-E" CDMC30064 2 15 25 DAC40-N17 3-CG9707-RA_2 CG9707 TCACCGGTCCTCAATCTAAGACGCGCTCAGCTAACTTCAATCGAGTCCTGGAGAACCTGTTGGAGCTGT 69 FBan0009707 FBgn0034628 Acox57D-p 2 2R fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0003997 ; EC:1.3.3.6; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 Acox57D-p acyl-Coenzyme A oxidase at 57D proximal "CG9707, acyl co-enzyme A oxidase, D-acox, acox, Acox57Dp, acyl-Coenzyme A oxidase at 57D proximal" CDMC30064 2 16 25 DAC40-N17 3-CG9707-RA_2 CG9707 TCACCGGTCCTCAATCTAAGACGCGCTCAGCTAACTTCAATCGAGTCCTGGAGAACCTGTTGGAGCTGT 69 FBan0009707 FBgn0034628 Acox57D-p 2 2R fatty acid beta-oxidation; GO:0006635 acyl-CoA oxidase activity; GO:0003997 ; EC:1.3.3.6; palmitoyl-CoA oxidase activity; GO:0016401 ; EC:1.3.3.-; ; GO:0003997 ; EC:1.3.3.6; ; GO:0016401 ; EC:1.3.3.- peroxisome; GO:0005777 Acox57D-p acyl-Coenzyme A oxidase at 57D proximal "CG9707, acyl co-enzyme A oxidase, D-acox, acox, Acox57Dp, acyl-Coenzyme A oxidase at 57D proximal" CDMC30065 2 17 25 DAC41-B05 AutoBlank AutoBlank CDMC30065 2 18 25 DAC41-B05 AutoBlank AutoBlank CDMC30066 2 19 25 DAC41-B17 AutoBlank AutoBlank CDMC30066 2 20 25 DAC41-B17 AutoBlank AutoBlank CDMC30067 2 21 25 DAC41-F05 AutoBlank AutoBlank CDMC30067 2 22 25 DAC41-F05 AutoBlank AutoBlank CDMC30068 2 23 25 DAC41-F17 AutoBlank AutoBlank CDMC30068 2 24 25 DAC41-F17 AutoBlank AutoBlank CDMC30069 2 25 25 DAC41-J05 AutoBlank AutoBlank CDMC30069 2 26 25 DAC41-J05 AutoBlank AutoBlank CDMC30070 2 1 26 DAC41-J17 AutoBlank AutoBlank CDMC30070 2 2 26 DAC41-J17 AutoBlank AutoBlank CDMC30071 2 3 26 DAC41-N05 AutoBlank AutoBlank CDMC30071 2 4 26 DAC41-N05 AutoBlank AutoBlank CDMC30072 2 5 26 DAC41-N17 AutoBlank AutoBlank CDMC30072 2 6 26 DAC41-N17 AutoBlank AutoBlank CDMC30073 2 7 26 DAC42-B05 150mM NaPO4 Blank CDMC30073 2 8 26 DAC42-B05 150mM NaPO4 Blank CDMC30074 2 9 26 DAC42-B17 150mM NaPO4 Blank CDMC30074 2 10 26 DAC42-B17 150mM NaPO4 Blank CDMC30075 2 11 26 DAC42-F05 150mM NaPO4 Blank CDMC30075 2 12 26 DAC42-F05 150mM NaPO4 Blank CDMC30076 2 13 26 DAC42-F17 150mM NaPO4 Blank CDMC30076 2 14 26 DAC42-F17 150mM NaPO4 Blank CDMC30077 2 15 26 DAC42-J05 150mM NaPO4 Blank CDMC30077 2 16 26 DAC42-J05 150mM NaPO4 Blank CDMC30078 2 17 26 DAC42-J17 5uM MSP 5uM MSP CDMC30078 2 18 26 DAC42-J17 5uM MSP 5uM MSP CDMC30079 2 19 26 DAC42-N05 10uM MSP 10uM MSP CDMC30079 2 20 26 DAC42-N05 10uM MSP 10uM MSP CDMC30080 2 21 26 DAC42-N17 20uM MSP 20uM MSP CDMC30080 2 22 26 DAC42-N17 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC30081 3 1 1 DAC01-C05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30081 3 2 1 DAC01-C05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30082 3 3 1 DAC01-C17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30082 3 4 1 DAC01-C17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30083 3 5 1 DAC01-G05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30083 3 6 1 DAC01-G05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30084 3 7 1 DAC01-G17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30084 3 8 1 DAC01-G17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30085 3 9 1 DAC01-K05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30085 3 10 1 DAC01-K05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30086 3 11 1 DAC01-K17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30086 3 12 1 DAC01-K17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30087 3 13 1 DAC01-O05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30087 3 14 1 DAC01-O05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30088 3 15 1 DAC01-O17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30088 3 16 1 DAC01-O17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30089 3 17 1 DAC02-C05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30089 3 18 1 DAC02-C05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30090 3 19 1 DAC02-C17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30090 3 20 1 DAC02-C17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30091 3 21 1 DAC02-G05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30091 3 22 1 DAC02-G05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30092 3 23 1 DAC02-G17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30092 3 24 1 DAC02-G17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30093 3 25 1 DAC02-K05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30093 3 26 1 DAC02-K05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30094 3 1 2 DAC02-K17 AutoBlank AutoBlank CDMC30094 3 2 2 DAC02-K17 AutoBlank AutoBlank CDMC30095 3 3 2 DAC02-O05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30095 3 4 2 DAC02-O05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30096 3 5 2 DAC02-O17 AutoBlank AutoBlank CDMC30096 3 6 2 DAC02-O17 AutoBlank AutoBlank CDMC30097 3 7 2 DAC03-C05 23-CG1710-RA_3 CG1710 ATAGCGTTACGCCATTCTAGTGCCTTTGGTCATATCTCTATGTGACGGACATCAGTTTCATTCATTTTT 69 FBan0001710 FBgn0039904 Hcf 4 4 "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" transcription factor activity; GO:0003700; transcription coactivator activity; GO:0003713; ; GO:0003700; ; GO:0003713 nucleus; GO:0005634 Hcf Host cell factor "CG1710, CG1710, dHCF, HCF, anon-WO0172774.48, Host cell factor" CDMC30097 3 8 2 DAC03-C05 23-CG1710-RA_3 CG1710 ATAGCGTTACGCCATTCTAGTGCCTTTGGTCATATCTCTATGTGACGGACATCAGTTTCATTCATTTTT 69 FBan0001710 FBgn0039904 Hcf 4 4 "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" transcription factor activity; GO:0003700; transcription coactivator activity; GO:0003713; ; GO:0003700; ; GO:0003713 nucleus; GO:0005634 Hcf Host cell factor "CG1710, CG1710, dHCF, HCF, anon-WO0172774.48, Host cell factor" CDMC30098 3 9 2 DAC03-C17 11-CG17124-RA_1 CG17124 CGATCTGCTGGATCGCGCAAAAACCCTGTAAATCGCCGATGCCTCATTTGAAAAATCATCCAGCAGACC 69 FBan0017124 FBgn0032297 CG17124 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG17124 CG17124 anon-WO0118547.153 CDMC30098 3 10 2 DAC03-C17 11-CG17124-RA_1 CG17124 CGATCTGCTGGATCGCGCAAAAACCCTGTAAATCGCCGATGCCTCATTTGAAAAATCATCCAGCAGACC 69 FBan0017124 FBgn0032297 CG17124 2 2L protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864 CG17124 CG17124 anon-WO0118547.153 CDMC30099 3 11 2 DAC03-G05 8-CG17167-RA_1 CG17167 CCGGTTGGATGCAATTCTGGTGGATCTTCGTCTTCCCCATTAAGGTCACGCTATCCCTATTGATCCCGC 69 CDMC30099 3 12 2 DAC03-G05 8-CG17167-RA_1 CG17167 CCGGTTGGATGCAATTCTGGTGGATCTTCGTCTTCCCCATTAAGGTCACGCTATCCCTATTGATCCCGC 69 CDMC30100 3 13 2 DAC03-G17 23-CG17177-RA_12 CG17177 CCAATGGATACAACTATTTTTCTTGACTTGGAAAAAAATGCAGAAACCTTAGAGAAACTCGCCGAAACG 69 FBan0017177 FBgn0036440 CG17177 3 3L cell communication; GO:0007154; signal transduction; GO:0007165 CG17177 CG17177 CDMC30100 3 14 2 DAC03-G17 23-CG17177-RA_12 CG17177 CCAATGGATACAACTATTTTTCTTGACTTGGAAAAAAATGCAGAAACCTTAGAGAAACTCGCCGAAACG 69 FBan0017177 FBgn0036440 CG17177 3 3L cell communication; GO:0007154; signal transduction; GO:0007165 CG17177 CG17177 CDMC30101 3 15 2 DAC03-K05 23-CG17209-RA_1 CG17209 GCCAGAATTAAGCTACTCGGCCTACACATTGATCTGGACACAATTGTATTTAGCATTCTGAAGTCGCGC 69 FBan0017209 FBgn0030687 CG17209 X X mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666 CG17209 CG17209 CDMC30101 3 16 2 DAC03-K05 23-CG17209-RA_1 CG17209 GCCAGAATTAAGCTACTCGGCCTACACATTGATCTGGACACAATTGTATTTAGCATTCTGAAGTCGCGC 69 FBan0017209 FBgn0030687 CG17209 X X mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666 CG17209 CG17209 CDMC30102 3 17 2 DAC03-K17 23-CG17219-RA_12 CG17219 CGGAGAAAGTACAACCACTGGATAACCTAATTTCGGCAATGGATTTCTATGAGCTTAACGCCAAGGAAA 69 FBan0017219 FBgn0031494 CG17219 2 2L CG17219 CG17219 CDMC30102 3 18 2 DAC03-K17 23-CG17219-RA_12 CG17219 CGGAGAAAGTACAACCACTGGATAACCTAATTTCGGCAATGGATTTCTATGAGCTTAACGCCAAGGAAA 69 FBan0017219 FBgn0031494 CG17219 2 2L CG17219 CG17219 CDMC30103 3 19 2 DAC03-O05 23-CG17261-RA_3 CG17261 AAACCTTCACAGGACCAACACAACAAAATCATTCTACTCAAGCTATTGAATCTATTTGGATCGGCACAC 69 FBan0017261 FBgn0031501 CG17261 2 2L CG17261 CG17261 CDMC30103 3 20 2 DAC03-O05 23-CG17261-RA_3 CG17261 AAACCTTCACAGGACCAACACAACAAAATCATTCTACTCAAGCTATTGAATCTATTTGGATCGGCACAC 69 FBan0017261 FBgn0031501 CG17261 2 2L CG17261 CG17261 CDMC30104 3 21 2 DAC03-O17 23-CG17271-RA_10 CG17271 CTGCAAGCATTCCAATCGGAGAACTTCATTGAACAAATTGTAACTAAACGTCCTTCTGAGAACTCTTTT 69 FBan0017271 FBgn0038829 CG17271 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG17271 CG17271 CDMC30104 3 22 2 DAC03-O17 23-CG17271-RA_10 CG17271 CTGCAAGCATTCCAATCGGAGAACTTCATTGAACAAATTGTAACTAAACGTCCTTCTGAGAACTCTTTT 69 FBan0017271 FBgn0038829 CG17271 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG17271 CG17271 CDMC30105 3 23 2 DAC04-C05 4-CG15919-RA_1 CG15919 CGGGCCAAGAAGATCTACGAGCCGGTGTGGAAAAAGGTCTGGACACCCACCATTCACAACGAGTG 65 FBan0015919 FBgn0040743 CG15919 2 2R CG15919 CG15919 CDMC30105 3 24 2 DAC04-C05 4-CG15919-RA_1 CG15919 CGGGCCAAGAAGATCTACGAGCCGGTGTGGAAAAAGGTCTGGACACCCACCATTCACAACGAGTG 65 FBan0015919 FBgn0040743 CG15919 2 2R CG15919 CG15919 CDMC30106 3 25 2 DAC04-C17 3-CG1619-RB_2 CG1619 TTCCTGCCTGAGATCAATTTGTCCACTTGCAGTCCGGATCTCGTGGTGAAGAATTGGGCCTACGC 65 FBgn0027511 CDMC30106 3 26 2 DAC04-C17 3-CG1619-RB_2 CG1619 TTCCTGCCTGAGATCAATTTGTCCACTTGCAGTCCGGATCTCGTGGTGAAGAATTGGGCCTACGC 65 FBgn0027511 CDMC30107 3 1 3 DAC04-G05 23-CG16800-RA_2 CG16800 AGGGCAAGCACAACATCCACAAACTAGACGAGAACAAGAAAGAGAAAAAGTTCTACGATGAGGAT 65 FBan0016800 FBgn0032462 CG16800 2 2L CG16800 CG16800 CDMC30107 3 2 3 DAC04-G05 23-CG16800-RA_2 CG16800 AGGGCAAGCACAACATCCACAAACTAGACGAGAACAAGAAAGAGAAAAAGTTCTACGATGAGGAT 65 FBan0016800 FBgn0032462 CG16800 2 2L CG16800 CG16800 CDMC30108 3 3 3 DAC04-G17 9-CG16854-RA_4 CG16854 AAGGATAGCTCACAGTGCAGAACCCTATACCTGAACTCCATACTCCAGGCTCTGATTGCAGCGCC 65 FBan0016854 FBgn0032338 CG16854 2 2L CG16854 CG16854 CDMC30108 3 4 3 DAC04-G17 9-CG16854-RA_4 CG16854 AAGGATAGCTCACAGTGCAGAACCCTATACCTGAACTCCATACTCCAGGCTCTGATTGCAGCGCC 65 FBan0016854 FBgn0032338 CG16854 2 2L CG16854 CG16854 CDMC30109 3 5 3 DAC04-K05 2-CG16989-RA_1 CG16989 GGAAAGCTTTGAAGAGTACAACCACCGGGATGCACTTCAGCAACAGTTGTGCCTAGCCATTGCCC 65 FBan0016989 FBgn0025621 CG16989 X X CG16989 CG16989 EG:34F3.4 CDMC30109 3 6 3 DAC04-K05 2-CG16989-RA_1 CG16989 GGAAAGCTTTGAAGAGTACAACCACCGGGATGCACTTCAGCAACAGTTGTGCCTAGCCATTGCCC 65 FBan0016989 FBgn0025621 CG16989 X X CG16989 CG16989 EG:34F3.4 CDMC30110 3 7 3 DAC04-K17 3-CG17044-RA_2 CG17044 CTCCTGGCGCATCGAGAACAAATTCACCTATCCGGATGCTAAGTTCGGAACGCACACAGTGGCTG 65 FBan0017044 FBgn0038151 yellow-e2 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e2 yellow-e2 "CG17044, CG17044" CDMC30110 3 8 3 DAC04-K17 3-CG17044-RA_2 CG17044 CTCCTGGCGCATCGAGAACAAATTCACCTATCCGGATGCTAAGTTCGGAACGCACACAGTGGCTG 65 FBan0017044 FBgn0038151 yellow-e2 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-e2 yellow-e2 "CG17044, CG17044" CDMC30111 3 9 3 DAC04-O05 1-CG17172-RC_2 CG17172 AGTGCCTCCTTCAAGCAGTCGTGCAACCTATCAACACACCGGAAGAAAAAGCACGCACTGAGAGG 65 CDMC30111 3 10 3 DAC04-O05 1-CG17172-RC_2 CG17172 AGTGCCTCCTTCAAGCAGTCGTGCAACCTATCAACACACCGGAAGAAAAAGCACGCACTGAGAGG 65 CDMC30112 3 11 3 DAC04-O17 3-CG17213-RA_1 CG17213 GCGGCCTGCTTTGTGGTGAGCATCTTTGGCATTTTCCTGGAGACCAAGGTCAACTTCATTGTGGG 65 FBan0017213 FBgn0032416 Gr33a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr33a Gustatory receptor 33a "CG17213, CG17213, Gr33C1, Gustatory receptor 33C1, Gustatory receptor 33a" CDMC30112 3 12 3 DAC04-O17 3-CG17213-RA_1 CG17213 GCGGCCTGCTTTGTGGTGAGCATCTTTGGCATTTTCCTGGAGACCAAGGTCAACTTCATTGTGGG 65 FBan0017213 FBgn0032416 Gr33a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr33a Gustatory receptor 33a "CG17213, CG17213, Gr33C1, Gustatory receptor 33C1, Gustatory receptor 33a" CDMC30113 3 13 3 DAC05-C05 2-CG10486-RA_1 CG10486 ACGAACTCCCGGAAACTCTCAGTGATGGCGCACAATTTGGGAAGAATCAAAGGATTTGGCACATGCCC 68 FBan0010486 FBgn0035647 CG10486 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 polyspecific organic cation transporter activity; GO:0015354; carbohydrate transporter activity; GO:0015144; ; GO:0015144; ; GO:0015354 membrane; GO:0016020 CG10486 CG10486 CDMC30113 3 14 3 DAC05-C05 2-CG10486-RA_1 CG10486 ACGAACTCCCGGAAACTCTCAGTGATGGCGCACAATTTGGGAAGAATCAAAGGATTTGGCACATGCCC 68 FBan0010486 FBgn0035647 CG10486 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 polyspecific organic cation transporter activity; GO:0015354; carbohydrate transporter activity; GO:0015144; ; GO:0015144; ; GO:0015354 membrane; GO:0016020 CG10486 CG10486 CDMC30114 3 15 3 DAC05-C17 3-CG10581-RA_1 CG10581 TGCTCGGCTCTGCAGGATAGAGGACGCATTCTTCAAGGATTCTACACAGAGGAAATGCGAGGTGAGGG 68 FBan0010581 FBgn0037046 CG10581 3 3L CG10581 CG10581 CDMC30114 3 16 3 DAC05-C17 3-CG10581-RA_1 CG10581 TGCTCGGCTCTGCAGGATAGAGGACGCATTCTTCAAGGATTCTACACAGAGGAAATGCGAGGTGAGGG 68 FBan0010581 FBgn0037046 CG10581 3 3L CG10581 CG10581 CDMC30115 3 17 3 DAC05-G05 3-CG11148-RB_2 CG11148 CTCGCGCTTGCCGTCTACATCCGTAGCGCCTTGGTCTTTTCAGTTGCAAAATTCTATGAGATCGGCGC 68 FBan0011148 FBgn0039936 CG11148 4 4 CG11148 CG11148 CDMC30115 3 18 3 DAC05-G05 3-CG11148-RB_2 CG11148 CTCGCGCTTGCCGTCTACATCCGTAGCGCCTTGGTCTTTTCAGTTGCAAAATTCTATGAGATCGGCGC 68 FBan0011148 FBgn0039936 CG11148 4 4 CG11148 CG11148 CDMC30116 3 19 3 DAC05-G17 3-CG11201-RA_2 CG11201 CGGGAGTCCATCCACCTGACCAATAATTCGGTGCAGAAGCGGTACAAGAACAAGACCAACCGGGATTC 68 FBan0011201 FBgn0031853 CG11201 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG11201 CG11201 CDMC30116 3 20 3 DAC05-G17 3-CG11201-RA_2 CG11201 CGGGAGTCCATCCACCTGACCAATAATTCGGTGCAGAAGCGGTACAAGAACAAGACCAACCGGGATTC 68 FBan0011201 FBgn0031853 CG11201 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG11201 CG11201 CDMC30117 3 21 3 DAC05-K05 17-CG11415-RA_1 CG11415 GCCACATCGGAGTATACGTACTCGAACTACGTGCTGACCATGATTCAGGAGAACATAGGTTGTTGCGG 68 FBan0011415 FBgn0024361 Tsp2A X X integral to membrane; GO:0016021 Tsp2A Tetraspanin 2A "CG11415, CG11415, CG11415, CG11415, Dm.Tsp2A, EG:8D8.7, D8.7, Tetraspanin 2A" CDMC30117 3 22 3 DAC05-K05 17-CG11415-RA_1 CG11415 GCCACATCGGAGTATACGTACTCGAACTACGTGCTGACCATGATTCAGGAGAACATAGGTTGTTGCGG 68 FBan0011415 FBgn0024361 Tsp2A X X integral to membrane; GO:0016021 Tsp2A Tetraspanin 2A "CG11415, CG11415, CG11415, CG11415, Dm.Tsp2A, EG:8D8.7, D8.7, Tetraspanin 2A" CDMC30118 3 23 3 DAC05-K17 3-CG1167-RA_3 CG1167 CGTCACGGACTACGATCCCACCATTGAAGACTCGTACACGAAGCAGTGCAACATCGACGATGTGCCAG 68 FBan0001167 FBgn0003206 Ras64B 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; muscle contraction; GO:0006936; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0019003; ; GO:0003924; ; GO:0005525 Ras64B Ras oncogene at 64B "CG1167, Dmras64B, D-ras-2, ras2, Ras2, c-ras2, Dras2, ras-2, D-ras2, ras, Dras64B, RAS, DRas2, ras oncogene, Ras, BcDNA:RE36103, C-ras2, Dm-ras-64B" CDMC30118 3 24 3 DAC05-K17 3-CG1167-RA_3 CG1167 CGTCACGGACTACGATCCCACCATTGAAGACTCGTACACGAAGCAGTGCAACATCGACGATGTGCCAG 68 FBan0001167 FBgn0003206 Ras64B 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; muscle contraction; GO:0006936; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0019003; ; GO:0003924; ; GO:0005525 Ras64B Ras oncogene at 64B "CG1167, Dmras64B, D-ras-2, ras2, Ras2, c-ras2, Dras2, ras-2, D-ras2, ras, Dras64B, RAS, DRas2, ras oncogene, Ras, BcDNA:RE36103, C-ras2, Dm-ras-64B" CDMC30119 3 25 3 DAC05-O05 1-CG12149-RA_1 CG12149 TAATGCCTTTGGTGAACTGCGAACTCTAGCTGACGAGGGAATGCTCAACTATCCGTACTCCACCCGCG 68 FBan0012149 FBgn0040234 c12.2 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c12.2 c12.2 "CG12149, CG12149" CDMC30119 3 26 3 DAC05-O05 1-CG12149-RA_1 CG12149 TAATGCCTTTGGTGAACTGCGAACTCTAGCTGACGAGGGAATGCTCAACTATCCGTACTCCACCCGCG 68 FBan0012149 FBgn0040234 c12.2 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c12.2 c12.2 "CG12149, CG12149" CDMC30120 3 1 4 DAC05-O17 3-CG12283-RA_4 CG12283 GCCGAGGCTAACAGATCTTCCGTACTCTACGCAGGGCTATGACAACAACGGAAGTGTCCTGTCCACTG 68 FBan0012283 FBgn0015399 kek1 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cell-cell signaling; GO:0007267; cytokinesis; GO:0000910; ectoderm development; GO:0007398; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.-; epidermal growth factor binding; GO:0048408; ; GO:0048408 integral to membrane; GO:0016021; plasma membrane; GO:0005886 kek1 kekkon-1 "CG12283, uns, unstrung, Kek1, NB1, kek-1, kekon, kekkon1, kekkon, GM02380, l(2)01433, n(2)k07332, kek, Kekkon, CT18186, Kek-1, KEK1, kekkonI, Kek, SD01674, Kekkon-1, Kekon-1, Dmkek1, BEST:GM02380, kekkon-1" CDMC30120 3 2 4 DAC05-O17 3-CG12283-RA_4 CG12283 GCCGAGGCTAACAGATCTTCCGTACTCTACGCAGGGCTATGACAACAACGGAAGTGTCCTGTCCACTG 68 FBan0012283 FBgn0015399 kek1 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cell-cell signaling; GO:0007267; cytokinesis; GO:0000910; ectoderm development; GO:0007398; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.-; epidermal growth factor binding; GO:0048408; ; GO:0048408 integral to membrane; GO:0016021; plasma membrane; GO:0005886 kek1 kekkon-1 "CG12283, uns, unstrung, Kek1, NB1, kek-1, kekon, kekkon1, kekkon, GM02380, l(2)01433, n(2)k07332, kek, Kekkon, CT18186, Kek-1, KEK1, kekkonI, Kek, SD01674, Kekkon-1, Kekon-1, Dmkek1, BEST:GM02380, kekkon-1" CDMC30121 3 3 4 DAC06-C05 1-CG33009-RA_1 CG33009 ACGGAGATCATCAAGAACAATGCTCAAGTTCCAGGTCCATTCTCCGGGCAAGGTCATACTCCATGGCGA 69 FBgn0053009 CDMC30121 3 4 4 DAC06-C05 1-CG33009-RA_1 CG33009 ACGGAGATCATCAAGAACAATGCTCAAGTTCCAGGTCCATTCTCCGGGCAAGGTCATACTCCATGGCGA 69 FBgn0053009 CDMC30122 3 5 4 DAC06-C17 2-CG33045-RA_1 CG33045 GCACGCAATCCTGCCTAACCACCCCTGAGTACAATCCCGTCTGGAGTAGTGATATGGTGAGCTACGACA 69 FBgn0026414 CDMC30122 3 6 4 DAC06-C17 2-CG33045-RA_1 CG33045 GCACGCAATCCTGCCTAACCACCCCTGAGTACAATCCCGTCTGGAGTAGTGATATGGTGAGCTACGACA 69 FBgn0026414 CDMC30123 3 7 4 DAC06-G05 23-CG33070-RC_7 CG33070 GCGTCGAACTCACTTAAATCGAATGCAAATAGTCTCAACCAAAGTAGCCTTAGTGAGTAAGCGGATATA 69 FBgn0053070 CDMC30123 3 8 4 DAC06-G05 23-CG33070-RC_7 CG33070 GCGTCGAACTCACTTAAATCGAATGCAAATAGTCTCAACCAAAGTAGCCTTAGTGAGTAAGCGGATATA 69 FBgn0053070 CDMC30124 3 9 4 DAC06-G17 23-CG3308-RA_6 CG3308 GAGATTCACGATAGACTCATACCTATGTGCCTTAACCACTAATCGAATTCAGGATGAAGCGCTTATCCT 69 FBan0003308 FBgn0038877 CG3308 3 3R DNA catabolism; GO:0006308 nucleic acid binding; GO:0003676; deoxyribonuclease activity; GO:0004536; ; GO:0003676; ; GO:0004536 CG3308 CG3308 CDMC30124 3 10 4 DAC06-G17 23-CG3308-RA_6 CG3308 GAGATTCACGATAGACTCATACCTATGTGCCTTAACCACTAATCGAATTCAGGATGAAGCGCTTATCCT 69 FBan0003308 FBgn0038877 CG3308 3 3R DNA catabolism; GO:0006308 nucleic acid binding; GO:0003676; deoxyribonuclease activity; GO:0004536; ; GO:0003676; ; GO:0004536 CG3308 CG3308 CDMC30125 3 11 4 DAC06-K05 14-CG33111-RA_2 CG33111 TCGCAACTCTAAAATATGCGTGGATCTGCACTCGTCCCGTGGAGTTGATGTTTGATCCTGTTCCTGACA 69 FBan0033111 FBgn0053111 CG33111 3 3R CG33111 CG33111 "CG11945, CG11957, CG10193" CDMC30125 3 12 4 DAC06-K05 14-CG33111-RA_2 CG33111 TCGCAACTCTAAAATATGCGTGGATCTGCACTCGTCCCGTGGAGTTGATGTTTGATCCTGTTCCTGACA 69 FBan0033111 FBgn0053111 CG33111 3 3R CG33111 CG33111 "CG11945, CG11957, CG10193" CDMC30126 3 13 4 DAC06-K17 14-CG33119-RA_1 CG33119 CGGACCGCCTCAGTCAGCATCTCAACACTAGCGAAAAGAGAAAGCACTTCAATCGCCAACTTGCTTATG 69 FBan0033119 FBgn0027929 CG33119 2 2L structural molecule activity; GO:0005198; ; GO:0005198 CG33119 CG33119 "CG8855, BG:DS00180.12, DS00180.12, CT25428, BcDNA:GH07762" CDMC30126 3 14 4 DAC06-K17 14-CG33119-RA_1 CG33119 CGGACCGCCTCAGTCAGCATCTCAACACTAGCGAAAAGAGAAAGCACTTCAATCGCCAACTTGCTTATG 69 FBan0033119 FBgn0027929 CG33119 2 2L structural molecule activity; GO:0005198; ; GO:0005198 CG33119 CG33119 "CG8855, BG:DS00180.12, DS00180.12, CT25428, BcDNA:GH07762" CDMC30127 3 15 4 DAC06-O05 9-CG33141-RA_1 CG33141 TGTGCTCCTCGCAAATCTTGTATGTCTTCCCCAGCTTGTCCTGACCACTGTTGAATGTCCTTGGTTCGA 69 FBan0033141 FBgn0024189 sns 2 2R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; larval visceral muscle development; GO:0007523; myoblast fusion; GO:0007520; nervous system development; GO:0007399; signal transduction; GO:0007165 plasma membrane; GO:0005886 sns sticks and stones "CG13755, CG12495, CG13754, CG2385, CG8278, CG13753, CG13752, CG33141, CG18464, CG13755, CG12495, CG13754, CG2385, CG8278, CG13753, CG13752, CG13755, 43-49, rost, SNS, CT33232, CT33230, sns20, sticks and stones" CDMC30127 3 16 4 DAC06-O05 9-CG33141-RA_1 CG33141 TGTGCTCCTCGCAAATCTTGTATGTCTTCCCCAGCTTGTCCTGACCACTGTTGAATGTCCTTGGTTCGA 69 FBan0033141 FBgn0024189 sns 2 2R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; larval visceral muscle development; GO:0007523; myoblast fusion; GO:0007520; nervous system development; GO:0007399; signal transduction; GO:0007165 plasma membrane; GO:0005886 sns sticks and stones "CG13755, CG12495, CG13754, CG2385, CG8278, CG13753, CG13752, CG33141, CG18464, CG13755, CG12495, CG13754, CG2385, CG8278, CG13753, CG13752, CG13755, 43-49, rost, SNS, CT33232, CT33230, sns20, sticks and stones" CDMC30128 3 17 4 DAC06-O17 2-CG33146-RA_1 CG33146 AGACGTTTGCTGAGACCCAATACCATTCCCAACAACGAGCTATTGGACTTCCTCTCGCGAGTGCCAGAT 69 FBan0033146 FBgn0053146 Mctp 2 2R Mctp Multiple C2 domain and transmembrane region protein "CG33146, CG33148, CG15078, CG33146, CG33148, CG33146, DmMCTP, Multiple C2 domain and transmembrane region protein" CDMC30128 3 18 4 DAC06-O17 2-CG33146-RA_1 CG33146 AGACGTTTGCTGAGACCCAATACCATTCCCAACAACGAGCTATTGGACTTCCTCTCGCGAGTGCCAGAT 69 FBan0033146 FBgn0053146 Mctp 2 2R Mctp Multiple C2 domain and transmembrane region protein "CG33146, CG33148, CG15078, CG33146, CG33148, CG33146, DmMCTP, Multiple C2 domain and transmembrane region protein" CDMC30129 3 19 4 DAC07-C05 18-CG5799-RA_1 CG5799 CGTTGCTTTCGAAGTCTTGGTATTTAATACCAACCCCCGAAATCTAGCCACCAATCAGCTTCGATGCGA 69 FBan0005799 FBgn0020307 dve 2 2R "midgut development; GO:0007494; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; wing morphogenesis; GO:0007476" AT DNA binding; GO:0003680; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003680 nucleus; GO:0005634 dve defective proventriculus "CG5799, dep, l(2)01738, Dve, Dve-s, compass, defective proventriculus" CDMC30129 3 20 4 DAC07-C05 18-CG5799-RA_1 CG5799 CGTTGCTTTCGAAGTCTTGGTATTTAATACCAACCCCCGAAATCTAGCCACCAATCAGCTTCGATGCGA 69 FBan0005799 FBgn0020307 dve 2 2R "midgut development; GO:0007494; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; wing morphogenesis; GO:0007476" AT DNA binding; GO:0003680; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003680 nucleus; GO:0005634 dve defective proventriculus "CG5799, dep, l(2)01738, Dve, Dve-s, compass, defective proventriculus" CDMC30130 3 21 4 DAC07-C17 11-CG5808-RA_1 CG5808 GCGCAACAGGACGGAAGATTTTCGAAATAGGATGAGCTCTGCAGAGCGAAGAAAAGCGAGAGAACAGCG 69 FBan0005808 FBgn0027617 CG5808 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 mRNA binding; GO:0003729; ; GO:0003729; isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG5808 CG5808 "cg5808, UKL, BcDNA:GH01073" CDMC30130 3 22 4 DAC07-C17 11-CG5808-RA_1 CG5808 GCGCAACAGGACGGAAGATTTTCGAAATAGGATGAGCTCTGCAGAGCGAAGAAAAGCGAGAGAACAGCG 69 FBan0005808 FBgn0027617 CG5808 3 3R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 mRNA binding; GO:0003729; ; GO:0003729; isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.- CG5808 CG5808 "cg5808, UKL, BcDNA:GH01073" CDMC30131 3 23 4 DAC07-G05 1-CG5847-RA_1 CG5847 GCCAGCCACGTACTTGCCACCTTCAACTACAAGAGCACCTAAGCCAAATTGCTACACGGGATCAACTGA 69 FBan0005847 FBgn0036985 CG5847 3 3L cell adhesion; GO:0007155; defense response; GO:0006952 structural constituent of cuticle (sensu Insecta); GO:0005214; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005214 CG5847 CG5847 CDMC30131 3 24 4 DAC07-G05 1-CG5847-RA_1 CG5847 GCCAGCCACGTACTTGCCACCTTCAACTACAAGAGCACCTAAGCCAAATTGCTACACGGGATCAACTGA 69 FBan0005847 FBgn0036985 CG5847 3 3L cell adhesion; GO:0007155; defense response; GO:0006952 structural constituent of cuticle (sensu Insecta); GO:0005214; receptor activity; GO:0004872; ; GO:0004872; ; GO:0005214 CG5847 CG5847 CDMC30132 3 25 4 DAC07-G17 15-CG5854-RB_2 CG5854 CTCCAGCACAAGCACCTCTACTTGGATAACACGAAACTGAAAGACTTTGGCTACGTGCTGCAGCATCCG 69 FBan0005854 FBgn0039130 CG5854 3 3R CG5854 CG5854 anon-WO0118547.306 CDMC30132 3 26 4 DAC07-G17 15-CG5854-RB_2 CG5854 CTCCAGCACAAGCACCTCTACTTGGATAACACGAAACTGAAAGACTTTGGCTACGTGCTGCAGCATCCG 69 FBan0005854 FBgn0039130 CG5854 3 3R CG5854 CG5854 anon-WO0118547.306 CDMC30133 3 1 5 DAC07-K05 13-CG5884-RA_1 CG5884 CGGGCATAACTAACCCCATACGAACGTGTACCCTGGGTAGATAGCAAGATCTAGGATAGACAGCAGCGA 69 FBan0005884 FBgn0026192 par-6 X X apical protein localization; GO:0045176; border follicle cell migration (sensu Insecta); GO:0007298; cell adhesion; GO:0007155; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; maintenance of oocyte identity (sensu Insecta); GO:0016350; morphogenesis of a polarized epithelium; GO:0001738; oocyte axis determination; GO:0007309; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; synaptogenesis; GO:0007416; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515 apical cortex; GO:0045179; apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; subapical complex; GO:0035003 par-6 par-6 "CG5884, DmPAR-6, dmPar-6, dPAR-6, DmPar-6, DPar-6, DmPar6, Dm-Par-6, Par6, DPar6, par, PAR6, dPar-6, Dmpar6, Par-6, par6" CDMC30133 3 2 5 DAC07-K05 13-CG5884-RA_1 CG5884 CGGGCATAACTAACCCCATACGAACGTGTACCCTGGGTAGATAGCAAGATCTAGGATAGACAGCAGCGA 69 FBan0005884 FBgn0026192 par-6 X X apical protein localization; GO:0045176; border follicle cell migration (sensu Insecta); GO:0007298; cell adhesion; GO:0007155; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; maintenance of oocyte identity (sensu Insecta); GO:0016350; morphogenesis of a polarized epithelium; GO:0001738; oocyte axis determination; GO:0007309; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; synaptogenesis; GO:0007416; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515 apical cortex; GO:0045179; apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; subapical complex; GO:0035003 par-6 par-6 "CG5884, DmPAR-6, dmPar-6, dPAR-6, DmPar-6, DPar-6, DmPar6, Dm-Par-6, Par6, DPar6, par, PAR6, dPar-6, Dmpar6, Par-6, par6" CDMC30134 3 3 5 DAC07-K17 10-CG5903-RA_1 CG5903 ACCCACTGCTTTCATTCGTCGTCATGCGTCATTCAGTCGAACCGTGCTGTGACAAATTACGCAATGTCT 69 FBan0005903 FBgn0038400 CG5903 3 3R CG5903 CG5903 "bs05g07.y1, anon-WO0118547.99, anon-EST:Posey87" CDMC30134 3 4 5 DAC07-K17 10-CG5903-RA_1 CG5903 ACCCACTGCTTTCATTCGTCGTCATGCGTCATTCAGTCGAACCGTGCTGTGACAAATTACGCAATGTCT 69 FBan0005903 FBgn0038400 CG5903 3 3R CG5903 CG5903 "bs05g07.y1, anon-WO0118547.99, anon-EST:Posey87" CDMC30135 3 5 5 DAC07-O05 18-CG5936-RA_1 CG5936 GGTAATCGTCTATCTACCGAGCATCTTTCGTGGCGAACTGATCAAATGCATCCTTGGATCGAGTGACGT 69 FBgn0030901 CDMC30135 3 6 5 DAC07-O05 18-CG5936-RA_1 CG5936 GGTAATCGTCTATCTACCGAGCATCTTTCGTGGCGAACTGATCAAATGCATCCTTGGATCGAGTGACGT 69 FBgn0030901 CDMC30136 3 7 5 DAC07-O17 14-CG5942-RB_1 CG5942 TGCAGCTATGCCAGAATGCACAGATCTACAACGAAGAGGCGTCTCTGATTTACCTGGACTCGATTGCCC 69 FBan0005942 FBgn0000212 brm 3 3L chromatin-mediated maintenance of transcription; GO:0048096; hemocyte proliferation (sensu Arthropoda); GO:0035172; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing vein specification; GO:0007474 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003676; transcription coactivator activity; GO:0003713; DNA helicase activity; GO:0003678; ; GO:0003713; protein binding; GO:0005515; ; GO:0003713; ; GO:0016251; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0005515 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 brm brahma "CG18438, CG5942, CG18438, l(3)72Aa, Brm, BRM, E(E2F)3A, dBRM, Complementation group 3.5, brahma" CDMC30136 3 8 5 DAC07-O17 14-CG5942-RB_1 CG5942 TGCAGCTATGCCAGAATGCACAGATCTACAACGAAGAGGCGTCTCTGATTTACCTGGACTCGATTGCCC 69 FBan0005942 FBgn0000212 brm 3 3L chromatin-mediated maintenance of transcription; GO:0048096; hemocyte proliferation (sensu Arthropoda); GO:0035172; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing vein specification; GO:0007474 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003676; transcription coactivator activity; GO:0003713; DNA helicase activity; GO:0003678; ; GO:0003713; protein binding; GO:0005515; ; GO:0003713; ; GO:0016251; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0005515 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 brm brahma "CG18438, CG5942, CG18438, l(3)72Aa, Brm, BRM, E(E2F)3A, dBRM, Complementation group 3.5, brahma" CDMC30137 3 9 5 DAC08-C05 12-CG8238-RA_3 CG8238 GGCCCAGAATCGAAGAAAGTTCAGTTTTCCAGCCACACTACATTCCGCATCACTACTGGAGGTTGGTGG 69 FBan0008238 FBgn0040491 Buffy 2 2R anti-apoptosis; GO:0006916; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of apoptosis; GO:0042981 Buffy Buffy "CG8238, CG8238, 48A-E Bcl-2-like, dBorg-2, buffy, Dbx, Buffy/DBorg-2, dBORG-2/BUFFY, Buffy/dBorg-2, Buffy/Borg2, Bcl-2-48AE" CDMC30137 3 10 5 DAC08-C05 12-CG8238-RA_3 CG8238 GGCCCAGAATCGAAGAAAGTTCAGTTTTCCAGCCACACTACATTCCGCATCACTACTGGAGGTTGGTGG 69 FBan0008238 FBgn0040491 Buffy 2 2R anti-apoptosis; GO:0006916; apoptosis; GO:0006915; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of apoptosis; GO:0042981 Buffy Buffy "CG8238, CG8238, 48A-E Bcl-2-like, dBorg-2, buffy, Dbx, Buffy/DBorg-2, dBORG-2/BUFFY, Buffy/dBorg-2, Buffy/Borg2, Bcl-2-48AE" CDMC30138 3 11 5 DAC08-C17 16-CG8250-RA_1 CG8250 GCACAGGACTCCCACACATTTTTGTACCCTGATGACATTACCTTGTGTACCTAAAGCCCACAACCTGAA 69 FBan0008250 FBgn0040505 Alk 2 2R electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; visceral muscle development; GO:0007522 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 Alk Alk "CG8250, CG8250, CG8250, DAlk, DAlk53, dALK, mili, ALK" CDMC30138 3 12 5 DAC08-C17 16-CG8250-RA_1 CG8250 GCACAGGACTCCCACACATTTTTGTACCCTGATGACATTACCTTGTGTACCTAAAGCCCACAACCTGAA 69 FBan0008250 FBgn0040505 Alk 2 2R electron transport; GO:0006118; protein amino acid phosphorylation; GO:0006468; regulation of hemocyte differentiation; GO:0045610; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169; visceral muscle development; GO:0007522 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 Alk Alk "CG8250, CG8250, CG8250, DAlk, DAlk53, dALK, mili, ALK" CDMC30139 3 13 5 DAC08-G05 3-CG8290-RB_3 CG8290 GGGCACCGAAGAGAGCATGAATCGGAATGAACAAGCTCACGCCTACGATCGAAAGTTGACACGCCTTCT 69 FBan0008290 FBgn0026573 CG8290 2 2R DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634 CG8290 CG8290 "LD29214, BEST:LD29214" CDMC30139 3 14 5 DAC08-G05 3-CG8290-RB_3 CG8290 GGGCACCGAAGAGAGCATGAATCGGAATGAACAAGCTCACGCCTACGATCGAAAGTTGACACGCCTTCT 69 FBan0008290 FBgn0026573 CG8290 2 2R DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634 CG8290 CG8290 "LD29214, BEST:LD29214" CDMC30140 3 15 5 DAC08-G17 9-CG8301-RA_1 CG8301 CTTGGAGAAGAACTTCAAGTGCAACGTTTGCGGTCGAGCCTATCTGTTTGAGAAGTCATTGCGGCTGCA 69 FBan0008301 FBgn0037717 CG8301 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8301 CG8301 CDMC30140 3 16 5 DAC08-G17 9-CG8301-RA_1 CG8301 CTTGGAGAAGAACTTCAAGTGCAACGTTTGCGGTCGAGCCTATCTGTTTGAGAAGTCATTGCGGCTGCA 69 FBan0008301 FBgn0037717 CG8301 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8301 CG8301 CDMC30141 3 17 5 DAC08-K05 11-CG8331-RA_1 CG8331 GCGACCCTACTTCCTGAAACATCACGAATCCGTTGACAGGATCATCGATGATGGCATGAAGAAAGCCGC 69 FBan0008331 FBgn0033906 CG8331 2 2R cell proliferation; GO:0008283 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG8331 CG8331 CT24597 CDMC30141 3 18 5 DAC08-K05 11-CG8331-RA_1 CG8331 GCGACCCTACTTCCTGAAACATCACGAATCCGTTGACAGGATCATCGATGATGGCATGAAGAAAGCCGC 69 FBan0008331 FBgn0033906 CG8331 2 2R cell proliferation; GO:0008283 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG8331 CG8331 CT24597 CDMC30142 3 19 5 DAC08-K17 2-CG8345-RA_2 CG8345 CGAGCGTCTAGGCAGTGGTACGGAAGTCCAAGTGAAGGATCTATGCTCCCGGTTCACCACTGACCTAAT 69 FBan0008345 FBgn0033065 Cyp6w1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6w1 Cyp6w1 "CG8345, 6w1, AntP450" CDMC30142 3 20 5 DAC08-K17 2-CG8345-RA_2 CG8345 CGAGCGTCTAGGCAGTGGTACGGAAGTCCAAGTGAAGGATCTATGCTCCCGGTTCACCACTGACCTAAT 69 FBan0008345 FBgn0033065 Cyp6w1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6w1 Cyp6w1 "CG8345, 6w1, AntP450" CDMC30143 3 21 5 DAC08-O05 2-CG8394-RA_3 CG8394 GCGATTGGGGTTGGTCCAAGGTTCGATTTAGCATCGACATGGAGAACTTTCCGATCTCACTGGGCGTCA 69 FBan0008394 FBgn0033911 CG8394 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; gamma-aminobutyric acid:hydrogen symporter activity; GO:0015495; ; GO:0015495 membrane; GO:0016020 CG8394 CG8394 "CG8394.2, CG8394.2" CDMC30143 3 22 5 DAC08-O05 2-CG8394-RA_3 CG8394 GCGATTGGGGTTGGTCCAAGGTTCGATTTAGCATCGACATGGAGAACTTTCCGATCTCACTGGGCGTCA 69 FBan0008394 FBgn0033911 CG8394 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; gamma-aminobutyric acid:hydrogen symporter activity; GO:0015495; ; GO:0015495 membrane; GO:0016020 CG8394 CG8394 "CG8394.2, CG8394.2" CDMC30144 3 23 5 DAC08-O17 23-CG8407-RA_1 CG8407 CCAAAACCGAACCAAACAAAAATTTAGCATTAATTTTAGTCATACACACAGAACACTCACCGTAGTTAA 69 FBan0008407 FBgn0033687 CG8407 2 2R microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003777" dynein complex; GO:0030286 CG8407 CG8407 CDMC30144 3 24 5 DAC08-O17 23-CG8407-RA_1 CG8407 CCAAAACCGAACCAAACAAAAATTTAGCATTAATTTTAGTCATACACACAGAACACTCACCGTAGTTAA 69 FBan0008407 FBgn0033687 CG8407 2 2R microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003777" dynein complex; GO:0030286 CG8407 CG8407 CDMC30145 3 25 5 DAC09-C06 3-CG12825-RA_1 CG12825 GGGAATACACATTTCGGCGCTGCAGATCTTGGGAAGCGTGGTCCTCATCGTTGGAGCCATAAAGCAAAA 69 FBan0012825 FBgn0033221 CG12825 2 2R CG12825 CG12825 CDMC30145 3 26 5 DAC09-C06 3-CG12825-RA_1 CG12825 GGGAATACACATTTCGGCGCTGCAGATCTTGGGAAGCGTGGTCCTCATCGTTGGAGCCATAAAGCAAAA 69 FBan0012825 FBgn0033221 CG12825 2 2R CG12825 CG12825 CDMC30146 3 1 6 DAC09-C18 1-CG12842-RA_1 CG12842 TGCACCAAGAATTTAATCAGAAACGACGCCTTGAATGTGCACATTGGCACCGGCAAGTCTGACATCCGC 69 FBan0012842 FBgn0033131 CG12842 2 2R CG12842 CG12842 CDMC30146 3 2 6 DAC09-C18 1-CG12842-RA_1 CG12842 TGCACCAAGAATTTAATCAGAAACGACGCCTTGAATGTGCACATTGGCACCGGCAAGTCTGACATCCGC 69 FBan0012842 FBgn0033131 CG12842 2 2R CG12842 CG12842 CDMC30147 3 3 6 DAC09-G06 2-CG12875-RA_1 CG12875 GCCACCGTGCAGTCCAGGAATCGATACGGATGGAGCGATTTGACCAACAGTTTCGTCTTCTCCACATCA 69 FBan0012875 FBgn0039545 CG12875 3 3R CG12875 CG12875 CDMC30147 3 4 6 DAC09-G06 2-CG12875-RA_1 CG12875 GCCACCGTGCAGTCCAGGAATCGATACGGATGGAGCGATTTGACCAACAGTTTCGTCTTCTCCACATCA 69 FBan0012875 FBgn0039545 CG12875 3 3R CG12875 CG12875 CDMC30148 3 5 6 DAC09-G18 23-CG12885-RA_9 CG12885 AGCCACCCAATTCAATGTGAACGACCGTCTCGATTTATTGCCAATTCATTGGGCGAAAGAAAATTCGAG 69 FBan0012885 FBgn0039523 CG12885 3 3R CG12885 CG12885 CDMC30148 3 6 6 DAC09-G18 23-CG12885-RA_9 CG12885 AGCCACCCAATTCAATGTGAACGACCGTCTCGATTTATTGCCAATTCATTGGGCGAAAGAAAATTCGAG 69 FBan0012885 FBgn0039523 CG12885 3 3R CG12885 CG12885 CDMC30149 3 7 6 DAC09-K06 12-CG12928-RA_2 CG12928 AGCGGTGGAGCTTTGGAAGTGGAGTAATGGCAATTACTCTCTATCAAGCAGGCTGATAGATGGGCAGGT 69 FBan0012928 FBgn0033432 CG12928 2 2R CG12928 CG12928 CDMC30149 3 8 6 DAC09-K06 12-CG12928-RA_2 CG12928 AGCGGTGGAGCTTTGGAAGTGGAGTAATGGCAATTACTCTCTATCAAGCAGGCTGATAGATGGGCAGGT 69 FBan0012928 FBgn0033432 CG12928 2 2R CG12928 CG12928 CDMC30150 3 9 6 DAC09-K18 9-CG12944-RA_1 CG12944 GCGATCTATTCGGGCTTCTTTCCGATGTCAGTAATACCGATTACTGGCCAGAACGTCAATGCCACGCGA 69 FBan0012944 FBgn0033573 Obp47a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp47a Odorant-binding protein 47a "CG12944, CG12944, CG12944, CG12944, 47a, Odorant-binding protein 47a" CDMC30150 3 10 6 DAC09-K18 9-CG12944-RA_1 CG12944 GCGATCTATTCGGGCTTCTTTCCGATGTCAGTAATACCGATTACTGGCCAGAACGTCAATGCCACGCGA 69 FBan0012944 FBgn0033573 Obp47a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp47a Odorant-binding protein 47a "CG12944, CG12944, CG12944, CG12944, 47a, Odorant-binding protein 47a" CDMC30151 3 11 6 DAC09-O06 1-CG12994-RA_1 CG12994 TCACTACTACAATGGACGCTCCTATGTGGGCATCAACGAGGAGATCATGTGGGTAAGCATCGGCATGGG 69 FBan0012994 FBgn0040877 CG12994 X X CG12994 CG12994 CDMC30151 3 12 6 DAC09-O06 1-CG12994-RA_1 CG12994 TCACTACTACAATGGACGCTCCTATGTGGGCATCAACGAGGAGATCATGTGGGTAAGCATCGGCATGGG 69 FBan0012994 FBgn0040877 CG12994 X X CG12994 CG12994 CDMC30152 3 13 6 DAC09-O18 23-CG13003-RA_3 CG13003 CACTAACAAATAGTTACGTTATGTAGAGCTGGTCATATAAGAAATAAACCCCGATTTGGTCCTGCTGCT 69 FBan0013003 FBgn0030798 CG13003 X X CG13003 CG13003 CDMC30152 3 14 6 DAC09-O18 23-CG13003-RA_3 CG13003 CACTAACAAATAGTTACGTTATGTAGAGCTGGTCATATAAGAAATAAACCCCGATTTGGTCCTGCTGCT 69 FBan0013003 FBgn0030798 CG13003 X X CG13003 CG13003 CDMC30153 3 15 6 DAC10-C05 14-CG10956-RA_7 CG10956 GCCAAGGACTTCTCGTAAATGCCATTTTCTTCAATTTGAGTTGGGAGCGGACATTCAATCCGGAGGCCA 69 FBan0010956 FBgn0034195 CG10956 2 2R negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG10956 CG10956 CDMC30153 3 16 6 DAC10-C05 14-CG10956-RA_7 CG10956 GCCAAGGACTTCTCGTAAATGCCATTTTCTTCAATTTGAGTTGGGAGCGGACATTCAATCCGGAGGCCA 69 FBan0010956 FBgn0034195 CG10956 2 2R negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG10956 CG10956 CDMC30154 3 17 6 DAC10-C17 14-CG10967-RA_1 CG10967 ACATGACCGATGAGAATGCTTAGTTACTCGGGCGGATAGAGCTATATTCCAACCATGAAGCACCGGCAA 69 FBgn0036313 CDMC30154 3 18 6 DAC10-C17 14-CG10967-RA_1 CG10967 ACATGACCGATGAGAATGCTTAGTTACTCGGGCGGATAGAGCTATATTCCAACCATGAAGCACCGGCAA 69 FBgn0036313 CDMC30155 3 19 6 DAC10-G05 1-CG11007-RA_2 CG11007 CGGAGAGGATGAAGCATGCGACCTGGACAGTCGTGAGGTGGAAATCTTGTTCTTCCTGCTAATCGTGGT 69 FBan0011007 FBgn0034455 CG11007 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG11007 CG11007 CDMC30155 3 20 6 DAC10-G05 1-CG11007-RA_2 CG11007 CGGAGAGGATGAAGCATGCGACCTGGACAGTCGTGAGGTGGAAATCTTGTTCTTCCTGCTAATCGTGGT 69 FBan0011007 FBgn0034455 CG11007 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG11007 CG11007 CDMC30156 3 21 6 DAC10-G17 3-CG11024-RA_3 CG11024 CGCTTTTCGGTCGCATACTCAGACGCTACTGCGCGGTGAATACTAATCCCAGCAAGATCATGGTGGTCA 69 FBan0011024 FBgn0000318 cl 2 2L electron transport; GO:0006118 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 cl clot "CG11024, BcDNA:RE06767" CDMC30156 3 22 6 DAC10-G17 3-CG11024-RA_3 CG11024 CGCTTTTCGGTCGCATACTCAGACGCTACTGCGCGGTGAATACTAATCCCAGCAAGATCATGGTGGTCA 69 FBan0011024 FBgn0000318 cl 2 2L electron transport; GO:0006118 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 cl clot "CG11024, BcDNA:RE06767" CDMC30157 3 23 6 DAC10-K05 3-CG1105-RA_1 CG1105 GGTGACGCTTGATCGTCCGTGGAAATTCGATCAGGACATGAAGATGGCGTTCACAGTAATAGCGCCCGT 69 FBan0001105 FBgn0037465 CG1105 3 3R CG1105 CG1105 CDMC30157 3 24 6 DAC10-K05 3-CG1105-RA_1 CG1105 GGTGACGCTTGATCGTCCGTGGAAATTCGATCAGGACATGAAGATGGCGTTCACAGTAATAGCGCCCGT 69 FBan0001105 FBgn0037465 CG1105 3 3R CG1105 CG1105 CDMC30158 3 25 6 DAC10-K17 1-CG11068-RA_1 CG11068 ACGTCACGCAGAACTACCGATACCTGTTCCACGTCACCTGATCTACCGAGCATTCCAGAAGGAGAGCAA 69 FBan0011068 FBgn0030536 CG11068 X X CG11068 CG11068 CDMC30158 3 26 6 DAC10-K17 1-CG11068-RA_1 CG11068 ACGTCACGCAGAACTACCGATACCTGTTCCACGTCACCTGATCTACCGAGCATTCCAGAAGGAGAGCAA 69 FBan0011068 FBgn0030536 CG11068 X X CG11068 CG11068 CDMC30159 3 1 7 DAC10-O05 2-CG11101-RA_3 CG11101 ATCGCATTTACGAGCACCGAATTGTGTGGGACACCAAGCTCATGGACAAACACAGCGAACCCTTTGGAC 69 FBan0011101 FBgn0003174 pwn 2 2R bristle morphogenesis; GO:0008407; phototransduction; GO:0007602 calcium ion binding; GO:0005509; ; GO:0005509 pwn pawn "CG11101, CG11101, l(2)pwn, CT31067, N-like" CDMC30159 3 2 7 DAC10-O05 2-CG11101-RA_3 CG11101 ATCGCATTTACGAGCACCGAATTGTGTGGGACACCAAGCTCATGGACAAACACAGCGAACCCTTTGGAC 69 FBan0011101 FBgn0003174 pwn 2 2R bristle morphogenesis; GO:0008407; phototransduction; GO:0007602 calcium ion binding; GO:0005509; ; GO:0005509 pwn pawn "CG11101, CG11101, l(2)pwn, CT31067, N-like" CDMC30160 3 3 7 DAC10-O17 3-CG11123-RA_5 CG11123 GCCAGGAACGAACTTTTCAGTCCAGCGTCTCCTTCAGCACATCAAAGAGGTGCCTGATTTCGAGTCCGT 69 FBan0011123 FBgn0033169 CG11123 2 2R mRNA metabolism; GO:0016071 mRNA binding; GO:0003729; ; GO:0003729 CG11123 CG11123 CDMC30160 3 4 7 DAC10-O17 3-CG11123-RA_5 CG11123 GCCAGGAACGAACTTTTCAGTCCAGCGTCTCCTTCAGCACATCAAAGAGGTGCCTGATTTCGAGTCCGT 69 FBan0011123 FBgn0033169 CG11123 2 2R mRNA metabolism; GO:0016071 mRNA binding; GO:0003729; ; GO:0003729 CG11123 CG11123 CDMC30161 3 5 7 DAC11-C05 18-CG12193-RA_1 CG12193 GCGTTCGTGAACATAGTAATGCTCATCCTTCTGCCGATCTCGATAAGCATCGAGTACCTCCACCGATTT 69 FBan0012193 FBgn0026398 Or22a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 dendrite; GO:0030425; integral to membrane; GO:0016021 Or22a Odorant receptor 22a "CG12193, CG12193, DOR22A.1, Olfactory receptor 22A.1, dor53, AN11, Dor53, 22A.1, DOR53, DOR22a, 22a, Or22A.1, Or53: Odorant receptor 53, Odorant receptor 53" CDMC30161 3 6 7 DAC11-C05 18-CG12193-RA_1 CG12193 GCGTTCGTGAACATAGTAATGCTCATCCTTCTGCCGATCTCGATAAGCATCGAGTACCTCCACCGATTT 69 FBan0012193 FBgn0026398 Or22a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 dendrite; GO:0030425; integral to membrane; GO:0016021 Or22a Odorant receptor 22a "CG12193, CG12193, DOR22A.1, Olfactory receptor 22A.1, dor53, AN11, Dor53, 22A.1, DOR53, DOR22a, 22a, Or22A.1, Or53: Odorant receptor 53, Odorant receptor 53" CDMC30162 3 7 7 DAC11-C17 9-CG12207-RA_1 CG12207 AGGCGCACAACAATGCCAATAATCTGAGCCAGAGCAACAAGAGCTTCATGAAGAGCAACGACATCAGCA 69 FBan0012207 FBgn0038220 CG12207 3 3R CG12207 CG12207 CDMC30162 3 8 7 DAC11-C17 9-CG12207-RA_1 CG12207 AGGCGCACAACAATGCCAATAATCTGAGCCAGAGCAACAAGAGCTTCATGAAGAGCAACGACATCAGCA 69 FBan0012207 FBgn0038220 CG12207 3 3R CG12207 CG12207 CDMC30163 3 9 7 DAC11-G05 14-CG12236-RA_2 CG12236 CGCGAAATGGGCTGTTCGACCAAGGGATTCACCAAGATCGAGTACAGCGATCACTGAGACAGCGGTATG 69 FBan0012236 FBgn0029822 CG12236 X X "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG12236 CG12236 CDMC30163 3 10 7 DAC11-G05 14-CG12236-RA_2 CG12236 CGCGAAATGGGCTGTTCGACCAAGGGATTCACCAAGATCGAGTACAGCGATCACTGAGACAGCGGTATG 69 FBan0012236 FBgn0029822 CG12236 X X "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transcription from RNA polymerase II promoter; GO:0006366; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG12236 CG12236 CDMC30164 3 11 7 DAC11-G17 9-CG12251-RA_1 CG12251 TCCATCCACTTTCCTCTCACCAAAGGTGATCATCTTCTGTATCCAATTGGCAGGCTGGAGCGAATCGGG 69 FBan0012251 FBgn0033807 AQP 2 2R water transport; GO:0006833 water transporter activity; GO:0005372; ; GO:0005372 AQP aquaporin "CG12251, AQP-dr, aquaporin" CDMC30164 3 12 7 DAC11-G17 9-CG12251-RA_1 CG12251 TCCATCCACTTTCCTCTCACCAAAGGTGATCATCTTCTGTATCCAATTGGCAGGCTGGAGCGAATCGGG 69 FBan0012251 FBgn0033807 AQP 2 2R water transport; GO:0006833 water transporter activity; GO:0005372; ; GO:0005372 AQP aquaporin "CG12251, AQP-dr, aquaporin" CDMC30165 3 13 7 DAC11-K05 23-CG12297-RA_9 CG12297 CAGGGAGTGAAGTTGCGTTGATACATTTTGGGAACTTAAGACCGCTGAAAATACCGTCTCTGTAAATTA 69 FBan0012297 FBgn0038928 BG4 3 3R antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; signal transduction; GO:0007165; sperm individualization; GO:0007291 protein binding; GO:0005515; death receptor binding; GO:0005123; ; GO:0005515; ; GO:0005123; ; GO:0005515 BG4 BG4 "CG12297, dFADD, FADD, dFadd, Fadd" CDMC30165 3 14 7 DAC11-K05 23-CG12297-RA_9 CG12297 CAGGGAGTGAAGTTGCGTTGATACATTTTGGGAACTTAAGACCGCTGAAAATACCGTCTCTGTAAATTA 69 FBan0012297 FBgn0038928 BG4 3 3R antibacterial polypeptide induction; GO:0006963; apoptosis; GO:0006915; defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; signal transduction; GO:0007165; sperm individualization; GO:0007291 protein binding; GO:0005515; death receptor binding; GO:0005123; ; GO:0005515; ; GO:0005123; ; GO:0005515 BG4 BG4 "CG12297, dFADD, FADD, dFadd, Fadd" CDMC30166 3 15 7 DAC11-K17 3-CG12307-RA_1 CG12307 AGGCGCCACATACCAACTGCCCCAAGTCCATTGTCCAACAACCTATATATCAACGAATGGAGACCCGGT 69 FBan0012307 FBgn0032370 CG12307 2 2L CG12307 CG12307 CDMC30166 3 16 7 DAC11-K17 3-CG12307-RA_1 CG12307 AGGCGCCACATACCAACTGCCCCAAGTCCATTGTCCAACAACCTATATATCAACGAATGGAGACCCGGT 69 FBan0012307 FBgn0032370 CG12307 2 2L CG12307 CG12307 CDMC30167 3 17 7 DAC11-O05 16-CG12345-RB_1 CG12345 CGATGACCTGGACTTCTATGTGTACCGCTACCAGAGTTACGGAAAGACCTTTATCAAATCGTGCCAGGT 69 FBan0012345 FBgn0000303 Cha 3 3R acetylcholine biosynthesis; GO:0008292; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 choline O-acetyltransferase activity; GO:0004102 ; EC:2.3.1.6; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004102 ; EC:2.3.1.6; ; GO:0008270 Cha Choline acetyltransferase "CG12345, CG12345, CG12345, CG12345, CG12345, ChAT, dChAT, cha, choline acetyltransferase, CT23399, choline acetyl transferase, ChaT, Cat, l(3)91Cc" CDMC30167 3 18 7 DAC11-O05 16-CG12345-RB_1 CG12345 CGATGACCTGGACTTCTATGTGTACCGCTACCAGAGTTACGGAAAGACCTTTATCAAATCGTGCCAGGT 69 FBan0012345 FBgn0000303 Cha 3 3R acetylcholine biosynthesis; GO:0008292; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 choline O-acetyltransferase activity; GO:0004102 ; EC:2.3.1.6; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004102 ; EC:2.3.1.6; ; GO:0008270 Cha Choline acetyltransferase "CG12345, CG12345, CG12345, CG12345, CG12345, ChAT, dChAT, cha, choline acetyltransferase, CT23399, choline acetyl transferase, ChaT, Cat, l(3)91Cc" CDMC30168 3 19 7 DAC11-O17 1-CG1234-RA_1 CG1234 TCCCACGAGCTGTTTACGCAATTCGACAGCACTCAGATGGCTTTCAATCCGACAATACCGCTGCCAAAA 69 FBan0001234 FBgn0037489 CG1234 3 3R CG1234 CG1234 CDMC30168 3 20 7 DAC11-O17 1-CG1234-RA_1 CG1234 TCCCACGAGCTGTTTACGCAATTCGACAGCACTCAGATGGCTTTCAATCCGACAATACCGCTGCCAAAA 69 FBan0001234 FBgn0037489 CG1234 3 3R CG1234 CG1234 CDMC30169 3 21 7 DAC12-C05 2-CG7864-RA_3 CG7864 AGCCGCAGCTAAAGAAGATTATTCAGAGGCTCAGGCAATCTCCCAGCTACGTAAAGGCCCTGCACAAGT 69 FBan0007864 FBgn0035233 CG7864 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG7864 CG7864 CDMC30169 3 22 7 DAC12-C05 2-CG7864-RA_3 CG7864 AGCCGCAGCTAAAGAAGATTATTCAGAGGCTCAGGCAATCTCCCAGCTACGTAAAGGCCCTGCACAAGT 69 FBan0007864 FBgn0035233 CG7864 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG7864 CG7864 CDMC30170 3 23 7 DAC12-C17 23-CG7874-RA_2 CG7874 GCTCCACGCTCCTTTTCTACAGATAAACCCTTCCATTTATGTTGGTCCCTTGCTCTAGTCTAGCGAAAT 69 FBan0007874 FBgn0030999 CG7874 X X CG7874 CG7874 anon-WO0140519.120 CDMC30170 3 24 7 DAC12-C17 23-CG7874-RA_2 CG7874 GCTCCACGCTCCTTTTCTACAGATAAACCCTTCCATTTATGTTGGTCCCTTGCTCTAGTCTAGCGAAAT 69 FBan0007874 FBgn0030999 CG7874 X X CG7874 CG7874 anon-WO0140519.120 CDMC30171 3 25 7 DAC12-G05 9-CG7908-RA_1 CG7908 CGCCATGAAATGAAGCTGATTGAGTGGAGCCAGAAACTGGACCTTATACATCCCAGTGACGAGAGGCGT 69 FBan0007908 FBgn0039734 Tace 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- Tace Tace "CG7908, CT23908, TACE, DTACE" CDMC30171 3 26 7 DAC12-G05 9-CG7908-RA_1 CG7908 CGCCATGAAATGAAGCTGATTGAGTGGAGCCAGAAACTGGACCTTATACATCCCAGTGACGAGAGGCGT 69 FBan0007908 FBgn0039734 Tace 3 3R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- Tace Tace "CG7908, CT23908, TACE, DTACE" CDMC30172 3 1 8 DAC12-G17 23-CG7919-RA_5 CG7919 TGGCAAGACTCGTTTGTAAATTCCTTATCATGGCAGTTTTTAGAACATAAGGCAGTAAATTGCACCGAA 69 FBan0007919 FBgn0028379 fan 3 3L intracellular protein transport; GO:0006886; synaptic transmission; GO:0007268; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 fan farinelli "CG7919, farinelli" CDMC30172 3 2 8 DAC12-G17 23-CG7919-RA_5 CG7919 TGGCAAGACTCGTTTGTAAATTCCTTATCATGGCAGTTTTTAGAACATAAGGCAGTAAATTGCACCGAA 69 FBan0007919 FBgn0028379 fan 3 3L intracellular protein transport; GO:0006886; synaptic transmission; GO:0007268; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 fan farinelli "CG7919, farinelli" CDMC30173 3 3 8 DAC12-K05 14-CG7945-RB_3 CG7945 TCGAAAAATCAACAATATTTTTGCATCGGGCCAAAGGTGCATTAAAACCGGAGCCTCAAGTCTCGGGCG 69 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC30173 3 4 8 DAC12-K05 14-CG7945-RB_3 CG7945 TCGAAAAATCAACAATATTTTTGCATCGGGCCAAAGGTGCATTAAAACCGGAGCCTCAAGTCTCGGGCG 69 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC30174 3 5 8 DAC12-K17 12-CG7956-RA_5 CG7956 GCAGAAGGATAGCATGTGCAAAACCACAGAGGATGTGCTAACCATTTCCATAACCTCCGTGACGGACCA 69 FBan0007956 FBgn0038890 CG7956 3 3R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.- CG7956 CG7956 CDMC30174 3 6 8 DAC12-K17 12-CG7956-RA_5 CG7956 GCAGAAGGATAGCATGTGCAAAACCACAGAGGATGTGCTAACCATTTCCATAACCTCCGTGACGGACCA 69 FBan0007956 FBgn0038890 CG7956 3 3R phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016791 ; EC:3.1.3.- CG7956 CG7956 CDMC30175 3 7 8 DAC12-O05 9-CG7993-RA_3 CG7993 ACGAGGTGCTGGACATGTTTGAACTGGGCATCAAGCGGTATCAGGCGATTTCCGAGTTTAAGAACGAGA 69 FBan0007993 FBgn0038585 CG7993 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7993 CG7993 CDMC30175 3 8 8 DAC12-O05 9-CG7993-RA_3 CG7993 ACGAGGTGCTGGACATGTTTGAACTGGGCATCAAGCGGTATCAGGCGATTTCCGAGTTTAAGAACGAGA 69 FBan0007993 FBgn0038585 CG7993 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7993 CG7993 CDMC30176 3 9 8 DAC12-O17 2-CG8006-RA_2 CG8006 GCTCCACATTCAATCGGGATGCACCTGACAGCGGAAGAACCCATTCCTCCAGTTCCTTATCCCAAGAGA 69 FBan0008006 FBgn0035857 CG8006 3 3L CG8006 CG8006 CDMC30176 3 10 8 DAC12-O17 2-CG8006-RA_2 CG8006 GCTCCACATTCAATCGGGATGCACCTGACAGCGGAAGAACCCATTCCTCCAGTTCCTTATCCCAAGAGA 69 FBan0008006 FBgn0035857 CG8006 3 3L CG8006 CG8006 CDMC30177 3 11 8 DAC13-C05 9-CG13272-RA_7 CG13272 CCACCGAAACCGCTACTAGGACCCATGTACCTCATCATCGAGGGTCATTCGAAAGTGAAGACCTACGGT 69 FBan0013272 FBgn0032607 CG13272 2 2L CG13272 CG13272 CDMC30177 3 12 8 DAC13-C05 9-CG13272-RA_7 CG13272 CCACCGAAACCGCTACTAGGACCCATGTACCTCATCATCGAGGGTCATTCGAAAGTGAAGACCTACGGT 69 FBan0013272 FBgn0032607 CG13272 2 2L CG13272 CG13272 CDMC30178 3 13 8 DAC13-C17 3-CG13283-RA_1 CG13283 CGCCTTTGCCGAGACCTTTGTGCTGGACTACTTCGGATTGAATCCACACAGGGTACTCTTCTATGCGGT 69 FBan0013283 FBgn0032613 CG13283 2 2L CG13283 CG13283 CDMC30178 3 14 8 DAC13-C17 3-CG13283-RA_1 CG13283 CGCCTTTGCCGAGACCTTTGTGCTGGACTACTTCGGATTGAATCCACACAGGGTACTCTTCTATGCGGT 69 FBan0013283 FBgn0032613 CG13283 2 2L CG13283 CG13283 CDMC30179 3 15 8 DAC13-G05 9-CG13313-RA_1 CG13313 AGCAGTTTGGCATTAGCTCCACTGTCGAAGGCTAATGAATCCCTGATCCTGGCGAATGATACCCTCCTC 69 FBan0013313 FBgn0035941 CG13313 3 3L CG13313 CG13313 CDMC30179 3 16 8 DAC13-G05 9-CG13313-RA_1 CG13313 AGCAGTTTGGCATTAGCTCCACTGTCGAAGGCTAATGAATCCCTGATCCTGGCGAATGATACCCTCCTC 69 FBan0013313 FBgn0035941 CG13313 3 3L CG13313 CG13313 CDMC30180 3 17 8 DAC13-G17 2-CG13320-RA_1 CG13320 GCAAGGCCCTGAAAGAATTGGCCGAGAAAAACTGCGAGAAACGTGTTAGGGAGTACATGAAGCGCCAGA 69 FBan0013320 FBgn0033785 CG13320 2 2R CG13320 CG13320 CDMC30180 3 18 8 DAC13-G17 2-CG13320-RA_1 CG13320 GCAAGGCCCTGAAAGAATTGGCCGAGAAAAACTGCGAGAAACGTGTTAGGGAGTACATGAAGCGCCAGA 69 FBan0013320 FBgn0033785 CG13320 2 2R CG13320 CG13320 CDMC30181 3 19 8 DAC13-K05 3-CG13345-RA_3 CG13345 CTATGTGCTGTGCTGTTGTGTCAAGGATTTCCTGAGGTCCCTAACAGAGCCTCTCATTCCCACCAGCCA 69 FBan0013345 FBgn0033881 RacGAP50C 2 2R Rho protein signal transduction; GO:0007266; cell proliferation; GO:0008283; cytokinesis; GO:0000910; negative regulation of Wnt receptor signaling pathway; GO:0030178 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; GTPase activator activity; GO:0005096; signal transducer activity; GO:0004871; ; GO:0019992; ; GO:0004871; ; GO:0005100; ; GO:0005096 RacGAP50C RacGAP50C "CG13345, CG13345, CG13345, CG13345, CG13345, CG13345, DRacGAP, RhoGAP-50C14, acGAP, AcGAP, eon, enhancer of naked, RacGAP, i249, RacGap50C, racGAP50C" CDMC30181 3 20 8 DAC13-K05 3-CG13345-RA_3 CG13345 CTATGTGCTGTGCTGTTGTGTCAAGGATTTCCTGAGGTCCCTAACAGAGCCTCTCATTCCCACCAGCCA 69 FBan0013345 FBgn0033881 RacGAP50C 2 2R Rho protein signal transduction; GO:0007266; cell proliferation; GO:0008283; cytokinesis; GO:0000910; negative regulation of Wnt receptor signaling pathway; GO:0030178 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; GTPase activator activity; GO:0005096; signal transducer activity; GO:0004871; ; GO:0019992; ; GO:0004871; ; GO:0005100; ; GO:0005096 RacGAP50C RacGAP50C "CG13345, CG13345, CG13345, CG13345, CG13345, CG13345, DRacGAP, RhoGAP-50C14, acGAP, AcGAP, eon, enhancer of naked, RacGAP, i249, RacGap50C, racGAP50C" CDMC30182 3 21 8 DAC13-K17 24-CG13367-RA_1 CG13367 ACTTGATGTACTGTAGTACCAACTGAACTCAATCAGCAATTAATGAATAAAATACAATTTTGTAATTAT 69 FBan0013367 FBgn0025634 CG13367 X X CG13367 CG13367 "anon-1BCb, EG:115C2.8" CDMC30182 3 22 8 DAC13-K17 24-CG13367-RA_1 CG13367 ACTTGATGTACTGTAGTACCAACTGAACTCAATCAGCAATTAATGAATAAAATACAATTTTGTAATTAT 69 FBan0013367 FBgn0025634 CG13367 X X CG13367 CG13367 "anon-1BCb, EG:115C2.8" CDMC30183 3 23 8 DAC13-O05 2-CG13407-RA_3 CG13407 GGGCTCCGATTACTATCAGCACCACTATAACCCGTATGCTGGCACAAACTCCCATCGGCATCCTTGGTC 69 FBan0013407 FBgn0038931 CG13407 3 3R CG13407 CG13407 CDMC30183 3 24 8 DAC13-O05 2-CG13407-RA_3 CG13407 GGGCTCCGATTACTATCAGCACCACTATAACCCGTATGCTGGCACAAACTCCCATCGGCATCCTTGGTC 69 FBan0013407 FBgn0038931 CG13407 3 3R CG13407 CG13407 CDMC30184 3 25 8 DAC13-O17 23-CG13418-RA_1 CG13418 CCGAAAACTCTTAGTTGCTAGCAATGTCCGTGTAAATAGTCCTAGATTAATGAAAATAATCATGCTCGA 69 FBan0013418 FBgn0038903 RpI12 3 3R "RNA elongation; GO:0006354; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase I promoter; GO:0006360" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003700; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736 RpI12 RpI12 CG13418 CDMC30184 3 26 8 DAC13-O17 23-CG13418-RA_1 CG13418 CCGAAAACTCTTAGTTGCTAGCAATGTCCGTGTAAATAGTCCTAGATTAATGAAAATAATCATGCTCGA 69 FBan0013418 FBgn0038903 RpI12 3 3R "RNA elongation; GO:0006354; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase I promoter; GO:0006360" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; transcription factor activity; GO:0003700; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003700; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736 RpI12 RpI12 CG13418 CDMC30185 3 1 9 DAC14-C05 3-CG8667-RA_1 CG8667 GCACAGCCTAAACGATGCATTTCAATCGCTTCGAGAGGTCATACCGCACGTGGAGATGGAGCGAC 65 FBgn0032942 CDMC30185 3 2 9 DAC14-C05 3-CG8667-RA_1 CG8667 GCACAGCCTAAACGATGCATTTCAATCGCTTCGAGAGGTCATACCGCACGTGGAGATGGAGCGAC 65 FBgn0032942 CDMC30186 3 3 9 DAC14-C17 6-CG8717-RA_1 CG8717 TTCGTGAACTAAGCCCTTGCGTACGGGACCATCTCTAGTCGAAAGTGCCATCTCTACGCCCTCGA 65 FBan0008717 FBgn0025469 slv 2 2R slv saliva "CG8717, saliva" CDMC30186 3 4 9 DAC14-C17 6-CG8717-RA_1 CG8717 TTCGTGAACTAAGCCCTTGCGTACGGGACCATCTCTAGTCGAAAGTGCCATCTCTACGCCCTCGA 65 FBan0008717 FBgn0025469 slv 2 2R slv saliva "CG8717, saliva" CDMC30187 3 5 9 DAC14-G05 2-CG8833-RA_1 CG8833 ATCGCATACAAACCACGAAAGGAGCGACTGAGAAACGATAGGGAGTTGGCAATGGCTGAGGTGGC 65 FBan0008833 FBgn0036386 CG8833 3 3L CG8833 CG8833 CDMC30187 3 6 9 DAC14-G05 2-CG8833-RA_1 CG8833 ATCGCATACAAACCACGAAAGGAGCGACTGAGAAACGATAGGGAGTTGGCAATGGCTGAGGTGGC 65 FBan0008833 FBgn0036386 CG8833 3 3L CG8833 CG8833 CDMC30188 3 7 9 DAC14-G17 1-CG8869-RA_2 CG8869 CTTCCGCCAGCACTCGGACTACAACACCAACAACCTGAACAACGACATCTCGCTGATCAACACCC 65 FBan0008869 FBgn0031654 Jon25Bii 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon25Bii Jonah 25Bii "CG8869, 25B, Jon25B, SP112, Jonah 25B" CDMC30188 3 8 9 DAC14-G17 1-CG8869-RA_2 CG8869 CTTCCGCCAGCACTCGGACTACAACACCAACAACCTGAACAACGACATCTCGCTGATCAACACCC 65 FBan0008869 FBgn0031654 Jon25Bii 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon25Bii Jonah 25Bii "CG8869, 25B, Jon25B, SP112, Jonah 25B" CDMC30189 3 9 9 DAC14-K05 18-CG8980-RA_15 CG8980 ATCTATTTGGTCGCAACAGTCAAATGAACGACTTCTGCATAGACCATGCCTCTTGTTCGCGGGTC 65 FBan0008980 FBgn0026402 NiPp1 2 2R negative regulation of protein amino acid dephosphorylation; GO:0035308; signal transduction; GO:0007165 mRNA binding; GO:0003729; ; GO:0003729; protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864; type 1 serine/threonine specific protein phosphatase inhibitor activity; GO:0004865; ; GO:0004864; ; GO:0004865; ; GO:0004864 nuclear speck; GO:0016607; nucleus; GO:0005634 NiPp1 Nuclear inhibitor of Protein phosphatase 1 "CG8980, NiPp-1, Nuclear inhibitor of PP1, NIPP-1Dm, NIPP1Dm, Nuclear inhibitor of Protein phosphatase 1" CDMC30189 3 10 9 DAC14-K05 18-CG8980-RA_15 CG8980 ATCTATTTGGTCGCAACAGTCAAATGAACGACTTCTGCATAGACCATGCCTCTTGTTCGCGGGTC 65 FBan0008980 FBgn0026402 NiPp1 2 2R negative regulation of protein amino acid dephosphorylation; GO:0035308; signal transduction; GO:0007165 mRNA binding; GO:0003729; ; GO:0003729; protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864; type 1 serine/threonine specific protein phosphatase inhibitor activity; GO:0004865; ; GO:0004864; ; GO:0004865; ; GO:0004864 nuclear speck; GO:0016607; nucleus; GO:0005634 NiPp1 Nuclear inhibitor of Protein phosphatase 1 "CG8980, NiPp-1, Nuclear inhibitor of PP1, NIPP-1Dm, NIPP1Dm, Nuclear inhibitor of Protein phosphatase 1" CDMC30190 3 11 9 DAC14-K17 5-CG9005-RA_1 CG9005 GTTATTCGGTTCCAAGATCGGGCACGGTACAGGCCACACTACTGAATCCCATAGGCACGGTGGTG 65 FBan0009005 FBgn0033638 CG9005 2 2R CG9005 CG9005 BcDNA:GH05710 CDMC30190 3 12 9 DAC14-K17 5-CG9005-RA_1 CG9005 GTTATTCGGTTCCAAGATCGGGCACGGTACAGGCCACACTACTGAATCCCATAGGCACGGTGGTG 65 FBan0009005 FBgn0033638 CG9005 2 2R CG9005 CG9005 BcDNA:GH05710 CDMC30191 3 13 9 DAC14-O05 1-CG9100-RA_1 CG9100 CGGTTCCGATCCATCACGCAAAGCTACTATCGATCGGCTCACGCCTTGATCCTGGTGTACGACAT 65 FBan0009100 FBgn0031882 Rab30 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab30 Rab30 "CG9100, DmRab30, AAF52477" CDMC30191 3 14 9 DAC14-O05 1-CG9100-RA_1 CG9100 CGGTTCCGATCCATCACGCAAAGCTACTATCGATCGGCTCACGCCTTGATCCTGGTGTACGACAT 65 FBan0009100 FBgn0031882 Rab30 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab30 Rab30 "CG9100, DmRab30, AAF52477" CDMC30192 3 15 9 DAC14-O17 3-CG9127-RA_2 CG9127 CCGACGGAACTGTATCCACTTAACCCGAACGGTAGTCCTCAGGGAATTGCTGGCCTTTGCTCGTC 65 FBan0009127 FBgn0000052 ade2 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144 phosphoribosylformylglycinamidine synthase activity; GO:0004642 ; EC:6.3.5.3; ; GO:0004642 ; EC:6.3.5.3; ; GO:0004642 ; EC:6.3.5.3 ade2 adenosine 2 "CG9127, adenosine2, pym" CDMC30192 3 16 9 DAC14-O17 3-CG9127-RA_2 CG9127 CCGACGGAACTGTATCCACTTAACCCGAACGGTAGTCCTCAGGGAATTGCTGGCCTTTGCTCGTC 65 FBan0009127 FBgn0000052 ade2 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144 phosphoribosylformylglycinamidine synthase activity; GO:0004642 ; EC:6.3.5.3; ; GO:0004642 ; EC:6.3.5.3; ; GO:0004642 ; EC:6.3.5.3 ade2 adenosine 2 "CG9127, adenosine2, pym" CDMC30193 3 17 9 DAC15-C05 23-CG8360-RA_5 CG8360 GGACAGGGTGCAATCCATGTGCAATAGTTTATGTGACATCCCATTTATAATGTTCTGTAAACCCACC 67 FBan0008360 FBgn0032001 CG8360 2 2L cytidine metabolism; GO:0046087; pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8360 CG8360 BcDNA:LP03131 CDMC30193 3 18 9 DAC15-C05 23-CG8360-RA_5 CG8360 GGACAGGGTGCAATCCATGTGCAATAGTTTATGTGACATCCCATTTATAATGTTCTGTAAACCCACC 67 FBan0008360 FBgn0032001 CG8360 2 2L cytidine metabolism; GO:0046087; pyrimidine base metabolism; GO:0006206 zinc ion binding; GO:0008270; cytidine deaminase activity; GO:0004126 ; EC:3.5.4.5; ; GO:0004126 ; EC:3.5.4.5; ; GO:0008270 CG8360 CG8360 BcDNA:LP03131 CDMC30194 3 19 9 DAC15-C17 16-CG8511-RA_1 CG8511 CGGAATACGCGTAGAGAACATTGGCTATCTGAAGAAGATCATCGTTCCCAAGACCGAGACCTCCGAT 67 FBan0008511 FBgn0033730 CG8511 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8511 CG8511 CDMC30194 3 20 9 DAC15-C17 16-CG8511-RA_1 CG8511 CGGAATACGCGTAGAGAACATTGGCTATCTGAAGAAGATCATCGTTCCCAAGACCGAGACCTCCGAT 67 FBan0008511 FBgn0033730 CG8511 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8511 CG8511 CDMC30195 3 21 9 DAC15-G05 3-CG8950-RA_3 CG8950 AGAGCATGAATCTACGCTTGGTCTGCAGCATGAAGTGGCATTCAACCTGCACCTCATCTACCGAGCC 67 FBan0008950 FBgn0034186 CG8950 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0030528; ; GO:0016251 CG8950 CG8950 CDMC30195 3 22 9 DAC15-G05 3-CG8950-RA_3 CG8950 AGAGCATGAATCTACGCTTGGTCTGCAGCATGAAGTGGCATTCAACCTGCACCTCATCTACCGAGCC 67 FBan0008950 FBgn0034186 CG8950 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0030528; ; GO:0016251 CG8950 CG8950 CDMC30196 3 23 9 DAC15-G17 3-CG9092-RA_2 CG9092 CCAAGGGTGATCCCGTCGAATCGATCAAGCCGAAAACCTTCGAGGAACTAGACTTGTACTCGGGCCT 67 FBgn0031761 CDMC30196 3 24 9 DAC15-G17 3-CG9092-RA_2 CG9092 CCAAGGGTGATCCCGTCGAATCGATCAAGCCGAAAACCTTCGAGGAACTAGACTTGTACTCGGGCCT 67 FBgn0031761 CDMC30197 3 25 9 DAC15-K05 2-CG9403-RC_1 CG9403 CGGCGTCTGCTACTGGGACAAGTGCAACAAGAAGCATGAGAGCAACTCCAAGTTGTTGGACCACATG 67 FBan0009403 FBgn0041145 jing 2 2R border follicle cell migration (sensu Insecta); GO:0007298; central nervous system development; GO:0007417; regulation of transcription; GO:0045449; tracheal system development (sensu Insecta); GO:0007424 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 jing jing "CG9403, CG9403, CG9403, CG9403, CG9403, l(2)01094, l(2)22F3, rhumba" CDMC30197 3 26 9 DAC15-K05 2-CG9403-RC_1 CG9403 CGGCGTCTGCTACTGGGACAAGTGCAACAAGAAGCATGAGAGCAACTCCAAGTTGTTGGACCACATG 67 FBan0009403 FBgn0041145 jing 2 2R border follicle cell migration (sensu Insecta); GO:0007298; central nervous system development; GO:0007417; regulation of transcription; GO:0045449; tracheal system development (sensu Insecta); GO:0007424 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 jing jing "CG9403, CG9403, CG9403, CG9403, CG9403, l(2)01094, l(2)22F3, rhumba" CDMC30198 3 1 10 DAC15-K17 3-CG9484-RA_2 CG9484 GCTTCGGAGGAGGGATTCCAACCATTGCCATCTGTCACCATAAGACCTGCGGATGACTCCCATCTAC 67 FBan0009484 FBgn0002431 hyd 3 3R eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; germ cell development; GO:0007281; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; negative regulation of smoothened signaling pathway; GO:0045879; regulation of cell proliferation; GO:0042127; regulation of proteolysis; GO:0030162; spermatogenesis; GO:0007283; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; nucleus; GO:0005634 hyd hyperplastic discs "CG9484, l(3)C43, l[[3]]c43, l(3)c43, l(3)C43-3, c43, HYD, l(3)85Ea, l(3)SG33, hyperplastic discs" CDMC30198 3 2 10 DAC15-K17 3-CG9484-RA_2 CG9484 GCTTCGGAGGAGGGATTCCAACCATTGCCATCTGTCACCATAAGACCTGCGGATGACTCCCATCTAC 67 FBan0009484 FBgn0002431 hyd 3 3R eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; germ cell development; GO:0007281; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; negative regulation of smoothened signaling pathway; GO:0045879; regulation of cell proliferation; GO:0042127; regulation of proteolysis; GO:0030162; spermatogenesis; GO:0007283; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 cytoplasm; GO:0005737; nucleus; GO:0005634 hyd hyperplastic discs "CG9484, l(3)C43, l[[3]]c43, l(3)c43, l(3)C43-3, c43, HYD, l(3)85Ea, l(3)SG33, hyperplastic discs" CDMC30199 3 3 10 DAC15-O05 3-CG9947-RA_1 CG9947 GCTTCCGGAAGCTATATCGCCGTCTCAACCAAACGAACACCAACTATGCCAACGGCCTGAAGTCTGG 67 FBan0009947 FBgn0030752 CG9947 X X cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 membrane; GO:0016020 CG9947 CG9947 CDMC30199 3 4 10 DAC15-O05 3-CG9947-RA_1 CG9947 GCTTCCGGAAGCTATATCGCCGTCTCAACCAAACGAACACCAACTATGCCAACGGCCTGAAGTCTGG 67 FBan0009947 FBgn0030752 CG9947 X X cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 membrane; GO:0016020 CG9947 CG9947 CDMC30200 3 5 10 DAC15-O17 3-CR33356-RA_1 CR33356 GGGCGCTCGTACGCGTTTAATACTTAAATGGTGGACCGCTTGGGAACACCGTGTGCTGTTGGACTAG 67 FBan0033356 FBgn0053356 5SrRNA-Psi:CR33356 2 2R 5SrRNA-Psi:CR33356 5SrRNA-Psi:CR33356 CR33356 CDMC30200 3 6 10 DAC15-O17 3-CR33356-RA_1 CR33356 GGGCGCTCGTACGCGTTTAATACTTAAATGGTGGACCGCTTGGGAACACCGTGTGCTGTTGGACTAG 67 FBan0033356 FBgn0053356 5SrRNA-Psi:CR33356 2 2R 5SrRNA-Psi:CR33356 5SrRNA-Psi:CR33356 CR33356 CDMC30201 3 7 10 DAC16-C05 23-CG4898-RA_6 CG4898 AATGGAGATCAGATGAAAGGGCAGAAACTAAAGCAAAACATTCTCGTAGCACAAGCGCATTCCAATTCA 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC30201 3 8 10 DAC16-C05 23-CG4898-RA_6 CG4898 AATGGAGATCAGATGAAAGGGCAGAAACTAAAGCAAAACATTCTCGTAGCACAAGCGCATTCCAATTCA 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC30202 3 9 10 DAC16-C17 23-CG4900-RA_3 CG4900 GTGTCGGATAGCAAGTTGTATCCATGGAGTGAAATATCAACATACATCAAACTACCACCGTTCTTCGAG 69 FBan0004900 FBgn0024958 Irp-1A 3 3R amino acid biosynthesis; GO:0008652; regulation of translational initiation by iron; GO:0006447; tricarboxylic acid cycle; GO:0006099 mRNA binding; GO:0003729; ; GO:0003729; iron ion binding; GO:0005506; ; GO:0005506; aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0005506; ; GO:0003729 Irp-1A Iron regulatory protein 1A "CG4900, IRP-1A, IRP-1, IRP1, cytosolic aconitase" CDMC30202 3 10 10 DAC16-C17 23-CG4900-RA_3 CG4900 GTGTCGGATAGCAAGTTGTATCCATGGAGTGAAATATCAACATACATCAAACTACCACCGTTCTTCGAG 69 FBan0004900 FBgn0024958 Irp-1A 3 3R amino acid biosynthesis; GO:0008652; regulation of translational initiation by iron; GO:0006447; tricarboxylic acid cycle; GO:0006099 mRNA binding; GO:0003729; ; GO:0003729; iron ion binding; GO:0005506; ; GO:0005506; aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0005506; ; GO:0003729 Irp-1A Iron regulatory protein 1A "CG4900, IRP-1A, IRP-1, IRP1, cytosolic aconitase" CDMC30203 3 11 10 DAC16-G05 23-CG4934-RA_10 CG4934 CGAGACAGCACCTAGACAACAGCCTTATAAAGTATATTAGGAGCAGTGGATGATACCTCAACCGTTCAG 69 FBan0004934 FBgn0000221 brn X X Notch signaling pathway; GO:0007219; border follicle cell migration (sensu Insecta); GO:0007298; egg chamber formation (sensu Insecta); GO:0007293; follicle cell adhesion (sensu Insecta); GO:0007299; glycosphingolipid biosynthesis; GO:0006688; gurken receptor signaling pathway; GO:0008314; maintenance of polarity of follicular epithelium; GO:0042248; morphogenesis of follicular epithelium; GO:0016333; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid glycosylation; GO:0006486 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity; GO:0046981; ; GO:0008375 ; EC:2.4.1.-; ; GO:0046981; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-" extracellular region; GO:0005576; membrane; GO:0016020 brn brainiac "CG4934, fs(1)107, fs(1)A107, l(1)6P6, Gene B, brc, EG:EG0007.6" CDMC30203 3 12 10 DAC16-G05 23-CG4934-RA_10 CG4934 CGAGACAGCACCTAGACAACAGCCTTATAAAGTATATTAGGAGCAGTGGATGATACCTCAACCGTTCAG 69 FBan0004934 FBgn0000221 brn X X Notch signaling pathway; GO:0007219; border follicle cell migration (sensu Insecta); GO:0007298; egg chamber formation (sensu Insecta); GO:0007293; follicle cell adhesion (sensu Insecta); GO:0007299; glycosphingolipid biosynthesis; GO:0006688; gurken receptor signaling pathway; GO:0008314; maintenance of polarity of follicular epithelium; GO:0042248; morphogenesis of follicular epithelium; GO:0016333; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein amino acid glycosylation; GO:0006486 "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity; GO:0046981; ; GO:0008375 ; EC:2.4.1.-; ; GO:0046981; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-" extracellular region; GO:0005576; membrane; GO:0016020 brn brainiac "CG4934, fs(1)107, fs(1)A107, l(1)6P6, Gene B, brc, EG:EG0007.6" CDMC30204 3 13 10 DAC16-G17 7-CG4945-RB_1 CG4945 CCGGCACTCGAGCTACGCTAATCTCCCATATGCTTCTCAAGTTAAAGACAGTGCCTACGGATCGGTCGA 69 FBan0004945 FBgn0034137 CG4945 2 2R mesoderm development; GO:0007498; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG4945 CG4945 "CT15864, PKN" CDMC30204 3 14 10 DAC16-G17 7-CG4945-RB_1 CG4945 CCGGCACTCGAGCTACGCTAATCTCCCATATGCTTCTCAAGTTAAAGACAGTGCCTACGGATCGGTCGA 69 FBan0004945 FBgn0034137 CG4945 2 2R mesoderm development; GO:0007498; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG4945 CG4945 "CT15864, PKN" CDMC30205 3 15 10 DAC16-K05 2-CG4975-RA_1 CG4975 ACGAGCCTGCGTAGCTTGTTACCAAAAGCTGGAGACTGAAGATCGTGTTGCTTTCCTCGACTACGTGGC 69 FBan0004975 FBgn0034266 CG4975 2 2R CG4975 CG4975 CDMC30205 3 16 10 DAC16-K05 2-CG4975-RA_1 CG4975 ACGAGCCTGCGTAGCTTGTTACCAAAAGCTGGAGACTGAAGATCGTGTTGCTTTCCTCGACTACGTGGC 69 FBan0004975 FBgn0034266 CG4975 2 2R CG4975 CG4975 CDMC30206 3 17 10 DAC16-K17 3-CG4983-RA_1 CG4983 CGCCACCGGTATTCGTACCCAAGTCCGAATATGTACAACCATCAGAGGAGTTGGTTTCCCGGAAGAGCA 69 FBan0004983 FBgn0032371 CG4983 2 2L CG4983 CG4983 anon-WO0140519.134 CDMC30206 3 18 10 DAC16-K17 3-CG4983-RA_1 CG4983 CGCCACCGGTATTCGTACCCAAGTCCGAATATGTACAACCATCAGAGGAGTTGGTTTCCCGGAAGAGCA 69 FBan0004983 FBgn0032371 CG4983 2 2L CG4983 CG4983 anon-WO0140519.134 CDMC30207 3 19 10 DAC16-O05 23-CG5016-RA_1 CG5016 CGCCGCAAAGTAAATGAGCTTTTGATAATTGCAGGCACAGAATTCAATAAAACATTTACTTAATTGTTT 69 FBan0005016 FBgn0011669 Mst57Db 3 3R oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Db Male-specific RNA 57Db "CG5016, mst-1, male specific transcript 57D, mst(2)ag-1" CDMC30207 3 20 10 DAC16-O05 23-CG5016-RA_1 CG5016 CGCCGCAAAGTAAATGAGCTTTTGATAATTGCAGGCACAGAATTCAATAAAACATTTACTTAATTGTTT 69 FBan0005016 FBgn0011669 Mst57Db 3 3R oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Db Male-specific RNA 57Db "CG5016, mst-1, male specific transcript 57D, mst(2)ag-1" CDMC30208 3 21 10 DAC16-O17 2-CG5027-RA_1 CG5027 CCGTTTTCCAATGGGTGAACGTGGAGAGGTTCACACTCTTCCCAAAGGTCACTCGGTTCAACATCCACC 69 FBan0005027 FBgn0036579 CG5027 3 3L electron transport; GO:0006118 calcium ion binding; GO:0005509; ; GO:0005509; electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 integral to membrane; GO:0016021 CG5027 CG5027 LD24073p CDMC30208 3 22 10 DAC16-O17 2-CG5027-RA_1 CG5027 CCGTTTTCCAATGGGTGAACGTGGAGAGGTTCACACTCTTCCCAAAGGTCACTCGGTTCAACATCCACC 69 FBan0005027 FBgn0036579 CG5027 3 3L electron transport; GO:0006118 calcium ion binding; GO:0005509; ; GO:0005509; electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 integral to membrane; GO:0016021 CG5027 CG5027 LD24073p CDMC30209 3 23 10 DAC17-C05 17-CG7105-RA_1 CG7105 GGGGAAGCCATGTTGCAAGCAAAAATGTTCTGGGTCCGAAAAAGGGGATACAATACAATAGTGTCGGAA 69 FBan0007105 FBgn0045038 Proct 2 2L ciliary or flagellar motility; GO:0001539 neuropeptide hormone activity; GO:0005184; structural molecule activity; GO:0005198; motor activity; GO:0003774; ; GO:0005198; ; GO:0005184; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288 Proct Proctolin "CG7105, CG7105, CG7105, PROC, Prct, Proctolin" CDMC30209 3 24 10 DAC17-C05 17-CG7105-RA_1 CG7105 GGGGAAGCCATGTTGCAAGCAAAAATGTTCTGGGTCCGAAAAAGGGGATACAATACAATAGTGTCGGAA 69 FBan0007105 FBgn0045038 Proct 2 2L ciliary or flagellar motility; GO:0001539 neuropeptide hormone activity; GO:0005184; structural molecule activity; GO:0005198; motor activity; GO:0003774; ; GO:0005198; ; GO:0005184; ; GO:0003774 flagellum (sensu Bacteria); GO:0009288 Proct Proctolin "CG7105, CG7105, CG7105, PROC, Prct, Proctolin" CDMC30210 3 25 10 DAC17-C17 17-CG7113-RA_1 CG7113 GCACGGTTTCGAATCGCTTAACAAGTTTTTGCTTAAAAAGCTTTGCCGAGCACTAAGTAACCACCGCCT 69 FBan0007113 FBgn0021765 scu X X acyl-CoA metabolism; GO:0006637; androgen metabolism; GO:0008209; ecdysone metabolism; GO:0008205; estrogen metabolism; GO:0008210; fatty acid beta-oxidation; GO:0006635; fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631; steroid metabolism; GO:0008202 3-hydroxyacyl-CoA dehydrogenase activity; GO:0003857 ; EC:1.1.1.35; ; GO:0003857 ; EC:1.1.1.35; 3-alpha(17-beta)-hydroxysteroid dehydrogenase (NAD+) activity; GO:0047035 ; EC:1.1.1.239; ; GO:0003857 ; EC:1.1.1.35; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity; GO:0047022 ; EC:1.1.1.201; acetoacetyl-CoA reductase activity; GO:0018454 ; EC:1.1.1.36; estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; testosterone 17-beta-dehydrogenase activity; GO:0050327 ; EC:1.1.1.63; ; GO:0047035 ; EC:1.1.1.239; ; GO:0047022 ; EC:1.1.1.201; ; GO:0018454 ; EC:1.1.1.36; ; GO:0004303 ; EC:1.1.1.62; ; GO:0016229 ; EC:1.1.1.-; ; GO:0050327 ; EC:1.1.1.63 cytosol; GO:0005829; mitochondrion; GO:0005739 scu scully "CG7113, CG7113, HLII, haplo-lethal region II, HL-X, Scu, 17beta-HSD10, l(1)16Fd, l(1)17Ad, lethal(1)17Ad, scully" CDMC30210 3 26 10 DAC17-C17 17-CG7113-RA_1 CG7113 GCACGGTTTCGAATCGCTTAACAAGTTTTTGCTTAAAAAGCTTTGCCGAGCACTAAGTAACCACCGCCT 69 FBan0007113 FBgn0021765 scu X X acyl-CoA metabolism; GO:0006637; androgen metabolism; GO:0008209; ecdysone metabolism; GO:0008205; estrogen metabolism; GO:0008210; fatty acid beta-oxidation; GO:0006635; fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631; steroid metabolism; GO:0008202 3-hydroxyacyl-CoA dehydrogenase activity; GO:0003857 ; EC:1.1.1.35; ; GO:0003857 ; EC:1.1.1.35; 3-alpha(17-beta)-hydroxysteroid dehydrogenase (NAD+) activity; GO:0047035 ; EC:1.1.1.239; ; GO:0003857 ; EC:1.1.1.35; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity; GO:0047022 ; EC:1.1.1.201; acetoacetyl-CoA reductase activity; GO:0018454 ; EC:1.1.1.36; estradiol 17-beta-dehydrogenase activity; GO:0004303 ; EC:1.1.1.62; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; testosterone 17-beta-dehydrogenase activity; GO:0050327 ; EC:1.1.1.63; ; GO:0047035 ; EC:1.1.1.239; ; GO:0047022 ; EC:1.1.1.201; ; GO:0018454 ; EC:1.1.1.36; ; GO:0004303 ; EC:1.1.1.62; ; GO:0016229 ; EC:1.1.1.-; ; GO:0050327 ; EC:1.1.1.63 cytosol; GO:0005829; mitochondrion; GO:0005739 scu scully "CG7113, CG7113, HLII, haplo-lethal region II, HL-X, Scu, 17beta-HSD10, l(1)16Fd, l(1)17Ad, lethal(1)17Ad, scully" CDMC30211 3 1 11 DAC17-G05 18-CG7160-RA_1 CG7160 AGGTGCCCCAACCAGATCTTGACTATGCTAAGCCTCCTAAGGTCTAATAAACGAGGCACTGAAATGGAA 69 FBan0007160 FBgn0037114 CG7160 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG7160 CG7160 BcDNA:LP06027 CDMC30211 3 2 11 DAC17-G05 18-CG7160-RA_1 CG7160 AGGTGCCCCAACCAGATCTTGACTATGCTAAGCCTCCTAAGGTCTAATAAACGAGGCACTGAAATGGAA 69 FBan0007160 FBgn0037114 CG7160 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG7160 CG7160 BcDNA:LP06027 CDMC30212 3 3 11 DAC17-G17 10-CG7169-RA_1 CG7169 ACTCCAAAACCGCCAAGAAACAAGAGGATTTTATGGGATCAGTACCACAGCCTAAGGTATCCACCGCGC 69 FBan0007169 FBgn0037105 S1P 3 3L proteolysis; GO:0006508; sterol regulatory element binding-protein cleavage; GO:0035103 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; subtilisin activity; GO:0004291 ; EC:3.4.21.62; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004291 ; EC:3.4.21.62 S1P S1P "CG7169, CG7169, CG7169, dS1P" CDMC30212 3 4 11 DAC17-G17 10-CG7169-RA_1 CG7169 ACTCCAAAACCGCCAAGAAACAAGAGGATTTTATGGGATCAGTACCACAGCCTAAGGTATCCACCGCGC 69 FBan0007169 FBgn0037105 S1P 3 3L proteolysis; GO:0006508; sterol regulatory element binding-protein cleavage; GO:0035103 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; subtilisin activity; GO:0004291 ; EC:3.4.21.62; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004291 ; EC:3.4.21.62 S1P S1P "CG7169, CG7169, CG7169, dS1P" CDMC30213 3 5 11 DAC17-K05 10-CG7200-RA_2 CG7200 TCTCGAGTGCTTATGGAAGATCACCCGGACTCTAACAGAGGATCCGACTATCCAGTGTAGTCCCCTCCA 69 FBan0007200 FBgn0032671 CG7200 2 2L CG7200 CG7200 CDMC30213 3 6 11 DAC17-K05 10-CG7200-RA_2 CG7200 TCTCGAGTGCTTATGGAAGATCACCCGGACTCTAACAGAGGATCCGACTATCCAGTGTAGTCCCCTCCA 69 FBan0007200 FBgn0032671 CG7200 2 2L CG7200 CG7200 CDMC30214 3 7 11 DAC17-K17 8-CG7218-RA_1 CG7218 GGCCTGCAAGCTAATGAAGGAACATCAGACCGAGCGCAACAGTTCTACACCGAGTAGCATGACCAATGT 69 FBan0007218 FBgn0038569 CG7218 3 3R CG7218 CG7218 CDMC30214 3 8 11 DAC17-K17 8-CG7218-RA_1 CG7218 GGCCTGCAAGCTAATGAAGGAACATCAGACCGAGCGCAACAGTTCTACACCGAGTAGCATGACCAATGT 69 FBan0007218 FBgn0038569 CG7218 3 3R CG7218 CG7218 CDMC30215 3 9 11 DAC17-O05 2-CG7259-RA_2 CG7259 CCCGTTCGCGAAACAACTTCCGACAAAACTTCCTGGGAAGACCATCTGCCACTGGTAGCTACTCAGACT 69 FBan0007259 FBgn0036491 Best4 3 3L ion transport; GO:0006811; transport; GO:0006810 Best4 Bestrophin 4 "CG7259, dbest4, CT22395, Bestrophin 4" CDMC30215 3 10 11 DAC17-O05 2-CG7259-RA_2 CG7259 CCCGTTCGCGAAACAACTTCCGACAAAACTTCCTGGGAAGACCATCTGCCACTGGTAGCTACTCAGACT 69 FBan0007259 FBgn0036491 Best4 3 3L ion transport; GO:0006811; transport; GO:0006810 Best4 Bestrophin 4 "CG7259, dbest4, CT22395, Bestrophin 4" CDMC30216 3 11 11 DAC17-O17 23-CG7269-RA_5 CG7269 TGAGGGACGCTAGAGCTCGAAGGTGCATGTTAATCGGAACAAGACTATGCACTTCGAATAGATACAAAC 69 FBan0007269 FBgn0014189 Hel25E 2 2L "mRNA export from nucleus; GO:0006406; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 Hel25E Helicase at 25E "CG7269, CG7269, CG7269, l(2)gdh-12, jf26, WM6, hel, helicase, RNA helicase, HEL, DmRH4, UAP56, uap56, l(2)k11511, Dbp25F, Hel, Wm6, l(2)25Eb, l(2)gdh12, l(2)jf26, lethal(2)25Eb" CDMC30216 3 12 11 DAC17-O17 23-CG7269-RA_5 CG7269 TGAGGGACGCTAGAGCTCGAAGGTGCATGTTAATCGGAACAAGACTATGCACTTCGAATAGATACAAAC 69 FBan0007269 FBgn0014189 Hel25E 2 2L "mRNA export from nucleus; GO:0006406; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" nucleus; GO:0005634; spliceosome complex; GO:0005681 Hel25E Helicase at 25E "CG7269, CG7269, CG7269, l(2)gdh-12, jf26, WM6, hel, helicase, RNA helicase, HEL, DmRH4, UAP56, uap56, l(2)k11511, Dbp25F, Hel, Wm6, l(2)25Eb, l(2)gdh12, l(2)jf26, lethal(2)25Eb" CDMC30217 3 13 11 DAC18-C05 22-CG32409-RA_2 CG32409 ACACCAAAAGGAATTGGACAAATACAAGCCGATCACAGTAGAAAAGCATTTGGAATGCCGACTCGACGT 69 FBan0032409 FBgn0052409 CG32409 3 3L ribosome biogenesis and assembly; GO:0042254 nucleus; GO:0005634 CG32409 CG32409 BcDNA:LD24586 CDMC30217 3 14 11 DAC18-C05 22-CG32409-RA_2 CG32409 ACACCAAAAGGAATTGGACAAATACAAGCCGATCACAGTAGAAAAGCATTTGGAATGCCGACTCGACGT 69 FBan0032409 FBgn0052409 CG32409 3 3L ribosome biogenesis and assembly; GO:0042254 nucleus; GO:0005634 CG32409 CG32409 BcDNA:LD24586 CDMC30218 3 15 11 DAC18-C17 14-CG32418-RA_1 CG32418 ATCTCGACCGCCTGATGAAGACCAAAACGCTGAAGAAAATGCACCAGAGCAAACTGTTCAAGCAGAAGG 69 FBan0032418 FBgn0052418 CG32418 3 3L CG32418 CG32418 "CG10569, CG10569, CG10569, CG10569" CDMC30218 3 16 11 DAC18-C17 14-CG32418-RA_1 CG32418 ATCTCGACCGCCTGATGAAGACCAAAACGCTGAAGAAAATGCACCAGAGCAAACTGTTCAAGCAGAAGG 69 FBan0032418 FBgn0052418 CG32418 3 3L CG32418 CG32418 "CG10569, CG10569, CG10569, CG10569" CDMC30219 3 17 11 DAC18-G05 23-CG32453-RA_1 CG32453 TCAACTTCAGGGATAGATAGGGCTGATTACCAATGTTACTAGCAATATAAAAATAAAGCCATAAGTGCT 69 FBan0032453 FBgn0052453 CG32453 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32453 CG32453 CDMC30219 3 18 11 DAC18-G05 23-CG32453-RA_1 CG32453 TCAACTTCAGGGATAGATAGGGCTGATTACCAATGTTACTAGCAATATAAAAATAAAGCCATAAGTGCT 69 FBan0032453 FBgn0052453 CG32453 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32453 CG32453 CDMC30220 3 19 11 DAC18-G17 23-CG32461-RA_5 CG32461 ACACCTTTACCATACCAAGTCAGCCACTTATTCGAAGATTCGCGGTAATAGTAAAACAACGGAAGATGG 69 FBan0032461 FBgn0052461 CG32461 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32461 CG32461 CDMC30220 3 20 11 DAC18-G17 23-CG32461-RA_5 CG32461 ACACCTTTACCATACCAAGTCAGCCACTTATTCGAAGATTCGCGGTAATAGTAAAACAACGGAAGATGG 69 FBan0032461 FBgn0052461 CG32461 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32461 CG32461 CDMC30221 3 21 11 DAC18-K05 9-CG32491-RI_8 CG32491 TCGGGTGGTCACCAATGTAGTTGAAGGTGTGCACAAAATAGTACTGGAATCGTGCCATCACACCTGCCT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30221 3 22 11 DAC18-K05 9-CG32491-RI_8 CG32491 TCGGGTGGTCACCAATGTAGTTGAAGGTGTGCACAAAATAGTACTGGAATCGTGCCATCACACCTGCCT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30222 3 23 11 DAC18-K17 2-CG32491-RU_1 CG32491 TCAGCGCGAATCGGTCAAACTCAACTACTGCGGTCATAGCTACGTCAAGTTCATGGAGAATGGACGCGG 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30222 3 24 11 DAC18-K17 2-CG32491-RU_1 CG32491 TCAGCGCGAATCGGTCAAACTCAACTACTGCGGTCATAGCTACGTCAAGTTCATGGAGAATGGACGCGG 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30223 3 25 11 DAC18-O05 3-CG3252-RA_1 CG3252 CCTGCAGAGCACCATTGTCACCATCATTTGCGATCAGTTCAAGGGATGGAAGTACTGGAAGGTGGCACT 69 FBan0003252 FBgn0029762 CG3252 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836; sodium ion transport; GO:0006814 neurotransmitter:sodium symporter activity; GO:0005328; cation transporter activity; GO:0008324; ; GO:0005328; ; GO:0008324; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; integrin complex; GO:0008305 CG3252 CG3252 anon-WO0149848.3 CDMC30223 3 26 11 DAC18-O05 3-CG3252-RA_1 CG3252 CCTGCAGAGCACCATTGTCACCATCATTTGCGATCAGTTCAAGGGATGGAAGTACTGGAAGGTGGCACT 69 FBan0003252 FBgn0029762 CG3252 X X amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836; sodium ion transport; GO:0006814 neurotransmitter:sodium symporter activity; GO:0005328; cation transporter activity; GO:0008324; ; GO:0005328; ; GO:0008324; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; integrin complex; GO:0008305 CG3252 CG3252 anon-WO0149848.3 CDMC30224 3 1 12 DAC18-O17 2-CG32543-RA_1 CG32543 CAAGGAGGTCCAAATCGAGCTAATCGAGCAGGTCAGTGGTGTTCAAACAGAGCCAGATAGTCCGCCCAC 69 FBan0032543 FBgn0052543 CG32543 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32543 CG32543 CDMC30224 3 2 12 DAC18-O17 2-CG32543-RA_1 CG32543 CAAGGAGGTCCAAATCGAGCTAATCGAGCAGGTCAGTGGTGTTCAAACAGAGCCAGATAGTCCGCCCAC 69 FBan0032543 FBgn0052543 CG32543 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32543 CG32543 CDMC30225 3 3 12 DAC19-C05 3-CG8187-RA_3 CG8187 GGAGCAGCCCTCAAAGCTTGAATGCCATCTGCAAATACCTGTGCGTTCCGATGTCTCTGTGGACG 65 FBan0008187 FBgn0034027 CG8187 2 2R CG8187 CG8187 CDMC30225 3 4 12 DAC19-C05 3-CG8187-RA_3 CG8187 GGAGCAGCCCTCAAAGCTTGAATGCCATCTGCAAATACCTGTGCGTTCCGATGTCTCTGTGGACG 65 FBan0008187 FBgn0034027 CG8187 2 2R CG8187 CG8187 CDMC30226 3 5 12 DAC19-C17 3-CG8211-RA_1 CG8211 GACAAGAATGGCATGATGCAGACGGATGCGATTTGGGAGGACCTAAGGACCACGCTGATTGCCTC 65 FBan0008211 FBgn0030858 CG8211 X X CG8211 CG8211 CDMC30226 3 6 12 DAC19-C17 3-CG8211-RA_1 CG8211 GACAAGAATGGCATGATGCAGACGGATGCGATTTGGGAGGACCTAAGGACCACGCTGATTGCCTC 65 FBan0008211 FBgn0030858 CG8211 X X CG8211 CG8211 CDMC30227 3 7 12 DAC19-G05 2-CG8276-RA_2 CG8276 TTGGAGCGATGCATATTATCCCCAGACGCCATATGAAGCATATCGGGGCATTTACGCCACCCTGC 65 FBan0008276 FBgn0033073 bin3 2 2R protein amino acid methylation; GO:0006479; regulation of transcription; GO:0045449 protein binding; GO:0005515; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0005515; ; GO:0008168 ; EC:2.1.1.- nucleus; GO:0005634 bin3 bicoid-interacting protein 3 "CG8276, CG8276, CG8276, Bin3, Bicoid interacting protein 3, bicoid-interacting protein 3" CDMC30227 3 8 12 DAC19-G05 2-CG8276-RA_2 CG8276 TTGGAGCGATGCATATTATCCCCAGACGCCATATGAAGCATATCGGGGCATTTACGCCACCCTGC 65 FBan0008276 FBgn0033073 bin3 2 2R protein amino acid methylation; GO:0006479; regulation of transcription; GO:0045449 protein binding; GO:0005515; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0005515; ; GO:0008168 ; EC:2.1.1.- nucleus; GO:0005634 bin3 bicoid-interacting protein 3 "CG8276, CG8276, CG8276, Bin3, Bicoid interacting protein 3, bicoid-interacting protein 3" CDMC30228 3 9 12 DAC19-G17 3-CG8309-RA_9 CG8309 ATCGCGGTGAGAACATTGTCCTGGCCTACTGCGAGAAGATGACCAAGGCTCCCAATCTTCCATTG 65 FBan0008309 FBgn0033902 CG8309 2 2R CG8309 CG8309 "anon-EST:Posey76, anon-EST:Posey67" CDMC30228 3 10 12 DAC19-G17 3-CG8309-RA_9 CG8309 ATCGCGGTGAGAACATTGTCCTGGCCTACTGCGAGAAGATGACCAAGGCTCCCAATCTTCCATTG 65 FBan0008309 FBgn0033902 CG8309 2 2R CG8309 CG8309 "anon-EST:Posey76, anon-EST:Posey67" CDMC30229 3 11 12 DAC19-K05 2-CG8400-RB_1 CG8400 AACAATCCCTACCTCAGGAGCCGTCCGAACAGGAAACGGGGACTTCAAAGATCCGAGTGCGTAAG 65 FBan0008400 FBgn0034068 CG8400 2 2R apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 CG8400 CG8400 CDMC30229 3 12 12 DAC19-K05 2-CG8400-RB_1 CG8400 AACAATCCCTACCTCAGGAGCCGTCCGAACAGGAAACGGGGACTTCAAAGATCCGAGTGCGTAAG 65 FBan0008400 FBgn0034068 CG8400 2 2R apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 CG8400 CG8400 CDMC30230 3 13 12 DAC19-K17 2-CG8419-RA_2 CG8419 ATGCCATAGCACGTGGAATCAACGACCGGTGTGACGACATCCAGACTCAAGTGGAGCGGTACATG 65 FBan0008419 FBgn0031999 CG8419 2 2L ATP synthesis coupled proton transport; GO:0015986; protein ubiquitination; GO:0016567 "ATP binding; GO:0005524; ; GO:0005524; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" intracellular; GO:0005622; proton-transporting two-sector ATPase complex; GO:0016469; ubiquitin ligase complex; GO:0000151 CG8419 CG8419 CDMC30230 3 14 12 DAC19-K17 2-CG8419-RA_2 CG8419 ATGCCATAGCACGTGGAATCAACGACCGGTGTGACGACATCCAGACTCAAGTGGAGCGGTACATG 65 FBan0008419 FBgn0031999 CG8419 2 2L ATP synthesis coupled proton transport; GO:0015986; protein ubiquitination; GO:0016567 "ATP binding; GO:0005524; ; GO:0005524; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" intracellular; GO:0005622; proton-transporting two-sector ATPase complex; GO:0016469; ubiquitin ligase complex; GO:0000151 CG8419 CG8419 CDMC30231 3 15 12 DAC19-O05 3-CG8516-RA_1 CG8516 TCCTCCCAAAACAGCTCACCTATTCTGGCAAGGAAACAGCAGCAAGATGGATTGGGGGTCAGTCC 65 FBan0008516 FBgn0037757 CG8516 3 3R CG8516 CG8516 CDMC30231 3 16 12 DAC19-O05 3-CG8516-RA_1 CG8516 TCCTCCCAAAACAGCTCACCTATTCTGGCAAGGAAACAGCAGCAAGATGGATTGGGGGTCAGTCC 65 FBan0008516 FBgn0037757 CG8516 3 3R CG8516 CG8516 CDMC30232 3 17 12 DAC19-O17 15-CG8563-RA_5 CG8563 GTCCCCGGCGGAAGACACAGTTCGAGGCGAGTCTTTCCAGTTTGGGAGTTAGCTACGAGATGCAG 65 FBan0008563 FBgn0035777 CG8563 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8563 CG8563 CDMC30232 3 18 12 DAC19-O17 15-CG8563-RA_5 CG8563 GTCCCCGGCGGAAGACACAGTTCGAGGCGAGTCTTTCCAGTTTGGGAGTTAGCTACGAGATGCAG 65 FBan0008563 FBgn0035777 CG8563 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8563 CG8563 CDMC30233 3 19 12 DAC20-C05 23-CG7673-RA_1 CG7673 TGCGGCCAGTCATTGTTATTTAGGTAGTTATCGTTAATAAAGGATTTCGATACAGATCATTTTCGTTTT 69 FBan0007673 FBgn0000551 Edg78E 3 3L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011 Edg78E Ecdysone-dependent gene 78E "CG7673, EDG78, EDG-78, Edg78, EDG78E, DMLCP78, Edg78e" CDMC30233 3 20 12 DAC20-C05 23-CG7673-RA_1 CG7673 TGCGGCCAGTCATTGTTATTTAGGTAGTTATCGTTAATAAAGGATTTCGATACAGATCATTTTCGTTTT 69 FBan0007673 FBgn0000551 Edg78E 3 3L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011 Edg78E Ecdysone-dependent gene 78E "CG7673, EDG78, EDG-78, Edg78, EDG78E, DMLCP78, Edg78e" CDMC30234 3 21 12 DAC20-C17 18-CG7694-RA_4 CG7694 CGAATTCCTGTCCTCTGTGTCGCTATGAACTGGAAACTGATGATCCTGTTTACGAGGAGTTGCGCAGGT 69 FBan0007694 FBgn0038627 CG7694 3 3R CG7694 CG7694 BcDNA:LP11469 CDMC30234 3 22 12 DAC20-C17 18-CG7694-RA_4 CG7694 CGAATTCCTGTCCTCTGTGTCGCTATGAACTGGAAACTGATGATCCTGTTTACGAGGAGTTGCGCAGGT 69 FBan0007694 FBgn0038627 CG7694 3 3R CG7694 CG7694 BcDNA:LP11469 CDMC30235 3 23 12 DAC20-G05 3-CG7730-RC_1 CG7730 GTTCGGCGGAAAATTCGTTGAGCATATCGGCAATCTGGCTAGCTTTACGGACGTTTTGGAGGCCATGGC 69 FBan0007730 FBgn0036689 CG7730 3 3L CG7730 CG7730 CDMC30235 3 24 12 DAC20-G05 3-CG7730-RC_1 CG7730 GTTCGGCGGAAAATTCGTTGAGCATATCGGCAATCTGGCTAGCTTTACGGACGTTTTGGAGGCCATGGC 69 FBan0007730 FBgn0036689 CG7730 3 3L CG7730 CG7730 CDMC30236 3 25 12 DAC20-G17 7-CG7742-RA_1 CG7742 GCCAACTATAGGCCTGTTTACGCTCCAAAGGATTTACTGGAGGTGCTACTCTCGCTAAAAGGACCCGCC 69 FBan0007742 FBgn0031690 CG7742 2 2L CG7742 CG7742 CDMC30236 3 26 12 DAC20-G17 7-CG7742-RA_1 CG7742 GCCAACTATAGGCCTGTTTACGCTCCAAAGGATTTACTGGAGGTGCTACTCTCGCTAAAAGGACCCGCC 69 FBan0007742 FBgn0031690 CG7742 2 2L CG7742 CG7742 CDMC30237 3 1 13 DAC20-K05 23-CG7776-RA_11 CG7776 TGATGCGTACAACATTTATGATTTGACACTTCTGCAACAGCAAATACGGGTAAAGACGAACACGAAACT 69 FBan0007776 FBgn0000581 E(Pc) 2 2R establishment and/or maintenance of chromatin architecture; GO:0006325 NOT polytene chromosome chromocenter; GO:0005701; chromatin; GO:0000785; intercalary heterochromatin; GO:0005725; polytene chromosome; GO:0005700 E(Pc) Enhancer of Polycomb "CG7776, CG7776, III, transcript group III, e(Pc), GH14582, GH05739, anon-48Ac, l(2)28-28-12" CDMC30237 3 2 13 DAC20-K05 23-CG7776-RA_11 CG7776 TGATGCGTACAACATTTATGATTTGACACTTCTGCAACAGCAAATACGGGTAAAGACGAACACGAAACT 69 FBan0007776 FBgn0000581 E(Pc) 2 2R establishment and/or maintenance of chromatin architecture; GO:0006325 NOT polytene chromosome chromocenter; GO:0005701; chromatin; GO:0000785; intercalary heterochromatin; GO:0005725; polytene chromosome; GO:0005700 E(Pc) Enhancer of Polycomb "CG7776, CG7776, III, transcript group III, e(Pc), GH14582, GH05739, anon-48Ac, l(2)28-28-12" CDMC30238 3 3 13 DAC20-K17 23-CG7785-RA_17 CG7785 TGGAACAGTCACTTCTTTAGATAGTCCACACAAAAGCCTTGAACAAATTAGCAGCATGAGAACAAAGCA 69 FBan0007785 FBgn0038564 CG7785 3 3R CG7785 CG7785 CDMC30238 3 4 13 DAC20-K17 23-CG7785-RA_17 CG7785 TGGAACAGTCACTTCTTTAGATAGTCCACACAAAAGCCTTGAACAAATTAGCAGCATGAGAACAAAGCA 69 FBan0007785 FBgn0038564 CG7785 3 3R CG7785 CG7785 CDMC30239 3 5 13 DAC20-O05 2-CG7820-RA_1 CG7820 AGTCGACGCTCCAATACGTTCCGCGCTACAACGATTCAACGATTGAACCATTCGGGATCCATTCCTCGA 69 FBan0007820 FBgn0027844 CAH1 2 2L one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CAH1 Carbonic anhydrase 1 "CG7820, CAH, BG:DS00941.1" CDMC30239 3 6 13 DAC20-O05 2-CG7820-RA_1 CG7820 AGTCGACGCTCCAATACGTTCCGCGCTACAACGATTCAACGATTGAACCATTCGGGATCCATTCCTCGA 69 FBan0007820 FBgn0027844 CAH1 2 2L one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CAH1 Carbonic anhydrase 1 "CG7820, CAH, BG:DS00941.1" CDMC30240 3 7 13 DAC20-O17 6-CG7830-RA_1 CG7830 GCCATCGCAGTATTCTTCTGCTTCGCCATGATCTCGGGTCAAATGTGGAATCATATCCGTGGACCACCG 69 FBan0007830 FBgn0032015 CG7830 2 2L electron transport; GO:0006118; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; electron transporter activity; GO:0005489; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0005489" CG7830 CG7830 CDMC30240 3 8 13 DAC20-O17 6-CG7830-RA_1 CG7830 GCCATCGCAGTATTCTTCTGCTTCGCCATGATCTCGGGTCAAATGTGGAATCATATCCGTGGACCACCG 69 FBan0007830 FBgn0032015 CG7830 2 2L electron transport; GO:0006118; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; electron transporter activity; GO:0005489; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0005489" CG7830 CG7830 CDMC30241 3 9 13 DAC21-C05 24-CG2621-RA_1 CG2621 CGCAAGCAAATATTTAGCATAAAATCGAAATAAAACCAAAAATCCACTTTAAACTATGCATAAATAATT 69 FBan0002621 FBgn0003371 sgg X X "Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; circadian rhythm; GO:0007623; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; mitosis; GO:0007067; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; regulation of hemocyte differentiation; GO:0045610; regulation of protein import into nucleus; GO:0042306; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; glycogen synthase kinase 3 activity; GO:0004696 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004696 ; EC:2.7.1.- sgg shaggy "CG2621, CG2621, CG2621, CG2621, CG2621, CG2621, zw3, l(1)zw3, zw-3, ZW-3, l(1)3Ba, zw3[sgg], zw3(sgg), zw[3], sgg/zw3, sgg-zw3, shaggy-zeste white 3, zest-white 3, Zw3, zeste white 3, zw3/sgg, GSK3, Zw3[sgg], zeste white-3, Zw-3, DMZ3K25Z, zeste-white 3, l(1)G0055, l(1)G0263, l(1)G0335, ZW3, sgg10, sgg39, sgg46, Zw3/GSK3, Zeste white-3, l(1)G0183, zeste-white3, DMSGG3, GSK3beta, GSK-3, Zeste-white 3, SGG/GSK3b, EG:155E2.3, Sgg, Zw3-sh, Zw3 kinase, GSK-3beta, GSKbeta, Gsk3, GSK, glycogen synthase kinase 3Beta, Glycogen Synthase Kinase 3, anon-WO03040301.254, EG:BACR7C10.8" CDMC30241 3 10 13 DAC21-C05 24-CG2621-RA_1 CG2621 CGCAAGCAAATATTTAGCATAAAATCGAAATAAAACCAAAAATCCACTTTAAACTATGCATAAATAATT 69 FBan0002621 FBgn0003371 sgg X X "Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; bristle morphogenesis; GO:0008407; circadian rhythm; GO:0007623; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; mitosis; GO:0007067; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of smoothened signaling pathway; GO:0045879; oogenesis (sensu Insecta); GO:0009993; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; regulation of hemocyte differentiation; GO:0045610; regulation of protein import into nucleus; GO:0042306; regulation of proteolysis; GO:0030162; regulation of smoothened signaling pathway; GO:0008589; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; segment polarity determination; GO:0007367; wing morphogenesis; GO:0007476" ATP binding; GO:0005524; ; GO:0005524; glycogen synthase kinase 3 activity; GO:0004696 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004696 ; EC:2.7.1.- sgg shaggy "CG2621, CG2621, CG2621, CG2621, CG2621, CG2621, zw3, l(1)zw3, zw-3, ZW-3, l(1)3Ba, zw3[sgg], zw3(sgg), zw[3], sgg/zw3, sgg-zw3, shaggy-zeste white 3, zest-white 3, Zw3, zeste white 3, zw3/sgg, GSK3, Zw3[sgg], zeste white-3, Zw-3, DMZ3K25Z, zeste-white 3, l(1)G0055, l(1)G0263, l(1)G0335, ZW3, sgg10, sgg39, sgg46, Zw3/GSK3, Zeste white-3, l(1)G0183, zeste-white3, DMSGG3, GSK3beta, GSK-3, Zeste-white 3, SGG/GSK3b, EG:155E2.3, Sgg, Zw3-sh, Zw3 kinase, GSK-3beta, GSKbeta, Gsk3, GSK, glycogen synthase kinase 3Beta, Glycogen Synthase Kinase 3, anon-WO03040301.254, EG:BACR7C10.8" CDMC30242 3 11 13 DAC21-C17 8-CG2657-RA_1 CG2657 CACAAACGCTTTCTCCTTCACCGGAAAATACTCGTGGAGCAACACGCGGAAAAATTCCACACGCCTTCT 69 FBan0002657 FBgn0031209 CG2657 2 2L transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG2657 CG2657 CT8983 CDMC30242 3 12 13 DAC21-C17 8-CG2657-RA_1 CG2657 CACAAACGCTTTCTCCTTCACCGGAAAATACTCGTGGAGCAACACGCGGAAAAATTCCACACGCCTTCT 69 FBan0002657 FBgn0031209 CG2657 2 2L transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG2657 CG2657 CT8983 CDMC30243 3 13 13 DAC21-G05 7-CG2694-RB_2 CG2694 GGACTGCTTTCAGAAGAAAACACCAGACTCTGTCAAGGAGCCCATTGATCTAAGCGAGCTTCCCAGCCA 69 FBan0002694 FBgn0024991 CG2694 X X CG2694 CG2694 "EG:95B7.10, EG:100G10.8" CDMC30243 3 14 13 DAC21-G05 7-CG2694-RB_2 CG2694 GGACTGCTTTCAGAAGAAAACACCAGACTCTGTCAAGGAGCCCATTGATCTAAGCGAGCTTCCCAGCCA 69 FBan0002694 FBgn0024991 CG2694 X X CG2694 CG2694 "EG:95B7.10, EG:100G10.8" CDMC30244 3 15 13 DAC21-G17 14-CG2709-RA_2 CG2709 CGGCAATCATCGGCACTTCGACAAGTACAAGGAGAGGAAGGAACTGGAGATGGATAAGCTGTTCAAGGA 69 FBan0002709 FBgn0024977 CG2709 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2709 CG2709 EG:95B7.5 CDMC30244 3 16 13 DAC21-G17 14-CG2709-RA_2 CG2709 CGGCAATCATCGGCACTTCGACAAGTACAAGGAGAGGAAGGAACTGGAGATGGATAAGCTGTTCAAGGA 69 FBan0002709 FBgn0024977 CG2709 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2709 CG2709 EG:95B7.5 CDMC30245 3 17 13 DAC21-K05 3-CG2807-RA_14 CG2807 AGGTGGGCGCCTCTGAGATTATCAATCGTGTGGTGGATGACCTGAAGGATGAGAACGAGCAGTACAGGA 69 FBan0002807 FBgn0031266 CG2807 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG2807 CG2807 anon-21Cd CDMC30245 3 18 13 DAC21-K05 3-CG2807-RA_14 CG2807 AGGTGGGCGCCTCTGAGATTATCAATCGTGTGGTGGATGACCTGAAGGATGAGAACGAGCAGTACAGGA 69 FBan0002807 FBgn0031266 CG2807 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG2807 CG2807 anon-21Cd CDMC30246 3 19 13 DAC21-K17 24-CG2827-RA_1 CG2827 AGGTGGAGGATGAATACATTCGTTTTTGAAAAAGACAATGATTTTATACTTTAATAAACACTACAATTA 69 FBan0002827 FBgn0023477 Tal 2 2R "pentose-phosphate shunt, non-oxidative branch; GO:0009052" transaldolase activity; GO:0004801 ; EC:2.2.1.2; ; GO:0004801 ; EC:2.2.1.2 cytoplasm; GO:0005737 Tal Tal "CG2827, CG2827, Transaldolase, CT9666, tal" CDMC30246 3 20 13 DAC21-K17 24-CG2827-RA_1 CG2827 AGGTGGAGGATGAATACATTCGTTTTTGAAAAAGACAATGATTTTATACTTTAATAAACACTACAATTA 69 FBan0002827 FBgn0023477 Tal 2 2R "pentose-phosphate shunt, non-oxidative branch; GO:0009052" transaldolase activity; GO:0004801 ; EC:2.2.1.2; ; GO:0004801 ; EC:2.2.1.2 cytoplasm; GO:0005737 Tal Tal "CG2827, CG2827, Transaldolase, CT9666, tal" CDMC30247 3 21 13 DAC21-O05 8-CG2887-RA_1 CG2887 TCGGGTAGGAACGGCGTTGATGGGGTACAATATGACAGAATTCTCACTGTCAAGATACCTCCGGGCTGT 69 FBan0002887 FBgn0030207 CG2887 X X defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG2887 CG2887 CDMC30247 3 22 13 DAC21-O05 8-CG2887-RA_1 CG2887 TCGGGTAGGAACGGCGTTGATGGGGTACAATATGACAGAATTCTCACTGTCAAGATACCTCCGGGCTGT 69 FBan0002887 FBgn0030207 CG2887 X X defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG2887 CG2887 CDMC30248 3 23 13 DAC21-O17 2-CG2910-RA_2 CG2910 ACACACATGATGCACACATACAGAGACAGAAGCAGAACCGAGGAGACTTCACCCACACCTCATGACCCA 69 FBan0002910 FBgn0027548 nito 2 2R mRNA binding; GO:0003729; ; GO:0003729 nito spenito "CG2910, CG2910, DmSSp, cg2910, Dm44A/spenito, BcDNA:GH11110, dOTT, One Twenty Two, spenito" CDMC30248 3 24 13 DAC21-O17 2-CG2910-RA_2 CG2910 ACACACATGATGCACACATACAGAGACAGAAGCAGAACCGAGGAGACTTCACCCACACCTCATGACCCA 69 FBan0002910 FBgn0027548 nito 2 2R mRNA binding; GO:0003729; ; GO:0003729 nito spenito "CG2910, CG2910, DmSSp, cg2910, Dm44A/spenito, BcDNA:GH11110, dOTT, One Twenty Two, spenito" CDMC30249 3 25 13 DAC22-C05 18-CG14564-RA_2 CG14564 CCGCCCCAGGGTTCCCTTTAATCTGCCCGGTGAAGTTCAACCCAAGATCGAGACGGAACCACTGA 65 FBan0014564 FBgn0037131 CG14564 3 3L CG14564 CG14564 CDMC30249 3 26 13 DAC22-C05 18-CG14564-RA_2 CG14564 CCGCCCCAGGGTTCCCTTTAATCTGCCCGGTGAAGTTCAACCCAAGATCGAGACGGAACCACTGA 65 FBan0014564 FBgn0037131 CG14564 3 3L CG14564 CG14564 CDMC30250 3 1 14 DAC22-C17 1-CG14583-RA_1 CG14583 AAGATGGCAGGGAGATTATTGCCCGCAACGGCTCACACCAGAAAACAAAAGCACAATCGGTGGAG 65 FBan0014583 FBgn0040644 CG14583 X X CG14583 CG14583 "CT34319, pp-CT34319" CDMC30250 3 2 14 DAC22-C17 1-CG14583-RA_1 CG14583 AAGATGGCAGGGAGATTATTGCCCGCAACGGCTCACACCAGAAAACAAAAGCACAATCGGTGGAG 65 FBan0014583 FBgn0040644 CG14583 X X CG14583 CG14583 "CT34319, pp-CT34319" CDMC30251 3 3 14 DAC22-G05 2-CG14655-RA_1 CG14655 AGCTCTGCCAAAAGACGTTCAGGTACAAGGTCAGTCAAAGGACCCATCGATGTCCCACCGAGGAG 65 FBan0014655 FBgn0037275 CG14655 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14655 CG14655 CDMC30251 3 4 14 DAC22-G05 2-CG14655-RA_1 CG14655 AGCTCTGCCAAAAGACGTTCAGGTACAAGGTCAGTCAAAGGACCCATCGATGTCCCACCGAGGAG 65 FBan0014655 FBgn0037275 CG14655 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14655 CG14655 CDMC30252 3 5 14 DAC22-G17 3-CG14689-RA_1 CG14689 CTGGCCCACAGTTCGCTACTCAAACTTTTCGCTTGGCTACGATCCGTACCACATCATTCGCCAGC 65 FBan0014689 FBgn0037826 CG14689 3 3R CG14689 CG14689 CDMC30252 3 6 14 DAC22-G17 3-CG14689-RA_1 CG14689 CTGGCCCACAGTTCGCTACTCAAACTTTTCGCTTGGCTACGATCCGTACCACATCATTCGCCAGC 65 FBan0014689 FBgn0037826 CG14689 3 3R CG14689 CG14689 CDMC30253 3 7 14 DAC22-K05 15-CG1478-RA_2 CG1478 ACTTCAGGCCCTCAATGCCGATCCCAACTACCAGAAGCTGAAGAACTCCGAGGATATTGCCGAAT 65 FBan0001478 FBgn0000359 Cp36 X X insect chorion formation; GO:0007306; oogenesis (sensu Insecta); GO:0009993; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp36 Chorion protein 36 "CG1478, dec[[2]], fs(1)C2, E4, s36-1, s36, s365, cp36, S36: Shell-36, dec2: defective chorion 2, Dms36, dec-2, Shell-36, defective chorion 2, S36, dec2" CDMC30253 3 8 14 DAC22-K05 15-CG1478-RA_2 CG1478 ACTTCAGGCCCTCAATGCCGATCCCAACTACCAGAAGCTGAAGAACTCCGAGGATATTGCCGAAT 65 FBan0001478 FBgn0000359 Cp36 X X insect chorion formation; GO:0007306; oogenesis (sensu Insecta); GO:0009993; vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp36 Chorion protein 36 "CG1478, dec[[2]], fs(1)C2, E4, s36-1, s36, s365, cp36, S36: Shell-36, dec2: defective chorion 2, Dms36, dec-2, Shell-36, defective chorion 2, S36, dec2" CDMC30254 3 9 14 DAC22-K17 2-CG14805-RA_1 CG14805 GTGGCCCTGCATAGCGTGATTGTCAGCAAGATGGAAACTAGGGTGTATGTTGGCTCCAGTGACGG 65 FBan0014805 FBgn0023514 CG14805 X X CG14805 CG14805 "EG:63B12.7, i207" CDMC30254 3 10 14 DAC22-K17 2-CG14805-RA_1 CG14805 GTGGCCCTGCATAGCGTGATTGTCAGCAAGATGGAAACTAGGGTGTATGTTGGCTCCAGTGACGG 65 FBan0014805 FBgn0023514 CG14805 X X CG14805 CG14805 "EG:63B12.7, i207" CDMC30255 3 11 14 DAC22-O05 6-CG14891-RA_1 CG14891 TGAGTGGCTCGCCCAATCTGTCCAATGAGGTCGTTGCGAAGTTGACCAAATCGCTTAGCGGACTG 65 FBan0014891 FBgn0038445 CG14891 3 3R CG14891 CG14891 CDMC30255 3 12 14 DAC22-O05 6-CG14891-RA_1 CG14891 TGAGTGGCTCGCCCAATCTGTCCAATGAGGTCGTTGCGAAGTTGACCAAATCGCTTAGCGGACTG 65 FBan0014891 FBgn0038445 CG14891 3 3R CG14891 CG14891 CDMC30256 3 13 14 DAC22-O17 3-CG14949-RA_1 CG14949 AACGCGTGGATCTGACCTTCTACGACACGCACAGCAACAAGAGTCACATTGACCTGGGCAACATC 65 FBan0014949 FBgn0035358 CG14949 3 3L CG14949 CG14949 CDMC30256 3 14 14 DAC22-O17 3-CG14949-RA_1 CG14949 AACGCGTGGATCTGACCTTCTACGACACGCACAGCAACAAGAGTCACATTGACCTGGGCAACATC 65 FBan0014949 FBgn0035358 CG14949 3 3L CG14949 CG14949 CDMC30257 3 15 14 DAC23-C05 24-CG6757-RA_4 CG6757 GGAACTCTTACTTTAAGCGTGGTTCTAACTAAATGTTAAACAGAAAAAATATTACATAATGTTGTTTGT 69 FBan0006757 FBgn0040475 SH3PX1 3 3L intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 SH3PX1 SH3PX1 "CG6757, DSH3PX1, p63" CDMC30257 3 16 14 DAC23-C05 24-CG6757-RA_4 CG6757 GGAACTCTTACTTTAAGCGTGGTTCTAACTAAATGTTAAACAGAAAAAATATTACATAATGTTGTTTGT 69 FBan0006757 FBgn0040475 SH3PX1 3 3L intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 SH3PX1 SH3PX1 "CG6757, DSH3PX1, p63" CDMC30258 3 17 14 DAC23-C17 23-CG6767-RA_8 CG6767 AACCAGAACACCGTTAGCAAGCCACAGCAAAATGAAAAGAGAAAAAAACCCACTTTAATAGCAATTTGT 69 FBan0006767 FBgn0036030 CG6767 3 3L nucleoside metabolism; GO:0009116; nucleotide biosynthesis; GO:0009165; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206; ribonucleoside monophosphate biosynthesis; GO:0009156 nucleotide kinase activity; GO:0019201; ; GO:0019201; lipoate-protein ligase B activity; GO:0016978; ; GO:0016978; ribose phosphate diphosphokinase activity; GO:0004749 ; EC:2.7.6.1; ; GO:0004749 ; EC:2.7.6.1 CG6767 CG6767 CDMC30258 3 18 14 DAC23-C17 23-CG6767-RA_8 CG6767 AACCAGAACACCGTTAGCAAGCCACAGCAAAATGAAAAGAGAAAAAAACCCACTTTAATAGCAATTTGT 69 FBan0006767 FBgn0036030 CG6767 3 3L nucleoside metabolism; GO:0009116; nucleotide biosynthesis; GO:0009165; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206; ribonucleoside monophosphate biosynthesis; GO:0009156 nucleotide kinase activity; GO:0019201; ; GO:0019201; lipoate-protein ligase B activity; GO:0016978; ; GO:0016978; ribose phosphate diphosphokinase activity; GO:0004749 ; EC:2.7.6.1; ; GO:0004749 ; EC:2.7.6.1 CG6767 CG6767 CDMC30259 3 19 14 DAC23-G05 23-CG6803-RB_8 CG6803 CAACTTATGAGTTCCCATTTGCAACATCAACATCGCACACTCAATGGGCTTCATAAATTGTTCCTTTTT 69 FBan0006803 FBgn0038294 Zeelin1 3 3R muscle thick filament assembly; GO:0030241 Zeelin1 Zeelin1 "CG6803, z1, BcDNA:GH23305, Zeelin1" CDMC30259 3 20 14 DAC23-G05 23-CG6803-RB_8 CG6803 CAACTTATGAGTTCCCATTTGCAACATCAACATCGCACACTCAATGGGCTTCATAAATTGTTCCTTTTT 69 FBan0006803 FBgn0038294 Zeelin1 3 3R muscle thick filament assembly; GO:0030241 Zeelin1 Zeelin1 "CG6803, z1, BcDNA:GH23305, Zeelin1" CDMC30260 3 21 14 DAC23-G17 23-CG6816-RB_5 CG6816 AGTGCTAGCTTAATGTCCAAACAACAAACAACAAAACAAACTGTGGTTTAGTCTTACAAGCACACATCA 69 FBan0006816 FBgn0010383 Cyp18a1 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp18a1 Cytochrome P450-18a1 "CG6816, Eig17-1, P450, P-450, CytP450, 181H6T, CYP18, cyp18, 18a1, CT20826, CYP18A1-Dm, Cyp18, Cyt-P450-17C: Cytochrome P450 17C, ESTS:181H6T, Cytochrome P450 17C" CDMC30260 3 22 14 DAC23-G17 23-CG6816-RB_5 CG6816 AGTGCTAGCTTAATGTCCAAACAACAAACAACAAAACAAACTGTGGTTTAGTCTTACAAGCACACATCA 69 FBan0006816 FBgn0010383 Cyp18a1 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp18a1 Cytochrome P450-18a1 "CG6816, Eig17-1, P450, P-450, CytP450, 181H6T, CYP18, cyp18, 18a1, CT20826, CYP18A1-Dm, Cyp18, Cyt-P450-17C: Cytochrome P450 17C, ESTS:181H6T, Cytochrome P450 17C" CDMC30261 3 23 14 DAC23-K05 1-CG6854-RA_1 CG6854 CACTCCGCTCGTACCAGAGGACGATGACTACCACTACTTGCTCAGCCTACATCCGTACATGAAGCAGCT 69 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC30261 3 24 14 DAC23-K05 1-CG6854-RA_1 CG6854 CACTCCGCTCGTACCAGAGGACGATGACTACCACTACTTGCTCAGCCTACATCCGTACATGAAGCAGCT 69 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC30262 3 25 14 DAC23-K17 2-CG6866-RB_1 CG6866 GCCACGGAGAACCAGTTCGAGGTGACCTATGTGGACATAGAGGAGAAGACCTTCTCTGGCCAGTTCCAG 69 FBan0006866 FBgn0032515 loqs 2 2L "cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" double-stranded RNA binding; GO:0003725; ; GO:0003725; ; GO:0003725 intracellular; GO:0005622 loqs loquacious "CG6866, CG6866, cg6866, R3D1-L, R3D1-S, loquacious" CDMC30262 3 26 14 DAC23-K17 2-CG6866-RB_1 CG6866 GCCACGGAGAACCAGTTCGAGGTGACCTATGTGGACATAGAGGAGAAGACCTTCTCTGGCCAGTTCCAG 69 FBan0006866 FBgn0032515 loqs 2 2L "cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" double-stranded RNA binding; GO:0003725; ; GO:0003725; ; GO:0003725 intracellular; GO:0005622 loqs loquacious "CG6866, CG6866, cg6866, R3D1-L, R3D1-S, loquacious" CDMC30263 3 1 15 DAC23-O05 23-CG6892-RB_1 CG6892 AGGCTGTTTTTCAGTAATATTGGGGTCAGCATCTCCTGAAAATTACATACAATATGGTTTCAAAATTGT 69 FBan0006892 FBgn0039225 Ets96B 3 3R "MAPKKK cascade; GO:0000165; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Ets96B Ets96B "CG6892, Ets" CDMC30263 3 2 15 DAC23-O05 23-CG6892-RB_1 CG6892 AGGCTGTTTTTCAGTAATATTGGGGTCAGCATCTCCTGAAAATTACATACAATATGGTTTCAAAATTGT 69 FBan0006892 FBgn0039225 Ets96B 3 3R "MAPKKK cascade; GO:0000165; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Ets96B Ets96B "CG6892, Ets" CDMC30264 3 3 15 DAC23-O17 10-CG6907-RA_1 CG6907 GGACTCCATGATGCTCTACAATGTCAAGACTACCTTGTGGGACGATAGCCCCAAGCATCTGGACATCGT 69 FBan0006907 FBgn0031711 CG6907 2 2L CG6907 CG6907 CDMC30264 3 4 15 DAC23-O17 10-CG6907-RA_1 CG6907 GGACTCCATGATGCTCTACAATGTCAAGACTACCTTGTGGGACGATAGCCCCAAGCATCTGGACATCGT 69 FBan0006907 FBgn0031711 CG6907 2 2L CG6907 CG6907 CDMC30265 3 5 15 DAC24-C05 15-CG2174-RA_1 CG2174 CCGAGTGCAGGAATTGAACTCCCACAGGCTCTGAGTCCAATCCTCTGGTCCCCTATTCATATTTCGATT 69 FBan0002174 FBgn0030252 Myo10A X X cytoskeleton organization and biogenesis; GO:0007010; sensory perception of sound; GO:0007605; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459; unconventional myosin; GO:0016461 Myo10A unconventional myosin class XV "CG2174, CG2136, CG2174, AAF47980, DmXV, 10A, Myosin XV, myosin XV" CDMC30265 3 6 15 DAC24-C05 15-CG2174-RA_1 CG2174 CCGAGTGCAGGAATTGAACTCCCACAGGCTCTGAGTCCAATCCTCTGGTCCCCTATTCATATTTCGATT 69 FBan0002174 FBgn0030252 Myo10A X X cytoskeleton organization and biogenesis; GO:0007010; sensory perception of sound; GO:0007605; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459; unconventional myosin; GO:0016461 Myo10A unconventional myosin class XV "CG2174, CG2136, CG2174, AAF47980, DmXV, 10A, Myosin XV, myosin XV" CDMC30266 3 7 15 DAC24-C17 23-CG2186-RA_6 CG2186 AGCAACACAAACTAGGACCCAAATGTGCATACTATGTGCATGCTCATAGCCCTTAGCCTATGTAATCAA 69 FBan0002186 FBgn0030243 CG2186 X X CG2186 CG2186 CDMC30266 3 8 15 DAC24-C17 23-CG2186-RA_6 CG2186 AGCAACACAAACTAGGACCCAAATGTGCATACTATGTGCATGCTCATAGCCCTTAGCCTATGTAATCAA 69 FBan0002186 FBgn0030243 CG2186 X X CG2186 CG2186 CDMC30267 3 9 15 DAC24-G05 24-CG2229-RA_2 CG2229 TCTCGTACTAAGAGCTTAGTGTTTTTCTACTAATAGCTTAGTGTTTTCTTTTCCGTTTATCTTTTTGGA 69 FBan0002229 FBgn0039777 Jon99Fii 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Fii Jonah 99Fii "CG2229, Jon99F, SP135, Jonah 99F" CDMC30267 3 10 15 DAC24-G05 24-CG2229-RA_2 CG2229 TCTCGTACTAAGAGCTTAGTGTTTTTCTACTAATAGCTTAGTGTTTTCTTTTCCGTTTATCTTTTTGGA 69 FBan0002229 FBgn0039777 Jon99Fii 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Fii Jonah 99Fii "CG2229, Jon99F, SP135, Jonah 99F" CDMC30268 3 11 15 DAC24-G17 23-CG2248-RA_5 CG2248 CCCAACTCTTGCTTTTGTTTCGTTTCCGAGTTCTGAGTTTGTTTCGAGTGTTCTGTAATTCATAATCCA 69 FBan0002248 FBgn0010333 Rac1 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; dendrite morphogenesis; GO:0016358; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, amnioserosa morphology change; GO:0046664; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of tissue polarity; GO:0007164; glial cell migration; GO:0008347; hemocyte migration (sensu Arthropoda); GO:0035099; intercellular junction assembly and/or maintenance; GO:0045216; microtubule-based process; GO:0007017; morphogenesis of larval imaginal disc epithelium; GO:0016335; myoblast fusion; GO:0007520; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; regulation of dendrite morphogenesis; GO:0050773; regulation of hemocyte differentiation; GO:0045610; regulation of synapse structure; GO:0050807; rhabdomere development; GO:0042052; small GTPase mediated signal transduction; GO:0007264; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing hair site selection; GO:0035320" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 rhabdomere; GO:0016028 Rac1 Rac1 "CG2248, Dmrac1, DRacA, Drac1, Rac, Drac1a, Drac, DRac1, D-Rac, DRac, D-Rac1, rac1, RacA, rac, DracA, dRac1, Rac GTPase, dRac, D-Rac 1, Dm Rac1, GTPase Rac1, DmRAC1" CDMC30268 3 12 15 DAC24-G17 23-CG2248-RA_5 CG2248 CCCAACTCTTGCTTTTGTTTCGTTTCCGAGTTCTGAGTTTGTTTCGAGTGTTCTGTAATTCATAATCCA 69 FBan0002248 FBgn0010333 Rac1 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; dendrite morphogenesis; GO:0016358; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, amnioserosa morphology change; GO:0046664; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of tissue polarity; GO:0007164; glial cell migration; GO:0008347; hemocyte migration (sensu Arthropoda); GO:0035099; intercellular junction assembly and/or maintenance; GO:0045216; microtubule-based process; GO:0007017; morphogenesis of larval imaginal disc epithelium; GO:0016335; myoblast fusion; GO:0007520; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; regulation of dendrite morphogenesis; GO:0050773; regulation of hemocyte differentiation; GO:0045610; regulation of synapse structure; GO:0050807; rhabdomere development; GO:0042052; small GTPase mediated signal transduction; GO:0007264; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing hair site selection; GO:0035320" GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 rhabdomere; GO:0016028 Rac1 Rac1 "CG2248, Dmrac1, DRacA, Drac1, Rac, Drac1a, Drac, DRac1, D-Rac, DRac, D-Rac1, rac1, RacA, rac, DracA, dRac1, Rac GTPase, dRac, D-Rac 1, Dm Rac1, GTPase Rac1, DmRAC1" CDMC30269 3 13 15 DAC24-K05 11-CG2310-RB_1 CG2310 GCGAACAACTAAACGCTTTGCGCAACCGAAATTCAGCTGCTTAAAGGGACATCGAAAGTGGTAGCTGCA 69 FBan0002310 FBgn0039665 CG2310 3 3R CG2310 CG2310 CDMC30269 3 14 15 DAC24-K05 11-CG2310-RB_1 CG2310 GCGAACAACTAAACGCTTTGCGCAACCGAAATTCAGCTGCTTAAAGGGACATCGAAAGTGGTAGCTGCA 69 FBan0002310 FBgn0039665 CG2310 3 3R CG2310 CG2310 CDMC30270 3 15 15 DAC24-K17 3-CG2336-RA_1 CG2336 ACCACTACGAGTCATTGACCTTTAAGGGAAAGCGCAAAGTGGTTGTCCATCCAGTTGGCACCATCTGGG 69 FBan0002336 FBgn0037455 CG2336 3 3R CG2336 CG2336 CDMC30270 3 16 15 DAC24-K17 3-CG2336-RA_1 CG2336 ACCACTACGAGTCATTGACCTTTAAGGGAAAGCGCAAAGTGGTTGTCCATCCAGTTGGCACCATCTGGG 69 FBan0002336 FBgn0037455 CG2336 3 3R CG2336 CG2336 CDMC30271 3 17 15 DAC24-O05 17-CG2471-RA_3 CG2471 CATCTTATGCGAAACACAGAGTTGATCACCTGCAATCTCAGTGGCAATGTGCTCAAAAGCGTTTCGCCC 69 FBan0002471 FBgn0030357 CG2471 X X CG2471 CG2471 CT8171 CDMC30271 3 18 15 DAC24-O05 17-CG2471-RA_3 CG2471 CATCTTATGCGAAACACAGAGTTGATCACCTGCAATCTCAGTGGCAATGTGCTCAAAAGCGTTTCGCCC 69 FBan0002471 FBgn0030357 CG2471 X X CG2471 CG2471 CT8171 CDMC30272 3 19 15 DAC24-O17 12-CG2519-RA_1 CG2519 ACCGGGCTTACATGCTAAATTCCAATTTGACTCCATCCCCAGAGCAACAAGCCCTCCAAGTATTTCCCA 69 FBan0002519 FBgn0037336 CG2519 3 3R CG2519 CG2519 CDMC30272 3 20 15 DAC24-O17 12-CG2519-RA_1 CG2519 ACCGGGCTTACATGCTAAATTCCAATTTGACTCCATCCCCAGAGCAACAAGCCCTCCAAGTATTTCCCA 69 FBan0002519 FBgn0037336 CG2519 3 3R CG2519 CG2519 CDMC30273 3 21 15 DAC25-C05 1-CG10102-RA_7 CG10102 GACCAGCTCAATTCCGATTTCAAGCCCCAATCGTTAGACGAGCACAGTTTGTGGCGGTTCCTCCG 65 FBan0010102 FBgn0033927 CG10102 2 2R CG10102 CG10102 CDMC30273 3 22 15 DAC25-C05 1-CG10102-RA_7 CG10102 GACCAGCTCAATTCCGATTTCAAGCCCCAATCGTTAGACGAGCACAGTTTGTGGCGGTTCCTCCG 65 FBan0010102 FBgn0033927 CG10102 2 2R CG10102 CG10102 CDMC30274 3 23 15 DAC25-C17 2-CG10149-RB_3 CG10149 ATTCGGGCCGCGATATAGATGCTATGAAATCAGTGGCTGAGGCTTCACACAAACGTTCCCTGGCC 65 FBan0010149 FBgn0028689 Rpn6 2 2R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn6 Proteasome p44.5 subunit "CG10149, CG10149, l(2)k00103, Pros44.5, BcDNA.LD18931, p42B, BcDNA:LD18931, Proteasome p44.5 subunit" CDMC30274 3 24 15 DAC25-C17 2-CG10149-RB_3 CG10149 ATTCGGGCCGCGATATAGATGCTATGAAATCAGTGGCTGAGGCTTCACACAAACGTTCCCTGGCC 65 FBan0010149 FBgn0028689 Rpn6 2 2R proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn6 Proteasome p44.5 subunit "CG10149, CG10149, l(2)k00103, Pros44.5, BcDNA.LD18931, p42B, BcDNA:LD18931, Proteasome p44.5 subunit" CDMC30275 3 25 15 DAC25-G05 12-CG10257-RA_4 CG10257 GCACGACCAGTACACCGAGGACATGACACGGCAATATCGACTGTGGCTATATACGGATGATGCGG 65 FBan0010257 FBgn0033985 CG10257 2 2R negative regulation of apoptosis; GO:0043066 CG10257 CG10257 BcDNA:RH51312 CDMC30275 3 26 15 DAC25-G05 12-CG10257-RA_4 CG10257 GCACGACCAGTACACCGAGGACATGACACGGCAATATCGACTGTGGCTATATACGGATGATGCGG 65 FBan0010257 FBgn0033985 CG10257 2 2R negative regulation of apoptosis; GO:0043066 CG10257 CG10257 BcDNA:RH51312 CDMC30276 3 1 16 DAC25-G17 2-CG10286-RA_1 CG10286 GCTCCAGCGATGAACAGAGCAACTGGGATACAGATAGCGAGCATTCAGAGTCTGAGAGCGTGGCC 65 FBan0010286 FBgn0037439 CG10286 3 3R CG10286 CG10286 CDMC30276 3 2 16 DAC25-G17 2-CG10286-RA_1 CG10286 GCTCCAGCGATGAACAGAGCAACTGGGATACAGATAGCGAGCATTCAGAGTCTGAGAGCGTGGCC 65 FBan0010286 FBgn0037439 CG10286 3 3R CG10286 CG10286 CDMC30277 3 3 16 DAC25-K05 1-CG10372-RA_1 CG10372 ATGGTGATGATCAGCCTTCGAGCAAATCGCATGATGATCGTCGGACGTTTCGAGGGGGATTGCAC 65 FBan0010372 FBgn0025608 Faf 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Faf Fas-associated factor "CG10372, GT#49, FFAF: Fly Fas-associated factor, Fly Fas-associated factor" CDMC30277 3 4 16 DAC25-K05 1-CG10372-RA_1 CG10372 ATGGTGATGATCAGCCTTCGAGCAAATCGCATGATGATCGTCGGACGTTTCGAGGGGGATTGCAC 65 FBan0010372 FBgn0025608 Faf 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Faf Fas-associated factor "CG10372, GT#49, FFAF: Fly Fas-associated factor, Fly Fas-associated factor" CDMC30278 3 5 16 DAC25-K17 2-CG10414-RA_1 CG10414 CATCGGTTGCGGATTCCTAGTGCCCGACGTAGGTTACAACGAGGCCTACATCTCATTCATGGCGG 65 FBan0010414 FBgn0032691 CG10414 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0003677; ; GO:0008080 ; EC:2.3.1.- CG10414 CG10414 CDMC30278 3 6 16 DAC25-K17 2-CG10414-RA_1 CG10414 CATCGGTTGCGGATTCCTAGTGCCCGACGTAGGTTACAACGAGGCCTACATCTCATTCATGGCGG 65 FBan0010414 FBgn0032691 CG10414 2 2L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0003677; ; GO:0008080 ; EC:2.3.1.- CG10414 CG10414 CDMC30279 3 7 16 DAC25-O05 3-CG10545-RA_1 CG10545 AACTGATCGTTTGGGACTCGCATACCACGAACAAAGTCCATGCCATTCCACTGCGATCCTCGTGG 65 FBan0010545 FBgn0001105 Gbeta13F X X G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; neuroblast division; GO:0045034 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Gbeta13F G protein beta-subunit 13F "CG10545, dgbeta, Gbeta, G protein beta subunit, Gbb, G[[beta]] brain, clone 1.22, G-protein beta 13F, G-beta, Gb13F, Gbeta13F, G[[beta]], G b13F, G-betab, anon-EST:Liang-1.22" CDMC30279 3 8 16 DAC25-O05 3-CG10545-RA_1 CG10545 AACTGATCGTTTGGGACTCGCATACCACGAACAAAGTCCATGCCATTCCACTGCGATCCTCGTGG 65 FBan0010545 FBgn0001105 Gbeta13F X X G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; neuroblast division; GO:0045034 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Gbeta13F G protein beta-subunit 13F "CG10545, dgbeta, Gbeta, G protein beta subunit, Gbb, G[[beta]] brain, clone 1.22, G-protein beta 13F, G-beta, Gb13F, Gbeta13F, G[[beta]], G b13F, G-betab, anon-EST:Liang-1.22" CDMC30280 3 9 16 DAC25-O17 3-CG10585-RA_2 CG10585 TATAAGCCAGGAACCTTCCAGCGACCATCTCTCAGCGTTGGAGTGGATTTCAACGAGCACGACGT 65 FBan0010585 FBgn0037044 CG10585 3 3L trans-hexaprenyltranstransferase activity; GO:0000010 ; EC:2.5.1.30; ; GO:0000010 ; EC:2.5.1.30 CG10585 CG10585 CDMC30280 3 10 16 DAC25-O17 3-CG10585-RA_2 CG10585 TATAAGCCAGGAACCTTCCAGCGACCATCTCTCAGCGTTGGAGTGGATTTCAACGAGCACGACGT 65 FBan0010585 FBgn0037044 CG10585 3 3L trans-hexaprenyltranstransferase activity; GO:0000010 ; EC:2.5.1.30; ; GO:0000010 ; EC:2.5.1.30 CG10585 CG10585 CDMC30281 3 11 16 DAC26-C05 4-CG6187-RA_1 CG6187 TCGCCAAAGGACGTTGGGTTGATGAGAAAATTCTGGATGTATTTGTCCGCGAATTTCGAGCCGCACCGC 69 FBan0006187 FBgn0032256 RluA-2 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; DRAP deaminase activity; GO:0017173; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; ; GO:0017173; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-2 RluA-2 "CG6187, CG6187, CG6187, CG6187, yumo" CDMC30281 3 12 16 DAC26-C05 4-CG6187-RA_1 CG6187 TCGCCAAAGGACGTTGGGTTGATGAGAAAATTCTGGATGTATTTGTCCGCGAATTTCGAGCCGCACCGC 69 FBan0006187 FBgn0032256 RluA-2 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; DRAP deaminase activity; GO:0017173; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; ; GO:0017173; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-2 RluA-2 "CG6187, CG6187, CG6187, CG6187, yumo" CDMC30282 3 13 16 DAC26-C17 1-CG6198-RA_2 CG6198 GAAACGAACCTCGGACTTTTCCCAGTTTATGGCGCAAAAGGGCTGTACCTACGGTGAGCACAAATGGGT 69 FBan0006198 FBgn0029503 CHORD 3 3R gametogenesis; GO:0007276; induction of apoptosis; GO:0006917; signal transduction; GO:0007165 zinc ion binding; GO:0008270; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008270 CHORD CHORD "CG6198, chp, CHORD containing protein, Q9U4A3" CDMC30282 3 14 16 DAC26-C17 1-CG6198-RA_2 CG6198 GAAACGAACCTCGGACTTTTCCCAGTTTATGGCGCAAAAGGGCTGTACCTACGGTGAGCACAAATGGGT 69 FBan0006198 FBgn0029503 CHORD 3 3R gametogenesis; GO:0007276; induction of apoptosis; GO:0006917; signal transduction; GO:0007165 zinc ion binding; GO:0008270; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008270 CHORD CHORD "CG6198, chp, CHORD containing protein, Q9U4A3" CDMC30283 3 15 16 DAC26-G05 1-CG6225-RA_1 CG6225 GGCCTTCTACTGGATGATGAACCAAACGCGTCACATTCGGGAGTATCTGCCTGAGGATGAGTACCGCTC 69 FBan0006225 FBgn0038072 CG6225 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235 CG6225 CG6225 CDMC30283 3 16 16 DAC26-G05 1-CG6225-RA_1 CG6225 GGCCTTCTACTGGATGATGAACCAAACGCGTCACATTCGGGAGTATCTGCCTGAGGATGAGTACCGCTC 69 FBan0006225 FBgn0038072 CG6225 3 3R proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235 CG6225 CG6225 CDMC30284 3 17 16 DAC26-G17 17-CG6235-RA_2 CG6235 TCACTTGCAATCAAATTGTTTGCCTAACACCATTACCTCAGGCCACCCTTATCCCTATCCCCATCCATG 69 FBan0006235 FBgn0004889 tws 3 3R MAPKKK cascade; GO:0000165; Wnt receptor signaling pathway; GO:0016055; chromosome segregation; GO:0007059; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; imaginal disc pattern formation; GO:0007447; mitotic anaphase; GO:0000090; protein amino acid dephosphorylation; GO:0006470; regulation of mitosis; GO:0007088; response to stress; GO:0006950; sensory organ development; GO:0007423 protein phosphatase type 2A activity; GO:0000158; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0000158; ; GO:0008601 cytoplasm; GO:0005737; protein phosphatase type 2A complex; GO:0000159 tws twins "CG6235, CG6235, CG6235, aar: abnormal anaphase resolution, PR55, regulatory B subunit of type 2A protein phosphatase, tw, DPR55, l(3)02414, 1466/06, 2414, l(3)S061805, phosphoprotein phosphatase 2A 55 kDa, PP2A, v158, B/PR55, tws/aar, Pp2A-85F, l(3)01436, l(3)j11C8, l(3)s1801, l(3)S022205b, l(3)S022361, l(3)S022440, l(3)S023013, l(3)S023141a, l(3)S023206, l(3)S023309, l(3)S023938, l(3)S024455, l(3)S024834a, l(3)S024838, l(3)S025806, l(3)S025832, l(3)S025913, l(3)S026226, l(3)S026326, l(3)S027127, l(3)S027313, l(3)S028707, l(3)S029110, l(3)S029403, l(3)S029701a, l(3)S031006, l(3)S032303, l(3)S032708c, l(3)S033903, l(3)S035505b, l(3)S042629, l(3)S042630, l(3)S043008b, l(3)S043029, l(3)S045519, l(3)S046918, l(3)S048006, l(3)S048013, l(3)S048507, l(3)S049902, l(3)S052810, l(3)S053011, l(3)S060203, l(3)S060804, l(3)S061915, l(3)S063110, l(3)S066017, l(3)S066813, l(3)S067109b, l(3)S067915, l(3)S069206a, l(3)S075110, l(3)S075515b, l(3)S075902b, l(3)S076415, l(3)S080409, l(3)S088513, l(3)S091905, l(3)S101413b, l(3)S105605, l(3)S110008a, l(3)S110815, l(3)S111515, l(3)S119908, l(3)S132907, l(3)S134601a, l(3)S141309, l(3)S146606, Protein phosphatase 2A at 85F, abnormal anaphase resolution, aar, twins" CDMC30284 3 18 16 DAC26-G17 17-CG6235-RA_2 CG6235 TCACTTGCAATCAAATTGTTTGCCTAACACCATTACCTCAGGCCACCCTTATCCCTATCCCCATCCATG 69 FBan0006235 FBgn0004889 tws 3 3R MAPKKK cascade; GO:0000165; Wnt receptor signaling pathway; GO:0016055; chromosome segregation; GO:0007059; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; imaginal disc pattern formation; GO:0007447; mitotic anaphase; GO:0000090; protein amino acid dephosphorylation; GO:0006470; regulation of mitosis; GO:0007088; response to stress; GO:0006950; sensory organ development; GO:0007423 protein phosphatase type 2A activity; GO:0000158; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0000158; ; GO:0008601 cytoplasm; GO:0005737; protein phosphatase type 2A complex; GO:0000159 tws twins "CG6235, CG6235, CG6235, aar: abnormal anaphase resolution, PR55, regulatory B subunit of type 2A protein phosphatase, tw, DPR55, l(3)02414, 1466/06, 2414, l(3)S061805, phosphoprotein phosphatase 2A 55 kDa, PP2A, v158, B/PR55, tws/aar, Pp2A-85F, l(3)01436, l(3)j11C8, l(3)s1801, l(3)S022205b, l(3)S022361, l(3)S022440, l(3)S023013, l(3)S023141a, l(3)S023206, l(3)S023309, l(3)S023938, l(3)S024455, l(3)S024834a, l(3)S024838, l(3)S025806, l(3)S025832, l(3)S025913, l(3)S026226, l(3)S026326, l(3)S027127, l(3)S027313, l(3)S028707, l(3)S029110, l(3)S029403, l(3)S029701a, l(3)S031006, l(3)S032303, l(3)S032708c, l(3)S033903, l(3)S035505b, l(3)S042629, l(3)S042630, l(3)S043008b, l(3)S043029, l(3)S045519, l(3)S046918, l(3)S048006, l(3)S048013, l(3)S048507, l(3)S049902, l(3)S052810, l(3)S053011, l(3)S060203, l(3)S060804, l(3)S061915, l(3)S063110, l(3)S066017, l(3)S066813, l(3)S067109b, l(3)S067915, l(3)S069206a, l(3)S075110, l(3)S075515b, l(3)S075902b, l(3)S076415, l(3)S080409, l(3)S088513, l(3)S091905, l(3)S101413b, l(3)S105605, l(3)S110008a, l(3)S110815, l(3)S111515, l(3)S119908, l(3)S132907, l(3)S134601a, l(3)S141309, l(3)S146606, Protein phosphatase 2A at 85F, abnormal anaphase resolution, aar, twins" CDMC30285 3 19 16 DAC26-K05 1-CG6291-RA_3 CG6291 TGGATGGTACTACGGATGTGACGAGGACCCTTCACTTCGGTGAACCCACTGAGTTTCAGAAGGAAGCCT 69 FBan0006291 FBgn0026150 ApepP 2 2L proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.-; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235 cytosol; GO:0005829 ApepP Aminopeptidase P "CG6291, CG6291, Daminopep-p, DAP-P, AP-P, Aminopeptidase P" CDMC30285 3 20 16 DAC26-K05 1-CG6291-RA_3 CG6291 TGGATGGTACTACGGATGTGACGAGGACCCTTCACTTCGGTGAACCCACTGAGTTTCAGAAGGAAGCCT 69 FBan0006291 FBgn0026150 ApepP 2 2L proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; metallopeptidase activity; GO:0008237; X-Pro aminopeptidase activity; GO:0008451 ; EC:3.4.11.9; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.-; ; GO:0008237; ; GO:0008451 ; EC:3.4.11.9; metalloexopeptidase activity; GO:0008235; ; GO:0008235 cytosol; GO:0005829 ApepP Aminopeptidase P "CG6291, CG6291, Daminopep-p, DAP-P, AP-P, Aminopeptidase P" CDMC30286 3 21 16 DAC26-K17 2-CG6301-RA_2 CG6301 CCTCTTTTGCGGAATGTGTGGAGACCGCTGTTCTGACGGACGTTGACTTTCCACAATGCTGTTGGACTT 69 FBan0006301 FBgn0034161 CG6301 2 2R CG6301 CG6301 bs26g12.y1 CDMC30286 3 22 16 DAC26-K17 2-CG6301-RA_2 CG6301 CCTCTTTTGCGGAATGTGTGGAGACCGCTGTTCTGACGGACGTTGACTTTCCACAATGCTGTTGGACTT 69 FBan0006301 FBgn0034161 CG6301 2 2R CG6301 CG6301 bs26g12.y1 CDMC30287 3 23 16 DAC26-O05 23-CG6342-RA_1 CG6342 TGGTGGAATCCTCAACTACATGATTCGCAAAATGCTCTCTTAAGCAACTCATCTTATTTTGTTTTTATA 69 FBan0006342 FBgn0024957 Irp-1B 3 3R amino acid biosynthesis; GO:0008652; regulation of translational initiation by iron; GO:0006447; tricarboxylic acid cycle; GO:0006099 mRNA binding; GO:0003729; iron ion binding; GO:0005506; ; GO:0005506; aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0005506; ; GO:0003729 Irp-1B Iron regulatory protein 1B "CG6342, IRP-1B, IRP-1, IRP1, cytosolic aconitase" CDMC30287 3 24 16 DAC26-O05 23-CG6342-RA_1 CG6342 TGGTGGAATCCTCAACTACATGATTCGCAAAATGCTCTCTTAAGCAACTCATCTTATTTTGTTTTTATA 69 FBan0006342 FBgn0024957 Irp-1B 3 3R amino acid biosynthesis; GO:0008652; regulation of translational initiation by iron; GO:0006447; tricarboxylic acid cycle; GO:0006099 mRNA binding; GO:0003729; iron ion binding; GO:0005506; ; GO:0005506; aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0005506; ; GO:0003729 Irp-1B Iron regulatory protein 1B "CG6342, IRP-1B, IRP-1, IRP1, cytosolic aconitase" CDMC30288 3 25 16 DAC26-O17 10-CG6355-RA_1 CG6355 TAGACGCCAATCCAACTCAATTCGATTTCAACAACCAACACTCTGTCAGCCAGCATTTCCGACTCCGCA 69 FBan0006355 FBgn0028741 CG6355 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphorylation; GO:0016310 nucleic acid binding; GO:0003676; 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0008270 nucleus; GO:0005634; vesicle membrane; GO:0012506 CG6355 CG6355 EG:52C10.5 CDMC30288 3 26 16 DAC26-O17 10-CG6355-RA_1 CG6355 TAGACGCCAATCCAACTCAATTCGATTTCAACAACCAACACTCTGTCAGCCAGCATTTCCGACTCCGCA 69 FBan0006355 FBgn0028741 CG6355 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphorylation; GO:0016310 nucleic acid binding; GO:0003676; 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0008270 nucleus; GO:0005634; vesicle membrane; GO:0012506 CG6355 CG6355 EG:52C10.5 CDMC30289 3 1 17 DAC27-C05 6-CG3708-RA_1 CG3708 TGCTTCTGGGCAAATCCAAGGAATCATCAGCCGAATTTTCGTTCCCAGTAGTAGGCCGGTTTCTGTGGA 69 FBan0003708 FBgn0040345 CG3708 X X nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461 histone binding; GO:0042393; ; GO:0042393 nucleus; GO:0005634 CG3708 CG3708 EG:BACR7A4.18 CDMC30289 3 2 17 DAC27-C05 6-CG3708-RA_1 CG3708 TGCTTCTGGGCAAATCCAAGGAATCATCAGCCGAATTTTCGTTCCCAGTAGTAGGCCGGTTTCTGTGGA 69 FBan0003708 FBgn0040345 CG3708 X X nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461 histone binding; GO:0042393; ; GO:0042393 nucleus; GO:0005634 CG3708 CG3708 EG:BACR7A4.18 CDMC30290 3 3 17 DAC27-C17 22-CG3717-RA_5 CG3717 GCCGCACCGAAACAAGAAACCAGGGTCAAAACAAAGCACTCATCAATTAAACAGCACTTTAATCCACCA 69 FBan0003717 FBgn0013432 bcn92 X X electron transport; GO:0006118 "oxidoreductase activity, acting on NADH or NADPH; GO:0016651 ; EC:1.6.-.-; ; GO:0016651 ; EC:1.6.-.-" mitochondrial inner membrane; GO:0005743 bcn92 bcn92 "CG3717, CG3717, EG:87B1.6, BcDNA:RE57896, NEST:bs15a04" CDMC30290 3 4 17 DAC27-C17 22-CG3717-RA_5 CG3717 GCCGCACCGAAACAAGAAACCAGGGTCAAAACAAAGCACTCATCAATTAAACAGCACTTTAATCCACCA 69 FBan0003717 FBgn0013432 bcn92 X X electron transport; GO:0006118 "oxidoreductase activity, acting on NADH or NADPH; GO:0016651 ; EC:1.6.-.-; ; GO:0016651 ; EC:1.6.-.-" mitochondrial inner membrane; GO:0005743 bcn92 bcn92 "CG3717, CG3717, EG:87B1.6, BcDNA:RE57896, NEST:bs15a04" CDMC30291 3 5 17 DAC27-G05 17-CG3754-RA_1 CG3754 GGCCGCCAATTCGATAGCTAATCGTGCCACCATTATTTTGAGTAAATCATGCAGCAATGTGGATGGTGA 69 FBan0003754 FBgn0030428 CG3754 X X CG3754 CG3754 CDMC30291 3 6 17 DAC27-G05 17-CG3754-RA_1 CG3754 GGCCGCCAATTCGATAGCTAATCGTGCCACCATTATTTTGAGTAAATCATGCAGCAATGTGGATGGTGA 69 FBan0003754 FBgn0030428 CG3754 X X CG3754 CG3754 CDMC30292 3 7 17 DAC27-G17 22-CG3764-RA_1 CG3764 GCCGTCTGCTGAGCTAGGACATTGCCAAACATTTTATCACTCAACGTTTCAAAGAGCTCTTCTCATGCA 69 FBan0003764 FBgn0036684 CG3764 3 3L CG3764 CG3764 CDMC30292 3 8 17 DAC27-G17 22-CG3764-RA_1 CG3764 GCCGTCTGCTGAGCTAGGACATTGCCAAACATTTTATCACTCAACGTTTCAAAGAGCTCTTCTCATGCA 69 FBan0003764 FBgn0036684 CG3764 3 3L CG3764 CG3764 CDMC30293 3 9 17 DAC27-K05 23-CG3811-RA_20 CG3811 TTAAGTGTTTGAAGTCTGCTGCATACGTTTCGCTTTATTTCGACTTTATGCAATCTCGGTTTCGAAGTT 69 FBan0003811 FBgn0032123 Oatp30B 2 2L organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; transporter activity; GO:0005215; ; GO:0008514; ; GO:0005215 integral to membrane; GO:0016021 Oatp30B Organic anion transporting polypeptide 30B "CG3811, CG3811, oatp 30B, Organic anion transporting polypeptide 30B" CDMC30293 3 10 17 DAC27-K05 23-CG3811-RA_20 CG3811 TTAAGTGTTTGAAGTCTGCTGCATACGTTTCGCTTTATTTCGACTTTATGCAATCTCGGTTTCGAAGTT 69 FBan0003811 FBgn0032123 Oatp30B 2 2L organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; transporter activity; GO:0005215; ; GO:0008514; ; GO:0005215 integral to membrane; GO:0016021 Oatp30B Organic anion transporting polypeptide 30B "CG3811, CG3811, oatp 30B, Organic anion transporting polypeptide 30B" CDMC30294 3 11 17 DAC27-K17 7-CG3823-RA_1 CG3823 AAGGGAGAGGTGTTCAAGCTAATCCATTTCCATTTGCCAAATGCGGACACTCCATATCGGCACTTCCCG 69 FBan0003823 FBgn0029863 CG3823 X X transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG3823 CG3823 CDMC30294 3 12 17 DAC27-K17 7-CG3823-RA_1 CG3823 AAGGGAGAGGTGTTCAAGCTAATCCATTTCCATTTGCCAAATGCGGACACTCCATATCGGCACTTCCCG 69 FBan0003823 FBgn0029863 CG3823 X X transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG3823 CG3823 CDMC30295 3 13 17 DAC27-O05 9-CG3858-RA_1 CG3858 AGGAGCCATCAGTTGTCACAATCCTCGAATTACGGCACCAATTCTTGGCCACTAAGTGGATCCGAGTCA 69 FBan0003858 FBgn0019809 gcm2 2 2L "NOT crystal cell differentiation; GO:0042688; cell proliferation; GO:0008283; ectoderm development; GO:0007398; embryonic plasmatocyte differentiation; GO:0035164; glial cell differentiation; GO:0010001; gliogenesis; GO:0042063; plasmatocyte differentiation; GO:0042387; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 gcm2 gcm2 "CG3858, dGCM2, glide2, glide glide2" CDMC30295 3 14 17 DAC27-O05 9-CG3858-RA_1 CG3858 AGGAGCCATCAGTTGTCACAATCCTCGAATTACGGCACCAATTCTTGGCCACTAAGTGGATCCGAGTCA 69 FBan0003858 FBgn0019809 gcm2 2 2L "NOT crystal cell differentiation; GO:0042688; cell proliferation; GO:0008283; ectoderm development; GO:0007398; embryonic plasmatocyte differentiation; GO:0035164; glial cell differentiation; GO:0010001; gliogenesis; GO:0042063; plasmatocyte differentiation; GO:0042387; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 gcm2 gcm2 "CG3858, dGCM2, glide2, glide glide2" CDMC30296 3 15 17 DAC27-O17 5-CG3874-RA_1 CG3874 TGGCTTGTCCTCCTTCATGATTACGGTGGTAAACAAGACGGTGCTTACCTCCTACCACTTCCCCTCGTT 69 FBan0003874 FBgn0042641 frc 3 3L Notch receptor processing; GO:0007220; UDP-N-acetylglucosamine transport; GO:0015788; UDP-galactose transport; GO:0015785; UDP-glucose transport; GO:0015786; UDP-glucuronic acid transport; GO:0015787; UDP-xylose transport; GO:0015790; carbohydrate metabolism; GO:0005975; compound eye morphogenesis (sensu Endopterygota); GO:0001745; embryonic pattern specification; GO:0009880; imaginal disc pattern formation; GO:0007447; pyrimidine nucleotide-sugar transport; GO:0015781; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 pyrimidine nucleotide sugar transporter activity; GO:0015165; UDP-galactose transporter activity; GO:0005459; NOT GDP-fucose transporter activity; GO:0005457; NOT GDP-mannose transporter activity; GO:0005458; NOT UDP-galactose transporter activity; GO:0005459; NOT UDP-glucose transporter activity; GO:0005460; UDP-N-acetylglucosamine transporter activity; GO:0005462; UDP-glucose transporter activity; GO:0005460; UDP-glucuronic acid transporter activity; GO:0005461; UDP-xylose transporter activity; GO:0005464; ; GO:0005459; ; GO:0005457; ; GO:0005458; ; GO:0005459; ; GO:0005460; ; GO:0005462; ; GO:0005460; ; GO:0005461; ; GO:0005464; ; GO:0015165 Golgi apparatus; GO:0005794 frc fringe connection "CG3874, l(3)02619, l(3)00073, l(3)10098, UST74C, ust74C, UDP-sugar transporter in 74C, UDP-GlcNAc/UDP-GlcUA, anon-WO0172774.5, anon-WO0172774.7, l(3)S070006, l(3)L6750, l(3)j2E3, fringe connection" CDMC30296 3 16 17 DAC27-O17 5-CG3874-RA_1 CG3874 TGGCTTGTCCTCCTTCATGATTACGGTGGTAAACAAGACGGTGCTTACCTCCTACCACTTCCCCTCGTT 69 FBan0003874 FBgn0042641 frc 3 3L Notch receptor processing; GO:0007220; UDP-N-acetylglucosamine transport; GO:0015788; UDP-galactose transport; GO:0015785; UDP-glucose transport; GO:0015786; UDP-glucuronic acid transport; GO:0015787; UDP-xylose transport; GO:0015790; carbohydrate metabolism; GO:0005975; compound eye morphogenesis (sensu Endopterygota); GO:0001745; embryonic pattern specification; GO:0009880; imaginal disc pattern formation; GO:0007447; pyrimidine nucleotide-sugar transport; GO:0015781; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 pyrimidine nucleotide sugar transporter activity; GO:0015165; UDP-galactose transporter activity; GO:0005459; NOT GDP-fucose transporter activity; GO:0005457; NOT GDP-mannose transporter activity; GO:0005458; NOT UDP-galactose transporter activity; GO:0005459; NOT UDP-glucose transporter activity; GO:0005460; UDP-N-acetylglucosamine transporter activity; GO:0005462; UDP-glucose transporter activity; GO:0005460; UDP-glucuronic acid transporter activity; GO:0005461; UDP-xylose transporter activity; GO:0005464; ; GO:0005459; ; GO:0005457; ; GO:0005458; ; GO:0005459; ; GO:0005460; ; GO:0005462; ; GO:0005460; ; GO:0005461; ; GO:0005464; ; GO:0015165 Golgi apparatus; GO:0005794 frc fringe connection "CG3874, l(3)02619, l(3)00073, l(3)10098, UST74C, ust74C, UDP-sugar transporter in 74C, UDP-GlcNAc/UDP-GlcUA, anon-WO0172774.5, anon-WO0172774.7, l(3)S070006, l(3)L6750, l(3)j2E3, fringe connection" CDMC30297 3 17 17 DAC28-C05 12-CG10198-RA_3 CG10198 GGGAGCGTCAGGAAAGCATCACCTTCAAGCCAAATATCTGCTAAAGGCAAAACATTTTGCTACGGCGCA 69 FBan0010198 FBgn0039120 Nup98 3 3R protein targeting; GO:0006605 nuclear pore; GO:0005643 Nup98 Nup98 "CG10198, CG10201, l(3)95BCd, Nup98-Nup96, Nup96" CDMC30297 3 18 17 DAC28-C05 12-CG10198-RA_3 CG10198 GGGAGCGTCAGGAAAGCATCACCTTCAAGCCAAATATCTGCTAAAGGCAAAACATTTTGCTACGGCGCA 69 FBan0010198 FBgn0039120 Nup98 3 3R protein targeting; GO:0006605 nuclear pore; GO:0005643 Nup98 Nup98 "CG10198, CG10201, l(3)95BCd, Nup98-Nup96, Nup96" CDMC30298 3 19 17 DAC28-C17 11-CG10207-RA_2 CG10207 ACGTCTTCTCCATATTCGCCGACTATCTTCTGCGCACGGATAAGATGAGTCGCACAAATGTCCGCAAGT 69 FBan0010207 FBgn0016684 NaPi-T 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316; phosphate transporter activity; GO:0015114; ; GO:0015114; ; GO:0005316 integral to membrane; GO:0016021 NaPi-T Na[+]-dependent inorganic phosphate cotransporter "CG10207, Na/Pi-cotransporter, Dropo" CDMC30298 3 20 17 DAC28-C17 11-CG10207-RA_2 CG10207 ACGTCTTCTCCATATTCGCCGACTATCTTCTGCGCACGGATAAGATGAGTCGCACAAATGTCCGCAAGT 69 FBan0010207 FBgn0016684 NaPi-T 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316; phosphate transporter activity; GO:0015114; ; GO:0015114; ; GO:0005316 integral to membrane; GO:0016021 NaPi-T Na[+]-dependent inorganic phosphate cotransporter "CG10207, Na/Pi-cotransporter, Dropo" CDMC30299 3 21 17 DAC28-G05 7-CG10238-RA_1 CG10238 TCGCGTGACGGTCAAACGGATCCAACCAAAGAAATGAGGAAATCGCTACCCAATTCACGACTACAGGCA 69 FBan0010238 FBgn0039280 CG10238 3 3R Mo-molybdopterin cofactor biosynthesis; GO:0006777; pteridine and derivative metabolism; GO:0042558 molybdopterin converting factor; GO:0019009 CG10238 CG10238 CDMC30299 3 22 17 DAC28-G05 7-CG10238-RA_1 CG10238 TCGCGTGACGGTCAAACGGATCCAACCAAAGAAATGAGGAAATCGCTACCCAATTCACGACTACAGGCA 69 FBan0010238 FBgn0039280 CG10238 3 3R Mo-molybdopterin cofactor biosynthesis; GO:0006777; pteridine and derivative metabolism; GO:0042558 molybdopterin converting factor; GO:0019009 CG10238 CG10238 CDMC30300 3 23 17 DAC28-G17 3-CG10247-RA_1 CG10247 CGCCTGGGACCAGTTGGAATCGGATTCGTCAATAGCTTTCCCAATTTGGCACGTCGCCTCCATATGAAA 69 FBan0010247 FBgn0033981 Cyp6a21 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a21 Cyp6a21 "CG10247, 6a21, cyp6a21" CDMC30300 3 24 17 DAC28-G17 3-CG10247-RA_1 CG10247 CGCCTGGGACCAGTTGGAATCGGATTCGTCAATAGCTTTCCCAATTTGGCACGTCGCCTCCATATGAAA 69 FBan0010247 FBgn0033981 Cyp6a21 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a21 Cyp6a21 "CG10247, 6a21, cyp6a21" CDMC30301 3 25 17 DAC28-K05 23-CG10279-RB_4 CG10279 TTTGGATACCTTTTATGGCTCAACACGAGAACAAGAATGTGTAAAGCAAACAAAGCAAACGGGAAATCA 69 FBan0010279 FBgn0003261 Rm62 3 3R "RNA interference; GO:0016246; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; ; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0008026; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634 Rm62 Rm62 "CG10279, CG10279, RM62, Lip, 4136, DmRH8, Dmp68, p68, l(3)01086, l(3)j3D2, l(3)j3D5, l(3)rG338, l(3)s5196, Lighten up" CDMC30301 3 26 17 DAC28-K05 23-CG10279-RB_4 CG10279 TTTGGATACCTTTTATGGCTCAACACGAGAACAAGAATGTGTAAAGCAAACAAAGCAAACGGGAAATCA 69 FBan0010279 FBgn0003261 Rm62 3 3R "RNA interference; GO:0016246; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; ; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0008026; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634 Rm62 Rm62 "CG10279, CG10279, RM62, Lip, 4136, DmRH8, Dmp68, p68, l(3)01086, l(3)j3D2, l(3)j3D5, l(3)rG338, l(3)s5196, Lighten up" CDMC30302 3 1 18 DAC28-K17 18-CG10295-RA_5 CG10295 ACGAGATCCTTGTGATGCGGGAGAACAAACACCCAAATGTAGTCAACTATCTTGACAGCTACCTCGTGT 69 FBan0010295 FBgn0014001 Pak 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; Rac protein signal transduction; GO:0016601; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 cytoskeleton; GO:0005856; focal adhesion; GO:0005925 Pak PAK-kinase "CG10295, CG10295, p65[PAK], DPAK, p21-associated kinase, PAK, PAK1, D-Pak, pak, Dpak1, PAK2, dPAK1, DPak, dpak, PaK, Pak1, dPak, Pak1 kinase, Dpak, pak1, DmPAK1" CDMC30302 3 2 18 DAC28-K17 18-CG10295-RA_5 CG10295 ACGAGATCCTTGTGATGCGGGAGAACAAACACCCAAATGTAGTCAACTATCTTGACAGCTACCTCGTGT 69 FBan0010295 FBgn0014001 Pak 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; Rac protein signal transduction; GO:0016601; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 cytoskeleton; GO:0005856; focal adhesion; GO:0005925 Pak PAK-kinase "CG10295, CG10295, p65[PAK], DPAK, p21-associated kinase, PAK, PAK1, D-Pak, pak, Dpak1, PAK2, dPAK1, DPak, dpak, PaK, Pak1, dPak, Pak1 kinase, Dpak, pak1, DmPAK1" CDMC30303 3 3 18 DAC28-O05 5-CG10328-RA_1 CG10328 CCGTCAGCAGGAGAACGATTTGCTAATGCAGGCCAAGAAACTCAACATGATCCTCGATCAGCAGGAGGG 69 FBan0010328 FBgn0015520 nonA-l 3 3R "hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA-l nonA-like "CG10328, CG10328, CG10328, Z, predicted gene Z, no-on transient A-like, no-on transient A gene, LD09360, nonA 1, nonA-1, BEST:LD09360" CDMC30303 3 4 18 DAC28-O05 5-CG10328-RA_1 CG10328 CCGTCAGCAGGAGAACGATTTGCTAATGCAGGCCAAGAAACTCAACATGATCCTCGATCAGCAGGAGGG 69 FBan0010328 FBgn0015520 nonA-l 3 3R "hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nuclear mRNA splicing, via spliceosome; GO:0000398" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187; transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 nonA-l nonA-like "CG10328, CG10328, CG10328, Z, predicted gene Z, no-on transient A-like, no-on transient A gene, LD09360, nonA 1, nonA-1, BEST:LD09360" CDMC30304 3 5 18 DAC28-O17 3-CG10343-RA_1 CG10343 CTGTGGCATGACCTATACCCTGTTCGAATGCCTTAAGGACAACCTGGAGCAATTGACCGCAGAGCAACC 69 FBan0010343 FBgn0032703 CG10343 2 2L CG10343 CG10343 anon-WO0118547.123 CDMC30304 3 6 18 DAC28-O17 3-CG10343-RA_1 CG10343 CTGTGGCATGACCTATACCCTGTTCGAATGCCTTAAGGACAACCTGGAGCAATTGACCGCAGAGCAACC 69 FBan0010343 FBgn0032703 CG10343 2 2L CG10343 CG10343 anon-WO0118547.123 CDMC30305 3 7 18 DAC29-C05 17-CG13906-RA_1 CG13906 ACATTGGACCAGCGTCTCACTACCAGTCAAAGTATTGAACAGTACAACCTAGCTATAAGGGCCACAGGC 69 FBan0013906 FBgn0028999 nerfin-1 3 3L axon guidance; GO:0007411; neuron lineage restriction; GO:0042055; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 nerfin-1 nervous fingers 1 "CG13906, nerfin 1, nervous fingers 1" CDMC30305 3 8 18 DAC29-C05 17-CG13906-RA_1 CG13906 ACATTGGACCAGCGTCTCACTACCAGTCAAAGTATTGAACAGTACAACCTAGCTATAAGGGCCACAGGC 69 FBan0013906 FBgn0028999 nerfin-1 3 3L axon guidance; GO:0007411; neuron lineage restriction; GO:0042055; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 nerfin-1 nervous fingers 1 "CG13906, nerfin 1, nervous fingers 1" CDMC30306 3 9 18 DAC29-C17 3-CG13927-RA_3 CG13927 GCTAGGCAACTGGTCCAAAATACAGGACGTCCATCCAAAAGATCCAGAGGAAGAGCTTTCCAAGCCGGG 69 FBan0013927 FBgn0035245 GC 3 3L peptidyl-glutamic acid carboxylation; GO:0017187; protein modification; GO:0006464 gamma-glutamyl carboxylase activity; GO:0008488 ; EC:4.1.1.-; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008488 ; EC:4.1.1.-; ; GO:0008488 ; EC:4.1.1.-; ; GO:0008488 ; EC:4.1.1.- GC gamma-glutamyl carboxylase "CG13927, CG13927, dGC, gamma-glutamyl-carboxylase, gamma-glutamyl carboxylase" CDMC30306 3 10 18 DAC29-C17 3-CG13927-RA_3 CG13927 GCTAGGCAACTGGTCCAAAATACAGGACGTCCATCCAAAAGATCCAGAGGAAGAGCTTTCCAAGCCGGG 69 FBan0013927 FBgn0035245 GC 3 3L peptidyl-glutamic acid carboxylation; GO:0017187; protein modification; GO:0006464 gamma-glutamyl carboxylase activity; GO:0008488 ; EC:4.1.1.-; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008488 ; EC:4.1.1.-; ; GO:0008488 ; EC:4.1.1.-; ; GO:0008488 ; EC:4.1.1.- GC gamma-glutamyl carboxylase "CG13927, CG13927, dGC, gamma-glutamyl-carboxylase, gamma-glutamyl carboxylase" CDMC30307 3 11 18 DAC29-G05 13-CG13978-RA_1 CG13978 TTTGATCTTAGGACATCGACATGATCCCCGAGTCTGGACATTCAATTCACTAACGCTGGTGGTCGGAGC 69 FBan0013978 FBgn0039518 CG13978 3 3R CG13978 CG13978 CDMC30307 3 12 18 DAC29-G05 13-CG13978-RA_1 CG13978 TTTGATCTTAGGACATCGACATGATCCCCGAGTCTGGACATTCAATTCACTAACGCTGGTGGTCGGAGC 69 FBan0013978 FBgn0039518 CG13978 3 3R CG13978 CG13978 CDMC30308 3 13 18 DAC29-G17 11-CG13994-RA_4 CG13994 AGAGCTCCTCTGAGGATGACGAAGACTGTGAGCACTGCTTTGGACATCCGGAAAAGCGTCAGAGAAACG 69 FBan0013994 FBgn0031772 CG13994 2 2L CG13994 CG13994 BcDNA:AT31406 CDMC30308 3 14 18 DAC29-G17 11-CG13994-RA_4 CG13994 AGAGCTCCTCTGAGGATGACGAAGACTGTGAGCACTGCTTTGGACATCCGGAAAAGCGTCAGAGAAACG 69 FBan0013994 FBgn0031772 CG13994 2 2L CG13994 CG13994 BcDNA:AT31406 CDMC30309 3 15 18 DAC29-K05 18-CG14029-RA_1 CG14029 TCCTCCTACCTTAATGTTTGTCGTTCGCCATTTATTTATGTTTTTTGCCGCTTCGGTCACCCGTGTGGC 69 FBan0014029 FBgn0016076 vri 2 2L "bristle morphogenesis; GO:0008407; cellular physiological process; GO:0050875; circadian rhythm; GO:0007623; development; GO:0007275; locomotor rhythm; GO:0045475; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; transcription, DNA-dependent; GO:0006351; wing hair organization and biogenesis; GO:0035317" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; ; GO:0003702; ; GO:0030528; ; GO:0046982; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 vri vrille "CG14029, jf23, mat(2)earlyRS32, argo, l(2)25Db, l(2)jf23, mat(2)ea-G, lethal(2)25Db, maternal effect early arrest G, vrille" CDMC30309 3 16 18 DAC29-K05 18-CG14029-RA_1 CG14029 TCCTCCTACCTTAATGTTTGTCGTTCGCCATTTATTTATGTTTTTTGCCGCTTCGGTCACCCGTGTGGC 69 FBan0014029 FBgn0016076 vri 2 2L "bristle morphogenesis; GO:0008407; cellular physiological process; GO:0050875; circadian rhythm; GO:0007623; development; GO:0007275; locomotor rhythm; GO:0045475; regulation of transcription, DNA-dependent; GO:0006355; rhythmic behavior; GO:0007622; transcription, DNA-dependent; GO:0006351; wing hair organization and biogenesis; GO:0035317" DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; protein heterodimerization activity; GO:0046982; protein homodimerization activity; GO:0042803; ; GO:0003702; ; GO:0030528; ; GO:0046982; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 vri vrille "CG14029, jf23, mat(2)earlyRS32, argo, l(2)25Db, l(2)jf23, mat(2)ea-G, lethal(2)25Db, maternal effect early arrest G, vrille" CDMC30310 3 17 18 DAC29-K17 9-CG14035-RA_1 CG14035 TGCCGCTGGAACCTCCGCAACCTAAATCCTATGTGATTTACGATGACGAAGAGGAGTTCGGTCCTTCGA 69 FBan0014035 FBgn0031685 CG14035 2 2L CG14035 CG14035 CDMC30310 3 18 18 DAC29-K17 9-CG14035-RA_1 CG14035 TGCCGCTGGAACCTCCGCAACCTAAATCCTATGTGATTTACGATGACGAAGAGGAGTTCGGTCCTTCGA 69 FBan0014035 FBgn0031685 CG14035 2 2L CG14035 CG14035 CDMC30311 3 19 18 DAC29-O05 3-CG14060-RA_4 CG14060 CGAGTCCCTCTACGAACCCATCACACCTGTTATGGATGAAACCAAGACTGAAGCCCAGACATCCAGCCT 69 FBan0014060 FBgn0036683 CG14060 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG14060 CG14060 CDMC30311 3 20 18 DAC29-O05 3-CG14060-RA_4 CG14060 CGAGTCCCTCTACGAACCCATCACACCTGTTATGGATGAAACCAAGACTGAAGCCCAGACATCCAGCCT 69 FBan0014060 FBgn0036683 CG14060 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 CG14060 CG14060 CDMC30312 3 21 18 DAC29-O17 13-CG14074-RA_1 CG14074 CGTCTCAATCGGATAGCACAAATCAACAAGTGGACGATAGCACAGCTGTCACTACAGTGGACCTGACCG 69 FBan0014074 FBgn0036818 CG14074 3 3L CG14074 CG14074 CDMC30312 3 22 18 DAC29-O17 13-CG14074-RA_1 CG14074 CGTCTCAATCGGATAGCACAAATCAACAAGTGGACGATAGCACAGCTGTCACTACAGTGGACCTGACCG 69 FBan0014074 FBgn0036818 CG14074 3 3L CG14074 CG14074 CDMC30313 3 23 18 DAC30-C05 11-CG15112-RB_1 CG15112 AGCCGGGCGTGTAATTTAAGGCATTCGCGACATATTCGATGATCGAAGCTCGCAACATTGCCAGAATGT 69 FBan0015112 FBgn0000578 ena 2 2R actin filament organization; GO:0007015; axon guidance; GO:0007411; axonogenesis; GO:0007409; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 ena enabled "CG15112, CG15112, CG15112, CG15112, l(2)02029, Ena, Enb, ENA/VASP, enb, enabled" CDMC30313 3 24 18 DAC30-C05 11-CG15112-RB_1 CG15112 AGCCGGGCGTGTAATTTAAGGCATTCGCGACATATTCGATGATCGAAGCTCGCAACATTGCCAGAATGT 69 FBan0015112 FBgn0000578 ena 2 2R actin filament organization; GO:0007015; axon guidance; GO:0007411; axonogenesis; GO:0007409; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 ena enabled "CG15112, CG15112, CG15112, CG15112, l(2)02029, Ena, Enb, ENA/VASP, enb, enabled" CDMC30314 3 25 18 DAC30-C17 3-CG1511-RA_1 CG1511 GGGCTACCGTTTACCAGCTCCGATGGATTGTCCAGAAGCCCTTTATCAGCTAATGTTGGATTGCTGGCA 69 FBan0001511 FBgn0025936 Eph 4 4 axonogenesis; GO:0007409; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ephrin receptor activity; GO:0005003; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005003 plasma membrane; GO:0005886 Eph Eph receptor tyrosine kinase "CG1511, CG1511, RPTK Dek7, Dek7, dek, Dek, Deph, Drosophila eph, eph, DEK, CT3831, Ek7" CDMC30314 3 26 18 DAC30-C17 3-CG1511-RA_1 CG1511 GGGCTACCGTTTACCAGCTCCGATGGATTGTCCAGAAGCCCTTTATCAGCTAATGTTGGATTGCTGGCA 69 FBan0001511 FBgn0025936 Eph 4 4 axonogenesis; GO:0007409; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ephrin receptor activity; GO:0005003; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005003 plasma membrane; GO:0005886 Eph Eph receptor tyrosine kinase "CG1511, CG1511, RPTK Dek7, Dek7, dek, Dek, Deph, Drosophila eph, eph, DEK, CT3831, Ek7" CDMC30315 3 1 19 DAC30-G05 16-CG15155-RA_1 CG15155 AGCGAAGAATCTGAAACTAGATCTCGACTGTGTAACACTTTCCCTGGTCTTGAGCAAAGAGGAAGCCCT 69 FBan0015155 FBgn0032669 CG15155 2 2L CG15155 CG15155 CT35055 CDMC30315 3 2 19 DAC30-G05 16-CG15155-RA_1 CG15155 AGCGAAGAATCTGAAACTAGATCTCGACTGTGTAACACTTTCCCTGGTCTTGAGCAAAGAGGAAGCCCT 69 FBan0015155 FBgn0032669 CG15155 2 2L CG15155 CG15155 CT35055 CDMC30316 3 3 19 DAC30-G17 23-CG1516-RI_7 CG1516 CATTCATGTTTCCGTGTTTCCAGGATCAATCGACCATGAGTAACTGGTCAAATTTTTTAGCTGTCCCTG 69 FBan0001516 FBgn0027580 CG1516 2 2R fatty acid biosynthesis; GO:0006633; gluconeogenesis; GO:0006094; pyruvate metabolism; GO:0006090 ATP binding; GO:0005524; ; GO:0005524; pyruvate carboxylase activity; GO:0004736 ; EC:6.4.1.1; ; GO:0004736 ; EC:6.4.1.1; biotin binding; GO:0009374; ; GO:0009374; ; GO:0004736 ; EC:6.4.1.1 mitochondrial matrix; GO:0005759 CG1516 CG1516 "BcDNA:GH06348, BcDNA, GH06348" CDMC30316 3 4 19 DAC30-G17 23-CG1516-RI_7 CG1516 CATTCATGTTTCCGTGTTTCCAGGATCAATCGACCATGAGTAACTGGTCAAATTTTTTAGCTGTCCCTG 69 FBan0001516 FBgn0027580 CG1516 2 2R fatty acid biosynthesis; GO:0006633; gluconeogenesis; GO:0006094; pyruvate metabolism; GO:0006090 ATP binding; GO:0005524; ; GO:0005524; pyruvate carboxylase activity; GO:0004736 ; EC:6.4.1.1; ; GO:0004736 ; EC:6.4.1.1; biotin binding; GO:0009374; ; GO:0009374; ; GO:0004736 ; EC:6.4.1.1 mitochondrial matrix; GO:0005759 CG1516 CG1516 "BcDNA:GH06348, BcDNA, GH06348" CDMC30317 3 5 19 DAC30-K05 22-CG1520-RA_1 CG1520 ACCGAGTGTTTCTTCAATATGTGGGTGAGTTTTGCAAACCCCGTTCAGACTACTGTGCCAAAAACTTGA 69 FBan0001520 FBgn0024273 WASp 3 3R asymmetric cell division; GO:0008356; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell fate commitment; GO:0045165; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; sensory organ development; GO:0007423; transmission of nerve impulse; GO:0019226 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515 WASp WASp "CG1520, CG1520, D-WASP, WASP, Wsp, Wasp, dWASP, Dm WASP, wasp, wsp" CDMC30317 3 6 19 DAC30-K05 22-CG1520-RA_1 CG1520 ACCGAGTGTTTCTTCAATATGTGGGTGAGTTTTGCAAACCCCGTTCAGACTACTGTGCCAAAAACTTGA 69 FBan0001520 FBgn0024273 WASp 3 3R asymmetric cell division; GO:0008356; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell fate commitment; GO:0045165; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; sensory organ development; GO:0007423; transmission of nerve impulse; GO:0019226 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515 WASp WASp "CG1520, CG1520, D-WASP, WASP, Wsp, Wasp, dWASP, Dm WASP, wasp, wsp" CDMC30318 3 7 19 DAC30-K17 23-CG15219-RA_2 CG15219 ATCTTTTTTCAAAATTTTCAGTCATGGAATACGGAAATGGTATGCAATACGATGGTTATAGCCAAGGTG 69 FBan0015219 FBgn0040519 CG15219 2 2L CG15219 CG15219 BcDNA:LP09525 CDMC30318 3 8 19 DAC30-K17 23-CG15219-RA_2 CG15219 ATCTTTTTTCAAAATTTTCAGTCATGGAATACGGAAATGGTATGCAATACGATGGTTATAGCCAAGGTG 69 FBan0015219 FBgn0040519 CG15219 2 2L CG15219 CG15219 BcDNA:LP09525 CDMC30319 3 9 19 DAC30-O05 13-CG15257-RA_1 CG15257 TCCGAAATCGTGAACCGCATATCATGCCTGATGCCAATGAAGGATACGGTGACTTCAACTCTTCCGGAT 69 FBan0015257 FBgn0020371 Tim17b2 2 2L protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17b2 Translocase inner membrane 17 "CG15257, dmTim17, BG:DS01845.2, Tim17, BcDNA:AT05822, BcDNA:AT13511" CDMC30319 3 10 19 DAC30-O05 13-CG15257-RA_1 CG15257 TCCGAAATCGTGAACCGCATATCATGCCTGATGCCAATGAAGGATACGGTGACTTCAACTCTTCCGGAT 69 FBan0015257 FBgn0020371 Tim17b2 2 2L protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17b2 Translocase inner membrane 17 "CG15257, dmTim17, BG:DS01845.2, Tim17, BcDNA:AT05822, BcDNA:AT13511" CDMC30320 3 11 19 DAC30-O17 3-CG15269-RA_5 CG15269 GCCTTCAATATGCATGTCCGGATTCATACCGGCGTGAAACCCCACAAATGCAACGAGTGCGGAAAGAGA 69 FBan0015269 FBgn0028878 CG15269 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15269 CG15269 "BG:DS04929.3, DS04929.3" CDMC30320 3 12 19 DAC30-O17 3-CG15269-RA_5 CG15269 GCCTTCAATATGCATGTCCGGATTCATACCGGCGTGAAACCCCACAAATGCAACGAGTGCGGAAAGAGA 69 FBan0015269 FBgn0028878 CG15269 2 2L cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; ; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15269 CG15269 "BG:DS04929.3, DS04929.3" CDMC30321 3 13 19 DAC31-C05 23-CG12859-RA_3 CG12859 GCCAGTTCAAGTTCATCTAAGCCATACATTCAGCCAATTGATCTTCGATTCGTATAGTGGAATTAAA 67 FBan0012859 FBgn0033961 CG12859 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12859 CG12859 "anon-EST:fe3B12, anon-fast-evolving-3B12" CDMC30321 3 14 19 DAC31-C05 23-CG12859-RA_3 CG12859 GCCAGTTCAAGTTCATCTAAGCCATACATTCAGCCAATTGATCTTCGATTCGTATAGTGGAATTAAA 67 FBan0012859 FBgn0033961 CG12859 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12859 CG12859 "anon-EST:fe3B12, anon-fast-evolving-3B12" CDMC30322 3 15 19 DAC31-C17 3-CG12912-RA_2 CG12912 GCAGCAGGATACGAAAACGAGGATGACAACGACCACAGGCAAACGCGGAGGACACAGATACAGAAGC 67 FBan0012912 FBgn0033497 CG12912 2 2R cellular physiological process; GO:0050875 CG12912 CG12912 CDMC30322 3 16 19 DAC31-C17 3-CG12912-RA_2 CG12912 GCAGCAGGATACGAAAACGAGGATGACAACGACCACAGGCAAACGCGGAGGACACAGATACAGAAGC 67 FBan0012912 FBgn0033497 CG12912 2 2R cellular physiological process; GO:0050875 CG12912 CG12912 CDMC30323 3 17 19 DAC31-G05 2-CG13377-RA_4 CG13377 TCGGGTTTTTGCTGGAATGAAAGAGGCCCAAGATTCGCTACCCGCCAAACTTCTTTGCGGTTGGATG 67 FBan0013377 FBgn0040369 CG13377 X X metabolism; GO:0008152 3-hydroxybutyrate dehydrogenase activity; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30 CG13377 CG13377 EG:BACR37P7.9 CDMC30323 3 18 19 DAC31-G05 2-CG13377-RA_4 CG13377 TCGGGTTTTTGCTGGAATGAAAGAGGCCCAAGATTCGCTACCCGCCAAACTTCTTTGCGGTTGGATG 67 FBan0013377 FBgn0040369 CG13377 X X metabolism; GO:0008152 3-hydroxybutyrate dehydrogenase activity; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30; ; GO:0003858 ; EC:1.1.1.30 CG13377 CG13377 EG:BACR37P7.9 CDMC30324 3 19 19 DAC31-G17 8-CG13492-RB_5 CG13492 ACGAGGATCGCTATTGCCGAAAGAATCCCGCTTTGTGTTTCACCTGCAAGTCGAACGAGTGCAATGA 67 FBan0013492 FBgn0034662 CG13492 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 CG13492 CG13492 CDMC30324 3 20 19 DAC31-G17 8-CG13492-RB_5 CG13492 ACGAGGATCGCTATTGCCGAAAGAATCCCGCTTTGTGTTTCACCTGCAAGTCGAACGAGTGCAATGA 67 FBan0013492 FBgn0034662 CG13492 2 2R glycolysis; GO:0006096 glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 CG13492 CG13492 CDMC30325 3 21 19 DAC31-K05 3-CG13708-RA_2 CG13708 ACCATCATCGCCAGTTACAGTTGCAAGCCAATCTCCTGAAGTAGCCATAGTGACACCGTCAGCACCG 67 FBan0013708 FBgn0035577 CG13708 3 3L CG13708 CG13708 CT33170 CDMC30325 3 22 19 DAC31-K05 3-CG13708-RA_2 CG13708 ACCATCATCGCCAGTTACAGTTGCAAGCCAATCTCCTGAAGTAGCCATAGTGACACCGTCAGCACCG 67 FBan0013708 FBgn0035577 CG13708 3 3L CG13708 CG13708 CT33170 CDMC30326 3 23 19 DAC31-K17 1-CG13861-RA_1 CG13861 TGAAGCGACCGGAGCCGCATCAGGACTTTGAAAAGACCATACAGAGACTAAAGACACAGAAGGCGGC 67 FBan0013861 FBgn0040584 CG13861 3 3R CG13861 CG13861 CDMC30326 3 24 19 DAC31-K17 1-CG13861-RA_1 CG13861 TGAAGCGACCGGAGCCGCATCAGGACTTTGAAAAGACCATACAGAGACTAAAGACACAGAAGGCGGC 67 FBan0013861 FBgn0040584 CG13861 3 3R CG13861 CG13861 CDMC30327 3 25 19 DAC31-O05 3-CG14342-RA_1 CG14342 GCTAACGTACGCCGACATTTGTCGTAAGCGCTATGCGGCATCGTTCCGGCGATACAACGAGTGTTTC 67 FBan0014342 FBgn0031324 CG14342 2 2L CG14342 CG14342 CDMC30327 3 26 19 DAC31-O05 3-CG14342-RA_1 CG14342 GCTAACGTACGCCGACATTTGTCGTAAGCGCTATGCGGCATCGTTCCGGCGATACAACGAGTGTTTC 67 FBan0014342 FBgn0031324 CG14342 2 2L CG14342 CG14342 CDMC30328 3 1 20 DAC31-O17 AutoBlank AutoBlank CDMC30328 3 2 20 DAC31-O17 AutoBlank AutoBlank CDMC30329 3 3 20 DAC32-C05 17-CG31721-RA_1 CG31721 AGGTGATCGAACCGGGTGGAGAGTAGCAAATTGTGTACATAGAGCTTGACATTTGGCAGTTATCGGTGT 69 FBan0031721 FBgn0051721 Trim9 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Trim9 Trim9 "CG6256, CG31721, CG13145, CG6256, CG6256, CG31721, CG31721, CG31721" CDMC30329 3 4 20 DAC32-C05 17-CG31721-RA_1 CG31721 AGGTGATCGAACCGGGTGGAGAGTAGCAAATTGTGTACATAGAGCTTGACATTTGGCAGTTATCGGTGT 69 FBan0031721 FBgn0051721 Trim9 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intracellular; GO:0005622; ubiquitin ligase complex; GO:0000151 Trim9 Trim9 "CG6256, CG31721, CG13145, CG6256, CG6256, CG31721, CG31721, CG31721" CDMC30330 3 5 20 DAC32-C17 9-CG31733-RA_1 CG31733 CATCTGGTGACTTCTCTTTGTGGCCTGATGCTCGAAATGACCAATCACATGGTGATTGCCTCCCTTGGC 69 FBan0031733 FBgn0011239 ms(2)35Ci 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ms(2)35Ci ms(2)35Ci "CG31733, ms(2)46AB: male sterile(2)46AB, BcDNA:AT28918, ms(2)02316, NEST:bs29a09, male sterile(2)46AB, ms(2)46AB" CDMC30330 3 6 20 DAC32-C17 9-CG31733-RA_1 CG31733 CATCTGGTGACTTCTCTTTGTGGCCTGATGCTCGAAATGACCAATCACATGGTGATTGCCTCCCTTGGC 69 FBan0031733 FBgn0011239 ms(2)35Ci 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ms(2)35Ci ms(2)35Ci "CG31733, ms(2)46AB: male sterile(2)46AB, BcDNA:AT28918, ms(2)02316, NEST:bs29a09, male sterile(2)46AB, ms(2)46AB" CDMC30331 3 7 20 DAC32-G05 3-CG31759-RB_3 CG31759 TGCGCTGAGGGAGTGGCAATTTTCTTTCGGAACTCGCGCTTCGATCTCTTGGATTCTCAAATCCTGCAT 69 FBan0031759 FBgn0051759 CG31759 2 2L "DNA methylation; GO:0006306; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG31759 CG31759 "BcDNA:LD05405, ms(2)01284, BcDNA:AT13596" CDMC30331 3 8 20 DAC32-G05 3-CG31759-RB_3 CG31759 TGCGCTGAGGGAGTGGCAATTTTCTTTCGGAACTCGCGCTTCGATCTCTTGGATTCTCAAATCCTGCAT 69 FBan0031759 FBgn0051759 CG31759 2 2L "DNA methylation; GO:0006306; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- CG31759 CG31759 "BcDNA:LD05405, ms(2)01284, BcDNA:AT13596" CDMC30332 3 9 20 DAC32-G17 3-CG31764-RC_2 CG31764 GGCTCTGGTTATCCCTTCCTTCAGCCGAATCCTTCGAGCTTCAATGTGGGCATCTTCGACTCCTTCGAT 69 FBgn0051764 CDMC30332 3 10 20 DAC32-G17 3-CG31764-RC_2 CG31764 GGCTCTGGTTATCCCTTCCTTCAGCCGAATCCTTCGAGCTTCAATGTGGGCATCTTCGACTCCTTCGAT 69 FBgn0051764 CDMC30333 3 11 20 DAC32-K05 8-CG31792-RA_1 CG31792 TGGTCAAGCAGACGGGTCAGGCAACATACGACACTCTCCTGAAGATTTCTCAACGGGTAAGAGTAGGCA 69 FBan0031792 FBgn0051792 CG31792 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; ion transport; GO:0006811; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; chloride channel activity; GO:0005254; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166; ; GO:0005254" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; membrane; GO:0016020 CG31792 CG31792 "CG17338, CG17338" CDMC30333 3 12 20 DAC32-K05 8-CG31792-RA_1 CG31792 TGGTCAAGCAGACGGGTCAGGCAACATACGACACTCTCCTGAAGATTTCTCAACGGGTAAGAGTAGGCA 69 FBan0031792 FBgn0051792 CG31792 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; ion transport; GO:0006811; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; chloride channel activity; GO:0005254; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166; ; GO:0005254" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; membrane; GO:0016020 CG31792 CG31792 "CG17338, CG17338" CDMC30334 3 13 20 DAC32-K17 18-CG31806-RA_4 CG31806 TGCATCTCGAGGATGCCTTTAAATTCAAAAATTCGATGCAAAGCTTTCACGTGTCGCCCACTGCTGAAT 69 FBan0031806 FBgn0051806 CG31806 2 2L CG31806 CG31806 "CG4855, CG4855" CDMC30334 3 14 20 DAC32-K17 18-CG31806-RA_4 CG31806 TGCATCTCGAGGATGCCTTTAAATTCAAAAATTCGATGCAAAGCTTTCACGTGTCGCCCACTGCTGAAT 69 FBan0031806 FBgn0051806 CG31806 2 2L CG31806 CG31806 "CG4855, CG4855" CDMC30335 3 15 20 DAC32-O05 23-CG31830-RA_5 CG31830 ACAACAACGGTAATTAACCTGTGCATGTTAATGAACTTCAAACTGCAAACTCCTACTCCACTGCACTGT 69 FBan0031830 FBgn0051830 CG31830 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31830 CG31830 CDMC30335 3 16 20 DAC32-O05 23-CG31830-RA_5 CG31830 ACAACAACGGTAATTAACCTGTGCATGTTAATGAACTTCAAACTGCAAACTCCTACTCCACTGCACTGT 69 FBan0031830 FBgn0051830 CG31830 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31830 CG31830 CDMC30336 3 17 20 DAC32-O17 3-CG31846-RA_2 CG31846 GCGCTACGTAACGACATAACCACAGTCGAGTCCACATCCGATCATCCGATTCCCGTACTTCACGCCGTT 69 FBan0031846 FBgn0051846 CG31846 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31846 CG31846 BcDNA:GH04046 CDMC30336 3 18 20 DAC32-O17 3-CG31846-RA_2 CG31846 GCGCTACGTAACGACATAACCACAGTCGAGTCCACATCCGATCATCCGATTCCCGTACTTCACGCCGTT 69 FBan0031846 FBgn0051846 CG31846 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31846 CG31846 BcDNA:GH04046 CDMC30337 3 19 20 DAC33-C05 14-CG15541-RA_2 CG15541 CCTGTGCCTGCTTATCTTTAACGTCTTCATGGTGATGAACTTCTTCCAGAGCATCGCGATTTGCACGGG 69 FBan0015541 FBgn0039794 CG15541 3 3R CG15541 CG15541 CDMC30337 3 20 20 DAC33-C05 14-CG15541-RA_2 CG15541 CCTGTGCCTGCTTATCTTTAACGTCTTCATGGTGATGAACTTCTTCCAGAGCATCGCGATTTGCACGGG 69 FBan0015541 FBgn0039794 CG15541 3 3R CG15541 CG15541 CDMC30338 3 21 20 DAC33-C17 8-CG15550-RA_1 CG15550 CCATACCCACCAAAGTGCTGATCATCTCCAGCGTAGTCCTGATCACTTGTATTTGGATAGGCTGCGCCT 69 FBan0015550 FBgn0039811 CG15550 3 3R CG15550 CG15550 CDMC30338 3 22 20 DAC33-C17 8-CG15550-RA_1 CG15550 CCATACCCACCAAAGTGCTGATCATCTCCAGCGTAGTCCTGATCACTTGTATTTGGATAGGCTGCGCCT 69 FBan0015550 FBgn0039811 CG15550 3 3R CG15550 CG15550 CDMC30339 3 23 20 DAC33-G05 1-CG15594-RA_1 CG15594 CATTCCGCAGACACTTTGCAGTTGGTAAGTCAGGGTTTTGGGCATGAAAAGTGACGACAGCAAACGCGT 69 FBan0015594 FBgn0037421 CG15594 3 3R CG15594 CG15594 CDMC30339 3 24 20 DAC33-G05 1-CG15594-RA_1 CG15594 CATTCCGCAGACACTTTGCAGTTGGTAAGTCAGGGTTTTGGGCATGAAAAGTGACGACAGCAAACGCGT 69 FBan0015594 FBgn0037421 CG15594 3 3R CG15594 CG15594 CDMC30340 3 25 20 DAC33-G17 17-CG15602-RA_2 CG15602 TGCCGCATACGAAAAGCTACGATAAGAAAGATCTGCTACTGTCCACCGACCAAAGAAACGATCAGGAGA 69 FBan0015602 FBgn0030694 CG15602 X X CG15602 CG15602 CDMC30340 3 26 20 DAC33-G17 17-CG15602-RA_2 CG15602 TGCCGCATACGAAAAGCTACGATAAGAAAGATCTGCTACTGTCCACCGACCAAAGAAACGATCAGGAGA 69 FBan0015602 FBgn0030694 CG15602 X X CG15602 CG15602 CDMC30341 3 1 21 DAC33-K05 2-CG15651-RA_1 CG15651 CGGACCACCAAGTCCTGCATAGGCAGTGTCTATAACGAGAGACCGTACTACTCCTACCTGGGCAAGCAT 69 FBan0015651 FBgn0034567 CG15651 2 2R CG15651 CG15651 CDMC30341 3 2 21 DAC33-K05 2-CG15651-RA_1 CG15651 CGGACCACCAAGTCCTGCATAGGCAGTGTCTATAACGAGAGACCGTACTACTCCTACCTGGGCAAGCAT 69 FBan0015651 FBgn0034567 CG15651 2 2R CG15651 CG15651 CDMC30342 3 3 21 DAC33-K17 2-CG15674-RA_1 CG15674 TCCATCGGGCAACTATACCGAGTGGGAGAACGCACAGGAAGAGGATTACGATGAGGAAGGTCCAGGATT 69 FBan0015674 FBgn0034642 CG15674 2 2R CG15674 CG15674 CDMC30342 3 4 21 DAC33-K17 2-CG15674-RA_1 CG15674 TCCATCGGGCAACTATACCGAGTGGGAGAACGCACAGGAAGAGGATTACGATGAGGAAGGTCCAGGATT 69 FBan0015674 FBgn0034642 CG15674 2 2R CG15674 CG15674 CDMC30343 3 5 21 DAC33-O05 15-CG15720-RA_1 CG15720 ACCATGACCGTGGAAACAACCAGTACATTTTTCGACTCCAGCACCCAGACAGGTGAGCACTTTGATTTT 69 FBan0015720 FBgn0030442 CG15720 X X CG15720 CG15720 CDMC30343 3 6 21 DAC33-O05 15-CG15720-RA_1 CG15720 ACCATGACCGTGGAAACAACCAGTACATTTTTCGACTCCAGCACCCAGACAGGTGAGCACTTTGATTTT 69 FBan0015720 FBgn0030442 CG15720 X X CG15720 CG15720 CDMC30344 3 7 21 DAC33-O17 1-CG15732-RA_1 CG15732 CCGGACGAAAGGCTAACCACAATTGCGCTGATCAGTAACTTGGCCTACTGGAATCACAAGCACCCGAAT 69 FBan0015732 FBgn0030385 CG15732 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15732 CG15732 CT35969 CDMC30344 3 8 21 DAC33-O17 1-CG15732-RA_1 CG15732 CCGGACGAAAGGCTAACCACAATTGCGCTGATCAGTAACTTGGCCTACTGGAATCACAAGCACCCGAAT 69 FBan0015732 FBgn0030385 CG15732 X X transport; GO:0006810 glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG15732 CG15732 CT35969 CDMC30345 3 9 21 DAC34-C05 3-CG3114-RB_1 CG3114 CCGGGGTTAGTGGGGGAGATGATGTAATGGTTCAGAAGCGTGGGAGACCCAATTCCTCTTCAAGAAGCA 69 FBan0003114 FBgn0005427 ewg X X central nervous system development; GO:0007417; ectoderm development; GO:0007398; imaginal disc morphogenesis; GO:0007560; mesoderm development; GO:0007498; muscle development; GO:0007517 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003704; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003704 nucleus; GO:0005634 ewg erect wing "CG3114, CG3114, EC3, l(1)EC3, l[EC3], l(1)DA659, EWG, l(1)1Ag, EG:BACR37P7.7, NRF-1, l(1)EC3f, l(1)VA720, erect wing" CDMC30345 3 10 21 DAC34-C05 3-CG3114-RB_1 CG3114 CCGGGGTTAGTGGGGGAGATGATGTAATGGTTCAGAAGCGTGGGAGACCCAATTCCTCTTCAAGAAGCA 69 FBan0003114 FBgn0005427 ewg X X central nervous system development; GO:0007417; ectoderm development; GO:0007398; imaginal disc morphogenesis; GO:0007560; mesoderm development; GO:0007498; muscle development; GO:0007517 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003704; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003704 nucleus; GO:0005634 ewg erect wing "CG3114, CG3114, EC3, l(1)EC3, l[EC3], l(1)DA659, EWG, l(1)1Ag, EG:BACR37P7.7, NRF-1, l(1)EC3f, l(1)VA720, erect wing" CDMC30346 3 11 21 DAC34-C17 2-CG31157-RA_1 CG31157 TGCTCAATCCCTTGATGAAGCGAAACATGAAACTCTGGCGACCCAAGATGACAAGTTTCTTGGCGGGCT 69 FBan0031157 FBgn0051157 CG31157 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31157 CG31157 CDMC30346 3 12 21 DAC34-C17 2-CG31157-RA_1 CG31157 TGCTCAATCCCTTGATGAAGCGAAACATGAAACTCTGGCGACCCAAGATGACAAGTTTCTTGGCGGGCT 69 FBan0031157 FBgn0051157 CG31157 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31157 CG31157 CDMC30347 3 13 21 DAC34-G05 22-CG31190-RB_4 CG31190 CCCTCGGAAAACGATTTGATGAACAATCTGATAAACTCAACAAATCCGACCAGCGGTGATTGGTTCGCA 69 FBan0031190 FBgn0051190 CG31190 3 3R cell adhesion; GO:0007155; cell proliferation; GO:0008283; ectoderm development; GO:0007398; nervous system development; GO:0007399 plasma membrane; GO:0005886 CG31190 CG31190 "CG12536, CG8106, CT33960, Dscam-like" CDMC30347 3 14 21 DAC34-G05 22-CG31190-RB_4 CG31190 CCCTCGGAAAACGATTTGATGAACAATCTGATAAACTCAACAAATCCGACCAGCGGTGATTGGTTCGCA 69 FBan0031190 FBgn0051190 CG31190 3 3R cell adhesion; GO:0007155; cell proliferation; GO:0008283; ectoderm development; GO:0007398; nervous system development; GO:0007399 plasma membrane; GO:0005886 CG31190 CG31190 "CG12536, CG8106, CT33960, Dscam-like" CDMC30348 3 15 21 DAC34-G17 4-CG3119-RA_1 CG3119 ACGCTTTGGATGGAGACACGAAGCCGAAGTTTATGCCCCTGGATCTGGAGAACTATATGTCGGATGCGA 69 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC30348 3 16 21 DAC34-G17 4-CG3119-RA_1 CG3119 ACGCTTTGGATGGAGACACGAAGCCGAAGTTTATGCCCCTGGATCTGGAGAACTATATGTCGGATGCGA 69 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC30349 3 17 21 DAC34-K05 3-CG31221-RA_3 CG31221 TGTCCCGGGGATGGTAATTGCATTTCCATCCAATATTTATGCGATGGTGCACCCGATTGCTCTGACGGA 69 FBan0031221 FBgn0051221 CG31221 3 3R lipoprotein receptor activity; GO:0030228; ; GO:0030228 CG31221 CG31221 "CG7237, CG11625, CG7237, anon-EST:Posey251, BcDNA:GH25289" CDMC30349 3 18 21 DAC34-K05 3-CG31221-RA_3 CG31221 TGTCCCGGGGATGGTAATTGCATTTCCATCCAATATTTATGCGATGGTGCACCCGATTGCTCTGACGGA 69 FBan0031221 FBgn0051221 CG31221 3 3R lipoprotein receptor activity; GO:0030228; ; GO:0030228 CG31221 CG31221 "CG7237, CG11625, CG7237, anon-EST:Posey251, BcDNA:GH25289" CDMC30350 3 19 21 DAC34-K17 18-CG31237-RA_1 CG31237 AAAAACCCTTTCGTTTCTCTTTGTTTCAGAGTTCGAAAATGCCGAGACGCTGCTGATATCGGAGGTGCA 69 FBgn0051237 CDMC30350 3 20 21 DAC34-K17 18-CG31237-RA_1 CG31237 AAAAACCCTTTCGTTTCTCTTTGTTTCAGAGTTCGAAAATGCCGAGACGCTGCTGATATCGGAGGTGCA 69 FBgn0051237 CDMC30351 3 21 21 DAC34-O05 1-CG31274-RA_2 CG31274 ATCCCTGCCTAACGGAGGTCCTCAGGAATTGTGCCAACATTCAGTCGCTGGAGAGCTTGAACTACGAAT 69 FBan0031274 FBgn0051274 CG31274 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31274 CG31274 BcDNA:LP05795 CDMC30351 3 22 21 DAC34-O05 1-CG31274-RA_2 CG31274 ATCCCTGCCTAACGGAGGTCCTCAGGAATTGTGCCAACATTCAGTCGCTGGAGAGCTTGAACTACGAAT 69 FBan0031274 FBgn0051274 CG31274 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31274 CG31274 BcDNA:LP05795 CDMC30352 3 23 21 DAC34-O17 23-CG31286-RB_9 CG31286 GGTTTTCGTGGTCAGATATACTCCACCTGGGAATGTGAAAGGATTATACACGGATAATGTTCCTCCCAG 69 FBan0031286 FBgn0051286 CG31286 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31286 CG31286 "BcDNA:AT25568, NEST:bs36b12" CDMC30352 3 24 21 DAC34-O17 23-CG31286-RB_9 CG31286 GGTTTTCGTGGTCAGATATACTCCACCTGGGAATGTGAAAGGATTATACACGGATAATGTTCCTCCCAG 69 FBan0031286 FBgn0051286 CG31286 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 CG31286 CG31286 "BcDNA:AT25568, NEST:bs36b12" CDMC30353 3 25 21 DAC35-C05 3-CG8079-RA_5 CG8079 ACTCTGGGCCAAACAAGACTACTGTGTCATGTCCACGAGGGTAACAGTACCTGCGGTTTGTGCGAG 66 FBan0008079 FBgn0034002 CG8079 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG8079 CG8079 CDMC30353 3 26 21 DAC35-C05 3-CG8079-RA_5 CG8079 ACTCTGGGCCAAACAAGACTACTGTGTCATGTCCACGAGGGTAACAGTACCTGCGGTTTGTGCGAG 66 FBan0008079 FBgn0034002 CG8079 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG8079 CG8079 CDMC30354 3 1 22 DAC35-C17 2-CG8233-RB_5 CG8233 GGTGCAGTGACGACCACAGCTTCCAGTAGTCCCATTATGGTTGATCCAGCCACAGGATCCAAGGTT 66 FBan0008233 FBgn0033897 CG8233 2 2R CG8233 CG8233 CDMC30354 3 2 22 DAC35-C17 2-CG8233-RB_5 CG8233 GGTGCAGTGACGACCACAGCTTCCAGTAGTCCCATTATGGTTGATCCAGCCACAGGATCCAAGGTT 66 FBan0008233 FBgn0033897 CG8233 2 2R CG8233 CG8233 CDMC30355 3 3 22 DAC35-G05 15-CG8614-RA_1 CG8614 AGCGAGCTCATGTATCCCACTTTCGAGGCAGTCAAGGAGGACAGAAGGCTAATGGAGCTACTTGCT 66 FBan0008614 FBgn0024542 Neos 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004812 ; EC:6.1.1.- Neos Neosin "CG8614, CG8614, l(3)L2249, BcDNA.HL05936, BcDNA:HL05936, Neosin" CDMC30355 3 4 22 DAC35-G05 15-CG8614-RA_1 CG8614 AGCGAGCTCATGTATCCCACTTTCGAGGCAGTCAAGGAGGACAGAAGGCTAATGGAGCTACTTGCT 66 FBan0008614 FBgn0024542 Neos 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004812 ; EC:6.1.1.- Neos Neosin "CG8614, CG8614, l(3)L2249, BcDNA.HL05936, BcDNA:HL05936, Neosin" CDMC30356 3 5 22 DAC35-G17 2-CG8881-RA_1 CG8881 CACTGGGCCACCTATCACAAGGACGATCCTGTGGTTACCGAAGAGGTTGAGAACAAGGAGAAGCGC 66 FBan0008881 FBgn0026176 skpB 2 2R cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; ; GO:0019237 skpB skpB "CG8881, CG8881, dskpB" CDMC30356 3 6 22 DAC35-G17 2-CG8881-RA_1 CG8881 CACTGGGCCACCTATCACAAGGACGATCCTGTGGTTACCGAAGAGGTTGAGAACAAGGAGAAGCGC 66 FBan0008881 FBgn0026176 skpB 2 2R cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; ; GO:0019237 skpB skpB "CG8881, CG8881, dskpB" CDMC30357 3 7 22 DAC35-K05 3-CG9319-RA_1 CG9319 AGATTTGCTCGACTCGGGAGTACTTTCCCTTCCAGAGAGGGCCAAGCTGTAAGACGCCAAGATGTG 66 FBan0009319 FBgn0032881 CG9319 2 2L fatty acid metabolism; GO:0006631 alpha-methylacyl-CoA racemase activity; GO:0008111 ; EC:5.1.99.4; ; GO:0008111 ; EC:5.1.99.4 CG9319 CG9319 38E.13 CDMC30357 3 8 22 DAC35-K05 3-CG9319-RA_1 CG9319 AGATTTGCTCGACTCGGGAGTACTTTCCCTTCCAGAGAGGGCCAAGCTGTAAGACGCCAAGATGTG 66 FBan0009319 FBgn0032881 CG9319 2 2L fatty acid metabolism; GO:0006631 alpha-methylacyl-CoA racemase activity; GO:0008111 ; EC:5.1.99.4; ; GO:0008111 ; EC:5.1.99.4 CG9319 CG9319 38E.13 CDMC30358 3 9 22 DAC35-K17 6-CG9538-RA_1 CG9538 CTAGAATGGGGCGTCGATATGTGGTACGATGAGGCGGTGTACACCAAACAGGCCTACATCGATGCC 66 FBan0009538 FBgn0015010 Ag5r X X defense response; GO:0006952 extracellular region; GO:0005576 Ag5r Antigen 5-related "CG9538, agr: antigen 5-related, Agr, Agr5, anon-WO0140519.74, antigen 5-related, agr" CDMC30358 3 10 22 DAC35-K17 6-CG9538-RA_1 CG9538 CTAGAATGGGGCGTCGATATGTGGTACGATGAGGCGGTGTACACCAAACAGGCCTACATCGATGCC 66 FBan0009538 FBgn0015010 Ag5r X X defense response; GO:0006952 extracellular region; GO:0005576 Ag5r Antigen 5-related "CG9538, agr: antigen 5-related, Agr, Agr5, anon-WO0140519.74, antigen 5-related, agr" CDMC30359 3 11 22 DAC35-O05 3-CG9951-RA_6 CG9951 ACAGCGGGAAACTAAAGCGAGAGAGGAGATCAGTCGCATTCAGCCCACGCTTAAACTGCACGAACG 66 FBan0009951 FBgn0036671 CG9951 3 3L CG9951 CG9951 CDMC30359 3 12 22 DAC35-O05 3-CG9951-RA_6 CG9951 ACAGCGGGAAACTAAAGCGAGAGAGGAGATCAGTCGCATTCAGCCCACGCTTAAACTGCACGAACG 66 FBan0009951 FBgn0036671 CG9951 3 3L CG9951 CG9951 CDMC30360 3 13 22 DAC35-O17 AutoBlank AutoBlank CDMC30360 3 14 22 DAC35-O17 AutoBlank AutoBlank CDMC30361 3 15 22 DAC36-C05 1-CG18179-RA_1 CG18179 GACTCTGGTGGTCCACTCGTTACCCATGACAACGCTCGGCTAGTGGGAGTGATTACCTTTGGCTC 65 FBan0018179 FBgn0036023 CG18179 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG18179 CG18179 "SP152, BEST:LP02275" CDMC30361 3 16 22 DAC36-C05 1-CG18179-RA_1 CG18179 GACTCTGGTGGTCCACTCGTTACCCATGACAACGCTCGGCTAGTGGGAGTGATTACCTTTGGCTC 65 FBan0018179 FBgn0036023 CG18179 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG18179 CG18179 "SP152, BEST:LP02275" CDMC30362 3 17 22 DAC36-C17 1-CG18275-RA_1 CG18275 TTGTGCTGTTAAAAGAACACAGTAACCTGATGTCAGACCGAGCAGCCCAGCCCAGTCTCCTGTGC 65 FBan0018275 FBgn0029523 CG18275 X X CG18275 CG18275 CDMC30362 3 18 22 DAC36-C17 1-CG18275-RA_1 CG18275 TTGTGCTGTTAAAAGAACACAGTAACCTGATGTCAGACCGAGCAGCCCAGCCCAGTCTCCTGTGC 65 FBan0018275 FBgn0029523 CG18275 X X CG18275 CG18275 CDMC30363 3 19 22 DAC36-G05 6-CG1845-RA_1 CG1845 CGCTGCGGAAGAACTGCCTCGACGAGATTGTGTTCCTGGTGCTTTTCTTCGATGTTAAGCGCACC 65 FBan0001845 FBgn0033155 CG1845 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG1845 CG1845 CDMC30363 3 20 22 DAC36-G05 6-CG1845-RA_1 CG1845 CGCTGCGGAAGAACTGCCTCGACGAGATTGTGTTCCTGGTGCTTTTCTTCGATGTTAAGCGCACC 65 FBan0001845 FBgn0033155 CG1845 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG1845 CG1845 CDMC30364 3 21 22 DAC36-G17 23-CG18530-RA_3 CG18530 TTTTCGTTGTGAGGGTGTACTGTTCGACCTTTTTTATGATCGTCAACGGAAAATTTTCAGATCAC 65 FBan0018530 FBgn0042207 CG18530 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG18530 CG18530 CG12294 CDMC30364 3 22 22 DAC36-G17 23-CG18530-RA_3 CG18530 TTTTCGTTGTGAGGGTGTACTGTTCGACCTTTTTTATGATCGTCAACGGAAAATTTTCAGATCAC 65 FBan0018530 FBgn0042207 CG18530 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG18530 CG18530 CG12294 CDMC30365 3 23 22 DAC36-K05 2-CG18654-RA_3 CG18654 TCTGCGTCAAGTTCCACCTGGAGCGTGAGAAGAACCCGCACAAATTCAACAGCCGCATGAAGAAC 65 FBan0018654 FBgn0004568 Dgk 2 2R intracellular signaling cascade; GO:0007242; phosphatidylinositol biosynthesis; GO:0006661; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; protein kinase C deactivation; GO:0042313 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004143 ; EC:2.7.1.107 Dgk Diacyl glycerol kinase "CG18654, CG1535, CG18654, DGKb, dDGK" CDMC30365 3 24 22 DAC36-K05 2-CG18654-RA_3 CG18654 TCTGCGTCAAGTTCCACCTGGAGCGTGAGAAGAACCCGCACAAATTCAACAGCCGCATGAAGAAC 65 FBan0018654 FBgn0004568 Dgk 2 2R intracellular signaling cascade; GO:0007242; phosphatidylinositol biosynthesis; GO:0006661; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; protein kinase C deactivation; GO:0042313 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004143 ; EC:2.7.1.107 Dgk Diacyl glycerol kinase "CG18654, CG1535, CG18654, DGKb, dDGK" CDMC30366 3 25 22 DAC36-K17 1-CG18681-RA_1 CG18681 GCAACCACGAGGGCTACAACTCCCGCACCATGGTCAACGACATTGCTATTATTCGCATCGAGTCC 65 FBan0018681 FBgn0010425 epsilonTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 epsilonTry epsilonTrypsin "CG18681, epsilon, DmEpsilonTry, Try, SP88, epsilonTry" CDMC30366 3 26 22 DAC36-K17 1-CG18681-RA_1 CG18681 GCAACCACGAGGGCTACAACTCCCGCACCATGGTCAACGACATTGCTATTATTCGCATCGAGTCC 65 FBan0018681 FBgn0010425 epsilonTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 epsilonTry epsilonTrypsin "CG18681, epsilon, DmEpsilonTry, Try, SP88, epsilonTry" CDMC30367 3 1 23 DAC36-O05 3-CG1893-RA_2 CG1893 CAACGAGGAGATCGGCAAAATCAGCAAACAATGGTCCGGACTGGGAAGGGAGCTGTTCACCGATG 65 FBan0001893 FBgn0035390 CG1893 3 3L lipid metabolism; GO:0006629; lipid transport; GO:0006869; phospholipid scrambling; GO:0017121 phospholipid scramblase activity; GO:0017128; carrier activity; GO:0005386; ; GO:0005386; ; GO:0017128; ; GO:0017128 CG1893 CG1893 CDMC30367 3 2 23 DAC36-O05 3-CG1893-RA_2 CG1893 CAACGAGGAGATCGGCAAAATCAGCAAACAATGGTCCGGACTGGGAAGGGAGCTGTTCACCGATG 65 FBan0001893 FBgn0035390 CG1893 3 3L lipid metabolism; GO:0006629; lipid transport; GO:0006869; phospholipid scrambling; GO:0017121 phospholipid scramblase activity; GO:0017128; carrier activity; GO:0005386; ; GO:0005386; ; GO:0017128; ; GO:0017128 CG1893 CG1893 CDMC30368 3 3 23 DAC36-O17 1-CG1935-RA_1 CG1935 CTTGGACTAGGAGCCCTAACGATGGTCACCATACTCGTCCTGTTCGTGGAATCTCGTTACGCGGC 65 FBan0001935 FBgn0025820 JTBR 3 3L JTBR JTBR "CG1935, CG1935, dJTBR, BcDNA:RH07980, anon-EST:fe2G4, dJTB-like, anon-fast-evolving-2G4" CDMC30368 3 4 23 DAC36-O17 1-CG1935-RA_1 CG1935 CTTGGACTAGGAGCCCTAACGATGGTCACCATACTCGTCCTGTTCGTGGAATCTCGTTACGCGGC 65 FBan0001935 FBgn0025820 JTBR 3 3L JTBR JTBR "CG1935, CG1935, dJTBR, BcDNA:RH07980, anon-EST:fe2G4, dJTB-like, anon-fast-evolving-2G4" CDMC30369 3 5 23 DAC37-C05 23-CG16922-RA_2 CG16922 GCGATTCGAGACCATGAACTCCAATGAGGTAACATTTTCAGGAATTTTGTTGTATCTACATCGAATCCT 69 FBan0016922 FBgn0030254 CG16922 X X CG16922 CG16922 CDMC30369 3 6 23 DAC37-C05 23-CG16922-RA_2 CG16922 GCGATTCGAGACCATGAACTCCAATGAGGTAACATTTTCAGGAATTTTGTTGTATCTACATCGAATCCT 69 FBan0016922 FBgn0030254 CG16922 X X CG16922 CG16922 CDMC30370 3 7 23 DAC37-C17 23-CG16936-RA_1 CG16936 CGGCGGCTCTATTATGTTTTGTTTTATATCCACACATTCTATATGCATATCCACTTTTGAATAAACGGA 69 FBan0016936 FBgn0027590 CG16936 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG16936 CG16936 BcDNA:GH04753 CDMC30370 3 8 23 DAC37-C17 23-CG16936-RA_1 CG16936 CGGCGGCTCTATTATGTTTTGTTTTATATCCACACATTCTATATGCATATCCACTTTTGAATAAACGGA 69 FBan0016936 FBgn0027590 CG16936 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG16936 CG16936 BcDNA:GH04753 CDMC30371 3 9 23 DAC37-G05 17-CG1696-RA_1 CG1696 GTCTGAGAATTGAGAAATCGTGGCACATCATCCGAAGCATCACAGGATATTCAGGATATTCCGGGCAGC 69 FBgn0031173 CDMC30371 3 10 23 DAC37-G05 17-CG1696-RA_1 CG1696 GTCTGAGAATTGAGAAATCGTGGCACATCATCCGAAGCATCACAGGATATTCAGGATATTCCGGGCAGC 69 FBgn0031173 CDMC30372 3 11 23 DAC37-G17 8-CG16976-RA_1 CG16976 GCACAAGCGCATGGGATCGAGACCGAAAAAGCCGAAATCTCATTACACACTCATCCAGGCTCACGTACT 69 FBan0016976 FBgn0035366 CG16976 3 3L CG16976 CG16976 CDMC30372 3 12 23 DAC37-G17 8-CG16976-RA_1 CG16976 GCACAAGCGCATGGGATCGAGACCGAAAAAGCCGAAATCTCATTACACACTCATCCAGGCTCACGTACT 69 FBan0016976 FBgn0035366 CG16976 3 3L CG16976 CG16976 CDMC30373 3 13 23 DAC37-K05 3-CG17010-RB_1 CG17010 CCGCAGATCAAGCTCCTGTGAAACCCGTGGAGACTGCTAATGAGCCACCTGCCAACAAAGCATAACATT 69 FBan0017010 FBgn0032424 CG17010 2 2L D-ribose metabolism; GO:0006014; carbohydrate metabolism; GO:0005975 ribokinase activity; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG17010 CG17010 CDMC30373 3 14 23 DAC37-K05 3-CG17010-RB_1 CG17010 CCGCAGATCAAGCTCCTGTGAAACCCGTGGAGACTGCTAATGAGCCACCTGCCAACAAAGCATAACATT 69 FBan0017010 FBgn0032424 CG17010 2 2L D-ribose metabolism; GO:0006014; carbohydrate metabolism; GO:0005975 ribokinase activity; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG17010 CG17010 CDMC30374 3 15 23 DAC37-K17 14-CG17025-RA_1 CG17025 GCAACATCAACTGAGGCATAGTCGAAATCGGTACTTCGCACAATCTAGCTCGAGTCGGTTCGAGTTGCT 69 FBan0017025 FBgn0040554 CG17025 3 3R CG17025 CG17025 CDMC30374 3 16 23 DAC37-K17 14-CG17025-RA_1 CG17025 GCAACATCAACTGAGGCATAGTCGAAATCGGTACTTCGCACAATCTAGCTCGAGTCGGTTCGAGTTGCT 69 FBan0017025 FBgn0040554 CG17025 3 3R CG17025 CG17025 CDMC30375 3 17 23 DAC37-O05 14-CG17051-RA_1 CG17051 TGGGAAAAAGGAAGATACCCTCGGTTACCGGATGGCATGATTTTTGGGTACTTACCACATCGGAGGACA 69 FBan0017051 FBgn0015379 dod X X cytokinesis; GO:0000910; epidermal growth factor receptor signaling pathway; GO:0007173; mitosis; GO:0007067; protein folding; GO:0006457 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 dod dodo "CG17051, Pin1, dodo" CDMC30375 3 18 23 DAC37-O05 14-CG17051-RA_1 CG17051 TGGGAAAAAGGAAGATACCCTCGGTTACCGGATGGCATGATTTTTGGGTACTTACCACATCGGAGGACA 69 FBan0017051 FBgn0015379 dod X X cytokinesis; GO:0000910; epidermal growth factor receptor signaling pathway; GO:0007173; mitosis; GO:0007067; protein folding; GO:0006457 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 dod dodo "CG17051, Pin1, dodo" CDMC30376 3 19 23 DAC37-O17 2-CG17064-RA_1 CG17064 CGCTGTGAGAAGGAGAAACGCAATAGCTTCTACCTGTCCAATGAGGAATCGCCCTTGGAAGTTCGCCGT 69 FBan0017064 FBgn0033845 mars 2 2R cell-cell signaling; GO:0007267 mars mars "CG17064, CG17064, CG17064, CG17064, CG17064, dhrp/gkap, gkap" CDMC30376 3 20 23 DAC37-O17 2-CG17064-RA_1 CG17064 CGCTGTGAGAAGGAGAAACGCAATAGCTTCTACCTGTCCAATGAGGAATCGCCCTTGGAAGTTCGCCGT 69 FBan0017064 FBgn0033845 mars 2 2R cell-cell signaling; GO:0007267 mars mars "CG17064, CG17064, CG17064, CG17064, CG17064, dhrp/gkap, gkap" CDMC30377 3 21 23 DAC38-C05 3-CG17584-RA_1 CG17584 TCGCGATCCCCGTGAACTGAGGGAGGAGATCATAGCCTGCATACGTTACCAGCAGAGCATTATCGAGTA 69 FBan0017584 FBgn0028963 Or49b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or49b Odorant receptor 49b "CG17584, CG17584, 49D.1, AN13, DOR105, 49b" CDMC30377 3 22 23 DAC38-C05 3-CG17584-RA_1 CG17584 TCGCGATCCCCGTGAACTGAGGGAGGAGATCATAGCCTGCATACGTTACCAGCAGAGCATTATCGAGTA 69 FBan0017584 FBgn0028963 Or49b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or49b Odorant receptor 49b "CG17584, CG17584, 49D.1, AN13, DOR105, 49b" CDMC30378 3 23 23 DAC38-C17 23-CG17598-RA_9 CG17598 TTACACTCCACACGAAAGGACAAATTCAAAACATTCAAAGTTTACATAATTTGCTTATGTACGCCCCCA 69 FBan0017598 FBgn0031194 CG17598 X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG17598 CG17598 PP2C CDMC30378 3 24 23 DAC38-C17 23-CG17598-RA_9 CG17598 TTACACTCCACACGAAAGGACAAATTCAAAACATTCAAAGTTTACATAATTTGCTTATGTACGCCCCCA 69 FBan0017598 FBgn0031194 CG17598 X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG17598 CG17598 PP2C CDMC30379 3 25 23 DAC38-G05 24-CG17639-RA_1 CG17639 CGGGCTAACAGTTCTTTAAATTAGTGTTACAGTAGCGAAAAAATATTTAATATTTAATATCAGTTGTGT 69 FBan0017639 FBgn0038029 CG17639 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG17639 CG17639 BcDNA:RE72392 CDMC30379 3 26 23 DAC38-G05 24-CG17639-RA_1 CG17639 CGGGCTAACAGTTCTTTAAATTAGTGTTACAGTAGCGAAAAAATATTTAATATTTAATATCAGTTGTGT 69 FBan0017639 FBgn0038029 CG17639 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG17639 CG17639 BcDNA:RE72392 CDMC30380 3 1 24 DAC38-G17 16-CG1765-RB_2 CG1765 GATCCTCCAAACTGCATGCGAAACAGATCAGAAAAGAGAACAGACAGTAGGGCGTGAACAGAGGGAAGA 69 FBan0001765 FBgn0000546 EcR 2 2R "autophagy; GO:0006914; border follicle cell migration (sensu Insecta); GO:0007298; cell adhesion; GO:0007155; central nervous system remodeling (sensu Insecta); GO:0035193; dendrite morphogenesis; GO:0016358; determination of adult life span; GO:0008340; ecdysis (sensu Insecta); GO:0018990; ecdysone receptor-mediated signaling pathway; GO:0035076; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; germ-band shortening; GO:0007390; hatching; GO:0035188; head involution; GO:0008258; hormone secretion; GO:0046879; imaginal disc eversion; GO:0007561; intracellular signaling cascade; GO:0007242; metamorphosis (sensu Insecta); GO:0046698; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; oogenesis (sensu Insecta); GO:0009993; pupariation; GO:0035073; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; sperm individualization; GO:0007291; spermatid development; GO:0007286; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; RNA polymerase I transcription factor activity; GO:0003701; steroid binding; GO:0005496; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0003701; ; GO:0005496; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 EcR Ecdysone receptor "CG1765, CG8347, CG1765, CG8347, EcdR, ms(2)42A: male sterile(2)42A, lie, dECR, DmEcR, ECR, snt, snaggletooth, EcR-A, long island expressway, DEcR, NR1H1, ecr, EcRB-1, Ecdysone Receptor, ecdysone receptor, EcR-B1, EcRB1, anon-WO0229075.1, Dhr23, ms(2)06410, male sterile(2)42A, ms(2)42A" CDMC30380 3 2 24 DAC38-G17 16-CG1765-RB_2 CG1765 GATCCTCCAAACTGCATGCGAAACAGATCAGAAAAGAGAACAGACAGTAGGGCGTGAACAGAGGGAAGA 69 FBan0001765 FBgn0000546 EcR 2 2R "autophagy; GO:0006914; border follicle cell migration (sensu Insecta); GO:0007298; cell adhesion; GO:0007155; central nervous system remodeling (sensu Insecta); GO:0035193; dendrite morphogenesis; GO:0016358; determination of adult life span; GO:0008340; ecdysis (sensu Insecta); GO:0018990; ecdysone receptor-mediated signaling pathway; GO:0035076; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; germ-band shortening; GO:0007390; hatching; GO:0035188; head involution; GO:0008258; hormone secretion; GO:0046879; imaginal disc eversion; GO:0007561; intracellular signaling cascade; GO:0007242; metamorphosis (sensu Insecta); GO:0046698; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; oogenesis (sensu Insecta); GO:0009993; pupariation; GO:0035073; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; sperm individualization; GO:0007291; spermatid development; GO:0007286; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; RNA polymerase I transcription factor activity; GO:0003701; steroid binding; GO:0005496; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0003701; ; GO:0005496; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 EcR Ecdysone receptor "CG1765, CG8347, CG1765, CG8347, EcdR, ms(2)42A: male sterile(2)42A, lie, dECR, DmEcR, ECR, snt, snaggletooth, EcR-A, long island expressway, DEcR, NR1H1, ecr, EcRB-1, Ecdysone Receptor, ecdysone receptor, EcR-B1, EcRB1, anon-WO0229075.1, Dhr23, ms(2)06410, male sterile(2)42A, ms(2)42A" CDMC30381 3 3 24 DAC38-K05 9-CG17706-RA_1 CG17706 GGTCGCCACGATTCGCACCGAATGTCATTTTGCGGGTGATTTTGCGGAAGAAATCTCACACCGATACTT 69 CDMC30381 3 4 24 DAC38-K05 9-CG17706-RA_1 CG17706 GGTCGCCACGATTCGCACCGAATGTCATTTTGCGGGTGATTTTGCGGAAGAAATCTCACACCGATACTT 69 CDMC30382 3 5 24 DAC38-K17 8-CG17717-RA_2 CG17717 TGCAGTGCATGGATAATATGAATCAAGGCAGCACCGATCAGTTAACCGTCCAGGAGGTGTTTGTCGCCT 69 FBan0017717 FBgn0029877 CG17717 X X CG17717 CG17717 BcDNA:AT19932 CDMC30382 3 6 24 DAC38-K17 8-CG17717-RA_2 CG17717 TGCAGTGCATGGATAATATGAATCAAGGCAGCACCGATCAGTTAACCGTCCAGGAGGTGTTTGTCGCCT 69 FBan0017717 FBgn0029877 CG17717 X X CG17717 CG17717 BcDNA:AT19932 CDMC30383 3 7 24 DAC38-O05 3-CG17753-RA_3 CG17753 AGGGCCACCTTTAGATTTGTGGATCCAGTGCTAGAGGTCTGGGACATAATCGGAAGGGCTGTCGTCCTA 69 FBan0017753 FBgn0010531 CCS 2 2R defense response; GO:0006952; intracellular copper ion transport; GO:0015680; superoxide metabolism; GO:0006801 "superoxide dismutase copper chaperone activity; GO:0016532; ; GO:0016532; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; copper ion binding; GO:0005507; ; GO:0016532; ; GO:0005507; ; GO:0046872; ; GO:0004785" CCS CCS "CG17753, CG17753, l(2)03221, CCD, anon-EST:Posey231" CDMC30383 3 8 24 DAC38-O05 3-CG17753-RA_3 CG17753 AGGGCCACCTTTAGATTTGTGGATCCAGTGCTAGAGGTCTGGGACATAATCGGAAGGGCTGTCGTCCTA 69 FBan0017753 FBgn0010531 CCS 2 2R defense response; GO:0006952; intracellular copper ion transport; GO:0015680; superoxide metabolism; GO:0006801 "superoxide dismutase copper chaperone activity; GO:0016532; ; GO:0016532; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; copper ion binding; GO:0005507; ; GO:0016532; ; GO:0005507; ; GO:0046872; ; GO:0004785" CCS CCS "CG17753, CG17753, l(2)03221, CCD, anon-EST:Posey231" CDMC30384 3 9 24 DAC38-O17 9-CG17762-RC_4 CG17762 TGTGGATTGGAACTAGTTTCGGTTCGATACTGACATTGTTCATCACCATGCCCGAGCGAGATGTGCGCA 69 FBan0017762 FBgn0030412 tomosyn X X establishment and/or maintenance of cell polarity; GO:0007163; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of progression through cell cycle; GO:0000074; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082 syntaxin-1 binding; GO:0017075; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0017075 synaptic vesicle; GO:0008021 tomosyn tomosyn "CG17762, CG11056, CG2205, CG17762, CG17762, CG17762, CG11056, CG17762, CG2205, Tomosyn, BcDNA:RH19475" CDMC30384 3 10 24 DAC38-O17 9-CG17762-RC_4 CG17762 TGTGGATTGGAACTAGTTTCGGTTCGATACTGACATTGTTCATCACCATGCCCGAGCGAGATGTGCGCA 69 FBan0017762 FBgn0030412 tomosyn X X establishment and/or maintenance of cell polarity; GO:0007163; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; regulation of progression through cell cycle; GO:0000074; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle priming; GO:0016082 syntaxin-1 binding; GO:0017075; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0017075 synaptic vesicle; GO:0008021 tomosyn tomosyn "CG17762, CG11056, CG2205, CG17762, CG17762, CG17762, CG11056, CG17762, CG2205, Tomosyn, BcDNA:RH19475" CDMC30385 3 11 24 DAC39-C05 1-CG32208-RA_1 CG32208 ATATTTCACCATGTTCAAATACGCTGTCGTCGTTCTCGCTCTCGTTGCCTGCGCTGCTGCCAAGC 65 FBan0032208 FBgn0052208 825-Oak 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 825-Oak 825-Oak CG32208 CDMC30385 3 12 24 DAC39-C05 1-CG32208-RA_1 CG32208 ATATTTCACCATGTTCAAATACGCTGTCGTCGTTCTCGCTCTCGTTGCCTGCGCTGCTGCCAAGC 65 FBan0032208 FBgn0052208 825-Oak 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 825-Oak 825-Oak CG32208 CDMC30386 3 13 24 DAC39-C17 2-CG32244-RB_2 CG32244 TGCATCCGAACCGACGACTATCCGCTGTAAGATTCCCGTAGCTAGTTGGTGAGCGGTACTCCCAG 65 FBan0032244 FBgn0052244 CG32244 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32244 CG32244 "CG18318, CG18318" CDMC30386 3 14 24 DAC39-C17 2-CG32244-RB_2 CG32244 TGCATCCGAACCGACGACTATCCGCTGTAAGATTCCCGTAGCTAGTTGGTGAGCGGTACTCCCAG 65 FBan0032244 FBgn0052244 CG32244 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32244 CG32244 "CG18318, CG18318" CDMC30387 3 15 24 DAC39-G05 9-CG32377-RA_1 CG32377 TGGTCTACCGACAGCCAGAGTTTGATGTAGAACACCACACGATCATGTCTGTGCGTCCACCCTCC 65 FBan0032377 FBgn0052377 CG32377 3 3L cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 membrane; GO:0016020 CG32377 CG32377 CDMC30387 3 16 24 DAC39-G05 9-CG32377-RA_1 CG32377 TGGTCTACCGACAGCCAGAGTTTGATGTAGAACACCACACGATCATGTCTGTGCGTCCACCCTCC 65 FBan0032377 FBgn0052377 CG32377 3 3L cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 membrane; GO:0016020 CG32377 CG32377 CDMC30388 3 17 24 DAC39-G17 23-CG32416-RA_1 CG32416 ATGCACATATATCGCCATTAGATAAAGAAGTAGGTATGCATCAACCGAAACAACAATGGATGTGA 65 FBan0032416 FBgn0052416 CG32416 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32416 CG32416 CDMC30388 3 18 24 DAC39-G17 23-CG32416-RA_1 CG32416 ATGCACATATATCGCCATTAGATAAAGAAGTAGGTATGCATCAACCGAAACAACAATGGATGTGA 65 FBan0032416 FBgn0052416 CG32416 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32416 CG32416 CDMC30389 3 19 24 DAC39-K05 1-CG32495-RA_1 CG32495 GAGGCGGCAATAATGTCTACGGCGTGGATATACCAGATGCACTAAAGCGCATGTCACGCGTGGAG 65 FBan0032495 FBgn0052495 CG32495 X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 ATP binding; GO:0005524; ; GO:0005524; ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 CG32495 CG32495 CDMC30389 3 20 24 DAC39-K05 1-CG32495-RA_1 CG32495 GAGGCGGCAATAATGTCTACGGCGTGGATATACCAGATGCACTAAAGCGCATGTCACGCGTGGAG 65 FBan0032495 FBgn0052495 CG32495 X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 ATP binding; GO:0005524; ; GO:0005524; ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 CG32495 CG32495 CDMC30390 3 21 24 DAC39-K17 9-CG32514-RA_1 CG32514 GCGGCTACGCATTCGACGATCAACAGCGTAGGTCCAGTTTTGTGAGCGATGCATTCGACCTGGAC 65 FBgn0052514 CDMC30390 3 22 24 DAC39-K17 9-CG32514-RA_1 CG32514 GCGGCTACGCATTCGACGATCAACAGCGTAGGTCCAGTTTTGTGAGCGATGCATTCGACCTGGAC 65 FBgn0052514 CDMC30391 3 23 24 DAC39-O05 3-CG32573-RA_1 CG32573 TCGCTCCGATCGCGAGTACATCTACACGACCATAACGGACGAGTGGAACTACGGTCTGAATGGGC 65 FBan0032573 FBgn0052573 CG32573 X X CG32573 CG32573 "CG13013, CG4524" CDMC30391 3 24 24 DAC39-O05 3-CG32573-RA_1 CG32573 TCGCTCCGATCGCGAGTACATCTACACGACCATAACGGACGAGTGGAACTACGGTCTGAATGGGC 65 FBan0032573 FBgn0052573 CG32573 X X CG32573 CG32573 "CG13013, CG4524" CDMC30392 3 25 24 DAC39-O17 3-CG32626-RA_1 CG32626 TTCAAGGTGAACCAGACGTGCTCCATTGCAGACATGAACGCCACATAGTCTGGTCCATGCGGTAC 65 FBan0032626 FBgn0052626 CG32626 X X purine base metabolism; GO:0006144; purine ribonucleoside monophosphate biosynthesis; GO:0009168 AMP deaminase activity; GO:0003876 ; EC:3.5.4.6; ; GO:0003876 ; EC:3.5.4.6; ; GO:0003876 ; EC:3.5.4.6 CG32626 CG32626 "CG11058, CG11065, CG15762, CG11058" CDMC30392 3 26 24 DAC39-O17 3-CG32626-RA_1 CG32626 TTCAAGGTGAACCAGACGTGCTCCATTGCAGACATGAACGCCACATAGTCTGGTCCATGCGGTAC 65 FBan0032626 FBgn0052626 CG32626 X X purine base metabolism; GO:0006144; purine ribonucleoside monophosphate biosynthesis; GO:0009168 AMP deaminase activity; GO:0003876 ; EC:3.5.4.6; ; GO:0003876 ; EC:3.5.4.6; ; GO:0003876 ; EC:3.5.4.6 CG32626 CG32626 "CG11058, CG11065, CG15762, CG11058" CDMC30393 3 1 25 DAC40-C05 23-CG41127-RA_1 CG41127 CGAAGTGGCATGATCACGAAGACTTTGAAAATGCTGTTGAGATTGTCCGAAAATTAAAAGTTTAA 65 FBgn0069924 CG41127 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41127 CG41127 CDMC30393 3 2 25 DAC40-C05 23-CG41127-RA_1 CG41127 CGAAGTGGCATGATCACGAAGACTTTGAAAATGCTGTTGAGATTGTCCGAAAATTAAAAGTTTAA 65 FBgn0069924 CG41127 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41127 CG41127 CDMC30394 3 3 25 DAC40-C17 2-CG4132-RA_1 CG4132 AGGTGGCCGAAATGATTGTCCGGGATGTTACGAGTGTCACTCTTAGTGGCAAGACTCCTCCGCTG 65 FBan0004132 FBgn0040079 pkaap 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; protein localization; GO:0008104; protein targeting; GO:0006605 kinase activator activity; GO:0019209; signal transducer activity; GO:0004871; protein kinase A binding; GO:0051018; ; GO:0019209; ; GO:0051018; ; GO:0004871 pkaap pkaap "CG4132, CG4132, BG:DS02740.4, DS02740.4" CDMC30394 3 4 25 DAC40-C17 2-CG4132-RA_1 CG4132 AGGTGGCCGAAATGATTGTCCGGGATGTTACGAGTGTCACTCTTAGTGGCAAGACTCCTCCGCTG 65 FBan0004132 FBgn0040079 pkaap 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; protein localization; GO:0008104; protein targeting; GO:0006605 kinase activator activity; GO:0019209; signal transducer activity; GO:0004871; protein kinase A binding; GO:0051018; ; GO:0019209; ; GO:0051018; ; GO:0004871 pkaap pkaap "CG4132, CG4132, BG:DS02740.4, DS02740.4" CDMC30395 3 5 25 DAC40-G05 2-CG4261-RA_1 CG4261 ACTTGCCGGAACTCTGGTCCGAGCATCAGTACGAGGAAGAGTACGACTTGGGCAACTTTGTGCAG 65 FBan0004261 FBgn0022787 Hel89B 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003; ; GO:0003677 Hel89B Helicase 89B "CG4261, 89B helicase, 89B, BTAF1" CDMC30395 3 6 25 DAC40-G05 2-CG4261-RA_1 CG4261 ACTTGCCGGAACTCTGGTCCGAGCATCAGTACGAGGAAGAGTACGACTTGGGCAACTTTGTGCAG 65 FBan0004261 FBgn0022787 Hel89B 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003; ; GO:0003677 Hel89B Helicase 89B "CG4261, 89B helicase, 89B, BTAF1" CDMC30396 3 7 25 DAC40-G17 17-CG4282-RA_1 CG4282 GCGCAAGCTGAAAAACCACATGAGCTCTATGCATGACCCAGAGAGTACCATAATCTGCGACAAGT 65 FBan0004282 FBgn0034114 CG4282 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG4282 CG4282 CDMC30396 3 8 25 DAC40-G17 17-CG4282-RA_1 CG4282 GCGCAAGCTGAAAAACCACATGAGCTCTATGCATGACCCAGAGAGTACCATAATCTGCGACAAGT 65 FBan0004282 FBgn0034114 CG4282 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG4282 CG4282 CDMC30397 3 9 25 DAC40-K05 6-CG4400-RA_2 CG4400 CCTGCGCAAGTACCGACTGCAGAATATCGAGCACAAATACCAGTCCGAGGAACAAGCTGCCGTCC 65 FBan0004400 FBgn0030434 CG4400 X X CG4400 CG4400 CDMC30397 3 10 25 DAC40-K05 6-CG4400-RA_2 CG4400 CCTGCGCAAGTACCGACTGCAGAATATCGAGCACAAATACCAGTCCGAGGAACAAGCTGCCGTCC 65 FBan0004400 FBgn0030434 CG4400 X X CG4400 CG4400 CDMC30398 3 11 25 DAC40-K17 3-CG4446-RB_2 CG4446 ATCCTGGCCTGGTGTACGTCTGTGATCCGGTTATGGGTGACAATGGTCAGCTCTATGTGCCCAAG 65 FBan0004446 FBgn0035979 CG4446 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin catabolism; GO:0009111 pyridoxal kinase activity; GO:0008478 ; EC:2.7.1.35; ; GO:0008478 ; EC:2.7.1.35 CG4446 CG4446 CDMC30398 3 12 25 DAC40-K17 3-CG4446-RB_2 CG4446 ATCCTGGCCTGGTGTACGTCTGTGATCCGGTTATGGGTGACAATGGTCAGCTCTATGTGCCCAAG 65 FBan0004446 FBgn0035979 CG4446 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin catabolism; GO:0009111 pyridoxal kinase activity; GO:0008478 ; EC:2.7.1.35; ; GO:0008478 ; EC:2.7.1.35 CG4446 CG4446 CDMC30399 3 13 25 DAC40-O05 2-CG4575-RA_1 CG4575 CATCAGCTCGGGCAGCCATGTTAAGGATACCGCATACTACGAGAGGCGTCGCAAGAACAATGCTG 65 FBan0004575 FBgn0029920 CG4575 X X "regulation of transcription, DNA-dependent; GO:0006355; segment specification; GO:0007379" protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 CG4575 CG4575 CDMC30399 3 14 25 DAC40-O05 2-CG4575-RA_1 CG4575 CATCAGCTCGGGCAGCCATGTTAAGGATACCGCATACTACGAGAGGCGTCGCAAGAACAATGCTG 65 FBan0004575 FBgn0029920 CG4575 X X "regulation of transcription, DNA-dependent; GO:0006355; segment specification; GO:0007379" protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 CG4575 CG4575 CDMC30400 3 15 25 DAC40-O17 2-CG4599-RA_3 CG4599 AGAACGGCAATATGCTATTCAAGTCGGGTCGGTATCGCGAGGCACACGTTATCTACACGGACGCC 65 FBan0004599 FBgn0032586 Tpr2 2 2L protein complex assembly; GO:0006461; protein folding; GO:0006457; protein metabolism; GO:0019538 Tpr2 Tetratricopeptide repeat protein 2 "CG4599, EU3220, dTPR2, dtpr2, BEST:LD24941, Tetratricopeptide repeat protein 2" CDMC30400 3 16 25 DAC40-O17 2-CG4599-RA_3 CG4599 AGAACGGCAATATGCTATTCAAGTCGGGTCGGTATCGCGAGGCACACGTTATCTACACGGACGCC 65 FBan0004599 FBgn0032586 Tpr2 2 2L protein complex assembly; GO:0006461; protein folding; GO:0006457; protein metabolism; GO:0019538 Tpr2 Tetratricopeptide repeat protein 2 "CG4599, EU3220, dTPR2, dtpr2, BEST:LD24941, Tetratricopeptide repeat protein 2" CDMC30401 3 17 25 DAC41-C05 17-CG4577-RA_1 CG4577 GCGAGAAGTACTTCTAAGGATCCCACGCGGAGATAGTCTACGTAGTACTTAATGATAGCCACAGGCCCC 69 FBan0004577 FBgn0031306 CG4577 2 2L CG4577 CG4577 CDMC30401 3 18 25 DAC41-C05 17-CG4577-RA_1 CG4577 GCGAGAAGTACTTCTAAGGATCCCACGCGGAGATAGTCTACGTAGTACTTAATGATAGCCACAGGCCCC 69 FBan0004577 FBgn0031306 CG4577 2 2L CG4577 CG4577 CDMC30402 3 19 25 DAC41-C17 1-CG4592-RA_1 CG4592 CCAAGTCATGTTGCGTAACAGGCTGATAGATGGAGTCAGGCGAATAAAACCCATACTTTGCGGGGGGCA 69 FBan0004592 FBgn0032162 CG4592 2 2L lipid metabolism; GO:0006629 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4592 CG4592 CDMC30402 3 20 25 DAC41-C17 1-CG4592-RA_1 CG4592 CCAAGTCATGTTGCGTAACAGGCTGATAGATGGAGTCAGGCGAATAAAACCCATACTTTGCGGGGGGCA 69 FBan0004592 FBgn0032162 CG4592 2 2L lipid metabolism; GO:0006629 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4592 CG4592 CDMC30403 3 21 25 DAC41-G05 24-CG4617-RA_1 CG4617 CCTATAATCCTTAAGTGAAATAAATGTGAATCACAAGATTCTTATTTCAGCTTCAAATTAAGCAGGCAC 69 FBan0004617 FBgn0029936 CG4617 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG4617 CG4617 CDMC30403 3 22 25 DAC41-G05 24-CG4617-RA_1 CG4617 CCTATAATCCTTAAGTGAAATAAATGTGAATCACAAGATTCTTATTTCAGCTTCAAATTAAGCAGGCAC 69 FBan0004617 FBgn0029936 CG4617 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG4617 CG4617 CDMC30404 3 23 25 DAC41-G17 14-CG4624-RA_2 CG4624 GCGGATTCAAGAACGGCATGCTAAAGCACTCGGACTATCTAAATCTGACCCAGTGTGAATCCCTCGAGG 69 FBan0004624 FBgn0039058 CG4624 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG4624 CG4624 anon-WO0118547.227 CDMC30404 3 24 25 DAC41-G17 14-CG4624-RA_2 CG4624 GCGGATTCAAGAACGGCATGCTAAAGCACTCGGACTATCTAAATCTGACCCAGTGTGAATCCCTCGAGG 69 FBan0004624 FBgn0039058 CG4624 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 CG4624 CG4624 anon-WO0118547.227 CDMC30405 3 25 25 DAC41-K05 18-CG4655-RA_7 CG4655 CACAGAAGGCACCGTTTTCCTCCTGGGACCATTAGATTTTGAGAAGCAAGCCATGTACCATCTAACGAT 69 FBan0004655 FBgn0037839 CG4655 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 CG4655 CG4655 "CT15041, DCad86C, BcDNA:LP07955" CDMC30405 3 26 25 DAC41-K05 18-CG4655-RA_7 CG4655 CACAGAAGGCACCGTTTTCCTCCTGGGACCATTAGATTTTGAGAAGCAAGCCATGTACCATCTAACGAT 69 FBan0004655 FBgn0037839 CG4655 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 CG4655 CG4655 "CT15041, DCad86C, BcDNA:LP07955" CDMC30406 3 1 26 DAC41-K17 15-CG4663-RA_5 CG4663 GCGAAGTGTGTTTGCCCAGTTTTGGACCACGTTTGCCATATTCCGCGGTCTAAACTGGATGTACAGAAA 69 FBan0004663 FBgn0033812 CG4663 2 2R "peroxisome organization and biogenesis; GO:0007031; protein import into peroxisome matrix, docking; GO:0016560; protein targeting to peroxisome; GO:0006625" integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG4663 CG4663 CDMC30406 3 2 26 DAC41-K17 15-CG4663-RA_5 CG4663 GCGAAGTGTGTTTGCCCAGTTTTGGACCACGTTTGCCATATTCCGCGGTCTAAACTGGATGTACAGAAA 69 FBan0004663 FBgn0033812 CG4663 2 2R "peroxisome organization and biogenesis; GO:0007031; protein import into peroxisome matrix, docking; GO:0016560; protein targeting to peroxisome; GO:0006625" integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG4663 CG4663 CDMC30407 3 3 26 DAC41-O05 16-CG4694-RA_1 CG4694 TGCGCGACTCGAATGACTCGCATGCAGATAATCAAGGACATGTACTCTAAACAGGGCACGTTAAGTCAA 69 FBan0004694 FBgn0001185 her 2 2L "female somatic sex determination; GO:0019101; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; sex differentiation; GO:0007548" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 her hermaphrodite "CG4694, l(2)mat: lethal(2)maternal, lethal(2)maternal" CDMC30407 3 4 26 DAC41-O05 16-CG4694-RA_1 CG4694 TGCGCGACTCGAATGACTCGCATGCAGATAATCAAGGACATGTACTCTAAACAGGGCACGTTAAGTCAA 69 FBan0004694 FBgn0001185 her 2 2L "female somatic sex determination; GO:0019101; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; sex differentiation; GO:0007548" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 her hermaphrodite "CG4694, l(2)mat: lethal(2)maternal, lethal(2)maternal" CDMC30408 3 5 26 DAC41-O17 10-CG4700-RA_1 CG4700 GCCAGAGTGTACATCTGGGCTGTTTCGTCAAAATACCCGAAGTGCTGAAGAATGAGCAAGTGACCTGGT 69 FBan0004700 FBgn0011260 Sema-2a 2 2R adult behavior; GO:0030534; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; drinking behavior; GO:0042756; ectoderm development; GO:0007398; flight behavior; GO:0007629; salivary gland development; GO:0007431; synaptic target inhibition; GO:0016201; visual behavior; GO:0007632 receptor binding; GO:0005102; receptor activity; GO:0004872; ; GO:0005102; ; GO:0004872 extracellular region; GO:0005576; membrane; GO:0016020 Sema-2a Sema-2a "CG4700, Sema2a, D-Sema II, D-semaII, D-Semaphorin II, semaII, SemaII, dSema-II, D-SemaII, 112/40, sema II, sema-II: semaphorin II, semaphorin, Semaphorin II, Dsema-II, l(2)03021, CT14922, D-Sema2a, semiphorin, D-Sema-II, BcDNA:LD09561, semaphorin II, sema-II" CDMC30408 3 6 26 DAC41-O17 10-CG4700-RA_1 CG4700 GCCAGAGTGTACATCTGGGCTGTTTCGTCAAAATACCCGAAGTGCTGAAGAATGAGCAAGTGACCTGGT 69 FBan0004700 FBgn0011260 Sema-2a 2 2R adult behavior; GO:0030534; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; drinking behavior; GO:0042756; ectoderm development; GO:0007398; flight behavior; GO:0007629; salivary gland development; GO:0007431; synaptic target inhibition; GO:0016201; visual behavior; GO:0007632 receptor binding; GO:0005102; receptor activity; GO:0004872; ; GO:0005102; ; GO:0004872 extracellular region; GO:0005576; membrane; GO:0016020 Sema-2a Sema-2a "CG4700, Sema2a, D-Sema II, D-semaII, D-Semaphorin II, semaII, SemaII, dSema-II, D-SemaII, 112/40, sema II, sema-II: semaphorin II, semaphorin, Semaphorin II, Dsema-II, l(2)03021, CT14922, D-Sema2a, semiphorin, D-Sema-II, BcDNA:LD09561, semaphorin II, sema-II" CDMC30409 3 7 26 DAC42-C05 150mM NaPO4 Blank CDMC30409 3 8 26 DAC42-C05 150mM NaPO4 Blank CDMC30410 3 9 26 DAC42-C17 150mM NaPO4 Blank CDMC30410 3 10 26 DAC42-C17 150mM NaPO4 Blank CDMC30411 3 11 26 DAC42-G05 150mM NaPO4 Blank CDMC30411 3 12 26 DAC42-G05 150mM NaPO4 Blank CDMC30412 3 13 26 DAC42-G17 150mM NaPO4 Blank CDMC30412 3 14 26 DAC42-G17 150mM NaPO4 Blank CDMC30413 3 15 26 DAC42-K05 150mM NaPO4 Blank CDMC30413 3 16 26 DAC42-K05 150mM NaPO4 Blank CDMC30414 3 17 26 DAC42-K17 5uM MSP 5uM MSP CDMC30414 3 18 26 DAC42-K17 5uM MSP 5uM MSP CDMC30415 3 19 26 DAC42-O05 10uM MSP 10uM MSP CDMC30415 3 20 26 DAC42-O05 10uM MSP 10uM MSP CDMC30416 3 21 26 DAC42-O17 20uM MSP 20uM MSP CDMC30416 3 22 26 DAC42-O17 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC30417 4 1 1 DAC01-D05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30417 4 2 1 DAC01-D05 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30418 4 3 1 DAC01-D17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30418 4 4 1 DAC01-D17 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30419 4 5 1 DAC01-H05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30419 4 6 1 DAC01-H05 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30420 4 7 1 DAC01-H17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30420 4 8 1 DAC01-H17 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30421 4 9 1 DAC01-L05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30421 4 10 1 DAC01-L05 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30422 4 11 1 DAC01-L17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30422 4 12 1 DAC01-L17 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30423 4 13 1 DAC01-P05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30423 4 14 1 DAC01-P05 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30424 4 15 1 DAC01-P17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30424 4 16 1 DAC01-P17 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30425 4 17 1 DAC02-D05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30425 4 18 1 DAC02-D05 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30426 4 19 1 DAC02-D17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30426 4 20 1 DAC02-D17 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30427 4 21 1 DAC02-H05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30427 4 22 1 DAC02-H05 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30428 4 23 1 DAC02-H17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30428 4 24 1 DAC02-H17 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30429 4 25 1 DAC02-L05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30429 4 26 1 DAC02-L05 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30430 4 1 2 DAC02-L17 N/A CG9075 (00001-00239) CDMC30430 4 2 2 DAC02-L17 N/A CG9075 (00001-00239) CDMC30431 4 3 2 DAC02-P05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30431 4 4 2 DAC02-P05 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30432 4 5 2 DAC02-P17 AutoBlank AutoBlank CDMC30432 4 6 2 DAC02-P17 AutoBlank AutoBlank CDMC30433 4 7 2 DAC03-D05 3-CG3878-RA_2 CG3878 GATTTGGTTGCCTGCAGAAGTCCTTTGCATCGCGTTGGATCGCCAAATCAGGTTGACTGGCACTC 65 FBgn0031025 CDMC30433 4 8 2 DAC03-D05 3-CG3878-RA_2 CG3878 GATTTGGTTGCCTGCAGAAGTCCTTTGCATCGCGTTGGATCGCCAAATCAGGTTGACTGGCACTC 65 FBgn0031025 CDMC30434 4 9 2 DAC03-D17 22-CG3898-RA_1 CG3898 GGTTTGGATCAAAACGAATCGGACAGGATTTCCGCTGTCATCGGGACCATAGATGCGTCCGCCAG 65 FBan0003898 FBgn0030070 CG3898 X X CG3898 CG3898 CDMC30434 4 10 2 DAC03-D17 22-CG3898-RA_1 CG3898 GGTTTGGATCAAAACGAATCGGACAGGATTTCCGCTGTCATCGGGACCATAGATGCGTCCGCCAG 65 FBan0003898 FBgn0030070 CG3898 X X CG3898 CG3898 CDMC30435 4 11 2 DAC03-H05 24-CG40002-RA_2 CG40002 GCTTTGACTTATTTGTTACATAATACTCGGTCCACATTGAGTTTTTTTTACCCAATCAACATGTA 65 FBgn0058002 CG40002 CG40002 CG40002 CDMC30435 4 12 2 DAC03-H05 24-CG40002-RA_2 CG40002 GCTTTGACTTATTTGTTACATAATACTCGGTCCACATTGAGTTTTTTTTACCCAATCAACATGTA 65 FBgn0058002 CG40002 CG40002 CG40002 CDMC30436 4 13 2 DAC03-H17 23-CG40088-RA_1 CG40088 GAATTGGAGAATATAATAAAAAAAAGATCGAATTGTGGTCATTTCGCTTTGTGGACCGTATGGGT 65 FBgn0058088 CG40088 CG40088 CG40088 CDMC30436 4 14 2 DAC03-H17 23-CG40088-RA_1 CG40088 GAATTGGAGAATATAATAAAAAAAAGATCGAATTGTGGTCATTTCGCTTTGTGGACCGTATGGGT 65 FBgn0058088 CG40088 CG40088 CG40088 CDMC30437 4 15 2 DAC03-L05 1-CG40230-RB_3 CG40230 CACAGGGGTCGAACGGTAGCTATGCGGACGTCGGACAGGCACAAATAAGATGCACCGTGAACTAA 65 FBgn0058230 CG40230 CG40230 CG40230 CDMC30437 4 16 2 DAC03-L05 1-CG40230-RB_3 CG40230 CACAGGGGTCGAACGGTAGCTATGCGGACGTCGGACAGGCACAAATAAGATGCACCGTGAACTAA 65 FBgn0058230 CG40230 CG40230 CG40230 CDMC30438 4 17 2 DAC03-L17 21-CG40315-RA_1 CG40315 CTTCTTCCTTCCTTCCTTCCTTCGCGAGTTATCAGTGTGGACACGAGGGGGAAGCCAGTGGGGCG 65 FBgn0058315 CG40315 CG40315 CG40315 CDMC30438 4 18 2 DAC03-L17 21-CG40315-RA_1 CG40315 CTTCTTCCTTCCTTCCTTCCTTCGCGAGTTATCAGTGTGGACACGAGGGGGAAGCCAGTGGGGCG 65 FBgn0058315 CG40315 CG40315 CG40315 CDMC30439 4 19 2 DAC03-P05 24-CG40496-RA_4 CG40496 GCTGGAGAGAGCGAAATTTAAATTACGAAAATTGAGTTCAAACTTTTCTCGCCTTTATAAATCCT 65 FBgn0069971 CG40496 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40496 CG40496 CDMC30439 4 20 2 DAC03-P05 24-CG40496-RA_4 CG40496 GCTGGAGAGAGCGAAATTTAAATTACGAAAATTGAGTTCAAACTTTTCTCGCCTTTATAAATCCT 65 FBgn0069971 CG40496 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40496 CG40496 CDMC30440 4 21 2 DAC03-P17 6-CG4080-RA_1 CG4080 AAGCAGCGGAATTCCCATCAGCTTGTGATCTCCTCATCCTTTGACCGCGGAGTGAATGGGGTCAG 65 FBan0004080 FBgn0035983 CG4080 3 3L CG4080 CG4080 CDMC30440 4 22 2 DAC03-P17 6-CG4080-RA_1 CG4080 AAGCAGCGGAATTCCCATCAGCTTGTGATCTCCTCATCCTTTGACCGCGGAGTGAATGGGGTCAG 65 FBan0004080 FBgn0035983 CG4080 3 3L CG4080 CG4080 CDMC30441 4 23 2 DAC04-D05 2-CG31528-RA_1 CG31528 ACGCGCTCTGCTCATATCTCTGGGCAATGTTGATTGCGCTGTAAGACTACTGGACCACTGGAATCGGTT 69 FBan0031528 FBgn0051528 CG31528 3 3R CG31528 CG31528 "BcDNA:GH26112, BEST:GH26112" CDMC30441 4 24 2 DAC04-D05 2-CG31528-RA_1 CG31528 ACGCGCTCTGCTCATATCTCTGGGCAATGTTGATTGCGCTGTAAGACTACTGGACCACTGGAATCGGTT 69 FBan0031528 FBgn0051528 CG31528 3 3R CG31528 CG31528 "BcDNA:GH26112, BEST:GH26112" CDMC30442 4 25 2 DAC04-D17 12-CG31536-RA_1 CG31536 AGATGCCGTTCAGAAGGAGTTCGTCTTCAAGCTTTCCTTTAAGAACCACGTCTACTTCTTCCGCGCGGA 69 FBan0031536 FBgn0051536 Cdep 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; Rho guanyl-nucleotide exchange factor activity; GO:0005089; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005089; ; GO:0003779 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Cdep Cdep "CG1283, CG31536, CG2008, CG1283, CG1283, CG31536, CG2008, i23, CDEP, BcDNA:AT26639, BcDNA:RH50880" CDMC30442 4 26 2 DAC04-D17 12-CG31536-RA_1 CG31536 AGATGCCGTTCAGAAGGAGTTCGTCTTCAAGCTTTCCTTTAAGAACCACGTCTACTTCTTCCGCGCGGA 69 FBan0031536 FBgn0051536 Cdep 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; Rho guanyl-nucleotide exchange factor activity; GO:0005089; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005089; ; GO:0003779 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Cdep Cdep "CG1283, CG31536, CG2008, CG1283, CG1283, CG31536, CG2008, i23, CDEP, BcDNA:AT26639, BcDNA:RH50880" CDMC30443 4 1 3 DAC04-H05 14-CG31605-RF_1 CG31605 CCTCAACCCTGCCCCTCTAGTTGCGCACTTTCTGTTTTTTCTTGTCGCCTCTGTTGATTTTGCTGTGTA 69 FBgn0051605 CDMC30443 4 2 3 DAC04-H05 14-CG31605-RF_1 CG31605 CCTCAACCCTGCCCCTCTAGTTGCGCACTTTCTGTTTTTTCTTGTCGCCTCTGTTGATTTTGCTGTGTA 69 FBgn0051605 CDMC30444 4 3 3 DAC04-H17 13-CG31620-RA_1 CG31620 ACGGTATTGCCATCCATCTATGTTGCTCTAAGCGGTAGCCTTCTCTACTTTTGGTCCTCCCTCCTGTCA 69 FBan0031620 FBgn0041245 Gr39b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr39b Gustatory receptor 39b "CG31620, 39D.1, Gustatory receptor 39D.1, Gr39D1, 39D1, GR39D.1, Gustatory receptor 39b" CDMC30444 4 4 3 DAC04-H17 13-CG31620-RA_1 CG31620 ACGGTATTGCCATCCATCTATGTTGCTCTAAGCGGTAGCCTTCTCTACTTTTGGTCCTCCCTCCTGTCA 69 FBan0031620 FBgn0041245 Gr39b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr39b Gustatory receptor 39b "CG31620, 39D.1, Gustatory receptor 39D.1, Gr39D1, 39D1, GR39D.1, Gustatory receptor 39b" CDMC30445 4 5 3 DAC04-L05 14-CG31642-RA_2 CG31642 TGGGAAACTATTGCTGTATCCTGTTAAGACCAAGGAATTGATGGAACGCTTCTACAGGGGTCTCGCCGA 69 FBan0031642 FBgn0051642 CG31642 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31642 CG31642 "CG5981, CG5981, CG5981, CG5981" CDMC30445 4 6 3 DAC04-L05 14-CG31642-RA_2 CG31642 TGGGAAACTATTGCTGTATCCTGTTAAGACCAAGGAATTGATGGAACGCTTCTACAGGGGTCTCGCCGA 69 FBan0031642 FBgn0051642 CG31642 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31642 CG31642 "CG5981, CG5981, CG5981, CG5981" CDMC30446 4 7 3 DAC04-L17 2-CG3164-RC_1 CG3164 TGGTCACTACCAATGAAAGGGGAGATGCCATGATCGATGTGGAGAAGTCCGTAAACTGCACCACTGCCT 69 FBan0003164 FBgn0025683 CG3164 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG3164 CG3164 "CK02656, BEST:CK02656" CDMC30446 4 8 3 DAC04-L17 2-CG3164-RC_1 CG3164 TGGTCACTACCAATGAAAGGGGAGATGCCATGATCGATGTGGAGAAGTCCGTAAACTGCACCACTGCCT 69 FBan0003164 FBgn0025683 CG3164 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG3164 CG3164 "CK02656, BEST:CK02656" CDMC30447 4 9 3 DAC04-P05 14-CG31678-RA_1 CG31678 AGCGCGCCCTTAACAACCTCTTTCGCAAGGCCTTCGATTTTTAACTAGAACCCAGTGTTTCGACTTGTT 69 FBan0031678 FBgn0051678 CG31678 2 2L electron transport; GO:0006118 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG31678 CG31678 "CG17465, CG17466, 38D.30" CDMC30447 4 10 3 DAC04-P05 14-CG31678-RA_1 CG31678 AGCGCGCCCTTAACAACCTCTTTCGCAAGGCCTTCGATTTTTAACTAGAACCCAGTGTTTCGACTTGTT 69 FBan0031678 FBgn0051678 CG31678 2 2L electron transport; GO:0006118 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG31678 CG31678 "CG17465, CG17466, 38D.30" CDMC30448 4 11 3 DAC04-P17 3-CG31686-RA_1 CG31686 TGTCCACAGAGGCAACCAGTGAACCATCCACTGTGACTTCTGACGTGCCCACACTAACTTCACCATCAT 69 FBan0031686 FBgn0051686 CG31686 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31686 CG31686 CDMC30448 4 12 3 DAC04-P17 3-CG31686-RA_1 CG31686 TGTCCACAGAGGCAACCAGTGAACCATCCACTGTGACTTCTGACGTGCCCACACTAACTTCACCATCAT 69 FBan0031686 FBgn0051686 CG31686 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31686 CG31686 CDMC30449 4 13 3 DAC05-D05 16-CG5998-RA_1 CG5998 GGTGGGGCACTTAAACATCATGGGTCAGAAGATACGACTGAACGATCGGGAATTAGCGGCCAACAAAGT 69 FBan0005998 FBgn0036751 Adgf-B 3 3L protein biosynthesis; GO:0006412; purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 intracellular; GO:0005622; ribosome; GO:0005840 Adgf-B Adenosine deaminase-related growth factor B "CG5998, CG5998, ADGF-B, adgfb" CDMC30449 4 14 3 DAC05-D05 16-CG5998-RA_1 CG5998 GGTGGGGCACTTAAACATCATGGGTCAGAAGATACGACTGAACGATCGGGAATTAGCGGCCAACAAAGT 69 FBan0005998 FBgn0036751 Adgf-B 3 3L protein biosynthesis; GO:0006412; purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 intracellular; GO:0005622; ribosome; GO:0005840 Adgf-B Adenosine deaminase-related growth factor B "CG5998, CG5998, ADGF-B, adgfb" CDMC30450 4 15 3 DAC05-D17 15-CG6009-RA_2 CG6009 TGTCTAACTACGCCCATGCAATCGGCAGCTGTTATTGATTAGAGGAGCGATAAAAGTCCAGCCACCTCA 69 FBan0006009 FBgn0015781 P5cr 3 3R proline biosynthesis; GO:0006561 pyrroline-5-carboxylate reductase activity; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2 P5cr Pyrroline 5-carboyxlate reductase "CG6009, P5CR, Pyrroline 5-carboyxlate reductase" CDMC30450 4 16 3 DAC05-D17 15-CG6009-RA_2 CG6009 TGTCTAACTACGCCCATGCAATCGGCAGCTGTTATTGATTAGAGGAGCGATAAAAGTCCAGCCACCTCA 69 FBan0006009 FBgn0015781 P5cr 3 3R proline biosynthesis; GO:0006561 pyrroline-5-carboxylate reductase activity; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2; ; GO:0004735 ; EC:1.5.1.2 P5cr Pyrroline 5-carboyxlate reductase "CG6009, P5CR, Pyrroline 5-carboyxlate reductase" CDMC30451 4 17 3 DAC05-H05 17-CG6044-RB_1 CG6044 TGCACACCACGTCGTTCTCTGGTACAAGGAGAAGGTACAGGTATCCAGCGGAATGAATATATTCAACCA 69 FBan0006044 FBgn0034725 CG6044 2 2R CG6044 CG6044 BcDNA:RH44966 CDMC30451 4 18 3 DAC05-H05 17-CG6044-RB_1 CG6044 TGCACACCACGTCGTTCTCTGGTACAAGGAGAAGGTACAGGTATCCAGCGGAATGAATATATTCAACCA 69 FBan0006044 FBgn0034725 CG6044 2 2R CG6044 CG6044 BcDNA:RH44966 CDMC30452 4 19 3 DAC05-H17 3-CG6054-RA_2 CG6054 CATGGATCGCCAGATGAGCGTCTTCGAACTGTTTCCCGAAACGCTGCTAAACCTACAGGACGATCTGGA 69 FBan0006054 FBgn0005355 Su(fu) 3 3R cell-cell signaling; GO:0007267; mesoderm development; GO:0007498; negative regulation of protein import into nucleus; GO:0042308; negative regulation of smoothened signaling pathway; GO:0045879; protein amino acid phosphorylation; GO:0006468; skeletal development; GO:0001501; smoothened signaling pathway; GO:0007224 kinase inhibitor activity; GO:0019210; ; GO:0019210 Hedgehog signaling complex; GO:0035301; colocalizes_with Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737 Su(fu) Suppressor of fused "CG6054, su(fu), Sufu, SuFu, suppressor of fused, Su(Fu)" CDMC30452 4 20 3 DAC05-H17 3-CG6054-RA_2 CG6054 CATGGATCGCCAGATGAGCGTCTTCGAACTGTTTCCCGAAACGCTGCTAAACCTACAGGACGATCTGGA 69 FBan0006054 FBgn0005355 Su(fu) 3 3R cell-cell signaling; GO:0007267; mesoderm development; GO:0007498; negative regulation of protein import into nucleus; GO:0042308; negative regulation of smoothened signaling pathway; GO:0045879; protein amino acid phosphorylation; GO:0006468; skeletal development; GO:0001501; smoothened signaling pathway; GO:0007224 kinase inhibitor activity; GO:0019210; ; GO:0019210 Hedgehog signaling complex; GO:0035301; colocalizes_with Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737 Su(fu) Suppressor of fused "CG6054, su(fu), Sufu, SuFu, suppressor of fused, Su(Fu)" CDMC30453 4 21 3 DAC05-L05 23-CG6096-RA_1 CG6096 CAGATCAGCTCAGCACATTTCTACAAATCTTCCAAAACAAAAAACACATTACAAAATGGCACCACAGAG 69 FBan0006096 FBgn0002631 HLHm5 3 3R cell fate commitment; GO:0045165; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; ; GO:0016566 nucleus; GO:0005634 HLHm5 E(spl) region transcript m5 "CG6096, m5, E(spl)m5, HLH-m5, E(spl)-m5, E(spl)M5, E(spl) transcription unit m5" CDMC30453 4 22 3 DAC05-L05 23-CG6096-RA_1 CG6096 CAGATCAGCTCAGCACATTTCTACAAATCTTCCAAAACAAAAAACACATTACAAAATGGCACCACAGAG 69 FBan0006096 FBgn0002631 HLHm5 3 3R cell fate commitment; GO:0045165; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; ; GO:0016566 nucleus; GO:0005634 HLHm5 E(spl) region transcript m5 "CG6096, m5, E(spl)m5, HLH-m5, E(spl)-m5, E(spl)M5, E(spl) transcription unit m5" CDMC30454 4 23 3 DAC05-L17 22-CG6114-RA_1 CG6114 TCACCACCAAACCCAACTAACTCATTTTAACTGCTTAGCACTGTGCAATGAGCAGCGAATATTTGCGCC 69 FBan0006114 FBgn0036544 CG6114 3 3L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG6114 CG6114 SNF1-related CDMC30454 4 24 3 DAC05-L17 22-CG6114-RA_1 CG6114 TCACCACCAAACCCAACTAACTCATTTTAACTGCTTAGCACTGTGCAATGAGCAGCGAATATTTGCGCC 69 FBan0006114 FBgn0036544 CG6114 3 3L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG6114 CG6114 SNF1-related CDMC30455 4 25 3 DAC05-P05 2-CG6145-RA_1 CG6145 AGGAGAGCTCCAAGTTCCAAAAAGTGCATCAACAGTACGCCGGAGTAAGAGCGCGTTTCCTGGATCTCC 69 FBan0006145 FBgn0033853 CG6145 2 2R CG6145 CG6145 CT19307 CDMC30455 4 26 3 DAC05-P05 2-CG6145-RA_1 CG6145 AGGAGAGCTCCAAGTTCCAAAAAGTGCATCAACAGTACGCCGGAGTAAGAGCGCGTTTCCTGGATCTCC 69 FBan0006145 FBgn0033853 CG6145 2 2R CG6145 CG6145 CT19307 CDMC30456 4 1 4 DAC05-P17 17-CG6155-RA_1 CG6155 CCCCCCCCTAAACCAATTTACATGGCGTGTGTCTCTCAATTGTTTGCAATTTGTTTTCCGCTGCAAAAT 69 FBan0006155 FBgn0014877 Roe1 2 2R protein folding; GO:0006457; protein targeting to mitochondrion; GO:0006626 protein homodimerization activity; GO:0042803; unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0051082; ; GO:0051082; adenyl-nucleotide exchange factor activity; GO:0000774; ; GO:0000774; ; GO:0051087; ; GO:0042803 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Roe1 Roe1 "CG6155, droe1, DROE1, Droe1, BcDNA:GM03203" CDMC30456 4 2 4 DAC05-P17 17-CG6155-RA_1 CG6155 CCCCCCCCTAAACCAATTTACATGGCGTGTGTCTCTCAATTGTTTGCAATTTGTTTTCCGCTGCAAAAT 69 FBan0006155 FBgn0014877 Roe1 2 2R protein folding; GO:0006457; protein targeting to mitochondrion; GO:0006626 protein homodimerization activity; GO:0042803; unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0051082; ; GO:0051082; adenyl-nucleotide exchange factor activity; GO:0000774; ; GO:0000774; ; GO:0051087; ; GO:0042803 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 Roe1 Roe1 "CG6155, droe1, DROE1, Droe1, BcDNA:GM03203" CDMC30457 4 3 4 DAC06-D05 8-CG11555-RA_1 CG11555 AGCCCTCCACGGAAAGAAAACAACAGCTCTCCACGGACGTTGAGAACTTCACTTTTAAGGAGCGGAACT 69 FBan0011555 FBgn0031241 CG11555 2 2L CG11555 CG11555 CDMC30457 4 4 4 DAC06-D05 8-CG11555-RA_1 CG11555 AGCCCTCCACGGAAAGAAAACAACAGCTCTCCACGGACGTTGAGAACTTCACTTTTAAGGAGCGGAACT 69 FBan0011555 FBgn0031241 CG11555 2 2L CG11555 CG11555 CDMC30458 4 5 4 DAC06-D17 2-CG11567-RA_1 CG11567 GGGCGAGTCGATTCTCTACTTCGGTTGCCGTAAGCGCAGTGAGGACTACATCTACGAATCCGAGTTGGA 69 FBan0011567 FBgn0015623 Cpr 2 2L electron transport; GO:0006118 NADPH-hemoprotein reductase activity; GO:0003958 ; EC:1.6.2.4; ; GO:0003958 ; EC:1.6.2.4; ; GO:0003958 ; EC:1.6.2.4; FMN binding; GO:0010181; ; GO:0010181 endoplasmic reticulum; GO:0005783 Cpr Cytochrome P450 reductase "CG11567, P450, CPR, NCPR, P450 reductase, cpr, DmCPR, DMR, NADPH-cytochrome P450 oxidoreductase" CDMC30458 4 6 4 DAC06-D17 2-CG11567-RA_1 CG11567 GGGCGAGTCGATTCTCTACTTCGGTTGCCGTAAGCGCAGTGAGGACTACATCTACGAATCCGAGTTGGA 69 FBan0011567 FBgn0015623 Cpr 2 2L electron transport; GO:0006118 NADPH-hemoprotein reductase activity; GO:0003958 ; EC:1.6.2.4; ; GO:0003958 ; EC:1.6.2.4; ; GO:0003958 ; EC:1.6.2.4; FMN binding; GO:0010181; ; GO:0010181 endoplasmic reticulum; GO:0005783 Cpr Cytochrome P450 reductase "CG11567, P450, CPR, NCPR, P450 reductase, cpr, DmCPR, DMR, NADPH-cytochrome P450 oxidoreductase" CDMC30459 4 7 4 DAC06-H05 22-CG11614-RA_2 CG11614 AGGGCCAGAAACAGTGGGGTTGGTTAAGTGAGTTTGGAGTTTGGTTAACCAAAGACAAATTGAGAACGA 69 FBan0011614 FBgn0002945 nkd 3 3L frizzled signaling pathway; GO:0007222 nkd naked cuticle "CG11614, CG18224, naked, Nkd, Naked" CDMC30459 4 8 4 DAC06-H05 22-CG11614-RA_2 CG11614 AGGGCCAGAAACAGTGGGGTTGGTTAAGTGAGTTTGGAGTTTGGTTAACCAAAGACAAATTGAGAACGA 69 FBan0011614 FBgn0002945 nkd 3 3L frizzled signaling pathway; GO:0007222 nkd naked cuticle "CG11614, CG18224, naked, Nkd, Naked" CDMC30460 4 9 4 DAC06-H17 11-CG11626-RA_3 CG11626 GGCTGACTTGGCTCACTTCATACGCCACCAAAAGTCAAATGACCCCGAAATGGAGGACTCCAAAGTCAT 69 FBan0011626 FBgn0038705 CG11626 3 3R proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG11626 CG11626 CDMC30460 4 10 4 DAC06-H17 11-CG11626-RA_3 CG11626 GGCTGACTTGGCTCACTTCATACGCCACCAAAAGTCAAATGACCCCGAAATGGAGGACTCCAAAGTCAT 69 FBan0011626 FBgn0038705 CG11626 3 3R proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG11626 CG11626 CDMC30461 4 11 4 DAC06-L05 23-CG11663-RA_1 CG11663 GCAAACCGTGCACTTTATCGAAGTTTTATCCATTAGATTCTTGAACCGATAATGCAATCGAAAATTCTT 69 FBan0011663 FBgn0029539 CG11663 X X CG11663 CG11663 BcDNA:AT05678 CDMC30461 4 12 4 DAC06-L05 23-CG11663-RA_1 CG11663 GCAAACCGTGCACTTTATCGAAGTTTTATCCATTAGATTCTTGAACCGATAATGCAATCGAAAATTCTT 69 FBan0011663 FBgn0029539 CG11663 X X CG11663 CG11663 BcDNA:AT05678 CDMC30462 4 13 4 DAC06-L17 23-CG11671-RA_3 CG11671 TGCACTCGAAGCAGTCAAGTCCTATATCACTGATCGTATGGGAATGACCATCGTTGATTAGGCATTAAT 69 FBan0011671 FBgn0037562 CG11671 3 3R CG11671 CG11671 BcDNA:GM23845 CDMC30462 4 14 4 DAC06-L17 23-CG11671-RA_3 CG11671 TGCACTCGAAGCAGTCAAGTCCTATATCACTGATCGTATGGGAATGACCATCGTTGATTAGGCATTAAT 69 FBan0011671 FBgn0037562 CG11671 3 3R CG11671 CG11671 BcDNA:GM23845 CDMC30463 4 15 4 DAC06-P05 18-CG11727-RA_1 CG11727 CGCGGAAGTACGGAGCTCTCCACATAACCTACAGATGGATCAGATCTAGCATATCCAAACCAACCAACA 69 FBan0011727 FBgn0030299 CG11727 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG11727 CG11727 "BcDNA:LD11130, BcDNA:GH08923" CDMC30463 4 16 4 DAC06-P05 18-CG11727-RA_1 CG11727 CGCGGAAGTACGGAGCTCTCCACATAACCTACAGATGGATCAGATCTAGCATATCCAAACCAACCAACA 69 FBan0011727 FBgn0030299 CG11727 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG11727 CG11727 "BcDNA:LD11130, BcDNA:GH08923" CDMC30464 4 17 4 DAC06-P17 10-CG11742-RA_1 CG11742 CGACAACCTGGTAATGCTTGTGCTTTTCCTGTTTTGTGCCATGGTTCAGGTCTTCATGATTGCCACCCA 69 FBan0011742 FBgn0037594 Or85d 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85d Odorant receptor 85d "CG11742, 85.2, 85A.2, DOR114, 85d" CDMC30464 4 18 4 DAC06-P17 10-CG11742-RA_1 CG11742 CGACAACCTGGTAATGCTTGTGCTTTTCCTGTTTTGTGCCATGGTTCAGGTCTTCATGATTGCCACCCA 69 FBan0011742 FBgn0037594 Or85d 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85d Odorant receptor 85d "CG11742, 85.2, 85A.2, DOR114, 85d" CDMC30465 4 19 4 DAC07-D05 2-CG15044-RA_1 CG15044 TCTCTACTATACGGACATAACGCCCGTGACCGACGAAACACGCTACACCACCCTCAATCCGGACG 65 FBan0015044 FBgn0030928 CG15044 X X CG15044 CG15044 BcDNA:RE30049 CDMC30465 4 20 4 DAC07-D05 2-CG15044-RA_1 CG15044 TCTCTACTATACGGACATAACGCCCGTGACCGACGAAACACGCTACACCACCCTCAATCCGGACG 65 FBan0015044 FBgn0030928 CG15044 X X CG15044 CG15044 BcDNA:RE30049 CDMC30466 4 21 4 DAC07-D17 15-CG15061-RA_1 CG15061 GTGTACTCCCCTCGGGATGAGCATGATCGTGAAGATCAGCTCCCAAGCAGCTCCCTCTTTGGCTG 65 FBan0015061 FBgn0030911 CG15061 X X CG15061 CG15061 CDMC30466 4 22 4 DAC07-D17 15-CG15061-RA_1 CG15061 GTGTACTCCCCTCGGGATGAGCATGATCGTGAAGATCAGCTCCCAAGCAGCTCCCTCTTTGGCTG 65 FBan0015061 FBgn0030911 CG15061 X X CG15061 CG15061 CDMC30467 4 23 4 DAC07-H05 3-CG15153-RA_3 CG15153 GGAGCGGCAGACAACGAGATAAGCTACAAGATCACGCACTTTGAGCTCTCGAAGGCGAACTCCGA 65 FBan0015153 FBgn0032663 CG15153 2 2L CG15153 CG15153 CDMC30467 4 24 4 DAC07-H05 3-CG15153-RA_3 CG15153 GGAGCGGCAGACAACGAGATAAGCTACAAGATCACGCACTTTGAGCTCTCGAAGGCGAACTCCGA 65 FBan0015153 FBgn0032663 CG15153 2 2L CG15153 CG15153 CDMC30468 4 25 4 DAC07-H17 1-CG15170-RA_1 CG15170 GCAGAAACCCCCATCATCGGAGCGACTTACTCAAAGACTTGCTCAACGAACCTGTGCAATGCGGG 65 FBan0015170 FBgn0032733 CG15170 2 2L CG15170 CG15170 CDMC30468 4 26 4 DAC07-H17 1-CG15170-RA_1 CG15170 GCAGAAACCCCCATCATCGGAGCGACTTACTCAAAGACTTGCTCAACGAACCTGTGCAATGCGGG 65 FBan0015170 FBgn0032733 CG15170 2 2L CG15170 CG15170 CDMC30469 4 1 5 DAC07-L05 3-CG15252-RA_2 CG15252 CCTGGAGGCCTAGATGTGCAAGGTCTGATTCAAACGGGAACCTCGCTGATCTCTGGTCTTCTGGG 65 FBan0015252 FBgn0030167 CG15252 X X CG15252 CG15252 CDMC30469 4 2 5 DAC07-L05 3-CG15252-RA_2 CG15252 CCTGGAGGCCTAGATGTGCAAGGTCTGATTCAAACGGGAACCTCGCTGATCTCTGGTCTTCTGGG 65 FBan0015252 FBgn0030167 CG15252 X X CG15252 CG15252 CDMC30470 4 3 5 DAC07-L17 24-CG1529-RA_3 CG1529 TGTTCGCTTACTTCGTATTTTATACGTTTTATATGCTCGCTTACTCCATATTTTAAGTGCCTAAT 65 FBan0001529 FBgn0031144 CG1529 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1529 CG1529 CDMC30470 4 4 5 DAC07-L17 24-CG1529-RA_3 CG1529 TGTTCGCTTACTTCGTATTTTATACGTTTTATATGCTCGCTTACTCCATATTTTAAGTGCCTAAT 65 FBan0001529 FBgn0031144 CG1529 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1529 CG1529 CDMC30471 4 5 5 DAC07-P05 3-CG15374-RA_3 CG15374 CAGGGATCCCGTATCCAGAAATCCTTCGGATTTGGCTGGTGGCAAAACCTGCGTTAGTTCCGCTC 65 FBan0015374 FBgn0037152 CG15374 3 3L CG15374 CG15374 CDMC30471 4 6 5 DAC07-P05 3-CG15374-RA_3 CG15374 CAGGGATCCCGTATCCAGAAATCCTTCGGATTTGGCTGGTGGCAAAACCTGCGTTAGTTCCGCTC 65 FBan0015374 FBgn0037152 CG15374 3 3L CG15374 CG15374 CDMC30472 4 7 5 DAC07-P17 1-CG15383-RA_1 CG15383 TCGTCCAAGTCTTGGGATGTGGATGTGGATGTGGATGTCTTGCTGTCAGTTTGTGCGCCTTCTGC 65 FBan0015383 FBgn0031394 CG15383 2 2L CG15383 CG15383 CDMC30472 4 8 5 DAC07-P17 1-CG15383-RA_1 CG15383 TCGTCCAAGTCTTGGGATGTGGATGTGGATGTGGATGTCTTGCTGTCAGTTTGTGCGCCTTCTGC 65 FBan0015383 FBgn0031394 CG15383 2 2L CG15383 CG15383 CDMC30473 4 9 5 DAC08-D05 24-CG14634-RA_2 CG14634 CATCTTCGGCACTTCTACTTATTATTTCTAGCCACAGAAATATGTGCTTTCTCTTCCCACTTGGCT 66 FBan0014634 FBgn0040892 CG14634 X X CG14634 CG14634 CDMC30473 4 10 5 DAC08-D05 24-CG14634-RA_2 CG14634 CATCTTCGGCACTTCTACTTATTATTTCTAGCCACAGAAATATGTGCTTTCTCTTCCCACTTGGCT 66 FBan0014634 FBgn0040892 CG14634 X X CG14634 CG14634 CDMC30474 4 11 5 DAC08-D17 2-CG14685-RD_1 CG14685 CCACTCCCAGAACTGTACTGCAAATTGGAAGAGAGGCTCCCCAAAATGAAAGAGAACCCGGCTCCC 66 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC30474 4 12 5 DAC08-D17 2-CG14685-RD_1 CG14685 CCACTCCCAGAACTGTACTGCAAATTGGAAGAGAGGCTCCCCAAAATGAAAGAGAACCCGGCTCCC 66 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC30475 4 13 5 DAC08-H05 17-CG14915-RA_1 CG14915 TGTCGAGCTCTAAACTTGCCCTTCTTATTCTGGTCATTGCCTGTTTGGTCCTTATCGCATGGGCAC 66 FBan0014915 FBgn0032335 CG14915 2 2L CG14915 CG14915 CDMC30475 4 14 5 DAC08-H05 17-CG14915-RA_1 CG14915 TGTCGAGCTCTAAACTTGCCCTTCTTATTCTGGTCATTGCCTGTTTGGTCCTTATCGCATGGGCAC 66 FBan0014915 FBgn0032335 CG14915 2 2L CG14915 CG14915 CDMC30476 4 15 5 DAC08-H17 3-CG15001-RA_1 CG15001 ACACAGTCACAGCTGCTGACCACCAGTCTGGAAATGCCCAAGACGGAGGATCTGTACAATCTGTCC 66 FBgn0035503 CDMC30476 4 16 5 DAC08-H17 3-CG15001-RA_1 CG15001 ACACAGTCACAGCTGCTGACCACCAGTCTGGAAATGCCCAAGACGGAGGATCTGTACAATCTGTCC 66 FBgn0035503 CDMC30477 4 17 5 DAC08-L05 15-CG15455-RA_1 CG15455 GGCAAGAGCTTCACACTGACGATTGTCATCTCAACGAACCCCATCCAGATAGCCACCTACACCAAG 66 FBan0015455 FBgn0031121 CG15455 X X "cellular physiological process; GO:0050875; regulation of transcription, DNA-dependent; GO:0006355" ATP binding; GO:0005524; ; GO:0005524; NOT transcription factor activity; GO:0003700; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 NOT nucleus; GO:0005634; nucleus; GO:0005634 CG15455 CG15455 CDMC30477 4 18 5 DAC08-L05 15-CG15455-RA_1 CG15455 GGCAAGAGCTTCACACTGACGATTGTCATCTCAACGAACCCCATCCAGATAGCCACCTACACCAAG 66 FBan0015455 FBgn0031121 CG15455 X X "cellular physiological process; GO:0050875; regulation of transcription, DNA-dependent; GO:0006355" ATP binding; GO:0005524; ; GO:0005524; NOT transcription factor activity; GO:0003700; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 NOT nucleus; GO:0005634; nucleus; GO:0005634 CG15455 CG15455 CDMC30478 4 19 5 DAC08-L17 3-CG15623-RA_1 CG15623 TCTGGAGGAGCTAACTGCCTTCGATGGCTCGAGTCCCAGTCTACCCATTTACACCGCTCTGAATGG 66 FBan0015623 FBgn0031367 CG15623 2 2L CG15623 CG15623 CDMC30478 4 20 5 DAC08-L17 3-CG15623-RA_1 CG15623 TCTGGAGGAGCTAACTGCCTTCGATGGCTCGAGTCCCAGTCTACCCATTTACACCGCTCTGAATGG 66 FBan0015623 FBgn0031367 CG15623 2 2L CG15623 CG15623 CDMC30479 4 21 5 DAC08-P05 3-CG17161-RA_1 CG17161 CAGGAGGCTCGGCTCAGTTACTCCTTCTCGCAACCAGCTTTGCTTGATGATCTCCTACTGGCTACC 66 FBan0017161 FBgn0011598 grp 2 2L DNA damage checkpoint; GO:0000077; cell cycle; GO:0007049; cell cycle arrest; GO:0007050; cell cycle checkpoint; GO:0000075; cellularization (sensu Metazoa); GO:0009796; embryonic development (sensu Insecta); GO:0001700; female meiosis chromosome segregation; GO:0016321; imaginal disc development; GO:0007444; intracellular signaling cascade; GO:0007242; mitotic checkpoint; GO:0007093; protein amino acid phosphorylation; GO:0006468; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; regulation of proteolysis; GO:0030162; response to radiation; GO:0009314 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 nucleus; GO:0005634 grp grapes "CG17161, CG17161, CG17161, 1C, lemp, last empress, dChk1, CHK1, Chk1, CHK1/Grapes, Pk36A, Pk?1, Checkpoint kinase 1, Protein kinase-like 36A, grapes" CDMC30479 4 22 5 DAC08-P05 3-CG17161-RA_1 CG17161 CAGGAGGCTCGGCTCAGTTACTCCTTCTCGCAACCAGCTTTGCTTGATGATCTCCTACTGGCTACC 66 FBan0017161 FBgn0011598 grp 2 2L DNA damage checkpoint; GO:0000077; cell cycle; GO:0007049; cell cycle arrest; GO:0007050; cell cycle checkpoint; GO:0000075; cellularization (sensu Metazoa); GO:0009796; embryonic development (sensu Insecta); GO:0001700; female meiosis chromosome segregation; GO:0016321; imaginal disc development; GO:0007444; intracellular signaling cascade; GO:0007242; mitotic checkpoint; GO:0007093; protein amino acid phosphorylation; GO:0006468; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; regulation of proteolysis; GO:0030162; response to radiation; GO:0009314 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 nucleus; GO:0005634 grp grapes "CG17161, CG17161, CG17161, 1C, lemp, last empress, dChk1, CHK1, Chk1, CHK1/Grapes, Pk36A, Pk?1, Checkpoint kinase 1, Protein kinase-like 36A, grapes" CDMC30480 4 23 5 DAC08-P17 AutoBlank AutoBlank CDMC30480 4 24 5 DAC08-P17 AutoBlank AutoBlank CDMC30481 4 25 5 DAC09-D06 23-CG14113-RA_2 CG14113 ACGATCAAAGCGCAATTTTAATTATTCGAAAATATGTAAACAAGTTTCGCAATAGTTGGCAATGGCTAT 69 FBan0014113 FBgn0040814 CG14113 3 3L CG14113 CG14113 CDMC30481 4 26 5 DAC09-D06 23-CG14113-RA_2 CG14113 ACGATCAAAGCGCAATTTTAATTATTCGAAAATATGTAAACAAGTTTCGCAATAGTTGGCAATGGCTAT 69 FBan0014113 FBgn0040814 CG14113 3 3L CG14113 CG14113 CDMC30482 4 1 6 DAC09-D18 9-CG1411-RC_1 CG1411 GGGCCGGGACCGTAAATGTCAGAGGGAACCATTGTTCCGCAAATTATTCGAGAATGTTGGAAGGCACAT 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC30482 4 2 6 DAC09-D18 9-CG1411-RC_1 CG1411 GGGCCGGGACCGTAAATGTCAGAGGGAACCATTGTTCCGCAAATTATTCGAGAATGTTGGAAGGCACAT 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC30483 4 3 6 DAC09-H06 18-CG14176-RB_5 CG14176 TGGATGGGCATGATTATGGTCTACTTTGTGACCATAGCTCTGGAGATCACTCTGTACAACGTGAGTGCA 69 FBan0014176 FBgn0036019 Or67b 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67b Odorant receptor 67b "CG14176, 67B.2, 67b" CDMC30483 4 4 6 DAC09-H06 18-CG14176-RB_5 CG14176 TGGATGGGCATGATTATGGTCTACTTTGTGACCATAGCTCTGGAGATCACTCTGTACAACGTGAGTGCA 69 FBan0014176 FBgn0036019 Or67b 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67b Odorant receptor 67b "CG14176, 67B.2, 67b" CDMC30484 4 5 6 DAC09-H18 23-CG14186-RA_3 CG14186 CTTTCCTTTAGATGCGTTTACGTGGCAGTTTAAGCTTCTACCTGAGCTGTATATAAACCGAGTGCAATA 69 FBan0014186 FBgn0036935 CG14186 3 3L CG14186 CG14186 CDMC30484 4 6 6 DAC09-H18 23-CG14186-RA_3 CG14186 CTTTCCTTTAGATGCGTTTACGTGGCAGTTTAAGCTTCTACCTGAGCTGTATATAAACCGAGTGCAATA 69 FBan0014186 FBgn0036935 CG14186 3 3L CG14186 CG14186 CDMC30485 4 7 6 DAC09-L06 3-CG14222-RA_1 CG14222 AAGGCCTTATCCAGGGACGTCAACAAAAAGTCGGTCATACCGTACACGCAGCCTGTACGACTGGAACAT 69 FBan0014222 FBgn0031043 CG14222 X X protein amino acid acetylation; GO:0006473 acyl-CoA N-acyltransferase activity; GO:0019186 ; EC:2.3.1.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0019186 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG14222 CG14222 DmAAF48987 CDMC30485 4 8 6 DAC09-L06 3-CG14222-RA_1 CG14222 AAGGCCTTATCCAGGGACGTCAACAAAAAGTCGGTCATACCGTACACGCAGCCTGTACGACTGGAACAT 69 FBan0014222 FBgn0031043 CG14222 X X protein amino acid acetylation; GO:0006473 acyl-CoA N-acyltransferase activity; GO:0019186 ; EC:2.3.1.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0019186 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG14222 CG14222 DmAAF48987 CDMC30486 4 9 6 DAC09-L18 3-CG14233-RA_1 CG14233 CCAGCGGATGCCGAATGAATCTCAACAGAGCCGGATTCACACCGCTACGATAATCTAGTTGGAGCTGCA 69 FBan0014233 FBgn0040089 meso18E X X mesoderm development; GO:0007498 meso18E meso18E "CG14233, Mmeso18E, Dmeso18E, ld26007, anon-18DEd, eso18E" CDMC30486 4 10 6 DAC09-L18 3-CG14233-RA_1 CG14233 CCAGCGGATGCCGAATGAATCTCAACAGAGCCGGATTCACACCGCTACGATAATCTAGTTGGAGCTGCA 69 FBan0014233 FBgn0040089 meso18E X X mesoderm development; GO:0007498 meso18E meso18E "CG14233, Mmeso18E, Dmeso18E, ld26007, anon-18DEd, eso18E" CDMC30487 4 11 6 DAC09-P06 24-CG14283-RA_1 CG14283 ACACGATTTAAGTGTAGCTCTTATTTAGTGTAAATATTGTGATTATCAATTAAAATGTTGCTGAAACAG 69 FBan0014283 FBgn0038678 mRpL55 3 3R mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739; nucleolus; GO:0005730; nucleus; GO:0005634 mRpL55 mitochondrial ribosomal protein L55 "CG14283, CG14283, CG14283, MRP-L55, tmb, tom thumb, BcDNA:RH10246, mitochondrial ribosomal protein L55" CDMC30487 4 12 6 DAC09-P06 24-CG14283-RA_1 CG14283 ACACGATTTAAGTGTAGCTCTTATTTAGTGTAAATATTGTGATTATCAATTAAAATGTTGCTGAAACAG 69 FBan0014283 FBgn0038678 mRpL55 3 3R mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrion; GO:0005739; nucleolus; GO:0005730; nucleus; GO:0005634 mRpL55 mitochondrial ribosomal protein L55 "CG14283, CG14283, CG14283, MRP-L55, tmb, tom thumb, BcDNA:RH10246, mitochondrial ribosomal protein L55" CDMC30488 4 13 6 DAC09-P18 3-CG14299-RA_2 CG14299 CGGGCCGTACCTCATATGGTCTGCCGACTCATCAGCATCTTCTACGAGGAGAGCTACCTGACAACCATT 69 FBan0014299 FBgn0038651 CG14299 3 3R CG14299 CG14299 CDMC30488 4 14 6 DAC09-P18 3-CG14299-RA_2 CG14299 CGGGCCGTACCTCATATGGTCTGCCGACTCATCAGCATCTTCTACGAGGAGAGCTACCTGACAACCATT 69 FBan0014299 FBgn0038651 CG14299 3 3R CG14299 CG14299 CDMC30489 4 15 6 DAC10-D05 17-CG1975-RA_2 CG1975 TCCGCTGCGCAATTAGATCCTAAGACCTTATGCTGAGATCAGCCAACACTGTACTCCCATCTAACCAAA 69 FBan0001975 FBgn0028408 Rep2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Rep2 Rep2 "CG1975, drep2, anon-WO0118547.162, anon-WO0118547.168, Drep2" CDMC30489 4 16 6 DAC10-D05 17-CG1975-RA_2 CG1975 TCCGCTGCGCAATTAGATCCTAAGACCTTATGCTGAGATCAGCCAACACTGTACTCCCATCTAACCAAA 69 FBan0001975 FBgn0028408 Rep2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Rep2 Rep2 "CG1975, drep2, anon-WO0118547.162, anon-WO0118547.168, Drep2" CDMC30490 4 17 6 DAC10-D17 12-CG1981-RA_2 CG1981 GCTCACCACCAGCATTTGAGTCCACGACTTGGAAATCAAACCCATCAGAATTCCTCCCCATCTGGTCAT 69 FBan0001981 FBgn0026869 Thd1 4 4 "mismatch repair; GO:0006298; nucleotide-excision repair; GO:0006289; regulation of transcription, DNA-dependent; GO:0006355" pyrimidine-specific mismatch base pair DNA N-glycosylase activity; GO:0008263; double-stranded DNA binding; GO:0003690; ; GO:0008263; ; GO:0003690; ; GO:0008263 nucleus; GO:0005634 Thd1 Thd1 "CG1981, G/T-mismatch-specific-thymine-DNA-glycosylase" CDMC30490 4 18 6 DAC10-D17 12-CG1981-RA_2 CG1981 GCTCACCACCAGCATTTGAGTCCACGACTTGGAAATCAAACCCATCAGAATTCCTCCCCATCTGGTCAT 69 FBan0001981 FBgn0026869 Thd1 4 4 "mismatch repair; GO:0006298; nucleotide-excision repair; GO:0006289; regulation of transcription, DNA-dependent; GO:0006355" pyrimidine-specific mismatch base pair DNA N-glycosylase activity; GO:0008263; double-stranded DNA binding; GO:0003690; ; GO:0008263; ; GO:0003690; ; GO:0008263 nucleus; GO:0005634 Thd1 Thd1 "CG1981, G/T-mismatch-specific-thymine-DNA-glycosylase" CDMC30491 4 19 6 DAC10-H05 23-CG2034-RA_2 CG2034 GCTTCAATTTAAAATAATATTTAGGTAGTCCCACAATAAATGCTAACAAAATGCTCTCCAACCTGGTGG 69 FBan0002034 FBgn0015359 CG2034 3 3L CG2034 CG2034 anon-i1 CDMC30491 4 20 6 DAC10-H05 23-CG2034-RA_2 CG2034 GCTTCAATTTAAAATAATATTTAGGTAGTCCCACAATAAATGCTAACAAAATGCTCTCCAACCTGGTGG 69 FBan0002034 FBgn0015359 CG2034 3 3L CG2034 CG2034 anon-i1 CDMC30492 4 21 6 DAC10-H17 12-CG2046-RA_1 CG2046 GCTTGCCAAGAAAGTGATCACTCTGACGCTTAAGCCAAAGGTCGAGTTCAAAAGCGAGGACATCCAGCT 69 FBan0002046 FBgn0037378 CG2046 3 3R CG2046 CG2046 CDMC30492 4 22 6 DAC10-H17 12-CG2046-RA_1 CG2046 GCTTGCCAAGAAAGTGATCACTCTGACGCTTAAGCCAAAGGTCGAGTTCAAAAGCGAGGACATCCAGCT 69 FBan0002046 FBgn0037378 CG2046 3 3R CG2046 CG2046 CDMC30493 4 23 6 DAC10-L05 23-CG2079-RA_1 CG2079 CAATAGGTTTCTTAAGTGTTGTTTTCGATTGCACCTCCTCTCAATAACCCAAATAAGAAACCCGCCCCA 69 FBan0002079 FBgn0029944 l(1)G0331 X X insulin receptor binding; GO:0005158; ; GO:0005158 l(1)G0331 lethal (1) G0331 "CG2079, CG2079, CG2079, CG2079" CDMC30493 4 24 6 DAC10-L05 23-CG2079-RA_1 CG2079 CAATAGGTTTCTTAAGTGTTGTTTTCGATTGCACCTCCTCTCAATAACCCAAATAAGAAACCCGCCCCA 69 FBan0002079 FBgn0029944 l(1)G0331 X X insulin receptor binding; GO:0005158; ; GO:0005158 l(1)G0331 lethal (1) G0331 "CG2079, CG2079, CG2079, CG2079" CDMC30494 4 25 6 DAC10-L17 1-CG2086-RA_1 CG2086 CCGGGCGAGTGTAGCTCTGACCTTAGTCCTGATGACCCTGTTTGCGTGCATAATCTTCGCAGTGTTCAT 69 FBan0002086 FBgn0027594 drpr 3 3L cell adhesion; GO:0007155; ectoderm development; GO:0007398; larval locomotory behavior; GO:0008345; nervous system development; GO:0007399; phagocytosis; GO:0006909; signal transduction; GO:0007165 extracellular matrix structural constituent; GO:0005201; receptor activity; GO:0004872; ; GO:0005201; ; GO:0004872 intrinsic to membrane; GO:0031224 drpr draper "CG18172, CG2086, CG18172, CT6730, CT41022, BcDNA:GH03529, draper" CDMC30494 4 26 6 DAC10-L17 1-CG2086-RA_1 CG2086 CCGGGCGAGTGTAGCTCTGACCTTAGTCCTGATGACCCTGTTTGCGTGCATAATCTTCGCAGTGTTCAT 69 FBan0002086 FBgn0027594 drpr 3 3L cell adhesion; GO:0007155; ectoderm development; GO:0007398; larval locomotory behavior; GO:0008345; nervous system development; GO:0007399; phagocytosis; GO:0006909; signal transduction; GO:0007165 extracellular matrix structural constituent; GO:0005201; receptor activity; GO:0004872; ; GO:0005201; ; GO:0004872 intrinsic to membrane; GO:0031224 drpr draper "CG18172, CG2086, CG18172, CT6730, CT41022, BcDNA:GH03529, draper" CDMC30495 4 1 7 DAC10-P05 9-CG2126-RA_1 CG2126 GCCAATGCCATCCACTATTCCCTCAAACTGGATCAAACCCTAAAGGCATTGGTTCACTCGTCGGTGTGG 69 FBan0002126 FBgn0039876 CG2126 3 3R CG2126 CG2126 anon-WO0118547.412 CDMC30495 4 2 7 DAC10-P05 9-CG2126-RA_1 CG2126 GCCAATGCCATCCACTATTCCCTCAAACTGGATCAAACCCTAAAGGCATTGGTTCACTCGTCGGTGTGG 69 FBan0002126 FBgn0039876 CG2126 3 3R CG2126 CG2126 anon-WO0118547.412 CDMC30496 4 3 7 DAC10-P17 23-CG2139-RB_2 CG2139 AAAGTCTAGAGCATCAACCAATCACTGAACGTCAACTTTTGCACTCAATGTAACTATTAAAGCGATAAA 69 FBan0002139 FBgn0028646 aralar1 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839; transport; GO:0006810 calcium ion binding; GO:0005509; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005386; ; GO:0005509; ; GO:0005509; ; GO:0005509; ; GO:0005386; ; GO:0005386 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 aralar1 aralar1 "CG2139, CG2139, DmAralar, BcDNA:GH07418" CDMC30496 4 4 7 DAC10-P17 23-CG2139-RB_2 CG2139 AAAGTCTAGAGCATCAACCAATCACTGAACGTCAACTTTTGCACTCAATGTAACTATTAAAGCGATAAA 69 FBan0002139 FBgn0028646 aralar1 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839; transport; GO:0006810 calcium ion binding; GO:0005509; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005386; ; GO:0005509; ; GO:0005509; ; GO:0005509; ; GO:0005386; ; GO:0005386 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 aralar1 aralar1 "CG2139, CG2139, DmAralar, BcDNA:GH07418" CDMC30497 4 5 7 DAC11-D05 1-CG9269-RA_2 CG9269 CAACCGCTGCAGCAAAATGAGTCCGGAAAAAACGAGGATAGCGAAAGGAGCGAGCGAGTGAGTCG 65 FBan0009269 FBgn0038161 CG9269 3 3R CG9269 CG9269 CDMC30497 4 6 7 DAC11-D05 1-CG9269-RA_2 CG9269 CAACCGCTGCAGCAAAATGAGTCCGGAAAAAACGAGGATAGCGAAAGGAGCGAGCGAGTGAGTCG 65 FBan0009269 FBgn0038161 CG9269 3 3R CG9269 CG9269 CDMC30498 4 7 7 DAC11-D17 21-CG9290-RA_1 CG9290 CACGCCACCAGCTACAGTTCGGTGACCAAGCACGAAGGACCCGTCCACAAGAGCCTGGGCTACGG 65 FBan0009290 FBgn0036879 CG9290 3 3L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 CG9290 CG9290 CDMC30498 4 8 7 DAC11-D17 21-CG9290-RA_1 CG9290 CACGCCACCAGCTACAGTTCGGTGACCAAGCACGAAGGACCCGTCCACAAGAGCCTGGGCTACGG 65 FBan0009290 FBgn0036879 CG9290 3 3L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 CG9290 CG9290 CDMC30499 4 9 7 DAC11-H05 23-CG9378-RB_3 CG9378 TTCAGCTGTTTTGTTCGGTCGAAAAAATGTCTTCGGCGTTAATAAAATGTTTAAATTTGGCAAAA 65 FBan0009378 FBgn0014023 Rlc1 3 3R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 Rlc1 Rlc1 "CG9378, MRP-L47, BcDNA:AT29239, mRpL47" CDMC30499 4 10 7 DAC11-H05 23-CG9378-RB_3 CG9378 TTCAGCTGTTTTGTTCGGTCGAAAAAATGTCTTCGGCGTTAATAAAATGTTTAAATTTGGCAAAA 65 FBan0009378 FBgn0014023 Rlc1 3 3R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 Rlc1 Rlc1 "CG9378, MRP-L47, BcDNA:AT29239, mRpL47" CDMC30500 4 11 7 DAC11-H17 2-CG9424-RA_1 CG9424 ACACCTCGATCTCGGGAAGATCTGTGCAGACTACTACCACGGTGTCGGATATGAGCTCCCAGTCG 65 FBan0009424 FBgn0037719 bocksbeutel 3 3R nuclear membrane; GO:0005635 bocksbeutel bocksbeutel CG9424 CDMC30500 4 12 7 DAC11-H17 2-CG9424-RA_1 CG9424 ACACCTCGATCTCGGGAAGATCTGTGCAGACTACTACCACGGTGTCGGATATGAGCTCCCAGTCG 65 FBan0009424 FBgn0037719 bocksbeutel 3 3R nuclear membrane; GO:0005635 bocksbeutel bocksbeutel CG9424 CDMC30501 4 13 7 DAC11-L05 3-CG9552-RA_2 CG9552 ATAACTCAAAAAGCGCTGCTGAAGTCAGTAGCCGGCTAAACGCGACTCGGATCGGAAGTCTCCGC 65 FBan0009552 FBgn0011705 rost 2 2L mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 rost rolling stone "CG9552, rolling stone" CDMC30501 4 14 7 DAC11-L05 3-CG9552-RA_2 CG9552 ATAACTCAAAAAGCGCTGCTGAAGTCAGTAGCCGGCTAAACGCGACTCGGATCGGAAGTCTCCGC 65 FBan0009552 FBgn0011705 rost 2 2L mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 integral to membrane; GO:0016021; membrane; GO:0016020; plasma membrane; GO:0005886 rost rolling stone "CG9552, rolling stone" CDMC30502 4 15 7 DAC11-L17 2-CG9578-RA_3 CG9578 GTGTGGCCTTCTGGACCAACCCGGATGAAATGCAAGAATTTGTGCCCGTGAAGTCCAAGCAGTTG 65 FBan0009578 FBgn0031094 CG9578 X X CG9578 CG9578 CDMC30502 4 16 7 DAC11-L17 2-CG9578-RA_3 CG9578 GTGTGGCCTTCTGGACCAACCCGGATGAAATGCAAGAATTTGTGCCCGTGAAGTCCAAGCAGTTG 65 FBan0009578 FBgn0031094 CG9578 X X CG9578 CG9578 CDMC30503 4 17 7 DAC11-P05 2-CG9652-RA_3 CG9652 CCGCTGATTTTCGAGGACAATGGCAAAAAGTATCCAACATGCGCTCTGGACCTCACGCCCACCTA 65 FBan0009652 FBgn0011582 DopR 3 3R dopamine receptor signaling pathway; GO:0007212; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; dopamine receptor activity; GO:0004952; ; GO:0004952; ; GO:0004930; ; GO:0004952; dopamine D1 receptor-like receptor activity; GO:0001588; ; GO:0001588; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 DopR Dopamine receptor "CG9652, dDA1, DmDop1, DopR35F, dopamine receptor, dopamine D1-like receptor, D1-like receptor, Dmdop1, dopamine D1 receptor, dDA1/DmDOP1, DA1" CDMC30503 4 18 7 DAC11-P05 2-CG9652-RA_3 CG9652 CCGCTGATTTTCGAGGACAATGGCAAAAAGTATCCAACATGCGCTCTGGACCTCACGCCCACCTA 65 FBan0009652 FBgn0011582 DopR 3 3R dopamine receptor signaling pathway; GO:0007212; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; dopamine receptor activity; GO:0004952; ; GO:0004952; ; GO:0004930; ; GO:0004952; dopamine D1 receptor-like receptor activity; GO:0001588; ; GO:0001588; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 DopR Dopamine receptor "CG9652, dDA1, DmDop1, DopR35F, dopamine receptor, dopamine D1-like receptor, D1-like receptor, Dmdop1, dopamine D1 receptor, dDA1/DmDOP1, DA1" CDMC30504 4 19 7 DAC11-P17 3-CG9692-RB_6 CG9692 GTGGAATCACTCCCCATATCTAGGCTCAAGGTCAAGGTGGTGCTATCCCCACGTCTCAAGCGGTC 65 FBan0009692 FBgn0036654 CG9692 3 3L CG9692 CG9692 CDMC30504 4 20 7 DAC11-P17 3-CG9692-RB_6 CG9692 GTGGAATCACTCCCCATATCTAGGCTCAAGGTCAAGGTGGTGCTATCCCCACGTCTCAAGCGGTC 65 FBan0009692 FBgn0036654 CG9692 3 3L CG9692 CG9692 CDMC30505 4 21 7 DAC12-D05 2-CG15449-RA_1 CG15449 CGCTGTCCATCGTCAATGGGGTGCTATTCGGATTCGATGCGGTGTTCACATTTCGCGACAAGTGA 65 FBan0015449 FBgn0031146 CG15449 X X CG15449 CG15449 CDMC30505 4 22 7 DAC12-D05 2-CG15449-RA_1 CG15449 CGCTGTCCATCGTCAATGGGGTGCTATTCGGATTCGATGCGGTGTTCACATTTCGCGACAAGTGA 65 FBan0015449 FBgn0031146 CG15449 X X CG15449 CG15449 CDMC30506 4 23 7 DAC12-D17 1-CG15475-RA_1 CG15475 CTGGCCAAGGAGAAAGTTCCGAAAATGAATGCCAAACGGTTCACCAGACCATCCAAGACCCAGGC 65 FBan0015475 FBgn0032867 CG15475 2 2L CG15475 CG15475 38D.19 CDMC30506 4 24 7 DAC12-D17 1-CG15475-RA_1 CG15475 CTGGCCAAGGAGAAAGTTCCGAAAATGAATGCCAAACGGTTCACCAGACCATCCAAGACCCAGGC 65 FBan0015475 FBgn0032867 CG15475 2 2L CG15475 CG15475 38D.19 CDMC30507 4 25 7 DAC12-H05 3-CG15549-RA_4 CG15549 ATTCGACGTGTGGCAAAAAGTGCAGTATGTTGGCCAATCTGTTGACCCTAAGCTGCCTTCTGGCC 65 FBan0015549 FBgn0039810 CG15549 3 3R CG15549 CG15549 BcDNA:AT07554 CDMC30507 4 26 7 DAC12-H05 3-CG15549-RA_4 CG15549 ATTCGACGTGTGGCAAAAAGTGCAGTATGTTGGCCAATCTGTTGACCCTAAGCTGCCTTCTGGCC 65 FBan0015549 FBgn0039810 CG15549 3 3R CG15549 CG15549 BcDNA:AT07554 CDMC30508 4 1 8 DAC12-H17 1-CG15589-RA_1 CG15589 GTAGACGGGGTCTAAAGGTCTCGGAGCCATCTCTCGGACGGTATGGGGTCGAGATGACAGCAAAG 65 FBan0015589 FBgn0037409 CG15589 3 3R CG15589 CG15589 CDMC30508 4 2 8 DAC12-H17 1-CG15589-RA_1 CG15589 GTAGACGGGGTCTAAAGGTCTCGGAGCCATCTCTCGGACGGTATGGGGTCGAGATGACAGCAAAG 65 FBan0015589 FBgn0037409 CG15589 3 3R CG15589 CG15589 CDMC30509 4 3 8 DAC12-L05 23-CG15671-RA_1 CG15671 GTTGTCCGTTTAACCTTAGTTACCCATTTAGTTACTACTCGCACACACTTACATTCATGAGCACG 65 FBan0015671 FBgn0000395 cv-2 2 2R wing vein specification; GO:0007474 structural molecule activity; GO:0005198; ; GO:0005198 cv-2 crossveinless 2 "CG15671, CT35855, cv 2, Cv 2" CDMC30509 4 4 8 DAC12-L05 23-CG15671-RA_1 CG15671 GTTGTCCGTTTAACCTTAGTTACCCATTTAGTTACTACTCGCACACACTTACATTCATGAGCACG 65 FBan0015671 FBgn0000395 cv-2 2 2R wing vein specification; GO:0007474 structural molecule activity; GO:0005198; ; GO:0005198 cv-2 crossveinless 2 "CG15671, CT35855, cv 2, Cv 2" CDMC30510 4 5 8 DAC12-L17 3-CG15711-RA_3 CG15711 ATGACCTATGTGGCGTTCGCAGTCATGCAACCGTGTTCCATGCGAAGGAAGCAGTTGATTGAGGG 65 FBan0015711 FBgn0034122 CG15711 2 2R CG15711 CG15711 CDMC30510 4 6 8 DAC12-L17 3-CG15711-RA_3 CG15711 ATGACCTATGTGGCGTTCGCAGTCATGCAACCGTGTTCCATGCGAAGGAAGCAGTTGATTGAGGG 65 FBan0015711 FBgn0034122 CG15711 2 2R CG15711 CG15711 CDMC30511 4 7 8 DAC12-P05 3-CG15786-RA_1 CG15786 TTGATTACGTTTTTCTAGCCCTAGTCGAAACAGCTATGCACCCGCGTTCGGATGGAATCCCGCCC 65 FBan0015786 FBgn0029749 CG15786 X X CG15786 CG15786 CDMC30511 4 8 8 DAC12-P05 3-CG15786-RA_1 CG15786 TTGATTACGTTTTTCTAGCCCTAGTCGAAACAGCTATGCACCCGCGTTCGGATGGAATCCCGCCC 65 FBan0015786 FBgn0029749 CG15786 X X CG15786 CG15786 CDMC30512 4 9 8 DAC12-P17 18-CG1582-RA_2 CG1582 GGCCTGATGAAGGAGAAGTGTTTCGACTCAAACCGCAACATGGAGTCACTGGACCTAGTCTGGGT 65 FBan0001582 FBgn0030246 CG1582 X X nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; ; GO:0008026 CG1582 CG1582 cg1582 CDMC30512 4 10 8 DAC12-P17 18-CG1582-RA_2 CG1582 GGCCTGATGAAGGAGAAGTGTTTCGACTCAAACCGCAACATGGAGTCACTGGACCTAGTCTGGGT 65 FBan0001582 FBgn0030246 CG1582 X X nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; ; GO:0008026 CG1582 CG1582 cg1582 CDMC30513 4 11 8 DAC13-D05 23-CG13041-RA_1 CG13041 CCTGCACCACTAAGGACGCAAATGTGATACAGTATTTACGATTTTTTGTTTCAATAAATGTTTTTCGTT 69 FBan0013041 FBgn0036605 CG13041 3 3L CG13041 CG13041 BcDNA:RE63063 CDMC30513 4 12 8 DAC13-D05 23-CG13041-RA_1 CG13041 CCTGCACCACTAAGGACGCAAATGTGATACAGTATTTACGATTTTTTGTTTCAATAAATGTTTTTCGTT 69 FBan0013041 FBgn0036605 CG13041 3 3L CG13041 CG13041 BcDNA:RE63063 CDMC30514 4 13 8 DAC13-D17 8-CG13061-RA_1 CG13061 AGCCAATCAGCGCTCCTGTTCAACCATAACATTTCCTGCGGATTACTTCAACCACAAGTTCTGTGCCCT 69 FBan0013061 FBgn0042201 Nplp3 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp3 Neuropeptide-like precursor 3 "CG13061, CG18502, CG13061, NPLP3, SHA peptide, VVIamide peptide, neuropeptide-like precursor 3, BcDNA:RH16169, Neuropeptide-like precursor 3" CDMC30514 4 14 8 DAC13-D17 8-CG13061-RA_1 CG13061 AGCCAATCAGCGCTCCTGTTCAACCATAACATTTCCTGCGGATTACTTCAACCACAAGTTCTGTGCCCT 69 FBan0013061 FBgn0042201 Nplp3 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp3 Neuropeptide-like precursor 3 "CG13061, CG18502, CG13061, NPLP3, SHA peptide, VVIamide peptide, neuropeptide-like precursor 3, BcDNA:RH16169, Neuropeptide-like precursor 3" CDMC30515 4 15 8 DAC13-H05 7-CG13095-RA_1 CG13095 TCCTCAAGGAGCAGAACTTTGTGAAGACGCGTCAGAATGTTTTGGCCGAGAAATCCTATCTGCGCACCA 69 FBan0013095 FBgn0032049 CG13095 2 2L proteolysis; GO:0006508 aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG13095 CG13095 anon-WO0140519.142 CDMC30515 4 16 8 DAC13-H05 7-CG13095-RA_1 CG13095 TCCTCAAGGAGCAGAACTTTGTGAAGACGCGTCAGAATGTTTTGGCCGAGAAATCCTATCTGCGCACCA 69 FBan0013095 FBgn0032049 CG13095 2 2L proteolysis; GO:0006508 aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG13095 CG13095 anon-WO0140519.142 CDMC30516 4 17 8 DAC13-H17 12-CG13108-RA_1 CG13108 TGGGATGATCAGCAGACGAGCGACTTCATAGAGGTCAAAGTCAACTGCTTGGATCCCAACAACAGACGT 69 FBan0013108 FBgn0032100 CG13108 2 2L CG13108 CG13108 CDMC30516 4 18 8 DAC13-H17 12-CG13108-RA_1 CG13108 TGGGATGATCAGCAGACGAGCGACTTCATAGAGGTCAAAGTCAACTGCTTGGATCCCAACAACAGACGT 69 FBan0013108 FBgn0032100 CG13108 2 2L CG13108 CG13108 CDMC30517 4 19 8 DAC13-L05 3-CG13155-RA_2 CG13155 CGGCTGGCAGATAATCCAGTTTCAATGGGTACGAGATGGCGATGAGTCCCATCCAGACACCAAGGAGTA 69 FBan0013155 FBgn0033723 CG13155 2 2R CG13155 CG13155 CDMC30517 4 20 8 DAC13-L05 3-CG13155-RA_2 CG13155 CGGCTGGCAGATAATCCAGTTTCAATGGGTACGAGATGGCGATGAGTCCCATCCAGACACCAAGGAGTA 69 FBan0013155 FBgn0033723 CG13155 2 2R CG13155 CG13155 CDMC30518 4 21 8 DAC13-L17 2-CG13171-RA_2 CG13171 GCCCTACGACTTGCTCCTGAGCCGTACCTTCAACCTAATCCAAGAGGACAGGATCAGGGAGACAAATGG 69 FBan0013171 FBgn0033701 CG13171 2 2R CG13171 CG13171 CDMC30518 4 22 8 DAC13-L17 2-CG13171-RA_2 CG13171 GCCCTACGACTTGCTCCTGAGCCGTACCTTCAACCTAATCCAAGAGGACAGGATCAGGGAGACAAATGG 69 FBan0013171 FBgn0033701 CG13171 2 2R CG13171 CG13171 CDMC30519 4 23 8 DAC13-P05 1-CG13208-RA_1 CG13208 CGCTAAGTTCTCCAACGATACCCTTTACGTGGAAACCATGACCATGGCGTTCTCCAAGTGTGAGCCCCA 69 FBan0013208 FBgn0033614 Obp47b 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp47b Odorant-binding protein 47b "CG13208, CG13208, Odorant-binding protein 47b" CDMC30519 4 24 8 DAC13-P05 1-CG13208-RA_1 CG13208 CGCTAAGTTCTCCAACGATACCCTTTACGTGGAAACCATGACCATGGCGTTCTCCAAGTGTGAGCCCCA 69 FBan0013208 FBgn0033614 Obp47b 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp47b Odorant-binding protein 47b "CG13208, CG13208, Odorant-binding protein 47b" CDMC30520 4 25 8 DAC13-P17 7-CG13218-RA_1 CG13218 TGCGATCTTCAAGTGCATTTTTTGTTATTACTGGCAATTGGCGCTTGGCGGACTGAAGCCCATTCCCTG 69 FBan0013218 FBgn0033587 CG13218 2 2R CG13218 CG13218 CDMC30520 4 26 8 DAC13-P17 7-CG13218-RA_1 CG13218 TGCGATCTTCAAGTGCATTTTTTGTTATTACTGGCAATTGGCGCTTGGCGGACTGAAGCCCATTCCCTG 69 FBan0013218 FBgn0033587 CG13218 2 2R CG13218 CG13218 CDMC30521 4 1 9 DAC14-D05 18-CG40176-RA_3 CG40176 GCAGCAACAATAAAACAGCATCAAAAACACGACCAACAACTCCAGCAACTTGTCAAACAACCAGGCCAC 69 FBan0040176 FBgn0058176 CG40176 2 2L CG40176 CG40176 CDMC30521 4 2 9 DAC14-D05 18-CG40176-RA_3 CG40176 GCAGCAACAATAAAACAGCATCAAAAACACGACCAACAACTCCAGCAACTTGTCAAACAACCAGGCCAC 69 FBan0040176 FBgn0058176 CG40176 2 2L CG40176 CG40176 CDMC30522 4 3 9 DAC14-D17 16-CG40191-RC_1 CG40191 TGGCATCGGGATGTGGAAACTGCCTCAGATTTCACCATGACAATTAGCAGTCAGGTATCCGTTTCAAAT 69 FBgn0058191 CG40191 CG40191 CG40191 "BcDNA:LD12604, BEST:HL02313" CDMC30522 4 4 9 DAC14-D17 16-CG40191-RC_1 CG40191 TGGCATCGGGATGTGGAAACTGCCTCAGATTTCACCATGACAATTAGCAGTCAGGTATCCGTTTCAAAT 69 FBgn0058191 CG40191 CG40191 CG40191 "BcDNA:LD12604, BEST:HL02313" CDMC30523 4 5 9 DAC14-H05 18-CG40241-RA_1 CG40241 GGATGCAACCCTTATCAGCTGCACCCGGAAAGTTTTGGGATAATTCGGTTATCGCAAAAATAGTGGGTT 69 FBgn0058241 CG40241 CG40241 CG40241 CDMC30523 4 6 9 DAC14-H05 18-CG40241-RA_1 CG40241 GGATGCAACCCTTATCAGCTGCACCCGGAAAGTTTTGGGATAATTCGGTTATCGCAAAAATAGTGGGTT 69 FBgn0058241 CG40241 CG40241 CG40241 CDMC30524 4 7 9 DAC14-H17 3-CG40264-RA_1 CG40264 ACCCTGCTGCCCATATGAACCTCAACGCACTCCTTACGAAGCTTATCAACGGTGAATACCTCCATCGCA 69 FBgn0058264 CG40264 CG40264 CG40264 CDMC30524 4 8 9 DAC14-H17 3-CG40264-RA_1 CG40264 ACCCTGCTGCCCATATGAACCTCAACGCACTCCTTACGAAGCTTATCAACGGTGAATACCTCCATCGCA 69 FBgn0058264 CG40264 CG40264 CG40264 CDMC30525 4 9 9 DAC14-L05 23-CG40313-RA_18 CG40313 GCGACGCTCATGTATTCGACTGACTTCTTATGGACTTATGACTTCTTATCGACTTATGGTGCCAAAAAT 69 FBgn0058313 CG40313 CG40313 CG40313 CDMC30525 4 10 9 DAC14-L05 23-CG40313-RA_18 CG40313 GCGACGCTCATGTATTCGACTGACTTCTTATGGACTTATGACTTCTTATCGACTTATGGTGCCAAAAAT 69 FBgn0058313 CG40313 CG40313 CG40313 CDMC30526 4 11 9 DAC14-L17 1-CG40341-RA_1 CG40341 GCCGGAAAAGCGTCGGGAAAAATGAGGGAGGAAAATATATGGCATACACTTAGGCGCGCCAAGTCGGAT 69 FBan0040341 FBgn0058341 CG40341 2 2L CG40341 CG40341 CDMC30526 4 12 9 DAC14-L17 1-CG40341-RA_1 CG40341 GCCGGAAAAGCGTCGGGAAAAATGAGGGAGGAAAATATATGGCATACACTTAGGCGCGCCAAGTCGGAT 69 FBan0040341 FBgn0058341 CG40341 2 2L CG40341 CG40341 CDMC30527 4 13 9 DAC14-P05 17-CG40397-RA_1 CG40397 ACGAGCTCGCAATTGCAGAGAAACCACCATTTGTGTTGCTAATAGTGCAGACAAAGGTAGTCAGGCATA 69 FBgn0058397 CG40397 CG40397 CG40397 CDMC30527 4 14 9 DAC14-P05 17-CG40397-RA_1 CG40397 ACGAGCTCGCAATTGCAGAGAAACCACCATTTGTGTTGCTAATAGTGCAGACAAAGGTAGTCAGGCATA 69 FBgn0058397 CG40397 CG40397 CG40397 CDMC30528 4 15 9 DAC14-P17 24-CG40410-RA_17 CG40410 GTTCGTCGTTTACATTTATGGCTAGACAATCATTTAATAAAATCTTCTAAACTGAGGGAGTGATTCGGA 69 FBgn0039995 CG40410 amino acid metabolism; GO:0006520 calcium ion binding; GO:0005509; ; GO:0005509 CG40410 CG40410 "CG17661, CG17661" CDMC30528 4 16 9 DAC14-P17 24-CG40410-RA_17 CG40410 GTTCGTCGTTTACATTTATGGCTAGACAATCATTTAATAAAATCTTCTAAACTGAGGGAGTGATTCGGA 69 FBgn0039995 CG40410 amino acid metabolism; GO:0006520 calcium ion binding; GO:0005509; ; GO:0005509 CG40410 CG40410 "CG17661, CG17661" CDMC30529 4 17 9 DAC15-D05 12-CG7303-RA_1 CG7303 TCCTGGCGAGAATTTACGGCAAGAGCAAGCAGTTCCAGAACCTCATCGACAAGTTCCTAACGAAGAGCA 69 FBan0007303 FBgn0041231 Gr68a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr68a Gustatory receptor 68a "CG7303, 68D.1, Gustatory receptor 68D.1, Gr68D1, GR68D.1, Gustatory receptor 68a" CDMC30529 4 18 9 DAC15-D05 12-CG7303-RA_1 CG7303 TCCTGGCGAGAATTTACGGCAAGAGCAAGCAGTTCCAGAACCTCATCGACAAGTTCCTAACGAAGAGCA 69 FBan0007303 FBgn0041231 Gr68a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr68a Gustatory receptor 68a "CG7303, 68D.1, Gustatory receptor 68D.1, Gr68D1, GR68D.1, Gustatory receptor 68a" CDMC30530 4 19 9 DAC15-D17 2-CG7319-RA_1 CG7319 GGCGTCGTCAAGCTAATTCCCCTAAAGCGCCCTAAGACTCAATTGCCGTTTCACCTAGTTGAGCGCGTA 69 FBan0007319 FBgn0036197 CG7319 3 3L rRNA metabolism; GO:0016072; rRNA modification; GO:0000154 "nucleic acid binding; GO:0003676; rRNA (adenine) methyltransferase activity; GO:0016433 ; EC:2.1.1.-; ; GO:0003676; ; GO:0016433 ; EC:2.1.1.-; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-" CG7319 CG7319 "d-mtTFB1, mtTFB1" CDMC30530 4 20 9 DAC15-D17 2-CG7319-RA_1 CG7319 GGCGTCGTCAAGCTAATTCCCCTAAAGCGCCCTAAGACTCAATTGCCGTTTCACCTAGTTGAGCGCGTA 69 FBan0007319 FBgn0036197 CG7319 3 3L rRNA metabolism; GO:0016072; rRNA modification; GO:0000154 "nucleic acid binding; GO:0003676; rRNA (adenine) methyltransferase activity; GO:0016433 ; EC:2.1.1.-; ; GO:0003676; ; GO:0016433 ; EC:2.1.1.-; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-" CG7319 CG7319 "d-mtTFB1, mtTFB1" CDMC30531 4 21 9 DAC15-H05 13-CG7342-RA_1 CG7342 CCATTCTTCTACCTCATCGTGCCTGAAAGCATTCAGTGGCTGATTTCCAAGCAGAAGTATGACAGCGCA 69 FBan0007342 FBgn0038716 CG7342 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7342 CG7342 CDMC30531 4 22 9 DAC15-H05 13-CG7342-RA_1 CG7342 CCATTCTTCTACCTCATCGTGCCTGAAAGCATTCAGTGGCTGATTTCCAAGCAGAAGTATGACAGCGCA 69 FBan0007342 FBgn0038716 CG7342 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7342 CG7342 CDMC30532 4 23 9 DAC15-H17 22-CG7354-RA_2 CG7354 TGCTCGAGATTGAGCGTTCCAAGAACTATATCACTAGGGAAAACTTGGATGCAGCCATTGAGACAGCGT 69 FBan0007354 FBgn0036774 mRpS26 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS26 mitochondrial ribosomal protein S26 "CG7354, MRP-S26, mitochondrial ribosomal protein S26" CDMC30532 4 24 9 DAC15-H17 22-CG7354-RA_2 CG7354 TGCTCGAGATTGAGCGTTCCAAGAACTATATCACTAGGGAAAACTTGGATGCAGCCATTGAGACAGCGT 69 FBan0007354 FBgn0036774 mRpS26 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS26 mitochondrial ribosomal protein S26 "CG7354, MRP-S26, mitochondrial ribosomal protein S26" CDMC30533 4 25 9 DAC15-L05 1-CG7383-RA_1 CG7383 CACCCTGGTGAGGTCACAAACGTTGACAGGCTAAGATTATCTCGTGATTGCCGGAGAATTCGCTCGCGT 69 FBan0007383 FBgn0000560 eg 3 3L central nervous system development; GO:0007417; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879 nucleus; GO:0005634 eg eagle "CG7383, spy, egon, embryonic gonad, EGON, eag, T1, T1 transcription unit, NR0A3, Egon, Embryonic gonad, spready, eagle" CDMC30533 4 26 9 DAC15-L05 1-CG7383-RA_1 CG7383 CACCCTGGTGAGGTCACAAACGTTGACAGGCTAAGATTATCTCGTGATTGCCGGAGAATTCGCTCGCGT 69 FBan0007383 FBgn0000560 eg 3 3L central nervous system development; GO:0007417; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879 nucleus; GO:0005634 eg eagle "CG7383, spy, egon, embryonic gonad, EGON, eag, T1, T1 transcription unit, NR0A3, Egon, Embryonic gonad, spready, eagle" CDMC30534 4 1 10 DAC15-L17 23-CG7393-RA_2 CG7393 AGGTGCATGCCTGAAATGTAGCCATTCGGAAATGTTTCCAAAAATCAATCAGAGTCACAGCCTTAATGT 69 FBan0007393 FBgn0024846 p38b 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; regulation of BMP signaling pathway; GO:0030510; regulation of innate immune response; GO:0045088; response to stress; GO:0006950; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; MP kinase activity; GO:0008339 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0008339 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 p38b p38b "CG7393, CG7393, 186F5S, D-p38b, p38, BG:DS00797.3, stress-activated p38b MAP kinase, p38 MAPK, p38B, p38 beta, Dp38, D-p38, ESTS:186F5S, Mpk34C, anon-sts23" CDMC30534 4 2 10 DAC15-L17 23-CG7393-RA_2 CG7393 AGGTGCATGCCTGAAATGTAGCCATTCGGAAATGTTTCCAAAAATCAATCAGAGTCACAGCCTTAATGT 69 FBan0007393 FBgn0024846 p38b 2 2L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; regulation of BMP signaling pathway; GO:0030510; regulation of innate immune response; GO:0045088; response to stress; GO:0006950; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; MP kinase activity; GO:0008339 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0008339 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 p38b p38b "CG7393, CG7393, 186F5S, D-p38b, p38, BG:DS00797.3, stress-activated p38b MAP kinase, p38 MAPK, p38B, p38 beta, Dp38, D-p38, ESTS:186F5S, Mpk34C, anon-sts23" CDMC30535 4 3 10 DAC15-P05 3-CG7441-RA_5 CG7441 CGCCCATCGTTCCCACTCAGTCTATGCGCGTAGAGAAACAACTAGGTAGCACTCGAACTCGGCACGTAT 69 FBan0007441 FBgn0036763 CG7441 3 3L tRNA aminoacylation for protein translation; GO:0006418; tryptophanyl-tRNA aminoacylation; GO:0006436 ATP binding; GO:0005524; ; GO:0005524; tryptophan-tRNA ligase activity; GO:0004830 ; EC:6.1.1.2; ; GO:0004830 ; EC:6.1.1.2 CG7441 CG7441 BEST:CK01295 CDMC30535 4 4 10 DAC15-P05 3-CG7441-RA_5 CG7441 CGCCCATCGTTCCCACTCAGTCTATGCGCGTAGAGAAACAACTAGGTAGCACTCGAACTCGGCACGTAT 69 FBan0007441 FBgn0036763 CG7441 3 3L tRNA aminoacylation for protein translation; GO:0006418; tryptophanyl-tRNA aminoacylation; GO:0006436 ATP binding; GO:0005524; ; GO:0005524; tryptophan-tRNA ligase activity; GO:0004830 ; EC:6.1.1.2; ; GO:0004830 ; EC:6.1.1.2 CG7441 CG7441 BEST:CK01295 CDMC30536 4 5 10 DAC15-P17 23-CG7450-RB_4 CG7450 TGCTGTCTTTGGCATGACTATTGTTCCTTTAAACGATATTTCTCAAAACGAATAACGAAAGCTGACGAC 69 FBan0007450 FBgn0004396 CrebA 3 3L dorsal/ventral pattern formation; GO:0009953; larval cuticle pattern formation (sensu Insecta); GO:0035293; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 CrebA Cyclic-AMP response element binding protein A "CG7450, BBF-2, Creb-A, dCREB-A, CREB, dCreb-A, CREB-a, BBF2_DROME, BOX B Binding Factor-2, creb, Creb, dCREBA, dCrebA, CREB-A, crebA, BcDNA:SD05937, Bbbf2, l(3)03576, Box B-binding factor 2" CDMC30536 4 6 10 DAC15-P17 23-CG7450-RB_4 CG7450 TGCTGTCTTTGGCATGACTATTGTTCCTTTAAACGATATTTCTCAAAACGAATAACGAAAGCTGACGAC 69 FBan0007450 FBgn0004396 CrebA 3 3L dorsal/ventral pattern formation; GO:0009953; larval cuticle pattern formation (sensu Insecta); GO:0035293; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 CrebA Cyclic-AMP response element binding protein A "CG7450, BBF-2, Creb-A, dCREB-A, CREB, dCreb-A, CREB-a, BBF2_DROME, BOX B Binding Factor-2, creb, Creb, dCREBA, dCrebA, CREB-A, crebA, BcDNA:SD05937, Bbbf2, l(3)03576, Box B-binding factor 2" CDMC30537 4 7 10 DAC16-D05 2-CG12428-RC_3 CG12428 CTGCTCTGATGCGACAGTACTACAATGGACGAACAGAGACCCTGCGATCATGCACTTCCGCTGTGG 66 FBan0012428 FBgn0039543 CG12428 3 3R amino acid metabolism; GO:0006520 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; carnitine O-octanoyltransferase activity; GO:0008458 ; EC:2.3.1.137; ; GO:0008458 ; EC:2.3.1.137 peroxisome; GO:0005777 CG12428 CG12428 CDMC30537 4 8 10 DAC16-D05 2-CG12428-RC_3 CG12428 CTGCTCTGATGCGACAGTACTACAATGGACGAACAGAGACCCTGCGATCATGCACTTCCGCTGTGG 66 FBan0012428 FBgn0039543 CG12428 3 3R amino acid metabolism; GO:0006520 acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; carnitine O-octanoyltransferase activity; GO:0008458 ; EC:2.3.1.137; ; GO:0008458 ; EC:2.3.1.137 peroxisome; GO:0005777 CG12428 CG12428 CDMC30538 4 9 10 DAC16-D17 1-CG12701-RA_1 CG12701 TGCAGTTGAGTGTCCTGTTCGGGTCAGCTTGGGGTTGTTCCGATTCAGTTTTAACGAGTTTCGCCC 66 FBan0012701 FBgn0031071 CG12701 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12701 CG12701 CDMC30538 4 10 10 DAC16-D17 1-CG12701-RA_1 CG12701 TGCAGTTGAGTGTCCTGTTCGGGTCAGCTTGGGGTTGTTCCGATTCAGTTTTAACGAGTTTCGCCC 66 FBan0012701 FBgn0031071 CG12701 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12701 CG12701 CDMC30539 4 11 10 DAC16-H05 3-CG13289-RA_3 CG13289 GCCCACTATCTGATCCTGCGGACGCAAAGGGGCTACAAGATAAAGGGCTTCACCAAGGAGTTCAGT 66 FBgn0035653 CDMC30539 4 12 10 DAC16-H05 3-CG13289-RA_3 CG13289 GCCCACTATCTGATCCTGCGGACGCAAAGGGGCTACAAGATAAAGGGCTTCACCAAGGAGTTCAGT 66 FBgn0035653 CDMC30540 4 13 10 DAC16-H17 1-CG13404-RA_2 CG13404 TCCCAGCTATCGCAAGTGCCAGGAGCTCAAGGTGAGTCCACCGCTTTATATAATCCCCAAAACCCC 66 FBan0013404 FBgn0030559 CG13404 X X CG13404 CG13404 CDMC30540 4 14 10 DAC16-H17 1-CG13404-RA_2 CG13404 TCCCAGCTATCGCAAGTGCCAGGAGCTCAAGGTGAGTCCACCGCTTTATATAATCCCCAAAACCCC 66 FBan0013404 FBgn0030559 CG13404 X X CG13404 CG13404 CDMC30541 4 15 10 DAC16-L05 13-CG13791-RA_1 CG13791 CCTACAGGACATTGGTGGATCATGGCCATCCGATTATAGTGGGAAGCAGTGAAATATCGCTGGCCC 66 FBan0013791 FBgn0031923 CG13791 2 2L CG13791 CG13791 CDMC30541 4 16 10 DAC16-L05 13-CG13791-RA_1 CG13791 CCTACAGGACATTGGTGGATCATGGCCATCCGATTATAGTGGGAAGCAGTGAAATATCGCTGGCCC 66 FBan0013791 FBgn0031923 CG13791 2 2L CG13791 CG13791 CDMC30542 4 17 10 DAC16-L17 1-CG13958-RA_1 CG13958 GGCCCAGTGCCTAGTCGACATGTCCAGTACAAGATACGCAAACCACGACCTCTATCAACCCACAGC 66 FBan0013958 FBgn0032825 CG13958 2 2L CG13958 CG13958 CDMC30542 4 18 10 DAC16-L17 1-CG13958-RA_1 CG13958 GGCCCAGTGCCTAGTCGACATGTCCAGTACAAGATACGCAAACCACGACCTCTATCAACCCACAGC 66 FBan0013958 FBgn0032825 CG13958 2 2L CG13958 CG13958 CDMC30543 4 19 10 DAC16-P05 1-CG14313-RA_1 CG14313 GGAGGACACCTTTAGCATCATGCAGCAGCGCAATATGTCGCCGGAGTCTATGAACTACCAGCCACG 66 FBan0014313 FBgn0038579 CG14313 3 3R CG14313 CG14313 CDMC30543 4 20 10 DAC16-P05 1-CG14313-RA_1 CG14313 GGAGGACACCTTTAGCATCATGCAGCAGCGCAATATGTCGCCGGAGTCTATGAACTACCAGCCACG 66 FBan0014313 FBgn0038579 CG14313 3 3R CG14313 CG14313 CDMC30544 4 21 10 DAC16-P17 AutoBlank AutoBlank CDMC30544 4 22 10 DAC16-P17 AutoBlank AutoBlank CDMC30545 4 23 10 DAC17-D05 3-CG17301-RA_1 CG17301 CGCTGGGGACGGTGGAGACTGCCTGAAGTTCTCGGATTTCATCCTCCGGAACATGGATCTTTACAAGAT 69 FBan0017301 FBgn0031442 CG17301 2 2L ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17301 CG17301 BcDNA:AT30033 CDMC30545 4 24 10 DAC17-D05 3-CG17301-RA_1 CG17301 CGCTGGGGACGGTGGAGACTGCCTGAAGTTCTCGGATTTCATCCTCCGGAACATGGATCTTTACAAGAT 69 FBan0017301 FBgn0031442 CG17301 2 2L ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG17301 CG17301 BcDNA:AT30033 CDMC30546 4 25 10 DAC17-D17 3-CG17323-RA_4 CG17323 ACCCAACATGCACATTATGAAGTGGTTGCCACAACGCGATATCCTCTGCCATCCCAACGTCAAGGTGTT 69 FBan0017323 FBgn0032713 CG17323 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG17323 CG17323 CT35071 CDMC30546 4 26 10 DAC17-D17 3-CG17323-RA_4 CG17323 ACCCAACATGCACATTATGAAGTGGTTGCCACAACGCGATATCCTCTGCCATCCCAACGTCAAGGTGTT 69 FBan0017323 FBgn0032713 CG17323 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG17323 CG17323 CT35071 CDMC30547 4 1 11 DAC17-H05 3-CG1736-RA_2 CG1736 GGCCACTGAACGAAGCGTTGACAAGCTCATGGACACCAGTATTCCTGTGCCAAGAATCTCGTGGTTGAA 69 FBan0001736 FBgn0039819 Prosalpha3T 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha3T Prosalpha3T "CG1736, CG1736, Prosalpha3T" CDMC30547 4 2 11 DAC17-H05 3-CG1736-RA_2 CG1736 GGCCACTGAACGAAGCGTTGACAAGCTCATGGACACCAGTATTCCTGTGCCAAGAATCTCGTGGTTGAA 69 FBan0001736 FBgn0039819 Prosalpha3T 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha3T Prosalpha3T "CG1736, CG1736, Prosalpha3T" CDMC30548 4 3 11 DAC17-H17 23-CG17378-RB_18 CG17378 AAAGCCAAACTAATCAGAGACAATATATATCGAATGTACCATGAGACGCAACTTTGGGGAGCTCGACAC 69 FBan0017378 FBgn0031858 CG17378 2 2L CG17378 CG17378 CDMC30548 4 4 11 DAC17-H17 23-CG17378-RB_18 CG17378 AAAGCCAAACTAATCAGAGACAATATATATCGAATGTACCATGAGACGCAACTTTGGGGAGCTCGACAC 69 FBan0017378 FBgn0031858 CG17378 2 2L CG17378 CG17378 CDMC30549 4 5 11 DAC17-L05 13-CG17443-RA_2 CG17443 TGGGACGTTGGAGTAGACACAAAATCAACTGATGGTCATCTTCTCTCCAAGTCCACTGCCCCATTGAGT 69 FBgn0039962 CG17443 CG17443 CG17443 CDMC30549 4 6 11 DAC17-L05 13-CG17443-RA_2 CG17443 TGGGACGTTGGAGTAGACACAAAATCAACTGATGGTCATCTTCTCTCCAAGTCCACTGCCCCATTGAGT 69 FBgn0039962 CG17443 CG17443 CG17443 CDMC30550 4 7 11 DAC17-L17 23-CG17472-RA_1 CG17472 CTACAAGTTCTCTAATCAGAAAAAAGAAGAGGTGTTTGTGAATAGTTTGAAGAAATGCTTTGCACCACC 69 FBan0017472 FBgn0032868 CG17472 2 2L CG17472 CG17472 "38D.23, BcDNA:GH20534" CDMC30550 4 8 11 DAC17-L17 23-CG17472-RA_1 CG17472 CTACAAGTTCTCTAATCAGAAAAAAGAAGAGGTGTTTGTGAATAGTTTGAAGAAATGCTTTGCACCACC 69 FBan0017472 FBgn0032868 CG17472 2 2L CG17472 CG17472 "38D.23, BcDNA:GH20534" CDMC30551 4 9 11 DAC17-P05 23-CG17510-RB_4 CG17510 TTGGTAATGCTCGTATCAAGGAGTATACGTCTGGCTTAAAATACTGCCGAGCTTTTCTTGACATCGAGT 69 FBan0017510 FBgn0039969 CG17510 2 2R CG17510 CG17510 "bs15a08.y1, NEST:bs15a08, BcDNA:RE29957" CDMC30551 4 10 11 DAC17-P05 23-CG17510-RB_4 CG17510 TTGGTAATGCTCGTATCAAGGAGTATACGTCTGGCTTAAAATACTGCCGAGCTTTTCTTGACATCGAGT 69 FBan0017510 FBgn0039969 CG17510 2 2R CG17510 CG17510 "bs15a08.y1, NEST:bs15a08, BcDNA:RE29957" CDMC30552 4 11 11 DAC17-P17 7-CG17522-RA_1 CG17522 CGGCTGCATTTCGAGACCGGTGTCCTTTTTCACGGCATCTTCAAGCAATTGCAGAGAGCTCTGTTCAAA 69 FBgn0034334 CDMC30552 4 12 11 DAC17-P17 7-CG17522-RA_1 CG17522 CGGCTGCATTTCGAGACCGGTGTCCTTTTTCACGGCATCTTCAAGCAATTGCAGAGAGCTCTGTTCAAA 69 FBgn0034334 CDMC30553 4 13 11 DAC18-D05 14-CG31316-RA_3 CG31316 TTGACGTTGTTGCAGGAATGACGAAGGGGACGTGAAATTTGCATATAAGCGAGTTGGCTCAAGGTGTGT 69 FBgn0051316 CG31316 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31316 CG31316 BcDNA:RH30043 CDMC30553 4 14 11 DAC18-D05 14-CG31316-RA_3 CG31316 TTGACGTTGTTGCAGGAATGACGAAGGGGACGTGAAATTTGCATATAAGCGAGTTGGCTCAAGGTGTGT 69 FBgn0051316 CG31316 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31316 CG31316 BcDNA:RH30043 CDMC30554 4 15 11 DAC18-D17 9-CG31327-RA_1 CG31327 CAGGGGCCATTCTACGAGCAGCTTGTCAAGTGATGCGCTTCTTTCTGATGGGCAAAAAGGATCGTAACA 69 FBan0031327 FBgn0051327 CG31327 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31327 CG31327 BcDNA:AT17065 CDMC30554 4 16 11 DAC18-D17 9-CG31327-RA_1 CG31327 CAGGGGCCATTCTACGAGCAGCTTGTCAAGTGATGCGCTTCTTTCTGATGGGCAAAAAGGATCGTAACA 69 FBan0031327 FBgn0051327 CG31327 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31327 CG31327 BcDNA:AT17065 CDMC30555 4 17 11 DAC18-H05 17-CG31361-RA_2 CG31361 GACCTTTATAGCGGATGAGCGATTCCAATCGATATATCAGGAGGATCACGACTACACCTGGTCCCTGCA 69 FBan0031361 FBgn0051361 dpr17 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr17 dpr17 "CG14738, CG31361, CG14737, CG14738, CG31361, CT34531, Dpr-17" CDMC30555 4 18 11 DAC18-H05 17-CG31361-RA_2 CG31361 GACCTTTATAGCGGATGAGCGATTCCAATCGATATATCAGGAGGATCACGACTACACCTGGTCCCTGCA 69 FBan0031361 FBgn0051361 dpr17 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr17 dpr17 "CG14738, CG31361, CG14737, CG14738, CG31361, CT34531, Dpr-17" CDMC30556 4 19 11 DAC18-H17 22-CG3136-RA_1 CG3136 CCAGTTAGCAAAACCCAAAGAGTGCGTAATTTTTACAAGGTGGGCTCTAGAAATCAAGCTACCGTCGCA 69 FBan0003136 FBgn0033010 CG3136 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG3136 CG3136 CDMC30556 4 20 11 DAC18-H17 22-CG3136-RA_1 CG3136 CCAGTTAGCAAAACCCAAAGAGTGCGTAATTTTTACAAGGTGGGCTCTAGAAATCAAGCTACCGTCGCA 69 FBan0003136 FBgn0033010 CG3136 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 CG3136 CG3136 CDMC30557 4 21 11 DAC18-L05 3-CG31411-RA_2 CG31411 ACACACACGGGGATTATCTGGAAGCGGAGACCAATCTGCATGACTACTGGAACTTCGAGGAACAACGCA 69 FBan0031411 FBgn0051411 CG31411 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31411 CG31411 "CG12949, CG12949" CDMC30557 4 22 11 DAC18-L05 3-CG31411-RA_2 CG31411 ACACACACGGGGATTATCTGGAAGCGGAGACCAATCTGCATGACTACTGGAACTTCGAGGAACAACGCA 69 FBan0031411 FBgn0051411 CG31411 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG31411 CG31411 "CG12949, CG12949" CDMC30558 4 23 11 DAC18-L17 12-CG31423-RA_4 CG31423 AACGCTATGGACAACATGAGGCAGGAGAGGATCATACTGTGGAGCGAAAGGGAACCCACGAAGATGTTG 69 FBan0031423 FBgn0051423 CG31423 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31423 CG31423 CDMC30558 4 24 11 DAC18-L17 12-CG31423-RA_4 CG31423 AACGCTATGGACAACATGAGGCAGGAGAGGATCATACTGTGGAGCGAAAGGGAACCCACGAAGATGTTG 69 FBan0031423 FBgn0051423 CG31423 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31423 CG31423 CDMC30559 4 25 11 DAC18-P05 8-CG31467-RA_1 CG31467 AGCACTATTTGCGACTGGTCGAGTTTATACTTATACGTCGGGATGAGCTTTCCGGTCCCCTGGGTCAGG 69 FBan0031467 FBgn0051467 CG31467 3 3R CG31467 CG31467 CG6471 CDMC30559 4 26 11 DAC18-P05 8-CG31467-RA_1 CG31467 AGCACTATTTGCGACTGGTCGAGTTTATACTTATACGTCGGGATGAGCTTTCCGGTCCCCTGGGTCAGG 69 FBan0031467 FBgn0051467 CG31467 3 3R CG31467 CG31467 CG6471 CDMC30560 4 1 12 DAC18-P17 3-CG31488-RA_1 CG31488 TGGGGGGAAGAGAAGGAACTGGAGTTCGGTTATTTGCGATACTTTTTCCGCTTTGTCGAGGACCGCAGT 69 FBan0031488 FBgn0051488 CG31488 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31488 CG31488 CDMC30560 4 2 12 DAC18-P17 3-CG31488-RA_1 CG31488 TGGGGGGAAGAGAAGGAACTGGAGTTCGGTTATTTGCGATACTTTTTCCGCTTTGTCGAGGACCGCAGT 69 FBan0031488 FBgn0051488 CG31488 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31488 CG31488 CDMC30561 4 3 12 DAC19-D05 9-CG6057-RA_1 CG6057 ACGGAAAAAGTGCAATCCACCAATGAGGAGTTTGAGAATGCGCGCAAGAAAGCAAAGAGGGCCAA 65 FBan0006057 FBgn0040283 SMC1 3 3R chromatin assembly or disassembly; GO:0006333; chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 DNA binding; GO:0003677; chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; nucleus; GO:0005634 SMC1 SMC1 "CG6057, DmSMC1" CDMC30561 4 4 12 DAC19-D05 9-CG6057-RA_1 CG6057 ACGGAAAAAGTGCAATCCACCAATGAGGAGTTTGAGAATGCGCGCAAGAAAGCAAAGAGGGCCAA 65 FBan0006057 FBgn0040283 SMC1 3 3R chromatin assembly or disassembly; GO:0006333; chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 DNA binding; GO:0003677; chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; nucleus; GO:0005634 SMC1 SMC1 "CG6057, DmSMC1" CDMC30562 4 5 12 DAC19-D17 3-CG6099-RA_1 CG6099 ACCTCAAGAACGCCCTCAAGGCCAACTCTTTGGAGTCTCTGGAATCCATGGAAAACAGCCGCAAC 65 FBan0006099 FBgn0002629 m4 3 3R Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423 nucleus; GO:0005634 m4 E(spl) region transcript m4 "CG6099, E(spl)m4" CDMC30562 4 6 12 DAC19-D17 3-CG6099-RA_1 CG6099 ACCTCAAGAACGCCCTCAAGGCCAACTCTTTGGAGTCTCTGGAATCCATGGAAAACAGCCGCAAC 65 FBan0006099 FBgn0002629 m4 3 3R Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423 nucleus; GO:0005634 m4 E(spl) region transcript m4 "CG6099, E(spl)m4" CDMC30563 4 7 12 DAC19-H05 8-CG6199-RA_2 CG6199 TGCCAAAGAGTATGCTACTGCCAAATTTGCTCTTTCCACTGACGAGTTGGATGAACGCCAGGGCA 65 FBan0006199 FBgn0036147 CG6199 3 3L protein metabolism; GO:0019538 procollagen-lysine 5-dioxygenase activity; GO:0008475 ; EC:1.14.11.4; ; GO:0008475 ; EC:1.14.11.4 CG6199 CG6199 "anon-WO0118547.416, anon-EST:ParkEST325" CDMC30563 4 8 12 DAC19-H05 8-CG6199-RA_2 CG6199 TGCCAAAGAGTATGCTACTGCCAAATTTGCTCTTTCCACTGACGAGTTGGATGAACGCCAGGGCA 65 FBan0006199 FBgn0036147 CG6199 3 3L protein metabolism; GO:0019538 procollagen-lysine 5-dioxygenase activity; GO:0008475 ; EC:1.14.11.4; ; GO:0008475 ; EC:1.14.11.4 CG6199 CG6199 "anon-WO0118547.416, anon-EST:ParkEST325" CDMC30564 4 9 12 DAC19-H17 2-CG6223-RA_1 CG6223 CTTCACCGACCTGCACGAATATCTCAAGCACCTGCTGAAGAGCACCAACATGAAGTGCCTCACGC 65 FBan0006223 FBgn0008635 betaCop X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126; Golgi apparatus; GO:0005794 betaCop beta-coatomer protein "CG6223, beta-COP, bcop, BcDNA.GH09317, beta-CopII, betaCOP, beta-Cop, BetaCop, betaCop, BcDNA:GH09317" CDMC30564 4 10 12 DAC19-H17 2-CG6223-RA_1 CG6223 CTTCACCGACCTGCACGAATATCTCAAGCACCTGCTGAAGAGCACCAACATGAAGTGCCTCACGC 65 FBan0006223 FBgn0008635 betaCop X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126; Golgi apparatus; GO:0005794 betaCop beta-coatomer protein "CG6223, beta-COP, bcop, BcDNA.GH09317, beta-CopII, betaCOP, beta-Cop, BetaCop, betaCop, BcDNA:GH09317" CDMC30565 4 11 12 DAC19-L05 23-CG6340-RC_2 CG6340 TAGCTTCTTCGATAGTGCGACAATCGATCAAATTTGTTATGACCACCACTGTGTGTGTAGTCCTG 65 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC30565 4 12 12 DAC19-L05 23-CG6340-RC_2 CG6340 TAGCTTCTTCGATAGTGCGACAATCGATCAAATTTGTTATGACCACCACTGTGTGTGTAGTCCTG 65 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC30566 4 13 12 DAC19-L17 14-CG6364-RA_2 CG6364 CCCAAGATACGAGAACTGTTCCACATGAAGCTGTTCGTGGACACAGACTCCGATACCAGGTTGGC 65 FBan0006364 FBgn0039179 CG6364 3 3R biosynthesis; GO:0009058; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; uridine kinase activity; GO:0004849 ; EC:2.7.1.48; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004849 ; EC:2.7.1.48; ; GO:0004849 ; EC:2.7.1.48 CG6364 CG6364 CDMC30566 4 14 12 DAC19-L17 14-CG6364-RA_2 CG6364 CCCAAGATACGAGAACTGTTCCACATGAAGCTGTTCGTGGACACAGACTCCGATACCAGGTTGGC 65 FBan0006364 FBgn0039179 CG6364 3 3R biosynthesis; GO:0009058; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; uridine kinase activity; GO:0004849 ; EC:2.7.1.48; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004849 ; EC:2.7.1.48; ; GO:0004849 ; EC:2.7.1.48 CG6364 CG6364 CDMC30567 4 15 12 DAC19-P05 1-CG6460-RA_1 CG6460 CAACGCCCAGAGTGCCATTCAGGGTCAGTACGATCAGTTGGGAGGATCCAGTCAGTCCCAGAATG 65 FBan0006460 FBgn0039439 CG6460 3 3R CG6460 CG6460 CDMC30567 4 16 12 DAC19-P05 1-CG6460-RA_1 CG6460 CAACGCCCAGAGTGCCATTCAGGGTCAGTACGATCAGTTGGGAGGATCCAGTCAGTCCCAGAATG 65 FBan0006460 FBgn0039439 CG6460 3 3R CG6460 CG6460 CDMC30568 4 17 12 DAC19-P17 2-CG6477-RA_1 CG6477 CTTGGACGAGTCCGATCTGAGCCCCAGTCTGCTCTACTGCCTGGACGGAAATGAGCCAACTTTAG 65 FBan0006477 FBgn0034249 RhoGAP54D 2 2R RhoGAP54D RhoGAP54D "CG6477, CG6477, CG6477, CG6477" CDMC30568 4 18 12 DAC19-P17 2-CG6477-RA_1 CG6477 CTTGGACGAGTCCGATCTGAGCCCCAGTCTGCTCTACTGCCTGGACGGAAATGAGCCAACTTTAG 65 FBan0006477 FBgn0034249 RhoGAP54D 2 2R RhoGAP54D RhoGAP54D "CG6477, CG6477, CG6477, CG6477" CDMC30569 4 19 12 DAC20-D05 23-CG30098-RA_2 CG30098 ATTCAGGCGGTCCATTGGGGTCACTTGTGAAATACGGACATAAAACCATATATGTTCAGTTTGGA 65 FBan0030098 FBgn0050098 CG30098 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30098 CG30098 CDMC30569 4 20 12 DAC20-D05 23-CG30098-RA_2 CG30098 ATTCAGGCGGTCCATTGGGGTCACTTGTGAAATACGGACATAAAACCATATATGTTCAGTTTGGA 65 FBan0030098 FBgn0050098 CG30098 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30098 CG30098 CDMC30570 4 21 12 DAC20-D17 23-CG30145-RA_1 CG30145 GGATTTGGGTCTGATTGATGAACGGGGTAATGTGCAGATCGATAAGTACATGAAATCCGGAGTGG 65 FBan0030145 FBgn0050145 Obp57e 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57e Odorant-binding protein 57e "CG13429, CG30145, CG13429, CG13429, CG13429, CG13429, CG13429, OBP57e, 57e, Obp57d, Odorant-binding protein 57e" CDMC30570 4 22 12 DAC20-D17 23-CG30145-RA_1 CG30145 GGATTTGGGTCTGATTGATGAACGGGGTAATGTGCAGATCGATAAGTACATGAAATCCGGAGTGG 65 FBan0030145 FBgn0050145 Obp57e 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp57e Odorant-binding protein 57e "CG13429, CG30145, CG13429, CG13429, CG13429, CG13429, CG13429, OBP57e, 57e, Obp57d, Odorant-binding protein 57e" CDMC30571 4 23 12 DAC20-H05 9-CG3026-RA_1 CG3026 GACCTGGGGTTGCTCAAGTTTCGGGCCCTATATGAGGATTCCGCAAAGAATGCCCAGCTCACAGT 65 FBan0003026 FBgn0040347 mus81 X X meiotic recombination; GO:0007131 crossover junction endodeoxyribonuclease activity; GO:0008821 ; EC:3.1.22.-; ; GO:0008821 ; EC:3.1.22.- mus81 mus81 "CG3026, CG3026, EG:BACR7A4.16" CDMC30571 4 24 12 DAC20-H05 9-CG3026-RA_1 CG3026 GACCTGGGGTTGCTCAAGTTTCGGGCCCTATATGAGGATTCCGCAAAGAATGCCCAGCTCACAGT 65 FBan0003026 FBgn0040347 mus81 X X meiotic recombination; GO:0007131 crossover junction endodeoxyribonuclease activity; GO:0008821 ; EC:3.1.22.-; ; GO:0008821 ; EC:3.1.22.- mus81 mus81 "CG3026, CG3026, EG:BACR7A4.16" CDMC30572 4 25 12 DAC20-H17 3-CG30324-RA_1 CG30324 ATGGTGGACGAGGATGGACGAAAGCGGTACTGCTACCATGGTGGAAAATGCAAGTGTGCCACTTG 65 FBan0030324 FBgn0050324 CG30324 2 2R CG30324 CG30324 "CG7750, CG7750" CDMC30572 4 26 12 DAC20-H17 3-CG30324-RA_1 CG30324 ATGGTGGACGAGGATGGACGAAAGCGGTACTGCTACCATGGTGGAAAATGCAAGTGTGCCACTTG 65 FBan0030324 FBgn0050324 CG30324 2 2R CG30324 CG30324 "CG7750, CG7750" CDMC30573 4 1 13 DAC20-L05 1-CG30410-RA_1 CG30410 ACATGTTATCTGGGTTTTTGCGACGAGGCGTCCAAAGAGCACGGTTCACCTTCACCCAGCAACTC 65 FBan0030410 FBgn0050410 CG30410 2 2R "carbohydrate metabolism; GO:0005975; pentose-phosphate shunt; GO:0006098; pentose-phosphate shunt, non-oxidative branch; GO:0009052" isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; ribose-5-phosphate isomerase activity; GO:0004751 ; EC:5.3.1.6; ; GO:0004751 ; EC:5.3.1.6 CG30410 CG30410 CG9872 CDMC30573 4 2 13 DAC20-L05 1-CG30410-RA_1 CG30410 ACATGTTATCTGGGTTTTTGCGACGAGGCGTCCAAAGAGCACGGTTCACCTTCACCCAGCAACTC 65 FBan0030410 FBgn0050410 CG30410 2 2R "carbohydrate metabolism; GO:0005975; pentose-phosphate shunt; GO:0006098; pentose-phosphate shunt, non-oxidative branch; GO:0009052" isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; ribose-5-phosphate isomerase activity; GO:0004751 ; EC:5.3.1.6; ; GO:0004751 ; EC:5.3.1.6 CG30410 CG30410 CG9872 CDMC30574 4 3 13 DAC20-L17 2-CG30424-RA_4 CG30424 ACTGATTCAGGGTCGACTCGTGGATGCGCAAAACTTTTTCGTCGTGGACAGGCTTCGTTCTTGGC 65 FBan0030424 FBgn0050424 CG30424 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30424 CG30424 CDMC30574 4 4 13 DAC20-L17 2-CG30424-RA_4 CG30424 ACTGATTCAGGGTCGACTCGTGGATGCGCAAAACTTTTTCGTCGTGGACAGGCTTCGTTCTTGGC 65 FBan0030424 FBgn0050424 CG30424 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30424 CG30424 CDMC30575 4 5 13 DAC20-P05 1-CG3074-RB_1 CG3074 CCTGGCCCTACGTCTACAGCTACTACAATGTGAAGTCGGCTTAAGGGGAATCAGAGGGCCTACGC 65 FBan0003074 FBgn0034709 CG3074 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 cathepsin B activity; GO:0004213 ; EC:3.4.22.1; ; GO:0004213 ; EC:3.4.22.1 CG3074 CG3074 CDMC30575 4 6 13 DAC20-P05 1-CG3074-RB_1 CG3074 CCTGGCCCTACGTCTACAGCTACTACAATGTGAAGTCGGCTTAAGGGGAATCAGAGGGCCTACGC 65 FBan0003074 FBgn0034709 CG3074 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 cathepsin B activity; GO:0004213 ; EC:3.4.22.1; ; GO:0004213 ; EC:3.4.22.1 CG3074 CG3074 CDMC30576 4 7 13 DAC20-P17 2-CG31031-RA_1 CG31031 TTCGTTCTACGGCGAAGATGTGATCCCCGGTTCTAGTTTCTACGAGTGCGATTCCAAGCCGCAGC 65 FBan0031031 FBgn0051031 CG31031 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31031 CG31031 CDMC30576 4 8 13 DAC20-P17 2-CG31031-RA_1 CG31031 TTCGTTCTACGGCGAAGATGTGATCCCCGGTTCTAGTTTCTACGAGTGCGATTCCAAGCCGCAGC 65 FBan0031031 FBgn0051031 CG31031 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31031 CG31031 CDMC30577 4 9 13 DAC21-D05 3-CG4004-RB_1 CG4004 GGACCTCGTATCGCCGGGAATTGCGAAAGGTGCTGGATAGTGGGAACACATATAAGCCAACGCTTTGG 68 FBan0004004 FBgn0030418 CG4004 X X CG4004 CG4004 "CG18137, CG18137" CDMC30577 4 10 13 DAC21-D05 3-CG4004-RB_1 CG4004 GGACCTCGTATCGCCGGGAATTGCGAAAGGTGCTGGATAGTGGGAACACATATAAGCCAACGCTTTGG 68 FBan0004004 FBgn0030418 CG4004 X X CG4004 CG4004 "CG18137, CG18137" CDMC30578 4 11 13 DAC21-D17 15-CG40442-RA_1 CG40442 TCATTCCAGGGGGGGAGGAGTTACCGATATCGCAGTACAGAGTATACACGATACCAACACGGTACCAA 68 FBgn0058442 CG40442 CG40442 CG40442 CDMC30578 4 12 13 DAC21-D17 15-CG40442-RA_1 CG40442 TCATTCCAGGGGGGGAGGAGTTACCGATATCGCAGTACAGAGTATACACGATACCAACACGGTACCAA 68 FBgn0058442 CG40442 CG40442 CG40442 CDMC30579 4 13 13 DAC21-H05 2-CG4450-RA_1 CG4450 AGCCACACGAGGCCTTCTTCTACGTGGAACTGGTCTGCAACGTCTGGTTCTTCATCGAGGTCATCATC 68 FBan0004450 FBgn0032113 CG4450 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG4450 CG4450 CDMC30579 4 14 13 DAC21-H05 2-CG4450-RA_1 CG4450 AGCCACACGAGGCCTTCTTCTACGTGGAACTGGTCTGCAACGTCTGGTTCTTCATCGAGGTCATCATC 68 FBan0004450 FBgn0032113 CG4450 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG4450 CG4450 CDMC30580 4 15 13 DAC21-H17 3-CG4622-RA_2 CG4622 TGGTGAAACTGCAGAACGAGAACTGACGAGACCAGGGAGACGGCAATACAAACCACATCAATTCCCGC 68 FBan0004622 FBgn0035021 CG4622 2 2R CG4622 CG4622 CDMC30580 4 16 13 DAC21-H17 3-CG4622-RA_2 CG4622 TGGTGAAACTGCAGAACGAGAACTGACGAGACCAGGGAGACGGCAATACAAACCACATCAATTCCCGC 68 FBan0004622 FBgn0035021 CG4622 2 2R CG4622 CG4622 CDMC30581 4 17 13 DAC21-L05 3-CG5125-RB_1 CG5125 ATGCTGCGCAAGACTAACTATCCGAGGGGATCCGAGACCAACACCTATGACTTTAACAATCGCCGCGG 68 FBan0005125 FBgn0002938 ninaC 2 2L "adaptation of rhodopsin mediated signaling; GO:0016062; cytoskeleton organization and biogenesis; GO:0007010; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular protein transport; GO:0006886; phototransduction, UV; GO:0007604; phototransduction, visible light; GO:0007603; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104" "calmodulin binding; GO:0005516; ; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; phosphoinositide binding; GO:0035091; ; GO:0004713 ; EC:2.7.1.112; ; GO:0003774; ; GO:0035091" cytoplasm; GO:0005737; cytoskeleton; GO:0005856; inaD signaling complex; GO:0016027; myosin; GO:0016459; myosin III; GO:0042385; rhabdomere; GO:0016028; unconventional myosin; GO:0016461 ninaC neither inactivation nor afterpotential C "CG54125, CG5125, CG54125, CG5125, myosin-III, myosin III, DRONINAC, 2.2, NINAC, CT16120, CT42491, NINA C, Dm NinaC, NinaC, Droninac, Nina C" CDMC30581 4 18 13 DAC21-L05 3-CG5125-RB_1 CG5125 ATGCTGCGCAAGACTAACTATCCGAGGGGATCCGAGACCAACACCTATGACTTTAACAATCGCCGCGG 68 FBan0005125 FBgn0002938 ninaC 2 2L "adaptation of rhodopsin mediated signaling; GO:0016062; cytoskeleton organization and biogenesis; GO:0007010; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular protein transport; GO:0006886; phototransduction, UV; GO:0007604; phototransduction, visible light; GO:0007603; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104" "calmodulin binding; GO:0005516; ; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; phosphoinositide binding; GO:0035091; ; GO:0004713 ; EC:2.7.1.112; ; GO:0003774; ; GO:0035091" cytoplasm; GO:0005737; cytoskeleton; GO:0005856; inaD signaling complex; GO:0016027; myosin; GO:0016459; myosin III; GO:0042385; rhabdomere; GO:0016028; unconventional myosin; GO:0016461 ninaC neither inactivation nor afterpotential C "CG54125, CG5125, CG54125, CG5125, myosin-III, myosin III, DRONINAC, 2.2, NINAC, CT16120, CT42491, NINA C, Dm NinaC, NinaC, Droninac, Nina C" CDMC30582 4 19 13 DAC21-L17 3-CG5202-RA_3 CG5202 GCGTCATTCGCATATTCAATCCGGTTAAGCACCAGTGCAGCAAAAACTACATTGGTCACGGGCACGCC 68 FBan0005202 FBgn0032391 escl 2 2L "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 polytene chromosome; GO:0005700 escl escl "CG5202, CG5202, esc-like, ESC-LIKE" CDMC30582 4 20 13 DAC21-L17 3-CG5202-RA_3 CG5202 GCGTCATTCGCATATTCAATCCGGTTAAGCACCAGTGCAGCAAAAACTACATTGGTCACGGGCACGCC 68 FBan0005202 FBgn0032391 escl 2 2L "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; transcription from RNA polymerase II promoter; GO:0006366" protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 polytene chromosome; GO:0005700 escl escl "CG5202, CG5202, esc-like, ESC-LIKE" CDMC30583 4 21 13 DAC21-P05 2-CG5653-RA_2 CG5653 CCGATGAAAGGAATACGGGCCCCTGGGATCTAGAGTCTCCTGTGTTGGGCGAAGATGGTCATTTAGGC 68 FBan0005653 FBgn0035943 CG5653 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG5653 CG5653 CDMC30583 4 22 13 DAC21-P05 2-CG5653-RA_2 CG5653 CCGATGAAAGGAATACGGGCCCCTGGGATCTAGAGTCTCCTGTGTTGGGCGAAGATGGTCATTTAGGC 68 FBan0005653 FBgn0035943 CG5653 3 3L electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG5653 CG5653 CDMC30584 4 23 13 DAC21-P17 5-CG5742-RA_1 CG5742 TCCCACACATTTCATGTCGCGTTTAGTGATCACTCCAGCAAAAGTCGGAGGATACAGCTCGAACGCGG 68 FBan0005742 FBgn0034304 CG5742 2 2R CG5742 CG5742 CDMC30584 4 24 13 DAC21-P17 5-CG5742-RA_1 CG5742 TCCCACACATTTCATGTCGCGTTTAGTGATCACTCCAGCAAAAGTCGGAGGATACAGCTCGAACGCGG 68 FBan0005742 FBgn0034304 CG5742 2 2R CG5742 CG5742 CDMC30585 4 25 13 DAC22-D05 23-CG4046-RA_2 CG4046 ACCAGAAGTCGTACCGTTAAACTACTCTGTCTGGTTTTCAATTTGGATTAGAGCTATTTTTTACAATTT 69 FBan0004046 FBgn0034743 RpS16 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS16 Ribosomal protein S16 "CG4046, bs32d05.y1, Ribosomal protein S16" CDMC30585 4 26 13 DAC22-D05 23-CG4046-RA_2 CG4046 ACCAGAAGTCGTACCGTTAAACTACTCTGTCTGGTTTTCAATTTGGATTAGAGCTATTTTTTACAATTT 69 FBan0004046 FBgn0034743 RpS16 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS16 Ribosomal protein S16 "CG4046, bs32d05.y1, Ribosomal protein S16" CDMC30586 4 1 14 DAC22-D17 3-CG40498-RA_1 CG40498 TCCAACAGGATCCGTGAGGCGAAAATACCACCATCCTCGTAATGCAGTTAGTTCTGGCACCGGAATGCT 69 FBgn0069969 CG40498 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40498 CG40498 CDMC30586 4 2 14 DAC22-D17 3-CG40498-RA_1 CG40498 TCCAACAGGATCCGTGAGGCGAAAATACCACCATCCTCGTAATGCAGTTAGTTCTGGCACCGGAATGCT 69 FBgn0069969 CG40498 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40498 CG40498 CDMC30587 4 3 14 DAC22-H05 3-CG4074-RA_2 CG4074 GCAATGTACTGCCGAAGCTAGAACTACCCATCCATATGGTCCTGCCCAGATTGTTCACCTGCCCTACGT 69 FBan0004074 FBgn0037017 CG4074 3 3L development; GO:0007275; intracellular protein transport; GO:0006886 CG4074 CG4074 CDMC30587 4 4 14 DAC22-H05 3-CG4074-RA_2 CG4074 GCAATGTACTGCCGAAGCTAGAACTACCCATCCATATGGTCCTGCCCAGATTGTTCACCTGCCCTACGT 69 FBan0004074 FBgn0037017 CG4074 3 3L development; GO:0007275; intracellular protein transport; GO:0006886 CG4074 CG4074 CDMC30588 4 5 14 DAC22-H17 2-CG4089-RA_1 CG4089 CCGGTATTGCCCGGTGAAATACCATCCCTTCGATGCCGAGAATGTGGACAAGTACATTGTGGGGGATGA 69 FBan0004089 FBgn0037838 CG4089 3 3R CG4089 CG4089 CDMC30588 4 6 14 DAC22-H17 2-CG4089-RA_1 CG4089 CCGGTATTGCCCGGTGAAATACCATCCCTTCGATGCCGAGAATGTGGACAAGTACATTGTGGGGGATGA 69 FBan0004089 FBgn0037838 CG4089 3 3R CG4089 CG4089 CDMC30589 4 7 14 DAC22-L05 2-CG4107-RA_1 CG4107 GCGGTCACCATGTCGGAACAAGTTAAGGGCTATGGCACGCACTTGATGAACCACTTGAAGGACTACAGC 69 FBan0004107 FBgn0020388 Pcaf 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 SAGA complex; GO:0000124; polytene chromosome; GO:0005700 Pcaf Pcaf "CG4107, CG4107, dPCAF, dGCN5, PCAF, Gcn5, p/CAF, dGCN5 HAT, Gcn5/PCAF, dGcn5, gcn5, dmHAG401, P/CAF, GCN5, anon-WO0172774.89" CDMC30589 4 8 14 DAC22-L05 2-CG4107-RA_1 CG4107 GCGGTCACCATGTCGGAACAAGTTAAGGGCTATGGCACGCACTTGATGAACCACTTGAAGGACTACAGC 69 FBan0004107 FBgn0020388 Pcaf 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 SAGA complex; GO:0000124; polytene chromosome; GO:0005700 Pcaf Pcaf "CG4107, CG4107, dPCAF, dGCN5, PCAF, Gcn5, p/CAF, dGCN5 HAT, Gcn5/PCAF, dGcn5, gcn5, dmHAG401, P/CAF, GCN5, anon-WO0172774.89" CDMC30590 4 9 14 DAC22-L17 15-CG41099-RB_3 CG41099 TTACGTGATAAGTCTGGAAACACACCGTTTGCAACTGCTTTGGACTTCCGTAATCACAACGCTGCCCAA 69 FBgn0039955 CG41099 cell adhesion; GO:0007155; ion transport; GO:0006811; transport; GO:0006810 receptor signaling protein activity; GO:0005057; zinc ion binding; GO:0008270; ; GO:0005057; ; GO:0008270 CG41099 CG41099 "CG17419, CG17416, CG17419, CG17419, CG17419, CG17416, GM10035, BEST:GM10035" CDMC30590 4 10 14 DAC22-L17 15-CG41099-RB_3 CG41099 TTACGTGATAAGTCTGGAAACACACCGTTTGCAACTGCTTTGGACTTCCGTAATCACAACGCTGCCCAA 69 FBgn0039955 CG41099 cell adhesion; GO:0007155; ion transport; GO:0006811; transport; GO:0006810 receptor signaling protein activity; GO:0005057; zinc ion binding; GO:0008270; ; GO:0005057; ; GO:0008270 CG41099 CG41099 "CG17419, CG17416, CG17419, CG17419, CG17419, CG17416, GM10035, BEST:GM10035" CDMC30591 4 11 14 DAC22-P05 2-CG4118-RA_6 CG4118 GCATCCACAGTCTGGGCAACCTACCTCTGAAGTCCCTGGTACTTCACGGAAATAAACTCTGCCGCAACT 69 FBan0004118 FBgn0036640 nxf2 3 3L mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nucleoplasm; GO:0005654 nxf2 nuclear RNA export factor 2 "CG4118, NXF2" CDMC30591 4 12 14 DAC22-P05 2-CG4118-RA_6 CG4118 GCATCCACAGTCTGGGCAACCTACCTCTGAAGTCCCTGGTACTTCACGGAAATAAACTCTGCCGCAACT 69 FBan0004118 FBgn0036640 nxf2 3 3L mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nucleoplasm; GO:0005654 nxf2 nuclear RNA export factor 2 "CG4118, NXF2" CDMC30592 4 13 14 DAC22-P17 16-CG4124-RA_1 CG4124 GGGCCTTTTAGTGTGGGTACTTTGCATTATAATGTATCAATCGTGGCGGTGTTATCCCCGGATCGAGTT 69 FBgn0031291 CDMC30592 4 14 14 DAC22-P17 16-CG4124-RA_1 CG4124 GGGCCTTTTAGTGTGGGTACTTTGCATTATAATGTATCAATCGTGGCGGTGTTATCCCCGGATCGAGTT 69 FBgn0031291 CDMC30593 4 15 14 DAC23-D05 5-CG3340-RA_1 CG3340 CACTGCGATCGTCAATTCGTTCAGGTGGCCAATCTTAGACGACATTTGCGAGTCCACACTGGAGAGCGT 69 FBan0003340 FBgn0001325 Kr 2 2R "Malpighian tubule morphogenesis; GO:0007443; axon guidance; GO:0007411; cell proliferation; GO:0008283; eye development (sensu Endopterygota); GO:0007456; ganglion mother cell fate determination; GO:0007402; muscle development; GO:0007517; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; neuroblast fate determination; GO:0007400; regulation of development, heterochronic; GO:0040034; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; specific RNA polymerase II transcription factor activity; GO:0003704; specific transcriptional repressor activity; GO:0016566; transcriptional repressor activity; GO:0016564; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 Kr Kruppel "CG3340, CG3340, If: Irregular facets, Krpple, kr, kruppel, Irregular facets, If" CDMC30593 4 16 14 DAC23-D05 5-CG3340-RA_1 CG3340 CACTGCGATCGTCAATTCGTTCAGGTGGCCAATCTTAGACGACATTTGCGAGTCCACACTGGAGAGCGT 69 FBan0003340 FBgn0001325 Kr 2 2R "Malpighian tubule morphogenesis; GO:0007443; axon guidance; GO:0007411; cell proliferation; GO:0008283; eye development (sensu Endopterygota); GO:0007456; ganglion mother cell fate determination; GO:0007402; muscle development; GO:0007517; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; neuroblast fate determination; GO:0007400; regulation of development, heterochronic; GO:0040034; trunk segmentation; GO:0035290; ventral cord development; GO:0007419; zygotic determination of anterior/posterior axis, embryo; GO:0007354" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682; specific RNA polymerase II transcription factor activity; GO:0003704; specific transcriptional repressor activity; GO:0016566; transcriptional repressor activity; GO:0016564; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 Kr Kruppel "CG3340, CG3340, If: Irregular facets, Krpple, kr, kruppel, Irregular facets, If" CDMC30594 4 17 14 DAC23-D17 2-CG33457-RA_1 CG33457 GCAGTGGCATACCATTGGGTACTGGCCGTTACAGCATTCGCGTGCAGGTATTTGCATATGACCAGAAGG 69 FBgn0053457 CDMC30594 4 18 14 DAC23-D17 2-CG33457-RA_1 CG33457 GCAGTGGCATACCATTGGGTACTGGCCGTTACAGCATTCGCGTGCAGGTATTTGCATATGACCAGAAGG 69 FBgn0053457 CDMC30595 4 19 14 DAC23-H05 12-CG3347-RA_3 CG3347 AAGACTAGTTCCCAGCGAGCTTATTCTCTGTCGCCTATTCCATCTCCCAAGTCATACAGGGCTGCGAGG 69 FBan0003347 FBgn0031513 CG3347 2 2L CG3347 CG3347 CDMC30595 4 20 14 DAC23-H05 12-CG3347-RA_3 CG3347 AAGACTAGTTCCCAGCGAGCTTATTCTCTGTCGCCTATTCCATCTCCCAAGTCATACAGGGCTGCGAGG 69 FBan0003347 FBgn0031513 CG3347 2 2L CG3347 CG3347 CDMC30596 4 21 14 DAC23-H17 1-CG33484-RA_1 CG33484 GCCCCCGCGTCACTTATTCGTCTTGTGGGCTGATGATGGACTTACAAAATGTCGCCCAAAACAACCCAT 69 FBgn0035303 CDMC30596 4 22 14 DAC23-H17 1-CG33484-RA_1 CG33484 GCCCCCGCGTCACTTATTCGTCTTGTGGGCTGATGATGGACTTACAAAATGTCGCCCAAAACAACCCAT 69 FBgn0035303 CDMC30597 4 23 14 DAC23-L05 15-CG3360-RA_1 CG3360 CCGGATAACTTCTTGGCGGAAAACATGGAACAAAAGCACCCATATGCCTACATTCCATTTGCGAGGGGA 69 FBan0003360 FBgn0038236 Cyp313a1 3 3R electron transport; GO:0006118; insecticide metabolism; GO:0017143; protein biosynthesis; GO:0006412; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; structural constituent of ribosome; GO:0003735; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003735; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 intracellular; GO:0005622; membrane; GO:0016020; microsome; GO:0005792; ribosome; GO:0005840 Cyp313a1 Cyp313a1 "CG3360, Cyp313a1p, 313a1, 313a1p" CDMC30597 4 24 14 DAC23-L05 15-CG3360-RA_1 CG3360 CCGGATAACTTCTTGGCGGAAAACATGGAACAAAAGCACCCATATGCCTACATTCCATTTGCGAGGGGA 69 FBan0003360 FBgn0038236 Cyp313a1 3 3R electron transport; GO:0006118; insecticide metabolism; GO:0017143; protein biosynthesis; GO:0006412; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; structural constituent of ribosome; GO:0003735; ; GO:0016491 ; EC:1.-.-.-; ; GO:0003735; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 intracellular; GO:0005622; membrane; GO:0016020; microsome; GO:0005792; ribosome; GO:0005840 Cyp313a1 Cyp313a1 "CG3360, Cyp313a1p, 313a1, 313a1p" CDMC30598 4 25 14 DAC23-L17 24-CG3379-RB_2 CG3379 ACTTAACTACATTCAAAATACTTGATCCAATTGAATCTTAATCAGTAGTATTCAACGCAAACTTAACCG 69 FBan0003379 FBgn0013981 His4r 3 3R chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His4r Histone H4 replacement "CG3379, H4r, His4R, BcDNA:RH52884, His4-88CD" CDMC30598 4 26 14 DAC23-L17 24-CG3379-RB_2 CG3379 ACTTAACTACATTCAAAATACTTGATCCAATTGAATCTTAATCAGTAGTATTCAACGCAAACTTAACCG 69 FBan0003379 FBgn0013981 His4r 3 3R chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His4r Histone H4 replacement "CG3379, H4r, His4R, BcDNA:RH52884, His4-88CD" CDMC30599 4 1 15 DAC23-P05 11-CG3421-RA_2 CG3421 GCCAGCCAGTCTGCTTAAGCTGTGGTACCGAGAACTGTACGATCCACTTATACCGGATGCCTACTACGA 69 FBan0003421 FBgn0038853 RhoGAP93B 3 3R axon guidance; GO:0007411 cytoskeleton; GO:0005856 RhoGAP93B RhoGAP93B "CG3421, CG3421, CG3421, vilse" CDMC30599 4 2 15 DAC23-P05 11-CG3421-RA_2 CG3421 GCCAGCCAGTCTGCTTAAGCTGTGGTACCGAGAACTGTACGATCCACTTATACCGGATGCCTACTACGA 69 FBan0003421 FBgn0038853 RhoGAP93B 3 3R axon guidance; GO:0007411 cytoskeleton; GO:0005856 RhoGAP93B RhoGAP93B "CG3421, CG3421, CG3421, vilse" CDMC30600 4 3 15 DAC23-P17 14-CG3441-RA_2 CG3441 ACTCCGCCGCGTATCACAGCACTGCATCGACGAGAATTTCGACGCAACTCGCAAAATTACGAATACTAA 69 FBan0003441 FBgn0035092 Nplp1 2 2R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp1 Neuropeptide-like precursor 1 "CG3441, CG3441, CG3441, NPLP1, MTYamide peptide, IPNamide peptide, APK peptide, neuropeptide-like precursor 1, Neuropeptide-like precursor 1" CDMC30600 4 4 15 DAC23-P17 14-CG3441-RA_2 CG3441 ACTCCGCCGCGTATCACAGCACTGCATCGACGAGAATTTCGACGCAACTCGCAAAATTACGAATACTAA 69 FBan0003441 FBgn0035092 Nplp1 2 2R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Nplp1 Neuropeptide-like precursor 1 "CG3441, CG3441, CG3441, NPLP1, MTYamide peptide, IPNamide peptide, APK peptide, neuropeptide-like precursor 1, Neuropeptide-like precursor 1" CDMC30601 4 5 15 DAC24-D05 3-CG33177-RA_3 CG33177 CCGGCTGATTTTGCTTAGCAAATCGAATCCCGTGATGGGTTGCTACATGTTCTGGACCAGTCTGCTCGT 69 FBan0033177 FBgn0053177 CG33177 X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG33177 CG33177 CG5579 CDMC30601 4 6 15 DAC24-D05 3-CG33177-RA_3 CG33177 CCGGCTGATTTTGCTTAGCAAATCGAATCCCGTGATGGGTTGCTACATGTTCTGGACCAGTCTGCTCGT 69 FBan0033177 FBgn0053177 CG33177 X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG33177 CG33177 CG5579 CDMC30602 4 7 15 DAC24-D17 23-CG33188-RB_3 CG33188 ATATGTAAATCGTGTGAAGCATACACACATATAGTTTCTTTGGGTATATGCACATTAAGGCGAAAAACA 69 FBgn0053188 CDMC30602 4 8 15 DAC24-D17 23-CG33188-RB_3 CG33188 ATATGTAAATCGTGTGAAGCATACACACATATAGTTTCTTTGGGTATATGCACATTAAGGCGAAAAACA 69 FBgn0053188 CDMC30603 4 9 15 DAC24-H05 1-CG33207-RA_1 CG33207 TTCCATGTGGAAAAACTGTAACTCGGCACTCGTCTAATCTGGGGCAAGTGTTTGTTTAGGCGCTGGCGA 69 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC30603 4 10 15 DAC24-H05 1-CG33207-RA_1 CG33207 TTCCATGTGGAAAAACTGTAACTCGGCACTCGTCTAATCTGGGGCAAGTGTTTGTTTAGGCGCTGGCGA 69 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC30604 4 11 15 DAC24-H17 23-CG33217-RA_10 CG33217 TTTGCTCTCATCAAAAATCAACAGTTCAGAGAGTTTACAAGGACAACCCCTAGAAATTTTGAATGGCAA 69 FBan0033217 FBgn0053217 CG33217 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33217 CG33217 BcDNA:RE15216 CDMC30604 4 12 15 DAC24-H17 23-CG33217-RA_10 CG33217 TTTGCTCTCATCAAAAATCAACAGTTCAGAGAGTTTACAAGGACAACCCCTAGAAATTTTGAATGGCAA 69 FBan0033217 FBgn0053217 CG33217 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33217 CG33217 BcDNA:RE15216 CDMC30605 4 13 15 DAC24-L05 14-CG33259-RA_1 CG33259 TCGGCGGTAAAGTGCTTTGCTGAGAAAGTCGATTGTTCAGTAAATGGAACTCAAACGGATTGCCCCACA 69 FBgn0053259 CDMC30605 4 14 15 DAC24-L05 14-CG33259-RA_1 CG33259 TCGGCGGTAAAGTGCTTTGCTGAGAAAGTCGATTGTTCAGTAAATGGAACTCAAACGGATTGCCCCACA 69 FBgn0053259 CDMC30606 4 15 15 DAC24-L17 17-CG33262-RA_2 CG33262 TGCTGGTATTGGTATTCCTGCGGATCTTGAGTATGAATCCCTGACTGTTGGCTATGTCCTTAAAGCGGA 69 FBan0033262 FBgn0053262 CG33262 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33262 CG33262 CDMC30606 4 16 15 DAC24-L17 17-CG33262-RA_2 CG33262 TGCTGGTATTGGTATTCCTGCGGATCTTGAGTATGAATCCCTGACTGTTGGCTATGTCCTTAAAGCGGA 69 FBan0033262 FBgn0053262 CG33262 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33262 CG33262 CDMC30607 4 17 15 DAC24-P05 6-CG33305-RA_1 CG33305 CGCGATGAATACAGTCCGCACAGAGGTGGTGGGAGTAGTAGGAGAATGCTTAATGCCATGTCCAGACCT 69 FBgn0053305 CDMC30607 4 18 15 DAC24-P05 6-CG33305-RA_1 CG33305 CGCGATGAATACAGTCCGCACAGAGGTGGTGGGAGTAGTAGGAGAATGCTTAATGCCATGTCCAGACCT 69 FBgn0053305 CDMC30608 4 19 15 DAC24-P17 15-CG33320-RA_4 CG33320 GCGATTGGCCTCCGTGAAGCTTTCGATATGAGGAATATAGTGACCGAGCTGGACATAGATGGCCTTCAT 69 FBgn0053320 CDMC30608 4 20 15 DAC24-P17 15-CG33320-RA_4 CG33320 GCGATTGGCCTCCGTGAAGCTTTCGATATGAGGAATATAGTGACCGAGCTGGACATAGATGGCCTTCAT 69 FBgn0053320 CDMC30609 4 21 15 DAC25-D05 23-CG10375-RA_4 CG10375 TAACTCCTTCTCAACAAATTGATCGTTTACTTCGTCCAGGTTCAACGTACTTCAATCTCAATCCGTTTG 69 FBan0010375 FBgn0039116 CG10375 3 3R CG10375 CG10375 CDMC30609 4 22 15 DAC25-D05 23-CG10375-RA_4 CG10375 TAACTCCTTCTCAACAAATTGATCGTTTACTTCGTCCAGGTTCAACGTACTTCAATCTCAATCCGTTTG 69 FBan0010375 FBgn0039116 CG10375 3 3R CG10375 CG10375 CDMC30610 4 23 15 DAC25-D17 23-CG10385-RA_9 CG10385 TTGGCTAAATATTGTTTCGTTTAACACTTCTTCTGTTTGACTTTCTGTCGCAATGATATGGAGCCTGCC 69 FBan0010385 FBgn0005617 msl-1 2 2L "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003677; ; GO:0003682; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 X chromosome; GO:0000805; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 msl-1 male-specific lethal 1 "CG10385, CG10385, msl, km(2)B, MSL-1, mls-1, msl1, MSL1, MSL, Msl1, i94, male specifc lethal, kmB: killer of males, killer-of-males-B" CDMC30610 4 24 15 DAC25-D17 23-CG10385-RA_9 CG10385 TTGGCTAAATATTGTTTCGTTTAACACTTCTTCTGTTTGACTTTCTGTCGCAATGATATGGAGCCTGCC 69 FBan0010385 FBgn0005617 msl-1 2 2L "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003677; ; GO:0003682; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 X chromosome; GO:0000805; chromosome; GO:0005694; dosage compensation complex (sensu Insecta); GO:0016456; nucleus; GO:0005634 msl-1 male-specific lethal 1 "CG10385, CG10385, msl, km(2)B, MSL-1, mls-1, msl1, MSL1, MSL, Msl1, i94, male specifc lethal, kmB: killer of males, killer-of-males-B" CDMC30611 4 25 15 DAC25-H05 3-CG10422-RA_6 CG10422 GCGCCAAAACTCAATGCCCTCGGACTATCTGTTCGATATGCCGGTGAAGAGCACGATGCCTAAGAGCTT 69 FBan0010422 FBgn0000158 bam 3 3R cell fate determination; GO:0001709; cell fate specification; GO:0001708; cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; gametogenesis; GO:0007276; germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; male meiosis; GO:0007140; oogenesis (sensu Insecta); GO:0009993; spectrosome organization and biogenesis; GO:0030721; spermatogenesis; GO:0007283; spermatogonial cell division; GO:0007284; vesicle targeting to fusome; GO:0045479 cytoplasm; GO:0005737; fusome; GO:0045169; spectrosome; GO:0045170 bam bag of marbles "CG10422, CG10422, alpha, transcript alpha, Bam, ham, BamC, bag-of-marbles, BamF, fs(3)neo61" CDMC30611 4 26 15 DAC25-H05 3-CG10422-RA_6 CG10422 GCGCCAAAACTCAATGCCCTCGGACTATCTGTTCGATATGCCGGTGAAGAGCACGATGCCTAAGAGCTT 69 FBan0010422 FBgn0000158 bam 3 3R cell fate determination; GO:0001709; cell fate specification; GO:0001708; cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; gametogenesis; GO:0007276; germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; male meiosis; GO:0007140; oogenesis (sensu Insecta); GO:0009993; spectrosome organization and biogenesis; GO:0030721; spermatogenesis; GO:0007283; spermatogonial cell division; GO:0007284; vesicle targeting to fusome; GO:0045479 cytoplasm; GO:0005737; fusome; GO:0045169; spectrosome; GO:0045170 bam bag of marbles "CG10422, CG10422, alpha, transcript alpha, Bam, ham, BamC, bag-of-marbles, BamF, fs(3)neo61" CDMC30612 4 1 16 DAC25-H17 2-CG10444-RA_1 CG10444 GGCGACGCCATAAAGAAGAACAAGACCAAACTGCCCAGGACGAAACGCTCACCAAACTAACTGAGCAGT 69 FBan0010444 FBgn0034494 CG10444 2 2R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG10444 CG10444 CDMC30612 4 2 16 DAC25-H17 2-CG10444-RA_1 CG10444 GGCGACGCCATAAAGAAGAACAAGACCAAACTGCCCAGGACGAAACGCTCACCAAACTAACTGAGCAGT 69 FBan0010444 FBgn0034494 CG10444 2 2R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG10444 CG10444 CDMC30613 4 3 16 DAC25-L05 7-CG10491-RA_1 CG10491 GGGCATACCCTGCAATTTCGACTACTGCTTCCATAATGGCACCTGTAGGATGATCCCGGACATCAACGA 69 FBan0010491 FBgn0003984 vn 3 3L anti-apoptosis; GO:0006916; brain development; GO:0007420; carbohydrate metabolism; GO:0005975; cell projection biogenesis; GO:0030031; cell-cell signaling; GO:0007267; epidermal growth factor receptor signaling pathway; GO:0007173; leg disc proximal/distal pattern formation; GO:0007479; muscle attachment; GO:0016203; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0005154 extracellular region; GO:0005576; plasma membrane; GO:0005886 vn vein "CG10491, l(3)L6A, ddd: defective dorsal discs, P1749, Vein, CT29452, Vn, vein, l(3)10567, l(3)10568, l(3)ddd, l(3)rF264, wvn, defective dorsal discs, ddd" CDMC30613 4 4 16 DAC25-L05 7-CG10491-RA_1 CG10491 GGGCATACCCTGCAATTTCGACTACTGCTTCCATAATGGCACCTGTAGGATGATCCCGGACATCAACGA 69 FBan0010491 FBgn0003984 vn 3 3L anti-apoptosis; GO:0006916; brain development; GO:0007420; carbohydrate metabolism; GO:0005975; cell projection biogenesis; GO:0030031; cell-cell signaling; GO:0007267; epidermal growth factor receptor signaling pathway; GO:0007173; leg disc proximal/distal pattern formation; GO:0007479; muscle attachment; GO:0016203; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; peripheral nervous system development; GO:0007422; positive regulation of epidermal growth factor receptor signaling pathway; GO:0045742; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474 epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0005154 extracellular region; GO:0005576; plasma membrane; GO:0005886 vn vein "CG10491, l(3)L6A, ddd: defective dorsal discs, P1749, Vein, CT29452, Vn, vein, l(3)10567, l(3)10568, l(3)ddd, l(3)rF264, wvn, defective dorsal discs, ddd" CDMC30614 4 5 16 DAC25-L17 2-CG10505-RA_1 CG10505 GCGACGAGTCCCTGTGGAGTGCATTGGATGACGTCAAACTGAAGAAGCATGTTGCCTCATTGGAAGGAG 69 FBan0010505 FBgn0034612 CG10505 2 2R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG10505 CG10505 CDMC30614 4 6 16 DAC25-L17 2-CG10505-RA_1 CG10505 GCGACGAGTCCCTGTGGAGTGCATTGGATGACGTCAAACTGAAGAAGCATGTTGCCTCATTGGAAGGAG 69 FBan0010505 FBgn0034612 CG10505 2 2R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG10505 CG10505 CDMC30615 4 7 16 DAC25-P05 23-CG10538-RA_14 CG10538 GATTTGTGTCTCGAGTGTTTTTATATTCTTGTTTTTGCGACTAAACTTTGACGCATGTATCGGAGATGA 69 FBan0010538 FBgn0032821 CdGAPr 2 2L intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; ; GO:0005096; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; ; GO:0005096 CdGAPr CdGAPr "CG10538, GAP, d-CdGAPr" CDMC30615 4 8 16 DAC25-P05 23-CG10538-RA_14 CG10538 GATTTGTGTCTCGAGTGTTTTTATATTCTTGTTTTTGCGACTAAACTTTGACGCATGTATCGGAGATGA 69 FBan0010538 FBgn0032821 CdGAPr 2 2L intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; ; GO:0005096; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; ; GO:0005096 CdGAPr CdGAPr "CG10538, GAP, d-CdGAPr" CDMC30616 4 9 16 DAC25-P17 5-CG10550-RA_2 CG10550 TGCCATGTACAACATGTCCATCTACAACGAGCAGAGTCGGGACCTCTTTGAGTCTCTGGGTAAGCAGCG 69 FBan0010550 FBgn0039321 CG10550 3 3R CG10550 CG10550 CDMC30616 4 10 16 DAC25-P17 5-CG10550-RA_2 CG10550 TGCCATGTACAACATGTCCATCTACAACGAGCAGAGTCGGGACCTCTTTGAGTCTCTGGGTAAGCAGCG 69 FBan0010550 FBgn0039321 CG10550 3 3R CG10550 CG10550 CDMC30617 4 11 16 DAC26-D05 9-CG15306-RA_9 CG15306 GCGCTGGCTACGATGCACTGGTAGCTCGTGACCATCAGAACATCGGTATCGGATCCTCAAAATTGACAA 69 FBan0015306 FBgn0030191 CG15306 X X cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG15306 CG15306 CDMC30617 4 12 16 DAC26-D05 9-CG15306-RA_9 CG15306 GCGCTGGCTACGATGCACTGGTAGCTCGTGACCATCAGAACATCGGTATCGGATCCTCAAAATTGACAA 69 FBan0015306 FBgn0030191 CG15306 X X cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG15306 CG15306 CDMC30618 4 13 16 DAC26-D17 17-CG15321-RA_1 CG15321 AGCATCGCCAACATCATCGATTACAAGATCCCAAAACACCAATACCAAAACCAAATCCCAATCCTCGCC 69 FBan0015321 FBgn0030150 CG15321 X X CG15321 CG15321 CDMC30618 4 14 16 DAC26-D17 17-CG15321-RA_1 CG15321 AGCATCGCCAACATCATCGATTACAAGATCCCAAAACACCAATACCAAAACCAAATCCCAATCCTCGCC 69 FBan0015321 FBgn0030150 CG15321 X X CG15321 CG15321 CDMC30619 4 15 16 DAC26-H05 2-CG15370-RA_2 CG15370 GCAGCACAGACCACATGGCTACGACTACGAGGATCACCATGAGCCCAGTGTGGAGACTTATCGAGTGAT 69 FBan0015370 FBgn0030107 CG15370 X X CG15370 CG15370 CDMC30619 4 16 16 DAC26-H05 2-CG15370-RA_2 CG15370 GCAGCACAGACCACATGGCTACGACTACGAGGATCACCATGAGCCCAGTGTGGAGACTTATCGAGTGAT 69 FBan0015370 FBgn0030107 CG15370 X X CG15370 CG15370 CDMC30620 4 17 16 DAC26-H17 16-CG15386-RA_1 CG15386 CCAAAACCTGCAATTTGGAAATTCATCAAAGGAAGTGCCAAAACACTGTTTGTCCTCGAGGCAGTCTGC 69 FBan0015386 FBgn0040715 CG15386 2 2L CG15386 CG15386 CDMC30620 4 18 16 DAC26-H17 16-CG15386-RA_1 CG15386 CCAAAACCTGCAATTTGGAAATTCATCAAAGGAAGTGCCAAAACACTGTTTGTCCTCGAGGCAGTCTGC 69 FBan0015386 FBgn0040715 CG15386 2 2L CG15386 CG15386 CDMC30621 4 19 16 DAC26-L05 2-CG15436-RA_4 CG15436 CGTAAAGAGCGCGTATGGGATAAGGCAAACTTGTGAGGAAAGCCACCAGTTCTACTGCCGAGTTCGCGA 69 FBan0015436 FBgn0031610 CG15436 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15436 CG15436 CDMC30621 4 20 16 DAC26-L05 2-CG15436-RA_4 CG15436 CGTAAAGAGCGCGTATGGGATAAGGCAAACTTGTGAGGAAAGCCACCAGTTCTACTGCCGAGTTCGCGA 69 FBan0015436 FBgn0031610 CG15436 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15436 CG15436 CDMC30622 4 21 16 DAC26-L17 3-CG15445-RA_4 CG15445 TGCTTTGCTGAACCTCGACATAGTGTGGTGCTATTTTTGCCTGAAGAACGTTACCCAGCTCCCGGATGC 69 FBan0015445 FBgn0031161 CG15445 X X CG15445 CG15445 CDMC30622 4 22 16 DAC26-L17 3-CG15445-RA_4 CG15445 TGCTTTGCTGAACCTCGACATAGTGTGGTGCTATTTTTGCCTGAAGAACGTTACCCAGCTCCCGGATGC 69 FBan0015445 FBgn0031161 CG15445 X X CG15445 CG15445 CDMC30623 4 23 16 DAC26-P05 8-CG15479-RA_1 CG15479 ACCGAGGCCATCCAAGACATCTTCAAGTACCACGTCAATATGGTGCGAAAATTCCCGAAGAAGGAGCGT 69 FBan0015479 FBgn0032493 CG15479 2 2L CG15479 CG15479 CDMC30623 4 24 16 DAC26-P05 8-CG15479-RA_1 CG15479 ACCGAGGCCATCCAAGACATCTTCAAGTACCACGTCAATATGGTGCGAAAATTCCCGAAGAAGGAGCGT 69 FBan0015479 FBgn0032493 CG15479 2 2L CG15479 CG15479 CDMC30624 4 25 16 DAC26-P17 22-CG15497-RA_2 CG15497 TGCCCTTCATCAAGCCGATGATTAACGAGTTGGTTAGCACGGCATTTACGGATATATTCAACGAGTCCT 69 FBan0015497 FBgn0038894 CG15497 3 3R CG15497 CG15497 CDMC30624 4 26 16 DAC26-P17 22-CG15497-RA_2 CG15497 TGCCCTTCATCAAGCCGATGATTAACGAGTTGGTTAGCACGGCATTTACGGATATATTCAACGAGTCCT 69 FBan0015497 FBgn0038894 CG15497 3 3R CG15497 CG15497 CDMC30625 4 1 17 DAC27-D05 5-CG9768-RA_2 CG9768 TCCATCTTCGTGCCCATGTACTCATACCTTTATGGCTACTGAGAGGGAAATCCTGGCGAGCTTTCCCCT 69 FBan0009768 FBgn0001204 hkb 3 3R "anterior midgut invagination; GO:0007375; anterior/posterior axis specification; GO:0009948; cell fate specification; GO:0001708; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm and mesoderm interaction; GO:0007499; endoderm formation; GO:0001706; gastrulation; GO:0007369; germ cell migration; GO:0008354; membrane organization and biogenesis; GO:0016044; neuroblast fate determination; GO:0007400; posterior midgut invagination; GO:0007374; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; transcription, DNA-dependent; GO:0006351; ventral cord development; GO:0007419" nucleic acid binding; GO:0003676; ; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003704; ; GO:0008270 nucleus; GO:0005634 hkb huckebein "CG9768, 5953, Hkb, anon-82B3" CDMC30625 4 2 17 DAC27-D05 5-CG9768-RA_2 CG9768 TCCATCTTCGTGCCCATGTACTCATACCTTTATGGCTACTGAGAGGGAAATCCTGGCGAGCTTTCCCCT 69 FBan0009768 FBgn0001204 hkb 3 3R "anterior midgut invagination; GO:0007375; anterior/posterior axis specification; GO:0009948; cell fate specification; GO:0001708; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm and mesoderm interaction; GO:0007499; endoderm formation; GO:0001706; gastrulation; GO:0007369; germ cell migration; GO:0008354; membrane organization and biogenesis; GO:0016044; neuroblast fate determination; GO:0007400; posterior midgut invagination; GO:0007374; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; transcription, DNA-dependent; GO:0006351; ventral cord development; GO:0007419" nucleic acid binding; GO:0003676; ; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003704; ; GO:0008270 nucleus; GO:0005634 hkb huckebein "CG9768, 5953, Hkb, anon-82B3" CDMC30626 4 3 17 DAC27-D17 16-CG9780-RA_4 CG9780 GGCAGTGTGTGGATCGATGAGATCTCTAGGCAGAGCTCGAGACAGTTTTTGGGTAACATAATGCACACT 69 FBan0009780 FBgn0037230 CG9780 3 3R CG9780 CG9780 CDMC30626 4 4 17 DAC27-D17 16-CG9780-RA_4 CG9780 GGCAGTGTGTGGATCGATGAGATCTCTAGGCAGAGCTCGAGACAGTTTTTGGGTAACATAATGCACACT 69 FBan0009780 FBgn0037230 CG9780 3 3R CG9780 CG9780 CDMC30627 4 5 17 DAC27-H05 22-CG9822-RA_2 CG9822 GGGCTTGTGGTTTGGAGAGCACAAACTCATCGACAGCAGTTACATTACCGATTTTAAGCTGACCAAAGA 69 FBan0009822 FBgn0034623 CG9822 2 2R CG9822 CG9822 Agr-like CDMC30627 4 6 17 DAC27-H05 22-CG9822-RA_2 CG9822 GGGCTTGTGGTTTGGAGAGCACAAACTCATCGACAGCAGTTACATTACCGATTTTAAGCTGACCAAAGA 69 FBan0009822 FBgn0034623 CG9822 2 2R CG9822 CG9822 Agr-like CDMC30628 4 7 17 DAC27-H17 3-CG9841-RA_4 CG9841 GCCGCCTTCGACAAGAATCCGCAATCAGTGGAGCGAGGCATAACTTTGGATTTGGGCTTTAGTGGACTT 69 FBan0009841 FBgn0034627 EfSec 2 2R translational elongation; GO:0006414 GTP binding; GO:0005525; transferase activity; GO:0016740 ; EC:2.-.-.-; translation elongation factor activity; GO:0003746; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003924; ; GO:0005525 EfSec EfSec "CG9841, CG9841, Eftu, EFSec" CDMC30628 4 8 17 DAC27-H17 3-CG9841-RA_4 CG9841 GCCGCCTTCGACAAGAATCCGCAATCAGTGGAGCGAGGCATAACTTTGGATTTGGGCTTTAGTGGACTT 69 FBan0009841 FBgn0034627 EfSec 2 2R translational elongation; GO:0006414 GTP binding; GO:0005525; transferase activity; GO:0016740 ; EC:2.-.-.-; translation elongation factor activity; GO:0003746; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003924; ; GO:0005525 EfSec EfSec "CG9841, CG9841, Eftu, EFSec" CDMC30629 4 9 17 DAC27-L05 1-CG9882-RA_2 CG9882 AGCTGCGCTCACTCACATTTTCGCTGAGCCCTACTTCCTCAATGCGATTCTACCCTGGGACAACTTCTA 69 FBan0009882 FBgn0034817 Art7 2 2R "peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919" protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- cellular component unknown; GO:0008372 Art7 Arginine methyltransferase 7 "CG9882, DART7, Arginine methyltransferase 7" CDMC30629 4 10 17 DAC27-L05 1-CG9882-RA_2 CG9882 AGCTGCGCTCACTCACATTTTCGCTGAGCCCTACTTCCTCAATGCGATTCTACCCTGGGACAACTTCTA 69 FBan0009882 FBgn0034817 Art7 2 2R "peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; GO:0019919" protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- cellular component unknown; GO:0008372 Art7 Arginine methyltransferase 7 "CG9882, DART7, Arginine methyltransferase 7" CDMC30630 4 11 17 DAC27-L17 23-CG9888-RA_5 CG9888 TGCCGCGTGTTGACGGACTCAATCACATTTCGTCGAAAGTTGTATTAAAAAGTGCAAGTACAGCAACAT 69 FBan0009888 FBgn0003062 Fib 2 2R 35S primary transcript processing; GO:0006365; RNA processing; GO:0006396; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 dense fibrillar component; GO:0001651; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 Fib Fibrillarin "CG9888, GCR-6, GCR6, Pen59C5, pen59C5, Fibrillarin" CDMC30630 4 12 17 DAC27-L17 23-CG9888-RA_5 CG9888 TGCCGCGTGTTGACGGACTCAATCACATTTCGTCGAAAGTTGTATTAAAAAGTGCAAGTACAGCAACAT 69 FBan0009888 FBgn0003062 Fib 2 2R 35S primary transcript processing; GO:0006365; RNA processing; GO:0006396; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 dense fibrillar component; GO:0001651; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 Fib Fibrillarin "CG9888, GCR-6, GCR6, Pen59C5, pen59C5, Fibrillarin" CDMC30631 4 13 17 DAC27-P05 14-CG9928-RA_1 CG9928 AGGTGGCAACTTGGACTGGAGCGATAGTGTTCACAGTTCTGATGACGATAGGACTCTGAAGCTACTGGA 69 FBan0009928 FBgn0032472 CG9928 2 2L CG9928 CG9928 "CT27834, BcDNA:RH70154" CDMC30631 4 14 17 DAC27-P05 14-CG9928-RA_1 CG9928 AGGTGGCAACTTGGACTGGAGCGATAGTGTTCACAGTTCTGATGACGATAGGACTCTGAAGCTACTGGA 69 FBan0009928 FBgn0032472 CG9928 2 2L CG9928 CG9928 "CT27834, BcDNA:RH70154" CDMC30632 4 15 17 DAC27-P17 2-CG9948-RA_1 CG9948 CAGGAGGCGACCATCCAGACGGAAACTCCTGTGCAATTTTTGTGGGACACTTTTGAGGATGGGGATGTT 69 FBan0009948 FBgn0035721 CG9948 3 3L CG9948 CG9948 CDMC30632 4 16 17 DAC27-P17 2-CG9948-RA_1 CG9948 CAGGAGGCGACCATCCAGACGGAAACTCCTGTGCAATTTTTGTGGGACACTTTTGAGGATGGGGATGTT 69 FBan0009948 FBgn0035721 CG9948 3 3L CG9948 CG9948 CDMC30633 4 17 17 DAC28-D05 15-CG11844-RB_3 CG11844 CGCCGAAGAGGATGAGTCCAAGCAGATGACCCTTGACGAGTGGAAGGCTTTGAGAGACCAGCGTG 65 FBan0011844 FBgn0046214 CG11844 3 3R CG11844 CG11844 "BcDNA:SD06613, anon-WO0118547.290" CDMC30633 4 18 17 DAC28-D05 15-CG11844-RB_3 CG11844 CGCCGAAGAGGATGAGTCCAAGCAGATGACCCTTGACGAGTGGAAGGCTTTGAGAGACCAGCGTG 65 FBan0011844 FBgn0046214 CG11844 3 3R CG11844 CG11844 "BcDNA:SD06613, anon-WO0118547.290" CDMC30634 4 19 17 DAC28-D17 12-CG11876-RD_3 CG11876 AATCCGTGATCCCGATCCAGTGGTCTTCCTGGAGAATGAGCTGGTCTATGGCACGGCATTCCCTG 65 FBan0011876 FBgn0039635 CG11876 3 3R "pyruvate metabolism; GO:0006090; regulation of transcription, DNA-dependent; GO:0006355; tricarboxylic acid cycle; GO:0006099" pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; transcription factor activity; GO:0003700; ; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1; ; GO:0003700 pyruvate dehydrogenase complex; GO:0045254 CG11876 CG11876 CDMC30634 4 20 17 DAC28-D17 12-CG11876-RD_3 CG11876 AATCCGTGATCCCGATCCAGTGGTCTTCCTGGAGAATGAGCTGGTCTATGGCACGGCATTCCCTG 65 FBan0011876 FBgn0039635 CG11876 3 3R "pyruvate metabolism; GO:0006090; regulation of transcription, DNA-dependent; GO:0006355; tricarboxylic acid cycle; GO:0006099" pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; transcription factor activity; GO:0003700; ; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1; ; GO:0003700 pyruvate dehydrogenase complex; GO:0045254 CG11876 CG11876 CDMC30635 4 21 17 DAC28-H05 2-CG12004-RA_2 CG12004 TTATAGCCCTAGCGCCTTAGCCCTAGCTTAATGCCCCACAGTATCCCCCGAAACCAAGCTCAGAG 65 FBan0012004 FBgn0035236 CG12004 3 3L CG12004 CG12004 "anon-EST:fe3A8, anon-fast-evolving-3A8" CDMC30635 4 22 17 DAC28-H05 2-CG12004-RA_2 CG12004 TTATAGCCCTAGCGCCTTAGCCCTAGCTTAATGCCCCACAGTATCCCCCGAAACCAAGCTCAGAG 65 FBan0012004 FBgn0035236 CG12004 3 3L CG12004 CG12004 "anon-EST:fe3A8, anon-fast-evolving-3A8" CDMC30636 4 23 17 DAC28-H17 18-CG12029-RA_1 CG12029 GCTGCTCCAAGGTGTACACAAAAAGCTCTCATCTGAAGGCCCATCAAAGGATACACACGGGTGAG 65 FBan0012029 FBgn0035454 CG12029 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12029 CG12029 CDMC30636 4 24 17 DAC28-H17 18-CG12029-RA_1 CG12029 GCTGCTCCAAGGTGTACACAAAAAGCTCTCATCTGAAGGCCCATCAAAGGATACACACGGGTGAG 65 FBan0012029 FBgn0035454 CG12029 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12029 CG12029 CDMC30637 4 25 17 DAC28-L05 3-CG12121-RA_1 CG12121 GTTCTTCGTGCTGACTGGCTACAAGTTCCGTCCAGTATCCTCGCATCCATACTTCACCGTGCCGG 65 FBan0012121 FBgn0030109 CG12121 X X integral to membrane; GO:0016021 CG12121 CG12121 CDMC30637 4 26 17 DAC28-L05 3-CG12121-RA_1 CG12121 GTTCTTCGTGCTGACTGGCTACAAGTTCCGTCCAGTATCCTCGCATCCATACTTCACCGTGCCGG 65 FBan0012121 FBgn0030109 CG12121 X X integral to membrane; GO:0016021 CG12121 CG12121 CDMC30638 4 1 18 DAC28-L17 18-CG12140-RA_3 CG12140 GAACCATGGACCCTAAAACACGGTCCCCAGGATCACGAGTCCTTGAAGCCAGCTAGCTCCTGCCC 65 FBan0012140 FBgn0033465 CG12140 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 electron-transferring-flavoprotein dehydrogenase activity; GO:0004174 ; EC:1.5.5.1; ; GO:0004174 ; EC:1.5.5.1; ; GO:0004174 ; EC:1.5.5.1 mitochondrial inner membrane; GO:0005743 CG12140 CG12140 CDMC30638 4 2 18 DAC28-L17 18-CG12140-RA_3 CG12140 GAACCATGGACCCTAAAACACGGTCCCCAGGATCACGAGTCCTTGAAGCCAGCTAGCTCCTGCCC 65 FBan0012140 FBgn0033465 CG12140 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 electron-transferring-flavoprotein dehydrogenase activity; GO:0004174 ; EC:1.5.5.1; ; GO:0004174 ; EC:1.5.5.1; ; GO:0004174 ; EC:1.5.5.1 mitochondrial inner membrane; GO:0005743 CG12140 CG12140 CDMC30639 4 3 18 DAC28-P05 9-CG12234-RA_2 CG12234 TAGCTTAGACGATGAGTTCGCACTTTTTCTCGCCCTTGTCCAAGACCATGACCCAGTCCGTGTCC 65 FBan0012234 FBgn0031051 Ranbp21 X X "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp21 Ranbp21 "CG12234, CG12234, RanBP21, Exp5" CDMC30639 4 4 18 DAC28-P05 9-CG12234-RA_2 CG12234 TAGCTTAGACGATGAGTTCGCACTTTTTCTCGCCCTTGTCCAAGACCATGACCCAGTCCGTGTCC 65 FBan0012234 FBgn0031051 Ranbp21 X X "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp21 Ranbp21 "CG12234, CG12234, RanBP21, Exp5" CDMC30640 4 5 18 DAC28-P17 3-CG12256-RA_1 CG12256 AGGAGCTGGTGACTAGTGACATTGCCATCCTCAAGATCGATCCGCCCTTTGAGCTGGACGAGAAG 65 FBan0012256 FBgn0038002 CG12256 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12256 CG12256 SP133 CDMC30640 4 6 18 DAC28-P17 3-CG12256-RA_1 CG12256 AGGAGCTGGTGACTAGTGACATTGCCATCCTCAAGATCGATCCGCCCTTTGAGCTGGACGAGAAG 65 FBan0012256 FBgn0038002 CG12256 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12256 CG12256 SP133 CDMC30641 4 7 18 DAC29-D05 17-CG3096-RA_1 CG3096 AGACTCCAACGGATTCGGTCTCTAAACATCATCCGCAACAGCTTTAACTCTCCACACTGTGCAAGTGGA 69 FBan0003096 FBgn0000216 Brd 3 3L Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 calmodulin inhibitor activity; GO:0005517; ; GO:0005517 Brd Bearded CG3096 CDMC30641 4 8 18 DAC29-D05 17-CG3096-RA_1 CG3096 AGACTCCAACGGATTCGGTCTCTAAACATCATCCGCAACAGCTTTAACTCTCCACACTGTGCAAGTGGA 69 FBan0003096 FBgn0000216 Brd 3 3L Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 calmodulin inhibitor activity; GO:0005517; ; GO:0005517 Brd Bearded CG3096 CDMC30642 4 9 18 DAC29-D17 24-CG31006-RA_1 CG31006 ACAAGGACCAAAACAAAGAATTTAGAATTGTAGAATTTGTAAGGAGTTTATCTAGCAAATAAATGTATA 69 FBan0031006 FBgn0051006 CG31006 3 3R intracellular signaling cascade; GO:0007242 CG31006 CG31006 "CG15557, CG15558, CG15559" CDMC30642 4 10 18 DAC29-D17 24-CG31006-RA_1 CG31006 ACAAGGACCAAAACAAAGAATTTAGAATTGTAGAATTTGTAAGGAGTTTATCTAGCAAATAAATGTATA 69 FBan0031006 FBgn0051006 CG31006 3 3R intracellular signaling cascade; GO:0007242 CG31006 CG31006 "CG15557, CG15558, CG15559" CDMC30643 4 11 18 DAC29-H05 3-CG31029-RA_2 CG31029 GGCTACGATGATCCCCGGAGGTTCGATCCAACCCCACTAAACAGACCTTGGCACAAGTCTAACTGACAT 69 FBan0031029 FBgn0051029 CG31029 3 3R CG31029 CG31029 "CG2164, CG2164, BcDNA:AT12234" CDMC30643 4 12 18 DAC29-H05 3-CG31029-RA_2 CG31029 GGCTACGATGATCCCCGGAGGTTCGATCCAACCCCACTAAACAGACCTTGGCACAAGTCTAACTGACAT 69 FBan0031029 FBgn0051029 CG31029 3 3R CG31029 CG31029 "CG2164, CG2164, BcDNA:AT12234" CDMC30644 4 13 18 DAC29-H17 14-CG31038-RB_2 CG31038 CGCGTGCTGTCACTGTAGTGCCGAAATATAACACACTTCTCGAGGGTACGAGCTGCATTTCGATGTGAA 69 FBan0031038 FBgn0051038 CG31038 3 3R CG31038 CG31038 "CG15512, CG7854" CDMC30644 4 14 18 DAC29-H17 14-CG31038-RB_2 CG31038 CGCGTGCTGTCACTGTAGTGCCGAAATATAACACACTTCTCGAGGGTACGAGCTGCATTTCGATGTGAA 69 FBan0031038 FBgn0051038 CG31038 3 3R CG31038 CG31038 "CG15512, CG7854" CDMC30645 4 15 18 DAC29-L05 17-CG31065-RA_1 CG31065 CCGCCTTGCGAATAGTGGAGACCATTGTTATCTGTCTGCGGTACAGAAAAACGATTGTGAAGTGGGTTA 69 FBan0031065 FBgn0051065 CG31065 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG31065 CG31065 CDMC30645 4 16 18 DAC29-L05 17-CG31065-RA_1 CG31065 CCGCCTTGCGAATAGTGGAGACCATTGTTATCTGTCTGCGGTACAGAAAAACGATTGTGAAGTGGGTTA 69 FBan0031065 FBgn0051065 CG31065 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG31065 CG31065 CDMC30646 4 17 18 DAC29-L17 13-CG31079-RA_1 CG31079 CCCCGCTGTCGACTTTTTGTTAACAGTTTCTGTTGCCTCCCCTCCTGTATTCTTTCTTTCGCTTCTGGT 69 FBan0031079 FBgn0051079 CG31079 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31079 CG31079 CDMC30646 4 18 18 DAC29-L17 13-CG31079-RA_1 CG31079 CCCCGCTGTCGACTTTTTGTTAACAGTTTCTGTTGCCTCCCCTCCTGTATTCTTTCTTTCGCTTCTGGT 69 FBan0031079 FBgn0051079 CG31079 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31079 CG31079 CDMC30647 4 19 18 DAC29-P05 16-CG31101-RA_1 CG31101 CTTCTGACTCACGAAGGTTGTGTCAACCCATAACTTCGGTTTCTGAAACACTCGAATCAAACGCTCCCA 69 FBan0031101 FBgn0051101 CG31101 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31101 CG31101 CDMC30647 4 20 18 DAC29-P05 16-CG31101-RA_1 CG31101 CTTCTGACTCACGAAGGTTGTGTCAACCCATAACTTCGGTTTCTGAAACACTCGAATCAAACGCTCCCA 69 FBan0031101 FBgn0051101 CG31101 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31101 CG31101 CDMC30648 4 21 18 DAC29-P17 2-CG31108-RA_1 CG31108 AGTGCTGACACTTCACACCAATGTGACCGGTATCATGCCCTTCCTGTACAACCGATGTGGACTGTCAGT 69 FBan0031108 FBgn0051108 CG31108 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG31108 CG31108 CG10057 CDMC30648 4 22 18 DAC29-P17 2-CG31108-RA_1 CG31108 AGTGCTGACACTTCACACCAATGTGACCGGTATCATGCCCTTCCTGTACAACCGATGTGGACTGTCAGT 69 FBan0031108 FBgn0051108 CG31108 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG31108 CG31108 CG10057 CDMC30649 4 23 18 DAC30-D05 23-CG2042-RA_5 CG2042 AGTCAAAGGTAAAAATCCAGTCAACCAAAAGGTCATAAACAAAGATAAGATTGTAAGTCCTCCCG 65 FBan0002042 FBgn0032944 CG2042 2 2L CG2042 CG2042 CDMC30649 4 24 18 DAC30-D05 23-CG2042-RA_5 CG2042 AGTCAAAGGTAAAAATCCAGTCAACCAAAAGGTCATAAACAAAGATAAGATTGTAAGTCCTCCCG 65 FBan0002042 FBgn0032944 CG2042 2 2L CG2042 CG2042 CDMC30650 4 25 18 DAC30-D17 3-CG2098-RA_2 CG2098 TAAGCAAGGCCTGAAGAACTTCATCCTTGTGCCCATTGCCTTCGTGAACGAGCACATCGAGACGC 65 FBan0002098 FBgn0024891 ferrochelatase 3 3R protoporphyrinogen IX biosynthesis; GO:0006782 ferrochelatase activity; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1 mitochondrial inner membrane; GO:0005743 ferrochelatase ferrochelatase "CG2098, CG2098, ferrochelatase" CDMC30650 4 26 18 DAC30-D17 3-CG2098-RA_2 CG2098 TAAGCAAGGCCTGAAGAACTTCATCCTTGTGCCCATTGCCTTCGTGAACGAGCACATCGAGACGC 65 FBan0002098 FBgn0024891 ferrochelatase 3 3R protoporphyrinogen IX biosynthesis; GO:0006782 ferrochelatase activity; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1; ; GO:0004325 ; EC:4.99.1.1 mitochondrial inner membrane; GO:0005743 ferrochelatase ferrochelatase "CG2098, CG2098, ferrochelatase" CDMC30651 4 1 19 DAC30-H05 3-CG2225-RE_2 CG2225 AACACTTTTCTAGGATCCACCACGCGAAAGGATACCAATCGCAAAGACAATGGAGCCTCGGGGGC 65 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC30651 4 2 19 DAC30-H05 3-CG2225-RE_2 CG2225 AACACTTTTCTAGGATCCACCACGCGAAAGGATACCAATCGCAAAGACAATGGAGCCTCGGGGGC 65 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC30652 4 3 19 DAC30-H17 2-CG2261-RB_1 CG2261 AGCAGGAGCACCAGACAGAGGCTGTATTCAACCACACAGAGGATTACGTGCTTTTCCCCGACGAG 65 FBan0002261 FBgn0039867 CstF-50 3 3R cell proliferation; GO:0008283; mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848 CstF-50 CstF-50 "CG2261, CG2261" CDMC30652 4 4 19 DAC30-H17 2-CG2261-RB_1 CG2261 AGCAGGAGCACCAGACAGAGGCTGTATTCAACCACACAGAGGATTACGTGCTTTTCCCCGACGAG 65 FBan0002261 FBgn0039867 CstF-50 3 3R cell proliferation; GO:0008283; mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848 CstF-50 CstF-50 "CG2261, CG2261" CDMC30653 4 5 19 DAC30-L05 38-CG2707-RA_1 CG2707 GACAGCGTCTCCTCCATACGCAACCTGTCGTCGTTCAGCAACAGCTCCATTCGTCGCTCCATTGG 65 FBan0002707 FBgn0000927 fs(1)Ya X X DNA replication; GO:0006260; chromatin assembly or disassembly; GO:0006333; chromosome condensation; GO:0030261; mitosis; GO:0007067; nuclear division; GO:0000280; pronuclear fusion; GO:0007344 nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 fs(1)Ya female sterile (1) Young arrest "CG2707, CG2707, CG2707, fs(1)M12, fs(1)73, fs(1)Y2, YA, Young Arrest, Ya, young arrest, fs(1)Y[a], EG:95B7.4" CDMC30653 4 6 19 DAC30-L05 38-CG2707-RA_1 CG2707 GACAGCGTCTCCTCCATACGCAACCTGTCGTCGTTCAGCAACAGCTCCATTCGTCGCTCCATTGG 65 FBan0002707 FBgn0000927 fs(1)Ya X X DNA replication; GO:0006260; chromatin assembly or disassembly; GO:0006333; chromosome condensation; GO:0030261; mitosis; GO:0007067; nuclear division; GO:0000280; pronuclear fusion; GO:0007344 nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 fs(1)Ya female sterile (1) Young arrest "CG2707, CG2707, CG2707, fs(1)M12, fs(1)73, fs(1)Y2, YA, Young Arrest, Ya, young arrest, fs(1)Y[a], EG:95B7.4" CDMC30654 4 7 19 DAC30-L17 3-CG2812-RA_1 CG2812 CTCTGTGAATACGCTGGATAACGATCGAAAGGATGGTGGTCTGGAGAGCTCCGCTGTAACCGCGG 65 FBan0002812 FBgn0034931 CG2812 2 2R GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG2812 CG2812 CDMC30654 4 8 19 DAC30-L17 3-CG2812-RA_1 CG2812 CTCTGTGAATACGCTGGATAACGATCGAAAGGATGGTGGTCTGGAGAGCTCCGCTGTAACCGCGG 65 FBan0002812 FBgn0034931 CG2812 2 2R GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG2812 CG2812 CDMC30655 4 9 19 DAC30-P05 17-CG2938-RB_1 CG2938 GTGGGCTATGTGGTCCTCAGGAACATTTCGGGTATTCTACGTACACGATACTCGGCGTTCTTCGC 65 FBan0002938 FBgn0029685 CG2938 X X CG2938 CG2938 CDMC30655 4 10 19 DAC30-P05 17-CG2938-RB_1 CG2938 GTGGGCTATGTGGTCCTCAGGAACATTTCGGGTATTCTACGTACACGATACTCGGCGTTCTTCGC 65 FBan0002938 FBgn0029685 CG2938 X X CG2938 CG2938 CDMC30656 4 11 19 DAC30-P17 14-CG2984-RA_1 CG2984 CCCATGCCGTGCACTATATATTCCAGCGCATTCAAAAGGTTCAGGACTCTGAGGCAACACCAGTG 65 FBan0002984 FBgn0022768 Pp2C1 X X electron transport; GO:0006118; protein amino acid dephosphorylation; GO:0006470 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0016491 ; EC:1.-.-.- protein serine/threonine phosphatase complex; GO:0008287 Pp2C1 Protein phosphatase 2C "CG2984, CG2984, CG2984, dpp2c1, PP2C1, PP2C, anon-WO03040301.132, Protein phosphatase 2C" CDMC30656 4 12 19 DAC30-P17 14-CG2984-RA_1 CG2984 CCCATGCCGTGCACTATATATTCCAGCGCATTCAAAAGGTTCAGGACTCTGAGGCAACACCAGTG 65 FBan0002984 FBgn0022768 Pp2C1 X X electron transport; GO:0006118; protein amino acid dephosphorylation; GO:0006470 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0016491 ; EC:1.-.-.- protein serine/threonine phosphatase complex; GO:0008287 Pp2C1 Protein phosphatase 2C "CG2984, CG2984, CG2984, dpp2c1, PP2C1, PP2C, anon-WO03040301.132, Protein phosphatase 2C" CDMC30657 4 13 19 DAC31-D05 2-CG31948-RB_3 CG31948 CCGCTGCCAGTCAATGCTGAAGCTTAACGACCACAAGATGAACATGGAGTTGCCCAATGAAGTTCGGC 68 FBan0031948 FBgn0051948 CG31948 2 2L CG31948 CG31948 "CG9966, CG9966" CDMC30657 4 14 19 DAC31-D05 2-CG31948-RB_3 CG31948 CCGCTGCCAGTCAATGCTGAAGCTTAACGACCACAAGATGAACATGGAGTTGCCCAATGAAGTTCGGC 68 FBan0031948 FBgn0051948 CG31948 2 2L CG31948 CG31948 "CG9966, CG9966" CDMC30658 4 15 19 DAC31-D17 13-CG32086-RA_1 CG32086 GGAACCAGCTGGAATTTCACAAGTACGCACTAAATTCAGTGCTGGAGAGGAGTGACACGGATGGAACG 68 FBan0032086 FBgn0052086 CG32086 3 3L CG32086 CG32086 "CG6100, CG6100" CDMC30658 4 16 19 DAC31-D17 13-CG32086-RA_1 CG32086 GGAACCAGCTGGAATTTCACAAGTACGCACTAAATTCAGTGCTGGAGAGGAGTGACACGGATGGAACG 68 FBan0032086 FBgn0052086 CG32086 3 3L CG32086 CG32086 "CG6100, CG6100" CDMC30659 4 17 19 DAC31-H05 23-CG32383-RA_3 CG32383 ACATTGTTAGTCCTATCACTAACTGTTTCGGTCGGTGAAAAAAATAAATTGAGTCCCAGGATCGCCGG 68 FBan0032383 FBgn0052383 CG32383 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG32383 CG32383 "CG8555, CG8555, SPH194" CDMC30659 4 18 19 DAC31-H05 23-CG32383-RA_3 CG32383 ACATTGTTAGTCCTATCACTAACTGTTTCGGTCGGTGAAAAAAATAAATTGAGTCCCAGGATCGCCGG 68 FBan0032383 FBgn0052383 CG32383 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG32383 CG32383 "CG8555, CG8555, SPH194" CDMC30660 4 19 19 DAC31-H17 3-CG3249-RA_1 CG3249 CCAAAATGGAGGGGGAAGTTAGGGATCAGCTGGGTTATGCGTTTTGTGACCACATGGCAACACATGGG 68 FBan0003249 FBgn0029764 CG3249 X X protein localization; GO:0008104; protein targeting; GO:0006605; signal transduction; GO:0007165 nucleic acid binding; GO:0003676; ; GO:0003676; receptor binding; GO:0005102; ; GO:0005102; protein kinase A binding; GO:0051018; ; GO:0051018 CG3249 CG3249 "PKA anchor protein, PKAAP, BcDNA:GM04319" CDMC30660 4 20 19 DAC31-H17 3-CG3249-RA_1 CG3249 CCAAAATGGAGGGGGAAGTTAGGGATCAGCTGGGTTATGCGTTTTGTGACCACATGGCAACACATGGG 68 FBan0003249 FBgn0029764 CG3249 X X protein localization; GO:0008104; protein targeting; GO:0006605; signal transduction; GO:0007165 nucleic acid binding; GO:0003676; ; GO:0003676; receptor binding; GO:0005102; ; GO:0005102; protein kinase A binding; GO:0051018; ; GO:0051018 CG3249 CG3249 "PKA anchor protein, PKAAP, BcDNA:GM04319" CDMC30661 4 21 19 DAC31-L05 11-CG33174-RA_1 CG33174 GCGGTTGTGATCAGCATACGTGGTACCCTTAGCATGAAGGACATACTTACGGATCTGAACGCCGAGGG 68 FBan0033174 FBgn0053174 CG33174 X X lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG33174 CG33174 "CG11102, CG32630, CG11104, CG15761, CG11096, CG11102, EP(X)1101" CDMC30661 4 22 19 DAC31-L05 11-CG33174-RA_1 CG33174 GCGGTTGTGATCAGCATACGTGGTACCCTTAGCATGAAGGACATACTTACGGATCTGAACGCCGAGGG 68 FBan0033174 FBgn0053174 CG33174 X X lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG33174 CG33174 "CG11102, CG32630, CG11104, CG15761, CG11096, CG11102, EP(X)1101" CDMC30662 4 23 19 DAC31-L17 11-CG33337-RA_1 CG33337 GACCGCCTTTTACGCCCAAAAAAGAAAGCACCAGCAGAGAATAAGCCGATGACGAACTCAGACCGAGT 68 FBan0033337 FBgn0053337 CG33337 3 3R biological process unknown; GO:0000004 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- cellular component unknown; GO:0008372 CG33337 CG33337 CDMC30662 4 24 19 DAC31-L17 11-CG33337-RA_1 CG33337 GACCGCCTTTTACGCCCAAAAAAGAAAGCACCAGCAGAGAATAAGCCGATGACGAACTCAGACCGAGT 68 FBan0033337 FBgn0053337 CG33337 3 3R biological process unknown; GO:0000004 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- cellular component unknown; GO:0008372 CG33337 CG33337 CDMC30663 4 25 19 DAC31-P05 1-CG3598-RA_1 CG3598 TTACAGGCAGAACCACGCTGATGACGAACAGGACGATGATCAGGATCAGGAGCAGGATCACGTTCAGG 68 FBan0003598 FBgn0025645 CG3598 X X CG3598 CG3598 EG:100G7.3 CDMC30663 4 26 19 DAC31-P05 1-CG3598-RA_1 CG3598 TTACAGGCAGAACCACGCTGATGACGAACAGGACGATGATCAGGATCAGGAGCAGGATCACGTTCAGG 68 FBan0003598 FBgn0025645 CG3598 X X CG3598 CG3598 EG:100G7.3 CDMC30664 4 1 20 DAC31-P17 3-CG3732-RA_2 CG3732 GCGGCGTGGTAGAGTACAAGGATCGTCAGGATTCGGATAGCGAGTACGATGAGTTCGGTCGTCGCAAG 68 FBan0003732 FBgn0034750 CG3732 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG3732 CG3732 CDMC30664 4 2 20 DAC31-P17 3-CG3732-RA_2 CG3732 GCGGCGTGGTAGAGTACAAGGATCGTCAGGATTCGGATAGCGAGTACGATGAGTTCGGTCGTCGCAAG 68 FBan0003732 FBgn0034750 CG3732 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG3732 CG3732 CDMC30665 4 3 20 DAC32-D05 23-CG15784-RA_1 CG15784 TTCCTTCAATACAACCTCCCACACATATAACCTTCAATATTACTATACATTTAACACCCAGAAGCTTCT 69 FBan0015784 FBgn0029766 CG15784 X X CG15784 CG15784 CDMC30665 4 4 20 DAC32-D05 23-CG15784-RA_1 CG15784 TTCCTTCAATACAACCTCCCACACATATAACCTTCAATATTACTATACATTTAACACCCAGAAGCTTCT 69 FBan0015784 FBgn0029766 CG15784 X X CG15784 CG15784 CDMC30666 4 5 20 DAC32-D17 5-CG15807-RA_1 CG15807 CCCGTCCTGGTGACCTGTGAACCTAAGATCCTTGAGGACATTTTCACGTCTCCCAATTGCAGCAACAGG 69 FBan0015807 FBgn0038005 Cyp313a5 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a5 Cyp313a5 "CG15807, 313a5" CDMC30666 4 6 20 DAC32-D17 5-CG15807-RA_1 CG15807 CCCGTCCTGGTGACCTGTGAACCTAAGATCCTTGAGGACATTTTCACGTCTCCCAATTGCAGCAACAGG 69 FBan0015807 FBgn0038005 Cyp313a5 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a5 Cyp313a5 "CG15807, 313a5" CDMC30667 4 7 20 DAC32-H05 18-CG15863-RA_1 CG15863 CCCTTCTCGGGTACACATCTTAAGCCCTTAGAAAAGAAGGAGTTCGACGCTCTGAAAGCAAATCTCCCA 69 FBan0015863 FBgn0033467 CG15863 2 2R CG15863 CG15863 CDMC30667 4 8 20 DAC32-H05 18-CG15863-RA_1 CG15863 CCCTTCTCGGGTACACATCTTAAGCCCTTAGAAAAGAAGGAGTTCGACGCTCTGAAAGCAAATCTCCCA 69 FBan0015863 FBgn0033467 CG15863 2 2R CG15863 CG15863 CDMC30668 4 9 20 DAC32-H17 9-CG15883-RA_1 CG15883 AGCCGGTGTCTGATCCAGGATTATTTCGGTGATGATGGGAAAATCGATCTGCAGAAGGTGGGAAAGCGA 69 FBan0015883 FBgn0030985 Obp18a X X sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp18a Odorant-binding protein 18a "CG15883, CG15883, CG15883, CG15883, 18a, BcDNA:RH25665, Odorant-binding protein 18a" CDMC30668 4 10 20 DAC32-H17 9-CG15883-RA_1 CG15883 AGCCGGTGTCTGATCCAGGATTATTTCGGTGATGATGGGAAAATCGATCTGCAGAAGGTGGGAAAGCGA 69 FBan0015883 FBgn0030985 Obp18a X X sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp18a Odorant-binding protein 18a "CG15883, CG15883, CG15883, CG15883, 18a, BcDNA:RH25665, Odorant-binding protein 18a" CDMC30669 4 11 20 DAC32-L05 6-CG15923-RA_1 CG15923 GCAGTCTGGCCAACATCTCTCTGTTCTCACTGACGGAGCCAGGATTTGGTTACTACATCCACGGACGAT 69 FBan0015923 FBgn0038814 CG15923 3 3R CG15923 CG15923 CDMC30669 4 12 20 DAC32-L05 6-CG15923-RA_1 CG15923 GCAGTCTGGCCAACATCTCTCTGTTCTCACTGACGGAGCCAGGATTTGGTTACTACATCCACGGACGAT 69 FBan0015923 FBgn0038814 CG15923 3 3R CG15923 CG15923 CDMC30670 4 13 20 DAC32-L17 11-CG1598-RA_1 CG1598 CCCGCTTCAAGATTCAGGAGAAGTACCTGGACCAGATTGCCGACCTGTATGAAGACTTCCACGTAACCA 69 FBan0001598 FBgn0033191 CG1598 2 2R anion transport; GO:0006820; defense response; GO:0006952; ion transport; GO:0006811; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; arsenite-transporting ATPase activity; GO:0015446 ; EC:3.6.3.16; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0015446 ; EC:3.6.3.16 membrane; GO:0016020 CG1598 CG1598 "gh10483, BcDNA:GM18141, BEST:GH10483" CDMC30670 4 14 20 DAC32-L17 11-CG1598-RA_1 CG1598 CCCGCTTCAAGATTCAGGAGAAGTACCTGGACCAGATTGCCGACCTGTATGAAGACTTCCACGTAACCA 69 FBan0001598 FBgn0033191 CG1598 2 2R anion transport; GO:0006820; defense response; GO:0006952; ion transport; GO:0006811; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; arsenite-transporting ATPase activity; GO:0015446 ; EC:3.6.3.16; nucleotide phosphatase activity; GO:0019204; ; GO:0019204; ; GO:0015446 ; EC:3.6.3.16 membrane; GO:0016020 CG1598 CG1598 "gh10483, BcDNA:GM18141, BEST:GH10483" CDMC30671 4 15 20 DAC32-P05 3-CG1636-RA_2 CG1636 ACGCTGTTCGCCAAGAACTTTAAGCTTTCCCTGAATGTGCCCATTTGGTTGTGGTACGGCCTCTCCATT 69 FBan0001636 FBgn0030030 CG1636 X X CG1636 CG1636 CDMC30671 4 16 20 DAC32-P05 3-CG1636-RA_2 CG1636 ACGCTGTTCGCCAAGAACTTTAAGCTTTCCCTGAATGTGCCCATTTGGTTGTGGTACGGCCTCTCCATT 69 FBan0001636 FBgn0030030 CG1636 X X CG1636 CG1636 CDMC30672 4 17 20 DAC32-P17 23-CG1643-RA_2 CG1643 TTATCGGTGGACTACAAGGATGTTTAGCCTTATCCCTATATGTATATAGCCCTATGTTTTGCCCAGTTC 69 FBan0001643 FBgn0029943 Atg5 X X apoptosis; GO:0006915; autophagic cell death; GO:0048102; autophagy; GO:0006914; salivary gland cell autophagic cell death; GO:0035071 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Atg5 Autophagy-specific gene 5 "CG1643, CG1643, CG1643, ATG5, Autophagy-specific gene 5" CDMC30672 4 18 20 DAC32-P17 23-CG1643-RA_2 CG1643 TTATCGGTGGACTACAAGGATGTTTAGCCTTATCCCTATATGTATATAGCCCTATGTTTTGCCCAGTTC 69 FBan0001643 FBgn0029943 Atg5 X X apoptosis; GO:0006915; autophagic cell death; GO:0048102; autophagy; GO:0006914; salivary gland cell autophagic cell death; GO:0035071 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 Atg5 Autophagy-specific gene 5 "CG1643, CG1643, CG1643, ATG5, Autophagy-specific gene 5" CDMC30673 4 19 20 DAC33-D05 23-CG11348-RB_9 CG11348 GCAAGGGCCGTTATGTAATCGTAAAGGAAAGAAATGCAAATGAAGGCCTAAAAACTCTGTTAACTCTGC 69 FBan0011348 FBgn0000038 nAcRbeta-64B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-64B nicotinic Acetylcholine Receptor beta 64B "CG12606, CG11348, CG12606, AChR64B, ard, ARD: AChR protein of Drosophila, Ard, Acr64B, AChR protein of Drosophila, beta 64B, AChR, nAChR, AchR64B, AcrD" CDMC30673 4 20 20 DAC33-D05 23-CG11348-RB_9 CG11348 GCAAGGGCCGTTATGTAATCGTAAAGGAAAGAAATGCAAATGAAGGCCTAAAAACTCTGTTAACTCTGC 69 FBan0011348 FBgn0000038 nAcRbeta-64B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-64B nicotinic Acetylcholine Receptor beta 64B "CG12606, CG11348, CG12606, AChR64B, ard, ARD: AChR protein of Drosophila, Ard, Acr64B, AChR protein of Drosophila, beta 64B, AChR, nAChR, AchR64B, AcrD" CDMC30674 4 21 20 DAC33-D17 13-CG11360-RA_1 CG11360 CGCGCATCACGTAAGCCTGTAAGCGATAGTCAGAACAATGGAATGGTAGGAAGTACGACTAGCTCCGGT 69 FBan0011360 FBgn0039920 CG11360 4 4 "protein ubiquitination; GO:0016567; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG11360 CG11360 cg11360 CDMC30674 4 22 20 DAC33-D17 13-CG11360-RA_1 CG11360 CGCGCATCACGTAAGCCTGTAAGCGATAGTCAGAACAATGGAATGGTAGGAAGTACGACTAGCTCCGGT 69 FBan0011360 FBgn0039920 CG11360 4 4 "protein ubiquitination; GO:0016567; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG11360 CG11360 cg11360 CDMC30675 4 23 20 DAC33-H05 23-CG11390-RA_2 CG11390 CGGTTCCGGAAACTCTTGGTTATATGCACTGTTAATTAGGTCTACGCTTATATCTGATCATCAAAATTA 69 FBan0011390 FBgn0011695 PebIII 2 2R metamorphosis (sensu Insecta); GO:0046698; response to virus; GO:0009615; sensory perception; GO:0007600 carrier activity; GO:0005386; ; GO:0005386 extracellular region; GO:0005576 PebIII Ejaculatory bulb protein III "CG11390, CG11390, CG11390, PEBmeIII, PEB, Phk-2, phk-2, Pherokine 2, BcDNA:RH74005" CDMC30675 4 24 20 DAC33-H05 23-CG11390-RA_2 CG11390 CGGTTCCGGAAACTCTTGGTTATATGCACTGTTAATTAGGTCTACGCTTATATCTGATCATCAAAATTA 69 FBan0011390 FBgn0011695 PebIII 2 2R metamorphosis (sensu Insecta); GO:0046698; response to virus; GO:0009615; sensory perception; GO:0007600 carrier activity; GO:0005386; ; GO:0005386 extracellular region; GO:0005576 PebIII Ejaculatory bulb protein III "CG11390, CG11390, CG11390, PEBmeIII, PEB, Phk-2, phk-2, Pherokine 2, BcDNA:RH74005" CDMC30676 4 25 20 DAC33-H17 3-CG11400-RA_5 CG11400 AGCCATCCGACTGGAATCCAGACTTAAGGAAATCGAGCGAGAAATGGCGGAGGTGACTAGAGCCACAAA 69 FBan0011400 FBgn0034198 CG11400 2 2R CG11400 CG11400 CDMC30676 4 26 20 DAC33-H17 3-CG11400-RA_5 CG11400 AGCCATCCGACTGGAATCCAGACTTAAGGAAATCGAGCGAGAAATGGCGGAGGTGACTAGAGCCACAAA 69 FBan0011400 FBgn0034198 CG11400 2 2R CG11400 CG11400 CDMC30677 4 1 21 DAC33-L05 1-CG1143-RA_1 CG1143 AGCGATGGCAAGCAGACCAAGATTAGCATCACCAAAACATCGATTACGTCCACGGCGCCAATTGAGAGT 69 FBan0001143 FBgn0035359 CG1143 3 3L CG1143 CG1143 CDMC30677 4 2 21 DAC33-L05 1-CG1143-RA_1 CG1143 AGCGATGGCAAGCAGACCAAGATTAGCATCACCAAAACATCGATTACGTCCACGGCGCCAATTGAGAGT 69 FBan0001143 FBgn0035359 CG1143 3 3L CG1143 CG1143 CDMC30678 4 3 21 DAC33-L17 8-CG11455-RB_3 CG11455 GGGGCCAGAGACTGCTAACGGCTTGAAGGCTTAAACCCCTTGTTTATTGTTACGTCACAGTGTGTGTGC 69 FBan0011455 FBgn0031228 CG11455 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11455 CG11455 CDMC30678 4 4 21 DAC33-L17 8-CG11455-RB_3 CG11455 GGGGCCAGAGACTGCTAACGGCTTGAAGGCTTAAACCCCTTGTTTATTGTTACGTCACAGTGTGTGTGC 69 FBan0011455 FBgn0031228 CG11455 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11455 CG11455 CDMC30679 4 5 21 DAC33-P05 23-CG11494-RA_13 CG11494 CGAGCCCCCAAATTGATCGATACAGGTATTAGAGAAACGGCAGCAATCTACTGTATATATAGCGGACCG 69 FBan0011494 FBgn0012049 BtbVII 3 3L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 BtbVII BTB-protein-VII "CG11494, BTB-VII, BTB protein VII" CDMC30679 4 6 21 DAC33-P05 23-CG11494-RA_13 CG11494 CGAGCCCCCAAATTGATCGATACAGGTATTAGAGAAACGGCAGCAATCTACTGTATATATAGCGGACCG 69 FBan0011494 FBgn0012049 BtbVII 3 3L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 BtbVII BTB-protein-VII "CG11494, BTB-VII, BTB protein VII" CDMC30680 4 7 21 DAC33-P17 12-CG11504-RB_1 CG11504 GGCCCAAGAGCTGGAGAAACTTATCGAGGAGACAACCAAAGACGTGGATGACATTGATGAGTCGGAGCT 69 FBan0011504 FBgn0039733 CG11504 3 3R CG11504 CG11504 CDMC30680 4 8 21 DAC33-P17 12-CG11504-RB_1 CG11504 GGCCCAAGAGCTGGAGAAACTTATCGAGGAGACAACCAAAGACGTGGATGACATTGATGAGTCGGAGCT 69 FBan0011504 FBgn0039733 CG11504 3 3R CG11504 CG11504 CDMC30681 4 9 21 DAC34-D05 3-CG1470-RA_1 CG1470 CGATCAACCAGGATGATTCGTTCCACTTGGAGTACCGCGGACCCGTTATCATGAAGGGCAAACCGAC 67 FBan0001470 FBgn0013973 Gycbeta100B 3 3R cGMP biosynthesis; GO:0006182; cell homeostasis; GO:0019725; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gycbeta100B Guanylyl cyclase beta-subunit at 100B "CG1470, CG1470, dgcbeta1, dgcb1, Dgc beta 1, Gycbeta100B, Gycbeta-100B" CDMC30681 4 10 21 DAC34-D05 3-CG1470-RA_1 CG1470 CGATCAACCAGGATGATTCGTTCCACTTGGAGTACCGCGGACCCGTTATCATGAAGGGCAAACCGAC 67 FBan0001470 FBgn0013973 Gycbeta100B 3 3R cGMP biosynthesis; GO:0006182; cell homeostasis; GO:0019725; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gycbeta100B Guanylyl cyclase beta-subunit at 100B "CG1470, CG1470, dgcbeta1, dgcb1, Dgc beta 1, Gycbeta100B, Gycbeta-100B" CDMC30682 4 11 21 DAC34-D17 2-CG14867-RA_1 CG14867 CCACCGTCACTTGGGCACCGACAATCAGCCACCAGGACCAAGGATCCGAGATTGATATCATAATGGC 67 FBan0014867 FBgn0038333 CG14867 3 3R CG14867 CG14867 CDMC30682 4 12 21 DAC34-D17 2-CG14867-RA_1 CG14867 CCACCGTCACTTGGGCACCGACAATCAGCCACCAGGACCAAGGATCCGAGATTGATATCATAATGGC 67 FBan0014867 FBgn0038333 CG14867 3 3R CG14867 CG14867 CDMC30683 4 13 21 DAC34-H05 6-CG15125-RA_1 CG15125 GCGGATTCTTCCACGATCACAACCAAACTACGGCCACAATTGAACGGGATTCGCGAAAAGTGCTGCG 67 FBan0015125 FBgn0034463 CG15125 2 2R CG15125 CG15125 CDMC30683 4 14 21 DAC34-H05 6-CG15125-RA_1 CG15125 GCGGATTCTTCCACGATCACAACCAAACTACGGCCACAATTGAACGGGATTCGCGAAAAGTGCTGCG 67 FBan0015125 FBgn0034463 CG15125 2 2R CG15125 CG15125 CDMC30684 4 15 21 DAC34-H17 1-CG15425-RA_1 CG15425 CCGGTGGATTACGAGAGGACGGTCAACCAGGTGATGCAGTACGTGAATCCCAATTTGCGCAATCCAC 67 FBan0015425 FBgn0031591 CG15425 2 2L CG15425 CG15425 CDMC30684 4 16 21 DAC34-H17 1-CG15425-RA_1 CG15425 CCGGTGGATTACGAGAGGACGGTCAACCAGGTGATGCAGTACGTGAATCCCAATTTGCGCAATCCAC 67 FBan0015425 FBgn0031591 CG15425 2 2L CG15425 CG15425 CDMC30685 4 17 21 DAC34-L05 41-CG15765-RA_1 CG15765 CCTCAACGAGGATGACAGCAATAGCGATGCCTCCAATGAGATATTCGAACATTTGCCGCACAAGAAG 67 FBan0015765 FBgn0029814 CG15765 X X sugar binding; GO:0005529; ; GO:0005529 CG15765 CG15765 CDMC30685 4 18 21 DAC34-L05 41-CG15765-RA_1 CG15765 CCTCAACGAGGATGACAGCAATAGCGATGCCTCCAATGAGATATTCGAACATTTGCCGCACAAGAAG 67 FBan0015765 FBgn0029814 CG15765 X X sugar binding; GO:0005529; ; GO:0005529 CG15765 CG15765 CDMC30686 4 19 21 DAC34-L17 2-CG15878-RA_3 CG15878 CCTGGCCGATTGCTGTGAGACTTTCTGGTTGATGAATCGCGTCTTCCAGATCGAGGATCACGTGCAG 67 FBan0015878 FBgn0035316 CG15878 3 3L CG15878 CG15878 CDMC30686 4 20 21 DAC34-L17 2-CG15878-RA_3 CG15878 CCTGGCCGATTGCTGTGAGACTTTCTGGTTGATGAATCGCGTCTTCCAGATCGAGGATCACGTGCAG 67 FBan0015878 FBgn0035316 CG15878 3 3L CG15878 CG15878 CDMC30687 4 21 21 DAC34-P05 2-CG17119-RB_3 CG17119 AGCTCACCGTCGATTCCCATGACATCACCGTTCTGCTGAACAGCAACGAGACTTTTCTGGTGTTCGC 67 FBan0017119 FBgn0039045 CG17119 3 3R L-cystine transport; GO:0015811 L-cystine transporter activity; GO:0015184; ; GO:0015184 lysosomal membrane; GO:0005765 CG17119 CG17119 CDMC30687 4 22 21 DAC34-P05 2-CG17119-RB_3 CG17119 AGCTCACCGTCGATTCCCATGACATCACCGTTCTGCTGAACAGCAACGAGACTTTTCTGGTGTTCGC 67 FBan0017119 FBgn0039045 CG17119 3 3R L-cystine transport; GO:0015811 L-cystine transporter activity; GO:0015184; ; GO:0015184 lysosomal membrane; GO:0005765 CG17119 CG17119 CDMC30688 4 23 21 DAC34-P17 AutoBlank AutoBlank CDMC30688 4 24 21 DAC34-P17 AutoBlank AutoBlank CDMC30689 4 25 21 DAC35-D05 2-CG11776-RA_3 CG11776 CGGATCCTGGCTCCAAACTCAAAGAGAGCTTCCACACGGAGAAGCACGATATCGAAGACTGGCAAACGA 69 FBan0011776 FBgn0037631 CG11776 3 3R CG11776 CG11776 CDMC30689 4 26 21 DAC35-D05 2-CG11776-RA_3 CG11776 CGGATCCTGGCTCCAAACTCAAAGAGAGCTTCCACACGGAGAAGCACGATATCGAAGACTGGCAAACGA 69 FBan0011776 FBgn0037631 CG11776 3 3R CG11776 CG11776 CDMC30690 4 1 22 DAC35-D17 18-CG11786-RA_3 CG11786 CCAGCTCCGTTCATTCCCTACCATTCGCACGACTCCATTCTGGAAAAGCTTAAGTCCAAGATCAATCTG 69 FBan0011786 FBgn0039264 CG11786 3 3R CG11786 CG11786 CDMC30690 4 2 22 DAC35-D17 18-CG11786-RA_3 CG11786 CCAGCTCCGTTCATTCCCTACCATTCGCACGACTCCATTCTGGAAAAGCTTAAGTCCAAGATCAATCTG 69 FBan0011786 FBgn0039264 CG11786 3 3R CG11786 CG11786 CDMC30691 4 3 22 DAC35-H05 11-CG11839-RA_1 CG11839 GCGAAGAGTAGACCCCAAGATGGAGGTCGATCCGGAATTGAGTTCAAGCGAAGAAGATTGCAGTGTGGA 69 FBan0011839 FBgn0039271 CG11839 3 3R CG11839 CG11839 CT36969 CDMC30691 4 4 22 DAC35-H05 11-CG11839-RA_1 CG11839 GCGAAGAGTAGACCCCAAGATGGAGGTCGATCCGGAATTGAGTTCAAGCGAAGAAGATTGCAGTGTGGA 69 FBan0011839 FBgn0039271 CG11839 3 3R CG11839 CG11839 CT36969 CDMC30692 4 5 22 DAC35-H17 3-CG11853-RA_2 CG11853 CCGCTGGTGAAGAATGGGGAGACCTACCTGGACGTTACCGATCTGAAAATAACGATGAAGCCGGAGTCC 69 FBan0011853 FBgn0039298 to 3 3R behavioral response to starvation; GO:0042595; circadian rhythm; GO:0007623; feeding behavior; GO:0007631; male courtship behavior; GO:0008049; mating behavior; GO:0007617; response to starvation; GO:0042594; rhythmic behavior; GO:0007622 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 to takeout "CG11853, CG11853, CG11853, CT33074, takeout" CDMC30692 4 6 22 DAC35-H17 3-CG11853-RA_2 CG11853 CCGCTGGTGAAGAATGGGGAGACCTACCTGGACGTTACCGATCTGAAAATAACGATGAAGCCGGAGTCC 69 FBan0011853 FBgn0039298 to 3 3R behavioral response to starvation; GO:0042595; circadian rhythm; GO:0007623; feeding behavior; GO:0007631; male courtship behavior; GO:0008049; mating behavior; GO:0007617; response to starvation; GO:0042594; rhythmic behavior; GO:0007622 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 to takeout "CG11853, CG11853, CG11853, CT33074, takeout" CDMC30693 4 7 22 DAC35-L05 5-CG11887-RA_1 CG11887 ACACGCATCATTTGGTCGTGTGATTGGTCGCATGATGGTCAGTTCTTTGTGACGAGCTCAAGGGATGGA 69 FBan0011887 FBgn0033540 CG11887 2 2R CG11887 CG11887 CDMC30693 4 8 22 DAC35-L05 5-CG11887-RA_1 CG11887 ACACGCATCATTTGGTCGTGTGATTGGTCGCATGATGGTCAGTTCTTTGTGACGAGCTCAAGGGATGGA 69 FBan0011887 FBgn0033540 CG11887 2 2R CG11887 CG11887 CDMC30694 4 9 22 DAC35-L17 13-CG11898-RA_1 CG11898 GGGACTTCCACTACTACCAGAACGAGAATACCTCTGCTCTGTACCTTCATGTGAGCATTAACCGGGCCT 69 FBan0011898 FBgn0039645 CG11898 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; multidrug transporter activity; GO:0015239; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ; GO:0000166; ; GO:0015239; ; GO:0008559 ; EC:3.6.3.44 integral to membrane; GO:0016021 CG11898 CG11898 CDMC30694 4 10 22 DAC35-L17 13-CG11898-RA_1 CG11898 GGGACTTCCACTACTACCAGAACGAGAATACCTCTGCTCTGTACCTTCATGTGAGCATTAACCGGGCCT 69 FBan0011898 FBgn0039645 CG11898 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; multidrug transporter activity; GO:0015239; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ; GO:0000166; ; GO:0015239; ; GO:0008559 ; EC:3.6.3.44 integral to membrane; GO:0016021 CG11898 CG11898 CDMC30695 4 11 22 DAC35-P05 23-CG1193-RB_4 CG1193 CCAGCACCCTCGATAATGATCGTATCCCATGTGTACTTCCCGATCACAATTATTTGTAACCTGTATAAA 69 FBan0001193 FBgn0037375 CG1193 3 3R intracellular protein transport; GO:0006886; microtubule severing; GO:0051013; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783; katanin; GO:0008352; microtubule associated complex; GO:0005875 CG1193 CG1193 DmCG1193 CDMC30695 4 12 22 DAC35-P05 23-CG1193-RB_4 CG1193 CCAGCACCCTCGATAATGATCGTATCCCATGTGTACTTCCCGATCACAATTATTTGTAACCTGTATAAA 69 FBan0001193 FBgn0037375 CG1193 3 3R intracellular protein transport; GO:0006886; microtubule severing; GO:0051013; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783; katanin; GO:0008352; microtubule associated complex; GO:0005875 CG1193 CG1193 DmCG1193 CDMC30696 4 13 22 DAC35-P17 23-CG11964-RA_2 CG11964 AACTCTACTGCAGCGAGATACTTTCCATACTTATACAAACGGAGAACGAGAACCGATTACTGCTGGGTT 69 FBan0011964 FBgn0037644 CG11964 3 3R CG11964 CG11964 CDMC30696 4 14 22 DAC35-P17 23-CG11964-RA_2 CG11964 AACTCTACTGCAGCGAGATACTTTCCATACTTATACAAACGGAGAACGAGAACCGATTACTGCTGGGTT 69 FBan0011964 FBgn0037644 CG11964 3 3R CG11964 CG11964 CDMC30697 4 15 22 DAC36-D05 1-CG8630-RA_1 CG8630 TGCACCCTCTACACAATCCCAATCTCGCACTTGTCGTTCGGGGATAATGAACACATCTGCCACCCTCTC 69 FBan0008630 FBgn0038130 CG8630 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG8630 CG8630 CDMC30697 4 16 22 DAC36-D05 1-CG8630-RA_1 CG8630 TGCACCCTCTACACAATCCCAATCTCGCACTTGTCGTTCGGGGATAATGAACACATCTGCCACCCTCTC 69 FBan0008630 FBgn0038130 CG8630 3 3R fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 CG8630 CG8630 CDMC30698 4 17 22 DAC36-D17 23-CG8639-RA_1 CG8639 GGTTCGGAAATCGCGTGTTTGAAAGAGGAATACAGAATAGCAGATATTGAATGTATAGTGTTGCGCCTC 69 FBan0008639 FBgn0033313 Cirl 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 latrotoxin receptor activity; GO:0016524; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; sugar binding; GO:0005529; ; GO:0016524; ; GO:0016524; ; GO:0005529 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Cirl Cirl "CG8639, CG8639, CG8639, CG8639, CIRL, dcirl, anon-WO0170980.7, anon-WO0170980.8, BcDNA:GH07331" CDMC30698 4 18 22 DAC36-D17 23-CG8639-RA_1 CG8639 GGTTCGGAAATCGCGTGTTTGAAAGAGGAATACAGAATAGCAGATATTGAATGTATAGTGTTGCGCCTC 69 FBan0008639 FBgn0033313 Cirl 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 latrotoxin receptor activity; GO:0016524; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; sugar binding; GO:0005529; ; GO:0016524; ; GO:0016524; ; GO:0005529 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Cirl Cirl "CG8639, CG8639, CG8639, CG8639, CIRL, dcirl, anon-WO0170980.7, anon-WO0170980.8, BcDNA:GH07331" CDMC30699 4 19 22 DAC36-H05 15-CG8676-RC_4 CG8676 CGACTACATCAACTAAATGGATTTGGAGGTGTACCCATTCCCTGCTCTACTTCTCTTCCAGCCAGCCCT 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC30699 4 20 22 DAC36-H05 15-CG8676-RC_4 CG8676 CGACTACATCAACTAAATGGATTTGGAGGTGTACCCATTCCCTGCTCTACTTCTCTTCCAGCCAGCCCT 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC30700 4 21 22 DAC36-H17 2-CG8687-RA_1 CG8687 CGCCGAGTTCCGACAGAAGGGTCGCGAAATATTCACAAGACGTCGTCATTCCACGCTAGTGCAATCCTT 69 FBan0008687 FBgn0033302 Cyp6a14 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a14 Cyp6a14 "CG8687, 6a14" CDMC30700 4 22 22 DAC36-H17 2-CG8687-RA_1 CG8687 CGCCGAGTTCCGACAGAAGGGTCGCGAAATATTCACAAGACGTCGTCATTCCACGCTAGTGCAATCCTT 69 FBan0008687 FBgn0033302 Cyp6a14 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a14 Cyp6a14 "CG8687, 6a14" CDMC30701 4 23 22 DAC36-L05 22-CG8726-RA_2 CG8726 ACTCAACTGTTCGTTAACGTCTAGACATACTCGGAGTCCTGGACTCAAACAAGTGGAAGCAACAGGACA 69 FBan0008726 FBgn0033244 CG8726 2 2R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG8726 CG8726 CDMC30701 4 24 22 DAC36-L05 22-CG8726-RA_2 CG8726 ACTCAACTGTTCGTTAACGTCTAGACATACTCGGAGTCCTGGACTCAAACAAGTGGAAGCAACAGGACA 69 FBan0008726 FBgn0033244 CG8726 2 2R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG8726 CG8726 CDMC30702 4 25 22 DAC36-L17 14-CG8736-RA_4 CG8736 CGCCGACCAGGAACCCAATTGGAAGTTTGAGCTACGACTCCATAGTCCAATTCGGCAAGGATTACCATA 69 FBan0008736 FBgn0033308 CG8736 2 2R CG8736 CG8736 BcDNA:RH08259 CDMC30702 4 26 22 DAC36-L17 14-CG8736-RA_4 CG8736 CGCCGACCAGGAACCCAATTGGAAGTTTGAGCTACGACTCCATAGTCCAATTCGGCAAGGATTACCATA 69 FBan0008736 FBgn0033308 CG8736 2 2R CG8736 CG8736 BcDNA:RH08259 CDMC30703 4 1 23 DAC36-P05 2-CG8773-RA_1 CG8773 TGAGGGGTCAGGACTACTTCACCTGCCTTACCTACATCTCTGCGAATCCAGTTGGTGAGTCCCTGGTTT 69 FBan0008773 FBgn0038135 CG8773 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG8773 CG8773 CDMC30703 4 2 23 DAC36-P05 2-CG8773-RA_1 CG8773 TGAGGGGTCAGGACTACTTCACCTGCCTTACCTACATCTCTGCGAATCCAGTTGGTGAGTCCCTGGTTT 69 FBan0008773 FBgn0038135 CG8773 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG8773 CG8773 CDMC30704 4 3 23 DAC36-P17 2-CG8788-RA_3 CG8788 ACGCCATCACAATCCTGGGCTTGATCTACTGGCTGATCTGCATGATTGCGTTCGGACCACTGATGTTCT 69 FBgn0033384 CDMC30704 4 4 23 DAC36-P17 2-CG8788-RA_3 CG8788 ACGCCATCACAATCCTGGGCTTGATCTACTGGCTGATCTGCATGATTGCGTTCGGACCACTGATGTTCT 69 FBgn0033384 CDMC30705 4 5 23 DAC37-D05 18-CG9014-RA_1 CG9014 CCCCATCCTCGGACTGGTCATGATCTTCGTCGACGGTGTGAATGAGGTAATATTTGGCGAAGAGATTAT 69 FBan0009014 FBgn0028847 CG9014 2 2L carbohydrate metabolism; GO:0005975; protein ubiquitination; GO:0016567 "ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" ubiquitin ligase complex; GO:0000151 CG9014 CG9014 "BG:DS08249.3, DS08249.3" CDMC30705 4 6 23 DAC37-D05 18-CG9014-RA_1 CG9014 CCCCATCCTCGGACTGGTCATGATCTTCGTCGACGGTGTGAATGAGGTAATATTTGGCGAAGAGATTAT 69 FBan0009014 FBgn0028847 CG9014 2 2L carbohydrate metabolism; GO:0005975; protein ubiquitination; GO:0016567 "ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" ubiquitin ligase complex; GO:0000151 CG9014 CG9014 "BG:DS08249.3, DS08249.3" CDMC30706 4 7 23 DAC37-D17 3-CG9025-RA_1 CG9025 TGCAGGATGGACAGACATTGCTGCATATCGCCGTCAATGGAGTGATGCCCGTAGACGAGTTCTACACAA 69 FBan0009025 FBgn0034542 CG9025 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG9025 CG9025 CDMC30706 4 8 23 DAC37-D17 3-CG9025-RA_1 CG9025 TGCAGGATGGACAGACATTGCTGCATATCGCCGTCAATGGAGTGATGCCCGTAGACGAGTTCTACACAA 69 FBan0009025 FBgn0034542 CG9025 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG9025 CG9025 CDMC30707 4 9 23 DAC37-H05 23-CG9056-RA_1 CG9056 AGCATTCAACCTAAGCACTGAGTCCCCACATTGGCAAAATACTTTCCTCGATCTTAATATGGTCGCGCG 69 FBan0009056 FBgn0030702 CG9056 X X CG9056 CG9056 CDMC30707 4 10 23 DAC37-H05 23-CG9056-RA_1 CG9056 AGCATTCAACCTAAGCACTGAGTCCCCACATTGGCAAAATACTTTCCTCGATCTTAATATGGTCGCGCG 69 FBan0009056 FBgn0030702 CG9056 X X CG9056 CG9056 CDMC30708 4 11 23 DAC37-H17 24-CG9074-RA_2 CG9074 GCCGAAAGTTAAATATTATGAGTCAGAGGTTATTTTCTTCTAATAAAATGGATCGCTAATCACAATATA 69 FBan0009074 FBgn0011668 Mst57Da 3 3R defense response; GO:0006952; oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Da Male-specific RNA 57Da "CG9074, CG9074, mst-1, bs30d07.y1, BcDNA:GH19893, Mst57D, mst(2)ag-1" CDMC30708 4 12 23 DAC37-H17 24-CG9074-RA_2 CG9074 GCCGAAAGTTAAATATTATGAGTCAGAGGTTATTTTCTTCTAATAAAATGGATCGCTAATCACAATATA 69 FBan0009074 FBgn0011668 Mst57Da 3 3R defense response; GO:0006952; oviposition; GO:0018991; post-mating behavior; GO:0045297 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 Mst57Da Male-specific RNA 57Da "CG9074, CG9074, mst-1, bs30d07.y1, BcDNA:GH19893, Mst57D, mst(2)ag-1" CDMC30709 4 13 23 DAC37-L05 16-CG9108-RA_1 CG9108 CGCCTCGCATGTATATCACCTGATGAAGAGCGACTCGTACTCCAGGTACCTGCGATCCGATATGTATAA 69 FBan0009108 FBgn0024941 RSG7 X X intracellular signaling cascade; GO:0007242; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; small GTPase regulator activity; GO:0005083; ; GO:0005083 heterotrimeric G-protein complex; GO:0005834 RSG7 Regulator of G-protein signaling 7 "CG9108, RGS7, dRGS7" CDMC30709 4 14 23 DAC37-L05 16-CG9108-RA_1 CG9108 CGCCTCGCATGTATATCACCTGATGAAGAGCGACTCGTACTCCAGGTACCTGCGATCCGATATGTATAA 69 FBan0009108 FBgn0024941 RSG7 X X intracellular signaling cascade; GO:0007242; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; ; GO:0016299; small GTPase regulator activity; GO:0005083; ; GO:0005083 heterotrimeric G-protein complex; GO:0005834 RSG7 Regulator of G-protein signaling 7 "CG9108, RGS7, dRGS7" CDMC30710 4 15 23 DAC37-L17 1-CG9120-RA_1 CG9120 ACGCTCTCTTGACCGATGACATCAAAAGTTCCGTAAGATGTGCCCTAAAGGTCCTGGGTCAACAGGGCT 69 FBan0009120 FBgn0004431 LysX 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998; defense response; GO:0006952 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysX Lysozyme X "CG9120, lysX, BcDNA:LP09906" CDMC30710 4 16 23 DAC37-L17 1-CG9120-RA_1 CG9120 ACGCTCTCTTGACCGATGACATCAAAAGTTCCGTAAGATGTGCCCTAAAGGTCCTGGGTCAACAGGGCT 69 FBan0009120 FBgn0004431 LysX 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998; defense response; GO:0006952 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysX Lysozyme X "CG9120, lysX, BcDNA:LP09906" CDMC30711 4 17 23 DAC37-P05 4-CG9153-RA_1 CG9153 AGGGCGACGATTTTAAGGAAGTCTTCGATCTGACCTTTGAGATATCGCGGGATGTATTCGGGGAGGCGG 69 FBan0009153 FBgn0035207 CG9153 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG9153 CG9153 FBgn0035207 CDMC30711 4 18 23 DAC37-P05 4-CG9153-RA_1 CG9153 AGGGCGACGATTTTAAGGAAGTCTTCGATCTGACCTTTGAGATATCGCGGGATGTATTCGGGGAGGCGG 69 FBan0009153 FBgn0035207 CG9153 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG9153 CG9153 FBgn0035207 CDMC30712 4 19 23 DAC37-P17 2-CG9165-RA_1 CG9165 ACCGGTGCAGTTTGGAGCCTGGATGGTGCAATAGAGATACGGAACCATCTGGCATGTGCCTTAAATGAA 69 FBan0009165 FBgn0010786 l(3)02640 3 3L porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778 deaminase activity; GO:0019239; ; GO:0019239; hydroxymethylbilane synthase activity; GO:0004418 ; EC:2.5.1.61; ; GO:0004418 ; EC:2.5.1.61 l(3)02640 lethal (3) 02640 "CG9165, CG9165, CG9165, 2640, 3544, l(3)3544, anon-WO0153538.70, l(3)j4E3" CDMC30712 4 20 23 DAC37-P17 2-CG9165-RA_1 CG9165 ACCGGTGCAGTTTGGAGCCTGGATGGTGCAATAGAGATACGGAACCATCTGGCATGTGCCTTAAATGAA 69 FBan0009165 FBgn0010786 l(3)02640 3 3L porphyrin biosynthesis; GO:0006779; porphyrin metabolism; GO:0006778 deaminase activity; GO:0019239; ; GO:0019239; hydroxymethylbilane synthase activity; GO:0004418 ; EC:2.5.1.61; ; GO:0004418 ; EC:2.5.1.61 l(3)02640 lethal (3) 02640 "CG9165, CG9165, CG9165, 2640, 3544, l(3)3544, anon-WO0153538.70, l(3)j4E3" CDMC30713 4 21 23 DAC38-D05 15-CG5890-RA_2 CG5890 ACCTTGCTGAGAGGTTCTGTATATGAGCGTCTGCGTTGGACCTTCAAGTTGTACGATCTGAACGGC 66 FBan0005890 FBgn0039380 CG5890 3 3R calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG5890 CG5890 CDMC30713 4 22 23 DAC38-D05 15-CG5890-RA_2 CG5890 ACCTTGCTGAGAGGTTCTGTATATGAGCGTCTGCGTTGGACCTTCAAGTTGTACGATCTGAACGGC 66 FBan0005890 FBgn0039380 CG5890 3 3R calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG5890 CG5890 CDMC30714 4 23 23 DAC38-D17 3-CG6116-RA_5 CG6116 CGACATCGACTGGAAAAAGAACGTCTGGAGCTACGAACCCTGGCACCTCAACATCTGGAACAGCGC 66 FBan0006116 FBgn0032499 CG6116 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6116 CG6116 CDMC30714 4 24 23 DAC38-D17 3-CG6116-RA_5 CG6116 CGACATCGACTGGAAAAAGAACGTCTGGAGCTACGAACCCTGGCACCTCAACATCTGGAACAGCGC 66 FBan0006116 FBgn0032499 CG6116 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6116 CG6116 CDMC30715 4 25 23 DAC38-H05 1-CG6444-RA_1 CG6444 GGATCCCATACAGTTCCTGGCCTCCTACCTACTAAAGCATAGCAACGGGTGCGACGAGAACAACGC 66 FBan0006444 FBgn0032293 CG6444 2 2L CG6444 CG6444 CDMC30715 4 26 23 DAC38-H05 1-CG6444-RA_1 CG6444 GGATCCCATACAGTTCCTGGCCTCCTACCTACTAAAGCATAGCAACGGGTGCGACGAGAACAACGC 66 FBan0006444 FBgn0032293 CG6444 2 2L CG6444 CG6444 CDMC30716 4 1 24 DAC38-H17 1-CG6623-RA_1 CG6623 GTGGCACTCAGAAGTTCCTGCAGGTGATCATGAAGGGCATGGAAGCACATCTCCTTTTGCAGCACG 66 FBan0006623 FBgn0038303 CG6623 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6623 CG6623 CDMC30716 4 2 24 DAC38-H17 1-CG6623-RA_1 CG6623 GTGGCACTCAGAAGTTCCTGCAGGTGATCATGAAGGGCATGGAAGCACATCTCCTTTTGCAGCACG 66 FBan0006623 FBgn0038303 CG6623 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6623 CG6623 CDMC30717 4 3 24 DAC38-L05 2-CG7102-RA_2 CG7102 AGAGCTTCAAGACTGCGAAGAGAGGTGAAGTGTGTCGAATTCCCGGATGCACAGTATCGCCAGCAG 66 FBan0007102 FBgn0031961 CG7102 2 2L protein binding; GO:0005515; ; GO:0005515 CG7102 CG7102 "CG17973, CG17973" CDMC30717 4 4 24 DAC38-L05 2-CG7102-RA_2 CG7102 AGAGCTTCAAGACTGCGAAGAGAGGTGAAGTGTGTCGAATTCCCGGATGCACAGTATCGCCAGCAG 66 FBan0007102 FBgn0031961 CG7102 2 2L protein binding; GO:0005515; ; GO:0005515 CG7102 CG7102 "CG17973, CG17973" CDMC30718 4 5 24 DAC38-L17 2-CG7179-RA_1 CG7179 CACCTGGGCGTCACAACTCAGCCACAGTCTTCGTCCCAATCCATAGTTAAGCCAGAGTCACCTCTG 66 FBan0007179 FBgn0020880 CG7179 2 2L CG7179 CG7179 "Opa, CT22169, tld-like, anon-28Cg" CDMC30718 4 6 24 DAC38-L17 2-CG7179-RA_1 CG7179 CACCTGGGCGTCACAACTCAGCCACAGTCTTCGTCCCAATCCATAGTTAAGCCAGAGTCACCTCTG 66 FBan0007179 FBgn0020880 CG7179 2 2L CG7179 CG7179 "Opa, CT22169, tld-like, anon-28Cg" CDMC30719 4 7 24 DAC38-P05 2-CG7744-RA_1 CG7744 TGTCGAAGCAACGGATGGAACAGCAGGCTTGGTCCTCGAACTATGGAGATGCCTCTACAGTGGTTG 66 FBan0007744 FBgn0034447 CG7744 2 2R CG7744 CG7744 CDMC30719 4 8 24 DAC38-P05 2-CG7744-RA_1 CG7744 TGTCGAAGCAACGGATGGAACAGCAGGCTTGGTCCTCGAACTATGGAGATGCCTCTACAGTGGTTG 66 FBan0007744 FBgn0034447 CG7744 2 2R CG7744 CG7744 CDMC30720 4 9 24 DAC38-P17 AutoBlank AutoBlank CDMC30720 4 10 24 DAC38-P17 AutoBlank AutoBlank CDMC30721 4 11 24 DAC39-D05 2-CG32055-RA_1 CG32055 GGCAGTGTCTGTGTCTGGACGAGATTACCTCCTGGTTAAATGGTCGTCACGTGTCTTACGCTCGACCCA 69 FBan0032055 FBgn0052055 CG32055 3 3L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872; insulin-like growth factor binding; GO:0005520; ; GO:0005520 insulin-like growth factor binding protein complex; GO:0016942 CG32055 CG32055 "CG6590, CT20492" CDMC30721 4 12 24 DAC39-D05 2-CG32055-RA_1 CG32055 GGCAGTGTCTGTGTCTGGACGAGATTACCTCCTGGTTAAATGGTCGTCACGTGTCTTACGCTCGACCCA 69 FBan0032055 FBgn0052055 CG32055 3 3L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 receptor activity; GO:0004872; ; GO:0004872; insulin-like growth factor binding; GO:0005520; ; GO:0005520 insulin-like growth factor binding protein complex; GO:0016942 CG32055 CG32055 "CG6590, CT20492" CDMC30722 4 13 24 DAC39-D17 18-CG32065-RA_8 CG32065 CGCAAAAAAAGGCCATAAAAAGAGACGAGTCTGAGCTGAGAAGTGAAACCAACTTTGTTAGGCGGCGTC 69 FBan0032065 FBgn0052065 CG32065 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32065 CG32065 CDMC30722 4 14 24 DAC39-D17 18-CG32065-RA_8 CG32065 CGCAAAAAAAGGCCATAAAAAGAGACGAGTCTGAGCTGAGAAGTGAAACCAACTTTGTTAGGCGGCGTC 69 FBan0032065 FBgn0052065 CG32065 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32065 CG32065 CDMC30723 4 15 24 DAC39-H05 2-CG32103-RA_1 CG32103 CGGCATCGATTTGGCGGTATATGAAACCCTCAAGAGGCGGTACATTGCCAATCACGACAACAACGAGCA 69 FBan0032103 FBgn0052103 CG32103 3 3L cation transport; GO:0006812; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; calcium ion binding; GO:0005509; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005509 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740; peroxisomal membrane; GO:0005778 CG32103 CG32103 "CG4392, CG18022, CG4392, CG4392" CDMC30723 4 16 24 DAC39-H05 2-CG32103-RA_1 CG32103 CGGCATCGATTTGGCGGTATATGAAACCCTCAAGAGGCGGTACATTGCCAATCACGACAACAACGAGCA 69 FBan0032103 FBgn0052103 CG32103 3 3L cation transport; GO:0006812; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; calcium ion binding; GO:0005509; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005509 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740; peroxisomal membrane; GO:0005778 CG32103 CG32103 "CG4392, CG18022, CG4392, CG4392" CDMC30724 4 17 24 DAC39-H17 18-CG32109-RA_4 CG32109 TCGACACTATTCCCAAGACGTTAGCGAAGAATGAACAGATTCAGCTGGGCTTTCTGCTAACCTCTTCCA 69 FBan0032109 FBgn0052109 CG32109 3 3L CG32109 CG32109 CG10982 CDMC30724 4 18 24 DAC39-H17 18-CG32109-RA_4 CG32109 TCGACACTATTCCCAAGACGTTAGCGAAGAATGAACAGATTCAGCTGGGCTTTCTGCTAACCTCTTCCA 69 FBan0032109 FBgn0052109 CG32109 3 3L CG32109 CG32109 CG10982 CDMC30725 4 19 24 DAC39-L05 16-CG32146-RA_1 CG32146 GCCAGAGAGTGAATGAATGTAGAAGTGAGTGCGTGTATGTCGCGGAGTGAATGCTTTTACCGAGTGTGA 69 FBan0032146 FBgn0041604 dlp 3 3L Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; decapentaplegic receptor signaling pathway; GO:0008101; positive regulation of smoothened signaling pathway; GO:0045880; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; wing disc dorsal/ventral pattern formation; GO:0048190 protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 dlp dally-like "CG32146, CG17703, CG5031, dly, CT16138, D-gpcB, D-glypican B, Dally-like, Dlp, Dly, dally-like" CDMC30725 4 20 24 DAC39-L05 16-CG32146-RA_1 CG32146 GCCAGAGAGTGAATGAATGTAGAAGTGAGTGCGTGTATGTCGCGGAGTGAATGCTTTTACCGAGTGTGA 69 FBan0032146 FBgn0041604 dlp 3 3L Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; decapentaplegic receptor signaling pathway; GO:0008101; positive regulation of smoothened signaling pathway; GO:0045880; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224; wing disc dorsal/ventral pattern formation; GO:0048190 protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 dlp dally-like "CG32146, CG17703, CG5031, dly, CT16138, D-gpcB, D-glypican B, Dally-like, Dlp, Dly, dally-like" CDMC30726 4 21 24 DAC39-L17 3-CG32155-RA_1 CG32155 CGCTTCAGAGGCTGGCATCTCATCGCCCATCATAGGGGTTCTCACACAGGAAGTTTACGTCGATGGTTT 69 FBan0032155 FBgn0052155 CG32155 3 3L proteolysis; GO:0006508 cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; gamma-glutamyl hydrolase activity; GO:0008464 ; EC:3.4.19.9; ; GO:0008464 ; EC:3.4.19.9 CG32155 CG32155 CG5082 CDMC30726 4 22 24 DAC39-L17 3-CG32155-RA_1 CG32155 CGCTTCAGAGGCTGGCATCTCATCGCCCATCATAGGGGTTCTCACACAGGAAGTTTACGTCGATGGTTT 69 FBan0032155 FBgn0052155 CG32155 3 3L proteolysis; GO:0006508 cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.-; gamma-glutamyl hydrolase activity; GO:0008464 ; EC:3.4.19.9; ; GO:0008464 ; EC:3.4.19.9 CG32155 CG32155 CG5082 CDMC30727 4 23 24 DAC39-P05 17-CG32183-RA_2 CG32183 ACCACTGGCAGCAAAACACATAGCGTAAACGATTCGCACGCAAACTATAAGATAGAATTCGATCGGCCG 69 FBan0032183 FBgn0052183 Ccn 3 3L growth factor activity; GO:0008083; ; GO:0008083 Ccn Ccn "CG32183, CG13735, CG13736, CG32183, dCCN" CDMC30727 4 24 24 DAC39-P05 17-CG32183-RA_2 CG32183 ACCACTGGCAGCAAAACACATAGCGTAAACGATTCGCACGCAAACTATAAGATAGAATTCGATCGGCCG 69 FBan0032183 FBgn0052183 Ccn 3 3L growth factor activity; GO:0008083; ; GO:0008083 Ccn Ccn "CG32183, CG13735, CG13736, CG32183, dCCN" CDMC30728 4 25 24 DAC39-P17 23-CG32192-RB_4 CG32192 GCTTCGGATTTAATTTTTGCCTTTACGTATGTCCTCGCAGGAGTTTTGCTAGCTTGGGGAATCAAAAGC 69 FBan0032192 FBgn0052192 CG32192 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32192 CG32192 "bs33g12.y1, NEST:bs36a12, NEST:bs33g12" CDMC30728 4 26 24 DAC39-P17 23-CG32192-RB_4 CG32192 GCTTCGGATTTAATTTTTGCCTTTACGTATGTCCTCGCAGGAGTTTTGCTAGCTTGGGGAATCAAAAGC 69 FBan0032192 FBgn0052192 CG32192 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32192 CG32192 "bs33g12.y1, NEST:bs36a12, NEST:bs33g12" CDMC30729 4 1 25 DAC40-D05 12-CG9587-RA_1 CG9587 GCCGTGTCAACCACAAAAGTAGAGATCATCTCACCTCCCCTGGAAGACGACTTGGGTTATGTCCTCCAC 69 FBan0009587 FBgn0036425 CG9587 3 3L protein binding; GO:0005515; ; GO:0005515 CG9587 CG9587 CDMC30729 4 2 25 DAC40-D05 12-CG9587-RA_1 CG9587 GCCGTGTCAACCACAAAAGTAGAGATCATCTCACCTCCCCTGGAAGACGACTTGGGTTATGTCCTCCAC 69 FBan0009587 FBgn0036425 CG9587 3 3L protein binding; GO:0005515; ; GO:0005515 CG9587 CG9587 CDMC30730 4 3 25 DAC40-D17 16-CG9594-RA_3 CG9594 GCTTCCGGCAAGCTAGATTTACTGTCAAAGATGCTAAAACAGCTAAAGGCGGACAATCACAGGGTCCTT 69 FBan0009594 FBgn0023395 Chd3 3 3L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003682; ; GO:0004386; ; GO:0004003; ; GO:0004003; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 Chd3 Chd3 "CG9594, CG9594, DmCHD3, chd3, CHD-3, CHD3" CDMC30730 4 4 25 DAC40-D17 16-CG9594-RA_3 CG9594 GCTTCCGGCAAGCTAGATTTACTGTCAAAGATGCTAAAACAGCTAAAGGCGGACAATCACAGGGTCCTT 69 FBan0009594 FBgn0023395 Chd3 3 3L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0003682; ; GO:0004386; ; GO:0004003; ; GO:0004003; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 Chd3 Chd3 "CG9594, CG9594, DmCHD3, chd3, CHD-3, CHD3" CDMC30731 4 5 25 DAC40-H05 3-CG9628-RA_3 CG9628 TCCCCGAGTGGCTTCCCTTTGCTATGTGACCTTTGGAGCACTGACCATCTACACGGCAATCTATCTGAT 69 FBan0009628 FBgn0036433 CG9628 3 3L CG9628 CG9628 CDMC30731 4 6 25 DAC40-H05 3-CG9628-RA_3 CG9628 TCCCCGAGTGGCTTCCCTTTGCTATGTGACCTTTGGAGCACTGACCATCTACACGGCAATCTATCTGAT 69 FBan0009628 FBgn0036433 CG9628 3 3L CG9628 CG9628 CDMC30732 4 7 25 DAC40-H17 2-CG9640-RA_1 CG9640 GGGCACCAGTCAGAGACAACACCAACTGCGTCTAAGTAGAAGACTGGAGTGTATCTGCTCGCGCTGTCT 69 FBan0009640 FBgn0034182 CG9640 2 2R CG9640 CG9640 CDMC30732 4 8 25 DAC40-H17 2-CG9640-RA_1 CG9640 GGGCACCAGTCAGAGACAACACCAACTGCGTCTAAGTAGAAGACTGGAGTGTATCTGCTCGCGCTGTCT 69 FBan0009640 FBgn0034182 CG9640 2 2R CG9640 CG9640 CDMC30733 4 9 25 DAC40-L05 3-CG9673-RA_4 CG9673 TGGTACTGCATCCTATAAACAGCAGAAGGCCAACTACAATACGCTGAGCCGATCCCTGTGCGAATGGGA 69 FBan0009673 FBgn0030775 CG9673 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9673 CG9673 SPH81 CDMC30733 4 10 25 DAC40-L05 3-CG9673-RA_4 CG9673 TGGTACTGCATCCTATAAACAGCAGAAGGCCAACTACAATACGCTGAGCCGATCCCTGTGCGAATGGGA 69 FBan0009673 FBgn0030775 CG9673 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9673 CG9673 SPH81 CDMC30734 4 11 25 DAC40-L17 3-CG9688-RA_1 CG9688 GTCGTCCGACTTGGATCTGCCGATCGACATAAAGAATCCCTATGAAAAGGACCCCCAGCAGTGCATCCT 69 FBan0009688 FBgn0039765 mRpS18C 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18C mitochondrial ribosomal protein S18C "CG9688, CG9688, MRP-S18-(1), mitochondrial ribosomal protein S18a, mRpS18a, mitochondrial ribosomal protein S18C" CDMC30734 4 12 25 DAC40-L17 3-CG9688-RA_1 CG9688 GTCGTCCGACTTGGATCTGCCGATCGACATAAAGAATCCCTATGAAAAGGACCCCCAGCAGTGCATCCT 69 FBan0009688 FBgn0039765 mRpS18C 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18C mitochondrial ribosomal protein S18C "CG9688, CG9688, MRP-S18-(1), mitochondrial ribosomal protein S18a, mRpS18a, mitochondrial ribosomal protein S18C" CDMC30735 4 13 25 DAC40-P05 8-CG9717-RA_1 CG9717 AGTGGCGCAGGTCTTCGAGGGTCTGAACAAGGATCTGGTGGTCATATACGATATTAACACCCTGCACGC 69 FBan0009717 FBgn0039789 CG9717 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG9717 CG9717 CDMC30735 4 14 25 DAC40-P05 8-CG9717-RA_1 CG9717 AGTGGCGCAGGTCTTCGAGGGTCTGAACAAGGATCTGGTGGTCATATACGATATTAACACCCTGCACGC 69 FBan0009717 FBgn0039789 CG9717 3 3R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 high affinity sulfate permease activity; GO:0015381; ; GO:0015381 CG9717 CG9717 CDMC30736 4 15 25 DAC40-P17 12-CG9733-RA_2 CG9733 CCCAATCAAACCCCTGGACTTTGTGTGCTCATTAATGAATGCCAGACACTCTACTCCGTGCTGAAGCGG 69 FBan0009733 FBgn0039759 CG9733 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG9733 CG9733 "proPO-AE, c-SP10, SP10" CDMC30736 4 16 25 DAC40-P17 12-CG9733-RA_2 CG9733 CCCAATCAAACCCCTGGACTTTGTGTGCTCATTAATGAATGCCAGACACTCTACTCCGTGCTGAAGCGG 69 FBan0009733 FBgn0039759 CG9733 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG9733 CG9733 "proPO-AE, c-SP10, SP10" CDMC30737 4 17 25 DAC41-D05 AutoBlank AutoBlank CDMC30737 4 18 25 DAC41-D05 AutoBlank AutoBlank CDMC30738 4 19 25 DAC41-D17 AutoBlank AutoBlank CDMC30738 4 20 25 DAC41-D17 AutoBlank AutoBlank CDMC30739 4 21 25 DAC41-H05 AutoBlank AutoBlank CDMC30739 4 22 25 DAC41-H05 AutoBlank AutoBlank CDMC30740 4 23 25 DAC41-H17 AutoBlank AutoBlank CDMC30740 4 24 25 DAC41-H17 AutoBlank AutoBlank CDMC30741 4 25 25 DAC41-L05 AutoBlank AutoBlank CDMC30741 4 26 25 DAC41-L05 AutoBlank AutoBlank CDMC30742 4 1 26 DAC41-L17 AutoBlank AutoBlank CDMC30742 4 2 26 DAC41-L17 AutoBlank AutoBlank CDMC30743 4 3 26 DAC41-P05 AutoBlank AutoBlank CDMC30743 4 4 26 DAC41-P05 AutoBlank AutoBlank CDMC30744 4 5 26 DAC41-P17 AutoBlank AutoBlank CDMC30744 4 6 26 DAC41-P17 AutoBlank AutoBlank CDMC30745 4 7 26 DAC42-D05 150mM NaPO4 Blank CDMC30745 4 8 26 DAC42-D05 150mM NaPO4 Blank CDMC30746 4 9 26 DAC42-D17 150mM NaPO4 Blank CDMC30746 4 10 26 DAC42-D17 150mM NaPO4 Blank CDMC30747 4 11 26 DAC42-H05 150mM NaPO4 Blank CDMC30747 4 12 26 DAC42-H05 150mM NaPO4 Blank CDMC30748 4 13 26 DAC42-H17 150mM NaPO4 Blank CDMC30748 4 14 26 DAC42-H17 150mM NaPO4 Blank CDMC30749 4 15 26 DAC42-L05 150mM NaPO4 Blank CDMC30749 4 16 26 DAC42-L05 150mM NaPO4 Blank CDMC30750 4 17 26 DAC42-L17 5uM MSP 5uM MSP CDMC30750 4 18 26 DAC42-L17 5uM MSP 5uM MSP CDMC30751 4 19 26 DAC42-P05 10uM MSP 10uM MSP CDMC30751 4 20 26 DAC42-P05 10uM MSP 10uM MSP CDMC30752 4 21 26 DAC42-P17 20uM MSP 20uM MSP CDMC30752 4 22 26 DAC42-P17 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC30753 1 1 1 DAC01-A04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30753 1 2 1 DAC01-A04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC30754 1 3 1 DAC01-A16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30754 1 4 1 DAC01-A16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC30755 1 5 1 DAC01-E04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30755 1 6 1 DAC01-E04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC30756 1 7 1 DAC01-E16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30756 1 8 1 DAC01-E16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC30757 1 9 1 DAC01-I04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30757 1 10 1 DAC01-I04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC30758 1 11 1 DAC01-I16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30758 1 12 1 DAC01-I16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC30759 1 13 1 DAC01-M04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30759 1 14 1 DAC01-M04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC30760 1 15 1 DAC01-M16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30760 1 16 1 DAC01-M16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC30761 1 17 1 DAC02-A04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30761 1 18 1 DAC02-A04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC30762 1 19 1 DAC02-A16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30762 1 20 1 DAC02-A16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC30763 1 21 1 DAC02-E04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30763 1 22 1 DAC02-E04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC30764 1 23 1 DAC02-E16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30764 1 24 1 DAC02-E16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC30765 1 25 1 DAC02-I04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30765 1 26 1 DAC02-I04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC30766 1 1 2 DAC02-I16 N/A CG9075 (00001-00239) CDMC30766 1 2 2 DAC02-I16 N/A CG9075 (00001-00239) CDMC30767 1 3 2 DAC02-M04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30767 1 4 2 DAC02-M04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC30768 1 5 2 DAC02-M16 AutoBlank AutoBlank CDMC30768 1 6 2 DAC02-M16 AutoBlank AutoBlank CDMC30769 1 7 2 DAC03-A04 8-CG32201-RA_1 CG32201 TCGCGACCTCATAGCCATGGGAAATTCGATGTACCAGCAAAGCGACTATCAGACAGCAGCCAAATGGTA 69 FBan0032201 FBgn0052201 CG32201 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG32201 CG32201 "CG13382, CG18230, CG13382, CG18230" CDMC30769 1 8 2 DAC03-A04 8-CG32201-RA_1 CG32201 TCGCGACCTCATAGCCATGGGAAATTCGATGTACCAGCAAAGCGACTATCAGACAGCAGCCAAATGGTA 69 FBan0032201 FBgn0052201 CG32201 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG32201 CG32201 "CG13382, CG18230, CG13382, CG18230" CDMC30770 1 9 2 DAC03-A16 15-CG32210-RA_6 CG32210 TGGCGGACGACATAGAGCTGAATGAGAAACAAAGTGAGAGTCTAGACGCCAGCACAACGATTTGCAAGT 69 FBan0032210 FBgn0052210 CG32210 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32210 CG32210 "CG9274, CG9268, CG9274" CDMC30770 1 10 2 DAC03-A16 15-CG32210-RA_6 CG32210 TGGCGGACGACATAGAGCTGAATGAGAAACAAAGTGAGAGTCTAGACGCCAGCACAACGATTTGCAAGT 69 FBan0032210 FBgn0052210 CG32210 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32210 CG32210 "CG9274, CG9268, CG9274" CDMC30771 1 11 2 DAC03-E04 18-CG32243-RA_1 CG32243 AGTCAAGGGGCAGGAAATAAACCTGCGAGAATACGGAACCCAACTCAAGAAACATATTGCAAGCTCAGA 69 FBan0032243 FBgn0052243 CG32243 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32243 CG32243 BcDNA:RE12890 CDMC30771 1 12 2 DAC03-E04 18-CG32243-RA_1 CG32243 AGTCAAGGGGCAGGAAATAAACCTGCGAGAATACGGAACCCAACTCAAGAAACATATTGCAAGCTCAGA 69 FBan0032243 FBgn0052243 CG32243 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32243 CG32243 BcDNA:RE12890 CDMC30772 1 13 2 DAC03-E16 17-CG32250-RA_2 CG32250 CCCTGTACCGAGGTCTTGGTCCTGTACTGCAGAGCCTTTGCATTTCGAACTTTGTCTACTTCTACACAT 69 FBan0032250 FBgn0052250 CG32250 3 3L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; transporter activity; GO:0005215; ; GO:0005215 integral to peroxisomal membrane; GO:0005779; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG32250 CG32250 "CG1326, CG1326, CG1326, BcDNA:RE36975" CDMC30772 1 14 2 DAC03-E16 17-CG32250-RA_2 CG32250 CCCTGTACCGAGGTCTTGGTCCTGTACTGCAGAGCCTTTGCATTTCGAACTTTGTCTACTTCTACACAT 69 FBan0032250 FBgn0052250 CG32250 3 3L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; transporter activity; GO:0005215; ; GO:0005215 integral to peroxisomal membrane; GO:0005779; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG32250 CG32250 "CG1326, CG1326, CG1326, BcDNA:RE36975" CDMC30773 1 15 2 DAC03-I04 18-CG32279-RA_1 CG32279 AAAGTACCAGACTCGTTCGGAACATCAGTTGCAATGGTGCAGATCAAATTCCTTTTCGTCTTCCTGGCT 69 FBan0032279 FBgn0052279 dro2 3 3L defense response; GO:0006952 dro2 drosomycin-2 "CG10813, CG32279, CG10813, CG10813, CG10813, CT30310, Dro-D, drosomycin-D" CDMC30773 1 16 2 DAC03-I04 18-CG32279-RA_1 CG32279 AAAGTACCAGACTCGTTCGGAACATCAGTTGCAATGGTGCAGATCAAATTCCTTTTCGTCTTCCTGGCT 69 FBan0032279 FBgn0052279 dro2 3 3L defense response; GO:0006952 dro2 drosomycin-2 "CG10813, CG32279, CG10813, CG10813, CG10813, CT30310, Dro-D, drosomycin-D" CDMC30774 1 17 2 DAC03-I16 11-CG32299-RA_1 CG32299 ACTGGTGCATTCGCAATCCTTTGAAAAGGCCTACAGTACTGCAGCACCATTTCTTTTCGCCAGTTTGGG 69 FBan0032299 FBgn0052299 CG32299 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32299 CG32299 "BcDNA:AT26229, NEST:bs19a11" CDMC30774 1 18 2 DAC03-I16 11-CG32299-RA_1 CG32299 ACTGGTGCATTCGCAATCCTTTGAAAAGGCCTACAGTACTGCAGCACCATTTCTTTTCGCCAGTTTGGG 69 FBan0032299 FBgn0052299 CG32299 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32299 CG32299 "BcDNA:AT26229, NEST:bs19a11" CDMC30775 1 19 2 DAC03-M04 23-CG32343-RA_7 CG32343 GTTTAGCGTAAGTTCGATAAGGTATATTTAGGATATTCAGCCGATAAGTGCATTTGTAAAGCACCCAGT 69 FBan0032343 FBgn0052343 CG32343 3 3L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32343 CG32343 "CG6994, cg6994" CDMC30775 1 20 2 DAC03-M04 23-CG32343-RA_7 CG32343 GTTTAGCGTAAGTTCGATAAGGTATATTTAGGATATTCAGCCGATAAGTGCATTTGTAAAGCACCCAGT 69 FBan0032343 FBgn0052343 CG32343 3 3L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32343 CG32343 "CG6994, cg6994" CDMC30776 1 21 2 DAC03-M16 9-CG32352-RB_3 CG32352 GGCTGGCTTTTACAAGTTCCACGACTTACAGGATGCTCAATCCACAGCCAGTTCTGGCAAGAAAGTGGT 69 FBan0032352 FBgn0052352 CG32352 3 3L CG32352 CG32352 "CG6239, CG17926, CG6239" CDMC30776 1 22 2 DAC03-M16 9-CG32352-RB_3 CG32352 GGCTGGCTTTTACAAGTTCCACGACTTACAGGATGCTCAATCCACAGCCAGTTCTGGCAAGAAAGTGGT 69 FBan0032352 FBgn0052352 CG32352 3 3L CG32352 CG32352 "CG6239, CG17926, CG6239" CDMC30777 1 23 2 DAC04-A04 3-CG2917-RA_2 CG2917 CGGGTGGCAAGCATTCCAAGAGCGTGATCTTTATTCTCGAGGAGTTCGACCTCTTCTGTGCTCACCACA 69 FBan0002917 FBgn0023181 Orc4 2 2R DNA replication initiation; GO:0006270 DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664 Orc4 Origin recognition complex subunit 4 "CG2917, DmORC4, ORC, ORC4, orc4, rDmORC, Origin recognition complex subunit 4" CDMC30777 1 24 2 DAC04-A04 3-CG2917-RA_2 CG2917 CGGGTGGCAAGCATTCCAAGAGCGTGATCTTTATTCTCGAGGAGTTCGACCTCTTCTGTGCTCACCACA 69 FBan0002917 FBgn0023181 Orc4 2 2R DNA replication initiation; GO:0006270 DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664 Orc4 Origin recognition complex subunit 4 "CG2917, DmORC4, ORC, ORC4, orc4, rDmORC, Origin recognition complex subunit 4" CDMC30778 1 25 2 DAC04-A16 22-CG2931-RA_1 CG2931 GCAGGCCTTCAATTCCATGACTTGAATCTGAGTGTGCATATCGTGTCCTTTAGGCTAGTTTCGGTCACT 69 FBan0002931 FBgn0037342 CG2931 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG2931 CG2931 cg2931 CDMC30778 1 26 2 DAC04-A16 22-CG2931-RA_1 CG2931 GCAGGCCTTCAATTCCATGACTTGAATCTGAGTGTGCATATCGTGTCCTTTAGGCTAGTTTCGGTCACT 69 FBan0002931 FBgn0037342 CG2931 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG2931 CG2931 cg2931 CDMC30779 1 1 3 DAC04-E04 18-CG2975-RA_9 CG2975 GCCTTTCTACACGCCCACAATTTCAGGGAACCGGTTTATTTTGGAAACAAGTTCCGCCAGCATGTAAAA 69 FBan0002975 FBgn0031468 CG2975 2 2L protein amino acid glycosylation; GO:0006486 "beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG2975 CG2975 CDMC30779 1 2 3 DAC04-E04 18-CG2975-RA_9 CG2975 GCCTTTCTACACGCCCACAATTTCAGGGAACCGGTTTATTTTGGAAACAAGTTCCGCCAGCATGTAAAA 69 FBan0002975 FBgn0031468 CG2975 2 2L protein amino acid glycosylation; GO:0006486 "beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG2975 CG2975 CDMC30780 1 3 3 DAC04-E16 23-CG2986-RD_4 CG2986 TCTGGCATAAACAATGGAATCATTTTTCGGTGGCAGTTAGAACCAGGATTAGCTCAAAGCAAAGCATAA 69 FBan0002986 FBgn0015521 oho23B 2 2L lymph gland development (sensu Arthropoda); GO:0048542; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 oho23B overgrown hematopoietic organs at 23B "CG2986, l(2)168/14, l(2)k16814, oho23, overgrown hematopoietic organs-23, RpS21: Ribosomal protein S21, rpS21, Ribosomal protein S21, l(2)03575, RpS21" CDMC30780 1 4 3 DAC04-E16 23-CG2986-RD_4 CG2986 TCTGGCATAAACAATGGAATCATTTTTCGGTGGCAGTTAGAACCAGGATTAGCTCAAAGCAAAGCATAA 69 FBan0002986 FBgn0015521 oho23B 2 2L lymph gland development (sensu Arthropoda); GO:0048542; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 oho23B overgrown hematopoietic organs at 23B "CG2986, l(2)168/14, l(2)k16814, oho23, overgrown hematopoietic organs-23, RpS21: Ribosomal protein S21, rpS21, Ribosomal protein S21, l(2)03575, RpS21" CDMC30781 1 5 3 DAC04-I04 23-CG30015-RB_2 CG30015 TAGAGTCTGTCGAGATTGCAGACCCATATGAATGTAAACGTGTAGAAATTTAATCATATTCACACCCAA 69 FBan0030015 FBgn0050015 CG30015 2 2R CG30015 CG30015 "CG7699, CG7701, anon-EST:Posey2" CDMC30781 1 6 3 DAC04-I04 23-CG30015-RB_2 CG30015 TAGAGTCTGTCGAGATTGCAGACCCATATGAATGTAAACGTGTAGAAATTTAATCATATTCACACCCAA 69 FBan0030015 FBgn0050015 CG30015 2 2R CG30015 CG30015 "CG7699, CG7701, anon-EST:Posey2" CDMC30782 1 7 3 DAC04-I16 23-CG3001-RA_4 CG3001 ACAGTAGAGCCACGCTAACTCACAAAAGCCCTATAGCCAAACGATATGAAAAAATGAAGCTGCCACGAC 69 FBan0003001 FBgn0001186 Hex-A X X glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-A Hexokinase A "CG3001, CG3001, CG3001, CG3001, HEX, HK, Hex, hexokinase, Hexokinase, DM1, hexokinase A, Hex-A,B, Hex-A:B" CDMC30782 1 8 3 DAC04-I16 23-CG3001-RA_4 CG3001 ACAGTAGAGCCACGCTAACTCACAAAAGCCCTATAGCCAAACGATATGAAAAAATGAAGCTGCCACGAC 69 FBan0003001 FBgn0001186 Hex-A X X glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 Hex-A Hexokinase A "CG3001, CG3001, CG3001, CG3001, HEX, HK, Hex, hexokinase, Hexokinase, DM1, hexokinase A, Hex-A,B, Hex-A:B" CDMC30783 1 9 3 DAC04-M04 16-CG30050-RA_2 CG30050 GCAACAGTTGAGTGTTTTCAGTGGTTCACTTCGAGTGTCCATACCCAATGCCAAGAAGGTCATAACCCA 69 FBan0030050 FBgn0050050 CG30050 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30050 CG30050 CDMC30783 1 10 3 DAC04-M04 16-CG30050-RA_2 CG30050 GCAACAGTTGAGTGTTTTCAGTGGTTCACTTCGAGTGTCCATACCCAATGCCAAGAAGGTCATAACCCA 69 FBan0030050 FBgn0050050 CG30050 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30050 CG30050 CDMC30784 1 11 3 DAC04-M16 23-CG30065-RA_1 CG30065 CTGGCGGAAGTTGTTAAACTGAACGTGACACTTTTAACCTAATTGGCAAATAAACGAGAGCCCGAGTCC 69 FBan0030065 FBgn0050065 CG30065 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30065 CG30065 BcDNA:AT19876 CDMC30784 1 12 3 DAC04-M16 23-CG30065-RA_1 CG30065 CTGGCGGAAGTTGTTAAACTGAACGTGACACTTTTAACCTAATTGGCAAATAAACGAGAGCCCGAGTCC 69 FBan0030065 FBgn0050065 CG30065 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30065 CG30065 BcDNA:AT19876 CDMC30785 1 13 3 DAC05-A04 1-CG17575-RA_1 CG17575 CCAGTGTCCACCAGTACATGACCTGCAACTTTGTCCGGACAAATGATGTCAATGCCCCGGTCTACCAG 68 FBan0017575 FBgn0033776 CG17575 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG17575 CG17575 CDMC30785 1 14 3 DAC05-A04 1-CG17575-RA_1 CG17575 CCAGTGTCCACCAGTACATGACCTGCAACTTTGTCCGGACAAATGATGTCAATGCCCCGGTCTACCAG 68 FBan0017575 FBgn0033776 CG17575 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG17575 CG17575 CDMC30786 1 15 3 DAC05-A16 18-CG1789-RA_2 CG1789 CGGGCGCAGAACAAGAATCCCGATGAGTTCTACCACCATATGATCAACTCCAAGCTGTCCAACGATGA 68 FBan0001789 FBgn0030063 CG1789 X X protein biosynthesis; GO:0006412; rRNA processing; GO:0006364 molecular function unknown; GO:0005554; ; GO:0005554 small nucleolar ribonucleoprotein complex; GO:0005732 CG1789 CG1789 CDMC30786 1 16 3 DAC05-A16 18-CG1789-RA_2 CG1789 CGGGCGCAGAACAAGAATCCCGATGAGTTCTACCACCATATGATCAACTCCAAGCTGTCCAACGATGA 68 FBan0001789 FBgn0030063 CG1789 X X protein biosynthesis; GO:0006412; rRNA processing; GO:0006364 molecular function unknown; GO:0005554; ; GO:0005554 small nucleolar ribonucleoprotein complex; GO:0005732 CG1789 CG1789 CDMC30787 1 17 3 DAC05-E04 1-CG2010-RA_2 CG2010 TGAGGTTCAGAGCTGAAAGCCAAGAGAGGATTGGTAGCTTGCACTTACCCGGTTGCAGAGCTCTGGAT 68 FBan0002010 FBgn0039667 CG2010 3 3R CG2010 CG2010 CDMC30787 1 18 3 DAC05-E04 1-CG2010-RA_2 CG2010 TGAGGTTCAGAGCTGAAAGCCAAGAGAGGATTGGTAGCTTGCACTTACCCGGTTGCAGAGCTCTGGAT 68 FBan0002010 FBgn0039667 CG2010 3 3R CG2010 CG2010 CDMC30788 1 19 3 DAC05-E16 3-CG2111-RA_1 CG2111 CGGGATATGGTCGAGTCGATGTACAAGCGCTCGAATTTTGCCGCTGAAAAGGAATCACTGCTGACCGC 68 FBan0002111 FBgn0030223 CG2111 X X proteolysis; GO:0006508 NOT pyroglutamyl-peptidase II activity; GO:0016921 ; EC:3.4.19.6; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0016921 ; EC:3.4.19.6; ; GO:0004179 ; EC:3.4.11.2 CG2111 CG2111 pepCG2111 CDMC30788 1 20 3 DAC05-E16 3-CG2111-RA_1 CG2111 CGGGATATGGTCGAGTCGATGTACAAGCGCTCGAATTTTGCCGCTGAAAAGGAATCACTGCTGACCGC 68 FBan0002111 FBgn0030223 CG2111 X X proteolysis; GO:0006508 NOT pyroglutamyl-peptidase II activity; GO:0016921 ; EC:3.4.19.6; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0016921 ; EC:3.4.19.6; ; GO:0004179 ; EC:3.4.11.2 CG2111 CG2111 pepCG2111 CDMC30789 1 21 3 DAC05-I04 2-CG2987-RA_2 CG2987 CAAGCTGGTCAAGTCGTTCCACGTACTGGCAACGAACTACGACATCGACAATCTGAACCAGCGCTCCT 68 FBan0002987 FBgn0029105 alpha-catenin-related 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; cadherin binding; GO:0045296; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0045296 actin cytoskeleton; GO:0015629; integral to membrane; GO:0016021; zonula adherens; GO:0005915 alpha-catenin-related alpha-catenin-related "CG2987, CG2987" CDMC30789 1 22 3 DAC05-I04 2-CG2987-RA_2 CG2987 CAAGCTGGTCAAGTCGTTCCACGTACTGGCAACGAACTACGACATCGACAATCTGAACCAGCGCTCCT 68 FBan0002987 FBgn0029105 alpha-catenin-related 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; cadherin binding; GO:0045296; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584; ; GO:0045296 actin cytoskeleton; GO:0015629; integral to membrane; GO:0016021; zonula adherens; GO:0005915 alpha-catenin-related alpha-catenin-related "CG2987, CG2987" CDMC30790 1 23 3 DAC05-I16 3-CG3020-RA_2 CG3020 CCGGAAGCGACAGACCCACATTCACAGGGGCGAATCCAATCCCTACTTTGACCAGCATTTCAAGTTCC 68 FBan0003020 FBgn0036464 CG3020 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG3020 CG3020 CDMC30790 1 24 3 DAC05-I16 3-CG3020-RA_2 CG3020 CCGGAAGCGACAGACCCACATTCACAGGGGCGAATCCAATCCCTACTTTGACCAGCATTTCAAGTTCC 68 FBan0003020 FBgn0036464 CG3020 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG3020 CG3020 CDMC30791 1 25 3 DAC05-M04 9-CG31241-RA_2 CG31241 GGCCAAGCATAATGCCGGCATTTATGGTGTGGCCCATAAGATCGAGTTTATCCACGCCGATTTTCTGC 68 FBan0031241 FBgn0051241 CG31241 3 3R CG31241 CG31241 "CG8045, CT24102, Dtl, Drosophila Tat-like" CDMC30791 1 26 3 DAC05-M04 9-CG31241-RA_2 CG31241 GGCCAAGCATAATGCCGGCATTTATGGTGTGGCCCATAAGATCGAGTTTATCCACGCCGATTTTCTGC 68 FBan0031241 FBgn0051241 CG31241 3 3R CG31241 CG31241 "CG8045, CT24102, Dtl, Drosophila Tat-like" CDMC30792 1 1 4 DAC05-M16 18-CG31311-RD_7 CG31311 TCTGAAACAAGCGCGCTTAAAACAGATAATGTAGATAAGTCCCCGACACCGCCTAAGGGTTAAGCCAT 68 FBgn0051311 CDMC30792 1 2 4 DAC05-M16 18-CG31311-RD_7 CG31311 TCTGAAACAAGCGCGCTTAAAACAGATAATGTAGATAAGTCCCCGACACCGCCTAAGGGTTAAGCCAT 68 FBgn0051311 CDMC30793 1 3 4 DAC06-A04 2-CG5220-RA_1 CG5220 GCGTCCTTCGAGCATTGAAGCTTTTGTGGTTTGCTCCGATTTTTGCCTTCCCGAGGGCTACATTCCTCA 69 FBan0005220 FBgn0038471 CG5220 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG5220 CG5220 CDMC30793 1 4 4 DAC06-A04 2-CG5220-RA_1 CG5220 GCGTCCTTCGAGCATTGAAGCTTTTGTGGTTTGCTCCGATTTTTGCCTTCCCGAGGGCTACATTCCTCA 69 FBan0005220 FBgn0038471 CG5220 3 3R rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG5220 CG5220 CDMC30794 1 5 4 DAC06-A16 11-CG5232-RA_2 CG5232 GCCAAAATCACCAAGGTTGTGTGGAAACAGCGAAGAAAATGATATGGGAGGCCAAAAAAGCCGGTTGCC 69 FBan0005232 FBgn0038045 Sas 3 3R carbohydrate biosynthesis; GO:0016051; carbohydrate metabolism; GO:0005975; homoiothermy; GO:0042309; protein amino acid glycosylation; GO:0006486; response to freezing; GO:0050826 N-acetylneuraminic acid phosphate synthase activity; GO:0019007; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0019007; ; GO:0016829 ; EC:4.-.-.-; ; GO:0019007; ice binding; GO:0050825; ; GO:0050825 Sas Sialic acid phosphate synthase "CG5232, CG5232, Neu5Ac synthase, N-acetylneuraminic acid phosphate synthase, DmSAS, Neu5Ac, CMP-NcuAc/Kdn-synthetase, Sialic acid phosphate synthase" CDMC30794 1 6 4 DAC06-A16 11-CG5232-RA_2 CG5232 GCCAAAATCACCAAGGTTGTGTGGAAACAGCGAAGAAAATGATATGGGAGGCCAAAAAAGCCGGTTGCC 69 FBan0005232 FBgn0038045 Sas 3 3R carbohydrate biosynthesis; GO:0016051; carbohydrate metabolism; GO:0005975; homoiothermy; GO:0042309; protein amino acid glycosylation; GO:0006486; response to freezing; GO:0050826 N-acetylneuraminic acid phosphate synthase activity; GO:0019007; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0019007; ; GO:0016829 ; EC:4.-.-.-; ; GO:0019007; ice binding; GO:0050825; ; GO:0050825 Sas Sialic acid phosphate synthase "CG5232, CG5232, Neu5Ac synthase, N-acetylneuraminic acid phosphate synthase, DmSAS, Neu5Ac, CMP-NcuAc/Kdn-synthetase, Sialic acid phosphate synthase" CDMC30795 1 7 4 DAC06-E04 23-CG5271-RA_2 CG5271 ACTCCACTCCCAAGAAAATCAAGCACAAGAGGAAGAAGGTCAAGCTAGCTGTCCTGAAATACTACAAGG 69 FBan0005271 FBgn0003942 RpS27A 2 2L "ATP-dependent proteolysis; GO:0006510; establishment and/or maintenance of chromatin architecture; GO:0006325; protein biosynthesis; GO:0006412; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; protein binding; GO:0005515; ; GO:0003735; ; GO:0003676; ; GO:0005515; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS27A Ribosomal protein S27A "CG5271, mfs48, UB3-D, l(2)04820, DUb80, Dub80, Ubi-f80: Ubiquitin fusion 80, Ubi-m, l(2)31Ei, mfs(2)31, mfs(2)48, Ubiquitin fusion 80, male female sterile 31" CDMC30795 1 8 4 DAC06-E04 23-CG5271-RA_2 CG5271 ACTCCACTCCCAAGAAAATCAAGCACAAGAGGAAGAAGGTCAAGCTAGCTGTCCTGAAATACTACAAGG 69 FBan0005271 FBgn0003942 RpS27A 2 2L "ATP-dependent proteolysis; GO:0006510; establishment and/or maintenance of chromatin architecture; GO:0006325; protein biosynthesis; GO:0006412; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; protein binding; GO:0005515; ; GO:0003735; ; GO:0003676; ; GO:0005515; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS27A Ribosomal protein S27A "CG5271, mfs48, UB3-D, l(2)04820, DUb80, Dub80, Ubi-f80: Ubiquitin fusion 80, Ubi-m, l(2)31Ei, mfs(2)31, mfs(2)48, Ubiquitin fusion 80, male female sterile 31" CDMC30796 1 9 4 DAC06-E16 3-CG5282-RA_1 CG5282 TGCCCTTGTATGAGGAGTGGATTCCGCACGAGTCCATCGAAAGCAATTCCTATTGCCGATATCCCGAGT 69 FBan0005282 FBgn0036986 CG5282 3 3L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0008239; ; GO:0004237 ; EC:3.4.13.19 CG5282 CG5282 CDMC30796 1 10 4 DAC06-E16 3-CG5282-RA_1 CG5282 TGCCCTTGTATGAGGAGTGGATTCCGCACGAGTCCATCGAAAGCAATTCCTATTGCCGATATCCCGAGT 69 FBan0005282 FBgn0036986 CG5282 3 3L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0008239; ; GO:0004237 ; EC:3.4.13.19 CG5282 CG5282 CDMC30797 1 11 4 DAC06-I04 7-CG5333-RA_1 CG5333 GGCGCTTTGTCCATGGACCACATTCGTGATTTGTATCAGGAGTACAAGCTGAGAGACCAGAATCCGGGT 69 FBan0005333 FBgn0038055 CG5333 3 3R apoptosis; GO:0006915 cytoplasm; GO:0005737 CG5333 CG5333 CDMC30797 1 12 4 DAC06-I04 7-CG5333-RA_1 CG5333 GGCGCTTTGTCCATGGACCACATTCGTGATTTGTATCAGGAGTACAAGCTGAGAGACCAGAATCCGGGT 69 FBan0005333 FBgn0038055 CG5333 3 3R apoptosis; GO:0006915 cytoplasm; GO:0005737 CG5333 CG5333 CDMC30798 1 13 4 DAC06-I16 3-CG5346-RA_2 CG5346 ACCATAGTCGGTCGAGCCATCCATCGCATCTCTACCTAAGCTGGGATGAAGTTCGTTGTGGGAACGGAT 69 FBan0005346 FBgn0038981 CG5346 3 3R CG5346 CG5346 CDMC30798 1 14 4 DAC06-I16 3-CG5346-RA_2 CG5346 ACCATAGTCGGTCGAGCCATCCATCGCATCTCTACCTAAGCTGGGATGAAGTTCGTTGTGGGAACGGAT 69 FBan0005346 FBgn0038981 CG5346 3 3R CG5346 CG5346 CDMC30799 1 15 4 DAC06-M04 22-CG5382-RA_2 CG5382 TGACCAACCAGTTTTGCTTTGAGCATCGAGTCAATGTTTGCGAACACTGTATGGTTCAGTCTCATCCAA 69 FBan0005382 FBgn0038950 CG5382 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5382 CG5382 CDMC30799 1 16 4 DAC06-M04 22-CG5382-RA_2 CG5382 TGACCAACCAGTTTTGCTTTGAGCATCGAGTCAATGTTTGCGAACACTGTATGGTTCAGTCTCATCCAA 69 FBan0005382 FBgn0038950 CG5382 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5382 CG5382 CDMC30800 1 17 4 DAC06-M16 8-CG5394-RA_1 CG5394 AGGCGCAAGAGGATATGACCAGTCACACGAAAAAGGTGACCAACTGGACGGACTTCTGTGGTTTCCTAG 69 FBan0005394 FBgn0005674 Aats-glupro 3 3R glutamyl-tRNA aminoacylation; GO:0006424; prolyl-tRNA aminoacylation; GO:0006433 actin binding; GO:0003779; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; proline-tRNA ligase activity; GO:0004827 ; EC:6.1.1.15; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004827 ; EC:6.1.1.15; ; GO:0004818 ; EC:6.1.1.17; ; GO:0003779; ; GO:0003729; ; GO:0004818 ; EC:6.1.1.17; ; GO:0004827 ; EC:6.1.1.15 aminoacyl-tRNA synthetase multienzyme complex; GO:0017101; cytoplasm; GO:0005737 Aats-glupro Glutamyl-prolyl-tRNA synthetase "CG5394, CG5394, aminoacyl-tRNA synthetase, GluPro-RS, glutamyl-prolyl-tRA synthetase, GluProRS, ERS, Glutamyl-tRNA synthetase, GluRS, glutamyl-prolyl-tRNA synthetase, AATs-GluPro, AATS, p200, EPRS, Aa-tRNA-syn-glupro, Aats-glu" CDMC30800 1 18 4 DAC06-M16 8-CG5394-RA_1 CG5394 AGGCGCAAGAGGATATGACCAGTCACACGAAAAAGGTGACCAACTGGACGGACTTCTGTGGTTTCCTAG 69 FBan0005394 FBgn0005674 Aats-glupro 3 3R glutamyl-tRNA aminoacylation; GO:0006424; prolyl-tRNA aminoacylation; GO:0006433 actin binding; GO:0003779; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; proline-tRNA ligase activity; GO:0004827 ; EC:6.1.1.15; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004827 ; EC:6.1.1.15; ; GO:0004818 ; EC:6.1.1.17; ; GO:0003779; ; GO:0003729; ; GO:0004818 ; EC:6.1.1.17; ; GO:0004827 ; EC:6.1.1.15 aminoacyl-tRNA synthetase multienzyme complex; GO:0017101; cytoplasm; GO:0005737 Aats-glupro Glutamyl-prolyl-tRNA synthetase "CG5394, CG5394, aminoacyl-tRNA synthetase, GluPro-RS, glutamyl-prolyl-tRA synthetase, GluProRS, ERS, Glutamyl-tRNA synthetase, GluRS, glutamyl-prolyl-tRNA synthetase, AATs-GluPro, AATS, p200, EPRS, Aa-tRNA-syn-glupro, Aats-glu" CDMC30801 1 19 4 DAC07-A04 5-CG9735-RA_5 CG9735 GTTGGAGGAGGTGAGAGTGGCTTACAGCAAAGGCGAAATGCTTACGGGCGAGATCAAGAAGCTGG 65 FBan0009735 FBgn0010803 Aats-trp 3 3R tryptophanyl-tRNA aminoacylation; GO:0006436 ATP binding; GO:0005524; ; GO:0005524; tryptophan-tRNA ligase activity; GO:0004830 ; EC:6.1.1.2; ; GO:0004830 ; EC:6.1.1.2 Aats-trp Tryptophanyl-tRNA synthetase "CG9735, CG9735, l(3)3559, 85D-WRS, TrpRS, WRS-85D, WRS, l(3)03559, l(3)03560" CDMC30801 1 20 4 DAC07-A04 5-CG9735-RA_5 CG9735 GTTGGAGGAGGTGAGAGTGGCTTACAGCAAAGGCGAAATGCTTACGGGCGAGATCAAGAAGCTGG 65 FBan0009735 FBgn0010803 Aats-trp 3 3R tryptophanyl-tRNA aminoacylation; GO:0006436 ATP binding; GO:0005524; ; GO:0005524; tryptophan-tRNA ligase activity; GO:0004830 ; EC:6.1.1.2; ; GO:0004830 ; EC:6.1.1.2 Aats-trp Tryptophanyl-tRNA synthetase "CG9735, CG9735, l(3)3559, 85D-WRS, TrpRS, WRS-85D, WRS, l(3)03559, l(3)03560" CDMC30802 1 21 4 DAC07-A16 3-CG9776-RA_5 CG9776 AGTCGTGGCCGACACTTCTCTCGTTCGCCCATAAGATCTAGTCGAAGAAGTCGATCCCGTCAGGG 65 FBan0009776 FBgn0027866 CG9776 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9776 CG9776 BcDNA:LD19168 CDMC30802 1 22 4 DAC07-A16 3-CG9776-RA_5 CG9776 AGTCGTGGCCGACACTTCTCTCGTTCGCCCATAAGATCTAGTCGAAGAAGTCGATCCCGTCAGGG 65 FBan0009776 FBgn0027866 CG9776 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9776 CG9776 BcDNA:LD19168 CDMC30803 1 23 4 DAC07-E04 2-CG9880-RA_2 CG9880 CTCAGCGAGGGTAGGTACTGGAGTTGGTCGATGCTATTGTGCATCTTGGTGTACCTGCCGACACC 65 FBan0009880 FBgn0026395 Or23a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or23a Odorant receptor 23a "CG9880, CG9880, DOR23A.1, Olfactory receptor 23A.1, dor64, AN5, Dor64, 23A.1, DOR64, AN5, DOR64, 23a, Or23A.1, Or64: Odorant receptor 64, Odorant receptor 64" CDMC30803 1 24 4 DAC07-E04 2-CG9880-RA_2 CG9880 CTCAGCGAGGGTAGGTACTGGAGTTGGTCGATGCTATTGTGCATCTTGGTGTACCTGCCGACACC 65 FBan0009880 FBgn0026395 Or23a 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or23a Odorant receptor 23a "CG9880, CG9880, DOR23A.1, Olfactory receptor 23A.1, dor64, AN5, Dor64, 23A.1, DOR64, AN5, DOR64, 23a, Or23A.1, Or64: Odorant receptor 64, Odorant receptor 64" CDMC30804 1 25 4 DAC07-E16 23-CG9927-RA_1 CG9927 ATTAAAAGTCATGCGAACTGGAATTATCAATATGCTGGTCCTGTACTTCGATGTCTTGTTTCCGT 65 FBan0009927 FBgn0038189 Art6 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art6 Arginine methyltransferase 6 "CG9927, DART6, Arginine methyltransferase 6" CDMC30804 1 26 4 DAC07-E16 23-CG9927-RA_1 CG9927 ATTAAAAGTCATGCGAACTGGAATTATCAATATGCTGGTCCTGTACTTCGATGTCTTGTTTCCGT 65 FBan0009927 FBgn0038189 Art6 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art6 Arginine methyltransferase 6 "CG9927, DART6, Arginine methyltransferase 6" CDMC30805 1 1 5 DAC07-I04 3-CR30304-RA_1 CR30304 GGCGCAATGGATAACGCGTCTGACTACGGATCAGAAGATTCCAGGTTCGACTCCTGGCAGGATCG 65 FBan0030304 FBgn0011958 tRNA:R2:42Ad 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:R2:42Ad transfer RNA:arg2:42Ad "tRNA[Arg][[2]], tRNA[arg], 35DArg, AE002769.trna10-ArgACG, CR30304, tRNA:arg2:42Ad, tRNA:R:ACG:AE002769-b, tRNA:arg1, tRNA:R1, transfer RNA:arg1" CDMC30805 1 2 5 DAC07-I04 3-CR30304-RA_1 CR30304 GGCGCAATGGATAACGCGTCTGACTACGGATCAGAAGATTCCAGGTTCGACTCCTGGCAGGATCG 65 FBan0030304 FBgn0011958 tRNA:R2:42Ad 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 tRNA:R2:42Ad transfer RNA:arg2:42Ad "tRNA[Arg][[2]], tRNA[arg], 35DArg, AE002769.trna10-ArgACG, CR30304, tRNA:arg2:42Ad, tRNA:R:ACG:AE002769-b, tRNA:arg1, tRNA:R1, transfer RNA:arg1" CDMC30806 1 3 5 DAC07-I16 20-CR31383-RA_1 CR31383 CGGTCTAAGGCGCTGGTTTTAGGCACCAGTCCGAAAGGGCGTGGGTTCGAATCCCACCGCTGTCA 65 FBan0031383 FBgn0051383 CR31383 3 3R CR31383 CR31383 "AE002708.trna33-LeuTAG, tRNA:L:TAG:AE002708-b" CDMC30806 1 4 5 DAC07-I16 20-CR31383-RA_1 CR31383 CGGTCTAAGGCGCTGGTTTTAGGCACCAGTCCGAAAGGGCGTGGGTTCGAATCCCACCGCTGTCA 65 FBan0031383 FBgn0051383 CR31383 3 3R CR31383 CR31383 "AE002708.trna33-LeuTAG, tRNA:L:TAG:AE002708-b" CDMC30807 1 5 5 DAC07-M04 23-CR32874-RA_1 CR32874 CTCTGATGATCTTTTACACAGACCTGTACTGAGCTCATAACCGTGCAGAAAATTGTAAACTGAAA 65 FBan0032874 FBgn0063389 snoRNA:U25:30E 2 2L snoRNA:U25:30E snoRNA:U25:30E "U25snoRNA, CR32874, snoRNA:U25" CDMC30807 1 6 5 DAC07-M04 23-CR32874-RA_1 CR32874 CTCTGATGATCTTTTACACAGACCTGTACTGAGCTCATAACCGTGCAGAAAATTGTAAACTGAAA 65 FBan0032874 FBgn0063389 snoRNA:U25:30E 2 2L snoRNA:U25:30E snoRNA:U25:30E "U25snoRNA, CR32874, snoRNA:U25" CDMC30808 1 7 5 DAC07-M16 24-CR32896-RA_2 CR32896 CTTTGTGATGAGCATCCTTTTAAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATACA 65 FBan0032896 FBgn0063374 snoRNA:snR38:54Eb 2 2R snoRNA:snR38:54Eb snoRNA:snR38:54Eb "Snr38snoRNA, CR32896" CDMC30808 1 8 5 DAC07-M16 24-CR32896-RA_2 CR32896 CTTTGTGATGAGCATCCTTTTAAAGCCAAACAGTTATCCCTGTCATAAGAATAATTGATGATACA 65 FBan0032896 FBgn0063374 snoRNA:snR38:54Eb 2 2R snoRNA:snR38:54Eb snoRNA:snR38:54Eb "Snr38snoRNA, CR32896" CDMC30809 1 9 5 DAC08-A04 23-CG5595-RA_4 CG5595 CTATGGAAATGTATTACTCGTGGAAGAAAACCTAAGCTGTACGAAGCGTTTTAGTATTAGGCCGTTTAT 69 FBgn0020911 CDMC30809 1 10 5 DAC08-A04 23-CG5595-RA_4 CG5595 CTATGGAAATGTATTACTCGTGGAAGAAAACCTAAGCTGTACGAAGCGTTTTAGTATTAGGCCGTTTAT 69 FBgn0020911 CDMC30810 1 11 5 DAC08-A16 3-CG5608-RA_2 CG5608 TGTGCGAGACCACAATCAGCCAGTTTCTGAAGTCCATAAGGAACGACTCGTCATCCGTGCGTATGGAGG 69 FBan0005608 FBgn0038058 CG5608 3 3R CG5608 CG5608 CDMC30810 1 12 5 DAC08-A16 3-CG5608-RA_2 CG5608 TGTGCGAGACCACAATCAGCCAGTTTCTGAAGTCCATAAGGAACGACTCGTCATCCGTGCGTATGGAGG 69 FBan0005608 FBgn0038058 CG5608 3 3R CG5608 CG5608 CDMC30811 1 13 5 DAC08-E04 2-CG5642-RA_3 CG5642 CGCATCCCCGGTGGTCCCAAGTTGGAGCAGAGGATCAACTCGTTCTTCAACTACTGCGACTTCTTCAAC 69 FBan0005642 FBgn0036258 CG5642 3 3L CG5642 CG5642 CDMC30811 1 14 5 DAC08-E04 2-CG5642-RA_3 CG5642 CGCATCCCCGGTGGTCCCAAGTTGGAGCAGAGGATCAACTCGTTCTTCAACTACTGCGACTTCTTCAAC 69 FBan0005642 FBgn0036258 CG5642 3 3L CG5642 CG5642 CDMC30812 1 15 5 DAC08-E16 23-CG5654-RA_9 CG5654 CGCGTTTTTTCGGTTTGTTTGCTTTTTGTTTAGTTTCGTAGGGCAGAGAATCAATTGTACAACTCATAC 69 FBan0005654 FBgn0022959 yps 3 3L oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 yps ypsilon schachtel "CG5654, CG5654, CG5654, YPS, p45, p57, Yps, Ypsilon Schachtel, ypsilon schachtel" CDMC30812 1 16 5 DAC08-E16 23-CG5654-RA_9 CG5654 CGCGTTTTTTCGGTTTGTTTGCTTTTTGTTTAGTTTCGTAGGGCAGAGAATCAATTGTACAACTCATAC 69 FBan0005654 FBgn0022959 yps 3 3L oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003676; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 yps ypsilon schachtel "CG5654, CG5654, CG5654, YPS, p45, p57, Yps, Ypsilon Schachtel, ypsilon schachtel" CDMC30813 1 17 5 DAC08-I04 16-CG5685-RA_1 CG5685 GGGGCCTCCTTGACAACTAGTTCTAGTCACCTCACACTATCGACACAAGTCCAACTAGCAACACTTTCA 69 FBan0005685 FBgn0013995 Calx 3 3R calcium ion transport; GO:0006816; cation transport; GO:0006812; cell communication; GO:0007154; rRNA processing; GO:0006364 calcium:sodium antiporter activity; GO:0005432; ; GO:0005432; cation transporter activity; GO:0008324; ; GO:0005432; ; GO:0008324; ; GO:0005432 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Calx Na/Ca-exchange protein "CG5685, CG5685, 9C5, NCX, Dmel/Ncx, Ncx, CALX1.1, anon-93ABa" CDMC30813 1 18 5 DAC08-I04 16-CG5685-RA_1 CG5685 GGGGCCTCCTTGACAACTAGTTCTAGTCACCTCACACTATCGACACAAGTCCAACTAGCAACACTTTCA 69 FBan0005685 FBgn0013995 Calx 3 3R calcium ion transport; GO:0006816; cation transport; GO:0006812; cell communication; GO:0007154; rRNA processing; GO:0006364 calcium:sodium antiporter activity; GO:0005432; ; GO:0005432; cation transporter activity; GO:0008324; ; GO:0005432; ; GO:0008324; ; GO:0005432 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Calx Na/Ca-exchange protein "CG5685, CG5685, 9C5, NCX, Dmel/Ncx, Ncx, CALX1.1, anon-93ABa" CDMC30814 1 19 5 DAC08-I16 16-CG5694-RB_2 CG5694 TGTTGCTGCAAAAGAACAACAGTTCCATTAGCGAAAACGTACAGCATATGATGGTTGAGCCACCACCTT 69 FBan0005694 FBgn0032197 CG5694 2 2L CG5694 CG5694 CDMC30814 1 20 5 DAC08-I16 16-CG5694-RB_2 CG5694 TGTTGCTGCAAAAGAACAACAGTTCCATTAGCGAAAACGTACAGCATATGATGGTTGAGCCACCACCTT 69 FBan0005694 FBgn0032197 CG5694 2 2L CG5694 CG5694 CDMC30815 1 21 5 DAC08-M04 23-CG5726-RA_12 CG5726 AGACCACTCAGTACATGAACTATTTGTCGGCCCAGAAATGAGTTTATACACTTTACGAAGTCATCCACA 69 FBan0005726 FBgn0034313 CG5726 2 2R CG5726 CG5726 CDMC30815 1 22 5 DAC08-M04 23-CG5726-RA_12 CG5726 AGACCACTCAGTACATGAACTATTTGTCGGCCCAGAAATGAGTTTATACACTTTACGAAGTCATCCACA 69 FBan0005726 FBgn0034313 CG5726 2 2R CG5726 CG5726 CDMC30816 1 23 5 DAC08-M16 23-CG5735-RA_4 CG5735 AGGTGTCCCTTTGAATAGCCACCAGAGTCTACAGTTTTAGAGGCGAGAAACGAAAGCAACATAGTTTTT 69 FBan0005735 FBgn0035938 orb2 3 3L RNA localization; GO:0006403; embryonic development; GO:0009790; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 orb2 orb2 "CG5735, cg5735, anon-WO0140519.222" CDMC30816 1 24 5 DAC08-M16 23-CG5735-RA_4 CG5735 AGGTGTCCCTTTGAATAGCCACCAGAGTCTACAGTTTTAGAGGCGAGAAACGAAAGCAACATAGTTTTT 69 FBan0005735 FBgn0035938 orb2 3 3L RNA localization; GO:0006403; embryonic development; GO:0009790; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 orb2 orb2 "CG5735, cg5735, anon-WO0140519.222" CDMC30817 1 25 5 DAC09-A05 3-CG31105-RA_1 CG31105 GCCCCTTCAACTGGTGGAAAATCTCGATGGCGTTGTCTACTGCACCTTGGGACACGTTTCCTGTCTC 67 FBan0031105 FBgn0051105 CG31105 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG31105 CG31105 CDMC30817 1 26 5 DAC09-A05 3-CG31105-RA_1 CG31105 GCCCCTTCAACTGGTGGAAAATCTCGATGGCGTTGTCTACTGCACCTTGGGACACGTTTCCTGTCTC 67 FBan0031105 FBgn0051105 CG31105 3 3R cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG31105 CG31105 CDMC30818 1 1 6 DAC09-A17 1-CG31297-RA_1 CG31297 CGTAAAAAAGAGATTCAGCACGCCCGTCCGTCCCCAAGCGATTTGTGAGCACTCTGTAAAAGGGCAG 67 FBan0031297 FBgn0051297 CG31297 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31297 CG31297 CDMC30818 1 2 6 DAC09-A17 1-CG31297-RA_1 CG31297 CGTAAAAAAGAGATTCAGCACGCCCGTCCGTCCCCAAGCGATTTGTGAGCACTCTGTAAAAGGGCAG 67 FBan0031297 FBgn0051297 CG31297 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31297 CG31297 CDMC30819 1 3 6 DAC09-E05 15-CG31859-RA_2 CG31859 CCGCAATCCTTTGGCCCAAAAGTGAAAGGATCTCGAAGCAGGATATTCGATCGACGTCGATATGCGT 67 FBan0031859 FBgn0051859 CG31859 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31859 CG31859 CDMC30819 1 4 6 DAC09-E05 15-CG31859-RA_2 CG31859 CCGCAATCCTTTGGCCCAAAAGTGAAAGGATCTCGAAGCAGGATATTCGATCGACGTCGATATGCGT 67 FBan0031859 FBgn0051859 CG31859 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31859 CG31859 CDMC30820 1 5 6 DAC09-E17 2-CG32048-RA_1 CG32048 GGGCACCATGAATCGGAATTCCTTTGCCGGGAGTTCGTCCTTGAACGAGGATATACGCCTGAGCATC 67 FBan0032048 FBgn0052048 CG32048 3 3L CG32048 CG32048 "CG17357, CG3179, CG14178, CG17357, CG3179, BcDNA:RE71517, BcDNA:RE71585" CDMC30820 1 6 6 DAC09-E17 2-CG32048-RA_1 CG32048 GGGCACCATGAATCGGAATTCCTTTGCCGGGAGTTCGTCCTTGAACGAGGATATACGCCTGAGCATC 67 FBan0032048 FBgn0052048 CG32048 3 3L CG32048 CG32048 "CG17357, CG3179, CG14178, CG17357, CG3179, BcDNA:RE71517, BcDNA:RE71585" CDMC30821 1 7 6 DAC09-I05 48-CG32491-RW_1 CG32491 TAGCAAAAAACTCTGGCTTTAGTTAGTTATTTTATTGGAAAAATATTTAGTCAAGAGCCAACAAACG 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30821 1 8 6 DAC09-I05 48-CG32491-RW_1 CG32491 TAGCAAAAAACTCTGGCTTTAGTTAGTTATTTTATTGGAAAAATATTTAGTCAAGAGCCAACAAACG 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC30822 1 9 6 DAC09-I17 2-CG32561-RA_1 CG32561 TGAAGACGCAGCCATCCGTTCGGATGACGACACAAACCTGGTTCAGCGGGAATCACAGAAGATATCG 67 FBan0032561 FBgn0016080 xmas-1 X X embryonic development; GO:0009790; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 xmas-1 xmas-1 "CG8919, CG32561, CG8919, CG8919, m(1)3, ms(1)3, ms3, l(1)15Ea, xmas, transcript g" CDMC30822 1 10 6 DAC09-I17 2-CG32561-RA_1 CG32561 TGAAGACGCAGCCATCCGTTCGGATGACGACACAAACCTGGTTCAGCGGGAATCACAGAAGATATCG 67 FBan0032561 FBgn0016080 xmas-1 X X embryonic development; GO:0009790; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 xmas-1 xmas-1 "CG8919, CG32561, CG8919, CG8919, m(1)3, ms(1)3, ms3, l(1)15Ea, xmas, transcript g" CDMC30823 1 11 6 DAC09-M05 3-CG33288-RB_4 CG33288 CCATCTGGAGAGGACTTCTCCCGAACTGGTCTCTAGTCTGGACACAGTGGAGGAAGTACCTACGGCC 67 FBan0033288 FBgn0053288 CG33288 3 3L GTPase regulator activity; GO:0030695; ; GO:0030695 CG33288 CG33288 CDMC30823 1 12 6 DAC09-M05 3-CG33288-RB_4 CG33288 CCATCTGGAGAGGACTTCTCCCGAACTGGTCTCTAGTCTGGACACAGTGGAGGAAGTACCTACGGCC 67 FBan0033288 FBgn0053288 CG33288 3 3L GTPase regulator activity; GO:0030695; ; GO:0030695 CG33288 CG33288 CDMC30824 1 13 6 DAC09-M17 3-CG33462-RA_2 CG33462 CGCCAACCCAAAGAGACGTGCTCCGAAATCTATGGCTGGAATATGACGTTCGAACAGATCTGCGCCG 67 FBan0033462 FBgn0053462 CG33462 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG33462 CG33462 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41" CDMC30824 1 14 6 DAC09-M17 3-CG33462-RA_2 CG33462 CGCCAACCCAAAGAGACGTGCTCCGAAATCTATGGCTGGAATATGACGTTCGAACAGATCTGCGCCG 67 FBan0033462 FBgn0053462 CG33462 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG33462 CG33462 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41" CDMC30825 1 15 6 DAC10-A04 22-CG1830-RB_1 CG1830 AGAGGATCCCAAGGATCTGATACGCAAATGTCTAGTCGTTGATCCTTCGCAACGTATAACCGTCAAGGA 69 FBan0001830 FBgn0011754 PhKgamma X X embryonic morphogenesis; GO:0048598; glucose catabolism; GO:0006007; glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977; protein amino acid phosphorylation; GO:0006468 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005516; phosphorylase kinase activity; GO:0004689 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004689 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 phosphorylase kinase complex; GO:0005964 PhKgamma Phosphorylase kinase gamma "CG1830, CG1830, DPhK-gamma, phosphorylase kinase gamma, DPhK-gamma, EP779, ESTS:194B3T, anon-sts6" CDMC30825 1 16 6 DAC10-A04 22-CG1830-RB_1 CG1830 AGAGGATCCCAAGGATCTGATACGCAAATGTCTAGTCGTTGATCCTTCGCAACGTATAACCGTCAAGGA 69 FBan0001830 FBgn0011754 PhKgamma X X embryonic morphogenesis; GO:0048598; glucose catabolism; GO:0006007; glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977; protein amino acid phosphorylation; GO:0006468 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005516; phosphorylase kinase activity; GO:0004689 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004689 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 phosphorylase kinase complex; GO:0005964 PhKgamma Phosphorylase kinase gamma "CG1830, CG1830, DPhK-gamma, phosphorylase kinase gamma, DPhK-gamma, EP779, ESTS:194B3T, anon-sts6" CDMC30826 1 17 6 DAC10-A16 8-CG18324-RA_2 CG18324 ACAAGGGCTTGGTGGACTGTTTCACTAAAATCTGGAGAACCGAAGGGATCCATGGGATGTACAAGGGCT 69 FBan0018324 FBgn0033905 CG18324 2 2R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18324 CG18324 CDMC30826 1 18 6 DAC10-A16 8-CG18324-RA_2 CG18324 ACAAGGGCTTGGTGGACTGTTTCACTAAAATCTGGAGAACCGAAGGGATCCATGGGATGTACAAGGGCT 69 FBan0018324 FBgn0033905 CG18324 2 2R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18324 CG18324 CDMC30827 1 19 6 DAC10-E04 11-CG18389-RA_1 CG18389 ACCGGAAACAGGAAATCGTCAATCGCGAATCGGAAAAAAGAAGCAGCACCAAATCGAACTGCAAAGGCA 69 FBan0018389 FBgn0013948 Eip93F 3 3R "autophagic cell death; GO:0048102; autophagy; GO:0006914; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; induction of apoptosis by hormones; GO:0008628; larval midgut histolysis; GO:0035069; phagocytosis, engulfment; GO:0006911; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; salivary gland cell autophagic cell death; GO:0035071" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634; polytene chromosome; GO:0005700 Eip93F Eip93F "CG18389, CG18389, CG18389, E93, anon-WO02059370.58" CDMC30827 1 20 6 DAC10-E04 11-CG18389-RA_1 CG18389 ACCGGAAACAGGAAATCGTCAATCGCGAATCGGAAAAAAGAAGCAGCACCAAATCGAACTGCAAAGGCA 69 FBan0018389 FBgn0013948 Eip93F 3 3R "autophagic cell death; GO:0048102; autophagy; GO:0006914; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; induction of apoptosis by hormones; GO:0008628; larval midgut histolysis; GO:0035069; phagocytosis, engulfment; GO:0006911; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; salivary gland cell autophagic cell death; GO:0035071" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634; polytene chromosome; GO:0005700 Eip93F Eip93F "CG18389, CG18389, CG18389, E93, anon-WO02059370.58" CDMC30828 1 21 6 DAC10-E16 14-CG18402-RA_1 CG18402 AGGCAGCGGTATGGCCATTAGCGACAATCCTAACTACAGACTACTAGACGAGTCAATAGCCAGCGAACA 69 FBan0018402 FBgn0013984 InR 3 3R aging; GO:0007568; axon guidance; GO:0007411; cell growth; GO:0016049; determination of adult life span; GO:0008340; dorsal closure; GO:0007391; embryonic development (sensu Insecta); GO:0001700; germ-band shortening; GO:0007390; growth; GO:0040007; imaginal disc growth; GO:0007446; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell proliferation; GO:0008284; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468; regulation of body size; GO:0040014; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to nutrient; GO:0007584; vitellogenesis; GO:0007296 ATP binding; GO:0005524; ; GO:0005524; insulin-like growth factor binding; GO:0005520; insulin receptor activity; GO:0005009; ; GO:0005009; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004896; ; GO:0005009; ; GO:0005520; ; GO:0005009; epidermal growth factor receptor activity; GO:0005006; ; GO:0005524; ; GO:0005006 insulin receptor complex; GO:0005899; integral to plasma membrane; GO:0005887; intercellular junction; GO:0005911; plasma membrane; GO:0005886 InR Insulin-like receptor "CG18402, CG18402, er10, DILR, dir, insulin receptor, DIRH, insulin receptor homolog, dIRH, dInsR, IR, DIR, DIHR, DIRbeta, dIR, inr, Inr, l(3)05545, DInr, INR, dinr, dInr, insulin/insulin-like growth factor receptor, dInR, DInR, InsR, Dir-a, Dir-b, Inr-alpha, Inr-beta, l(3)93Dj, l(3)er10, lethal(3)93Dj" CDMC30828 1 22 6 DAC10-E16 14-CG18402-RA_1 CG18402 AGGCAGCGGTATGGCCATTAGCGACAATCCTAACTACAGACTACTAGACGAGTCAATAGCCAGCGAACA 69 FBan0018402 FBgn0013984 InR 3 3R aging; GO:0007568; axon guidance; GO:0007411; cell growth; GO:0016049; determination of adult life span; GO:0008340; dorsal closure; GO:0007391; embryonic development (sensu Insecta); GO:0001700; germ-band shortening; GO:0007390; growth; GO:0040007; imaginal disc growth; GO:0007446; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell proliferation; GO:0008284; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468; regulation of body size; GO:0040014; regulation of cell proliferation; GO:0042127; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to nutrient; GO:0007584; vitellogenesis; GO:0007296 ATP binding; GO:0005524; ; GO:0005524; insulin-like growth factor binding; GO:0005520; insulin receptor activity; GO:0005009; ; GO:0005009; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004896; ; GO:0005009; ; GO:0005520; ; GO:0005009; epidermal growth factor receptor activity; GO:0005006; ; GO:0005524; ; GO:0005006 insulin receptor complex; GO:0005899; integral to plasma membrane; GO:0005887; intercellular junction; GO:0005911; plasma membrane; GO:0005886 InR Insulin-like receptor "CG18402, CG18402, er10, DILR, dir, insulin receptor, DIRH, insulin receptor homolog, dIRH, dInsR, IR, DIR, DIHR, DIRbeta, dIR, inr, Inr, l(3)05545, DInr, INR, dinr, dInr, insulin/insulin-like growth factor receptor, dInR, DInR, InsR, Dir-a, Dir-b, Inr-alpha, Inr-beta, l(3)93Dj, l(3)er10, lethal(3)93Dj" CDMC30829 1 23 6 DAC10-I04 23-CG18473-RA_8 CG18473 TCTCCACTGGTCTTCGTAGAGATCGGTCCGCTAAAAGTACCTTCTAAAAATTCCTTTTAAAACGTGAGA 69 FBan0018473 FBgn0037683 CG18473 3 3R catabolism; GO:0009056 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; aryldialkylphosphatase activity; GO:0004063 ; EC:3.1.8.1; ; GO:0004063 ; EC:3.1.8.1; ; GO:0008270 cellular component unknown; GO:0008372 CG18473 CG18473 CG8125 CDMC30829 1 24 6 DAC10-I04 23-CG18473-RA_8 CG18473 TCTCCACTGGTCTTCGTAGAGATCGGTCCGCTAAAAGTACCTTCTAAAAATTCCTTTTAAAACGTGAGA 69 FBan0018473 FBgn0037683 CG18473 3 3R catabolism; GO:0009056 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; aryldialkylphosphatase activity; GO:0004063 ; EC:3.1.8.1; ; GO:0004063 ; EC:3.1.8.1; ; GO:0008270 cellular component unknown; GO:0008372 CG18473 CG18473 CG8125 CDMC30830 1 25 6 DAC10-I16 9-CG18490-RB_1 CG18490 AGTCGGCGCAATCCAACAACTTTTTGCGTAAGAACGATGCCAAGAGCACTCTGAAGCCAGCAGATCAAA 69 FBan0018490 FBgn0036149 CG18490 3 3L CG18490 CG18490 CDMC30830 1 26 6 DAC10-I16 9-CG18490-RB_1 CG18490 AGTCGGCGCAATCCAACAACTTTTTGCGTAAGAACGATGCCAAGAGCACTCTGAAGCCAGCAGATCAAA 69 FBan0018490 FBgn0036149 CG18490 3 3L CG18490 CG18490 CDMC30831 1 1 7 DAC10-M04 17-CG18540-RA_1 CG18540 TTCAAGGTCGGAATTCGGGTTTTCAGGCACATTCTTCTGGAATATTGATGTGGACGATAGCGTGATGGT 69 FBan0018540 FBgn0034326 CG18540 2 2R CG18540 CG18540 CDMC30831 1 2 7 DAC10-M04 17-CG18540-RA_1 CG18540 TTCAAGGTCGGAATTCGGGTTTTCAGGCACATTCTTCTGGAATATTGATGTGGACGATAGCGTGATGGT 69 FBan0018540 FBgn0034326 CG18540 2 2R CG18540 CG18540 CDMC30832 1 3 7 DAC10-M16 2-CG18558-RA_1 CG18558 TGCTGAAACCCTACTCACCGAGCAATCCGATTTACTTTGGCTCCCCATTCAAGCTGGGATCCACTCTCT 69 FBan0018558 FBgn0031469 CG18558 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG18558 CG18558 CDMC30832 1 4 7 DAC10-M16 2-CG18558-RA_1 CG18558 TGCTGAAACCCTACTCACCGAGCAATCCGATTTACTTTGGCTCCCCATTCAAGCTGGGATCCACTCTCT 69 FBan0018558 FBgn0031469 CG18558 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG18558 CG18558 CDMC30833 1 5 7 DAC11-A04 38-CG10089-RD_4 CG10089 ACTTTCTCTACTTACTCTCCCTCTCTCGCGAGTAGAAGTCGTACTTGAAGGTCCCCATGTGGCAGCT 67 FBan0010089 FBgn0036369 CG10089 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- CG10089 CG10089 MKP-like CDMC30833 1 6 7 DAC11-A04 38-CG10089-RD_4 CG10089 ACTTTCTCTACTTACTCTCCCTCTCTCGCGAGTAGAAGTCGTACTTGAAGGTCCCCATGTGGCAGCT 67 FBan0010089 FBgn0036369 CG10089 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- CG10089 CG10089 MKP-like CDMC30834 1 7 7 DAC11-A16 3-CG10220-RA_3 CG10220 CGTGACGCCCTTTGAGCGAAAGTTTGTGAAGCCCTTCACCGTCTTTGGATTCGATGTTTTCCAGGCG 67 FBgn0033974 CDMC30834 1 8 7 DAC11-A16 3-CG10220-RA_3 CG10220 CGTGACGCCCTTTGAGCGAAAGTTTGTGAAGCCCTTCACCGTCTTTGGATTCGATGTTTTCCAGGCG 67 FBgn0033974 CDMC30835 1 9 7 DAC11-E04 3-CG1070-RA_2 CG1070 GCAGCTGCACATGGAGGTCCAGGATCACTCGATCTACACTCCCGATTCAATGAACTCGCAATACGCC 67 FBan0001070 FBgn0037471 Alh 3 3R "larval development (sensu Insecta); GO:0002168; molting cycle (sensu Insecta); GO:0007591; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Alh Alhambra "CG1070, l(3)j8C8, AF10, Dalf, anon-WO0118547.226, l(3)j13A6, Alhambra" CDMC30835 1 10 7 DAC11-E04 3-CG1070-RA_2 CG1070 GCAGCTGCACATGGAGGTCCAGGATCACTCGATCTACACTCCCGATTCAATGAACTCGCAATACGCC 67 FBan0001070 FBgn0037471 Alh 3 3R "larval development (sensu Insecta); GO:0002168; molting cycle (sensu Insecta); GO:0007591; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Alh Alhambra "CG1070, l(3)j8C8, AF10, Dalf, anon-WO0118547.226, l(3)j13A6, Alhambra" CDMC30836 1 11 7 DAC11-E16 2-CG10798-RA_4 CG10798 CAAGCTTCACCACCTCCAGTTCGAACAAGGGACGCAAACGATCCAGTCTGAAGGATCCAGGCTTGTT 67 FBan0010798 FBgn0000472 dm X X "DNA endoreduplication; GO:0042023; cell competition (sensu Metazoa); GO:0035212; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; embryonic development (sensu Metazoa); GO:0009792; oogenesis (sensu Insecta); GO:0009993; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of growth; GO:0045927; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dm diminutive "CG10798, CG10798, myc, dMyc, dMyc1, dmyc1, d-myc, l(1)G0139, dmyc, DMYc, Myc, dMYC, Dmyc, D-Myc, c-Myc, c-MYC, EG:BACN5I9.1, anon-WO03040301.171" CDMC30836 1 12 7 DAC11-E16 2-CG10798-RA_4 CG10798 CAAGCTTCACCACCTCCAGTTCGAACAAGGGACGCAAACGATCCAGTCTGAAGGATCCAGGCTTGTT 67 FBan0010798 FBgn0000472 dm X X "DNA endoreduplication; GO:0042023; cell competition (sensu Metazoa); GO:0035212; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; embryonic development (sensu Metazoa); GO:0009792; oogenesis (sensu Insecta); GO:0009993; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of growth; GO:0045927; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dm diminutive "CG10798, CG10798, myc, dMyc, dMyc1, dmyc1, d-myc, l(1)G0139, dmyc, DMYc, Myc, dMYC, Dmyc, D-Myc, c-Myc, c-MYC, EG:BACN5I9.1, anon-WO03040301.171" CDMC30837 1 13 7 DAC11-I04 2-CG11111-RB_1 CG11111 TGCCAGCTACTGGGAGAGTCCGGATGTGATTGCCTTTATTCTACGGCAGATTGGCAAATTCGAGGGC 67 FBan0011111 FBgn0003218 rdgB X X deactivation of rhodopsin mediated signaling; GO:0016059; lipid metabolism; GO:0006629; lipid transport; GO:0006869; phosphoinositide metabolism; GO:0030384; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056; sensory perception of smell; GO:0007608; visual perception; GO:0007601 calcium ion binding; GO:0005509; phosphatidylcholine transporter activity; GO:0008525; phosphatidylinositol transporter activity; GO:0008526; ; GO:0008526; ; GO:0008526; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; phosphoinositide binding; GO:0035091; ; GO:0035091; ; GO:0005509; ; GO:0008526; ; GO:0005388 ; EC:3.6.3.8; ; GO:0008525 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622; plasma membrane; GO:0005886; subrhabdomeral cisterna; GO:0016029 rdgB retinal degeneration B "CG11111, receptor-degeneration-II, ota1: olfactory-trap-abnormal-1, DrdgB, DrdgBalpha, RdgBalpha, hypoF, x36, ota1" CDMC30837 1 14 7 DAC11-I04 2-CG11111-RB_1 CG11111 TGCCAGCTACTGGGAGAGTCCGGATGTGATTGCCTTTATTCTACGGCAGATTGGCAAATTCGAGGGC 67 FBan0011111 FBgn0003218 rdgB X X deactivation of rhodopsin mediated signaling; GO:0016059; lipid metabolism; GO:0006629; lipid transport; GO:0006869; phosphoinositide metabolism; GO:0030384; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056; sensory perception of smell; GO:0007608; visual perception; GO:0007601 calcium ion binding; GO:0005509; phosphatidylcholine transporter activity; GO:0008525; phosphatidylinositol transporter activity; GO:0008526; ; GO:0008526; ; GO:0008526; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; phosphoinositide binding; GO:0035091; ; GO:0035091; ; GO:0005509; ; GO:0008526; ; GO:0005388 ; EC:3.6.3.8; ; GO:0008525 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; intracellular; GO:0005622; plasma membrane; GO:0005886; subrhabdomeral cisterna; GO:0016029 rdgB retinal degeneration B "CG11111, receptor-degeneration-II, ota1: olfactory-trap-abnormal-1, DrdgB, DrdgBalpha, RdgBalpha, hypoF, x36, ota1" CDMC30838 1 15 7 DAC11-I16 3-CG11246-RA_3 CG11246 TGCGAGTCCGAGTCGTTTAAGATGGACCTCATCCTGGACATCAACTCGTGGCTATACCCCATGGAGC 67 FBan0011246 FBgn0037121 Rpb8 3 3L mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb8 Rpb8 "CG11246, CG11246, RPB8" CDMC30838 1 16 7 DAC11-I16 3-CG11246-RA_3 CG11246 TGCGAGTCCGAGTCGTTTAAGATGGACCTCATCCTGGACATCAACTCGTGGCTATACCCCATGGAGC 67 FBan0011246 FBgn0037121 Rpb8 3 3L mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb8 Rpb8 "CG11246, CG11246, RPB8" CDMC30839 1 17 7 DAC11-M04 2-CG11739-RA_2 CG11739 TGAGCCCTCTCCCACGAGTCAACATCGACGAGCCGAAATATGATCAGAACTCCTACTTGGGCAGAGC 67 FBan0011739 FBgn0037239 CG11739 3 3R cation transport; GO:0006812 tricarboxylate carrier activity; GO:0005371; ; GO:0005371 membrane; GO:0016020 CG11739 CG11739 anon-EST:Posey55 CDMC30839 1 18 7 DAC11-M04 2-CG11739-RA_2 CG11739 TGAGCCCTCTCCCACGAGTCAACATCGACGAGCCGAAATATGATCAGAACTCCTACTTGGGCAGAGC 67 FBan0011739 FBgn0037239 CG11739 3 3R cation transport; GO:0006812 tricarboxylate carrier activity; GO:0005371; ; GO:0005371 membrane; GO:0016020 CG11739 CG11739 anon-EST:Posey55 CDMC30840 1 19 7 DAC11-M16 3-CG12010-RA_2 CG12010 TCTCGAAGATGACGGCTGGGTTTGAGGTTATCGGAGGCATGGAAGCACTGAAACGTACCTTGCAAGT 67 FBan0012010 FBgn0035443 CG12010 3 3L mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 endoplasmic reticulum; GO:0005783 CG12010 CG12010 CDMC30840 1 20 7 DAC11-M16 3-CG12010-RA_2 CG12010 TCTCGAAGATGACGGCTGGGTTTGAGGTTATCGGAGGCATGGAAGCACTGAAACGTACCTTGCAAGT 67 FBan0012010 FBgn0035443 CG12010 3 3L mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 endoplasmic reticulum; GO:0005783 CG12010 CG12010 CDMC30841 1 21 7 DAC12-A04 2-CG10053-RA_1 CG10053 GTGCCACCTAAGCAAGAACCATACAGTCCCTCGGAGCAATTAGAACTCCTCACTGGCTACCTGCGC 66 FBan0010053 FBgn0037490 CG10053 3 3R CG10053 CG10053 "BEST:LD41878, BEST:LD45537" CDMC30841 1 22 7 DAC12-A04 2-CG10053-RA_1 CG10053 GTGCCACCTAAGCAAGAACCATACAGTCCCTCGGAGCAATTAGAACTCCTCACTGGCTACCTGCGC 66 FBan0010053 FBgn0037490 CG10053 3 3R CG10053 CG10053 "BEST:LD41878, BEST:LD45537" CDMC30842 1 23 7 DAC12-A16 3-CG10142-RA_2 CG10142 CCACCTCTACAAGATGCAACTACCCTTTGGTCTCGACACGGAGCCATGTCCTGGATTTGGAGCTGC 66 FBan0010142 FBgn0035076 Ance-5 2 2R protein secretion; GO:0009306; proteolysis; GO:0006508 NOT peptidase activity; GO:0008233 ; EC:3.4.-.-; NOT peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; ; GO:0008233 ; EC:3.4.-.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-5 Ance-5 "CG10142, CG10142, CG10142" CDMC30842 1 24 7 DAC12-A16 3-CG10142-RA_2 CG10142 CCACCTCTACAAGATGCAACTACCCTTTGGTCTCGACACGGAGCCATGTCCTGGATTTGGAGCTGC 66 FBan0010142 FBgn0035076 Ance-5 2 2R protein secretion; GO:0009306; proteolysis; GO:0006508 NOT peptidase activity; GO:0008233 ; EC:3.4.-.-; NOT peptidyl-dipeptidase activity; GO:0008241 ; EC:3.4.15.-; ; GO:0008233 ; EC:3.4.-.-; peptidyl-dipeptidase A activity; GO:0004246 ; EC:3.4.15.1; ; GO:0008241 ; EC:3.4.15.-; ; GO:0004246 ; EC:3.4.15.1 membrane; GO:0016020 Ance-5 Ance-5 "CG10142, CG10142, CG10142" CDMC30843 1 25 7 DAC12-E04 1-CG10571-RA_1 CG10571 GCTTTGAGTCTCCTGCCTACCGCTACTCAAGTCCCTATGACCGCTACCTGTCGCAGTAGTAACGCC 66 FBan0010571 FBgn0015904 ara 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; equator specification; GO:0045317; nervous system development; GO:0007399; notum cell fate specification; GO:0035310; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation; GO:0006352; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 ara araucan "CG10571, iro, iroquois, Iroquois, Iro-C, IRO-C, iroquois-complex, iro-C, Iroquis complex, Iro, iroquois gene complex, araucan" CDMC30843 1 26 7 DAC12-E04 1-CG10571-RA_1 CG10571 GCTTTGAGTCTCCTGCCTACCGCTACTCAAGTCCCTATGACCGCTACCTGTCGCAGTAGTAACGCC 66 FBan0010571 FBgn0015904 ara 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; equator specification; GO:0045317; nervous system development; GO:0007399; notum cell fate specification; GO:0035310; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation; GO:0006352; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 ara araucan "CG10571, iro, iroquois, Iroquois, Iro-C, IRO-C, iroquois-complex, iro-C, Iroquis complex, Iro, iroquois gene complex, araucan" CDMC30844 1 1 8 DAC12-E16 2-CG10702-RB_1 CG10702 TGAGGACTCTCGTTTCATTGCGGACATGAGGGAACAATATCGCTGCACCCTTGATGATCGCGAGCA 66 FBan0010702 FBgn0032752 CG10702 2 2L protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; epidermal growth factor receptor activity; GO:0005006; insulin-like growth factor receptor activity; GO:0005010; ; GO:0005010; ; GO:0005006 membrane; GO:0016020 CG10702 CG10702 CDMC30844 1 2 8 DAC12-E16 2-CG10702-RB_1 CG10702 TGAGGACTCTCGTTTCATTGCGGACATGAGGGAACAATATCGCTGCACCCTTGATGATCGCGAGCA 66 FBan0010702 FBgn0032752 CG10702 2 2L protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; epidermal growth factor receptor activity; GO:0005006; insulin-like growth factor receptor activity; GO:0005010; ; GO:0005010; ; GO:0005006 membrane; GO:0016020 CG10702 CG10702 CDMC30845 1 3 8 DAC12-I04 2-CG11110-RA_1 CG11110 GCTCTCCAACCAGTTCATCCATGGCATTTCGGTTCTTTGGCAAGTCCTTGCTGTACGCTCTGCCAC 66 FBan0011110 FBgn0034535 CG11110 2 2R mitochondrial protein processing; GO:0006627; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- mitochondrial inner membrane; GO:0005743 CG11110 CG11110 CDMC30845 1 4 8 DAC12-I04 2-CG11110-RA_1 CG11110 GCTCTCCAACCAGTTCATCCATGGCATTTCGGTTCTTTGGCAAGTCCTTGCTGTACGCTCTGCCAC 66 FBan0011110 FBgn0034535 CG11110 2 2R mitochondrial protein processing; GO:0006627; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- mitochondrial inner membrane; GO:0005743 CG11110 CG11110 CDMC30846 1 5 8 DAC12-I16 1-CG1113-RA_1 CG1113 AGCAACTGCGTAAGGTCTATGGCTCAGAAAAGTCCTGTTCGAGGCAGTCTCAACGAAGCAAGCGGT 66 FBan0001113 FBgn0037304 CG1113 3 3R CG1113 CG1113 CDMC30846 1 6 8 DAC12-I16 1-CG1113-RA_1 CG1113 AGCAACTGCGTAAGGTCTATGGCTCAGAAAAGTCCTGTTCGAGGCAGTCTCAACGAAGCAAGCGGT 66 FBan0001113 FBgn0037304 CG1113 3 3R CG1113 CG1113 CDMC30847 1 7 8 DAC12-M04 1-CG11771-RA_2 CG11771 TGTCCGGTCATGTGATGAGCAACTTCCTCGACGATCCCACAGTGATTCGAAGCCTATCCGGACACT 66 FBan0011771 FBgn0039252 CG11771 3 3R protein targeting to mitochondrion; GO:0006626; proteolysis; GO:0006508 oligopeptidase A activity; GO:0008944 ; EC:3.4.24.70; ; GO:0008944 ; EC:3.4.24.70 CG11771 CG11771 anon-EST:Posey100 CDMC30847 1 8 8 DAC12-M04 1-CG11771-RA_2 CG11771 TGTCCGGTCATGTGATGAGCAACTTCCTCGACGATCCCACAGTGATTCGAAGCCTATCCGGACACT 66 FBan0011771 FBgn0039252 CG11771 3 3R protein targeting to mitochondrion; GO:0006626; proteolysis; GO:0006508 oligopeptidase A activity; GO:0008944 ; EC:3.4.24.70; ; GO:0008944 ; EC:3.4.24.70 CG11771 CG11771 anon-EST:Posey100 CDMC30848 1 9 8 DAC12-M16 2-CG12000-RA_1 CG12000 CCGCCCGCCTAAAGTCTGTTCACACTGCGCTGACTCTTGATTTTATTTGTGCCCGTCATTCTCCGG 66 FBan0012000 FBgn0037314 CG12000 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome core complex (sensu Eukaryota); GO:0005839 CG12000 CG12000 "GC12000, beta-type 4 subunit, anon-WO0118547.326" CDMC30848 1 10 8 DAC12-M16 2-CG12000-RA_1 CG12000 CCGCCCGCCTAAAGTCTGTTCACACTGCGCTGACTCTTGATTTTATTTGTGCCCGTCATTCTCCGG 66 FBan0012000 FBgn0037314 CG12000 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome core complex (sensu Eukaryota); GO:0005839 CG12000 CG12000 "GC12000, beta-type 4 subunit, anon-WO0118547.326" CDMC30849 1 11 8 DAC13-A04 9-CG1451-RA_2 CG1451 GGCCAAAACCAAGCAATCGTCATCCAACCTGAGGACGCAGAAAACCAAATCTTCCAACATGCTCAACGC 69 FBan0001451 FBgn0015589 Apc 3 3R "apoptosis; GO:0006915; cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; frizzled-2 signaling pathway; GO:0007223; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of progression through cell cycle; GO:0000074" microtubule binding; GO:0008017; ; GO:0008017; beta-catenin binding; GO:0008013; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008013 apicolateral plasma membrane; GO:0016327; microtubule associated complex; GO:0005875 Apc APC-like "CG1451, CG1451, d-APC, D-APC, adenomatous polyposis coli, APC, dAPC, D-APC1, dApc, DAPC, Apc1, APC1, apc1, dAPC1, apc, APC-like" CDMC30849 1 12 8 DAC13-A04 9-CG1451-RA_2 CG1451 GGCCAAAACCAAGCAATCGTCATCCAACCTGAGGACGCAGAAAACCAAATCTTCCAACATGCTCAACGC 69 FBan0001451 FBgn0015589 Apc 3 3R "apoptosis; GO:0006915; cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; frizzled-2 signaling pathway; GO:0007223; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of progression through cell cycle; GO:0000074" microtubule binding; GO:0008017; ; GO:0008017; beta-catenin binding; GO:0008013; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008013 apicolateral plasma membrane; GO:0016327; microtubule associated complex; GO:0005875 Apc APC-like "CG1451, CG1451, d-APC, D-APC, adenomatous polyposis coli, APC, dAPC, D-APC1, dApc, DAPC, Apc1, APC1, apc1, dAPC1, apc, APC-like" CDMC30850 1 13 8 DAC13-A16 1-CG14535-RA_1 CG14535 ACCGTCACACAGTCCAAGTCAAGGGTCACTCCCCAGTTTGAATGGCATCATGGAGATAGCAGGAATGGA 69 FBan0014535 FBgn0031955 CG14535 2 2L ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; ; GO:0003774 microtubule associated complex; GO:0005875 CG14535 CG14535 CDMC30850 1 14 8 DAC13-A16 1-CG14535-RA_1 CG14535 ACCGTCACACAGTCCAAGTCAAGGGTCACTCCCCAGTTTGAATGGCATCATGGAGATAGCAGGAATGGA 69 FBan0014535 FBgn0031955 CG14535 2 2L ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; ; GO:0003774 microtubule associated complex; GO:0005875 CG14535 CG14535 CDMC30851 1 15 8 DAC13-E04 8-CG14574-RA_1 CG14574 AGTGCAGCATTCTGGGTTCTTGGTATGCGTCAGAGATTCCTAACGTTTTTGTCGATCTCAACGGCGGGA 69 FBan0014574 FBgn0037104 CG14574 3 3L CG14574 CG14574 CDMC30851 1 16 8 DAC13-E04 8-CG14574-RA_1 CG14574 AGTGCAGCATTCTGGGTTCTTGGTATGCGTCAGAGATTCCTAACGTTTTTGTCGATCTCAACGGCGGGA 69 FBan0014574 FBgn0037104 CG14574 3 3L CG14574 CG14574 CDMC30852 1 17 8 DAC13-E16 15-CG14586-RA_4 CG14586 GGCCAGCCGATTAAGTCCAACATACGTACACTGCAACAACTGGCAGATAGCAATTTGGATGTGGGCATA 69 FBan0014586 FBgn0036758 CG14586 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG14586 CG14586 CT34327 CDMC30852 1 18 8 DAC13-E16 15-CG14586-RA_4 CG14586 GGCCAGCCGATTAAGTCCAACATACGTACACTGCAACAACTGGCAGATAGCAATTTGGATGTGGGCATA 69 FBan0014586 FBgn0036758 CG14586 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG14586 CG14586 CT34327 CDMC30853 1 19 8 DAC13-I04 2-CG14626-RA_1 CG14626 GGCTCTACAAGCGAGATTCCCAGGAGGACCGGTCGAGAATCGTCAAGGAAACCTTACCCGAACCTTAGA 69 FBan0014626 FBgn0040360 CG14626 X X CG14626 CG14626 EG:BACR42I17.6 CDMC30853 1 20 8 DAC13-I04 2-CG14626-RA_1 CG14626 GGCTCTACAAGCGAGATTCCCAGGAGGACCGGTCGAGAATCGTCAAGGAAACCTTACCCGAACCTTAGA 69 FBan0014626 FBgn0040360 CG14626 X X CG14626 CG14626 EG:BACR42I17.6 CDMC30854 1 21 8 DAC13-I16 3-CG14642-RA_2 CG14642 GCGTTCGCAGAGCCCTTACGATGCTTCGCAATCTGTCCGTGTGTCTGATATCATTTATCGGGCTCTGGT 69 FBan0014642 FBgn0037222 CG14642 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14642 CG14642 SP29 CDMC30854 1 22 8 DAC13-I16 3-CG14642-RA_2 CG14642 GCGTTCGCAGAGCCCTTACGATGCTTCGCAATCTGTCCGTGTGTCTGATATCATTTATCGGGCTCTGGT 69 FBan0014642 FBgn0037222 CG14642 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG14642 CG14642 SP29 CDMC30855 1 23 8 DAC13-M04 2-CG14675-RA_1 CG14675 TCCATCGCTGGAACAGGGTTTGAGCAAACTCGTGGAGAAGTTTCAGAACTACCAGGACCAGCAGTCGAA 69 FBan0014675 FBgn0037385 CG14675 3 3R CG14675 CG14675 CDMC30855 1 24 8 DAC13-M04 2-CG14675-RA_1 CG14675 TCCATCGCTGGAACAGGGTTTGAGCAAACTCGTGGAGAAGTTTCAGAACTACCAGGACCAGCAGTCGAA 69 FBan0014675 FBgn0037385 CG14675 3 3R CG14675 CG14675 CDMC30856 1 25 8 DAC13-M16 7-CG14687-RA_1 CG14687 CGAGCGAGTTCGTCCGGAACAGAGAGCTACAACCGATGAAAGCCGTATTTGTTGGATAGAAACGCGGAC 69 FBan0014687 FBgn0037835 CG14687 3 3R CG14687 CG14687 BcDNA:RE74890 CDMC30856 1 26 8 DAC13-M16 7-CG14687-RA_1 CG14687 CGAGCGAGTTCGTCCGGAACAGAGAGCTACAACCGATGAAAGCCGTATTTGTTGGATAGAAACGCGGAC 69 FBan0014687 FBgn0037835 CG14687 3 3R CG14687 CG14687 BcDNA:RE74890 CDMC30857 1 1 9 DAC14-A04 6-CG17223-RA_1 CG17223 TAACCCGTGTGGCTCAGAAGATATGTGGCACCAAAGACATTGCTCTGATGCGAGAGGACCCCAAG 65 FBan0017223 FBgn0031491 alpha4GT1 2 2L carbohydrate metabolism; GO:0005975; glycolipid biosynthesis; GO:0009247; glycolipid metabolism; GO:0006664; lipid metabolism; GO:0006629 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; alpha-1,4-N-acetylgalactosaminyltransferase activity; GO:0035248; ; GO:0035248; ; GO:0035248" Golgi stack; GO:0005795 alpha4GT1 alpha4GT1 "CG17223, CG17223" CDMC30857 1 2 9 DAC14-A04 6-CG17223-RA_1 CG17223 TAACCCGTGTGGCTCAGAAGATATGTGGCACCAAAGACATTGCTCTGATGCGAGAGGACCCCAAG 65 FBan0017223 FBgn0031491 alpha4GT1 2 2L carbohydrate metabolism; GO:0005975; glycolipid biosynthesis; GO:0009247; glycolipid metabolism; GO:0006664; lipid metabolism; GO:0006629 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; alpha-1,4-N-acetylgalactosaminyltransferase activity; GO:0035248; ; GO:0035248; ; GO:0035248" Golgi stack; GO:0005795 alpha4GT1 alpha4GT1 "CG17223, CG17223" CDMC30858 1 3 9 DAC14-A16 2-CG17250-RA_1 CG17250 TTTGCGTTGATTGCTACCCAGTCAATTTCGTTTTGGTCCTGCGTGCCCACATGTCGATCTTCGCG 65 FBan0017250 FBgn0033041 Or42a 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or42a Odorant receptor 42a "CG17250, 41E.2, DOR117, 42a" CDMC30858 1 4 9 DAC14-A16 2-CG17250-RA_1 CG17250 TTTGCGTTGATTGCTACCCAGTCAATTTCGTTTTGGTCCTGCGTGCCCACATGTCGATCTTCGCG 65 FBan0017250 FBgn0033041 Or42a 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or42a Odorant receptor 42a "CG17250, 41E.2, DOR117, 42a" CDMC30859 1 5 9 DAC14-E04 3-CG17385-RA_2 CG17385 CTTTGATACCTTCGCTGACTATGAGAAGCACGAAGCCAAGTGCCATGAGGACCACGAAAGGGCCC 65 FBan0017385 FBgn0033934 CG17385 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17385 CG17385 CDMC30859 1 6 9 DAC14-E04 3-CG17385-RA_2 CG17385 CTTTGATACCTTCGCTGACTATGAGAAGCACGAAGCCAAGTGCCATGAGGACCACGAAAGGGCCC 65 FBan0017385 FBgn0033934 CG17385 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17385 CG17385 CDMC30860 1 7 9 DAC14-E16 2-CG1744-RA_1 CG1744 GTATGGCTGTTTGGACTCGTTGCCTCACTTGCGATCGCTTAAGCTCACTGCCTATTCCCACCTGG 65 FBan0001744 FBgn0000313 chp 3 3R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; eye photoreceptor development (sensu Endopterygota); GO:0042051; homophilic cell adhesion; GO:0007156; visual perception; GO:0007601 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 plasma membrane; GO:0005886 chp chaoptic "CG1744, 516, Chaoptin, chaoptin, mAb24B10, mAb 24B10, 24B10, MAb24B10, MAb 24B10, CT5040, Mab24B10, Nsp: Neural-specific-protein, Neural-specific-protein" CDMC30860 1 8 9 DAC14-E16 2-CG1744-RA_1 CG1744 GTATGGCTGTTTGGACTCGTTGCCTCACTTGCGATCGCTTAAGCTCACTGCCTATTCCCACCTGG 65 FBan0001744 FBgn0000313 chp 3 3R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; eye photoreceptor development (sensu Endopterygota); GO:0042051; homophilic cell adhesion; GO:0007156; visual perception; GO:0007601 structural molecule activity; GO:0005198; receptor activity; GO:0004872; ; GO:0005198; ; GO:0004872 plasma membrane; GO:0005886 chp chaoptic "CG1744, 516, Chaoptin, chaoptin, mAb24B10, mAb 24B10, 24B10, MAb24B10, MAb 24B10, CT5040, Mab24B10, Nsp: Neural-specific-protein, Neural-specific-protein" CDMC30861 1 9 9 DAC14-I04 2-CG17633-RA_1 CG17633 GCCGTGAACAAGCGTTACGGTACCACGTACACTGGAGGCAACATTTACGATGCCATCTACCCAGC 65 FBan0017633 FBgn0032144 CG17633 2 2L proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG17633 CG17633 CDMC30861 1 10 9 DAC14-I04 2-CG17633-RA_1 CG17633 GCCGTGAACAAGCGTTACGGTACCACGTACACTGGAGGCAACATTTACGATGCCATCTACCCAGC 65 FBan0017633 FBgn0032144 CG17633 2 2L proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG17633 CG17633 CDMC30862 1 11 9 DAC14-I16 23-CG17664-RA_1 CG17664 AGCTCGCCTAAATGGATTTACTACACATAGGACAAGTTATCGTTTAAGTTCGTGTTCGTGAGAGC 65 FBan0017664 FBgn0034883 CG17664 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015250 membrane; GO:0016020 CG17664 CG17664 CDMC30862 1 12 9 DAC14-I16 23-CG17664-RA_1 CG17664 AGCTCGCCTAAATGGATTTACTACACATAGGACAAGTTATCGTTTAAGTTCGTGTTCGTGAGAGC 65 FBan0017664 FBgn0034883 CG17664 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 water channel activity; GO:0015250; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015250 membrane; GO:0016020 CG17664 CG17664 CDMC30863 1 13 9 DAC14-M04 21-CG17788-RA_1 CG17788 GGCACCAAAAGCGTCGGCCTCAAACGCGTCTCCTTTGGGTCCTCGAAGGGTTCGATGGTGGAGAC 65 FBan0017788 FBgn0030392 CG17788 X X CG17788 CG17788 CDMC30863 1 14 9 DAC14-M04 21-CG17788-RA_1 CG17788 GGCACCAAAAGCGTCGGCCTCAAACGCGTCTCCTTTGGGTCCTCGAAGGGTTCGATGGTGGAGAC 65 FBan0017788 FBgn0030392 CG17788 X X CG17788 CG17788 CDMC30864 1 15 9 DAC14-M16 18-CG1782-RA_2 CG1782 GCCCCGATCCCCTGGTCTTTGATGTCAACGATCCCATGCACCTCGACTTTATCTACGCAGCCGCC 65 FBan0001782 FBgn0023143 Uba1 2 2R proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004839; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004839 Uba1 Ubiquitin activating enzyme 1 "CG1782, CG1782 (E1), CG1782, CG1782, CG1782, l(2)03405, l(2)05642, 2/31, E1, UBA-1, Uba 1, DmUba1, uba-1, ubiquitin-activating enzyme (E1), UBA-1 (E1), l(2)03405 (E1), l(2)05642 (E1), l(2)s3484 (E1), ubiquitin-activating enzyme" CDMC30864 1 16 9 DAC14-M16 18-CG1782-RA_2 CG1782 GCCCCGATCCCCTGGTCTTTGATGTCAACGATCCCATGCACCTCGACTTTATCTACGCAGCCGCC 65 FBan0001782 FBgn0023143 Uba1 2 2R proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004839; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004839 Uba1 Ubiquitin activating enzyme 1 "CG1782, CG1782 (E1), CG1782, CG1782, CG1782, l(2)03405, l(2)05642, 2/31, E1, UBA-1, Uba 1, DmUba1, uba-1, ubiquitin-activating enzyme (E1), UBA-1 (E1), l(2)03405 (E1), l(2)05642 (E1), l(2)s3484 (E1), ubiquitin-activating enzyme" CDMC30865 1 17 9 DAC15-A04 5-CG12321-RA_1 CG12321 GGACAAGCGTACCACTCTGGACGTAGCAGAGCACACAGTAATCATACCGAGCATTTGCGTGGGAAACG 68 FBan0012321 FBgn0038577 CG12321 3 3R CG12321 CG12321 CDMC30865 1 18 9 DAC15-A04 5-CG12321-RA_1 CG12321 GGACAAGCGTACCACTCTGGACGTAGCAGAGCACACAGTAATCATACCGAGCATTTGCGTGGGAAACG 68 FBan0012321 FBgn0038577 CG12321 3 3R CG12321 CG12321 CDMC30866 1 19 9 DAC15-A16 1-CG12689-RA_1 CG12689 CGCTATGCTGGTCTAAAGGACCTGACAAGACTTCGGCCTCAGTTCTCAACAGCCATTTGCCCAAGAGC 68 FBan0012689 FBgn0029952 CG12689 X X CG12689 CG12689 CDMC30866 1 20 9 DAC15-A16 1-CG12689-RA_1 CG12689 CGCTATGCTGGTCTAAAGGACCTGACAAGACTTCGGCCTCAGTTCTCAACAGCCATTTGCCCAAGAGC 68 FBan0012689 FBgn0029952 CG12689 X X CG12689 CG12689 CDMC30867 1 21 9 DAC15-E04 3-CG13229-RA_2 CG13229 TCGGATTCGTGCTGTACGGTCTGATGTCGAAACAGTTCCGGACCACCTTCCGATCGCTGTTCATGAAG 68 FBan0013229 FBgn0033579 CG13229 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0008188; ; GO:0016526" integral to membrane; GO:0016021 CG13229 CG13229 "anon-WO0170980.142, anon-WO0170980.143" CDMC30867 1 22 9 DAC15-E04 3-CG13229-RA_2 CG13229 TCGGATTCGTGCTGTACGGTCTGATGTCGAAACAGTTCCGGACCACCTTCCGATCGCTGTTCATGAAG 68 FBan0013229 FBgn0033579 CG13229 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 "neuropeptide receptor activity; GO:0008188; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0008188; ; GO:0016526" integral to membrane; GO:0016021 CG13229 CG13229 "anon-WO0170980.142, anon-WO0170980.143" CDMC30868 1 23 9 DAC15-E16 2-CG13385-RA_1 CG13385 GGGGGAGCAGAATCAAACAACAGGCTTGAGTCCACATTCAGAAGCAGTAGCAGAAAGTCCCGACCACC 68 FBan0013385 FBgn0032039 CG13385 2 2L CG13385 CG13385 CDMC30868 1 24 9 DAC15-E16 2-CG13385-RA_1 CG13385 GGGGGAGCAGAATCAAACAACAGGCTTGAGTCCACATTCAGAAGCAGTAGCAGAAAGTCCCGACCACC 68 FBan0013385 FBgn0032039 CG13385 2 2L CG13385 CG13385 CDMC30869 1 25 9 DAC15-I04 2-CG13726-RA_3 CG13726 GCGCTGGACCGTTTTCCTGGACAGGTTGATGATTTTTCTCGGATTCCTGGTCTTCTGCGAGCACAACG 68 FBan0013726 FBgn0036709 Or74a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or74a Odorant receptor 74a "CG13726, 74A.1, DOR26, 74a" CDMC30869 1 26 9 DAC15-I04 2-CG13726-RA_3 CG13726 GCGCTGGACCGTTTTCCTGGACAGGTTGATGATTTTTCTCGGATTCCTGGTCTTCTGCGAGCACAACG 68 FBan0013726 FBgn0036709 Or74a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or74a Odorant receptor 74a "CG13726, 74A.1, DOR26, 74a" CDMC30870 1 1 10 DAC15-I16 3-CG13836-RA_1 CG13836 CCGTCTGCCTGGAGGATACCTACAAGCGTACCTCAACTTATGCCTCAAACATCAATTCAACGGGCGGC 68 FBan0013836 FBgn0039060 CG13836 3 3R CG13836 CG13836 CDMC30870 1 2 10 DAC15-I16 3-CG13836-RA_1 CG13836 CCGTCTGCCTGGAGGATACCTACAAGCGTACCTCAACTTATGCCTCAAACATCAATTCAACGGGCGGC 68 FBan0013836 FBgn0039060 CG13836 3 3R CG13836 CG13836 CDMC30871 1 3 10 DAC15-M04 1-CG14187-RA_1 CG14187 GGCAACAGTTTTCTTGTTGGTTTCACAGCTTTGCTTTGCCCTGCCCTTTGCATCTTCCACCGGAAACG 68 FBan0014187 FBgn0036938 CG14187 3 3L CG14187 CG14187 CDMC30871 1 4 10 DAC15-M04 1-CG14187-RA_1 CG14187 GGCAACAGTTTTCTTGTTGGTTTCACAGCTTTGCTTTGCCCTGCCCTTTGCATCTTCCACCGGAAACG 68 FBan0014187 FBgn0036938 CG14187 3 3L CG14187 CG14187 CDMC30872 1 5 10 DAC15-M16 2-CG14321-RA_1 CG14321 GCCAAGATCAACTGCATCCGACAGTGCATTTCGCCATCGTGCTACCAGGACATCTATGCCTTCAACGA 68 FBan0014321 FBgn0038540 CG14321 3 3R CG14321 CG14321 CDMC30872 1 6 10 DAC15-M16 2-CG14321-RA_1 CG14321 GCCAAGATCAACTGCATCCGACAGTGCATTTCGCCATCGTGCTACCAGGACATCTATGCCTTCAACGA 68 FBan0014321 FBgn0038540 CG14321 3 3R CG14321 CG14321 CDMC30873 1 7 10 DAC16-A04 3-CG31039-RA_2 CG31039 CCCCATTCGCTGGTCCATCCACGCGATCTGGAGATTCGTCATGGAGGGATTGAGGGTCGTATTAC 65 FBan0031039 FBgn0003358 Jon99Ci 3 3R digestion; GO:0007586; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Ci Jonah 99Ci "CG17951, CG31039, CG17951, CG17951, Jon99Cbetai, Jon99Calphai, Jon99Cbeta, Jon99Calpha, 99Calpha, Jon99C, Jon99C2, Jon99C1, SER3, serine protease, Ser99Dc, SP150, Jonah 99C Beta, Jonah 99C Alpha, Jon99B, JonC, Ser3, Serine protease 3, Jonah 99Ci" CDMC30873 1 8 10 DAC16-A04 3-CG31039-RA_2 CG31039 CCCCATTCGCTGGTCCATCCACGCGATCTGGAGATTCGTCATGGAGGGATTGAGGGTCGTATTAC 65 FBan0031039 FBgn0003358 Jon99Ci 3 3R digestion; GO:0007586; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon99Ci Jonah 99Ci "CG17951, CG31039, CG17951, CG17951, Jon99Cbetai, Jon99Calphai, Jon99Cbeta, Jon99Calpha, 99Calpha, Jon99C, Jon99C2, Jon99C1, SER3, serine protease, Ser99Dc, SP150, Jonah 99C Beta, Jonah 99C Alpha, Jon99B, JonC, Ser3, Serine protease 3, Jonah 99Ci" CDMC30874 1 9 10 DAC16-A16 23-CG31062-RA_1 CG31062 ACAGTTTCGTTTGAATAATTTAGAACCGGGACGTGAATATCAATTTTTAGTTTACGCCGTCAACG 65 FBan0031062 FBgn0016061 side 3 3R cell-cell adhesion; GO:0016337; motor axon guidance; GO:0008045; signal transduction; GO:0007165 side sidestep "CG31062, CG12510, CG13973, CG13974, CG13975, CG13979, CG31062, CT33528, CT33527, Doe, doe, downstream of eyeless, sidestep" CDMC30874 1 10 10 DAC16-A16 23-CG31062-RA_1 CG31062 ACAGTTTCGTTTGAATAATTTAGAACCGGGACGTGAATATCAATTTTTAGTTTACGCCGTCAACG 65 FBan0031062 FBgn0016061 side 3 3R cell-cell adhesion; GO:0016337; motor axon guidance; GO:0008045; signal transduction; GO:0007165 side sidestep "CG31062, CG12510, CG13973, CG13974, CG13975, CG13979, CG31062, CT33528, CT33527, Doe, doe, downstream of eyeless, sidestep" CDMC30875 1 11 10 DAC16-E04 2-CG31159-RA_1 CG31159 AATACCAGATGCCGTGTACTTCTGTTCGATCGAGCCTCCCAGTGTATCCTCGCAAACGGCCATGG 65 FBan0031159 FBgn0051159 CG31159 3 3R translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG31159 CG31159 CG6943 CDMC30875 1 12 10 DAC16-E04 2-CG31159-RA_1 CG31159 AATACCAGATGCCGTGTACTTCTGTTCGATCGAGCCTCCCAGTGTATCCTCGCAAACGGCCATGG 65 FBan0031159 FBgn0051159 CG31159 3 3R translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG31159 CG31159 CG6943 CDMC30876 1 13 10 DAC16-E16 3-CG3121-RA_1 CG3121 AGTGACCCCTCGACAGATTGTCGTTTCGCGGCAGATCAAGAAGTTCCTAACAGGCGATCTGGAGG 65 FBan0003121 FBgn0034957 CG3121 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule associated complex; GO:0005875 CG3121 CG3121 anon-WO0140519.109 CDMC30876 1 14 10 DAC16-E16 3-CG3121-RA_1 CG3121 AGTGACCCCTCGACAGATTGTCGTTTCGCGGCAGATCAAGAAGTTCCTAACAGGCGATCTGGAGG 65 FBan0003121 FBgn0034957 CG3121 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule associated complex; GO:0005875 CG3121 CG3121 anon-WO0140519.109 CDMC30877 1 15 10 DAC16-I04 3-CG31299-RA_4 CG31299 CACTTCAAGTTCCTGCAGACCGTGTTGGGTAGCCAGAACTACGCAGGCATCTTCTTCCCGAAACC 65 FBan0031299 FBgn0037872 nocturnin 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 nocturnin nocturnin "CG31299, CG4782, CG4796, nocturin, Dnocturnin" CDMC30877 1 16 10 DAC16-I04 3-CG31299-RA_4 CG31299 CACTTCAAGTTCCTGCAGACCGTGTTGGGTAGCCAGAACTACGCAGGCATCTTCTTCCCGAAACC 65 FBan0031299 FBgn0037872 nocturnin 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 nocturnin nocturnin "CG31299, CG4782, CG4796, nocturin, Dnocturnin" CDMC30878 1 17 10 DAC16-I16 1-CG31321-RB_1 CG31321 GTGGACATGTTCGTCAGTCTGCGAGTGATTGCCATCAAGACCATCGGTTCGAGCATTGTGGCTGG 65 FBan0031321 FBgn0051321 CG31321 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31321 CG31321 BcDNA:RH31685 CDMC30878 1 18 10 DAC16-I16 1-CG31321-RB_1 CG31321 GTGGACATGTTCGTCAGTCTGCGAGTGATTGCCATCAAGACCATCGGTTCGAGCATTGTGGCTGG 65 FBan0031321 FBgn0051321 CG31321 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31321 CG31321 BcDNA:RH31685 CDMC30879 1 19 10 DAC16-M04 17-CG31457-RB_7 CG31457 ACTGGTTGCTTGGAAAGATTGCTAGATTGTCCATCATTCCGAATCGTGCCTAATCAGGTGTCCGG 65 FBan0031457 FBgn0051457 CG31457 3 3R CG31457 CG31457 CG4639 CDMC30879 1 20 10 DAC16-M04 17-CG31457-RB_7 CG31457 ACTGGTTGCTTGGAAAGATTGCTAGATTGTCCATCATTCCGAATCGTGCCTAATCAGGTGTCCGG 65 FBan0031457 FBgn0051457 CG31457 3 3R CG31457 CG31457 CG4639 CDMC30880 1 21 10 DAC16-M16 12-CG31492-RA_1 CG31492 GCGGCATGCAGGAGATAAGTGCGTTTGAGCAGAACCCACCGGATATGTCACACATGGAACACCCA 65 FBgn0051492 CDMC30880 1 22 10 DAC16-M16 12-CG31492-RA_1 CG31492 GCGGCATGCAGGAGATAAGTGCGTTTGAGCAGAACCCACCGGATATGTCACACATGGAACACCCA 65 FBgn0051492 CDMC30881 1 23 10 DAC17-A04 2-CG32632-RB_1 CG32632 GTCGGACCAGGTTATCAAGCCGGTTAATCTGGAGGCGATGTCCAAATGGGTTGGCCAAATACCCG 65 FBan0032632 FBgn0052632 CG32632 X X protein modification; GO:0006464 protein-tyrosine sulfotransferase activity; GO:0008476 ; EC:2.8.2.20; ; GO:0008476 ; EC:2.8.2.20; ; GO:0008476 ; EC:2.8.2.20 CG32632 CG32632 "CG15759, CG1573, CG15759, CG1573" CDMC30881 1 24 10 DAC17-A04 2-CG32632-RB_1 CG32632 GTCGGACCAGGTTATCAAGCCGGTTAATCTGGAGGCGATGTCCAAATGGGTTGGCCAAATACCCG 65 FBan0032632 FBgn0052632 CG32632 X X protein modification; GO:0006464 protein-tyrosine sulfotransferase activity; GO:0008476 ; EC:2.8.2.20; ; GO:0008476 ; EC:2.8.2.20; ; GO:0008476 ; EC:2.8.2.20 CG32632 CG32632 "CG15759, CG1573, CG15759, CG1573" CDMC30882 1 25 10 DAC17-A16 2-CG32672-RA_1 CG32672 TGTTTACGGCATGGCCAAAATTAACTAACTTTGCTCCGGTCGGGATGCATCGGAATGAAGCCCCC 65 FBan0032672 FBgn0052672 Atg8a X X cytoskeleton organization and biogenesis; GO:0007010 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 Atg8a Autophagy-specific gene 8a "CG32672, CG1534, CG1534, CG1534, CG1534, ATG8a, BcDNA:LD05816, Autophagy-specific gene 8a" CDMC30882 1 26 10 DAC17-A16 2-CG32672-RA_1 CG32672 TGTTTACGGCATGGCCAAAATTAACTAACTTTGCTCCGGTCGGGATGCATCGGAATGAAGCCCCC 65 FBan0032672 FBgn0052672 Atg8a X X cytoskeleton organization and biogenesis; GO:0007010 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 Atg8a Autophagy-specific gene 8a "CG32672, CG1534, CG1534, CG1534, CG1534, ATG8a, BcDNA:LD05816, Autophagy-specific gene 8a" CDMC30883 1 1 11 DAC17-E04 3-CG32804-RA_1 CG32804 AAAACAAAACAACTGGAATATCGCGTGGAAGGGAGGATGAGAGCCTGGGAGCGTGCAACAGGTCG 65 FBan0032804 FBgn0052804 CG32804 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32804 CG32804 CDMC30883 1 2 11 DAC17-E04 3-CG32804-RA_1 CG32804 AAAACAAAACAACTGGAATATCGCGTGGAAGGGAGGATGAGAGCCTGGGAGCGTGCAACAGGTCG 65 FBan0032804 FBgn0052804 CG32804 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32804 CG32804 CDMC30884 1 3 11 DAC17-E16 3-CG32825-RA_3 CG32825 GCCTCTTCAAGTCACTGGAGAGATCCCTTTCGATGACCTGCTTTCTGCAGTTCTTCAGCACGGCG 65 FBan0032825 FBgn0062565 Or19b X X G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021; membrane; GO:0016020 Or19b Odorant receptor 19b "CG32825, Odorant receptor 19b" CDMC30884 1 4 11 DAC17-E16 3-CG32825-RA_3 CG32825 GCCTCTTCAAGTCACTGGAGAGATCCCTTTCGATGACCTGCTTTCTGCAGTTCTTCAGCACGGCG 65 FBan0032825 FBgn0062565 Or19b X X G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021; membrane; GO:0016020 Or19b Odorant receptor 19b "CG32825, Odorant receptor 19b" CDMC30885 1 5 11 DAC17-I04 2-CG3302-RA_2 CG3302 TATCGCAGCTCCAACGTTCACTGATTGCCAGAAACTGTGTCCCCGGTTCGGACTTCAATGCCAAC 65 FBan0003302 FBgn0013767 Crz 3 3R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 Crz Corazonin "CG3302, corazonin, preprocorazonin, Drm-COR, Dm-Crz, Cora, COR" CDMC30885 1 6 11 DAC17-I04 2-CG3302-RA_2 CG3302 TATCGCAGCTCCAACGTTCACTGATTGCCAGAAACTGTGTCCCCGGTTCGGACTTCAATGCCAAC 65 FBan0003302 FBgn0013767 Crz 3 3R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 Crz Corazonin "CG3302, corazonin, preprocorazonin, Drm-COR, Dm-Crz, Cora, COR" CDMC30886 1 7 11 DAC17-I16 2-CG33085-RA_1 CG33085 AGTGCTCGAGGTTACCGATGGTGTCCTACAGACGATTCAGGTCAAGCAGGAATCAATGGAGGCGG 65 FBgn0053085 CDMC30886 1 8 11 DAC17-I16 2-CG33085-RA_1 CG33085 AGTGCTCGAGGTTACCGATGGTGTCCTACAGACGATTCAGGTCAAGCAGGAATCAATGGAGGCGG 65 FBgn0053085 CDMC30887 1 9 11 DAC17-M04 15-CG33179-RA_2 CG33179 GTTGAGTTACAAAACTCGACGGACGTGGTCGTTGTCCTGCGCTCAGTTAGCCTTCAGTCAACTGG 65 FBan0033179 FBgn0053179 beat-IIIb 2 2L extracellular region; GO:0005576 beat-IIIb beat-IIIb "CG33179, CG15135, CG4855, beat IIIb" CDMC30887 1 10 11 DAC17-M04 15-CG33179-RA_2 CG33179 GTTGAGTTACAAAACTCGACGGACGTGGTCGTTGTCCTGCGCTCAGTTAGCCTTCAGTCAACTGG 65 FBan0033179 FBgn0053179 beat-IIIb 2 2L extracellular region; GO:0005576 beat-IIIb beat-IIIb "CG33179, CG15135, CG4855, beat IIIb" CDMC30888 1 11 11 DAC17-M16 3-CG33222-RA_1 CG33222 ATACACCGTGGAAGCCAACGTATCCGCGCTGACTTTGGTCGTTCTCAAGAAGAATCCCTCCCCAT 65 FBan0033222 FBgn0053222 CG33222 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 CG33222 CG33222 CG11386 CDMC30888 1 12 11 DAC17-M16 3-CG33222-RA_1 CG33222 ATACACCGTGGAAGCCAACGTATCCGCGCTGACTTTGGTCGTTCTCAAGAAGAATCCCTCCCCAT 65 FBan0033222 FBgn0053222 CG33222 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 CG33222 CG33222 CG11386 CDMC30889 1 13 11 DAC18-A04 2-CG5824-RA_3 CG5824 AACAGCTGCAGCCTACTGACTTGGTCACCCAGACGATCACTCCAGATTTCAAGGTTCGAGCACTGGAC 68 FBan0005824 FBgn0010926 l(3)07882 3 3R l(3)07882 lethal (3) 07882 CG5824 CDMC30889 1 14 11 DAC18-A04 2-CG5824-RA_3 CG5824 AACAGCTGCAGCCTACTGACTTGGTCACCCAGACGATCACTCCAGATTTCAAGGTTCGAGCACTGGAC 68 FBan0005824 FBgn0010926 l(3)07882 3 3R l(3)07882 lethal (3) 07882 CG5824 CDMC30890 1 15 11 DAC18-A16 2-CG5888-RA_2 CG5888 CGCTTTTGGACCCCAAGAACTCTGGCACATGACCGAACTTCAGTCGATCGAGCTCTTCAATTGCGGTG 68 FBan0005888 FBgn0028523 CG5888 2 2L transmembrane receptor activity; GO:0004888; ; GO:0004888 CG5888 CG5888 "BG:DS02780.1, CT18477" CDMC30890 1 16 11 DAC18-A16 2-CG5888-RA_2 CG5888 CGCTTTTGGACCCCAAGAACTCTGGCACATGACCGAACTTCAGTCGATCGAGCTCTTCAATTGCGGTG 68 FBan0005888 FBgn0028523 CG5888 2 2L transmembrane receptor activity; GO:0004888; ; GO:0004888 CG5888 CG5888 "BG:DS02780.1, CT18477" CDMC30891 1 17 11 DAC18-E04 9-CG6188-RA_10 CG6188 GGAGGAGGGCTTCGAAGTTGTGTCCGTAGATGCCTCTGATAAGATGTTGAAGTACGCCCTCAAGGAGC 68 FBan0006188 FBgn0038074 CG6188 3 3R amino acid biosynthesis; GO:0008652 glycine N-methyltransferase activity; GO:0017174 ; EC:2.1.1.20; ; GO:0017174 ; EC:2.1.1.20 CG6188 CG6188 CDMC30891 1 18 11 DAC18-E04 9-CG6188-RA_10 CG6188 GGAGGAGGGCTTCGAAGTTGTGTCCGTAGATGCCTCTGATAAGATGTTGAAGTACGCCCTCAAGGAGC 68 FBan0006188 FBgn0038074 CG6188 3 3R amino acid biosynthesis; GO:0008652 glycine N-methyltransferase activity; GO:0017174 ; EC:2.1.1.20; ; GO:0017174 ; EC:2.1.1.20 CG6188 CG6188 CDMC30892 1 19 11 DAC18-E16 7-CG6303-RA_1 CG6303 TGTGCTGGTGCAAAAAACCACAGATGCTGATGCGCTAATCAACATGTTGCATACCAACGAAGACGGCA 68 FBan0006303 FBgn0037808 Bruce 3 3R anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066; programmed cell death; GO:0012501; protein modification; GO:0006464; proteolysis; GO:0006508; sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; small protein conjugating enzyme activity; GO:0008639; ; GO:0008639 intracellular; GO:0005622 Bruce Bruce "CG6303, CG6303, CG6303, dBRUCE, dBruce, dbruce, bruce" CDMC30892 1 20 11 DAC18-E16 7-CG6303-RA_1 CG6303 TGTGCTGGTGCAAAAAACCACAGATGCTGATGCGCTAATCAACATGTTGCATACCAACGAAGACGGCA 68 FBan0006303 FBgn0037808 Bruce 3 3R anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066; programmed cell death; GO:0012501; protein modification; GO:0006464; proteolysis; GO:0006508; sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; small protein conjugating enzyme activity; GO:0008639; ; GO:0008639 intracellular; GO:0005622 Bruce Bruce "CG6303, CG6303, CG6303, dBRUCE, dBruce, dbruce, bruce" CDMC30893 1 21 11 DAC18-I04 2-CG6723-RA_1 CG6723 GCGCTATGTGGCTACAATGGTCTGCTGATATACGCCACCTACCAGAACTGTGATCCCCTGACCACCAA 68 FBan0006723 FBgn0037895 CG6723 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG6723 CG6723 CDMC30893 1 22 11 DAC18-I04 2-CG6723-RA_1 CG6723 GCGCTATGTGGCTACAATGGTCTGCTGATATACGCCACCTACCAGAACTGTGATCCCCTGACCACCAA 68 FBan0006723 FBgn0037895 CG6723 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG6723 CG6723 CDMC30894 1 23 11 DAC18-I16 1-CG6841-RA_2 CG6841 GCGGTGGAAGTGTTCCCAGATTTCCCCAAACTGTGGATGATGAAGGGTCAGATTGAGGAGCAGCAGAG 68 FBan0006841 FBgn0036828 CG6841 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" major (U2-dependent) spliceosome; GO:0005684; nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG6841 CG6841 "Prp6, BcDNA:LD43276" CDMC30894 1 24 11 DAC18-I16 1-CG6841-RA_2 CG6841 GCGGTGGAAGTGTTCCCAGATTTCCCCAAACTGTGGATGATGAAGGGTCAGATTGAGGAGCAGCAGAG 68 FBan0006841 FBgn0036828 CG6841 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" major (U2-dependent) spliceosome; GO:0005684; nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG6841 CG6841 "Prp6, BcDNA:LD43276" CDMC30895 1 25 11 DAC18-M04 2-CG7329-RA_3 CG7329 CAAGGGCCACGTGAAACTCAACCCCAATACGGACAAGTCCTACTGGAGCTTCTCTTGGCACGAGATTG 68 FBan0007329 FBgn0032271 CG7329 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG7329 CG7329 CDMC30895 1 26 11 DAC18-M04 2-CG7329-RA_3 CG7329 CAAGGGCCACGTGAAACTCAACCCCAATACGGACAAGTCCTACTGGAGCTTCTCTTGGCACGAGATTG 68 FBan0007329 FBgn0032271 CG7329 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG7329 CG7329 CDMC30896 1 1 12 DAC18-M16 1-CG7433-RA_1 CG7433 CCGGCAAGGTTCTGAAGAACGGTTTGCTGAGCCTGGAGAAGGAATTCCCGCATATCTTGAACTCCACC 68 FBan0007433 FBgn0036927 CG7433 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; gamma-aminobutyric acid metabolism; GO:0009448 4-aminobutyrate transaminase activity; GO:0003867 ; EC:2.6.1.19; ; GO:0003867 ; EC:2.6.1.19; ; GO:0003867 ; EC:2.6.1.19; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG7433 CG7433 CDMC30896 1 2 12 DAC18-M16 1-CG7433-RA_1 CG7433 CCGGCAAGGTTCTGAAGAACGGTTTGCTGAGCCTGGAGAAGGAATTCCCGCATATCTTGAACTCCACC 68 FBan0007433 FBgn0036927 CG7433 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; gamma-aminobutyric acid metabolism; GO:0009448 4-aminobutyrate transaminase activity; GO:0003867 ; EC:2.6.1.19; ; GO:0003867 ; EC:2.6.1.19; ; GO:0003867 ; EC:2.6.1.19; pyridoxal phosphate binding; GO:0030170; ; GO:0030170 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG7433 CG7433 CDMC30897 1 3 12 DAC19-A04 17-CG17766-RA_1 CG17766 GGCTCCGAGACGCGATTCAATGTCTAAGGTGAAGGAGCAATGATAATGGACTAGTGAATCTTGCGGGAT 69 FBan0017766 FBgn0023510 CG17766 X X G-protein coupled receptor protein signaling pathway; GO:0007186 GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG17766 CG17766 EG:86E4.3 CDMC30897 1 4 12 DAC19-A04 17-CG17766-RA_1 CG17766 GGCTCCGAGACGCGATTCAATGTCTAAGGTGAAGGAGCAATGATAATGGACTAGTGAATCTTGCGGGAT 69 FBan0017766 FBgn0023510 CG17766 X X G-protein coupled receptor protein signaling pathway; GO:0007186 GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG17766 CG17766 EG:86E4.3 CDMC30898 1 5 12 DAC19-A16 22-CG17784-RA_1 CG17784 TGGTCCACAGAGTTCTGACCTGGCTTTTGTTTCTCCTCAGTTTGCTATTCACCATTGACTTGGTGCTGA 69 FBan0017784 FBgn0039192 CG17784 3 3R CG17784 CG17784 CDMC30898 1 6 12 DAC19-A16 22-CG17784-RA_1 CG17784 TGGTCCACAGAGTTCTGACCTGGCTTTTGTTTCTCCTCAGTTTGCTATTCACCATTGACTTGGTGCTGA 69 FBan0017784 FBgn0039192 CG17784 3 3R CG17784 CG17784 CDMC30899 1 7 12 DAC19-E04 2-CG17836-RA_1 CG17836 CCAGATCAAAACCGAGCTAGCTCCAGCATTCAGTCCGACCACACCGGAGATTATCAACCAGCTCCTGAA 69 FBan0017836 FBgn0038661 CG17836 3 3R "cellular physiological process; GO:0050875; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 CG17836 CG17836 "clone 2.44, anon-EST:Liang-2.44" CDMC30899 1 8 12 DAC19-E04 2-CG17836-RA_1 CG17836 CCAGATCAAAACCGAGCTAGCTCCAGCATTCAGTCCGACCACACCGGAGATTATCAACCAGCTCCTGAA 69 FBan0017836 FBgn0038661 CG17836 3 3R "cellular physiological process; GO:0050875; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; protein dimerization activity; GO:0046983; ; GO:0046983; ; GO:0003677 nucleus; GO:0005634 CG17836 CG17836 "clone 2.44, anon-EST:Liang-2.44" CDMC30900 1 9 12 DAC19-E16 2-CG17853-RA_1 CG17853 TGCAACTGTGCCTCAACACTTGGTGCTTCGCTCTGAAGTTCTTCACTCTGATCGTCTATACGCACCGCT 69 FBan0017853 FBgn0026393 Or43b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0005549 integral to membrane; GO:0016021 Or43b Odorant receptor 43b "CG17853, CG17853, DOR25A.1, Olfactory receptor 25A.1, AN7, 25A.1/43, DOR81, OR43b, 43b, Or25A.1" CDMC30900 1 10 12 DAC19-E16 2-CG17853-RA_1 CG17853 TGCAACTGTGCCTCAACACTTGGTGCTTCGCTCTGAAGTTCTTCACTCTGATCGTCTATACGCACCGCT 69 FBan0017853 FBgn0026393 Or43b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0005549 integral to membrane; GO:0016021 Or43b Odorant receptor 43b "CG17853, CG17853, DOR25A.1, Olfactory receptor 25A.1, AN7, 25A.1/43, DOR81, OR43b, 43b, Or25A.1" CDMC30901 1 11 12 DAC19-I04 18-CG17907-RA_1 CG17907 AGTCCTTGTTGCCTGAAGATAGTTGGCCAAATTGCATTGGTTTCATGCTTAGGTTGAGGGTTCGTTTGA 69 FBan0017907 FBgn0000024 Ace 3 3R acetylcholine catabolism; GO:0006581; acetylcholine catabolism in synaptic cleft; GO:0001507; neuromuscular synaptic transmission; GO:0007274; neurotransmitter secretion; GO:0007269; response to carbamate; GO:0046681; response to organophosphorus; GO:0046683; synaptic transmission; GO:0007268 acetylcholinesterase activity; GO:0003990 ; EC:3.1.1.7; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0003990 ; EC:3.1.1.7; ; GO:0004104 ; EC:3.1.1.8; ; GO:0003990 ; EC:3.1.1.7 cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886; synapse; GO:0045202 Ace Acetylcholine esterase "CG17907, AChE, AcChE, ACE, CHE, ache, dAChE, ace, AchE, dmAChE, DmAChE, acetylcholinesterase, FBgn0000024, l(3)26, l(3)87Ed" CDMC30901 1 12 12 DAC19-I04 18-CG17907-RA_1 CG17907 AGTCCTTGTTGCCTGAAGATAGTTGGCCAAATTGCATTGGTTTCATGCTTAGGTTGAGGGTTCGTTTGA 69 FBan0017907 FBgn0000024 Ace 3 3R acetylcholine catabolism; GO:0006581; acetylcholine catabolism in synaptic cleft; GO:0001507; neuromuscular synaptic transmission; GO:0007274; neurotransmitter secretion; GO:0007269; response to carbamate; GO:0046681; response to organophosphorus; GO:0046683; synaptic transmission; GO:0007268 acetylcholinesterase activity; GO:0003990 ; EC:3.1.1.7; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0003990 ; EC:3.1.1.7; ; GO:0004104 ; EC:3.1.1.8; ; GO:0003990 ; EC:3.1.1.7 cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886; synapse; GO:0045202 Ace Acetylcholine esterase "CG17907, AChE, AcChE, ACE, CHE, ache, dAChE, ace, AchE, dmAChE, DmAChE, acetylcholinesterase, FBgn0000024, l(3)26, l(3)87Ed" CDMC30902 1 13 12 DAC19-I16 16-CG17923-RA_1 CG17923 GCTCTGGGCACTATAGCAATTCTATGCATCGATATCGGCACTGATATGCTTCCGGCAATATCGCTAGCT 69 FBan0017923 FBgn0040037 CG17923 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672 ATP binding; GO:0005524; ; GO:0005524; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 CG17923 CG17923 JYalpha CDMC30902 1 14 12 DAC19-I16 16-CG17923-RA_1 CG17923 GCTCTGGGCACTATAGCAATTCTATGCATCGATATCGGCACTGATATGCTTCCGGCAATATCGCTAGCT 69 FBan0017923 FBgn0040037 CG17923 4 4 calcium ion homeostasis; GO:0006874; cation transport; GO:0006812; metabolism; GO:0008152; monovalent inorganic cation transport; GO:0015672 ATP binding; GO:0005524; ; GO:0005524; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; monovalent inorganic cation transporter activity; GO:0015077; ; GO:0015077 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 CG17923 CG17923 JYalpha CDMC30903 1 15 12 DAC19-M04 3-CG17959-RA_2 CG17959 GGCTGAGCAGTTGGCAAAATTCAAAACGCAGAAGGACGAATATGGCGGTGATCTGGTGGAGGAAGAGGA 69 FBan0017959 FBgn0029647 CG17959 X X CG17959 CG17959 CDMC30903 1 16 12 DAC19-M04 3-CG17959-RA_2 CG17959 GGCTGAGCAGTTGGCAAAATTCAAAACGCAGAAGGACGAATATGGCGGTGATCTGGTGGAGGAAGAGGA 69 FBan0017959 FBgn0029647 CG17959 X X CG17959 CG17959 CDMC30904 1 17 12 DAC19-M16 2-CG17976-RA_1 CG17976 ACGTCTCATGATGACGATCTCCTGCCTCTGCTCTGCAATCTTTTTGGTCCTACTTGTCGTTGGCCTGGA 69 FBan0017976 FBgn0028561 sut3 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut3 sugar transporter 3 "CG17976, CG17976" CDMC30904 1 18 12 DAC19-M16 2-CG17976-RA_1 CG17976 ACGTCTCATGATGACGATCTCCTGCCTCTGCTCTGCAATCTTTTTGGTCCTACTTGTCGTTGGCCTGGA 69 FBan0017976 FBgn0028561 sut3 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005355; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 sut3 sugar transporter 3 "CG17976, CG17976" CDMC30905 1 19 12 DAC20-A04 3-CG10587-RA_2 CG10587 GTTTCCGGTTGGGGTCTCACCGAGAACAGTGAGTTTGGCCCACAGAAACTATTGCGTACGGTGAC 65 FBan0010587 FBgn0037039 CG10587 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG10587 CG10587 SP167 CDMC30905 1 20 12 DAC20-A04 3-CG10587-RA_2 CG10587 GTTTCCGGTTGGGGTCTCACCGAGAACAGTGAGTTTGGCCCACAGAAACTATTGCGTACGGTGAC 65 FBan0010587 FBgn0037039 CG10587 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG10587 CG10587 SP167 CDMC30906 1 21 12 DAC20-A16 3-CG10620-RA_1 CG10620 GCCCTACGACAGCATGTGCGATCTGTGTCATGGAACTAGCTATCGCTATTGTCGTCGCGATGCCT 65 FBan0010620 FBgn0036299 Tsf2 3 3L cation transport; GO:0006812; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; iron ion transporter activity; GO:0005381; ; GO:0005381; ; GO:0008199 extracellular region; GO:0005576 Tsf2 Transferrin 2 "CG10620, Transferrin 2" CDMC30906 1 22 12 DAC20-A16 3-CG10620-RA_1 CG10620 GCCCTACGACAGCATGTGCGATCTGTGTCATGGAACTAGCTATCGCTATTGTCGTCGCGATGCCT 65 FBan0010620 FBgn0036299 Tsf2 3 3L cation transport; GO:0006812; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; iron ion transporter activity; GO:0005381; ; GO:0005381; ; GO:0008199 extracellular region; GO:0005576 Tsf2 Transferrin 2 "CG10620, Transferrin 2" CDMC30907 1 23 12 DAC20-E04 2-CG10737-RA_1 CG10737 AGCTGAGATCCTGTTCGAGGTGTATGACCATCCGGTGATTGCCTCAGATCCGCCCAAGTTTCTGG 65 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC30907 1 24 12 DAC20-E04 2-CG10737-RA_1 CG10737 AGCTGAGATCCTGTTCGAGGTGTATGACCATCCGGTGATTGCCTCAGATCCGCCCAAGTTTCTGG 65 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC30908 1 25 12 DAC20-E16 2-CG1074-RA_1 CG1074 TCGAGTCCATGGATTACCTGCCAATAGAGGGAACGGTCAATCTGGAGAAACCCGTGGTGGAGTGG 65 FBan0001074 FBgn0037250 CG1074 3 3R CG1074 CG1074 anon-WO0118547.308 CDMC30908 1 26 12 DAC20-E16 2-CG1074-RA_1 CG1074 TCGAGTCCATGGATTACCTGCCAATAGAGGGAACGGTCAATCTGGAGAAACCCGTGGTGGAGTGG 65 FBan0001074 FBgn0037250 CG1074 3 3R CG1074 CG1074 anon-WO0118547.308 CDMC30909 1 1 13 DAC20-I04 24-CG10889-RA_1 CG10889 AACTTATAATATTTAAACACTAATACTTCATTCCCTGTTTATCTAATGTTATTTACGCCTCAGGC 65 FBan0010889 FBgn0038769 CG10889 3 3R CG10889 CG10889 CDMC30909 1 2 13 DAC20-I04 24-CG10889-RA_1 CG10889 AACTTATAATATTTAAACACTAATACTTCATTCCCTGTTTATCTAATGTTATTTACGCCTCAGGC 65 FBan0010889 FBgn0038769 CG10889 3 3R CG10889 CG10889 CDMC30910 1 3 13 DAC20-I16 3-CG10915-RA_1 CG10915 AATAACCGATATTGGGCGTAGCGATAAGCGAAATACTCAAGCGGCGTAGTCCCTCGGTGACCGCG 65 FBan0010915 FBgn0034308 CG10915 2 2R CG10915 CG10915 CDMC30910 1 4 13 DAC20-I16 3-CG10915-RA_1 CG10915 AATAACCGATATTGGGCGTAGCGATAAGCGAAATACTCAAGCGGCGTAGTCCCTCGGTGACCGCG 65 FBan0010915 FBgn0034308 CG10915 2 2R CG10915 CG10915 CDMC30911 1 5 13 DAC20-M04 12-CG11071-RA_1 CG11071 TGTGCGGCATGCAGTTTCGCTACCTGAAGAGCTTCAAGAAGCATCGCTTGAACCATGCCCTCGAG 65 FBan0011071 FBgn0030532 CG11071 X X transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11071 CG11071 CDMC30911 1 6 13 DAC20-M04 12-CG11071-RA_1 CG11071 TGTGCGGCATGCAGTTTCGCTACCTGAAGAGCTTCAAGAAGCATCGCTTGAACCATGCCCTCGAG 65 FBan0011071 FBgn0030532 CG11071 X X transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11071 CG11071 CDMC30912 1 7 13 DAC20-M16 18-CG11085-RA_1 CG11085 CCAGAACTGGAGCTCTCCAACGACGATTCGGATATAGACATTGAGGATCGATCTACGCCGGACTC 65 FBan0011085 FBgn0030408 CG11085 X X transcription factor activity; GO:0003700; ; GO:0003700 CG11085 CG11085 CDMC30912 1 8 13 DAC20-M16 18-CG11085-RA_1 CG11085 CCAGAACTGGAGCTCTCCAACGACGATTCGGATATAGACATTGAGGATCGATCTACGCCGGACTC 65 FBan0011085 FBgn0030408 CG11085 X X transcription factor activity; GO:0003700; ; GO:0003700 CG11085 CG11085 CDMC30913 1 9 13 DAC21-A04 15-CG1115-RA_1 CG1115 ACGAAGTTCTCCAGGTGCTCCGAACACAAAAGACCAGTGTTTTCGAGGACAACAGGAGTCGGGCG 65 FBan0001115 FBgn0037299 CG1115 3 3R CG1115 CG1115 CDMC30913 1 10 13 DAC21-A04 15-CG1115-RA_1 CG1115 ACGAAGTTCTCCAGGTGCTCCGAACACAAAAGACCAGTGTTTTCGAGGACAACAGGAGTCGGGCG 65 FBan0001115 FBgn0037299 CG1115 3 3R CG1115 CG1115 CDMC30914 1 11 13 DAC21-A16 9-CG11192-RA_1 CG11192 GAGGAGAGTGCAGTCAGCGGTGAAGTTGGAGTGTCTCCGCAACTTCGTTTCGTGGACGTGGATCT 65 FBan0011192 FBgn0034507 CG11192 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11192 CG11192 SP82 CDMC30914 1 12 13 DAC21-A16 9-CG11192-RA_1 CG11192 GAGGAGAGTGCAGTCAGCGGTGAAGTTGGAGTGTCTCCGCAACTTCGTTTCGTGGACGTGGATCT 65 FBan0011192 FBgn0034507 CG11192 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11192 CG11192 SP82 CDMC30915 1 13 13 DAC21-E04 3-CG11305-RA_2 CG11305 GAGTTTTCCACGGAAGTTGGCGCGAACCCAGGCAGGATGGTATGGCAAGGGCTATAAGAAAGGTC 65 FBan0011305 FBgn0039631 Sirt7 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0030528; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt7 Sirt7 "CG11305, CG11305, CG11305, CG11305, CG11305, D.mel5, dSIRT7, dmSRT409" CDMC30915 1 14 13 DAC21-E04 3-CG11305-RA_2 CG11305 GAGTTTTCCACGGAAGTTGGCGCGAACCCAGGCAGGATGGTATGGCAAGGGCTATAAGAAAGGTC 65 FBan0011305 FBgn0039631 Sirt7 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0030528; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt7 Sirt7 "CG11305, CG11305, CG11305, CG11305, CG11305, D.mel5, dSIRT7, dmSRT409" CDMC30916 1 15 13 DAC21-E16 5-CG11356-RA_1 CG11356 GATCTGGGTGCGGATCCAATGGTAATGCAGGGCACATTCTCACTGCTAACCGATTGCCTTGTGGG 65 FBan0011356 FBgn0030375 CG11356 X X CG11356 CG11356 CDMC30916 1 16 13 DAC21-E16 5-CG11356-RA_1 CG11356 GATCTGGGTGCGGATCCAATGGTAATGCAGGGCACATTCTCACTGCTAACCGATTGCCTTGTGGG 65 FBan0011356 FBgn0030375 CG11356 X X CG11356 CG11356 CDMC30917 1 17 13 DAC21-I04 2-CG11508-RA_1 CG11508 ATGTGCCCTCCACTTTTACTGCTCTAAGCCAGCACAAGGACAAGTCCCGTAAGTGTCCCTTTGGC 65 FBan0011508 FBgn0033267 CG11508 2 2R snRNA-activating protein complex; GO:0019185 CG11508 CG11508 CDMC30917 1 18 13 DAC21-I04 2-CG11508-RA_1 CG11508 ATGTGCCCTCCACTTTTACTGCTCTAAGCCAGCACAAGGACAAGTCCCGTAAGTGTCCCTTTGGC 65 FBan0011508 FBgn0033267 CG11508 2 2R snRNA-activating protein complex; GO:0019185 CG11508 CG11508 CDMC30918 1 19 13 DAC21-I16 16-CG1152-RA_1 CG1152 GAGTTGCTCTCGAATAACTCTCGGTCCATTCAGATCTTCCCAGCTGTTTTGAACCCTCGATCGCG 65 FBan0001152 FBgn0001112 Gld 3 3R cuticle biosynthesis; GO:0042335; electron transport; GO:0006118; glucose metabolism; GO:0006006; pupal cuticle biosynthesis (sensu Insecta); GO:0008364; sperm storage; GO:0046693 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 extracellular region; GO:0005576 Gld Glucose dehydrogenase "CG1152, GLD, GDH, gld, Go, glucose oxidase, l(3)84Cg, Glucose oxidase" CDMC30918 1 20 13 DAC21-I16 16-CG1152-RA_1 CG1152 GAGTTGCTCTCGAATAACTCTCGGTCCATTCAGATCTTCCCAGCTGTTTTGAACCCTCGATCGCG 65 FBan0001152 FBgn0001112 Gld 3 3R cuticle biosynthesis; GO:0042335; electron transport; GO:0006118; glucose metabolism; GO:0006006; pupal cuticle biosynthesis (sensu Insecta); GO:0008364; sperm storage; GO:0046693 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 extracellular region; GO:0005576 Gld Glucose dehydrogenase "CG1152, GLD, GDH, gld, Go, glucose oxidase, l(3)84Cg, Glucose oxidase" CDMC30919 1 21 13 DAC21-M04 6-CG11621-RB_1 CG11621 AGTGCCCTCGACTGTCGGGGTTAGCTCTAGTAGCCACACTGGAAACAATGGTCATTCCTCGGTCC 65 FBan0011621 FBgn0015278 Pi3K68D 3 3L defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; phospholipid binding; GO:0005543; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; ; GO:0005543" phosphoinositide 3-kinase complex; GO:0005942 Pi3K68D Phosphotidylinositol 3 kinase 68D "CG11621, CG11621, dPIK, PI3K-68D, PI3K_68D, cpk, PI3K 68_D, Cpk, PI3K-68D/E, PI3K, PI3K 68D, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, BcDNA:LD15217, Pi3K, Phosphotidylinositol 3 kinase 68D" CDMC30919 1 22 13 DAC21-M04 6-CG11621-RB_1 CG11621 AGTGCCCTCGACTGTCGGGGTTAGCTCTAGTAGCCACACTGGAAACAATGGTCATTCCTCGGTCC 65 FBan0011621 FBgn0015278 Pi3K68D 3 3L defense response; GO:0006952; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035005 ; EC:2.7.1.154; ; GO:0035004 ; EC:2.7.1.-; phospholipid binding; GO:0005543; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; ; GO:0005543" phosphoinositide 3-kinase complex; GO:0005942 Pi3K68D Phosphotidylinositol 3 kinase 68D "CG11621, CG11621, dPIK, PI3K-68D, PI3K_68D, cpk, PI3K 68_D, Cpk, PI3K-68D/E, PI3K, PI3K 68D, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, BcDNA:LD15217, Pi3K, Phosphotidylinositol 3 kinase 68D" CDMC30920 1 23 13 DAC21-M16 15-CG11666-RA_1 CG11666 ACATTGGGCGAGAGGACATCTTGGAACGTAAATTGGAAATGGAGAGTGAGCGAATGGTCCAGCCC 65 FBan0011666 FBgn0040648 CG11666 X X CG11666 CG11666 CDMC30920 1 24 13 DAC21-M16 15-CG11666-RA_1 CG11666 ACATTGGGCGAGAGGACATCTTGGAACGTAAATTGGAAATGGAGAGTGAGCGAATGGTCCAGCCC 65 FBan0011666 FBgn0040648 CG11666 X X CG11666 CG11666 CDMC30921 1 25 13 DAC22-A04 1-CG31607-RA_1 CG31607 CTCCTTCTGCCTTCAGCTTCAACAACACCCGGGAGTTCATCGCTGGCTTGAATAGCACCAAGGAG 65 FBan0031607 FBgn0051607 CG31607 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31607 CG31607 BcDNA:RE27850 CDMC30921 1 26 13 DAC22-A04 1-CG31607-RA_1 CG31607 CTCCTTCTGCCTTCAGCTTCAACAACACCCGGGAGTTCATCGCTGGCTTGAATAGCACCAAGGAG 65 FBan0031607 FBgn0051607 CG31607 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31607 CG31607 BcDNA:RE27850 CDMC30922 1 1 14 DAC22-A16 2-CG31630-RA_1 CG31630 TTCGAGCATGGCAACCAGCTGAATAGCACCTTTTCCTTGGACGTCGAAACCGGCAGTTCGTCAAC 65 FBan0031630 FBgn0051630 CG31630 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31630 CG31630 CDMC30922 1 2 14 DAC22-A16 2-CG31630-RA_1 CG31630 TTCGAGCATGGCAACCAGCTGAATAGCACCTTTTCCTTGGACGTCGAAACCGGCAGTTCGTCAAC 65 FBan0031630 FBgn0051630 CG31630 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31630 CG31630 CDMC30923 1 3 14 DAC22-E04 23-CG31713-RA_1 CG31713 CGACAAGTTCCACCAAATGATTTTAGATCAAAACAAACCAATGTGAACTGAAAACAATTGCCGGT 65 FBan0031713 FBgn0051713 CG31713 2 2L bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; GO:0004081 ; EC:3.6.1.17; ; GO:0004081 ; EC:3.6.1.17; ; GO:0004081 ; EC:3.6.1.17 CG31713 CG31713 CDMC30923 1 4 14 DAC22-E04 23-CG31713-RA_1 CG31713 CGACAAGTTCCACCAAATGATTTTAGATCAAAACAAACCAATGTGAACTGAAAACAATTGCCGGT 65 FBan0031713 FBgn0051713 CG31713 2 2L bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; GO:0004081 ; EC:3.6.1.17; ; GO:0004081 ; EC:3.6.1.17; ; GO:0004081 ; EC:3.6.1.17 CG31713 CG31713 CDMC30924 1 5 14 DAC22-E16 3-CG31748-RA_1 CG31748 CCTCCAAATGGCCATGGTCTTGAGTGCAATGGGGAGTGTGGACTCTCAATTCTACCTGGGACTGG 65 FBan0031748 FBgn0045485 Gr36c 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36c Gustatory receptor 36c "CG15137, CG31748, CG15137, CG15137, Gr36B3, Gustatory receptor 36B3, Gr36B.3, Gustatory receptor 36c" CDMC30924 1 6 14 DAC22-E16 3-CG31748-RA_1 CG31748 CCTCCAAATGGCCATGGTCTTGAGTGCAATGGGGAGTGTGGACTCTCAATTCTACCTGGGACTGG 65 FBan0031748 FBgn0045485 Gr36c 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36c Gustatory receptor 36c "CG15137, CG31748, CG15137, CG15137, Gr36B3, Gustatory receptor 36B3, Gr36B.3, Gustatory receptor 36c" CDMC30925 1 7 14 DAC22-I04 3-CG3187-RB_5 CG3187 TTCATGGCAGTGGCTATGTGGTCAAGTGCCTGTCATGCGAGTACCGGATCGATCGTCACGAGTTC 65 FBan0003187 FBgn0029783 Sirt4 X X "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt4 Sirt4 "CG3187, CG3187, CG3187, D.mel3, dSIRT4, dmSRT407" CDMC30925 1 8 14 DAC22-I04 3-CG3187-RB_5 CG3187 TTCATGGCAGTGGCTATGTGGTCAAGTGCCTGTCATGCGAGTACCGGATCGATCGTCACGAGTTC 65 FBan0003187 FBgn0029783 Sirt4 X X "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt4 Sirt4 "CG3187, CG3187, CG3187, D.mel3, dSIRT4, dmSRT407" CDMC30926 1 9 14 DAC22-I16 23-CG31917-RA_3 CG31917 ACGACAAGGACGCTTAGAACCTACACAACCCATAAAATCCAATAGCCAAAAGTAAAAACCTAAAA 65 FBgn0051917 CDMC30926 1 10 14 DAC22-I16 23-CG31917-RA_3 CG31917 ACGACAAGGACGCTTAGAACCTACACAACCCATAAAATCCAATAGCCAAAAGTAAAAACCTAAAA 65 FBgn0051917 CDMC30927 1 11 14 DAC22-M04 23-CG32061-RA_8 CG32061 TGGATGCTGGTTAAGGCCATAATGTATTCACTACTATCTATGATCGGAGTTTGGTACTCACGACA 65 FBan0032061 FBgn0052061 CG32061 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004178 ; EC:3.4.11.1 cytoplasm; GO:0005737; intracellular; GO:0005622 CG32061 CG32061 CG8040 CDMC30927 1 12 14 DAC22-M04 23-CG32061-RA_8 CG32061 TGGATGCTGGTTAAGGCCATAATGTATTCACTACTATCTATGATCGGAGTTTGGTACTCACGACA 65 FBan0032061 FBgn0052061 CG32061 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004178 ; EC:3.4.11.1 cytoplasm; GO:0005737; intracellular; GO:0005622 CG32061 CG32061 CG8040 CDMC30928 1 13 14 DAC22-M16 6-CG3208-RB_1 CG3208 CCAGCAAAGCCCATACATGACCTTAAATGGCCGGAAACTTAGGGCTCTGTCCAATGAGCTGGGCA 65 FBan0003208 FBgn0029778 RhoGAP5A X X ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; nervous system development; GO:0007399 diacylglycerol binding; GO:0019992; ; GO:0019992; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085 RhoGAP5A RhoGAP5A "CG3208, CG3208, CG3208" CDMC30928 1 14 14 DAC22-M16 6-CG3208-RB_1 CG3208 CCAGCAAAGCCCATACATGACCTTAAATGGCCGGAAACTTAGGGCTCTGTCCAATGAGCTGGGCA 65 FBan0003208 FBgn0029778 RhoGAP5A X X ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; nervous system development; GO:0007399 diacylglycerol binding; GO:0019992; ; GO:0019992; receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085 RhoGAP5A RhoGAP5A "CG3208, CG3208, CG3208" CDMC30929 1 15 14 DAC23-A04 7-CG10732-RA_1 CG10732 AGCTCACTACATGGACTACATCGAGCTACCCCAGATTACTCCAGTGGACACTACTCCTACGCTCGGACA 69 FBan0010732 FBgn0036365 CG10732 3 3L CG10732 CG10732 NEST:bs28e06 CDMC30929 1 16 14 DAC23-A04 7-CG10732-RA_1 CG10732 AGCTCACTACATGGACTACATCGAGCTACCCCAGATTACTCCAGTGGACACTACTCCTACGCTCGGACA 69 FBan0010732 FBgn0036365 CG10732 3 3L CG10732 CG10732 NEST:bs28e06 CDMC30930 1 17 14 DAC23-A16 22-CG10746-RA_1 CG10746 CAAACGGCACTTTGTTTACCGACAAACAATAGCGCACGACGAAAAAATCAAGTAACGAAAACCTGCCCC 69 FBan0010746 FBgn0020303 fok 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fok fledgling of Klp38B "CG10746, CG10746, CG10746, Fok, 38B.11, l(2)k07614, fledgling of Klp38B" CDMC30930 1 18 14 DAC23-A16 22-CG10746-RA_1 CG10746 CAAACGGCACTTTGTTTACCGACAAACAATAGCGCACGACGAAAAAATCAAGTAACGAAAACCTGCCCC 69 FBan0010746 FBgn0020303 fok 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fok fledgling of Klp38B "CG10746, CG10746, CG10746, Fok, 38B.11, l(2)k07614, fledgling of Klp38B" CDMC30931 1 19 14 DAC23-E04 23-CG10781-RA_1 CG10781 CAATCCCAATGCTGAACCCAATGACAACCATAGCACTTAACTTTTGAATAGTTTATAATGAAATAGCAA 69 FBan0010781 FBgn0002933 ng1 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng1 new glue 1 "CG10781, SC1, ngp: new glue protein, ng-1, ng, nested, EG:96G10.5, new glue protein, ngp" CDMC30931 1 20 14 DAC23-E04 23-CG10781-RA_1 CG10781 CAATCCCAATGCTGAACCCAATGACAACCATAGCACTTAACTTTTGAATAGTTTATAATGAAATAGCAA 69 FBan0010781 FBgn0002933 ng1 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng1 new glue 1 "CG10781, SC1, ngp: new glue protein, ng-1, ng, nested, EG:96G10.5, new glue protein, ngp" CDMC30932 1 21 14 DAC23-E16 12-CG10799-RA_1 CG10799 GCAAGCGAGCTACCAAGGACACTAGTAACAGCACGGAAGATGATGAGCTCACGGATGGTAGCAATGAGA 69 FBan0010799 FBgn0033821 CG10799 2 2R CG10799 CG10799 CT30256 CDMC30932 1 22 14 DAC23-E16 12-CG10799-RA_1 CG10799 GCAAGCGAGCTACCAAGGACACTAGTAACAGCACGGAAGATGATGAGCTCACGGATGGTAGCAATGAGA 69 FBan0010799 FBgn0033821 CG10799 2 2R CG10799 CG10799 CT30256 CDMC30933 1 23 14 DAC23-I04 3-CG10827-RA_2 CG10827 AGGAGAAGTCCCTGTCCTTCGAAAACTTCCCCTTCACGGGCCTCTCGAAGACCTATTCCGTGGATAAGA 69 FBan0010827 FBgn0038845 CG10827 3 3R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG10827 CG10827 CDMC30933 1 24 14 DAC23-I04 3-CG10827-RA_2 CG10827 AGGAGAAGTCCCTGTCCTTCGAAAACTTCCCCTTCACGGGCCTCTCGAAGACCTATTCCGTGGATAAGA 69 FBan0010827 FBgn0038845 CG10827 3 3R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG10827 CG10827 CDMC30934 1 25 14 DAC23-I16 23-CG10837-RD_6 CG10837 AACCCAAGTCTCAAAAAAAATACGAAATTTAGATGGCGATGATAGCGATGATGGAAGTGGTACATTGCC 69 CDMC30934 1 26 14 DAC23-I16 23-CG10837-RD_6 CG10837 AACCCAAGTCTCAAAAAAAATACGAAATTTAGATGGCGATGATAGCGATGATGGAAGTGGTACATTGCC 69 CDMC30935 1 1 15 DAC23-M04 17-CG10868-RA_1 CG10868 ATTGTTAGACGACTCCCCCAAAAACGAACACCCTCGAATCGAAACAGAAGAGAGACCCCCATTCATACT 69 FBan0010868 FBgn0004882 orb 3 3R embryonic axis specification; GO:0000578; germ cell development; GO:0007281; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; mRNA polyadenylylation; GO:0006378; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; positive regulation of oskar mRNA translation; GO:0046012; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0008143; protein binding; GO:0005515; uridine-rich cytoplasmic polyadenylylation element binding; GO:0017131; ; GO:0017131; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 orb oo18 RNA-binding protein "CG10868, oo18, Orb, ORB, fs(3)00107" CDMC30935 1 2 15 DAC23-M04 17-CG10868-RA_1 CG10868 ATTGTTAGACGACTCCCCCAAAAACGAACACCCTCGAATCGAAACAGAAGAGAGACCCCCATTCATACT 69 FBan0010868 FBgn0004882 orb 3 3R embryonic axis specification; GO:0000578; germ cell development; GO:0007281; germ-line cyst formation; GO:0048134; intracellular mRNA localization; GO:0008298; mRNA polyadenylylation; GO:0006378; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; positive regulation of oskar mRNA translation; GO:0046012; positive regulation of translation; GO:0045946; regulation of oskar mRNA translation; GO:0046011 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0008143; protein binding; GO:0005515; uridine-rich cytoplasmic polyadenylylation element binding; GO:0017131; ; GO:0017131; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 orb oo18 RNA-binding protein "CG10868, oo18, Orb, ORB, fs(3)00107" CDMC30936 1 3 15 DAC23-M16 7-CG10899-RB_1 CG10899 GCCTGTGCGATCCTTTATCCGTGATCAACAATGGGCTAACAGTTCTCATGCGGATACCCAAGACCGTCG 69 FBan0010899 FBgn0039235 CG10899 3 3R one-carbon compound metabolism; GO:0006730 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG10899 CG10899 BcDNA:AT02719 CDMC30936 1 4 15 DAC23-M16 7-CG10899-RB_1 CG10899 GCCTGTGCGATCCTTTATCCGTGATCAACAATGGGCTAACAGTTCTCATGCGGATACCCAAGACCGTCG 69 FBan0010899 FBgn0039235 CG10899 3 3R one-carbon compound metabolism; GO:0006730 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG10899 CG10899 BcDNA:AT02719 CDMC30937 1 5 15 DAC24-A04 17-CG14919-RA_1 CG14919 GCCCGAGAGCAAACGTCAAGTTAGATACCGGCAGTGCTACTTTAATCCCATCTCCTGCTTTAGGAAGTA 69 FBan0014919 FBgn0032336 Ast-C 2 2L neuropeptide signaling pathway; GO:0007218; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005179; ; GO:0005184; ; GO:0005179 Ast-C Allatostatin C "CG14919, CG14919, CG14919, gh06087, DAP-C, Drm-AST-C, M-ASH, FLT, flatline, flt, drostatin-C, Ast2: Allatostatin 2, Drostatin-C, AstC, BcDNA:RH36507, BEST:GH06087, Allatostatin 2, Ast2, Allatostatin C" CDMC30937 1 6 15 DAC24-A04 17-CG14919-RA_1 CG14919 GCCCGAGAGCAAACGTCAAGTTAGATACCGGCAGTGCTACTTTAATCCCATCTCCTGCTTTAGGAAGTA 69 FBan0014919 FBgn0032336 Ast-C 2 2L neuropeptide signaling pathway; GO:0007218; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005179; ; GO:0005184; ; GO:0005179 Ast-C Allatostatin C "CG14919, CG14919, CG14919, gh06087, DAP-C, Drm-AST-C, M-ASH, FLT, flatline, flt, drostatin-C, Ast2: Allatostatin 2, Drostatin-C, AstC, BcDNA:RH36507, BEST:GH06087, Allatostatin 2, Ast2, Allatostatin C" CDMC30938 1 7 15 DAC24-A16 24-CG14930-RA_1 CG14930 CGCATGCAACTATGAAATAATCGAAATCTTTAAAATTATAATACTTTTATTACATTGGCAACTGTCAAT 69 FBan0014930 FBgn0032366 CG14930 2 2L CG14930 CG14930 CDMC30938 1 8 15 DAC24-A16 24-CG14930-RA_1 CG14930 CGCATGCAACTATGAAATAATCGAAATCTTTAAAATTATAATACTTTTATTACATTGGCAACTGTCAAT 69 FBan0014930 FBgn0032366 CG14930 2 2L CG14930 CG14930 CDMC30939 1 9 15 DAC24-E04 22-CG1495-RA_1 CG1495 CGACTGGAGCGTGGACTTCTAACGTTCTCTCTTCGCAGCAATCTGTACAAAGTCATGCACAAGAAATGA 69 FBan0001495 FBgn0016126 CaMKI 4 4 calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; calmodulin-dependent protein kinase I activity; GO:0004684; ; GO:0004684; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004684 cytosol; GO:0005829 CaMKI Calcium/calmodulin-dependent protein kinase I "CG1495, CG1495, dCKI, camKI, calmodulin-dependent kinase, Calcium/calmodulin-dependent protein kinase, CamKI, caMKI" CDMC30939 1 10 15 DAC24-E04 22-CG1495-RA_1 CG1495 CGACTGGAGCGTGGACTTCTAACGTTCTCTCTTCGCAGCAATCTGTACAAAGTCATGCACAAGAAATGA 69 FBan0001495 FBgn0016126 CaMKI 4 4 calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; calmodulin-dependent protein kinase I activity; GO:0004684; ; GO:0004684; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004684 cytosol; GO:0005829 CaMKI Calcium/calmodulin-dependent protein kinase I "CG1495, CG1495, dCKI, camKI, calmodulin-dependent kinase, Calcium/calmodulin-dependent protein kinase, CamKI, caMKI" CDMC30940 1 11 15 DAC24-E16 15-CG14967-RA_5 CG14967 TGGCATAGCTGATCTTGTCCTTAGTGCTTTTCTGTACACCAAGAAGTCCAAGAGCGACGATTCGGTGGA 69 FBan0014967 FBgn0035420 CG14967 3 3L CG14967 CG14967 CDMC30940 1 12 15 DAC24-E16 15-CG14967-RA_5 CG14967 TGGCATAGCTGATCTTGTCCTTAGTGCTTTTCTGTACACCAAGAAGTCCAAGAGCGACGATTCGGTGGA 69 FBan0014967 FBgn0035420 CG14967 3 3L CG14967 CG14967 CDMC30941 1 13 15 DAC24-I04 16-CG14997-RB_1 CG14997 TCGCTTCCCGTGATTTTTGGTGTTAAGCATTACGCAGAGGCCCTGATGAAACTGATCAAGAGGAGAAAT 69 FBan0014997 FBgn0035515 CG14997 3 3L CG14997 CG14997 BcDNA:GH04863 CDMC30941 1 14 15 DAC24-I04 16-CG14997-RB_1 CG14997 TCGCTTCCCGTGATTTTTGGTGTTAAGCATTACGCAGAGGCCCTGATGAAACTGATCAAGAGGAGAAAT 69 FBan0014997 FBgn0035515 CG14997 3 3L CG14997 CG14997 BcDNA:GH04863 CDMC30942 1 15 15 DAC24-I16 11-CG15007-RA_2 CG15007 CCGACAGCATTGTCAAGCACAAAGCACCATTGGAAAACCACTATCCACCAGCAAATCTAGTCATGGCCC 69 FBan0015007 FBgn0035511 CG15007 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15007 CG15007 CDMC30942 1 16 15 DAC24-I16 11-CG15007-RA_2 CG15007 CCGACAGCATTGTCAAGCACAAAGCACCATTGGAAAACCACTATCCACCAGCAAATCTAGTCATGGCCC 69 FBan0015007 FBgn0035511 CG15007 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15007 CG15007 CDMC30943 1 17 15 DAC24-M04 23-CG15034-RA_8 CG15034 CAGTCCTACGGCTCGAACATTTGGATATAGTTTAGTTTTCTCTGACCCGGTGAACGATAAGCAACCAAA 69 FBan0015034 FBgn0029946 CG15034 X X CG15034 CG15034 CDMC30943 1 18 15 DAC24-M04 23-CG15034-RA_8 CG15034 CAGTCCTACGGCTCGAACATTTGGATATAGTTTAGTTTTCTCTGACCCGGTGAACGATAAGCAACCAAA 69 FBan0015034 FBgn0029946 CG15034 X X CG15034 CG15034 CDMC30944 1 19 15 DAC24-M16 3-CG15049-RA_2 CG15049 TGGGTCATCGACGGTCCCAACACGCATGAGAAGGTGATCATCCTCTCAGATCATCCATATGCCACTCGA 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC30944 1 20 15 DAC24-M16 3-CG15049-RA_2 CG15049 TGGGTCATCGACGGTCCCAACACGCATGAGAAGGTGATCATCCTCTCAGATCATCCATATGCCACTCGA 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC30945 1 21 15 DAC25-A04 3-CG14303-RA_2 CG14303 TGCAGATAGCCCCATGTCTCTCGGAGTTCACAAAGCATGAAATCAGCCTGATCCAGGAGACGAGCACTT 69 FBan0014303 FBgn0038633 CG14303 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 CG14303 CG14303 CDMC30945 1 22 15 DAC25-A04 3-CG14303-RA_2 CG14303 TGCAGATAGCCCCATGTCTCTCGGAGTTCACAAAGCATGAAATCAGCCTGATCCAGGAGACGAGCACTT 69 FBan0014303 FBgn0038633 CG14303 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 CG14303 CG14303 CDMC30946 1 23 15 DAC25-A16 12-CG14309-RA_6 CG14309 TGGAAAGCATTTCCTCAGCCACATCAACGAGCATGAACACGAGTTTTCTCTAGGAGATGAGGGCATGCG 69 FBan0014309 FBgn0038611 CG14309 3 3R CG14309 CG14309 CDMC30946 1 24 15 DAC25-A16 12-CG14309-RA_6 CG14309 TGGAAAGCATTTCCTCAGCCACATCAACGAGCATGAACACGAGTTTTCTCTAGGAGATGAGGGCATGCG 69 FBan0014309 FBgn0038611 CG14309 3 3R CG14309 CG14309 CDMC30947 1 25 15 DAC25-E04 6-CG14351-RA_1 CG14351 CGCTGAACAACTACTGCGATACATCGGACAACTGGACGGATCACGACATGGACATCTATATGGCCCGCA 69 FBan0014351 FBgn0031349 CG14351 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 CG14351 CG14351 "CT33985, tartan/capricious-like" CDMC30947 1 26 15 DAC25-E04 6-CG14351-RA_1 CG14351 CGCTGAACAACTACTGCGATACATCGGACAACTGGACGGATCACGACATGGACATCTATATGGCCCGCA 69 FBan0014351 FBgn0031349 CG14351 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102 CG14351 CG14351 "CT33985, tartan/capricious-like" CDMC30948 1 1 16 DAC25-E16 3-CG1435-RA_1 CG1435 ACAAGCTCTTCTTCCGTTGTCTGGGACTGACCGAAGACGATGCTGCCGTTTCATTCGCTGTGATAGACA 69 FBan0001435 FBgn0026144 CBP X X calcium ion binding; GO:0005509; ; GO:0005509 sarcoplasmic reticulum; GO:0016529 CBP sarcoplasmic calcium-binding protein "CG1435, CG1435, CG1435, CG1435, CG1435, BcDNA.GH12350, Ca2+ - binding protein, BcDNA:GH12350" CDMC30948 1 2 16 DAC25-E16 3-CG1435-RA_1 CG1435 ACAAGCTCTTCTTCCGTTGTCTGGGACTGACCGAAGACGATGCTGCCGTTTCATTCGCTGTGATAGACA 69 FBan0001435 FBgn0026144 CBP X X calcium ion binding; GO:0005509; ; GO:0005509 sarcoplasmic reticulum; GO:0016529 CBP sarcoplasmic calcium-binding protein "CG1435, CG1435, CG1435, CG1435, CG1435, BcDNA.GH12350, Ca2+ - binding protein, BcDNA:GH12350" CDMC30949 1 3 16 DAC25-I04 1-CG14413-RA_5 CG14413 CGCCGTTTGTGCGCTGCTACTTCGACGATGGACGCGATATGCTTATAGATTTGGACAGTCGGAATCGGA 69 FBan0014413 FBgn0030572 mRpS25 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS25 mitochondrial ribosomal protein S25 "CG14413, CG14413, CG14413, MRP-S25, Mitochondrial ribosomal protein S25, MrpS25, mitochondrial ribosomal protein S25" CDMC30949 1 4 16 DAC25-I04 1-CG14413-RA_5 CG14413 CGCCGTTTGTGCGCTGCTACTTCGACGATGGACGCGATATGCTTATAGATTTGGACAGTCGGAATCGGA 69 FBan0014413 FBgn0030572 mRpS25 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS25 mitochondrial ribosomal protein S25 "CG14413, CG14413, CG14413, MRP-S25, Mitochondrial ribosomal protein S25, MrpS25, mitochondrial ribosomal protein S25" CDMC30950 1 5 16 DAC25-I16 23-CG14426-RA_1 CG14426 AGATTAACATAGAGCCATTTGTATAGCCAATATTGTGATAGCTCGTAAGCCCAAAAAAAAGTTCTGAAT 69 FBan0014426 FBgn0004143 nullo X X "actin cytoskeleton organization and biogenesis; GO:0030036; cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; intercellular junction assembly; GO:0007043; protein localization; GO:0008104" actin binding; GO:0003779; ; GO:0003779 actin filament; GO:0005884; adherens junction; GO:0005912; intercellular junction; GO:0005911 nullo nullo "CG14426, CG14426, BcDNA:RE47733" CDMC30950 1 6 16 DAC25-I16 23-CG14426-RA_1 CG14426 AGATTAACATAGAGCCATTTGTATAGCCAATATTGTGATAGCTCGTAAGCCCAAAAAAAAGTTCTGAAT 69 FBan0014426 FBgn0004143 nullo X X "actin cytoskeleton organization and biogenesis; GO:0030036; cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; intercellular junction assembly; GO:0007043; protein localization; GO:0008104" actin binding; GO:0003779; ; GO:0003779 actin filament; GO:0005884; adherens junction; GO:0005912; intercellular junction; GO:0005911 nullo nullo "CG14426, CG14426, BcDNA:RE47733" CDMC30951 1 7 16 DAC25-M04 3-CG14469-RA_1 CG14469 CGGACCATCCGCCATAAAATCAAACACCAACACACAGGTCTCGACACCGACTGGCATCATTTCCCACTT 69 FBan0014469 FBgn0033044 dpr12 2 2R dpr12 dpr12 "CG14469, CG14469, CG14469, CT34165, Dpr-12" CDMC30951 1 8 16 DAC25-M04 3-CG14469-RA_1 CG14469 CGGACCATCCGCCATAAAATCAAACACCAACACACAGGTCTCGACACCGACTGGCATCATTTCCCACTT 69 FBan0014469 FBgn0033044 dpr12 2 2R dpr12 dpr12 "CG14469, CG14469, CG14469, CT34165, Dpr-12" CDMC30952 1 9 16 DAC25-M16 2-CG14487-RA_1 CG14487 GTCGCACGAAAATACCATTGGTTACGACCGAGGAAGACTTTCCCACATGGATGAAACTGCGTGTGCCCA 69 FBan0014487 FBgn0034272 CG14487 2 2R CG14487 CG14487 CDMC30952 1 10 16 DAC25-M16 2-CG14487-RA_1 CG14487 GTCGCACGAAAATACCATTGGTTACGACCGAGGAAGACTTTCCCACATGGATGAAACTGCGTGTGCCCA 69 FBan0014487 FBgn0034272 CG14487 2 2R CG14487 CG14487 CDMC30953 1 11 16 DAC26-A04 17-CG4706-RA_1 CG4706 TGGGTCAGAACTCCGAGAAGAATGGCTATCCGATGGAAATCAAAGTGAGTCTAATTGGTTCCTGCACGA 69 FBan0004706 FBgn0037862 CG4706 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3 mitochondrion; GO:0005739 CG4706 CG4706 CDMC30953 1 12 16 DAC26-A04 17-CG4706-RA_1 CG4706 TGGGTCAGAACTCCGAGAAGAATGGCTATCCGATGGAAATCAAAGTGAGTCTAATTGGTTCCTGCACGA 69 FBan0004706 FBgn0037862 CG4706 3 3R amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3 mitochondrion; GO:0005739 CG4706 CG4706 CDMC30954 1 13 16 DAC26-A16 2-CG4717-RA_1 CG4717 TGCGGCTAGTGCCATGAGGGGAATATTCGTGTGTGTCTAAGTACACGGCGAAAAAACCAAGTGGGAGGA 69 FBan0004717 FBgn0001320 kni 3 3L "branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of mitosis; GO:0007088; regulation of tracheal tube size; GO:0035151; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; zygotic determination of anterior/posterior axis, embryo; GO:0007354" ligand-dependent nuclear receptor activity; GO:0004879; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0016566; ; GO:0004879; ; GO:0003700 nucleus; GO:0005634 kni knirps "CG4717, CG4717, ri, kn, NR0A1, Knirps, KNI, Kni, Col, radius incompletus, knirps" CDMC30954 1 14 16 DAC26-A16 2-CG4717-RA_1 CG4717 TGCGGCTAGTGCCATGAGGGGAATATTCGTGTGTGTCTAAGTACACGGCGAAAAAACCAAGTGGGAGGA 69 FBan0004717 FBgn0001320 kni 3 3L "branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of mitosis; GO:0007088; regulation of tracheal tube size; GO:0035151; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; trunk segmentation; GO:0035290; zygotic determination of anterior/posterior axis, embryo; GO:0007354" ligand-dependent nuclear receptor activity; GO:0004879; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0016566; ; GO:0004879; ; GO:0003700 nucleus; GO:0005634 kni knirps "CG4717, CG4717, ri, kn, NR0A1, Knirps, KNI, Kni, Col, radius incompletus, knirps" CDMC30955 1 15 16 DAC26-E04 23-CG4749-RA_1 CG4749 ACCAGAAATGTGTGATTAAATGAAAGTTGTTGGCTGATTAACAAGACTATATAACTGTTGCCCCAATAA 69 FBan0004749 FBgn0031308 CG4749 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG4749 CG4749 anon-WO0118547.81 CDMC30955 1 16 16 DAC26-E04 23-CG4749-RA_1 CG4749 ACCAGAAATGTGTGATTAAATGAAAGTTGTTGGCTGATTAACAAGACTATATAACTGTTGCCCCAATAA 69 FBan0004749 FBgn0031308 CG4749 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG4749 CG4749 anon-WO0118547.81 CDMC30956 1 17 16 DAC26-E16 21-CG4755-RA_4 CG4755 CACCTTCGCCTCCTACCACCAATGGAAATGGGATAATTATGACCACATCACAGACTTCGCACCGACCAC 69 FBan0004755 FBgn0038747 RhoGAP92B 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157 GTPase activator activity; GO:0005096; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP92B RhoGAP92B "CG4755, CG4755, CG4755" CDMC30956 1 18 16 DAC26-E16 21-CG4755-RA_4 CG4755 CACCTTCGCCTCCTACCACCAATGGAAATGGGATAATTATGACCACATCACAGACTTCGCACCGACCAC 69 FBan0004755 FBgn0038747 RhoGAP92B 3 3R intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157 GTPase activator activity; GO:0005096; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP92B RhoGAP92B "CG4755, CG4755, CG4755" CDMC30957 1 19 16 DAC26-I04 1-CG4781-RA_3 CG4781 CGGGGTGAACTGGAAACTCTCCACCTTAAGACTGGACGCTTGTAGCCTAAATGATCTTCACCTGCCCGT 69 FBan0004781 FBgn0035043 CG4781 2 2R CG4781 CG4781 CT15357 CDMC30957 1 20 16 DAC26-I04 1-CG4781-RA_3 CG4781 CGGGGTGAACTGGAAACTCTCCACCTTAAGACTGGACGCTTGTAGCCTAAATGATCTTCACCTGCCCGT 69 FBan0004781 FBgn0035043 CG4781 2 2R CG4781 CG4781 CT15357 CDMC30958 1 21 16 DAC26-I16 3-CG4789-RA_1 CG4789 AGTGCCAAAATGGAAGACAGCGTCTTGCCCCTCCTGGATACCCAAGACCTCAAGTGACTAATGCACTCA 69 FBan0004789 FBgn0030792 CG4789 X X "regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0003677" CG4789 CG4789 CDMC30958 1 22 16 DAC26-I16 3-CG4789-RA_1 CG4789 AGTGCCAAAATGGAAGACAGCGTCTTGCCCCTCCTGGATACCCAAGACCTCAAGTGACTAATGCACTCA 69 FBan0004789 FBgn0030792 CG4789 X X "regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0003677" CG4789 CG4789 CDMC30959 1 23 16 DAC26-M04 18-CG4821-RC_6 CG4821 TCTCAAGACTTACGGGGAAATGTTCAAAGCCAGCTGTCTTCACTTAGATCGTGTCCACCCAATGTCCAG 69 FBan0004821 FBgn0023479 Tequila 3 3L ATP synthesis coupled proton transport; GO:0015986; chitin metabolism; GO:0006030; proteolysis; GO:0006508 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0008132 ; EC:3.4.21.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044; ; GO:0008061" extracellular region; GO:0005576; membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 Tequila Tequila "CG18153, CG4948, CG18403, CG4821, CG18153, CG4948, CG4948, CG18403, CK00198, graal, SP72, BEST:CK00198, BEST:GH18038, anon-EST:ParkEST161" CDMC30959 1 24 16 DAC26-M04 18-CG4821-RC_6 CG4821 TCTCAAGACTTACGGGGAAATGTTCAAAGCCAGCTGTCTTCACTTAGATCGTGTCCACCCAATGTCCAG 69 FBan0004821 FBgn0023479 Tequila 3 3L ATP synthesis coupled proton transport; GO:0015986; chitin metabolism; GO:0006030; proteolysis; GO:0006508 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0008132 ; EC:3.4.21.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044; ; GO:0008061" extracellular region; GO:0005576; membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 Tequila Tequila "CG18153, CG4948, CG18403, CG4821, CG18153, CG4948, CG4948, CG18403, CK00198, graal, SP72, BEST:CK00198, BEST:GH18038, anon-EST:ParkEST161" CDMC30960 1 25 16 DAC26-M16 2-CG4840-RA_1 CG4840 CCACGGACAGTGAATCTCATCCGACAACGACACCAGGTCACAGAATCTCAAGTTCATCGCTGGAGGCAT 69 FBan0004840 FBgn0033840 CG4840 2 2R CG4840 CG4840 CDMC30960 1 26 16 DAC26-M16 2-CG4840-RA_1 CG4840 CCACGGACAGTGAATCTCATCCGACAACGACACCAGGTCACAGAATCTCAAGTTCATCGCTGGAGGCAT 69 FBan0004840 FBgn0033840 CG4840 2 2R CG4840 CG4840 CDMC30961 1 1 17 DAC27-A04 23-CG3454-RA_9 CG3454 TTTGACACCTCAGTTCATTGTATATATGTATGTGTGATTGGGAAAGAGGGGTAAATCATCGAACGCTGC 69 FBan0003454 FBgn0005619 Hdc 2 2R amino acid metabolism; GO:0006520; eye photoreceptor development (sensu Endopterygota); GO:0042051; transmission of nerve impulse; GO:0019226 histidine decarboxylase activity; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22 Hdc Histidine decarboxylase "CG3454, JK910, hdc, histidine decarboxylase, anon-WO0140519.259" CDMC30961 1 2 17 DAC27-A04 23-CG3454-RA_9 CG3454 TTTGACACCTCAGTTCATTGTATATATGTATGTGTGATTGGGAAAGAGGGGTAAATCATCGAACGCTGC 69 FBan0003454 FBgn0005619 Hdc 2 2R amino acid metabolism; GO:0006520; eye photoreceptor development (sensu Endopterygota); GO:0042051; transmission of nerve impulse; GO:0019226 histidine decarboxylase activity; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22; ; GO:0004398 ; EC:4.1.1.22 Hdc Histidine decarboxylase "CG3454, JK910, hdc, histidine decarboxylase, anon-WO0140519.259" CDMC30962 1 3 17 DAC27-A16 8-CG3477-RA_1 CG3477 CGGCAGAGCAGTTGACGGTGGTCACTTCGTACTTGGATCTCTCGCTGGTATATGGCAACTCCATTCAAC 69 FBan0003477 FBgn0004577 Pxd 3 3R insect chorion formation; GO:0007306; response to oxidative stress; GO:0006979 heme binding; GO:0020037; iron ion binding; GO:0005506; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0020037; ; GO:0005506; ; GO:0004601 ; EC:1.11.1.7 chorion; GO:0042600; extracellular region; GO:0005576 Pxd Peroxidase "CG3477, CG3477, DmPO, PO, Dpxd" CDMC30962 1 4 17 DAC27-A16 8-CG3477-RA_1 CG3477 CGGCAGAGCAGTTGACGGTGGTCACTTCGTACTTGGATCTCTCGCTGGTATATGGCAACTCCATTCAAC 69 FBan0003477 FBgn0004577 Pxd 3 3R insect chorion formation; GO:0007306; response to oxidative stress; GO:0006979 heme binding; GO:0020037; iron ion binding; GO:0005506; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0020037; ; GO:0005506; ; GO:0004601 ; EC:1.11.1.7 chorion; GO:0042600; extracellular region; GO:0005576 Pxd Peroxidase "CG3477, CG3477, DmPO, PO, Dpxd" CDMC30963 1 5 17 DAC27-E04 21-CG3515-RA_3 CG3515 GCCGAAGACTAAAATGTGTACCGATCTTTTGGTAGAATAAAGGCACGGGTTGTTCATCAGCTGGCTGCT 69 FBan0003515 FBgn0031431 CG3515 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3515 CG3515 CDMC30963 1 6 17 DAC27-E04 21-CG3515-RA_3 CG3515 GCCGAAGACTAAAATGTGTACCGATCTTTTGGTAGAATAAAGGCACGGGTTGTTCATCAGCTGGCTGCT 69 FBan0003515 FBgn0031431 CG3515 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3515 CG3515 CDMC30964 1 7 17 DAC27-E16 3-CG3528-RA_5 CG3528 TCCAGGACACTCGCTATTTGGGCAACAAAGAGATCCAGAGGAACCTGATCCAGAATGCCTGCGGTAAGA 69 FBan0003528 FBgn0031430 CG3528 2 2L CG3528 CG3528 CDMC30964 1 8 17 DAC27-E16 3-CG3528-RA_5 CG3528 TCCAGGACACTCGCTATTTGGGCAACAAAGAGATCCAGAGGAACCTGATCCAGAATGCCTGCGGTAAGA 69 FBan0003528 FBgn0031430 CG3528 2 2L CG3528 CG3528 CDMC30965 1 9 17 DAC27-I04 12-CG3570-RA_1 CG3570 GCGTAAGAAGGCTACCAGCAAGCCACTACGAGTGCGTCATTTTCAGTTTGCTACTGGAATACATGCCCA 69 FBan0003570 FBgn0035035 CG3570 2 2R CG3570 CG3570 CDMC30965 1 10 17 DAC27-I04 12-CG3570-RA_1 CG3570 GCGTAAGAAGGCTACCAGCAAGCCACTACGAGTGCGTCATTTTCAGTTTGCTACTGGAATACATGCCCA 69 FBan0003570 FBgn0035035 CG3570 2 2R CG3570 CG3570 CDMC30966 1 11 17 DAC27-I16 16-CG3585-RA_1 CG3585 TGGTCAAAGTTCCGAGAACAAGAACATCAACATCTGGGACACATTGCTTCCCCACAAAAAGTCCTGTGT 69 FBan0003585 FBgn0023458 CG3585 X X N-terminal protein myristoylation; GO:0006499; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; tracheal system development (sensu Insecta); GO:0007424 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198; glycylpeptide N-tetradecanoyltransferase activity; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97 microtubule; GO:0005874 CG3585 CG3585 "Dmx, DmX, X, anon-X" CDMC30966 1 12 17 DAC27-I16 16-CG3585-RA_1 CG3585 TGGTCAAAGTTCCGAGAACAAGAACATCAACATCTGGGACACATTGCTTCCCCACAAAAAGTCCTGTGT 69 FBan0003585 FBgn0023458 CG3585 X X N-terminal protein myristoylation; GO:0006499; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; tracheal system development (sensu Insecta); GO:0007424 receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198; glycylpeptide N-tetradecanoyltransferase activity; GO:0004379 ; EC:2.3.1.97; ; GO:0004379 ; EC:2.3.1.97 microtubule; GO:0005874 CG3585 CG3585 "Dmx, DmX, X, anon-X" CDMC30967 1 13 17 DAC27-M04 15-CG3620-RB_11 CG3620 GGCTGTGCTAAGATTTGGCGTTTATGAAGAAAGCGGAAAGATTCTGGGTCAACGTATTCTGCCGCTGGA 69 FBan0003620 FBgn0004625 norpA X X "calcium-mediated signaling; GO:0019722; diacylglycerol biosynthesis; GO:0006651; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; light-induced release of internally sequestered calcium ion; GO:0008377; phosphatidylinositol metabolism; GO:0046488; phosphoinositide metabolism; GO:0030384; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644; phototransduction; GO:0007602; response to abiotic stimulus; GO:0009628; sensory perception of smell; GO:0007608" phospholipase C activity; GO:0004629 ; EC:3.1.4.3; GTPase activator activity; GO:0005096; phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004435 ; EC:3.1.4.11; ; GO:0005096; ; GO:0004629 ; EC:3.1.4.3 inaD signaling complex; GO:0016027; membrane fraction; GO:0005624; rhabdomere; GO:0016028 norpA no receptor potential A "CG3620, CG3620, CG3620, rof, nofC, PI-PLC, CdkA, DIP2, PLC-beta, PLCbeta, PLC, phospholipase C-beta, phospholipase C, NorpA, x12, x13, x16, x24, anon-EST:Posey221" CDMC30967 1 14 17 DAC27-M04 15-CG3620-RB_11 CG3620 GGCTGTGCTAAGATTTGGCGTTTATGAAGAAAGCGGAAAGATTCTGGGTCAACGTATTCTGCCGCTGGA 69 FBan0003620 FBgn0004625 norpA X X "calcium-mediated signaling; GO:0019722; diacylglycerol biosynthesis; GO:0006651; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; light-induced release of internally sequestered calcium ion; GO:0008377; phosphatidylinositol metabolism; GO:0046488; phosphoinositide metabolism; GO:0030384; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644; phototransduction; GO:0007602; response to abiotic stimulus; GO:0009628; sensory perception of smell; GO:0007608" phospholipase C activity; GO:0004629 ; EC:3.1.4.3; GTPase activator activity; GO:0005096; phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004435 ; EC:3.1.4.11; ; GO:0005096; ; GO:0004629 ; EC:3.1.4.3 inaD signaling complex; GO:0016027; membrane fraction; GO:0005624; rhabdomere; GO:0016028 norpA no receptor potential A "CG3620, CG3620, CG3620, rof, nofC, PI-PLC, CdkA, DIP2, PLC-beta, PLCbeta, PLC, phospholipase C-beta, phospholipase C, NorpA, x12, x13, x16, x24, anon-EST:Posey221" CDMC30968 1 15 17 DAC27-M16 9-CG3635-RA_1 CG3635 CGCTGTTGGGGATGTGAAGTATCTGGCCTCACTCCTACCATGCGCCCAACTATACCGTATTCCATTCAG 69 FBan0003635 FBgn0032981 CG3635 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG3635 CG3635 CDMC30968 1 16 17 DAC27-M16 9-CG3635-RA_1 CG3635 CGCTGTTGGGGATGTGAAGTATCTGGCCTCACTCCTACCATGCGCCCAACTATACCGTATTCCATTCAG 69 FBan0003635 FBgn0032981 CG3635 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG3635 CG3635 CDMC30969 1 17 17 DAC28-A04 18-CG14719-RA_4 CG14719 CAAGTGGCATCCAATACTACAACCGAACCAACGTTTGAGATGAGACGAAAGCTTTTTGACGAGGCCGAG 69 FBan0014719 FBgn0025821 I-t 3 3R negative regulation of protein amino acid dephosphorylation; GO:0035308 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864 I-t inhibitor-t "CG14719, Inhibitor-t, pp1d6, inhibitor-t" CDMC30969 1 18 17 DAC28-A04 18-CG14719-RA_4 CG14719 CAAGTGGCATCCAATACTACAACCGAACCAACGTTTGAGATGAGACGAAAGCTTTTTGACGAGGCCGAG 69 FBan0014719 FBgn0025821 I-t 3 3R negative regulation of protein amino acid dephosphorylation; GO:0035308 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864 I-t inhibitor-t "CG14719, Inhibitor-t, pp1d6, inhibitor-t" CDMC30970 1 19 17 DAC28-A16 3-CG14739-RA_4 CG14739 CGCCATCATGAAACACTCGGAGCAACTCTTTCGCGAGCACGTTATCCTTTGCATGAAGACGTACGCCAT 69 FBan0014739 FBgn0037987 CG14739 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG14739 CG14739 CDMC30970 1 20 17 DAC28-A16 3-CG14739-RA_4 CG14739 CGCCATCATGAAACACTCGGAGCAACTCTTTCGCGAGCACGTTATCCTTTGCATGAAGACGTACGCCAT 69 FBan0014739 FBgn0037987 CG14739 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 CG14739 CG14739 CDMC30971 1 21 17 DAC28-E04 14-CG14792-RA_1 CG14792 AGGTCCGTAACTCTTTCCACGTTAACATGTCGGGAGGCTTAGATATTCTGTCCCTCAAGGAGGACGACA 69 FBan0014792 FBgn0003517 sta X X protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sta stubarista "CG14792, CG14792, CG14792, 37LRP/p40, Rp40, clone 2.56, P40, l(1)G0130, k14, Stubarista, l(1)G0448, EG:80H7.6, Sa, Laminin receptor, RpSA, Ribosomal protein SA, Lam-r: Laminin-receptor, anon-EST:Liang-2.56, l(1)2Af, Laminin-receptor" CDMC30971 1 22 17 DAC28-E04 14-CG14792-RA_1 CG14792 AGGTCCGTAACTCTTTCCACGTTAACATGTCGGGAGGCTTAGATATTCTGTCCCTCAAGGAGGACGACA 69 FBan0014792 FBgn0003517 sta X X protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 sta stubarista "CG14792, CG14792, CG14792, 37LRP/p40, Rp40, clone 2.56, P40, l(1)G0130, k14, Stubarista, l(1)G0448, EG:80H7.6, Sa, Laminin receptor, RpSA, Ribosomal protein SA, Lam-r: Laminin-receptor, anon-EST:Liang-2.56, l(1)2Af, Laminin-receptor" CDMC30972 1 23 17 DAC28-E16 7-CG14803-RA_1 CG14803 TCAGGTCTGGGTGAAGTCTCTGGTCCTCCTAAACGCACAACACGAATCTGTATTGGCTTTAATGCCCCA 69 FBan0014803 FBgn0023513 CG14803 X X CG14803 CG14803 EG:63B12.9 CDMC30972 1 24 17 DAC28-E16 7-CG14803-RA_1 CG14803 TCAGGTCTGGGTGAAGTCTCTGGTCCTCCTAAACGCACAACACGAATCTGTATTGGCTTTAATGCCCCA 69 FBan0014803 FBgn0023513 CG14803 X X CG14803 CG14803 EG:63B12.9 CDMC30973 1 25 17 DAC28-I04 3-CG14838-RA_4 CG14838 GGCGGTGGTATCATTACAGCGATAACGGAGCATCGACCCTCGCTTCCACATAAGATCTTGGGCATTGGT 69 FBan0014838 FBgn0035799 CG14838 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG14838 CG14838 CDMC30973 1 26 17 DAC28-I04 3-CG14838-RA_4 CG14838 GGCGGTGGTATCATTACAGCGATAACGGAGCATCGACCCTCGCTTCCACATAAGATCTTGGGCATTGGT 69 FBan0014838 FBgn0035799 CG14838 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG14838 CG14838 CDMC30974 1 1 18 DAC28-I16 23-CG14855-RA_1 CG14855 AGGCATATTTGATTTTCTTCGTCATATGTTTAGGAGGGAAGGCAGTAAATCAGAGGTGGAAATGGGTCC 69 FBan0014855 FBgn0038260 CG14855 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14855 CG14855 CDMC30974 1 2 18 DAC28-I16 23-CG14855-RA_1 CG14855 AGGCATATTTGATTTTCTTCGTCATATGTTTAGGAGGGAAGGCAGTAAATCAGAGGTGGAAATGGGTCC 69 FBan0014855 FBgn0038260 CG14855 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14855 CG14855 CDMC30975 1 3 18 DAC28-M04 14-CG14886-RA_1 CG14886 TGCATAATCCTGGAGTGAACCCAAAGACCTTTATTGGCAGTCACATATTGGAGCGGTTCAAGTGCCGTC 69 FBan0014886 FBgn0038436 Gyc-89Db 3 3R cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; contributes_to guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gyc-89Db Guanylyl cyclase at 89Db "CG14886, CG14886, Guanylyl cyclase at 89Db" CDMC30975 1 4 18 DAC28-M04 14-CG14886-RA_1 CG14886 TGCATAATCCTGGAGTGAACCCAAAGACCTTTATTGGCAGTCACATATTGGAGCGGTTCAAGTGCCGTC 69 FBan0014886 FBgn0038436 Gyc-89Db 3 3R cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; contributes_to guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gyc-89Db Guanylyl cyclase at 89Db "CG14886, CG14886, Guanylyl cyclase at 89Db" CDMC30976 1 5 18 DAC28-M16 3-CG14895-RA_4 CG14895 TCGGCCGGATATCAAGAGCTGGGATAAGCTGAGTCCCAACCTTCAAGACTTTCTCGATCGCTGTCTCCA 69 FBan0014895 FBgn0044826 Pak3 3 3R MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Pak3 Pak3 "CG14895, CG14895, PAK3, dPAK3, pak3, D-Pak3, DPAK3, DmPAK3, anon-WO0118547.285" CDMC30976 1 6 18 DAC28-M16 3-CG14895-RA_4 CG14895 TCGGCCGGATATCAAGAGCTGGGATAAGCTGAGTCCCAACCTTCAAGACTTTCTCGATCGCTGTCTCCA 69 FBan0014895 FBgn0044826 Pak3 3 3R MAPKKK cascade; GO:0000165; actin filament organization; GO:0007015; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Pak3 Pak3 "CG14895, CG14895, PAK3, dPAK3, pak3, D-Pak3, DPAK3, DmPAK3, anon-WO0118547.285" CDMC30977 1 7 18 DAC29-A04 23-CG6371-RA_1 CG6371 CCACATATATGCATAGTGAATGACTACTCTACTAGTTACTAGCGCTATAACCCTGATTTGAGAGGAACT 69 FBan0006371 FBgn0028374 hug 3 3R ecdysis (sensu Insecta); GO:0018990; neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; neurotrophin receptor binding; GO:0005165; ; GO:0005102; ; GO:0005184; ; GO:0005179; ; GO:0005165 cellular component unknown; GO:0008372 hug hugin "CG6371, CG6371, CG6371, CG6371, pyrokinin/PBAN-like, Drm-MT2, Drm-PK-2, huggamma, hug gamma, pyrokinin, HUGgamma, hug-gamma, pyrokinin-2, SVPFKPRLamide, hugin" CDMC30977 1 8 18 DAC29-A04 23-CG6371-RA_1 CG6371 CCACATATATGCATAGTGAATGACTACTCTACTAGTTACTAGCGCTATAACCCTGATTTGAGAGGAACT 69 FBan0006371 FBgn0028374 hug 3 3R ecdysis (sensu Insecta); GO:0018990; neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; neurotrophin receptor binding; GO:0005165; ; GO:0005102; ; GO:0005184; ; GO:0005179; ; GO:0005165 cellular component unknown; GO:0008372 hug hugin "CG6371, CG6371, CG6371, CG6371, pyrokinin/PBAN-like, Drm-MT2, Drm-PK-2, huggamma, hug gamma, pyrokinin, HUGgamma, hug-gamma, pyrokinin-2, SVPFKPRLamide, hugin" CDMC30978 1 9 18 DAC29-A16 15-CG6386-RB_1 CG6386 CGCGGACACCAGCCGTCACTGTGCGGAAATACCAGGGATAGGAGCCTTTGTTTTCTGTATTTTTACATT 69 FBan0006386 FBgn0027889 ball 3 3R histone phosphorylation; GO:0016572; peptidyl-threonine phosphorylation; GO:0018107; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; histone threonine kinase activity; GO:0035184; ; GO:0035184 ball ballchen "CG6386, CG6386, CG6386, CG6386, VRK, BcDNA:LD09009, NHK-1, nucleosomal histone kinase-1, ballchen" CDMC30978 1 10 18 DAC29-A16 15-CG6386-RB_1 CG6386 CGCGGACACCAGCCGTCACTGTGCGGAAATACCAGGGATAGGAGCCTTTGTTTTCTGTATTTTTACATT 69 FBan0006386 FBgn0027889 ball 3 3R histone phosphorylation; GO:0016572; peptidyl-threonine phosphorylation; GO:0018107; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; histone threonine kinase activity; GO:0035184; ; GO:0035184 ball ballchen "CG6386, CG6386, CG6386, CG6386, VRK, BcDNA:LD09009, NHK-1, nucleosomal histone kinase-1, ballchen" CDMC30979 1 11 18 DAC29-E04 3-CG6418-RB_2 CG6418 AGCAGGGCAAAGGCAAGAGACCAACAAATACCCACACAGGATTGGGCTATCGGGAGAAAGGAAATGGAG 69 FBan0006418 FBgn0036104 CG6418 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG6418 CG6418 "cg6418, DmRH27" CDMC30979 1 12 18 DAC29-E04 3-CG6418-RB_2 CG6418 AGCAGGGCAAAGGCAAGAGACCAACAAATACCCACACAGGATTGGGCTATCGGGAGAAAGGAAATGGAG 69 FBan0006418 FBgn0036104 CG6418 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG6418 CG6418 "cg6418, DmRH27" CDMC30980 1 13 18 DAC29-E16 5-CG6431-RA_1 CG6431 GCCCGGCCTTTAATTGAGCGCATGAAGAGCAACAAGTTTCGGTTGTCGATCGATGATGCCAACGTCATT 69 FBan0006431 FBgn0032289 CG6431 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6431 CG6431 CDMC30980 1 14 18 DAC29-E16 5-CG6431-RA_1 CG6431 GCCCGGCCTTTAATTGAGCGCATGAAGAGCAACAAGTTTCGGTTGTCGATCGATGATGCCAACGTCATT 69 FBan0006431 FBgn0032289 CG6431 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6431 CG6431 CDMC30981 1 15 18 DAC29-I04 23-CG6464-RA_2 CG6464 ACGGATGCCAATGTATCCCACTCTGTTCGTAAGCATTAAGCATAGTCTCATAATTTATTACGCAAGCCC 69 FBan0006464 FBgn0004579 salm 2 2L R7 cell differentiation; GO:0045466; R8 cell differentiation; GO:0045465; antennal joint morphogenesis; GO:0048098; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; negative regulation of transcription; GO:0016481; oenocyte development; GO:0007438; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription; GO:0045449; segment specification; GO:0007379; sensory organ development; GO:0007423; spiracle morphogenesis; GO:0035277; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; wing vein morphogenesis; GO:0008586 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 salm spalt major "CG6464, sal: spalt, spalt, salM, 3602, l(2)03602, spalt-major, Sal, Spalt, SPALT, SalM, salII, sal major, sal" CDMC30981 1 16 18 DAC29-I04 23-CG6464-RA_2 CG6464 ACGGATGCCAATGTATCCCACTCTGTTCGTAAGCATTAAGCATAGTCTCATAATTTATTACGCAAGCCC 69 FBan0006464 FBgn0004579 salm 2 2L R7 cell differentiation; GO:0045466; R8 cell differentiation; GO:0045465; antennal joint morphogenesis; GO:0048098; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; negative regulation of transcription; GO:0016481; oenocyte development; GO:0007438; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription; GO:0045449; segment specification; GO:0007379; sensory organ development; GO:0007423; spiracle morphogenesis; GO:0035277; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424; wing vein morphogenesis; GO:0008586 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 salm spalt major "CG6464, sal: spalt, spalt, salM, 3602, l(2)03602, spalt-major, Sal, Spalt, SPALT, SalM, salII, sal major, sal" CDMC30982 1 17 18 DAC29-I16 9-CG6480-RA_4 CG6480 ACGCAAGAAGGAAAAGGATGAGGCTGGATCTTCCAAAAAGGCCAAGGTAGTAGTGGATGAGGATGCCGT 69 FBan0006480 FBgn0036964 CG6480 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6480 CG6480 CDMC30982 1 18 18 DAC29-I16 9-CG6480-RA_4 CG6480 ACGCAAGAAGGAAAAGGATGAGGCTGGATCTTCCAAAAAGGCCAAGGTAGTAGTGGATGAGGATGCCGT 69 FBan0006480 FBgn0036964 CG6480 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG6480 CG6480 CDMC30983 1 19 18 DAC29-M04 2-CG6518-RA_5 CG6518 TCTAGCCCTATCCGGACGTCCTCCTTTCCTCGTCTCCATGCACTCATGTTTCCAGACTATGGACCGATT 69 FBan0006518 FBgn0004784 inaC 2 2R adaptation of rhodopsin mediated signaling; GO:0016062; calcium-mediated signaling; GO:0019722; cell motility; GO:0006928; cell proliferation; GO:0008283; deactivation of rhodopsin mediated signaling; GO:0016059; female gonad development; GO:0008585; intracellular signaling cascade; GO:0007242; phototransduction; GO:0007602; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 inaC inactivation no afterpotential C "CG6518, CG6518, CG6518, dPKC53E(ey), dPKC53E, PKC-eye, pkc-2, eye-PKC, Dpkc2, eye PKC, PKC, eye-specific PKC, ePKC, InaC, protein kinase C, PKC 53E, PKCi, INAC, Pkc2: Protein-kinase-2, Protein kinase-c2, Protein-kinase-2" CDMC30983 1 20 18 DAC29-M04 2-CG6518-RA_5 CG6518 TCTAGCCCTATCCGGACGTCCTCCTTTCCTCGTCTCCATGCACTCATGTTTCCAGACTATGGACCGATT 69 FBan0006518 FBgn0004784 inaC 2 2R adaptation of rhodopsin mediated signaling; GO:0016062; calcium-mediated signaling; GO:0019722; cell motility; GO:0006928; cell proliferation; GO:0008283; deactivation of rhodopsin mediated signaling; GO:0016059; female gonad development; GO:0008585; intracellular signaling cascade; GO:0007242; phototransduction; GO:0007602; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- inaD signaling complex; GO:0016027; rhabdomere; GO:0016028 inaC inactivation no afterpotential C "CG6518, CG6518, CG6518, dPKC53E(ey), dPKC53E, PKC-eye, pkc-2, eye-PKC, Dpkc2, eye PKC, PKC, eye-specific PKC, ePKC, InaC, protein kinase C, PKC 53E, PKCi, INAC, Pkc2: Protein-kinase-2, Protein kinase-c2, Protein-kinase-2" CDMC30984 1 21 18 DAC29-M16 23-CG6531-RA_7 CG6531 TATGCATGGAACGCATATAGACGCACGTATTGTTAACATCACCCATATCCCATATCCTAGTACTAGTAT 69 FBan0006531 FBgn0030941 wgn X X apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166 tumor necrosis factor receptor activity; GO:0005031; protein binding; GO:0005515; ; GO:0005031; ; GO:0005515; ; GO:0005031 integral to plasma membrane; GO:0005887 wgn wengen "CG6531, vader, Wengen, wengen" CDMC30984 1 22 18 DAC29-M16 23-CG6531-RA_7 CG6531 TATGCATGGAACGCATATAGACGCACGTATTGTTAACATCACCCATATCCCATATCCTAGTACTAGTAT 69 FBan0006531 FBgn0030941 wgn X X apoptosis; GO:0006915; cell surface receptor linked signal transduction; GO:0007166 tumor necrosis factor receptor activity; GO:0005031; protein binding; GO:0005515; ; GO:0005031; ; GO:0005515; ; GO:0005031 integral to plasma membrane; GO:0005887 wgn wengen "CG6531, vader, Wengen, wengen" CDMC30985 1 23 18 DAC30-A04 12-CG3663-RA_1 CG3663 TCGACTTGGTTCGAGATAAGAACAACCCCAAGTTCGATGTGGTCCGGAAATTGGTGAACCAGCCGTC 67 FBan0003663 FBgn0035044 CG3663 2 2R CG3663 CG3663 CDMC30985 1 24 18 DAC30-A04 12-CG3663-RA_1 CG3663 TCGACTTGGTTCGAGATAAGAACAACCCCAAGTTCGATGTGGTCCGGAAATTGGTGAACCAGCCGTC 67 FBan0003663 FBgn0035044 CG3663 2 2R CG3663 CG3663 CDMC30986 1 25 18 DAC30-A16 3-CG3805-RA_1 CG3805 CCCGTAAATATTACCTCACCGGGTCCCATCCCCATAAATCTGTGCATTGGTCGCATGCGTTTGGAGC 67 FBan0003805 FBgn0031665 CG3805 2 2L CG3805 CG3805 CDMC30986 1 26 18 DAC30-A16 3-CG3805-RA_1 CG3805 CCCGTAAATATTACCTCACCGGGTCCCATCCCCATAAATCTGTGCATTGGTCGCATGCGTTTGGAGC 67 FBan0003805 FBgn0031665 CG3805 2 2L CG3805 CG3805 CDMC30987 1 1 19 DAC30-E04 24-CG40396-RA_1 CG40396 CGGATGCATATTTTTTTTGTCCTAACCATTAAAAAAAATTGTAGAATCGAGTGGAAATATTTCTGCC 67 FBgn0058396 CG40396 CG40396 CG40396 BcDNA:AT30578 CDMC30987 1 2 19 DAC30-E04 24-CG40396-RA_1 CG40396 CGGATGCATATTTTTTTTGTCCTAACCATTAAAAAAAATTGTAGAATCGAGTGGAAATATTTCTGCC 67 FBgn0058396 CG40396 CG40396 CG40396 BcDNA:AT30578 CDMC30988 1 3 19 DAC30-E16 24-CG41123-RA_7 CG41123 GAAATGCGTTCTCTTGGTATCCTACCCCTGATACGACATATTTTAAAGGGTATCACAAAAAATTATC 67 FBgn0069928 CG41123 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41123 CG41123 CDMC30988 1 4 19 DAC30-E16 24-CG41123-RA_7 CG41123 GAAATGCGTTCTCTTGGTATCCTACCCCTGATACGACATATTTTAAAGGGTATCACAAAAAATTATC 67 FBgn0069928 CG41123 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41123 CG41123 CDMC30989 1 5 19 DAC30-I04 3-CG4572-RB_2 CG4572 GCTACTCCGGCTATTTGACCGTGGACCCTGGCTTCAAATCCAACATGTTCTTCTGGTACTTCCCCGC 67 FBan0004572 FBgn0038738 CG4572 3 3R proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG4572 CG4572 "CT14806, anon-WO02059370.13" CDMC30989 1 6 19 DAC30-I04 3-CG4572-RB_2 CG4572 GCTACTCCGGCTATTTGACCGTGGACCCTGGCTTCAAATCCAACATGTTCTTCTGGTACTTCCCCGC 67 FBan0004572 FBgn0038738 CG4572 3 3R proteolysis; GO:0006508 serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG4572 CG4572 "CT14806, anon-WO02059370.13" CDMC30990 1 7 19 DAC30-I16 1-CG4792-RA_2 CG4792 ATCGGTCGTACCTGTTGCAAGCCATGACACATGCCAGTTACACGCCCAATCGATTGACGGATTGCTA 67 FBan0004792 FBgn0039016 Dcr-1 3 3R "RNA catabolism; GO:0006401; RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; germ-line stem cell division; GO:0042078; miRNA-mediated gene silencing; GO:0035195; miRNA-mediated gene silencing, production of miRNAs; GO:0035196; pre-microRNA processing; GO:0031054" double-stranded RNA binding; GO:0003725; ; GO:0003725; ATP binding; GO:0005524; ; GO:0005524; bidentate ribonuclease III activity; GO:0016443 ; EC:3.1.26.-; protein binding; GO:0005515; ; GO:0005515; endodeoxyribonuclease activity; GO:0004520; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004520; ; GO:0016443 ; EC:3.1.26.-; ; GO:0008026; ; GO:0005515 RNA-induced silencing complex; GO:0016442 Dcr-1 Dicer-1 "CG4792, CG4792, CG4792, CG4792, cg4792, dicer, Dicer, DICER, Dicer1, dcr-1, dicer-1, dcr1, dicer1, DCR1, Dicer-1" CDMC30990 1 8 19 DAC30-I16 1-CG4792-RA_2 CG4792 ATCGGTCGTACCTGTTGCAAGCCATGACACATGCCAGTTACACGCCCAATCGATTGACGGATTGCTA 67 FBan0004792 FBgn0039016 Dcr-1 3 3R "RNA catabolism; GO:0006401; RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; germ-line stem cell division; GO:0042078; miRNA-mediated gene silencing; GO:0035195; miRNA-mediated gene silencing, production of miRNAs; GO:0035196; pre-microRNA processing; GO:0031054" double-stranded RNA binding; GO:0003725; ; GO:0003725; ATP binding; GO:0005524; ; GO:0005524; bidentate ribonuclease III activity; GO:0016443 ; EC:3.1.26.-; protein binding; GO:0005515; ; GO:0005515; endodeoxyribonuclease activity; GO:0004520; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0005515; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004520; ; GO:0016443 ; EC:3.1.26.-; ; GO:0008026; ; GO:0005515 RNA-induced silencing complex; GO:0016442 Dcr-1 Dicer-1 "CG4792, CG4792, CG4792, CG4792, cg4792, dicer, Dicer, DICER, Dicer1, dcr-1, dicer-1, dcr1, dicer1, DCR1, Dicer-1" CDMC30991 1 9 19 DAC30-M04 3-CG5199-RA_1 CG5199 GCTAAAAATGGAGGATAGACCTGTGGGGCAGACGAACACAGATGCGACGCTACCATCCCTGTTGCAG 67 FBan0005199 FBgn0036994 CG5199 3 3L CG5199 CG5199 CDMC30991 1 10 19 DAC30-M04 3-CG5199-RA_1 CG5199 GCTAAAAATGGAGGATAGACCTGTGGGGCAGACGAACACAGATGCGACGCTACCATCCCTGTTGCAG 67 FBan0005199 FBgn0036994 CG5199 3 3L CG5199 CG5199 CDMC30992 1 11 19 DAC30-M16 13-CG5300-RA_2 CG5300 AGTCTTTGATCAGCAACGCCACATACGACATCCCGCAAGACGACAAGAATTCCGAGTTCCATCAAGT 67 FBan0005300 FBgn0032243 Klp31E 2 2L microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003777 cytoplasm; GO:0005737; kinesin complex; GO:0005871 Klp31E Klp31E "CG5300, CG5300, CG5300, CG5300, DmKlp31D, DmKlp31E, DmCG5300, KIF21A" CDMC30992 1 12 19 DAC30-M16 13-CG5300-RA_2 CG5300 AGTCTTTGATCAGCAACGCCACATACGACATCCCGCAAGACGACAAGAATTCCGAGTTCCATCAAGT 67 FBan0005300 FBgn0032243 Klp31E 2 2L microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003777 cytoplasm; GO:0005737; kinesin complex; GO:0005871 Klp31E Klp31E "CG5300, CG5300, CG5300, CG5300, DmKlp31D, DmKlp31E, DmCG5300, KIF21A" CDMC30993 1 13 19 DAC31-A04 1-CG7461-RA_1 CG7461 CGGCAAGGAAGGTGATGGATTCAAGGTTGCCATGAACATATTGAACAACGGTCGGTTTGGAATGGGCGC 69 FBan0007461 FBgn0034432 CG7461 2 2R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 very-long-chain-acyl-CoA dehydrogenase activity; GO:0017099 ; EC:1.3.99.-; ; GO:0017099 ; EC:1.3.99.- CG7461 CG7461 CDMC30993 1 14 19 DAC31-A04 1-CG7461-RA_1 CG7461 CGGCAAGGAAGGTGATGGATTCAAGGTTGCCATGAACATATTGAACAACGGTCGGTTTGGAATGGGCGC 69 FBan0007461 FBgn0034432 CG7461 2 2R acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 very-long-chain-acyl-CoA dehydrogenase activity; GO:0017099 ; EC:1.3.99.-; ; GO:0017099 ; EC:1.3.99.- CG7461 CG7461 CDMC30994 1 15 19 DAC31-A16 16-CG7470-RA_1 CG7470 ACCGAATCGCGTTCCAAAGTAGAGTGCACTTTCGTCATCTTTTAGAGGAGTGCATTTTGAGCGAAGGGT 69 FBan0007470 FBgn0037146 CG7470 3 3L proline biosynthesis; GO:0006561 delta1-pyrroline-5-carboxylate synthetase activity; GO:0017084; glutamate 5-kinase activity; GO:0004349 ; EC:2.7.2.11; glutamate-5-semialdehyde dehydrogenase activity; GO:0004350 ; EC:1.2.1.41; ; GO:0017084; ; GO:0004349 ; EC:2.7.2.11; ; GO:0004350 ; EC:1.2.1.41; ; GO:0017084 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG7470 CG7470 CDMC30994 1 16 19 DAC31-A16 16-CG7470-RA_1 CG7470 ACCGAATCGCGTTCCAAAGTAGAGTGCACTTTCGTCATCTTTTAGAGGAGTGCATTTTGAGCGAAGGGT 69 FBan0007470 FBgn0037146 CG7470 3 3L proline biosynthesis; GO:0006561 delta1-pyrroline-5-carboxylate synthetase activity; GO:0017084; glutamate 5-kinase activity; GO:0004349 ; EC:2.7.2.11; glutamate-5-semialdehyde dehydrogenase activity; GO:0004350 ; EC:1.2.1.41; ; GO:0017084; ; GO:0004349 ; EC:2.7.2.11; ; GO:0004350 ; EC:1.2.1.41; ; GO:0017084 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG7470 CG7470 CDMC30995 1 17 19 DAC31-E04 23-CG7518-RB_2 CG7518 TTGAGTTGAACTCCTCACATTCATAACAGTCTCTCACATACGCAGACATTTCATCGATGAAAAGCAGAA 69 FBan0007518 FBgn0038108 CG7518 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG7518 CG7518 CDMC30995 1 18 19 DAC31-E04 23-CG7518-RB_2 CG7518 TTGAGTTGAACTCCTCACATTCATAACAGTCTCTCACATACGCAGACATTTCATCGATGAAAAGCAGAA 69 FBan0007518 FBgn0038108 CG7518 3 3R DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG7518 CG7518 CDMC30996 1 19 19 DAC31-E16 27-CG7527-RA_2 CG7527 GGCCGAGTATACGGGAATCAAGACCTTTGAGGTGCAGTCCGATTTCCAGAGAAGCTGCTTGGACGACAT 69 FBan0007527 FBgn0032655 CadN2 2 2L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to plasma membrane; GO:0005887 CadN2 CadN2 "CG7527, CG7527, DN-like, CT23007, DN-cadh-like, DmNCad2, NCad2, N-Cad2, DN-Cad2" CDMC30996 1 20 19 DAC31-E16 27-CG7527-RA_2 CG7527 GGCCGAGTATACGGGAATCAAGACCTTTGAGGTGCAGTCCGATTTCCAGAGAAGCTGCTTGGACGACAT 69 FBan0007527 FBgn0032655 CadN2 2 2L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to plasma membrane; GO:0005887 CadN2 CadN2 "CG7527, CG7527, DN-like, CT23007, DN-cadh-like, DmNCad2, NCad2, N-Cad2, DN-Cad2" CDMC30997 1 21 19 DAC31-I04 15-CG7560-RA_4 CG7560 TTATCACACAGTTATGCTACCGTCCCGAGGTCATAGTGCAATTTGTGAAGGACTGTCGAGCAGCTGGAA 69 FBan0007560 FBgn0036157 CG7560 3 3L coenzyme metabolism; GO:0006732; methionine metabolism; GO:0006555; prosthetic group metabolism; GO:0051189 methylenetetrahydrofolate reductase (NADPH) activity; GO:0004489 ; EC:1.5.1.20; ; GO:0004489 ; EC:1.5.1.20 CG7560 CG7560 "gh18008, BEST:GH18008" CDMC30997 1 22 19 DAC31-I04 15-CG7560-RA_4 CG7560 TTATCACACAGTTATGCTACCGTCCCGAGGTCATAGTGCAATTTGTGAAGGACTGTCGAGCAGCTGGAA 69 FBan0007560 FBgn0036157 CG7560 3 3L coenzyme metabolism; GO:0006732; methionine metabolism; GO:0006555; prosthetic group metabolism; GO:0051189 methylenetetrahydrofolate reductase (NADPH) activity; GO:0004489 ; EC:1.5.1.20; ; GO:0004489 ; EC:1.5.1.20 CG7560 CG7560 "gh18008, BEST:GH18008" CDMC30998 1 23 19 DAC31-I16 15-CG7574-RA_2 CG7574 GCGATGTGCTGTCCATAAACTCCGACTACGAAGCCTCGTTACCACTATCAGCCTTAGAGGATTCCCAGA 69 FBan0007574 FBgn0026263 bip1 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bip1 bip1 "CG7574, bip-I, anon-WO0118547.246" CDMC30998 1 24 19 DAC31-I16 15-CG7574-RA_2 CG7574 GCGATGTGCTGTCCATAAACTCCGACTACGAAGCCTCGTTACCACTATCAGCCTTAGAGGATTCCCAGA 69 FBan0007574 FBgn0026263 bip1 3 3L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bip1 bip1 "CG7574, bip-I, anon-WO0118547.246" CDMC30999 1 25 19 DAC31-M04 16-CG7603-RA_1 CG7603 ACGACCAGACTGCTATTGTTTGGATACACCCAAAGACCGCAATAGACTGTCACTCTCTCTTCCCCAAAA 69 FBan0007603 FBgn0036726 CG7603 3 3L CG7603 CG7603 CDMC30999 1 26 19 DAC31-M04 16-CG7603-RA_1 CG7603 ACGACCAGACTGCTATTGTTTGGATACACCCAAAGACCGCAATAGACTGTCACTCTCTCTTCCCCAAAA 69 FBan0007603 FBgn0036726 CG7603 3 3L CG7603 CG7603 CDMC31000 1 1 20 DAC31-M16 1-CG7616-RA_1 CG7616 GCGTGCGGACATCATCTTGCTGGATCATGGACTTTACGAAGAACTGCCTCAAAATGTGCGAGGTCCACT 69 FBan0007616 FBgn0036142 CG7616 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 protein kinase activity; GO:0004672 ; EC:2.7.1.37; transporter activity; GO:0005215; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005215 CG7616 CG7616 CDMC31000 1 2 20 DAC31-M16 1-CG7616-RA_1 CG7616 GCGTGCGGACATCATCTTGCTGGATCATGGACTTTACGAAGAACTGCCTCAAAATGTGCGAGGTCCACT 69 FBan0007616 FBgn0036142 CG7616 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 protein kinase activity; GO:0004672 ; EC:2.7.1.37; transporter activity; GO:0005215; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005215 CG7616 CG7616 CDMC31001 1 3 20 DAC32-A04 5-CG14629-RA_1 CG14629 ACAAGCTGCTGGAGTTCATATGCTACAAGAACGGAGACCAGATTGCGCTCTTTATCGCCGAAGAGGGC 68 FBan0014629 FBgn0040398 CG14629 X X CG14629 CG14629 EG:103E12.2 CDMC31001 1 4 20 DAC32-A04 5-CG14629-RA_1 CG14629 ACAAGCTGCTGGAGTTCATATGCTACAAGAACGGAGACCAGATTGCGCTCTTTATCGCCGAAGAGGGC 68 FBan0014629 FBgn0040398 CG14629 X X CG14629 CG14629 EG:103E12.2 CDMC31002 1 5 20 DAC32-A16 3-CG14767-RB_1 CG14767 CCCATCCTCTTCTTGCCCAGATGATCTGGTTTCTGGTCCCTCATTTCGCAGCTATCATTCCCAGGCAC 68 FBan0014767 FBgn0040777 CG14767 2 2R nucleobase transporter activity; GO:0015205; ; GO:0015205 integral to membrane; GO:0016021; lysosomal membrane; GO:0005765 CG14767 CG14767 "CG8575, CG8575" CDMC31002 1 6 20 DAC32-A16 3-CG14767-RB_1 CG14767 CCCATCCTCTTCTTGCCCAGATGATCTGGTTTCTGGTCCCTCATTTCGCAGCTATCATTCCCAGGCAC 68 FBan0014767 FBgn0040777 CG14767 2 2R nucleobase transporter activity; GO:0015205; ; GO:0015205 integral to membrane; GO:0016021; lysosomal membrane; GO:0005765 CG14767 CG14767 "CG8575, CG8575" CDMC31003 1 7 20 DAC32-E04 2-CG15207-RA_2 CG15207 CCAGAGGCATCGTTAGCGTTACAGCAGCCCATTTAGAACGCCCGGATTATCGAATCATCCCACATCCC 68 FBan0015207 FBgn0030248 CG15207 X X CG15207 CG15207 CDMC31003 1 8 20 DAC32-E04 2-CG15207-RA_2 CG15207 CCAGAGGCATCGTTAGCGTTACAGCAGCCCATTTAGAACGCCCGGATTATCGAATCATCCCACATCCC 68 FBan0015207 FBgn0030248 CG15207 X X CG15207 CG15207 CDMC31004 1 9 20 DAC32-E16 3-CG15326-RA_3 CG15326 CCACCTTGGTCCTTAGGAGTGGCTACCAGTCGGGAATGTATCAGCTGCTAAGGCAGGATACCCAAAGG 68 FBan0015326 FBgn0029965 CG15326 X X CG15326 CG15326 CDMC31004 1 10 20 DAC32-E16 3-CG15326-RA_3 CG15326 CCACCTTGGTCCTTAGGAGTGGCTACCAGTCGGGAATGTATCAGCTGCTAAGGCAGGATACCCAAAGG 68 FBan0015326 FBgn0029965 CG15326 X X CG15326 CG15326 CDMC31005 1 11 20 DAC32-I04 3-CG15666-RA_3 CG15666 TCCGACTATGTGGAGACCTTCGCCATGATTCTTGAGCGGATTGTGGAGAGAACTCTGCAGCTGGACAG 68 FBan0015666 FBgn0034622 CG15666 2 2R CG15666 CG15666 BcDNA:RH67628 CDMC31005 1 12 20 DAC32-I04 3-CG15666-RA_3 CG15666 TCCGACTATGTGGAGACCTTCGCCATGATTCTTGAGCGGATTGTGGAGAGAACTCTGCAGCTGGACAG 68 FBan0015666 FBgn0034622 CG15666 2 2R CG15666 CG15666 BcDNA:RH67628 CDMC31006 1 13 20 DAC32-I16 3-CG15889-RA_1 CG15889 CCAGTGCACAGTACTCCACTCAGTGGGATGTGCCAAGCTCAGGAGATCAATTCCAAGGCCACCATAAC 68 FBan0015889 FBgn0038128 Ravus 3 3R DNA binding; GO:0003677; ; GO:0003677 colocalizes_with nuclear chromatin; GO:0000790 Ravus Ravus "CG15889, CG15889" CDMC31006 1 14 20 DAC32-I16 3-CG15889-RA_1 CG15889 CCAGTGCACAGTACTCCACTCAGTGGGATGTGCCAAGCTCAGGAGATCAATTCCAAGGCCACCATAAC 68 FBan0015889 FBgn0038128 Ravus 3 3R DNA binding; GO:0003677; ; GO:0003677 colocalizes_with nuclear chromatin; GO:0000790 Ravus Ravus "CG15889, CG15889" CDMC31007 1 15 20 DAC32-M04 2-CG17010-RA_3 CG17010 CCTTTCAGGATGCGAAGGTGCTTCTCTGCCAACTGGAAACGGATATGAATGCCACCATGTGTGCGTTG 68 FBan0017010 FBgn0032424 CG17010 2 2L D-ribose metabolism; GO:0006014; carbohydrate metabolism; GO:0005975 ribokinase activity; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG17010 CG17010 CDMC31007 1 16 20 DAC32-M04 2-CG17010-RA_3 CG17010 CCTTTCAGGATGCGAAGGTGCTTCTCTGCCAACTGGAAACGGATATGAATGCCACCATGTGTGCGTTG 68 FBan0017010 FBgn0032424 CG17010 2 2L D-ribose metabolism; GO:0006014; carbohydrate metabolism; GO:0005975 ribokinase activity; GO:0004747 ; EC:2.7.1.15; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004747 ; EC:2.7.1.15 CG17010 CG17010 CDMC31008 1 17 20 DAC32-M16 2-CG17121-RA_2 CG17121 CGTGGACATTCTGGTCAACAATGCCTCCCTCATGCCCATGACTTCAACACCCAGTCTGAAGAGCGATG 68 FBan0017121 FBgn0039043 CG17121 3 3R metabolism; GO:0008152; visual perception; GO:0007601 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG17121 CG17121 CDMC31008 1 18 20 DAC32-M16 2-CG17121-RA_2 CG17121 CGTGGACATTCTGGTCAACAATGCCTCCCTCATGCCCATGACTTCAACACCCAGTCTGAAGAGCGATG 68 FBan0017121 FBgn0039043 CG17121 3 3R metabolism; GO:0008152; visual perception; GO:0007601 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG17121 CG17121 CDMC31009 1 19 20 DAC33-A04 23-CG31303-RA_1 CG31303 ACAGCGCAATCATCTCAATAACAATAATAGTAAGCAAAATAGCTGTGATAAAACTGGCAACGATGA 66 FBan0031303 FBgn0051303 CG31303 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31303 CG31303 CDMC31009 1 20 20 DAC33-A04 23-CG31303-RA_1 CG31303 ACAGCGCAATCATCTCAATAACAATAATAGTAAGCAAAATAGCTGTGATAAAACTGGCAACGATGA 66 FBan0031303 FBgn0051303 CG31303 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31303 CG31303 CDMC31010 1 21 20 DAC33-A16 3-CG31469-RA_1 CG31469 GGTAGTGAAACGGAATCTGCAGGACTGGTATGTGGACAGTGCTGGCCTCAGGAGTTGGAACGTTGG 66 FBan0031469 FBgn0051469 CG31469 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG31469 CG31469 CG9599 CDMC31010 1 22 20 DAC33-A16 3-CG31469-RA_1 CG31469 GGTAGTGAAACGGAATCTGCAGGACTGGTATGTGGACAGTGCTGGCCTCAGGAGTTGGAACGTTGG 66 FBan0031469 FBgn0051469 CG31469 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 CG31469 CG31469 CG9599 CDMC31011 1 23 20 DAC33-E04 3-CG31935-RA_2 CG31935 GTTCGGGCCTGACCACCCAAATGATGTGTACTTCATTGCTCTCCGATATGGAAGCCTTCAAGGCCG 66 FBan0031935 FBgn0051935 CG31935 2 2L regulation of GTPase activity; GO:0043087 Rab GTPase activator activity; GO:0005097; Rab GTPase binding; GO:0017137; ; GO:0005097; ; GO:0017137 soluble fraction; GO:0005625 CG31935 CG31935 "CG10870, CG7373, CG10870, CG7373" CDMC31011 1 24 20 DAC33-E04 3-CG31935-RA_2 CG31935 GTTCGGGCCTGACCACCCAAATGATGTGTACTTCATTGCTCTCCGATATGGAAGCCTTCAAGGCCG 66 FBan0031935 FBgn0051935 CG31935 2 2L regulation of GTPase activity; GO:0043087 Rab GTPase activator activity; GO:0005097; Rab GTPase binding; GO:0017137; ; GO:0005097; ; GO:0017137 soluble fraction; GO:0005625 CG31935 CG31935 "CG10870, CG7373, CG10870, CG7373" CDMC31012 1 25 20 DAC33-E16 12-CG32193-RA_2 CG32193 GCAGTTTGAAACATTCGCGTTTCGCTCAGCCTCTGACGTCGTGCAAAAATTGCAGCCGAACGAAAC 66 FBan0032193 FBgn0052193 CG32193 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32193 CG32193 CDMC31012 1 26 20 DAC33-E16 12-CG32193-RA_2 CG32193 GCAGTTTGAAACATTCGCGTTTCGCTCAGCCTCTGACGTCGTGCAAAAATTGCAGCCGAACGAAAC 66 FBan0032193 FBgn0052193 CG32193 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32193 CG32193 CDMC31013 1 1 21 DAC33-I04 23-CG32586-RA_4 CG32586 TGGAGCCTACGGATTCGATTCAATGAGATCGTATCGTATCTATTTTGCCTACGCTCTTGGCCAAAT 66 FBan0032586 FBgn0052586 CG32586 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32586 CG32586 CDMC31013 1 2 21 DAC33-I04 23-CG32586-RA_4 CG32586 TGGAGCCTACGGATTCGATTCAATGAGATCGTATCGTATCTATTTTGCCTACGCTCTTGGCCAAAT 66 FBan0032586 FBgn0052586 CG32586 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32586 CG32586 CDMC31014 1 3 21 DAC33-I16 3-CG3268-RA_5 CG3268 TCTGGGCTTTGTCCAACGCCTTTGCCTGACCCTCATACTGTTCATAATATTCGCCGTTGCAGAGCG 66 FBan0003268 FBgn0028579 phtf 2 2R phtf phtf "CG3268, CG3268, BcDNA.GH08636, d-phtf, BcDNA:GH08636" CDMC31014 1 4 21 DAC33-I16 3-CG3268-RA_5 CG3268 TCTGGGCTTTGTCCAACGCCTTTGCCTGACCCTCATACTGTTCATAATATTCGCCGTTGCAGAGCG 66 FBan0003268 FBgn0028579 phtf 2 2R phtf phtf "CG3268, CG3268, BcDNA.GH08636, d-phtf, BcDNA:GH08636" CDMC31015 1 5 21 DAC33-M04 3-CG3324-RA_3 CG3324 CCTGGACAGGGATTCCTTCAAGCGGCTAATTGGGGATCTATGCGAGCTGAAGGAGAAGGACTACGG 66 FBan0003324 FBgn0000442 Pkg21D 2 2L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; cyclic nucleotide binding; GO:0030551; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; ; GO:0030551; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952 Pkg21D cGMP-dependent protein kinase 21D "CG3324, CG3324, DG1, cGMP, dg1, PKG, PKG 21D, Dg1, Pkg1" CDMC31015 1 6 21 DAC33-M04 3-CG3324-RA_3 CG3324 CCTGGACAGGGATTCCTTCAAGCGGCTAATTGGGGATCTATGCGAGCTGAAGGAGAAGGACTACGG 66 FBan0003324 FBgn0000442 Pkg21D 2 2L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; cyclic nucleotide binding; GO:0030551; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; ; GO:0030551; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952 Pkg21D cGMP-dependent protein kinase 21D "CG3324, CG3324, DG1, cGMP, dg1, PKG, PKG 21D, Dg1, Pkg1" CDMC31016 1 7 21 DAC33-M16 2-CG33329-RB_1 CG33329 ATCGGCCGTCTATCACAAGGAGGTTCGAGCTCTGGCCTTTAAGTGCAGAGGATCCCTGATCTCGTC 66 FBan0033329 FBgn0053329 CG33329 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33329 CG33329 CDMC31016 1 8 21 DAC33-M16 2-CG33329-RB_1 CG33329 ATCGGCCGTCTATCACAAGGAGGTTCGAGCTCTGGCCTTTAAGTGCAGAGGATCCCTGATCTCGTC 66 FBan0033329 FBgn0053329 CG33329 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33329 CG33329 CDMC31017 1 9 21 DAC34-A04 35-CG13424-RA_1 CG13424 GGATGACAACATGGACGACGGCAAAAGTGATATCGATTTGGCCTCAGATGATGGAAACGGCCTTGGTGA 69 FBan0013424 FBgn0034520 CG13424 2 2R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG13424 CG13424 CDMC31017 1 10 21 DAC34-A04 35-CG13424-RA_1 CG13424 GGATGACAACATGGACGACGGCAAAAGTGATATCGATTTGGCCTCAGATGATGGAAACGGCCTTGGTGA 69 FBan0013424 FBgn0034520 CG13424 2 2R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG13424 CG13424 CDMC31018 1 11 21 DAC34-A16 3-CG13441-RA_1 CG13441 GCCAGGTGGTTTCCATGATCCAGGAGCTGCACTATCTCATCCAGGAGATTAACCGAGTTTACGCCCTCA 69 FBan0013441 FBgn0041240 Gr57a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr57a Gustatory receptor 57a "CG13441, CG13441, 57B.1, Gustatory receptor 57B.1, Gr57B1, GR57B.1, Gustatory receptor 57a" CDMC31018 1 12 21 DAC34-A16 3-CG13441-RA_1 CG13441 GCCAGGTGGTTTCCATGATCCAGGAGCTGCACTATCTCATCCAGGAGATTAACCGAGTTTACGCCCTCA 69 FBan0013441 FBgn0041240 Gr57a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr57a Gustatory receptor 57a "CG13441, CG13441, 57B.1, Gustatory receptor 57B.1, Gr57B1, GR57B.1, Gustatory receptor 57a" CDMC31019 1 13 21 DAC34-E04 16-CG13480-RA_1 CG13480 AATTCCGGAGATTCCACTCCCATCGTTTTTCCCATCCAAGTGTATGAACAGCCAAAGTTGAAGTCCTCT 69 FBan0013480 FBgn0028418 Leucokinin 3 3L calcium-mediated signaling; GO:0019722; fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0008613; ; GO:0005184; ; GO:0005179; ; GO:0008613 Leucokinin Leucokinin "CG13480, CG13480, DLK, pp, leucokinin, Drm-KIN, myokinin-like, Drosokinin, LK, Leucokinin-1, drosokinin" CDMC31019 1 14 21 DAC34-E04 16-CG13480-RA_1 CG13480 AATTCCGGAGATTCCACTCCCATCGTTTTTCCCATCCAAGTGTATGAACAGCCAAAGTTGAAGTCCTCT 69 FBan0013480 FBgn0028418 Leucokinin 3 3L calcium-mediated signaling; GO:0019722; fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 hormone activity; GO:0005179; neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0008613; ; GO:0005184; ; GO:0005179; ; GO:0008613 Leucokinin Leucokinin "CG13480, CG13480, DLK, pp, leucokinin, Drm-KIN, myokinin-like, Drosokinin, LK, Leucokinin-1, drosokinin" CDMC31020 1 15 21 DAC34-E16 16-CG13499-RC_1 CG13499 TCGTCTGCAGAAGTCAGCAGTAGCGGTTCGTAGTGCTCCGTAATTTCAATGTGTACAGAGTGTTGTGTT 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC31020 1 16 21 DAC34-E16 16-CG13499-RC_1 CG13499 TCGTCTGCAGAAGTCAGCAGTAGCGGTTCGTAGTGCTCCGTAATTTCAATGTGTACAGAGTGTTGTGTT 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC31021 1 17 21 DAC34-I04 23-CG13552-RA_6 CG13552 CCAGCCGGGTTATAAATATAAAAATGACAGACCAACAAAAGCGAAAGGAAGGCAATTCTGGGTGCTCCT 69 FBan0013552 FBgn0034864 CG13552 2 2R CG13552 CG13552 CDMC31021 1 18 21 DAC34-I04 23-CG13552-RA_6 CG13552 CCAGCCGGGTTATAAATATAAAAATGACAGACCAACAAAAGCGAAAGGAAGGCAATTCTGGGTGCTCCT 69 FBan0013552 FBgn0034864 CG13552 2 2R CG13552 CG13552 CDMC31022 1 19 21 DAC34-I16 15-CG13567-RA_6 CG13567 ACCACCTCCGGACCTTTGCCCACTGAGTTTATTCACCTATACATCAGCAATTGCATCTCGACTTGCGAA 69 FBan0013567 FBgn0034963 CG13567 2 2R CG13567 CG13567 CDMC31022 1 20 21 DAC34-I16 15-CG13567-RA_6 CG13567 ACCACCTCCGGACCTTTGCCCACTGAGTTTATTCACCTATACATCAGCAATTGCATCTCGACTTGCGAA 69 FBan0013567 FBgn0034963 CG13567 2 2R CG13567 CG13567 CDMC31023 1 21 21 DAC34-M04 12-CG13603-RA_1 CG13603 CCCCGCCGATCGTTTCGAACGCATCCTCCGACACGGAACAGAACAAATAGTTGACGTTTGTGATCAATC 69 FBan0013603 FBgn0039135 CG13603 3 3R CG13603 CG13603 CDMC31023 1 22 21 DAC34-M04 12-CG13603-RA_1 CG13603 CCCCGCCGATCGTTTCGAACGCATCCTCCGACACGGAACAGAACAAATAGTTGACGTTTGTGATCAATC 69 FBan0013603 FBgn0039135 CG13603 3 3R CG13603 CG13603 CDMC31024 1 23 21 DAC34-M16 11-CG13610-RA_1 CG13610 TTCTGGGCAGCATTGTGTTTGGTCAACTGAGCGATAAGTACGGAAGAAAACCCATCCTCTTCGCCTCAC 69 FBgn0039176 CDMC31024 1 24 21 DAC34-M16 11-CG13610-RA_1 CG13610 TTCTGGGCAGCATTGTGTTTGGTCAACTGAGCGATAAGTACGGAAGAAAACCCATCCTCTTCGCCTCAC 69 FBgn0039176 CDMC31025 1 25 21 DAC35-A04 9-CG17258-RA_1 CG17258 CGGTGGCGCATGAAAATATGGGAGCTCTTGCCTGACTACAAACCGAGAGAGGACAGCTTGTGGTAG 66 FBan0017258 FBgn0031496 CG17258 2 2L CG17258 CG17258 CDMC31025 1 26 21 DAC35-A04 9-CG17258-RA_1 CG17258 CGGTGGCGCATGAAAATATGGGAGCTCTTGCCTGACTACAAACCGAGAGAGGACAGCTTGTGGTAG 66 FBan0017258 FBgn0031496 CG17258 2 2L CG17258 CG17258 CDMC31026 1 1 22 DAC35-A16 1-CG17533-RA_1 CG17533 GGAAGAATCCCCAGCATACGGTGCCCACTTTAGAGGACGATGGCCATTTCATCTGGGACTCACACG 66 FBgn0034342 CDMC31026 1 2 22 DAC35-A16 1-CG17533-RA_1 CG17533 GGAAGAATCCCCAGCATACGGTGCCCACTTTAGAGGACGATGGCCATTTCATCTGGGACTCACACG 66 FBgn0034342 CDMC31027 1 3 22 DAC35-E04 3-CG1842-RA_1 CG1842 CCTGGTCTTTGAGGCTAATTTGGCCACTTCGGAGGATCTGAGTCACTGGATTCTGCAGGGCGTCTG 66 FBan0001842 FBgn0013813 Dhc98D 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; protein biosynthesis; GO:0006412 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; structural constituent of ribosome; GO:0003735; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0003735" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875; ribosome; GO:0005840 Dhc98D Dynein heavy chain at 89D "CG1842, CG1842, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC31027 1 4 22 DAC35-E04 3-CG1842-RA_1 CG1842 CCTGGTCTTTGAGGCTAATTTGGCCACTTCGGAGGATCTGAGTCACTGGATTCTGCAGGGCGTCTG 66 FBan0001842 FBgn0013813 Dhc98D 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018; protein biosynthesis; GO:0006412 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; structural constituent of ribosome; GO:0003735; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0003735" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875; ribosome; GO:0005840 Dhc98D Dynein heavy chain at 89D "CG1842, CG1842, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC31028 1 5 22 DAC35-E16 3-CG18745-RA_3 CG18745 AGCTGGCTGTTGAAGAAGTAGCCACTGCTCCAAACTCTTCAAGTCCATGGTCTGTCGACGCATCCA 66 FBan0018745 FBgn0042102 CG18745 3 3R CG18745 CG18745 CDMC31028 1 6 22 DAC35-E16 3-CG18745-RA_3 CG18745 AGCTGGCTGTTGAAGAAGTAGCCACTGCTCCAAACTCTTCAAGTCCATGGTCTGTCGACGCATCCA 66 FBan0018745 FBgn0042102 CG18745 3 3R CG18745 CG18745 CDMC31029 1 7 22 DAC35-I04 2-CG2901-RA_2 CG2901 GCTGCGATATGATCGGGTGAACAACTGCTTTGAACCGGATGTGATGGTCCCGATTACCATGTGCCT 66 FBan0002901 FBgn0029679 CG2901 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG2901 CG2901 CDMC31029 1 8 22 DAC35-I04 2-CG2901-RA_2 CG2901 GCTGCGATATGATCGGGTGAACAACTGCTTTGAACCGGATGTGATGGTCCCGATTACCATGTGCCT 66 FBan0002901 FBgn0029679 CG2901 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG2901 CG2901 CDMC31030 1 9 22 DAC35-I16 2-CG30036-RA_2 CG30036 GTACGCGGAAGCCCTAACCACATCTCTCGTCCATCTGGAAGATGTCTTCGTCACTGGCATCTGTGC 66 FBan0030036 FBgn0050036 CG30036 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG30036 CG30036 CG8976 CDMC31030 1 10 22 DAC35-I16 2-CG30036-RA_2 CG30036 GTACGCGGAAGCCCTAACCACATCTCTCGTCCATCTGGAAGATGTCTTCGTCACTGGCATCTGTGC 66 FBan0030036 FBgn0050036 CG30036 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG30036 CG30036 CG8976 CDMC31031 1 11 22 DAC35-M04 3-CG3059-RC_1 CG3059 TCACGTCCAGCAAGAAGATCAACGTCTTCACGCACAGCTATCTGGGACTGGGTCTAATGGCTGCAC 66 FBan0003059 FBgn0024947 NTPase 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleotide phosphatase activity; GO:0019204; guanosine-diphosphatase activity; GO:0004382 ; EC:3.6.1.42; nucleoside-diphosphatase activity; GO:0017110 ; EC:3.6.1.6; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0019204; ; GO:0004382 ; EC:3.6.1.42; ; GO:0017110 ; EC:3.6.1.6; ; GO:0017111 ; EC:3.6.1.15 NTPase NTPase "CG3059, dmNTPase, CD39-like NTPase" CDMC31031 1 12 22 DAC35-M04 3-CG3059-RC_1 CG3059 TCACGTCCAGCAAGAAGATCAACGTCTTCACGCACAGCTATCTGGGACTGGGTCTAATGGCTGCAC 66 FBan0003059 FBgn0024947 NTPase 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleotide phosphatase activity; GO:0019204; guanosine-diphosphatase activity; GO:0004382 ; EC:3.6.1.42; nucleoside-diphosphatase activity; GO:0017110 ; EC:3.6.1.6; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0019204; ; GO:0004382 ; EC:3.6.1.42; ; GO:0017110 ; EC:3.6.1.6; ; GO:0017111 ; EC:3.6.1.15 NTPase NTPase "CG3059, dmNTPase, CD39-like NTPase" CDMC31032 1 13 22 DAC35-M16 3-CG31119-RA_1 CG31119 TCCATCACTGTTGCTCGTACAGAGGCGGTGGTTTCTGTCCATATGCTGACATCTCGCTGCTCATCG 66 FBan0031119 FBgn0051119 CG31119 3 3R histone deacetylation; GO:0016575 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.- histone deacetylase complex; GO:0000118 CG31119 CG31119 dmHDA403 CDMC31032 1 14 22 DAC35-M16 3-CG31119-RA_1 CG31119 TCCATCACTGTTGCTCGTACAGAGGCGGTGGTTTCTGTCCATATGCTGACATCTCGCTGCTCATCG 66 FBan0031119 FBgn0051119 CG31119 3 3R histone deacetylation; GO:0016575 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.- histone deacetylase complex; GO:0000118 CG31119 CG31119 dmHDA403 CDMC31033 1 15 22 DAC36-A04 14-CG17295-RA_2 CG17295 GCTTAAAATGCCTCACAAACGTAGGAACCGAGTACATGCGAACCAAAGGAATTTCACAGCGCGACGC 67 FBan0017295 FBgn0032034 CG17295 2 2L CG17295 CG17295 BcDNA:SD16838 CDMC31033 1 16 22 DAC36-A04 14-CG17295-RA_2 CG17295 GCTTAAAATGCCTCACAAACGTAGGAACCGAGTACATGCGAACCAAAGGAATTTCACAGCGCGACGC 67 FBan0017295 FBgn0032034 CG17295 2 2L CG17295 CG17295 BcDNA:SD16838 CDMC31034 1 17 22 DAC36-A16 1-CG17559-RA_1 CG17559 CGGCGTTTCCATTGAGGATCACACCACACCGTTTGTCCTCTATCCCGCTCTGAACAATACCCGCAAC 67 FBan0017559 FBgn0024245 dnt 2 2L axon guidance; GO:0007411; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; muscle attachment; GO:0016203; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 dnt doughnut on 2 "CG17559, CG17559, doughnut, Doughnut, doughnut on 2" CDMC31034 1 18 22 DAC36-A16 1-CG17559-RA_1 CG17559 CGGCGTTTCCATTGAGGATCACACCACACCGTTTGTCCTCTATCCCGCTCTGAACAATACCCGCAAC 67 FBan0017559 FBgn0024245 dnt 2 2L axon guidance; GO:0007411; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; muscle attachment; GO:0016203; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.- integral to membrane; GO:0016021; plasma membrane; GO:0005886 dnt doughnut on 2 "CG17559, CG17559, doughnut, Doughnut, doughnut on 2" CDMC31035 1 19 22 DAC36-E04 45-CG18437-RA_5 CG18437 TGTCGCCCTATGATCCGGAGTCCATGGCCTGTCGGGGTCTGCAACGCTATATGCAGGCGGTTTTGCC 67 FBan0018437 FBgn0039536 CG18437 3 3R CG18437 CG18437 CDMC31035 1 20 22 DAC36-E04 45-CG18437-RA_5 CG18437 TGTCGCCCTATGATCCGGAGTCCATGGCCTGTCGGGGTCTGCAACGCTATATGCAGGCGGTTTTGCC 67 FBan0018437 FBgn0039536 CG18437 3 3R CG18437 CG18437 CDMC31036 1 21 22 DAC36-E16 17-CG18578-RA_2 CG18578 AGAACTGATGAAATCCAACCAGACCTTCGATGCCGTAATATCCGAGGTGTTCCTGAACGAAGCTCAC 67 FBan0018578 FBgn0040259 Ugt86Da 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Da Ugt86Da "CG18578, CG18578, CG18578, GM04645, AC 006491A, BEST:GM04645" CDMC31036 1 22 22 DAC36-E16 17-CG18578-RA_2 CG18578 AGAACTGATGAAATCCAACCAGACCTTCGATGCCGTAATATCCGAGGTGTTCCTGAACGAAGCTCAC 67 FBan0018578 FBgn0040259 Ugt86Da 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Da Ugt86Da "CG18578, CG18578, CG18578, GM04645, AC 006491A, BEST:GM04645" CDMC31037 1 23 22 DAC36-I04 3-CG2493-RA_1 CG2493 ACTACGTGGAGGAGGTGTACAGCAATCTCGCCATGGTCAATTACCCGTACAACAGCAGTTTCCTGGC 67 FBan0002493 FBgn0032864 CG2493 2 2L proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG2493 CG2493 38C.55 CDMC31037 1 24 22 DAC36-I04 3-CG2493-RA_1 CG2493 ACTACGTGGAGGAGGTGTACAGCAATCTCGCCATGGTCAATTACCCGTACAACAGCAGTTTCCTGGC 67 FBan0002493 FBgn0032864 CG2493 2 2L proteolysis; GO:0006508 serine-type Pro-X carboxypeptidase activity; GO:0004188 ; EC:3.4.16.2; ; GO:0004188 ; EC:3.4.16.2 CG2493 CG2493 38C.55 CDMC31038 1 25 22 DAC36-I16 15-CG2772-RA_1 CG2772 ACTGCTTCACGAGGTGCCCGATTCCACATGGGGTCACTTGGACTTTATCTTCGCCACGGAGGTCAAG 67 FBan0002772 FBgn0031533 CG2772 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG2772 CG2772 BcDNA:RE45077 CDMC31038 1 26 22 DAC36-I16 15-CG2772-RA_1 CG2772 ACTGCTTCACGAGGTGCCCGATTCCACATGGGGTCACTTGGACTTTATCTTCGCCACGGAGGTCAAG 67 FBan0002772 FBgn0031533 CG2772 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG2772 CG2772 BcDNA:RE45077 CDMC31039 1 1 23 DAC36-M04 1-CG30274-RA_1 CG30274 GGTCACCCGCTGTTTGGTTGAAGTCTCCAGGAATTTGGATCAGTTGGAGCTACCCCTGAACCTCACC 67 FBan0030274 FBgn0050274 CG30274 2 2R CG30274 CG30274 CG13529 CDMC31039 1 2 23 DAC36-M04 1-CG30274-RA_1 CG30274 GGTCACCCGCTGTTTGGTTGAAGTCTCCAGGAATTTGGATCAGTTGGAGCTACCCCTGAACCTCACC 67 FBan0030274 FBgn0050274 CG30274 2 2R CG30274 CG30274 CG13529 CDMC31040 1 3 23 DAC36-M16 2-CG3036-RA_1 CG3036 CGTTATGGCTGTGGCTTCATCCTACCTGGCTGATTACCTGCGCAAGAAGGGTACTTTGAGCACGACG 67 FBan0003036 FBgn0031645 CG3036 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021 CG3036 CG3036 CT10168 CDMC31040 1 4 23 DAC36-M16 2-CG3036-RA_1 CG3036 CGTTATGGCTGTGGCTTCATCCTACCTGGCTGATTACCTGCGCAAGAAGGGTACTTTGAGCACGACG 67 FBan0003036 FBgn0031645 CG3036 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021 CG3036 CG3036 CT10168 CDMC31041 1 5 23 DAC37-A04 3-CG7543-RA_5 CG7543 TAGGTTGTGGGTAGTGACAGGAGGGATTCGTGGGTTTGCCGGATTCGAAGGATTCGTGGGCTTAG 65 FBan0007543 FBgn0036164 CG7543 3 3L CG7543 CG7543 CDMC31041 1 6 23 DAC37-A04 3-CG7543-RA_5 CG7543 TAGGTTGTGGGTAGTGACAGGAGGGATTCGTGGGTTTGCCGGATTCGAAGGATTCGTGGGCTTAG 65 FBan0007543 FBgn0036164 CG7543 3 3L CG7543 CG7543 CDMC31042 1 7 23 DAC37-A16 15-CG7581-RA_1 CG7581 AAGAAGCGCCTTTGTCAGTTCCACGAATACGATACCTCCATATCCACGCTCAACTTCAGCTCCGA 65 FBan0007581 FBgn0025457 Bub3 3 3R RNA localization; GO:0006403; chromosome segregation; GO:0007059; mitotic checkpoint; GO:0007093; mitotic spindle checkpoint; GO:0007094 mRNA binding; GO:0003729; ; GO:0003729 kinetochore; GO:0000776; nucleoplasm; GO:0005654 Bub3 Bub3 "CG7581, dBUB3, bub3, Dmbub3" CDMC31042 1 8 23 DAC37-A16 15-CG7581-RA_1 CG7581 AAGAAGCGCCTTTGTCAGTTCCACGAATACGATACCTCCATATCCACGCTCAACTTCAGCTCCGA 65 FBan0007581 FBgn0025457 Bub3 3 3R RNA localization; GO:0006403; chromosome segregation; GO:0007059; mitotic checkpoint; GO:0007093; mitotic spindle checkpoint; GO:0007094 mRNA binding; GO:0003729; ; GO:0003729 kinetochore; GO:0000776; nucleoplasm; GO:0005654 Bub3 Bub3 "CG7581, dBUB3, bub3, Dmbub3" CDMC31043 1 9 23 DAC37-E04 3-CG7698-RA_5 CG7698 ACACGGACTACCAGCAGACCAGTGAATTCATCCGCCTACTAAAGCCAACGCATGTCGTGCTCGTC 65 FBan0007698 FBgn0038636 CG7698 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG7698 CG7698 CDMC31043 1 10 23 DAC37-E04 3-CG7698-RA_5 CG7698 ACACGGACTACCAGCAGACCAGTGAATTCATCCGCCTACTAAAGCCAACGCATGTCGTGCTCGTC 65 FBan0007698 FBgn0038636 CG7698 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG7698 CG7698 CDMC31044 1 11 23 DAC37-E16 6-CG7727-RA_2 CG7727 ATACACGAGCCACACAAAGCAAAGGTCGAAGGTCAGCCAGCTAGGGAAGAATGACGACGCTTGGC 65 FBan0007727 FBgn0000108 Appl X X apoptotic program; GO:0008632; cell surface receptor linked signal transduction; GO:0007166; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nerve-nerve synaptic transmission; GO:0007270; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422 receptor activity; GO:0004872; protein binding; GO:0005515; ; GO:0004872; ; GO:0005515 extracellular region; GO:0005576; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Appl beta amyloid protein precursor-like "CG7727, CG7727, CG7727, beta-amyloid-protein-precursor-like, APPL, appl, EG:65F1.5, Abeta, APP, BcDNA:GH04413" CDMC31044 1 12 23 DAC37-E16 6-CG7727-RA_2 CG7727 ATACACGAGCCACACAAAGCAAAGGTCGAAGGTCAGCCAGCTAGGGAAGAATGACGACGCTTGGC 65 FBan0007727 FBgn0000108 Appl X X apoptotic program; GO:0008632; cell surface receptor linked signal transduction; GO:0007166; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; nerve-nerve synaptic transmission; GO:0007270; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422 receptor activity; GO:0004872; protein binding; GO:0005515; ; GO:0004872; ; GO:0005515 extracellular region; GO:0005576; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Appl beta amyloid protein precursor-like "CG7727, CG7727, CG7727, beta-amyloid-protein-precursor-like, APPL, appl, EG:65F1.5, Abeta, APP, BcDNA:GH04413" CDMC31045 1 13 23 DAC37-I04 15-CG7893-RA_1 CG7893 CTGCCAAAGCACAGACCACAAAATGGAGATCTACACGTTTGACGCCCCGACAACGTGCCGTCACT 65 FBan0007893 FBgn0040068 vav X X Rho protein signal transduction; GO:0007266; actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0019992; ; GO:0005085; ; GO:0005100; ; GO:0005085 cellular component unknown; GO:0008372 vav vav "CG7893, DroVav, Vav, BcDNA:GH01128" CDMC31045 1 14 23 DAC37-I04 15-CG7893-RA_1 CG7893 CTGCCAAAGCACAGACCACAAAATGGAGATCTACACGTTTGACGCCCCGACAACGTGCCGTCACT 65 FBan0007893 FBgn0040068 vav X X Rho protein signal transduction; GO:0007266; actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 diacylglycerol binding; GO:0019992; Rho GTPase activator activity; GO:0005100; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0019992; ; GO:0005085; ; GO:0005100; ; GO:0005085 cellular component unknown; GO:0008372 vav vav "CG7893, DroVav, Vav, BcDNA:GH01128" CDMC31046 1 15 23 DAC37-I16 3-CG7924-RA_1 CG7924 AATGAACACCTTCAACTGCAAACACCGCGATTTGTCGTTCCGTGCAGTGGATGAGGATGTGTGCC 65 FBan0007924 FBgn0036416 CG7924 3 3L CG7924 CG7924 CDMC31046 1 16 23 DAC37-I16 3-CG7924-RA_1 CG7924 AATGAACACCTTCAACTGCAAACACCGCGATTTGTCGTTCCGTGCAGTGGATGAGGATGTGTGCC 65 FBan0007924 FBgn0036416 CG7924 3 3L CG7924 CG7924 CDMC31047 1 17 23 DAC37-M04 1-CG8005-RA_3 CG8005 TATATCGTGGGGCAAGATCAGGAAGGATGCCACCCCTGTTAAGGTGTATGCCGAGGCTAGCTTGG 65 FBan0008005 FBgn0035854 CG8005 3 3L "hypusine biosynthesis from peptidyl-lysine; GO:0008612; spermidine catabolism to deoxyhypusine, using deoxyhypusine synthase; GO:0050983" CG8005 CG8005 CDMC31047 1 18 23 DAC37-M04 1-CG8005-RA_3 CG8005 TATATCGTGGGGCAAGATCAGGAAGGATGCCACCCCTGTTAAGGTGTATGCCGAGGCTAGCTTGG 65 FBan0008005 FBgn0035854 CG8005 3 3L "hypusine biosynthesis from peptidyl-lysine; GO:0008612; spermidine catabolism to deoxyhypusine, using deoxyhypusine synthase; GO:0050983" CG8005 CG8005 CDMC31048 1 19 23 DAC37-M16 23-CG8023-RA_1 CG8023 CGCGCACCAATGCTTTTCGAGATAGATATCGGTTGTACCATGAATAAAGTATTGCGTAGAGCAGT 65 FBan0008023 FBgn0035860 CG8023 3 3L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8023 CG8023 anon-WO0140519.227 CDMC31048 1 20 23 DAC37-M16 23-CG8023-RA_1 CG8023 CGCGCACCAATGCTTTTCGAGATAGATATCGGTTGTACCATGAATAAAGTATTGCGTAGAGCAGT 65 FBan0008023 FBgn0035860 CG8023 3 3L protein biosynthesis; GO:0006412; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8023 CG8023 anon-WO0140519.227 CDMC31049 1 21 23 DAC38-A04 24-CG4139-RB_2 CG4139 GTGGGTTTATCGCTCGTTCTTGTATTATTAGTCTAATCAATCAACTAAGAGAAAATATTATACGAAAAC 69 FBan0004139 FBgn0030334 Karl X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Karl Karl "CG4139, CG4139" CDMC31049 1 22 23 DAC38-A04 24-CG4139-RB_2 CG4139 GTGGGTTTATCGCTCGTTCTTGTATTATTAGTCTAATCAATCAACTAAGAGAAAATATTATACGAAAAC 69 FBan0004139 FBgn0030334 Karl X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Karl Karl "CG4139, CG4139" CDMC31050 1 23 23 DAC38-A16 23-CG4153-RA_1 CG4153 TGCAATTGCAGTTTTTTTAGTTAAAACAAAATTAGTTTCCAGTCAACTAGTATTCAAACAGCCCAGACA 69 FBan0004153 FBgn0004926 eIF-2beta 3 3L formation of translation initiation ternary complex; GO:0001677; regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; ; GO:0005525; tRNA binding; GO:0000049; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000049 cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850 eIF-2beta Eukaryotic initiation factor 2beta "CG4153, CG4153, eIF-2, elF2beta, IF2B, D-eIF2beta, eIF2beta, eIF-2beta, Eif2beta" CDMC31050 1 24 23 DAC38-A16 23-CG4153-RA_1 CG4153 TGCAATTGCAGTTTTTTTAGTTAAAACAAAATTAGTTTCCAGTCAACTAGTATTCAAACAGCCCAGACA 69 FBan0004153 FBgn0004926 eIF-2beta 3 3L formation of translation initiation ternary complex; GO:0001677; regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; ; GO:0005525; tRNA binding; GO:0000049; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000049 cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850 eIF-2beta Eukaryotic initiation factor 2beta "CG4153, CG4153, eIF-2, elF2beta, IF2B, D-eIF2beta, eIF2beta, eIF-2beta, Eif2beta" CDMC31051 1 25 23 DAC38-E04 23-CG4195-RA_8 CG4195 ATTGACAATGCGTAAATATCGTAATTAGGAGAGTCGCTAGTGTTAGTCCCCTCGAAACCATGAGTGTAT 69 FBan0004195 FBgn0002283 l(3)73Ah 3 3L "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 l(3)73Ah lethal (3) 73Ah "CG4195, l(3)02540, lethal(3)73Ah, l(3)133.18" CDMC31051 1 26 23 DAC38-E04 23-CG4195-RA_8 CG4195 ATTGACAATGCGTAAATATCGTAATTAGGAGAGTCGCTAGTGTTAGTCCCCTCGAAACCATGAGTGTAT 69 FBan0004195 FBgn0002283 l(3)73Ah 3 3L "development; GO:0007275; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 l(3)73Ah lethal (3) 73Ah "CG4195, l(3)02540, lethal(3)73Ah, l(3)133.18" CDMC31052 1 1 24 DAC38-E16 9-CG4203-RA_5 CG4203 TGGTTTTGCTATCGCACGTCTTTCTCAGCATCGGAAACTCAAAGGAAAGCATGAACATGGTGACGCCGG 69 FBan0004203 FBgn0038300 CG4203 3 3R CG4203 CG4203 CDMC31052 1 2 24 DAC38-E16 9-CG4203-RA_5 CG4203 TGGTTTTGCTATCGCACGTCTTTCTCAGCATCGGAAACTCAAAGGAAAGCATGAACATGGTGACGCCGG 69 FBan0004203 FBgn0038300 CG4203 3 3R CG4203 CG4203 CDMC31053 1 3 24 DAC38-I04 6-CG4229-RA_1 CG4229 GCAAACTTGAAAAATGAAAATCTTCTCGCTTGGTGGTGTCCTTACCCTCTCCGCTGTGGCCAGTGTGGC 69 FBan0004229 FBgn0036639 CG4229 3 3L CG4229 CG4229 CDMC31053 1 4 24 DAC38-I04 6-CG4229-RA_1 CG4229 GCAAACTTGAAAAATGAAAATCTTCTCGCTTGGTGGTGTCCTTACCCTCTCCGCTGTGGCCAGTGTGGC 69 FBan0004229 FBgn0036639 CG4229 3 3L CG4229 CG4229 CDMC31054 1 5 24 DAC38-I16 10-CG4241-RA_1 CG4241 GCCACTCGTCACCCATAAACACCACACCAAAAACGCACTGCTTTGATCTTAAGTCTCGCGATCGATGGA 69 FBgn0038801 CDMC31054 1 6 24 DAC38-I16 10-CG4241-RA_1 CG4241 GCCACTCGTCACCCATAAACACCACACCAAAAACGCACTGCTTTGATCTTAAGTCTCGCGATCGATGGA 69 FBgn0038801 CDMC31055 1 7 24 DAC38-M04 15-CG4272-RA_2 CG4272 GGATTGGATTAGCAGTGGCAGTAATCAAAATACACATCGTAGGCGTCGCTCATCGACTTCAGGAGGCCT 69 FBan0004272 FBgn0028485 CG4272 2 2L CG4272 CG4272 BcDNA:GH09817 CDMC31055 1 8 24 DAC38-M04 15-CG4272-RA_2 CG4272 GGATTGGATTAGCAGTGGCAGTAATCAAAATACACATCGTAGGCGTCGCTCATCGACTTCAGGAGGCCT 69 FBan0004272 FBgn0028485 CG4272 2 2L CG4272 CG4272 BcDNA:GH09817 CDMC31056 1 9 24 DAC38-M16 11-CG4299-RA_1 CG4299 AGCGCAACTCCGAATACAAAACCTTCTTCGATTGGTTCTCGGATAACACCGATCCCGTCAACGACGAGA 69 FBan0004299 FBgn0014879 Set 3 3R DNA replication; GO:0006260; nucleosome assembly; GO:0006334; spermatogenesis; GO:0007283 cyclin binding; GO:0030332; phosphatase inhibitor activity; GO:0019212; ; GO:0030332; ; GO:0019212 nucleus; GO:0005634 Set Set "CG4299, CG4299, SET" CDMC31056 1 10 24 DAC38-M16 11-CG4299-RA_1 CG4299 AGCGCAACTCCGAATACAAAACCTTCTTCGATTGGTTCTCGGATAACACCGATCCCGTCAACGACGAGA 69 FBan0004299 FBgn0014879 Set 3 3R DNA replication; GO:0006260; nucleosome assembly; GO:0006334; spermatogenesis; GO:0007283 cyclin binding; GO:0030332; phosphatase inhibitor activity; GO:0019212; ; GO:0030332; ; GO:0019212 nucleus; GO:0005634 Set Set "CG4299, CG4299, SET" CDMC31057 1 11 24 DAC39-A04 15-CG6914-RA_1 CG6914 AGCTGGAAAGGCGCAAATCGAGGTCCAACGGGTTTGTTACAGGCCACAACAATAAATTTGCATGCTTAA 69 FBan0006914 FBgn0037172 CG6914 3 3L ATP synthesis coupled electron transport; GO:0042773 NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6914 CG6914 BcDNA:AT13913 CDMC31057 1 12 24 DAC39-A04 15-CG6914-RA_1 CG6914 AGCTGGAAAGGCGCAAATCGAGGTCCAACGGGTTTGTTACAGGCCACAACAATAAATTTGCATGCTTAA 69 FBan0006914 FBgn0037172 CG6914 3 3L ATP synthesis coupled electron transport; GO:0042773 NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6914 CG6914 BcDNA:AT13913 CDMC31058 1 13 24 DAC39-A16 2-CG6927-RA_1 CG6927 GCTTCACCGTTCACCTGACGCGAGTGGTTGGCTTTTACCTGATGGACTACTTTCTACCCTCCATGCTGA 69 FBan0006927 FBgn0029733 CG6927 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG6927 CG6927 CDMC31058 1 14 24 DAC39-A16 2-CG6927-RA_1 CG6927 GCTTCACCGTTCACCTGACGCGAGTGGTTGGCTTTTACCTGATGGACTACTTTCTACCCTCCATGCTGA 69 FBan0006927 FBgn0029733 CG6927 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0016934; ; GO:0004890 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG6927 CG6927 CDMC31059 1 15 24 DAC39-E04 23-CG6961-RA_1 CG6961 GCAAACTAGACTAGTTTAAGTGAATTCTGCCATGTCTGTCCACTTTAGAATTTTGTGTTTAGTGAGTAA 69 FBan0006961 FBgn0030959 CG6961 X X mRNA binding; GO:0003729; ; GO:0003729 CG6961 CG6961 cg6961 CDMC31059 1 16 24 DAC39-E04 23-CG6961-RA_1 CG6961 GCAAACTAGACTAGTTTAAGTGAATTCTGCCATGTCTGTCCACTTTAGAATTTTGTGTTTAGTGAGTAA 69 FBan0006961 FBgn0030959 CG6961 X X mRNA binding; GO:0003729; ; GO:0003729 CG6961 CG6961 cg6961 CDMC31060 1 17 24 DAC39-E16 11-CG6974-RA_1 CG6974 TCGCGATGAGTACGTGCAAATCGACTACGACAATATCCCGAGGAAATACTGGTCGCAGTTCATGGCCAT 69 FBan0006974 FBgn0038285 CG6974 3 3R proteolysis; GO:0006508 meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0004238 ; EC:3.4.24.18; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 meprin A complex; GO:0017090 CG6974 CG6974 CDMC31060 1 18 24 DAC39-E16 11-CG6974-RA_1 CG6974 TCGCGATGAGTACGTGCAAATCGACTACGACAATATCCCGAGGAAATACTGGTCGCAGTTCATGGCCAT 69 FBan0006974 FBgn0038285 CG6974 3 3R proteolysis; GO:0006508 meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0004238 ; EC:3.4.24.18; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 meprin A complex; GO:0017090 CG6974 CG6974 CDMC31061 1 19 24 DAC39-I04 8-CG7000-RA_1 CG7000 AGCCCTTGCCTTCAGCAAATCCAAAGCAATCTTCTACTGTGCACCCTGTTCAGTTGCCCAATACTCTGA 69 FBan0007000 FBgn0038867 CG7000 3 3R apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; sensory perception; GO:0007600; transmission of nerve impulse; GO:0019226 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7000 CG7000 CDMC31061 1 20 24 DAC39-I04 8-CG7000-RA_1 CG7000 AGCCCTTGCCTTCAGCAAATCCAAAGCAATCTTCTACTGTGCACCCTGTTCAGTTGCCCAATACTCTGA 69 FBan0007000 FBgn0038867 CG7000 3 3R apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; sensory perception; GO:0007600; transmission of nerve impulse; GO:0019226 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7000 CG7000 CDMC31062 1 21 24 DAC39-I16 2-CG7010-RB_1 CG7010 GGAACGGATCCGAAGAGACCCACAAAAAGCTTAGCTAATCGGAGCACTCCAACCACACATCGTAGCGCA 69 FBgn0029721 CDMC31062 1 22 24 DAC39-I16 2-CG7010-RB_1 CG7010 GGAACGGATCCGAAGAGACCCACAAAAAGCTTAGCTAATCGGAGCACTCCAACCACACATCGTAGCGCA 69 FBgn0029721 CDMC31063 1 23 24 DAC39-M04 20-CG7039-RA_3 CG7039 TACACATTGATGCACGGCTTCTACAAATACATGACTCAGAAGGACGACTACTGCGTGGTAATCCTGGGC 69 FBan0007039 FBgn0030088 CG7039 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7039 CG7039 CDMC31063 1 24 24 DAC39-M04 20-CG7039-RA_3 CG7039 TACACATTGATGCACGGCTTCTACAAATACATGACTCAGAAGGACGACTACTGCGTGGTAATCCTGGGC 69 FBan0007039 FBgn0030088 CG7039 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7039 CG7039 CDMC31064 1 25 24 DAC39-M16 17-CG7047-RA_1 CG7047 TGCCACCTGATCAAAATATCCTACGACGTCTTCTTCGTGATCGAACCCAAGTCCATGGAGAAGGAGATT 69 FBan0007047 FBgn0035103 CG7047 3 3L CG7047 CG7047 CDMC31064 1 26 24 DAC39-M16 17-CG7047-RA_1 CG7047 TGCCACCTGATCAAAATATCCTACGACGTCTTCTTCGTGATCGAACCCAAGTCCATGGAGAAGGAGATT 69 FBan0007047 FBgn0035103 CG7047 3 3L CG7047 CG7047 CDMC31065 1 1 25 DAC40-A04 2-CG3327-RB_1 CG3327 GATCCGGTACACCTCCATGATCCACTACGCCTACCAGAACATGCAGATTCTCGAGTTCCGCGAGG 65 FBan0003327 FBgn0020445 E23 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; ; GO:0005215; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 E23 Early gene at 23 "CG3327, CG15410, CG3327, CG15410, Early gene at 23" CDMC31065 1 2 25 DAC40-A04 2-CG3327-RB_1 CG3327 GATCCGGTACACCTCCATGATCCACTACGCCTACCAGAACATGCAGATTCTCGAGTTCCGCGAGG 65 FBan0003327 FBgn0020445 E23 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; ; GO:0005215; ; GO:0042626; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 E23 Early gene at 23 "CG3327, CG15410, CG3327, CG15410, Early gene at 23" CDMC31066 1 3 25 DAC40-A16 3-CG33304-RA_2 CG33304 TGGTTACGACAACTTCACCAATGCCGATCACCATGGCGTCGATGTTGTGAGCAGCAATACGCGAT 65 FBan0033304 FBgn0041723 rho-5 2 2L signal transduction; GO:0007165 integral to membrane; GO:0016021 rho-5 rhomboid-5 "CG5364, CG33304, CG5364, CT17046, Rho-related[31D10], rhomboid-5" CDMC31066 1 4 25 DAC40-A16 3-CG33304-RA_2 CG33304 TGGTTACGACAACTTCACCAATGCCGATCACCATGGCGTCGATGTTGTGAGCAGCAATACGCGAT 65 FBan0033304 FBgn0041723 rho-5 2 2L signal transduction; GO:0007165 integral to membrane; GO:0016021 rho-5 rhomboid-5 "CG5364, CG33304, CG5364, CT17046, Rho-related[31D10], rhomboid-5" CDMC31067 1 5 25 DAC40-E04 13-CG33491-RA_2 CG33491 GTCTTCGAGGAGTACAAGGAGCTCTCCGGGCAGACCATCGAGCAGGCCATCAAGCACGAGATGTC 65 FBan0033491 FBgn0053491 CG33491 X X biological process unknown; GO:0000004 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544 cellular component unknown; GO:0008372 CG33491 CG33491 CDMC31067 1 6 25 DAC40-E04 13-CG33491-RA_2 CG33491 GTCTTCGAGGAGTACAAGGAGCTCTCCGGGCAGACCATCGAGCAGGCCATCAAGCACGAGATGTC 65 FBan0033491 FBgn0053491 CG33491 X X biological process unknown; GO:0000004 calcium-dependent phospholipid binding; GO:0005544; ; GO:0005544 cellular component unknown; GO:0008372 CG33491 CG33491 CDMC31068 1 7 25 DAC40-E16 1-CG3389-RA_1 CG3389 TTCCGAGGGATTGGAGAACGTACGCAAAGCTCCCTTCCTTCTCGATCAGGAAACCGGAGAAGTGC 65 FBan0003389 FBgn0038247 Cad88C 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad88C Cad88C "CG3389, CG3389, CT11389, DCad88C" CDMC31068 1 8 25 DAC40-E16 1-CG3389-RA_1 CG3389 TTCCGAGGGATTGGAGAACGTACGCAAAGCTCCCTTCCTTCTCGATCAGGAAACCGGAGAAGTGC 65 FBan0003389 FBgn0038247 Cad88C 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad88C Cad88C "CG3389, CG3389, CT11389, DCad88C" CDMC31069 1 9 25 DAC40-I04 18-CG3529-RB_1 CG3529 CCACAACTACCGCCGTGAGCAATACGCCGCAAAGTGACCAACTGCTGATCGATCTAATCGAAAGC 65 FBan0003529 FBgn0035995 CG3529 3 3L intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; signal transduction; GO:0007165 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795 CG3529 CG3529 CDMC31069 1 10 25 DAC40-I04 18-CG3529-RB_1 CG3529 CCACAACTACCGCCGTGAGCAATACGCCGCAAAGTGACCAACTGCTGATCGATCTAATCGAAAGC 65 FBan0003529 FBgn0035995 CG3529 3 3L intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; signal transduction; GO:0007165 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215; protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795 CG3529 CG3529 CDMC31070 1 11 25 DAC40-I16 11-CG3578-RA_1 CG3578 CGCCTTCGGAACTTAAGAGCATGGAGAAGATGGTCAACGGACTGGAGGTTCAACACAATGGCAGT 65 FBan0003578 FBgn0000179 bi X X compound eye morphogenesis (sensu Endopterygota); GO:0001745; mesoderm development; GO:0007498; pigmentation during development; GO:0048066; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100; wing disc morphogenesis; GO:0007472 transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0030528; ; GO:0003702 nucleus; GO:0005634 bi bifid "CG3578, omb: optomotor blind, Qd: Quadroon, T3, l(1)omb, l(1)bi, optomotor-blind, optomotor blind, BI, Dm-omb, dm-omb, optomotor-blind gene, OMB, Optomotor blind, optomoter blind, Dm-OMB, Omb, Optomotor-blind, optomotorblind, Quadroon, omb, Qd" CDMC31070 1 12 25 DAC40-I16 11-CG3578-RA_1 CG3578 CGCCTTCGGAACTTAAGAGCATGGAGAAGATGGTCAACGGACTGGAGGTTCAACACAATGGCAGT 65 FBan0003578 FBgn0000179 bi X X compound eye morphogenesis (sensu Endopterygota); GO:0001745; mesoderm development; GO:0007498; pigmentation during development; GO:0048066; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100; wing disc morphogenesis; GO:0007472 transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0030528; ; GO:0003702 nucleus; GO:0005634 bi bifid "CG3578, omb: optomotor blind, Qd: Quadroon, T3, l(1)omb, l(1)bi, optomotor-blind, optomotor blind, BI, Dm-omb, dm-omb, optomotor-blind gene, OMB, Optomotor blind, optomoter blind, Dm-OMB, Omb, Optomotor-blind, optomotorblind, Quadroon, omb, Qd" CDMC31071 1 13 25 DAC40-M04 12-CG3658-RA_7 CG3658 CCGCCGCTTTGATGGTTTTTGAGTTGGCCTGGAAGCTCTCAAAAGACAACATGGACCTGCTCTGG 65 FBan0003658 FBgn0026143 CDC45L X X DNA amplification; GO:0006277; DNA replication; GO:0006260; DNA replication initiation; GO:0006270; chromosome condensation; GO:0030261; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688 cytoplasm; GO:0005737; nucleus; GO:0005634; pre-replicative complex; GO:0005656 CDC45L CDC45L "CG3658, CG3658, CG3658, CG3658, CG3658, D, Transcription unit D, DmCdc45, EG:BACR7A4.11, Cdc45, anon-1Ec" CDMC31071 1 14 25 DAC40-M04 12-CG3658-RA_7 CG3658 CCGCCGCTTTGATGGTTTTTGAGTTGGCCTGGAAGCTCTCAAAAGACAACATGGACCTGCTCTGG 65 FBan0003658 FBgn0026143 CDC45L X X DNA amplification; GO:0006277; DNA replication; GO:0006260; DNA replication initiation; GO:0006270; chromosome condensation; GO:0030261; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003682; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688 cytoplasm; GO:0005737; nucleus; GO:0005634; pre-replicative complex; GO:0005656 CDC45L CDC45L "CG3658, CG3658, CG3658, CG3658, CG3658, D, Transcription unit D, DmCdc45, EG:BACR7A4.11, Cdc45, anon-1Ec" CDMC31072 1 15 25 DAC40-M16 3-CG3700-RA_1 CG3700 GATCGGAGCCGAAGTCAAGTACTGCGACGAGTTCAACGACATTGTCTGCTGTCCCATACCGCTGG 65 FBan0003700 FBgn0034796 CG3700 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG3700 CG3700 "c-SP48, SP48" CDMC31072 1 16 25 DAC40-M16 3-CG3700-RA_1 CG3700 GATCGGAGCCGAAGTCAAGTACTGCGACGAGTTCAACGACATTGTCTGCTGTCCCATACCGCTGG 65 FBan0003700 FBgn0034796 CG3700 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG3700 CG3700 "c-SP48, SP48" CDMC31073 1 17 25 DAC41-A04 AutoBlank AutoBlank CDMC31073 1 18 25 DAC41-A04 AutoBlank AutoBlank CDMC31074 1 19 25 DAC41-A16 AutoBlank AutoBlank CDMC31074 1 20 25 DAC41-A16 AutoBlank AutoBlank CDMC31075 1 21 25 DAC41-E04 AutoBlank AutoBlank CDMC31075 1 22 25 DAC41-E04 AutoBlank AutoBlank CDMC31076 1 23 25 DAC41-E16 AutoBlank AutoBlank CDMC31076 1 24 25 DAC41-E16 AutoBlank AutoBlank CDMC31077 1 25 25 DAC41-I04 AutoBlank AutoBlank CDMC31077 1 26 25 DAC41-I04 AutoBlank AutoBlank CDMC31078 1 1 26 DAC41-I16 AutoBlank AutoBlank CDMC31078 1 2 26 DAC41-I16 AutoBlank AutoBlank CDMC31079 1 3 26 DAC41-M04 AutoBlank AutoBlank CDMC31079 1 4 26 DAC41-M04 AutoBlank AutoBlank CDMC31080 1 5 26 DAC41-M16 AutoBlank AutoBlank CDMC31080 1 6 26 DAC41-M16 AutoBlank AutoBlank CDMC31081 1 7 26 DAC42-A04 150mM NaPO4 Blank CDMC31081 1 8 26 DAC42-A04 150mM NaPO4 Blank CDMC31082 1 9 26 DAC42-A16 150mM NaPO4 Blank CDMC31082 1 10 26 DAC42-A16 150mM NaPO4 Blank CDMC31083 1 11 26 DAC42-E04 150mM NaPO4 Blank CDMC31083 1 12 26 DAC42-E04 150mM NaPO4 Blank CDMC31084 1 13 26 DAC42-E16 150mM NaPO4 Blank CDMC31084 1 14 26 DAC42-E16 150mM NaPO4 Blank CDMC31085 1 15 26 DAC42-I04 150mM NaPO4 Blank CDMC31085 1 16 26 DAC42-I04 150mM NaPO4 Blank CDMC31086 1 17 26 DAC42-I16 5uM MSP 5uM MSP CDMC31086 1 18 26 DAC42-I16 5uM MSP 5uM MSP CDMC31087 1 19 26 DAC42-M04 10uM MSP 10uM MSP CDMC31087 1 20 26 DAC42-M04 10uM MSP 10uM MSP CDMC31088 1 21 26 DAC42-M16 20uM MSP 20uM MSP CDMC31088 1 22 26 DAC42-M16 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC31089 2 1 1 DAC01-B04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31089 2 2 1 DAC01-B04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31090 2 3 1 DAC01-B16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31090 2 4 1 DAC01-B16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31091 2 5 1 DAC01-F04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31091 2 6 1 DAC01-F04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31092 2 7 1 DAC01-F16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31092 2 8 1 DAC01-F16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31093 2 9 1 DAC01-J04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31093 2 10 1 DAC01-J04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31094 2 11 1 DAC01-J16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31094 2 12 1 DAC01-J16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31095 2 13 1 DAC01-N04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31095 2 14 1 DAC01-N04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31096 2 15 1 DAC01-N16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31096 2 16 1 DAC01-N16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31097 2 17 1 DAC02-B04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31097 2 18 1 DAC02-B04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31098 2 19 1 DAC02-B16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31098 2 20 1 DAC02-B16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31099 2 21 1 DAC02-F04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31099 2 22 1 DAC02-F04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31100 2 23 1 DAC02-F16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31100 2 24 1 DAC02-F16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31101 2 25 1 DAC02-J04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31101 2 26 1 DAC02-J04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31102 2 1 2 DAC02-J16 N/A CG9075 (00001-00239) CDMC31102 2 2 2 DAC02-J16 N/A CG9075 (00001-00239) CDMC31103 2 3 2 DAC02-N04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31103 2 4 2 DAC02-N04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31104 2 5 2 DAC02-N16 AutoBlank AutoBlank CDMC31104 2 6 2 DAC02-N16 AutoBlank AutoBlank CDMC31105 2 7 2 DAC03-B04 2-CG5429-RA_2 CG5429 TCGCTGAGGACGAGTGGGATGTGTACAAGGCTTATTTGGATGAACTAGAGCAACAGCGTGTAGCACCCA 69 FBgn0039144 CDMC31105 2 8 2 DAC03-B04 2-CG5429-RA_2 CG5429 TCGCTGAGGACGAGTGGGATGTGTACAAGGCTTATTTGGATGAACTAGAGCAACAGCGTGTAGCACCCA 69 FBgn0039144 CDMC31106 2 9 2 DAC03-B16 13-CG5439-RA_1 CG5439 GCGGAGCTTAGTCTTCAAAATCGCCTGCTTATCCGAAGGCTAACCAAACAGTTTGAAGAGACCGGCATC 69 FBan0005439 FBgn0032476 CG5439 2 2L intracellular signaling cascade; GO:0007242 CG5439 CG5439 CDMC31106 2 10 2 DAC03-B16 13-CG5439-RA_1 CG5439 GCGGAGCTTAGTCTTCAAAATCGCCTGCTTATCCGAAGGCTAACCAAACAGTTTGAAGAGACCGGCATC 69 FBan0005439 FBgn0032476 CG5439 2 2L intracellular signaling cascade; GO:0007242 CG5439 CG5439 CDMC31107 2 11 2 DAC03-F04 24-CG5468-RA_1 CG5468 CCAGCGATTTTTGACTGATATTAAATCGTAGTTTTTGTTGACTAATGCTTAAATAAATTCAATTCTTAA 69 FBan0005468 FBgn0039434 CG5468 3 3R CG5468 CG5468 CDMC31107 2 12 2 DAC03-F04 24-CG5468-RA_1 CG5468 CCAGCGATTTTTGACTGATATTAAATCGTAGTTTTTGTTGACTAATGCTTAAATAAATTCAATTCTTAA 69 FBan0005468 FBgn0039434 CG5468 3 3R CG5468 CG5468 CDMC31108 2 13 2 DAC03-F16 23-CG5473-RA_1 CG5473 TGGGACGAGCCTTAGAAATGGATCTGAACTGGGAACGTAAAAGCGATATATAACGATAAATAATTATTA 69 FBan0005473 FBgn0034371 SP2637 2 2R asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1; protein N-terminal asparagine amidohydrolase activity; GO:0008418 ; EC:3.5.1.-; ; GO:0008418 ; EC:3.5.1.- SP2637 SP2637 "CG5473, dm-ntan1, BEST:GH24992" CDMC31108 2 14 2 DAC03-F16 23-CG5473-RA_1 CG5473 TGGGACGAGCCTTAGAAATGGATCTGAACTGGGAACGTAAAAGCGATATATAACGATAAATAATTATTA 69 FBan0005473 FBgn0034371 SP2637 2 2R asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1; protein N-terminal asparagine amidohydrolase activity; GO:0008418 ; EC:3.5.1.-; ; GO:0008418 ; EC:3.5.1.- SP2637 SP2637 "CG5473, dm-ntan1, BEST:GH24992" CDMC31109 2 15 2 DAC03-J04 1-CG5495-RA_1 CG5495 TGCGCCCATCTTCGAGACGTTTCCAACAAAGTACCCAAAGGCCATCTTCCTGAAAGTGGATGTGGACAA 69 FBan0005495 FBgn0035631 Txl 3 3L electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Txl Thioredoxin-like "CG5495, txl, anon-WO0118547.248" CDMC31109 2 16 2 DAC03-J04 1-CG5495-RA_1 CG5495 TGCGCCCATCTTCGAGACGTTTCCAACAAAGTACCCAAAGGCCATCTTCCTGAAAGTGGATGTGGACAA 69 FBan0005495 FBgn0035631 Txl 3 3L electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Txl Thioredoxin-like "CG5495, txl, anon-WO0118547.248" CDMC31110 2 17 2 DAC03-J16 3-CG5504-RB_1 CG5504 AGGACCAGGAGCAGAAAAAAGCGAAGGCAAAGACCAGTGGACGGACAACGAGAAAACCAAAGCGAAAGA 69 FBan0005504 FBgn0002174 l(2)tid 2 2R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950; smoothened signaling pathway; GO:0007224 unfolded protein binding; GO:0051082; patched binding; GO:0005113; ; GO:0005113; ; GO:0051082 cytosol; GO:0005829; mitochondrion; GO:0005739 l(2)tid lethal (2) tumorous imaginal discs "CG5504, l(2)tud, l(2)td, l(2)tumorous disc, cDNA 10D, tid, DnaJ, TID56, l(2)tumorous imaginal discs, l(2)701" CDMC31110 2 18 2 DAC03-J16 3-CG5504-RB_1 CG5504 AGGACCAGGAGCAGAAAAAAGCGAAGGCAAAGACCAGTGGACGGACAACGAGAAAACCAAAGCGAAAGA 69 FBan0005504 FBgn0002174 l(2)tid 2 2R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950; smoothened signaling pathway; GO:0007224 unfolded protein binding; GO:0051082; patched binding; GO:0005113; ; GO:0005113; ; GO:0051082 cytosol; GO:0005829; mitochondrion; GO:0005739 l(2)tid lethal (2) tumorous imaginal discs "CG5504, l(2)tud, l(2)td, l(2)tumorous disc, cDNA 10D, tid, DnaJ, TID56, l(2)tumorous imaginal discs, l(2)701" CDMC31111 2 19 2 DAC03-N04 14-CG5549-RA_1 CG5549 GGCTGCCTCGGTTAAAGTGTCGCAAACGGATAAAACAGCACCACTTAAGACCACAATATCAGCCAGTGT 69 FBan0005549 FBgn0034911 CG5549 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 glycine:sodium symporter activity; GO:0015375; ; GO:0015375 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG5549 CG5549 CDMC31111 2 20 2 DAC03-N04 14-CG5549-RA_1 CG5549 GGCTGCCTCGGTTAAAGTGTCGCAAACGGATAAAACAGCACCACTTAAGACCACAATATCAGCCAGTGT 69 FBan0005549 FBgn0034911 CG5549 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 glycine:sodium symporter activity; GO:0015375; ; GO:0015375 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG5549 CG5549 CDMC31112 2 21 2 DAC03-N16 9-CG5558-RB_2 CG5558 CCAGCGAAAAGGCAGGTTATCACACCGATTACCAGTATTAGCCGGCTGAGATGGGCAAGAAGAACAGGA 69 FBan0005558 FBgn0038684 CG5558 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG5558 CG5558 CDMC31112 2 22 2 DAC03-N16 9-CG5558-RB_2 CG5558 CCAGCGAAAAGGCAGGTTATCACACCGATTACCAGTATTAGCCGGCTGAGATGGGCAAGAAGAACAGGA 69 FBan0005558 FBgn0038684 CG5558 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG5558 CG5558 CDMC31113 2 23 2 DAC04-B04 9-CG12357-RA_1 CG12357 GCCGCGGGGGTTATGGCAAACTGTTGTCACAGAAGATTGCACCCAACACGGACAATCGCTAGTTATTAG 69 FBan0012357 FBgn0022943 Cbp20 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 nucleus; GO:0005634; snRNA cap binding complex; GO:0005846; spliceosome complex; GO:0005681 Cbp20 cap binding protein 20 "CG12357, CG12357, CBP20" CDMC31113 2 24 2 DAC04-B04 9-CG12357-RA_1 CG12357 GCCGCGGGGGTTATGGCAAACTGTTGTCACAGAAGATTGCACCCAACACGGACAATCGCTAGTTATTAG 69 FBan0012357 FBgn0022943 Cbp20 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 nucleus; GO:0005634; snRNA cap binding complex; GO:0005846; spliceosome complex; GO:0005681 Cbp20 cap binding protein 20 "CG12357, CG12357, CBP20" CDMC31114 2 25 2 DAC04-B16 1-CG12369-RA_1 CG12369 CCAGCCCAGCCGTAAACGATGCATTTCACCTTGATCCCGTCCGTTTTGCTTTCTGATCTGGCACTGTAT 69 FBan0012369 FBgn0010238 Lac 2 2R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; homophilic cell adhesion; GO:0007156; maintenance of tracheal epithelial integrity; GO:0035160; regulation of tracheal tube size; GO:0035151; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424 extrinsic to membrane; GO:0019898; septate junction; GO:0005918 Lac Lachesin "CG12369, l(2)k11012, lachesin, l(2)k11012b, CT24921, bulb, lac, lachesin bulbous, bulbous" CDMC31114 2 26 2 DAC04-B16 1-CG12369-RA_1 CG12369 CCAGCCCAGCCGTAAACGATGCATTTCACCTTGATCCCGTCCGTTTTGCTTTCTGATCTGGCACTGTAT 69 FBan0012369 FBgn0010238 Lac 2 2R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; homophilic cell adhesion; GO:0007156; maintenance of tracheal epithelial integrity; GO:0035160; regulation of tracheal tube size; GO:0035151; signal transduction; GO:0007165; tracheal system development (sensu Insecta); GO:0007424 extrinsic to membrane; GO:0019898; septate junction; GO:0005918 Lac Lachesin "CG12369, l(2)k11012, lachesin, l(2)k11012b, CT24921, bulb, lac, lachesin bulbous, bulbous" CDMC31115 2 1 3 DAC04-F04 23-CG12400-RA_1 CG12400 TGCGCTAAGTGGATCTAAATCTTTGTTGTCAAACGAACGATGGAAGTAGTTAATAAAACAGCTTTAATT 69 FBan0012400 FBgn0031505 CG12400 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12400 CG12400 BcDNA:RE29623 CDMC31115 2 2 3 DAC04-F04 23-CG12400-RA_1 CG12400 TGCGCTAAGTGGATCTAAATCTTTGTTGTCAAACGAACGATGGAAGTAGTTAATAAAACAGCTTTAATT 69 FBan0012400 FBgn0031505 CG12400 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12400 CG12400 BcDNA:RE29623 CDMC31116 2 3 3 DAC04-F16 16-CG12414-RA_1 CG12414 GGCACCCTGGGTTAAGCGCGTCTTTATTGACTTTTTGCCAGCGTTTTTATTCATTAAAAGGCCGACGTA 69 FBan0012414 FBgn0037212 nAcRalpha-80B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-80B nicotinic Acetylcholine Receptor alpha 80B "CG12414, CG17552, CG12414, CG17552, Dalpha4, Dalpha4, nAChR, nAcRaplha-80B, nAcRalpha-80, anon-WO0138359.1, nicotinic Acetylcholine Receptor alpha 80B" CDMC31116 2 4 3 DAC04-F16 16-CG12414-RA_1 CG12414 GGCACCCTGGGTTAAGCGCGTCTTTATTGACTTTTTGCCAGCGTTTTTATTCATTAAAAGGCCGACGTA 69 FBan0012414 FBgn0037212 nAcRalpha-80B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-80B nicotinic Acetylcholine Receptor alpha 80B "CG12414, CG17552, CG12414, CG17552, Dalpha4, Dalpha4, nAChR, nAcRaplha-80B, nAcRalpha-80, anon-WO0138359.1, nicotinic Acetylcholine Receptor alpha 80B" CDMC31117 2 5 3 DAC04-J04 15-CG12449-RB_1 CG12449 CCGAGACGTTCTGCAGCTGGACTCCAAAGTTAAAGAACTGGCCAAAGACCTATACCAACACAAGTCGCT 69 CDMC31117 2 6 3 DAC04-J04 15-CG12449-RB_1 CG12449 CCGAGACGTTCTGCAGCTGGACTCCAAAGTTAAAGAACTGGCCAAAGACCTATACCAACACAAGTCGCT 69 CDMC31118 2 7 3 DAC04-J16 12-CG12467-RA_3 CG12467 TGCGGGAAAAGGGATCAGGCAAGTTCGAGAACTCTCGGGTGATTCAACTTAGCTACAAGAACCGTCTGT 69 FBan0012467 FBgn0025623 CG12467 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cytoskeleton; GO:0005856 CG12467 CG12467 "EG:34F3.1, EG:34F3.2" CDMC31118 2 8 3 DAC04-J16 12-CG12467-RA_3 CG12467 TGCGGGAAAAGGGATCAGGCAAGTTCGAGAACTCTCGGGTGATTCAACTTAGCTACAAGAACCGTCTGT 69 FBan0012467 FBgn0025623 CG12467 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cytoskeleton; GO:0005856 CG12467 CG12467 "EG:34F3.1, EG:34F3.2" CDMC31119 2 9 3 DAC04-N04 17-CG12516-RA_1 CG12516 AGCGGGCATTCGAGCTAAGGAAGTATAGTGCTTGTATACATCGTGGTTATCACTATGAAACCCTGCCCA 69 FBan0012516 FBgn0039577 CG12516 3 3R CG12516 CG12516 CDMC31119 2 10 3 DAC04-N04 17-CG12516-RA_1 CG12516 AGCGGGCATTCGAGCTAAGGAAGTATAGTGCTTGTATACATCGTGGTTATCACTATGAAACCCTGCCCA 69 FBan0012516 FBgn0039577 CG12516 3 3R CG12516 CG12516 CDMC31120 2 11 3 DAC04-N16 24-CG1252-RA_3 CG1252 TAGATCCTGGCTAAAATCGACGCTGTACATATATAGAATTGTTGGCTTTATTATAACTGTTCATTTATT 69 FBan0001252 FBgn0004782 Ccp84Ab 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ab Ccp84Ab "CG1252, BG:DS00004.2, cc7: cuticle cluster 7, cuticle cluster 7" CDMC31120 2 12 3 DAC04-N16 24-CG1252-RA_3 CG1252 TAGATCCTGGCTAAAATCGACGCTGTACATATATAGAATTGTTGGCTTTATTATAACTGTTCATTTATT 69 FBan0001252 FBgn0004782 Ccp84Ab 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ab Ccp84Ab "CG1252, BG:DS00004.2, cc7: cuticle cluster 7, cuticle cluster 7" CDMC31121 2 13 3 DAC05-B04 22-CG5034-RA_3 CG5034 TCAAAAGAGCAAAGCAATGTCTGGATCCTCACACAGCCAGTTTGATTCAAAACTGCAAAAGGACTCGGA 69 FBan0005034 FBgn0032223 GATAd 2 2L "regulation of transcription, DNA-dependent; GO:0006355" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 GATAd GATAd "CG5034, dGATAd, dGATA-D" CDMC31121 2 14 3 DAC05-B04 22-CG5034-RA_3 CG5034 TCAAAAGAGCAAAGCAATGTCTGGATCCTCACACAGCCAGTTTGATTCAAAACTGCAAAAGGACTCGGA 69 FBan0005034 FBgn0032223 GATAd 2 2L "regulation of transcription, DNA-dependent; GO:0006355" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 GATAd GATAd "CG5034, dGATAd, dGATA-D" CDMC31122 2 15 3 DAC05-B16 23-CG5045-RA_4 CG5045 TGATTTAAAGTGTGTATTCTTAGCCTTAAGAACAGCTGTTTTGCATAACATTGCGAATCCGGTTGATTT 69 FBan0005045 FBgn0032229 CG5045 2 2L ATP-dependent proteolysis; GO:0006510 endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92 mitochondrion; GO:0005739 CG5045 CG5045 CDMC31122 2 16 3 DAC05-B16 23-CG5045-RA_4 CG5045 TGATTTAAAGTGTGTATTCTTAGCCTTAAGAACAGCTGTTTTGCATAACATTGCGAATCCGGTTGATTT 69 FBan0005045 FBgn0032229 CG5045 2 2L ATP-dependent proteolysis; GO:0006510 endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92 mitochondrion; GO:0005739 CG5045 CG5045 CDMC31123 2 17 3 DAC05-F04 3-CG5076-RA_10 CG5076 CCCTCCAGCAAGATCTATACCCAACATAAGTGGAGTTGCGGGCACAAGATCAGGAGTTGCAGTCGAGCA 69 FBan0005076 FBgn0011589 elk 2 2R "potassium ion transport; GO:0006813; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; two-component signal transduction system (phosphorelay); GO:0000160" potassium channel activity; GO:0005267; voltage-gated potassium channel activity; GO:0005249; signal transducer activity; GO:0004871; ; GO:0005249; ; GO:0005267; ; GO:0004871; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- voltage-gated potassium channel complex; GO:0008076 elk eag-like K[+] channel "CG5076, eag-like K[+] channel" CDMC31123 2 18 3 DAC05-F04 3-CG5076-RA_10 CG5076 CCCTCCAGCAAGATCTATACCCAACATAAGTGGAGTTGCGGGCACAAGATCAGGAGTTGCAGTCGAGCA 69 FBan0005076 FBgn0011589 elk 2 2R "potassium ion transport; GO:0006813; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; two-component signal transduction system (phosphorelay); GO:0000160" potassium channel activity; GO:0005267; voltage-gated potassium channel activity; GO:0005249; signal transducer activity; GO:0004871; ; GO:0005249; ; GO:0005267; ; GO:0004871; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- voltage-gated potassium channel complex; GO:0008076 elk eag-like K[+] channel "CG5076, eag-like K[+] channel" CDMC31124 2 19 3 DAC05-F16 1-CG5087-RA_2 CG5087 GCCACCATTCTCGATTCGTTGCGTGGAGGTTAGTGATGACGAGGATACAGGCGACACAATCGGAAGTGT 69 FBan0005087 FBgn0035953 CG5087 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG5087 CG5087 CDMC31124 2 20 3 DAC05-F16 1-CG5087-RA_2 CG5087 GCCACCATTCTCGATTCGTTGCGTGGAGGTTAGTGATGACGAGGATACAGGCGACACAATCGGAAGTGT 69 FBan0005087 FBgn0035953 CG5087 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG5087 CG5087 CDMC31125 2 21 3 DAC05-J04 11-CG5124-RA_4 CG5124 GTCCCGAGGAAGGTATTGGTGTCAGGCTCTTGAACCTGCACGATCAGTTGGAGAACACAGAGGCCAAAT 69 FBgn0034305 CDMC31125 2 22 3 DAC05-J04 11-CG5124-RA_4 CG5124 GTCCCGAGGAAGGTATTGGTGTCAGGCTCTTGAACCTGCACGATCAGTTGGAGAACACAGAGGCCAAAT 69 FBgn0034305 CDMC31126 2 23 3 DAC05-J16 22-CG5134-RB_2 CG5134 TCGTGTTTTTTATGATGGATTTGTCGCCAAACAATCAGATCGAGGACAGAAAACCCATCCTAACCGCCG 69 FBan0005134 FBgn0034311 MED9 2 2R mediator complex; GO:0000119 MED9 Mediator complex subunit 9 "CG5134, CG30113, CG30112, BcDNA:RH42446, BcDNA:LD07740, Mediator complex subunit 9" CDMC31126 2 24 3 DAC05-J16 22-CG5134-RB_2 CG5134 TCGTGTTTTTTATGATGGATTTGTCGCCAAACAATCAGATCGAGGACAGAAAACCCATCCTAACCGCCG 69 FBan0005134 FBgn0034311 MED9 2 2R mediator complex; GO:0000119 MED9 Mediator complex subunit 9 "CG5134, CG30113, CG30112, BcDNA:RH42446, BcDNA:LD07740, Mediator complex subunit 9" CDMC31127 2 25 3 DAC05-N04 13-CG5171-RA_1 CG5171 GCCGTGTATATTCTGAAGCAGAAATTCGGGGATAATTGGTCGCAGAAAGTGAGTGTGGTCTTTGCGGGC 69 FBan0005171 FBgn0031907 CG5171 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12 CG5171 CG5171 CDMC31127 2 26 3 DAC05-N04 13-CG5171-RA_1 CG5171 GCCGTGTATATTCTGAAGCAGAAATTCGGGGATAATTGGTCGCAGAAAGTGAGTGTGGTCTTTGCGGGC 69 FBan0005171 FBgn0031907 CG5171 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12 CG5171 CG5171 CDMC31128 2 1 4 DAC05-N16 16-CG5178-RA_1 CG5178 CGAACCCATCGCACAACAATTATCATCCAACTCAGATTCACAGCAGATAATCAGAGGCAACCTCCGGTT 69 FBan0005178 FBgn0000047 Act88F 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 Act88F Actin 88F "CG5178, CG5178, rsd, act88F, Ifm(3)7, actin, Actin, Arthrin, Act88-F, act 88F, Act(88F), 88F actin, arthrin, E" CDMC31128 2 2 4 DAC05-N16 16-CG5178-RA_1 CG5178 CGAACCCATCGCACAACAATTATCATCCAACTCAGATTCACAGCAGATAATCAGAGGCAACCTCCGGTT 69 FBan0005178 FBgn0000047 Act88F 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin filament; GO:0005884 Act88F Actin 88F "CG5178, CG5178, rsd, act88F, Ifm(3)7, actin, Actin, Arthrin, Act88-F, act 88F, Act(88F), 88F actin, arthrin, E" CDMC31129 2 3 4 DAC06-B04 9-CG9364-RE_2 CG9364 AGAATCTGTAGCCAGGCCAGAACGCAATCCATCAGACATCATTGTCAGCATCATCACAGGCTCGAAGCC 69 FBan0009364 FBgn0003748 Treh 2 2R trehalose metabolism; GO:0005991 "alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004555 ; EC:3.2.1.28" anchored to plasma membrane; GO:0046658 Treh Trehalase "CG9364, TRE, TREH, Tre, 87D3T, trehalase, ESTS:87D3T, anon-EST:Posey159, anon-sts38" CDMC31129 2 4 4 DAC06-B04 9-CG9364-RE_2 CG9364 AGAATCTGTAGCCAGGCCAGAACGCAATCCATCAGACATCATTGTCAGCATCATCACAGGCTCGAAGCC 69 FBan0009364 FBgn0003748 Treh 2 2R trehalose metabolism; GO:0005991 "alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004555 ; EC:3.2.1.28" anchored to plasma membrane; GO:0046658 Treh Trehalase "CG9364, TRE, TREH, Tre, 87D3T, trehalase, ESTS:87D3T, anon-EST:Posey159, anon-sts38" CDMC31130 2 5 4 DAC06-B16 14-CG9380-RA_2 CG9380 TCTGGGAGGACGATCATTAGTTGCACTTTTAATACCCAGTCCGCTGTCCTACGTGGATGAGGAGGACTA 69 FBan0009380 FBgn0035094 CG9380 2 2R CG9380 CG9380 CDMC31130 2 6 4 DAC06-B16 14-CG9380-RA_2 CG9380 TCTGGGAGGACGATCATTAGTTGCACTTTTAATACCCAGTCCGCTGTCCTACGTGGATGAGGAGGACTA 69 FBan0009380 FBgn0035094 CG9380 2 2R CG9380 CG9380 CDMC31131 2 7 4 DAC06-F04 15-CG9416-RA_6 CG9416 TCTGGTGCCCTTGTTCTGTCTGTTCCGCAAGTCCAAGACAATTATCTCAATGTTTGGCATCTGCACGAT 69 FBan0009416 FBgn0034438 CG9416 2 2R CG9416 CG9416 CDMC31131 2 8 4 DAC06-F04 15-CG9416-RA_6 CG9416 TCTGGTGCCCTTGTTCTGTCTGTTCCGCAAGTCCAAGACAATTATCTCAATGTTTGGCATCTGCACGAT 69 FBan0009416 FBgn0034438 CG9416 2 2R CG9416 CG9416 CDMC31132 2 9 4 DAC06-F16 3-CG9429-RA_2 CG9429 AAGACATCCGCTGCAAAGATGACGTGTACACCCACTTCTACACGCTGATTGTCAGACCCGACAACACGT 69 FBan0009429 FBgn0005585 Crc 3 3R central nervous system development; GO:0007417; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; olfactory behavior; GO:0042048; peripheral nervous system development; GO:0007422; protein folding; GO:0006457 calcium ion binding; GO:0005509; unfolded protein binding; GO:0051082; ; GO:0005509; ; GO:0005509; ; GO:0051082 endoplasmic reticulum lumen; GO:0005788 Crc Calreticulin "CG9429, CG9429, CG9429, eth, Clr, calreticulin, potp, pot pourri, clone 2.11, clone 2.17, potpourri, anon-EST:Liang-2.11, anon-EST:Liang-2.17, anon-EST:fe3D7, anon-fast-evolving-3D7" CDMC31132 2 10 4 DAC06-F16 3-CG9429-RA_2 CG9429 AAGACATCCGCTGCAAAGATGACGTGTACACCCACTTCTACACGCTGATTGTCAGACCCGACAACACGT 69 FBan0009429 FBgn0005585 Crc 3 3R central nervous system development; GO:0007417; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; olfactory behavior; GO:0042048; peripheral nervous system development; GO:0007422; protein folding; GO:0006457 calcium ion binding; GO:0005509; unfolded protein binding; GO:0051082; ; GO:0005509; ; GO:0005509; ; GO:0051082 endoplasmic reticulum lumen; GO:0005788 Crc Calreticulin "CG9429, CG9429, CG9429, eth, Clr, calreticulin, potp, pot pourri, clone 2.11, clone 2.17, potpourri, anon-EST:Liang-2.11, anon-EST:Liang-2.17, anon-EST:fe3D7, anon-fast-evolving-3D7" CDMC31133 2 11 4 DAC06-J04 15-CG9456-RA_1 CG9456 TTTCCTGTGGGTCACTTCAGTGGCATGTCAGACCTCCAAAGAGATCTACCAACTACTTTCCAAGAGCCA 69 FBan0009456 FBgn0028988 Spn1 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Spn1 Serine protease inhibitor 1 "CG9456, CG9456, CG9456, CG9456, CG9456, sp1: serpin 1, serpin 1, sp1" CDMC31133 2 12 4 DAC06-J04 15-CG9456-RA_1 CG9456 TTTCCTGTGGGTCACTTCAGTGGCATGTCAGACCTCCAAAGAGATCTACCAACTACTTTCCAAGAGCCA 69 FBan0009456 FBgn0028988 Spn1 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Spn1 Serine protease inhibitor 1 "CG9456, CG9456, CG9456, CG9456, CG9456, sp1: serpin 1, serpin 1, sp1" CDMC31134 2 13 4 DAC06-J16 22-CG9470-RA_1 CG9470 TGCATCAGTTGTGGTCAGCAGCAAAATCAAGTGAATCATCTCAGTGCAACTAAAGGCCTAAATAGCCCA 69 FBan0009470 FBgn0002868 MtnA 3 3R metal ion binding; GO:0046872; ; GO:0046872 MtnA Metallothionein A "CG9470, Mtn, metallothionein, DrosMtn, MTN, metallothionein N, anon-WO0153538.42, anon-WO0153538.44, anon-WO0153538.49, BcDNA:GH18460" CDMC31134 2 14 4 DAC06-J16 22-CG9470-RA_1 CG9470 TGCATCAGTTGTGGTCAGCAGCAAAATCAAGTGAATCATCTCAGTGCAACTAAAGGCCTAAATAGCCCA 69 FBan0009470 FBgn0002868 MtnA 3 3R metal ion binding; GO:0046872; ; GO:0046872 MtnA Metallothionein A "CG9470, Mtn, metallothionein, DrosMtn, MTN, metallothionein N, anon-WO0153538.42, anon-WO0153538.44, anon-WO0153538.49, BcDNA:GH18460" CDMC31135 2 15 4 DAC06-N04 9-CG9503-RA_1 CG9503 GGTGGTGGATGCCAAGCTAAGGGTCTACGGTATCCGAGGACTTCGCGTCATTGATGCCAGTATTATGCC 69 FBan0009503 FBgn0030598 CG9503 X X electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" CG9503 CG9503 CDMC31135 2 16 4 DAC06-N04 9-CG9503-RA_1 CG9503 GGTGGTGGATGCCAAGCTAAGGGTCTACGGTATCCGAGGACTTCGCGTCATTGATGCCAGTATTATGCC 69 FBan0009503 FBgn0030598 CG9503 X X electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" CG9503 CG9503 CDMC31136 2 17 4 DAC06-N16 9-CG9514-RA_2 CG9514 TCCCCTCAGATATCCGTTGCTCTATCACAACTACCTCACCCATCCGGATGATGTGAATGTGCTGAGGGA 69 FBan0009514 FBgn0030592 CG9514 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9514 CG9514 CDMC31136 2 18 4 DAC06-N16 9-CG9514-RA_2 CG9514 TCCCCTCAGATATCCGTTGCTCTATCACAACTACCTCACCCATCCGGATGATGTGAATGTGCTGAGGGA 69 FBan0009514 FBgn0030592 CG9514 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9514 CG9514 CDMC31137 2 19 4 DAC07-B04 2-CG6563-RB_1 CG6563 GCCCAGTCGCTGTACACTCAGTCTCTTGGGCTATGGAGACGACACGCTTTATGCCGATGAAGTGGAATT 69 FBan0006563 FBgn0038306 Art3 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art3 Arginine methyltransferase 3 "CG6563, DART3, Arginine methyltransferase 3" CDMC31137 2 20 4 DAC07-B04 2-CG6563-RB_1 CG6563 GCCCAGTCGCTGTACACTCAGTCTCTTGGGCTATGGAGACGACACGCTTTATGCCGATGAAGTGGAATT 69 FBan0006563 FBgn0038306 Art3 3 3R protein amino acid methylation; GO:0006479 protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- Art3 Arginine methyltransferase 3 "CG6563, DART3, Arginine methyltransferase 3" CDMC31138 2 21 4 DAC07-B16 16-CG6575-RA_1 CG6575 ACTAGCGAATTGGCAGATCAGAAGCAGTAACTTTGGATCAGAATGACGATGACAAATAGCCCCTGGCGG 69 FBan0006575 FBgn0015229 glec 3 3R cell adhesion; GO:0007155; heterophilic cell adhesion; GO:0007157; nervous system development; GO:0007399 carbohydrate binding; GO:0030246; ; GO:0030246; ; GO:0030246 integral to membrane; GO:0016021; membrane fraction; GO:0005624 glec gliolectin "CG6575, CG6575, CG6575, CG6575, Gliolectin, gliolectin" CDMC31138 2 22 4 DAC07-B16 16-CG6575-RA_1 CG6575 ACTAGCGAATTGGCAGATCAGAAGCAGTAACTTTGGATCAGAATGACGATGACAAATAGCCCCTGGCGG 69 FBan0006575 FBgn0015229 glec 3 3R cell adhesion; GO:0007155; heterophilic cell adhesion; GO:0007157; nervous system development; GO:0007399 carbohydrate binding; GO:0030246; ; GO:0030246; ; GO:0030246 integral to membrane; GO:0016021; membrane fraction; GO:0005624 glec gliolectin "CG6575, CG6575, CG6575, CG6575, Gliolectin, gliolectin" CDMC31139 2 23 4 DAC07-F04 9-CG6603-RB_1 CG6603 GCCCCGTCGACCTGAGCAACTACACACAGCAAGAGTCAAAAATGATTGGCAACGATCAGAAGGAAACGG 69 FBan0006603 FBgn0026418 Hsc70Cb 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; chaperone binding; GO:0051087; ; GO:0051087 Hsc70Cb Hsc70Cb "CG6603, 0041/12, 0318/20, 1342/17, 1348/02, 1485/13, LD32772, l(3)07621, l(3)70Cb, l(3)00082, hsc70Cb, l(3)134217, l(3)148513, l(3)70Ca, HSC-70, HSC70, Hsc70, anon-WO0118547.302, BEST:LD32772, l(3)S134217, l(3)S134802, l(3)S148513" CDMC31139 2 24 4 DAC07-F04 9-CG6603-RB_1 CG6603 GCCCCGTCGACCTGAGCAACTACACACAGCAAGAGTCAAAAATGATTGGCAACGATCAGAAGGAAACGG 69 FBan0006603 FBgn0026418 Hsc70Cb 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; chaperone binding; GO:0051087; ; GO:0051087 Hsc70Cb Hsc70Cb "CG6603, 0041/12, 0318/20, 1342/17, 1348/02, 1485/13, LD32772, l(3)07621, l(3)70Cb, l(3)00082, hsc70Cb, l(3)134217, l(3)148513, l(3)70Ca, HSC-70, HSC70, Hsc70, anon-WO0118547.302, BEST:LD32772, l(3)S134217, l(3)S134802, l(3)S148513" CDMC31140 2 25 4 DAC07-F16 17-CG6611-RA_2 CG6611 GCCACAACCACTTCATCGATGCCATCTTCTCGAGGATCAATCGCATTGTTTCGGAAAACTATGATCCCT 69 FBan0006611 FBgn0000451 ect 3 3L ect ectodermal "CG6611, CG11965, Difl, DROECT, Ifl, Interferon-like protein" CDMC31140 2 26 4 DAC07-F16 17-CG6611-RA_2 CG6611 GCCACAACCACTTCATCGATGCCATCTTCTCGAGGATCAATCGCATTGTTTCGGAAAACTATGATCCCT 69 FBan0006611 FBgn0000451 ect 3 3L ect ectodermal "CG6611, CG11965, Difl, DROECT, Ifl, Interferon-like protein" CDMC31141 2 1 5 DAC07-J04 14-CG6649-RA_1 CG6649 AGGAACTTAAGGAGACCATCGAGATATTGCTCAAGGAGCCGAGATTTGCGCAGATTGCTAGGCAGATGT 69 FBan0006649 FBgn0026314 Ugt35b 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt35b UDP-glycosyltransferase 35b "CG6649, DmeUgt35b, AC 006491B, UDP-glycosyltransferase, ugt35b, UDPGT2, Ugt86Db, UDP-glycosyltransferase 35b" CDMC31141 2 2 5 DAC07-J04 14-CG6649-RA_1 CG6649 AGGAACTTAAGGAGACCATCGAGATATTGCTCAAGGAGCCGAGATTTGCGCAGATTGCTAGGCAGATGT 69 FBan0006649 FBgn0026314 Ugt35b 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt35b UDP-glycosyltransferase 35b "CG6649, DmeUgt35b, AC 006491B, UDP-glycosyltransferase, ugt35b, UDPGT2, Ugt86Db, UDP-glycosyltransferase 35b" CDMC31142 2 3 5 DAC07-J16 11-CG6658-RA_2 CG6658 AAGCATTAGGTGGGCTCAAACAGCGTGTTCTCTGGAAATTTGAGCTGGATAACCTGCCCAACAAACCGG 69 FBan0006658 FBgn0040251 Ugt86Di 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Di Ugt86Di "CG6658, CG6658, AC 006491I" CDMC31142 2 4 5 DAC07-J16 11-CG6658-RA_2 CG6658 AAGCATTAGGTGGGCTCAAACAGCGTGTTCTCTGGAAATTTGAGCTGGATAACCTGCCCAACAAACCGG 69 FBan0006658 FBgn0040251 Ugt86Di 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Di Ugt86Di "CG6658, CG6658, AC 006491I" CDMC31143 2 5 5 DAC07-N04 3-CG6687-RA_2 CG6687 CGAATTTCGTTGGCGCCAAAGTCCCATGGAGCTCTCGTCTGCGAACAGAATTTTCGTCGACAGGACAAT 69 FBan0006687 FBgn0038299 CG6687 3 3R ATP synthesis coupled proton transport; GO:0015986; proteolysis; GO:0006508 "serine-type endopeptidase inhibitor activity; GO:0004867; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004867" membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 CG6687 CG6687 CDMC31143 2 6 5 DAC07-N04 3-CG6687-RA_2 CG6687 CGAATTTCGTTGGCGCCAAAGTCCCATGGAGCTCTCGTCTGCGAACAGAATTTTCGTCGACAGGACAAT 69 FBan0006687 FBgn0038299 CG6687 3 3R ATP synthesis coupled proton transport; GO:0015986; proteolysis; GO:0006508 "serine-type endopeptidase inhibitor activity; GO:0004867; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004867" membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 CG6687 CG6687 CDMC31144 2 7 5 DAC07-N16 2-CG6694-RA_2 CG6694 CGCGAGCCCATTTAATCACCGCCAAACAGAGAAGCCTGACGTTGCTCAACAAATCGTTGGTGAAGACCA 69 FBan0006694 FBgn0035900 CG6694 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG6694 CG6694 CDMC31144 2 8 5 DAC07-N16 2-CG6694-RA_2 CG6694 CGCGAGCCCATTTAATCACCGCCAAACAGAGAAGCCTGACGTTGCTCAACAAATCGTTGGTGAAGACCA 69 FBan0006694 FBgn0035900 CG6694 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG6694 CG6694 CDMC31145 2 9 5 DAC08-B04 18-CG31856-RA_4 CG31856 GCTTCAATGGGCTGTCAAACAATTTATCAAGCCTGAATTTGAATCCGCATTAGCTGAGCGCTTTTGGCG 69 FBan0031856 FBgn0051856 CG31856 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31856 CG31856 BcDNA:SD21618 CDMC31145 2 10 5 DAC08-B04 18-CG31856-RA_4 CG31856 GCTTCAATGGGCTGTCAAACAATTTATCAAGCCTGAATTTGAATCCGCATTAGCTGAGCGCTTTTGGCG 69 FBan0031856 FBgn0051856 CG31856 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31856 CG31856 BcDNA:SD21618 CDMC31146 2 11 5 DAC08-B16 1-CG31864-RA_2 CG31864 TGGACGCTATGCTCCCCTATCTGACCAATTTCTACGGAAATCTGGTTCGTACGCTTCGCCTTCAACGCC 69 FBan0031864 FBgn0051864 CG31864 2 2L CG31864 CG31864 CG17749 CDMC31146 2 12 5 DAC08-B16 1-CG31864-RA_2 CG31864 TGGACGCTATGCTCCCCTATCTGACCAATTTCTACGGAAATCTGGTTCGTACGCTTCGCCTTCAACGCC 69 FBan0031864 FBgn0051864 CG31864 2 2L CG31864 CG31864 CG17749 CDMC31147 2 13 5 DAC08-F04 12-CG31894-RA_1 CG31894 AGGTGCAAAAACGTTCTGACATTGGAGTTTCGCCGAAGAGCTTTGACTCACTTGCGATGTCTAAGGCGT 69 FBan0031894 FBgn0051894 CG31894 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31894 CG31894 CDMC31147 2 14 5 DAC08-F04 12-CG31894-RA_1 CG31894 AGGTGCAAAAACGTTCTGACATTGGAGTTTCGCCGAAGAGCTTTGACTCACTTGCGATGTCTAAGGCGT 69 FBan0031894 FBgn0051894 CG31894 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31894 CG31894 CDMC31148 2 15 5 DAC08-F16 47-CG31904-RB_1 CG31904 TGCACACTCAATGGAACTCACATATACGCATTGTACGAAAAAACTACGTAGAAAGCCGTATATATATTT 69 FBan0031904 FBgn0051904 CG31904 2 2L CG31904 CG31904 anon-WO0149848.5 CDMC31148 2 16 5 DAC08-F16 47-CG31904-RB_1 CG31904 TGCACACTCAATGGAACTCACATATACGCATTGTACGAAAAAACTACGTAGAAAGCCGTATATATATTT 69 FBan0031904 FBgn0051904 CG31904 2 2L CG31904 CG31904 anon-WO0149848.5 CDMC31149 2 17 5 DAC08-J04 23-CG3192-RA_2 CG3192 TGAGTTTTGAGTGCGAAATGAAAATAAAAAACGTTTGCGAAAATTGAGTGAAAAAATCAATGCGACGGC 69 FBan0003192 FBgn0029888 CG3192 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3192 CG3192 CDMC31149 2 18 5 DAC08-J04 23-CG3192-RA_2 CG3192 TGAGTTTTGAGTGCGAAATGAAAATAAAAAACGTTTGCGAAAATTGAGTGAAAAAATCAATGCGACGGC 69 FBan0003192 FBgn0029888 CG3192 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG3192 CG3192 CDMC31150 2 19 5 DAC08-J16 1-CG31953-RA_4 CG31953 AGTCCATTGCAACTGGTGCTCTTTGCTTTCCAGACTGGCGAGGACACCTTTCCTTTGGGTAACAATCGT 69 FBan0031953 FBgn0051953 CG31953 2 2L tyrosyl-DNA phosophodiesterase activity; GO:0017005; ; GO:0017005; ; GO:0017005 CG31953 CG31953 CDMC31150 2 20 5 DAC08-J16 1-CG31953-RA_4 CG31953 AGTCCATTGCAACTGGTGCTCTTTGCTTTCCAGACTGGCGAGGACACCTTTCCTTTGGGTAACAATCGT 69 FBan0031953 FBgn0051953 CG31953 2 2L tyrosyl-DNA phosophodiesterase activity; GO:0017005; ; GO:0017005; ; GO:0017005 CG31953 CG31953 CDMC31151 2 21 5 DAC08-N04 7-CG3199-RA_1 CG3199 GGCGAAACTTGCCCCAATTTGGACAGGAACCTTAGCCCAAGGGACATAGTATTTGTGGTCGGCAAATCG 69 FBan0003199 FBgn0038210 CG3199 3 3R CG3199 CG3199 CDMC31151 2 22 5 DAC08-N04 7-CG3199-RA_1 CG3199 GGCGAAACTTGCCCCAATTTGGACAGGAACCTTAGCCCAAGGGACATAGTATTTGTGGTCGGCAAATCG 69 FBan0003199 FBgn0038210 CG3199 3 3R CG3199 CG3199 CDMC31152 2 23 5 DAC08-N16 2-CG32016-RC_1 CG32016 ACCAATCAATTGGCGCAATGGTTTTCCCCTGAGCTTCTTGCAAAAGCCTCTGCTGGAAAACTGCCACTT 69 FBan0032016 FBgn0052016 CG32016 4 4 CG32016 CG32016 "CG11097, CG11232" CDMC31152 2 24 5 DAC08-N16 2-CG32016-RC_1 CG32016 ACCAATCAATTGGCGCAATGGTTTTCCCCTGAGCTTCTTGCAAAAGCCTCTGCTGGAAAACTGCCACTT 69 FBan0032016 FBgn0052016 CG32016 4 4 CG32016 CG32016 "CG11097, CG11232" CDMC31153 2 25 5 DAC09-B05 6-CG5379-RA_1 CG5379 TGTTCGGTGAGGTCCTTCCCATTTCGCACCAGGATCTGCCCAAATTCTGGAACCTCCGAGATGAG 65 FBan0005379 FBgn0038956 CG5379 3 3R one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG5379 CG5379 CDMC31153 2 26 5 DAC09-B05 6-CG5379-RA_1 CG5379 TGTTCGGTGAGGTCCTTCCCATTTCGCACCAGGATCTGCCCAAATTCTGGAACCTCCGAGATGAG 65 FBan0005379 FBgn0038956 CG5379 3 3R one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG5379 CG5379 CDMC31154 2 1 6 DAC09-B17 2-CG5395-RA_2 CG5395 TTGTTCCCGCCGACATAACAGTCAGTTGGGCCGATATCGCCGGTCTGGATTCAGTCATTCAGGAG 65 FBan0005395 FBgn0005322 nmd 2 2L intracellular protein transport; GO:0006886; spermatid development; GO:0007286 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783; mitochondrial outer membrane; GO:0005741 nmd no mitochondrial derivative "CG5395, CG5395, l(2)08774, clone 1.79, Msp1, Mitochondrial sorting protein 1, DmCG5395, ms(2)4, ms(2)ry4, anon-EST:Liang-1.79" CDMC31154 2 2 6 DAC09-B17 2-CG5395-RA_2 CG5395 TTGTTCCCGCCGACATAACAGTCAGTTGGGCCGATATCGCCGGTCTGGATTCAGTCATTCAGGAG 65 FBan0005395 FBgn0005322 nmd 2 2L intracellular protein transport; GO:0006886; spermatid development; GO:0007286 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783; mitochondrial outer membrane; GO:0005741 nmd no mitochondrial derivative "CG5395, CG5395, l(2)08774, clone 1.79, Msp1, Mitochondrial sorting protein 1, DmCG5395, ms(2)4, ms(2)ry4, anon-EST:Liang-1.79" CDMC31155 2 3 6 DAC09-F05 2-CG5524-RA_1 CG5524 TGGAGAGGAAAATGCTTGGCGAGAAGGAAACCGTGCTAAGCGAATTGGAAAAGGCTCGCACCGAG 65 FBan0005524 FBgn0039164 CG5524 3 3R DNA repair; GO:0006281; chromosome segregation; GO:0007059 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATPase activity; GO:0016887; ; GO:0016887 nucleus; GO:0005634 CG5524 CG5524 CDMC31155 2 4 6 DAC09-F05 2-CG5524-RA_1 CG5524 TGGAGAGGAAAATGCTTGGCGAGAAGGAAACCGTGCTAAGCGAATTGGAAAAGGCTCGCACCGAG 65 FBan0005524 FBgn0039164 CG5524 3 3R DNA repair; GO:0006281; chromosome segregation; GO:0007059 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATPase activity; GO:0016887; ; GO:0016887 nucleus; GO:0005634 CG5524 CG5524 CDMC31156 2 5 6 DAC09-F17 2-CG5580-RA_2 CG5580 TTTGTTCCCCGTTGGATTCCAACTTCTTCCCGTCGAAACCTGTCACAGTCTTGGCTGCCTCAACG 65 FBan0005580 FBgn0010575 sbb 2 2R axon guidance; GO:0007411; axon target recognition; GO:0007412; larval locomotory behavior; GO:0008345; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; photoreceptor cell development; GO:0042461 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sbb scribbler "CG5580, CG5580, CG5580, CG5580, scribble, l(2)04440, mtv, master of thickveins, bks, brakeless, Bks, Brakeless, GM04742, Group IIa, Scrib, Scribble, disc6" CDMC31156 2 6 6 DAC09-F17 2-CG5580-RA_2 CG5580 TTTGTTCCCCGTTGGATTCCAACTTCTTCCCGTCGAAACCTGTCACAGTCTTGGCTGCCTCAACG 65 FBan0005580 FBgn0010575 sbb 2 2R axon guidance; GO:0007411; axon target recognition; GO:0007412; larval locomotory behavior; GO:0008345; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; photoreceptor cell development; GO:0042461 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sbb scribbler "CG5580, CG5580, CG5580, CG5580, scribble, l(2)04440, mtv, master of thickveins, bks, brakeless, Bks, Brakeless, GM04742, Group IIa, Scrib, Scribble, disc6" CDMC31157 2 7 6 DAC09-J05 3-CG5697-RA_2 CG5697 CTTGTTCGGCACACATCCAGGGTACCACACGGCAAATATGTCCTGCAACGAGAAGACAGCGCTTC 65 FBan0005697 FBgn0038846 CG5697 3 3R CG5697 CG5697 BcDNA:RH32180 CDMC31157 2 8 6 DAC09-J05 3-CG5697-RA_2 CG5697 CTTGTTCGGCACACATCCAGGGTACCACACGGCAAATATGTCCTGCAACGAGAAGACAGCGCTTC 65 FBan0005697 FBgn0038846 CG5697 3 3R CG5697 CG5697 BcDNA:RH32180 CDMC31158 2 9 6 DAC09-J17 3-CG5731-RA_2 CG5731 GTAGCACCTTCGGTAAATGCCTCGACAATGGGCTTGCCAAAACTCCTCCAATGGGTTGGCTTTCC 65 FBan0005731 FBgn0032192 CG5731 2 2L polysaccharide metabolism; GO:0005976 alpha-N-acetylgalactosaminidase activity; GO:0008456 ; EC:3.2.1.49; ; GO:0008456 ; EC:3.2.1.49 CG5731 CG5731 CDMC31158 2 10 6 DAC09-J17 3-CG5731-RA_2 CG5731 GTAGCACCTTCGGTAAATGCCTCGACAATGGGCTTGCCAAAACTCCTCCAATGGGTTGGCTTTCC 65 FBan0005731 FBgn0032192 CG5731 2 2L polysaccharide metabolism; GO:0005976 alpha-N-acetylgalactosaminidase activity; GO:0008456 ; EC:3.2.1.49; ; GO:0008456 ; EC:3.2.1.49 CG5731 CG5731 CDMC31159 2 11 6 DAC09-N05 1-CG5859-RA_1 CG5859 TAACCTCACAGAATTTCCACCTCTCCTTTACCTGGATAAACGGGCGGGTCCCCTGGAACTACCCC 65 FBan0005859 FBgn0025830 CG5859 2 2R CG5859 CG5859 EG:EG0003.5 CDMC31159 2 12 6 DAC09-N05 1-CG5859-RA_1 CG5859 TAACCTCACAGAATTTCCACCTCTCCTTTACCTGGATAAACGGGCGGGTCCCCTGGAACTACCCC 65 FBan0005859 FBgn0025830 CG5859 2 2R CG5859 CG5859 EG:EG0003.5 CDMC31160 2 13 6 DAC09-N17 3-CG5910-RA_4 CG5910 GAAGGTGCACACATCATCCGTGGAATCCTGCTTCACATTCGTCCAGGTCAAGGAGTGCTGCTGTG 65 FBan0005910 FBgn0036993 CG5910 3 3L CG5910 CG5910 CK02563 CDMC31160 2 14 6 DAC09-N17 3-CG5910-RA_4 CG5910 GAAGGTGCACACATCATCCGTGGAATCCTGCTTCACATTCGTCCAGGTCAAGGAGTGCTGCTGTG 65 FBan0005910 FBgn0036993 CG5910 3 3L CG5910 CG5910 CK02563 CDMC31161 2 15 6 DAC10-B04 3-CG6481-RA_3 CG6481 TTGAGGAGAAGCAAGTGGATGTTGATGAGCCAAGCTCCGCGATGAACCAGATGTCGATGCAGGAG 65 FBan0006481 FBgn0030936 CG6481 X X CG6481 CG6481 CDMC31161 2 16 6 DAC10-B04 3-CG6481-RA_3 CG6481 TTGAGGAGAAGCAAGTGGATGTTGATGAGCCAAGCTCCGCGATGAACCAGATGTCGATGCAGGAG 65 FBan0006481 FBgn0030936 CG6481 X X CG6481 CG6481 CDMC31162 2 17 6 DAC10-B16 2-CG6508-RA_1 CG6508 TGGGGTGGAATCGATCGGAGCATCTACAGGGGTTGCATCAACTACGTTCCAGTATCGATGCCTGC 65 FBan0006508 FBgn0032303 CG6508 2 2L proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG6508 CG6508 CDMC31162 2 18 6 DAC10-B16 2-CG6508-RA_1 CG6508 TGGGGTGGAATCGATCGGAGCATCTACAGGGGTTGCATCAACTACGTTCCAGTATCGATGCCTGC 65 FBan0006508 FBgn0032303 CG6508 2 2L proteolysis; GO:0006508 cathepsin D activity; GO:0004192 ; EC:3.4.23.5; ; GO:0004192 ; EC:3.4.23.5; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG6508 CG6508 CDMC31163 2 19 6 DAC10-F04 15-CG6637-RA_5 CG6637 CCAGGTGGTGGAGGTTTGTCTAGCTGCCAATCACAAAACCGGTGGACTTATGGAGCTGGACGATC 65 FBan0006637 FBgn0038908 CG6637 3 3R CG6637 CG6637 CDMC31163 2 20 6 DAC10-F04 15-CG6637-RA_5 CG6637 CCAGGTGGTGGAGGTTTGTCTAGCTGCCAATCACAAAACCGGTGGACTTATGGAGCTGGACGATC 65 FBan0006637 FBgn0038908 CG6637 3 3R CG6637 CG6637 CDMC31164 2 21 6 DAC10-F16 3-CG6674-RA_1 CG6674 CCGCACAAATGGAAGAAGTACTCCCTGTCTGATGTGGACATTTCCGAACAGAGCAACTCCGCCGC 65 FBan0006674 FBgn0036063 CG6674 3 3L CG6674 CG6674 CDMC31164 2 22 6 DAC10-F16 3-CG6674-RA_1 CG6674 CCGCACAAATGGAAGAAGTACTCCCTGTCTGATGTGGACATTTCCGAACAGAGCAACTCCGCCGC 65 FBan0006674 FBgn0036063 CG6674 3 3L CG6674 CG6674 CDMC31165 2 23 6 DAC10-J04 6-CG6769-RA_4 CG6769 ACGCCATTCCAGAGTGCCAACGAAAACGAGAGTGCCAGTCAAGCGATCATCGAATCCACTCAGCG 65 FBan0006769 FBgn0030878 CG6769 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6769 CG6769 CDMC31165 2 24 6 DAC10-J04 6-CG6769-RA_4 CG6769 ACGCCATTCCAGAGTGCCAACGAAAACGAGAGTGCCAGTCAAGCGATCATCGAATCCACTCAGCG 65 FBan0006769 FBgn0030878 CG6769 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6769 CG6769 CDMC31166 2 25 6 DAC10-J16 2-CG6793-RA_1 CG6793 AGGCCAAATGGAGAAAGTCGAAGGAACAGGCCAAGAACGCCCGTTTAGCTGTGCAAAGAGAGGAG 65 FBan0006793 FBgn0036242 CG6793 3 3L CG6793 CG6793 CDMC31166 2 26 6 DAC10-J16 2-CG6793-RA_1 CG6793 AGGCCAAATGGAGAAAGTCGAAGGAACAGGCCAAGAACGCCCGTTTAGCTGTGCAAAGAGAGGAG 65 FBan0006793 FBgn0036242 CG6793 3 3L CG6793 CG6793 CDMC31167 2 1 7 DAC10-N04 13-CG6901-RA_1 CG6901 TGGCGTTCTTCGTGTGATTGGAGTAATGGTGGCTTTGATATTCCTGGACACTTTGGGTCGCAAGG 65 FBan0006901 FBgn0038414 CG6901 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG6901 CG6901 CDMC31167 2 2 7 DAC10-N04 13-CG6901-RA_1 CG6901 TGGCGTTCTTCGTGTGATTGGAGTAATGGTGGCTTTGATATTCCTGGACACTTTGGGTCGCAAGG 65 FBan0006901 FBgn0038414 CG6901 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG6901 CG6901 CDMC31168 2 3 7 DAC10-N16 2-CG6933-RC_1 CG6933 CAGTAAACGCCACTGGCTATTGGAACCAATGTCCCACCGGTACCCAATTCAATGCTGGCAAGTGC 65 FBan0006933 FBgn0036952 CG6933 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6933 CG6933 CDMC31168 2 4 7 DAC10-N16 2-CG6933-RC_1 CG6933 CAGTAAACGCCACTGGCTATTGGAACCAATGTCCCACCGGTACCCAATTCAATGCTGGCAAGTGC 65 FBan0006933 FBgn0036952 CG6933 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG6933 CG6933 CDMC31169 2 5 7 DAC11-B04 17-Gal4_cds_1 Gal4_cds_1 AGCAACGGTCCGAACCTCATAACAACTCAAACAAATTCTCAAGCGCTTTCACAACCAATTGCCTCCTCT 69 CDMC31169 2 6 7 DAC11-B04 17-Gal4_cds_1 Gal4_cds_1 AGCAACGGTCCGAACCTCATAACAACTCAAACAAATTCTCAAGCGCTTTCACAACCAATTGCCTCCTCT 69 CDMC31170 2 7 7 DAC11-B16 3-CG10006-RA_2 CG10006 GCTCCCCCATGCCCTTTTCAAGGAGGAAAAGCACGAGGAGGAAGTCACTGGTATCAATCCCTTGGAATC 69 FBan0010006 FBgn0036461 CG10006 3 3L ion transport; GO:0006811; metal ion transport; GO:0030001; transport; GO:0006810 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG10006 CG10006 CDMC31170 2 8 7 DAC11-B16 3-CG10006-RA_2 CG10006 GCTCCCCCATGCCCTTTTCAAGGAGGAAAAGCACGAGGAGGAAGTCACTGGTATCAATCCCTTGGAATC 69 FBan0010006 FBgn0036461 CG10006 3 3L ion transport; GO:0006811; metal ion transport; GO:0030001; transport; GO:0006810 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG10006 CG10006 CDMC31171 2 9 7 DAC11-F04 23-CG10043-RA_15 CG10043 TTTGCAGATCGCATGCATAATTTGAACTTCGGGCAAATTTAACAACATCGAACATCTGCTTATAGCCCA 69 FBan0010043 FBgn0015803 rtGEF 2 2L regulation of synapse structure; GO:0050807 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 rtGEF rho-type guanine exchange factor "CG10043, Rho/RacGEF, RhoGEF, DrtGEF, Drosophila rho-type guanine exchange factor, rhoGEF, DrhoGEF, 38C.40, dpix, rho-type guanine exchange factor" CDMC31171 2 10 7 DAC11-F04 23-CG10043-RA_15 CG10043 TTTGCAGATCGCATGCATAATTTGAACTTCGGGCAAATTTAACAACATCGAACATCTGCTTATAGCCCA 69 FBan0010043 FBgn0015803 rtGEF 2 2L regulation of synapse structure; GO:0050807 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 rtGEF rho-type guanine exchange factor "CG10043, Rho/RacGEF, RhoGEF, DrtGEF, Drosophila rho-type guanine exchange factor, rhoGEF, DrhoGEF, 38C.40, dpix, rho-type guanine exchange factor" CDMC31172 2 11 7 DAC11-F16 23-CG10052-RA_4 CG10052 AATTTCGTGTTGTAAGTACATATTTCTGAGGCAGTTTCTTAGATGGTAAACTCAACGTGTGCAAAGTGT 69 FBan0010052 FBgn0020617 Rx 2 2R brain development; GO:0007420; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Rx Retinal Homeobox "CG10052, CG10052, CG10052, E97, bk50, PPH17, Drx, DRx, W60, Drosophila Rx, drx, wom, wombat, Retinal Homeobox" CDMC31172 2 12 7 DAC11-F16 23-CG10052-RA_4 CG10052 AATTTCGTGTTGTAAGTACATATTTCTGAGGCAGTTTCTTAGATGGTAAACTCAACGTGTGCAAAGTGT 69 FBan0010052 FBgn0020617 Rx 2 2R brain development; GO:0007420; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Rx Retinal Homeobox "CG10052, CG10052, CG10052, E97, bk50, PPH17, Drx, DRx, W60, Drosophila Rx, drx, wom, wombat, Retinal Homeobox" CDMC31173 2 13 7 DAC11-J04 8-CG10081-RA_2 CG10081 TCCGTTGCTGGAGTCCAATGTGGATCTCACTGGTCTGGTCAACATGACATCCGATTGTGCCAAGTACAT 69 FBan0010081 FBgn0034441 CG10081 2 2R CG10081 CG10081 CDMC31173 2 14 7 DAC11-J04 8-CG10081-RA_2 CG10081 TCCGTTGCTGGAGTCCAATGTGGATCTCACTGGTCTGGTCAACATGACATCCGATTGTGCCAAGTACAT 69 FBan0010081 FBgn0034441 CG10081 2 2R CG10081 CG10081 CDMC31174 2 15 7 DAC11-J16 3-CG10092-RA_1 CG10092 CCACCAGTCAAGCGCTGAAAAGATTGCCTGTGAAACAAGAGTCCAGCCTAGAGAAGCAACTCCAACGCC 69 FBan0010092 FBgn0037526 CG10092 3 3R arginyl-tRNA aminoacylation; GO:0006420; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; arginine-tRNA ligase activity; GO:0004814 ; EC:6.1.1.19; ; GO:0003729; ; GO:0004814 ; EC:6.1.1.19 CG10092 CG10092 CDMC31174 2 16 7 DAC11-J16 3-CG10092-RA_1 CG10092 CCACCAGTCAAGCGCTGAAAAGATTGCCTGTGAAACAAGAGTCCAGCCTAGAGAAGCAACTCCAACGCC 69 FBan0010092 FBgn0037526 CG10092 3 3R arginyl-tRNA aminoacylation; GO:0006420; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; arginine-tRNA ligase activity; GO:0004814 ; EC:6.1.1.19; ; GO:0003729; ; GO:0004814 ; EC:6.1.1.19 CG10092 CG10092 CDMC31175 2 17 7 DAC11-N04 23-CG10126-RA_5 CG10126 TCTGGAGAAAAGTCTGAGGATGAAATTCTTACCGACTTTTTGCACAACTTTGAGGGAGGTCGAGGAAAC 69 FBan0010126 FBgn0038088 CG10126 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG10126 CG10126 CT28495 CDMC31175 2 18 7 DAC11-N04 23-CG10126-RA_5 CG10126 TCTGGAGAAAAGTCTGAGGATGAAATTCTTACCGACTTTTTGCACAACTTTGAGGGAGGTCGAGGAAAC 69 FBan0010126 FBgn0038088 CG10126 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG10126 CG10126 CT28495 CDMC31176 2 19 7 DAC11-N16 2-CG10132-RA_3 CG10132 CCGGATGCTATGTGGCTTCGATGTGCACGGACCGATCTGAGATCTGCATATGGGACGTGAAGAATTGCT 69 FBan0010132 FBgn0032798 CG10132 2 2L CG10132 CG10132 CDMC31176 2 20 7 DAC11-N16 2-CG10132-RA_3 CG10132 CCGGATGCTATGTGGCTTCGATGTGCACGGACCGATCTGAGATCTGCATATGGGACGTGAAGAATTGCT 69 FBan0010132 FBgn0032798 CG10132 2 2L CG10132 CG10132 CDMC31177 2 21 7 DAC12-B04 1-CG30090-RA_1 CG30090 CCAGCGCTATAATTCATCCCAGTGCATGCAAGCTCTTGGCAGGTTAGTGCAGCAGAACCAAATTTGCGC 69 FBan0030090 FBgn0050090 CG30090 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30090 CG30090 "CG8215, CG8215, CG8215, CG8215, CG8215, CG8215, SP41, BcDNA:GH21666" CDMC31177 2 22 7 DAC12-B04 1-CG30090-RA_1 CG30090 CCAGCGCTATAATTCATCCCAGTGCATGCAAGCTCTTGGCAGGTTAGTGCAGCAGAACCAAATTTGCGC 69 FBan0030090 FBgn0050090 CG30090 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30090 CG30090 "CG8215, CG8215, CG8215, CG8215, CG8215, CG8215, SP41, BcDNA:GH21666" CDMC31178 2 23 7 DAC12-B16 2-CG30099-RA_1 CG30099 ACCAGGGCCAACACCTACGTTCGAAAGTTCACGAATGGATCGCAGCAAAGTCGAGATATCAGCATGCCA 69 FBan0030099 FBgn0050099 CG30099 2 2R CG30099 CG30099 CG7750 CDMC31178 2 24 7 DAC12-B16 2-CG30099-RA_1 CG30099 ACCAGGGCCAACACCTACGTTCGAAAGTTCACGAATGGATCGCAGCAAAGTCGAGATATCAGCATGCCA 69 FBan0030099 FBgn0050099 CG30099 2 2R CG30099 CG30099 CG7750 CDMC31179 2 25 7 DAC12-F04 2-CG30130-RA_1 CG30130 CACCTTGTCGAACCTAATTTGGCTCCACTGAAGTCCGTGCATTTCGGTCGAAACAAAGCGATGGGAGGA 69 FBan0030130 FBgn0050130 CG30130 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30130 CG30130 CDMC31179 2 26 7 DAC12-F04 2-CG30130-RA_1 CG30130 CACCTTGTCGAACCTAATTTGGCTCCACTGAAGTCCGTGCATTTCGGTCGAAACAAAGCGATGGGAGGA 69 FBan0030130 FBgn0050130 CG30130 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30130 CG30130 CDMC31180 2 1 8 DAC12-F16 14-CG30149-RB_4 CG30149 TGGCCATTGTTCTTACAGAAGACTCTGCCAAGATCGACAAGTCGGTGCTCATATCGAAGCTGTTCAGCT 69 FBan0030149 FBgn0050149 rig 2 2R molting cycle (sensu Insecta); GO:0007591; response to ecdysone; GO:0035075 ligand-dependent nuclear receptor transcription coactivator activity; GO:0030374; protein binding; GO:0005515; ; GO:0030374; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 rig rigor mortis "CG3014, CG30149, CG11171, CG13440, l(2)05056" CDMC31180 2 2 8 DAC12-F16 14-CG30149-RB_4 CG30149 TGGCCATTGTTCTTACAGAAGACTCTGCCAAGATCGACAAGTCGGTGCTCATATCGAAGCTGTTCAGCT 69 FBan0030149 FBgn0050149 rig 2 2R molting cycle (sensu Insecta); GO:0007591; response to ecdysone; GO:0035075 ligand-dependent nuclear receptor transcription coactivator activity; GO:0030374; protein binding; GO:0005515; ; GO:0030374; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 rig rigor mortis "CG3014, CG30149, CG11171, CG13440, l(2)05056" CDMC31181 2 3 8 DAC12-J04 3-CG30177-RA_1 CG30177 TCGCCATCAGCATGAGAGCCCTATGATGATTCATTCCCCTCGGCATTTACGAGCAGCTGAACTGGACAA 69 FBan0030177 FBgn0050177 CG30177 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30177 CG30177 CDMC31181 2 4 8 DAC12-J04 3-CG30177-RA_1 CG30177 TCGCCATCAGCATGAGAGCCCTATGATGATTCATTCCCCTCGGCATTTACGAGCAGCTGAACTGGACAA 69 FBan0030177 FBgn0050177 CG30177 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30177 CG30177 CDMC31182 2 5 8 DAC12-J16 1-CG30187-RA_4 CG30187 TCCAGAGACGAGTAGAGTGGAATCAACTGTGCGTCGAACATCCGTACGGAATGGGCTTCATTGGGAGCT 69 FBan0030187 FBgn0050187 CG30187 2 2R CG30187 CG30187 BcDNA:SD12357 CDMC31182 2 6 8 DAC12-J16 1-CG30187-RA_4 CG30187 TCCAGAGACGAGTAGAGTGGAATCAACTGTGCGTCGAACATCCGTACGGAATGGGCTTCATTGGGAGCT 69 FBan0030187 FBgn0050187 CG30187 2 2R CG30187 CG30187 BcDNA:SD12357 CDMC31183 2 7 8 DAC12-N04 1-CG30275-RB_2 CG30275 CGAACCTGTGCTCTTCCAAGCCATTCTTCCGTTGCGGTACTTCATCACAAAAGTGACCATGCCTCGGAG 69 FBan0030275 FBgn0050275 CG30275 2 2R CG30275 CG30275 "CG13520, CG13520" CDMC31183 2 8 8 DAC12-N04 1-CG30275-RB_2 CG30275 CGAACCTGTGCTCTTCCAAGCCATTCTTCCGTTGCGGTACTTCATCACAAAAGTGACCATGCCTCGGAG 69 FBan0030275 FBgn0050275 CG30275 2 2R CG30275 CG30275 "CG13520, CG13520" CDMC31184 2 9 8 DAC12-N16 14-CG30283-RA_1 CG30283 GTTTAGAACCTACGGCTGGGGAAAAACCGAATCGAGATCATCTAGTCGGATGCTCCAGAAAACCTCGCT 69 FBan0030283 FBgn0050283 CG30283 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30283 CG30283 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC31184 2 10 8 DAC12-N16 14-CG30283-RA_1 CG30283 GTTTAGAACCTACGGCTGGGGAAAAACCGAATCGAGATCATCTAGTCGGATGCTCCAGAAAACCTCGCT 69 FBan0030283 FBgn0050283 CG30283 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30283 CG30283 "CG10450, CG10450, CG10450, SPH37, SP37" CDMC31185 2 11 8 DAC13-B04 24-CG13222-RA_2 CG13222 ATAACGACAAATTAATGTCATTTAAATGATTGATTAGTTTGAAGATGTAGTCGCAACTCAAAGGC 65 FBan0013222 FBgn0033602 CG13222 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13222 CG13222 CDMC31185 2 12 8 DAC13-B04 24-CG13222-RA_2 CG13222 ATAACGACAAATTAATGTCATTTAAATGATTGATTAGTTTGAAGATGTAGTCGCAACTCAAAGGC 65 FBan0013222 FBgn0033602 CG13222 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG13222 CG13222 CDMC31186 2 13 8 DAC13-B16 12-CG13232-RA_5 CG13232 AGCCGGACGTAATCCCTTGGTTGTGCTGAACTTTGCACTGTTTTGCTACGAAACCGGCAGATTGG 65 FBan0013232 FBgn0033578 BBS4 2 2R cilium biogenesis; GO:0042384; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- cellular component unknown; GO:0008372 BBS4 BBS4 "CG13232, CG13232" CDMC31186 2 14 8 DAC13-B16 12-CG13232-RA_5 CG13232 AGCCGGACGTAATCCCTTGGTTGTGCTGAACTTTGCACTGTTTTGCTACGAAACCGGCAGATTGG 65 FBan0013232 FBgn0033578 BBS4 2 2R cilium biogenesis; GO:0042384; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.- cellular component unknown; GO:0008372 BBS4 BBS4 "CG13232, CG13232" CDMC31187 2 15 8 DAC13-F04 23-CG13380-RA_2 CG13380 CAGTTCGCAAGAATTTCCACGTACTAATGGGGTAACTAGACTGCGCTTCTCTCTCAACATGCTGA 65 FBan0013380 FBgn0036799 CG13380 3 3L CG13380 CG13380 CDMC31187 2 16 8 DAC13-F04 23-CG13380-RA_2 CG13380 CAGTTCGCAAGAATTTCCACGTACTAATGGGGTAACTAGACTGCGCTTCTCTCTCAACATGCTGA 65 FBan0013380 FBgn0036799 CG13380 3 3L CG13380 CG13380 CDMC31188 2 17 8 DAC13-F16 3-CG13427-RA_1 CG13427 GACCAAGTCTCTAACAGCATACGCGGTCCACGCCATCTCCTGAGCAAATTGTTCCAGCCCAAGAC 65 FBan0013427 FBgn0034514 CG13427 2 2R CG13427 CG13427 CDMC31188 2 18 8 DAC13-F16 3-CG13427-RA_1 CG13427 GACCAAGTCTCTAACAGCATACGCGGTCCACGCCATCTCCTGAGCAAATTGTTCCAGCCCAAGAC 65 FBan0013427 FBgn0034514 CG13427 2 2R CG13427 CG13427 CDMC31189 2 19 8 DAC13-J04 2-CG13533-RA_1 CG13533 CTTTGTGGGCAAGTTCAGTTACCAGCAGAAGTGTGCCGAGAAGATCATGCGCCTACCCAACTCCC 65 FBan0013533 FBgn0034793 asrij 2 2R asrij asrij "CG13533, Dmasrij, asrij" CDMC31189 2 20 8 DAC13-J04 2-CG13533-RA_1 CG13533 CTTTGTGGGCAAGTTCAGTTACCAGCAGAAGTGTGCCGAGAAGATCATGCGCCTACCCAACTCCC 65 FBan0013533 FBgn0034793 asrij 2 2R asrij asrij "CG13533, Dmasrij, asrij" CDMC31190 2 21 8 DAC13-J16 23-CG13556-RA_1 CG13556 GAGCTCAGCATTTCGTATCAAATTTGTGATAACTGTAGAAGTAAGTACAAGCTAACTGGCCGCCG 65 FBan0013556 FBgn0034868 CG13556 2 2R CG13556 CG13556 CDMC31190 2 22 8 DAC13-J16 23-CG13556-RA_1 CG13556 GAGCTCAGCATTTCGTATCAAATTTGTGATAACTGTAGAAGTAAGTACAAGCTAACTGGCCGCCG 65 FBan0013556 FBgn0034868 CG13556 2 2R CG13556 CG13556 CDMC31191 2 23 8 DAC13-N04 26-CG13648-RA_1 CG13648 AGATGAAGACCAGGCTCCCGTTACTGTGTCTCCTCAGGATGCTGAAAAGACTCCAGTTTCCCCGG 65 FBan0013648 FBgn0039257 tnc 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538; wing disc morphogenesis; GO:0007472 kinase regulator activity; GO:0019207; ; GO:0019207; integrin binding; GO:0005178; ; GO:0005178 tnc tenectin "CG13648, CG13648, tenectin" CDMC31191 2 24 8 DAC13-N04 26-CG13648-RA_1 CG13648 AGATGAAGACCAGGCTCCCGTTACTGTGTCTCCTCAGGATGCTGAAAAGACTCCAGTTTCCCCGG 65 FBan0013648 FBgn0039257 tnc 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538; wing disc morphogenesis; GO:0007472 kinase regulator activity; GO:0019207; ; GO:0019207; integrin binding; GO:0005178; ; GO:0005178 tnc tenectin "CG13648, CG13648, tenectin" CDMC31192 2 25 8 DAC13-N16 3-CG13675-RA_1 CG13675 GAACTGCGAGGGATCAGAGCAACTCTACCAGAACAACGACGAACTGTATCGCATCCCAGAGCGCC 65 FBan0013675 FBgn0035845 CG13675 3 3L CG13675 CG13675 CDMC31192 2 26 8 DAC13-N16 3-CG13675-RA_1 CG13675 GAACTGCGAGGGATCAGAGCAACTCTACCAGAACAACGACGAACTGTATCGCATCCCAGAGCGCC 65 FBan0013675 FBgn0035845 CG13675 3 3L CG13675 CG13675 CDMC31193 2 1 9 DAC14-B04 23-CG1648-RA_2 CG1648 ACAAAAATTCGAATTCCATCCGGATCAAACAAACTTACAAACCCGAAAATTAGTTCTTCGACTCCAACG 69 FBan0001648 FBgn0033446 CG1648 2 2R CG1648 CG1648 CDMC31193 2 2 9 DAC14-B04 23-CG1648-RA_2 CG1648 ACAAAAATTCGAATTCCATCCGGATCAAACAAACTTACAAACCCGAAAATTAGTTCTTCGACTCCAACG 69 FBan0001648 FBgn0033446 CG1648 2 2R CG1648 CG1648 CDMC31194 2 3 9 DAC14-B16 9-CG1658-RA_2 CG1658 TAAGAAAGTCGCTTAAGCGCTAGTTGGAATGCATCCCCATGTCTACACCTGTCACTGAACCGGGAGCCG 69 FBgn0000480 CDMC31194 2 4 9 DAC14-B16 9-CG1658-RA_2 CG1658 TAAGAAAGTCGCTTAAGCGCTAGTTGGAATGCATCCCCATGTCTACACCTGTCACTGAACCGGGAGCCG 69 FBgn0000480 CDMC31195 2 5 9 DAC14-F04 2-CG16721-RA_1 CG16721 CGCACCCGTAACCACCAAGTAGAAATGAGTACTCCAGATGCAAATCCCCCTGCAAAAAAGCCAGTGGGA 69 FBan0016721 FBgn0029820 CG16721 X X development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 receptor activity; GO:0004872; ; GO:0004872 CG16721 CG16721 CDMC31195 2 6 9 DAC14-F04 2-CG16721-RA_1 CG16721 CGCACCCGTAACCACCAAGTAGAAATGAGTACTCCAGATGCAAATCCCCCTGCAAAAAAGCCAGTGGGA 69 FBan0016721 FBgn0029820 CG16721 X X development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 receptor activity; GO:0004872; ; GO:0004872 CG16721 CG16721 CDMC31196 2 7 9 DAC14-F16 9-CG16734-RA_4 CG16734 GGAGGACCTGGACAACATTCAGCTGGAGACGTCGCAATTCGACAGCTACCATTCCCTACTTATCCAGGA 69 FBan0016734 FBgn0037667 CG16734 3 3R CG16734 CG16734 CDMC31196 2 8 9 DAC14-F16 9-CG16734-RA_4 CG16734 GGAGGACCTGGACAACATTCAGCTGGAGACGTCGCAATTCGACAGCTACCATTCCCTACTTATCCAGGA 69 FBan0016734 FBgn0037667 CG16734 3 3R CG16734 CG16734 CDMC31197 2 9 9 DAC14-J04 13-CG16765-RB_1 CG16765 GCGACGTACACGAACTGTCTCTGTCACTGATAGCGATCGATAGCTGTACCTCCATGTGTGTGCATGAGT 69 FBan0016765 FBgn0024515 l(3)10615 3 3R l(3)10615 lethal (3) 10615 "CG16765, CG16765, EP(3)3406, BcDNA:RE47781" CDMC31197 2 10 9 DAC14-J04 13-CG16765-RB_1 CG16765 GCGACGTACACGAACTGTCTCTGTCACTGATAGCGATCGATAGCTGTACCTCCATGTGTGTGCATGAGT 69 FBan0016765 FBgn0024515 l(3)10615 3 3R l(3)10615 lethal (3) 10615 "CG16765, CG16765, EP(3)3406, BcDNA:RE47781" CDMC31198 2 11 9 DAC14-J16 2-CG16783-RA_1 CG16783 CCGGAACTTTGTCAATGCTCCGGGAGACTCCAATGTGTACGAGAGCTCTGTGTACTCATGCCTCTTGCG 69 FBan0016783 FBgn0034937 fzr2 2 2R cell cycle; GO:0007049; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 fzr2 fizzy-related 2 "CG16783, fizzy-related 2" CDMC31198 2 12 9 DAC14-J16 2-CG16783-RA_1 CG16783 CCGGAACTTTGTCAATGCTCCGGGAGACTCCAATGTGTACGAGAGCTCTGTGTACTCATGCCTCTTGCG 69 FBan0016783 FBgn0034937 fzr2 2 2R cell cycle; GO:0007049; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 fzr2 fizzy-related 2 "CG16783, fizzy-related 2" CDMC31199 2 13 9 DAC14-N04 11-CG16827-RA_1 CG16827 TGCTATCTGGAAAATCATTGTGTCCGTCATCGTTGGCATTTTGGTGTTTTCGGCCGCAACATATGCCCT 69 FBan0016827 FBgn0034005 alphaPS4 2 2R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157 cell adhesion molecule binding; GO:0050839; ; GO:0050839; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 alphaPS4 alphaPS4 "CG16827, alphaPS4, CT37393, alpha-ps4" CDMC31199 2 14 9 DAC14-N04 11-CG16827-RA_1 CG16827 TGCTATCTGGAAAATCATTGTGTCCGTCATCGTTGGCATTTTGGTGTTTTCGGCCGCAACATATGCCCT 69 FBan0016827 FBgn0034005 alphaPS4 2 2R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157 cell adhesion molecule binding; GO:0050839; ; GO:0050839; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 alphaPS4 alphaPS4 "CG16827, alphaPS4, CT37393, alpha-ps4" CDMC31200 2 15 9 DAC14-N16 16-CG1683-RA_1 CG1683 GCCCCACATGGTGGTCGGTCCCTCATTTCAGATTGTGTTCACTTTCGCAGTGGTTGAGAAAATACAAAT 69 FBan0001683 FBgn0025111 Ant2 X X "ADP transport; GO:0015866; ATP transport; GO:0015867; cation transport; GO:0006812; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" carrier activity; GO:0005386; ATP:ADP antiporter activity; GO:0005471; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005471; ; GO:0005471 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ant2 Adenine nucleotide translocase 2 "CG1683, ADP/ATP translocase., l(1)G0386, l(1)G0247, l(1)G0126, Adenine nucleotide translocase 2" CDMC31200 2 16 9 DAC14-N16 16-CG1683-RA_1 CG1683 GCCCCACATGGTGGTCGGTCCCTCATTTCAGATTGTGTTCACTTTCGCAGTGGTTGAGAAAATACAAAT 69 FBan0001683 FBgn0025111 Ant2 X X "ADP transport; GO:0015866; ATP transport; GO:0015867; cation transport; GO:0006812; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" carrier activity; GO:0005386; ATP:ADP antiporter activity; GO:0005471; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005471; ; GO:0005471 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Ant2 Adenine nucleotide translocase 2 "CG1683, ADP/ATP translocase., l(1)G0386, l(1)G0247, l(1)G0126, Adenine nucleotide translocase 2" CDMC31201 2 17 9 DAC15-B04 2-CG18609-RA_1 CG18609 CGAGGGCCATGAACGCAAACAATTGGAACGAGTATTGCATGCCGCATATCTGCTGAACAAGGTCCTCGA 69 FBan0018609 FBgn0034382 CG18609 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG18609 CG18609 CT42569 CDMC31201 2 18 9 DAC15-B04 2-CG18609-RA_1 CG18609 CGAGGGCCATGAACGCAAACAATTGGAACGAGTATTGCATGCCGCATATCTGCTGAACAAGGTCCTCGA 69 FBan0018609 FBgn0034382 CG18609 2 2R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG18609 CG18609 CT42569 CDMC31202 2 19 9 DAC15-B16 13-CG18631-RA_1 CG18631 CCTGTGCGACATGGAAGACCTATCCACCTTCTCCAGAGGACGATATGATGAGCCCATATTTAGCGAGCA 69 FBan0018631 FBgn0034239 CG18631 2 2R CG18631 CG18631 CDMC31202 2 20 9 DAC15-B16 13-CG18631-RA_1 CG18631 CCTGTGCGACATGGAAGACCTATCCACCTTCTCCAGAGGACGATATGATGAGCCCATATTTAGCGAGCA 69 FBan0018631 FBgn0034239 CG18631 2 2R CG18631 CG18631 CDMC31203 2 21 9 DAC15-F04 2-CG1868-RB_1 CG1868 GCCAGCTGCACAATCTATCCCACTCGGATCCTATCACGGCTATCAATCTGCCCTACTTGAGCTTGTGCA 69 FBan0001868 FBgn0033427 CG1868 2 2R CG1868 CG1868 CDMC31203 2 22 9 DAC15-F04 2-CG1868-RB_1 CG1868 GCCAGCTGCACAATCTATCCCACTCGGATCCTATCACGGCTATCAATCTGCCCTACTTGAGCTTGTGCA 69 FBan0001868 FBgn0033427 CG1868 2 2R CG1868 CG1868 CDMC31204 2 23 9 DAC15-F16 2-CG18747-RA_2 CG18747 CGTCCTTTGAGGGTCGCCATGGATGCATCCGCTATATAGTGAAAGTCCTGCTGATCAGACCGTGGAAGT 69 FBan0018747 FBgn0042104 CG18747 3 3R CG18747 CG18747 CDMC31204 2 24 9 DAC15-F16 2-CG18747-RA_2 CG18747 CGTCCTTTGAGGGTCGCCATGGATGCATCCGCTATATAGTGAAAGTCCTGCTGATCAGACCGTGGAAGT 69 FBan0018747 FBgn0042104 CG18747 3 3R CG18747 CG18747 CDMC31205 2 25 9 DAC15-J04 8-CG18809-RA_1 CG18809 AGCACAAATCGCCACTAAAAGCTAAAAGGCTAACAAGCTGAATCGCACTGATTCGCACGTAGCCAGCCA 69 FBan0018809 FBgn0042132 CG18809 X X "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG18809 CG18809 CDMC31205 2 26 9 DAC15-J04 8-CG18809-RA_1 CG18809 AGCACAAATCGCCACTAAAAGCTAAAAGGCTAACAAGCTGAATCGCACTGATTCGCACGTAGCCAGCCA 69 FBan0018809 FBgn0042132 CG18809 X X "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG18809 CG18809 CDMC31206 2 1 10 DAC15-J16 2-CG18816-RA_1 CG18816 CGCCAAGGATGTAATTTCCCAGGTTCGGACCACCACAATGATCTGGTATCTCGTGGGTGCAAAGCGATT 69 FBan0018816 FBgn0042086 Tsp42Eb 2 2R integral to membrane; GO:0016021 Tsp42Eb Tetraspanin 42Eb "CG18816, CG18816, LP06288, Dm.Tsp42Eb, tetraspanin 42E, BEST:LP06288, Tetraspanin 42Eb" CDMC31206 2 2 10 DAC15-J16 2-CG18816-RA_1 CG18816 CGCCAAGGATGTAATTTCCCAGGTTCGGACCACCACAATGATCTGGTATCTCGTGGGTGCAAAGCGATT 69 FBan0018816 FBgn0042086 Tsp42Eb 2 2R integral to membrane; GO:0016021 Tsp42Eb Tetraspanin 42Eb "CG18816, CG18816, LP06288, Dm.Tsp42Eb, tetraspanin 42E, BEST:LP06288, Tetraspanin 42Eb" CDMC31207 2 3 10 DAC15-N04 14-CG1902-RC_4 CG1902 TGGTGGAGATCATCGACTTCACCAAGATACCCTACTCTCTGCTACTGCAGTTCGATCCTGGCATGTTCA 69 FBan0001902 FBgn0033434 CG1902 2 2R CG1902 CG1902 CDMC31207 2 4 10 DAC15-N04 14-CG1902-RC_4 CG1902 TGGTGGAGATCATCGACTTCACCAAGATACCCTACTCTCTGCTACTGCAGTTCGATCCTGGCATGTTCA 69 FBan0001902 FBgn0033434 CG1902 2 2R CG1902 CG1902 CDMC31208 2 5 10 DAC15-N16 1-CG1909-RA_1 CG1909 TATCACGATCCCTGCAACTCGGTGACCTAAACTCATGCCACCATAGAGCAGCTCTATTGCGAATGGCGG 69 FBan0001909 FBgn0039911 CG1909 4 4 protein ubiquitination; GO:0016567; synaptic transmission; GO:0007268 receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; ubiquitin ligase complex; GO:0000151 CG1909 CG1909 CDMC31208 2 6 10 DAC15-N16 1-CG1909-RA_1 CG1909 TATCACGATCCCTGCAACTCGGTGACCTAAACTCATGCCACCATAGAGCAGCTCTATTGCGAATGGCGG 69 FBan0001909 FBgn0039911 CG1909 4 4 protein ubiquitination; GO:0016567; synaptic transmission; GO:0007268 receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; ubiquitin ligase complex; GO:0000151 CG1909 CG1909 CDMC31209 2 7 10 DAC16-B04 6-CG32736-RB_2 CG32736 AGGCTGTTCACCTTTACTATAAGCCTCTGGAGGACTTGCGCGTCTACATCGAACAGGAGCAACACAGCA 69 FBan0032736 FBgn0052736 CG32736 X X CG32736 CG32736 "CG14428, CG14429, BcDNA:RE60462" CDMC31209 2 8 10 DAC16-B04 6-CG32736-RB_2 CG32736 AGGCTGTTCACCTTTACTATAAGCCTCTGGAGGACTTGCGCGTCTACATCGAACAGGAGCAACACAGCA 69 FBan0032736 FBgn0052736 CG32736 X X CG32736 CG32736 "CG14428, CG14429, BcDNA:RE60462" CDMC31210 2 9 10 DAC16-B16 1-CG32745-RB_1 CG32745 TGCTGACGTTGATTGCCCAGGGATCGGCTAACTTTCAGGATGTTTTGCGACACGCCATCAAGATCTTCA 69 FBan0032745 FBgn0052745 CG32745 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.-; ; GO:0004812 ; EC:6.1.1.- CG32745 CG32745 CDMC31210 2 10 10 DAC16-B16 1-CG32745-RB_1 CG32745 TGCTGACGTTGATTGCCCAGGGATCGGCTAACTTTCAGGATGTTTTGCGACACGCCATCAAGATCTTCA 69 FBan0032745 FBgn0052745 CG32745 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.-; ; GO:0003916 ; EC:5.99.1.-; ; GO:0004812 ; EC:6.1.1.- CG32745 CG32745 CDMC31211 2 11 10 DAC16-F04 23-CG32788-RB_5 CG32788 ACCGATATGAAATCTGCCTACAGCCAGACAAAAAAAACCTTAAAGAGAAAGATCAGAAGAGGAACAGAA 69 FBan0032788 FBgn0021738 Crg-1 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Crg-1 Circadianly Regulated Gene "CG32788, crg1, Circadianly Regulated Gene" CDMC31211 2 12 10 DAC16-F04 23-CG32788-RB_5 CG32788 ACCGATATGAAATCTGCCTACAGCCAGACAAAAAAAACCTTAAAGAGAAAGATCAGAAGAGGAACAGAA 69 FBan0032788 FBgn0021738 Crg-1 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Crg-1 Circadianly Regulated Gene "CG32788, crg1, Circadianly Regulated Gene" CDMC31212 2 13 10 DAC16-F16 1-CG32797-RA_6 CG32797 GTCGTTACCTCACTGATGCTGGAGGCTCAGTGTCTGGAGCAGGATCTGGATCTACGGCTGGATCTGAAT 69 FBan0032797 FBgn0052797 CG32797 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32797 CG32797 CDMC31212 2 14 10 DAC16-F16 1-CG32797-RA_6 CG32797 GTCGTTACCTCACTGATGCTGGAGGCTCAGTGTCTGGAGCAGGATCTGGATCTACGGCTGGATCTGAAT 69 FBan0032797 FBgn0052797 CG32797 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32797 CG32797 CDMC31213 2 15 10 DAC16-J04 22-CG32823-RB_1 CG32823 GGTCGCTAAAGCTACCCATTTCAAGTTGCCAGTTCTCTGTCGTCTCCGGAATTAATTCAAATAAGCCGC 69 FBan0032823 FBgn0052823 Sdic:CG32823 X X "RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; vesicle-mediated transport; GO:0016192" structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0005509 Sdic:CG32823 Sdic:CG32823 CG32823 CDMC31213 2 16 10 DAC16-J04 22-CG32823-RB_1 CG32823 GGTCGCTAAAGCTACCCATTTCAAGTTGCCAGTTCTCTGTCGTCTCCGGAATTAATTCAAATAAGCCGC 69 FBan0032823 FBgn0052823 Sdic:CG32823 X X "RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; mitosis; GO:0007067; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; vesicle-mediated transport; GO:0016192" structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0005509 Sdic:CG32823 Sdic:CG32823 CG32823 CDMC31214 2 17 10 DAC16-J16 3-CG3283-RA_1 CG3283 TCCCCTGCTGTCCTTAACCAGTGAGCTAAGCCTCCGAAAATGTGTATTGGAGACTCCTCCAGCCAACAT 69 FBan0003283 FBgn0014028 SdhB 2 2R electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; electron transporter activity; GO:0005489; ; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 respiratory chain complex II (sensu Eukaryota); GO:0005749 SdhB Succinate dehydrogenase B "CG3283, SDHb, SDH-IP, Succinate dehydrogenase Iron Protein, Ip, sdhB" CDMC31214 2 18 10 DAC16-J16 3-CG3283-RA_1 CG3283 TCCCCTGCTGTCCTTAACCAGTGAGCTAAGCCTCCGAAAATGTGTATTGGAGACTCCTCCAGCCAACAT 69 FBan0003283 FBgn0014028 SdhB 2 2R electron transport; GO:0006118; tricarboxylic acid cycle; GO:0006099 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; electron transporter activity; GO:0005489; ; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 respiratory chain complex II (sensu Eukaryota); GO:0005749 SdhB Succinate dehydrogenase B "CG3283, SDHb, SDH-IP, Succinate dehydrogenase Iron Protein, Ip, sdhB" CDMC31215 2 19 10 DAC16-N04 13-CG32918-RA_1 CG32918 TCCTTTGGTTTTACCTCGCTCACATTTCAACTGGGACTGCTCATAAGGTGATCCACTATCGCAGCGTGA 69 FBgn0052918 CDMC31215 2 20 10 DAC16-N04 13-CG32918-RA_1 CG32918 TCCTTTGGTTTTACCTCGCTCACATTTCAACTGGGACTGCTCATAAGGTGATCCACTATCGCAGCGTGA 69 FBgn0052918 CDMC31216 2 21 10 DAC16-N16 23-CG32937-RA_3 CG32937 TCTTCCCTATTGCGGTAGTGATGGTTTAAGTAAAGCGTCCAAGGACTATAGCAATATGGACTCGGGTAT 69 FBan0032937 FBgn0052937 CG32937 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32937 CG32937 CDMC31216 2 22 10 DAC16-N16 23-CG32937-RA_3 CG32937 TCTTCCCTATTGCGGTAGTGATGGTTTAAGTAAAGCGTCCAAGGACTATAGCAATATGGACTCGGGTAT 69 FBan0032937 FBgn0052937 CG32937 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32937 CG32937 CDMC31217 2 23 10 DAC17-B04 3-CG12273-RA_2 CG12273 GTGGCTCTACTCAATCGCGACAATGTGGCCTTGTTTGCCAGGTTCCGATTCAAAAAGCAGCAGGA 65 FBan0012273 FBgn0016762 angel 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 angel angel CG12273 CDMC31217 2 24 10 DAC17-B04 3-CG12273-RA_2 CG12273 GTGGCTCTACTCAATCGCGACAATGTGGCCTTGTTTGCCAGGTTCCGATTCAAAAAGCAGCAGGA 65 FBan0012273 FBgn0016762 angel 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 angel angel CG12273 CDMC31218 2 25 10 DAC17-B16 3-CG12309-RA_1 CG12309 TAGACACTCCATTTGTGGTCCATGCTGCACGAAGAACCGGTGGGGCTAGATGGTGCACATGAAAC 65 FBan0012309 FBgn0033542 CG12309 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG12309 CG12309 CDMC31218 2 26 10 DAC17-B16 3-CG12309-RA_1 CG12309 TAGACACTCCATTTGTGGTCCATGCTGCACGAAGAACCGGTGGGGCTAGATGGTGCACATGAAAC 65 FBan0012309 FBgn0033542 CG12309 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG12309 CG12309 CDMC31219 2 1 11 DAC17-F04 3-CG1246-RB_1 CG1246 ATCTCCGGAGTGGTCTATTGGCCCTGGTTCCTATCCGTGCTAGCTGGCAGTATCCTAGATGTGGT 65 FBan0001246 FBgn0035360 CG1246 3 3L CG1246 CG1246 CDMC31219 2 2 11 DAC17-F04 3-CG1246-RB_1 CG1246 ATCTCCGGAGTGGTCTATTGGCCCTGGTTCCTATCCGTGCTAGCTGGCAGTATCCTAGATGTGGT 65 FBan0001246 FBgn0035360 CG1246 3 3L CG1246 CG1246 CDMC31220 2 3 11 DAC17-F16 3-CG12498-RA_1 CG12498 AATCGCCAACTGAAAATCCATCGAGGGGAAAAGCGGATACCGTAGACGAGGAGGAAGATCCGGGG 65 FBan0012498 FBgn0040356 CG12498 X X CG12498 CG12498 EG:BACR43E12.1 CDMC31220 2 4 11 DAC17-F16 3-CG12498-RA_1 CG12498 AATCGCCAACTGAAAATCCATCGAGGGGAAAAGCGGATACCGTAGACGAGGAGGAAGATCCGGGG 65 FBan0012498 FBgn0040356 CG12498 X X CG12498 CG12498 EG:BACR43E12.1 CDMC31221 2 5 11 DAC17-J04 2-CG12590-RA_1 CG12590 TTGAGAGCCTACTTCTGTGCGACACGATGGGTACCGGCACCACTTACGACATTCGGAGCATTAGG 65 FBan0012590 FBgn0037294 CG12590 3 3R CG12590 CG12590 CDMC31221 2 6 11 DAC17-J04 2-CG12590-RA_1 CG12590 TTGAGAGCCTACTTCTGTGCGACACGATGGGTACCGGCACCACTTACGACATTCGGAGCATTAGG 65 FBan0012590 FBgn0037294 CG12590 3 3R CG12590 CG12590 CDMC31222 2 7 11 DAC17-J16 23-CG12645-RA_1 CG12645 GACCTACTATGATGCAATGCAAACGTTTACGATTCAGAATAATTTGGATTATTCCAACGATCGGC 65 FBan0012645 FBgn0030181 CG12645 X X CG12645 CG12645 CDMC31222 2 8 11 DAC17-J16 23-CG12645-RA_1 CG12645 GACCTACTATGATGCAATGCAAACGTTTACGATTCAGAATAATTTGGATTATTCCAACGATCGGC 65 FBan0012645 FBgn0030181 CG12645 X X CG12645 CG12645 CDMC31223 2 9 11 DAC17-N04 16-CG12732-RA_1 CG12732 CAGGCGCTACAATCGTTACAGCCGCAAGTGCCGCAAACACAAATGTCGCAACCGGTGAACACGGC 65 FBan0012732 FBgn0029759 CG12732 X X CG12732 CG12732 CDMC31223 2 10 11 DAC17-N04 16-CG12732-RA_1 CG12732 CAGGCGCTACAATCGTTACAGCCGCAAGTGCCGCAAACACAAATGTCGCAACCGGTGAACACGGC 65 FBan0012732 FBgn0029759 CG12732 X X CG12732 CG12732 CDMC31224 2 11 11 DAC17-N16 2-CG12792-RA_2 CG12792 GACATACACGTGTGGACTCCGGTAGAAGACGGCACATGGAAAGTTGATCAACGTCCCCTAGCGGG 65 FBan0012792 FBgn0022288 l(2)09851 2 2R l(2)09851 lethal (2) 09851 "CG12792, CG12792, CG12792, l(2)k08138" CDMC31224 2 12 11 DAC17-N16 2-CG12792-RA_2 CG12792 GACATACACGTGTGGACTCCGGTAGAAGACGGCACATGGAAAGTTGATCAACGTCCCCTAGCGGG 65 FBan0012792 FBgn0022288 l(2)09851 2 2R l(2)09851 lethal (2) 09851 "CG12792, CG12792, CG12792, l(2)k08138" CDMC31225 2 13 11 DAC18-B04 3-CG5687-RA_13 CG5687 GGGCTGCTTCTACAGTGGCAATCCCATCCAGGTCTTTCAGACTGCTTCCGATCACAATCGCTTGGAG 67 FBan0005687 FBgn0035293 CG5687 3 3L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG5687 CG5687 anon-EST:Posey42 CDMC31225 2 14 11 DAC18-B04 3-CG5687-RA_13 CG5687 GGGCTGCTTCTACAGTGGCAATCCCATCCAGGTCTTTCAGACTGCTTCCGATCACAATCGCTTGGAG 67 FBan0005687 FBgn0035293 CG5687 3 3L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG5687 CG5687 anon-EST:Posey42 CDMC31226 2 15 11 DAC18-B16 3-CG5784-RA_1 CG5784 CACAGCCTTGGAATCGCTTAGCTTGATCAACGTGGGTCTCACCACACTGAAAGGTTTCCCCAAGCTG 67 FBan0005784 FBgn0034282 Mapmodulin 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; phosphatase inhibitor activity; GO:0019212; ; GO:0019212 microtubule associated complex; GO:0005875 Mapmodulin Mapmodulin "CG5784, CG5784, CT18148, CT42180, anon-EST:fe3A2, anon-fast-evolving-3A2, Mapmodulin" CDMC31226 2 16 11 DAC18-B16 3-CG5784-RA_1 CG5784 CACAGCCTTGGAATCGCTTAGCTTGATCAACGTGGGTCTCACCACACTGAAAGGTTTCCCCAAGCTG 67 FBan0005784 FBgn0034282 Mapmodulin 2 2R microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; phosphatase inhibitor activity; GO:0019212; ; GO:0019212 microtubule associated complex; GO:0005875 Mapmodulin Mapmodulin "CG5784, CG5784, CT18148, CT42180, anon-EST:fe3A2, anon-fast-evolving-3A2, Mapmodulin" CDMC31227 2 17 11 DAC18-F04 2-CG6413-RA_1 CG6413 GACGTGGTGTTCCACTCCTTTGATCCAGTCACGGTTCGTCTTAGCCTGGATTCCAGCAATGTGCAGC 67 FBan0006413 FBgn0039183 Dis3 3 3R mRNA processing; GO:0006397; mitosis; GO:0007067 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Dis3 Dis3 "CG6413, CG6413, dDis3" CDMC31227 2 18 11 DAC18-F04 2-CG6413-RA_1 CG6413 GACGTGGTGTTCCACTCCTTTGATCCAGTCACGGTTCGTCTTAGCCTGGATTCCAGCAATGTGCAGC 67 FBan0006413 FBgn0039183 Dis3 3 3R mRNA processing; GO:0006397; mitosis; GO:0007067 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Dis3 Dis3 "CG6413, CG6413, dDis3" CDMC31228 2 19 11 DAC18-F16 23-CG6544-RC_2 CG6544 CTCAAAGCATCCAAATCTAAAAATCTCAACATGGTTTACGAAAGTGGATTTACGACCCGCAGAACCT 67 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC31228 2 20 11 DAC18-F16 23-CG6544-RC_2 CG6544 CTCAAAGCATCCAAATCTAAAAATCTCAACATGGTTTACGAAAGTGGATTTACGACCCGCAGAACCT 67 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC31229 2 21 11 DAC18-J04 3-CG7121-RA_1 CG7121 CCCACAAAGTGGACAGTTTTTGAGCCCTCGTCCAAATATCCCAGCTGGCTTAGGCCTTTGGATGAGC 67 FBan0007121 FBgn0026760 Tehao 2 2L Toll signaling pathway; GO:0008063; antifungal polypeptide induction; GO:0006967; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Tehao Tehao "CG7121, Toll-5, Tl-5, CT22017, tehao, dTLR5, toll, dToll5, Toll 5" CDMC31229 2 22 11 DAC18-J04 3-CG7121-RA_1 CG7121 CCCACAAAGTGGACAGTTTTTGAGCCCTCGTCCAAATATCCCAGCTGGCTTAGGCCTTTGGATGAGC 67 FBan0007121 FBgn0026760 Tehao 2 2L Toll signaling pathway; GO:0008063; antifungal polypeptide induction; GO:0006967; cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Tehao Tehao "CG7121, Toll-5, Tl-5, CT22017, tehao, dTLR5, toll, dToll5, Toll 5" CDMC31230 2 23 11 DAC18-J16 3-CG7207-RA_1 CG7207 AGTACGCCAAGCAGGAGTCAAAGAATGGAAAATGCGTACGGATCTTCCTGACCGTCATCCTGGCCTG 67 FBan0007207 FBgn0027569 CG7207 3 3L protein amino acid phosphorylation; GO:0006468 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG7207 CG7207 BcDNA:GH07688 CDMC31230 2 24 11 DAC18-J16 3-CG7207-RA_1 CG7207 AGTACGCCAAGCAGGAGTCAAAGAATGGAAAATGCGTACGGATCTTCCTGACCGTCATCCTGGCCTG 67 FBan0007207 FBgn0027569 CG7207 3 3L protein amino acid phosphorylation; GO:0006468 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG7207 CG7207 BcDNA:GH07688 CDMC31231 2 25 11 DAC18-N04 3-CG7803-RA_1 CG7803 GCAAAAAGAGGAGGAACAACTGCGGAAGTGCTCCACTTCATGAGGTCTGGAGGACATAAGCGACGCC 67 FBan0007803 FBgn0004050 z X X "ommochrome biosynthesis; GO:0006727; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634 z zeste "CG7803, CG7803, en-bx, EG:BACH59J11.3, e(bx): enhancer-of-bithorax, enhancer-of-bithorax, zeste" CDMC31231 2 26 11 DAC18-N04 3-CG7803-RA_1 CG7803 GCAAAAAGAGGAGGAACAACTGCGGAAGTGCTCCACTTCATGAGGTCTGGAGGACATAAGCGACGCC 67 FBan0007803 FBgn0004050 z X X "ommochrome biosynthesis; GO:0006727; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634 z zeste "CG7803, CG7803, en-bx, EG:BACH59J11.3, e(bx): enhancer-of-bithorax, enhancer-of-bithorax, zeste" CDMC31232 2 1 12 DAC18-N16 2-CG7927-RA_2 CG7927 AGGAACCTCAATCAGCTGCCCAATATGGCCTACTCGTATGCTTTGGCTCTACACACGCTCTATGGCG 67 FBan0007927 FBgn0027549 CG7927 3 3L CG7927 CG7927 "BcDNA:GH11023, anon-WO0172774.138" CDMC31232 2 2 12 DAC18-N16 2-CG7927-RA_2 CG7927 AGGAACCTCAATCAGCTGCCCAATATGGCCTACTCGTATGCTTTGGCTCTACACACGCTCTATGGCG 67 FBan0007927 FBgn0027549 CG7927 3 3L CG7927 CG7927 "BcDNA:GH11023, anon-WO0172774.138" CDMC31233 2 3 12 DAC19-B04 1-CG7811-RA_1 CG7811 TCCGTACTTCATCAATCAGTTGTACTCGGGTGTGGATCCATACGCGCTGGTAGGTCAATGGCTCACCG 68 FBan0007811 FBgn0000153 b 2 2L amino acid metabolism; GO:0006520; beta-alanine biosynthesis; GO:0019483; pigmentation during development; GO:0048066; sulfur metabolism; GO:0006790; synaptic transmission; GO:0007268; uracil catabolism; GO:0006212; visual behavior; GO:0007632 aspartate 1-decarboxylase activity; GO:0004068 ; EC:4.1.1.11; ; GO:0004068 ; EC:4.1.1.11; glutamate decarboxylase activity; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004068 ; EC:4.1.1.11 b black "CG7811, GAD[[2]], cDNA 1, DGad2, BG:DS00941.5, Gad2, anon-34Db, Oregon-R glutamate decarboxylase, DmGad2, Glutamic acid decarboxylase 2" CDMC31233 2 4 12 DAC19-B04 1-CG7811-RA_1 CG7811 TCCGTACTTCATCAATCAGTTGTACTCGGGTGTGGATCCATACGCGCTGGTAGGTCAATGGCTCACCG 68 FBan0007811 FBgn0000153 b 2 2L amino acid metabolism; GO:0006520; beta-alanine biosynthesis; GO:0019483; pigmentation during development; GO:0048066; sulfur metabolism; GO:0006790; synaptic transmission; GO:0007268; uracil catabolism; GO:0006212; visual behavior; GO:0007632 aspartate 1-decarboxylase activity; GO:0004068 ; EC:4.1.1.11; ; GO:0004068 ; EC:4.1.1.11; glutamate decarboxylase activity; GO:0004351 ; EC:4.1.1.15; ; GO:0004351 ; EC:4.1.1.15; ; GO:0004068 ; EC:4.1.1.11 b black "CG7811, GAD[[2]], cDNA 1, DGad2, BG:DS00941.5, Gad2, anon-34Db, Oregon-R glutamate decarboxylase, DmGad2, Glutamic acid decarboxylase 2" CDMC31234 2 5 12 DAC19-B16 14-CG7928-RA_1 CG7928 AGAGGACGATCTCGACCGAGAGACCACCATAAGCAAATTCGATGGGAATATTGAGGAGGCACAGCAAC 68 FBan0007928 FBgn0039740 CG7928 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7928 CG7928 CDMC31234 2 6 12 DAC19-B16 14-CG7928-RA_1 CG7928 AGAGGACGATCTCGACCGAGAGACCACCATAAGCAAATTCGATGGGAATATTGAGGAGGCACAGCAAC 68 FBan0007928 FBgn0039740 CG7928 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7928 CG7928 CDMC31235 2 7 12 DAC19-F04 3-CG8494-RA_1 CG8494 GGTGAACGGTGTGCACGAGAAGTCACGTGACAAGGGAAAATTGCGGAATAGTTCAAAAAGCGGCAGCA 68 FBan0008494 FBgn0033916 CG8494 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG8494 CG8494 CDMC31235 2 8 12 DAC19-F04 3-CG8494-RA_1 CG8494 GGTGAACGGTGTGCACGAGAAGTCACGTGACAAGGGAAAATTGCGGAATAGTTCAAAAAGCGGCAGCA 68 FBan0008494 FBgn0033916 CG8494 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG8494 CG8494 CDMC31236 2 9 12 DAC19-F16 1-CG8637-RA_1 CG8637 TGGGAGTCATCATGTACGAAATGCTGATGGGCTATCCTCCATTCTGCTCGGACAATCCCCAGGACACC 68 FBan0008637 FBgn0003744 trc 3 3L antennal morphogenesis; GO:0007469; cytokinesis; GO:0000910; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of dendrite morphogenesis; GO:0050773; regulation of progression through cell cycle; GO:0000074; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 nucleus; GO:0005634 trc tricornered "CG8637, CG8637, tricorner, Ndr, NDR, 0669/17, dmTRC, l(3)S066917, Nuclear Dbf2-related protein kinase" CDMC31236 2 10 12 DAC19-F16 1-CG8637-RA_1 CG8637 TGGGAGTCATCATGTACGAAATGCTGATGGGCTATCCTCCATTCTGCTCGGACAATCCCCAGGACACC 68 FBan0008637 FBgn0003744 trc 3 3L antennal morphogenesis; GO:0007469; cytokinesis; GO:0000910; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of dendrite morphogenesis; GO:0050773; regulation of progression through cell cycle; GO:0000074; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 nucleus; GO:0005634 trc tricornered "CG8637, CG8637, tricorner, Ndr, NDR, 0669/17, dmTRC, l(3)S066917, Nuclear Dbf2-related protein kinase" CDMC31237 2 11 12 DAC19-J04 24-CG9088-RA_3 CG9088 ACCGGTATTTACTAAGTTTAGTAAAGTCACTTGAGAGTTTTTGTAGTACATATTTACCAATTATCGCT 68 FBan0009088 FBgn0031759 lid 2 2L "development; GO:0007275; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 intracellular; GO:0005622; nucleus; GO:0005634 lid little imaginal discs "CG9088, CG9088, l(2)10424, little imaginal discs" CDMC31237 2 12 12 DAC19-J04 24-CG9088-RA_3 CG9088 ACCGGTATTTACTAAGTTTAGTAAAGTCACTTGAGAGTTTTTGTAGTACATATTTACCAATTATCGCT 68 FBan0009088 FBgn0031759 lid 2 2L "development; GO:0007275; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 intracellular; GO:0005622; nucleus; GO:0005634 lid little imaginal discs "CG9088, CG9088, l(2)10424, little imaginal discs" CDMC31238 2 13 12 DAC19-J16 3-CG9248-RA_2 CG9248 TGGGCGTGCTAGTCCAGAACTGTCCAGAACTGACCCATGATGTGGCCAAGATCTTTGGAGAGTACTGG 68 FBan0009248 FBgn0032923 CG9248 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9248 CG9248 CDMC31238 2 14 12 DAC19-J16 3-CG9248-RA_2 CG9248 TGGGCGTGCTAGTCCAGAACTGTCCAGAACTGACCCATGATGTGGCCAAGATCTTTGGAGAGTACTGG 68 FBan0009248 FBgn0032923 CG9248 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9248 CG9248 CDMC31239 2 15 12 DAC19-N04 3-CG9730-RA_1 CG9730 ACATGCGCATCAACTTCCAGAGATCTCCGCACACCATGGTCCGGATCAATTCAATTGAACTGGCTCGT 68 FBan0009730 FBgn0036853 mRpL21 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL21 mitochondrial ribosomal protein L21 "CG9730, CG9730, MRP-L21, mitochondrial ribosomal protein L21" CDMC31239 2 16 12 DAC19-N04 3-CG9730-RA_1 CG9730 ACATGCGCATCAACTTCCAGAGATCTCCGCACACCATGGTCCGGATCAATTCAATTGAACTGGCTCGT 68 FBan0009730 FBgn0036853 mRpL21 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL21 mitochondrial ribosomal protein L21 "CG9730, CG9730, MRP-L21, mitochondrial ribosomal protein L21" CDMC31240 2 17 12 DAC19-N16 18-CG9907-RA_6 CG9907 CTGTTCCTGGTCATGTTCATCTTTGCCATTTTCGGCATGTCGTTCTTCATGCACGTGAAGGAGAAGAG 68 FBan0009907 FBgn0003036 para X X "male courtship behavior (sensu Insecta), song production; GO:0045433; muscle contraction; GO:0006936; response to DDT; GO:0046680; response to pyrethroid; GO:0046684; sodium ion transport; GO:0006814; synaptic transmission; GO:0007268" voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; voltage-gated sodium channel complex; GO:0001518 para paralytic "CG9907, CG9907, CG9907, smellblind, olfD, sbl: smellblind, DmNa[[v]]1, paralyzed, l(1)14Da, l(1)ESHS48, sbl" CDMC31240 2 18 12 DAC19-N16 18-CG9907-RA_6 CG9907 CTGTTCCTGGTCATGTTCATCTTTGCCATTTTCGGCATGTCGTTCTTCATGCACGTGAAGGAGAAGAG 68 FBan0009907 FBgn0003036 para X X "male courtship behavior (sensu Insecta), song production; GO:0045433; muscle contraction; GO:0006936; response to DDT; GO:0046680; response to pyrethroid; GO:0046684; sodium ion transport; GO:0006814; synaptic transmission; GO:0007268" voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; voltage-gated sodium channel complex; GO:0001518 para paralytic "CG9907, CG9907, CG9907, smellblind, olfD, sbl: smellblind, DmNa[[v]]1, paralyzed, l(1)14Da, l(1)ESHS48, sbl" CDMC31241 2 19 12 DAC20-B04 22-CG18026-RA_2 CG18026 CCCAGGCGCTCAATACAGCAGCTCTCAACCCATCAATGATACTGTGCGGCAAAAAAGATCAAGTAAATT 69 FBgn0040483 CDMC31241 2 20 12 DAC20-B04 22-CG18026-RA_2 CG18026 CCCAGGCGCTCAATACAGCAGCTCTCAACCCATCAATGATACTGTGCGGCAAAAAAGATCAAGTAAATT 69 FBgn0040483 CDMC31242 2 21 12 DAC20-B16 2-CG1804-RA_1 CG1804 TGGGCATCTTCGGAACCGTCTTTCTGCTGATCTCCATCTCGTTTGTGGTCTGTCTCTGCAAACGCACTA 69 FBan0001804 FBgn0039862 kek6 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004601 ; EC:1.11.1.7 kek6 kek6 "CG1804, CG1804, kekkon-like" CDMC31242 2 22 12 DAC20-B16 2-CG1804-RA_1 CG1804 TGGGCATCTTCGGAACCGTCTTTCTGCTGATCTCCATCTCGTTTGTGGTCTGTCTCTGCAAACGCACTA 69 FBan0001804 FBgn0039862 kek6 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004601 ; EC:1.11.1.7 kek6 kek6 "CG1804, CG1804, kekkon-like" CDMC31243 2 23 12 DAC20-F04 18-CG18105-RA_1 CG18105 GCGGGGGAAATCGCTACGATCGCCAATTCCTCAAGTACAACATCCTGTGAGATGTGGAGTATTCGATTT 69 FBan0018105 FBgn0028738 ETH 2 2R ecdysis (sensu Insecta); GO:0018990; neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255; ; GO:0005102; ; GO:0005184; ; GO:0008255 ETH Ecdysis triggering hormone "CG18105, CG18105, DmETH, eth, Drm-ETH-1, Drm-ETH-2, ETH1, ETH2, ecdysis-triggering hormone-1, ecdysis-triggering hormone-2, ecdysis triggering hormone-1, ecdysis triggering hormone-2, ETH-1" CDMC31243 2 24 12 DAC20-F04 18-CG18105-RA_1 CG18105 GCGGGGGAAATCGCTACGATCGCCAATTCCTCAAGTACAACATCCTGTGAGATGTGGAGTATTCGATTT 69 FBan0018105 FBgn0028738 ETH 2 2R ecdysis (sensu Insecta); GO:0018990; neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255; ; GO:0005102; ; GO:0005184; ; GO:0008255 ETH Ecdysis triggering hormone "CG18105, CG18105, DmETH, eth, Drm-ETH-1, Drm-ETH-2, ETH1, ETH2, ecdysis-triggering hormone-1, ecdysis-triggering hormone-2, ecdysis triggering hormone-1, ecdysis triggering hormone-2, ETH-1" CDMC31244 2 25 12 DAC20-F16 17-CG1812-RA_1 CG1812 GCTAGCGTAGACCTATGTACATGCGAGATTTTGTGATGACTGCAGTAACGAAAATGTGCCAAGCACGGA 69 FBan0001812 FBgn0031119 CG1812 X X actin binding; GO:0003779; ; GO:0003779 CG1812 CG1812 CDMC31244 2 26 12 DAC20-F16 17-CG1812-RA_1 CG1812 GCTAGCGTAGACCTATGTACATGCGAGATTTTGTGATGACTGCAGTAACGAAAATGTGCCAAGCACGGA 69 FBan0001812 FBgn0031119 CG1812 X X actin binding; GO:0003779; ; GO:0003779 CG1812 CG1812 CDMC31245 2 1 13 DAC20-J04 18-CG18188-RA_4 CG18188 GGGTCCGTTGAGAGCTGACGCGAAAAAAATGAACAACGAACCCTATATTAAGTGTTACAGCTGCTCCGA 69 FBan0018188 FBgn0033659 Damm 2 2R apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 Damm Death associated molecule related to Mch2 "CG18188, CG18188, DAMM: Death Associated Molecule related to Mch2, daydream, Daydream, damm, Damm/Daydream, Death Associated Molecule related to Mch2, DAMM, Death associated molecule related to Mch2" CDMC31245 2 2 13 DAC20-J04 18-CG18188-RA_4 CG18188 GGGTCCGTTGAGAGCTGACGCGAAAAAAATGAACAACGAACCCTATATTAAGTGTTACAGCTGCTCCGA 69 FBan0018188 FBgn0033659 Damm 2 2R apoptosis; GO:0006915; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; programmed cell death; GO:0012501; proteolysis; GO:0006508 caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 Damm Death associated molecule related to Mch2 "CG18188, CG18188, DAMM: Death Associated Molecule related to Mch2, daydream, Daydream, damm, Damm/Daydream, Death Associated Molecule related to Mch2, DAMM, Death associated molecule related to Mch2" CDMC31246 2 3 13 DAC20-J16 1-CG18211-RA_1 CG18211 CCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTGATCAACAACGCCTAATTATTTTTCGAAA 69 FBan0018211 FBgn0010357 betaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 betaTry betaTrypsin "CG18211, beta, beta, DmBetaTry, Try, SP119" CDMC31246 2 4 13 DAC20-J16 1-CG18211-RA_1 CG18211 CCGGTGTCTATGCCGATGTTGCTGCCCTCCGCTCCTGGGTGATCAACAACGCCTAATTATTTTTCGAAA 69 FBan0018211 FBgn0010357 betaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 betaTry betaTrypsin "CG18211, beta, beta, DmBetaTry, Try, SP119" CDMC31247 2 5 13 DAC20-N04 23-CG18255-RE_3 CG18255 GCCCACCTCAGTCTTCTTTCCTGACCCTATGTGTTCACTCCAACCAATACAATATATCGTTCTGACTAC 69 CDMC31247 2 6 13 DAC20-N04 23-CG18255-RE_3 CG18255 GCCCACCTCAGTCTTCTTTCCTGACCCTATGTGTTCACTCCAACCAATACAATATATCGTTCTGACTAC 69 CDMC31248 2 7 13 DAC20-N16 3-CG18268-RA_1 CG18268 CCAGCCACCTGTAGACTTCCTTTCGGCAATGTGGAGTATGTGCTCAAGGTTGTTCTCGAAAGACGGGGA 69 FBan0018268 FBgn0037520 CG18268 3 3R CG18268 CG18268 CDMC31248 2 8 13 DAC20-N16 3-CG18268-RA_1 CG18268 CCAGCCACCTGTAGACTTCCTTTCGGCAATGTGGAGTATGTGCTCAAGGTTGTTCTCGAAAGACGGGGA 69 FBan0018268 FBgn0037520 CG18268 3 3R CG18268 CG18268 CDMC31249 2 9 13 DAC21-B04 23-CG3886-RA_1 CG3886 CAGCAGCCCCTCGTAGATCGTAGCTCTAATTAATTTTTAAAGACCTTGTTTTAGTTATTCATTTACGTT 69 FBan0003886 FBgn0005624 Psc 2 2R chromatin remodeling; GO:0006338; chromatin silencing; GO:0006342; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Psc Posterior sex combs "CG3886, CG3886, 49Ea, l(2)Psc, Su(z)2-C, l(2)49Ea, vr14, psc, PSC, Psc1, dPSC, D-Bmi, l(2)vr14" CDMC31249 2 10 13 DAC21-B04 23-CG3886-RA_1 CG3886 CAGCAGCCCCTCGTAGATCGTAGCTCTAATTAATTTTTAAAGACCTTGTTTTAGTTATTCATTTACGTT 69 FBan0003886 FBgn0005624 Psc 2 2R chromatin remodeling; GO:0006338; chromatin silencing; GO:0006342; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 PRC1 complex; GO:0035102; intercalary heterochromatin; GO:0005725; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Psc Posterior sex combs "CG3886, CG3886, 49Ea, l(2)Psc, Su(z)2-C, l(2)49Ea, vr14, psc, PSC, Psc1, dPSC, D-Bmi, l(2)vr14" CDMC31250 2 11 13 DAC21-B16 9-CG3907-RA_2 CG3907 TCTCACAGCTACCCACGATTCAGGCTAACGCTTTACCCGCAAACTTATCGGATGATATTGCTGCGCTGA 69 FBan0003907 FBgn0034958 CG3907 2 2R purine ribonucleoside monophosphate biosynthesis; GO:0009168 deaminase activity; GO:0019239; ; GO:0019239 CG3907 CG3907 CDMC31250 2 12 13 DAC21-B16 9-CG3907-RA_2 CG3907 TCTCACAGCTACCCACGATTCAGGCTAACGCTTTACCCGCAAACTTATCGGATGATATTGCTGCGCTGA 69 FBan0003907 FBgn0034958 CG3907 2 2R purine ribonucleoside monophosphate biosynthesis; GO:0009168 deaminase activity; GO:0019239; ; GO:0019239 CG3907 CG3907 CDMC31251 2 13 13 DAC21-F04 2-CG3942-RA_1 CG3942 GGCGCAAAAATCGCCTATGCATGAACATCGGGCACAAAGGATCGGGAAATACGTACCGGTTAGGATCCG 69 FBan0003942 FBgn0038008 CG3942 3 3R CG3942 CG3942 CDMC31251 2 14 13 DAC21-F04 2-CG3942-RA_1 CG3942 GGCGCAAAAATCGCCTATGCATGAACATCGGGCACAAAGGATCGGGAAATACGTACCGGTTAGGATCCG 69 FBan0003942 FBgn0038008 CG3942 3 3R CG3942 CG3942 CDMC31252 2 15 13 DAC21-F16 23-CG3954-RB_10 CG3954 AGTAACTGAGGCAGTAAGCACGTAACGATAATGATACAAAAAGCGTTGATTGTGATTCGAGTGACAGCG 69 FBan0003954 FBgn0000382 csw X X "R7 cell fate commitment; GO:0007465; determination of anterior/posterior axis, embryo; GO:0008595; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; epidermal growth factor receptor signaling pathway; GO:0007173; fibroblast growth factor receptor signaling pathway; GO:0008543; imaginal disc development; GO:0007444; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid dephosphorylation; GO:0006470; sevenless signaling pathway; GO:0045500; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal epithelial cell migration (sensu Insecta); GO:0007427; ventral midline development; GO:0007418" protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; ; GO:0004726; receptor signaling protein tyrosine phosphatase activity; GO:0004728; protein binding; GO:0005515; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004726; ; GO:0004728; ; GO:0005515 cytoplasm; GO:0005737 csw corkscrew "CG3954, CG3954, CG3954, CG3954, l(1)csw, l(1)2Db, E(sev)1A: Enhancer of sevenless 1A, 19-106, l(1)2Dd, Csw, l(1)G0170, CSW, Csw/Shp2, EG:BACN25G24.2, anon-WO03040301.207, anon-WO03040301.209, anon-WO03040301.219, l(1)GA114, Enhancer of sevenless 1A, E(sev)1A" CDMC31252 2 16 13 DAC21-F16 23-CG3954-RB_10 CG3954 AGTAACTGAGGCAGTAAGCACGTAACGATAATGATACAAAAAGCGTTGATTGTGATTCGAGTGACAGCG 69 FBan0003954 FBgn0000382 csw X X "R7 cell fate commitment; GO:0007465; determination of anterior/posterior axis, embryo; GO:0008595; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; epidermal growth factor receptor signaling pathway; GO:0007173; fibroblast growth factor receptor signaling pathway; GO:0008543; imaginal disc development; GO:0007444; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid dephosphorylation; GO:0006470; sevenless signaling pathway; GO:0045500; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal epithelial cell migration (sensu Insecta); GO:0007427; ventral midline development; GO:0007418" protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; ; GO:0004726; receptor signaling protein tyrosine phosphatase activity; GO:0004728; protein binding; GO:0005515; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004726; ; GO:0004728; ; GO:0005515 cytoplasm; GO:0005737 csw corkscrew "CG3954, CG3954, CG3954, CG3954, l(1)csw, l(1)2Db, E(sev)1A: Enhancer of sevenless 1A, 19-106, l(1)2Dd, Csw, l(1)G0170, CSW, Csw/Shp2, EG:BACN25G24.2, anon-WO03040301.207, anon-WO03040301.209, anon-WO03040301.219, l(1)GA114, Enhancer of sevenless 1A, E(sev)1A" CDMC31253 2 17 13 DAC21-J04 3-CG3987-RA_1 CG3987 GCCCAGTGTGCCGGTTGTTTCCAGGGATACGGAGCTCCCCTCATGTATAATCCTCCTTGGATGTACAAT 69 FBan0003987 FBgn0038292 CG3987 3 3R mesoderm development; GO:0007498 CG3987 CG3987 anon-WO0140519.215 CDMC31253 2 18 13 DAC21-J04 3-CG3987-RA_1 CG3987 GCCCAGTGTGCCGGTTGTTTCCAGGGATACGGAGCTCCCCTCATGTATAATCCTCCTTGGATGTACAAT 69 FBan0003987 FBgn0038292 CG3987 3 3R mesoderm development; GO:0007498 CG3987 CG3987 anon-WO0140519.215 CDMC31254 2 19 13 DAC21-J16 16-CG40006-RC_1 CG40006 GGACGGGGACCATTGCAGCAACATAGAGTTTGCATCTGATGGTACAAAGTTCAAAAGCTTCATTCAGCC 69 FBgn0058006 CG40006 apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004872; ; GO:0004867 membrane; GO:0016020 CG40006 CG40006 BcDNA:RE68569 CDMC31254 2 20 13 DAC21-J16 16-CG40006-RC_1 CG40006 GGACGGGGACCATTGCAGCAACATAGAGTTTGCATCTGATGGTACAAAGTTCAAAAGCTTCATTCAGCC 69 FBgn0058006 CG40006 apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 receptor activity; GO:0004872; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004872; ; GO:0004867 membrane; GO:0016020 CG40006 CG40006 BcDNA:RE68569 CDMC31255 2 21 13 DAC21-N04 1-CG40085-RA_2 CG40085 ACCGGAAGGCATAGGAACAGAACGACAAACCACGGAGATGGAAGGAGCAAATGAGAGGAAGGCAGACAA 69 FBgn0058085 CG40085 CG40085 CG40085 CDMC31255 2 22 13 DAC21-N04 1-CG40085-RA_2 CG40085 ACCGGAAGGCATAGGAACAGAACGACAAACCACGGAGATGGAAGGAGCAAATGAGAGGAAGGCAGACAA 69 FBgn0058085 CG40085 CG40085 CG40085 CDMC31256 2 23 13 DAC21-N16 23-CG40103-RA_3 CG40103 CATCAAACCAACTCAACAACTCAACCTACTATTGACGAGCCTAAACAAATGATGAAACAATTAATAGCT 69 FBgn0058103 CG40103 CG40103 CG40103 CDMC31256 2 24 13 DAC21-N16 23-CG40103-RA_3 CG40103 CATCAAACCAACTCAACAACTCAACCTACTATTGACGAGCCTAAACAAATGATGAAACAATTAATAGCT 69 FBgn0058103 CG40103 CG40103 CG40103 CDMC31257 2 25 13 DAC22-B04 5-CG13728-RA_4 CG13728 CCCATGTTCCCCATGATGTCTATGCCAATGCCATGGTATAATCCCGGTGTGATGCCCCACCAAAG 65 FBan0013728 FBgn0036716 CG13728 3 3L CG13728 CG13728 CDMC31257 2 26 13 DAC22-B04 5-CG13728-RA_4 CG13728 CCCATGTTCCCCATGATGTCTATGCCAATGCCATGGTATAATCCCGGTGTGATGCCCCACCAAAG 65 FBan0013728 FBgn0036716 CG13728 3 3L CG13728 CG13728 CDMC31258 2 1 14 DAC22-B16 9-CG1374-RA_7 CG1374 TTGTGGAAAGGAGTTCCCCAAAAACACCGTCTTCGGCAGCAAGTCCTCAGACAAGGTTGCTACCT 65 FBan0001374 FBgn0003866 tsh 2 2L "leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; specification of segmental identity, abdomen; GO:0007385; specification of segmental identity, thorax; GO:0007384; specification of segmental identity, trunk; GO:0035292" nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 tsh teashirt "CG1374, ae, aeroplane, ae[l], T shirt, l(2)04319, l(2)B4-2-12" CDMC31258 2 2 14 DAC22-B16 9-CG1374-RA_7 CG1374 TTGTGGAAAGGAGTTCCCCAAAAACACCGTCTTCGGCAGCAAGTCCTCAGACAAGGTTGCTACCT 65 FBan0001374 FBgn0003866 tsh 2 2L "leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; specification of segmental identity, abdomen; GO:0007385; specification of segmental identity, thorax; GO:0007384; specification of segmental identity, trunk; GO:0035292" nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 tsh teashirt "CG1374, ae, aeroplane, ae[l], T shirt, l(2)04319, l(2)B4-2-12" CDMC31259 2 3 14 DAC22-F04 15-CG13819-RA_1 CG13819 AATCGCCATCGCAGGTATCCATAGCCGTACATGCCGCCGGCGCACAATTGGATCTGGATCAGATC 65 FBan0013819 FBgn0039103 CG13819 3 3R CG13819 CG13819 CDMC31259 2 4 14 DAC22-F04 15-CG13819-RA_1 CG13819 AATCGCCATCGCAGGTATCCATAGCCGTACATGCCGCCGGCGCACAATTGGATCTGGATCAGATC 65 FBan0013819 FBgn0039103 CG13819 3 3R CG13819 CG13819 CDMC31260 2 5 14 DAC22-F16 21-CG13858-RA_1 CG13858 GCACCTCGACGAAGCCGCAGCGCCTGAACAAGGTCTCCTTCGCACCGCTGGACCTTCCGTTTCCC 65 FBan0013858 FBgn0040585 CG13858 3 3R CG13858 CG13858 CDMC31260 2 6 14 DAC22-F16 21-CG13858-RA_1 CG13858 GCACCTCGACGAAGCCGCAGCGCCTGAACAAGGTCTCCTTCGCACCGCTGGACCTTCCGTTTCCC 65 FBan0013858 FBgn0040585 CG13858 3 3R CG13858 CG13858 CDMC31261 2 7 14 DAC22-J04 15-CG13931-RA_1 CG13931 ATGGGCAGCATAGGAGGAATGGGACACGGCGAAATCACATACGAGGACATGCACGGATGCGAGAG 65 FBan0013931 FBgn0035258 CG13931 3 3L CG13931 CG13931 CDMC31261 2 8 14 DAC22-J04 15-CG13931-RA_1 CG13931 ATGGGCAGCATAGGAGGAATGGGACACGGCGAAATCACATACGAGGACATGCACGGATGCGAGAG 65 FBan0013931 FBgn0035258 CG13931 3 3L CG13931 CG13931 CDMC31262 2 9 14 DAC22-J16 3-CG13948-RA_1 CG13948 AATCTGGACGGGTATGCAAACATCAACCGCGAGCTGATCACGACCAACATCTCGTTCATGGCCAC 65 FBan0013948 FBgn0041250 Gr21a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr21a Gustatory receptor 21a "CG13948, CG13948, CG13948, CG13948, 21D.1, Gustatory receptor 21D.1, Gr21D1, GR21D.1, Gustatory receptor 21a" CDMC31262 2 10 14 DAC22-J16 3-CG13948-RA_1 CG13948 AATCTGGACGGGTATGCAAACATCAACCGCGAGCTGATCACGACCAACATCTCGTTCATGGCCAC 65 FBan0013948 FBgn0041250 Gr21a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr21a Gustatory receptor 21a "CG13948, CG13948, CG13948, CG13948, 21D.1, Gustatory receptor 21D.1, Gr21D1, GR21D.1, Gustatory receptor 21a" CDMC31263 2 11 14 DAC22-N04 3-CG14014-RA_3 CG14014 CTACTGCGTGGTGTACAAGCGAGATCACTACGTGCTCAATAACCCGCCCAACTTCAAGAGCCCCA 65 FBan0014014 FBgn0031718 CG14014 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG14014 CG14014 CDMC31263 2 12 14 DAC22-N04 3-CG14014-RA_3 CG14014 CTACTGCGTGGTGTACAAGCGAGATCACTACGTGCTCAATAACCCGCCCAACTTCAAGAGCCCCA 65 FBan0014014 FBgn0031718 CG14014 2 2L protein dimerization activity; GO:0046983; ; GO:0046983 CG14014 CG14014 CDMC31264 2 13 14 DAC22-N16 18-CG14062-RA_4 CG14062 GGAGACCATCGAGCGATTCGTTCGTAATTCGGTGACCGGAAACAACTTTGTGAATGTGCGCACCG 65 FBan0014062 FBgn0039592 CG14062 3 3R CG14062 CG14062 CDMC31264 2 14 14 DAC22-N16 18-CG14062-RA_4 CG14062 GGAGACCATCGAGCGATTCGTTCGTAATTCGGTGACCGGAAACAACTTTGTGAATGTGCGCACCG 65 FBan0014062 FBgn0039592 CG14062 3 3R CG14062 CG14062 CDMC31265 2 15 14 DAC23-B04 5-CG4612-RA_1 CG4612 ATGTGGCCAAAGACGAGGATGGCAATTCACGCGGCTATGGGTTTGTGCATTTCGATTCGGAGGAG 65 FBan0004612 FBgn0035016 CG4612 2 2R histone mRNA 3'-end processing; GO:0006398 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 CG4612 CG4612 cg4612 CDMC31265 2 16 14 DAC23-B04 5-CG4612-RA_1 CG4612 ATGTGGCCAAAGACGAGGATGGCAATTCACGCGGCTATGGGTTTGTGCATTTCGATTCGGAGGAG 65 FBan0004612 FBgn0035016 CG4612 2 2R histone mRNA 3'-end processing; GO:0006398 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143 CG4612 CG4612 cg4612 CDMC31266 2 17 14 DAC23-B16 3-CG4665-RA_1 CG4665 TTCCTTAAGTGGACCCAAGATCAGGAGAGGCCCAAAACTGGATCCCTGTTGCAGCTGATCACCAC 65 FBan0004665 FBgn0035964 Dhpr 3 3L amino acid catabolism; GO:0009063; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; pteridine and derivative metabolism; GO:0042558 "6,7-dihydropteridine reductase activity; GO:0004155 ; EC:1.5.1.34; ; GO:0004155 ; EC:1.5.1.34; ; GO:0004155 ; EC:1.5.1.34" Dhpr Dihydropteridine reductase "CG4665, CG4665, CG4665, DHPR, Dihydropteridine reductase" CDMC31266 2 18 14 DAC23-B16 3-CG4665-RA_1 CG4665 TTCCTTAAGTGGACCCAAGATCAGGAGAGGCCCAAAACTGGATCCCTGTTGCAGCTGATCACCAC 65 FBan0004665 FBgn0035964 Dhpr 3 3L amino acid catabolism; GO:0009063; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; pteridine and derivative metabolism; GO:0042558 "6,7-dihydropteridine reductase activity; GO:0004155 ; EC:1.5.1.34; ; GO:0004155 ; EC:1.5.1.34; ; GO:0004155 ; EC:1.5.1.34" Dhpr Dihydropteridine reductase "CG4665, CG4665, CG4665, DHPR, Dihydropteridine reductase" CDMC31267 2 19 14 DAC23-F04 3-CG4843-RC_2 CG4843 CGTTGGATCTTGGGGTCGCTTTCTGGGCTAAGCAACTTGGTCAGCATCAGTGTTCTCGGGGTTTC 65 FBan0004843 FBgn0004117 Tm2 3 3R muscle contraction; GO:0006936 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 muscle thin filament tropomyosin; GO:0005862 Tm2 Tropomyosin 2 "CG4843, CG4843, CG4843, mTmI, Ifm(3)3, dro Tm, TmI, Tropomyosin-2, tropomyosin, Ifm-TmI, Tn-H, Tm1, DROTROPI1, Tropomyosin, tropomyosin I, l(3)nc99Eb, Tropomyosin I, Troponin H, Tm, Ifm(3)5: Indirect flight muscle, lethal(3)nc99Eb" CDMC31267 2 20 14 DAC23-F04 3-CG4843-RC_2 CG4843 CGTTGGATCTTGGGGTCGCTTTCTGGGCTAAGCAACTTGGTCAGCATCAGTGTTCTCGGGGTTTC 65 FBan0004843 FBgn0004117 Tm2 3 3R muscle contraction; GO:0006936 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 muscle thin filament tropomyosin; GO:0005862 Tm2 Tropomyosin 2 "CG4843, CG4843, CG4843, mTmI, Ifm(3)3, dro Tm, TmI, Tropomyosin-2, tropomyosin, Ifm-TmI, Tn-H, Tm1, DROTROPI1, Tropomyosin, tropomyosin I, l(3)nc99Eb, Tropomyosin I, Troponin H, Tm, Ifm(3)5: Indirect flight muscle, lethal(3)nc99Eb" CDMC31268 2 21 14 DAC23-F16 2-CG4886-RA_1 CG4886 GTTAAGGAGGACAGTTTCAAGCCTATCTGGGCAGATGACGACTGGTTGCAGAAGCATGCGGGAGC 65 FBan0004886 FBgn0028382 cyp33 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 cyp33 cyclophilin-33 "CG4886, Dcyp33, Cyp33" CDMC31268 2 22 14 DAC23-F16 2-CG4886-RA_1 CG4886 GTTAAGGAGGACAGTTTCAAGCCTATCTGGGCAGATGACGACTGGTTGCAGAAGCATGCGGGAGC 65 FBan0004886 FBgn0028382 cyp33 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 nucleus; GO:0005634 cyp33 cyclophilin-33 "CG4886, Dcyp33, Cyp33" CDMC31269 2 23 14 DAC23-J04 5-CG5084-RA_1 CG5084 TCGCAGGCCTACCGTGCTCAGTCCCAGTTCGTTTCCAATGCCACTCAGATGAATGCCGAGAAATC 65 FBan0005084 FBgn0034288 CG5084 2 2R CG5084 CG5084 CDMC31269 2 24 14 DAC23-J04 5-CG5084-RA_1 CG5084 TCGCAGGCCTACCGTGCTCAGTCCCAGTTCGTTTCCAATGCCACTCAGATGAATGCCGAGAAATC 65 FBan0005084 FBgn0034288 CG5084 2 2R CG5084 CG5084 CDMC31270 2 25 14 DAC23-J16 3-CG5140-RA_3 CG5140 GCTTGCTCAAGAACGAGGCTGATCCACATGTCCTAGCCAACTGGGTGTCCACTCTCAAGAGGGAG 65 FBan0005140 FBgn0034314 CG5140 2 2R defense response; GO:0006952; protein ubiquitination; GO:0016567; signal transduction; GO:0007165 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5140 CG5140 CDMC31270 2 26 14 DAC23-J16 3-CG5140-RA_3 CG5140 GCTTGCTCAAGAACGAGGCTGATCCACATGTCCTAGCCAACTGGGTGTCCACTCTCAAGAGGGAG 65 FBan0005140 FBgn0034314 CG5140 2 2R defense response; GO:0006952; protein ubiquitination; GO:0016567; signal transduction; GO:0007165 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG5140 CG5140 CDMC31271 2 1 15 DAC23-N04 9-CG5229-RA_1 CG5229 ATGGCAGCCCTTCATCAATATCCAGCCGAGCTCATCTCCATAACCACGTGGTTGGAAGCATGCCA 65 FBan0005229 FBgn0028387 chm 2 2L gene silencing; GO:0016458; negative regulation of transcription; GO:0016481; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48; ; GO:0003700 nucleus; GO:0005634 chm chameau "CG5229, CG5229, HAT1, dmHAG404, HAT, chameau" CDMC31271 2 2 15 DAC23-N04 9-CG5229-RA_1 CG5229 ATGGCAGCCCTTCATCAATATCCAGCCGAGCTCATCTCCATAACCACGTGGTTGGAAGCATGCCA 65 FBan0005229 FBgn0028387 chm 2 2L gene silencing; GO:0016458; negative regulation of transcription; GO:0016481; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48; ; GO:0003700 nucleus; GO:0005634 chm chameau "CG5229, CG5229, HAT1, dmHAG404, HAT, chameau" CDMC31272 2 3 15 DAC23-N16 2-CG5274-RA_1 CG5274 AGATGCTCTGCTGGACACCATAACCGAATGGATGATGGAGAATCCCACTTTGTGTCAGGCCTCGC 65 FBan0005274 FBgn0036987 CG5274 3 3L CG5274 CG5274 CDMC31272 2 4 15 DAC23-N16 2-CG5274-RA_1 CG5274 AGATGCTCTGCTGGACACCATAACCGAATGGATGATGGAGAATCCCACTTTGTGTCAGGCCTCGC 65 FBan0005274 FBgn0036987 CG5274 3 3L CG5274 CG5274 CDMC31273 2 5 15 DAC24-B04 16-CG9181-RD_4 CG9181 GCCTACGCATACACGAAGCTAGGTTAAGTGCCCCGTAGCCACTAAGTAGTCGTAGATCAGTAGTAGCAA 69 FBan0009181 FBgn0003138 Ptp61F 3 3L axon guidance; GO:0007411; germ-band extension; GO:0007377; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; nucleus; GO:0005634 Ptp61F Protein tyrosine phosphatase 61F "CG9181, CG9178, CG9181, dPTP61F, DPTP61F, dptp61F, PTP61F, protein tyrosine phosphatase, protein-tyrosine-phosphatase, R-PTP 61F, ptp61F, anon-WO0140519.98, anon-WO0118547.297, BEST:LP01280" CDMC31273 2 6 15 DAC24-B04 16-CG9181-RD_4 CG9181 GCCTACGCATACACGAAGCTAGGTTAAGTGCCCCGTAGCCACTAAGTAGTCGTAGATCAGTAGTAGCAA 69 FBan0009181 FBgn0003138 Ptp61F 3 3L axon guidance; GO:0007411; germ-band extension; GO:0007377; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; nucleus; GO:0005634 Ptp61F Protein tyrosine phosphatase 61F "CG9181, CG9178, CG9181, dPTP61F, DPTP61F, dptp61F, PTP61F, protein tyrosine phosphatase, protein-tyrosine-phosphatase, R-PTP 61F, ptp61F, anon-WO0140519.98, anon-WO0118547.297, BEST:LP01280" CDMC31274 2 7 15 DAC24-B16 12-CG9193-RA_1 CG9193 TGGCACCCAAGATCGAGGACAACGAGACATAAGTCAGCTGTGTTCCTCATATTTATGTCCCCGCATCGT 69 FBan0009193 FBgn0005655 mus209 2 2R DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; leading strand elongation; GO:0006272; mismatch repair; GO:0006298; mitotic spindle organization and biogenesis; GO:0007052; nucleotide-excision repair; GO:0006289; regulation of DNA replication; GO:0006275 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 delta-DNA polymerase cofactor complex; GO:0005660; nucleus; GO:0005634 mus209 mutagen-sensitive 209 "CG9193, PCNA, proliferating cell nuclear antigen, Pcna: Proliferating-cell-nuclear-antigen, l(2)02448, DmPCNA, 53/13, pcna, PCNA/mus209, l(2)56F, l(2)56Fa, l(2)s1534, Proliferating-cell-nuclear-antigen, Pcna" CDMC31274 2 8 15 DAC24-B16 12-CG9193-RA_1 CG9193 TGGCACCCAAGATCGAGGACAACGAGACATAAGTCAGCTGTGTTCCTCATATTTATGTCCCCGCATCGT 69 FBan0009193 FBgn0005655 mus209 2 2R DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; leading strand elongation; GO:0006272; mismatch repair; GO:0006298; mitotic spindle organization and biogenesis; GO:0007052; nucleotide-excision repair; GO:0006289; regulation of DNA replication; GO:0006275 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA polymerase processivity factor activity; GO:0030337; ; GO:0030337; ; GO:0003677 delta-DNA polymerase cofactor complex; GO:0005660; nucleus; GO:0005634 mus209 mutagen-sensitive 209 "CG9193, PCNA, proliferating cell nuclear antigen, Pcna: Proliferating-cell-nuclear-antigen, l(2)02448, DmPCNA, 53/13, pcna, PCNA/mus209, l(2)56F, l(2)56Fa, l(2)s1534, Proliferating-cell-nuclear-antigen, Pcna" CDMC31275 2 9 15 DAC24-F04 9-CG9235-RA_3 CG9235 TGCTCGCTAGAAGACATATCCTGTCGACTCCAGGACAGCAATCTCCTCAAATTCATCCTGGCCATCGGT 69 FBan0009235 FBgn0034560 CG9235 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG9235 CG9235 CDMC31275 2 10 15 DAC24-F04 9-CG9235-RA_3 CG9235 TGCTCGCTAGAAGACATATCCTGTCGACTCCAGGACAGCAATCTCCTCAAATTCATCCTGGCCATCGGT 69 FBan0009235 FBgn0034560 CG9235 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG9235 CG9235 CDMC31276 2 11 15 DAC24-F16 3-CG9245-RA_2 CG9245 TTCATGTGCTGCGTCAATGAGCTGTTTTACGTGTGCTTGTACCTCTTGCATTTCACCTACGGCCCGCTG 69 FBan0009245 FBgn0030670 CG9245 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity; GO:0003881 ; EC:2.7.8.11; ; GO:0003881 ; EC:2.7.8.11 CG9245 CG9245 anon-WO02059370.38 CDMC31276 2 12 15 DAC24-F16 3-CG9245-RA_2 CG9245 TTCATGTGCTGCGTCAATGAGCTGTTTTACGTGTGCTTGTACCTCTTGCATTTCACCTACGGCCCGCTG 69 FBan0009245 FBgn0030670 CG9245 X X phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity; GO:0003881 ; EC:2.7.8.11; ; GO:0003881 ; EC:2.7.8.11 CG9245 CG9245 anon-WO02059370.38 CDMC31277 2 13 15 DAC24-J04 23-CG9282-RA_3 CG9282 TAGTGATGTGCTAAAGTTAGTCCAGGATTTAAGGAACCACTCGTGAATTGAAAATTAAACAAACGCCGC 69 FBan0009282 FBgn0032518 RpL24 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL24 Ribosomal protein L24 "CG9282, CG9282, CG9282, anon-EST:Posey37, anon-EST:Posey242, Ribosomal protein L24" CDMC31277 2 14 15 DAC24-J04 23-CG9282-RA_3 CG9282 TAGTGATGTGCTAAAGTTAGTCCAGGATTTAAGGAACCACTCGTGAATTGAAAATTAAACAAACGCCGC 69 FBan0009282 FBgn0032518 RpL24 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL24 Ribosomal protein L24 "CG9282, CG9282, CG9282, anon-EST:Posey37, anon-EST:Posey242, Ribosomal protein L24" CDMC31278 2 15 15 DAC24-J16 6-CG9294-RB_1 CG9294 TGTGGTGCTGCCTCAATCGGAGTGTCGCAATGGCACAACGTATAGGCCTGGACAAATTACGGATAACAT 69 FBan0009294 FBgn0034666 CG9294 2 2R defense response; GO:0006952; protein metabolism; GO:0019538; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG9294 CG9294 SP20 CDMC31278 2 16 15 DAC24-J16 6-CG9294-RB_1 CG9294 TGTGGTGCTGCCTCAATCGGAGTGTCGCAATGGCACAACGTATAGGCCTGGACAAATTACGGATAACAT 69 FBan0009294 FBgn0034666 CG9294 2 2R defense response; GO:0006952; protein metabolism; GO:0019538; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG9294 CG9294 SP20 CDMC31279 2 17 15 DAC24-N04 23-CG9325-RC_4 CG9325 ATGATTTTGTGCCTCATTTAGGGATTTCGCTGCCTCAAAAACAAGACAATAGCGCTAAAACAATGCAAA 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC31279 2 18 15 DAC24-N04 23-CG9325-RC_4 CG9325 ATGATTTTGTGCCTCATTTAGGGATTTCGCTGCCTCAAAAACAAGACAATAGCGCTAAAACAATGCAAA 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC31280 2 19 15 DAC24-N16 2-CG9333-RA_1 CG9333 GCCAGCGAAACAAATATTCTGGTGGGAGTACACGACTCGTGCTACAGCATCTGGTATTGTCCCGGGGAA 69 FBan0009333 FBgn0032891 Oseg5 2 2L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg5 Oseg5 "CG9333, OSEG5" CDMC31280 2 20 15 DAC24-N16 2-CG9333-RA_1 CG9333 GCCAGCGAAACAAATATTCTGGTGGGAGTACACGACTCGTGCTACAGCATCTGGTATTGTCCCGGGGAA 69 FBan0009333 FBgn0032891 Oseg5 2 2L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg5 Oseg5 "CG9333, OSEG5" CDMC31281 2 21 15 DAC25-B04 3-CG10563-RA_1 CG10563 AGACACCACCAAGACACTGCTCATCCTTGGGAGACAGCTGTCAACATTTCCCCTCTTGGCACAACTCTT 69 FBan0010563 FBgn0032760 CG10563 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0030528; ; GO:0016251 CG10563 CG10563 CDMC31281 2 22 15 DAC25-B04 3-CG10563-RA_1 CG10563 AGACACCACCAAGACACTGCTCATCCTTGGGAGACAGCTGTCAACATTTCCCCTCTTGGCACAACTCTT 69 FBan0010563 FBgn0032760 CG10563 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription regulator activity; GO:0030528; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0030528; ; GO:0016251 CG10563 CG10563 CDMC31282 2 23 15 DAC25-B16 17-CG10574-RA_1 CG10574 AGCAATGTCAACCCATCAATCAATCACTAATGTTTACCTAGCGGACAATGGACGATTCTGAGGGCAGCT 69 FBan0010574 FBgn0028429 I-2 3 3L negative regulation of protein amino acid dephosphorylation; GO:0035308 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864; ; GO:0004864 I-2 Inhibitor-2 "CG10574, I-2Dm, Dm I-2, inhibitor-2" CDMC31282 2 24 15 DAC25-B16 17-CG10574-RA_1 CG10574 AGCAATGTCAACCCATCAATCAATCACTAATGTTTACCTAGCGGACAATGGACGATTCTGAGGGCAGCT 69 FBan0010574 FBgn0028429 I-2 3 3L negative regulation of protein amino acid dephosphorylation; GO:0035308 protein phosphatase inhibitor activity; GO:0004864; ; GO:0004864; ; GO:0004864; ; GO:0004864 I-2 Inhibitor-2 "CG10574, I-2Dm, Dm I-2, inhibitor-2" CDMC31283 2 25 15 DAC25-F04 23-CG10603-RA_2 CG10603 TGGAGAACTTCCCCAACATTATGGATTATCCCAAGGATTATATCTTGCGTTGATATGCTGATAGGAAAT 69 FBan0010603 FBgn0032720 mRpL13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL13 mitochondrial ribosomal protein L13 "CG10603, CG10603, CG10603, L13, anon-EST:fe3C4, anon-fast-evolving-3C4, mitochondrial ribosomal protein L13" CDMC31283 2 26 15 DAC25-F04 23-CG10603-RA_2 CG10603 TGGAGAACTTCCCCAACATTATGGATTATCCCAAGGATTATATCTTGCGTTGATATGCTGATAGGAAAT 69 FBan0010603 FBgn0032720 mRpL13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL13 mitochondrial ribosomal protein L13 "CG10603, CG10603, CG10603, L13, anon-EST:fe3C4, anon-fast-evolving-3C4, mitochondrial ribosomal protein L13" CDMC31284 2 1 16 DAC25-F16 3-CG10618-RA_1 CG10618 TGGCCACTAAGGGTCAGTATCCGGAAATCGTGCTGAACGGATTCTTCAAGGAGGAAAACAGGCCGATGA 69 FBan0010618 FBgn0045761 CG10618 3 3R CG10618 CG10618 BcDNA:GH03753 CDMC31284 2 2 16 DAC25-F16 3-CG10618-RA_1 CG10618 TGGCCACTAAGGGTCAGTATCCGGAAATCGTGCTGAACGGATTCTTCAAGGAGGAAAACAGGCCGATGA 69 FBan0010618 FBgn0045761 CG10618 3 3R CG10618 CG10618 BcDNA:GH03753 CDMC31285 2 3 16 DAC25-J04 2-CG10641-RA_1 CG10641 TCGCACCTACAAAGTGGTCAACGTCTACACCGACTTCCCCGAGTTCTCCCGTAACCAGATCAAGGACTA 69 FBan0010641 FBgn0032731 CG10641 2 2L mesoderm development; GO:0007498 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 CG10641 CG10641 CDMC31285 2 4 16 DAC25-J04 2-CG10641-RA_1 CG10641 TCGCACCTACAAAGTGGTCAACGTCTACACCGACTTCCCCGAGTTCTCCCGTAACCAGATCAAGGACTA 69 FBan0010641 FBgn0032731 CG10641 2 2L mesoderm development; GO:0007498 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 CG10641 CG10641 CDMC31286 2 5 16 DAC25-J16 3-CG10653-RA_3 CG10653 AAGCAGTTACCCAGAGCACGTCTCTGCAATGCAAGGTGACTCAGCTGGAAACCAATTTATCAGCGCGTG 69 FBan0010653 FBgn0001202 hk 2 2L R7 development; GO:0045467; cytoskeleton-dependent intracellular transport; GO:0030705; endocytosis; GO:0006897; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 cytoplasm; GO:0005737; endosome; GO:0005768; synapse; GO:0045202 hk hook "CG10653, dHk, hook" CDMC31286 2 6 16 DAC25-J16 3-CG10653-RA_3 CG10653 AAGCAGTTACCCAGAGCACGTCTCTGCAATGCAAGGTGACTCAGCTGGAAACCAATTTATCAGCGCGTG 69 FBan0010653 FBgn0001202 hk 2 2L R7 development; GO:0045467; cytoskeleton-dependent intracellular transport; GO:0030705; endocytosis; GO:0006897; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 cytoplasm; GO:0005737; endosome; GO:0005768; synapse; GO:0045202 hk hook "CG10653, dHk, hook" CDMC31287 2 7 16 DAC25-N04 3-CG10683-RA_3 CG10683 GGGCGCACCAAAAGAAGGGGACATTGGCTTGGATTTATCTGGCAGTGATTCCATGGATTCCGAAGTGGA 69 FBan0010683 FBgn0004400 rhi 2 2R chromatin assembly or disassembly; GO:0006333; eggshell pattern formation (sensu Insecta); GO:0030381 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 rhi rhino "CG10683, HP1D, rno" CDMC31287 2 8 16 DAC25-N04 3-CG10683-RA_3 CG10683 GGGCGCACCAAAAGAAGGGGACATTGGCTTGGATTTATCTGGCAGTGATTCCATGGATTCCGAAGTGGA 69 FBan0010683 FBgn0004400 rhi 2 2R chromatin assembly or disassembly; GO:0006333; eggshell pattern formation (sensu Insecta); GO:0030381 chromatin binding; GO:0003682; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634 rhi rhino "CG10683, HP1D, rno" CDMC31288 2 9 16 DAC25-N16 6-CG10693-RA_1 CG10693 CGGATCGGGGGACCAAGAACTTTAGCCCTGATATCCATCGTTCAACTGCCAACTGATTGCTTCCCACAT 69 FBan0010693 FBgn0003429 slo 3 3R "circadian rhythm; GO:0007623; male courtship behavior (sensu Insecta), song production; GO:0045433; potassium ion transport; GO:0006813; response to drug; GO:0042493; synaptic transmission; GO:0007268" calcium-activated potassium channel activity; GO:0015269; voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0015269; ; GO:0015269; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005249 plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 slo slowpoke "CG10693, CG10693, CG10693, fSlo, dSlo, dslo, Dslo, BcDNA:GH10751, slowpoke" CDMC31288 2 10 16 DAC25-N16 6-CG10693-RA_1 CG10693 CGGATCGGGGGACCAAGAACTTTAGCCCTGATATCCATCGTTCAACTGCCAACTGATTGCTTCCCACAT 69 FBan0010693 FBgn0003429 slo 3 3R "circadian rhythm; GO:0007623; male courtship behavior (sensu Insecta), song production; GO:0045433; potassium ion transport; GO:0006813; response to drug; GO:0042493; synaptic transmission; GO:0007268" calcium-activated potassium channel activity; GO:0015269; voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0015269; ; GO:0015269; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005249 plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 slo slowpoke "CG10693, CG10693, CG10693, fSlo, dSlo, dslo, Dslo, BcDNA:GH10751, slowpoke" CDMC31289 2 11 16 DAC26-B04 11-CG8024-RA_1 CG8024 TTCCCATTCCCAGTTTAAGAGCGAGTTTCAACACAGAAACGCCATGTGCCTACGTCCACTCCATGTTCA 69 FBgn0015788 CDMC31289 2 12 16 DAC26-B04 11-CG8024-RA_1 CG8024 TTCCCATTCCCAGTTTAAGAGCGAGTTTCAACACAGAAACGCCATGTGCCTACGTCCACTCCATGTTCA 69 FBgn0015788 CDMC31290 2 13 16 DAC26-B16 22-CG8031-RA_2 CG8031 TGGATGGACATGAAGACTGACGAGGATGAACACTCCATCGAGATGCATTTACCCTACATTGCCAAAGTG 69 FBan0008031 FBgn0038110 CG8031 3 3R CG8031 CG8031 CDMC31290 2 14 16 DAC26-B16 22-CG8031-RA_2 CG8031 TGGATGGACATGAAGACTGACGAGGATGAACACTCCATCGAGATGCATTTACCCTACATTGCCAAAGTG 69 FBan0008031 FBgn0038110 CG8031 3 3R CG8031 CG8031 CDMC31291 2 15 16 DAC26-F04 23-CG8068-RF_14 CG8068 AGGCGCCCAAACGTCGGCTAAGCAAAGTTAATAGAGTATTTTTCGGTTTTATACCACCATTTGTCCTAA 69 FBan0008068 FBgn0003612 Su(var)2-10 2 2R chromosome condensation; GO:0030261; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; imaginal disc growth; GO:0007446; negative regulation of JAK-STAT cascade; GO:0046426; protein modification; GO:0006464; regulation of JAK-STAT cascade; GO:0046425; regulation of protein catabolism; GO:0042176; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; DEAD/H-box RNA helicase binding; GO:0017151; zinc ion binding; GO:0008270; ; GO:0017151; ; GO:0008270 "cytoplasm; GO:0005737; nuclear lamina; GO:0005652; nucleoplasm; GO:0005654; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome, telomeric region; GO:0035012" Su(var)2-10 Suppressor of variegation 2-10 "CG8068, CG8068, Su-var(2)10, zimp, Suvar(2)10, CLOT2057, zinc finger-containing Miz1 PIAS3-like, l(2)03697, dpias, dPIAS, Dpias, ZimpA, ZimpB, Su(Var)2-10, i184, PIAS, DPIAS" CDMC31291 2 16 16 DAC26-F04 23-CG8068-RF_14 CG8068 AGGCGCCCAAACGTCGGCTAAGCAAAGTTAATAGAGTATTTTTCGGTTTTATACCACCATTTGTCCTAA 69 FBan0008068 FBgn0003612 Su(var)2-10 2 2R chromosome condensation; GO:0030261; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; imaginal disc growth; GO:0007446; negative regulation of JAK-STAT cascade; GO:0046426; protein modification; GO:0006464; regulation of JAK-STAT cascade; GO:0046425; regulation of protein catabolism; GO:0042176; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; DEAD/H-box RNA helicase binding; GO:0017151; zinc ion binding; GO:0008270; ; GO:0017151; ; GO:0008270 "cytoplasm; GO:0005737; nuclear lamina; GO:0005652; nucleoplasm; GO:0005654; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome, telomeric region; GO:0035012" Su(var)2-10 Suppressor of variegation 2-10 "CG8068, CG8068, Su-var(2)10, zimp, Suvar(2)10, CLOT2057, zinc finger-containing Miz1 PIAS3-like, l(2)03697, dpias, dPIAS, Dpias, ZimpA, ZimpB, Su(Var)2-10, i184, PIAS, DPIAS" CDMC31292 2 17 16 DAC26-F16 3-CG8085-RC_2 CG8085 CGCTGCAAACACTAGAGCTAGGCCTTCCATGGGTGCAGCCAATAGCAATCACCAAGCTTCGAGAGAATG 69 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC31292 2 18 16 DAC26-F16 3-CG8085-RC_2 CG8085 CGCTGCAAACACTAGAGCTAGGCCTTCCATGGGTGCAGCCAATAGCAATCACCAAGCTTCGAGAGAATG 69 FBan0008085 FBgn0020620 RN-tre 2 2R cell adhesion; GO:0007155; protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- RN-tre tre oncogene-related protein "CG13351, CG8085, CG13351, DRN-tre" CDMC31293 2 19 16 DAC26-J04 23-CG8118-RA_5 CG8118 CGGACAAGAGTAAAATCGATTTTGGTGAGACGTGTGGTTTTTCATTTGATTAGCCGGATGTATTGGGGC 69 FBan0008118 FBgn0002643 mam 2 2R Notch signaling pathway; GO:0007219; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesodermal cell fate determination; GO:0007500; nervous system development; GO:0007399 nucleus; GO:0005634 mam mastermind "CG8118, CG8118, CG8118, CG8118, N-2G, SR2-4, mam(CAG)[[7]], Dm0064, dMam, Mam, l(2)03505, l(2)04615" CDMC31293 2 20 16 DAC26-J04 23-CG8118-RA_5 CG8118 CGGACAAGAGTAAAATCGATTTTGGTGAGACGTGTGGTTTTTCATTTGATTAGCCGGATGTATTGGGGC 69 FBan0008118 FBgn0002643 mam 2 2R Notch signaling pathway; GO:0007219; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesodermal cell fate determination; GO:0007500; nervous system development; GO:0007399 nucleus; GO:0005634 mam mastermind "CG8118, CG8118, CG8118, CG8118, N-2G, SR2-4, mam(CAG)[[7]], Dm0064, dMam, Mam, l(2)03505, l(2)04615" CDMC31294 2 21 16 DAC26-J16 23-CG8129-RA_3 CG8129 CGCCAAAAATTTCGTTGATAAATTTGGCTGCACATAAAAGTCAAAGATCCGATAAGATAGGGTTTAATT 69 FBan0008129 FBgn0037684 CG8129 3 3R amino acid biosynthesis; GO:0008652; amino acid catabolism; GO:0009063 threonine ammonia-lyase activity; GO:0004794 ; EC:4.3.1.19; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004794 ; EC:4.3.1.19; amino acid binding; GO:0016597; ; GO:0016597 CG8129 CG8129 CT24308 CDMC31294 2 22 16 DAC26-J16 23-CG8129-RA_3 CG8129 CGCCAAAAATTTCGTTGATAAATTTGGCTGCACATAAAAGTCAAAGATCCGATAAGATAGGGTTTAATT 69 FBan0008129 FBgn0037684 CG8129 3 3R amino acid biosynthesis; GO:0008652; amino acid catabolism; GO:0009063 threonine ammonia-lyase activity; GO:0004794 ; EC:4.3.1.19; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0004794 ; EC:4.3.1.19; amino acid binding; GO:0016597; ; GO:0016597 CG8129 CG8129 CT24308 CDMC31295 2 23 16 DAC26-N04 2-CG8170-RA_1 CG8170 GGGAATCTATCACAGCGTCAGCAAGACCGTGGACTGGGTATCCTACGTCGTCGGACTCACGATGAACAT 69 FBan0008170 FBgn0033365 CG8170 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8170 CG8170 SP54 CDMC31295 2 24 16 DAC26-N04 2-CG8170-RA_1 CG8170 GGGAATCTATCACAGCGTCAGCAAGACCGTGGACTGGGTATCCTACGTCGTCGGACTCACGATGAACAT 69 FBan0008170 FBgn0033365 CG8170 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8170 CG8170 SP54 CDMC31296 2 25 16 DAC26-N16 23-CG8180-RA_3 CG8180 AAAACGTAGATCTTAAGGTCCCAACATCTCTCTGACTGACTCTGATGCAATTAGCTTTTAACCAATTTA 69 FBan0008180 FBgn0034021 CG8180 2 2R CG8180 CG8180 CDMC31296 2 26 16 DAC26-N16 23-CG8180-RA_3 CG8180 AAAACGTAGATCTTAAGGTCCCAACATCTCTCTGACTGACTCTGATGCAATTAGCTTTTAACCAATTTA 69 FBan0008180 FBgn0034021 CG8180 2 2R CG8180 CG8180 CDMC31297 2 1 17 DAC27-B04 1-CG8416-RA_1 CG8416 CCTGCGGTAAAACTTGCCTTCTGATTGTCTTCAGCAAAGATCAGTTCCCCGAGGTCTATGTGCCCACCG 69 FBan0008416 FBgn0014020 Rho1 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; NOT muscle attachment; GO:0016203; NOT myofibril assembly; GO:0030239; actin cable formation; GO:0045011; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; axon guidance; GO:0007411; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; endocytosis; GO:0006897; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; germ-band extension; GO:0007377; glial cell migration; GO:0008347; motor axon guidance; GO:0008045; neuroblast proliferation; GO:0007405; ommatidial rotation; GO:0016318; peripheral nervous system development; GO:0007422; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; small GTPase mediated signal transduction; GO:0007264; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; ventral furrow formation; GO:0007370; wound healing; GO:0042060" GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 Rho1 Rho1 "CG8416, l(2)k02107b, DrhoA, Rho: Rhombotin, RhoA, DRhoA, rhoA, rho, E3.10/J3.8, rho1, Drho1, DRho1, n(2)k07236, dRho1, dRhoA, DRho, dnRho, RHO, Rho GTPase, Rho kinase, AAF01186, Dm Rho1, DmRHO-A, l(2)52Fa, Rho" CDMC31297 2 2 17 DAC27-B04 1-CG8416-RA_1 CG8416 CCTGCGGTAAAACTTGCCTTCTGATTGTCTTCAGCAAAGATCAGTTCCCCGAGGTCTATGTGCCCACCG 69 FBan0008416 FBgn0014020 Rho1 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; JNK cascade; GO:0007254; NOT dorsal closure, amnioserosa morphology change; GO:0046664; NOT muscle attachment; GO:0016203; NOT myofibril assembly; GO:0030239; actin cable formation; GO:0045011; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; axon guidance; GO:0007411; cellularization; GO:0007349; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal closure, leading edge cell differentiation; GO:0046663; dorsal closure, spreading of leading edge cells; GO:0007395; endocytosis; GO:0006897; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; frizzled signaling pathway; GO:0007222; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; germ-band extension; GO:0007377; glial cell migration; GO:0008347; motor axon guidance; GO:0008045; neuroblast proliferation; GO:0007405; ommatidial rotation; GO:0016318; peripheral nervous system development; GO:0007422; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; small GTPase mediated signal transduction; GO:0007264; tracheal branch fusion; GO:0035147; tracheal lumen formation; GO:0035149; ventral furrow formation; GO:0007370; wound healing; GO:0042060" GTP binding; GO:0005525; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 Rho1 Rho1 "CG8416, l(2)k02107b, DrhoA, Rho: Rhombotin, RhoA, DRhoA, rhoA, rho, E3.10/J3.8, rho1, Drho1, DRho1, n(2)k07236, dRho1, dRhoA, DRho, dnRho, RHO, Rho GTPase, Rho kinase, AAF01186, Dm Rho1, DmRHO-A, l(2)52Fa, Rho" CDMC31298 2 3 17 DAC27-B16 2-CG8422-RA_1 CG8422 CAGCTGCATTGCTCTGATCACCCTGTTCCACTTCTTCACCCTGACCAACTTCTTTTGGATGCTGGTCGA 69 FBan0008422 FBgn0033932 CG8422 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; neuropeptide hormone activity; GO:0005184; diuretic hormone receptor activity; GO:0008036; secretin-like receptor activity; GO:0001633; ; GO:0005184; ; GO:0008188; ; GO:0008036; ; GO:0001633; ; GO:0008036 integral to membrane; GO:0016021 CG8422 CG8422 "anon-WO0170980.100, anon-WO0170980.101" CDMC31298 2 4 17 DAC27-B16 2-CG8422-RA_1 CG8422 CAGCTGCATTGCTCTGATCACCCTGTTCCACTTCTTCACCCTGACCAACTTCTTTTGGATGCTGGTCGA 69 FBan0008422 FBgn0033932 CG8422 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; neuropeptide hormone activity; GO:0005184; diuretic hormone receptor activity; GO:0008036; secretin-like receptor activity; GO:0001633; ; GO:0005184; ; GO:0008188; ; GO:0008036; ; GO:0001633; ; GO:0008036 integral to membrane; GO:0016021 CG8422 CG8422 "anon-WO0170980.100, anon-WO0170980.101" CDMC31299 2 5 17 DAC27-F04 2-CG8464-RA_1 CG8464 ACGCTCACACCGGATATTCTGTTCGAGCTCAAGTCACGAAGCCAAAACATGCCCAGCAACTTAACGCAC 69 FBan0008464 FBgn0038233 CG8464 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; protein binding; GO:0005515; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0005515; ; GO:0004252 ; EC:3.4.21.- CG8464 CG8464 CDMC31299 2 6 17 DAC27-F04 2-CG8464-RA_1 CG8464 ACGCTCACACCGGATATTCTGTTCGAGCTCAAGTCACGAAGCCAAAACATGCCCAGCAACTTAACGCAC 69 FBan0008464 FBgn0038233 CG8464 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; protein binding; GO:0005515; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0005515; ; GO:0004252 ; EC:3.4.21.- CG8464 CG8464 CDMC31300 2 7 17 DAC27-F16 1-CG8481-RA_1 CG8481 GCAGCCCGTTCAATGTGGTTCCCATTCACAACTACCCGGAGCTTATGAAAGACACTTGCGCCCTAATCA 69 FBan0008481 FBgn0037747 CG8481 3 3R furin activity; GO:0004276 ; EC:3.4.21.75; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004276 ; EC:3.4.21.75; ; GO:0008080 ; EC:2.3.1.- CG8481 CG8481 CDMC31300 2 8 17 DAC27-F16 1-CG8481-RA_1 CG8481 GCAGCCCGTTCAATGTGGTTCCCATTCACAACTACCCGGAGCTTATGAAAGACACTTGCGCCCTAATCA 69 FBan0008481 FBgn0037747 CG8481 3 3R furin activity; GO:0004276 ; EC:3.4.21.75; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0004276 ; EC:3.4.21.75; ; GO:0008080 ; EC:2.3.1.- CG8481 CG8481 CDMC31301 2 9 17 DAC27-J04 1-CG8520-RA_1 CG8520 AGCGCACGAACTTTCTGCCCTTCATTGCGTTACTTCAGCGTCGCTGTAAGGTGTCCCAGTTGGATTCTA 69 FBan0008520 FBgn0033734 CG8520 2 2R ATPase activity; GO:0016887; ; GO:0016887 CG8520 CG8520 CDMC31301 2 10 17 DAC27-J04 1-CG8520-RA_1 CG8520 AGCGCACGAACTTTCTGCCCTTCATTGCGTTACTTCAGCGTCGCTGTAAGGTGTCCCAGTTGGATTCTA 69 FBan0008520 FBgn0033734 CG8520 2 2R ATPase activity; GO:0016887; ; GO:0016887 CG8520 CG8520 CDMC31302 2 11 17 DAC27-J16 14-CG8534-RA_1 CG8534 AGAAAGCCCTACGATCTCCGCAGAGTCATCAGGGCATACAACATTATGCAGATTGTCTACAACGGCGTT 69 FBan0008534 FBgn0037761 CG8534 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG8534 CG8534 CDMC31302 2 12 17 DAC27-J16 14-CG8534-RA_1 CG8534 AGAAAGCCCTACGATCTCCGCAGAGTCATCAGGGCATACAACATTATGCAGATTGTCTACAACGGCGTT 69 FBan0008534 FBgn0037761 CG8534 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG8534 CG8534 CDMC31303 2 13 17 DAC27-N04 14-CG8565-RA_6 CG8565 GCGTCCAACGAGGTGTCCGTTCGGACCGAGATCAAGACGGCAATTGAAGTATATTTGAAGGCCAACGAG 69 FBan0008565 FBgn0030697 CG8565 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 CG8565 CG8565 SPRK2 CDMC31303 2 14 17 DAC27-N04 14-CG8565-RA_6 CG8565 GCGTCCAACGAGGTGTCCGTTCGGACCGAGATCAAGACGGCAATTGAAGTATATTTGAAGGCCAACGAG 69 FBan0008565 FBgn0030697 CG8565 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674 CG8565 CG8565 SPRK2 CDMC31304 2 15 17 DAC27-N16 24-CG8579-RA_2 CG8579 ACACCGGCATTGTCTACTAAGAACTGTGTTTTGATAAAGCAATCATATAAAAAGCTATTTAATTTCTTC 69 FBgn0033319 CDMC31304 2 16 17 DAC27-N16 24-CG8579-RA_2 CG8579 ACACCGGCATTGTCTACTAAGAACTGTGTTTTGATAAAGCAATCATATAAAAAGCTATTTAATTTCTTC 69 FBgn0033319 CDMC31305 2 17 17 DAC28-B04 23-CG30336-RA_2 CG30336 TGTATGTTTGCGCTGTGTACATATAATCGAGAGACTTGCATACATACTGCTATCGATAATCTATGAACC 69 FBan0030336 FBgn0050336 CG30336 2 2R "DNA metabolism; GO:0006259; intracellular protein transport; GO:0006886; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG30336 CG30336 "CG1931, CG1931" CDMC31305 2 18 17 DAC28-B04 23-CG30336-RA_2 CG30336 TGTATGTTTGCGCTGTGTACATATAATCGAGAGACTTGCATACATACTGCTATCGATAATCTATGAACC 69 FBan0030336 FBgn0050336 CG30336 2 2R "DNA metabolism; GO:0006259; intracellular protein transport; GO:0006886; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG30336 CG30336 "CG1931, CG1931" CDMC31306 2 19 17 DAC28-B16 17-CG30345-RA_1 CG30345 ACCAGGCAACAGTTAACTTCTATCCGGGAATCTTCAACTTCATCAGTGTGGGACTGTACTTCCTGTGCT 69 FBan0030345 FBgn0050345 CG30345 2 2R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG30345 CG30345 CDMC31306 2 20 17 DAC28-B16 17-CG30345-RA_1 CG30345 ACCAGGCAACAGTTAACTTCTATCCGGGAATCTTCAACTTCATCAGTGTGGGACTGTACTTCCTGTGCT 69 FBan0030345 FBgn0050345 CG30345 2 2R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG30345 CG30345 CDMC31307 2 21 17 DAC28-F04 15-CG30378-RA_1 CG30378 TGCGAAGCTAGGAATTCCAAATTGAAGGCACAAATTAACCACGAACCCCTTTCGAAAGAGCCCAACCCA 69 FBan0030378 FBgn0050378 CG30378 2 2R calcium-mediated signaling; GO:0019722; mitosis; GO:0007067 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 CG30378 CG30378 NEST:bs08d04 CDMC31307 2 22 17 DAC28-F04 15-CG30378-RA_1 CG30378 TGCGAAGCTAGGAATTCCAAATTGAAGGCACAAATTAACCACGAACCCCTTTCGAAAGAGCCCAACCCA 69 FBan0030378 FBgn0050378 CG30378 2 2R calcium-mediated signaling; GO:0019722; mitosis; GO:0007067 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 CG30378 CG30378 NEST:bs08d04 CDMC31308 2 23 17 DAC28-F16 9-CG30391-RA_2 CG30391 TGTGTCCGCCGTACGAACACCATCAGAAGATCAAGGATCAGTCCGACGCATATCTCAGTCATGCCAAGA 69 FBan0030391 FBgn0050391 CG30391 2 2R CG30391 CG30391 CG15662 CDMC31308 2 24 17 DAC28-F16 9-CG30391-RA_2 CG30391 TGTGTCCGCCGTACGAACACCATCAGAAGATCAAGGATCAGTCCGACGCATATCTCAGTCATGCCAAGA 69 FBan0030391 FBgn0050391 CG30391 2 2R CG30391 CG30391 CG15662 CDMC31309 2 25 17 DAC28-J04 15-CG30432-RA_2 CG30432 TCGTCATCCTATACGTGGTATTTCGAAAGAGGGAGTGTTTGAGGGTGCAGACTCTAGAGGACACTCGGC 69 FBan0030432 FBgn0050432 CG30432 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30432 CG30432 CDMC31309 2 26 17 DAC28-J04 15-CG30432-RA_2 CG30432 TCGTCATCCTATACGTGGTATTTCGAAAGAGGGAGTGTTTGAGGGTGCAGACTCTAGAGGACACTCGGC 69 FBan0030432 FBgn0050432 CG30432 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30432 CG30432 CDMC31310 2 1 18 DAC28-J16 1-CG30443-RA_1 CG30443 AGTCCTCCCGTAAATTAGCCCAGCGTACTAGTCTCGATAAGGAGAAACCCGGGTTTCCCTGCCAGTACT 69 FBan0030443 FBgn0050443 CG30443 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG30443 CG30443 "CG12397, CG12397, CG12397, CG12397, CG12397, CG12397, BcDNA:RE37461" CDMC31310 2 2 18 DAC28-J16 1-CG30443-RA_1 CG30443 AGTCCTCCCGTAAATTAGCCCAGCGTACTAGTCTCGATAAGGAGAAACCCGGGTTTCCCTGCCAGTACT 69 FBan0030443 FBgn0050443 CG30443 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG30443 CG30443 "CG12397, CG12397, CG12397, CG12397, CG12397, CG12397, BcDNA:RE37461" CDMC31311 2 3 18 DAC28-N04 12-CG30483-RA_1 CG30483 CCCAAGGCGAACCACCATAGGTTGCACTAAACTAAGCCTGGGGAATCAAATCAACCGTTTGCCAAATCG 69 FBan0030483 FBgn0040752 Prosap 2 2R protein binding; GO:0005515; ; GO:0005515 Prosap Prosap "CG8122, CG30483, CG13354, CG8122, Shank, D-ProSAP, anon-WO0118547.149, BcDNA:GH23107" CDMC31311 2 4 18 DAC28-N04 12-CG30483-RA_1 CG30483 CCCAAGGCGAACCACCATAGGTTGCACTAAACTAAGCCTGGGGAATCAAATCAACCGTTTGCCAAATCG 69 FBan0030483 FBgn0040752 Prosap 2 2R protein binding; GO:0005515; ; GO:0005515 Prosap Prosap "CG8122, CG30483, CG13354, CG8122, Shank, D-ProSAP, anon-WO0118547.149, BcDNA:GH23107" CDMC31312 2 5 18 DAC28-N16 22-CG30490-RA_1 CG30490 GCACAGCATCAACAAGCTTACTGGCTGCTAAAAATCGTCATTACGCTGAGATCATTATTCCCATCGGCG 69 FBan0030490 FBgn0050490 CG30490 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30490 CG30490 CDMC31312 2 6 18 DAC28-N16 22-CG30490-RA_1 CG30490 GCACAGCATCAACAAGCTTACTGGCTGCTAAAAATCGTCATTACGCTGAGATCATTATTCCCATCGGCG 69 FBan0030490 FBgn0050490 CG30490 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30490 CG30490 CDMC31313 2 7 18 DAC29-B04 3-CG9962-RA_1 CG9962 GCAGAAGGCGGAGATGATCTTGGAAATGAAGCTGTCCACCTTGCCGAATAGCCTGTGTGCTGGATATCC 69 FBan0009962 FBgn0031441 CG9962 2 2L intracellular signaling cascade; GO:0007242; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; sugar porter activity; GO:0005351; ; GO:0004681 ; EC:2.7.1.-; ; GO:0005351 CG9962 CG9962 CKIa-like CDMC31313 2 8 18 DAC29-B04 3-CG9962-RA_1 CG9962 GCAGAAGGCGGAGATGATCTTGGAAATGAAGCTGTCCACCTTGCCGAATAGCCTGTGTGCTGGATATCC 69 FBan0009962 FBgn0031441 CG9962 2 2L intracellular signaling cascade; GO:0007242; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; sugar porter activity; GO:0005351; ; GO:0004681 ; EC:2.7.1.-; ; GO:0005351 CG9962 CG9962 CKIa-like CDMC31314 2 9 18 DAC29-B16 14-CG9983-RA_1 CG9983 AGCAGTGTGTGAGCTAAACAGAAGAAACACAGCAAGTGGCAGTACACGTACACAGAAGGTGACCAGGAT 69 FBan0009983 FBgn0001215 Hrb98DE 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530; ribonucleoprotein complex; GO:0030529 Hrb98DE Heterogeneous nuclear ribonucleoprotein at 98DE "CG9983, CG9983, CG9983, p9, E7Delta6, HDP(P9), hrp38, HRB98DE/hrp38, hrb98DE, Hrb1: hnRNA-binding protein 1, Pen9, anon-E7Delta6, hnRNA-binding protein 1" CDMC31314 2 10 18 DAC29-B16 14-CG9983-RA_1 CG9983 AGCAGTGTGTGAGCTAAACAGAAGAAACACAGCAAGTGGCAGTACACGTACACAGAAGGTGACCAGGAT 69 FBan0009983 FBgn0001215 Hrb98DE 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530; ribonucleoprotein complex; GO:0030529 Hrb98DE Heterogeneous nuclear ribonucleoprotein at 98DE "CG9983, CG9983, CG9983, p9, E7Delta6, HDP(P9), hrp38, HRB98DE/hrp38, hrb98DE, Hrb1: hnRNA-binding protein 1, Pen9, anon-E7Delta6, hnRNA-binding protein 1" CDMC31315 2 11 18 DAC29-F04 23-CR17875-RA_8 CR17875 TGTCTGCATTTACGCTACTTTCGTACCTTTCAATTGATTTGATAGAATGCAAACGTAGAGCCCTATGTA 69 FBan0017875 FBgn0038034 Cyp9f3Psi 3 3R Cyp9f3Psi Cyp9f3Psi "CG17875, CG17875, Cyp9f3p, 9f3p, Cyp9f3, CR17875, Cyp9f3Psi" CDMC31315 2 12 18 DAC29-F04 23-CR17875-RA_8 CR17875 TGTCTGCATTTACGCTACTTTCGTACCTTTCAATTGATTTGATAGAATGCAAACGTAGAGCCCTATGTA 69 FBan0017875 FBgn0038034 Cyp9f3Psi 3 3R Cyp9f3Psi Cyp9f3Psi "CG17875, CG17875, Cyp9f3p, 9f3p, Cyp9f3, CR17875, Cyp9f3Psi" CDMC31316 2 13 18 DAC29-F16 11-CR30425-RA_1 CR30425 GGAACTCTTGATTGATGCTAACACCGAAACGAAAAACGCCGACTGGGTAGCCCTAAAATGGTGGCCCTA 69 FBgn0047072 CDMC31316 2 14 18 DAC29-F16 11-CR30425-RA_1 CR30425 GGAACTCTTGATTGATGCTAACACCGAAACGAAAAACGCCGACTGGGTAGCCCTAAAATGGTGGCCCTA 69 FBgn0047072 CDMC31317 2 15 18 DAC29-J04 16-CR31931-RA_1 CR31931 ACAGATGCTGAAAACCACACTTTATGGATCCTGGCTACTCGGTATATTCCCCTTTACCCTCGACTCCGG 69 FBan0031931 FBgn0045500 Gr22b 2 2L Gr22b Gustatory receptor 22b "CG31931, Gr2940.4, Gustatory receptor 2940.4, Gr22bP, CR31931, Gustatory receptor 22b" CDMC31317 2 16 18 DAC29-J04 16-CR31931-RA_1 CR31931 ACAGATGCTGAAAACCACACTTTATGGATCCTGGCTACTCGGTATATTCCCCTTTACCCTCGACTCCGG 69 FBan0031931 FBgn0045500 Gr22b 2 2L Gr22b Gustatory receptor 22b "CG31931, Gr2940.4, Gustatory receptor 2940.4, Gr22bP, CR31931, Gustatory receptor 22b" CDMC31318 2 17 18 DAC29-J16 22-CR32314-RA_3 CR32314 ACGTGCGCGCTATCATTACTGTTGTGTTTGAGAATAGCTCGAAAGGTTCGATTGAAAGCGGAATCCAGA 69 FBan0032314 FBgn0047306 CR32314 3 3L CR32314 CR32314 BcDNA:GH25089 CDMC31318 2 18 18 DAC29-J16 22-CR32314-RA_3 CR32314 ACGTGCGCGCTATCATTACTGTTGTGTTTGAGAATAGCTCGAAAGGTTCGATTGAAAGCGGAATCCAGA 69 FBan0032314 FBgn0047306 CR32314 3 3L CR32314 CR32314 BcDNA:GH25089 CDMC31319 2 19 18 DAC29-N04 16-CR32886-RA_1 CR32886 GGTATCGTGCGAATTGCAAAGATCGACCAACGCCATTTCACTCCAAACCCCAAATTGCTGTAGTCATTT 69 FBan0032886 FBgn0045800 Uhg1 2 2R Uhg1 U snoRNA host gene 1 "CG14486, dUHG1, Dros-UHG1, BEST:GM03135, CR32886, U snoRNA host gene 1" CDMC31319 2 20 18 DAC29-N04 16-CR32886-RA_1 CR32886 GGTATCGTGCGAATTGCAAAGATCGACCAACGCCATTTCACTCCAAACCCCAAATTGCTGTAGTCATTT 69 FBan0032886 FBgn0045800 Uhg1 2 2R Uhg1 U snoRNA host gene 1 "CG14486, dUHG1, Dros-UHG1, BEST:GM03135, CR32886, U snoRNA host gene 1" CDMC31320 2 21 18 DAC29-N16 2-CR33258-RA_1 CR33258 ACCAACCCAAGCCATATTTCGATTCTACGACCAGCCTTTGCGTATCGACGAAACCAACGGGATGCTCCT 69 FBan0033258 FBgn0053258 CG33258 3 3L CG33258 CG33258 "BP1001, CR33258" CDMC31320 2 22 18 DAC29-N16 2-CR33258-RA_1 CR33258 ACCAACCCAAGCCATATTTCGATTCTACGACCAGCCTTTGCGTATCGACGAAACCAACGGGATGCTCCT 69 FBan0033258 FBgn0053258 CG33258 3 3L CG33258 CG33258 "BP1001, CR33258" CDMC31321 2 23 18 DAC30-B04 23-CG11979-RA_2 CG11979 ATTGGTGTGCTGATCCTGGACTTATGAATTATTTTAAGAAACCTATGATTTAAGGAAAAGGCAGCGAGT 69 FBan0011979 FBgn0033571 Rpb5 2 2R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb5 Rpb5 "CG11979, CG11979, RPB5, DmRPB5" CDMC31321 2 24 18 DAC30-B04 23-CG11979-RA_2 CG11979 ATTGGTGTGCTGATCCTGGACTTATGAATTATTTTAAGAAACCTATGATTTAAGGAAAAGGCAGCGAGT 69 FBan0011979 FBgn0033571 Rpb5 2 2R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb5 Rpb5 "CG11979, CG11979, RPB5, DmRPB5" CDMC31322 2 25 18 DAC30-B16 11-CG11990-RA_2 CG11990 ACCCTCACCGCATTCTTAAACGTTCTGCTGAAACACGACACCTGCTGTTTTCAATCCCACTCCCAAGTA 69 FBan0011990 FBgn0037657 CG11990 3 3R CG11990 CG11990 CDMC31322 2 26 18 DAC30-B16 11-CG11990-RA_2 CG11990 ACCCTCACCGCATTCTTAAACGTTCTGCTGAAACACGACACCTGCTGTTTTCAATCCCACTCCCAAGTA 69 FBan0011990 FBgn0037657 CG11990 3 3R CG11990 CG11990 CDMC31323 2 1 19 DAC30-F04 21-CG12020-RA_2 CG12020 CATTCTGTGAACACTTCTGCCAGTTGTTATACGCTTCGACTCCGAATAGAAACAATGAACCGGCCGGAG 69 FBan0012020 FBgn0035273 CG12020 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG12020 CG12020 CDMC31323 2 2 19 DAC30-F04 21-CG12020-RA_2 CG12020 CATTCTGTGAACACTTCTGCCAGTTGTTATACGCTTCGACTCCGAATAGAAACAATGAACCGGCCGGAG 69 FBan0012020 FBgn0035273 CG12020 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG12020 CG12020 CDMC31324 2 3 19 DAC30-F16 15-CG12026-RA_2 CG12026 GCCAAATACTCGGTCACCTCTTGCATCAGAGTTCCCTGACTCAAAAGCATTACTCTATCGCCACGAGGT 69 FBan0012026 FBgn0035289 CG12026 3 3L CG12026 CG12026 CDMC31324 2 4 19 DAC30-F16 15-CG12026-RA_2 CG12026 GCCAAATACTCGGTCACCTCTTGCATCAGAGTTCCCTGACTCAAAAGCATTACTCTATCGCCACGAGGT 69 FBan0012026 FBgn0035289 CG12026 3 3L CG12026 CG12026 CDMC31325 2 5 19 DAC30-J04 14-CG12052-RW_1 CG12052 ACGAGGGCTATGTGATTGAAAAAATTCACGGTGATGGGGAGACGGTTAATCAGCCGCAAGAAAAGCTGT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC31325 2 6 19 DAC30-J04 14-CG12052-RW_1 CG12052 ACGAGGGCTATGTGATTGAAAAAATTCACGGTGATGGGGAGACGGTTAATCAGCCGCAAGAAAAGCTGT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC31326 2 7 19 DAC30-J16 9-CG12069-RA_1 CG12069 GCCCAACATCAGCAATCCCGAGGATATATCCAACTTCGATAAGGTCTCTGATAAGCCGCGACCCAAGGC 69 FBan0012069 FBgn0039796 CG12069 3 3R anti-apoptosis; GO:0006916; cell homeostasis; GO:0019725; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG12069 CG12069 PKA-like CDMC31326 2 8 19 DAC30-J16 9-CG12069-RA_1 CG12069 GCCCAACATCAGCAATCCCGAGGATATATCCAACTTCGATAAGGTCTCTGATAAGCCGCGACCCAAGGC 69 FBan0012069 FBgn0039796 CG12069 3 3R anti-apoptosis; GO:0006916; cell homeostasis; GO:0019725; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- CG12069 CG12069 PKA-like CDMC31327 2 9 19 DAC30-N04 14-CG12109-RB_1 CG12109 GGTGCGCCTTACCCACGGCAATCGGAACTCGAAGACGTTCCTGATCAACGAATATTTAGAGTACCTGAA 69 FBan0012109 FBgn0030054 Caf1-180 X X nucleosome assembly; GO:0006334 chromatin binding; GO:0003682; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-180 Caf1-180 "CG12109, p180" CDMC31327 2 10 19 DAC30-N04 14-CG12109-RB_1 CG12109 GGTGCGCCTTACCCACGGCAATCGGAACTCGAAGACGTTCCTGATCAACGAATATTTAGAGTACCTGAA 69 FBan0012109 FBgn0030054 Caf1-180 X X nucleosome assembly; GO:0006334 chromatin binding; GO:0003682; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-180 Caf1-180 "CG12109, p180" CDMC31328 2 11 19 DAC30-N16 18-CG12116-RA_2 CG12116 GGTGACAATCGGAAAGTTGGACAAAGATCACTCGAATGGTGTGCAGCTAATGGAACAGGCATTGATGGA 69 FBan0012116 FBgn0030041 CG12116 X X sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 CG12116 CG12116 CDMC31328 2 12 19 DAC30-N16 18-CG12116-RA_2 CG12116 GGTGACAATCGGAAAGTTGGACAAAGATCACTCGAATGGTGTGCAGCTAATGGAACAGGCATTGATGGA 69 FBan0012116 FBgn0030041 CG12116 X X sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 CG12116 CG12116 CDMC31329 2 13 19 DAC31-B04 5-CG3592-RA_1 CG3592 TGAGCCGCACTTTAATTCCAAACATGGATTGTGTGGCCTTTTGGGATTCCTGCTTATCGCTGGGGC 66 FBan0003592 FBgn0029642 CG3592 X X CG3592 CG3592 frag7 CDMC31329 2 14 19 DAC31-B04 5-CG3592-RA_1 CG3592 TGAGCCGCACTTTAATTCCAAACATGGATTGTGTGGCCTTTTGGGATTCCTGCTTATCGCTGGGGC 66 FBan0003592 FBgn0029642 CG3592 X X CG3592 CG3592 frag7 CDMC31330 2 15 19 DAC31-B16 7-CG3706-RA_1 CG3706 GCCACTAATCTTCGGCAAGTACCCACTGAAAGGCATCTTTTACCGGGTGAAGTTCTGGATCGCCCT 66 FBan0003706 FBgn0040342 CG3706 X X CG3706 CG3706 "EG:BAC7A4.20, EG:BACR7A4.20, ESTS:99F6T" CDMC31330 2 16 19 DAC31-B16 7-CG3706-RA_1 CG3706 GCCACTAATCTTCGGCAAGTACCCACTGAAAGGCATCTTTTACCGGGTGAAGTTCTGGATCGCCCT 66 FBan0003706 FBgn0040342 CG3706 X X CG3706 CG3706 "EG:BAC7A4.20, EG:BACR7A4.20, ESTS:99F6T" CDMC31331 2 17 19 DAC31-F04 2-CG40473-RA_1 CG40473 GGCGCTATCATAAAGCCAACGGTCGGCATGTCGAAGTTGCCAGTCAAACCGAAGACTTCGAATGCC 66 FBgn0069976 CG40473 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40473 CG40473 CDMC31331 2 18 19 DAC31-F04 2-CG40473-RA_1 CG40473 GGCGCTATCATAAAGCCAACGGTCGGCATGTCGAAGTTGCCAGTCAAACCGAAGACTTCGAATGCC 66 FBgn0069976 CG40473 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40473 CG40473 CDMC31332 2 19 19 DAC31-F16 3-CG4233-RA_2 CG4233 CGATGCCATCTTGGGTGTCACGGAAGCCTTCAAGAAGGACACCAACCCCAAGAAGATCAACTTGGG 66 FBgn0031380 CDMC31332 2 20 19 DAC31-F16 3-CG4233-RA_2 CG4233 CGATGCCATCTTGGGTGTCACGGAAGCCTTCAAGAAGGACACCAACCCCAAGAAGATCAACTTGGG 66 FBgn0031380 CDMC31333 2 21 19 DAC31-J04 3-CG4721-RA_8 CG4721 GCTTACATTGGAGACCAGGCAGAAGGCAATCACCAAACTGGAGGCTTTGAAGCTGCACTTCCGGAC 66 FBan0004721 FBgn0039024 CG4721 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4721 CG4721 anon-EST:Posey132 CDMC31333 2 22 19 DAC31-J04 3-CG4721-RA_8 CG4721 GCTTACATTGGAGACCAGGCAGAAGGCAATCACCAAACTGGAGGCTTTGAAGCTGCACTTCCGGAC 66 FBan0004721 FBgn0039024 CG4721 3 3R proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4721 CG4721 anon-EST:Posey132 CDMC31334 2 23 19 DAC31-J16 3-CG4839-RB_2 CG4839 CCAGTAGTCAGCGCAACGATACGAGTGGTCGTTCCAGCACCAAGTCTCTGGAGTTCGACAACGAGT 66 FBan0004839 FBgn0032187 CG4839 2 2L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.- CG4839 CG4839 PKG-like CDMC31334 2 24 19 DAC31-J16 3-CG4839-RB_2 CG4839 CCAGTAGTCAGCGCAACGATACGAGTGGTCGTTCCAGCACCAAGTCTCTGGAGTTCGACAACGAGT 66 FBan0004839 FBgn0032187 CG4839 2 2L intracellular signaling cascade; GO:0007242; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.- CG4839 CG4839 PKG-like CDMC31335 2 25 19 DAC31-N04 2-CG5094-RA_1 CG5094 GCAGTGCAGCAGAGTTTCGTGCGTAGCTTCATTGACTACCTGAAGAAGCAGGGGGACGTGATGTCG 66 FBan0005094 FBgn0032640 Sgt 2 2L neuromuscular synaptic transmission; GO:0007274 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Sgt small glutamine-rich tetratricopeptide containing protein "CG5094, CG5094, dsgt, small glutamine-rich tetratricopeptide containing protein" CDMC31335 2 26 19 DAC31-N04 2-CG5094-RA_1 CG5094 GCAGTGCAGCAGAGTTTCGTGCGTAGCTTCATTGACTACCTGAAGAAGCAGGGGGACGTGATGTCG 66 FBan0005094 FBgn0032640 Sgt 2 2L neuromuscular synaptic transmission; GO:0007274 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Sgt small glutamine-rich tetratricopeptide containing protein "CG5094, CG5094, dsgt, small glutamine-rich tetratricopeptide containing protein" CDMC31336 2 1 20 DAC31-N16 3-CG5285-RA_2 CG5285 ATGCAGACCTTCTCCCAGCAGTGTTTCGTCCACAATTTCTGTCCGCTAGCTTTCTTTGGCGCAGAT 66 FBan0005285 FBgn0038490 CG5285 3 3R nucleic acid binding; GO:0003676; single-strand selective uracil DNA N-glycosylase activity; GO:0017065 ; EC:3.2.2.-; ; GO:0003676; ; GO:0017065 ; EC:3.2.2.- CG5285 CG5285 CDMC31336 2 2 20 DAC31-N16 3-CG5285-RA_2 CG5285 ATGCAGACCTTCTCCCAGCAGTGTTTCGTCCACAATTTCTGTCCGCTAGCTTTCTTTGGCGCAGAT 66 FBan0005285 FBgn0038490 CG5285 3 3R nucleic acid binding; GO:0003676; single-strand selective uracil DNA N-glycosylase activity; GO:0017065 ; EC:3.2.2.-; ; GO:0003676; ; GO:0017065 ; EC:3.2.2.- CG5285 CG5285 CDMC31337 2 3 20 DAC32-B04 2-CG1112-RA_1 CG1112 GCTGCCACGGGTAATCCCTACAGCGAGAAGATCAACGGTATGGACACTCTGACCATTGATCCAGTTCGC 69 FBan0001112 FBgn0015575 alpha-Est7 3 3R biological process unknown; GO:0000004 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 cellular component unknown; GO:0008372 alpha-Est7 alpha-Esterase-7 "CG1112, Est23, ali, Esterase 23, alphaE7, H, fragment H, aE7, EST23, alpha-Est7, Ali, Est-23, Mce, Aliesterase, Malathion carboxylesterase, aliesteraseless" CDMC31337 2 4 20 DAC32-B04 2-CG1112-RA_1 CG1112 GCTGCCACGGGTAATCCCTACAGCGAGAAGATCAACGGTATGGACACTCTGACCATTGATCCAGTTCGC 69 FBan0001112 FBgn0015575 alpha-Est7 3 3R biological process unknown; GO:0000004 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 cellular component unknown; GO:0008372 alpha-Est7 alpha-Esterase-7 "CG1112, Est23, ali, Esterase 23, alphaE7, H, fragment H, aE7, EST23, alpha-Est7, Ali, Est-23, Mce, Aliesterase, Malathion carboxylesterase, aliesteraseless" CDMC31338 2 5 20 DAC32-B16 23-CG11142-RB_6 CG11142 TTGGCTGAGCATCGCAGTAGCTCTTCCTTAGTTTAACTTTTAGTGATCACATTGCCATTCGAAAACAAC 69 FBan0011142 FBgn0031737 CG11142 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG11142 CG11142 CDMC31338 2 6 20 DAC32-B16 23-CG11142-RB_6 CG11142 TTGGCTGAGCATCGCAGTAGCTCTTCCTTAGTTTAACTTTTAGTGATCACATTGCCATTCGAAAACAAC 69 FBan0011142 FBgn0031737 CG11142 2 2L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG11142 CG11142 CDMC31339 2 7 20 DAC32-F04 7-CG11175-RA_1 CG11175 CGCGATGTGGCTCTTTGAGTCCGTTTTTTTGGTTCTGGAAACCGGATCCCAATCGATCATCAGTCAGCG 69 FBan0011175 FBgn0034530 CG11175 2 2R CG11175 CG11175 CDMC31339 2 8 20 DAC32-F04 7-CG11175-RA_1 CG11175 CGCGATGTGGCTCTTTGAGTCCGTTTTTTTGGTTCTGGAAACCGGATCCCAATCGATCATCAGTCAGCG 69 FBan0011175 FBgn0034530 CG11175 2 2R CG11175 CG11175 CDMC31340 2 9 20 DAC32-F16 7-CG11191-RA_1 CG11191 CGGCGGCTTTGTAACCTCCACTTTGCGTCCAGCGATAGAGCACGAAAACCAGTCTTGTGAGAATTACCT 69 FBan0011191 FBgn0033249 CG11191 2 2R CG11191 CG11191 CDMC31340 2 10 20 DAC32-F16 7-CG11191-RA_1 CG11191 CGGCGGCTTTGTAACCTCCACTTTGCGTCCAGCGATAGAGCACGAAAACCAGTCTTGTGAGAATTACCT 69 FBan0011191 FBgn0033249 CG11191 2 2R CG11191 CG11191 CDMC31341 2 11 20 DAC32-J04 16-CG11248-RA_1 CG11248 GCACCTGAATGAATTGTTCGCTGGACAAAATGATGAACTGCAAAAGCTCCAGAAATTGAGCCAAGCGCA 69 FBan0011248 FBgn0037117 CG11248 3 3L cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG11248 CG11248 CDMC31341 2 12 20 DAC32-J04 16-CG11248-RA_1 CG11248 GCACCTGAATGAATTGTTCGCTGGACAAAATGATGAACTGCAAAAGCTCCAGAAATTGAGCCAAGCGCA 69 FBan0011248 FBgn0037117 CG11248 3 3L cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG11248 CG11248 CDMC31342 2 13 20 DAC32-J16 3-CG11259-RA_1 CG11259 GCGAAGCGAAGAATCGAGTCCCACTACCAGTCTTAGCTCTATTACCTCTCCGATGCGGAAGAAGCGCCA 69 FBan0011259 FBgn0036333 MICAL-like 3 3L cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 MICAL-like MICAL-like "CG11259, CG11259, AAK93415" CDMC31342 2 14 20 DAC32-J16 3-CG11259-RA_1 CG11259 GCGAAGCGAAGAATCGAGTCCCACTACCAGTCTTAGCTCTATTACCTCTCCGATGCGGAAGAAGCGCCA 69 FBan0011259 FBgn0036333 MICAL-like 3 3L cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 MICAL-like MICAL-like "CG11259, CG11259, AAK93415" CDMC31343 2 15 20 DAC32-N04 3-CG11290-RA_1 CG11290 GGCACTCCATCGAACCCGATGTACCCCACGTATTCCCCCTACTTACCTCTCAACGGTTCTATTCGCAGA 69 FBan0011290 FBgn0034975 enok 2 2R mushroom body development; GO:0016319; neuroblast proliferation; GO:0007405; nucleosome assembly; GO:0006334; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48; ; GO:0003677 histone acetyltransferase complex; GO:0000123; nucleosome; GO:0000786; nucleus; GO:0005634 enok enoki mushroom "CG11290, CG11290, CG11290, CG11290, CG11290, rotkehlchen, S1, rot, anon-WO0200864.2, dmHAG406, anon-60Ba, anon-WO0200864.1, enoki mushroom" CDMC31343 2 16 20 DAC32-N04 3-CG11290-RA_1 CG11290 GGCACTCCATCGAACCCGATGTACCCCACGTATTCCCCCTACTTACCTCTCAACGGTTCTATTCGCAGA 69 FBan0011290 FBgn0034975 enok 2 2R mushroom body development; GO:0016319; neuroblast proliferation; GO:0007405; nucleosome assembly; GO:0006334; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48; ; GO:0003677 histone acetyltransferase complex; GO:0000123; nucleosome; GO:0000786; nucleus; GO:0005634 enok enoki mushroom "CG11290, CG11290, CG11290, CG11290, CG11290, rotkehlchen, S1, rot, anon-WO0200864.2, dmHAG406, anon-60Ba, anon-WO0200864.1, enoki mushroom" CDMC31344 2 17 20 DAC32-N16 2-CG11306-RA_6 CG11306 AACAAGAAGTACGTGGCGAGGAACCCCTTTCTCACCTGGACTAAGCTTGCCTACTACCGCCTCTTCTCA 69 FBan0011306 FBgn0037108 CG11306 3 3L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; protein amino acid prenylation; GO:0018346 "alpha-1,2-mannosyltransferase activity; GO:0000026 ; EC:2.4.1.-; ; GO:0000026 ; EC:2.4.1.-; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.-" CG11306 CG11306 CDMC31344 2 18 20 DAC32-N16 2-CG11306-RA_6 CG11306 AACAAGAAGTACGTGGCGAGGAACCCCTTTCTCACCTGGACTAAGCTTGCCTACTACCGCCTCTTCTCA 69 FBan0011306 FBgn0037108 CG11306 3 3L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486; protein amino acid prenylation; GO:0018346 "alpha-1,2-mannosyltransferase activity; GO:0000026 ; EC:2.4.1.-; ; GO:0000026 ; EC:2.4.1.-; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.-" CG11306 CG11306 CDMC31345 2 19 20 DAC33-B04 23-CG12576-RA_11 CG12576 CGGACGAGAGCGATTTTGAGATACTCGAATCGGATGACTTTAAGTAAAGATTGGATCAATCGGCGATCG 69 FBan0012576 FBgn0031190 CG12576 X X CG12576 CG12576 anon-WO0140519.40 CDMC31345 2 20 20 DAC33-B04 23-CG12576-RA_11 CG12576 CGGACGAGAGCGATTTTGAGATACTCGAATCGGATGACTTTAAGTAAAGATTGGATCAATCGGCGATCG 69 FBan0012576 FBgn0031190 CG12576 X X CG12576 CG12576 anon-WO0140519.40 CDMC31346 2 21 20 DAC33-B16 9-CG1258-RA_3 CG1258 GGCACTCGAGAAGAAGGTTCGCATCCACGAGAGCTCCATTGACGTGCTTAACAATACGCTAAGCAAGCA 69 FBan0001258 FBgn0011692 pav 3 3L "cytokinesis; GO:0000910; cytokinesis, contractile ring contraction; GO:0000916; cytokinesis, contractile ring formation; GO:0000915; female meiosis chromosome segregation; GO:0016321; microtubule-based movement; GO:0007018; mitosis; GO:0007067; peripheral nervous system development; GO:0007422; protein targeting; GO:0006605; smoothened signaling pathway; GO:0007224" ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 centrosome; GO:0005813; kinesin complex; GO:0005871; midbody; GO:0030496; nucleus; GO:0005634; spindle; GO:0005819 pav pavarotti "CG1258, CG1258, Mklp1, 0934/13, 0973/08, 2A12, Pav-KLP, 2A12MEL, DmMKLP1, Mitotic kinesin-like protein 1, PAV-MKLP, DmKLP1/pav, PAV-KLP, anon2A12, KIF23, Pav, pav-Klp, PAV/KLP, Pav-klp, Pavarotti-KLP, Pavarotti KLP, group D, anon-EST:fe2A12: anon-fast-evolving-2A12, anon-fast-evolving-2A12, pavarotti" CDMC31346 2 22 20 DAC33-B16 9-CG1258-RA_3 CG1258 GGCACTCGAGAAGAAGGTTCGCATCCACGAGAGCTCCATTGACGTGCTTAACAATACGCTAAGCAAGCA 69 FBan0001258 FBgn0011692 pav 3 3L "cytokinesis; GO:0000910; cytokinesis, contractile ring contraction; GO:0000916; cytokinesis, contractile ring formation; GO:0000915; female meiosis chromosome segregation; GO:0016321; microtubule-based movement; GO:0007018; mitosis; GO:0007067; peripheral nervous system development; GO:0007422; protein targeting; GO:0006605; smoothened signaling pathway; GO:0007224" ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 centrosome; GO:0005813; kinesin complex; GO:0005871; midbody; GO:0030496; nucleus; GO:0005634; spindle; GO:0005819 pav pavarotti "CG1258, CG1258, Mklp1, 0934/13, 0973/08, 2A12, Pav-KLP, 2A12MEL, DmMKLP1, Mitotic kinesin-like protein 1, PAV-MKLP, DmKLP1/pav, PAV-KLP, anon2A12, KIF23, Pav, pav-Klp, PAV/KLP, Pav-klp, Pavarotti-KLP, Pavarotti KLP, group D, anon-EST:fe2A12: anon-fast-evolving-2A12, anon-fast-evolving-2A12, pavarotti" CDMC31347 2 23 20 DAC33-F04 18-CG12632-RB_1 CG12632 TCCGAGGAGGAAGTACTCTTCAGCGACGAGTTCAACCTTAACTACTTTGGCTATAATCCGGGTAGCGAT 69 FBan0012632 FBgn0061173 fd3F X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd3F forkhead domain 3F "CG12632, CG12632, CG12632" CDMC31347 2 24 20 DAC33-F04 18-CG12632-RB_1 CG12632 TCCGAGGAGGAAGTACTCTTCAGCGACGAGTTCAACCTTAACTACTTTGGCTATAATCCGGGTAGCGAT 69 FBan0012632 FBgn0061173 fd3F X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fd3F forkhead domain 3F "CG12632, CG12632, CG12632" CDMC31348 2 25 20 DAC33-F16 23-CG12650-RB_1 CG12650 CGCCGTTGAAACATTTTTCGATTTTAACCCTCTTATTTTTGTTGTTAGTTATTTGTGTGGTTTGACTGT 69 FBan0012650 FBgn0040932 CG12650 X X CG12650 CG12650 CDMC31348 2 26 20 DAC33-F16 23-CG12650-RB_1 CG12650 CGCCGTTGAAACATTTTTCGATTTTAACCCTCTTATTTTTGTTGTTAGTTATTTGTGTGGTTTGACTGT 69 FBan0012650 FBgn0040932 CG12650 X X CG12650 CG12650 CDMC31349 2 1 21 DAC33-J04 23-CG12690-RA_5 CG12690 CACGAGGGACACAAGCAAAGTGAACTTTTCCAGCGTATCAGTGACAAGGTTTATATCAAAAGAGAACAT 69 FBan0012690 FBgn0029504 CHES-1-like X X "regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CHES-1-like Checkpoint suppressor homologue "CG12690, CG12690, CG12690, Dmches-1, anon-EST:Posey7, Checkpoint suppressor homologue" CDMC31349 2 2 21 DAC33-J04 23-CG12690-RA_5 CG12690 CACGAGGGACACAAGCAAAGTGAACTTTTCCAGCGTATCAGTGACAAGGTTTATATCAAAAGAGAACAT 69 FBan0012690 FBgn0029504 CHES-1-like X X "regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CHES-1-like Checkpoint suppressor homologue "CG12690, CG12690, CG12690, Dmches-1, anon-EST:Posey7, Checkpoint suppressor homologue" CDMC31350 2 3 21 DAC33-J16 23-CG12700-RA_1 CG12700 TCTCTGAATCACTCGTTTGTAGTAGTTTGGCAAATAGAAAGGCAAGGCAAACCGAAAATGGATGCTCCC 69 FBan0012700 FBgn0026174 skpD X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein metabolism; GO:0019538; proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; ; GO:0019237 skpD skpD "CG12700, CG12700, dskpD, BcDNA:AT18217" CDMC31350 2 4 21 DAC33-J16 23-CG12700-RA_1 CG12700 TCTCTGAATCACTCGTTTGTAGTAGTTTGGCAAATAGAAAGGCAAGGCAAACCGAAAATGGATGCTCCC 69 FBan0012700 FBgn0026174 skpD X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; mitosis; GO:0007067; protein metabolism; GO:0019538; proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; ; GO:0019237 skpD skpD "CG12700, CG12700, dskpD, BcDNA:AT18217" CDMC31351 2 5 21 DAC33-N04 2-CG12753-RA_2 CG12753 GGCGCGACAAAAGAAGATGTACCAGATTGCGCAACTCATCGAGATTCCTGGACAGATGGACTCTCCCGT 69 FBan0012753 FBgn0038427 CG12753 3 3R CG12753 CG12753 CDMC31351 2 6 21 DAC33-N04 2-CG12753-RA_2 CG12753 GGCGCGACAAAAGAAGATGTACCAGATTGCGCAACTCATCGAGATTCCTGGACAGATGGACTCTCCCGT 69 FBan0012753 FBgn0038427 CG12753 3 3R CG12753 CG12753 CDMC31352 2 7 21 DAC33-N16 15-CG12766-RA_1 CG12766 ACCGGAAAGGGTGGAGTATGCCTGCCGAAAGACCTTGAAGAATATTGGCCTGGATTATGTTGACCTCTA 69 FBan0012766 FBgn0035476 CG12766 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG12766 CG12766 CDMC31352 2 8 21 DAC33-N16 15-CG12766-RA_1 CG12766 ACCGGAAAGGGTGGAGTATGCCTGCCGAAAGACCTTGAAGAATATTGGCCTGGATTATGTTGACCTCTA 69 FBan0012766 FBgn0035476 CG12766 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG12766 CG12766 CDMC31353 2 9 21 DAC34-B04 17-CG4337-RA_1 CG4337 GGCAACCAGAAGACTAGCACCAGTATCATAGCCGACGATGTGTTGTTTTTCCGTGATGCCAACAACTAA 69 FBan0004337 FBgn0010438 mtSSB 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260; mitochondrial genome maintenance; GO:0000002 single-stranded DNA binding; GO:0003697; ; GO:0003697; ; GO:0003697; ; GO:0003697 mitochondrial chromosome; GO:0000262; mitochondrion; GO:0005739 mtSSB mitochondrial single stranded DNA-binding protein "CG4337, c3a, SSB, DmmtSSB, 0046/13, mitochondrial single-stranded DNA-binding, lopo, low power, mitochondrial single strand binding protein" CDMC31353 2 10 21 DAC34-B04 17-CG4337-RA_1 CG4337 GGCAACCAGAAGACTAGCACCAGTATCATAGCCGACGATGTGTTGTTTTTCCGTGATGCCAACAACTAA 69 FBan0004337 FBgn0010438 mtSSB 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260; mitochondrial genome maintenance; GO:0000002 single-stranded DNA binding; GO:0003697; ; GO:0003697; ; GO:0003697; ; GO:0003697 mitochondrial chromosome; GO:0000262; mitochondrion; GO:0005739 mtSSB mitochondrial single stranded DNA-binding protein "CG4337, c3a, SSB, DmmtSSB, 0046/13, mitochondrial single-stranded DNA-binding, lopo, low power, mitochondrial single strand binding protein" CDMC31354 2 11 21 DAC34-B16 16-CG4351-RA_1 CG4351 CCGCCTTGCCTCAAAGTGTTACAATCCCTGTATAAATGGGCTCTCTCAAAGACGGTGTGCCAAAAAAAA 69 FBan0004351 FBgn0030448 CG4351 X X CG4351 CG4351 CDMC31354 2 12 21 DAC34-B16 16-CG4351-RA_1 CG4351 CCGCCTTGCCTCAAAGTGTTACAATCCCTGTATAAATGGGCTCTCTCAAAGACGGTGTGCCAAAAAAAA 69 FBan0004351 FBgn0030448 CG4351 X X CG4351 CG4351 CDMC31355 2 13 21 DAC34-F04 8-CG4382-RA_1 CG4382 TGCAGCTACTTCGATGGGTCAAGTTGCACATCTCTCGCTTTGGAGGAGATCCTAGCTCTATCACCCTCT 69 FBan0004382 FBgn0032132 CG4382 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG4382 CG4382 CDMC31355 2 14 21 DAC34-F04 8-CG4382-RA_1 CG4382 TGCAGCTACTTCGATGGGTCAAGTTGCACATCTCTCGCTTTGGAGGAGATCCTAGCTCTATCACCCTCT 69 FBan0004382 FBgn0032132 CG4382 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG4382 CG4382 CDMC31356 2 15 21 DAC34-F16 2-CG4398-RA_2 CG4398 CCGGAGCTACAAATACTCCCCGGAGCTGATAGCCGAACTGAAAGACTTTGAGAAGCTGATTCCCACGGT 69 FBan0004398 FBgn0034126 CG4398 2 2R CG4398 CG4398 CDMC31356 2 16 21 DAC34-F16 2-CG4398-RA_2 CG4398 CCGGAGCTACAAATACTCCCCGGAGCTGATAGCCGAACTGAAAGACTTTGAGAAGCTGATTCCCACGGT 69 FBan0004398 FBgn0034126 CG4398 2 2R CG4398 CG4398 CDMC31357 2 17 21 DAC34-J04 3-CG4435-RA_1 CG4435 GCCAGTACCACATAGGCGATTCTTCTCCGGGAGCATCACTCTTTGAGAAGTTCGAGTGTGCAGTGTGCT 69 FBan0004435 FBgn0032117 FucTB 2 2L protein amino acid glycosylation; GO:0006486 "fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-" plasma membrane; GO:0005886 FucTB FucTB "CG4435, CG4435, alpha1,3-fucosyltransferase, CT14430" CDMC31357 2 18 21 DAC34-J04 3-CG4435-RA_1 CG4435 GCCAGTACCACATAGGCGATTCTTCTCCGGGAGCATCACTCTTTGAGAAGTTCGAGTGTGCAGTGTGCT 69 FBan0004435 FBgn0032117 FucTB 2 2L protein amino acid glycosylation; GO:0006486 "fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; alpha(1,3)-fucosyltransferase activity; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-; ; GO:0046920 ; EC:2.4.1.-" plasma membrane; GO:0005886 FucTB FucTB "CG4435, CG4435, alpha1,3-fucosyltransferase, CT14430" CDMC31358 2 19 21 DAC34-J16 3-CG4447-RA_4 CG4447 GCGCGAGATCCTCAATTTCGATGGCCTGAATAGCCAGATGCAGAAGTCCGTGATGCAGATGAAGGAGGA 69 FBan0004447 FBgn0035980 CG4447 3 3L protein biosynthesis; GO:0006412 CG4447 CG4447 CDMC31358 2 20 21 DAC34-J16 3-CG4447-RA_4 CG4447 GCGCGAGATCCTCAATTTCGATGGCCTGAATAGCCAGATGCAGAAGTCCGTGATGCAGATGAAGGAGGA 69 FBan0004447 FBgn0035980 CG4447 3 3L protein biosynthesis; GO:0006412 CG4447 CG4447 CDMC31359 2 21 21 DAC34-N04 12-CG4483-RA_7 CG4483 TGCGGCGCTTCATACACTGGGGTCCAATCACTCTATTAACCCTGACTCTGATTGTTACGTGGACTGTCA 69 FBan0004483 FBgn0035970 CG4483 3 3L metal ion binding; GO:0046872; ; GO:0046872 CG4483 CG4483 CDMC31359 2 22 21 DAC34-N04 12-CG4483-RA_7 CG4483 TGCGGCGCTTCATACACTGGGGTCCAATCACTCTATTAACCCTGACTCTGATTGTTACGTGGACTGTCA 69 FBan0004483 FBgn0035970 CG4483 3 3L metal ion binding; GO:0046872; ; GO:0046872 CG4483 CG4483 CDMC31360 2 23 21 DAC34-N16 17-CG4495-RA_2 CG4495 TGAAGAGGGTTAAGAGGAGGTTTAGGGACCATGGCAAAGGCATCTCCAAACAGGACTATCTGGATTTCT 69 FBan0004495 FBgn0031893 CG4495 2 2L calcium ion binding; GO:0005509; ; GO:0005509 CG4495 CG4495 CDMC31360 2 24 21 DAC34-N16 17-CG4495-RA_2 CG4495 TGAAGAGGGTTAAGAGGAGGTTTAGGGACCATGGCAAAGGCATCTCCAAACAGGACTATCTGGATTTCT 69 FBan0004495 FBgn0031893 CG4495 2 2L calcium ion binding; GO:0005509; ; GO:0005509 CG4495 CG4495 CDMC31361 2 25 21 DAC35-B04 22-CG8800-RA_1 CG8800 TGTGGCTCAGCTACAACCTAATCGAGAAAATTAAGGGTTTGACTGGTCTGAAATGCCTGAAGGTGCTCT 69 FBan0008800 FBgn0033408 CG8800 2 2R CG8800 CG8800 CDMC31361 2 26 21 DAC35-B04 22-CG8800-RA_1 CG8800 TGTGGCTCAGCTACAACCTAATCGAGAAAATTAAGGGTTTGACTGGTCTGAAATGCCTGAAGGTGCTCT 69 FBan0008800 FBgn0033408 CG8800 2 2R CG8800 CG8800 CDMC31362 2 1 22 DAC35-B16 1-CG8809-RA_1 CG8809 GCATCTCGTCGTATCCCTTTGAGGCGGATTTCTCCAAGCTAACCCTAACAGACACGGAACAGCGAGAGC 69 FBan0008809 FBgn0033417 Camta 2 2R positive regulation of transcription; GO:0045941 DNA binding; GO:0003677; calmodulin binding; GO:0005516; ; GO:0003677; ; GO:0005516; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Camta Calmodulin-binding transcription activator "CG8809, CG8809, DmCAMTA, camta, Calmodulin-binding transcription activator" CDMC31362 2 2 22 DAC35-B16 1-CG8809-RA_1 CG8809 GCATCTCGTCGTATCCCTTTGAGGCGGATTTCTCCAAGCTAACCCTAACAGACACGGAACAGCGAGAGC 69 FBan0008809 FBgn0033417 Camta 2 2R positive regulation of transcription; GO:0045941 DNA binding; GO:0003677; calmodulin binding; GO:0005516; ; GO:0003677; ; GO:0005516; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Camta Calmodulin-binding transcription activator "CG8809, CG8809, DmCAMTA, camta, Calmodulin-binding transcription activator" CDMC31363 2 3 22 DAC35-F04 22-CG8836-RA_1 CG8836 CGCGATCTCTACAATCTACGACGTTTCTACGATGGCTTCTACAAGAAGTACAATCCCTACATCGCCGCT 69 FBan0008836 FBgn0033726 CG8836 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8836 CG8836 CDMC31363 2 4 22 DAC35-F04 22-CG8836-RA_1 CG8836 CGCGATCTCTACAATCTACGACGTTTCTACGATGGCTTCTACAAGAAGTACAATCCCTACATCGCCGCT 69 FBan0008836 FBgn0033726 CG8836 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8836 CG8836 CDMC31364 2 5 22 DAC35-F16 5-CG8852-RA_2 CG8852 ACTCCTGTAAGTGGAGGTACCTCGATTTGCAATTGCACTGGTCACAGAGAATCCACCTGCTCGAGGACC 69 FBan0008852 FBgn0031548 CG8852 2 2L CG8852 CG8852 CT9284 CDMC31364 2 6 22 DAC35-F16 5-CG8852-RA_2 CG8852 ACTCCTGTAAGTGGAGGTACCTCGATTTGCAATTGCACTGGTCACAGAGAATCCACCTGCTCGAGGACC 69 FBan0008852 FBgn0031548 CG8852 2 2L CG8852 CG8852 CT9284 CDMC31365 2 7 22 DAC35-J04 2-CG8892-RC_1 CG8892 CGCAGACTTTGAACCGCGATGTCTGGTCGGACAAGGAGCTTAAGAAACTGATACGTCGCCAGTTCACCT 69 FBan0008892 FBgn0031664 CG8892 2 2L CG8892 CG8892 CDMC31365 2 8 22 DAC35-J04 2-CG8892-RC_1 CG8892 CGCAGACTTTGAACCGCGATGTCTGGTCGGACAAGGAGCTTAAGAAACTGATACGTCGCCAGTTCACCT 69 FBan0008892 FBgn0031664 CG8892 2 2L CG8892 CG8892 CDMC31366 2 9 22 DAC35-J16 16-CG8910-RA_4 CG8910 CCCGTGTAACCGTACTATATCAAGCCAGATAGGATCGGATGGAATCAGACCTCCAACTCACACACCTCA 69 FBan0008910 FBgn0025833 CG8910 2 2R CG8910 CG8910 "EG:EG0003.1, anon-WO0140519.220" CDMC31366 2 10 22 DAC35-J16 16-CG8910-RA_4 CG8910 CCCGTGTAACCGTACTATATCAAGCCAGATAGGATCGGATGGAATCAGACCTCCAACTCACACACCTCA 69 FBan0008910 FBgn0025833 CG8910 2 2R CG8910 CG8910 "EG:EG0003.1, anon-WO0140519.220" CDMC31367 2 11 22 DAC35-N04 1-CG8946-RA_1 CG8946 ACCGTTCGGTGATCGGAGAAGTGACTCGCCTATTCCTGCACTCCATGTACTACACTCCCAGCCAGAAAT 69 FBan0008946 FBgn0010591 Sply 2 2R amino acid metabolism; GO:0006520; phospholipid metabolism; GO:0006644; sphingolipid catabolism; GO:0030149 sphinganine-1-phosphate aldolase activity; GO:0008117 ; EC:4.1.2.27; ; GO:0008117 ; EC:4.1.2.27; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.-; ; GO:0008117 ; EC:4.1.2.27 integral to endoplasmic reticulum membrane; GO:0030176 Sply Sphingosine-1-phosphate lyase "CG8946, CG8946, CG8946, l(2)05091, Spl, spl: split, SPL, sphingosine-1-phosphate lyase, anon-WO0142479.5, Sphingosine-1-phosphate lyase, spl" CDMC31367 2 12 22 DAC35-N04 1-CG8946-RA_1 CG8946 ACCGTTCGGTGATCGGAGAAGTGACTCGCCTATTCCTGCACTCCATGTACTACACTCCCAGCCAGAAAT 69 FBan0008946 FBgn0010591 Sply 2 2R amino acid metabolism; GO:0006520; phospholipid metabolism; GO:0006644; sphingolipid catabolism; GO:0030149 sphinganine-1-phosphate aldolase activity; GO:0008117 ; EC:4.1.2.27; ; GO:0008117 ; EC:4.1.2.27; carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.-; ; GO:0008117 ; EC:4.1.2.27 integral to endoplasmic reticulum membrane; GO:0030176 Sply Sphingosine-1-phosphate lyase "CG8946, CG8946, CG8946, l(2)05091, Spl, spl: split, SPL, sphingosine-1-phosphate lyase, anon-WO0142479.5, Sphingosine-1-phosphate lyase, spl" CDMC31368 2 13 22 DAC35-N16 13-CG8958-RA_1 CG8958 CCGTTGCGGAAGCTATTTTTGGTCCAGGAGATTGTTTCGGAGACGTAGAAATGGTTGAGGAATGCCCAA 69 FBan0008958 FBgn0030725 CG8958 X X CG8958 CG8958 CDMC31368 2 14 22 DAC35-N16 13-CG8958-RA_1 CG8958 CCGTTGCGGAAGCTATTTTTGGTCCAGGAGATTGTTTCGGAGACGTAGAAATGGTTGAGGAATGCCCAA 69 FBan0008958 FBgn0030725 CG8958 X X CG8958 CG8958 CDMC31369 2 15 22 DAC36-B04 2-CG7034-RA_2 CG7034 TTTCTGGACGAGTTCGTGTGTCACATGACCAACACGGAGAGGAGCGTATCTCAGACACCATCGGC 65 FBan0007034 FBgn0038856 sec15 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec15 sec15 "CG7034, CG7034, dsec15, Sec15, Sec15p" CDMC31369 2 16 22 DAC36-B04 2-CG7034-RA_2 CG7034 TTTCTGGACGAGTTCGTGTGTCACATGACCAACACGGAGAGGAGCGTATCTCAGACACCATCGGC 65 FBan0007034 FBgn0038856 sec15 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 exocyst; GO:0000145 sec15 sec15 "CG7034, CG7034, dsec15, Sec15, Sec15p" CDMC31370 2 17 22 DAC36-B16 1-CG7061-RB_1 CG7061 TCAGCTTGGAATCGGGCGTCCTCTTAAGTCTCATGTCGTGGCAGTACATGGTCCAGTGGAGCAAG 65 FBan0007061 FBgn0027505 rab3-GAP 2 2L neurotransmitter secretion; GO:0007269; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 Rab GTPase activator activity; GO:0005097; protein heterodimerization activity; GO:0046982; ; GO:0005097; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0046982 soluble fraction; GO:0005625; synaptic vesicle; GO:0008021 rab3-GAP rab3-GAP "CG7061, CG7061, CG7061, BcDNA:LD23336" CDMC31370 2 18 22 DAC36-B16 1-CG7061-RB_1 CG7061 TCAGCTTGGAATCGGGCGTCCTCTTAAGTCTCATGTCGTGGCAGTACATGGTCCAGTGGAGCAAG 65 FBan0007061 FBgn0027505 rab3-GAP 2 2L neurotransmitter secretion; GO:0007269; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 Rab GTPase activator activity; GO:0005097; protein heterodimerization activity; GO:0046982; ; GO:0005097; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0046982 soluble fraction; GO:0005625; synaptic vesicle; GO:0008021 rab3-GAP rab3-GAP "CG7061, CG7061, CG7061, BcDNA:LD23336" CDMC31371 2 19 22 DAC36-F04 2-CG7199-RD_1 CG7199 CAATGAGGCGGTCTTTGAACAGGATCTTCTCACCGATGTGCAGTGTGCCTTTCATGTGCAACCGC 65 FBan0007199 FBgn0015239 Hr78 3 3L autophagic cell death; GO:0048102; carbohydrate metabolism; GO:0005975; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165; tracheal liquid clearance; GO:0035002; tracheal system development (sensu Insecta); GO:0007424 "DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; ; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003707; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" nucleus; GO:0005634 Hr78 Hormone-receptor-like in 78 "CG7199, CG7199, DHR78, XR78E/F, X receptor at 78E/F, Dhr78, HR78, NR2D1, Hr78D" CDMC31371 2 20 22 DAC36-F04 2-CG7199-RD_1 CG7199 CAATGAGGCGGTCTTTGAACAGGATCTTCTCACCGATGTGCAGTGTGCCTTTCATGTGCAACCGC 65 FBan0007199 FBgn0015239 Hr78 3 3L autophagic cell death; GO:0048102; carbohydrate metabolism; GO:0005975; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165; tracheal liquid clearance; GO:0035002; tracheal system development (sensu Insecta); GO:0007424 "DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; ; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003707; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" nucleus; GO:0005634 Hr78 Hormone-receptor-like in 78 "CG7199, CG7199, DHR78, XR78E/F, X receptor at 78E/F, Dhr78, HR78, NR2D1, Hr78D" CDMC31372 2 21 22 DAC36-F16 3-CG7225-RA_1 CG7225 GAGCTGCTGAGGAAACTGAACATCCTGGAAGTCTTCAGGGTTCACAAGGTCACCAAGACAGCGCC 65 FBan0007225 FBgn0004003 wbl 2 2R "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; embryonic development (sensu Metazoa); GO:0009792; exocytosis; GO:0006887; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; protein processing; GO:0016485; protein targeting to Golgi; GO:0000042" endoplasmic reticulum; GO:0005783 wbl windbeutel "CG7225, wind, Wind, wbt, Windb" CDMC31372 2 22 22 DAC36-F16 3-CG7225-RA_1 CG7225 GAGCTGCTGAGGAAACTGAACATCCTGGAAGTCTTCAGGGTTCACAAGGTCACCAAGACAGCGCC 65 FBan0007225 FBgn0004003 wbl 2 2R "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; embryonic development (sensu Metazoa); GO:0009792; exocytosis; GO:0006887; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; protein processing; GO:0016485; protein targeting to Golgi; GO:0000042" endoplasmic reticulum; GO:0005783 wbl windbeutel "CG7225, wind, Wind, wbt, Windb" CDMC31373 2 23 22 DAC36-J04 6-CG7305-RA_1 CG7305 CAGCCCAGATCAGGTGGCGCCTATCCCGATGATGACCCCAGATACTATCAGGGTGAACTCGATGG 65 FBgn0038557 CDMC31373 2 24 22 DAC36-J04 6-CG7305-RA_1 CG7305 CAGCCCAGATCAGGTGGCGCCTATCCCGATGATGACCCCAGATACTATCAGGGTGAACTCGATGG 65 FBgn0038557 CDMC31374 2 25 22 DAC36-J16 3-CG7356-RA_3 CG7356 ACCGTGGACGTGTTCATCGACGCGAACAACAAGAAGTTGGATGCAGAGACCACGGACTCGATCTG 65 FBan0007356 FBgn0031975 CG7356 2 2L peptide cross-linking; GO:0018149; protein modification; GO:0006464 protein-glutamine gamma-glutamyltransferase activity; GO:0003810 ; EC:2.3.2.13; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003810 ; EC:2.3.2.13 CG7356 CG7356 CDMC31374 2 26 22 DAC36-J16 3-CG7356-RA_3 CG7356 ACCGTGGACGTGTTCATCGACGCGAACAACAAGAAGTTGGATGCAGAGACCACGGACTCGATCTG 65 FBan0007356 FBgn0031975 CG7356 2 2L peptide cross-linking; GO:0018149; protein modification; GO:0006464 protein-glutamine gamma-glutamyltransferase activity; GO:0003810 ; EC:2.3.2.13; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003810 ; EC:2.3.2.13 CG7356 CG7356 CDMC31375 2 1 23 DAC36-N04 18-CG7429-RA_2 CG7429 ACGGCTGGTGAAAATAAAATAATGGATGCAACTGCAGCAATCACCGGCAATGTGGACAAGACCCA 65 FBan0007429 FBgn0031979 CG7429 2 2L CG7429 CG7429 CDMC31375 2 2 23 DAC36-N04 18-CG7429-RA_2 CG7429 ACGGCTGGTGAAAATAAAATAATGGATGCAACTGCAGCAATCACCGGCAATGTGGACAAGACCCA 65 FBan0007429 FBgn0031979 CG7429 2 2L CG7429 CG7429 CDMC31376 2 3 23 DAC36-N16 23-CG7448-RB_1 CG7448 TGTGACCTCTTCAATCCTATACTTCCTTGCTTTATGATCCTGTACTTCTTCACCTCCGAGATCTT 65 FBan0007448 FBgn0037143 CG7448 3 3L organic cation porter activity; GO:0008513; ; GO:0008513 CG7448 CG7448 CDMC31376 2 4 23 DAC36-N16 23-CG7448-RB_1 CG7448 TGTGACCTCTTCAATCCTATACTTCCTTGCTTTATGATCCTGTACTTCTTCACCTCCGAGATCTT 65 FBan0007448 FBgn0037143 CG7448 3 3L organic cation porter activity; GO:0008513; ; GO:0008513 CG7448 CG7448 CDMC31377 2 5 23 DAC37-B04 17-CG12870-RA_5 CG12870 TCCACATCTTTGTCGGCGACTTGAGCTCAGAAATTGAAACTCAGCAATTGCGCGAAGCATTCACA 65 FBan0012870 FBgn0039570 CG12870 3 3R apoptosis; GO:0006915; protein metabolism; GO:0019538 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG12870 CG12870 BcDNA:RE10833 CDMC31377 2 6 23 DAC37-B04 17-CG12870-RA_5 CG12870 TCCACATCTTTGTCGGCGACTTGAGCTCAGAAATTGAAACTCAGCAATTGCGCGAAGCATTCACA 65 FBan0012870 FBgn0039570 CG12870 3 3R apoptosis; GO:0006915; protein metabolism; GO:0019538 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG12870 CG12870 BcDNA:RE10833 CDMC31378 2 7 23 DAC37-B16 23-CG12897-RA_1 CG12897 ACCTGCCGATGAGTGCTTAATTAATGTGACGGACTTTAGTGATATACAAATAAGTGAGGGGACTG 65 FBan0012897 FBgn0033517 CG12897 2 2R CG12897 CG12897 CDMC31378 2 8 23 DAC37-B16 23-CG12897-RA_1 CG12897 ACCTGCCGATGAGTGCTTAATTAATGTGACGGACTTTAGTGATATACAAATAAGTGAGGGGACTG 65 FBan0012897 FBgn0033517 CG12897 2 2R CG12897 CG12897 CDMC31379 2 9 23 DAC37-F04 3-CG12983-RA_1 CG12983 GTTTGCGGAGCTCGACGCATGTTTCTACATCGATCAGGGCTATTTCTCGCAGAAGCACCTGGCAG 65 FBan0012983 FBgn0037040 CG12983 3 3L CG12983 CG12983 "bs29a07.y1, NEST:bs29a07" CDMC31379 2 10 23 DAC37-F04 3-CG12983-RA_1 CG12983 GTTTGCGGAGCTCGACGCATGTTTCTACATCGATCAGGGCTATTTCTCGCAGAAGCACCTGGCAG 65 FBan0012983 FBgn0037040 CG12983 3 3L CG12983 CG12983 "bs29a07.y1, NEST:bs29a07" CDMC31380 2 11 23 DAC37-F16 24-CG13014-RA_1 CG13014 ATTGTTTTGATGCAACAAATATTTAATAAAGTTTAACTAAAGATCATTTATCCGCCGTTACATCG 65 FBan0013014 FBgn0030759 CG13014 X X CG13014 CG13014 CDMC31380 2 12 23 DAC37-F16 24-CG13014-RA_1 CG13014 ATTGTTTTGATGCAACAAATATTTAATAAAGTTTAACTAAAGATCATTTATCCGCCGTTACATCG 65 FBan0013014 FBgn0030759 CG13014 X X CG13014 CG13014 CDMC31381 2 13 23 DAC37-J04 23-CG13057-RA_11 CG13057 TTCTCATCCGCAACTAAGGATCCATTCAACAGATTAACACGATGAACTCGCCAAAGCTATGATAC 65 FBan0013057 FBgn0040074 retinin 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 retinin retinin "CG13057, CG13057, retinin" CDMC31381 2 14 23 DAC37-J04 23-CG13057-RA_11 CG13057 TTCTCATCCGCAACTAAGGATCCATTCAACAGATTAACACGATGAACTCGCCAAAGCTATGATAC 65 FBan0013057 FBgn0040074 retinin 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 retinin retinin "CG13057, CG13057, retinin" CDMC31382 2 15 23 DAC37-J16 19-CG13066-RA_1 CG13066 CTACACCCCTGCCTACGCCCCCTACGTGGCCCCCTATGCCAGTAGCTACAGTGCCCACAGTGTGG 65 FBan0013066 FBgn0040797 CG13066 3 3L CG13066 CG13066 CDMC31382 2 16 23 DAC37-J16 19-CG13066-RA_1 CG13066 CTACACCCCTGCCTACGCCCCCTACGTGGCCCCCTATGCCAGTAGCTACAGTGCCCACAGTGTGG 65 FBan0013066 FBgn0040797 CG13066 3 3L CG13066 CG13066 CDMC31383 2 17 23 DAC37-N04 1-CG13141-RA_3 CG13141 TCACCACATAATCACAATCCGGCGATATCGCGCTCGGCTATCAAACAGTTTTCCAGCACCGTGGC 65 FBan0013141 FBgn0032226 CG13141 2 2L CG13141 CG13141 CDMC31383 2 18 23 DAC37-N04 1-CG13141-RA_3 CG13141 TCACCACATAATCACAATCCGGCGATATCGCGCTCGGCTATCAAACAGTTTTCCAGCACCGTGGC 65 FBan0013141 FBgn0032226 CG13141 2 2L CG13141 CG13141 CDMC31384 2 19 23 DAC37-N16 13-CG13164-RC_1 CG13164 TCATCAAGTTGTTAAAGGAGCAGAATTCGCGGGTATCATTGTTGCGAGCCAATCAGGACGAGCGG 65 FBgn0033709 CDMC31384 2 20 23 DAC37-N16 13-CG13164-RC_1 CG13164 TCATCAAGTTGTTAAAGGAGCAGAATTCGCGGGTATCATTGTTGCGAGCCAATCAGGACGAGCGG 65 FBgn0033709 CDMC31385 2 21 23 DAC38-B04 12-CG32556-RA_1 CG32556 CGGCAGCAACGATCCTAGTCCCATTTACATCGAGAAGCTCACAAGGAACAACTATCAGCAGCGTCAGGA 69 FBan0032556 FBgn0052556 CG32556 X X CG32556 CG32556 "CG12987, CG12988, CG12989" CDMC31385 2 22 23 DAC38-B04 12-CG32556-RA_1 CG32556 CGGCAGCAACGATCCTAGTCCCATTTACATCGAGAAGCTCACAAGGAACAACTATCAGCAGCGTCAGGA 69 FBan0032556 FBgn0052556 CG32556 X X CG32556 CG32556 "CG12987, CG12988, CG12989" CDMC31386 2 23 23 DAC38-B16 22-CG32575-RB_2 CG32575 GGCCGTCGATCAGTTGAATGATCCCGGCTTTACCTGTGATCTATGTCAACTTTGTTTCGATTCTCAGGA 69 FBan0032575 FBgn0026575 hang X X behavioral response to ethanol; GO:0048149; response to ethanol; GO:0045471; response to heat; GO:0009408; response to stress; GO:0006950 nucleic acid binding; GO:0003676; calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; ; GO:0005509; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 hang hangover "CG4411, CG4416, CG32575, CG4411, CG4416, LD22118, BcDNA:LD22118, BcDNA:GM07804, hangover" CDMC31386 2 24 23 DAC38-B16 22-CG32575-RB_2 CG32575 GGCCGTCGATCAGTTGAATGATCCCGGCTTTACCTGTGATCTATGTCAACTTTGTTTCGATTCTCAGGA 69 FBan0032575 FBgn0026575 hang X X behavioral response to ethanol; GO:0048149; response to ethanol; GO:0045471; response to heat; GO:0009408; response to stress; GO:0006950 nucleic acid binding; GO:0003676; calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; ; GO:0005509; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 hang hangover "CG4411, CG4416, CG32575, CG4411, CG4416, LD22118, BcDNA:LD22118, BcDNA:GM07804, hangover" CDMC31387 2 25 23 DAC38-F04 15-CG32600-RA_2 CG32600 AGTGTTGAATGTAAATGCGAGATTTGGGCAGACGAAACTCAAAGAGCTCCTTCCAAAGGGCAACAGGCC 69 FBan0032600 FBgn0052600 dpr8 X X dpr8 dpr8 "CG5291, CG32600, CG11477, CG14415, CG5291, CT16867, Dpr-8" CDMC31387 2 26 23 DAC38-F04 15-CG32600-RA_2 CG32600 AGTGTTGAATGTAAATGCGAGATTTGGGCAGACGAAACTCAAAGAGCTCCTTCCAAAGGGCAACAGGCC 69 FBan0032600 FBgn0052600 dpr8 X X dpr8 dpr8 "CG5291, CG32600, CG11477, CG14415, CG5291, CT16867, Dpr-8" CDMC31388 2 1 24 DAC38-F16 18-CG32625-RA_4 CG32625 TGCCGCTTTGTGCCAAGAAATTTCCATCGGACGAATTAGCTCGCTGTCCATATAACAGAACCCATATGT 69 FBan0032625 FBgn0052625 CG32625 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32625 CG32625 CDMC31388 2 2 24 DAC38-F16 18-CG32625-RA_4 CG32625 TGCCGCTTTGTGCCAAGAAATTTCCATCGGACGAATTAGCTCGCTGTCCATATAACAGAACCCATATGT 69 FBan0032625 FBgn0052625 CG32625 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32625 CG32625 CDMC31389 2 3 24 DAC38-J04 9-CG32650-RA_1 CG32650 GACCCAAAGCATGAAGAGGAAGAACGAGTTGTTTCACCATGATTGCGTCTCGGACATCGACGGATCCGT 69 FBan0032650 FBgn0052650 CG32650 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32650 CG32650 "CG4410, CG4410" CDMC31389 2 4 24 DAC38-J04 9-CG32650-RA_1 CG32650 GACCCAAAGCATGAAGAGGAAGAACGAGTTGTTTCACCATGATTGCGTCTCGGACATCGACGGATCCGT 69 FBan0032650 FBgn0052650 CG32650 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32650 CG32650 "CG4410, CG4410" CDMC31390 2 5 24 DAC38-J16 23-CG32656-RA_2 CG32656 ATGCCACAATCAACTGCACTTAAATATTGGCAATGATATTCTATCTCCATTTCCTGGGTCCTATCTAAT 69 FBan0032656 FBgn0052656 CG32656 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32656 CG32656 CG2779 CDMC31390 2 6 24 DAC38-J16 23-CG32656-RA_2 CG32656 ATGCCACAATCAACTGCACTTAAATATTGGCAATGATATTCTATCTCCATTTCCTGGGTCCTATCTAAT 69 FBan0032656 FBgn0052656 CG32656 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32656 CG32656 CG2779 CDMC31391 2 7 24 DAC38-N04 2-CG32697-RA_1 CG32697 GGGCCAATCTGACCAAGAATCGCTACACAGACGTCCTCTGCTACGATCACAGTCGAGTTGTTCTGGCAC 69 FBgn0052697 CDMC31391 2 8 24 DAC38-N04 2-CG32697-RA_1 CG32697 GGGCCAATCTGACCAAGAATCGCTACACAGACGTCCTCTGCTACGATCACAGTCGAGTTGTTCTGGCAC 69 FBgn0052697 CDMC31392 2 9 24 DAC38-N16 2-CG32702-RA_1 CG32702 TGCTGAGGGTGCAGTTCGTCAACTTTGATCTCCACGGACCGAATCAAAATGGTAGCTGCGTGGATGACT 69 FBan0032702 FBgn0052702 CG32702 X X receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0004872; ; GO:0005509 CG32702 CG32702 "CG2996, CG2996, CT7882, tok-like" CDMC31392 2 10 24 DAC38-N16 2-CG32702-RA_1 CG32702 TGCTGAGGGTGCAGTTCGTCAACTTTGATCTCCACGGACCGAATCAAAATGGTAGCTGCGTGGATGACT 69 FBan0032702 FBgn0052702 CG32702 X X receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0004872; ; GO:0005509 CG32702 CG32702 "CG2996, CG2996, CT7882, tok-like" CDMC31393 2 11 24 DAC39-B04 1-CG13650-RA_1 CG13650 AGCGCCGTCTTTAAAAGGAGCTGCCCTAGTGAAACTATCGGCTTTGAAGATCCAATCGCAGACCTGGGA 69 FBan0013650 FBgn0039277 CG13650 3 3R CG13650 CG13650 CDMC31393 2 12 24 DAC39-B04 1-CG13650-RA_1 CG13650 AGCGCCGTCTTTAAAAGGAGCTGCCCTAGTGAAACTATCGGCTTTGAAGATCCAATCGCAGACCTGGGA 69 FBan0013650 FBgn0039277 CG13650 3 3R CG13650 CG13650 CDMC31394 2 13 24 DAC39-B16 12-CG13663-RA_2 CG13663 AGGAGAAAGGAAACGGTAGACAACTTCAAGGACAAACTACGGAGATTCTGGATGTTGGGAACCGGGGCT 69 FBan0013663 FBgn0039291 CG13663 3 3R CG13663 CG13663 CDMC31394 2 14 24 DAC39-B16 12-CG13663-RA_2 CG13663 AGGAGAAAGGAAACGGTAGACAACTTCAAGGACAAACTACGGAGATTCTGGATGTTGGGAACCGGGGCT 69 FBan0013663 FBgn0039291 CG13663 3 3R CG13663 CG13663 CDMC31395 2 15 24 DAC39-F04 3-CG13707-RA_1 CG13707 GCCCTATCCCCTTATCTTCAAAGGCACAATCGACGAGGCACATGTCGCACAAATACTCAATGCCAGCGA 69 FBan0013707 FBgn0035578 CG13707 3 3L CG13707 CG13707 CDMC31395 2 16 24 DAC39-F04 3-CG13707-RA_1 CG13707 GCCCTATCCCCTTATCTTCAAAGGCACAATCGACGAGGCACATGTCGCACAAATACTCAATGCCAGCGA 69 FBan0013707 FBgn0035578 CG13707 3 3L CG13707 CG13707 CDMC31396 2 17 24 DAC39-F16 11-CG13733-RA_2 CG13733 CGGCGGGCTCTGATAAGCCACCAAGTTTTGAGGCGAATCCCAGGTCTTCAAAAATTCGATCCCATAACT 69 FBan0013733 FBgn0036729 CG13733 3 3L CG13733 CG13733 CDMC31396 2 18 24 DAC39-F16 11-CG13733-RA_2 CG13733 CGGCGGGCTCTGATAAGCCACCAAGTTTTGAGGCGAATCCCAGGTCTTCAAAAATTCGATCCCATAACT 69 FBan0013733 FBgn0036729 CG13733 3 3L CG13733 CG13733 CDMC31397 2 19 24 DAC39-J04 8-CG13775-RA_1 CG13775 ACCCGTGCACACTTACACCTTACGATCCCTGTCAATGGAATTCCGCTTTTCAGATGATGAGCAGCGTGT 69 FBan0013775 FBgn0031874 CG13775 2 2L CG13775 CG13775 CDMC31397 2 20 24 DAC39-J04 8-CG13775-RA_1 CG13775 ACCCGTGCACACTTACACCTTACGATCCCTGTCAATGGAATTCCGCTTTTCAGATGATGAGCAGCGTGT 69 FBan0013775 FBgn0031874 CG13775 2 2L CG13775 CG13775 CDMC31398 2 21 24 DAC39-J16 12-CG13783-RA_1 CG13783 GGCGATGCGAGAGAAGAGCCGGAATACCCCTCTCATAAGGAACATTGAGAATGAGGTGAGTCTGGCATT 69 FBan0013783 FBgn0031892 CG13783 2 2L CG13783 CG13783 CDMC31398 2 22 24 DAC39-J16 12-CG13783-RA_1 CG13783 GGCGATGCGAGAGAAGAGCCGGAATACCCCTCTCATAAGGAACATTGAGAATGAGGTGAGTCTGGCATT 69 FBan0013783 FBgn0031892 CG13783 2 2L CG13783 CG13783 CDMC31399 2 23 24 DAC39-N04 16-CG13822-RA_1 CG13822 TGCCCACCATTGTGTTCGAGAATGACTTTGATCCTTACGACCAGAGAAGCATTCGCAACAACTTCGAAA 69 FBan0013822 FBgn0039098 CG13822 3 3R CG13822 CG13822 CDMC31399 2 24 24 DAC39-N04 16-CG13822-RA_1 CG13822 TGCCCACCATTGTGTTCGAGAATGACTTTGATCCTTACGACCAGAGAAGCATTCGCAACAACTTCGAAA 69 FBan0013822 FBgn0039098 CG13822 3 3R CG13822 CG13822 CDMC31400 2 25 24 DAC39-N16 7-CG13841-RA_1 CG13841 GGCGGATAACAATGGCTATCATGTCAAGTACAACATCACCTTGGATACCGTGGAGCTTGACCGTCGCCT 69 FBan0013841 FBgn0040588 CG13841 3 3R CG13841 CG13841 CDMC31400 2 26 24 DAC39-N16 7-CG13841-RA_1 CG13841 GGCGGATAACAATGGCTATCATGTCAAGTACAACATCACCTTGGATACCGTGGAGCTTGACCGTCGCCT 69 FBan0013841 FBgn0040588 CG13841 3 3R CG13841 CG13841 CDMC31401 2 1 25 DAC40-B04 2-CG14107-RA_2 CG14107 GAGGTCCCTGCTGTCGTTTCCGAAAAGGAGACTCTGGCAGTGGAACCCATGAAGATGGAGGAGTC 65 FBan0014107 FBgn0036351 CG14107 3 3L CG14107 CG14107 CDMC31401 2 2 25 DAC40-B04 2-CG14107-RA_2 CG14107 GAGGTCCCTGCTGTCGTTTCCGAAAAGGAGACTCTGGCAGTGGAACCCATGAAGATGGAGGAGTC 65 FBan0014107 FBgn0036351 CG14107 3 3L CG14107 CG14107 CDMC31402 2 3 25 DAC40-B16 1-CG14137-RA_1 CG14137 CTTTCCCAGACCCGGAGACATTGCCACTCCCACTCGTACTCCCGAACATATCCCAAACCCAGAAG 65 FBan0014137 FBgn0036178 CG14137 3 3L CG14137 CG14137 CDMC31402 2 4 25 DAC40-B16 1-CG14137-RA_1 CG14137 CTTTCCCAGACCCGGAGACATTGCCACTCCCACTCGTACTCCCGAACATATCCCAAACCCAGAAG 65 FBan0014137 FBgn0036178 CG14137 3 3L CG14137 CG14137 CDMC31403 2 5 25 DAC40-F04 24-CG14206-RB_1 CG14206 AAATGTTCAACTGAAGATCCATACCCTTAACAATAGAAGAAACCAACATCTGAAAAATGTGTGTG 65 FBan0014206 FBgn0031035 RpS10b X X cytoskeleton organization and biogenesis; GO:0007010; protein biosynthesis; GO:0006412 actin binding; GO:0003779; nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003779; intermediate filament binding; GO:0019215; ; GO:0008017; ; GO:0005200; structural constituent of ribosome; GO:0003735; ; GO:0019215; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS10b Ribosomal protein S10b "CG14206, CT33819, GM19176, i73, i3, Ribosomal protein S10b" CDMC31403 2 6 25 DAC40-F04 24-CG14206-RB_1 CG14206 AAATGTTCAACTGAAGATCCATACCCTTAACAATAGAAGAAACCAACATCTGAAAAATGTGTGTG 65 FBan0014206 FBgn0031035 RpS10b X X cytoskeleton organization and biogenesis; GO:0007010; protein biosynthesis; GO:0006412 actin binding; GO:0003779; nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003779; intermediate filament binding; GO:0019215; ; GO:0008017; ; GO:0005200; structural constituent of ribosome; GO:0003735; ; GO:0019215; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS10b Ribosomal protein S10b "CG14206, CT33819, GM19176, i73, i3, Ribosomal protein S10b" CDMC31404 2 7 25 DAC40-F16 2-CG14240-RA_1 CG14240 AGGCTGCTCTCCAGAGGGCTCTTGCCTCGGTCAAGAAGAACATTCGCGTCATCTTCATCAAGTCG 65 FBan0014240 FBgn0039435 CG14240 3 3R CG14240 CG14240 CDMC31404 2 8 25 DAC40-F16 2-CG14240-RA_1 CG14240 AGGCTGCTCTCCAGAGGGCTCTTGCCTCGGTCAAGAAGAACATTCGCGTCATCTTCATCAAGTCG 65 FBan0014240 FBgn0039435 CG14240 3 3R CG14240 CG14240 CDMC31405 2 9 25 DAC40-J04 23-CG1429-RE_2 CG1429 GAACTGAACTGACCTGATTGCATGCTTGCTCGAAACTCTAACTAACTCTAACTCTTTAACCGTGC 65 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC31405 2 10 25 DAC40-J04 23-CG1429-RE_2 CG1429 GAACTGAACTGACCTGATTGCATGCTTGCTCGAAACTCTAACTAACTCTAACTCTTTAACCGTGC 65 FBan0001429 FBgn0011656 Mef2 2 2R "cell proliferation; GO:0008283; heart development; GO:0007507; mesoderm development; GO:0007498; ovarian follicle cell development (sensu Insecta); GO:0030707; regulation of striated muscle development; GO:0016202; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; striated muscle development; GO:0007519; transcription from RNA polymerase II promoter; GO:0006366" transcription factor activity; GO:0003700; calcium ion binding; GO:0005509; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003700; ; GO:0005509; ; GO:0003702 nucleus; GO:0005634 Mef2 Myocyte enhancing factor 2 "CG1429, D-mef2, 22.21, DMEF2, C: Group C, Myocyte-specific enhancer factor 2, Complementation group C, Dmef2, mef2, D-MEF2, DMEF-2, Mef, DMef2, Dmef-2, MEF2, mef-2, D-Mef2, DMef-2, Dmef, dMEF2, MEF-2, mef, dMef2, SD04091, dmef2, DMedf2, MEF2#, l(2)46CFr, BEST:SD04091, Group C" CDMC31406 2 11 25 DAC40-J16 12-CG14333-RA_1 CG14333 GAGGCCTTTGCGAATCATTTCAGCAGCCATCTGGGACGCCACCTCTTCTACTGGGCCATCGAATC 65 FBan0014333 FBgn0038500 CG14333 3 3R CG14333 CG14333 CDMC31406 2 12 25 DAC40-J16 12-CG14333-RA_1 CG14333 GAGGCCTTTGCGAATCATTTCAGCAGCCATCTGGGACGCCACCTCTTCTACTGGGCCATCGAATC 65 FBan0014333 FBgn0038500 CG14333 3 3R CG14333 CG14333 CDMC31407 2 13 25 DAC40-N04 21-CG14418-RA_2 CG14418 GCTGCAGGTCACCGGTTTCATCACCAAATCCGGCAACATCTACGAGATTGAGGACAAACGGGGCT 65 FBan0014418 FBgn0040354 CG14418 X X CG14418 CG14418 EG:BACR43E12.5 CDMC31407 2 14 25 DAC40-N04 21-CG14418-RA_2 CG14418 GCTGCAGGTCACCGGTTTCATCACCAAATCCGGCAACATCTACGAGATTGAGGACAAACGGGGCT 65 FBan0014418 FBgn0040354 CG14418 X X CG14418 CG14418 EG:BACR43E12.5 CDMC31408 2 15 25 DAC40-N16 23-CG14448-RA_1 CG14448 TCCTTACCAAAAAAATTGCAACCGTCTTCCCAAAGAAACTAGTTCCTCTATATTACAAGACTCAA 65 FBan0014448 FBgn0037191 CG14448 3 3L CG14448 CG14448 CDMC31408 2 16 25 DAC40-N16 23-CG14448-RA_1 CG14448 TCCTTACCAAAAAAATTGCAACCGTCTTCCCAAAGAAACTAGTTCCTCTATATTACAAGACTCAA 65 FBan0014448 FBgn0037191 CG14448 3 3L CG14448 CG14448 CDMC31409 2 17 25 DAC41-B04 AutoBlank AutoBlank CDMC31409 2 18 25 DAC41-B04 AutoBlank AutoBlank CDMC31410 2 19 25 DAC41-B16 AutoBlank AutoBlank CDMC31410 2 20 25 DAC41-B16 AutoBlank AutoBlank CDMC31411 2 21 25 DAC41-F04 AutoBlank AutoBlank CDMC31411 2 22 25 DAC41-F04 AutoBlank AutoBlank CDMC31412 2 23 25 DAC41-F16 AutoBlank AutoBlank CDMC31412 2 24 25 DAC41-F16 AutoBlank AutoBlank CDMC31413 2 25 25 DAC41-J04 AutoBlank AutoBlank CDMC31413 2 26 25 DAC41-J04 AutoBlank AutoBlank CDMC31414 2 1 26 DAC41-J16 AutoBlank AutoBlank CDMC31414 2 2 26 DAC41-J16 AutoBlank AutoBlank CDMC31415 2 3 26 DAC41-N04 AutoBlank AutoBlank CDMC31415 2 4 26 DAC41-N04 AutoBlank AutoBlank CDMC31416 2 5 26 DAC41-N16 AutoBlank AutoBlank CDMC31416 2 6 26 DAC41-N16 AutoBlank AutoBlank CDMC31417 2 7 26 DAC42-B04 150mM NaPO4 Blank CDMC31417 2 8 26 DAC42-B04 150mM NaPO4 Blank CDMC31418 2 9 26 DAC42-B16 150mM NaPO4 Blank CDMC31418 2 10 26 DAC42-B16 150mM NaPO4 Blank CDMC31419 2 11 26 DAC42-F04 150mM NaPO4 Blank CDMC31419 2 12 26 DAC42-F04 150mM NaPO4 Blank CDMC31420 2 13 26 DAC42-F16 150mM NaPO4 Blank CDMC31420 2 14 26 DAC42-F16 150mM NaPO4 Blank CDMC31421 2 15 26 DAC42-J04 150mM NaPO4 Blank CDMC31421 2 16 26 DAC42-J04 150mM NaPO4 Blank CDMC31422 2 17 26 DAC42-J16 5uM MSP 5uM MSP CDMC31422 2 18 26 DAC42-J16 5uM MSP 5uM MSP CDMC31423 2 19 26 DAC42-N04 10uM MSP 10uM MSP CDMC31423 2 20 26 DAC42-N04 10uM MSP 10uM MSP CDMC31424 2 21 26 DAC42-N16 20uM MSP 20uM MSP CDMC31424 2 22 26 DAC42-N16 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC31425 3 1 1 DAC01-C04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31425 3 2 1 DAC01-C04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31426 3 3 1 DAC01-C16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31426 3 4 1 DAC01-C16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31427 3 5 1 DAC01-G04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31427 3 6 1 DAC01-G04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31428 3 7 1 DAC01-G16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31428 3 8 1 DAC01-G16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31429 3 9 1 DAC01-K04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31429 3 10 1 DAC01-K04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31430 3 11 1 DAC01-K16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31430 3 12 1 DAC01-K16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31431 3 13 1 DAC01-O04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31431 3 14 1 DAC01-O04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31432 3 15 1 DAC01-O16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31432 3 16 1 DAC01-O16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31433 3 17 1 DAC02-C04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31433 3 18 1 DAC02-C04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31434 3 19 1 DAC02-C16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31434 3 20 1 DAC02-C16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31435 3 21 1 DAC02-G04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31435 3 22 1 DAC02-G04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31436 3 23 1 DAC02-G16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31436 3 24 1 DAC02-G16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31437 3 25 1 DAC02-K04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31437 3 26 1 DAC02-K04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31438 3 1 2 DAC02-K16 N/A CG9075 (01674-01910) CDMC31438 3 2 2 DAC02-K16 N/A CG9075 (01674-01910) CDMC31439 3 3 2 DAC02-O04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31439 3 4 2 DAC02-O04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31440 3 5 2 DAC02-O16 AutoBlank AutoBlank CDMC31440 3 6 2 DAC02-O16 AutoBlank AutoBlank CDMC31441 3 7 2 DAC03-C04 18-CG32224-RA_1 CG32224 CCCATCGCCAAATTTCCAAGTGGTGTTCTTGAGTATGACATCACGGTTTCACGTTACCGAGTGTCTTGC 69 FBan0032224 FBgn0052224 CG32224 3 3L CG32224 CG32224 CDMC31441 3 8 2 DAC03-C04 18-CG32224-RA_1 CG32224 CCCATCGCCAAATTTCCAAGTGGTGTTCTTGAGTATGACATCACGGTTTCACGTTACCGAGTGTCTTGC 69 FBan0032224 FBgn0052224 CG32224 3 3L CG32224 CG32224 CDMC31442 3 9 2 DAC03-C16 15-CG32233-RA_1 CG32233 GGCGCGACGACACAAACAGAACGTGATTCGCATACAAATAAACAAGGCTACAGAGCGCACTGTAGAGGA 69 FBan0032233 FBgn0052233 CG32233 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32233 CG32233 CDMC31442 3 10 2 DAC03-C16 15-CG32233-RA_1 CG32233 GGCGCGACGACACAAACAGAACGTGATTCGCATACAAATAAACAAGGCTACAGAGCGCACTGTAGAGGA 69 FBan0032233 FBgn0052233 CG32233 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32233 CG32233 CDMC31443 3 11 2 DAC03-G04 14-CG32259-RB_2 CG32259 CGGACACCACTGAGGATTCCAACGCGAAGAAGAGTTTGCAAATGGATTCCGATTCATCAGACGTGTCGA 69 FBan0032259 FBgn0052259 CG32259 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32259 CG32259 NEST:bs27e11 CDMC31443 3 12 2 DAC03-G04 14-CG32259-RB_2 CG32259 CGGACACCACTGAGGATTCCAACGCGAAGAAGAGTTTGCAAATGGATTCCGATTCATCAGACGTGTCGA 69 FBan0032259 FBgn0052259 CG32259 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32259 CG32259 NEST:bs27e11 CDMC31444 3 13 2 DAC03-G16 23-CG32267-RA_4 CG32267 GTCCTGAAGCATTTAAATACGGCGTAGAAGAAAAAATGATCGAAGAAGACTAAAAGCTGTCTACTTATT 69 FBan0032267 FBgn0052267 CG32267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32267 CG32267 CDMC31444 3 14 2 DAC03-G16 23-CG32267-RA_4 CG32267 GTCCTGAAGCATTTAAATACGGCGTAGAAGAAAAAATGATCGAAGAAGACTAAAAGCTGTCTACTTATT 69 FBan0032267 FBgn0052267 CG32267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32267 CG32267 CDMC31445 3 15 2 DAC03-K04 11-CG32308-RA_1 CG32308 CGCCATGGGAGCATCGACAGTTAAGCCCTTTTCTGAAGCGGAATGCAAGGCTATCAAGAAGTTCACGAA 69 FBan0032308 FBgn0052308 CG32308 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32308 CG32308 NEST:bs32f07 CDMC31445 3 16 2 DAC03-K04 11-CG32308-RA_1 CG32308 CGCCATGGGAGCATCGACAGTTAAGCCCTTTTCTGAAGCGGAATGCAAGGCTATCAAGAAGTTCACGAA 69 FBan0032308 FBgn0052308 CG32308 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32308 CG32308 NEST:bs32f07 CDMC31446 3 17 2 DAC03-K16 17-CG3231-RA_3 CG3231 TCCCCTACTCACAACGCTACTGAAAACGTTAATCCGAAGAGTCATTCCATCCTTACTGTGGGTGCTGCT 69 FBan0003231 FBgn0027522 CG3231 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG3231 CG3231 BcDNA:LD21643 CDMC31446 3 18 2 DAC03-K16 17-CG3231-RA_3 CG3231 TCCCCTACTCACAACGCTACTGAAAACGTTAATCCGAAGAGTCATTCCATCCTTACTGTGGGTGCTGCT 69 FBan0003231 FBgn0027522 CG3231 2 2R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG3231 CG3231 BcDNA:LD21643 CDMC31447 3 19 2 DAC03-O04 3-CG32369-RA_1 CG32369 GCCAAAGCCAGTGAATGGTTCGAAAGCCTGAGTACAGAGCAGAAGCACGAGATTCTGCAGAGCTTTGGC 69 FBan0032369 FBgn0052369 CG32369 3 3L ATP-dependent proteolysis; GO:0006510; carbohydrate metabolism; GO:0005975; protein ubiquitination; GO:0016567 "ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ATP-dependent peptidase activity; GO:0004176; ; GO:0008270; ; GO:0004176; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" ubiquitin ligase complex; GO:0000151 CG32369 CG32369 "CG13684, CG7388" CDMC31447 3 20 2 DAC03-O04 3-CG32369-RA_1 CG32369 GCCAAAGCCAGTGAATGGTTCGAAAGCCTGAGTACAGAGCAGAAGCACGAGATTCTGCAGAGCTTTGGC 69 FBan0032369 FBgn0052369 CG32369 3 3L ATP-dependent proteolysis; GO:0006510; carbohydrate metabolism; GO:0005975; protein ubiquitination; GO:0016567 "ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ATP-dependent peptidase activity; GO:0004176; ; GO:0008270; ; GO:0004176; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" ubiquitin ligase complex; GO:0000151 CG32369 CG32369 "CG13684, CG7388" CDMC31448 3 21 2 DAC03-O16 3-CG32386-RA_1 CG32386 ACCCTGCCTGCTGATGATGGACAATGTGTTGGAGGATGTGGTACACCATGATTCGCATTCGCACAACAT 69 FBan0032386 FBgn0028383 corn 3 3L microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 corn cornetto "CG32386, CG8621, CG32386, CG32386, cornetto" CDMC31448 3 22 2 DAC03-O16 3-CG32386-RA_1 CG32386 ACCCTGCCTGCTGATGATGGACAATGTGTTGGAGGATGTGGTACACCATGATTCGCATTCGCACAACAT 69 FBan0032386 FBgn0028383 corn 3 3L microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 corn cornetto "CG32386, CG8621, CG32386, CG32386, cornetto" CDMC31449 3 23 2 DAC04-C04 8-CG2945-RB_1 CG2945 GGCCTGTGGGCTACGATCTAAGCACCAATGATCGAATTTTTCCTGCTCTAGATCCTTCTCCCGTGGTGG 69 FBan0002945 FBgn0000316 cin X X Mo-molybdopterin cofactor biosynthesis; GO:0006777; embryonic development (sensu Insecta); GO:0001700; proteolysis; GO:0006508; pteridine and derivative metabolism; GO:0042558 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- cin cinnamon "CG2945, CG2945, fs(1)M50, l(1)G0142, EG:BACR37P7.3, l(1)1Ae" CDMC31449 3 24 2 DAC04-C04 8-CG2945-RB_1 CG2945 GGCCTGTGGGCTACGATCTAAGCACCAATGATCGAATTTTTCCTGCTCTAGATCCTTCTCCCGTGGTGG 69 FBan0002945 FBgn0000316 cin X X Mo-molybdopterin cofactor biosynthesis; GO:0006777; embryonic development (sensu Insecta); GO:0001700; proteolysis; GO:0006508; pteridine and derivative metabolism; GO:0042558 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- cin cinnamon "CG2945, CG2945, fs(1)M50, l(1)G0142, EG:BACR37P7.3, l(1)1Ae" CDMC31450 3 25 2 DAC04-C16 24-CG2961-RA_1 CG2961 ACTATCTTCTATTCTATCGTTATGTATTTTTTTTCCTAGGCTAATTCTTCACAGTCATTATCAGAAAAA 69 FBan0002961 FBgn0030187 Ipod X X DNA methylation; GO:0006306 molecular function unknown; GO:0005554; ; GO:0005554 chromatin; GO:0000785 Ipod Interaction partner of Dnmt2 "CG2961, IPOD, Interaction partner of Dnmt2" CDMC31450 3 26 2 DAC04-C16 24-CG2961-RA_1 CG2961 ACTATCTTCTATTCTATCGTTATGTATTTTTTTTCCTAGGCTAATTCTTCACAGTCATTATCAGAAAAA 69 FBan0002961 FBgn0030187 Ipod X X DNA methylation; GO:0006306 molecular function unknown; GO:0005554; ; GO:0005554 chromatin; GO:0000785 Ipod Interaction partner of Dnmt2 "CG2961, IPOD, Interaction partner of Dnmt2" CDMC31451 3 1 3 DAC04-G04 3-CG2995-RA_5 CG2995 CGAGCATCAGGACTACAGATTCCCTAAGATCGCCTTTTTTTCCTGCCGTGACATCGATGCCGGAGAGGA 69 FBan0002995 FBgn0040372 CG2995 X X "chromatin assembly or disassembly; GO:0006333; chromatin modification; GO:0016568; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538" "chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003682; transferase activity; GO:0016740 ; EC:2.-.-.-; translation factor activity, nucleic acid binding; GO:0008135; DNA-methyltransferase activity; GO:0009008 ; EC:2.1.1.-; translation initiation factor activity; GO:0003743; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; zinc ion binding; GO:0008270; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003743; ; GO:0008135; ; GO:0009008 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0008270; ; GO:0018024 ; EC:2.1.1.43" nucleus; GO:0005634 CG2995 CG2995 "EG:BACR37P7.2, cab65850 G9a Dm" CDMC31451 3 2 3 DAC04-G04 3-CG2995-RA_5 CG2995 CGAGCATCAGGACTACAGATTCCCTAAGATCGCCTTTTTTTCCTGCCGTGACATCGATGCCGGAGAGGA 69 FBan0002995 FBgn0040372 CG2995 X X "chromatin assembly or disassembly; GO:0006333; chromatin modification; GO:0016568; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein biosynthesis; GO:0006412; protein metabolism; GO:0019538" "chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003682; transferase activity; GO:0016740 ; EC:2.-.-.-; translation factor activity, nucleic acid binding; GO:0008135; DNA-methyltransferase activity; GO:0009008 ; EC:2.1.1.-; translation initiation factor activity; GO:0003743; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; zinc ion binding; GO:0008270; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003743; ; GO:0008135; ; GO:0009008 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; histone-lysine N-methyltransferase activity; GO:0018024 ; EC:2.1.1.43; ; GO:0008270; ; GO:0018024 ; EC:2.1.1.43" nucleus; GO:0005634 CG2995 CG2995 "EG:BACR37P7.2, cab65850 G9a Dm" CDMC31452 3 3 3 DAC04-G16 2-CG30004-RA_1 CG30004 AGCAGTCCATCGAGGAAACACCCAAGCTAAGCAACGGAAATAGCTCCTCTAGCAAATCCCTGGTCCAGT 69 FBan0030004 FBgn0050004 CG30004 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30004 CG30004 CDMC31452 3 4 3 DAC04-G16 2-CG30004-RA_1 CG30004 AGCAGTCCATCGAGGAAACACCCAAGCTAAGCAACGGAAATAGCTCCTCTAGCAAATCCCTGGTCCAGT 69 FBan0030004 FBgn0050004 CG30004 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30004 CG30004 CDMC31453 3 5 3 DAC04-K04 7-CG30030-RA_1 CG30030 AGGATGCAAGAGTTCGATCGTTCCGTTTTGATGGTGTTCCCTCATGTTCAGTGGAACTATCGACGCGCT 69 FBan0030030 FBgn0041241 Gr47b 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr47b Gustatory receptor 47b "CG30030, CG30030, 47F.1, Gustatory receptor 47F.1, Gr47F1, GR47F.1, Gustatory receptor 47b" CDMC31453 3 6 3 DAC04-K04 7-CG30030-RA_1 CG30030 AGGATGCAAGAGTTCGATCGTTCCGTTTTGATGGTGTTCCCTCATGTTCAGTGGAACTATCGACGCGCT 69 FBan0030030 FBgn0041241 Gr47b 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr47b Gustatory receptor 47b "CG30030, CG30030, 47F.1, Gustatory receptor 47F.1, Gr47F1, GR47F.1, Gustatory receptor 47b" CDMC31454 3 7 3 DAC04-K16 3-CG30043-RA_2 CG30043 TCGGAGGTGATTTTACCCGGTGAACTTACCCTGGACTTTCTGGGATATACGGTGCTCGAGTCCGGAACA 69 FBan0030043 FBgn0050043 CG30043 2 2R CG30043 CG30043 CG13161 CDMC31454 3 8 3 DAC04-K16 3-CG30043-RA_2 CG30043 TCGGAGGTGATTTTACCCGGTGAACTTACCCTGGACTTTCTGGGATATACGGTGCTCGAGTCCGGAACA 69 FBan0030043 FBgn0050043 CG30043 2 2R CG30043 CG30043 CG13161 CDMC31455 3 9 3 DAC04-O04 9-CG30074-RA_4 CG30074 GGGCTCTGATGAATTTGTGCACGTGTATCTGGATGGATTCAGGAGCTGCGGTAATCAGGAGAAGGTGCT 69 FBan0030074 FBgn0050074 Obp50d 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50d Odorant-binding protein 50d "CG30074, CG30074, Odorant-binding protein 50d" CDMC31455 3 10 3 DAC04-O04 9-CG30074-RA_4 CG30074 GGGCTCTGATGAATTTGTGCACGTGTATCTGGATGGATTCAGGAGCTGCGGTAATCAGGAGAAGGTGCT 69 FBan0030074 FBgn0050074 Obp50d 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50d Odorant-binding protein 50d "CG30074, CG30074, Odorant-binding protein 50d" CDMC31456 3 11 3 DAC04-O16 11-CG30081-RA_1 CG30081 GGGCTGGTGTGTCTTGGGAATTGGTTGGATACTGTCAGCTCTGGTTTTCTCTTGTGAATACTGGCACCT 69 FBan0030081 FBgn0050081 CG30081 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30081 CG30081 CDMC31456 3 12 3 DAC04-O16 11-CG30081-RA_1 CG30081 GGGCTGGTGTGTCTTGGGAATTGGTTGGATACTGTCAGCTCTGGTTTTCTCTTGTGAATACTGGCACCT 69 FBan0030081 FBgn0050081 CG30081 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30081 CG30081 CDMC31457 3 13 3 DAC05-C04 2-CG18332-RA_1 CG18332 CCTGCTGCTATCATTTCTACGCTCATCCAATCCCCAACACCGTTTACCAGAACTTGTCGAAGCCGCGA 68 FBan0018332 FBgn0027055 CSN3 3 3L signalosome complex; GO:0008180 CSN3 COP9 complex homolog subunit 3 "CG18332, Dch3, Drosophila COP9 signalosome homolog 3, DCH3, COP9 complex homolog subunit 3, CH3" CDMC31457 3 14 3 DAC05-C04 2-CG18332-RA_1 CG18332 CCTGCTGCTATCATTTCTACGCTCATCCAATCCCCAACACCGTTTACCAGAACTTGTCGAAGCCGCGA 68 FBan0018332 FBgn0027055 CSN3 3 3L signalosome complex; GO:0008180 CSN3 COP9 complex homolog subunit 3 "CG18332, Dch3, Drosophila COP9 signalosome homolog 3, DCH3, COP9 complex homolog subunit 3, CH3" CDMC31458 3 15 3 DAC05-C16 3-CG18660-RC_2 CG18660 ACCGGTGCCAAGTTCCGCCACGGCCTGTTACAGCTAATGATACACACGATAGATCCACTACACGATGG 68 FBan0018660 FBgn0028704 Nckx30C 2 2L calcium ion transport; GO:0006816; eye development (sensu Endopterygota); GO:0007456 "calcium, potassium:sodium antiporter activity; GO:0008273; ; GO:0008273; ; GO:0008273; alpha-type channel activity; GO:0015268; ; GO:0008273; ; GO:0015268; ; GO:0008273" integral to membrane; GO:0016021 Nckx30C Nckx30C "CG4106, CG18660, CG4106, potassium-dependent sodium/calcium" CDMC31458 3 16 3 DAC05-C16 3-CG18660-RC_2 CG18660 ACCGGTGCCAAGTTCCGCCACGGCCTGTTACAGCTAATGATACACACGATAGATCCACTACACGATGG 68 FBan0018660 FBgn0028704 Nckx30C 2 2L calcium ion transport; GO:0006816; eye development (sensu Endopterygota); GO:0007456 "calcium, potassium:sodium antiporter activity; GO:0008273; ; GO:0008273; ; GO:0008273; alpha-type channel activity; GO:0015268; ; GO:0008273; ; GO:0015268; ; GO:0008273" integral to membrane; GO:0016021 Nckx30C Nckx30C "CG4106, CG18660, CG4106, potassium-dependent sodium/calcium" CDMC31459 3 17 3 DAC05-G04 24-CG2534-RA_4 CG2534 CGTTAGCTCTACATAACAAAACACACACATAGATATATAGGTCATGTTATATATGTCGGAACACTTTA 68 FBan0002534 FBgn0000340 cno 3 3R "JNK cascade; GO:0007254; Notch signaling pathway; GO:0007219; Ras protein signal transduction; GO:0007265; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; establishment and/or maintenance of cell polarity; GO:0007163; ommatidial rotation; GO:0016318; regulation of JNK cascade; GO:0046328" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 adherens junction; GO:0005912; myosin; GO:0016459; zonula adherens; GO:0005915 cno canoe "CG2534, lip: lips, lips, Cno, Canoe, anon-WO0172774.47, dlhA: dorsal holes A, mis, dorsal holes A, misty, lip, canoe" CDMC31459 3 18 3 DAC05-G04 24-CG2534-RA_4 CG2534 CGTTAGCTCTACATAACAAAACACACACATAGATATATAGGTCATGTTATATATGTCGGAACACTTTA 68 FBan0002534 FBgn0000340 cno 3 3R "JNK cascade; GO:0007254; Notch signaling pathway; GO:0007219; Ras protein signal transduction; GO:0007265; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; establishment and/or maintenance of cell polarity; GO:0007163; ommatidial rotation; GO:0016318; regulation of JNK cascade; GO:0046328" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 adherens junction; GO:0005912; myosin; GO:0016459; zonula adherens; GO:0005915 cno canoe "CG2534, lip: lips, lips, Cno, Canoe, anon-WO0172774.47, dlhA: dorsal holes A, mis, dorsal holes A, misty, lip, canoe" CDMC31460 3 19 3 DAC05-G16 3-CG2899-RA_4 CG2899 GCTACCTGCACGCAAGGGAGATCATCCACAAAGATCTGCGCACCAAGAACATCTTCATCGAGAACGGC 68 FBan0002899 FBgn0015402 ksr 3 3R "MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; protein amino acid phosphorylation; GO:0006468; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 ksr kinase suppressor of ras "CG2899, CG2899, CG2899, l(3)j5E2, SR3-1: Suppressor of Ras1 3-1, kinase suppressor of Ras85D, Ksr-1, Ksr, KSR, Kinase suppressor of Ras, dKsr, EK3-1, KSR-1, Suppressor of Ras1 3-1, SR3-1" CDMC31460 3 20 3 DAC05-G16 3-CG2899-RA_4 CG2899 GCTACCTGCACGCAAGGGAGATCATCCACAAAGATCTGCGCACCAAGAACATCTTCATCGAGAACGGC 68 FBan0002899 FBgn0015402 ksr 3 3R "MAPKKK cascade; GO:0000165; Ras protein signal transduction; GO:0007265; determination of anterior/posterior axis, embryo; GO:0008595; protein amino acid phosphorylation; GO:0006468; torso signaling pathway; GO:0008293" ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 ksr kinase suppressor of ras "CG2899, CG2899, CG2899, l(3)j5E2, SR3-1: Suppressor of Ras1 3-1, kinase suppressor of Ras85D, Ksr-1, Ksr, KSR, Kinase suppressor of Ras, dKsr, EK3-1, KSR-1, Suppressor of Ras1 3-1, SR3-1" CDMC31461 3 21 3 DAC05-K04 2-CG30437-RC_1 CG30437 CAACTGGCTATCCTGCGTTACGCTCGTGGACCTTATCAGCCAGCATCTTCTCCGCCAACATACGATGT 68 FBan0030437 FBgn0050437 CG30437 2 2R defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507 CG30437 CG30437 "CG10408, CG10398, CG10408" CDMC31461 3 22 3 DAC05-K04 2-CG30437-RC_1 CG30437 CAACTGGCTATCCTGCGTTACGCTCGTGGACCTTATCAGCCAGCATCTTCTCCGCCAACATACGATGT 68 FBan0030437 FBgn0050437 CG30437 2 2R defense response; GO:0006952; response to toxin; GO:0009636 copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507 CG30437 CG30437 "CG10408, CG10398, CG10408" CDMC31462 3 23 3 DAC05-K16 1-CG31001-RA_2 CG31001 CCATCGGTGGAACCTACCTTATCGTCGTTTCTTCGCGAACCAGGTGATCGCAACGCCAAAGGAAGTTG 68 FBan0031001 FBgn0051001 CG31001 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31001 CG31001 CDMC31462 3 24 3 DAC05-K16 1-CG31001-RA_2 CG31001 CCATCGGTGGAACCTACCTTATCGTCGTTTCTTCGCGAACCAGGTGATCGCAACGCCAAAGGAAGTTG 68 FBan0031001 FBgn0051001 CG31001 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31001 CG31001 CDMC31463 3 25 3 DAC05-O04 1-CG31410-RA_5 CG31410 TGCGTTGTGTACAAAGGAACCATAGCAGTCATGGAGGTGCACTTCCTGGGCAGTAAGTTTCGGCCATC 68 FBan0031410 FBgn0051410 CG31410 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31410 CG31410 "CG3928, CG3928" CDMC31463 3 26 3 DAC05-O04 1-CG31410-RA_5 CG31410 TGCGTTGTGTACAAAGGAACCATAGCAGTCATGGAGGTGCACTTCCTGGGCAGTAAGTTTCGGCCATC 68 FBan0031410 FBgn0051410 CG31410 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31410 CG31410 "CG3928, CG3928" CDMC31464 3 1 4 DAC05-O16 14-CG31659-RA_1 CG31659 GAGAAAGGCAGACATACTGAACGTGGAGCCAGAATTTGGGCGGTATGTTTTGGGCACAACAAGTACGG 68 FBan0031659 FBgn0051659 CG31659 2 2L CG31659 CG31659 CG16933 CDMC31464 3 2 4 DAC05-O16 14-CG31659-RA_1 CG31659 GAGAAAGGCAGACATACTGAACGTGGAGCCAGAATTTGGGCGGTATGTTTTGGGCACAACAAGTACGG 68 FBan0031659 FBgn0051659 CG31659 2 2L CG31659 CG31659 CG16933 CDMC31465 3 3 4 DAC06-C04 7-CG5247-RA_1 CG5247 GGGCTTCAAGCATCGATCCTCTCTTCCCGAAGTTAGCTACATCAAGCCAGCGAATTTCATGTACCCCGA 69 FBan0005247 FBgn0011774 Irbp 3 3R DNA recombination; GO:0006310; DNA replication; GO:0006260; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; DNA-dependent protein kinase activity; GO:0004677 ; EC:2.7.1.-; ; GO:0004677 ; EC:2.7.1.-; ; GO:0004677 ; EC:2.7.1.-; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004677 ; EC:2.7.1.- nucleus; GO:0005634 Irbp Inverted repeat-binding protein "CG5247, YPF1, YPF1beta, IRBP, Ku70, p70, IRBP/Ku70, Ku, dp70, DmKu70, Ypf1b, Yolk protein factor 1b" CDMC31465 3 4 4 DAC06-C04 7-CG5247-RA_1 CG5247 GGGCTTCAAGCATCGATCCTCTCTTCCCGAAGTTAGCTACATCAAGCCAGCGAATTTCATGTACCCCGA 69 FBan0005247 FBgn0011774 Irbp 3 3R DNA recombination; GO:0006310; DNA replication; GO:0006260; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; DNA-dependent protein kinase activity; GO:0004677 ; EC:2.7.1.-; ; GO:0004677 ; EC:2.7.1.-; ; GO:0004677 ; EC:2.7.1.-; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004677 ; EC:2.7.1.- nucleus; GO:0005634 Irbp Inverted repeat-binding protein "CG5247, YPF1, YPF1beta, IRBP, Ku70, p70, IRBP/Ku70, Ku, dp70, DmKu70, Ypf1b, Yolk protein factor 1b" CDMC31466 3 5 4 DAC06-C16 12-CG5265-RA_2 CG5265 ACGCCCCGTAATAGAGTTGCCCTGAAAACCATTCAGAATGCTATGTTCACAGTGTCCCTCGACGAGTGT 69 FBan0005265 FBgn0038486 CG5265 3 3R amino acid metabolism; GO:0006520; carnitine metabolism; GO:0009437; fatty acid metabolism; GO:0006631 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 endoplasmic reticulum; GO:0005783; mitochondrial inner membrane; GO:0005743; peroxisome; GO:0005777 CG5265 CG5265 CDMC31466 3 6 4 DAC06-C16 12-CG5265-RA_2 CG5265 ACGCCCCGTAATAGAGTTGCCCTGAAAACCATTCAGAATGCTATGTTCACAGTGTCCCTCGACGAGTGT 69 FBan0005265 FBgn0038486 CG5265 3 3R amino acid metabolism; GO:0006520; carnitine metabolism; GO:0009437; fatty acid metabolism; GO:0006631 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 endoplasmic reticulum; GO:0005783; mitochondrial inner membrane; GO:0005743; peroxisome; GO:0005777 CG5265 CG5265 CDMC31467 3 7 4 DAC06-G04 18-CG5310-RA_2 CG5310 TCCGAGCCCTGATCTCCCAGAACTTCACCATTCTTGACCAGAAGGAGGTTTGCATTACGAAAGAACTAT 69 FBan0005310 FBgn0030573 nmdyn-D6 X X CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; nucleotide kinase activity; GO:0019201; ; GO:0019201; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 nmdyn-D6 nmdyn-D6 CG5310 CDMC31467 3 8 4 DAC06-G04 18-CG5310-RA_2 CG5310 TCCGAGCCCTGATCTCCCAGAACTTCACCATTCTTGACCAGAAGGAGGTTTGCATTACGAAAGAACTAT 69 FBan0005310 FBgn0030573 nmdyn-D6 X X CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; nucleotide kinase activity; GO:0019201; ; GO:0019201; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 nmdyn-D6 nmdyn-D6 CG5310 CDMC31468 3 9 4 DAC06-G16 3-CG5321-RA_1 CG5321 GGGTGCAGAGTTTCAGGATATTGCCCAGCACTTTAGCTACGATGAGGTGATGTCCCAGGATTCGGTGCT 69 FBan0005321 FBgn0030575 CG5321 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG5321 CG5321 anon-EST:Posey66 CDMC31468 3 10 4 DAC06-G16 3-CG5321-RA_1 CG5321 GGGTGCAGAGTTTCAGGATATTGCCCAGCACTTTAGCTACGATGAGGTGATGTCCCAGGATTCGGTGCT 69 FBan0005321 FBgn0030575 CG5321 X X coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG5321 CG5321 anon-EST:Posey66 CDMC31469 3 11 4 DAC06-K04 18-CG5357-RA_3 CG5357 CCGAGTTACTCAGCCCACATCATATTCACATGCCAAACTTTTCCAATCGAAAGTTTTCGGCCAGACGGT 69 FBan0005357 FBgn0034862 CG5357 2 2R CG5357 CG5357 CDMC31469 3 12 4 DAC06-K04 18-CG5357-RA_3 CG5357 CCGAGTTACTCAGCCCACATCATATTCACATGCCAAACTTTTCCAATCGAAAGTTTTCGGCCAGACGGT 69 FBan0005357 FBgn0034862 CG5357 2 2R CG5357 CG5357 CDMC31470 3 13 4 DAC06-K16 9-CG5373-RA_1 CG5373 GCTCTGGTGGAGCAGATTCATCGGTTCACCCAATACTGGCGGAAGTAGAGGACATTGCTTGCACAAGAA 69 FBan0005373 FBgn0015277 Pi3K59F 2 2R endocytosis; GO:0006897; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035004 ; EC:2.7.1.-; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; NOT phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0035005 ; EC:2.7.1.154" "phosphoinositide 3-kinase complex, class III; GO:0035032" Pi3K59F Phosphotidylinositol 3 kinase 59F "CG5373, CG5373, DmVps34, PI3K-59F, PI3K_59F, PI3K, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, Phosphotidylinositol 3 kinase 59F" CDMC31470 3 14 4 DAC06-K16 9-CG5373-RA_1 CG5373 GCTCTGGTGGAGCAGATTCATCGGTTCACCCAATACTGGCGGAAGTAGAGGACATTGCTTGCACAAGAA 69 FBan0005373 FBgn0015277 Pi3K59F 2 2R endocytosis; GO:0006897; phosphoinositide phosphorylation; GO:0046854; protein targeting; GO:0006605 "phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; phosphoinositide 3-kinase activity; GO:0035004 ; EC:2.7.1.-; ; GO:0016303 ; EC:2.7.1.137; ; GO:0016303 ; EC:2.7.1.137; ; GO:0035004 ; EC:2.7.1.-; NOT phosphatidylinositol-4,5-bisphosphate 3-kinase activity; GO:0046934 ; EC:2.7.1.153; ; GO:0046934 ; EC:2.7.1.153; NOT phosphatidylinositol-4-phosphate 3-kinase activity; GO:0035005 ; EC:2.7.1.154; ; GO:0035005 ; EC:2.7.1.154" "phosphoinositide 3-kinase complex, class III; GO:0035032" Pi3K59F Phosphotidylinositol 3 kinase 59F "CG5373, CG5373, DmVps34, PI3K-59F, PI3K_59F, PI3K, PI(3)K, PI 3-kinase, PI3-kinase, dPI 3-kinase, dPI3K, Phosphotidylinositol 3 kinase 59F" CDMC31471 3 15 4 DAC06-O04 23-CG5403-RB_3 CG5403 CGCATCACACCGCAGTAATACACATGCATATCCATTATGACCGCATCGTAGACATATTTAGACGTAAAA 69 FBan0005403 FBgn0004795 retn 2 2R anterior/posterior pattern formation; GO:0009952; axon guidance; GO:0007411; embryonic pattern specification; GO:0009880; gliogenesis; GO:0042063; male courtship behavior; GO:0008049; muscle development; GO:0007517; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription; GO:0045941; regulation of female receptivity; GO:0045924; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016564; ; GO:0016563 nucleus; GO:0005634 retn retained "CG5403, l(2)02535, dri, dead ringer, 2535, EY2-10, Dri, DRI, retn/dri, Dead Ringer/Retain, BcDNA:LD35748" CDMC31471 3 16 4 DAC06-O04 23-CG5403-RB_3 CG5403 CGCATCACACCGCAGTAATACACATGCATATCCATTATGACCGCATCGTAGACATATTTAGACGTAAAA 69 FBan0005403 FBgn0004795 retn 2 2R anterior/posterior pattern formation; GO:0009952; axon guidance; GO:0007411; embryonic pattern specification; GO:0009880; gliogenesis; GO:0042063; male courtship behavior; GO:0008049; muscle development; GO:0007517; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription; GO:0045941; regulation of female receptivity; GO:0045924; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016564; ; GO:0016563 nucleus; GO:0005634 retn retained "CG5403, l(2)02535, dri, dead ringer, 2535, EY2-10, Dri, DRI, retn/dri, Dead Ringer/Retain, BcDNA:LD35748" CDMC31472 3 17 4 DAC06-O16 5-CG5417-RA_1 CG5417 CCCGCCATGATGAGCATGTACTCGCAGTTCATGAAGAGCAAGATGGACGGGCTAAAGCGGGTTAAGAAA 69 FBan0005417 FBgn0038808 CG5417 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614 mRNA binding; GO:0003729; ; GO:0003729 signal recognition particle (sensu Eukaryota); GO:0005786 CG5417 CG5417 BcDNA:RE48595 CDMC31472 3 18 4 DAC06-O16 5-CG5417-RA_1 CG5417 CCCGCCATGATGAGCATGTACTCGCAGTTCATGAAGAGCAAGATGGACGGGCTAAAGCGGGTTAAGAAA 69 FBan0005417 FBgn0038808 CG5417 3 3R SRP-dependent cotranslational protein targeting to membrane; GO:0006614 mRNA binding; GO:0003729; ; GO:0003729 signal recognition particle (sensu Eukaryota); GO:0005786 CG5417 CG5417 BcDNA:RE48595 CDMC31473 3 19 4 DAC07-C04 3-CG9806-RA_5 CG9806 ACACATTGCAGGAGGAATCGGACAACCAGATGAGCTTGCGTCAGGACATCAAAGTGAGCCAGCTG 65 FBan0009806 FBgn0030222 CG9806 X X proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG9806 CG9806 CDMC31473 3 20 4 DAC07-C04 3-CG9806-RA_5 CG9806 ACACATTGCAGGAGGAATCGGACAACCAGATGAGCTTGCGTCAGGACATCAAAGTGAGCCAGCTG 65 FBan0009806 FBgn0030222 CG9806 X X proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG9806 CG9806 CDMC31474 3 21 4 DAC07-C16 2-CG9855-RA_1 CG9855 TTGTGCTTGGTCGATTGATTCGCTGGGAGGATGCATTGTTGCGTCTTATTCGAAACCGCGGGACG 65 FBan0009855 FBgn0037242 CG9855 3 3R CG9855 CG9855 CDMC31474 3 22 4 DAC07-C16 2-CG9855-RA_1 CG9855 TTGTGCTTGGTCGATTGATTCGCTGGGAGGATGCATTGTTGCGTCTTATTCGAAACCGCGGGACG 65 FBan0009855 FBgn0037242 CG9855 3 3R CG9855 CG9855 CDMC31475 3 23 4 DAC07-G04 3-CG9969-RA_2 CG9969 GAAGAGGCGCAACTATCGCAGCATCAGGGAGATGATCCGACTCTCCTATACGGTGGGCTTCAACC 65 FBan0009969 FBgn0035382 Or63a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 membrane; GO:0016020 Or63a Odorant receptor 63a "CG9969, 63B.1, DOR28, 63a" CDMC31475 3 24 4 DAC07-G04 3-CG9969-RA_2 CG9969 GAAGAGGCGCAACTATCGCAGCATCAGGGAGATGATCCGACTCTCCTATACGGTGGGCTTCAACC 65 FBan0009969 FBgn0035382 Or63a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 membrane; GO:0016020 Or63a Odorant receptor 63a "CG9969, 63B.1, DOR28, 63a" CDMC31476 3 25 4 DAC07-G16 23-CR18775-RA_1 CR18775 CTATACTGTTTAGGGCTACTACTTCCGACTACTACAAAACCATTTCAATTGCCCTGTGCCTAACT 65 FBan0018775 FBgn0020646 Lcp65APsi 3 3L Lcp65APsi Lcp65APsi "CG18775, Lcp-a[Psi], LCP65Aapsi, Lcp-Psi, Lcp65APsi, CR18775, DCP4[Psi]" CDMC31476 3 26 4 DAC07-G16 23-CR18775-RA_1 CR18775 CTATACTGTTTAGGGCTACTACTTCCGACTACTACAAAACCATTTCAATTGCCCTGTGCCTAACT 65 FBan0018775 FBgn0020646 Lcp65APsi 3 3L Lcp65APsi Lcp65APsi "CG18775, Lcp-a[Psi], LCP65Aapsi, Lcp-Psi, Lcp65APsi, CR18775, DCP4[Psi]" CDMC31477 3 1 5 DAC07-K04 23-CR31877-RA_1 CR31877 AAATGATGAAACAGATGACGAGACTGAAGGAACAAATTCTCGACTTGGCGCTGTATTTTTCAGTG 65 FBan0031877 FBgn0025881 snoRNA:Z5 2 2L nucleolus; GO:0005730 snoRNA:Z5 snoRNA:Z5 "Z5 snoRNA, U15snoRNA, CR31877, snoRNA:U15" CDMC31477 3 2 5 DAC07-K04 23-CR31877-RA_1 CR31877 AAATGATGAAACAGATGACGAGACTGAAGGAACAAATTCTCGACTTGGCGCTGTATTTTTCAGTG 65 FBan0031877 FBgn0025881 snoRNA:Z5 2 2L nucleolus; GO:0005730 snoRNA:Z5 snoRNA:Z5 "Z5 snoRNA, U15snoRNA, CR31877, snoRNA:U15" CDMC31478 3 3 5 DAC07-K16 23-CR32747-RA_1 CR32747 ATAATTTTGATACTTCCATATCTCGCTGTAAAATGGGTGATGATCATAAACTAGGTGGCGTGGAG 65 FBan0032747 FBgn0016974 swaPsi X X swaPsi swallow pseudogene "CG3429, CR32747, swallow pseudogene" CDMC31478 3 4 5 DAC07-K16 23-CR32747-RA_1 CR32747 ATAATTTTGATACTTCCATATCTCGCTGTAAAATGGGTGATGATCATAAACTAGGTGGCGTGGAG 65 FBan0032747 FBgn0016974 swaPsi X X swaPsi swallow pseudogene "CG3429, CR32747, swallow pseudogene" CDMC31479 3 5 5 DAC07-O04 23-CR32911-RA_1 CR32911 TTTGTCTTCTTGATAGGAAGTGCCAACTGACACATAAATGAAGCTAGTTTAACCCTCTGAAAGCA 65 FBan0032911 FBgn0060292 snoRNA:U49:66Da 3 3L snoRNA:U49:66Da snoRNA:U49:66Da "U49a, Dmel\U49a, CR32911" CDMC31479 3 6 5 DAC07-O04 23-CR32911-RA_1 CR32911 TTTGTCTTCTTGATAGGAAGTGCCAACTGACACATAAATGAAGCTAGTTTAACCCTCTGAAAGCA 65 FBan0032911 FBgn0060292 snoRNA:U49:66Da 3 3L snoRNA:U49:66Da snoRNA:U49:66Da "U49a, Dmel\U49a, CR32911" CDMC31480 3 7 5 DAC07-O16 1-CR33345-RA_1 CR33345 CTGACTTCTCCGGAGGCATGGCGCTACTTTGAGTATGGCATGTTTTGGATGGGATGGATGGCTCC 65 FBgn0053345 CDMC31480 3 8 5 DAC07-O16 1-CR33345-RA_1 CR33345 CTGACTTCTCCGGAGGCATGGCGCTACTTTGAGTATGGCATGTTTTGGATGGGATGGATGGCTCC 65 FBgn0053345 CDMC31481 3 9 5 DAC08-C04 8-CG5614-RA_1 CG5614 GCGCGATTGGAAGTTCGGTGTGCAAAAAGGAGGTTCCAAAAAGTTGGTTCAGCTACCGGATCCTATGGA 69 FBan0005614 FBgn0038359 CG5614 3 3R CG5614 CG5614 CDMC31481 3 10 5 DAC08-C04 8-CG5614-RA_1 CG5614 GCGCGATTGGAAGTTCGGTGTGCAAAAAGGAGGTTCCAAAAAGTTGGTTCAGCTACCGGATCCTATGGA 69 FBan0005614 FBgn0038359 CG5614 3 3R CG5614 CG5614 CDMC31482 3 11 5 DAC08-C16 1-CG5629-RB_1 CG5629 CCTTAGTGTGCACCCACATATCAAGATACCCCCCCCATGTGTACTTCTCCCCGCGTATCGATTGTGCAT 69 FBan0005629 FBgn0027595 CG5629 3 3R CG5629 CG5629 "GH03502, anon-WO0118547.401, BcDNA:GH03502" CDMC31482 3 12 5 DAC08-C16 1-CG5629-RB_1 CG5629 CCTTAGTGTGCACCCACATATCAAGATACCCCCCCCATGTGTACTTCTCCCCGCGTATCGATTGTGCAT 69 FBan0005629 FBgn0027595 CG5629 3 3R CG5629 CG5629 "GH03502, anon-WO0118547.401, BcDNA:GH03502" CDMC31483 3 13 5 DAC08-G04 12-CG5665-RA_3 CG5665 GCCGTTGAGTATTTCGCCGAGAGTGCATATCCACACCAAGAGAAGAACTTTATGGGCAAGAAGTGCGCT 69 FBan0005665 FBgn0036977 CG5665 3 3L female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004465 ; EC:3.1.1.34 CG5665 CG5665 CDMC31483 3 14 5 DAC08-G04 12-CG5665-RA_3 CG5665 GCCGTTGAGTATTTCGCCGAGAGTGCATATCCACACCAAGAGAAGAACTTTATGGGCAAGAAGTGCGCT 69 FBan0005665 FBgn0036977 CG5665 3 3L female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004465 ; EC:3.1.1.34 CG5665 CG5665 CDMC31484 3 15 5 DAC08-G16 2-CG5674-RA_2 CG5674 CGCCTGTAGTTCTAAGCTCAACCCTCTAGCCAGCTAAACGCATCCGAAAGTTTGAGGGCACACACACCT 69 FBan0005674 FBgn0032656 CG5674 2 2L CG5674 CG5674 CDMC31484 3 16 5 DAC08-G16 2-CG5674-RA_2 CG5674 CGCCTGTAGTTCTAAGCTCAACCCTCTAGCCAGCTAAACGCATCCGAAAGTTTGAGGGCACACACACCT 69 FBan0005674 FBgn0032656 CG5674 2 2L CG5674 CG5674 CDMC31485 3 17 5 DAC08-K04 13-CG5708-RA_1 CG5708 TCCATTCATACAGAGACATACTAGCGGCACATCACCAAGACTCATCTAGTCCTGAGAACTTCGCCCCCA 69 FBan0005708 FBgn0032196 CG5708 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 CG5708 CG5708 CDMC31485 3 18 5 DAC08-K04 13-CG5708-RA_1 CG5708 TCCATTCATACAGAGACATACTAGCGGCACATCACCAAGACTCATCTAGTCCTGAGAACTTCGCCCCCA 69 FBan0005708 FBgn0032196 CG5708 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 CG5708 CG5708 CDMC31486 3 19 5 DAC08-K16 23-CG5717-RA_3 CG5717 ACGATTGAGTCCGTATCCCTCCACTTTCTTAGGCTTAAGATTCAAACTGATTTGTTGTCGTTACTGGGT 69 FBan0005717 FBgn0041709 yellow-g 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-g yellow-g "CG5717, CG5717, yellow-g" CDMC31486 3 20 5 DAC08-K16 23-CG5717-RA_3 CG5717 ACGATTGAGTCCGTATCCCTCCACTTTCTTAGGCTTAAGATTCAAACTGATTTGTTGTCGTTACTGGGT 69 FBan0005717 FBgn0041709 yellow-g 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-g yellow-g "CG5717, CG5717, yellow-g" CDMC31487 3 21 5 DAC08-O04 5-CG5751-RA_3 CG5751 GGCCGCTTCAATAGCAGTCTTTCTGTCGTGGTTCCGATTGCTACTGTTCCTGCAAAGATTCGACCAGGT 69 FBan0005751 FBgn0035934 TrpA1 3 3L calcium ion transport; GO:0006816; response to temperature stimulus; GO:0009266; thermotaxis; GO:0043052 calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005262; ; GO:0005057 membrane; GO:0016020 TrpA1 Transient receptor potential A1 "CG5751, CT18073, dANKTM1, ANKTM1, dTRPA1, TRPA1, dTrpA1, Anktm1, Transient receptor potential A1" CDMC31487 3 22 5 DAC08-O04 5-CG5751-RA_3 CG5751 GGCCGCTTCAATAGCAGTCTTTCTGTCGTGGTTCCGATTGCTACTGTTCCTGCAAAGATTCGACCAGGT 69 FBan0005751 FBgn0035934 TrpA1 3 3L calcium ion transport; GO:0006816; response to temperature stimulus; GO:0009266; thermotaxis; GO:0043052 calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005262; ; GO:0005057 membrane; GO:0016020 TrpA1 Transient receptor potential A1 "CG5751, CT18073, dANKTM1, ANKTM1, dTRPA1, TRPA1, dTrpA1, Anktm1, Transient receptor potential A1" CDMC31488 3 23 5 DAC08-O16 10-CG5765-RA_1 CG5765 TGGAGGACCAGACCAACGTGATCATGGGTTACAACCTACAGTACACCGGATGTCTGAGAACAGCACAAA 69 FBan0005765 FBgn0034294 CG5765 2 2R CG5765 CG5765 CDMC31488 3 24 5 DAC08-O16 10-CG5765-RA_1 CG5765 TGGAGGACCAGACCAACGTGATCATGGGTTACAACCTACAGTACACCGGATGTCTGAGAACAGCACAAA 69 FBan0005765 FBgn0034294 CG5765 2 2R CG5765 CG5765 CDMC31489 3 25 5 DAC09-C05 2-CG31482-RA_5 CG31482 CAATCGGTTGAGGGAGAAGCATGGAAGTCCGCCTCTGACCTTGGACGATGAACTCACAAAGGGATGC 67 FBan0031482 FBgn0051482 CG31482 3 3R extracellular region; GO:0005576 CG31482 CG31482 "CG2337, CG2337" CDMC31489 3 26 5 DAC09-C05 2-CG31482-RA_5 CG31482 CAATCGGTTGAGGGAGAAGCATGGAAGTCCGCCTCTGACCTTGGACGATGAACTCACAAAGGGATGC 67 FBan0031482 FBgn0051482 CG31482 3 3R extracellular region; GO:0005576 CG31482 CG31482 "CG2337, CG2337" CDMC31490 3 1 6 DAC09-C17 9-CG31689-RB_4 CG31689 CCTACCTGAAGCTGGGCATTCATGTGCTCTGTTCCATTTTGATTGGCTTGTTCTTCGGCGATTCGGG 67 FBgn0051689 CDMC31490 3 2 6 DAC09-C17 9-CG31689-RB_4 CG31689 CCTACCTGAAGCTGGGCATTCATGTGCTCTGTTCCATTTTGATTGGCTTGTTCTTCGGCGATTCGGG 67 FBgn0051689 CDMC31491 3 3 6 DAC09-G05 2-CG32145-RA_1 CG32145 CCACTGGGACGGAAAGAACGACATCATATTCTACACGGCCAACACAGAGGATCATCCCGAGCAGCTG 67 FBan0032145 FBgn0002997 ome 3 3L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 ome omega "CG9370, CG32145, CG17705, CG9370, CG9370, LD21715, BEST:LD21715" CDMC31491 3 4 6 DAC09-G05 2-CG32145-RA_1 CG32145 CCACTGGGACGGAAAGAACGACATCATATTCTACACGGCCAACACAGAGGATCATCCCGAGCAGCTG 67 FBan0032145 FBgn0002997 ome 3 3L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 ome omega "CG9370, CG32145, CG17705, CG9370, CG9370, LD21715, BEST:LD21715" CDMC31492 3 5 6 DAC09-G17 2-CG32374-RA_1 CG32374 CCGGTGTGTCCAGAAGGTGAAGCTTCCCTCCACGAGAACGAAGCGATTTCCTAAATGTTACCTGGCC 67 FBan0032374 FBgn0052374 CG32374 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG32374 CG32374 "CG8528, SP148" CDMC31492 3 6 6 DAC09-G17 2-CG32374-RA_1 CG32374 CCGGTGTGTCCAGAAGGTGAAGCTTCCCTCCACGAGAACGAAGCGATTTCCTAAATGTTACCTGGCC 67 FBan0032374 FBgn0052374 CG32374 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG32374 CG32374 "CG8528, SP148" CDMC31493 3 7 6 DAC09-K05 13-CG32792-RB_4 CG32792 AGTTCCCTATTCGCATCGGAATATAAGTCTGCCAGAGGGATTCCATGCAGTCAATTGGCATGCCGAG 67 FBan0032792 FBgn0052792 CG32792 X X cation transport; GO:0006812; development; GO:0007275; ion transport; GO:0006811; sodium ion transport; GO:0006814; transport; GO:0006810 alpha-type channel activity; GO:0015268; sodium channel activity; GO:0005272; ; GO:0015268; ; GO:0005272 membrane; GO:0016020 CG32792 CG32792 CDMC31493 3 8 6 DAC09-K05 13-CG32792-RB_4 CG32792 AGTTCCCTATTCGCATCGGAATATAAGTCTGCCAGAGGGATTCCATGCAGTCAATTGGCATGCCGAG 67 FBan0032792 FBgn0052792 CG32792 X X cation transport; GO:0006812; development; GO:0007275; ion transport; GO:0006811; sodium ion transport; GO:0006814; transport; GO:0006810 alpha-type channel activity; GO:0015268; sodium channel activity; GO:0005272; ; GO:0015268; ; GO:0005272 membrane; GO:0016020 CG32792 CG32792 CDMC31494 3 9 6 DAC09-K17 15-CG33148-RB_8 CG33148 GCAAATCTGCCTCGGAGTTGAATGGTCACGATTGCCATCTCAGTGAATCACCGCACATATCACCGAA 67 FBan0033148 FBgn0053148 2 2R CDMC31494 3 10 6 DAC09-K17 15-CG33148-RB_8 CG33148 GCAAATCTGCCTCGGAGTTGAATGGTCACGATTGCCATCTCAGTGAATCACCGCACATATCACCGAA 67 FBan0033148 FBgn0053148 2 2R CDMC31495 3 11 6 DAC09-O05 3-CG3488-RA_3 CG3488 CCCGAGTTGGATGAGGCTTACACGCGGAGAGTGTACAACTTTCCCTCCACCCAGGAGTTGTACAAGT 67 FBan0003488 FBgn0014906 CG3488 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG3488 CG3488 "c24, anon-23D, DMU29170, anon-23Da, CT11757, C24" CDMC31495 3 12 6 DAC09-O05 3-CG3488-RA_3 CG3488 CCCGAGTTGGATGAGGCTTACACGCGGAGAGTGTACAACTTTCCCTCCACCCAGGAGTTGTACAAGT 67 FBan0003488 FBgn0014906 CG3488 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG3488 CG3488 "c24, anon-23D, DMU29170, anon-23Da, CT11757, C24" CDMC31496 3 13 6 DAC09-O17 AutoBlank AutoBlank CDMC31496 3 14 6 DAC09-O17 AutoBlank AutoBlank CDMC31497 3 15 6 DAC10-C04 15-CG18343-RA_13 CG18343 TGTCGGCTTATCCAGCATATACGTCAGTCTAAACATGGAGAAAAGCTGCAGTATTGGCAACGGACGGGA 69 FBan0018343 FBgn0033683 CG18343 2 2R CG18343 CG18343 CDMC31497 3 16 6 DAC10-C04 15-CG18343-RA_13 CG18343 TGTCGGCTTATCCAGCATATACGTCAGTCTAAACATGGAGAAAAGCTGCAGTATTGGCAACGGACGGGA 69 FBan0018343 FBgn0033683 CG18343 2 2R CG18343 CG18343 CDMC31498 3 17 6 DAC10-C16 3-CG18367-RA_1 CG18367 CGAATGTCATCAAGTCATGGCTGAGACACTTCGAGAGCACAGGATCCTCGCAAGGAGGTTGTGGAGGAT 69 FBan0018367 FBgn0034460 CG18367 2 2R CG18367 CG18367 CG15123 CDMC31498 3 18 6 DAC10-C16 3-CG18367-RA_1 CG18367 CGAATGTCATCAAGTCATGGCTGAGACACTTCGAGAGCACAGGATCCTCGCAAGGAGGTTGTGGAGGAT 69 FBan0018367 FBgn0034460 CG18367 2 2R CG18367 CG18367 CG15123 CDMC31499 3 19 6 DAC10-G04 1-CG1841-RA_1 CG1841 TACCAGGCTGCTCTTTGAACACAGTGCGTCTACGGGTTACCTGCAAGCATCAAAACATCGGAGAGGAGC 69 FBan0001841 FBgn0030330 CG1841 X X protein binding; GO:0005515; ; GO:0005515 CG1841 CG1841 CDMC31499 3 20 6 DAC10-G04 1-CG1841-RA_1 CG1841 TACCAGGCTGCTCTTTGAACACAGTGCGTCTACGGGTTACCTGCAAGCATCAAAACATCGGAGAGGAGC 69 FBan0001841 FBgn0030330 CG1841 X X protein binding; GO:0005515; ; GO:0005515 CG1841 CG1841 CDMC31500 3 21 6 DAC10-G16 18-CG18449-RA_1 CG18449 AGGCGTTACGTAGAAGCTGCATCAGATCGAATGGCGTTTGATGGATACTAGCTGATACACGGCTTGTTT 69 FBan0018449 FBgn0033285 CG18449 2 2R CG18449 CG18449 CDMC31500 3 22 6 DAC10-G16 18-CG18449-RA_1 CG18449 AGGCGTTACGTAGAAGCTGCATCAGATCGAATGGCGTTTGATGGATACTAGCTGATACACGGCTTGTTT 69 FBan0018449 FBgn0033285 CG18449 2 2R CG18449 CG18449 CDMC31501 3 23 6 DAC10-K04 23-CG1849-RA_8 CG1849 TACAAATCCCAGCAGAAAACACGAAAACTCAAAAACTCAGCCCAAAAAGAAAATACCAAGAAAGCAAAC 69 FBan0001849 FBgn0003300 run X X "central nervous system development; GO:0007417; germ-band extension; GO:0007377; neuroblast fate determination; GO:0007400; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; ; GO:0030528; ; GO:0005515 nucleus; GO:0005634 run runt "CG1849, 1, section 1, 2, section 2, lLB5, AA33, LB5, P235, leg: legless, l(1)AA33, Runt, l(1)19Ea, l(1)B2/13.1, l(1)LB9, legless, leg, runt" CDMC31501 3 24 6 DAC10-K04 23-CG1849-RA_8 CG1849 TACAAATCCCAGCAGAAAACACGAAAACTCAAAAACTCAGCCCAAAAAGAAAATACCAAGAAAGCAAAC 69 FBan0001849 FBgn0003300 run X X "central nervous system development; GO:0007417; germ-band extension; GO:0007377; neuroblast fate determination; GO:0007400; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; ; GO:0003704; ; GO:0030528; ; GO:0005515 nucleus; GO:0005634 run runt "CG1849, 1, section 1, 2, section 2, lLB5, AA33, LB5, P235, leg: legless, l(1)AA33, Runt, l(1)19Ea, l(1)B2/13.1, l(1)LB9, legless, leg, runt" CDMC31502 3 25 6 DAC10-K16 8-CG18519-RB_2 CG18519 TGGCTTCAAAGCTAAGGAGACCTGCCAGATTTGTCCAGACCATAGAGTCCATGATGGAGACCATTGGCA 69 FBan0018519 FBgn0038348 CG18519 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18519 CG18519 DmAO2 CDMC31502 3 26 6 DAC10-K16 8-CG18519-RB_2 CG18519 TGGCTTCAAAGCTAAGGAGACCTGCCAGATTTGTCCAGACCATAGAGTCCATGATGGAGACCATTGGCA 69 FBan0018519 FBgn0038348 CG18519 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18519 CG18519 DmAO2 CDMC31503 3 1 7 DAC10-O04 2-CG18584-RA_5 CG18584 CCACGCGTTGCACTGAGAGCTACCAGACAAAGTCAGCCCAGATATCGGTGTTTGGAATTCCACTCTGGT 69 FBan0018584 FBgn0033107 CG18584 2 2R CG18584 CG18584 CDMC31503 3 2 7 DAC10-O04 2-CG18584-RA_5 CG18584 CCACGCGTTGCACTGAGAGCTACCAGACAAAGTCAGCCCAGATATCGGTGTTTGGAATTCCACTCTGGT 69 FBan0018584 FBgn0033107 CG18584 2 2R CG18584 CG18584 CDMC31504 3 3 7 DAC10-O16 12-CG18599-RA_1 CG18599 TGGCATTGATAAGGCAAACTCAACTGCCAGGTACATCGTTATTGGGCAATCAAGTATCCGTGTCGGCCA 69 FBan0018599 FBgn0038592 CG18599 3 3R CG18599 CG18599 CDMC31504 3 4 7 DAC10-O16 12-CG18599-RA_1 CG18599 TGGCATTGATAAGGCAAACTCAACTGCCAGGTACATCGTTATTGGGCAATCAAGTATCCGTGTCGGCCA 69 FBan0018599 FBgn0038592 CG18599 3 3R CG18599 CG18599 CDMC31505 3 5 7 DAC11-C04 3-CG10424-RA_4 CG10424 CCAGTGCTAGACTGTGTGGATGCAGTGGAGAGAATAGCGCCCTGGTTAGAGCGACTTCACGTCGTTG 67 FBan0010424 FBgn0036848 CG10424 3 3L CG10424 CG10424 CDMC31505 3 6 7 DAC11-C04 3-CG10424-RA_4 CG10424 CCAGTGCTAGACTGTGTGGATGCAGTGGAGAGAATAGCGCCCTGGTTAGAGCGACTTCACGTCGTTG 67 FBan0010424 FBgn0036848 CG10424 3 3L CG10424 CG10424 CDMC31506 3 7 7 DAC11-C16 3-CG10564-RA_3 CG10564 CCAGATCGAGACGACGATATCGAAGAGCCACAACGATGCGTTATAGCCGAGTACGCGCACTCACTGG 67 FBan0010564 FBgn0024150 Ac78C 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 Ac78C Adenylyl cyclase 78C "CG10564, CG10554, CG10564, CG10554, DAC78C-s, DAC78C, AC 78C" CDMC31506 3 8 7 DAC11-C16 3-CG10564-RA_3 CG10564 CCAGATCGAGACGACGATATCGAAGAGCCACAACGATGCGTTATAGCCGAGTACGCGCACTCACTGG 67 FBan0010564 FBgn0024150 Ac78C 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 Ac78C Adenylyl cyclase 78C "CG10564, CG10554, CG10564, CG10554, DAC78C-s, DAC78C, AC 78C" CDMC31507 3 9 7 DAC11-G04 14-CG10923-RA_2 CG10923 GACGACGATCTGCATTTGAGCATGGAGGACTTTGATAGCCAGGACACCGAATCAGATTCCGAGGAGC 67 FBan0010923 FBgn0004379 Klp67A 3 3L centrosome separation; GO:0051299; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; male meiosis chromosome segregation; GO:0007060; male meiotic chromosome movement towards spindle pole; GO:0016346; meiotic spindle assembly; GO:0051226; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; protein targeting; GO:0006605; sister chromatid biorientation; GO:0031134; spindle assembly; GO:0051225 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; ; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003777 cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Klp67A Kinesin-like protein at 67A "CG10923, CG10923, KLP3, KLP67A, 0427/05, KRP67A, kinesin like protein 67a, KIF18A, DmKlp67A, anon-WO0140519.224, anon-WO0172774.120, Klp3, l(3)S042705, lethal (3) S042705" CDMC31507 3 10 7 DAC11-G04 14-CG10923-RA_2 CG10923 GACGACGATCTGCATTTGAGCATGGAGGACTTTGATAGCCAGGACACCGAATCAGATTCCGAGGAGC 67 FBan0010923 FBgn0004379 Klp67A 3 3L centrosome separation; GO:0051299; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; male meiosis chromosome segregation; GO:0007060; male meiotic chromosome movement towards spindle pole; GO:0016346; meiotic spindle assembly; GO:0051226; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; protein targeting; GO:0006605; sister chromatid biorientation; GO:0031134; spindle assembly; GO:0051225 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; ; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0003777 cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Klp67A Kinesin-like protein at 67A "CG10923, CG10923, KLP3, KLP67A, 0427/05, KRP67A, kinesin like protein 67a, KIF18A, DmKlp67A, anon-WO0140519.224, anon-WO0172774.120, Klp3, l(3)S042705, lethal (3) S042705" CDMC31508 3 11 7 DAC11-G16 13-CG11006-RB_2 CG11006 GCCCACACATAAGTTGGCCAACAATCATTTTCATCGGTACACTGATGTTAAGCCAAGGGAGGAGCGG 67 FBan0011006 FBgn0027534 CG11006 3 3L CG11006 CG11006 BcDNA:LD21213 CDMC31508 3 12 7 DAC11-G16 13-CG11006-RB_2 CG11006 GCCCACACATAAGTTGGCCAACAATCATTTTCATCGGTACACTGATGTTAAGCCAAGGGAGGAGCGG 67 FBan0011006 FBgn0027534 CG11006 3 3L CG11006 CG11006 BcDNA:LD21213 CDMC31509 3 13 7 DAC11-K04 1-CG11349-RA_1 CG11349 TCGATCCAACTACCAGGGTCTCAATGTGCTGAATGGAAACGTTTTCGGACAACCCCATCTCCAGGGA 67 FBan0011349 FBgn0035550 CG11349 3 3L CG11349 CG11349 CDMC31509 3 14 7 DAC11-K04 1-CG11349-RA_1 CG11349 TCGATCCAACTACCAGGGTCTCAATGTGCTGAATGGAAACGTTTTCGGACAACCCCATCTCCAGGGA 67 FBan0011349 FBgn0035550 CG11349 3 3L CG11349 CG11349 CDMC31510 3 15 7 DAC11-K16 17-CG11456-RA_1 CG11456 TGCTCCTTTGGAAAGGAATGCCCCTTCAAGTTCCAAGATGCTACCAAAATGGAGCTCCACTGTAGTT 67 FBan0011456 FBgn0037031 CG11456 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11456 CG11456 CDMC31510 3 16 7 DAC11-K16 17-CG11456-RA_1 CG11456 TGCTCCTTTGGAAAGGAATGCCCCTTCAAGTTCCAAGATGCTACCAAAATGGAGCTCCACTGTAGTT 67 FBan0011456 FBgn0037031 CG11456 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11456 CG11456 CDMC31511 3 17 7 DAC11-O04 2-CG12125-RA_1 CG12125 GCTCCGAGCGAGAATCCAGCTGAAATACCTCCGATTGCATGGGTAAAGTGGATCCAGGTGACAGACG 67 FBan0012125 FBgn0030037 CG12125 X X CG12125 CG12125 CDMC31511 3 18 7 DAC11-O04 2-CG12125-RA_1 CG12125 GCTCCGAGCGAGAATCCAGCTGAAATACCTCCGATTGCATGGGTAAAGTGGATCCAGGTGACAGACG 67 FBan0012125 FBgn0030037 CG12125 X X CG12125 CG12125 CDMC31512 3 19 7 DAC11-O16 AutoBlank AutoBlank CDMC31512 3 20 7 DAC11-O16 AutoBlank AutoBlank CDMC31513 3 21 7 DAC12-C04 2-CG10233-RA_2 CG10233 ACGCACGGCTTTCCCAGAAACGAGGGATTCTTTCAAGACTGCCGCTTTATGAGACGACGTCGATGT 66 FBan0010233 FBgn0037302 CG10233 3 3R CG10233 CG10233 "9C4, anon-83ABa" CDMC31513 3 22 7 DAC12-C04 2-CG10233-RA_2 CG10233 ACGCACGGCTTTCCCAGAAACGAGGGATTCTTTCAAGACTGCCGCTTTATGAGACGACGTCGATGT 66 FBan0010233 FBgn0037302 CG10233 3 3R CG10233 CG10233 "9C4, anon-83ABa" CDMC31514 3 23 7 DAC12-C16 3-CG10367-RA_2 CG10367 GTGATGATCCGCTGGAATCCACACCAGATGCCAGTCAGTGGAGCTATGACCAGGACTAGTGCAAGC 66 FBan0010367 FBgn0001205 Hmgcr 3 3R cholesterol metabolism; GO:0008203; germ cell attraction; GO:0035232; germ cell migration; GO:0008354; gonad development; GO:0008406; isoprenoid biosynthesis; GO:0008299; pole cell migration; GO:0007280 hydroxymethylglutaryl-CoA reductase (NADPH) activity; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; intracellular; GO:0005622 Hmgcr HMG Coenzyme A reductase "CG10367, CG10367, l(3)01152, clb, columbus, HmG-CoAR, bs32f05.y1, hmgcr, HMGCoAr, HMGCoAR, DmHMG-CoAr, HMG-CoA reductase, HMGCR_Dm, HMGCoARr, 3-hydroxy-3-methylglutaryl coenzyme A reductase, BcDNA:LD15354, Hmg" CDMC31514 3 24 7 DAC12-C16 3-CG10367-RA_2 CG10367 GTGATGATCCGCTGGAATCCACACCAGATGCCAGTCAGTGGAGCTATGACCAGGACTAGTGCAAGC 66 FBan0010367 FBgn0001205 Hmgcr 3 3R cholesterol metabolism; GO:0008203; germ cell attraction; GO:0035232; germ cell migration; GO:0008354; gonad development; GO:0008406; isoprenoid biosynthesis; GO:0008299; pole cell migration; GO:0007280 hydroxymethylglutaryl-CoA reductase (NADPH) activity; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34; ; GO:0004420 ; EC:1.1.1.34 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; intracellular; GO:0005622 Hmgcr HMG Coenzyme A reductase "CG10367, CG10367, l(3)01152, clb, columbus, HmG-CoAR, bs32f05.y1, hmgcr, HMGCoAr, HMGCoAR, DmHMG-CoAr, HMG-CoA reductase, HMGCR_Dm, HMGCoARr, 3-hydroxy-3-methylglutaryl coenzyme A reductase, BcDNA:LD15354, Hmg" CDMC31515 3 25 7 DAC12-G04 2-CG10858-RA_1 CG10858 GGCACACTTCCTTTTCGGCGTGTCACTATTGTGGATTGTGGGTTTGTGCCCCTCATAGCCAGATGA 66 FBan0010858 FBgn0035458 CG10858 3 3L sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG10858 CG10858 CDMC31515 3 26 7 DAC12-G04 2-CG10858-RA_1 CG10858 GGCACACTTCCTTTTCGGCGTGTCACTATTGTGGATTGTGGGTTTGTGCCCCTCATAGCCAGATGA 66 FBan0010858 FBgn0035458 CG10858 3 3L sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG10858 CG10858 CDMC31516 3 1 8 DAC12-G16 6-CG11018-RA_2 CG11018 GGCTTGCCATTGGCTACAACCGATCTGGAGTCACTTCCAATCGTCTTGGCAGAGGATGTTCCGGTG 66 FBan0011018 FBgn0034464 CG11018 2 2R CG11018 CG11018 anon-WO0140519.121 CDMC31516 3 2 8 DAC12-G16 6-CG11018-RA_2 CG11018 GGCTTGCCATTGGCTACAACCGATCTGGAGTCACTTCCAATCGTCTTGGCAGAGGATGTTCCGGTG 66 FBan0011018 FBgn0034464 CG11018 2 2R CG11018 CG11018 anon-WO0140519.121 CDMC31517 3 3 8 DAC12-K04 1-CG11203-RA_2 CG11203 AGATGGAGGAGAATCCCATAGTAATCATTCCACAGGAGTGCCGTTGTCCCGCTGCTCCGGATTTGG 66 FBan0011203 FBgn0030249 CG11203 X X CG11203 CG11203 CDMC31517 3 4 8 DAC12-K04 1-CG11203-RA_2 CG11203 AGATGGAGGAGAATCCCATAGTAATCATTCCACAGGAGTGCCGTTGTCCCGCTGCTCCGGATTTGG 66 FBan0011203 FBgn0030249 CG11203 X X CG11203 CG11203 CDMC31518 3 5 8 DAC12-K16 3-CG11326-RA_3 CG11326 TGACTTTCGCACTCTTCAAACCATTCCACTGGATCCCAAAGGCCTATCGCAAGCGGATCCCAACTG 66 FBan0011326 FBgn0031850 Tsp 2 2L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 Tsp Thrombospondin "CG11326, CG11326, CG11326, CG11326, CG11326, CT31613, DTSP, D-TSP, SP295, tsp, thrombospondin, Thrombospondin" CDMC31518 3 6 8 DAC12-K16 3-CG11326-RA_3 CG11326 TGACTTTCGCACTCTTCAAACCATTCCACTGGATCCCAAAGGCCTATCGCAAGCGGATCCCAACTG 66 FBan0011326 FBgn0031850 Tsp 2 2L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 Tsp Thrombospondin "CG11326, CG11326, CG11326, CG11326, CG11326, CT31613, DTSP, D-TSP, SP295, tsp, thrombospondin, Thrombospondin" CDMC31519 3 7 8 DAC12-O04 3-CG12104-RA_1 CG12104 TCAGCCACCTCCTCTAGTCACAACCAAATTGGAGTCTGTCGAGGATCTGCAACAGTCGGTGGATGC 66 FBan0012104 FBgn0035238 CG12104 3 3L CG12104 CG12104 CDMC31519 3 8 8 DAC12-O04 3-CG12104-RA_1 CG12104 TCAGCCACCTCCTCTAGTCACAACCAAATTGGAGTCTGTCGAGGATCTGCAACAGTCGGTGGATGC 66 FBan0012104 FBgn0035238 CG12104 3 3L CG12104 CG12104 CDMC31520 3 9 8 DAC12-O16 AutoBlank AutoBlank CDMC31520 3 10 8 DAC12-O16 AutoBlank AutoBlank CDMC31521 3 11 8 DAC13-C04 2-CG14545-RA_1 CG14545 AGGAAGCCGTCTCATCATCGAGCGAAGATTCCATGGTGGAGAGCATTGAGACTACGATGGACTCCACGA 69 FBan0014545 FBgn0040602 CG14545 3 3R CG14545 CG14545 BcDNA:RE55691 CDMC31521 3 12 8 DAC13-C04 2-CG14545-RA_1 CG14545 AGGAAGCCGTCTCATCATCGAGCGAAGATTCCATGGTGGAGAGCATTGAGACTACGATGGACTCCACGA 69 FBan0014545 FBgn0040602 CG14545 3 3R CG14545 CG14545 BcDNA:RE55691 CDMC31522 3 13 8 DAC13-C16 4-CG1455-RA_1 CG1455 CCTGCGATTGCTGAGCTTTCGATTGCAGGTGCATACTTATAGAATCTCTCCGCAAAAACTCCCGGGCGA 69 FBan0001455 FBgn0010015 CanA1 3 3R neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004723; ; GO:0004722; ; GO:0004723 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanA1 Calcineurin A1 "CG1455, CG1455, D14, PP2B 21EF, CnnA21EF, PP2B, protein phosphatase from PCR fragment D14, CNA1, pMY4, calcineurin, CAN A1/PP2B, canA, Can, PpD14, Protein phosphatase D14" CDMC31522 3 14 8 DAC13-C16 4-CG1455-RA_1 CG1455 CCTGCGATTGCTGAGCTTTCGATTGCAGGTGCATACTTATAGAATCTCTCCGCAAAAACTCCCGGGCGA 69 FBan0001455 FBgn0010015 CanA1 3 3R neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004723; ; GO:0004722; ; GO:0004723 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanA1 Calcineurin A1 "CG1455, CG1455, D14, PP2B 21EF, CnnA21EF, PP2B, protein phosphatase from PCR fragment D14, CNA1, pMY4, calcineurin, CAN A1/PP2B, canA, Can, PpD14, Protein phosphatase D14" CDMC31523 3 15 8 DAC13-G04 8-CG14605-RB_2 CG14605 ACCATCTTCGAACAGCTCGGTAGCAGGATGGAGCCCAATCTATGTGGCATATTTCTGGGTGTTGTGCAA 69 FBan0014605 FBgn0037486 CG14605 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG14605 CG14605 BcDNA:AT16877 CDMC31523 3 16 8 DAC13-G04 8-CG14605-RB_2 CG14605 ACCATCTTCGAACAGCTCGGTAGCAGGATGGAGCCCAATCTATGTGGCATATTTCTGGGTGTTGTGCAA 69 FBan0014605 FBgn0037486 CG14605 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG14605 CG14605 BcDNA:AT16877 CDMC31524 3 17 8 DAC13-G16 6-CG14614-RA_1 CG14614 TTGGTCTGGTCCTTGCTGAAGCACCTGACTGCAATTGCTGAACAACGCACAGTCAACAAAGAAGCAAGT 69 FBan0014614 FBgn0031186 CG14614 X X CG14614 CG14614 BcDNA:GM08142 CDMC31524 3 18 8 DAC13-G16 6-CG14614-RA_1 CG14614 TTGGTCTGGTCCTTGCTGAAGCACCTGACTGCAATTGCTGAACAACGCACAGTCAACAAAGAAGCAAGT 69 FBan0014614 FBgn0031186 CG14614 X X CG14614 CG14614 BcDNA:GM08142 CDMC31525 3 19 8 DAC13-K04 2-CG14652-RA_3 CG14652 GCAAGTGCAACATCAGGCTCAACGAGTGGGCGTTTTAATACCTCCTTCGCTGCACGTTGATTTGACGCA 69 FBan0014652 FBgn0037259 CG14652 3 3R CG14652 CG14652 CDMC31525 3 20 8 DAC13-K04 2-CG14652-RA_3 CG14652 GCAAGTGCAACATCAGGCTCAACGAGTGGGCGTTTTAATACCTCCTTCGCTGCACGTTGATTTGACGCA 69 FBan0014652 FBgn0037259 CG14652 3 3R CG14652 CG14652 CDMC31526 3 21 8 DAC13-K16 3-CG14662-RA_3 CG14662 CGGTTGCATCTGCAGATCTGGGAAAATCGTCGTGCCAGGATGGTTTACTGGTGGAGATCTGCGAATCGA 69 FBan0014662 FBgn0037291 CG14662 3 3R CG14662 CG14662 CT34440 CDMC31526 3 22 8 DAC13-K16 3-CG14662-RA_3 CG14662 CGGTTGCATCTGCAGATCTGGGAAAATCGTCGTGCCAGGATGGTTTACTGGTGGAGATCTGCGAATCGA 69 FBan0014662 FBgn0037291 CG14662 3 3R CG14662 CG14662 CT34440 CDMC31527 3 23 8 DAC13-O04 2-CG14694-RA_2 CG14694 GGGCAAGCTAGTTGCGGGAATCCTGGCTCAGATGGTCATTGGAATGAGGTGGATGAACTACAAGCAACT 69 FBan0014694 FBgn0037845 CG14694 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 membrane; GO:0016020 CG14694 CG14694 CDMC31527 3 24 8 DAC13-O04 2-CG14694-RA_2 CG14694 GGGCAAGCTAGTTGCGGGAATCCTGGCTCAGATGGTCATTGGAATGAGGTGGATGAACTACAAGCAACT 69 FBan0014694 FBgn0037845 CG14694 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 membrane; GO:0016020 CG14694 CG14694 CDMC31528 3 25 8 DAC13-O16 24-CG14711-RA_1 CG14711 GGGCGCTATTAGTCGAAAACAATGCAATACAATTTCTGTTAGATAATTCATTAATGTACATTTAATTAT 69 FBan0014711 FBgn0037922 CG14711 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG14711 CG14711 CDMC31528 3 26 8 DAC13-O16 24-CG14711-RA_1 CG14711 GGGCGCTATTAGTCGAAAACAATGCAATACAATTTCTGTTAGATAATTCATTAATGTACATTTAATTAT 69 FBan0014711 FBgn0037922 CG14711 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG14711 CG14711 CDMC31529 3 1 9 DAC14-C04 23-CG17282-RA_6 CG17282 TCGCCAAATCGCAAACTTTGCTTACTGCTAAATTTCGAAGCTCCCAATTTGCAAATATTCCAAAA 65 FBan0017282 FBgn0038857 CG17282 3 3R CG17282 CG17282 CDMC31529 3 2 9 DAC14-C04 23-CG17282-RA_6 CG17282 TCGCCAAATCGCAAACTTTGCTTACTGCTAAATTTCGAAGCTCCCAATTTGCAAATATTCCAAAA 65 FBan0017282 FBgn0038857 CG17282 3 3R CG17282 CG17282 CDMC31530 3 3 9 DAC14-C16 2-CG17343-RA_1 CG17343 GAACTGCAGACCATCCAGCTGAAGCTGTCCGATCTCAAGGAGTACGAGCAGGCTAAGATGGAGCG 65 FBan0017343 FBgn0032751 CG17343 2 2L CG17343 CG17343 CDMC31530 3 4 9 DAC14-C16 2-CG17343-RA_1 CG17343 GAACTGCAGACCATCCAGCTGAAGCTGTCCGATCTCAAGGAGTACGAGCAGGCTAAGATGGAGCG 65 FBan0017343 FBgn0032751 CG17343 2 2L CG17343 CG17343 CDMC31531 3 5 9 DAC14-G04 3-CG1753-RB_2 CG1753 CCCCCGGTCATTCTCAAGTCGGATGCAACTGTTGGTGAGGCTATTGCCCTGATGAAGAAACACCG 65 FBan0001753 FBgn0031148 CG1753 X X amino acid biosynthesis; GO:0008652; cysteine biosynthesis from serine; GO:0006535; cysteine biosynthesis via cystathione; GO:0019343 cystathionine beta-synthase activity; GO:0004122 ; EC:4.2.1.22; ; GO:0004122 ; EC:4.2.1.22 cytoplasm; GO:0005737 CG1753 CG1753 CDMC31531 3 6 9 DAC14-G04 3-CG1753-RB_2 CG1753 CCCCCGGTCATTCTCAAGTCGGATGCAACTGTTGGTGAGGCTATTGCCCTGATGAAGAAACACCG 65 FBan0001753 FBgn0031148 CG1753 X X amino acid biosynthesis; GO:0008652; cysteine biosynthesis from serine; GO:0006535; cysteine biosynthesis via cystathione; GO:0019343 cystathionine beta-synthase activity; GO:0004122 ; EC:4.2.1.22; ; GO:0004122 ; EC:4.2.1.22 cytoplasm; GO:0005737 CG1753 CG1753 CDMC31532 3 7 9 DAC14-G16 3-CG17592-RB_1 CG17592 TTACCAATCACCACACCGCTGATTTGTCAGAGGCCCTGGTCCACAGTTCCTTTGCCAATGGTCAG 65 FBan0017592 FBgn0029711 Usf X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Usf Usf "CG17592, CG17592, CG17592, CG17592, Dm Usf, DmUsf" CDMC31532 3 8 9 DAC14-G16 3-CG17592-RB_1 CG17592 TTACCAATCACCACACCGCTGATTTGTCAGAGGCCCTGGTCCACAGTTCCTTTGCCAATGGTCAG 65 FBan0017592 FBgn0029711 Usf X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Usf Usf "CG17592, CG17592, CG17592, CG17592, Dm Usf, DmUsf" CDMC31533 3 9 9 DAC14-K04 23-CG17704-RE_1 CG17704 ATTATAGAGAGAGGTCCTGCACAAAATCCGGGGATTTAAGAATCCACCATATGTAGTGCACCGTT 65 CDMC31533 3 10 9 DAC14-K04 23-CG17704-RE_1 CG17704 ATTATAGAGAGAGGTCCTGCACAAAATCCGGGGATTTAAGAATCCACCATATGTAGTGCACCGTT 65 CDMC31534 3 11 9 DAC14-K16 20-CG17757-RA_1 CG17757 GGAGCTCTGAACCGGAATCGCTGTGCAACAACTGGCGCGGCTGGAAGAAGCCCGCTGCAGGCAGC 65 FBan0017757 FBgn0040883 CG17757 X X CG17757 CG17757 CDMC31534 3 12 9 DAC14-K16 20-CG17757-RA_1 CG17757 GGAGCTCTGAACCGGAATCGCTGTGCAACAACTGGCGCGGCTGGAAGAAGCCCGCTGCAGGCAGC 65 FBan0017757 FBgn0040883 CG17757 X X CG17757 CG17757 CDMC31535 3 13 9 DAC14-O04 1-CG17924-RA_2 CG17924 GATACGTTGCGGTTGTCCTTCAGGCCATTCCCGTCGTCCCAGAAGTAGTACTTGTACCACCTGGT 65 FBan0017924 FBgn0002863 Acp95EF 3 3R extracellular region; GO:0005576 Acp95EF Accessory gland-specific peptide 95EF "CG17924, mst-3, mst316, mst 316, Mst95E, Mst95F, mst(3)ag-3, mst316F" CDMC31535 3 14 9 DAC14-O04 1-CG17924-RA_2 CG17924 GATACGTTGCGGTTGTCCTTCAGGCCATTCCCGTCGTCCCAGAAGTAGTACTTGTACCACCTGGT 65 FBan0017924 FBgn0002863 Acp95EF 3 3R extracellular region; GO:0005576 Acp95EF Accessory gland-specific peptide 95EF "CG17924, mst-3, mst316, mst 316, Mst95E, Mst95F, mst(3)ag-3, mst316F" CDMC31536 3 15 9 DAC14-O16 23-CG18001-RA_1 CG18001 TTCGAGGTTCCTTTACACCCTTGTCGTACAGGATAAAGAAAAGGCTGACAAAATTAAGCAGTCTT 65 CDMC31536 3 16 9 DAC14-O16 23-CG18001-RA_1 CG18001 TTCGAGGTTCCTTTACACCCTTGTCGTACAGGATAAAGAAAAGGCTGACAAAATTAAGCAGTCTT 65 CDMC31537 3 17 9 DAC15-C04 3-CG12873-RA_4 CG12873 GACGGCCAGATGTCCATCCAAGACATGTGTAGTGGTTACGGCGTTTTTGCTGTGGTATCCTTCCTGGC 68 FBan0012873 FBgn0039549 CG12873 3 3R CG12873 CG12873 CDMC31537 3 18 9 DAC15-C04 3-CG12873-RA_4 CG12873 GACGGCCAGATGTCCATCCAAGACATGTGTAGTGGTTACGGCGTTTTTGCTGTGGTATCCTTCCTGGC 68 FBan0012873 FBgn0039549 CG12873 3 3R CG12873 CG12873 CDMC31538 3 19 9 DAC15-C16 3-CG12985-RA_4 CG12985 GGTGCCATTCCCTTATCTGGGATGCACCACAAGACCGTCCTACCAATCTGGATGTGAAAGCATGGACG 68 FBan0012985 FBgn0030881 CG12985 X X CG12985 CG12985 CDMC31538 3 20 9 DAC15-C16 3-CG12985-RA_4 CG12985 GGTGCCATTCCCTTATCTGGGATGCACCACAAGACCGTCCTACCAATCTGGATGTGAAAGCATGGACG 68 FBan0012985 FBgn0030881 CG12985 X X CG12985 CG12985 CDMC31539 3 21 9 DAC15-G04 12-CG13465-RA_1 CG13465 AGAGAAGAAATCTCTTACCGGCGCCTCCACCAACCTGAAGAAGCTGCTGAAGACCATCAAGAAGGTCT 68 FBan0013465 FBgn0040809 CG13465 3 3L CG13465 CG13465 CDMC31539 3 22 9 DAC15-G04 12-CG13465-RA_1 CG13465 AGAGAAGAAATCTCTTACCGGCGCCTCCACCAACCTGAAGAAGCTGCTGAAGACCATCAAGAAGGTCT 68 FBan0013465 FBgn0040809 CG13465 3 3L CG13465 CG13465 CDMC31540 3 23 9 DAC15-G16 3-CG13601-RA_2 CG13601 AGCAGGTCAGCAAGCCGATAGCCAACGTGATTAAGTCCAATGCCAAATCGAGCCCCTTCTTCAGGAAG 68 FBan0013601 FBgn0039126 CG13601 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- membrane; GO:0016020 CG13601 CG13601 CDMC31540 3 24 9 DAC15-G16 3-CG13601-RA_2 CG13601 AGCAGGTCAGCAAGCCGATAGCCAACGTGATTAAGTCCAATGCCAAATCGAGCCCCTTCTTCAGGAAG 68 FBan0013601 FBgn0039126 CG13601 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- membrane; GO:0016020 CG13601 CG13601 CDMC31541 3 25 9 DAC15-K04 3-CG13887-RB_1 CG13887 TAGACCGTCCGTCCCGAATCCGTAGACTTAGCAGCTAATTTGGACGCATTTCTGCTTACAGGCGGCAG 68 FBan0013887 FBgn0035165 CG13887 3 3L B cell mediated immunity; GO:0019724; apoptosis; GO:0006915; defense response; GO:0006952; intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG13887 CG13887 CDMC31541 3 26 9 DAC15-K04 3-CG13887-RB_1 CG13887 TAGACCGTCCGTCCCGAATCCGTAGACTTAGCAGCTAATTTGGACGCATTTCTGCTTACAGGCGGCAG 68 FBan0013887 FBgn0035165 CG13887 3 3L B cell mediated immunity; GO:0019724; apoptosis; GO:0006915; defense response; GO:0006952; intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG13887 CG13887 CDMC31542 3 1 10 DAC15-K16 3-CG13969-RA_2 CG13969 AGAACGAGTTCGAGTTCGGGATACCCTTCATTTCGATCCGGAATCCAGGTAAGGCTCTGCGCAACACC 68 FBan0013969 FBgn0045064 bwa 2 2L brain development; GO:0007420; ceramide metabolism; GO:0006672 ceramidase activity; GO:0017040 ; EC:3.5.1.23; ; GO:0017040 ; EC:3.5.1.23 Golgi membrane; GO:0000139; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 bwa brain washing "CG13969, CG13969, CG13969, 38B.6, brain washing" CDMC31542 3 2 10 DAC15-K16 3-CG13969-RA_2 CG13969 AGAACGAGTTCGAGTTCGGGATACCCTTCATTTCGATCCGGAATCCAGGTAAGGCTCTGCGCAACACC 68 FBan0013969 FBgn0045064 bwa 2 2L brain development; GO:0007420; ceramide metabolism; GO:0006672 ceramidase activity; GO:0017040 ; EC:3.5.1.23; ; GO:0017040 ; EC:3.5.1.23 Golgi membrane; GO:0000139; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 bwa brain washing "CG13969, CG13969, CG13969, 38B.6, brain washing" CDMC31543 3 3 10 DAC15-O04 11-CG1444-RA_3 CG1444 ACCAGGAACCACTAATCTCCATCATCAACATCATGGAGGAGAACAACTCGCAAGTGCTGAGCCTGCTG 68 FBan0001444 FBgn0029975 CG1444 X X steroid metabolism; GO:0008202 steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.- CG1444 CG1444 CDMC31543 3 4 10 DAC15-O04 11-CG1444-RA_3 CG1444 ACCAGGAACCACTAATCTCCATCATCAACATCATGGAGGAGAACAACTCGCAAGTGCTGAGCCTGCTG 68 FBan0001444 FBgn0029975 CG1444 X X steroid metabolism; GO:0008202 steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.- CG1444 CG1444 CDMC31544 3 5 10 DAC15-O16 3-CG14546-RA_4 CG14546 ATCTCCCAAGACAATCCACTTCTTACAGCATGCCAGACCTTTCCGGCCGTACTTCCCCCAATCCTACG 68 FBan0014546 FBgn0039395 CG14546 3 3R CG14546 CG14546 CDMC31544 3 6 10 DAC15-O16 3-CG14546-RA_4 CG14546 ATCTCCCAAGACAATCCACTTCTTACAGCATGCCAGACCTTTCCGGCCGTACTTCCCCCAATCCTACG 68 FBan0014546 FBgn0039395 CG14546 3 3R CG14546 CG14546 CDMC31545 3 7 10 DAC16-C04 3-CG31081-RA_4 CG31081 AGGATGCCCCATCTGAAGAGTATCCAGCTGGCCAAGTAGGTTATCTGCCATCCCCTCAACAGTCC 65 FBan0031081 FBgn0051081 CG31081 3 3R CG31081 CG31081 "CG14241, CG14241" CDMC31545 3 8 10 DAC16-C04 3-CG31081-RA_4 CG31081 AGGATGCCCCATCTGAAGAGTATCCAGCTGGCCAAGTAGGTTATCTGCCATCCCCTCAACAGTCC 65 FBan0031081 FBgn0051081 CG31081 3 3R CG31081 CG31081 "CG14241, CG14241" CDMC31546 3 9 10 DAC16-C16 23-CG31125-RA_2 CG31125 GCCTTCTACATACCCTACAGTGCCTCGAAATTCAAAGCCTTCAAGTAACCTCAAACAATAAAACT 65 FBan0031125 FBgn0051125 CG31125 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31125 CG31125 BcDNA:SD02419 CDMC31546 3 10 10 DAC16-C16 23-CG31125-RA_2 CG31125 GCCTTCTACATACCCTACAGTGCCTCGAAATTCAAAGCCTTCAAGTAACCTCAAACAATAAAACT 65 FBan0031125 FBgn0051125 CG31125 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31125 CG31125 BcDNA:SD02419 CDMC31547 3 11 10 DAC16-G04 6-CG31238-RA_1 CG31238 GTGTGGCTCTTGGCTTTTAGACCCTGTTATCACGCCGGACAAGGCTATCAAGCTGGGCAAACGTG 65 FBan0031238 FBgn0051238 CG31238 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31238 CG31238 CDMC31547 3 12 10 DAC16-G04 6-CG31238-RA_1 CG31238 GTGTGGCTCTTGGCTTTTAGACCCTGTTATCACGCCGGACAAGGCTATCAAGCTGGGCAAACGTG 65 FBan0031238 FBgn0051238 CG31238 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31238 CG31238 CDMC31548 3 13 10 DAC16-G16 23-CG31270-RA_1 CG31270 GTGCGACTTGAGAAAAATATTGGATATGAAAAGCCTGGACAAAAATGTATTTACCAGCATTTCCG 65 FBan0031270 FBgn0051270 CG31270 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31270 CG31270 CDMC31548 3 14 10 DAC16-G16 23-CG31270-RA_1 CG31270 GTGCGACTTGAGAAAAATATTGGATATGAAAAGCCTGGACAAAAATGTATTTACCAGCATTTCCG 65 FBan0031270 FBgn0051270 CG31270 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31270 CG31270 CDMC31549 3 15 10 DAC16-K04 23-CG31362-RA_1 CG31362 TAAGCAGTTGATGTTCCTTAATTCTGAGGGGTTTCTTCAATAAACGATTATAGCAAGCAACTCAA 65 FBan0031362 FBgn0003357 Jon99Ciii 3 3R digestion; GO:0007586; proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon99Ciii Jonah 99Ciii "CG15519, CG31362, CG15519, CG15519, Jon99Cbetaiii, Jon99Calphaii, Jon99Cbeta, Jon99Calpha, 99Calpha, Jon99C, Jon99C2, Jon99C1, SER2, Ser2: Serine protease 2, Ser5, Serine protease 5, Ser99Db, SP143, Jonah 99C Beta, Jonah 99C Alpha, Jon99B, JonC, Serine protease 2, Jonah 99Ciii, Ser2" CDMC31549 3 16 10 DAC16-K04 23-CG31362-RA_1 CG31362 TAAGCAGTTGATGTTCCTTAATTCTGAGGGGTTTCTTCAATAAACGATTATAGCAAGCAACTCAA 65 FBan0031362 FBgn0003357 Jon99Ciii 3 3R digestion; GO:0007586; proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon99Ciii Jonah 99Ciii "CG15519, CG31362, CG15519, CG15519, Jon99Cbetaiii, Jon99Calphaii, Jon99Cbeta, Jon99Calpha, 99Calpha, Jon99C, Jon99C2, Jon99C1, SER2, Ser2: Serine protease 2, Ser5, Serine protease 5, Ser99Db, SP143, Jonah 99C Beta, Jonah 99C Alpha, Jon99B, JonC, Serine protease 2, Jonah 99Ciii, Ser2" CDMC31550 3 17 10 DAC16-K16 4-CG31412-RA_2 CG31412 CGTCTTTGGAACAAGTGGACGTTATACGATCATCGGCATCGTGGCCTTTGGACCGACGCTGTGCG 65 FBan0031412 FBgn0051412 CG31412 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG31412 CG31412 "CG12949, CG12949, SP12, c-SP12" CDMC31550 3 18 10 DAC16-K16 4-CG31412-RA_2 CG31412 CGTCTTTGGAACAAGTGGACGTTATACGATCATCGGCATCGTGGCCTTTGGACCGACGCTGTGCG 65 FBan0031412 FBgn0051412 CG31412 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG31412 CG31412 "CG12949, CG12949, SP12, c-SP12" CDMC31551 3 19 10 DAC16-O04 3-CG31537-RA_7 CG31537 CAACAAATTGCTCGGCTGATGGTTTTAGTTCCGGAGGCTCGGGGTCGAATAGCCAGCGTTCATCC 65 FBan0031537 FBgn0051537 CG31537 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31537 CG31537 CDMC31551 3 20 10 DAC16-O04 3-CG31537-RA_7 CG31537 CAACAAATTGCTCGGCTGATGGTTTTAGTTCCGGAGGCTCGGGGTCGAATAGCCAGCGTTCATCC 65 FBan0031537 FBgn0051537 CG31537 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31537 CG31537 CDMC31552 3 21 10 DAC16-O16 17-CG31559-RA_1 CG31559 AGTATGCTGACGACCAATACTACAGCTTTCACATCAACGAGCACGAGAACTTCGGTGCGAGAAGC 65 FBan0031559 FBgn0051559 CG31559 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG31559 CG31559 "CG11461, CG15584" CDMC31552 3 22 10 DAC16-O16 17-CG31559-RA_1 CG31559 AGTATGCTGACGACCAATACTACAGCTTTCACATCAACGAGCACGAGAACTTCGGTGCGAGAAGC 65 FBan0031559 FBgn0051559 CG31559 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489 CG31559 CG31559 "CG11461, CG15584" CDMC31553 3 23 10 DAC17-C04 3-CG32694-RD_3 CG32694 CAACAAACGAACGATTGGACTGCTGCGCGAACTTTTCCCCGACATCACCAAGCAAATCGACGAGC 65 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC31553 3 24 10 DAC17-C04 3-CG32694-RD_3 CG32694 CAACAAACGAACGATTGGACTGCTGCGCGAACTTTTCCCCGACATCACCAAGCAAATCGACGAGC 65 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC31554 3 25 10 DAC17-C16 23-CG32771-RA_1 CG32771 CCAAGTTTCAAGACCAATTAATCAAGAGACTGAACGAGGATGTTATGCTGCAATTATCGCACGAC 65 FBan0032771 FBgn0052771 CG32771 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG32771 CG32771 CG6952 CDMC31554 3 26 10 DAC17-C16 23-CG32771-RA_1 CG32771 CCAAGTTTCAAGACCAATTAATCAAGAGACTGAACGAGGATGTTATGCTGCAATTATCGCACGAC 65 FBan0032771 FBgn0052771 CG32771 X X transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 membrane; GO:0016020 CG32771 CG32771 CG6952 CDMC31555 3 1 11 DAC17-G04 1-CG32855-RA_1 CG32855 AAGTCACACAGTACTCTAAGCATGGGCAGGACTAGGATGCAGGTGTACCAGTCCCCGGAATTGGC 65 FBan0032855 FBgn0052855 CG32855 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32855 CG32855 CDMC31555 3 2 11 DAC17-G04 1-CG32855-RA_1 CG32855 AAGTCACACAGTACTCTAAGCATGGGCAGGACTAGGATGCAGGTGTACCAGTCCCCGGAATTGGC 65 FBan0032855 FBgn0052855 CG32855 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32855 CG32855 CDMC31556 3 3 11 DAC17-G16 5-CG32970-RA_1 CG32970 GATCGGGAATGCCAGTCTATACGCAACAGCAACACTTTATACCGCTGCGATCCACGACGACCCCG 65 FBan0032970 FBgn0052970 CG32970 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32970 CG32970 BG:DS03792.2 CDMC31556 3 4 11 DAC17-G16 5-CG32970-RA_1 CG32970 GATCGGGAATGCCAGTCTATACGCAACAGCAACACTTTATACCGCTGCGATCCACGACGACCCCG 65 FBan0032970 FBgn0052970 CG32970 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32970 CG32970 BG:DS03792.2 CDMC31557 3 5 11 DAC17-K04 2-CG33125-RA_2 CG33125 TGAGGTATTCCCAAGGAAAACAAGTAGTTGGCCGCGACAAAGTCCACGAAGCTTTCCAGGGCCAC 65 FBan0033125 FBgn0053125 CG33125 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33125 CG33125 CDMC31557 3 6 11 DAC17-K04 2-CG33125-RA_2 CG33125 TGAGGTATTCCCAAGGAAAACAAGTAGTTGGCCGCGACAAAGTCCACGAAGCTTTCCAGGGCCAC 65 FBan0033125 FBgn0053125 CG33125 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33125 CG33125 CDMC31558 3 7 11 DAC17-K16 2-CG33157-RA_1 CG33157 TCGGAGGAGGTCCAAATGGACAATGTGGCTCTGACTGGCATGAAATTCTTTCGGCTAACACGCGG 65 FBgn0053157 CDMC31558 3 8 11 DAC17-K16 2-CG33157-RA_1 CG33157 TCGGAGGAGGTCCAAATGGACAATGTGGCTCTGACTGGCATGAAATTCTTTCGGCTAACACGCGG 65 FBgn0053157 CDMC31559 3 9 11 DAC17-O04 23-CG33255-RA_1 CG33255 CATTGGTTTATAAAGCGCTAGTTCTTCTCATTCCAAATGTGATTCTTCCCAGCATATTGAGATGA 65 FBan0033255 FBgn0053255 CG33255 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33255 CG33255 CDMC31559 3 10 11 DAC17-O04 23-CG33255-RA_1 CG33255 CATTGGTTTATAAAGCGCTAGTTCTTCTCATTCCAAATGTGATTCTTCCCAGCATATTGAGATGA 65 FBan0033255 FBgn0053255 CG33255 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33255 CG33255 CDMC31560 3 11 11 DAC17-O16 3-CG33273-RA_3 CG33273 GACATGCTGAGGGTTGCCTGTCCCAATGGATTCAATTCAATGTTCGCCAAACGAGGCACCTTGGG 65 FBgn0053273 CDMC31560 3 12 11 DAC17-O16 3-CG33273-RA_3 CG33273 GACATGCTGAGGGTTGCCTGTCCCAATGGATTCAATTCAATGTTCGCCAAACGAGGCACCTTGGG 65 FBgn0053273 CDMC31561 3 13 11 DAC18-C04 3-CG5955-RA_4 CG5955 CCGACATCCTGGACTTCAAGGGTCTCCAGAAGATCGTTGTGGACCATCGCATTGACTGGCTGATCCAT 68 FBan0005955 FBgn0036997 CG5955 3 3L UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG5955 CG5955 CDMC31561 3 14 11 DAC18-C04 3-CG5955-RA_4 CG5955 CCGACATCCTGGACTTCAAGGGTCTCCAGAAGATCGTTGTGGACCATCGCATTGACTGGCTGATCCAT 68 FBan0005955 FBgn0036997 CG5955 3 3L UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG5955 CG5955 CDMC31562 3 15 11 DAC18-C16 12-CG6016-RA_2 CG6016 ACGTTTAAGTCCTGTAACCACCCATTGGCAATCGATCCATCCCACGAAAGACAGCAGATCAAGTGCGA 68 FBan0006016 FBgn0033844 CG6016 2 2R phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 ethanolaminephosphotransferase activity; GO:0004307 ; EC:2.7.8.1; ; GO:0004307 ; EC:2.7.8.1 CG6016 CG6016 CDMC31562 3 16 11 DAC18-C16 12-CG6016-RA_2 CG6016 ACGTTTAAGTCCTGTAACCACCCATTGGCAATCGATCCATCCCACGAAAGACAGCAGATCAAGTGCGA 68 FBan0006016 FBgn0033844 CG6016 2 2R phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 ethanolaminephosphotransferase activity; GO:0004307 ; EC:2.7.8.1; ; GO:0004307 ; EC:2.7.8.1 CG6016 CG6016 CDMC31563 3 17 11 DAC18-G04 3-CG6538-RA_1 CG6538 GCCGGATAACGAAAAGTTGTATATGGAGGGCAGGATTGTGCAAAAGCTAGAGTGCCGACCCATCGCCG 68 FBan0006538 FBgn0010421 TfIIFbeta 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIIF complex; GO:0005674 TfIIFbeta Transcription factor TFIIFbeta "CG6538, CG6538, TFIIF, factor 5, TfIIF, l(3)j3C1, dTFIIF30, TFIIFbeta, RAP30, TfIIFbeta, TFIIF small subunit, F[[S]]" CDMC31563 3 18 11 DAC18-G04 3-CG6538-RA_1 CG6538 GCCGGATAACGAAAAGTTGTATATGGAGGGCAGGATTGTGCAAAAGCTAGAGTGCCGACCCATCGCCG 68 FBan0006538 FBgn0010421 TfIIFbeta 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; transcription initiation factor activity; GO:0016986; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0016986 nucleus; GO:0005634; transcription factor TFIIF complex; GO:0005674 TfIIFbeta Transcription factor TFIIFbeta "CG6538, CG6538, TFIIF, factor 5, TfIIF, l(3)j3C1, dTFIIF30, TFIIFbeta, RAP30, TfIIFbeta, TFIIF small subunit, F[[S]]" CDMC31564 3 19 11 DAC18-G16 3-CG6643-RA_4 CG6643 CTTCGCGATCCCAGCAATATCCCCGATCCGTATGTTAAGCTGTATCTGTTGCCTGGACGCACCAAGGA 68 FBan0006643 FBgn0039208 CG6643 3 3R CG6643 CG6643 CDMC31564 3 20 11 DAC18-G16 3-CG6643-RA_4 CG6643 CTTCGCGATCCCAGCAATATCCCCGATCCGTATGTTAAGCTGTATCTGTTGCCTGGACGCACCAAGGA 68 FBan0006643 FBgn0039208 CG6643 3 3R CG6643 CG6643 CDMC31565 3 21 11 DAC18-K04 3-CG7031-RA_1 CG7031 CCGTGGAGAAACACATCCCAGTACCGGTGGAGAAGCATGTGCCCTATCATGTGGTCAAATATGTGCCC 68 FBan0007031 FBgn0039027 CG7031 3 3R CG7031 CG7031 CDMC31565 3 22 11 DAC18-K04 3-CG7031-RA_1 CG7031 CCGTGGAGAAACACATCCCAGTACCGGTGGAGAAGCATGTGCCCTATCATGTGGTCAAATATGTGCCC 68 FBan0007031 FBgn0039027 CG7031 3 3R CG7031 CG7031 CDMC31566 3 23 11 DAC18-K16 12-CG7145-RA_6 CG7145 AGCATTTAAACGCATTACGGGCTACATTGAGCATGCCAAAAAATCCCCGAACCTCGAGATTCTCGCCG 68 FBan0007145 FBgn0037138 CG7145 3 3L amino acid catabolism; GO:0009063; proline biosynthesis; GO:0006561; proline metabolism; GO:0006560 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG7145 CG7145 CDMC31566 3 24 11 DAC18-K16 12-CG7145-RA_6 CG7145 AGCATTTAAACGCATTACGGGCTACATTGAGCATGCCAAAAAATCCCCGAACCTCGAGATTCTCGCCG 68 FBan0007145 FBgn0037138 CG7145 3 3L amino acid catabolism; GO:0009063; proline biosynthesis; GO:0006561; proline metabolism; GO:0006560 1-pyrroline-5-carboxylate dehydrogenase activity; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12; ; GO:0003842 ; EC:1.5.1.12 mitochondrial matrix; GO:0005759 CG7145 CG7145 CDMC31567 3 25 11 DAC18-O04 15-CG7484-RB_1 CG7484 CCCCAACCTGCAGATCAAATACGTAAGAGGACTGGATCCCGTGGTTAAGCTCCTAGATGCCAGTGGCA 68 FBan0007484 FBgn0036745 CG7484 3 3L CG7484 CG7484 BcDNA:SD16138 CDMC31567 3 26 11 DAC18-O04 15-CG7484-RB_1 CG7484 CCCCAACCTGCAGATCAAATACGTAAGAGGACTGGATCCCGTGGTTAAGCTCCTAGATGCCAGTGGCA 68 FBan0007484 FBgn0036745 CG7484 3 3L CG7484 CG7484 BcDNA:SD16138 CDMC31568 3 1 12 DAC18-O16 12-CG7665-RB_4 CG7665 AGCATTTGCCTTCCGATGGAAAATCGCGATGTGTACGACACCATTTACCTGATTGCCATTCTGGGCTC 68 FBan0007665 FBgn0016650 Fsh 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021 Fsh Fsh-Tsh-like receptor "CG7665, FSH-TSH, TSH, FSH, LH/CG receptor, DLGR-1, Fsh/CG7665, DLGR1" CDMC31568 3 2 12 DAC18-O16 12-CG7665-RB_4 CG7665 AGCATTTGCCTTCCGATGGAAAATCGCGATGTGTACGACACCATTTACCTGATTGCCATTCTGGGCTC 68 FBan0007665 FBgn0016650 Fsh 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021 Fsh Fsh-Tsh-like receptor "CG7665, FSH-TSH, TSH, FSH, LH/CG receptor, DLGR-1, Fsh/CG7665, DLGR1" CDMC31569 3 3 12 DAC19-C04 13-CG17800-RE_2 CG17800 CCACGACATGAGCAACTCCTCATTCAACGACTCCAAGGAGAGTAATGAGATCTCAGAGGCAGAGTGCGA 69 FBan0017800 FBgn0033159 Dscam 2 2R amino acid metabolism; GO:0006520; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell proliferation; GO:0008283; ectoderm development; GO:0007398; peripheral nervous system development; GO:0007422 axon guidance receptor activity; GO:0008046; ; GO:0008046 integral to plasma membrane; GO:0005887 Dscam Down syndrome cell adhesion molecule "CG17800, l(2)43Bc, 43Bc, p270, CT39257, Dscam1, Neu1, FBgn0033159, l(2)05518, lethal(2)43Bc, Down syndrome cell adhesion molecule" CDMC31569 3 4 12 DAC19-C04 13-CG17800-RE_2 CG17800 CCACGACATGAGCAACTCCTCATTCAACGACTCCAAGGAGAGTAATGAGATCTCAGAGGCAGAGTGCGA 69 FBan0017800 FBgn0033159 Dscam 2 2R amino acid metabolism; GO:0006520; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell proliferation; GO:0008283; ectoderm development; GO:0007398; peripheral nervous system development; GO:0007422 axon guidance receptor activity; GO:0008046; ; GO:0008046 integral to plasma membrane; GO:0005887 Dscam Down syndrome cell adhesion molecule "CG17800, l(2)43Bc, 43Bc, p270, CT39257, Dscam1, Neu1, FBgn0033159, l(2)05518, lethal(2)43Bc, Down syndrome cell adhesion molecule" CDMC31570 3 5 12 DAC19-C16 17-CG17816-RA_1 CG17816 GCCAAATCAGCATTAAGCGCTAATCAGGCTCATGCTAATCAATCACAATCATCACATGCCAAGAGCGGT 69 FBan0017816 FBgn0037525 CG17816 3 3R CG17816 CG17816 CDMC31570 3 6 12 DAC19-C16 17-CG17816-RA_1 CG17816 GCCAAATCAGCATTAAGCGCTAATCAGGCTCATGCTAATCAATCACAATCATCACATGCCAAGAGCGGT 69 FBan0017816 FBgn0037525 CG17816 3 3R CG17816 CG17816 CDMC31571 3 7 12 DAC19-G04 8-CG17870-RA_1 CG17870 ACTGGCGTTGAGCTCTCAAATGAGGAAAGAAATCTGCTCTCCGTTGCCTACAAAAATGTGGTCGGTGCC 69 FBan0017870 FBgn0004907 14-3-3zeta 2 2R "Ras protein signal transduction; GO:0007265; cell proliferation; GO:0008283; chromosome segregation; GO:0007059; learning and/or memory; GO:0007611; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic cell cycle, embryonic; GO:0045448; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of progression through cell cycle; GO:0000074; tryptophan hydroxylase activation; GO:0006588" protein kinase C inhibitor activity; GO:0008426; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0008426; tryptophan hydroxylase activator activity; GO:0016483; ; GO:0004863; ; GO:0016483; protein domain specific binding; GO:0019904; ; GO:0019904 nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3zeta 14-3-3zeta "CG17870, CG17870, 549, 2G1, 5.11, leonardo, leo: leonardo, D14-3-3zeta, K, Complementation group K, 14-3-3, 14-3-3zeta, Leonardo-13-3-3, leonardo 14-3-3, 4-3-3 zeta, par-5, Par-5, PAR5, d14-3-3zeta, l(2)46CFe, l(2)46Ee, D14-3-3: D14 3 3 protein, l(2)07103, BEST:GH05075, D14 3 3 protein, leo" CDMC31571 3 8 12 DAC19-G04 8-CG17870-RA_1 CG17870 ACTGGCGTTGAGCTCTCAAATGAGGAAAGAAATCTGCTCTCCGTTGCCTACAAAAATGTGGTCGGTGCC 69 FBan0017870 FBgn0004907 14-3-3zeta 2 2R "Ras protein signal transduction; GO:0007265; cell proliferation; GO:0008283; chromosome segregation; GO:0007059; learning and/or memory; GO:0007611; maintenance of oocyte identity (sensu Insecta); GO:0016350; mitotic cell cycle, embryonic; GO:0045448; olfactory learning; GO:0008355; oocyte microtubule cytoskeleton polarization (sensu Insecta); GO:0048129; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of progression through cell cycle; GO:0000074; tryptophan hydroxylase activation; GO:0006588" protein kinase C inhibitor activity; GO:0008426; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; diacylglycerol-activated phospholipid-dependent protein kinase C inhibitor activity; GO:0004863; ; GO:0008426; tryptophan hydroxylase activator activity; GO:0016483; ; GO:0004863; ; GO:0016483; protein domain specific binding; GO:0019904; ; GO:0019904 nucleus; GO:0005634; ring canal (sensu Insecta); GO:0045172 14-3-3zeta 14-3-3zeta "CG17870, CG17870, 549, 2G1, 5.11, leonardo, leo: leonardo, D14-3-3zeta, K, Complementation group K, 14-3-3, 14-3-3zeta, Leonardo-13-3-3, leonardo 14-3-3, 4-3-3 zeta, par-5, Par-5, PAR5, d14-3-3zeta, l(2)46CFe, l(2)46Ee, D14-3-3: D14 3 3 protein, l(2)07103, BEST:GH05075, D14 3 3 protein, leo" CDMC31572 3 9 12 DAC19-G16 23-CG17888-RC_4 CG17888 TCAAGACAGAGTTAAAGAAATAAACCTAAAGCCGTAACCGAAATCGAAACTAACCCTAACGATAGACGC 69 FBan0017888 FBgn0016694 Pdp1 3 3L circadian rhythm; GO:0007623; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein homodimerization activity; GO:0042803; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 Pdp1 PAR-domain protein 1 "CG17888, CG17888, PDP1, pdp1, PAR-Domain Protein 1, Pdp1epsilon, anon-WO0140519.206" CDMC31572 3 10 12 DAC19-G16 23-CG17888-RC_4 CG17888 TCAAGACAGAGTTAAAGAAATAAACCTAAAGCCGTAACCGAAATCGAAACTAACCCTAACGATAGACGC 69 FBan0017888 FBgn0016694 Pdp1 3 3L circadian rhythm; GO:0007623; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein homodimerization activity; GO:0042803; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 Pdp1 PAR-domain protein 1 "CG17888, CG17888, PDP1, pdp1, PAR-Domain Protein 1, Pdp1epsilon, anon-WO0140519.206" CDMC31573 3 11 12 DAC19-K04 23-CG17931-RA_4 CG17931 TACATGAAGCAACATACATAATTCACGAGAATTGTATACAACTACGCATAGATATTACCGGGCTGTACA 69 FBan0017931 FBgn0038421 CG17931 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17931 CG17931 BcDNA:AT19233 CDMC31573 3 12 12 DAC19-K04 23-CG17931-RA_4 CG17931 TACATGAAGCAACATACATAATTCACGAGAATTGTATACAACTACGCATAGATATTACCGGGCTGTACA 69 FBan0017931 FBgn0038421 CG17931 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17931 CG17931 BcDNA:AT19233 CDMC31574 3 13 12 DAC19-K16 3-CG17944-RB_2 CG17944 CGACGGCAGCAAATCAACGTCCCCGAACATCAACGTCCCGACGATTGAAGTTTCTGAGAAAAATGGCGT 69 FBan0017944 FBgn0037500 CG17944 3 3R CG17944 CG17944 CDMC31574 3 14 12 DAC19-K16 3-CG17944-RB_2 CG17944 CGACGGCAGCAAATCAACGTCCCCGAACATCAACGTCCCGACGATTGAAGTTTCTGAGAAAAATGGCGT 69 FBan0017944 FBgn0037500 CG17944 3 3R CG17944 CG17944 CDMC31575 3 15 12 DAC19-O04 3-CG17998-RA_1 CG17998 CGTAGACGTCGACACATAGCACAAATTGCGCACAGTTACCCCGGATCGGAAGAGTTCAGCAGGAGCATA 69 FBan0017998 FBgn0004834 Gprk2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; protein amino acid phosphorylation; GO:0006468; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; regulator of G-protein signaling activity; GO:0016299; ; GO:0004703 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; ; GO:0016299 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Gprk2 G protein-coupled receptor kinase 2 "CG17998, CG17998, Gprk-2, gprk2" CDMC31575 3 16 12 DAC19-O04 3-CG17998-RA_1 CG17998 CGTAGACGTCGACACATAGCACAAATTGCGCACAGTTACCCCGGATCGGAAGAGTTCAGCAGGAGCATA 69 FBan0017998 FBgn0004834 Gprk2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; protein amino acid phosphorylation; GO:0006468; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; regulator of G-protein signaling activity; GO:0016299; ; GO:0004703 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004703 ; EC:2.7.1.-; ; GO:0016299 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Gprk2 G protein-coupled receptor kinase 2 "CG17998, CG17998, Gprk-2, gprk2" CDMC31576 3 17 12 DAC19-O16 15-CG1800-RA_1 CG1800 TCCTCCGGGTCCAATTTGAACAACGTGGAACTTTGATTGGGAAACACACATCTCTCTCGCCAACATTGA 69 FBan0001800 FBgn0039861 pasha 3 3R primary microRNA processing; GO:0031053 double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 pasha partner of drosha "CG1800, CG1800, CG1800, CG1800, cg1800, Pasha, dmDGCR8, partner of drosha" CDMC31576 3 18 12 DAC19-O16 15-CG1800-RA_1 CG1800 TCCTCCGGGTCCAATTTGAACAACGTGGAACTTTGATTGGGAAACACACATCTCTCTCGCCAACATTGA 69 FBan0001800 FBgn0039861 pasha 3 3R primary microRNA processing; GO:0031053 double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 pasha partner of drosha "CG1800, CG1800, CG1800, CG1800, cg1800, Pasha, dmDGCR8, partner of drosha" CDMC31577 3 19 12 DAC20-C04 2-CG10667-RA_2 CG10667 GTGCCGAGAACGGGAATTCGAGAACATTTACGCCTTTCTGGAGGGCAAGATCCAGGATCAGTGCG 65 FBan0010667 FBgn0022772 Orc1 2 2R DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634 Orc1 Origin recognition complex subunit 1 "CG10667, DmORC1, ORC, ORC1, dORC1, rDmORC" CDMC31577 3 20 12 DAC20-C04 2-CG10667-RA_2 CG10667 GTGCCGAGAACGGGAATTCGAGAACATTTACGCCTTTCTGGAGGGCAAGATCCAGGATCAGTGCG 65 FBan0010667 FBgn0022772 Orc1 2 2R DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chromatin silencing; GO:0006342; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634 Orc1 Origin recognition complex subunit 1 "CG10667, DmORC1, ORC, ORC1, dORC1, rDmORC" CDMC31578 3 21 12 DAC20-C16 24-CG10704-RA_1 CG10704 AATTTAGTGCAATTTTTACATAATTTATTCAGTTTCTATCACTGCAAACAAAACTTCTAACCGCG 65 FBan0010704 FBgn0036285 toe 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 toe twin of eyg "CG10704, CG10704, twin of eyegone, anon-WO0172774.89, twin of eyg" CDMC31578 3 22 12 DAC20-C16 24-CG10704-RA_1 CG10704 AATTTAGTGCAATTTTTACATAATTTATTCAGTTTCTATCACTGCAAACAAAACTTCTAACCGCG 65 FBan0010704 FBgn0036285 toe 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 toe twin of eyg "CG10704, CG10704, twin of eyegone, anon-WO0172774.89, twin of eyg" CDMC31579 3 23 12 DAC20-G04 3-CG10823-RB_1 CG10823 AGCTCCTTGGGCTCATCGAGTGCCATTAAACTGAATAACAGCGCCATTACGGACACTCTGCTGGG 65 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC31579 3 24 12 DAC20-G04 3-CG10823-RB_1 CG10823 AGCTCCTTGGGCTCATCGAGTGCCATTAAACTGAATAACAGCGCCATTACGGACACTCTGCTGGG 65 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC31580 3 25 12 DAC20-G16 18-CG10863-RA_6 CG10863 ACTGTGGAACGGTCAAGATGTCCAGCAAAATTCCCTACGTAAAGCACAACAACGGCACCCAAATC 65 FBan0010863 FBgn0027552 CG10863 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10863 CG10863 BcDNA:GH10614 CDMC31580 3 26 12 DAC20-G16 18-CG10863-RA_6 CG10863 ACTGTGGAACGGTCAAGATGTCCAGCAAAATTCCCTACGTAAAGCACAACAACGGCACCCAAATC 65 FBan0010863 FBgn0027552 CG10863 3 3L aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10863 CG10863 BcDNA:GH10614 CDMC31581 3 1 13 DAC20-K04 24-CG10944-RB_2 CG10944 TGATCACAACCAAATGATCCACGAGAGGAGAAATAAAACTTTGTAACCATTTATGTTAAATAAAC 65 FBan0010944 FBgn0004922 RpS6 X X immune response; GO:0006955; protein biosynthesis; GO:0006412; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS6 Ribosomal protein S6 "CG10944, CG10944, CG10944, CG10944, l(1)air8: lethal-aberrant-immune-response-8, S6, hen: hemocytes enlarged, rpS6, air8, l(1)air[8], air[8], pp30, ribosomal protein S6, rps6, DS6, lethal(1)abberant immune response[8], anon-WO02059370.61, l(1)hen: lethal-(1)-haemocytes enlarged, hemocytes enlarged, lethal-aberrant-immune-response-8, lethal-(1)-haemocytes enlarged, l(1)air8, hen" CDMC31581 3 2 13 DAC20-K04 24-CG10944-RB_2 CG10944 TGATCACAACCAAATGATCCACGAGAGGAGAAATAAAACTTTGTAACCATTTATGTTAAATAAAC 65 FBan0010944 FBgn0004922 RpS6 X X immune response; GO:0006955; protein biosynthesis; GO:0006412; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS6 Ribosomal protein S6 "CG10944, CG10944, CG10944, CG10944, l(1)air8: lethal-aberrant-immune-response-8, S6, hen: hemocytes enlarged, rpS6, air8, l(1)air[8], air[8], pp30, ribosomal protein S6, rps6, DS6, lethal(1)abberant immune response[8], anon-WO02059370.61, l(1)hen: lethal-(1)-haemocytes enlarged, hemocytes enlarged, lethal-aberrant-immune-response-8, lethal-(1)-haemocytes enlarged, l(1)air8, hen" CDMC31582 3 3 13 DAC20-K16 2-CG10979-RA_1 CG10979 CAAGGACTTCGTCTACGACTTGGTCAGTTTCAAACCGGATGGATCATGCCAGCAACCTCCGGGTG 65 FBan0010979 FBgn0037379 CG10979 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10979 CG10979 CDMC31582 3 4 13 DAC20-K16 2-CG10979-RA_1 CG10979 CAAGGACTTCGTCTACGACTTGGTCAGTTTCAAACCGGATGGATCATGCCAGCAACCTCCGGGTG 65 FBan0010979 FBgn0037379 CG10979 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10979 CG10979 CDMC31583 3 5 13 DAC20-O04 3-CG11109-RA_4 CG11109 TACTGCTTGCCAAACCTACCCGAGATGTTGTGCATTGATCCGCTGGACTCACAGCTCACCAAAGC 65 FBan0011109 FBgn0037200 CG11109 3 3L rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; ; GO:0003676; ; GO:0003729; ; GO:0008649 ; EC:2.1.1.- nucleolus; GO:0005730 CG11109 CG11109 CT31087 CDMC31583 3 6 13 DAC20-O04 3-CG11109-RA_4 CG11109 TACTGCTTGCCAAACCTACCCGAGATGTTGTGCATTGATCCGCTGGACTCACAGCTCACCAAAGC 65 FBan0011109 FBgn0037200 CG11109 3 3L rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; ; GO:0003676; ; GO:0003729; ; GO:0008649 ; EC:2.1.1.- nucleolus; GO:0005730 CG11109 CG11109 CT31087 CDMC31584 3 7 13 DAC20-O16 15-CG11143-RA_1 CG11143 CCGTGGAATCGGTCACCAATGGAAAGAAGCTCCATGCCAATGGACACTCCAATGGGTCCGCCAAG 65 FBan0011143 FBgn0025885 Inos 2 2R myo-inositol biosynthesis; GO:0006021; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 inositol-3-phosphate synthase activity; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0016849 ; EC:4.6.-.-; ; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4 cytoplasm; GO:0005737 Inos Inos "CG11143, CG11143, INOS, bs36h12.y1, myo-inositol-1-phosphate-synthase" CDMC31584 3 8 13 DAC20-O16 15-CG11143-RA_1 CG11143 CCGTGGAATCGGTCACCAATGGAAAGAAGCTCCATGCCAATGGACACTCCAATGGGTCCGCCAAG 65 FBan0011143 FBgn0025885 Inos 2 2R myo-inositol biosynthesis; GO:0006021; phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 inositol-3-phosphate synthase activity; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0016849 ; EC:4.6.-.-; ; GO:0004512 ; EC:5.5.1.4; ; GO:0004512 ; EC:5.5.1.4 cytoplasm; GO:0005737 Inos Inos "CG11143, CG11143, INOS, bs36h12.y1, myo-inositol-1-phosphate-synthase" CDMC31585 3 9 13 DAC21-C04 23-CG11233-RA_1 CG11233 TTGATTGATTATGCGAACTGTCTGCGCGAACTTGTAACTAGATTAATGAACTTTTTGCAGTGGAT 65 FBgn0031136 CDMC31585 3 10 13 DAC21-C04 23-CG11233-RA_1 CG11233 TTGATTGATTATGCGAACTGTCTGCGCGAACTTGTAACTAGATTAATGAACTTTTTGCAGTGGAT 65 FBgn0031136 CDMC31586 3 11 13 DAC21-C16 2-CG11276-RA_1 CG11276 GAGCGTCATCCCGGTTCCTTCGACATTGTGCACATTAAGGACTCGCAAGGTCATGTGTTCGCCAC 65 FBan0011276 FBgn0011284 RpS4 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS4 Ribosomal protein S4 "CG11276, RPS4, rpS4, SX4, anon-EST:Posey270" CDMC31586 3 12 13 DAC21-C16 2-CG11276-RA_1 CG11276 GAGCGTCATCCCGGTTCCTTCGACATTGTGCACATTAAGGACTCGCAAGGTCATGTGTTCGCCAC 65 FBan0011276 FBgn0011284 RpS4 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS4 Ribosomal protein S4 "CG11276, RPS4, rpS4, SX4, anon-EST:Posey270" CDMC31587 3 13 13 DAC21-G04 2-CG11407-RA_1 CG11407 ATCGGATCAGGAGTCGCCTAAGCAAGGACTGCCTACACTTTGCCTACGGCTTTACAGAACTGGGC 65 FBan0011407 FBgn0038733 CG11407 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11407 CG11407 CDMC31587 3 14 13 DAC21-G04 2-CG11407-RA_1 CG11407 ATCGGATCAGGAGTCGCCTAAGCAAGGACTGCCTACACTTTGCCTACGGCTTTACAGAACTGGGC 65 FBan0011407 FBgn0038733 CG11407 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11407 CG11407 CDMC31588 3 15 13 DAC21-G16 2-CG11454-RA_1 CG11454 CAAGCAGCTACCTGCCTACAACCAAAGTCGTCTGCGCAATCAGTTCATGATGGAGGCTCTACCGC 65 FBan0011454 FBgn0031224 CG11454 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG11454 CG11454 cg11454 CDMC31588 3 16 13 DAC21-G16 2-CG11454-RA_1 CG11454 CAAGCAGCTACCTGCCTACAACCAAAGTCGTCTGCGCAATCAGTTCATGATGGAGGCTCTACCGC 65 FBan0011454 FBgn0031224 CG11454 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG11454 CG11454 cg11454 CDMC31589 3 17 13 DAC21-K04 1-CG11576-RA_1 CG11576 CAGCCTGGACTTTGCTGGTAGGGATTGTGAGCTACACGAAACTGGGAATCACCACGGTTATGCGG 65 FBan0011576 FBgn0039882 CG11576 3 3R CG11576 CG11576 CDMC31589 3 18 13 DAC21-K04 1-CG11576-RA_1 CG11576 CAGCCTGGACTTTGCTGGTAGGGATTGTGAGCTACACGAAACTGGGAATCACCACGGTTATGCGG 65 FBan0011576 FBgn0039882 CG11576 3 3R CG11576 CG11576 CDMC31590 3 19 13 DAC21-K16 3-CG11597-RA_1 CG11597 GATCCTATGGATTCTACGAGGAGTGCCTTTCGCGGTACGGCTCTGCGAATGTCTGGAGGATGTGC 65 FBan0011597 FBgn0036212 CG11597 3 3L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A activity; GO:0000158; ; GO:0000158 protein phosphatase type 2A complex; GO:0000159 CG11597 CG11597 PP4-like CDMC31590 3 20 13 DAC21-K16 3-CG11597-RA_1 CG11597 GATCCTATGGATTCTACGAGGAGTGCCTTTCGCGGTACGGCTCTGCGAATGTCTGGAGGATGTGC 65 FBan0011597 FBgn0036212 CG11597 3 3L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A activity; GO:0000158; ; GO:0000158 protein phosphatase type 2A complex; GO:0000159 CG11597 CG11597 PP4-like CDMC31591 3 21 13 DAC21-O04 5-CG11694-RA_1 CG11694 GTGCCCCGTGCGACTTCAAGATGAATGGAAAGACCAGGGTAAAGGCCTCATGCATTGCGCAGAAG 65 FBan0011694 FBgn0037571 CG11694 3 3R CG11694 CG11694 CDMC31591 3 22 13 DAC21-O04 5-CG11694-RA_1 CG11694 GTGCCCCGTGCGACTTCAAGATGAATGGAAAGACCAGGGTAAAGGCCTCATGCATTGCGCAGAAG 65 FBan0011694 FBgn0037571 CG11694 3 3R CG11694 CG11694 CDMC31592 3 23 13 DAC21-O16 2-CG1171-RA_1 CG1171 AAATGCTGCTCGAGATCTTCCGCTTCGTGCAATCTCAGGCACAGCTCTTTCTGGACTGCAAGCAC 65 FBan0001171 FBgn0004552 Akh 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005179; ; GO:0005184 Akh Adipokinetic hormone-like "CG1171, adipokinetic hormone, Drm-AKH, AKH, dAkh, akh, Hrth: Hypertrehaloseaemic-hormone, Hypertrehaloseaemic-hormone" CDMC31592 3 24 13 DAC21-O16 2-CG1171-RA_1 CG1171 AAATGCTGCTCGAGATCTTCCGCTTCGTGCAATCTCAGGCACAGCTCTTTCTGGACTGCAAGCAC 65 FBan0001171 FBgn0004552 Akh 3 3L neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; hormone activity; GO:0005179; ; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005179; ; GO:0005184 Akh Adipokinetic hormone-like "CG1171, adipokinetic hormone, Drm-AKH, AKH, dAkh, akh, Hrth: Hypertrehaloseaemic-hormone, Hypertrehaloseaemic-hormone" CDMC31593 3 25 13 DAC22-C04 3-CG31668-RA_1 CG31668 TCCCAACGACTTCCGGTCTCTGTGGAAGGATGCTTGGCCAATGCTAGTGTTGCTGAAAACGCTTG 65 FBan0031668 FBgn0051668 CG31668 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 cation transporter activity; GO:0008324; transporter activity; GO:0005215; ; GO:0008324; ; GO:0005215 membrane; GO:0016020 CG31668 CG31668 CG10879 CDMC31593 3 26 13 DAC22-C04 3-CG31668-RA_1 CG31668 TCCCAACGACTTCCGGTCTCTGTGGAAGGATGCTTGGCCAATGCTAGTGTTGCTGAAAACGCTTG 65 FBan0031668 FBgn0051668 CG31668 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 cation transporter activity; GO:0008324; transporter activity; GO:0005215; ; GO:0008324; ; GO:0005215 membrane; GO:0016020 CG31668 CG31668 CG10879 CDMC31594 3 1 14 DAC22-C16 23-CG31699-RA_1 CG31699 ATTAGACAGGGCTCTTAGGTTCTACGGTACAGCCAATTCTACGATTATGATTCAGCACTTTCTGC 65 FBan0031699 FBgn0051699 CG31699 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31699 CG31699 CDMC31594 3 2 14 DAC22-C16 23-CG31699-RA_1 CG31699 ATTAGACAGGGCTCTTAGGTTCTACGGTACAGCCAATTCTACGATTATGATTCAGCACTTTCTGC 65 FBan0031699 FBgn0051699 CG31699 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31699 CG31699 CDMC31595 3 3 14 DAC22-G04 14-CG31786-RA_1 CG31786 AAAGAAGCGCAGAGTGAAATCAGGACGATGACGGAGCTAAGACGAACTAATGGCCTGCACAAGCA 65 FBan0031786 FBgn0051786 CG31786 2 2L CG31786 CG31786 "CG15158, CG15158, CG15158" CDMC31595 3 4 14 DAC22-G04 14-CG31786-RA_1 CG31786 AAAGAAGCGCAGAGTGAAATCAGGACGATGACGGAGCTAAGACGAACTAATGGCCTGCACAAGCA 65 FBan0031786 FBgn0051786 CG31786 2 2L CG31786 CG31786 "CG15158, CG15158, CG15158" CDMC31596 3 5 14 DAC22-G16 18-CG31818-RA_1 CG31818 AGGTGCCAATTTGTATCTCAACTGGAAAGGCGAATACCTGTCGCTGTTGCAAATGTGCTCCATCT 65 FBan0031818 FBgn0051818 CG31818 2 2L CG31818 CG31818 "CG18115, CG18115, BG:DS02740.19, DS02740.19" CDMC31596 3 6 14 DAC22-G16 18-CG31818-RA_1 CG31818 AGGTGCCAATTTGTATCTCAACTGGAAAGGCGAATACCTGTCGCTGTTGCAAATGTGCTCCATCT 65 FBan0031818 FBgn0051818 CG31818 2 2L CG31818 CG31818 "CG18115, CG18115, BG:DS02740.19, DS02740.19" CDMC31597 3 7 14 DAC22-K04 18-CG31950-RA_1 CG31950 GACGCAGGAAGCTCCAGAAGTGGCTGGGTCGAGTTCTTCGGATCGTGATTACGGACGGACGCGTG 65 FBan0031950 FBgn0051950 CG31950 2 2L small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 CG31950 CG31950 CDMC31597 3 8 14 DAC22-K04 18-CG31950-RA_1 CG31950 GACGCAGGAAGCTCCAGAAGTGGCTGGGTCGAGTTCTTCGGATCGTGATTACGGACGGACGCGTG 65 FBan0031950 FBgn0051950 CG31950 2 2L small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 CG31950 CG31950 CDMC31598 3 9 14 DAC22-K16 6-CG3200-RA_2 CG3200 GCTTTCGCCTCATAACCTTCGATGTGACCAACACTCTGCTCCAATTCCGAACCACTCCCGGCAAG 65 FBan0003200 FBgn0016715 Reg-2 3 3L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 Reg-2 Rhythmically expressed gene 2 "CG3200, CG3200, CG3200, Dreg-2, Drosophila Rhythmically expressed gene 2, rhythmically expressed gene 2" CDMC31598 3 10 14 DAC22-K16 6-CG3200-RA_2 CG3200 GCTTTCGCCTCATAACCTTCGATGTGACCAACACTCTGCTCCAATTCCGAACCACTCCCGGCAAG 65 FBan0003200 FBgn0016715 Reg-2 3 3L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 Reg-2 Rhythmically expressed gene 2 "CG3200, CG3200, CG3200, Dreg-2, Drosophila Rhythmically expressed gene 2, rhythmically expressed gene 2" CDMC31599 3 11 14 DAC22-O04 3-CG32121-RA_3 CG32121 CGCTCTCGGCCAAGGTCAACTCTATAGTAGCAAGCCACCACTTTATAGTGCAGCAGTCACGCCGA 65 FBan0032121 FBgn0052121 CG32121 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG32121 CG32121 CDMC31599 3 12 14 DAC22-O04 3-CG32121-RA_3 CG32121 CGCTCTCGGCCAAGGTCAACTCTATAGTAGCAAGCCACCACTTTATAGTGCAGCAGTCACGCCGA 65 FBan0032121 FBgn0052121 CG32121 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG32121 CG32121 CDMC31600 3 13 14 DAC22-O16 21-CG32149-RC_1 CG32149 ACAGCAGGAGCAACACTATGACGATATGATGGACACGGAGGATAGCTACGGACAGCAGAAGGAGC 65 FBan0032149 FBgn0036518 RhoGAP71E 3 3L metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 RhoGAP71E RhoGAP71E "CG7396, CG16980, CG32149, CG7396, CG16980, l(3)j6B9, RhoGAP-71E1, BcDNA:LD07615" CDMC31600 3 14 14 DAC22-O16 21-CG32149-RC_1 CG32149 ACAGCAGGAGCAACACTATGACGATATGATGGACACGGAGGATAGCTACGGACAGCAGAAGGAGC 65 FBan0032149 FBgn0036518 RhoGAP71E 3 3L metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 RhoGAP71E RhoGAP71E "CG7396, CG16980, CG32149, CG7396, CG16980, l(3)j6B9, RhoGAP-71E1, BcDNA:LD07615" CDMC31601 3 15 14 DAC23-C04 9-CG10752-RA_1 CG10752 ATCTACAAGTGCCAAGTGTTCGTACTCCGCATCTACTGCAAGCTGTTTACCAACAACCTCAAGCGGGGT 69 FBan0010752 FBgn0036325 CG10752 3 3L CG10752 CG10752 anon-WO0140519.236 CDMC31601 3 16 14 DAC23-C04 9-CG10752-RA_1 CG10752 ATCTACAAGTGCCAAGTGTTCGTACTCCGCATCTACTGCAAGCTGTTTACCAACAACCTCAAGCGGGGT 69 FBan0010752 FBgn0036325 CG10752 3 3L CG10752 CG10752 anon-WO0140519.236 CDMC31602 3 17 14 DAC23-C16 2-CG1075-RA_1 CG1075 GGCCAGATACAAGAAGCGTTACGGCCTAGAGGACCGATACCACCGGCGAATACTCGAAAAGAGAGTGCA 69 FBan0001075 FBgn0037397 CG1075 3 3R proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG1075 CG1075 CDMC31602 3 18 14 DAC23-C16 2-CG1075-RA_1 CG1075 GGCCAGATACAAGAAGCGTTACGGCCTAGAGGACCGATACCACCGGCGAATACTCGAAAAGAGAGTGCA 69 FBan0001075 FBgn0037397 CG1075 3 3R proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG1075 CG1075 CDMC31603 3 19 14 DAC23-G04 11-CG10806-RA_1 CG10806 CCACATCCCCAGCATTTCCTACACATACAACACATAGTCCCGCTTCCGATTCGCTCCACTTGTTGTGTC 69 FBan0010806 FBgn0031865 CG10806 2 2L regulation of pH; GO:0006885 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 CG10806 CG10806 serine protease CDMC31603 3 20 14 DAC23-G04 11-CG10806-RA_1 CG10806 CCACATCCCCAGCATTTCCTACACATACAACACATAGTCCCGCTTCCGATTCGCTCCACTTGTTGTGTC 69 FBan0010806 FBgn0031865 CG10806 2 2L regulation of pH; GO:0006885 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 CG10806 CG10806 serine protease CDMC31604 3 21 14 DAC23-G16 14-CG10814-RA_2 CG10814 GCAGAAGTTGTGGAGCGGTCTGGACTTTGAGAAAATCCGTCAGGTGTTCTACTACCAAGAACTGCTCGA 69 FBan0010814 FBgn0033830 CG10814 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG10814 CG10814 CDMC31604 3 22 14 DAC23-G16 14-CG10814-RA_2 CG10814 GCAGAAGTTGTGGAGCGGTCTGGACTTTGAGAAAATCCGTCAGGTGTTCTACTACCAAGAACTGCTCGA 69 FBan0010814 FBgn0033830 CG10814 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG10814 CG10814 CDMC31605 3 23 14 DAC23-K04 18-CG10845-RA_2 CG10845 ACAGCCCGAAGACGCACATACGGTACTATAACATTCGACTGACAAGGCTACTCAATCAACTAATGGGCA 69 FBan0010845 FBgn0039246 CG10845 3 3R cytoskeleton organization and biogenesis; GO:0007010 motor activity; GO:0003774; ; GO:0003774 kinesin complex; GO:0005871; microtubule associated complex; GO:0005875 CG10845 CG10845 CDMC31605 3 24 14 DAC23-K04 18-CG10845-RA_2 CG10845 ACAGCCCGAAGACGCACATACGGTACTATAACATTCGACTGACAAGGCTACTCAATCAACTAATGGGCA 69 FBan0010845 FBgn0039246 CG10845 3 3R cytoskeleton organization and biogenesis; GO:0007010 motor activity; GO:0003774; ; GO:0003774 kinesin complex; GO:0005871; microtubule associated complex; GO:0005875 CG10845 CG10845 CDMC31606 3 25 14 DAC23-K16 15-CG10851-RG_5 CG10851 GGCTGACTGGTTGAGTTAACGATGTTCGATCGGACTTTCGATGAGGTCATGAGGTGTCCTTGGTGTCAT 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC31606 3 26 14 DAC23-K16 15-CG10851-RG_5 CG10851 GGCTGACTGGTTGAGTTAACGATGTTCGATCGGACTTTCGATGAGGTCATGAGGTGTCCTTGGTGTCAT 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC31607 3 1 15 DAC23-O04 3-CG10908-RA_1 CG10908 GCATGACGTCACTGTTCGTCTTTCCCATCTCGTCGAACACGGCCTTCCACTTCCTCATCAACTGCTTCT 69 FBan0010908 FBgn0031376 CG10908 2 2L ER-associated protein catabolism; GO:0030433; misfolded or incompletely synthesized protein catabolism; GO:0006515 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- endoplasmic reticulum membrane; GO:0005789 CG10908 CG10908 Dm Derlin-1 CDMC31607 3 2 15 DAC23-O04 3-CG10908-RA_1 CG10908 GCATGACGTCACTGTTCGTCTTTCCCATCTCGTCGAACACGGCCTTCCACTTCCTCATCAACTGCTTCT 69 FBan0010908 FBgn0031376 CG10908 2 2L ER-associated protein catabolism; GO:0030433; misfolded or incompletely synthesized protein catabolism; GO:0006515 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- endoplasmic reticulum membrane; GO:0005789 CG10908 CG10908 Dm Derlin-1 CDMC31608 3 3 15 DAC23-O16 18-CG10917-RA_5 CG10917 CTACCGCCAGAATACGGATCAGATTCAGGGCGAGATATTCAGCTACTACTTGGGCCAGCTCTTAAACAT 69 FBan0010917 FBgn0000658 fj 2 2R "cell-cell signaling; GO:0007267; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; leg joint morphogenesis (sensu Endopterygota); GO:0016348; proximal/distal pattern formation, imaginal disc; GO:0007449; wing vein specification; GO:0007474" integral to membrane; GO:0016021; plasma membrane; GO:0005886 fj four-jointed CG10917 CDMC31608 3 4 15 DAC23-O16 18-CG10917-RA_5 CG10917 CTACCGCCAGAATACGGATCAGATTCAGGGCGAGATATTCAGCTACTACTTGGGCCAGCTCTTAAACAT 69 FBan0010917 FBgn0000658 fj 2 2R "cell-cell signaling; GO:0007267; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; imaginal disc development; GO:0007444; imaginal disc growth; GO:0007446; leg joint morphogenesis (sensu Endopterygota); GO:0016348; proximal/distal pattern formation, imaginal disc; GO:0007449; wing vein specification; GO:0007474" integral to membrane; GO:0016021; plasma membrane; GO:0005886 fj four-jointed CG10917 CDMC31609 3 5 15 DAC24-C04 2-CG14937-RA_2 CG14937 GGCCTGCTGGAATTCGTGATCAATTGTCGACAGCTGAGAGTCCTCGACATCACTCGAACCTTCTGCCAT 69 FBan0014937 FBgn0032377 CG14937 2 2L CG14937 CG14937 CDMC31609 3 6 15 DAC24-C04 2-CG14937-RA_2 CG14937 GGCCTGCTGGAATTCGTGATCAATTGTCGACAGCTGAGAGTCCTCGACATCACTCGAACCTTCTGCCAT 69 FBan0014937 FBgn0032377 CG14937 2 2L CG14937 CG14937 CDMC31610 3 7 15 DAC24-C16 1-CG14950-RA_2 CG14950 GCTGAAGATGGGCTTCCTGAAGATCAAGGGCAACGTAGAGGTGGAGCTAATCTGCGCCCGTAACATTGT 69 FBan0014950 FBgn0035364 CG14950 3 3L CG14950 CG14950 CDMC31610 3 8 15 DAC24-C16 1-CG14950-RA_2 CG14950 GCTGAAGATGGGCTTCCTGAAGATCAAGGGCAACGTAGAGGTGGAGCTAATCTGCGCCCGTAACATTGT 69 FBan0014950 FBgn0035364 CG14950 3 3L CG14950 CG14950 CDMC31611 3 9 15 DAC24-G04 15-CG14979-RA_3 CG14979 TCGCAACTCTCCGAGGGATTTGGCATCAAGGACATAGGACTGACTATCACGGCTTTGTGGAACATAGGA 69 FBan0014979 FBgn0035468 Gr63a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr63a Gustatory receptor 63a "CG14979, Gr63F1, Gustatory receptor 63F1, Gustatory receptor 63a" CDMC31611 3 10 15 DAC24-G04 15-CG14979-RA_3 CG14979 TCGCAACTCTCCGAGGGATTTGGCATCAAGGACATAGGACTGACTATCACGGCTTTGTGGAACATAGGA 69 FBan0014979 FBgn0035468 Gr63a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr63a Gustatory receptor 63a "CG14979, Gr63F1, Gustatory receptor 63F1, Gustatory receptor 63a" CDMC31612 3 11 15 DAC24-G16 12-CG14989-RB_1 CG14989 AGTGTCGCAATTAGGCCAAAGTGCCAACCAAGAGTTTAGTGTTGGTTACGGCCCTTAAACGCAAAAGCA 69 FBan0014989 FBgn0035495 CG14989 3 3L CG14989 CG14989 BcDNA:GH06302 CDMC31612 3 12 15 DAC24-G16 12-CG14989-RB_1 CG14989 AGTGTCGCAATTAGGCCAAAGTGCCAACCAAGAGTTTAGTGTTGGTTACGGCCCTTAAACGCAAAAGCA 69 FBan0014989 FBgn0035495 CG14989 3 3L CG14989 CG14989 BcDNA:GH06302 CDMC31613 3 13 15 DAC24-K04 23-CG15013-RB_9 CG15013 ATCCCACAATCCGCCACTTTCAAATGGTTTCCTACTTTACCACTACGCTCTATCCTTCATATGTTTCCC 69 FBgn0035530 CDMC31613 3 14 15 DAC24-K04 23-CG15013-RB_9 CG15013 ATCCCACAATCCGCCACTTTCAAATGGTTTCCTACTTTACCACTACGCTCTATCCTTCATATGTTTCCC 69 FBgn0035530 CDMC31614 3 15 15 DAC24-K16 3-CG15020-RA_3 CG15020 AACCATGTCACTGGAGGAATCTGAAAGCAGTGACCAAGCGCGATACCTCCAACATGACAGCCACAAACA 69 FBan0015020 FBgn0035543 CG15020 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG15020 CG15020 CDMC31614 3 16 15 DAC24-K16 3-CG15020-RA_3 CG15020 AACCATGTCACTGGAGGAATCTGAAAGCAGTGACCAAGCGCGATACCTCCAACATGACAGCCACAAACA 69 FBan0015020 FBgn0035543 CG15020 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG15020 CG15020 CDMC31615 3 17 15 DAC24-O04 24-CG15067-RA_1 CG15067 GGAGGAATCATCTGTAAACCAATATTCGAATTTTTTCTTATAGTCTCTATAAATGATTGCGATTTAAAT 69 FBan0015067 FBgn0034331 CG15067 2 2R CG15067 CG15067 anon-EST:Posey85 CDMC31615 3 18 15 DAC24-O04 24-CG15067-RA_1 CG15067 GGAGGAATCATCTGTAAACCAATATTCGAATTTTTTCTTATAGTCTCTATAAATGATTGCGATTTAAAT 69 FBan0015067 FBgn0034331 CG15067 2 2R CG15067 CG15067 anon-EST:Posey85 CDMC31616 3 19 15 DAC24-O16 16-CG1507-RB_6 CG1507 GCTCAAGCTTTCGCTGTGACTCAAAAACACTCCAAAACTCGGATTTGCATCAGTCTTCCTACAAAGGCG 69 FBan0001507 FBgn0022361 Pur-alpha 4 4 DNA replication; GO:0006260; mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 single-stranded DNA binding; GO:0003697; ; GO:0003697; transcriptional activator activity; GO:0016563; ; GO:0016563 Pur-alpha Purine-rich binding protein-alpha "CG1507, CG1507, PURalpha, pur-alpha, Pur-alpha" CDMC31616 3 20 15 DAC24-O16 16-CG1507-RB_6 CG1507 GCTCAAGCTTTCGCTGTGACTCAAAAACACTCCAAAACTCGGATTTGCATCAGTCTTCCTACAAAGGCG 69 FBan0001507 FBgn0022361 Pur-alpha 4 4 DNA replication; GO:0006260; mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 single-stranded DNA binding; GO:0003697; ; GO:0003697; transcriptional activator activity; GO:0016563; ; GO:0016563 Pur-alpha Purine-rich binding protein-alpha "CG1507, CG1507, PURalpha, pur-alpha, Pur-alpha" CDMC31617 3 21 15 DAC25-C04 9-CG14323-RA_1 CG14323 GGCGGCTATTGGTCCTCAACCAGGTTACTACGCTACACCTGCAGGATTTTACACCATGCCTCTGAATCA 69 FBan0014323 FBgn0038529 CG14323 3 3R CG14323 CG14323 CDMC31617 3 22 15 DAC25-C04 9-CG14323-RA_1 CG14323 GGCGGCTATTGGTCCTCAACCAGGTTACTACGCTACACCTGCAGGATTTTACACCATGCCTCTGAATCA 69 FBan0014323 FBgn0038529 CG14323 3 3R CG14323 CG14323 CDMC31618 3 23 15 DAC25-C16 22-CG14334-RA_1 CG14334 AAACAGAGCAGCATAACAAACCAAAGCCAGAAATCAAAGGTGTGTATCCGAGGGAAGGGAAATGTGTGT 69 FBan0014334 FBgn0038498 beat-IIa 3 3R axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415; development; GO:0007275 extracellular region; GO:0005576 beat-IIa beaten path IIa "CG14334, CG14335, CT33965, beat IIa, BcDNA:RE17794, beaten path IIa" CDMC31618 3 24 15 DAC25-C16 22-CG14334-RA_1 CG14334 AAACAGAGCAGCATAACAAACCAAAGCCAGAAATCAAAGGTGTGTATCCGAGGGAAGGGAAATGTGTGT 69 FBan0014334 FBgn0038498 beat-IIa 3 3R axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415; development; GO:0007275 extracellular region; GO:0005576 beat-IIa beaten path IIa "CG14334, CG14335, CT33965, beat IIa, BcDNA:RE17794, beaten path IIa" CDMC31619 3 25 15 DAC25-G04 15-CG14380-RA_1 CG14380 ACATTTGCCTGATTTACGCCATGAGCACCTGGTTATACCACTCGAATTATTCCAGGACCCGTCTGCACA 69 FBan0014380 FBgn0038124 CG14380 3 3R CG14380 CG14380 CDMC31619 3 26 15 DAC25-G04 15-CG14380-RA_1 CG14380 ACATTTGCCTGATTTACGCCATGAGCACCTGGTTATACCACTCGAATTATTCCAGGACCCGTCTGCACA 69 FBan0014380 FBgn0038124 CG14380 3 3R CG14380 CG14380 CDMC31620 3 1 16 DAC25-G16 3-CG14400-RA_3 CG14400 TGGTGGTGTCCACGTGGGGAAAACTGAAAGCCGACTACCCTAGAGATGTGGCTAAGATCGAGGATTTGG 69 FBan0014400 FBgn0032896 CG14400 2 2L CG14400 CG14400 CDMC31620 3 2 16 DAC25-G16 3-CG14400-RA_3 CG14400 TGGTGGTGTCCACGTGGGGAAAACTGAAAGCCGACTACCCTAGAGATGTGGCTAAGATCGAGGATTTGG 69 FBan0014400 FBgn0032896 CG14400 2 2L CG14400 CG14400 CDMC31621 3 3 16 DAC25-K04 3-CG14437-RA_2 CG14437 GGGCAAGACCATCGGACACATGTGGGAGCAGGAGAAAGAGCATCGTAAACAGTTCGAGCAGCTCATTCA 69 FBan0014437 FBgn0029502 COQ7 X X gluconeogenesis; GO:0006094; ubiquinone biosynthesis; GO:0006744; ubiquinone metabolism; GO:0006743 mitochondrial inner membrane; GO:0005743 COQ7 COQ7 "CG14437, Dclk1" CDMC31621 3 4 16 DAC25-K04 3-CG14437-RA_2 CG14437 GGGCAAGACCATCGGACACATGTGGGAGCAGGAGAAAGAGCATCGTAAACAGTTCGAGCAGCTCATTCA 69 FBan0014437 FBgn0029502 COQ7 X X gluconeogenesis; GO:0006094; ubiquinone biosynthesis; GO:0006744; ubiquinone metabolism; GO:0006743 mitochondrial inner membrane; GO:0005743 COQ7 COQ7 "CG14437, Dclk1" CDMC31622 3 5 16 DAC25-K16 4-CG14450-RA_1 CG14450 GGCACTTCTCCTCAGCTTAGCCTTTACTCGTCTCGTGCTTCAGCAAGATCCGCAAAGCATTGCATCTGT 69 FBan0014450 FBgn0037184 CG14450 3 3L CG14450 CG14450 CDMC31622 3 6 16 DAC25-K16 4-CG14450-RA_1 CG14450 GGCACTTCTCCTCAGCTTAGCCTTTACTCGTCTCGTGCTTCAGCAAGATCCGCAAAGCATTGCATCTGT 69 FBan0014450 FBgn0037184 CG14450 3 3L CG14450 CG14450 CDMC31623 3 7 16 DAC25-O04 23-CG14500-RA_1 CG14500 GGCGAAGATACCCGTTTAAGTAAATTCAGGGGGCCATAATTGTTCGTTTTTCAATAATTATAAATTGTC 69 FBan0014500 FBgn0034318 CG14500 2 2R sugar binding; GO:0005529; ; GO:0005529 CG14500 CG14500 CDMC31623 3 8 16 DAC25-O04 23-CG14500-RA_1 CG14500 GGCGAAGATACCCGTTTAAGTAAATTCAGGGGGCCATAATTGTTCGTTTTTCAATAATTATAAATTGTC 69 FBan0014500 FBgn0034318 CG14500 2 2R sugar binding; GO:0005529; ; GO:0005529 CG14500 CG14500 CDMC31624 3 9 16 DAC25-O16 10-CG14511-RA_1 CG14511 GCCTGTGCACGTTGATCCTGAAGAGGAGTTACCGGTTGAGTCAGTACATATCGGTGCTCATGATCAGCG 69 FBan0014511 FBgn0039641 CG14511 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 UDP-N-acetylglucosamine transporter activity; GO:0005462; ; GO:0005462 CG14511 CG14511 CDMC31624 3 10 16 DAC25-O16 10-CG14511-RA_1 CG14511 GCCTGTGCACGTTGATCCTGAAGAGGAGTTACCGGTTGAGTCAGTACATATCGGTGCTCATGATCAGCG 69 FBan0014511 FBgn0039641 CG14511 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 UDP-N-acetylglucosamine transporter activity; GO:0005462; ; GO:0005462 CG14511 CG14511 CDMC31625 3 11 16 DAC26-C04 13-CG4729-RC_1 CG4729 TGCTGATGCACGTCTTTATCAAGCCCATAGACAAGCGACTCTTCCGCAAGTTGATGTACTATGCCTGCT 69 FBan0004729 FBgn0036623 CG4729 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4729 CG4729 CDMC31625 3 12 16 DAC26-C04 13-CG4729-RC_1 CG4729 TGCTGATGCACGTCTTTATCAAGCCCATAGACAAGCGACTCTTCCGCAAGTTGATGTACTATGCCTGCT 69 FBan0004729 FBgn0036623 CG4729 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4729 CG4729 CDMC31626 3 13 16 DAC26-C16 23-CG4740-RA_4 CG4740 CAGTCAACAGTCAGCCGCTTAGTCAAGTAGATCGAAAATCAAGAGATTAATACAGCAAGATGAGCAAAA 69 FBan0004740 FBgn0041579 AttC 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial humoral response; GO:0019731; defense response; GO:0006952; defense response to bacteria; GO:0042742 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 AttC Attacin-C "CG4740, DIM 16, Drosophila Immune induced molecule 16, Attacin, attacin C, attacin, Attacin C, att, Attackin, Att, DIM-16, MPAC, Attacin-C" CDMC31626 3 14 16 DAC26-C16 23-CG4740-RA_4 CG4740 CAGTCAACAGTCAGCCGCTTAGTCAAGTAGATCGAAAATCAAGAGATTAATACAGCAAGATGAGCAAAA 69 FBan0004740 FBgn0041579 AttC 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial humoral response; GO:0019731; defense response; GO:0006952; defense response to bacteria; GO:0042742 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 AttC Attacin-C "CG4740, DIM 16, Drosophila Immune induced molecule 16, Attacin, attacin C, attacin, Attacin C, att, Attackin, Att, DIM-16, MPAC, Attacin-C" CDMC31627 3 15 16 DAC26-G04 2-CG4760-RB_1 CG4760 CCAGTCGCATCCACAATCCCCATGCTGGAGTATCGAGGATCTGAGGGATACTTTGCCGAGGGTATAGCT 69 FBan0004760 FBgn0011206 bol 3 3L male meiosis; GO:0007140; meiotic G2/MI transition; GO:0008315; positive regulation of meiosis; GO:0045836; regulation of translation; GO:0006445; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 bol boule "CG4760, CG4727, CG4760, CG4727, CG4760, CG4727, CG4727, Boule, ms(3)07272, BcDNA:AT13332" CDMC31627 3 16 16 DAC26-G04 2-CG4760-RB_1 CG4760 CCAGTCGCATCCACAATCCCCATGCTGGAGTATCGAGGATCTGAGGGATACTTTGCCGAGGGTATAGCT 69 FBan0004760 FBgn0011206 bol 3 3L male meiosis; GO:0007140; meiotic G2/MI transition; GO:0008315; positive regulation of meiosis; GO:0045836; regulation of translation; GO:0006445; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 bol boule "CG4760, CG4727, CG4760, CG4727, CG4760, CG4727, CG4727, Boule, ms(3)07272, BcDNA:AT13332" CDMC31628 3 17 16 DAC26-G16 3-CG4771-RA_7 CG4771 GCGTGGTTTGTCAAAACTGGACAGACACTTTCTGCAAGCTGTGCAAAATGCCCTTCTGCAATGCCTCCT 69 FBan0004771 FBgn0039018 CG4771 3 3R CG4771 CG4771 CDMC31628 3 18 16 DAC26-G16 3-CG4771-RA_7 CG4771 GCGTGGTTTGTCAAAACTGGACAGACACTTTCTGCAAGCTGTGCAAAATGCCCTTCTGCAATGCCTCCT 69 FBan0004771 FBgn0039018 CG4771 3 3R CG4771 CG4771 CDMC31629 3 19 16 DAC26-K04 23-CG4800-RA_5 CG4800 TAAAAACGCTGACAAAAATGCCTGTCTTCGATCAGTGCGATTTTATATCTAATTTCTTTTTACCGGAGC 69 FBan0004800 FBgn0037874 Tctp 3 3R DNA transposition; GO:0006313; defense response; GO:0006952 DNA binding; GO:0003677; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 cytoplasm; GO:0005737 Tctp Translationally controlled tumor protein "CG4800, TCTP, dTCTP, Translationally controlled tumor protein" CDMC31629 3 20 16 DAC26-K04 23-CG4800-RA_5 CG4800 TAAAAACGCTGACAAAAATGCCTGTCTTCGATCAGTGCGATTTTATATCTAATTTCTTTTTACCGGAGC 69 FBan0004800 FBgn0037874 Tctp 3 3R DNA transposition; GO:0006313; defense response; GO:0006952 DNA binding; GO:0003677; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 cytoplasm; GO:0005737 Tctp Translationally controlled tumor protein "CG4800, TCTP, dTCTP, Translationally controlled tumor protein" CDMC31630 3 21 16 DAC26-K16 9-CG4812-RA_1 CG4812 ACTCCAACAGCAAGATTAACGACATTGGAGTGGTGCGTCTGAAGACTAAGCTGACCTTTGGCTCGACCA 69 FBan0004812 FBgn0019928 Ser8 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Ser8 Ser8 "CG4812, CG4812, CG4812, SP#3, SP90, SP3: Serine Protease 3, Serine Protease 3" CDMC31630 3 22 16 DAC26-K16 9-CG4812-RA_1 CG4812 ACTCCAACAGCAAGATTAACGACATTGGAGTGGTGCGTCTGAAGACTAAGCTGACCTTTGGCTCGACCA 69 FBan0004812 FBgn0019928 Ser8 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Ser8 Ser8 "CG4812, CG4812, CG4812, SP#3, SP90, SP3: Serine Protease 3, Serine Protease 3" CDMC31631 3 23 16 DAC26-O04 3-CG4849-RA_2 CG4849 GTCGCAGGAAGGGTCTGTCCGAGGACGTGTCCATCAACAAATTCTTCGACGATCCTATGTTGCTGGAGT 69 FBan0004849 FBgn0039566 CG4849 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; translational elongation; GO:0006414" GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 cytosol; GO:0005829; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG4849 CG4849 eEF2 CDMC31631 3 24 16 DAC26-O04 3-CG4849-RA_2 CG4849 GTCGCAGGAAGGGTCTGTCCGAGGACGTGTCCATCAACAAATTCTTCGACGATCCTATGTTGCTGGAGT 69 FBan0004849 FBgn0039566 CG4849 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; translational elongation; GO:0006414" GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0005525 cytosol; GO:0005829; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG4849 CG4849 eEF2 CDMC31632 3 25 16 DAC26-O16 23-CG4859-RA_15 CG4859 CGGGCAGTGCATTTGTGAACCTTAGGATCAACGCTAGCCACTCGAGTAAAGTTTCCAAAATTTTACTGC 69 FBan0004859 FBgn0035049 Mmp1 2 2R anti-apoptosis; GO:0006916; autophagic cell death; GO:0048102; dorsal trunk growth; GO:0035001; larval development (sensu Insecta); GO:0002168; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071; tracheal system development (sensu Insecta); GO:0007424 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578 Mmp1 Matrix metalloproteinase 1 "CG4859, CG4859, CG4859, CG4859, CG4859, CG4859, l(2)k04809, Dm1-MMP, dm1-MMP, Matrix metalloproteinase 1" CDMC31632 3 26 16 DAC26-O16 23-CG4859-RA_15 CG4859 CGGGCAGTGCATTTGTGAACCTTAGGATCAACGCTAGCCACTCGAGTAAAGTTTCCAAAATTTTACTGC 69 FBan0004859 FBgn0035049 Mmp1 2 2R anti-apoptosis; GO:0006916; autophagic cell death; GO:0048102; dorsal trunk growth; GO:0035001; larval development (sensu Insecta); GO:0002168; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071; tracheal system development (sensu Insecta); GO:0007424 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; ; GO:0004222 ; EC:3.4.24.-; structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 extracellular matrix (sensu Metazoa); GO:0005578 Mmp1 Matrix metalloproteinase 1 "CG4859, CG4859, CG4859, CG4859, CG4859, CG4859, l(2)k04809, Dm1-MMP, dm1-MMP, Matrix metalloproteinase 1" CDMC31633 3 1 17 DAC27-C04 23-CG3492-RA_5 CG3492 TGCTAGGCGGAAATCTATATTCTTATTCTTAAGCCATGTCACCCCACTTAAAGCTGCTGTAAACCACAA 69 FBan0003492 FBgn0035007 CG3492 2 2R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG3492 CG3492 anon-WO0140519.253 CDMC31633 3 2 17 DAC27-C04 23-CG3492-RA_5 CG3492 TGCTAGGCGGAAATCTATATTCTTATTCTTAAGCCATGTCACCCCACTTAAAGCTGCTGTAAACCACAA 69 FBan0003492 FBgn0035007 CG3492 2 2R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG3492 CG3492 anon-WO0140519.253 CDMC31634 3 3 17 DAC27-C16 15-CG3501-RA_1 CG3501 CGGAGCCATGCGGGATTTGGTTGACTTTGACAACCATCTAGATAATCCGGACAAAAACTGGACCAACGA 69 FBan0003501 FBgn0034791 CG3501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3501 CG3501 BcDNA:SD01117 CDMC31634 3 4 17 DAC27-C16 15-CG3501-RA_1 CG3501 CGGAGCCATGCGGGATTTGGTTGACTTTGACAACCATCTAGATAATCCGGACAAAAACTGGACCAACGA 69 FBan0003501 FBgn0034791 CG3501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3501 CG3501 BcDNA:SD01117 CDMC31635 3 5 17 DAC27-G04 7-CG3541-RB_1 CG3541 GCCCCCCCTCCTAAGCGTGTTTCTACATCCCTGACTAACCCCATTCCCAGAACAATCTGTCGAACTAAC 69 FBgn0035030 CDMC31635 3 6 17 DAC27-G04 7-CG3541-RB_1 CG3541 GCCCCCCCTCCTAAGCGTGTTTCTACATCCCTGACTAACCCCATTCCCAGAACAATCTGTCGAACTAAC 69 FBgn0035030 CDMC31636 3 7 17 DAC27-G16 2-CG3561-RA_1 CG3561 CGCCACACTTCTGTCACTCGTGAAGCATGATCTTGCCAAACGTCGCCCTCTTATCGTGTTCAGCAACAA 69 FBan0003561 FBgn0031280 CG3561 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG3561 CG3561 "cg3561, DmRH9" CDMC31636 3 8 17 DAC27-G16 2-CG3561-RA_1 CG3561 CGCCACACTTCTGTCACTCGTGAAGCATGATCTTGCCAAACGTCGCCCTCTTATCGTGTTCAGCAACAA 69 FBan0003561 FBgn0031280 CG3561 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG3561 CG3561 "cg3561, DmRH9" CDMC31637 3 9 17 DAC27-K04 3-CG3594-RA_1 CG3594 GCAGATAACCAGTGACCAGCTGAGTTCACTGCTTCGAGGAGCCTCCAAAACCAACAGACACGTCCTGTA 69 FBan0003594 FBgn0035063 Eap 2 2R mRNA binding; GO:0003729; ; GO:0003729 Eap Exu-associated protein "CG3594, cg3594, Exu-associated protein" CDMC31637 3 10 17 DAC27-K04 3-CG3594-RA_1 CG3594 GCAGATAACCAGTGACCAGCTGAGTTCACTGCTTCGAGGAGCCTCCAAAACCAACAGACACGTCCTGTA 69 FBan0003594 FBgn0035063 Eap 2 2R mRNA binding; GO:0003729; ; GO:0003729 Eap Exu-associated protein "CG3594, cg3594, Exu-associated protein" CDMC31638 3 11 17 DAC27-K16 3-CG3612-RA_3 CG3612 GGCGATGTGTCCGCCTACATTCCAACCAACGTCATCTCGATTACCGACGGACAGATCTTCTTGGAGACC 69 FBan0003612 FBgn0011211 blw 2 2R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; growth; GO:0040007; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proton transport; GO:0015992; spermatid development; GO:0007286" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" blw bellwether "CG3612, CG3612, ATPsyn-alpha, ATP synthetase alpha chain, l(2)59ABa, colibri, A2(2nd)27, mitochondrial ATP synthase alpha subunit, l(2)k00212, l(2)01410, l(2)03972, ms(2)01504, ms(2)Pry58F" CDMC31638 3 12 17 DAC27-K16 3-CG3612-RA_3 CG3612 GGCGATGTGTCCGCCTACATTCCAACCAACGTCATCTCGATTACCGACGGACAGATCTTCTTGGAGACC 69 FBan0003612 FBgn0011211 blw 2 2R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; growth; GO:0040007; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proton transport; GO:0015992; spermatid development; GO:0007286" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" blw bellwether "CG3612, CG3612, ATPsyn-alpha, ATP synthetase alpha chain, l(2)59ABa, colibri, A2(2nd)27, mitochondrial ATP synthase alpha subunit, l(2)k00212, l(2)01410, l(2)03972, ms(2)01504, ms(2)Pry58F" CDMC31639 3 13 17 DAC27-O04 12-CG3651-RA_5 CG3651 GGCGACGGACGGAAAGTAGTGTCAATCTCAAGCAGCTATTAATACAGGCCTCAAAGCAGCAGGGAAACC 69 FBan0003651 FBgn0032974 CG3651 2 2L CG3651 CG3651 CDMC31639 3 14 17 DAC27-O04 12-CG3651-RA_5 CG3651 GGCGACGGACGGAAAGTAGTGTCAATCTCAAGCAGCTATTAATACAGGCCTCAAAGCAGCAGGGAAACC 69 FBan0003651 FBgn0032974 CG3651 2 2L CG3651 CG3651 CDMC31640 3 15 17 DAC27-O16 4-CG3665-RB_2 CG3665 CCCGCAGCGATTTGATTGTGCATCCCGTAACGAGGCAGTATTACTCTGGATACAAGTGCATTGCGACCA 69 FBan0003665 FBgn0000635 Fas2 X X Bolwig's organ morphogenesis; GO:0001746; axonal fasciculation; GO:0007413; behavioral response to ethanol; GO:0048149; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; learning; GO:0007612; learning and/or memory; GO:0007611; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; mushroom body development; GO:0016319; neuromuscular junction development; GO:0007528; neuron recognition; GO:0008038; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; regulation of synapse structure and function; GO:0050803; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; short-term memory; GO:0007614; signal transduction; GO:0007165 axon; GO:0030424; cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211; presynaptic membrane; GO:0042734 Fas2 Fasciclin 2 "CG3665, CG3665, CG3665, fasciclin II, fasII, FASII, FasII, fas II, Fasciclin II, fas-II, fasciclinII, fasciclin 2, Fas II, FascII, clone 1.60, l(1)G0081, l(1)G0293, l(1)G0336, mAB1D4, l(1)G0048, l(1)G0032, 1D4, FAS II, mAb1D4, CT12301, FASCICLIN II, Ab 1D4, mAb 1D4, fas2, fasciclin-II, FasciclinII, Fascilin II, EG:EG0007.3, anon-EST:Liang-1.60" CDMC31640 3 16 17 DAC27-O16 4-CG3665-RB_2 CG3665 CCCGCAGCGATTTGATTGTGCATCCCGTAACGAGGCAGTATTACTCTGGATACAAGTGCATTGCGACCA 69 FBan0003665 FBgn0000635 Fas2 X X Bolwig's organ morphogenesis; GO:0001746; axonal fasciculation; GO:0007413; behavioral response to ethanol; GO:0048149; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; learning; GO:0007612; learning and/or memory; GO:0007611; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; mushroom body development; GO:0016319; neuromuscular junction development; GO:0007528; neuron recognition; GO:0008038; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; regulation of synapse structure and function; GO:0050803; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; short-term memory; GO:0007614; signal transduction; GO:0007165 axon; GO:0030424; cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211; presynaptic membrane; GO:0042734 Fas2 Fasciclin 2 "CG3665, CG3665, CG3665, fasciclin II, fasII, FASII, FasII, fas II, Fasciclin II, fas-II, fasciclinII, fasciclin 2, Fas II, FascII, clone 1.60, l(1)G0081, l(1)G0293, l(1)G0336, mAB1D4, l(1)G0048, l(1)G0032, 1D4, FAS II, mAb1D4, CT12301, FASCICLIN II, Ab 1D4, mAb 1D4, fas2, fasciclin-II, FasciclinII, Fascilin II, EG:EG0007.3, anon-EST:Liang-1.60" CDMC31641 3 17 17 DAC28-C04 23-CG14756-RA_2 CG14756 GCTGGACACTCCCACCTACAAATGCAGCTTTAAAACTCATTAAAACAGCAGCGAAAATACTAATAAATA 69 FBan0014756 FBgn0033275 CG14756 2 2R CG14756 CG14756 CDMC31641 3 18 17 DAC28-C04 23-CG14756-RA_2 CG14756 GCTGGACACTCCCACCTACAAATGCAGCTTTAAAACTCATTAAAACAGCAGCGAAAATACTAATAAATA 69 FBan0014756 FBgn0033275 CG14756 2 2R CG14756 CG14756 CDMC31642 3 19 17 DAC28-C16 15-CG14766-RA_3 CG14766 ACACACCAAGGGAGGCAGAAATTATTTCTAACCGCAAAGCCTTCCGTACCATGGACACGAATCTGAGGA 69 FBan0014766 FBgn0033237 CG14766 2 2R CG14766 CG14766 CDMC31642 3 20 17 DAC28-C16 15-CG14766-RA_3 CG14766 ACACACCAAGGGAGGCAGAAATTATTTCTAACCGCAAAGCCTTCCGTACCATGGACACGAATCTGAGGA 69 FBan0014766 FBgn0033237 CG14766 2 2R CG14766 CG14766 CDMC31643 3 21 17 DAC28-G04 8-CG14816-RA_1 CG14816 AACTGAGACCTTGAGCACAGATCGCGAGACTGTGTAAACCACCATGTACATTTTGCCGCACCGTAACGT 69 FBan0014816 FBgn0023517 CG14816 X X CG14816 CG14816 EG:63B12.4 CDMC31643 3 22 17 DAC28-G04 8-CG14816-RA_1 CG14816 AACTGAGACCTTGAGCACAGATCGCGAGACTGTGTAAACCACCATGTACATTTTGCCGCACCGTAACGT 69 FBan0014816 FBgn0023517 CG14816 X X CG14816 CG14816 EG:63B12.4 CDMC31644 3 23 17 DAC28-G16 1-CG14825-RA_1 CG14825 TCACGTCCTCACGCTCGTTACTCAATCTGGTGGTATCGTGGTTAAGATCCTGAGACGTGTGTCCCGCTT 69 FBan0014825 FBgn0035741 BBS1 3 3L cilium biogenesis; GO:0042384 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BBS1 BBS1 "CG14825, CG14825" CDMC31644 3 24 17 DAC28-G16 1-CG14825-RA_1 CG14825 TCACGTCCTCACGCTCGTTACTCAATCTGGTGGTATCGTGGTTAAGATCCTGAGACGTGTGTCCCGCTT 69 FBan0014825 FBgn0035741 BBS1 3 3L cilium biogenesis; GO:0042384 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BBS1 BBS1 "CG14825, CG14825" CDMC31645 3 25 17 DAC28-K04 11-CG14869-RA_1 CG14869 TCATCATAGGTCGTCGCTCAGATAAGCCCGTATTTGTGCCAACTCCGGTATGCAGTGATGGAAGATGCA 69 FBan0014869 FBgn0038341 CG14869 3 3R cell communication; GO:0007154; cell-cell adhesion; GO:0016337; protein metabolism; GO:0019538; proteolysis; GO:0006508; signal transduction; GO:0007165 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- CG14869 CG14869 "CG6107, CG6107, CT19033" CDMC31645 3 26 17 DAC28-K04 11-CG14869-RA_1 CG14869 TCATCATAGGTCGTCGCTCAGATAAGCCCGTATTTGTGCCAACTCCGGTATGCAGTGATGGAAGATGCA 69 FBan0014869 FBgn0038341 CG14869 3 3R cell communication; GO:0007154; cell-cell adhesion; GO:0016337; protein metabolism; GO:0019538; proteolysis; GO:0006508; signal transduction; GO:0007165 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; ; GO:0008270; ; GO:0004222 ; EC:3.4.24.- CG14869 CG14869 "CG6107, CG6107, CT19033" CDMC31646 3 1 18 DAC28-K16 1-CG14879-RA_1 CG14879 GCCCTAAGCTACAACTGATCGGGAGAAGAATCCCAAAGATCCCATGATCCCCAAGGTAGCCCGCAATGT 69 FBan0014879 FBgn0038419 CG14879 3 3R CG14879 CG14879 BcDNA:RE20991 CDMC31646 3 2 18 DAC28-K16 1-CG14879-RA_1 CG14879 GCCCTAAGCTACAACTGATCGGGAGAAGAATCCCAAAGATCCCATGATCCCCAAGGTAGCCCGCAATGT 69 FBan0014879 FBgn0038419 CG14879 3 3R CG14879 CG14879 BcDNA:RE20991 CDMC31647 3 3 18 DAC28-O04 13-CG14901-RA_2 CG14901 TGGTGGTCCACATTGTTCCTCTGGCTTAAGTTGCTACTCTCCCTCTACGACCTGTTATGTAGTGTGCCA 69 FBan0014901 FBgn0038440 Gr89a 3 3R Gr89a Gr89a "CG14901, CG14901" CDMC31647 3 4 18 DAC28-O04 13-CG14901-RA_2 CG14901 TGGTGGTCCACATTGTTCCTCTGGCTTAAGTTGCTACTCTCCCTCTACGACCTGTTATGTAGTGTGCCA 69 FBan0014901 FBgn0038440 Gr89a 3 3R Gr89a Gr89a "CG14901, CG14901" CDMC31648 3 5 18 DAC28-O16 2-CG14907-RA_1 CG14907 GCCTAAACTGCCCGACCTGGAGAGTCTAAGGGATTTCTGCGATCAGGTGATTAAGGGGATAGCCGAGGA 69 FBan0014907 FBgn0038455 CG14907 3 3R CG14907 CG14907 CDMC31648 3 6 18 DAC28-O16 2-CG14907-RA_1 CG14907 GCCTAAACTGCCCGACCTGGAGAGTCTAAGGGATTTCTGCGATCAGGTGATTAAGGGGATAGCCGAGGA 69 FBan0014907 FBgn0038455 CG14907 3 3R CG14907 CG14907 CDMC31649 3 7 18 DAC29-C04 14-CG6395-RA_1 CG6395 CATTGTTCAAGCCATGCATCTAGCCTTGCAGCTGTACCACTATACAACTCGAATCGATAGCCAAGCCGC 69 FBan0006395 FBgn0004179 Csp 3 3L defense response; GO:0006952; electron transport; GO:0006118; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein folding; GO:0006457; response to stress; GO:0006950; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle uncoating; GO:0016191; vesicle-mediated transport; GO:0016192 "ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506; ; GO:0051082" plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Csp Cysteine string protein "CG6395, CG6395, CG6395, csp, l(3)03988, Dcsp, DCSP-1, MAB ab49, CSP, D-CSP, CSP32, csp29, csp32, D.M.CSP, ab49, cysteine string protein, Cys, anon-WO02059370.50" CDMC31649 3 8 18 DAC29-C04 14-CG6395-RA_1 CG6395 CATTGTTCAAGCCATGCATCTAGCCTTGCAGCTGTACCACTATACAACTCGAATCGATAGCCAAGCCGC 69 FBan0006395 FBgn0004179 Csp 3 3L defense response; GO:0006952; electron transport; GO:0006118; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein folding; GO:0006457; response to stress; GO:0006950; synaptic vesicle exocytosis; GO:0016079; synaptic vesicle uncoating; GO:0016191; vesicle-mediated transport; GO:0016192 "ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506; ; GO:0051082" plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 Csp Cysteine string protein "CG6395, CG6395, CG6395, csp, l(3)03988, Dcsp, DCSP-1, MAB ab49, CSP, D-CSP, CSP32, csp29, csp32, D.M.CSP, ab49, cysteine string protein, Cys, anon-WO02059370.50" CDMC31650 3 9 18 DAC29-C16 14-CG6407-RA_1 CG6407 GCGTGGCGTTAAGAGAAAACGCGAGGAGATCAACAAGAATCGCATGCATTCCGATGACACGAATGCTTT 69 FBan0006407 FBgn0010194 Wnt5 X X Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; frizzled-2 signaling pathway; GO:0007223; negative chemotaxis; GO:0050919 receptor binding; GO:0005102; ; GO:0005102; growth factor activity; GO:0008083; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871; ; GO:0008083; ; GO:0005102 extracellular region; GO:0005576 Wnt5 Wnt oncogene analog 5 "CG6407, Dwnt5, DWnt-3, Dm-3, Dwnt-3, DWnt-3/5, Wnt-3, Wnt3, Wnt, DWnt3, Dwnt-5, DWnt-5, Wnt3/5, DWnt5, wnt5, anon-WO03040301.228, wnt3: wnt-oncogene-analog-3, wnt-oncogene-analog-3" CDMC31650 3 10 18 DAC29-C16 14-CG6407-RA_1 CG6407 GCGTGGCGTTAAGAGAAAACGCGAGGAGATCAACAAGAATCGCATGCATTCCGATGACACGAATGCTTT 69 FBan0006407 FBgn0010194 Wnt5 X X Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; frizzled-2 signaling pathway; GO:0007223; negative chemotaxis; GO:0050919 receptor binding; GO:0005102; ; GO:0005102; growth factor activity; GO:0008083; signal transducer activity; GO:0004871; ; GO:0005102; ; GO:0004871; ; GO:0008083; ; GO:0005102 extracellular region; GO:0005576 Wnt5 Wnt oncogene analog 5 "CG6407, Dwnt5, DWnt-3, Dm-3, Dwnt-3, DWnt-3/5, Wnt-3, Wnt3, Wnt, DWnt3, Dwnt-5, DWnt-5, Wnt3/5, DWnt5, wnt5, anon-WO03040301.228, wnt3: wnt-oncogene-analog-3, wnt-oncogene-analog-3" CDMC31651 3 11 18 DAC29-G04 23-CG6447-RB_3 CG6447 GCGCCTTCATCGTAAGTGGTGTAGCCAGGACTTAAGACGAATTCACAACTAACGGATAACCCTTGAATC 69 FBan0006447 FBgn0039437 CG6447 3 3R CG6447 CG6447 CDMC31651 3 12 18 DAC29-G04 23-CG6447-RB_3 CG6447 GCGCCTTCATCGTAAGTGGTGTAGCCAGGACTTAAGACGAATTCACAACTAACGGATAACCCTTGAATC 69 FBan0006447 FBgn0039437 CG6447 3 3R CG6447 CG6447 CDMC31652 3 13 18 DAC29-G16 9-CG6455-RA_1 CG6455 GGCCTGCCCATCTACTTCCTGTCCTATCTGCAATCGCTGTTCATCTTGCGACCCGATAATCCCATATCC 69 FBan0006455 FBgn0019960 CG6455 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrial inner membrane; GO:0005743 CG6455 CG6455 "Motor-protein: Motor protein, Motor protein, Motor-protein" CDMC31652 3 14 18 DAC29-G16 9-CG6455-RA_1 CG6455 GGCCTGCCCATCTACTTCCTGTCCTATCTGCAATCGCTGTTCATCTTGCGACCCGATAATCCCATATCC 69 FBan0006455 FBgn0019960 CG6455 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrial inner membrane; GO:0005743 CG6455 CG6455 "Motor-protein: Motor protein, Motor protein, Motor-protein" CDMC31653 3 15 18 DAC29-K04 3-CG6493-RA_1 CG6493 TGTTCTGGAGGCCCTTATTGCAGCCGTATACCTGGACTGCCGAGATCTCCAACGTACTTGGGAGGTAAT 69 FBan0006493 FBgn0034246 Dcr-2 2 2R "RNA catabolism; GO:0006401; RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423" double-stranded RNA binding; GO:0003725; ; GO:0003725; ATP binding; GO:0005524; ; GO:0003725; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; endodeoxyribonuclease activity; GO:0004520; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0004520; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0008026; ; GO:0004525 ; EC:3.1.26.3 intracellular; GO:0005622 Dcr-2 Dicer-2 "CG6493, CG6493, cg6493, Dicer, dcr-2, dicer-2, DICER, dicer, DCR2, dicer2, Dicer2, Dicer-2" CDMC31653 3 16 18 DAC29-K04 3-CG6493-RA_1 CG6493 TGTTCTGGAGGCCCTTATTGCAGCCGTATACCTGGACTGCCGAGATCTCCAACGTACTTGGGAGGTAAT 69 FBan0006493 FBgn0034246 Dcr-2 2 2R "RNA catabolism; GO:0006401; RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423" double-stranded RNA binding; GO:0003725; ; GO:0003725; ATP binding; GO:0005524; ; GO:0003725; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; endodeoxyribonuclease activity; GO:0004520; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0004520; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0008026; ; GO:0004525 ; EC:3.1.26.3 intracellular; GO:0005622 Dcr-2 Dicer-2 "CG6493, CG6493, cg6493, Dicer, dcr-2, dicer-2, DICER, dicer, DCR2, dicer2, Dicer2, Dicer-2" CDMC31654 3 17 18 DAC29-K16 16-CG6504-RA_2 CG6504 GCACCCAGACTTCCGTAACTTCATCACCTCGATTTTGACCATGATTCGGATGATTCTTGGCGACTTTCA 69 FBan0006504 FBgn0041195 Pkd2 2 2L cation transport; GO:0006812; cell homeostasis; GO:0019725; development; GO:0007275; ion transport; GO:0006811; larval feeding behavior; GO:0030536; smooth muscle contraction; GO:0006939; sperm competition; GO:0046692; sperm motility; GO:0030317 cation channel activity; GO:0005261; calcium ion binding; GO:0005509; ; GO:0005261; ; GO:0005509 membrane; GO:0016020 Pkd2 Polycystic kidney disease gene-2 "CG6504, Dmpkd2, PKD2, Amo, amo, almost there, Almost there, pkd2, polycystin-2, Polycystic kidney disease gene-2" CDMC31654 3 18 18 DAC29-K16 16-CG6504-RA_2 CG6504 GCACCCAGACTTCCGTAACTTCATCACCTCGATTTTGACCATGATTCGGATGATTCTTGGCGACTTTCA 69 FBan0006504 FBgn0041195 Pkd2 2 2L cation transport; GO:0006812; cell homeostasis; GO:0019725; development; GO:0007275; ion transport; GO:0006811; larval feeding behavior; GO:0030536; smooth muscle contraction; GO:0006939; sperm competition; GO:0046692; sperm motility; GO:0030317 cation channel activity; GO:0005261; calcium ion binding; GO:0005509; ; GO:0005261; ; GO:0005509 membrane; GO:0016020 Pkd2 Polycystic kidney disease gene-2 "CG6504, Dmpkd2, PKD2, Amo, amo, almost there, Almost there, pkd2, polycystin-2, Polycystic kidney disease gene-2" CDMC31655 3 19 18 DAC29-O04 2-CG6544-RA_2 CG6544 GCCCGTGTCACAAATCCTGTCCGTCATATTGCCAAGGAAGTTCACAATATTTCGCACTACCCCAGGCCA 69 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC31655 3 20 18 DAC29-O04 2-CG6544-RA_2 CG6544 GCCCGTGTCACAAATCCTGTCCGTCATATTGCCAAGGAAGTTCACAATATTTCGCACTACCCCAGGCCA 69 FBan0006544 FBgn0020439 fau 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fau fau "CG6544, Fau, BcDNA:HL07933" CDMC31656 3 21 18 DAC29-O16 13-CG6551-RA_3 CG6551 AGACCCTCGACGAGATCAGTCACTTCACTTTTTTCGTCACCTAGCCGGCACTTTCTTTTATTGGCCTCA 69 FBan0006551 FBgn0001079 fu X X activation of hh target transcription factor; GO:0007228; egg chamber formation (sensu Insecta); GO:0007293; protein amino acid phosphorylation; GO:0006468; regulation of proteolysis; GO:0030162; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; membrane; GO:0016020 fu fused "CG6551, CG6551, l(1)fu, Dm fu, fu[mel], Fu, fused" CDMC31656 3 22 18 DAC29-O16 13-CG6551-RA_3 CG6551 AGACCCTCGACGAGATCAGTCACTTCACTTTTTTCGTCACCTAGCCGGCACTTTCTTTTATTGGCCTCA 69 FBan0006551 FBgn0001079 fu X X activation of hh target transcription factor; GO:0007228; egg chamber formation (sensu Insecta); GO:0007293; protein amino acid phosphorylation; GO:0006468; regulation of proteolysis; GO:0030162; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; membrane; GO:0016020 fu fused "CG6551, CG6551, l(1)fu, Dm fu, fu[mel], Fu, fused" CDMC31657 3 23 18 DAC30-C04 2-CG3989-RA_1 CG3989 TTTGGGTGGCCGAACAACTGGCTGATATTGTGCCCAAGAAGGATCACCTGGTTGTCATTCTGATGGG 67 FBan0003989 FBgn0020513 ade5 X X 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 phosphoribosylaminoimidazole carboxylase activity; GO:0004638 ; EC:4.1.1.21; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6 phosphoribosylaminoimidazole carboxylase complex; GO:0009320 ade5 ade5 "CG3989, AIRc-SAICARs: AIR-carboxylase-SAICAR synthetase, AIR-carboxylase-SAICAR synthetase, Ade5, AIRc-SAICARs" CDMC31657 3 24 18 DAC30-C04 2-CG3989-RA_1 CG3989 TTTGGGTGGCCGAACAACTGGCTGATATTGTGCCCAAGAAGGATCACCTGGTTGTCATTCTGATGGG 67 FBan0003989 FBgn0020513 ade5 X X 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 phosphoribosylaminoimidazole carboxylase activity; GO:0004638 ; EC:4.1.1.21; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6 phosphoribosylaminoimidazole carboxylase complex; GO:0009320 ade5 ade5 "CG3989, AIRc-SAICARs: AIR-carboxylase-SAICAR synthetase, AIR-carboxylase-SAICAR synthetase, Ade5, AIRc-SAICARs" CDMC31658 3 25 18 DAC30-C16 15-CG40225-RA_1 CG40225 CTAGCAGTGCCTCTAAAGATACGCAAAGAAGCACGGAACCAACCCATAGCATCGAAAACCCGACTGG 67 FBgn0058225 CG40225 CG40225 CG40225 CDMC31658 3 26 18 DAC30-C16 15-CG40225-RA_1 CG40225 CTAGCAGTGCCTCTAAAGATACGCAAAGAAGCACGGAACCAACCCATAGCATCGAAAACCCGACTGG 67 FBgn0058225 CG40225 CG40225 CG40225 CDMC31659 3 1 19 DAC30-G04 3-CG4270-RA_1 CG4270 ACAGACCCAATCCCAAGTACGGCGAAAACATTTTCCTCTCCGGTGGAATGGATGTGACCGGTGATCT 67 FBan0004270 FBgn0031407 CG4270 2 2L CG4270 CG4270 BcDNA:AT04879 CDMC31659 3 2 19 DAC30-G04 3-CG4270-RA_1 CG4270 ACAGACCCAATCCCAAGTACGGCGAAAACATTTTCCTCTCCGGTGGAATGGATGTGACCGGTGATCT 67 FBan0004270 FBgn0031407 CG4270 2 2L CG4270 CG4270 BcDNA:AT04879 CDMC31660 3 3 19 DAC30-G16 16-CG4393-RA_1 CG4393 AGTCCACCAAGAAGTCCATACAAAAACTGAAGACCTCAGCTGATGGTGAAGTCAAATCGGGGTCACC 67 FBan0004393 FBgn0039075 CG4393 3 3R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG4393 CG4393 CDMC31660 3 4 19 DAC30-G16 16-CG4393-RA_1 CG4393 AGTCCACCAAGAAGTCCATACAAAAACTGAAGACCTCAGCTGATGGTGAAGTCAAATCGGGGTCACC 67 FBan0004393 FBgn0039075 CG4393 3 3R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG4393 CG4393 CDMC31661 3 5 19 DAC30-K04 2-CG4908-RA_2 CG4908 GGACCAGGGAACAACAGACATTGGACCTTCACATGGGTGTTCCTTGGGAGACAGTGACGCTTACAGC 67 FBan0004908 FBgn0032195 CG4908 2 2L electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; protein complex assembly; GO:0006461 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 mitochondrial inner membrane; GO:0005743 CG4908 CG4908 CDMC31661 3 6 19 DAC30-K04 2-CG4908-RA_2 CG4908 GGACCAGGGAACAACAGACATTGGACCTTCACATGGGTGTTCCTTGGGAGACAGTGACGCTTACAGC 67 FBan0004908 FBgn0032195 CG4908 2 2L electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; protein complex assembly; GO:0006461 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 mitochondrial inner membrane; GO:0005743 CG4908 CG4908 CDMC31662 3 7 19 DAC30-K16 2-CG5092-RA_2 CG5092 TTTTGGTAGGTCAACCGATCCGGCATAGATCCCGTGCGACAACCGGCAATTGACTGAGCGAGATTAC 67 FBan0005092 FBgn0021796 Tor 2 2L autophagy; GO:0006914; cell growth; GO:0016049; detection of nutrient; GO:0009594; determination of adult life span; GO:0008340; growth; GO:0040007; phosphorylation; GO:0016310; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein metabolism; GO:0019538; regulation of translation; GO:0006445; response to nutrient; GO:0007584; signal transduction; GO:0007165 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 Tor Target of rapamycin "CG5092, CG5092, CG5092, l(2)k17004, FRAP/TOR, dTOR, CT16317, CT24745, CT24817, TOR, dTor, mTOR, dtor, target-of-rapamycin, Target of rapamycin" CDMC31662 3 8 19 DAC30-K16 2-CG5092-RA_2 CG5092 TTTTGGTAGGTCAACCGATCCGGCATAGATCCCGTGCGACAACCGGCAATTGACTGAGCGAGATTAC 67 FBan0005092 FBgn0021796 Tor 2 2L autophagy; GO:0006914; cell growth; GO:0016049; detection of nutrient; GO:0009594; determination of adult life span; GO:0008340; growth; GO:0040007; phosphorylation; GO:0016310; positive regulation of body size; GO:0040018; positive regulation of cell growth; GO:0030307; positive regulation of cell size; GO:0045793; positive regulation of organ size; GO:0046622; protein metabolism; GO:0019538; regulation of translation; GO:0006445; response to nutrient; GO:0007584; signal transduction; GO:0007165 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 Tor Target of rapamycin "CG5092, CG5092, CG5092, l(2)k17004, FRAP/TOR, dTOR, CT16317, CT24745, CT24817, TOR, dTor, mTOR, dtor, target-of-rapamycin, Target of rapamycin" CDMC31663 3 9 19 DAC30-O04 2-CG5460-RB_1 CG5460 TGGCCACGCCAAAACTGACTGATAGTAGTACCGACCAAATGTCTGCAACGTCCAGTCATCGCACAGC 67 FBan0005460 FBgn0001169 H 3 3R Notch signaling pathway; GO:0007219; negative regulation of Notch signaling pathway; GO:0045746; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 H Hairless "CG5460, hairless" CDMC31663 3 10 19 DAC30-O04 2-CG5460-RB_1 CG5460 TGGCCACGCCAAAACTGACTGATAGTAGTACCGACCAAATGTCTGCAACGTCCAGTCATCGCACAGC 67 FBan0005460 FBgn0001169 H 3 3R Notch signaling pathway; GO:0007219; negative regulation of Notch signaling pathway; GO:0045746; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 H Hairless "CG5460, hairless" CDMC31664 3 11 19 DAC30-O16 AutoBlank AutoBlank CDMC31664 3 12 19 DAC30-O16 AutoBlank AutoBlank CDMC31665 3 13 19 DAC31-C04 18-CG7490-RA_1 CG7490 GGCGTTTACCCACTAAGACCCTTTGTTATGTTTTCTATGTGCAAATTATTGCCGCGGTTTGACGGACCC 69 FBan0007490 FBgn0000100 RpLP0 3 3L DNA repair; GO:0006281; protein biosynthesis; GO:0006412; translational elongation; GO:0006414 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; ; GO:0003729; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0003735 cytoplasm; GO:0005737; cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830; nucleus; GO:0005634; ribosome; GO:0005840 RpLP0 Ribosomal protein LP0 "CG7490, RpP0: Ribosomal protein P0, PO, AP3, RLA0, Ape: Apurinic endonuclease 3, l(3)0154, P0, P35, RpPO, Ap3, l(3)01544, Ribosomal protein P0, Apurinic endonuclease 3, RpP0, Ape" CDMC31665 3 14 19 DAC31-C04 18-CG7490-RA_1 CG7490 GGCGTTTACCCACTAAGACCCTTTGTTATGTTTTCTATGTGCAAATTATTGCCGCGGTTTGACGGACCC 69 FBan0007490 FBgn0000100 RpLP0 3 3L DNA repair; GO:0006281; protein biosynthesis; GO:0006412; translational elongation; GO:0006414 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; ; GO:0003729; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0003735 cytoplasm; GO:0005737; cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830; nucleus; GO:0005634; ribosome; GO:0005840 RpLP0 Ribosomal protein LP0 "CG7490, RpP0: Ribosomal protein P0, PO, AP3, RLA0, Ape: Apurinic endonuclease 3, l(3)0154, P0, P35, RpPO, Ap3, l(3)01544, Ribosomal protein P0, Apurinic endonuclease 3, RpP0, Ape" CDMC31666 3 15 19 DAC31-C16 3-CG7504-RA_1 CG7504 GCTGCTAGGCTCAGTTTTGCGTGTGATGAACCGCGACCAATTCCACCTACTACGTTTTGGAATGCACGA 69 FBan0007504 FBgn0035842 CG7504 3 3L DNA replication; GO:0006260; tRNA metabolism; GO:0006399 nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003678; ; GO:0004004 CG7504 CG7504 CDMC31666 3 16 19 DAC31-C16 3-CG7504-RA_1 CG7504 GCTGCTAGGCTCAGTTTTGCGTGTGATGAACCGCGACCAATTCCACCTACTACGTTTTGGAATGCACGA 69 FBan0007504 FBgn0035842 CG7504 3 3L DNA replication; GO:0006260; tRNA metabolism; GO:0006399 nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003678; ; GO:0004004 CG7504 CG7504 CDMC31667 3 17 19 DAC31-G04 1-CG7540-RA_2 CG7540 CCCTGATAGCCACTCTGATGTGTCTCCTGGGAGTAGGAATCTTCTGCTTCACCATGTACCGAGGAGCCT 69 FBan0007540 FBgn0037092 M6 3 3L cytoskeleton organization and biogenesis; GO:0007010; transmission of nerve impulse; GO:0019226 structural constituent of myelin sheath; GO:0019911; ; GO:0019911 plasma membrane; GO:0005886 M6 M6 "CG7540, dM6a" CDMC31667 3 18 19 DAC31-G04 1-CG7540-RA_2 CG7540 CCCTGATAGCCACTCTGATGTGTCTCCTGGGAGTAGGAATCTTCTGCTTCACCATGTACCGAGGAGCCT 69 FBan0007540 FBgn0037092 M6 3 3L cytoskeleton organization and biogenesis; GO:0007010; transmission of nerve impulse; GO:0019226 structural constituent of myelin sheath; GO:0019911; ; GO:0019911 plasma membrane; GO:0005886 M6 M6 "CG7540, dM6a" CDMC31668 3 19 19 DAC31-G16 14-CG7551-RB_1 CG7551 TCCTAGGAATGCTGAGCAGTTGGAGTGTGTTTCAAGTTCTGGTCGATGACTTGAAGAGTCGTGGCATCA 69 FBan0007551 FBgn0036161 CG7551 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7551 CG7551 BcDNA:AT07524 CDMC31668 3 20 19 DAC31-G16 14-CG7551-RB_1 CG7551 TCCTAGGAATGCTGAGCAGTTGGAGTGTGTTTCAAGTTCTGGTCGATGACTTGAAGAGTCGTGGCATCA 69 FBan0007551 FBgn0036161 CG7551 3 3L monosaccharide metabolism; GO:0005996 ketohexokinase activity; GO:0004454 ; EC:2.7.1.3; ; GO:0004454 ; EC:2.7.1.3 CG7551 CG7551 BcDNA:AT07524 CDMC31669 3 21 19 DAC31-K04 9-CG7582-RA_1 CG7582 TGAAACCCCCAGTTGTTTACTTCGTGCACACGAAACTGGACGAGATTCTCATCATCGGAGTGCCCATCT 69 FBan0007582 FBgn0039681 CG7582 3 3R CG7582 CG7582 CDMC31669 3 22 19 DAC31-K04 9-CG7582-RA_1 CG7582 TGAAACCCCCAGTTGTTTACTTCGTGCACACGAAACTGGACGAGATTCTCATCATCGGAGTGCCCATCT 69 FBan0007582 FBgn0039681 CG7582 3 3R CG7582 CG7582 CDMC31670 3 23 19 DAC31-K16 23-CG7593-RA_1 CG7593 TTAGTCGAATTGCCATTTTTACAAAATTTTAAGCAAACAATGCGGAATCAGGACGATCTAAGTCAGGGC 69 FBan0007593 FBgn0039687 CG7593 3 3R CG7593 CG7593 CDMC31670 3 24 19 DAC31-K16 23-CG7593-RA_1 CG7593 TTAGTCGAATTGCCATTTTTACAAAATTTTAAGCAAACAATGCGGAATCAGGACGATCTAAGTCAGGGC 69 FBan0007593 FBgn0039687 CG7593 3 3R CG7593 CG7593 CDMC31671 3 25 19 DAC31-O04 2-CG7626-RA_2 CG7626 GCAGTCTGGCCTTTCTCCATTGCCGCATGTACACGGAGAACGGTGGAATATTTGTGTGCAAGACTAGGC 69 FBan0007626 FBgn0040273 Spt5 2 2R "RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" chromatin binding; GO:0003682; transcriptional elongation regulator activity; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; ; GO:0016251; ; GO:0003711 nuclear exosome (RNase complex); GO:0000176; nucleus; GO:0005634 Spt5 Spt5 "CG7626, Dspt5, dSpt5, DSIF, dDSIF, spt5" CDMC31671 3 26 19 DAC31-O04 2-CG7626-RA_2 CG7626 GCAGTCTGGCCTTTCTCCATTGCCGCATGTACACGGAGAACGGTGGAATATTTGTGTGCAAGACTAGGC 69 FBan0007626 FBgn0040273 Spt5 2 2R "RNA elongation from RNA polymerase II promoter; GO:0006368; chromatin assembly or disassembly; GO:0006333; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" chromatin binding; GO:0003682; transcriptional elongation regulator activity; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; ; GO:0016251; ; GO:0003711 nuclear exosome (RNase complex); GO:0000176; nucleus; GO:0005634 Spt5 Spt5 "CG7626, Dspt5, dSpt5, DSIF, dDSIF, spt5" CDMC31672 3 1 20 DAC31-O16 24-CG7636-RA_2 CG7636 CCGCATTTCGATTTTGTAACAGTTTGCATATATTTTCGTTCTATTTAATTTTTCAAATAAAACTATCGA 69 FBan0007636 FBgn0036135 mRpL2 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL2 mitochondrial ribosomal protein L2 "CG7636, CG7636, L2, mitochondrial ribosomal protein L2" CDMC31672 3 2 20 DAC31-O16 24-CG7636-RA_2 CG7636 CCGCATTTCGATTTTGTAACAGTTTGCATATATTTTCGTTCTATTTAATTTTTCAAATAAAACTATCGA 69 FBan0007636 FBgn0036135 mRpL2 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL2 mitochondrial ribosomal protein L2 "CG7636, CG7636, L2, mitochondrial ribosomal protein L2" CDMC31673 3 3 20 DAC32-C04 2-CG14941-RA_2 CG14941 GCCCGAGTTCCATCACAAGATCGAACTGTCGAACACTTTCAGCCAGGAGAAGTCAACGCTGCCTTTCC 68 FBan0014941 FBgn0000588 esc 2 2L cell surface receptor linked signal transduction; GO:0007166; chromatin silencing; GO:0006342; gene silencing; GO:0016458; histone methylation; GO:0016571; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0003677; ; GO:0005515 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 esc extra sexcombs "CG14941, extra sex combs, ESC, L41867, Esc" CDMC31673 3 4 20 DAC32-C04 2-CG14941-RA_2 CG14941 GCCCGAGTTCCATCACAAGATCGAACTGTCGAACACTTTCAGCCAGGAGAAGTCAACGCTGCCTTTCC 68 FBan0014941 FBgn0000588 esc 2 2L cell surface receptor linked signal transduction; GO:0007166; chromatin silencing; GO:0006342; gene silencing; GO:0016458; histone methylation; GO:0016571; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0003677; ; GO:0005515 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 esc extra sexcombs "CG14941, extra sex combs, ESC, L41867, Esc" CDMC31674 3 5 20 DAC32-C16 3-CG1504-RA_1 CG1504 CGCAGGCACCTCAAACATCAAGCTGATTCTGCTGACCAACAATCCGTTAATCCGCATCGACAGCTCGG 68 FBan0001504 FBgn0031100 CG1504 X X cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG1504 CG1504 CT3673 CDMC31674 3 6 20 DAC32-C16 3-CG1504-RA_1 CG1504 CGCAGGCACCTCAAACATCAAGCTGATTCTGCTGACCAACAATCCGTTAATCCGCATCGACAGCTCGG 68 FBan0001504 FBgn0031100 CG1504 X X cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG1504 CG1504 CT3673 CDMC31675 3 7 20 DAC32-G04 3-CG15399-RA_1 CG15399 GGGCAAGACTAGTTTGACCAATTTGATGGCCACTACGGAAATTACGCCCACTCCAGACTCGCGAACCG 68 FBan0015399 FBgn0031460 CG15399 2 2L CG15399 CG15399 CDMC31675 3 8 20 DAC32-G04 3-CG15399-RA_1 CG15399 GGGCAAGACTAGTTTGACCAATTTGATGGCCACTACGGAAATTACGCCCACTCCAGACTCGCGAACCG 68 FBan0015399 FBgn0031460 CG15399 2 2L CG15399 CG15399 CDMC31676 3 9 20 DAC32-G16 1-CG15551-RA_1 CG15551 AGGCCAACTACAATTACAACCAGCCAACGTATCCTCCAAGGACCAACCAACAATCGGGAACCCAGGTC 68 FBgn0039813 CDMC31676 3 10 20 DAC32-G16 1-CG15551-RA_1 CG15551 AGGCCAACTACAATTACAACCAGCCAACGTATCCTCCAAGGACCAACCAACAATCGGGAACCCAGGTC 68 FBgn0039813 CDMC31677 3 11 20 DAC32-K04 1-CG16727-RA_1 CG16727 GCCCTCGATCTTCATCAGCGTTCTAATGTTCCTAGGTGCTCTACTCTGCCTGACCCTTCCCGAAACGC 68 FBan0016727 FBgn0038719 CG16727 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG16727 CG16727 CDMC31677 3 12 20 DAC32-K04 1-CG16727-RA_1 CG16727 GCCCTCGATCTTCATCAGCGTTCTAATGTTCCTAGGTGCTCTACTCTGCCTGACCCTTCCCGAAACGC 68 FBan0016727 FBgn0038719 CG16727 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG16727 CG16727 CDMC31678 3 13 20 DAC32-K16 3-CG16903-RA_2 CG16903 GCTCTCCTGGAACTTCATGAATGACTCGCTGAGGACGGACGTTTTTATGCGCTACACACCAGAGGCGA 68 FBan0016903 FBgn0040394 CG16903 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016251; ; GO:0016538 ; EC:2.7.1.- nucleus; GO:0005634 CG16903 CG16903 "EG:67A9.2, anon-WO03040301.211" CDMC31678 3 14 20 DAC32-K16 3-CG16903-RA_2 CG16903 GCTCTCCTGGAACTTCATGAATGACTCGCTGAGGACGGACGTTTTTATGCGCTACACACCAGAGGCGA 68 FBan0016903 FBgn0040394 CG16903 X X "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016251; ; GO:0016538 ; EC:2.7.1.- nucleus; GO:0005634 CG16903 CG16903 "EG:67A9.2, anon-WO03040301.211" CDMC31679 3 15 20 DAC32-O04 17-CG17266-RA_1 CG17266 TGGAATCAAATACAGTCCCAACTGAGAAGCTCCAACAATCCCGTCGTTTTCTTCGACATTGCCGTAGG 68 FBan0017266 FBgn0033089 CG17266 2 2R "defense response; GO:0006952; nuclear mRNA splicing, via spliceosome; GO:0000398; protein folding; GO:0006457; protein targeting; GO:0006605" peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG17266 CG17266 CDMC31679 3 16 20 DAC32-O04 17-CG17266-RA_1 CG17266 TGGAATCAAATACAGTCCCAACTGAGAAGCTCCAACAATCCCGTCGTTTTCTTCGACATTGCCGTAGG 68 FBan0017266 FBgn0033089 CG17266 2 2R "defense response; GO:0006952; nuclear mRNA splicing, via spliceosome; GO:0000398; protein folding; GO:0006457; protein targeting; GO:0006605" peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG17266 CG17266 CDMC31680 3 17 20 DAC32-O16 2-CG17381-RA_3 CG17381 GCCAATGTCGATGGGTTCCTTAAGTCGCATGCACGAGATGTCCTATCCGGTTAATCAGGCCAGTTGGT 68 FBan0017381 FBgn0039079 CG17381 3 3R CG17381 CG17381 CDMC31680 3 18 20 DAC32-O16 2-CG17381-RA_3 CG17381 GCCAATGTCGATGGGTTCCTTAAGTCGCATGCACGAGATGTCCTATCCGGTTAATCAGGCCAGTTGGT 68 FBan0017381 FBgn0039079 CG17381 3 3R CG17381 CG17381 CDMC31681 3 19 20 DAC33-C04 6-CG31612-RA_1 CG31612 CTCATTCCACGGAGAAGAATGGTGAGGAGTGGTTTTCGTGCGATCAATGCGATTTCAGAGCCCGCA 66 FBan0031612 FBgn0051612 CG31612 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31612 CG31612 "CG11631, CG11632" CDMC31681 3 20 20 DAC33-C04 6-CG31612-RA_1 CG31612 CTCATTCCACGGAGAAGAATGGTGAGGAGTGGTTTTCGTGCGATCAATGCGATTTCAGAGCCCGCA 66 FBan0031612 FBgn0051612 CG31612 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31612 CG31612 "CG11631, CG11632" CDMC31682 3 21 20 DAC33-C16 5-CG31771-RA_1 CG31771 ACGGACAAAGAGAGTGAAAAGGACGTTCACGCGACAGACAACAGGCACACACTTAACCACACGCAC 66 FBan0031771 FBgn0028873 CG31771 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31771 CG31771 "BG:DS05899.6, DS05899.6" CDMC31682 3 22 20 DAC33-C16 5-CG31771-RA_1 CG31771 ACGGACAAAGAGAGTGAAAAGGACGTTCACGCGACAGACAACAGGCACACACTTAACCACACGCAC 66 FBan0031771 FBgn0028873 CG31771 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31771 CG31771 "BG:DS05899.6, DS05899.6" CDMC31683 3 23 20 DAC33-G04 3-CG3226-RA_1 CG3226 GACGGTGACTCCAAGACGAAGCAGATGATCGCCAAAGCTTGGACCGAGAGTCAGGATAAGGCGAAG 66 FBan0003226 FBgn0029882 CG3226 X X CG3226 CG3226 Q9W3Y3 CDMC31683 3 24 20 DAC33-G04 3-CG3226-RA_1 CG3226 GACGGTGACTCCAAGACGAAGCAGATGATCGCCAAAGCTTGGACCGAGAGTCAGGATAAGGCGAAG 66 FBan0003226 FBgn0029882 CG3226 X X CG3226 CG3226 Q9W3Y3 CDMC31684 3 25 20 DAC33-G16 15-CG32469-RA_5 CG32469 AGACCGAAAATCGCAAAAAGTAACTGCAAAGCAAGCTAACCGAGTGGAAAAGCAAATAGCCCGGGC 66 FBgn0052469 CDMC31684 3 26 20 DAC33-G16 15-CG32469-RA_5 CG32469 AGACCGAAAATCGCAAAAAGTAACTGCAAAGCAAGCTAACCGAGTGGAAAAGCAAATAGCCCGGGC 66 FBgn0052469 CDMC31685 3 1 21 DAC33-K04 17-CG32809-RB_2 CG32809 TGCATCCTGTCTAACGAGATGGAGAAAGTGGTGCGAGAAGAAAAGTTCCTCAAAGAAGAGCCCGAC 66 FBan0032809 FBgn0023531 CG32809 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32809 CG32809 "CG3783, CG3737, CG3791, CG3783, EG:171E4.3, EG:73D1.1, EG:9D2.2" CDMC31685 3 2 21 DAC33-K04 17-CG32809-RB_2 CG32809 TGCATCCTGTCTAACGAGATGGAGAAAGTGGTGCGAGAAGAAAAGTTCCTCAAAGAAGAGCCCGAC 66 FBan0032809 FBgn0023531 CG32809 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32809 CG32809 "CG3783, CG3737, CG3791, CG3783, EG:171E4.3, EG:73D1.1, EG:9D2.2" CDMC31686 3 3 21 DAC33-K16 3-CG33131-RA_6 CG33131 GGAAGACGCGAAGAGAAACCAGGGTATAACCCACATCCACCTGAACGGCGATCGAGTGATTGTGGC 66 FBan0033131 FBgn0033052 SCAP 2 2R protein processing; GO:0016485; protein targeting to Golgi; GO:0000042; sterol regulatory element binding-protein cleavage; GO:0035103 SCAP SCAP "CG8356, CG33131, CG14592, CG8356, dSCAP, Scap_Dm" CDMC31686 3 4 21 DAC33-K16 3-CG33131-RA_6 CG33131 GGAAGACGCGAAGAGAAACCAGGGTATAACCCACATCCACCTGAACGGCGATCGAGTGATTGTGGC 66 FBan0033131 FBgn0033052 SCAP 2 2R protein processing; GO:0016485; protein targeting to Golgi; GO:0000042; sterol regulatory element binding-protein cleavage; GO:0035103 SCAP SCAP "CG8356, CG33131, CG14592, CG8356, dSCAP, Scap_Dm" CDMC31687 3 5 21 DAC33-O04 16-CG3483-RA_1 CG3483 AAACAAGTCAGCTCCACTCACAACTCACATTTCGGGCCTCAAATTCTCCAAAATGAACACCCTGCG 66 FBan0003483 FBgn0035005 CG3483 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759 CG3483 CG3483 anon-WO0140519.111 CDMC31687 3 6 21 DAC33-O04 16-CG3483-RA_1 CG3483 AAACAAGTCAGCTCCACTCACAACTCACATTTCGGGCCTCAAATTCTCCAAAATGAACACCCTGCG 66 FBan0003483 FBgn0035005 CG3483 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; carbohydrate metabolism; GO:0005975; tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; isocitrate dehydrogenase (NAD+) activity; GO:0004449 ; EC:1.1.1.41; ; GO:0004449 ; EC:1.1.1.41 mitochondrial matrix; GO:0005759 CG3483 CG3483 anon-WO0140519.111 CDMC31688 3 7 21 DAC33-O16 AutoBlank AutoBlank CDMC31688 3 8 21 DAC33-O16 AutoBlank AutoBlank CDMC31689 3 9 21 DAC34-C04 9-CG13457-RB_1 CG13457 CGCAACCGCAGACGATTCACATGCGAATACCTCCGTTTAATGGTTGTCCCTGCATGTACCAGACCTACT 69 FBan0013457 FBgn0036482 CG13457 3 3L CG13457 CG13457 "BcDNA:AT15860, BcDNA:AT16542" CDMC31689 3 10 21 DAC34-C04 9-CG13457-RB_1 CG13457 CGCAACCGCAGACGATTCACATGCGAATACCTCCGTTTAATGGTTGTCCCTGCATGTACCAGACCTACT 69 FBan0013457 FBgn0036482 CG13457 3 3L CG13457 CG13457 "BcDNA:AT15860, BcDNA:AT16542" CDMC31690 3 11 21 DAC34-C16 1-CG13471-RA_1 CG13471 CCTATGGGTCCCCTCTCCCCTAGCGAGAGACAGGAAATGACTCGACTGATCACGGAATTCATGGAGGAT 69 FBan0013471 FBgn0036443 CG13471 3 3L CG13471 CG13471 CDMC31690 3 12 21 DAC34-C16 1-CG13471-RA_1 CG13471 CCTATGGGTCCCCTCTCCCCTAGCGAGAGACAGGAAATGACTCGACTGATCACGGAATTCATGGAGGAT 69 FBan0013471 FBgn0036443 CG13471 3 3L CG13471 CG13471 CDMC31691 3 13 21 DAC34-G04 6-CG13518-RA_1 CG13518 AACACACTGGATATGGACAAGGTGCGCTCGTACTACAAGCGGTACCATCAAACAGATCCGGAGTACGCG 69 FBan0013518 FBgn0034768 Obp58b 2 2R proteolysis; GO:0006508; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- Obp58b Odorant-binding protein 58b "CG13518, CG13518, Odorant-binding protein 58b" CDMC31691 3 14 21 DAC34-G04 6-CG13518-RA_1 CG13518 AACACACTGGATATGGACAAGGTGCGCTCGTACTACAAGCGGTACCATCAAACAGATCCGGAGTACGCG 69 FBan0013518 FBgn0034768 Obp58b 2 2R proteolysis; GO:0006508; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- Obp58b Odorant-binding protein 58b "CG13518, CG13518, Odorant-binding protein 58b" CDMC31692 3 15 21 DAC34-G16 8-CG13539-RA_1 CG13539 AGCGCATCCAACACCATCCCAATTACCTGAAGACAGTGAAGCTCATCGATCGAATGAACTGCTCCACCA 69 FBan0013539 FBgn0034833 CG13539 2 2R CG13539 CG13539 CDMC31692 3 16 21 DAC34-G16 8-CG13539-RA_1 CG13539 AGCGCATCCAACACCATCCCAATTACCTGAAGACAGTGAAGCTCATCGATCGAATGAACTGCTCCACCA 69 FBan0013539 FBgn0034833 CG13539 2 2R CG13539 CG13539 CDMC31693 3 17 21 DAC34-K04 23-CG13581-RA_3 CG13581 CTGCCCAATTTCAATGAAATGCTTCTATCCACAGAGGCCTCTAAAATATTCGGATTAGAATGCGTACCT 69 FBan0013581 FBgn0035014 CG13581 2 2R CG13581 CG13581 BcDNA:AT03240 CDMC31693 3 18 21 DAC34-K04 23-CG13581-RA_3 CG13581 CTGCCCAATTTCAATGAAATGCTTCTATCCACAGAGGCCTCTAAAATATTCGGATTAGAATGCGTACCT 69 FBan0013581 FBgn0035014 CG13581 2 2R CG13581 CG13581 BcDNA:AT03240 CDMC31694 3 19 21 DAC34-K16 23-CG13594-RA_5 CG13594 CTGGTCAACAAATCGCAAATAAATTAATTGGGAATTGCAATTTCAATTCAATCCAATTCCGAAGCAGCG 69 FBan0013594 FBgn0035041 CG13594 2 2R CG13594 CG13594 CDMC31694 3 20 21 DAC34-K16 23-CG13594-RA_5 CG13594 CTGGTCAACAAATCGCAAATAAATTAATTGGGAATTGCAATTTCAATTCAATCCAATTCCGAAGCAGCG 69 FBan0013594 FBgn0035041 CG13594 2 2R CG13594 CG13594 CDMC31695 3 21 21 DAC34-O04 2-CG13622-RA_1 CG13622 TGGGGCTGGGAACGAACAGGAGGTATTGACACCTCGAACACGAACCATCATGAAAGGTACACGGACAAT 69 FBan0013622 FBgn0039202 CG13622 3 3R CG13622 CG13622 CDMC31695 3 22 21 DAC34-O04 2-CG13622-RA_1 CG13622 TGGGGCTGGGAACGAACAGGAGGTATTGACACCTCGAACACGAACCATCATGAAAGGTACACGGACAAT 69 FBan0013622 FBgn0039202 CG13622 3 3R CG13622 CG13622 CDMC31696 3 23 21 DAC34-O16 2-CG13634-RA_1 CG13634 GCTGCATCGAAATGGACAAGCCAATCCCTTCTCCGATTCAAGCAGTGCACTAGAGCTGGAGGATTTGCT 69 FBan0013634 FBgn0039224 CG13634 3 3R CG13634 CG13634 CDMC31696 3 24 21 DAC34-O16 2-CG13634-RA_1 CG13634 GCTGCATCGAAATGGACAAGCCAATCCCTTCTCCGATTCAAGCAGTGCACTAGAGCTGGAGGATTTGCT 69 FBan0013634 FBgn0039224 CG13634 3 3R CG13634 CG13634 CDMC31697 3 25 21 DAC35-C04 3-CG17905-RA_1 CG17905 GTGGCCCAGAGATGTGGTGGTCCAAGAATGCCACAATTGAGGATTGGTTCGATGAGATGGTTGGCC 66 FBan0017905 FBgn0032598 CG17905 2 2L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG17905 CG17905 CDMC31697 3 26 21 DAC35-C04 3-CG17905-RA_1 CG17905 GTGGCCCAGAGATGTGGTGGTCCAAGAATGCCACAATTGAGGATTGGTTCGATGAGATGGTTGGCC 66 FBan0017905 FBgn0032598 CG17905 2 2L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG17905 CG17905 CDMC31698 3 1 22 DAC35-C16 3-CG18171-RA_1 CG18171 CGATCTTAGCTTTGTGCGCCACTTTGTCAATCTGGTATCGCTGAACCTGGAGTTTCTGGGTCCGGC 66 FBan0018171 FBgn0035262 CG18171 3 3L CG18171 CG18171 CDMC31698 3 2 22 DAC35-C16 3-CG18171-RA_1 CG18171 CGATCTTAGCTTTGTGCGCCACTTTGTCAATCTGGTATCGCTGAACCTGGAGTTTCTGGGTCCGGC 66 FBan0018171 FBgn0035262 CG18171 3 3L CG18171 CG18171 CDMC31699 3 3 22 DAC35-G04 15-CG2163-RA_1 CG2163 CGGCACAATCAACCGAGTAACCATACTCTGCAACAAGGCTGACGGGCACCCCAAGGGATTCGCATA 66 FBan0002163 FBgn0005648 Pabp2 2 2R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143 nucleus; GO:0005634 Pabp2 Pabp2 "CG2163, CG2163, ROX2, dpabII, polyA-binding protein II, rox2, pAbp2, pabp2, Rox2" CDMC31699 3 4 22 DAC35-G04 15-CG2163-RA_1 CG2163 CGGCACAATCAACCGAGTAACCATACTCTGCAACAAGGCTGACGGGCACCCCAAGGGATTCGCATA 66 FBan0002163 FBgn0005648 Pabp2 2 2R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008143; ; GO:0008143; ; GO:0008143 nucleus; GO:0005634 Pabp2 Pabp2 "CG2163, CG2163, ROX2, dpabII, polyA-binding protein II, rox2, pAbp2, pabp2, Rox2" CDMC31700 3 5 22 DAC35-G16 2-CG2736-RA_2 CG2736 AGGAGCGTTACAACGGCCTTGATACCTTCCGCTACACTCTGCTTCAGTCACATCAAAAGCCTCCCG 66 FBan0002736 FBgn0035090 CG2736 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG2736 CG2736 CDMC31700 3 6 22 DAC35-G16 2-CG2736-RA_2 CG2736 AGGAGCGTTACAACGGCCTTGATACCTTCCGCTACACTCTGCTTCAGTCACATCAAAAGCCTCCCG 66 FBan0002736 FBgn0035090 CG2736 2 2R cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG2736 CG2736 CDMC31701 3 7 22 DAC35-K04 3-CG30183-RA_8 CG30183 TCCGCCTTCTTTCGAGACTGTGGCTTGGAGTTCTACAGTGGAGAAAATGCGGACTCCTTGGAGCTG 66 FBan0030183 FBgn0050183 CG30183 2 2R CG30183 CG30183 "CG4093, CG4530" CDMC31701 3 8 22 DAC35-K04 3-CG30183-RA_8 CG30183 TCCGCCTTCTTTCGAGACTGTGGCTTGGAGTTCTACAGTGGAGAAAATGCGGACTCCTTGGAGCTG 66 FBan0030183 FBgn0050183 CG30183 2 2R CG30183 CG30183 "CG4093, CG4530" CDMC31702 3 9 22 DAC35-K16 2-CG30401-RA_1 CG30401 TTCCACAATCCTGGCCATGACCCTAGCGAAACCGCAAGTTACCATCAGCACAAAATCGTCGGCTTC 66 FBan0030401 FBgn0050401 CG30401 2 2R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG30401 CG30401 "CG13496, CG13496, CG13496, CG13496" CDMC31702 3 10 22 DAC35-K16 2-CG30401-RA_1 CG30401 TTCCACAATCCTGGCCATGACCCTAGCGAAACCGCAAGTTACCATCAGCACAAAATCGTCGGCTTC 66 FBan0030401 FBgn0050401 CG30401 2 2R DNA binding; GO:0003677; ; GO:0003677 "chromosome, pericentric region; GO:0000775; nucleus; GO:0005634" CG30401 CG30401 "CG13496, CG13496, CG13496, CG13496" CDMC31703 3 11 22 DAC35-O04 12-CG31220-RA_1 CG31220 TGGCCGAGTGTTTTCACACGAACGGCGAAGTTTTACAAATGGATACGGGCACACTTAAGGCCCTAG 66 FBan0031220 FBgn0051220 CG31220 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31220 CG31220 "CG16731, CG16731, CG16731, c-SP6, SP6" CDMC31703 3 12 22 DAC35-O04 12-CG31220-RA_1 CG31220 TGGCCGAGTGTTTTCACACGAACGGCGAAGTTTTACAAATGGATACGGGCACACTTAAGGCCCTAG 66 FBan0031220 FBgn0051220 CG31220 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31220 CG31220 "CG16731, CG16731, CG16731, c-SP6, SP6" CDMC31704 3 13 22 DAC35-O16 AutoBlank AutoBlank CDMC31704 3 14 22 DAC35-O16 AutoBlank AutoBlank CDMC31705 3 15 22 DAC36-C04 1-CG17916-RA_1 CG17916 ACGCAGAAACGGATCTGACGGTCTACTGGTTTTCCTACTGGGGATTGGCTCATTGTGCCTATGTGGC 67 FBan0017916 FBgn0038798 Or92a 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or92a Odorant receptor 92a "CG17916, 92E.1, DOR111, 92a" CDMC31705 3 16 22 DAC36-C04 1-CG17916-RA_1 CG17916 ACGCAGAAACGGATCTGACGGTCTACTGGTTTTCCTACTGGGGATTGGCTCATTGTGCCTATGTGGC 67 FBan0017916 FBgn0038798 Or92a 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or92a Odorant receptor 92a "CG17916, 92E.1, DOR111, 92a" CDMC31706 3 17 22 DAC36-C16 2-CG1810-RA_2 CG1810 CCGTCTCCATGGACAGGGAGAACATAAAGCGGCTAAGCGAGATACCGTATCGTGTGTCGTGGAAGGC 67 FBan0001810 FBgn0030556 mRNA-capping-enzyme X X mRNA capping; GO:0006370; protein amino acid dephosphorylation; GO:0006470 nucleic acid binding; GO:0003676; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; mRNA guanylyltransferase activity; GO:0004484 ; EC:2.7.7.50; ; GO:0003676; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004484 ; EC:2.7.7.50 nucleoplasm; GO:0005654 mRNA-capping-enzyme mRNA-capping-enzyme "CG1810, CG1810, PIR" CDMC31706 3 18 22 DAC36-C16 2-CG1810-RA_2 CG1810 CCGTCTCCATGGACAGGGAGAACATAAAGCGGCTAAGCGAGATACCGTATCGTGTGTCGTGGAAGGC 67 FBan0001810 FBgn0030556 mRNA-capping-enzyme X X mRNA capping; GO:0006370; protein amino acid dephosphorylation; GO:0006470 nucleic acid binding; GO:0003676; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; mRNA guanylyltransferase activity; GO:0004484 ; EC:2.7.7.50; ; GO:0003676; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004484 ; EC:2.7.7.50 nucleoplasm; GO:0005654 mRNA-capping-enzyme mRNA-capping-enzyme "CG1810, CG1810, PIR" CDMC31707 3 19 22 DAC36-G04 8-CG1944-RA_1 CG1944 TTCGATTCCCATCATGGGTCGTCAGACACTCCAGGAAACGGAACTAGAGAATGGCCTAATCCTGCCG 67 FBan0001944 FBgn0033395 Cyp4p2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p2 Cyp4p2 "CG1944, 4p2" CDMC31707 3 20 22 DAC36-G04 8-CG1944-RA_1 CG1944 TTCGATTCCCATCATGGGTCGTCAGACACTCCAGGAAACGGAACTAGAGAATGGCCTAATCCTGCCG 67 FBan0001944 FBgn0033395 Cyp4p2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p2 Cyp4p2 "CG1944, 4p2" CDMC31708 3 21 22 DAC36-G16 2-CG2182-RA_3 CG2182 TCTAGCGCGATTTCGTCACCAGAAGGCTCGGAAGTGTCTTGCTCGGATGGACTGTGTAATCACGACG 67 FBan0002182 FBgn0037360 CG2182 3 3R CG2182 CG2182 CDMC31708 3 22 22 DAC36-G16 2-CG2182-RA_3 CG2182 TCTAGCGCGATTTCGTCACCAGAAGGCTCGGAAGTGTCTTGCTCGGATGGACTGTGTAATCACGACG 67 FBan0002182 FBgn0037360 CG2182 3 3R CG2182 CG2182 CDMC31709 3 23 22 DAC36-K04 5-CG30005-RA_1 CG30005 ACATTCGTCTTGCATGTTCCATGTACTTTCGAGATGCCTGGCTGTTTCCCATGAACGGGATAGCGCC 67 FBan0030005 FBgn0050005 CG30005 2 2R CG30005 CG30005 "CG12930A, CG12930, CG12930A, CG12930A" CDMC31709 3 24 22 DAC36-K04 5-CG30005-RA_1 CG30005 ACATTCGTCTTGCATGTTCCATGTACTTTCGAGATGCCTGGCTGTTTCCCATGAACGGGATAGCGCC 67 FBan0030005 FBgn0050005 CG30005 2 2R CG30005 CG30005 "CG12930A, CG12930, CG12930A, CG12930A" CDMC31710 3 25 22 DAC36-K16 6-CG30088-RA_1 CG30088 CGGTGCTGTCCATGCCAATCACAATTAATCAGCTTTGCGTCGGATTTCAGGGATCGGACACCTGCTC 67 FBan0030088 FBgn0050088 CG30088 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30088 CG30088 "CG8215, CG8215, CG8215, CG8215, CG8215, SP41" CDMC31710 3 26 22 DAC36-K16 6-CG30088-RA_1 CG30088 CGGTGCTGTCCATGCCAATCACAATTAATCAGCTTTGCGTCGGATTTCAGGGATCGGACACCTGCTC 67 FBan0030088 FBgn0050088 CG30088 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30088 CG30088 "CG8215, CG8215, CG8215, CG8215, CG8215, SP41" CDMC31711 3 1 23 DAC36-O04 3-CG30421-RA_3 CG30421 GTGCTGCACAACCATCAATGGCACGGATCTAGGAGCAGCGTGTCAGCTGTAGAGAATGCTACGCAAC 67 FBan0030421 FBgn0050421 CG30421 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG30421 CG30421 "CG3872, CG9189" CDMC31711 3 2 23 DAC36-O04 3-CG30421-RA_3 CG30421 GTGCTGCACAACCATCAATGGCACGGATCTAGGAGCAGCGTGTCAGCTGTAGAGAATGCTACGCAAC 67 FBan0030421 FBgn0050421 CG30421 2 2R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG30421 CG30421 "CG3872, CG9189" CDMC31712 3 3 23 DAC36-O16 AutoBlank AutoBlank CDMC31712 3 4 23 DAC36-O16 AutoBlank AutoBlank CDMC31713 3 5 23 DAC37-C04 18-CG7605-RA_5 CG7605 ACGGCGATGATGGAAAGTTCAATGTGCATGATTTTGTGCGTGACAATACAAAGGCGCGCTCGGTT 65 FBan0007605 FBgn0037072 Rab26 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab26 Rab26 "CG7605, CG7605, DmRab26, AAF51708, rab26" CDMC31713 3 6 23 DAC37-C04 18-CG7605-RA_5 CG7605 ACGGCGATGATGGAAAGTTCAATGTGCATGATTTTGTGCGTGACAATACAAAGGCGCGCTCGGTT 65 FBan0007605 FBgn0037072 Rab26 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab26 Rab26 "CG7605, CG7605, DmRab26, AAF51708, rab26" CDMC31714 3 7 23 DAC37-C16 13-CG7642-RA_3 CG7642 AGGAACTCATGTACTCACCACAAGGCATGCTTTACTCCAGAGGTCCGGGCATGTATAAGCTGCCA 65 FBan0007642 FBgn0003308 ry 3 3R defense response; GO:0006952; electron transport; GO:0006118; eye pigmentation (sensu Endopterygota); GO:0048072; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144 electron transporter activity; GO:0005489; ; GO:0005489; xanthine dehydrogenase activity; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4 peroxisome; GO:0005777 ry rosy "CG7642, XDH, Xdh, Xdh/ry, xanthine dehydrogenase, Xanthine DH, XOR" CDMC31714 3 8 23 DAC37-C16 13-CG7642-RA_3 CG7642 AGGAACTCATGTACTCACCACAAGGCATGCTTTACTCCAGAGGTCCGGGCATGTATAAGCTGCCA 65 FBan0007642 FBgn0003308 ry 3 3R defense response; GO:0006952; electron transport; GO:0006118; eye pigmentation (sensu Endopterygota); GO:0048072; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144 electron transporter activity; GO:0005489; ; GO:0005489; xanthine dehydrogenase activity; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4; ; GO:0004854 ; EC:1.17.1.4 peroxisome; GO:0005777 ry rosy "CG7642, XDH, Xdh, Xdh/ry, xanthine dehydrogenase, Xanthine DH, XOR" CDMC31715 3 9 23 DAC37-G04 3-CG7794-RA_6 CG7794 AATAGGATCATCGCACAAGTGGTTTCCAGCTTTACGGCCTCACAGCGTTTTGGTGGCGGATCGAC 65 FBan0007794 FBgn0038565 CG7794 3 3R cell motility; GO:0006928; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525; ; GO:0005200 microtubule; GO:0005874; tubulin; GO:0045298 CG7794 CG7794 anon-WO0140519.191 CDMC31715 3 10 23 DAC37-G04 3-CG7794-RA_6 CG7794 AATAGGATCATCGCACAAGTGGTTTCCAGCTTTACGGCCTCACAGCGTTTTGGTGGCGGATCGAC 65 FBan0007794 FBgn0038565 CG7794 3 3R cell motility; GO:0006928; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525; ; GO:0005200 microtubule; GO:0005874; tubulin; GO:0045298 CG7794 CG7794 anon-WO0140519.191 CDMC31716 3 11 23 DAC37-G16 1-CG7849-RA_1 CG7849 CAACGAGACGCAGGAGTACTTAGCTACGCTAGTGCACGATATGGCTTTGGACCTCCGAACCGTGG 65 FBan0007849 FBgn0033060 CG7849 2 2R CG7849 CG7849 CDMC31716 3 12 23 DAC37-G16 1-CG7849-RA_1 CG7849 CAACGAGACGCAGGAGTACTTAGCTACGCTAGTGCACGATATGGCTTTGGACCTCCGAACCGTGG 65 FBan0007849 FBgn0033060 CG7849 2 2R CG7849 CG7849 CDMC31717 3 13 23 DAC37-K04 2-CG7945-RA_1 CG7945 ATCAACAATATTTTTGCATCGGGCCAAAGGTGCATTAAAACCGGAGCCTCAAGTCTCGGGCGGCA 65 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC31717 3 14 23 DAC37-K04 2-CG7945-RA_1 CG7945 ATCAACAATATTTTTGCATCGGGCCAAAGGTGCATTAAAACCGGAGCCTCAAGTCTCGGGCGGCA 65 FBan0007945 FBgn0036505 CG7945 3 3L chitin metabolism; GO:0006030; protein folding; GO:0006457 chitin binding; GO:0008061; unfolded protein binding; GO:0051082; ; GO:0051082; ; GO:0008061 extracellular region; GO:0005576 CG7945 CG7945 CG17014 CDMC31718 3 15 23 DAC37-K16 3-CG7970-RA_4 CG7970 GTGCGCTTCCGAAGATTCTTCCTGTTCCTGTCCGAGCGACTGGTCTATGCTCCGATTTACCAGGC 65 FBan0007970 FBgn0035252 CG7970 3 3L cytosol; GO:0005829; integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG7970 CG7970 anon-WO0118547.268 CDMC31718 3 16 23 DAC37-K16 3-CG7970-RA_4 CG7970 GTGCGCTTCCGAAGATTCTTCCTGTTCCTGTCCGAGCGACTGGTCTATGCTCCGATTTACCAGGC 65 FBan0007970 FBgn0035252 CG7970 3 3L cytosol; GO:0005829; integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG7970 CG7970 anon-WO0118547.268 CDMC31719 3 17 23 DAC37-O04 2-CG8060-RA_1 CG8060 GATCCACCGACTCAAGAACTGGTACCCATTGAAAGGAAGCCCCTGAAAGAGCAAACACCTCCGCC 65 FBan0008060 FBgn0034113 CG8060 2 2R protein binding; GO:0005515; ; GO:0005515 CG8060 CG8060 CDMC31719 3 18 23 DAC37-O04 2-CG8060-RA_1 CG8060 GATCCACCGACTCAAGAACTGGTACCCATTGAAAGGAAGCCCCTGAAAGAGCAAACACCTCCGCC 65 FBan0008060 FBgn0034113 CG8060 2 2R protein binding; GO:0005515; ; GO:0005515 CG8060 CG8060 CDMC31720 3 19 23 DAC37-O16 3-CG8092-RB_5 CG8092 ATGTGACCAAGTTTCCCTACACTGGTGGCTATGTGTGGATCAGCGAATGTTGCCCCTACCGCTTC 65 FBan0008092 FBgn0033998 CG8092 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8092 CG8092 anon-WO0118547.194 CDMC31720 3 20 23 DAC37-O16 3-CG8092-RB_5 CG8092 ATGTGACCAAGTTTCCCTACACTGGTGGCTATGTGTGGATCAGCGAATGTTGCCCCTACCGCTTC 65 FBan0008092 FBgn0033998 CG8092 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8092 CG8092 anon-WO0118547.194 CDMC31721 3 21 23 DAC38-C04 1-CG4163-RA_1 CG4163 ACACCATGGTGATTGCCTGTTTCAGGGGAATGCTGATCAACCCAGTCGACTTTCCCGATCCAGAGTCAT 69 FBan0004163 FBgn0001992 Cyp303a1 2 2L electron transport; GO:0006118; sensory organ development; GO:0007423; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp303a1 Cyp303a1 "CG4163, BG:DS02740.6, I(2)35Fb, l(2)35Fb: lethal(2)35Fb, 303a1, nompH, CYP303A1-Dm, lethal(2)35Fb, l(2)35Fb" CDMC31721 3 22 23 DAC38-C04 1-CG4163-RA_1 CG4163 ACACCATGGTGATTGCCTGTTTCAGGGGAATGCTGATCAACCCAGTCGACTTTCCCGATCCAGAGTCAT 69 FBan0004163 FBgn0001992 Cyp303a1 2 2L electron transport; GO:0006118; sensory organ development; GO:0007423; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp303a1 Cyp303a1 "CG4163, BG:DS02740.6, I(2)35Fb, l(2)35Fb: lethal(2)35Fb, 303a1, nompH, CYP303A1-Dm, lethal(2)35Fb, l(2)35Fb" CDMC31722 3 23 23 DAC38-C16 23-CG4182-RA_1 CG4182 CGAGCAATCCAAAAAAAATCGAATAATTGAAAAATCCAAAATGAACCCACTAGGAATGTTGAGCCTGGG 69 FBan0004182 FBgn0041713 yellow-c 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-c yellow-c "CG4182, CG4182, BG:DS00929.8, anon-EST:ParkEST125, yellow-c" CDMC31722 3 24 23 DAC38-C16 23-CG4182-RA_1 CG4182 CGAGCAATCCAAAAAAAATCGAATAATTGAAAAATCCAAAATGAACCCACTAGGAATGTTGAGCCTGGG 69 FBan0004182 FBgn0041713 yellow-c 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-c yellow-c "CG4182, CG4182, BG:DS00929.8, anon-EST:ParkEST125, yellow-c" CDMC31723 3 25 23 DAC38-G04 23-CG4209-RA_1 CG4209 CATTCCTCCTTCCATTCGAAATGACATACTTTCGAGGTTCGAACAGCTCTACGATTGGGATTGTTCGCA 69 FBan0004209 FBgn0010014 CanB X X calcium-mediated signaling; GO:0019722; cell homeostasis; GO:0019725; neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanB Calcineurin B "CG4209, dCnB1, CNB, canB-4F, Can, BcDNA:RH11383" CDMC31723 3 26 23 DAC38-G04 23-CG4209-RA_1 CG4209 CATTCCTCCTTCCATTCGAAATGACATACTTTCGAGGTTCGAACAGCTCTACGATTGGGATTGTTCGCA 69 FBan0004209 FBgn0010014 CanB X X calcium-mediated signaling; GO:0019722; cell homeostasis; GO:0019725; neurotransmitter secretion; GO:0007269; protein amino acid dephosphorylation; GO:0006470; vesicle-mediated transport; GO:0016192 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955; synaptic vesicle; GO:0008021 CanB Calcineurin B "CG4209, dCnB1, CNB, canB-4F, Can, BcDNA:RH11383" CDMC31724 3 1 24 DAC38-G16 17-CG4215-RB_1 CG4215 GGTGGACTCCATTCTTGGAAGAGTGGGAGCTAGTGACAACATCATCAAGGGTTTGAGCACATTTATGGT 69 FBan0004215 FBgn0015546 spel1 2 2L mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 nucleus; GO:0005634 spel1 spellchecker1 "CG4215, CG4215, spel-1, SPEL1, BG:DS01068.9, Msh2, spellchecker, spel" CDMC31724 3 2 24 DAC38-G16 17-CG4215-RB_1 CG4215 GGTGGACTCCATTCTTGGAAGAGTGGGAGCTAGTGACAACATCATCAAGGGTTTGAGCACATTTATGGT 69 FBan0004215 FBgn0015546 spel1 2 2L mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 nucleus; GO:0005634 spel1 spellchecker1 "CG4215, CG4215, spel-1, SPEL1, BG:DS01068.9, Msh2, spellchecker, spel" CDMC31725 3 3 24 DAC38-K04 6-CG4254-RA_4 CG4254 TCGCGATGAAAAGCAGATTGATGTGGAGACTGTGGCAGATCGCAACGCCGAGTACGACCAGTTTCTAGA 69 FBan0004254 FBgn0011726 tsr 2 2R "actin filament depolymerization; GO:0030042; actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; female gonad development; GO:0008585; mitosis; GO:0007067; mushroom body development; GO:0016319; protein complex assembly; GO:0006461" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 tsr twinstar "CG4254, CG4254, CG4254, l(2)k05633, D61, l(2)03101, 12/8, ntf, no terminal filament, cofilin/actin depolymerizing factor homolog, D-cof, cofilin, ADFcofilin, Cofilin, ADF/cofilin, cofilin/ADF, Adf, T8, Cadf, l(2)k03101, l(2)k13409, Cofilin/actin depolymerizing factor-like, twinstar" CDMC31725 3 4 24 DAC38-K04 6-CG4254-RA_4 CG4254 TCGCGATGAAAAGCAGATTGATGTGGAGACTGTGGCAGATCGCAACGCCGAGTACGACCAGTTTCTAGA 69 FBan0004254 FBgn0011726 tsr 2 2R "actin filament depolymerization; GO:0030042; actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; female gonad development; GO:0008585; mitosis; GO:0007067; mushroom body development; GO:0016319; protein complex assembly; GO:0006461" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 tsr twinstar "CG4254, CG4254, CG4254, l(2)k05633, D61, l(2)03101, 12/8, ntf, no terminal filament, cofilin/actin depolymerizing factor homolog, D-cof, cofilin, ADFcofilin, Cofilin, ADF/cofilin, cofilin/ADF, Adf, T8, Cadf, l(2)k03101, l(2)k13409, Cofilin/actin depolymerizing factor-like, twinstar" CDMC31726 3 5 24 DAC38-K16 23-CG4264-RA_8 CG4264 CATTCACCCCCACACCTCAATGCAACCATACAGTAACAGTTCTCCAAACAATTTACCAACCAAACACAG 69 FBan0004264 FBgn0001219 Hsc70-4 3 3R axon guidance; GO:0007411; axonal fasciculation; GO:0007413; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; nervous system development; GO:0007399; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; protein folding; GO:0006457; protein refolding; GO:0042026; response to heat; GO:0009408; synaptic vesicle transport; GO:0048489; vesicle-mediated transport; GO:0016192 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739; nucleus; GO:0005634 Hsc70-4 Heat shock protein cognate 4 "CG4264, CG4264, CG4264, CG4264, CG4264, CG4264, Hsc4, hsc70, HSC4, hsc4, l(3)L3929, Hsc70, dhsc70, HSC70, scd, scattered, E(csp)1545, BAP74, Hsc4p, E(nd)195, bs17d06.y1, HSC-70, i190, hsc70-4, heat-shock protein 70, anon-WO0118547.237, l(3)03550, l(3)j7A4" CDMC31726 3 6 24 DAC38-K16 23-CG4264-RA_8 CG4264 CATTCACCCCCACACCTCAATGCAACCATACAGTAACAGTTCTCCAAACAATTTACCAACCAAACACAG 69 FBan0004264 FBgn0001219 Hsc70-4 3 3R axon guidance; GO:0007411; axonal fasciculation; GO:0007413; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; nervous system development; GO:0007399; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; protein folding; GO:0006457; protein refolding; GO:0042026; response to heat; GO:0009408; synaptic vesicle transport; GO:0048489; vesicle-mediated transport; GO:0016192 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739; nucleus; GO:0005634 Hsc70-4 Heat shock protein cognate 4 "CG4264, CG4264, CG4264, CG4264, CG4264, CG4264, Hsc4, hsc70, HSC4, hsc4, l(3)L3929, Hsc70, dhsc70, HSC70, scd, scattered, E(csp)1545, BAP74, Hsc4p, E(nd)195, bs17d06.y1, HSC-70, i190, hsc70-4, heat-shock protein 70, anon-WO0118547.237, l(3)03550, l(3)j7A4" CDMC31727 3 7 24 DAC38-O04 23-CG4317-RA_7 CG4317 ATTCGAAGGAACTGGAGTTCAACAATGATCAGATTAGGATTAGGACTAGTTTTGTAAGTGATGAGCGGC 69 FBan0004317 FBgn0026060 Mipp2 X X acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0004437; ; GO:0004437; ; GO:0003993 ; EC:3.1.3.2 Mipp2 Multiple inositol polyphosphate phosphatase 2 "CG4317, l(1)G0050, l(1)G0303" CDMC31727 3 8 24 DAC38-O04 23-CG4317-RA_7 CG4317 ATTCGAAGGAACTGGAGTTCAACAATGATCAGATTAGGATTAGGACTAGTTTTGTAAGTGATGAGCGGC 69 FBan0004317 FBgn0026060 Mipp2 X X acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0004437; ; GO:0004437; ; GO:0003993 ; EC:3.1.3.2 Mipp2 Multiple inositol polyphosphate phosphatase 2 "CG4317, l(1)G0050, l(1)G0303" CDMC31728 3 9 24 DAC38-O16 9-CG4323-RA_3 CG4323 CGATTGACTTGATCAAGGTGCTTATCCAAACTCAGGCGGAGAAGCTATCGGTATTCCAGACCACCCGCA 69 FBan0004323 FBgn0038797 CG4323 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4323 CG4323 CDMC31728 3 10 24 DAC38-O16 9-CG4323-RA_3 CG4323 CGATTGACTTGATCAAGGTGCTTATCCAAACTCAGGCGGAGAAGCTATCGGTATTCCAGACCACCCGCA 69 FBan0004323 FBgn0038797 CG4323 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG4323 CG4323 CDMC31729 3 11 24 DAC39-C04 3-CG6945-RA_1 CG6945 GCCACCCGCAAATCAGGCTCATACTCAGAACCAGAACCTAAGTCACAGTGGTAATGGCAGTTCAAGCGG 69 FBan0006945 FBgn0036476 CG6945 3 3L CG6945 CG6945 CDMC31729 3 12 24 DAC39-C04 3-CG6945-RA_1 CG6945 GCCACCCGCAAATCAGGCTCATACTCAGAACCAGAACCTAAGTCACAGTGGTAATGGCAGTTCAAGCGG 69 FBan0006945 FBgn0036476 CG6945 3 3L CG6945 CG6945 CDMC31730 3 13 24 DAC39-C16 1-CG6954-RA_1 CG6954 CGTGGTTCTCAAAGGGAACAATGGCCCCATCTATGGACCCGAGATGCTAGAGAACTTTTGCCTGGTTGC 69 FBan0006954 FBgn0039000 CG6954 3 3R signal transduction; GO:0007165 CG6954 CG6954 CDMC31730 3 14 24 DAC39-C16 1-CG6954-RA_1 CG6954 CGTGGTTCTCAAAGGGAACAATGGCCCCATCTATGGACCCGAGATGCTAGAGAACTTTTGCCTGGTTGC 69 FBan0006954 FBgn0039000 CG6954 3 3R signal transduction; GO:0007165 CG6954 CG6954 CDMC31731 3 15 24 DAC39-G04 2-CG6981-RB_1 CG6981 TGCGGAAATCGTAGCCTCAGGCGTCATGGTTGGATTCTTGATTTACACTGGATGCCACACCATTGCCTT 69 FBan0006981 FBgn0036945 CG6981 3 3L CG6981 CG6981 CT21613 CDMC31731 3 16 24 DAC39-G04 2-CG6981-RB_1 CG6981 TGCGGAAATCGTAGCCTCAGGCGTCATGGTTGGATTCTTGATTTACACTGGATGCCACACCATTGCCTT 69 FBan0006981 FBgn0036945 CG6981 3 3L CG6981 CG6981 CT21613 CDMC31732 3 17 24 DAC39-G16 14-CG6989-RA_1 CG6989 CGCCGTCATCTCGAGCTCCATATCGTTCTGGATACCCTGCACCATTATGATATTCACCTACCTGGCCAT 69 FBan0033976 FBgn0038063 Octbeta2R 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 Octbeta2R Octbeta2R "CG6989, CG33976, CG18553, CG6989, CG6989, CG6989, CG33976, DmCG6989, OctBeta2, anon-WO0170980.184, anon-WO0170980.185" CDMC31732 3 18 24 DAC39-G16 14-CG6989-RA_1 CG6989 CGCCGTCATCTCGAGCTCCATATCGTTCTGGATACCCTGCACCATTATGATATTCACCTACCTGGCCAT 69 FBan0033976 FBgn0038063 Octbeta2R 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 Octbeta2R Octbeta2R "CG6989, CG33976, CG18553, CG6989, CG6989, CG6989, CG33976, DmCG6989, OctBeta2, anon-WO0170980.184, anon-WO0170980.185" CDMC31733 3 19 24 DAC39-K04 23-CG7018-RA_18 CG7018 ATAAACCCGTAAGCCCTAACCACAATGAATAGAAACCAACCCCCAGCTAAATATTTTATGTGTGCGCGA 69 FBan0007018 FBgn0005658 Ets65A 3 3L "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Ets65A Ets at 65A "CG7018, CG13294, CG6882, D-Ets-3, ETS3, D-ets-3, Ets, Ets3, ets65A" CDMC31733 3 20 24 DAC39-K04 23-CG7018-RA_18 CG7018 ATAAACCCGTAAGCCCTAACCACAATGAATAGAAACCAACCCCCAGCTAAATATTTTATGTGTGCGCGA 69 FBan0007018 FBgn0005658 Ets65A 3 3L "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003700 nucleus; GO:0005634 Ets65A Ets at 65A "CG7018, CG13294, CG6882, D-Ets-3, ETS3, D-ets-3, Ets, Ets3, ets65A" CDMC31734 3 21 24 DAC39-K16 44-CG7029-RA_1 CG7029 AGACTAATGCCAGCACAGACGTGATCTTCTCACCCTTCAACTACAAGATGACAATGGATGGAGCGACTG 69 FBan0007029 FBgn0039026 CG7029 3 3R CG7029 CG7029 CDMC31734 3 22 24 DAC39-K16 44-CG7029-RA_1 CG7029 AGACTAATGCCAGCACAGACGTGATCTTCTCACCCTTCAACTACAAGATGACAATGGATGGAGCGACTG 69 FBan0007029 FBgn0039026 CG7029 3 3R CG7029 CG7029 CDMC31735 3 23 24 DAC39-O04 15-CG7058-RA_3 CG7058 ACGAGGACTCCGTGGTCTGCCTACTGGGAATAGCCGATCGATATATGGCCACTGCTTTAAAGTCGAAAT 69 FBan0007058 FBgn0030961 CG7058 X X CG7058 CG7058 CDMC31735 3 24 24 DAC39-O04 15-CG7058-RA_3 CG7058 ACGAGGACTCCGTGGTCTGCCTACTGGGAATAGCCGATCGATATATGGCCACTGCTTTAAAGTCGAAAT 69 FBan0007058 FBgn0030961 CG7058 X X CG7058 CG7058 CDMC31736 3 25 24 DAC39-O16 2-CG7071-RB_2 CG7071 GCGAAGTGGAGAAACTTTTCCAGGTCACCGAAACAGTGGGATCTCTGAAGTACGATCTGTCCCGGTGCA 69 FBan0007071 FBgn0038949 CG7071 3 3R CG7071 CG7071 BcDNA:RE40914 CDMC31736 3 26 24 DAC39-O16 2-CG7071-RB_2 CG7071 GCGAAGTGGAGAAACTTTTCCAGGTCACCGAAACAGTGGGATCTCTGAAGTACGATCTGTCCCGGTGCA 69 FBan0007071 FBgn0038949 CG7071 3 3R CG7071 CG7071 BcDNA:RE40914 CDMC31737 3 1 25 DAC40-C04 3-CG33324-RA_1 CG33324 TCTGCGAAAGAAACTGGGAGTACGACTGTGATGAACTGCTGGCCTACTCCAACTCCAGTGCACCG 65 FBan0033324 FBgn0053324 CG33324 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33324 CG33324 "CG10272, CG10272" CDMC31737 3 2 25 DAC40-C04 3-CG33324-RA_1 CG33324 TCTGCGAAAGAAACTGGGAGTACGACTGTGATGAACTGCTGGCCTACTCCAACTCCAGTGCACCG 65 FBan0033324 FBgn0053324 CG33324 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33324 CG33324 "CG10272, CG10272" CDMC31738 3 3 25 DAC40-C16 26-CG33352-RA_2 CG33352 AGTCTGCGCACAACTCCCCCCTCAAAGAGGACCTGACCGTGTACTACGACTCCTACTTGGATCTG 65 FBgn0053352 CDMC31738 3 4 25 DAC40-C16 26-CG33352-RA_2 CG33352 AGTCTGCGCACAACTCCCCCCTCAAAGAGGACCTGACCGTGTACTACGACTCCTACTTGGATCTG 65 FBgn0053352 CDMC31739 3 5 25 DAC40-G04 3-CG3427-RA_1 CG3427 CTGCAAGGAGTACCAGAACCTAAACGCCTTCTTCGCTGTGGTAATGGGTCTGTCCAACATGGCGG 65 FBan0003427 FBgn0033102 Epac 2 2R MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; small GTPase mediated signal transduction; GO:0007264 cAMP-dependent protein kinase regulator activity; GO:0008603; cyclic nucleotide-dependent guanyl-nucleotide exchange factor activity; GO:0017132; ; GO:0017132; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952 Epac Epac "CG3427, CG3427, CG3427, CG3427, D-EPAC" CDMC31739 3 6 25 DAC40-G04 3-CG3427-RA_1 CG3427 CTGCAAGGAGTACCAGAACCTAAACGCCTTCTTCGCTGTGGTAATGGGTCTGTCCAACATGGCGG 65 FBan0003427 FBgn0033102 Epac 2 2R MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; small GTPase mediated signal transduction; GO:0007264 cAMP-dependent protein kinase regulator activity; GO:0008603; cyclic nucleotide-dependent guanyl-nucleotide exchange factor activity; GO:0017132; ; GO:0017132; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952 Epac Epac "CG3427, CG3427, CG3427, CG3427, D-EPAC" CDMC31740 3 7 25 DAC40-G16 3-CG3466-RA_2 CG3466 TTTGTCAAGAAGAACCAGCGCAAGTACGGTCGCCTTTACAGGGTGTGGATTCTCCACCAGTTGGC 65 FBan0003466 FBgn0011576 Cyp4d2 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d2 Cytochrome P450-4d2 "CG3466, CG3466, P450, P-450, CYP4D2, cytochrome P-450., EG:152A3.4, 4d2, Cyt-P450-4D2: Cytochrome P450 4D2, Cytochrome P450 4D2" CDMC31740 3 8 25 DAC40-G16 3-CG3466-RA_2 CG3466 TTTGTCAAGAAGAACCAGCGCAAGTACGGTCGCCTTTACAGGGTGTGGATTCTCCACCAGTTGGC 65 FBan0003466 FBgn0011576 Cyp4d2 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d2 Cytochrome P450-4d2 "CG3466, CG3466, P450, P-450, CYP4D2, cytochrome P-450., EG:152A3.4, 4d2, Cyt-P450-4D2: Cytochrome P450 4D2, Cytochrome P450 4D2" CDMC31741 3 9 25 DAC40-K04 3-CG3619-RB_3 CG3619 AGCGAGAGCCGATGGTTTGACCAATGCCCAGGTAGTCCTAATTGCTGTTTTCTCCGTTGCGATGC 65 FBan0003619 FBgn0000463 Dl 3 3R "Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R8 cell differentiation; GO:0045465; antennal morphogenesis; GO:0007469; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; cell adhesion; GO:0007155; cell fate specification; GO:0001708; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; lateral inhibition; GO:0046331; leg joint morphogenesis; GO:0035111; leg morphogenesis (sensu Endopterygota); GO:0007480; leg segmentation; GO:0035286; mesoderm development; GO:0007498; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005112; ; GO:0004871; ; GO:0005509 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Dl Delta "CG3619, CG3619, C1, Complementation group 1, D, 0495/20, 0926/11, 1053/14, 1119/09, 1304/03, 1423/11, 1440/11, 1485/04, dmDelta, delta D1, delta, Overflow, CT12133, Delta, anon-WO0118547.269, l(3)05151, l(3)92Ab, l(3)j8C3" CDMC31741 3 10 25 DAC40-K04 3-CG3619-RB_3 CG3619 AGCGAGAGCCGATGGTTTGACCAATGCCCAGGTAGTCCTAATTGCTGTTTTCTCCGTTGCGATGC 65 FBan0003619 FBgn0000463 Dl 3 3R "Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R8 cell differentiation; GO:0045465; antennal morphogenesis; GO:0007469; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; cell adhesion; GO:0007155; cell fate specification; GO:0001708; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; lateral inhibition; GO:0046331; leg joint morphogenesis; GO:0035111; leg morphogenesis (sensu Endopterygota); GO:0007480; leg segmentation; GO:0035286; mesoderm development; GO:0007498; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005112; ; GO:0004871; ; GO:0005509 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Dl Delta "CG3619, CG3619, C1, Complementation group 1, D, 0495/20, 0926/11, 1053/14, 1119/09, 1304/03, 1423/11, 1440/11, 1485/04, dmDelta, delta D1, delta, Overflow, CT12133, Delta, anon-WO0118547.269, l(3)05151, l(3)92Ab, l(3)j8C3" CDMC31742 3 11 25 DAC40-K16 2-CG3645-RB_3 CG3645 TACGGCAATACCTAGCCACTGCAAATCAGCTCGTGCAATTCCAAGCCGTCGTGCAACAAGTACGG 65 FBan0003645 FBgn0031238 CG3645 2 2L CG3645 CG3645 CDMC31742 3 12 25 DAC40-K16 2-CG3645-RB_3 CG3645 TACGGCAATACCTAGCCACTGCAAATCAGCTCGTGCAATTCCAAGCCGTCGTGCAACAAGTACGG 65 FBan0003645 FBgn0031238 CG3645 2 2L CG3645 CG3645 CDMC31743 3 13 25 DAC40-O04 6-CG3722-RA_3 CG3722 CAGCCCTTCTACGAGGAGAAGCTGTACAAAGATCCTCATGCGTTACAGGGGAACATGCGCGACCC 65 FBan0003722 FBgn0003391 shg 2 2R asymmetric cell division; GO:0008356; axon guidance; GO:0007411; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; calcium-dependent cell-cell adhesion; GO:0016339; cell projection biogenesis; GO:0030031; establishment and/or maintenance of cell polarity; GO:0007163; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; follicle cell migration (sensu Insecta); GO:0007297; gastrulation (sensu Insecta); GO:0010004; germ cell migration; GO:0008354; germ-line stem cell division; GO:0042078; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; head involution; GO:0008258; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; morphogenesis of an epithelium; GO:0002009; nervous system development; GO:0007399; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; optic placode development (sensu Endopterygota); GO:0001748; pole cell migration; GO:0007280; signal transduction; GO:0007165; somatic stem cell division; GO:0048103; somatic stem cell maintenance; GO:0035019; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 beta-catenin binding; GO:0008013; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0008013 adherens junction; GO:0005912; cell-cell adherens junction; GO:0005913; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 shg shotgun "CG3722, cadherin, gp150, D-cad, DE-cadherin, E-cadherin, DE-Cadherin, Drosophila E-Cadherin, DE-cad, E-Cadherin, DECad, CADH, l(2)k03401, l(2)k10220, Cad, D-Ecadherin, DE-CAD, Cadherin, DEC, Drosophila E-cadherin, DCad, DCAD2, Ecad, DE[cyto], DE, CT12481, shg/DE-Cad, Shg, DE-Cad, E-cad, De-cadherin, E-Cad, eta-catenin, CadE, l(2)10469, Cadherin-E, shotgun" CDMC31743 3 14 25 DAC40-O04 6-CG3722-RA_3 CG3722 CAGCCCTTCTACGAGGAGAAGCTGTACAAAGATCCTCATGCGTTACAGGGGAACATGCGCGACCC 65 FBan0003722 FBgn0003391 shg 2 2R asymmetric cell division; GO:0008356; axon guidance; GO:0007411; axonogenesis; GO:0007409; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; calcium-dependent cell-cell adhesion; GO:0016339; cell projection biogenesis; GO:0030031; establishment and/or maintenance of cell polarity; GO:0007163; female germ-line cyst encapsulation (sensu Insecta); GO:0030708; follicle cell migration (sensu Insecta); GO:0007297; gastrulation (sensu Insecta); GO:0010004; germ cell migration; GO:0008354; germ-line stem cell division; GO:0042078; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; head involution; GO:0008258; heart development; GO:0007507; homophilic cell adhesion; GO:0007156; morphogenesis of an epithelium; GO:0002009; nervous system development; GO:0007399; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; optic placode development (sensu Endopterygota); GO:0001748; pole cell migration; GO:0007280; signal transduction; GO:0007165; somatic stem cell division; GO:0048103; somatic stem cell maintenance; GO:0035019; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 beta-catenin binding; GO:0008013; receptor activity; GO:0004872; structural molecule activity; GO:0005198; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0004872; ; GO:0005509; ; GO:0050839; ; GO:0008013 adherens junction; GO:0005912; cell-cell adherens junction; GO:0005913; integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 shg shotgun "CG3722, cadherin, gp150, D-cad, DE-cadherin, E-cadherin, DE-Cadherin, Drosophila E-Cadherin, DE-cad, E-Cadherin, DECad, CADH, l(2)k03401, l(2)k10220, Cad, D-Ecadherin, DE-CAD, Cadherin, DEC, Drosophila E-cadherin, DCad, DCAD2, Ecad, DE[cyto], DE, CT12481, shg/DE-Cad, Shg, DE-Cad, E-cad, De-cadherin, E-Cad, eta-catenin, CadE, l(2)10469, Cadherin-E, shotgun" CDMC31744 3 15 25 DAC40-O16 23-CG3769-RA_2 CG3769 ATAATTGTCGGTGGGAAGTACGATGTGTTTTCTGGTTTCGATCCTATTATCAGGAAGCACACCTG 65 FBan0003769 FBgn0032119 CG3769 2 2L CG3769 CG3769 CDMC31744 3 16 25 DAC40-O16 23-CG3769-RA_2 CG3769 ATAATTGTCGGTGGGAAGTACGATGTGTTTTCTGGTTTCGATCCTATTATCAGGAAGCACACCTG 65 FBan0003769 FBgn0032119 CG3769 2 2L CG3769 CG3769 CDMC31745 3 17 25 DAC41-C04 AutoBlank AutoBlank CDMC31745 3 18 25 DAC41-C04 AutoBlank AutoBlank CDMC31746 3 19 25 DAC41-C16 AutoBlank AutoBlank CDMC31746 3 20 25 DAC41-C16 AutoBlank AutoBlank CDMC31747 3 21 25 DAC41-G04 AutoBlank AutoBlank CDMC31747 3 22 25 DAC41-G04 AutoBlank AutoBlank CDMC31748 3 23 25 DAC41-G16 AutoBlank AutoBlank CDMC31748 3 24 25 DAC41-G16 AutoBlank AutoBlank CDMC31749 3 25 25 DAC41-K04 AutoBlank AutoBlank CDMC31749 3 26 25 DAC41-K04 AutoBlank AutoBlank CDMC31750 3 1 26 DAC41-K16 AutoBlank AutoBlank CDMC31750 3 2 26 DAC41-K16 AutoBlank AutoBlank CDMC31751 3 3 26 DAC41-O04 AutoBlank AutoBlank CDMC31751 3 4 26 DAC41-O04 AutoBlank AutoBlank CDMC31752 3 5 26 DAC41-O16 AutoBlank AutoBlank CDMC31752 3 6 26 DAC41-O16 AutoBlank AutoBlank CDMC31753 3 7 26 DAC42-C04 150mM NaPO4 Blank CDMC31753 3 8 26 DAC42-C04 150mM NaPO4 Blank CDMC31754 3 9 26 DAC42-C16 150mM NaPO4 Blank CDMC31754 3 10 26 DAC42-C16 150mM NaPO4 Blank CDMC31755 3 11 26 DAC42-G04 150mM NaPO4 Blank CDMC31755 3 12 26 DAC42-G04 150mM NaPO4 Blank CDMC31756 3 13 26 DAC42-G16 150mM NaPO4 Blank CDMC31756 3 14 26 DAC42-G16 150mM NaPO4 Blank CDMC31757 3 15 26 DAC42-K04 150mM NaPO4 Blank CDMC31757 3 16 26 DAC42-K04 150mM NaPO4 Blank CDMC31758 3 17 26 DAC42-K16 5uM MSP 5uM MSP CDMC31758 3 18 26 DAC42-K16 5uM MSP 5uM MSP CDMC31759 3 19 26 DAC42-O04 10uM MSP 10uM MSP CDMC31759 3 20 26 DAC42-O04 10uM MSP 10uM MSP CDMC31760 3 21 26 DAC42-O16 20uM MSP 20uM MSP CDMC31760 3 22 26 DAC42-O16 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC31761 4 1 1 DAC01-D04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31761 4 2 1 DAC01-D04 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC31762 4 3 1 DAC01-D16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31762 4 4 1 DAC01-D16 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC31763 4 5 1 DAC01-H04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31763 4 6 1 DAC01-H04 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC31764 4 7 1 DAC01-H16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31764 4 8 1 DAC01-H16 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC31765 4 9 1 DAC01-L04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31765 4 10 1 DAC01-L04 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC31766 4 11 1 DAC01-L16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31766 4 12 1 DAC01-L16 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC31767 4 13 1 DAC01-P04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31767 4 14 1 DAC01-P04 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC31768 4 15 1 DAC01-P16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31768 4 16 1 DAC01-P16 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC31769 4 17 1 DAC02-D04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31769 4 18 1 DAC02-D04 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC31770 4 19 1 DAC02-D16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31770 4 20 1 DAC02-D16 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC31771 4 21 1 DAC02-H04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31771 4 22 1 DAC02-H04 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC31772 4 23 1 DAC02-H16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31772 4 24 1 DAC02-H16 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC31773 4 25 1 DAC02-L04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31773 4 26 1 DAC02-L04 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC31774 4 1 2 DAC02-L16 N/A CG9075 (01435-01673) CDMC31774 4 2 2 DAC02-L16 N/A CG9075 (01435-01673) CDMC31775 4 3 2 DAC02-P04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31775 4 4 2 DAC02-P04 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC31776 4 5 2 DAC02-P16 AutoBlank AutoBlank CDMC31776 4 6 2 DAC02-P16 AutoBlank AutoBlank CDMC31777 4 7 2 DAC03-D04 12-CG5447-RA_1 CG5447 ACAGGCATGTGAAGGAGAAGAGTCCGTTTCAGCAATTATCAAGCAAAAGTCAGCGCCATCAGAGTGCGT 69 FBan0005447 FBgn0039427 CG5447 3 3R CG5447 CG5447 CDMC31777 4 8 2 DAC03-D04 12-CG5447-RA_1 CG5447 ACAGGCATGTGAAGGAGAAGAGTCCGTTTCAGCAATTATCAAGCAAAAGTCAGCGCCATCAGAGTGCGT 69 FBan0005447 FBgn0039427 CG5447 3 3R CG5447 CG5447 CDMC31778 4 9 2 DAC03-D16 23-CG5461-RA_5 CG5461 AAATCGATAAAGTGTACTAGAGTGCCAGGGAAAACACACAGAAAATGAATAGGGACAGAAGGGAAAATA 69 FBan0005461 FBgn0010460 bun 2 2L autophagic cell death; GO:0048102; cell fate determination; GO:0001709; decapentaplegic receptor signaling pathway; GO:0008101; dorsal appendage formation; GO:0046843; eggshell formation (sensu Insecta); GO:0007304; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; negative regulation of cell fate specification; GO:0009996; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; segmentation; GO:0035282 RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 bun bunched "CG5461, CG5461, CG5461, TSC-22, shs, l(2)00255, 1550, shortsighted, l(2)02687, l(2)05479, l(2)06475, l(2)k02903, EP(2)0488, short-sighted, Tsc22, l(2)rI043, short sighted, bunched" CDMC31778 4 10 2 DAC03-D16 23-CG5461-RA_5 CG5461 AAATCGATAAAGTGTACTAGAGTGCCAGGGAAAACACACAGAAAATGAATAGGGACAGAAGGGAAAATA 69 FBan0005461 FBgn0010460 bun 2 2L autophagic cell death; GO:0048102; cell fate determination; GO:0001709; decapentaplegic receptor signaling pathway; GO:0008101; dorsal appendage formation; GO:0046843; eggshell formation (sensu Insecta); GO:0007304; eye development (sensu Endopterygota); GO:0007456; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; negative regulation of cell fate specification; GO:0009996; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; segmentation; GO:0035282 RNA polymerase II transcription factor activity; GO:0003702; protein homodimerization activity; GO:0042803; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 cytoplasm; GO:0005737; nucleus; GO:0005634 bun bunched "CG5461, CG5461, CG5461, TSC-22, shs, l(2)00255, 1550, shortsighted, l(2)02687, l(2)05479, l(2)06475, l(2)k02903, EP(2)0488, short-sighted, Tsc22, l(2)rI043, short sighted, bunched" CDMC31779 4 11 2 DAC03-H04 12-CG5478-RA_1 CG5478 ACATTTTCGACGCTCTGGGGAGAAAGGCGAAAAAATCAAAATCCAAGCACTGAACCGTTTCTGGTGGGG 69 FBan0005478 FBgn0038386 CG5478 3 3R CG5478 CG5478 CDMC31779 4 12 2 DAC03-H04 12-CG5478-RA_1 CG5478 ACATTTTCGACGCTCTGGGGAGAAAGGCGAAAAAATCAAAATCCAAGCACTGAACCGTTTCTGGTGGGG 69 FBan0005478 FBgn0038386 CG5478 3 3R CG5478 CG5478 CDMC31780 4 13 2 DAC03-H16 3-CG5489-RA_1 CG5489 GGTCTGCTAGGAATTTTGCCTCACTCCATCCGTGGAATGCTGTGCAACTACGAGAATATTCTGCCCGCC 69 FBan0005489 FBgn0034366 Atg7 2 2R autophagy; GO:0006914; intracellular signaling cascade; GO:0007242; protein metabolism; GO:0019538; proteolysis; GO:0006508; signal transduction; GO:0007165 carrier activity; GO:0005386; catalytic activity; GO:0003824; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0003824 Atg7 Autophagy-specific gene 7 "CG5489, CG5489, Autophagy-specific gene 7" CDMC31780 4 14 2 DAC03-H16 3-CG5489-RA_1 CG5489 GGTCTGCTAGGAATTTTGCCTCACTCCATCCGTGGAATGCTGTGCAACTACGAGAATATTCTGCCCGCC 69 FBan0005489 FBgn0034366 Atg7 2 2R autophagy; GO:0006914; intracellular signaling cascade; GO:0007242; protein metabolism; GO:0019538; proteolysis; GO:0006508; signal transduction; GO:0007165 carrier activity; GO:0005386; catalytic activity; GO:0003824; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0003824 Atg7 Autophagy-specific gene 7 "CG5489, CG5489, Autophagy-specific gene 7" CDMC31781 4 15 2 DAC03-L04 23-CG5518-RA_13 CG5518 ATAGTTCGAATAACTCCCATTCATCACTTCAGGCAACAGTTTAAGTCCACAACACAATATCTGCCACGA 69 FBan0005518 FBgn0015541 sda 3 3R mechanosensory behavior; GO:0007638; proteolysis; GO:0006508; response to mechanical stimulus; GO:0009612 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 sda slamdance "CG5518, BcDNA:GH07466, slamdance" CDMC31781 4 16 2 DAC03-L04 23-CG5518-RA_13 CG5518 ATAGTTCGAATAACTCCCATTCATCACTTCAGGCAACAGTTTAAGTCCACAACACAATATCTGCCACGA 69 FBan0005518 FBgn0015541 sda 3 3R mechanosensory behavior; GO:0007638; proteolysis; GO:0006508; response to mechanical stimulus; GO:0009612 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 sda slamdance "CG5518, BcDNA:GH07466, slamdance" CDMC31782 4 17 2 DAC03-L16 23-CG5532-RA_9 CG5532 AACACCTCCACTTCTCACCAAAACAAAGGTTACCCCGAAATTTAATCAAAATAAATCGAAATGCCGGTG 69 FBan0005532 FBgn0034902 CG5532 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 membrane; GO:0016020 CG5532 CG5532 CDMC31782 4 18 2 DAC03-L16 23-CG5532-RA_9 CG5532 AACACCTCCACTTCTCACCAAAACAAAGGTTACCCCGAAATTTAATCAAAATAAATCGAAATGCCGGTG 69 FBan0005532 FBgn0034902 CG5532 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 membrane; GO:0016020 CG5532 CG5532 CDMC31783 4 19 2 DAC03-P04 9-CG5568-RA_1 CG5568 TGCTGTCCAATTGCCCGGAATTCTATGCGGCGGACCTATCATCCGTGAAGTATTTCTTTTACGGCGGAT 69 FBan0005568 FBgn0035641 CG5568 3 3L metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016207 ; EC:6.2.1.12 CG5568 CG5568 CDMC31783 4 20 2 DAC03-P04 9-CG5568-RA_1 CG5568 TGCTGTCCAATTGCCCGGAATTCTATGCGGCGGACCTATCATCCGTGAAGTATTTCTTTTACGGCGGAT 69 FBan0005568 FBgn0035641 CG5568 3 3L metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016207 ; EC:6.2.1.12 CG5568 CG5568 CDMC31784 4 21 2 DAC03-P16 3-CG5588-RA_1 CG5588 GGCTGTTTTTTTCTGCGGATCGTTGCTGTCACACATTTGGCAAACCACGATTCCCTCCCGCAACAACTA 69 FBan0005588 FBgn0039532 Mtl 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; morphogenesis of an epithelium; GO:0002009; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Mtl Mig-2-like "CG5588, Mt1/Mig2-like, Rac GTPase, mtl, dMig-2, Mtl(Rac-like), Mig-2-like" CDMC31784 4 22 2 DAC03-P16 3-CG5588-RA_1 CG5588 GGCTGTTTTTTTCTGCGGATCGTTGCTGTCACACATTTGGCAAACCACGATTCCCTCCCGCAACAACTA 69 FBan0005588 FBgn0039532 Mtl 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; morphogenesis of an epithelium; GO:0002009; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Mtl Mig-2-like "CG5588, Mt1/Mig2-like, Rac GTPase, mtl, dMig-2, Mtl(Rac-like), Mig-2-like" CDMC31785 4 23 2 DAC04-D04 2-CG12376-RA_1 CG12376 TCCATGGTTTCAGGAGGCCTGATCTGCTACACGAGTCCCTTCAAGATGAACGCGTACGAAAGTGTTCGG 69 FBan0012376 FBgn0033323 CG12376 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 integral to membrane; GO:0016021 CG12376 CG12376 anon-WO0140519.77 CDMC31785 4 24 2 DAC04-D04 2-CG12376-RA_1 CG12376 TCCATGGTTTCAGGAGGCCTGATCTGCTACACGAGTCCCTTCAAGATGAACGCGTACGAAAGTGTTCGG 69 FBan0012376 FBgn0033323 CG12376 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 integral to membrane; GO:0016021 CG12376 CG12376 anon-WO0140519.77 CDMC31786 4 25 2 DAC04-D16 15-CG12388-RA_1 CG12388 TGGAACCGATGGATTTATTTACCCAGTAGCCAATTGGACCCATCATCCGAACTACGATCCCGTGACAGT 69 FBan0012388 FBgn0043471 kappaTry 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 kappaTry kappaTry "CG12388, SPH109" CDMC31786 4 26 2 DAC04-D16 15-CG12388-RA_1 CG12388 TGGAACCGATGGATTTATTTACCCAGTAGCCAATTGGACCCATCATCCGAACTACGATCCCGTGACAGT 69 FBan0012388 FBgn0043471 kappaTry 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 kappaTry kappaTry "CG12388, SPH109" CDMC31787 4 1 3 DAC04-H04 23-CG12424-RB_9 CG12424 ACTGAAAAGCTTTGGACAAACCATGTATACTTTTGTACTTTTCCTAAACTCTCCTCCCATTCCCGAAAC 69 FBan0012424 FBgn0033987 CG12424 2 2R CG12424 CG12424 BcDNA:GM06913 CDMC31787 4 2 3 DAC04-H04 23-CG12424-RB_9 CG12424 ACTGAAAAGCTTTGGACAAACCATGTATACTTTTGTACTTTTCCTAAACTCTCCTCCCATTCCCGAAAC 69 FBan0012424 FBgn0033987 CG12424 2 2R CG12424 CG12424 BcDNA:GM06913 CDMC31788 4 3 3 DAC04-H16 17-CG12438-RA_1 CG12438 GCTGCTCATTTGTGCCGTTCTAATTAGCACTGGATTTTATATGAACCCCTTCAAACTGGCCGTTGTGGG 69 FBan0012438 FBgn0032065 CG12438 2 2L CG12438 CG12438 CDMC31788 4 4 3 DAC04-H16 17-CG12438-RA_1 CG12438 GCTGCTCATTTGTGCCGTTCTAATTAGCACTGGATTTTATATGAACCCCTTCAAACTGGCCGTTGTGGG 69 FBan0012438 FBgn0032065 CG12438 2 2L CG12438 CG12438 CDMC31789 4 5 3 DAC04-L04 23-CG12488-RA_3 CG12488 TACACTATATAGAACAGAACGCATTATGATCGTGAGGAGGGAATCTAGACGTAAGCTCGTATGAACATT 69 FBan0012488 FBgn0033772 CG12488 2 2R CG12488 CG12488 BcDNA:SD15892 CDMC31789 4 6 3 DAC04-L04 23-CG12488-RA_3 CG12488 TACACTATATAGAACAGAACGCATTATGATCGTGAGGAGGGAATCTAGACGTAAGCTCGTATGAACATT 69 FBan0012488 FBgn0033772 CG12488 2 2R CG12488 CG12488 BcDNA:SD15892 CDMC31790 4 7 3 DAC04-L16 3-CG12499-RA_2 CG12499 ACAGCAGGAGACGAATGTGGCTCAGGTGCTAGCCCTGATTGTTCGAGAGACTAGCGAGTACACCATTGA 69 FBan0012499 FBgn0038968 CG12499 3 3R CG12499 CG12499 CDMC31790 4 8 3 DAC04-L16 3-CG12499-RA_2 CG12499 ACAGCAGGAGACGAATGTGGCTCAGGTGCTAGCCCTGATTGTTCGAGAGACTAGCGAGTACACCATTGA 69 FBan0012499 FBgn0038968 CG12499 3 3R CG12499 CG12499 CDMC31791 4 9 3 DAC04-P04 22-CG12539-RA_1 CG12539 ACTTGCAAATATTCACCTTTTCGCAAGTGACCCGCATTCTGATCGATGAGGCTACGAAATCCGCTTACG 69 FBan0012539 FBgn0030586 CG12539 X X electron transport; GO:0006118 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 CG12539 CG12539 CDMC31791 4 10 3 DAC04-P04 22-CG12539-RA_1 CG12539 ACTTGCAAATATTCACCTTTTCGCAAGTGACCCGCATTCTGATCGATGAGGCTACGAAATCCGCTTACG 69 FBan0012539 FBgn0030586 CG12539 X X electron transport; GO:0006118 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 CG12539 CG12539 CDMC31792 4 11 3 DAC04-P16 12-CG12558-RA_9 CG12558 AGCGGAGGCAACAAAGAACCCAACAGCCTAGAGATAATTCCCGCTGAAATCGAGACTCTCCTTACCGAT 69 FBan0012558 FBgn0039599 CG12558 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG12558 CG12558 SPH202 CDMC31792 4 12 3 DAC04-P16 12-CG12558-RA_9 CG12558 AGCGGAGGCAACAAAGAACCCAACAGCCTAGAGATAATTCCCGCTGAAATCGAGACTCTCCTTACCGAT 69 FBan0012558 FBgn0039599 CG12558 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG12558 CG12558 SPH202 CDMC31793 4 13 3 DAC05-D04 3-CG5056-RA_1 CG5056 GCAGACCACGTCGTAGATCCGAGAGTTGTCTGCAGGACTGCAAGCAAGAGGACTCCTTTGTTCCAGAAG 69 FBan0005056 FBgn0032231 CG5056 2 2L CG5056 CG5056 CDMC31793 4 14 3 DAC05-D04 3-CG5056-RA_1 CG5056 GCAGACCACGTCGTAGATCCGAGAGTTGTCTGCAGGACTGCAAGCAAGAGGACTCCTTTGTTCCAGAAG 69 FBan0005056 FBgn0032231 CG5056 2 2L CG5056 CG5056 CDMC31794 4 15 3 DAC05-D16 14-CG5065-RA_2 CG5065 CCGAGGTTATCTACGCACCGCCCTACAATCCCGATGATATCATTTCACTAATCAACTGGCTTCCGGAGG 69 FBan0005065 FBgn0034145 CG5065 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG5065 CG5065 CDMC31794 4 16 3 DAC05-D16 14-CG5065-RA_2 CG5065 CCGAGGTTATCTACGCACCGCCCTACAATCCCGATGATATCATTTCACTAATCAACTGGCTTCCGGAGG 69 FBan0005065 FBgn0034145 CG5065 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG5065 CG5065 CDMC31795 4 17 3 DAC05-H04 23-CG5099-RA_7 CG5099 GATCCTTCGACCTATTTCCCAATCACCAAGTCTTTCATTTGCATAACCATCCAAACAGCTCATGAACCA 69 FBan0005099 FBgn0011666 msi 3 3R cell fate determination; GO:0001709; ectoderm development; GO:0007398; mRNA processing; GO:0006397; negative regulation of translation; GO:0016478; nervous system development; GO:0007399; regulation of translation; GO:0006445; transmission of nerve impulse; GO:0019226 "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation regulator activity; GO:0045182; ; GO:0000900; ; GO:0045182" msi musashi "CG5099, clone 2.35, DMSIDNA, SIDNA, anon-EST:Liang-2.35, musashi" CDMC31795 4 18 3 DAC05-H04 23-CG5099-RA_7 CG5099 GATCCTTCGACCTATTTCCCAATCACCAAGTCTTTCATTTGCATAACCATCCAAACAGCTCATGAACCA 69 FBan0005099 FBgn0011666 msi 3 3R cell fate determination; GO:0001709; ectoderm development; GO:0007398; mRNA processing; GO:0006397; negative regulation of translation; GO:0016478; nervous system development; GO:0007399; regulation of translation; GO:0006445; transmission of nerve impulse; GO:0019226 "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation regulator activity; GO:0045182; ; GO:0000900; ; GO:0045182" msi musashi "CG5099, clone 2.35, DMSIDNA, SIDNA, anon-EST:Liang-2.35, musashi" CDMC31796 4 19 3 DAC05-H16 13-CG5110-RA_1 CG5110 ATTGGGCAGAAACAAGACCATCATCTCCATGTACTCCAATTACCAGGTGGTCCAGATGAACAAGCTGCC 69 FBan0005110 FBgn0032642 CG5110 2 2L phosphorylation; GO:0016310 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 cellular component unknown; GO:0008372 CG5110 CG5110 "MP1, BcDNA:RE09173" CDMC31796 4 20 3 DAC05-H16 13-CG5110-RA_1 CG5110 ATTGGGCAGAAACAAGACCATCATCTCCATGTACTCCAATTACCAGGTGGTCCAGATGAACAAGCTGCC 69 FBan0005110 FBgn0032642 CG5110 2 2L phosphorylation; GO:0016310 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 cellular component unknown; GO:0008372 CG5110 CG5110 "MP1, BcDNA:RE09173" CDMC31797 4 21 3 DAC05-L04 8-CG5149-RA_1 CG5149 CGAAAATCAACGGGGAAAGCTTCTCGACGATGTTGGGAAAAGTGCTGGACAAAGGACCAACGCTGTTCT 69 FBan0005149 FBgn0031904 CG5149 2 2L CG5149 CG5149 CDMC31797 4 22 3 DAC05-L04 8-CG5149-RA_1 CG5149 CGAAAATCAACGGGGAAAGCTTCTCGACGATGTTGGGAAAAGTGCTGGACAAAGGACCAACGCTGTTCT 69 FBan0005149 FBgn0031904 CG5149 2 2L CG5149 CG5149 CDMC31798 4 23 3 DAC05-L16 15-CG5164-RA_1 CG5164 GTCGAGCTCTGGAATTGTACTCTATGGGACAGATCTCAGTCCCTGTGTGAGGACCGTCAAACTTACCCT 69 FBan0005164 FBgn0034335 GstE1 2 2R defense response; GO:0006952; response to oxidative stress; GO:0006979; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstE1 Glutathione S transferase E1 "CG5164, CG5164, gst-3, Gst-theta 55F, Gst55F, Gst3, Gst-3, GST-3, DmGSTE1, GST3, DmGST-3, CT16545, Glutathione S-transferase, glutathione-S-transferase, DmGSTE1-1, Glutathione S transferase E1" CDMC31798 4 24 3 DAC05-L16 15-CG5164-RA_1 CG5164 GTCGAGCTCTGGAATTGTACTCTATGGGACAGATCTCAGTCCCTGTGTGAGGACCGTCAAACTTACCCT 69 FBan0005164 FBgn0034335 GstE1 2 2R defense response; GO:0006952; response to oxidative stress; GO:0006979; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstE1 Glutathione S transferase E1 "CG5164, CG5164, gst-3, Gst-theta 55F, Gst55F, Gst3, Gst-3, GST-3, DmGSTE1, GST3, DmGST-3, CT16545, Glutathione S-transferase, glutathione-S-transferase, DmGSTE1-1, Glutathione S transferase E1" CDMC31799 4 25 3 DAC05-P04 8-CG5193-RA_1 CG5193 CCGCAGCCGCAATCTATATGGCCTCACAAGCATCCGAGCATAAGAGAAGCCAGAAGGAAATCGGTGATA 69 FBan0005193 FBgn0004915 TfIIB 2 2L regulation of DNA binding; GO:0051101; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor binding; GO:0008134; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0008134 nucleus; GO:0005634; transcription factor complex; GO:0005667 TfIIB Transcription factor IIB "CG5193, CG5193, TFIIB, dTfIIB, dTFIIB, Tfiib" CDMC31799 4 26 3 DAC05-P04 8-CG5193-RA_1 CG5193 CCGCAGCCGCAATCTATATGGCCTCACAAGCATCCGAGCATAAGAGAAGCCAGAAGGAAATCGGTGATA 69 FBan0005193 FBgn0004915 TfIIB 2 2L regulation of DNA binding; GO:0051101; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor binding; GO:0008134; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0008134 nucleus; GO:0005634; transcription factor complex; GO:0005667 TfIIB Transcription factor IIB "CG5193, CG5193, TFIIB, dTfIIB, dTFIIB, Tfiib" CDMC31800 4 1 4 DAC05-P16 12-CG5203-RA_3 CG5203 CGAGTGCTTCGGTGTTGTTGGACACACACTCACTTTTCATCGGTGGAAAATCAAATTTGGGACCAGGCG 69 FBan0005203 FBgn0027052 CHIP 2 2L protein folding; GO:0006457; protein metabolism; GO:0019538; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CHIP CHIP "CG5203, dCHIP" CDMC31800 4 2 4 DAC05-P16 12-CG5203-RA_3 CG5203 CGAGTGCTTCGGTGTTGTTGGACACACACTCACTTTTCATCGGTGGAAAATCAAATTTGGGACCAGGCG 69 FBan0005203 FBgn0027052 CHIP 2 2L protein folding; GO:0006457; protein metabolism; GO:0019538; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CHIP CHIP "CG5203, dCHIP" CDMC31801 4 3 4 DAC06-D04 16-CG9389-RA_1 CG9389 GCAGAGCATAAACAGCAAGTTGACCAATACCGACATCACTTTTCACCCATCCAAGGTATTCGCCTCGAA 69 FBan0009389 FBgn0037064 CG9389 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG9389 CG9389 IMP CDMC31801 4 4 4 DAC06-D04 16-CG9389-RA_1 CG9389 GCAGAGCATAAACAGCAAGTTGACCAATACCGACATCACTTTTCACCCATCCAAGGTATTCGCCTCGAA 69 FBan0009389 FBgn0037064 CG9389 3 3L dephosphorylation; GO:0016311; intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644 inositol-1(or 4)-monophosphatase activity; GO:0008934 ; EC:3.1.3.25; ; GO:0008934 ; EC:3.1.3.25 CG9389 CG9389 IMP CDMC31802 4 5 4 DAC06-D16 15-CG9406-RA_1 CG9406 TGCCGAGGTTATCAAGGAGGAACTAGCACAAGCCGAAAAAGAAAAGGGCAAGAAACCACAACAACCACT 69 FBan0009406 FBgn0034592 CG9406 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG9406 CG9406 CDMC31802 4 6 4 DAC06-D16 15-CG9406-RA_1 CG9406 TGCCGAGGTTATCAAGGAGGAACTAGCACAAGCCGAAAAAGAAAAGGGCAAGAAACCACAACAACCACT 69 FBan0009406 FBgn0034592 CG9406 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG9406 CG9406 CDMC31803 4 7 4 DAC06-H04 23-CG9434-RA_7 CG9434 AAGAATCCACTATCGATTCTTCAGCGGTCTAGGAAGTTAGTTTCATTGTTACCAAGGTTTCTGGTTCAT 69 FBan0009434 FBgn0037724 Fst 3 3R response to cold; GO:0009409 Fst Frost "CG9434, CG9434, frost, Frost" CDMC31803 4 8 4 DAC06-H04 23-CG9434-RA_7 CG9434 AAGAATCCACTATCGATTCTTCAGCGGTCTAGGAAGTTAGTTTCATTGTTACCAAGGTTTCTGGTTCAT 69 FBan0009434 FBgn0037724 Fst 3 3R response to cold; GO:0009409 Fst Frost "CG9434, CG9434, frost, Frost" CDMC31804 4 9 4 DAC06-H16 23-CG9445-RA_4 CG9445 ATAGCACCCATGTATGAGCCATCATAAGAGGAATATATGTATCTAATGTTGCACCAACCTTGGGCTACA 69 FBan0009445 FBgn0040674 CG9445 2 2R mesoderm development; GO:0007498 CG9445 CG9445 CDMC31804 4 10 4 DAC06-H16 23-CG9445-RA_4 CG9445 ATAGCACCCATGTATGAGCCATCATAAGAGGAATATATGTATCTAATGTTGCACCAACCTTGGGCTACA 69 FBan0009445 FBgn0040674 CG9445 2 2R mesoderm development; GO:0007498 CG9445 CG9445 CDMC31805 4 11 4 DAC06-L04 2-CG9480-RB_1 CG9480 TGCCCAGGATTTGATTCAGCTGTGGTGGAACATCTTTTGCGAAAATGTCATCCAGTCCCTGTCCACCGA 69 FBan0009480 FBgn0034603 Glycogenin 2 2R carbohydrate biosynthesis; GO:0016051; mesoderm development; GO:0007498 glycogenin glucosyltransferase activity; GO:0008466 ; EC:2.4.1.186; ; GO:0008466 ; EC:2.4.1.186 Glycogenin Glycogenin "CG9480, CG9480, CG9480, CG9480, CG9480, FBgn0034603, NEST:bs16a02, Glycogenin" CDMC31805 4 12 4 DAC06-L04 2-CG9480-RB_1 CG9480 TGCCCAGGATTTGATTCAGCTGTGGTGGAACATCTTTTGCGAAAATGTCATCCAGTCCCTGTCCACCGA 69 FBan0009480 FBgn0034603 Glycogenin 2 2R carbohydrate biosynthesis; GO:0016051; mesoderm development; GO:0007498 glycogenin glucosyltransferase activity; GO:0008466 ; EC:2.4.1.186; ; GO:0008466 ; EC:2.4.1.186 Glycogenin Glycogenin "CG9480, CG9480, CG9480, CG9480, CG9480, FBgn0034603, NEST:bs16a02, Glycogenin" CDMC31806 4 13 4 DAC06-L16 18-CG9495-RA_3 CG9495 AGGTGATCCAGTACATCGAGAGCAACGACAACTCCCTTGCAGTTCATGGTGATCTCTTCCGAAAGCACG 69 FBan0009495 FBgn0003334 Scm 3 3R female germ-line cyst encapsulation (sensu Insecta); GO:0030708; gene silencing; GO:0016458; regulation of transcription; GO:0045449; stalk formation (sensu Insecta); GO:0030713 chromatin binding; GO:0003682; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003682; ; GO:0003704 PRC1 complex; GO:0035102; nucleus; GO:0005634 Scm Sex comb on midleg "CG9495, CG9495, Su(z)302, SCM, scm, l(3)85Ef, Sex combs on midleg" CDMC31806 4 14 4 DAC06-L16 18-CG9495-RA_3 CG9495 AGGTGATCCAGTACATCGAGAGCAACGACAACTCCCTTGCAGTTCATGGTGATCTCTTCCGAAAGCACG 69 FBan0009495 FBgn0003334 Scm 3 3R female germ-line cyst encapsulation (sensu Insecta); GO:0030708; gene silencing; GO:0016458; regulation of transcription; GO:0045449; stalk formation (sensu Insecta); GO:0030713 chromatin binding; GO:0003682; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003682; ; GO:0003704 PRC1 complex; GO:0035102; nucleus; GO:0005634 Scm Sex comb on midleg "CG9495, CG9495, Su(z)302, SCM, scm, l(3)85Ef, Sex combs on midleg" CDMC31807 4 15 4 DAC06-P04 23-CG9523-RA_1 CG9523 CCGGATCTGGAGATCTACCGTGACCCATCTAGATGCATTGATATTAGACAATTCGTTAATTTATTATTT 69 FBan0009523 FBgn0031812 CG9523 2 2L CG9523 CG9523 CDMC31807 4 16 4 DAC06-P04 23-CG9523-RA_1 CG9523 CCGGATCTGGAGATCTACCGTGACCCATCTAGATGCATTGATATTAGACAATTCGTTAATTTATTATTT 69 FBan0009523 FBgn0031812 CG9523 2 2L CG9523 CG9523 CDMC31808 4 17 4 DAC06-P16 16-CG9536-RA_2 CG9536 ACCCCCCATCAGTGTTCCCATTTTGTAATTACCGTTCGTGTGTTTCGTAGTGTCCTGTAGACTTACGCT 69 FBan0009536 FBgn0031818 CG9536 2 2L CG9536 CG9536 CDMC31808 4 18 4 DAC06-P16 16-CG9536-RA_2 CG9536 ACCCCCCATCAGTGTTCCCATTTTGTAATTACCGTTCGTGTGTTTCGTAGTGTCCTGTAGACTTACGCT 69 FBan0009536 FBgn0031818 CG9536 2 2L CG9536 CG9536 CDMC31809 4 19 4 DAC07-D04 23-CG6584-RB_9 CG6584 TGGCCAATTTTAGCTCGTAGTCAAGTCAATCGCCCCTCTGTTTGTGTAAATAGCTAATGTTTTGGTTCG 69 FBan0006584 FBgn0037847 SelR 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; peptidyl-methionine modification; GO:0018206 zinc ion binding; GO:0008270; ; GO:0008270; protein-methionine-R-oxide reductase activity; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.-; ; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.- SelR SelR "CG6584, MsrB, methionine-R-sulfoxide reductase, BcDNA:RE36040, BcDNA:RH61230" CDMC31809 4 20 4 DAC07-D04 23-CG6584-RB_9 CG6584 TGGCCAATTTTAGCTCGTAGTCAAGTCAATCGCCCCTCTGTTTGTGTAAATAGCTAATGTTTTGGTTCG 69 FBan0006584 FBgn0037847 SelR 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; peptidyl-methionine modification; GO:0018206 zinc ion binding; GO:0008270; ; GO:0008270; protein-methionine-R-oxide reductase activity; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.-; ; GO:0000318 ; EC:1.8.4.-; ; GO:0008270; ; GO:0000318 ; EC:1.8.4.- SelR SelR "CG6584, MsrB, methionine-R-sulfoxide reductase, BcDNA:RE36040, BcDNA:RH61230" CDMC31810 4 21 4 DAC07-D16 17-CG6593-RA_1 CG6593 ACACACACAAAACACAAATAGGGAAAACAGAAAGGAGAATCCGTGTGTCCACATTCAACGGAAAGCGCA 69 FBan0006593 FBgn0003134 Pp1alpha-96A 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0004722; ; GO:0000163 protein phosphatase type 1 complex; GO:0000164 Pp1alpha-96A Protein phosphatase 1alpha at 96A "CG6593, CG6593, PP1alpha96A, PP1alpha[[1]], PP1 96A, Pp1-96A, PP1, PP1c, Pp1alpha-96A" CDMC31810 4 22 4 DAC07-D16 17-CG6593-RA_1 CG6593 ACACACACAAAACACAAATAGGGAAAACAGAAAGGAGAATCCGTGTGTCCACATTCAACGGAAAGCGCA 69 FBan0006593 FBgn0003134 Pp1alpha-96A 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0004722; ; GO:0000163 protein phosphatase type 1 complex; GO:0000164 Pp1alpha-96A Protein phosphatase 1alpha at 96A "CG6593, CG6593, PP1alpha96A, PP1alpha[[1]], PP1 96A, Pp1-96A, PP1, PP1c, Pp1alpha-96A" CDMC31811 4 23 4 DAC07-H04 23-CG6625-RA_1 CG6625 AATCAATTATTGAATTTATTGAATGAAGATCTCCAGGAAACACACAACACCACTGAAACCTGACCCAAC 69 FBan0006625 FBgn0011712 Snap 3 3L ER to Golgi transport; GO:0006888; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; extrinsic to membrane; GO:0019898 Snap Soluble NSF attachment protein "CG6625, CG6625, dSNAP, dalphaSNAP, alphaSnap, soluble NSF attachment protein, SNAP, alpha-SNAP, alpha-SNAP, dsnap, dalpha-SNAP" CDMC31811 4 24 4 DAC07-H04 23-CG6625-RA_1 CG6625 AATCAATTATTGAATTTATTGAATGAAGATCTCCAGGAAACACACAACACCACTGAAACCTGACCCAAC 69 FBan0006625 FBgn0011712 Snap 3 3L ER to Golgi transport; GO:0006888; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 soluble NSF attachment protein activity; GO:0005483; ; GO:0005483 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; extrinsic to membrane; GO:0019898 Snap Soluble NSF attachment protein "CG6625, CG6625, dSNAP, dalphaSNAP, alphaSnap, soluble NSF attachment protein, SNAP, alpha-SNAP, alpha-SNAP, dsnap, dalpha-SNAP" CDMC31812 4 25 4 DAC07-H16 12-CG6633-RA_4 CG6633 GGAGCGCTTGGAAAATCACTACGAAGTCATTGTGGAGGACATTCATCGCCATTTCGTTCACCTGCCACA 69 FBan0006633 FBgn0040256 Ugt86Dd 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dd Ugt86Dd "CG6633, CG6633, AC 006491D" CDMC31812 4 26 4 DAC07-H16 12-CG6633-RA_4 CG6633 GGAGCGCTTGGAAAATCACTACGAAGTCATTGTGGAGGACATTCATCGCCATTTCGTTCACCTGCCACA 69 FBan0006633 FBgn0040256 Ugt86Dd 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt86Dd Ugt86Dd "CG6633, CG6633, AC 006491D" CDMC31813 4 1 5 DAC07-L04 24-CG6667-RA_3 CG6667 TTGTTTAGTGCTGTAATAACTAGTCTTAAGGCGAAATGTAATGTGTTTTTGTAGGAAGTAAGGTTTTTT 69 FBan0006667 FBgn0000462 dl 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; cellular defense response; GO:0006968; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; heart development; GO:0007507; immune response; GO:0006955; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; plasmatocyte differentiation; GO:0042387; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; morphogen activity; GO:0016015; transcriptional repressor activity; GO:0016564; protein binding; GO:0005515; ; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0016015; ; GO:0016563; ; GO:0016564; ; GO:0005515; ; GO:0005515; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 dl dorsal "CG6667, CG6667, CG6667, fs(2)k10816, dL, mat(2)dorsal, anon-EST:GressD7" CDMC31813 4 2 5 DAC07-L04 24-CG6667-RA_3 CG6667 TTGTTTAGTGCTGTAATAACTAGTCTTAAGGCGAAATGTAATGTGTTTTTGTAGGAAGTAAGGTTTTTT 69 FBan0006667 FBgn0000462 dl 2 2L "I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; cellular defense response; GO:0006968; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; ectoderm development; GO:0007398; ectodermal cell fate specification; GO:0001715; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; germ cell migration; GO:0008354; heart development; GO:0007507; immune response; GO:0006955; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; mesodermal cell fate specification; GO:0007501; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; plasmatocyte differentiation; GO:0042387; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; RNA polymerase II transcription factor activity; GO:0003702; morphogen activity; GO:0016015; transcriptional repressor activity; GO:0016564; protein binding; GO:0005515; ; GO:0003702; ; GO:0003700; ; GO:0005515; ; GO:0016015; ; GO:0016563; ; GO:0016564; ; GO:0005515; ; GO:0005515; ; GO:0003700; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 dl dorsal "CG6667, CG6667, CG6667, fs(2)k10816, dL, mat(2)dorsal, anon-EST:GressD7" CDMC31814 4 3 5 DAC07-L16 1-CG6675-RA_1 CG6675 GCTGAGATGGGGGAGTTCATGAATGCTCTACCGAACCTCGATGATACCCCCTATGGCTTAGGACAGCGA 69 FBan0006675 FBgn0032973 CG6675 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG6675 CG6675 CDMC31814 4 4 5 DAC07-L16 1-CG6675-RA_1 CG6675 GCTGAGATGGGGGAGTTCATGAATGCTCTACCGAACCTCGATGATACCCCCTATGGCTTAGGACAGCGA 69 FBan0006675 FBgn0032973 CG6675 2 2L lipid metabolism; GO:0006629 lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- CG6675 CG6675 CDMC31815 4 5 5 DAC07-P04 21-CG6703-RA_5 CG6703 CGCCAGCTATACGGTCACTTCTTCGATCTGACGATTGTGAACAACGATATTAGCGAGACGATTGCCACG 69 FBan0006703 FBgn0013759 Caki 3 3R adult walking behavior; GO:0007628; asymmetric protein localization; GO:0008105; calcium-mediated signaling; GO:0019722; cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 ATP binding; GO:0005524; ; GO:0005524; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; receptor binding; GO:0005102; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005102; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004385 ; EC:2.7.4.8; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0005515 calcium- and calmodulin-dependent protein kinase complex; GO:0005954; membrane; GO:0016020 Caki Calcium/calmodulin-dependent protein kinase "CG13413, CG13412, CG6703, CG13413, CG13412, CG6703, CG13412, CG6703, cmg, camguk, caki, CamGUK, Camguk, CAKI, CASK, CMG/CASK, calmodulin-dependent kinase, Cmg, DLin-2, Cask, Calcium/calmodulin-dependent protein kinase" CDMC31815 4 6 5 DAC07-P04 21-CG6703-RA_5 CG6703 CGCCAGCTATACGGTCACTTCTTCGATCTGACGATTGTGAACAACGATATTAGCGAGACGATTGCCACG 69 FBan0006703 FBgn0013759 Caki 3 3R adult walking behavior; GO:0007628; asymmetric protein localization; GO:0008105; calcium-mediated signaling; GO:0019722; cell adhesion; GO:0007155; establishment and/or maintenance of cell polarity; GO:0007163; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; protein amino acid phosphorylation; GO:0006468; protein targeting; GO:0006605; regulation of cell shape; GO:0008360; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 ATP binding; GO:0005524; ; GO:0005524; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; receptor binding; GO:0005102; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005102; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004385 ; EC:2.7.4.8; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0005515 calcium- and calmodulin-dependent protein kinase complex; GO:0005954; membrane; GO:0016020 Caki Calcium/calmodulin-dependent protein kinase "CG13413, CG13412, CG6703, CG13413, CG13412, CG6703, CG13412, CG6703, cmg, camguk, caki, CamGUK, Camguk, CAKI, CASK, CMG/CASK, calmodulin-dependent kinase, Cmg, DLin-2, Cask, Calcium/calmodulin-dependent protein kinase" CDMC31816 4 7 5 DAC07-P16 23-CG6717-RA_6 CG6717 GCCCTCAGCTGACTTAAATGGGCTCGTCCTAGAATCTGGTGCTAAGATCGATAAAATTGTGCAAAAGGC 69 FBgn0031924 CDMC31816 4 8 5 DAC07-P16 23-CG6717-RA_6 CG6717 GCCCTCAGCTGACTTAAATGGGCTCGTCCTAGAATCTGGTGCTAAGATCGATAAAATTGTGCAAAAGGC 69 FBgn0031924 CDMC31817 4 9 5 DAC08-D04 2-CG31871-RA_1 CG31871 CCTTCCGGCCAATATCGACTACATCCTGAGCAAGACGGGATACGAGCAGGTCCACTACATCGGTCACTC 69 FBan0031871 FBgn0051871 CG31871 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31871 CG31871 "CG17087, CG17099" CDMC31817 4 10 5 DAC08-D04 2-CG31871-RA_1 CG31871 CCTTCCGGCCAATATCGACTACATCCTGAGCAAGACGGGATACGAGCAGGTCCACTACATCGGTCACTC 69 FBan0031871 FBgn0051871 CG31871 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31871 CG31871 "CG17087, CG17099" CDMC31818 4 11 5 DAC08-D16 14-CG31878-RB_1 CG31878 GCCGAGAATGCCTACGATCTTGAGTCTCGAGTTTACAACTCCAACTTGTTCGCCATGAATGTCCTGGCT 69 FBan0031878 FBgn0051878 CG31878 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG31878 CG31878 CG4588 CDMC31818 4 12 5 DAC08-D16 14-CG31878-RB_1 CG31878 GCCGAGAATGCCTACGATCTTGAGTCTCGAGTTTACAACTCCAACTTGTTCGCCATGAATGTCCTGGCT 69 FBan0031878 FBgn0051878 CG31878 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG31878 CG31878 CG4588 CDMC31819 4 13 5 DAC08-H04 3-CG31910-RA_3 CG31910 GCCGCATCTAACCAAGCAGCTCAAGAAGCACTACGGGATTGAGGCAGAAGTTCTGGGTCTCCTTGTCAA 69 FBan0031910 FBgn0051910 CG31910 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31910 CG31910 "BcDNA:AT21561, NEST:bs09e03" CDMC31819 4 14 5 DAC08-H04 3-CG31910-RA_3 CG31910 GCCGCATCTAACCAAGCAGCTCAAGAAGCACTACGGGATTGAGGCAGAAGTTCTGGGTCTCCTTGTCAA 69 FBan0031910 FBgn0051910 CG31910 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31910 CG31910 "BcDNA:AT21561, NEST:bs09e03" CDMC31820 4 15 5 DAC08-H16 1-CG31921-RA_2 CG31921 GCACGACTATGATGAGCTGTATAAGCGGTTCCAAGCCTGCTTCGAGGAAAAGGGTCAACCAGATCCCGA 69 FBan0031921 FBgn0051921 CG31921 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31921 CG31921 NEST:bs08h12 CDMC31820 4 16 5 DAC08-H16 1-CG31921-RA_2 CG31921 GCACGACTATGATGAGCTGTATAAGCGGTTCCAAGCCTGCTTCGAGGAAAAGGGTCAACCAGATCCCGA 69 FBan0031921 FBgn0051921 CG31921 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31921 CG31921 NEST:bs08h12 CDMC31821 4 17 5 DAC08-L04 3-CG31962-RA_4 CG31962 AGCATCAAGTTCGAGTGCAATCCCGGATTTTCTTTGCAGGGAAAGACGTGGCACCTTGGCAATGGAAAT 69 FBan0031962 FBgn0020376 Sr-CIII 2 2L scavenger receptor activity; GO:0005044; ; GO:0005044 membrane; GO:0016020 Sr-CIII "Scavenger receptor class C, type III" "CG31962, dSR-CIII, Scavenger Receptor, SR-CIII" CDMC31821 4 18 5 DAC08-L04 3-CG31962-RA_4 CG31962 AGCATCAAGTTCGAGTGCAATCCCGGATTTTCTTTGCAGGGAAAGACGTGGCACCTTGGCAATGGAAAT 69 FBan0031962 FBgn0020376 Sr-CIII 2 2L scavenger receptor activity; GO:0005044; ; GO:0005044 membrane; GO:0016020 Sr-CIII "Scavenger receptor class C, type III" "CG31962, dSR-CIII, Scavenger Receptor, SR-CIII" CDMC31822 4 19 5 DAC08-L16 15-CG3198-RA_1 CG3198 ACCAAGAACACAAGTAAATAATCCGAAAGTCCGGAGCACTTCCAGTTTCCAAAGCCCCATACCGCAAGT 69 FBan0003198 FBgn0029887 CG3198 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U1; GO:0005685 CG3198 CG3198 CDMC31822 4 20 5 DAC08-L16 15-CG3198-RA_1 CG3198 ACCAAGAACACAAGTAAATAATCCGAAAGTCCGGAGCACTTCCAGTTTCCAAAGCCCCATACCGCAAGT 69 FBan0003198 FBgn0029887 CG3198 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U1; GO:0005685 CG3198 CG3198 CDMC31823 4 21 5 DAC08-P04 4-CG32024-RA_1 CG32024 TGTTCGACAGGAGAGGTGTGTCTATACCAAATTGGCAATCCTTGTGTGGCCTCACCAAACGGCACAAGT 69 FBan0032024 FBgn0052024 CG32024 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32024 CG32024 CDMC31823 4 22 5 DAC08-P04 4-CG32024-RA_1 CG32024 TGTTCGACAGGAGAGGTGTGTCTATACCAAATTGGCAATCCTTGTGTGGCCTCACCAAACGGCACAAGT 69 FBan0032024 FBgn0052024 CG32024 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32024 CG32024 CDMC31824 4 23 5 DAC08-P16 23-CG32033-RA_1 CG32033 TGCCAACGGCTCTAGATTAGACAATTTCCTATCCATTCCAGTTGGATTTTATACAGCGACATAAATGGG 69 FBan0032033 FBgn0052033 CG32033 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32033 CG32033 CDMC31824 4 24 5 DAC08-P16 23-CG32033-RA_1 CG32033 TGCCAACGGCTCTAGATTAGACAATTTCCTATCCATTCCAGTTGGATTTTATACAGCGACATAAATGGG 69 FBan0032033 FBgn0052033 CG32033 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32033 CG32033 CDMC31825 4 25 5 DAC09-D05 2-CG5433-RA_1 CG5433 TACGAGGTAGCCGTTCCCCTCTGCAAGCAAGCATTGGAAGATCTCGAAAGGACAAGTGGTCACGA 65 FBan0005433 FBgn0010235 Klc 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003777 kinesin complex; GO:0005871 Klc Kinesin light chain "CG5433, CG5433, CG5433, KLC, klc, kinesin light chain, DKLC, kinesin, kinesin I" CDMC31825 4 26 5 DAC09-D05 2-CG5433-RA_1 CG5433 TACGAGGTAGCCGTTCCCCTCTGCAAGCAAGCATTGGAAGATCTCGAAAGGACAAGTGGTCACGA 65 FBan0005433 FBgn0010235 Klc 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003777 kinesin complex; GO:0005871 Klc Kinesin light chain "CG5433, CG5433, CG5433, KLC, klc, kinesin light chain, DKLC, kinesin, kinesin I" CDMC31826 4 1 6 DAC09-D17 3-CG5482-RA_3 CG5482 CAAACGCTCGGAGTTCACAACCGCCATTCACCTGTACAGACGTGCCCTCGACTTTCTGGACAATC 65 FBan0005482 FBgn0034368 CG5482 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG5482 CG5482 CDMC31826 4 2 6 DAC09-D17 3-CG5482-RA_3 CG5482 CAAACGCTCGGAGTTCACAACCGCCATTCACCTGTACAGACGTGCCCTCGACTTTCTGGACAATC 65 FBan0005482 FBgn0034368 CG5482 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG5482 CG5482 CDMC31827 4 3 6 DAC09-H05 2-CG5604-RA_3 CG5604 CCTGGCCCTTACGTTCACGTATCTGCCGAGTTCCTCGATCTATGGTTACACCCAGGCCGAATTGC 65 FBan0005604 FBgn0032208 CG5604 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004842 ; EC:6.3.2.19 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG5604 CG5604 CDMC31827 4 4 6 DAC09-H05 2-CG5604-RA_3 CG5604 CCTGGCCCTTACGTTCACGTATCTGCCGAGTTCCTCGATCTATGGTTACACCCAGGCCGAATTGC 65 FBan0005604 FBgn0032208 CG5604 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004842 ; EC:6.3.2.19 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG5604 CG5604 CDMC31828 4 5 6 DAC09-H17 3-CG5649-RA_2 CG5649 TCATTTGGAGACGGTAATCCCCGCTTTGGACAAGCCTGTCATGGTGGTTAATGGCGCTTATCGGG 65 FBan0005649 FBgn0024887 kin17 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 kin17 kin17 CG5649 CDMC31828 4 6 6 DAC09-H17 3-CG5649-RA_2 CG5649 TCATTTGGAGACGGTAATCCCCGCTTTGGACAAGCCTGTCATGGTGGTTAATGGCGCTTATCGGG 65 FBan0005649 FBgn0024887 kin17 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 kin17 kin17 CG5649 CDMC31829 4 7 6 DAC09-L05 1-CG5767-RA_1 CG5767 ATGCCCGCAATTTGGATACCACCGTTTCCGCTGATGTGACCACCCAGTGCTTCAACCTCTATCTG 65 FBan0005767 FBgn0034292 CG5767 2 2R CG5767 CG5767 CT18118 CDMC31829 4 8 6 DAC09-L05 1-CG5767-RA_1 CG5767 ATGCCCGCAATTTGGATACCACCGTTTCCGCTGATGTGACCACCCAGTGCTTCAACCTCTATCTG 65 FBan0005767 FBgn0034292 CG5767 2 2R CG5767 CG5767 CT18118 CDMC31830 4 9 6 DAC09-L17 3-CG5828-RA_1 CG5828 AACTACTGGTCTATGCAAATGGACAGACTGGTCCCTGCCTGGATATGCGCACTCTCCCCAAGGAG 65 FBan0005828 FBgn0031682 CG5828 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 kinase activity; GO:0016301; ; GO:0016301 CG5828 CG5828 CDMC31830 4 10 6 DAC09-L17 3-CG5828-RA_1 CG5828 AACTACTGGTCTATGCAAATGGACAGACTGGTCCCTGCCTGGATATGCGCACTCTCCCCAAGGAG 65 FBan0005828 FBgn0031682 CG5828 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 kinase activity; GO:0016301; ; GO:0016301 CG5828 CG5828 CDMC31831 4 11 6 DAC09-P05 6-CG5929-RA_4 CG5929 CGCTGCCGAATACGCAAAGCAGTACCAGGAGGTAGAAGCCACGAGAATATACAAGGGCAGCGTGC 65 FBan0005929 FBgn0032982 CG5929 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription, RNA-dependent; GO:0006410" nucleic acid binding; GO:0003676; ; GO:0003676; RNA-directed DNA polymerase activity; GO:0003964 ; EC:2.7.7.49; ; GO:0003964 ; EC:2.7.7.49 CG5929 CG5929 CDMC31831 4 12 6 DAC09-P05 6-CG5929-RA_4 CG5929 CGCTGCCGAATACGCAAAGCAGTACCAGGAGGTAGAAGCCACGAGAATATACAAGGGCAGCGTGC 65 FBan0005929 FBgn0032982 CG5929 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription, RNA-dependent; GO:0006410" nucleic acid binding; GO:0003676; ; GO:0003676; RNA-directed DNA polymerase activity; GO:0003964 ; EC:2.7.7.49; ; GO:0003964 ; EC:2.7.7.49 CG5929 CG5929 CDMC31832 4 13 6 DAC09-P17 3-CG5978-RA_3 CG5978 GTGCCCGATGTGCAGAGTTTTCGAGCACTCAGTTGGAAGCTACTCCTTGGCTATTTGGGGCCTAG 65 FBan0005978 FBgn0035916 CG5978 3 3L CG5978 CG5978 BEST:LD24460 CDMC31832 4 14 6 DAC09-P17 3-CG5978-RA_3 CG5978 GTGCCCGATGTGCAGAGTTTTCGAGCACTCAGTTGGAAGCTACTCCTTGGCTATTTGGGGCCTAG 65 FBan0005978 FBgn0035916 CG5978 3 3L CG5978 CG5978 BEST:LD24460 CDMC31833 4 15 6 DAC10-D04 2-CG6525-RA_3 CG6525 GCTACTTGCACGGCCTGACGACGAGTTCACTGTGGTCCGGTACTCTCAAGATGATCGATTTGGCC 65 FBgn0038041 CDMC31833 4 16 6 DAC10-D04 2-CG6525-RA_3 CG6525 GCTACTTGCACGGCCTGACGACGAGTTCACTGTGGTCCGGTACTCTCAAGATGATCGATTTGGCC 65 FBgn0038041 CDMC31834 4 17 6 DAC10-D16 3-CG6578-RA_1 CG6578 CTATCGAATGTGTCCCGGCGAAGAGATGGCTCGCATGATACTCACGCTCTTTACGGGTCGCATCC 65 FBgn0030948 CDMC31834 4 18 6 DAC10-D16 3-CG6578-RA_1 CG6578 CTATCGAATGTGTCCCGGCGAAGAGATGGCTCGCATGATACTCACGCTCTTTACGGGTCGCATCC 65 FBgn0030948 CDMC31835 4 19 6 DAC10-H04 6-CG6709-RA_1 CG6709 TCATACCCACCGACATCGAGAACGAGTACTTTGACAGCATACTCCTCTCGCAGTTGGACGCCTGG 65 FBan0006709 FBgn0036056 CG6709 3 3L CG6709 CG6709 CDMC31835 4 20 6 DAC10-H04 6-CG6709-RA_1 CG6709 TCATACCCACCGACATCGAGAACGAGTACTTTGACAGCATACTCCTCTCGCAGTTGGACGCCTGG 65 FBan0006709 FBgn0036056 CG6709 3 3L CG6709 CG6709 CDMC31836 4 21 6 DAC10-H16 3-CG6746-RA_6 CG6746 CCGTGAGAACAGCGTGTGGAGTGTGGTGATGCCCAACAAGTGGAACGCCACCTTCTCGTATTTTG 65 FBan0006746 FBgn0032394 CG6746 2 2L protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG6746 CG6746 CDMC31836 4 22 6 DAC10-H16 3-CG6746-RA_6 CG6746 CCGTGAGAACAGCGTGTGGAGTGTGGTGATGCCCAACAAGTGGAACGCCACCTTCTCGTATTTTG 65 FBan0006746 FBgn0032394 CG6746 2 2L protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464 phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0004721 ; EC:3.1.3.16; ; GO:0016791 ; EC:3.1.3.- CG6746 CG6746 CDMC31837 4 23 6 DAC10-L04 2-CG6839-RA_1 CG6839 CTGGGTCTCCAAGAACAAGCTGAACGTGAACTGCTATACCGGTGTCTACGGCGTGACCACTCTGC 65 FBan0006839 FBgn0036831 CG6839 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; endonuclease activity; GO:0004519; ; GO:0004519 CG6839 CG6839 CDMC31837 4 24 6 DAC10-L04 2-CG6839-RA_1 CG6839 CTGGGTCTCCAAGAACAAGCTGAACGTGAACTGCTATACCGGTGTCTACGGCGTGACCACTCTGC 65 FBan0006839 FBgn0036831 CG6839 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; endonuclease activity; GO:0004519; ; GO:0004519 CG6839 CG6839 CDMC31838 4 25 6 DAC10-L16 18-CG6873-RA_1 CG6873 TGGCATCTGGAATTAATTTGAGCCGCGAGTGTCAGCACGTGTTCGAGCAGATCCGGAAGCTGAAG 65 FBan0006873 FBgn0030951 CG6873 X X cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067; protein complex assembly; GO:0006461 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG6873 CG6873 Adf/cofilin-like CDMC31838 4 26 6 DAC10-L16 18-CG6873-RA_1 CG6873 TGGCATCTGGAATTAATTTGAGCCGCGAGTGTCAGCACGTGTTCGAGCAGATCCGGAAGCTGAAG 65 FBan0006873 FBgn0030951 CG6873 X X cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; mitosis; GO:0007067; protein complex assembly; GO:0006461 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 intracellular; GO:0005622 CG6873 CG6873 Adf/cofilin-like CDMC31839 4 1 7 DAC10-P04 3-CG6966-RA_1 CG6966 CTACGAGGGAACCGTACCAGCCACACTGTACGAGTTCATCGAGCTGCACTAGAGACGAGGATCGG 65 FBan0006966 FBgn0038286 CG6966 3 3R cell proliferation; GO:0008283 receptor binding; GO:0005102; ; GO:0005102 CG6966 CG6966 BcDNA:AT05246 CDMC31839 4 2 7 DAC10-P04 3-CG6966-RA_1 CG6966 CTACGAGGGAACCGTACCAGCCACACTGTACGAGTTCATCGAGCTGCACTAGAGACGAGGATCGG 65 FBan0006966 FBgn0038286 CG6966 3 3R cell proliferation; GO:0008283 receptor binding; GO:0005102; ; GO:0005102 CG6966 CG6966 BcDNA:AT05246 CDMC31840 4 3 7 DAC10-P16 2-CG7008-RA_3 CG7008 GCGGATCCAAGCTAGAGTCGCTTATGAGCAAACTTCACGCCGATTTCCAGTCCAACCCACCCATC 65 FBan0007008 FBgn0035121 Tudor-SN 3 3L transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; ; GO:0003676; transcription coactivator activity; GO:0003713; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0003713; ; GO:0004518 ; EC:3.1.-.- RNA-induced silencing complex; GO:0016442 Tudor-SN Tudor-SN "CG7008, CG7008, tudor staphylococcus/micrococcal nuclease, TSN, TSN-1" CDMC31840 4 4 7 DAC10-P16 2-CG7008-RA_3 CG7008 GCGGATCCAAGCTAGAGTCGCTTATGAGCAAACTTCACGCCGATTTCCAGTCCAACCCACCCATC 65 FBan0007008 FBgn0035121 Tudor-SN 3 3L transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; ; GO:0003676; transcription coactivator activity; GO:0003713; nuclease activity; GO:0004518 ; EC:3.1.-.-; ; GO:0003713; ; GO:0004518 ; EC:3.1.-.- RNA-induced silencing complex; GO:0016442 Tudor-SN Tudor-SN "CG7008, CG7008, tudor staphylococcus/micrococcal nuclease, TSN, TSN-1" CDMC31841 4 5 7 DAC11-D04 1-CG10017-RA_1 CG10017 TCTCCAGGATCAGGAGCGATTGCAGGATCGGGTTCATTGAATGGAAACGTGGTGCTGACCAAAATGGAA 69 FBan0010017 FBgn0031557 CG10017 2 2L CG10017 CG10017 CDMC31841 4 6 7 DAC11-D04 1-CG10017-RA_1 CG10017 TCTCCAGGATCAGGAGCGATTGCAGGATCGGGTTCATTGAATGGAAACGTGGTGCTGACCAAAATGGAA 69 FBan0010017 FBgn0031557 CG10017 2 2L CG10017 CG10017 CDMC31842 4 7 7 DAC11-D16 11-CG10033-RA_1 CG10033 CGCCAGATGATGTCACTGGATGGGACAAGGACTTCTGAGGAGAATCAGAACCCGTTTCCTAGACGATGC 69 FBan0010033 FBgn0000721 for 2 2L cytoskeleton organization and biogenesis; GO:0007010; feeding behavior; GO:0007631; intracellular signaling cascade; GO:0007242; larval feeding behavior; GO:0030536; larval locomotory behavior; GO:0008345; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of heart contraction rate; GO:0008016; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; cyclic nucleotide-dependent protein kinase activity; GO:0004690 ; EC:2.7.1.-; ; GO:0004690 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 for foraging "CG10033, CG10033, DG2, dg2, l(2)06860, PKG, FOR/PKG, anon-WO0140519.260, anon-WO02059370.47, BcDNA:GM08338, Dg2, Pkg2, Pkg24A" CDMC31842 4 8 7 DAC11-D16 11-CG10033-RA_1 CG10033 CGCCAGATGATGTCACTGGATGGGACAAGGACTTCTGAGGAGAATCAGAACCCGTTTCCTAGACGATGC 69 FBan0010033 FBgn0000721 for 2 2L cytoskeleton organization and biogenesis; GO:0007010; feeding behavior; GO:0007631; intracellular signaling cascade; GO:0007242; larval feeding behavior; GO:0030536; larval locomotory behavior; GO:0008345; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468; regulation of heart contraction rate; GO:0008016; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; cGMP-dependent protein kinase activity; GO:0004692 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004692 ; EC:2.7.1.-; cyclic nucleotide-dependent protein kinase activity; GO:0004690 ; EC:2.7.1.-; ; GO:0004690 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; ; GO:0008603 cAMP-dependent protein kinase complex; GO:0005952; plasma membrane; GO:0005886 for foraging "CG10033, CG10033, DG2, dg2, l(2)06860, PKG, FOR/PKG, anon-WO0140519.260, anon-WO02059370.47, BcDNA:GM08338, Dg2, Pkg2, Pkg24A" CDMC31843 4 9 7 DAC11-H04 18-CG10067-RA_2 CG10067 TACGAATGAACCGACACCCTCATGTATTTTGTACAGAACCTAACAACTTCCCCGATAGAGCGGATGGGG 69 FBan0010067 FBgn0000044 Act57B 2 2R chondroitin sulfate biosynthesis; GO:0030206; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012 structural constituent of cytoskeleton; GO:0005200; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0005200; motor activity; GO:0003774; ; GO:0015020 ; EC:2.4.1.17; ; GO:0003774 actin filament; GO:0005884 Act57B Actin 57B "CG10067, CG30294, CG10067, CG10067, CG30294, CG10067, Act57A, actin, Actin, act57A, M: M repeat, act 57A, C: Group C, T10, anon-EST:CL2c12, BEST:RE38067" CDMC31843 4 10 7 DAC11-H04 18-CG10067-RA_2 CG10067 TACGAATGAACCGACACCCTCATGTATTTTGTACAGAACCTAACAACTTCCCCGATAGAGCGGATGGGG 69 FBan0010067 FBgn0000044 Act57B 2 2R chondroitin sulfate biosynthesis; GO:0030206; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; heart development; GO:0007507; heparan sulfate proteoglycan biosynthesis; GO:0015012 structural constituent of cytoskeleton; GO:0005200; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0005200; motor activity; GO:0003774; ; GO:0015020 ; EC:2.4.1.17; ; GO:0003774 actin filament; GO:0005884 Act57B Actin 57B "CG10067, CG30294, CG10067, CG10067, CG30294, CG10067, Act57A, actin, Actin, act57A, M: M repeat, act 57A, C: Group C, T10, anon-EST:CL2c12, BEST:RE38067" CDMC31844 4 11 7 DAC11-H16 14-CG10076-RA_2 CG10076 CAGAGGAGAATACCGAGAATTCCTGGCTGAAGCTTTGTACATTTTCTGCCGGCTACAGAGAGATCCGCT 69 FBan0010076 FBgn0003475 spir 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; eggshell formation (sensu Insecta); GO:0007304; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 spir spire "CG10076, CG18621, CG10076, CG10076, p150-Spir, 38C.34, 38C.37, l(2)08327, p150Spir, Spir, spire" CDMC31844 4 12 7 DAC11-H16 14-CG10076-RA_2 CG10076 CAGAGGAGAATACCGAGAATTCCTGGCTGAAGCTTTGTACATTTTCTGCCGGCTACAGAGAGATCCGCT 69 FBan0010076 FBgn0003475 spir 2 2L actin cytoskeleton organization and biogenesis; GO:0030036; eggshell formation (sensu Insecta); GO:0007304; oogenesis (sensu Insecta); GO:0009993; pole plasm RNA localization; GO:0007316; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 spir spire "CG10076, CG18621, CG10076, CG10076, p150-Spir, 38C.34, 38C.37, l(2)08327, p150Spir, Spir, spire" CDMC31845 4 13 7 DAC11-L04 16-CG10103-RA_1 CG10103 CCCGCCTACAGAGCGATATAGCCGAGCTGAAGATCATATCGGACATATTTGTGACCAAATACGGTCCAC 69 FBan0010103 FBgn0035715 CG10103 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; pancreatic ribonuclease activity; GO:0004522 ; EC:3.1.27.5; ; GO:0004522 ; EC:3.1.27.5 CG10103 CG10103 CDMC31845 4 14 7 DAC11-L04 16-CG10103-RA_1 CG10103 CCCGCCTACAGAGCGATATAGCCGAGCTGAAGATCATATCGGACATATTTGTGACCAAATACGGTCCAC 69 FBan0010103 FBgn0035715 CG10103 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; pancreatic ribonuclease activity; GO:0004522 ; EC:3.1.27.5; ; GO:0004522 ; EC:3.1.27.5 CG10103 CG10103 CDMC31846 4 15 7 DAC11-L16 3-CG10116-RA_1 CG10116 AGGCATCTATTTCCTGGAGACCCGACAGTCCTCACCCTTCTCCCGTGGAGCATACTTCATAAGCTTCCT 69 FBan0010116 FBgn0036367 CG10116 3 3L female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG10116 CG10116 CDMC31846 4 16 7 DAC11-L16 3-CG10116-RA_1 CG10116 AGGCATCTATTTCCTGGAGACCCGACAGTCCTCACCCTTCTCCCGTGGAGCATACTTCATAAGCTTCCT 69 FBan0010116 FBgn0036367 CG10116 3 3L female gamete generation; GO:0007292; phospholipid metabolism; GO:0006644 lipoprotein lipase activity; GO:0004465 ; EC:3.1.1.34; ; GO:0004465 ; EC:3.1.1.34 CG10116 CG10116 CDMC31847 4 17 7 DAC11-P04 17-CG10143-RA_1 CG10143 GCGGGAAACTGTGCAAATCTACAAGGACACACTGGAGCGATTTAAGAAGGAGCATCCAGGATTCATCGA 69 FBan0010143 FBgn0033952 Adgf-E 2 2R purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; ; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular region; GO:0005576 Adgf-E Adenosine deaminase-related growth factor E "CG10143, CG10143, ADGF-E, adgfe" CDMC31847 4 18 7 DAC11-P04 17-CG10143-RA_1 CG10143 GCGGGAAACTGTGCAAATCTACAAGGACACACTGGAGCGATTTAAGAAGGAGCATCCAGGATTCATCGA 69 FBan0010143 FBgn0033952 Adgf-E 2 2R purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; ; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular region; GO:0005576 Adgf-E Adenosine deaminase-related growth factor E "CG10143, CG10143, ADGF-E, adgfe" CDMC31848 4 19 7 DAC11-P16 9-CG10163-RA_5 CG10163 AAGAGCACAGCCCAGATGATCATCGCAGTCTGCCTGATCTGTCAATCTTTGGCAGTGGAGGATAAGGAT 69 FBan0010163 FBgn0035697 CG10163 3 3L cell adhesion; GO:0007155; lipid metabolism; GO:0006629; regulation of cell shape; GO:0008360 phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0008970 ; EC:3.1.1.32 CG10163 CG10163 CDMC31848 4 20 7 DAC11-P16 9-CG10163-RA_5 CG10163 AAGAGCACAGCCCAGATGATCATCGCAGTCTGCCTGATCTGTCAATCTTTGGCAGTGGAGGATAAGGAT 69 FBan0010163 FBgn0035697 CG10163 3 3L cell adhesion; GO:0007155; lipid metabolism; GO:0006629; regulation of cell shape; GO:0008360 phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0008970 ; EC:3.1.1.32 CG10163 CG10163 CDMC31849 4 21 7 DAC12-D04 10-CG30106-RA_1 CG30106 TGGTCCTGTTGCACTTCCTGGTCTACTACGCCATTCCTTTGGTCGTCATAGCAGTTTTCTACGTGCTCA 69 FBan0030106 FBgn0050106 CG30106 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell glucose homeostasis; GO:0001678; muscle contraction; GO:0006936 neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008188; bombesin receptor activity; GO:0004946; ; GO:0004946 integral to membrane; GO:0016021 CG30106 CG30106 "CG14484, CG18192, CG14484, CG14484, CG18192, CG14484" CDMC31849 4 22 7 DAC12-D04 10-CG30106-RA_1 CG30106 TGGTCCTGTTGCACTTCCTGGTCTACTACGCCATTCCTTTGGTCGTCATAGCAGTTTTCTACGTGCTCA 69 FBan0030106 FBgn0050106 CG30106 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell glucose homeostasis; GO:0001678; muscle contraction; GO:0006936 neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008188; bombesin receptor activity; GO:0004946; ; GO:0004946 integral to membrane; GO:0016021 CG30106 CG30106 "CG14484, CG18192, CG14484, CG14484, CG18192, CG14484" CDMC31850 4 23 7 DAC12-D16 23-CG3011-RA_5 CG3011 GCCTGCTTTGTTTGTCCCTTTTTCTTTTGTTCGCCTTACGATTTACATCCTCGAAAAGTCCGCTTGTTA 69 FBan0003011 FBgn0029823 CG3011 X X "L-serine biosynthesis; GO:0006564; glycine metabolism; GO:0006544; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" glycine hydroxymethyltransferase activity; GO:0004372 ; EC:2.1.2.1; ; GO:0004372 ; EC:2.1.2.1; ; GO:0004372 ; EC:2.1.2.1 mitochondrion; GO:0005739 CG3011 CG3011 anon-WO03040301.100 CDMC31850 4 24 7 DAC12-D16 23-CG3011-RA_5 CG3011 GCCTGCTTTGTTTGTCCCTTTTTCTTTTGTTCGCCTTACGATTTACATCCTCGAAAAGTCCGCTTGTTA 69 FBan0003011 FBgn0029823 CG3011 X X "L-serine biosynthesis; GO:0006564; glycine metabolism; GO:0006544; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" glycine hydroxymethyltransferase activity; GO:0004372 ; EC:2.1.2.1; ; GO:0004372 ; EC:2.1.2.1; ; GO:0004372 ; EC:2.1.2.1 mitochondrion; GO:0005739 CG3011 CG3011 anon-WO03040301.100 CDMC31851 4 25 7 DAC12-H04 14-CG30158-RA_3 CG30158 TCGAGGCAGGACTAGGTTAAGCGCGTTTTCGACTGGCGGATTGTCATAATATTGTGACAGGTGGCATAG 69 FBan0030158 FBgn0050158 CG30158 2 2R nitric oxide mediated signal transduction; GO:0007263; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG30158 CG30158 "CG15243, CG15244, CG9464, BcDNA:RE28276" CDMC31851 4 26 7 DAC12-H04 14-CG30158-RA_3 CG30158 TCGAGGCAGGACTAGGTTAAGCGCGTTTTCGACTGGCGGATTGTCATAATATTGTGACAGGTGGCATAG 69 FBan0030158 FBgn0050158 CG30158 2 2R nitric oxide mediated signal transduction; GO:0007263; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG30158 CG30158 "CG15243, CG15244, CG9464, BcDNA:RE28276" CDMC31852 4 1 8 DAC12-H16 23-CG3016-RA_7 CG3016 CCGCATAATCCAAACTCTGTGTACGGCTTATTGCATATAGGAACTCCCTATCGTAACAGAGAGCTCGAC 69 FBan0003016 FBgn0029819 CG3016 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG3016 CG3016 CDMC31852 4 2 8 DAC12-H16 23-CG3016-RA_7 CG3016 CCGCATAATCCAAACTCTGTGTACGGCTTATTGCATATAGGAACTCCCTATCGTAACAGAGAGCTCGAC 69 FBan0003016 FBgn0029819 CG3016 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG3016 CG3016 CDMC31853 4 3 8 DAC12-L04 3-CG30203-RA_6 CG30203 TCGGAGAGACGGATCACGGCGGTTACATGGGCAAAACCACTTCTTGGAACAGTAAACAGGAGCATTCCA 69 FBan0030203 FBgn0050203 CG30203 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 CG30203 CG30203 "CG17740, CT39323" CDMC31853 4 4 8 DAC12-L04 3-CG30203-RA_6 CG30203 TCGGAGAGACGGATCACGGCGGTTACATGGGCAAAACCACTTCTTGGAACAGTAAACAGGAGCATTCCA 69 FBan0030203 FBgn0050203 CG30203 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 CG30203 CG30203 "CG17740, CT39323" CDMC31854 4 5 8 DAC12-L16 2-CG30264-RA_1 CG30264 TCTCGCCGATCCTTTGATCAAGGCCCTCACTGAAATAGCCAACAAAAGACCCAGAGATCCCGTTGCCTA 69 FBan0030264 FBgn0050264 CG30264 2 2R CG30264 CG30264 CG13529 CDMC31854 4 6 8 DAC12-L16 2-CG30264-RA_1 CG30264 TCTCGCCGATCCTTTGATCAAGGCCCTCACTGAAATAGCCAACAAAAGACCCAGAGATCCCGTTGCCTA 69 FBan0030264 FBgn0050264 CG30264 2 2R CG30264 CG30264 CG13529 CDMC31855 4 7 8 DAC12-P04 2-CG30290-RA_1 CG30290 CGCTGCTCTTTGCACCTGCGATGAATACCCGTATGTACGACCATCCAATAACTCGGGAGCAGATCGACA 69 FBan0030290 FBgn0050290 CG30290 2 2R CG30290 CG30290 BcDNA:LD37882 CDMC31855 4 8 8 DAC12-P04 2-CG30290-RA_1 CG30290 CGCTGCTCTTTGCACCTGCGATGAATACCCGTATGTACGACCATCCAATAACTCGGGAGCAGATCGACA 69 FBan0030290 FBgn0050290 CG30290 2 2R CG30290 CG30290 BcDNA:LD37882 CDMC31856 4 9 8 DAC12-P16 6-CG30325-RA_2 CG30325 AGTCGAAATCAGAGGGCACCATCGAAGAGGAAGAGAAACCTGTGGACCCAAGACAGAGTTTCGCTTCCA 69 FBan0030325 FBgn0050325 CG30325 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30325 CG30325 CDMC31856 4 10 8 DAC12-P16 6-CG30325-RA_2 CG30325 AGTCGAAATCAGAGGGCACCATCGAAGAGGAAGAGAAACCTGTGGACCCAAGACAGAGTTTCGCTTCCA 69 FBan0030325 FBgn0050325 CG30325 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30325 CG30325 CDMC31857 4 11 8 DAC13-D04 3-CG1324-RA_3 CG1324 TAGCTGTTCCAGGACACTGATCCTGCTTAACTCCCTGAAATCCATGCACCACAAGAGCCTGCACG 65 FBan0001324 FBgn0031129 CG1324 X X CG1324 CG1324 anon-WO0140519.192 CDMC31857 4 12 8 DAC13-D04 3-CG1324-RA_3 CG1324 TAGCTGTTCCAGGACACTGATCCTGCTTAACTCCCTGAAATCCATGCACCACAAGAGCCTGCACG 65 FBan0001324 FBgn0031129 CG1324 X X CG1324 CG1324 anon-WO0140519.192 CDMC31858 4 13 8 DAC13-D16 1-CG13331-RB_1 CG13331 AACAGGTCACCAGCTCCTCCCTGACCGCCTCCAATGCCAAGCCCATAACGATTATCTTCAACAAG 65 FBan0013331 FBgn0033850 CG13331 2 2R CG13331 CG13331 CDMC31858 4 14 8 DAC13-D16 1-CG13331-RB_1 CG13331 AACAGGTCACCAGCTCCTCCCTGACCGCCTCCAATGCCAAGCCCATAACGATTATCTTCAACAAG 65 FBan0013331 FBgn0033850 CG13331 2 2R CG13331 CG13331 CDMC31859 4 15 8 DAC13-H04 23-CG13473-RA_5 CG13473 TGCAGAAGAAGGTCATCATTGTGGATTCGAAGAGTTACTTTGATAAGCTCATCGATGATGCGGGA 65 FBan0013473 FBgn0036442 CG13473 3 3L electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG13473 CG13473 CDMC31859 4 16 8 DAC13-H04 23-CG13473-RA_5 CG13473 TGCAGAAGAAGGTCATCATTGTGGATTCGAAGAGTTACTTTGATAAGCTCATCGATGATGCGGGA 65 FBan0013473 FBgn0036442 CG13473 3 3L electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG13473 CG13473 CDMC31860 4 17 8 DAC13-H16 4-CG13504-RA_1 CG13504 CTTGATTATGGACACTCGGCTCCGGACTACAGCTACGCCCATGCCGCTCCTGCCATAACATATGC 65 FBan0013504 FBgn0034699 CG13504 2 2R CG13504 CG13504 CDMC31860 4 18 8 DAC13-H16 4-CG13504-RA_1 CG13504 CTTGATTATGGACACTCGGCTCCGGACTACAGCTACGCCCATGCCGCTCCTGCCATAACATATGC 65 FBan0013504 FBgn0034699 CG13504 2 2R CG13504 CG13504 CDMC31861 4 19 8 DAC13-L04 7-CG13595-RA_1 CG13595 GAGGAGGCGATTGACAGGGACCTGGTCCAGACATTCTACGACGTTGTTGGTCTGTCTAAGCCCCG 65 FBgn0035051 CDMC31861 4 20 8 DAC13-L04 7-CG13595-RA_1 CG13595 GAGGAGGCGATTGACAGGGACCTGGTCCAGACATTCTACGACGTTGTTGGTCTGTCTAAGCCCCG 65 FBgn0035051 CDMC31862 4 21 8 DAC13-L16 2-CG1362-RB_2 CG1362 ATCTTCCTGGTAATGGATTTCTGCGAGCAGGACCTAGCCTCCGTGCTAGACAACATGTCGCAGCC 65 FBan0001362 FBgn0013435 cdc2rk 2 2R mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- cdc2rk cdc2-related-kinase "CG1362, CG1362, Dcdrk" CDMC31862 4 22 8 DAC13-L16 2-CG1362-RB_2 CG1362 ATCTTCCTGGTAATGGATTTCTGCGAGCAGGACCTAGCCTCCGTGCTAGACAACATGTCGCAGCC 65 FBan0001362 FBgn0013435 cdc2rk 2 2R mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- cdc2rk cdc2-related-kinase "CG1362, CG1362, Dcdrk" CDMC31863 4 23 8 DAC13-P04 3-CG13691-RA_1 CG13691 TACTACCACGAAGCGGATGTGCAAAAAGCCCACTCCCTTTGTCAAGCGGTTCTGGAAGTTGAGCG 65 FBan0013691 FBgn0031255 BBS2 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BBS2 BBS2 CG13691 CDMC31863 4 24 8 DAC13-P04 3-CG13691-RA_1 CG13691 TACTACCACGAAGCGGATGTGCAAAAAGCCCACTCCCTTTGTCAAGCGGTTCTGGAAGTTGAGCG 65 FBan0013691 FBgn0031255 BBS2 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 BBS2 BBS2 CG13691 CDMC31864 4 25 8 DAC13-P16 2-CG1371-RA_1 CG1371 GACGCTGCGCATTGTGATGTACCGCAAAGGAAACTCGGATTCTCCTGTGTTCTCGCAACGTGTGG 65 FBan0001371 FBgn0033482 CG1371 2 2R CG1371 CG1371 CDMC31864 4 26 8 DAC13-P16 2-CG1371-RA_1 CG1371 GACGCTGCGCATTGTGATGTACCGCAAAGGAAACTCGGATTCTCCTGTGTTCTCGCAACGTGTGG 65 FBan0001371 FBgn0033482 CG1371 2 2R CG1371 CG1371 CDMC31865 4 1 9 DAC14-D04 1-CG1667-RA_1 CG1667 CCGATATGGACCAAAGCACCCTGAGCTACTCGCACTGGATACGTGACTCCCATGGACTAGACTATGCGG 69 FBan0001667 FBgn0033453 CG1667 2 2R CG1667 CG1667 CDMC31865 4 2 9 DAC14-D04 1-CG1667-RA_1 CG1667 CCGATATGGACCAAAGCACCCTGAGCTACTCGCACTGGATACGTGACTCCCATGGACTAGACTATGCGG 69 FBan0001667 FBgn0033453 CG1667 2 2R CG1667 CG1667 CDMC31866 4 3 9 DAC14-D16 23-CG16711-RB_1 CG16711 GTTTTACCGCCAGGAATTGGTAAAGGATAAACCATGATTTTCCTTTAGTTTAATACACAGGAACAGCAA 69 FBan0016711 FBgn0036032 CG16711 3 3L CG16711 CG16711 CDMC31866 4 4 9 DAC14-D16 23-CG16711-RB_1 CG16711 GTTTTACCGCCAGGAATTGGTAAAGGATAAACCATGATTTTCCTTTAGTTTAATACACAGGAACAGCAA 69 FBan0016711 FBgn0036032 CG16711 3 3L CG16711 CG16711 CDMC31867 4 5 9 DAC14-H04 13-CG16740-RA_1 CG16740 GGACACCATACCTTGTCATTTGCTACTTCGGACTCTTCAAAATCGACGGATTGACCCCACTGACGACCA 69 FBan0016740 FBgn0003248 Rh2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh2 Rhodopsin 2 "CG16740, RH2, Dm Rh2, Rh, rhodopsin, DMELRH2, Rhodopsin" CDMC31867 4 6 9 DAC14-H04 13-CG16740-RA_1 CG16740 GGACACCATACCTTGTCATTTGCTACTTCGGACTCTTCAAAATCGACGGATTGACCCCACTGACGACCA 69 FBan0016740 FBgn0003248 Rh2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh2 Rhodopsin 2 "CG16740, RH2, Dm Rh2, Rh, rhodopsin, DMELRH2, Rhodopsin" CDMC31868 4 7 9 DAC14-H16 16-CG1674-RB_7 CG1674 CACCTTCACAGCAGTGCGAAATTCACTCGAAACATTTTGAAAGGCCATACGAAGACACTTTTCCGCGCA 69 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC31868 4 8 9 DAC14-H16 16-CG1674-RB_7 CG1674 CACCTTCACAGCAGTGCGAAATTCACTCGAAACATTTTGAAAGGCCATACGAAGACACTTTTCCGCGCA 69 FBan0001674 FBgn0039897 CG1674 4 4 CG1674 CG1674 CDMC31869 4 9 9 DAC14-L04 23-CG16792-RA_3 CG16792 CGAAATGCGCGACTAGCCAATGGATTCACCTACATACACCCACACCTTACTTCTAAGTCTACAAACGTA 69 FBan0016792 FBgn0000426 DebB 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 DebB Developmental embryonic B "CG16792, CG16792, Deb-B, Deb, deb-b, BcDNA:GM23968" CDMC31869 4 10 9 DAC14-L04 23-CG16792-RA_3 CG16792 CGAAATGCGCGACTAGCCAATGGATTCACCTACATACACCCACACCTTACTTCTAAGTCTACAAACGTA 69 FBan0016792 FBgn0000426 DebB 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 DebB Developmental embryonic B "CG16792, CG16792, Deb-B, Deb, deb-b, BcDNA:GM23968" CDMC31870 4 11 9 DAC14-L16 23-CG16807-RA_4 CG16807 GTTGAGCCTGCGTTTTGCTTTCAAGACTTTGTACATCAGTTTGATTCGAAGCAAAAGTGAGAAAGATTT 69 FBan0016807 FBgn0036621 CG16807 3 3L protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG16807 CG16807 NEST:bs21b12 CDMC31870 4 12 9 DAC14-L16 23-CG16807-RA_4 CG16807 GTTGAGCCTGCGTTTTGCTTTCAAGACTTTGTACATCAGTTTGATTCGAAGCAAAAGTGAGAAAGATTT 69 FBan0016807 FBgn0036621 CG16807 3 3L protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG16807 CG16807 NEST:bs21b12 CDMC31871 4 13 9 DAC14-P04 3-CG1685-RA_3 CG1685 GCGATCTGTACCGGAAGGCCAAGGATTCGAATGTGAAGACTCTGAGCGACACCTATAAGGAGGCCACGA 69 FBan0001685 FBgn0015527 pen X X apposition of dorsal and ventral wing surfaces; GO:0007475; mRNA metabolism; GO:0016071 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 pen penguin "CG1685, penguin" CDMC31871 4 14 9 DAC14-P04 3-CG1685-RA_3 CG1685 GCGATCTGTACCGGAAGGCCAAGGATTCGAATGTGAAGACTCTGAGCGACACCTATAAGGAGGCCACGA 69 FBan0001685 FBgn0015527 pen X X apposition of dorsal and ventral wing surfaces; GO:0007475; mRNA metabolism; GO:0016071 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 pen penguin "CG1685, penguin" CDMC31872 4 15 9 DAC14-P16 24-CG16884-RA_3 CG16884 CATCCAGTCAAAGGTTTGGAATCGCTAGTGATTCTACAATCCTTCCACAGTCTATTTCGCTGTTACTGA 69 FBan0016884 FBgn0028544 CG16884 2 2L CG16884 CG16884 BG:DS00180.3 CDMC31872 4 16 9 DAC14-P16 24-CG16884-RA_3 CG16884 CATCCAGTCAAAGGTTTGGAATCGCTAGTGATTCTACAATCCTTCCACAGTCTATTTCGCTGTTACTGA 69 FBan0016884 FBgn0028544 CG16884 2 2L CG16884 CG16884 BG:DS00180.3 CDMC31873 4 17 9 DAC15-D04 16-CG1864-RB_2 CG1864 GCCCCTAAGTTATGCCTCCTAGGATATACAGAGAAAGGACCCCATAGGACGGACGCAACTAGCTTTAGT 69 FBan0001864 FBgn0014859 Hr38 2 2L epidermis development; GO:0008544; intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 Hr38 Hormone receptor-like in 38 "CG1864, DHR38, Dhr38, NR4A4, HR38, 38E.3, 38E.7, l(2)02306" CDMC31873 4 18 9 DAC15-D04 16-CG1864-RB_2 CG1864 GCCCCTAAGTTATGCCTCCTAGGATATACAGAGAAAGGACCCCATAGGACGGACGCAACTAGCTTTAGT 69 FBan0001864 FBgn0014859 Hr38 2 2L epidermis development; GO:0008544; intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0003707 nucleus; GO:0005634 Hr38 Hormone receptor-like in 38 "CG1864, DHR38, Dhr38, NR4A4, HR38, 38E.3, 38E.7, l(2)02306" CDMC31874 4 19 9 DAC15-D16 2-CG18662-RA_2 CG18662 GGGCTTGTGCACCCAGGGTCTTGGAGGTGGTTACTTGGTTCACGACAAGGAAAAGAAGTACATCAAGCT 69 FBan0018662 FBgn0040963 CG18662 2 2L CG18662 CG18662 CDMC31874 4 20 9 DAC15-D16 2-CG18662-RA_2 CG18662 GGGCTTGTGCACCCAGGGTCTTGGAGGTGGTTACTTGGTTCACGACAAGGAAAAGAAGTACATCAAGCT 69 FBan0018662 FBgn0040963 CG18662 2 2L CG18662 CG18662 CDMC31875 4 21 9 DAC15-H04 23-CG18769-RB_19 CG18769 TGTGTTGAAAACTGTTTGCCTGTGCTATTAAACCCAATCCTAGAAACCAATCAGAGGACTCCACTCTCT 69 FBan0018769 FBgn0042185 CG18769 3 3L CG18769 CG18769 CG8352 CDMC31875 4 22 9 DAC15-H04 23-CG18769-RB_19 CG18769 TGTGTTGAAAACTGTTTGCCTGTGCTATTAAACCCAATCCTAGAAACCAATCAGAGGACTCCACTCTCT 69 FBan0018769 FBgn0042185 CG18769 3 3L CG18769 CG18769 CG8352 CDMC31876 4 23 9 DAC15-H16 15-CG18780-RA_2 CG18780 TGCTGCAGGGATTCCTCGGCATTGCTGTGAATAAGGACTTTCCCTCCTATTTCGCTCCACAGACAATAA 69 FBan0018780 FBgn0013531 MED20 2 2L transcription; GO:0006350; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0016455; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 Srb-mediator complex; GO:0016592; mediator complex; GO:0000119; nucleus; GO:0005634 MED20 Mediator complex subunit 20 "CG18780, CG18267, l(2)28DE: lethal(2)28DE, lethal(2)28DE, Trfp: Trf-proximal, Tmr: Transcription mediator-related, Transcription mediator-related, dTrap26, p29, Mediator, dTrfp, Srb2/TRFP, TrfP, Med20, Trf-proximal, Trfp, l(2)28DE, Mediator complex subunit 20, Tmr" CDMC31876 4 24 9 DAC15-H16 15-CG18780-RA_2 CG18780 TGCTGCAGGGATTCCTCGGCATTGCTGTGAATAAGGACTTTCCCTCCTATTTCGCTCCACAGACAATAA 69 FBan0018780 FBgn0013531 MED20 2 2L transcription; GO:0006350; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0016455; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 Srb-mediator complex; GO:0016592; mediator complex; GO:0000119; nucleus; GO:0005634 MED20 Mediator complex subunit 20 "CG18780, CG18267, l(2)28DE: lethal(2)28DE, lethal(2)28DE, Trfp: Trf-proximal, Tmr: Transcription mediator-related, Transcription mediator-related, dTrap26, p29, Mediator, dTrfp, Srb2/TRFP, TrfP, Med20, Trf-proximal, Trfp, l(2)28DE, Mediator complex subunit 20, Tmr" CDMC31877 4 25 9 DAC15-L04 1-CG18853-RA_3 CG18853 AGAGGACTTTTCCCATCTGTGGCTCATCTATCATTTTCACCGCAACAATTCCCACCCCAAGGCCAAGGC 69 FBan0018853 FBgn0042173 CG18853 2 2R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA photolyase activity; GO:0003913 ; EC:4.1.99.-; deoxyribodipyrimidine photo-lyase activity; GO:0003904 ; EC:4.1.99.3; ; GO:0003913 ; EC:4.1.99.-; ; GO:0003904 ; EC:4.1.99.3 CG18853 CG18853 CDMC31877 4 26 9 DAC15-L04 1-CG18853-RA_3 CG18853 AGAGGACTTTTCCCATCTGTGGCTCATCTATCATTTTCACCGCAACAATTCCCACCCCAAGGCCAAGGC 69 FBan0018853 FBgn0042173 CG18853 2 2R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA photolyase activity; GO:0003913 ; EC:4.1.99.-; deoxyribodipyrimidine photo-lyase activity; GO:0003904 ; EC:4.1.99.3; ; GO:0003913 ; EC:4.1.99.-; ; GO:0003904 ; EC:4.1.99.3 CG18853 CG18853 CDMC31878 4 1 10 DAC15-L16 8-CG1894-RA_1 CG1894 ACCGCCCTATATGCGCAAGGGATACGGAAAGTTGTTGATTGATCTGAGCTACGAGATCTCTCGCAGGGA 69 FBan0001894 FBgn0039585 CG1894 3 3R protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 CG1894 CG1894 dmHAG407 CDMC31878 4 2 10 DAC15-L16 8-CG1894-RA_1 CG1894 ACCGCCCTATATGCGCAAGGGATACGGAAAGTTGTTGATTGATCTGAGCTACGAGATCTCTCGCAGGGA 69 FBan0001894 FBgn0039585 CG1894 3 3R protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 CG1894 CG1894 dmHAG407 CDMC31879 4 3 10 DAC15-P04 23-CG1921-RC_15 CG1921 TTACTTTACCAACTACGAAGCCGGAACAAATCTGAGGAGCGAAAATATGGGATAACGAAATCGATTGCT 69 FBan0001921 FBgn0014388 sty 3 3L "MAPKKK cascade; GO:0000165; branching morphogenesis; GO:0001763; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of fibroblast growth factor receptor signaling pathway; GO:0040037; negative regulation of signal transduction; GO:0009968; negative regulation of terminal cell fate specification; GO:0035155; ovarian follicle cell development (sensu Insecta); GO:0030707; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" receptor binding; GO:0005102; ; GO:0005102 intracellular; GO:0005622; plasma membrane; GO:0005886 sty sprouty "CG1921, spry, Sprouty, sprouty, Sry, dSPRY, Sty, dSprouty, CS3-3, Calcineurin suppressor, chromosome 3, group 3, Spry" CDMC31879 4 4 10 DAC15-P04 23-CG1921-RC_15 CG1921 TTACTTTACCAACTACGAAGCCGGAACAAATCTGAGGAGCGAAAATATGGGATAACGAAATCGATTGCT 69 FBan0001921 FBgn0014388 sty 3 3L "MAPKKK cascade; GO:0000165; branching morphogenesis; GO:0001763; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of fibroblast growth factor receptor signaling pathway; GO:0040037; negative regulation of signal transduction; GO:0009968; negative regulation of terminal cell fate specification; GO:0035155; ovarian follicle cell development (sensu Insecta); GO:0030707; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" receptor binding; GO:0005102; ; GO:0005102 intracellular; GO:0005622; plasma membrane; GO:0005886 sty sprouty "CG1921, spry, Sprouty, sprouty, Sry, dSPRY, Sty, dSprouty, CS3-3, Calcineurin suppressor, chromosome 3, group 3, Spry" CDMC31880 4 5 10 DAC15-P16 3-CG1937-RA_2 CG1937 TTCCTTGAAGAGCGGAACAAGTCTGCAGCCACTAATGAACGCACGACAGCGGAATAGACGCCCTACAAT 69 FBan0001937 FBgn0039875 sip3 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 sip3 septin interacting protein 3 "CG1937, CG1937, CG1937, septin interacting protein 3" CDMC31880 4 6 10 DAC15-P16 3-CG1937-RA_2 CG1937 TTCCTTGAAGAGCGGAACAAGTCTGCAGCCACTAATGAACGCACGACAGCGGAATAGACGCCCTACAAT 69 FBan0001937 FBgn0039875 sip3 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 sip3 septin interacting protein 3 "CG1937, CG1937, CG1937, septin interacting protein 3" CDMC31881 4 7 10 DAC16-D04 22-CG32758-RA_2 CG32758 TCAAATGTTTTCGGCACTTAGCACATAGAGCAAACACAGGCACCAATTTAGATCAAGCAGAACCGACGA 69 FBan0032758 FBgn0052758 CG32758 X X intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 CG32758 CG32758 "CG11465, CG3130, CG3138" CDMC31881 4 8 10 DAC16-D04 22-CG32758-RA_2 CG32758 TCAAATGTTTTCGGCACTTAGCACATAGAGCAAACACAGGCACCAATTTAGATCAAGCAGAACCGACGA 69 FBan0032758 FBgn0052758 CG32758 X X intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 CG32758 CG32758 "CG11465, CG3130, CG3138" CDMC31882 4 9 10 DAC16-D16 8-CG32773-RA_3 CG32773 AGTGTCCTCGGGCAAAAGTGACACCAAATTGTCGGCTAATCTGTCGATGACTTTCACCCTCGAAAGCGA 69 FBan0032773 FBgn0052773 CG32773 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32773 CG32773 CDMC31882 4 10 10 DAC16-D16 8-CG32773-RA_3 CG32773 AGTGTCCTCGGGCAAAAGTGACACCAAATTGTCGGCTAATCTGTCGATGACTTTCACCCTCGAAAGCGA 69 FBan0032773 FBgn0052773 CG32773 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32773 CG32773 CDMC31883 4 11 10 DAC16-H04 2-CG32806-RA_1 CG32806 CGGGCACAGATAGCGTCTATCTCGCCAACCCTTCGATGAACGAGCTAATGCGAGCTATTCAAAGTGGCT 69 FBan0032806 FBgn0052806 CG32806 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32806 CG32806 NEST:bs06b11 CDMC31883 4 12 10 DAC16-H04 2-CG32806-RA_1 CG32806 CGGGCACAGATAGCGTCTATCTCGCCAACCCTTCGATGAACGAGCTAATGCGAGCTATTCAAAGTGGCT 69 FBan0032806 FBgn0052806 CG32806 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32806 CG32806 NEST:bs06b11 CDMC31884 4 13 10 DAC16-H16 23-CG32813-RA_11 CG32813 TCAAAAGTGAAGAACGAAAGAGCTACAGAAAAGAAATCGAAATTGTTACGCCTAGCCGAGAACTTGTGT 69 FBan0032813 FBgn0052813 CG32813 X X CG32813 CG32813 "CG14771, CG11446, CG14771, anon-WO0153538.75" CDMC31884 4 14 10 DAC16-H16 23-CG32813-RA_11 CG32813 TCAAAAGTGAAGAACGAAAGAGCTACAGAAAAGAAATCGAAATTGTTACGCCTAGCCGAGAACTTGTGT 69 FBan0032813 FBgn0052813 CG32813 X X CG32813 CG32813 "CG14771, CG11446, CG14771, anon-WO0153538.75" CDMC31885 4 15 10 DAC16-L04 3-CG32849-RA_6 CG32849 TGGGTGGCTCTAATTTCAGGGTGCTTCTGGTGAACCTGATTAGCAACTCGGACGTGGAAACCATGTCGA 69 FBan0032849 FBgn0042710 Hex-t2 3 3R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 cellular component unknown; GO:0008372 Hex-t2 Hex-t2 "CG5443, CG32849, CG5443, CG5443, CG5443, Hex, Hexokinase, HK, hexokinase, anon-WO0140519.203" CDMC31885 4 16 10 DAC16-L04 3-CG32849-RA_6 CG32849 TGGGTGGCTCTAATTTCAGGGTGCTTCTGGTGAACCTGATTAGCAACTCGGACGTGGAAACCATGTCGA 69 FBan0032849 FBgn0042710 Hex-t2 3 3R glycolysis; GO:0006096 ATP binding; GO:0005524; ; GO:0005524; hexokinase activity; GO:0004396 ; EC:2.7.1.1; ; GO:0004396 ; EC:2.7.1.1 cellular component unknown; GO:0008372 Hex-t2 Hex-t2 "CG5443, CG32849, CG5443, CG5443, CG5443, Hex, Hexokinase, HK, hexokinase, anon-WO0140519.203" CDMC31886 4 17 10 DAC16-L16 10-CG32856-RA_2 CG32856 TCGAGTCCTTCAAAAAGAGCAGGCTGAACTATTTGCTATCCAGAAGAAACTCGACCGAGTGCTCCCCGT 69 FBan0032856 FBgn0052856 CG32856 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32856 CG32856 BcDNA:GM32296 CDMC31886 4 18 10 DAC16-L16 10-CG32856-RA_2 CG32856 TCGAGTCCTTCAAAAAGAGCAGGCTGAACTATTTGCTATCCAGAAGAAACTCGACCGAGTGCTCCCCGT 69 FBan0032856 FBgn0052856 CG32856 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32856 CG32856 BcDNA:GM32296 CDMC31887 4 19 10 DAC16-P04 2-CG32950-RB_1 CG32950 CGCCACCGATTAGCATAGGTCAGTCCAACGAAAGCCACCCCTAGTTCAAGATGAAGTTCCTGCCTCTGT 69 FBgn0052950 CDMC31887 4 20 10 DAC16-P04 2-CG32950-RB_1 CG32950 CGCCACCGATTAGCATAGGTCAGTCCAACGAAAGCCACCCCTAGTTCAAGATGAAGTTCCTGCCTCTGT 69 FBgn0052950 CDMC31888 4 21 10 DAC16-P16 9-CG32954-RG_1 CG32954 GCCGACACGAACTGGAAACCAACAACTAACGGAGCCCTCTTCCAATTGAAACAGATCGAAAGAGCCTGC 69 FBgn0052954 CDMC31888 4 22 10 DAC16-P16 9-CG32954-RG_1 CG32954 GCCGACACGAACTGGAAACCAACAACTAACGGAGCCCTCTTCCAATTGAAACAGATCGAAAGAGCCTGC 69 FBgn0052954 CDMC31889 4 23 10 DAC17-D04 1-CG12379-RA_1 CG12379 CAGACCCGGAACATGAAGACCATTTCGAAGCTGGCATACCAACGCGGCGTTGTTATCGTGACCTG 65 FBan0012379 FBgn0030676 CG12379 X X CG12379 CG12379 CDMC31889 4 24 10 DAC17-D04 1-CG12379-RA_1 CG12379 CAGACCCGGAACATGAAGACCATTTCGAAGCTGGCATACCAACGCGGCGTTGTTATCGTGACCTG 65 FBan0012379 FBgn0030676 CG12379 X X CG12379 CG12379 CDMC31890 4 25 10 DAC17-D16 8-CG12436-RA_1 CG12436 CGTCGACGCCAAAGAAGTCCAACTGGGAGGTGATCGAACATTTCAATACGAGTGCCAAGGGAGGC 65 FBan0012436 FBgn0036637 CG12436 3 3L CG12436 CG12436 CDMC31890 4 26 10 DAC17-D16 8-CG12436-RA_1 CG12436 CGTCGACGCCAAAGAAGTCCAACTGGGAGGTGATCGAACATTTCAATACGAGTGCCAAGGGAGGC 65 FBan0012436 FBgn0036637 CG12436 3 3L CG12436 CG12436 CDMC31891 4 1 11 DAC17-H04 1-CG12517-RA_1 CG12517 TCTGACCATGACCTTGCGCTATGCCTTCGGCGAAATTCTGCTGGACACAAGTCGAAAATGCCGTC 65 FBan0012517 FBgn0032311 CG12517 2 2L CG12517 CG12517 CDMC31891 4 2 11 DAC17-H04 1-CG12517-RA_1 CG12517 TCTGACCATGACCTTGCGCTATGCCTTCGGCGAAATTCTGCTGGACACAAGTCGAAAATGCCGTC 65 FBan0012517 FBgn0032311 CG12517 2 2L CG12517 CG12517 CDMC31892 4 3 11 DAC17-H16 23-CG12543-RA_1 CG12543 TGGATCGTTTGTGGTCGATAACGGAGGACCTGAATATATTGTATAAGGAGAATTGGACGCGACTC 65 FBan0012543 FBgn0029872 CG12543 X X CG12543 CG12543 CDMC31892 4 4 11 DAC17-H16 23-CG12543-RA_1 CG12543 TGGATCGTTTGTGGTCGATAACGGAGGACCTGAATATATTGTATAAGGAGAATTGGACGCGACTC 65 FBan0012543 FBgn0029872 CG12543 X X CG12543 CG12543 CDMC31893 4 5 11 DAC17-L04 15-CG12667-RA_1 CG12667 GAAATGCGGACGCACGAGAATGCCGAAGAAGATGGAGCGGATGGAGATTCCACGCCCTGGATACC 65 FBan0012667 FBgn0030124 CG12667 X X CG12667 CG12667 CDMC31893 4 6 11 DAC17-L04 15-CG12667-RA_1 CG12667 GAAATGCGGACGCACGAGAATGCCGAAGAAGATGGAGCGGATGGAGATTCCACGCCCTGGATACC 65 FBan0012667 FBgn0030124 CG12667 X X CG12667 CG12667 CDMC31894 4 7 11 DAC17-L16 2-CG12715-RA_2 CG12715 TTCCCGACGTCGACATGACCGATAGATTTGTGGAATGGCTGGAACTGATGAGGCTACTGGGTGCC 65 FBan0012715 FBgn0030443 CG12715 X X CG12715 CG12715 CDMC31894 4 8 11 DAC17-L16 2-CG12715-RA_2 CG12715 TTCCCGACGTCGACATGACCGATAGATTTGTGGAATGGCTGGAACTGATGAGGCTACTGGGTGCC 65 FBan0012715 FBgn0030443 CG12715 X X CG12715 CG12715 CDMC31895 4 9 11 DAC17-P04 18-CG12820-RA_1 CG12820 CTGGGCGGACATCTATCCCACGATCCTAGCAAGACCGGCAGTGTCCATCCGATGCTCACGGTGAC 65 FBan0012820 FBgn0033230 CG12820 2 2R CG12820 CG12820 CDMC31895 4 10 11 DAC17-P04 18-CG12820-RA_1 CG12820 CTGGGCGGACATCTATCCCACGATCCTAGCAAGACCGGCAGTGTCCATCCGATGCTCACGGTGAC 65 FBan0012820 FBgn0033230 CG12820 2 2R CG12820 CG12820 CDMC31896 4 11 11 DAC17-P16 17-CG12852-RA_1 CG12852 AGCAGCCGCAGCAACAGCAGCAACAACCACCAGTGGCTCAGGTTTATGGCATGTCCGAAGTGTAG 65 FBan0012852 FBgn0039573 CG12852 3 3R CG12852 CG12852 CDMC31896 4 12 11 DAC17-P16 17-CG12852-RA_1 CG12852 AGCAGCCGCAGCAACAGCAGCAACAACCACCAGTGGCTCAGGTTTATGGCATGTCCGAAGTGTAG 65 FBan0012852 FBgn0039573 CG12852 3 3R CG12852 CG12852 CDMC31897 4 13 11 DAC18-D04 1-CG5970-RA_1 CG5970 GGAGCGACTATACAACGAGCTGCTTCGAGATGTTCCCAAGGGAGTTCATGTGGTACTGCTGCCCAAG 67 FBan0005970 FBgn0033842 CG5970 2 2R "mRNA polyadenylylation; GO:0006378; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" poly(A) binding; GO:0008143; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0008143; ; GO:0003729 CG5970 CG5970 cg5970 CDMC31897 4 14 11 DAC18-D04 1-CG5970-RA_1 CG5970 GGAGCGACTATACAACGAGCTGCTTCGAGATGTTCCCAAGGGAGTTCATGTGGTACTGCTGCCCAAG 67 FBan0005970 FBgn0033842 CG5970 2 2R "mRNA polyadenylylation; GO:0006378; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" poly(A) binding; GO:0008143; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0008143; ; GO:0003729 CG5970 CG5970 cg5970 CDMC31898 4 15 11 DAC18-D16 14-CG6253-RA_1 CG6253 TCCTTCTCTTTCTTTCCGGTTAGCGTCATGCCTTTCGAGAGATTCGTACAAACTGGTCGCATTGCCA 67 FBan0006253 FBgn0017579 RpL14 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830; ribosome; GO:0005840 RpL14 Ribosomal protein L14 "CG6253, CG6253, M(3)66, M(3)66D, ribosomal protein L14, Minute(3)66D, L14, anon-EST:Posey6, rpl14, Minute (3)66D, anon-EST:Posey193U" CDMC31898 4 16 11 DAC18-D16 14-CG6253-RA_1 CG6253 TCCTTCTCTTTCTTTCCGGTTAGCGTCATGCCTTTCGAGAGATTCGTACAAACTGGTCGCATTGCCA 67 FBan0006253 FBgn0017579 RpL14 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830; ribosome; GO:0005840 RpL14 Ribosomal protein L14 "CG6253, CG6253, M(3)66, M(3)66D, ribosomal protein L14, Minute(3)66D, L14, anon-EST:Posey6, rpl14, Minute (3)66D, anon-EST:Posey193U" CDMC31899 4 17 11 DAC18-H04 3-CG6712-RA_2 CG6712 GCCCACTTCAAGCTGTCCAACGTGAAGCTCACCTCGGACATAAAGCGCGATCACAAGGAGATAACCA 67 FBan0006712 FBgn0032408 CG6712 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072; ribosome biogenesis; GO:0007046" RNA binding; GO:0003723; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ; GO:0003723 nucleolus; GO:0005730 CG6712 CG6712 ORF2 CDMC31899 4 18 11 DAC18-H04 3-CG6712-RA_2 CG6712 GCCCACTTCAAGCTGTCCAACGTGAAGCTCACCTCGGACATAAAGCGCGATCACAAGGAGATAACCA 67 FBan0006712 FBgn0032408 CG6712 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072; ribosome biogenesis; GO:0007046" RNA binding; GO:0003723; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ; GO:0003723 nucleolus; GO:0005730 CG6712 CG6712 ORF2 CDMC31900 4 19 11 DAC18-H16 1-CG6819-RA_1 CG6819 GCTTCGCTACTTTGCCTACCACAACGCAGGACTTCATGCCGTTACGGTCAGCTTTATCGCAGAGCTG 67 FBan0006819 FBgn0026207 mbo 3 3R antimicrobial humoral response (sensu Protostomia); GO:0006960; immune response; GO:0006955; negative regulation of protein export from nucleus; GO:0046826; protein import into nucleus; GO:0006606; protein targeting; GO:0006605; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 transporter activity; GO:0005215; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515; ; GO:0005515; ; GO:0005515 nuclear membrane; GO:0005635; nuclear pore; GO:0005643 mbo members only "CG6819, l(3)05043, 1465/07, 1465/7, l(3)S146507, Dnup88, Nup88, DNup88, dNup88, Dnup 88, anon-WO0118547.263, members only" CDMC31900 4 20 11 DAC18-H16 1-CG6819-RA_1 CG6819 GCTTCGCTACTTTGCCTACCACAACGCAGGACTTCATGCCGTTACGGTCAGCTTTATCGCAGAGCTG 67 FBan0006819 FBgn0026207 mbo 3 3R antimicrobial humoral response (sensu Protostomia); GO:0006960; immune response; GO:0006955; negative regulation of protein export from nucleus; GO:0046826; protein import into nucleus; GO:0006606; protein targeting; GO:0006605; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424 transporter activity; GO:0005215; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515; ; GO:0005515; ; GO:0005515 nuclear membrane; GO:0005635; nuclear pore; GO:0005643 mbo members only "CG6819, l(3)05043, 1465/07, 1465/7, l(3)S146507, Dnup88, Nup88, DNup88, dNup88, Dnup 88, anon-WO0118547.263, members only" CDMC31901 4 21 11 DAC18-L04 3-CG7281-RA_5 CG7281 CCTGGAGTGCGAGTTTTACCTGCTGGAGAACCTGGATTGCTGCTTGATTGTCTACCAGCCGTACAGA 67 FBan0007281 FBgn0004597 CycC 3 3R G1/S transition of mitotic cell cycle; GO:0000082; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 nucleic acid binding; GO:0003676; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0003676; kinase activator activity; GO:0019209; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016455; ; GO:0019209; ; GO:0003899 ; EC:2.7.7.6; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- mediator complex; GO:0000119; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycC Cyclin C "CG7281, CG7281, Cln3, cycC, DmcycC, Cyc-C, cyclin C, SRB11, dTRAP33, cyclinC" CDMC31901 4 22 11 DAC18-L04 3-CG7281-RA_5 CG7281 CCTGGAGTGCGAGTTTTACCTGCTGGAGAACCTGGATTGCTGCTTGATTGTCTACCAGCCGTACAGA 67 FBan0007281 FBgn0004597 CycC 3 3R G1/S transition of mitotic cell cycle; GO:0000082; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 nucleic acid binding; GO:0003676; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0003676; kinase activator activity; GO:0019209; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016455; ; GO:0019209; ; GO:0003899 ; EC:2.7.7.6; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- mediator complex; GO:0000119; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycC Cyclin C "CG7281, CG7281, Cln3, cycC, DmcycC, Cyc-C, cyclin C, SRB11, dTRAP33, cyclinC" CDMC31902 4 23 11 DAC18-L16 3-CG7663-RA_1 CG7663 CCATCGATTCTTTCACGCCGGAATTTATGGTCTTCGCGCCCATAAAGAGCAAACAATGGGGCTCGCC 67 FBan0007663 FBgn0037068 CG7663 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG7663 CG7663 "BcDNA:RE38359, anon-EST:ParkEST240" CDMC31902 4 24 11 DAC18-L16 3-CG7663-RA_1 CG7663 CCATCGATTCTTTCACGCCGGAATTTATGGTCTTCGCGCCCATAAAGAGCAAACAATGGGGCTCGCC 67 FBan0007663 FBgn0037068 CG7663 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG7663 CG7663 "BcDNA:RE38359, anon-EST:ParkEST240" CDMC31903 4 25 11 DAC18-P04 3-CG8002-RA_1 CG8002 GGCAGCAATGACTCCTCGTCAGCCCTAAGATATTCCACTGTGACCAAGAGCTTGTCGGCATCGATGG 67 FBan0008002 FBgn0031006 rictor X X rictor rapamycin-insensitive companion of Tor "CG8002, CG8002, dRictor, rapamycin-insensitive companion of Tor" CDMC31903 4 26 11 DAC18-P04 3-CG8002-RA_1 CG8002 GGCAGCAATGACTCCTCGTCAGCCCTAAGATATTCCACTGTGACCAAGAGCTTGTCGGCATCGATGG 67 FBan0008002 FBgn0031006 rictor X X rictor rapamycin-insensitive companion of Tor "CG8002, CG8002, dRictor, rapamycin-insensitive companion of Tor" CDMC31904 4 1 12 DAC18-P16 AutoBlank AutoBlank CDMC31904 4 2 12 DAC18-P16 AutoBlank AutoBlank CDMC31905 4 3 12 DAC19-D04 3-CG8146-RA_1 CG8146 ACCTTTTCCTTTGGCTCGTATGCCAAGTTCAAGTCGCAGACCATCACCGAGTTCATTGAGAAGGCCGT 68 FBan0008146 FBgn0030869 Socs16D X X JAK-STAT cascade; GO:0007259; cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; development; GO:0007275; hemopoiesis; GO:0030097; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 Socs16D Suppressor of Cytokine Signaling at 16D "CG8146, SOCS, Socs16E, Suppressor of Cytokine Signaling at 16E, SOCS16D, dmSocs16D, socs16D" CDMC31905 4 4 12 DAC19-D04 3-CG8146-RA_1 CG8146 ACCTTTTCCTTTGGCTCGTATGCCAAGTTCAAGTCGCAGACCATCACCGAGTTCATTGAGAAGGCCGT 68 FBan0008146 FBgn0030869 Socs16D X X JAK-STAT cascade; GO:0007259; cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; development; GO:0007275; hemopoiesis; GO:0030097; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 Socs16D Suppressor of Cytokine Signaling at 16D "CG8146, SOCS, Socs16E, Suppressor of Cytokine Signaling at 16E, SOCS16D, dmSocs16D, socs16D" CDMC31906 4 5 12 DAC19-D16 15-CG8197-RA_1 CG8197 GCTTGCTGGATGCCGAGGTAGTACTCCACTCCGAGCTGGACATCAGTTACACATACGACGAGGCACTG 68 FBan0008197 FBgn0033369 CG8197 2 2R CG8197 CG8197 CDMC31906 4 6 12 DAC19-D16 15-CG8197-RA_1 CG8197 GCTTGCTGGATGCCGAGGTAGTACTCCACTCCGAGCTGGACATCAGTTACACATACGACGAGGCACTG 68 FBan0008197 FBgn0033369 CG8197 2 2R CG8197 CG8197 CDMC31907 4 7 12 DAC19-H04 2-CG8795-RA_1 CG8795 GCGAAAGTGAAAGTGCTCAAGAGCTCAAGCCCGTTCAAGGGTCTCAGGACCAAATTCAATTGGCGTGC 68 FBan0008795 FBgn0038139 CG8795 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; electron transporter activity; GO:0005489; copper ion binding; GO:0005507; ; GO:0001653; ; GO:0016520; ; GO:0005489; ; GO:0005507 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG8795 CG8795 "anon-WO0170980.193, anon-WO0170980.194" CDMC31907 4 8 12 DAC19-H04 2-CG8795-RA_1 CG8795 GCGAAAGTGAAAGTGCTCAAGAGCTCAAGCCCGTTCAAGGGTCTCAGGACCAAATTCAATTGGCGTGC 68 FBan0008795 FBgn0038139 CG8795 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; peptide receptor activity; GO:0001653; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; electron transporter activity; GO:0005489; copper ion binding; GO:0005507; ; GO:0001653; ; GO:0016520; ; GO:0005489; ; GO:0005507 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG8795 CG8795 "anon-WO0170980.193, anon-WO0170980.194" CDMC31908 4 9 12 DAC19-H16 3-CG8952-RA_1 CG8952 GGGTCTCGTCCTTCCTCGGCTTCATTGCAGACAAAACGGGCATTGCTGTATGAAATCGACACGGACAC 68 FBan0008952 FBgn0030688 CG8952 X X proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG8952 CG8952 SP52 CDMC31908 4 10 12 DAC19-H16 3-CG8952-RA_1 CG8952 GGGTCTCGTCCTTCCTCGGCTTCATTGCAGACAAAACGGGCATTGCTGTATGAAATCGACACGGACAC 68 FBan0008952 FBgn0030688 CG8952 X X proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG8952 CG8952 SP52 CDMC31909 4 11 12 DAC19-L04 3-CG9374-RA_2 CG9374 CCCCCCCTGAAGGGTGACAAATACCGCAACTCCACGGTGATACCTTACTTGGAAGCTTACCACTACGG 68 FBan0009374 FBgn0038167 lkb1 3 3R establishment and/or maintenance of cell polarity; GO:0007163; oocyte microtubule cytoskeleton organization; GO:0016325; pole plasm oskar mRNA localization; GO:0045451; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 lkb1 lkb1 "CG9374, CG9374, STK11, LKB1/PEUTZ JEGHERS KINASE, LKB1, PAR-4, dLKB1, DmLKB1, Lkb1, anon-EST:Posey135, par-4" CDMC31909 4 12 12 DAC19-L04 3-CG9374-RA_2 CG9374 CCCCCCCTGAAGGGTGACAAATACCGCAACTCCACGGTGATACCTTACTTGGAAGCTTACCACTACGG 68 FBan0009374 FBgn0038167 lkb1 3 3R establishment and/or maintenance of cell polarity; GO:0007163; oocyte microtubule cytoskeleton organization; GO:0016325; pole plasm oskar mRNA localization; GO:0045451; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 lkb1 lkb1 "CG9374, CG9374, STK11, LKB1/PEUTZ JEGHERS KINASE, LKB1, PAR-4, dLKB1, DmLKB1, Lkb1, anon-EST:Posey135, par-4" CDMC31910 4 13 12 DAC19-L16 3-CG9481-RA_2 CG9481 GTGACCAGCCCTCCAATGCCGATGTCATGGTGATGCATGGCTTTGGAATCAAGCAAAGCATCCTTACC 68 FBan0009481 FBgn0026755 Ugt37b1 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt37b1 UDP-glycosyltransferase 37b1 "CG9481, DmeUgt37b1, AC 005285A, UDP-glycosyltransferase 37b1" CDMC31910 4 14 12 DAC19-L16 3-CG9481-RA_2 CG9481 GTGACCAGCCCTCCAATGCCGATGTCATGGTGATGCATGGCTTTGGAATCAAGCAAAGCATCCTTACC 68 FBan0009481 FBgn0026755 Ugt37b1 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt37b1 UDP-glycosyltransferase 37b1 "CG9481, DmeUgt37b1, AC 005285A, UDP-glycosyltransferase 37b1" CDMC31911 4 15 12 DAC19-P04 12-CG9933-RA_1 CG9933 TCTCCATGCACTGCCTTCGAGACGAAAGTCAAGCTTATATCACAGAACCTCAAGGAAACCACGCTGGC 68 FBgn0032468 CDMC31911 4 16 12 DAC19-P04 12-CG9933-RA_1 CG9933 TCTCCATGCACTGCCTTCGAGACGAAAGTCAAGCTTATATCACAGAACCTCAAGGAAACCACGCTGGC 68 FBgn0032468 CDMC31912 4 17 12 DAC19-P16 AutoBlank AutoBlank CDMC31912 4 18 12 DAC19-P16 AutoBlank AutoBlank CDMC31913 4 19 12 DAC20-D04 3-CG1806-RA_3 CG1806 GGCACAGCCGCATGATCGTTGTCAATCACAAAAACCACGACAGTCTCCAGGCCACCAGGAATCTGAATA 69 FBan0001806 FBgn0030360 CG1806 X X CG1806 CG1806 CDMC31913 4 20 12 DAC20-D04 3-CG1806-RA_3 CG1806 GGCACAGCCGCATGATCGTTGTCAATCACAAAAACCACGACAGTCTCCAGGCCACCAGGAATCTGAATA 69 FBan0001806 FBgn0030360 CG1806 X X CG1806 CG1806 CDMC31914 4 21 12 DAC20-D16 6-CG18094-RA_1 CG18094 GCTGCGATGACTGCATGTTTGGAGTTCTTCCTGGTGATGAGCTCTATCCCAAAGAACCAGGCGCTTGTA 69 FBan0018094 FBgn0032791 CG18094 2 2L CG18094 CG18094 CG10048 CDMC31914 4 22 12 DAC20-D16 6-CG18094-RA_1 CG18094 GCTGCGATGACTGCATGTTTGGAGTTCTTCCTGGTGATGAGCTCTATCCCAAAGAACCAGGCGCTTGTA 69 FBan0018094 FBgn0032791 CG18094 2 2L CG18094 CG18094 CG10048 CDMC31915 4 23 12 DAC20-H04 23-CG18144-RA_9 CG18144 GCGAACCCAAAGTATAAACAATGCGTTTTCCTATCTGCGAGAAAAGATTCCCAACGTTCCTACAGATAC 69 FBan0018144 FBgn0032209 Hand 2 2L angiogenesis; GO:0001525; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hand Hand "CG18144, CG18144, CG18144, CG18144, CG18144, dHAND, dHand, hand, Dhand" CDMC31915 4 24 12 DAC20-H04 23-CG18144-RA_9 CG18144 GCGAACCCAAAGTATAAACAATGCGTTTTCCTATCTGCGAGAAAAGATTCCCAACGTTCCTACAGATAC 69 FBan0018144 FBgn0032209 Hand 2 2L angiogenesis; GO:0001525; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Hand Hand "CG18144, CG18144, CG18144, CG18144, CG18144, dHAND, dHand, hand, Dhand" CDMC31916 4 25 12 DAC20-H16 1-CG18166-RB_7 CG18166 CCTGCGCCGTCTCTCCTCACAAGTGGACTATCGCGCGGAAAGAAAGCTGACACAGGACATAAGTGAAAC 69 FBan0018166 FBgn0029526 CG18166 X X CG18166 CG18166 "CG13372, CG13372, BEST:GH02584" CDMC31916 4 26 12 DAC20-H16 1-CG18166-RB_7 CG18166 CCTGCGCCGTCTCTCCTCACAAGTGGACTATCGCGCGGAAAGAAAGCTGACACAGGACATAAGTGAAAC 69 FBan0018166 FBgn0029526 CG18166 X X CG18166 CG18166 "CG13372, CG13372, BEST:GH02584" CDMC31917 4 1 13 DAC20-L04 7-CG18223-RB_1 CG18223 ACCGGAAGCCCACTGATTTTCAACGAAACAGTCTTTGGTGTGGTTAGCTACCGAGTAGGCTGTGGATCT 69 FBan0018223 FBgn0036832 CG18223 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18223 CG18223 "SPH200, BcDNA:AT03311" CDMC31917 4 2 13 DAC20-L04 7-CG18223-RB_1 CG18223 ACCGGAAGCCCACTGATTTTCAACGAAACAGTCTTTGGTGTGGTTAGCTACCGAGTAGGCTGTGGATCT 69 FBan0018223 FBgn0036832 CG18223 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18223 CG18223 "SPH200, BcDNA:AT03311" CDMC31918 4 3 13 DAC20-L16 6-CG18243-RA_4 CG18243 GGCATCCCGAACCCGTTCAACGTCAGCGAAGGGATGGAGAGGTGACATCCGATGAGGAAATTGTTTTTA 69 FBan0018243 FBgn0034085 Ptp52F 2 2R axon guidance; GO:0007411; electron transport; GO:0006118; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 Ptp52F Ptp52F "CG18243, CT18044, DPTP52F" CDMC31918 4 4 13 DAC20-L16 6-CG18243-RA_4 CG18243 GGCATCCCGAACCCGTTCAACGTCAGCGAAGGGATGGAGAGGTGACATCCGATGAGGAAATTGTTTTTA 69 FBan0018243 FBgn0034085 Ptp52F 2 2R axon guidance; GO:0007411; electron transport; GO:0006118; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 Ptp52F Ptp52F "CG18243, CT18044, DPTP52F" CDMC31919 4 5 13 DAC20-P04 11-CG1827-RB_1 CG1827 CCTACGCGCTTGGAAACGGTCAAATGCATAGGTGGTCAGGACAAAGTAAATATCGTGGCGTTGTGAGGT 69 FBan0001827 FBgn0033431 CG1827 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG1827 CG1827 CDMC31919 4 6 13 DAC20-P04 11-CG1827-RB_1 CG1827 CCTACGCGCTTGGAAACGGTCAAATGCATAGGTGGTCAGGACAAAGTAAATATCGTGGCGTTGTGAGGT 69 FBan0001827 FBgn0033431 CG1827 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG1827 CG1827 CDMC31920 4 7 13 DAC20-P16 2-CG18296-RA_2 CG18296 GCGAGCACACGAGTTTTCTGGGCGAATTCTGTTCGGAGGAGAAAGGAGCAGATTTCAGTGGCGAATCGA 69 FBan0018296 FBgn0026729 axo 3 3L cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuron recognition; GO:0008038; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 extracellular region; GO:0005576 axo axotactin "CG18296, CT1277" CDMC31920 4 8 13 DAC20-P16 2-CG18296-RA_2 CG18296 GCGAGCACACGAGTTTTCTGGGCGAATTCTGTTCGGAGGAGAAAGGAGCAGATTTCAGTGGCGAATCGA 69 FBan0018296 FBgn0026729 axo 3 3L cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuron recognition; GO:0008038; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 extracellular region; GO:0005576 axo axotactin "CG18296, CT1277" CDMC31921 4 9 13 DAC21-D04 5-CG3921-RA_1 CG3921 CCGGGATAACTCCACCTACGGTGATAACACCCGAGCCAATTCCATTAGTACCAGTGTGGCAGAGGACAC 69 FBan0003921 FBgn0031571 CG3921 2 2L scavenger receptor activity; GO:0005044; sugar binding; GO:0005529; ; GO:0005044; ; GO:0005529 membrane; GO:0016020 CG3921 CG3921 CDMC31921 4 10 13 DAC21-D04 5-CG3921-RA_1 CG3921 CCGGGATAACTCCACCTACGGTGATAACACCCGAGCCAATTCCATTAGTACCAGTGTGGCAGAGGACAC 69 FBan0003921 FBgn0031571 CG3921 2 2L scavenger receptor activity; GO:0005044; sugar binding; GO:0005529; ; GO:0005044; ; GO:0005529 membrane; GO:0016020 CG3921 CG3921 CDMC31922 4 11 13 DAC21-D16 1-CG3934-RA_1 CG3934 AGCTTCAAGAAGTTATCCCTGTGCCTAGTGCTTTCTATCATGTGGACCTCGGTTGCAGACAGCACGCCA 69 FBan0003934 FBgn0037783 CG3934 3 3R CG3934 CG3934 DmML5A CDMC31922 4 12 13 DAC21-D16 1-CG3934-RA_1 CG3934 AGCTTCAAGAAGTTATCCCTGTGCCTAGTGCTTTCTATCATGTGGACCTCGGTTGCAGACAGCACGCCA 69 FBan0003934 FBgn0037783 CG3934 3 3R CG3934 CG3934 DmML5A CDMC31923 4 13 13 DAC21-H04 18-CG3961-RA_3 CG3961 CACTCTCCGTCCTGTGCAATAATAAGAATGTCAAGGAACTGATCATGAACGACATGCTCAACTGGGGCA 69 FBan0003961 FBgn0036821 CG3961 3 3L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG3961 CG3961 CDMC31923 4 14 13 DAC21-H04 18-CG3961-RA_3 CG3961 CACTCTCCGTCCTGTGCAATAATAAGAATGTCAAGGAACTGATCATGAACGACATGCTCAACTGGGGCA 69 FBan0003961 FBgn0036821 CG3961 3 3L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG3961 CG3961 CDMC31924 4 15 13 DAC21-H16 23-CG3977-RA_3 CG3977 AAAACAGTCGTACGATTTTTGCTCAATCCGAAAATGGCTGTTGTGAAATTGCTTTCCTAAACGAATGGC 69 FBgn0029886 CDMC31924 4 16 13 DAC21-H16 23-CG3977-RA_3 CG3977 AAAACAGTCGTACGATTTTTGCTCAATCCGAAAATGGCTGTTGTGAAATTGCTTTCCTAAACGAATGGC 69 FBgn0029886 CDMC31925 4 17 13 DAC21-L04 15-CG40049-RB_1 CG40049 CCGCTAAAGCGCCAGAAGTTCGTACGGCCCTTCGAAAATCAAAGAACCGAGCAGGACAAAAACTAATCA 69 CDMC31925 4 18 13 DAC21-L04 15-CG40049-RB_1 CG40049 CCGCTAAAGCGCCAGAAGTTCGTACGGCCCTTCGAAAATCAAAGAACCGAGCAGGACAAAAACTAATCA 69 CDMC31926 4 19 13 DAC21-L16 16-CG40064-RA_2 CG40064 GCATTTTCCTGTGGGCTACAAGTACGTGTGCGATGAAATTCTGATGCCCATGTCAGGCGATGAATTACA 69 FBgn0058064 CG40064 metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40064 CG40064 CDMC31926 4 20 13 DAC21-L16 16-CG40064-RA_2 CG40064 GCATTTTCCTGTGGGCTACAAGTACGTGTGCGATGAAATTCTGATGCCCATGTCAGGCGATGAATTACA 69 FBgn0058064 CG40064 metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40064 CG40064 CDMC31927 4 21 13 DAC21-P04 18-CG40116-RA_2 CG40116 GCCAGCTTCATTTATATCTGGCAGAGCCATGCAGCAGCTAGCAGAAGACGAAAATAACGTCGTTTCCAA 69 FBgn0058116 CG40116 CG40116 CG40116 CDMC31927 4 22 13 DAC21-P04 18-CG40116-RA_2 CG40116 GCCAGCTTCATTTATATCTGGCAGAGCCATGCAGCAGCTAGCAGAAGACGAAAATAACGTCGTTTCCAA 69 FBgn0058116 CG40116 CG40116 CG40116 CDMC31928 4 23 13 DAC21-P16 1-CG4012-RA_1 CG4012 GGGATGGCATTCAAAATCAACGACTCCTAGACTTACCAACCACGCTCGAAACAGCCGATCAAGCCTGCA 69 FBan0004012 FBgn0023081 gek 2 2R actin polymerization and/or depolymerization; GO:0008154; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; small GTPase regulator activity; GO:0005083; ; GO:0005083 gek genghis khan "CG4012, CG4012, CG4012, l(2)09373, Gek, dMRCK, MRCKalpha, Genghis Kahn, MdaPk, Mrck, anon-WO0200864.1, genghis khan" CDMC31928 4 24 13 DAC21-P16 1-CG4012-RA_1 CG4012 GGGATGGCATTCAAAATCAACGACTCCTAGACTTACCAACCACGCTCGAAACAGCCGATCAAGCCTGCA 69 FBan0004012 FBgn0023081 gek 2 2R actin polymerization and/or depolymerization; GO:0008154; cell adhesion; GO:0007155; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; small GTPase regulator activity; GO:0005083; ; GO:0005083 gek genghis khan "CG4012, CG4012, CG4012, l(2)09373, Gek, dMRCK, MRCKalpha, Genghis Kahn, MdaPk, Mrck, anon-WO0200864.1, genghis khan" CDMC31929 4 25 13 DAC22-D04 1-CG13789-RA_1 CG13789 CTTCAACGGTAGACCACTCCTGTACGAGATAGACCACCTCTTGACCTACGCCAATGGGCTGGCAA 65 FBgn0031922 CDMC31929 4 26 13 DAC22-D04 1-CG13789-RA_1 CG13789 CTTCAACGGTAGACCACTCCTGTACGAGATAGACCACCTCTTGACCTACGCCAATGGGCTGGCAA 65 FBgn0031922 CDMC31930 4 1 14 DAC22-D16 2-CG13804-RA_1 CG13804 CTGGAGGGCCTGACTTCCAGCAATTCCCGTCTCCAATATCTGGTAGTGGACTATGCTCCGGATGG 65 FBan0013804 FBgn0035328 yellow-g2 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-g2 yellow-g2 "CG13804, CG13804, CG13804" CDMC31930 4 2 14 DAC22-D16 2-CG13804-RA_1 CG13804 CTGGAGGGCCTGACTTCCAGCAATTCCCGTCTCCAATATCTGGTAGTGGACTATGCTCCGGATGG 65 FBan0013804 FBgn0035328 yellow-g2 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-g2 yellow-g2 "CG13804, CG13804, CG13804" CDMC31931 4 3 14 DAC22-H04 3-CG13880-RA_4 CG13880 CGTCACTGCGTTGGTGAAGCACGAGCGTATTGAACTGTTCTACAACCGTGCCGATGAAGCTCGTG 65 FBan0013880 FBgn0035122 mRpL17 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL17 mitochondrial ribosomal protein L17 "CG13880, CG13880, L17, BcDNA:RE43278, mitochondrial ribosomal protein L17" CDMC31931 4 4 14 DAC22-H04 3-CG13880-RA_4 CG13880 CGTCACTGCGTTGGTGAAGCACGAGCGTATTGAACTGTTCTACAACCGTGCCGATGAAGCTCGTG 65 FBan0013880 FBgn0035122 mRpL17 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL17 mitochondrial ribosomal protein L17 "CG13880, CG13880, L17, BcDNA:RE43278, mitochondrial ribosomal protein L17" CDMC31932 4 5 14 DAC22-H16 2-CG13913-RA_1 CG13913 GAGGTGAAGCGCTTCAACGAACTCCATATTGACGTGGACCAGATGATAACCCGGGCAAGGGATGC 65 FBan0013913 FBgn0035190 CG13913 3 3L cell organization and biogenesis; GO:0016043 actin binding; GO:0003779; ; GO:0003779 CG13913 CG13913 CDMC31932 4 6 14 DAC22-H16 2-CG13913-RA_1 CG13913 GAGGTGAAGCGCTTCAACGAACTCCATATTGACGTGGACCAGATGATAACCCGGGCAAGGGATGC 65 FBan0013913 FBgn0035190 CG13913 3 3L cell organization and biogenesis; GO:0016043 actin binding; GO:0003779; ; GO:0003779 CG13913 CG13913 CDMC31933 4 7 14 DAC22-L04 15-CG13955-RA_3 CG13955 AGGAGATCCTGCTGGAGTCCAAGCAAGCCCAACTCCATCAAATCGAGGAGAAAAAGGCGCTCAAA 65 FBan0013955 FBgn0033412 CG13955 2 2R CG13955 CG13955 CDMC31933 4 8 14 DAC22-L04 15-CG13955-RA_3 CG13955 AGGAGATCCTGCTGGAGTCCAAGCAAGCCCAACTCCATCAAATCGAGGAGAAAAAGGCGCTCAAA 65 FBan0013955 FBgn0033412 CG13955 2 2R CG13955 CG13955 CDMC31934 4 9 14 DAC22-L16 5-CG13993-RA_1 CG13993 GCGCGAGGACCTGAAGGCTAGGCAGGAGAAATGCGACAAAGCGATAGAACTGCTGGAGAAGAAGA 65 FBan0013993 FBgn0031776 CG13993 2 2L CG13993 CG13993 anon-EST:Posey288 CDMC31934 4 10 14 DAC22-L16 5-CG13993-RA_1 CG13993 GCGCGAGGACCTGAAGGCTAGGCAGGAGAAATGCGACAAAGCGATAGAACTGCTGGAGAAGAAGA 65 FBan0013993 FBgn0031776 CG13993 2 2L CG13993 CG13993 anon-EST:Posey288 CDMC31935 4 11 14 DAC22-P04 3-CG14071-RA_3 CG14071 GCCGACTTTGAGGCCATGACCATCGAGCGATCTGATTTGGATCACGAATTGAGCCGATTGCGCAA 65 FBan0014071 FBgn0032312 CG14071 2 2L CG14071 CG14071 CDMC31935 4 12 14 DAC22-P04 3-CG14071-RA_3 CG14071 GCCGACTTTGAGGCCATGACCATCGAGCGATCTGATTTGGATCACGAATTGAGCCGATTGCGCAA 65 FBan0014071 FBgn0032312 CG14071 2 2L CG14071 CG14071 CDMC31936 4 13 14 DAC22-P16 9-CG14104-RA_1 CG14104 GAAGCCTTGGCCAACCTAAAATGCGTACCCGTCGGATCGGTTTACGCTACATACAACCTGCCCCG 65 FBan0014104 FBgn0040786 CG14104 3 3L CG14104 CG14104 CDMC31936 4 14 14 DAC22-P16 9-CG14104-RA_1 CG14104 GAAGCCTTGGCCAACCTAAAATGCGTACCCGTCGGATCGGTTTACGCTACATACAACCTGCCCCG 65 FBan0014104 FBgn0040786 CG14104 3 3L CG14104 CG14104 CDMC31937 4 15 14 DAC23-D04 6-CG4716-RA_1 CG4716 TCTGCATATGACCGGGCCGTAAGCTTTTGTAAGCAAAGGGAGTCTAGACGAAGACGCCAGGCTGC 65 FBan0004716 FBgn0033820 CG4716 2 2R methylenetetrahydrofolate dehydrogenase activity; GO:0004486 ; EC:1.5.1.-; ; GO:0004486 ; EC:1.5.1.- CG4716 CG4716 "gh18008, BEST:GH18008" CDMC31937 4 16 14 DAC23-D04 6-CG4716-RA_1 CG4716 TCTGCATATGACCGGGCCGTAAGCTTTTGTAAGCAAAGGGAGTCTAGACGAAGACGCCAGGCTGC 65 FBan0004716 FBgn0033820 CG4716 2 2R methylenetetrahydrofolate dehydrogenase activity; GO:0004486 ; EC:1.5.1.-; ; GO:0004486 ; EC:1.5.1.- CG4716 CG4716 "gh18008, BEST:GH18008" CDMC31938 4 17 14 DAC23-D16 2-CG4767-RA_1 CG4767 GAAATCCATGGTGGTTTTGGGCGTACCGGAATCCATAGCCAAGGAGTGCATTGAGAAGAGGGCCA 65 FBan0004767 FBgn0028902 Tektin-A 2 2L microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Tektin-A Tektin A "CG4767, CG4767, BG:DS02252.2, TEKTIN A, anon-WO0140519.235, Tektin A" CDMC31938 4 18 14 DAC23-D16 2-CG4767-RA_1 CG4767 GAAATCCATGGTGGTTTTGGGCGTACCGGAATCCATAGCCAAGGAGTGCATTGAGAAGAGGGCCA 65 FBan0004767 FBgn0028902 Tektin-A 2 2L microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule; GO:0005874; microtubule associated complex; GO:0005875 Tektin-A Tektin A "CG4767, CG4767, BG:DS02252.2, TEKTIN A, anon-WO0140519.235, Tektin A" CDMC31939 4 19 14 DAC23-H04 3-CG4935-RA_3 CG4935 AGGACTCCTCGATAGCCATTTCCGGGGGTCGAGATAATGCCGTAATGTGCTGGGACATTCGAACG 65 FBan0004935 FBgn0028897 CG4935 2 2L cell cycle; GO:0007049; electron transport; GO:0006118 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 CG4935 CG4935 "BG:DS02740.2, MET30" CDMC31939 4 20 14 DAC23-H04 3-CG4935-RA_3 CG4935 AGGACTCCTCGATAGCCATTTCCGGGGGTCGAGATAATGCCGTAATGTGCTGGGACATTCGAACG 65 FBan0004935 FBgn0028897 CG4935 2 2L cell cycle; GO:0007049; electron transport; GO:0006118 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 CG4935 CG4935 "BG:DS02740.2, MET30" CDMC31940 4 21 14 DAC23-H16 1-CG5020-RA_1 CG5020 GACCGCACTCCGTCAAGCCAACGATGCCCAAAAGACTGCTTATCTGGAGACTAAGGAACTGAGGC 65 FBan0005020 FBgn0020503 CLIP-190 2 2L cellularization; GO:0007349; microtubule-based process; GO:0007017; protein targeting; GO:0006605; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 Golgi apparatus; GO:0005794; cell cortex; GO:0005938; fusome; GO:0045169; microtubule associated complex; GO:0005875; spindle microtubule; GO:0005876 CLIP-190 CLIP-190 "CG5020, CG5020, D-CLIP-190, D-CLIP-90, CLIP190, D-CLIP-195, D-CLIP-19, Clip-190, Clip190" CDMC31940 4 22 14 DAC23-H16 1-CG5020-RA_1 CG5020 GACCGCACTCCGTCAAGCCAACGATGCCCAAAAGACTGCTTATCTGGAGACTAAGGAACTGAGGC 65 FBan0005020 FBgn0020503 CLIP-190 2 2L cellularization; GO:0007349; microtubule-based process; GO:0007017; protein targeting; GO:0006605; vesicle-mediated transport; GO:0016192 actin binding; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515 Golgi apparatus; GO:0005794; cell cortex; GO:0005938; fusome; GO:0045169; microtubule associated complex; GO:0005875; spindle microtubule; GO:0005876 CLIP-190 CLIP-190 "CG5020, CG5020, D-CLIP-190, D-CLIP-90, CLIP190, D-CLIP-195, D-CLIP-19, Clip-190, Clip190" CDMC31941 4 23 14 DAC23-L04 3-CG5180-RA_5 CG5180 TAAAACGCGAGTGAAAGGGACCATGAACTTAGACCTGCGTTCGTACTCACGCCACTGGCTCACGG 65 FBan0005180 FBgn0043457 CG5180 3 3R CG5180 CG5180 "BEST:LD05530, LD05530" CDMC31941 4 24 14 DAC23-L04 3-CG5180-RA_5 CG5180 TAAAACGCGAGTGAAAGGGACCATGAACTTAGACCTGCGTTCGTACTCACGCCACTGGCTCACGG 65 FBan0005180 FBgn0043457 CG5180 3 3R CG5180 CG5180 "BEST:LD05530, LD05530" CDMC31942 4 25 14 DAC23-L16 3-CG5197-RA_5 CG5197 GTGTCCATGCCACCTATTTGTCGCACAAAAACGGGGAGCTCAATCTCAACCTGGGACTTGTGCAC 65 FBan0005197 FBgn0034147 CG5197 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG5197 CG5197 SP118 CDMC31942 4 26 14 DAC23-L16 3-CG5197-RA_5 CG5197 GTGTCCATGCCACCTATTTGTCGCACAAAAACGGGGAGCTCAATCTCAACCTGGGACTTGTGCAC 65 FBan0005197 FBgn0034147 CG5197 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 CG5197 CG5197 SP118 CDMC31943 4 1 15 DAC23-P04 14-CG5317-RA_1 CG5317 ACGCAGAAAAGAAATGACCGCATCAAAAAGAGAACCGCCACCAAGAATCACCACAAATTCCGCCG 65 FBan0005317 FBgn0032404 CG5317 2 2L protein biosynthesis; GO:0006412; proteolysis; GO:0006508; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; ; GO:0003735; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG5317 CG5317 CDMC31943 4 2 15 DAC23-P04 14-CG5317-RA_1 CG5317 ACGCAGAAAAGAAATGACCGCATCAAAAAGAGAACCGCCACCAAGAATCACCACAAATTCCGCCG 65 FBan0005317 FBgn0032404 CG5317 2 2L protein biosynthesis; GO:0006412; proteolysis; GO:0006508; regulation of translation; GO:0006445 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; ; GO:0003735; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG5317 CG5317 CDMC31944 4 3 15 DAC23-P16 1-CG5353-RA_1 CG5353 GAAGATCACCAAGAACTCCTCTACCTACTGGGAGGGTAAGGCTGACGCTGAGACACTGCAACGCG 65 FBan0005353 FBgn0027081 Aats-thr 2 2L threonyl-tRNA aminoacylation; GO:0006435 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; threonine-tRNA ligase activity; GO:0004829 ; EC:6.1.1.3; ; GO:0004829 ; EC:6.1.1.3; ; GO:0003729; ; GO:0004829 ; EC:6.1.1.3 Aats-thr Threonyl-tRNA synthetase "CG5353, CG5353, l(2)k04203, 42/3, TRS, ThrRS, threonyl-tRNA synthetase, P539, Threonyl-tRNA synthetase" CDMC31944 4 4 15 DAC23-P16 1-CG5353-RA_1 CG5353 GAAGATCACCAAGAACTCCTCTACCTACTGGGAGGGTAAGGCTGACGCTGAGACACTGCAACGCG 65 FBan0005353 FBgn0027081 Aats-thr 2 2L threonyl-tRNA aminoacylation; GO:0006435 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; threonine-tRNA ligase activity; GO:0004829 ; EC:6.1.1.3; ; GO:0004829 ; EC:6.1.1.3; ; GO:0003729; ; GO:0004829 ; EC:6.1.1.3 Aats-thr Threonyl-tRNA synthetase "CG5353, CG5353, l(2)k04203, 42/3, TRS, ThrRS, threonyl-tRNA synthetase, P539, Threonyl-tRNA synthetase" CDMC31945 4 5 15 DAC24-D04 15-CG9205-RA_2 CG9205 CCGCCAAAATGGAGAGCAACTTGAACAGGATCATTCGTGAATCGGCCAAACTGAAACTCTGCGGTCAGC 69 FBan0009205 FBgn0035181 CG9205 3 3L CG9205 CG9205 CDMC31945 4 6 15 DAC24-D04 15-CG9205-RA_2 CG9205 CCGCCAAAATGGAGAGCAACTTGAACAGGATCATTCGTGAATCGGCCAAACTGAAACTCTGCGGTCAGC 69 FBan0009205 FBgn0035181 CG9205 3 3L CG9205 CG9205 CDMC31946 4 7 15 DAC24-D16 8-CG9212-RA_4 CG9212 GTCGCACAGTCGAATGCTCAGCGATAAGGAAATCATATATGCCCTTCATACCCACAACGTCAGGCCCGA 69 FBan0009212 FBgn0030724 Nipsnap X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Nipsnap Nipsnap CG9212 CDMC31946 4 8 15 DAC24-D16 8-CG9212-RA_4 CG9212 GTCGCACAGTCGAATGCTCAGCGATAAGGAAATCATATATGCCCTTCATACCCACAACGTCAGGCCCGA 69 FBan0009212 FBgn0030724 Nipsnap X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Nipsnap Nipsnap CG9212 CDMC31947 4 9 15 DAC24-H04 3-CG9252-RA_1 CG9252 AGCATTTCAGCTCCCCTACTGGCACACGTCTATGAAGCTCTCAGTAAGTGCGGTATGCAGAAAGAGGCA 69 FBan0009252 FBgn0032920 CG9252 2 2L CG9252 CG9252 CDMC31947 4 10 15 DAC24-H04 3-CG9252-RA_1 CG9252 AGCATTTCAGCTCCCCTACTGGCACACGTCTATGAAGCTCTCAGTAAGTGCGGTATGCAGAAAGAGGCA 69 FBan0009252 FBgn0032920 CG9252 2 2L CG9252 CG9252 CDMC31948 4 11 15 DAC24-H16 1-CG9264-RB_1 CG9264 GGGTGGGGTATTCCTGAGGGCCCTTTACCTCCTATACATCCCTTACAGACCCAAATATATGGCGCCCAG 69 FBan0009264 FBgn0032911 CG9264 2 2L CG9264 CG9264 CDMC31948 4 12 15 DAC24-H16 1-CG9264-RB_1 CG9264 GGGTGGGGTATTCCTGAGGGCCCTTTACCTCCTATACATCCCTTACAGACCCAAATATATGGCGCCCAG 69 FBan0009264 FBgn0032911 CG9264 2 2L CG9264 CG9264 CDMC31949 4 13 15 DAC24-L04 2-CG9305-RA_1 CG9305 AGCACTCCTCTATCCTAAGGCCTTCAACATTCAGGAGCTCAAGGATCAACTGGAAGAGGAGGACCGCGA 69 FBan0009305 FBgn0032512 CG9305 2 2L transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9305 CG9305 CDMC31949 4 14 15 DAC24-L04 2-CG9305-RA_1 CG9305 AGCACTCCTCTATCCTAAGGCCTTCAACATTCAGGAGCTCAAGGATCAACTGGAAGAGGAGGACCGCGA 69 FBan0009305 FBgn0032512 CG9305 2 2L transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG9305 CG9305 CDMC31950 4 15 15 DAC24-L16 18-CG9312-RA_2 CG9312 GCGAGGTTCAAGCGAAACGTTCCACGAAAGATATATACGGCTAAAGTGGTGCAGTTGTCCAAGGAATCC 69 FBan0009312 FBgn0038179 CG9312 3 3R CG9312 CG9312 CT26517 CDMC31950 4 16 15 DAC24-L16 18-CG9312-RA_2 CG9312 GCGAGGTTCAAGCGAAACGTTCCACGAAAGATATATACGGCTAAAGTGGTGCAGTTGTCCAAGGAATCC 69 FBan0009312 FBgn0038179 CG9312 3 3R CG9312 CG9312 CT26517 CDMC31951 4 17 15 DAC24-P04 23-CG9339-RC_8 CG9339 ATACTCTGTGAGTTCATGTTTCAAAACGCAAAGCTTTGAAATTACAATACCCTAGTTGTTATAACCCCT 69 FBan0009339 FBgn0032901 CG9339 2 2L CG9339 CG9339 "CG14399, CG9340, anon-WO0118547.455" CDMC31951 4 18 15 DAC24-P04 23-CG9339-RC_8 CG9339 ATACTCTGTGAGTTCATGTTTCAAAACGCAAAGCTTTGAAATTACAATACCCTAGTTGTTATAACCCCT 69 FBan0009339 FBgn0032901 CG9339 2 2L CG9339 CG9339 "CG14399, CG9340, anon-WO0118547.455" CDMC31952 4 19 15 DAC24-P16 3-CG9356-RA_1 CG9356 GCCACCGATGTAATCAGCCTAAGTGCCGAAAACCTTAACATTCTCCAACGCATGGTCCTGCACACTGGC 69 FBan0009356 FBgn0037688 CG9356 3 3R CG9356 CG9356 CDMC31952 4 20 15 DAC24-P16 3-CG9356-RA_1 CG9356 GCCACCGATGTAATCAGCCTAAGTGCCGAAAACCTTAACATTCTCCAACGCATGGTCCTGCACACTGGC 69 FBan0009356 FBgn0037688 CG9356 3 3R CG9356 CG9356 CDMC31953 4 21 15 DAC25-D04 17-CG10588-RA_2 CG10588 TCGAGCAGATTATGTGGAGCAACGTATTGAAGCCTTTAGGTCTCGAATGGCTGAACTTGTCTCCCAGAT 69 FBan0010588 FBgn0037037 CG10588 3 3L proteolysis; GO:0006508 nardilysin activity; GO:0016919 ; EC:3.4.24.61; ; GO:0016919 ; EC:3.4.24.61 CG10588 CG10588 CDMC31953 4 22 15 DAC25-D04 17-CG10588-RA_2 CG10588 TCGAGCAGATTATGTGGAGCAACGTATTGAAGCCTTTAGGTCTCGAATGGCTGAACTTGTCTCCCAGAT 69 FBan0010588 FBgn0037037 CG10588 3 3L proteolysis; GO:0006508 nardilysin activity; GO:0016919 ; EC:3.4.24.61; ; GO:0016919 ; EC:3.4.24.61 CG10588 CG10588 CDMC31954 4 23 15 DAC25-D16 23-CG10598-RA_1 CG10598 AACAAGGGCTGGTAAATGTGGAGCAAGCCAATATGGACCAACTATAAATAGTTCAAACTGCCAAACCGA 69 FBan0010598 FBgn0003057 CG10598 X X CG10598 CG10598 "GCR-11, GCR 17, anon-Pen15EF, GCR11, GCR17, Pen15EF, pen15EF" CDMC31954 4 24 15 DAC25-D16 23-CG10598-RA_1 CG10598 AACAAGGGCTGGTAAATGTGGAGCAAGCCAATATGGACCAACTATAAATAGTTCAAACTGCCAAACCGA 69 FBan0010598 FBgn0003057 CG10598 X X CG10598 CG10598 "GCR-11, GCR 17, anon-Pen15EF, GCR11, GCR17, Pen15EF, pen15EF" CDMC31955 4 25 15 DAC25-H04 7-CG10625-RC_1 CG10625 ACCCGAAACCAAGGTGACTAGTGAGACGAACTGAGACAAGGACGAGAGGACAATCAAATTCCCCTCCCA 69 FBan0010625 FBgn0035612 CG10625 3 3L CG10625 CG10625 anon-WO0118547.236 CDMC31955 4 26 15 DAC25-H04 7-CG10625-RC_1 CG10625 ACCCGAAACCAAGGTGACTAGTGAGACGAACTGAGACAAGGACGAGAGGACAATCAAATTCCCCTCCCA 69 FBan0010625 FBgn0035612 CG10625 3 3L CG10625 CG10625 anon-WO0118547.236 CDMC31956 4 1 16 DAC25-H16 23-CG10631-RA_2 CG10631 CCTGTAATATCCTTGAGCGTATATGTGTATGTAGACTTGTAGATGGCCCAATATTAGTTGGAGGTTTTC 69 FBan0010631 FBgn0032817 CG10631 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10631 CG10631 CDMC31956 4 2 16 DAC25-H16 23-CG10631-RA_2 CG10631 CCTGTAATATCCTTGAGCGTATATGTGTATGTAGACTTGTAGATGGCCCAATATTAGTTGGAGGTTTTC 69 FBan0010631 FBgn0032817 CG10631 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10631 CG10631 CDMC31957 4 3 16 DAC25-L04 3-CG10660-RA_1 CG10660 AGTGGGACGATGGATCCGGTGAGGGTACGATAGATATACCGCTCCAGAGACTCGATCAGTTGGAGGACA 69 FBan0010660 FBgn0036288 CG10660 3 3L CG10660 CG10660 CDMC31957 4 4 16 DAC25-L04 3-CG10660-RA_1 CG10660 AGTGGGACGATGGATCCGGTGAGGGTACGATAGATATACCGCTCCAGAGACTCGATCAGTTGGAGGACA 69 FBan0010660 FBgn0036288 CG10660 3 3L CG10660 CG10660 CDMC31958 4 5 16 DAC25-L16 9-CG10672-RA_3 CG10672 TCGAGTGCGATGAGAAGGTGTGGGACAAGATCTTCGATGTGAACGTGAAGAGTTCCTATCTGCTGGCCA 69 FBan0010672 FBgn0035588 CG10672 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG10672 CG10672 CDMC31958 4 6 16 DAC25-L16 9-CG10672-RA_3 CG10672 TCGAGTGCGATGAGAAGGTGTGGGACAAGATCTTCGATGTGAACGTGAAGAGTTCCTATCTGCTGGCCA 69 FBan0010672 FBgn0035588 CG10672 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG10672 CG10672 CDMC31959 4 7 16 DAC25-P04 1-CG10701-RB_1 CG10701 GCACTGGGTCTGAACATTTACGAGCAGGACGATAGGTTGACGCCGAAAATTGGTTTCCCATGGTCCGAG 69 FBan0010701 FBgn0011661 Moe X X actin cytoskeleton organization and biogenesis; GO:0030036; actin filament-based process; GO:0030029; anterior/posterior pattern formation; GO:0009952; cytoskeleton organization and biogenesis; GO:0007010; establishment and/or maintenance of apical/basal cell polarity; GO:0035088; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; eye photoreceptor cell development; GO:0042462; morphogenesis of an epithelium; GO:0002009; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; pole plasm assembly; GO:0007315; pole plasm protein localization; GO:0007318; protein localization; GO:0008104; rhabdomere development; GO:0042052; rhabdomere membrane biogenesis; GO:0045313 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515 NOT fusome; GO:0045169; adherens junction; GO:0005912; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; plasma membrane; GO:0005886; subapical complex; GO:0035003 Moe Moesin "CG10701, CG10701, CG10701, D17, Dmoesin, moe, moesin, l(1)G0067, l(1)G0323, l(1)G0404, l(1)G0415, moesin/ezrin/radixin homolog mRNA, EMR1, ERM, DMoesin, Dmoe, anon-WO03040301.155, anon-WO03040301.157, anon-WO03040301.159, anon-WO03040301.161, Emr1: Ezrin-moesin-radixin-1, Ezrin-moesin-radixin-1, Moesin" CDMC31959 4 8 16 DAC25-P04 1-CG10701-RB_1 CG10701 GCACTGGGTCTGAACATTTACGAGCAGGACGATAGGTTGACGCCGAAAATTGGTTTCCCATGGTCCGAG 69 FBan0010701 FBgn0011661 Moe X X actin cytoskeleton organization and biogenesis; GO:0030036; actin filament-based process; GO:0030029; anterior/posterior pattern formation; GO:0009952; cytoskeleton organization and biogenesis; GO:0007010; establishment and/or maintenance of apical/basal cell polarity; GO:0035088; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; eye photoreceptor cell development; GO:0042462; morphogenesis of an epithelium; GO:0002009; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; pole plasm assembly; GO:0007315; pole plasm protein localization; GO:0007318; protein localization; GO:0008104; rhabdomere development; GO:0042052; rhabdomere membrane biogenesis; GO:0045313 actin binding; GO:0003779; ; GO:0003779; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515 NOT fusome; GO:0045169; adherens junction; GO:0005912; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; plasma membrane; GO:0005886; subapical complex; GO:0035003 Moe Moesin "CG10701, CG10701, CG10701, D17, Dmoesin, moe, moesin, l(1)G0067, l(1)G0323, l(1)G0404, l(1)G0415, moesin/ezrin/radixin homolog mRNA, EMR1, ERM, DMoesin, Dmoe, anon-WO03040301.155, anon-WO03040301.157, anon-WO03040301.159, anon-WO03040301.161, Emr1: Ezrin-moesin-radixin-1, Ezrin-moesin-radixin-1, Moesin" CDMC31960 4 9 16 DAC25-P16 1-CG10722-RA_2 CG10722 AGAACCAGACAATCGGAGGATCTCTTGGTAGAGCGGAATTCCATAAGCCATGTGGTAACCTTGCCGGGA 69 FBan0010722 FBgn0032848 CG10722 2 2L CG10722 CG10722 38B.16 CDMC31960 4 10 16 DAC25-P16 1-CG10722-RA_2 CG10722 AGAACCAGACAATCGGAGGATCTCTTGGTAGAGCGGAATTCCATAAGCCATGTGGTAACCTTGCCGGGA 69 FBan0010722 FBgn0032848 CG10722 2 2L CG10722 CG10722 38B.16 CDMC31961 4 11 16 DAC26-D04 3-CG8049-RB_2 CG8049 TGTGCTGATGTGGGAGATCTTCACTTGCGGCAAGATGCCATACGGTCGCCTAAAGAATACCGAGGTTGT 69 FBan0008049 FBgn0003502 Btk29A 2 2L JNK cascade; GO:0007254; cellularization; GO:0007349; copulation; GO:0007620; courtship behavior; GO:0007619; determination of adult life span; GO:0008340; dorsal closure; GO:0007391; head involution; GO:0008258; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; ovarian ring canal formation; GO:0007301; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112 cytoplasm; GO:0005737; plasma membrane; GO:0005886; ring canal (sensu Insecta); GO:0045172 Btk29A Btk family kinase at 29A "CG8049, CG18355, src-4, src28C, Dsrc28C, dsrc29A, c-src/fps, Dsrc29A, fic, fickle, Dm SRC2, Tec29, Src29A: Src oncogene 29A, Tec29A, Tec, DSrc28, DTec29, CT2415, CT41718, SRC 29A, tec29, C-src2, C-src4, S13, Src2, src2, src4, Src oncogene 29A, Src29A" CDMC31961 4 12 16 DAC26-D04 3-CG8049-RB_2 CG8049 TGTGCTGATGTGGGAGATCTTCACTTGCGGCAAGATGCCATACGGTCGCCTAAAGAATACCGAGGTTGT 69 FBan0008049 FBgn0003502 Btk29A 2 2L JNK cascade; GO:0007254; cellularization; GO:0007349; copulation; GO:0007620; courtship behavior; GO:0007619; determination of adult life span; GO:0008340; dorsal closure; GO:0007391; head involution; GO:0008258; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; ovarian ring canal formation; GO:0007301; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112 cytoplasm; GO:0005737; plasma membrane; GO:0005886; ring canal (sensu Insecta); GO:0045172 Btk29A Btk family kinase at 29A "CG8049, CG18355, src-4, src28C, Dsrc28C, dsrc29A, c-src/fps, Dsrc29A, fic, fickle, Dm SRC2, Tec29, Src29A: Src oncogene 29A, Tec29A, Tec, DSrc28, DTec29, CT2415, CT41718, SRC 29A, tec29, C-src2, C-src4, S13, Src2, src2, src4, Src oncogene 29A, Src29A" CDMC31962 4 13 16 DAC26-D16 13-CG8063-RA_1 CG8063 TCCGGTTGTCTTTCCTGGAAAGTATTCTCGTCGAAAGCGTAAGATTATGACCTCCCGCGATACACCGGT 69 FBan0008063 FBgn0038105 yellow-f2 3 3R ectoderm development; GO:0007398; indole derivative biosynthesis; GO:0042435; larval or pupal development (sensu Insecta); GO:0002165; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066 dopachrome isomerase activity; GO:0004167 ; EC:5.3.3.12; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0004167 ; EC:5.3.3.12; intramolecular oxidoreductase activity; GO:0016860 ; EC:5.3.-.-; ; GO:0005102; ; GO:0005198; ; GO:0016860 ; EC:5.3.-.- extracellular region; GO:0005576 yellow-f2 yellow-f2 "CG8063, CG8063, CG8063" CDMC31962 4 14 16 DAC26-D16 13-CG8063-RA_1 CG8063 TCCGGTTGTCTTTCCTGGAAAGTATTCTCGTCGAAAGCGTAAGATTATGACCTCCCGCGATACACCGGT 69 FBan0008063 FBgn0038105 yellow-f2 3 3R ectoderm development; GO:0007398; indole derivative biosynthesis; GO:0042435; larval or pupal development (sensu Insecta); GO:0002165; melanin biosynthesis from tyrosine; GO:0006583; pigmentation during development; GO:0048066 dopachrome isomerase activity; GO:0004167 ; EC:5.3.3.12; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0004167 ; EC:5.3.3.12; intramolecular oxidoreductase activity; GO:0016860 ; EC:5.3.-.-; ; GO:0005102; ; GO:0005198; ; GO:0016860 ; EC:5.3.-.- extracellular region; GO:0005576 yellow-f2 yellow-f2 "CG8063, CG8063, CG8063" CDMC31963 4 15 16 DAC26-H04 1-CG8092-RA_1 CG8092 CGCGATGGAGAAACCTCTGGTGAAGGTGCAGATATTAGCGAGACTGCTGATGATGTCGCGGATCAGAGC 69 FBan0008092 FBgn0033998 CG8092 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8092 CG8092 anon-WO0118547.194 CDMC31963 4 16 16 DAC26-H04 1-CG8092-RA_1 CG8092 CGCGATGGAGAAACCTCTGGTGAAGGTGCAGATATTAGCGAGACTGCTGATGATGTCGCGGATCAGAGC 69 FBan0008092 FBgn0033998 CG8092 2 2R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG8092 CG8092 anon-WO0118547.194 CDMC31964 4 17 16 DAC26-H16 15-CG8105-RA_2 CG8105 GGCCATTGAAAAACTGGAGAGAAAGTCTCAGGAGGATGGGAATGGTTACTTCGTGTTCATTGAGGGCGG 69 FBan0008105 FBgn0030661 CG8105 X X mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG8105 CG8105 CDMC31964 4 18 16 DAC26-H16 15-CG8105-RA_2 CG8105 GGCCATTGAAAAACTGGAGAGAAAGTCTCAGGAGGATGGGAATGGTTACTTCGTGTTCATTGAGGGCGG 69 FBan0008105 FBgn0030661 CG8105 X X mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG8105 CG8105 CDMC31965 4 19 16 DAC26-L04 13-CG8138-RA_1 CG8138 AAGGGAGATCACAAGAACATACCCGTTACCACCAAGAAGAACCCCTTTTCCAGCAACGTTAGACGCTCT 69 FBan0008138 FBgn0038122 CG8138 3 3R CG8138 CG8138 CDMC31965 4 20 16 DAC26-L04 13-CG8138-RA_1 CG8138 AAGGGAGATCACAAGAACATACCCGTTACCACCAAGAAGAACCCCTTTTCCAGCAACGTTAGACGCTCT 69 FBan0008138 FBgn0038122 CG8138 3 3R CG8138 CG8138 CDMC31966 4 21 16 DAC26-L16 23-CG8156-RC_7 CG8156 AGCCGGTAAATATCCGTAAAGTAAATTATGCGTGAAGCACAGAGACATAAAGCAAAACATCAACGGAGA 69 FBan0008156 FBgn0013750 Arf51F 2 2R cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; myoblast fusion; GO:0007520; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; NAD(P)+-protein-arginine ADP-ribosyltransferase activity; GO:0003956 ; EC:2.4.2.31; ; GO:0003956 ; EC:2.4.2.31 Arf51F ADP ribosylation factor 51F "CG8156, CG8156, dARFIII, ADP ribosylation factor III, Arf51f, EP(2)2612, LD12493, ARF6, AFR51F, Dm Arf51F, arf6, Arf6, ARF3, ARFIII, ADP ribosylation factor 51F" CDMC31966 4 22 16 DAC26-L16 23-CG8156-RC_7 CG8156 AGCCGGTAAATATCCGTAAAGTAAATTATGCGTGAAGCACAGAGACATAAAGCAAAACATCAACGGAGA 69 FBan0008156 FBgn0013750 Arf51F 2 2R cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; myoblast fusion; GO:0007520; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; NAD(P)+-protein-arginine ADP-ribosyltransferase activity; GO:0003956 ; EC:2.4.2.31; ; GO:0003956 ; EC:2.4.2.31 Arf51F ADP ribosylation factor 51F "CG8156, CG8156, dARFIII, ADP ribosylation factor III, Arf51f, EP(2)2612, LD12493, ARF6, AFR51F, Dm Arf51F, arf6, Arf6, ARF3, ARFIII, ADP ribosylation factor 51F" CDMC31967 4 23 16 DAC26-P04 2-CG8190-RA_2 CG8190 CCTGGAGCCGTGGTAAAATCAACCCAAACGAAGGAGATCATAGCGGCTGACAATGCCAAGTTGTCCGAA 69 FBan0008190 FBgn0034029 eIF2B-gamma 2 2R translational initiation; GO:0006413 guanyl-nucleotide exchange factor activity; GO:0005085; translation initiation factor activity; GO:0003743; ; GO:0003743; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005085; ; GO:0003743; ; GO:0003743; ; GO:0016779 ; EC:2.7.7.- cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-gamma eIF2B-gamma "CG8190, CG8190, CG8190, eIF2Bgamma, eIF2B-gamma" CDMC31967 4 24 16 DAC26-P04 2-CG8190-RA_2 CG8190 CCTGGAGCCGTGGTAAAATCAACCCAAACGAAGGAGATCATAGCGGCTGACAATGCCAAGTTGTCCGAA 69 FBan0008190 FBgn0034029 eIF2B-gamma 2 2R translational initiation; GO:0006413 guanyl-nucleotide exchange factor activity; GO:0005085; translation initiation factor activity; GO:0003743; ; GO:0003743; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005085; ; GO:0003743; ; GO:0003743; ; GO:0016779 ; EC:2.7.7.- cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-gamma eIF2B-gamma "CG8190, CG8190, CG8190, eIF2Bgamma, eIF2B-gamma" CDMC31968 4 25 16 DAC26-P16 23-CG8201-RF_3 CG8201 TAACACTTGCATTTGCTGTCCACAAGACTCTGGGTGTGGTTAAAAAAAAGCTGGGAGTTTGTTAACAAA 69 FBgn0050131 CDMC31968 4 26 16 DAC26-P16 23-CG8201-RF_3 CG8201 TAACACTTGCATTTGCTGTCCACAAGACTCTGGGTGTGGTTAAAAAAAAGCTGGGAGTTTGTTAACAAA 69 FBgn0050131 CDMC31969 4 1 17 DAC27-D04 47-CG8439-RA_1 CG8439 AAACTCGGGAATTAAATCTTGGAAAAACGTGCGAATCCGTCATCCTTTCATCTAAAAAACCATGAGCGC 69 FBan0008439 FBgn0010621 Cct5 2 2R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 Cct5 T-complex Chaperonin 5 "CG8439, l(2)06444, BcDNA.GM12270, BcDNA:GM12270, T-complex Chaperonin 5" CDMC31969 4 2 17 DAC27-D04 47-CG8439-RA_1 CG8439 AAACTCGGGAATTAAATCTTGGAAAAACGTGCGAATCCGTCATCCTTTCATCTAAAAAACCATGAGCGC 69 FBan0008439 FBgn0010621 Cct5 2 2R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 Cct5 T-complex Chaperonin 5 "CG8439, l(2)06444, BcDNA.GM12270, BcDNA:GM12270, T-complex Chaperonin 5" CDMC31970 4 3 17 DAC27-D16 15-CG8448-RC_1 CG8448 TAGTTTTTGAACACAGCTGCCCTACAACAAAATTGCACCGGTGGAATAAAGCCAACACCATCGAGCACC 69 FBan0008448 FBgn0034091 mrj 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 "ATPase activity, coupled; GO:0042623; ; GO:0042623" mrj mrj "CG8448, CG8448, CG8448, dmrj, dMRJ" CDMC31970 4 4 17 DAC27-D16 15-CG8448-RC_1 CG8448 TAGTTTTTGAACACAGCTGCCCTACAACAAAATTGCACCGGTGGAATAAAGCCAACACCATCGAGCACC 69 FBan0008448 FBgn0034091 mrj 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 "ATPase activity, coupled; GO:0042623; ; GO:0042623" mrj mrj "CG8448, CG8448, CG8448, dmrj, dMRJ" CDMC31971 4 5 17 DAC27-H04 14-CG8490-RA_2 CG8490 AGCAGCTTTAAGGCCATCAGAATGGAATCCGATTCGAGCGAAAGAGGAGAGACAAAAGCGAAGGGAAGT 69 FBan0008490 FBgn0033715 CG8490 2 2R CG8490 CG8490 CDMC31971 4 6 17 DAC27-H04 14-CG8490-RA_2 CG8490 AGCAGCTTTAAGGCCATCAGAATGGAATCCGATTCGAGCGAAAGAGGAGAGACAAAAGCGAAGGGAAGT 69 FBan0008490 FBgn0033715 CG8490 2 2R CG8490 CG8490 CDMC31972 4 7 17 DAC27-H16 14-CG8502-RC_2 CG8502 CCGTTCCGGATAATAATGGCAAGTATACGGTTCCACAGCAATCCTCTAACGATGGCAAGTATCGCCCCA 69 FBan0008502 FBgn0033725 CG8502 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8502 CG8502 CDMC31972 4 8 17 DAC27-H16 14-CG8502-RC_2 CG8502 CCGTTCCGGATAATAATGGCAAGTATACGGTTCCACAGCAATCCTCTAACGATGGCAAGTATCGCCCCA 69 FBan0008502 FBgn0033725 CG8502 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8502 CG8502 CDMC31973 4 9 17 DAC27-L04 3-CG8544-RB_1 CG8544 ACACGGGCTATGAGCAGTTCCTGAAGTTGTCCGCTCATGAATATTCAGAAACTGACAGACGCTCCGCGG 69 FBan0008544 FBgn0003345 sd X X nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 sd scalloped "CG8544, CG8544, CG8544, CG8544, sp, spatula, DROEXO2, clone 2.14, DROEXO, l(1)G0309, l(1)G0262, l(1)G0239, l(1)G0483, EP(X)1088, Sd: Segregation distorter, EP1088, l(1)HF394, l(1)III, l(1)G0315, anon-EST:Liang-2.14, Sd, scalloped" CDMC31973 4 10 17 DAC27-L04 3-CG8544-RB_1 CG8544 ACACGGGCTATGAGCAGTTCCTGAAGTTGTCCGCTCATGAATATTCAGAAACTGACAGACGCTCCGCGG 69 FBan0008544 FBgn0003345 sd X X nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 transcription factor activity; GO:0003700; ; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 sd scalloped "CG8544, CG8544, CG8544, CG8544, sp, spatula, DROEXO2, clone 2.14, DROEXO, l(1)G0309, l(1)G0262, l(1)G0239, l(1)G0483, EP(X)1088, Sd: Segregation distorter, EP1088, l(1)HF394, l(1)III, l(1)G0315, anon-EST:Liang-2.14, Sd, scalloped" CDMC31974 4 11 17 DAC27-L16 3-CG8550-RA_2 CG8550 CGAATACCGTCCATATGCCTTTGAGCAGGAGTTCACGGCTCCCCAACTGTTTCACCTTAGCTACGCACA 69 FBan0008550 FBgn0033742 CG8550 2 2R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG8550 CG8550 CDMC31974 4 12 17 DAC27-L16 3-CG8550-RA_2 CG8550 CGAATACCGTCCATATGCCTTTGAGCAGGAGTTCACGGCTCCCCAACTGTTTCACCTTAGCTACGCACA 69 FBan0008550 FBgn0033742 CG8550 2 2R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG8550 CG8550 CDMC31975 4 13 17 DAC27-P04 9-CG8588-RB_4 CG8588 CACACTTGTGAGATCGTAGAAGCCGTAAGGGTGTACTTCATGTCCCTGAATCCAAATGCGTTCCCGGGT 69 FBan0008588 FBgn0035770 pst 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 pst pastrel "CG8588, CG8588, CG8588, CG8588, Dm-65, pastrel" CDMC31975 4 14 17 DAC27-P04 9-CG8588-RB_4 CG8588 CACACTTGTGAGATCGTAGAAGCCGTAAGGGTGTACTTCATGTCCCTGAATCCAAATGCGTTCCCGGGT 69 FBan0008588 FBgn0035770 pst 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 pst pastrel "CG8588, CG8588, CG8588, CG8588, Dm-65, pastrel" CDMC31976 4 15 17 DAC27-P16 3-CG8599-RA_1 CG8599 ACGGATTCCGTGCGTTGTGTACCTCTTGACAAACTAACAACACAGAGTCGGACCAACGTGAACGGACGA 69 FBan0008599 FBgn0003598 Su(var)3-7 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 "chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701" Su(var)3-7 Suppressor of variegation 3-7 "CG8599, Su-var(3)7, Su(var)(3)3, Suvar(3)7, Su(var)(3)7, SU(VAR)3-7, l(3)87El" CDMC31976 4 16 17 DAC27-P16 3-CG8599-RA_1 CG8599 ACGGATTCCGTGCGTTGTGTACCTCTTGACAAACTAACAACACAGAGTCGGACCAACGTGAACGGACGA 69 FBan0008599 FBgn0003598 Su(var)3-7 3 3R DNA binding; GO:0003677; nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; ; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 "chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701" Su(var)3-7 Suppressor of variegation 3-7 "CG8599, Su-var(3)7, Su(var)(3)3, Suvar(3)7, Su(var)(3)7, SU(VAR)3-7, l(3)87El" CDMC31977 4 17 17 DAC28-D04 14-CG30357-RA_2 CG30357 GCAATGCCCCACACAGACGACACATTTCCGGAAGGCAGTTCTTGTTGTCCTATTGACATTGTTTCCTCA 69 FBan0030357 FBgn0050357 CG30357 2 2R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 CG30357 CG30357 BcDNA:AT27059 CDMC31977 4 18 17 DAC28-D04 14-CG30357-RA_2 CG30357 GCAATGCCCCACACAGACGACACATTTCCGGAAGGCAGTTCTTGTTGTCCTATTGACATTGTTTCCTCA 69 FBan0030357 FBgn0050357 CG30357 2 2R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 CG30357 CG30357 BcDNA:AT27059 CDMC31978 4 19 17 DAC28-D16 3-CG30366-RA_2 CG30366 AGACCGCTCCGAAAAAGAGAGTGCCTTTGCTTGGAGACCACCCCGAAATGTATAGCTCTTGCGGAAAGA 69 FBan0030366 FBgn0050366 CG30366 2 2R CG30366 CG30366 "CG2149, CG2149, CG2149" CDMC31978 4 20 17 DAC28-D16 3-CG30366-RA_2 CG30366 AGACCGCTCCGAAAAAGAGAGTGCCTTTGCTTGGAGACCACCCCGAAATGTATAGCTCTTGCGGAAAGA 69 FBan0030366 FBgn0050366 CG30366 2 2R CG30366 CG30366 "CG2149, CG2149, CG2149" CDMC31979 4 21 17 DAC28-H04 13-CG3039-RA_2 CG3039 CCCCCGATATGCCGTTCGATATATCAATCACCCTGCCTATTAGTCCCCATCATTTTGTCCGAAACCCGA 69 FBan0003039 FBgn0004646 ogre X X nervous system development; GO:0007399; phototransduction; GO:0007602; signal transduction; GO:0007165; visual behavior; GO:0007632 gap-junction forming channel activity; GO:0005243; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 ogre optic ganglion reduced "CG3039, jnL3, l(1)ogre, Inx1, inx1, Dm-inx1, Innexin 1, CB8, cb-8: contrast-blind-8, l(1)6Ec, l(1)jnL3, contrast-blind-8" CDMC31979 4 22 17 DAC28-H04 13-CG3039-RA_2 CG3039 CCCCCGATATGCCGTTCGATATATCAATCACCCTGCCTATTAGTCCCCATCATTTTGTCCGAAACCCGA 69 FBan0003039 FBgn0004646 ogre X X nervous system development; GO:0007399; phototransduction; GO:0007602; signal transduction; GO:0007165; visual behavior; GO:0007632 gap-junction forming channel activity; GO:0005243; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 ogre optic ganglion reduced "CG3039, jnL3, l(1)ogre, Inx1, inx1, Dm-inx1, Innexin 1, CB8, cb-8: contrast-blind-8, l(1)6Ec, l(1)jnL3, contrast-blind-8" CDMC31980 4 23 17 DAC28-H16 11-CG30422-RA_1 CG30422 TGGTAGCTGTGGATTCGGACAGCAGTGTTGAGCTAATAGAGAGTCCTGTCAAATTCTCCTCCGCCAACG 69 FBan0030422 FBgn0050422 CG30422 2 2R CG30422 CG30422 "CG12196, AAF47268 Dm" CDMC31980 4 24 17 DAC28-H16 11-CG30422-RA_1 CG30422 TGGTAGCTGTGGATTCGGACAGCAGTGTTGAGCTAATAGAGAGTCCTGTCAAATTCTCCTCCGCCAACG 69 FBan0030422 FBgn0050422 CG30422 2 2R CG30422 CG30422 "CG12196, AAF47268 Dm" CDMC31981 4 25 17 DAC28-L04 3-CG30458-RA_1 CG30458 ACCGCAACTAAGTCTGTGTCCCCCAATTGTTGACTAATGTGATAGGCCCCAGGCAATGTTCACCTTGCC 69 FBan0030458 FBgn0050458 CG30458 2 2R CG30458 CG30458 CG17288 CDMC31981 4 26 17 DAC28-L04 3-CG30458-RA_1 CG30458 ACCGCAACTAAGTCTGTGTCCCCCAATTGTTGACTAATGTGATAGGCCCCAGGCAATGTTCACCTTGCC 69 FBan0030458 FBgn0050458 CG30458 2 2R CG30458 CG30458 CG17288 CDMC31982 4 1 18 DAC28-L16 1-CG30468-RA_1 CG30468 GGGGTCCTCCCATCGAACCACGCCTGACCTCATTTGACGATGTAAAAAAGTCTAGGTACACGATGGCCA 69 FBan0030468 FBgn0050468 CG30468 2 2R CG30468 CG30468 CG12961 CDMC31982 4 2 18 DAC28-L16 1-CG30468-RA_1 CG30468 GGGGTCCTCCCATCGAACCACGCCTGACCTCATTTGACGATGTAAAAAAGTCTAGGTACACGATGGCCA 69 FBan0030468 FBgn0050468 CG30468 2 2R CG30468 CG30468 CG12961 CDMC31983 4 3 18 DAC28-P04 12-CG30495-RA_1 CG30495 CGTGACGGTCAACGCCCTTAATCCTGGAATAGCAGACACGGAGATAGCCAGGAACATGATCTTCTTCCA 69 FBan0030495 FBgn0050495 CG30495 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30495 CG30495 CG17986 CDMC31983 4 4 18 DAC28-P04 12-CG30495-RA_1 CG30495 CGTGACGGTCAACGCCCTTAATCCTGGAATAGCAGACACGGAGATAGCCAGGAACATGATCTTCTTCCA 69 FBan0030495 FBgn0050495 CG30495 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG30495 CG30495 CG17986 CDMC31984 4 5 18 DAC28-P16 9-CG3050-RA_1 CG3050 GCCCGATAGCAAACTTGTGATCCAAAAGGGTACTCCCATCATAATCTCCCTCATCGGAATGCACCGCGA 69 FBan0003050 FBgn0038194 Cyp6d5 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d5 Cyp6d5 "CG3050, 6d5, cyp6d5" CDMC31984 4 6 18 DAC28-P16 9-CG3050-RA_1 CG3050 GCCCGATAGCAAACTTGTGATCCAAAAGGGTACTCCCATCATAATCTCCCTCATCGGAATGCACCGCGA 69 FBan0003050 FBgn0038194 Cyp6d5 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d5 Cyp6d5 "CG3050, 6d5, cyp6d5" CDMC31985 4 7 18 DAC29-D04 23-CG9990-RB_4 CG9990 TCAGTAATCCGTTGCTCTAGATGTCCATTATTTGCAACCCTCTGTACTAGACCTTTTCTCGACGCCGAC 69 FBan0009990 FBgn0039594 CG9990 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG9990 CG9990 CDMC31985 4 8 18 DAC29-D04 23-CG9990-RB_4 CG9990 TCAGTAATCCGTTGCTCTAGATGTCCATTATTTGCAACCCTCTGTACTAGACCTTTTCTCGACGCCGAC 69 FBan0009990 FBgn0039594 CG9990 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG9990 CG9990 CDMC31986 4 9 18 DAC29-D16 2-CG9997-RA_1 CG9997 GGCGAACGAGTCGGAATCCTCGAACACTCATCTCCATCGCTATATGCTGGACACCTATAAGCCGCAGCA 69 FBan0009997 FBgn0039597 CG9997 3 3R CG9997 CG9997 CDMC31986 4 10 18 DAC29-D16 2-CG9997-RA_1 CG9997 GGCGAACGAGTCGGAATCCTCGAACACTCATCTCCATCGCTATATGCTGGACACCTATAAGCCGCAGCA 69 FBan0009997 FBgn0039597 CG9997 3 3R CG9997 CG9997 CDMC31987 4 11 18 DAC29-H04 2-CR31339-RA_1 CR31339 TGCCAACAAATCAGGGTTCTTGTGACTGGTTAGCTCAACACCCGGATTCTCACCAGATGGCACCATGAT 69 FBan0031339 FBgn0051339 CR31339 3 3R CR31339 CR31339 CDMC31987 4 12 18 DAC29-H04 2-CR31339-RA_1 CR31339 TGCCAACAAATCAGGGTTCTTGTGACTGGTTAGCTCAACACCCGGATTCTCACCAGATGGCACCATGAT 69 FBan0031339 FBgn0051339 CR31339 3 3R CR31339 CR31339 CDMC31988 4 13 18 DAC29-H16 18-CR31621-RA_8 CR31621 CGCATTTTGGTCGAAGACTTCCCCGAATTCTCGAGCAGCTTTAAGAGCACAGATGCGATACGAGATACA 69 FBan0031621 FBgn0041336 Cyp6t2Psi 2 2L Cyp6t2Psi Cyp6t2Psi "Cyp6t2p, 6t2p, CR31621" CDMC31988 4 14 18 DAC29-H16 18-CR31621-RA_8 CR31621 CGCATTTTGGTCGAAGACTTCCCCGAATTCTCGAGCAGCTTTAAGAGCACAGATGCGATACGAGATACA 69 FBan0031621 FBgn0041336 Cyp6t2Psi 2 2L Cyp6t2Psi Cyp6t2Psi "Cyp6t2p, 6t2p, CR31621" CDMC31989 4 15 18 DAC29-L04 23-CR32657-RA_1 CR32657 GGACGAGTAGCTTGCATCGATTCTAACATGTGATACACAAATCGGCTAAAAACTACATACTAATATCAT 69 FBan0032657 FBgn0052657 CR32657 X X CR32657 CR32657 BEST:GH20356 CDMC31989 4 16 18 DAC29-L04 23-CR32657-RA_1 CR32657 GGACGAGTAGCTTGCATCGATTCTAACATGTGATACACAAATCGGCTAAAAACTACATACTAATATCAT 69 FBan0032657 FBgn0052657 CR32657 X X CR32657 CR32657 BEST:GH20356 CDMC31990 4 17 18 DAC29-L16 12-CR32807-RA_1 CR32807 AGCCACGCCTCAACGCCTCGGAGTGTTTGCCCCCAGTCTCTGATAGATACACCATATTCTAATACACAC 69 FBan0032807 FBgn0044508 snoRNA:M X X snoRNA:M snoRNA:M CR32807 CDMC31990 4 18 18 DAC29-L16 12-CR32807-RA_1 CR32807 AGCCACGCCTCAACGCCTCGGAGTGTTTGCCCCCAGTCTCTGATAGATACACCATATTCTAATACACAC 69 FBan0032807 FBgn0044508 snoRNA:M X X snoRNA:M snoRNA:M CR32807 CDMC31991 4 19 18 DAC29-P04 3-CR33460-RA_3 CR33460 TGCGGTCTTATGCGAGAAGAGTTTTCAACATCTTTGGGTCCCTGGACAGCTCTACTGCACACGGATGGT 69 FBan0033460 FBgn0053460 CG33460 2 2R CG33460 CG33460 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41, CR33460" CDMC31991 4 20 18 DAC29-P04 3-CR33460-RA_3 CR33460 TGCGGTCTTATGCGAGAAGAGTTTTCAACATCTTTGGGTCCCTGGACAGCTCTACTGCACACGGATGGT 69 FBan0033460 FBgn0053460 CG33460 2 2R CG33460 CG33460 "CG8215, CG30086, CG8215, CG8215, CG8215, CG8215, SP41, CR33460" CDMC31992 4 21 18 DAC29-P16 23-CR40474-RA_1 CR40474 TGAAGGATTTAGGGAAATTAATTTTTGGATTAACTTCCGCATTTTTTGTAAGAATGGGGGTCATCAAAA 69 FBgn0069912 CR40474 CR40474 CR40474 CDMC31992 4 22 18 DAC29-P16 23-CR40474-RA_1 CR40474 TGAAGGATTTAGGGAAATTAATTTTTGGATTAACTTCCGCATTTTTTGTAAGAATGGGGGTCATCAAAA 69 FBgn0069912 CR40474 CR40474 CR40474 CDMC31993 4 23 18 DAC30-D04 12-CG12000-RB_1 CG12000 AGGGGCCCTTCCAAGTTAACGAAAACTGGACATTCGCCGAAACCATAAAGGGATACTAGAGCCTCCGAT 69 FBan0012000 FBgn0037314 CG12000 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome core complex (sensu Eukaryota); GO:0005839 CG12000 CG12000 "GC12000, beta-type 4 subunit, anon-WO0118547.326" CDMC31993 4 24 18 DAC30-D04 12-CG12000-RB_1 CG12000 AGGGGCCCTTCCAAGTTAACGAAAACTGGACATTCGCCGAAACCATAAAGGGATACTAGAGCCTCCGAT 69 FBan0012000 FBgn0037314 CG12000 3 3R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 cytoplasm; GO:0005737; nucleus; GO:0005634; proteasome core complex (sensu Eukaryota); GO:0005839 CG12000 CG12000 "GC12000, beta-type 4 subunit, anon-WO0118547.326" CDMC31994 4 25 18 DAC30-D16 6-CG12008-RC_1 CG12008 CCGCAGAGGATTCCCTCCGGCAGGATCGACTCTACGAGGAAGTTTATCGAAATGGAGGCGCATAACAAT 69 FBan0012008 FBgn0004167 kst 3 3L cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; ovarian follicle cell development (sensu Insecta); GO:0030707; plasma membrane organization and biogenesis; GO:0007009; rRNA processing; GO:0006364; zonula adherens assembly; GO:0045186 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 apicolateral plasma membrane; GO:0016327; spectrin; GO:0008091 kst karst "CG12008, CG12008, beta[[H]], beta[[H]]-spectrin, beta[[heavy]]-Spec, beta[[H]] spectrin, beta[[Heavy]]-spectrin, Beta[[Heavy]]-spectrin, beta[[Heavy]]-Spectrin, Spectrin beta-heavy chain, beta[[(HEAVY)]]-spectrin, beta[[Heavy]]spectrin, beta[[H]]-Spectrin, beta-heavy-spectrin, betaHeavy-spectrin, beta[[H]]spectrin, betaH-Spectrin, betaH-spectrin, betaHeavy-Spectrin, betaH-Spec, betaheavy-spectrin, beta-H spectrin, beta[[heavy]]-Spectrin, betaH, spectrin, beta[[heavy]]spectrin, beta[[H]]-SPEC, Spec-beta[[H]]: Spectrin-beta[[H]], l(3)01318, Spectrin-beta[[H]], karst" CDMC31994 4 26 18 DAC30-D16 6-CG12008-RC_1 CG12008 CCGCAGAGGATTCCCTCCGGCAGGATCGACTCTACGAGGAAGTTTATCGAAATGGAGGCGCATAACAAT 69 FBan0012008 FBgn0004167 kst 3 3L cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; ovarian follicle cell development (sensu Insecta); GO:0030707; plasma membrane organization and biogenesis; GO:0007009; rRNA processing; GO:0006364; zonula adherens assembly; GO:0045186 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; microtubule binding; GO:0008017; ; GO:0008017; cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 apicolateral plasma membrane; GO:0016327; spectrin; GO:0008091 kst karst "CG12008, CG12008, beta[[H]], beta[[H]]-spectrin, beta[[heavy]]-Spec, beta[[H]] spectrin, beta[[Heavy]]-spectrin, Beta[[Heavy]]-spectrin, beta[[Heavy]]-Spectrin, Spectrin beta-heavy chain, beta[[(HEAVY)]]-spectrin, beta[[Heavy]]spectrin, beta[[H]]-Spectrin, beta-heavy-spectrin, betaHeavy-spectrin, beta[[H]]spectrin, betaH-Spectrin, betaH-spectrin, betaHeavy-Spectrin, betaH-Spec, betaheavy-spectrin, beta-H spectrin, beta[[heavy]]-Spectrin, betaH, spectrin, beta[[heavy]]spectrin, beta[[H]]-SPEC, Spec-beta[[H]]: Spectrin-beta[[H]], l(3)01318, Spectrin-beta[[H]], karst" CDMC31995 4 1 19 DAC30-H04 2-CG12038-RB_2 CG12038 GGTGGGCATTTTCAGCTACGCCTTTCTCAACCTCAAGTTCTGCTTCAAGTTGATGTCCCATCGGAGCCT 69 FBan0012038 FBgn0035179 CG12038 3 3L CG12038 CG12038 CDMC31995 4 2 19 DAC30-H04 2-CG12038-RB_2 CG12038 GGTGGGCATTTTCAGCTACGCCTTTCTCAACCTCAAGTTCTGCTTCAAGTTGATGTCCCATCGGAGCCT 69 FBan0012038 FBgn0035179 CG12038 3 3L CG12038 CG12038 CDMC31996 4 3 19 DAC30-H16 22-CG12052-RG_1 CG12052 TGCCCAGAAACCCTCTGCCATCCAACGATCTCTTGACTTGGCTTGATTAAGCTACTAAGACCAAAACTT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC31996 4 4 19 DAC30-H16 22-CG12052-RG_1 CG12052 TGCCCAGAAACCCTCTGCCATCCAACGATCTCTTGACTTGGCTTGATTAAGCTACTAAGACCAAAACTT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC31997 4 5 19 DAC30-L04 18-CG12077-RA_3 CG12077 TGTCCTTCTGGGCAACCTGATATTTGGACACTATGGATTGGATGTAGCCATGGTCTCTAAGGTAGGCAA 69 FBan0012077 FBgn0035435 CG12077 3 3L GPI anchor biosynthesis; GO:0006506; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0017176 ; EC:2.4.1.198" integral to membrane; GO:0016021 CG12077 CG12077 CDMC31997 4 6 19 DAC30-L04 18-CG12077-RA_3 CG12077 TGTCCTTCTGGGCAACCTGATATTTGGACACTATGGATTGGATGTAGCCATGGTCTCTAAGGTAGGCAA 69 FBan0012077 FBgn0035435 CG12077 3 3L GPI anchor biosynthesis; GO:0006506; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; phosphatidylinositol N-acetylglucosaminyltransferase activity; GO:0017176 ; EC:2.4.1.198; ; GO:0017176 ; EC:2.4.1.198" integral to membrane; GO:0016021 CG12077 CG12077 CDMC31998 4 7 19 DAC30-L16 12-CG12093-RA_2 CG12093 TCACAGCTTGTACCAACCGGATTTGTCCAGAGAAGCCATTCTTACGGAGCACTTTCTACCTAGCGCCTA 69 FBan0012093 FBgn0035372 CG12093 3 3L CG12093 CG12093 CDMC31998 4 8 19 DAC30-L16 12-CG12093-RA_2 CG12093 TCACAGCTTGTACCAACCGGATTTGTCCAGAGAAGCCATTCTTACGGAGCACTTTCTACCTAGCGCCTA 69 FBan0012093 FBgn0035372 CG12093 3 3L CG12093 CG12093 CDMC31999 4 9 19 DAC30-P04 23-CG12128-RB_2 CG12128 GGCGGACAATTGGTTACTAAGCTTGTTTTGGTTAGATCTAAGTGTCTATTTCTAAAAATCGCTGGCAAA 69 FBan0012128 FBgn0033473 CG12128 2 2R CG12128 CG12128 CDMC31999 4 10 19 DAC30-P04 23-CG12128-RB_2 CG12128 GGCGGACAATTGGTTACTAAGCTTGTTTTGGTTAGATCTAAGTGTCTATTTCTAAAAATCGCTGGCAAA 69 FBan0012128 FBgn0033473 CG12128 2 2R CG12128 CG12128 CDMC32000 4 11 19 DAC30-P16 23-CG12135-RA_3 CG12135 TACCGATTGGTTTCGTACGTAGCAAACTGACCATTTTGTAAGGCATTTGCTTTTTAAGTTTTTCAGTTT 69 FBan0012135 FBgn0040235 c12.1 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c12.1 c12.1 CG12135 CDMC32000 4 12 19 DAC30-P16 23-CG12135-RA_3 CG12135 TACCGATTGGTTTCGTACGTAGCAAACTGACCATTTTGTAAGGCATTTGCTTTTTAAGTTTTTCAGTTT 69 FBan0012135 FBgn0040235 c12.1 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 c12.1 c12.1 CG12135 CDMC32001 4 13 19 DAC31-D04 2-CG3885-RA_1 CG3885 CGGCGCCATGATCAACCTGGAGTTCAACATTCAGGACATACTCGCCTTCTTCTCGGACATAGCGCG 66 FBan0003885 FBgn0036718 CG3885 3 3L synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 exocyst; GO:0000145 CG3885 CG3885 CDMC32001 4 14 19 DAC31-D04 2-CG3885-RA_1 CG3885 CGGCGCCATGATCAACCTGGAGTTCAACATTCAGGACATACTCGCCTTCTTCTCGGACATAGCGCG 66 FBan0003885 FBgn0036718 CG3885 3 3L synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 exocyst; GO:0000145 CG3885 CG3885 CDMC32002 4 15 19 DAC31-D16 13-CG40091-RA_2 CG40091 ACAAAGCCACTAAACGACGAGGGAGTCTTCCAGTCTATGGCTGCAAACTTAAGATCCACACGGTGT 66 FBgn0058091 CG40091 CG40091 CG40091 CDMC32002 4 16 19 DAC31-D16 13-CG40091-RA_2 CG40091 ACAAAGCCACTAAACGACGAGGGAGTCTTCCAGTCTATGGCTGCAAACTTAAGATCCACACGGTGT 66 FBgn0058091 CG40091 CG40091 CG40091 CDMC32003 4 17 19 DAC31-H04 2-CG4332-RA_2 CG4332 GCACGCTCATTGAGCTGTGGAAGTGCAAGAAAATCTTCCGTCTGGAGCTTAGCTTCAGTGGCCTGG 66 FBan0004332 FBgn0030456 CG4332 X X CG4332 CG4332 CDMC32003 4 18 19 DAC31-H04 2-CG4332-RA_2 CG4332 GCACGCTCATTGAGCTGTGGAAGTGCAAGAAAATCTTCCGTCTGGAGCTTAGCTTCAGTGGCCTGG 66 FBan0004332 FBgn0030456 CG4332 X X CG4332 CG4332 CDMC32004 4 19 19 DAC31-H16 12-CG4576-RA_8 CG4576 ATTCCAGTGGGGATTCTATGGCTGTTTAGTGCTCATCCCATCTTCCAGCACTACTACGTGACGCCG 66 FBan0004576 FBgn0038366 CG4576 3 3R CG4576 CG4576 CDMC32004 4 20 19 DAC31-H16 12-CG4576-RA_8 CG4576 ATTCCAGTGGGGATTCTATGGCTGTTTAGTGCTCATCCCATCTTCCAGCACTACTACGTGACGCCG 66 FBan0004576 FBgn0038366 CG4576 3 3R CG4576 CG4576 CDMC32005 4 21 19 DAC31-L04 1-CG4909-RA_1 CG4909 CGAACGATGTGTGGACGGTTGGTTCAAGGGAAAAAACTGGTTGGACATCACTGGAGTGTTCCCGGG 66 FBan0004909 FBgn0040294 POSH 2 2R determination of adult life span; GO:0008340; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; protein ubiquitination; GO:0016567; rhabdomere development; GO:0042052 receptor signaling complex scaffold activity; GO:0030159; structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0030159; ; GO:0008270 ubiquitin ligase complex; GO:0000151 POSH Plenty of SH3s "CG4909, CG4909, GM09451, l(2)k15815, DPOSH, posh, BEST:GM09451, Plenty of SH3s" CDMC32005 4 22 19 DAC31-L04 1-CG4909-RA_1 CG4909 CGAACGATGTGTGGACGGTTGGTTCAAGGGAAAAAACTGGTTGGACATCACTGGAGTGTTCCCGGG 66 FBan0004909 FBgn0040294 POSH 2 2R determination of adult life span; GO:0008340; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; protein ubiquitination; GO:0016567; rhabdomere development; GO:0042052 receptor signaling complex scaffold activity; GO:0030159; structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0030159; ; GO:0008270 ubiquitin ligase complex; GO:0000151 POSH Plenty of SH3s "CG4909, CG4909, GM09451, l(2)k15815, DPOSH, posh, BEST:GM09451, Plenty of SH3s" CDMC32006 4 23 19 DAC31-L16 1-CG5008-RA_1 CG5008 GGTCGGGACAGCTGAGAATCGCTTATACCCGTCCGAATGGAGGTAATCTGGATTTGTATGGCGCCG 66 FBan0005008 FBgn0040321 GNBP3 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to fungi; GO:0009620 Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- GNBP3 Gram-negative bacteria binding protein 3 "CG5008, DGNBP-3, GNBP, Hades, Gram-negative bacteria binding protein 3" CDMC32006 4 24 19 DAC31-L16 1-CG5008-RA_1 CG5008 GGTCGGGACAGCTGAGAATCGCTTATACCCGTCCGAATGGAGGTAATCTGGATTTGTATGGCGCCG 66 FBan0005008 FBgn0040321 GNBP3 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to fungi; GO:0009620 Gram-negative bacterial binding; GO:0008368; pattern recognition receptor activity; GO:0008329; ; GO:0008329; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008329; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- GNBP3 Gram-negative bacteria binding protein 3 "CG5008, DGNBP-3, GNBP, Hades, Gram-negative bacteria binding protein 3" CDMC32007 4 25 19 DAC31-P04 3-CG5386-RA_1 CG5386 TCTCCAGCCAAAGCCAATTCAGACGGCACAACAATATGGAGGAGTCGGGCCAAAAGTCGTTAAGGC 66 FBan0005386 FBgn0038945 CG5386 3 3R CG5386 CG5386 CDMC32007 4 26 19 DAC31-P04 3-CG5386-RA_1 CG5386 TCTCCAGCCAAAGCCAATTCAGACGGCACAACAATATGGAGGAGTCGGGCCAAAAGTCGTTAAGGC 66 FBan0005386 FBgn0038945 CG5386 3 3R CG5386 CG5386 CDMC32008 4 1 20 DAC31-P16 AutoBlank AutoBlank CDMC32008 4 2 20 DAC31-P16 AutoBlank AutoBlank CDMC32009 4 3 20 DAC32-D04 3-CG11152-RA_1 CG11152 CGAGTTCCCAGTCTGCTCTGCAACTATCTGCCCTGGGTTATCCATACCACCAGCACTATATCGGCCAAT 69 FBan0011152 FBgn0039937 CG11152 4 4 regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11152 CG11152 Dmcg11152 CDMC32009 4 4 20 DAC32-D04 3-CG11152-RA_1 CG11152 CGAGTTCCCAGTCTGCTCTGCAACTATCTGCCCTGGGTTATCCATACCACCAGCACTATATCGGCCAAT 69 FBan0011152 FBgn0039937 CG11152 4 4 regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG11152 CG11152 Dmcg11152 CDMC32010 4 5 20 DAC32-D16 15-CG11162-RA_5 CG11162 GGCAGCACAGTGGTCATTTTCATCGTATACTGGCTCTATGCGGGCATCTTCACCCTGATGGACATTACG 69 FBan0011162 FBgn0030509 CG11162 X X cholesterol metabolism; GO:0008203 C-4 methylsterol oxidase activity; GO:0000254 ; EC:1.14.13.-; ; GO:0000254 ; EC:1.14.13.- CG11162 CG11162 CDMC32010 4 6 20 DAC32-D16 15-CG11162-RA_5 CG11162 GGCAGCACAGTGGTCATTTTCATCGTATACTGGCTCTATGCGGGCATCTTCACCCTGATGGACATTACG 69 FBan0011162 FBgn0030509 CG11162 X X cholesterol metabolism; GO:0008203 C-4 methylsterol oxidase activity; GO:0000254 ; EC:1.14.13.-; ; GO:0000254 ; EC:1.14.13.- CG11162 CG11162 CDMC32011 4 7 20 DAC32-H04 23-CG11212-RA_3 CG11212 GCCCGCAATTTAATGACACAACACAAGCATTTCATCGATAAGAGCTCAGAGAACTTAAAATACCAACAA 69 FBan0011212 FBgn0033068 Ptr 2 2R cell surface receptor linked signal transduction; GO:0007166 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; ; GO:0008158 plasma membrane; GO:0005886 Ptr Ptc-related "CG11212, CG11212, CG11212, Ptr_Dm, Ptc-related Disp-like, Ptc-related" CDMC32011 4 8 20 DAC32-H04 23-CG11212-RA_3 CG11212 GCCCGCAATTTAATGACACAACACAAGCATTTCATCGATAAGAGCTCAGAGAACTTAAAATACCAACAA 69 FBan0011212 FBgn0033068 Ptr 2 2R cell surface receptor linked signal transduction; GO:0007166 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; ; GO:0008158 plasma membrane; GO:0005886 Ptr Ptc-related "CG11212, CG11212, CG11212, Ptr_Dm, Ptc-related Disp-like, Ptc-related" CDMC32012 4 9 20 DAC32-H16 23-CG11230-RA_8 CG11230 ACACTCGTTGGTATTTCCGTGTCCTCTAAATGTTGCCTTTTCTTTTACATATTTCTCATACATTTTCAT 69 FBan0011230 FBgn0031137 CG11230 X X CG11230 CG11230 CDMC32012 4 10 20 DAC32-H16 23-CG11230-RA_8 CG11230 ACACTCGTTGGTATTTCCGTGTCCTCTAAATGTTGCCTTTTCTTTTACATATTTCTCATACATTTTCAT 69 FBan0011230 FBgn0031137 CG11230 X X CG11230 CG11230 CDMC32013 4 11 20 DAC32-L04 3-CG1126-RA_2 CG1126 CCTCTACATCCTGGCGGTAAGCAACGAGACCCGCTTTGAGTTCCTTTTCACCGACGTATCTGGGGAAAC 69 FBan0001126 FBgn0037280 CG1126 3 3R CG1126 CG1126 CDMC32013 4 12 20 DAC32-L04 3-CG1126-RA_2 CG1126 CCTCTACATCCTGGCGGTAAGCAACGAGACCCGCTTTGAGTTCCTTTTCACCGACGTATCTGGGGAAAC 69 FBan0001126 FBgn0037280 CG1126 3 3R CG1126 CG1126 CDMC32014 4 13 20 DAC32-L16 14-CG11279-RA_1 CG11279 AGGCCAAGTTCAATGAGACGCAGAAGATCAAGTCCGTTATTTCGAAGTCGGTCAACAAGAGCGTGGAGA 69 FBan0011279 FBgn0036342 CG11279 3 3L CG11279 CG11279 BcDNA:GM21080 CDMC32014 4 14 20 DAC32-L16 14-CG11279-RA_1 CG11279 AGGCCAAGTTCAATGAGACGCAGAAGATCAAGTCCGTTATTTCGAAGTCGGTCAACAAGAGCGTGGAGA 69 FBan0011279 FBgn0036342 CG11279 3 3L CG11279 CG11279 BcDNA:GM21080 CDMC32015 4 15 20 DAC32-P04 23-CG11315-RA_5 CG11315 GCGGCACCTGTTTATAATCTGTATACCCAGTAATTGGACTCATTTCACCTTGAATATGTCAGCAGAACA 69 FBan0011315 FBgn0039801 CG11315 3 3R CG11315 CG11315 "DmML1A, BcDNA:GH26608, BcDNA:RH04252, BcDNA:RH68460" CDMC32015 4 16 20 DAC32-P04 23-CG11315-RA_5 CG11315 GCGGCACCTGTTTATAATCTGTATACCCAGTAATTGGACTCATTTCACCTTGAATATGTCAGCAGAACA 69 FBan0011315 FBgn0039801 CG11315 3 3R CG11315 CG11315 "DmML1A, BcDNA:GH26608, BcDNA:RH04252, BcDNA:RH68460" CDMC32016 4 17 20 DAC32-P16 9-CG11323-RA_2 CG11323 CGGCGCCGACTTCATGATCTGTGAGAATTTCTATCCCTGGCTCATCGAGATCAACTCCAGTCCGGATCT 69 FBan0011323 FBgn0031854 CG11323 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG11323 CG11323 CDMC32016 4 18 20 DAC32-P16 9-CG11323-RA_2 CG11323 CGGCGCCGACTTCATGATCTGTGAGAATTTCTATCCCTGGCTCATCGAGATCAACTCCAGTCCGGATCT 69 FBan0011323 FBgn0031854 CG11323 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG11323 CG11323 CDMC32017 4 19 20 DAC33-D04 18-CG1259-RB_1 CG1259 TCCCATCGTCGCCTAAGTAGAAGGAGGAGAAGTAGGAGTCGTAAAGGAAGTATTGACCGCAATTCGACA 69 FBan0001259 FBgn0035513 CG1259 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG1259 CG1259 CDMC32017 4 20 20 DAC33-D04 18-CG1259-RB_1 CG1259 TCCCATCGTCGCCTAAGTAGAAGGAGGAGAAGTAGGAGTCGTAAAGGAAGTATTGACCGCAATTCGACA 69 FBan0001259 FBgn0035513 CG1259 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG1259 CG1259 CDMC32018 4 21 20 DAC33-D16 23-CG12617-RA_3 CG12617 TCCCTGATCTTACGACACGCTTTCCTTTAAACGGTGACTTCTGAATAACACTTTCCTGGGGTTTCCATA 69 FBan0012617 FBgn0040996 CG12617 2 2L CG12617 CG12617 38C.31 CDMC32018 4 22 20 DAC33-D16 23-CG12617-RA_3 CG12617 TCCCTGATCTTACGACACGCTTTCCTTTAAACGGTGACTTCTGAATAACACTTTCCTGGGGTTTCCATA 69 FBan0012617 FBgn0040996 CG12617 2 2L CG12617 CG12617 38C.31 CDMC32019 4 23 20 DAC33-H04 2-CG12663-RA_1 CG12663 TGGGTGCTTCGACCAGGTGATCATTAGCAACTCATCCATACTGATCGGTGCCATGAGTGGTTCGCATCA 69 FBan0012663 FBgn0029961 CG12663 X X CG12663 CG12663 CDMC32019 4 24 20 DAC33-H04 2-CG12663-RA_1 CG12663 TGGGTGCTTCGACCAGGTGATCATTAGCAACTCATCCATACTGATCGGTGCCATGAGTGGTTCGCATCA 69 FBan0012663 FBgn0029961 CG12663 X X CG12663 CG12663 CDMC32020 4 25 20 DAC33-H16 22-CG12677-RA_1 CG12677 CCCAATTGCTGTGTTCTCGATATTGACTCAACGCGGATACTGCTTAAAATGGGTCAGAAATTTCGCCCA 69 FBan0012677 FBgn0040706 CG12677 2 2L CG12677 CG12677 BcDNA:AT09846 CDMC32020 4 26 20 DAC33-H16 22-CG12677-RA_1 CG12677 CCCAATTGCTGTGTTCTCGATATTGACTCAACGCGGATACTGCTTAAAATGGGTCAGAAATTTCGCCCA 69 FBan0012677 FBgn0040706 CG12677 2 2L CG12677 CG12677 BcDNA:AT09846 CDMC32021 4 1 21 DAC33-L04 2-CG12729-RA_1 CG12729 AGTGGCCTTCAACATCGTCGAAAGCACCCATTCGCTGGAGTCTTAAAAGATGCAGAGCACACCATGCAA 69 FBan0012729 FBgn0029816 CG12729 X X CG12729 CG12729 CDMC32021 4 2 21 DAC33-L04 2-CG12729-RA_1 CG12729 AGTGGCCTTCAACATCGTCGAAAGCACCCATTCGCTGGAGTCTTAAAAGATGCAGAGCACACCATGCAA 69 FBan0012729 FBgn0029816 CG12729 X X CG12729 CG12729 CDMC32022 4 3 21 DAC33-L16 17-CG12744-RA_1 CG12744 TGGCTAGGCGCTGACAACTGTTTTATGTAGAGGAACATAGAACCAGGATATGTCTTGCGAAGGGCTGAC 69 FBan0012744 FBgn0033459 CG12744 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12744 CG12744 CDMC32022 4 4 21 DAC33-L16 17-CG12744-RA_1 CG12744 TGGCTAGGCGCTGACAACTGTTTTATGTAGAGGAACATAGAACCAGGATATGTCTTGCGAAGGGCTGAC 69 FBan0012744 FBgn0033459 CG12744 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12744 CG12744 CDMC32023 4 5 21 DAC33-P04 16-CG12780-RA_1 CG12780 TTTCACTGTTCGGATTCCACGGCAGACTAAACGAACCAATTGTTGATCTTGGGAATCAGACATGGGCGG 69 FBan0012780 FBgn0033301 CG12780 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976 Gram-negative bacterial binding; GO:0008368; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- CG12780 CG12780 GNBP-like CDMC32023 4 6 21 DAC33-P04 16-CG12780-RA_1 CG12780 TTTCACTGTTCGGATTCCACGGCAGACTAAACGAACCAATTGTTGATCTTGGGAATCAGACATGGGCGG 69 FBan0012780 FBgn0033301 CG12780 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976 Gram-negative bacterial binding; GO:0008368; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0008368; ; GO:0015926 ; EC:3.2.1.- CG12780 CG12780 GNBP-like CDMC32024 4 7 21 DAC33-P16 6-CG12794-RA_2 CG12794 GCTTCGTCCACTACAGTGTCCTCCACTACAGAGTCCTCTACGGAATCCTCGACGGAATCATCCACAGCA 69 FBan0012794 FBgn0028583 lcs X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 lcs la costa "CG12794, leader sequence, collagen-related repetitive motif and a serine/threonine-rich motif, la costa" CDMC32024 4 8 21 DAC33-P16 6-CG12794-RA_2 CG12794 GCTTCGTCCACTACAGTGTCCTCCACTACAGAGTCCTCTACGGAATCCTCGACGGAATCATCCACAGCA 69 FBan0012794 FBgn0028583 lcs X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 lcs la costa "CG12794, leader sequence, collagen-related repetitive motif and a serine/threonine-rich motif, la costa" CDMC32025 4 9 21 DAC34-D04 9-CG4362-RA_2 CG4362 CCGCCTGCGATTCATCGATGGAAGCGATAGAAAGGATATCGGCGATCAGATGGGCGAATTCGATGTGAC 69 FBan0004362 FBgn0038784 CG4362 3 3R viral capsid; GO:0019028 CG4362 CG4362 CDMC32025 4 10 21 DAC34-D04 9-CG4362-RA_2 CG4362 CCGCCTGCGATTCATCGATGGAAGCGATAGAAAGGATATCGGCGATCAGATGGGCGAATTCGATGTGAC 69 FBan0004362 FBgn0038784 CG4362 3 3R viral capsid; GO:0019028 CG4362 CG4362 CDMC32026 4 11 21 DAC34-D16 3-CG4373-RA_1 CG4373 CCATTCGCAAATACCCCGGGCTACCATTCCTCAATCGAGAGTGCACCGAAGATTATCCCGTACCTGGAA 69 FBan0004373 FBgn0034756 Cyp6d2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d2 Cyp6d2 "CG4373, 6d2" CDMC32026 4 12 21 DAC34-D16 3-CG4373-RA_1 CG4373 CCATTCGCAAATACCCCGGGCTACCATTCCTCAATCGAGAGTGCACCGAAGATTATCCCGTACCTGGAA 69 FBan0004373 FBgn0034756 Cyp6d2 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6d2 Cyp6d2 "CG4373, 6d2" CDMC32027 4 13 21 DAC34-H04 17-CG4415-RA_3 CG4415 TGCGCTGCCAATTTGGAAATTTTTTTGGAGAAGTTGTCCTCGCAAATCTGTGATCGCAAATCCCTCAGT 69 FBan0004415 FBgn0031296 CG4415 2 2L protein targeting; GO:0006605 unfolded protein binding; GO:0051082; ; GO:0051082 nascent polypeptide-associated complex; GO:0005854 CG4415 CG4415 CDMC32027 4 14 21 DAC34-H04 17-CG4415-RA_3 CG4415 TGCGCTGCCAATTTGGAAATTTTTTTGGAGAAGTTGTCCTCGCAAATCTGTGATCGCAAATCCCTCAGT 69 FBan0004415 FBgn0031296 CG4415 2 2L protein targeting; GO:0006605 unfolded protein binding; GO:0051082; ; GO:0051082 nascent polypeptide-associated complex; GO:0005854 CG4415 CG4415 CDMC32028 4 15 21 DAC34-H16 23-CG4427-RA_10 CG4427 TGCCTTCTCGCTCTCATGTAGCTGGTGTAGACTTAAGCTTAGTTAGGAGCTAGATCTTGTCACCGTTTT 69 FBan0004427 FBgn0043364 cbt 2 2L JNK cascade; GO:0007254; autophagic cell death; GO:0048102; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; eye morphogenesis; GO:0048592; germ-band shortening; GO:0007390; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; sensory organ development; GO:0007423 nucleic acid binding; GO:0003676; transcriptional activator activity; GO:0016563; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 cbt cabut "CG4427, CG4427, CG4427, CG4427, EP2237, EP(2)2237, dTIEG, TGF-beta-inducible early gene" CDMC32028 4 16 21 DAC34-H16 23-CG4427-RA_10 CG4427 TGCCTTCTCGCTCTCATGTAGCTGGTGTAGACTTAAGCTTAGTTAGGAGCTAGATCTTGTCACCGTTTT 69 FBan0004427 FBgn0043364 cbt 2 2L JNK cascade; GO:0007254; autophagic cell death; GO:0048102; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; eye morphogenesis; GO:0048592; germ-band shortening; GO:0007390; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland cell autophagic cell death; GO:0035071; sensory organ development; GO:0007423 nucleic acid binding; GO:0003676; transcriptional activator activity; GO:0016563; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0008270 nucleus; GO:0005634 cbt cabut "CG4427, CG4427, CG4427, CG4427, EP2237, EP(2)2237, dTIEG, TGF-beta-inducible early gene" CDMC32029 4 17 21 DAC34-L04 9-CG4455-RA_4 CG4455 GCGCTCCATTCAATCCATAGAGAACTATCCCGACCAGAAACACCATCATACGTTGGCCTGATTCGGGGT 69 FBan0004455 FBgn0028506 CG4455 2 2L CG4455 CG4455 "BG:DS09218.3, LD27171, BEST:LD27171" CDMC32029 4 18 21 DAC34-L04 9-CG4455-RA_4 CG4455 GCGCTCCATTCAATCCATAGAGAACTATCCCGACCAGAAACACCATCATACGTTGGCCTGATTCGGGGT 69 FBan0004455 FBgn0028506 CG4455 2 2L CG4455 CG4455 "BG:DS09218.3, LD27171, BEST:LD27171" CDMC32030 4 19 21 DAC34-L16 6-CG4471-RA_1 CG4471 ACGGGCCTGCTCTCAAATCTGCTCTATATGCTACTCGGCATAGGAGTGATGTCTGGAGCAGGACTAGGA 69 FBan0004471 FBgn0033137 Tsp42Ep 2 2R integral to membrane; GO:0016021 Tsp42Ep Tetraspanin 42Ep "CG4471, CG4471, CG4471, Dm.Tsp42Ep, tetraspanin 42E, Tetraspanin 42Ep" CDMC32030 4 20 21 DAC34-L16 6-CG4471-RA_1 CG4471 ACGGGCCTGCTCTCAAATCTGCTCTATATGCTACTCGGCATAGGAGTGATGTCTGGAGCAGGACTAGGA 69 FBan0004471 FBgn0033137 Tsp42Ep 2 2R integral to membrane; GO:0016021 Tsp42Ep Tetraspanin 42Ep "CG4471, CG4471, CG4471, Dm.Tsp42Ep, tetraspanin 42E, Tetraspanin 42Ep" CDMC32031 4 21 21 DAC34-P04 15-CG4521-RA_2 CG4521 AGTTCGGGTCACATTAACACGTTCTAATTGGACACTCCGGTCAGTGTTGCGAAATGGAATGTGCAGCAT 69 FBan0004521 FBgn0030766 mthl1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl1 methuselah-like 1 "CG4521, mth-like 1, Mth-like 1, anon-WO0170980.22, anon-WO0170980.23" CDMC32031 4 22 21 DAC34-P04 15-CG4521-RA_2 CG4521 AGTTCGGGTCACATTAACACGTTCTAATTGGACACTCCGGTCAGTGTTGCGAAATGGAATGTGCAGCAT 69 FBan0004521 FBgn0030766 mthl1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl1 methuselah-like 1 "CG4521, mth-like 1, Mth-like 1, anon-WO0170980.22, anon-WO0170980.23" CDMC32032 4 23 21 DAC34-P16 23-CG4533-RA_1 CG4533 TTTGTACCGCCTTCAGTGTTAGTTAGTTTATGTCTACGTGTGCCTTATATATTGGACTCTACATATTTT 69 FBan0004533 FBgn0011296 l(2)efl 2 2R defense response; GO:0006952; embryonic development; GO:0009790; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 l(2)efl lethal (2) essential for life "CG4533, l(2)Efl, lethal (2) essential for life, el(2)13-1, l(2)13-1, l(2)59Fa" CDMC32032 4 24 21 DAC34-P16 23-CG4533-RA_1 CG4533 TTTGTACCGCCTTCAGTGTTAGTTAGTTTATGTCTACGTGTGCCTTATATATTGGACTCTACATATTTT 69 FBan0004533 FBgn0011296 l(2)efl 2 2R defense response; GO:0006952; embryonic development; GO:0009790; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 l(2)efl lethal (2) essential for life "CG4533, l(2)Efl, lethal (2) essential for life, el(2)13-1, l(2)13-1, l(2)59Fa" CDMC32033 4 25 21 DAC35-D04 3-CG8818-RA_2 CG8818 CCGCTAAATGAGCTGCAGAACGAACAGTTCCTCAGTCTGTTCCTCGACCAGAGCGATCCTGTGGACTCT 69 FBan0008818 FBgn0033751 CG8818 2 2R CG8818 CG8818 CDMC32033 4 26 21 DAC35-D04 3-CG8818-RA_2 CG8818 CCGCTAAATGAGCTGCAGAACGAACAGTTCCTCAGTCTGTTCCTCGACCAGAGCGATCCTGTGGACTCT 69 FBan0008818 FBgn0033751 CG8818 2 2R CG8818 CG8818 CDMC32034 4 1 22 DAC35-D16 22-CG8825-RA_1 CG8825 TTTTTCGGTAAATGTCCAATTCTGCCCATACTTCTTGGATCGGAGTGCTAATTCTGTTTGCACCGCAGG 69 FBan0008825 FBgn0031506 gkt 2 2L central nervous system development; GO:0007417; establishment and/or maintenance of epithelial cell polarity; GO:0045197 tyrosyl-DNA phosophodiesterase activity; GO:0017005; ; GO:0017005 gkt glaikit "CG8825, CG8826, Tdp1, Tyrosyl-DNA phosophodiesterase 1, glaikit" CDMC32034 4 2 22 DAC35-D16 22-CG8825-RA_1 CG8825 TTTTTCGGTAAATGTCCAATTCTGCCCATACTTCTTGGATCGGAGTGCTAATTCTGTTTGCACCGCAGG 69 FBan0008825 FBgn0031506 gkt 2 2L central nervous system development; GO:0007417; establishment and/or maintenance of epithelial cell polarity; GO:0045197 tyrosyl-DNA phosophodiesterase activity; GO:0017005; ; GO:0017005 gkt glaikit "CG8825, CG8826, Tdp1, Tyrosyl-DNA phosophodiesterase 1, glaikit" CDMC32035 4 3 22 DAC35-H04 15-CG8862-RA_1 CG8862 CGGCGGGATTGCTCTTCTTCGATCAAATCAATCGCAAGCAGCTAACCACCATCAATGGCAAGAAAGTCT 69 FBan0008862 FBgn0033690 CG8862 2 2R DNA-dependent DNA replication; GO:0006261; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; ; GO:0004520 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG8862 CG8862 CDMC32035 4 4 22 DAC35-H04 15-CG8862-RA_1 CG8862 CGGCGGGATTGCTCTTCTTCGATCAAATCAATCGCAAGCAGCTAACCACCATCAATGGCAAGAAAGTCT 69 FBan0008862 FBgn0033690 CG8862 2 2R DNA-dependent DNA replication; GO:0006261; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; ; GO:0004520 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG8862 CG8862 CDMC32036 4 5 22 DAC35-H16 1-CG8874-RA_1 CG8874 TGTCTACAAGGCCAAACTGAAGTCCACCAAACTGGATGTGGCTGTCAAAACCTGTCGAATGACCCTGCC 69 FBan0008874 FBgn0000723 Fps85D 3 3R JAK-STAT cascade; GO:0007259; defense response; GO:0006952; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886 Fps85D Fps oncogene analog "CG8874, CG8874, CG8874, dfps85D, dfps, fps, Fer, DFer, Dm FPS, Dfps, DmHD-179, dFer, dfps 85D, fer, FPS, DFER, Dfer, FER, HD-179, fps85D" CDMC32036 4 6 22 DAC35-H16 1-CG8874-RA_1 CG8874 TGTCTACAAGGCCAAACTGAAGTCCACCAAACTGGATGTGGCTGTCAAAACCTGTCGAATGACCCTGCC 69 FBan0008874 FBgn0000723 Fps85D 3 3R JAK-STAT cascade; GO:0007259; defense response; GO:0006952; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 cytoplasm; GO:0005737; membrane; GO:0016020; plasma membrane; GO:0005886 Fps85D Fps oncogene analog "CG8874, CG8874, CG8874, dfps85D, dfps, fps, Fer, DFer, Dm FPS, Dfps, DmHD-179, dFer, dfps 85D, fer, FPS, DFER, Dfer, FER, HD-179, fps85D" CDMC32037 4 7 22 DAC35-L04 17-CG8920-RC_3 CG8920 GGGCGACGATGGAGTAATTGCCTGTGATCAACTGAAAACTCTAAATCCGGAGTTAAGAAAGCTGCCCAA 69 FBan0008920 FBgn0027529 CG8920 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG8920 CG8920 BcDNA:LD21403 CDMC32037 4 8 22 DAC35-L04 17-CG8920-RC_3 CG8920 GGGCGACGATGGAGTAATTGCCTGTGATCAACTGAAAACTCTAAATCCGGAGTTAAGAAAGCTGCCCAA 69 FBan0008920 FBgn0027529 CG8920 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG8920 CG8920 BcDNA:LD21403 CDMC32038 4 9 22 DAC35-L16 18-CG8932-RA_3 CG8932 TCTTCATGGGTTGGCTTAGTATTTCGGCCCAAATTGCCATTAACTCTGGGGAAATTCATCCCGAGGAAA 69 FBan0008932 FBgn0039390 CG8932 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG8932 CG8932 CDMC32038 4 10 22 DAC35-L16 18-CG8932-RA_3 CG8932 TCTTCATGGGTTGGCTTAGTATTTCGGCCCAAATTGCCATTAACTCTGGGGAAATTCATCCCGAGGAAA 69 FBan0008932 FBgn0039390 CG8932 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 membrane; GO:0016020 CG8932 CG8932 CDMC32039 4 11 22 DAC35-P04 2-CG8968-RA_2 CG8968 CCTCCCCTGATTCCATAGACAGCGTTATAAGTGCACCAAGATCGGCCAAAGTACCCTCGGGAAGTGAGG 69 FBan0008968 FBgn0039400 CG8968 3 3R CG8968 CG8968 CDMC32039 4 12 22 DAC35-P04 2-CG8968-RA_2 CG8968 CCTCCCCTGATTCCATAGACAGCGTTATAAGTGCACCAAGATCGGCCAAAGTACCCTCGGGAAGTGAGG 69 FBan0008968 FBgn0039400 CG8968 3 3R CG8968 CG8968 CDMC32040 4 13 22 DAC35-P16 10-CG8982-RA_1 CG8982 GGGCAACTGCAAAACACTCGAAAGTCCACAAAGCCGTGTAAGAAACGTTCTAGTAAGGATAGCGCCCCA 69 FBan0008982 FBgn0002855 Acp26Aa 2 2L "mating; GO:0007618; oviposition; GO:0018991; ovulation; GO:0030728; post-mating behavior; GO:0045297; regulation of oviposition; GO:0046662; regulation of oviposition, post-mating; GO:0048042; sperm competition; GO:0046692; sperm displacement; GO:0007321" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp26Aa Accessory gland-specific peptide 26Aa "CG8982, mst355a, mst 355a, Mst26A, Acp26A, Mst26Aa, ovulin, Acp26Aab, Ovulin, msP355a" CDMC32040 4 14 22 DAC35-P16 10-CG8982-RA_1 CG8982 GGGCAACTGCAAAACACTCGAAAGTCCACAAAGCCGTGTAAGAAACGTTCTAGTAAGGATAGCGCCCCA 69 FBan0008982 FBgn0002855 Acp26Aa 2 2L "mating; GO:0007618; oviposition; GO:0018991; ovulation; GO:0030728; post-mating behavior; GO:0045297; regulation of oviposition; GO:0046662; regulation of oviposition, post-mating; GO:0048042; sperm competition; GO:0046692; sperm displacement; GO:0007321" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp26Aa Accessory gland-specific peptide 26Aa "CG8982, mst355a, mst 355a, Mst26A, Acp26A, Mst26Aa, ovulin, Acp26Aab, Ovulin, msP355a" CDMC32041 4 15 22 DAC36-D04 15-CG7081-RA_1 CG7081 AATCCAACCGGAGCTCGACTTGATCATTCAATCCGCAATTTGGTTTGGTTCCGTCGGCAAGCGGT 65 FBan0007081 FBgn0035876 CG7081 3 3L peroxisome organization and biogenesis; GO:0007031; protein complex assembly; GO:0006461; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 peroxisomal membrane; GO:0005778; ubiquitin ligase complex; GO:0000151 CG7081 CG7081 CDMC32041 4 16 22 DAC36-D04 15-CG7081-RA_1 CG7081 AATCCAACCGGAGCTCGACTTGATCATTCAATCCGCAATTTGGTTTGGTTCCGTCGGCAAGCGGT 65 FBan0007081 FBgn0035876 CG7081 3 3L peroxisome organization and biogenesis; GO:0007031; protein complex assembly; GO:0006461; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 peroxisomal membrane; GO:0005778; ubiquitin ligase complex; GO:0000151 CG7081 CG7081 CDMC32042 4 17 22 DAC36-D16 3-CG7137-RA_2 CG7137 TCGTAGCGACATCATTGCCTGCAACATCACGGATACTCCACTCCAAGCTCGAACTCTGGACGTGG 65 FBan0007137 FBgn0034422 CG7137 2 2R CG7137 CG7137 Gene 3 CDMC32042 4 18 22 DAC36-D16 3-CG7137-RA_2 CG7137 TCGTAGCGACATCATTGCCTGCAACATCACGGATACTCCACTCCAAGCTCGAACTCTGGACGTGG 65 FBan0007137 FBgn0034422 CG7137 2 2R CG7137 CG7137 Gene 3 CDMC32043 4 19 22 DAC36-H04 14-CG7246-RA_2 CG7246 CCATGCTGGCACTCAATAGCGATGGAAAGACGGAGCGTATACTAAAGCAACAGTGCCTAGCGGAT 65 FBan0007246 FBgn0030081 CG7246 X X "DNA metabolism; GO:0006259; DNA repair; GO:0006281; RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003684; ; GO:0030528 intracellular; GO:0005622 CG7246 CG7246 CDMC32043 4 20 22 DAC36-H04 14-CG7246-RA_2 CG7246 CCATGCTGGCACTCAATAGCGATGGAAAGACGGAGCGTATACTAAAGCAACAGTGCCTAGCGGAT 65 FBan0007246 FBgn0030081 CG7246 X X "DNA metabolism; GO:0006259; DNA repair; GO:0006281; RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003684; ; GO:0030528 intracellular; GO:0005622 CG7246 CG7246 CDMC32044 4 21 22 DAC36-H16 2-CG7277-RA_2 CG7277 ATCAATCACAACTCCATCGAGCTGTTCAAGTCCATTGATGCGTGGAAGCACATCGAGTCGGCGCG 65 FBan0007277 FBgn0031713 CG7277 2 2L aromatic compound metabolism; GO:0006725; coenzyme metabolism; GO:0006732; electron transport; GO:0006118 ubiquinone biosynthesis monooxygenase activity; GO:0015997 ; EC:1.14.13.-; ; GO:0015997 ; EC:1.14.13.-; ; GO:0015997 ; EC:1.14.13.- CG7277 CG7277 CDMC32044 4 22 22 DAC36-H16 2-CG7277-RA_2 CG7277 ATCAATCACAACTCCATCGAGCTGTTCAAGTCCATTGATGCGTGGAAGCACATCGAGTCGGCGCG 65 FBan0007277 FBgn0031713 CG7277 2 2L aromatic compound metabolism; GO:0006725; coenzyme metabolism; GO:0006732; electron transport; GO:0006118 ubiquinone biosynthesis monooxygenase activity; GO:0015997 ; EC:1.14.13.-; ; GO:0015997 ; EC:1.14.13.-; ; GO:0015997 ; EC:1.14.13.- CG7277 CG7277 CDMC32045 4 23 22 DAC36-L04 5-CG7382-RA_1 CG7382 GTCCGCTGGATCTTCCTTTGGCAACCTAGCCCTGATGTCCAATAGCCGGGATAAGTAGGCGGATC 65 FBan0007382 FBgn0031708 CG7382 2 2L CG7382 CG7382 CDMC32045 4 24 22 DAC36-L04 5-CG7382-RA_1 CG7382 GTCCGCTGGATCTTCCTTTGGCAACCTAGCCCTGATGTCCAATAGCCGGGATAAGTAGGCGGATC 65 FBan0007382 FBgn0031708 CG7382 2 2L CG7382 CG7382 CDMC32046 4 25 22 DAC36-L16 15-CG7413-RA_7 CG7413 CCTACAAAACGGAGCTCAAGTTCCCGTGGGTGCTCGACTGTTTCAGTATTAGCGCGTTCGAGTTC 65 FBan0007413 FBgn0015799 Rbf X X DNA endoreduplication; GO:0042023; G1 phase of mitotic cell cycle; GO:0000080; chorion gene amplification; GO:0007307; endomitotic cell cycle; GO:0007113; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of DNA binding; GO:0051101; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008134; ; GO:0008134 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; chromatin; GO:0000785; nucleus; GO:0005634 Rbf Retinoblastoma-family protein "CG7413, CG7413, dRBF, FBF, RBF, rbf, Rb, Rb1, RBF1, EG:34F3.3, RbF, Rbf1, rb, rbf1, Retinoblastoma-family protein" CDMC32046 4 26 22 DAC36-L16 15-CG7413-RA_7 CG7413 CCTACAAAACGGAGCTCAAGTTCCCGTGGGTGCTCGACTGTTTCAGTATTAGCGCGTTCGAGTTC 65 FBan0007413 FBgn0015799 Rbf X X DNA endoreduplication; GO:0042023; G1 phase of mitotic cell cycle; GO:0000080; chorion gene amplification; GO:0007307; endomitotic cell cycle; GO:0007113; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of DNA binding; GO:0051101; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008134; ; GO:0008134 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; chromatin; GO:0000785; nucleus; GO:0005634 Rbf Retinoblastoma-family protein "CG7413, CG7413, dRBF, FBF, RBF, rbf, Rb, Rb1, RBF1, EG:34F3.3, RbF, Rbf1, rb, rbf1, Retinoblastoma-family protein" CDMC32047 4 1 23 DAC36-P04 18-CG7481-RA_2 CG7481 AACTATGATCGCATCTTTCATCCGGACAATGAGCGTCTAGTTTGTTAGGATGCAGGCTACCCGCC 65 FBan0007481 FBgn0030986 RhoGAP18B X X actin filament organization; GO:0007015; intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP18B RhoGAP18B "CG7481, CG17015, CG7531, CG7481" CDMC32047 4 2 23 DAC36-P04 18-CG7481-RA_2 CG7481 AACTATGATCGCATCTTTCATCCGGACAATGAGCGTCTAGTTTGTTAGGATGCAGGCTACCCGCC 65 FBan0007481 FBgn0030986 RhoGAP18B X X actin filament organization; GO:0007015; intracellular signaling cascade; GO:0007242 GTPase activator activity; GO:0005096; ; GO:0005096; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP18B RhoGAP18B "CG7481, CG17015, CG7531, CG7481" CDMC32048 4 3 23 DAC36-P16 2-CG7537-RB_2 CG7537 CACCCTGGAGAGTCCCGTCTAGGATCGCTAGTGATCAGGTCCACGGATTGGATTAGGATCCCCAG 65 FBan0007537 FBgn0030989 inx5 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx5 inx5 "CG7537, Dm-inx5" CDMC32048 4 4 23 DAC36-P16 2-CG7537-RB_2 CG7537 CACCCTGGAGAGTCCCGTCTAGGATCGCTAGTGATCAGGTCCACGGATTGGATTAGGATCCCCAG 65 FBan0007537 FBgn0030989 inx5 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx5 inx5 "CG7537, Dm-inx5" CDMC32049 4 5 23 DAC37-D04 17-CG12929-RA_1 CG12929 GCGCTATTGGATACCCTTCGGTCTCAACCAGTGCGGGAGTGCTCTGTACGTTTGGACGCTCCAGA 65 FBan0012929 FBgn0033429 CG12929 2 2R CG12929 CG12929 CDMC32049 4 6 23 DAC37-D04 17-CG12929-RA_1 CG12929 GCGCTATTGGATACCCTTCGGTCTCAACCAGTGCGGGAGTGCTCTGTACGTTTGGACGCTCCAGA 65 FBan0012929 FBgn0033429 CG12929 2 2R CG12929 CG12929 CDMC32050 4 7 23 DAC37-D16 23-CG1294-RA_1 CG1294 ATGCTTCTGGTCACTCAATTTATCACTTCCAAAGTTTTAAAAGCCTTAACCAGCAAGTCGATTGC 65 FBan0001294 FBgn0033030 CG1294 2 2R CG1294 CG1294 CDMC32050 4 8 23 DAC37-D16 23-CG1294-RA_1 CG1294 ATGCTTCTGGTCACTCAATTTATCACTTCCAAAGTTTTAAAAGCCTTAACCAGCAAGTCGATTGC 65 FBan0001294 FBgn0033030 CG1294 2 2R CG1294 CG1294 CDMC32051 4 9 23 DAC37-H04 16-CG13038-RA_1 CG13038 CTCGTCTGCTCATCGATTCAGCGCCCTCAGTGGTCTCCTACCAGGGTTCCTCACAGGCCCAAACC 65 FBan0013038 FBgn0040795 CG13038 3 3L CG13038 CG13038 CDMC32051 4 10 23 DAC37-H04 16-CG13038-RA_1 CG13038 CTCGTCTGCTCATCGATTCAGCGCCCTCAGTGGTCTCCTACCAGGGTTCCTCACAGGCCCAAACC 65 FBan0013038 FBgn0040795 CG13038 3 3L CG13038 CG13038 CDMC32052 4 11 23 DAC37-H16 15-CG13046-RA_1 CG13046 GAGCCAGAGGAACCAGTACCAACAGAACCAGCAGTATCCCCAAGTGGCACGACAGTTTGCCGAGC 65 FBan0013046 FBgn0036595 CG13046 3 3L CG13046 CG13046 CDMC32052 4 12 23 DAC37-H16 15-CG13046-RA_1 CG13046 GAGCCAGAGGAACCAGTACCAACAGAACCAGCAGTATCCCCAAGTGGCACGACAGTTTGCCGAGC 65 FBan0013046 FBgn0036595 CG13046 3 3L CG13046 CG13046 CDMC32053 4 13 23 DAC37-L04 2-CG13089-RA_2 CG13089 TCTACTGCCTCGTGAAGGGAATGCTCATTCCATGCCTTCTAGTCCTCGCGTTCGAAACTGTCCGC 65 FBan0013089 FBgn0032052 CG13089 2 2L CG13089 CG13089 CDMC32053 4 14 23 DAC37-L04 2-CG13089-RA_2 CG13089 TCTACTGCCTCGTGAAGGGAATGCTCATTCCATGCCTTCTAGTCCTCGCGTTCGAAACTGTCCGC 65 FBan0013089 FBgn0032052 CG13089 2 2L CG13089 CG13089 CDMC32054 4 15 23 DAC37-L16 23-CG13123-RA_3 CG13123 AACCAGGCTAGTGATGAATTCGAGATACTGGAGGAATTCAGGAGGATACCACTGGATTATGTGGT 65 FBan0013123 FBgn0032150 CG13123 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13123 CG13123 CDMC32054 4 16 23 DAC37-L16 23-CG13123-RA_3 CG13123 AACCAGGCTAGTGATGAATTCGAGATACTGGAGGAATTCAGGAGGATACCACTGGATTATGTGGT 65 FBan0013123 FBgn0032150 CG13123 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13123 CG13123 CDMC32055 4 17 23 DAC37-P04 3-CG13185-RA_1 CG13185 CAGTTTGACGGTCCCCGCTTGGTAAATGCTCTGAACTTCGCTCAGGACAAGACAAAGATCGCCGG 65 FBan0013185 FBgn0033661 CG13185 2 2R "cell cycle; GO:0007049; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; development; GO:0007275; heart development; GO:0007507; mesoderm development; GO:0007498; mitosis; GO:0007067; regulation of transcription, DNA-dependent; GO:0006355" nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; transcription factor activity; GO:0003700; ; GO:0019237; nucleotide binding; GO:0000166; steroid hormone receptor activity; GO:0003707; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003700; ; GO:0000166; ; GO:0003707; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634 CG13185 CG13185 CG18329 CDMC32055 4 18 23 DAC37-P04 3-CG13185-RA_1 CG13185 CAGTTTGACGGTCCCCGCTTGGTAAATGCTCTGAACTTCGCTCAGGACAAGACAAAGATCGCCGG 65 FBan0013185 FBgn0033661 CG13185 2 2R "cell cycle; GO:0007049; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; development; GO:0007275; heart development; GO:0007507; mesoderm development; GO:0007498; mitosis; GO:0007067; regulation of transcription, DNA-dependent; GO:0006355" nucleic acid binding; GO:0003676; ; GO:0003676; centromeric DNA binding; GO:0019237; transcription factor activity; GO:0003700; ; GO:0019237; nucleotide binding; GO:0000166; steroid hormone receptor activity; GO:0003707; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003700; ; GO:0000166; ; GO:0003707; ; GO:0017111 ; EC:3.6.1.15 nucleus; GO:0005634 CG13185 CG13185 CG18329 CDMC32056 4 19 23 DAC37-P16 3-CG13207-RB_2 CG13207 TTCCTCCATACGCACCCATGAGCGCTTCACAGAGATCGGACATATGCCCAACCTGAATGGAGGAG 65 FBan0013207 FBgn0016047 nompA 2 2R dendrite morphogenesis; GO:0016358; detection of mechanical stimulus during sensory perception of sound; GO:0050910; sensory perception of mechanical stimulus; GO:0050954; sensory perception of sound; GO:0007605 extracellular region; GO:0005576 nompA no mechanoreceptor potential A "CG13207, nomp, no mechanoreceptor potential A" CDMC32056 4 20 23 DAC37-P16 3-CG13207-RB_2 CG13207 TTCCTCCATACGCACCCATGAGCGCTTCACAGAGATCGGACATATGCCCAACCTGAATGGAGGAG 65 FBan0013207 FBgn0016047 nompA 2 2R dendrite morphogenesis; GO:0016358; detection of mechanical stimulus during sensory perception of sound; GO:0050910; sensory perception of mechanical stimulus; GO:0050954; sensory perception of sound; GO:0007605 extracellular region; GO:0005576 nompA no mechanoreceptor potential A "CG13207, nomp, no mechanoreceptor potential A" CDMC32057 4 21 23 DAC38-D04 17-CG32584-RB_1 CG32584 TAACTCACTTGAGGACACGAACTACATGAATGCGGTGGAATCAGAAGCTCAAAAGAATATCGCCGGCCT 69 FBan0032584 FBgn0052584 CG32584 X X CG32584 CG32584 "CG18620, CG15644, CG18620" CDMC32057 4 22 23 DAC38-D04 17-CG32584-RB_1 CG32584 TAACTCACTTGAGGACACGAACTACATGAATGCGGTGGAATCAGAAGCTCAAAAGAATATCGCCGGCCT 69 FBan0032584 FBgn0052584 CG32584 X X CG32584 CG32584 "CG18620, CG15644, CG18620" CDMC32058 4 23 23 DAC38-D16 23-CG32593-RC_11 CG32593 CAGAACACAAAAAACAACCAACGTTAATCTCAGCTAAAGTTATGCATTTCGAACGCAACATTTTGTGGC 69 FBan0032593 FBgn0024753 Flo-2 X X cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399 structural molecule activity; GO:0005198; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005198 flotillin complex; GO:0016600; integral to membrane; GO:0016021 Flo-2 flotillin 2 "CG32593, CG11547, CG14409, CG32593, CG11547, CG14409, FLO[Dm]-2, FLO2, flotillin 2" CDMC32058 4 24 23 DAC38-D16 23-CG32593-RC_11 CG32593 CAGAACACAAAAAACAACCAACGTTAATCTCAGCTAAAGTTATGCATTTCGAACGCAACATTTTGTGGC 69 FBan0032593 FBgn0024753 Flo-2 X X cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399 structural molecule activity; GO:0005198; receptor binding; GO:0005102; ; GO:0005102; ; GO:0005198 flotillin complex; GO:0016600; integral to membrane; GO:0016021 Flo-2 flotillin 2 "CG32593, CG11547, CG14409, CG32593, CG11547, CG14409, FLO[Dm]-2, FLO2, flotillin 2" CDMC32059 4 25 23 DAC38-H04 1-CG32634-RA_2 CG32634 AGTCCAGCAACGCTTCAAAAAGTCAACTTCCTACGTCTCCAAGTTGTGCGGTTGTCTTCAGCCTGCTCC 69 FBan0032634 FBgn0052634 CG32634 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32634 CG32634 BcDNA:GM08788 CDMC32059 4 26 23 DAC38-H04 1-CG32634-RA_2 CG32634 AGTCCAGCAACGCTTCAAAAAGTCAACTTCCTACGTCTCCAAGTTGTGCGGTTGTCTTCAGCCTGCTCC 69 FBan0032634 FBgn0052634 CG32634 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32634 CG32634 BcDNA:GM08788 CDMC32060 4 1 24 DAC38-H16 3-CG32643-RA_1 CG32643 ACTGGCGCAGATCTCCCATTGAATCGGGAATAGCGAAGGAACGAGGAACCATGCCAGTGTACACAACAA 69 FBan0032643 FBgn0052643 CG32643 X X CG32643 CG32643 NEST:bs08h10 CDMC32060 4 2 24 DAC38-H16 3-CG32643-RA_1 CG32643 ACTGGCGCAGATCTCCCATTGAATCGGGAATAGCGAAGGAACGAGGAACCATGCCAGTGTACACAACAA 69 FBan0032643 FBgn0052643 CG32643 X X CG32643 CG32643 NEST:bs08h10 CDMC32061 4 3 24 DAC38-L04 23-CG32679-RA_1 CG32679 CTCCCTGCTGGATTTTCCTTTTATATTTGGTCCTTATCATTTTCACTTTTACTTTCGCACAAAACTATT 69 FBan0032679 FBgn0052679 CG32679 X X defense response; GO:0006952 extracellular region; GO:0005576 CG32679 CG32679 CDMC32061 4 4 24 DAC38-L04 23-CG32679-RA_1 CG32679 CTCCCTGCTGGATTTTCCTTTTATATTTGGTCCTTATCATTTTCACTTTTACTTTCGCACAAAACTATT 69 FBan0032679 FBgn0052679 CG32679 X X defense response; GO:0006952 extracellular region; GO:0005576 CG32679 CG32679 CDMC32062 4 5 24 DAC38-L16 23-CG32687-RA_13 CG32687 TTCCCATTGGCTTCTTCACACGTTACCAATTTGAACTAGTTTGCTAAGTGATTACACGACCTGTTTGCT 69 FBan0032687 FBgn0052687 CG32687 X X cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG32687 CG32687 "CG2143, CG2892, CG2143, CG2143, CG2892, CT6984, CT7080, BcDNA:RH29237" CDMC32062 4 6 24 DAC38-L16 23-CG32687-RA_13 CG32687 TTCCCATTGGCTTCTTCACACGTTACCAATTTGAACTAGTTTGCTAAGTGATTACACGACCTGTTTGCT 69 FBan0032687 FBgn0052687 CG32687 X X cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG32687 CG32687 "CG2143, CG2892, CG2143, CG2143, CG2892, CT6984, CT7080, BcDNA:RH29237" CDMC32063 4 7 24 DAC38-P04 11-CG3270-RA_1 CG3270 AGCAGTTCTCTTTGGCCGAGAACATAGAGATGTCGCTCTTCGGATACAACTTCGTGGTTAACGGCAGGG 69 FBan0003270 FBgn0033093 CG3270 2 2R electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3270 CG3270 CDMC32063 4 8 24 DAC38-P04 11-CG3270-RA_1 CG3270 AGCAGTTCTCTTTGGCCGAGAACATAGAGATGTCGCTCTTCGGATACAACTTCGTGGTTAACGGCAGGG 69 FBan0003270 FBgn0033093 CG3270 2 2R electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3270 CG3270 CDMC32064 4 9 24 DAC38-P16 11-CG3271-RA_7 CG3271 CGGGGTGTTATCACGTTGGCATTCCTCTCCTACTACATTAACTACTTTGCCTACCTGAGCGTGGGACGG 69 FBan0003271 FBgn0033088 CG3271 2 2R CG3271 CG3271 CDMC32064 4 10 24 DAC38-P16 11-CG3271-RA_7 CG3271 CGGGGTGTTATCACGTTGGCATTCCTCTCCTACTACATTAACTACTTTGCCTACCTGAGCGTGGGACGG 69 FBan0003271 FBgn0033088 CG3271 2 2R CG3271 CG3271 CDMC32065 4 11 24 DAC39-D04 18-CG13680-RA_1 CG13680 TGGACACCACAGCATCGAGAATGGCAGGCAAATCAATACCAGCTCTAGTTCATGCAGTAGTCTTAAGGA 69 FBan0013680 FBgn0040834 CG13680 3 3L CG13680 CG13680 CDMC32065 4 12 24 DAC39-D04 18-CG13680-RA_1 CG13680 TGGACACCACAGCATCGAGAATGGCAGGCAAATCAATACCAGCTCTAGTTCATGCAGTAGTCTTAAGGA 69 FBan0013680 FBgn0040834 CG13680 3 3L CG13680 CG13680 CDMC32066 4 13 24 DAC39-D16 22-CG13695-RB_4 CG13695 TGATGAAGCTCAGCTACAAAGTGAGGGTCTAGCCACTGGATCCGAACCTTAAGTATTAGGATGTAGGCG 69 FBan0013695 FBgn0020300 gk 3 3L response to ethanol; GO:0045471 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 gk geko "CG13695, CG13696, Geko, CT33153, BcDNA:RE30284, geko" CDMC32066 4 14 24 DAC39-D16 22-CG13695-RB_4 CG13695 TGATGAAGCTCAGCTACAAAGTGAGGGTCTAGCCACTGGATCCGAACCTTAAGTATTAGGATGTAGGCG 69 FBan0013695 FBgn0020300 gk 3 3L response to ethanol; GO:0045471 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 gk geko "CG13695, CG13696, Geko, CT33153, BcDNA:RE30284, geko" CDMC32067 4 15 24 DAC39-H04 1-CG13741-RA_1 CG13741 AGGAGTCCCGAAGTGTCGCATTGCCTGAACGTGAAGGAGGAAGGGACCAACTGCAACGTTTTAACTAGA 69 FBan0013741 FBgn0033374 CG13741 2 2R CG13741 CG13741 CG30346 CDMC32067 4 16 24 DAC39-H04 1-CG13741-RA_1 CG13741 AGGAGTCCCGAAGTGTCGCATTGCCTGAACGTGAAGGAGGAAGGGACCAACTGCAACGTTTTAACTAGA 69 FBan0013741 FBgn0033374 CG13741 2 2R CG13741 CG13741 CG30346 CDMC32068 4 17 24 DAC39-H16 10-CG13751-RA_2 CG13751 CCCAGCGGACTGTGTGTCATAGCAAAAGCTGAAATTTCTCGGGGGAAAAATGCCTGTTTTGGAGCACAT 69 FBan0013751 FBgn0033340 CG13751 2 2R CG13751 CG13751 BcDNA:RH09719 CDMC32068 4 18 24 DAC39-H16 10-CG13751-RA_2 CG13751 CCCAGCGGACTGTGTGTCATAGCAAAAGCTGAAATTTCTCGGGGGAAAAATGCCTGTTTTGGAGCACAT 69 FBan0013751 FBgn0033340 CG13751 2 2R CG13751 CG13751 BcDNA:RH09719 CDMC32069 4 19 24 DAC39-L04 4-CG13788-RD_1 CG13788 CCAACTGGATGTTGTTGGGTAATGATGTGCGACCCATTTACACAGCAATTGTGGCGTTCTACGTGCCCC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC32069 4 20 24 DAC39-L04 4-CG13788-RD_1 CG13788 CCAACTGGATGTTGTTGGGTAATGATGTGCGACCCATTTACACAGCAATTGTGGCGTTCTACGTGCCCC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC32070 4 21 24 DAC39-L16 15-CG13796-RB_2 CG13796 CCCGGTTGGGGCAGTATCATAACCTTGTCTAGCTACAACAACTTTCGCAGAGATGCCGAAAGACTGAGT 69 FBan0013796 FBgn0031939 CG13796 2 2L "amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0015187; ; GO:0003700; ; GO:0005328 integral to plasma membrane; GO:0005887; intracellular; GO:0005622; membrane; GO:0016020 CG13796 CG13796 "CG18590, CG18590, CT42497" CDMC32070 4 22 24 DAC39-L16 15-CG13796-RB_2 CG13796 CCCGGTTGGGGCAGTATCATAACCTTGTCTAGCTACAACAACTTTCGCAGAGATGCCGAAAGACTGAGT 69 FBan0013796 FBgn0031939 CG13796 2 2L "amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0015187; ; GO:0003700; ; GO:0005328 integral to plasma membrane; GO:0005887; intracellular; GO:0005622; membrane; GO:0016020 CG13796 CG13796 "CG18590, CG18590, CT42497" CDMC32071 4 23 24 DAC39-P04 11-CG13856-RA_1 CG13856 ACGACATCTAGCCCCAATCTGGATCATCGGAATCCGAGCAAAGTACTTCGAGTGCAACACCTCAAGGAT 69 FBan0013856 FBgn0038959 CG13856 3 3R CG13856 CG13856 CDMC32071 4 24 24 DAC39-P04 11-CG13856-RA_1 CG13856 ACGACATCTAGCCCCAATCTGGATCATCGGAATCCGAGCAAAGTACTTCGAGTGCAACACCTCAAGGAT 69 FBan0013856 FBgn0038959 CG13856 3 3R CG13856 CG13856 CDMC32072 4 25 24 DAC39-P16 1-CG13871-RA_1 CG13871 CCGACGACAACAGACGTATCAATCTGGAAGCCTTGAGCGTGGTAGTCAAGCCAATGTCCTCCTTTCCCA 69 FBan0013871 FBgn0034502 CG13871 2 2R CG13871 CG13871 CDMC32072 4 26 24 DAC39-P16 1-CG13871-RA_1 CG13871 CCGACGACAACAGACGTATCAATCTGGAAGCCTTGAGCGTGGTAGTCAAGCCAATGTCCTCCTTTCCCA 69 FBan0013871 FBgn0034502 CG13871 2 2R CG13871 CG13871 CDMC32073 4 1 25 DAC40-D04 6-CG14163-RA_3 CG14163 AGCGACATGTTCTCGCTGGGAATGGTGATCTGTGCGGTCTTCAATAACGGAAGGCCACTGATTCA 65 FBan0014163 FBgn0036060 CG14163 3 3L DNA methylation; GO:0006306; protein amino acid phosphorylation; GO:0006468 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003677 CG14163 CG14163 CDMC32073 4 2 25 DAC40-D04 6-CG14163-RA_3 CG14163 AGCGACATGTTCTCGCTGGGAATGGTGATCTGTGCGGTCTTCAATAACGGAAGGCCACTGATTCA 65 FBan0014163 FBgn0036060 CG14163 3 3L DNA methylation; GO:0006306; protein amino acid phosphorylation; GO:0006468 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003677 CG14163 CG14163 CDMC32074 4 3 25 DAC40-D16 20-CG14182-RA_1 CG14182 ACTGATGTGGACCTGCATGACGCTATATAACCGACCGCAAGTGTGCTATACACCCGAACTGCAGC 65 FBan0014182 FBgn0036922 CG14182 3 3L CG14182 CG14182 CDMC32074 4 4 25 DAC40-D16 20-CG14182-RA_1 CG14182 ACTGATGTGGACCTGCATGACGCTATATAACCGACCGCAAGTGTGCTATACACCCGAACTGCAGC 65 FBan0014182 FBgn0036922 CG14182 3 3L CG14182 CG14182 CDMC32075 4 5 25 DAC40-H04 1-CG14250-RA_2 CG14250 CACGCAACAACAGATTCCAGCTGCTGCGGATGAGTTCAGCAAGGAGTTCTACACCTACGCTGCAC 65 FBan0014250 FBgn0039448 CG14250 3 3R CG14250 CG14250 CDMC32075 4 6 25 DAC40-H04 1-CG14250-RA_2 CG14250 CACGCAACAACAGATTCCAGCTGCTGCGGATGAGTTCAGCAAGGAGTTCTACACCTACGCTGCAC 65 FBan0014250 FBgn0039448 CG14250 3 3R CG14250 CG14250 CDMC32076 4 7 25 DAC40-H16 15-CG14274-RA_1 CG14274 GTCCGCTCATGAATTGCCAAAAAGTTGTGGCCAAAGACCCTGATACAAGGAAAGTGGTGACGGCG 65 FBan0014274 FBgn0032023 CG14274 2 2L CG14274 CG14274 CDMC32076 4 8 25 DAC40-H16 15-CG14274-RA_1 CG14274 GTCCGCTCATGAATTGCCAAAAAGTTGTGGCCAAAGACCCTGATACAAGGAAAGTGGTGACGGCG 65 FBan0014274 FBgn0032023 CG14274 2 2L CG14274 CG14274 CDMC32077 4 9 25 DAC40-L04 23-CG14368-RA_1 CG14368 TTGGCACTAATTGAATGTAAATACACTTTTGCTTTGCTGTCAAGTCTTGTGTCTAGGCGACGTCG 65 FBan0014368 FBgn0038162 CG14368 3 3R CG14368 CG14368 CDMC32077 4 10 25 DAC40-L04 23-CG14368-RA_1 CG14368 TTGGCACTAATTGAATGTAAATACACTTTTGCTTTGCTGTCAAGTCTTGTGTCTAGGCGACGTCG 65 FBan0014368 FBgn0038162 CG14368 3 3R CG14368 CG14368 CDMC32078 4 11 25 DAC40-L16 2-CG14398-RA_1 CG14398 GAGAAGCCCCACGAAGAGAGATCCATCCTGGTGGACTTCCAACTGTGTCGATATAGCCCACCTGC 65 FBgn0032912 CDMC32078 4 12 25 DAC40-L16 2-CG14398-RA_1 CG14398 GAGAAGCCCCACGAAGAGAGATCCATCCTGGTGGACTTCCAACTGTGTCGATATAGCCCACCTGC 65 FBgn0032912 CDMC32079 4 13 25 DAC40-P04 5-CG14471-RB_1 CG14471 CCGCAACGCGTTGACCAAGTCTAGCTCACTAGACGCCATCTCACTTTCAGTAGCCATTTCGCCTG 65 FBan0014471 FBgn0033049 CG14471 2 2R CG14471 CG14471 CDMC32079 4 14 25 DAC40-P04 5-CG14471-RB_1 CG14471 CCGCAACGCGTTGACCAAGTCTAGCTCACTAGACGCCATCTCACTTTCAGTAGCCATTTCGCCTG 65 FBan0014471 FBgn0033049 CG14471 2 2R CG14471 CG14471 CDMC32080 4 15 25 DAC40-P16 3-CG14492-RA_2 CG14492 CTGCTCAATGTGACCACCGATGGCTGTCAGTTACTCGCGAATCGCAATCAAGTGCCCCTTATGCG 65 FBan0014492 FBgn0034283 CG14492 2 2R CG14492 CG14492 CDMC32080 4 16 25 DAC40-P16 3-CG14492-RA_2 CG14492 CTGCTCAATGTGACCACCGATGGCTGTCAGTTACTCGCGAATCGCAATCAAGTGCCCCTTATGCG 65 FBan0014492 FBgn0034283 CG14492 2 2R CG14492 CG14492 CDMC32081 4 17 25 DAC41-D04 AutoBlank AutoBlank CDMC32081 4 18 25 DAC41-D04 AutoBlank AutoBlank CDMC32082 4 19 25 DAC41-D16 AutoBlank AutoBlank CDMC32082 4 20 25 DAC41-D16 AutoBlank AutoBlank CDMC32083 4 21 25 DAC41-H04 AutoBlank AutoBlank CDMC32083 4 22 25 DAC41-H04 AutoBlank AutoBlank CDMC32084 4 23 25 DAC41-H16 AutoBlank AutoBlank CDMC32084 4 24 25 DAC41-H16 AutoBlank AutoBlank CDMC32085 4 25 25 DAC41-L04 AutoBlank AutoBlank CDMC32085 4 26 25 DAC41-L04 AutoBlank AutoBlank CDMC32086 4 1 26 DAC41-L16 AutoBlank AutoBlank CDMC32086 4 2 26 DAC41-L16 AutoBlank AutoBlank CDMC32087 4 3 26 DAC41-P04 AutoBlank AutoBlank CDMC32087 4 4 26 DAC41-P04 AutoBlank AutoBlank CDMC32088 4 5 26 DAC41-P16 AutoBlank AutoBlank CDMC32088 4 6 26 DAC41-P16 AutoBlank AutoBlank CDMC32089 4 7 26 DAC42-D04 150mM NaPO4 Blank CDMC32089 4 8 26 DAC42-D04 150mM NaPO4 Blank CDMC32090 4 9 26 DAC42-D16 150mM NaPO4 Blank CDMC32090 4 10 26 DAC42-D16 150mM NaPO4 Blank CDMC32091 4 11 26 DAC42-H04 150mM NaPO4 Blank CDMC32091 4 12 26 DAC42-H04 150mM NaPO4 Blank CDMC32092 4 13 26 DAC42-H16 150mM NaPO4 Blank CDMC32092 4 14 26 DAC42-H16 150mM NaPO4 Blank CDMC32093 4 15 26 DAC42-L04 150mM NaPO4 Blank CDMC32093 4 16 26 DAC42-L04 150mM NaPO4 Blank CDMC32094 4 17 26 DAC42-L16 5uM MSP 5uM MSP CDMC32094 4 18 26 DAC42-L16 5uM MSP 5uM MSP CDMC32095 4 19 26 DAC42-P04 10uM MSP 10uM MSP CDMC32095 4 20 26 DAC42-P04 10uM MSP 10uM MSP CDMC32096 4 21 26 DAC42-P16 20uM MSP 20uM MSP CDMC32096 4 22 26 DAC42-P16 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC32097 1 1 1 DAC01-A03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32097 1 2 1 DAC01-A03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32098 1 3 1 DAC01-A15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32098 1 4 1 DAC01-A15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32099 1 5 1 DAC01-E03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32099 1 6 1 DAC01-E03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32100 1 7 1 DAC01-E15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32100 1 8 1 DAC01-E15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32101 1 9 1 DAC01-I03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32101 1 10 1 DAC01-I03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32102 1 11 1 DAC01-I15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32102 1 12 1 DAC01-I15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32103 1 13 1 DAC01-M03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32103 1 14 1 DAC01-M03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32104 1 15 1 DAC01-M15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32104 1 16 1 DAC01-M15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32105 1 17 1 DAC02-A03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32105 1 18 1 DAC02-A03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32106 1 19 1 DAC02-A15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32106 1 20 1 DAC02-A15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32107 1 21 1 DAC02-E03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32107 1 22 1 DAC02-E03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32108 1 23 1 DAC02-E15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32108 1 24 1 DAC02-E15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32109 1 25 1 DAC02-I03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32109 1 26 1 DAC02-I03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32110 1 1 2 DAC02-I15 N/A CG9075 (01435-01673) CDMC32110 1 2 2 DAC02-I15 N/A CG9075 (01435-01673) CDMC32111 1 3 2 DAC02-M03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32111 1 4 2 DAC02-M03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32112 1 5 2 DAC02-M15 AutoBlank AutoBlank CDMC32112 1 6 2 DAC02-M15 AutoBlank AutoBlank CDMC32113 1 7 2 DAC03-A03 3-CG17078-RA_6 CG17078 ACCCGAACGATTCGACGGTCTCTAATGACGAAACCATGTCACTGTCCAGCGTAACGCCATCAAGTGCAA 69 FBan0017078 FBgn0031243 CG17078 2 2L CG17078 CG17078 CDMC32113 1 8 2 DAC03-A03 3-CG17078-RA_6 CG17078 ACCCGAACGATTCGACGGTCTCTAATGACGAAACCATGTCACTGTCCAGCGTAACGCCATCAAGTGCAA 69 FBan0017078 FBgn0031243 CG17078 2 2L CG17078 CG17078 CDMC32114 1 9 2 DAC03-A15 23-CG1708-RA_7 CG1708 GCTACTTAAGATACTCGCAAGACAAACCGTACACAAAACTCGCTCAAAGTGTTGACCTAAGTCTCCGCA 69 FBan0001708 FBgn0000352 cos 2 2R activation of hh target transcription factor; GO:0007228; microtubule-based movement; GO:0007018; negative regulation of smoothened signaling pathway; GO:0045879; negative regulation of transcription factor import into nucleus; GO:0042992; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of smoothened signaling pathway; GO:0045880; protein targeting; GO:0006605; regulation of proteolysis; GO:0030162; smoothened signaling pathway; GO:0007224 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; protein binding; GO:0005515; ; GO:0003777; smoothened binding; GO:0005119; protein kinase binding; GO:0019901; ; GO:0005515; ; GO:0019901; ; GO:0005119 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; plasma membrane; GO:0005886; vesicle membrane; GO:0012506 cos costa "CG1708, CG1708, l(2)cos[[2]], cos-2, costal-2, l(2)161/28, cos2: costal-2, Cos[2], Cos2, cos22, Costal2, COS[2], Costal-2, Cos-2, costal2, costal 2, Costal 2, COSTAL2, l(2)k16101, l(2)k16128, Enhancer of Epaulette, cos2" CDMC32114 1 10 2 DAC03-A15 23-CG1708-RA_7 CG1708 GCTACTTAAGATACTCGCAAGACAAACCGTACACAAAACTCGCTCAAAGTGTTGACCTAAGTCTCCGCA 69 FBan0001708 FBgn0000352 cos 2 2R activation of hh target transcription factor; GO:0007228; microtubule-based movement; GO:0007018; negative regulation of smoothened signaling pathway; GO:0045879; negative regulation of transcription factor import into nucleus; GO:0042992; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of smoothened signaling pathway; GO:0045880; protein targeting; GO:0006605; regulation of proteolysis; GO:0030162; smoothened signaling pathway; GO:0007224 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003774; protein binding; GO:0005515; ; GO:0003777; smoothened binding; GO:0005119; protein kinase binding; GO:0019901; ; GO:0005515; ; GO:0019901; ; GO:0005119 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; plasma membrane; GO:0005886; vesicle membrane; GO:0012506 cos costa "CG1708, CG1708, l(2)cos[[2]], cos-2, costal-2, l(2)161/28, cos2: costal-2, Cos[2], Cos2, cos22, Costal2, COS[2], Costal-2, Cos-2, costal2, costal 2, Costal 2, COSTAL2, l(2)k16101, l(2)k16128, Enhancer of Epaulette, cos2" CDMC32115 1 11 2 DAC03-E03 23-CG17137-RA_3 CG17137 GCTAATCGAGGCTGTTGAAAAGTAGACAAAAAATTTCGAAATTAGTCGGGCCATATATACCATACCACC 69 FBgn0032308 CDMC32115 1 12 2 DAC03-E03 23-CG17137-RA_3 CG17137 GCTAATCGAGGCTGTTGAAAAGTAGACAAAAAATTTCGAAATTAGTCGGGCCATATATACCATACCACC 69 FBgn0032308 CDMC32116 1 13 2 DAC03-E15 3-CG17150-RA_4 CG17150 TCGGGTCCCCTTAAGTCCCACTCGCTTGAATTCCATAGAGTATGTCTCCAGTTTCCCGTTGAGTCCCCA 69 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC32116 1 14 2 DAC03-E15 3-CG17150-RA_4 CG17150 TCGGGTCCCCTTAAGTCCCACTCGCTTGAATTCCATAGAGTATGTCTCCAGTTTCCCGTTGAGTCCCCA 69 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC32117 1 15 2 DAC03-I03 18-CG17186-RA_5 CG17186 CGCAGACATGCCAGAGAACGGAAACACTGACGATAGAGGCTCTAGATTTCATCTACGAGGACGAAATGG 69 FBan0017186 FBgn0038741 CG17186 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17186 CG17186 CDMC32117 1 16 2 DAC03-I03 18-CG17186-RA_5 CG17186 CGCAGACATGCCAGAGAACGGAAACACTGACGATAGAGGCTCTAGATTTCATCTACGAGGACGAAATGG 69 FBan0017186 FBgn0038741 CG17186 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17186 CG17186 CDMC32118 1 17 2 DAC03-I15 9-CG17198-RA_1 CG17198 CGGCCATCGGTAGCGCAGTGGCCTTATTTGATAACTTCATGTTGGCCCATAAGCACGGTGTTGGATTTT 69 FBan0017198 FBgn0039366 CG17198 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17198 CG17198 CDMC32118 1 18 2 DAC03-I15 9-CG17198-RA_1 CG17198 CGGCCATCGGTAGCGCAGTGGCCTTATTTGATAACTTCATGTTGGCCCATAAGCACGGTGTTGGATTTT 69 FBan0017198 FBgn0039366 CG17198 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17198 CG17198 CDMC32119 1 19 2 DAC03-M03 7-CG17233-RC_1 CG17233 GCGCTTCCGGGAGGTCATGCAGTAAAAGCCATTGTTACCAGGACCCATTATCAGTATCAGGAGGTCTCC 69 FBan0017233 FBgn0036958 CG17233 3 3L CG17233 CG17233 CG6918 CDMC32119 1 20 2 DAC03-M03 7-CG17233-RC_1 CG17233 GCGCTTCCGGGAGGTCATGCAGTAAAAGCCATTGTTACCAGGACCCATTATCAGTATCAGGAGGTCTCC 69 FBan0017233 FBgn0036958 CG17233 3 3L CG17233 CG17233 CG6918 CDMC32120 1 21 2 DAC03-M15 11-CG17246-RA_1 CG17246 TCGTGGGTGTGCAATGACAACGGAGACATTACGCTGGACTACAGAAACGTGATCGATACCACGCTGGAC 69 FBan0017246 FBgn0017539 Scs-fp 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; ; GO:0004776 ; EC:6.2.1.4; ; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 respiratory chain complex II (sensu Eukaryota); GO:0005749 Scs-fp Succinyl coenzyme A synthetase flavoprotein subunit "CG17246, succinate dehydrogenase flavoprotein subunit, scs-fp" CDMC32120 1 22 2 DAC03-M15 11-CG17246-RA_1 CG17246 TCGTGGGTGTGCAATGACAACGGAGACATTACGCTGGACTACAGAAACGTGATCGATACCACGCTGGAC 69 FBan0017246 FBgn0017539 Scs-fp 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; ; GO:0004776 ; EC:6.2.1.4; ; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 respiratory chain complex II (sensu Eukaryota); GO:0005749 Scs-fp Succinyl coenzyme A synthetase flavoprotein subunit "CG17246, succinate dehydrogenase flavoprotein subunit, scs-fp" CDMC32121 1 23 2 DAC04-A03 1-CG15864-RA_1 CG15864 GAGGAGTTGTCGACCAAGCAGAACTGCGCTGTTGTGGTCCAAAAACCAAGTCGACTCCACTGTCG 65 FBan0015864 FBgn0040528 CG15864 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG15864 CG15864 CG7553 CDMC32121 1 24 2 DAC04-A03 1-CG15864-RA_1 CG15864 GAGGAGTTGTCGACCAAGCAGAACTGCGCTGTTGTGGTCCAAAAACCAAGTCGACTCCACTGTCG 65 FBan0015864 FBgn0040528 CG15864 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG15864 CG15864 CG7553 CDMC32122 1 25 2 DAC04-A15 6-CG15877-RA_1 CG15877 AGCTCGTCCGGAGAACGCTTATGCAGTGGTTACAGTGCGCCAAAAGAAGAAACAGAAGCACCAGC 65 FBan0015877 FBgn0035337 CG15877 3 3L CG15877 CG15877 CDMC32122 1 26 2 DAC04-A15 6-CG15877-RA_1 CG15877 AGCTCGTCCGGAGAACGCTTATGCAGTGGTTACAGTGCGCCAAAAGAAGAAACAGAAGCACCAGC 65 FBan0015877 FBgn0035337 CG15877 3 3L CG15877 CG15877 CDMC32123 1 1 3 DAC04-E03 3-CG16710-RA_1 CG16710 GAACGCGGACGAGTGCTCATTGAGTGAACCATCCTTGGGATTGGACAAGGAGACCCACATATGCG 65 FBan0016710 FBgn0039101 CG16710 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004263 ; EC:3.4.21.1 CG16710 CG16710 SP16 CDMC32123 1 2 3 DAC04-E03 3-CG16710-RA_1 CG16710 GAACGCGGACGAGTGCTCATTGAGTGAACCATCCTTGGGATTGGACAAGGAGACCCACATATGCG 65 FBan0016710 FBgn0039101 CG16710 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004263 ; EC:3.4.21.1 CG16710 CG16710 SP16 CDMC32124 1 3 3 DAC04-E15 3-CG16762-RA_2 CG16762 GATCGGTTTATTGGTTTTGTCTCCTGCGGAGGGTATCAGCCGACCATTGCCTCCATACGTGGGTC 65 FBan0016762 FBgn0035343 CG16762 3 3L CG16762 CG16762 CDMC32124 1 4 3 DAC04-E15 3-CG16762-RA_2 CG16762 GATCGGTTTATTGGTTTTGTCTCCTGCGGAGGGTATCAGCCGACCATTGCCTCCATACGTGGGTC 65 FBan0016762 FBgn0035343 CG16762 3 3L CG16762 CG16762 CDMC32125 1 5 3 DAC04-I03 6-CG16874-RA_1 CG16874 ATCACTTAGTTCATCATGCAGATCGTTGCTCTCACCCTCGTTGCGTTTGTGGCCATTGCCGGTGC 65 FBan0016874 FBgn0014076 Vm32E 2 2L vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm32E Vitelline membrane 32E "CG16874, CG16874, VMP32E, VM32E, Vm32Ec, Vm3, Vm32Ea" CDMC32125 1 6 3 DAC04-I03 6-CG16874-RA_1 CG16874 ATCACTTAGTTCATCATGCAGATCGTTGCTCTCACCCTCGTTGCGTTTGTGGCCATTGCCGGTGC 65 FBan0016874 FBgn0014076 Vm32E 2 2L vitelline membrane formation (sensu Insecta); GO:0007305 structural constituent of vitelline membrane (sensu Insecta); GO:0008316; ; GO:0008316 Vm32E Vitelline membrane 32E "CG16874, CG16874, VMP32E, VM32E, Vm32Ec, Vm3, Vm32Ea" CDMC32126 1 7 3 DAC04-I15 2-CG16912-RA_1 CG16912 TTCAGGGTGCTACTATGGTGAACCTGTTGACCGAGCCAGGAATGTCCATCCTAGAGCTCGCCATG 65 FBan0016912 FBgn0035064 CG16912 2 2R protein biosynthesis; GO:0006412; tRNA aminoacylation for protein translation; GO:0006418; tyrosyl-tRNA aminoacylation; GO:0006437 ATP binding; GO:0005524; ; GO:0005524; tyrosine-tRNA ligase activity; GO:0004831 ; EC:6.1.1.1; ; GO:0004831 ; EC:6.1.1.1; ; GO:0004831 ; EC:6.1.1.1 mitochondrion; GO:0005739 CG16912 CG16912 "anon-EST:fe1E12, anon-fast-evolving-1E12" CDMC32126 1 8 3 DAC04-I15 2-CG16912-RA_1 CG16912 TTCAGGGTGCTACTATGGTGAACCTGTTGACCGAGCCAGGAATGTCCATCCTAGAGCTCGCCATG 65 FBan0016912 FBgn0035064 CG16912 2 2R protein biosynthesis; GO:0006412; tRNA aminoacylation for protein translation; GO:0006418; tyrosyl-tRNA aminoacylation; GO:0006437 ATP binding; GO:0005524; ; GO:0005524; tyrosine-tRNA ligase activity; GO:0004831 ; EC:6.1.1.1; ; GO:0004831 ; EC:6.1.1.1; ; GO:0004831 ; EC:6.1.1.1 mitochondrion; GO:0005739 CG16912 CG16912 "anon-EST:fe1E12, anon-fast-evolving-1E12" CDMC32127 1 9 3 DAC04-M03 3-CG17085-RA_2 CG17085 ACTTTCGCCGGGAATGTGAGCGATGATGGCGTCTGCCCGCAGTTGGATTGCATAACCATATTGAG 65 FBan0017085 FBgn0032309 CG17085 2 2L CG17085 CG17085 CDMC32127 1 10 3 DAC04-M03 3-CG17085-RA_2 CG17085 ACTTTCGCCGGGAATGTGAGCGATGATGGCGTCTGCCCGCAGTTGGATTGCATAACCATATTGAG 65 FBan0017085 FBgn0032309 CG17085 2 2L CG17085 CG17085 CDMC32128 1 11 3 DAC04-M15 23-CG17136-RB_4 CG17136 TACTTGGCTCAATGTGTCTCCCAAATGGAACAATGGATCACTTGACTCCAAAAATTGGGTACTTT 65 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC32128 1 12 3 DAC04-M15 23-CG17136-RB_4 CG17136 TACTTGGCTCAATGTGTCTCCCAAATGGAACAATGGATCACTTGACTCCAAAAATTGGGTACTTT 65 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC32129 1 13 3 DAC05-A03 14-CG10128-RC_4 CG10128 TTGACTGGCAGTTTGGAAAAAAGGTTCAACTGTCATAGGGCCCTTTCATTTGGATTTGCCCCCTCAGC 68 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC32129 1 14 3 DAC05-A03 14-CG10128-RC_4 CG10128 TTGACTGGCAGTTTGGAAAAAAGGTTCAACTGTCATAGGGCCCTTTCATTTGGATTTGCCCCCTCAGC 68 FBan0010128 FBgn0003742 tra2 2 2R "RNA splicing; GO:0008380; female sex determination; GO:0030237; female somatic sex determination; GO:0019101; mRNA processing; GO:0006397; male somatic sex determination; GO:0019102; regulation of nuclear mRNA splicing, via spliceosome; GO:0048024; reproduction; GO:0000003; sex determination; GO:0007530; spermatogenesis; GO:0007283; spliceosome assembly; GO:0000245" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 tra2 transformer 2 "CG10128, tra-2, Tra2, TRA-2, Tra-2, transformer-2" CDMC32130 1 15 3 DAC05-A15 23-CG10253-RA_2 CG10253 GTTCGGGTCTCCAGTTCTTTTGTAGCGGGCTCATGTTTTCTATGGGTTTTGATAAATAAATGGAGTAT 68 FBan0010253 FBgn0033983 CG10253 2 2R carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; ether lipid biosynthesis; GO:0008611 alkylglycerone-phosphate synthase activity; GO:0008609 ; EC:2.5.1.26; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008609 ; EC:2.5.1.26 peroxisome; GO:0005777 CG10253 CG10253 CDMC32130 1 16 3 DAC05-A15 23-CG10253-RA_2 CG10253 GTTCGGGTCTCCAGTTCTTTTGTAGCGGGCTCATGTTTTCTATGGGTTTTGATAAATAAATGGAGTAT 68 FBan0010253 FBgn0033983 CG10253 2 2R carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; ether lipid biosynthesis; GO:0008611 alkylglycerone-phosphate synthase activity; GO:0008609 ; EC:2.5.1.26; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008609 ; EC:2.5.1.26 peroxisome; GO:0005777 CG10253 CG10253 CDMC32131 1 17 3 DAC05-E03 2-CG1071-RA_1 CG1071 TGGCAGCGCAATTGACATTCGCCTGGTGACGAACCAAGGAAAGAGTACTACAAATCCGCACGATGTGG 68 FBan0001071 FBgn0024371 E2f2 2 2L DNA endoreduplication; GO:0042023; G1/S transition of mitotic cell cycle; GO:0000082; endomitotic cell cycle; GO:0007113; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; regulation of progression through cell cycle; GO:0000074; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0005515; ; GO:0016564; ; GO:0003700 Myb complex; GO:0031523; chromatin; GO:0000785; nucleus; GO:0005634; transcription factor complex; GO:0005667 E2f2 E2F transcription factor 2 "CG1071, dE2F-2, dE2F2, de2f2, E2F, E2F2, dE2f2, E2F transcription factor 2" CDMC32131 1 18 3 DAC05-E03 2-CG1071-RA_1 CG1071 TGGCAGCGCAATTGACATTCGCCTGGTGACGAACCAAGGAAAGAGTACTACAAATCCGCACGATGTGG 68 FBan0001071 FBgn0024371 E2f2 2 2L DNA endoreduplication; GO:0042023; G1/S transition of mitotic cell cycle; GO:0000082; endomitotic cell cycle; GO:0007113; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; regulation of progression through cell cycle; GO:0000074; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 protein binding; GO:0005515; transcriptional repressor activity; GO:0016564; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0005515; ; GO:0016564; ; GO:0003700 Myb complex; GO:0031523; chromatin; GO:0000785; nucleus; GO:0005634; transcription factor complex; GO:0005667 E2f2 E2F transcription factor 2 "CG1071, dE2F-2, dE2F2, de2f2, E2F, E2F2, dE2f2, E2F transcription factor 2" CDMC32132 1 19 3 DAC05-E15 3-CG10955-RA_1 CG10955 AGTGGCCGAAATTGTGGGAGTGGTTGAGACGGGGAAGATCTACAGTCTGGGCACTACACGAACCAATC 68 FBan0010955 FBgn0034722 CG10955 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" CG10955 CG10955 CDMC32132 1 20 3 DAC05-E15 3-CG10955-RA_1 CG10955 AGTGGCCGAAATTGTGGGAGTGGTTGAGACGGGGAAGATCTACAGTCTGGGCACTACACGAACCAATC 68 FBan0010955 FBgn0034722 CG10955 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367" CG10955 CG10955 CDMC32133 1 21 3 DAC05-I03 3-CG1121-RA_6 CG1121 TCGAGCCCTATTTGACTCCTCATTGTGTGATTCCCAAGTCGCCACTGGAAATGATGCGGGACTGTTGG 68 FBan0001121 FBgn0015576 alpha-Est8 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est8 alpha-Esterase-8 "CG1121, alphaE8, I: Intensifier of Bar, fragment I, aE8, I" CDMC32133 1 22 3 DAC05-I03 3-CG1121-RA_6 CG1121 TCGAGCCCTATTTGACTCCTCATTGTGTGATTCCCAAGTCGCCACTGGAAATGATGCGGGACTGTTGG 68 FBan0001121 FBgn0015576 alpha-Est8 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 alpha-Est8 alpha-Esterase-8 "CG1121, alphaE8, I: Intensifier of Bar, fragment I, aE8, I" CDMC32134 1 23 3 DAC05-I15 2-CG11331-RA_3 CG11331 AAAGCAAAGACCCGAGGAAGATCGAGACGCAGAAGCTTAGGGAAGCACAGATGACAAAGATGGGCGGA 68 FBan0011331 FBgn0028990 Spn27A 2 2L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; melanization defense response; GO:0035006; melanotic encapsulation of foreign target; GO:0035011; negative regulation of melanization defense response; GO:0035009; response to pest, pathogen or parasite; GO:0009613; response to wounding; GO:0009611" serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; enzyme inhibitor activity; GO:0004857; ; GO:0004857 Spn27A Serpin-27A "CG11331, CG11331, CG11331, CG11331, EST1, spn27A, Serpin27A, serpin-27A, serpin27A, Serpin-27A" CDMC32134 1 24 3 DAC05-I15 2-CG11331-RA_3 CG11331 AAAGCAAAGACCCGAGGAAGATCGAGACGCAGAAGCTTAGGGAAGCACAGATGACAAAGATGGGCGGA 68 FBan0011331 FBgn0028990 Spn27A 2 2L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; melanization defense response; GO:0035006; melanotic encapsulation of foreign target; GO:0035011; negative regulation of melanization defense response; GO:0035009; response to pest, pathogen or parasite; GO:0009613; response to wounding; GO:0009611" serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; enzyme inhibitor activity; GO:0004857; ; GO:0004857 Spn27A Serpin-27A "CG11331, CG11331, CG11331, CG11331, EST1, spn27A, Serpin27A, serpin-27A, serpin27A, Serpin-27A" CDMC32135 1 25 3 DAC05-M03 3-CG11836-RB_4 CG11836 CCCACGGGTGTTAATCAATATCCTTGGATGGCACGAATCGTGTACGACGGCAAGTTCCATTGCGGAGG 68 FBan0011836 FBgn0039272 CG11836 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11836 CG11836 SP23 CDMC32135 1 26 3 DAC05-M03 3-CG11836-RB_4 CG11836 CCCACGGGTGTTAATCAATATCCTTGGATGGCACGAATCGTGTACGACGGCAAGTTCCATTGCGGAGG 68 FBan0011836 FBgn0039272 CG11836 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11836 CG11836 SP23 CDMC32136 1 1 4 DAC05-M15 23-CG12056-RA_1 CG12056 AGGGCCGGGATTTGTAAATAGTAATTAGTGCATTTGGATCAATAAATTATTAGGTGGAGTTAACATGG 68 FBan0012056 FBgn0030099 CG12056 X X CG12056 CG12056 CDMC32136 1 2 4 DAC05-M15 23-CG12056-RA_1 CG12056 AGGGCCGGGATTTGTAAATAGTAATTAGTGCATTTGGATCAATAAATTATTAGGTGGAGTTAACATGG 68 FBan0012056 FBgn0030099 CG12056 X X CG12056 CG12056 CDMC32137 1 3 4 DAC06-A03 23-CG32975-RA_4 CG32975 CTATGGTCGTTGACAGACTGTGCCTTATCATATTCACAATGTTCACAATATTAGCCACAATAGCTGTAC 69 FBan0032975 FBgn0028875 nAcRalpha-34E 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-34E nicotinic Acetylcholine Receptor alpha 34E "CG32975, CG16878, CG4498, BG:DS05899.4, BG:DS05899.5, CT14633, Dalpha5, nAChR, anon-WO02059370.44" CDMC32137 1 4 4 DAC06-A03 23-CG32975-RA_4 CG32975 CTATGGTCGTTGACAGACTGTGCCTTATCATATTCACAATGTTCACAATATTAGCCACAATAGCTGTAC 69 FBan0032975 FBgn0028875 nAcRalpha-34E 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-34E nicotinic Acetylcholine Receptor alpha 34E "CG32975, CG16878, CG4498, BG:DS05899.4, BG:DS05899.5, CT14633, Dalpha5, nAChR, anon-WO02059370.44" CDMC32138 1 5 4 DAC06-A15 3-CG32988-RA_2 CG32988 GCATTGACCTTGTTATGCTGGGGATTGGTGCTGGGATCCTTGTTCTTTCTCACCCTGTTCGGAGCGTAT 69 FBan0032988 FBgn0052988 CG32988 2 2L CG32988 CG32988 CG18663 CDMC32138 1 6 4 DAC06-A15 3-CG32988-RA_2 CG32988 GCATTGACCTTGTTATGCTGGGGATTGGTGCTGGGATCCTTGTTCTTTCTCACCCTGTTCGGAGCGTAT 69 FBan0032988 FBgn0052988 CG32988 2 2L CG32988 CG32988 CG18663 CDMC32139 1 7 4 DAC06-E03 1-CG3304-RB_1 CG3304 CGTCTGTATGTGTCACAGAACTACGTCTGCTTCCACGCGAACATCTTCAGTTGGGAGACCCACGTGAGC 69 FBan0003304 FBgn0031527 CG3304 2 2L CG3304 CG3304 BcDNA:RE58243 CDMC32139 1 8 4 DAC06-E03 1-CG3304-RB_1 CG3304 CGTCTGTATGTGTCACAGAACTACGTCTGCTTCCACGCGAACATCTTCAGTTGGGAGACCCACGTGAGC 69 FBan0003304 FBgn0031527 CG3304 2 2L CG3304 CG3304 BcDNA:RE58243 CDMC32140 1 9 4 DAC06-E15 2-CG33060-RA_1 CG33060 GGTCGGAAGAATTTCAGGCCAAAGAATGTCCCCGAACGAAAAGCTTCAAGCCACCAGAAGAGAGGCGAA 69 FBan0033060 FBgn0053060 CG33060 3 3L CG33060 CG33060 "CG13057, CG13057, CG13057" CDMC32140 1 10 4 DAC06-E15 2-CG33060-RA_1 CG33060 GGTCGGAAGAATTTCAGGCCAAAGAATGTCCCCGAACGAAAAGCTTCAAGCCACCAGAAGAGAGGCGAA 69 FBan0033060 FBgn0053060 CG33060 3 3L CG33060 CG33060 "CG13057, CG13057, CG13057" CDMC32141 1 11 4 DAC06-I03 13-CG33096-RA_1 CG33096 CCGAACCCGAAGTCTGAACCCAAAAACTCCGTTAGTCCTTTGTTGATGGTAATCGTGCATTTGAGGCGA 69 FBan0033096 FBgn0053096 CG33096 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG33096 CG33096 CG11935 CDMC32141 1 12 4 DAC06-I03 13-CG33096-RA_1 CG33096 CCGAACCCGAAGTCTGAACCCAAAAACTCCGTTAGTCCTTTGTTGATGGTAATCGTGCATTTGAGGCGA 69 FBan0033096 FBgn0053096 CG33096 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG33096 CG33096 CG11935 CDMC32142 1 13 4 DAC06-I15 11-CG33101-RA_1 CG33101 TGGCCCAGTTGAGTGATTTCCCATTCGTTAAGGTCTGCTCCCCGGAAGATATGGTAGGATTTACGGAGT 69 FBan0033101 FBgn0013998 Nsf2 3 3R ER to Golgi transport; GO:0006888; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082; vesicle-mediated transport; GO:0016192 ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 cytoplasm; GO:0005737 Nsf2 NEM-sensitive fusion protein 2 "CG9931, CG33101, CG9931, CG9931, dNSF-2, NSF2, dNSF, dNSF2, NSF-2, dNsf2, DmNSF2, dnsf2, NEM-sensitive fusion protein 2" CDMC32142 1 14 4 DAC06-I15 11-CG33101-RA_1 CG33101 TGGCCCAGTTGAGTGATTTCCCATTCGTTAAGGTCTGCTCCCCGGAAGATATGGTAGGATTTACGGAGT 69 FBan0033101 FBgn0013998 Nsf2 3 3R ER to Golgi transport; GO:0006888; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082; vesicle-mediated transport; GO:0016192 ATP binding; GO:0005524; ; GO:0005524; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 cytoplasm; GO:0005737 Nsf2 NEM-sensitive fusion protein 2 "CG9931, CG33101, CG9931, CG9931, dNSF-2, NSF2, dNSF, dNSF2, NSF-2, dNsf2, DmNSF2, dnsf2, NEM-sensitive fusion protein 2" CDMC32143 1 15 4 DAC06-M03 23-CG33126-RA_12 CG33126 TTCTAAGCCAGAAGTAGAACGGATACCAAGTTCAGTGGATAGCGACCGTATCTCCCAGTATATTCCAGA 69 FBan0033126 FBgn0053126 NLaz 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 binding; GO:0005488; carrier activity; GO:0005386; ; GO:0005488; ; GO:0005386; lipid binding; GO:0008289; ; GO:0008289 extracellular space; GO:0005615 NLaz Neural Lazarillo "CG33126, CG16933, CT33980, BcDNA:RE67583, Neural Lazarillo" CDMC32143 1 16 4 DAC06-M03 23-CG33126-RA_12 CG33126 TTCTAAGCCAGAAGTAGAACGGATACCAAGTTCAGTGGATAGCGACCGTATCTCCCAGTATATTCCAGA 69 FBan0033126 FBgn0053126 NLaz 2 2L lipid metabolism; GO:0006629; lipid transport; GO:0006869 binding; GO:0005488; carrier activity; GO:0005386; ; GO:0005488; ; GO:0005386; lipid binding; GO:0008289; ; GO:0008289 extracellular space; GO:0005615 NLaz Neural Lazarillo "CG33126, CG16933, CT33980, BcDNA:RE67583, Neural Lazarillo" CDMC32144 1 17 4 DAC06-M15 2-CG33133-RA_2 CG33133 GGGCATCAAAACAGAGCGACAGTCACCCGACATGGAACTCCTCTTTGAGGATGCCAACAATGAACAGGA 69 FBan0033133 FBgn0001133 grau 2 2R cellularization; GO:0007349; egg activation; GO:0007343; female meiosis; GO:0007143; homologous chromosome segregation; GO:0045143; pole cell formation; GO:0007279; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 grau grauzone "CG3282, CG33133, CG3282" CDMC32144 1 18 4 DAC06-M15 2-CG33133-RA_2 CG33133 GGGCATCAAAACAGAGCGACAGTCACCCGACATGGAACTCCTCTTTGAGGATGCCAACAATGAACAGGA 69 FBan0033133 FBgn0001133 grau 2 2R cellularization; GO:0007349; egg activation; GO:0007343; female meiosis; GO:0007143; homologous chromosome segregation; GO:0045143; pole cell formation; GO:0007279; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 grau grauzone "CG3282, CG33133, CG3282" CDMC32145 1 19 4 DAC07-A03 22-CG5778-RA_1 CG5778 GCTACGATGATGGCGGTCTTACGCAGATTATAAGCGGCTGAGATTATAATCTCGAAGCTTTGCTAGCGC 69 FBan0005778 FBgn0038930 CG5778 3 3R CG5778 CG5778 "CT18134, BcDNA:GH13168" CDMC32145 1 20 4 DAC07-A03 22-CG5778-RA_1 CG5778 GCTACGATGATGGCGGTCTTACGCAGATTATAAGCGGCTGAGATTATAATCTCGAAGCTTTGCTAGCGC 69 FBan0005778 FBgn0038930 CG5778 3 3R CG5778 CG5778 "CT18134, BcDNA:GH13168" CDMC32146 1 21 4 DAC07-A15 5-CG5788-RA_1 CG5788 CCGGCGGCTGAACGAGAGTATTACATATCCGGAAGACAAAACCATCGATTTGCAGCTCACACAAGGGCA 69 FBan0005788 FBgn0026316 UbcD10 2 2R protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD10 Ubiquitin conjugating enzyme 10 "CG5788, ubc, ubcD10, EG:52C10.4" CDMC32146 1 22 4 DAC07-A15 5-CG5788-RA_1 CG5788 CCGGCGGCTGAACGAGAGTATTACATATCCGGAAGACAAAACCATCGATTTGCAGCTCACACAAGGGCA 69 FBan0005788 FBgn0026316 UbcD10 2 2R protein metabolism; GO:0019538; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 UbcD10 Ubiquitin conjugating enzyme 10 "CG5788, ubc, ubcD10, EG:52C10.4" CDMC32147 1 23 4 DAC07-E03 5-CG5814-RA_1 CG5814 CGTGGACATCGACGCTTATCTACTACACCGGCTATCAATTGGCGGACTTTGCTGAAATTGTGACCGCGC 69 FBan0005814 FBgn0015625 CycB3 3 3R cytokinesis after mitosis; GO:0000281; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 microtubule cytoskeleton; GO:0015630; nucleus; GO:0005634 CycB3 CycB3 "CG5814, cyclin B3, l(3)L6540, cycB3, Cyclin B3, anon-WO0118547.414" CDMC32147 1 24 4 DAC07-E03 5-CG5814-RA_1 CG5814 CGTGGACATCGACGCTTATCTACTACACCGGCTATCAATTGGCGGACTTTGCTGAAATTGTGACCGCGC 69 FBan0005814 FBgn0015625 CycB3 3 3R cytokinesis after mitosis; GO:0000281; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 microtubule cytoskeleton; GO:0015630; nucleus; GO:0005634 CycB3 CycB3 "CG5814, cyclin B3, l(3)L6540, cycB3, Cyclin B3, anon-WO0118547.414" CDMC32148 1 25 4 DAC07-E15 6-CG5835-RA_1 CG5835 ACGGTGGGCTTCAATTGGACCTGGTTTCGGTTTAAAGTGCACACTCACCACACAATTCAGACGAGACGA 69 FBan0005835 FBgn0038682 CG5835 3 3R CG5835 CG5835 CDMC32148 1 26 4 DAC07-E15 6-CG5835-RA_1 CG5835 ACGGTGGGCTTCAATTGGACCTGGTTTCGGTTTAAAGTGCACACTCACCACACAATTCAGACGAGACGA 69 FBan0005835 FBgn0038682 CG5835 3 3R CG5835 CG5835 CDMC32149 1 1 5 DAC07-I03 14-CG5866-RA_3 CG5866 AGCGAAGGTTCCCCAGAAAGGATATCTGCCTGTCGAAGATGCTTCAGTGCATCAAATCGTTCCTAACGA 69 FBan0005866 FBgn0038508 CG5866 3 3R CG5866 CG5866 CDMC32149 1 2 5 DAC07-I03 14-CG5866-RA_3 CG5866 AGCGAAGGTTCCCCAGAAAGGATATCTGCCTGTCGAAGATGCTTCAGTGCATCAAATCGTTCCTAACGA 69 FBan0005866 FBgn0038508 CG5866 3 3R CG5866 CG5866 CDMC32150 1 3 5 DAC07-I15 23-CG5874-RA_1 CG5874 AATTGCTGTCGAGTAAAAAGTGTGTAATTATCTTACCAAGCAGCATAAAATTTAGAGACGCTGATCGGC 69 FBan0005874 FBgn0038872 CG5874 3 3R "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 CG5874 CG5874 BcDNA:SD07139 CDMC32150 1 4 5 DAC07-I15 23-CG5874-RA_1 CG5874 AATTGCTGTCGAGTAAAAAGTGTGTAATTATCTTACCAAGCAGCATAAAATTTAGAGACGCTGATCGGC 69 FBan0005874 FBgn0038872 CG5874 3 3R "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 CG5874 CG5874 BcDNA:SD07139 CDMC32151 1 5 5 DAC07-M03 3-CG5916-RA_1 CG5916 GCCCTGGCCAATCTATTCCGGGATACCATGATCCAGGACAACATTGTGACGGACTGTCATGGCTTTGTT 69 FBan0005916 FBgn0038401 CG5916 3 3R cytoskeleton organization and biogenesis; GO:0007010 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG5916 CG5916 CDMC32151 1 6 5 DAC07-M03 3-CG5916-RA_1 CG5916 GCCCTGGCCAATCTATTCCGGGATACCATGATCCAGGACAACATTGTGACGGACTGTCATGGCTTTGTT 69 FBan0005916 FBgn0038401 CG5916 3 3R cytoskeleton organization and biogenesis; GO:0007010 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG5916 CG5916 CDMC32152 1 7 5 DAC07-M15 14-CG5924-RA_6 CG5924 ACGATGTGATGCACGTGATCATTGACAATCTGCAATTTATGATGGGCGTGTCCACATTTCGAGGCGACA 69 FBan0005924 FBgn0032154 CG5924 2 2L CG5924 CG5924 CDMC32152 1 8 5 DAC07-M15 14-CG5924-RA_6 CG5924 ACGATGTGATGCACGTGATCATTGACAATCTGCAATTTATGATGGGCGTGTCCACATTTCGAGGCGACA 69 FBan0005924 FBgn0032154 CG5924 2 2L CG5924 CG5924 CDMC32153 1 9 5 DAC08-A03 23-CG8210-RA_2 CG8210 TTGCTTTACACCCTGTAAACAACTATCCATAGATTCAGTGCTTCGCCTTTGTTCTTATCGTGTATTTAA 69 FBan0008210 FBgn0010426 Vha14 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha14 Vacuolar H[+] ATPase 14kD subunit "CG8210, vha14, F subunit, ATPase, V-ATPase 14kD subunit, V-ATPase" CDMC32153 1 10 5 DAC08-A03 23-CG8210-RA_2 CG8210 TTGCTTTACACCCTGTAAACAACTATCCATAGATTCAGTGCTTCGCCTTTGTTCTTATCGTGTATTTAA 69 FBan0008210 FBgn0010426 Vha14 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha14 Vacuolar H[+] ATPase 14kD subunit "CG8210, vha14, F subunit, ATPase, V-ATPase 14kD subunit, V-ATPase" CDMC32154 1 11 5 DAC08-A15 9-CG8226-RA_7 CG8226 TATCCGAGGGAGTTAAGGATCGTTTGGGATTTGTGGTTGGAGTCGTCCAGACTGGATTCCACTGGGGAT 69 FBan0008226 FBgn0033357 Tom7 2 2R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742 Tom7 Translocase of outer membrane 7 "CG8226, CG8226, dtom7, BcDNA:AT23266, Translocase of outer membrane 7" CDMC32154 1 12 5 DAC08-A15 9-CG8226-RA_7 CG8226 TATCCGAGGGAGTTAAGGATCGTTTGGGATTTGTGGTTGGAGTCGTCCAGACTGGATTCCACTGGGGAT 69 FBan0008226 FBgn0033357 Tom7 2 2R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial outer membrane translocase complex; GO:0005742 Tom7 Translocase of outer membrane 7 "CG8226, CG8226, dtom7, BcDNA:AT23266, Translocase of outer membrane 7" CDMC32155 1 13 5 DAC08-E03 8-CG8268-RA_1 CG8268 TGCCGTCGAGAACATGTACTTGGCCAATCCACAGAACTGTCGACTTACCATGAAATACGCGCACTCCAA 69 FBan0008268 FBgn0035827 CG8268 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614; negative regulation of translational elongation; GO:0045900 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0003729; ; GO:0008312; receptor activity; GO:0004872; ; GO:0004872 signal recognition particle (sensu Eukaryota); GO:0005786 CG8268 CG8268 CDMC32155 1 14 5 DAC08-E03 8-CG8268-RA_1 CG8268 TGCCGTCGAGAACATGTACTTGGCCAATCCACAGAACTGTCGACTTACCATGAAATACGCGCACTCCAA 69 FBan0008268 FBgn0035827 CG8268 3 3L SRP-dependent cotranslational protein targeting to membrane; GO:0006614; negative regulation of translational elongation; GO:0045900 mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; ; GO:0003729; ; GO:0008312; receptor activity; GO:0004872; ; GO:0004872 signal recognition particle (sensu Eukaryota); GO:0005786 CG8268 CG8268 CDMC32156 1 15 5 DAC08-E15 12-CG8280-RA_1 CG8280 CCCAAGGATAAGAGTGCACACTGGGAAAACACTTGCATTTATGCATCCACTCCTCATCCACTTCCCCGT 69 FBan0008280 FBgn0000556 Ef1alpha48D 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0003924; ; GO:0003747; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1alpha48D Elongation factor 1alpha48D "CG8280, CG8280, CG8280, CG8280, CG8280, F1, DmEF1, EF-1alpha, EF-1a, l(2)k07303, F1 EF-1alpha, EF-1alpha F1, EF-1, EF-1[a], Ef1a10, 1275, EF-1alphaF[[1]], EF-1alphaF, clone 1.17, clone 2.46, EF1-alpha, EF1alpha, l(2)1275, elongation factor 1-alpha F1, Dm0084, EF-1alphaF1, eEF1alpha, EF, Translational elongation factor1, EF1alpha48D, Ef1alpha48E, Ef1alpha48D, ef-1alpha, Ef1alpha1, anon-EST:Liang-1.17, anon-EST:Liang-2.46, l(2)01275" CDMC32156 1 16 5 DAC08-E15 12-CG8280-RA_1 CG8280 CCCAAGGATAAGAGTGCACACTGGGAAAACACTTGCATTTATGCATCCACTCCTCATCCACTTCCCCGT 69 FBan0008280 FBgn0000556 Ef1alpha48D 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; GTPase activity; GO:0003924; ; GO:0003746; ; GO:0003924; ; GO:0003747; ; GO:0005525 cytoplasm; GO:0005737; cytosol; GO:0005829; eukaryotic translation elongation factor 1 complex; GO:0005853 Ef1alpha48D Elongation factor 1alpha48D "CG8280, CG8280, CG8280, CG8280, CG8280, F1, DmEF1, EF-1alpha, EF-1a, l(2)k07303, F1 EF-1alpha, EF-1alpha F1, EF-1, EF-1[a], Ef1a10, 1275, EF-1alphaF[[1]], EF-1alphaF, clone 1.17, clone 2.46, EF1-alpha, EF1alpha, l(2)1275, elongation factor 1-alpha F1, Dm0084, EF-1alphaF1, eEF1alpha, EF, Translational elongation factor1, EF1alpha48D, Ef1alpha48E, Ef1alpha48D, ef-1alpha, Ef1alpha1, anon-EST:Liang-1.17, anon-EST:Liang-2.46, l(2)01275" CDMC32157 1 17 5 DAC08-I03 9-CG8314-RA_1 CG8314 CCGCCGGCCACTATATTCCTGCTGCTTTTTCTCACCTTTGAGGGCCTTATGTTCGGCATATTCACCATC 69 FBan0008314 FBgn0034057 CG8314 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG8314 CG8314 anon-WO0118547.93 CDMC32157 1 18 5 DAC08-I03 9-CG8314-RA_1 CG8314 CCGCCGGCCACTATATTCCTGCTGCTTTTTCTCACCTTTGAGGGCCTTATGTTCGGCATATTCACCATC 69 FBan0008314 FBgn0034057 CG8314 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG8314 CG8314 anon-WO0118547.93 CDMC32158 1 19 5 DAC08-I15 3-CG8322-RB_1 CG8322 GAACGAGAGGCTGATGATTGAGTTCATTGAGGGGGATTTTCGGCGGCCTACCACTGAGGTTTTGGTGAC 69 FBan0008322 FBgn0020236 ATPCL 2 2R acetyl-CoA biosynthesis; GO:0006085; citrate metabolism; GO:0006101; tricarboxylic acid cycle; GO:0006099 ATP citrate synthase activity; GO:0003878 ; EC:2.3.3.8; ; GO:0003878 ; EC:2.3.3.8; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0003878 ; EC:2.3.3.8; ; GO:0003878 ; EC:2.3.3.8 cytoplasm; GO:0005737 ATPCL ATP citrate lyase "CG8322, CG8322, DmATPCL, ATP citrate lyase, l(2)01466, n(2)k09217, l(2)k09217, BcDNA:LD21334, anon-WO0140519.179" CDMC32158 1 20 5 DAC08-I15 3-CG8322-RB_1 CG8322 GAACGAGAGGCTGATGATTGAGTTCATTGAGGGGGATTTTCGGCGGCCTACCACTGAGGTTTTGGTGAC 69 FBan0008322 FBgn0020236 ATPCL 2 2R acetyl-CoA biosynthesis; GO:0006085; citrate metabolism; GO:0006101; tricarboxylic acid cycle; GO:0006099 ATP citrate synthase activity; GO:0003878 ; EC:2.3.3.8; ; GO:0003878 ; EC:2.3.3.8; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.-; ; GO:0003878 ; EC:2.3.3.8; ; GO:0003878 ; EC:2.3.3.8 cytoplasm; GO:0005737 ATPCL ATP citrate lyase "CG8322, CG8322, DmATPCL, ATP citrate lyase, l(2)01466, n(2)k09217, l(2)k09217, BcDNA:LD21334, anon-WO0140519.179" CDMC32159 1 21 5 DAC08-M03 3-CG8363-RC_1 CG8363 GCGCCAGTAGAATGGCCTTCTTCGAGCCCAAGAGGAAGGATGAGTTTGAGTTCATCTCGGGAACCAAGA 69 FBan0008363 FBgn0020389 Paps 3 3L amino acid biosynthesis; GO:0008652; sulfate assimilation; GO:0000103; sulfur metabolism; GO:0006790 ATP binding; GO:0005524; ; GO:0005524; adenylylsulfate kinase activity; GO:0004020 ; EC:2.7.1.25; sulfate adenylyltransferase (ATP) activity; GO:0004781 ; EC:2.7.7.4; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004781 ; EC:2.7.7.4; ; GO:0004781 ; EC:2.7.7.4; ; GO:0004020 ; EC:2.7.1.25; ; GO:0004020 ; EC:2.7.1.25 Paps PAPS synthetase "CG8363, CG8363, DmPAPSS, paps synthetase, PAPS, PAPS synthetase" CDMC32159 1 22 5 DAC08-M03 3-CG8363-RC_1 CG8363 GCGCCAGTAGAATGGCCTTCTTCGAGCCCAAGAGGAAGGATGAGTTTGAGTTCATCTCGGGAACCAAGA 69 FBan0008363 FBgn0020389 Paps 3 3L amino acid biosynthesis; GO:0008652; sulfate assimilation; GO:0000103; sulfur metabolism; GO:0006790 ATP binding; GO:0005524; ; GO:0005524; adenylylsulfate kinase activity; GO:0004020 ; EC:2.7.1.25; sulfate adenylyltransferase (ATP) activity; GO:0004781 ; EC:2.7.7.4; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004781 ; EC:2.7.7.4; ; GO:0004781 ; EC:2.7.7.4; ; GO:0004020 ; EC:2.7.1.25; ; GO:0004020 ; EC:2.7.1.25 Paps PAPS synthetase "CG8363, CG8363, DmPAPSS, paps synthetase, PAPS, PAPS synthetase" CDMC32160 1 23 5 DAC08-M15 12-CG8374-RA_4 CG8374 CCTGGGCGAATCACATTCGAAGCAAACCGACATCAGATATATGTTGTGCTCCACTATGATTGCGCCGCC 69 FBan0008374 FBgn0016792 dmt 3 3R peripheral nervous system development; GO:0007422 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 dmt dalmatian "CG8374, 0481/03, s048103, anon-WO0118547.317, dalmatian" CDMC32160 1 24 5 DAC08-M15 12-CG8374-RA_4 CG8374 CCTGGGCGAATCACATTCGAAGCAAACCGACATCAGATATATGTTGTGCTCCACTATGATTGCGCCGCC 69 FBan0008374 FBgn0016792 dmt 3 3R peripheral nervous system development; GO:0007422 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 dmt dalmatian "CG8374, 0481/03, s048103, anon-WO0118547.317, dalmatian" CDMC32161 1 25 5 DAC09-A04 13-CG12802-RA_1 CG12802 CGACGCTACCAAGGATGAGGTGATTGTCAAGATCACAACAGTTGGAAATGAGGTGAGTGGGCACATCCT 69 FBan0012802 FBgn0037767 CG12802 3 3R CG12802 CG12802 BcDNA:RE66512 CDMC32161 1 26 5 DAC09-A04 13-CG12802-RA_1 CG12802 CGACGCTACCAAGGATGAGGTGATTGTCAAGATCACAACAGTTGGAAATGAGGTGAGTGGGCACATCCT 69 FBan0012802 FBgn0037767 CG12802 3 3R CG12802 CG12802 BcDNA:RE66512 CDMC32162 1 1 6 DAC09-A16 12-CG12814-RA_3 CG12814 GCGTGTGCACAAGACCCTGGAATTGGCGGACGATAAGTTTTATGTGATTACCTGTGGCAAATCGGGCTA 69 FBan0012814 FBgn0037796 CG12814 3 3R CG12814 CG12814 CDMC32162 1 2 6 DAC09-A16 12-CG12814-RA_3 CG12814 GCGTGTGCACAAGACCCTGGAATTGGCGGACGATAAGTTTTATGTGATTACCTGTGGCAAATCGGGCTA 69 FBan0012814 FBgn0037796 CG12814 3 3R CG12814 CG12814 CDMC32163 1 3 6 DAC09-E04 2-CG12851-RA_2 CG12851 CGACGCACGATGATGGTGACTTCTTCTACCACGACAACGGTGATCAGCTTCAACGGCAGTGATCCTGAG 69 FBan0012851 FBgn0035086 CG12851 2 2R CG12851 CG12851 CDMC32163 1 4 6 DAC09-E04 2-CG12851-RA_2 CG12851 CGACGCACGATGATGGTGACTTCTTCTACCACGACAACGGTGATCAGCTTCAACGGCAGTGATCCTGAG 69 FBan0012851 FBgn0035086 CG12851 2 2R CG12851 CG12851 CDMC32164 1 5 6 DAC09-E16 8-CG12860-RA_2 CG12860 CCCCCCCGGGATCGAAGACATTCTCATACGGATGGCGTCAGTGATAAGTGCGCGAAGAACAAAAAAGAT 69 FBan0012860 FBgn0033954 CG12860 2 2R CG12860 CG12860 "bs33f06.y1, anon-WO0140519.75" CDMC32164 1 6 6 DAC09-E16 8-CG12860-RA_2 CG12860 CCCCCCCGGGATCGAAGACATTCTCATACGGATGGCGTCAGTGATAAGTGCGCGAAGAACAAAAAAGAT 69 FBan0012860 FBgn0033954 CG12860 2 2R CG12860 CG12860 "bs33f06.y1, anon-WO0140519.75" CDMC32165 1 7 6 DAC09-I04 23-CG12901-RA_3 CG12901 AATTTCTCCTCTAGTTAGTCCAAAACGTACTAGTAGACATGAGCAAAACTCCAACGTCGACGATGCAAT 69 FBan0012901 FBgn0033513 CG12901 2 2R CG12901 CG12901 CDMC32165 1 8 6 DAC09-I04 23-CG12901-RA_3 CG12901 AATTTCTCCTCTAGTTAGTCCAAAACGTACTAGTAGACATGAGCAAAACTCCAACGTCGACGATGCAAT 69 FBan0012901 FBgn0033513 CG12901 2 2R CG12901 CG12901 CDMC32166 1 9 6 DAC09-I16 2-CG12911-RA_2 CG12911 ACGTGTGCCAGGTGCTAAAATTGTGATCGATTCGGTGGAGCCATTTGAAGAGGGAACACCATGAGTGCT 69 FBan0012911 FBgn0033501 CG12911 2 2R CG12911 CG12911 CDMC32166 1 10 6 DAC09-I16 2-CG12911-RA_2 CG12911 ACGTGTGCCAGGTGCTAAAATTGTGATCGATTCGGTGGAGCCATTTGAAGAGGGAACACCATGAGTGCT 69 FBan0012911 FBgn0033501 CG12911 2 2R CG12911 CG12911 CDMC32167 1 11 6 DAC09-M04 18-CG12958-RA_1 CG12958 GTCAATGAGCTTCAAGAAGATTTGTCCATGAAGAAGTTCGACCTGCGAGCCAAGCAGATCCATTTGGCG 69 FBan0012958 FBgn0034018 CG12958 2 2R CG12958 CG12958 CDMC32167 1 12 6 DAC09-M04 18-CG12958-RA_1 CG12958 GTCAATGAGCTTCAAGAAGATTTGTCCATGAAGAAGTTCGACCTGCGAGCCAAGCAGATCCATTTGGCG 69 FBan0012958 FBgn0034018 CG12958 2 2R CG12958 CG12958 CDMC32168 1 13 6 DAC09-M16 1-CG12975-RA_1 CG12975 CCGGAGACAGGTCGTGTGTTTCCCATCAGCGATGGTATACCAAACATGCTCCTTAACGAGGACGAGGTC 69 FBan0012975 FBgn0037061 CG12975 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG12975 CG12975 BcDNA:RE57810 CDMC32168 1 14 6 DAC09-M16 1-CG12975-RA_1 CG12975 CCGGAGACAGGTCGTGTGTTTCCCATCAGCGATGGTATACCAAACATGCTCCTTAACGAGGACGAGGTC 69 FBan0012975 FBgn0037061 CG12975 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG12975 CG12975 BcDNA:RE57810 CDMC32169 1 15 6 DAC10-A03 1-CG10927-RA_1 CG10927 GCAGCGTGCTCATATGTCCCAGCTCAGAGATCGGAGTGTCTCAAAGCCTGGAACAACACCTTGAACAGT 69 FBan0010927 FBgn0034360 CG10927 2 2R CG10927 CG10927 CDMC32169 1 16 6 DAC10-A03 1-CG10927-RA_1 CG10927 GCAGCGTGCTCATATGTCCCAGCTCAGAGATCGGAGTGTCTCAAAGCCTGGAACAACACCTTGAACAGT 69 FBan0010927 FBgn0034360 CG10927 2 2R CG10927 CG10927 CDMC32170 1 17 6 DAC10-A15 23-CG10943-RA_11 CG10943 AAAGTCTCAGATAGGCGACAATGATGTAAAGCTAAAGGACAAACAAGATCTTATAGCAACACTCGAAGC 69 FBan0010943 FBgn0036320 CG10943 3 3L CG10943 CG10943 CDMC32170 1 18 6 DAC10-A15 23-CG10943-RA_11 CG10943 AAAGTCTCAGATAGGCGACAATGATGTAAAGCTAAAGGACAAACAAGATCTTATAGCAACACTCGAAGC 69 FBan0010943 FBgn0036320 CG10943 3 3L CG10943 CG10943 CDMC32171 1 19 6 DAC10-E03 17-CG10975-RA_1 CG10975 CCGCGATACTGGGCAGATGATGAGGTTCAATACGATCACATACTCGTGAAATACGTGCACAGCGAAAGT 69 FBan0010975 FBgn0014007 Ptp69D 3 3L axon guidance; GO:0007411; axonal defasciculation; GO:0007414; defasciculation of motor neuron; GO:0007415; motor axon guidance; GO:0008045; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor signaling protein tyrosine phosphatase activity; GO:0004728; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp69D Protein tyrosine phosphatase 69D "CG10975, CG10975, DPTP, DPTP69D, dptp69D, ptp69D, PTP69D, R-PTP 69D, CT30751, PTPase, Dptp69D, Ptp69d, Ptp" CDMC32171 1 20 6 DAC10-E03 17-CG10975-RA_1 CG10975 CCGCGATACTGGGCAGATGATGAGGTTCAATACGATCACATACTCGTGAAATACGTGCACAGCGAAAGT 69 FBan0010975 FBgn0014007 Ptp69D 3 3L axon guidance; GO:0007411; axonal defasciculation; GO:0007414; defasciculation of motor neuron; GO:0007415; motor axon guidance; GO:0008045; protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor signaling protein tyrosine phosphatase activity; GO:0004728; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp69D Protein tyrosine phosphatase 69D "CG10975, CG10975, DPTP, DPTP69D, dptp69D, ptp69D, PTP69D, R-PTP 69D, CT30751, PTPase, Dptp69D, Ptp69d, Ptp" CDMC32172 1 21 6 DAC10-E15 23-CG1098-RA_1 CG1098 TTAACATGATGTGCAGCGTTAAAATCAAAGAGGATAGCAATGACATAACCATGACAATACTGCTGCGCA 69 FBan0001098 FBgn0027497 Madm 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- Madm MLF1-adaptor molecule "CG1098, CG1098, dMADM, anon-WO0118547.406, BcDNA:LD28657, MLF1-adaptor molecule" CDMC32172 1 22 6 DAC10-E15 23-CG1098-RA_1 CG1098 TTAACATGATGTGCAGCGTTAAAATCAAAGAGGATAGCAATGACATAACCATGACAATACTGCTGCGCA 69 FBan0001098 FBgn0027497 Madm 3 3R intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- Madm MLF1-adaptor molecule "CG1098, CG1098, dMADM, anon-WO0118547.406, BcDNA:LD28657, MLF1-adaptor molecule" CDMC32173 1 23 6 DAC10-I03 16-CG11037-RA_1 CG11037 ACCACAAATGCCAAGTTGGGAGGATACCTAACAGCCTTGCTTTATGAAGACGATTTTGTTTGTGGCGGT 69 FBan0011037 FBgn0037038 CG11037 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11037 CG11037 SP191 CDMC32173 1 24 6 DAC10-I03 16-CG11037-RA_1 CG11037 ACCACAAATGCCAAGTTGGGAGGATACCTAACAGCCTTGCTTTATGAAGACGATTTTGTTTGTGGCGGT 69 FBan0011037 FBgn0037038 CG11037 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11037 CG11037 SP191 CDMC32174 1 25 6 DAC10-I15 3-CG11049-RA_1 CG11049 AGTGGCATGGTAATTCGGCTACCGTAGAAGCCTTGTGCGTACACAATGCGTGGTTTTCTTGGCCTTTGT 69 FBan0011049 FBgn0005561 sv 4 4 cell proliferation; GO:0008283; cone cell fate commitment (sensu Endopterygota); GO:0007466; ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; nervous system development; GO:0007399; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; metallopeptidase activity; GO:0008237; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 sv shaven "CG11049, spa, sparkling, Cat, dPax258, D-Pax2, DPax-2, Sparkling, Dpax-2, Pax2, spa-sv, pax2/sparkling, en(lz)4G/I, dPax2, D-pax2, shaven/sparkling, d-Pax2, PAX2, Pax2/5/8, Dpax2, Pax258, l(4)40, pol: poliert, Cataract, poliert" CDMC32174 1 26 6 DAC10-I15 3-CG11049-RA_1 CG11049 AGTGGCATGGTAATTCGGCTACCGTAGAAGCCTTGTGCGTACACAATGCGTGGTTTTCTTGGCCTTTGT 69 FBan0011049 FBgn0005561 sv 4 4 cell proliferation; GO:0008283; cone cell fate commitment (sensu Endopterygota); GO:0007466; ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; nervous system development; GO:0007399; proteolysis; GO:0006508; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; metallopeptidase activity; GO:0008237; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 sv shaven "CG11049, spa, sparkling, Cat, dPax258, D-Pax2, DPax-2, Sparkling, Dpax-2, Pax2, spa-sv, pax2/sparkling, en(lz)4G/I, dPax2, D-pax2, shaven/sparkling, d-Pax2, PAX2, Pax2/5/8, Dpax2, Pax258, l(4)40, pol: poliert, Cataract, poliert" CDMC32175 1 1 7 DAC10-M03 23-CG11081-RD_1 CG11081 GTATCGAAAATGGGTAGATCGCTATTATAGAGACATTCGGGATATGTCCCCCATTTCAGATCAGGACAT 69 FBan0011081 FBgn0025741 plexA 4 4 axon guidance; GO:0007411; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 axon guidance receptor activity; GO:0008046; semaphorin receptor activity; GO:0017154; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004714 ; EC:2.7.1.-; ; GO:0008046; ; GO:0017154; ; GO:0004867; ; GO:0017154 membrane; GO:0016020 plexA plexin A "CG11081, CG11081, PlexA, D-Plex A, plexin, plexin-A, DPlexA, PlexA1, Plex1, Plexin A, BcDNA:GM05237" CDMC32175 1 2 7 DAC10-M03 23-CG11081-RD_1 CG11081 GTATCGAAAATGGGTAGATCGCTATTATAGAGACATTCGGGATATGTCCCCCATTTCAGATCAGGACAT 69 FBan0011081 FBgn0025741 plexA 4 4 axon guidance; GO:0007411; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 axon guidance receptor activity; GO:0008046; semaphorin receptor activity; GO:0017154; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004714 ; EC:2.7.1.-; ; GO:0008046; ; GO:0017154; ; GO:0004867; ; GO:0017154 membrane; GO:0016020 plexA plexin A "CG11081, CG11081, PlexA, D-Plex A, plexin, plexin-A, DPlexA, PlexA1, Plex1, Plexin A, BcDNA:GM05237" CDMC32176 1 3 7 DAC10-M15 23-CG11094-RA_12 CG11094 TCCCCGAAAAACGTTTCTAATTGATCTCAAGCAACTGAAATAAACAAGCATAAAACAGTGAACTAAGCC 69 FBan0011094 FBgn0000504 dsx 3 3R "behavior; GO:0007610; central nervous system development; GO:0007417; courtship behavior; GO:0007619; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; female sex differentiation; GO:0046660; female somatic sex determination; GO:0019101; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; male analia morphogenesis (sensu Endopterygota); GO:0045496; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), song production; GO:0045433; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; male sex differentiation; GO:0046661; male somatic sex determination; GO:0019102; negative regulation of pigmentation; GO:0048086; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nuclear mRNA splicing, via spliceosome; GO:0000398; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of imaginal disc growth; GO:0045570; regulation of transcription; GO:0045449; sex comb development; GO:0045498; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; somatic sex determination; GO:0018993; spermatogenesis; GO:0007283; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; zinc ion binding; GO:0008270; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003704; ; GO:0003702; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0008270 nucleus; GO:0005634 dsx doublesex "CG11094, Dmdsx, Dsx, Hr: Hermaphrodite, ix-62c: intersex-62c, Hermaphrodite, intersex-62c" CDMC32176 1 4 7 DAC10-M15 23-CG11094-RA_12 CG11094 TCCCCGAAAAACGTTTCTAATTGATCTCAAGCAACTGAAATAAACAAGCATAAAACAGTGAACTAAGCC 69 FBan0011094 FBgn0000504 dsx 3 3R "behavior; GO:0007610; central nervous system development; GO:0007417; courtship behavior; GO:0007619; female analia morphogenesis (sensu Endopterygota); GO:0045497; female genitalia morphogenesis (sensu Endopterygota); GO:0007486; female sex differentiation; GO:0046660; female somatic sex determination; GO:0019101; genital disc development; GO:0035215; genital disc morphogenesis; GO:0007483; genital disc sexually dimorphic development; GO:0035263; male analia morphogenesis (sensu Endopterygota); GO:0045496; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), song production; GO:0045433; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; male sex differentiation; GO:0046661; male somatic sex determination; GO:0019102; negative regulation of pigmentation; GO:0048086; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transcription, DNA-dependent; GO:0045892; nuclear mRNA splicing, via spliceosome; GO:0000398; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of imaginal disc growth; GO:0045570; regulation of transcription; GO:0045449; sex comb development; GO:0045498; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; somatic sex determination; GO:0018993; spermatogenesis; GO:0007283; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; zinc ion binding; GO:0008270; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003704; ; GO:0003702; ; GO:0003700; ; GO:0003704; ; GO:0030528; ; GO:0008270 nucleus; GO:0005634 dsx doublesex "CG11094, Dmdsx, Dsx, Hr: Hermaphrodite, ix-62c: intersex-62c, Hermaphrodite, intersex-62c" CDMC32177 1 5 7 DAC11-A03 9-CG12161-RA_1 CG12161 CCACGCATTATGTTCAACGGCTTACCAACCTTGATGAAATACCCAGACCGATCGCCTTTTCTGTGCGGT 69 FBan0012161 FBgn0037296 CG12161 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG12161 CG12161 CDMC32177 1 6 7 DAC11-A03 9-CG12161-RA_1 CG12161 CCACGCATTATGTTCAACGGCTTACCAACCTTGATGAAATACCCAGACCGATCGCCTTTTCTGTGCGGT 69 FBan0012161 FBgn0037296 CG12161 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 CG12161 CG12161 CDMC32178 1 7 7 DAC11-A15 3-CG12176-RA_2 CG12176 TCACCCGAAAATCGTTGCACTTTCCGCGCACTGAGATGAAACGGGATGATAAGACCTGGAGCGAGTGTA 69 FBan0012176 FBgn0030506 Lig4 X X DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 nucleus; GO:0005634 Lig4 Ligase4 "CG12176, RE37186, ligase4, Ligase IV, lig4, ligase IV, Ligase4" CDMC32178 1 8 7 DAC11-A15 3-CG12176-RA_2 CG12176 TCACCCGAAAATCGTTGCACTTTCCGCGCACTGAGATGAAACGGGATGATAAGACCTGGAGCGAGTGTA 69 FBan0012176 FBgn0030506 Lig4 X X DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 nucleus; GO:0005634 Lig4 Ligase4 "CG12176, RE37186, ligase4, Ligase IV, lig4, ligase IV, Ligase4" CDMC32179 1 9 7 DAC11-E03 6-CG12217-RA_1 CG12217 GCGGAGCGTGTGATACCCAAGCAGAACACAACGCCCTACTTCCTGTAAAACGTTCTGATGTGATGCGAT 69 FBan0012217 FBgn0003139 PpV X X protein amino acid dephosphorylation; GO:0006470; regulation of progression through cell cycle; GO:0000074 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737 PpV Protein phosphatase V "CG12217, CG12217, PPV, PPV 6A, PPPV6A" CDMC32179 1 10 7 DAC11-E03 6-CG12217-RA_1 CG12217 GCGGAGCGTGTGATACCCAAGCAGAACACAACGCCCTACTTCCTGTAAAACGTTCTGATGTGATGCGAT 69 FBan0012217 FBgn0003139 PpV X X protein amino acid dephosphorylation; GO:0006470; regulation of progression through cell cycle; GO:0000074 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737 PpV Protein phosphatase V "CG12217, CG12217, PPV, PPV 6A, PPPV6A" CDMC32180 1 11 7 DAC11-E15 3-CG12224-RA_1 CG12224 CGGATTTGGTGTTACCAATCCTGCAATTGCATCACGGTCACGAACTAGGCCTCAACCTAGCCAGACTGG 69 FBan0012224 FBgn0037974 CG12224 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12224 CG12224 CDMC32180 1 12 7 DAC11-E15 3-CG12224-RA_1 CG12224 CGGATTTGGTGTTACCAATCCTGCAATTGCATCACGGTCACGAACTAGGCCTCAACCTAGCCAGACTGG 69 FBan0012224 FBgn0037974 CG12224 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12224 CG12224 CDMC32181 1 13 7 DAC11-I03 23-CG12262-RA_5 CG12262 GGGTCAAGCCTAAGTCAGTTTTAACTAGGATTCCTCATCTCCATTCACCTCATCAGTTGTCATGCTCAT 69 FBan0012262 FBgn0035811 CG12262 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG12262 CG12262 CDMC32181 1 14 7 DAC11-I03 23-CG12262-RA_5 CG12262 GGGTCAAGCCTAAGTCAGTTTTAACTAGGATTCCTCATCTCCATTCACCTCATCAGTTGTCATGCTCAT 69 FBan0012262 FBgn0035811 CG12262 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; fatty acid beta-oxidation; GO:0006635 acyl-CoA dehydrogenase activity; GO:0003995 ; EC:1.3.99.3; ; GO:0003995 ; EC:1.3.99.3 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG12262 CG12262 CDMC32182 1 15 7 DAC11-I15 1-CG1227-RA_1 CG1227 GGCCAACATCTGCCTGTCGGACTCTTTTGAGCCAATTATTGTGGATCTCGGGTCAATGACAGAAGCCCG 69 FBan0001227 FBgn0037491 CG1227 3 3R cell proliferation; GO:0008283; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG1227 CG1227 MPSK/PSK CDMC32182 1 16 7 DAC11-I15 1-CG1227-RA_1 CG1227 GGCCAACATCTGCCTGTCGGACTCTTTTGAGCCAATTATTGTGGATCTCGGGTCAATGACAGAAGCCCG 69 FBan0001227 FBgn0037491 CG1227 3 3R cell proliferation; GO:0008283; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG1227 CG1227 MPSK/PSK CDMC32183 1 17 7 DAC11-M03 23-CG12317-RA_3 CG12317 ATTTGAAACCGTTTTAAGTGCCGTTTGTATGATATTTTAGCATTGCTCATCACCAAAATTGGCGTCGAT 69 FBan0012317 FBgn0028425 JhI-21 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; L-amino acid transporter activity; GO:0015179; ; GO:0015171; ; GO:0015179; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 JhI-21 JhI-21 CG12317 CDMC32183 1 18 7 DAC11-M03 23-CG12317-RA_3 CG12317 ATTTGAAACCGTTTTAAGTGCCGTTTGTATGATATTTTAGCATTGCTCATCACCAAAATTGGCGTCGAT 69 FBan0012317 FBgn0028425 JhI-21 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; L-amino acid transporter activity; GO:0015179; ; GO:0015171; ; GO:0015179; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 JhI-21 JhI-21 CG12317 CDMC32184 1 19 7 DAC11-M15 15-CG12334-RA_2 CG12334 AGGCCGGCAGCTACATAAGACCTTCGTACCAAATCCAAAACGAAAACCCATTTTTCGCTCCGTTTCGAT 69 FBan0012334 FBgn0038539 Atg8b 3 3R cytoskeleton organization and biogenesis; GO:0007010 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 Atg8b Autophagy-specific gene 8b "CG12334, CG12334, ATG8b, Autophagy-specific gene 8b" CDMC32184 1 20 7 DAC11-M15 15-CG12334-RA_2 CG12334 AGGCCGGCAGCTACATAAGACCTTCGTACCAAATCCAAAACGAAAACCCATTTTTCGCTCCGTTTCGAT 69 FBan0012334 FBgn0038539 Atg8b 3 3R cytoskeleton organization and biogenesis; GO:0007010 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 Atg8b Autophagy-specific gene 8b "CG12334, CG12334, ATG8b, Autophagy-specific gene 8b" CDMC32185 1 21 7 DAC12-A03 12-CG7839-RA_1 CG7839 TGACGACTGGGGTGATGACGACTTGGCAGAAGATGAAGATGATGAAATTGAGGGCGAAGATCAGTCCGA 69 FBan0007839 FBgn0036124 CG7839 3 3L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7839 CG7839 "anon-EST:fe2H6, anon-fast-evolving-2H6" CDMC32185 1 22 7 DAC12-A03 12-CG7839-RA_1 CG7839 TGACGACTGGGGTGATGACGACTTGGCAGAAGATGAAGATGATGAAATTGAGGGCGAAGATCAGTCCGA 69 FBan0007839 FBgn0036124 CG7839 3 3L regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7839 CG7839 "anon-EST:fe2H6, anon-fast-evolving-2H6" CDMC32186 1 23 7 DAC12-A15 2-CG7850-RA_1 CG7850 AGGAGGCACCGGATAGCAGGATTAACCATGTGGCTAGCAATTTGACGAGGGACTGAGATAAGGTGCCTG 69 FBan0007850 FBgn0004210 puc 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; epidermis development; GO:0008544; establishment of planar polarity; GO:0001736; micropyle formation; GO:0046844; negative regulation of JNK cascade; GO:0046329; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360; response to oxidative stress; GO:0006979; suture of dorsal opening; GO:0007396; wound healing; GO:0042060 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; JUN kinase phosphatase activity; GO:0008579 ; EC:3.1.3.-; ; GO:0008579 ; EC:3.1.3.-; ; GO:0008579 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0008579 ; EC:3.1.3.- puc puckered "CG7850, CG7850, CG7850, l(3)84Eh, vco: velcro, hearty, hrt, Velcro, 0238/03, 1351/08, l(3)A251.1, PUC/MKP, PUC, velcro, vco, puckered" CDMC32186 1 24 7 DAC12-A15 2-CG7850-RA_1 CG7850 AGGAGGCACCGGATAGCAGGATTAACCATGTGGCTAGCAATTTGACGAGGGACTGAGATAAGGTGCCTG 69 FBan0007850 FBgn0004210 puc 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; determination of adult life span; GO:0008340; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; epidermis development; GO:0008544; establishment of planar polarity; GO:0001736; micropyle formation; GO:0046844; negative regulation of JNK cascade; GO:0046329; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360; response to oxidative stress; GO:0006979; suture of dorsal opening; GO:0007396; wound healing; GO:0042060 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; JUN kinase phosphatase activity; GO:0008579 ; EC:3.1.3.-; ; GO:0008579 ; EC:3.1.3.-; ; GO:0008579 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0008579 ; EC:3.1.3.- puc puckered "CG7850, CG7850, CG7850, l(3)84Eh, vco: velcro, hearty, hrt, Velcro, 0238/03, 1351/08, l(3)A251.1, PUC/MKP, PUC, velcro, vco, puckered" CDMC32187 1 25 7 DAC12-E03 3-CG7882-RA_3 CG7882 GCCTCGCATTCTACGGTCTTCTCGTGCTTGTGTGTTATGCACCTTTTAGGTGGTATCCTGAGAGCCCCA 69 FBan0007882 FBgn0033047 CG7882 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG7882 CG7882 CDMC32187 1 26 7 DAC12-E03 3-CG7882-RA_3 CG7882 GCCTCGCATTCTACGGTCTTCTCGTGCTTGTGTGTTATGCACCTTTTAGGTGGTATCCTGAGAGCCCCA 69 FBan0007882 FBgn0033047 CG7882 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG7882 CG7882 CDMC32188 1 1 8 DAC12-E15 23-CG7892-RB_4 CG7892 GCGTTTGTCTGTTTGAAAGTCAAAGCATTCCACCACCGAAATTAACTAAAACAAAACAAAAACAATTAT 69 FBan0007892 FBgn0011817 nmo 3 3L MAPKKK cascade; GO:0000165; anti-apoptosis; GO:0006916; cell proliferation; GO:0008283; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; gravitactic behavior; GO:0048062; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of frizzled signaling pathway; GO:0045810; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nmo nemo "CG7892, CG7892, CG7892, adk, adirondack, clone 2.43, NEMO, NEMO/NLK, Nemo, Nlk, anon-WO0118547.332, anon-WO0140519.256, anon-EST:Liang-2.43, anon-EST:Gibbs3, anon-WO0172774.138, nemo" CDMC32188 1 2 8 DAC12-E15 23-CG7892-RB_4 CG7892 GCGTTTGTCTGTTTGAAAGTCAAAGCATTCCACCACCGAAATTAACTAAAACAAAACAAAAACAATTAT 69 FBan0007892 FBgn0011817 nmo 3 3L MAPKKK cascade; GO:0000165; anti-apoptosis; GO:0006916; cell proliferation; GO:0008283; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; gravitactic behavior; GO:0048062; negative regulation of Wnt receptor signaling pathway; GO:0030178; negative regulation of frizzled signaling pathway; GO:0045810; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nmo nemo "CG7892, CG7892, CG7892, adk, adirondack, clone 2.43, NEMO, NEMO/NLK, Nemo, Nlk, anon-WO0118547.332, anon-WO0140519.256, anon-EST:Liang-2.43, anon-EST:Gibbs3, anon-WO0172774.138, nemo" CDMC32189 1 3 8 DAC12-I03 2-CG7923-RA_1 CG7923 CCGGAGTGCTTTACGAATCCGATGTCGAGACAGTAGACGGTGGATTGTCGACGGAGCTAAGCAATCGGA 69 FBan0007923 FBgn0029172 Fad2 3 3L cytokinesis; GO:0000910; fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 Fad2 Fad2 "CG7923, CG7923, fad, fad2" CDMC32189 1 4 8 DAC12-I03 2-CG7923-RA_1 CG7923 CCGGAGTGCTTTACGAATCCGATGTCGAGACAGTAGACGGTGGATTGTCGACGGAGCTAAGCAATCGGA 69 FBan0007923 FBgn0029172 Fad2 3 3L cytokinesis; GO:0000910; fatty acid biosynthesis; GO:0006633; fatty acid metabolism; GO:0006631 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 Fad2 Fad2 "CG7923, CG7923, fad, fad2" CDMC32190 1 5 8 DAC12-I15 23-CG7933-RC_1 CG7933 CCATGATTTTATTGGAAATGGCATTTAAAATTGAGAAATGCTCTGAAAGGCAGTTAGTCTGTAGCTTTG 69 FBan0007933 FBgn0001280 janA 3 3R sex differentiation; GO:0007548 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 janA janus A "CG7933, Y, Jan, jan A, jan, janus, BcDNA:AT12574" CDMC32190 1 6 8 DAC12-I15 23-CG7933-RC_1 CG7933 CCATGATTTTATTGGAAATGGCATTTAAAATTGAGAAATGCTCTGAAAGGCAGTTAGTCTGTAGCTTTG 69 FBan0007933 FBgn0001280 janA 3 3R sex differentiation; GO:0007548 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 janA janus A "CG7933, Y, Jan, jan A, jan, janus, BcDNA:AT12574" CDMC32191 1 7 8 DAC12-M03 3-CG7967-RA_2 CG7967 CCAGGCACACATCGAGAACTACGCCTTGAAACTATTCCTGTACGCCGACAAACAGGATCGCGAGGAGAA 69 FBan0007967 FBgn0035251 CG7967 3 3L CG7967 CG7967 CDMC32191 1 8 8 DAC12-M03 3-CG7967-RA_2 CG7967 CCAGGCACACATCGAGAACTACGCCTTGAAACTATTCCTGTACGCCGACAAACAGGATCGCGAGGAGAA 69 FBan0007967 FBgn0035251 CG7967 3 3L CG7967 CG7967 CDMC32192 1 9 8 DAC12-M15 17-CG7978-RA_1 CG7978 AGCACAACGTGGTCATTTTGGTGGAGTTTGCGATTGCTTTGATGTCCATACTGGACTCGATTAATCGCG 69 FBan0007978 FBgn0004852 Ac76E 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac76E Adenylyl cyclase 76E "CG7978, CG7978, adenylyl cyclase, DAC2, DAC76E, AC 76E" CDMC32192 1 10 8 DAC12-M15 17-CG7978-RA_1 CG7978 AGCACAACGTGGTCATTTTGGTGGAGTTTGCGATTGCTTTGATGTCCATACTGGACTCGATTAATCGCG 69 FBan0007978 FBgn0004852 Ac76E 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac76E Adenylyl cyclase 76E "CG7978, CG7978, adenylyl cyclase, DAC2, DAC76E, AC 76E" CDMC32193 1 11 8 DAC13-A03 1-CG13225-RA_1 CG13225 GGGCGGATCCCTTAAAGAATCACAGGCCACATTGAACAAAGTCTTTGCCCTGTACCAGACCAGCTTGGA 69 FBan0013225 FBgn0026386 Or47a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or47a Odorant receptor 47a "CG13225, CG13225, DOR47E.1, Olfactory receptor 47E.1, dor24, AN10, DOR24, 47E.1, 47a, Or24, Or47E.1" CDMC32193 1 12 8 DAC13-A03 1-CG13225-RA_1 CG13225 GGGCGGATCCCTTAAAGAATCACAGGCCACATTGAACAAAGTCTTTGCCCTGTACCAGACCAGCTTGGA 69 FBan0013225 FBgn0026386 Or47a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or47a Odorant receptor 47a "CG13225, CG13225, DOR47E.1, Olfactory receptor 47E.1, dor24, AN10, DOR24, 47E.1, 47a, Or24, Or47E.1" CDMC32194 1 13 8 DAC13-A15 1-CG13251-RA_1 CG13251 CGCACCATCACGAAACCCATTAAGCAACCCAGGGATTCCAGAAAAGAGGACCCGAAAGAACCAACCCAA 69 FBan0013251 FBgn0037014 CG13251 3 3L CG13251 CG13251 CDMC32194 1 14 8 DAC13-A15 1-CG13251-RA_1 CG13251 CGCACCATCACGAAACCCATTAAGCAACCCAGGGATTCCAGAAAAGAGGACCCGAAAGAACCAACCCAA 69 FBan0013251 FBgn0037014 CG13251 3 3L CG13251 CG13251 CDMC32195 1 15 8 DAC13-E03 9-CG13291-RA_1 CG13291 ACAGTCGCAGCAACAACACAATGCCAACACGAAACCTTCCAAGAGCTGGAATTGGACTGGGAATAGGAA 69 FBan0013291 FBgn0035655 CG13291 3 3L CG13291 CG13291 CDMC32195 1 16 8 DAC13-E03 9-CG13291-RA_1 CG13291 ACAGTCGCAGCAACAACACAATGCCAACACGAAACCTTCCAAGAGCTGGAATTGGACTGGGAATAGGAA 69 FBan0013291 FBgn0035655 CG13291 3 3L CG13291 CG13291 CDMC32196 1 17 8 DAC13-E15 12-CG13306-RA_1 CG13306 GGTGGATCCAAGGAGCCGTATCACTTCCAATGGTGGGCCTACATCTACACCTGTTATGCATACGCCGTG 69 FBan0013306 FBgn0040828 CG13306 3 3L CG13306 CG13306 CDMC32196 1 18 8 DAC13-E15 12-CG13306-RA_1 CG13306 GGTGGATCCAAGGAGCCGTATCACTTCCAATGGTGGGCCTACATCTACACCTGTTATGCATACGCCGTG 69 FBan0013306 FBgn0040828 CG13306 3 3L CG13306 CG13306 CDMC32197 1 19 8 DAC13-I03 3-CG13325-RA_2 CG13325 CGGCCATTGTGAAGATCTGTTCAGCCCGGTCCAATTCTCGAGCCCTATTTCGCGTTGTAGAAAGCCATT 69 FBan0013325 FBgn0033792 CG13325 2 2R CG13325 CG13325 CDMC32197 1 20 8 DAC13-I03 3-CG13325-RA_2 CG13325 CGGCCATTGTGAAGATCTGTTCAGCCCGGTCCAATTCTCGAGCCCTATTTCGCGTTGTAGAAAGCCATT 69 FBan0013325 FBgn0033792 CG13325 2 2R CG13325 CG13325 CDMC32198 1 21 8 DAC13-I15 8-CG13337-RA_1 CG13337 AAGTGCGAGGCAGAAAAGGAATGTGGAGATAGTTGCGTTCAAAAGAAGTGGAAAGAGGCATGCCCCACT 69 FBan0013337 FBgn0033863 CG13337 2 2R CG13337 CG13337 CDMC32198 1 22 8 DAC13-I15 8-CG13337-RA_1 CG13337 AAGTGCGAGGCAGAAAAGGAATGTGGAGATAGTTGCGTTCAAAAGAAGTGGAAAGAGGCATGCCCCACT 69 FBan0013337 FBgn0033863 CG13337 2 2R CG13337 CG13337 CDMC32199 1 23 8 DAC13-M03 3-CG13387-RA_1 CG13387 TGCCATCATTCTGGCGTACATGTTCTCACTGGTGGAGAACAGGAAGATTACGGTGAACCTGGGTCCGAT 69 FBan0013387 FBgn0020497 emb 2 2L "development; GO:0007275; protein export from nucleus; GO:0006611; protein import into nucleus, docking; GO:0000059; protein transport; GO:0015031" nuclear export signal receptor activity; GO:0005049; ; GO:0005049; protein binding; GO:0005515; ; GO:0005049; protein transporter activity; GO:0008565; ; GO:0005515; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643 emb embargoed "CG13387, Crm1: Chromosomal region maintenance 1, Chromosomal region maintenance 1, l(2)k16715, CRM1, dCRM1, crm1, Exportin, Crm1" CDMC32199 1 24 8 DAC13-M03 3-CG13387-RA_1 CG13387 TGCCATCATTCTGGCGTACATGTTCTCACTGGTGGAGAACAGGAAGATTACGGTGAACCTGGGTCCGAT 69 FBan0013387 FBgn0020497 emb 2 2L "development; GO:0007275; protein export from nucleus; GO:0006611; protein import into nucleus, docking; GO:0000059; protein transport; GO:0015031" nuclear export signal receptor activity; GO:0005049; ; GO:0005049; protein binding; GO:0005515; ; GO:0005049; protein transporter activity; GO:0008565; ; GO:0005515; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643 emb embargoed "CG13387, Crm1: Chromosomal region maintenance 1, Chromosomal region maintenance 1, l(2)k16715, CRM1, dCRM1, crm1, Exportin, Crm1" CDMC32200 1 25 8 DAC13-M15 3-CG13394-RA_1 CG13394 CGCCTGACCAAGCAGATTAGGAACGGTCCACGAGCTCAAGGACTGATTCTGCTCTCATCGAGTCCATTG 69 FBan0013394 FBgn0032037 CG13394 2 2L CG13394 CG13394 CDMC32200 1 26 8 DAC13-M15 3-CG13394-RA_1 CG13394 CGCCTGACCAAGCAGATTAGGAACGGTCCACGAGCTCAAGGACTGATTCTGCTCTCATCGAGTCCATTG 69 FBan0013394 FBgn0032037 CG13394 2 2L CG13394 CG13394 CDMC32201 1 1 9 DAC14-A03 15-CG8590-RA_6 CG8590 ATGACAGCTTCCAGATAGTGGATGGCAACGAGACAGTGGTACTAAGCGATGTCAGCGACGATCCC 65 FBan0008590 FBgn0011606 Klp3A X X chromosome segregation; GO:0007059; cytokinesis; GO:0000910; fertilization (sensu Metazoa); GO:0007338; male meiosis; GO:0007140; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; pronuclear fusion; GO:0007344; protein targeting; GO:0006605; regulation of mitosis; GO:0007088; spindle elongation; GO:0051231; spindle pole body separation; GO:0000073 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4; ; GO:0003777 aster; GO:0005818; central plaque of spindle pole body; GO:0005823; cytoplasm; GO:0005737; intermediate layer of spindle pole body; GO:0005821; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; midbody; GO:0030496; nucleus; GO:0005634; spindle; GO:0005819 Klp3A Kinesin-like protein at 3A "CG8590, CG8590, CG8590, mei-352, fs(1)M4, 3A7Kin, Kinesin-Like-Protein-at-3A, DmKlp3A, klp3A, KLP3A, DmKLP3A, KLP-3A, EG:BACR25B3.9, KIF4A, Klp3a, BcDNA:LD21815, female sterile(1)M4, meiotic 352" CDMC32201 1 2 9 DAC14-A03 15-CG8590-RA_6 CG8590 ATGACAGCTTCCAGATAGTGGATGGCAACGAGACAGTGGTACTAAGCGATGTCAGCGACGATCCC 65 FBan0008590 FBgn0011606 Klp3A X X chromosome segregation; GO:0007059; cytokinesis; GO:0000910; fertilization (sensu Metazoa); GO:0007338; male meiosis; GO:0007140; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; pronuclear fusion; GO:0007344; protein targeting; GO:0006605; regulation of mitosis; GO:0007088; spindle elongation; GO:0051231; spindle pole body separation; GO:0000073 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4; ; GO:0003777 aster; GO:0005818; central plaque of spindle pole body; GO:0005823; cytoplasm; GO:0005737; intermediate layer of spindle pole body; GO:0005821; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; midbody; GO:0030496; nucleus; GO:0005634; spindle; GO:0005819 Klp3A Kinesin-like protein at 3A "CG8590, CG8590, CG8590, mei-352, fs(1)M4, 3A7Kin, Kinesin-Like-Protein-at-3A, DmKlp3A, klp3A, KLP3A, DmKLP3A, KLP-3A, EG:BACR25B3.9, KIF4A, Klp3a, BcDNA:LD21815, female sterile(1)M4, meiotic 352" CDMC32202 1 3 9 DAC14-A15 1-CG8629-RA_2 CG8629 AAAATGGTCAGTTTTGAGGAAGCCGCCGAACTCGCCAAGAACTTCTCCAAGAAGCCCACCGACTC 65 FBan0008629 FBgn0035742 CG8629 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8629 CG8629 BcDNA:RE33457 CDMC32202 1 4 9 DAC14-A15 1-CG8629-RA_2 CG8629 AAAATGGTCAGTTTTGAGGAAGCCGCCGAACTCGCCAAGAACTTCTCCAAGAAGCCCACCGACTC 65 FBan0008629 FBgn0035742 CG8629 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8629 CG8629 BcDNA:RE33457 CDMC32203 1 5 9 DAC14-E03 2-CG8757-RA_2 CG8757 AGGAGTTCCAGAGGCACAAAACTGCCGTGAGGGTTTCGACAGTCAGTCCCGGCATAGTTGATACG 65 FBan0008757 FBgn0036380 CG8757 3 3L metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG8757 CG8757 CDMC32203 1 6 9 DAC14-E03 2-CG8757-RA_2 CG8757 AGGAGTTCCAGAGGCACAAAACTGCCGTGAGGGTTTCGACAGTCAGTCCCGGCATAGTTGATACG 65 FBan0008757 FBgn0036380 CG8757 3 3L metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG8757 CG8757 CDMC32204 1 7 9 DAC14-E15 42-CG8784-RA_5 CG8784 CGACTTAATACTGTTGGTCTCAGGCATCCCCCAGGAGCTGTACAACCTTTGGTATCCGGATATGT 65 FBan0008784 FBgn0038140 CG8784 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; electron transporter activity; GO:0005489; copper ion binding; GO:0005507; ; GO:0016520; ; GO:0005489; ; GO:0005507 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG8784 CG8784 "anon-WO0170980.190, anon-WO0170980.191" CDMC32204 1 8 9 DAC14-E15 42-CG8784-RA_5 CG8784 CGACTTAATACTGTTGGTCTCAGGCATCCCCCAGGAGCTGTACAACCTTTGGTATCCGGATATGT 65 FBan0008784 FBgn0038140 CG8784 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; electron transport; GO:0006118 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; electron transporter activity; GO:0005489; copper ion binding; GO:0005507; ; GO:0016520; ; GO:0005489; ; GO:0005507 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG8784 CG8784 "anon-WO0170980.190, anon-WO0170980.191" CDMC32205 1 9 9 DAC14-I03 1-CG8890-RA_1 CG8890 CTAAATACCCGGCTAATTGCTATGTCGACTTCCGATGGGGCCCCGGAAACCAAGAAGCAACGTCC 65 FBan0008890 FBgn0031661 Gmd 2 2L 'de novo' GDP-L-fucose biosynthesis; GO:0042351 "GDP-mannose 4,6-dehydratase activity; GO:0008446 ; EC:4.2.1.47; ; GO:0008446 ; EC:4.2.1.47; ; GO:0008446 ; EC:4.2.1.47; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008446 ; EC:4.2.1.47" Gmd "GDP-mannose 4,6-dehydratase" "CG8890, CG8890, Dm-gmd, l(2)SH2 1606, l(2)SH1606, GDP-mannose 4,6-dehydratase" CDMC32205 1 10 9 DAC14-I03 1-CG8890-RA_1 CG8890 CTAAATACCCGGCTAATTGCTATGTCGACTTCCGATGGGGCCCCGGAAACCAAGAAGCAACGTCC 65 FBan0008890 FBgn0031661 Gmd 2 2L 'de novo' GDP-L-fucose biosynthesis; GO:0042351 "GDP-mannose 4,6-dehydratase activity; GO:0008446 ; EC:4.2.1.47; ; GO:0008446 ; EC:4.2.1.47; ; GO:0008446 ; EC:4.2.1.47; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008446 ; EC:4.2.1.47" Gmd "GDP-mannose 4,6-dehydratase" "CG8890, CG8890, Dm-gmd, l(2)SH2 1606, l(2)SH1606, GDP-mannose 4,6-dehydratase" CDMC32206 1 11 9 DAC14-I15 6-CG8939-RA_3 CG8939 GAGGAGGTTGTCCAGGGTAAGAAGGCCAAACGTCGTGCACGCCATGAGACCGCAACTAAAGACAG 65 FBan0008939 FBgn0030720 CG8939 X X rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; ; GO:0008649 ; EC:2.1.1.- nucleolus; GO:0005730 CG8939 CG8939 CDMC32206 1 12 9 DAC14-I15 6-CG8939-RA_3 CG8939 GAGGAGGTTGTCCAGGGTAAGAAGGCCAAACGTCGTGCACGCCATGAGACCGCAACTAAAGACAG 65 FBan0008939 FBgn0030720 CG8939 X X rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA methyltransferase activity; GO:0008649 ; EC:2.1.1.-; ; GO:0008649 ; EC:2.1.1.- nucleolus; GO:0005730 CG8939 CG8939 CDMC32207 1 13 9 DAC14-M03 23-CG9018-RA_3 CG9018 TGAAGGAAACGAAGGAGTCACTTTAAGATTACATATATATTTGCAATTGTCCCCCTAATCGCACC 65 FBan0009018 FBgn0035318 CG9018 3 3L CG9018 CG9018 CDMC32207 1 14 9 DAC14-M03 23-CG9018-RA_3 CG9018 TGAAGGAAACGAAGGAGTCACTTTAAGATTACATATATATTTGCAATTGTCCCCCTAATCGCACC 65 FBan0009018 FBgn0035318 CG9018 3 3L CG9018 CG9018 CDMC32208 1 15 9 DAC14-M15 3-CG9057-RA_1 CG9057 CTCCCGACAGATCAAGCAGGTCCAGAAGGGCAACATCAACGACTATCTGAGCTCCCTGATAGCCG 65 FBan0009057 FBgn0030608 Lsd-2 X X lipid particle transport along microtubule; GO:0031887; sequestering of lipid; GO:0019915; sequestering of triacylglycerol; GO:0030730 protein binding; GO:0005515; ; GO:0005515 lipid particle; GO:0005811 Lsd-2 Lipid storage droplet-2 "CG9057, CG9057, CG9057, LSD-2, Lsd2, LSD2, Lipid storage droplet-2" CDMC32208 1 16 9 DAC14-M15 3-CG9057-RA_1 CG9057 CTCCCGACAGATCAAGCAGGTCCAGAAGGGCAACATCAACGACTATCTGAGCTCCCTGATAGCCG 65 FBan0009057 FBgn0030608 Lsd-2 X X lipid particle transport along microtubule; GO:0031887; sequestering of lipid; GO:0019915; sequestering of triacylglycerol; GO:0030730 protein binding; GO:0005515; ; GO:0005515 lipid particle; GO:0005811 Lsd-2 Lipid storage droplet-2 "CG9057, CG9057, CG9057, LSD-2, Lsd2, LSD2, Lipid storage droplet-2" CDMC32209 1 17 9 DAC15-A03 3-CG8145-RA_5 CG8145 CCAATGCTCCGGATATGGTGTGCTTTTGCTGCCAGACAGATCTGCAATCGGCCATGATTTTCCGGAG 67 FBan0008145 FBgn0037617 CG8145 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8145 CG8145 CDMC32209 1 18 9 DAC15-A03 3-CG8145-RA_5 CG8145 CCAATGCTCCGGATATGGTGTGCTTTTGCTGCCAGACAGATCTGCAATCGGCCATGATTTTCCGGAG 67 FBan0008145 FBgn0037617 CG8145 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8145 CG8145 CDMC32210 1 19 9 DAC15-A15 14-CG8216-RA_2 CG8216 AGAGCGGGCTTTCCACTAGTGATGATGTACTAACGTGACCACTATGAGCATTTTTCCGAGGTGGGCA 67 FBan0008216 FBgn0033358 CG8216 2 2R DNA transposition; GO:0006313; development; GO:0007275 DNA binding; GO:0003677; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 nucleus; GO:0005634 CG8216 CG8216 CDMC32210 1 20 9 DAC15-A15 14-CG8216-RA_2 CG8216 AGAGCGGGCTTTCCACTAGTGATGATGTACTAACGTGACCACTATGAGCATTTTTCCGAGGTGGGCA 67 FBan0008216 FBgn0033358 CG8216 2 2R DNA transposition; GO:0006313; development; GO:0007275 DNA binding; GO:0003677; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 nucleus; GO:0005634 CG8216 CG8216 CDMC32211 1 21 9 DAC15-E03 14-CG8571-RA_2 CG8571 CGCCGACCCAAACTTTTGCCTCACTCTCATTGATTTCGTAGATGCCATTAAGGTGATGCAGCCTTCG 67 FBan0008571 FBgn0016983 smid 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- smid smallminded "CG8571, l(3)j6B8, l(3)j8A6, l(3)s2898, smallminded" CDMC32211 1 22 9 DAC15-E03 14-CG8571-RA_2 CG8571 CGCCGACCCAAACTTTTGCCTCACTCTCATTGATTTCGTAGATGCCATTAAGGTGATGCAGCCTTCG 67 FBan0008571 FBgn0016983 smid 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- smid smallminded "CG8571, l(3)j6B8, l(3)j8A6, l(3)s2898, smallminded" CDMC32212 1 23 9 DAC15-E15 3-CG8756-RC_1 CG8756 CGATGTTTTGCGCCAACTTTGCGATTGGAAGTCGAATGTGAAGTCCTGCGATGTGCTCGAGAAGCCG 67 FBan0008756 FBgn0036901 LCBP1 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 LCBP1 LDLa domain containing chitin binding protein 1 "CG8756, CG8756, LDLa domain containing chitin binding protein 1" CDMC32212 1 24 9 DAC15-E15 3-CG8756-RC_1 CG8756 CGATGTTTTGCGCCAACTTTGCGATTGGAAGTCGAATGTGAAGTCCTGCGATGTGCTCGAGAAGCCG 67 FBan0008756 FBgn0036901 LCBP1 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 LCBP1 LDLa domain containing chitin binding protein 1 "CG8756, CG8756, LDLa domain containing chitin binding protein 1" CDMC32213 1 25 9 DAC15-I03 3-CG9154-RA_1 CG9154 AGATTTTGTGCACTACGACTTGAACTGCGTAGGGAGCAACCCGGACTACCTCAAAGAGCACCACCAG 67 FBan0009154 FBgn0031777 CG9154 2 2L CG9154 CG9154 CDMC32213 1 26 9 DAC15-I03 3-CG9154-RA_1 CG9154 AGATTTTGTGCACTACGACTTGAACTGCGTAGGGAGCAACCCGGACTACCTCAAAGAGCACCACCAG 67 FBan0009154 FBgn0031777 CG9154 2 2L CG9154 CG9154 CDMC32214 1 1 10 DAC15-I15 2-CG9242-RA_1 CG9242 GCCCAACTGGCAGGATCTTCTCTTCCTCGCCAAAATCATACCGCGAATTCTGCACAACGTGAACAGG 67 FBan0009242 FBgn0000239 bur 2 2L GMP biosynthesis; GO:0006177; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; GMP synthase activity; GO:0003921 ; EC:6.3.4.1; GMP synthase (glutamine-hydrolyzing) activity; GO:0003922 ; EC:6.3.5.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003922 ; EC:6.3.5.2; ; GO:0003921 ; EC:6.3.4.1; anthranilate synthase activity; GO:0004049 ; EC:4.1.3.27; ; GO:0004049 ; EC:4.1.3.27 bur burgundy "CG9242, CG9242, ES2-2, Enhancer of GMR-sina 2-2, P174, l(2)10523, anon-WO0118547.193, anon-WO0118547.204, gua2" CDMC32214 1 2 10 DAC15-I15 2-CG9242-RA_1 CG9242 GCCCAACTGGCAGGATCTTCTCTTCCTCGCCAAAATCATACCGCGAATTCTGCACAACGTGAACAGG 67 FBan0009242 FBgn0000239 bur 2 2L GMP biosynthesis; GO:0006177; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; GMP synthase activity; GO:0003921 ; EC:6.3.4.1; GMP synthase (glutamine-hydrolyzing) activity; GO:0003922 ; EC:6.3.5.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003922 ; EC:6.3.5.2; ; GO:0003921 ; EC:6.3.4.1; anthranilate synthase activity; GO:0004049 ; EC:4.1.3.27; ; GO:0004049 ; EC:4.1.3.27 bur burgundy "CG9242, CG9242, ES2-2, Enhancer of GMR-sina 2-2, P174, l(2)10523, anon-WO0118547.193, anon-WO0118547.204, gua2" CDMC32215 1 3 10 DAC15-M03 9-CG9646-RA_1 CG9646 TGGTTATCCTAAGTGAGAGCGACAGCAAGCTAATGATTAGTGTGCGTGGACGAGAAGAGCTGCCGGT 67 FBan0009646 FBgn0034184 CG9646 2 2R CG9646 CG9646 CDMC32215 1 4 10 DAC15-M03 9-CG9646-RA_1 CG9646 TGGTTATCCTAAGTGAGAGCGACAGCAAGCTAATGATTAGTGTGCGTGGACGAGAAGAGCTGCCGGT 67 FBan0009646 FBgn0034184 CG9646 2 2R CG9646 CG9646 CDMC32216 1 5 10 DAC15-M15 3-CG9815-RA_1 CG9815 CGTCCGCTGATCGACAGCATTTTCGAGATTCCAATTTCGACGCTGCGTGCTGTTAACAACCTGGTGG 67 FBan0009815 FBgn0034861 CG9815 2 2R CG9815 CG9815 CDMC32216 1 6 10 DAC15-M15 3-CG9815-RA_1 CG9815 CGTCCGCTGATCGACAGCATTTTCGAGATTCCAATTTCGACGCTGCGTGCTGTTAACAACCTGGTGG 67 FBan0009815 FBgn0034861 CG9815 2 2R CG9815 CG9815 CDMC32217 1 7 10 DAC16-A03 23-CG4866-RA_3 CG4866 GTGACGATTTCCAAATGTAGAGAGACTACCTCCCTTAAGATAACCAGTAGAGTAACTAAAGCTAACTTG 69 FBan0004866 FBgn0034232 CG4866 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial ribosome; GO:0005761 CG4866 CG4866 mRpS4 CDMC32217 1 8 10 DAC16-A03 23-CG4866-RA_3 CG4866 GTGACGATTTCCAAATGTAGAGAGACTACCTCCCTTAAGATAACCAGTAGAGTAACTAAAGCTAACTTG 69 FBan0004866 FBgn0034232 CG4866 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735 mitochondrial ribosome; GO:0005761 CG4866 CG4866 mRpS4 CDMC32218 1 9 10 DAC16-A15 1-CG4881-RA_1 CG4881 TCCACTGAGTCGCATCAAGGTGGAGAACAATCAAAACGAGTCCATGGGTGGCTTTAACGAGCAGGAGGA 69 FBan0004881 FBgn0000287 salr 2 2L antennal joint morphogenesis; GO:0048098; regulation of transcription; GO:0045449; wing vein morphogenesis; GO:0008586 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 salr spalt-related "CG4881, 32F, salR, sal-r, spalt, Sal-r, sal related, sal-related, Spalt, sal: spalt, Cf3: Chorion factor 3, Chorion factor 3, sal, spalt-related" CDMC32218 1 10 10 DAC16-A15 1-CG4881-RA_1 CG4881 TCCACTGAGTCGCATCAAGGTGGAGAACAATCAAAACGAGTCCATGGGTGGCTTTAACGAGCAGGAGGA 69 FBan0004881 FBgn0000287 salr 2 2L antennal joint morphogenesis; GO:0048098; regulation of transcription; GO:0045449; wing vein morphogenesis; GO:0008586 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 salr spalt-related "CG4881, 32F, salR, sal-r, spalt, Sal-r, sal related, sal-related, Spalt, sal: spalt, Cf3: Chorion factor 3, Chorion factor 3, sal, spalt-related" CDMC32219 1 11 10 DAC16-E03 3-CG4912-RB_4 CG4912 TCGCAGCCACTACAGCCCATTAGTAAGCGAAATCGCAAAGGCTAGGGAACACATACAGAACTCGCTGGA 69 FBan0004912 FBgn0032198 eEF1delta 2 2L translational elongation; GO:0006414 guanyl-nucleotide exchange factor activity; GO:0005085; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005085 eukaryotic translation elongation factor 1 complex; GO:0005853 eEF1delta eEF1delta "CG4912, CG4912, CG4912, eEF1d, eEF1delta" CDMC32219 1 12 10 DAC16-E03 3-CG4912-RB_4 CG4912 TCGCAGCCACTACAGCCCATTAGTAAGCGAAATCGCAAAGGCTAGGGAACACATACAGAACTCGCTGGA 69 FBan0004912 FBgn0032198 eEF1delta 2 2L translational elongation; GO:0006414 guanyl-nucleotide exchange factor activity; GO:0005085; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005085 eukaryotic translation elongation factor 1 complex; GO:0005853 eEF1delta eEF1delta "CG4912, CG4912, CG4912, eEF1d, eEF1delta" CDMC32220 1 13 10 DAC16-E15 3-CG4924-RA_4 CG4924 GGACATTCACACCGTAGACACTATGTACAGTGCCATGACGACTTGCCAGGCCCTACATCCTGATTCGGC 69 FBan0004924 FBgn0029079 icln 2 2R chloride transport; GO:0006821; regulation of cell volume; GO:0006884 volume-sensitive anion channel activity; GO:0005225; ; GO:0005225 icln icln "CG4924, CG4924" CDMC32220 1 14 10 DAC16-E15 3-CG4924-RA_4 CG4924 GGACATTCACACCGTAGACACTATGTACAGTGCCATGACGACTTGCCAGGCCCTACATCCTGATTCGGC 69 FBan0004924 FBgn0029079 icln 2 2R chloride transport; GO:0006821; regulation of cell volume; GO:0006884 volume-sensitive anion channel activity; GO:0005225; ; GO:0005225 icln icln "CG4924, CG4924" CDMC32221 1 15 10 DAC16-I03 18-CG4951-RA_1 CG4951 AGCCGCGCGAGGTTAAGATTTTGTAAGTGACTCGACTAGATGCAAATAAAGCGAACACGAATGTGCCTT 69 FBan0004951 FBgn0039563 CG4951 3 3R CG4951 CG4951 CDMC32221 1 16 10 DAC16-I03 18-CG4951-RA_1 CG4951 AGCCGCGCGAGGTTAAGATTTTGTAAGTGACTCGACTAGATGCAAATAAAGCGAACACGAATGTGCCTT 69 FBan0004951 FBgn0039563 CG4951 3 3R CG4951 CG4951 CDMC32222 1 17 10 DAC16-I15 11-CG4959-RB_1 CG4959 ACGGGCCGTATGGTGGACATTGTTAGCCTGCTTAGAAGGAATGTAGGGTTTCTTTATCCGCGATCTGGA 69 FBan0004959 FBgn0028883 CG4959 2 2L CG4959 CG4959 "BG:DS04095.3, bs04e09.y1, BcDNA:GH21762" CDMC32222 1 18 10 DAC16-I15 11-CG4959-RB_1 CG4959 ACGGGCCGTATGGTGGACATTGTTAGCCTGCTTAGAAGGAATGTAGGGTTTCTTTATCCGCGATCTGGA 69 FBan0004959 FBgn0028883 CG4959 2 2L CG4959 CG4959 "BG:DS04095.3, bs04e09.y1, BcDNA:GH21762" CDMC32223 1 19 10 DAC16-M03 23-CG4994-RB_2 CG4994 GGCCACACATGCGAATATGATATTAATGCTGTTTCAATTGTCTGACCCGATACCCAAGAAAGCACTCTG 69 FBan0004994 FBgn0026409 Mpcp 3 3L phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 carrier activity; GO:0005386; phosphate transporter activity; GO:0015114; ; GO:0015114; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015114; ; GO:0015114; ; GO:0015114 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 Mpcp Mitochondrial phosphate carrier protein "CG4994, CG4994, l(3)00564, PpsM, mitochondrial proton/phosphate symporter, MPCP, Mitochondrial phophate carrier protein" CDMC32223 1 20 10 DAC16-M03 23-CG4994-RB_2 CG4994 GGCCACACATGCGAATATGATATTAATGCTGTTTCAATTGTCTGACCCGATACCCAAGAAAGCACTCTG 69 FBan0004994 FBgn0026409 Mpcp 3 3L phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 carrier activity; GO:0005386; phosphate transporter activity; GO:0015114; ; GO:0015114; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015114; ; GO:0015114; ; GO:0015114 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 Mpcp Mitochondrial phosphate carrier protein "CG4994, CG4994, l(3)00564, PpsM, mitochondrial proton/phosphate symporter, MPCP, Mitochondrial phophate carrier protein" CDMC32224 1 21 10 DAC16-M15 2-CG5004-RA_1 CG5004 GGGTGCCAGCACAAAGATCTTTGACAGCATCATGGAGATCGAACGGAATCGCAAACTTCTGTTGGCCCA 69 FBan0005004 FBgn0030820 CG5004 X X CG5004 CG5004 CDMC32224 1 22 10 DAC16-M15 2-CG5004-RA_1 CG5004 GGGTGCCAGCACAAAGATCTTTGACAGCATCATGGAGATCGAACGGAATCGCAAACTTCTGTTGGCCCA 69 FBan0005004 FBgn0030820 CG5004 X X CG5004 CG5004 CDMC32225 1 23 10 DAC17-A03 11-CG7082-RC_3 CG7082 TCCAAGCCGTTGAATGCTTCTTGGCCAATGTAAAATCTACCATCCAGACGGAGCCTATTACGTGGCCAA 69 FBan0007082 FBgn0031401 CG7082 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG7082 CG7082 cg7082 CDMC32225 1 24 10 DAC17-A03 11-CG7082-RC_3 CG7082 TCCAAGCCGTTGAATGCTTCTTGGCCAATGTAAAATCTACCATCCAGACGGAGCCTATTACGTGGCCAA 69 FBan0007082 FBgn0031401 CG7082 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG7082 CG7082 cg7082 CDMC32226 1 25 10 DAC17-A15 3-CG7095-RA_1 CG7095 CCTGGAGAAGGAGTACTCGCACGAGAATATTCGCTTCTGGATAGCAGTCAATCGATTGCGCCGTTCCGC 69 FBan0007095 FBgn0030962 CG7095 X X intracellular signaling cascade; GO:0007242; proteolysis; GO:0006508; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0016299; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004182 ; EC:3.4.17.1; small GTPase regulator activity; GO:0005083; ; GO:0005083 heterotrimeric G-protein complex; GO:0005834 CG7095 CG7095 CDMC32226 1 26 10 DAC17-A15 3-CG7095-RA_1 CG7095 CCTGGAGAAGGAGTACTCGCACGAGAATATTCGCTTCTGGATAGCAGTCAATCGATTGCGCCGTTCCGC 69 FBan0007095 FBgn0030962 CG7095 X X intracellular signaling cascade; GO:0007242; proteolysis; GO:0006508; regulation of G-protein coupled receptor protein signaling pathway; GO:0008277 regulator of G-protein signaling activity; GO:0016299; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0016299; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004182 ; EC:3.4.17.1; small GTPase regulator activity; GO:0005083; ; GO:0005083 heterotrimeric G-protein complex; GO:0005834 CG7095 CG7095 CDMC32227 1 1 11 DAC17-E03 7-CG7127-RA_1 CG7127 TGGTCACCTTGGCTGAGCCTGAGTGCGAACATAGCTACATGGAGATGATACGTGAACTGAAGGCTAGCT 69 FBan0007127 FBgn0035892 exo70 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 neurotransmitter transporter activity; GO:0005326; ; GO:0005326 exocyst; GO:0000145 exo70 exo70 "CG7127, CG7127, Exo70, Exo70p" CDMC32227 1 2 11 DAC17-E03 7-CG7127-RA_1 CG7127 TGGTCACCTTGGCTGAGCCTGAGTGCGAACATAGCTACATGGAGATGATACGTGAACTGAAGGCTAGCT 69 FBan0007127 FBgn0035892 exo70 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080; vesicle-mediated transport; GO:0016192 neurotransmitter transporter activity; GO:0005326; ; GO:0005326 exocyst; GO:0000145 exo70 exo70 "CG7127, CG7127, Exo70, Exo70p" CDMC32228 1 3 11 DAC17-E15 6-CG7143-RA_1 CG7143 AGTGCCCCGAGTGTAAGGCTTTCATCAAGTGTGTAGACATGCCGGAACACTTAGACTACCACGTAGCCA 69 FBan0007143 FBgn0037141 DNApol-eta 3 3L bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; eta DNA polymerase activity; GO:0015999; ; GO:0015999; ; GO:0015999; ; GO:0003887 ; EC:2.7.7.7; ; GO:0015999 DNApol-eta DNApol-eta "CG7143, drad30A, POLH, AAF51794, DNApol-eta" CDMC32228 1 4 11 DAC17-E15 6-CG7143-RA_1 CG7143 AGTGCCCCGAGTGTAAGGCTTTCATCAAGTGTGTAGACATGCCGGAACACTTAGACTACCACGTAGCCA 69 FBan0007143 FBgn0037141 DNApol-eta 3 3L bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; eta DNA polymerase activity; GO:0015999; ; GO:0015999; ; GO:0015999; ; GO:0003887 ; EC:2.7.7.7; ; GO:0015999 DNApol-eta DNApol-eta "CG7143, drad30A, POLH, AAF51794, DNApol-eta" CDMC32229 1 5 11 DAC17-I03 3-CG7177-RA_3 CG7177 AGGGATCCCAGCAAGGATCACAGCAATTTAATTTGCCTGGCACACAACAGACTCATCCTCAGCACCAGT 69 FBan0007177 FBgn0037098 CG7177 3 3L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301 CG7177 CG7177 CDMC32229 1 6 11 DAC17-I03 3-CG7177-RA_3 CG7177 AGGGATCCCAGCAAGGATCACAGCAATTTAATTTGCCTGGCACACAACAGACTCATCCTCAGCACCAGT 69 FBan0007177 FBgn0037098 CG7177 3 3L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301 CG7177 CG7177 CDMC32230 1 7 11 DAC17-I15 13-CG7186-RA_1 CG7186 ACAGATGTACAACCCGCTCAGAGATTGGATGGCCTACGAGATACCACCAATATTGCGTTTTCCACACCA 69 FBan0007186 FBgn0026371 SAK 3 3L chromosome segregation; GO:0007059; embryonic development; GO:0009790; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 SAK SAK "CG7186, CG7186, SAK/PLK" CDMC32230 1 8 11 DAC17-I15 13-CG7186-RA_1 CG7186 ACAGATGTACAACCCGCTCAGAGATTGGATGGCCTACGAGATACCACCAATATTGCGTTTTCCACACCA 69 FBan0007186 FBgn0026371 SAK 3 3L chromosome segregation; GO:0007059; embryonic development; GO:0009790; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 SAK SAK "CG7186, CG7186, SAK/PLK" CDMC32231 1 9 11 DAC17-M03 3-CG7228-RA_1 CG7228 AGTTGCTCATCGAGGATGTCGTTCCAATTCACGTCACATACCACCACATTACCTACCACGCATGCCCCA 69 FBan0007228 FBgn0031969 CG7228 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7228 CG7228 CDMC32231 1 10 11 DAC17-M03 3-CG7228-RA_1 CG7228 AGTTGCTCATCGAGGATGTCGTTCCAATTCACGTCACATACCACCACATTACCTACCACGCATGCCCCA 69 FBan0007228 FBgn0031969 CG7228 2 2L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952; macrophage activation; GO:0042116 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG7228 CG7228 CDMC32232 1 11 11 DAC17-M15 13-CG7236-RA_1 CG7236 GCGAGAAATTAGGCTACTGAAGAACCTGAAGCATCCGAACCTTGTCTCCCTGCTAGAAGTGTTCCGACG 69 FBan0007236 FBgn0031730 CG7236 2 2L cytokinesis; GO:0000910; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- CG7236 CG7236 "AC018104, KKIALRE" CDMC32232 1 12 11 DAC17-M15 13-CG7236-RA_1 CG7236 GCGAGAAATTAGGCTACTGAAGAACCTGAAGCATCCGAACCTTGTCTCCCTGCTAGAAGTGTTCCGACG 69 FBan0007236 FBgn0031730 CG7236 2 2L cytokinesis; GO:0000910; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- CG7236 CG7236 "AC018104, KKIALRE" CDMC32233 1 13 11 DAC18-A03 23-CG32392-RA_3 CG32392 GGGATACTGATTCCGCACACATGTAACACTAACACACTCCTGCTATTAAATCAAGGTTGGCTGCAACTT 69 FBan0032392 FBgn0052392 CG32392 3 3L microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017 microtubule associated complex; GO:0005875 CG32392 CG32392 "CG10099, CG14912, CG10099" CDMC32233 1 14 11 DAC18-A03 23-CG32392-RA_3 CG32392 GGGATACTGATTCCGCACACATGTAACACTAACACACTCCTGCTATTAAATCAAGGTTGGCTGCAACTT 69 FBan0032392 FBgn0052392 CG32392 3 3L microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017 microtubule associated complex; GO:0005875 CG32392 CG32392 "CG10099, CG14912, CG10099" CDMC32234 1 15 11 DAC18-A15 11-CG32401-RA_1 CG32401 CGCAGACATTACCCTTTCACGTCTCTTGGCCCTTTCAACTTCACGATCCATCGAAACATCCGATTGCCT 69 FBgn0052401 CDMC32234 1 16 11 DAC18-A15 11-CG32401-RA_1 CG32401 CGCAGACATTACCCTTTCACGTCTCTTGGCCCTTTCAACTTCACGATCCATCGAAACATCCGATTGCCT 69 FBgn0052401 CDMC32235 1 17 11 DAC18-E03 10-CG32434-RA_1 CG32434 GGCAACCTTCTATGCCCATACCCGTTTTGATCTACCCCTCCCCTTACGAATTACAAAAGCGATTGGCGA 69 FBgn0052434 CDMC32235 1 18 11 DAC18-E03 10-CG32434-RA_1 CG32434 GGCAACCTTCTATGCCCATACCCGTTTTGATCTACCCCTCCCCTTACGAATTACAAAAGCGATTGGCGA 69 FBgn0052434 CDMC32236 1 19 11 DAC18-E15 15-CG32445-RA_1 CG32445 CCGCTTTGGCTCTTGTCCCAAGCGAGTGTAGCAACTTAGTTGATGCTCCCAAAATTAGGCCGCTAAAAT 69 FBan0032445 FBgn0052445 CG32445 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG32445 CG32445 "CG12562, CG12562, anon-WO0140519.131" CDMC32236 1 20 11 DAC18-E15 15-CG32445-RA_1 CG32445 CCGCTTTGGCTCTTGTCCCAAGCGAGTGTAGCAACTTAGTTGATGCTCCCAAAATTAGGCCGCTAAAAT 69 FBan0032445 FBgn0052445 CG32445 3 3L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG32445 CG32445 "CG12562, CG12562, anon-WO0140519.131" CDMC32237 1 21 11 DAC18-I03 5-CG32474-RA_1 CG32474 TCACCATCCGCATATGGGAACCTATGGTGGAGTCTATCATGCGAAGGCAGCAATCGAGCTTAAGGAGGA 69 FBan0032474 FBgn0039411 dys 3 3R "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424" transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 dys dysfusion "CG12561, CG14554, CG32474, CG14552, CG14553, CG12561, CG12561, CG14554, cranky, Dys, Dysfusion, dysfusion" CDMC32237 1 22 11 DAC18-I03 5-CG32474-RA_1 CG32474 TCACCATCCGCATATGGGAACCTATGGTGGAGTCTATCATGCGAAGGCAGCAATCGAGCTTAAGGAGGA 69 FBan0032474 FBgn0039411 dys 3 3R "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; tracheal branch fusion; GO:0035147; tracheal system development (sensu Insecta); GO:0007424" transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 dys dysfusion "CG12561, CG14554, CG32474, CG14552, CG14553, CG12561, CG12561, CG14554, cranky, Dys, Dysfusion, dysfusion" CDMC32238 1 23 11 DAC18-I15 2-CG32487-RA_1 CG32487 CGCACTTCGTGCCATGGGAAAGAAGGCCTTTATTTGCACCAATAACTCAGTGACTTCGGTCGAGGGCAT 69 FBan0032487 FBgn0052487 CG32487 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG32487 CG32487 CG2077 CDMC32238 1 24 11 DAC18-I15 2-CG32487-RA_1 CG32487 CGCACTTCGTGCCATGGGAAAGAAGGCCTTTATTTGCACCAATAACTCAGTGACTTCGGTCGAGGGCAT 69 FBan0032487 FBgn0052487 CG32487 3 3L metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG32487 CG32487 CG2077 CDMC32239 1 25 11 DAC18-M03 1-CG32499-RA_1 CG32499 TGGCTACAGGAGGACTTTTCGCGCTACTACGAACAGAACAAGGCTCCATACATGATGCCCTTCCACACT 69 FBan0032499 FBgn0052499 CG32499 X X carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG32499 CG32499 "CG13238, CG12447, CG9557, CG9558, CG13238, BcDNA:RE51076" CDMC32239 1 26 11 DAC18-M03 1-CG32499-RA_1 CG32499 TGGCTACAGGAGGACTTTTCGCGCTACTACGAACAGAACAAGGCTCCATACATGATGCCCTTCCACACT 69 FBan0032499 FBgn0052499 CG32499 X X carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG32499 CG32499 "CG13238, CG12447, CG9557, CG9558, CG13238, BcDNA:RE51076" CDMC32240 1 1 12 DAC18-M15 23-CG32513-RA_8 CG32513 GACACTTGATTGCACATGAATTAGTTTCAGTTTGAGTGGGGTTTTCAATTGAACACGATCAGAAAGCCA 69 FBan0032513 FBgn0031150 bves X X membrane; GO:0016020 bves bves "CG32513, CG15448, CG1754, BcDNA:SD21670" CDMC32240 1 2 12 DAC18-M15 23-CG32513-RA_8 CG32513 GACACTTGATTGCACATGAATTAGTTTCAGTTTGAGTGGGGTTTTCAATTGAACACGATCAGAAAGCCA 69 FBan0032513 FBgn0031150 bves X X membrane; GO:0016020 bves bves "CG32513, CG15448, CG1754, BcDNA:SD21670" CDMC32241 1 3 12 DAC19-A03 8-CG8110-RB_2 CG8110 CTCACCGCAACAAGATCTTCATCGTGGACCCCGTATCGCTCAACATTGTGCATTCGCTGGACGCG 65 FBan0008110 FBgn0024187 syd 3 3L axon cargo transport; GO:0008088; intracellular signaling cascade; GO:0007242 kinesin binding; GO:0019894; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019894 integral to membrane; GO:0016021; membrane; GO:0016020; microtubule associated complex; GO:0005875; trans-Golgi network transport vesicle; GO:0030140 syd sunday driver "CG8110, CG8110, CG8110, JIP-3, sunday driver" CDMC32241 1 4 12 DAC19-A03 8-CG8110-RB_2 CG8110 CTCACCGCAACAAGATCTTCATCGTGGACCCCGTATCGCTCAACATTGTGCATTCGCTGGACGCG 65 FBan0008110 FBgn0024187 syd 3 3L axon cargo transport; GO:0008088; intracellular signaling cascade; GO:0007242 kinesin binding; GO:0019894; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019894 integral to membrane; GO:0016021; membrane; GO:0016020; microtubule associated complex; GO:0005875; trans-Golgi network transport vesicle; GO:0030140 syd sunday driver "CG8110, CG8110, CG8110, JIP-3, sunday driver" CDMC32242 1 5 12 DAC19-A15 5-CG8149-RA_1 CG8149 CCTGACAAAGCACCGACCTCAAAGGCCGATGATCGTCTCCAGAAACGGAAGGAGCGATTTGGAGC 65 FBan0008149 FBgn0037700 CG8149 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 DNA binding; GO:0003677; ; GO:0003677 CG8149 CG8149 CDMC32242 1 6 12 DAC19-A15 5-CG8149-RA_1 CG8149 CCTGACAAAGCACCGACCTCAAAGGCCGATGATCGTCTCCAGAAACGGAAGGAGCGATTTGGAGC 65 FBan0008149 FBgn0037700 CG8149 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 DNA binding; GO:0003677; ; GO:0003677 CG8149 CG8149 CDMC32243 1 7 12 DAC19-E03 3-CG8237-RA_2 CG8237 GCTGACCAAGTTCATCGTTTGCTGCTACGAAGCGCTGTGGACATACCTATACCAAGGGGCTACGC 65 FBan0008237 FBgn0033350 CG8237 2 2R CG8237 CG8237 CDMC32243 1 8 12 DAC19-E03 3-CG8237-RA_2 CG8237 GCTGACCAAGTTCATCGTTTGCTGCTACGAAGCGCTGTGGACATACCTATACCAAGGGGCTACGC 65 FBan0008237 FBgn0033350 CG8237 2 2R CG8237 CG8237 CDMC32244 1 9 12 DAC19-E15 2-CG8253-RA_1 CG8253 TAAACCAGCTCCTCTCGTGTCTCGTGCAATCTCCCAGTCCCCAGTGACAATTAGCTCCATCTCCG 65 FBan0008253 FBgn0034046 tun 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 tun tungus "CG8253, CG8253, CG8253, CG8253, CG8253, BcDNA:LD38553, tungus" CDMC32244 1 10 12 DAC19-E15 2-CG8253-RA_1 CG8253 TAAACCAGCTCCTCTCGTGTCTCGTGCAATCTCCCAGTCCCCAGTGACAATTAGCTCCATCTCCG 65 FBan0008253 FBgn0034046 tun 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 tun tungus "CG8253, CG8253, CG8253, CG8253, CG8253, BcDNA:LD38553, tungus" CDMC32245 1 11 12 DAC19-I03 18-CG8337-RA_1 CG8337 CAAGATGAAGACCAGCTACAGCATCAAGCAGGTCCTGAAGACGCTCTTCAAGAAGCAACAGAAGC 65 FBan0008337 FBgn0002732 malpha 3 3R Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423 malpha E(spl) region transcript malpha "CG8337, E(spl)malpha, E(spl)malpha, E(spl)ma" CDMC32245 1 12 12 DAC19-I03 18-CG8337-RA_1 CG8337 CAAGATGAAGACCAGCTACAGCATCAAGCAGGTCCTGAAGACGCTCTTCAAGAAGCAACAGAAGC 65 FBan0008337 FBgn0002732 malpha 3 3R Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; sensory organ development; GO:0007423 malpha E(spl) region transcript malpha "CG8337, E(spl)malpha, E(spl)malpha, E(spl)ma" CDMC32246 1 13 12 DAC19-I15 1-CG8365-RA_3 CG8365 AATCGGTGATGACTCACCTGGGACGCGTCTACAAGAACTTGCAGCAATTCCACGAAGCACAGTCC 65 FBan0008365 FBgn0000591 E(spl) 3 3R Notch signaling pathway; GO:0007219; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; mesoderm development; GO:0007498; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564 nucleus; GO:0005634 E(spl) Enhancer of split "CG8365, m8, E(spl)m8, E(spl)-m8, Hes, clone 1.71, E(spl)M8, E(spl) m8, En(spl)-C, e(spl), E(spl)bHLH, En(spl), Enhancer of split m8, Enhancer of split m7, Su(H)[[m8]], anon-EST:Liang-1.71, l(3)96Fd" CDMC32246 1 14 12 DAC19-I15 1-CG8365-RA_3 CG8365 AATCGGTGATGACTCACCTGGGACGCGTCTACAAGAACTTGCAGCAATTCCACGAAGCACAGTCC 65 FBan0008365 FBgn0000591 E(spl) 3 3R Notch signaling pathway; GO:0007219; cell fate commitment; GO:0045165; cell proliferation; GO:0008283; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; mesoderm development; GO:0007498; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0016564 nucleus; GO:0005634 E(spl) Enhancer of split "CG8365, m8, E(spl)m8, E(spl)-m8, Hes, clone 1.71, E(spl)M8, E(spl) m8, En(spl)-C, e(spl), E(spl)bHLH, En(spl), Enhancer of split m8, Enhancer of split m7, Su(H)[[m8]], anon-EST:Liang-1.71, l(3)96Fd" CDMC32247 1 15 12 DAC19-M03 17-CG8444-RA_1 CG8444 GCGACTACCCGGTGATCTTCAACATCATCCTGTGGTTCATGGTCGTCTTCGGACTGTCTCTGCTG 65 FBan0008444 FBgn0037671 CG8444 3 3R CG8444 CG8444 CDMC32247 1 16 12 DAC19-M03 17-CG8444-RA_1 CG8444 GCGACTACCCGGTGATCTTCAACATCATCCTGTGGTTCATGGTCGTCTTCGGACTGTCTCTGCTG 65 FBan0008444 FBgn0037671 CG8444 3 3R CG8444 CG8444 CDMC32248 1 17 12 DAC19-M15 3-CG8478-RA_2 CG8478 CTGGAACGTGCCTTGCACATCCATTTAATGCAGAACTGCGACAAGATACCGCCGTCCGAGAAGCG 65 FBan0008478 FBgn0037746 CG8478 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8478 CG8478 CDMC32248 1 18 12 DAC19-M15 3-CG8478-RA_2 CG8478 CTGGAACGTGCCTTGCACATCCATTTAATGCAGAACTGCGACAAGATACCGCCGTCCGAGAAGCG 65 FBan0008478 FBgn0037746 CG8478 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8478 CG8478 CDMC32249 1 19 12 DAC20-A03 22-CG7646-RA_2 CG7646 AGGCAATTTATGACATGCTAGGAGCGTGCTCATCTAATCGTCCAGCTGATTCAGCAGAAGAAAGAGCAA 69 FBan0007646 FBgn0036926 CG7646 3 3L calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG7646 CG7646 "BcDNA:RH69723, anon-EST:Posey160" CDMC32249 1 20 12 DAC20-A03 22-CG7646-RA_2 CG7646 AGGCAATTTATGACATGCTAGGAGCGTGCTCATCTAATCGTCCAGCTGATTCAGCAGAAGAAAGAGCAA 69 FBan0007646 FBgn0036926 CG7646 3 3L calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG7646 CG7646 "BcDNA:RH69723, anon-EST:Posey160" CDMC32250 1 21 12 DAC20-A15 3-CG7659-RA_2 CG7659 CCAAGGAGCTCTTCGATGCTCTTTTCGTGAATCCACAGCCGTATCCCTTGTTCGGACGAATGTTCCCCT 69 FBan0007659 FBgn0015550 tap 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423 specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 tap target of Poxn "CG7659, CG7659, target of poxn, bps, biparous, l(3)01658" CDMC32250 1 22 12 DAC20-A15 3-CG7659-RA_2 CG7659 CCAAGGAGCTCTTCGATGCTCTTTTCGTGAATCCACAGCCGTATCCCTTGTTCGGACGAATGTTCCCCT 69 FBan0007659 FBgn0015550 tap 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ development; GO:0007423 specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704 nucleus; GO:0005634 tap target of Poxn "CG7659, CG7659, target of poxn, bps, biparous, l(3)01658" CDMC32251 1 23 12 DAC20-E03 24-CG7705-RB_1 CG7705 ATTTTAACTACATTTAGTGTTGAATAAAATATAGTCTTTCTAAACAACAAAAGGTGAAACATGCAGGAG 69 FBan0007705 FBgn0038639 CG7705 3 3R CG7705 CG7705 CDMC32251 1 24 12 DAC20-E03 24-CG7705-RB_1 CG7705 ATTTTAACTACATTTAGTGTTGAATAAAATATAGTCTTTCTAAACAACAAAAGGTGAAACATGCAGGAG 69 FBan0007705 FBgn0038639 CG7705 3 3R CG7705 CG7705 CDMC32252 1 25 12 DAC20-E15 23-CG7714-RA_2 CG7714 GGCTGCCACCAAATAAGTCCTCGAGTTGATTCTATCCAAAACCCCAGATTTTGTGGCTGAATAAAGTGT 69 FBan0007714 FBgn0038645 CG7714 3 3R CG7714 CG7714 anon-EST:ParkEST066 CDMC32252 1 26 12 DAC20-E15 23-CG7714-RA_2 CG7714 GGCTGCCACCAAATAAGTCCTCGAGTTGATTCTATCCAAAACCCCAGATTTTGTGGCTGAATAAAGTGT 69 FBan0007714 FBgn0038645 CG7714 3 3R CG7714 CG7714 anon-EST:ParkEST066 CDMC32253 1 1 13 DAC20-I03 13-CG7753-RA_1 CG7753 GCAATGCCACTCTTAGTGTTCCCCGAAATTCATCCGGAAACGTGATCTCGGAATATCGACGAGTCAGCT 69 FBan0007753 FBgn0002716 mei-W68 2 2R DNA topological change; GO:0006265; early meiotic recombination nodule assembly; GO:0042139; late meiotic recombination nodule assembly; GO:0042140; meiotic DNA double-strand break formation; GO:0042138; meiotic recombination; GO:0007131 ATP binding; GO:0005524; ; GO:0005524; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3 mei-W68 meiotic W68 "CG7753, CG30132, mei W-68, l(2)k05603, W68, meiW68" CDMC32253 1 2 13 DAC20-I03 13-CG7753-RA_1 CG7753 GCAATGCCACTCTTAGTGTTCCCCGAAATTCATCCGGAAACGTGATCTCGGAATATCGACGAGTCAGCT 69 FBan0007753 FBgn0002716 mei-W68 2 2R DNA topological change; GO:0006265; early meiotic recombination nodule assembly; GO:0042139; late meiotic recombination nodule assembly; GO:0042140; meiotic DNA double-strand break formation; GO:0042138; meiotic recombination; GO:0007131 ATP binding; GO:0005524; ; GO:0005524; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3 mei-W68 meiotic W68 "CG7753, CG30132, mei W-68, l(2)k05603, W68, meiW68" CDMC32254 1 3 13 DAC20-I15 16-CG7763-RA_1 CG7763 GGCACTTCAACGAACTTGCAGCTGGAAAATCAAAATACTTCGCAACAACTGCTGACACACGGTACAGCA 69 FBan0007763 FBgn0040503 CG7763 2 2R sugar binding; GO:0005529; ; GO:0005529 CG7763 CG7763 "CK02422A, CK02422a, BEST:CK02422" CDMC32254 1 4 13 DAC20-I15 16-CG7763-RA_1 CG7763 GGCACTTCAACGAACTTGCAGCTGGAAAATCAAAATACTTCGCAACAACTGCTGACACACGGTACAGCA 69 FBan0007763 FBgn0040503 CG7763 2 2R sugar binding; GO:0005529; ; GO:0005529 CG7763 CG7763 "CK02422A, CK02422a, BEST:CK02422" CDMC32255 1 5 13 DAC20-M03 17-CG7796-RA_1 CG7796 GCGCGGCGGTATAAATGGCGACTCAAAATTGGATAATAATCTCGACTCGAGCGACAGTCCAATGTTTGA 69 FBan0007796 FBgn0040847 CG7796 2 2R CG7796 CG7796 CDMC32255 1 6 13 DAC20-M03 17-CG7796-RA_1 CG7796 GCGCGGCGGTATAAATGGCGACTCAAAATTGGATAATAATCTCGACTCGAGCGACAGTCCAATGTTTGA 69 FBan0007796 FBgn0040847 CG7796 2 2R CG7796 CG7796 CDMC32256 1 7 13 DAC20-M15 3-CG7807-RA_1 CG7807 GGTCGCCTCAGTCTCCTATCGAGCACCTCGAAATACAAGGTCACCATAGCCGAAGTACAGCGTCGACTC 69 FBan0007807 FBgn0023417 AP-2 3 3L "leg joint morphogenesis (sensu Endopterygota); GO:0016348; leg morphogenesis (sensu Endopterygota); GO:0007480; proboscis development; GO:0048728; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 AP-2 AP-2 "CG7807, DAP-2, dAP-2, dAP-2alpha, stummelbein" CDMC32256 1 8 13 DAC20-M15 3-CG7807-RA_1 CG7807 GGTCGCCTCAGTCTCCTATCGAGCACCTCGAAATACAAGGTCACCATAGCCGAAGTACAGCGTCGACTC 69 FBan0007807 FBgn0023417 AP-2 3 3L "leg joint morphogenesis (sensu Endopterygota); GO:0016348; leg morphogenesis (sensu Endopterygota); GO:0007480; proboscis development; GO:0048728; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 AP-2 AP-2 "CG7807, DAP-2, dAP-2, dAP-2alpha, stummelbein" CDMC32257 1 9 13 DAC21-A03 23-CG2530-RA_2 CG2530 TGAAACAAAATTCTGTCTAGCTGCTATGAGAAATTGTTGTCCGACGGTGAGAAAAGAGGAAATGAGCGA 69 FBan0002530 FBgn0010313 corto 3 3R protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0005515 centrosome; GO:0005813; nucleus; GO:0005634 corto corto "CG2530, CG2530, l(3)neo31, ccf, centrosomal and chromosomal factor, 7128, Centrosomal and chromosomal factor, l(3)07128, CP-1, Ccf: Centrosomal and chromosomal factor, anon-WO02059370.59, l(3)neo32, Ccf" CDMC32257 1 10 13 DAC21-A03 23-CG2530-RA_2 CG2530 TGAAACAAAATTCTGTCTAGCTGCTATGAGAAATTGTTGTCCGACGGTGAGAAAAGAGGAAATGAGCGA 69 FBan0002530 FBgn0010313 corto 3 3R protein binding; GO:0005515; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0005515 centrosome; GO:0005813; nucleus; GO:0005634 corto corto "CG2530, CG2530, l(3)neo31, ccf, centrosomal and chromosomal factor, 7128, Centrosomal and chromosomal factor, l(3)07128, CP-1, Ccf: Centrosomal and chromosomal factor, anon-WO02059370.59, l(3)neo32, Ccf" CDMC32258 1 11 13 DAC21-A15 13-CG2574-RA_1 CG2574 ATGAGTGAGTGCAATCCAGATGATCCGCTAGTCATGTGCATTGCCGATCAGTACAAAACCAATCGCAGG 69 FBan0002574 FBgn0030386 CG2574 X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG2574 CG2574 bs21b01.y1 CDMC32258 1 12 13 DAC21-A15 13-CG2574-RA_1 CG2574 ATGAGTGAGTGCAATCCAGATGATCCGCTAGTCATGTGCATTGCCGATCAGTACAAAACCAATCGCAGG 69 FBan0002574 FBgn0030386 CG2574 X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG2574 CG2574 bs21b01.y1 CDMC32259 1 13 13 DAC21-E03 11-CG2665-RA_1 CG2665 TGGAGGAGGTTCTAGGCTGGACATCAACAGAAGGGTAACTATAGTACCACCCGAAGGCGAACTCTCGTT 69 FBan0002665 FBgn0011694 PebII 2 2R PebII Protein ejaculatory bulb II "CG2665, PEBmeII, PEB" CDMC32259 1 14 13 DAC21-E03 11-CG2665-RA_1 CG2665 TGGAGGAGGTTCTAGGCTGGACATCAACAGAAGGGTAACTATAGTACCACCCGAAGGCGAACTCTCGTT 69 FBan0002665 FBgn0011694 PebII 2 2R PebII Protein ejaculatory bulb II "CG2665, PEBmeII, PEB" CDMC32260 1 15 13 DAC21-E15 3-CG2675-RA_1 CG2675 CGGCAGTAGGATCTTCGACCAGGGATTCTTCAAGGGCTACGATCTGTTTGTCTGGTACCTGGTCCTGCT 69 FBan0002675 FBgn0024994 Csat X X NOT CMP-sialic acid transport; GO:0015782; UDP-N-acetylgalactosamine transport; GO:0015789; UDP-galactose transport; GO:0015785; carbohydrate metabolism; GO:0005975; galactose transport; GO:0015757; protein amino acid glycosylation; GO:0006486 NOT CMP-sialic acid transporter activity; GO:0005456; NOT UDP-glucuronic acid transporter activity; GO:0005461; NOT UDP-xylose transporter activity; GO:0005464; UDP-N-acetylgalactosamine transporter activity; GO:0005463; ; GO:0005463; UDP-galactose transporter activity; GO:0005459; ; GO:0005459; ; GO:0005459; sugar porter activity; GO:0005351; ; GO:0005459; ; GO:0005456; ; GO:0005461; ; GO:0005464; ; GO:0005463; ; GO:0005351 Golgi membrane; GO:0000139; integral to membrane; GO:0016021 Csat Csat "CG2675, CG2675, CG2675, CG2675, anon-3Bb, EG:100G10.5, ugt, CSAT, DmUGT, DmNST, D.melanogaster nucleotide sugar transporter, dNST-1, dNST-2, UDP-Gal/UDP-GalNAc" CDMC32260 1 16 13 DAC21-E15 3-CG2675-RA_1 CG2675 CGGCAGTAGGATCTTCGACCAGGGATTCTTCAAGGGCTACGATCTGTTTGTCTGGTACCTGGTCCTGCT 69 FBan0002675 FBgn0024994 Csat X X NOT CMP-sialic acid transport; GO:0015782; UDP-N-acetylgalactosamine transport; GO:0015789; UDP-galactose transport; GO:0015785; carbohydrate metabolism; GO:0005975; galactose transport; GO:0015757; protein amino acid glycosylation; GO:0006486 NOT CMP-sialic acid transporter activity; GO:0005456; NOT UDP-glucuronic acid transporter activity; GO:0005461; NOT UDP-xylose transporter activity; GO:0005464; UDP-N-acetylgalactosamine transporter activity; GO:0005463; ; GO:0005463; UDP-galactose transporter activity; GO:0005459; ; GO:0005459; ; GO:0005459; sugar porter activity; GO:0005351; ; GO:0005459; ; GO:0005456; ; GO:0005461; ; GO:0005464; ; GO:0005463; ; GO:0005351 Golgi membrane; GO:0000139; integral to membrane; GO:0016021 Csat Csat "CG2675, CG2675, CG2675, CG2675, anon-3Bb, EG:100G10.5, ugt, CSAT, DmUGT, DmNST, D.melanogaster nucleotide sugar transporter, dNST-1, dNST-2, UDP-Gal/UDP-GalNAc" CDMC32261 1 17 13 DAC21-I03 23-CG2718-RC_1 CG2718 AGAAGGAAATATCACTGAAATCGGACGATATGCATATTAATCATTCATATCCATGAGCACGAATACACA 69 FBan0002718 FBgn0001142 Gs1 2 2L amino acid biosynthesis; GO:0008652; glutamine metabolism; GO:0006541; nitrogen fixation; GO:0009399 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; glutamate synthase activity; GO:0015930 ; EC:1.4.-.-; ; GO:0004356 ; EC:6.3.1.2; ; GO:0015930 ; EC:1.4.-.- mitochondrion; GO:0005739 Gs1 Glutamine synthetase 1 "CG2718, GSI, GS1, gsI, gs-m, mitochondrial glutamine synthetase, fs(2)P52, fs(2)throng, mt-gs, Glutamate-ammonia ligase, glutamine synthetase I, GsI, l(2)21Bc, thg, throng" CDMC32261 1 18 13 DAC21-I03 23-CG2718-RC_1 CG2718 AGAAGGAAATATCACTGAAATCGGACGATATGCATATTAATCATTCATATCCATGAGCACGAATACACA 69 FBan0002718 FBgn0001142 Gs1 2 2L amino acid biosynthesis; GO:0008652; glutamine metabolism; GO:0006541; nitrogen fixation; GO:0009399 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; glutamate synthase activity; GO:0015930 ; EC:1.4.-.-; ; GO:0004356 ; EC:6.3.1.2; ; GO:0015930 ; EC:1.4.-.- mitochondrion; GO:0005739 Gs1 Glutamine synthetase 1 "CG2718, GSI, GS1, gsI, gs-m, mitochondrial glutamine synthetase, fs(2)P52, fs(2)throng, mt-gs, Glutamate-ammonia ligase, glutamine synthetase I, GsI, l(2)21Bc, thg, throng" CDMC32262 1 19 13 DAC21-I15 23-CG2774-RA_12 CG2774 GCTATGCGCGCTATTAACTAATTCTGCGGGACCAAATTCGATCTTAATCTTGCGATTTGGAGCTACAAC 69 FBan0002774 FBgn0031534 CG2774 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 CG2774 CG2774 CDMC32262 1 20 13 DAC21-I15 23-CG2774-RA_12 CG2774 GCTATGCGCGCTATTAACTAATTCTGCGGGACCAAATTCGATCTTAATCTTGCGATTTGGAGCTACAAC 69 FBan0002774 FBgn0031534 CG2774 2 2L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 CG2774 CG2774 CDMC32263 1 21 13 DAC21-M03 18-CG2841-RC_4 CG2841 CGTATAGAAAAACCACTGGATCAGGACCAAAACTCCCTTCAAAACCATTCCTCTACATTGCCGCGTCCA 69 FBan0002841 FBgn0003159 ptr X X ptr proximal to raf "CG2841, CG2841, EG:BACH48C10.5" CDMC32263 1 22 13 DAC21-M03 18-CG2841-RC_4 CG2841 CGTATAGAAAAACCACTGGATCAGGACCAAAACTCCCTTCAAAACCATTCCTCTACATTGCCGCGTCCA 69 FBan0002841 FBgn0003159 ptr X X ptr proximal to raf "CG2841, CG2841, EG:BACH48C10.5" CDMC32264 1 23 13 DAC21-M15 15-CG2861-RA_1 CG2861 GCCGTCTCCCAGTACATATCCAATGGGTGGTATTCCCTTTCAGAACAATAACACGCTCTATCCCCCGAT 69 FBan0002861 FBgn0029728 CG2861 X X CG2861 CG2861 CDMC32264 1 24 13 DAC21-M15 15-CG2861-RA_1 CG2861 GCCGTCTCCCAGTACATATCCAATGGGTGGTATTCCCTTTCAGAACAATAACACGCTCTATCCCCCGAT 69 FBan0002861 FBgn0029728 CG2861 X X CG2861 CG2861 CDMC32265 1 25 13 DAC22-A03 6-CG14501-RA_3 CG14501 GACCCCCAGCGTTAAGATCGACATTAGCACTTGCCAATCGAACCGTCCGATGGAATCGCGAACGG 65 FBgn0034319 CDMC32265 1 26 13 DAC22-A03 6-CG14501-RA_3 CG14501 GACCCCCAGCGTTAAGATCGACATTAGCACTTGCCAATCGAACCGTCCGATGGAATCGCGAACGG 65 FBgn0034319 CDMC32266 1 1 14 DAC22-A15 3-CG14526-RA_1 CG14526 GAGAATGTGCGATATACAAGCCTACTTGGGGCCAAACAGATGCGGGAGATGCTTCACAAGCCGGC 65 FBan0014526 FBgn0027578 CG14526 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14526 CG14526 BcDNA:GH07188 CDMC32266 1 2 14 DAC22-A15 3-CG14526-RA_1 CG14526 GAGAATGTGCGATATACAAGCCTACTTGGGGCCAAACAGATGCGGGAGATGCTTCACAAGCCGGC 65 FBan0014526 FBgn0027578 CG14526 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; zinc ion binding; GO:0008270; ; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14526 CG14526 BcDNA:GH07188 CDMC32267 1 3 14 DAC22-E03 1-CG14624-RA_2 CG14624 CACCTCGACATCCTGGTCAGCCTGATCAGCCTAATCAGCTGTTTTGCATTGATGAACGCCCAGCA 65 FBan0014624 FBgn0040357 CG14624 X X CG14624 CG14624 "BACR42I17.9, EG:BACR42I17.9" CDMC32267 1 4 14 DAC22-E03 1-CG14624-RA_2 CG14624 CACCTCGACATCCTGGTCAGCCTGATCAGCCTAATCAGCTGTTTTGCATTGATGAACGCCCAGCA 65 FBan0014624 FBgn0040357 CG14624 X X CG14624 CG14624 "BACR42I17.9, EG:BACR42I17.9" CDMC32268 1 5 14 DAC22-E15 1-CG14636-RA_1 CG14636 ATTGCGCTTTGGACGGAACCTTGACCCCTCTAAGGTGCGAGTGATAAACTTCAAGTCCAGCACGG 65 FBan0014636 FBgn0037217 CG14636 3 3R CG14636 CG14636 CDMC32268 1 6 14 DAC22-E15 1-CG14636-RA_1 CG14636 ATTGCGCTTTGGACGGAACCTTGACCCCTCTAAGGTGCGAGTGATAAACTTCAAGTCCAGCACGG 65 FBan0014636 FBgn0037217 CG14636 3 3R CG14636 CG14636 CDMC32269 1 7 14 DAC22-I03 1-CG14740-RA_1 CG14740 CTAACGTGTTTAGGGATGGCGAAGGTTCACGGGAGGTCAACTATGAGGAGGACTGGTCCGGCAAC 65 FBan0014740 FBgn0037988 CG14740 3 3R citrate metabolism; GO:0006101; tricarboxylic acid cycle; GO:0006099 citrate (Si)-synthase activity; GO:0004108 ; EC:2.3.3.1; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0004108 ; EC:2.3.3.1; ; GO:0016829 ; EC:4.-.-.-; ; GO:0004108 ; EC:2.3.3.1 mitochondrial matrix; GO:0005759 CG14740 CG14740 anon-WO0140519.178 CDMC32269 1 8 14 DAC22-I03 1-CG14740-RA_1 CG14740 CTAACGTGTTTAGGGATGGCGAAGGTTCACGGGAGGTCAACTATGAGGAGGACTGGTCCGGCAAC 65 FBan0014740 FBgn0037988 CG14740 3 3R citrate metabolism; GO:0006101; tricarboxylic acid cycle; GO:0006099 citrate (Si)-synthase activity; GO:0004108 ; EC:2.3.3.1; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0004108 ; EC:2.3.3.1; ; GO:0016829 ; EC:4.-.-.-; ; GO:0004108 ; EC:2.3.3.1 mitochondrial matrix; GO:0005759 CG14740 CG14740 anon-WO0140519.178 CDMC32270 1 9 14 DAC22-I15 15-CG14770-RA_1 CG14770 CTCTGAAGATCCACGACTACCACCAGGGGCACGAGGAGTACGAGCACCACGACCATCATGAGCAC 65 FBan0014770 FBgn0029573 CG14770 X X CG14770 CG14770 CDMC32270 1 10 14 DAC22-I15 15-CG14770-RA_1 CG14770 CTCTGAAGATCCACGACTACCACCAGGGGCACGAGGAGTACGAGCACCACGACCATCATGAGCAC 65 FBan0014770 FBgn0029573 CG14770 X X CG14770 CG14770 CDMC32271 1 11 14 DAC22-M03 2-CG14827-RA_1 CG14827 CTGCTCCAGCTATGCAACTTAGCGATCTAAGCCTCACACCCGATGAGATCCAAACTCCGGAGCGG 65 FBan0014827 FBgn0016036 mei-P22 3 3L meiotic DNA double-strand break formation; GO:0042138; meiotic recombination; GO:0007131 mei-P22 meiotic P22 "CG14827, CG14827, CG14827, MEI-P22, meiotic P22" CDMC32271 1 12 14 DAC22-M03 2-CG14827-RA_1 CG14827 CTGCTCCAGCTATGCAACTTAGCGATCTAAGCCTCACACCCGATGAGATCCAAACTCCGGAGCGG 65 FBan0014827 FBgn0016036 mei-P22 3 3L meiotic DNA double-strand break formation; GO:0042138; meiotic recombination; GO:0007131 mei-P22 meiotic P22 "CG14827, CG14827, CG14827, MEI-P22, meiotic P22" CDMC32272 1 13 14 DAC22-M15 3-CG14852-RA_4 CG14852 CTTGGCCTTCTGGTCCTGTGCTTTTCCAGCTACAGTTTTGCCGAAGACGATCCCACCGATGGAAG 65 FBan0014852 FBgn0038242 CG14852 3 3R CG14852 CG14852 CDMC32272 1 14 14 DAC22-M15 3-CG14852-RA_4 CG14852 CTTGGCCTTCTGGTCCTGTGCTTTTCCAGCTACAGTTTTGCCGAAGACGATCCCACCGATGGAAG 65 FBan0014852 FBgn0038242 CG14852 3 3R CG14852 CG14852 CDMC32273 1 15 14 DAC23-A03 9-CG6733-RA_1 CG6733 GGCATGGCGGAGTTTGTTAAGACGGATTACTACAAGAAAATGAACGCGGGATTCAGCCTGGACGAAGGC 69 FBan0006733 FBgn0039052 CG6733 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6733 CG6733 CDMC32273 1 16 14 DAC23-A03 9-CG6733-RA_1 CG6733 GGCATGGCGGAGTTTGTTAAGACGGATTACTACAAGAAAATGAACGCGGGATTCAGCCTGGACGAAGGC 69 FBan0006733 FBgn0039052 CG6733 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG6733 CG6733 CDMC32274 1 17 14 DAC23-A15 1-CG6744-RA_1 CG6744 ACCGGGATGCGTACATTCGGAAGAACGTGGTACCGCGGGAATACAGAAAGCATTTCCCATTGGTCATGA 69 FBan0006744 FBgn0037901 CG6744 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 CG6744 CG6744 CDMC32274 1 18 14 DAC23-A15 1-CG6744-RA_1 CG6744 ACCGGGATGCGTACATTCGGAAGAACGTGGTACCGCGGGAATACAGAAAGCATTTCCCATTGGTCATGA 69 FBan0006744 FBgn0037901 CG6744 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 CG6744 CG6744 CDMC32275 1 19 14 DAC23-E03 23-CG6775-RA_1 CG6775 CGGCGAATCGGTTTTTTTCTATACAGACCTTTACAACTCTAGGCTAGTAAGCAAAACTATGTTTTTTTT 69 FBan0006775 FBgn0003244 rg X X cone cell differentiation (sensu Endopterygota); GO:0042674; electron transport; GO:0006118; protein localization; GO:0008104; protein targeting; GO:0006605 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; protein kinase A binding; GO:0051018; ; GO:0051018; ; GO:0051018 cytoplasm; GO:0005737; integral to membrane; GO:0016021 rg rugose "CG6775, fas, facetious, Akap550, DAKAP550, A kinase anchor protein 550, Drosophila A kinase anchor protein, pebbled" CDMC32275 1 20 14 DAC23-E03 23-CG6775-RA_1 CG6775 CGGCGAATCGGTTTTTTTCTATACAGACCTTTACAACTCTAGGCTAGTAAGCAAAACTATGTTTTTTTT 69 FBan0006775 FBgn0003244 rg X X cone cell differentiation (sensu Endopterygota); GO:0042674; electron transport; GO:0006118; protein localization; GO:0008104; protein targeting; GO:0006605 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; protein kinase A binding; GO:0051018; ; GO:0051018; ; GO:0051018 cytoplasm; GO:0005737; integral to membrane; GO:0016021 rg rugose "CG6775, fas, facetious, Akap550, DAKAP550, A kinase anchor protein 550, Drosophila A kinase anchor protein, pebbled" CDMC32276 1 21 14 DAC23-E15 14-CG6790-RA_2 CG6790 GCTGCGGTAATGATTGCGTCGATTTACTGCAACTGTCCTTTGAGCTTGGCCTATATCCTCTGTGTTGGC 69 FBan0006790 FBgn0037915 CG6790 3 3R CG6790 CG6790 "anon-WO0140519.186, NEST:bs22e02" CDMC32276 1 22 14 DAC23-E15 14-CG6790-RA_2 CG6790 GCTGCGGTAATGATTGCGTCGATTTACTGCAACTGTCCTTTGAGCTTGGCCTATATCCTCTGTGTTGGC 69 FBan0006790 FBgn0037915 CG6790 3 3R CG6790 CG6790 "anon-WO0140519.186, NEST:bs22e02" CDMC32277 1 23 14 DAC23-I03 13-CG6829-RA_1 CG6829 CGGCACACTTCGCTTGTTTTGGACACTGCTCTCTAAACAGGAGGAAATGGTCCAGAAATTTGTGGAGGA 69 FBan0006829 FBgn0024252 Ark 2 2R apoptosis; GO:0006915; caspase activation; GO:0006919; caspase activation via cytochrome c; GO:0008635; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of retinal programmed cell death; GO:0046668; response to DNA damage stimulus; GO:0006974; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activator activity; GO:0008656; ; GO:0008656; ; GO:0005515; ; GO:0008656 Ark Apaf-1-related-killer "CG6829, CG6829, T1, Transcription unit 1, dark, Dark, Drosophila Apaf-1-related killer, dapaf-1L, dapaf-1S, DARK, Apaf-1 related killer, Hac1, dapaf-1, hac-1, Hac-1/Dark, ark, dark/hac-1/dapaf-1, dark/dapaf-1/hac-1, dApaf-1/DARK/HAC-1, arc, Hac-1, dApaf-1, Dapaf-1, ARK, dArk, Dark/Hac-1/dApaf-1, dapaf, D-Apaf-1, Dark/Dapaf-1/HAC1, anon-53Fa" CDMC32277 1 24 14 DAC23-I03 13-CG6829-RA_1 CG6829 CGGCACACTTCGCTTGTTTTGGACACTGCTCTCTAAACAGGAGGAAATGGTCCAGAAATTTGTGGAGGA 69 FBan0006829 FBgn0024252 Ark 2 2R apoptosis; GO:0006915; caspase activation; GO:0006919; caspase activation via cytochrome c; GO:0008635; induction of apoptosis; GO:0006917; programmed cell death; GO:0012501; regulation of retinal programmed cell death; GO:0046668; response to DNA damage stimulus; GO:0006974; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activator activity; GO:0008656; ; GO:0008656; ; GO:0005515; ; GO:0008656 Ark Apaf-1-related-killer "CG6829, CG6829, T1, Transcription unit 1, dark, Dark, Drosophila Apaf-1-related killer, dapaf-1L, dapaf-1S, DARK, Apaf-1 related killer, Hac1, dapaf-1, hac-1, Hac-1/Dark, ark, dark/hac-1/dapaf-1, dark/dapaf-1/hac-1, dApaf-1/DARK/HAC-1, arc, Hac-1, dApaf-1, Dapaf-1, ARK, dArk, Dark/Hac-1/dApaf-1, dapaf, D-Apaf-1, Dark/Dapaf-1/HAC1, anon-53Fa" CDMC32278 1 25 14 DAC23-I15 1-CG6835-RC_1 CG6835 AGGATGTGTCGTACAACATTTGCGACCAGCGGTTCCACGAGTTCTACATTCGCGAGACATATCCGCACA 69 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC32278 1 26 14 DAC23-I15 1-CG6835-RC_1 CG6835 AGGATGTGTCGTACAACATTTGCGACCAGCGGTTCCACGAGTTCTACATTCGCGAGACATATCCGCACA 69 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC32279 1 1 15 DAC23-M03 8-CG6871-RA_1 CG6871 GCACTGATCCGGATTACAGCATTCGCGATCTGTACAACAGGATCAAGACCTGCAAGTTCCCCAGTTGGA 69 FBan0006871 FBgn0000261 Cat 3 3L aging; GO:0007568; calcium-dependent cell-cell adhesion; GO:0016339; defense response; GO:0006952; determination of adult life span; GO:0008340; electron transport; GO:0006118; response to hydrogen peroxide; GO:0042542; response to oxidative stress; GO:0006979 heme binding; GO:0020037; antioxidant activity; GO:0016209; catalase activity; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0020037; ; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6 peroxisome; GO:0005777; plasma membrane; GO:0005886 Cat Catalase "CG6871, CG6871, CAT, DMCATHPO, CatA, CATA, DROCATHPO, CATHPO, catalase, cytosolic catalase, bs36h11.y1, CT21282, U00145, cat" CDMC32279 1 2 15 DAC23-M03 8-CG6871-RA_1 CG6871 GCACTGATCCGGATTACAGCATTCGCGATCTGTACAACAGGATCAAGACCTGCAAGTTCCCCAGTTGGA 69 FBan0006871 FBgn0000261 Cat 3 3L aging; GO:0007568; calcium-dependent cell-cell adhesion; GO:0016339; defense response; GO:0006952; determination of adult life span; GO:0008340; electron transport; GO:0006118; response to hydrogen peroxide; GO:0042542; response to oxidative stress; GO:0006979 heme binding; GO:0020037; antioxidant activity; GO:0016209; catalase activity; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0020037; ; GO:0004096 ; EC:1.11.1.6; ; GO:0004096 ; EC:1.11.1.6 peroxisome; GO:0005777; plasma membrane; GO:0005886 Cat Catalase "CG6871, CG6871, CAT, DMCATHPO, CatA, CATA, DROCATHPO, CATHPO, catalase, cytosolic catalase, bs36h11.y1, CT21282, U00145, cat" CDMC32280 1 3 15 DAC23-M15 15-CG6885-RA_2 CG6885 TTCCACTGGAGGCGTGTGTCATCAGAAGGATGAAGGTGACGGTCAAGAGATTTTGCGTCTCGCCTAAGA 69 FBan0006885 FBgn0036810 CG6885 3 3L CG6885 CG6885 anon-WO0118547.731 CDMC32280 1 4 15 DAC23-M15 15-CG6885-RA_2 CG6885 TTCCACTGGAGGCGTGTGTCATCAGAAGGATGAAGGTGACGGTCAAGAGATTTTGCGTCTCGCCTAAGA 69 FBan0006885 FBgn0036810 CG6885 3 3L CG6885 CG6885 anon-WO0118547.731 CDMC32281 1 5 15 DAC24-A03 7-CG2146-RC_1 CG2146 GGGGCGATATTTGCATGTGGGAGACTGGCATGATAATCCGCTACAATATCGGCTGCATTGAGGATTGGG 69 FBan0002146 FBgn0015933 didum 2 2R RNA localization; GO:0006403; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 "actin binding; GO:0003779; calmodulin binding; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003779; ; GO:0005516; ; GO:0003774" myosin; GO:0016459 didum dilute class unconventional myosin "CG2146, CG2146, myosin-V, myosin V, MyoV43CD, NMC7, 43CD, MYOV, DmV, MyoV, MyosinV, NEST:bs14c05" CDMC32281 1 6 15 DAC24-A03 7-CG2146-RC_1 CG2146 GGGGCGATATTTGCATGTGGGAGACTGGCATGATAATCCGCTACAATATCGGCTGCATTGAGGATTGGG 69 FBan0002146 FBgn0015933 didum 2 2R RNA localization; GO:0006403; intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 "actin binding; GO:0003779; calmodulin binding; GO:0005516; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003779; ; GO:0005516; ; GO:0003774" myosin; GO:0016459 didum dilute class unconventional myosin "CG2146, CG2146, myosin-V, myosin V, MyoV43CD, NMC7, 43CD, MYOV, DmV, MyoV, MyosinV, NEST:bs14c05" CDMC32282 1 7 15 DAC24-A15 18-CG2162-RA_3 CG2162 GGCGCATCATGAAACAAACCTTCAACTCAGATGTGCTGGAGATTCCCGAGAAAATAGAGACATCGGCAA 69 FBan0002162 FBgn0035388 CG2162 3 3L CG2162 CG2162 anon-EST:Posey170 CDMC32282 1 8 15 DAC24-A15 18-CG2162-RA_3 CG2162 GGCGCATCATGAAACAAACCTTCAACTCAGATGTGCTGGAGATTCCCGAGAAAATAGAGACATCGGCAA 69 FBan0002162 FBgn0035388 CG2162 3 3L CG2162 CG2162 anon-EST:Posey170 CDMC32283 1 9 15 DAC24-E03 3-CG2199-RA_1 CG2199 ACGCCGCCAAACTACAGTGCACCCTATGCAAGGAAGTCTACCAGAACCAAATGGATTACGTGGCTCACT 69 FBan0002199 FBgn0035213 CG2199 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2199 CG2199 CDMC32283 1 10 15 DAC24-E03 3-CG2199-RA_1 CG2199 ACGCCGCCAAACTACAGTGCACCCTATGCAAGGAAGTCTACCAGAACCAAATGGATTACGTGGCTCACT 69 FBan0002199 FBgn0035213 CG2199 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG2199 CG2199 CDMC32284 1 11 15 DAC24-E15 16-CG2207-RA_1 CG2207 GCTGATATTTAAGGCGTGCTTGGTGATCCAAAAACCCTCAGTTACAACGTGTTTTCTCGCTTCGCGTTT 69 FBan0002207 FBgn0022893 Df31 2 2L establishment and/or maintenance of chromatin architecture; GO:0006325; nucleosome assembly; GO:0006334 histone binding; GO:0042393; ; GO:0042393 chromatin; GO:0000785 Df31 Decondensation factor 31 "CG2207, CG2207, CG2207, CG2207, CG2207, CG2207, DF31, clone 1.46, LD04967, anon1A4, DF 31, anon-EST:Posey126, anon-WO0153538.53, anon-EST:Liang-1.46, BEST:LD04967, anon-EST:fe1A4, l(2)k05815, anon-fast-evolving-1A4, Decondensation factor 31" CDMC32284 1 12 15 DAC24-E15 16-CG2207-RA_1 CG2207 GCTGATATTTAAGGCGTGCTTGGTGATCCAAAAACCCTCAGTTACAACGTGTTTTCTCGCTTCGCGTTT 69 FBan0002207 FBgn0022893 Df31 2 2L establishment and/or maintenance of chromatin architecture; GO:0006325; nucleosome assembly; GO:0006334 histone binding; GO:0042393; ; GO:0042393 chromatin; GO:0000785 Df31 Decondensation factor 31 "CG2207, CG2207, CG2207, CG2207, CG2207, CG2207, DF31, clone 1.46, LD04967, anon1A4, DF 31, anon-EST:Posey126, anon-WO0153538.53, anon-EST:Liang-1.46, BEST:LD04967, anon-EST:fe1A4, l(2)k05815, anon-fast-evolving-1A4, Decondensation factor 31" CDMC32285 1 13 15 DAC24-I03 18-CG2257-RA_2 CG2257 CGCCAGCCTACGGAACTACCGCTAACACTAACACTGACAACAGCCTAATACAAATGCTTCGAGAATCCA 69 FBan0002257 FBgn0029996 Ubc-E2H X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Ubc-E2H Ubc-E2H "CG2257, CG2257, dUbc-E2H" CDMC32285 1 14 15 DAC24-I03 18-CG2257-RA_2 CG2257 CGCCAGCCTACGGAACTACCGCTAACACTAACACTGACAACAGCCTAATACAAATGCTTCGAGAATCCA 69 FBan0002257 FBgn0029996 Ubc-E2H X X protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Ubc-E2H Ubc-E2H "CG2257, CG2257, dUbc-E2H" CDMC32286 1 15 15 DAC24-I15 22-CG2272-RA_1 CG2272 GCCAGAGGAGTGGCTAGAAAATTGCAATGTGTAGCACAGAAGTGAGGACGAACTTTTGAGGATCAAACG 69 FBan0002272 FBgn0030018 slpr X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of JNK activity; GO:0007257; activation of JNKK activity; GO:0007256; cell surface receptor linked signal transduction; GO:0007166; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; JUN kinase kinase kinase activity; GO:0004706 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; protein homodimerization activity; GO:0042803; ; GO:0004706 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0042803 cellular component unknown; GO:0008372 slpr slipper "CG2272, MLK2, dMLK, dMLK2, Mlk2, Mixed lineage protein kinase 2, slipper" CDMC32286 1 16 15 DAC24-I15 22-CG2272-RA_1 CG2272 GCCAGAGGAGTGGCTAGAAAATTGCAATGTGTAGCACAGAAGTGAGGACGAACTTTTGAGGATCAAACG 69 FBan0002272 FBgn0030018 slpr X X "JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of JNK activity; GO:0007257; activation of JNKK activity; GO:0007256; cell surface receptor linked signal transduction; GO:0007166; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; protein amino acid autophosphorylation; GO:0046777; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; JUN kinase kinase kinase activity; GO:0004706 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; ; GO:0004706 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; protein homodimerization activity; GO:0042803; ; GO:0004706 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0042803 cellular component unknown; GO:0008372 slpr slipper "CG2272, MLK2, dMLK, dMLK2, Mlk2, Mixed lineage protein kinase 2, slipper" CDMC32287 1 17 15 DAC24-M03 23-CG2368-RB_20 CG2368 ATGACCCACAGACAAAAAATTCCCAAGGGTAGGATAAAGCAATCACAAAACCACTTTTCAACTAGATGG 69 FBan0002368 FBgn0004399 psq 2 2R "gene silencing; GO:0016458; pole plasm assembly; GO:0007315; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 psq pipsqueak "CG2368, CG2368, CG2368, zep, zepplin, psk, pipsqueak, BTB-V, psq-1, pip, Psq, BtbV, BTB-protein-V, zeppelin" CDMC32287 1 18 15 DAC24-M03 23-CG2368-RB_20 CG2368 ATGACCCACAGACAAAAAATTCCCAAGGGTAGGATAAAGCAATCACAAAACCACTTTTCAACTAGATGG 69 FBan0002368 FBgn0004399 psq 2 2R "gene silencing; GO:0016458; pole plasm assembly; GO:0007315; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 psq pipsqueak "CG2368, CG2368, CG2368, zep, zepplin, psk, pipsqueak, BTB-V, psq-1, pip, Psq, BtbV, BTB-protein-V, zeppelin" CDMC32288 1 19 15 DAC24-M15 17-CG2411-RA_1 CG2411 ACGAAGCGAGGAACGATTGTAAACGCGGCATTTATCCATGTACATTTGTTGCACGAAGACTGACTGTCT 69 FBan0002411 FBgn0003892 ptc 2 2R "Bolwig's organ morphogenesis; GO:0001746; anterior/posterior lineage restriction, imaginal disc; GO:0048099; anterior/posterior pattern formation; GO:0009952; blastoderm segmentation; GO:0007350; cell-cell signaling; GO:0007267; dephosphorylation; GO:0016311; embryonic pattern specification; GO:0009880; eye-antennal disc morphogenesis; GO:0007455; germ-line stem cell division; GO:0042078; negative regulation of smoothened activity; GO:0045877; negative regulation of smoothened signaling pathway; GO:0045879; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; proteolysis; GO:0006508; regulation of progression through mitotic cell cycle; GO:0007346; regulation of protein import into nucleus; GO:0042306; smoothened signaling pathway; GO:0007224; somatic stem cell division; GO:0048103; wing disc anterior/posterior pattern formation; GO:0048100" transmembrane receptor activity; GO:0004888; hedgehog receptor activity; GO:0008158; protein binding; GO:0005515; ; GO:0004888; ; GO:0008158; ; GO:0008158; ; GO:0005515 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 ptc patched "CG2411, tuf: tufted, rubr, PTC, l(2)k02507, Ptc_Dm, Ptc, BcDNA:RH36596, Conf, pat, Confused, patch, rubberneck, tufted, tuf" CDMC32288 1 20 15 DAC24-M15 17-CG2411-RA_1 CG2411 ACGAAGCGAGGAACGATTGTAAACGCGGCATTTATCCATGTACATTTGTTGCACGAAGACTGACTGTCT 69 FBan0002411 FBgn0003892 ptc 2 2R "Bolwig's organ morphogenesis; GO:0001746; anterior/posterior lineage restriction, imaginal disc; GO:0048099; anterior/posterior pattern formation; GO:0009952; blastoderm segmentation; GO:0007350; cell-cell signaling; GO:0007267; dephosphorylation; GO:0016311; embryonic pattern specification; GO:0009880; eye-antennal disc morphogenesis; GO:0007455; germ-line stem cell division; GO:0042078; negative regulation of smoothened activity; GO:0045877; negative regulation of smoothened signaling pathway; GO:0045879; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; proteolysis; GO:0006508; regulation of progression through mitotic cell cycle; GO:0007346; regulation of protein import into nucleus; GO:0042306; smoothened signaling pathway; GO:0007224; somatic stem cell division; GO:0048103; wing disc anterior/posterior pattern formation; GO:0048100" transmembrane receptor activity; GO:0004888; hedgehog receptor activity; GO:0008158; protein binding; GO:0005515; ; GO:0004888; ; GO:0008158; ; GO:0008158; ; GO:0005515 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 ptc patched "CG2411, tuf: tufted, rubr, PTC, l(2)k02507, Ptc_Dm, Ptc, BcDNA:RH36596, Conf, pat, Confused, patch, rubberneck, tufted, tuf" CDMC32289 1 21 15 DAC25-A03 3-CG10001-RA_2 CG10001 GATGCAAAGAAGAACATCACCTACGGCATGTGCACCTTCACGACGAACGACTTCCTTGGTCCGCG 65 FBan0010001 FBgn0039595 AR-2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004930; galanin receptor activity; GO:0004966; ; GO:0004966 integral to membrane; GO:0016021 AR-2 Allatostatin Receptor 2 "CG10001, CG10001, CG10001, CG10001, DAR-2, DAR, D.AlstR2, anon-WO0131005.7, anon-WO0170980.115, anon-WO0170980.116, Allatostatin Receptor 2" CDMC32289 1 22 15 DAC25-A03 3-CG10001-RA_2 CG10001 GATGCAAAGAAGAACATCACCTACGGCATGTGCACCTTCACGACGAACGACTTCCTTGGTCCGCG 65 FBan0010001 FBgn0039595 AR-2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004930; galanin receptor activity; GO:0004966; ; GO:0004966 integral to membrane; GO:0016021 AR-2 Allatostatin Receptor 2 "CG10001, CG10001, CG10001, CG10001, DAR-2, DAR, D.AlstR2, anon-WO0131005.7, anon-WO0170980.115, anon-WO0170980.116, Allatostatin Receptor 2" CDMC32290 1 23 15 DAC25-A15 3-CG10061-RA_5 CG10061 ATACGCTCTGGATGAGAGCTACGCCTCTAGTAGTTCTGTGGAATCGGAGGAAGTTCAGCCGCCCG 65 FBgn0037480 CDMC32290 1 24 15 DAC25-A15 3-CG10061-RA_5 CG10061 ATACGCTCTGGATGAGAGCTACGCCTCTAGTAGTTCTGTGGAATCGGAGGAAGTTCAGCCGCCCG 65 FBgn0037480 CDMC32291 1 25 15 DAC25-E03 3-CG10158-RA_1 CG10158 AACACTGCACCAGTGCATAGTCAAAGTGAAACACAAGCACCAAGTGTGACATTGGAGACGGCGCC 65 FBan0010158 FBgn0031871 CG10158 2 2L CG10158 CG10158 CDMC32291 1 26 15 DAC25-E03 3-CG10158-RA_1 CG10158 AACACTGCACCAGTGCATAGTCAAAGTGAAACACAAGCACCAAGTGTGACATTGGAGACGGCGCC 65 FBan0010158 FBgn0031871 CG10158 2 2L CG10158 CG10158 CDMC32292 1 1 16 DAC25-E15 1-CG10192-RA_1 CG10192 GAAGAAGCCTACTCCCGGTTTGGCGACGATTTTCCTGATCTGCTGGTGGATGTACCAAACGGCTG 65 FBan0010192 FBgn0039122 CG10192 3 3R autophagic cell death; GO:0048102; regulation of translation; GO:0006445; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 CG10192 CG10192 CDMC32292 1 2 16 DAC25-E15 1-CG10192-RA_1 CG10192 GAAGAAGCCTACTCCCGGTTTGGCGACGATTTTCCTGATCTGCTGGTGGATGTACCAAACGGCTG 65 FBan0010192 FBgn0039122 CG10192 3 3R autophagic cell death; GO:0048102; regulation of translation; GO:0006445; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 CG10192 CG10192 CDMC32293 1 3 16 DAC25-I03 15-CG10309-RA_9 CG10309 TGGAAGCAATGGCACGTCCACCAACGAGTTCAAGCGATTGATAACCCAGACAAAGCCACAACCGC 65 FBan0010309 FBgn0038418 CG10309 3 3R "development; GO:0007275; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; skeletal development; GO:0001501; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10309 CG10309 CDMC32293 1 4 16 DAC25-I03 15-CG10309-RA_9 CG10309 TGGAAGCAATGGCACGTCCACCAACGAGTTCAAGCGATTGATAACCCAGACAAAGCCACAACCGC 65 FBan0010309 FBgn0038418 CG10309 3 3R "development; GO:0007275; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; skeletal development; GO:0001501; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10309 CG10309 CDMC32294 1 5 16 DAC25-I15 9-CG10339-RA_3 CG10339 GAAGGTGATTGTGGTGACCTTCTCGTATCGGCTGAACATCTTCGGGTTCTTCACCACCGACGACG 65 FBan0010339 FBgn0034972 CG10339 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215; carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG10339 CG10339 CDMC32294 1 6 16 DAC25-I15 9-CG10339-RA_3 CG10339 GAAGGTGATTGTGGTGACCTTCTCGTATCGGCTGAACATCTTCGGGTTCTTCACCACCGACGACG 65 FBan0010339 FBgn0034972 CG10339 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215; carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG10339 CG10339 CDMC32295 1 7 16 DAC25-M03 1-CG10462-RA_1 CG10462 TACTTACGCAGTGAGGACCCGCTCAACATTTTGTCCCAACGTGATCAAACCAACTCAACCCCGCC 65 FBan0010462 FBgn0032815 CG10462 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10462 CG10462 BcDNA:SD07008 CDMC32295 1 8 16 DAC25-M03 1-CG10462-RA_1 CG10462 TACTTACGCAGTGAGGACCCGCTCAACATTTTGTCCCAACGTGATCAAACCAACTCAACCCCGCC 65 FBan0010462 FBgn0032815 CG10462 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10462 CG10462 BcDNA:SD07008 CDMC32296 1 9 16 DAC25-M15 1-CG10484-RA_1 CG10484 GTGGTATCCCAATACGGACCCAAGTTCCAACTGGACCACACATTCACCCTGATTATCCGGCTGCG 65 FBan0010484 FBgn0000486 Dox-A2 2 2L phenol metabolism; GO:0018958; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; enzyme activator activity; GO:0008047; ; GO:0004175; ; GO:0008047 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Dox-A2 Diphenol oxidase A2 "CG10484, l(2)37Bf, Diphenol oxidase, DPO, phenol oxidase, DoxA, DXA2_DROME, Dox, p58, phenoloxidase, DmePPO2, PO, proPO, prophenoloxidase, DoxA2, l(2)37Bf[+]" CDMC32296 1 10 16 DAC25-M15 1-CG10484-RA_1 CG10484 GTGGTATCCCAATACGGACCCAAGTTCCAACTGGACCACACATTCACCCTGATTATCCGGCTGCG 65 FBan0010484 FBgn0000486 Dox-A2 2 2L phenol metabolism; GO:0018958; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175; enzyme activator activity; GO:0008047; ; GO:0004175; ; GO:0008047 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Dox-A2 Diphenol oxidase A2 "CG10484, l(2)37Bf, Diphenol oxidase, DPO, phenol oxidase, DoxA, DXA2_DROME, Dox, p58, phenoloxidase, DmePPO2, PO, proPO, prophenoloxidase, DoxA2, l(2)37Bf[+]" CDMC32297 1 11 16 DAC26-A03 3-CG6167-RA_2 CG6167 CAGGAGCTGGACGATGATGAAATCGAGGCCAACAATCATCCGCATTCCACTCCTTCGCAAGTCGATTGC 69 FBan0006167 FBgn0032447 PICK1 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 PICK1 PICK1 "CG6167, CG6167" CDMC32297 1 12 16 DAC26-A03 3-CG6167-RA_2 CG6167 CAGGAGCTGGACGATGATGAAATCGAGGCCAACAATCATCCGCATTCCACTCCTTCGCAAGTCGATTGC 69 FBan0006167 FBgn0032447 PICK1 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 PICK1 PICK1 "CG6167, CG6167" CDMC32298 1 13 16 DAC26-A15 8-CG6176-RA_2 CG6176 TCTCCATCGTTTTAGCCGAAAAAGTTCTGTTCGTGGGACAAACAGTGCTGGTCTTCAAAATGGGGCGCA 69 FBan0006176 FBgn0026431 Grip75 2 2L DNA repair; GO:0006281; cell cycle; GO:0007049; microtubule nucleation; GO:0007020 DNA binding; GO:0003677; microtubule binding; GO:0008017; tubulin binding; GO:0015631; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; endonuclease activity; GO:0004519; ; GO:0015631; ; GO:0003677; ; GO:0004519 gamma-tubulin ring complex; GO:0008274 Grip75 Grip75 "CG6176, Dgrip75, 75p, Dgrip75/d75p, d75p, Dgrip75s" CDMC32298 1 14 16 DAC26-A15 8-CG6176-RA_2 CG6176 TCTCCATCGTTTTAGCCGAAAAAGTTCTGTTCGTGGGACAAACAGTGCTGGTCTTCAAAATGGGGCGCA 69 FBan0006176 FBgn0026431 Grip75 2 2L DNA repair; GO:0006281; cell cycle; GO:0007049; microtubule nucleation; GO:0007020 DNA binding; GO:0003677; microtubule binding; GO:0008017; tubulin binding; GO:0015631; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; endonuclease activity; GO:0004519; ; GO:0015631; ; GO:0003677; ; GO:0004519 gamma-tubulin ring complex; GO:0008274 Grip75 Grip75 "CG6176, Dgrip75, 75p, Dgrip75/d75p, d75p, Dgrip75s" CDMC32299 1 15 16 DAC26-E03 3-CG6206-RA_8 CG6206 GCCAGGTGGTGCGTGTTTACAACAAGGATTCATACGCCGAATTCGAATGGTTGGTTGGACCCATTCCCA 69 FBan0006206 FBgn0027611 CG6206 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG6206 CG6206 BcDNA:GH02419 CDMC32299 1 16 16 DAC26-E03 3-CG6206-RA_8 CG6206 GCCAGGTGGTGCGTGTTTACAACAAGGATTCATACGCCGAATTCGAATGGTTGGTTGGACCCATTCCCA 69 FBan0006206 FBgn0027611 CG6206 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG6206 CG6206 BcDNA:GH02419 CDMC32300 1 17 16 DAC26-E15 2-CG6214-RO_1 CG6214 GCTGTCGCATCTCAAGTCCTTTGTAAAGAGTTTGGCAGCTGGTCTGAATCACGAGATTGCCGAGGGTGG 69 FBan0006214 FBgn0032456 CG6214 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; protein amino acid phosphorylation; GO:0006468; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166 integral to membrane; GO:0016021 CG6214 CG6214 "dMRP, Multidrug-resistance protein, dMRP/CG6214" CDMC32300 1 18 16 DAC26-E15 2-CG6214-RO_1 CG6214 GCTGTCGCATCTCAAGTCCTTTGTAAAGAGTTTGGCAGCTGGTCTGAATCACGAGATTGCCGAGGGTGG 69 FBan0006214 FBgn0032456 CG6214 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; protein amino acid phosphorylation; GO:0006468; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166 integral to membrane; GO:0016021 CG6214 CG6214 "dMRP, Multidrug-resistance protein, dMRP/CG6214" CDMC32301 1 19 16 DAC26-I03 17-CG6249-RA_2 CG6249 AGCATTTTAACAATTGCCACATATTGGTCACACTGCATTGCACGTGTGTTTCCATTTGTTGATGCGGCT 69 FBan0006249 FBgn0032346 Csl4 2 2L mRNA processing; GO:0006397; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Csl4 Csl4 "CG6249, CG6249, CG6249, CG6249, dCsl4, CSL4" CDMC32301 1 20 16 DAC26-I03 17-CG6249-RA_2 CG6249 AGCATTTTAACAATTGCCACATATTGGTCACACTGCATTGCACGTGTGTTTCCATTTGTTGATGCGGCT 69 FBan0006249 FBgn0032346 Csl4 2 2L mRNA processing; GO:0006397; rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176; polytene chromosome; GO:0005700 Csl4 Csl4 "CG6249, CG6249, CG6249, CG6249, dCsl4, CSL4" CDMC32302 1 21 16 DAC26-I15 3-CG6269-RA_1 CG6269 CGTTCCTGAGAAAACCGAAATGCCCGAACTGTGAGCGAGAAATAGAGGTCTCCATGGTGCTGGCGATGA 69 FBan0006269 FBgn0024184 unc-4 X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 unc-4 unc-4 "CG6269, Dunc-4, DPHD-1, Paired HomeoDomain 1" CDMC32302 1 22 16 DAC26-I15 3-CG6269-RA_1 CG6269 CGTTCCTGAGAAAACCGAAATGCCCGAACTGTGAGCGAGAAATAGAGGTCTCCATGGTGCTGGCGATGA 69 FBan0006269 FBgn0024184 unc-4 X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 unc-4 unc-4 "CG6269, Dunc-4, DPHD-1, Paired HomeoDomain 1" CDMC32303 1 23 16 DAC26-M03 13-CG6311-RB_1 CG6311 GGATCCCGCAGTGACTGTTTTGCGTTAGGAGTAGAAACGATGACCAGACCTTAAAGGGATGTTGGTGGC 69 FBan0006311 FBgn0036735 CG6311 3 3L CG6311 CG6311 CDMC32303 1 24 16 DAC26-M03 13-CG6311-RB_1 CG6311 GGATCCCGCAGTGACTGTTTTGCGTTAGGAGTAGAAACGATGACCAGACCTTAAAGGGATGTTGGTGGC 69 FBan0006311 FBgn0036735 CG6311 3 3L CG6311 CG6311 CDMC32304 1 25 16 DAC26-M15 1-CG6325-RA_1 CG6325 GGGCGGTGTAATGCCAGAGAAGCCTGTGTGCACAAAGAAGCTAAGAAGACGCTATGTAGAGGAGGACGA 69 FBan0006325 FBgn0037814 CG6325 3 3R CG6325 CG6325 CDMC32304 1 26 16 DAC26-M15 1-CG6325-RA_1 CG6325 GGGCGGTGTAATGCCAGAGAAGCCTGTGTGCACAAAGAAGCTAAGAAGACGCTATGTAGAGGAGGACGA 69 FBan0006325 FBgn0037814 CG6325 3 3R CG6325 CG6325 CDMC32305 1 1 17 DAC27-A03 13-CG3682-RA_1 CG3682 TGGTGACGGAACACAAGACACACCAACCCAGATATATCACGATGTGGACTGAGAAAGAGTCCGAGCGAA 69 FBan0003682 FBgn0034789 PIP5K59B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphorylation; GO:0016310 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 PIP5K59B PIP5K59B "CG3682, CG17281, CG3682, CG3682, PIP5K 59B" CDMC32305 1 2 17 DAC27-A03 13-CG3682-RA_1 CG3682 TGGTGACGGAACACAAGACACACCAACCCAGATATATCACGATGTGGACTGAGAAAGAGTCCGAGCGAA 69 FBan0003682 FBgn0034789 PIP5K59B 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; phosphorylation; GO:0016310 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 PIP5K59B PIP5K59B "CG3682, CG17281, CG3682, CG3682, PIP5K 59B" CDMC32306 1 3 17 DAC27-A15 1-CG3691-RA_1 CG3691 TGCACCTAATGCGTGACATTAAGAAAGAGTGCGACTATTTGGGCATCCCTGATCCCGTACCGGCTACCA 69 FBan0003691 FBgn0035047 Pof 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003729 autosome; GO:0030849; chromosome; GO:0005694; ribosome; GO:0005840 Pof Painting of fourth "CG3691, cg3691, painting-of-fourth, Painting of fourth" CDMC32306 1 4 17 DAC27-A15 1-CG3691-RA_1 CG3691 TGCACCTAATGCGTGACATTAAGAAAGAGTGCGACTATTTGGGCATCCCTGATCCCGTACCGGCTACCA 69 FBan0003691 FBgn0035047 Pof 2 2R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003729 autosome; GO:0030849; chromosome; GO:0005694; ribosome; GO:0005840 Pof Painting of fourth "CG3691, cg3691, painting-of-fourth, Painting of fourth" CDMC32307 1 5 17 DAC27-E03 3-CG3733-RA_2 CG3733 GGCAAGCAGATCGATGTTTGCCTCAATCCCTACGCCGAGACAGAGAAAAAGGAATGGCGCAGTAACCTT 69 FBan0003733 FBgn0016132 Chd1 2 2L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0003678; ; GO:0008026 chromatin; GO:0000785; nucleus; GO:0005634; polytene chromosome interband; GO:0005705; polytene chromosome puff; GO:0005703 Chd1 Chromodomain-helicase-DNA-binding protein "CG3733, dCHD1, chromo-ATPase/helicase-DNA-binding domain, CHD-1, DmCHD1, chd1, CHD1" CDMC32307 1 6 17 DAC27-E03 3-CG3733-RA_2 CG3733 GGCAAGCAGATCGATGTTTGCCTCAATCCCTACGCCGAGACAGAGAAAAAGGAATGGCGCAGTAACCTT 69 FBan0003733 FBgn0016132 Chd1 2 2L chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0004386; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0003678; ; GO:0008026 chromatin; GO:0000785; nucleus; GO:0005634; polytene chromosome interband; GO:0005705; polytene chromosome puff; GO:0005703 Chd1 Chromodomain-helicase-DNA-binding protein "CG3733, dCHD1, chromo-ATPase/helicase-DNA-binding domain, CHD-1, DmCHD1, chd1, CHD1" CDMC32308 1 7 17 DAC27-E15 23-CG3743-RA_3 CG3743 TATTACCACCCCAGATCAAAAGCGATCCATGCCTTAGGGACGTAATAATATATTTATATGTGGGGGACT 69 FBan0003743 FBgn0040305 MTF-1 3 3L cell proliferation; GO:0008283; metal ion homeostasis; GO:0006875; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleoplasm; GO:0005654; nucleus; GO:0005634 MTF-1 MTF-1 "CG3743, mtf-1, dMTF-1, anon-WO0118547.411" CDMC32308 1 8 17 DAC27-E15 23-CG3743-RA_3 CG3743 TATTACCACCCCAGATCAAAAGCGATCCATGCCTTAGGGACGTAATAATATATTTATATGTGGGGGACT 69 FBan0003743 FBgn0040305 MTF-1 3 3L cell proliferation; GO:0008283; metal ion homeostasis; GO:0006875; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription; GO:0006350 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleoplasm; GO:0005654; nucleus; GO:0005634 MTF-1 MTF-1 "CG3743, mtf-1, dMTF-1, anon-WO0118547.411" CDMC32309 1 9 17 DAC27-I03 17-CG3779-RA_1 CG3779 ACTGGGGAAGATCCCTTAGTCACTCAACAATTGACCAAGCTACCAAGTTACCCACGAAAGTCCACCATA 69 FBan0003779 FBgn0002973 numb 2 2L Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; central nervous system development; GO:0007417; ectoderm development; GO:0007398; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; negative regulation of Notch signaling pathway; GO:0045746; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of Notch signaling pathway; GO:0008593; rhythmic behavior; GO:0007622; sensory organ precursor cell fate determination; GO:0016360; ventral cord development; GO:0007419 nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005102; ; GO:0005515; ; GO:0005112; ; GO:0005515; ; GO:0005515 basal cortex; GO:0045180; basal part of cell; GO:0045178; cytoplasm; GO:0005737; nucleus; GO:0005634 numb numb "CG3779, CG3779, l(2)03235, l(2)3235, d-numb, dNumb, d-Numb, nb, Numb, N7-1, l(2)s2201" CDMC32309 1 10 17 DAC27-I03 17-CG3779-RA_1 CG3779 ACTGGGGAAGATCCCTTAGTCACTCAACAATTGACCAAGCTACCAAGTTACCCACGAAAGTCCACCATA 69 FBan0003779 FBgn0002973 numb 2 2L Notch signaling pathway; GO:0007219; asymmetric cell division; GO:0008356; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; central nervous system development; GO:0007417; ectoderm development; GO:0007398; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; negative regulation of Notch signaling pathway; GO:0045746; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of Notch signaling pathway; GO:0008593; rhythmic behavior; GO:0007622; sensory organ precursor cell fate determination; GO:0016360; ventral cord development; GO:0007419 nucleic acid binding; GO:0003676; protein binding; GO:0005515; ; GO:0003676; receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005102; ; GO:0005515; ; GO:0005112; ; GO:0005515; ; GO:0005515 basal cortex; GO:0045180; basal part of cell; GO:0045178; cytoplasm; GO:0005737; nucleus; GO:0005634 numb numb "CG3779, CG3779, l(2)03235, l(2)3235, d-numb, dNumb, d-Numb, nb, Numb, N7-1, l(2)s2201" CDMC32310 1 11 17 DAC27-I15 15-CG3796-RA_1 CG3796 TCCCGGCGCCAATAAAAAACTGAGCAAAGTTAGCACACTGAAAATGGCAGTAGAGTACATACGGCGCTT 69 FBan0003796 FBgn0000022 ac X X "bristle morphogenesis; GO:0008407; central nervous system development; GO:0007417; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional activator activity; GO:0016563; ; GO:0003700; ; GO:0003704; ; GO:0016563 nucleus; GO:0005634 ac achaete "CG3796, CG3796, Hw: Hairy-wing, T5, AS-C T5, ascT5, Hairy wing, AS-C T5ac, 990 E5 F1, achaete-scute, Ac: Argentine Curly, EG:125H10.3, ASC, sc/T5, Hairy-wing, Hw, Ac" CDMC32310 1 12 17 DAC27-I15 15-CG3796-RA_1 CG3796 TCCCGGCGCCAATAAAAAACTGAGCAAAGTTAGCACACTGAAAATGGCAGTAGAGTACATACGGCGCTT 69 FBan0003796 FBgn0000022 ac X X "bristle morphogenesis; GO:0008407; central nervous system development; GO:0007417; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional activator activity; GO:0016563; ; GO:0003700; ; GO:0003704; ; GO:0016563 nucleus; GO:0005634 ac achaete "CG3796, CG3796, Hw: Hairy-wing, T5, AS-C T5, ascT5, Hairy wing, AS-C T5ac, 990 E5 F1, achaete-scute, Ac: Argentine Curly, EG:125H10.3, ASC, sc/T5, Hairy-wing, Hw, Ac" CDMC32311 1 13 17 DAC27-M03 2-CG3835-RA_1 CG3835 GCTCCTGGGCAAGAACTTCGTGCTCACTGAGGACCTGGAGGGATACAACATCTGCTTCCTTAAGAGGAT 69 FBan0003835 FBgn0023507 CG3835 X X carbohydrate metabolism; GO:0005975; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3835 CG3835 "EG:87B1.3, EG87B1" CDMC32311 1 14 17 DAC27-M03 2-CG3835-RA_1 CG3835 GCTCCTGGGCAAGAACTTCGTGCTCACTGAGGACCTGGAGGGATACAACATCTGCTTCCTTAAGAGGAT 69 FBan0003835 FBgn0023507 CG3835 X X carbohydrate metabolism; GO:0005975; electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3835 CG3835 "EG:87B1.3, EG87B1" CDMC32312 1 15 17 DAC27-M15 3-CG3845-RA_6 CG3845 TGTGACCACTCCAGATCGCTTCACCAAGCTTGTAGATGGTTTCCTCGAGCTTAAGCTGCCAGAGAAGGC 69 FBan0003845 FBgn0010488 l(2)01424 2 2R autophagic cell death; GO:0048102; regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 mRNA cap complex; GO:0005845 l(2)01424 lethal (2) 01424 "CG3845, CG3845, CG3845, CG3845" CDMC32312 1 16 17 DAC27-M15 3-CG3845-RA_6 CG3845 TGTGACCACTCCAGATCGCTTCACCAAGCTTGTAGATGGTTTCCTCGAGCTTAAGCTGCCAGAGAAGGC 69 FBan0003845 FBgn0010488 l(2)01424 2 2R autophagic cell death; GO:0048102; regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 mRNA cap complex; GO:0005845 l(2)01424 lethal (2) 01424 "CG3845, CG3845, CG3845, CG3845" CDMC32313 1 17 17 DAC28-A03 2-CG10170-RA_1 CG10170 CGGGGGTCTGCTAAGTGTAATGGAGGCTGTTTACAGTGGAGTGCCGATCTTGGGATTGCCTGTGTTCTT 69 FBan0010170 FBgn0039085 CG10170 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG10170 CG10170 CDMC32313 1 18 17 DAC28-A03 2-CG10170-RA_1 CG10170 CGGGGGTCTGCTAAGTGTAATGGAGGCTGTTTACAGTGGAGTGCCGATCTTGGGATTGCCTGTGTTCTT 69 FBan0010170 FBgn0039085 CG10170 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG10170 CG10170 CDMC32314 1 19 17 DAC28-A15 9-CG10181-RA_1 CG10181 CTGACCCTCGATGGAGTAAGGACCAAATTGGGCATAGTCTCTCAAGAACCCACTCTCTTCGAGCGCTCT 69 FBan0010181 FBgn0004513 Mdr65 3 3L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; multidrug transporter activity; GO:0015239; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626; ; GO:0015239" integral to plasma membrane; GO:0005887 Mdr65 Multiple drug resistance 65 "CG10181, P-glycoprotein65-Dm, Mdr65A" CDMC32314 1 20 17 DAC28-A15 9-CG10181-RA_1 CG10181 CTGACCCTCGATGGAGTAAGGACCAAATTGGGCATAGTCTCTCAAGAACCCACTCTCTTCGAGCGCTCT 69 FBan0010181 FBgn0004513 Mdr65 3 3L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; multidrug transporter activity; GO:0015239; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626; ; GO:0015239" integral to plasma membrane; GO:0005887 Mdr65 Multiple drug resistance 65 "CG10181, P-glycoprotein65-Dm, Mdr65A" CDMC32315 1 21 17 DAC28-E03 3-CG10215-RA_3 CG10215 ACGACATCGTGCCCGATTATGTGGTCGGTCGAACATCCTGCGTGCTGTACCTCTCGCTAAAGTACCATA 69 FBan0010215 FBgn0028434 Ercc1 2 2R nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684; protein binding; GO:0005515; ; GO:0005515; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0003677; ; GO:0000014 nucleus; GO:0005634 Ercc1 Ercc1 "CG10215, ERCC1" CDMC32315 1 22 17 DAC28-E03 3-CG10215-RA_3 CG10215 ACGACATCGTGCCCGATTATGTGGTCGGTCGAACATCCTGCGTGCTGTACCTCTCGCTAAAGTACCATA 69 FBan0010215 FBgn0028434 Ercc1 2 2R nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684; protein binding; GO:0005515; ; GO:0005515; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0003677; ; GO:0000014 nucleus; GO:0005634 Ercc1 Ercc1 "CG10215, ERCC1" CDMC32316 1 23 17 DAC28-E15 24-CG10225-RA_1 CG10225 TTTTTATACGATTCATACATGGAGAAATAAAACACTCACAACAAACACTAATTAATAAAGCGCGCCGTG 69 FBan0010225 FBgn0039110 CG10225 3 3R "intracellular protein transport; GO:0006886; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein targeting; GO:0006605" CG10225 CG10225 CDMC32316 1 24 17 DAC28-E15 24-CG10225-RA_1 CG10225 TTTTTATACGATTCATACATGGAGAAATAAAACACTCACAACAAACACTAATTAATAAAGCGCGCCGTG 69 FBan0010225 FBgn0039110 CG10225 3 3R "intracellular protein transport; GO:0006886; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein targeting; GO:0006605" CG10225 CG10225 CDMC32317 1 25 17 DAC28-I03 15-CG10254-RA_6 CG10254 GCACCCAACTGGGCAATGAGAACTCTCGTGTCTACAACGAGATGGCCATCATAAAAATTGCCCAATCCA 69 FBan0010254 FBgn0027512 CG10254 3 3R anti-apoptosis; GO:0006916; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; enzyme inhibitor activity; GO:0004857; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004857 CG10254 CG10254 BcDNA:LD22087 CDMC32317 1 26 17 DAC28-I03 15-CG10254-RA_6 CG10254 GCACCCAACTGGGCAATGAGAACTCTCGTGTCTACAACGAGATGGCCATCATAAAAATTGCCCAATCCA 69 FBan0010254 FBgn0027512 CG10254 3 3R anti-apoptosis; GO:0006916; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; enzyme inhibitor activity; GO:0004857; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004857 CG10254 CG10254 BcDNA:LD22087 CDMC32318 1 1 18 DAC28-I15 12-CG10267-RA_2 CG10267 ACACCATCGAGTACTTGGAGGACAACTACACCATCGAGATGAACTCCGATCAGACCGAGATCGTCCTGG 69 FBan0010267 FBgn0037446 CG10267 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10267 CG10267 anon-WO0118547.391 CDMC32318 1 2 18 DAC28-I15 12-CG10267-RA_2 CG10267 ACACCATCGAGTACTTGGAGGACAACTACACCATCGAGATGAACTCCGATCAGACCGAGATCGTCCTGG 69 FBan0010267 FBgn0037446 CG10267 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10267 CG10267 anon-WO0118547.391 CDMC32319 1 3 18 DAC28-M03 12-CG10302-RA_1 CG10302 CCGGACAGCAAGGCCTAGAGGTTTCTGCAAAAGGTCCTTGTTTAGTGTAGGCCGTCGTGATTAAAGCTT 69 FBan0010302 FBgn0032679 bsf 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730 cytoplasm; GO:0005737 bsf bicoid stability factor CG10302 CDMC32319 1 4 18 DAC28-M03 12-CG10302-RA_1 CG10302 CCGGACAGCAAGGCCTAGAGGTTTCTGCAAAAGGTCCTTGTTTAGTGTAGGCCGTCGTGATTAAAGCTT 69 FBan0010302 FBgn0032679 bsf 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730 cytoplasm; GO:0005737 bsf bicoid stability factor CG10302 CDMC32320 1 5 18 DAC28-M15 1-CG10317-RA_1 CG10317 CCATGTCAGAGGAAAACCAGAGGACGGATCTTGAGGGCGGTAGTAGCCTTTGCAACATGTCCATGTCGG 69 FBan0010317 FBgn0038423 CG10317 3 3R CG10317 CG10317 CDMC32320 1 6 18 DAC28-M15 1-CG10317-RA_1 CG10317 CCATGTCAGAGGAAAACCAGAGGACGGATCTTGAGGGCGGTAGTAGCCTTTGCAACATGTCCATGTCGG 69 FBan0010317 FBgn0038423 CG10317 3 3R CG10317 CG10317 CDMC32321 1 7 18 DAC29-A03 23-CG1387-RA_2 CG1387 AAGCCGGAATCTAATGGAATGGTTCTGAAAACGAAGGGATTAAATCGATCACAGATGAAGAAGACAGCA 69 FBan0001387 FBgn0030033 CG1387 X X CG1387 CG1387 CDMC32321 1 8 18 DAC29-A03 23-CG1387-RA_2 CG1387 AAGCCGGAATCTAATGGAATGGTTCTGAAAACGAAGGGATTAAATCGATCACAGATGAAGAAGACAGCA 69 FBan0001387 FBgn0030033 CG1387 X X CG1387 CG1387 CDMC32322 1 9 18 DAC29-A15 2-CG13893-RA_1 CG13893 CCCCTGGGAACCGTGTACTCCAACGAGATGGACGAGATTGGTTACATCTCTACACGACCGAACACCACT 69 FBan0013893 FBgn0035146 CG13893 3 3L intracellular protein transport; GO:0006886; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; protein carrier activity; GO:0008320; ; GO:0008320 intracellular; GO:0005622; membrane; GO:0016020 CG13893 CG13893 CDMC32322 1 10 18 DAC29-A15 2-CG13893-RA_1 CG13893 CCCCTGGGAACCGTGTACTCCAACGAGATGGACGAGATTGGTTACATCTCTACACGACCGAACACCACT 69 FBan0013893 FBgn0035146 CG13893 3 3L intracellular protein transport; GO:0006886; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; protein carrier activity; GO:0008320; ; GO:0008320 intracellular; GO:0005622; membrane; GO:0016020 CG13893 CG13893 CDMC32323 1 11 18 DAC29-E03 6-CG13939-RA_3 CG13939 TCGGCGAACTCCAAGTATCCCAGCTATGCTCATCTGTGCTATCCTGATTGCATTTATCGCGAGACGGGT 69 FBan0013939 FBgn0033931 Obp50e 2 2R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp50e Odorant-binding protein 50e "CG13939, CG13939, CG13939, CG13939, CG13939, Odorant-binding protein 50e" CDMC32323 1 12 18 DAC29-E03 6-CG13939-RA_3 CG13939 TCGGCGAACTCCAAGTATCCCAGCTATGCTCATCTGTGCTATCCTGATTGCATTTATCGCGAGACGGGT 69 FBan0013939 FBgn0033931 Obp50e 2 2R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp50e Odorant-binding protein 50e "CG13939, CG13939, CG13939, CG13939, CG13939, Odorant-binding protein 50e" CDMC32324 1 13 18 DAC29-E15 2-CG13964-RA_4 CG13964 GCCGACCAGTCCACGCCTTAATCTGTACGAGCTTCCAATTGTGACCCAAAGGAGCAACAGTACGGAACT 69 FBan0013964 FBgn0032831 CG13964 2 2L CG13964 CG13964 CDMC32324 1 14 18 DAC29-E15 2-CG13964-RA_4 CG13964 GCCGACCAGTCCACGCCTTAATCTGTACGAGCTTCCAATTGTGACCCAAAGGAGCAACAGTACGGAACT 69 FBan0013964 FBgn0032831 CG13964 2 2L CG13964 CG13964 CDMC32325 1 15 18 DAC29-I03 2-CG14001-RA_4 CG14001 ACGGAGGTATCTTCGCAGGACAAACCCGACACCGTCTCTTTGGAAGGCAAGGACAATAAGGACGACAAA 69 FBan0014001 FBgn0043362 bchs 2 2L lysosomal transport; GO:0007041; protein targeting; GO:0006605 zinc ion binding; GO:0008270; ; GO:0008270 axon; GO:0030424; cytoplasm; GO:0005737 bchs blue cheese "CG14001, CG9011, CG14001, CG9011, EP2299, DBEACH1, Beached, Beach1, Beached 1, dbeach1, beached, BcDNA:SD12984, bchd, blue cheese" CDMC32325 1 16 18 DAC29-I03 2-CG14001-RA_4 CG14001 ACGGAGGTATCTTCGCAGGACAAACCCGACACCGTCTCTTTGGAAGGCAAGGACAATAAGGACGACAAA 69 FBan0014001 FBgn0043362 bchs 2 2L lysosomal transport; GO:0007041; protein targeting; GO:0006605 zinc ion binding; GO:0008270; ; GO:0008270 axon; GO:0030424; cytoplasm; GO:0005737 bchs blue cheese "CG14001, CG9011, CG14001, CG9011, EP2299, DBEACH1, Beached, Beach1, Beached 1, dbeach1, beached, BcDNA:SD12984, bchd, blue cheese" CDMC32326 1 17 18 DAC29-I15 6-CG1401-RA_3 CG1401 TGCTCTGCGTAGCTCTAGATATTATGTTTTGTGCGCTACATGCACCCTGGAAATTCCGAACCCACGCCC 69 FBan0001401 FBgn0039632 cul-5 3 3R induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 vasopressin activated calcium mobilizing receptor activity; GO:0016931; ; GO:0016931 cul-5 cullin-5 "CG1401, CG1401, CG1401, CG1401, Cul5, CUL5, cullin-5" CDMC32326 1 18 18 DAC29-I15 6-CG1401-RA_3 CG1401 TGCTCTGCGTAGCTCTAGATATTATGTTTTGTGCGCTACATGCACCCTGGAAATTCCGAACCCACGCCC 69 FBan0001401 FBgn0039632 cul-5 3 3R induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 vasopressin activated calcium mobilizing receptor activity; GO:0016931; ; GO:0016931 cul-5 cullin-5 "CG1401, CG1401, CG1401, CG1401, Cul5, CUL5, cullin-5" CDMC32327 1 19 18 DAC29-M03 3-CG14040-RA_7 CG14040 GGCCTTTGTCAACTTGGCCACATTCGATCCCACCACCTACTATCTGCTACTGCAGCTACGTGTCGTTGT 69 FBan0014040 FBgn0031676 CG14040 2 2L carbohydrate transport; GO:0008643 UDP-galactose transporter activity; GO:0005459; sugar porter activity; GO:0005351; ; GO:0005459; ; GO:0005351 Golgi membrane; GO:0000139; integral to membrane; GO:0016021 CG14040 CG14040 CDMC32327 1 20 18 DAC29-M03 3-CG14040-RA_7 CG14040 GGCCTTTGTCAACTTGGCCACATTCGATCCCACCACCTACTATCTGCTACTGCAGCTACGTGTCGTTGT 69 FBan0014040 FBgn0031676 CG14040 2 2L carbohydrate transport; GO:0008643 UDP-galactose transporter activity; GO:0005459; sugar porter activity; GO:0005351; ; GO:0005459; ; GO:0005351 Golgi membrane; GO:0000139; integral to membrane; GO:0016021 CG14040 CG14040 CDMC32328 1 21 18 DAC29-M15 23-CG14048-RA_1 CG14048 TGCGTTTCCCTTGAGTTTAATGAATTAAATAAAATAGGAACTACAATAATACCTGCGAATAATGGCGCT 69 FBan0014048 FBgn0040389 mRpL14 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL14 mitochondrial ribosomal protein L14 "CG14048, CG14048, EG:BACH48C10.6, L14, BcDNA:RH18819, mitochondrial ribosomal protein L14" CDMC32328 1 22 18 DAC29-M15 23-CG14048-RA_1 CG14048 TGCGTTTCCCTTGAGTTTAATGAATTAAATAAAATAGGAACTACAATAATACCTGCGAATAATGGCGCT 69 FBan0014048 FBgn0040389 mRpL14 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL14 mitochondrial ribosomal protein L14 "CG14048, CG14048, EG:BACH48C10.6, L14, BcDNA:RH18819, mitochondrial ribosomal protein L14" CDMC32329 1 23 18 DAC30-A03 23-CG15092-RA_8 CG15092 GTACGAGAGTTTAAAAGAAGGCCTATAGAATTGCACAAAATAGCGTGAGAAAGGCAATCGAAAAGACCG 69 FBan0015092 FBgn0034388 CG15092 2 2R CG15092 CG15092 anon-WO0118547.167 CDMC32329 1 24 18 DAC30-A03 23-CG15092-RA_8 CG15092 GTACGAGAGTTTAAAAGAAGGCCTATAGAATTGCACAAAATAGCGTGAGAAAGGCAATCGAAAAGACCG 69 FBan0015092 FBgn0034388 CG15092 2 2R CG15092 CG15092 anon-WO0118547.167 CDMC32330 1 25 18 DAC30-A15 9-CG15102-RA_4 CG15102 GGTCCAACATTGAAGGAACCTTATCGGGAGAACAAGGCCATCCTACCCTTCGACATCAGCGTAAAGCCA 69 FBan0015102 FBgn0034405 Jheh2 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- microsome; GO:0005792 Jheh2 Juvenile hormone epoxide hydrolase 2 "CG15102, CT34977, DmEH" CDMC32330 1 26 18 DAC30-A15 9-CG15102-RA_4 CG15102 GGTCCAACATTGAAGGAACCTTATCGGGAGAACAAGGCCATCCTACCCTTCGACATCAGCGTAAAGCCA 69 FBan0015102 FBgn0034405 Jheh2 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- microsome; GO:0005792 Jheh2 Juvenile hormone epoxide hydrolase 2 "CG15102, CT34977, DmEH" CDMC32331 1 1 19 DAC30-E03 15-CG1512-RA_2 CG1512 GCCGTAGTGCCGAGTATGTGGCGAAATACTGTGATACGCTACTGAAAAAGTCTAAGACCTGCGAGGCAG 69 FBan0001512 FBgn0032956 cul-2 2 2L proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nuclear ubiquitin ligase complex; GO:0000152 cul-2 cul-2 "CG1512, CG1512, CG1512, CG1512, CG1512, l(2)02074, DMcul-2, Cul2, CUL2" CDMC32331 1 2 19 DAC30-E03 15-CG1512-RA_2 CG1512 GCCGTAGTGCCGAGTATGTGGCGAAATACTGTGATACGCTACTGAAAAAGTCTAAGACCTGCGAGGCAG 69 FBan0001512 FBgn0032956 cul-2 2 2L proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 nuclear ubiquitin ligase complex; GO:0000152 cul-2 cul-2 "CG1512, CG1512, CG1512, CG1512, CG1512, l(2)02074, DMcul-2, Cul2, CUL2" CDMC32332 1 3 19 DAC30-E15 8-CG15145-RA_1 CG15145 GTTCCGAGTACGCCCAAAAACTTGCCAGGGATGTGCAGAAAAACGACCTGAAAAGCATGATTTTGGCCT 69 FBan0015145 FBgn0032649 CG15145 2 2L CG15145 CG15145 CDMC32332 1 4 19 DAC30-E15 8-CG15145-RA_1 CG15145 GTTCCGAGTACGCCCAAAAACTTGCCAGGGATGTGCAGAAAAACGACCTGAAAAGCATGATTTTGGCCT 69 FBan0015145 FBgn0032649 CG15145 2 2L CG15145 CG15145 CDMC32333 1 5 19 DAC30-I03 11-CG15180-RA_1 CG15180 TGCCATGGCAATGATGAAGCTGATGTCAAAGCTGGTCCAAACACTGGATTGCAATCTAGCTTTCCGCTT 69 FBan0015180 FBgn0037458 CG15180 3 3R CG15180 CG15180 CDMC32333 1 6 19 DAC30-I03 11-CG15180-RA_1 CG15180 TGCCATGGCAATGATGAAGCTGATGTCAAAGCTGGTCCAAACACTGGATTGCAATCTAGCTTTCCGCTT 69 FBan0015180 FBgn0037458 CG15180 3 3R CG15180 CG15180 CDMC32334 1 7 19 DAC30-I15 3-CG15199-RA_1 CG15199 TCTCACCCAACGACTATGATTTCAAGTTCCCCGAGTGCTGTCCCCAACTCGAGTGCTCCGACGAATACT 69 FBan0015199 FBgn0030270 CG15199 X X CG15199 CG15199 CDMC32334 1 8 19 DAC30-I15 3-CG15199-RA_1 CG15199 TCTCACCCAACGACTATGATTTCAAGTTCCCCGAGTGCTGTCCCCAACTCGAGTGCTCCGACGAATACT 69 FBan0015199 FBgn0030270 CG15199 X X CG15199 CG15199 CDMC32335 1 9 19 DAC30-M03 16-CG15227-RA_1 CG15227 GCGCTCAGCTGAATAACAACTTCGAATACCTCACCCTGTCCTATCTCTTTGCACTGAGTCACGTCAAGA 69 FBan0015227 FBgn0034554 CG15227 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG15227 CG15227 CDMC32335 1 10 19 DAC30-M03 16-CG15227-RA_1 CG15227 GCGCTCAGCTGAATAACAACTTCGAATACCTCACCCTGTCCTATCTCTTTGCACTGAGTCACGTCAAGA 69 FBan0015227 FBgn0034554 CG15227 2 2R one-carbon compound metabolism; GO:0006730 zinc ion binding; GO:0008270; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG15227 CG15227 CDMC32336 1 11 19 DAC30-M15 23-CG15236-RB_19 CG15236 TAAAAGCAAACAACGTTCTCCTCATTTGCATGCATGTTATTGTTTCGCGCTTCTTTGGAAATTAAGCCA 69 FBan0015236 FBgn0033108 CG15236 2 2R CG15236 CG15236 CDMC32336 1 12 19 DAC30-M15 23-CG15236-RB_19 CG15236 TAAAAGCAAACAACGTTCTCCTCATTTGCATGCATGTTATTGTTTCGCGCTTCTTTGGAAATTAAGCCA 69 FBan0015236 FBgn0033108 CG15236 2 2R CG15236 CG15236 CDMC32337 1 13 19 DAC31-A03 2-CG1231-RA_1 CG1231 CACCTTGCACCGGGAGAGACCCCCAAAATTCGTGTGGATAGTGCCTGTATCGAATCTCATCCAGACG 67 FBan0001231 FBgn0035134 CG1231 3 3L CG1231 CG1231 CDMC32337 1 14 19 DAC31-A03 2-CG1231-RA_1 CG1231 CACCTTGCACCGGGAGAGACCCCCAAAATTCGTGTGGATAGTGCCTGTATCGAATCTCATCCAGACG 67 FBan0001231 FBgn0035134 CG1231 3 3L CG1231 CG1231 CDMC32338 1 15 19 DAC31-A15 18-CG12680-RA_1 CG12680 ATGCAGGAGTGCCTCATAGAGAATGAGATGACCAATGGCTTTCTGAACGATATCCTTCGCACACGAC 67 FBan0012680 FBgn0029740 CG12680 X X CG12680 CG12680 CDMC32338 1 16 19 DAC31-A15 18-CG12680-RA_1 CG12680 ATGCAGGAGTGCCTCATAGAGAATGAGATGACCAATGGCTTTCTGAACGATATCCTTCGCACACGAC 67 FBan0012680 FBgn0029740 CG12680 X X CG12680 CG12680 CDMC32339 1 17 19 DAC31-E03 1-CG13068-RA_1 CG13068 CGCTGCCTACTCTGCTTATCCGTATGCCGCCTACCCTTACAGCGCTGCATACACCACTGTTTTGTAA 67 FBan0013068 FBgn0036588 CG13068 3 3L CG13068 CG13068 CDMC32339 1 18 19 DAC31-E03 1-CG13068-RA_1 CG13068 CGCTGCCTACTCTGCTTATCCGTATGCCGCCTACCCTTACAGCGCTGCATACACCACTGTTTTGTAA 67 FBan0013068 FBgn0036588 CG13068 3 3L CG13068 CG13068 CDMC32340 1 19 19 DAC31-E15 3-CG13215-RA_4 CG13215 TCGTTGTGATCTCCATGATCTTCGGTTTAAGCCTGATCCAAGCAGCACCCATCGCTAAGGATGCCCA 67 FBan0013215 FBgn0033592 CG13215 2 2R CG13215 CG13215 CDMC32340 1 20 19 DAC31-E15 3-CG13215-RA_4 CG13215 TCGTTGTGATCTCCATGATCTTCGGTTTAAGCCTGATCCAAGCAGCACCCATCGCTAAGGATGCCCA 67 FBan0013215 FBgn0033592 CG13215 2 2R CG13215 CG13215 CDMC32341 1 21 19 DAC31-I03 2-CG13563-RA_3 CG13563 CCGCTCAACACGATTGAGTACAGTTCCCCTCCGGTAAACGCACCTATTGGTTTCAGTTCAGCCCCAG 67 FBan0013563 FBgn0034966 CG13563 2 2R CG13563 CG13563 CDMC32341 1 22 19 DAC31-I03 2-CG13563-RA_3 CG13563 CCGCTCAACACGATTGAGTACAGTTCCCCTCCGGTAAACGCACCTATTGGTTTCAGTTCAGCCCCAG 67 FBan0013563 FBgn0034966 CG13563 2 2R CG13563 CG13563 CDMC32342 1 23 19 DAC31-I15 2-CG13643-RA_1 CG13643 GCATGCCACCTTCAACACGGACTTCCTGGATAGCTCTTCGCATACCAAGAGTCCATCTTACAGCGCG 67 FBan0013643 FBgn0040601 CG13643 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13643 CG13643 "CG13642, CG13642" CDMC32342 1 24 19 DAC31-I15 2-CG13643-RA_1 CG13643 GCATGCCACCTTCAACACGGACTTCCTGGATAGCTCTTCGCATACCAAGAGTCCATCTTACAGCGCG 67 FBan0013643 FBgn0040601 CG13643 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG13643 CG13643 "CG13642, CG13642" CDMC32343 1 25 19 DAC31-M03 2-CG1394-RA_2 CG1394 GCCACCCGTGGACCGTTCAATATATGGAGACATACCCGGACGAAATGAACCGTGCATCGACAATGGC 67 FBan0001394 FBgn0030277 CG1394 X X CG1394 CG1394 "bs30g07.y1, anon-WO0140519.177, BEST:GH24085" CDMC32343 1 26 19 DAC31-M03 2-CG1394-RA_2 CG1394 GCCACCCGTGGACCGTTCAATATATGGAGACATACCCGGACGAAATGAACCGTGCATCGACAATGGC 67 FBan0001394 FBgn0030277 CG1394 X X CG1394 CG1394 "bs30g07.y1, anon-WO0140519.177, BEST:GH24085" CDMC32344 1 1 20 DAC31-M15 6-CG14122-RA_2 CG14122 TCGCTTCGAGTGCGAGTATATGGACTTGATGATCGGTTCTGGCATGTCCATCCTGTGCTTCATCGCG 67 FBan0014122 FBgn0036282 CG14122 3 3L CG14122 CG14122 CDMC32344 1 2 20 DAC31-M15 6-CG14122-RA_2 CG14122 TCGCTTCGAGTGCGAGTATATGGACTTGATGATCGGTTCTGGCATGTCCATCCTGTGCTTCATCGCG 67 FBan0014122 FBgn0036282 CG14122 3 3L CG14122 CG14122 CDMC32345 1 3 20 DAC32-A03 2-CG31698-RA_1 CG31698 CCATCCGTTCATTGGCCTGAACAAGTGCAATGGTAATGGCTATAAGGAGCCCAAACTTCCACCTCGGGA 69 FBan0031698 FBgn0051698 CG31698 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31698 CG31698 BcDNA:LP02725 CDMC32345 1 4 20 DAC32-A03 2-CG31698-RA_1 CG31698 CCATCCGTTCATTGGCCTGAACAAGTGCAATGGTAATGGCTATAAGGAGCCCAAACTTCCACCTCGGGA 69 FBan0031698 FBgn0051698 CG31698 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31698 CG31698 BcDNA:LP02725 CDMC32346 1 5 20 DAC32-A15 15-CG31712-RA_5 CG31712 TGGCAGCCAAGTTAAGCCCTTCGACTAGCTCGAAATCTTATACAATCACACAATCCAGCACCATGGGCT 69 FBan0031712 FBgn0051712 CG31712 2 2L CG31712 CG31712 CG5879 CDMC32346 1 6 20 DAC32-A15 15-CG31712-RA_5 CG31712 TGGCAGCCAAGTTAAGCCCTTCGACTAGCTCGAAATCTTATACAATCACACAATCCAGCACCATGGGCT 69 FBan0031712 FBgn0051712 CG31712 2 2L CG31712 CG31712 CG5879 CDMC32347 1 7 20 DAC32-E03 8-CG3173-RA_1 CG3173 TGCTCCAAGCCTACATCAACTACAATCCCTCAAGTGCTCTGCTCTTCATCGAACAGTACGTGGGCATCC 69 FBan0003173 FBgn0034964 CG3173 2 2R CG3173 CG3173 CDMC32347 1 8 20 DAC32-E03 8-CG3173-RA_1 CG3173 TGCTCCAAGCCTACATCAACTACAATCCCTCAAGTGCTCTGCTCTTCATCGAACAGTACGTGGGCATCC 69 FBan0003173 FBgn0034964 CG3173 2 2R CG3173 CG3173 CDMC32348 1 9 20 DAC32-E15 23-CG31749-RA_4 CG31749 CCACACTTTGCTCTCAAATAGTTGCTCTCTCAAAAAAGTTACACAAATCTCAAAAGGCGCACAACAAAA 69 FBan0031749 FBgn0051749 CG31749 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31749 CG31749 CDMC32348 1 10 20 DAC32-E15 23-CG31749-RA_4 CG31749 CCACACTTTGCTCTCAAATAGTTGCTCTCTCAAAAAAGTTACACAAATCTCAAAAGGCGCACAACAAAA 69 FBan0031749 FBgn0051749 CG31749 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31749 CG31749 CDMC32349 1 11 20 DAC32-I03 15-CG31772-RA_6 CG31772 TGCTGGCTCCAGTCCTTGTGTACTGCCCGATACGGAACAGAGTCAGCACATTATCTATAAGGGACACTA 69 FBan0031772 FBgn0051772 CG31772 2 2L protein binding; GO:0005515; ; GO:0005515 CG31772 CG31772 CG10020 CDMC32349 1 12 20 DAC32-I03 15-CG31772-RA_6 CG31772 TGCTGGCTCCAGTCCTTGTGTACTGCCCGATACGGAACAGAGTCAGCACATTATCTATAAGGGACACTA 69 FBan0031772 FBgn0051772 CG31772 2 2L protein binding; GO:0005515; ; GO:0005515 CG31772 CG31772 CG10020 CDMC32350 1 13 20 DAC32-I15 2-CG31782-RB_1 CG31782 ACCGCACCAGTGTCCACTCTGCTACTGGGCCTTTAAGCAAAAACACCATCTCGTACGACACATGATCGT 69 FBan0031782 FBgn0051782 CG31782 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31782 CG31782 "l(2)SH1590, BcDNA:GM06363" CDMC32350 1 14 20 DAC32-I15 2-CG31782-RB_1 CG31782 ACCGCACCAGTGTCCACTCTGCTACTGGGCCTTTAAGCAAAAACACCATCTCGTACGACACATGATCGT 69 FBan0031782 FBgn0051782 CG31782 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG31782 CG31782 "l(2)SH1590, BcDNA:GM06363" CDMC32351 1 15 20 DAC32-M03 23-CG31811-RA_9 CG31811 TTGAAATTGCTTGATAATCGGTTTAAACAAATGAACACGCCCAAAATGTAGCTTATGCAGAACCAAAAT 69 FBan0031811 FBgn0028509 cenG1A 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of GTPase activity; GO:0043087; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; ; GO:0005525 nucleus; GO:0005634 cenG1A centaurin gamma 1A "CG31811, CG16866, CG16867, CG7982, BG:DS08220.1, ceng1A, centaurin gamma 1A" CDMC32351 1 16 20 DAC32-M03 23-CG31811-RA_9 CG31811 TTGAAATTGCTTGATAATCGGTTTAAACAAATGAACACGCCCAAAATGTAGCTTATGCAGAACCAAAAT 69 FBan0031811 FBgn0028509 cenG1A 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of GTPase activity; GO:0043087; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; ; GO:0005525 nucleus; GO:0005634 cenG1A centaurin gamma 1A "CG31811, CG16866, CG16867, CG7982, BG:DS08220.1, ceng1A, centaurin gamma 1A" CDMC32352 1 17 20 DAC32-M15 3-CG3181-RA_1 CG3181 CGACAATGGGGAGTCACCAAGTAAACAGCAGGCCCCTGTCAATCGGGATGAGATGCACTACTTGGATCT 69 FBan0003181 FBgn0024920 Ts 2 2L DNA metabolism; GO:0006259; dTMP biosynthesis; GO:0006231; deoxyribonucleotide biosynthesis; GO:0009263; pyrimidine base metabolism; GO:0006206 thymidylate synthase activity; GO:0004799 ; EC:2.1.1.45; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004799 ; EC:2.1.1.45; ; GO:0004799 ; EC:2.1.1.45 Ts Ts "CG3181, CG3181, c1.5, TS, FBgn0024920, anon-23Ca" CDMC32352 1 18 20 DAC32-M15 3-CG3181-RA_1 CG3181 CGACAATGGGGAGTCACCAAGTAAACAGCAGGCCCCTGTCAATCGGGATGAGATGCACTACTTGGATCT 69 FBan0003181 FBgn0024920 Ts 2 2L DNA metabolism; GO:0006259; dTMP biosynthesis; GO:0006231; deoxyribonucleotide biosynthesis; GO:0009263; pyrimidine base metabolism; GO:0006206 thymidylate synthase activity; GO:0004799 ; EC:2.1.1.45; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004799 ; EC:2.1.1.45; ; GO:0004799 ; EC:2.1.1.45 Ts Ts "CG3181, CG3181, c1.5, TS, FBgn0024920, anon-23Ca" CDMC32353 1 19 20 DAC33-A03 16-CG15506-RA_1 CG15506 GCATCACTTGCATACTTAAGTCCAAGGAAACAGATCACAAGCAAACGGGGAAATCAAATCACACGGCCA 69 FBan0015506 FBgn0039686 CG15506 3 3R CG15506 CG15506 CDMC32353 1 20 20 DAC33-A03 16-CG15506-RA_1 CG15506 GCATCACTTGCATACTTAAGTCCAAGGAAACAGATCACAAGCAAACGGGGAAATCAAATCACACGGCCA 69 FBan0015506 FBgn0039686 CG15506 3 3R CG15506 CG15506 CDMC32354 1 21 20 DAC33-A15 2-CG15523-RB_4 CG15523 GAGCGTCAGCAAATCCTTACAGTTCCCCTCCGATTCGGACAATCTCTAGGACTGCACTACCTCAGCGGA 69 FBan0015523 FBgn0039727 CG15523 3 3R CG15523 CG15523 CDMC32354 1 22 20 DAC33-A15 2-CG15523-RB_4 CG15523 GAGCGTCAGCAAATCCTTACAGTTCCCCTCCGATTCGGACAATCTCTAGGACTGCACTACCTCAGCGGA 69 FBan0015523 FBgn0039727 CG15523 3 3R CG15523 CG15523 CDMC32355 1 23 20 DAC33-E03 2-CG1555-RA_1 CG1555 TGCCGGGCTTCAACTACTCCCAGGAGTACATAGAAACGGGGTATCTGGAGCTCTGCATACCCTCGAAAT 69 FBan0001555 FBgn0000337 cn 2 2R electron transport; GO:0006118; eye pigment biosynthesis; GO:0006726; eye pigmentation (sensu Endopterygota); GO:0048072; ommochrome biosynthesis; GO:0006727; tryptophan catabolism; GO:0006569 kynurenine 3-monooxygenase activity; GO:0004502 ; EC:1.14.13.9; ; GO:0004502 ; EC:1.14.13.9; ; GO:0004502 ; EC:1.14.13.9 cn cinnabar CG1555 CDMC32355 1 24 20 DAC33-E03 2-CG1555-RA_1 CG1555 TGCCGGGCTTCAACTACTCCCAGGAGTACATAGAAACGGGGTATCTGGAGCTCTGCATACCCTCGAAAT 69 FBan0001555 FBgn0000337 cn 2 2R electron transport; GO:0006118; eye pigment biosynthesis; GO:0006726; eye pigmentation (sensu Endopterygota); GO:0048072; ommochrome biosynthesis; GO:0006727; tryptophan catabolism; GO:0006569 kynurenine 3-monooxygenase activity; GO:0004502 ; EC:1.14.13.9; ; GO:0004502 ; EC:1.14.13.9; ; GO:0004502 ; EC:1.14.13.9 cn cinnabar CG1555 CDMC32356 1 25 20 DAC33-E15 17-CG15578-RA_2 CG15578 CCCAACCTACTTAAGTCCATTATAATGGTCCTGGAGCATACTAGCCGACCCATGACTGACACAGAGCTG 69 FBan0015578 FBgn0040905 CG15578 X X CG15578 CG15578 CDMC32356 1 26 20 DAC33-E15 17-CG15578-RA_2 CG15578 CCCAACCTACTTAAGTCCATTATAATGGTCCTGGAGCATACTAGCCGACCCATGACTGACACAGAGCTG 69 FBan0015578 FBgn0040905 CG15578 X X CG15578 CG15578 CDMC32357 1 1 21 DAC33-I03 1-CG15618-RA_1 CG15618 ACCACCATTCTTGGACACCATGATCGGTAAGCTGACCTTCGATGACTTCAACATGGTACAGCGCCTGGT 69 FBan0015618 FBgn0031077 CG15618 X X CG15618 CG15618 CDMC32357 1 2 21 DAC33-I03 1-CG15618-RA_1 CG15618 ACCACCATTCTTGGACACCATGATCGGTAAGCTGACCTTCGATGACTTCAACATGGTACAGCGCCTGGT 69 FBan0015618 FBgn0031077 CG15618 X X CG15618 CG15618 CDMC32358 1 3 21 DAC33-I15 2-CG15632-RA_1 CG15632 GCGACGTTAGCGTGCTGGACCTGAAGTTCATCCTCAAGCGGGAGTTCAACATGGAGTTCCCAATTGAAT 69 FBan0015632 FBgn0031623 Taf12L 2 2L male meiosis; GO:0007140; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf12L TBP-associated factor 30kD subunit alpha-2 "CG15632, CG15632, CG15632, TAF30alpha-2, TFIID, Taf30alpha-2, dmTAF12L, TAF[[II]], rye, dTAF[[II]]30alpha-2, dmTAF12b, dTAF[[II]]30a, ryan express, TAF, dTAF12L, dTAF12" CDMC32358 1 4 21 DAC33-I15 2-CG15632-RA_1 CG15632 GCGACGTTAGCGTGCTGGACCTGAAGTTCATCCTCAAGCGGGAGTTCAACATGGAGTTCCCAATTGAAT 69 FBan0015632 FBgn0031623 Taf12L 2 2L male meiosis; GO:0007140; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf12L TBP-associated factor 30kD subunit alpha-2 "CG15632, CG15632, CG15632, TAF30alpha-2, TFIID, Taf30alpha-2, dmTAF12L, TAF[[II]], rye, dTAF[[II]]30alpha-2, dmTAF12b, dTAF[[II]]30a, ryan express, TAF, dTAF12L, dTAF12" CDMC32359 1 5 21 DAC33-M03 2-CG15695-RA_1 CG15695 TCTGGACAACCGCTAGACCGCACAAAAAAGGACTCGCTACTGCAATCTTTCGGATCTCGGAGCCTTTGT 69 FBan0015695 FBgn0038832 CG15695 3 3R CG15695 CG15695 CDMC32359 1 6 21 DAC33-M03 2-CG15695-RA_1 CG15695 TCTGGACAACCGCTAGACCGCACAAAAAAGGACTCGCTACTGCAATCTTTCGGATCTCGGAGCCTTTGT 69 FBan0015695 FBgn0038832 CG15695 3 3R CG15695 CG15695 CDMC32360 1 7 21 DAC33-M15 3-CG15706-RA_1 CG15706 ACGCCTGCCTTGATCATCATGTGCGTGTTCAGTTTGCTCGATCTGTTCAGTGTGTCCAAGCTGAAGCTG 69 FBan0015706 FBgn0034093 CG15706 2 2R CG15706 CG15706 CDMC32360 1 8 21 DAC33-M15 3-CG15706-RA_1 CG15706 ACGCCTGCCTTGATCATCATGTGCGTGTTCAGTTTGCTCGATCTGTTCAGTGTGTCCAAGCTGAAGCTG 69 FBan0015706 FBgn0034093 CG15706 2 2R CG15706 CG15706 CDMC32361 1 9 21 DAC34-A03 23-CG31117-RA_1 CG31117 ACTGTTGTGTTACAACGAATTCGAAGGACCTTTGTAGTTTTGGACACTCGAATCCTAAAGAATTCGAAG 69 FBan0031117 FBgn0051117 CG31117 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31117 CG31117 CDMC32361 1 10 21 DAC34-A03 23-CG31117-RA_1 CG31117 ACTGTTGTGTTACAACGAATTCGAAGGACCTTTGTAGTTTTGGACACTCGAATCCTAAAGAATTCGAAG 69 FBan0031117 FBgn0051117 CG31117 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31117 CG31117 CDMC32362 1 11 21 DAC34-A15 3-CG31139-RA_1 CG31139 GCACTTCCTATCCGGCCTAAGTGGTCCGGTGTTTTCCTATTCCATCACGAATCGCCACCTGGACATCAT 69 FBan0031139 FBgn0051139 CG31139 3 3R CG31139 CG31139 "CG17138, CG17138, BcDNA:AT07872" CDMC32362 1 12 21 DAC34-A15 3-CG31139-RA_1 CG31139 GCACTTCCTATCCGGCCTAAGTGGTCCGGTGTTTTCCTATTCCATCACGAATCGCCACCTGGACATCAT 69 FBan0031139 FBgn0051139 CG31139 3 3R CG31139 CG31139 "CG17138, CG17138, BcDNA:AT07872" CDMC32363 1 13 21 DAC34-E03 2-CG31169-RA_2 CG31169 GCGCCCCCATAGCCATATCAAGACGGAAGAAACTGGCCATCACGAGTGGGATTGGCTAATGAACAATGA 69 FBan0031169 FBgn0051169 CG31169 3 3R carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 DNA binding; GO:0003677; glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0003677 glycerol-3-phosphate dehydrogenase complex; GO:0009331 CG31169 CG31169 "CG12757, CG18427, bs16c09.y1, NEST:bs15d11, NEST:bs16c09" CDMC32363 1 14 21 DAC34-E03 2-CG31169-RA_2 CG31169 GCGCCCCCATAGCCATATCAAGACGGAAGAAACTGGCCATCACGAGTGGGATTGGCTAATGAACAATGA 69 FBan0031169 FBgn0051169 CG31169 3 3R carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629 DNA binding; GO:0003677; glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0003677 glycerol-3-phosphate dehydrogenase complex; GO:0009331 CG31169 CG31169 "CG12757, CG18427, bs16c09.y1, NEST:bs15d11, NEST:bs16c09" CDMC32364 1 15 21 DAC34-E15 3-CG31179-RA_1 CG31179 GGGATGGATGGCTCAAGGGTGGACCAACCAGAAGAGGCAGGTTGCTGGTATTATGGTAGGTTAGGTTCA 69 FBan0031179 FBgn0051179 CG31179 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31179 CG31179 CDMC32364 1 16 21 DAC34-E15 3-CG31179-RA_1 CG31179 GGGATGGATGGCTCAAGGGTGGACCAACCAGAAGAGGCAGGTTGCTGGTATTATGGTAGGTTAGGTTCA 69 FBan0031179 FBgn0051179 CG31179 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31179 CG31179 CDMC32365 1 17 21 DAC34-I03 14-CG31205-RA_1 CG31205 TGCCTTCAGTATCCGAAATGGTTCCAGGAAGTGAAACCTCCAATTCAAAGCTTATCGTTGCCGGACTGG 69 FBan0031205 FBgn0051205 CG31205 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31205 CG31205 CDMC32365 1 18 21 DAC34-I03 14-CG31205-RA_1 CG31205 TGCCTTCAGTATCCGAAATGGTTCCAGGAAGTGAAACCTCCAATTCAAAGCTTATCGTTGCCGGACTGG 69 FBan0031205 FBgn0051205 CG31205 3 3R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31205 CG31205 CDMC32366 1 19 21 DAC34-I15 23-CG31211-RB_1 CG31211 TCAGCAGTCAAATGGTATAGGTGATGCACATAAATCCAAAGAACTCCTAAGCATACATTGCCATCATTT 69 FBgn0051211 CG31211 CG31211 CG31211 "CG18546, CG14732, CG18546, CG14732, cDNA, anon-WO03070958.3" CDMC32366 1 20 21 DAC34-I15 23-CG31211-RB_1 CG31211 TCAGCAGTCAAATGGTATAGGTGATGCACATAAATCCAAAGAACTCCTAAGCATACATTGCCATCATTT 69 FBgn0051211 CG31211 CG31211 CG31211 "CG18546, CG14732, CG18546, CG14732, cDNA, anon-WO03070958.3" CDMC32367 1 21 21 DAC34-M03 11-CG31246-RA_2 CG31246 AGCCCGGGGAAAAGGATTAAATATGCAGCACAAGTCGAGACCAGGAAGACTCTTAGTCACACGGAAGGA 69 FBan0031246 FBgn0051246 CG31246 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31246 CG31246 CDMC32367 1 22 21 DAC34-M03 11-CG31246-RA_2 CG31246 AGCCCGGGGAAAAGGATTAAATATGCAGCACAAGTCGAGACCAGGAAGACTCTTAGTCACACGGAAGGA 69 FBan0031246 FBgn0051246 CG31246 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31246 CG31246 CDMC32368 1 23 21 DAC34-M15 16-CG31262-RA_1 CG31262 AGGCACTTCCTTTGGAGTATTCACATTAGGAATGTTGTTTCCATGGGCAAACACTATAGGCACAGCGGT 69 FBan0031262 FBgn0051262 CG31262 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 membrane; GO:0016020 CG31262 CG31262 CDMC32368 1 24 21 DAC34-M15 16-CG31262-RA_1 CG31262 AGGCACTTCCTTTGGAGTATTCACATTAGGAATGTTGTTTCCATGGGCAAACACTATAGGCACAGCGGT 69 FBan0031262 FBgn0051262 CG31262 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 membrane; GO:0016020 CG31262 CG31262 CDMC32369 1 25 21 DAC35-A03 23-CG7772-RA_4 CG7772 TACTCCACGGTGATAGTTCTTAGATACTAAGAGTTTACATGAACTGTAGCAAAGCTTTAGCCCCAA 66 FBan0007772 FBgn0030883 CG7772 X X CG7772 CG7772 bs13c01.y1 CDMC32369 1 26 21 DAC35-A03 23-CG7772-RA_4 CG7772 TACTCCACGGTGATAGTTCTTAGATACTAAGAGTTTACATGAACTGTAGCAAAGCTTTAGCCCCAA 66 FBan0007772 FBgn0030883 CG7772 X X CG7772 CG7772 bs13c01.y1 CDMC32370 1 1 22 DAC35-A15 13-CG7876-RA_1 CG7876 CCGTCGAACCAAGTGCCGAAAAACGAAACCCCAAACGAAATGTTTAAGCTAACGATGCTGATGGGC 66 FBan0007876 FBgn0031000 CG7876 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG7876 CG7876 CDMC32370 1 2 22 DAC35-A15 13-CG7876-RA_1 CG7876 CCGTCGAACCAAGTGCCGAAAAACGAAACCCCAAACGAAATGTTTAAGCTAACGATGCTGATGGGC 66 FBan0007876 FBgn0031000 CG7876 X X chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG7876 CG7876 CDMC32371 1 3 22 DAC35-E03 1-CG8310-RA_4 CG8310 AGCACGTGATCATCCCCCGCATCAACCGCACCATAGAGTATATCATCAGCGAGCTGGACGAATTGG 66 FBan0008310 FBgn0040377 CG8310 X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG8310 CG8310 EG:BACR25B3.4 CDMC32371 1 4 22 DAC35-E03 1-CG8310-RA_4 CG8310 AGCACGTGATCATCCCCCGCATCAACCGCACCATAGAGTATATCATCAGCGAGCTGGACGAATTGG 66 FBan0008310 FBgn0040377 CG8310 X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG8310 CG8310 EG:BACR25B3.4 CDMC32372 1 5 22 DAC35-E15 9-CG8364-RA_3 CG8364 GGTCGACGATGAGGAGTACTTCAGCACTCTGGAGCCAAATGCCGAATTGATTGCCGTCTTTCCTGG 66 FBan0008364 FBgn0028407 Rep3 2 2R apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 Rep3 Rep3 "CG8364, CG13187, drep3, Drep3, BcDNA:AT08574" CDMC32372 1 6 22 DAC35-E15 9-CG8364-RA_3 CG8364 GGTCGACGATGAGGAGTACTTCAGCACTCTGGAGCCAAATGCCGAATTGATTGCCGTCTTTCCTGG 66 FBan0008364 FBgn0028407 Rep3 2 2R apoptosis; GO:0006915 protein binding; GO:0005515; ; GO:0005515 intracellular; GO:0005622 Rep3 Rep3 "CG8364, CG13187, drep3, Drep3, BcDNA:AT08574" CDMC32373 1 7 22 DAC35-I03 1-CG9077-RA_1 CG9077 AGCTCTTCCCGTAGATCCCGAACGTGAACCCGTGGCTATCCTGAAGTCCGAGATCATCAAGACAGA 66 FBan0009077 FBgn0033600 CG9077 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9077 CG9077 CDMC32373 1 8 22 DAC35-I03 1-CG9077-RA_1 CG9077 AGCTCTTCCCGTAGATCCCGAACGTGAACCCGTGGCTATCCTGAAGTCCGAGATCATCAAGACAGA 66 FBan0009077 FBgn0033600 CG9077 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9077 CG9077 CDMC32374 1 9 22 DAC35-I15 2-CG9181-RB_3 CG9181 TGCCTGGTGGACTGTTGCCTGGTACTTATCGACAAGTACGGAGAGTGCAATGTGTCCAAGGTGCTC 66 FBan0009181 FBgn0003138 Ptp61F 3 3L axon guidance; GO:0007411; germ-band extension; GO:0007377; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; nucleus; GO:0005634 Ptp61F Protein tyrosine phosphatase 61F "CG9181, CG9178, CG9181, dPTP61F, DPTP61F, dptp61F, PTP61F, protein tyrosine phosphatase, protein-tyrosine-phosphatase, R-PTP 61F, ptp61F, anon-WO0140519.98, anon-WO0118547.297, BEST:LP01280" CDMC32374 1 10 22 DAC35-I15 2-CG9181-RB_3 CG9181 TGCCTGGTGGACTGTTGCCTGGTACTTATCGACAAGTACGGAGAGTGCAATGTGTCCAAGGTGCTC 66 FBan0009181 FBgn0003138 Ptp61F 3 3L axon guidance; GO:0007411; germ-band extension; GO:0007377; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; nucleus; GO:0005634 Ptp61F Protein tyrosine phosphatase 61F "CG9181, CG9178, CG9181, dPTP61F, DPTP61F, dptp61F, PTP61F, protein tyrosine phosphatase, protein-tyrosine-phosphatase, R-PTP 61F, ptp61F, anon-WO0140519.98, anon-WO0118547.297, BEST:LP01280" CDMC32375 1 11 22 DAC35-M03 3-CG9670-RA_2 CG9670 CCTCATCGACTCGTAGAAGTCCCCAGCAACGACTGTTCCGGATCGGACATCATACGGGTGAACAGG 66 FBan0009670 FBgn0028380 fal 3 3L gastrulation; GO:0007369 GTPase activity; GO:0003924; ; GO:0003924 cellular component unknown; GO:0008372 fal falten "CG9670, falten" CDMC32375 1 12 22 DAC35-M03 3-CG9670-RA_2 CG9670 CCTCATCGACTCGTAGAAGTCCCCAGCAACGACTGTTCCGGATCGGACATCATACGGGTGAACAGG 66 FBan0009670 FBgn0028380 fal 3 3L gastrulation; GO:0007369 GTPase activity; GO:0003924; ; GO:0003924 cellular component unknown; GO:0008372 fal falten "CG9670, falten" CDMC32376 1 13 22 DAC35-M15 23-CG9836-RA_6 CG9836 TCGTCTGTCATTGATACTAAAGGATAGCTGGAACTGATCTTGTATGAATGCATATGCACGTGTGTG 66 FBan0009836 FBgn0037637 CG9836 3 3R nitrogen compound metabolism; GO:0006807; nitrogen utilization; GO:0019740 CG9836 CG9836 CDMC32376 1 14 22 DAC35-M15 23-CG9836-RA_6 CG9836 TCGTCTGTCATTGATACTAAAGGATAGCTGGAACTGATCTTGTATGAATGCATATGCACGTGTGTG 66 FBan0009836 FBgn0037637 CG9836 3 3R nitrogen compound metabolism; GO:0006807; nitrogen utilization; GO:0019740 CG9836 CG9836 CDMC32377 1 15 22 DAC36-A03 6-CG1803-RB_2 CG1803 AGCCTGCTCCGCTACGACTATGCGCAGAACAAGGTCTACAAGACAAAGATCGAGGGCGAAACCTT 65 FBan0001803 FBgn0030362 regucalcin X X anterior/posterior axis specification; GO:0009948; calcium-mediated signaling; GO:0019722 regucalcin regucalcin "CG1803, CG1803, CG1803, CG1803, T1" CDMC32377 1 16 22 DAC36-A03 6-CG1803-RB_2 CG1803 AGCCTGCTCCGCTACGACTATGCGCAGAACAAGGTCTACAAGACAAAGATCGAGGGCGAAACCTT 65 FBan0001803 FBgn0030362 regucalcin X X anterior/posterior axis specification; GO:0009948; calcium-mediated signaling; GO:0019722 regucalcin regucalcin "CG1803, CG1803, CG1803, CG1803, T1" CDMC32378 1 17 22 DAC36-A15 8-CG18128-RA_1 CG18128 CCATGGCCAAGTACATCGTGAACGTTAGCCACATCAGGCCAAAGTACGGACTAATCTGCGGCAGC 65 FBan0018128 FBgn0034898 CG18128 2 2R purine base metabolism; GO:0006144 purine-nucleoside phosphorylase activity; GO:0004731 ; EC:2.4.2.1; ; GO:0004731 ; EC:2.4.2.1 CG18128 CG18128 CDMC32378 1 18 22 DAC36-A15 8-CG18128-RA_1 CG18128 CCATGGCCAAGTACATCGTGAACGTTAGCCACATCAGGCCAAAGTACGGACTAATCTGCGGCAGC 65 FBan0018128 FBgn0034898 CG18128 2 2R purine base metabolism; GO:0006144 purine-nucleoside phosphorylase activity; GO:0004731 ; EC:2.4.2.1; ; GO:0004731 ; EC:2.4.2.1 CG18128 CG18128 CDMC32379 1 19 22 DAC36-E03 2-CG18335-RA_3 CG18335 CATCGGGATCTACTGGAGAGTGGGAACGGACTCTTCGACCGCAAGATCAACGAAAGACTGCTGCC 65 FBan0018335 FBgn0033610 CG18335 2 2R CG18335 CG18335 CDMC32379 1 20 22 DAC36-E03 2-CG18335-RA_3 CG18335 CATCGGGATCTACTGGAGAGTGGGAACGGACTCTTCGACCGCAAGATCAACGAAAGACTGCTGCC 65 FBan0018335 FBgn0033610 CG18335 2 2R CG18335 CG18335 CDMC32380 1 21 22 DAC36-E15 2-CG18369-RA_1 CG18369 GTGGCGCTACTTCAAGCAGCTGGTAACCCCGAATCTCACCTTCGACATCAGCAATAGGGGCATTG 65 FBan0018369 FBgn0033860 CG18369 2 2R mesoderm development; GO:0007498; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0008237; ; GO:0004177 ; EC:3.4.11.- intracellular; GO:0005622 CG18369 CG18369 CDMC32380 1 22 22 DAC36-E15 2-CG18369-RA_1 CG18369 GTGGCGCTACTTCAAGCAGCTGGTAACCCCGAATCTCACCTTCGACATCAGCAATAGGGGCATTG 65 FBan0018369 FBgn0033860 CG18369 2 2R mesoderm development; GO:0007498; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0008237; ; GO:0004177 ; EC:3.4.11.- intracellular; GO:0005622 CG18369 CG18369 CDMC32381 1 23 22 DAC36-I03 45-CG18554-RA_1 CG18554 GGGCAAGATGATCCCTTCGAAGGAGCTCGATAAGGAGCATTCTCATCCCAATGGCCCGCAACAGC 65 FBan0018554 FBgn0038060 CG18554 3 3R CG18554 CG18554 CDMC32381 1 24 22 DAC36-I03 45-CG18554-RA_1 CG18554 GGGCAAGATGATCCCTTCGAAGGAGCTCGATAAGGAGCATTCTCATCCCAATGGCCCGCAACAGC 65 FBan0018554 FBgn0038060 CG18554 3 3R CG18554 CG18554 CDMC32382 1 25 22 DAC36-I15 18-CG18622-RA_10 CG18622 AGCACTCGCAGTCGAAAGAGACCAAACGGCAGCACTAGTAGGCGTTATAGTCGAACTCGGAGGGG 65 FBan0018622 FBgn0038460 CG18622 3 3R CG18622 CG18622 BcDNA:RH18149 CDMC32382 1 26 22 DAC36-I15 18-CG18622-RA_10 CG18622 AGCACTCGCAGTCGAAAGAGACCAAACGGCAGCACTAGTAGGCGTTATAGTCGAACTCGGAGGGG 65 FBan0018622 FBgn0038460 CG18622 3 3R CG18622 CG18622 BcDNA:RH18149 CDMC32383 1 1 23 DAC36-M03 17-CG18740-RA_2 CG18740 CCTTCGGGCGATAAGTCAGCCATCAAGTCAGACAAATCAAACAAATCCTCACCCACAGAAACCGC 65 FBan0018740 FBgn0002783 mor 3 3R "chromatin remodeling; GO:0006338; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; transcription cofactor activity; GO:0003712; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0003712; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0005515; ; GO:0005515; ; GO:0005515 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585 mor moira "CG18740, CG4275, CG18740, BAP155, brahma-associated protein 155, Swi3D, E(E2F)3B, brahma associated protein 155 kDa, Moira, dmMOIRA, l(3)89B1, brahma-like, moira" CDMC32383 1 2 23 DAC36-M03 17-CG18740-RA_2 CG18740 CCTTCGGGCGATAAGTCAGCCATCAAGTCAGACAAATCAAACAAATCCTCACCCACAGAAACCGC 65 FBan0018740 FBgn0002783 mor 3 3R "chromatin remodeling; GO:0006338; oogenesis (sensu Insecta); GO:0009993; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; general RNA polymerase II transcription factor activity; GO:0016251; transcription cofactor activity; GO:0003712; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0003712; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713; ; GO:0005515; ; GO:0005515; ; GO:0005515 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585 mor moira "CG18740, CG4275, CG18740, BAP155, brahma-associated protein 155, Swi3D, E(E2F)3B, brahma associated protein 155 kDa, Moira, dmMOIRA, l(3)89B1, brahma-like, moira" CDMC32384 1 3 23 DAC36-M15 3-CG18803-RA_2 CG18803 TTATGTGGAACTTTGGAGTGGTCGGAATGATGTCCATCCATTGGCAGGGACCTCTGCGGTTGCAG 65 FBan0018803 FBgn0019947 Psn 3 3L Notch receptor processing; GO:0007220; cell fate commitment; GO:0045165; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; membrane protein ectodomain proteolysis; GO:0006509; nervous system development; GO:0007399 receptor binding; GO:0005102; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0005102; ; GO:0008233 ; EC:3.4.-.- apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; integral to Golgi membrane; GO:0030173; integral to endoplasmic reticulum membrane; GO:0030176 Psn Presenilin "CG5868, CG18803, CG5868, CG5868, Dps, DPS, DrosPS, presenilin, PS, DmPS, l(3)77CDb, pres, PS1, psn, DPsn, dPresenilin, Dpresenilin, Presenilin" CDMC32384 1 4 23 DAC36-M15 3-CG18803-RA_2 CG18803 TTATGTGGAACTTTGGAGTGGTCGGAATGATGTCCATCCATTGGCAGGGACCTCTGCGGTTGCAG 65 FBan0018803 FBgn0019947 Psn 3 3L Notch receptor processing; GO:0007220; cell fate commitment; GO:0045165; cell-cell adhesion; GO:0016337; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; membrane protein ectodomain proteolysis; GO:0006509; nervous system development; GO:0007399 receptor binding; GO:0005102; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0005102; ; GO:0008233 ; EC:3.4.-.- apical plasma membrane; GO:0016324; cell cortex; GO:0005938; cytoplasm; GO:0005737; integral to Golgi membrane; GO:0030173; integral to endoplasmic reticulum membrane; GO:0030176 Psn Presenilin "CG5868, CG18803, CG5868, CG5868, Dps, DPS, DrosPS, presenilin, PS, DmPS, l(3)77CDb, pres, PS1, psn, DPsn, dPresenilin, Dpresenilin, Presenilin" CDMC32385 1 5 23 DAC37-A03 23-CG16889-RA_4 CG16889 TTGGAGTACTCCATTGGGGTTTATTAAAAACTCATTAGGCTGGTCAGGAAATTGATTAATGTCCGAAAA 69 FBan0016889 FBgn0028658 adat 2 2L RNA processing; GO:0006396; purine base metabolism; GO:0006144; tRNA modification; GO:0006400 mRNA binding; GO:0003729; tRNA specific adenosine deaminase activity; GO:0008251; ; GO:0008251; ; GO:0008251; ; GO:0003729; ; GO:0008251; ; GO:0008251 adat adat "CG16889, BG:DS00941.2, dADAT1, Adat" CDMC32385 1 6 23 DAC37-A03 23-CG16889-RA_4 CG16889 TTGGAGTACTCCATTGGGGTTTATTAAAAACTCATTAGGCTGGTCAGGAAATTGATTAATGTCCGAAAA 69 FBan0016889 FBgn0028658 adat 2 2L RNA processing; GO:0006396; purine base metabolism; GO:0006144; tRNA modification; GO:0006400 mRNA binding; GO:0003729; tRNA specific adenosine deaminase activity; GO:0008251; ; GO:0008251; ; GO:0008251; ; GO:0003729; ; GO:0008251; ; GO:0008251 adat adat "CG16889, BG:DS00941.2, dADAT1, Adat" CDMC32386 1 7 23 DAC37-A15 23-CG16901-RB_1 CG16901 TGTTTTTCTAATGTAGTCCCATACATTATGCGAGGTAATTGTTTAACGCGTCAGTAGAGCACAGGATGT 69 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC32386 1 8 23 DAC37-A15 23-CG16901-RB_1 CG16901 TGTTTTTCTAATGTAGTCCCATACATTATGCGAGGTAATTGTTTAACGCGTCAGTAGAGCACAGGATGT 69 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC32387 1 9 23 DAC37-E03 3-CG16944-RA_1 CG16944 GGGTCGTCCCACATCTCCCCAGCCAAATCAGTGTTATCGATCGGATGCAAAGAATCGAACCGAAGACCT 69 FBan0016944 FBgn0003360 sesB X X "ADP transport; GO:0015866; ATP transport; GO:0015867; cation transport; GO:0006812; flight behavior; GO:0007629; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; response to mechanical stimulus; GO:0009612" carrier activity; GO:0005386; ATP:ADP antiporter activity; GO:0005471; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005471; ; GO:0005471; ; GO:0005471; ; GO:0005471 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 sesB stress-sensitive B "CG16944, CG16944, CG16944, CG16944, l(1)S12, EM12, S12, ADT2, A/A-T/sesB, Hmr, ADP/ATP translocase, orangi, ses B, anon-WO02059370.55, l(1)G0126, l(1)G0247, l(1)G0386, A/A-T, l(1)9Ed, l(1)9Fa, l(1)DC701, l(1)EM31, Adenine nucleotide translocase, lethal(1)9Ed" CDMC32387 1 10 23 DAC37-E03 3-CG16944-RA_1 CG16944 GGGTCGTCCCACATCTCCCCAGCCAAATCAGTGTTATCGATCGGATGCAAAGAATCGAACCGAAGACCT 69 FBan0016944 FBgn0003360 sesB X X "ADP transport; GO:0015866; ATP transport; GO:0015867; cation transport; GO:0006812; flight behavior; GO:0007629; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; response to mechanical stimulus; GO:0009612" carrier activity; GO:0005386; ATP:ADP antiporter activity; GO:0005471; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005471; ; GO:0005471; ; GO:0005471; ; GO:0005471 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 sesB stress-sensitive B "CG16944, CG16944, CG16944, CG16944, l(1)S12, EM12, S12, ADT2, A/A-T/sesB, Hmr, ADP/ATP translocase, orangi, ses B, anon-WO02059370.55, l(1)G0126, l(1)G0247, l(1)G0386, A/A-T, l(1)9Ed, l(1)9Fa, l(1)DC701, l(1)EM31, Adenine nucleotide translocase, lethal(1)9Ed" CDMC32388 1 11 23 DAC37-E15 11-CG1695-RB_1 CG1695 AGGATCAGGAGGACCATGATCAACGCGAAATGCCACGACTCAGCGAGAAACTTGTTTTGGAGTTCCAAA 69 FBan0001695 FBgn0031116 CG1695 X X intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG1695 CG1695 CDMC32388 1 12 23 DAC37-E15 11-CG1695-RB_1 CG1695 AGGATCAGGAGGACCATGATCAACGCGAAATGCCACGACTCAGCGAGAAACTTGTTTTGGAGTTCCAAA 69 FBan0001695 FBgn0031116 CG1695 X X intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG1695 CG1695 CDMC32389 1 13 23 DAC37-I03 23-CG16983-RC_4 CG16983 TGCGTGGAAATAGTGTCAGTACGTTTAAAGGCATCATCGTAAGGTTAGTCGGAAAACAAATAAAAAGCC 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC32389 1 14 23 DAC37-I03 23-CG16983-RC_4 CG16983 TGCGTGGAAATAGTGTCAGTACGTTTAAAGGCATCATCGTAAGGTTAGTCGGAAAACAAATAAAAAGCC 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC32390 1 15 23 DAC37-I15 18-CG16991-RA_2 CG16991 ACACTTGAGTCGCAAATCCAATGTCCAGAATCCTGTCCAACAACGGCATGCATATGGATGAGCCAATAA 69 FBan0016991 FBgn0035786 Tsp66A 3 3L integral to membrane; GO:0016021 Tsp66A Tetraspanin 66A "CG16991, CG1699, CG16991, CG1699, Dm.Tsp66A, Tetraspanin 66A" CDMC32390 1 16 23 DAC37-I15 18-CG16991-RA_2 CG16991 ACACTTGAGTCGCAAATCCAATGTCCAGAATCCTGTCCAACAACGGCATGCATATGGATGAGCCAATAA 69 FBan0016991 FBgn0035786 Tsp66A 3 3L integral to membrane; GO:0016021 Tsp66A Tetraspanin 66A "CG16991, CG1699, CG16991, CG1699, Dm.Tsp66A, Tetraspanin 66A" CDMC32391 1 17 23 DAC37-M03 15-CG17030-RA_3 CG17030 CTTTTCCACCCGCTAACACTTAAAGCACAACACAAAAACACAGGACACCATGGCCAAAAAGGAGGAGCC 69 FBan0017030 FBgn0035584 CG17030 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG17030 CG17030 CDMC32391 1 18 23 DAC37-M03 15-CG17030-RA_3 CG17030 CTTTTCCACCCGCTAACACTTAAAGCACAACACAAAAACACAGGACACCATGGCCAAAAAGGAGGAGCC 69 FBan0017030 FBgn0035584 CG17030 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG17030 CG17030 CDMC32392 1 19 23 DAC37-M15 2-CG1703-RA_1 CG1703 GGCATTGGGTTCCTTTGGTTTGGTCAGTCATGCACACACCATCAAGATGAAGGATCTGTCCGGTGGTCA 69 FBan0001703 FBgn0030321 CG1703 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1703 CG1703 CDMC32392 1 20 23 DAC37-M15 2-CG1703-RA_1 CG1703 GGCATTGGGTTCCTTTGGTTTGGTCAGTCATGCACACACCATCAAGATGAAGGATCTGTCCGGTGGTCA 69 FBan0001703 FBgn0030321 CG1703 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1703 CG1703 CDMC32393 1 21 23 DAC38-A03 11-CG17531-RA_1 CG17531 TCGTAAAGGTGGACACGACCAAATATCCTCGGATAGCTGCATGGTTCAAGAGACTCCAAAAGCTGCCCT 69 FBgn0034341 CDMC32393 1 22 23 DAC38-A03 11-CG17531-RA_1 CG17531 TCGTAAAGGTGGACACGACCAAATATCCTCGGATAGCTGCATGGTTCAAGAGACTCCAAAAGCTGCCCT 69 FBgn0034341 CDMC32394 1 23 23 DAC38-A15 23-CG17567-RC_2 CG17567 CGAAACACGTTCAACCATATTGTACCTGAAACACTCGTAGATACCCAACATGTCCCAATAAACGAATTT 69 FBan0017567 FBgn0040994 CG17567 2 2L CG17567 CG17567 "bs35c03.y1, bs36b02.y1, anon-WO0140519.80, BcDNA:GH05530" CDMC32394 1 24 23 DAC38-A15 23-CG17567-RC_2 CG17567 CGAAACACGTTCAACCATATTGTACCTGAAACACTCGTAGATACCCAACATGTCCCAATAAACGAATTT 69 FBan0017567 FBgn0040994 CG17567 2 2L CG17567 CG17567 "bs35c03.y1, bs36b02.y1, anon-WO0140519.80, BcDNA:GH05530" CDMC32395 1 25 23 DAC38-E03 3-CG17608-RA_1 CG17608 GGGGCAGTGGTGATAATGAACCACCAAAGTGCTGTTGATCTTTGCGTTCTGGCCTATTTGTGGCCTGTG 69 FBan0017608 FBgn0026718 fu12 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 membrane; GO:0016020 fu12 fu12 CG17608 CDMC32395 1 26 23 DAC38-E03 3-CG17608-RA_1 CG17608 GGGGCAGTGGTGATAATGAACCACCAAAGTGCTGTTGATCTTTGCGTTCTGGCCTATTTGTGGCCTGTG 69 FBan0017608 FBgn0026718 fu12 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 membrane; GO:0016020 fu12 fu12 CG17608 CDMC32396 1 1 24 DAC38-E15 17-CG17626-RB_4 CG17626 TGCAGGACCTTTGACGTATACAAGTATGATGCACCATGAGGAATGTAAGGTCGCTGAACCTTGGTCTCA 69 FBgn0040032 CG17626 CG17626 CG17626 CDMC32396 1 2 24 DAC38-E15 17-CG17626-RB_4 CG17626 TGCAGGACCTTTGACGTATACAAGTATGATGCACCATGAGGAATGTAAGGTCGCTGAACCTTGGTCTCA 69 FBgn0040032 CG17626 CG17626 CG17626 CDMC32397 1 3 24 DAC38-I03 6-CG17667-RA_4 CG17667 GACCTCCATCGACACGATTAGCTTCCTCAACTACGACATCAGCTGCTACGAATTCGTACTGGGCACCCC 69 FBan0017667 FBgn0036312 CG17667 3 3L CG17667 CG17667 EP3622 CDMC32397 1 4 24 DAC38-I03 6-CG17667-RA_4 CG17667 GACCTCCATCGACACGATTAGCTTCCTCAACTACGACATCAGCTGCTACGAATTCGTACTGGGCACCCC 69 FBan0017667 FBgn0036312 CG17667 3 3L CG17667 CG17667 EP3622 CDMC32398 1 5 24 DAC38-I15 23-CG17686-RA_1 CG17686 CGAATAATCTAAACGCAGGATTCCTTGGTAATGCTGATTAATTTTTTCCGTGTATTTTGCGACACACTG 69 FBan0017686 FBgn0024807 DIP1 X X double-stranded RNA binding; GO:0003725; chromatin binding; GO:0003682; ; GO:0003725; ; GO:0003682; ; GO:0003725; ; GO:0003725; protein binding; GO:0005515; ; GO:0005515 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 DIP1 DISCO Interacting Protein 1 "CG17686, CG17686, dip1, UbxBP1, Ultrabithorax binding protein 1, klett, TO34, TO67, clot 10495, clot 2020, dip1a, klt, DISCO Interacting Protein 1" CDMC32398 1 6 24 DAC38-I15 23-CG17686-RA_1 CG17686 CGAATAATCTAAACGCAGGATTCCTTGGTAATGCTGATTAATTTTTTCCGTGTATTTTGCGACACACTG 69 FBan0017686 FBgn0024807 DIP1 X X double-stranded RNA binding; GO:0003725; chromatin binding; GO:0003682; ; GO:0003725; ; GO:0003682; ; GO:0003725; ; GO:0003725; protein binding; GO:0005515; ; GO:0005515 chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634 DIP1 DISCO Interacting Protein 1 "CG17686, CG17686, dip1, UbxBP1, Ultrabithorax binding protein 1, klett, TO34, TO67, clot 10495, clot 2020, dip1a, klt, DISCO Interacting Protein 1" CDMC32399 1 7 24 DAC38-M03 9-CG17725-RA_3 CG17725 TGGTGTGGCTCCAGGAACCTCAATGGAGACCAATCCCATTGCCATGAACACTGTTTTCAAGAACACCAT 69 FBan0017725 FBgn0003067 Pepck 2 2R gluconeogenesis; GO:0006094 GTP binding; GO:0005525; phosphoenolpyruvate carboxykinase (GTP) activity; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0005525 mitochondrion; GO:0005739 Pepck Phosphoenolpyruvate carboxykinase "CG17725, CG17725" CDMC32399 1 8 24 DAC38-M03 9-CG17725-RA_3 CG17725 TGGTGTGGCTCCAGGAACCTCAATGGAGACCAATCCCATTGCCATGAACACTGTTTTCAAGAACACCAT 69 FBan0017725 FBgn0003067 Pepck 2 2R gluconeogenesis; GO:0006094 GTP binding; GO:0005525; phosphoenolpyruvate carboxykinase (GTP) activity; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0005525 mitochondrion; GO:0005739 Pepck Phosphoenolpyruvate carboxykinase "CG17725, CG17725" CDMC32400 1 9 24 DAC38-M15 24-CG1773-RA_4 CG1773 ATGTGAATTATTAATGTGTACGATCTAGTAGTCCATGATTTTGTGTCGTTCATTTGTATAGCAAGTAAT 69 FBan0001773 FBgn0033439 CG1773 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG1773 CG1773 SP74 CDMC32400 1 10 24 DAC38-M15 24-CG1773-RA_4 CG1773 ATGTGAATTATTAATGTGTACGATCTAGTAGTCCATGATTTTGTGTCGTTCATTTGTATAGCAAGTAAT 69 FBan0001773 FBgn0033439 CG1773 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG1773 CG1773 SP74 CDMC32401 1 11 24 DAC39-A03 8-CG32158-RF_6 CG32158 GTCGCAGCTTTCTCATTATCCTTCTGGTCAGCATGGCACTGTACACCTTCCAGCGTGACGAGGGG 65 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC32401 1 12 24 DAC39-A03 8-CG32158-RF_6 CG32158 GTCGCAGCTTTCTCATTATCCTTCTGGTCAGCATGGCACTGTACACCTTCCAGCGTGACGAGGGG 65 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC32402 1 13 24 DAC39-A15 17-CG32179-RA_2 CG32179 CCTTAAACTGCATTGCCACATTCCCAAGTAAGCTGCCATGAGTTAAGATCAAGATGCGAGCCCAG 65 FBan0032179 FBgn0052179 Krn 3 3L MAPKKK cascade; GO:0000165; epidermal growth factor receptor signaling pathway; GO:0007173; ommatidial rotation; GO:0016318; positive regulation of epidermal growth factor receptor activity; GO:0045741 growth factor activity; GO:0008083; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0008083 plasma membrane; GO:0005886 Krn Keren "CG32179, CG8056, gritz, CT19073, keren, spitz-2, spitz2, Ker, keren/spitz2, Keren" CDMC32402 1 14 24 DAC39-A15 17-CG32179-RA_2 CG32179 CCTTAAACTGCATTGCCACATTCCCAAGTAAGCTGCCATGAGTTAAGATCAAGATGCGAGCCCAG 65 FBan0032179 FBgn0052179 Krn 3 3L MAPKKK cascade; GO:0000165; epidermal growth factor receptor signaling pathway; GO:0007173; ommatidial rotation; GO:0016318; positive regulation of epidermal growth factor receptor activity; GO:0045741 growth factor activity; GO:0008083; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0008083 plasma membrane; GO:0005886 Krn Keren "CG32179, CG8056, gritz, CT19073, keren, spitz-2, spitz2, Ker, keren/spitz2, Keren" CDMC32403 1 15 24 DAC39-E03 6-CG32266-RA_1 CG32266 TACGGAGCCTATCCCTACAGCTCGCTGTACCTGAGACGCTGAAGTTCCCACACCATCGAATGCAC 65 FBan0032266 FBgn0052266 CG32266 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32266 CG32266 BcDNA:GM24338 CDMC32403 1 16 24 DAC39-E03 6-CG32266-RA_1 CG32266 TACGGAGCCTATCCCTACAGCTCGCTGTACCTGAGACGCTGAAGTTCCCACACCATCGAATGCAC 65 FBan0032266 FBgn0052266 CG32266 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32266 CG32266 BcDNA:GM24338 CDMC32404 1 17 24 DAC39-E15 6-CG32295-RA_1 CG32295 TTCGATCTTCATTTGCAGGATGGTTCGGATTTTGACCCACATTCCAACTCGGGGCGCGTTCGTGT 65 FBan0032295 FBgn0052295 CG32295 3 3L CG32295 CG32295 "CG16757, BEST:GH20547, NEST:bs09a12" CDMC32404 1 18 24 DAC39-E15 6-CG32295-RA_1 CG32295 TTCGATCTTCATTTGCAGGATGGTTCGGATTTTGACCCACATTCCAACTCGGGGCGCGTTCGTGT 65 FBan0032295 FBgn0052295 CG32295 3 3L CG32295 CG32295 "CG16757, BEST:GH20547, NEST:bs09a12" CDMC32405 1 19 24 DAC39-I03 21-CG32439-RA_1 CG32439 CCGGAATACATGACCTCAGCCTCCATATTCCGGGATCATGCTCCACAGACATCGCAATCGCAGTC 65 FBan0032439 FBgn0052439 CG32439 3 3L CG32439 CG32439 CDMC32405 1 20 24 DAC39-I03 21-CG32439-RA_1 CG32439 CCGGAATACATGACCTCAGCCTCCATATTCCGGGATCATGCTCCACAGACATCGCAATCGCAGTC 65 FBan0032439 FBgn0052439 CG32439 3 3L CG32439 CG32439 CDMC32406 1 21 24 DAC39-I15 6-CG32486-RD_2 CG32486 CTCCAAATGAAACCCTACCGCACAGACGAGTACGTGCACAAGCTCTTTTATGAGACGGCCCGCTT 65 FBan0032486 FBgn0052486 CG32486 3 3L development; GO:0007275; protein ubiquitination; GO:0016567; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG32486 CG32486 "CG16745, CG14954, CG16745, anon-WO0118547.267" CDMC32406 1 22 24 DAC39-I15 6-CG32486-RD_2 CG32486 CTCCAAATGAAACCCTACCGCACAGACGAGTACGTGCACAAGCTCTTTTATGAGACGGCCCGCTT 65 FBan0032486 FBgn0052486 CG32486 3 3L development; GO:0007275; protein ubiquitination; GO:0016567; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG32486 CG32486 "CG16745, CG14954, CG16745, anon-WO0118547.267" CDMC32407 1 23 24 DAC39-M03 23-CG32536-RA_1 CG32536 TTTCCCCTTTCTTTTGTTCGATTTAGTTGATTGGCTACACGAAATAAATCTTGCCTTTCACTCGC 65 FBan0032536 FBgn0052536 CG32536 X X CG32536 CG32536 "CG8020, CG8020" CDMC32407 1 24 24 DAC39-M03 23-CG32536-RA_1 CG32536 TTTCCCCTTTCTTTTGTTCGATTTAGTTGATTGGCTACACGAAATAAATCTTGCCTTTCACTCGC 65 FBan0032536 FBgn0052536 CG32536 X X CG32536 CG32536 "CG8020, CG8020" CDMC32408 1 25 24 DAC39-M15 2-CG32549-RA_1 CG32549 ACGTGCATCCGCGATGTGACACACAAGATGGACATGTCCTACGGTATGATGGGCTCACTCTTCCG 65 FBan0032549 FBgn0052549 CG32549 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 cytosol; GO:0005829 CG32549 CG32549 "CG6278, CG6247, CG6267, CG6278" CDMC32408 1 26 24 DAC39-M15 2-CG32549-RA_1 CG32549 ACGTGCATCCGCGATGTGACACACAAGATGGACATGTCCTACGGTATGATGGGCTCACTCTTCCG 65 FBan0032549 FBgn0052549 CG32549 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144" 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 cytosol; GO:0005829 CG32549 CG32549 "CG6278, CG6247, CG6267, CG6278" CDMC32409 1 1 25 DAC40-A03 3-CG4090-RA_7 CG4090 GAACCTGGTACGACGGAGAGTACAACCAGCTCTGGAAAACCTGAAACCACCTCAAAGGCCCCTGA 65 FBan0004090 FBgn0038492 CG4090 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG4090 CG4090 CT13556 CDMC32409 1 2 25 DAC40-A03 3-CG4090-RA_7 CG4090 GAACCTGGTACGACGGAGAGTACAACCAGCTCTGGAAAACCTGAAACCACCTCAAAGGCCCCTGA 65 FBan0004090 FBgn0038492 CG4090 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG4090 CG4090 CT13556 CDMC32410 1 3 25 DAC40-A15 3-CG41074-RA_1 CG41074 GAGAGTTTCATTAGCGAGCGCCTGGCGAAAGAACTGGACAGCGGGAAGAGCCTCAGATCAAACTG 65 FBgn0069949 CG41074 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41074 CG41074 CDMC32410 1 4 25 DAC40-A15 3-CG41074-RA_1 CG41074 GAGAGTTTCATTAGCGAGCGCCTGGCGAAAGAACTGGACAGCGGGAAGAGCCTCAGATCAAACTG 65 FBgn0069949 CG41074 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41074 CG41074 CDMC32411 1 5 25 DAC40-E03 13-CG4152-RA_1 CG4152 CACCCAGATCAGCTCAATCCGCGTGTACTTCCCCAACGATCTACGCAGTGCTGACAATCGGCGAG 65 FBan0004152 FBgn0001986 l(2)35Df 2 2L RNA localization; GO:0006403; mRNA processing; GO:0006397; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 l(2)35Df lethal (2) 35Df "CG4152, CG4152, l(2)br44, br44, l(2)k14423, BG:DS09217.2, l.2.35Df, cg4152, BcDNA:GH07290, l(2)k14422" CDMC32411 1 6 25 DAC40-E03 13-CG4152-RA_1 CG4152 CACCCAGATCAGCTCAATCCGCGTGTACTTCCCCAACGATCTACGCAGTGCTGACAATCGGCGAG 65 FBan0004152 FBgn0001986 l(2)35Df 2 2L RNA localization; GO:0006403; mRNA processing; GO:0006397; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 l(2)35Df lethal (2) 35Df "CG4152, CG4152, l(2)br44, br44, l(2)k14423, BG:DS09217.2, l.2.35Df, cg4152, BcDNA:GH07290, l(2)k14422" CDMC32412 1 7 25 DAC40-E15 2-CG4184-RA_2 CG4184 TTGCCCGCATCTCGAAGTTGCCCAAGAACTACTCGCTCTCACATTTGTTGGACACCTGGGAGATG 65 FBan0004184 FBgn0027592 MED15 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED15 Mediator complex subunit 15 "CG4184, dARC105, Med9/ARC105, Arc105, BcDNA:GH03922, Mediator complex subunit 15" CDMC32412 1 8 25 DAC40-E15 2-CG4184-RA_2 CG4184 TTGCCCGCATCTCGAAGTTGCCCAAGAACTACTCGCTCTCACATTTGTTGGACACCTGGGAGATG 65 FBan0004184 FBgn0027592 MED15 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED15 Mediator complex subunit 15 "CG4184, dARC105, Med9/ARC105, Arc105, BcDNA:GH03922, Mediator complex subunit 15" CDMC32413 1 9 25 DAC40-I03 3-CG4312-RA_1 CG4312 ATACATACAAGATGGTTTGCAAGGGTTGTGGAACAAACTGCCAGTGCTCGGCCCAAAAGTGCGGG 65 FBan0004312 FBgn0002869 MtnB 3 3R metal ion homeostasis; GO:0006875 copper ion binding; GO:0005507; metal ion binding; GO:0046872; ; GO:0046872; ; GO:0005507 MtnB Metallothionein B "CG4312, Mto, DrosMto, MTN, MTO" CDMC32413 1 10 25 DAC40-I03 3-CG4312-RA_1 CG4312 ATACATACAAGATGGTTTGCAAGGGTTGTGGAACAAACTGCCAGTGCTCGGCCCAAAAGTGCGGG 65 FBan0004312 FBgn0002869 MtnB 3 3R metal ion homeostasis; GO:0006875 copper ion binding; GO:0005507; metal ion binding; GO:0046872; ; GO:0046872; ; GO:0005507 MtnB Metallothionein B "CG4312, Mto, DrosMto, MTN, MTO" CDMC32414 1 11 25 DAC40-I15 3-CG4370-RB_5 CG4370 CTTCCTGCTTCCTGTTCTCCATTGAAACGCAGCACACTATTGGCTACGGTGTCCGAACCACCTCG 65 FBan0004370 FBgn0039081 Irk2 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; G-protein activated inward rectifier potassium channel activity; GO:0015467; ; GO:0005242; ; GO:0015467 membrane; GO:0016020 Irk2 Inwardly rectifying potassium channel 2 "CG4370, CG10180, irk2, dKirII" CDMC32414 1 12 25 DAC40-I15 3-CG4370-RB_5 CG4370 CTTCCTGCTTCCTGTTCTCCATTGAAACGCAGCACACTATTGGCTACGGTGTCCGAACCACCTCG 65 FBan0004370 FBgn0039081 Irk2 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813 inward rectifier potassium channel activity; GO:0005242; G-protein activated inward rectifier potassium channel activity; GO:0015467; ; GO:0005242; ; GO:0015467 membrane; GO:0016020 Irk2 Inwardly rectifying potassium channel 2 "CG4370, CG10180, irk2, dKirII" CDMC32415 1 13 25 DAC40-M03 6-CG4472-RA_2 CG4472 TATCGAAGGGATCTGGACTCAGTGGTGCTCCCATTGTTCATGAGACATGTGGAGTTGCACCCGGC 65 FBan0004472 FBgn0020416 Idgf1 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Idgf1 Imaginal disc growth factor 1 "CG4472, CG4472, CG4472, IDGF, BG:DS02780.5, IDGF1, idgf1, Imaginal disc growth factor1, IDGF-1, Imaginal disc growth factor 1" CDMC32415 1 14 25 DAC40-M03 6-CG4472-RA_2 CG4472 TATCGAAGGGATCTGGACTCAGTGGTGCTCCCATTGTTCATGAGACATGTGGAGTTGCACCCGGC 65 FBan0004472 FBgn0020416 Idgf1 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Idgf1 Imaginal disc growth factor 1 "CG4472, CG4472, CG4472, IDGF, BG:DS02780.5, IDGF1, idgf1, Imaginal disc growth factor1, IDGF-1, Imaginal disc growth factor 1" CDMC32416 1 15 25 DAC40-M15 21-CG4547-RA_1 CG4547 CCCCAGCCTGGTGACACTCACCTTCAGCTACGACACACACCACGCCAAGATGGACTTGCAGGTGC 65 FBan0004547 FBgn0029907 CG4547 X X CG4547 CG4547 CDMC32416 1 16 25 DAC40-M15 21-CG4547-RA_1 CG4547 CCCCAGCCTGGTGACACTCACCTTCAGCTACGACACACACCACGCCAAGATGGACTTGCAGGTGC 65 FBan0004547 FBgn0029907 CG4547 X X CG4547 CG4547 CDMC32417 1 17 25 DAC41-A03 16-CG4545-RA_1 CG4545 TGGGTCATCGATGGTGTTAGCAATGGAACCCTTAGCCTTAGTTCGTAAGCGTTAACTAGCTCAGCTGTA 69 FBan0004545 FBgn0010414 SerT 2 2R extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 serotonin transporter activity; GO:0015222; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0015222; ; GO:0005328 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 SerT Serotonin transporter "CG4545, dSERT1, dSERT, cocaine-sensitive serotonin transporter, serotonin transporter, SERT, dSerT, Sert, dSert" CDMC32417 1 18 25 DAC41-A03 16-CG4545-RA_1 CG4545 TGGGTCATCGATGGTGTTAGCAATGGAACCCTTAGCCTTAGTTCGTAAGCGTTAACTAGCTCAGCTGTA 69 FBan0004545 FBgn0010414 SerT 2 2R extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 serotonin transporter activity; GO:0015222; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0015222; ; GO:0005328 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 SerT Serotonin transporter "CG4545, dSERT1, dSERT, cocaine-sensitive serotonin transporter, serotonin transporter, SERT, dSerT, Sert, dSert" CDMC32418 1 19 25 DAC41-A15 6-CG4561-RA_1 CG4561 TGGCGGCGATGTTACCTTCCTGAAATACGAGGATCTGGAGAAGTACTACGCGGAGGACAAACTGCACCC 69 FBgn0036630 CDMC32418 1 20 25 DAC41-A15 6-CG4561-RA_1 CG4561 TGGCGGCGATGTTACCTTCCTGAAATACGAGGATCTGGAGAAGTACTACGCGGAGGACAAACTGCACCC 69 FBgn0036630 CDMC32419 1 21 25 DAC41-E03 2-CG4600-RA_1 CG4600 TGGCCCAGTACCCGCCATTCAGAACGTCCTGAAGGTTTCCGGCAAGAAACTGGAGGATATTGATCTGAT 69 FBan0004600 FBgn0040064 yip2 2 2L fatty acid beta-oxidation; GO:0006635 acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16 mitochondrion; GO:0005739 yip2 yippee interacting protein 2 "CG4600, CG4600, Yip2, yippee interacting protein 2" CDMC32419 1 22 25 DAC41-E03 2-CG4600-RA_1 CG4600 TGGCCCAGTACCCGCCATTCAGAACGTCCTGAAGGTTTCCGGCAAGAAACTGGAGGATATTGATCTGAT 69 FBan0004600 FBgn0040064 yip2 2 2L fatty acid beta-oxidation; GO:0006635 acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16; ; GO:0003988 ; EC:2.3.1.16 mitochondrion; GO:0005739 yip2 yippee interacting protein 2 "CG4600, CG4600, Yip2, yippee interacting protein 2" CDMC32420 1 23 25 DAC41-E15 23-CG4608-RA_3 CG4608 TATCGTCGAAACCAGATGTACCACCGATCCACACAACAAAGCTAAAGTTCCTGATCTTTAAGCATAAGA 69 FBan0004608 FBgn0014135 bnl 3 3R "branching morphogenesis; GO:0001763; chemotaxis; GO:0006935; cytoneme biogenesis; GO:0035231; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; positive chemotaxis; GO:0050918; primary tracheal branching (sensu Insecta); GO:0007428; regulation of tracheal tube architecture; GO:0035152; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104; growth factor activity; GO:0008083; ; GO:0005104; ; GO:0008083 extracellular region; GO:0005576 bnl branchless "CG4608, DFGF, l(3)06916, fibroblast growth factor, Bnl, FGF, l(3)neo52, branchless" CDMC32420 1 24 25 DAC41-E15 23-CG4608-RA_3 CG4608 TATCGTCGAAACCAGATGTACCACCGATCCACACAACAAAGCTAAAGTTCCTGATCTTTAAGCATAAGA 69 FBan0004608 FBgn0014135 bnl 3 3R "branching morphogenesis; GO:0001763; chemotaxis; GO:0006935; cytoneme biogenesis; GO:0035231; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; positive chemotaxis; GO:0050918; primary tracheal branching (sensu Insecta); GO:0007428; regulation of tracheal tube architecture; GO:0035152; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104; growth factor activity; GO:0008083; ; GO:0005104; ; GO:0008083 extracellular region; GO:0005576 bnl branchless "CG4608, DFGF, l(3)06916, fibroblast growth factor, Bnl, FGF, l(3)neo52, branchless" CDMC32421 1 25 25 DAC41-I03 1-CG4631-RA_1 CG4631 GCCGCGGGTAAGACCCTGTACTGAGAACCAAAACAGATTCTCCGGTGGTTTCATGATGCCCGAACCATA 69 FBan0004631 FBgn0032590 CG4631 2 2L CG4631 CG4631 CDMC32421 1 26 25 DAC41-I03 1-CG4631-RA_1 CG4631 GCCGCGGGTAAGACCCTGTACTGAGAACCAAAACAGATTCTCCGGTGGTTTCATGATGCCCGAACCATA 69 FBan0004631 FBgn0032590 CG4631 2 2L CG4631 CG4631 CDMC32422 1 1 26 DAC41-I15 14-CG4645-RA_3 CG4645 TGCGTACAAATGGCACTACAACTTCCATCTGGTCTCCTATGCGGCTACGTCCATCTTCTTGTATGCCAA 69 FBan0004645 FBgn0030435 CG4645 X X CG4645 CG4645 CDMC32422 1 2 26 DAC41-I15 14-CG4645-RA_3 CG4645 TGCGTACAAATGGCACTACAACTTCCATCTGGTCTCCTATGCGGCTACGTCCATCTTCTTGTATGCCAA 69 FBan0004645 FBgn0030435 CG4645 X X CG4645 CG4645 CDMC32423 1 3 26 DAC41-M03 7-CG4673-RA_1 CG4673 TGGTTGGATTTTCACTGATCTCATCACGGACGATGCGAGTATCGGCACTGTCAAACAGATCCGTGGCAT 69 FBan0004673 FBgn0039348 CG4673 3 3R protein targeting; GO:0006605 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 CG4673 CG4673 CDMC32423 1 4 26 DAC41-M03 7-CG4673-RA_1 CG4673 TGGTTGGATTTTCACTGATCTCATCACGGACGATGCGAGTATCGGCACTGTCAAACAGATCCGTGGCAT 69 FBan0004673 FBgn0039348 CG4673 3 3R protein targeting; GO:0006605 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 CG4673 CG4673 CDMC32424 1 5 26 DAC41-M15 3-CG4679-RA_1 CG4679 CCGAAGTCTTCGCCCACATTGACAAGAACCAGCACAGAATTCCCGGAACACCAAGCCTAAATGCTCTGA 69 FBan0004679 FBgn0033816 CG4679 2 2R CG4679 CG4679 CDMC32424 1 6 26 DAC41-M15 3-CG4679-RA_1 CG4679 CCGAAGTCTTCGCCCACATTGACAAGAACCAGCACAGAATTCCCGGAACACCAAGCCTAAATGCTCTGA 69 FBan0004679 FBgn0033816 CG4679 2 2R CG4679 CG4679 CDMC32425 1 7 26 DAC42-A03 150mM NaPO4 Blank CDMC32425 1 8 26 DAC42-A03 150mM NaPO4 Blank CDMC32426 1 9 26 DAC42-A15 150mM NaPO4 Blank CDMC32426 1 10 26 DAC42-A15 150mM NaPO4 Blank CDMC32427 1 11 26 DAC42-E03 150mM NaPO4 Blank CDMC32427 1 12 26 DAC42-E03 150mM NaPO4 Blank CDMC32428 1 13 26 DAC42-E15 150mM NaPO4 Blank CDMC32428 1 14 26 DAC42-E15 150mM NaPO4 Blank CDMC32429 1 15 26 DAC42-I03 150mM NaPO4 Blank CDMC32429 1 16 26 DAC42-I03 150mM NaPO4 Blank CDMC32430 1 17 26 DAC42-I15 5uM MSP 5uM MSP CDMC32430 1 18 26 DAC42-I15 5uM MSP 5uM MSP CDMC32431 1 19 26 DAC42-M03 10uM MSP 10uM MSP CDMC32431 1 20 26 DAC42-M03 10uM MSP 10uM MSP CDMC32432 1 21 26 DAC42-M15 20uM MSP 20uM MSP CDMC32432 1 22 26 DAC42-M15 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC32433 2 1 1 DAC01-B03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32433 2 2 1 DAC01-B03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32434 2 3 1 DAC01-B15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32434 2 4 1 DAC01-B15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32435 2 5 1 DAC01-F03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32435 2 6 1 DAC01-F03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32436 2 7 1 DAC01-F15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32436 2 8 1 DAC01-F15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32437 2 9 1 DAC01-J03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32437 2 10 1 DAC01-J03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32438 2 11 1 DAC01-J15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32438 2 12 1 DAC01-J15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32439 2 13 1 DAC01-N03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32439 2 14 1 DAC01-N03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32440 2 15 1 DAC01-N15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32440 2 16 1 DAC01-N15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32441 2 17 1 DAC02-B03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32441 2 18 1 DAC02-B03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32442 2 19 1 DAC02-B15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32442 2 20 1 DAC02-B15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32443 2 21 1 DAC02-F03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32443 2 22 1 DAC02-F03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32444 2 23 1 DAC02-F15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32444 2 24 1 DAC02-F15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32445 2 25 1 DAC02-J03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32445 2 26 1 DAC02-J03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32446 2 1 2 DAC02-J15 N/A CG9075 (00957-01195) CDMC32446 2 2 2 DAC02-J15 N/A CG9075 (00957-01195) CDMC32447 2 3 2 DAC02-N03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32447 2 4 2 DAC02-N03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32448 2 5 2 DAC02-N15 AutoBlank AutoBlank CDMC32448 2 6 2 DAC02-N15 AutoBlank AutoBlank CDMC32449 2 7 2 DAC03-B03 12-CG3774-RB_4 CG3774 TTCTGATCATGGCCGGCAATATAGTCCAACACTTTGGTATCGCATGGTCATCGGAACCAGTGGCC 65 FBan0003774 FBgn0029849 CG3774 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 nucleotide-sugar transporter activity; GO:0005338; ; GO:0005338 CG3774 CG3774 CDMC32449 2 8 2 DAC03-B03 12-CG3774-RB_4 CG3774 TTCTGATCATGGCCGGCAATATAGTCCAACACTTTGGTATCGCATGGTCATCGGAACCAGTGGCC 65 FBan0003774 FBgn0029849 CG3774 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 nucleotide-sugar transporter activity; GO:0005338; ; GO:0005338 CG3774 CG3774 CDMC32450 2 9 2 DAC03-B15 18-CG3814-RA_1 CG3814 TGCGAAAGTGTACGCCGTAAGACGCCTCTTAACTTCATCTTTCTTTTCCTGTTCACCGTGGCGGA 65 FBan0003814 FBgn0025692 CG3814 2 2R N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 CG3814 CG3814 "CK02213, BEST:CK02213" CDMC32450 2 10 2 DAC03-B15 18-CG3814-RA_1 CG3814 TGCGAAAGTGTACGCCGTAAGACGCCTCTTAACTTCATCTTTCTTTTCCTGTTCACCGTGGCGGA 65 FBan0003814 FBgn0025692 CG3814 2 2R N-methyl-D-aspartate selective glutamate receptor activity; GO:0004972; ; GO:0004972 N-methyl-D-aspartate selective glutamate receptor complex; GO:0017146 CG3814 CG3814 "CK02213, BEST:CK02213" CDMC32451 2 11 2 DAC03-F03 1-CG3925-RA_1 CG3925 TGTCCTTCTGGTTGGTGCGTAACCTTCACCTGACCGAGAAGATGATGCGGCTTACCTTCCTCACC 65 FBan0003925 FBgn0037780 CG3925 3 3R CG3925 CG3925 CDMC32451 2 12 2 DAC03-F03 1-CG3925-RA_1 CG3925 TGTCCTTCTGGTTGGTGCGTAACCTTCACCTGACCGAGAAGATGATGCGGCTTACCTTCCTCACC 65 FBan0003925 FBgn0037780 CG3925 3 3R CG3925 CG3925 CDMC32452 2 13 2 DAC03-F15 2-CG3969-RB_1 CG3969 AGACGCGTTGCCGTCAACAGAGTCTGTGTCGGAAGTGAGTCGCTTCTCAAGTGTGGACAATGAGC 65 FBan0003969 FBgn0013955 PR2 2 2R autophagic cell death; GO:0048102; defense response; GO:0006952; intracellular signaling cascade; GO:0007242; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; serine-type peptidase activity; GO:0008236; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0005509; sugar porter activity; GO:0005351; ; GO:0008236; ; GO:0005351 membrane; GO:0016020 PR2 Fak-like tyrosine kinase "CG3969, CG3969, DPR2, DRODPR2, DmHD-11, focal adhesion kinase, PR2/ACK, HD-11, Rp2" CDMC32452 2 14 2 DAC03-F15 2-CG3969-RB_1 CG3969 AGACGCGTTGCCGTCAACAGAGTCTGTGTCGGAAGTGAGTCGCTTCTCAAGTGTGGACAATGAGC 65 FBan0003969 FBgn0013955 PR2 2 2R autophagic cell death; GO:0048102; defense response; GO:0006952; intracellular signaling cascade; GO:0007242; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; serine-type peptidase activity; GO:0008236; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0005509; sugar porter activity; GO:0005351; ; GO:0008236; ; GO:0005351 membrane; GO:0016020 PR2 Fak-like tyrosine kinase "CG3969, CG3969, DPR2, DRODPR2, DmHD-11, focal adhesion kinase, PR2/ACK, HD-11, Rp2" CDMC32453 2 15 2 DAC03-J03 1-CG40124-RA_1 CG40124 TCCGCCTTCTCCTTCATCACTAGCTGCTCTCCACCTCCGGCCATTTCTGAAGAAACGTATCCACC 65 FBgn0058124 CG40124 CG40124 CG40124 CDMC32453 2 16 2 DAC03-J03 1-CG40124-RA_1 CG40124 TCCGCCTTCTCCTTCATCACTAGCTGCTCTCCACCTCCGGCCATTTCTGAAGAAACGTATCCACC 65 FBgn0058124 CG40124 CG40124 CG40124 CDMC32454 2 17 2 DAC03-J15 23-CG40172-RA_1 CG40172 GAACAAGAAAAGGCAGGCAAAAAATAGTCACTTTGAATCGGAACAGAAAGGAAAAGCGATACTGA 65 FBan0040172 FBgn0058172 CG40172 2 2L CG40172 CG40172 CDMC32454 2 18 2 DAC03-J15 23-CG40172-RA_1 CG40172 GAACAAGAAAAGGCAGGCAAAAAATAGTCACTTTGAATCGGAACAGAAAGGAAAAGCGATACTGA 65 FBan0040172 FBgn0058172 CG40172 2 2L CG40172 CG40172 CDMC32455 2 19 2 DAC03-N03 14-CG40368-RA_1 CG40368 TAGAGGCATTATTCAAGGAGTACGGAGGGAGACATGCCGTAGAGGTCAGCCTCGACTTCACTAGC 65 FBgn0040035 CG40368 CG40368 CG40368 CG12458 CDMC32455 2 20 2 DAC03-N03 14-CG40368-RA_1 CG40368 TAGAGGCATTATTCAAGGAGTACGGAGGGAGACATGCCGTAGAGGTCAGCCTCGACTTCACTAGC 65 FBgn0040035 CG40368 CG40368 CG40368 CG12458 CDMC32456 2 21 2 DAC03-N15 23-CG40390-RA_6 CG40390 CCAACGCAAAGGATTACATTAAATACTGGAGTAAACTACGCGGGGCCATATCATATAAGGTGCTC 65 FBgn0058390 CG40390 CG40390 CG40390 CDMC32456 2 22 2 DAC03-N15 23-CG40390-RA_6 CG40390 CCAACGCAAAGGATTACATTAAATACTGGAGTAAACTACGCGGGGCCATATCATATAAGGTGCTC 65 FBgn0058390 CG40390 CG40390 CG40390 CDMC32457 2 23 2 DAC04-B03 3-CG31509-RA_2 CG31509 GGAGTTCCGATTCAGGGAGGTCGAAAGGCGAGGATCGTTGGAAAGATTGTATCTCCAGGTGTGAAGGGC 69 FBan0031509 FBgn0028396 TotA 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065; response to heat; GO:0009408; response to stress; GO:0006950 TotA Turandot A "CG31509, Turt, Turandot, Tot, totA, tot" CDMC32457 2 24 2 DAC04-B03 3-CG31509-RA_2 CG31509 GGAGTTCCGATTCAGGGAGGTCGAAAGGCGAGGATCGTTGGAAAGATTGTATCTCCAGGTGTGAAGGGC 69 FBan0031509 FBgn0028396 TotA 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065; response to heat; GO:0009408; response to stress; GO:0006950 TotA Turandot A "CG31509, Turt, Turandot, Tot, totA, tot" CDMC32458 2 25 2 DAC04-B15 23-CG3151-RA_6 CG3151 TAGTCAAACCACTTGCAAATAGACAATGCAGAATGAGAAGGCAGCTAGATGCGAAAGAAAACCAAACAA 69 FBan0003151 FBgn0010263 Rbp9 2 2L cell proliferation; GO:0008283; egg chamber formation (sensu Insecta); GO:0007293; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 nucleus; GO:0005634 Rbp9 RNA-binding protein 9 "CG3151, CG15402, fes, fs(2)B, rbp9, rrm10, rrm9, female sterile, female sterile(2)Bridges, rbp, rbp9a, RBP9-2, RBP9, RRM10, RRM9, Rbp10, RNA-binding protein 10" CDMC32458 2 26 2 DAC04-B15 23-CG3151-RA_6 CG3151 TAGTCAAACCACTTGCAAATAGACAATGCAGAATGAGAAGGCAGCTAGATGCGAAAGAAAACCAAACAA 69 FBan0003151 FBgn0010263 Rbp9 2 2L cell proliferation; GO:0008283; egg chamber formation (sensu Insecta); GO:0007293; mRNA processing; GO:0006397 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 nucleus; GO:0005634 Rbp9 RNA-binding protein 9 "CG3151, CG15402, fes, fs(2)B, rbp9, rrm10, rrm9, female sterile, female sterile(2)Bridges, rbp, rbp9a, RBP9-2, RBP9, RRM10, RRM9, Rbp10, RNA-binding protein 10" CDMC32459 2 1 3 DAC04-F03 18-CG31546-RA_1 CG31546 TGGCAAGCAGGTCATGTGTCCGCGCTAGTCTCTGCTAGGATATTCTATATGATCATCTGATCCTGTCCA 69 FBan0031546 FBgn0051546 CG31546 3 3R metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31546 CG31546 "CG2907, anon-WO0140519.189" CDMC32459 2 2 3 DAC04-F03 18-CG31546-RA_1 CG31546 TGGCAAGCAGGTCATGTGTCCGCGCTAGTCTCTGCTAGGATATTCTATATGATCATCTGATCCTGTCCA 69 FBan0031546 FBgn0051546 CG31546 3 3R metabolism; GO:0008152 ATP binding; GO:0005524; ; GO:0005524; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG31546 CG31546 "CG2907, anon-WO0140519.189" CDMC32460 2 3 3 DAC04-F15 17-CG31557-RA_1 CG31557 TGTACCATGAGTACAAATGCTGGGAGCGAGTAAATGGGAATAAGCTAGTGGAGGACAACGAAGAGCAGT 69 FBan0031557 FBgn0046876 Obp83ef 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83ef Odorant-binding protein 83ef "CG15583, CG31557, CG15583, CG15583, CG15583, CG15583, CG15583, CG31557, 83f, OBP83e, Odorant-binding protein 83f, Pseudogene 83e, Obp83e, Obp83f, 83f-1, 83f-2" CDMC32460 2 4 3 DAC04-F15 17-CG31557-RA_1 CG31557 TGTACCATGAGTACAAATGCTGGGAGCGAGTAAATGGGAATAAGCTAGTGGAGGACAACGAAGAGCAGT 69 FBan0031557 FBgn0046876 Obp83ef 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83ef Odorant-binding protein 83ef "CG15583, CG31557, CG15583, CG15583, CG15583, CG15583, CG15583, CG31557, 83f, OBP83e, Odorant-binding protein 83f, Pseudogene 83e, Obp83e, Obp83f, 83f-1, 83f-2" CDMC32461 2 5 3 DAC04-J03 15-CG31623-RA_2 CG31623 AATCTTCAGATTTTGAGCGACGAAGGAGACGTTGTGGTCGAAGAGCTCAGTGTCAATGCTCAGGTGTCG 69 FBgn0051623 CDMC32461 2 6 3 DAC04-J03 15-CG31623-RA_2 CG31623 AATCTTCAGATTTTGAGCGACGAAGGAGACGTTGTGGTCGAAGAGCTCAGTGTCAATGCTCAGGTGTCG 69 FBgn0051623 CDMC32462 2 7 3 DAC04-J15 1-CG31635-RA_3 CG31635 ACATCGACGCACACATAAGTACAAAAGCCGTAGAGGTAACCGGGCAAAAGGTTTCTCCGCACCTGACCA 69 FBan0031635 FBgn0051635 CG31635 2 2L CG31635 CG31635 "CG13769, CG13768, CG13769, CT33252, BcDNA:GM03875" CDMC32462 2 8 3 DAC04-J15 1-CG31635-RA_3 CG31635 ACATCGACGCACACATAAGTACAAAAGCCGTAGAGGTAACCGGGCAAAAGGTTTCTCCGCACCTGACCA 69 FBan0031635 FBgn0051635 CG31635 2 2L CG31635 CG31635 "CG13769, CG13768, CG13769, CT33252, BcDNA:GM03875" CDMC32463 2 9 3 DAC04-N03 18-CG31658-RA_1 CG31658 GCCCTCTGCGCATGCACAACTTGAATCTAAGCATCACATTCATGGAGCAACAGCTTAAGAAACAGGAAA 69 FBan0031658 FBgn0051658 CG31658 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31658 CG31658 CDMC32463 2 10 3 DAC04-N03 18-CG31658-RA_1 CG31658 GCCCTCTGCGCATGCACAACTTGAATCTAAGCATCACATTCATGGAGCAACAGCTTAAGAAACAGGAAA 69 FBan0031658 FBgn0051658 CG31658 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31658 CG31658 CDMC32464 2 11 3 DAC04-N15 15-CG31666-RD_1 CG31666 ACGGACAGACAAGCGAACACACGAAAAACAGATGGCGAATTTGATGACCACCAACTTTTTGCAGGCATT 69 FBan0031666 FBgn0051666 CG31666 2 2L transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG31666 CG31666 "CG17156, CG10871, CG17649, CG17156, CG17156, CG10871" CDMC32464 2 12 3 DAC04-N15 15-CG31666-RD_1 CG31666 ACGGACAGACAAGCGAACACACGAAAAACAGATGGCGAATTTGATGACCACCAACTTTTTGCAGGCATT 69 FBan0031666 FBgn0051666 CG31666 2 2L transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG31666 CG31666 "CG17156, CG10871, CG17649, CG17156, CG17156, CG10871" CDMC32465 2 13 3 DAC05-B03 1-CG5963-RA_1 CG5963 TGGTCCTGGAGCAGCACGCCCTCTTCACCAAACTGAAGTTTGTGCAGTATCTCAAGAGTATCCGCAAGA 69 FBgn0030910 CDMC32465 2 14 3 DAC05-B03 1-CG5963-RA_1 CG5963 TGGTCCTGGAGCAGCACGCCCTCTTCACCAAACTGAAGTTTGTGCAGTATCTCAAGAGTATCCGCAAGA 69 FBgn0030910 CDMC32466 2 15 3 DAC05-B15 14-CG5976-RA_4 CG5976 ACCTCGAGTTGTGGGCACAACAAATCATAGCATCGTTCGCGAATACATCGTCCAGAGTTTGAGGGATCT 69 FBan0005976 FBgn0036999 CG5976 3 3L amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; glutaminyl-peptide cyclotransferase activity; GO:0016603 ; EC:2.3.2.5; ; GO:0016603 ; EC:2.3.2.5 CG5976 CG5976 CG32426 CDMC32466 2 16 3 DAC05-B15 14-CG5976-RA_4 CG5976 ACCTCGAGTTGTGGGCACAACAAATCATAGCATCGTTCGCGAATACATCGTCCAGAGTTTGAGGGATCT 69 FBan0005976 FBgn0036999 CG5976 3 3L amino acid biosynthesis; GO:0008652; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; glutaminyl-peptide cyclotransferase activity; GO:0016603 ; EC:2.3.2.5; ; GO:0016603 ; EC:2.3.2.5 CG5976 CG5976 CG32426 CDMC32467 2 17 3 DAC05-F03 17-CG6023-RA_1 CG6023 AGGCTATGCCCACGAGTATCCAGATCCGTATTCGTCTACTAGACACCCTCATCTGCCTTAGACCCTATT 69 FBan0006023 FBgn0030912 CG6023 X X CG6023 CG6023 CDMC32467 2 18 3 DAC05-F03 17-CG6023-RA_1 CG6023 AGGCTATGCCCACGAGTATCCAGATCCGTATTCGTCTACTAGACACCCTCATCTGCCTTAGACCCTATT 69 FBan0006023 FBgn0030912 CG6023 X X CG6023 CG6023 CDMC32468 2 19 3 DAC05-F15 15-CG6036-RA_2 CG6036 TGGGTCATAAAATGGGTGGCTTCTTGGAAAAACCAGAAACTGAAAAGCAGGCTCAAGAGGGTCATGGGA 69 FBan0006036 FBgn0039421 CG6036 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2C activity; GO:0015071; ; GO:0015071 protein serine/threonine phosphatase complex; GO:0008287 CG6036 CG6036 PP2Cb CDMC32468 2 20 3 DAC05-F15 15-CG6036-RA_2 CG6036 TGGGTCATAAAATGGGTGGCTTCTTGGAAAAACCAGAAACTGAAAAGCAGGCTCAAGAGGGTCATGGGA 69 FBan0006036 FBgn0039421 CG6036 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2C activity; GO:0015071; ; GO:0015071 protein serine/threonine phosphatase complex; GO:0008287 CG6036 CG6036 PP2Cb CDMC32469 2 21 3 DAC05-J03 23-CG6064-RA_5 CG6064 AGCCAGCAAGTCATTTTTGTCGTTAACACAACTGATGGAATTTTCGTTTTTAACACAGATGAGGAAGTG 69 FBan0006064 FBgn0036746 TORC 3 3L cytoplasm; GO:0005737; nucleus; GO:0005634 TORC TORC "CG6064, CG6064, CG6064, dTORC" CDMC32469 2 22 3 DAC05-J03 23-CG6064-RA_5 CG6064 AGCCAGCAAGTCATTTTTGTCGTTAACACAACTGATGGAATTTTCGTTTTTAACACAGATGAGGAAGTG 69 FBan0006064 FBgn0036746 TORC 3 3L cytoplasm; GO:0005737; nucleus; GO:0005634 TORC TORC "CG6064, CG6064, CG6064, dTORC" CDMC32470 2 23 3 DAC05-J15 15-CG6073-RA_2 CG6073 GGCACCATTGGCATTCTGAAGAACGTTTGCTTCGACACTGTCTACCACGATGTGATCCTAAACGAGCAG 69 FBan0006073 FBgn0039417 CG6073 3 3R CG6073 CG6073 CDMC32470 2 24 3 DAC05-J15 15-CG6073-RA_2 CG6073 GGCACCATTGGCATTCTGAAGAACGTTTGCTTCGACACTGTCTACCACGATGTGATCCTAAACGAGCAG 69 FBan0006073 FBgn0039417 CG6073 3 3R CG6073 CG6073 CDMC32471 2 25 3 DAC05-N03 3-CG6121-RA_3 CG6121 GCCTGGAGAGGCACCTGTCCAAGTGCAATCTTAGGCATCCACCGGGAAACGAGATCTATCGCAAACATA 69 FBan0006121 FBgn0026080 Tip60 X X chromatin assembly or disassembly; GO:0006333; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 chromatin; GO:0000785; nucleus; GO:0005634 Tip60 Tip60 "CG6121, CG6121, CG6121, CG6121, DmEG0007.7, EG0007.7, dmHAG405, EG:EG0007.7, dTip60" CDMC32471 2 26 3 DAC05-N03 3-CG6121-RA_3 CG6121 GCCTGGAGAGGCACCTGTCCAAGTGCAATCTTAGGCATCCACCGGGAAACGAGATCTATCGCAAACATA 69 FBan0006121 FBgn0026080 Tip60 X X chromatin assembly or disassembly; GO:0006333; protein amino acid acetylation; GO:0006473; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; ; GO:0004402 ; EC:2.3.1.48 chromatin; GO:0000785; nucleus; GO:0005634 Tip60 Tip60 "CG6121, CG6121, CG6121, CG6121, DmEG0007.7, EG0007.7, dmHAG405, EG:EG0007.7, dTip60" CDMC32472 2 1 4 DAC05-N15 5-CG6134-RA_1 CG6134 CCTGCGCCAAGGATGAAAGCCAACACCTTAGAAACTTCTGCACGAATGTGGACGACTATCCGGACCTTT 69 FBan0006134 FBgn0003495 spz 3 3R "Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; dorsal/ventral axis specification; GO:0009950; embryonic axis specification; GO:0000578; immune response; GO:0006955; innate immune response; GO:0045087; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; oocyte dorsal/ventral axis determination; GO:0007310; response to fungi; GO:0009620" Toll binding; GO:0005121; ; GO:0005121; ; GO:0005121; morphogen activity; GO:0016015; cytokine activity; GO:0005125; ; GO:0016015; ; GO:0005125; ; GO:0005121 extracellular region; GO:0005576 spz spatzle "CG6134, CG6134, CG6134, spaetzle, Spatzle, Spaetzle, mel(3)7" CDMC32472 2 2 4 DAC05-N15 5-CG6134-RA_1 CG6134 CCTGCGCCAAGGATGAAAGCCAACACCTTAGAAACTTCTGCACGAATGTGGACGACTATCCGGACCTTT 69 FBan0006134 FBgn0003495 spz 3 3R "Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal polypeptide induction; GO:0006967; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; dorsal/ventral axis specification; GO:0009950; embryonic axis specification; GO:0000578; immune response; GO:0006955; innate immune response; GO:0045087; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded; GO:0007311; oocyte dorsal/ventral axis determination; GO:0007310; response to fungi; GO:0009620" Toll binding; GO:0005121; ; GO:0005121; ; GO:0005121; morphogen activity; GO:0016015; cytokine activity; GO:0005125; ; GO:0016015; ; GO:0005125; ; GO:0005121 extracellular region; GO:0005576 spz spatzle "CG6134, CG6134, CG6134, spaetzle, Spatzle, Spaetzle, mel(3)7" CDMC32473 2 3 4 DAC06-B03 3-CG11513-RA_1 CG11513 GGGCCATTTCACTCACGTGCTGTTCGATGAAGCTGGTCAATGCACCGAACCAGAAACAATGGTACCCAT 69 FBgn0035448 CDMC32473 2 4 4 DAC06-B03 3-CG11513-RA_1 CG11513 GGGCCATTTCACTCACGTGCTGTTCGATGAAGCTGGTCAATGCACCGAACCAGAAACAATGGTACCCAT 69 FBgn0035448 CDMC32474 2 5 4 DAC06-B15 17-CG11533-RA_6 CG11533 GCCACTTGAGTCCGCAGAAGTTCCACAGGAAATCCCTTACCATCCACAGTCTGATACGACATATTCTGT 69 FBan0011533 FBgn0039908 CG11533 4 4 intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG11533 CG11533 "CKI-like, CK I" CDMC32474 2 6 4 DAC06-B15 17-CG11533-RA_6 CG11533 GCCACTTGAGTCCGCAGAAGTTCCACAGGAAATCCCTTACCATCCACAGTCTGATACGACATATTCTGT 69 FBan0011533 FBgn0039908 CG11533 4 4 intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG11533 CG11533 "CKI-like, CK I" CDMC32475 2 7 4 DAC06-F03 8-CG1157-RA_1 CG1157 TGCACATTTCCCCATCCACATGTCTCTTGGCGGTCGTACATGTCACTCAGGTTCATCGAAAGCAACGAA 69 FBan0001157 FBgn0037424 Osi15 3 3R Osi15 Osiris 15 "CG1157, CG1157, Osiris, Osiris 15" CDMC32475 2 8 4 DAC06-F03 8-CG1157-RA_1 CG1157 TGCACATTTCCCCATCCACATGTCTCTTGGCGGTCGTACATGTCACTCAGGTTCATCGAAAGCAACGAA 69 FBan0001157 FBgn0037424 Osi15 3 3R Osi15 Osiris 15 "CG1157, CG1157, Osiris, Osiris 15" CDMC32476 2 9 4 DAC06-F15 2-CG11592-RA_1 CG11592 GGCGATCCTTTTGGCAGAGGAATCCACCATTACCTTTGGATCTGATAAGCAGCCCTCCTGTGAGAGCGA 69 FBan0011592 FBgn0025686 CG11592 2 2L CG11592 CG11592 "CK02467, BEST:CK02467" CDMC32476 2 10 4 DAC06-F15 2-CG11592-RA_1 CG11592 GGCGATCCTTTTGGCAGAGGAATCCACCATTACCTTTGGATCTGATAAGCAGCCCTCCTGTGAGAGCGA 69 FBan0011592 FBgn0025686 CG11592 2 2L CG11592 CG11592 "CK02467, BEST:CK02467" CDMC32477 2 11 4 DAC06-J03 17-CG11637-RA_1 CG11637 CGGCGAATGCGAATCAGTTGCGATTCCTGATCACCTATAACGACAAGGCTTCCACGTACATATACAGCA 69 FBan0011637 FBgn0036822 CG11637 3 3L cell adhesion; GO:0007155; tissue regeneration; GO:0042246 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- integral to membrane; GO:0016021 CG11637 CG11637 CDMC32477 2 12 4 DAC06-J03 17-CG11637-RA_1 CG11637 CGGCGAATGCGAATCAGTTGCGATTCCTGATCACCTATAACGACAAGGCTTCCACGTACATATACAGCA 69 FBan0011637 FBgn0036822 CG11637 3 3L cell adhesion; GO:0007155; tissue regeneration; GO:0042246 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- integral to membrane; GO:0016021 CG11637 CG11637 CDMC32478 2 13 4 DAC06-J15 18-CG11648-RE_3 CG11648 ATTCATTATTTCGGTAAGTACACCAAAGAGGAGGATGCTACCACATCGCAAGCGACCTCTCACCATCGA 69 FBan0011648 FBgn0000015 Abd-B 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; male gonad development; GO:0008584; midgut development; GO:0007494; negative regulation of cardioblast cell fate specification; GO:0009997; negative regulation of salivary gland determination; GO:0045705; negative regulation of striated muscle development; GO:0045843; pigmentation during development; GO:0048066; pole cell migration; GO:0007280; positive regulation of pigmentation; GO:0048087; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; specification of segmental identity, abdomen; GO:0007385; spiracle morphogenesis; GO:0035277" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Abd-B Abdominal B "CG11648, CG10291, tuh-3, Mcp: Miscadastral pigmentation, iab-5, iab-8, iab-7, AbdB, twig, Sab: Superabdominal, Tab: Transabdominal, iab5: infra-abdominal 5, iab6: infra-abdominal 6, iab7: infra-abdominal 7, iab8: infra-abdominal 8, iab9: infra-abdominal 9, Male chauvinist pigmentation, Miscadastral pigmentation, Superabdominal, Transabdominal, infra-abdominal 5, infra-abdominal 6, infra-abdominal 7, infra-abdominal 8, infra-abdominal 9, Mc: Microcephalus, FAB, MCP, Fab7, DROABDB, Fab-7, Abd B, abdB, AbdB(CA)[[26]], ABDB, pH189, abd-B, AbdB-I, AbdB-II, iab-6, Abd-b, Abdominal-B, AdbB, Uab-5[Sab], iab8.9: infraabdominal-8.9, iab: infraabdominal, l(3)89Ed, Microcephalus, infraabdominal-8.9, infraabdominal, Mcp, iab6, iab7, iab8, iab9, Mc, iab5, Sab, Tab" CDMC32478 2 14 4 DAC06-J15 18-CG11648-RE_3 CG11648 ATTCATTATTTCGGTAAGTACACCAAAGAGGAGGATGCTACCACATCGCAAGCGACCTCTCACCATCGA 69 FBan0011648 FBgn0000015 Abd-B 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; male gonad development; GO:0008584; midgut development; GO:0007494; negative regulation of cardioblast cell fate specification; GO:0009997; negative regulation of salivary gland determination; GO:0045705; negative regulation of striated muscle development; GO:0045843; pigmentation during development; GO:0048066; pole cell migration; GO:0007280; positive regulation of pigmentation; GO:0048087; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; specification of segmental identity, abdomen; GO:0007385; spiracle morphogenesis; GO:0035277" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Abd-B Abdominal B "CG11648, CG10291, tuh-3, Mcp: Miscadastral pigmentation, iab-5, iab-8, iab-7, AbdB, twig, Sab: Superabdominal, Tab: Transabdominal, iab5: infra-abdominal 5, iab6: infra-abdominal 6, iab7: infra-abdominal 7, iab8: infra-abdominal 8, iab9: infra-abdominal 9, Male chauvinist pigmentation, Miscadastral pigmentation, Superabdominal, Transabdominal, infra-abdominal 5, infra-abdominal 6, infra-abdominal 7, infra-abdominal 8, infra-abdominal 9, Mc: Microcephalus, FAB, MCP, Fab7, DROABDB, Fab-7, Abd B, abdB, AbdB(CA)[[26]], ABDB, pH189, abd-B, AbdB-I, AbdB-II, iab-6, Abd-b, Abdominal-B, AdbB, Uab-5[Sab], iab8.9: infraabdominal-8.9, iab: infraabdominal, l(3)89Ed, Microcephalus, infraabdominal-8.9, infraabdominal, Mcp, iab6, iab7, iab8, iab9, Mc, iab5, Sab, Tab" CDMC32479 2 15 4 DAC06-N03 2-CG11696-RA_1 CG11696 GCACTGGCTATGTGAAGTGCTGCAACAATCGGTACAAGAAGCGGACACTGTACGTCGACCATTTGCACT 69 FBan0011696 FBgn0030314 CG11696 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG11696 CG11696 b CDMC32479 2 16 4 DAC06-N03 2-CG11696-RA_1 CG11696 GCACTGGCTATGTGAAGTGCTGCAACAATCGGTACAAGAAGCGGACACTGTACGTCGACCATTTGCACT 69 FBan0011696 FBgn0030314 CG11696 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG11696 CG11696 b CDMC32480 2 17 4 DAC06-N15 23-CG11715-RA_1 CG11715 ACCGTACACCGCAAACAATAAGCTACACAGAACGGACACTTATCCATACATATAACTCCACTTGTTGGC 69 FBan0011715 FBgn0030304 Cyp4g15 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694; transport; GO:0006810 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g15 Cyp4g15 "CG11715, 4g15" CDMC32480 2 18 4 DAC06-N15 23-CG11715-RA_1 CG11715 ACCGTACACCGCAAACAATAAGCTACACAGAACGGACACTTATCCATACATATAACTCCACTTGTTGGC 69 FBan0011715 FBgn0030304 Cyp4g15 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694; transport; GO:0006810 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4g15 Cyp4g15 "CG11715, 4g15" CDMC32481 2 19 4 DAC07-B03 3-CG14964-RA_4 CG14964 GATCTGGAGACCTATCATCCGCGTACCATGGGTGCTGGAACCTTTACACCATACAGGGCTCCCAC 65 FBan0014964 FBgn0035410 CG14964 3 3L cell adhesion; GO:0007155; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468 myosin binding; GO:0017022; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0005200; ; GO:0004702 ; EC:2.7.1.-; ; GO:0017022 CG14964 CG14964 CT34810 CDMC32481 2 20 4 DAC07-B03 3-CG14964-RA_4 CG14964 GATCTGGAGACCTATCATCCGCGTACCATGGGTGCTGGAACCTTTACACCATACAGGGCTCCCAC 65 FBan0014964 FBgn0035410 CG14964 3 3L cell adhesion; GO:0007155; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468 myosin binding; GO:0017022; structural constituent of cytoskeleton; GO:0005200; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0005200; ; GO:0004702 ; EC:2.7.1.-; ; GO:0017022 CG14964 CG14964 CT34810 CDMC32482 2 21 4 DAC07-B15 15-CG1500-RA_2 CG1500 GATCGGCGGAGTATCACTGCATACCGAACTACAATCGGATTGGCCAGTATTTGCGCAAGTGCACC 65 FBan0001500 FBgn0001083 fw X X sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 serine-type peptidase activity; GO:0008236; ; GO:0008236; sugar binding; GO:0005529; ; GO:0005529 fw furrowed "CG1500, wr: wrinkled, wrinkled, CT3745, fw-like, wr" CDMC32482 2 22 4 DAC07-B15 15-CG1500-RA_2 CG1500 GATCGGCGGAGTATCACTGCATACCGAACTACAATCGGATTGGCCAGTATTTGCGCAAGTGCACC 65 FBan0001500 FBgn0001083 fw X X sensory organ development; GO:0007423; wing morphogenesis; GO:0007476 serine-type peptidase activity; GO:0008236; ; GO:0008236; sugar binding; GO:0005529; ; GO:0005529 fw furrowed "CG1500, wr: wrinkled, wrinkled, CT3745, fw-like, wr" CDMC32483 2 23 4 DAC07-F03 2-CG15088-RA_1 CG15088 GTCACCGGCACAGCTACGTGAGATCCTTCATGAGGTGCCCAACATAGACAACGGACTGAGTCTGC 65 FBan0015088 FBgn0034381 CG15088 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15088 CG15088 CDMC32483 2 24 4 DAC07-F03 2-CG15088-RA_1 CG15088 GTCACCGGCACAGCTACGTGAGATCCTTCATGAGGTGCCCAACATAGACAACGGACTGAGTCTGC 65 FBan0015088 FBgn0034381 CG15088 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG15088 CG15088 CDMC32484 2 25 4 DAC07-F15 3-CG15121-RA_1 CG15121 CACCACGGCGTGGATTGTCTTATCCGCGGGAATACCCATTAGTTCGCTGGCTTTCTGTTTGGAGC 65 FBan0015121 FBgn0034456 CG15121 2 2R CG15121 CG15121 CDMC32484 2 26 4 DAC07-F15 3-CG15121-RA_1 CG15121 CACCACGGCGTGGATTGTCTTATCCGCGGGAATACCCATTAGTTCGCTGGCTTTCTGTTTGGAGC 65 FBan0015121 FBgn0034456 CG15121 2 2R CG15121 CG15121 CDMC32485 2 1 5 DAC07-J03 3-CG15194-RA_1 CG15194 GTCGATGAAGTGGAAGTCGGCGCTCAATCACATCGGACTGCTCGTCTCCCTGTCCATTTACTGCG 65 FBan0015194 FBgn0030302 CG15194 X X CG15194 CG15194 CDMC32485 2 2 5 DAC07-J03 3-CG15194-RA_1 CG15194 GTCGATGAAGTGGAAGTCGGCGCTCAATCACATCGGACTGCTCGTCTCCCTGTCCATTTACTGCG 65 FBan0015194 FBgn0030302 CG15194 X X CG15194 CG15194 CDMC32486 2 3 5 DAC07-J15 3-CG15221-RA_3 CG15221 CTTTCTCGGTGAACATCTGGATGCTGATCGTGTTCCGCTTCCTGACGGGCTTCTTCATTTCCGGC 65 FBan0015221 FBgn0030331 CG15221 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG15221 CG15221 CDMC32486 2 4 5 DAC07-J15 3-CG15221-RA_3 CG15221 CTTTCTCGGTGAACATCTGGATGCTGATCGTGTTCCGCTTCCTGACGGGCTTCTTCATTTCCGGC 65 FBan0015221 FBgn0030331 CG15221 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG15221 CG15221 CDMC32487 2 5 5 DAC07-N03 3-CG15319-RB_2 CG15319 AGGCGATGTGGCTAGAGGGCTAGGGCTAGACTGAATGAATGAATGAGTGTCCAGTAGCCGCAGAC 65 FBan0015319 FBgn0015624 nej X X R3/R4 cell fate commitment; GO:0007464; R7 cell differentiation; GO:0045466; Wnt receptor signaling pathway; GO:0016055; compound eye morphogenesis (sensu Endopterygota); GO:0001745; hemopoiesis; GO:0030097; neurotransmitter secretion; GO:0007269; regulation of mitosis; GO:0007088; regulation of transcription from RNA polymerase II promoter; GO:0006357; smoothened signaling pathway; GO:0007224; synaptic vesicle transport; GO:0048489; synaptogenesis; GO:0007416 chromatin binding; GO:0003682; cAMP response element binding protein binding; GO:0008140; ; GO:0008140; transcription coactivator activity; GO:0003713; ; GO:0003682; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0003713; zinc ion binding; GO:0008270; ; GO:0003713; ; GO:0016407 ; EC:2.3.1.-; ; GO:0008270 nucleus; GO:0005634 nej nejire "CG15319, CG15319, Cbp, CREB-binding protein, dCBP, CBP, cbp, CREB binding protein, CBP/p300, p300/CBP, anon-WO0147981.11, dmCBP, anon-WO03040301.89, Crbp: CREB-binding protein, nejire" CDMC32487 2 6 5 DAC07-N03 3-CG15319-RB_2 CG15319 AGGCGATGTGGCTAGAGGGCTAGGGCTAGACTGAATGAATGAATGAGTGTCCAGTAGCCGCAGAC 65 FBan0015319 FBgn0015624 nej X X R3/R4 cell fate commitment; GO:0007464; R7 cell differentiation; GO:0045466; Wnt receptor signaling pathway; GO:0016055; compound eye morphogenesis (sensu Endopterygota); GO:0001745; hemopoiesis; GO:0030097; neurotransmitter secretion; GO:0007269; regulation of mitosis; GO:0007088; regulation of transcription from RNA polymerase II promoter; GO:0006357; smoothened signaling pathway; GO:0007224; synaptic vesicle transport; GO:0048489; synaptogenesis; GO:0007416 chromatin binding; GO:0003682; cAMP response element binding protein binding; GO:0008140; ; GO:0008140; transcription coactivator activity; GO:0003713; ; GO:0003682; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; ; GO:0003713; zinc ion binding; GO:0008270; ; GO:0003713; ; GO:0016407 ; EC:2.3.1.-; ; GO:0008270 nucleus; GO:0005634 nej nejire "CG15319, CG15319, Cbp, CREB-binding protein, dCBP, CBP, cbp, CREB binding protein, CBP/p300, p300/CBP, anon-WO0147981.11, dmCBP, anon-WO03040301.89, Crbp: CREB-binding protein, nejire" CDMC32488 2 7 5 DAC07-N15 15-CG15352-RA_1 CG15352 GTCCACGATGTCGTTTTCCTCGACGATTTCGAACGCAACGTGAAGCCTTTGATTTACCGCCCCGT 65 FBan0015352 FBgn0040930 CG15352 X X CG15352 CG15352 CDMC32488 2 8 5 DAC07-N15 15-CG15352-RA_1 CG15352 GTCCACGATGTCGTTTTCCTCGACGATTTCGAACGCAACGTGAAGCCTTTGATTTACCGCCCCGT 65 FBan0015352 FBgn0040930 CG15352 X X CG15352 CG15352 CDMC32489 2 9 5 DAC08-B03 14-CG14410-RA_2 CG14410 CCCAATGAAGAGCAGTACGTCGGGAATCAGTTGCCACTTAGAAATCCCGCTCAATCGACTCCAACT 66 FBan0014410 FBgn0030583 CG14410 X X CG14410 CG14410 CDMC32489 2 10 5 DAC08-B03 14-CG14410-RA_2 CG14410 CCCAATGAAGAGCAGTACGTCGGGAATCAGTTGCCACTTAGAAATCCCGCTCAATCGACTCCAACT 66 FBan0014410 FBgn0030583 CG14410 X X CG14410 CG14410 CDMC32490 2 11 5 DAC08-B15 3-CG14479-RA_1 CG14479 CCAAGAAGCCGAAGAAGCCAAGAACGACACGACGATCAGACTCGCTGCTTCCAGAAGAACTCCAGC 66 FBan0014479 FBgn0034228 CG14479 2 2R CG14479 CG14479 CDMC32490 2 12 5 DAC08-B15 3-CG14479-RA_1 CG14479 CCAAGAAGCCGAAGAAGCCAAGAACGACACGACGATCAGACTCGCTGCTTCCAGAAGAACTCCAGC 66 FBan0014479 FBgn0034228 CG14479 2 2R CG14479 CG14479 CDMC32491 2 13 5 DAC08-F03 3-CG14717-RA_3 CG14717 CTACATGGGCGAAGTCTTGCTCATAGCCGGTTCCCAGTCGGAATTCGTGACCACGACCAGTATTGC 66 FBan0014717 FBgn0037938 CG14717 3 3R lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG14717 CG14717 CDMC32491 2 14 5 DAC08-F03 3-CG14717-RA_3 CG14717 CTACATGGGCGAAGTCTTGCTCATAGCCGGTTCCCAGTCGGAATTCGTGACCACGACCAGTATTGC 66 FBan0014717 FBgn0037938 CG14717 3 3R lipid metabolism; GO:0006629 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.- CG14717 CG14717 CDMC32492 2 15 5 DAC08-F15 6-CG14785-RA_5 CG14785 ACTGCGAGCAGTTCGTTTACCCCACCTACGACGCGTTCAAAGAATACCTGGCCAGGATTATCTGCT 66 FBan0014785 FBgn0027795 CG14785 X X CG14785 CG14785 EG:BACN32G11.2 CDMC32492 2 16 5 DAC08-F15 6-CG14785-RA_5 CG14785 ACTGCGAGCAGTTCGTTTACCCCACCTACGACGCGTTCAAAGAATACCTGGCCAGGATTATCTGCT 66 FBan0014785 FBgn0027795 CG14785 X X CG14785 CG14785 EG:BACN32G11.2 CDMC32493 2 17 5 DAC08-J03 2-CG15142-RA_1 CG15142 ACACCAACCAGGAGCTAGCAATCAAGACGCATGTGCCACAAGTGGAGATAACGAGGGTGAGTGGAG 66 FBan0015142 FBgn0032645 CG15142 2 2L CG15142 CG15142 CDMC32493 2 18 5 DAC08-J03 2-CG15142-RA_1 CG15142 ACACCAACCAGGAGCTAGCAATCAAGACGCATGTGCCACAAGTGGAGATAACGAGGGTGAGTGGAG 66 FBan0015142 FBgn0032645 CG15142 2 2L CG15142 CG15142 CDMC32494 2 19 5 DAC08-J15 17-CG15330-RA_1 CG15330 AGCATCCAATAATAACACCTTGGATCTACTTGTCGTGGGTCAACAGCTGCAAATGCATCGTCCACC 66 FBan0015330 FBgn0029987 CG15330 X X CG15330 CG15330 CDMC32494 2 20 5 DAC08-J15 17-CG15330-RA_1 CG15330 AGCATCCAATAATAACACCTTGGATCTACTTGTCGTGGGTCAACAGCTGCAAATGCATCGTCCACC 66 FBan0015330 FBgn0029987 CG15330 X X CG15330 CG15330 CDMC32495 2 21 5 DAC08-N03 2-CG15814-RA_4 CG15814 CTGGATGCTGGGACTGGAGTAGATCCTGATACCGGCACTAGCTTTCCTCGGCGTCTAGTCAAGCAC 66 FBan0015814 FBgn0030873 CG15814 X X CG15814 CG15814 CDMC32495 2 22 5 DAC08-N03 2-CG15814-RA_4 CG15814 CTGGATGCTGGGACTGGAGTAGATCCTGATACCGGCACTAGCTTTCCTCGGCGTCTAGTCAAGCAC 66 FBan0015814 FBgn0030873 CG15814 X X CG15814 CG15814 CDMC32496 2 23 5 DAC08-N15 3-CG1637-RB_2 CG1637 TCAAGGGCAAAATACCCGAATGGAGCGCTTTTCACAGCCAGGACTATGGTTACACACGGCTCAAGG 66 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC32496 2 24 5 DAC08-N15 3-CG1637-RB_2 CG1637 TCAAGGGCAAAATACCCGAATGGAGCGCTTTTCACAGCCAGGACTATGGTTACACACGGCTCAAGG 66 FBan0001637 FBgn0030245 CG1637 X X phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG1637 CG1637 CDMC32497 2 25 5 DAC09-B04 14-CG14080-RA_1 CG14080 GCGAAGCTTTTCCTAACTTGGTTCTCGCGCAAAACACCCGGATAAACCACACATACATATGAGCCGCTT 69 FBan0014080 FBgn0036844 Mkp3 3 3L MAPKKK cascade; GO:0000165; glycolysis; GO:0006096; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- cytoplasm; GO:0005737 Mkp3 Mitogen-activated protein kinase phosphatase 3 "CG14080, CG14081, MKP-like, DMKP-3, MKP-3-like, Dmkp3, Mitogen-activated protein kinase phosphatase 3" CDMC32497 2 26 5 DAC09-B04 14-CG14080-RA_1 CG14080 GCGAAGCTTTTCCTAACTTGGTTCTCGCGCAAAACACCCGGATAAACCACACATACATATGAGCCGCTT 69 FBan0014080 FBgn0036844 Mkp3 3 3L MAPKKK cascade; GO:0000165; glycolysis; GO:0006096; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; MAP kinase phosphatase activity; GO:0017017 ; EC:3.1.3.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; ; GO:0017017 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- cytoplasm; GO:0005737 Mkp3 Mitogen-activated protein kinase phosphatase 3 "CG14080, CG14081, MKP-like, DMKP-3, MKP-3-like, Dmkp3, Mitogen-activated protein kinase phosphatase 3" CDMC32498 2 1 6 DAC09-B16 1-CG14096-RA_2 CG14096 GCTCCTTTTGCCTACGCTTCTCCTTTGGCCTACTCCGCTCCTCTGGCTTACACTTCTCCATTGGCTTAT 69 FBan0014096 FBgn0036871 CG14096 3 3L CG14096 CG14096 CDMC32498 2 2 6 DAC09-B16 1-CG14096-RA_2 CG14096 GCTCCTTTTGCCTACGCTTCTCCTTTGGCCTACTCCGCTCCTCTGGCTTACACTTCTCCATTGGCTTAT 69 FBan0014096 FBgn0036871 CG14096 3 3L CG14096 CG14096 CDMC32499 2 3 6 DAC09-F04 1-CG14131-RA_1 CG14131 GCCCAGGTCTACCAAATCAGCCAGATCCCTCAATGTTCGTGGTAGTACTTCTCCCCTTGCGTGCTATCA 69 FBan0014131 FBgn0036205 CG14131 3 3L CG14131 CG14131 CDMC32499 2 4 6 DAC09-F04 1-CG14131-RA_1 CG14131 GCCCAGGTCTACCAAATCAGCCAGATCCCTCAATGTTCGTGGTAGTACTTCTCCCCTTGCGTGCTATCA 69 FBan0014131 FBgn0036205 CG14131 3 3L CG14131 CG14131 CDMC32500 2 5 6 DAC09-F16 6-CG14153-RA_1 CG14153 TGCCCCTGATGATCGATGCAGTTTGTGGGAGAGCTCAGTATGCATCACCTTATGGCAGTGCTTATGCAA 69 FBan0014153 FBgn0036094 CG14153 3 3L CG14153 CG14153 CDMC32500 2 6 6 DAC09-F16 6-CG14153-RA_1 CG14153 TGCCCCTGATGATCGATGCAGTTTGTGGGAGAGCTCAGTATGCATCACCTTATGGCAGTGCTTATGCAA 69 FBan0014153 FBgn0036094 CG14153 3 3L CG14153 CG14153 CDMC32501 2 7 6 DAC09-J04 16-CG14196-RA_1 CG14196 GGTTCTCTGCTAATCTCCGGGAGTCTCATACTAACCGCCTTCTGTGAAACCTTTCTCAGCTACATGGTG 69 FBan0014196 FBgn0031002 CG14196 X X monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG14196 CG14196 CDMC32501 2 8 6 DAC09-J04 16-CG14196-RA_1 CG14196 GGTTCTCTGCTAATCTCCGGGAGTCTCATACTAACCGCCTTCTGTGAAACCTTTCTCAGCTACATGGTG 69 FBan0014196 FBgn0031002 CG14196 X X monocarboxylate porter activity; GO:0015355; ; GO:0015355 CG14196 CG14196 CDMC32502 2 9 6 DAC09-J16 11-CG14212-RA_1 CG14212 AGGAGCTCCTGATGCCCAAAATCGTGGCGTAGAGTTTGTGGTAAGGCCAGGTTATTAATGCTGCTGTTT 69 FBan0014212 FBgn0031045 CG14212 X X CG14212 CG14212 CDMC32502 2 10 6 DAC09-J16 11-CG14212-RA_1 CG14212 AGGAGCTCCTGATGCCCAAAATCGTGGCGTAGAGTTTGTGGTAAGGCCAGGTTATTAATGCTGCTGTTT 69 FBan0014212 FBgn0031045 CG14212 X X CG14212 CG14212 CDMC32503 2 11 6 DAC09-N04 15-CG14251-RA_2 CG14251 GGAAGCCAGTTGGTTGAGTCCAATTCTTCCGACGATACACTTTTCTCCGATGACTACGATCCCAGCTCG 69 FBgn0039460 CDMC32503 2 12 6 DAC09-N04 15-CG14251-RA_2 CG14251 GGAAGCCAGTTGGTTGAGTCCAATTCTTCCGACGATACACTTTTCTCCGATGACTACGATCCCAGCTCG 69 FBgn0039460 CDMC32504 2 13 6 DAC09-N16 15-CG14264-RA_1 CG14264 CGACATTGTCCAAGTGTTGGCCCAAATGCGCGAAAAGATACCCTACACTCTCGCATTACAACACGTGTA 69 FBan0014264 FBgn0039512 CG14264 3 3R CG14264 CG14264 CDMC32504 2 14 6 DAC09-N16 15-CG14264-RA_1 CG14264 CGACATTGTCCAAGTGTTGGCCCAAATGCGCGAAAAGATACCCTACACTCTCGCATTACAACACGTGTA 69 FBan0014264 FBgn0039512 CG14264 3 3R CG14264 CG14264 CDMC32505 2 15 6 DAC10-B03 22-CG1951-RA_3 CG1951 CCAACGAGCTGGAGAACTCTACTCTCTCCCCCTACGGTTCCATCAATGGTAATAAGATCAACGATGACA 69 FBan0001951 FBgn0039623 CG1951 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1951 CG1951 CDMC32505 2 16 6 DAC10-B03 22-CG1951-RA_3 CG1951 CCAACGAGCTGGAGAACTCTACTCTCTCCCCCTACGGTTCCATCAATGGTAATAAGATCAACGATGACA 69 FBan0001951 FBgn0039623 CG1951 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1951 CG1951 CDMC32506 2 17 6 DAC10-B15 2-CG1962-RA_1 CG1962 TGGAGTGCTCAAGAAGGCAGCTGATAATAACGAAGAAGACAAGCTTCCGTCCCTGCATGACGACGCACA 69 FBan0001962 FBgn0032876 CG1962 2 2L CG1962 CG1962 38E.1 CDMC32506 2 18 6 DAC10-B15 2-CG1962-RA_1 CG1962 TGGAGTGCTCAAGAAGGCAGCTGATAATAACGAAGAAGACAAGCTTCCGTCCCTGCATGACGACGCACA 69 FBan0001962 FBgn0032876 CG1962 2 2L CG1962 CG1962 38E.1 CDMC32507 2 19 6 DAC10-F03 3-CG1989-RA_3 CG1989 GCGAGTGAGGTAGAGGAGGGAGCACAATGGGACGCATTTTCTTGGAACATCTTGGGGGTCTGAAACTCT 69 FBan0001989 FBgn0026749 Yippee X X biological process unknown; GO:0000004 zinc ion binding; GO:0008270; metal ion binding; GO:0046872; ; GO:0008270; ; GO:0046872 cellular component unknown; GO:0008372 Yippee Yippee CG1989 CDMC32507 2 20 6 DAC10-F03 3-CG1989-RA_3 CG1989 GCGAGTGAGGTAGAGGAGGGAGCACAATGGGACGCATTTTCTTGGAACATCTTGGGGGTCTGAAACTCT 69 FBan0001989 FBgn0026749 Yippee X X biological process unknown; GO:0000004 zinc ion binding; GO:0008270; metal ion binding; GO:0046872; ; GO:0008270; ; GO:0046872 cellular component unknown; GO:0008372 Yippee Yippee CG1989 CDMC32508 2 21 6 DAC10-F15 23-CG2016-RB_3 CG2016 AGTGGATCAACCTGAATTAGAATGTAGTTTCTCTAGTCTAAGACCTTATTTATTGCACACAGTTCCGCG 69 FBan0002016 FBgn0037289 CG2016 3 3R CG2016 CG2016 CDMC32508 2 22 6 DAC10-F15 23-CG2016-RB_3 CG2016 AGTGGATCAACCTGAATTAGAATGTAGTTTCTCTAGTCTAAGACCTTATTTATTGCACACAGTTCCGCG 69 FBan0002016 FBgn0037289 CG2016 3 3R CG2016 CG2016 CDMC32509 2 23 6 DAC10-J03 2-CG2051-RA_4 CG2051 TGCAGACGTTCATCTTGTGGTTCGTGGATGCTGCCTCCTACATCGACACTGATGATCCACAGTGGTGTT 69 FBan0002051 FBgn0037376 CG2051 3 3R chromatin assembly or disassembly; GO:0006333 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 CG2051 CG2051 dmHAG409 CDMC32509 2 24 6 DAC10-J03 2-CG2051-RA_4 CG2051 TGCAGACGTTCATCTTGTGGTTCGTGGATGCTGCCTCCTACATCGACACTGATGATCCACAGTGGTGTT 69 FBan0002051 FBgn0037376 CG2051 3 3R chromatin assembly or disassembly; GO:0006333 histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48 CG2051 CG2051 dmHAG409 CDMC32510 2 25 6 DAC10-J15 2-CG2064-RA_1 CG2064 ACGCTGCTTTGGATCCGGAGCTTAAGAACATCTCTGGCCTGTACTTCAGTGACTGCAAACCAAAGCCTG 69 FBan0002064 FBgn0033205 CG2064 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2064 CG2064 BcDNA:SD07613 CDMC32510 2 26 6 DAC10-J15 2-CG2064-RA_1 CG2064 ACGCTGCTTTGGATCCGGAGCTTAAGAACATCTCTGGCCTGTACTTCAGTGACTGCAAACCAAAGCCTG 69 FBan0002064 FBgn0033205 CG2064 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2064 CG2064 BcDNA:SD07613 CDMC32511 2 1 7 DAC10-N03 1-CG2100-RA_1 CG2100 CGGAGCCGCATTGTTTCTGGAGATGCACCGTTGTAACCTATTCGAGTACATTGGGCTGCCTAAAGAGCC 69 FBan0002100 FBgn0037369 CG2100 3 3R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19 CG2100 CG2100 CDMC32511 2 2 7 DAC10-N03 1-CG2100-RA_1 CG2100 CGGAGCCGCATTGTTTCTGGAGATGCACCGTTGTAACCTATTCGAGTACATTGGGCTGCCTAAAGAGCC 69 FBan0002100 FBgn0037369 CG2100 3 3R mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0004652 ; EC:2.7.7.19 CG2100 CG2100 CDMC32512 2 3 7 DAC10-N15 12-CG2109-RA_1 CG2109 ACCGGAGACCCTTTGACTTTGCCATTCAGCTAGAACCAAAGACCGTGCGACTTGGCTGAGAATCAAAAC 69 FBan0002109 FBgn0037330 mRpL44 3 3R RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3 mitochondrial large ribosomal subunit; GO:0005762 mRpL44 mitochondrial ribosomal protein L44 "CG2109, MRP-L44, mitochondrial ribosomal protein L44" CDMC32512 2 4 7 DAC10-N15 12-CG2109-RA_1 CG2109 ACCGGAGACCCTTTGACTTTGCCATTCAGCTAGAACCAAAGACCGTGCGACTTGGCTGAGAATCAAAAC 69 FBan0002109 FBgn0037330 mRpL44 3 3R RNA processing; GO:0006396 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ribonuclease III activity; GO:0004525 ; EC:3.1.26.3; ; GO:0004525 ; EC:3.1.26.3 mitochondrial large ribosomal subunit; GO:0005762 mRpL44 mitochondrial ribosomal protein L44 "CG2109, MRP-L44, mitochondrial ribosomal protein L44" CDMC32513 2 5 7 DAC11-B03 9-CG9176-RB_1 CG9176 CACGTGATCAAGACGCACATGAACGAGATGCACTCCAAGTTCGAGACGCAATTCTCCAGCATGGC 65 FBan0009176 FBgn0029090 cngl X X cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 membrane; GO:0016020 cngl CNG channel-like "CG9176, CG9176, CNG channel-like" CDMC32513 2 6 7 DAC11-B03 9-CG9176-RB_1 CG9176 CACGTGATCAAGACGCACATGAACGAGATGCACTCCAAGTTCGAGACGCAATTCTCCAGCATGGC 65 FBan0009176 FBgn0029090 cngl X X cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 membrane; GO:0016020 cngl CNG channel-like "CG9176, CG9176, CNG channel-like" CDMC32514 2 7 7 DAC11-B15 14-CG9196-RA_1 CG9196 AAGGCCGACGATACCCTACCCAAGGTCACCCAGATCATTCGAGATGAACCCGTGGAACAGCTGGA 65 FBan0009196 FBgn0035056 CG9196 2 2R CG9196 CG9196 BcDNA:LP10725 CDMC32514 2 8 7 DAC11-B15 14-CG9196-RA_1 CG9196 AAGGCCGACGATACCCTACCCAAGGTCACCCAGATCATTCGAGATGAACCCGTGGAACAGCTGGA 65 FBan0009196 FBgn0035056 CG9196 2 2R CG9196 CG9196 BcDNA:LP10725 CDMC32515 2 9 7 DAC11-F03 18-CG9322-RA_8 CG9322 AATCGCGATCGCAGTGAAAGGGGTCTAAGCAACTCCATTCAGAATCTGGATCAGGTCCTGGAGGA 65 FBan0009322 FBgn0038178 CG9322 3 3R CG9322 CG9322 CDMC32515 2 10 7 DAC11-F03 18-CG9322-RA_8 CG9322 AATCGCGATCGCAGTGAAAGGGGTCTAAGCAACTCCATTCAGAATCTGGATCAGGTCCTGGAGGA 65 FBan0009322 FBgn0038178 CG9322 3 3R CG9322 CG9322 CDMC32516 2 11 7 DAC11-F15 24-CG9354-RB_1 CG9354 ACTTTTAAAATAAATTGGTTTTTTCCAACTGGATTTACTGTTTGTATTTTTAGTTTGACAGTCCA 65 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC32516 2 12 7 DAC11-F15 24-CG9354-RB_1 CG9354 ACTTTTAAAATAAATTGGTTTTTTCCAACTGGATTTACTGTTTGTATTTTTAGTTTGACAGTCCA 65 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC32517 2 13 7 DAC11-J03 6-CG9472-RA_3 CG9472 GCAGTTCACCAAGGCGTTCTTCCTGAAGGTCTGGTACGATCCTCGACAGTTGAAGACCCTGTGGG 65 FBan0009472 FBgn0036874 CG9472 3 3L calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG9472 CG9472 CT26822 CDMC32517 2 14 7 DAC11-J03 6-CG9472-RA_3 CG9472 GCAGTTCACCAAGGCGTTCTTCCTGAAGGTCTGGTACGATCCTCGACAGTTGAAGACCCTGTGGG 65 FBan0009472 FBgn0036874 CG9472 3 3L calcium ion transport; GO:0006816 calcium channel activity; GO:0005262; calcium ion binding; GO:0005509; ; GO:0005262; ; GO:0005509 membrane; GO:0016020 CG9472 CG9472 CT26822 CDMC32518 2 15 7 DAC11-J15 9-CG9521-RA_2 CG9521 CAGCAGGATGGTCTGAAGTACAGGGACTACAATGGACGCATTCAGAATGGTGTGGCCTTCCTGCA 65 FBan0009521 FBgn0030588 CG9521 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9521 CG9521 CDMC32518 2 16 7 DAC11-J15 9-CG9521-RA_2 CG9521 CAGCAGGATGGTCTGAAGTACAGGGACTACAATGGACGCATTCAGAATGGTGTGGCCTTCCTGCA 65 FBan0009521 FBgn0030588 CG9521 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9521 CG9521 CDMC32519 2 17 7 DAC11-N03 1-CG9598-RA_1 CG9598 TGCCAAGGATGGACGTCTAAAGAAGGGTGATCGAATCCTTGCCGTCAATGGAATGAGCATGCGCG 65 FBan0009598 FBgn0036424 CG9598 3 3L protein binding; GO:0005515; ; GO:0005515 CG9598 CG9598 CDMC32519 2 18 7 DAC11-N03 1-CG9598-RA_1 CG9598 TGCCAAGGATGGACGTCTAAAGAAGGGTGATCGAATCCTTGCCGTCAATGGAATGAGCATGCGCG 65 FBan0009598 FBgn0036424 CG9598 3 3L protein binding; GO:0005515; ; GO:0005515 CG9598 CG9598 CDMC32520 2 19 7 DAC11-N15 23-CG9615-RA_1 CG9615 TTCGGAATAAAGTAACCTAGTTTAAGGCGCATCTGATGGTAAAGACCACCCTGTTTGCTTTCCAA 65 FBan0009615 FBgn0037569 tex 3 3R tex tex CG9615 CDMC32520 2 20 7 DAC11-N15 23-CG9615-RA_1 CG9615 TTCGGAATAAAGTAACCTAGTTTAAGGCGCATCTGATGGTAAAGACCACCCTGTTTGCTTTCCAA 65 FBan0009615 FBgn0037569 tex 3 3R tex tex CG9615 CDMC32521 2 21 7 DAC12-B03 19-CG15411-RA_1 CG15411 CCCACAGCCTCTTCCATCGTCCTTCGTCCACGCAGGGCAAGCACAAGCGCACCGCCAGCCTAAAT 65 FBan0015411 FBgn0040712 CG15411 2 2L CG15411 CG15411 CDMC32521 2 22 7 DAC12-B03 19-CG15411-RA_1 CG15411 CCCACAGCCTCTTCCATCGTCCTTCGTCCACGCAGGGCAAGCACAAGCGCACCGCCAGCCTAAAT 65 FBan0015411 FBgn0040712 CG15411 2 2L CG15411 CG15411 CDMC32522 2 23 7 DAC12-B15 23-CG15434-RA_1 CG15434 CCTGAACATTTCAAAATCGCAAAAGTGGTGCCAAAATGGGTATTACTCTGTTCCGATTGGCCAGT 65 FBan0015434 FBgn0040705 CG15434 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG15434 CG15434 CDMC32522 2 24 7 DAC12-B15 23-CG15434-RA_1 CG15434 CCTGAACATTTCAAAATCGCAAAAGTGGTGCCAAAATGGGTATTACTCTGTTCCGATTGGCCAGT 65 FBan0015434 FBgn0040705 CG15434 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG15434 CG15434 CDMC32523 2 25 7 DAC12-F03 16-CG15504-RA_1 CG15504 ATCTCAGTCTCAAGAAGGAGGACAGCCAGTCGCCGCCCAACACGCCCGCCGAGAATCTTCATCTG 65 FBan0015504 FBgn0039683 dmrt99B 3 3R "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt99B doublesex-Mab related 99B "CG15504, CG15504, doublesex-Mab related 99B" CDMC32523 2 26 7 DAC12-F03 16-CG15504-RA_1 CG15504 ATCTCAGTCTCAAGAAGGAGGACAGCCAGTCGCCGCCCAACACGCCCGCCGAGAATCTTCATCTG 65 FBan0015504 FBgn0039683 dmrt99B 3 3R "mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription, DNA-dependent; GO:0006355; sex differentiation; GO:0007548; skeletal development; GO:0001501" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 dmrt99B doublesex-Mab related 99B "CG15504, CG15504, doublesex-Mab related 99B" CDMC32524 2 1 8 DAC12-F15 3-CG15526-RA_1 CG15526 TTCGAGTGCCAGAGCAACTGCACGACATGACCCGCATATCCATTGAGCTCATCGGTCACTACCAG 65 FBan0015526 FBgn0039744 CG15526 3 3R CG15526 CG15526 CDMC32524 2 2 8 DAC12-F15 3-CG15526-RA_1 CG15526 TTCGAGTGCCAGAGCAACTGCACGACATGACCCGCATATCCATTGAGCTCATCGGTCACTACCAG 65 FBan0015526 FBgn0039744 CG15526 3 3R CG15526 CG15526 CDMC32525 2 3 8 DAC12-J03 5-CG15615-RA_2 CG15615 CTGCAGCTTCCCAGGTGGATAGCAAAAGTGTCGCTCAGCAGAGGATCGATCTGGGATTGGGTCTG 65 FBan0015615 FBgn0034159 CG15615 2 2R CG15615 CG15615 CDMC32525 2 4 8 DAC12-J03 5-CG15615-RA_2 CG15615 CTGCAGCTTCCCAGGTGGATAGCAAAAGTGTCGCTCAGCAGAGGATCGATCTGGGATTGGGTCTG 65 FBan0015615 FBgn0034159 CG15615 2 2R CG15615 CG15615 CDMC32526 2 5 8 DAC12-J15 7-CG15646-RA_1 CG15646 GATCGCAAACAGGATCGGAATCGGGATCGGGATCAGGATCTCTCGAGCAGAAGGCCGAAGTGGTG 65 FBan0015646 FBgn0030665 CG15646 X X CG15646 CG15646 CDMC32526 2 6 8 DAC12-J15 7-CG15646-RA_1 CG15646 GATCGCAAACAGGATCGGAATCGGGATCGGGATCAGGATCTCTCGAGCAGAAGGCCGAAGTGGTG 65 FBan0015646 FBgn0030665 CG15646 X X CG15646 CG15646 CDMC32527 2 7 8 DAC12-N03 2-CG15738-RA_1 CG15738 TCTGGCACGACTCCATAGACAAGTGCTTTGAGCCGGATTCCCAAAGATCGTACGTGGAGGACCAG 65 FBan0015738 FBgn0030352 CG15738 X X CG15738 CG15738 CDMC32527 2 8 8 DAC12-N03 2-CG15738-RA_1 CG15738 TCTGGCACGACTCCATAGACAAGTGCTTTGAGCCGGATTCCCAAAGATCGTACGTGGAGGACCAG 65 FBan0015738 FBgn0030352 CG15738 X X CG15738 CG15738 CDMC32528 2 9 8 DAC12-N15 3-CG15767-RA_1 CG15767 CAATCGGCACTTCCACAAATGCTGCAAAGGCTTGACCGTGTTCAGCGTCATAACCTTTGGCTGGG 65 FBan0015767 FBgn0029809 CG15767 X X protein folding; GO:0006457 CG15767 CG15767 CDMC32528 2 10 8 DAC12-N15 3-CG15767-RA_1 CG15767 CAATCGGCACTTCCACAAATGCTGCAAAGGCTTGACCGTGTTCAGCGTCATAACCTTTGGCTGGG 65 FBan0015767 FBgn0029809 CG15767 X X protein folding; GO:0006457 CG15767 CG15767 CDMC32529 2 11 8 DAC13-B03 13-CG13016-RA_1 CG13016 AGGCCTTGTTCAGCTATCCTTGGGTTTCTGCGCCATGAAGCTATACCAGAAGCACACATACATACTCCT 69 FBan0013016 FBgn0033899 CG13016 2 2R CG13016 CG13016 CDMC32529 2 12 8 DAC13-B03 13-CG13016-RA_1 CG13016 AGGCCTTGTTCAGCTATCCTTGGGTTTCTGCGCCATGAAGCTATACCAGAAGCACACATACATACTCCT 69 FBan0013016 FBgn0033899 CG13016 2 2R CG13016 CG13016 CDMC32530 2 13 8 DAC13-B15 3-CG13028-RA_2 CG13028 TGGCAGTAACCTACAGGACCTGGTAATGCTGAGAGGAGTTCTTCAGGCTCTGAAAGCGAGTCCCTCGAA 69 FBan0013028 FBgn0036676 CG13028 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13028 CG13028 CDMC32530 2 14 8 DAC13-B15 3-CG13028-RA_2 CG13028 TGGCAGTAACCTACAGGACCTGGTAATGCTGAGAGGAGTTCTTCAGGCTCTGAAAGCGAGTCCCTCGAA 69 FBan0013028 FBgn0036676 CG13028 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13028 CG13028 CDMC32531 2 15 8 DAC13-F03 14-CG13072-RA_1 CG13072 GACGACGAGGATTACGGCTGCTGATTCGTCCGAAATTCCGCCCAACATCTAATTTAAGTTATGCCCGCT 69 FBan0013072 FBgn0036580 PDCD-5 3 3L apoptosis; GO:0006915 PDCD-5 PDCD-5 "CG13072, DMPDCD-5, Programmed Cell Death gene-5, BcDNA:RE17056" CDMC32531 2 16 8 DAC13-F03 14-CG13072-RA_1 CG13072 GACGACGAGGATTACGGCTGCTGATTCGTCCGAAATTCCGCCCAACATCTAATTTAAGTTATGCCCGCT 69 FBan0013072 FBgn0036580 PDCD-5 3 3L apoptosis; GO:0006915 PDCD-5 PDCD-5 "CG13072, DMPDCD-5, Programmed Cell Death gene-5, BcDNA:RE17056" CDMC32532 2 17 8 DAC13-F15 2-CG13079-RA_3 CG13079 GGCCTCACAGCCCTGATTGAGTATGCTGAAAAGTGGGACTACAATCCAACGGCTTGGGAAGTGAGCATC 69 FBan0013079 FBgn0032808 CG13079 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG13079 CG13079 CG13080 CDMC32532 2 18 8 DAC13-F15 2-CG13079-RA_3 CG13079 GGCCTCACAGCCCTGATTGAGTATGCTGAAAAGTGGGACTACAATCCAACGGCTTGGGAAGTGAGCATC 69 FBan0013079 FBgn0032808 CG13079 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 CG13079 CG13079 CG13080 CDMC32533 2 19 8 DAC13-J03 15-CG13117-RA_1 CG13117 GGGAGGCCTAATCGATTAACCCATTAAGTGGCAAGAGCTGCAGGATAGTGAAATTCCATTCCGTTGCCA 69 FBan0013117 FBgn0032140 CG13117 2 2L CG13117 CG13117 BcDNA:SD27505 CDMC32533 2 20 8 DAC13-J03 15-CG13117-RA_1 CG13117 GGGAGGCCTAATCGATTAACCCATTAAGTGGCAAGAGCTGCAGGATAGTGAAATTCCATTCCGTTGCCA 69 FBan0013117 FBgn0032140 CG13117 2 2L CG13117 CG13117 BcDNA:SD27505 CDMC32534 2 21 8 DAC13-J15 18-CG13130-RA_1 CG13130 CCTGTTGGTTTTACCGCCATACATGAGTAATGCCTCGTACTCACCACCCATTCGGCAGCATAATCATAA 69 FBan0013130 FBgn0040965 CG13130 2 2L CG13130 CG13130 CDMC32534 2 22 8 DAC13-J15 18-CG13130-RA_1 CG13130 CCTGTTGGTTTTACCGCCATACATGAGTAATGCCTCGTACTCACCACCCATTCGGCAGCATAATCATAA 69 FBan0013130 FBgn0040965 CG13130 2 2L CG13130 CG13130 CDMC32535 2 23 8 DAC13-N03 14-CG13188-RB_1 CG13188 AGCCGGACTACGATGATATCGATTTGGAGACCCGTATCAAACTGTCTCGCGGTAAATCTGACAAGGGCA 69 FBan0013188 FBgn0033668 CG13188 2 2R CG13188 CG13188 CDMC32535 2 24 8 DAC13-N03 14-CG13188-RB_1 CG13188 AGCCGGACTACGATGATATCGATTTGGAGACCCGTATCAAACTGTCTCGCGGTAAATCTGACAAGGGCA 69 FBan0013188 FBgn0033668 CG13188 2 2R CG13188 CG13188 CDMC32536 2 25 8 DAC13-N15 23-CG13194-RA_11 CG13194 AGTAGCGTTAGTGTTAATCATGCAATACCTGCCTTGCCAAAAAACTACAACTACTTGTACAGTAACGAG 69 FBan0013194 FBgn0033649 pyr 2 2R fibroblast growth factor receptor signaling pathway; GO:0008543; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498 fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104 pyr pyramus "CG13194, CG13194, CG13194, FGF8-like2, fgf8-like, DFGF8-2, pyramus" CDMC32536 2 26 8 DAC13-N15 23-CG13194-RA_11 CG13194 AGTAGCGTTAGTGTTAATCATGCAATACCTGCCTTGCCAAAAAACTACAACTACTTGTACAGTAACGAG 69 FBan0013194 FBgn0033649 pyr 2 2R fibroblast growth factor receptor signaling pathway; GO:0008543; heart development; GO:0007507; hindgut morphogenesis; GO:0007442; mesoderm development; GO:0007498 fibroblast growth factor receptor binding; GO:0005104; ; GO:0005104; ; GO:0005104 pyr pyramus "CG13194, CG13194, CG13194, FGF8-like2, fgf8-like, DFGF8-2, pyramus" CDMC32537 2 1 9 DAC14-B03 16-CG40154-RB_1 CG40154 CCACAGCCTCAATAACCGTGGTCATCATCTTTCTTGTCTACCGTCTGAAAGCCAAACGTCAACAACCAT 69 FBgn0058154 CG40154 CG40154 CG40154 CDMC32537 2 2 9 DAC14-B03 16-CG40154-RB_1 CG40154 CCACAGCCTCAATAACCGTGGTCATCATCTTTCTTGTCTACCGTCTGAAAGCCAAACGTCAACAACCAT 69 FBgn0058154 CG40154 CG40154 CG40154 CDMC32538 2 3 9 DAC14-B15 24-CG40160-RA_6 CG40160 AGAGCAACAAAGTAAATCGATCTACATCTATAAAGTAATAGACAAATTTTTACCGTAAATAACTATGGT 69 FBgn0058160 CG40160 amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; electron transport; GO:0006118; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0030234; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG40160 CG40160 BcDNA:LD13269 CDMC32538 2 4 9 DAC14-B15 24-CG40160-RA_6 CG40160 AGAGCAACAAAGTAAATCGATCTACATCTATAAAGTAATAGACAAATTTTTACCGTAAATAACTATGGT 69 FBgn0058160 CG40160 amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; electron transport; GO:0006118; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; enzyme regulator activity; GO:0030234; enzyme activator activity; GO:0008047; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0030234; ; GO:0008047; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG40160 CG40160 BcDNA:LD13269 CDMC32539 2 5 9 DAC14-F03 2-CG40203-RA_1 CG40203 CCTCCACCAACAGCAAGCCTCAGCAAACTTGTGATGGTGTCTTTGGTCGGACCTACCCAAGTGATCATT 69 FBgn0058203 CG40203 CG40203 CG40203 CDMC32539 2 6 9 DAC14-F03 2-CG40203-RA_1 CG40203 CCTCCACCAACAGCAAGCCTCAGCAAACTTGTGATGGTGTCTTTGGTCGGACCTACCCAAGTGATCATT 69 FBgn0058203 CG40203 CG40203 CG40203 CDMC32540 2 7 9 DAC14-F15 17-CG40218-RA_1 CG40218 TGGACCGTCAAGACTTTTTGGAGAGAACCGATCTTAGGCAGTTTGAAATGGAAAAGAAGTTGCGGCTGT 69 FBgn0043842 Yeti kinesin binding; GO:0019894; ; GO:0019894 Yeti Yeti "CG40218, BEST:GH01620, BcDNA:RE36623" CDMC32540 2 8 9 DAC14-F15 17-CG40218-RA_1 CG40218 TGGACCGTCAAGACTTTTTGGAGAGAACCGATCTTAGGCAGTTTGAAATGGAAAAGAAGTTGCGGCTGT 69 FBgn0043842 Yeti kinesin binding; GO:0019894; ; GO:0019894 Yeti Yeti "CG40218, BEST:GH01620, BcDNA:RE36623" CDMC32541 2 9 9 DAC14-J03 13-CG40275-RA_1 CG40275 TGGTGCTACGGCAGTTTTATGTTATTTTCTGGGGCTACGGAATATAGCTGGTGTTGCCGAGCGATCACA 69 FBgn0058275 CG40275 CG40275 CG40275 CDMC32541 2 10 9 DAC14-J03 13-CG40275-RA_1 CG40275 TGGTGCTACGGCAGTTTTATGTTATTTTCTGGGGCTACGGAATATAGCTGGTGTTGCCGAGCGATCACA 69 FBgn0058275 CG40275 CG40275 CG40275 CDMC32542 2 11 9 DAC14-J15 23-CG4029-RA_5 CG4029 CATGATCAGGCCTCAGAAGTAAATAGTACAAAGAGCTAGACTTTTGGGTCCAAGCAGTTACAAAGCCAA 69 FBan0004029 FBgn0015396 jumu 3 3R "ATP synthesis coupled proton transport; GO:0015986; asymmetric protein localization; GO:0008105; dorsal closure; GO:0007391; establishment and/or maintenance of chromatin architecture; GO:0006325; eye development (sensu Endopterygota); GO:0007456; neuroblast fate determination; GO:0007400; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366; wing morphogenesis; GO:0007476" "chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleolus; GO:0005730; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome chromocenter; GO:0005701; proton-transporting two-sector ATPase complex; GO:0016469 jumu jumeau "CG4029, CG4029, E(var)631, Dom, Domina, l(3)06142, 5295, l(3)06439, Dwhn, Whn, winged-helix nude, jumeaux, Scim31, jumu/Dom, Dmjumu" CDMC32542 2 12 9 DAC14-J15 23-CG4029-RA_5 CG4029 CATGATCAGGCCTCAGAAGTAAATAGTACAAAGAGCTAGACTTTTGGGTCCAAGCAGTTACAAAGCCAA 69 FBan0004029 FBgn0015396 jumu 3 3R "ATP synthesis coupled proton transport; GO:0015986; asymmetric protein localization; GO:0008105; dorsal closure; GO:0007391; establishment and/or maintenance of chromatin architecture; GO:0006325; eye development (sensu Endopterygota); GO:0007456; neuroblast fate determination; GO:0007400; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366; wing morphogenesis; GO:0007476" "chromatin binding; GO:0003682; ; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" nucleolus; GO:0005730; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome chromocenter; GO:0005701; proton-transporting two-sector ATPase complex; GO:0016469 jumu jumeau "CG4029, CG4029, E(var)631, Dom, Domina, l(3)06142, 5295, l(3)06439, Dwhn, Whn, winged-helix nude, jumeaux, Scim31, jumu/Dom, Dmjumu" CDMC32543 2 13 9 DAC14-N03 2-CG40356-RA_1 CG40356 CCAACACGAAACTGAGCGTTCTTACGTGGCCTCTTCGATCATCGGCTTATGTATGCTCTCCTTGCCGGT 69 FBgn0058356 CG40356 CG40356 CG40356 CDMC32543 2 14 9 DAC14-N03 2-CG40356-RA_1 CG40356 CCAACACGAAACTGAGCGTTCTTACGTGGCCTCTTCGATCATCGGCTTATGTATGCTCTCCTTGCCGGT 69 FBgn0058356 CG40356 CG40356 CG40356 CDMC32544 2 15 9 DAC14-N15 3-CG40376-RA_1 CG40376 GCACTATGGGCAGCAATCCGCACAACATGGCAGCACTAGAATATCAATAGATAGAGGCAACGCCGCTCG 69 FBgn0058376 CG40376 CG40376 CG40376 CDMC32544 2 16 9 DAC14-N15 3-CG40376-RA_1 CG40376 GCACTATGGGCAGCAATCCGCACAACATGGCAGCACTAGAATATCAATAGATAGAGGCAACGCCGCTCG 69 FBgn0058376 CG40376 CG40376 CG40376 CDMC32545 2 17 9 DAC15-B03 4-CG7283-RB_1 CG7283 CGTGCTTGGATAGAAGCTCCCATGGGAGTTGAGTTCATCACGTCATCAGGTAGTCGAGGACATGTGGCT 69 FBan0007283 FBgn0036213 RpL10Ab 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Ab Ribosomal protein L10Ab "CG7283, BcDNA:RH06366, anon-EST:Posey188, Ribosomal protein L10Ab" CDMC32545 2 18 9 DAC15-B03 4-CG7283-RB_1 CG7283 CGTGCTTGGATAGAAGCTCCCATGGGAGTTGAGTTCATCACGTCATCAGGTAGTCGAGGACATGTGGCT 69 FBan0007283 FBgn0036213 RpL10Ab 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Ab Ribosomal protein L10Ab "CG7283, BcDNA:RH06366, anon-EST:Posey188, Ribosomal protein L10Ab" CDMC32546 2 19 9 DAC15-B15 18-CG7291-RA_2 CG7291 GCGGACATCATCTGCGTCGAGATTCCCGCTAAAATTCAGTAGGCAGTCACCCTCTAAATTAACCTCGAA 69 FBan0007291 FBgn0031381 NPC2 2 2L receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 NPC2 Niemann-Pick Type C-2 "CG7291, CG7291, CG7291, Epididymal secretory protein, CT22505, DmML3, BcDNA:GH22047, BcDNA:RH53228, BEST:GH08376, Niemann-Pick Type C-2" CDMC32546 2 20 9 DAC15-B15 18-CG7291-RA_2 CG7291 GCGGACATCATCTGCGTCGAGATTCCCGCTAAAATTCAGTAGGCAGTCACCCTCTAAATTAACCTCGAA 69 FBan0007291 FBgn0031381 NPC2 2 2L receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 NPC2 Niemann-Pick Type C-2 "CG7291, CG7291, CG7291, Epididymal secretory protein, CT22505, DmML3, BcDNA:GH22047, BcDNA:RH53228, BEST:GH08376, Niemann-Pick Type C-2" CDMC32547 2 21 9 DAC15-F03 3-CG7326-RA_2 CG7326 CGCTGCCCCAAATGGATGTATCACCGAACATGTTCCTAAAGATTCAGAAGCGCCTCGAGACGAATGGCC 69 FBan0007326 FBgn0030970 CG7326 X X CG7326 CG7326 CDMC32547 2 22 9 DAC15-F03 3-CG7326-RA_2 CG7326 CGCTGCCCCAAATGGATGTATCACCGAACATGTTCCTAAAGATTCAGAAGCGCCTCGAGACGAATGGCC 69 FBan0007326 FBgn0030970 CG7326 X X CG7326 CG7326 CDMC32548 2 23 9 DAC15-F15 2-CG7334-RB_1 CG7334 TGCCCATCGAACTGATGAACGGGGTGACCTTCGGTCTATTTTATGCAACAATGGCCTCCTATGCAAGCA 69 FBan0007334 FBgn0036191 Sug 3 3L determination of adult life span; GO:0008340; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 Sug Sug "CG7334, CG7334, Sugar-baby" CDMC32548 2 24 9 DAC15-F15 2-CG7334-RB_1 CG7334 TGCCCATCGAACTGATGAACGGGGTGACCTTCGGTCTATTTTATGCAACAATGGCCTCCTATGCAAGCA 69 FBan0007334 FBgn0036191 Sug 3 3L determination of adult life span; GO:0008340; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 Sug Sug "CG7334, CG7334, Sugar-baby" CDMC32549 2 25 9 DAC15-J03 4-CG7362-RA_1 CG7362 GGCCGCTCAATCCTTGCTTTTTCGTGGCGTTTATCCACTCCTTGTCAAGGAAATGGTTTATGGCAGCGT 69 FBan0007362 FBgn0038258 CG7362 3 3R glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG7362 CG7362 CDMC32549 2 26 9 DAC15-J03 4-CG7362-RA_1 CG7362 GGCCGCTCAATCCTTGCTTTTTCGTGGCGTTTATCCACTCCTTGTCAAGGAAATGGTTTATGGCAGCGT 69 FBan0007362 FBgn0038258 CG7362 3 3R glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG7362 CG7362 CDMC32550 2 1 10 DAC15-J15 1-CG7371-RA_1 CG7371 GCTCTCTTTCGGTCGGAGCAATACGCCCTAGTGGACAATGCCTGTCGGGAATACCTATTTGTCACGGAG 69 FBan0007371 FBgn0031710 CG7371 2 2L CG7371 CG7371 CDMC32550 2 2 10 DAC15-J15 1-CG7371-RA_1 CG7371 GCTCTCTTTCGGTCGGAGCAATACGCCCTAGTGGACAATGCCTGTCGGGAATACCTATTTGTCACGGAG 69 FBan0007371 FBgn0031710 CG7371 2 2L CG7371 CG7371 CDMC32551 2 3 10 DAC15-N03 1-CG7402-RA_1 CG7402 CCCCTGGGTGAGAGCTACGAACAACATGTCTTGGCATCGGATGTTCAAAGCCTACTAGGAAATCGGGGA 69 FBan0007402 FBgn0036768 CG7402 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG7402 CG7402 CDMC32551 2 4 10 DAC15-N03 1-CG7402-RA_1 CG7402 CCCCTGGGTGAGAGCTACGAACAACATGTCTTGGCATCGGATGTTCAAAGCCTACTAGGAAATCGGGGA 69 FBan0007402 FBgn0036768 CG7402 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG7402 CG7402 CDMC32552 2 5 10 DAC15-N15 16-CG7422-RA_2 CG7422 ACGACATTGGTCCGGAACATGATAACGAGTGCTTCTGTGTTGACAAATTGGCGAATGTGATCAAGAGGA 69 FBan0007422 FBgn0035815 CG7422 3 3L cell adhesion; GO:0007155 integral to membrane; GO:0016021; membrane; GO:0016020 CG7422 CG7422 CDMC32552 2 6 10 DAC15-N15 16-CG7422-RA_2 CG7422 ACGACATTGGTCCGGAACATGATAACGAGTGCTTCTGTGTTGACAAATTGGCGAATGTGATCAAGAGGA 69 FBan0007422 FBgn0035815 CG7422 3 3L cell adhesion; GO:0007155 integral to membrane; GO:0016021; membrane; GO:0016020 CG7422 CG7422 CDMC32553 2 7 10 DAC16-B03 1-CG12227-RA_2 CG12227 CCCTTTGTGGGCGAAAACGGACCATGCCAGTCATCAAATTGCAGTCCTCCGATGGCGAAATTTTCG 66 FBan0012227 FBgn0034863 skpF 2 2R chromosome segregation; GO:0007059; mitosis; GO:0007067; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; centromeric DNA binding; GO:0019237; ; GO:0004842 ; EC:6.3.2.19; ; GO:0019237 nuclear ubiquitin ligase complex; GO:0000152 skpF skpF "CG12227, CG12227" CDMC32553 2 8 10 DAC16-B03 1-CG12227-RA_2 CG12227 CCCTTTGTGGGCGAAAACGGACCATGCCAGTCATCAAATTGCAGTCCTCCGATGGCGAAATTTTCG 66 FBan0012227 FBgn0034863 skpF 2 2R chromosome segregation; GO:0007059; mitosis; GO:0007067; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; centromeric DNA binding; GO:0019237; ; GO:0004842 ; EC:6.3.2.19; ; GO:0019237 nuclear ubiquitin ligase complex; GO:0000152 skpF skpF "CG12227, CG12227" CDMC32554 2 9 10 DAC16-B15 8-CG12278-RA_2 CG12278 AGCTCAGCGACTTGTACTACGTACTACAGTGTCCACCAAAGCATGATGAAGGCATTCCCAAGGCGC 66 FBan0012278 FBgn0038847 CG12278 3 3R CG12278 CG12278 CDMC32554 2 10 10 DAC16-B15 8-CG12278-RA_2 CG12278 AGCTCAGCGACTTGTACTACGTACTACAGTGTCCACCAAAGCATGATGAAGGCATTCCCAAGGCGC 66 FBan0012278 FBgn0038847 CG12278 3 3R CG12278 CG12278 CDMC32555 2 11 10 DAC16-F03 2-CG12844-RA_1 CG12844 CCCGAAATAGACCCGATCGGCTGACATTGAAAGGGATTGTGGCCTTTGTTTAGCTAGGTGGCTGCC 66 FBan0012844 FBgn0033129 Tsp42Eh 2 2R integral to membrane; GO:0016021 Tsp42Eh Tetraspanin 42Eh "CG12844, CG12844, CG12844, Dm.Tsp42Eh, tetraspanin 42E, Tetraspanin 42Eh" CDMC32555 2 12 10 DAC16-F03 2-CG12844-RA_1 CG12844 CCCGAAATAGACCCGATCGGCTGACATTGAAAGGGATTGTGGCCTTTGTTTAGCTAGGTGGCTGCC 66 FBan0012844 FBgn0033129 Tsp42Eh 2 2R integral to membrane; GO:0016021 Tsp42Eh Tetraspanin 42Eh "CG12844, CG12844, CG12844, Dm.Tsp42Eh, tetraspanin 42E, Tetraspanin 42Eh" CDMC32556 2 13 10 DAC16-F15 9-CG13082-RA_1 CG13082 GGAGGGGCAGTACAACATTCGTGCTGATCTGGAGAACTTCATGATCCTCCTGATTCCACCTGGACC 66 FBan0013082 FBgn0032803 CG13082 2 2L CG13082 CG13082 CDMC32556 2 14 10 DAC16-F15 9-CG13082-RA_1 CG13082 GGAGGGGCAGTACAACATTCGTGCTGATCTGGAGAACTTCATGATCCTCCTGATTCCACCTGGACC 66 FBan0013082 FBgn0032803 CG13082 2 2L CG13082 CG13082 CDMC32557 2 15 10 DAC16-J03 23-CG13444-RA_3 CG13444 GCAAAAACAACGTAACAAAATAGGTAAAACAGTATAAACAACGCAACATTGTAAGCTGGCTGAAAG 66 FBgn0036543 CDMC32557 2 16 10 DAC16-J03 23-CG13444-RA_3 CG13444 GCAAAAACAACGTAACAAAATAGGTAAAACAGTATAAACAACGCAACATTGTAAGCTGGCTGAAAG 66 FBgn0036543 CDMC32558 2 17 10 DAC16-J15 2-CG13550-RA_2 CG13550 CGGGAGTACGACAATTCGGATGCCCTGATCACGGTGATCAAGCACCTGTTGATGAACCGGCAGTAC 66 FBan0013550 FBgn0034853 CG13550 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG13550 CG13550 CDMC32558 2 18 10 DAC16-J15 2-CG13550-RA_2 CG13550 CGGGAGTACGACAATTCGGATGCCCTGATCACGGTGATCAAGCACCTGTTGATGAACCGGCAGTAC 66 FBan0013550 FBgn0034853 CG13550 2 2R calcium ion binding; GO:0005509; ; GO:0005509 CG13550 CG13550 CDMC32559 2 19 10 DAC16-N03 9-CG1407-RA_10 CG1407 GGTTCTGCGAAAAGTGCAAGATCATCAAGCCAGACCGAGCTCACCACTGTAGTGTGTGCAGTTGCT 66 FBan0001407 FBgn0033474 CG1407 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG1407 CG1407 CDMC32559 2 20 10 DAC16-N03 9-CG1407-RA_10 CG1407 GGTTCTGCGAAAAGTGCAAGATCATCAAGCCAGACCGAGCTCACCACTGTAGTGTGTGCAGTTGCT 66 FBan0001407 FBgn0033474 CG1407 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG1407 CG1407 CDMC32560 2 21 10 DAC16-N15 17-CG14174-RA_1 CG14174 TGCCAGGAAGGAAACACCCGTTCAAGATACAAAGAAACCCACATTCAATGAAAACGTTCTGGCCAC 66 FBan0014174 FBgn0036036 CG14174 3 3L CG14174 CG14174 CDMC32560 2 22 10 DAC16-N15 17-CG14174-RA_1 CG14174 TGCCAGGAAGGAAACACCCGTTCAAGATACAAAGAAACCCACATTCAATGAAAACGTTCTGGCCAC 66 FBan0014174 FBgn0036036 CG14174 3 3L CG14174 CG14174 CDMC32561 2 23 10 DAC17-B03 18-CG17278-RA_1 CG17278 AGAGCTATGGATCCATTGATCTGTAGTCCAGCGGAAATAACTTAATCATGGAGGGGAGCGAGTTGACGC 69 FBan0017278 FBgn0046763 CG17278 3 3R CG17278 CG17278 BcDNA:SD04019 CDMC32561 2 24 10 DAC17-B03 18-CG17278-RA_1 CG17278 AGAGCTATGGATCCATTGATCTGTAGTCCAGCGGAAATAACTTAATCATGGAGGGGAGCGAGTTGACGC 69 FBan0017278 FBgn0046763 CG17278 3 3R CG17278 CG17278 BcDNA:SD04019 CDMC32562 2 25 10 DAC17-B15 18-CG1728-RA_4 CG1728 AGCCCGGTCAATTTGTAGATTGCTCACTGAAAATCACACGATGTCCGATTTTGAGAACCTTTCCGGCAA 69 FBan0001728 FBgn0027359 Tim8 X X protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim8 Tim8 "CG1728, BcDNA:SD06593" CDMC32562 2 26 10 DAC17-B15 18-CG1728-RA_4 CG1728 AGCCCGGTCAATTTGTAGATTGCTCACTGAAAATCACACGATGTCCGATTTTGAGAACCTTTCCGGCAA 69 FBan0001728 FBgn0027359 Tim8 X X protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim8 Tim8 "CG1728, BcDNA:SD06593" CDMC32563 2 1 11 DAC17-F03 1-CG17330-RA_2 CG17330 CCTGAGGAGCTTAGCGGCAGATTTGACCATGTCACCTCGTTCTACTGCCTCCATTGGGTGCAAAATCTG 69 FBan0017330 FBgn0028841 jhamt 2 2L juvenile hormone biosynthesis; GO:0006718 juvenile hormone acid methyltransferase activity; GO:0035049; ; GO:0035049; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0035049 jhamt juvenile hormone acid methyltransferase "CG17330, CG17330, BG:DS09218.5, JAHMT, DmJHAMT" CDMC32563 2 2 11 DAC17-F03 1-CG17330-RA_2 CG17330 CCTGAGGAGCTTAGCGGCAGATTTGACCATGTCACCTCGTTCTACTGCCTCCATTGGGTGCAAAATCTG 69 FBan0017330 FBgn0028841 jhamt 2 2L juvenile hormone biosynthesis; GO:0006718 juvenile hormone acid methyltransferase activity; GO:0035049; ; GO:0035049; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0035049 jhamt juvenile hormone acid methyltransferase "CG17330, CG17330, BG:DS09218.5, JAHMT, DmJHAMT" CDMC32564 2 3 11 DAC17-F15 12-CG17348-RA_2 CG17348 ACCAGCGGTGCTGAAGCATGCCAAGACCTGTAAATATAACAAGAGGCGACGTCGCAAGATTTTCCAACA 69 FBan0017348 FBgn0015380 drl 2 2L Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; learning and/or memory; GO:0007611; memory; GO:0007613; muscle attachment; GO:0016203; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; Wnt-protein binding; GO:0017147; ; GO:0004713 ; EC:2.7.1.112; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 drl derailed "CG10758, CG17348, CG10758, CG17348, CG17348, lio: linotte, linotte, lio/drl, lin, DRL, lionette, lio, derailed" CDMC32564 2 4 11 DAC17-F15 12-CG17348-RA_2 CG17348 ACCAGCGGTGCTGAAGCATGCCAAGACCTGTAAATATAACAAGAGGCGACGTCGCAAGATTTTCCAACA 69 FBan0017348 FBgn0015380 drl 2 2L Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell-cell signaling; GO:0007267; ectoderm development; GO:0007398; learning and/or memory; GO:0007611; memory; GO:0007613; muscle attachment; GO:0016203; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; Wnt-protein binding; GO:0017147; ; GO:0004713 ; EC:2.7.1.112; ; GO:0017147 integral to membrane; GO:0016021; plasma membrane; GO:0005886 drl derailed "CG10758, CG17348, CG10758, CG17348, CG17348, lio: linotte, linotte, lio/drl, lin, DRL, lionette, lio, derailed" CDMC32565 2 5 11 DAC17-J03 3-CG17386-RA_1 CG17386 GGCCATTCCCGTGGATGTGCGTCAGTTCATGAACAAGTATCCAGAACTGCAGCAAAAGGAGTGTGCTCT 69 FBan0017386 FBgn0033936 CG17386 2 2R CG17386 CG17386 CT33484 CDMC32565 2 6 11 DAC17-J03 3-CG17386-RA_1 CG17386 GGCCATTCCCGTGGATGTGCGTCAGTTCATGAACAAGTATCCAGAACTGCAGCAAAAGGAGTGTGCTCT 69 FBan0017386 FBgn0033936 CG17386 2 2R CG17386 CG17386 CT33484 CDMC32566 2 7 11 DAC17-J15 17-CG17420-RB_1 CG17420 TCGCCCGGATAAAGCAAGACGTTTAGGATACAGAGCCAAACAGGGGTTCGTGATTTATAGAATCCGTGT 69 CDMC32566 2 8 11 DAC17-J15 17-CG17420-RB_1 CG17420 TCGCCCGGATAAAGCAAGACGTTTAGGATACAGAGCCAAACAGGGGTTCGTGATTTATAGAATCCGTGT 69 CDMC32567 2 9 11 DAC17-N03 2-CG17486-RA_1 CG17486 GCGCCAACTTGCTGTGCAAAACGAACTTGAAAGGGACTGGCAACGTATTTCGGCCCGTAATTTAGCCAG 69 FBgn0032997 CG17486 amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; asparagine biosynthesis; GO:0006529 ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; asparagine synthase (glutamine-hydrolyzing) activity; GO:0004066 ; EC:6.3.5.4; ; GO:0004066 ; EC:6.3.5.4 CG17486 CG17486 "CG40291, CG40291" CDMC32567 2 10 11 DAC17-N03 2-CG17486-RA_1 CG17486 GCGCCAACTTGCTGTGCAAAACGAACTTGAAAGGGACTGGCAACGTATTTCGGCCCGTAATTTAGCCAG 69 FBgn0032997 CG17486 amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; asparagine biosynthesis; GO:0006529 ligase activity; GO:0016874 ; EC:6.-.-.-; catalytic activity; GO:0003824; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003824; asparagine synthase (glutamine-hydrolyzing) activity; GO:0004066 ; EC:6.3.5.4; ; GO:0004066 ; EC:6.3.5.4 CG17486 CG17486 "CG40291, CG40291" CDMC32568 2 11 11 DAC17-N15 16-CG17493-RA_1 CG17493 GCTCTGGGATTCGAGCCAAAAAAGGAGGAGATTAAGAGGATGATTTCCGACATTGACAAGGACTGCAGT 69 FBgn0040010 CG17493 calcium-mediated signaling; GO:0019722; chromosome segregation; GO:0007059; mitosis; GO:0007067 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 cytoskeleton; GO:0005856 CG17493 CG17493 "CG40016, CG40016, CG40016, CG40016, CG40016" CDMC32568 2 12 11 DAC17-N15 16-CG17493-RA_1 CG17493 GCTCTGGGATTCGAGCCAAAAAAGGAGGAGATTAAGAGGATGATTTCCGACATTGACAAGGACTGCAGT 69 FBgn0040010 CG17493 calcium-mediated signaling; GO:0019722; chromosome segregation; GO:0007059; mitosis; GO:0007067 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 cytoskeleton; GO:0005856 CG17493 CG17493 "CG40016, CG40016, CG40016, CG40016, CG40016" CDMC32569 2 13 11 DAC18-B03 2-CG31292-RA_1 CG31292 CGGATGACGTCTTGACCCTCTCGAAGAATCTGTACGCGGAGGAGACCGAGGTCAGTCCATACCTCTACA 69 FBan0031292 FBgn0051292 CG31292 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31292 CG31292 CDMC32569 2 14 11 DAC18-B03 2-CG31292-RA_1 CG31292 CGGATGACGTCTTGACCCTCTCGAAGAATCTGTACGCGGAGGAGACCGAGGTCAGTCCATACCTCTACA 69 FBan0031292 FBgn0051292 CG31292 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31292 CG31292 CDMC32570 2 15 11 DAC18-B15 18-CG31301-RA_6 CG31301 ATGTGAGATCGGACGATATACGTGACATGCAGTTTGAGCCCACGTTTTCGAAGGAAGAAAGAACCACGC 69 FBan0031301 FBgn0051301 CG31301 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG31301 CG31301 "CG12258, CG12258, CG12258" CDMC32570 2 16 11 DAC18-B15 18-CG31301-RA_6 CG31301 ATGTGAGATCGGACGATATACGTGACATGCAGTTTGAGCCCACGTTTTCGAAGGAAGAAAGAACCACGC 69 FBan0031301 FBgn0051301 CG31301 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 intracellular; GO:0005622 CG31301 CG31301 "CG12258, CG12258, CG12258" CDMC32571 2 17 11 DAC18-F03 17-CG31337-RA_1 CG31337 GCGGACTTTGATCTGCTAAATCAGTTGGTAGCTTTTTGTTTGGGCCCATAACCGAAATGTTATGGCCGC 69 FBan0031337 FBgn0051337 CG31337 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31337 CG31337 BcDNA:RE40816 CDMC32571 2 18 11 DAC18-F03 17-CG31337-RA_1 CG31337 GCGGACTTTGATCTGCTAAATCAGTTGGTAGCTTTTTGTTTGGGCCCATAACCGAAATGTTATGGCCGC 69 FBan0031337 FBgn0051337 CG31337 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31337 CG31337 BcDNA:RE40816 CDMC32572 2 19 11 DAC18-F15 22-CG31350-RA_1 CG31350 TACGAAAATGCAACAATCAACTGCAAGCAGAGCACGAATTTTCCAATAAATCCTCGCTGATCCGACGCG 69 FBgn0051350 CDMC32572 2 20 11 DAC18-F15 22-CG31350-RA_1 CG31350 TACGAAAATGCAACAATCAACTGCAAGCAGAGCACGAATTTTCCAATAAATCCTCGCTGATCCGACGCG 69 FBgn0051350 CDMC32573 2 21 11 DAC18-J03 8-CG31380-RA_1 CG31380 GGCCCCGAGACTTCAGAGATTGGATGAGCAGCATGTGAGTTTGGTTCTTAGGAAGTTGGCCAAAATGCA 69 FBan0031380 FBgn0051380 CG31380 3 3R CG31380 CG31380 CG4964 CDMC32573 2 22 11 DAC18-J03 8-CG31380-RA_1 CG31380 GGCCCCGAGACTTCAGAGATTGGATGAGCAGCATGTGAGTTTGGTTCTTAGGAAGTTGGCCAAAATGCA 69 FBan0031380 FBgn0051380 CG31380 3 3R CG31380 CG31380 CG4964 CDMC32574 2 23 11 DAC18-J15 18-CG31395-RA_1 CG31395 CGGCGACAAATTGGGCAGTACTACAAAATCCAAACTTGCATTCGAAAGCCGCTACGAACATGGCAATTT 69 FBan0031395 FBgn0051395 CG31395 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31395 CG31395 CDMC32574 2 24 11 DAC18-J15 18-CG31395-RA_1 CG31395 CGGCGACAAATTGGGCAGTACTACAAAATCCAAACTTGCATTCGAAAGCCGCTACGAACATGGCAATTT 69 FBan0031395 FBgn0051395 CG31395 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31395 CG31395 CDMC32575 2 25 11 DAC18-N03 3-CG31437-RA_1 CG31437 ACACCACCTTCCATGAACCACAAATCAGGGAGGAAGATCCAGACACCGAATCGGATAAGGACAGTCGCA 69 FBan0031437 FBgn0051437 CG31437 3 3R phosphate transport; GO:0006817 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 CG31437 CG31437 CDMC32575 2 26 11 DAC18-N03 3-CG31437-RA_1 CG31437 ACACCACCTTCCATGAACCACAAATCAGGGAGGAAGATCCAGACACCGAATCGGATAAGGACAGTCGCA 69 FBan0031437 FBgn0051437 CG31437 3 3R phosphate transport; GO:0006817 molecular function unknown; GO:0005554; ; GO:0005554 cytoplasm; GO:0005737 CG31437 CG31437 CDMC32576 2 1 12 DAC18-N15 24-CG31450-RA_1 CG31450 CAACAAGTACTTCCTGGAGTCCACAATTAAATACTAGTGTTAAATACAATAAATGTTGTTAATAGAAAA 69 FBan0031450 FBgn0051450 mRpS18A 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18A mitochondrial ribosomal protein S18A "CG11744, CG31450, CG11744, MRP-S18-(3), mitochondrial ribosomal protein S18c, mRpS18c, BcDNA:SD13983, mitochondrial ribosomal protein S18A" CDMC32576 2 2 12 DAC18-N15 24-CG31450-RA_1 CG31450 CAACAAGTACTTCCTGGAGTCCACAATTAAATACTAGTGTTAAATACAATAAATGTTGTTAATAGAAAA 69 FBan0031450 FBgn0051450 mRpS18A 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18A mitochondrial ribosomal protein S18A "CG11744, CG31450, CG11744, MRP-S18-(3), mitochondrial ribosomal protein S18c, mRpS18c, BcDNA:SD13983, mitochondrial ribosomal protein S18A" CDMC32577 2 3 12 DAC19-B03 3-CG5987-RA_5 CG5987 CTGCGCATCTTCGTGTACAACGAGGGATTGGCCAGATTTGCTACGAACAAGTACGTGGAGCCCAC 65 FBan0005987 FBgn0039501 CG5987 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG5987 CG5987 CDMC32577 2 4 12 DAC19-B03 3-CG5987-RA_5 CG5987 CTGCGCATCTTCGTGTACAACGAGGGATTGGCCAGATTTGCTACGAACAAGTACGTGGAGCCCAC 65 FBan0005987 FBgn0039501 CG5987 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG5987 CG5987 CDMC32578 2 5 12 DAC19-B15 23-CG6020-RA_1 CG6020 TAGTTGGAATTGTTTAAGGCGATGCGTCAATAAAGAGAAGTCGAAAGACCCAATGACAACGAAGG 65 FBan0006020 FBgn0037001 CG6020 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6020 CG6020 CDMC32578 2 6 12 DAC19-B15 23-CG6020-RA_1 CG6020 TAGTTGGAATTGTTTAAGGCGATGCGTCAATAAAGAGAAGTCGAAAGACCCAATGACAACGAAGG 65 FBan0006020 FBgn0037001 CG6020 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG6020 CG6020 CDMC32579 2 7 12 DAC19-F03 2-CG6126-RA_1 CG6126 TGTCGGGAGCCCTTACTCCGCTCATTACATTGCTGGACTCATTTGATCCGAAGATACCGGCCGTG 65 FBan0006126 FBgn0038407 CG6126 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG6126 CG6126 CT19169 CDMC32579 2 8 12 DAC19-F03 2-CG6126-RA_1 CG6126 TGTCGGGAGCCCTTACTCCGCTCATTACATTGCTGGACTCATTTGATCCGAAGATACCGGCCGTG 65 FBan0006126 FBgn0038407 CG6126 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG6126 CG6126 CT19169 CDMC32580 2 9 12 DAC19-F15 12-CG6154-RA_2 CG6154 CTGGAGCAGATCGACCTGATTCGTCGACTTGTTCAGCTCTATCCGCATCACATGGCGCTGGTCAC 65 FBan0006154 FBgn0039420 CG6154 3 3R proteolysis; GO:0006508; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0004812 ; EC:6.1.1.-; ; GO:0008239 CG6154 CG6154 CDMC32580 2 10 12 DAC19-F15 12-CG6154-RA_2 CG6154 CTGGAGCAGATCGACCTGATTCGTCGACTTGTTCAGCTCTATCCGCATCACATGGCGCTGGTCAC 65 FBan0006154 FBgn0039420 CG6154 3 3R proteolysis; GO:0006508; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0004812 ; EC:6.1.1.-; ; GO:0008239 CG6154 CG6154 CDMC32581 2 11 12 DAC19-J03 2-CG6280-RA_1 CG6280 GTGGAGCACTACGTGGATCGTCCGTACCCAGTGGAGACCATTGTCGAACATCCCGTTCCATATCC 65 FBan0006280 FBgn0033866 CG6280 2 2R CG6280 CG6280 CDMC32581 2 12 12 DAC19-J03 2-CG6280-RA_1 CG6280 GTGGAGCACTACGTGGATCGTCCGTACCCAGTGGAGACCATTGTCGAACATCCCGTTCCATATCC 65 FBan0006280 FBgn0033866 CG6280 2 2R CG6280 CG6280 CDMC32582 2 13 12 DAC19-J15 12-CG6323-RB_1 CG6323 GGTGCCCACGGATTTGCGCAAACAAGTGCAGGATAGTCTGAAATGCTGCGGATTCAATGCCACCG 65 FBan0006323 FBgn0039465 Tsp97E 3 3R receptor activity; GO:0004872; ; GO:0004872 integral to membrane; GO:0016021 Tsp97E Tetraspanin 97E "CG6323, CG6323, CG6323, CG6323, Dm.Tsp97E, Tetraspanin 97E" CDMC32582 2 14 12 DAC19-J15 12-CG6323-RB_1 CG6323 GGTGCCCACGGATTTGCGCAAACAAGTGCAGGATAGTCTGAAATGCTGCGGATTCAATGCCACCG 65 FBan0006323 FBgn0039465 Tsp97E 3 3R receptor activity; GO:0004872; ; GO:0004872 integral to membrane; GO:0016021 Tsp97E Tetraspanin 97E "CG6323, CG6323, CG6323, CG6323, Dm.Tsp97E, Tetraspanin 97E" CDMC32583 2 15 12 DAC19-N03 18-CG6410-RA_8 CG6410 CCCGTGGACCCCAACGCTGTGCTAAGGGTGCCCATTATTGGTTACGAGGTTATGGAGGAACGTGC 65 FBan0006410 FBgn0034265 CG6410 2 2R intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 CG6410 CG6410 CDMC32583 2 16 12 DAC19-N03 18-CG6410-RA_8 CG6410 CCCGTGGACCCCAACGCTGTGCTAAGGGTGCCCATTATTGGTTACGAGGTTATGGAGGAACGTGC 65 FBan0006410 FBgn0034265 CG6410 2 2R intracellular signaling cascade; GO:0007242; protein targeting; GO:0006605 CG6410 CG6410 CDMC32584 2 17 12 DAC19-N15 18-CG6437-RA_2 CG6437 GGCCGCCAAGTACGACTTTGTGATGATCTCAGACAGCGGCATCAAGATGAAAGACGACACGCTGC 65 FBgn0034690 CDMC32584 2 18 12 DAC19-N15 18-CG6437-RA_2 CG6437 GGCCGCCAAGTACGACTTTGTGATGATCTCAGACAGCGGCATCAAGATGAAAGACGACACGCTGC 65 FBgn0034690 CDMC32585 2 19 12 DAC20-B03 1-CG30028-RA_2 CG30028 GTGTCACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAAC 65 FBan0030028 FBgn0010359 gammaTry 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 gammaTry gammaTrypsin "CG30028, CG30028, gamma, gamma, DmGammaTry, gamma-Try, SPH180, BcDNA:RE40325" CDMC32585 2 20 12 DAC20-B03 1-CG30028-RA_2 CG30028 GTGTCACCTTCTCTGTGTCCTCCTTCAAGAACCACGAGGGCTACAACGCCAACACCATGGTCAAC 65 FBan0030028 FBgn0010359 gammaTry 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 gammaTry gammaTrypsin "CG30028, CG30028, gamma, gamma, DmGammaTry, gamma-Try, SPH180, BcDNA:RE40325" CDMC32586 2 21 12 DAC20-B15 23-CG30051-RB_4 CG30051 TCGATAGCAACGGCCTGTTTATCTCGACAGTTTTCTCAATACCTATTTTGCTTAATTGCATGCTT 65 FBan0030051 FBgn0050051 CG30051 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30051 CG30051 anon-AE003822.1 CDMC32586 2 22 12 DAC20-B15 23-CG30051-RB_4 CG30051 TCGATAGCAACGGCCTGTTTATCTCGACAGTTTTCTCAATACCTATTTTGCTTAATTGCATGCTT 65 FBan0030051 FBgn0050051 CG30051 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30051 CG30051 anon-AE003822.1 CDMC32587 2 23 12 DAC20-F03 1-CG30160-RA_1 CG30160 GAGTTCGTCGATTTCTGGGCCTCCAATACGGACCTGATTCGATGGAGCAGTCTGATCATCGCCCT 65 FBan0030160 FBgn0050160 CG30160 2 2R integral to membrane; GO:0016021 CG30160 CG30160 CDMC32587 2 24 12 DAC20-F03 1-CG30160-RA_1 CG30160 GAGTTCGTCGATTTCTGGGCCTCCAATACGGACCTGATTCGATGGAGCAGTCTGATCATCGCCCT 65 FBan0030160 FBgn0050160 CG30160 2 2R integral to membrane; GO:0016021 CG30160 CG30160 CDMC32588 2 25 12 DAC20-F15 24-CG30192-RA_2 CG30192 ACTTTGAAGTGTGATTAAAATTTAAATCCAAATTGTGAGTTTTCATAGAAATTTCTACTTCACCA 65 FBan0030192 FBgn0050192 CG30192 2 2R CG30192 CG30192 BcDNA:AT30929 CDMC32588 2 26 12 DAC20-F15 24-CG30192-RA_2 CG30192 ACTTTGAAGTGTGATTAAAATTTAAATCCAAATTGTGAGTTTTCATAGAAATTTCTACTTCACCA 65 FBan0030192 FBgn0050192 CG30192 2 2R CG30192 CG30192 BcDNA:AT30929 CDMC32589 2 1 13 DAC20-J03 24-CG3034-RA_1 CG3034 CGAGAAGCGGGTTTGTCTAAAATAAATTGTTGAACTAAGTTAAGGTAGAATTAGGACAATGGCCA 65 FBan0003034 FBgn0040339 MED22 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED22 Mediator complex subunit 22 "CG3034, CG18830, CG3034, CG18830, Med24, clone 1.82, EG:BACR7A4.6, dMED24, Srb6/Surf5, Med22, anon-EST:Liang-1.82, Mediator complex subunit 22" CDMC32589 2 2 13 DAC20-J03 24-CG3034-RA_1 CG3034 CGAGAAGCGGGTTTGTCTAAAATAAATTGTTGAACTAAGTTAAGGTAGAATTAGGACAATGGCCA 65 FBan0003034 FBgn0040339 MED22 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED22 Mediator complex subunit 22 "CG3034, CG18830, CG3034, CG18830, Med24, clone 1.82, EG:BACR7A4.6, dMED24, Srb6/Surf5, Med22, anon-EST:Liang-1.82, Mediator complex subunit 22" CDMC32590 2 3 13 DAC20-J15 2-CG30380-RA_1 CG30380 GTAACTGCGCTATTGCTCAAGGCTTTGTTTGTGCTCGGGCTGACCGTACTTTCGGGACCAGGAAG 65 FBan0030380 FBgn0050380 CG30380 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30380 CG30380 CDMC32590 2 4 13 DAC20-J15 2-CG30380-RA_1 CG30380 GTAACTGCGCTATTGCTCAAGGCTTTGTTTGTGCTCGGGCTGACCGTACTTTCGGGACCAGGAAG 65 FBan0030380 FBgn0050380 CG30380 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30380 CG30380 CDMC32591 2 5 13 DAC20-N03 5-CG3045-RA_4 CG3045 AACCCGGGCGTAATAAGTGACCTGCTTGATGTGGAGTCTAATCCCTGCAAGCCTCAGTACACCCC 65 FBan0003045 FBgn0034703 CG3045 2 2R tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70 CG3045 CG3045 CDMC32591 2 6 13 DAC20-N03 5-CG3045-RA_4 CG3045 AACCCGGGCGTAATAAGTGACCTGCTTGATGTGGAGTCTAATCCCTGCAAGCCTCAGTACACCCC 65 FBan0003045 FBgn0034703 CG3045 2 2R tRNA metabolism; GO:0006399; tRNA processing; GO:0008033 pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70 CG3045 CG3045 CDMC32592 2 7 13 DAC20-N15 1-CG30489-RA_2 CG30489 AATGGAGACCACAGTGGCCAAGTTGATTCGCAATTTCCATGTGGAGTTCAATCGGGATGCCAGCC 65 FBan0030489 FBgn0050489 Cyp12d1-p 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12d1-p Cyp12d1-p "CG30489, CG18240, CYP12D1, 12D1, 12d1, Cyp12d1" CDMC32592 2 8 13 DAC20-N15 1-CG30489-RA_2 CG30489 AATGGAGACCACAGTGGCCAAGTTGATTCGCAATTTCCATGTGGAGTTCAATCGGGATGCCAGCC 65 FBan0030489 FBgn0050489 Cyp12d1-p 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12d1-p Cyp12d1-p "CG30489, CG18240, CYP12D1, 12D1, 12d1, Cyp12d1" CDMC32593 2 9 13 DAC21-B03 3-CG3848-RD_2 CG3848 CTGCCCGTACAGCAAGCAGTTCGTGCATTCGAAGAGCTCCCAGTACAAAAAGATGAAGCAGGAGTGGC 68 FBan0003848 FBgn0023518 trr X X eye development (sensu Endopterygota); GO:0007456; histone methylation; GO:0016571; positive regulation of transcription; GO:0045941; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of transcription from RNA polymerase II promoter; GO:0006357; smoothened signaling pathway; GO:0007224; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; ; GO:0003677; histone methyltransferase activity; GO:0042054; transcription regulator activity; GO:0030528; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ; GO:0030528; receptor binding; GO:0005102; ; GO:0042800; ; GO:0042054; transcription coactivator activity; GO:0003713; ; GO:0005102; ; GO:0005102; ; GO:0003713 nucleus; GO:0005634; polytene chromosome; GO:0005700 trr trithorax-related "CG3848, CG3848, EG:63B12.3, anon-2Bb, trithorax-related" CDMC32593 2 10 13 DAC21-B03 3-CG3848-RD_2 CG3848 CTGCCCGTACAGCAAGCAGTTCGTGCATTCGAAGAGCTCCCAGTACAAAAAGATGAAGCAGGAGTGGC 68 FBan0003848 FBgn0023518 trr X X eye development (sensu Endopterygota); GO:0007456; histone methylation; GO:0016571; positive regulation of transcription; GO:0045941; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of transcription from RNA polymerase II promoter; GO:0006357; smoothened signaling pathway; GO:0007224; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; ; GO:0003677; histone methyltransferase activity; GO:0042054; transcription regulator activity; GO:0030528; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ; GO:0030528; receptor binding; GO:0005102; ; GO:0042800; ; GO:0042054; transcription coactivator activity; GO:0003713; ; GO:0005102; ; GO:0005102; ; GO:0003713 nucleus; GO:0005634; polytene chromosome; GO:0005700 trr trithorax-related "CG3848, CG3848, EG:63B12.3, anon-2Bb, trithorax-related" CDMC32594 2 11 13 DAC21-B15 17-CG3939-RA_1 CG3939 GGAGACCGATCCGAAGAAGTCCAATTTTGTCGCCCAATAAAACGCGATTTGGCTTTGGCTTAAACTCA 68 FBan0003939 FBgn0040396 CG3939 X X CG3939 CG3939 "EG:140G11.5, BEST:SD07039" CDMC32594 2 12 13 DAC21-B15 17-CG3939-RA_1 CG3939 GGAGACCGATCCGAAGAAGTCCAATTTTGTCGCCCAATAAAACGCGATTTGGCTTTGGCTTAAACTCA 68 FBan0003939 FBgn0040396 CG3939 X X CG3939 CG3939 "EG:140G11.5, BEST:SD07039" CDMC32595 2 13 13 DAC21-F03 1-CG4181-RA_1 CG4181 AGCCCGGATCGGATGAGGACTTGAAGAGAATCGAAACCGCGTTTGGATTTCTCGACACCTTCCTGGAG 68 FBan0004181 FBgn0010038 GstD2 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9 GstD2 Glutathione S transferase D2 "CG4181, CG4181, DmGST21, gstD21, GST, Gst, DmGSTD2, GstD21: Glutathione S transferase D21, Glutathione S transferase D21, Glutathione S transferase D2, GstD21" CDMC32595 2 14 13 DAC21-F03 1-CG4181-RA_1 CG4181 AGCCCGGATCGGATGAGGACTTGAAGAGAATCGAAACCGCGTTTGGATTTCTCGACACCTTCCTGGAG 68 FBan0004181 FBgn0010038 GstD2 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004602 ; EC:1.11.1.9 GstD2 Glutathione S transferase D2 "CG4181, CG4181, DmGST21, gstD21, GST, Gst, DmGSTD2, GstD21: Glutathione S transferase D21, Glutathione S transferase D21, Glutathione S transferase D2, GstD21" CDMC32596 2 15 13 DAC21-F15 23-CG4307-RB_1 CG4307 CCGCGGGTAGTTTATGTTTAATAAGCCGAAAAACTTACCAAGTGCTCTTGTTTGCTTATCCCGCAGAG 68 FBan0004307 FBgn0016691 Oscp 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" Oscp Oligomycin sensitivity-conferring protein "CG4307, OSCP" CDMC32596 2 16 13 DAC21-F15 23-CG4307-RB_1 CG4307 CCGCGGGTAGTTTATGTTTAATAAGCCGAAAAACTTACCAAGTGCTCTTGTTTGCTTATCCCGCAGAG 68 FBan0004307 FBgn0016691 Oscp 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" Oscp Oligomycin sensitivity-conferring protein "CG4307, OSCP" CDMC32597 2 17 13 DAC21-J03 2-CG4829-RB_1 CG4829 TTTGGCCGATGATCTGGAGTCGTACGAGGCCGATGTAATCAACTCCATCACCATGGACTTGGGTGACG 68 FBan0004829 FBgn0030796 CG4829 X X amino acid metabolism; GO:0006520; protein modification; GO:0006464; proteolysis; GO:0006508 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; protein-glutamine gamma-glutamyltransferase activity; GO:0003810 ; EC:2.3.2.13; gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; ; GO:0003810 ; EC:2.3.2.13; ; GO:0003840 ; EC:2.3.2.2 CG4829 CG4829 CDMC32597 2 18 13 DAC21-J03 2-CG4829-RB_1 CG4829 TTTGGCCGATGATCTGGAGTCGTACGAGGCCGATGTAATCAACTCCATCACCATGGACTTGGGTGACG 68 FBan0004829 FBgn0030796 CG4829 X X amino acid metabolism; GO:0006520; protein modification; GO:0006464; proteolysis; GO:0006508 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; protein-glutamine gamma-glutamyltransferase activity; GO:0003810 ; EC:2.3.2.13; gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; ; GO:0003810 ; EC:2.3.2.13; ; GO:0003840 ; EC:2.3.2.2 CG4829 CG4829 CDMC32598 2 19 13 DAC21-J15 2-CG5017-RA_2 CG5017 GCGTGCCCAACTTTTGGCTGAGGGTTCTCAAAGCATCGTACACCGAGTTCATCAGCAAGAGGGATGAG 68 FBan0005017 FBgn0039553 CG5017 3 3R nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461 nucleus; GO:0005634 CG5017 CG5017 CDMC32598 2 20 13 DAC21-J15 2-CG5017-RA_2 CG5017 GCGTGCCCAACTTTTGGCTGAGGGTTCTCAAAGCATCGTACACCGAGTTCATCAGCAAGAGGGATGAG 68 FBan0005017 FBgn0039553 CG5017 3 3R nucleosome assembly; GO:0006334; protein complex assembly; GO:0006461 nucleus; GO:0005634 CG5017 CG5017 CDMC32599 2 21 13 DAC21-N03 1-CG5342-RA_1 CG5342 GCTCGAAAGGATTCCTCTGGTGGTACAGGCGATCCTACTCATACCCTCACTGTACTGGAGGACGACGC 68 FBan0005342 FBgn0037916 CG5342 3 3R CG5342 CG5342 CDMC32599 2 22 13 DAC21-N03 1-CG5342-RA_1 CG5342 GCTCGAAAGGATTCCTCTGGTGGTACAGGCGATCCTACTCATACCCTCACTGTACTGGAGGACGACGC 68 FBan0005342 FBgn0037916 CG5342 3 3R CG5342 CG5342 CDMC32600 2 23 13 DAC21-N15 5-CG5499-RA_2 CG5499 CCGAATTCCGTAGAAACAACTCGCACGCTCCGGTTTCGTGTTGCAACAAAATAGGCATTCCCATCGCG 68 FBan0005499 FBgn0001197 His2Av 3 3R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 chromosome; GO:0005694; nucleosome; GO:0000786; nucleus; GO:0005634; polytene chromosome; GO:0005700 His2Av Histone H2A variant "CG5499, CG5499, CG5499, H2AvD, l(3)97Dd, His2AvD, l(3)05146, l(3)L1602, H2Av, H2AZ, H2A.Z, l(3)810" CDMC32600 2 24 13 DAC21-N15 5-CG5499-RA_2 CG5499 CCGAATTCCGTAGAAACAACTCGCACGCTCCGGTTTCGTGTTGCAACAAAATAGGCATTCCCATCGCG 68 FBan0005499 FBgn0001197 His2Av 3 3R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; ; GO:0003677 chromosome; GO:0005694; nucleosome; GO:0000786; nucleus; GO:0005634; polytene chromosome; GO:0005700 His2Av Histone H2A variant "CG5499, CG5499, CG5499, H2AvD, l(3)97Dd, His2AvD, l(3)05146, l(3)L1602, H2Av, H2AZ, H2A.Z, l(3)810" CDMC32601 2 25 13 DAC22-B03 23-CG40440-RA_9 CG40440 ATTGCTGGAATGAAAGACTATCACACTTTGCGATTAGATGAGCGAGAAGACACAATTGCGACTCGAACA 69 CDMC32601 2 26 13 DAC22-B03 23-CG40440-RA_9 CG40440 ATTGCTGGAATGAAAGACTATCACACTTTGCGATTAGATGAGCGAGAAGACACAATTGCGACTCGAACA 69 CDMC32602 2 1 14 DAC22-B15 23-CG40451-RA_6 CG40451 TCTGGGGTGGTATGTTCAGTACCATTGATTGTACCCTTGTCCACTTTCGAAAAAAAGAAGATCCGTGGA 69 FBgn0067318 CG40451 intracellular protein transport; GO:0006886; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386 CG40451 CG40451 CDMC32602 2 2 14 DAC22-B15 23-CG40451-RA_6 CG40451 TCTGGGGTGGTATGTTCAGTACCATTGATTGTACCCTTGTCCACTTTCGAAAAAAAGAAGATCCGTGGA 69 FBgn0067318 CG40451 intracellular protein transport; GO:0006886; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386 CG40451 CG40451 CDMC32603 2 3 14 DAC22-F03 2-CG4053-RA_5 CG4053 GGTGCTCCGGAAAGTAGCTATCCCACAGTGCAATATCTGCAGACCCTCAACCTGACCATCATCGCACAC 69 FBan0004053 FBgn0038482 CG4053 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4053 CG4053 SP185 CDMC32603 2 4 14 DAC22-F03 2-CG4053-RA_5 CG4053 GGTGCTCCGGAAAGTAGCTATCCCACAGTGCAATATCTGCAGACCCTCAACCTGACCATCATCGCACAC 69 FBan0004053 FBgn0038482 CG4053 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4053 CG4053 SP185 CDMC32604 2 5 14 DAC22-F15 3-CG4062-RB_3 CG4062 CGCGACATCAACCTGGACATCAATCGCGTTCTGGGATATCGTTTCTTCTGCAACAAGCTGTGGAACGCC 69 FBan0004062 FBgn0027079 Aats-val 2 2R valyl-tRNA aminoacylation; GO:0006438 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; valine-tRNA ligase activity; GO:0004832 ; EC:6.1.1.9; ; GO:0003729; ; GO:0004832 ; EC:6.1.1.9; ; GO:0004818 ; EC:6.1.1.17 Aats-val Valyl-tRNA synthetase "CG4062, l(2)03531, l(2)rI255, VRS, ValRS, ld45671, BEST:LD45671, Valyl-tRNA synthetase" CDMC32604 2 6 14 DAC22-F15 3-CG4062-RB_3 CG4062 CGCGACATCAACCTGGACATCAATCGCGTTCTGGGATATCGTTTCTTCTGCAACAAGCTGTGGAACGCC 69 FBan0004062 FBgn0027079 Aats-val 2 2R valyl-tRNA aminoacylation; GO:0006438 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; valine-tRNA ligase activity; GO:0004832 ; EC:6.1.1.9; ; GO:0003729; ; GO:0004832 ; EC:6.1.1.9; ; GO:0004818 ; EC:6.1.1.17 Aats-val Valyl-tRNA synthetase "CG4062, l(2)03531, l(2)rI255, VRS, ValRS, ld45671, BEST:LD45671, Valyl-tRNA synthetase" CDMC32605 2 7 14 DAC22-J03 15-CG4099-RA_1 CG4099 GTTCTGGCCAACGTCGTTAATCGCTGGATAATACCAATCACTGGATCAAAGACCAGCAGCGAAAAGGCT 69 FBan0004099 FBgn0014033 Sr-CI 2 2L defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; phagocytosis; GO:0006909; response to bacteria; GO:0009617 scavenger receptor activity; GO:0005044; ; GO:0005044; polysaccharide binding; GO:0030247; ; GO:0005044; ; GO:0030247 integral to plasma membrane; GO:0005887 Sr-CI "Scavenger receptor class C, type I" "CG4099, dSR-CI, SR-CI, DSR-CI, CT9876, dScR-I, Scavenger Receptor, dSR-C1, dSRC-I, D-SR-CI, Sr-Cl" CDMC32605 2 8 14 DAC22-J03 15-CG4099-RA_1 CG4099 GTTCTGGCCAACGTCGTTAATCGCTGGATAATACCAATCACTGGATCAAAGACCAGCAGCGAAAAGGCT 69 FBan0004099 FBgn0014033 Sr-CI 2 2L defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; phagocytosis; GO:0006909; response to bacteria; GO:0009617 scavenger receptor activity; GO:0005044; ; GO:0005044; polysaccharide binding; GO:0030247; ; GO:0005044; ; GO:0030247 integral to plasma membrane; GO:0005887 Sr-CI "Scavenger receptor class C, type I" "CG4099, dSR-CI, SR-CI, DSR-CI, CT9876, dScR-I, Scavenger Receptor, dSR-C1, dSRC-I, D-SR-CI, Sr-Cl" CDMC32606 2 9 14 DAC22-J15 3-CG41050-RA_1 CG41050 TCCACTTGACAGCGAACATTGCACCACCAACGGTTGAAGTCCCGAAAGCGGCAAATCATATAGCCTACA 69 FBgn0069962 CG41050 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41050 CG41050 CDMC32606 2 10 14 DAC22-J15 3-CG41050-RA_1 CG41050 TCCACTTGACAGCGAACATTGCACCACCAACGGTTGAAGTCCCGAAAGCGGCAAATCATATAGCCTACA 69 FBgn0069962 CG41050 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41050 CG41050 CDMC32607 2 11 14 DAC22-N03 1-CG4110-RA_1 CG4110 GGATGCGGCTATCCCACGGGTCTCTCGGTTCTGCTTAACCCCATGATATCGGACTATTATGGCACCTTC 69 FBgn0032146 CDMC32607 2 12 14 DAC22-N03 1-CG4110-RA_1 CG4110 GGATGCGGCTATCCCACGGGTCTCTCGGTTCTGCTTAACCCCATGATATCGGACTATTATGGCACCTTC 69 FBgn0032146 CDMC32608 2 13 14 DAC22-N15 2-CG41125-RA_1 CG41125 GGTGCGTCTCCTGGAACGTTCGAAGGCTGTCTTGCAGACGCTGTATCTTGTTGCATGCAATACGTCATT 69 FBgn0069926 CG41125 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41125 CG41125 CDMC32608 2 14 14 DAC22-N15 2-CG41125-RA_1 CG41125 GGTGCGTCTCCTGGAACGTTCGAAGGCTGTCTTGCAGACGCTGTATCTTGTTGCATGCAATACGTCATT 69 FBgn0069926 CG41125 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41125 CG41125 CDMC32609 2 15 14 DAC23-B03 9-CG33330-RA_1 CG33330 GCCATCTGGTTTGGTACTCCGCCCAGGGATAAGAAGGACGAGAAACTGTTTGAGGTGCATCATGTGCAG 69 FBan0033330 FBgn0053330 CG33330 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33330 CG33330 CG3563 CDMC32609 2 16 14 DAC23-B03 9-CG33330-RA_1 CG33330 GCCATCTGGTTTGGTACTCCGCCCAGGGATAAGAAGGACGAGAAACTGTTTGAGGTGCATCATGTGCAG 69 FBan0033330 FBgn0053330 CG33330 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33330 CG33330 CG3563 CDMC32610 2 17 14 DAC23-B15 16-CG33343-RA_3 CG33343 ACCGAAACTCCACAGACATTGTCCGCAAATCCAGTAAATCCCGGGACTAAAGCTACATCATCTCCATCA 69 FBan0033343 FBgn0053343 CG33343 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33343 CG33343 "CG9469, CG9469, CG9469" CDMC32610 2 18 14 DAC23-B15 16-CG33343-RA_3 CG33343 ACCGAAACTCCACAGACATTGTCCGCAAATCCAGTAAATCCCGGGACTAAAGCTACATCATCTCCATCA 69 FBan0033343 FBgn0053343 CG33343 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33343 CG33343 "CG9469, CG9469, CG9469" CDMC32611 2 19 14 DAC23-F03 8-CG33466-RA_1 CG33466 ATATGCGGCTACAACAACCAGACATACAACTCGTGGTGTGAGATGCACAAACACTCCTGCGAATCCCGC 69 FBan0033466 FBgn0034004 Fs 2 2R cell homeostasis; GO:0019725 activin inhibitor activity; GO:0017106; ; GO:0017106 Fs Fs "CG12955, CG33466, CG12956, CG12955, CG12955, CG12955, dFS, dFollistatin, follistatin" CDMC32611 2 20 14 DAC23-F03 8-CG33466-RA_1 CG33466 ATATGCGGCTACAACAACCAGACATACAACTCGTGGTGTGAGATGCACAAACACTCCTGCGAATCCCGC 69 FBan0033466 FBgn0034004 Fs 2 2R cell homeostasis; GO:0019725 activin inhibitor activity; GO:0017106; ; GO:0017106 Fs Fs "CG12955, CG33466, CG12956, CG12955, CG12955, CG12955, dFS, dFollistatin, follistatin" CDMC32612 2 21 14 DAC23-F15 17-CG33473-RB_1 CG33473 GGAATCCAGCGGAAACTGTGTGCCATCAAGGAACGATGAAAAACTTGCGTAACGCTAATCAAAACCACT 69 FBgn0033575 CDMC32612 2 22 14 DAC23-F15 17-CG33473-RB_1 CG33473 GGAATCCAGCGGAAACTGTGTGCCATCAAGGAACGATGAAAAACTTGCGTAACGCTAATCAAAACCACT 69 FBgn0033575 CDMC32613 2 23 14 DAC23-J03 22-CG33492-RA_3 CG33492 GCCTTTGCGGTTGACTAGTTGGTACCTTCCCTTAGAGCCTTTCAAAGAAACTTTATGGGCTGCAATTCT 69 FBgn0053492 CDMC32613 2 24 14 DAC23-J03 22-CG33492-RA_3 CG33492 GCCTTTGCGGTTGACTAGTTGGTACCTTCCCTTAGAGCCTTTCAAAGAAACTTTATGGGCTGCAATTCT 69 FBgn0053492 CDMC32614 2 25 14 DAC23-J15 23-CG33503-RA_7 CG33503 CACGGATATCGAACAATAATTTGCTTCTCATTTGTGGCCTTTACTTGTGTTCCTTATAGTTGCGATTTT 69 FBan0033503 FBgn0053503 Cyp12d1-d 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12d1-d Cyp12d1-d "CG18239, CG33503, CG18240, CG18239, CT26082, CYP12D1, 12D1, Cyp12d1, 12d1, Cyp12d2" CDMC32614 2 26 14 DAC23-J15 23-CG33503-RA_7 CG33503 CACGGATATCGAACAATAATTTGCTTCTCATTTGTGGCCTTTACTTGTGTTCCTTATAGTTGCGATTTT 69 FBan0033503 FBgn0053503 Cyp12d1-d 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12d1-d Cyp12d1-d "CG18239, CG33503, CG18240, CG18239, CT26082, CYP12D1, 12D1, Cyp12d1, 12d1, Cyp12d2" CDMC32615 2 1 15 DAC23-N03 18-CG3395-RA_1 CG3395 ACTAAGCAGTGGTAGCCAGCTGTAGCCAAGACAAATACATGGCGCAGACTTGATAAAAATCCGTTTGCT 69 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC32615 2 2 15 DAC23-N03 18-CG3395-RA_1 CG3395 ACTAAGCAGTGGTAGCCAGCTGTAGCCAAGACAAATACATGGCGCAGACTTGATAAAAATCCGTTTGCT 69 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC32616 2 3 15 DAC23-N15 13-CG3410-RA_1 CG3410 GGGTCCTGGTGAACCCCATCACAATAATGACCAAGAGCGATGCGTTTCAATCTTGCGAAAACTCATGCA 69 FBan0003410 FBgn0040104 lectin-24A 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-24A lectin-24A "CG3410, CG3410, AC 005149A, AC005149a, Lectin24A" CDMC32616 2 4 15 DAC23-N15 13-CG3410-RA_1 CG3410 GGGTCCTGGTGAACCCCATCACAATAATGACCAAGAGCGATGCGTTTCAATCTTGCGAAAACTCATGCA 69 FBan0003410 FBgn0040104 lectin-24A 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-24A lectin-24A "CG3410, CG3410, AC 005149A, AC005149a, Lectin24A" CDMC32617 2 5 15 DAC24-B03 15-CG33151-RA_1 CG33151 CGTCCTGATGGCCATTGTCATTTTCCTCATTCAAATCGGACTGGGCAATAAGTCGCTAATGGGCGTTGC 69 FBan0033151 FBgn0041233 Gr59e 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of taste; GO:0050909; sodium ion transport; GO:0006814 taste receptor activity; GO:0008527; ; GO:0008527; sodium channel activity; GO:0005272; ; GO:0008527; ; GO:0005272 integral to membrane; GO:0016021 Gr59e Gustatory receptor 59e "CG15872, CG33151, CG15872, 59E.2, Gustatory receptor 59E.2, Gr59E2, 59E2, GR59E.2, Gustatory receptor 59e" CDMC32617 2 6 15 DAC24-B03 15-CG33151-RA_1 CG33151 CGTCCTGATGGCCATTGTCATTTTCCTCATTCAAATCGGACTGGGCAATAAGTCGCTAATGGGCGTTGC 69 FBan0033151 FBgn0041233 Gr59e 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of taste; GO:0050909; sodium ion transport; GO:0006814 taste receptor activity; GO:0008527; ; GO:0008527; sodium channel activity; GO:0005272; ; GO:0008527; ; GO:0005272 integral to membrane; GO:0016021 Gr59e Gustatory receptor 59e "CG15872, CG33151, CG15872, 59E.2, Gustatory receptor 59E.2, Gr59E2, 59E2, GR59E.2, Gustatory receptor 59e" CDMC32618 2 7 15 DAC24-B15 14-CG33169-RB_3 CG33169 TGGATTTTCCATGACACGAACAACACCCTGCTGTTCAAGTGCAGTTCCTGGGAATTTGAGATTTGGGGA 69 FBan0033169 FBgn0053169 CG33169 3 3L CG33169 CG33169 "CG8244, BcDNA:RH56317, EP3524" CDMC32618 2 8 15 DAC24-B15 14-CG33169-RB_3 CG33169 TGGATTTTCCATGACACGAACAACACCCTGCTGTTCAAGTGCAGTTCCTGGGAATTTGAGATTTGGGGA 69 FBan0033169 FBgn0053169 CG33169 3 3L CG33169 CG33169 "CG8244, BcDNA:RH56317, EP3524" CDMC32619 2 9 15 DAC24-F03 14-CG33193-RA_1 CG33193 CCATCGACTCATCGCGAAATCAGTGCCTTATACGAAACCAGACGAGATGGTAGCCAAGCAGATCCATGA 69 FBan0033193 FBgn0053193 sav 3 3R apoptosis; GO:0006915; imaginal disc development; GO:0007444; induction of apoptosis; GO:0006917; negative regulation of cell proliferation; GO:0008285; negative regulation of organ size; GO:0046621; regulation of cell proliferation; GO:0042127; regulation of imaginal disc growth; GO:0045570; regulation of progression through cell cycle; GO:0000074; retinal cell programmed cell death; GO:0046666; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 sav salvador "CG13831, CG33193, CG13832, CG13831, CG33193, shar-pei, salvador/shar-pei, anon-WO0172774.152, salvador" CDMC32619 2 10 15 DAC24-F03 14-CG33193-RA_1 CG33193 CCATCGACTCATCGCGAAATCAGTGCCTTATACGAAACCAGACGAGATGGTAGCCAAGCAGATCCATGA 69 FBan0033193 FBgn0053193 sav 3 3R apoptosis; GO:0006915; imaginal disc development; GO:0007444; induction of apoptosis; GO:0006917; negative regulation of cell proliferation; GO:0008285; negative regulation of organ size; GO:0046621; regulation of cell proliferation; GO:0042127; regulation of imaginal disc growth; GO:0045570; regulation of progression through cell cycle; GO:0000074; retinal cell programmed cell death; GO:0046666; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 sav salvador "CG13831, CG33193, CG13832, CG13831, CG33193, shar-pei, salvador/shar-pei, anon-WO0172774.152, salvador" CDMC32620 2 11 15 DAC24-F15 23-CG33198-RA_1 CG33198 TCGAAAACAAAGGAGCAAACACCCACATATTTGAAGAGGATTAATCATGGACATCTCAAAGGCACCAAA 69 FBan0033198 FBgn0053198 pen-2 2 2R endopeptidase activity; GO:0004175; ; GO:0004175 plasma membrane; GO:0005886 pen-2 presenilin enhancer "CG33198, CG33198, Pen-2, anon-AE003800.1" CDMC32620 2 12 15 DAC24-F15 23-CG33198-RA_1 CG33198 TCGAAAACAAAGGAGCAAACACCCACATATTTGAAGAGGATTAATCATGGACATCTCAAAGGCACCAAA 69 FBan0033198 FBgn0053198 pen-2 2 2R endopeptidase activity; GO:0004175; ; GO:0004175 plasma membrane; GO:0005886 pen-2 presenilin enhancer "CG33198, CG33198, Pen-2, anon-AE003800.1" CDMC32621 2 13 15 DAC24-J03 8-CG33224-RA_1 CG33224 TGTGGACGCCAGGAGTAGTCCGCAACAAATGGAAAGGGATGAGGATCTGCAAATCGCTGATGATCAGGT 69 FBan0033224 FBgn0053224 CG33224 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33224 CG33224 CG4040 CDMC32621 2 14 15 DAC24-J03 8-CG33224-RA_1 CG33224 TGTGGACGCCAGGAGTAGTCCGCAACAAATGGAAAGGGATGAGGATCTGCAAATCGCTGATGATCAGGT 69 FBan0033224 FBgn0053224 CG33224 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33224 CG33224 CG4040 CDMC32622 2 15 15 DAC24-J15 2-CG3322-RA_2 CG3322 ACAAGAGGATGGATGATGGCCACATCGAGAATCAACTGCCAACTGTGCTTCACCAGTTTCAAGCCAGCA 69 FBan0003322 FBgn0002528 LanB2 3 3L cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; embryonic morphogenesis; GO:0048598; organ morphogenesis; GO:0009887; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; signal transduction; GO:0007165; tissue development; GO:0009888; transport; GO:0006810 "structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024; ; GO:0005351" basal lamina; GO:0005605; basement membrane; GO:0005604 LanB2 Laminin B2 "CG3322, laminin, laminin B2, lamB2, laminin gamma, laminin gamma1, DROLAMB2A, LAMB2A, gamma1, laminin gamma-chain, LM-B2/gamma, CT11145, Laminin, Lam-B2, anon-EST:fe2H3, anon-fast-evolving-2H3" CDMC32622 2 16 15 DAC24-J15 2-CG3322-RA_2 CG3322 ACAAGAGGATGGATGATGGCCACATCGAGAATCAACTGCCAACTGTGCTTCACCAGTTTCAAGCCAGCA 69 FBan0003322 FBgn0002528 LanB2 3 3L cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; embryonic morphogenesis; GO:0048598; organ morphogenesis; GO:0009887; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; signal transduction; GO:0007165; tissue development; GO:0009888; transport; GO:0006810 "structural molecule activity; GO:0005198; ; GO:0005198; zinc ion binding; GO:0008270; sugar porter activity; GO:0005351; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024; ; GO:0005351" basal lamina; GO:0005605; basement membrane; GO:0005604 LanB2 Laminin B2 "CG3322, laminin, laminin B2, lamB2, laminin gamma, laminin gamma1, DROLAMB2A, LAMB2A, gamma1, laminin gamma-chain, LM-B2/gamma, CT11145, Laminin, Lam-B2, anon-EST:fe2H3, anon-fast-evolving-2H3" CDMC32623 2 17 15 DAC24-N03 18-CG33283-RA_5 CG33283 GCCGGAGATCTTGAAAATAAATGTTGGGGAAAGAATCGCGAATCCAACAAACACGGATGCACTGGTACC 69 FBan0033283 FBgn0053283 CG33283 3 3L CG33283 CG33283 CDMC32623 2 18 15 DAC24-N03 18-CG33283-RA_5 CG33283 GCCGGAGATCTTGAAAATAAATGTTGGGGAAAGAATCGCGAATCCAACAAACACGGATGCACTGGTACC 69 FBan0033283 FBgn0053283 CG33283 3 3L CG33283 CG33283 CDMC32624 2 19 15 DAC24-N15 8-CG33293-RA_1 CG33293 CGGCTGCTAGACGACTACATTGTGCCCTTTGAATGCGGTCTTTGATTCTCGATCCCCATCTCCTGTTCA 69 FBan0033293 FBgn0053293 CG33293 3 3R cellular component unknown; GO:0008372 CG33293 CG33293 "CG12163, bs07d08.y1, bs06b05.y1, bs34a01.y1, bs35d06.y1, NEST:bs07d08, BcDNA:GH07964, NEST:bs35d06, NEST:bs06b05, NEST:bs34a01" CDMC32624 2 20 15 DAC24-N15 8-CG33293-RA_1 CG33293 CGGCTGCTAGACGACTACATTGTGCCCTTTGAATGCGGTCTTTGATTCTCGATCCCCATCTCCTGTTCA 69 FBan0033293 FBgn0053293 CG33293 3 3R cellular component unknown; GO:0008372 CG33293 CG33293 "CG12163, bs07d08.y1, bs06b05.y1, bs34a01.y1, bs35d06.y1, NEST:bs07d08, BcDNA:GH07964, NEST:bs35d06, NEST:bs06b05, NEST:bs34a01" CDMC32625 2 21 15 DAC25-B03 1-CG10348-RA_2 CG10348 GCCCTTAACACCACCGCAATGTTCGATACCTGCCGTACATCCCACACTCCTAGAAGCCATGACCAAGAA 69 FBan0010348 FBgn0032707 CG10348 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; zinc ion binding; GO:0008270; ; GO:0003735; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634; ribosome; GO:0005840 CG10348 CG10348 CDMC32625 2 22 15 DAC25-B03 1-CG10348-RA_2 CG10348 GCCCTTAACACCACCGCAATGTTCGATACCTGCCGTACATCCCACACTCCTAGAAGCCATGACCAAGAA 69 FBan0010348 FBgn0032707 CG10348 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; zinc ion binding; GO:0008270; ; GO:0003735; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634; ribosome; GO:0005840 CG10348 CG10348 CDMC32626 2 23 15 DAC25-B15 2-CG10359-RA_1 CG10359 GCCACGCTTTTGGCTTCTACTGCTCTCAGTGTCAGATCTGTGCAGGTTGAAGTGGCCAATCTTTCACGG 69 FBan0010359 FBgn0035452 CG10359 3 3L defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG10359 CG10359 CDMC32626 2 24 15 DAC25-B15 2-CG10359-RA_1 CG10359 GCCACGCTTTTGGCTTCTACTGCTCTCAGTGTCAGATCTGTGCAGGTTGAAGTGGCCAATCTTTCACGG 69 FBan0010359 FBgn0035452 CG10359 3 3L defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG10359 CG10359 CDMC32627 2 25 15 DAC25-F03 12-CG10393-RA_9 CG10393 CCCTTGAGCCTGCAAACGTAAACATGTTGACCAACAACGAGCTAATGGAGCAGTTCTACTTCCCCGACG 69 FBan0010393 FBgn0003270 amos 2 2L "nervous system development; GO:0007399; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 amos absent MD neurons and olfactory sensilla "CG10393, Tft, Roi, asolo, Amos, rolo, Tufted, Rough eye" CDMC32627 2 26 15 DAC25-F03 12-CG10393-RA_9 CG10393 CCCTTGAGCCTGCAAACGTAAACATGTTGACCAACAACGAGCTAATGGAGCAGTTCTACTTCCCCGACG 69 FBan0010393 FBgn0003270 amos 2 2L "nervous system development; GO:0007399; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 amos absent MD neurons and olfactory sensilla "CG10393, Tft, Roi, asolo, Amos, rolo, Tufted, Rough eye" CDMC32628 2 1 16 DAC25-F15 9-CG10415-RA_1 CG10415 GGGGCCGGATGGTAAGGCGCAGAAGGTCAATTACTACTTCATCAACTACAAGACCTTCGTGAACGTGGT 69 FBan0010415 FBgn0015828 TfIIEalpha 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIE complex; GO:0005673 TfIIEalpha Transcription factor IIEalpha "CG10415, CG10415, TFIIE, TfIIE, dTFIIE-L, dTFIIEL, TFIIE-L, TfIIEalpha, TFIIEalpha, Transcription factor IIEalpha" CDMC32628 2 2 16 DAC25-F15 9-CG10415-RA_1 CG10415 GGGGCCGGATGGTAAGGCGCAGAAGGTCAATTACTACTTCATCAACTACAAGACCTTCGTGAACGTGGT 69 FBan0010415 FBgn0015828 TfIIEalpha 3 3L transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIIE complex; GO:0005673 TfIIEalpha Transcription factor IIEalpha "CG10415, CG10415, TFIIE, TfIIE, dTFIIE-L, dTFIIEL, TFIIE-L, TfIIEalpha, TFIIEalpha, Transcription factor IIEalpha" CDMC32629 2 3 16 DAC25-J03 3-CG10463-RA_3 CG10463 GGCAGGAACCTCAAAAGGGAGGACTACGATGAAAATGCTCCTCCAACCACATGCAATGGCGTCAGTTCA 69 FBan0010463 FBgn0032819 CG10463 2 2L CG10463 CG10463 CDMC32629 2 4 16 DAC25-J03 3-CG10463-RA_3 CG10463 GGCAGGAACCTCAAAAGGGAGGACTACGATGAAAATGCTCCTCCAACCACATGCAATGGCGTCAGTTCA 69 FBan0010463 FBgn0032819 CG10463 2 2L CG10463 CG10463 CDMC32630 2 5 16 DAC25-J15 3-CG10477-RA_1 CG10477 ACCTTTGGGTCATCTGTGGTCACCAGTGGAGTTATCTGCGTGGAGTCCATCAACAAGAAGTCGACCTGT 69 FBan0010477 FBgn0035661 CG10477 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10477 CG10477 "NF-YB-like, SP51, anon-WO0140519.232" CDMC32630 2 6 16 DAC25-J15 3-CG10477-RA_1 CG10477 ACCTTTGGGTCATCTGTGGTCACCAGTGGAGTTATCTGCGTGGAGTCCATCAACAAGAAGTCGACCTGT 69 FBan0010477 FBgn0035661 CG10477 3 3L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10477 CG10477 "NF-YB-like, SP51, anon-WO0140519.232" CDMC32631 2 7 16 DAC25-N03 2-CG10520-RA_1 CG10520 ACTGTGTCGGACAACCCAAGCAACAGAACTAGCTCAACGGATCCGCCTAACATTCCGCGAATCACTCTT 69 FBan0010520 FBgn0003882 tub 3 3R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; response to fungi; GO:0009620; zygotic determination of dorsal/ventral axis; GO:0007352 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 tub tube "CG10520, tube" CDMC32631 2 8 16 DAC25-N03 2-CG10520-RA_1 CG10520 ACTGTGTCGGACAACCCAAGCAACAGAACTAGCTCAACGGATCCGCCTAACATTCCGCGAATCACTCTT 69 FBan0010520 FBgn0003882 tub 3 3R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; response to fungi; GO:0009620; zygotic determination of dorsal/ventral axis; GO:0007352 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737 tub tube "CG10520, tube" CDMC32632 2 9 16 DAC25-N15 18-CG10528-RB_1 CG10528 AGGACTGCAACTGGCAACTCACATCACTTACAGTTCATTGCAGTCAGCACATTTGACAAATGCCCAAAA 69 FBan0010528 FBgn0004811 fs(2)ltoPP43 2 2L eggshell formation (sensu Insecta); GO:0007304 fs(2)ltoPP43 female sterile (2) ltoPP43 "CG10528, CG10528, CG10528, LD12957, l(2)38Ac, BEST:LD12957" CDMC32632 2 10 16 DAC25-N15 18-CG10528-RB_1 CG10528 AGGACTGCAACTGGCAACTCACATCACTTACAGTTCATTGCAGTCAGCACATTTGACAAATGCCCAAAA 69 FBan0010528 FBgn0004811 fs(2)ltoPP43 2 2L eggshell formation (sensu Insecta); GO:0007304 fs(2)ltoPP43 female sterile (2) ltoPP43 "CG10528, CG10528, CG10528, LD12957, l(2)38Ac, BEST:LD12957" CDMC32633 2 11 16 DAC26-B03 18-CG15277-RA_1 CG15277 CCTCGCAGGATCTGGACGATAACATCAATATAAATGCGATTAAGGACTGCCTCATGACGCAGCGAGTGC 69 FBan0015277 FBgn0032555 CG15277 2 2L CG15277 CG15277 CDMC32633 2 12 16 DAC26-B03 18-CG15277-RA_1 CG15277 CCTCGCAGGATCTGGACGATAACATCAATATAAATGCGATTAAGGACTGCCTCATGACGCAGCGAGTGC 69 FBan0015277 FBgn0032555 CG15277 2 2L CG15277 CG15277 CDMC32634 2 13 16 DAC26-B15 23-CG15282-RA_2 CG15282 CGAGTGCAACATCGAAGCATCCTCATCTTCTGGGATATTAGTACAAATTGAATTCATTTTCAAATTCAA 69 FBan0015282 FBgn0028855 CG15282 2 2L CG15282 CG15282 "BG:DS07721.3, DS07721.3, BcDNA:RE15191" CDMC32634 2 14 16 DAC26-B15 23-CG15282-RA_2 CG15282 CGAGTGCAACATCGAAGCATCCTCATCTTCTGGGATATTAGTACAAATTGAATTCATTTTCAAATTCAA 69 FBan0015282 FBgn0028855 CG15282 2 2L CG15282 CG15282 "BG:DS07721.3, DS07721.3, BcDNA:RE15191" CDMC32635 2 15 16 DAC26-F03 11-CG1532-RA_1 CG1532 AGCGACTGGATCGAAACATCGAAAAGGATCCCTTCCAACCGAAATGACTTTCCCAGCAATCCTTGAGCA 69 FBan0001532 FBgn0031143 CG1532 X X metabolism; GO:0008152 lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.- CG1532 CG1532 CDMC32635 2 16 16 DAC26-F03 11-CG1532-RA_1 CG1532 AGCGACTGGATCGAAACATCGAAAAGGATCCCTTCCAACCGAAATGACTTTCCCAGCAATCCTTGAGCA 69 FBan0001532 FBgn0031143 CG1532 X X metabolism; GO:0008152 lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0016829 ; EC:4.-.-.- CG1532 CG1532 CDMC32636 2 17 16 DAC26-F15 2-CG15351-RA_1 CG15351 ACACACCGCACAGAAACACGTATGCAATGCCTCAGAATTATGGGCAGCAGAACTACAAGCCGCAGAGTT 69 FBgn0030045 CDMC32636 2 18 16 DAC26-F15 2-CG15351-RA_1 CG15351 ACACACCGCACAGAAACACGTATGCAATGCCTCAGAATTATGGGCAGCAGAACTACAAGCCGCAGAGTT 69 FBgn0030045 CDMC32637 2 19 16 DAC26-J03 8-CG15398-RA_1 CG15398 TCCGGTAGTGACCCGTTATGACACCTCGAAGTATCCGTTCCTGGTGTACAAGATGATGGGAACAACGGT 69 FBan0015398 FBgn0031446 CG15398 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 CG15398 CG15398 CDMC32637 2 20 16 DAC26-J03 8-CG15398-RA_1 CG15398 TCCGGTAGTGACCCGTTATGACACCTCGAAGTATCCGTTCCTGGTGTACAAGATGATGGGAACAACGGT 69 FBan0015398 FBgn0031446 CG15398 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 CG15398 CG15398 CDMC32638 2 21 16 DAC26-J15 16-CG15415-RA_1 CG15415 GGGGAAACCACCAAGGAAAATGACAAGCCAAAGGAAAGTGAAGACAACCAGGACGTAAAACCCACAATT 69 FBan0015415 FBgn0031549 CG15415 2 2L CG15415 CG15415 CDMC32638 2 22 16 DAC26-J15 16-CG15415-RA_1 CG15415 GGGGAAACCACCAAGGAAAATGACAAGCCAAAGGAAAGTGAAGACAACCAGGACGTAAAACCCACAATT 69 FBan0015415 FBgn0031549 CG15415 2 2L CG15415 CG15415 CDMC32639 2 23 16 DAC26-N03 14-CG15457-RB_2 CG15457 TGGAGTGCGTGCTCAAGAAGATCAAGTTGGTGAGTAGCCGGACGTTTGTCACAACCAGAACTAAAAGGT 69 FBan0015457 FBgn0031111 Obp19c X X sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp19c Odorant-binding protein 19c "CG15457, CG15457, CG15457, 19c, Odorant-binding protein 19c" CDMC32639 2 24 16 DAC26-N03 14-CG15457-RB_2 CG15457 TGGAGTGCGTGCTCAAGAAGATCAAGTTGGTGAGTAGCCGGACGTTTGTCACAACCAGAACTAAAAGGT 69 FBan0015457 FBgn0031111 Obp19c X X sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp19c Odorant-binding protein 19c "CG15457, CG15457, CG15457, 19c, Odorant-binding protein 19c" CDMC32640 2 25 16 DAC26-N15 15-CG15465-RA_7 CG15465 AGCTCAAGATCGCTACTCTCCAAGTTCTCATCGACCAATTCGGATAATCGCATACATCCGGAGGCTGGA 69 FBan0015465 FBgn0029746 CG15465 X X CG15465 CG15465 CDMC32640 2 26 16 DAC26-N15 15-CG15465-RA_7 CG15465 AGCTCAAGATCGCTACTCTCCAAGTTCTCATCGACCAATTCGGATAATCGCATACATCCGGAGGCTGGA 69 FBan0015465 FBgn0029746 CG15465 X X CG15465 CG15465 CDMC32641 2 1 17 DAC27-B03 3-CG9741-RA_2 CG9741 AGCTGGAGCTTCCTACGTCCAAATCTACACGGCTTTAGTGTACGAGGGACCCGCTCTTGTGGAAGACAT 69 FBan0009741 FBgn0000447 Dhod 3 3R "'de novo' pyrimidine base biosynthesis; GO:0006207; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; pyrimidine base metabolism; GO:0006206" dihydroorotate dehydrogenase activity; GO:0004152 ; EC:1.3.99.11; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004152 ; EC:1.3.99.11; dihydroorotate oxidase activity; GO:0004158 ; EC:1.3.3.1; ; GO:0004158 ; EC:1.3.3.1 mitochondrial inner membrane; GO:0005743 Dhod Dihydroorotate dehydrogenase "CG9741, dhod, l(3)s3512, DHODH, DHOD" CDMC32641 2 2 17 DAC27-B03 3-CG9741-RA_2 CG9741 AGCTGGAGCTTCCTACGTCCAAATCTACACGGCTTTAGTGTACGAGGGACCCGCTCTTGTGGAAGACAT 69 FBan0009741 FBgn0000447 Dhod 3 3R "'de novo' pyrimidine base biosynthesis; GO:0006207; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; pyrimidine base metabolism; GO:0006206" dihydroorotate dehydrogenase activity; GO:0004152 ; EC:1.3.99.11; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004152 ; EC:1.3.99.11; ; GO:0004152 ; EC:1.3.99.11; dihydroorotate oxidase activity; GO:0004158 ; EC:1.3.3.1; ; GO:0004158 ; EC:1.3.3.1 mitochondrial inner membrane; GO:0005743 Dhod Dihydroorotate dehydrogenase "CG9741, dhod, l(3)s3512, DHODH, DHOD" CDMC32642 2 3 17 DAC27-B15 1-CG9754-RA_1 CG9754 GCAAAATCCGCACTTTGACCCCATGAACCTGACTCAGCATCAGTCGAACGTTATGTTAGCCCTGCAGGA 69 FBan0009754 FBgn0034617 CG9754 2 2R CG9754 CG9754 CDMC32642 2 4 17 DAC27-B15 1-CG9754-RA_1 CG9754 GCAAAATCCGCACTTTGACCCCATGAACCTGACTCAGCATCAGTCGAACGTTATGTTAGCCCTGCAGGA 69 FBan0009754 FBgn0034617 CG9754 2 2R CG9754 CG9754 CDMC32643 2 5 17 DAC27-F03 2-CG9791-RA_1 CG9791 TGGCCATTCAAGCTACCCAAGACGATATTGGACCTGGTCCATCTTGAGGCCGTCTTTGACGTGATGGAT 69 FBan0009791 FBgn0037232 CG9791 3 3R DNA metabolism; GO:0006259 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003678; ; GO:0004004 CG9791 CG9791 CDMC32643 2 6 17 DAC27-F03 2-CG9791-RA_1 CG9791 TGGCCATTCAAGCTACCCAAGACGATATTGGACCTGGTCCATCTTGAGGCCGTCTTTGACGTGATGGAT 69 FBan0009791 FBgn0037232 CG9791 3 3R DNA metabolism; GO:0006259 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003678; ; GO:0004004 CG9791 CG9791 CDMC32644 2 7 17 DAC27-F15 1-CG9802-RB_1 CG9802 CCGCCCAAAACCTCATCCCTCAACCCACCACAACCATCTCTCGCCCCAATTATTAGTTTCGTAGGCGTA 69 FBan0009802 FBgn0015615 Cap X X chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; nucleus; GO:0005634 Cap Chromosome-associated protein "CG9802, cap, SMC3, DmSMC3/Cap, Smc3, DmSMC3" CDMC32644 2 8 17 DAC27-F15 1-CG9802-RB_1 CG9802 CCGCCCAAAACCTCATCCCTCAACCCACCACAACCATCTCTCGCCCCAATTATTAGTTTCGTAGGCGTA 69 FBan0009802 FBgn0015615 Cap X X chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; nucleus; GO:0005634 Cap Chromosome-associated protein "CG9802, cap, SMC3, DmSMC3/Cap, Smc3, DmSMC3" CDMC32645 2 9 17 DAC27-J03 13-CG9852-RA_2 CG9852 CGACTCGATCGCGACGAAAACATTCAACAGGCGTTCAAAAAACTGACAGAGGACGAAAACCCAGAGCTT 69 FBan0009852 FBgn0010340 140up 3 3R development; GO:0007275; protein transport; GO:0015031 protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane; GO:0005743 140up upstream of RpII140 "CG9852, DmRP140-upstream, l(3)Z6, DmRP140up, l(3)88Ba" CDMC32645 2 10 17 DAC27-J03 13-CG9852-RA_2 CG9852 CGACTCGATCGCGACGAAAACATTCAACAGGCGTTCAAAAAACTGACAGAGGACGAAAACCCAGAGCTT 69 FBan0009852 FBgn0010340 140up 3 3R development; GO:0007275; protein transport; GO:0015031 protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane; GO:0005743 140up upstream of RpII140 "CG9852, DmRP140-upstream, l(3)Z6, DmRP140up, l(3)88Ba" CDMC32646 2 11 17 DAC27-J15 2-CG9865-RA_3 CG9865 GGCTGGGGACACACCCTTCGCCAGGCATACTTACCGATATAGCCCAATCATGGCATATCTGCAGACTTT 69 FBan0009865 FBgn0034649 CG9865 2 2R CG9865 CG9865 CDMC32646 2 12 17 DAC27-J15 2-CG9865-RA_3 CG9865 GGCTGGGGACACACCCTTCGCCAGGCATACTTACCGATATAGCCCAATCATGGCATATCTGCAGACTTT 69 FBan0009865 FBgn0034649 CG9865 2 2R CG9865 CG9865 CDMC32647 2 13 17 DAC27-N03 9-CG9901-RA_3 CG9901 ACTACACGTTCGGTCCCAAAAAGATGGACATCGATCCGACGAACACAAAAATCCTGCTAACCGAGCCGC 69 FBan0009901 FBgn0011742 Arp14D X X cytoskeleton organization and biogenesis; GO:0007010; regulation of actin polymerization and/or depolymerization; GO:0008064 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 Arp2/3 protein complex; GO:0005885; actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp14D Actin-related protein 14D "CG9901, CG9901, arp2, ARP14D, ARP2, Arp2, Actr14D, Actin-related protein 14D" CDMC32647 2 14 17 DAC27-N03 9-CG9901-RA_3 CG9901 ACTACACGTTCGGTCCCAAAAAGATGGACATCGATCCGACGAACACAAAAATCCTGCTAACCGAGCCGC 69 FBan0009901 FBgn0011742 Arp14D X X cytoskeleton organization and biogenesis; GO:0007010; regulation of actin polymerization and/or depolymerization; GO:0008064 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 Arp2/3 protein complex; GO:0005885; actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp14D Actin-related protein 14D "CG9901, CG9901, arp2, ARP14D, ARP2, Arp2, Actr14D, Actin-related protein 14D" CDMC32648 2 15 17 DAC27-N15 3-CG9918-RC_1 CG9918 CGGCATAGTGCGGGTCATAGTGAAGCACTCATTCCAGCTGTCCACGTTCATATTCTTCCTGGCTCCGAT 69 FBan0009918 FBgn0038201 CG9918 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; ; GO:0016520 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG9918 CG9918 "anon-WO0170980.112, anon-WO0170980.113" CDMC32648 2 16 17 DAC27-N15 3-CG9918-RC_1 CG9918 CGGCATAGTGCGGGTCATAGTGAAGCACTCATTCCAGCTGTCCACGTTCATATTCTTCCTGGCTCCGAT 69 FBan0009918 FBgn0038201 CG9918 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0008188; ; GO:0004930; growth hormone-releasing hormone receptor activity; GO:0016520; ; GO:0008188; ; GO:0004930; ; GO:0016520 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG9918 CG9918 "anon-WO0170980.112, anon-WO0170980.113" CDMC32649 2 17 17 DAC28-B03 5-CG11761-RA_1 CG11761 AGTCTGAGGGCTTCCATCTGGATGTGGAGGACTATCTACTGGGCATACTGCAGTTGGCGTCGGAG 65 FBan0011761 FBgn0033528 translin 2 2R DNA recombination; GO:0006310 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 translin translin "CG11761, CG11761" CDMC32649 2 18 17 DAC28-B03 5-CG11761-RA_1 CG11761 AGTCTGAGGGCTTCCATCTGGATGTGGAGGACTATCTACTGGGCATACTGCAGTTGGCGTCGGAG 65 FBan0011761 FBgn0033528 translin 2 2R DNA recombination; GO:0006310 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 translin translin "CG11761, CG11761" CDMC32650 2 19 17 DAC28-B15 1-CG11802-RA_1 CG11802 GACCTGCCATATGTGTCCTATACAGATCGGCCAATCGGTGATTCGCCCAAGATACGCAGCAAGCC 65 FBan0011802 FBgn0030346 CG11802 X X CG11802 CG11802 CDMC32650 2 20 17 DAC28-B15 1-CG11802-RA_1 CG11802 GACCTGCCATATGTGTCCTATACAGATCGGCCAATCGGTGATTCGCCCAAGATACGCAGCAAGCC 65 FBan0011802 FBgn0030346 CG11802 X X CG11802 CG11802 CDMC32651 2 21 17 DAC28-F03 2-CG11905-RF_1 CG11905 AAGCGCAAGGGTTCCTTCAGTGAGGAGGACAACAAGATCTATGCCAGCAGCTTACTGGAACTGGG 65 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC32651 2 22 17 DAC28-F03 2-CG11905-RF_1 CG11905 AAGCGCAAGGGTTCCTTCAGTGAGGAGGACAACAAGATCTATGCCAGCAGCTTACTGGAACTGGG 65 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC32652 2 23 17 DAC28-F15 2-CG11967-RA_3 CG11967 TCAACACACTGCAGCAAATGTCCAACATTGCCTCGTACGGCTTCCTCAAGGCTCGCCTAGAATCC 65 FBan0011967 FBgn0037646 CG11967 3 3R carbon utilization; GO:0015976; metabolism; GO:0008152 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG11967 CG11967 CDMC32652 2 24 17 DAC28-F15 2-CG11967-RA_3 CG11967 TCAACACACTGCAGCAAATGTCCAACATTGCCTCGTACGGCTTCCTCAAGGCTCGCCTAGAATCC 65 FBan0011967 FBgn0037646 CG11967 3 3R carbon utilization; GO:0015976; metabolism; GO:0008152 lyase activity; GO:0016829 ; EC:4.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; zinc ion binding; GO:0008270; ; GO:0016829 ; EC:4.-.-.-; carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008270; ; GO:0004089 ; EC:4.2.1.1 CG11967 CG11967 CDMC32653 2 25 17 DAC28-J03 3-CG12052-RX_1 CG12052 TCTGCTCCCGTGTCTGTCGATCCCAGGCCTTTCTTAACGAACATATGCGCAAGGAGCACTCTGTG 65 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC32653 2 26 17 DAC28-J03 3-CG12052-RX_1 CG12052 TCTGCTCCCGTGTCTGTCGATCCCAGGCCTTTCTTAACGAACATATGCGCAAGGAGCACTCTGTG 65 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC32654 2 1 18 DAC28-J15 6-CG12096-RA_3 CG12096 TTGCCAATTTGGCCACTACTCCACAGGGCAAGATACTGCTGAACATGCACTTTAGCGGGGCCATG 65 FBan0012096 FBgn0030457 CG12096 X X CG12096 CG12096 CDMC32654 2 2 18 DAC28-J15 6-CG12096-RA_3 CG12096 TTGCCAATTTGGCCACTACTCCACAGGGCAAGATACTGCTGAACATGCACTTTAGCGGGGCCATG 65 FBan0012096 FBgn0030457 CG12096 X X CG12096 CG12096 CDMC32655 2 3 18 DAC28-N03 23-CG12158-RA_1 CG12158 CAAATTCAACATGAAGCAGTTCGCATTGTTCAGCATCTTCCTTCTAATTCTGGCTGTGGGTTTGG 65 FBan0012158 FBgn0040775 CG12158 2 2R CG12158 CG12158 "anon-WO0153538.61, BcDNA:RH45738" CDMC32655 2 4 18 DAC28-N03 23-CG12158-RA_1 CG12158 CAAATTCAACATGAAGCAGTTCGCATTGTTCAGCATCTTCCTTCTAATTCTGGCTGTGGGTTTGG 65 FBan0012158 FBgn0040775 CG12158 2 2R CG12158 CG12158 "anon-WO0153538.61, BcDNA:RH45738" CDMC32656 2 5 18 DAC28-N15 18-CG12177-RA_3 CG12177 GGTCCGGAGTTTGGGAATAACTTTCGTGATCTGTTCATTATGGGCGGCAACTATCAGGGCGTGGG 65 FBan0012177 FBgn0030510 CG12177 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12177 CG12177 CDMC32656 2 6 18 DAC28-N15 18-CG12177-RA_3 CG12177 GGTCCGGAGTTTGGGAATAACTTTCGTGATCTGTTCATTATGGGCGGCAACTATCAGGGCGTGGG 65 FBan0012177 FBgn0030510 CG12177 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12177 CG12177 CDMC32657 2 7 18 DAC29-B03 1-CG3066-RB_1 CG3066 TCCCCAATATGATCCTGCCAACAAGAACCGCATTCACGACATTGCCTTATTGCGATTAGATCGGCCCGT 69 FBan0003066 FBgn0037515 CG3066 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004263 ; EC:3.4.21.1 CG3066 CG3066 "proPO-AE, SP13, c-SP7, SP7, anon-Ryu" CDMC32657 2 8 18 DAC29-B03 1-CG3066-RB_1 CG3066 TCCCCAATATGATCCTGCCAACAAGAACCGCATTCACGACATTGCCTTATTGCGATTAGATCGGCCCGT 69 FBan0003066 FBgn0037515 CG3066 3 3R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004185 ; EC:3.4.16.-; ; GO:0004263 ; EC:3.4.21.1 CG3066 CG3066 "proPO-AE, SP13, c-SP7, SP7, anon-Ryu" CDMC32658 2 9 18 DAC29-B15 3-CG3078-RA_1 CG3078 GCGCTGGTTCCATCTGAATACTGAACAAAGCTGGTCGCAAACGAATTAAACCGGTGGGACAGGAAGCCA 69 FBan0003078 FBgn0023524 CG3078 X X GABA-B receptor activity; GO:0004965; ; GO:0004965 CG3078 CG3078 EG:30B8.6 CDMC32658 2 10 18 DAC29-B15 3-CG3078-RA_1 CG3078 GCGCTGGTTCCATCTGAATACTGAACAAAGCTGGTCGCAAACGAATTAAACCGGTGGGACAGGAAGCCA 69 FBan0003078 FBgn0023524 CG3078 X X GABA-B receptor activity; GO:0004965; ; GO:0004965 CG3078 CG3078 EG:30B8.6 CDMC32659 2 11 18 DAC29-F03 23-CG31012-RA_3 CG31012 TCGCGGGAAATTCGACAATTGGATGTTTTAATTGATCAGCGGATCAGATCAGCCGTTAGATCGAACGAT 69 FBan0031012 FBgn0027598 CG31012 3 3R receptor binding; GO:0005102; ; GO:0005102; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31012 CG31012 "CG11316, CG1408, CG11316, BcDNA:GH03163" CDMC32659 2 12 18 DAC29-F03 23-CG31012-RA_3 CG31012 TCGCGGGAAATTCGACAATTGGATGTTTTAATTGATCAGCGGATCAGATCAGCCGTTAGATCGAACGAT 69 FBan0031012 FBgn0027598 CG31012 3 3R receptor binding; GO:0005102; ; GO:0005102; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG31012 CG31012 "CG11316, CG1408, CG11316, BcDNA:GH03163" CDMC32660 2 13 18 DAC29-F15 3-CG31017-RA_1 CG31017 CACCGCTCGGTGGACCACTTTTGGATAGCTTGACTCAGAGGATGCGGGATATCACTGGCCTACAAATCC 69 FBan0031017 FBgn0051017 PH4alphaNE3 3 3R protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE3 prolyl-4-hydroxylase-alpha NE3 "CG9708, CG31017, CG9708, prolyl-4-hydroxylase-alpha NE3" CDMC32660 2 14 18 DAC29-F15 3-CG31017-RA_1 CG31017 CACCGCTCGGTGGACCACTTTTGGATAGCTTGACTCAGAGGATGCGGGATATCACTGGCCTACAAATCC 69 FBan0031017 FBgn0051017 PH4alphaNE3 3 3R protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE3 prolyl-4-hydroxylase-alpha NE3 "CG9708, CG31017, CG9708, prolyl-4-hydroxylase-alpha NE3" CDMC32661 2 15 18 DAC29-J03 11-CG31050-RA_1 CG31050 GGGGAACTCGTCGTGCATTGGACTCGTATTAGTGGAAGTACTCAGTCTCCCATCAAATTGCTGCCTCCT 69 FBan0031050 FBgn0051050 CG31050 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31050 CG31050 "bs32b08.y1, NEST:bs32b08" CDMC32661 2 16 18 DAC29-J03 11-CG31050-RA_1 CG31050 GGGGAACTCGTCGTGCATTGGACTCGTATTAGTGGAAGTACTCAGTCTCCCATCAAATTGCTGCCTCCT 69 FBan0031050 FBgn0051050 CG31050 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31050 CG31050 "bs32b08.y1, NEST:bs32b08" CDMC32662 2 17 18 DAC29-J15 1-CG31058-RA_1 CG31058 TCCCAAGCTCCAAAGTATACCCAATACCGAGTATGTGCGACCACCACAGAACTTTGTCTTGCCACCGCA 69 FBan0031058 FBgn0051058 CG31058 3 3R CG31058 CG31058 "CG5606, CG5606, CG5606, CG5606" CDMC32662 2 18 18 DAC29-J15 1-CG31058-RA_1 CG31058 TCCCAAGCTCCAAAGTATACCCAATACCGAGTATGTGCGACCACCACAGAACTTTGTCTTGCCACCGCA 69 FBan0031058 FBgn0051058 CG31058 3 3R CG31058 CG31058 "CG5606, CG5606, CG5606, CG5606" CDMC32663 2 19 18 DAC29-N03 6-CG31085-RA_5 CG31085 TGTCGGGGGAAATGATTATGGAACAATTCTGTCCAGTGCACACCGGATGCAATCAGACGATGCTGAGCT 69 FBgn0051085 CDMC32663 2 20 18 DAC29-N03 6-CG31085-RA_5 CG31085 TGTCGGGGGAAATGATTATGGAACAATTCTGTCCAGTGCACACCGGATGCAATCAGACGATGCTGAGCT 69 FBgn0051085 CDMC32664 2 21 18 DAC29-N15 2-CG31091-RA_1 CG31091 GGTATCCACTACATAGGACACTCCCAAGGCACCACGGTTATGTTTGTGCTGCTGTCCTCAAGACCGGAA 69 FBan0031091 FBgn0051091 CG31091 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31091 CG31091 CG5990 CDMC32664 2 22 18 DAC29-N15 2-CG31091-RA_1 CG31091 GGTATCCACTACATAGGACACTCCCAAGGCACCACGGTTATGTTTGTGCTGCTGTCCTCAAGACCGGAA 69 FBan0031091 FBgn0051091 CG31091 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31091 CG31091 CG5990 CDMC32665 2 23 18 DAC30-B03 3-CG1950-RA_2 CG1950 ATCTAATGGCCCTGGTCTCGGATCGTCAGCGATGCTACGAGCGGAAGATCCAAATGCTGGTCAAC 65 FBan0001950 FBgn0030370 CG1950 X X ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG1950 CG1950 CDMC32665 2 24 18 DAC30-B03 3-CG1950-RA_2 CG1950 ATCTAATGGCCCTGGTCTCGGATCGTCAGCGATGCTACGAGCGGAAGATCCAAATGCTGGTCAAC 65 FBan0001950 FBgn0030370 CG1950 X X ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG1950 CG1950 CDMC32666 2 25 18 DAC30-B15 16-CG1971-RA_1 CG1971 CCGAGATTCAAGGTCTATTGGTGGAATTTGAGCACCTCAATGAAAGCCAAGTTCTGCGGGAGAGC 65 FBan0001971 FBgn0039881 CG1971 3 3R CG1971 CG1971 CDMC32666 2 26 18 DAC30-B15 16-CG1971-RA_1 CG1971 CCGAGATTCAAGGTCTATTGGTGGAATTTGAGCACCTCAATGAAAGCCAAGTTCTGCGGGAGAGC 65 FBan0001971 FBgn0039881 CG1971 3 3R CG1971 CG1971 CDMC32667 2 1 19 DAC30-F03 1-CG2140-RA_1 CG2140 ATGCCCGCGACATGATGAAGAAGTACAAAATCGGTGAGCTGGTGGAGAGCGAAAGGACAAGCGTG 65 FBan0002140 FBgn0033189 Cyt-b5 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489 membrane; GO:0016020; microsome; GO:0005792 Cyt-b5 Cyt-b5 "CG2140, CG2140, CG2140, CG2140, 1857, l(2)01857, CYTB5, BcDNA:GH02503, BcDNA:RE66521" CDMC32667 2 2 19 DAC30-F03 1-CG2140-RA_1 CG2140 ATGCCCGCGACATGATGAAGAAGTACAAAATCGGTGAGCTGGTGGAGAGCGAAAGGACAAGCGTG 65 FBan0002140 FBgn0033189 Cyt-b5 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0005489 membrane; GO:0016020; microsome; GO:0005792 Cyt-b5 Cyt-b5 "CG2140, CG2140, CG2140, CG2140, 1857, l(2)01857, CYTB5, BcDNA:GH02503, BcDNA:RE66521" CDMC32668 2 3 19 DAC30-F15 3-CG2185-RA_1 CG2185 CTGGACCGCACCGACGTGGATCAGAAGATGTCCATACGGTTTCTCAACTAGGCTAGCTGGATGCG 65 FBan0002185 FBgn0037358 CG2185 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG2185 CG2185 CDMC32668 2 4 19 DAC30-F15 3-CG2185-RA_1 CG2185 CTGGACCGCACCGACGTGGATCAGAAGATGTCCATACGGTTTCTCAACTAGGCTAGCTGGATGCG 65 FBan0002185 FBgn0037358 CG2185 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG2185 CG2185 CDMC32669 2 5 19 DAC30-J03 17-CG2331-RA_1 CG2331 GCCCAACACCACCTGGACAGACATCGGAGGTCTGGAGAGCGTCAAGAAGGAATTGCAGGAGCTGG 65 FBan0002331 FBgn0024923 TER94 2 2R ER organization and biogenesis; GO:0007029; Golgi organization and biogenesis; GO:0007030; endoplasmic reticulum membrane fusion; GO:0016320; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; proteolysis; GO:0006508; regulation of pole plasm oskar mRNA localization; GO:0007317; rhabdomere development; GO:0042052 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- endoplasmic reticulum; GO:0005783; fusome; GO:0045169; microtubule cytoskeleton; GO:0015630; proteasome complex (sensu Eukaryota); GO:0000502 TER94 TER94 "CG2331, CG2331, l(2)03775, 22.26, 7.12, I: Intensifier of Bar, Complementation group I, ter94, Apple, Vcp, Valosin-containing protein, transitional endoplasmic reticulum ATPase, BcDNA.GM02885, Ter94, DmTER94, anon-WO2004063362.65, anon-WO2004063362.67, l(2)46Ch, l(2)46CFs, l(2)46CFf, BcDNA:GM02885, I" CDMC32669 2 6 19 DAC30-J03 17-CG2331-RA_1 CG2331 GCCCAACACCACCTGGACAGACATCGGAGGTCTGGAGAGCGTCAAGAAGGAATTGCAGGAGCTGG 65 FBan0002331 FBgn0024923 TER94 2 2R ER organization and biogenesis; GO:0007029; Golgi organization and biogenesis; GO:0007030; endoplasmic reticulum membrane fusion; GO:0016320; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; proteolysis; GO:0006508; regulation of pole plasm oskar mRNA localization; GO:0007317; rhabdomere development; GO:0042052 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- endoplasmic reticulum; GO:0005783; fusome; GO:0045169; microtubule cytoskeleton; GO:0015630; proteasome complex (sensu Eukaryota); GO:0000502 TER94 TER94 "CG2331, CG2331, l(2)03775, 22.26, 7.12, I: Intensifier of Bar, Complementation group I, ter94, Apple, Vcp, Valosin-containing protein, transitional endoplasmic reticulum ATPase, BcDNA.GM02885, Ter94, DmTER94, anon-WO2004063362.65, anon-WO2004063362.67, l(2)46Ch, l(2)46CFs, l(2)46CFf, BcDNA:GM02885, I" CDMC32670 2 7 19 DAC30-J15 1-CG2540-RA_2 CG2540 TAGTCAAAAGGGTGCTGTGTTGGACCATCTGGATTACCGGGAGAAGAACGGGTATGAGCGCTGCA 65 FBan0002540 FBgn0030411 CG2540 X X CG2540 CG2540 CDMC32670 2 8 19 DAC30-J15 1-CG2540-RA_2 CG2540 TAGTCAAAAGGGTGCTGTGTTGGACCATCTGGATTACCGGGAGAAGAACGGGTATGAGCGCTGCA 65 FBan0002540 FBgn0030411 CG2540 X X CG2540 CG2540 CDMC32671 2 9 19 DAC30-N03 3-CG2859-RA_1 CG2859 AGCATTCCAGCGGACACAGTTCCAGCAAGGACAAGAAAAACCCCAAGGACAGGAAGTACACGCTG 65 FBan0002859 FBgn0028398 Taf10 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 SAGA complex; GO:0000124; histone acetyltransferase complex; GO:0000123; transcription factor TFIID complex; GO:0005669 Taf10 TBP-associated factor 10 "CG2859, CG2859, dtafII24, TAF[[II]]24, dTAF[[II]]24, TFIID, TAF10, TAF[[II]], dmTAF10, dmTaf10, taf24, TAF, BcDNA:RE73934, Taf24: TBP-associated factor 24kD, TafII24, dTAFII24, TBP-associated factor 24kD" CDMC32671 2 10 19 DAC30-N03 3-CG2859-RA_1 CG2859 AGCATTCCAGCGGACACAGTTCCAGCAAGGACAAGAAAAACCCCAAGGACAGGAAGTACACGCTG 65 FBan0002859 FBgn0028398 Taf10 2 2L transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 SAGA complex; GO:0000124; histone acetyltransferase complex; GO:0000123; transcription factor TFIID complex; GO:0005669 Taf10 TBP-associated factor 10 "CG2859, CG2859, dtafII24, TAF[[II]]24, dTAF[[II]]24, TFIID, TAF10, TAF[[II]], dmTAF10, dmTaf10, taf24, TAF, BcDNA:RE73934, Taf24: TBP-associated factor 24kD, TafII24, dTAFII24, TBP-associated factor 24kD" CDMC32672 2 11 19 DAC30-N15 1-CG2904-RB_1 CG2904 TTGACTCATCGTTTCGAGCAAACCTCCATTCGATCCTACGCCTCGCAGGAGCTATTGTCCCAGCC 65 FBgn0025376 CDMC32672 2 12 19 DAC30-N15 1-CG2904-RB_1 CG2904 TTGACTCATCGTTTCGAGCAAACCTCCATTCGATCCTACGCCTCGCAGGAGCTATTGTCCCAGCC 65 FBgn0025376 CDMC32673 2 13 19 DAC31-B03 1-CG31693-RA_1 CG31693 GGCTCGGGGACAGAACGGTTGGATTTCTTAGGAGTTTGGAACCACAGAACCAGATTGCGGTAACCACC 68 FBan0031693 FBgn0051693 CG31693 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0005215; ; GO:0015137 integral to membrane; GO:0016021 CG31693 CG31693 BcDNA:GH25177 CDMC32673 2 14 19 DAC31-B03 1-CG31693-RA_1 CG31693 GGCTCGGGGACAGAACGGTTGGATTTCTTAGGAGTTTGGAACCACAGAACCAGATTGCGGTAACCACC 68 FBan0031693 FBgn0051693 CG31693 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005215; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0005215; ; GO:0015137 integral to membrane; GO:0016021 CG31693 CG31693 BcDNA:GH25177 CDMC32674 2 15 19 DAC31-B15 23-CG31781-RB_3 CG31781 TGTAAGCACAGCTGAGAAGAAAGGAATTTACAAAATCGAAGGAAGAAGTGAAAGAAGGAGTGAAAAAA 68 FBan0031781 FBgn0051781 CG31781 2 2L CG31781 CG31781 "CG15131, CG15132, CG15131, BcDNA:LP04536, BcDNA:GH27691" CDMC32674 2 16 19 DAC31-B15 23-CG31781-RB_3 CG31781 TGTAAGCACAGCTGAGAAGAAAGGAATTTACAAAATCGAAGGAAGAAGTGAAAGAAGGAGTGAAAAAA 68 FBan0031781 FBgn0051781 CG31781 2 2L CG31781 CG31781 "CG15131, CG15132, CG15131, BcDNA:LP04536, BcDNA:GH27691" CDMC32675 2 17 19 DAC31-F03 2-CG32136-RB_3 CG32136 CCTACTCGCCATTATCATGAGCTGCACCGGACTTGCTTCGCAACGGGCTAGGCTTAAGAAACCTGTTC 68 FBan0032136 FBgn0043550 Tsp68C 3 3L hemopoiesis; GO:0030097 integral to membrane; GO:0016021 Tsp68C Tetraspanin 68C "CG32136, Dm.Tsp68C, Tetraspanin 68C" CDMC32675 2 18 19 DAC31-F03 2-CG32136-RB_3 CG32136 CCTACTCGCCATTATCATGAGCTGCACCGGACTTGCTTCGCAACGGGCTAGGCTTAAGAAACCTGTTC 68 FBan0032136 FBgn0043550 Tsp68C 3 3L hemopoiesis; GO:0030097 integral to membrane; GO:0016021 Tsp68C Tetraspanin 68C "CG32136, Dm.Tsp68C, Tetraspanin 68C" CDMC32676 2 19 19 DAC31-F15 1-CG32300-RB_1 CG32300 GGAAAGCTCTTGGGTCCCCAAAGTGACTTGCTTTTGAGCTACACACTCCAAGCAAACGCAGATTCGGG 68 FBan0032300 FBgn0015360 oxt 3 3L D-xylose metabolism; GO:0042732; chondroitin sulfate biosynthesis; GO:0030206; chondroitin sulfate proteoglycan biosynthesis; GO:0050650; heparan sulfate proteoglycan biosynthesis; GO:0015012; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 protein xylosyltransferase activity; GO:0030158 ; EC:2.4.2.26; ; GO:0030158 ; EC:2.4.2.26; acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0030158 ; EC:2.4.2.26; ; GO:0030158 ; EC:2.4.2.26; ; GO:0008375 ; EC:2.4.1.- integral to membrane; GO:0016021; membrane; GO:0016020 oxt peptide O-xylosyltransferase "CG17771, CG17772, CG32300, CG17771, CG17772, CG17771, CG17771, CG17772, CG17771, CG17771, anon-i2" CDMC32676 2 20 19 DAC31-F15 1-CG32300-RB_1 CG32300 GGAAAGCTCTTGGGTCCCCAAAGTGACTTGCTTTTGAGCTACACACTCCAAGCAAACGCAGATTCGGG 68 FBan0032300 FBgn0015360 oxt 3 3L D-xylose metabolism; GO:0042732; chondroitin sulfate biosynthesis; GO:0030206; chondroitin sulfate proteoglycan biosynthesis; GO:0050650; heparan sulfate proteoglycan biosynthesis; GO:0015012; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 protein xylosyltransferase activity; GO:0030158 ; EC:2.4.2.26; ; GO:0030158 ; EC:2.4.2.26; acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0030158 ; EC:2.4.2.26; ; GO:0030158 ; EC:2.4.2.26; ; GO:0008375 ; EC:2.4.1.- integral to membrane; GO:0016021; membrane; GO:0016020 oxt peptide O-xylosyltransferase "CG17771, CG17772, CG32300, CG17771, CG17772, CG17771, CG17771, CG17772, CG17771, CG17771, anon-i2" CDMC32677 2 21 19 DAC31-J03 16-CG32684-RB_2 CG32684 GCACTGAGATCGCAGGAGAAGTACTACATTCTACGGCCAGAGACTTTCGAGAGCTACTTTGTGCTGTG 68 FBan0032684 FBgn0010338 alpha-Man-I X X protein amino acid N-linked glycosylation; GO:0006487 "mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" Golgi apparatus; GO:0005794; Golgi membrane; GO:0000139 alpha-Man-I alpha Mannosidase I "CG18799, CG32684, CG17809, CG18799, MAN-1, mas-1, MA12, Man'ase, DM-GI, alpha 1,2 mannosidase, alpha-Man-l, alpha-mannosidase, alpha-D-mannosidase, alpha-mannosidase, alpha-Man-I, alpha Mannosidase I" CDMC32677 2 22 19 DAC31-J03 16-CG32684-RB_2 CG32684 GCACTGAGATCGCAGGAGAAGTACTACATTCTACGGCCAGAGACTTTCGAGAGCTACTTTGTGCTGTG 68 FBan0032684 FBgn0010338 alpha-Man-I X X protein amino acid N-linked glycosylation; GO:0006487 "mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" Golgi apparatus; GO:0005794; Golgi membrane; GO:0000139 alpha-Man-I alpha Mannosidase I "CG18799, CG32684, CG17809, CG18799, MAN-1, mas-1, MA12, Man'ase, DM-GI, alpha 1,2 mannosidase, alpha-Man-l, alpha-mannosidase, alpha-D-mannosidase, alpha-mannosidase, alpha-Man-I, alpha Mannosidase I" CDMC32678 2 23 19 DAC31-J15 3-CG3305-RA_1 CG3305 CGACACTGGTTTCTCAGTTGGACACGATTGCGATAGCTCGGAAACTTCGGATGTGGTTCCCATTGCCG 68 FBan0003305 FBgn0032949 CG3305 2 2L membrane; GO:0016020 CG3305 CG3305 CDMC32678 2 24 19 DAC31-J15 3-CG3305-RA_1 CG3305 CGACACTGGTTTCTCAGTTGGACACGATTGCGATAGCTCGGAAACTTCGGATGTGGTTCCCATTGCCG 68 FBan0003305 FBgn0032949 CG3305 2 2L membrane; GO:0016020 CG3305 CG3305 CDMC32679 2 25 19 DAC31-N03 2-CG3400-RB_1 CG3400 GCCGGTCATTGCGAGGAAATGACGTACGAGCAAATCAAGGAGAAGTTCCCCGAGGAATTCAAGGCTCG 68 FBan0003400 FBgn0027621 Pfrx X X "fructose 2,6-bisphosphate metabolism; GO:0006003; fructose metabolism; GO:0006000; glycolysis; GO:0006096" "ATP binding; GO:0005524; ; GO:0005524; 6-phosphofructo-2-kinase activity; GO:0003873 ; EC:2.7.1.105; fructose-2,6-bisphosphate 2-phosphatase activity; GO:0004331 ; EC:3.1.3.46; ; GO:0003873 ; EC:2.7.1.105; ; GO:0004331 ; EC:3.1.3.46; ; GO:0003873 ; EC:2.7.1.105; ; GO:0004331 ; EC:3.1.3.46" Pfrx 6-phosphofructo-2-kinase "CG3400, fructose 2,6 bisphosphatase, phosphofructokinase" CDMC32679 2 26 19 DAC31-N03 2-CG3400-RB_1 CG3400 GCCGGTCATTGCGAGGAAATGACGTACGAGCAAATCAAGGAGAAGTTCCCCGAGGAATTCAAGGCTCG 68 FBan0003400 FBgn0027621 Pfrx X X "fructose 2,6-bisphosphate metabolism; GO:0006003; fructose metabolism; GO:0006000; glycolysis; GO:0006096" "ATP binding; GO:0005524; ; GO:0005524; 6-phosphofructo-2-kinase activity; GO:0003873 ; EC:2.7.1.105; fructose-2,6-bisphosphate 2-phosphatase activity; GO:0004331 ; EC:3.1.3.46; ; GO:0003873 ; EC:2.7.1.105; ; GO:0004331 ; EC:3.1.3.46; ; GO:0003873 ; EC:2.7.1.105; ; GO:0004331 ; EC:3.1.3.46" Pfrx 6-phosphofructo-2-kinase "CG3400, fructose 2,6 bisphosphatase, phosphofructokinase" CDMC32680 2 1 20 DAC31-N15 1-CG3495-RA_1 CG3495 TGCCTGTCCACATGCATTTTTCCGGACAAAACCAGCTACCCCATAGATGAGACCATGGTGCACAATGG 68 FBan0003495 FBgn0034794 Gmer 2 2R 'de novo' GDP-L-fucose biosynthesis; GO:0042351 "GDP-4-dehydro-D-rhamnose reductase activity; GO:0042356 ; EC:1.1.1.187; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0042356 ; EC:1.1.1.187; racemase and epimerase activity, acting on carbohydrates and derivatives; GO:0016857 ; EC:5.1.3.-; ; GO:0016616 ; EC:1.1.1.-; ; GO:0016857 ; EC:5.1.3.-" cellular component unknown; GO:0008372 Gmer "GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase" "CG3495, CG3495, CG3495, CG3495, GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase" CDMC32680 2 2 20 DAC31-N15 1-CG3495-RA_1 CG3495 TGCCTGTCCACATGCATTTTTCCGGACAAAACCAGCTACCCCATAGATGAGACCATGGTGCACAATGG 68 FBan0003495 FBgn0034794 Gmer 2 2R 'de novo' GDP-L-fucose biosynthesis; GO:0042351 "GDP-4-dehydro-D-rhamnose reductase activity; GO:0042356 ; EC:1.1.1.187; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0042356 ; EC:1.1.1.187; racemase and epimerase activity, acting on carbohydrates and derivatives; GO:0016857 ; EC:5.1.3.-; ; GO:0016616 ; EC:1.1.1.-; ; GO:0016857 ; EC:5.1.3.-" cellular component unknown; GO:0008372 Gmer "GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase" "CG3495, CG3495, CG3495, CG3495, GDP-4-keto-6-deoxy-D-mannose 3,5-epimerase/4-reductase" CDMC32681 2 3 20 DAC32-B03 23-CG15739-RA_1 CG15739 TGAATCATAGTAAGCAAACAGAGTTGACGAACTTGGGAGTTCCAGGAAAACAAAACCACTGCAACCATT 69 FBan0015739 FBgn0030347 CG15739 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG15739 CG15739 CDMC32681 2 4 20 DAC32-B03 23-CG15739-RA_1 CG15739 TGAATCATAGTAAGCAAACAGAGTTGACGAACTTGGGAGTTCCAGGAAAACAAAACCACTGCAACCATT 69 FBan0015739 FBgn0030347 CG15739 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG15739 CG15739 CDMC32682 2 5 20 DAC32-B15 23-CG15747-RA_7 CG15747 TAGGTTCACAAATATCTCGTTCACTGAGCCGGAAACTCCTAATCCAAGTTCTAATACCCACTGCAAGGG 69 FBan0015747 FBgn0030474 CG15747 X X CG15747 CG15747 CDMC32682 2 6 20 DAC32-B15 23-CG15747-RA_7 CG15747 TAGGTTCACAAATATCTCGTTCACTGAGCCGGAAACTCCTAATCCAAGTTCTAATACCCACTGCAAGGG 69 FBan0015747 FBgn0030474 CG15747 X X CG15747 CG15747 CDMC32683 2 7 20 DAC32-F03 2-CG15824-RA_1 CG15824 GGACCGACGCCTAATCGAGGAATACTACAACAGCCTGAACCGTTCCGTTTATCCAGACCACAAGCACCA 69 FBan0015824 FBgn0031292 CG15824 2 2L CG15824 CG15824 CDMC32683 2 8 20 DAC32-F03 2-CG15824-RA_1 CG15824 GGACCGACGCCTAATCGAGGAATACTACAACAGCCTGAACCGTTCCGTTTATCCAGACCACAAGCACCA 69 FBan0015824 FBgn0031292 CG15824 2 2L CG15824 CG15824 CDMC32684 2 9 20 DAC32-F15 8-CG15844-RA_3 CG15844 CGACCACTCCTCACGTTCTCATACAATATTGACGGTCCACATCCTATCCGATCAGCAGACGGACGGTGG 69 FBan0015844 FBgn0004377 Klp54D 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; signal transducer activity; GO:0004871; ; GO:0003777; ; GO:0004871; ; GO:0003777 heterotrimeric G-protein complex; GO:0005834; kinesin complex; GO:0005871 Klp54D Kinesin-like protein at 54D "CG15844, CG15844, CG15844, KLP1, Klp1" CDMC32684 2 10 20 DAC32-F15 8-CG15844-RA_3 CG15844 CGACCACTCCTCACGTTCTCATACAATATTGACGGTCCACATCCTATCCGATCAGCAGACGGACGGTGG 69 FBan0015844 FBgn0004377 Klp54D 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; microtubule-based movement; GO:0007018; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; signal transducer activity; GO:0004871; ; GO:0003777; ; GO:0004871; ; GO:0003777 heterotrimeric G-protein complex; GO:0005834; kinesin complex; GO:0005871 Klp54D Kinesin-like protein at 54D "CG15844, CG15844, CG15844, KLP1, Klp1" CDMC32685 2 11 20 DAC32-J03 2-CG15894-RA_2 CG15894 CCTTCGCATCTGGAGGAATACTGTACGGGAATCATGACGCCGCAAGAGGCCATACCAGGTGGTTATCAA 69 FBan0015894 FBgn0029864 CG15894 X X CG15894 CG15894 CDMC32685 2 12 20 DAC32-J03 2-CG15894-RA_2 CG15894 CCTTCGCATCTGGAGGAATACTGTACGGGAATCATGACGCCGCAAGAGGCCATACCAGGTGGTTATCAA 69 FBan0015894 FBgn0029864 CG15894 X X CG15894 CG15894 CDMC32686 2 13 20 DAC32-J15 18-CG15910-RA_1 CG15910 TCAGTGCCGGTTCCTTATACTCAAGGCAATCTGGCACAAAAATATGGATCACTGCGGGTTTTTGTACGA 69 FBan0015910 FBgn0030117 ric8b X X ric8b ric8b "CG15910, CR15910" CDMC32686 2 14 20 DAC32-J15 18-CG15910-RA_1 CG15910 TCAGTGCCGGTTCCTTATACTCAAGGCAATCTGGCACAAAAATATGGATCACTGCGGGTTTTTGTACGA 69 FBan0015910 FBgn0030117 ric8b X X ric8b ric8b "CG15910, CR15910" CDMC32687 2 15 20 DAC32-N03 23-CG1615-RB_5 CG1615 GCATGTATGCCACAAAGTCGATAAGGCTGCCAAAAGTCCTTAGTTGTTATGCTAATGTTATCCTTAAAC 69 FBan0001615 FBgn0017561 Ork1 X X potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 potassium channel activity; GO:0005267; inward rectifier potassium channel activity; GO:0005242; outward rectifier potassium channel activity; GO:0015271; ; GO:0005267; ; GO:0005242; ; GO:0015271 plasma membrane; GO:0005886 Ork1 Open rectifier K[+] channel 1 "CG1615, ORK1, d-ORK1, KCNK0, dORK, anon-WO0161006.1, anon-WO0161006.22, anon-WO0161006.23, Open rectifier K[+] channel 1" CDMC32687 2 16 20 DAC32-N03 23-CG1615-RB_5 CG1615 GCATGTATGCCACAAAGTCGATAAGGCTGCCAAAAGTCCTTAGTTGTTATGCTAATGTTATCCTTAAAC 69 FBan0001615 FBgn0017561 Ork1 X X potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 potassium channel activity; GO:0005267; inward rectifier potassium channel activity; GO:0005242; outward rectifier potassium channel activity; GO:0015271; ; GO:0005267; ; GO:0005242; ; GO:0015271 plasma membrane; GO:0005886 Ork1 Open rectifier K[+] channel 1 "CG1615, ORK1, d-ORK1, KCNK0, dORK, anon-WO0161006.1, anon-WO0161006.22, anon-WO0161006.23, Open rectifier K[+] channel 1" CDMC32688 2 17 20 DAC32-N15 23-CG1625-RA_2 CG1625 GCGCAAGGATTATTGTGTTAAATAGACAATTACTCGAAATAGGTGTATGGGACCTCCAAGCTAAATATT 69 FBan0001625 FBgn0033447 CG1625 2 2R cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG1625 CG1625 CDMC32688 2 18 20 DAC32-N15 23-CG1625-RA_2 CG1625 GCGCAAGGATTATTGTGTTAAATAGACAATTACTCGAAATAGGTGTATGGGACCTCCAAGCTAAATATT 69 FBan0001625 FBgn0033447 CG1625 2 2R cell cycle; GO:0007049; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 CG1625 CG1625 CDMC32689 2 19 20 DAC33-B03 9-CG11327-RA_1 CG11327 AGGAAACGGATCCGGACCTAAAACAAACTGGCAAGCCCTTGAGTTTCTTGAGGCGTCTAGTCAACCACA 69 FBan0011327 FBgn0031849 CG11327 2 2L CG11327 CG11327 CDMC32689 2 20 20 DAC33-B03 9-CG11327-RA_1 CG11327 AGGAAACGGATCCGGACCTAAAACAAACTGGCAAGCCCTTGAGTTTCTTGAGGCGTCTAGTCAACCACA 69 FBan0011327 FBgn0031849 CG11327 2 2L CG11327 CG11327 CDMC32690 2 21 20 DAC33-B15 17-CG11335-RA_2 CG11335 GCCACAGACACTACCACAGCATGAATGTTTTTGCCACCTTTGATGTTTACGACCTCAACTACCGGAAGG 69 FBan0011335 FBgn0039848 lox 3 3R cell adhesion; GO:0007155; protein modification; GO:0006464 copper ion binding; GO:0005507; structural molecule activity; GO:0005198; ; GO:0005198; scavenger receptor activity; GO:0005044; protein-lysine 6-oxidase activity; GO:0004720 ; EC:1.4.3.13; ; GO:0004720 ; EC:1.4.3.13; ; GO:0005507; ; GO:0005507; ; GO:0005044; ; GO:0004720 ; EC:1.4.3.13; ; GO:0004720 ; EC:1.4.3.13 membrane; GO:0016020 lox lysyl oxidase-like "CG11335, Dmloxl-1, dmlox-1, DmLOXL-1, lysyl oxidase-like" CDMC32690 2 22 20 DAC33-B15 17-CG11335-RA_2 CG11335 GCCACAGACACTACCACAGCATGAATGTTTTTGCCACCTTTGATGTTTACGACCTCAACTACCGGAAGG 69 FBan0011335 FBgn0039848 lox 3 3R cell adhesion; GO:0007155; protein modification; GO:0006464 copper ion binding; GO:0005507; structural molecule activity; GO:0005198; ; GO:0005198; scavenger receptor activity; GO:0005044; protein-lysine 6-oxidase activity; GO:0004720 ; EC:1.4.3.13; ; GO:0004720 ; EC:1.4.3.13; ; GO:0005507; ; GO:0005507; ; GO:0005044; ; GO:0004720 ; EC:1.4.3.13; ; GO:0004720 ; EC:1.4.3.13 membrane; GO:0016020 lox lysyl oxidase-like "CG11335, Dmloxl-1, dmlox-1, DmLOXL-1, lysyl oxidase-like" CDMC32691 2 23 20 DAC33-F03 7-CG11371-RB_1 CG11371 AGCGAGGCAATCATGAAGAACCTGTGAAGCAACTTGCCGATTCCACAACCAAGCTAAGTGCAGCAGAAT 69 FBgn0028472 CDMC32691 2 24 20 DAC33-F03 7-CG11371-RB_1 CG11371 AGCGAGGCAATCATGAAGAACCTGTGAAGCAACTTGCCGATTCCACAACCAAGCTAAGTGCAGCAGAAT 69 FBgn0028472 CDMC32692 2 25 20 DAC33-F15 14-CG11379-RA_2 CG11379 CCGTAAAACTGGAAGTGTACACCTAGGAGGACATCTGGAGATGGCTCGACTAATGGCCTTGATCATGGC 69 FBan0011379 FBgn0040362 CG11379 X X CG11379 CG11379 "bs31h12.y1, EG:BACR42I17.4" CDMC32692 2 26 20 DAC33-F15 14-CG11379-RA_2 CG11379 CCGTAAAACTGGAAGTGTACACCTAGGAGGACATCTGGAGATGGCTCGACTAATGGCCTTGATCATGGC 69 FBan0011379 FBgn0040362 CG11379 X X CG11379 CG11379 "bs31h12.y1, EG:BACR42I17.4" CDMC32693 2 1 21 DAC33-J03 23-CG11413-RA_1 CG11413 TCTGTGACAAGTTCATCACTCGGCTTTAAAAACAATCTATAAACCACTTCAGTGTAAAATGCTTATACT 69 FBan0011413 FBgn0035022 CG11413 2 2R CG11413 CG11413 "CT31865, BcDNA:RH33060" CDMC32693 2 2 21 DAC33-J03 23-CG11413-RA_1 CG11413 TCTGTGACAAGTTCATCACTCGGCTTTAAAAACAATCTATAAACCACTTCAGTGTAAAATGCTTATACT 69 FBan0011413 FBgn0035022 CG11413 2 2R CG11413 CG11413 "CT31865, BcDNA:RH33060" CDMC32694 2 3 21 DAC33-J15 3-CG11422-RA_1 CG11422 CCATTCCGGGAGAAAAGCTGAGGAACATTATGATGGAGGCTTCCAAGGGATGCATTCATCCTGAGGGCG 69 FBan0011422 FBgn0010403 Os-E 3 3R response to pheromone; GO:0019236; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; ; GO:0005550; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Os-E Olfactory-specific E "CG11422, OS-E, PBP-H1, Pheromone-binding protein Homolog 1, 83b, Obp83b, Olfactory-specific E" CDMC32694 2 4 21 DAC33-J15 3-CG11422-RA_1 CG11422 CCATTCCGGGAGAAAAGCTGAGGAACATTATGATGGAGGCTTCCAAGGGATGCATTCATCCTGAGGGCG 69 FBan0011422 FBgn0010403 Os-E 3 3R response to pheromone; GO:0019236; signal transduction; GO:0007165; transport; GO:0006810 pheromone binding; GO:0005550; ; GO:0005550; receptor binding; GO:0005102; ; GO:0005102 extracellular region; GO:0005576 Os-E Olfactory-specific E "CG11422, OS-E, PBP-H1, Pheromone-binding protein Homolog 1, 83b, Obp83b, Olfactory-specific E" CDMC32695 2 5 21 DAC33-N03 8-CG11471-RA_1 CG11471 ATGCCAGCATAATCAAGACGGCCATTAAGTCGGAGTTTGCTCCCTATTCATCTGAGCAGGCGTCCAAGA 69 FBan0011471 FBgn0027086 Aats-ile 3 3L isoleucyl-tRNA aminoacylation; GO:0006428 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; isoleucine-tRNA ligase activity; GO:0004822 ; EC:6.1.1.5; ; GO:0004822 ; EC:6.1.1.5; ; GO:0003729; ; GO:0004822 ; EC:6.1.1.5 Aats-ile Isoleucyl-tRNA synthetase "CG11471, l(3)00827, IRS, IleRS, Isoleucyl-tRNA synthetase" CDMC32695 2 6 21 DAC33-N03 8-CG11471-RA_1 CG11471 ATGCCAGCATAATCAAGACGGCCATTAAGTCGGAGTTTGCTCCCTATTCATCTGAGCAGGCGTCCAAGA 69 FBan0011471 FBgn0027086 Aats-ile 3 3L isoleucyl-tRNA aminoacylation; GO:0006428 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; isoleucine-tRNA ligase activity; GO:0004822 ; EC:6.1.1.5; ; GO:0004822 ; EC:6.1.1.5; ; GO:0003729; ; GO:0004822 ; EC:6.1.1.5 Aats-ile Isoleucyl-tRNA synthetase "CG11471, l(3)00827, IRS, IleRS, Isoleucyl-tRNA synthetase" CDMC32696 2 7 21 DAC33-N15 23-CG11488-RA_3 CG11488 CTTGATGTCCATGCTAAAAACCAGATGAATGAGGAAACGCCAAAGTCTACGTAGAAGTCAAAAAAGTCA 69 FBan0011488 FBgn0031231 mRpL10 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL10 mitochondrial ribosomal protein L10 "CG11488, CG11488, L10, mitochondrial ribosomal protein L10" CDMC32696 2 8 21 DAC33-N15 23-CG11488-RA_3 CG11488 CTTGATGTCCATGCTAAAAACCAGATGAATGAGGAAACGCCAAAGTCTACGTAGAAGTCAAAAAAGTCA 69 FBan0011488 FBgn0031231 mRpL10 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL10 mitochondrial ribosomal protein L10 "CG11488, CG11488, L10, mitochondrial ribosomal protein L10" CDMC32697 2 9 21 DAC34-B03 8-CG14459-RA_1 CG14459 ACCAATACAACCTGCAGCCATCGAATGACAGTCGCAACATCTACAACAACCCCTATATTCCGCCGCA 67 FBan0014459 FBgn0037171 CG14459 3 3L CG14459 CG14459 CDMC32697 2 10 21 DAC34-B03 8-CG14459-RA_1 CG14459 ACCAATACAACCTGCAGCCATCGAATGACAGTCGCAACATCTACAACAACCCCTATATTCCGCCGCA 67 FBan0014459 FBgn0037171 CG14459 3 3L CG14459 CG14459 CDMC32698 2 11 21 DAC34-B15 2-CG14593-RA_1 CG14593 CCATCCTACTGGGCATGCCTTCGGTTCTTTTCTCCGACATCAAGTCCTACCCTGTGTTCACAGCCAC 67 FBan0014593 FBgn0033058 CG14593 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; muscle contraction; GO:0006936 neuropeptide receptor activity; GO:0008188; ; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; bombesin receptor activity; GO:0004946; ; GO:0004946 integral to membrane; GO:0016021 CG14593 CG14593 "CG14594, anon-WO0131005.23" CDMC32698 2 12 21 DAC34-B15 2-CG14593-RA_1 CG14593 CCATCCTACTGGGCATGCCTTCGGTTCTTTTCTCCGACATCAAGTCCTACCCTGTGTTCACAGCCAC 67 FBan0014593 FBgn0033058 CG14593 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; muscle contraction; GO:0006936 neuropeptide receptor activity; GO:0008188; ; GO:0008188; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; bombesin receptor activity; GO:0004946; ; GO:0004946 integral to membrane; GO:0016021 CG14593 CG14593 "CG14594, anon-WO0131005.23" CDMC32699 2 13 21 DAC34-F03 18-CG14946-RA_5 CG14946 CTGGCGGATCGGATCAAGTCGGATGTTGGATGCATATCGGTGCTGGTTAATAATGTGGGCATAATGC 67 FBan0014946 FBgn0032405 CG14946 2 2L metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG14946 CG14946 CDMC32699 2 14 21 DAC34-F03 18-CG14946-RA_5 CG14946 CTGGCGGATCGGATCAAGTCGGATGTTGGATGCATATCGGTGCTGGTTAATAATGTGGGCATAATGC 67 FBan0014946 FBgn0032405 CG14946 2 2L metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG14946 CG14946 CDMC32700 2 15 21 DAC34-F15 2-CG15032-RA_1 CG15032 CGACCGCCATCGAATTCCATGTACCATTTCAATTACCGATCGCCGGGTAGTCCAATGCCTGTGGCTC 67 FBan0015032 FBgn0030626 CG15032 X X CG15032 CG15032 CDMC32700 2 16 21 DAC34-F15 2-CG15032-RA_1 CG15032 CGACCGCCATCGAATTCCATGTACCATTTCAATTACCGATCGCCGGGTAGTCCAATGCCTGTGGCTC 67 FBan0015032 FBgn0030626 CG15032 X X CG15032 CG15032 CDMC32701 2 17 21 DAC34-J03 2-CG15539-RA_1 CG15539 CCACGACGCGGACCCCTTTCAGGTTTTGAACTACGGAATAGGCGGTTTCTACGGCATCCACTTTGAC 67 FBan0015539 FBgn0039782 CG15539 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG15539 CG15539 "CG15539-NE4, CG15539-NE4" CDMC32701 2 18 21 DAC34-J03 2-CG15539-RA_1 CG15539 CCACGACGCGGACCCCTTTCAGGTTTTGAACTACGGAATAGGCGGTTTCTACGGCATCCACTTTGAC 67 FBan0015539 FBgn0039782 CG15539 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG15539 CG15539 "CG15539-NE4, CG15539-NE4" CDMC32702 2 19 21 DAC34-J15 3-CG15632-RB_1 CG15632 CGATCTGGCTTAGTTCCGTGGAGATAAGCAGCTAAGTGACTTTGTCCCGACATCCCATGGCCCATGG 67 FBan0015632 FBgn0031623 Taf12L 2 2L male meiosis; GO:0007140; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf12L TBP-associated factor 30kD subunit alpha-2 "CG15632, CG15632, CG15632, TAF30alpha-2, TFIID, Taf30alpha-2, dmTAF12L, TAF[[II]], rye, dTAF[[II]]30alpha-2, dmTAF12b, dTAF[[II]]30a, ryan express, TAF, dTAF12L, dTAF12" CDMC32702 2 20 21 DAC34-J15 3-CG15632-RB_1 CG15632 CGATCTGGCTTAGTTCCGTGGAGATAAGCAGCTAAGTGACTTTGTCCCGACATCCCATGGCCCATGG 67 FBan0015632 FBgn0031623 Taf12L 2 2L male meiosis; GO:0007140; spermatogenesis; GO:0007283; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669 Taf12L TBP-associated factor 30kD subunit alpha-2 "CG15632, CG15632, CG15632, TAF30alpha-2, TFIID, Taf30alpha-2, dmTAF12L, TAF[[II]], rye, dTAF[[II]]30alpha-2, dmTAF12b, dTAF[[II]]30a, ryan express, TAF, dTAF12L, dTAF12" CDMC32703 2 21 21 DAC34-N03 3-CG16719-RA_2 CG16719 GCAAAGATTGTCAAGCGCAGTCATCCTCGTCTGGTGGATCTGCACAACTATACGCCCAAGAGCAGCG 67 FBan0016719 FBgn0036029 CG16719 3 3L mesoderm development; GO:0007498 CG16719 CG16719 CDMC32703 2 22 21 DAC34-N03 3-CG16719-RA_2 CG16719 GCAAAGATTGTCAAGCGCAGTCATCCTCGTCTGGTGGATCTGCACAACTATACGCCCAAGAGCAGCG 67 FBan0016719 FBgn0036029 CG16719 3 3L mesoderm development; GO:0007498 CG16719 CG16719 CDMC32704 2 23 21 DAC34-N15 2-CG1698-RA_1 CG1698 GGCGGTCGTCACTCCTCTGCTAATGCTCACCATTCTCATCTACACCTTGGTTCTGTACGAGCCCCTC 67 FBan0001698 FBgn0033443 CG1698 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG1698 CG1698 CDMC32704 2 24 21 DAC34-N15 2-CG1698-RA_1 CG1698 GGCGGTCGTCACTCCTCTGCTAATGCTCACCATTCTCATCTACACCTTGGTTCTGTACGAGCCCCTC 67 FBan0001698 FBgn0033443 CG1698 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG1698 CG1698 CDMC32705 2 25 21 DAC35-B03 1-CG11753-RA_2 CG11753 GCCAAGCTCTGTCTGGACTTTAGTTGCACCTTCCACGTGCTGCATTTGCTGATCTGCTGGTGGTACAAC 69 FBan0011753 FBgn0037603 CG11753 3 3R CG11753 CG11753 CDMC32705 2 26 21 DAC35-B03 1-CG11753-RA_2 CG11753 GCCAAGCTCTGTCTGGACTTTAGTTGCACCTTCCACGTGCTGCATTTGCTGATCTGCTGGTGGTACAAC 69 FBan0011753 FBgn0037603 CG11753 3 3R CG11753 CG11753 CDMC32706 2 1 22 DAC35-B15 18-CG11762-RA_2 CG11762 ACGACTCTTCGTCGGGTGATGAAGATACCAATGACAATTCGGAACTGGAATCGGAAAAATGCGCATTCA 69 FBan0011762 FBgn0037618 CG11762 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11762 CG11762 i36 CDMC32706 2 2 22 DAC35-B15 18-CG11762-RA_2 CG11762 ACGACTCTTCGTCGGGTGATGAAGATACCAATGACAATTCGGAACTGGAATCGGAAAAATGCGCATTCA 69 FBan0011762 FBgn0037618 CG11762 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11762 CG11762 i36 CDMC32707 2 3 22 DAC35-F03 23-CG11798-RB_3 CG11798 AAAACGCGGAATAGAAAGTCGGCGAGAACAAGATGGAAACACAAGAACAACTTACAAAATACTCAAAGA 69 FBgn0033992 CDMC32707 2 4 22 DAC35-F03 23-CG11798-RB_3 CG11798 AAAACGCGGAATAGAAAGTCGGCGAGAACAAGATGGAAACACAAGAACAACTTACAAAATACTCAAAGA 69 FBgn0033992 CDMC32708 2 5 22 DAC35-F15 18-CG11815-RA_3 CG11815 GCTGCCCTACAAGAACCCAACTTACTTTGGCTATCATCGATTCTCATTTATGGAACTCACGGTCACGGC 69 FBan0011815 FBgn0035299 CG11815 3 3L CG11815 CG11815 CDMC32708 2 6 22 DAC35-F15 18-CG11815-RA_3 CG11815 GCTGCCCTACAAGAACCCAACTTACTTTGGCTATCATCGATTCTCATTTATGGAACTCACGGTCACGGC 69 FBan0011815 FBgn0035299 CG11815 3 3L CG11815 CG11815 CDMC32709 2 7 22 DAC35-J03 3-CG11859-RA_6 CG11859 GCGTGAGGATGATTTGGATGCCGAGGTACATTGCACAGGCTATGGCTTCACTAAGGAGATGGAGCAGGA 69 FBan0011859 FBgn0039306 CG11859 3 3R protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG11859 CG11859 CDMC32709 2 8 22 DAC35-J03 3-CG11859-RA_6 CG11859 GCGTGAGGATGATTTGGATGCCGAGGTACATTGCACAGGCTATGGCTTCACTAAGGAGATGGAGCAGGA 69 FBan0011859 FBgn0039306 CG11859 3 3R protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG11859 CG11859 CDMC32710 2 9 22 DAC35-J15 3-CG11874-RA_1 CG11874 GCGTCCGCGACACTAACTGAAAGCCGAATGGAGTTGGTGCATTCATGCCGCAACTATCGTTTAACTCGT 69 FBan0011874 FBgn0039634 CG11874 3 3R protein amino acid N-linked glycosylation; GO:0006487 "calcium ion binding; GO:0005509; ; GO:0005509; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG11874 CG11874 CDMC32710 2 10 22 DAC35-J15 3-CG11874-RA_1 CG11874 GCGTCCGCGACACTAACTGAAAGCCGAATGGAGTTGGTGCATTCATGCCGCAACTATCGTTTAACTCGT 69 FBan0011874 FBgn0039634 CG11874 3 3R protein amino acid N-linked glycosylation; GO:0006487 "calcium ion binding; GO:0005509; ; GO:0005509; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG11874 CG11874 CDMC32711 2 11 22 DAC35-N03 3-CG11906-RA_1 CG11906 GCTACCAGACGGACACCCTAGTGGCTCTAATGAAGCACGACTACATGGAGCACTGGAAGATGAGCTGGT 69 FBan0011906 FBgn0034425 CG11906 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11906 CG11906 "Gene 6, 11906" CDMC32711 2 12 22 DAC35-N03 3-CG11906-RA_1 CG11906 GCTACCAGACGGACACCCTAGTGGCTCTAATGAAGCACGACTACATGGAGCACTGGAAGATGAGCTGGT 69 FBan0011906 FBgn0034425 CG11906 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11906 CG11906 "Gene 6, 11906" CDMC32712 2 13 22 DAC35-N15 2-CG11913-RA_1 CG11913 CCGGGCCAAGTACATACGCACCATGTTTTCGGAGATAATGAGGCTGACGAATCACACGATGGCCATTGG 69 FBan0011913 FBgn0039331 CG11913 3 3R "cell wall modification; GO:0042545; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; pectinesterase activity; GO:0030599 ; EC:3.1.1.11; ; GO:0030599 ; EC:3.1.1.11 cell wall; GO:0005618; respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11913 CG11913 "CG111913, CG111913" CDMC32712 2 14 22 DAC35-N15 2-CG11913-RA_1 CG11913 CCGGGCCAAGTACATACGCACCATGTTTTCGGAGATAATGAGGCTGACGAATCACACGATGGCCATTGG 69 FBan0011913 FBgn0039331 CG11913 3 3R "cell wall modification; GO:0042545; mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; pectinesterase activity; GO:0030599 ; EC:3.1.1.11; ; GO:0030599 ; EC:3.1.1.11 cell wall; GO:0005618; respiratory chain complex I (sensu Eukaryota); GO:0005747 CG11913 CG11913 "CG111913, CG111913" CDMC32713 2 15 22 DAC36-B03 23-CG8607-RA_2 CG8607 GGCAAACTACTTTGGTTTTCCTACCATTCGCTTCGCTTTAAAATCAAATATGCAACGATTCCTGAAGGT 69 FBan0008607 FBgn0035760 CG8607 3 3L CG8607 CG8607 CDMC32713 2 16 22 DAC36-B03 23-CG8607-RA_2 CG8607 GGCAAACTACTTTGGTTTTCCTACCATTCGCTTCGCTTTAAAATCAAATATGCAACGATTCCTGAAGGT 69 FBan0008607 FBgn0035760 CG8607 3 3L CG8607 CG8607 CDMC32714 2 17 22 DAC36-B15 23-CG8620-RA_2 CG8620 TCCGCAGCAGTTATATCCAGTTCAGAGAAACAGTAGTTAATCAGTAATTAAAGTGTTGAGTGAATTTCT 69 FBan0008620 FBgn0040837 CG8620 3 3L CG8620 CG8620 CDMC32714 2 18 22 DAC36-B15 23-CG8620-RA_2 CG8620 TCCGCAGCAGTTATATCCAGTTCAGAGAAACAGTAGTTAATCAGTAATTAAAGTGTTGAGTGAATTTCT 69 FBan0008620 FBgn0040837 CG8620 3 3L CG8620 CG8620 CDMC32715 2 19 22 DAC36-F03 23-CG8651-RA_7 CG8651 TTGTTTGCCTTGATTGAAGCTCAAGCGTAATCATAATTTGTAACGCCTATCTTTAGTTCGGCTCCCTTG 69 FBan0008651 FBgn0003862 trx 3 3R chromatin assembly or disassembly; GO:0006333; chromatin-mediated maintenance of transcription; GO:0048096; germ cell migration; GO:0008354; hemopoiesis; GO:0030097; histone methylation; GO:0016571; mesoderm development; GO:0007498; protein ubiquitination; GO:0016567; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; contributes_to histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ; GO:0042800; ; GO:0042800; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 histone methyltransferase complex; GO:0035097; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 trx trithorax "CG8651, Rg-bx, l(3)j14A6, l(3)s5452, 4720, 4733, TRX, NR0A5, trxI and trxII, DMTRXIII, Trx, trx-g, R-bx: Regulator of bithorax, l(3)bx[v], l(3)j3A2, Regulator of bithorax, trithorax" CDMC32715 2 20 22 DAC36-F03 23-CG8651-RA_7 CG8651 TTGTTTGCCTTGATTGAAGCTCAAGCGTAATCATAATTTGTAACGCCTATCTTTAGTTCGGCTCCCTTG 69 FBan0008651 FBgn0003862 trx 3 3R chromatin assembly or disassembly; GO:0006333; chromatin-mediated maintenance of transcription; GO:0048096; germ cell migration; GO:0008354; hemopoiesis; GO:0030097; histone methylation; GO:0016571; mesoderm development; GO:0007498; protein ubiquitination; GO:0016567; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; contributes_to histone lysine N-methyltransferase activity (H3-K4 specific); GO:0042800; ; GO:0042800; ; GO:0042800; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 histone methyltransferase complex; GO:0035097; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 trx trithorax "CG8651, Rg-bx, l(3)j14A6, l(3)s5452, 4720, 4733, TRX, NR0A5, trxI and trxII, DMTRXIII, Trx, trx-g, R-bx: Regulator of bithorax, l(3)bx[v], l(3)j3A2, Regulator of bithorax, trithorax" CDMC32716 2 21 22 DAC36-F15 2-CG8665-RA_1 CG8665 GGCGCAAAGCTGGTGTACGGAGGATGTCGAGTCCCAAACCTCAAGGGATATTTTTTCACTCCCACAGTG 69 FBan0008665 FBgn0032945 CG8665 2 2L 10-formyltetrahydrofolate catabolism; GO:0009258; amino acid catabolism; GO:0009063; biosynthesis; GO:0009058; one-carbon compound metabolism; GO:0006730 "formyltetrahydrofolate dehydrogenase activity; GO:0016155 ; EC:1.5.1.6; ; GO:0016155 ; EC:1.5.1.6; cofactor binding; GO:0048037; ; GO:0048037; hydroxymethyl-, formyl- and related transferase activity; GO:0016742 ; EC:2.1.2.-; ; GO:0016742 ; EC:2.1.2.-" cytoplasm; GO:0005737 CG8665 CG8665 CDMC32716 2 22 22 DAC36-F15 2-CG8665-RA_1 CG8665 GGCGCAAAGCTGGTGTACGGAGGATGTCGAGTCCCAAACCTCAAGGGATATTTTTTCACTCCCACAGTG 69 FBan0008665 FBgn0032945 CG8665 2 2L 10-formyltetrahydrofolate catabolism; GO:0009258; amino acid catabolism; GO:0009063; biosynthesis; GO:0009058; one-carbon compound metabolism; GO:0006730 "formyltetrahydrofolate dehydrogenase activity; GO:0016155 ; EC:1.5.1.6; ; GO:0016155 ; EC:1.5.1.6; cofactor binding; GO:0048037; ; GO:0048037; hydroxymethyl-, formyl- and related transferase activity; GO:0016742 ; EC:2.1.2.-; ; GO:0016742 ; EC:2.1.2.-" cytoplasm; GO:0005737 CG8665 CG8665 CDMC32717 2 23 22 DAC36-J03 2-CG8701-RA_2 CG8701 GGGGCGTTGAATGCAACTGCCTAGATGTTCCAAGCTCCTGTGACCTGATTCGTGAGCTGAAGAAGTTCG 69 FBan0008701 FBgn0033287 CG8701 2 2R CG8701 CG8701 anon-WO0140519.78 CDMC32717 2 24 22 DAC36-J03 2-CG8701-RA_2 CG8701 GGGGCGTTGAATGCAACTGCCTAGATGTTCCAAGCTCCTGTGACCTGATTCGTGAGCTGAAGAAGTTCG 69 FBan0008701 FBgn0033287 CG8701 2 2R CG8701 CG8701 anon-WO0140519.78 CDMC32718 2 25 22 DAC36-J15 3-CG8712-RB_2 CG8712 GGAGCGAATCACCATGCAGAACGTTATTCAAGATCGAAGGTGCTGTGCAGAGAGCATGTTGTTGCGGGA 69 FBan0008712 FBgn0033258 CG8712 2 2R CG8712 CG8712 CDMC32718 2 26 22 DAC36-J15 3-CG8712-RB_2 CG8712 GGAGCGAATCACCATGCAGAACGTTATTCAAGATCGAAGGTGCTGTGCAGAGAGCATGTTGTTGCGGGA 69 FBan0008712 FBgn0033258 CG8712 2 2R CG8712 CG8712 CDMC32719 2 1 23 DAC36-N03 11-CG8743-RA_1 CG8743 CCCAGCCCAACAGTGGTTACACCAGCCTTTCTAGTATTATGAAGTAACTGGGTGCGCTATGTCGACCCG 69 FBan0008743 FBgn0036904 CG8743 3 3L calcium ion transport; GO:0006816; lipid metabolism; GO:0006629; lipid transport; GO:0006869 calcium channel activity; GO:0005262; ; GO:0005262 membrane; GO:0016020 CG8743 CG8743 CT25240 CDMC32719 2 2 23 DAC36-N03 11-CG8743-RA_1 CG8743 CCCAGCCCAACAGTGGTTACACCAGCCTTTCTAGTATTATGAAGTAACTGGGTGCGCTATGTCGACCCG 69 FBan0008743 FBgn0036904 CG8743 3 3L calcium ion transport; GO:0006816; lipid metabolism; GO:0006629; lipid transport; GO:0006869 calcium channel activity; GO:0005262; ; GO:0005262 membrane; GO:0016020 CG8743 CG8743 CT25240 CDMC32720 2 3 23 DAC36-N15 14-CG8760-RA_1 CG8760 TCCGTTGGGACCAAGTCAATTGAAATTCAGGCAGACCAAAGACAATCAGCAACAGGAATACGGCTGTGA 69 FBan0008760 FBgn0036383 CG8760 3 3L protein binding; GO:0005515; ; GO:0005515 CG8760 CG8760 CDMC32720 2 4 23 DAC36-N15 14-CG8760-RA_1 CG8760 TCCGTTGGGACCAAGTCAATTGAAATTCAGGCAGACCAAAGACAATCAGCAACAGGAATACGGCTGTGA 69 FBan0008760 FBgn0036383 CG8760 3 3L protein binding; GO:0005515; ; GO:0005515 CG8760 CG8760 CDMC32721 2 5 23 DAC37-B03 23-CG8993-RA_1 CG8993 TCTTGTCATTATTTTGCAATCAATCGCTGAACTTTTTGCACTGAGAAATTGTAGAAAATAAGCCATGCA 69 FBan0008993 FBgn0035334 CG8993 3 3L electron transport; GO:0006118; sulfur metabolism; GO:0006790 electron transporter activity; GO:0005489; thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG8993 CG8993 thioredoxin CDMC32721 2 6 23 DAC37-B03 23-CG8993-RA_1 CG8993 TCTTGTCATTATTTTGCAATCAATCGCTGAACTTTTTGCACTGAGAAATTGTAGAAAATAAGCCATGCA 69 FBan0008993 FBgn0035334 CG8993 3 3L electron transport; GO:0006118; sulfur metabolism; GO:0006790 electron transporter activity; GO:0005489; thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG8993 CG8993 thioredoxin CDMC32722 2 7 23 DAC37-B15 2-CG9000-RA_2 CG9000 GGCGCGGAAATATGGTCTGGACCAGGAGAAATTCGGCATCTTCAAAGCTGTTGTTATGGATGTGGCCCT 69 FBan0009000 FBgn0034176 CG9000 2 2R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 membrane; GO:0016020 CG9000 CG9000 CDMC32722 2 8 23 DAC37-B15 2-CG9000-RA_2 CG9000 GGCGCGGAAATATGGTCTGGACCAGGAGAAATTCGGCATCTTCAAAGCTGTTGTTATGGATGTGGCCCT 69 FBan0009000 FBgn0034176 CG9000 2 2R cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 membrane; GO:0016020 CG9000 CG9000 CDMC32723 2 9 23 DAC37-F03 23-CG9032-RB_1 CG9032 ACCAGAAGCCTTTTAATTGGGATCAGTGATAGGTTTCTTGCTATAATTTTGTCAACGCATATTTGTATA 69 FBan0009032 FBgn0014391 sun X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" sun stunted "CG9032, CG9032, l(1)XV, BcDNA:RE19513, BcDNA:RH48911, l(1)13Fe, stunted" CDMC32723 2 10 23 DAC37-F03 23-CG9032-RB_1 CG9032 ACCAGAAGCCTTTTAATTGGGATCAGTGATAGGTTTCTTGCTATAATTTTGTCAACGCATATTTGTATA 69 FBan0009032 FBgn0014391 sun X X ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" sun stunted "CG9032, CG9032, l(1)XV, BcDNA:RE19513, BcDNA:RH48911, l(1)13Fe, stunted" CDMC32724 2 11 23 DAC37-F15 23-CG9042-RC_4 CG9042 TTTTAATCGGACTGCGTAGACACTAGAATTAAATGATTACCCAAAGGTCGTTGCAAAAATAAAAGCTGA 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC32724 2 12 23 DAC37-F15 23-CG9042-RC_4 CG9042 TTTTAATCGGACTGCGTAGACACTAGAATTAAATGATTACCCAAAGGTCGTTGCAAAAATAAAAGCTGA 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC32725 2 13 23 DAC37-J03 6-CG9081-RA_1 CG9081 TGGCCGAATTGGTGACTAAAAGTGGAAATGGCATTCGACTTCGGATCTTGCCACGGGATGAGAACGGAA 69 FBan0009081 FBgn0030615 Cyp4s3 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4s3 Cyp4s3 "CG9081, 4s3" CDMC32725 2 14 23 DAC37-J03 6-CG9081-RA_1 CG9081 TGGCCGAATTGGTGACTAAAAGTGGAAATGGCATTCGACTTCGGATCTTGCCACGGGATGAGAACGGAA 69 FBan0009081 FBgn0030615 Cyp4s3 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4s3 Cyp4s3 "CG9081, 4s3" CDMC32726 2 15 23 DAC37-J15 3-CG9091-RA_1 CG9091 TAGGAGGCTCTGTGTGTCCCAAGATGTATATCCCACACCGGGCTATATGGACGGAGATAGCAGCTGCTC 69 FBan0009091 FBgn0030616 RpL37a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL37a Ribosomal protein L37a "CG9091, RpL37, Ribosomal protein L37a" CDMC32726 2 16 23 DAC37-J15 3-CG9091-RA_1 CG9091 TAGGAGGCTCTGTGTGTCCCAAGATGTATATCCCACACCGGGCTATATGGACGGAGATAGCAGCTGCTC 69 FBan0009091 FBgn0030616 RpL37a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL37a Ribosomal protein L37a "CG9091, RpL37, Ribosomal protein L37a" CDMC32727 2 17 23 DAC37-N03 3-CG9128-RA_1 CG9128 CCCATCTCCTTTCGAGACCCATGACGTTAGTGTCGTCTAGCAGAGTCACTGGGAACTACCTCTGCAGCT 69 FBan0009128 FBgn0035195 Sac1 3 3L "dorsal closure; GO:0007391; dorsal closure, amnioserosa morphology change; GO:0046664; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; negative regulation of JNK cascade; GO:0046329" polyphosphoinositide phosphatase activity; GO:0017120; ; GO:0017120 Sac1 Sac1 "CG9128, CG9128, CG9128, dsac1, sac1" CDMC32727 2 18 23 DAC37-N03 3-CG9128-RA_1 CG9128 CCCATCTCCTTTCGAGACCCATGACGTTAGTGTCGTCTAGCAGAGTCACTGGGAACTACCTCTGCAGCT 69 FBan0009128 FBgn0035195 Sac1 3 3L "dorsal closure; GO:0007391; dorsal closure, amnioserosa morphology change; GO:0046664; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; negative regulation of JNK cascade; GO:0046329" polyphosphoinositide phosphatase activity; GO:0017120; ; GO:0017120 Sac1 Sac1 "CG9128, CG9128, CG9128, dsac1, sac1" CDMC32728 2 19 23 DAC37-N15 3-CG9140-RA_4 CG9140 GGCGGCTCTTCCACCCCCATCATACCCAAAAATGTCTGCGACGATGTTATCATGGACTTCGATGGCCTA 69 FBan0009140 FBgn0031771 CG9140 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9140 CG9140 CDMC32728 2 20 23 DAC37-N15 3-CG9140-RA_4 CG9140 GGCGGCTCTTCCACCCCCATCATACCCAAAAATGTCTGCGACGATGTTATCATGGACTTCGATGGCCTA 69 FBan0009140 FBgn0031771 CG9140 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG9140 CG9140 CDMC32729 2 21 23 DAC38-B03 3-CG5525-RA_1 CG5525 ACCAACAAGTTTGTGAAGATCACCGGCATTCAGAACATGGGACGCACTGTCTCGATCATCTGCCGC 66 FBan0005525 FBgn0032444 CG5525 2 2L protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG5525 CG5525 CDMC32729 2 22 23 DAC38-B03 3-CG5525-RA_1 CG5525 ACCAACAAGTTTGTGAAGATCACCGGCATTCAGAACATGGGACGCACTGTCTCGATCATCTGCCGC 66 FBan0005525 FBgn0032444 CG5525 2 2L protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0042623; ; GO:0051082" chaperonin-containing T-complex; GO:0005832 CG5525 CG5525 CDMC32730 2 23 23 DAC38-B15 2-CG5718-RA_2 CG5718 AAGGGTCGTGTGGTCACCATCGATGAGAATGGCAAGGAACAGGTTGTCAAGGGACTGTACTCCTGC 66 FBan0005718 FBgn0036222 CG5718 3 3L carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG5718 CG5718 CDMC32730 2 24 23 DAC38-B15 2-CG5718-RA_2 CG5718 AAGGGTCGTGTGGTCACCATCGATGAGAATGGCAAGGAACAGGTTGTCAAGGGACTGTACTCCTGC 66 FBan0005718 FBgn0036222 CG5718 3 3L carbohydrate metabolism; GO:0005975; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 succinate dehydrogenase (ubiquinone) activity; GO:0008177 ; EC:1.3.5.1; ; GO:0008177 ; EC:1.3.5.1; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 respiratory chain complex II (sensu Eukaryota); GO:0005749 CG5718 CG5718 CDMC32731 2 25 23 DAC38-F03 1-CG6211-RA_1 CG6211 CGCGGTCGTGACGATGTCATTCCACTGCACACCATTAGCGGCAATGATATCATTCTGACTGGCTGC 66 FBan0006211 FBgn0030627 gce X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 transcription factor activity; GO:0003700; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 gce germ cell-expressed bHLH-PAS "CG6211, CG6211, CG6211, CG6211, germ cell-expressed bHLH-PAS" CDMC32731 2 26 23 DAC38-F03 1-CG6211-RA_1 CG6211 CGCGGTCGTGACGATGTCATTCCACTGCACACCATTAGCGGCAATGATATCATTCTGACTGGCTGC 66 FBan0006211 FBgn0030627 gce X X regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 transcription factor activity; GO:0003700; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 gce germ cell-expressed bHLH-PAS "CG6211, CG6211, CG6211, CG6211, germ cell-expressed bHLH-PAS" CDMC32732 2 1 24 DAC38-F15 3-CG6322-RA_2 CG6322 CAGCCGGTCTATACCATTCCTGCGCACACCAATCTGATTTCGGACGTGAAGTACCAGCAGGAGTGC 66 FBan0006322 FBgn0036733 CG6322 3 3L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U4; GO:0005687; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG6322 CG6322 CDMC32732 2 2 24 DAC38-F15 3-CG6322-RA_2 CG6322 CAGCCGGTCTATACCATTCCTGCGCACACCAATCTGATTTCGGACGTGAAGTACCAGCAGGAGTGC 66 FBan0006322 FBgn0036733 CG6322 3 3L "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U4; GO:0005687; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG6322 CG6322 CDMC32733 2 3 24 DAC38-J03 3-CG6716-RA_5 CG6716 GCACCACCATCAGTTCTACAATCCCAGCGCTAACACAGCCAGCTACATAATGCCGGGTGAGAATGG 66 FBan0006716 FBgn0003145 prd 2 2L ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 prd paired "CG6716, Prd, pr" CDMC32733 2 4 24 DAC38-J03 3-CG6716-RA_5 CG6716 GCACCACCATCAGTTCTACAATCCCAGCGCTAACACAGCCAGCTACATAATGCCGGGTGAGAATGG 66 FBan0006716 FBgn0003145 prd 2 2L ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; periodic partitioning by pair rule gene; GO:0007366; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 prd paired "CG6716, Prd, pr" CDMC32734 2 5 24 DAC38-J15 2-CG6864-RA_3 CG6864 TCACAACCGACCTGCACGGATCAGACGTTGATAGTACCAATGCAACCTCAAGTTCAGTCGCCCGTA 66 FBan0006864 FBgn0020399 Mst89B 3 3R Mst89B Mst89B CG6864 CDMC32734 2 6 24 DAC38-J15 2-CG6864-RA_3 CG6864 TCACAACCGACCTGCACGGATCAGACGTTGATAGTACCAATGCAACCTCAAGTTCAGTCGCCCGTA 66 FBan0006864 FBgn0020399 Mst89B 3 3R Mst89B Mst89B CG6864 CDMC32735 2 7 24 DAC38-N03 2-CG7352-RA_1 CG7352 TCAGGTGATGAATGACCGGGAGCTGAGCCTTCTGATGCAGAAGCAAATCCAGGAAGAGGATCGAGC 66 FBan0007352 FBgn0037581 CG7352 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0005200; ; GO:0005198 CG7352 CG7352 CDMC32735 2 8 24 DAC38-N03 2-CG7352-RA_1 CG7352 TCAGGTGATGAATGACCGGGAGCTGAGCCTTCTGATGCAGAAGCAAATCCAGGAAGAGGATCGAGC 66 FBan0007352 FBgn0037581 CG7352 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0005200; ; GO:0005198 CG7352 CG7352 CDMC32736 2 9 24 DAC38-N15 3-CG7584-RA_2 CG7584 GGAGATCAGGAAAATCCGCGTTGATTGCCTCAAGGAGAATCCGCTGAGCAACGACCAGATCTCCCA 66 FBan0007584 FBgn0039682 Obp99c 3 3R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp99c Odorant-binding protein 99c "CG7584, CG7584, CG7584, CG7584, CG7584, 99c, Obp99b, Odorant-binding protein 99c" CDMC32736 2 10 24 DAC38-N15 3-CG7584-RA_2 CG7584 GGAGATCAGGAAAATCCGCGTTGATTGCCTCAAGGAGAATCCGCTGAGCAACGACCAGATCTCCCA 66 FBan0007584 FBgn0039682 Obp99c 3 3R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp99c Odorant-binding protein 99c "CG7584, CG7584, CG7584, CG7584, CG7584, 99c, Obp99b, Odorant-binding protein 99c" CDMC32737 2 11 24 DAC39-B03 23-CG32041-RA_3 CG32041 ATGAACTGGACAAGGCTCTAAATCTGGATGGATCTGCTTTTAAAAACAAGTACGGAAGATCGAAGCCGG 69 FBgn0052041 CDMC32737 2 12 24 DAC39-B03 23-CG32041-RA_3 CG32041 ATGAACTGGACAAGGCTCTAAATCTGGATGGATCTGCTTTTAAAAACAAGTACGGAAGATCGAAGCCGG 69 FBgn0052041 CDMC32738 2 13 24 DAC39-B15 23-CG32046-RA_10 CG32046 CTGATTTGGATACCAGTTTTCAGTTCTTCAGTTATCGAACCACAACTAATTTGTCTTCTGACTGGCGCT 69 FBan0032046 FBgn0052046 CG32046 3 3L CG32046 CG32046 "CG14170, CG6740" CDMC32738 2 14 24 DAC39-B15 23-CG32046-RA_10 CG32046 CTGATTTGGATACCAGTTTTCAGTTCTTCAGTTATCGAACCACAACTAATTTGTCTTCTGACTGGCGCT 69 FBan0032046 FBgn0052046 CG32046 3 3L CG32046 CG32046 "CG14170, CG6740" CDMC32739 2 15 24 DAC39-F03 17-CG32075-RA_6 CG32075 GGATGCTGGCAAACTGCATCGCAAGGACAAGCTTAAGTTTGAAAAGGCTGTGACAGATCTTCTGGAGAT 69 FBan0032075 FBgn0052075 CG32075 3 3L CG32075 CG32075 "CG6316, CG6316, CG6316, CG6316, CG6316" CDMC32739 2 16 24 DAC39-F03 17-CG32075-RA_6 CG32075 GGATGCTGGCAAACTGCATCGCAAGGACAAGCTTAAGTTTGAAAAGGCTGTGACAGATCTTCTGGAGAT 69 FBan0032075 FBgn0052075 CG32075 3 3L CG32075 CG32075 "CG6316, CG6316, CG6316, CG6316, CG6316" CDMC32740 2 17 24 DAC39-F15 15-CG32085-RA_1 CG32085 ACCTCCAGTCGGCAAGTTCCTCGCGTGCTATGTGACTTTAACTTTCCGTCAACACTGTACTCTATCCCT 69 FBan0032085 FBgn0052085 CG32085 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; protein metabolism; GO:0019538; proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG32085 CG32085 "CG6060, CG14134, CG6060, CG6060, CT33735, BcDNA:RH06780" CDMC32740 2 18 24 DAC39-F15 15-CG32085-RA_1 CG32085 ACCTCCAGTCGGCAAGTTCCTCGCGTGCTATGTGACTTTAACTTTCCGTCAACACTGTACTCTATCCCT 69 FBan0032085 FBgn0052085 CG32085 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; protein metabolism; GO:0019538; proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG32085 CG32085 "CG6060, CG14134, CG6060, CG6060, CT33735, BcDNA:RH06780" CDMC32741 2 19 24 DAC39-J03 18-CG32115-RA_2 CG32115 GGGCATGTACTTCGAGGAAATTGGAGCAGTCTCAACTTATACGCGGTCCATTCCAATCTTTCAGCTCCT 69 FBan0032115 FBgn0052115 CG32115 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32115 CG32115 BcDNA:RE40923 CDMC32741 2 20 24 DAC39-J03 18-CG32115-RA_2 CG32115 GGGCATGTACTTCGAGGAAATTGGAGCAGTCTCAACTTATACGCGGTCCATTCCAATCTTTCAGCTCCT 69 FBan0032115 FBgn0052115 CG32115 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32115 CG32115 BcDNA:RE40923 CDMC32742 2 21 24 DAC39-J15 5-CG32135-RA_1 CG32135 GCCAGTCCGGAGTTGTCTCTGCACTTTTGTCCGCTGCATATGGTCAAGCTGCTAGAAACAGTGCTAGTT 69 FBan0032135 FBgn0052135 CG32135 3 3L mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 intracellular; GO:0005622; nucleus; GO:0005634 CG32135 CG32135 CDMC32742 2 22 24 DAC39-J15 5-CG32135-RA_1 CG32135 GCCAGTCCGGAGTTGTCTCTGCACTTTTGTCCGCTGCATATGGTCAAGCTGCTAGAAACAGTGCTAGTT 69 FBan0032135 FBgn0052135 CG32135 3 3L mRNA export from nucleus; GO:0006406; protein import into nucleus; GO:0006606 protein transporter activity; GO:0008565; ; GO:0008565 intracellular; GO:0005622; nucleus; GO:0005634 CG32135 CG32135 CDMC32743 2 23 24 DAC39-N03 9-CG32164-RA_9 CG32164 GCCTTCGCGCCCTATTTGCAATCTGCATTCGAGAACGTCTACAAGATGATTGATCATCCGCAAGGCGAC 69 FBan0032164 FBgn0042177 CG32164 3 3L "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 CG32164 CG32164 "CG18860, CG18219, CG18860" CDMC32743 2 24 24 DAC39-N03 9-CG32164-RA_9 CG32164 GCCTTCGCGCCCTATTTGCAATCTGCATTCGAGAACGTCTACAAGATGATTGATCATCCGCAAGGCGAC 69 FBan0032164 FBgn0042177 CG32164 3 3L "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 CG32164 CG32164 "CG18860, CG18219, CG18860" CDMC32744 2 25 24 DAC39-N15 2-CG32174-RB_1 CG32174 CCACACCAGCACCATTGACTTCAAGTATCTGGAAACTTTGCCACCGGATACCTTTGGAGCCGCTTACGT 69 FBan0032174 FBgn0052174 CG32174 3 3L ubiquinone biosynthesis; GO:0006744 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG32174 CG32174 CG3877 CDMC32744 2 26 24 DAC39-N15 2-CG32174-RB_1 CG32174 CCACACCAGCACCATTGACTTCAAGTATCTGGAAACTTTGCCACCGGATACCTTTGGAGCCGCTTACGT 69 FBan0032174 FBgn0052174 CG32174 3 3L ubiquinone biosynthesis; GO:0006744 molecular function unknown; GO:0005554; ; GO:0005554 mitochondrial inner membrane; GO:0005743; mitochondrion; GO:0005739 CG32174 CG32174 CG3877 CDMC32745 2 1 25 DAC40-B03 22-CG9553-RA_1 CG9553 GCCGTGCGGTAAAGCAACAGCGATCCATATCCAGATCCATATATATCAGTTCAACTTAATCCGCACCCA 69 FBan0009553 FBgn0000308 chic 2 2L "actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; actin polymerization and/or depolymerization; GO:0008154; brain development; GO:0007420; cellular morphogenesis; GO:0000902; central nervous system remodeling (sensu Insecta); GO:0035193; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; dorsal closure; GO:0007391; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; spermatogenesis; GO:0007283" "actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; phosphatidylinositol-4,5-bisphosphate binding; GO:0005546; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005546" actin cytoskeleton; GO:0015629 chic chickadee "CG9553, CG9553, sand, stranded, D88, l(2)27/7, profilin, Profilin, chi, Chic, Chi, chickadee" CDMC32745 2 2 25 DAC40-B03 22-CG9553-RA_1 CG9553 GCCGTGCGGTAAAGCAACAGCGATCCATATCCAGATCCATATATATCAGTTCAACTTAATCCGCACCCA 69 FBan0009553 FBgn0000308 chic 2 2L "actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; actin polymerization and/or depolymerization; GO:0008154; brain development; GO:0007420; cellular morphogenesis; GO:0000902; central nervous system remodeling (sensu Insecta); GO:0035193; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; dorsal closure; GO:0007391; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; spermatogenesis; GO:0007283" "actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; phosphatidylinositol-4,5-bisphosphate binding; GO:0005546; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005546" actin cytoskeleton; GO:0015629 chic chickadee "CG9553, CG9553, sand, stranded, D88, l(2)27/7, profilin, Profilin, chi, Chic, Chi, chickadee" CDMC32746 2 3 25 DAC40-B15 3-CG9570-RA_1 CG9570 TGCCTTGCTCCCCGTGCTAGGCTTGCTCTCAACTTCCCAAAACCAATACGAATGCCAAAATGCCAAAAA 69 FBan0009570 FBgn0031085 CG9570 X X CG9570 CG9570 CDMC32746 2 4 25 DAC40-B15 3-CG9570-RA_1 CG9570 TGCCTTGCTCCCCGTGCTAGGCTTGCTCTCAACTTCCCAAAACCAATACGAATGCCAAAATGCCAAAAA 69 FBan0009570 FBgn0031085 CG9570 X X CG9570 CG9570 CDMC32747 2 5 25 DAC40-F03 2-CG9610-RA_1 CG9610 TCAGCGAGGGCATATGCGACAAAACGAATGTACCCAGTGTGAGCTCCATATCGAGAATCCTGCGCAACA 69 FBan0009610 FBgn0003129 Poxm 3 3R cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 specific RNA polymerase II transcription factor activity; GO:0003704; hormone activity; GO:0005179; ; GO:0003704; ; GO:0005179 extracellular region; GO:0005576; nucleus; GO:0005634 Poxm Pox meso "CG9610, P29, pox meso, poxm, pox-meso, meso, Pox-meso, Pox-m: Paired box mesodermal, Paired box mesodermal, Pox meso" CDMC32747 2 6 25 DAC40-F03 2-CG9610-RA_1 CG9610 TCAGCGAGGGCATATGCGACAAAACGAATGTACCCAGTGTGAGCTCCATATCGAGAATCCTGCGCAACA 69 FBan0009610 FBgn0003129 Poxm 3 3R cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 specific RNA polymerase II transcription factor activity; GO:0003704; hormone activity; GO:0005179; ; GO:0003704; ; GO:0005179 extracellular region; GO:0005576; nucleus; GO:0005634 Poxm Pox meso "CG9610, P29, pox meso, poxm, pox-meso, meso, Pox-meso, Pox-m: Paired box mesodermal, Paired box mesodermal, Pox meso" CDMC32748 2 7 25 DAC40-F15 7-CG9614-RG_1 CG9614 ACGACGATCTAACGCTGGAAAGACGTGGTCTCCATACCAGAACCGTTCGGCAAATGGACAAAAAGCAGA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC32748 2 8 25 DAC40-F15 7-CG9614-RG_1 CG9614 ACGACGATCTAACGCTGGAAAGACGTGGTCTCCATACCAGAACCGTTCGGCAAATGGACAAAAAGCAGA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC32749 2 9 25 DAC40-J03 23-CG9653-RA_5 CG9653 TCTAAGCGCAAACATATATCTTCCAAGCATATCAGCAAAAAAAACCCCAAACCCTAGGTATAAACCCTT 69 FBan0009653 FBgn0024250 brk X X cell competition (sensu Metazoa); GO:0035212; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; nervous system development; GO:0007399; regulation of BMP signaling pathway; GO:0030510; salivary gland determination; GO:0007432; transforming growth factor beta receptor signaling pathway; GO:0007179 RNA polymerase II transcription factor activity; GO:0003702; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; transcriptional repressor activity; GO:0016564; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016564; ; GO:0016566; ; GO:0003700 nucleus; GO:0005634 brk brinker "CG9653, CG9653, CG9653, ssg-1, small salivary glands-1, Brk, Brinker, brinker" CDMC32749 2 10 25 DAC40-J03 23-CG9653-RA_5 CG9653 TCTAAGCGCAAACATATATCTTCCAAGCATATCAGCAAAAAAAACCCCAAACCCTAGGTATAAACCCTT 69 FBan0009653 FBgn0024250 brk X X cell competition (sensu Metazoa); GO:0035212; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; nervous system development; GO:0007399; regulation of BMP signaling pathway; GO:0030510; salivary gland determination; GO:0007432; transforming growth factor beta receptor signaling pathway; GO:0007179 RNA polymerase II transcription factor activity; GO:0003702; specific transcriptional repressor activity; GO:0016566; ; GO:0016566; transcriptional repressor activity; GO:0016564; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0016564; ; GO:0016566; ; GO:0003700 nucleus; GO:0005634 brk brinker "CG9653, CG9653, CG9653, ssg-1, small salivary glands-1, Brk, Brinker, brinker" CDMC32750 2 11 25 DAC40-J15 14-CG9660-RA_1 CG9660 GCACTCACTTGATGTCCTTAATTGAAAACCTAATGCCCGCTATTTGTGGACCAGGTGAGGTATCCGCCC 69 FBan0009660 FBgn0015600 toc 2 2L mitotic sister chromatid segregation; GO:0000070; mitotic spindle organization and biogenesis; GO:0007052; ovarian follicle cell development (sensu Insecta); GO:0030707; proteolysis; GO:0006508 protein kinase binding; GO:0019901; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0019901; ; GO:0004197 ; EC:3.4.22.- cell cortex; GO:0005938; nucleus; GO:0005634; spindle microtubule; GO:0005876 toc toucan "CG9660, l(2)05527, l(2)k08224, l(2)K08224, BA34, BcDNA:LD27161, l(2)01361" CDMC32750 2 12 25 DAC40-J15 14-CG9660-RA_1 CG9660 GCACTCACTTGATGTCCTTAATTGAAAACCTAATGCCCGCTATTTGTGGACCAGGTGAGGTATCCGCCC 69 FBan0009660 FBgn0015600 toc 2 2L mitotic sister chromatid segregation; GO:0000070; mitotic spindle organization and biogenesis; GO:0007052; ovarian follicle cell development (sensu Insecta); GO:0030707; proteolysis; GO:0006508 protein kinase binding; GO:0019901; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0019901; ; GO:0004197 ; EC:3.4.22.- cell cortex; GO:0005938; nucleus; GO:0005634; spindle microtubule; GO:0005876 toc toucan "CG9660, l(2)05527, l(2)k08224, l(2)K08224, BA34, BcDNA:LD27161, l(2)01361" CDMC32751 2 13 25 DAC40-N03 22-CG9697-RA_1 CG9697 AGTGCCAGTTGGTACTTAGGCAAATTCGAGCCGATCATATGCGCAGAAAGTTCAGGGATATTGGCTATA 69 FBan0009697 FBgn0043577 PGRP-SB2 3 3L defense response; GO:0006952; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 receptor activity; GO:0004872; ; GO:0004872; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SB2 PGRP-SB2 CG9697 CDMC32751 2 14 25 DAC40-N03 22-CG9697-RA_1 CG9697 AGTGCCAGTTGGTACTTAGGCAAATTCGAGCCGATCATATGCGCAGAAAGTTCAGGGATATTGGCTATA 69 FBan0009697 FBgn0043577 PGRP-SB2 3 3L defense response; GO:0006952; immune response; GO:0006955; peptidoglycan catabolism; GO:0009253 receptor activity; GO:0004872; ; GO:0004872; N-acetylmuramoyl-L-alanine amidase activity; GO:0008745 ; EC:3.5.1.28; peptidoglycan binding; GO:0042834; ; GO:0042834; ; GO:0042834; ; GO:0008745 ; EC:3.5.1.28 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887 PGRP-SB2 PGRP-SB2 CG9697 CDMC32752 2 15 25 DAC40-N15 3-CG9706-RA_3 CG9706 CAGCTGGCTACTTCTTGGGCTATGTGGTGTTCATTGCCCTGGAGTCCAAGGATTTCTGCAACACCTACA 69 FBan0009706 FBgn0036662 CG9706 3 3L transport; GO:0006810 acetyl-CoA transporter activity; GO:0008521; ; GO:0008521 CG9706 CG9706 CDMC32752 2 16 25 DAC40-N15 3-CG9706-RA_3 CG9706 CAGCTGGCTACTTCTTGGGCTATGTGGTGTTCATTGCCCTGGAGTCCAAGGATTTCTGCAACACCTACA 69 FBan0009706 FBgn0036662 CG9706 3 3L transport; GO:0006810 acetyl-CoA transporter activity; GO:0008521; ; GO:0008521 CG9706 CG9706 CDMC32753 2 17 25 DAC41-B03 AutoBlank AutoBlank CDMC32753 2 18 25 DAC41-B03 AutoBlank AutoBlank CDMC32754 2 19 25 DAC41-B15 AutoBlank AutoBlank CDMC32754 2 20 25 DAC41-B15 AutoBlank AutoBlank CDMC32755 2 21 25 DAC41-F03 AutoBlank AutoBlank CDMC32755 2 22 25 DAC41-F03 AutoBlank AutoBlank CDMC32756 2 23 25 DAC41-F15 AutoBlank AutoBlank CDMC32756 2 24 25 DAC41-F15 AutoBlank AutoBlank CDMC32757 2 25 25 DAC41-J03 AutoBlank AutoBlank CDMC32757 2 26 25 DAC41-J03 AutoBlank AutoBlank CDMC32758 2 1 26 DAC41-J15 AutoBlank AutoBlank CDMC32758 2 2 26 DAC41-J15 AutoBlank AutoBlank CDMC32759 2 3 26 DAC41-N03 AutoBlank AutoBlank CDMC32759 2 4 26 DAC41-N03 AutoBlank AutoBlank CDMC32760 2 5 26 DAC41-N15 AutoBlank AutoBlank CDMC32760 2 6 26 DAC41-N15 AutoBlank AutoBlank CDMC32761 2 7 26 DAC42-B03 150mM NaPO4 Blank CDMC32761 2 8 26 DAC42-B03 150mM NaPO4 Blank CDMC32762 2 9 26 DAC42-B15 150mM NaPO4 Blank CDMC32762 2 10 26 DAC42-B15 150mM NaPO4 Blank CDMC32763 2 11 26 DAC42-F03 150mM NaPO4 Blank CDMC32763 2 12 26 DAC42-F03 150mM NaPO4 Blank CDMC32764 2 13 26 DAC42-F15 150mM NaPO4 Blank CDMC32764 2 14 26 DAC42-F15 150mM NaPO4 Blank CDMC32765 2 15 26 DAC42-J03 150mM NaPO4 Blank CDMC32765 2 16 26 DAC42-J03 150mM NaPO4 Blank CDMC32766 2 17 26 DAC42-J15 5uM MSP 5uM MSP CDMC32766 2 18 26 DAC42-J15 5uM MSP 5uM MSP CDMC32767 2 19 26 DAC42-N03 10uM MSP 10uM MSP CDMC32767 2 20 26 DAC42-N03 10uM MSP 10uM MSP CDMC32768 2 21 26 DAC42-N15 20uM MSP 20uM MSP CDMC32768 2 22 26 DAC42-N15 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC32769 3 1 1 DAC01-C03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32769 3 2 1 DAC01-C03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC32770 3 3 1 DAC01-C15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32770 3 4 1 DAC01-C15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC32771 3 5 1 DAC01-G03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32771 3 6 1 DAC01-G03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC32772 3 7 1 DAC01-G15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32772 3 8 1 DAC01-G15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC32773 3 9 1 DAC01-K03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32773 3 10 1 DAC01-K03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC32774 3 11 1 DAC01-K15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32774 3 12 1 DAC01-K15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC32775 3 13 1 DAC01-O03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32775 3 14 1 DAC01-O03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC32776 3 15 1 DAC01-O15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32776 3 16 1 DAC01-O15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC32777 3 17 1 DAC02-C03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32777 3 18 1 DAC02-C03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC32778 3 19 1 DAC02-C15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32778 3 20 1 DAC02-C15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC32779 3 21 1 DAC02-G03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32779 3 22 1 DAC02-G03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC32780 3 23 1 DAC02-G15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32780 3 24 1 DAC02-G15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC32781 3 25 1 DAC02-K03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32781 3 26 1 DAC02-K03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC32782 3 1 2 DAC02-K15 N/A CG9075 (00957-01195) CDMC32782 3 2 2 DAC02-K15 N/A CG9075 (00957-01195) CDMC32783 3 3 2 DAC02-O03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32783 3 4 2 DAC02-O03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC32784 3 5 2 DAC02-O15 AutoBlank AutoBlank CDMC32784 3 6 2 DAC02-O15 AutoBlank AutoBlank CDMC32785 3 7 2 DAC03-C03 18-CG17108-RA_1 CG17108 CGGCGGCTATCATGGCTAGTCTGGATTACCCAAAGCCCAATATACCTGTAATTCTCCCAGTGGCTTAAA 69 FBan0017108 FBgn0032285 CG17108 2 2L transport; GO:0006810 acetyl-CoA carboxylase activity; GO:0003989 ; EC:6.4.1.2; transporter activity; GO:0005215; ; GO:0005215; ; GO:0003989 ; EC:6.4.1.2 integral to membrane; GO:0016021 CG17108 CG17108 "gh23489, CT33647, BEST:GH23489" CDMC32785 3 8 2 DAC03-C03 18-CG17108-RA_1 CG17108 CGGCGGCTATCATGGCTAGTCTGGATTACCCAAAGCCCAATATACCTGTAATTCTCCCAGTGGCTTAAA 69 FBan0017108 FBgn0032285 CG17108 2 2L transport; GO:0006810 acetyl-CoA carboxylase activity; GO:0003989 ; EC:6.4.1.2; transporter activity; GO:0005215; ; GO:0005215; ; GO:0003989 ; EC:6.4.1.2 integral to membrane; GO:0016021 CG17108 CG17108 "gh23489, CT33647, BEST:GH23489" CDMC32786 3 9 2 DAC03-C15 3-CG17122-RA_2 CG17122 AGGGTCTGACCAGGAACTACGAGAAACTGAAAGCCAAGTACGTGGAGGTACTGCGCTACAAGAAGGCCT 69 FBan0017122 FBgn0036962 CG17122 3 3L CG17122 CG17122 CDMC32786 3 10 2 DAC03-C15 3-CG17122-RA_2 CG17122 AGGGTCTGACCAGGAACTACGAGAAACTGAAAGCCAAGTACGTGGAGGTACTGCGCTACAAGAAGGCCT 69 FBan0017122 FBgn0036962 CG17122 3 3L CG17122 CG17122 CDMC32787 3 11 2 DAC03-G03 2-CG17166-RA_2 CG17166 ACCCTTGCAGGAATCCTGTACTCTGCAGCTGCTTAACTTCCATGTTTCCGAGCCACATGTGGTCAACAA 69 FBan0017166 FBgn0036462 mRpL39 3 3L protein biosynthesis; GO:0006412; threonyl-tRNA aminoacylation; GO:0006435 structural constituent of ribosome; GO:0003735; ; GO:0003735; threonine-tRNA ligase activity; GO:0004829 ; EC:6.1.1.3; ; GO:0004829 ; EC:6.1.1.3; ; GO:0003735; ; GO:0004829 ; EC:6.1.1.3 mitochondrial large ribosomal subunit; GO:0005762 mRpL39 mitochondrial ribosomal protein L39 "CG17166, MRP-L5, mitochondrial ribosomal protein L5, mRpL5, mitochondrial ribosomal protein L39" CDMC32787 3 12 2 DAC03-G03 2-CG17166-RA_2 CG17166 ACCCTTGCAGGAATCCTGTACTCTGCAGCTGCTTAACTTCCATGTTTCCGAGCCACATGTGGTCAACAA 69 FBan0017166 FBgn0036462 mRpL39 3 3L protein biosynthesis; GO:0006412; threonyl-tRNA aminoacylation; GO:0006435 structural constituent of ribosome; GO:0003735; ; GO:0003735; threonine-tRNA ligase activity; GO:0004829 ; EC:6.1.1.3; ; GO:0004829 ; EC:6.1.1.3; ; GO:0003735; ; GO:0004829 ; EC:6.1.1.3 mitochondrial large ribosomal subunit; GO:0005762 mRpL39 mitochondrial ribosomal protein L39 "CG17166, MRP-L5, mitochondrial ribosomal protein L5, mRpL5, mitochondrial ribosomal protein L39" CDMC32788 3 13 2 DAC03-G15 15-CG17176-RA_3 CG17176 TGGACATTATAGAGAGCAAGCTCTACAACTATGACATGGATCCGTTTACCTGCTTCCACCCCTGGGCCT 69 FBan0017176 FBgn0040510 ACXA 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXA ACXA "CG17176, CG17176, CG17176, adenylyl cyclase, Ac62D, AC62D, DACXA, AC, Adenylyl cyclase 62D" CDMC32788 3 14 2 DAC03-G15 15-CG17176-RA_3 CG17176 TGGACATTATAGAGAGCAAGCTCTACAACTATGACATGGATCCGTTTACCTGCTTCCACCCCTGGGCCT 69 FBan0017176 FBgn0040510 ACXA 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXA ACXA "CG17176, CG17176, CG17176, adenylyl cyclase, Ac62D, AC62D, DACXA, AC, Adenylyl cyclase 62D" CDMC32789 3 15 2 DAC03-K03 24-CG17208-RA_1 CG17208 GCACTGGAACAACTAATTTCATAAAACATGCTTCAAAACTATATCTTCTTATGTCAGTTAAATTTATTT 69 FBan0017208 FBgn0040573 CG17208 3 3R CG17208 CG17208 CDMC32789 3 16 2 DAC03-K03 24-CG17208-RA_1 CG17208 GCACTGGAACAACTAATTTCATAAAACATGCTTCAAAACTATATCTTCTTATGTCAGTTAAATTTATTT 69 FBan0017208 FBgn0040573 CG17208 3 3R CG17208 CG17208 CDMC32790 3 17 2 DAC03-K15 14-CG17218-RA_1 CG17218 TGACGCGCGAACAGTCTTGTGGTGAATGAGCGATGTGTAATCAAGTGCCTTTTCTGTAACGGACTCGTA 69 FBan0017218 FBgn0032421 CG17218 2 2L CG17218 CG17218 BcDNA:RE65321 CDMC32790 3 18 2 DAC03-K15 14-CG17218-RA_1 CG17218 TGACGCGCGAACAGTCTTGTGGTGAATGAGCGATGTGTAATCAAGTGCCTTTTCTGTAACGGACTCGTA 69 FBan0017218 FBgn0032421 CG17218 2 2L CG17218 CG17218 BcDNA:RE65321 CDMC32791 3 19 2 DAC03-O03 1-CG1725-RC_1 CG1725 GCCATAACAACGGCATTCAAGCCAAAATGCTTAAGCGCGCTTTTGAGTCCACCTAGTTTTACCCCGCCA 69 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC32791 3 20 2 DAC03-O03 1-CG1725-RC_1 CG1725 GCCATAACAACGGCATTCAAGCCAAAATGCTTAAGCGCGCTTTTGAGTCCACCTAGTTTTACCCCGCCA 69 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC32792 3 21 2 DAC03-O15 8-CG17270-RA_1 CG17270 TGGATCTGGATGACGAAAACTCACAGCTGCTCAAGCAAATGACGGGCTTCAAGAGACGACGAGCGAAAA 69 FBan0017270 FBgn0038828 CG17270 3 3R CG17270 CG17270 anon-Liu CDMC32792 3 22 2 DAC03-O15 8-CG17270-RA_1 CG17270 TGGATCTGGATGACGAAAACTCACAGCTGCTCAAGCAAATGACGGGCTTCAAGAGACGACGAGCGAAAA 69 FBan0017270 FBgn0038828 CG17270 3 3R CG17270 CG17270 anon-Liu CDMC32793 3 23 2 DAC04-C03 3-CG15918-RA_1 CG15918 TCTAAGCAGGACTGTCAAATAGGCCCCTGTCCAGAGGCATCCATTCCCGGATTCTGGGTGAATCC 65 FBan0015918 FBgn0034197 CG15918 2 2R CG15918 CG15918 CDMC32793 3 24 2 DAC04-C03 3-CG15918-RA_1 CG15918 TCTAAGCAGGACTGTCAAATAGGCCCCTGTCCAGAGGCATCCATTCCCGGATTCTGGGTGAATCC 65 FBan0015918 FBgn0034197 CG15918 2 2R CG15918 CG15918 CDMC32794 3 25 2 DAC04-C15 3-CG1609-RA_6 CG1609 TCCACCGCTAAAGGATGTGACCTATATCATGCGTCTGCTGTGGTCGGTTGGCATCCGATGTGGAA 65 FBan0001609 FBgn0019990 Gcn2 3 3R protein amino acid phosphorylation; GO:0006468; regulation of translation; GO:0006445 ATP binding; GO:0005524; ; GO:0005524; eukaryotic elongation factor-2 kinase activity; GO:0004686 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004686 ; EC:2.7.1.-; ; GO:0004812 ; EC:6.1.1.- cytosol; GO:0005829 Gcn2 Gcn2 "CG1609, CG1609, dGCN2, DGCN2, GCN2, EIF2" CDMC32794 3 26 2 DAC04-C15 3-CG1609-RA_6 CG1609 TCCACCGCTAAAGGATGTGACCTATATCATGCGTCTGCTGTGGTCGGTTGGCATCCGATGTGGAA 65 FBan0001609 FBgn0019990 Gcn2 3 3R protein amino acid phosphorylation; GO:0006468; regulation of translation; GO:0006445 ATP binding; GO:0005524; ; GO:0005524; eukaryotic elongation factor-2 kinase activity; GO:0004686 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004686 ; EC:2.7.1.-; ; GO:0004812 ; EC:6.1.1.- cytosol; GO:0005829 Gcn2 Gcn2 "CG1609, CG1609, dGCN2, DGCN2, GCN2, EIF2" CDMC32795 3 1 3 DAC04-G03 12-CG16791-RA_2 CG16791 GAGTACTCCTGCCACGGATCTTGGAGCGAGAACAGCACCTTCTACATCATAGCGCGCCACAAGGG 65 FBan0016791 FBgn0038881 CG16791 3 3R CG16791 CG16791 anon-WO0172774.78 CDMC32795 3 2 3 DAC04-G03 12-CG16791-RA_2 CG16791 GAGTACTCCTGCCACGGATCTTGGAGCGAGAACAGCACCTTCTACATCATAGCGCGCCACAAGGG 65 FBan0016791 FBgn0038881 CG16791 3 3R CG16791 CG16791 anon-WO0172774.78 CDMC32796 3 3 3 DAC04-G15 11-CG16853-RA_1 CG16853 TGCACAATGTATTGGAAGTAATCTGTCGCTTCTCACGCGAGATTCCTGATGCAATGGAGGGCCGG 65 FBan0016853 FBgn0028941 CG16853 2 2L CG16853 CG16853 BG:BACR48E02.3 CDMC32796 3 4 3 DAC04-G15 11-CG16853-RA_1 CG16853 TGCACAATGTATTGGAAGTAATCTGTCGCTTCTCACGCGAGATTCCTGATGCAATGGAGGGCCGG 65 FBan0016853 FBgn0028941 CG16853 2 2L CG16853 CG16853 BG:BACR48E02.3 CDMC32797 3 5 3 DAC04-K03 23-CG16986-RA_1 CG16986 TCGAATTCGCTAAACACATCACCGAGATTATCAACAAGTCAACGGGCTTTGAAAGTCACCTACAG 65 FBan0016986 FBgn0035356 CG16986 3 3L CG16986 CG16986 CDMC32797 3 6 3 DAC04-K03 23-CG16986-RA_1 CG16986 TCGAATTCGCTAAACACATCACCGAGATTATCAACAAGTCAACGGGCTTTGAAAGTCACCTACAG 65 FBan0016986 FBgn0035356 CG16986 3 3L CG16986 CG16986 CDMC32798 3 7 3 DAC04-K15 18-CG17042-RA_9 CG17042 CTGGAGATGCAGCGAAAGTTGTCAGCCATTGCCGAAATACCGAAAATCCTGTGCTCCACTTTGGC 65 FBan0017042 FBgn0033823 CG17042 2 2R CG17042 CG17042 CDMC32798 3 8 3 DAC04-K15 18-CG17042-RA_9 CG17042 CTGGAGATGCAGCGAAAGTTGTCAGCCATTGCCGAAATACCGAAAATCCTGTGCTCCACTTTGGC 65 FBan0017042 FBgn0033823 CG17042 2 2R CG17042 CG17042 CDMC32799 3 9 3 DAC04-O03 3-CG1716-RA_1 CG1716 TTAAGCACATTCGACCCCTAGGATGCGATCTACCCCTCGTAGTGGGTAGCGTTTTAAGTGGGGGC 65 FBan0001716 FBgn0030486 CG1716 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription factor binding; GO:0008134; ATP binding; GO:0005524; ; GO:0005524; transcription cofactor activity; GO:0003712; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003712; ; GO:0008134; ; GO:0003677; ; GO:0008026 nucleus; GO:0005634 CG1716 CG1716 CDMC32799 3 10 3 DAC04-O03 3-CG1716-RA_1 CG1716 TTAAGCACATTCGACCCCTAGGATGCGATCTACCCCTCGTAGTGGGTAGCGTTTTAAGTGGGGGC 65 FBan0001716 FBgn0030486 CG1716 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription factor binding; GO:0008134; ATP binding; GO:0005524; ; GO:0005524; transcription cofactor activity; GO:0003712; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0003712; ; GO:0008134; ; GO:0003677; ; GO:0008026 nucleus; GO:0005634 CG1716 CG1716 CDMC32800 3 11 3 DAC04-O15 23-CG17204-RA_3 CG17204 AAACTGCATCAGAGAATCTTCAATGATAATCTTGCCCTAATTGATACGCCACTTATTGCCATGGG 65 FBgn0038793 CDMC32800 3 12 3 DAC04-O15 23-CG17204-RA_3 CG17204 AAACTGCATCAGAGAATCTTCAATGATAATCTTGCCCTAATTGATACGCCACTTATTGCCATGGG 65 FBgn0038793 CDMC32801 3 13 3 DAC05-C03 9-CG10466-RA_7 CG10466 GGACAACCTGAATGGCATCAAGATCCTCGATAGGACACTAAGGGTCGATCACGTGGCCGACTACAAGC 68 FBan0010466 FBgn0032822 CG10466 2 2L mRNA processing; GO:0006397; proteolysis; GO:0006508 mRNA binding; GO:0003729; ; GO:0003729; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG10466 CG10466 "cg10466, anon-WO0140519.255" CDMC32801 3 14 3 DAC05-C03 9-CG10466-RA_7 CG10466 GGACAACCTGAATGGCATCAAGATCCTCGATAGGACACTAAGGGTCGATCACGTGGCCGACTACAAGC 68 FBan0010466 FBgn0032822 CG10466 2 2L mRNA processing; GO:0006397; proteolysis; GO:0006508 mRNA binding; GO:0003729; ; GO:0003729; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 CG10466 CG10466 "cg10466, anon-WO0140519.255" CDMC32802 3 15 3 DAC05-C15 12-CG10578-RA_4 CG10578 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC32802 3 16 3 DAC05-C15 12-CG10578-RA_4 CG10578 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC32803 3 17 3 DAC05-G03 2-CG11035-RA_1 CG11035 GCCGAAAGCTCCTACGACACTCCCAAGCAGAAAGCGAAGGAACGATACAGACGCGATCAAGAAGAGCG 68 FBan0011035 FBgn0037544 CG11035 3 3R protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0051087; ; GO:0051082 CG11035 CG11035 anon-WO0118547.426 CDMC32803 3 18 3 DAC05-G03 2-CG11035-RA_1 CG11035 GCCGAAAGCTCCTACGACACTCCCAAGCAGAAAGCGAAGGAACGATACAGACGCGATCAAGAAGAGCG 68 FBan0011035 FBgn0037544 CG11035 3 3R protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0051087; ; GO:0051082 CG11035 CG11035 anon-WO0118547.426 CDMC32804 3 19 3 DAC05-G15 4-CG11200-RA_1 CG11200 AGGAGTTCCCGAAGTCCTGGTTCGAGTGGAAGACTGAGTTTCGGTATCAGTACCTGGGAATCGTTGGG 68 FBan0011200 FBgn0034500 CG11200 2 2R carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 CG11200 CG11200 CDMC32804 3 20 3 DAC05-G15 4-CG11200-RA_1 CG11200 AGGAGTTCCCGAAGTCCTGGTTCGAGTGGAAGACTGAGTTTCGGTATCAGTACCTGGGAATCGTTGGG 68 FBan0011200 FBgn0034500 CG11200 2 2R carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 CG11200 CG11200 CDMC32805 3 21 3 DAC05-K03 1-CG11411-RA_1 CG11411 ACCCGGAGCCATGTACTTATTGGCAGTGGTTCAAGCTCGACGCGTCACTTTCTACGAAGTGGTGGTAG 68 FBan0011411 FBgn0004650 fs(1)N X X "determination of anterior/posterior axis, embryo; GO:0008595; eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306; oogenesis (sensu Insecta); GO:0009993; terminal region determination; GO:0007362; vitelline membrane formation (sensu Insecta); GO:0007305" cytoplasm; GO:0005737; external side of plasma membrane; GO:0009897; extracellular region; GO:0005576; ring canal (sensu Insecta); GO:0045172 fs(1)N female sterile (1) Nasrat "CG11411, CG11411, CG11411, CG11411, fs(1)K1540, 371, fs(1)M6, fs(1)Nasrat, fs(1)Nas, fs(1)A371, Nasrat, 8D8.1, EG:8D8.1, fs(1)[nas]" CDMC32805 3 22 3 DAC05-K03 1-CG11411-RA_1 CG11411 ACCCGGAGCCATGTACTTATTGGCAGTGGTTCAAGCTCGACGCGTCACTTTCTACGAAGTGGTGGTAG 68 FBan0011411 FBgn0004650 fs(1)N X X "determination of anterior/posterior axis, embryo; GO:0008595; eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306; oogenesis (sensu Insecta); GO:0009993; terminal region determination; GO:0007362; vitelline membrane formation (sensu Insecta); GO:0007305" cytoplasm; GO:0005737; external side of plasma membrane; GO:0009897; extracellular region; GO:0005576; ring canal (sensu Insecta); GO:0045172 fs(1)N female sterile (1) Nasrat "CG11411, CG11411, CG11411, CG11411, fs(1)K1540, 371, fs(1)M6, fs(1)Nasrat, fs(1)Nas, fs(1)A371, Nasrat, 8D8.1, EG:8D8.1, fs(1)[nas]" CDMC32806 3 23 3 DAC05-K15 23-CG11650-RA_1 CG11650 ACCTTTCGAACTATTAGCTTAAGTAATCGTACTGTTTGTAAAATACACGCAATTGTTAACGGCAGAAA 68 FBan0011650 FBgn0002531 Lcp1 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp1 Larval cuticle protein 1 "CG11650, Gene I, LCP1, CP1, I: Intensifier of Bar, LCP-1, 1, cuticle p. I, L[[3]]CP1, DMLCP1, I" CDMC32806 3 24 3 DAC05-K15 23-CG11650-RA_1 CG11650 ACCTTTCGAACTATTAGCTTAAGTAATCGTACTGTTTGTAAAATACACGCAATTGTTAACGGCAGAAA 68 FBan0011650 FBgn0002531 Lcp1 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp1 Larval cuticle protein 1 "CG11650, Gene I, LCP1, CP1, I: Intensifier of Bar, LCP-1, 1, cuticle p. I, L[[3]]CP1, DMLCP1, I" CDMC32807 3 25 3 DAC05-O03 2-CG12143-RA_1 CG12143 GGAAACTCACGTGCGACATTGTGGCAACATGGAGAAGTCGTTTCCCATAACACCCTGGAAGTACGGCC 68 FBan0012143 FBgn0033132 Tsp42Ej 2 2R integral to membrane; GO:0016021 Tsp42Ej Tetraspanin 42Ej "CG12143, CG12143, CG12143, CG12143, Dm.Tsp42Ej, Sun, sunglass, tetraspanin 42E, sun, sunglasses, Tetraspanin 42Ej" CDMC32807 3 26 3 DAC05-O03 2-CG12143-RA_1 CG12143 GGAAACTCACGTGCGACATTGTGGCAACATGGAGAAGTCGTTTCCCATAACACCCTGGAAGTACGGCC 68 FBan0012143 FBgn0033132 Tsp42Ej 2 2R integral to membrane; GO:0016021 Tsp42Ej Tetraspanin 42Ej "CG12143, CG12143, CG12143, CG12143, Dm.Tsp42Ej, Sun, sunglass, tetraspanin 42E, sun, sunglasses, Tetraspanin 42Ej" CDMC32808 3 1 4 DAC05-O15 3-CG12254-RA_3 CG12254 AACTCACCAGCCTGTGACCTTAAGGTTCTCATCCTACTCTACACGCCCGATCGCAACGCTTTTCTGGG 68 FBan0012254 FBgn0038760 MED25 3 3R transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED25 Mediator complex subunit 25 "CG12254, CG12254, dARC92, LD07688, Arc92, Med25, Mediator complex subunit 25" CDMC32808 3 2 4 DAC05-O15 3-CG12254-RA_3 CG12254 AACTCACCAGCCTGTGACCTTAAGGTTCTCATCCTACTCTACACGCCCGATCGCAACGCTTTTCTGGG 68 FBan0012254 FBgn0038760 MED25 3 3R transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED25 Mediator complex subunit 25 "CG12254, CG12254, dARC92, LD07688, Arc92, Med25, Mediator complex subunit 25" CDMC32809 3 3 4 DAC06-C03 23-CG33006-RD_2 CG33006 CCCAACCCAGATCAAGAGATTACGCAAGGATAACGTGATTAAAAACAAGTTACTTTAGTTGACCATAAA 69 FBgn0053006 CDMC32809 3 4 4 DAC06-C03 23-CG33006-RD_2 CG33006 CCCAACCCAGATCAAGAGATTACGCAAGGATAACGTGATTAAAAACAAGTTACTTTAGTTGACCATAAA 69 FBgn0053006 CDMC32810 3 5 4 DAC06-C15 10-CG33041-RA_1 CG33041 CACACGGGACTCACCCTGCGAATCTTCCAGTTTCGAGGACCAAATCCATCCTACACATATAAGGCTCGA 69 FBan0033041 FBgn0053041 CG33041 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 plasma membrane; GO:0005886 CG33041 CG33041 "CG12484, CG12484, CT32777" CDMC32810 3 6 4 DAC06-C15 10-CG33041-RA_1 CG33041 CACACGGGACTCACCCTGCGAATCTTCCAGTTTCGAGGACCAAATCCATCCTACACATATAAGGCTCGA 69 FBan0033041 FBgn0053041 CG33041 2 2R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 plasma membrane; GO:0005886 CG33041 CG33041 "CG12484, CG12484, CT32777" CDMC32811 3 7 4 DAC06-G03 1-CG33070-RB_1 CG33070 ACGATCTTCGGCAAGTACGGTTCCATTGTGCAGAAGAACATCTTGCGTGACAAGCTCACAGGTCGTCCT 69 FBgn0053070 CDMC32811 3 8 4 DAC06-G03 1-CG33070-RB_1 CG33070 ACGATCTTCGGCAAGTACGGTTCCATTGTGCAGAAGAACATCTTGCGTGACAAGCTCACAGGTCGTCCT 69 FBgn0053070 CDMC32812 3 9 4 DAC06-G15 18-CG33088-RA_1 CG33088 GCAGACACGCATTTCCTACGATCTACTCACCGAACTCGCCAATTGTGTGCTAAACGATGGCATTTTTGT 69 FBgn0053088 CDMC32812 3 10 4 DAC06-G15 18-CG33088-RA_1 CG33088 GCAGACACGCATTTCCTACGATCTACTCACCGAACTCGCCAATTGTGTGCTAAACGATGGCATTTTTGT 69 FBgn0053088 CDMC32813 3 11 4 DAC06-K03 9-CG33110-RA_1 CG33110 CGCCATCTGTGGCTGCATTCGCATGTGTAGAACCGTACAACAAACTGGGTCAATTTTCGAGATCTGCCT 69 FBan0033110 FBgn0053110 CG33110 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG33110 CG33110 "CG13844, CG6926, CG13844" CDMC32813 3 12 4 DAC06-K03 9-CG33110-RA_1 CG33110 CGCCATCTGTGGCTGCATTCGCATGTGTAGAACCGTACAACAAACTGGGTCAATTTTCGAGATCTGCCT 69 FBan0033110 FBgn0053110 CG33110 3 3R fatty acid biosynthesis; GO:0006633; very-long-chain fatty acid metabolism; GO:0000038 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG33110 CG33110 "CG13844, CG6926, CG13844" CDMC32814 3 13 4 DAC06-K15 5-CG33117-RA_1 CG33117 CCCGAGAAATAGCCCAAGTATTCGGCAATCCCTCCGTCGATAAATACACGAAGGCTCGCAATTTGCCCA 69 FBan0033117 FBgn0053117 Victoria 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 extracellular region; GO:0005576 Victoria Victoria "CG33117, CG13963, TotE, Turandot E" CDMC32814 3 14 4 DAC06-K15 5-CG33117-RA_1 CG33117 CCCGAGAAATAGCCCAAGTATTCGGCAATCCCTCCGTCGATAAATACACGAAGGCTCGCAATTTGCCCA 69 FBan0033117 FBgn0053117 Victoria 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 extracellular region; GO:0005576 Victoria Victoria "CG33117, CG13963, TotE, Turandot E" CDMC32815 3 15 4 DAC06-O03 2-CG3313-RA_2 CG3313 ACGCCCGAACCCTTCAAACCATTAAGAAGATCACATCTCGATACAGTGGCTGCGGTATACGGGCGACTT 69 FBan0003313 FBgn0037980 CG3313 3 3R CG3313 CG3313 CDMC32815 3 16 4 DAC06-O03 2-CG3313-RA_2 CG3313 ACGCCCGAACCCTTCAAACCATTAAGAAGATCACATCTCGATACAGTGGCTGCGGTATACGGGCGACTT 69 FBan0003313 FBgn0037980 CG3313 3 3R CG3313 CG3313 CDMC32816 3 17 4 DAC06-O15 2-CG33145-RB_1 CG33145 GCGCTTGTTCGAGGCTTCGCTTAATACGACGCTGGTCTATCTGGAGGACGTGTACATCACTGGGTTGTG 69 FBan0033145 FBgn0053145 CG33145 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG33145 CG33145 CG8976 CDMC32816 3 18 4 DAC06-O15 2-CG33145-RB_1 CG33145 GCGCTTGTTCGAGGCTTCGCTTAATACGACGCTGGTCTATCTGGAGGACGTGTACATCACTGGGTTGTG 69 FBan0033145 FBgn0053145 CG33145 2 2R protein amino acid glycosylation; GO:0006486 "UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG33145 CG33145 CG8976 CDMC32817 3 19 4 DAC07-C03 12-CG5798-RA_2 CG5798 GCTGCCGCCAAACTCGAATGTATGTCAGCTGAACCAGTGCATGGACATGTACTTCAGTGGAGAAAGGAT 69 FBan0005798 FBgn0038862 CG5798 3 3R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5798 CG5798 CT18196 CDMC32817 3 20 4 DAC07-C03 12-CG5798-RA_2 CG5798 GCTGCCGCCAAACTCGAATGTATGTCAGCTGAACCAGTGCATGGACATGTACTTCAGTGGAGAAAGGAT 69 FBan0005798 FBgn0038862 CG5798 3 3R protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5798 CG5798 CT18196 CDMC32818 3 21 4 DAC07-C15 23-CG5807-RA_14 CG5807 TGCAACATAAGCCGCAGTCAATTTGCAGTAGGCGTAGTTTAGAATTTCGTTTCTTGTCGTTCAGAGTGA 69 FBan0005807 FBgn0027539 CG5807 3 3R CG5807 CG5807 "BcDNA:GH12663, anon-WO0118547.355" CDMC32818 3 22 4 DAC07-C15 23-CG5807-RA_14 CG5807 TGCAACATAAGCCGCAGTCAATTTGCAGTAGGCGTAGTTTAGAATTTCGTTTCTTGTCGTTCAGAGTGA 69 FBan0005807 FBgn0027539 CG5807 3 3R CG5807 CG5807 "BcDNA:GH12663, anon-WO0118547.355" CDMC32819 3 23 4 DAC07-G03 23-CG5846-RA_2 CG5846 CTTTACCACACCACAGAAAAATCTACAGCAACTAGAAGATAGGTGTACCAGTTATATGATGCCCTGTTA 69 FBan0005846 FBgn0032171 CG5846 2 2L CG5846 CG5846 CDMC32819 3 24 4 DAC07-G03 23-CG5846-RA_2 CG5846 CTTTACCACACCACAGAAAAATCTACAGCAACTAGAAGATAGGTGTACCAGTTATATGATGCCCTGTTA 69 FBan0005846 FBgn0032171 CG5846 2 2L CG5846 CG5846 CDMC32820 3 25 4 DAC07-G15 1-CG5853-RA_1 CG5853 CCAGCTACTCAAACCAGTGCTCTGTGCTTTTGCGACGAGGTTTCATCAAAGCCAAACGAGACACGACCA 69 FBan0005853 FBgn0032167 CG5853 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG5853 CG5853 CDMC32820 3 26 4 DAC07-G15 1-CG5853-RA_1 CG5853 CCAGCTACTCAAACCAGTGCTCTGTGCTTTTGCGACGAGGTTTCATCAAAGCCAAACGAGACACGACCA 69 FBan0005853 FBgn0032167 CG5853 2 2L anion transport; GO:0006820; lipid metabolism; GO:0006629; lipid transport; GO:0006869 "ATP binding; GO:0005524; ; GO:0005524; anion channel activity; GO:0005253; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005253; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG5853 CG5853 CDMC32821 3 1 5 DAC07-K03 10-CG5883-RA_2 CG5883 CGGATGCGTTGTTGGGCAAAGGAACATGCAACCTGGGAATGTACTTCGATCAAGTAAGCAAGAGTTGCG 69 FBan0005883 FBgn0036225 CG5883 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG5883 CG5883 CDMC32821 3 2 5 DAC07-K03 10-CG5883-RA_2 CG5883 CGGATGCGTTGTTGGGCAAAGGAACATGCAACCTGGGAATGTACTTCGATCAAGTAAGCAAGAGTTGCG 69 FBan0005883 FBgn0036225 CG5883 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG5883 CG5883 CDMC32822 3 3 5 DAC07-K15 2-CG5899-RA_1 CG5899 CGACCGCCGTAAATGTCCGCCAGGATTTGATCACCGACTTCAATGGGGACGATAGCATCTTTGTGTTCC 69 FBan0005899 FBgn0032157 CG5899 2 2L DNA metabolism; GO:0006259; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 CG5899 CG5899 CDMC32822 3 4 5 DAC07-K15 2-CG5899-RA_1 CG5899 CGACCGCCGTAAATGTCCGCCAGGATTTGATCACCGACTTCAATGGGGACGATAGCATCTTTGTGTTCC 69 FBan0005899 FBgn0032157 CG5899 2 2L DNA metabolism; GO:0006259; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 CG5899 CG5899 CDMC32823 3 5 5 DAC07-O03 9-CG5935-RB_1 CG5935 GCAAAGTCAGGACGTTGTACGCCGATGCAGAAAGAAGTTGGGCATGGTTCGCGAAATGTAACTCCAAGT 69 FBgn0010567 CDMC32823 3 6 5 DAC07-O03 9-CG5935-RB_1 CG5935 GCAAAGTCAGGACGTTGTACGCCGATGCAGAAAGAAGTTGGGCATGGTTCGCGAAATGTAACTCCAAGT 69 FBgn0010567 CDMC32824 3 7 5 DAC07-O15 23-CG5941-RA_1 CG5941 ACTCCTTTTGTTTATTGATTAGTCTAAAGAGCAACGAAACAAGGCCTGTAGCTTAAAGTTTGCCAGGGC 69 FBan0005941 FBgn0029833 CG5941 X X cell cycle; GO:0007049 mRNA binding; GO:0003729; receptor activity; GO:0004872; ; GO:0003729; ; GO:0004872 CG5941 CG5941 "anon-WO03040301.150, anon-WO03040301.151" CDMC32824 3 8 5 DAC07-O15 23-CG5941-RA_1 CG5941 ACTCCTTTTGTTTATTGATTAGTCTAAAGAGCAACGAAACAAGGCCTGTAGCTTAAAGTTTGCCAGGGC 69 FBan0005941 FBgn0029833 CG5941 X X cell cycle; GO:0007049 mRNA binding; GO:0003729; receptor activity; GO:0004872; ; GO:0003729; ; GO:0004872 CG5941 CG5941 "anon-WO03040301.150, anon-WO03040301.151" CDMC32825 3 9 5 DAC08-C03 2-CG8236-RA_1 CG8236 GCAGAACGTTTTGTCGAGTGGCTGAACTCCTTTGGCACCTTGGAAAGCAATTTGACCCCGGAAAAGGTC 69 FBan0008236 FBgn0037626 CG8236 3 3R CG8236 CG8236 CDMC32825 3 10 5 DAC08-C03 2-CG8236-RA_1 CG8236 GCAGAACGTTTTGTCGAGTGGCTGAACTCCTTTGGCACCTTGGAAAGCAATTTGACCCCGGAAAAGGTC 69 FBan0008236 FBgn0037626 CG8236 3 3R CG8236 CG8236 CDMC32826 3 11 5 DAC08-C15 9-CG8249-RA_1 CG8249 GGCCATTGTGGGCTTCATTGTGCTGAGCACTCTAGGTCTTTACACCCTGCCCTTCTTTATGATCTCCGA 69 FBan0008249 FBgn0034045 CG8249 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG8249 CG8249 CDMC32826 3 12 5 DAC08-C15 9-CG8249-RA_1 CG8249 GGCCATTGTGGGCTTCATTGTGCTGAGCACTCTAGGTCTTTACACCCTGCCCTTCTTTATGATCTCCGA 69 FBan0008249 FBgn0034045 CG8249 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG8249 CG8249 CDMC32827 3 13 5 DAC08-G03 18-CG8290-RA_12 CG8290 TTGGAAAAGATTCCCCAACGACCCAAGGTAAAGGTCAAGATTCCGATAAACTTAAGAACGCACGTGCGG 69 FBan0008290 FBgn0026573 CG8290 2 2R DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634 CG8290 CG8290 "LD29214, BEST:LD29214" CDMC32827 3 14 5 DAC08-G03 18-CG8290-RA_12 CG8290 TTGGAAAAGATTCCCCAACGACCCAAGGTAAAGGTCAAGATTCCGATAAACTTAAGAACGCACGTGCGG 69 FBan0008290 FBgn0026573 CG8290 2 2R DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003677 nucleus; GO:0005634 CG8290 CG8290 "LD29214, BEST:LD29214" CDMC32828 3 15 5 DAC08-G15 3-CG8300-RA_2 CG8300 GCGCAGCGTCAATCAATCGAGGCGGTACTTAATCGGGTTTAGAGCTATCCATAGCCATGTCAGCGGAGA 69 FBan0008300 FBgn0029937 CG8300 X X CG8300 CG8300 CDMC32828 3 16 5 DAC08-G15 3-CG8300-RA_2 CG8300 GCGCAGCGTCAATCAATCGAGGCGGTACTTAATCGGGTTTAGAGCTATCCATAGCCATGTCAGCGGAGA 69 FBan0008300 FBgn0029937 CG8300 X X CG8300 CG8300 CDMC32829 3 17 5 DAC08-K03 23-CG8330-RA_2 CG8330 CGGAACGGAAAACAATTTTGGTAGAAGCAAAAAAGAAAAAAAATTTAATCACGTTAGATCCAAAACGGT 69 FBan0008330 FBgn0033074 tomboy40 2 2R anion transport; GO:0006820; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; receptor activity; GO:0004872; ; GO:0005386; ; GO:0004872; protein translocase activity; GO:0015450; ; GO:0015450; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 tomboy40 tomboy40 "CG8330, CG8330, dtomboy40" CDMC32829 3 18 5 DAC08-K03 23-CG8330-RA_2 CG8330 CGGAACGGAAAACAATTTTGGTAGAAGCAAAAAAGAAAAAAAATTTAATCACGTTAGATCCAAAACGGT 69 FBan0008330 FBgn0033074 tomboy40 2 2R anion transport; GO:0006820; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; receptor activity; GO:0004872; ; GO:0005386; ; GO:0004872; protein translocase activity; GO:0015450; ; GO:0015450; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308 mitochondrial outer membrane translocase complex; GO:0005742; mitochondrion; GO:0005739 tomboy40 tomboy40 "CG8330, CG8330, dtomboy40" CDMC32830 3 19 5 DAC08-K15 2-CG8344-RA_2 CG8344 TGGGTCCCATGAAAGATGCGCTGACGAACAAGGTTATCTTCAAGCACGACGTTCTGGACACTGACGGAA 69 FBan0008344 FBgn0004463 RpIII128 2 2R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666; nucleus; GO:0005634 RpIII128 RNA polymerase III 128kD subunit "CG8344, RNA polymerase III, DmRP128, RP128, RNA polymerase IIIb" CDMC32830 3 20 5 DAC08-K15 2-CG8344-RA_2 CG8344 TGGGTCCCATGAAAGATGCGCTGACGAACAAGGTTATCTTCAAGCACGACGTTCTGGACACTGACGGAA 69 FBan0008344 FBgn0004463 RpIII128 2 2R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase III complex; GO:0005666; nucleus; GO:0005634 RpIII128 RNA polymerase III 128kD subunit "CG8344, RNA polymerase III, DmRP128, RP128, RNA polymerase IIIb" CDMC32831 3 21 5 DAC08-O03 9-CG8390-RA_4 CG8390 AGGGGTGCTCCTCGATCTTGCATGGCTCCTGATGTACTGCTTGTAGATAACGAGTCAAGTCCAGACCAT 69 FBan0008390 FBgn0010633 vlc 2 2R cell-cell signaling; GO:0007267; leg morphogenesis (sensu Endopterygota); GO:0007480 septate junction; GO:0005918 vlc vulcan "CG8390, l(2)07022, anon-WO0118547.98, vulcan" CDMC32831 3 22 5 DAC08-O03 9-CG8390-RA_4 CG8390 AGGGGTGCTCCTCGATCTTGCATGGCTCCTGATGTACTGCTTGTAGATAACGAGTCAAGTCCAGACCAT 69 FBan0008390 FBgn0010633 vlc 2 2R cell-cell signaling; GO:0007267; leg morphogenesis (sensu Endopterygota); GO:0007480 septate junction; GO:0005918 vlc vulcan "CG8390, l(2)07022, anon-WO0118547.98, vulcan" CDMC32832 3 23 5 DAC08-O15 3-CG8405-RA_1 CG8405 AGTGGCGAGCCTCCAGAAACGTACACAACACAAACCCAATTCCGAAATCGAATCCGAACACAAGCCCAA 69 FBan0008405 FBgn0034071 CG8405 2 2R CG8405 CG8405 CDMC32832 3 24 5 DAC08-O15 3-CG8405-RA_1 CG8405 AGTGGCGAGCCTCCAGAAACGTACACAACACAAACCCAATTCCGAAATCGAATCCGAACACAAGCCCAA 69 FBan0008405 FBgn0034071 CG8405 2 2R CG8405 CG8405 CDMC32833 3 25 5 DAC09-C04 1-CG12824-RA_1 CG12824 GCGGAGCCATCAAGGTCGGCCATACTCCCAATGCAACTTCCAATTTTTCACCCACATTCTCTCATCGCA 69 FBan0012824 FBgn0033222 CG12824 2 2R CG12824 CG12824 CDMC32833 3 26 5 DAC09-C04 1-CG12824-RA_1 CG12824 GCGGAGCCATCAAGGTCGGCCATACTCCCAATGCAACTTCCAATTTTTCACCCACATTCTCTCATCGCA 69 FBan0012824 FBgn0033222 CG12824 2 2R CG12824 CG12824 CDMC32834 3 1 6 DAC09-C16 17-CG12840-RA_1 CG12840 GCGATTCGGTTGCATTCTAGCCAAAGGCAAAAGTTTGAAGTGGAAAAACATTCGAAATGGGTTGCGCAA 69 FBan0012840 FBgn0033134 Tsp42El 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42El Tetraspanin 42El "CG12840, CG12840, CG12840, Dm.Tsp42El, tetraspanin 42E, anon-EST:Posey244, Tetraspanin 42El" CDMC32834 3 2 6 DAC09-C16 17-CG12840-RA_1 CG12840 GCGATTCGGTTGCATTCTAGCCAAAGGCAAAAGTTTGAAGTGGAAAAACATTCGAAATGGGTTGCGCAA 69 FBan0012840 FBgn0033134 Tsp42El 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42El Tetraspanin 42El "CG12840, CG12840, CG12840, Dm.Tsp42El, tetraspanin 42E, anon-EST:Posey244, Tetraspanin 42El" CDMC32835 3 3 6 DAC09-G04 12-CG12872-RA_2 CG12872 CCACCTTGCAGCAGACAACCACTACTACATCCAACTGTTCATACGGCAATTGTCTGATGCCAGCACCTG 69 FBan0012872 FBgn0039569 CG12872 3 3R CG12872 CG12872 CDMC32835 3 4 6 DAC09-G04 12-CG12872-RA_2 CG12872 CCACCTTGCAGCAGACAACCACTACTACATCCAACTGTTCATACGGCAATTGTCTGATGCCAGCACCTG 69 FBan0012872 FBgn0039569 CG12872 3 3R CG12872 CG12872 CDMC32836 3 5 6 DAC09-G16 12-CG12880-RA_1 CG12880 TCCTGGCGAATCCCGATCACATCTATAGCATCCTGGCCAAATGTTTAACAATTGCGATGGGTGCGTTCT 69 FBgn0039539 CDMC32836 3 6 6 DAC09-G16 12-CG12880-RA_1 CG12880 TCCTGGCGAATCCCGATCACATCTATAGCATCCTGGCCAAATGTTTAACAATTGCGATGGGTGCGTTCT 69 FBgn0039539 CDMC32837 3 7 6 DAC09-K04 1-CG12924-RA_1 CG12924 CCTGCTAGCCACAATGAATCCAACGAAAGGAGAAGAGTTCGGGTGGTGATTCGCAAACACGGATCGGTG 69 FBan0012924 FBgn0033450 CG12924 2 2R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634 CG12924 CG12924 CDMC32837 3 8 6 DAC09-K04 1-CG12924-RA_1 CG12924 CCTGCTAGCCACAATGAATCCAACGAAAGGAGAAGAGTTCGGGTGGTGATTCGCAAACACGGATCGGTG 69 FBan0012924 FBgn0033450 CG12924 2 2R "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634 CG12924 CG12924 CDMC32838 3 9 6 DAC09-K16 18-CG12943-RA_9 CG12943 CCGCCGTCTAAAGTATTTGGTACCCTTGAATTTGATCTCCAACTTCTTGCTATACGCGGGATTCGCCCT 69 FBan0012943 FBgn0033572 CG12943 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12943 CG12943 CDMC32838 3 10 6 DAC09-K16 18-CG12943-RA_9 CG12943 CCGCCGTCTAAAGTATTTGGTACCCTTGAATTTGATCTCCAACTTCTTGCTATACGCGGGATTCGCCCT 69 FBan0012943 FBgn0033572 CG12943 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12943 CG12943 CDMC32839 3 11 6 DAC09-O04 23-CG12993-RA_6 CG12993 CAGGGATCAATGAGTAGCACATAGTCTAGTTATTTTATTTGCTCGACCAGTTGCTCTTAGCTCTACATT 69 FBan0012993 FBgn0030840 CG12993 X X CG12993 CG12993 CDMC32839 3 12 6 DAC09-O04 23-CG12993-RA_6 CG12993 CAGGGATCAATGAGTAGCACATAGTCTAGTTATTTTATTTGCTCGACCAGTTGCTCTTAGCTCTACATT 69 FBan0012993 FBgn0030840 CG12993 X X CG12993 CG12993 CDMC32840 3 13 6 DAC09-O16 2-CG13002-RA_1 CG13002 ACGCTTGCCATGAAGAGGGACAGCTTCTGCATGTCCTTGTCAAATCCCATGGAGCTCTGGTATCCCATA 69 FBan0013002 FBgn0030804 CG13002 X X CG13002 CG13002 CDMC32840 3 14 6 DAC09-O16 2-CG13002-RA_1 CG13002 ACGCTTGCCATGAAGAGGGACAGCTTCTGCATGTCCTTGTCAAATCCCATGGAGCTCTGGTATCCCATA 69 FBan0013002 FBgn0030804 CG13002 X X CG13002 CG13002 CDMC32841 3 15 6 DAC10-C03 12-CG10954-RA_1 CG10954 GCGAGCAACACGACTAAGGGATGCCACCAACTTGTTATATAGTCGCAATGGAGGATTCATCCCCGCAAT 69 FBan0010954 FBgn0032859 Arc-p34 2 2L cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; regulation of actin filament polymerization; GO:0030833; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Arp2/3 protein complex; GO:0005885 Arc-p34 Arc-p34 "CG10954, CG10954, CG10954, CG10954, ARC-P34, 38C.47, p34, Arpc2, ARC-p34, ARPC2/p34, anon-WO0118547.154" CDMC32841 3 16 6 DAC10-C03 12-CG10954-RA_1 CG10954 GCGAGCAACACGACTAAGGGATGCCACCAACTTGTTATATAGTCGCAATGGAGGATTCATCCCCGCAAT 69 FBan0010954 FBgn0032859 Arc-p34 2 2L cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; regulation of actin filament polymerization; GO:0030833; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Arp2/3 protein complex; GO:0005885 Arc-p34 Arc-p34 "CG10954, CG10954, CG10954, CG10954, ARC-P34, 38C.47, p34, Arpc2, ARC-p34, ARPC2/p34, anon-WO0118547.154" CDMC32842 3 17 6 DAC10-C15 18-CG10964-RA_1 CG10964 TCACTATTTTCACGCTTGTGTTACGGCAATAAAGTCGATTGATAAGCACGGAAAGATCTGGCTGCGGGT 69 FBan0010964 FBgn0030026 sni X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 sni sniffer "CG10964, Sniffer, anon-WO03040301.183, sniffer" CDMC32842 3 18 6 DAC10-C15 18-CG10964-RA_1 CG10964 TCACTATTTTCACGCTTGTGTTACGGCAATAAAGTCGATTGATAAGCACGGAAAGATCTGGCTGCGGGT 69 FBan0010964 FBgn0030026 sni X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 sni sniffer "CG10964, Sniffer, anon-WO03040301.183, sniffer" CDMC32843 3 19 6 DAC10-G03 22-CG11001-RA_1 CG11001 TCCGCTCGGTAATTTGCCAGAAAAAAACTAATCGAAATGGGCGTACAAGTAGTTCCAATTGCTCCTGGT 69 FBan0011001 FBgn0013954 FK506-bp2 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005528; ; GO:0003755 ; EC:5.2.1.8 cytoplasm; GO:0005737 FK506-bp2 FK506-binding protein 2 "CG11001, DrFKBP12, FKBP12, FKBP, FK506-binding protein, dFKBP12" CDMC32843 3 20 6 DAC10-G03 22-CG11001-RA_1 CG11001 TCCGCTCGGTAATTTGCCAGAAAAAAACTAATCGAAATGGGCGTACAAGTAGTTCCAATTGCTCCTGGT 69 FBan0011001 FBgn0013954 FK506-bp2 2 2R protein folding; GO:0006457 FK506 binding; GO:0005528; ; GO:0005528; peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8; ; GO:0005528; ; GO:0003755 ; EC:5.2.1.8 cytoplasm; GO:0005737 FK506-bp2 FK506-binding protein 2 "CG11001, DrFKBP12, FKBP12, FKBP, FK506-binding protein, dFKBP12" CDMC32844 3 21 6 DAC10-G15 18-CG11023-RA_1 CG11023 ACCGACCAGTGCTGGACGCTCTAGAGAAATATCTACGCGAAGAGTCAATATTCAAGCCCAAAAAGCAGT 69 FBan0011023 FBgn0031208 CG11023 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; protein targeting; GO:0006605; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- CG11023 CG11023 CDMC32844 3 22 6 DAC10-G15 18-CG11023-RA_1 CG11023 ACCGACCAGTGCTGGACGCTCTAGAGAAATATCTACGCGAAGAGTCAATATTCAAGCCCAAAAAGCAGT 69 FBan0011023 FBgn0031208 CG11023 2 2L protein metabolism; GO:0019538; protein modification; GO:0006464; protein targeting; GO:0006605; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008234 ; EC:3.4.-.- CG11023 CG11023 CDMC32845 3 23 6 DAC10-K03 23-CG11059-RA_1 CG11059 TGTAAAATGCACATGTCTACCAAATTTCAACTGAATTCTGTCGCAATGCATAGGAGGAAGTTTCTCCGT 69 FBan0011059 FBgn0039928 cals 4 4 calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; synaptic transmission; GO:0007268 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887; postsynaptic membrane; GO:0045211 cals calsyntenin-1 "CG11059, CG11059, CG11059, CT30877, Cad102F, DCad102F, CALS, calsyntenin-1" CDMC32845 3 24 6 DAC10-K03 23-CG11059-RA_1 CG11059 TGTAAAATGCACATGTCTACCAAATTTCAACTGAATTCTGTCGCAATGCATAGGAGGAAGTTTCTCCGT 69 FBan0011059 FBgn0039928 cals 4 4 calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; synaptic transmission; GO:0007268 calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509 extracellular region; GO:0005576; integral to plasma membrane; GO:0005887; postsynaptic membrane; GO:0045211 cals calsyntenin-1 "CG11059, CG11059, CG11059, CT30877, Cad102F, DCad102F, CALS, calsyntenin-1" CDMC32846 3 25 6 DAC10-K15 16-CG11064-RA_2 CG11064 TCGGCCGCCCTAGGCAACGACTATGGAGTAGGAAAATGCACAGCAATTGAATTTGACAATAACCAGTTT 69 FBan0011064 FBgn0016724 RfaBp 4 4 Wnt receptor signaling pathway; GO:0016055; lipid transport; GO:0006869; smoothened signaling pathway; GO:0007224; transport; GO:0006810 fatty acid binding; GO:0005504; retinoid binding; GO:0005501; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0005504; ; GO:0005501; heme binding; GO:0020037; structural molecule activity; GO:0005198; lipid transporter activity; GO:0005319; ; GO:0020037; ; GO:0005198; ; GO:0005319; retinol binding; GO:0019841; ; GO:0019841 extracellular region; GO:0005576 RfaBp Retinoid- and fatty-acid binding protein "CG11064, CG11064, CG11064, CG11064, CG11064, RFABG, Retinoid- and fatty-acid binding glycoprotein, DRBP, Retinoid and Fatty Acid Binding Glycoprotein, RFBP, retinoid- and fatty acid-binding gene, RfaBP, retinoid-fatty acid binding protein, T3, ApoLI, ApoLII, apolipophorin I, apolipophorin II" CDMC32846 3 26 6 DAC10-K15 16-CG11064-RA_2 CG11064 TCGGCCGCCCTAGGCAACGACTATGGAGTAGGAAAATGCACAGCAATTGAATTTGACAATAACCAGTTT 69 FBan0011064 FBgn0016724 RfaBp 4 4 Wnt receptor signaling pathway; GO:0016055; lipid transport; GO:0006869; smoothened signaling pathway; GO:0007224; transport; GO:0006810 fatty acid binding; GO:0005504; retinoid binding; GO:0005501; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0005504; ; GO:0005501; heme binding; GO:0020037; structural molecule activity; GO:0005198; lipid transporter activity; GO:0005319; ; GO:0020037; ; GO:0005198; ; GO:0005319; retinol binding; GO:0019841; ; GO:0019841 extracellular region; GO:0005576 RfaBp Retinoid- and fatty-acid binding protein "CG11064, CG11064, CG11064, CG11064, CG11064, RFABG, Retinoid- and fatty-acid binding glycoprotein, DRBP, Retinoid and Fatty Acid Binding Glycoprotein, RFBP, retinoid- and fatty acid-binding gene, RfaBP, retinoid-fatty acid binding protein, T3, ApoLI, ApoLII, apolipophorin I, apolipophorin II" CDMC32847 3 1 7 DAC10-O03 23-CG11100-RB_11 CG11100 CGGAGGAGAAGAGCGCTAAGTGTACGGGTGTAATTATAGTAGCCAAAAAAAAGTACATAATGGAATGAT 69 FBan0011100 FBgn0037207 Mes2 3 3L embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 Mes2 Mes2 "CG11100, CG11100, CG11100, CG11100, CG11100, CG11100, adfR" CDMC32847 3 2 7 DAC10-O03 23-CG11100-RB_11 CG11100 CGGAGGAGAAGAGCGCTAAGTGTACGGGTGTAATTATAGTAGCCAAAAAAAAGTACATAATGGAATGAT 69 FBan0011100 FBgn0037207 Mes2 3 3L embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 Mes2 Mes2 "CG11100, CG11100, CG11100, CG11100, CG11100, CG11100, adfR" CDMC32848 3 3 7 DAC10-O15 24-CG11122-RA_1 CG11122 GCGGAGTATATGCAACATATTTTTCTTTCTTTTAAACATCTAAGCGTTACATTATTTAGGTTTTTTTTA 69 FBan0011122 FBgn0030266 CG11122 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11122 CG11122 CDMC32848 3 4 7 DAC10-O15 24-CG11122-RA_1 CG11122 GCGGAGTATATGCAACATATTTTTCTTTCTTTTAAACATCTAAGCGTTACATTATTTAGGTTTTTTTTA 69 FBan0011122 FBgn0030266 CG11122 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11122 CG11122 CDMC32849 3 5 7 DAC11-C03 17-CG12190-RA_3 CG12190 ACGGCGAGTCGATTGCATTTACACGACGCTCTCCAAATCCCATTTTAAAATGCGCTAGACCCTGTAAAT 69 FBan0012190 FBgn0034763 CG12190 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG12190 CG12190 CDMC32849 3 6 7 DAC11-C03 17-CG12190-RA_3 CG12190 ACGGCGAGTCGATTGCATTTACACGACGCTCTCCAAATCCCATTTTAAAATGCGCTAGACCCTGTAAAT 69 FBan0012190 FBgn0034763 CG12190 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG12190 CG12190 CDMC32850 3 7 7 DAC11-C15 12-CG12206-RA_2 CG12206 GGCAGACCATTGCAATTCGAAACGGATGGCTATTACACATTCCATGTGCGCGAACACGAGAATTTCCGG 69 FBan0012206 FBgn0029662 CG12206 X X CG12206 CG12206 CDMC32850 3 8 7 DAC11-C15 12-CG12206-RA_2 CG12206 GGCAGACCATTGCAATTCGAAACGGATGGCTATTACACATTCCATGTGCGCGAACACGAGAATTTCCGG 69 FBan0012206 FBgn0029662 CG12206 X X CG12206 CG12206 CDMC32851 3 9 7 DAC11-G03 3-CG12233-RA_1 CG12233 CGAAGAGAAGTATCTGGATACGGTGTGCCTGAACATGGTCCAGAACCCCGGAAAATACGACGTGCTGGT 69 FBgn0031024 CDMC32851 3 10 7 DAC11-G03 3-CG12233-RA_1 CG12233 CGAAGAGAAGTATCTGGATACGGTGTGCCTGAACATGGTCCAGAACCCCGGAAAATACGACGTGCTGGT 69 FBgn0031024 CDMC32852 3 11 7 DAC11-G15 16-CG12250-RA_2 CG12250 ACCAAGGATTCGGCATACTATATGTACTTGGAGACACGCAAAGGTCCCTGGTACAAGCAAAAGAGTCGT 69 FBan0012250 FBgn0039345 CG12250 3 3R CG12250 CG12250 BcDNA:AT03213 CDMC32852 3 12 7 DAC11-G15 16-CG12250-RA_2 CG12250 ACCAAGGATTCGGCATACTATATGTACTTGGAGACACGCAAAGGTCCCTGGTACAAGCAAAAGAGTCGT 69 FBan0012250 FBgn0039345 CG12250 3 3R CG12250 CG12250 BcDNA:AT03213 CDMC32853 3 13 7 DAC11-K03 14-CG12296-RA_1 CG12296 TCGCGCGTCAAATGAACCCCCAGGAGTTTAGATAGCCAGGATCTTCGATACAGCTAGCAATTCCATGTT 69 FBan0012296 FBgn0013469 klu 3 3L cell proliferation; GO:0008283; negative regulation of Ras protein signal transduction; GO:0046580; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 klu klumpfuss "CG12296, l(3)09036, l(3)10052, klumphuss, P09036, klumpfuss" CDMC32853 3 14 7 DAC11-K03 14-CG12296-RA_1 CG12296 TCGCGCGTCAAATGAACCCCCAGGAGTTTAGATAGCCAGGATCTTCGATACAGCTAGCAATTCCATGTT 69 FBan0012296 FBgn0013469 klu 3 3L cell proliferation; GO:0008283; negative regulation of Ras protein signal transduction; GO:0046580; positive regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046672; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 klu klumpfuss "CG12296, l(3)09036, l(3)10052, klumphuss, P09036, klumpfuss" CDMC32854 3 15 7 DAC11-K15 7-CG12306-RA_1 CG12306 GCCCCATTTACACTCCTGGTTCCGTACAACATGTGCCGTAGTTATGCATTTGACCAACGGTTCTGTGCA 69 FBan0012306 FBgn0003124 polo 3 3L cell cycle; GO:0007049; cytokinesis; GO:0000910; embryonic development; GO:0009790; female meiosis II; GO:0007147; female meiosis II spindle assembly (sensu Metazoa); GO:0007058; intracellular signaling cascade; GO:0007242; male meiosis; GO:0007140; male meiosis chromosome segregation; GO:0007060; mitosis; GO:0007067; pronuclear fusion; GO:0007344; pronuclear migration; GO:0035046; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; sperm aster formation; GO:0035044 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 centrosome; GO:0005813; cytoplasm; GO:0005737; kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940; spindle; GO:0005819; spindle pole; GO:0000922 polo polo "CG12306, CG12306, l(3)01673, l(3)77Aa, 0256/04, 1324/08, POLO/PLK1, Polo protein kinase, POLO, anon-WO0172774.3, l(3)S025604, l(3)S132408" CDMC32854 3 16 7 DAC11-K15 7-CG12306-RA_1 CG12306 GCCCCATTTACACTCCTGGTTCCGTACAACATGTGCCGTAGTTATGCATTTGACCAACGGTTCTGTGCA 69 FBan0012306 FBgn0003124 polo 3 3L cell cycle; GO:0007049; cytokinesis; GO:0000910; embryonic development; GO:0009790; female meiosis II; GO:0007147; female meiosis II spindle assembly (sensu Metazoa); GO:0007058; intracellular signaling cascade; GO:0007242; male meiosis; GO:0007140; male meiosis chromosome segregation; GO:0007060; mitosis; GO:0007067; pronuclear fusion; GO:0007344; pronuclear migration; GO:0035046; protein amino acid phosphorylation; GO:0006468; protein localization; GO:0008104; sperm aster formation; GO:0035044 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 centrosome; GO:0005813; cytoplasm; GO:0005737; kinetochore; GO:0000776; outer kinetochore of condensed chromosome; GO:0000940; spindle; GO:0005819; spindle pole; GO:0000922 polo polo "CG12306, CG12306, l(3)01673, l(3)77Aa, 0256/04, 1324/08, POLO/PLK1, Polo protein kinase, POLO, anon-WO0172774.3, l(3)S025604, l(3)S132408" CDMC32855 3 17 7 DAC11-O03 23-CG12345-RA_5 CG12345 CTAACTAACTTAGCAGAGCTTACGAACTTGTTTATACCCCTACTGTCAGCGAATTATGGCAAGCAAGCC 69 FBan0012345 FBgn0000303 Cha 3 3R acetylcholine biosynthesis; GO:0008292; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 choline O-acetyltransferase activity; GO:0004102 ; EC:2.3.1.6; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004102 ; EC:2.3.1.6; ; GO:0008270 Cha Choline acetyltransferase "CG12345, CG12345, CG12345, CG12345, CG12345, ChAT, dChAT, cha, choline acetyltransferase, CT23399, choline acetyl transferase, ChaT, Cat, l(3)91Cc" CDMC32855 3 18 7 DAC11-O03 23-CG12345-RA_5 CG12345 CTAACTAACTTAGCAGAGCTTACGAACTTGTTTATACCCCTACTGTCAGCGAATTATGGCAAGCAAGCC 69 FBan0012345 FBgn0000303 Cha 3 3R acetylcholine biosynthesis; GO:0008292; amino acid metabolism; GO:0006520; proteolysis; GO:0006508 choline O-acetyltransferase activity; GO:0004102 ; EC:2.3.1.6; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004102 ; EC:2.3.1.6; ; GO:0008270 Cha Choline acetyltransferase "CG12345, CG12345, CG12345, CG12345, CG12345, ChAT, dChAT, cha, choline acetyltransferase, CT23399, choline acetyl transferase, ChaT, Cat, l(3)91Cc" CDMC32856 3 19 7 DAC11-O15 23-CG12348-RD_2 CG12348 GACTGGCCTTCTATAGGGATTTCCTTGTTTCTCCTTTCATTTTCCTTCTGGTAATCTACACACCGAAAA 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC32856 3 20 7 DAC11-O15 23-CG12348-RD_2 CG12348 GACTGGCCTTCTATAGGGATTTCCTTGTTTCTCCTTTCATTTTCCTTCTGGTAATCTACACACCGAAAA 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC32857 3 21 7 DAC12-C03 18-CG7860-RA_1 CG7860 GGTGGTGCACCAGGAACCGTTCACACTTTCCACGTAACTAAATTCGGAGTACCTACCTATCCAAGGATT 69 FBan0007860 FBgn0030653 CG7860 X X amino acid catabolism; GO:0009063; autophagic cell death; GO:0048102; glycoprotein catabolism; GO:0006516; protein amino acid glycosylation; GO:0006486; salivary gland cell autophagic cell death; GO:0035071 asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1 CG7860 CG7860 CDMC32857 3 22 7 DAC12-C03 18-CG7860-RA_1 CG7860 GGTGGTGCACCAGGAACCGTTCACACTTTCCACGTAACTAAATTCGGAGTACCTACCTATCCAAGGATT 69 FBan0007860 FBgn0030653 CG7860 X X amino acid catabolism; GO:0009063; autophagic cell death; GO:0048102; glycoprotein catabolism; GO:0006516; protein amino acid glycosylation; GO:0006486; salivary gland cell autophagic cell death; GO:0035071 asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004067 ; EC:3.5.1.1 CG7860 CG7860 CDMC32858 3 23 7 DAC12-C15 15-CG7873-RA_1 CG7873 GGACCCCATGCGCAGACCCACGTTTGAGACGCTACAATGGAAACTGGAAGACTTCTATACATCTGATCA 69 FBan0007873 FBgn0004603 Src42A 2 2R JNK cascade; GO:0007254; cell communication; GO:0007154; dorsal closure; GO:0007391; eye development (sensu Endopterygota); GO:0007456; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- adherens junction; GO:0005912 Src42A Src oncogene at 42A "CG7873, CG7873, dtk5, Su(D-raf)1, Su(phl)1, Suppressor of raf-like-oncogene, Suppressor of pole hole, Dsrc41, dtk-5, Dm SRC41, Dsrc42A, Su1, DmHD-29, SK2-4, Su(Raf)1, Src41, src, SRC 42A, Src, Src42, src42, DSrc42A, SRC42A, Dtk5, HD-29, Tk5: Tyrosine kinase 5, l(2)k10108, Tyrosine kinase 5" CDMC32858 3 24 7 DAC12-C15 15-CG7873-RA_1 CG7873 GGACCCCATGCGCAGACCCACGTTTGAGACGCTACAATGGAAACTGGAAGACTTCTATACATCTGATCA 69 FBan0007873 FBgn0004603 Src42A 2 2R JNK cascade; GO:0007254; cell communication; GO:0007154; dorsal closure; GO:0007391; eye development (sensu Endopterygota); GO:0007456; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; peptidyl-tyrosine phosphorylation; GO:0018108; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- adherens junction; GO:0005912 Src42A Src oncogene at 42A "CG7873, CG7873, dtk5, Su(D-raf)1, Su(phl)1, Suppressor of raf-like-oncogene, Suppressor of pole hole, Dsrc41, dtk-5, Dm SRC41, Dsrc42A, Su1, DmHD-29, SK2-4, Su(Raf)1, Src41, src, SRC 42A, Src, Src42, src42, DSrc42A, SRC42A, Dtk5, HD-29, Tk5: Tyrosine kinase 5, l(2)k10108, Tyrosine kinase 5" CDMC32859 3 25 7 DAC12-G03 2-CG7906-RA_2 CG7906 GCAACGGCAAATGTGTGGTCAATTTTCCAGGCCAATGTGAGCTGAGTCAGTGGAACTGCTTCAACACCA 69 FBan0007906 FBgn0036417 CG7906 3 3L CG7906 CG7906 CDMC32859 3 26 7 DAC12-G03 2-CG7906-RA_2 CG7906 GCAACGGCAAATGTGTGGTCAATTTTCCAGGCCAATGTGAGCTGAGTCAGTGGAACTGCTTCAACACCA 69 FBan0007906 FBgn0036417 CG7906 3 3L CG7906 CG7906 CDMC32860 3 1 8 DAC12-G15 23-CG7917-RA_1 CG7917 ACAATCTAGTTCCTTTTGAACAGCTCCTTTTACATTCAATTCAAAGACAACGTTGTGTGCTCGGTCGTG 69 FBan0007917 FBgn0016685 Nlp 3 3R nucleosome spacing; GO:0016584 "nucleic acid binding; GO:0003676; histone binding; GO:0042393; ; GO:0003676; ATPase activity, coupled; GO:0042623; ; GO:0042393; ; GO:0042623; ; GO:0042393" nucleolus; GO:0005730; nucleus; GO:0005634 Nlp Nucleoplasmin "CG7917, dNLP, Nucleoplasmin-like, CRP1, p22, dNLP-S, nucleoplasmin-1, Crp1, Chromatin decondensation protein 1" CDMC32860 3 2 8 DAC12-G15 23-CG7917-RA_1 CG7917 ACAATCTAGTTCCTTTTGAACAGCTCCTTTTACATTCAATTCAAAGACAACGTTGTGTGCTCGGTCGTG 69 FBan0007917 FBgn0016685 Nlp 3 3R nucleosome spacing; GO:0016584 "nucleic acid binding; GO:0003676; histone binding; GO:0042393; ; GO:0003676; ATPase activity, coupled; GO:0042623; ; GO:0042393; ; GO:0042623; ; GO:0042393" nucleolus; GO:0005730; nucleus; GO:0005634 Nlp Nucleoplasmin "CG7917, dNLP, Nucleoplasmin-like, CRP1, p22, dNLP-S, nucleoplasmin-1, Crp1, Chromatin decondensation protein 1" CDMC32861 3 3 8 DAC12-K03 15-CG7943-RA_1 CG7943 TCGCCTAAGTCGCTTGTGCACAGATGCTGAATTCTAGGTGTTAATGTACATACACGCATCCCAAGCGGA 69 FBan0007943 FBgn0039741 CG7943 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG7943 CG7943 CDMC32861 3 4 8 DAC12-K03 15-CG7943-RA_1 CG7943 TCGCCTAAGTCGCTTGTGCACAGATGCTGAATTCTAGGTGTTAATGTACATACACGCATCCCAAGCGGA 69 FBan0007943 FBgn0039741 CG7943 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740 CG7943 CG7943 CDMC32862 3 5 8 DAC12-K15 3-CG7954-RA_2 CG7954 TGCTTCCGACCCTTCCAGGATGGGATATTCTACGAGTTCGAGGGCCGTAAGTACTGTGAACGCGACTTT 69 FBan0007954 FBgn0020249 stck 3 3R apposition of dorsal and ventral wing surfaces; GO:0007475; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 stck steamer duck "CG7954, stk, dpin: d-pinch, pin85A, d-pinch, D-PINCH, PINCH, pinch, dPINCH, steamerduck, steamer duck, dpin" CDMC32862 3 6 8 DAC12-K15 3-CG7954-RA_2 CG7954 TGCTTCCGACCCTTCCAGGATGGGATATTCTACGAGTTCGAGGGCCGTAAGTACTGTGAACGCGACTTT 69 FBan0007954 FBgn0020249 stck 3 3R apposition of dorsal and ventral wing surfaces; GO:0007475; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 stck steamer duck "CG7954, stk, dpin: d-pinch, pin85A, d-pinch, D-PINCH, PINCH, pinch, dPINCH, steamerduck, steamer duck, dpin" CDMC32863 3 7 8 DAC12-O03 15-CG7990-RB_5 CG7990 GCGGCTTCTGGTGCTCACGGGGTCAGAAGGTCAGTGGTATAAGCAAATGTAGCCAAGTAAACAATTGTT 69 FBan0007990 FBgn0030997 CG7990 X X cell proliferation; GO:0008283; signal transduction; GO:0007165 CG7990 CG7990 CDMC32863 3 8 8 DAC12-O03 15-CG7990-RB_5 CG7990 GCGGCTTCTGGTGCTCACGGGGTCAGAAGGTCAGTGGTATAAGCAAATGTAGCCAAGTAAACAATTGTT 69 FBan0007990 FBgn0030997 CG7990 X X cell proliferation; GO:0008283; signal transduction; GO:0007165 CG7990 CG7990 CDMC32864 3 9 8 DAC12-O15 23-CG8004-RA_12 CG8004 TTACTCCGTTAATTTACAATGACATCCCAGTACCTGAGCCAGCTAATAACGGCCGACAAATTGTCCGCC 69 FBan0008004 FBgn0036920 CG8004 3 3L protein targeting to mitochondrion; GO:0006626 mitochondrial outer membrane; GO:0005741 CG8004 CG8004 CDMC32864 3 10 8 DAC12-O15 23-CG8004-RA_12 CG8004 TTACTCCGTTAATTTACAATGACATCCCAGTACCTGAGCCAGCTAATAACGGCCGACAAATTGTCCGCC 69 FBan0008004 FBgn0036920 CG8004 3 3L protein targeting to mitochondrion; GO:0006626 mitochondrial outer membrane; GO:0005741 CG8004 CG8004 CDMC32865 3 11 8 DAC13-C03 5-CG13271-RA_1 CG13271 GGTCGCGCTACCGATCTTTGGCGATCAACAGGGAAATGCTGAAATCATGACAAAATCTGGCTTTGGCCG 69 FBan0013271 FBgn0040261 Ugt36Bb 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Bb Ugt36Bb "CG13271, CG13271, AC 005121B" CDMC32865 3 12 8 DAC13-C03 5-CG13271-RA_1 CG13271 GGTCGCGCTACCGATCTTTGGCGATCAACAGGGAAATGCTGAAATCATGACAAAATCTGGCTTTGGCCG 69 FBan0013271 FBgn0040261 Ugt36Bb 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Bb Ugt36Bb "CG13271, CG13271, AC 005121B" CDMC32866 3 13 8 DAC13-C15 1-CG13282-RA_1 CG13282 CGCGCCACAATCCGATGGACAGACAGTGCCTTCACATAGACGAGTCACTGGAGAAGTCCAATCTGACTG 69 FBan0013282 FBgn0032612 CG13282 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG13282 CG13282 CDMC32866 3 14 8 DAC13-C15 1-CG13282-RA_1 CG13282 CGCGCCACAATCCGATGGACAGACAGTGCCTTCACATAGACGAGTCACTGGAGAAGTCCAATCTGACTG 69 FBan0013282 FBgn0032612 CG13282 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG13282 CG13282 CDMC32867 3 15 8 DAC13-G03 3-CG13312-RA_1 CG13312 GGGGTGGCAATATGTACACATGTCCCGGTAGCCTCTACTACAACAGTGCCAGCAGAACATGTGTCTCCA 69 FBan0013312 FBgn0035931 CG13312 3 3L CG13312 CG13312 CDMC32867 3 16 8 DAC13-G03 3-CG13312-RA_1 CG13312 GGGGTGGCAATATGTACACATGTCCCGGTAGCCTCTACTACAACAGTGCCAGCAGAACATGTGTCTCCA 69 FBan0013312 FBgn0035931 CG13312 3 3L CG13312 CG13312 CDMC32868 3 17 8 DAC13-G15 8-CG13319-RA_1 CG13319 TGGATCGATTAATGGGCCCTCTGTTCGAGAAGACGCTAGTCACCTACATGCAAGACCATCTGGAGCACT 69 FBan0013319 FBgn0033781 CG13319 2 2R CG13319 CG13319 BcDNA:GH19585 CDMC32868 3 18 8 DAC13-G15 8-CG13319-RA_1 CG13319 TGGATCGATTAATGGGCCCTCTGTTCGAGAAGACGCTAGTCACCTACATGCAAGACCATCTGGAGCACT 69 FBan0013319 FBgn0033781 CG13319 2 2R CG13319 CG13319 BcDNA:GH19585 CDMC32869 3 19 8 DAC13-K03 23-CG13344-RA_3 CG13344 CCCATAGCACAAAGAAACGTATGAACCCAGCTTGTACTTGAGTTAGTTGGATGATTAAAGTTGAAGCGG 69 FBan0013344 FBgn0033884 CG13344 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG13344 CG13344 "anon-EST:GressD1, anon-EST:GreesD1" CDMC32869 3 20 8 DAC13-K03 23-CG13344-RA_3 CG13344 CCCATAGCACAAAGAAACGTATGAACCCAGCTTGTACTTGAGTTAGTTGGATGATTAAAGTTGAAGCGG 69 FBan0013344 FBgn0033884 CG13344 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG13344 CG13344 "anon-EST:GressD1, anon-EST:GreesD1" CDMC32870 3 21 8 DAC13-K15 3-CG13366-RA_1 CG13366 GCGCAACGCCTTGTTGAAGTGGTGCCAAAACAAAACAGTGGGCTACCGTAACATCGACATCACCAACTT 69 FBan0013366 FBgn0025633 CG13366 X X muscle contraction; GO:0006936 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG13366 CG13366 "EG:118B3.2, AAD55419" CDMC32870 3 22 8 DAC13-K15 3-CG13366-RA_1 CG13366 GCGCAACGCCTTGTTGAAGTGGTGCCAAAACAAAACAGTGGGCTACCGTAACATCGACATCACCAACTT 69 FBan0013366 FBgn0025633 CG13366 X X muscle contraction; GO:0006936 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG13366 CG13366 "EG:118B3.2, AAD55419" CDMC32871 3 23 8 DAC13-O03 13-CG13405-RA_1 CG13405 AGGAGATCCATTTAAAGGTTCTCGTGAATAGAGCCATGCACCTCCAAAACTTCGGTTCACCTAGGCGCT 69 FBan0013405 FBgn0035097 CG13405 3 3L CG13405 CG13405 BcDNA:AT11049 CDMC32871 3 24 8 DAC13-O03 13-CG13405-RA_1 CG13405 AGGAGATCCATTTAAAGGTTCTCGTGAATAGAGCCATGCACCTCCAAAACTTCGGTTCACCTAGGCGCT 69 FBan0013405 FBgn0035097 CG13405 3 3L CG13405 CG13405 BcDNA:AT11049 CDMC32872 3 25 8 DAC13-O15 14-CG13417-RA_1 CG13417 CGCTGCATTGTGGTTATGATATACGCCGGATTATGGCCAATGTTGACCTCAGCCGTAATAGGCAAACGA 69 FBan0013417 FBgn0041229 Gr93a 3 3R "regulation of transcription, DNA-dependent; GO:0006355; sensory perception of taste; GO:0050909" taste receptor activity; GO:0008527; ; GO:0008527; transcription factor activity; GO:0003700; ; GO:0008527; ; GO:0003700 integral to membrane; GO:0016021; nucleus; GO:0005634 Gr93a Gustatory receptor 93a "CG13417, CG13417, 93F.1, Gustatory receptor 93F.1, Gr93F1, GR93F.1, Gustatory receptor 93a" CDMC32872 3 26 8 DAC13-O15 14-CG13417-RA_1 CG13417 CGCTGCATTGTGGTTATGATATACGCCGGATTATGGCCAATGTTGACCTCAGCCGTAATAGGCAAACGA 69 FBan0013417 FBgn0041229 Gr93a 3 3R "regulation of transcription, DNA-dependent; GO:0006355; sensory perception of taste; GO:0050909" taste receptor activity; GO:0008527; ; GO:0008527; transcription factor activity; GO:0003700; ; GO:0008527; ; GO:0003700 integral to membrane; GO:0016021; nucleus; GO:0005634 Gr93a Gustatory receptor 93a "CG13417, CG13417, 93F.1, Gustatory receptor 93F.1, Gr93F1, GR93F.1, Gustatory receptor 93a" CDMC32873 3 1 9 DAC14-C03 3-CG8654-RA_6 CG8654 CTGTGCGCTCATGACCAAGTACCTCGGACGCAAGAAGACCCTGCTTCTTTCCAATGGATGCAGTG 65 FBan0008654 FBgn0034479 CG8654 2 2R anion transport; GO:0006820; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 integral to membrane; GO:0016021 CG8654 CG8654 CDMC32873 3 2 9 DAC14-C03 3-CG8654-RA_6 CG8654 CTGTGCGCTCATGACCAAGTACCTCGGACGCAAGAAGACCCTGCTTCTTTCCAATGGATGCAGTG 65 FBan0008654 FBgn0034479 CG8654 2 2R anion transport; GO:0006820; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; ; GO:0008513 integral to membrane; GO:0016021 CG8654 CG8654 CDMC32874 3 3 9 DAC14-C15 12-CG8708-RA_2 CG8708 TGCTCTATCCGTACAATCCCGAAACACCCGTGCACTTCGGATTCAAGTTCAAGCCCTTCGTGAAG 65 FBan0008708 FBgn0033271 CG8708 2 2R protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG8708 CG8708 "anon-WO0140519.114, anon-WO0144478.10" CDMC32874 3 4 9 DAC14-C15 12-CG8708-RA_2 CG8708 TGCTCTATCCGTACAATCCCGAAACACCCGTGCACTTCGGATTCAAGTTCAAGCCCTTCGTGAAG 65 FBan0008708 FBgn0033271 CG8708 2 2R protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG8708 CG8708 "anon-WO0140519.114, anon-WO0144478.10" CDMC32875 3 5 9 DAC14-G03 23-CG8829-RA_1 CG8829 GATTTCGATTTGATTACAGTGGAGCAAATTGCAAGTGACGTGTCAACAATTGGACTGCATGCAGC 65 FBan0008829 FBgn0031508 CG8829 2 2L CG8829 CG8829 CDMC32875 3 6 9 DAC14-G03 23-CG8829-RA_1 CG8829 GATTTCGATTTGATTACAGTGGAGCAAATTGCAAGTGACGTGTCAACAATTGGACTGCATGCAGC 65 FBan0008829 FBgn0031508 CG8829 2 2L CG8829 CG8829 CDMC32876 3 7 9 DAC14-G15 2-CG8866-RA_1 CG8866 GTGGAAATGTCGACGTTGTCGCAAACCTCGCGGGAAAACCTAATCACCGAAATACGCCTCCTCCG 65 FBan0008866 FBgn0037679 CG8866 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8866 CG8866 UNC 51-like CDMC32876 3 8 9 DAC14-G15 2-CG8866-RA_1 CG8866 GTGGAAATGTCGACGTTGTCGCAAACCTCGCGGGAAAACCTAATCACCGAAATACGCCTCCTCCG 65 FBan0008866 FBgn0037679 CG8866 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8866 CG8866 UNC 51-like CDMC32877 3 9 9 DAC14-K03 1-CG8979-RC_1 CG8979 CTTCTAGACCCTGTATTCACGGGAAACTCGCGCGAAGTTACCACGCAGACGACCAACTCACCACG 65 FBan0008979 FBgn0033669 CG8979 2 2R proteasome inhibitor activity; GO:0008539; ; GO:0008539; ; GO:0008539 CG8979 CG8979 cg8979 CDMC32877 3 10 9 DAC14-K03 1-CG8979-RC_1 CG8979 CTTCTAGACCCTGTATTCACGGGAAACTCGCGCGAAGTTACCACGCAGACGACCAACTCACCACG 65 FBan0008979 FBgn0033669 CG8979 2 2R proteasome inhibitor activity; GO:0008539; ; GO:0008539; ; GO:0008539 CG8979 CG8979 cg8979 CDMC32878 3 11 9 DAC14-K15 3-CG9003-RA_4 CG9003 AAGTGCGCGGACCTCACCGATCTCACTCTGTTGTCCCTCTCGCAGCACAATCATCTACTGAACAC 65 FBan0009003 FBgn0033639 CG9003 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG9003 CG9003 CDMC32878 3 12 9 DAC14-K15 3-CG9003-RA_4 CG9003 AAGTGCGCGGACCTCACCGATCTCACTCTGTTGTCCCTCTCGCAGCACAATCATCTACTGAACAC 65 FBan0009003 FBgn0033639 CG9003 2 2R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG9003 CG9003 CDMC32879 3 13 9 DAC14-O03 3-CG9096-RC_5 CG9096 CAGCACCATAGCTGCATCGAGCATAGCTGCGTCAATGAATGGCCTAAAGTGGCATCTGCGATCGG 65 FBan0009096 FBgn0010315 CycD X X JAK-STAT cascade; GO:0007259; cell growth; GO:0016049; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; mitochondrion organization and biogenesis; GO:0007005; positive regulation of cell growth; GO:0030307; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 CycD Cyclin D "CG9096, CDI3, Cdi3: Cyclin-dependent kinase interactor 3, cycD, cyclin D, cyclinD, DmcycD, cdi3, Cyclin-dependent kinase interactor 3, Cdi3" CDMC32879 3 14 9 DAC14-O03 3-CG9096-RC_5 CG9096 CAGCACCATAGCTGCATCGAGCATAGCTGCGTCAATGAATGGCCTAAAGTGGCATCTGCGATCGG 65 FBan0009096 FBgn0010315 CycD X X JAK-STAT cascade; GO:0007259; cell growth; GO:0016049; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; mitochondrion organization and biogenesis; GO:0007005; positive regulation of cell growth; GO:0030307; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0005515 nucleus; GO:0005634 CycD Cyclin D "CG9096, CDI3, Cdi3: Cyclin-dependent kinase interactor 3, cycD, cyclin D, cyclinD, DmcycD, cdi3, Cyclin-dependent kinase interactor 3, Cdi3" CDMC32880 3 15 9 DAC14-O15 18-CG9115-RA_1 CG9115 ATCGGTCCGCTTGTGGAAGGGCCTATACTGTCGCTGGAATCCTGGTCTGTGCGCTCCTCAGCATG 65 FBan0009115 FBgn0025742 myotubularin 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- myotubularin myotubularin "CG9115, CG9115, dMTMH1, MTM1" CDMC32880 3 16 9 DAC14-O15 18-CG9115-RA_1 CG9115 ATCGGTCCGCTTGTGGAAGGGCCTATACTGTCGCTGGAATCCTGGTCTGTGCGCTCCTCAGCATG 65 FBan0009115 FBgn0025742 myotubularin 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- myotubularin myotubularin "CG9115, CG9115, dMTMH1, MTM1" CDMC32881 3 17 9 DAC15-C03 2-CG8358-RA_4 CG8358 CGATGGCAATGGTCACATGGAGTCCTTGTTGTCGGAAATTTCGCAACAGGCATTAGAGGATCGCGCC 67 FBan0008358 FBgn0037727 CG8358 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11; ; GO:0008270 membrane; GO:0016020 CG8358 CG8358 CDMC32881 3 18 9 DAC15-C03 2-CG8358-RA_4 CG8358 CGATGGCAATGGTCACATGGAGTCCTTGTTGTCGGAAATTTCGCAACAGGCATTAGAGGATCGCGCC 67 FBan0008358 FBgn0037727 CG8358 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004245 ; EC:3.4.24.11; ; GO:0008270 membrane; GO:0016020 CG8358 CG8358 CDMC32882 3 19 9 DAC15-C15 7-CG8476-RA_1 CG8476 CCGCAAGAATCCACGTTTACCGGCAGACGAGTCTATACGGTTTGGTCACAGTATCAGTCCGCTGTCC 67 FBan0008476 FBgn0038127 CG8476 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG8476 CG8476 CDMC32882 3 20 9 DAC15-C15 7-CG8476-RA_1 CG8476 CCGCAAGAATCCACGTTTACCGGCAGACGAGTCTATACGGTTTGGTCACAGTATCAGTCCGCTGTCC 67 FBan0008476 FBgn0038127 CG8476 3 3R protein folding; GO:0006457 unfolded protein binding; GO:0051082; ; GO:0051082 CG8476 CG8476 CDMC32883 3 21 9 DAC15-G03 2-CG8920-RA_2 CG8920 TCGTGTTCGTGCAATTTCTGTGGATGAGGAGACCCGCTCGGGCCGTTATCACTTTATCGACTTTGGC 67 FBan0008920 FBgn0027529 CG8920 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG8920 CG8920 BcDNA:LD21403 CDMC32883 3 22 9 DAC15-G03 2-CG8920-RA_2 CG8920 TCGTGTTCGTGCAATTTCTGTGGATGAGGAGACCCGCTCGGGCCGTTATCACTTTATCGACTTTGGC 67 FBan0008920 FBgn0027529 CG8920 2 2R nucleic acid binding; GO:0003676; ; GO:0003676 CG8920 CG8920 BcDNA:LD21403 CDMC32884 3 23 9 DAC15-G15 3-CG9072-RA_1 CG9072 GGATAACGTCTACTCGGATCCACGCCTCGAGCAACTGATTGTCTATCGGGCTTTGTTGCAGCACCTG 67 FBan0009072 FBgn0030614 CG9072 X X CG9072 CG9072 CDMC32884 3 24 9 DAC15-G15 3-CG9072-RA_1 CG9072 GGATAACGTCTACTCGGATCCACGCCTCGAGCAACTGATTGTCTATCGGGCTTTGTTGCAGCACCTG 67 FBan0009072 FBgn0030614 CG9072 X X CG9072 CG9072 CDMC32885 3 25 9 DAC15-K03 2-CG9398-RA_1 CG9398 TGCACAATAAGACGCCAGTGTGGAACGATGAAACCCAATCGTATGTGCTCAACTTTCATGGGCGCGT 67 FBgn0034589 CDMC32885 3 26 9 DAC15-K03 2-CG9398-RA_1 CG9398 TGCACAATAAGACGCCAGTGTGGAACGATGAAACCCAATCGTATGTGCTCAACTTTCATGGGCGCGT 67 FBgn0034589 CDMC32886 3 1 10 DAC15-K15 1-CG9480-RA_1 CG9480 AAGCTCAAGTCCGAGTCGGGTACCAAGAAGATCGTTCCTTCCGAAAATCCCGGAGATGTGACCACCG 67 FBan0009480 FBgn0034603 Glycogenin 2 2R carbohydrate biosynthesis; GO:0016051; mesoderm development; GO:0007498 glycogenin glucosyltransferase activity; GO:0008466 ; EC:2.4.1.186; ; GO:0008466 ; EC:2.4.1.186 Glycogenin Glycogenin "CG9480, CG9480, CG9480, CG9480, CG9480, FBgn0034603, NEST:bs16a02, Glycogenin" CDMC32886 3 2 10 DAC15-K15 1-CG9480-RA_1 CG9480 AAGCTCAAGTCCGAGTCGGGTACCAAGAAGATCGTTCCTTCCGAAAATCCCGGAGATGTGACCACCG 67 FBan0009480 FBgn0034603 Glycogenin 2 2R carbohydrate biosynthesis; GO:0016051; mesoderm development; GO:0007498 glycogenin glucosyltransferase activity; GO:0008466 ; EC:2.4.1.186; ; GO:0008466 ; EC:2.4.1.186 Glycogenin Glycogenin "CG9480, CG9480, CG9480, CG9480, CG9480, FBgn0034603, NEST:bs16a02, Glycogenin" CDMC32887 3 3 10 DAC15-O03 16-CG9934-RA_1 CG9934 TCAAGAATCCATATGTGACTGCCAAACTGGTTGAGGTGATGTTTGTGTTCTCCTTGAAGCCAGCCAA 67 FBan0009934 FBgn0032467 CG9934 2 2L defense response; GO:0006952; protein ubiquitination; GO:0016567; response to stress; GO:0006950; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CG9934 CG9934 CDMC32887 3 4 10 DAC15-O03 16-CG9934-RA_1 CG9934 TCAAGAATCCATATGTGACTGCCAAACTGGTTGAGGTGATGTTTGTGTTCTCCTTGAAGCCAGCCAA 67 FBan0009934 FBgn0032467 CG9934 2 2L defense response; GO:0006952; protein ubiquitination; GO:0016567; response to stress; GO:0006950; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 CG9934 CG9934 CDMC32888 3 5 10 DAC15-O15 16-CR33326-RA_1 CR33326 AGTGTGGTTAGCTGGTTGTGTAGCCAATTATTGCCGTTGACAATTCACAGCCACTATCTTCACTGCC 67 FBgn0053326 CDMC32888 3 6 10 DAC15-O15 16-CR33326-RA_1 CR33326 AGTGTGGTTAGCTGGTTGTGTAGCCAATTATTGCCGTTGACAATTCACAGCCACTATCTTCACTGCC 67 FBgn0053326 CDMC32889 3 7 10 DAC16-C03 15-CG4897-RA_1 CG4897 GCTGCGCAAGATGGTCTAAGGACTCCTTTTGATTTATGTGCTGAAACGACAACTGCAGCGGTTCGATGT 69 FBan0004897 FBgn0005593 RpL7 2 2L protein biosynthesis; GO:0006412; proteolysis; GO:0006508; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; rRNA binding; GO:0019843; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003735; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0019843; ; GO:0004197 ; EC:3.4.22.-; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7 Ribosomal protein L7 "CG4897, CG4897, L7, BEST:GH04411" CDMC32889 3 8 10 DAC16-C03 15-CG4897-RA_1 CG4897 GCTGCGCAAGATGGTCTAAGGACTCCTTTTGATTTATGTGCTGAAACGACAACTGCAGCGGTTCGATGT 69 FBan0004897 FBgn0005593 RpL7 2 2L protein biosynthesis; GO:0006412; proteolysis; GO:0006508; regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; structural constituent of ribosome; GO:0003735; rRNA binding; GO:0019843; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003735; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0019843; ; GO:0004197 ; EC:3.4.22.-; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7 Ribosomal protein L7 "CG4897, CG4897, L7, BEST:GH04411" CDMC32890 3 9 10 DAC16-C15 3-CG4899-RA_3 CG4899 TGAAGCCACAAGGAATACCACCGACTACTACACGAATCAGCCAGACCAAGATGTCCTTTCGCGGCAAGA 69 FBan0004899 FBgn0011693 Pdh 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0016616 ; EC:1.1.1.-; ; GO:0004022 ; EC:1.1.1.1" Pdh Photoreceptor dehydrogenase "CG4899, pcdr, pigment cell dehydrogenase reductase" CDMC32890 3 10 10 DAC16-C15 3-CG4899-RA_3 CG4899 TGAAGCCACAAGGAATACCACCGACTACTACACGAATCAGCCAGACCAAGATGTCCTTTCGCGGCAAGA 69 FBan0004899 FBgn0011693 Pdh 3 3L lipid metabolism; GO:0006629 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0016616 ; EC:1.1.1.-; ; GO:0004022 ; EC:1.1.1.1" Pdh Photoreceptor dehydrogenase "CG4899, pcdr, pigment cell dehydrogenase reductase" CDMC32891 3 11 10 DAC16-G03 3-CG4933-RA_1 CG4933 CCGCTCTGGCACTAGGATGCCCTTTGAGGAATCTTATGTGACTCAGCGATTTCGAACGGACGAAGTGCT 69 FBan0004933 FBgn0036615 CG4933 3 3L proteolysis; GO:0006508 O-sialoglycoprotein endopeptidase activity; GO:0008450 ; EC:3.4.24.57; zinc ion binding; GO:0008270; ; GO:0008450 ; EC:3.4.24.57; ; GO:0008270 CG4933 CG4933 CDMC32891 3 12 10 DAC16-G03 3-CG4933-RA_1 CG4933 CCGCTCTGGCACTAGGATGCCCTTTGAGGAATCTTATGTGACTCAGCGATTTCGAACGGACGAAGTGCT 69 FBan0004933 FBgn0036615 CG4933 3 3L proteolysis; GO:0006508 O-sialoglycoprotein endopeptidase activity; GO:0008450 ; EC:3.4.24.57; zinc ion binding; GO:0008270; ; GO:0008450 ; EC:3.4.24.57; ; GO:0008270 CG4933 CG4933 CDMC32892 3 13 10 DAC16-G15 3-CG4944-RA_3 CG4944 TTGGAGGGATTCAACCAGGACAAACTGAAGAACGCTAGCACCCAGGAGAAGATCATTCTTCCCACCGCC 69 FBan0004944 FBgn0026084 cib X X brain development; GO:0007420; central nervous system remodeling (sensu Insecta); GO:0035193; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; actin monomer binding; GO:0003785; ; GO:0003785 cytosol; GO:0005829 cib ciboulot "CG4944, CG4944, CG4944, EG0007-11, EG:EG0007.11, ciboulot" CDMC32892 3 14 10 DAC16-G15 3-CG4944-RA_3 CG4944 TTGGAGGGATTCAACCAGGACAAACTGAAGAACGCTAGCACCCAGGAGAAGATCATTCTTCCCACCGCC 69 FBan0004944 FBgn0026084 cib X X brain development; GO:0007420; central nervous system remodeling (sensu Insecta); GO:0035193; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; actin monomer binding; GO:0003785; ; GO:0003785 cytosol; GO:0005829 cib ciboulot "CG4944, CG4944, CG4944, EG0007-11, EG:EG0007.11, ciboulot" CDMC32893 3 15 10 DAC16-K03 17-CG4974-RA_1 CG4974 CCCTTGAAGTGCACCTCTCCTTCTAGCTTTTCCAAATTTGATGCTCATCGAACTTCCATGCCGAATCCA 69 FBan0004974 FBgn0011577 dally 3 3L Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; decapentaplegic receptor signaling pathway; GO:0008101; meiotic G2/MI transition; GO:0008315; nervous system development; GO:0007399; regulation of progression through cell cycle; GO:0000074; sensory organ determination; GO:0008052; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc dorsal/ventral pattern formation; GO:0048190 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576; extrinsic to plasma membrane; GO:0019897 dally division abnormally delayed "CG4974, CG4974, CG4974, CG4974, gem, genitalia missing, Dally, clone 1.63, CT15952, anon-EST:Liang-1.63, l(3)06464, division abnormally delayed" CDMC32893 3 16 10 DAC16-K03 17-CG4974-RA_1 CG4974 CCCTTGAAGTGCACCTCTCCTTCTAGCTTTTCCAAATTTGATGCTCATCGAACTTCCATGCCGAATCCA 69 FBan0004974 FBgn0011577 dally 3 3L Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; decapentaplegic receptor signaling pathway; GO:0008101; meiotic G2/MI transition; GO:0008315; nervous system development; GO:0007399; regulation of progression through cell cycle; GO:0000074; sensory organ determination; GO:0008052; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc dorsal/ventral pattern formation; GO:0048190 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576; extrinsic to plasma membrane; GO:0019897 dally division abnormally delayed "CG4974, CG4974, CG4974, CG4974, gem, genitalia missing, Dally, clone 1.63, CT15952, anon-EST:Liang-1.63, l(3)06464, division abnormally delayed" CDMC32894 3 17 10 DAC16-K15 23-CG4982-RA_2 CG4982 ACCCCAGCATTTATCTGAAGTAGAACAACGAACAAAGAAACCCTTCTCCACAGAAAATCTCATTTTTGG 69 FBan0004982 FBgn0036598 CG4982 3 3L CG4982 CG4982 CDMC32894 3 18 10 DAC16-K15 23-CG4982-RA_2 CG4982 ACCCCAGCATTTATCTGAAGTAGAACAACGAACAAAGAAACCCTTCTCCACAGAAAATCTCATTTTTGG 69 FBan0004982 FBgn0036598 CG4982 3 3L CG4982 CG4982 CDMC32895 3 19 10 DAC16-O03 23-CG5014-RA_7 CG5014 TCGCAAGGGGGAACATCTCTCAAGAACTCTTTAAAATCCGCTAAGATCCATACGTATATTTGCTCAGAT 69 FBan0005014 FBgn0029687 Vap-33-1 X X intracellular protein transport; GO:0006886; neuromuscular junction development; GO:0007528; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; synaptic vesicle priming; GO:0016082; transmission of nerve impulse; GO:0019226; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 synaptic vesicle; GO:0008021 Vap-33-1 Vap-33-1 "CG5014, CG5014, CG5014, clone 2.42, l(1)G0231, VAP-33-1, DVAP-33A, vap-33A, anon-WO03040301.124, BcDNA:GM03307, anon-EST:Liang-2.42" CDMC32895 3 20 10 DAC16-O03 23-CG5014-RA_7 CG5014 TCGCAAGGGGGAACATCTCTCAAGAACTCTTTAAAATCCGCTAAGATCCATACGTATATTTGCTCAGAT 69 FBan0005014 FBgn0029687 Vap-33-1 X X intracellular protein transport; GO:0006886; neuromuscular junction development; GO:0007528; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; synaptic vesicle priming; GO:0016082; transmission of nerve impulse; GO:0019226; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 synaptic vesicle; GO:0008021 Vap-33-1 Vap-33-1 "CG5014, CG5014, CG5014, clone 2.42, l(1)G0231, VAP-33-1, DVAP-33A, vap-33A, anon-WO03040301.124, BcDNA:GM03307, anon-EST:Liang-2.42" CDMC32896 3 21 10 DAC16-O15 1-CG5026-RA_2 CG5026 GAAGGGGTTCATCGTGGACACTTGGGGTAAGGGCAAATCGAATACGGAAACTGACCTGCACTACTCGCA 69 FBan0005026 FBgn0035945 CG5026 3 3L protein metabolism; GO:0019538 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG5026 CG5026 CDMC32896 3 22 10 DAC16-O15 1-CG5026-RA_2 CG5026 GAAGGGGTTCATCGTGGACACTTGGGGTAAGGGCAAATCGAATACGGAAACTGACCTGCACTACTCGCA 69 FBan0005026 FBgn0035945 CG5026 3 3L protein metabolism; GO:0019538 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG5026 CG5026 CDMC32897 3 23 10 DAC17-C03 16-CG7104-RA_1 CG7104 CGCCTACGATCCTGATAACGATTGCAAGGGCATTTTTATGGATTGGTTCCTGTTTCCTTCGTGCTGTGT 69 FBan0007104 FBgn0031959 Spz3 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Spz3 Spz3 "CG14533, CG7104, CG14533" CDMC32897 3 24 10 DAC17-C03 16-CG7104-RA_1 CG7104 CGCCTACGATCCTGATAACGATTGCAAGGGCATTTTTATGGATTGGTTCCTGTTTCCTTCGTGCTGTGT 69 FBan0007104 FBgn0031959 Spz3 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Spz3 Spz3 "CG14533, CG7104, CG14533" CDMC32898 3 25 10 DAC17-C15 12-CG7112-RA_3 CG7112 CGCCTCCCAATGGTTCCTAACCTTATATACAGCGCGATTCCCATTGTGTTTTGTGTTCCACGTGCTGGA 69 FBan0007112 FBgn0035879 CG7112 3 3L chromosome segregation; GO:0007059; mitosis; GO:0007067; transport; GO:0006810 Rab GTPase activator activity; GO:0005097; ; GO:0005097 CG7112 CG7112 CDMC32898 3 26 10 DAC17-C15 12-CG7112-RA_3 CG7112 CGCCTCCCAATGGTTCCTAACCTTATATACAGCGCGATTCCCATTGTGTTTTGTGTTCCACGTGCTGGA 69 FBan0007112 FBgn0035879 CG7112 3 3L chromosome segregation; GO:0007059; mitosis; GO:0007067; transport; GO:0006810 Rab GTPase activator activity; GO:0005097; ; GO:0005097 CG7112 CG7112 CDMC32899 3 1 11 DAC17-G03 8-CG7154-RA_1 CG7154 ACGAGGGTCCTGAAAGGGTAGTAACAATTGGTGATCTAGTTGGCAAACTGCAAAAGGGAAGCGCACAGC 69 FBan0007154 FBgn0031947 CG7154 2 2L DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 nucleus; GO:0005634 CG7154 CG7154 CDMC32899 3 2 11 DAC17-G03 8-CG7154-RA_1 CG7154 ACGAGGGTCCTGAAAGGGTAGTAACAATTGGTGATCTAGTTGGCAAACTGCAAAAGGGAAGCGCACAGC 69 FBan0007154 FBgn0031947 CG7154 2 2L DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 nucleus; GO:0005634 CG7154 CG7154 CDMC32900 3 3 11 DAC17-G15 23-CG7168-RA_3 CG7168 GCGCATTCGCAATATTGTCGACGGAATACACTGATACGACTCCAGAACTCATACACTTGTTAAAGCTAA 69 FBan0007168 FBgn0038586 CG7168 3 3R CG7168 CG7168 CDMC32900 3 4 11 DAC17-G15 23-CG7168-RA_3 CG7168 GCGCATTCGCAATATTGTCGACGGAATACACTGATACGACTCCAGAACTCATACACTTGTTAAAGCTAA 69 FBan0007168 FBgn0038586 CG7168 3 3R CG7168 CG7168 CDMC32901 3 5 11 DAC17-K03 16-CG7196-RA_1 CG7196 TGGTTTCCCATCCATGAGAGTCCAGATATTTCACCAAATCGTGCAAACATCAATTAGGCTGGGGTACCT 69 FBan0007196 FBgn0031944 CG7196 2 2L CG7196 CG7196 CDMC32901 3 6 11 DAC17-K03 16-CG7196-RA_1 CG7196 TGGTTTCCCATCCATGAGAGTCCAGATATTTCACCAAATCGTGCAAACATCAATTAGGCTGGGGTACCT 69 FBan0007196 FBgn0031944 CG7196 2 2L CG7196 CG7196 CDMC32902 3 7 11 DAC17-K15 3-CG7214-RA_1 CG7214 CGCTCTTAGTCCCAACCCCCTCGATACGAACACGATCCTGATCTTGGGTCCATGTCCATATCCTCTGGA 69 FBan0007214 FBgn0031940 CG7214 2 2L CG7214 CG7214 CDMC32902 3 8 11 DAC17-K15 3-CG7214-RA_1 CG7214 CGCTCTTAGTCCCAACCCCCTCGATACGAACACGATCCTGATCTTGGGTCCATGTCCATATCCTCTGGA 69 FBan0007214 FBgn0031940 CG7214 2 2L CG7214 CG7214 CDMC32903 3 9 11 DAC17-O03 7-CG7257-RA_1 CG7257 CCCCTGGTGTACAACATGACCCATGAAGATCCCGGAAACGTAAACTACGCTGAAATCGGTGGACTTGGT 69 FBan0007257 FBgn0036224 CG7257 3 3L proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0003676; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG7257 CG7257 "DmCG7257, Dm_Rpt4c" CDMC32903 3 10 11 DAC17-O03 7-CG7257-RA_1 CG7257 CCCCTGGTGTACAACATGACCCATGAAGATCCCGGAAACGTAAACTACGCTGAAATCGGTGGACTTGGT 69 FBan0007257 FBgn0036224 CG7257 3 3L proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0003676; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG7257 CG7257 "DmCG7257, Dm_Rpt4c" CDMC32904 3 11 11 DAC17-O15 3-CG7266-RC_3 CG7266 CCACCAATCTCAACAGGGGCGATCATACGGAGGTGCTGGAAATCGACTATGATCCCACGGTCATTAGCT 69 FBan0007266 FBgn0000565 Eip71CD 3 3L autophagic cell death; GO:0048102; defense response; GO:0006952; protein modification; GO:0006464; response to stress; GO:0006950; salivary gland cell autophagic cell death; GO:0035071; sulfur amino acid metabolism; GO:0000096 protein-methionine-S-oxide reductase activity; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6 Eip71CD Ecdysone-induced protein 28/29kD "CG7266, Eip28/29, Eip28, DROZ60MEX, Eip28 /29, eip28/29, MsrA, methionine-S-sulfoxide reductase, Eip71C" CDMC32904 3 12 11 DAC17-O15 3-CG7266-RC_3 CG7266 CCACCAATCTCAACAGGGGCGATCATACGGAGGTGCTGGAAATCGACTATGATCCCACGGTCATTAGCT 69 FBan0007266 FBgn0000565 Eip71CD 3 3L autophagic cell death; GO:0048102; defense response; GO:0006952; protein modification; GO:0006464; response to stress; GO:0006950; salivary gland cell autophagic cell death; GO:0035071; sulfur amino acid metabolism; GO:0000096 protein-methionine-S-oxide reductase activity; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6 Eip71CD Ecdysone-induced protein 28/29kD "CG7266, Eip28/29, Eip28, DROZ60MEX, Eip28 /29, eip28/29, MsrA, methionine-S-sulfoxide reductase, Eip71C" CDMC32905 3 13 11 DAC18-C03 3-CG32407-RA_9 CG32407 GCTCGCAGGTTAGACATTCCGCTCCCAGATAAAGAAAACTACCCCCCCGAGCTCGTCCACGAAAATTGT 69 FBan0032407 FBgn0052407 CG32407 3 3L CG32407 CG32407 "CG10727, BcDNA:AT29938" CDMC32905 3 14 11 DAC18-C03 3-CG32407-RA_9 CG32407 GCTCGCAGGTTAGACATTCCGCTCCCAGATAAAGAAAACTACCCCCCCGAGCTCGTCCACGAAAATTGT 69 FBan0032407 FBgn0052407 CG32407 3 3L CG32407 CG32407 "CG10727, BcDNA:AT29938" CDMC32906 3 15 11 DAC18-C15 2-CG32417-RA_1 CG32417 AGGTCCTGGACACCTCATCGTTCCGACGCAAAAAGCTCTTCGTCCTGGAATATGACGACGAGTGAGTGA 69 FBan0032417 FBgn0040298 Myt1 3 3L G2/M transition of mitotic cell cycle; GO:0000086; male germ-line stem cell division; GO:0048133; mitosis; GO:0007067; negative regulation of progression through mitotic cell cycle; GO:0045930; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.- Golgi apparatus; GO:0005794; cytoplasm; GO:0005737 Myt1 Myt1 "CG10569, CG32417, CG10569, CG10569, Dmyt1, MYT 1, dMyt1" CDMC32906 3 16 11 DAC18-C15 2-CG32417-RA_1 CG32417 AGGTCCTGGACACCTCATCGTTCCGACGCAAAAAGCTCTTCGTCCTGGAATATGACGACGAGTGAGTGA 69 FBan0032417 FBgn0040298 Myt1 3 3L G2/M transition of mitotic cell cycle; GO:0000086; male germ-line stem cell division; GO:0048133; mitosis; GO:0007067; negative regulation of progression through mitotic cell cycle; GO:0045930; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.-; ; GO:0004712 ; EC:2.7.1.- Golgi apparatus; GO:0005794; cytoplasm; GO:0005737 Myt1 Myt1 "CG10569, CG32417, CG10569, CG10569, Dmyt1, MYT 1, dMyt1" CDMC32907 3 17 11 DAC18-G03 23-CG32451-RB_1 CG32451 CCTGCAGATCGCATTTAAAGGACCAATCGTTAAATACTTCATTTGATCACACACATTAAGATCAGCTTA 69 FBan0032451 FBgn0052451 SPoCk 3 3L calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; diuresis; GO:0030146; metabolism; GO:0008152; proton transport; GO:0015992 ATP binding; GO:0005524; ; GO:0005524; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020; peroxisome; GO:0005777 SPoCk Secretory Pathway Calcium atpase "CG32451, CG14449, CG7651, anon-WO0118547.249, Secretory Pathway Calcium atpase" CDMC32907 3 18 11 DAC18-G03 23-CG32451-RB_1 CG32451 CCTGCAGATCGCATTTAAAGGACCAATCGTTAAATACTTCATTTGATCACACACATTAAGATCAGCTTA 69 FBan0032451 FBgn0052451 SPoCk 3 3L calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; diuresis; GO:0030146; metabolism; GO:0008152; proton transport; GO:0015992 ATP binding; GO:0005524; ; GO:0005524; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021; membrane; GO:0016020; peroxisome; GO:0005777 SPoCk Secretory Pathway Calcium atpase "CG32451, CG14449, CG7651, anon-WO0118547.249, Secretory Pathway Calcium atpase" CDMC32908 3 19 11 DAC18-G15 9-CG3245-RA_2 CG3245 GCGTGAGCCACACCTTCGGTTCAGATGTGGTCAGTGCCTTCTTGCACCGATTCAAATTGAACCTCATTT 69 FBan0003245 FBgn0025573 PpN58A 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 nucleus; GO:0005634 PpN58A Protein phosphatase N at 58A "CG3245, CG3245, PPN 58A, PPN, Protein phosphatase N at 58A" CDMC32908 3 20 11 DAC18-G15 9-CG3245-RA_2 CG3245 GCGTGAGCCACACCTTCGGTTCAGATGTGGTCAGTGCCTTCTTGCACCGATTCAAATTGAACCTCATTT 69 FBan0003245 FBgn0025573 PpN58A 2 2R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 nucleus; GO:0005634 PpN58A Protein phosphatase N at 58A "CG3245, CG3245, PPN 58A, PPN, Protein phosphatase N at 58A" CDMC32909 3 21 11 DAC18-K03 2-CG32491-RG_1 CG32491 CCGCGGTGGACAAAAACTCACAGGAGCGAATCATCAAATGCACCTACGAGCATGATCACAGCCGGAAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC32909 3 22 11 DAC18-K03 2-CG32491-RG_1 CG32491 CCGCGGTGGACAAAAACTCACAGGAGCGAATCATCAAATGCACCTACGAGCATGATCACAGCCGGAAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC32910 3 23 11 DAC18-K15 12-CG32491-RT_1 CG32491 CGCCAAGGAGGAAGAAGTGGACCCCAATGATTTCCGTGAAAAAATCAAGCGACGACTGCAAAAAGCACT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC32910 3 24 11 DAC18-K15 12-CG32491-RT_1 CG32491 CGCCAAGGAGGAAGAAGTGGACCCCAATGATTTCCGTGAAAAAATCAAGCGACGACTGCAAAAAGCACT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC32911 3 25 11 DAC18-O03 23-CG32529-RA_15 CG32529 ACAAACATACACCAGACCAAAATGTAGGCGAAGGCTTTTCACTTAGACGTGAGAATTTCGAGAGATGCG 69 FBan0032529 FBgn0052529 CG32529 X X DNA binding; GO:0003677; ; GO:0003677 CG32529 CG32529 "CG15619, CG11936, CG15619" CDMC32911 3 26 11 DAC18-O03 23-CG32529-RA_15 CG32529 ACAAACATACACCAGACCAAAATGTAGGCGAAGGCTTTTCACTTAGACGTGAGAATTTCGAGAGATGCG 69 FBan0032529 FBgn0052529 CG32529 X X DNA binding; GO:0003677; ; GO:0003677 CG32529 CG32529 "CG15619, CG11936, CG15619" CDMC32912 3 1 12 DAC18-O15 23-CG32542-RA_1 CG32542 TGCCAGGATTTCTTTTGCTTCGACCTACATATATGTGTCCGTCTTTTCCGACTTTATAACGACCGAGCA 69 FBan0032542 FBgn0052542 CG32542 X X CG32542 CG32542 "CG7307, CG15037, CG7317, CG7307, CG7307" CDMC32912 3 2 12 DAC18-O15 23-CG32542-RA_1 CG32542 TGCCAGGATTTCTTTTGCTTCGACCTACATATATGTGTCCGTCTTTTCCGACTTTATAACGACCGAGCA 69 FBan0032542 FBgn0052542 CG32542 X X CG32542 CG32542 "CG7307, CG15037, CG7317, CG7307, CG7307" CDMC32913 3 3 12 DAC19-C03 15-CG8181-RA_1 CG8181 CTGAAACCACCGATTACAGCGGCGAAGAACCGAACACAACGACCATCGAGGCTACAGGCAGCACC 65 FBan0008181 FBgn0033361 CG8181 2 2R serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG8181 CG8181 CDMC32913 3 4 12 DAC19-C03 15-CG8181-RA_1 CG8181 CTGAAACCACCGATTACAGCGGCGAAGAACCGAACACAACGACCATCGAGGCTACAGGCAGCACC 65 FBan0008181 FBgn0033361 CG8181 2 2R serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG8181 CG8181 CDMC32914 3 5 12 DAC19-C15 23-CG8206-RA_1 CG8206 GTTGATTGTTTCGGGCCGTGAGTAATGCCTAAAAAAGTGATTAAAGGAACGACCAGTTCAAAAGC 65 FBan0008206 FBgn0030679 CG8206 X X CG8206 CG8206 CDMC32914 3 6 12 DAC19-C15 23-CG8206-RA_1 CG8206 GTTGATTGTTTCGGGCCGTGAGTAATGCCTAAAAAAGTGATTAAAGGAACGACCAGTTCAAAAGC 65 FBan0008206 FBgn0030679 CG8206 X X CG8206 CG8206 CDMC32915 3 7 12 DAC19-G03 3-CG8273-RA_2 CG8273 GTCACCCAGGATAAGCATCCCGTGTGTGTGCTCAACGAACTGACCTCGAAGAACAAGTGGATGCC 65 FBan0008273 FBgn0037716 CG8273 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG8273 CG8273 cg8273 CDMC32915 3 8 12 DAC19-G03 3-CG8273-RA_2 CG8273 GTCACCCAGGATAAGCATCCCGTGTGTGTGCTCAACGAACTGACCTCGAAGAACAAGTGGATGCC 65 FBan0008273 FBgn0037716 CG8273 3 3R mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG8273 CG8273 cg8273 CDMC32916 3 9 12 DAC19-G15 1-CG8306-RA_1 CG8306 AACAGCTATCTGCACGACTATCCTCTGAACAGTGCCGTCTGGTATCCCAACCTGCGTCTGGTGAA 65 FBan0008306 FBgn0034142 CG8306 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8306 CG8306 CDMC32916 3 10 12 DAC19-G15 1-CG8306-RA_1 CG8306 AACAGCTATCTGCACGACTATCCTCTGAACAGTGCCGTCTGGTATCCCAACCTGCGTCTGGTGAA 65 FBan0008306 FBgn0034142 CG8306 2 2R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8306 CG8306 CDMC32917 3 11 12 DAC19-K03 2-CG8398-RA_3 CG8398 ACTTCGAGCTGATCGTCCGCTACATGGAGAAGCACTTCATTCCCTACCGCGATCACAAGCACCTG 65 FBan0008398 FBgn0035708 CG8398 3 3L CG8398 CG8398 anon-EST:Posey31 CDMC32917 3 12 12 DAC19-K03 2-CG8398-RA_3 CG8398 ACTTCGAGCTGATCGTCCGCTACATGGAGAAGCACTTCATTCCCTACCGCGATCACAAGCACCTG 65 FBan0008398 FBgn0035708 CG8398 3 3L CG8398 CG8398 anon-EST:Posey31 CDMC32918 3 13 12 DAC19-K15 3-CG8418-RA_1 CG8418 ATTACATCGACGAGGCATTCTACACGTTGGTCCGCGAGATTCGACGCAAGGAAATGCACAAGGCC 65 FBan0008418 FBgn0017549 Ric 2 2R DNA replication; GO:0006260; G-protein coupled receptor protein signaling pathway; GO:0007186; cell motility; GO:0006928; cell proliferation; GO:0008283; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; muscle contraction; GO:0006936; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; transmission of nerve impulse; GO:0019226 "DNA binding; GO:0003677; calmodulin binding; GO:0005516; GTP binding; GO:0005525; ; GO:0005516; ; GO:0005516; ; GO:0005516; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525; ; GO:0005516; ; GO:0003677; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408" plasma membrane; GO:0005886 Ric Ras which interacts with Calmodulin "CG8418, RIC, Ras-related which interacted with Calmodulin" CDMC32918 3 14 12 DAC19-K15 3-CG8418-RA_1 CG8418 ATTACATCGACGAGGCATTCTACACGTTGGTCCGCGAGATTCGACGCAAGGAAATGCACAAGGCC 65 FBan0008418 FBgn0017549 Ric 2 2R DNA replication; GO:0006260; G-protein coupled receptor protein signaling pathway; GO:0007186; cell motility; GO:0006928; cell proliferation; GO:0008283; cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; muscle contraction; GO:0006936; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264; transmission of nerve impulse; GO:0019226 "DNA binding; GO:0003677; calmodulin binding; GO:0005516; GTP binding; GO:0005525; ; GO:0005516; ; GO:0005516; ; GO:0005516; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525; ; GO:0005516; ; GO:0003677; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408" plasma membrane; GO:0005886 Ric Ras which interacts with Calmodulin "CG8418, RIC, Ras-related which interacted with Calmodulin" CDMC32919 3 15 12 DAC19-O03 3-CG8510-RA_1 CG8510 TCTTGAAGTCCGTGAATGCCGATCACAACGGGGAGTCGGTCAATGGAAAGTACTCCTTCGTCGCC 65 FBan0008510 FBgn0033729 CG8510 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG8510 CG8510 CDMC32919 3 16 12 DAC19-O03 3-CG8510-RA_1 CG8510 TCTTGAAGTCCGTGAATGCCGATCACAACGGGGAGTCGGTCAATGGAAAGTACTCCTTCGTCGCC 65 FBan0008510 FBgn0033729 CG8510 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG8510 CG8510 CDMC32920 3 17 12 DAC19-O15 2-CG8560-RA_1 CG8560 GTTAGCTTCAAGGCGTTCCATCGTCATGCCGAGATCAATGCCTACCTGGATGAACTGGCTGCTGC 65 FBan0008560 FBgn0035781 CG8560 3 3L proteolysis; GO:0006508 NOT carboxypeptidase activity; GO:0004180; ; GO:0004180; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG8560 CG8560 CT14378 CDMC32920 3 18 12 DAC19-O15 2-CG8560-RA_1 CG8560 GTTAGCTTCAAGGCGTTCCATCGTCATGCCGAGATCAATGCCTACCTGGATGAACTGGCTGCTGC 65 FBan0008560 FBgn0035781 CG8560 3 3L proteolysis; GO:0006508 NOT carboxypeptidase activity; GO:0004180; ; GO:0004180; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG8560 CG8560 CT14378 CDMC32921 3 19 12 DAC20-C03 23-CG7672-RA_14 CG7672 TCCCATCTGGATAAGAAACCTTAAAGGAGGACCACTCAGTGAATTATACGGGGATAGTCACTCTATCGC 69 FBan0007672 FBgn0004618 gl 3 3R cell proliferation; GO:0008283; entrainment of circadian clock; GO:0009649; eye photoreceptor development (sensu Endopterygota); GO:0042051; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 gl glass "CG7672, none: no-ocelli--narrow-eyes, E(sina)5, Enhancer of seven in absentia 5, Glass, SS3-2, Suppressor of GMR-sina 3-2, SY3-3, rh, no-ocelli--narrow-eyes, rauhig, none, glass" CDMC32921 3 20 12 DAC20-C03 23-CG7672-RA_14 CG7672 TCCCATCTGGATAAGAAACCTTAAAGGAGGACCACTCAGTGAATTATACGGGGATAGTCACTCTATCGC 69 FBan0007672 FBgn0004618 gl 3 3R cell proliferation; GO:0008283; entrainment of circadian clock; GO:0009649; eye photoreceptor development (sensu Endopterygota); GO:0042051; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; regulation of transcription from RNA polymerase II promoter; GO:0006357; ring gland development; GO:0035271 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 gl glass "CG7672, none: no-ocelli--narrow-eyes, E(sina)5, Enhancer of seven in absentia 5, Glass, SS3-2, Suppressor of GMR-sina 3-2, SY3-3, rh, no-ocelli--narrow-eyes, rauhig, none, glass" CDMC32922 3 21 12 DAC20-C15 23-CG7693-RA_4 CG7693 TGAAGAATCGTGTACTTATTCGTTTCGTTTGTCTTTAAGTAGCTCTGTACATACACCCCACACGTATAT 69 FBan0007693 FBgn0023083 fray 3 3R MAPKKK cascade; GO:0000165; axonal fasciculation; GO:0007413; cell proliferation; GO:0008283; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; establishment of blood-nerve barrier; GO:0008065; induction of apoptosis; GO:0006917; nerve ensheathment; GO:0008366; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 fray frayed "CG7693, CG7693, CG7693, 4624, lag, laggard, l(3)07551, Ste20-like protein kinase, Ste20-like, STE20-like/SPAK" CDMC32922 3 22 12 DAC20-C15 23-CG7693-RA_4 CG7693 TGAAGAATCGTGTACTTATTCGTTTCGTTTGTCTTTAAGTAGCTCTGTACATACACCCCACACGTATAT 69 FBan0007693 FBgn0023083 fray 3 3R MAPKKK cascade; GO:0000165; axonal fasciculation; GO:0007413; cell proliferation; GO:0008283; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; establishment of blood-nerve barrier; GO:0008065; induction of apoptosis; GO:0006917; nerve ensheathment; GO:0008366; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 fray frayed "CG7693, CG7693, CG7693, 4624, lag, laggard, l(3)07551, Ste20-like protein kinase, Ste20-like, STE20-like/SPAK" CDMC32923 3 23 12 DAC20-G03 3-CG7726-RA_2 CG7726 GCAACTTCGGTTTCGGCATCCAGGAACACATCGATCTGGGCATCAAGTACGATCCCTCCATCGGTATCT 69 FBan0007726 FBgn0013325 RpL11 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; protein binding; GO:0005515; ; GO:0003676; ; GO:0005515; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL11 Ribosomal protein L11 "CG7726, l(2)k16914, DL11, ribosomal protein DL11, EST A, L11, BcDNA:LD17235, Ribosomal protein L11" CDMC32923 3 24 12 DAC20-G03 3-CG7726-RA_2 CG7726 GCAACTTCGGTTTCGGCATCCAGGAACACATCGATCTGGGCATCAAGTACGATCCCTCCATCGGTATCT 69 FBan0007726 FBgn0013325 RpL11 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; protein binding; GO:0005515; ; GO:0003676; ; GO:0005515; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL11 Ribosomal protein L11 "CG7726, l(2)k16914, DL11, ribosomal protein DL11, EST A, L11, BcDNA:LD17235, Ribosomal protein L11" CDMC32924 3 25 12 DAC20-G15 2-CG7741-RA_2 CG7741 GGATGCCCAAAGATGAGACTACCCAGTTTGAACTGTGCACTCGCTTCATTTCCCTTGCGGAAGTGGGAA 69 FBan0007741 FBgn0033615 CG7741 2 2R RNA lariat debranching enzyme activity; GO:0008419; ; GO:0008419 CG7741 CG7741 CDMC32924 3 26 12 DAC20-G15 2-CG7741-RA_2 CG7741 GGATGCCCAAAGATGAGACTACCCAGTTTGAACTGTGCACTCGCTTCATTTCCCTTGCGGAAGTGGGAA 69 FBan0007741 FBgn0033615 CG7741 2 2R RNA lariat debranching enzyme activity; GO:0008419; ; GO:0008419 CG7741 CG7741 CDMC32925 3 1 13 DAC20-K03 13-CG7773-RA_1 CG7773 TGAGCGGCAAGCATCTGGAAACCAAGCAATATTACACCCTGTACAACACACTCAACGACAAAAAGCGCT 69 FBan0007773 FBgn0025519 fidipidine 2 2R fidipidine fidipidine CG7773 CDMC32925 3 2 13 DAC20-K03 13-CG7773-RA_1 CG7773 TGAGCGGCAAGCATCTGGAAACCAAGCAATATTACACCCTGTACAACACACTCAACGACAAAAAGCGCT 69 FBan0007773 FBgn0025519 fidipidine 2 2R fidipidine fidipidine CG7773 CDMC32926 3 3 13 DAC20-K15 7-CG7781-RA_1 CG7781 GCCCCCGGATAGCCGTGTGATTAGGACCTGTGCCTATCAGAATCAGACCTCCACCAACTATTGCTATCA 69 FBan0007781 FBgn0032021 CG7781 2 2L CG7781 CG7781 CDMC32926 3 4 13 DAC20-K15 7-CG7781-RA_1 CG7781 GCCCCCGGATAGCCGTGTGATTAGGACCTGTGCCTATCAGAATCAGACCTCCACCAACTATTGCTATCA 69 FBan0007781 FBgn0032021 CG7781 2 2L CG7781 CG7781 CDMC32927 3 5 13 DAC20-O03 2-CG7818-RA_3 CG7818 AGAACTTCATCCGTGATGTCGGCCTAGCTGACCGCTTCGAGGAGTATCCCAAGTTGAGGGAACTGATCA 69 FBan0007818 FBgn0032016 CG7818 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG7818 CG7818 CDMC32927 3 6 13 DAC20-O03 2-CG7818-RA_3 CG7818 AGAACTTCATCCGTGATGTCGGCCTAGCTGACCGCTTCGAGGAGTATCCCAAGTTGAGGGAACTGATCA 69 FBan0007818 FBgn0032016 CG7818 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG7818 CG7818 CDMC32928 3 7 13 DAC20-O15 22-CG7828-RA_3 CG7828 AGCCAACAGACCGAACTTCTTCGACAGCTTCGATTTAGTGATTGCCTCCAATCTCAATGAGCAGACTTT 69 FBan0007828 FBgn0036127 CG7828 3 3L protein modification; GO:0006464 ubiquitin activating enzyme activity; GO:0004839; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004839 CG7828 CG7828 "APPBP1, anon-WO0140519.225" CDMC32928 3 8 13 DAC20-O15 22-CG7828-RA_3 CG7828 AGCCAACAGACCGAACTTCTTCGACAGCTTCGATTTAGTGATTGCCTCCAATCTCAATGAGCAGACTTT 69 FBan0007828 FBgn0036127 CG7828 3 3L protein modification; GO:0006464 ubiquitin activating enzyme activity; GO:0004839; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004839 CG7828 CG7828 "APPBP1, anon-WO0140519.225" CDMC32929 3 9 13 DAC21-C03 16-CG2617-RA_1 CG2617 CCGGCGTTCTTGTTTTGATTTTGTGTTTCTTCCTTTTCTTAATTCGAGGACAGTATGAGCCCCCCGCCA 69 FBan0002617 FBgn0032877 CG2617 2 2L metabolism; GO:0008152; protein ubiquitination; GO:0016567 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2617 CG2617 38E.2 CDMC32929 3 10 13 DAC21-C03 16-CG2617-RA_1 CG2617 CCGGCGTTCTTGTTTTGATTTTGTGTTTCTTCCTTTTCTTAATTCGAGGACAGTATGAGCCCCCCGCCA 69 FBan0002617 FBgn0032877 CG2617 2 2L metabolism; GO:0008152; protein ubiquitination; GO:0016567 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2617 CG2617 38E.2 CDMC32930 3 11 13 DAC21-C15 23-CG2655-RA_1 CG2655 CGCAGGACGTAGAATAAGGAATCTAATGGATGGAATCTTGGAAAAAGTGGATACCGGCTTTGCCAAAGC 69 FBan0002655 FBgn0011276 HLH3B X X mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH3B Helix loop helix protein 3B "CG2655, CG2655, DroSCL, EG:155E2.2, HLH3b" CDMC32930 3 12 13 DAC21-C15 23-CG2655-RA_1 CG2655 CGCAGGACGTAGAATAAGGAATCTAATGGATGGAATCTTGGAAAAAGTGGATACCGGCTTTGCCAAAGC 69 FBan0002655 FBgn0011276 HLH3B X X mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 HLH3B Helix loop helix protein 3B "CG2655, CG2655, DroSCL, EG:155E2.2, HLH3b" CDMC32931 3 13 13 DAC21-G03 17-CG2684-RA_1 CG2684 ACCGTCAGGACATTGTTAATGAGTTCAACGATCGCAACAATCAGAAGCGCGTTCTCTTGCTTTCCCTTA 69 FBan0002684 FBgn0002542 lds 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription termination; GO:0006353; transcription termination from RNA polymerase II promoter; GO:0006369 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0008026; RNA polymerase II transcription termination factor activity; GO:0003717; ; GO:0003717 nucleoplasm; GO:0005654; nucleus; GO:0005634 lds lodestar "CG2684, factor 2, Fs(3)Horka, transcript A, lod, Fs(3)Hor, Negative transcription elongation factor 2, Horka, DmF2, NTef2, early, Fs(3)Sz11, early-3, early-5, early-B, Female sterile (3) Horka" CDMC32931 3 14 13 DAC21-G03 17-CG2684-RA_1 CG2684 ACCGTCAGGACATTGTTAATGAGTTCAACGATCGCAACAATCAGAAGCGCGTTCTCTTGCTTTCCCTTA 69 FBan0002684 FBgn0002542 lds 3 3R DNA repair; GO:0006281; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription termination; GO:0006353; transcription termination from RNA polymerase II promoter; GO:0006369 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0003678; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0008026; RNA polymerase II transcription termination factor activity; GO:0003717; ; GO:0003717 nucleoplasm; GO:0005654; nucleus; GO:0005634 lds lodestar "CG2684, factor 2, Fs(3)Horka, transcript A, lod, Fs(3)Hor, Negative transcription elongation factor 2, Horka, DmF2, NTef2, early, Fs(3)Sz11, early-3, early-5, early-B, Female sterile (3) Horka" CDMC32932 3 15 13 DAC21-G15 2-CG2708-RA_3 CG2708 TCTTTGTGCACTGGCGAAAACTGAAAGCCACAATTCACAGGAGCTGATTGCCAGGGTTTTGAATGCGGT 69 FBan0002708 FBgn0010812 Tom34 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 ATP binding; GO:0005524; ; GO:0005524; carrier activity; GO:0005386; ; GO:0005386; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 mitochondrial outer membrane translocase complex; GO:0005742 Tom34 Translocase of outer membrane 34 "CG2708, l(3)03692, DmUnc-45, dunc-45, unc-45, Translocase of outer membrane 34" CDMC32932 3 16 13 DAC21-G15 2-CG2708-RA_3 CG2708 TCTTTGTGCACTGGCGAAAACTGAAAGCCACAATTCACAGGAGCTGATTGCCAGGGTTTTGAATGCGGT 69 FBan0002708 FBgn0010812 Tom34 3 3R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 ATP binding; GO:0005524; ; GO:0005524; carrier activity; GO:0005386; ; GO:0005386; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 mitochondrial outer membrane translocase complex; GO:0005742 Tom34 Translocase of outer membrane 34 "CG2708, l(3)03692, DmUnc-45, dunc-45, unc-45, Translocase of outer membrane 34" CDMC32933 3 17 13 DAC21-K03 1-CG2794-RA_1 CG2794 CGGGCGAAACTGTCAAATGGAATCCAGAAACCAAACAGCCACAAACGGAACTGGTTCAGCAAGCGAAGT 69 FBan0002794 FBgn0031265 CG2794 2 2L CG2794 CG2794 CDMC32933 3 18 13 DAC21-K03 1-CG2794-RA_1 CG2794 CGGGCGAAACTGTCAAATGGAATCCAGAAACCAAACAGCCACAAACGGAACTGGTTCAGCAAGCGAAGT 69 FBan0002794 FBgn0031265 CG2794 2 2L CG2794 CG2794 CDMC32934 3 19 13 DAC21-K15 9-CG2826-RA_3 CG2826 GCCTGTGGGCTCTATGGAATCCGTGCAAAGGATGTGTGTCCTCGAATGTCAACGGATAAGGAAGTGTGT 69 FBan0002826 FBgn0040107 lectin-21Ca 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-21Ca lectin-21Ca "CG2826, AC 004573A, AC004573a, Lectin21Ca" CDMC32934 3 20 13 DAC21-K15 9-CG2826-RA_3 CG2826 GCCTGTGGGCTCTATGGAATCCGTGCAAAGGATGTGTGTCCTCGAATGTCAACGGATAAGGAAGTGTGT 69 FBan0002826 FBgn0040107 lectin-21Ca 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-21Ca lectin-21Ca "CG2826, AC 004573A, AC004573a, Lectin21Ca" CDMC32935 3 21 13 DAC21-O03 12-CG2872-RB_5 CG2872 TGTGGCCCTCGAACGGATCGTATCCACAATAGTTCCCGTATTCTTTGGCATTATCGGATTCGCAGGACT 69 FBan0002872 FBgn0028961 AlstR X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; galanin receptor activity; GO:0004966; ; GO:0008261; ; GO:0008188; ; GO:0004930; ; GO:0004966 integral to membrane; GO:0016021 AlstR Allatostatin Receptor "CG2872, GR, Galanin Receptor, DGR, DAR-1, EG:121E7.2, D.AlstR1, Allatostatin Receptor" CDMC32935 3 22 13 DAC21-O03 12-CG2872-RB_5 CG2872 TGTGGCCCTCGAACGGATCGTATCCACAATAGTTCCCGTATTCTTTGGCATTATCGGATTCGCAGGACT 69 FBan0002872 FBgn0028961 AlstR X X G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; allatostatin receptor activity; GO:0008261; ; GO:0008261; galanin receptor activity; GO:0004966; ; GO:0008261; ; GO:0008188; ; GO:0004930; ; GO:0004966 integral to membrane; GO:0016021 AlstR Allatostatin Receptor "CG2872, GR, Galanin Receptor, DGR, DAR-1, EG:121E7.2, D.AlstR1, Allatostatin Receptor" CDMC32936 3 23 13 DAC21-O15 2-CG2909-RA_1 CG2909 TGCGGTCACGTTGATCTGAACACGAAAACTTTGGAACGTCACGGGGTTATTGTGGGCATGATTGGAGCC 69 FBan0002909 FBgn0030189 CG2909 X X CG2909 CG2909 CDMC32936 3 24 13 DAC21-O15 2-CG2909-RA_1 CG2909 TGCGGTCACGTTGATCTGAACACGAAAACTTTGGAACGTCACGGGGTTATTGTGGGCATGATTGGAGCC 69 FBan0002909 FBgn0030189 CG2909 X X CG2909 CG2909 CDMC32937 3 25 13 DAC22-C03 1-CG14561-RA_1 CG14561 GAAGAGGAACCCCAGAACGATCCTCAGTACGTTGCCCTACACGAGATAAACGCCCAGATCAGCCC 65 FBan0014561 FBgn0037149 CG14561 3 3L CG14561 CG14561 CDMC32937 3 26 13 DAC22-C03 1-CG14561-RA_1 CG14561 GAAGAGGAACCCCAGAACGATCCTCAGTACGTTGCCCTACACGAGATAAACGCCCAGATCAGCCC 65 FBan0014561 FBgn0037149 CG14561 3 3L CG14561 CG14561 CDMC32938 3 1 14 DAC22-C15 3-CG14573-RA_1 CG14573 GAGGATGTGGATACAGATGCCTTGCCTTCGGAACAGGATCCACCAGTGGACACCTTCGAGCCTAG 65 FBan0014573 FBgn0037125 CG14573 3 3L CG14573 CG14573 CDMC32938 3 2 14 DAC22-C15 3-CG14573-RA_1 CG14573 GAGGATGTGGATACAGATGCCTTGCCTTCGGAACAGGATCCACCAGTGGACACCTTCGAGCCTAG 65 FBan0014573 FBgn0037125 CG14573 3 3L CG14573 CG14573 CDMC32939 3 3 14 DAC22-G03 18-CG14648-RA_1 CG14648 AGTTGACAAATCTGTCTCGTGATATTCGCGTCAAGGACTTAAAGTCGGAGCTCCGCAAACGCGAA 65 FBan0014648 FBgn0037245 CG14648 3 3R metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14648 CG14648 anon-WO0118547.126 CDMC32939 3 4 14 DAC22-G03 18-CG14648-RA_1 CG14648 AGTTGACAAATCTGTCTCGTGATATTCGCGTCAAGGACTTAAAGTCGGAGCTCCGCAAACGCGAA 65 FBan0014648 FBgn0037245 CG14648 3 3R metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14648 CG14648 anon-WO0118547.126 CDMC32940 3 5 14 DAC22-G15 3-CG14684-RA_1 CG14684 ATGATGGACAAGAGTGATTTGTGGGACAGTCAGGAGTACTTCAAGGCCAAGTCTGCGCTTGGGGC 65 FBan0014684 FBgn0037824 CG14684 3 3R CG14684 CG14684 CDMC32940 3 6 14 DAC22-G15 3-CG14684-RA_1 CG14684 ATGATGGACAAGAGTGATTTGTGGGACAGTCAGGAGTACTTCAAGGCCAAGTCTGCGCTTGGGGC 65 FBan0014684 FBgn0037824 CG14684 3 3R CG14684 CG14684 CDMC32941 3 7 14 DAC22-K03 2-CG14787-RA_1 CG14787 GAACCGTTGGCTCTCAAACAGGGTCTGGAGAATAGGAGTAGGCGTACCGCTTCCCACGAAGAAGC 65 FBan0014787 FBgn0027793 CG14787 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14787 CG14787 EG:BACN32G11.4 CDMC32941 3 8 14 DAC22-K03 2-CG14787-RA_1 CG14787 GAACCGTTGGCTCTCAAACAGGGTCTGGAGAATAGGAGTAGGCGTACCGCTTCCCACGAAGAAGC 65 FBan0014787 FBgn0027793 CG14787 X X metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG14787 CG14787 EG:BACN32G11.4 CDMC32942 3 9 14 DAC22-K15 23-CG14799-RA_2 CG14799 TCAGGGCAAATGCAAAGTGCTAAGCTTGACCGGTCAAGGATTCTTTGGAGGAAAATAAAGCATCA 65 FBan0014799 FBgn0029591 CG14799 X X CG14799 CG14799 CDMC32942 3 10 14 DAC22-K15 23-CG14799-RA_2 CG14799 TCAGGGCAAATGCAAAGTGCTAAGCTTGACCGGTCAAGGATTCTTTGGAGGAAAATAAAGCATCA 65 FBan0014799 FBgn0029591 CG14799 X X CG14799 CG14799 CDMC32943 3 11 14 DAC22-O03 4-CG14890-RA_2 CG14890 CAATCATCTCGACGCCCGTGCACAAGGATTATTTGCCCGATGTAACGCAGCCGGAAAGCAACACC 65 FBan0014890 FBgn0038444 CG14890 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14890 CG14890 CDMC32943 3 12 14 DAC22-O03 4-CG14890-RA_2 CG14890 CAATCATCTCGACGCCCGTGCACAAGGATTATTTGCCCGATGTAACGCAGCCGGAAAGCAACACC 65 FBan0014890 FBgn0038444 CG14890 3 3R phosphate transport; GO:0006817 cytoplasm; GO:0005737 CG14890 CG14890 CDMC32944 3 13 14 DAC22-O15 2-CG14939-RA_1 CG14939 TATACGATGAACGATATTCGGCTTCCCCGCGTCAGGCTTCAGGCACAAATCGATTTTCTGGGGGC 65 FBan0014939 FBgn0032378 CG14939 2 2L CG14939 CG14939 "i182, anon-WO0118547.165" CDMC32944 3 14 14 DAC22-O15 2-CG14939-RA_1 CG14939 TATACGATGAACGATATTCGGCTTCCCCGCGTCAGGCTTCAGGCACAAATCGATTTTCTGGGGGC 65 FBan0014939 FBgn0032378 CG14939 2 2L CG14939 CG14939 "i182, anon-WO0118547.165" CDMC32945 3 15 14 DAC23-C03 9-CG6756-RB_1 CG6756 CGGAGGAATACTACAAAAAGGCCATGGTATTGGCGCCAACAAATCCTGCACTTATCGTTCACCAGGCCA 69 FBan0006756 FBgn0032397 Tom70 2 2L protein targeting to mitochondrion; GO:0006626 "carrier activity; GO:0005386; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0005386; ; GO:0016757 ; EC:2.4.-.-; protein translocase activity; GO:0015450; ; GO:0015450" mitochondrial outer membrane translocase complex; GO:0005742 Tom70 Translocase of outer membrane 70 "CG6756, CG6756, CG6756, dtom70, Translocase of outer membrane 70" CDMC32945 3 16 14 DAC23-C03 9-CG6756-RB_1 CG6756 CGGAGGAATACTACAAAAAGGCCATGGTATTGGCGCCAACAAATCCTGCACTTATCGTTCACCAGGCCA 69 FBan0006756 FBgn0032397 Tom70 2 2L protein targeting to mitochondrion; GO:0006626 "carrier activity; GO:0005386; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0005386; ; GO:0016757 ; EC:2.4.-.-; protein translocase activity; GO:0015450; ; GO:0015450" mitochondrial outer membrane translocase complex; GO:0005742 Tom70 Translocase of outer membrane 70 "CG6756, CG6756, CG6756, dtom70, Translocase of outer membrane 70" CDMC32946 3 17 14 DAC23-C15 1-CG6766-RA_1 CG6766 AGCAGCCTCTGAAACTGGACCAACACCCATCACTGATCTGACGCCCCTTAAGGACTTTATATCGGGCAA 69 FBan0006766 FBgn0032398 CG6766 2 2L CG6766 CG6766 CDMC32946 3 18 14 DAC23-C15 1-CG6766-RA_1 CG6766 AGCAGCCTCTGAAACTGGACCAACACCCATCACTGATCTGACGCCCCTTAAGGACTTTATATCGGGCAA 69 FBan0006766 FBgn0032398 CG6766 2 2L CG6766 CG6766 CDMC32947 3 19 14 DAC23-G03 2-CG6802-RA_1 CG6802 AAACGTCTCAGGATCTGAAGCTGTCCAATGGTATAGTGGTTCCCAAAGGGGTCCAGATCGCCATCGACA 69 FBan0006802 FBgn0038076 Cyp313a4 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a4 Cyp313a4 "CG6802, 313a4" CDMC32947 3 20 14 DAC23-G03 2-CG6802-RA_1 CG6802 AAACGTCTCAGGATCTGAAGCTGTCCAATGGTATAGTGGTTCCCAAAGGGGTCCAGATCGCCATCGACA 69 FBan0006802 FBgn0038076 Cyp313a4 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313a4 Cyp313a4 "CG6802, 313a4" CDMC32948 3 21 14 DAC23-G15 8-CG6814-RA_1 CG6814 GCCAAGCTGTATCCGGATTTTGGTACCAAGGACAAAGACACAGTTACGACGGGGGCCAGTATTACGCCC 69 FBan0006814 FBgn0020407 Mat89Bb 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mat89Bb Maternal transcript 89Bb CG6814 CDMC32948 3 22 14 DAC23-G15 8-CG6814-RA_1 CG6814 GCCAAGCTGTATCCGGATTTTGGTACCAAGGACAAAGACACAGTTACGACGGGGGCCAGTATTACGCCC 69 FBan0006814 FBgn0020407 Mat89Bb 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mat89Bb Maternal transcript 89Bb CG6814 CDMC32949 3 23 14 DAC23-K03 9-CG6852-RA_1 CG6852 CCGCTTTGAGATCCCCAATAGTCGACATGTCCACCAAGCAGGCGAAATTCGTTGAAAACACCATTGCCA 69 FBan0006852 FBgn0036820 CG6852 3 3L CG6852 CG6852 BcDNA:GH24739 CDMC32949 3 24 14 DAC23-K03 9-CG6852-RA_1 CG6852 CCGCTTTGAGATCCCCAATAGTCGACATGTCCACCAAGCAGGCGAAATTCGTTGAAAACACCATTGCCA 69 FBan0006852 FBgn0036820 CG6852 3 3L CG6852 CG6852 BcDNA:GH24739 CDMC32950 3 25 14 DAC23-K15 9-CG6865-RA_2 CG6865 GCTGCAGCAGTTCATGAAACCAGCTCAAATCCAAGGAGTTGTGGGTTTGCATAGCATCAGGGAGTACCT 69 FBan0006865 FBgn0036817 CG6865 3 3L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6865 CG6865 SP63 CDMC32950 3 26 14 DAC23-K15 9-CG6865-RA_2 CG6865 GCTGCAGCAGTTCATGAAACCAGCTCAAATCCAAGGAGTTGTGGGTTTGCATAGCATCAGGGAGTACCT 69 FBan0006865 FBgn0036817 CG6865 3 3L defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6865 CG6865 SP63 CDMC32951 3 1 15 DAC23-O03 1-CG6891-RB_3 CG6891 CGACCCCAAGTCACTTATCAAATCTCTGACCTGCTTTCCGCCGGCTGCTGATTGAAAATTGTCACGCGT 69 FBan0006891 FBgn0030955 CG6891 X X actin binding; GO:0003779; ; GO:0003779 intracellular; GO:0005622 CG6891 CG6891 CDMC32951 3 2 15 DAC23-O03 1-CG6891-RB_3 CG6891 CGACCCCAAGTCACTTATCAAATCTCTGACCTGCTTTCCGCCGGCTGCTGATTGAAAATTGTCACGCGT 69 FBan0006891 FBgn0030955 CG6891 X X actin binding; GO:0003779; ; GO:0003779 intracellular; GO:0005622 CG6891 CG6891 CDMC32952 3 3 15 DAC23-O15 15-CG6902-RA_2 CG6902 TCCTGCTCTCTGTGCGTGTTATTTGACTTTGACCATTGGCAGCAGAAACGCCATATCATGTCTGCGAGA 69 FBan0006902 FBgn0035899 CG6902 3 3L CG6902 CG6902 CDMC32952 3 4 15 DAC23-O15 15-CG6902-RA_2 CG6902 TCCTGCTCTCTGTGCGTGTTATTTGACTTTGACCATTGGCAGCAGAAACGCCATATCATGTCTGCGAGA 69 FBan0006902 FBgn0035899 CG6902 3 3L CG6902 CG6902 CDMC32953 3 5 15 DAC24-C03 3-CG2173-RA_5 CG2173 ACGTGAGGATAAGGAGGGCGACCGTGAACCCATTCTGGCTAGTTTGATTTGCAGGACGTTCCATGATCA 69 FBan0002173 FBgn0021995 Rs1 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; ribosome biogenesis; GO:0007046" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004004 Rs1 Rs1 "CG2173, l(2)k09514, Drs1, cg2173, DmRH21, BcDNA:GM05306" CDMC32953 3 6 15 DAC24-C03 3-CG2173-RA_5 CG2173 ACGTGAGGATAAGGAGGGCGACCGTGAACCCATTCTGGCTAGTTTGATTTGCAGGACGTTCCATGATCA 69 FBan0002173 FBgn0021995 Rs1 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; ribosome biogenesis; GO:0007046" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004004 Rs1 Rs1 "CG2173, l(2)k09514, Drs1, cg2173, DmRH21, BcDNA:GM05306" CDMC32954 3 7 15 DAC24-C15 3-CG2184-RA_1 CG2184 CGGTCGGGGGGGTTTTAGTTTGAATAAGGTGCCCATAACCACTAGTACCTAGGCTGATCGGAGGAAGCA 69 FBan0002184 FBgn0002773 Mlc2 3 3R muscle contraction; GO:0006936 "calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; ; GO:0005516; microfilament motor activity; GO:0000146; ; GO:0042623; ; GO:0005509; ; GO:0000146" muscle myosin; GO:0005859; myosin; GO:0016459 Mlc2 Myosin light chain 2 "CG2184, CG2184, MLC-2, MLC2, dro MLC-2, Myosin Light Chain-2, Ifm(3)99Eb, LC2, MRLC, muscle-specific myosin regulatory light chain, Myosin Regulatory Light Chain, myosin regulatory light chain, mlc2, RLC, MYL2, Myosin LC2, Dmlc2, RLC2, DmMLC2, mlc-2, l(3)99Eb" CDMC32954 3 8 15 DAC24-C15 3-CG2184-RA_1 CG2184 CGGTCGGGGGGGTTTTAGTTTGAATAAGGTGCCCATAACCACTAGTACCTAGGCTGATCGGAGGAAGCA 69 FBan0002184 FBgn0002773 Mlc2 3 3R muscle contraction; GO:0006936 "calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ATPase activity, coupled; GO:0042623; ; GO:0005516; microfilament motor activity; GO:0000146; ; GO:0042623; ; GO:0005509; ; GO:0000146" muscle myosin; GO:0005859; myosin; GO:0016459 Mlc2 Myosin light chain 2 "CG2184, CG2184, MLC-2, MLC2, dro MLC-2, Myosin Light Chain-2, Ifm(3)99Eb, LC2, MRLC, muscle-specific myosin regulatory light chain, Myosin Regulatory Light Chain, myosin regulatory light chain, mlc2, RLC, MYL2, Myosin LC2, Dmlc2, RLC2, DmMLC2, mlc-2, l(3)99Eb" CDMC32955 3 9 15 DAC24-G03 2-CG2227-RA_1 CG2227 CCGGTGAGCTGGACTACGGATTTGTGTTCAAGGCTCTCCAGGAATTCGGCTATGATGGATGGATCGGTT 69 FBan0002227 FBgn0011770 Gip X X DNA repair; GO:0006281; carbohydrate metabolism; GO:0005975 DNA binding; GO:0003677; isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; endonuclease activity; GO:0004519; ; GO:0003677; ; GO:0004519 intracellular; GO:0005622 Gip GIP-like "CG2227, CG2227, CG2227, T15" CDMC32955 3 10 15 DAC24-G03 2-CG2227-RA_1 CG2227 CCGGTGAGCTGGACTACGGATTTGTGTTCAAGGCTCTCCAGGAATTCGGCTATGATGGATGGATCGGTT 69 FBan0002227 FBgn0011770 Gip X X DNA repair; GO:0006281; carbohydrate metabolism; GO:0005975 DNA binding; GO:0003677; isomerase activity; GO:0016853 ; EC:5.-.-.-; ; GO:0016853 ; EC:5.-.-.-; endonuclease activity; GO:0004519; ; GO:0003677; ; GO:0004519 intracellular; GO:0005622 Gip GIP-like "CG2227, CG2227, CG2227, T15" CDMC32956 3 11 15 DAC24-G15 2-CG2247-RA_1 CG2247 TGCCGAATCCTCCGGATATTCTCGCTACACTCGACATTAGCGTCCTGAAAGCATTGCGTGTTCTTCGCA 69 FBan0002247 FBgn0030320 CG2247 X X CG2247 CG2247 CDMC32956 3 12 15 DAC24-G15 2-CG2247-RA_1 CG2247 TGCCGAATCCTCCGGATATTCTCGCTACACTCGACATTAGCGTCCTGAAAGCATTGCGTGTTCTTCGCA 69 FBan0002247 FBgn0030320 CG2247 X X CG2247 CG2247 CDMC32957 3 13 15 DAC24-K03 23-CG2304-RD_2 CG2304 TGAACGCTGATCGGCAATGAGACGATAATTCAAACGGAGATGATCTACATATGTACGTTAAGTTTATGG 69 FBan0002304 FBgn0039668 Trc8 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Trc8 Trc8 "CG2304, CG2304, CG2304, Dtrc8, TRC8" CDMC32957 3 14 15 DAC24-K03 23-CG2304-RD_2 CG2304 TGAACGCTGATCGGCAATGAGACGATAATTCAAACGGAGATGATCTACATATGTACGTTAAGTTTATGG 69 FBan0002304 FBgn0039668 Trc8 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Trc8 Trc8 "CG2304, CG2304, CG2304, Dtrc8, TRC8" CDMC32958 3 15 15 DAC24-K15 23-CG2331-RB_1 CG2331 GCGAAATCAGATGACATACCCGATTCAATATTCACTTCTTTGATACCATCCTTACTCTTGGTCGCGGAT 69 FBan0002331 FBgn0024923 TER94 2 2R ER organization and biogenesis; GO:0007029; Golgi organization and biogenesis; GO:0007030; endoplasmic reticulum membrane fusion; GO:0016320; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; proteolysis; GO:0006508; regulation of pole plasm oskar mRNA localization; GO:0007317; rhabdomere development; GO:0042052 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- endoplasmic reticulum; GO:0005783; fusome; GO:0045169; microtubule cytoskeleton; GO:0015630; proteasome complex (sensu Eukaryota); GO:0000502 TER94 TER94 "CG2331, CG2331, l(2)03775, 22.26, 7.12, I: Intensifier of Bar, Complementation group I, ter94, Apple, Vcp, Valosin-containing protein, transitional endoplasmic reticulum ATPase, BcDNA.GM02885, Ter94, DmTER94, anon-WO2004063362.65, anon-WO2004063362.67, l(2)46Ch, l(2)46CFs, l(2)46CFf, BcDNA:GM02885, I" CDMC32958 3 16 15 DAC24-K15 23-CG2331-RB_1 CG2331 GCGAAATCAGATGACATACCCGATTCAATATTCACTTCTTTGATACCATCCTTACTCTTGGTCGCGGAT 69 FBan0002331 FBgn0024923 TER94 2 2R ER organization and biogenesis; GO:0007029; Golgi organization and biogenesis; GO:0007030; endoplasmic reticulum membrane fusion; GO:0016320; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; proteolysis; GO:0006508; regulation of pole plasm oskar mRNA localization; GO:0007317; rhabdomere development; GO:0042052 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0016887; nucleotide binding; GO:0000166; ATP-dependent peptidase activity; GO:0004176; ; GO:0000166; ; GO:0004176; ; GO:0004252 ; EC:3.4.21.- endoplasmic reticulum; GO:0005783; fusome; GO:0045169; microtubule cytoskeleton; GO:0015630; proteasome complex (sensu Eukaryota); GO:0000502 TER94 TER94 "CG2331, CG2331, l(2)03775, 22.26, 7.12, I: Intensifier of Bar, Complementation group I, ter94, Apple, Vcp, Valosin-containing protein, transitional endoplasmic reticulum ATPase, BcDNA.GM02885, Ter94, DmTER94, anon-WO2004063362.65, anon-WO2004063362.67, l(2)46Ch, l(2)46CFs, l(2)46CFf, BcDNA:GM02885, I" CDMC32959 3 17 15 DAC24-O03 14-CG2469-RB_1 CG2469 GGCCATGGCCATACTCAAGGATGAGAAATCTACTCTGGAAATTGTGCTGCAAGCTGTCCATGAACTGGA 69 FBan0002469 FBgn0035205 CG2469 3 3L CG2469 CG2469 CDMC32959 3 18 15 DAC24-O03 14-CG2469-RB_1 CG2469 GGCCATGGCCATACTCAAGGATGAGAAATCTACTCTGGAAATTGTGCTGCAAGCTGTCCATGAACTGGA 69 FBan0002469 FBgn0035205 CG2469 3 3L CG2469 CG2469 CDMC32960 3 19 15 DAC24-O15 17-CG2512-RA_1 CG2512 TGCTGAGGAGTACTAGAGCGGATAGGTGTGCATCCCTCAAAATCTTGCTTATTTTCATACGCTCCCACT 69 FBan0002512 FBgn0003885 alphaTub84D 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub84D alpha-Tubulin at 84D "CG2512, CG2512, DTA4, alpha84D, 3t, alpha-tubulin, T, alpha tubulin, tubulin, aTub84D, alpha3, alphatubulin, D.m.ALPHA-84D, ALPHA 84D, alpha-Tubulin, alpha-Tub, tubulin alpha3, alphaTUB, alphaTub84D, alpha-tubulin, alpha-Tub84D, alpha3t, alphaTub3" CDMC32960 3 20 15 DAC24-O15 17-CG2512-RA_1 CG2512 TGCTGAGGAGTACTAGAGCGGATAGGTGTGCATCCCTCAAAATCTTGCTTATTTTCATACGCTCCCACT 69 FBan0002512 FBgn0003885 alphaTub84D 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub84D alpha-Tubulin at 84D "CG2512, CG2512, DTA4, alpha84D, 3t, alpha-tubulin, T, alpha tubulin, tubulin, aTub84D, alpha3, alphatubulin, D.m.ALPHA-84D, ALPHA 84D, alpha-Tubulin, alpha-Tub, tubulin alpha3, alphaTUB, alphaTub84D, alpha-tubulin, alpha-Tub84D, alpha3t, alphaTub3" CDMC32961 3 21 15 DAC25-C03 12-CG10089-RA_3 CG10089 CCCCCACCGGATTTTAGCTTGGGCAAGGACCTTATGCCAAGTGTGCGTTACTACGATCCGGAGTG 65 FBan0010089 FBgn0036369 CG10089 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- CG10089 CG10089 MKP-like CDMC32961 3 22 15 DAC25-C03 12-CG10089-RA_3 CG10089 CCCCCACCGGATTTTAGCTTGGGCAAGGACCTTATGCCAAGTGTGCGTTACTACGATCCGGAGTG 65 FBan0010089 FBgn0036369 CG10089 3 3L MAPKKK cascade; GO:0000165; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; ; GO:0019210; ; GO:0016791 ; EC:3.1.3.- CG10089 CG10089 MKP-like CDMC32962 3 23 15 DAC25-C15 3-CG10147-RA_2 CG10147 ACGACATTGGCAAGCCTTTGAAGACCCATATGTGCGAGTTCTGTGGTCGGGTGTTCAAGACTGGC 65 FBan0010147 FBgn0035702 CG10147 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10147 CG10147 CDMC32962 3 24 15 DAC25-C15 3-CG10147-RA_2 CG10147 ACGACATTGGCAAGCCTTTGAAGACCCATATGTGCGAGTTCTGTGGTCGGGTGTTCAAGACTGGC 65 FBan0010147 FBgn0035702 CG10147 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10147 CG10147 CDMC32963 3 25 15 DAC25-G03 3-CG10251-RA_1 CG10251 ATTTTCAATCCGATTGTCGGCAATGCGTCCAGCAAGTTTGGTTACCGCCTTCCCATTGTGGTCGG 65 FBan0010251 FBgn0043005 CG10251 3 3R transmission of nerve impulse; GO:0019226; transport; GO:0006810 hydrogen:vesicular amine antiporter activity; GO:0005276; ; GO:0005276 integral to membrane; GO:0016021 CG10251 CG10251 CDMC32963 3 26 15 DAC25-G03 3-CG10251-RA_1 CG10251 ATTTTCAATCCGATTGTCGGCAATGCGTCCAGCAAGTTTGGTTACCGCCTTCCCATTGTGGTCGG 65 FBan0010251 FBgn0043005 CG10251 3 3R transmission of nerve impulse; GO:0019226; transport; GO:0006810 hydrogen:vesicular amine antiporter activity; GO:0005276; ; GO:0005276 integral to membrane; GO:0016021 CG10251 CG10251 CDMC32964 3 1 16 DAC25-G15 6-CG10278-RA_1 CG10278 CTGTCGATGAAGAAGGAGGGCATCCAGAAGCGCAAACGGAAGCCTAAGAACAACGGAGGAGCACC 65 FBan0010278 FBgn0038391 GATAe 3 3R endoderm development; GO:0007492; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 GATAe GATAe "CG10278, dGATAe, dGATA-E" CDMC32964 3 2 16 DAC25-G15 6-CG10278-RA_1 CG10278 CTGTCGATGAAGAAGGAGGGCATCCAGAAGCGCAAACGGAAGCCTAAGAACAACGGAGGAGCACC 65 FBan0010278 FBgn0038391 GATAe 3 3R endoderm development; GO:0007492; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 GATAe GATAe "CG10278, dGATAe, dGATA-E" CDMC32965 3 3 16 DAC25-K03 15-CG10371-RB_2 CG10371 TACGAGGAAGATTTCCGCCCGTGTGAATCACCAACTTTTGTCTCGTCCAATCCAAGTCAGCCACT 65 FBan0010371 FBgn0039111 Plip 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- Plip PTEN-like phosphatase "CG10371, CG10371, MKP-like, PLIP, PTEN-like phosphatase" CDMC32965 3 4 16 DAC25-K03 15-CG10371-RB_2 CG10371 TACGAGGAAGATTTCCGCCCGTGTGAATCACCAACTTTTGTCTCGTCCAATCCAAGTCAGCCACT 65 FBan0010371 FBgn0039111 Plip 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- Plip PTEN-like phosphatase "CG10371, CG10371, MKP-like, PLIP, PTEN-like phosphatase" CDMC32966 3 5 16 DAC25-K15 23-CG10406-RA_1 CG10406 ATGAAAAGCATAGCAAACTAATATTAACTATGTCCCACAAGTACACGGAGCTGATTAAGGTCGGC 65 FBan0010406 FBgn0038426 mRpS33 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS33 mitochondrial ribosomal protein S33 "CG10406, CG10406, MRP-S33, mitochondrial ribosomal protein S33" CDMC32966 3 6 16 DAC25-K15 23-CG10406-RA_1 CG10406 ATGAAAAGCATAGCAAACTAATATTAACTATGTCCCACAAGTACACGGAGCTGATTAAGGTCGGC 65 FBan0010406 FBgn0038426 mRpS33 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS33 mitochondrial ribosomal protein S33 "CG10406, CG10406, MRP-S33, mitochondrial ribosomal protein S33" CDMC32967 3 7 16 DAC25-O03 3-CG10537-RC_1 CG10537 AACAAAACGTTGGTACGCGCGGTTGCTCGATAGTGGGACCCTTGTTCCAGGAGGTGAGATTCAAG 65 FBan0010537 FBgn0004244 Rdl 3 3L anion transport; GO:0006820; negative regulation of synaptic transmission; GO:0050805; nerve-nerve synaptic transmission; GO:0007270; response to cyclodiene; GO:0046682; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Rdl Resistant to dieldrin "CG10537, CG10537, GABA[[A]], GABA receptor, GABA[[A]] receptor, LCCH1, GABA, RDL, resistance to dieldrin, DmRDL, DmRdl, gaba, GABAr: GABA receptor" CDMC32967 3 8 16 DAC25-O03 3-CG10537-RC_1 CG10537 AACAAAACGTTGGTACGCGCGGTTGCTCGATAGTGGGACCCTTGTTCCAGGAGGTGAGATTCAAG 65 FBan0010537 FBgn0004244 Rdl 3 3L anion transport; GO:0006820; negative regulation of synaptic transmission; GO:0050805; nerve-nerve synaptic transmission; GO:0007270; response to cyclodiene; GO:0046682; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Rdl Resistant to dieldrin "CG10537, CG10537, GABA[[A]], GABA receptor, GABA[[A]] receptor, LCCH1, GABA, RDL, resistance to dieldrin, DmRDL, DmRdl, gaba, GABAr: GABA receptor" CDMC32968 3 9 16 DAC25-O15 2-CG10582-RA_1 CG10582 TCCTGTCGAAGAACCTGAGGGACAGCCTGTATCTCTTTCAATACCCCACGAAAACGGAGCTCCCC 65 FBan0010582 FBgn0028402 Sin 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" protein binding; GO:0005515; ; GO:0005515 colocalizes_with snRNP U1; GO:0005685 Sin Sex-lethal interactor "CG10582, sin" CDMC32968 3 10 16 DAC25-O15 2-CG10582-RA_1 CG10582 TCCTGTCGAAGAACCTGAGGGACAGCCTGTATCTCTTTCAATACCCCACGAAAACGGAGCTCCCC 65 FBan0010582 FBgn0028402 Sin 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" protein binding; GO:0005515; ; GO:0005515 colocalizes_with snRNP U1; GO:0005685 Sin Sex-lethal interactor "CG10582, sin" CDMC32969 3 11 16 DAC26-C03 24-CG6186-RA_1 CG6186 GCAGTGATCACATTTTATACTACTAGATCCCACTATCTGCATCAATAAAATTTAATTCGAATATAAACA 69 FBan0006186 FBgn0022355 Tsf1 X X defense response; GO:0006952; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; ; GO:0008199; ; GO:0008199; iron ion transporter activity; GO:0005381; ; GO:0005381; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005381 extracellular region; GO:0005576 Tsf1 Transferrin 1 "CG6186, CG6186, CG6186, CG6186, Trf, Transferrin, transferrin, Tf, transferrin precursor, DTAF-transferrin, TSF1, anon-EST:Posey265, Transferrin 1" CDMC32969 3 12 16 DAC26-C03 24-CG6186-RA_1 CG6186 GCAGTGATCACATTTTATACTACTAGATCCCACTATCTGCATCAATAAAATTTAATTCGAATATAAACA 69 FBan0006186 FBgn0022355 Tsf1 X X defense response; GO:0006952; iron ion homeostasis; GO:0006879; iron ion transport; GO:0006826 ferric iron binding; GO:0008199; ; GO:0008199; ; GO:0008199; iron ion transporter activity; GO:0005381; ; GO:0005381; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005381 extracellular region; GO:0005576 Tsf1 Transferrin 1 "CG6186, CG6186, CG6186, CG6186, Trf, Transferrin, transferrin, Tf, transferrin precursor, DTAF-transferrin, TSF1, anon-EST:Posey265, Transferrin 1" CDMC32970 3 13 16 DAC26-C15 9-CG6195-RA_1 CG6195 TGAGTTCACCACTTTGACCTGCATTCCGGGTGTCATTGAGTATCAGGGTGCCAATATCCAGTTGCTGGA 69 FBan0006195 FBgn0038723 CG6195 3 3R "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" CG6195 CG6195 BEST:GH15838 CDMC32970 3 14 16 DAC26-C15 9-CG6195-RA_1 CG6195 TGAGTTCACCACTTTGACCTGCATTCCGGGTGTCATTGAGTATCAGGGTGCCAATATCCAGTTGCTGGA 69 FBan0006195 FBgn0038723 CG6195 3 3R "GTP binding; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-; ; GO:0005525" CG6195 CG6195 BEST:GH15838 CDMC32971 3 15 16 DAC26-G03 23-CG6224-RA_18 CG6224 CCGGAATAGTATTAGAGTTAGCATTGTTCCCACGTTCACCTGCAATAACACATCCCCATCACTCCTGTG 69 FBan0006224 FBgn0040230 dbo 3 3L induction of apoptosis; GO:0006917 actin binding; GO:0003779; ; GO:0003779 dbo diablo "CG6224, CG6224, Smac, DIABLO, Dm.DBO, diablo" CDMC32971 3 16 16 DAC26-G03 23-CG6224-RA_18 CG6224 CCGGAATAGTATTAGAGTTAGCATTGTTCCCACGTTCACCTGCAATAACACATCCCCATCACTCCTGTG 69 FBan0006224 FBgn0040230 dbo 3 3L induction of apoptosis; GO:0006917 actin binding; GO:0003779; ; GO:0003779 dbo diablo "CG6224, CG6224, Smac, DIABLO, Dm.DBO, diablo" CDMC32972 3 17 16 DAC26-G15 2-CG6234-RA_1 CG6234 GGAGCATCTAAAGGAACAAAGAGTCCAGACAGTTTCCGAGTCCAACCGTCAAGCAAGTCCCACCGAGGA 69 FBan0006234 FBgn0038071 CG6234 3 3R CG6234 CG6234 CDMC32972 3 18 16 DAC26-G15 2-CG6234-RA_1 CG6234 GGAGCATCTAAAGGAACAAAGAGTCCAGACAGTTTCCGAGTCCAACCGTCAAGCAAGTCCCACCGAGGA 69 FBan0006234 FBgn0038071 CG6234 3 3R CG6234 CG6234 CDMC32973 3 19 16 DAC26-K03 8-CG6289-RA_4 CG6289 ACCTGCTGCAAATGGAATCCACGCATTTAAACCTGGAAAACTTTGCGATGACGCCATTTTCCACGTGGT 69 FBan0006289 FBgn0036970 CG6289 3 3L negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG6289 CG6289 CDMC32973 3 20 16 DAC26-K03 8-CG6289-RA_4 CG6289 ACCTGCTGCAAATGGAATCCACGCATTTAAACCTGGAAAACTTTGCGATGACGCCATTTTCCACGTGGT 69 FBan0006289 FBgn0036970 CG6289 3 3L negative regulation of proteolysis; GO:0045861 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 CG6289 CG6289 CDMC32974 3 21 16 DAC26-K15 14-CG6300-RA_1 CG6300 ACGAATCGAATCGGTCTTACTGGCTAAACGTGTGAGTGTGGTGATCTTTGCTAGGTCTTCTCCTGCCGG 69 FBan0006300 FBgn0038730 CG6300 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG6300 CG6300 CDMC32974 3 22 16 DAC26-K15 14-CG6300-RA_1 CG6300 ACGAATCGAATCGGTCTTACTGGCTAAACGTGTGAGTGTGGTGATCTTTGCTAGGTCTTCTCCTGCCGG 69 FBan0006300 FBgn0038730 CG6300 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG6300 CG6300 CDMC32975 3 23 16 DAC26-O03 22-CG6340-RD_1 CG6340 GGCGCAGATTCGTAGATCCATACGCTCTAATGTAATTCTCCTCAATGTGTTGCTTCATCCCGTTCCAGG 69 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC32975 3 24 16 DAC26-O03 22-CG6340-RD_1 CG6340 GGCGCAGATTCGTAGATCCATACGCTCTAATGTAATTCTCCTCAATGTGTTGCTTCATCCCGTTCCAGG 69 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC32976 3 25 16 DAC26-O15 18-CG6354-RB_4 CG6354 AGCTGTTCGTAGGCGGTCTTAAGGATAACCACGATGAGGAATGCCTTCGTGAATACTTCCTCCAATTCG 69 FBan0006354 FBgn0004903 Rb97D 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397; spermatid development; GO:0007286; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Rb97D Ribonuclear protein at 97D "CG6354, Rb97D1, rbf, Hrb97D, R16, ms(3)03445" CDMC32976 3 26 16 DAC26-O15 18-CG6354-RB_4 CG6354 AGCTGTTCGTAGGCGGTCTTAAGGATAACCACGATGAGGAATGCCTTCGTGAATACTTCCTCCAATTCG 69 FBan0006354 FBgn0004903 Rb97D 3 3R RNA localization; GO:0006403; mRNA processing; GO:0006397; spermatid development; GO:0007286; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Rb97D Ribonuclear protein at 97D "CG6354, Rb97D1, rbf, Hrb97D, R16, ms(3)03445" CDMC32977 3 1 17 DAC27-C03 1-CG3707-RA_1 CG3707 TGGGATCTGAATCGGAATCGAAGAGCCATCGCAATTGTCGTTAACCACACCGAAAGCCTGCCACCAAAA 69 FBan0003707 FBgn0004655 wapl X X female meiosis chromosome segregation; GO:0016321; sister chromatid cohesion; GO:0007062 wapl wings apart-like "CG3707, CG3707, wap, N2, l(1)C204, l(1)2Dd, pasc: parallel sister chromatids protein, C204, l(1)2Df, RNAD, RNA D, l74, EG:87B1.2, l(1)N2, l(1)N5[72], parallel sister chromatids protein, pasc" CDMC32977 3 2 17 DAC27-C03 1-CG3707-RA_1 CG3707 TGGGATCTGAATCGGAATCGAAGAGCCATCGCAATTGTCGTTAACCACACCGAAAGCCTGCCACCAAAA 69 FBan0003707 FBgn0004655 wapl X X female meiosis chromosome segregation; GO:0016321; sister chromatid cohesion; GO:0007062 wapl wings apart-like "CG3707, CG3707, wap, N2, l(1)C204, l(1)2Dd, pasc: parallel sister chromatids protein, C204, l(1)2Df, RNAD, RNA D, l74, EG:87B1.2, l(1)N2, l(1)N5[72], parallel sister chromatids protein, pasc" CDMC32978 3 3 17 DAC27-C15 2-CG3714-RE_1 CG3714 GTAGAGCTGGAACTCGTTCCGTCACACGAGGATTTCCCGCTGACTATGAAGCACAAACTCCCACGCAAT 69 FBan0003714 FBgn0031589 CG3714 2 2L coenzyme metabolism; GO:0006732; pyridine nucleotide biosynthesis; GO:0019363 nicotinate phosphoribosyltransferase activity; GO:0004516 ; EC:2.4.2.11; ; GO:0004516 ; EC:2.4.2.11 CG3714 CG3714 AAF51037 CDMC32978 3 4 17 DAC27-C15 2-CG3714-RE_1 CG3714 GTAGAGCTGGAACTCGTTCCGTCACACGAGGATTTCCCGCTGACTATGAAGCACAAACTCCCACGCAAT 69 FBan0003714 FBgn0031589 CG3714 2 2L coenzyme metabolism; GO:0006732; pyridine nucleotide biosynthesis; GO:0019363 nicotinate phosphoribosyltransferase activity; GO:0004516 ; EC:2.4.2.11; ; GO:0004516 ; EC:2.4.2.11 CG3714 CG3714 AAF51037 CDMC32979 3 5 17 DAC27-G03 16-CG3753-RA_2 CG3753 GTGATGGAAAGCAGTCAACTTTTGGTTGGGATGCCAATGGTCAATCGAATTTGGAGGAACTGAAGGTCA 69 FBan0003753 FBgn0031655 Marcal1 2 2L DNA metabolism; GO:0006259; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0003678; ; GO:0003677 Marcal1 Marcal1 "CG3753, CG3753, CG3753, dsmarcal1" CDMC32979 3 6 17 DAC27-G03 16-CG3753-RA_2 CG3753 GTGATGGAAAGCAGTCAACTTTTGGTTGGGATGCCAATGGTCAATCGAATTTGGAGGAACTGAAGGTCA 69 FBan0003753 FBgn0031655 Marcal1 2 2L DNA metabolism; GO:0006259; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0003678; ; GO:0003677 Marcal1 Marcal1 "CG3753, CG3753, CG3753, dsmarcal1" CDMC32980 3 7 17 DAC27-G15 16-CG3763-RA_1 CG3763 ACATCACAATCCAAGCCACGTCAACCCCAAATAATTAACCCCAAGCAAAAATGTTTGACTGGACCGGTA 69 FBan0003763 FBgn0000640 Fbp2 2 2L lipid metabolism; GO:0006629 nutrient reservoir activity; GO:0045735; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0045735; ; GO:0004022 ; EC:1.1.1.1 Fbp2 Fat body protein 2 "CG3763, CG3763, P6: Protein-6, fat body protein P6, T19, Protein-6, P6" CDMC32980 3 8 17 DAC27-G15 16-CG3763-RA_1 CG3763 ACATCACAATCCAAGCCACGTCAACCCCAAATAATTAACCCCAAGCAAAAATGTTTGACTGGACCGGTA 69 FBan0003763 FBgn0000640 Fbp2 2 2L lipid metabolism; GO:0006629 nutrient reservoir activity; GO:0045735; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; alcohol dehydrogenase activity; GO:0004022 ; EC:1.1.1.1; ; GO:0045735; ; GO:0004022 ; EC:1.1.1.1 Fbp2 Fat body protein 2 "CG3763, CG3763, P6: Protein-6, fat body protein P6, T19, Protein-6, P6" CDMC32981 3 9 17 DAC27-K03 1-CG3810-RA_1 CG3810 GGCCGGTGTTCGCATTCACCCACTTTTGGAAGACGGAGAACTAAGTGAGGAAGCACGTAAAAGGCCATT 69 FBan0003810 FBgn0023511 CG3810 X X protein amino acid N-linked glycosylation; GO:0006487 "mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG3810 CG3810 "DM-pI, EG:86E4.2" CDMC32981 3 10 17 DAC27-K03 1-CG3810-RA_1 CG3810 GGCCGGTGTTCGCATTCACCCACTTTTGGAAGACGGAGAACTAAGTGAGGAAGCACGTAAAAGGCCATT 69 FBan0003810 FBgn0023511 CG3810 X X protein amino acid N-linked glycosylation; GO:0006487 "mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG3810 CG3810 "DM-pI, EG:86E4.2" CDMC32982 3 11 17 DAC27-K15 10-CG3820-RA_1 CG3820 GCTCCAGTGGCTAGTCCCTTTCAGTCAGCTGCAAAAAGTCCAGTTTCGAGTGCAAACATTTTTGGCAGT 69 FBan0003820 FBgn0010660 Nup214 2 2R "protein import into nucleus, docking; GO:0000059; transport; GO:0006810" transporter activity; GO:0005215; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515 nuclear pore; GO:0005643 Nup214 Nup214 "CG3820, CG3820, CG3820, l(2)10444, DCAN, dCAN, CAN/Nup214, DNup214" CDMC32982 3 12 17 DAC27-K15 10-CG3820-RA_1 CG3820 GCTCCAGTGGCTAGTCCCTTTCAGTCAGCTGCAAAAAGTCCAGTTTCGAGTGCAAACATTTTTGGCAGT 69 FBan0003820 FBgn0010660 Nup214 2 2R "protein import into nucleus, docking; GO:0000059; transport; GO:0006810" transporter activity; GO:0005215; protein binding; GO:0005515; ; GO:0005215; ; GO:0005515 nuclear pore; GO:0005643 Nup214 Nup214 "CG3820, CG3820, CG3820, l(2)10444, DCAN, dCAN, CAN/Nup214, DNup214" CDMC32983 3 13 17 DAC27-O03 3-CG3857-RA_3 CG3857 TGGGTGAAGCGGCTTGGACTGGGATACGCAGTCCTGAATCATTCAAGTGATTCAAGTTCCAGTGGCAAT 69 FBan0003857 FBgn0023520 CG3857 X X CG3857 CG3857 EG:39E1.3 CDMC32983 3 14 17 DAC27-O03 3-CG3857-RA_3 CG3857 TGGGTGAAGCGGCTTGGACTGGGATACGCAGTCCTGAATCATTCAAGTGATTCAAGTTCCAGTGGCAAT 69 FBan0003857 FBgn0023520 CG3857 X X CG3857 CG3857 EG:39E1.3 CDMC32984 3 15 17 DAC27-O15 16-CG3871-RA_1 CG3871 CCGCGCATGTTCAATGCTCCAAGCTATTATCCCGAAACGATTTTCAATGGGCAATAAACTGCGATGTGA 69 FBan0003871 FBgn0027364 Six4 3 3L gonad development; GO:0008406; myoblast fusion; GO:0007520; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Six4 Six4 "CG3871, D-Six4, Dsix4, myotonix, six4/5, six4" CDMC32984 3 16 17 DAC27-O15 16-CG3871-RA_1 CG3871 CCGCGCATGTTCAATGCTCCAAGCTATTATCCCGAAACGATTTTCAATGGGCAATAAACTGCGATGTGA 69 FBan0003871 FBgn0027364 Six4 3 3L gonad development; GO:0008406; myoblast fusion; GO:0007520; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Six4 Six4 "CG3871, D-Six4, Dsix4, myotonix, six4/5, six4" CDMC32985 3 17 17 DAC28-C03 23-CG10197-RA_2 CG10197 AGCGGCCAATACAAGCATATCTCTATAAGAAACGCATAAACAGCAGAACTTAGCCGCAAAATCGATTTG 69 FBan0010197 FBgn0001319 kn 2 2R "anterior head segmentation; GO:0035288; blastoderm segmentation; GO:0007350; cell-mediated immune response; GO:0042087; embryonic development (sensu Insecta); GO:0001700; head segmentation; GO:0035287; pattern specification; GO:0007389; posterior head segmentation; GO:0035289; regulation of lamellocyte differentiation; GO:0035203; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; response to pest, pathogen or parasite; GO:0009613; specification of segmental identity, intercalary segment; GO:0035291; transcription initiation from RNA polymerase II promoter; GO:0006367; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 kn knot "CG10197, col, knotted, Col, collier, Kn, Collier, Knot, Collier-Knot" CDMC32985 3 18 17 DAC28-C03 23-CG10197-RA_2 CG10197 AGCGGCCAATACAAGCATATCTCTATAAGAAACGCATAAACAGCAGAACTTAGCCGCAAAATCGATTTG 69 FBan0010197 FBgn0001319 kn 2 2R "anterior head segmentation; GO:0035288; blastoderm segmentation; GO:0007350; cell-mediated immune response; GO:0042087; embryonic development (sensu Insecta); GO:0001700; head segmentation; GO:0035287; pattern specification; GO:0007389; posterior head segmentation; GO:0035289; regulation of lamellocyte differentiation; GO:0035203; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355; response to pest, pathogen or parasite; GO:0009613; specification of segmental identity, intercalary segment; GO:0035291; transcription initiation from RNA polymerase II promoter; GO:0006367; wing morphogenesis; GO:0007476; wing vein specification; GO:0007474" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 kn knot "CG10197, col, knotted, Col, collier, Kn, Collier, Knot, Collier-Knot" CDMC32986 3 19 17 DAC28-C15 12-CG10206-RA_1 CG10206 CGAGGAGGATGTGCTGAACATTCAGTGTCTGTGCGACGAGATCATATCGATCAACGATTACCGCACCCA 69 FBan0010206 FBgn0026196 nop5 2 2L rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 mRNA binding; GO:0003729; ; GO:0003729 microtubule associated complex; GO:0005875 nop5 nop5 "CG10206, 2/30, Dnop5, FBgn0026196" CDMC32986 3 20 17 DAC28-C15 12-CG10206-RA_1 CG10206 CGAGGAGGATGTGCTGAACATTCAGTGTCTGTGCGACGAGATCATATCGATCAACGATTACCGCACCCA 69 FBan0010206 FBgn0026196 nop5 2 2L rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 mRNA binding; GO:0003729; ; GO:0003729 microtubule associated complex; GO:0005875 nop5 nop5 "CG10206, 2/30, Dnop5, FBgn0026196" CDMC32987 3 21 17 DAC28-G03 9-CG10236-RA_1 CG10236 GGAGTGGTTCCGTGCTCTGAGCAGGTGGAACGCGGTTTGTTCTTCAATAACCAGAAGGCGTTTGTAAAG 69 FBan0010236 FBgn0002526 LanA 3 3L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; central nervous system development; GO:0007417; embryonic morphogenesis; GO:0048598; female meiosis chromosome segregation; GO:0016321; heart development; GO:0007507; mesoderm development; GO:0007498; organ morphogenesis; GO:0009887; peripheral nervous system development; GO:0007422; proteolysis; GO:0006508; regulation of cell adhesion; GO:0030155; regulation of cell migration; GO:0030334; regulation of embryonic development; GO:0045995; signal transduction; GO:0007165; tissue development; GO:0009888 mRNA binding; GO:0003729; receptor binding; GO:0005102; structural molecule activity; GO:0005198; serine-type peptidase activity; GO:0008236; ; GO:0003729; ; GO:0005102; ; GO:0005198; ; GO:0008236 basal lamina; GO:0005605; basement membrane; GO:0005604; laminin-1; GO:0005606; membrane; GO:0016020 LanA Laminin A "CG10236, CG10236, CG10236, CG10236, laminin, laminin A, lamA, LamA, hdln, headline, laminin alpha, laminin alpha3,5, laminin alpha-chain, Lam-A, lanA, Laminin alpha3,5, LamininA, alpha3/5, LM-A/alpha1, CT28769, Laminin, laminin alpha3/5" CDMC32987 3 22 17 DAC28-G03 9-CG10236-RA_1 CG10236 GGAGTGGTTCCGTGCTCTGAGCAGGTGGAACGCGGTTTGTTCTTCAATAACCAGAAGGCGTTTGTAAAG 69 FBan0010236 FBgn0002526 LanA 3 3L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; central nervous system development; GO:0007417; embryonic morphogenesis; GO:0048598; female meiosis chromosome segregation; GO:0016321; heart development; GO:0007507; mesoderm development; GO:0007498; organ morphogenesis; GO:0009887; peripheral nervous system development; GO:0007422; proteolysis; GO:0006508; regulation of cell adhesion; GO:0030155; regulation of cell migration; GO:0030334; regulation of embryonic development; GO:0045995; signal transduction; GO:0007165; tissue development; GO:0009888 mRNA binding; GO:0003729; receptor binding; GO:0005102; structural molecule activity; GO:0005198; serine-type peptidase activity; GO:0008236; ; GO:0003729; ; GO:0005102; ; GO:0005198; ; GO:0008236 basal lamina; GO:0005605; basement membrane; GO:0005604; laminin-1; GO:0005606; membrane; GO:0016020 LanA Laminin A "CG10236, CG10236, CG10236, CG10236, laminin, laminin A, lamA, LamA, hdln, headline, laminin alpha, laminin alpha3,5, laminin alpha-chain, Lam-A, lanA, Laminin alpha3,5, LamininA, alpha3/5, LM-A/alpha1, CT28769, Laminin, laminin alpha3/5" CDMC32988 3 23 17 DAC28-G15 1-CG10246-RA_1 CG10246 CCTTTGGCATTGAGTGCAGTAGTCTTAAGGATCCAGAGGCAGAGTTCAGGGTAATGGGTCGTCGAGCCA 69 FBan0010246 FBgn0013771 Cyp6a9 2 2R electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a9 Cytochrome P450-6a9 "CG10246, P450, P-450, CYP6A9, 6a9, Cyt-P450-rAF4: cytochrome P450 related AF4, cytochrome P450 related AF4" CDMC32988 3 24 17 DAC28-G15 1-CG10246-RA_1 CG10246 CCTTTGGCATTGAGTGCAGTAGTCTTAAGGATCCAGAGGCAGAGTTCAGGGTAATGGGTCGTCGAGCCA 69 FBan0010246 FBgn0013771 Cyp6a9 2 2R electron transport; GO:0006118; insecticide metabolism; GO:0017143; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a9 Cytochrome P450-6a9 "CG10246, P450, P-450, CYP6A9, 6a9, Cyt-P450-rAF4: cytochrome P450 related AF4, cytochrome P450 related AF4" CDMC32989 3 25 17 DAC28-K03 9-CG10277-RA_2 CG10277 TCGCCCGCATCGAACAACATCCTCAATCCGAATTTAAGCGGCTCCTTTAAGGACGAAGACGATATGCCA 69 FBan0010277 FBgn0037442 CG10277 3 3R CG10277 CG10277 CDMC32989 3 26 17 DAC28-K03 9-CG10277-RA_2 CG10277 TCGCCCGCATCGAACAACATCCTCAATCCGAATTTAAGCGGCTCCTTTAAGGACGAAGACGATATGCCA 69 FBan0010277 FBgn0037442 CG10277 3 3R CG10277 CG10277 CDMC32990 3 1 18 DAC28-K15 23-CG10293-RA_4 CG10293 CACATTACATTAATCGTATGCTGTGCCCCTAACATCGCATAATAAACATCATTCATTCATTGCCAGCAT 69 FBan0010293 FBgn0017397 how 3 3R "apoptosis; GO:0006915; apposition of dorsal and ventral wing surfaces; GO:0007475; cell differentiation; GO:0030154; embryonic development; GO:0009790; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; somatic muscle development; GO:0007525" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 how held out wings "CG10293, CG10293, l(3)j5B5, SZ1, who: wings held out, wings held-out, struthio, qkr, qkr[93F], quaking related, 93F, stru, P62, sci, scorpion, Who/How, clone 2.39, How, HOW, anon-EST:Liang-2.39, KH93F, l(3)j5D5, l(3)s2612, KH motif at 93F, wings held out, who, held out wings" CDMC32990 3 2 18 DAC28-K15 23-CG10293-RA_4 CG10293 CACATTACATTAATCGTATGCTGTGCCCCTAACATCGCATAATAAACATCATTCATTCATTGCCAGCAT 69 FBan0010293 FBgn0017397 how 3 3R "apoptosis; GO:0006915; apposition of dorsal and ventral wing surfaces; GO:0007475; cell differentiation; GO:0030154; embryonic development; GO:0009790; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; somatic muscle development; GO:0007525" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 how held out wings "CG10293, CG10293, l(3)j5B5, SZ1, who: wings held out, wings held-out, struthio, qkr, qkr[93F], quaking related, 93F, stru, P62, sci, scorpion, Who/How, clone 2.39, How, HOW, anon-EST:Liang-2.39, KH93F, l(3)j5D5, l(3)s2612, KH motif at 93F, wings held out, who, held out wings" CDMC32991 3 3 18 DAC28-O03 23-CG10327-RC_4 CG10327 AAGATGACACTGGATGGCTAATAACACAATTGATAAAACACACTTCAAAATAAATTCTGCGCCAAAGCT 69 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC32991 3 4 18 DAC28-O03 23-CG10327-RC_4 CG10327 AAGATGACACTGGATGGCTAATAACACAATTGATAAAACACACTTCAAAATAAATTCTGCGCCAAAGCT 69 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC32992 3 5 18 DAC28-O15 3-CG10342-RA_3 CG10342 TCCAACTCCAGACCTCCGCGAAAGAACGATGTCAACACTATGGCTGATGCCTACAAGTTCCTGCAGGAT 69 FBan0010342 FBgn0027109 npf 3 3R larval feeding behavior; GO:0030536; larval foraging behavior; GO:0035177; larval locomotory behavior; GO:0008345; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 npf neuropeptide F "CG10342, CG10342, dNPF, dnpf, Drm-NPF, NP-PP, NPF89D3, NPF-A1, NPF-A2, NPF, Dm-NPF" CDMC32992 3 6 18 DAC28-O15 3-CG10342-RA_3 CG10342 TCCAACTCCAGACCTCCGCGAAAGAACGATGTCAACACTATGGCTGATGCCTACAAGTTCCTGCAGGAT 69 FBan0010342 FBgn0027109 npf 3 3R larval feeding behavior; GO:0030536; larval foraging behavior; GO:0035177; larval locomotory behavior; GO:0008345; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 npf neuropeptide F "CG10342, CG10342, dNPF, dnpf, Drm-NPF, NP-PP, NPF89D3, NPF-A1, NPF-A2, NPF, Dm-NPF" CDMC32993 3 7 18 DAC29-C03 17-CG13904-RA_2 CG13904 CCTCGTCTTAGGCATTATGTTGGGCATTCGACTCACCGATTTTATAGGCTACCTGAAGCTGTGGAGGAA 69 FBgn0035175 CDMC32993 3 8 18 DAC29-C03 17-CG13904-RA_2 CG13904 CCTCGTCTTAGGCATTATGTTGGGCATTCGACTCACCGATTTTATAGGCTACCTGAAGCTGTGGAGGAA 69 FBgn0035175 CDMC32994 3 9 18 DAC29-C15 3-CG13924-RA_2 CG13924 GCTCCCTTCAACTGAGACAGGGCACTTTCGACCAGGATGACTCCGACCAGAAGAGTCTAACCAATCTGC 69 FBan0013924 FBgn0035286 CG13924 3 3L CG13924 CG13924 CDMC32994 3 10 18 DAC29-C15 3-CG13924-RA_2 CG13924 GCTCCCTTCAACTGAGACAGGGCACTTTCGACCAGGATGACTCCGACCAGAAGAGTCTAACCAATCTGC 69 FBan0013924 FBgn0035286 CG13924 3 3L CG13924 CG13924 CDMC32995 3 11 18 DAC29-G03 9-CG13977-RA_3 CG13977 GCCATGCTCATTAAGAACTTCACATTCTCCCCATGCTCAGCGACACCAGATCCCTTGACCTTCGATCCT 69 FBan0013977 FBgn0039519 Cyp6a18 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a18 Cyp6a18 "CG13977, 6a18" CDMC32995 3 12 18 DAC29-G03 9-CG13977-RA_3 CG13977 GCCATGCTCATTAAGAACTTCACATTCTCCCCATGCTCAGCGACACCAGATCCCTTGACCTTCGATCCT 69 FBan0013977 FBgn0039519 Cyp6a18 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a18 Cyp6a18 "CG13977, 6a18" CDMC32996 3 13 18 DAC29-G15 3-CG13990-RA_2 CG13990 CGTCCCGCATTGGAAATCGATGAACTGTCGGCTCCCAAAGCCCAAGAGCTAACCATGTCCACCTATACA 69 FBan0013990 FBgn0040950 CG13990 2 2L CG13990 CG13990 BcDNA:RE30702 CDMC32996 3 14 18 DAC29-G15 3-CG13990-RA_2 CG13990 CGTCCCGCATTGGAAATCGATGAACTGTCGGCTCCCAAAGCCCAAGAGCTAACCATGTCCACCTATACA 69 FBan0013990 FBgn0040950 CG13990 2 2L CG13990 CG13990 BcDNA:RE30702 CDMC32997 3 15 18 DAC29-K03 23-CG14028-RA_2 CG14028 TGTAGAACAAGAGTTGCGCTTCTGTATTGAAAACTAAATAGATTTCAGTCTACGTACGTGCACGAAGGC 69 FBan0014028 FBgn0015031 cype 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 cype cyclope "CG14028, CG18323, CG14028, l(2)03771, Cyc, Cyclope, cyc, BcDNA:GH04604, cyclope" CDMC32997 3 16 18 DAC29-K03 23-CG14028-RA_2 CG14028 TGTAGAACAAGAGTTGCGCTTCTGTATTGAAAACTAAATAGATTTCAGTCTACGTACGTGCACGAAGGC 69 FBan0014028 FBgn0015031 cype 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 cype cyclope "CG14028, CG18323, CG14028, l(2)03771, Cyc, Cyclope, cyc, BcDNA:GH04604, cyclope" CDMC32998 3 17 18 DAC29-K15 23-CG14034-RA_10 CG14034 TGCTGGCTTAGATGATATGAACTGTTTTTCCCTGCAAAACGAAATTTGTCCCAATGCCAACATTTCCTT 69 FBan0014034 FBgn0031691 CG14034 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG14034 CG14034 CDMC32998 3 18 18 DAC29-K15 23-CG14034-RA_10 CG14034 TGCTGGCTTAGATGATATGAACTGTTTTTCCCTGCAAAACGAAATTTGTCCCAATGCCAACATTTCCTT 69 FBan0014034 FBgn0031691 CG14034 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG14034 CG14034 CDMC32999 3 19 18 DAC29-O03 1-CG14059-RA_4 CG14059 CCCGGCTGTCGTCATCCGAAGTGGTTAATCCAGATGTGTCCAGAGCGGCGATCCAGATTCACATTGAAA 69 FBan0014059 FBgn0036690 CG14059 3 3L CG14059 CG14059 CDMC32999 3 20 18 DAC29-O03 1-CG14059-RA_4 CG14059 CCCGGCTGTCGTCATCCGAAGTGGTTAATCCAGATGTGTCCAGAGCGGCGATCCAGATTCACATTGAAA 69 FBan0014059 FBgn0036690 CG14059 3 3L CG14059 CG14059 CDMC33000 3 21 18 DAC29-O15 8-CG14070-RA_1 CG14070 TGTGGGGCTGGAACGATACTCTGCTGTCGATACAATACTTCTCCCTGCTGTTCTGCAAAATTGGCGGAT 69 FBan0014070 FBgn0032313 CG14070 2 2L CG14070 CG14070 CDMC33000 3 22 18 DAC29-O15 8-CG14070-RA_1 CG14070 TGTGGGGCTGGAACGATACTCTGCTGTCGATACAATACTTCTCCCTGCTGTTCTGCAAAATTGGCGGAT 69 FBan0014070 FBgn0032313 CG14070 2 2L CG14070 CG14070 CDMC33001 3 23 18 DAC30-C03 23-CG15110-RA_7 CG15110 GCCACTGATAAGCCAATCGAGATAGCACAGCCTGCATTTCACCGAATAATAACTATTTTTTCGCACGGC 69 FBan0015110 FBgn0027535 botv 2 2R "N-acetylglucosamine metabolism; GO:0006044; Wnt receptor signaling pathway; GO:0016055; cellular physiological process; GO:0050875; decapentaplegic receptor signaling pathway; GO:0008101; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224" acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; heparan sulfate N-acetylglucosaminyltransferase activity; GO:0042328; ; GO:0008375 ; EC:2.4.1.-; ; GO:0042328; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; GO:0001888 ; EC:2.4.1.223; ; GO:0001888 ; EC:2.4.1.223 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 botv brother of tout-velu "CG15110, CG15110, CG15110, DEXT3, Dextl3, Drosophila Ext-like 3, Botv, BcDNA:LD21192, brother of tout-velu" CDMC33001 3 24 18 DAC30-C03 23-CG15110-RA_7 CG15110 GCCACTGATAAGCCAATCGAGATAGCACAGCCTGCATTTCACCGAATAATAACTATTTTTTCGCACGGC 69 FBan0015110 FBgn0027535 botv 2 2R "N-acetylglucosamine metabolism; GO:0006044; Wnt receptor signaling pathway; GO:0016055; cellular physiological process; GO:0050875; decapentaplegic receptor signaling pathway; GO:0008101; glycosaminoglycan biosynthesis; GO:0006024; heparan sulfate proteoglycan biosynthesis; GO:0015012; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis; GO:0015014; segment polarity determination; GO:0007367; smoothened signaling pathway; GO:0007224" acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; heparan sulfate N-acetylglucosaminyltransferase activity; GO:0042328; ; GO:0008375 ; EC:2.4.1.-; ; GO:0042328; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; GO:0001888 ; EC:2.4.1.223; ; GO:0001888 ; EC:2.4.1.223 Golgi apparatus; GO:0005794; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 botv brother of tout-velu "CG15110, CG15110, CG15110, DEXT3, Dextl3, Drosophila Ext-like 3, Botv, BcDNA:LD21192, brother of tout-velu" CDMC33002 3 25 18 DAC30-C15 12-CG15119-RA_1 CG15119 CCTGTTTGAGCGAAGTTTGGACCTGTCCAAATACCAGGATAAGACTCCTTTGTACCCCATATGCCGCGC 69 FBan0015119 FBgn0034430 mip40 2 2R chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 molecular function unknown; GO:0005554; ; GO:0005554 Myb complex; GO:0031523 mip40 Myb-interacting protein 40 "CG15119, p40, Mip40, Myb-interacting protein 40" CDMC33002 3 26 18 DAC30-C15 12-CG15119-RA_1 CG15119 CCTGTTTGAGCGAAGTTTGGACCTGTCCAAATACCAGGATAAGACTCCTTTGTACCCCATATGCCGCGC 69 FBan0015119 FBgn0034430 mip40 2 2R chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 molecular function unknown; GO:0005554; ; GO:0005554 Myb complex; GO:0031523 mip40 Myb-interacting protein 40 "CG15119, p40, Mip40, Myb-interacting protein 40" CDMC33003 3 1 19 DAC30-G03 16-CG15154-RA_1 CG15154 CTCGGACGGATTTTTGAGTTGTGGCACTCTTGAAAGCGAGCTGGTAGAATGTAGAATCGAAATCGCAGT 69 FBan0015154 FBgn0041184 Socs36E 2 2L JAK-STAT cascade; GO:0007259; regulation of JAK-STAT cascade; GO:0046425 Socs36E Suppressor of cytokine signaling at 36E "CG15154, CG15154, CG15154, clone 2.2, dSOCS, Suppressor of cytokine signaling, Socs, SOCS, socs36E, SOCS36E, socs60E1, dmSocs36E, anon-EST:Liang-2.2, Suppressor of cytokine signaling at 36E" CDMC33003 3 2 19 DAC30-G03 16-CG15154-RA_1 CG15154 CTCGGACGGATTTTTGAGTTGTGGCACTCTTGAAAGCGAGCTGGTAGAATGTAGAATCGAAATCGCAGT 69 FBan0015154 FBgn0041184 Socs36E 2 2L JAK-STAT cascade; GO:0007259; regulation of JAK-STAT cascade; GO:0046425 Socs36E Suppressor of cytokine signaling at 36E "CG15154, CG15154, CG15154, clone 2.2, dSOCS, Suppressor of cytokine signaling, Socs, SOCS, socs36E, SOCS36E, socs60E1, dmSocs36E, anon-EST:Liang-2.2, Suppressor of cytokine signaling at 36E" CDMC33004 3 3 19 DAC30-G15 2-CG15169-RA_4 CG15169 CGGCGGACTAGCGGGTGAAAAGTCAGAAAACTCAGGCATTGAAGCCGGTGAAAATGACACAGAATCCCT 69 FBan0015169 FBgn0032734 CG15169 2 2L CG15169 CG15169 CDMC33004 3 4 19 DAC30-G15 2-CG15169-RA_4 CG15169 CGGCGGACTAGCGGGTGAAAAGTCAGAAAACTCAGGCATTGAAGCCGGTGAAAATGACACAGAATCCCT 69 FBan0015169 FBgn0032734 CG15169 2 2L CG15169 CG15169 CDMC33005 3 5 19 DAC30-K03 23-CG15209-RA_5 CG15209 TGACCCATGCAGATATACATACTATGGCAACTATATGATATTCTCCGACCTGACTTTCTTTAGAACATT 69 FBan0015209 FBgn0030237 CG15209 X X CG15209 CG15209 "BcDNA:SD22308, anon-EST:Posey262" CDMC33005 3 6 19 DAC30-K03 23-CG15209-RA_5 CG15209 TGACCCATGCAGATATACATACTATGGCAACTATATGATATTCTCCGACCTGACTTTCTTTAGAACATT 69 FBan0015209 FBgn0030237 CG15209 X X CG15209 CG15209 "BcDNA:SD22308, anon-EST:Posey262" CDMC33006 3 7 19 DAC30-K15 3-CG15218-RA_5 CG15218 GCAAATGGCGTGGAACTTCGTCAACGACTCTCTCAGCACAGTAGTTTGTCTACAGTGGGAGCCGGAGAT 69 FBan0015218 FBgn0025674 CycK 2 2L RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0030528; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycK Cyclin K "CG15218, cyclin K" CDMC33006 3 8 19 DAC30-K15 3-CG15218-RA_5 CG15218 GCAAATGGCGTGGAACTTCGTCAACGACTCTCTCAGCACAGTAGTTTGTCTACAGTGGGAGCCGGAGAT 69 FBan0015218 FBgn0025674 CycK 2 2L RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0030528; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycK Cyclin K "CG15218, cyclin K" CDMC33007 3 9 19 DAC30-O03 1-CG15256-RA_1 CG15256 CCGCCCATGTTGTCGAGCTACACAAGGCAATACTCCCAGCCGTATCCAAATCGTTGTAAGCCCTTTGTT 69 FBan0015256 FBgn0028880 CG15256 2 2L CG15256 CG15256 BG:DS04862.2 CDMC33007 3 10 19 DAC30-O03 1-CG15256-RA_1 CG15256 CCGCCCATGTTGTCGAGCTACACAAGGCAATACTCCCAGCCGTATCCAAATCGTTGTAAGCCCTTTGTT 69 FBan0015256 FBgn0028880 CG15256 2 2L CG15256 CG15256 BG:DS04862.2 CDMC33008 3 11 19 DAC30-O15 12-CG15267-RA_2 CG15267 TCCTGTCCATTTACCTGAGCAAGTGCACTACGTTTTTTGATCAGCTGGAGAAGAGTCTGCCTACGGCCT 69 FBan0015267 FBgn0028862 CG15267 2 2L CG15267 CG15267 "BG:DS07295.2, anon-WO0140519.126" CDMC33008 3 12 19 DAC30-O15 12-CG15267-RA_2 CG15267 TCCTGTCCATTTACCTGAGCAAGTGCACTACGTTTTTTGATCAGCTGGAGAAGAGTCTGCCTACGGCCT 69 FBan0015267 FBgn0028862 CG15267 2 2L CG15267 CG15267 "BG:DS07295.2, anon-WO0140519.126" CDMC33009 3 13 19 DAC31-C03 3-CG12784-RA_5 CG12784 TGTTTGACCGTTTGGATGCGTGGACTAAAAGTGAAGTGAAGCCCGGTGAAATGGGACGCATCTTGGC 67 FBan0012784 FBgn0038356 CG12784 3 3R CG12784 CG12784 CDMC33009 3 14 19 DAC31-C03 3-CG12784-RA_5 CG12784 TGTTTGACCGTTTGGATGCGTGGACTAAAAGTGAAGTGAAGCCCGGTGAAATGGGACGCATCTTGGC 67 FBan0012784 FBgn0038356 CG12784 3 3R CG12784 CG12784 CDMC33010 3 15 19 DAC31-C15 9-CG12906-RA_5 CG12906 ACGAATGCGTTCCGAGTCTCCTCGAAGCTCAAGATATACTGCGCTATCCATCATGCCCTCTGTGTGC 67 FBan0012906 FBgn0041242 Gr47a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr47a Gustatory receptor 47a "CG12906, CG12906, 47A.1, Gustatory receptor 47A.1, Gr47A1, 47A1, GR47A.1, Gustatory receptor 47a" CDMC33010 3 16 19 DAC31-C15 9-CG12906-RA_5 CG12906 ACGAATGCGTTCCGAGTCTCCTCGAAGCTCAAGATATACTGCGCTATCCATCATGCCCTCTGTGTGC 67 FBan0012906 FBgn0041242 Gr47a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 Gr47a Gustatory receptor 47a "CG12906, CG12906, 47A.1, Gustatory receptor 47A.1, Gr47A1, 47A1, GR47A.1, Gustatory receptor 47a" CDMC33011 3 17 19 DAC31-G03 3-CG13362-RA_3 CG13362 AGCAGCAGACCGTAGTATCGGAGCAAGGGGTCTCCAGTAACAGTCGCATTCAATTTGTTCCCTGCAT 67 FBan0013362 FBgn0029531 CG13362 X X CG13362 CG13362 CDMC33011 3 18 19 DAC31-G03 3-CG13362-RA_3 CG13362 AGCAGCAGACCGTAGTATCGGAGCAAGGGGTCTCCAGTAACAGTCGCATTCAATTTGTTCCCTGCAT 67 FBan0013362 FBgn0029531 CG13362 X X CG13362 CG13362 CDMC33012 3 19 19 DAC31-G15 2-CG13488-RA_1 CG13488 TGGAGGAAAATCTTGACTCGTGGCGGACCCCGAAGATTGGAGAAGCTGAGGGAATTCGTCAAATGGC 67 FBan0013488 FBgn0034670 CG13488 2 2R CG13488 CG13488 CDMC33012 3 20 19 DAC31-G15 2-CG13488-RA_1 CG13488 TGGAGGAAAATCTTGACTCGTGGCGGACCCCGAAGATTGGAGAAGCTGAGGGAATTCGTCAAATGGC 67 FBan0013488 FBgn0034670 CG13488 2 2R CG13488 CG13488 CDMC33013 3 21 19 DAC31-K03 3-CG13701-RA_1 CG13701 CCAACAGCACAAGTCGTCCGGAAAATCCAGCAAACTAAAGGCCACCGTTCAAATACAACCGCAGGCG 67 FBan0013701 FBgn0036786 skl 3 3L apoptosis; GO:0006915; cell death; GO:0008219; induction of apoptosis; GO:0006917 skl sickle "CG13701, CG13701, CG13701, CG13701, CG13701, Skl, Sickle, veto, BcDNA:RE14076, meph: mephisto, mephisto" CDMC33013 3 22 19 DAC31-K03 3-CG13701-RA_1 CG13701 CCAACAGCACAAGTCGTCCGGAAAATCCAGCAAACTAAAGGCCACCGTTCAAATACAACCGCAGGCG 67 FBan0013701 FBgn0036786 skl 3 3L apoptosis; GO:0006915; cell death; GO:0008219; induction of apoptosis; GO:0006917 skl sickle "CG13701, CG13701, CG13701, CG13701, CG13701, Skl, Sickle, veto, BcDNA:RE14076, meph: mephisto, mephisto" CDMC33014 3 23 19 DAC31-K15 23-CG13860-RA_1 CG13860 TGTTTGGTTTTTATGGCTTTTAATTCAATTAAATTGGTTTGCGCTTAAACTTTGGCTGTCTGGTTAA 67 FBan0013860 FBgn0038939 CG13860 3 3R CG13860 CG13860 CDMC33014 3 24 19 DAC31-K15 23-CG13860-RA_1 CG13860 TGTTTGGTTTTTATGGCTTTTAATTCAATTAAATTGGTTTGCGCTTAAACTTTGGCTGTCTGGTTAA 67 FBan0013860 FBgn0038939 CG13860 3 3R CG13860 CG13860 CDMC33015 3 25 19 DAC31-O03 1-CG14317-RA_1 CG14317 CGATCAGGTACGCATGGCTAGGGCCTATCCACAGTTCATGCCACAGATTCTCAAGTTCTGGCAGAGG 67 FBan0014317 FBgn0038566 CG14317 3 3R CG14317 CG14317 anon-WO0172774.95 CDMC33015 3 26 19 DAC31-O03 1-CG14317-RA_1 CG14317 CGATCAGGTACGCATGGCTAGGGCCTATCCACAGTTCATGCCACAGATTCTCAAGTTCTGGCAGAGG 67 FBan0014317 FBgn0038566 CG14317 3 3R CG14317 CG14317 anon-WO0172774.95 CDMC33016 3 1 20 DAC31-O15 AutoBlank AutoBlank CDMC33016 3 2 20 DAC31-O15 AutoBlank AutoBlank CDMC33017 3 3 20 DAC32-C03 12-CG31720-RA_5 CG31720 CGACGATGCGGATTTGGATAGAGGTGCATTACCGGAACAGAAGTTTCTGGTGCGTGCTTGTCAGGAAAT 69 FBan0031720 FBgn0051720 CG31720 2 2L G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 membrane; GO:0016020 CG31720 CG31720 CDMC33017 3 4 20 DAC32-C03 12-CG31720-RA_5 CG31720 CGACGATGCGGATTTGGATAGAGGTGCATTACCGGAACAGAAGTTTCTGGTGCGTGCTTGTCAGGAAAT 69 FBan0031720 FBgn0051720 CG31720 2 2L G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 membrane; GO:0016020 CG31720 CG31720 CDMC33018 3 5 20 DAC32-C15 2-CG31732-RB_1 CG31732 GCCAACTGCGAGACCTCCCTTCCCTGCTGAAAAACCAAGAAAATCAAAGCGTGGAACTCTGCACGAAGT 69 FBgn0028877 CDMC33018 3 6 20 DAC32-C15 2-CG31732-RB_1 CG31732 GCCAACTGCGAGACCTCCCTTCCCTGCTGAAAAACCAAGAAAATCAAAGCGTGGAACTCTGCACGAAGT 69 FBgn0028877 CDMC33019 3 7 20 DAC32-G03 11-CG31756-RA_2 CG31756 TGCTGCTGAACAAGGGATCTATACACTCCGCCTCAGACACGAACATTTGCTACGAATCCGACTGGAAGC 69 FBgn0051756 CDMC33019 3 8 20 DAC32-G03 11-CG31756-RA_2 CG31756 TGCTGCTGAACAAGGGATCTATACACTCCGCCTCAGACACGAACATTTGCTACGAATCCGACTGGAAGC 69 FBgn0051756 CDMC33020 3 9 20 DAC32-G15 11-CG31764-RB_1 CG31764 TGGGCCGAATTCGATCAGGATCAGGATCGAGAGCACGATCGGAATGAGGATCAGGATCATGATTTGGAC 69 FBgn0051764 CDMC33020 3 10 20 DAC32-G15 11-CG31764-RB_1 CG31764 TGGGCCGAATTCGATCAGGATCAGGATCGAGAGCACGATCGGAATGAGGATCAGGATCATGATTTGGAC 69 FBgn0051764 CDMC33021 3 11 20 DAC32-K03 11-CG31791-RA_1 CG31791 CGCAGCTCGGAGATGATATACTCCTGGGAAGTGGAAAAGCTTAAGACACGCAATAGGGAGTGGGAGGTC 69 FBan0031791 FBgn0051791 CG31791 2 2L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0008965 ; EC:2.7.3.9 cytoplasm; GO:0005737 CG31791 CG31791 "CG15165, CG15165" CDMC33021 3 12 20 DAC32-K03 11-CG31791-RA_1 CG31791 CGCAGCTCGGAGATGATATACTCCTGGGAAGTGGAAAAGCTTAAGACACGCAATAGGGAGTGGGAGGTC 69 FBan0031791 FBgn0051791 CG31791 2 2L phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0008965 ; EC:2.7.3.9 cytoplasm; GO:0005737 CG31791 CG31791 "CG15165, CG15165" CDMC33022 3 13 20 DAC32-K15 8-CG31804-RA_1 CG31804 AGACAGAACGAAACGGACACAGTGGATTCGGCTATGGATGTAGCTACCAGGCAAAGTGCATCCACCAAA 69 FBan0031804 FBgn0051804 CG31804 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31804 CG31804 "NEST:bs12c10, NEST:bs13h04, NEST:bs34f07, NEST:bs27h11" CDMC33022 3 14 20 DAC32-K15 8-CG31804-RA_1 CG31804 AGACAGAACGAAACGGACACAGTGGATTCGGCTATGGATGTAGCTACCAGGCAAAGTGCATCCACCAAA 69 FBan0031804 FBgn0051804 CG31804 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31804 CG31804 "NEST:bs12c10, NEST:bs13h04, NEST:bs34f07, NEST:bs27h11" CDMC33023 3 15 20 DAC32-O03 2-CG3182-RB_4 CG3182 CGCCTGGCGATATCCTAGTACACCGAGGAGATGTGCTCACCTCATTGTACTTCATAGCCAGGGGATCCA 69 FBan0003182 FBgn0003353 sei 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249 voltage-gated potassium channel complex; GO:0008076 sei seizure "CG3182, erg, eag related gene, seizure potassium channel, Derg" CDMC33023 3 16 20 DAC32-O03 2-CG3182-RB_4 CG3182 CGCCTGGCGATATCCTAGTACACCGAGGAGATGTGCTCACCTCATTGTACTTCATAGCCAGGGGATCCA 69 FBan0003182 FBgn0003353 sei 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249 voltage-gated potassium channel complex; GO:0008076 sei seizure "CG3182, erg, eag related gene, seizure potassium channel, Derg" CDMC33024 3 17 20 DAC32-O15 22-CG31840-RA_1 CG31840 CGGACGAGCGACATACATGCGAACCAGTACGGGTATGCACGAGTATGTACATCGGTATGTTCATATGTA 69 FBan0031840 FBgn0051840 CG31840 2 2L proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 cellular component unknown; GO:0008372 CG31840 CG31840 CDMC33024 3 18 20 DAC32-O15 22-CG31840-RA_1 CG31840 CGGACGAGCGACATACATGCGAACCAGTACGGGTATGCACGAGTATGTACATCGGTATGTTCATATGTA 69 FBan0031840 FBgn0051840 CG31840 2 2L proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 cellular component unknown; GO:0008372 CG31840 CG31840 CDMC33025 3 19 20 DAC33-C03 2-CG15536-RA_1 CG15536 GCACGGCAACCAGAAGAACCAGCTTGAAAACAGTCCACAGAGCAGTAAAATCGTTGAGCTACAGGGCGA 69 FBan0015536 FBgn0039766 CG15536 3 3R CG15536 CG15536 CDMC33025 3 20 20 DAC33-C03 2-CG15536-RA_1 CG15536 GCACGGCAACCAGAAGAACCAGCTTGAAAACAGTCCACAGAGCAGTAAAATCGTTGAGCTACAGGGCGA 69 FBan0015536 FBgn0039766 CG15536 3 3R CG15536 CG15536 CDMC33026 3 21 20 DAC33-C15 23-CG1554-RA_1 CG1554 ACTATTTGTAGCGTTTTCCATATACCCTTTAAATCCCTAATTAACCCGATCAGTTGTTTTCGCCTGCAC 69 FBan0001554 FBgn0003277 RpII215 X X mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII215 RNA polymerase II 215kD subunit "CG1554, CG1554, 5, RpII, l(1)DF912, L5, l(1)L5, RNA polymerase II, Rpll215, Ubl: Ultrabithorax-like, RNApolII, RNA PolII, RNAP II LS, PolII, Pol II, RNAP II, RPB1, II, polII, l(1)G0040, H5, RNA polymerase II large subunit, RNA polII, RNA pol II, pol II, dRPB1, POL, RNA Pol II, Pol IIa, 8WG16, Pol II CTD, RNAPII, Rpb1, RNAP, l(1)10Ca, l(1)DC912, Ultrabithorax-like, Ubl" CDMC33026 3 22 20 DAC33-C15 23-CG1554-RA_1 CG1554 ACTATTTGTAGCGTTTTCCATATACCCTTTAAATCCCTAATTAACCCGATCAGTTGTTTTCGCCTGCAC 69 FBan0001554 FBgn0003277 RpII215 X X mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 "DNA-directed RNA polymerase II, core complex; GO:0005665" RpII215 RNA polymerase II 215kD subunit "CG1554, CG1554, 5, RpII, l(1)DF912, L5, l(1)L5, RNA polymerase II, Rpll215, Ubl: Ultrabithorax-like, RNApolII, RNA PolII, RNAP II LS, PolII, Pol II, RNAP II, RPB1, II, polII, l(1)G0040, H5, RNA polymerase II large subunit, RNA polII, RNA pol II, pol II, dRPB1, POL, RNA Pol II, Pol IIa, 8WG16, Pol II CTD, RNAPII, Rpb1, RNAP, l(1)10Ca, l(1)DC912, Ultrabithorax-like, Ubl" CDMC33027 3 23 20 DAC33-G03 15-CG15593-RA_2 CG15593 TCTGGGCTTAAAGTTCAATCTGGTGGCCCTAGTACCCCTGATATTTGCTGGCATATGTCTGCTGCTCAA 69 FBan0015593 FBgn0037417 Osi10 3 3R Osi10 Osiris 10 "CG15593, CG15593, CG15593, CG15593, Osiris, Osiris 10" CDMC33027 3 24 20 DAC33-G03 15-CG15593-RA_2 CG15593 TCTGGGCTTAAAGTTCAATCTGGTGGCCCTAGTACCCCTGATATTTGCTGGCATATGTCTGCTGCTCAA 69 FBan0015593 FBgn0037417 Osi10 3 3R Osi10 Osiris 10 "CG15593, CG15593, CG15593, CG15593, Osiris, Osiris 10" CDMC33028 3 25 20 DAC33-G15 3-CG15601-RA_1 CG15601 AGGCCTACGGAGCGATCATCCGGTCCCTGAAGATACCCCAACTGACAGTGTCGGACATAAAGCTAAAGA 69 FBan0015601 FBgn0030673 CG15601 X X CG15601 CG15601 CDMC33028 3 26 20 DAC33-G15 3-CG15601-RA_1 CG15601 AGGCCTACGGAGCGATCATCCGGTCCCTGAAGATACCCCAACTGACAGTGTCGGACATAAAGCTAAAGA 69 FBan0015601 FBgn0030673 CG15601 X X CG15601 CG15601 CDMC33029 3 1 21 DAC33-K03 8-CG15645-RA_1 CG15645 TCCAGAAGTTGTTGGACCAGAACGTGGATCTCGCCGAGAATCTCATCCGAATGAAGAGCAAGCACCAAT 69 FBan0015645 FBgn0030657 CG15645 X X CG15645 CG15645 CDMC33029 3 2 21 DAC33-K03 8-CG15645-RA_1 CG15645 TCCAGAAGTTGTTGGACCAGAACGTGGATCTCGCCGAGAATCTCATCCGAATGAAGAGCAAGCACCAAT 69 FBan0015645 FBgn0030657 CG15645 X X CG15645 CG15645 CDMC33030 3 3 21 DAC33-K15 23-CG15669-RA_2 CG15669 AGTGTATAAAGAAAAACACCCATCAAGAACAAGAACCAACAACTTACATGTTATCAAGTGACATAACGT 69 FBan0015669 FBgn0043070 MESK2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK2 Misexpression suppressor of KSR 2 "CG15669, CG15668, CG15669, l(2)01467, BcDNA:GH12032, BcDNA:LD27504, BcDNA:RH10174, Misexpression suppressor of KSR 2" CDMC33030 3 4 21 DAC33-K15 23-CG15669-RA_2 CG15669 AGTGTATAAAGAAAAACACCCATCAAGAACAAGAACCAACAACTTACATGTTATCAAGTGACATAACGT 69 FBan0015669 FBgn0043070 MESK2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK2 Misexpression suppressor of KSR 2 "CG15669, CG15668, CG15669, l(2)01467, BcDNA:GH12032, BcDNA:LD27504, BcDNA:RH10174, Misexpression suppressor of KSR 2" CDMC33031 3 5 21 DAC33-O03 7-CG1571-RA_1 CG1571 GGGATCTGTTGCTTCATCACCGTAAGCCCATTCGTTCCGTGGACTTTAAGGTAGCCATTGCGGATTTGG 69 FBan0001571 FBgn0029993 CG1571 X X microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG1571 CG1571 CDMC33031 3 6 21 DAC33-O03 7-CG1571-RA_1 CG1571 GGGATCTGTTGCTTCATCACCGTAAGCCCATTCGTTCCGTGGACTTTAAGGTAGCCATTGCGGATTTGG 69 FBan0001571 FBgn0029993 CG1571 X X microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG1571 CG1571 CDMC33032 3 7 21 DAC33-O15 17-CG15731-RA_1 CG15731 TGGCTTCCTCATCTGCTACGTGAAGTTCCATAGTTTTCAACCCCCAAGCAAGAAACTTCCAGCAATGAA 69 FBan0015731 FBgn0030390 CG15731 X X CG15731 CG15731 CDMC33032 3 8 21 DAC33-O15 17-CG15731-RA_1 CG15731 TGGCTTCCTCATCTGCTACGTGAAGTTCCATAGTTTTCAACCCCCAAGCAAGAAACTTCCAGCAATGAA 69 FBan0015731 FBgn0030390 CG15731 X X CG15731 CG15731 CDMC33033 3 9 21 DAC34-C03 13-CG31149-RA_1 CG31149 ACGCTTCTCGTCGTCTCGTCCCTAATCTGTCTCCTATGCATACTCTGTCACTCCAGAAGAAGCCGTAGA 69 FBan0031149 FBgn0051149 CG31149 3 3R CG31149 CG31149 "CG5449, CG14289, CG5449, CG5449, CT17110, CT33918, tld-like" CDMC33033 3 10 21 DAC34-C03 13-CG31149-RA_1 CG31149 ACGCTTCTCGTCGTCTCGTCCCTAATCTGTCTCCTATGCATACTCTGTCACTCCAGAAGAAGCCGTAGA 69 FBan0031149 FBgn0051149 CG31149 3 3R CG31149 CG31149 "CG5449, CG14289, CG5449, CG5449, CT17110, CT33918, tld-like" CDMC33034 3 11 21 DAC34-C15 1-CG31156-RA_1 CG31156 CGGCATCGCTGAATGACGTTGTGTCCGAGTGTGTCAGTTATGTTGGCGTTGATCTCAACACAGCCAGTC 69 FBan0031156 FBgn0051156 CG31156 3 3R "chromatin assembly or disassembly; GO:0006333; mRNA transcription; GO:0009299; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" "chromatin binding; GO:0003682; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003682; ; GO:0003729; ; GO:0016788 ; EC:3.1.-.-" CG31156 CG31156 "CG5253, CG5257, CG5253, CG5257" CDMC33034 3 12 21 DAC34-C15 1-CG31156-RA_1 CG31156 CGGCATCGCTGAATGACGTTGTGTCCGAGTGTGTCAGTTATGTTGGCGTTGATCTCAACACAGCCAGTC 69 FBan0031156 FBgn0051156 CG31156 3 3R "chromatin assembly or disassembly; GO:0006333; mRNA transcription; GO:0009299; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" "chromatin binding; GO:0003682; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003682; ; GO:0003729; ; GO:0016788 ; EC:3.1.-.-" CG31156 CG31156 "CG5253, CG5257, CG5253, CG5257" CDMC33035 3 13 21 DAC34-G03 2-CG31189-RA_1 CG31189 CCAGTCGCGGTCCTATCTGGATGGACTTTCGAATGCGGGACAATGTGAACAAGGGCTTCAATAATGCCA 69 FBan0031189 FBgn0051189 CG31189 3 3R CG31189 CG31189 "CG7096, CG7096, CG7096, CG7096, CG7096" CDMC33035 3 14 21 DAC34-G03 2-CG31189-RA_1 CG31189 CCAGTCGCGGTCCTATCTGGATGGACTTTCGAATGCGGGACAATGTGAACAAGGGCTTCAATAATGCCA 69 FBan0031189 FBgn0051189 CG31189 3 3R CG31189 CG31189 "CG7096, CG7096, CG7096, CG7096, CG7096" CDMC33036 3 15 21 DAC34-G15 2-CG31199-RA_2 CG31199 CCTGCTCAACGAGACCCTGGTTGCTCAGACGTTTGTAGTAGCTGGTCTTCGCGTCTTTGAGGACTTCAG 69 FBan0031199 FBgn0051199 CG31199 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG31199 CG31199 CG17837 CDMC33036 3 16 21 DAC34-G15 2-CG31199-RA_2 CG31199 CCTGCTCAACGAGACCCTGGTTGCTCAGACGTTTGTAGTAGCTGGTCTTCGCGTCTTTGAGGACTTCAG 69 FBan0031199 FBgn0051199 CG31199 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG31199 CG31199 CG17837 CDMC33037 3 17 21 DAC34-K03 3-CG31219-RA_1 CG31219 GGCATTCCTGGAATTTACACCAGAACCAGTGCATTCCTGCCATGGATAAAGGCGGTATTGAGGCCCTGA 69 FBan0031219 FBgn0051219 CG31219 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG31219 CG31219 "CG16731, CG16731" CDMC33037 3 18 21 DAC34-K03 3-CG31219-RA_1 CG31219 GGCATTCCTGGAATTTACACCAGAACCAGTGCATTCCTGCCATGGATAAAGGCGGTATTGAGGCCCTGA 69 FBan0031219 FBgn0051219 CG31219 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG31219 CG31219 "CG16731, CG16731" CDMC33038 3 19 21 DAC34-K15 2-CG31233-RA_2 CG31233 CGCCTATACCGTCAACGACAAGCAGAAGGATGCCTTGCAAGAGTTGGTGGACACTGTCAAGGGTTCTGA 69 FBan0031233 FBgn0051233 CG31233 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG31233 CG31233 "CG5839, CG5839, CG5839, anon-WO0140519.125, anon-WO0140519.65" CDMC33038 3 20 21 DAC34-K15 2-CG31233-RA_2 CG31233 CGCCTATACCGTCAACGACAAGCAGAAGGATGCCTTGCAAGAGTTGGTGGACACTGTCAAGGGTTCTGA 69 FBan0031233 FBgn0051233 CG31233 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2 CG31233 CG31233 "CG5839, CG5839, CG5839, anon-WO0140519.125, anon-WO0140519.65" CDMC33039 3 21 21 DAC34-O03 20-CG31272-RA_3 CG31272 TGTGTGCGTTTTTGGCAGTGCCTTGAGTCAAAACTTCAGTATGCTGGTGATGTTCAAGTTTCTGGGGGG 69 FBan0031272 FBgn0051272 CG31272 3 3R lipid metabolism; GO:0006629; neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- integral to membrane; GO:0016021; synaptic vesicle membrane; GO:0030672 CG31272 CG31272 CG6529 CDMC33039 3 22 21 DAC34-O03 20-CG31272-RA_3 CG31272 TGTGTGCGTTTTTGGCAGTGCCTTGAGTCAAAACTTCAGTATGCTGGTGATGTTCAAGTTTCTGGGGGG 69 FBan0031272 FBgn0051272 CG31272 3 3R lipid metabolism; GO:0006629; neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.- integral to membrane; GO:0016021; synaptic vesicle membrane; GO:0030672 CG31272 CG31272 CG6529 CDMC33040 3 23 21 DAC34-O15 2-CG31284-RC_1 CG31284 TGCCGGGCAATTCACCACACTAACCACAAAGATCGATGACAATGCTGATCGGATCGAGTTCCTCACCCA 69 FBan0031284 FBgn0051284 CG31284 3 3R "DNA replication; GO:0006260; calcium ion transport; GO:0006816; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005262; ; GO:0005057; ; GO:0016779 ; EC:2.7.7.- membrane; GO:0016020 CG31284 CG31284 "CG10409, CG17817, CT29234" CDMC33040 3 24 21 DAC34-O15 2-CG31284-RC_1 CG31284 TGCCGGGCAATTCACCACACTAACCACAAAGATCGATGACAATGCTGATCGGATCGAGTTCCTCACCCA 69 FBan0031284 FBgn0051284 CG31284 3 3R "DNA replication; GO:0006260; calcium ion transport; GO:0006816; protein amino acid ADP-ribosylation; GO:0006471; transcription, RNA-dependent; GO:0006410" calcium channel activity; GO:0005262; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; ; GO:0005262; ; GO:0005057; ; GO:0016779 ; EC:2.7.7.- membrane; GO:0016020 CG31284 CG31284 "CG10409, CG17817, CT29234" CDMC33041 3 25 21 DAC35-C03 3-CG8001-RA_2 CG8001 GGAGGCGTCATAAAGCCCATCCGTCTGTACACACACAGCGAGTCCGTTCACAAGATCATCGTGGTG 66 FBan0008001 FBgn0035268 CG8001 3 3L CG8001 CG8001 CDMC33041 3 26 21 DAC35-C03 3-CG8001-RA_2 CG8001 GGAGGCGTCATAAAGCCCATCCGTCTGTACACACACAGCGAGTCCGTTCACAAGATCATCGTGGTG 66 FBan0008001 FBgn0035268 CG8001 3 3L CG8001 CG8001 CDMC33042 3 1 22 DAC35-C15 3-CG8201-RA_3 CG8201 GGTGCGTGCATGGAGATCCCAATACGGACTCACTGGTGCAATGGGAAATAGAAGTGTGCAAGCTGC 66 FBgn0050131 CDMC33042 3 2 22 DAC35-C15 3-CG8201-RA_3 CG8201 GGTGCGTGCATGGAGATCCCAATACGGACTCACTGGTGCAATGGGAAATAGAAGTGTGCAAGCTGC 66 FBgn0050131 CDMC33043 3 3 22 DAC35-G03 18-CG8604-RA_5 CG8604 GATGTGGATGAGCTGAGCTTCGAGATTGGTGACCTTATTCGCGTTATTGAGTACGACGATCCCGAG 66 FBan0008604 FBgn0027356 Amph 2 2R NOT synaptic vesicle endocytosis; GO:0048488; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; receptor mediated endocytosis; GO:0006898; regulation of muscle contraction; GO:0006937; rhabdomere development; GO:0042052; rhabdomere membrane biogenesis; GO:0045313; synaptic vesicle endocytosis; GO:0048488 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886; synapse; GO:0045202 Amph Amphiphysin "CG8604, CG8604, CG8604, CG8604, CG8604, DAMP, amphiphysin, Damp, amph, damph, dAmph, Amp, Amphiphysin" CDMC33043 3 4 22 DAC35-G03 18-CG8604-RA_5 CG8604 GATGTGGATGAGCTGAGCTTCGAGATTGGTGACCTTATTCGCGTTATTGAGTACGACGATCCCGAG 66 FBan0008604 FBgn0027356 Amph 2 2R NOT synaptic vesicle endocytosis; GO:0048488; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; receptor mediated endocytosis; GO:0006898; regulation of muscle contraction; GO:0006937; rhabdomere development; GO:0042052; rhabdomere membrane biogenesis; GO:0045313; synaptic vesicle endocytosis; GO:0048488 protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886; synapse; GO:0045202 Amph Amphiphysin "CG8604, CG8604, CG8604, CG8604, CG8604, DAMP, amphiphysin, Damp, amph, damph, dAmph, Amp, Amphiphysin" CDMC33044 3 5 22 DAC35-G15 1-CG8877-RA_1 CG8877 CCTGCCTTCGCACTACGAACGCGTTCAGATGCTGTTGTCGAACAAGTTCCTTGGGTTCTTCATGGT 66 FBan0008877 FBgn0033688 CG8877 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG8877 CG8877 CDMC33044 3 6 22 DAC35-G15 1-CG8877-RA_1 CG8877 CCTGCCTTCGCACTACGAACGCGTTCAGATGCTGTTGTCGAACAAGTTCCTTGGGTTCTTCATGGT 66 FBan0008877 FBgn0033688 CG8877 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG8877 CG8877 CDMC33045 3 7 22 DAC35-K03 3-CG9295-RB_1 CG9295 CGACCCGAGAATTCCGGTCCGGTTCTCTTCCCAAAGAGCCTAGAGGACGAGTTTGAGGACTTCGAG 66 FBan0009295 FBgn0036880 CG9295 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9295 CG9295 CDMC33045 3 8 22 DAC35-K03 3-CG9295-RB_1 CG9295 CGACCCGAGAATTCCGGTCCGGTTCTCTTCCCAAAGAGCCTAGAGGACGAGTTTGAGGACTTCGAG 66 FBan0009295 FBgn0036880 CG9295 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG9295 CG9295 CDMC33046 3 9 22 DAC35-K15 2-CG9506-RA_1 CG9506 CGTGGATCAGGGCTTTGAGACATGCTCGAACGATCCGATGGACAACAGTCCGATACGCCGATCTTC 66 FBgn0031806 CDMC33046 3 10 22 DAC35-K15 2-CG9506-RA_1 CG9506 CGTGGATCAGGGCTTTGAGACATGCTCGAACGATCCGATGGACAACAGTCCGATACGCCGATCTTC 66 FBgn0031806 CDMC33047 3 11 22 DAC35-O03 23-CG9946-RA_2 CG9946 ACACGTTTTTCATTTCGAAAAGTCCAAATTGCCCATTTTTTGGCCATAGACCACAGACTTTAACAT 66 FBan0009946 FBgn0004925 eIF-2alpha X X formation of translation initiation ternary complex; GO:0001677; translational initiation; GO:0006413 GTP binding; GO:0005525; ; GO:0005525; tRNA binding; GO:0000049; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000049 cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF-2alpha eIF-2alpha "CG9946, CG9946, CG9946, eIF-2, elF2alpha, eIF-2 alpha, eIF2alpha, eIF-2alpha, eIF-2 a, Eif2alpha, Eukaryotic initiation factor 2alpha" CDMC33047 3 12 22 DAC35-O03 23-CG9946-RA_2 CG9946 ACACGTTTTTCATTTCGAAAAGTCCAAATTGCCCATTTTTTGGCCATAGACCACAGACTTTAACAT 66 FBan0009946 FBgn0004925 eIF-2alpha X X formation of translation initiation ternary complex; GO:0001677; translational initiation; GO:0006413 GTP binding; GO:0005525; ; GO:0005525; tRNA binding; GO:0000049; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0003743; ; GO:0000049 cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF-2alpha eIF-2alpha "CG9946, CG9946, CG9946, eIF-2, elF2alpha, eIF-2 alpha, eIF2alpha, eIF-2alpha, eIF-2 a, Eif2alpha, Eukaryotic initiation factor 2alpha" CDMC33048 3 13 22 DAC35-O15 AutoBlank AutoBlank CDMC33048 3 14 22 DAC35-O15 AutoBlank AutoBlank CDMC33049 3 15 22 DAC36-C03 18-CG18174-RA_1 CG18174 TGGAAGGACGGCCTCACGTTGTCCGACTACAATGAGCACTGTTCCATCAACGAGGACACCGTGGC 65 FBan0018174 FBgn0028694 Rpn11 2 2L cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn11 Rpn11 "CG18174, yip5, yippee interacting protein 5, p37B, S13" CDMC33049 3 16 22 DAC36-C03 18-CG18174-RA_1 CG18174 TGGAAGGACGGCCTCACGTTGTCCGACTACAATGAGCACTGTTCCATCAACGAGGACACCGTGGC 65 FBan0018174 FBgn0028694 Rpn11 2 2L cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn11 Rpn11 "CG18174, yip5, yippee interacting protein 5, p37B, S13" CDMC33050 3 17 22 DAC36-C15 3-CG18247-RA_1 CG18247 CTGGAAGGAACGACCCAAAGATCGGCCAACCTTTGTCTATCTCACCGAGTTTTTCGCCCGCGATC 65 FBan0018247 FBgn0015295 shark 2 2R "JNK cascade; GO:0007254; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; insect chorion formation; GO:0007306; maintenance of epithelial cell polarity; GO:0045199; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- cytoplasm; GO:0005737 shark "Src homology 2, ankyrin repeat, tyrosine kinase" "CG18247, CG18247, CG18247, dtk7, Shark, l(2R)W4, SYK/SHARK, SHARK, Dtk7, Tk7, l(2)W4, Tyrosine kinase 7" CDMC33050 3 18 22 DAC36-C15 3-CG18247-RA_1 CG18247 CTGGAAGGAACGACCCAAAGATCGGCCAACCTTTGTCTATCTCACCGAGTTTTTCGCCCGCGATC 65 FBan0018247 FBgn0015295 shark 2 2R "JNK cascade; GO:0007254; defense response; GO:0006952; dorsal appendage formation; GO:0046843; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; insect chorion formation; GO:0007306; maintenance of epithelial cell polarity; GO:0045199; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.- cytoplasm; GO:0005737 shark "Src homology 2, ankyrin repeat, tyrosine kinase" "CG18247, CG18247, CG18247, dtk7, Shark, l(2R)W4, SYK/SHARK, SHARK, Dtk7, Tk7, l(2)W4, Tyrosine kinase 7" CDMC33051 3 19 22 DAC36-G03 2-CG1844-RA_2 CG1844 TCGCGCCGACAGAAGGCTGGTCGTGTATAGCAGCACCCTGAATGACCCAGATATCACGGTTTATC 65 FBan0001844 FBgn0030350 SelG X X determination of adult life span; GO:0008340; embryonic development; GO:0009790; regulation of cell redox homeostasis; GO:0030503 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SelG Selenoprotein G "CG1844, CG1844, dselG, G-rich, BcDNA:GH03581, Selenoprotein G" CDMC33051 3 20 22 DAC36-G03 2-CG1844-RA_2 CG1844 TCGCGCCGACAGAAGGCTGGTCGTGTATAGCAGCACCCTGAATGACCCAGATATCACGGTTTATC 65 FBan0001844 FBgn0030350 SelG X X determination of adult life span; GO:0008340; embryonic development; GO:0009790; regulation of cell redox homeostasis; GO:0030503 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 SelG Selenoprotein G "CG1844, CG1844, dselG, G-rich, BcDNA:GH03581, Selenoprotein G" CDMC33052 3 21 22 DAC36-G15 2-CG18525-RA_1 CG18525 TCAGCCGATCGCATATTCTTCGCCAATGATCTGCATGTGACCGAATGCGCAAGGAATCGTCTGGC 65 FBan0018525 FBgn0028984 Spn5 3 3R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn5 Serine protease inhibitor 5 "CG18525, CG18525, CG18525, CG18525, CG18525, CG18525, sp5: serpin 5, serpin 5, Sp5, sp5" CDMC33052 3 22 22 DAC36-G15 2-CG18525-RA_1 CG18525 TCAGCCGATCGCATATTCTTCGCCAATGATCTGCATGTGACCGAATGCGCAAGGAATCGTCTGGC 65 FBan0018525 FBgn0028984 Spn5 3 3R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn5 Serine protease inhibitor 5 "CG18525, CG18525, CG18525, CG18525, CG18525, CG18525, sp5: serpin 5, serpin 5, Sp5, sp5" CDMC33053 3 23 22 DAC36-K03 15-CG18649-RA_1 CG18649 TTTGACAATACAATGCGTGCCTATTTGCTGCTTGCCCTGTTTGGATGTGTGCTTTTGGCCACAGT 65 FBan0018649 FBgn0036469 CG18649 3 3L CG18649 CG18649 BcDNA:RE73239 CDMC33053 3 24 22 DAC36-K03 15-CG18649-RA_1 CG18649 TTTGACAATACAATGCGTGCCTATTTGCTGCTTGCCCTGTTTGGATGTGTGCTTTTGGCCACAGT 65 FBan0018649 FBgn0036469 CG18649 3 3L CG18649 CG18649 BcDNA:RE73239 CDMC33054 3 25 22 DAC36-K15 3-CG18679-RA_1 CG18679 AAATGTCTGTGCCGCAAGGGATTCTACTTCCCGGACATCGTCTCGCAGCACAAGTTCTTCAACGG 65 FBan0018679 FBgn0040663 CG18679 2 2R CG18679 CG18679 CDMC33054 3 26 22 DAC36-K15 3-CG18679-RA_1 CG18679 AAATGTCTGTGCCGCAAGGGATTCTACTTCCCGGACATCGTCTCGCAGCACAAGTTCTTCAACGG 65 FBan0018679 FBgn0040663 CG18679 2 2R CG18679 CG18679 CDMC33055 3 1 23 DAC36-O03 2-CG1891-RA_1 CG1891 GCACCATTTCTTGCGGCATAGCAGAGGAGTACAAGGTGCCCTTCTACGATGTGGTGCCAATGGAT 65 FBan0001891 FBgn0003317 sax 2 2R "BMP signaling pathway; GO:0030509; anterior/posterior pattern formation, imaginal disc; GO:0007448; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytokine and chemokine mediated signaling pathway; GO:0019221; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; nurse cell to oocyte transport (sensu Insecta); GO:0007300; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; protein amino acid phosphorylation; GO:0006468; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476" "ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025" plasma membrane; GO:0005886 sax saxophone "CG1891, CG1891, Sax, Brk43E, Bkr43E, STK-B, saxophone" CDMC33055 3 2 23 DAC36-O03 2-CG1891-RA_1 CG1891 GCACCATTTCTTGCGGCATAGCAGAGGAGTACAAGGTGCCCTTCTACGATGTGGTGCCAATGGAT 65 FBan0001891 FBgn0003317 sax 2 2R "BMP signaling pathway; GO:0030509; anterior/posterior pattern formation, imaginal disc; GO:0007448; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytokine and chemokine mediated signaling pathway; GO:0019221; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; maternal determination of anterior/posterior axis, embryo; GO:0008358; mesoderm development; GO:0007498; nurse cell to oocyte transport (sensu Insecta); GO:0007300; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; protein amino acid phosphorylation; GO:0006468; transforming growth factor beta receptor signaling pathway; GO:0007179; wing morphogenesis; GO:0007476" "ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025" plasma membrane; GO:0005886 sax saxophone "CG1891, CG1891, Sax, Brk43E, Bkr43E, STK-B, saxophone" CDMC33056 3 3 23 DAC36-O15 2-CG1915-RC_1 CG1915 CTCGGCTACCACATTGCTATACGGGACATGAAGAAGACCATGTGGATCGAGGTGGGTCGTGTGCC 65 FBan0001915 FBgn0003432 sls 3 3L "cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; mitotic chromosome condensation; GO:0007076; muscle contraction; GO:0006936; muscle development; GO:0007517; myoblast fusion; GO:0007520; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; ; GO:0004687 ; EC:2.7.1.117 sls sallimus "CG1915, CG18242, CG18245, CG18857, CG1915, CG1915, CG18242, sam, l(3)dre8, Titin, Ket, l(3)Ca, l(3)62Ca, l(3)rL182, D-Titin, titin, kettin, l(3)j1D7, Kettin, CT41299, D-titin, Dtitin, sal: spalt, MCP, anon-CREST, Mitotic Chromosomal Protein, lethal(3)62Ca, sal, sallimus" CDMC33056 3 4 23 DAC36-O15 2-CG1915-RC_1 CG1915 CTCGGCTACCACATTGCTATACGGGACATGAAGAAGACCATGTGGATCGAGGTGGGTCGTGTGCC 65 FBan0001915 FBgn0003432 sls 3 3L "cytoskeleton organization and biogenesis; GO:0007010; mesoderm development; GO:0007498; mitotic chromosome condensation; GO:0007076; muscle contraction; GO:0006936; muscle development; GO:0007517; myoblast fusion; GO:0007520; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; myosin light chain kinase activity; GO:0004687 ; EC:2.7.1.117; ; GO:0004687 ; EC:2.7.1.117 sls sallimus "CG1915, CG18242, CG18245, CG18857, CG1915, CG1915, CG18242, sam, l(3)dre8, Titin, Ket, l(3)Ca, l(3)62Ca, l(3)rL182, D-Titin, titin, kettin, l(3)j1D7, Kettin, CT41299, D-titin, Dtitin, sal: spalt, MCP, anon-CREST, Mitotic Chromosomal Protein, lethal(3)62Ca, sal, sallimus" CDMC33057 3 5 23 DAC37-C03 12-CG1691-RA_2 CG1691 AGCGAAAGCGCCAAAAATAGCCAAGGCAGGGTTTTCTACTGTTGATACTACCTCCACAGCACACCCATA 69 FBan0001691 FBgn0030235 Imp X X regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Imp IGF-II mRNA-binding protein "CG1691, CG1691, CG1691, CG1691, CG1691, l(1)G0072, cg1691, dIMP, KH-domain protein, IMP, anon-WO0140519.39, IGF-II, anon-EST:fe2B3, anon-fast-evolving-2B3, IGF-II mRNA-binding protein" CDMC33057 3 6 23 DAC37-C03 12-CG1691-RA_2 CG1691 AGCGAAAGCGCCAAAAATAGCCAAGGCAGGGTTTTCTACTGTTGATACTACCTCCACAGCACACCCATA 69 FBan0001691 FBgn0030235 Imp X X regulation of translation; GO:0006445 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Imp IGF-II mRNA-binding protein "CG1691, CG1691, CG1691, CG1691, CG1691, l(1)G0072, cg1691, dIMP, KH-domain protein, IMP, anon-WO0140519.39, IGF-II, anon-EST:fe2B3, anon-fast-evolving-2B3, IGF-II mRNA-binding protein" CDMC33058 3 7 23 DAC37-C15 3-CG16935-RA_1 CG16935 GCCACTGGACCCCTCATTTTCAAGGACATTGCATTTAGAGGCTTCTGGATGACTCGCTGGTCCAAGGAG 69 FBan0016935 FBgn0033883 CG16935 2 2R carbohydrate metabolism; GO:0005975; fatty acid metabolism; GO:0006631 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024; trans-2-enoyl-CoA reductase (NADPH) activity; GO:0019166 ; EC:1.3.1.38; ; GO:0019166 ; EC:1.3.1.38" mitochondrion; GO:0005739 CG16935 CG16935 DM_7303260 CDMC33058 3 8 23 DAC37-C15 3-CG16935-RA_1 CG16935 GCCACTGGACCCCTCATTTTCAAGGACATTGCATTTAGAGGCTTCTGGATGACTCGCTGGTCCAAGGAG 69 FBan0016935 FBgn0033883 CG16935 2 2R carbohydrate metabolism; GO:0005975; fatty acid metabolism; GO:0006631 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024; trans-2-enoyl-CoA reductase (NADPH) activity; GO:0019166 ; EC:1.3.1.38; ; GO:0019166 ; EC:1.3.1.38" mitochondrion; GO:0005739 CG16935 CG16935 DM_7303260 CDMC33059 3 9 23 DAC37-G03 17-CG16969-RA_1 CG16969 CCAAATCCGAGTGATGAAATCAAAAGAGCCCTCAAATTGGTTTCCATTGGAAGTTATGCGCGACTCGGC 69 FBan0016969 FBgn0032390 CG16969 2 2L CG16969 CG16969 CDMC33059 3 10 23 DAC37-G03 17-CG16969-RA_1 CG16969 CCAAATCCGAGTGATGAAATCAAAAGAGCCCTCAAATTGGTTTCCATTGGAAGTTATGCGCGACTCGGC 69 FBan0016969 FBgn0032390 CG16969 2 2L CG16969 CG16969 CDMC33060 3 11 23 DAC37-G15 23-CG16975-RA_6 CG16975 AGTCTCACAGCGCGTTATTTTATACCGATTAAATTGTAAACCGTAGACCTTAGGCGTACGCTCATGTTA 69 FBan0016975 FBgn0032475 CG16975 2 2L development; GO:0007275; regulation of transcription; GO:0045449 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 CG16975 CG16975 CDMC33060 3 12 23 DAC37-G15 23-CG16975-RA_6 CG16975 AGTCTCACAGCGCGTTATTTTATACCGATTAAATTGTAAACCGTAGACCTTAGGCGTACGCTCATGTTA 69 FBan0016975 FBgn0032475 CG16975 2 2L development; GO:0007275; regulation of transcription; GO:0045449 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 CG16975 CG16975 CDMC33061 3 13 23 DAC37-K03 8-CG17005-RA_2 CG17005 GCCGTTGTGGGTCCAAAATATCACGATGTCACACTTGTCATTCTCGTTTGCTTCAAGGGATCGTGGCCT 69 FBan0017005 FBgn0032109 CG17005 2 2L CG17005 CG17005 CDMC33061 3 14 23 DAC37-K03 8-CG17005-RA_2 CG17005 GCCGTTGTGGGTCCAAAATATCACGATGTCACACTTGTCATTCTCGTTTGCTTCAAGGGATCGTGGCCT 69 FBan0017005 FBgn0032109 CG17005 2 2L CG17005 CG17005 CDMC33062 3 15 23 DAC37-K15 6-CG17024-RA_1 CG17024 TCCGAACCGCTTACGTGGATCAGTGTGGCGATAACGCTTTTATAGCACGAAAATGCCAGATGGTGCACA 69 FBan0017024 FBgn0032437 CG17024 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 phosphoribosylaminoimidazole carboxylase activity; GO:0004638 ; EC:4.1.1.21; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6 phosphoribosylaminoimidazole carboxylase complex; GO:0009320 CG17024 CG17024 CDMC33062 3 16 23 DAC37-K15 6-CG17024-RA_1 CG17024 TCCGAACCGCTTACGTGGATCAGTGTGGCGATAACGCTTTTATAGCACGAAAATGCCAGATGGTGCACA 69 FBan0017024 FBgn0032437 CG17024 2 2L 'de novo' IMP biosynthesis; GO:0006189; purine base metabolism; GO:0006144; purine nucleotide biosynthesis; GO:0006164 phosphoribosylaminoimidazole carboxylase activity; GO:0004638 ; EC:4.1.1.21; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; GO:0004639 ; EC:6.3.2.6; ; GO:0004638 ; EC:4.1.1.21; ; GO:0004639 ; EC:6.3.2.6 phosphoribosylaminoimidazole carboxylase complex; GO:0009320 CG17024 CG17024 CDMC33063 3 17 23 DAC37-O03 6-CG17050-RA_1 CG17050 AGGGGCATCTTTGCTCACAGTTACCCATGAATGAGCGGAAGACCAAGCTTCTAAAGCGGATTAAGGGCA 69 FBan0017050 FBgn0033831 CG17050 2 2R CG17050 CG17050 CDMC33063 3 18 23 DAC37-O03 6-CG17050-RA_1 CG17050 AGGGGCATCTTTGCTCACAGTTACCCATGAATGAGCGGAAGACCAAGCTTCTAAAGCGGATTAAGGGCA 69 FBan0017050 FBgn0033831 CG17050 2 2R CG17050 CG17050 CDMC33064 3 19 23 DAC37-O15 15-CG17060-RA_2 CG17060 TCCGCACGGACGAAGCAAAAAACAAAGCAATAGAGCCGGGGTCATTCGCACGTAGGAAACTTACTTATT 69 FBan0017060 FBgn0015789 Rab10 X X "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab10 Rab-protein 10 "CG17060, CG17060, DRAB10, DRab10, rab10, DmRab10, AAF50924, Rab-r10" CDMC33064 3 20 23 DAC37-O15 15-CG17060-RA_2 CG17060 TCCGCACGGACGAAGCAAAAAACAAAGCAATAGAGCCGGGGTCATTCGCACGTAGGAAACTTACTTATT 69 FBan0017060 FBgn0015789 Rab10 X X "endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 Rab10 Rab-protein 10 "CG17060, CG17060, DRAB10, DRab10, rab10, DmRab10, AAF50924, Rab-r10" CDMC33065 3 21 23 DAC38-C03 23-CG17580-RA_6 CG17580 GCTTGGTTATATCACTATCAACTTACGTGCAGTCCAATACTTGTCATACATGAATTCTAGCAGCTGGAT 69 FBan0017580 FBgn0040755 CG17580 2 2R CG17580 CG17580 BcDNA:AT18054 CDMC33065 3 22 23 DAC38-C03 23-CG17580-RA_6 CG17580 GCTTGGTTATATCACTATCAACTTACGTGCAGTCCAATACTTGTCATACATGAATTCTAGCAGCTGGAT 69 FBan0017580 FBgn0040755 CG17580 2 2R CG17580 CG17580 BcDNA:AT18054 CDMC33066 3 23 23 DAC38-C15 10-CG17597-RA_1 CG17597 GCAACCTGTTGATCCACTTCAGTCGATACAGAAAGTCCAATCCGTGATCCCGCAAAGAACCAACAGCCG 69 FBan0017597 FBgn0032715 CG17597 2 2L acyl-CoA metabolism; GO:0006637; fatty acid beta-oxidation; GO:0006635; lipid transport; GO:0006869 sterol carrier protein X-related thiolase activity; GO:0004770; acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0003988 ; EC:2.3.1.16; ; GO:0005488; ; GO:0005386; ; GO:0004770 CG17597 CG17597 CDMC33066 3 24 23 DAC38-C15 10-CG17597-RA_1 CG17597 GCAACCTGTTGATCCACTTCAGTCGATACAGAAAGTCCAATCCGTGATCCCGCAAAGAACCAACAGCCG 69 FBan0017597 FBgn0032715 CG17597 2 2L acyl-CoA metabolism; GO:0006637; fatty acid beta-oxidation; GO:0006635; lipid transport; GO:0006869 sterol carrier protein X-related thiolase activity; GO:0004770; acetyl-CoA C-acyltransferase activity; GO:0003988 ; EC:2.3.1.16; carrier activity; GO:0005386; binding; GO:0005488; ; GO:0003988 ; EC:2.3.1.16; ; GO:0005488; ; GO:0005386; ; GO:0004770 CG17597 CG17597 CDMC33067 3 25 23 DAC38-G03 23-CG17637-RA_3 CG17637 AAGGAAAAGAAAGAGAACTTAAATGGAGAAGGAAAGGTGAATGTTGAAGTGAACAAACCCACCTCACAG 69 FBan0017637 FBgn0037004 CG17637 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021 CG17637 CG17637 CDMC33067 3 26 23 DAC38-G03 23-CG17637-RA_3 CG17637 AAGGAAAAGAAAGAGAACTTAAATGGAGAAGGAAAGGTGAATGTTGAAGTGAACAAACCCACCTCACAG 69 FBan0017637 FBgn0037004 CG17637 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; tetracycline transport; GO:0015904 carbohydrate transporter activity; GO:0015144; tetracycline:hydrogen antiporter activity; GO:0015520; ; GO:0015520; ; GO:0015144 integral to membrane; GO:0016021 CG17637 CG17637 CDMC33068 3 1 24 DAC38-G15 8-CG17657-RA_2 CG17657 TCGTCCATCAAGGTGGTCCACTTCGGCGTGGTCTAATAATTCATAGTGCAATTCCCAGGCGTACACCAC 69 FBan0017657 FBgn0031358 CG17657 2 2L CG17657 CG17657 CDMC33068 3 2 24 DAC38-G15 8-CG17657-RA_2 CG17657 TCGTCCATCAAGGTGGTCCACTTCGGCGTGGTCTAATAATTCATAGTGCAATTCCCAGGCGTACACCAC 69 FBan0017657 FBgn0031358 CG17657 2 2L CG17657 CG17657 CDMC33069 3 3 24 DAC38-K03 18-CG17702-RA_1 CG17702 GATTTTTTTGATCGGCCGGATAGGAGTGTCCTCGAGATCCCCGATCGCTCTTACCGATTGGTTTTGAAT 69 FBgn0040003 CG17702 CG17702 CG17702 "CG40220, CG40220" CDMC33069 3 4 24 DAC38-K03 18-CG17702-RA_1 CG17702 GATTTTTTTGATCGGCCGGATAGGAGTGTCCTCGAGATCCCCGATCGCTCTTACCGATTGGTTTTGAAT 69 FBgn0040003 CG17702 CG17702 CG17702 "CG40220, CG40220" CDMC33070 3 5 24 DAC38-K15 23-CG17716-RA_3 CG17716 ATAAATTGGAGGATGATAAGCCCCCCTACAACAGAATCAAAAACTAACTATTAAGCGACTCCGTTCACT 69 FBan0017716 FBgn0000633 fas 2 2R Malpighian tubule morphogenesis; GO:0007443; cardioblast cell fate determination; GO:0007510; dorsal closure; GO:0007391; foregut morphogenesis; GO:0007440; head involution; GO:0008258; maintenance of polarity of embryonic epithelium; GO:0042250; morphogenesis of an epithelium; GO:0002009; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435 fas faint sausage "CG17716, l(2)05488, l(2)5488, CT39263" CDMC33070 3 6 24 DAC38-K15 23-CG17716-RA_3 CG17716 ATAAATTGGAGGATGATAAGCCCCCCTACAACAGAATCAAAAACTAACTATTAAGCGACTCCGTTCACT 69 FBan0017716 FBgn0000633 fas 2 2R Malpighian tubule morphogenesis; GO:0007443; cardioblast cell fate determination; GO:0007510; dorsal closure; GO:0007391; foregut morphogenesis; GO:0007440; head involution; GO:0008258; maintenance of polarity of embryonic epithelium; GO:0042250; morphogenesis of an epithelium; GO:0002009; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435 fas faint sausage "CG17716, l(2)05488, l(2)5488, CT39263" CDMC33071 3 7 24 DAC38-O03 15-CG17752-RA_2 CG17752 CCTGCAGTGTCATTCAGTATGATGTCGACATGACCTCTTTTCGGGATAACAAGTGCTCCTCCTGGGACT 69 FBan0017752 FBgn0038718 CG17752 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG17752 CG17752 CDMC33071 3 8 24 DAC38-O03 15-CG17752-RA_2 CG17752 CCTGCAGTGTCATTCAGTATGATGTCGACATGACCTCTTTTCGGGATAACAAGTGCTCCTCCTGGGACT 69 FBan0017752 FBgn0038718 CG17752 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG17752 CG17752 CDMC33072 3 9 24 DAC38-O15 1-CG17761-RA_1 CG17761 TCCCTACATTCATGAGATGCGCGAAAGATTACTGGACCAGCCGCGGGAGACACTTCAACTGGAGAACAT 69 FBan0017761 FBgn0040914 CG17761 X X CG17761 CG17761 CDMC33072 3 10 24 DAC38-O15 1-CG17761-RA_1 CG17761 TCCCTACATTCATGAGATGCGCGAAAGATTACTGGACCAGCCGCGGGAGACACTTCAACTGGAGAACAT 69 FBan0017761 FBgn0040914 CG17761 X X CG17761 CG17761 CDMC33073 3 11 24 DAC39-C03 23-CG32202-RA_1 CG32202 CGGAAAATGAGCGATGTGTGATGAGAGTAAATGGGATCAAAAAGATAGTAAGAAGGCGCAATCAT 65 FBan0032202 FBgn0052202 CG32202 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32202 CG32202 "CG13381, CG13381" CDMC33073 3 12 24 DAC39-C03 23-CG32202-RA_1 CG32202 CGGAAAATGAGCGATGTGTGATGAGAGTAAATGGGATCAAAAAGATAGTAAGAAGGCGCAATCAT 65 FBan0032202 FBgn0052202 CG32202 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32202 CG32202 "CG13381, CG13381" CDMC33074 3 13 24 DAC39-C15 7-CG32241-RA_2 CG32241 CACCGAAGAAGGTCGTCTACACTCCACCCCCAACTGGCATCCTGAAGGACGATGGCTACCACTAC 65 FBan0032241 FBgn0052241 CG32241 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32241 CG32241 CDMC33074 3 14 24 DAC39-C15 7-CG32241-RA_2 CG32241 CACCGAAGAAGGTCGTCTACACTCCACCCCCAACTGGCATCCTGAAGGACGATGGCTACCACTAC 65 FBan0032241 FBgn0052241 CG32241 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32241 CG32241 CDMC33075 3 15 24 DAC39-G03 3-CG32375-RA_1 CG32375 CAAAAAGGGAGCAGTAGTTGAAGGTTGCGGCAAAATGGCCCAGTTTGTGACCCACATCCAGCCAA 65 FBan0032375 FBgn0052375 CG32375 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32375 CG32375 CDMC33075 3 16 24 DAC39-G03 3-CG32375-RA_1 CG32375 CAAAAAGGGAGCAGTAGTTGAAGGTTGCGGCAAAATGGCCCAGTTTGTGACCCACATCCAGCCAA 65 FBan0032375 FBgn0052375 CG32375 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32375 CG32375 CDMC33076 3 17 24 DAC39-G15 3-CG32415-RA_8 CG32415 TTAAAAGCCAAGCTAGCCGTGCTAACCGTGCCTATCTGGGGCCTTTCCATCTCATTGCAGTCGAG 65 FBan0032415 FBgn0052415 CG32415 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32415 CG32415 CDMC33076 3 18 24 DAC39-G15 3-CG32415-RA_8 CG32415 TTAAAAGCCAAGCTAGCCGTGCTAACCGTGCCTATCTGGGGCCTTTCCATCTCATTGCAGTCGAG 65 FBan0032415 FBgn0052415 CG32415 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32415 CG32415 CDMC33077 3 19 24 DAC39-K03 3-CG32491-RY_1 CG32491 CTGACCATCGATGGGAAGCCCTTCACCCTCAATCGTCGGATCAAGGATGTGTGCTACTGGGAGTG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC33077 3 20 24 DAC39-K03 3-CG32491-RY_1 CG32491 CTGACCATCGATGGGAAGCCCTTCACCCTCAATCGTCGGATCAAGGATGTGTGCTACTGGGAGTG 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC33078 3 21 24 DAC39-K15 7-CG32510-RA_1 CG32510 AAAAAAAACAAGAAGGACTAGACCTATGTGCTCAGAAGGCGGCCGAGGCGATGACCTGCAGGGCC 65 FBan0032510 FBgn0052510 CG32510 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32510 CG32510 CDMC33078 3 22 24 DAC39-K15 7-CG32510-RA_1 CG32510 AAAAAAAACAAGAAGGACTAGACCTATGTGCTCAGAAGGCGGCCGAGGCGATGACCTGCAGGGCC 65 FBan0032510 FBgn0052510 CG32510 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32510 CG32510 CDMC33079 3 23 24 DAC39-O03 21-CG32571-RA_1 CG32571 CGTTTCCTCCGTGATCGGTAGCCTGGGCGATAATGGAGCCTCCGGAGTGTTGACCGATGCCAGCG 65 FBan0032571 FBgn0052571 CG32571 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32571 CG32571 CDMC33079 3 24 24 DAC39-O03 21-CG32571-RA_1 CG32571 CGTTTCCTCCGTGATCGGTAGCCTGGGCGATAATGGAGCCTCCGGAGTGTTGACCGATGCCAGCG 65 FBan0032571 FBgn0052571 CG32571 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32571 CG32571 CDMC33080 3 25 24 DAC39-O15 23-CG32611-RB_2 CG32611 TGATCACGCATTTGTCGGTACATACAGGTGATCGACCATTTAAATGTGAGTTTTGTGGCAAAGCA 65 FBan0032611 FBgn0052611 CG32611 X X nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG32611 CG32611 "CG11075, CG11082" CDMC33080 3 26 24 DAC39-O15 23-CG32611-RB_2 CG32611 TGATCACGCATTTGTCGGTACATACAGGTGATCGACCATTTAAATGTGAGTTTTGTGGCAAAGCA 65 FBan0032611 FBgn0052611 CG32611 X X nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG32611 CG32611 "CG11075, CG11082" CDMC33081 3 1 25 DAC40-C03 1-CG41124-RA_1 CG41124 ACTCCACTGACCCTTACGAACACGCCAAGTTCTTGCCTTCCCTTCTGAAGACTCCGTTCCGACTG 65 FBgn0069927 CG41124 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41124 CG41124 CDMC33081 3 2 25 DAC40-C03 1-CG41124-RA_1 CG41124 ACTCCACTGACCCTTACGAACACGCCAAGTTCTTGCCTTCCCTTCTGAAGACTCCGTTCCGACTG 65 FBgn0069927 CG41124 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41124 CG41124 CDMC33082 3 3 25 DAC40-C15 5-CG4123-RA_1 CG4123 CTGGTGCAGCGTCGGTCTGTGCAAGTGGTCAGATGTCCTCGAGAAGTACAAGACCATTGCGGATG 65 FBan0004123 FBgn0026061 Mipp1 3 3L phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0004437; ; GO:0004437; ; GO:0003993 ; EC:3.1.3.2 Mipp1 Multiple inositol polyphosphate phosphatase 1 "CG4123, CG4123, CK2082" CDMC33082 3 4 25 DAC40-C15 5-CG4123-RA_1 CG4123 CTGGTGCAGCGTCGGTCTGTGCAAGTGGTCAGATGTCCTCGAGAAGTACAAGACCATTGCGGATG 65 FBan0004123 FBgn0026061 Mipp1 3 3L phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0004437; ; GO:0004437; ; GO:0003993 ; EC:3.1.3.2 Mipp1 Multiple inositol polyphosphate phosphatase 1 "CG4123, CG4123, CK2082" CDMC33083 3 5 25 DAC40-G03 3-CG4225-RA_1 CG4225 GAACAGAGTGGTGGTTCTGATAACGGAGACGCTAGTGCAGAATCGGGATCGGAGAAACGCAGGGC 65 FBan0004225 FBgn0038376 CG4225 3 3R extracellular transport; GO:0006858; heme transport; GO:0015886; tRNA aminoacylation for protein translation; GO:0006418 "ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; heme transporter activity; GO:0015232; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0015232; ; GO:0004812 ; EC:6.1.1.-; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG4225 CG4225 EP(3)3387 CDMC33083 3 6 25 DAC40-G03 3-CG4225-RA_1 CG4225 GAACAGAGTGGTGGTTCTGATAACGGAGACGCTAGTGCAGAATCGGGATCGGAGAAACGCAGGGC 65 FBan0004225 FBgn0038376 CG4225 3 3R extracellular transport; GO:0006858; heme transport; GO:0015886; tRNA aminoacylation for protein translation; GO:0006418 "ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; heme transporter activity; GO:0015232; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0015232; ; GO:0004812 ; EC:6.1.1.-; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG4225 CG4225 EP(3)3387 CDMC33084 3 7 25 DAC40-G15 3-CG4281-RA_3 CG4281 CTTCCCGCCAAATCGAGAGTGAGATGTCCGGCGAAACCTCTAATCCGTTTCTTTCCTCGTCGCCT 65 FBan0004281 FBgn0025626 CG4281 X X CG4281 CG4281 EG:22E5.7 CDMC33084 3 8 25 DAC40-G15 3-CG4281-RA_3 CG4281 CTTCCCGCCAAATCGAGAGTGAGATGTCCGGCGAAACCTCTAATCCGTTTCTTTCCTCGTCGCCT 65 FBan0004281 FBgn0025626 CG4281 X X CG4281 CG4281 EG:22E5.7 CDMC33085 3 9 25 DAC40-K03 3-CG4396-RA_2 CG4396 AAGTCTCAGGTAATTTGGTCTTGCCAGCATCGTTGACCGCTCTCAATCCGGCATTGCAGCAAGGT 65 FBan0004396 FBgn0040222 fne X X "cell proliferation; GO:0008283; ectoderm development; GO:0007398; histone mRNA 3'-end processing; GO:0006398; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fne found in neurons "CG4396, CG4396, cg4396, Fne, found in neurons" CDMC33085 3 10 25 DAC40-K03 3-CG4396-RA_2 CG4396 AAGTCTCAGGTAATTTGGTCTTGCCAGCATCGTTGACCGCTCTCAATCCGGCATTGCAGCAAGGT 65 FBan0004396 FBgn0040222 fne X X "cell proliferation; GO:0008283; ectoderm development; GO:0007398; histone mRNA 3'-end processing; GO:0006398; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fne found in neurons "CG4396, CG4396, cg4396, Fne, found in neurons" CDMC33086 3 11 25 DAC40-K15 11-CG4444-RA_1 CG4444 AGTGGAATGCCTCCGACTACCTCTAGTTCCCACATTCCCAACATGGGTCACTATTACCACCACGG 65 FBan0004444 FBgn0003175 px 2 2R wing vein morphogenesis; GO:0008586 nucleoplasm; GO:0005654 px plexus "CG4444, l(2)k08316, l(2)k08134, plexus" CDMC33086 3 12 25 DAC40-K15 11-CG4444-RA_1 CG4444 AGTGGAATGCCTCCGACTACCTCTAGTTCCCACATTCCCAACATGGGTCACTATTACCACCACGG 65 FBan0004444 FBgn0003175 px 2 2R wing vein morphogenesis; GO:0008586 nucleoplasm; GO:0005654 px plexus "CG4444, l(2)k08316, l(2)k08134, plexus" CDMC33087 3 13 25 DAC40-O03 23-CG4560-RA_1 CG4560 TGAATCCTTATGCTACTTGCTACTTGAATTCACAAACTATGTTTTACCATTTTCAGTCCGACGTG 65 FBan0004560 FBgn0038369 Arpc3A 3 3R cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arpc3A Arpc3A "CG4560, CG4560, ARC-P21" CDMC33087 3 14 25 DAC40-O03 23-CG4560-RA_1 CG4560 TGAATCCTTATGCTACTTGCTACTTGAATTCACAAACTATGTTTTACCATTTTCAGTCCGACGTG 65 FBan0004560 FBgn0038369 Arpc3A 3 3R cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arpc3A Arpc3A "CG4560, CG4560, ARC-P21" CDMC33088 3 15 25 DAC40-O15 2-CG4593-RA_1 CG4593 TTGCAGTTCGTCCTCTGGAATCTGGCGCAATGGTGTTCTACTTCAAGAGCAATGTGGTCCAGCCG 65 FBan0004593 FBgn0029929 CG4593 X X CG4593 CG4593 CDMC33088 3 16 25 DAC40-O15 2-CG4593-RA_1 CG4593 TTGCAGTTCGTCCTCTGGAATCTGGCGCAATGGTGTTCTACTTCAAGAGCAATGTGGTCCAGCCG 65 FBan0004593 FBgn0029929 CG4593 X X CG4593 CG4593 CDMC33089 3 17 25 DAC41-C03 2-CG4574-RA_1 CG4574 GCGATTTTGCAGTTTGCGGGAGCTAACATACCGATCCGGGTTACCCTGAAATTGTCGACTTGTGCCACA 69 FBan0004574 FBgn0004611 Plc21C 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; diacylglycerol biosynthesis; GO:0006651; intracellular signaling cascade; GO:0007242; phosphatidylinositol biosynthesis; GO:0006661 phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11 Plc21C Phospholipase C at 21C "CG4574, CG4574, plc-21, plc21, PLC, PLC[[Beta]], PLC-21C" CDMC33089 3 18 25 DAC41-C03 2-CG4574-RA_1 CG4574 GCGATTTTGCAGTTTGCGGGAGCTAACATACCGATCCGGGTTACCCTGAAATTGTCGACTTGTGCCACA 69 FBan0004574 FBgn0004611 Plc21C 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; diacylglycerol biosynthesis; GO:0006651; intracellular signaling cascade; GO:0007242; phosphatidylinositol biosynthesis; GO:0006661 phosphoinositide phospholipase C activity; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11; ; GO:0004435 ; EC:3.1.4.11 Plc21C Phospholipase C at 21C "CG4574, CG4574, plc-21, plc21, PLC, PLC[[Beta]], PLC-21C" CDMC33090 3 19 25 DAC41-C15 5-CG4590-RA_1 CG4590 GGACGCCTCAAGATGCTGGTCATGGATCTCAACAGCCCTATTGTGAACGATGAGTGCAAGAACGATCGC 69 FBan0004590 FBgn0027108 inx2 X X foregut morphogenesis; GO:0007440; morphogenesis of embryonic epithelium; GO:0016331; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx2 innexin 2 "CG4590, CG4590, l(1)G0118, l(1)G0059, l(1)G0043, l(1)G0035, l(1)G0317, l(1)G0036, prp33, pas related protein 33, l(1)G0157, Ix2, l(1)G0364, Dm-inx2, Dm-inx, inx-2, kropf, Inx2, D-inx-2, innexin 2" CDMC33090 3 20 25 DAC41-C15 5-CG4590-RA_1 CG4590 GGACGCCTCAAGATGCTGGTCATGGATCTCAACAGCCCTATTGTGAACGATGAGTGCAAGAACGATCGC 69 FBan0004590 FBgn0027108 inx2 X X foregut morphogenesis; GO:0007440; morphogenesis of embryonic epithelium; GO:0016331; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 inx2 innexin 2 "CG4590, CG4590, l(1)G0118, l(1)G0059, l(1)G0043, l(1)G0035, l(1)G0317, l(1)G0036, prp33, pas related protein 33, l(1)G0157, Ix2, l(1)G0364, Dm-inx2, Dm-inx, inx-2, kropf, Inx2, D-inx-2, innexin 2" CDMC33091 3 21 25 DAC41-G03 18-CG4615-RA_5 CG4615 TGATATACCCGATGTACCCGAGTCTCTGCTCCACAATTAGCCAAATTTTAAGCGAGCGAGGACGCCTAG 69 FBan0004615 FBgn0029935 CG4615 X X cytolysis; GO:0019835; defense response; GO:0006952 integral to membrane; GO:0016021 CG4615 CG4615 CDMC33091 3 22 25 DAC41-G03 18-CG4615-RA_5 CG4615 TGATATACCCGATGTACCCGAGTCTCTGCTCCACAATTAGCCAAATTTTAAGCGAGCGAGGACGCCTAG 69 FBan0004615 FBgn0029935 CG4615 X X cytolysis; GO:0019835; defense response; GO:0006952 integral to membrane; GO:0016021 CG4615 CG4615 CDMC33092 3 23 25 DAC41-G15 23-CG4623-RA_1 CG4623 CCCATGCTAGTGAAACTAATCAGCAAACTAAAGATACACTAAGCCAAAGAATATTAAGTGAAACACACA 69 FBan0004623 FBgn0035587 CG4623 3 3L CG4623 CG4623 CDMC33092 3 24 25 DAC41-G15 23-CG4623-RA_1 CG4623 CCCATGCTAGTGAAACTAATCAGCAAACTAAAGATACACTAAGCCAAAGAATATTAAGTGAAACACACA 69 FBan0004623 FBgn0035587 CG4623 3 3L CG4623 CG4623 CDMC33093 3 25 25 DAC41-K03 12-CG4654-RA_1 CG4654 AAGACTGGCGAAAATATGTACGAATCGGATGACGAGGACAATGAGTTCAACGGGTACCTGGAGTCGGCC 69 FBan0004654 FBgn0011763 Dp 2 2R "cell cycle; GO:0007049; chorion gene amplification; GO:0007307; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; endomitotic cell cycle; GO:0007113; nurse cell apoptosis; GO:0045476; oogenesis (sensu Insecta); GO:0009993; positive regulation of nurse cell apoptosis; GO:0045850; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634; transcription factor complex; GO:0005667 Dp DP transcription factor "CG4654, 49Fk, l(2)vr10, DP, vr10, DmDP, dDP, dDp, dDP1, DP1, l(2)49Fk, lethal(2)49Fk" CDMC33093 3 26 25 DAC41-K03 12-CG4654-RA_1 CG4654 AAGACTGGCGAAAATATGTACGAATCGGATGACGAGGACAATGAGTTCAACGGGTACCTGGAGTCGGCC 69 FBan0004654 FBgn0011763 Dp 2 2R "cell cycle; GO:0007049; chorion gene amplification; GO:0007307; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; endomitotic cell cycle; GO:0007113; nurse cell apoptosis; GO:0045476; oogenesis (sensu Insecta); GO:0009993; positive regulation of nurse cell apoptosis; GO:0045850; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003704; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634; transcription factor complex; GO:0005667 Dp DP transcription factor "CG4654, 49Fk, l(2)vr10, DP, vr10, DmDP, dDP, dDp, dDP1, DP1, l(2)49Fk, lethal(2)49Fk" CDMC33094 3 1 26 DAC41-K15 17-CG4662-RB_1 CG4662 TTCGCTTGTCAAGGATCTCCACGAATGGGAGGAGTGTTGGGATAGGTAGGTGTGTCTTAACTAATGCAT 69 FBan0004662 FBgn0038735 CG4662 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4662 CG4662 CDMC33094 3 2 26 DAC41-K15 17-CG4662-RB_1 CG4662 TTCGCTTGTCAAGGATCTCCACGAATGGGAGGAGTGTTGGGATAGGTAGGTGTGTCTTAACTAATGCAT 69 FBan0004662 FBgn0038735 CG4662 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4662 CG4662 CDMC33095 3 3 26 DAC41-O03 2-CG4691-RA_2 CG4691 CGGATCCAGAGTTTCAGATGCACGCCTTTATCGATTCGCGCAAAAGTTGTTTAGAAGACCCCTGCGCCA 69 FBan0004691 FBgn0028870 CG4691 2 2L CG4691 CG4691 "BG:DS06874.1, anon-WO0140519.47" CDMC33095 3 4 26 DAC41-O03 2-CG4691-RA_2 CG4691 CGGATCCAGAGTTTCAGATGCACGCCTTTATCGATTCGCGCAAAAGTTGTTTAGAAGACCCCTGCGCCA 69 FBan0004691 FBgn0028870 CG4691 2 2L CG4691 CG4691 "BG:DS06874.1, anon-WO0140519.47" CDMC33096 3 5 26 DAC41-O15 23-CG4699-RB_3 CG4699 GCATAGAGCTAAGCAGTTACTGATAATTGTACACTAACCAACGATCAAGAAATCATCGAACGCACCCAC 69 FBan0004699 FBgn0038364 CG4699 3 3R CG4699 CG4699 CDMC33096 3 6 26 DAC41-O15 23-CG4699-RB_3 CG4699 GCATAGAGCTAAGCAGTTACTGATAATTGTACACTAACCAACGATCAAGAAATCATCGAACGCACCCAC 69 FBan0004699 FBgn0038364 CG4699 3 3R CG4699 CG4699 CDMC33097 3 7 26 DAC42-C03 150mM NaPO4 Blank CDMC33097 3 8 26 DAC42-C03 150mM NaPO4 Blank CDMC33098 3 9 26 DAC42-C15 150mM NaPO4 Blank CDMC33098 3 10 26 DAC42-C15 150mM NaPO4 Blank CDMC33099 3 11 26 DAC42-G03 150mM NaPO4 Blank CDMC33099 3 12 26 DAC42-G03 150mM NaPO4 Blank CDMC33100 3 13 26 DAC42-G15 150mM NaPO4 Blank CDMC33100 3 14 26 DAC42-G15 150mM NaPO4 Blank CDMC33101 3 15 26 DAC42-K03 150mM NaPO4 Blank CDMC33101 3 16 26 DAC42-K03 150mM NaPO4 Blank CDMC33102 3 17 26 DAC42-K15 5uM MSP 5uM MSP CDMC33102 3 18 26 DAC42-K15 5uM MSP 5uM MSP CDMC33103 3 19 26 DAC42-O03 10uM MSP 10uM MSP CDMC33103 3 20 26 DAC42-O03 10uM MSP 10uM MSP CDMC33104 3 21 26 DAC42-O15 20uM MSP 20uM MSP CDMC33104 3 22 26 DAC42-O15 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC33105 4 1 1 DAC01-D03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33105 4 2 1 DAC01-D03 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33106 4 3 1 DAC01-D15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33106 4 4 1 DAC01-D15 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33107 4 5 1 DAC01-H03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33107 4 6 1 DAC01-H03 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33108 4 7 1 DAC01-H15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33108 4 8 1 DAC01-H15 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33109 4 9 1 DAC01-L03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33109 4 10 1 DAC01-L03 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33110 4 11 1 DAC01-L15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33110 4 12 1 DAC01-L15 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33111 4 13 1 DAC01-P03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33111 4 14 1 DAC01-P03 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33112 4 15 1 DAC01-P15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33112 4 16 1 DAC01-P15 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33113 4 17 1 DAC02-D03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33113 4 18 1 DAC02-D03 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33114 4 19 1 DAC02-D15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33114 4 20 1 DAC02-D15 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33115 4 21 1 DAC02-H03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33115 4 22 1 DAC02-H03 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33116 4 23 1 DAC02-H15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33116 4 24 1 DAC02-H15 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33117 4 25 1 DAC02-L03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33117 4 26 1 DAC02-L03 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33118 4 1 2 DAC02-L15 N/A CG9075 (00957-01195) CDMC33118 4 2 2 DAC02-L15 N/A CG9075 (00957-01195) CDMC33119 4 3 2 DAC02-P03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33119 4 4 2 DAC02-P03 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33120 4 5 2 DAC02-P15 AutoBlank AutoBlank CDMC33120 4 6 2 DAC02-P15 AutoBlank AutoBlank CDMC33121 4 7 2 DAC03-D03 23-CG3850-RA_1 CG3850 TTTCCCAGCTCTTGTCACCACACCTAGATTACTATTTAACGTGATTAAAGACTGTTGTAATTGAA 65 FBan0003850 FBgn0033782 sug 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sug sugarbabe "CG3850, CG3850, CG3850, CG3850, sugarbabe" CDMC33121 4 8 2 DAC03-D03 23-CG3850-RA_1 CG3850 TTTCCCAGCTCTTGTCACCACACCTAGATTACTATTTAACGTGATTAAAGACTGTTGTAATTGAA 65 FBan0003850 FBgn0033782 sug 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sug sugarbabe "CG3850, CG3850, CG3850, CG3850, sugarbabe" CDMC33122 4 9 2 DAC03-D15 2-CG3895-RA_1 CG3895 CTTCACCACTTTCGTTGCCCCTGACATTGCCCTTGCCAATTGCAATAGCTCCCACTGTGTCACTG 65 FBan0003895 FBgn0004860 ph-d X X chromatin silencing; GO:0006342; mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 chromatin binding; GO:0003682; ; GO:0003682 PRC1 complex; GO:0035102; chromatin; GO:0000785 ph-d polyhomeotic distal "CG3895, CG3895, CG3895, ph: polyhomeotic, polyhomeotic, phm, DROZFP, ph-D, ph[D], phd, Ph, PH, Polyhomeotic, EG:BACN25G24.3, PH-d, ph" CDMC33122 4 10 2 DAC03-D15 2-CG3895-RA_1 CG3895 CTTCACCACTTTCGTTGCCCCTGACATTGCCCTTGCCAATTGCAATAGCTCCCACTGTGTCACTG 65 FBan0003895 FBgn0004860 ph-d X X chromatin silencing; GO:0006342; mRNA transcription; GO:0009299; transcription from RNA polymerase II promoter; GO:0006366 chromatin binding; GO:0003682; ; GO:0003682 PRC1 complex; GO:0035102; chromatin; GO:0000785 ph-d polyhomeotic distal "CG3895, CG3895, CG3895, ph: polyhomeotic, polyhomeotic, phm, DROZFP, ph-D, ph[D], phd, Ph, PH, Polyhomeotic, EG:BACN25G24.3, PH-d, ph" CDMC33123 4 11 2 DAC03-H03 23-CG40000-RA_4 CG40000 TGCTGATCAATCTGAGAATGACACACTTACCGCAATAGTAAATCGATTTTGGGAAATTGAAGAAT 65 FBgn0058000 CG40000 CG40000 CG40000 CDMC33123 4 12 2 DAC03-H03 23-CG40000-RA_4 CG40000 TGCTGATCAATCTGAGAATGACACACTTACCGCAATAGTAAATCGATTTTGGGAAATTGAAGAAT 65 FBgn0058000 CG40000 CG40000 CG40000 CDMC33124 4 13 2 DAC03-H15 18-CG4007-RA_6 CG4007 TCCTGGACTTGTTCCCGATCAGGAAGATCTACTAGTCGCTGTTAAGATGCTAAAGGACGACGCCA 65 FBan0004007 FBgn0020391 Nrk 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 Nrk Neurospecific receptor kinase "CG4007, CG4007, CG4007, Dnrk, Drosophila neurospecific receptor kinase, nrtk_dros, DmHD-434, DNRK, neurospecific receptor tyrosine kinase, anon-WO2004063362.79, HD-434, l(2)k14301" CDMC33124 4 14 2 DAC03-H15 18-CG4007-RA_6 CG4007 TCCTGGACTTGTTCCCGATCAGGAAGATCTACTAGTCGCTGTTAAGATGCTAAAGGACGACGCCA 65 FBan0004007 FBgn0020391 Nrk 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.- plasma membrane; GO:0005886 Nrk Neurospecific receptor kinase "CG4007, CG4007, CG4007, Dnrk, Drosophila neurospecific receptor kinase, nrtk_dros, DmHD-434, DNRK, neurospecific receptor tyrosine kinase, anon-WO2004063362.79, HD-434, l(2)k14301" CDMC33125 4 15 2 DAC03-L03 1-CG4021-RA_5 CG4021 GCGAGATTACTGAGGAACAGCCAACTACCACACACGAGTACCAGCCGCGTCTGAACGAGATAGCC 65 FBan0004021 FBgn0034659 CG4021 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG4021 CG4021 cg4021 CDMC33125 4 16 2 DAC03-L03 1-CG4021-RA_5 CG4021 GCGAGATTACTGAGGAACAGCCAACTACCACACACGAGTACCAGCCGCGTCTGAACGAGATAGCC 65 FBan0004021 FBgn0034659 CG4021 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729 CG4021 CG4021 cg4021 CDMC33126 4 17 2 DAC03-L15 1-CG4027-RA_3 CG4027 AAATCGTCCGTGACATCAAGGAGAAGCTGTGCTATGTTGCCCTCGACTTTGAGCAGGAGATGGCC 65 FBan0004027 FBgn0000042 Act5C X X cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; sperm individualization; GO:0007291 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act5C Actin 5C "CG4027, CG4027, CG4027, CG4027, CG4027, CG4027, CG4027, actin, act5C, Actin, A, Ac5C, actin A1, act 5C, M32055, 5C actin, BAP47, actin 5C, l(1)G0117, l(1)G0079, l(1)G0009, l(1)G0330, l(1)G0245, l(1)G0177, l(1)G0025, cyt5C, l(1)G0420, l(1)G0486, l(1)G0010, Bap47, beta-actin/Bap47, T11, anon-EST:fe2D2, anon-fast-evolving-2D2" CDMC33126 4 18 2 DAC03-L15 1-CG4027-RA_3 CG4027 AAATCGTCCGTGACATCAAGGAGAAGCTGTGCTATGTTGCCCTCGACTTTGAGCAGGAGATGGCC 65 FBan0004027 FBgn0000042 Act5C X X cytokinesis; GO:0000910; cytoskeleton organization and biogenesis; GO:0007010; sperm individualization; GO:0007291 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act5C Actin 5C "CG4027, CG4027, CG4027, CG4027, CG4027, CG4027, CG4027, actin, act5C, Actin, A, Ac5C, actin A1, act 5C, M32055, 5C actin, BAP47, actin 5C, l(1)G0117, l(1)G0079, l(1)G0009, l(1)G0330, l(1)G0245, l(1)G0177, l(1)G0025, cyt5C, l(1)G0420, l(1)G0486, l(1)G0010, Bap47, beta-actin/Bap47, T11, anon-EST:fe2D2, anon-fast-evolving-2D2" CDMC33127 4 19 2 DAC03-P03 9-CG40494-RA_7 CG40494 GAGCCTGTTGGTTGGGGACCTGTACATGGGAGTTCATGGATTGGAAGGACTGGAGCAAGCGAACG 65 CDMC33127 4 20 2 DAC03-P03 9-CG40494-RA_7 CG40494 GAGCCTGTTGGTTGGGGACCTGTACATGGGAGTTCATGGATTGGAAGGACTGGAGCAAGCGAACG 65 CDMC33128 4 21 2 DAC03-P15 3-CG4078-RA_11 CG4078 TCTGCCATTCCCACCGCTAAAGGATCCCAAGGTGATACTGAAACGTCGCTACCTGGAGGCGAATC 65 FBan0004078 FBgn0029798 CG4078 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634 CG4078 CG4078 CDMC33128 4 22 2 DAC03-P15 3-CG4078-RA_11 CG4078 TCTGCCATTCCCACCGCTAAAGGATCCCAAGGTGATACTGAAACGTCGCTACCTGGAGGCGAATC 65 FBan0004078 FBgn0029798 CG4078 X X chromosome segregation; GO:0007059; mitosis; GO:0007067; nucleotide-excision repair; GO:0006289 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634 CG4078 CG4078 CDMC33129 4 23 2 DAC04-D03 3-CG31526-RA_3 CG31526 CCGCCTCACCTAACCACCTCCGAAATGCATCTTCCCTTAGCCTTTGGCACGGTATTCCATTTCCTGTTT 69 FBan0031526 FBgn0051526 CG31526 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31526 CG31526 CDMC33129 4 24 2 DAC04-D03 3-CG31526-RA_3 CG31526 CCGCCTCACCTAACCACCTCCGAAATGCATCTTCCCTTAGCCTTTGGCACGGTATTCCATTTCCTGTTT 69 FBan0031526 FBgn0051526 CG31526 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31526 CG31526 CDMC33130 4 25 2 DAC04-D15 23-CG31535-RA_5 CG31535 CGCGTTTCTTAGCTTGTTTAATCGATGATTTCACTTGGCCCGTGTATCGATTTAAGCCGATTGAAGGGC 69 FBan0031535 FBgn0047299 CG31535 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31535 CG31535 BcDNA:GH26355 CDMC33130 4 26 2 DAC04-D15 23-CG31535-RA_5 CG31535 CGCGTTTCTTAGCTTGTTTAATCGATGATTTCACTTGGCCCGTGTATCGATTTAAGCCGATTGAAGGGC 69 FBan0031535 FBgn0047299 CG31535 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31535 CG31535 BcDNA:GH26355 CDMC33131 4 1 3 DAC04-H03 16-CG31601-RA_4 CG31601 CCTAGAAATATCGTTCGGCATGAACAACATGGACAACGATCCCTACTACACACAGAATGAGCCGGAGGT 69 FBan0031601 FBgn0051601 CG31601 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31601 CG31601 CDMC33131 4 2 3 DAC04-H03 16-CG31601-RA_4 CG31601 CCTAGAAATATCGTTCGGCATGAACAACATGGACAACGATCCCTACTACACACAGAATGAGCCGGAGGT 69 FBan0031601 FBgn0051601 CG31601 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31601 CG31601 CDMC33132 4 3 3 DAC04-H15 17-CG3161-RC_1 CG3161 TCGACTTGAAGCAACGCATACATATAACGAGCGCGCATAACATTCAGATTCATCTGTGCAAAACGCCGA 69 FBan0003161 FBgn0004145 Vha16 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 Vha16 Vacuolar H[+] ATPase 16kD subunit "CG3161, CG3161, CG3161, CG3161, ductin, vha16, Ductin, c subunit, vha16-1, ductin, vacuolar H(+)-ATPase subunit C proteolipid, V-ATPase, BcDNA:SD02875, DucC, EP2372, Vhac: Vacuolar H[+]-ATPase c subunit, Ductin subunit C, Vacuolar H[+]-ATPase c subunit" CDMC33132 4 4 3 DAC04-H15 17-CG3161-RC_1 CG3161 TCGACTTGAAGCAACGCATACATATAACGAGCGCGCATAACATTCAGATTCATCTGTGCAAAACGCCGA 69 FBan0003161 FBgn0004145 Vha16 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 Vha16 Vacuolar H[+] ATPase 16kD subunit "CG3161, CG3161, CG3161, CG3161, ductin, vha16, Ductin, c subunit, vha16-1, ductin, vacuolar H(+)-ATPase subunit C proteolipid, V-ATPase, BcDNA:SD02875, DucC, EP2372, Vhac: Vacuolar H[+]-ATPase c subunit, Ductin subunit C, Vacuolar H[+]-ATPase c subunit" CDMC33133 4 5 3 DAC04-L03 3-CG31641-RB_4 CG31641 GCTGGAGTCGAAAATGGAGCTGCATGTGGAGAAGCGAGAGGCCATCATCAGTGACATGAAGGAGAAGCT 69 FBan0031641 FBgn0051641 stai 2 2L germ cell migration; GO:0008354; hormone secretion; GO:0046879; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; nervous system development; GO:0007399; signal transduction; GO:0007165 microtubule binding; GO:0008017; ; GO:0008017 microtubule associated complex; GO:0005875 stai stathmin "CG5981, CG31641, CG5981, CG5981, CG5981, CG5981, LD33989, D-stathmin, BEST:LD33989, stathmin" CDMC33133 4 6 3 DAC04-L03 3-CG31641-RB_4 CG31641 GCTGGAGTCGAAAATGGAGCTGCATGTGGAGAAGCGAGAGGCCATCATCAGTGACATGAAGGAGAAGCT 69 FBan0031641 FBgn0051641 stai 2 2L germ cell migration; GO:0008354; hormone secretion; GO:0046879; intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; nervous system development; GO:0007399; signal transduction; GO:0007165 microtubule binding; GO:0008017; ; GO:0008017 microtubule associated complex; GO:0005875 stai stathmin "CG5981, CG31641, CG5981, CG5981, CG5981, CG5981, LD33989, D-stathmin, BEST:LD33989, stathmin" CDMC33134 4 7 3 DAC04-L15 9-CG31649-RA_1 CG31649 TCGCGAGTTCCTCCTGGATTTGGAGAGTCACAAGTCCATCATATCGTCGTTGAATGTGGTCGGTGACCA 69 FBgn0051649 CDMC33134 4 8 3 DAC04-L15 9-CG31649-RA_1 CG31649 TCGCGAGTTCCTCCTGGATTTGGAGAGTCACAAGTCCATCATATCGTCGTTGAATGTGGTCGGTGACCA 69 FBgn0051649 CDMC33135 4 9 3 DAC04-P03 12-CG31677-RA_1 CG31677 ACCAGTTAGCTGCCGACGTTGTGTGGTTATCAATATGGCCAATATTCCAATCCACAGCACATCCGCACA 69 FBan0031677 FBgn0051677 CG31677 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31677 CG31677 CDMC33135 4 10 3 DAC04-P03 12-CG31677-RA_1 CG31677 ACCAGTTAGCTGCCGACGTTGTGTGGTTATCAATATGGCCAATATTCCAATCCACAGCACATCCGCACA 69 FBan0031677 FBgn0051677 CG31677 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31677 CG31677 CDMC33136 4 11 3 DAC04-P15 2-CG31684-RA_2 CG31684 CGTCTCGGATGAGTTGAGGGGCTCGTACTTCCTCCAGACTGCAAGTAAATCACCCTATGCCCTCGGAAA 69 FBan0031684 FBgn0051684 CG31684 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31684 CG31684 CG9966 CDMC33136 4 12 3 DAC04-P15 2-CG31684-RA_2 CG31684 CGTCTCGGATGAGTTGAGGGGCTCGTACTTCCTCCAGACTGCAAGTAAATCACCCTATGCCCTCGGAAA 69 FBan0031684 FBgn0051684 CG31684 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG31684 CG31684 CG9966 CDMC33137 4 13 3 DAC05-D03 23-CG5994-RA_5 CG5994 ACGGGGTTAATTTCAAGCAGACATTTTCCCAACATGGTTTACATACACTTCCCCAACAATTTAACCGAA 69 FBan0005994 FBgn0017430 Nelf-E 3 3L "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 Nelf-E Negative elongation factor E "CG5994, CG5994, CG5994, cg5994, anon-66Da: anonymous-66Da, NELF-E, NELF, anonymous-66Da, anon-66Da, Negative elongation factor E" CDMC33137 4 14 3 DAC05-D03 23-CG5994-RA_5 CG5994 ACGGGGTTAATTTCAAGCAGACATTTTCCCAACATGGTTTACATACACTTCCCCAACAATTTAACCGAA 69 FBan0005994 FBgn0017430 Nelf-E 3 3L "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 Nelf-E Negative elongation factor E "CG5994, CG5994, CG5994, cg5994, anon-66Da: anonymous-66Da, NELF-E, NELF, anonymous-66Da, anon-66Da, Negative elongation factor E" CDMC33138 4 15 3 DAC05-D15 12-CG6006-RA_2 CG6006 CGGATCTGCTCTGGCTGAAGATCACATTCCTGATGATGGGCAAGTTCACCATTAGTGCTGGCAATACCA 69 FBgn0038403 CDMC33138 4 16 3 DAC05-D15 12-CG6006-RA_2 CG6006 CGGATCTGCTCTGGCTGAAGATCACATTCCTGATGATGGGCAAGTTCACCATTAGTGCTGGCAATACCA 69 FBgn0038403 CDMC33139 4 17 3 DAC05-H03 23-CG6043-RD_20 CG6043 TGCAGGTCACATAATACGCTCAGCTAATCAATTTGTCGATCAAGGTTACCAGAATTACCCACCACAAGC 69 FBan0006043 FBgn0032497 CG6043 2 2L CG6043 CG6043 CDMC33139 4 18 3 DAC05-H03 23-CG6043-RD_20 CG6043 TGCAGGTCACATAATACGCTCAGCTAATCAATTTGTCGATCAAGGTTACCAGAATTACCCACCACAAGC 69 FBan0006043 FBgn0032497 CG6043 2 2L CG6043 CG6043 CDMC33140 4 19 3 DAC05-H15 9-CG6052-RA_1 CG6052 TCGGATTCGCCAAGCACATGGATAAGCAAACGAAGCATTACAGTGGCGGAAATAGGCGAAAGTTGAGCA 69 FBan0006052 FBgn0036747 CG6052 3 3L "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG6052 CG6052 CDMC33140 4 20 3 DAC05-H15 9-CG6052-RA_1 CG6052 TCGGATTCGCCAAGCACATGGATAAGCAAACGAAGCATTACAGTGGCGGAAATAGGCGAAAGTTGAGCA 69 FBan0006052 FBgn0036747 CG6052 3 3L "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG6052 CG6052 CDMC33141 4 21 3 DAC05-L03 2-CG6093-RA_1 CG6093 TGGCGAGTGCTTCAGTAGCCAGGACACCATACTCAAGAGCAGGATCTTTGAACGCCTGTTTCCCACAAA 69 FBan0006093 FBgn0000018 abo 2 2L negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528 nucleus; GO:0005634; polytene chromosome; GO:0005700 abo abnormal oocyte CG6093 CDMC33141 4 22 3 DAC05-L03 2-CG6093-RA_1 CG6093 TGGCGAGTGCTTCAGTAGCCAGGACACCATACTCAAGAGCAGGATCTTTGAACGCCTGTTTCCCACAAA 69 FBan0006093 FBgn0000018 abo 2 2L negative regulation of transcription from RNA polymerase II promoter; GO:0000122; oogenesis (sensu Insecta); GO:0009993; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528 nucleus; GO:0005634; polytene chromosome; GO:0005700 abo abnormal oocyte CG6093 CDMC33142 4 23 3 DAC05-L15 16-CG6106-RA_1 CG6106 CGTCGTCACCTTCCCGTCTTACCGATACACTTTCCCAGGGGTATAGCTCTTTTCTGGCATATGATTCAA 69 FBan0006106 FBgn0030914 CG6106 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" DNA binding; GO:0003677; allantoinase activity; GO:0004038 ; EC:3.5.2.5; ; GO:0004038 ; EC:3.5.2.5; ; GO:0003677 nucleus; GO:0005634 CG6106 CG6106 CDMC33142 4 24 3 DAC05-L15 16-CG6106-RA_1 CG6106 CGTCGTCACCTTCCCGTCTTACCGATACACTTTCCCAGGGGTATAGCTCTTTTCTGGCATATGATTCAA 69 FBan0006106 FBgn0030914 CG6106 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" DNA binding; GO:0003677; allantoinase activity; GO:0004038 ; EC:3.5.2.5; ; GO:0004038 ; EC:3.5.2.5; ; GO:0003677 nucleus; GO:0005634 CG6106 CG6106 CDMC33143 4 25 3 DAC05-P03 23-CG6143-RA_1 CG6143 CTTGAAACTGACGAGGGAGAACACAAACAAGTTAATTGAATCGAGAATCGTATTACCTACCCGATTCCC 69 FBan0006143 FBgn0004401 Pep 3 3L DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; ; GO:0003677; single-stranded RNA binding; GO:0003727; nucleic acid binding; GO:0003676; ; GO:0003697; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003727 colocalizes_with polytene chromosome puff; GO:0005703; heterogeneous nuclear ribonucleoprotein complex; GO:0030530; nucleus; GO:0005634 Pep Protein on ecdysone puffs "CG6143, 74F gene, PEP, X4/PEP, p100, PEP/X4" CDMC33143 4 26 3 DAC05-P03 23-CG6143-RA_1 CG6143 CTTGAAACTGACGAGGGAGAACACAAACAAGTTAATTGAATCGAGAATCGTATTACCTACCCGATTCCC 69 FBan0006143 FBgn0004401 Pep 3 3L DNA binding; GO:0003677; single-stranded DNA binding; GO:0003697; ; GO:0003677; single-stranded RNA binding; GO:0003727; nucleic acid binding; GO:0003676; ; GO:0003697; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003727 colocalizes_with polytene chromosome puff; GO:0005703; heterogeneous nuclear ribonucleoprotein complex; GO:0030530; nucleus; GO:0005634 Pep Protein on ecdysone puffs "CG6143, 74F gene, PEP, X4/PEP, p100, PEP/X4" CDMC33144 4 1 4 DAC05-P15 14-CG6151-RB_1 CG6151 GGTTCGCGTGCAGCAGAACGCAAAGTACAACAGGATTTTTTTCGTTCCGTGTGACGTGAAAAGTGCAAA 69 FBan0006151 FBgn0036533 CG6151 3 3L CG6151 CG6151 anon-WO0118547.242 CDMC33144 4 2 4 DAC05-P15 14-CG6151-RB_1 CG6151 GGTTCGCGTGCAGCAGAACGCAAAGTACAACAGGATTTTTTTCGTTCCGTGTGACGTGAAAAGTGCAAA 69 FBan0006151 FBgn0036533 CG6151 3 3L CG6151 CG6151 anon-WO0118547.242 CDMC33145 4 3 4 DAC06-D03 3-CG11552-RA_1 CG11552 ACGAGGAGGGGAACTACGACTATGCTGGACTTCATACCAGACCTATGGAGAAGGTTCCTGCCAAGGACA 69 FBan0011552 FBgn0036465 CG11552 3 3L proteolysis; GO:0006508 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG11552 CG11552 CDMC33145 4 4 4 DAC06-D03 3-CG11552-RA_1 CG11552 ACGAGGAGGGGAACTACGACTATGCTGGACTTCATACCAGACCTATGGAGAAGGTTCCTGCCAAGGACA 69 FBan0011552 FBgn0036465 CG11552 3 3L proteolysis; GO:0006508 proteasome regulatory particle (sensu Eukaryota); GO:0005838 CG11552 CG11552 CDMC33146 4 5 4 DAC06-D15 17-CG11563-RA_1 CG11563 GCAGTTCCGCTTGAAGATTCGCAGATTTATGTCGATTCCGGAGCAGTTTAACGTTTACCTGGAGCAGAA 69 FBan0011563 FBgn0039868 CG11563 3 3R CG11563 CG11563 BcDNA:RE07994 CDMC33146 4 6 4 DAC06-D15 17-CG11563-RA_1 CG11563 GCAGTTCCGCTTGAAGATTCGCAGATTTATGTCGATTCCGGAGCAGTTTAACGTTTACCTGGAGCAGAA 69 FBan0011563 FBgn0039868 CG11563 3 3R CG11563 CG11563 BcDNA:RE07994 CDMC33147 4 7 4 DAC06-H03 23-CG11607-RA_5 CG11607 TTGAAATCAATGTGGTGGAGTAGAGCCGCCTATGTAGATAGCTCCGTTTACACGTGTAAAATGCCATGT 69 FBan0011607 FBgn0001170 H2.0 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 H2.0 Homeodomain protein 2.0 CG11607 CDMC33147 4 8 4 DAC06-H03 23-CG11607-RA_5 CG11607 TTGAAATCAATGTGGTGGAGTAGAGCCGCCTATGTAGATAGCTCCGTTTACACGTGTAAAATGCCATGT 69 FBan0011607 FBgn0001170 H2.0 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 H2.0 Homeodomain protein 2.0 CG11607 CDMC33148 4 9 4 DAC06-H15 23-CG11624-RB_1 CG11624 CCTTTCTGCATTGTCAAAAGGGAAGACATCAGAAAAATTCTAAATTTCAGTAAACGCCATGACATAAAT 69 FBan0011624 FBgn0003943 Ubi-p63E 3 3L "ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; establishment and/or maintenance of chromatin architecture; GO:0006325; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to heat; GO:0009408; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Ubi-p63E Ubiquitin-63E "CG11624, CG11624, CG11624, polyubiquitin, Ubip, Ub, Ubp, Ubiquitin, Ubi-p, Ubi63E, DmUb, ubiquitin, ubi63E" CDMC33148 4 10 4 DAC06-H15 23-CG11624-RB_1 CG11624 CCTTTCTGCATTGTCAAAAGGGAAGACATCAGAAAAATTCTAAATTTCAGTAAACGCCATGACATAAAT 69 FBan0011624 FBgn0003943 Ubi-p63E 3 3L "ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; establishment and/or maintenance of chromatin architecture; GO:0006325; protein modification; GO:0006464; regulation of transcription, DNA-dependent; GO:0006355; response to heat; GO:0009408; response to stress; GO:0006950; ribosome biogenesis; GO:0007046; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511" protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Ubi-p63E Ubiquitin-63E "CG11624, CG11624, CG11624, polyubiquitin, Ubip, Ub, Ubp, Ubiquitin, Ubi-p, Ubi63E, DmUb, ubiquitin, ubi63E" CDMC33149 4 11 4 DAC06-L03 23-CG11661-RC_5 CG11661 TGAAACGTATGCAGACTCTTTGATACGATTTTTTGCTGACGAAATTGTTAAGAGCATTGTGTGAAAGTA 69 FBgn0036682 CDMC33149 4 12 4 DAC06-L03 23-CG11661-RC_5 CG11661 TGAAACGTATGCAGACTCTTTGATACGATTTTTTGCTGACGAAATTGTTAAGAGCATTGTGTGAAAGTA 69 FBgn0036682 CDMC33150 4 13 4 DAC06-L15 2-CG11670-RA_2 CG11670 GCCACCAAATCACCATCGCAACTTCCACAACATCTTCCTGAACACCGAAAGCAAAGTGGACGGGGAGAA 69 FBan0011670 FBgn0038114 CG11670 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11670 CG11670 SP27 CDMC33150 4 14 4 DAC06-L15 2-CG11670-RA_2 CG11670 GCCACCAAATCACCATCGCAACTTCCACAACATCTTCCTGAACACCGAAAGCAAAGTGGACGGGGAGAA 69 FBan0011670 FBgn0038114 CG11670 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG11670 CG11670 SP27 CDMC33151 4 15 4 DAC06-P03 5-CG11726-RA_1 CG11726 ACTCTAGCCATTATTCGGCCAGTGTCAGTGATCTCAGCACCATCGATTCGCCAATCTCTGCGAGGAACT 69 FBan0011726 FBgn0036156 CG11726 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG11726 CG11726 cg11726 CDMC33151 4 16 4 DAC06-P03 5-CG11726-RA_1 CG11726 ACTCTAGCCATTATTCGGCCAGTGTCAGTGATCTCAGCACCATCGATTCGCCAATCTCTGCGAGGAACT 69 FBan0011726 FBgn0036156 CG11726 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG11726 CG11726 cg11726 CDMC33152 4 17 4 DAC06-P15 14-CG11737-RA_10 CG11737 GGCGCTGCTCTACATCTATCGTACTGGCACCACCAAGGATTCCATCTTCAACATCCTTCGCATTTTCGT 69 FBan0011737 FBgn0037592 CG11737 3 3R CG11737 CG11737 CDMC33152 4 18 4 DAC06-P15 14-CG11737-RA_10 CG11737 GGCGCTGCTCTACATCTATCGTACTGGCACCACCAAGGATTCCATCTTCAACATCCTTCGCATTTTCGT 69 FBan0011737 FBgn0037592 CG11737 3 3R CG11737 CG11737 CDMC33153 4 19 4 DAC07-D03 16-CG15030-RA_1 CG15030 GATTGATACGATTTGGAGTGCTCCCAGGGCCGCCGACATCCGCTTCCCTCGATCCGCTCCTGAAT 65 FBan0015030 FBgn0030621 CG15030 X X CG15030 CG15030 CDMC33153 4 20 4 DAC07-D03 16-CG15030-RA_1 CG15030 GATTGATACGATTTGGAGTGCTCCCAGGGCCGCCGACATCCGCTTCCCTCGATCCGCTCCTGAAT 65 FBan0015030 FBgn0030621 CG15030 X X CG15030 CG15030 CDMC33154 4 21 4 DAC07-D15 8-CG15059-RA_1 CG15059 GCCATCGCCAGAAAGAAGGCAGAGTCTCATCTTCAGCGCTAGCCTGTCTCGTCCTGAGCCGTAAG 65 FBan0015059 FBgn0030905 CG15059 X X CG15059 CG15059 CDMC33154 4 22 4 DAC07-D15 8-CG15059-RA_1 CG15059 GCCATCGCCAGAAAGAAGGCAGAGTCTCATCTTCAGCGCTAGCCTGTCTCGTCCTGAGCCGTAAG 65 FBan0015059 FBgn0030905 CG15059 X X CG15059 CG15059 CDMC33155 4 23 4 DAC07-H03 2-CG15152-RA_1 CG15152 ATGGTCAGCTTCCTGTCCGGGGTGTTTATTCTGGGAACCGTGATGCTGGTGGTCCAAGTTTTCAC 65 FBan0015152 FBgn0032665 CG15152 2 2L CG15152 CG15152 CDMC33155 4 24 4 DAC07-H03 2-CG15152-RA_1 CG15152 ATGGTCAGCTTCCTGTCCGGGGTGTTTATTCTGGGAACCGTGATGCTGGTGGTCCAAGTTTTCAC 65 FBan0015152 FBgn0032665 CG15152 2 2L CG15152 CG15152 CDMC33156 4 25 4 DAC07-H15 23-CG15168-RA_1 CG15168 TAATTGTTCAATAAAAATGGGCAGTAAACTGTTTAACAAACTCTTGCTAATTGCCGGATTTGCCA 65 FBan0015168 FBgn0032732 CG15168 2 2L CG15168 CG15168 BcDNA:RE09053 CDMC33156 4 26 4 DAC07-H15 23-CG15168-RA_1 CG15168 TAATTGTTCAATAAAAATGGGCAGTAAACTGTTTAACAAACTCTTGCTAATTGCCGGATTTGCCA 65 FBan0015168 FBgn0032732 CG15168 2 2L CG15168 CG15168 BcDNA:RE09053 CDMC33157 4 1 5 DAC07-L03 23-CG15250-RA_3 CG15250 CCCTCTGAACTATTGAACAAATCTCTAGTGACGGTCACCAATATCTCAAAGTCGTTGTCTCGCCT 65 FBan0015250 FBgn0030165 CG15250 X X CG15250 CG15250 CDMC33157 4 2 5 DAC07-L03 23-CG15250-RA_3 CG15250 CCCTCTGAACTATTGAACAAATCTCTAGTGACGGTCACCAATATCTCAAAGTCGTTGTCTCGCCT 65 FBan0015250 FBgn0030165 CG15250 X X CG15250 CG15250 CDMC33158 4 3 5 DAC07-L15 3-CG15292-RA_1 CG15292 ATCCCTCGAAAATCTTGCAGCCAGTCAAGGCGATGAGATGGAGACCTACGAAGCGAGCAAGGGAC 65 FBan0015292 FBgn0040977 CG15292 2 2L CG15292 CG15292 CDMC33158 4 4 5 DAC07-L15 3-CG15292-RA_1 CG15292 ATCCCTCGAAAATCTTGCAGCCAGTCAAGGCGATGAGATGGAGACCTACGAAGCGAGCAAGGGAC 65 FBan0015292 FBgn0040977 CG15292 2 2L CG15292 CG15292 CDMC33159 4 5 5 DAC07-P03 2-CG15371-RA_1 CG15371 GCGGAGTACTCGCGATTTGCTAGCGAAACGGGTCGGAGTTTTCCTGGATTCGAAAGTTTCCTGCG 65 FBan0015371 FBgn0030108 Gr8a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr8a Gustatory receptor 8a "CG15371, Gr8D1, Gustatory receptor 8D1, Gustatory receptor 8a" CDMC33159 4 6 5 DAC07-P03 2-CG15371-RA_1 CG15371 GCGGAGTACTCGCGATTTGCTAGCGAAACGGGTCGGAGTTTTCCTGGATTCGAAAGTTTCCTGCG 65 FBan0015371 FBgn0030108 Gr8a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr8a Gustatory receptor 8a "CG15371, Gr8D1, Gustatory receptor 8D1, Gustatory receptor 8a" CDMC33160 4 7 5 DAC07-P15 24-CG1537-RA_1 CG1537 ATGTAGTGCGATTTAGAAAGAAAGTATTATTAAATCAAAAGACCTAATTTATGAGAACGAACGAA 65 FBan0001537 FBgn0030260 CG1537 X X CG1537 CG1537 BcDNA:GH02938 CDMC33160 4 8 5 DAC07-P15 24-CG1537-RA_1 CG1537 ATGTAGTGCGATTTAGAAAGAAAGTATTATTAAATCAAAAGACCTAATTTATGAGAACGAACGAA 65 FBan0001537 FBgn0030260 CG1537 X X CG1537 CG1537 BcDNA:GH02938 CDMC33161 4 9 5 DAC08-D03 15-CG14633-RA_1 CG14633 GGAACTCTATAGAACAACGAACTCCGGCTAATAATTGCGAAGTGGACCCGATGGATGCCACTGGGT 66 FBan0014633 FBgn0029537 CG14633 X X CG14633 CG14633 CDMC33161 4 10 5 DAC08-D03 15-CG14633-RA_1 CG14633 GGAACTCTATAGAACAACGAACTCCGGCTAATAATTGCGAAGTGGACCCGATGGATGCCACTGGGT 66 FBan0014633 FBgn0029537 CG14633 X X CG14633 CG14633 CDMC33162 4 11 5 DAC08-D15 2-CG14676-RA_1 CG14676 CCTGCTGAAAACCACCTATATGTCGGACTACTCGCCCAAAGACTACCAGTCGCTCATCAGCCAGCG 66 FBan0014676 FBgn0037388 CG14676 3 3R CG14676 CG14676 CDMC33162 4 12 5 DAC08-D15 2-CG14676-RA_1 CG14676 CCTGCTGAAAACCACCTATATGTCGGACTACTCGCCCAAAGACTACCAGTCGCTCATCAGCCAGCG 66 FBan0014676 FBgn0037388 CG14676 3 3R CG14676 CG14676 CDMC33163 4 13 5 DAC08-H03 3-CG14893-RA_1 CG14893 CCTCTTCGGCATGCGACTTTACCTGACCAAGGAACCTCCAACGCAGGAATCTCTTGAACAGGGTCG 66 FBan0014893 FBgn0038451 CG14893 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG14893 CG14893 CT34717 CDMC33163 4 14 5 DAC08-H03 3-CG14893-RA_1 CG14893 CCTCTTCGGCATGCGACTTTACCTGACCAAGGAACCTCCAACGCAGGAATCTCTTGAACAGGGTCG 66 FBan0014893 FBgn0038451 CG14893 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG14893 CG14893 CT34717 CDMC33164 4 15 5 DAC08-H15 12-CG14995-RB_2 CG14995 TCGCCTACCTACAAAATCTTCCGAGTCTCAGGAATCTCTGGCTGGAGGAAAATCCCTGCTGCGAAC 66 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC33164 4 16 5 DAC08-H15 12-CG14995-RB_2 CG14995 TCGCCTACCTACAAAATCTTCCGAGTCTCAGGAATCTCTGGCTGGAGGAAAATCCCTGCTGCGAAC 66 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC33165 4 17 5 DAC08-L03 2-CG15412-RA_3 CG15412 GCCATTCTGACCAGTTCTTTGAAGGCCTTCCTCTGCAATTCCACCGATCTGAAGAGACTGGCGGTG 66 FBan0015412 FBgn0031528 CG15412 2 2L CG15412 CG15412 CDMC33165 4 18 5 DAC08-L03 2-CG15412-RA_3 CG15412 GCCATTCTGACCAGTTCTTTGAAGGCCTTCCTCTGCAATTCCACCGATCTGAAGAGACTGGCGGTG 66 FBan0015412 FBgn0031528 CG15412 2 2L CG15412 CG15412 CDMC33166 4 19 5 DAC08-L15 3-CG15604-RA_1 CG15604 GGAGCAGTACAAGCGTAACATTGGTTCCAAGTCCAGTTCGCGTGAGAACATCTGCGACAATGCCGC 66 FBan0015604 FBgn0030713 CG15604 X X CG15604 CG15604 CDMC33166 4 20 5 DAC08-L15 3-CG15604-RA_1 CG15604 GGAGCAGTACAAGCGTAACATTGGTTCCAAGTCCAGTTCGCGTGAGAACATCTGCGACAATGCCGC 66 FBan0015604 FBgn0030713 CG15604 X X CG15604 CG15604 CDMC33167 4 21 5 DAC08-P03 6-CG1715-RA_2 CG1715 ACACCATCCTGGAGAAGGAGTACGCCAATGCTGTAGAAAATGTGCACAAGCGATTCGTCAGCACCG 66 FBan0001715 FBgn0010808 l(3)03670 3 3R l(3)03670 lethal (3) 03670 "CG1715, 0205/14, 0353/13, 0812/02, 0966/01, 1274/08, x94917, l(3)S127408, l(3)3670, anon-l, l(3)96601, pMY8" CDMC33167 4 22 5 DAC08-P03 6-CG1715-RA_2 CG1715 ACACCATCCTGGAGAAGGAGTACGCCAATGCTGTAGAAAATGTGCACAAGCGATTCGTCAGCACCG 66 FBan0001715 FBgn0010808 l(3)03670 3 3R l(3)03670 lethal (3) 03670 "CG1715, 0205/14, 0353/13, 0812/02, 0966/01, 1274/08, x94917, l(3)S127408, l(3)3670, anon-l, l(3)96601, pMY8" CDMC33168 4 23 5 DAC08-P15 AutoBlank AutoBlank CDMC33168 4 24 5 DAC08-P15 AutoBlank AutoBlank CDMC33169 4 25 5 DAC09-D04 3-CG14111-RA_2 CG14111 ACGACTTCCACAACGATCGTCTTCCCGCCTTATCAGAGGATGAGTACAACAACCTGAGTGAGGACGCCA 69 FBan0014111 FBgn0036350 CG14111 3 3L CG14111 CG14111 CDMC33169 4 26 5 DAC09-D04 3-CG14111-RA_2 CG14111 ACGACTTCCACAACGATCGTCTTCCCGCCTTATCAGAGGATGAGTACAACAACCTGAGTGAGGACGCCA 69 FBan0014111 FBgn0036350 CG14111 3 3L CG14111 CG14111 CDMC33170 4 1 6 DAC09-D16 1-CG1411-RB_1 CG1411 ACCCGATTCGAAGTAGAGCACATCGATCATGCCACGTGAGACAAAGAGTGCTTGGGAGCAAATTCGGCA 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC33170 4 2 6 DAC09-D16 1-CG1411-RB_1 CG1411 ACCCGATTCGAAGTAGAGCACATCGATCATGCCACGTGAGACAAAGAGTGCTTGGGAGCAAATTCGGCA 69 FBan0001411 FBgn0023023 CRMP 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" dihydropyrimidinase activity; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2; ; GO:0004157 ; EC:3.5.2.2 CRMP Collapsin Response Mediator Protein "CG1411, Collapsin Response Mediating Protein, EP(3)3238, Pyd2, dihydropyrimidine amidohydrolase, BcDNA:HL02693, l(3)83Ba, EP3238" CDMC33171 4 3 6 DAC09-H04 15-CG14173-RA_1 CG14173 AGGATACTCTTTTAGTCCACTGCTAACCAATCTGTACGGATCCGAGGTCCTGATCAAGATGCGTCGCCA 69 FBgn0036045 CDMC33171 4 4 6 DAC09-H04 15-CG14173-RA_1 CG14173 AGGATACTCTTTTAGTCCACTGCTAACCAATCTGTACGGATCCGAGGTCCTGATCAAGATGCGTCGCCA 69 FBgn0036045 CDMC33172 4 5 6 DAC09-H16 3-CG14185-RA_1 CG14185 TCCAACAGCAGCCTCGACGTCCAATCATCGTCCCATTATGTCTTCAGCACACAGTCAACGCTGGACTAG 69 FBan0014185 FBgn0036936 CG14185 3 3L CG14185 CG14185 CT33794 CDMC33172 4 6 6 DAC09-H16 3-CG14185-RA_1 CG14185 TCCAACAGCAGCCTCGACGTCCAATCATCGTCCCATTATGTCTTCAGCACACAGTCAACGCTGGACTAG 69 FBan0014185 FBgn0036936 CG14185 3 3L CG14185 CG14185 CT33794 CDMC33173 4 7 6 DAC09-L04 1-CG1421-RA_1 CG1421 CGCGTAAAAGTCACAGCTGAGAACCCCGTTTCCGAGAATGCCGTCAGTGAATTTCTGGAGCAATGCTCA 69 FBan0001421 FBgn0032966 CG1421 2 2L CG1421 CG1421 BcDNA:LP11549 CDMC33173 4 8 6 DAC09-L04 1-CG1421-RA_1 CG1421 CGCGTAAAAGTCACAGCTGAGAACCCCGTTTCCGAGAATGCCGTCAGTGAATTTCTGGAGCAATGCTCA 69 FBan0001421 FBgn0032966 CG1421 2 2L CG1421 CG1421 BcDNA:LP11549 CDMC33174 4 9 6 DAC09-L16 23-CG14231-RA_4 CG14231 ACCTGTTGGCCACTTTTCCAGGAACGTAATAACTGATATGACGACAGGTCTTTATCACGCGAATCGATA 69 FBan0014231 FBgn0031060 CG14231 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; O-sialoglycoprotein endopeptidase activity; GO:0008450 ; EC:3.4.24.57; ; GO:0008270; ; GO:0008450 ; EC:3.4.24.57 CG14231 CG14231 CDMC33174 4 10 6 DAC09-L16 23-CG14231-RA_4 CG14231 ACCTGTTGGCCACTTTTCCAGGAACGTAATAACTGATATGACGACAGGTCTTTATCACGCGAATCGATA 69 FBan0014231 FBgn0031060 CG14231 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; O-sialoglycoprotein endopeptidase activity; GO:0008450 ; EC:3.4.24.57; ; GO:0008270; ; GO:0008450 ; EC:3.4.24.57 CG14231 CG14231 CDMC33175 4 11 6 DAC09-P04 15-CG14280-RA_4 CG14280 AGTCACTCAGGTGGACGACAATTTGGCACCCAATAATTGTTTGCAATATTTCCACGATGCTGAGGGCGT 69 FBan0014280 FBgn0038695 CG14280 3 3R CG14280 CG14280 CDMC33175 4 12 6 DAC09-P04 15-CG14280-RA_4 CG14280 AGTCACTCAGGTGGACGACAATTTGGCACCCAATAATTGTTTGCAATATTTCCACGATGCTGAGGGCGT 69 FBan0014280 FBgn0038695 CG14280 3 3R CG14280 CG14280 CDMC33176 4 13 6 DAC09-P16 2-CG14298-RA_1 CG14298 AACGAGGGTAACTTTTGCAGCAGGAAGGATCAGACCAAGGTCGTTACACGCTGGTACTTCGACAAGGGC 69 FBan0014298 FBgn0038654 CG14298 3 3R protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0030414 CG14298 CG14298 CDMC33176 4 14 6 DAC09-P16 2-CG14298-RA_1 CG14298 AACGAGGGTAACTTTTGCAGCAGGAAGGATCAGACCAAGGTCGTTACACGCTGGTACTTCGACAAGGGC 69 FBan0014298 FBgn0038654 CG14298 3 3R protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0030414 CG14298 CG14298 CDMC33177 4 15 6 DAC10-D03 11-CG1973-RA_1 CG1973 AGGATTGAGAGTCGGGGACTCAATCGATATCAGCGAGGAGTGGATACGAGGTCCTTTTCCAATCCCACT 69 FBan0001973 FBgn0039692 CG1973 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1973 CG1973 CDMC33177 4 16 6 DAC10-D03 11-CG1973-RA_1 CG1973 AGGATTGAGAGTCGGGGACTCAATCGATATCAGCGAGGAGTGGATACGAGGTCCTTTTCCAATCCCACT 69 FBan0001973 FBgn0039692 CG1973 3 3R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1973 CG1973 CDMC33178 4 17 6 DAC10-D15 13-CG1980-RB_1 CG1980 GGGCAAGCAAAATTTGTCGATGTCTCTATTCACGATCCGCAACACATTCGTTCTGCACTCGTCAGTCCA 69 FBan0001980 FBgn0019828 dj 3 3R sperm individualization; GO:0007291; spermatid development; GO:0007286; spermatogenesis; GO:0007283 DNA binding; GO:0003677; ; GO:0003677 flagellum (sensu Eukaryota); GO:0009434; mitochondrial derivative; GO:0016007; mitochondrion; GO:0005739; nucleus; GO:0005634 dj don juan "CG1980, bs02h03.y1, DJ" CDMC33178 4 18 6 DAC10-D15 13-CG1980-RB_1 CG1980 GGGCAAGCAAAATTTGTCGATGTCTCTATTCACGATCCGCAACACATTCGTTCTGCACTCGTCAGTCCA 69 FBan0001980 FBgn0019828 dj 3 3R sperm individualization; GO:0007291; spermatid development; GO:0007286; spermatogenesis; GO:0007283 DNA binding; GO:0003677; ; GO:0003677 flagellum (sensu Eukaryota); GO:0009434; mitochondrial derivative; GO:0016007; mitochondrion; GO:0005739; nucleus; GO:0005634 dj don juan "CG1980, bs02h03.y1, DJ" CDMC33179 4 19 6 DAC10-H03 23-CG2033-RD_1 CG2033 TACGTGTACTCCGAGTTTTGTTCAACAAAATTGTATTTAACTCTCTTTTATTTCCTCTATTTGCAGCGG 69 FBan0002033 FBgn0010198 RpS15Aa X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS15Aa Ribosomal protein S15Aa "CG2033, CG2033, CG2033, RpS15A: Ribosomal protein S15A, S15: Shell-15, RpS15a, anon-EST:Posey44, Ribosomal protein S15A, RpS15A, S15, Ribosomal protein S15Aa" CDMC33179 4 20 6 DAC10-H03 23-CG2033-RD_1 CG2033 TACGTGTACTCCGAGTTTTGTTCAACAAAATTGTATTTAACTCTCTTTTATTTCCTCTATTTGCAGCGG 69 FBan0002033 FBgn0010198 RpS15Aa X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS15Aa Ribosomal protein S15Aa "CG2033, CG2033, CG2033, RpS15A: Ribosomal protein S15A, S15: Shell-15, RpS15a, anon-EST:Posey44, Ribosomal protein S15A, RpS15A, S15, Ribosomal protein S15Aa" CDMC33180 4 21 6 DAC10-H15 17-CG2044-RA_1 CG2044 GGCCGAGGGAACAAACGCTGCTTCAGATTATCACGAACTGTCTGGATGTTACGTGATTGATCTTAGCCA 69 FBan0002044 FBgn0002535 Lcp4 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp4 Larval cuticle protein 4 "CG2044, Gene IV, LCP4, IV: transcript group IV, LCP-4, 4, cuticle p. IV, L[[3]]CP4, IV" CDMC33180 4 22 6 DAC10-H15 17-CG2044-RA_1 CG2044 GGCCGAGGGAACAAACGCTGCTTCAGATTATCACGAACTGTCTGGATGTTACGTGATTGATCTTAGCCA 69 FBan0002044 FBgn0002535 Lcp4 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp4 Larval cuticle protein 4 "CG2044, Gene IV, LCP4, IV: transcript group IV, LCP-4, 4, cuticle p. IV, L[[3]]CP4, IV" CDMC33181 4 23 6 DAC10-L03 3-CG2078-RA_1 CG2078 TCCCCGGGTGACCACTCCCAGCATTCGGATTCAGATCAACGACAAGGATGTCACTGATATGCCAAACTA 69 FBan0002078 FBgn0033402 Myd88 2 2R Toll signaling pathway; GO:0008063; anti-Gram-positive bacterial polypeptide induction; GO:0006965; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral pattern formation; GO:0009953; immune response; GO:0006955; innate immune response; GO:0045087; response to fungi; GO:0009620; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; protein binding; GO:0005515; ; GO:0004888; ; GO:0005515 membrane; GO:0016020 Myd88 Myd88 "CG2078, CG2078, CG2078, CG2078, MyD88, DmMyd88, dMyD88, dMyd88, DMMYD88, EP(2)2535, LD20892, DmMyD88, kra, krapfen" CDMC33181 4 24 6 DAC10-L03 3-CG2078-RA_1 CG2078 TCCCCGGGTGACCACTCCCAGCATTCGGATTCAGATCAACGACAAGGATGTCACTGATATGCCAAACTA 69 FBan0002078 FBgn0033402 Myd88 2 2R Toll signaling pathway; GO:0008063; anti-Gram-positive bacterial polypeptide induction; GO:0006965; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral pattern formation; GO:0009953; immune response; GO:0006955; innate immune response; GO:0045087; response to fungi; GO:0009620; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; protein binding; GO:0005515; ; GO:0004888; ; GO:0005515 membrane; GO:0016020 Myd88 Myd88 "CG2078, CG2078, CG2078, CG2078, MyD88, DmMyd88, dMyD88, dMyd88, DMMYD88, EP(2)2535, LD20892, DmMyD88, kra, krapfen" CDMC33182 4 25 6 DAC10-L15 23-CG2083-RA_8 CG2083 AGGCCTAATCTTAAGAATCCACACAAATCAATCCTGTTCCGGGTTTGAATTACGATTGAATCGGGCGGA 69 FBan0002083 FBgn0035376 CG2083 3 3L CG2083 CG2083 CDMC33182 4 26 6 DAC10-L15 23-CG2083-RA_8 CG2083 AGGCCTAATCTTAAGAATCCACACAAATCAATCCTGTTCCGGGTTTGAATTACGATTGAATCGGGCGGA 69 FBan0002083 FBgn0035376 CG2083 3 3L CG2083 CG2083 CDMC33183 4 1 7 DAC10-P03 17-CG2125-RA_1 CG2125 TGGGCATGCCAAATGCGAAAGCTTCCATCACCAGTCTCAAAAATATATGAACACTGACATTGGCTCCAA 69 FBan0002125 FBgn0004859 ci 4 4 blastoderm segmentation; GO:0007350; genital disc anterior/posterior pattern formation; GO:0035224; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription; GO:0045449; smoothened signaling pathway; GO:0007224; wing disc anterior/posterior pattern formation; GO:0048100 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0016564; ; GO:0008270 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 ci cubitus interruptus "CG2125, CG2125, CG2125, l(4)13, l(4)17, ci-D: cubitus-interruptus-dominant, ci[D], Ce: Cell, Ci[D], cubitus-interruptus-Dominant, CiD, ciD, CID, Ci, CI, Cubitus interruptus, ci155, l(4)102ABc, Cell, cubitus-interruptus-dominant, ci-D, Ce, cubitus interruptus" CDMC33183 4 2 7 DAC10-P03 17-CG2125-RA_1 CG2125 TGGGCATGCCAAATGCGAAAGCTTCCATCACCAGTCTCAAAAATATATGAACACTGACATTGGCTCCAA 69 FBan0002125 FBgn0004859 ci 4 4 blastoderm segmentation; GO:0007350; genital disc anterior/posterior pattern formation; GO:0035224; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of progression through mitotic cell cycle; GO:0007346; regulation of transcription; GO:0045449; smoothened signaling pathway; GO:0007224; wing disc anterior/posterior pattern formation; GO:0048100 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; transcriptional repressor activity; GO:0016564; ; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0016563; ; GO:0016564; ; GO:0008270 Hedgehog signaling complex; GO:0035301; cytoplasm; GO:0005737; membrane; GO:0016020; nucleus; GO:0005634 ci cubitus interruptus "CG2125, CG2125, CG2125, l(4)13, l(4)17, ci-D: cubitus-interruptus-dominant, ci[D], Ce: Cell, Ci[D], cubitus-interruptus-Dominant, CiD, ciD, CID, Ci, CI, Cubitus interruptus, ci155, l(4)102ABc, Cell, cubitus-interruptus-dominant, ci-D, Ce, cubitus interruptus" CDMC33184 4 3 7 DAC10-P15 15-CG2137-RA_6 CG2137 GCAGTCCGATACACTGCACCATACCCGTTTCAAGAACCATGTAATCCAGCTAGGACCTCGAAACATGCT 69 FBan0002137 FBgn0033190 CG2137 2 2R electron transport; GO:0006118; glycerol metabolism; GO:0006071; glycerol-3-phosphate metabolism; GO:0006072 calcium ion binding; GO:0005509; ; GO:0005509; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; mitochondrion; GO:0005739 CG2137 CG2137 CDMC33184 4 4 7 DAC10-P15 15-CG2137-RA_6 CG2137 GCAGTCCGATACACTGCACCATACCCGTTTCAAGAACCATGTAATCCAGCTAGGACCTCGAAACATGCT 69 FBan0002137 FBgn0033190 CG2137 2 2R electron transport; GO:0006118; glycerol metabolism; GO:0006071; glycerol-3-phosphate metabolism; GO:0006072 calcium ion binding; GO:0005509; ; GO:0005509; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; mitochondrion; GO:0005739 CG2137 CG2137 CDMC33185 4 5 7 DAC11-D03 18-CG9262-RA_4 CG9262 CCATGGCCATTATCATCTTTGCCACCGTCATGTTCTACGCCGAGAAGAACGTCAATGGCACCAAC 65 FBan0009262 FBgn0005564 Shal 3 3L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shal Shaker cognate l "CG9262, shal, Shaker cognate 1, dShal, Sh-l: Shaker-like, Shl: Shaker-like, Shaker-like" CDMC33185 4 6 7 DAC11-D03 18-CG9262-RA_4 CG9262 CCATGGCCATTATCATCTTTGCCACCGTCATGTTCTACGCCGAGAAGAACGTCAATGGCACCAAC 65 FBan0009262 FBgn0005564 Shal 3 3L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; ; GO:0005249 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shal Shaker cognate l "CG9262, shal, Shaker cognate 1, dShal, Sh-l: Shaker-like, Shl: Shaker-like, Shaker-like" CDMC33186 4 7 7 DAC11-D15 2-CG9285-RC_1 CG9285 TGTCCAGATCGATGATCCAAGGGCCGAAGCTATTTTCCAGGAAGCTCTCATTCTGGAGGCCGGTC 65 FBan0009285 FBgn0000454 Dip-B 3 3R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; dipeptidyl-peptidase and tripeptidyl-peptidase activity; GO:0016806 ; EC:3.4.14.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004178 ; EC:3.4.11.1; ; GO:0016806 ; EC:3.4.14.-; manganese ion binding; GO:0030145; ; GO:0030145 lysosome; GO:0005764 Dip-B Dipeptidase B "CG9285, CG9285, CG9285, DipB" CDMC33186 4 8 7 DAC11-D15 2-CG9285-RC_1 CG9285 TGTCCAGATCGATGATCCAAGGGCCGAAGCTATTTTCCAGGAAGCTCTCATTCTGGAGGCCGGTC 65 FBan0009285 FBgn0000454 Dip-B 3 3R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; dipeptidyl-peptidase and tripeptidyl-peptidase activity; GO:0016806 ; EC:3.4.14.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004178 ; EC:3.4.11.1; ; GO:0016806 ; EC:3.4.14.-; manganese ion binding; GO:0030145; ; GO:0030145 lysosome; GO:0005764 Dip-B Dipeptidase B "CG9285, CG9285, CG9285, DipB" CDMC33187 4 9 7 DAC11-H03 23-CG9378-RA_1 CG9378 CCAAGAAGTATGTTGCCCTTAGTTAAATGGGATATCTCAATAAAAATTGTTATTTTGCAGCCGCT 65 FBan0009378 FBgn0014023 Rlc1 3 3R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 Rlc1 Rlc1 "CG9378, MRP-L47, BcDNA:AT29239, mRpL47" CDMC33187 4 10 7 DAC11-H03 23-CG9378-RA_1 CG9378 CCAAGAAGTATGTTGCCCTTAGTTAAATGGGATATCTCAATAAAAATTGTTATTTTGCAGCCGCT 65 FBan0009378 FBgn0014023 Rlc1 3 3R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 Rlc1 Rlc1 "CG9378, MRP-L47, BcDNA:AT29239, mRpL47" CDMC33188 4 11 7 DAC11-H15 18-CG9411-RA_1 CG9411 CTCGGAGAACAGCTACAGCGCCTCACAGTTCCACTCCCAAGGACTTCCATTGCCGCAACAGGCTC 65 FBan0009411 FBgn0030569 CG9411 X X CG9411 CG9411 CDMC33188 4 12 7 DAC11-H15 18-CG9411-RA_1 CG9411 CTCGGAGAACAGCTACAGCGCCTCACAGTTCCACTCCCAAGGACTTCCATTGCCGCAACAGGCTC 65 FBan0009411 FBgn0030569 CG9411 X X CG9411 CG9411 CDMC33189 4 13 7 DAC11-L03 2-CG9550-RA_1 CG9550 AGTCCGCCTTCGAGTGGATAAGCGAAATGATGGTGGACGATATTGGGGCTGTACAGGACGTGTGC 65 FBan0009550 FBgn0031826 CG9550 2 2L carbohydrate metabolism; GO:0005975 chondroitin 6-sulfotransferase activity; GO:0008459 ; EC:2.8.2.17; ; GO:0008459 ; EC:2.8.2.17 CG9550 CG9550 CDMC33189 4 14 7 DAC11-L03 2-CG9550-RA_1 CG9550 AGTCCGCCTTCGAGTGGATAAGCGAAATGATGGTGGACGATATTGGGGCTGTACAGGACGTGTGC 65 FBan0009550 FBgn0031826 CG9550 2 2L carbohydrate metabolism; GO:0005975 chondroitin 6-sulfotransferase activity; GO:0008459 ; EC:2.8.2.17; ; GO:0008459 ; EC:2.8.2.17 CG9550 CG9550 CDMC33190 4 15 7 DAC11-L15 2-CG9577-RA_4 CG9577 CCGTAAAGACAACCAAGGAGAGCCTCGTGTACTCCCTGGAGCACACCAATCAAGAGGGCTTGGAT 65 FBan0009577 FBgn0031092 CG9577 X X fatty acid beta-oxidation; GO:0006635 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; delta5-delta2,4-dienoyl-CoA isomerase activity; GO:0008416 ; EC:5.3.3.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008416 ; EC:5.3.3.-" CG9577 CG9577 CDMC33190 4 16 7 DAC11-L15 2-CG9577-RA_4 CG9577 CCGTAAAGACAACCAAGGAGAGCCTCGTGTACTCCCTGGAGCACACCAATCAAGAGGGCTTGGAT 65 FBan0009577 FBgn0031092 CG9577 X X fatty acid beta-oxidation; GO:0006635 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; delta5-delta2,4-dienoyl-CoA isomerase activity; GO:0008416 ; EC:5.3.3.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0008416 ; EC:5.3.3.-" CG9577 CG9577 CDMC33191 4 17 7 DAC11-P03 14-CG9650-RA_1 CG9650 TTCTGCGGAAAGGTGTTCAAGAACTGCTCGAATCTGACAGTGCACCGCAGAAGTCACACCGGCGA 65 FBan0009650 FBgn0029939 CG9650 X X "development; GO:0007275; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9650 CG9650 CDMC33191 4 18 7 DAC11-P03 14-CG9650-RA_1 CG9650 TTCTGCGGAAAGGTGTTCAAGAACTGCTCGAATCTGACAGTGCACCGCAGAAGTCACACCGGCGA 65 FBan0009650 FBgn0029939 CG9650 X X "development; GO:0007275; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9650 CG9650 CDMC33192 4 19 7 DAC11-P15 23-CG9689-RA_2 CG9689 CCGGTGTTTACAAAAGAAATCTTGAATTTAGCATAACTGGAACCCAAAAACTTGTTGTGACTACA 65 FBan0009689 FBgn0030159 CG9689 X X CG9689 CG9689 BcDNA:GH05731 CDMC33192 4 20 7 DAC11-P15 23-CG9689-RA_2 CG9689 CCGGTGTTTACAAAAGAAATCTTGAATTTAGCATAACTGGAACCCAAAAACTTGTTGTGACTACA 65 FBan0009689 FBgn0030159 CG9689 X X CG9689 CG9689 BcDNA:GH05731 CDMC33193 4 21 7 DAC12-D03 5-CG15446-RA_1 CG15446 ACCCACCGAAGTGAAGCATCCGAACAACCCCGTTAATCGTCGTCCCGTTTCGTATCGCCAAATGG 65 FBan0015446 FBgn0031155 CG15446 X X CG15446 CG15446 CDMC33193 4 22 7 DAC12-D03 5-CG15446-RA_1 CG15446 ACCCACCGAAGTGAAGCATCCGAACAACCCCGTTAATCGTCGTCCCGTTTCGTATCGCCAAATGG 65 FBan0015446 FBgn0031155 CG15446 X X CG15446 CG15446 CDMC33194 4 23 7 DAC12-D15 18-CG15470-RA_1 CG15470 CCCTGCTGACAAACCTGGGCATCTGCATGCTGCTTCTCGCCTACACACTTCTGGGTAAGCGCTAA 65 FBan0015470 FBgn0029731 CG15470 X X CG15470 CG15470 CDMC33194 4 24 7 DAC12-D15 18-CG15470-RA_1 CG15470 CCCTGCTGACAAACCTGGGCATCTGCATGCTGCTTCTCGCCTACACACTTCTGGGTAAGCGCTAA 65 FBan0015470 FBgn0029731 CG15470 X X CG15470 CG15470 CDMC33195 4 25 7 DAC12-H03 3-CG15546-RA_1 CG15546 GATCAGGACCCGTACGACCATCTGGAAAGTCGAGTCCGAAGATTGCAACTAACCCGAAGTCCCGG 65 FBan0015546 FBgn0039807 CG15546 3 3R CG15546 CG15546 CDMC33195 4 26 7 DAC12-H03 3-CG15546-RA_1 CG15546 GATCAGGACCCGTACGACCATCTGGAAAGTCGAGTCCGAAGATTGCAACTAACCCGAAGTCCCGG 65 FBan0015546 FBgn0039807 CG15546 3 3R CG15546 CG15546 CDMC33196 4 1 8 DAC12-H15 12-CG15585-RA_1 CG15585 ATCCTGCCCCTCGTCATTCTGATGAAGATTGCCCACCTGAAGATGACTTTGGTGAGCATGCTGAT 65 FBan0015585 FBgn0037406 Osi1 3 3R Osi1 Osiris 1 "CG15585, CG15585, CG15585, Osiris, Osiris 1" CDMC33196 4 2 8 DAC12-H15 12-CG15585-RA_1 CG15585 ATCCTGCCCCTCGTCATTCTGATGAAGATTGCCCACCTGAAGATGACTTTGGTGAGCATGCTGAT 65 FBan0015585 FBgn0037406 Osi1 3 3R Osi1 Osiris 1 "CG15585, CG15585, CG15585, Osiris, Osiris 1" CDMC33197 4 3 8 DAC12-L03 2-CG15669-RB_1 CG15669 AATCCGACCAATCTTGCCATGCTGATCAACGCGTACATCCATCGTAACGACCTGCATCTGGCACG 65 FBan0015669 FBgn0043070 MESK2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK2 Misexpression suppressor of KSR 2 "CG15669, CG15668, CG15669, l(2)01467, BcDNA:GH12032, BcDNA:LD27504, BcDNA:RH10174, Misexpression suppressor of KSR 2" CDMC33197 4 4 8 DAC12-L03 2-CG15669-RB_1 CG15669 AATCCGACCAATCTTGCCATGCTGATCAACGCGTACATCCATCGTAACGACCTGCATCTGGCACG 65 FBan0015669 FBgn0043070 MESK2 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK2 Misexpression suppressor of KSR 2 "CG15669, CG15668, CG15669, l(2)01467, BcDNA:GH12032, BcDNA:LD27504, BcDNA:RH10174, Misexpression suppressor of KSR 2" CDMC33198 4 5 8 DAC12-L15 3-CG15699-RA_1 CG15699 TCGTGAAGATCGATTGCTCCGAAGAGGATGAGCCCGAGCTGCTGCCCTTCAAATTCGAGTGGTAA 65 FBan0015699 FBgn0034056 CG15699 2 2R CG15699 CG15699 CDMC33198 4 6 8 DAC12-L15 3-CG15699-RA_1 CG15699 TCGTGAAGATCGATTGCTCCGAAGAGGATGAGCCCGAGCTGCTGCCCTTCAAATTCGAGTGGTAA 65 FBan0015699 FBgn0034056 CG15699 2 2R CG15699 CG15699 CDMC33199 4 7 8 DAC12-P03 19-CG15781-RA_1 CG15781 GCCACAGAAGCGCCAACCGATCTGACGACAACTGCCGGTGCAACGGTGGCAAAAGAGCGCCAAAC 65 FBgn0029774 CDMC33199 4 8 8 DAC12-P03 19-CG15781-RA_1 CG15781 GCCACAGAAGCGCCAACCGATCTGACGACAACTGCCGGTGCAACGGTGGCAAAAGAGCGCCAAAC 65 FBgn0029774 CDMC33200 4 9 8 DAC12-P15 3-CG15828-RB_6 CG15828 CTTGAACAACGAGCCCTACGACGAGTACACCATGTCCAGTGGCGTGATCTCCAATGAGACGCAGC 65 FBan0015828 FBgn0032136 CG15828 2 2L lipid transport; GO:0006869 lipid transporter activity; GO:0005319; lipid binding; GO:0008289; ; GO:0008289; ; GO:0005319 extracellular space; GO:0005615 CG15828 CG15828 CT39214 CDMC33200 4 10 8 DAC12-P15 3-CG15828-RB_6 CG15828 CTTGAACAACGAGCCCTACGACGAGTACACCATGTCCAGTGGCGTGATCTCCAATGAGACGCAGC 65 FBan0015828 FBgn0032136 CG15828 2 2L lipid transport; GO:0006869 lipid transporter activity; GO:0005319; lipid binding; GO:0008289; ; GO:0008289; ; GO:0005319 extracellular space; GO:0005615 CG15828 CG15828 CT39214 CDMC33201 4 11 8 DAC13-D03 14-CG1303-RA_1 CG1303 GGGAGTGATAAACCCAATATCCGGCGATTCGAAAGACCAAGTCGCAATTGGTGTGCTTCACTTCGTGAT 69 FBan0001303 FBgn0024912 agt 3 3R DNA dealkylation; GO:0006307; DNA metabolism; GO:0006259; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; methylated-DNA-[protein]-cysteine S-methyltransferase activity; GO:0003908 ; EC:2.1.1.63; ; GO:0003908 ; EC:2.1.1.63; ; GO:0003676; DNA-methyltransferase activity; GO:0009008 ; EC:2.1.1.-; ; GO:0009008 ; EC:2.1.1.-; ; GO:0003908 ; EC:2.1.1.63; ; GO:0003908 ; EC:2.1.1.63 agt O-6-alkylguanine-DNA alkyltransferase "CG1303, DmAGT, BG:DS00004.10, O-6-alkylguanine-DNA alkyltransferase" CDMC33201 4 12 8 DAC13-D03 14-CG1303-RA_1 CG1303 GGGAGTGATAAACCCAATATCCGGCGATTCGAAAGACCAAGTCGCAATTGGTGTGCTTCACTTCGTGAT 69 FBan0001303 FBgn0024912 agt 3 3R DNA dealkylation; GO:0006307; DNA metabolism; GO:0006259; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; methylated-DNA-[protein]-cysteine S-methyltransferase activity; GO:0003908 ; EC:2.1.1.63; ; GO:0003908 ; EC:2.1.1.63; ; GO:0003676; DNA-methyltransferase activity; GO:0009008 ; EC:2.1.1.-; ; GO:0009008 ; EC:2.1.1.-; ; GO:0003908 ; EC:2.1.1.63; ; GO:0003908 ; EC:2.1.1.63 agt O-6-alkylguanine-DNA alkyltransferase "CG1303, DmAGT, BG:DS00004.10, O-6-alkylguanine-DNA alkyltransferase" CDMC33202 4 13 8 DAC13-D15 24-CG13060-RA_1 CG13060 GCACCACTAAAGCGTTCAAATTGTTTGTTTGTTAACCAATTATATGAAAATAAAATAAAATTCTGAAAA 69 FBan0013060 FBgn0036606 CG13060 3 3L CG13060 CG13060 BcDNA:RE40431 CDMC33202 4 14 8 DAC13-D15 24-CG13060-RA_1 CG13060 GCACCACTAAAGCGTTCAAATTGTTTGTTTGTTAACCAATTATATGAAAATAAAATAAAATTCTGAAAA 69 FBan0013060 FBgn0036606 CG13060 3 3L CG13060 CG13060 BcDNA:RE40431 CDMC33203 4 15 8 DAC13-H03 3-CG13094-RC_2 CG13094 ACGACCTACTCATGGAACTGATGACTCGCTTTGGACGCACCATCATACGGGCTCGAAACGATCTGGAGA 69 FBan0013094 FBgn0032048 Dh31 2 2L fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0008613; ; GO:0008613; ; GO:0005184; ; GO:0008613 Dh31 Diuretic hormone 31 "CG13094, CG13094, Drm-DH[[31]], Drome-DH[[31]], diuretic hormone, DH31, DH-II, diuretic hormone 31, drome-DH31, anon-WO02059370.45, anon-EST:Posey114, Diuretic hormone 31" CDMC33203 4 16 8 DAC13-H03 3-CG13094-RC_2 CG13094 ACGACCTACTCATGGAACTGATGACTCGCTTTGGACGCACCATCATACGGGCTCGAAACGATCTGGAGA 69 FBan0013094 FBgn0032048 Dh31 2 2L fluid secretion; GO:0007589; neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; diuretic hormone activity; GO:0008613; ; GO:0008613; ; GO:0008613; ; GO:0005184; ; GO:0008613 Dh31 Diuretic hormone 31 "CG13094, CG13094, Drm-DH[[31]], Drome-DH[[31]], diuretic hormone, DH31, DH-II, diuretic hormone 31, drome-DH31, anon-WO02059370.45, anon-EST:Posey114, Diuretic hormone 31" CDMC33204 4 17 8 DAC13-H15 15-CG13106-RA_1 CG13106 GGATGGACTTTGATGTGGACACACAAAAGACTTTGAAGTTCCTCATCATGCGCTCGCAAAAGCCCTTGG 69 FBan0013106 FBgn0032096 Or30a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or30a Odorant receptor 30a "CG13106, 30A.1, DOR56, 30a" CDMC33204 4 18 8 DAC13-H15 15-CG13106-RA_1 CG13106 GGATGGACTTTGATGTGGACACACAAAAGACTTTGAAGTTCCTCATCATGCGCTCGCAAAAGCCCTTGG 69 FBan0013106 FBgn0032096 Or30a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or30a Odorant receptor 30a "CG13106, 30A.1, DOR56, 30a" CDMC33205 4 19 8 DAC13-L03 2-CG13151-RA_2 CG13151 TGCGGTCTTAGCTCCCAAGTAGATGCAGTCCAGGCATATGAGCAAACCTCAGAAGCCTGTCAGCAGTTT 69 FBan0013151 FBgn0033750 CG13151 2 2R CG13151 CG13151 CDMC33205 4 20 8 DAC13-L03 2-CG13151-RA_2 CG13151 TGCGGTCTTAGCTCCCAAGTAGATGCAGTCCAGGCATATGAGCAAACCTCAGAAGCCTGTCAGCAGTTT 69 FBan0013151 FBgn0033750 CG13151 2 2R CG13151 CG13151 CDMC33206 4 21 8 DAC13-L15 3-CG1316-RA_3 CG1316 CGGGACTGATCGACGTCTACCTTCTGCCCAACAAGAACTGTGGCTACGTCAAGTATGCGGAGGTTGAGA 69 FBan0001316 FBgn0035526 CG1316 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG1316 CG1316 cg1316 CDMC33206 4 22 8 DAC13-L15 3-CG1316-RA_3 CG1316 CGGGACTGATCGACGTCTACCTTCTGCCCAACAAGAACTGTGGCTACGTCAAGTATGCGGAGGTTGAGA 69 FBan0001316 FBgn0035526 CG1316 3 3L mRNA binding; GO:0003729; ; GO:0003729 CG1316 CG1316 cg1316 CDMC33207 4 23 8 DAC13-P03 15-CG13202-RA_1 CG13202 AGCACTCAGAACTACGAAGAATTCAAGAACATAGTGGATGCGGCTCATCTTCGTCCAGTGACCAAGGGC 69 FBan0013202 FBgn0033623 CG13202 2 2R CG13202 CG13202 CDMC33207 4 24 8 DAC13-P03 15-CG13202-RA_1 CG13202 AGCACTCAGAACTACGAAGAATTCAAGAACATAGTGGATGCGGCTCATCTTCGTCCAGTGACCAAGGGC 69 FBan0013202 FBgn0033623 CG13202 2 2R CG13202 CG13202 CDMC33208 4 25 8 DAC13-P15 3-CG13217-RA_1 CG13217 GGTGGACTTGGCAGCTTCAAGAGCCTATTCGGCAAGAAGTTCCGCTAAAGCAACAGCACTCACCCAAAA 69 FBan0013217 FBgn0033590 CG13217 2 2R CG13217 CG13217 BcDNA:RE32413 CDMC33208 4 26 8 DAC13-P15 3-CG13217-RA_1 CG13217 GGTGGACTTGGCAGCTTCAAGAGCCTATTCGGCAAGAAGTTCCGCTAAAGCAACAGCACTCACCCAAAA 69 FBan0013217 FBgn0033590 CG13217 2 2R CG13217 CG13217 BcDNA:RE32413 CDMC33209 4 1 9 DAC14-D03 1-CG40175-RA_2 CG40175 CTGGATGGCTGAGGAAGTGGCGTGGTCGTTGGGCGGAGTGGCATCATAATGCTAATGATATTTGCCTTA 69 FBan0040175 FBgn0058175 CG40175 2 2L CG40175 CG40175 CDMC33209 4 2 9 DAC14-D03 1-CG40175-RA_2 CG40175 CTGGATGGCTGAGGAAGTGGCGTGGTCGTTGGGCGGAGTGGCATCATAATGCTAATGATATTTGCCTTA 69 FBan0040175 FBgn0058175 CG40175 2 2L CG40175 CG40175 CDMC33210 4 3 9 DAC14-D15 23-CG40188-RC_12 CG40188 TGACGTCATTGCATGCAGTTGTTAAACTTCGGGACCATTTAATTAGATACTCGACTCATAAACAAAAGG 69 FBgn0058188 CG40188 CG40188 CG40188 CDMC33210 4 4 9 DAC14-D15 23-CG40188-RC_12 CG40188 TGACGTCATTGCATGCAGTTGTTAAACTTCGGGACCATTTAATTAGATACTCGACTCATAAACAAAAGG 69 FBgn0058188 CG40188 CG40188 CG40188 CDMC33211 4 5 9 DAC14-H03 14-CG40239-RA_3 CG40239 AGCGGCAGAGTTGATTGCACTTCCTTGCTAAAAACCAAAGTGAGCGCATACAAGAAGGGACAGTTTGGT 69 FBgn0058239 CG40239 CG40239 CG40239 CDMC33211 4 6 9 DAC14-H03 14-CG40239-RA_3 CG40239 AGCGGCAGAGTTGATTGCACTTCCTTGCTAAAAACCAAAGTGAGCGCATACAAGAAGGGACAGTTTGGT 69 FBgn0058239 CG40239 CG40239 CG40239 CDMC33212 4 7 9 DAC14-H15 12-CG40263-RA_1 CG40263 TGGAGGGGTTGCCACAGAATTGTTTGGAACCAAGTGCGTATTTGGATGGTCTCAGTTAGCAACAGCTCT 69 FBgn0058263 CG40263 carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG40263 CG40263 "bs24e02.y1, BEST:LD07241" CDMC33212 4 8 9 DAC14-H15 12-CG40263-RA_1 CG40263 TGGAGGGGTTGCCACAGAATTGTTTGGAACCAAGTGCGTATTTGGATGGTCTCAGTTAGCAACAGCTCT 69 FBgn0058263 CG40263 carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG40263 CG40263 "bs24e02.y1, BEST:LD07241" CDMC33213 4 9 9 DAC14-L03 23-CG40311-RA_5 CG40311 TCTGTTATTTGTAGGCGCACAAATATAACTATGTATATGCAATCTTGTGTAACTACGTTCATTGCCTTT 69 FBgn0058311 CG40311 CG40311 CG40311 CDMC33213 4 10 9 DAC14-L03 23-CG40311-RA_5 CG40311 TCTGTTATTTGTAGGCGCACAAATATAACTATGTATATGCAATCTTGTGTAACTACGTTCATTGCCTTT 69 FBgn0058311 CG40311 CG40311 CG40311 CDMC33214 4 11 9 DAC14-L15 9-CG4033-RA_9 CG4033 GCAGAGGACTTGCCATTTACGGAATCTGGTTTGATTCCAGACATTGTGTTCAATCCCCACGGCTTCCCC 69 FBan0004033 FBgn0003278 RpI135 2 2L transcription from RNA polymerase I promoter; GO:0006360 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736; nucleus; GO:0005634 RpI135 RNA polymerase I 135kD subunit "CG4033, DmRP135, RP135, RNA polymerase I, RpIII135, l(2)k16513" CDMC33214 4 12 9 DAC14-L15 9-CG4033-RA_9 CG4033 GCAGAGGACTTGCCATTTACGGAATCTGGTTTGATTCCAGACATTGTGTTCAATCCCCACGGCTTCCCC 69 FBan0004033 FBgn0003278 RpI135 2 2L transcription from RNA polymerase I promoter; GO:0006360 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 DNA-directed RNA polymerase I complex; GO:0005736; nucleus; GO:0005634 RpI135 RNA polymerase I 135kD subunit "CG4033, DmRP135, RP135, RNA polymerase I, RpIII135, l(2)k16513" CDMC33215 4 13 9 DAC14-P03 6-CG4038-RA_2 CG4038 GGTCCACCAGAGAGAGTCATCCCCTTGGGCAACTATGTTTACTCCTGCCAAAACGACCTTGTGTGCAAA 69 FBan0004038 FBgn0011824 CG4038 2 2R 35S primary transcript processing; GO:0006365; rRNA processing; GO:0006364; rRNA pseudouridine synthesis; GO:0031118; ribosome biogenesis; GO:0007046 rRNA binding; GO:0019843; ; GO:0019843; rRNA pseudouridylation guide activity; GO:0030559; snoRNA binding; GO:0030515; ; GO:0030559; ; GO:0030515 small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 CG4038 CG4038 "GCR 101, GCR101 SnRNP, GCR101, Pen101, anon-Pen101" CDMC33215 4 14 9 DAC14-P03 6-CG4038-RA_2 CG4038 GGTCCACCAGAGAGAGTCATCCCCTTGGGCAACTATGTTTACTCCTGCCAAAACGACCTTGTGTGCAAA 69 FBan0004038 FBgn0011824 CG4038 2 2R 35S primary transcript processing; GO:0006365; rRNA processing; GO:0006364; rRNA pseudouridine synthesis; GO:0031118; ribosome biogenesis; GO:0007046 rRNA binding; GO:0019843; ; GO:0019843; rRNA pseudouridylation guide activity; GO:0030559; snoRNA binding; GO:0030515; ; GO:0030559; ; GO:0030515 small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732 CG4038 CG4038 "GCR 101, GCR101 SnRNP, GCR101, Pen101, anon-Pen101" CDMC33216 4 15 9 DAC14-P15 16-CG4040-RA_1 CG4040 CGAAGCAAAAGCAACATCGAGACCAATTTCACCAGTCAACCAAAGATAATCTCGACGACAAATGCCGCG 69 FBan0004040 FBgn0030076 CG4040 X X CG4040 CG4040 CDMC33216 4 16 9 DAC14-P15 16-CG4040-RA_1 CG4040 CGAAGCAAAAGCAACATCGAGACCAATTTCACCAGTCAACCAAAGATAATCTCGACGACAAATGCCGCG 69 FBan0004040 FBgn0030076 CG4040 X X CG4040 CG4040 CDMC33217 4 17 9 DAC15-D03 7-CG7300-RA_6 CG7300 GGCAATGCCAAAATCACTGGATCTTCGTCAACTGGTGCACACCATACTGGATCTGTTCAGGCTGGTTCT 69 FBan0007300 FBgn0032286 CG7300 2 2L CG7300 CG7300 CDMC33217 4 18 9 DAC15-D03 7-CG7300-RA_6 CG7300 GGCAATGCCAAAATCACTGGATCTTCGTCAACTGGTGCACACCATACTGGATCTGTTCAGGCTGGTTCT 69 FBan0007300 FBgn0032286 CG7300 2 2L CG7300 CG7300 CDMC33218 4 19 9 DAC15-D15 1-CG7314-RA_1 CG7314 TGAGCTGCCCGTCTACGACTTTTGCAAGCTGCAGTTAATGAATGCCTTCGGAGATCACGTTGGCAATCA 69 FBan0007314 FBgn0036199 Bmcp 3 3L cation transport; GO:0006812; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Bmcp Bmcp "CG7314, CG7314, DmBMCP, DmUCP5, dmUCP5" CDMC33218 4 20 9 DAC15-D15 1-CG7314-RA_1 CG7314 TGAGCTGCCCGTCTACGACTTTTGCAAGCTGCAGTTAATGAATGCCTTCGGAGATCACGTTGGCAATCA 69 FBan0007314 FBgn0036199 Bmcp 3 3L cation transport; GO:0006812; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 Bmcp Bmcp "CG7314, CG7314, DmBMCP, DmUCP5, dmUCP5" CDMC33219 4 21 9 DAC15-H03 2-CG7341-RB_2 CG7341 TGCTTCTGAAAGACGGAAAACGGTTGGAAGGGATGCTATGCTCTGGAAGTCATCTGGGACACAGCCTCA 69 FBan0007341 FBgn0036777 CG7341 3 3L CG7341 CG7341 CDMC33219 4 22 9 DAC15-H03 2-CG7341-RB_2 CG7341 TGCTTCTGAAAGACGGAAAACGGTTGGAAGGGATGCTATGCTCTGGAAGTCATCTGGGACACAGCCTCA 69 FBan0007341 FBgn0036777 CG7341 3 3L CG7341 CG7341 CDMC33220 4 23 9 DAC15-H15 4-CG7351-RA_1 CG7351 GGGGTACATCTCACATGCTCACAACAAACTGGTCGTGTCGAAGCAAAATCCATTCCCCTCAGTGTCCCT 69 FBan0007351 FBgn0036184 CG7351 3 3L immune response; GO:0006955 calcium-independent phospholipase A2 activity; GO:0047499; tumor necrosis factor receptor binding; GO:0005164; ; GO:0047499; ; GO:0005164 cytosol; GO:0005829; membrane; GO:0016020 CG7351 CG7351 CDMC33220 4 24 9 DAC15-H15 4-CG7351-RA_1 CG7351 GGGGTACATCTCACATGCTCACAACAAACTGGTCGTGTCGAAGCAAAATCCATTCCCCTCAGTGTCCCT 69 FBan0007351 FBgn0036184 CG7351 3 3L immune response; GO:0006955 calcium-independent phospholipase A2 activity; GO:0047499; tumor necrosis factor receptor binding; GO:0005164; ; GO:0047499; ; GO:0005164 cytosol; GO:0005829; membrane; GO:0016020 CG7351 CG7351 CDMC33221 4 25 9 DAC15-L03 17-CG7381-RB_3 CG7381 CGCACTCGATTTGTTCCAAGAATATTTGCCTATGTCGCCAGGGTTACTATGCCCGCAATGGAAAATGTT 69 FBan0007381 FBgn0038098 CG7381 3 3R CG7381 CG7381 CT22687 CDMC33221 4 26 9 DAC15-L03 17-CG7381-RB_3 CG7381 CGCACTCGATTTGTTCCAAGAATATTTGCCTATGTCGCCAGGGTTACTATGCCCGCAATGGAAAATGTT 69 FBan0007381 FBgn0038098 CG7381 3 3R CG7381 CG7381 CT22687 CDMC33222 4 1 10 DAC15-L15 11-CG7390-RA_2 CG7390 TGTACAGGGCTAAAATCGAGGGCGAGATATTTGCATCGTTCATTCTGCCGGTTGAGAACAAACCGCAGG 69 FBan0007390 FBgn0038257 smp-30 3 3R anterior/posterior axis specification; GO:0009948; calcium-mediated signaling; GO:0019722; development; GO:0007275; electron transport; GO:0006118; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 smp-30 Senescence marker protein-30 "CG7390, Dca, Drosophila cold acclimation gene, CT22723, Smp-30, Senescence marker protein-30" CDMC33222 4 2 10 DAC15-L15 11-CG7390-RA_2 CG7390 TGTACAGGGCTAAAATCGAGGGCGAGATATTTGCATCGTTCATTCTGCCGGTTGAGAACAAACCGCAGG 69 FBan0007390 FBgn0038257 smp-30 3 3R anterior/posterior axis specification; GO:0009948; calcium-mediated signaling; GO:0019722; development; GO:0007275; electron transport; GO:0006118; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 smp-30 Senescence marker protein-30 "CG7390, Dca, Drosophila cold acclimation gene, CT22723, Smp-30, Senescence marker protein-30" CDMC33223 4 3 10 DAC15-P03 2-CG7440-RA_1 CG7440 TGGCATGGACTTTTGGTTGTACAAGTACGCCTACTACAATCCGAGATCGTGCATGGACTGCCTGTCGGA 69 FBan0007440 FBgn0030984 tgy X X foregut morphogenesis; GO:0007440; wing disc development; GO:0035220 galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.- tgy twiggy "CG7440, twiggy" CDMC33223 4 4 10 DAC15-P03 2-CG7440-RA_1 CG7440 TGGCATGGACTTTTGGTTGTACAAGTACGCCTACTACAATCCGAGATCGTGCATGGACTGCCTGTCGGA 69 FBan0007440 FBgn0030984 tgy X X foregut morphogenesis; GO:0007440; wing disc development; GO:0035220 galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.- tgy twiggy "CG7440, twiggy" CDMC33224 4 5 10 DAC15-P15 5-CG7449-RB_1 CG7449 GCCAAACGTTTGCCACAAGACCAATTCGTTCGCAGACCCCTCACCACAGAAAAACCGAAAGATACACCC 69 FBan0007449 FBgn0029082 hbs 2 2R cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; myoblast fusion; GO:0007520; nervous system development; GO:0007399; regulation of striated muscle development; GO:0016202; signal transduction; GO:0007165 plasma membrane; GO:0005886 hbs hibris "CG7449, CT22841, Hbs, icon, inappropriate contact, inappropriate contacts, hibris" CDMC33224 4 6 10 DAC15-P15 5-CG7449-RB_1 CG7449 GCCAAACGTTTGCCACAAGACCAATTCGTTCGCAGACCCCTCACCACAGAAAAACCGAAAGATACACCC 69 FBan0007449 FBgn0029082 hbs 2 2R cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; myoblast fusion; GO:0007520; nervous system development; GO:0007399; regulation of striated muscle development; GO:0016202; signal transduction; GO:0007165 plasma membrane; GO:0005886 hbs hibris "CG7449, CT22841, Hbs, icon, inappropriate contact, inappropriate contacts, hibris" CDMC33225 4 7 10 DAC16-D03 3-CG12399-RA_3 CG12399 CAGTCGGTGAACAATGGATTCGAGGCCGTCTACGAGCTGACAAAGATGTGCACGATCCGGATGTCG 66 FBan0012399 FBgn0011648 Mad 2 2L cell-cell signaling; GO:0007267; dorsal closure; GO:0007391; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing vein morphogenesis; GO:0008586 "DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; GO:0030618; ; GO:0003702; protein binding; GO:0005515; ; GO:0030618; ; GO:0003702; ; GO:0005515" cytoplasm; GO:0005737; nucleus; GO:0005634 Mad Mothers against dpp "CG12399, mad: many abnormal discs, MAD, l(2)K00237, 2/23, pMAD, p-Mad, pMad, E(zen)2, En(vvl), l(2)k00237, apg, apang, mad" CDMC33225 4 8 10 DAC16-D03 3-CG12399-RA_3 CG12399 CAGTCGGTGAACAATGGATTCGAGGCCGTCTACGAGCTGACAAAGATGTGCACGATCCGGATGTCG 66 FBan0012399 FBgn0011648 Mad 2 2L cell-cell signaling; GO:0007267; dorsal closure; GO:0007391; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of salivary gland determination; GO:0045705; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of synaptic growth at neuromuscular junction; GO:0045887; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179; wing disc anterior/posterior pattern formation; GO:0048100; wing vein morphogenesis; GO:0008586 "DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; GO:0030618; ; GO:0003702; protein binding; GO:0005515; ; GO:0030618; ; GO:0003702; ; GO:0005515" cytoplasm; GO:0005737; nucleus; GO:0005634 Mad Mothers against dpp "CG12399, mad: many abnormal discs, MAD, l(2)K00237, 2/23, pMAD, p-Mad, pMad, E(zen)2, En(vvl), l(2)k00237, apg, apang, mad" CDMC33226 4 9 10 DAC16-D15 1-CG12644-RA_2 CG12644 CCAAGACAATGTCATTGGCGGCACTGATTTTGGGTCTGATGGGTCTAGCGTTGGTAACCCTGGCAG 66 FBan0012644 FBgn0040940 CG12644 X X CG12644 CG12644 CDMC33226 4 10 10 DAC16-D15 1-CG12644-RA_2 CG12644 CCAAGACAATGTCATTGGCGGCACTGATTTTGGGTCTGATGGGTCTAGCGTTGGTAACCCTGGCAG 66 FBan0012644 FBgn0040940 CG12644 X X CG12644 CG12644 CDMC33227 4 11 10 DAC16-H03 2-CG1327-RA_1 CG1327 CGCTTCTTTCGCTCTGCAATTTGCCAACCAACCTCAAACGCTCGCCAAATGGCTTTCAAGCTCGTT 66 FBan0001327 FBgn0004781 Ccp84Ac 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ac Ccp84Ac "CG1327, BG:DS00004.3, cc6: cuticle cluster 6, cuticle cluster 6" CDMC33227 4 12 10 DAC16-H03 2-CG1327-RA_1 CG1327 CGCTTCTTTCGCTCTGCAATTTGCCAACCAACCTCAAACGCTCGCCAAATGGCTTTCAAGCTCGTT 66 FBan0001327 FBgn0004781 Ccp84Ac 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Ac Ccp84Ac "CG1327, BG:DS00004.3, cc6: cuticle cluster 6, cuticle cluster 6" CDMC33228 4 13 10 DAC16-H15 2-CG13350-RA_1 CG13350 CCAGTGTGTCGCACAACTTCTTTGTGGTCGCTGTATCCGAGAAACGTCAGATAGTCCAGGCGGTCC 66 FBan0013350 FBgn0033890 CG13350 2 2R DNA binding; GO:0003677; ; GO:0003677 CG13350 CG13350 anon-WO0140519.180 CDMC33228 4 14 10 DAC16-H15 2-CG13350-RA_1 CG13350 CCAGTGTGTCGCACAACTTCTTTGTGGTCGCTGTATCCGAGAAACGTCAGATAGTCCAGGCGGTCC 66 FBan0013350 FBgn0033890 CG13350 2 2R DNA binding; GO:0003677; ; GO:0003677 CG13350 CG13350 anon-WO0140519.180 CDMC33229 4 15 10 DAC16-L03 2-CG1372-RA_1 CG1372 GGTGCGGTCAACAGCCTGGAATTGGAACATGAACACGAGCAGAACGGTCACTTTCACTGGCTGATG 66 FBan0001372 FBgn0004649 yl X X intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; protein biosynthesis; GO:0006412; receptor mediated endocytosis; GO:0006898; vitellogenesis; GO:0007296 vitellogenin receptor activity; GO:0008196; ; GO:0008196; calcium ion binding; GO:0005509; structural constituent of ribosome; GO:0003735; ; GO:0008196; ; GO:0003735; ; GO:0005509 intracellular; GO:0005622; membrane; GO:0016020; ribosome; GO:0005840 yl yolkless "CG1372, fs(1)M25, fs(1)K184, fs(1)148, fs(1)A148, fs(1)yolkless, fs(1)L186, LR13, DmYPR, CT3114, YP receptor, fs(1)5, fs(1)L193, fs(1)L196, fs(1)L211, fs(1)M205, fs(1)yl" CDMC33229 4 16 10 DAC16-L03 2-CG1372-RA_1 CG1372 GGTGCGGTCAACAGCCTGGAATTGGAACATGAACACGAGCAGAACGGTCACTTTCACTGGCTGATG 66 FBan0001372 FBgn0004649 yl X X intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; protein biosynthesis; GO:0006412; receptor mediated endocytosis; GO:0006898; vitellogenesis; GO:0007296 vitellogenin receptor activity; GO:0008196; ; GO:0008196; calcium ion binding; GO:0005509; structural constituent of ribosome; GO:0003735; ; GO:0008196; ; GO:0003735; ; GO:0005509 intracellular; GO:0005622; membrane; GO:0016020; ribosome; GO:0005840 yl yolkless "CG1372, fs(1)M25, fs(1)K184, fs(1)148, fs(1)A148, fs(1)yolkless, fs(1)L186, LR13, DmYPR, CT3114, YP receptor, fs(1)5, fs(1)L193, fs(1)L196, fs(1)L211, fs(1)M205, fs(1)yl" CDMC33230 4 17 10 DAC16-L15 2-CG13914-RA_1 CG13914 GCTGAGATGACCCTGTCCAAGATCCTGGAGAACTTCAAGCTGCTCATGTCTAGCAGTGACCAGCGG 66 FBan0013914 FBgn0035209 CG13914 3 3L CG13914 CG13914 CDMC33230 4 18 10 DAC16-L15 2-CG13914-RA_1 CG13914 GCTGAGATGACCCTGTCCAAGATCCTGGAGAACTTCAAGCTGCTCATGTCTAGCAGTGACCAGCGG 66 FBan0013914 FBgn0035209 CG13914 3 3L CG13914 CG13914 CDMC33231 4 19 10 DAC16-P03 2-CG14270-RA_3 CG14270 TCTGCTAAGGGGTGCCACAAATCGAATGATCACAGTGCCGGTAGAACTTCAGAATCCCGTGTCCGC 66 FBan0014270 FBgn0029665 CG14270 X X CG14270 CG14270 CDMC33231 4 20 10 DAC16-P03 2-CG14270-RA_3 CG14270 TCTGCTAAGGGGTGCCACAAATCGAATGATCACAGTGCCGGTAGAACTTCAGAATCCCGTGTCCGC 66 FBan0014270 FBgn0029665 CG14270 X X CG14270 CG14270 CDMC33232 4 21 10 DAC16-P15 AutoBlank AutoBlank CDMC33232 4 22 10 DAC16-P15 AutoBlank AutoBlank CDMC33233 4 23 10 DAC17-D03 8-CG17300-RA_1 CG17300 TGGGCATCATGGAAGATGGCTACTACAGCAGTGGAATCACCATCGGTATCCTGACCACATTTGCTGTGA 69 FBan0017300 FBgn0036345 CG17300 3 3L CG17300 CG17300 CDMC33233 4 24 10 DAC17-D03 8-CG17300-RA_1 CG17300 TGGGCATCATGGAAGATGGCTACTACAGCAGTGGAATCACCATCGGTATCCTGACCACATTTGCTGTGA 69 FBan0017300 FBgn0036345 CG17300 3 3L CG17300 CG17300 CDMC33234 4 25 10 DAC17-D15 9-CG17321-RA_3 CG17321 TGAGCTCCACACTGCTTGTCCACATGGTGCTATATGCGACTGAATACACATGGGTATCCAAGCACTCCA 69 FBan0017321 FBgn0032719 CG17321 2 2L CG17321 CG17321 CDMC33234 4 26 10 DAC17-D15 9-CG17321-RA_3 CG17321 TGAGCTCCACACTGCTTGTCCACATGGTGCTATATGCGACTGAATACACATGGGTATCCAAGCACTCCA 69 FBan0017321 FBgn0032719 CG17321 2 2L CG17321 CG17321 CDMC33235 4 1 11 DAC17-H03 14-CG17364-RA_3 CG17364 AAATCAACTCAAGCATCAGTCATCCCGCATCCATTTGTACGATCGTGTGGTCTGCTCATTCCCATTCGC 69 FBan0017364 FBgn0036391 CG17364 3 3L CG17364 CG17364 CDMC33235 4 2 11 DAC17-H03 14-CG17364-RA_3 CG17364 AAATCAACTCAAGCATCAGTCATCCCGCATCCATTTGTACGATCGTGTGGTCTGCTCATTCCCATTCGC 69 FBan0017364 FBgn0036391 CG17364 3 3L CG17364 CG17364 CDMC33236 4 3 11 DAC17-H15 23-CG17378-RA_1 CG17378 AAACAAATTGGAATCGCATATCAAAATTAAGTTTGGAATCAAAACCAGTTACAAGAACATCCGTACTGC 69 FBan0017378 FBgn0031858 CG17378 2 2L CG17378 CG17378 CDMC33236 4 4 11 DAC17-H15 23-CG17378-RA_1 CG17378 AAACAAATTGGAATCGCATATCAAAATTAAGTTTGGAATCAAAACCAGTTACAAGAACATCCGTACTGC 69 FBan0017378 FBgn0031858 CG17378 2 2L CG17378 CG17378 CDMC33237 4 5 11 DAC17-L03 23-CG17440-RA_2 CG17440 AAGAAAAATTCCCTGAAACTTAATTGACGGATTTGGAATTGGACTTTAGTTGTCAGAAAGATTGGTGCG 69 FBan0017440 FBgn0030120 CG17440 X X CG17440 CG17440 CDMC33237 4 6 11 DAC17-L03 23-CG17440-RA_2 CG17440 AAGAAAAATTCCCTGAAACTTAATTGACGGATTTGGAATTGGACTTTAGTTGTCAGAAAGATTGGTGCG 69 FBan0017440 FBgn0030120 CG17440 X X CG17440 CG17440 CDMC33238 4 7 11 DAC17-L15 18-CG17470-RA_2 CG17470 TGGGTAGTTAGTTTCCGCACTCGAAACACCGACAAAAACCATGTTTCGCAATCTTTCGATGCTGAGGAA 69 FBan0017470 FBgn0032869 CG17470 2 2L mesoderm development; GO:0007498 CG17470 CG17470 "38D.25, anon-WO0140519.68, anon-WO0153538.51" CDMC33238 4 8 11 DAC17-L15 18-CG17470-RA_2 CG17470 TGGGTAGTTAGTTTCCGCACTCGAAACACCGACAAAAACCATGTTTCGCAATCTTTCGATGCTGAGGAA 69 FBan0017470 FBgn0032869 CG17470 2 2L mesoderm development; GO:0007498 CG17470 CG17470 "38D.25, anon-WO0140519.68, anon-WO0153538.51" CDMC33239 4 9 11 DAC17-P03 18-CG17510-RA_1 CG17510 ACAAATGACGTTAGAAAGGGAATTATGATTTTGGAGGAACTGGCTCGTACGCATCCAGATGGAAGGCGT 69 FBan0017510 FBgn0039969 CG17510 2 2R CG17510 CG17510 "bs15a08.y1, NEST:bs15a08, BcDNA:RE29957" CDMC33239 4 10 11 DAC17-P03 18-CG17510-RA_1 CG17510 ACAAATGACGTTAGAAAGGGAATTATGATTTTGGAGGAACTGGCTCGTACGCATCCAGATGGAAGGCGT 69 FBan0017510 FBgn0039969 CG17510 2 2R CG17510 CG17510 "bs15a08.y1, NEST:bs15a08, BcDNA:RE29957" CDMC33240 4 11 11 DAC17-P15 23-CG17521-RB_5 CG17521 AGCTACAGTTGAGGATTTTCCCCTGTGTGTTCATTTGGTTTCTGATGAATACGAACAGCTGAGTAGTGA 69 FBan0017521 FBgn0024733 Qm 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 Qm Qm "CG17521, DQM, Ribosome RL10, RpL10, Ribosomal protein L10, BcDNA:LD24589, anon-EST:Posey179" CDMC33240 4 12 11 DAC17-P15 23-CG17521-RB_5 CG17521 AGCTACAGTTGAGGATTTTCCCCTGTGTGTTCATTTGGTTTCTGATGAATACGAACAGCTGAGTAGTGA 69 FBan0017521 FBgn0024733 Qm 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 Qm Qm "CG17521, DQM, Ribosome RL10, RpL10, Ribosomal protein L10, BcDNA:LD24589, anon-EST:Posey179" CDMC33241 4 13 11 DAC18-D03 6-CG31314-RA_1 CG31314 GCGACCCCGCGAGGTGTGCCAAAAACTAAACCAGCACAATTAACTACAGTGAAATACGCTTGCACTGCC 69 FBan0007649 FBgn0051314 Neu3 3 3R cell-cell adhesion; GO:0016337; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 Neu3 Neu3 "CG7649, CG31314, CG31385, CG7649, CG7649, CT23341, Meltrin-like, DMeltrin" CDMC33241 4 14 11 DAC18-D03 6-CG31314-RA_1 CG31314 GCGACCCCGCGAGGTGTGCCAAAAACTAAACCAGCACAATTAACTACAGTGAAATACGCTTGCACTGCC 69 FBan0007649 FBgn0051314 Neu3 3 3R cell-cell adhesion; GO:0016337; proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270 Neu3 Neu3 "CG7649, CG31314, CG31385, CG7649, CG7649, CT23341, Meltrin-like, DMeltrin" CDMC33242 4 15 11 DAC18-D15 23-CG31324-RA_1 CG31324 CCTCTCTGGCATATTCCTCCTACCTAAAGGAACAAATCATCCAACTCATAACAAAAGAATTCATCAATA 69 FBan0031324 FBgn0051324 CG31324 3 3R CG31324 CG31324 "CG14557, CG14555, CG14557, CG14557, BcDNA:RH68619" CDMC33242 4 16 11 DAC18-D15 23-CG31324-RA_1 CG31324 CCTCTCTGGCATATTCCTCCTACCTAAAGGAACAAATCATCCAACTCATAACAAAAGAATTCATCAATA 69 FBan0031324 FBgn0051324 CG31324 3 3R CG31324 CG31324 "CG14557, CG14555, CG14557, CG14557, BcDNA:RH68619" CDMC33243 4 17 11 DAC18-H03 23-CG31360-RA_1 CG31360 GCCTTCCTATTGGCACAGTCGAAAAAAAGACAAGCGAAACCTCTGGAGAATTTCACTATGAAAGGCTTG 69 FBan0031360 FBgn0051360 CG31360 3 3R CG31360 CG31360 BcDNA:RE06652 CDMC33243 4 18 11 DAC18-H03 23-CG31360-RA_1 CG31360 GCCTTCCTATTGGCACAGTCGAAAAAAAGACAAGCGAAACCTCTGGAGAATTTCACTATGAAAGGCTTG 69 FBan0031360 FBgn0051360 CG31360 3 3R CG31360 CG31360 BcDNA:RE06652 CDMC33244 4 19 11 DAC18-H15 15-CG31369-RA_1 CG31369 GCCCGTTGGCATCTATACAAAGAAATACGAATGGGCCTCACGTATGCCGACAAGCGACAATGGAAATGT 69 FBan0031369 FBgn0051369 CG31369 3 3R CG31369 CG31369 "CG11731, CG11733, CT32186" CDMC33244 4 20 11 DAC18-H15 15-CG31369-RA_1 CG31369 GCCCGTTGGCATCTATACAAAGAAATACGAATGGGCCTCACGTATGCCGACAAGCGACAATGGAAATGT 69 FBan0031369 FBgn0051369 CG31369 3 3R CG31369 CG31369 "CG11731, CG11733, CT32186" CDMC33245 4 21 11 DAC18-L03 6-CG3140-RA_1 CG3140 AGCTCGACACATTGCTGGACAAGAGGAAAACCAACTTGGATGCTGTCATCGAGTTTGCCATCGACGACA 69 FBan0003140 FBgn0022708 Adk2 2 2R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3 mitochondrial intermembrane space; GO:0005758; mitochondrion; GO:0005739 Adk2 Adenylate kinase-2 "CG3140, CG3140, ADK-2, Dak2, BcDNA:SD09634, anon-Dak2, Adenylate kinase-2" CDMC33245 4 22 11 DAC18-L03 6-CG3140-RA_1 CG3140 AGCTCGACACATTGCTGGACAAGAGGAAAACCAACTTGGATGCTGTCATCGAGTTTGCCATCGACGACA 69 FBan0003140 FBgn0022708 Adk2 2 2R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3 mitochondrial intermembrane space; GO:0005758; mitochondrion; GO:0005739 Adk2 Adenylate kinase-2 "CG3140, CG3140, ADK-2, Dak2, BcDNA:SD09634, anon-Dak2, Adenylate kinase-2" CDMC33246 4 23 11 DAC18-L15 2-CG31421-RA_1 CG31421 TGGCGAACAGTATGAATCCGGCACTGACGAGGACTTTATCAAGCCTTTGGATGAGGATACCGTGGCTGT 69 FBgn0051421 CDMC33246 4 24 11 DAC18-L15 2-CG31421-RA_1 CG31421 TGGCGAACAGTATGAATCCGGCACTGACGAGGACTTTATCAAGCCTTTGGATGAGGATACCGTGGCTGT 69 FBgn0051421 CDMC33247 4 25 11 DAC18-P03 2-CG31464-RA_1 CG31464 AGCCAAGGACACACTGGATGACCATCAGCAAGTGGTTAGTGGACGCTTGGAGATGTTTTTTGGAAGCCA 69 FBan0031464 FBgn0051464 CG31464 3 3R CG31464 CG31464 CG11673 CDMC33247 4 26 11 DAC18-P03 2-CG31464-RA_1 CG31464 AGCCAAGGACACACTGGATGACCATCAGCAAGTGGTTAGTGGACGCTTGGAGATGTTTTTTGGAAGCCA 69 FBan0031464 FBgn0051464 CG31464 3 3R CG31464 CG31464 CG11673 CDMC33248 4 1 12 DAC18-P15 24-CG31484-RA_3 CG31484 TGGAAAAACCCCTATCAGTAAGAGTCACTAGAACTATAGGTTTATTTTTAAAAATAATCAGCTCCTTTA 69 FBan0031484 FBgn0051484 CG31484 3 3R CG31484 CG31484 CG2337 CDMC33248 4 2 12 DAC18-P15 24-CG31484-RA_3 CG31484 TGGAAAAACCCCTATCAGTAAGAGTCACTAGAACTATAGGTTTATTTTTAAAAATAATCAGCTCCTTTA 69 FBan0031484 FBgn0051484 CG31484 3 3R CG31484 CG31484 CG2337 CDMC33249 4 3 12 DAC19-D03 1-CG6050-RA_1 CG6050 GATCCGAGAGCTGCTTACCGAGATGGGCTATGATGGTGACAAGATCCCTGTGGTAAAGGGCTCGG 65 FBan0006050 FBgn0024556 EfTuM 2 2R regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; ; GO:0003746; ; GO:0003747; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 EfTuM Elongation factor Tu mitochondrial "CG6050, CG6050, CG6050, l(3)L4569, mtEF-Tu, Elongation factor Tu mitochondrial" CDMC33249 4 4 12 DAC19-D03 1-CG6050-RA_1 CG6050 GATCCGAGAGCTGCTTACCGAGATGGGCTATGATGGTGACAAGATCCCTGTGGTAAAGGGCTCGG 65 FBan0006050 FBgn0024556 EfTuM 2 2R regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; translation release factor activity; GO:0003747; ; GO:0003746; ; GO:0003747; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 EfTuM Elongation factor Tu mitochondrial "CG6050, CG6050, CG6050, l(3)L4569, mtEF-Tu, Elongation factor Tu mitochondrial" CDMC33250 4 5 12 DAC19-D15 2-CG6095-RB_2 CG6095 CTGCTCAAGGAGTTGTCCAACAGTCACAATCGCAATCTGCAGATCGCTCTGAGAGCAGCCAAGCG 65 FBan0006095 FBgn0039401 CG6095 3 3R exocyst; GO:0000145 CG6095 CG6095 anon-WO0153538.55 CDMC33250 4 6 12 DAC19-D15 2-CG6095-RB_2 CG6095 CTGCTCAAGGAGTTGTCCAACAGTCACAATCGCAATCTGCAGATCGCTCTGAGAGCAGCCAAGCG 65 FBan0006095 FBgn0039401 CG6095 3 3R exocyst; GO:0000145 CG6095 CG6095 anon-WO0153538.55 CDMC33251 4 7 12 DAC19-H03 3-CG6197-RA_1 CG6197 GTTTGTGATCCCCGCATCACTGCAGACTTTTGGCAAACTTGGAAGGAGTTCGAAGTGCGTCACGG 65 FBan0006197 FBgn0033859 CG6197 2 2R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003684; ; GO:0030528 intracellular; GO:0005622; nucleus; GO:0005634 CG6197 CG6197 CDMC33251 4 8 12 DAC19-H03 3-CG6197-RA_1 CG6197 GTTTGTGATCCCCGCATCACTGCAGACTTTTGGCAAACTTGGAAGGAGTTCGAAGTGCGTCACGG 65 FBan0006197 FBgn0033859 CG6197 2 2R "DNA metabolism; GO:0006259; DNA repair; GO:0006281; RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0003684; ; GO:0030528 intracellular; GO:0005622; nucleus; GO:0005634 CG6197 CG6197 CDMC33252 4 9 12 DAC19-H15 2-CG6217-RA_2 CG6217 CGCCGTGCGTTCAGGTTTTGGGTCAAAACAAAGGAGTTTGCCGTGACGATGTGGTTGGTGGATTG 65 FBan0006217 FBgn0001321 knk 3 3R catecholamine metabolism; GO:0006584; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1 knk knickkopf "CG6217, CG6217, CG6217, l(3)85Eg, knickkopf" CDMC33252 4 10 12 DAC19-H15 2-CG6217-RA_2 CG6217 CGCCGTGCGTTCAGGTTTTGGGTCAAAACAAAGGAGTTTGCCGTGACGATGTGGTTGGTGGATTG 65 FBan0006217 FBgn0001321 knk 3 3R catecholamine metabolism; GO:0006584; embryonic cuticle biosynthesis (sensu Insecta); GO:0008362; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 dopamine beta-monooxygenase activity; GO:0004500 ; EC:1.14.17.1; ; GO:0004500 ; EC:1.14.17.1 knk knickkopf "CG6217, CG6217, CG6217, l(3)85Eg, knickkopf" CDMC33253 4 11 12 DAC19-L03 24-CG6340-RB_2 CG6340 AACAACTTTTTGTTTGTGTTGAGAAAATTTTTTGTTTTTTTGATTTCAAATAAACGTTGCAACAG 65 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC33253 4 12 12 DAC19-L03 24-CG6340-RB_2 CG6340 AACAACTTTTTGTTTGTGTTGAGAAAATTTTTTGTTTTTTTGATTTCAAATAAACGTTGCAACAG 65 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC33254 4 13 12 DAC19-L15 6-CG6363-RA_2 CG6363 TTGGCTCAATGCTCAGCTACTCTGCGTTGGATCAGCAGTCCATGCAGAACCTACTCACGCACGTG 65 FBan0006363 FBgn0027378 MRG15 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 MRG15 MRG15 "CG6363, CG6363, l(3)j6A3, DmMRG15, Dmrg15, dMRG15, dMrg15" CDMC33254 4 14 12 DAC19-L15 6-CG6363-RA_2 CG6363 TTGGCTCAATGCTCAGCTACTCTGCGTTGGATCAGCAGTCCATGCAGAACCTACTCACGCACGTG 65 FBan0006363 FBgn0027378 MRG15 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528 nucleus; GO:0005634 MRG15 MRG15 "CG6363, CG6363, l(3)j6A3, DmMRG15, Dmrg15, dMRG15, dMrg15" CDMC33255 4 15 12 DAC19-P03 3-CG6454-RA_3 CG6454 CGATCCGGGAAAATGGTGGCATCAGCGGATTTGTCCATGGCTTCATTACCGAACTGTTGGCTGTG 65 FBan0006454 FBgn0039187 CG6454 3 3R CG6454 CG6454 CDMC33255 4 16 12 DAC19-P03 3-CG6454-RA_3 CG6454 CGATCCGGGAAAATGGTGGCATCAGCGGATTTGTCCATGGCTTCATTACCGAACTGTTGGCTGTG 65 FBan0006454 FBgn0039187 CG6454 3 3R CG6454 CG6454 CDMC33256 4 17 12 DAC19-P15 12-CG6476-RB_4 CG6476 GTTTGATTGGCTGGGGTCAGATCTTCGGAGGCAAGACAATCACACCCGTTCTGGACAGCCAGGTG 65 FBan0006476 FBgn0003600 Su(var)3-9 3 3R DNA methylation; GO:0006306; chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; chromatin silencing at telomere; GO:0006348; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; histone H3-K9 methylation; GO:0051567; histone methylation; GO:0016571; histone modification; GO:0016570; oogenesis (sensu Insecta); GO:0009993; translational initiation; GO:0006413 chromatin binding; GO:0003682; GTP binding; GO:0005525; ; GO:0003682; ; GO:0005525; tRNA binding; GO:0000049; histone methyltransferase activity; GO:0042054; translation initiation factor activity; GO:0003743; ; GO:0042054; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046974; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0003743; ; GO:0000049; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008270 "chromosome, pericentric region; GO:0000775; cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; heterochromatin; GO:0000792; nucleus; GO:0005634" Su(var)3-9 Suppressor of variegation 3-9 "CG6476, CG6476, Su-var(3)9, Su-var(3)902, E(var)3-2, Enhancer of variegation 3-2, Suvar(3)9, Su(var)3-902, Su(Var)3-9, eIF2gamma, dIF2, ptn, pitkin, caa56376 Suvar39 Dm, eIF-2G, eIF2G, SUV39H1, SU(VAR)3-9, SUV39, su(var)3-9, dSU(VAR)3-9, SuVar3-9, Suvar3-9, Suvar39, Su(var)306, Su(var)310, Su(var)328, eIF-2gamma, Suppressor of variegation 306, Suppressor of variegation 310, Suppressor of variegation 328" CDMC33256 4 18 12 DAC19-P15 12-CG6476-RB_4 CG6476 GTTTGATTGGCTGGGGTCAGATCTTCGGAGGCAAGACAATCACACCCGTTCTGGACAGCCAGGTG 65 FBan0006476 FBgn0003600 Su(var)3-9 3 3R DNA methylation; GO:0006306; chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; chromatin silencing at centromere; GO:0030702; chromatin silencing at telomere; GO:0006348; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; histone H3-K9 methylation; GO:0051567; histone methylation; GO:0016571; histone modification; GO:0016570; oogenesis (sensu Insecta); GO:0009993; translational initiation; GO:0006413 chromatin binding; GO:0003682; GTP binding; GO:0005525; ; GO:0003682; ; GO:0005525; tRNA binding; GO:0000049; histone methyltransferase activity; GO:0042054; translation initiation factor activity; GO:0003743; ; GO:0042054; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046974; zinc ion binding; GO:0008270; ; GO:0042054; ; GO:0003743; ; GO:0000049; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008270 "chromosome, pericentric region; GO:0000775; cytosol; GO:0005829; eukaryotic translation initiation factor 2 complex; GO:0005850; heterochromatin; GO:0000792; nucleus; GO:0005634" Su(var)3-9 Suppressor of variegation 3-9 "CG6476, CG6476, Su-var(3)9, Su-var(3)902, E(var)3-2, Enhancer of variegation 3-2, Suvar(3)9, Su(var)3-902, Su(Var)3-9, eIF2gamma, dIF2, ptn, pitkin, caa56376 Suvar39 Dm, eIF-2G, eIF2G, SUV39H1, SU(VAR)3-9, SUV39, su(var)3-9, dSU(VAR)3-9, SuVar3-9, Suvar3-9, Suvar39, Su(var)306, Su(var)310, Su(var)328, eIF-2gamma, Suppressor of variegation 306, Suppressor of variegation 310, Suppressor of variegation 328" CDMC33257 4 19 12 DAC20-D03 23-CG30093-RA_2 CG30093 TTTAACTTAGCTTACTACGAACTGATGGTAAGAAGTTCCCACTAAATGGAATGCCACCTAGATTT 65 FBan0030093 FBgn0050093 CG30093 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial membrane; GO:0005740 CG30093 CG30093 NEST:bs02a12 CDMC33257 4 20 12 DAC20-D03 23-CG30093-RA_2 CG30093 TTTAACTTAGCTTACTACGAACTGATGGTAAGAAGTTCCCACTAAATGGAATGCCACCTAGATTT 65 FBan0030093 FBgn0050093 CG30093 2 2R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrial membrane; GO:0005740 CG30093 CG30093 NEST:bs02a12 CDMC33258 4 21 12 DAC20-D15 10-CG30126-RA_1 CG30126 CTTGGCAAGCACGATTAAGGCGCTTTATCACCCGCAACAACGGCAGCAACACGAACGACAAGCAC 65 FBan0030126 FBgn0050126 CG30126 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30126 CG30126 CDMC33258 4 22 12 DAC20-D15 10-CG30126-RA_1 CG30126 CTTGGCAAGCACGATTAAGGCGCTTTATCACCCGCAACAACGGCAGCAACACGAACGACAAGCAC 65 FBan0030126 FBgn0050126 CG30126 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30126 CG30126 CDMC33259 4 23 12 DAC20-H03 3-CG30267-RA_2 CG30267 GGGGCTCACAGTAGGGGAAGAGCTAGAAGATGAAGAAGGAGCTTATCCAGAAGGAACGGCCAGCG 65 FBan0030267 FBgn0050267 CG30267 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30267 CG30267 BcDNA:AT28638 CDMC33259 4 24 12 DAC20-H03 3-CG30267-RA_2 CG30267 GGGGCTCACAGTAGGGGAAGAGCTAGAAGATGAAGAAGGAGCTTATCCAGAAGGAACGGCCAGCG 65 FBan0030267 FBgn0050267 CG30267 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30267 CG30267 BcDNA:AT28638 CDMC33260 4 25 12 DAC20-H15 23-CG30322-RA_1 CG30322 AAAGTCAGTGACTCAAACTGTTGTGCTAAAAAGCAACAAAAATACTCTATTGCCGACTTTAGCCA 65 FBgn0050322 CDMC33260 4 26 12 DAC20-H15 23-CG30322-RA_1 CG30322 AAAGTCAGTGACTCAAACTGTTGTGCTAAAAAGCAACAAAAATACTCTATTGCCGACTTTAGCCA 65 FBgn0050322 CDMC33261 4 1 13 DAC20-L03 3-CG30403-RA_3 CG30403 GATAGGCCGTTGGATGCTACACCCTCTTCCTTATTTACCGTTCTGCCAGCACCTATGCCCGTGGA 65 FBan0030403 FBgn0050403 CG30403 2 2R biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG30403 CG30403 BcDNA:RE26725 CDMC33261 4 2 13 DAC20-L03 3-CG30403-RA_3 CG30403 GATAGGCCGTTGGATGCTACACCCTCTTCCTTATTTACCGTTCTGCCAGCACCTATGCCCGTGGA 65 FBan0030403 FBgn0050403 CG30403 2 2R biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG30403 CG30403 BcDNA:RE26725 CDMC33262 4 3 13 DAC20-L15 17-CG3041-RA_2 CG3041 CACATTTGTTCTTAATCGTCCATAATCTGGATGGAGCCATGCTTCGCAATGTGAAGGCACAGGCG 65 FBan0003041 FBgn0015270 Orc2 3 3R DNA replication; GO:0006260; DNA replication and chromosome cycle; GO:0000067; DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; chromatin silencing; GO:0006342; chromosome condensation; GO:0030261; mitotic chromosome condensation; GO:0007076; mitotic spindle organization and biogenesis; GO:0007052; proteolysis; GO:0006508 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- nuclear origin of replication recognition complex; GO:0005664 Orc2 Origin recognition complex subunit 2 "CG3041, l(3)k43, l(3)88Ab, l(3)K43, fs(3)293, DmORC2, Orc2p, k43, ORC, ORC2, orc2, DmORC 2, rDmORC, fs(3)293-19, l(3)A5, l(3)SG44, l(3)dsl5, lethal(3)88Ab" CDMC33262 4 4 13 DAC20-L15 17-CG3041-RA_2 CG3041 CACATTTGTTCTTAATCGTCCATAATCTGGATGGAGCCATGCTTCGCAATGTGAAGGCACAGGCG 65 FBan0003041 FBgn0015270 Orc2 3 3R DNA replication; GO:0006260; DNA replication and chromosome cycle; GO:0000067; DNA replication initiation; GO:0006270; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; chromatin silencing; GO:0006342; chromosome condensation; GO:0030261; mitotic chromosome condensation; GO:0007076; mitotic spindle organization and biogenesis; GO:0007052; proteolysis; GO:0006508 DNA binding; GO:0003677; ; GO:0003677; DNA replication origin binding; GO:0003688; ; GO:0003688; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- nuclear origin of replication recognition complex; GO:0005664 Orc2 Origin recognition complex subunit 2 "CG3041, l(3)k43, l(3)88Ab, l(3)K43, fs(3)293, DmORC2, Orc2p, k43, ORC, ORC2, orc2, DmORC 2, rDmORC, fs(3)293-19, l(3)A5, l(3)SG44, l(3)dsl5, lethal(3)88Ab" CDMC33263 4 5 13 DAC20-P03 1-CG3062-RA_1 CG3062 CTGAGTGGGCGGTACAAGTTTGTTGACTTTCCGCGTGACCTGTGCAATTGTCAGCGAGAGAACCG 65 FBan0003062 FBgn0025612 CG3062 X X CG3062 CG3062 EG:84H4.5 CDMC33263 4 6 13 DAC20-P03 1-CG3062-RA_1 CG3062 CTGAGTGGGCGGTACAAGTTTGTTGACTTTCCGCGTGACCTGTGCAATTGTCAGCGAGAGAACCG 65 FBan0003062 FBgn0025612 CG3062 X X CG3062 CG3062 EG:84H4.5 CDMC33264 4 7 13 DAC20-P15 2-CG31025-RB_1 CG31025 CCGCCAATCCCTACGTGAGAATGAAGCCCGTTCAGTTTCGGATCGTCAAGAATCCGCTGCTGAAG 65 FBan0031025 FBgn0051025 CG31025 3 3R CG31025 CG31025 "CG2164, CG2164, anon-WO0140519.94" CDMC33264 4 8 13 DAC20-P15 2-CG31025-RB_1 CG31025 CCGCCAATCCCTACGTGAGAATGAAGCCCGTTCAGTTTCGGATCGTCAAGAATCCGCTGCTGAAG 65 FBan0031025 FBgn0051025 CG31025 3 3R CG31025 CG31025 "CG2164, CG2164, anon-WO0140519.94" CDMC33265 4 9 13 DAC21-D03 3-CG4001-RA_1 CG4001 CCGCCTACATCTACGAGGAGAAGTTCTCCATCAAAGACCTGCAGCAGGATGTCTACCACATGGCCTCC 68 FBan0004001 FBgn0003071 Pfk 2 2R glycolysis; GO:0006096 6-phosphofructokinase activity; GO:0003872 ; EC:2.7.1.11; ; GO:0003872 ; EC:2.7.1.11 6-phosphofructokinase complex; GO:0005945; cytoplasm; GO:0005737 Pfk Phosphofructokinase "CG4001, CG4001, l(2)06339, pfk, BcDNA.GH12192, 6-phosphofructokinase, BcDNA:GH12192" CDMC33265 4 10 13 DAC21-D03 3-CG4001-RA_1 CG4001 CCGCCTACATCTACGAGGAGAAGTTCTCCATCAAAGACCTGCAGCAGGATGTCTACCACATGGCCTCC 68 FBan0004001 FBgn0003071 Pfk 2 2R glycolysis; GO:0006096 6-phosphofructokinase activity; GO:0003872 ; EC:2.7.1.11; ; GO:0003872 ; EC:2.7.1.11 6-phosphofructokinase complex; GO:0005945; cytoplasm; GO:0005737 Pfk Phosphofructokinase "CG4001, CG4001, l(2)06339, pfk, BcDNA.GH12192, 6-phosphofructokinase, BcDNA:GH12192" CDMC33266 4 11 13 DAC21-D15 27-CG4032-RA_5 CG4032 AGCTGACCAACGGCAATAGTACTGGGTCCGGATTCAAGGCTCAGCTGAAGAAAGTCGAGCCCAAAAAG 68 FBan0004032 FBgn0000017 Abl 3 3L axon guidance; GO:0007411; central nervous system development; GO:0007417; dorsal closure; GO:0007391; intracellular signaling cascade; GO:0007242; morphogenesis of an epithelium; GO:0002009; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004715 ; EC:2.7.1.-; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737; extrinsic to plasma membrane; GO:0019897; intercellular junction; GO:0005911; muscle tendon junction; GO:0005927 Abl Abl tyrosine kinase "CG4032, CG4032, CG4032, CG4032, l(3)c-abl, D-ash, abl, Dabl, cAbl, D-abl, l(3)04674, abelson, DROTKABL3, Am ABL, DAbl, Dash, 4674, c-abl, Ddash/abl, Abelson, D-abelson, ABL, abl kinase, AblK, Ableson, Abl1, C-abl, Dsrc7, abl1, l(3)73Ba, Abl oncogene" CDMC33266 4 12 13 DAC21-D15 27-CG4032-RA_5 CG4032 AGCTGACCAACGGCAATAGTACTGGGTCCGGATTCAAGGCTCAGCTGAAGAAAGTCGAGCCCAAAAAG 68 FBan0004032 FBgn0000017 Abl 3 3L axon guidance; GO:0007411; central nervous system development; GO:0007417; dorsal closure; GO:0007391; intracellular signaling cascade; GO:0007242; morphogenesis of an epithelium; GO:0002009; protein amino acid phosphorylation; GO:0006468; regulation of actin polymerization and/or depolymerization; GO:0008064; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein binding; GO:0005515; ; GO:0004715 ; EC:2.7.1.-; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737; extrinsic to plasma membrane; GO:0019897; intercellular junction; GO:0005911; muscle tendon junction; GO:0005927 Abl Abl tyrosine kinase "CG4032, CG4032, CG4032, CG4032, l(3)c-abl, D-ash, abl, Dabl, cAbl, D-abl, l(3)04674, abelson, DROTKABL3, Am ABL, DAbl, Dash, 4674, c-abl, Ddash/abl, Abelson, D-abelson, ABL, abl kinase, AblK, Ableson, Abl1, C-abl, Dsrc7, abl1, l(3)73Ba, Abl oncogene" CDMC33267 4 13 13 DAC21-H03 3-CG4446-RA_1 CG4446 GCCATACTGTCCATCCTGAATCCTCTGCTTGCACCGGGATTGCTTCTTTTGGGTGTGAATTTGGGAGC 68 FBan0004446 FBgn0035979 CG4446 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin catabolism; GO:0009111 pyridoxal kinase activity; GO:0008478 ; EC:2.7.1.35; ; GO:0008478 ; EC:2.7.1.35 CG4446 CG4446 CDMC33267 4 14 13 DAC21-H03 3-CG4446-RA_1 CG4446 GCCATACTGTCCATCCTGAATCCTCTGCTTGCACCGGGATTGCTTCTTTTGGGTGTGAATTTGGGAGC 68 FBan0004446 FBgn0035979 CG4446 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin catabolism; GO:0009111 pyridoxal kinase activity; GO:0008478 ; EC:2.7.1.35; ; GO:0008478 ; EC:2.7.1.35 CG4446 CG4446 CDMC33268 4 15 13 DAC21-H15 3-CG4570-RA_1 CG4570 GCGGGGATCAGACCGAGTTCTGCTAGCCAAGCTGTGGATTCCAATCGCACCCTGATTCTTGAATGTTG 68 FBan0004570 FBgn0037844 CG4570 3 3R DNA integration; GO:0015074 DNA binding; GO:0003677; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 nucleus; GO:0005634 CG4570 CG4570 CDMC33268 4 16 13 DAC21-H15 3-CG4570-RA_1 CG4570 GCGGGGATCAGACCGAGTTCTGCTAGCCAAGCTGTGGATTCCAATCGCACCCTGATTCTTGAATGTTG 68 FBan0004570 FBgn0037844 CG4570 3 3R DNA integration; GO:0015074 DNA binding; GO:0003677; ; GO:0003677; transposase activity; GO:0004803; ; GO:0004803 nucleus; GO:0005634 CG4570 CG4570 CDMC33269 4 17 13 DAC21-L03 12-CG5097-RA_1 CG5097 CCTGTAATCAGGACTGCAAGTGCGTGTGCAAGAATGGCCCCAAAGATCAGTGTTGCAAGAGCAAGTAG 68 FBan0005097 FBgn0038790 MtnC 3 3R metal ion binding; GO:0046872; ; GO:0046872 MtnC Metallothionein C "CG5097, CG5097, CG5097, CG5097, Metallothionein C" CDMC33269 4 18 13 DAC21-L03 12-CG5097-RA_1 CG5097 CCTGTAATCAGGACTGCAAGTGCGTGTGCAAGAATGGCCCCAAAGATCAGTGTTGCAAGAGCAAGTAG 68 FBan0005097 FBgn0038790 MtnC 3 3R metal ion binding; GO:0046872; ; GO:0046872 MtnC Metallothionein C "CG5097, CG5097, CG5097, CG5097, Metallothionein C" CDMC33270 4 19 13 DAC21-L15 2-CG5190-RA_2 CG5190 CTTTGCGGAGAACCGGATGAATGATGAGCCCTTCGATCTGCACTATTGCAACACCCAGATGGACAGCA 68 FBan0005190 FBgn0034351 CG5190 2 2R CG5190 CG5190 CDMC33270 4 20 13 DAC21-L15 2-CG5190-RA_2 CG5190 CTTTGCGGAGAACCGGATGAATGATGAGCCCTTCGATCTGCACTATTGCAACACCCAGATGGACAGCA 68 FBan0005190 FBgn0034351 CG5190 2 2R CG5190 CG5190 CDMC33271 4 21 13 DAC21-P03 12-CG5625-RA_2 CG5625 CCAGCTTGCAGCCATAACGCTCATCATGTCCACTTTTGAACAAATGTCCTGCTTTGGCGAGGAGAACG 68 FBan0005625 FBgn0034708 CG5625 2 2R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 CG5625 CG5625 CDMC33271 4 22 13 DAC21-P03 12-CG5625-RA_2 CG5625 CCAGCTTGCAGCCATAACGCTCATCATGTCCACTTTTGAACAAATGTCCTGCTTTGGCGAGGAGAACG 68 FBan0005625 FBgn0034708 CG5625 2 2R intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 CG5625 CG5625 CDMC33272 4 23 13 DAC21-P15 2-CG5733-RA_1 CG5733 ACCACACAGAAACCGTGTTCAAGGACTATCGGGTGGAGAACGTTGACGAAATCATGAACCTCCTGCGC 68 FBan0005733 FBgn0034310 CG5733 2 2R CG5733 CG5733 CDMC33272 4 24 13 DAC21-P15 2-CG5733-RA_1 CG5733 ACCACACAGAAACCGTGTTCAAGGACTATCGGGTGGAGAACGTTGACGAAATCATGAACCTCCTGCGC 68 FBan0005733 FBgn0034310 CG5733 2 2R CG5733 CG5733 CDMC33273 4 25 13 DAC22-D03 22-CG40467-RA_1 CG40467 TCGGGAACTACAACAGCTGTTATTAGTACCGCCAGTTTTCTCAGTTTTTGTGGAGCTTTGTCCGCTACA 69 FBgn0069977 CG40467 CG40467 CG40467 CDMC33273 4 26 13 DAC22-D03 22-CG40467-RA_1 CG40467 TCGGGAACTACAACAGCTGTTATTAGTACCGCCAGTTTTCTCAGTTTTTGTGGAGCTTTGTCCGCTACA 69 FBgn0069977 CG40467 CG40467 CG40467 CDMC33274 4 1 14 DAC22-D15 23-CG40485-RA_3 CG40485 AGGAGATGCGAGATTTCAAGACCAAAGTCAAGGTCACGGTGAGTACGTGTTTAATGAATGCACTACAAA 69 FBgn0069973 CG40485 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40485 CG40485 CDMC33274 4 2 14 DAC22-D15 23-CG40485-RA_3 CG40485 AGGAGATGCGAGATTTCAAGACCAAAGTCAAGGTCACGGTGAGTACGTGTTTAATGAATGCACTACAAA 69 FBgn0069973 CG40485 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40485 CG40485 CDMC33275 4 3 14 DAC22-H03 21-CG4073-RA_6 CG4073 AATGCGATACGTCTCGATGGTCAGTCTGATCTACGTGGCTAGTCTCATCCTCTTCACCATCACCGTTAT 69 FBan0004073 FBgn0037827 CG4073 3 3R CG4073 CG4073 CDMC33275 4 4 14 DAC22-H03 21-CG4073-RA_6 CG4073 AATGCGATACGTCTCGATGGTCAGTCTGATCTACGTGGCTAGTCTCATCCTCTTCACCATCACCGTTAT 69 FBan0004073 FBgn0037827 CG4073 3 3R CG4073 CG4073 CDMC33276 4 5 14 DAC22-H15 9-CG4086-RA_2 CG4086 CCCTTGACCAGTGGACCACTGAGCTGAAAAAGAGGAACACGAAATTCATGGGCGGAAAACAGCCAAGTC 69 FBan0004086 FBgn0004465 Su(P) 3 3L Su(P) Suppressor of ref(2)P sterility CG4086 CDMC33276 4 6 14 DAC22-H15 9-CG4086-RA_2 CG4086 CCCTTGACCAGTGGACCACTGAGCTGAAAAAGAGGAACACGAAATTCATGGGCGGAAAACAGCCAAGTC 69 FBan0004086 FBgn0004465 Su(P) 3 3L Su(P) Suppressor of ref(2)P sterility CG4086 CDMC33277 4 7 14 DAC22-L03 9-CG41075-RA_1 CG41075 TGGACGCTCATCGCTCTTATCCTATGAAAACCGCCCAAGACGAACGATTTTTCCCTGGACGCGAAGAAT 69 FBgn0069948 CG41075 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41075 CG41075 CDMC33277 4 8 14 DAC22-L03 9-CG41075-RA_1 CG41075 TGGACGCTCATCGCTCTTATCCTATGAAAACCGCCCAAGACGAACGATTTTTCCCTGGACGCGAAGAAT 69 FBgn0069948 CG41075 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41075 CG41075 CDMC33278 4 9 14 DAC22-L15 23-CG41096-RA_20 CG41096 AGTATGTGCACTACTTTATGTGGGCAGTTCATCAAGTCAGATGATGCACTTCTATGAGAGGCTGGAGAA 69 FBgn0069944 CG41096 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41096 CG41096 CDMC33278 4 10 14 DAC22-L15 23-CG41096-RA_20 CG41096 AGTATGTGCACTACTTTATGTGGGCAGTTCATCAAGTCAGATGATGCACTTCTATGAGAGGCTGGAGAA 69 FBgn0069944 CG41096 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41096 CG41096 CDMC33279 4 11 14 DAC22-P03 23-CG4115-RA_1 CG4115 TTGCTGCATGATATACTTACTTATGAACCCTATCCTGGTAACCACCTTCCAATTCTCTGCGCTCTGTTC 69 FBan0004115 FBgn0038017 CG4115 3 3R sugar binding; GO:0005529; ; GO:0005529 CG4115 CG4115 CDMC33279 4 12 14 DAC22-P03 23-CG4115-RA_1 CG4115 TTGCTGCATGATATACTTACTTATGAACCCTATCCTGGTAACCACCTTCCAATTCTCTGCGCTCTGTTC 69 FBan0004115 FBgn0038017 CG4115 3 3R sugar binding; GO:0005529; ; GO:0005529 CG4115 CG4115 CDMC33280 4 13 14 DAC22-P15 9-CG4122-RG_2 CG4122 CGGCTTGGCCACAGAGAACGTGGTCTTTCACCTAAAAGTTAACGAGCATGTCTTTGGATTGCCTCGCTT 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC33280 4 14 14 DAC22-P15 9-CG4122-RG_2 CG4122 CGGCTTGGCCACAGAGAACGTGGTCTTTCACCTAAAAGTTAACGAGCATGTCTTTGGATTGCCTCGCTT 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC33281 4 15 14 DAC23-D03 2-CG3338-RA_2 CG3338 GGCTGCGAGCAACTCTTGTTGGACACCCATTCGCTAAAGACGGCTTTATTAGAGCTACCTTCCGTGGGA 69 FBan0003338 FBgn0031598 CG3338 2 2L CG3338 CG3338 CDMC33281 4 16 14 DAC23-D03 2-CG3338-RA_2 CG3338 GGCTGCGAGCAACTCTTGTTGGACACCCATTCGCTAAAGACGGCTTTATTAGAGCTACCTTCCGTGGGA 69 FBan0003338 FBgn0031598 CG3338 2 2L CG3338 CG3338 CDMC33282 4 17 14 DAC23-D15 1-CG33455-RA_1 CG33455 CCTACCCCGTATGGCGTTTCAACCGAAACTGACTCAAACCACCGCTTACGCACCATCCGAATATCAGCT 69 FBan0033455 FBgn0053455 CG33455 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33455 CG33455 "CG15610, CG15610" CDMC33282 4 18 14 DAC23-D15 1-CG33455-RA_1 CG33455 CCTACCCCGTATGGCGTTTCAACCGAAACTGACTCAAACCACCGCTTACGCACCATCCGAATATCAGCT 69 FBan0033455 FBgn0053455 CG33455 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33455 CG33455 "CG15610, CG15610" CDMC33283 4 19 14 DAC23-H03 2-CG33479-RA_2 CG33479 GGGGATACGGACAGTGCAATACTTTTCGGGAACACATCTGCGTGGAATGTACCTTCGGATCAGCAGCCA 69 FBan0033479 FBgn0053479 CG33479 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33479 CG33479 CDMC33283 4 20 14 DAC23-H03 2-CG33479-RA_2 CG33479 GGGGATACGGACAGTGCAATACTTTTCGGGAACACATCTGCGTGGAATGTACCTTCGGATCAGCAGCCA 69 FBan0033479 FBgn0053479 CG33479 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33479 CG33479 CDMC33284 4 21 14 DAC23-H15 16-CG33483-RA_1 CG33483 CCCATGGGGATTACCTTTTCCACTCCGACTGGTATGCATACGGAATTAATCGCGCAACCGTAGATTTTT 69 FBan0033483 FBgn0053483 CG33483 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33483 CG33483 CDMC33284 4 22 14 DAC23-H15 16-CG33483-RA_1 CG33483 CCCATGGGGATTACCTTTTCCACTCCGACTGGTATGCATACGGAATTAATCGCGCAACCGTAGATTTTT 69 FBan0033483 FBgn0053483 CG33483 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33483 CG33483 CDMC33285 4 23 14 DAC23-L03 2-CG3359-RD_2 CG3359 CGGCTACGATGATCAGTTCGACGATCTGGACAACGTGACCATCTTTGCACCAACTGACAAGGCTCTGCA 69 FBan0003359 FBgn0024211 mfas 3 3R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; signal transduction; GO:0007165 plasma membrane; GO:0005886 mfas midline fasciclin "CG3359, CG3359, clone 97, gh06752, anon-WO0140519.174, anon-EST:Liang-97, BEST:GH06752" CDMC33285 4 24 14 DAC23-L03 2-CG3359-RD_2 CG3359 CGGCTACGATGATCAGTTCGACGATCTGGACAACGTGACCATCTTTGCACCAACTGACAAGGCTCTGCA 69 FBan0003359 FBgn0024211 mfas 3 3R axonogenesis; GO:0007409; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; signal transduction; GO:0007165 plasma membrane; GO:0005886 mfas midline fasciclin "CG3359, CG3359, clone 97, gh06752, anon-WO0140519.174, anon-EST:Liang-97, BEST:GH06752" CDMC33286 4 25 14 DAC23-L15 8-CG3376-RB_2 CG3376 AGGTCCCTCTGTATCGCCCTATTACGATCTGAACCCCGGCTATCGTATCTACTACGTGGATGGCGATCA 69 FBan0003376 FBgn0034997 CG3376 2 2R sphingomyelin catabolism; GO:0006685 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG3376 CG3376 aSMase CDMC33286 4 26 14 DAC23-L15 8-CG3376-RB_2 CG3376 AGGTCCCTCTGTATCGCCCTATTACGATCTGAACCCCGGCTATCGTATCTACTACGTGGATGGCGATCA 69 FBan0003376 FBgn0034997 CG3376 2 2R sphingomyelin catabolism; GO:0006685 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG3376 CG3376 aSMase CDMC33287 4 1 15 DAC23-P03 3-CG3420-RA_4 CG3420 GGACTCGGCCAAAACAATTCCCAGTAACCTGCTCGAGGATAAGCAAACGGCCGTTCTGCAAAAGGAGAA 69 FBan0003420 FBgn0033100 CG3420 2 2R CG3420 CG3420 BcDNA:RE40412 CDMC33287 4 2 15 DAC23-P03 3-CG3420-RA_4 CG3420 GGACTCGGCCAAAACAATTCCCAGTAACCTGCTCGAGGATAAGCAAACGGCCGTTCTGCAAAAGGAGAA 69 FBan0003420 FBgn0033100 CG3420 2 2R CG3420 CG3420 BcDNA:RE40412 CDMC33288 4 3 15 DAC23-P15 3-CG3437-RA_3 CG3437 GGTGCGTCGGGAGATCGTGATCCAGATGTACGATGCCAGTCAGAAGATTTGCCTGTTAGAGCCCATTGT 69 FBan0003437 FBgn0035998 CG3437 3 3L CG3437 CG3437 CDMC33288 4 4 15 DAC23-P15 3-CG3437-RA_3 CG3437 GGTGCGTCGGGAGATCGTGATCCAGATGTACGATGCCAGTCAGAAGATTTGCCTGTTAGAGCCCATTGT 69 FBan0003437 FBgn0035998 CG3437 3 3L CG3437 CG3437 CDMC33289 4 5 15 DAC24-D03 3-CG33175-RA_1 CG33175 GCGCCACAAGTGGTGATGCGAAATATGCGCCAGTTCATGAGCGGCATGAAGAACTATCTGGTGAAGCAT 69 FBan0033175 FBgn0030216 spri X X endocytosis; GO:0006897; intracellular signaling cascade; GO:0007242 Ras GTPase binding; GO:0017016; ; GO:0017016; ; GO:0017016; ; GO:0017016 cellular component unknown; GO:0008372 spri sprint "CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, CG33175, CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, sprint-a, sprint-b, anon-WO03040301.275, sprint" CDMC33289 4 6 15 DAC24-D03 3-CG33175-RA_1 CG33175 GCGCCACAAGTGGTGATGCGAAATATGCGCCAGTTCATGAGCGGCATGAAGAACTATCTGGTGAAGCAT 69 FBan0033175 FBgn0030216 spri X X endocytosis; GO:0006897; intracellular signaling cascade; GO:0007242 Ras GTPase binding; GO:0017016; ; GO:0017016; ; GO:0017016; ; GO:0017016 cellular component unknown; GO:0008372 spri sprint "CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, CG33175, CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, sprint-a, sprint-b, anon-WO03040301.275, sprint" CDMC33290 4 7 15 DAC24-D15 14-CG33184-RA_2 CG33184 CTCTCCCGGTTCATCACCATCAAGCCCGTCGATTTCTAAGCCAATTGTATTGTTCAATTCCGCACACGT 69 FBgn0064127 CDMC33290 4 8 15 DAC24-D15 14-CG33184-RA_2 CG33184 CTCTCCCGGTTCATCACCATCAAGCCCGTCGATTTCTAAGCCAATTGTATTGTTCAATTCCGCACACGT 69 FBgn0064127 CDMC33291 4 9 15 DAC24-H03 12-CG33205-RA_1 CG33205 TGAGCTCAAGGAATCCTCTGGGCGAACCACAATCACCAATTGTAAATTGTTCCCCGATATCGTGGCACA 69 FBan0033205 FBgn0053205 CG33205 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG33205 CG33205 "CG8154, CG32049, CG32051, CG14172, CG8163, CG8154, CG8154, BcDNA:RE55923, BcDNA:RH19933" CDMC33291 4 10 15 DAC24-H03 12-CG33205-RA_1 CG33205 TGAGCTCAAGGAATCCTCTGGGCGAACCACAATCACCAATTGTAAATTGTTCCCCGATATCGTGGCACA 69 FBan0033205 FBgn0053205 CG33205 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG33205 CG33205 "CG8154, CG32049, CG32051, CG14172, CG8163, CG8154, CG8154, BcDNA:RE55923, BcDNA:RH19933" CDMC33292 4 11 15 DAC24-H15 1-CG33214-RA_1 CG33214 TCGGCCCATCCATGACCCCATTCCGAAACCCAGAAGTATACTTTCACTCAACCCTGTCTGCCTTTCGAT 69 FBan0033214 FBgn0053214 CG33214 3 3L cell adhesion; GO:0007155; intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; fibroblast growth factor binding; GO:0017134; ; GO:0017134 membrane; GO:0016020 CG33214 CG33214 "CG7190, CG7193, CG7195, CG7190, CG7193, CG7195, GLG1" CDMC33292 4 12 15 DAC24-H15 1-CG33214-RA_1 CG33214 TCGGCCCATCCATGACCCCATTCCGAAACCCAGAAGTATACTTTCACTCAACCCTGTCTGCCTTTCGAT 69 FBan0033214 FBgn0053214 CG33214 3 3L cell adhesion; GO:0007155; intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; fibroblast growth factor binding; GO:0017134; ; GO:0017134 membrane; GO:0016020 CG33214 CG33214 "CG7190, CG7193, CG7195, CG7190, CG7193, CG7195, GLG1" CDMC33293 4 13 15 DAC24-L03 3-CG33253-RA_1 CG33253 CGTGCTGATCATGGTGCTAACCTTTCCCATCTCGGTGTTCATCTGCTTCAAGGTGGTCTCCGAGTACGA 69 FBgn0053253 CDMC33293 4 14 15 DAC24-L03 3-CG33253-RA_1 CG33253 CGTGCTGATCATGGTGCTAACCTTTCCCATCTCGGTGTTCATCTGCTTCAAGGTGGTCTCCGAGTACGA 69 FBgn0053253 CDMC33294 4 15 15 DAC24-L15 23-CG33261-RD_1 CG33261 TAAGCAGCTCAAAAGTAATTGATCTGATCAAAAGAGAGTTCGCTCAACAAGGTTTCTAAAAACCCACCC 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC33294 4 16 15 DAC24-L15 23-CG33261-RD_1 CG33261 TAAGCAGCTCAAAAGTAATTGATCTGATCAAAAGAGAGTTCGCTCAACAAGGTTTCTAAAAACCCACCC 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC33295 4 17 15 DAC24-P03 17-CG33303-RA_1 CG33303 GCACATGCGCGCGAAAAGTCGAAAATTATTTCCGAGTGGTTTGAACTTTTTCGACGAGTGTGCTGTGTA 69 FBan0033303 FBgn0053303 CG33303 2 2L protein amino acid glycosylation; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 integral to membrane; GO:0016021; oligosaccharyl transferase complex; GO:0008250 CG33303 CG33303 "CG5364, CG5364, CG5364" CDMC33295 4 18 15 DAC24-P03 17-CG33303-RA_1 CG33303 GCACATGCGCGCGAAAAGTCGAAAATTATTTCCGAGTGGTTTGAACTTTTTCGACGAGTGTGCTGTGTA 69 FBan0033303 FBgn0053303 CG33303 2 2L protein amino acid glycosylation; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 integral to membrane; GO:0016021; oligosaccharyl transferase complex; GO:0008250 CG33303 CG33303 "CG5364, CG5364, CG5364" CDMC33296 4 19 15 DAC24-P15 1-CG33317-RA_1 CG33317 GCCGAGACTGGTCGTATTCCCGGCAAGGAGTTATACGCAGACGTGTACAAGCAGAAGCCGACAAAGATT 69 FBan0033317 FBgn0053317 CG33317 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG33317 CG33317 "CG18078, CG18092, CG18078, CG18078, cg18092" CDMC33296 4 20 15 DAC24-P15 1-CG33317-RA_1 CG33317 GCCGAGACTGGTCGTATTCCCGGCAAGGAGTTATACGCAGACGTGTACAAGCAGAAGCCGACAAAGATT 69 FBan0033317 FBgn0053317 CG33317 2 2L mRNA binding; GO:0003729; ; GO:0003729 CG33317 CG33317 "CG18078, CG18092, CG18078, CG18078, cg18092" CDMC33297 4 21 15 DAC25-D03 17-CG10374-RA_3 CG10374 ACCGCATCATCACAATCTCACGGCTGGACAAGGTTAAAACCATCTCCAAAGAGGAAGCTGAATCTCTTT 69 FBan0010374 FBgn0039114 Lsd-1 3 3R sequestering of lipid; GO:0019915 colocalizes_with lipid particle; GO:0005811 Lsd-1 Lipid storage droplet-1 "CG10374, LSDP1, LSD-1, Lsdp1: Lipid storage droplets surface binding protein, Lipid storage droplets surface binding protein, Lsdp1, Lipid storage droplet-1" CDMC33297 4 22 15 DAC25-D03 17-CG10374-RA_3 CG10374 ACCGCATCATCACAATCTCACGGCTGGACAAGGTTAAAACCATCTCCAAAGAGGAAGCTGAATCTCTTT 69 FBan0010374 FBgn0039114 Lsd-1 3 3R sequestering of lipid; GO:0019915 colocalizes_with lipid particle; GO:0005811 Lsd-1 Lipid storage droplet-1 "CG10374, LSDP1, LSD-1, Lsdp1: Lipid storage droplets surface binding protein, Lipid storage droplets surface binding protein, Lsdp1, Lipid storage droplet-1" CDMC33298 4 23 15 DAC25-D15 17-CG10384-RA_1 CG10384 GGGAGGATCAGCGAGAGTCTCGAGGAGATTAGCGAATATTTCTAGGCGATGTTTGCGTAGTTGATGCGT 69 FBan0010384 FBgn0034731 CG10384 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 CG10384 CG10384 cg10384 CDMC33298 4 24 15 DAC25-D15 17-CG10384-RA_1 CG10384 GGGAGGATCAGCGAGAGTCTCGAGGAGATTAGCGAATATTTCTAGGCGATGTTTGCGTAGTTGATGCGT 69 FBan0010384 FBgn0034731 CG10384 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; catalytic activity; GO:0003824; ; GO:0003729; ; GO:0003824 CG10384 CG10384 cg10384 CDMC33299 4 25 15 DAC25-H03 8-CG10421-RA_1 CG10421 GCCCGGCAAACATCTCAAGTACGTCATTCCCGATCCCGTAAATTCGCAGTTCTTTAGCGTAGGATCGCT 69 FBan0010421 FBgn0039294 Cad96Cb 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad96Cb Cad96Cb "CG10421, CG10421, CT29262, DCad96Cb" CDMC33299 4 26 15 DAC25-H03 8-CG10421-RA_1 CG10421 GCCCGGCAAACATCTCAAGTACGTCATTCCCGATCCCGTAAATTCGCAGTTCTTTAGCGTAGGATCGCT 69 FBan0010421 FBgn0039294 Cad96Cb 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad96Cb Cad96Cb "CG10421, CG10421, CT29262, DCad96Cb" CDMC33300 4 1 16 DAC25-H15 14-CG10443-RA_1 CG10443 TGCCAGGTCCACAGAGCTAAAATCTCATCGACCCTGCGTTCGTTGCATACTTATTTCGAACTCTACGCA 69 FBan0010443 FBgn0000464 Lar 2 2L axon guidance; GO:0007411; cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; embryonic development (sensu Insecta); GO:0001700; motor axon guidance; GO:0008045; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0005001 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Lar Leukocyte-antigen-related-like "CG10443, CG10443, Dlar, DLAR, dlar, PTP38A, bypass, LAR, DLar" CDMC33300 4 2 16 DAC25-H15 14-CG10443-RA_1 CG10443 TGCCAGGTCCACAGAGCTAAAATCTCATCGACCCTGCGTTCGTTGCATACTTATTTCGAACTCTACGCA 69 FBan0010443 FBgn0000464 Lar 2 2L axon guidance; GO:0007411; cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; embryonic development (sensu Insecta); GO:0001700; motor axon guidance; GO:0008045; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; regulation of cell shape; GO:0008360 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; ; GO:0005001 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Lar Leukocyte-antigen-related-like "CG10443, CG10443, Dlar, DLAR, dlar, PTP38A, bypass, LAR, DLar" CDMC33301 4 3 16 DAC25-L03 23-CG1048-RA_4 CG1048 CGGCATTCAGCAGTCTTCAGCTAATCGAACTAGAAAGGGAGTTCCATCTCAACAAATATTTAGCCCGAA 69 FBan0001048 FBgn0004054 zen2 3 3R "dorsal/ventral pattern formation, imaginal disc; GO:0007450; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 zen2 zerknullt-related "CG1048, z2, zerknullt 2, BG:DS00276.10, zpr: zen-pattern-related, zen-pattern-related" CDMC33301 4 4 16 DAC25-L03 23-CG1048-RA_4 CG1048 CGGCATTCAGCAGTCTTCAGCTAATCGAACTAGAAAGGGAGTTCCATCTCAACAAATATTTAGCCCGAA 69 FBan0001048 FBgn0004054 zen2 3 3R "dorsal/ventral pattern formation, imaginal disc; GO:0007450; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 zen2 zerknullt-related "CG1048, z2, zerknullt 2, BG:DS00276.10, zpr: zen-pattern-related, zen-pattern-related" CDMC33302 4 5 16 DAC25-L15 3-CG10504-RA_4 CG10504 CCCGGGATGCTACTTTGTCCCGTTTCAAGGGAATCAGTATGGGAGACCTAGACCTGCATACCAAGCTGT 69 FBan0010504 FBgn0028427 Ilk 3 3L MAPKKK cascade; GO:0000165; apposition of dorsal and ventral wing surfaces; GO:0007475; cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; cytoskeletal anchoring; GO:0007016; integrin-mediated signaling pathway; GO:0007229; muscle attachment; GO:0016203; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 focal adhesion; GO:0005925 Ilk Integrin linked kinase "CG10504, CG10504, CG10504, l(3)78Ca, DmILK, ILK, CT29478, ilk, integrin-linked kinase, Integrin linked kinase" CDMC33302 4 6 16 DAC25-L15 3-CG10504-RA_4 CG10504 CCCGGGATGCTACTTTGTCCCGTTTCAAGGGAATCAGTATGGGAGACCTAGACCTGCATACCAAGCTGT 69 FBan0010504 FBgn0028427 Ilk 3 3L MAPKKK cascade; GO:0000165; apposition of dorsal and ventral wing surfaces; GO:0007475; cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; cytoskeletal anchoring; GO:0007016; integrin-mediated signaling pathway; GO:0007229; muscle attachment; GO:0016203; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 focal adhesion; GO:0005925 Ilk Integrin linked kinase "CG10504, CG10504, CG10504, l(3)78Ca, DmILK, ILK, CT29478, ilk, integrin-linked kinase, Integrin linked kinase" CDMC33303 4 7 16 DAC25-P03 23-CG10537-RB_1 CG10537 ATTTTAACTAGCGATATGAAAATGCAGAGGCAGGAGAGTTTATGGTTTAATACAATTGCGGGAAGGACA 69 FBan0010537 FBgn0004244 Rdl 3 3L anion transport; GO:0006820; negative regulation of synaptic transmission; GO:0050805; nerve-nerve synaptic transmission; GO:0007270; response to cyclodiene; GO:0046682; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Rdl Resistant to dieldrin "CG10537, CG10537, GABA[[A]], GABA receptor, GABA[[A]] receptor, LCCH1, GABA, RDL, resistance to dieldrin, DmRDL, DmRdl, gaba, GABAr: GABA receptor" CDMC33303 4 8 16 DAC25-P03 23-CG10537-RB_1 CG10537 ATTTTAACTAGCGATATGAAAATGCAGAGGCAGGAGAGTTTATGGTTTAATACAATTGCGGGAAGGACA 69 FBan0010537 FBgn0004244 Rdl 3 3L anion transport; GO:0006820; negative regulation of synaptic transmission; GO:0050805; nerve-nerve synaptic transmission; GO:0007270; response to cyclodiene; GO:0046682; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Rdl Resistant to dieldrin "CG10537, CG10537, GABA[[A]], GABA receptor, GABA[[A]] receptor, LCCH1, GABA, RDL, resistance to dieldrin, DmRDL, DmRdl, gaba, GABAr: GABA receptor" CDMC33304 4 9 16 DAC25-P15 16-CG10543-RA_1 CG10543 CGGAAACAGGAAAACAGGAAACGGAATACGGAACAAGTTCGCTTAGATTGTAAGTTTAGGGGGGACGGT 69 FBan0010543 FBgn0034570 CG10543 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10543 CG10543 CDMC33304 4 10 16 DAC25-P15 16-CG10543-RA_1 CG10543 CGGAAACAGGAAAACAGGAAACGGAATACGGAACAAGTTCGCTTAGATTGTAAGTTTAGGGGGGACGGT 69 FBan0010543 FBgn0034570 CG10543 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10543 CG10543 CDMC33305 4 11 16 DAC26-D03 23-CG15304-RA_2 CG15304 CGAAGACCGATAGACCTCGATAGACTCAGTTGTATAACCTCTGCTCGCAAATATTTTTTACAGGCAACT 69 FBgn0040943 CDMC33305 4 12 16 DAC26-D03 23-CG15304-RA_2 CG15304 CGAAGACCGATAGACCTCGATAGACTCAGTTGTATAACCTCTGCTCGCAAATATTTTTTACAGGCAACT 69 FBgn0040943 CDMC33306 4 13 16 DAC26-D15 3-CG1531-RB_2 CG1531 GCCTCGAATTGATTCCCAGCATATTAGCGGATCCCATTGCTCTGCTGCTCAAGTTTATCCTGCTGGCGC 69 FBan0001531 FBgn0029985 CG1531 X X CG1531 CG1531 CDMC33306 4 14 16 DAC26-D15 3-CG1531-RB_2 CG1531 GCCTCGAATTGATTCCCAGCATATTAGCGGATCCCATTGCTCTGCTGCTCAAGTTTATCCTGCTGGCGC 69 FBan0001531 FBgn0029985 CG1531 X X CG1531 CG1531 CDMC33307 4 15 16 DAC26-H03 15-CG15369-RA_2 CG15369 GCAACGTCCCAGGTGGTCTCTGGCTTTAAGAATGATTACTCTGTGGAGCTGATCGATAATCAGGGTGCT 69 FBan0015369 FBgn0030105 CG15369 X X cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG15369 CG15369 CDMC33307 4 16 16 DAC26-H03 15-CG15369-RA_2 CG15369 GCAACGTCCCAGGTGGTCTCTGGCTTTAAGAATGATTACTCTGTGGAGCTGATCGATAATCAGGGTGCT 69 FBan0015369 FBgn0030105 CG15369 X X cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 CG15369 CG15369 CDMC33308 4 17 16 DAC26-H15 17-CG15382-RA_1 CG15382 TGCGGCTCTCTTGTTGCTCCGCTACCAATACGATCGACAAGTGTGCAATAACATTATAACCTACACGGA 69 FBan0015382 FBgn0031393 CG15382 2 2L CG15382 CG15382 BcDNA:RE26473 CDMC33308 4 18 16 DAC26-H15 17-CG15382-RA_1 CG15382 TGCGGCTCTCTTGTTGCTCCGCTACCAATACGATCGACAAGTGTGCAATAACATTATAACCTACACGGA 69 FBan0015382 FBgn0031393 CG15382 2 2L CG15382 CG15382 BcDNA:RE26473 CDMC33309 4 19 16 DAC26-L03 1-CG15432-RA_1 CG15432 TGTCCGACGAGTACGCCTGCGTGGCCAAGGGCAAGCTTAAACTAAAGAACGATTCGGATCTCAAGAAGA 69 FBan0015432 FBgn0031603 CG15432 2 2L CG15432 CG15432 CDMC33309 4 20 16 DAC26-L03 1-CG15432-RA_1 CG15432 TGTCCGACGAGTACGCCTGCGTGGCCAAGGGCAAGCTTAAACTAAAGAACGATTCGGATCTCAAGAAGA 69 FBan0015432 FBgn0031603 CG15432 2 2L CG15432 CG15432 CDMC33310 4 21 16 DAC26-L15 2-CG15444-RA_2 CG15444 GCACGGGAAGACTGTCGAAGAACGTCAAGCAAATGACCGGAAAGGCGCCTTCGTTCTATCTCAGATCCT 69 FBan0015444 FBgn0011603 ine 2 2L extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328; ; GO:0005328; ; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ine inebriated "CG15444, CG15444, ine/rosA, rosA, inebriated" CDMC33310 4 22 16 DAC26-L15 2-CG15444-RA_2 CG15444 GCACGGGAAGACTGTCGAAGAACGTCAAGCAAATGACCGGAAAGGCGCCTTCGTTCTATCTCAGATCCT 69 FBan0015444 FBgn0011603 ine 2 2L extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328; ; GO:0005328; ; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ine inebriated "CG15444, CG15444, ine/rosA, rosA, inebriated" CDMC33311 4 23 16 DAC26-P03 22-CG15477-RA_1 CG15477 GCATCGCTTGCCAAAATCCGCATTAAATTTATGCACTTTTGTTGTTACGGGCAAACGTAGCCGGAATGT 69 FBan0015477 FBgn0032865 CG15477 2 2L CG15477 CG15477 CDMC33311 4 24 16 DAC26-P03 22-CG15477-RA_1 CG15477 GCATCGCTTGCCAAAATCCGCATTAAATTTATGCACTTTTGTTGTTACGGGCAAACGTAGCCGGAATGT 69 FBan0015477 FBgn0032865 CG15477 2 2L CG15477 CG15477 CDMC33312 4 25 16 DAC26-P15 3-CG15489-RA_1 CG15489 AGCTCCTTCAGCAACATGTGGCCAACAGTTCACCACTGCAACATCTGAGCAATCTGTTTGGCCAACATT 69 FBan0015489 FBgn0032438 CG15489 2 2L CG15489 CG15489 CDMC33312 4 26 16 DAC26-P15 3-CG15489-RA_1 CG15489 AGCTCCTTCAGCAACATGTGGCCAACAGTTCACCACTGCAACATCTGAGCAATCTGTTTGGCCAACATT 69 FBan0015489 FBgn0032438 CG15489 2 2L CG15489 CG15489 CDMC33313 4 1 17 DAC27-D03 3-CG9766-RB_1 CG9766 GGCGGCTTTGGATGGTGTTGGCAAAACTTGCACTGACTTGGCGAAACTTTATCACAGACAGGAGGCAAA 69 FBan0009766 FBgn0037229 CG9766 3 3R CG9766 CG9766 CDMC33313 4 2 17 DAC27-D03 3-CG9766-RB_1 CG9766 GGCGGCTTTGGATGGTGTTGGCAAAACTTGCACTGACTTGGCGAAACTTTATCACAGACAGGAGGCAAA 69 FBan0009766 FBgn0037229 CG9766 3 3R CG9766 CG9766 CDMC33314 4 3 17 DAC27-D15 23-CG9778-RA_1 CG9778 TTTGTCTAAAGCAGAGGTCTGTGTTTGTGATTTGTTTTTACAAGGTCGATGCCAAATGACGACTGCTGT 69 FBan0009778 FBgn0037233 CG9778 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG9778 CG9778 CDMC33314 4 4 17 DAC27-D15 23-CG9778-RA_1 CG9778 TTTGTCTAAAGCAGAGGTCTGTGTTTGTGATTTGTTTTTACAAGGTCGATGCCAAATGACGACTGCTGT 69 FBan0009778 FBgn0037233 CG9778 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG9778 CG9778 CDMC33315 4 5 17 DAC27-H03 9-CG9821-RA_2 CG9821 CGCCCTTGGTAACTGCACATTCCAACAGTATTGCCAGCAGTACAAATAACGCCCAATTCCTGAGCTCCT 69 FBan0009821 FBgn0037636 CG9821 3 3R CG9821 CG9821 "CG31442, anon-WO0118547.399, anon-WO0118547.424" CDMC33315 4 6 17 DAC27-H03 9-CG9821-RA_2 CG9821 CGCCCTTGGTAACTGCACATTCCAACAGTATTGCCAGCAGTACAAATAACGCCCAATTCCTGAGCTCCT 69 FBan0009821 FBgn0037636 CG9821 3 3R CG9821 CG9821 "CG31442, anon-WO0118547.399, anon-WO0118547.424" CDMC33316 4 7 17 DAC27-H15 3-CG9839-RA_2 CG9839 GGGAGGAGAGCTCAAGTCCAATCCCACAACTGCCGAAGAAATGGAAATCTTTATGGCGCTTTCCCTGCT 69 FBan0009839 FBgn0037633 CG9839 3 3R CG9839 CG9839 CDMC33316 4 8 17 DAC27-H15 3-CG9839-RA_2 CG9839 GGGAGGAGAGCTCAAGTCCAATCCCACAACTGCCGAAGAAATGGAAATCTTTATGGCGCTTTCCCTGCT 69 FBan0009839 FBgn0037633 CG9839 3 3R CG9839 CG9839 CDMC33317 4 9 17 DAC27-L03 16-CG9878-RB_1 CG9878 CTGGCACCCATTAACCCACATTTCCGCTTAACCAATGTGCATTTTTGAAGCGCTACGATTGTTAGAGGT 69 FBan0009878 FBgn0027360 Tim10 2 2R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim10 Tim10 "CG9878, CG9878, tim10, bs31d12.y1" CDMC33317 4 10 17 DAC27-L03 16-CG9878-RB_1 CG9878 CTGGCACCCATTAACCCACATTTCCGCTTAACCAATGTGCATTTTTGAAGCGCTACGATTGTTAGAGGT 69 FBan0009878 FBgn0027360 Tim10 2 2R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim10 Tim10 "CG9878, CG9878, tim10, bs31d12.y1" CDMC33318 4 11 17 DAC27-L15 3-CG9887-RA_2 CG9887 CGCCTACGGGGTGTTCGGAATCATATGGTACATGTTCTGGATATGGTTGTGCTTCGAGAACCCGCGCAA 69 FBan0009887 FBgn0031424 VGlut 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021; integral to synaptic vesicle membrane; GO:0030285; synaptic vesicle; GO:0008021 VGlut Vesicular glutamate transporter "CG9887, CG9887, DVGLUT, Vesicular glutamate transporter" CDMC33318 4 12 17 DAC27-L15 3-CG9887-RA_2 CG9887 CGCCTACGGGGTGTTCGGAATCATATGGTACATGTTCTGGATATGGTTGTGCTTCGAGAACCCGCGCAA 69 FBan0009887 FBgn0031424 VGlut 2 2L cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021; integral to synaptic vesicle membrane; GO:0030285; synaptic vesicle; GO:0008021 VGlut Vesicular glutamate transporter "CG9887, CG9887, DVGLUT, Vesicular glutamate transporter" CDMC33319 4 13 17 DAC27-P03 3-CG9925-RA_4 CG9925 CGCCTTTTCCTGCCGACGTGACAAGTACAAAGTCAGCTTCCCACGTTCTGCCCATTAAACGCTTCCTTT 69 FBan0009925 FBgn0038191 CG9925 3 3R CG9925 CG9925 CDMC33319 4 14 17 DAC27-P03 3-CG9925-RA_4 CG9925 CGCCTTTTCCTGCCGACGTGACAAGTACAAAGTCAGCTTCCCACGTTCTGCCCATTAAACGCTTCCTTT 69 FBan0009925 FBgn0038191 CG9925 3 3R CG9925 CG9925 CDMC33320 4 15 17 DAC27-P15 9-CG9945-RA_1 CG9945 TCCGGTAAAGCGATCACATAGCTCGGATCATGACAAAAAGCCCCTGAGAAGATCACGACGTTTGGCGAA 69 FBan0009945 FBgn0034527 CG9945 2 2R CG9945 CG9945 CDMC33320 4 16 17 DAC27-P15 9-CG9945-RA_1 CG9945 TCCGGTAAAGCGATCACATAGCTCGGATCATGACAAAAAGCCCCTGAGAAGATCACGACGTTTGGCGAA 69 FBan0009945 FBgn0034527 CG9945 2 2R CG9945 CG9945 CDMC33321 4 17 17 DAC28-D03 15-CG11841-RA_1 CG11841 GTCCAGTGCTGGCCTATCACAAGGATCTCGCCTGCATGTACCACGTAATGGGCATCACCTCAGCC 65 FBan0011841 FBgn0039628 CG11841 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11841 CG11841 "SP45, anon-WO0140519.18, anon-WO0140519.6, BcDNA:GH26583" CDMC33321 4 18 17 DAC28-D03 15-CG11841-RA_1 CG11841 GTCCAGTGCTGGCCTATCACAAGGATCTCGCCTGCATGTACCACGTAATGGGCATCACCTCAGCC 65 FBan0011841 FBgn0039628 CG11841 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11841 CG11841 "SP45, anon-WO0140519.18, anon-WO0140519.6, BcDNA:GH26583" CDMC33322 4 19 17 DAC28-D15 23-CG11876-RB_1 CG11876 CCCATAGCCCATTTTTAGTTAGATAATAGCACTTAAAACCCAAAAAATAACACCTACAGCCGGCA 65 FBan0011876 FBgn0039635 CG11876 3 3R "pyruvate metabolism; GO:0006090; regulation of transcription, DNA-dependent; GO:0006355; tricarboxylic acid cycle; GO:0006099" pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; transcription factor activity; GO:0003700; ; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1; ; GO:0003700 pyruvate dehydrogenase complex; GO:0045254 CG11876 CG11876 CDMC33322 4 20 17 DAC28-D15 23-CG11876-RB_1 CG11876 CCCATAGCCCATTTTTAGTTAGATAATAGCACTTAAAACCCAAAAAATAACACCTACAGCCGGCA 65 FBan0011876 FBgn0039635 CG11876 3 3R "pyruvate metabolism; GO:0006090; regulation of transcription, DNA-dependent; GO:0006355; tricarboxylic acid cycle; GO:0006099" pyruvate dehydrogenase (acetyl-transferring) activity; GO:0004739 ; EC:1.2.4.1; transcription factor activity; GO:0003700; ; GO:0004739 ; EC:1.2.4.1; ; GO:0004739 ; EC:1.2.4.1; ; GO:0003700 pyruvate dehydrogenase complex; GO:0045254 CG11876 CG11876 CDMC33323 4 21 17 DAC28-H03 2-CG12002-RB_1 CG12002 CACATCTCTGGATCAGTCGTGGTGCAGTACCCACATAGAGTCCCCTTTCAGGCCACACTCCATCG 65 FBan0012002 FBgn0011828 Pxn 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 extracellular matrix (sensu Metazoa); GO:0005578 Pxn Peroxidasin "CG12002, CG12002, Protein X, peroxidasin, CT1239, pxn, Dpxn" CDMC33323 4 22 17 DAC28-H03 2-CG12002-RB_1 CG12002 CACATCTCTGGATCAGTCGTGGTGCAGTACCCACATAGAGTCCCCTTTCAGGCCACACTCCATCG 65 FBan0012002 FBgn0011828 Pxn 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 extracellular matrix (sensu Metazoa); GO:0005578 Pxn Peroxidasin "CG12002, CG12002, Protein X, peroxidasin, CT1239, pxn, Dpxn" CDMC33324 4 23 17 DAC28-H15 1-CG12021-RC_1 CG12021 CTCCCTAGACGGCTCCACGAAGATCATACCCACGGAAGTTGTACCCTTGGCGGATAAAACGGAGG 65 FBgn0024246 CDMC33324 4 24 17 DAC28-H15 1-CG12021-RC_1 CG12021 CTCCCTAGACGGCTCCACGAAGATCATACCCACGGAAGTTGTACCCTTGGCGGATAAAACGGAGG 65 FBgn0024246 CDMC33325 4 25 17 DAC28-L03 2-CG12120-RA_1 CG12120 GTTGGCATCTTCGATCTCAGTGCCAGGACCATTTCCCTGTATTCCGACAATCCCAGCGAGACGGA 65 FBan0012120 FBgn0030106 CG12120 X X CG12120 CG12120 CDMC33325 4 26 17 DAC28-L03 2-CG12120-RA_1 CG12120 GTTGGCATCTTCGATCTCAGTGCCAGGACCATTTCCCTGTATTCCGACAATCCCAGCGAGACGGA 65 FBan0012120 FBgn0030106 CG12120 X X CG12120 CG12120 CDMC33326 4 1 18 DAC28-L15 3-CG1213-RB_2 CG1213 TTCTTCGTCCTCTTCGTGGTGATGGAGACAAAGGGGCTTAGTTTGCAGCAGATCCAGGATCGCCT 65 FBan0001213 FBgn0037387 CG1213 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1213 CG1213 CT30783 CDMC33326 4 2 18 DAC28-L15 3-CG1213-RB_2 CG1213 TTCTTCGTCCTCTTCGTGGTGATGGAGACAAAGGGGCTTAGTTTGCAGCAGATCCAGGATCGCCT 65 FBan0001213 FBgn0037387 CG1213 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1213 CG1213 CT30783 CDMC33327 4 3 18 DAC28-P03 23-CG12203-RA_1 CG12203 AATCGAAAAGCGCTTGTGTTCCAAATTTTACGTAATTCGTATTTTGAAGCCGATTTCTGCCGTGT 65 FBan0012203 FBgn0031021 CG12203 X X "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; oxidative phosphorylation; GO:0006119" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12203 CG12203 CDMC33327 4 4 18 DAC28-P03 23-CG12203-RA_1 CG12203 AATCGAAAAGCGCTTGTGTTCCAAATTTTACGTAATTCGTATTTTGAAGCCGATTTCTGCCGTGT 65 FBan0012203 FBgn0031021 CG12203 X X "electron transport; GO:0006118; mitochondrial electron transport, NADH to ubiquinone; GO:0006120; oxidative phosphorylation; GO:0006119" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG12203 CG12203 CDMC33328 4 5 18 DAC28-P15 3-CG12252-RA_3 CG12252 GTTAACGCCGCCAAAAAAGAGCCTGCCATTAAAGTGGTCAATGCGAATTGGTTGTGGACCTGCGC 65 FBan0012252 FBgn0035026 CG12252 2 2R transcription initiation from RNA polymerase II promoter; GO:0006367 CTD phosphatase activity; GO:0008420; ; GO:0008420 intracellular; GO:0005622 CG12252 CG12252 CDMC33328 4 6 18 DAC28-P15 3-CG12252-RA_3 CG12252 GTTAACGCCGCCAAAAAAGAGCCTGCCATTAAAGTGGTCAATGCGAATTGGTTGTGGACCTGCGC 65 FBan0012252 FBgn0035026 CG12252 2 2R transcription initiation from RNA polymerase II promoter; GO:0006367 CTD phosphatase activity; GO:0008420; ; GO:0008420 intracellular; GO:0005622 CG12252 CG12252 CDMC33329 4 7 18 DAC29-D03 22-CG3095-RA_3 CG3095 GCTACCCCAAAGACTGCCGGACAACACATTTATGCTCAATATCACAAACAACAAGATAACCAGCCTGGG 69 FBgn0023532 CDMC33329 4 8 18 DAC29-D03 22-CG3095-RA_3 CG3095 GCTACCCCAAAGACTGCCGGACAACACATTTATGCTCAATATCACAAACAACAAGATAACCAGCCTGGG 69 FBgn0023532 CDMC33330 4 9 18 DAC29-D15 23-CG31005-RA_4 CG31005 AGCCTGCTCTACACTGAAAGAAAGGCAAATGAAAGATATAATGCAGAAATTTGCTGGCTAGTTAATCAA 69 FBan0031005 FBgn0051005 CG31005 3 3R isoprenoid biosynthesis; GO:0008299 trans-hexaprenyltranstransferase activity; GO:0000010 ; EC:2.5.1.30; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0000010 ; EC:2.5.1.30 CG31005 CG31005 "CG15565, CG3684, anon-WO0118547.422" CDMC33330 4 10 18 DAC29-D15 23-CG31005-RA_4 CG31005 AGCCTGCTCTACACTGAAAGAAAGGCAAATGAAAGATATAATGCAGAAATTTGCTGGCTAGTTAATCAA 69 FBan0031005 FBgn0051005 CG31005 3 3R isoprenoid biosynthesis; GO:0008299 trans-hexaprenyltranstransferase activity; GO:0000010 ; EC:2.5.1.30; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0000010 ; EC:2.5.1.30 CG31005 CG31005 "CG15565, CG3684, anon-WO0118547.422" CDMC33331 4 11 18 DAC29-H03 3-CG31028-RB_6 CG31028 GGTGGAAATCACCCAGCAATCGGAGTATGATGTCAGCAATGTGGAGGTGCAACTTAAGGGGCTTCAGGA 69 FBan0031028 FBgn0051028 CG31028 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG31028 CG31028 CG2176 CDMC33331 4 12 18 DAC29-H03 3-CG31028-RB_6 CG31028 GGTGGAAATCACCCAGCAATCGGAGTATGATGTCAGCAATGTGGAGGTGCAACTTAAGGGGCTTCAGGA 69 FBan0031028 FBgn0051028 CG31028 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG31028 CG31028 CG2176 CDMC33332 4 13 18 DAC29-H15 3-CG31037-RA_3 CG31037 GGAGCTTCGTTTCCGGTTCAGATCCTGGATCCTCTGAAATTTCGTTCAACACGCATCAGTTGAGGGCCC 69 FBgn0051037 CDMC33332 4 14 18 DAC29-H15 3-CG31037-RA_3 CG31037 GGAGCTTCGTTTCCGGTTCAGATCCTGGATCCTCTGAAATTTCGTTCAACACGCATCAGTTGAGGGCCC 69 FBgn0051037 CDMC33333 4 15 18 DAC29-L03 17-CG31064-RB_6 CG31064 CAATCTGCAGGCCAAAGTAGAGTCCTTAACGACCACAAATGCCCTGATGAAAGAGGATTTGGCAATCGC 69 FBan0031064 FBgn0051064 CG31064 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 zinc ion binding; GO:0008270; ; GO:0008270 CG31064 CG31064 "CG6001, CG14261, CG6001" CDMC33333 4 16 18 DAC29-L03 17-CG31064-RB_6 CG31064 CAATCTGCAGGCCAAAGTAGAGTCCTTAACGACCACAAATGCCCTGATGAAAGAGGATTTGGCAATCGC 69 FBan0031064 FBgn0051064 CG31064 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 zinc ion binding; GO:0008270; ; GO:0008270 CG31064 CG31064 "CG6001, CG14261, CG6001" CDMC33334 4 17 18 DAC29-L15 23-CG31072-RA_4 CG31072 TACCCTTCGTATGTAAAGGAGAATCCCCAACCTAACCCGTACCTATAGCTATAGTTAAATGCGGCCTGC 69 FBan0031072 FBgn0051072 Lerp 3 3R lysosomal transport; GO:0007041; post-Golgi transport; GO:0006892; transport; GO:0006810 transporter activity; GO:0005215; protein binding; GO:0005515; receptor activity; GO:0004872; ; GO:0005215; ; GO:0004872; ; GO:0005515 cytoplasm; GO:0005737; lysosome; GO:0005764; membrane; GO:0016020 Lerp Lerp "CG6396, CG31072, CG6390, CG14256, CG14255, CG6396, LERP, anon-WO0118547.383" CDMC33334 4 18 18 DAC29-L15 23-CG31072-RA_4 CG31072 TACCCTTCGTATGTAAAGGAGAATCCCCAACCTAACCCGTACCTATAGCTATAGTTAAATGCGGCCTGC 69 FBan0031072 FBgn0051072 Lerp 3 3R lysosomal transport; GO:0007041; post-Golgi transport; GO:0006892; transport; GO:0006810 transporter activity; GO:0005215; protein binding; GO:0005515; receptor activity; GO:0004872; ; GO:0005215; ; GO:0004872; ; GO:0005515 cytoplasm; GO:0005737; lysosome; GO:0005764; membrane; GO:0016020 Lerp Lerp "CG6396, CG31072, CG6390, CG14256, CG14255, CG6396, LERP, anon-WO0118547.383" CDMC33335 4 19 18 DAC29-P03 2-CG31100-RA_5 CG31100 GGTCACTTTTCCGGAAAGACACCGCTGCAAACATATGCCGTTCAGATTTTCCACACCCTCAAGGCTCCG 69 FBan0031100 FBgn0051100 CG31100 3 3R carbohydrate metabolism; GO:0005975; monosaccharide transport; GO:0015749 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021 CG31100 CG31100 "CG11976, CG11978" CDMC33335 4 20 18 DAC29-P03 2-CG31100-RA_5 CG31100 GGTCACTTTTCCGGAAAGACACCGCTGCAAACATATGCCGTTCAGATTTTCCACACCCTCAAGGCTCCG 69 FBan0031100 FBgn0051100 CG31100 3 3R carbohydrate metabolism; GO:0005975; monosaccharide transport; GO:0015749 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021 CG31100 CG31100 "CG11976, CG11978" CDMC33336 4 21 18 DAC29-P15 9-CG31107-RA_1 CG31107 CGCCAGAGGCACTGTGACTCCTGGTCAACTGAAATCACGGCTAGAGACTTTGAAGCGCTTATCCATCAA 69 FBan0031107 FBgn0051107 5PtaseI 3 3R inositol phosphate dephosphorylation; GO:0046855 inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0004445 ; EC:3.1.3.56 5PtaseI 5PtaseI "CG31107, CG7613, CG31107, dm5PtaseI" CDMC33336 4 22 18 DAC29-P15 9-CG31107-RA_1 CG31107 CGCCAGAGGCACTGTGACTCCTGGTCAACTGAAATCACGGCTAGAGACTTTGAAGCGCTTATCCATCAA 69 FBan0031107 FBgn0051107 5PtaseI 3 3R inositol phosphate dephosphorylation; GO:0046855 inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0004445 ; EC:3.1.3.56 5PtaseI 5PtaseI "CG31107, CG7613, CG31107, dm5PtaseI" CDMC33337 4 23 18 DAC30-D03 17-CG2025-RA_1 CG2025 TGTTATAAGCATTGACGGCGATAACATGAGAAAGCTATCCGTGCAGGTGATTGGCCATCGACCAG 65 FBan0002025 FBgn0030344 CG2025 X X proteolysis; GO:0006508 nardilysin activity; GO:0016919 ; EC:3.4.24.61; ; GO:0016919 ; EC:3.4.24.61 CG2025 CG2025 CDMC33337 4 24 18 DAC30-D03 17-CG2025-RA_1 CG2025 TGTTATAAGCATTGACGGCGATAACATGAGAAAGCTATCCGTGCAGGTGATTGGCCATCGACCAG 65 FBan0002025 FBgn0030344 CG2025 X X proteolysis; GO:0006508 nardilysin activity; GO:0016919 ; EC:3.4.24.61; ; GO:0016919 ; EC:3.4.24.61 CG2025 CG2025 CDMC33338 4 25 18 DAC30-D15 3-CG2087-RA_1 CG2087 CCAAGGATTTCGCTGTCAATTACCCGCAGCAGTACGACTTGCTCCAGCAAATGCTATCCGCCCAG 65 FBan0002087 FBgn0037327 PEK 3 3R ER overload response; GO:0006983; electron transport; GO:0006118; negative regulation of protein biosynthesis; GO:0017148; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412; response to unfolded protein; GO:0006986 ATP binding; GO:0005524; ; GO:0005524; eukaryotic elongation factor-2 kinase activity; GO:0004686 ; EC:2.7.1.-; ; GO:0004686 ; EC:2.7.1.-; ; GO:0004686 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; translation initiation factor activity; GO:0003743; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003743; ; GO:0004686 ; EC:2.7.1.- endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 PEK PEK "CG2087, CG2087, CG2087, DmPEK, PERK, Perk, EIF2-like, DPERK" CDMC33338 4 26 18 DAC30-D15 3-CG2087-RA_1 CG2087 CCAAGGATTTCGCTGTCAATTACCCGCAGCAGTACGACTTGCTCCAGCAAATGCTATCCGCCCAG 65 FBan0002087 FBgn0037327 PEK 3 3R ER overload response; GO:0006983; electron transport; GO:0006118; negative regulation of protein biosynthesis; GO:0017148; protein amino acid phosphorylation; GO:0006468; protein biosynthesis; GO:0006412; response to unfolded protein; GO:0006986 ATP binding; GO:0005524; ; GO:0005524; eukaryotic elongation factor-2 kinase activity; GO:0004686 ; EC:2.7.1.-; ; GO:0004686 ; EC:2.7.1.-; ; GO:0004686 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; translation initiation factor activity; GO:0003743; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0003743; ; GO:0004686 ; EC:2.7.1.- endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 PEK PEK "CG2087, CG2087, CG2087, DmPEK, PERK, Perk, EIF2-like, DPERK" CDMC33339 4 1 19 DAC30-H03 15-CG2224-RA_4 CG2224 ACCACGAGAACGCATTCATCCTGTACTTGCGCTACATGACCCTCTTCATCGAGAAGATCCGCCAG 65 FBan0002224 FBgn0039773 CG2224 3 3R CG2224 CG2224 CDMC33339 4 2 19 DAC30-H03 15-CG2224-RA_4 CG2224 ACCACGAGAACGCATTCATCCTGTACTTGCGCTACATGACCCTCTTCATCGAGAAGATCCGCCAG 65 FBan0002224 FBgn0039773 CG2224 3 3R CG2224 CG2224 CDMC33340 4 3 19 DAC30-H15 23-CG2258-RA_3 CG2258 CTTGGCCTTCAATCAGCAATTTAGCGAACATACCTATAATGTCATCATCGAAGGTATGCAGAATC 65 FBan0002258 FBgn0029997 CG2258 X X CG2258 CG2258 CDMC33340 4 4 19 DAC30-H15 23-CG2258-RA_3 CG2258 CTTGGCCTTCAATCAGCAATTTAGCGAACATACCTATAATGTCATCATCGAAGGTATGCAGAATC 65 FBan0002258 FBgn0029997 CG2258 X X CG2258 CG2258 CDMC33341 4 5 19 DAC30-L03 6-CG2692-RA_2 CG2692 CACACCATCACACACAGATGGGTGGCTACGATTTGGTCCAAAGTGCGGCTCAACACGGATTTCCC 65 FBan0002692 FBgn0001147 gsb-n 2 2R ectoderm development; GO:0007398; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 gsb-n gooseberry-neuro "CG2692, gsb-p: gooseberry proximal, gsb, BSH4, BSH-4, Gsb-p, gsbn: gooseberry-neuro, gooseberry neuro, gsb-neuro, gooseberry, gsbp, gooseberry proximal, gooseberry-neuro, gsb-p, gsbn" CDMC33341 4 6 19 DAC30-L03 6-CG2692-RA_2 CG2692 CACACCATCACACACAGATGGGTGGCTACGATTTGGTCCAAAGTGCGGCTCAACACGGATTTCCC 65 FBan0002692 FBgn0001147 gsb-n 2 2R ectoderm development; GO:0007398; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 gsb-n gooseberry-neuro "CG2692, gsb-p: gooseberry proximal, gsb, BSH4, BSH-4, Gsb-p, gsbn: gooseberry-neuro, gooseberry neuro, gsb-neuro, gooseberry, gsbp, gooseberry proximal, gooseberry-neuro, gsb-p, gsbn" CDMC33342 4 7 19 DAC30-L15 21-CG2808-RA_1 CG2808 CGACTCCCGTGAATCCTCGCCAGACATAACGGGTGAAATAGACGATGACATGGATGACTTGCCGC 65 FBan0002808 FBgn0031556 CG2808 2 2L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG2808 CG2808 CDMC33342 4 8 19 DAC30-L15 21-CG2808-RA_1 CG2808 CGACTCCCGTGAATCCTCGCCAGACATAACGGGTGAAATAGACGATGACATGGATGACTTGCCGC 65 FBan0002808 FBgn0031556 CG2808 2 2L "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG2808 CG2808 CDMC33343 4 9 19 DAC30-P03 13-CG2929-RA_1 CG2929 CGAAGATGAACCCTCGTCGAGATCCCCCCCTACGTCGGAACCCGATTGGAATGTGGTGAACTCGG 65 FBan0002929 FBgn0037339 Pi4KIIalpha 3 3R phosphoinositide phosphorylation; GO:0046854 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 Pi4KIIalpha Pi4KIIalpha "CG2929, CG2929" CDMC33343 4 10 19 DAC30-P03 13-CG2929-RA_1 CG2929 CGAAGATGAACCCTCGTCGAGATCCCCCCCTACGTCGGAACCCGATTGGAATGTGGTGAACTCGG 65 FBan0002929 FBgn0037339 Pi4KIIalpha 3 3R phosphoinositide phosphorylation; GO:0046854 1-phosphatidylinositol 4-kinase activity; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67; ; GO:0004430 ; EC:2.7.1.67 Pi4KIIalpha Pi4KIIalpha "CG2929, CG2929" CDMC33344 4 11 19 DAC30-P15 2-CG2977-RA_1 CG2977 GTGCCCTTTGTCCTGTTCTTCCAGGCTCTCTGCTTCTACATTCCCCATGCCCTGTGGAAGAGTTG 65 FBan0002977 FBgn0027106 inx7 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; gap-junction forming channel activity; GO:0005243; ; GO:0015286; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 inx7 innexin 7 "CG2977, CG32731, prp7, pas related protein 7, Dm-inx7, D-inx-7, innexin 7, innexin7" CDMC33344 4 12 19 DAC30-P15 2-CG2977-RA_1 CG2977 GTGCCCTTTGTCCTGTTCTTCCAGGCTCTCTGCTTCTACATTCCCCATGCCCTGTGGAAGAGTTG 65 FBan0002977 FBgn0027106 inx7 X X signal transduction; GO:0007165 innexin channel activity; GO:0015286; gap-junction forming channel activity; GO:0005243; ; GO:0015286; ; GO:0005243 gap junction; GO:0005921; integral to membrane; GO:0016021 inx7 innexin 7 "CG2977, CG32731, prp7, pas related protein 7, Dm-inx7, D-inx-7, innexin 7, innexin7" CDMC33345 4 13 19 DAC31-D03 3-CG31926-RA_1 CG31926 GCCGAAATCACCAATGCACCAGAGACCGCATTTCTGAAGTCCCAGCTCGATGGAATTTTGGGATTGGG 68 FBan0031926 FBgn0051926 CG31926 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31926 CG31926 CG10872 CDMC33345 4 14 19 DAC31-D03 3-CG31926-RA_1 CG31926 GCCGAAATCACCAATGCACCAGAGACCGCATTTCTGAAGTCCCAGCTCGATGGAATTTTGGGATTGGG 68 FBan0031926 FBgn0051926 CG31926 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31926 CG31926 CG10872 CDMC33346 4 15 19 DAC31-D15 1-CG32079-RA_1 CG32079 GCTGGTGGCAATTCAGTATCCGGATTTTGGCCTCTTGCTATCCTTGGTGGGATCCTTTTGTTTGGCCC 68 FBan0032079 FBgn0052079 CG32079 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG32079 CG32079 "CG11806, CG11806" CDMC33346 4 16 19 DAC31-D15 1-CG32079-RA_1 CG32079 GCTGGTGGCAATTCAGTATCCGGATTTTGGCCTCTTGCTATCCTTGGTGGGATCCTTTTGTTTGGCCC 68 FBan0032079 FBgn0052079 CG32079 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG32079 CG32079 "CG11806, CG11806" CDMC33347 4 17 19 DAC31-H03 1-CG32382-RA_1 CG32382 GCTGGGGAACTGATAAACGAAAGGTAAGGCTGCCCACATGGATGCGTTGCGTAGAAGTGGAGGTCATG 68 FBan0032382 FBgn0052382 CG32382 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG32382 CG32382 "CG8555, CG8555, SPH194" CDMC33347 4 18 19 DAC31-H03 1-CG32382-RA_1 CG32382 GCTGGGGAACTGATAAACGAAAGGTAAGGCTGCCCACATGGATGCGTTGCGTAGAAGTGGAGGTCATG 68 FBan0032382 FBgn0052382 CG32382 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG32382 CG32382 "CG8555, CG8555, SPH194" CDMC33348 4 19 19 DAC31-H15 2-CG32463-RA_3 CG32463 TACCAGATGGTCTGCCACTACGATCGTTTCTCTGCGACATCCGGGAGATTGAGCACTACGCAGGTCTC 68 FBan0032463 FBgn0052463 CG32463 2 2L DNA replication; GO:0006260; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG32463 CG32463 CG17006 CDMC33348 4 20 19 DAC31-H15 2-CG32463-RA_3 CG32463 TACCAGATGGTCTGCCACTACGATCGTTTCTCTGCGACATCCGGGAGATTGAGCACTACGCAGGTCTC 68 FBan0032463 FBgn0052463 CG32463 2 2L DNA replication; GO:0006260; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG32463 CG32463 CG17006 CDMC33349 4 21 19 DAC31-L03 2-CG3315-RA_1 CG3315 CCGCACACCAAACTGATGTTGATTTTGCAGCGAGCTTGATACACCATGCAGACTGAGCAAAGGGACGC 68 FBan0003315 FBgn0029752 TrxT X X electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Y chromosome; GO:0000806; nucleus; GO:0005634 TrxT Thioredoxin T "CG3315, CG3315, thioredoxin" CDMC33349 4 22 19 DAC31-L03 2-CG3315-RA_1 CG3315 CCGCACACCAAACTGATGTTGATTTTGCAGCGAGCTTGATACACCATGCAGACTGAGCAAAGGGACGC 68 FBan0003315 FBgn0029752 TrxT X X electron transport; GO:0006118; protein folding; GO:0006457; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Y chromosome; GO:0000806; nucleus; GO:0005634 TrxT Thioredoxin T "CG3315, CG3315, thioredoxin" CDMC33350 4 23 19 DAC31-L15 2-CG33332-RA_1 CG33332 GCACTTTCTATCAGGGAAAAGAGCGACCCGACTTTAGCGATCGATCATCCTGGACGAAGACCCCGCAG 68 FBan0033332 FBgn0067629 CG33332 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33332 CG33332 "CG3641, CG3641, BcDNA:RE07395" CDMC33350 4 24 19 DAC31-L15 2-CG33332-RA_1 CG33332 GCACTTTCTATCAGGGAAAAGAGCGACCCGACTTTAGCGATCGATCATCCTGGACGAAGACCCCGCAG 68 FBan0033332 FBgn0067629 CG33332 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33332 CG33332 "CG3641, CG3641, BcDNA:RE07395" CDMC33351 4 25 19 DAC31-P03 3-CG3588-RB_2 CG3588 GCACCTTCAGCGTGATCTATGACTGGATCAGCGGATTTTTCAACTCCTGCGTCTCACCCTGCACCTTG 68 FBan0003588 FBgn0025643 CG3588 X X CG3588 CG3588 EG:100G7.6 CDMC33351 4 26 19 DAC31-P03 3-CG3588-RB_2 CG3588 GCACCTTCAGCGTGATCTATGACTGGATCAGCGGATTTTTCAACTCCTGCGTCTCACCCTGCACCTTG 68 FBan0003588 FBgn0025643 CG3588 X X CG3588 CG3588 EG:100G7.6 CDMC33352 4 1 20 DAC31-P15 3-CG3725-RA_2 CG3725 TGCTGGCTGACGACAACTTCTCCTCCATCGTGTCTGCCGTTGAAGAAGGTCGCGCTATCTACAACAAC 68 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC33352 4 2 20 DAC31-P15 3-CG3725-RA_2 CG3725 TGCTGGCTGACGACAACTTCTCCTCCATCGTGTCTGCCGTTGAAGAAGGTCGCGCTATCTACAACAAC 68 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC33353 4 3 20 DAC32-D03 13-CG15779-RA_1 CG15779 CGGTGGCCACTTATGAACTAGTGCTCATTCAGTTTCACGAGGATAAAAAGACCTGGGACTGCTCACCCT 69 FBan0015779 FBgn0003747 Tre X X G-protein coupled receptor protein signaling pathway; GO:0007186; detection of chemical stimulus during sensory perception of taste; GO:0050912; sensory perception of sweet taste; GO:0050916; sensory perception of taste; GO:0050909 G-protein coupled receptor activity; GO:0004930; taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527; ; GO:0008527; ; GO:0004930; ; GO:0008527 integral to membrane; GO:0016021 Tre Trehalose-sensitivity "CG15779, CG15779, CG15779, CG15779, CG15779, LU.7, Gustatory receptor LU.7, Gr5A1, Gr5a, GrLU7, tre, GRLU.7" CDMC33353 4 4 20 DAC32-D03 13-CG15779-RA_1 CG15779 CGGTGGCCACTTATGAACTAGTGCTCATTCAGTTTCACGAGGATAAAAAGACCTGGGACTGCTCACCCT 69 FBan0015779 FBgn0003747 Tre X X G-protein coupled receptor protein signaling pathway; GO:0007186; detection of chemical stimulus during sensory perception of taste; GO:0050912; sensory perception of sweet taste; GO:0050916; sensory perception of taste; GO:0050909 G-protein coupled receptor activity; GO:0004930; taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527; ; GO:0008527; ; GO:0004930; ; GO:0008527 integral to membrane; GO:0016021 Tre Trehalose-sensitivity "CG15779, CG15779, CG15779, CG15779, CG15779, LU.7, Gustatory receptor LU.7, Gr5A1, Gr5a, GrLU7, tre, GRLU.7" CDMC33354 4 5 20 DAC32-D15 9-CG15804-RB_4 CG15804 ACGCTTTCTCAAGTTGCAGAAGGAGATCCGTACCACCTGTCGAGATTTGGCTATGGGAATCAAGGGCAT 69 FBan0015804 FBgn0013811 Dhc62B 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; nucleotide binding; GO:0000166; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc62B Dynein heavy chain at 62B "CG15804, CG18613, CG15804, CG18613, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC33354 4 6 20 DAC32-D15 9-CG15804-RB_4 CG15804 ACGCTTTCTCAAGTTGCAGAAGGAGATCCGTACCACCTGTCGAGATTTGGCTATGGGAATCAAGGGCAT 69 FBan0015804 FBgn0013811 Dhc62B 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; nucleotide binding; GO:0000166; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc62B Dynein heavy chain at 62B "CG15804, CG18613, CG15804, CG18613, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC33355 4 7 20 DAC32-H03 23-CG15862-RB_3 CG15862 TCACTTGCAGGCTTCTTAGGATTTTAATTTGTAACCATGTTTCTTTCTAATTGAGCAACTCTACGGACA 69 FBan0015862 FBgn0022382 Pka-R2 2 2R axon guidance; GO:0007411; behavioral response to cocaine; GO:0048148; behavioral response to ethanol; GO:0048149; circadian rhythm; GO:0007623; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0008603; ; GO:0008603; ; GO:0005515 cAMP-dependent protein kinase complex; GO:0005952; cytoplasm; GO:0005737 Pka-R2 cAMP-dependent protein kinase R2 "CG15862, CG15862, Cos-1, PKA, Cos, Costal, Costal-1, RII, pkA, PKA-RII, RII[[DR]], Pka-RII, pka-RII, Cos1, PKA RII, cAMP-dependent protein kinase type II, PKa-R2, BcDNA:GM01761, cos1: costal-1, Epa: Epaulette, Epaulette, costal-1, cAMP-dependent protein kinase R2" CDMC33355 4 8 20 DAC32-H03 23-CG15862-RB_3 CG15862 TCACTTGCAGGCTTCTTAGGATTTTAATTTGTAACCATGTTTCTTTCTAATTGAGCAACTCTACGGACA 69 FBan0015862 FBgn0022382 Pka-R2 2 2R axon guidance; GO:0007411; behavioral response to cocaine; GO:0048148; behavioral response to ethanol; GO:0048149; circadian rhythm; GO:0007623; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468; rhythmic behavior; GO:0007622; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; cAMP-dependent protein kinase regulator activity; GO:0008603; protein binding; GO:0005515; ; GO:0004702 ; EC:2.7.1.-; ; GO:0008603; ; GO:0008603; ; GO:0005515 cAMP-dependent protein kinase complex; GO:0005952; cytoplasm; GO:0005737 Pka-R2 cAMP-dependent protein kinase R2 "CG15862, CG15862, Cos-1, PKA, Cos, Costal, Costal-1, RII, pkA, PKA-RII, RII[[DR]], Pka-RII, pka-RII, Cos1, PKA RII, cAMP-dependent protein kinase type II, PKa-R2, BcDNA:GM01761, cos1: costal-1, Epa: Epaulette, Epaulette, costal-1, cAMP-dependent protein kinase R2" CDMC33356 4 9 20 DAC32-H15 23-CG15881-RA_1 CG15881 CAATAGGTGGAACAAATGCAATGACTAGTTTTAGGTGGATTTATTAGCAGAAGTCTCATGGAACTGCCA 69 FBan0015881 FBgn0036909 CG15881 3 3L CG15881 CG15881 BcDNA:HL01254 CDMC33356 4 10 20 DAC32-H15 23-CG15881-RA_1 CG15881 CAATAGGTGGAACAAATGCAATGACTAGTTTTAGGTGGATTTATTAGCAGAAGTCTCATGGAACTGCCA 69 FBan0015881 FBgn0036909 CG15881 3 3L CG15881 CG15881 BcDNA:HL01254 CDMC33357 4 11 20 DAC32-L03 23-CG15922-RA_1 CG15922 CAGGAAGTTCGACGGAATGACAAACCCTCTGGTGATGAGCTTAAGACATACAATCTATTTATTGTATAG 69 FBan0015922 FBgn0040575 CG15922 3 3R CG15922 CG15922 BcDNA:RH34302 CDMC33357 4 12 20 DAC32-L03 23-CG15922-RA_1 CG15922 CAGGAAGTTCGACGGAATGACAAACCCTCTGGTGATGAGCTTAAGACATACAATCTATTTATTGTATAG 69 FBan0015922 FBgn0040575 CG15922 3 3R CG15922 CG15922 BcDNA:RH34302 CDMC33358 4 13 20 DAC32-L15 4-CG1594-RA_1 CG1594 CCCCAAAAACCACTTGACGCAATCCTTGGCTTAAAGCGCTATCGGAAGAATCACATTGACCCCCAACCA 69 FBan0001594 FBgn0004864 hop X X JAK-STAT cascade; GO:0007259; STAT protein nuclear translocation; GO:0007262; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; cellular defense response; GO:0006968; cytokinesis; GO:0000910; defense response; GO:0006952; ectoderm development; GO:0007398; encapsulation of foreign target; GO:0035010; equator specification; GO:0045317; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; germ-line stem cell division; GO:0042078; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; hindgut morphogenesis; GO:0007442; humoral immune response; GO:0006959; immune response; GO:0006955; lamellocyte differentiation; GO:0035171; leg morphogenesis (sensu Endopterygota); GO:0007480; mesoderm development; GO:0007498; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; periodic partitioning; GO:0007365; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; primary sex determination; GO:0007538; protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; regulation of hemocyte differentiation; GO:0045610; sex determination; GO:0007530; somatic stem cell division; GO:0048103; stem cell maintenance; GO:0019827; tracheal system development (sensu Insecta); GO:0007424; tyrosine phosphorylation of STAT protein; GO:0007260; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; Janus kinase activity; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; metallopeptidase activity; GO:0008237; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; zinc ion binding; GO:0008270; ; GO:0004718 ; EC:2.7.1.-; ; GO:0008237; ; GO:0008270 cytoplasm; GO:0005737; cytoskeleton; GO:0005856 hop hopscotch "CG1594, CG1594, 4, locus 18, L4, l(1)hop, l(1)L4, Tum: Tumorous, l(1)10Be, Jak, Hop, Dm JAK, JAK, DmHD-160, Hop1, Jak/Stat, Jak-STAT, Tum-1, Hopskotch, JAK-STAT, HD-160, l(1)G18, msvl, Tumorous, Tum" CDMC33358 4 14 20 DAC32-L15 4-CG1594-RA_1 CG1594 CCCCAAAAACCACTTGACGCAATCCTTGGCTTAAAGCGCTATCGGAAGAATCACATTGACCCCCAACCA 69 FBan0001594 FBgn0004864 hop X X JAK-STAT cascade; GO:0007259; STAT protein nuclear translocation; GO:0007262; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; cellular defense response; GO:0006968; cytokinesis; GO:0000910; defense response; GO:0006952; ectoderm development; GO:0007398; encapsulation of foreign target; GO:0035010; equator specification; GO:0045317; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; germ-line stem cell division; GO:0042078; hemocyte differentiation (sensu Arthropoda); GO:0042386; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; hindgut morphogenesis; GO:0007442; humoral immune response; GO:0006959; immune response; GO:0006955; lamellocyte differentiation; GO:0035171; leg morphogenesis (sensu Endopterygota); GO:0007480; mesoderm development; GO:0007498; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; periodic partitioning; GO:0007365; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; primary sex determination; GO:0007538; protein amino acid phosphorylation; GO:0006468; proteolysis; GO:0006508; regulation of hemocyte differentiation; GO:0045610; sex determination; GO:0007530; somatic stem cell division; GO:0048103; stem cell maintenance; GO:0019827; tracheal system development (sensu Insecta); GO:0007424; tyrosine phosphorylation of STAT protein; GO:0007260; wing morphogenesis; GO:0007476 ATP binding; GO:0005524; ; GO:0005524; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; Janus kinase activity; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; ; GO:0004718 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; metallopeptidase activity; GO:0008237; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; zinc ion binding; GO:0008270; ; GO:0004718 ; EC:2.7.1.-; ; GO:0008237; ; GO:0008270 cytoplasm; GO:0005737; cytoskeleton; GO:0005856 hop hopscotch "CG1594, CG1594, 4, locus 18, L4, l(1)hop, l(1)L4, Tum: Tumorous, l(1)10Be, Jak, Hop, Dm JAK, JAK, DmHD-160, Hop1, Jak/Stat, Jak-STAT, Tum-1, Hopskotch, JAK-STAT, HD-160, l(1)G18, msvl, Tumorous, Tum" CDMC33359 4 15 20 DAC32-P03 9-CG1634-RB_2 CG1634 ACGCTCTGGTCACACAATTCAAGCCCGATTCAAAGAACTATGCCCGCATTTTGGCTTACAATGGACGCT 69 FBan0001634 FBgn0002968 Nrg X X axonogenesis; GO:0007409; central complex development; GO:0048036; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; mushroom body development; GO:0016319; neuron adhesion; GO:0007158; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991 calcium ion binding; GO:0005509; ; GO:0005509 lateral plasma membrane; GO:0016328; plasma membrane; GO:0005886; pleated septate junction; GO:0005919 Nrg Neuroglian "CG1634, CG1634, CG1634, RA35, NRG, ceb, nrg, l(1)G0099, neuroglian, l(1)G0413, CT4318, Ngl, l(1)7Fa, l(1)G0488, central brain deranged" CDMC33359 4 16 20 DAC32-P03 9-CG1634-RB_2 CG1634 ACGCTCTGGTCACACAATTCAAGCCCGATTCAAAGAACTATGCCCGCATTTTGGCTTACAATGGACGCT 69 FBan0001634 FBgn0002968 Nrg X X axonogenesis; GO:0007409; central complex development; GO:0048036; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; mushroom body development; GO:0016319; neuron adhesion; GO:0007158; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991 calcium ion binding; GO:0005509; ; GO:0005509 lateral plasma membrane; GO:0016328; plasma membrane; GO:0005886; pleated septate junction; GO:0005919 Nrg Neuroglian "CG1634, CG1634, CG1634, RA35, NRG, ceb, nrg, l(1)G0099, neuroglian, l(1)G0413, CT4318, Ngl, l(1)7Fa, l(1)G0488, central brain deranged" CDMC33360 4 17 20 DAC32-P15 14-CG1641-RA_1 CG1641 TGGAGCAGTGATATCATAGTGTAGCTATGTGTCGCAGGAACGGATCCCTGACTAGTCCAGCATTAGCCA 69 FBan0001641 FBgn0003411 sisA X X "anterior midgut development; GO:0007496; endoderm development; GO:0007492; posterior midgut development; GO:0007497; primary sex determination; GO:0007538; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540" transcription factor activity; GO:0003700; ; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; ; GO:0046982 nucleus; GO:0005634 sisA sisterless A "CG1641, sis-a, sisa, sis a, sis A, sis-A" CDMC33360 4 18 20 DAC32-P15 14-CG1641-RA_1 CG1641 TGGAGCAGTGATATCATAGTGTAGCTATGTGTCGCAGGAACGGATCCCTGACTAGTCCAGCATTAGCCA 69 FBan0001641 FBgn0003411 sisA X X "anterior midgut development; GO:0007496; endoderm development; GO:0007492; posterior midgut development; GO:0007497; primary sex determination; GO:0007538; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540" transcription factor activity; GO:0003700; ; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003700; ; GO:0046982 nucleus; GO:0005634 sisA sisterless A "CG1641, sis-a, sisa, sis a, sis A, sis-A" CDMC33361 4 19 20 DAC33-D03 16-CG11348-RA_1 CG11348 CTTCTCACACGATCGCAGCTAGCAAAAAGATCGACTTAATCGTAGGCTCCGAAGATCCGAAGATCCGGA 69 FBan0011348 FBgn0000038 nAcRbeta-64B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-64B nicotinic Acetylcholine Receptor beta 64B "CG12606, CG11348, CG12606, AChR64B, ard, ARD: AChR protein of Drosophila, Ard, Acr64B, AChR protein of Drosophila, beta 64B, AChR, nAChR, AchR64B, AcrD" CDMC33361 4 20 20 DAC33-D03 16-CG11348-RA_1 CG11348 CTTCTCACACGATCGCAGCTAGCAAAAAGATCGACTTAATCGTAGGCTCCGAAGATCCGAAGATCCGGA 69 FBan0011348 FBgn0000038 nAcRbeta-64B 3 3L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRbeta-64B nicotinic Acetylcholine Receptor beta 64B "CG12606, CG11348, CG12606, AChR64B, ard, ARD: AChR protein of Drosophila, Ard, Acr64B, AChR protein of Drosophila, beta 64B, AChR, nAChR, AchR64B, AcrD" CDMC33362 4 21 20 DAC33-D15 2-CG1135-RA_1 CG1135 GCACTGCCAAATCCTTGCAAAACCATTGGCTTCTTCTCAAGCAGTACACCCTGTTGCCGGATCAGTCAG 69 FBan0001135 FBgn0035489 CG1135 3 3L nucleolus; GO:0005730 CG1135 CG1135 p78 CDMC33362 4 22 20 DAC33-D15 2-CG1135-RA_1 CG1135 GCACTGCCAAATCCTTGCAAAACCATTGGCTTCTTCTCAAGCAGTACACCCTGTTGCCGGATCAGTCAG 69 FBan0001135 FBgn0035489 CG1135 3 3L nucleolus; GO:0005730 CG1135 CG1135 p78 CDMC33363 4 23 20 DAC33-H03 8-CG1138-RA_1 CG1138 ACAGCACCAACTGACTCAGATGCAATCCGTCCGAAGATCATCCAATCTGGCCAAAAAACTGGTACGGGA 69 FBan0001138 FBgn0037456 CG1138 3 3R CG1138 CG1138 CDMC33363 4 24 20 DAC33-H03 8-CG1138-RA_1 CG1138 ACAGCACCAACTGACTCAGATGCAATCCGTCCGAAGATCATCCAATCTGGCCAAAAAACTGGTACGGGA 69 FBan0001138 FBgn0037456 CG1138 3 3R CG1138 CG1138 CDMC33364 4 25 20 DAC33-H15 13-CG1139-RA_1 CG1139 CGTGACGGTTTACCCAACCACACTGGAATTAACGACCCCAACAAAATCAGCGAATGGCAGTAACGATGA 69 FBan0001139 FBgn0035300 CG1139 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG1139 CG1139 CDMC33364 4 26 20 DAC33-H15 13-CG1139-RA_1 CG1139 CGTGACGGTTTACCCAACCACACTGGAATTAACGACCCCAACAAAATCAGCGAATGGCAGTAACGATGA 69 FBan0001139 FBgn0035300 CG1139 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG1139 CG1139 CDMC33365 4 1 21 DAC33-L03 18-CG11436-RA_5 CG11436 CCCAGCACATTGCCGAGAACACAGCAGGTGCGAAACTTTATAAGTTGCCTAGAGAACCTAACGAAGAAA 69 FBan0011436 FBgn0029713 CG11436 X X CG11436 CG11436 CDMC33365 4 2 21 DAC33-L03 18-CG11436-RA_5 CG11436 CCCAGCACATTGCCGAGAACACAGCAGGTGCGAAACTTTATAAGTTGCCTAGAGAACCTAACGAAGAAA 69 FBan0011436 FBgn0029713 CG11436 X X CG11436 CG11436 CDMC33366 4 3 21 DAC33-L15 7-CG11451-RA_1 CG11451 TCCTTCACGGACATCCTACGCCCCGAACTGCATCTCTTCAATGAAAACATTCAGTATCTGCCCAAGGGA 69 FBan0011451 FBgn0037025 CG11451 3 3L cell communication; GO:0007154; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; signal transduction; GO:0007165 sugar porter activity; GO:0005351; ; GO:0005351 CG11451 CG11451 CDMC33366 4 4 21 DAC33-L15 7-CG11451-RA_1 CG11451 TCCTTCACGGACATCCTACGCCCCGAACTGCATCTCTTCAATGAAAACATTCAGTATCTGCCCAAGGGA 69 FBan0011451 FBgn0037025 CG11451 3 3L cell communication; GO:0007154; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; signal transduction; GO:0007165 sugar porter activity; GO:0005351; ; GO:0005351 CG11451 CG11451 CDMC33367 4 5 21 DAC33-P03 3-CG11491-RF_1 CG11491 AGCTAGCGACGGGAGTATTCAGAGCAGAATCATAAAGGGAATAGGGCCGCAGTTAGCACTGCCCCAAAA 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC33367 4 6 21 DAC33-P03 3-CG11491-RF_1 CG11491 AGCTAGCGACGGGAGTATTCAGAGCAGAATCATAAAGGGAATAGGGCCGCAGTTAGCACTGCCCCAAAA 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC33368 4 7 21 DAC33-P15 16-CG11502-RB_1 CG11502 TCGATTCTCGACTGGTTTTTCTCGGCGGATGTATCTCAAAGATGCTTCTGTATGGGAAGGCCGAATTGT 69 FBan0011502 FBgn0003651 svp 3 3R R1/R6 cell fate commitment; GO:0007462; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; cardioblast cell fate determination; GO:0007510; central nervous system development; GO:0007417; embryonic development (sensu Insecta); GO:0001700; eye development (sensu Endopterygota); GO:0007456; fat body development; GO:0007503; heart development; GO:0007507; nerve-nerve synaptic transmission; GO:0007270; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; phototactic behavior; GO:0046953; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 ligand-dependent nuclear receptor activity; GO:0004879; receptor activity; GO:0004872; ; GO:0004872; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0004872; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0005515; ; GO:0003707 cytoplasm; GO:0005737; nucleus; GO:0005634 svp seven up "CG18158, CG11502, CG18158, CG18158, CG18158, l(3)ck16, Svp, ck16, SVP, 0005/12, 0042/01, 0106/18, 0114/20, 0351/01, 0598/01, 0861/07, NR2F3, seven-up, don, down-and-out, SEVEN-UP, complementation group 7, BcDNA:GH08189, l(3)07842, l(3)87Bd, l(3)j2E2, l(3)rA028, l(3)rL069" CDMC33368 4 8 21 DAC33-P15 16-CG11502-RB_1 CG11502 TCGATTCTCGACTGGTTTTTCTCGGCGGATGTATCTCAAAGATGCTTCTGTATGGGAAGGCCGAATTGT 69 FBan0011502 FBgn0003651 svp 3 3R R1/R6 cell fate commitment; GO:0007462; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; cardioblast cell fate determination; GO:0007510; central nervous system development; GO:0007417; embryonic development (sensu Insecta); GO:0001700; eye development (sensu Endopterygota); GO:0007456; fat body development; GO:0007503; heart development; GO:0007507; nerve-nerve synaptic transmission; GO:0007270; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; phototactic behavior; GO:0046953; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 ligand-dependent nuclear receptor activity; GO:0004879; receptor activity; GO:0004872; ; GO:0004872; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0004872; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0005515; ; GO:0003707 cytoplasm; GO:0005737; nucleus; GO:0005634 svp seven up "CG18158, CG11502, CG18158, CG18158, CG18158, l(3)ck16, Svp, ck16, SVP, 0005/12, 0042/01, 0106/18, 0114/20, 0351/01, 0598/01, 0861/07, NR2F3, seven-up, don, down-and-out, SEVEN-UP, complementation group 7, BcDNA:GH08189, l(3)07842, l(3)87Bd, l(3)j2E2, l(3)rA028, l(3)rL069" CDMC33369 4 9 21 DAC34-D03 2-CG14696-RA_3 CG14696 AGCAAGGTGAACTTCGTCTTCGACAGCAATCCTTTGGGGCTCTATCAAGCCGGTCAGCTTATCTCCG 67 FBan0014696 FBgn0037853 CG14696 3 3R CG14696 CG14696 CDMC33369 4 10 21 DAC34-D03 2-CG14696-RA_3 CG14696 AGCAAGGTGAACTTCGTCTTCGACAGCAATCCTTTGGGGCTCTATCAAGCCGGTCAGCTTATCTCCG 67 FBan0014696 FBgn0037853 CG14696 3 3R CG14696 CG14696 CDMC33370 4 11 21 DAC34-D15 2-CG14866-RA_2 CG14866 TCGGAGCAGCTGATCTACTATCTGATGGCCGGAAACAATCAGAAGGAGGTGAAGGATCCCTGTCCCG 67 FBan0014866 FBgn0038315 CG14866 3 3R sugar binding; GO:0005529; ; GO:0005529 CG14866 CG14866 CDMC33370 4 12 21 DAC34-D15 2-CG14866-RA_2 CG14866 TCGGAGCAGCTGATCTACTATCTGATGGCCGGAAACAATCAGAAGGAGGTGAAGGATCCCTGTCCCG 67 FBan0014866 FBgn0038315 CG14866 3 3R sugar binding; GO:0005529; ; GO:0005529 CG14866 CG14866 CDMC33371 4 13 21 DAC34-H03 1-CG15095-RA_1 CG15095 CGCTATGGAGCCAAGACCATGCTGATGTACGGATTGGGTATAGCCGCTTTGATCACGATGCTCTCGC 67 FBan0015095 FBgn0010651 l(2)08717 2 2R carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 l(2)08717 lethal (2) 08717 "CG15095, CG15095, CG15095, 8717" CDMC33371 4 14 21 DAC34-H03 1-CG15095-RA_1 CG15095 CGCTATGGAGCCAAGACCATGCTGATGTACGGATTGGGTATAGCCGCTTTGATCACGATGCTCTCGC 67 FBan0015095 FBgn0010651 l(2)08717 2 2R carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 l(2)08717 lethal (2) 08717 "CG15095, CG15095, CG15095, 8717" CDMC33372 4 15 21 DAC34-H15 1-CG15422-RA_1 CG15422 GCAGGCGTACGAGTATCAGTACCAGTATCAGCAGCCCTACAACAATCCACCGTATCCGCAGTGGTGA 67 FBan0015422 FBgn0031579 CG15422 2 2L CG15422 CG15422 CDMC33372 4 16 21 DAC34-H15 1-CG15422-RA_1 CG15422 GCAGGCGTACGAGTATCAGTACCAGTATCAGCAGCCCTACAACAATCCACCGTATCCGCAGTGGTGA 67 FBan0015422 FBgn0031579 CG15422 2 2L CG15422 CG15422 CDMC33373 4 17 21 DAC34-L03 3-CG1575-RA_2 CG1575 TCATGGCCGCTCTAGTCCGTTCTGCTCCTGAGATAGTCAGTCACTTGGATAAGCTGCAGATCACGGG 67 FBan0001575 FBgn0029999 CG1575 X X CG1575 CG1575 CDMC33373 4 18 21 DAC34-L03 3-CG1575-RA_2 CG1575 TCATGGCCGCTCTAGTCCGTTCTGCTCCTGAGATAGTCAGTCACTTGGATAAGCTGCAGATCACGGG 67 FBan0001575 FBgn0029999 CG1575 X X CG1575 CG1575 CDMC33374 4 19 21 DAC34-L15 9-CG15820-RA_1 CG15820 GCGGAGAATCGAGGATCCCAGCAAGTTGACCAAGGACATAGAAGGTTATTTGCTGGAGGAGAGGCGA 67 FBan0015820 FBgn0035312 CG15820 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG15820 CG15820 BcDNA:SD08776 CDMC33374 4 20 21 DAC34-L15 9-CG15820-RA_1 CG15820 GCGGAGAATCGAGGATCCCAGCAAGTTGACCAAGGACATAGAAGGTTATTTGCTGGAGGAGAGGCGA 67 FBan0015820 FBgn0035312 CG15820 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG15820 CG15820 BcDNA:SD08776 CDMC33375 4 21 21 DAC34-P03 3-CG17100-RA_7 CG17100 TGCCCCTGAACGTGGACTATAATGCACTGGTGCCCTTCCTCAACGGTATGGATCTGCTCGAGAAGAG 67 FBgn0016941 stich1 "peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 stich1 sticky ch1 "sticky ch, 1437/02, sticky ch1-1, sticky ch-1, sticky-chordotonals, sticky ch1" CDMC33375 4 22 21 DAC34-P03 3-CG17100-RA_7 CG17100 TGCCCCTGAACGTGGACTATAATGCACTGGTGCCCTTCCTCAACGGTATGGATCTGCTCGAGAAGAG 67 FBgn0016941 stich1 "peripheral nervous system development; GO:0007422; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 stich1 sticky ch1 "sticky ch, 1437/02, sticky ch1-1, sticky ch-1, sticky-chordotonals, sticky ch1" CDMC33376 4 23 21 DAC34-P15 AutoBlank AutoBlank CDMC33376 4 24 21 DAC34-P15 AutoBlank AutoBlank CDMC33377 4 25 21 DAC35-D03 1-CG11775-RA_1 CG11775 TCCAACACTTCCTAACCCTGGGACACAAGCACGAGTCCAGAATTCGGGAACAAATGCTGGAAGTTTCCG 69 FBan0011775 FBgn0037630 CG11775 3 3R glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG11775 CG11775 CT32618 CDMC33377 4 26 21 DAC35-D03 1-CG11775-RA_1 CG11775 TCCAACACTTCCTAACCCTGGGACACAAGCACGAGTCCAGAATTCGGGAACAAATGCTGGAAGTTTCCG 69 FBan0011775 FBgn0037630 CG11775 3 3R glutamate-gated ion channel activity; GO:0005234; ; GO:0005234 CG11775 CG11775 CT32618 CDMC33378 4 1 22 DAC35-D15 3-CG11785-RA_2 CG11785 GGACACATCCTGTCGCAGAAGGAGCACATCACTAAGGGCAAGTTCAGCTTCATGTCCGAGGTGTACGAT 69 FBgn0039262 CDMC33378 4 2 22 DAC35-D15 3-CG11785-RA_2 CG11785 GGACACATCCTGTCGCAGAAGGAGCACATCACTAAGGGCAAGTTCAGCTTCATGTCCGAGGTGTACGAT 69 FBgn0039262 CDMC33379 4 3 22 DAC35-H03 17-CG11837-RA_1 CG11837 GGCGGCTACCTTTAAGGTGACGTCCGTTTTGGAGATGTTGGAGAAAAACTACAAGCTATACCGCTCACT 69 FBan0011837 FBgn0039627 CG11837 3 3R rRNA modification; GO:0000154 "nucleic acid binding; GO:0003676; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0003676; ; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-" cellular component unknown; GO:0008372 CG11837 CG11837 FBgn0039627 CDMC33379 4 4 22 DAC35-H03 17-CG11837-RA_1 CG11837 GGCGGCTACCTTTAAGGTGACGTCCGTTTTGGAGATGTTGGAGAAAAACTACAAGCTATACCGCTCACT 69 FBan0011837 FBgn0039627 CG11837 3 3R rRNA modification; GO:0000154 "nucleic acid binding; GO:0003676; rRNA (adenine-N6,N6-)-dimethyltransferase activity; GO:0000179 ; EC:2.1.1.-; ; GO:0003676; ; GO:0000179 ; EC:2.1.1.-; ; GO:0000179 ; EC:2.1.1.-" cellular component unknown; GO:0008372 CG11837 CG11837 FBgn0039627 CDMC33380 4 5 22 DAC35-H15 3-CG11851-RA_5 CG11851 TGGTGCTGGAGATGCTTTTAAGGCAGCGTGATTGGAAGACCTTTGTTCAGTGGACACTGATATCGGGCG 69 FBan0011851 FBgn0039293 CG11851 3 3R protein amino acid glycosylation; GO:0006486 mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0000030 ; EC:2.4.1.- CG11851 CG11851 CDMC33380 4 6 22 DAC35-H15 3-CG11851-RA_5 CG11851 TGGTGCTGGAGATGCTTTTAAGGCAGCGTGATTGGAAGACCTTTGTTCAGTGGACACTGATATCGGGCG 69 FBan0011851 FBgn0039293 CG11851 3 3R protein amino acid glycosylation; GO:0006486 mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0000030 ; EC:2.4.1.- CG11851 CG11851 CDMC33381 4 7 22 DAC35-L03 3-CG11885-RA_2 CG11885 AGCTCGGCAAGATTCCCGGCATCTACAACGTGCACTTCGATGTCAAAAAGGACGAAAGAGTGGTTCCCT 69 FBan0011885 FBgn0031253 CG11885 2 2L CG11885 CG11885 BcDNA:AT13539 CDMC33381 4 8 22 DAC35-L03 3-CG11885-RA_2 CG11885 AGCTCGGCAAGATTCCCGGCATCTACAACGTGCACTTCGATGTCAAAAAGGACGAAAGAGTGGTTCCCT 69 FBan0011885 FBgn0031253 CG11885 2 2L CG11885 CG11885 BcDNA:AT13539 CDMC33382 4 9 22 DAC35-L15 21-CG11897-RB_2 CG11897 AAGCACCCGTGTTAAAGGATCTTAACTTCACTATAGAACCGCGCGAAAAAATAGGAATTGTGGGGCGCA 69 FBan0011897 FBgn0039644 CG11897 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; nitrogen fixation; GO:0009399; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166; nitrogenase activity; GO:0016163 ; EC:1.18.6.1; ; GO:0016163 ; EC:1.18.6.1 integral to membrane; GO:0016021 CG11897 CG11897 CDMC33382 4 10 22 DAC35-L15 21-CG11897-RB_2 CG11897 AAGCACCCGTGTTAAAGGATCTTAACTTCACTATAGAACCGCGCGAAAAAATAGGAATTGTGGGGCGCA 69 FBan0011897 FBgn0039644 CG11897 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; nitrogen fixation; GO:0009399; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; multidrug transporter activity; GO:0015239; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; nucleotide binding; GO:0000166; ; GO:0015239; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166; nitrogenase activity; GO:0016163 ; EC:1.18.6.1; ; GO:0016163 ; EC:1.18.6.1 integral to membrane; GO:0016021 CG11897 CG11897 CDMC33383 4 11 22 DAC35-P03 23-CG11937-RA_3 CG11937 TCTTTTGGGAGAGATGAGATAGCAAAGAAAAGCCAAAACACTAGAACAATCCAGAAGCCAAGTTTTCCG 69 FBan0011937 FBgn0000076 amn X X NOT learning; GO:0007612; anesthesia-resistant memory; GO:0007615; antimicrobial humoral response (sensu Protostomia); GO:0006960; behavioral response to ethanol; GO:0048149; cAMP biosynthesis; GO:0006171; cAMP-mediated signaling; GO:0019933; courtship behavior; GO:0007619; learning and/or memory; GO:0007611; long-term memory; GO:0007616; male courtship behavior (sensu Insecta); GO:0016542; memory; GO:0007613; neuropeptide signaling pathway; GO:0007218; olfactory learning; GO:0008355; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184; G-protein-coupled receptor binding; GO:0001664; ; GO:0001664 amn amnesiac "CG11937, CG11937, CG11937, CG11937, chpd, cheapdate, Drm-amn, EP(X)1442, cheap date" CDMC33383 4 12 22 DAC35-P03 23-CG11937-RA_3 CG11937 TCTTTTGGGAGAGATGAGATAGCAAAGAAAAGCCAAAACACTAGAACAATCCAGAAGCCAAGTTTTCCG 69 FBan0011937 FBgn0000076 amn X X NOT learning; GO:0007612; anesthesia-resistant memory; GO:0007615; antimicrobial humoral response (sensu Protostomia); GO:0006960; behavioral response to ethanol; GO:0048149; cAMP biosynthesis; GO:0006171; cAMP-mediated signaling; GO:0019933; courtship behavior; GO:0007619; learning and/or memory; GO:0007611; long-term memory; GO:0007616; male courtship behavior (sensu Insecta); GO:0016542; memory; GO:0007613; neuropeptide signaling pathway; GO:0007218; olfactory learning; GO:0008355; regulation of heart contraction rate; GO:0008016 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184; ; GO:0005184; G-protein-coupled receptor binding; GO:0001664; ; GO:0001664 amn amnesiac "CG11937, CG11937, CG11937, CG11937, chpd, cheapdate, Drm-amn, EP(X)1442, cheap date" CDMC33384 4 13 22 DAC35-P15 3-CG11961-RA_5 CG11961 TGGACCCAATCACATGGCCCTCTTTATACAGCCCTTGAACGGAGCAAAGATGATGGACTGGTCCTTCCA 69 FBan0011961 FBgn0034436 CG11961 2 2R CG11961 CG11961 CDMC33384 4 14 22 DAC35-P15 3-CG11961-RA_5 CG11961 TGGACCCAATCACATGGCCCTCTTTATACAGCCCTTGAACGGAGCAAAGATGATGGACTGGTCCTTCCA 69 FBan0011961 FBgn0034436 CG11961 2 2R CG11961 CG11961 CDMC33385 4 15 22 DAC36-D03 3-CG8628-RA_2 CG8628 CCACTGAACTCGCCAACAAGTTCACCAAGAAGCCCACGGATGCCGAGTTCTTGGAATTCTACGGTCTCT 69 FBan0008628 FBgn0035744 CG8628 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8628 CG8628 CDMC33385 4 16 22 DAC36-D03 3-CG8628-RA_2 CG8628 CCACTGAACTCGCCAACAAGTTCACCAAGAAGCCCACGGATGCCGAGTTCTTGGAATTCTACGGTCTCT 69 FBan0008628 FBgn0035744 CG8628 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857 CG8628 CG8628 CDMC33386 4 17 22 DAC36-D15 12-CG8638-RA_2 CG8638 GGCATCCAGCATATATAGTGCACATCAAGCAGCAGAAAGAACCATCGGAGCAACTACATCTGGACGCGG 69 FBan0008638 FBgn0035736 CG8638 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8638 CG8638 BcDNA:RE28679 CDMC33386 4 18 22 DAC36-D15 12-CG8638-RA_2 CG8638 GGCATCCAGCATATATAGTGCACATCAAGCAGCAGAAAGAACCATCGGAGCAACTACATCTGGACGCGG 69 FBan0008638 FBgn0035736 CG8638 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8638 CG8638 BcDNA:RE28679 CDMC33387 4 19 22 DAC36-H03 23-CG8676-RB_11 CG8676 TATGTATGCATGTGTCTATATGTGAGTACGTACCATACAAATTCCTGTCCCACCAGAAAAATCACACGC 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC33387 4 20 22 DAC36-H03 23-CG8676-RB_11 CG8676 TATGTATGCATGTGTCTATATGTGAGTACGTACCATACAAATTCCTGTCCCACCAGAAAAATCACACGC 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC33388 4 21 22 DAC36-H15 16-CG8681-RA_1 CG8681 ACAGTCACTCCACCTCCAGAGATAGGCTGGAAACTGGACAAGTCAACACAAATCGATGTAGTTCCAACA 69 FBan0008681 FBgn0026255 clumsy 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 clumsy clumsy "CG8681, CG8681, CT9037, GluR39B, clumsy" CDMC33388 4 22 22 DAC36-H15 16-CG8681-RA_1 CG8681 ACAGTCACTCCACCTCCAGAGATAGGCTGGAAACTGGACAAGTCAACACAAATCGATGTAGTTCCAACA 69 FBan0008681 FBgn0026255 clumsy 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274; potassium ion transport; GO:0006813 kainate selective glutamate receptor activity; GO:0015277; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; potassium channel activity; GO:0005267; ; GO:0015277; glutamate-gated ion channel activity; GO:0005234; ; GO:0005267; ; GO:0005234 membrane; GO:0016020 clumsy clumsy "CG8681, CG8681, CT9037, GluR39B, clumsy" CDMC33389 4 23 22 DAC36-L03 2-CG8725-RA_1 CG8725 AGCTGAGCAAGTTGCCTGACGATCTGTCCAAGATGCTTTCTCACTTCACCCTGGAAAAGGTCAATCCGC 69 FBan0008725 FBgn0027054 CSN4 2 2R photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein deneddylation; GO:0000338; proteolysis; GO:0006508 NEDD8 activating enzyme activity; GO:0019781; ; GO:0019781 signalosome complex; GO:0008180 CSN4 COP9 complex homolog subunit 4 "CG8725, l(2)k08018, Cops4, Dch4, Drosophila COP9 signalosome homolog 4, DCH4, COP9 complex homolog subunit 4, Csn4, csn4, COP9 signalosome subunit 4, CH4" CDMC33389 4 24 22 DAC36-L03 2-CG8725-RA_1 CG8725 AGCTGAGCAAGTTGCCTGACGATCTGTCCAAGATGCTTTCTCACTTCACCCTGGAAAAGGTCAATCCGC 69 FBan0008725 FBgn0027054 CSN4 2 2R photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein deneddylation; GO:0000338; proteolysis; GO:0006508 NEDD8 activating enzyme activity; GO:0019781; ; GO:0019781 signalosome complex; GO:0008180 CSN4 COP9 complex homolog subunit 4 "CG8725, l(2)k08018, Cops4, Dch4, Drosophila COP9 signalosome homolog 4, DCH4, COP9 complex homolog subunit 4, Csn4, csn4, COP9 signalosome subunit 4, CH4" CDMC33390 4 25 22 DAC36-L15 23-CG8735-RA_3 CG8735 GTCTAAGTTTGTTCGTTTCTAGTTAAATTGCGGATCATACACCATGGGATTTGTGTTATCCAAGCTGCG 69 FBan0008735 FBgn0033309 CG8735 2 2R CG8735 CG8735 CDMC33390 4 26 22 DAC36-L15 23-CG8735-RA_3 CG8735 GTCTAAGTTTGTTCGTTTCTAGTTAAATTGCGGATCATACACCATGGGATTTGTGTTATCCAAGCTGCG 69 FBan0008735 FBgn0033309 CG8735 2 2R CG8735 CG8735 CDMC33391 4 1 23 DAC36-P03 8-CG8772-RB_1 CG8772 TGGTCTCCATGTTCAATTTCCATCGCTACGACAACCTGAAGCATCTGTCCAACAAGAAGGATCCGCGGA 69 FBan0008772 FBgn0033765 nemy 2 2R glutamine metabolism; GO:0006541; locomotory behavior; GO:0007626; memory; GO:0007613 glutaminase activity; GO:0004359 ; EC:3.5.1.2; ; GO:0004359 ; EC:3.5.1.2; ; GO:0004359 ; EC:3.5.1.2 mitochondrion; GO:0005739 nemy no extended memory "CG8772, CG8772, CG8772, anon-WO0140519.146, no extended memory" CDMC33391 4 2 23 DAC36-P03 8-CG8772-RB_1 CG8772 TGGTCTCCATGTTCAATTTCCATCGCTACGACAACCTGAAGCATCTGTCCAACAAGAAGGATCCGCGGA 69 FBan0008772 FBgn0033765 nemy 2 2R glutamine metabolism; GO:0006541; locomotory behavior; GO:0007626; memory; GO:0007613 glutaminase activity; GO:0004359 ; EC:3.5.1.2; ; GO:0004359 ; EC:3.5.1.2; ; GO:0004359 ; EC:3.5.1.2 mitochondrion; GO:0005739 nemy no extended memory "CG8772, CG8772, CG8772, anon-WO0140519.146, no extended memory" CDMC33392 4 3 23 DAC36-P15 9-CG8785-RA_1 CG8785 TCCTCTGGCGCAAGATCAGTCACAAGTTCAGTCCCGAGAAGCACAATATTACACAGATTCTGCTGCGCA 69 FBan0008785 FBgn0033760 CG8785 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG8785 CG8785 CDMC33392 4 4 23 DAC36-P15 9-CG8785-RA_1 CG8785 TCCTCTGGCGCAAGATCAGTCACAAGTTCAGTCCCGAGAAGCACAATATTACACAGATTCTGCTGCGCA 69 FBan0008785 FBgn0033760 CG8785 2 2R amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG8785 CG8785 CDMC33393 4 5 23 DAC37-D03 23-CG9009-RA_13 CG9009 TCGTCTCAATCAGGAATGGTACACAGACAAATGTGGAGGTCCTAAAGCAATCAACCTATTGCCAAATTT 69 FBan0009009 FBgn0027601 CG9009 X X fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG9009 CG9009 BcDNA:GH02901 CDMC33393 4 6 23 DAC37-D03 23-CG9009-RA_13 CG9009 TCGTCTCAATCAGGAATGGTACACAGACAAATGTGGAGGTCCTAAAGCAATCAACCTATTGCCAAATTT 69 FBan0009009 FBgn0027601 CG9009 X X fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG9009 CG9009 BcDNA:GH02901 CDMC33394 4 7 23 DAC37-D15 23-CG9024-RB_2 CG9024 GAAAGTGATGAATGGCATGTTGAGAACCCTATACGACTACAGTGTTCAGGATAGTGTGAACGATGCGAC 69 FBan0009024 FBgn0002856 Acp26Ab 2 2L oviposition; GO:0018991; post-mating behavior; GO:0045297 hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp26Ab Accessory gland-specific peptide 26Ab "CG9024, mst355b, mst 355b, Mst26A, Acp26A, Mst26Ab, Acp26Aab, msP355b" CDMC33394 4 8 23 DAC37-D15 23-CG9024-RB_2 CG9024 GAAAGTGATGAATGGCATGTTGAGAACCCTATACGACTACAGTGTTCAGGATAGTGTGAACGATGCGAC 69 FBan0009024 FBgn0002856 Acp26Ab 2 2L oviposition; GO:0018991; post-mating behavior; GO:0045297 hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp26Ab Accessory gland-specific peptide 26Ab "CG9024, mst355b, mst 355b, Mst26A, Acp26A, Mst26Ab, Acp26Aab, msP355b" CDMC33395 4 9 23 DAC37-H03 2-CG9054-RA_1 CG9054 GCATCTGGTACAACGAACCAAACCTACTGGCCGAAGTTGAGGACCACTTGAACATCACCATCCAGCAGG 69 FBan0009054 FBgn0015075 Ddx1 3 3L embryonic development (sensu Insecta); GO:0001700; regulation of translational initiation; GO:0006446; ribosome biogenesis; GO:0007046; spliceosome assembly; GO:0000245 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0008026 cellular component unknown; GO:0008372 Ddx1 Dead-box-1 "CG9054, DmDDX1, DmRH12, DDX1, Dbp79E, anon-79E" CDMC33395 4 10 23 DAC37-H03 2-CG9054-RA_1 CG9054 GCATCTGGTACAACGAACCAAACCTACTGGCCGAAGTTGAGGACCACTTGAACATCACCATCCAGCAGG 69 FBan0009054 FBgn0015075 Ddx1 3 3L embryonic development (sensu Insecta); GO:0001700; regulation of translational initiation; GO:0006446; ribosome biogenesis; GO:0007046; spliceosome assembly; GO:0000245 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0008026 cellular component unknown; GO:0008372 Ddx1 Dead-box-1 "CG9054, DmDDX1, DmRH12, DDX1, Dbp79E, anon-79E" CDMC33396 4 11 23 DAC37-H15 3-CG9071-RB_1 CG9071 GGCATGTCGCTGTTCGGAAATGTCAAGCTCCAAGGTGCTCTCGATGACATGGTGAACTTCCAGACCTTC 69 FBan0009071 FBgn0002920 NaCP60E 2 2R calcium ion transport; GO:0006816; muscle contraction; GO:0006936; olfactory behavior; GO:0042048; response to chemical stimulus; GO:0042221; sodium ion transport; GO:0006814; synaptic transmission; GO:0007268 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248; voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 NaCP60E Na channel protein 60E "CG9071, CG9071, DIC60, DSC, DSC1, smi60E, smell impaired 60E, put. sodium channel gene, CT24831, dsc1, DSCI, Na-CP" CDMC33396 4 12 23 DAC37-H15 3-CG9071-RB_1 CG9071 GGCATGTCGCTGTTCGGAAATGTCAAGCTCCAAGGTGCTCTCGATGACATGGTGAACTTCCAGACCTTC 69 FBan0009071 FBgn0002920 NaCP60E 2 2R calcium ion transport; GO:0006816; muscle contraction; GO:0006936; olfactory behavior; GO:0042048; response to chemical stimulus; GO:0042221; sodium ion transport; GO:0006814; synaptic transmission; GO:0007268 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248; voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 plasma membrane; GO:0005886; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 NaCP60E Na channel protein 60E "CG9071, CG9071, DIC60, DSC, DSC1, smi60E, smell impaired 60E, put. sodium channel gene, CT24831, dsc1, DSCI, Na-CP" CDMC33397 4 13 23 DAC37-L03 6-CG9098-RA_1 CG9098 GCCCAGCTCTGTACCACACCTGTATTGCTCCTTGGGAGTCGAAAGCGGATGACTTTGGCATGACCATTA 69 FBan0009098 FBgn0031762 CG9098 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG9098 CG9098 CDMC33397 4 14 23 DAC37-L03 6-CG9098-RA_1 CG9098 GCCCAGCTCTGTACCACACCTGTATTGCTCCTTGGGAGTCGAAAGCGGATGACTTTGGCATGACCATTA 69 FBan0009098 FBgn0031762 CG9098 2 2L intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 CG9098 CG9098 CDMC33398 4 15 23 DAC37-L15 3-CG9119-RA_3 CG9119 CAGTCGTGTTTGCAACGATCTAGCGAGCGGTAGGTAGCCTCAGCGCGACTAGAATACTTGGTGGGCTAG 69 FBan0009119 FBgn0035189 CG9119 3 3L CG9119 CG9119 CT9987 CDMC33398 4 16 23 DAC37-L15 3-CG9119-RA_3 CG9119 CAGTCGTGTTTGCAACGATCTAGCGAGCGGTAGGTAGCCTCAGCGCGACTAGAATACTTGGTGGGCTAG 69 FBan0009119 FBgn0035189 CG9119 3 3L CG9119 CG9119 CT9987 CDMC33399 4 17 23 DAC37-P03 23-CG9151-RA_3 CG9151 CCGAGCGCCCAAAAATCGAAATGGAGAAAACTCGAGCATTATCCAAGTAAACATCGTTGGCAAATAACA 69 FBan0009151 FBgn0000028 acj6 X X chemosensory jump behavior; GO:0007636; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to chemical stimulus; GO:0042221; synaptic target recognition; GO:0008039; visual perception; GO:0007601 NOT DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; protein phosphatase type 1 activity; GO:0000163; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003714; ; GO:0000163; ; GO:0003700 nucleus; GO:0005634 acj6 abnormal chemosensory jump 6 "CG9151, CG9151, I-POU, tI-POU, Acj6, Twin of I-POU, ACJ6, Abnormal chemosensory jumb, Ipou" CDMC33399 4 18 23 DAC37-P03 23-CG9151-RA_3 CG9151 CCGAGCGCCCAAAAATCGAAATGGAGAAAACTCGAGCATTATCCAAGTAAACATCGTTGGCAAATAACA 69 FBan0009151 FBgn0000028 acj6 X X chemosensory jump behavior; GO:0007636; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to chemical stimulus; GO:0042221; synaptic target recognition; GO:0008039; visual perception; GO:0007601 NOT DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; protein phosphatase type 1 activity; GO:0000163; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003714; ; GO:0000163; ; GO:0003700 nucleus; GO:0005634 acj6 abnormal chemosensory jump 6 "CG9151, CG9151, I-POU, tI-POU, Acj6, Twin of I-POU, ACJ6, Abnormal chemosensory jumb, Ipou" CDMC33400 4 19 23 DAC37-P15 6-CG9164-RA_1 CG9164 TGTTGTGCTTCATCGCTCACCAAAGCTCAACTCATCCGCAACTTATCCTTTGGTCACGTTGAGGTCCCA 69 FBan0009164 FBgn0030634 CG9164 X X sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG9164 CG9164 CDMC33400 4 20 23 DAC37-P15 6-CG9164-RA_1 CG9164 TGTTGTGCTTCATCGCTCACCAAAGCTCAACTCATCCGCAACTTATCCTTTGGTCACGTTGAGGTCCCA 69 FBan0009164 FBgn0030634 CG9164 X X sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG9164 CG9164 CDMC33401 4 21 23 DAC38-D03 3-CG5820-RC_4 CG5820 ACAAGGCCTTCGACACGTTCGTGAACAAGGAACTGAAGCCAGTCCTGAAGACCGATGGTATCCAGG 66 FBan0005820 FBgn0013272 Gp150 2 2R cell adhesion; GO:0007155; eye development (sensu Endopterygota); GO:0007456; transmembrane receptor protein tyrosine phosphatase signaling pathway; GO:0007185; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524 plasma membrane; GO:0005886 Gp150 Gp150 "CG5820, gp150, glycoprotein 150, CT18251, GP150, l(2)52A, anon-EST:fe2A1, p150, anon-fast-evolving-2A1" CDMC33401 4 22 23 DAC38-D03 3-CG5820-RC_4 CG5820 ACAAGGCCTTCGACACGTTCGTGAACAAGGAACTGAAGCCAGTCCTGAAGACCGATGGTATCCAGG 66 FBan0005820 FBgn0013272 Gp150 2 2R cell adhesion; GO:0007155; eye development (sensu Endopterygota); GO:0007456; transmembrane receptor protein tyrosine phosphatase signaling pathway; GO:0007185; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524 plasma membrane; GO:0005886 Gp150 Gp150 "CG5820, gp150, glycoprotein 150, CT18251, GP150, l(2)52A, anon-EST:fe2A1, p150, anon-fast-evolving-2A1" CDMC33402 4 23 23 DAC38-D15 2-CG6113-RA_1 CG6113 TTTCCGGCAGTATGATCACGGATGGCTCAGAAACCACTGGATCTACGGAACCATTGACCCGCCATC 66 FBan0006113 FBgn0032264 CG6113 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6113 CG6113 CDMC33402 4 24 23 DAC38-D15 2-CG6113-RA_1 CG6113 TTTCCGGCAGTATGATCACGGATGGCTCAGAAACCACTGGATCTACGGAACCATTGACCCGCCATC 66 FBan0006113 FBgn0032264 CG6113 2 2L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG6113 CG6113 CDMC33403 4 25 23 DAC38-H03 2-CG6414-RA_1 CG6414 GGTTCGTGCGAACATTGCATCATTTGGTGGTGATCCGAACAGTGTTACGGTCTTTGGCGAGAGCGC 66 FBan0006414 FBgn0029690 CG6414 X X carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG6414 CG6414 CDMC33403 4 26 23 DAC38-H03 2-CG6414-RA_1 CG6414 GGTTCGTGCGAACATTGCATCATTTGGTGGTGATCCGAACAGTGTTACGGTCTTTGGCGAGAGCGC 66 FBan0006414 FBgn0029690 CG6414 X X carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG6414 CG6414 CDMC33404 4 1 24 DAC38-H15 1-CG6543-RA_3 CG6543 TGATGAAGGAGCTGTCCACCGCATTGCAGCAATTCAGCAAGGATAAGACCATCTCCGCCATCGTTT 66 FBan0006543 FBgn0033879 CG6543 2 2R fatty acid beta-oxidation; GO:0006635 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG6543 CG6543 CG18645 CDMC33404 4 2 24 DAC38-H15 1-CG6543-RA_3 CG6543 TGATGAAGGAGCTGTCCACCGCATTGCAGCAATTCAGCAAGGATAAGACCATCTCCGCCATCGTTT 66 FBan0006543 FBgn0033879 CG6543 2 2R fatty acid beta-oxidation; GO:0006635 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17 mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG6543 CG6543 CG18645 CDMC33405 4 3 24 DAC38-L03 3-CG7062-RA_1 CG7062 CACTGCCAAACGAGGAACACTTCGACTTCCTGTTCAAGATCGTCCTCATTGGTGACTGCGGGACGG 66 FBan0007062 FBgn0015793 Rab-RP3 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; Rab GTPase activator activity; GO:0005097; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005097; ; GO:0016818 ; EC:3.6.1.-" Rab-RP3 Rab-related protein 3 "CG7062, DRABR3, DRabRP3, rab-related protein 3, DmRab19, AAF50452, Rab-r3" CDMC33405 4 4 24 DAC38-L03 3-CG7062-RA_1 CG7062 CACTGCCAAACGAGGAACACTTCGACTTCCTGTTCAAGATCGTCCTCATTGGTGACTGCGGGACGG 66 FBan0007062 FBgn0015793 Rab-RP3 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 "GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; Rab GTPase activator activity; GO:0005097; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005097; ; GO:0016818 ; EC:3.6.1.-" Rab-RP3 Rab-related protein 3 "CG7062, DRABR3, DRabRP3, rab-related protein 3, DmRab19, AAF50452, Rab-r3" CDMC33406 4 5 24 DAC38-L15 3-CG7170-RA_1 CG7170 CCACAACTCCGAGTGCTCCGGATACTATGGAAGCGTGGGAGACAACATCCTCTGTGTCAGGACTCC 66 FBan0007170 FBgn0035887 Jon66Cii 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon66Cii Jonah 66Cii "CG7170, 66C, Jon66C, SP165, Jonah 66C" CDMC33406 4 6 24 DAC38-L15 3-CG7170-RA_1 CG7170 CCACAACTCCGAGTGCTCCGGATACTATGGAAGCGTGGGAGACAACATCCTCTGTGTCAGGACTCC 66 FBan0007170 FBgn0035887 Jon66Cii 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4 Jon66Cii Jonah 66Cii "CG7170, 66C, Jon66C, SP165, Jonah 66C" CDMC33407 4 7 24 DAC38-P03 3-CG7736-RD_1 CG7736 TCCAGGGACAGGATGAGCAGCTAGACATGATCAGCGATTCGATTGGTACCCTCAAGACGGTCTCGC 66 FBan0007736 FBgn0037084 Syx6 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx6 Syntaxin 6 "CG7736, CG7736, CG7736, SYX6/10, Dm Syx6, DmSyx6, CT23545, syntaxin, Syntaxin 6" CDMC33407 4 8 24 DAC38-P03 3-CG7736-RD_1 CG7736 TCCAGGGACAGGATGAGCAGCTAGACATGATCAGCGATTCGATTGGTACCCTCAAGACGGTCTCGC 66 FBan0007736 FBgn0037084 Syx6 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx6 Syntaxin 6 "CG7736, CG7736, CG7736, SYX6/10, Dm Syx6, DmSyx6, CT23545, syntaxin, Syntaxin 6" CDMC33408 4 9 24 DAC38-P15 AutoBlank AutoBlank CDMC33408 4 10 24 DAC38-P15 AutoBlank AutoBlank CDMC33409 4 11 24 DAC39-D03 3-CG32054-RA_7 CG32054 TGTGCATCGAGTCTCCGGTAATCATGCTGGCCAAGAACAATGACGAACAGGGAGCTATTGACGCACTGA 69 FBan0032054 FBgn0052054 CG32054 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG32054 CG32054 "CG6645, CG6645, CG6645, BcDNA:GM13904" CDMC33409 4 12 24 DAC39-D03 3-CG32054-RA_7 CG32054 TGTGCATCGAGTCTCCGGTAATCATGCTGGCCAAGAACAATGACGAACAGGGAGCTATTGACGCACTGA 69 FBan0032054 FBgn0052054 CG32054 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144 integral to membrane; GO:0016021; membrane; GO:0016020 CG32054 CG32054 "CG6645, CG6645, CG6645, BcDNA:GM13904" CDMC33410 4 13 24 DAC39-D15 21-CG32064-RA_2 CG32064 AATCACCGATGAAATGGGATATGATTTAAGCAATGATGGTCGAGGACTGGCGAATTCCTGTTTGGCGGC 69 FBan0032064 FBgn0052064 CG32064 3 3L proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG32064 CG32064 "CG8040, CG8040, CG8040, bs04d09.y1, anon-WO0140519.141, anon-WO0140519.223" CDMC33410 4 14 24 DAC39-D15 21-CG32064-RA_2 CG32064 AATCACCGATGAAATGGGATATGATTTAAGCAATGATGGTCGAGGACTGGCGAATTCCTGTTTGGCGGC 69 FBan0032064 FBgn0052064 CG32064 3 3L proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG32064 CG32064 "CG8040, CG8040, CG8040, bs04d09.y1, anon-WO0140519.141, anon-WO0140519.223" CDMC33411 4 15 24 DAC39-H03 3-CG32102-RA_1 CG32102 ACGTGTCCAAGGTTCACTCTGGATCGCAATGGATGCAATTTGGCCACTTCACTGCACATTTGACCGGAT 69 FBan0032102 FBgn0052102 CG32102 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32102 CG32102 BcDNA:RE42781 CDMC33411 4 16 24 DAC39-H03 3-CG32102-RA_1 CG32102 ACGTGTCCAAGGTTCACTCTGGATCGCAATGGATGCAATTTGGCCACTTCACTGCACATTTGACCGGAT 69 FBan0032102 FBgn0052102 CG32102 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32102 CG32102 BcDNA:RE42781 CDMC33412 4 17 24 DAC39-H15 2-CG32108-RA_1 CG32108 ACAATTCGAGCACAGGACCCTTGATGGAACCCTAACAACGACACGGGAAATGCATACCAATTGCCAGCA 69 FBan0032108 FBgn0052108 CG32108 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32108 CG32108 BcDNA:SD20456 CDMC33412 4 18 24 DAC39-H15 2-CG32108-RA_1 CG32108 ACAATTCGAGCACAGGACCCTTGATGGAACCCTAACAACGACACGGGAAATGCATACCAATTGCCAGCA 69 FBan0032108 FBgn0052108 CG32108 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32108 CG32108 BcDNA:SD20456 CDMC33413 4 19 24 DAC39-L03 23-CG32141-RA_6 CG32141 CGAACCTCGAGAAGATTCCGTAGTAAAAAATAGGGTGCGATTTGCTCTAACAGATCAGGGAAAACCAGC 69 FBan0032141 FBgn0052141 CG32141 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32141 CG32141 CDMC33413 4 20 24 DAC39-L03 23-CG32141-RA_6 CG32141 CGAACCTCGAGAAGATTCCGTAGTAAAAAATAGGGTGCGATTTGCTCTAACAGATCAGGGAAAACCAGC 69 FBan0032141 FBgn0052141 CG32141 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32141 CG32141 CDMC33414 4 21 24 DAC39-L15 3-CG32152-RA_1 CG32152 GCTGAACCTTGTGTGGCCCTAACGACCGGCAAAAAACTTCTGACGATGGCTCATTGCGTTCTCAGACTA 69 FBan0032152 FBgn0052152 CG32152 3 3L protein amino acid methylation; GO:0006479; protein metabolism; GO:0019538; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- CG32152 CG32152 CDMC33414 4 22 24 DAC39-L15 3-CG32152-RA_1 CG32152 GCTGAACCTTGTGTGGCCCTAACGACCGGCAAAAAACTTCTGACGATGGCTCATTGCGTTCTCAGACTA 69 FBan0032152 FBgn0052152 CG32152 3 3L protein amino acid methylation; GO:0006479; protein metabolism; GO:0019538; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; protein-arginine N-methyltransferase activity; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.-; ; GO:0016274 ; EC:2.1.1.- CG32152 CG32152 CDMC33415 4 23 24 DAC39-P03 17-CG32182-RA_1 CG32182 ACGATTTTCGAGCTTGATACTGCAATTGTGGTCCAACAGATACGCCAAGCTATTTGATTTTCGCCGGGA 69 FBan0032182 FBgn0052182 CG32182 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32182 CG32182 CDMC33415 4 24 24 DAC39-P03 17-CG32182-RA_1 CG32182 ACGATTTTCGAGCTTGATACTGCAATTGTGGTCCAACAGATACGCCAAGCTATTTGATTTTCGCCGGGA 69 FBan0032182 FBgn0052182 CG32182 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32182 CG32182 CDMC33416 4 25 24 DAC39-P15 2-CG32190-RA_1 CG32190 AGGCCCAACTAGAGGATGTGTGGGAGAAGCAGGACCACATGGACAAGAACGACTTTGATCCGAAGACAT 69 FBan0032190 FBgn0052190 NUCB1 3 3L DNA binding; GO:0003677; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003677 Golgi apparatus; GO:0005794 NUCB1 NUCB1 "CG5587, CG32190, CG5587, nucb1" CDMC33416 4 26 24 DAC39-P15 2-CG32190-RA_1 CG32190 AGGCCCAACTAGAGGATGTGTGGGAGAAGCAGGACCACATGGACAAGAACGACTTTGATCCGAAGACAT 69 FBan0032190 FBgn0052190 NUCB1 3 3L DNA binding; GO:0003677; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0003677 Golgi apparatus; GO:0005794 NUCB1 NUCB1 "CG5587, CG32190, CG5587, nucb1" CDMC33417 4 1 25 DAC40-D03 23-CG9586-RB_1 CG9586 TGTTTGCATGTTTGCCTAAAGCGAAGTAAACTTTGAAGAGATCTACCGAACTGTTGAATATAAATGTAT 69 FBan0009586 FBgn0032101 CG9586 2 2L CG9586 CG9586 CDMC33417 4 2 25 DAC40-D03 23-CG9586-RB_1 CG9586 TGTTTGCATGTTTGCCTAAAGCGAAGTAAACTTTGAAGAGATCTACCGAACTGTTGAATATAAATGTAT 69 FBan0009586 FBgn0032101 CG9586 2 2L CG9586 CG9586 CDMC33418 4 3 25 DAC40-D15 3-CG9593-RA_3 CG9593 GGTGGATGGCGTCTATAGGTTTCTGGTTCCGGAGCGCAATGAAGTCCAGCGTGATTTGTACGAGCGTTA 69 FBan0009593 FBgn0038365 CG9593 3 3R defense response; GO:0006952; defense response to bacteria; GO:0042742; development; GO:0007275; mesoderm development; GO:0007498 receptor binding; GO:0005102; ; GO:0005102 CG9593 CG9593 CDMC33418 4 4 25 DAC40-D15 3-CG9593-RA_3 CG9593 GGTGGATGGCGTCTATAGGTTTCTGGTTCCGGAGCGCAATGAAGTCCAGCGTGATTTGTACGAGCGTTA 69 FBan0009593 FBgn0038365 CG9593 3 3R defense response; GO:0006952; defense response to bacteria; GO:0042742; development; GO:0007275; mesoderm development; GO:0007498 receptor binding; GO:0005102; ; GO:0005102 CG9593 CG9593 CDMC33419 4 5 25 DAC40-H03 11-CG9623-RB_2 CG9623 ATCGAGCTCTTAGTCGAGTTTTAAACCATGCGATGTCGACACGGGAGGTGCAAGTGCATAATCCCCTCT 69 FBan0009623 FBgn0001250 if X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157; maintenance of protein localization; GO:0045185; midgut development; GO:0007494; muscle attachment; GO:0016203; myofibril assembly; GO:0030239; regulation of cell shape; GO:0008360; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; wing morphogenesis; GO:0007476 protein binding; GO:0005515; receptor activity; GO:0004872; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0005515; ; GO:0004872; ; GO:0050839 contractile fiber; GO:0043292; integrin complex; GO:0008305 if inflated "CG9623, CG9623, PS2alpha, PS 2, alpha[[PS2(ms8)]], PS2, alpha[[PS2]], alphaPS2, inf, in, alpha integrin, aPS2, position-specific antigen 2, CT27194, PSalpha2, alphaPS2 integrin, alphaPS2" CDMC33419 4 6 25 DAC40-H03 11-CG9623-RB_2 CG9623 ATCGAGCTCTTAGTCGAGTTTTAAACCATGCGATGTCGACACGGGAGGTGCAAGTGCATAATCCCCTCT 69 FBan0009623 FBgn0001250 if X X apposition of dorsal and ventral wing surfaces; GO:0007475; axon guidance; GO:0007411; cell adhesion; GO:0007155; cell migration; GO:0016477; cell-cell adhesion; GO:0016337; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157; maintenance of protein localization; GO:0045185; midgut development; GO:0007494; muscle attachment; GO:0016203; myofibril assembly; GO:0030239; regulation of cell shape; GO:0008360; salivary gland development; GO:0007431; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; wing morphogenesis; GO:0007476 protein binding; GO:0005515; receptor activity; GO:0004872; ; GO:0004872; cell adhesion molecule binding; GO:0050839; ; GO:0050839; ; GO:0005515; ; GO:0004872; ; GO:0050839 contractile fiber; GO:0043292; integrin complex; GO:0008305 if inflated "CG9623, CG9623, PS2alpha, PS 2, alpha[[PS2(ms8)]], PS2, alpha[[PS2]], alphaPS2, inf, in, alpha integrin, aPS2, position-specific antigen 2, CT27194, PSalpha2, alphaPS2 integrin, alphaPS2" CDMC33420 4 7 25 DAC40-H15 23-CG9638-RA_1 CG9638 GTTGTTCCTTTGTGTGAGATGTCGGGATTCAGATATTGTGTATTAACTAAGCTTAAGTAGGGGACCCAA 69 FBan0009638 FBgn0037555 Ada2b 3 3R positive regulation of histone acetylation; GO:0035066; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; deaminase activity; GO:0019239; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004402 ; EC:2.3.1.48; ; GO:0019239; ; GO:0008270; ; GO:0003677 SAGA complex; GO:0000124; polytene chromosome; GO:0005700 Ada2b Ada2b "CG9638, CG9638, dAda2S, dAda2b, ada2b, ADA2b, Ada2S: Transcriptional adapter 2S, BcDNA:LD24527, Transcriptional adapter 2S" CDMC33420 4 8 25 DAC40-H15 23-CG9638-RA_1 CG9638 GTTGTTCCTTTGTGTGAGATGTCGGGATTCAGATATTGTGTATTAACTAAGCTTAAGTAGGGGACCCAA 69 FBan0009638 FBgn0037555 Ada2b 3 3R positive regulation of histone acetylation; GO:0035066; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; deaminase activity; GO:0019239; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004402 ; EC:2.3.1.48; ; GO:0019239; ; GO:0008270; ; GO:0003677 SAGA complex; GO:0000124; polytene chromosome; GO:0005700 Ada2b Ada2b "CG9638, CG9638, dAda2S, dAda2b, ada2b, ADA2b, Ada2S: Transcriptional adapter 2S, BcDNA:LD24527, Transcriptional adapter 2S" CDMC33421 4 9 25 DAC40-L03 1-CG9669-RA_1 CG9669 GCTGATTAGCCTGTGCGCCTCCATTTTCCTGGGATTCGGCATTGTTTTCCTGCTTCTAACCGTCGGTAT 69 FBan0009669 FBgn0036667 CG9669 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG9669 CG9669 CDMC33421 4 10 25 DAC40-L03 1-CG9669-RA_1 CG9669 GCTGATTAGCCTGTGCGCCTCCATTTTCCTGGGATTCGGCATTGTTTTCCTGCTTCTAACCGTCGGTAT 69 FBan0009669 FBgn0036667 CG9669 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG9669 CG9669 CDMC33422 4 11 25 DAC40-L15 2-CG9684-RA_1 CG9684 CCGCACAACCCGAATGCAGCACAGGTTTCCTATCTGGCTGAGGTTTTGAAGGTCCATCAGTCAGTTCAT 69 FBan0009684 FBgn0037583 CG9684 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 CG9684 CG9684 CDMC33422 4 12 25 DAC40-L15 2-CG9684-RA_1 CG9684 CCGCACAACCCGAATGCAGCACAGGTTTCCTATCTGGCTGAGGTTTTGAAGGTCCATCAGTCAGTTCAT 69 FBan0009684 FBgn0037583 CG9684 3 3R nucleic acid binding; GO:0003676; ; GO:0003676 CG9684 CG9684 CDMC33423 4 13 25 DAC40-P03 6-CG9716-RA_1 CG9716 GCAGTTGAGGGCTGGTCAAAGTTCTTGCACCCGATGAAATTGAGGAGGTGAATTTGAAGGTGGTGGAGC 69 FBan0009716 FBgn0037601 Cyp313b1 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313b1 Cyp313b1 "CG9716, 313b1" CDMC33423 4 14 25 DAC40-P03 6-CG9716-RA_1 CG9716 GCAGTTGAGGGCTGGTCAAAGTTCTTGCACCCGATGAAATTGAGGAGGTGAATTTGAAGGTGGTGGAGC 69 FBan0009716 FBgn0037601 Cyp313b1 3 3R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp313b1 Cyp313b1 "CG9716, 313b1" CDMC33424 4 15 25 DAC40-P15 1-CG9731-RA_1 CG9731 GGCTCGAGTGGAGTGTACCAAATCGCGGATAGGGTCTATACCACCAGCAAGATGTTTCTACGCGATGGC 69 FBan0009731 FBgn0037640 CG9731 3 3R CG9731 CG9731 CDMC33424 4 16 25 DAC40-P15 1-CG9731-RA_1 CG9731 GGCTCGAGTGGAGTGTACCAAATCGCGGATAGGGTCTATACCACCAGCAAGATGTTTCTACGCGATGGC 69 FBan0009731 FBgn0037640 CG9731 3 3R CG9731 CG9731 CDMC33425 4 17 25 DAC41-D03 AutoBlank AutoBlank CDMC33425 4 18 25 DAC41-D03 AutoBlank AutoBlank CDMC33426 4 19 25 DAC41-D15 AutoBlank AutoBlank CDMC33426 4 20 25 DAC41-D15 AutoBlank AutoBlank CDMC33427 4 21 25 DAC41-H03 AutoBlank AutoBlank CDMC33427 4 22 25 DAC41-H03 AutoBlank AutoBlank CDMC33428 4 23 25 DAC41-H15 AutoBlank AutoBlank CDMC33428 4 24 25 DAC41-H15 AutoBlank AutoBlank CDMC33429 4 25 25 DAC41-L03 AutoBlank AutoBlank CDMC33429 4 26 25 DAC41-L03 AutoBlank AutoBlank CDMC33430 4 1 26 DAC41-L15 AutoBlank AutoBlank CDMC33430 4 2 26 DAC41-L15 AutoBlank AutoBlank CDMC33431 4 3 26 DAC41-P03 AutoBlank AutoBlank CDMC33431 4 4 26 DAC41-P03 AutoBlank AutoBlank CDMC33432 4 5 26 DAC41-P15 AutoBlank AutoBlank CDMC33432 4 6 26 DAC41-P15 AutoBlank AutoBlank CDMC33433 4 7 26 DAC42-D03 150mM NaPO4 Blank CDMC33433 4 8 26 DAC42-D03 150mM NaPO4 Blank CDMC33434 4 9 26 DAC42-D15 150mM NaPO4 Blank CDMC33434 4 10 26 DAC42-D15 150mM NaPO4 Blank CDMC33435 4 11 26 DAC42-H03 150mM NaPO4 Blank CDMC33435 4 12 26 DAC42-H03 150mM NaPO4 Blank CDMC33436 4 13 26 DAC42-H15 150mM NaPO4 Blank CDMC33436 4 14 26 DAC42-H15 150mM NaPO4 Blank CDMC33437 4 15 26 DAC42-L03 150mM NaPO4 Blank CDMC33437 4 16 26 DAC42-L03 150mM NaPO4 Blank CDMC33438 4 17 26 DAC42-L15 5uM MSP 5uM MSP CDMC33438 4 18 26 DAC42-L15 5uM MSP 5uM MSP CDMC33439 4 19 26 DAC42-P03 10uM MSP 10uM MSP CDMC33439 4 20 26 DAC42-P03 10uM MSP 10uM MSP CDMC33440 4 21 26 DAC42-P15 20uM MSP 20uM MSP CDMC33440 4 22 26 DAC42-P15 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC33441 1 1 1 DAC01-A02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33441 1 2 1 DAC01-A02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33442 1 3 1 DAC01-A14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33442 1 4 1 DAC01-A14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33443 1 5 1 DAC01-E02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33443 1 6 1 DAC01-E02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33444 1 7 1 DAC01-E14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33444 1 8 1 DAC01-E14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33445 1 9 1 DAC01-I02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33445 1 10 1 DAC01-I02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33446 1 11 1 DAC01-I14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33446 1 12 1 DAC01-I14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33447 1 13 1 DAC01-M02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33447 1 14 1 DAC01-M02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33448 1 15 1 DAC01-M14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33448 1 16 1 DAC01-M14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33449 1 17 1 DAC02-A02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33449 1 18 1 DAC02-A02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33450 1 19 1 DAC02-A14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33450 1 20 1 DAC02-A14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33451 1 21 1 DAC02-E02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33451 1 22 1 DAC02-E02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33452 1 23 1 DAC02-E14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33452 1 24 1 DAC02-E14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33453 1 25 1 DAC02-I02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33453 1 26 1 DAC02-I02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33454 1 1 2 DAC02-I14 N/A CG9075 (01196-01434) CDMC33454 1 2 2 DAC02-I14 N/A CG9075 (01196-01434) CDMC33455 1 3 2 DAC02-M02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33455 1 4 2 DAC02-M02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33456 1 5 2 DAC02-M14 AutoBlank AutoBlank CDMC33456 1 6 2 DAC02-M14 AutoBlank AutoBlank CDMC33457 1 7 2 DAC03-A02 3-CG3219-RA_3 CG3219 CCGGAAGGCATCAGAGCTCAATGGATGGCATCTATGCAATGGCCGCTAAGGACGTGTTCTCCACTCTAA 69 FBan0003219 FBgn0034824 Klp59C 2 2R microtubule-based movement; GO:0007018; mitotic sister chromatid segregation; GO:0000070; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777 kinesin complex; GO:0005871; kinetochore microtubule; GO:0005828 Klp59C Klp59C "CG3219, CG3219, CG3219, DmKlp59C, DmCG3219, KIF2B, KLP59C, DmKLP59C" CDMC33457 1 8 2 DAC03-A02 3-CG3219-RA_3 CG3219 CCGGAAGGCATCAGAGCTCAATGGATGGCATCTATGCAATGGCCGCTAAGGACGTGTTCTCCACTCTAA 69 FBan0003219 FBgn0034824 Klp59C 2 2R microtubule-based movement; GO:0007018; mitotic sister chromatid segregation; GO:0000070; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; ; GO:0005200; ; GO:0003774; ; GO:0003777 kinesin complex; GO:0005871; kinetochore microtubule; GO:0005828 Klp59C Klp59C "CG3219, CG3219, CG3219, DmKlp59C, DmCG3219, KIF2B, KLP59C, DmKLP59C" CDMC33458 1 9 2 DAC03-A14 9-CG32209-RB_1 CG32209 GGACTCCTGCTCGAACATCCTGACCGGTGACCAGTTCTACAACTTCCTGAACCACAACTTCGACCGTCA 69 FBan0032209 FBgn0052209 CG32209 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG32209 CG32209 "CG8748, CG8747, CG8748, CG8747, CG8748" CDMC33458 1 10 2 DAC03-A14 9-CG32209-RB_1 CG32209 GGACTCCTGCTCGAACATCCTGACCGGTGACCAGTTCTACAACTTCCTGAACCACAACTTCGACCGTCA 69 FBan0032209 FBgn0052209 CG32209 3 3L carbohydrate metabolism; GO:0005975; chitin metabolism; GO:0006030 "chitin binding; GO:0008061; ; GO:0008061; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; GO:0016810 ; EC:3.5.-.-; ; GO:0016810 ; EC:3.5.-.-" extracellular region; GO:0005576 CG32209 CG32209 "CG8748, CG8747, CG8748, CG8747, CG8748" CDMC33459 1 11 2 DAC03-E02 15-CG32242-RA_5 CG32242 TCTTTCAACAATCGGGAGACAAATGAACTGTATTCCAGCAGTAACAAGGTGCGCGTAAAGCTGCCTGGT 69 FBan0032242 FBgn0052242 CG32242 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32242 CG32242 "CG18318, CG18318" CDMC33459 1 12 2 DAC03-E02 15-CG32242-RA_5 CG32242 TCTTTCAACAATCGGGAGACAAATGAACTGTATTCCAGCAGTAACAAGGTGCGCGTAAAGCTGCCTGGT 69 FBan0032242 FBgn0052242 CG32242 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32242 CG32242 "CG18318, CG18318" CDMC33460 1 13 2 DAC03-E14 3-CG32249-RA_2 CG32249 GGCGAGATAATGTGGGGAATCAATTAGCGGCCAAGCAACGGAAGCCAAGTTAACACAGCCAACCAGCTA 69 FBan0032249 FBgn0052249 CG32249 3 3L signal transducer activity; GO:0004871; ; GO:0004871 CG32249 CG32249 CDMC33460 1 14 2 DAC03-E14 3-CG32249-RA_2 CG32249 GGCGAGATAATGTGGGGAATCAATTAGCGGCCAAGCAACGGAAGCCAAGTTAACACAGCCAACCAGCTA 69 FBan0032249 FBgn0052249 CG32249 3 3L signal transducer activity; GO:0004871; ; GO:0004871 CG32249 CG32249 CDMC33461 1 15 2 DAC03-I02 17-CG32278-RA_1 CG32278 GATGGGAAGTCCTCAGCCAGGTGGAGACTACGTAGCCAAATACCTCTTGACCTCTTTTAAAGCTAGCAT 69 FBan0032278 FBgn0052278 CG32278 3 3L CG32278 CG32278 "CG12032, CG12032, CG12032" CDMC33461 1 16 2 DAC03-I02 17-CG32278-RA_1 CG32278 GATGGGAAGTCCTCAGCCAGGTGGAGACTACGTAGCCAAATACCTCTTGACCTCTTTTAAAGCTAGCAT 69 FBan0032278 FBgn0052278 CG32278 3 3L CG32278 CG32278 "CG12032, CG12032, CG12032" CDMC33462 1 17 2 DAC03-I14 15-CG32297-RA_4 CG32297 TGGGCCAGCATTCTGTTAATGAGGAAACACTTCAGAAGATGTCCTCGTGTGCATTGTTGGAGAATGCCA 69 FBan0032297 FBgn0052297 CG32297 3 3L snRNP protein import into nucleus; GO:0006608 RNA cap binding; GO:0000339; ; GO:0000339 nuclear membrane; GO:0005635 CG32297 CG32297 "CG1247, CG1248" CDMC33462 1 18 2 DAC03-I14 15-CG32297-RA_4 CG32297 TGGGCCAGCATTCTGTTAATGAGGAAACACTTCAGAAGATGTCCTCGTGTGCATTGTTGGAGAATGCCA 69 FBan0032297 FBgn0052297 CG32297 3 3L snRNP protein import into nucleus; GO:0006608 RNA cap binding; GO:0000339; ; GO:0000339 nuclear membrane; GO:0005635 CG32297 CG32297 "CG1247, CG1248" CDMC33463 1 19 2 DAC03-M02 23-CG32341-RA_20 CG32341 AATCAACCAGATCACGCACTTGAAATAAAACTGTCAAAGATCTGTGGGGAACATCTAGTTCTGGCCGCA 69 FBan0032341 FBgn0052341 CG32341 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32341 CG32341 BcDNA:SD01284 CDMC33463 1 20 2 DAC03-M02 23-CG32341-RA_20 CG32341 AATCAACCAGATCACGCACTTGAAATAAAACTGTCAAAGATCTGTGGGGAACATCTAGTTCTGGCCGCA 69 FBan0032341 FBgn0052341 CG32341 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32341 CG32341 BcDNA:SD01284 CDMC33464 1 21 2 DAC03-M14 23-CG32351-RA_3 CG32351 CGAACGGTGTTTAAGTTTAATGAGACGATGCCACACGTTCATCGGTATTCTTTTAACGACTGACCAACC 69 FBan0032351 FBgn0052351 CG32351 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0008237; ; GO:0004178 ; EC:3.4.11.1 cytoplasm; GO:0005737 CG32351 CG32351 "anon-WO0140519.85, BcDNA:LP03301" CDMC33464 1 22 2 DAC03-M14 23-CG32351-RA_3 CG32351 CGAACGGTGTTTAAGTTTAATGAGACGATGCCACACGTTCATCGGTATTCTTTTAACGACTGACCAACC 69 FBan0032351 FBgn0052351 CG32351 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0008237; ; GO:0004178 ; EC:3.4.11.1 cytoplasm; GO:0005737 CG32351 CG32351 "anon-WO0140519.85, BcDNA:LP03301" CDMC33465 1 23 2 DAC04-A02 2-CG2916-RA_1 CG2916 TCCAAGTCGGAGCTGTCGGGGTTTAAGGAACGCATAATGGACGAACTACGGCGGAACAATGTGAGCATA 69 FBan0002916 FBgn0026361 5-Sep 2 2R cytokinesis; GO:0000910; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 septin ring; GO:0005940 5-Sep 5-Sep "CG2916, CG2916, CG2916, CG2916, CG2916, sep5, septin, Sep" CDMC33465 1 24 2 DAC04-A02 2-CG2916-RA_1 CG2916 TCCAAGTCGGAGCTGTCGGGGTTTAAGGAACGCATAATGGACGAACTACGGCGGAACAATGTGAGCATA 69 FBan0002916 FBgn0026361 5-Sep 2 2R cytokinesis; GO:0000910; mitosis; GO:0007067 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 septin ring; GO:0005940 5-Sep 5-Sep "CG2916, CG2916, CG2916, CG2916, CG2916, sep5, septin, Sep" CDMC33466 1 25 2 DAC04-A14 23-CG2930-RB_4 CG2930 CATTAGCGCTGACAAAATACCTAAAGTCCTTACTGATAATACGGCTTGGTCTCTGTTCCTCAATCCGCT 69 FBan0002930 FBgn0028491 CG2930 X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG2930 CG2930 "CG32780, CG32787, BcDNA:GH06717" CDMC33466 1 26 2 DAC04-A14 23-CG2930-RB_4 CG2930 CATTAGCGCTGACAAAATACCTAAAGTCCTTACTGATAATACGGCTTGGTCTCTGTTCCTCAATCCGCT 69 FBan0002930 FBgn0028491 CG2930 X X oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG2930 CG2930 "CG32780, CG32787, BcDNA:GH06717" CDMC33467 1 1 3 DAC04-E02 12-CG2974-RA_1 CG2974 GCTGTGCGTCAAGCTGTGATTTCTGCATTTATGCGGTTTCCCAATAAACGATGGAGTCTTGAGCCGCAA 69 FBan0002974 FBgn0030178 CG2974 X X CG2974 CG2974 CDMC33467 1 2 3 DAC04-E02 12-CG2974-RA_1 CG2974 GCTGTGCGTCAAGCTGTGATTTCTGCATTTATGCGGTTTCCCAATAAACGATGGAGTCTTGAGCCGCAA 69 FBan0002974 FBgn0030178 CG2974 X X CG2974 CG2974 CDMC33468 1 3 3 DAC04-E14 5-CG2985-RA_1 CG2985 ACCAACCAGGACAGCAAGGACTACCAGTAAGGATGAGTCTGCTTACTCTGGACACCTGGAATGGCAACT 69 FBan0002985 FBgn0004045 Yp1 X X phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 catalytic activity; GO:0003824; structural molecule activity; GO:0005198; ; GO:0003824; ; GO:0005198 Yp1 Yolk protein 1 "CG2985, fs(1)1163, YP1, YPI, yp1, YP, VG1, vitellogenin, YP[[1]], YP-1, yolk protein, DmYP1, yp-1, yolk protein I, yp, yolk-protein 1, yolk protein 1, fs(1)A1163" CDMC33468 1 4 3 DAC04-E14 5-CG2985-RA_1 CG2985 ACCAACCAGGACAGCAAGGACTACCAGTAAGGATGAGTCTGCTTACTCTGGACACCTGGAATGGCAACT 69 FBan0002985 FBgn0004045 Yp1 X X phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 catalytic activity; GO:0003824; structural molecule activity; GO:0005198; ; GO:0003824; ; GO:0005198 Yp1 Yolk protein 1 "CG2985, fs(1)1163, YP1, YPI, yp1, YP, VG1, vitellogenin, YP[[1]], YP-1, yolk protein, DmYP1, yp-1, yolk protein I, yp, yolk-protein 1, yolk protein 1, fs(1)A1163" CDMC33469 1 5 3 DAC04-I02 2-CG30011-RC_2 CG30011 ATCAACAAGCAGGACAACAACTAAGCGATGTTCTGGCAACGCGTATGCACTGCAGTAGAGACCACCCGA 69 FBan0030011 FBgn0050011 gem 2 2R defense response; GO:0006952; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 gem gemini "CG11867, CG3459, CG30011, CG11867, CG3459, CG11867, CG30011, CG30011, dCP2, persephone, BcDNA:HL07889, anon-AE003830.1, gemini" CDMC33469 1 6 3 DAC04-I02 2-CG30011-RC_2 CG30011 ATCAACAAGCAGGACAACAACTAAGCGATGTTCTGGCAACGCGTATGCACTGCAGTAGAGACCACCCGA 69 FBan0030011 FBgn0050011 gem 2 2R defense response; GO:0006952; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 gem gemini "CG11867, CG3459, CG30011, CG11867, CG3459, CG11867, CG30011, CG30011, dCP2, persephone, BcDNA:HL07889, anon-AE003830.1, gemini" CDMC33470 1 7 3 DAC04-I14 8-CG30019-RC_1 CG30019 GCGCTGATCGGTTGCCAAAATTTGGGAGACATCACGTCGGCAATGGTGGTACATGAGAGTCAATATGCC 69 FBgn0050019 CDMC33470 1 8 3 DAC04-I14 8-CG30019-RC_1 CG30019 GCGCTGATCGGTTGCCAAAATTTGGGAGACATCACGTCGGCAATGGTGGTACATGAGAGTCAATATGCC 69 FBgn0050019 CDMC33471 1 9 3 DAC04-M02 15-CG3004-RA_1 CG3004 GCCAACCCAGCGAGACAATCCGCCAGGAACAAATAATTTGGCATTTTTTGAAACAGTGGGGAGAGTAGC 69 FBan0003004 FBgn0030142 CG3004 X X rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729; GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG3004 CG3004 CDMC33471 1 10 3 DAC04-M02 15-CG3004-RA_1 CG3004 GCCAACCCAGCGAGACAATCCGCCAGGAACAAATAATTTGGCATTTTTTGAAACAGTGGGGAGAGTAGC 69 FBan0003004 FBgn0030142 CG3004 X X rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729; GTPase activity; GO:0003924; ; GO:0003924 heterotrimeric G-protein complex; GO:0005834 CG3004 CG3004 CDMC33472 1 11 3 DAC04-M14 6-CG30060-RA_3 CG30060 CCACGGCAGTAACATCCATCGAATCGTCTTCCTGGCCTTCAAGCAGTATCTGGAGCTCGATTTCGACGA 69 FBan0030060 FBgn0050060 CG30060 2 2R signal transduction; GO:0007165 phosphatidylethanolamine binding; GO:0008429; kinase inhibitor activity; GO:0019210; ; GO:0019210; ; GO:0008429; ; GO:0008429 CG30060 CG30060 CDMC33472 1 12 3 DAC04-M14 6-CG30060-RA_3 CG30060 CCACGGCAGTAACATCCATCGAATCGTCTTCCTGGCCTTCAAGCAGTATCTGGAGCTCGATTTCGACGA 69 FBan0030060 FBgn0050060 CG30060 2 2R signal transduction; GO:0007165 phosphatidylethanolamine binding; GO:0008429; kinase inhibitor activity; GO:0019210; ; GO:0019210; ; GO:0008429; ; GO:0008429 CG30060 CG30060 CDMC33473 1 13 3 DAC05-A02 18-CG17570-RA_1 CG17570 GGTCCACGAAAAGTATATGGTTGTCCGTGGATTCCTGAGTCGTGACAAAAGAAATCTGCTCGCTGGTC 68 FBan0017570 FBgn0032948 CG17570 2 2L CG17570 CG17570 CDMC33473 1 14 3 DAC05-A02 18-CG17570-RA_1 CG17570 GGTCCACGAAAAGTATATGGTTGTCCGTGGATTCCTGAGTCGTGACAAAAGAAATCTGCTCGCTGGTC 68 FBan0017570 FBgn0032948 CG17570 2 2L CG17570 CG17570 CDMC33474 1 15 3 DAC05-A14 1-CG1787-RA_1 CG1787 GCTGTGGTCGCAATTCCATCAGCGGAACCTCAATGCATGGGACGAGATTAACGAGCGTATGTATCCGG 68 FBan0001787 FBgn0041629 Hexo2 X X polysaccharide metabolism; GO:0005976 "beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-" Hexo2 Hexosaminidase 2 "CG1787, DmHex2, HEX 2, HEX2, Hexosaminidase 2" CDMC33474 1 16 3 DAC05-A14 1-CG1787-RA_1 CG1787 GCTGTGGTCGCAATTCCATCAGCGGAACCTCAATGCATGGGACGAGATTAACGAGCGTATGTATCCGG 68 FBan0001787 FBgn0041629 Hexo2 X X polysaccharide metabolism; GO:0005976 "beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-" Hexo2 Hexosaminidase 2 "CG1787, DmHex2, HEX 2, HEX2, Hexosaminidase 2" CDMC33475 1 17 3 DAC05-E02 2-CG1967-RA_1 CG1967 GCGGTGGATTGCTTCTACGAGGAGATCAAGAAGAACTCGAGCGCCTACTTTGAGTTCCAGGTGTCGGC 68 FBan0001967 FBgn0030341 CG1967 X X intracellular protein transport; GO:0006886; post-Golgi transport; GO:0006892 intracellular transporter activity; GO:0005478; protein carrier activity; GO:0008320; ; GO:0005478; ; GO:0008320 coated vesicle; GO:0030135; membrane; GO:0016020; transport vesicle; GO:0030133 CG1967 CG1967 "clone 1.45, anon-EST:Liang-1.45" CDMC33475 1 18 3 DAC05-E02 2-CG1967-RA_1 CG1967 GCGGTGGATTGCTTCTACGAGGAGATCAAGAAGAACTCGAGCGCCTACTTTGAGTTCCAGGTGTCGGC 68 FBan0001967 FBgn0030341 CG1967 X X intracellular protein transport; GO:0006886; post-Golgi transport; GO:0006892 intracellular transporter activity; GO:0005478; protein carrier activity; GO:0008320; ; GO:0005478; ; GO:0008320 coated vesicle; GO:0030135; membrane; GO:0016020; transport vesicle; GO:0030133 CG1967 CG1967 "clone 1.45, anon-EST:Liang-1.45" CDMC33476 1 19 3 DAC05-E14 3-CG2107-RA_6 CG2107 GCTGGACTCCAGTGGATACATCGAGAGTCCCAGTGTGATTCTGGGCAGACTAAGGGCTGTGCTTAAGC 68 FBan0002107 FBgn0035383 CG2107 3 3L amino acid metabolism; GO:0006520 carnitine O-palmitoyltransferase activity; GO:0004095 ; EC:2.3.1.21; ; GO:0004095 ; EC:2.3.1.21 CG2107 CG2107 CDMC33476 1 20 3 DAC05-E14 3-CG2107-RA_6 CG2107 GCTGGACTCCAGTGGATACATCGAGAGTCCCAGTGTGATTCTGGGCAGACTAAGGGCTGTGCTTAAGC 68 FBan0002107 FBgn0035383 CG2107 3 3L amino acid metabolism; GO:0006520 carnitine O-palmitoyltransferase activity; GO:0004095 ; EC:2.3.1.21; ; GO:0004095 ; EC:2.3.1.21 CG2107 CG2107 CDMC33477 1 21 3 DAC05-I02 2-CG2979-RA_1 CG2979 AGGAAGCAGAACGGTGAACAGGATGATACCAAGACCGGAGACCTGATTGTGATTCAGCTGGGCAATGC 68 FBan0002979 FBgn0005391 Yp2 X X oogenesis (sensu Insecta); GO:0009993; phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 catalytic activity; GO:0003824; structural molecule activity; GO:0005198; ; GO:0003824; ; GO:0005198 NOT ACF complex; GO:0016590 Yp2 Yolk protein 2 "CG2979, YP2, YPII, fs(1)K313, fs(1)m35, yp2, fs(1)M35, YP, VG2, vitellogenin, YP[[2]], YP-2, yolk protein, yp, fs(1)A59" CDMC33477 1 22 3 DAC05-I02 2-CG2979-RA_1 CG2979 AGGAAGCAGAACGGTGAACAGGATGATACCAAGACCGGAGACCTGATTGTGATTCAGCTGGGCAATGC 68 FBan0002979 FBgn0005391 Yp2 X X oogenesis (sensu Insecta); GO:0009993; phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 catalytic activity; GO:0003824; structural molecule activity; GO:0005198; ; GO:0003824; ; GO:0005198 NOT ACF complex; GO:0016590 Yp2 Yolk protein 2 "CG2979, YP2, YPII, fs(1)K313, fs(1)m35, yp2, fs(1)M35, YP, VG2, vitellogenin, YP[[2]], YP-2, yolk protein, yp, fs(1)A59" CDMC33478 1 23 3 DAC05-I14 2-CG30194-RB_1 CG30194 TACACGCTTGGCTTCAAGGATCAGGATGTGTTCTATACTCCCTTGCCCCTATATCACACCGCTGGCGG 68 FBan0030194 FBgn0050194 CG30194 2 2R fatty acid metabolism; GO:0006631; long-chain fatty acid transport; GO:0015909 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain fatty acid transporter activity; GO:0005324; ; GO:0005324 CG30194 CG30194 "CG13536, CG3037" CDMC33478 1 24 3 DAC05-I14 2-CG30194-RB_1 CG30194 TACACGCTTGGCTTCAAGGATCAGGATGTGTTCTATACTCCCTTGCCCCTATATCACACCGCTGGCGG 68 FBan0030194 FBgn0050194 CG30194 2 2R fatty acid metabolism; GO:0006631; long-chain fatty acid transport; GO:0015909 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain fatty acid transporter activity; GO:0005324; ; GO:0005324 CG30194 CG30194 "CG13536, CG3037" CDMC33479 1 25 3 DAC05-M02 3-CG31226-RA_1 CG31226 GTGGACCAAGTGGATTCTACGATCCGTGCTTTGGACCCTACAACGGACCATTTAACTCCTGGTGCGGA 68 FBan0031226 FBgn0051226 CG31226 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31226 CG31226 "BcDNA:AT26083, NEST:bs14h12" CDMC33479 1 26 3 DAC05-M02 3-CG31226-RA_1 CG31226 GTGGACCAAGTGGATTCTACGATCCGTGCTTTGGACCCTACAACGGACCATTTAACTCCTGGTGCGGA 68 FBan0031226 FBgn0051226 CG31226 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31226 CG31226 "BcDNA:AT26083, NEST:bs14h12" CDMC33480 1 1 4 DAC05-M14 2-CG31305-RB_1 CG31305 GCGGCGAAGAAGTACAACGGCATCTTTGATTGCGTTAAGAAGACGGTGGGAGAACGTGGATTCCTGGG 68 FBgn0051305 CDMC33480 1 2 4 DAC05-M14 2-CG31305-RB_1 CG31305 GCGGCGAAGAAGTACAACGGCATCTTTGATTGCGTTAAGAAGACGGTGGGAGAACGTGGATTCCTGGG 68 FBgn0051305 CDMC33481 1 3 4 DAC06-A02 6-CG5216-RA_2 CG5216 GCGTCTGCAGCCTGGAACATTCTATTCGCACACCAACAACTATTCGTATGTGTTTCCAGGAGCCCAGGT 69 FBan0005216 FBgn0024291 Sir2 2 2L "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; determination of adult life span; GO:0008340; histone deacetylation; GO:0016575; regulation of transcription, DNA-dependent; GO:0006355; response to nutrient; GO:0007584" chromatin binding; GO:0003682; NAD-dependent histone deacetylase activity; GO:0017136; ; GO:0017136; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0017136; ; GO:0004407 ; EC:3.5.1.- chromatin silencing complex; GO:0005677; cytoplasm; GO:0005737; nucleus; GO:0005634 Sir2 Sir2 "CG5216, CG5216, dSIR2, D.mel1, dSir2, SIR2, dsir2, dmSRT406, Sir2L, l(2)05326, BEST:LD38188" CDMC33481 1 4 4 DAC06-A02 6-CG5216-RA_2 CG5216 GCGTCTGCAGCCTGGAACATTCTATTCGCACACCAACAACTATTCGTATGTGTTTCCAGGAGCCCAGGT 69 FBan0005216 FBgn0024291 Sir2 2 2L "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; determination of adult life span; GO:0008340; histone deacetylation; GO:0016575; regulation of transcription, DNA-dependent; GO:0006355; response to nutrient; GO:0007584" chromatin binding; GO:0003682; NAD-dependent histone deacetylase activity; GO:0017136; ; GO:0017136; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0017136; ; GO:0004407 ; EC:3.5.1.- chromatin silencing complex; GO:0005677; cytoplasm; GO:0005737; nucleus; GO:0005634 Sir2 Sir2 "CG5216, CG5216, dSIR2, D.mel1, dSir2, SIR2, dsir2, dmSRT406, Sir2L, l(2)05326, BEST:LD38188" CDMC33482 1 5 4 DAC06-A14 3-CG5231-RB_2 CG5231 TGGCAAAGGGTCCGAATTTCCATGACTTTGTGCAGAATCCGGACAACACCAGAAACGAGTGGGAACAGT 69 FBan0005231 FBgn0029158 Las 3 3L coenzyme metabolism; GO:0006732; lipoate biosynthesis; GO:0009107; lipoic acid biosynthesis; GO:0009105; prosthetic group metabolism; GO:0051189 lipoic acid synthase activity; GO:0017140; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0017140; ; GO:0005506; lipoate synthase activity; GO:0016992; ; GO:0016992 mitochondrion; GO:0005739 Las Lipoic acid synthase "CG5231, CG5231, Lipoic acid synthase" CDMC33482 1 6 4 DAC06-A14 3-CG5231-RB_2 CG5231 TGGCAAAGGGTCCGAATTTCCATGACTTTGTGCAGAATCCGGACAACACCAGAAACGAGTGGGAACAGT 69 FBan0005231 FBgn0029158 Las 3 3L coenzyme metabolism; GO:0006732; lipoate biosynthesis; GO:0009107; lipoic acid biosynthesis; GO:0009105; prosthetic group metabolism; GO:0051189 lipoic acid synthase activity; GO:0017140; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0017140; ; GO:0005506; lipoate synthase activity; GO:0016992; ; GO:0016992 mitochondrion; GO:0005739 Las Lipoic acid synthase "CG5231, CG5231, Lipoic acid synthase" CDMC33483 1 7 4 DAC06-E02 23-CG5270-RA_2 CG5270 GCAAGTATTCCACCCTCCAGCTCAAAAAGACTCTCCCAGCATGTAACCAAATTATATTATTGATTGTAC 69 FBan0005270 FBgn0037897 CG5270 3 3R CG5270 CG5270 CDMC33483 1 8 4 DAC06-E02 23-CG5270-RA_2 CG5270 GCAAGTATTCCACCCTCCAGCTCAAAAAGACTCTCCCAGCATGTAACCAAATTATATTATTGATTGTAC 69 FBan0005270 FBgn0037897 CG5270 3 3R CG5270 CG5270 CDMC33484 1 9 4 DAC06-E14 12-CG5281-RA_1 CG5281 AGTGTGGTTCCAGAGCAACTAAAAGAGTTCGCGGTTTCTCCCTCGTCTTGTCACATCGTTCTCACCCAA 69 FBan0005281 FBgn0037902 CG5281 3 3R CG5281 CG5281 CDMC33484 1 10 4 DAC06-E14 12-CG5281-RA_1 CG5281 AGTGTGGTTCCAGAGCAACTAAAAGAGTTCGCGGTTTCTCCCTCGTCTTGTCACATCGTTCTCACCCAA 69 FBan0005281 FBgn0037902 CG5281 3 3R CG5281 CG5281 CDMC33485 1 11 4 DAC06-I02 23-CG5327-RA_1 CG5327 CGTCCATCCAACTTATCAATAGCAGATTTTACCAATACCCTCGGCTATATAATACACGTATTTCTCAGT 69 FBan0005327 FBgn0034363 CG5327 2 2R CG5327 CG5327 NEST:bs33e07 CDMC33485 1 12 4 DAC06-I02 23-CG5327-RA_1 CG5327 CGTCCATCCAACTTATCAATAGCAGATTTTACCAATACCCTCGGCTATATAATACACGTATTTCTCAGT 69 FBan0005327 FBgn0034363 CG5327 2 2R CG5327 CG5327 NEST:bs33e07 CDMC33486 1 13 4 DAC06-I14 7-CG5339-RA_1 CG5339 TGCAGAACCTGGAATTGATTCTGTGCCTCAACGTATTGGACCGCTGCTTCGATTCATTCAAGCTGCTCG 69 FBan0005339 FBgn0034925 CG5339 2 2R CG5339 CG5339 CDMC33486 1 14 4 DAC06-I14 7-CG5339-RA_1 CG5339 TGCAGAACCTGGAATTGATTCTGTGCCTCAACGTATTGGACCGCTGCTTCGATTCATTCAAGCTGCTCG 69 FBan0005339 FBgn0034925 CG5339 2 2R CG5339 CG5339 CDMC33487 1 15 4 DAC06-M02 2-CG5381-RA_1 CG5381 CCAGCCTAATCCCTGCACTTCCAGTACTCCCGAGTGCAACGCTAGCATTCACATAAAGCAGTCTTCCGA 69 FBan0005381 FBgn0032218 CG5381 2 2L CG5381 CG5381 CDMC33487 1 16 4 DAC06-M02 2-CG5381-RA_1 CG5381 CCAGCCTAATCCCTGCACTTCCAGTACTCCCGAGTGCAACGCTAGCATTCACATAAAGCAGTCTTCCGA 69 FBan0005381 FBgn0032218 CG5381 2 2L CG5381 CG5381 CDMC33488 1 17 4 DAC06-M14 9-CG5393-RA_1 CG5393 AAAGCAGGATCCACAGCTACACATCCAGACCCGACACACAGAGAGACATTCCTGGCATTGTTGATCAGT 69 FBan0005393 FBgn0015903 apt 2 2R central nervous system development; GO:0007417; heart development; GO:0007507; negative regulation of oskar mRNA translation; GO:0007319; neuromuscular synaptic transmission; GO:0007274; primary tracheal branching (sensu Insecta); GO:0007428; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 apt apontic "CG5393, CG5393, CG5393, CG5393, CG5393, CG5393, tdf, tracheae defective, l(2)09049, l(2)59Ea, 3041, l(2)06369, Trachea defective, TDF, TDF/APT, l(2)03041, l(2)k11531, apontic" CDMC33488 1 18 4 DAC06-M14 9-CG5393-RA_1 CG5393 AAAGCAGGATCCACAGCTACACATCCAGACCCGACACACAGAGAGACATTCCTGGCATTGTTGATCAGT 69 FBan0005393 FBgn0015903 apt 2 2R central nervous system development; GO:0007417; heart development; GO:0007507; negative regulation of oskar mRNA translation; GO:0007319; neuromuscular synaptic transmission; GO:0007274; primary tracheal branching (sensu Insecta); GO:0007428; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003677 nucleus; GO:0005634 apt apontic "CG5393, CG5393, CG5393, CG5393, CG5393, CG5393, tdf, tracheae defective, l(2)09049, l(2)59Ea, 3041, l(2)06369, Trachea defective, TDF, TDF/APT, l(2)03041, l(2)k11531, apontic" CDMC33489 1 19 4 DAC07-A02 15-CG9728-RA_1 CG9728 AGCCTGGATCCCTATGTGGCAACCTTCCATGATATACTGAGTCCCGGAAAGATCTCGCAGCTCCG 65 FBan0009728 FBgn0039780 PH4alphaNE1 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401; two-component signal transduction system (phosphorelay); GO:0000160 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE1 prolyl-4-hydroxylase-alpha NE1 "CG9728, prolyl-4-hydroxylase-alpha NE1" CDMC33489 1 20 4 DAC07-A02 15-CG9728-RA_1 CG9728 AGCCTGGATCCCTATGTGGCAACCTTCCATGATATACTGAGTCCCGGAAAGATCTCGCAGCTCCG 65 FBan0009728 FBgn0039780 PH4alphaNE1 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401; two-component signal transduction system (phosphorelay); GO:0000160 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2; two-component sensor molecule activity; GO:0000155 ; EC:2.7.3.-; ; GO:0000155 ; EC:2.7.3.- "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaNE1 prolyl-4-hydroxylase-alpha NE1 "CG9728, prolyl-4-hydroxylase-alpha NE1" CDMC33490 1 21 4 DAC07-A14 3-CG9761-RA_1 CG9761 CATTGTCCAGAGGGATCACCCATGAATCCGGTCCAAAAGTGCGAGGTTTGGTAGGAACTGCTCCG 65 FBan0009761 FBgn0027570 Nep2 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep2 Neprilysin 2 "CG9761, CG9761, CG9761, dNEP2, BcDNA:GH07643, Neprilysin 2" CDMC33490 1 22 4 DAC07-A14 3-CG9761-RA_1 CG9761 CATTGTCCAGAGGGATCACCCATGAATCCGGTCCAAAAGTGCGAGGTTTGGTAGGAACTGCTCCG 65 FBan0009761 FBgn0027570 Nep2 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11; ; GO:0016511 membrane; GO:0016020 Nep2 Neprilysin 2 "CG9761, CG9761, CG9761, dNEP2, BcDNA:GH07643, Neprilysin 2" CDMC33491 1 23 4 DAC07-E02 16-CG9873-RA_1 CG9873 GCAACTCGTCGTACCATCTGCAGAAATCGAAGTGCTCCCAGTGCGGCTATCCTGCGGCCAAGACC 65 FBan0009873 FBgn0034822 RpL37b 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL37b Ribosomal protein L37b "CG9873, CG9873, Ribosomal protein L37b" CDMC33491 1 24 4 DAC07-E02 16-CG9873-RA_1 CG9873 GCAACTCGTCGTACCATCTGCAGAAATCGAAGTGCTCCCAGTGCGGCTATCCTGCGGCCAAGACC 65 FBan0009873 FBgn0034822 RpL37b 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL37b Ribosomal protein L37b "CG9873, CG9873, Ribosomal protein L37b" CDMC33492 1 25 4 DAC07-E14 23-CG9906-RA_2 CG9906 GAAGATGAGGAAGACACATTAAAGAACAAGGAACCTACCCCAAAAAAAAGGAAGCGTAAAGCACT 65 FBan0009906 FBgn0030755 CG9906 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 unfolded protein binding; GO:0051082; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0051082 CG9906 CG9906 Calnexin CDMC33492 1 26 4 DAC07-E14 23-CG9906-RA_2 CG9906 GAAGATGAGGAAGACACATTAAAGAACAAGGAACCTACCCCAAAAAAAAGGAAGCGTAAAGCACT 65 FBan0009906 FBgn0030755 CG9906 X X exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 unfolded protein binding; GO:0051082; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0051082 CG9906 CG9906 Calnexin CDMC33493 1 1 5 DAC07-I02 11-CR30249-RA_1 CR30249 GTGATCGTCTAGTGGTTAGGACCCCACGTTGTGGCCGTGGTAACCCAGGTTCGAATCCTGGTCAC 65 FBan0030249 FBgn0050249 CR30249 2 2R CR30249 CR30249 "AE002787.trna21-HisGTG, tRNA:H:GTG:AE002787-d" CDMC33493 1 2 5 DAC07-I02 11-CR30249-RA_1 CR30249 GTGATCGTCTAGTGGTTAGGACCCCACGTTGTGGCCGTGGTAACCCAGGTTCGAATCCTGGTCAC 65 FBan0030249 FBgn0050249 CR30249 2 2R CR30249 CR30249 "AE002787.trna21-HisGTG, tRNA:H:GTG:AE002787-d" CDMC33494 1 3 5 DAC07-I14 18-CR31379-RA_1 CR31379 AAATTGGAACGATACAGAGAAGATTAGCATGGCCCCTGCGCAAGGATGACACGCAAAATCGTGAA 65 FBan0031379 FBgn0004188 snRNA:U6:96Aa 3 3R nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U6; GO:0005688 snRNA:U6:96Aa small nuclear RNA U6 at 96Aa "dU6, K1, snRNA[[4]], U6-1, DU6-1, U6 RNA, U6, U6snRNA, U6-1 small nuclear RNA, snRNA-b, U6-96Aa, snRNA:U6, CR31379, U6snRNA96Aa, snRNA4, snRNA6, small nuclear RNA U6, small nuclear RNA b" CDMC33494 1 4 5 DAC07-I14 18-CR31379-RA_1 CR31379 AAATTGGAACGATACAGAGAAGATTAGCATGGCCCCTGCGCAAGGATGACACGCAAAATCGTGAA 65 FBan0031379 FBgn0004188 snRNA:U6:96Aa 3 3R nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U6; GO:0005688 snRNA:U6:96Aa small nuclear RNA U6 at 96Aa "dU6, K1, snRNA[[4]], U6-1, DU6-1, U6 RNA, U6, U6snRNA, U6-1 small nuclear RNA, snRNA-b, U6-96Aa, snRNA:U6, CR31379, U6snRNA96Aa, snRNA4, snRNA6, small nuclear RNA U6, small nuclear RNA b" CDMC33495 1 5 5 DAC07-M02 24-CR32873-RA_1 CR32873 GACGTTGCCTTGTGTAAAAGATCTTGATATAAAAAGAATTGGACATCTTCAAATACTAAAATAAA 65 FBan0032873 FBgn0063449 Uhg2 2 2L Uhg2 U snoRNA host gene 2 "dUHG2, Dros-UHG2, CR32873, U snoRNA host gene 2" CDMC33495 1 6 5 DAC07-M02 24-CR32873-RA_1 CR32873 GACGTTGCCTTGTGTAAAAGATCTTGATATAAAAAGAATTGGACATCTTCAAATACTAAAATAAA 65 FBan0032873 FBgn0063449 Uhg2 2 2L Uhg2 U snoRNA host gene 2 "dUHG2, Dros-UHG2, CR32873, U snoRNA host gene 2" CDMC33496 1 7 5 DAC07-M14 23-CR32895-RA_1 CR32895 CAGCTCGCTTTGATATACAATGAAGAGAACTGTTCCATATCCAACGCAAAACTAAAATGCTGATT 65 FBan0032895 FBgn0063382 snoRNA:U29:54Ed 2 2R snoRNA:U29:54Ed snoRNA:U29:54Ed "U29snoRNA, CR32895" CDMC33496 1 8 5 DAC07-M14 23-CR32895-RA_1 CR32895 CAGCTCGCTTTGATATACAATGAAGAGAACTGTTCCATATCCAACGCAAAACTAAAATGCTGATT 65 FBan0032895 FBgn0063382 snoRNA:U29:54Ed 2 2R snoRNA:U29:54Ed snoRNA:U29:54Ed "U29snoRNA, CR32895" CDMC33497 1 9 5 DAC08-A02 16-CG5594-RB_6 CG5594 GGCGTCCCCAAATTTTGGTGCTTTCGAAGCTCAACGACAACCTCTTGCCAAAATACAGGAAGATATTCT 69 FBan0005594 FBgn0025698 CG5594 2 2R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 potassium:chloride symporter activity; GO:0015379; ; GO:0015379; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015379; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021 CG5594 CG5594 "CG2768, CK01510, BEST:CK01510" CDMC33497 1 10 5 DAC08-A02 16-CG5594-RB_6 CG5594 GGCGTCCCCAAATTTTGGTGCTTTCGAAGCTCAACGACAACCTCTTGCCAAAATACAGGAAGATATTCT 69 FBan0005594 FBgn0025698 CG5594 2 2R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 potassium:chloride symporter activity; GO:0015379; ; GO:0015379; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015379; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021 CG5594 CG5594 "CG2768, CK01510, BEST:CK01510" CDMC33498 1 11 5 DAC08-A14 2-CG5605-RA_2 CG5605 GCCGACGACAACAAATTTGGATTCATCGTGATGGATGGTAACGGAGCGCTATTCGGTACCCTTCAGGGC 69 FBan0005605 FBgn0036974 eRF1 3 3L autophagic cell death; GO:0048102; protein targeting; GO:0006605; salivary gland cell autophagic cell death; GO:0035071; smoothened signaling pathway; GO:0007224; translational termination; GO:0006415 "translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; translation release factor activity, codon specific; GO:0016149; ; GO:0016149" cytoplasm; GO:0005737; cytosol; GO:0005829; translation release factor complex; GO:0018444 eRF1 eukaryotic release factor 1 "CG5605, CG5605, CG5605, l(3)neo28, l(3)05637, l(3)00103, l(3)77ABb, Dm0184, Group J, group J, eukaryotic release factor 1" CDMC33498 1 12 5 DAC08-A14 2-CG5605-RA_2 CG5605 GCCGACGACAACAAATTTGGATTCATCGTGATGGATGGTAACGGAGCGCTATTCGGTACCCTTCAGGGC 69 FBan0005605 FBgn0036974 eRF1 3 3L autophagic cell death; GO:0048102; protein targeting; GO:0006605; salivary gland cell autophagic cell death; GO:0035071; smoothened signaling pathway; GO:0007224; translational termination; GO:0006415 "translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; translation release factor activity, codon specific; GO:0016149; ; GO:0016149" cytoplasm; GO:0005737; cytosol; GO:0005829; translation release factor complex; GO:0018444 eRF1 eukaryotic release factor 1 "CG5605, CG5605, CG5605, l(3)neo28, l(3)05637, l(3)00103, l(3)77ABb, Dm0184, Group J, group J, eukaryotic release factor 1" CDMC33499 1 13 5 DAC08-E02 3-CG5639-RA_1 CG5639 GGAGTCCAGTGTTACGGAGAGAGTACTAGAGCTGGCGAACTCACTGCTGGACTCTCAGCTATCCGTGGA 69 FBan0005639 FBgn0039527 CG5639 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5639 CG5639 "CT17816, N-like" CDMC33499 1 14 5 DAC08-E02 3-CG5639-RA_1 CG5639 GGAGTCCAGTGTTACGGAGAGAGTACTAGAGCTGGCGAACTCACTGCTGGACTCTCAGCTATCCGTGGA 69 FBan0005639 FBgn0039527 CG5639 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5639 CG5639 "CT17816, N-like" CDMC33500 1 15 5 DAC08-E14 23-CG5652-RA_3 CG5652 CGGATTAGTCTGGATGCACACACTCTTTCTTAGCTATGTATAACTTGTAAATGTCTTAGCATTTAGTGG 69 FBgn0027917 CDMC33500 1 16 5 DAC08-E14 23-CG5652-RA_3 CG5652 CGGATTAGTCTGGATGCACACACTCTTTCTTAGCTATGTATAACTTGTAAATGTCTTAGCATTTAGTGG 69 FBgn0027917 CDMC33501 1 17 5 DAC08-I02 23-CG5683-RA_19 CG5683 TGACTAAGAACTTACCAAGATGATTGTATAGCAAACGCTTCAAAAGTAGGTAAACGAAAGGCGCCGACA 69 FBan0005683 FBgn0005694 Aef1 3 3L cell proliferation; GO:0008283; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 RNA polymerase II transcription factor activity; GO:0003702; specific transcriptional repressor activity; GO:0016566; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 Aef1 Adult enhancer factor 1 "CG5683, AEF-1, Adh enhancer factor 1" CDMC33501 1 18 5 DAC08-I02 23-CG5683-RA_19 CG5683 TGACTAAGAACTTACCAAGATGATTGTATAGCAAACGCTTCAAAAGTAGGTAAACGAAAGGCGCCGACA 69 FBan0005683 FBgn0005694 Aef1 3 3L cell proliferation; GO:0008283; negative regulation of transcription from RNA polymerase II promoter; GO:0000122 RNA polymerase II transcription factor activity; GO:0003702; specific transcriptional repressor activity; GO:0016566; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0016566; ; GO:0008270 nucleus; GO:0005634 Aef1 Adult enhancer factor 1 "CG5683, AEF-1, Adh enhancer factor 1" CDMC33502 1 19 5 DAC08-I14 8-CG5693-RA_1 CG5693 AGCTCCGGGAACAGAAGTAGTGGGGAAAAAGGCAAAGCTGCAAAAATGAACCAGGAGTCCTTTGGAGAT 69 FBan0005693 FBgn0040989 CG5693 2 2L CG5693 CG5693 CDMC33502 1 20 5 DAC08-I14 8-CG5693-RA_1 CG5693 AGCTCCGGGAACAGAAGTAGTGGGGAAAAAGGCAAAGCTGCAAAAATGAACCAGGAGTCCTTTGGAGAT 69 FBan0005693 FBgn0040989 CG5693 2 2L CG5693 CG5693 CDMC33503 1 21 5 DAC08-M02 18-CG5724-RA_3 CG5724 AGGAAGCCACATAAATCCGGACACGGTTGTGAAGATGTTCAATGTATTGTCGAAGCTCAAGCAAAGGGT 69 FBan0005724 FBgn0038082 CG5724 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG5724 CG5724 CDMC33503 1 22 5 DAC08-M02 18-CG5724-RA_3 CG5724 AGGAAGCCACATAAATCCGGACACGGTTGTGAAGATGTTCAATGTATTGTCGAAGCTCAAGCAAAGGGT 69 FBan0005724 FBgn0038082 CG5724 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG5724 CG5724 CDMC33504 1 23 5 DAC08-M14 23-CG5734-RA_4 CG5734 TTGAATGAAGGCGCTAAAATGTGTTGTAAAGAATTGAATGCTCAAGATGAATGGCACGTTTTACCATCA 69 FBan0005734 FBgn0032191 CG5734 2 2L CG5734 CG5734 CDMC33504 1 24 5 DAC08-M14 23-CG5734-RA_4 CG5734 TTGAATGAAGGCGCTAAAATGTGTTGTAAAGAATTGAATGCTCAAGATGAATGGCACGTTTTACCATCA 69 FBan0005734 FBgn0032191 CG5734 2 2L CG5734 CG5734 CDMC33505 1 25 5 DAC09-A03 1-CG31077-RA_1 CG31077 CCACCTCTGTCGACCCATTTGCCAAATGCAGGGATGGTCAGCTCAGGTTAGATCCCAAAAACTGTGC 67 FBan0031077 FBgn0051077 CG31077 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG31077 CG31077 CDMC33505 1 26 5 DAC09-A03 1-CG31077-RA_1 CG31077 CCACCTCTGTCGACCCATTTGCCAAATGCAGGGATGGTCAGCTCAGGTTAGATCCCAAAAACTGTGC 67 FBan0031077 FBgn0051077 CG31077 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG31077 CG31077 CDMC33506 1 1 6 DAC09-A15 3-CG31265-RA_3 CG31265 GGATCATAACTGCTGGACACTGCGTGGAAAATTTCATTCCCGCCCTGGTCAATGTGATCACGGGCAC 67 FBan0031265 FBgn0051265 CG31265 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31265 CG31265 "CG5233, SP126" CDMC33506 1 2 6 DAC09-A15 3-CG31265-RA_3 CG31265 GGATCATAACTGCTGGACACTGCGTGGAAAATTTCATTCCCGCCCTGGTCAATGTGATCACGGGCAC 67 FBan0031265 FBgn0051265 CG31265 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31265 CG31265 "CG5233, SP126" CDMC33507 1 3 6 DAC09-E03 2-CG3184-RA_1 CG3184 GCTCACGGGTAGCTATGATGAGCAGTTGCGTCTCTTCGACACCAGATCGATGAAGCGATCACTGGCG 67 FBan0003184 FBgn0029892 CG3184 X X CG3184 CG3184 CDMC33507 1 4 6 DAC09-E03 2-CG3184-RA_1 CG3184 GCTCACGGGTAGCTATGATGAGCAGTTGCGTCTCTTCGACACCAGATCGATGAAGCGATCACTGGCG 67 FBan0003184 FBgn0029892 CG3184 X X CG3184 CG3184 CDMC33508 1 5 6 DAC09-E15 9-CG32045-RB_3 CG32045 CGAGCTGCAGGCAACCTCACCCAAGCTCTTTGAGACGTTGCGCTTTAATGTTTTGGAGGTGCAGGAG 67 FBan0032045 FBgn0016081 fry 3 3L NOT frizzled signaling pathway; GO:0007222; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407; regulation of dendrite morphogenesis; GO:0050773; rhabdomere development; GO:0042052; trichome organization and biogenesis (sensu Insecta); GO:0035316; wing morphogenesis; GO:0007476 fry furry "CG32045, CG14171, CG6774, CG6780, l(3)02240, yeti, SS3-7, Suppressor of GMR-sina 3-7, furry" CDMC33508 1 6 6 DAC09-E15 9-CG32045-RB_3 CG32045 CGAGCTGCAGGCAACCTCACCCAAGCTCTTTGAGACGTTGCGCTTTAATGTTTTGGAGGTGCAGGAG 67 FBan0032045 FBgn0016081 fry 3 3L NOT frizzled signaling pathway; GO:0007222; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407; regulation of dendrite morphogenesis; GO:0050773; rhabdomere development; GO:0042052; trichome organization and biogenesis (sensu Insecta); GO:0035316; wing morphogenesis; GO:0007476 fry furry "CG32045, CG14171, CG6774, CG6780, l(3)02240, yeti, SS3-7, Suppressor of GMR-sina 3-7, furry" CDMC33509 1 7 6 DAC09-I03 9-CG32491-RS_3 CG32491 CCGCACCTCATCCAACGAGCACAACTTTGTGTATGTGGGATTGCCTCGCATGAAGGGAAAGTGCGTG 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC33509 1 8 6 DAC09-I03 9-CG32491-RS_3 CG32491 CCGCACCTCATCCAACGAGCACAACTTTGTGTATGTGGGATTGCCTCGCATGAAGGGAAAGTGCGTG 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC33510 1 9 6 DAC09-I15 1-CG32551-RA_3 CG32551 AATATGCAGGGCCCACAAAGTTCGGAGTATGGTGACGGGACATTCAATGGAACGCCCTTTCTACCCG 67 FBan0032551 FBgn0052551 CG32551 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32551 CG32551 CDMC33510 1 10 6 DAC09-I15 1-CG32551-RA_3 CG32551 AATATGCAGGGCCCACAAAGTTCGGAGTATGGTGACGGGACATTCAATGGAACGCCCTTTCTACCCG 67 FBan0032551 FBgn0052551 CG32551 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32551 CG32551 CDMC33511 1 11 6 DAC09-M03 1-CG33278-RA_1 CG33278 GGAACAGCCAAAGTCTTTGCAACAGCAACCTCGAAGTGGTAGACACGCCATTCAGCCTGATTTGCGC 67 FBan0033278 FBgn0053278 CG33278 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33278 CG33278 "CG18656, CG18656, cg18656" CDMC33511 1 12 6 DAC09-M03 1-CG33278-RA_1 CG33278 GGAACAGCCAAAGTCTTTGCAACAGCAACCTCGAAGTGGTAGACACGCCATTCAGCCTGATTTGCGC 67 FBan0033278 FBgn0053278 CG33278 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33278 CG33278 "CG18656, CG18656, cg18656" CDMC33512 1 13 6 DAC09-M15 2-CG33344-RA_1 CG33344 GGTTGGTCGTCGGCTTCACAACAGTTGCGATTCGATGAGGACACTGACCACTTCGTTGACGGTTTCC 67 FBgn0053344 CDMC33512 1 14 6 DAC09-M15 2-CG33344-RA_1 CG33344 GGTTGGTCGTCGGCTTCACAACAGTTGCGATTCGATGAGGACACTGACCACTTCGTTGACGGTTTCC 67 FBgn0053344 CDMC33513 1 15 6 DAC10-A02 23-CG1830-RA_1 CG1830 TAAGAGGAAACACAGTAAGCAAGAAACCAAGAAACAAACCAACAAACGAATTAGCAAAAGCTACTACTA 69 FBan0001830 FBgn0011754 PhKgamma X X embryonic morphogenesis; GO:0048598; glucose catabolism; GO:0006007; glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977; protein amino acid phosphorylation; GO:0006468 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005516; phosphorylase kinase activity; GO:0004689 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004689 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 phosphorylase kinase complex; GO:0005964 PhKgamma Phosphorylase kinase gamma "CG1830, CG1830, DPhK-gamma, phosphorylase kinase gamma, DPhK-gamma, EP779, ESTS:194B3T, anon-sts6" CDMC33513 1 16 6 DAC10-A02 23-CG1830-RA_1 CG1830 TAAGAGGAAACACAGTAAGCAAGAAACCAAGAAACAAACCAACAAACGAATTAGCAAAAGCTACTACTA 69 FBan0001830 FBgn0011754 PhKgamma X X embryonic morphogenesis; GO:0048598; glucose catabolism; GO:0006007; glycogen biosynthesis; GO:0005978; glycogen metabolism; GO:0005977; protein amino acid phosphorylation; GO:0006468 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0005516; phosphorylase kinase activity; GO:0004689 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004689 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 phosphorylase kinase complex; GO:0005964 PhKgamma Phosphorylase kinase gamma "CG1830, CG1830, DPhK-gamma, phosphorylase kinase gamma, DPhK-gamma, EP779, ESTS:194B3T, anon-sts6" CDMC33514 1 17 6 DAC10-A14 1-CG18321-RA_1 CG18321 TCCTGTGCGTACCGTCAGCAAGAAGTGTAAAGCAAATGGCAATTCCAGTGGAGGAAAACAACACGGCCA 69 FBan0018321 FBgn0029002 miple2 3 3L miple2 miple2 CG18321 CDMC33514 1 18 6 DAC10-A14 1-CG18321-RA_1 CG18321 TCCTGTGCGTACCGTCAGCAAGAAGTGTAAAGCAAATGGCAATTCCAGTGGAGGAAAACAACACGGCCA 69 FBan0018321 FBgn0029002 miple2 3 3L miple2 miple2 CG18321 CDMC33515 1 19 6 DAC10-E02 23-CG1837-RA_1 CG1837 GCGATGATAAGCCATTTAGCGAACTTACATTTCAATTTTAAAGTCATTTTGAGTAGCCTACGTTTTAGG 69 FBan0001837 FBgn0030329 CG1837 X X electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG1837 CG1837 anon-EST:Posey253 CDMC33515 1 20 6 DAC10-E02 23-CG1837-RA_1 CG1837 GCGATGATAAGCCATTTAGCGAACTTACATTTCAATTTTAAAGTCATTTTGAGTAGCCTACGTTTTAGG 69 FBan0001837 FBgn0030329 CG1837 X X electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG1837 CG1837 anon-EST:Posey253 CDMC33516 1 21 6 DAC10-E14 9-CG1839-RA_1 CG1839 CCACCAAGCTGCACGAGTTCATCAACAACGATCTTAGTCAGTTTCTGGCGGACAATTGTGTGGATGGCG 69 FBan0001839 FBgn0030555 CG1839 X X CG1839 CG1839 CDMC33516 1 22 6 DAC10-E14 9-CG1839-RA_1 CG1839 CCACCAAGCTGCACGAGTTCATCAACAACGATCTTAGTCAGTTTCTGGCGGACAATTGTGTGGATGGCG 69 FBan0001839 FBgn0030555 CG1839 X X CG1839 CG1839 CDMC33517 1 23 6 DAC10-I02 1-CG18472-RA_1 CG18472 GGGAGGTGCACCTAAGAAGCCACAAAGTCCTCCTATGACACCAAAGGAAACCTTACTGCGTTTGCCACA 69 FBan0018472 FBgn0039463 CG18472 3 3R CG18472 CG18472 CDMC33517 1 24 6 DAC10-I02 1-CG18472-RA_1 CG18472 GGGAGGTGCACCTAAGAAGCCACAAAGTCCTCCTATGACACCAAAGGAAACCTTACTGCGTTTGCCACA 69 FBan0018472 FBgn0039463 CG18472 3 3R CG18472 CG18472 CDMC33518 1 25 6 DAC10-I14 23-CG1848-RC_10 CG1848 AGTTATATTGCGAAAGAGATAGCGAAAGACGGATAAAGAGAGAAGGAAGAAACTTGTGCCATGATGTTG 69 FBan0001848 FBgn0041203 LIMK1 X X actin cytoskeleton organization and biogenesis; GO:0030036; ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515; ; GO:0004674 LIMK1 LIM-kinase1 "CG1848, CG1848, CG1848, LIM-kinase, DLIMK, DLIMK1, LIM-DOMAIN KINASE, Limk, LIM kinase, limk, dLIMK, D-LIMK1, Dlimk, LIMK, LIM-kinase1" CDMC33518 1 26 6 DAC10-I14 23-CG1848-RC_10 CG1848 AGTTATATTGCGAAAGAGATAGCGAAAGACGGATAAAGAGAGAAGGAAGAAACTTGTGCCATGATGTTG 69 FBan0001848 FBgn0041203 LIMK1 X X actin cytoskeleton organization and biogenesis; GO:0030036; ectoderm development; GO:0007398; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515; ; GO:0004674 LIMK1 LIM-kinase1 "CG1848, CG1848, CG1848, LIM-kinase, DLIMK, DLIMK1, LIM-DOMAIN KINASE, Limk, LIM kinase, limk, dLIMK, D-LIMK1, Dlimk, LIMK, LIM-kinase1" CDMC33519 1 1 7 DAC10-M02 18-CG18539-RA_1 CG18539 CTAAACGGTTTCTACAAGGACGCGTTCATCAAGAATGTGGGCCATTGCTCCAATATGGTGCAGTTCGAT 69 FBan0018539 FBgn0034325 CG18539 2 2R CG18539 CG18539 CDMC33519 1 2 7 DAC10-M02 18-CG18539-RA_1 CG18539 CTAAACGGTTTCTACAAGGACGCGTTCATCAAGAATGTGGGCCATTGCTCCAATATGGTGCAGTTCGAT 69 FBan0018539 FBgn0034325 CG18539 2 2R CG18539 CG18539 CDMC33520 1 3 7 DAC10-M14 2-CG18555-RA_2 CG18555 TCCGACAATGTTTCCGAGGATAAGGGTCACATCTGCACACAGTGTCACATGTCCTTTCGGAGACCTGGT 69 FBan0018555 FBgn0031510 CG18555 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18555 CG18555 CDMC33520 1 4 7 DAC10-M14 2-CG18555-RA_2 CG18555 TCCGACAATGTTTCCGAGGATAAGGGTCACATCTGCACACAGTGTCACATGTCCTTTCGGAGACCTGGT 69 FBan0018555 FBgn0031510 CG18555 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18555 CG18555 CDMC33521 1 5 7 DAC11-A02 23-CG10002-RA_5 CG10002 AAGAAGGGATCGTGTGTAATGTTCTTTCATAAAACAAAGCCCCAAATGAAACAGTCCCAAAAAGAGA 67 FBan0010002 FBgn0000659 fkh 3 3R "Malpighian tubule morphogenesis; GO:0007443; anti-apoptosis; GO:0006916; ectodermal gut development; GO:0007439; endoderm formation; GO:0001706; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription, DNA-dependent; GO:0006355; salivary gland determination; GO:0007432; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fkh fork head "CG10002, Sebp2, Secretion enhancer-binding protein 2, FORK HEAD, Fkh, Forkhead, Dmfkh, Fork Head" CDMC33521 1 6 7 DAC11-A02 23-CG10002-RA_5 CG10002 AAGAAGGGATCGTGTGTAATGTTCTTTCATAAAACAAAGCCCCAAATGAAACAGTCCCAAAAAGAGA 67 FBan0010002 FBgn0000659 fkh 3 3R "Malpighian tubule morphogenesis; GO:0007443; anti-apoptosis; GO:0006916; ectodermal gut development; GO:0007439; endoderm formation; GO:0001706; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of transcription, DNA-dependent; GO:0006355; salivary gland determination; GO:0007432; salivary gland development; GO:0007431; salivary gland morphogenesis; GO:0007435" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 fkh fork head "CG10002, Sebp2, Secretion enhancer-binding protein 2, FORK HEAD, Fkh, Forkhead, Dmfkh, Fork Head" CDMC33522 1 7 7 DAC11-A14 18-CG10186-RC_1 CG10186 ATGGGAGATACCTTTGGGAAACCGTCCTCCATGTGGTAAACTCCACTAATGAATCTCTGCGTCTTGC 67 FBan0010186 FBgn0032797 CG10186 2 2L defense response; GO:0006952; electron transport; GO:0006118; transport; GO:0006810 transporter activity; GO:0005215; electron transporter activity; GO:0005489; ; GO:0005215; copper ion binding; GO:0005507; ; GO:0005489; ; GO:0005507 membrane; GO:0016020 CG10186 CG10186 "CT28647, anon-EST:Posey189" CDMC33522 1 8 7 DAC11-A14 18-CG10186-RC_1 CG10186 ATGGGAGATACCTTTGGGAAACCGTCCTCCATGTGGTAAACTCCACTAATGAATCTCTGCGTCTTGC 67 FBan0010186 FBgn0032797 CG10186 2 2L defense response; GO:0006952; electron transport; GO:0006118; transport; GO:0006810 transporter activity; GO:0005215; electron transporter activity; GO:0005489; ; GO:0005215; copper ion binding; GO:0005507; ; GO:0005489; ; GO:0005507 membrane; GO:0016020 CG10186 CG10186 "CT28647, anon-EST:Posey189" CDMC33523 1 9 7 DAC11-E02 2-CG10680-RA_1 CG10680 CGGAGCGAATCCTATAGCTACACATCGGATGGAAGAGGACCTCCCCAAATCGAGCGGGATGTGTTCG 67 FBan0010680 FBgn0032836 CG10680 2 2L CG10680 CG10680 CDMC33523 1 10 7 DAC11-E02 2-CG10680-RA_1 CG10680 CGGAGCGAATCCTATAGCTACACATCGGATGGAAGAGGACCTCCCCAAATCGAGCGGGATGTGTTCG 67 FBan0010680 FBgn0032836 CG10680 2 2L CG10680 CG10680 CDMC33524 1 11 7 DAC11-E14 1-CG10772-RB_1 CG10772 ACTCCGGCGAGAAATCCTATGACGAGAAGAGTCGCAAAGTGGTGGGTGAGATCACGACGAATTCCGG 67 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC33524 1 12 7 DAC11-E14 1-CG10772-RB_1 CG10772 ACTCCGGCGAGAAATCCTATGACGAGAAGAGTCGCAAAGTGGTGGGTGAGATCACGACGAATTCCGG 67 FBan0010772 FBgn0004509 Fur1 3 3R proteolysis; GO:0006508 furin activity; GO:0004276 ; EC:3.4.21.75; ; GO:0004276 ; EC:3.4.21.75; kexin activity; GO:0004290 ; EC:3.4.21.61; ; GO:0004276 ; EC:3.4.21.75; ; GO:0004290 ; EC:3.4.21.61 Golgi stack; GO:0005795; integral to Golgi membrane; GO:0030173; integral to membrane; GO:0016021; plasma membrane; GO:0005886 Fur1 Furin 1 "CG10772, CG10772, Dfur1, Dfurin1, dKLIP-1, l(3)rL205, fur1, dFurin 1, furin, dFur1, Furl, fur[1], Furin-like protease, Furin, Klip1" CDMC33525 1 13 7 DAC11-I02 2-CG11107-RA_2 CG11107 GCCCTGGATGATGACGGAAATCTTACAGACCTGGGTGCCGTTATGTCCGAGTTTCCATTGGATCCGC 67 FBan0011107 FBgn0033160 CG11107 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" "ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; structural constituent of ribosome; GO:0003735; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003735; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0008026; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" ribosome; GO:0005840; spliceosome complex; GO:0005681 CG11107 CG11107 "clone 1.18, cg11107, anon-EST:Liang-1.18" CDMC33525 1 14 7 DAC11-I02 2-CG11107-RA_2 CG11107 GCCCTGGATGATGACGGAAATCTTACAGACCTGGGTGCCGTTATGTCCGAGTTTCCATTGGATCCGC 67 FBan0011107 FBgn0033160 CG11107 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" "ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; structural constituent of ribosome; GO:0003735; ATP-dependent helicase activity; GO:0008026; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003735; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0008026; ; GO:0004004; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" ribosome; GO:0005840; spliceosome complex; GO:0005681 CG11107 CG11107 "clone 1.18, cg11107, anon-EST:Liang-1.18" CDMC33526 1 15 7 DAC11-I14 3-CG11237-RA_4 CG11237 GGATCCCCGGTATGCAAAGAAGATCGAGTCGATTGTCCGCAAGGCTCCCAAGGGTATCAAGCAGTTG 67 FBan0011237 FBgn0034452 Oseg6 2 2R sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg6 Oseg6 "CG11237, OSEG6" CDMC33526 1 16 7 DAC11-I14 3-CG11237-RA_4 CG11237 GGATCCCCGGTATGCAAAGAAGATCGAGTCGATTGTCCGCAAGGCTCCCAAGGGTATCAAGCAGTTG 67 FBan0011237 FBgn0034452 Oseg6 2 2R sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg6 Oseg6 "CG11237, OSEG6" CDMC33527 1 17 7 DAC11-M02 2-CG11692-RA_3 CG11692 CCGGAGCTTAGCCATCCATGGGTCGAATTATGGTGGCACAAAATCCGATGCGTTTTCAACCCAAGCG 67 FBan0011692 FBgn0031125 CG11692 X X CG11692 CG11692 CDMC33527 1 18 7 DAC11-M02 2-CG11692-RA_3 CG11692 CCGGAGCTTAGCCATCCATGGGTCGAATTATGGTGGCACAAAATCCGATGCGTTTTCAACCCAAGCG 67 FBan0011692 FBgn0031125 CG11692 X X CG11692 CG11692 CDMC33528 1 19 7 DAC11-M14 15-CG11984-RB_2 CG11984 GCGACGAGTATCGCTATAAAAACAAAAAGGCCAACACAACACAAACGAGCGGTACTGGCGGATTGGG 67 FBan0011984 FBgn0037655 CG11984 3 3R nucleic acid binding; GO:0003676; potassium channel regulator activity; GO:0015459; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0015459; ; GO:0008270 nucleus; GO:0005634 CG11984 CG11984 CDMC33528 1 20 7 DAC11-M14 15-CG11984-RB_2 CG11984 GCGACGAGTATCGCTATAAAAACAAAAAGGCCAACACAACACAAACGAGCGGTACTGGCGGATTGGG 67 FBan0011984 FBgn0037655 CG11984 3 3R nucleic acid binding; GO:0003676; potassium channel regulator activity; GO:0015459; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0015459; ; GO:0008270 nucleus; GO:0005634 CG11984 CG11984 CDMC33529 1 21 7 DAC12-A02 1-CG10034-RA_1 CG10034 ACTTCCACAATCTGGAACTGACGCCCATCAACATGCACTCGAACTCGTACGGTAGTGCTTCGGGTG 66 FBgn0032786 CDMC33529 1 22 7 DAC12-A02 1-CG10034-RA_1 CG10034 ACTTCCACAATCTGGAACTGACGCCCATCAACATGCACTCGAACTCGTACGGTAGTGCTTCGGGTG 66 FBgn0032786 CDMC33530 1 23 7 DAC12-A14 1-CG10133-RA_2 CG10133 GCCAAGCCTCTGAAAGTACGTGTTCACGCGGGAGACATCCTATACCTGCCCAACTACTGGTTCCAC 66 FBan0010133 FBgn0036366 CG10133 3 3L phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 CG10133 CG10133 CDMC33530 1 24 7 DAC12-A14 1-CG10133-RA_2 CG10133 GCCAAGCCTCTGAAAGTACGTGTTCACGCGGGAGACATCCTATACCTGCCCAACTACTGGTTCCAC 66 FBan0010133 FBgn0036366 CG10133 3 3L phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 CG10133 CG10133 CDMC33531 1 25 7 DAC12-E02 2-CG10506-RA_4 CG10506 GGAGCGTCCCATTGAGGAGTCACTTCGGCTGTTTGAAGACATGAAGCGTGGAAAGATCGACGAGGG 66 FBan0010506 FBgn0027090 Aats-gln 3 3R glutaminyl-tRNA aminoacylation; GO:0006425; glutamyl-tRNA aminoacylation; GO:0006424 ATP binding; GO:0005524; ; GO:0005524; glutamine-tRNA ligase activity; GO:0004819 ; EC:6.1.1.18; ; GO:0004819 ; EC:6.1.1.18; ; GO:0004819 ; EC:6.1.1.18; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004819 ; EC:6.1.1.18; ; GO:0004818 ; EC:6.1.1.17 Aats-gln Glutaminyl-tRNA synthetase "CG10506, l(3)05461, QRS, GlnRS, Aast-g1n, BcDNA:GH11673, Glutaminyl-tRNA synthetase" CDMC33531 1 26 7 DAC12-E02 2-CG10506-RA_4 CG10506 GGAGCGTCCCATTGAGGAGTCACTTCGGCTGTTTGAAGACATGAAGCGTGGAAAGATCGACGAGGG 66 FBan0010506 FBgn0027090 Aats-gln 3 3R glutaminyl-tRNA aminoacylation; GO:0006425; glutamyl-tRNA aminoacylation; GO:0006424 ATP binding; GO:0005524; ; GO:0005524; glutamine-tRNA ligase activity; GO:0004819 ; EC:6.1.1.18; ; GO:0004819 ; EC:6.1.1.18; ; GO:0004819 ; EC:6.1.1.18; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004819 ; EC:6.1.1.18; ; GO:0004818 ; EC:6.1.1.17 Aats-gln Glutaminyl-tRNA synthetase "CG10506, l(3)05461, QRS, GlnRS, Aast-g1n, BcDNA:GH11673, Glutaminyl-tRNA synthetase" CDMC33532 1 1 8 DAC12-E14 3-CG1063-RA_4 CG1063 ACCCTGGTCAATGTTATTCGATCCGTGACCCGCAATGGTCGCTCTATCGTGTTGACAGCTGTCCTG 66 FBan0001063 FBgn0010051 Itp-r83A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; calcium ion transport; GO:0006816; cation transport; GO:0006812; molting cycle (sensu Insecta); GO:0007591; response to oxidative stress; GO:0006979 "inositol-1,4,5-triphosphate receptor activity; GO:0008095; ; GO:0008095; ; GO:0008095; calcium channel activity; GO:0005262; ligand-gated ion channel activity; GO:0015276; ; GO:0005262; ; GO:0015276; ; GO:0008095; inositol 1,4,5-triphosphate-sensitive calcium-release channel activity; GO:0005220; ; GO:0005220" endoplasmic reticulum membrane; GO:0005789 Itp-r83A "Inositol 1,4,5,-tris-phosphate receptor" "CG1063, CG1063, dip, IP[[3]]R, InsP[[3]]R, itpr, DIP, inositol 1,4,5-trisphosphate receptor, l(3)05616, InsP[[3]], Itp-r[1], dm_IP3 receptor, IP[[3]] receptor, IP3 receptor, DmInsP[[3R]], DmInsP[[3]]R, IP3R, anon-WO02059370.49, IP, Insp3R, Itp-r, Itp-r42B: Inositol(1,4,5)-triphosphate receptor 42B, l(3)j5B4, Inositol(1,4,5)-triphosphate receptor 42B, Inositol 1,4,5,-tris-phosphate receptor" CDMC33532 1 2 8 DAC12-E14 3-CG1063-RA_4 CG1063 ACCCTGGTCAATGTTATTCGATCCGTGACCCGCAATGGTCGCTCTATCGTGTTGACAGCTGTCCTG 66 FBan0001063 FBgn0010051 Itp-r83A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; calcium ion transport; GO:0006816; cation transport; GO:0006812; molting cycle (sensu Insecta); GO:0007591; response to oxidative stress; GO:0006979 "inositol-1,4,5-triphosphate receptor activity; GO:0008095; ; GO:0008095; ; GO:0008095; calcium channel activity; GO:0005262; ligand-gated ion channel activity; GO:0015276; ; GO:0005262; ; GO:0015276; ; GO:0008095; inositol 1,4,5-triphosphate-sensitive calcium-release channel activity; GO:0005220; ; GO:0005220" endoplasmic reticulum membrane; GO:0005789 Itp-r83A "Inositol 1,4,5,-tris-phosphate receptor" "CG1063, CG1063, dip, IP[[3]]R, InsP[[3]]R, itpr, DIP, inositol 1,4,5-trisphosphate receptor, l(3)05616, InsP[[3]], Itp-r[1], dm_IP3 receptor, IP[[3]] receptor, IP3 receptor, DmInsP[[3R]], DmInsP[[3]]R, IP3R, anon-WO02059370.49, IP, Insp3R, Itp-r, Itp-r42B: Inositol(1,4,5)-triphosphate receptor 42B, l(3)j5B4, Inositol(1,4,5)-triphosphate receptor 42B, Inositol 1,4,5,-tris-phosphate receptor" CDMC33533 1 3 8 DAC12-I02 2-CG11069-RA_2 CG11069 TCCCTTGTCCACAGCTCGAGAATCCCTTGATGTACTATCTCTGCCTGTCCACTGTGGATCGTCGCA 66 FBan0011069 FBgn0039244 CG11069 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG11069 CG11069 CDMC33533 1 4 8 DAC12-I02 2-CG11069-RA_2 CG11069 TCCCTTGTCCACAGCTCGAGAATCCCTTGATGTACTATCTCTGCCTGTCCACTGTGGATCGTCGCA 66 FBan0011069 FBgn0039244 CG11069 3 3R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG11069 CG11069 CDMC33534 1 5 8 DAC12-I14 2-CG11136-RA_1 CG11136 CCAGAACAAGGCTTTGGCCAATTTCTCGAGACTGGTGAGCCTCTCACTGCGTCACAACCAGATCGA 66 FBan0011136 FBgn0034540 CG11136 2 2R cell adhesion; GO:0007155; defense response; GO:0006952; transmission of nerve impulse; GO:0019226 CG11136 CG11136 "CT31131, tartan/capricious-like" CDMC33534 1 6 8 DAC12-I14 2-CG11136-RA_1 CG11136 CCAGAACAAGGCTTTGGCCAATTTCTCGAGACTGGTGAGCCTCTCACTGCGTCACAACCAGATCGA 66 FBan0011136 FBgn0034540 CG11136 2 2R cell adhesion; GO:0007155; defense response; GO:0006952; transmission of nerve impulse; GO:0019226 CG11136 CG11136 "CT31131, tartan/capricious-like" CDMC33535 1 7 8 DAC12-M02 1-CG11500-RA_2 CG11500 TGTGAATTGCACAAAATGTTGGACATCCAGACGCATATGGACTTCGCGGGTCAGGGAAAGGCGGAG 66 FBan0011500 FBgn0040623 CG11500 3 3R signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; microsome; GO:0005792; signal peptidase complex; GO:0005787 CG11500 CG11500 CG31042 CDMC33535 1 8 8 DAC12-M02 1-CG11500-RA_2 CG11500 TGTGAATTGCACAAAATGTTGGACATCCAGACGCATATGGACTTCGCGGGTCAGGGAAAGGCGGAG 66 FBan0011500 FBgn0040623 CG11500 3 3R signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; microsome; GO:0005792; signal peptidase complex; GO:0005787 CG11500 CG11500 CG31042 CDMC33536 1 9 8 DAC12-M14 17-CG11956-RB_5 CG11956 AGTATCGATCTCTGCCCAAGAGCTATGACATCAAGAGCATCATGGACTCATGGACCCTGCAAACTG 66 FBan0011956 FBgn0040282 SP1029 3 3R proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; receptor activity; GO:0004872; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004872; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 SP1029 SP1029 "CG11956, CG11956" CDMC33536 1 10 8 DAC12-M14 17-CG11956-RB_5 CG11956 AGTATCGATCTCTGCCCAAGAGCTATGACATCAAGAGCATCATGGACTCATGGACCCTGCAAACTG 66 FBan0011956 FBgn0040282 SP1029 3 3R proteolysis; GO:0006508 aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; receptor activity; GO:0004872; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004872; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 SP1029 SP1029 "CG11956, CG11956" CDMC33537 1 11 8 DAC13-A02 22-CG14518-RA_1 CG14518 GGCGGAGAAATAATGCCTTGATTCGGATCGTTTGGGAGCTCTTCAAAGAGTACTCGACGATCAATCACA 69 FBan0014518 FBgn0039621 CG14518 3 3R CG14518 CG14518 CDMC33537 1 12 8 DAC13-A02 22-CG14518-RA_1 CG14518 GGCGGAGAAATAATGCCTTGATTCGGATCGTTTGGGAGCTCTTCAAAGAGTACTCGACGATCAATCACA 69 FBan0014518 FBgn0039621 CG14518 3 3R CG14518 CG14518 CDMC33538 1 13 8 DAC13-A14 3-CG14531-RA_3 CG14531 AACTCTCTGTGGCCGATGAAGAAATATTTAGCAGCTGTCCCAATCCTGAGCCAGGCACCCTCGACATCC 69 FBan0014531 FBgn0040619 CG14531 3 3R CG14531 CG14531 CDMC33538 1 14 8 DAC13-A14 3-CG14531-RA_3 CG14531 AACTCTCTGTGGCCGATGAAGAAATATTTAGCAGCTGTCCCAATCCTGAGCCAGGCACCCTCGACATCC 69 FBan0014531 FBgn0040619 CG14531 3 3R CG14531 CG14531 CDMC33539 1 15 8 DAC13-E02 6-CG14570-RA_3 CG14570 GCACACCACAATGTCCGGTTATCCAAGTGCTTCTCTGGTCACCTTTGCGCTTTGTTCCATTCTTTGCCT 69 FBan0014570 FBgn0037122 CG14570 3 3L CG14570 CG14570 CDMC33539 1 16 8 DAC13-E02 6-CG14570-RA_3 CG14570 GCACACCACAATGTCCGGTTATCCAAGTGCTTCTCTGGTCACCTTTGCGCTTTGTTCCATTCTTTGCCT 69 FBan0014570 FBgn0037122 CG14570 3 3L CG14570 CG14570 CDMC33540 1 17 8 DAC13-E14 2-CG14585-RA_1 CG14585 GCCCTTCAGTCCGTTGGTTTGGTATCTCTTCGGCGGAGTACTTTCGTTGATTGGTGTCCTCCTGTGGAT 69 FBan0014585 FBgn0036757 CG14585 3 3L CG14585 CG14585 CDMC33540 1 18 8 DAC13-E14 2-CG14585-RA_1 CG14585 GCCCTTCAGTCCGTTGGTTTGGTATCTCTTCGGCGGAGTACTTTCGTTGATTGGTGTCCTCCTGTGGAT 69 FBan0014585 FBgn0036757 CG14585 3 3L CG14585 CG14585 CDMC33541 1 19 8 DAC13-I02 23-CG14622-RB_1 CG14622 ACGAGATCCAGAGTCGAACCCGTATTGAACTTACATATATTTTAAGGCGCTTTAGGAGTTTGCACAGAC 69 FBan0014622 FBgn0025641 DAAM X X actin cytoskeleton organization and biogenesis; GO:0030036; cell organization and biogenesis; GO:0016043; cuticle pattern formation; GO:0035017; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; spermatogenesis; GO:0007283 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; Rho GTPase binding; GO:0017048; ; GO:0017048 DAAM Dishevelled Associated Activator of Morphogenesis "CG14622, CG14622, CG14622, CG14622, EG:114D9.2, dDAAM, anon-EST:Posey148, Dishevelled Associated Activator of Morphogenesis" CDMC33541 1 20 8 DAC13-I02 23-CG14622-RB_1 CG14622 ACGAGATCCAGAGTCGAACCCGTATTGAACTTACATATATTTTAAGGCGCTTTAGGAGTTTGCACAGAC 69 FBan0014622 FBgn0025641 DAAM X X actin cytoskeleton organization and biogenesis; GO:0030036; cell organization and biogenesis; GO:0016043; cuticle pattern formation; GO:0035017; intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; spermatogenesis; GO:0007283 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; Rho GTPase binding; GO:0017048; ; GO:0017048 DAAM Dishevelled Associated Activator of Morphogenesis "CG14622, CG14622, CG14622, CG14622, EG:114D9.2, dDAAM, anon-EST:Posey148, Dishevelled Associated Activator of Morphogenesis" CDMC33542 1 21 8 DAC13-I14 24-CG14639-RA_1 CG14639 ACTTTTTAAAAAGTTGTAGTAAGAATCCTATCGCTTTCATTGTTTTATATCAACCATCATACTGTAGTA 69 FBan0014639 FBgn0037224 CG14639 3 3R CG14639 CG14639 CDMC33542 1 22 8 DAC13-I14 24-CG14639-RA_1 CG14639 ACTTTTTAAAAAGTTGTAGTAAGAATCCTATCGCTTTCATTGTTTTATATCAACCATCATACTGTAGTA 69 FBan0014639 FBgn0037224 CG14639 3 3R CG14639 CG14639 CDMC33543 1 23 8 DAC13-M02 12-CG14673-RA_3 CG14673 GAGGTCCTGTGCCAATTTCTGGGTTTCTTCGAGGCATTTAGAATGCTACTCTTCACGCTTCTCTGGGGC 69 FBan0014673 FBgn0037352 CG14673 3 3R CG14673 CG14673 CDMC33543 1 24 8 DAC13-M02 12-CG14673-RA_3 CG14673 GAGGTCCTGTGCCAATTTCTGGGTTTCTTCGAGGCATTTAGAATGCTACTCTTCACGCTTCTCTGGGGC 69 FBan0014673 FBgn0037352 CG14673 3 3R CG14673 CG14673 CDMC33544 1 25 8 DAC13-M14 2-CG14686-RA_1 CG14686 GCGAGCCAATGATCGAGCCTGTGAAGAGGTGTACTCCAATTGTCCGCTGGACAGTAAATCAGCTACGGA 69 FBan0014686 FBgn0037832 CG14686 3 3R CG14686 CG14686 CDMC33544 1 26 8 DAC13-M14 2-CG14686-RA_1 CG14686 GCGAGCCAATGATCGAGCCTGTGAAGAGGTGTACTCCAATTGTCCGCTGGACAGTAAATCAGCTACGGA 69 FBan0014686 FBgn0037832 CG14686 3 3R CG14686 CG14686 CDMC33545 1 1 9 DAC14-A02 3-CG1721-RA_2 CG1721 CGACCTTGGACGGCTCCCTTGTAGGTCAAACTTCAGCAGAATTCCCACATATTGCAGTCGCAGCA 65 FBan0001721 FBgn0014869 Pglym78 3 3R glycolysis; GO:0006096 phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 Pglym78 Phosphoglyceromutase "CG1721, Pglym, PGAM" CDMC33545 1 2 9 DAC14-A02 3-CG1721-RA_2 CG1721 CGACCTTGGACGGCTCCCTTGTAGGTCAAACTTCAGCAGAATTCCCACATATTGCAGTCGCAGCA 65 FBan0001721 FBgn0014869 Pglym78 3 3R glycolysis; GO:0006096 phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 Pglym78 Phosphoglyceromutase "CG1721, Pglym, PGAM" CDMC33546 1 3 9 DAC14-A14 2-CG1724-RA_1 CG1724 ATCCGGAATGGGATCAGGCGATATTAATTCATCACCGGGCTTTGAGTTCCCCGTAGTGCAGCAGG 65 FBan0001724 FBgn0031164 CG1724 X X protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG1724 CG1724 BcDNA:AT13347 CDMC33546 1 4 9 DAC14-A14 2-CG1724-RA_1 CG1724 ATCCGGAATGGGATCAGGCGATATTAATTCATCACCGGGCTTTGAGTTCCCCGTAGTGCAGCAGG 65 FBan0001724 FBgn0031164 CG1724 X X protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG1724 CG1724 BcDNA:AT13347 CDMC33547 1 5 9 DAC14-E02 6-CG17375-RA_1 CG17375 CAACACCCGGCCCTTTGACATCCTTCGCGAGCTAGACGAGATGTACGCACTGCTGTTTGAACTGG 65 FBan0017375 FBgn0031861 CG17375 2 2L CG17375 CG17375 CDMC33547 1 6 9 DAC14-E02 6-CG17375-RA_1 CG17375 CAACACCCGGCCCTTTGACATCCTTCGCGAGCTAGACGAGATGTACGCACTGCTGTTTGAACTGG 65 FBan0017375 FBgn0031861 CG17375 2 2L CG17375 CG17375 CDMC33548 1 7 9 DAC14-E14 24-CG1742-RA_1 CG1742 CCAGACCAGACATTTTACGTACTATAAAGATAATAAAGTTATAGTTAAAACACATACAATGGCCA 65 FBan0001742 FBgn0025814 Mgstl X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 microsome; GO:0005792; mitochondrial outer membrane; GO:0005741 Mgstl Microsomal glutathione S-transferase-like "CG1742, Mgst1, BcDNA:RE10696, BcDNA:RH59553" CDMC33548 1 8 9 DAC14-E14 24-CG1742-RA_1 CG1742 CCAGACCAGACATTTTACGTACTATAAAGATAATAAAGTTATAGTTAAAACACATACAATGGCCA 65 FBan0001742 FBgn0025814 Mgstl X X defense response; GO:0006952; protein modification; GO:0006464; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 microsome; GO:0005792; mitochondrial outer membrane; GO:0005741 Mgstl Microsomal glutathione S-transferase-like "CG1742, Mgst1, BcDNA:RE10696, BcDNA:RH59553" CDMC33549 1 9 9 DAC14-I02 16-CG17631-RA_1 CG17631 CAAAACCTCGCCACGCTACGCCACGCCACACCCCGGAATCAGAACCACAATCGAAACCAGACCAG 65 FBan0017631 FBgn0038392 CG17631 3 3R CG17631 CG17631 CDMC33549 1 10 9 DAC14-I02 16-CG17631-RA_1 CG17631 CAAAACCTCGCCACGCTACGCCACGCCACACCCCGGAATCAGAACCACAATCGAAACCAGACCAG 65 FBan0017631 FBgn0038392 CG17631 3 3R CG17631 CG17631 CDMC33550 1 11 9 DAC14-I14 3-CG17658-RA_7 CG17658 ACAAGCCACTCTGCGAGGTGCTGAGGGATCTGCAGAAGTCCATGAAGATCGATCACCCGTTGAAG 65 FBan0017658 FBgn0034924 CG17658 2 2R CG17658 CG17658 CDMC33550 1 12 9 DAC14-I14 3-CG17658-RA_7 CG17658 ACAAGCCACTCTGCGAGGTGCTGAGGGATCTGCAGAAGTCCATGAAGATCGATCACCCGTTGAAG 65 FBan0017658 FBgn0034924 CG17658 2 2R CG17658 CG17658 CDMC33551 1 13 9 DAC14-M02 23-CG17782-RA_1 CG17782 CTACTGGGCTTTAAACTCAAGACTCAAAGATAGATACTACGGCTACAAAAGTCAACAGGCAGCAC 65 FBan0017782 FBgn0039195 CG17782 3 3R CG17782 CG17782 CDMC33551 1 14 9 DAC14-M02 23-CG17782-RA_1 CG17782 CTACTGGGCTTTAAACTCAAGACTCAAAGATAGATACTACGGCTACAAAAGTCAACAGGCAGCAC 65 FBan0017782 FBgn0039195 CG17782 3 3R CG17782 CG17782 CDMC33552 1 15 9 DAC14-M14 18-CG17828-RB_5 CG17828 GACATTCGAAAATTGGGATTGAAAACTCAAGATGCCGACTACACCACAGGATCTTGCCCTTGCCC 65 FBan0017828 FBgn0016038 mod(r) X X mod(r) modifier of rudimentary "CG17828, CG17828, EG:115C2.5, anon-WO0153538.78, modifier of rudimentary" CDMC33552 1 16 9 DAC14-M14 18-CG17828-RB_5 CG17828 GACATTCGAAAATTGGGATTGAAAACTCAAGATGCCGACTACACCACAGGATCTTGCCCTTGCCC 65 FBan0017828 FBgn0016038 mod(r) X X mod(r) modifier of rudimentary "CG17828, CG17828, EG:115C2.5, anon-WO0153538.78, modifier of rudimentary" CDMC33553 1 17 9 DAC15-A02 3-CG1228-RB_4 CG1228 TTGGCGCATGGTACAGCAAGAGAGCAGTCATCTCCTGGTGATGCTAACGACCGTAATGGAGTCTGGTC 68 FBan0001228 FBgn0035133 Ptpmeg 3 3L autophagic cell death; GO:0048102; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470; salivary gland cell autophagic cell death; GO:0035071 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Ptpmeg Ptpmeg "CG1228, CG1228, CG1228, CG1228, MEG1, scc, split central complex, dMEG1, ptpmeg, anon-WO0118547.211" CDMC33553 1 18 9 DAC15-A02 3-CG1228-RB_4 CG1228 TTGGCGCATGGTACAGCAAGAGAGCAGTCATCTCCTGGTGATGCTAACGACCGTAATGGAGTCTGGTC 68 FBan0001228 FBgn0035133 Ptpmeg 3 3L autophagic cell death; GO:0048102; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470; salivary gland cell autophagic cell death; GO:0035071 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020 Ptpmeg Ptpmeg "CG1228, CG1228, CG1228, CG1228, MEG1, scc, split central complex, dMEG1, ptpmeg, anon-WO0118547.211" CDMC33554 1 19 9 DAC15-A14 3-CG12621-RA_2 CG12621 AGCCCGTCTGTCACCTCAGTTGGCTAATAAATGGGGAACCGGTGCAAAAGACACACCTTCGGCAATAC 68 FBan0012621 FBgn0032627 beat-IIIa 2 2L extracellular region; GO:0005576 beat-IIIa beat-IIIa "CG12621, beat IIIa" CDMC33554 1 20 9 DAC15-A14 3-CG12621-RA_2 CG12621 AGCCCGTCTGTCACCTCAGTTGGCTAATAAATGGGGAACCGGTGCAAAAGACACACCTTCGGCAATAC 68 FBan0012621 FBgn0032627 beat-IIIa 2 2L extracellular region; GO:0005576 beat-IIIa beat-IIIa "CG12621, beat IIIa" CDMC33555 1 21 9 DAC15-E02 1-CG13210-RA_1 CG13210 TTCCCGGGAGTACCTGGTGTTCTTCGTGATGCTGGCCCTCATACTCATTGTCTTTGGTAAGCGTCCTC 68 FBan0013210 FBgn0033612 CG13210 2 2R CG13210 CG13210 CDMC33555 1 22 9 DAC15-E02 1-CG13210-RA_1 CG13210 TTCCCGGGAGTACCTGGTGTTCTTCGTGATGCTGGCCCTCATACTCATTGTCTTTGGTAAGCGTCCTC 68 FBan0013210 FBgn0033612 CG13210 2 2R CG13210 CG13210 CDMC33556 1 23 9 DAC15-E14 3-CG13375-RA_2 CG13375 TGCCGAGGATAAGCCAAAGCGTGATAAGGTTGGTAGAAACAACGCGGTAGATGATGCCATTGGACCGG 68 FBan0013375 FBgn0040370 CG13375 X X intracellular protein transport; GO:0006886; nitric oxide mediated signal transduction; GO:0007263; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG13375 CG13375 EG:BACR37P7.8 CDMC33556 1 24 9 DAC15-E14 3-CG13375-RA_2 CG13375 TGCCGAGGATAAGCCAAAGCGTGATAAGGTTGGTAGAAACAACGCGGTAGATGATGCCATTGGACCGG 68 FBan0013375 FBgn0040370 CG13375 X X intracellular protein transport; GO:0006886; nitric oxide mediated signal transduction; GO:0007263; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG13375 CG13375 EG:BACR37P7.8 CDMC33557 1 25 9 DAC15-I02 23-CG13716-RA_2 CG13716 GCTGAGAAGGAGAAAACTTCATGTCTCTCGGGTTTCAGTTACCAAAATTCACCTAACCAGCGAACTAA 68 FBan0013716 FBgn0035563 CG13716 3 3L CG13716 CG13716 HL1 CDMC33557 1 26 9 DAC15-I02 23-CG13716-RA_2 CG13716 GCTGAGAAGGAGAAAACTTCATGTCTCTCGGGTTTCAGTTACCAAAATTCACCTAACCAGCGAACTAA 68 FBan0013716 FBgn0035563 CG13716 3 3L CG13716 CG13716 HL1 CDMC33558 1 1 10 DAC15-I14 2-CG13825-RA_1 CG13825 GGCGACGCAAATGTTCCCGAGTGCTCCTTAAGCTGTCGCCGATTTTCTACAATTTTACGCTCGTCCGG 68 FBan0013825 FBgn0040592 CG13825 3 3R CG13825 CG13825 CDMC33558 1 2 10 DAC15-I14 2-CG13825-RA_1 CG13825 GGCGACGCAAATGTTCCCGAGTGCTCCTTAAGCTGTCGCCGATTTTCTACAATTTTACGCTCGTCCGG 68 FBan0013825 FBgn0040592 CG13825 3 3R CG13825 CG13825 CDMC33559 1 3 10 DAC15-M02 3-CG14127-RA_2 CG14127 CGAGACCAAGACACTTGTCCATCAGGATAGCGTAGGATCCAGTTCGGGTGACCAGCATACCGCGAAAA 68 FBan0014127 FBgn0036219 CG14127 3 3L CG14127 CG14127 CDMC33559 1 4 10 DAC15-M02 3-CG14127-RA_2 CG14127 CGAGACCAAGACACTTGTCCATCAGGATAGCGTAGGATCCAGTTCGGGTGACCAGCATACCGCGAAAA 68 FBan0014127 FBgn0036219 CG14127 3 3L CG14127 CG14127 CDMC33560 1 5 10 DAC15-M14 3-CG14312-RA_1 CG14312 ATCACGGTTTCGGTGTACGCCTTCTACAGTCTCTACCATGCCATACTCAAGAAGTTCCCTTCGCGCCA 68 FBan0014312 FBgn0038596 CG14312 3 3R CG14312 CG14312 CDMC33560 1 6 10 DAC15-M14 3-CG14312-RA_1 CG14312 ATCACGGTTTCGGTGTACGCCTTCTACAGTCTCTACCATGCCATACTCAAGAAGTTCCCTTCGCGCCA 68 FBan0014312 FBgn0038596 CG14312 3 3R CG14312 CG14312 CDMC33561 1 7 10 DAC16-A02 3-CG31033-RB_4 CG31033 AGGAAACGTTCGGCTAAACTGAAACGTGACCTAGAAGACGCGGTTCGTGAGCCCAGTTCGTCCAG 65 FBgn0051033 CDMC33561 1 8 10 DAC16-A02 3-CG31033-RB_4 CG31033 AGGAAACGTTCGGCTAAACTGAAACGTGACCTAGAAGACGCGGTTCGTGAGCCCAGTTCGTCCAG 65 FBgn0051033 CDMC33562 1 9 10 DAC16-A14 15-CG3104-RA_1 CG3104 ACCAGCAAAAGTACACCTCCATCTGTGATTATCTCCAGGAACGCATACGGACTATGGTGGCGCGC 65 FBan0003104 FBgn0031473 CG3104 2 2L cell proliferation; GO:0008283 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG3104 CG3104 CDMC33562 1 10 10 DAC16-A14 15-CG3104-RA_1 CG3104 ACCAGCAAAAGTACACCTCCATCTGTGATTATCTCCAGGAACGCATACGGACTATGGTGGCGCGC 65 FBan0003104 FBgn0031473 CG3104 2 2L cell proliferation; GO:0008283 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG3104 CG3104 CDMC33563 1 11 10 DAC16-E02 1-CG31148-RA_1 CG31148 ACAGGTGGACAGGATTTGGACGCCTCAAGAGGGCTTACTACCAGACTTGGGCCGATTACCATCTG 65 FBan0031148 FBgn0051148 CG31148 3 3R lipid metabolism; GO:0006629; lysosome organization and biogenesis; GO:0007040; sphingolipid metabolism; GO:0006665 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-; glucosylceramidase activity; GO:0004348 ; EC:3.2.1.45; ; GO:0004348 ; EC:3.2.1.45" lysosome; GO:0005764 CG31148 CG31148 "CG10299, CG10299, CG10299, CT28913, anon-WO0140519.234" CDMC33563 1 12 10 DAC16-E02 1-CG31148-RA_1 CG31148 ACAGGTGGACAGGATTTGGACGCCTCAAGAGGGCTTACTACCAGACTTGGGCCGATTACCATCTG 65 FBan0031148 FBgn0051148 CG31148 3 3R lipid metabolism; GO:0006629; lysosome organization and biogenesis; GO:0007040; sphingolipid metabolism; GO:0006665 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0015926 ; EC:3.2.1.-; glucosylceramidase activity; GO:0004348 ; EC:3.2.1.45; ; GO:0004348 ; EC:3.2.1.45" lysosome; GO:0005764 CG31148 CG31148 "CG10299, CG10299, CG10299, CT28913, anon-WO0140519.234" CDMC33564 1 13 10 DAC16-E14 2-CG31204-RA_1 CG31204 GTTTGAGCTGCCCATAGGTCCTGACTTGAAGGATTCCAGGCGCAAGATCCTAAGGATGGCCGATG 65 FBan0031204 FBgn0051204 CG31204 3 3R CG31204 CG31204 "CG15569, BcDNA:AT25127" CDMC33564 1 14 10 DAC16-E14 2-CG31204-RA_1 CG31204 GTTTGAGCTGCCCATAGGTCCTGACTTGAAGGATTCCAGGCGCAAGATCCTAAGGATGGCCGATG 65 FBan0031204 FBgn0051204 CG31204 3 3R CG31204 CG31204 "CG15569, BcDNA:AT25127" CDMC33565 1 15 10 DAC16-I02 5-CG31295-RA_1 CG31295 AAGCCCGCTAATTACAAGTGGACGTAATGTGTGCATTTGCAACGCATTTGCTGAAGTGCGGGCGC 65 FBan0031295 FBgn0051295 CG31295 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31295 CG31295 BcDNA:SD17750 CDMC33565 1 16 10 DAC16-I02 5-CG31295-RA_1 CG31295 AAGCCCGCTAATTACAAGTGGACGTAATGTGTGCATTTGCAACGCATTTGCTGAAGTGCGGGCGC 65 FBan0031295 FBgn0051295 CG31295 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31295 CG31295 BcDNA:SD17750 CDMC33566 1 17 10 DAC16-I14 3-CG31318-RB_11 CG31318 GAAAAGACGCGGGACCAGAATAGCAGTGTTCCATCGGCTACAAAGGATGCCAATCGGTGTGCCAC 65 FBgn0051318 CDMC33566 1 18 10 DAC16-I14 3-CG31318-RB_11 CG31318 GAAAAGACGCGGGACCAGAATAGCAGTGTTCCATCGGCTACAAAGGATGCCAATCGGTGTGCCAC 65 FBgn0051318 CDMC33567 1 19 10 DAC16-M02 3-CG31454-RA_1 CG31454 TGTATGGATTTTTCACCGCCGTACTCTGTCACTCAACGGTTCTGGAGGCAAAATCCATGCGGCCC 65 FBan0031454 FBgn0051454 CG31454 3 3R CG31454 CG31454 CG11740 CDMC33567 1 20 10 DAC16-M02 3-CG31454-RA_1 CG31454 TGTATGGATTTTTCACCGCCGTACTCTGTCACTCAACGGTTCTGGAGGCAAAATCCATGCGGCCC 65 FBan0031454 FBgn0051454 CG31454 3 3R CG31454 CG31454 CG11740 CDMC33568 1 21 10 DAC16-M14 2-CG31473-RA_1 CG31473 AAAGCTGTGGTGTACGCTTTGGTCAGCAGGATCACTAGGTCGCTTTGCACAGCACATGAGCAACG 65 FBan0031473 FBgn0051473 CG31473 3 3R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; coenzyme metabolism; GO:0006732; pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 integrin complex; GO:0008305 CG31473 CG31473 "CG2649, CG2649, CG2649" CDMC33568 1 22 10 DAC16-M14 2-CG31473-RA_1 CG31473 AAAGCTGTGGTGTACGCTTTGGTCAGCAGGATCACTAGGTCGCTTTGCACAGCACATGAGCAACG 65 FBan0031473 FBgn0051473 CG31473 3 3R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; coenzyme metabolism; GO:0006732; pyridoxine biosynthesis; GO:0008615 pyridoxamine-phosphate oxidase activity; GO:0004733 ; EC:1.4.3.5; ; GO:0004733 ; EC:1.4.3.5 integrin complex; GO:0008305 CG31473 CG31473 "CG2649, CG2649, CG2649" CDMC33569 1 23 10 DAC17-A02 3-CG32629-RA_1 CG32629 CCGATTCCGATGCCATTGGTCAATTGGTAAGGGGCTTTGGGAAGTGTAAGAGGAAGAGCGTGCGG 65 FBan0032629 FBgn0052629 CG32629 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32629 CG32629 CDMC33569 1 24 10 DAC17-A02 3-CG32629-RA_1 CG32629 CCGATTCCGATGCCATTGGTCAATTGGTAAGGGGCTTTGGGAAGTGTAAGAGGAAGAGCGTGCGG 65 FBan0032629 FBgn0052629 CG32629 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32629 CG32629 CDMC33570 1 25 10 DAC17-A14 6-CG32669-RA_1 CG32669 CAAACGCACGCTCACCGACCGTCAGACCTTGTGGTACTCCAAGCTGTTGTCCCTATTCTTCGGAG 65 FBan0032669 FBgn0052669 CG32669 X X cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; ion transport; GO:0006811; prosthetic group metabolism; GO:0051189; transport; GO:0006810; vitamin transport; GO:0051180 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0005215; ; GO:0005215; ; GO:0008523 integral to membrane; GO:0016021 CG32669 CG32669 CDMC33570 1 26 10 DAC17-A14 6-CG32669-RA_1 CG32669 CAAACGCACGCTCACCGACCGTCAGACCTTGTGGTACTCCAAGCTGTTGTCCCTATTCTTCGGAG 65 FBan0032669 FBgn0052669 CG32669 X X cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; ion transport; GO:0006811; prosthetic group metabolism; GO:0051189; transport; GO:0006810; vitamin transport; GO:0051180 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0005215; ; GO:0005215; ; GO:0008523 integral to membrane; GO:0016021 CG32669 CG32669 CDMC33571 1 1 11 DAC17-E02 21-CG32802-RA_1 CG32802 GTGGCATGTGGCTTGAAAATATTCTGAGCACCCTGGAAGCTGGGTATTATTCGATCCTGCGGTGC 65 FBan0032802 FBgn0052802 CG32802 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32802 CG32802 CDMC33571 1 2 11 DAC17-E02 21-CG32802-RA_1 CG32802 GTGGCATGTGGCTTGAAAATATTCTGAGCACCCTGGAAGCTGGGTATTATTCGATCCTGCGGTGC 65 FBan0032802 FBgn0052802 CG32802 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32802 CG32802 CDMC33572 1 3 11 DAC17-E14 23-CG32822-RA_6 CG32822 AACGGTTATGTGAAGAAGCCGAGCATCTATTTATCTCTGTCGGACGCATTGAGAAAAGCTATGAT 65 FBan0032822 FBgn0052822 CG32822 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32822 CG32822 CDMC33572 1 4 11 DAC17-E14 23-CG32822-RA_6 CG32822 AACGGTTATGTGAAGAAGCCGAGCATCTATTTATCTCTGTCGGACGCATTGAGAAAAGCTATGAT 65 FBan0032822 FBgn0052822 CG32822 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32822 CG32822 CDMC33573 1 5 11 DAC17-I02 1-CG33017-RB_1 CG33017 GCGACGTGGAAAGTGATCCGAAAGATCCCAAGTCAACTGTGCCGGAGAAACGAAATCAGGCTGGC 65 FBan0033017 FBgn0053017 CG33017 2 2R CG33017 CG33017 "CG15702, CG15703" CDMC33573 1 6 11 DAC17-I02 1-CG33017-RB_1 CG33017 GCGACGTGGAAAGTGATCCGAAAGATCCCAAGTCAACTGTGCCGGAGAAACGAAATCAGGCTGGC 65 FBan0033017 FBgn0053017 CG33017 2 2R CG33017 CG33017 "CG15702, CG15703" CDMC33574 1 7 11 DAC17-I14 17-CG33080-RA_1 CG33080 CTGGGCCACATTGTCATCAATGAGTTCTGGCAGGAGAATATTGGCGACTTTACGGTGGACAAGGC 65 FBan0033080 FBgn0053080 CG33080 X X carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG33080 CG33080 "CG3141, CG15774, CG15775, CG3141" CDMC33574 1 8 11 DAC17-I14 17-CG33080-RA_1 CG33080 CTGGGCCACATTGTCATCAATGAGTTCTGGCAGGAGAATATTGGCGACTTTACGGTGGACAAGGC 65 FBan0033080 FBgn0053080 CG33080 X X carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG33080 CG33080 "CG3141, CG15774, CG15775, CG3141" CDMC33575 1 9 11 DAC17-M02 5-CG33175-RH_3 CG33175 CCAGCATCGCAGTCAAATGTTACACGCCAGCCAAAGACACTCGGAACCACTTAAAGCGGGCTTCG 65 FBan0033175 FBgn0030216 spri X X endocytosis; GO:0006897; intracellular signaling cascade; GO:0007242 Ras GTPase binding; GO:0017016; ; GO:0017016; ; GO:0017016; ; GO:0017016 cellular component unknown; GO:0008372 spri sprint "CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, CG33175, CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, sprint-a, sprint-b, anon-WO03040301.275, sprint" CDMC33575 1 10 11 DAC17-M02 5-CG33175-RH_3 CG33175 CCAGCATCGCAGTCAAATGTTACACGCCAGCCAAAGACACTCGGAACCACTTAAAGCGGGCTTCG 65 FBan0033175 FBgn0030216 spri X X endocytosis; GO:0006897; intracellular signaling cascade; GO:0007242 Ras GTPase binding; GO:0017016; ; GO:0017016; ; GO:0017016; ; GO:0017016 cellular component unknown; GO:0008372 spri sprint "CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, CG33175, CG15300, CG15299, CG15298, CG15297, CG12638, CG15301, CG32674, sprint-a, sprint-b, anon-WO03040301.275, sprint" CDMC33576 1 11 11 DAC17-M14 3-CG33209-RA_1 CG33209 CGGAACACCTGGCCTCGTTGTCCCAGAAGCGTCTCTCCCTGCAGATCTCATTCAATAACTCGGTG 65 FBan0033209 FBgn0053209 comm3 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 comm3 comm3 "CG13448, CG33209, CG13447, CG13448, CG33209" CDMC33576 1 12 11 DAC17-M14 3-CG33209-RA_1 CG33209 CGGAACACCTGGCCTCGTTGTCCCAGAAGCGTCTCTCCCTGCAGATCTCATTCAATAACTCGGTG 65 FBan0033209 FBgn0053209 comm3 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 comm3 comm3 "CG13448, CG33209, CG13447, CG13448, CG33209" CDMC33577 1 13 11 DAC18-A02 3-CG5776-RA_2 CG5776 TGGAGGCACTGCAAAATGTCACCATAGTCGCTGCCACCAATCGTCCAGATATGATCGACAAGGCACTG 68 FBan0005776 FBgn0032450 CG5776 2 2L mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783 CG5776 CG5776 CDMC33577 1 14 11 DAC18-A02 3-CG5776-RA_2 CG5776 TGGAGGCACTGCAAAATGTCACCATAGTCGCTGCCACCAATCGTCCAGATATGATCGACAAGGCACTG 68 FBan0005776 FBgn0032450 CG5776 2 2L mitosis; GO:0007067 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 endoplasmic reticulum; GO:0005783 CG5776 CG5776 CDMC33578 1 15 11 DAC18-A14 3-CG5886-RA_4 CG5886 TCGGGAGCACCAACTGAAGGAGCAACTGAACATATACACCGCCAAGTACGATGACTTCCAGCAGTCGC 68 FBan0005886 FBgn0039379 CG5886 3 3R CG5886 CG5886 CDMC33578 1 16 11 DAC18-A14 3-CG5886-RA_4 CG5886 TCGGGAGCACCAACTGAAGGAGCAACTGAACATATACACCGCCAAGTACGATGACTTCCAGCAGTCGC 68 FBan0005886 FBgn0039379 CG5886 3 3R CG5886 CG5886 CDMC33579 1 17 11 DAC18-E02 1-CG6181-RB_1 CG6181 CCTGCACCACCTTACGACCTCAGGGACAGCATTAAGCAGCTTTTGATGGCTGGACAAATCAACAAGGC 68 FBan0006181 FBgn0032340 CG6181 2 2L CG6181 CG6181 CDMC33579 1 18 11 DAC18-E02 1-CG6181-RB_1 CG6181 CCTGCACCACCTTACGACCTCAGGGACAGCATTAAGCAGCTTTTGATGGCTGGACAAATCAACAAGGC 68 FBan0006181 FBgn0032340 CG6181 2 2L CG6181 CG6181 CDMC33580 1 19 11 DAC18-E14 3-CG6284-RA_1 CG6284 GCCGTGGAAACAGTGGGTCAAAAATCCCTGCAACGTGCCTGCAAGTCTTCAATGGATAGCAAAGGTCG 68 FBan0006284 FBgn0037802 Sirt6 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0030528; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt6 Sirt6 "CG6284, CG6284, CG6284, D.mel4, dSIRT6, dmSRT408" CDMC33580 1 20 11 DAC18-E14 3-CG6284-RA_1 CG6284 GCCGTGGAAACAGTGGGTCAAAAATCCCTGCAACGTGCCTGCAAGTCTTCAATGGATAGCAAAGGTCG 68 FBan0006284 FBgn0037802 Sirt6 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0003682; deacetylase activity; GO:0019213; ; GO:0030528; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019213 chromatin silencing complex; GO:0005677 Sirt6 Sirt6 "CG6284, CG6284, CG6284, D.mel4, dSIRT6, dmSRT408" CDMC33581 1 21 11 DAC18-I02 3-CG6711-RA_4 CG6711 CCCAACTGCTGATCGATAATCCGCCTTTCACACGCGAATCTCGCAGCCGTCTGGATAAACCCAATCTC 68 FBan0006711 FBgn0011836 Taf2 3 3L "DNA methylation; GO:0006306; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf2 TBP-associated factor 2 "CG6711, CG6711, TAFII150, TAF150, dTAF[[II]]150, Taf150: TBP-associated factor 150kD, Taf[[II]]150, TAF[[II]]150, TafII150, dTAF II 150, dTAF150, TFIID, dTAFII150, TAF2, TAF[II]150, TAF[[II]], TAF, TBP-associated factor 150kD, Taf150" CDMC33581 1 22 11 DAC18-I02 3-CG6711-RA_4 CG6711 CCCAACTGCTGATCGATAATCCGCCTTTCACACGCGAATCTCGCAGCCGTCTGGATAAACCCAATCTC 68 FBan0006711 FBgn0011836 Taf2 3 3L "DNA methylation; GO:0006306; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.- nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 Taf2 TBP-associated factor 2 "CG6711, CG6711, TAFII150, TAF150, dTAF[[II]]150, Taf150: TBP-associated factor 150kD, Taf[[II]]150, TAF[[II]]150, TafII150, dTAF II 150, dTAF150, TFIID, dTAFII150, TAF2, TAF[II]150, TAF[[II]], TAF, TBP-associated factor 150kD, Taf150" CDMC33582 1 23 11 DAC18-I14 3-CG6816-RA_3 CG6816 GACCGGACACTCCCTTCATGCAGACGCTGAACGGATATGGCATTATCAACAGCACTGGCAAACTGTGG 68 FBan0006816 FBgn0010383 Cyp18a1 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp18a1 Cytochrome P450-18a1 "CG6816, Eig17-1, P450, P-450, CytP450, 181H6T, CYP18, cyp18, 18a1, CT20826, CYP18A1-Dm, Cyp18, Cyt-P450-17C: Cytochrome P450 17C, ESTS:181H6T, Cytochrome P450 17C" CDMC33582 1 24 11 DAC18-I14 3-CG6816-RA_3 CG6816 GACCGGACACTCCCTTCATGCAGACGCTGAACGGATATGGCATTATCAACAGCACTGGCAAACTGTGG 68 FBan0006816 FBgn0010383 Cyp18a1 X X electron transport; GO:0006118; steroid biosynthesis; GO:0006694 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp18a1 Cytochrome P450-18a1 "CG6816, Eig17-1, P450, P-450, CytP450, 181H6T, CYP18, cyp18, 18a1, CT20826, CYP18A1-Dm, Cyp18, Cyt-P450-17C: Cytochrome P450 17C, ESTS:181H6T, Cytochrome P450 17C" CDMC33583 1 25 11 DAC18-M02 2-CG7295-RA_1 CG7295 GCGAAGTGGTCAACTCGCCCTACGTCATAATCGCGCTGACCTGTGTCCTGGGATATGTGGCCTATATG 68 FBan0007295 FBgn0031372 CG7295 2 2L CG7295 CG7295 CDMC33583 1 26 11 DAC18-M02 2-CG7295-RA_1 CG7295 GCGAAGTGGTCAACTCGCCCTACGTCATAATCGCGCTGACCTGTGTCCTGGGATATGTGGCCTATATG 68 FBan0007295 FBgn0031372 CG7295 2 2L CG7295 CG7295 CDMC33584 1 1 12 DAC18-M14 6-CG7408-RB_4 CG7408 AGGTGTCATTCGGAGAGCGCAACATCAGCGAACTAAGAGATCAGAGCAGGATCGAATGCCCAGATCCT 68 FBan0007408 FBgn0036765 CG7408 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG7408 CG7408 CDMC33584 1 2 12 DAC18-M14 6-CG7408-RB_4 CG7408 AGGTGTCATTCGGAGAGCGCAACATCAGCGAACTAAGAGATCAGAGCAGGATCGAATGCCCAGATCCT 68 FBan0007408 FBgn0036765 CG7408 3 3L phospholipid metabolism; GO:0006644; sulfur metabolism; GO:0006790 N-acetylgalactosamine-4-sulfatase activity; GO:0003943 ; EC:3.1.6.12; ; GO:0003943 ; EC:3.1.6.12 CG7408 CG7408 CDMC33585 1 3 12 DAC19-A02 23-CG17765-RA_1 CG17765 ATCACTCCACAGTCATATTGCAATCTCCTGGTATCAGAATCAAATTTCAAAAGTATTTGTTAACGCAGT 69 FBan0017765 FBgn0033529 CG17765 2 2R induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17765 CG17765 CDMC33585 1 4 12 DAC19-A02 23-CG17765-RA_1 CG17765 ATCACTCCACAGTCATATTGCAATCTCCTGGTATCAGAATCAAATTTCAAAAGTATTTGTTAACGCAGT 69 FBan0017765 FBgn0033529 CG17765 2 2R induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG17765 CG17765 CDMC33586 1 5 12 DAC19-A14 8-CG17780-RA_2 CG17780 GCTTCGATGGTCGAGCTTGCATGCTGAAGTCGTTCTGCACTGCCATTAACGATGTGGATAATCCCAAGC 69 FBan0017780 FBgn0039197 CG17780 3 3R CG17780 CG17780 BcDNA:RE41041 CDMC33586 1 6 12 DAC19-A14 8-CG17780-RA_2 CG17780 GCTTCGATGGTCGAGCTTGCATGCTGAAGTCGTTCTGCACTGCCATTAACGATGTGGATAATCCCAAGC 69 FBan0017780 FBgn0039197 CG17780 3 3R CG17780 CG17780 BcDNA:RE41041 CDMC33587 1 7 12 DAC19-E02 23-CG17835-RB_2 CG17835 TATGGAGTAGTGTGTAAGCTAGCTTTAGAAATTCTGAGCGATTAAGTTGTACAATATTCTAGTCCGCCG 69 FBan0017835 FBgn0001269 inv 2 2R compartment specification; GO:0007386; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 inv invected "CG17835, CG17835, er, engrailed-related, in, Engrailed/Invected, IV: transcript group IV, transcript group IV, engrailed-invected, invected" CDMC33587 1 8 12 DAC19-E02 23-CG17835-RB_2 CG17835 TATGGAGTAGTGTGTAAGCTAGCTTTAGAAATTCTGAGCGATTAAGTTGTACAATATTCTAGTCCGCCG 69 FBan0017835 FBgn0001269 inv 2 2R compartment specification; GO:0007386; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 inv invected "CG17835, CG17835, er, engrailed-related, in, Engrailed/Invected, IV: transcript group IV, transcript group IV, engrailed-invected, invected" CDMC33588 1 9 12 DAC19-E14 23-CG17841-RA_13 CG17841 TCAGCATCGCTATACTGTTCTTGCCACAGCTCTACTGGTTCTATCTGATGGTTTTGGGTGCTCTCAAGG 69 FBan0017841 FBgn0028480 CG17841 X X CG17841 CG17841 "clone 2.12, BcDNA:GH12326, anon-EST:Liang-2.12" CDMC33588 1 10 12 DAC19-E14 23-CG17841-RA_13 CG17841 TCAGCATCGCTATACTGTTCTTGCCACAGCTCTACTGGTTCTATCTGATGGTTTTGGGTGCTCTCAAGG 69 FBan0017841 FBgn0028480 CG17841 X X CG17841 CG17841 "clone 2.12, BcDNA:GH12326, anon-EST:Liang-2.12" CDMC33589 1 11 12 DAC19-I02 1-CG17906-RA_4 CG17906 ACGGAGAGCGGAATTTAATCTGGGTTCTATACCGATGGCTTCTGGCTGCTTTCTTTGCCGCTGGAGTCA 69 FBan0017906 FBgn0032086 CG17906 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG17906 CG17906 CDMC33589 1 12 12 DAC19-I02 1-CG17906-RA_4 CG17906 ACGGAGAGCGGAATTTAATCTGGGTTCTATACCGATGGCTTCTGGCTGCTTTCTTTGCCGCTGGAGTCA 69 FBan0017906 FBgn0032086 CG17906 2 2L development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 CG17906 CG17906 CDMC33590 1 13 12 DAC19-I14 3-CG17922-RA_1 CG17922 GCGCTGCCGAGACGCAAGATCAAAAGGGCTTAAAGACAGGACGATGTTCGCCAGATTTGCTATCTTCCA 69 FBan0017922 FBgn0034656 CG17922 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 intracellular cyclic nucleotide activated cation channel complex; GO:0017071 CG17922 CG17922 CDMC33590 1 14 12 DAC19-I14 3-CG17922-RA_1 CG17922 GCGCTGCCGAGACGCAAGATCAAAAGGGCTTAAAGACAGGACGATGTTCGCCAGATTTGCTATCTTCCA 69 FBan0017922 FBgn0034656 CG17922 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600; signal transduction; GO:0007165 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; receptor activity; GO:0004872; ; GO:0004872; potassium channel activity; GO:0005267; ; GO:0005221; ; GO:0005267 intracellular cyclic nucleotide activated cation channel complex; GO:0017071 CG17922 CG17922 CDMC33591 1 15 12 DAC19-M02 22-CG17956-RA_1 CG17956 TGGCCATGTCCAAGAAGGGTTCACCAGAACACCAAGACGATAGGATAGAACCTATCCCTATTTCATCCT 69 FBan0017956 FBgn0002862 Mst87F 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst87F Male-specific RNA 87F "CG17956, mst-9, mst(3)gl-9, mst(3)87F, mst(3)gl9, Mst, bs35f12.y1, mst87F, BEST:GH23081" CDMC33591 1 16 12 DAC19-M02 22-CG17956-RA_1 CG17956 TGGCCATGTCCAAGAAGGGTTCACCAGAACACCAAGACGATAGGATAGAACCTATCCCTATTTCATCCT 69 FBan0017956 FBgn0002862 Mst87F 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; iron ion binding; GO:0005506; ; GO:0005489; ; GO:0005506 Mst87F Male-specific RNA 87F "CG17956, mst-9, mst(3)gl-9, mst(3)87F, mst(3)gl9, Mst, bs35f12.y1, mst87F, BEST:GH23081" CDMC33592 1 17 12 DAC19-M14 3-CG17974-RA_2 CG17974 ACGACGAGCTGCAGTACTTGTCCATGCTAAATACCCGCACCTGTAAGTTGGACCACGATGATTGCCACA 69 FBan0017974 FBgn0034624 CG17974 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG17974 CG17974 CDMC33592 1 18 12 DAC19-M14 3-CG17974-RA_2 CG17974 ACGACGAGCTGCAGTACTTGTCCATGCTAAATACCCGCACCTGTAAGTTGGACCACGATGATTGCCACA 69 FBan0017974 FBgn0034624 CG17974 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG17974 CG17974 CDMC33593 1 19 12 DAC20-A02 3-CG10586-RA_1 CG10586 AACATCGGAACTCTATCCTTGTGCAGTACGGCCTTGACTCCGGGACAGACAATGGACGTATCCGG 65 FBan0010586 FBgn0037036 CG10586 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG10586 CG10586 SP168 CDMC33593 1 20 12 DAC20-A02 3-CG10586-RA_1 CG10586 AACATCGGAACTCTATCCTTGTGCAGTACGGCCTTGACTCCGGGACAGACAATGGACGTATCCGG 65 FBan0010586 FBgn0037036 CG10586 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; endopeptidase activity; GO:0004175; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004175; ; GO:0004263 ; EC:3.4.21.1 CG10586 CG10586 SP168 CDMC33594 1 21 12 DAC20-A14 23-CG10609-RA_1 CG10609 TTATCTACCTGGCTGTTAACCAGAAGAATTTCTACAGAACATTGAATATATGGAACCAGGTGAAC 65 FBan0010609 FBgn0037324 Or83b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or83b Odorant receptor 83b "CG10609, 83A.2, DOR45, OR83b, 83b, A45" CDMC33594 1 22 12 DAC20-A14 23-CG10609-RA_1 CG10609 TTATCTACCTGGCTGTTAACCAGAAGAATTTCTACAGAACATTGAATATATGGAACCAGGTGAAC 65 FBan0010609 FBgn0037324 Or83b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or83b Odorant receptor 83b "CG10609, 83A.2, DOR45, OR83b, 83b, A45" CDMC33595 1 23 12 DAC20-E02 3-CG10724-RA_1 CG10724 AAATCACTCGGTTGGTCTGGCTGGACAATAACACTGTGATCTCCACCGGACAGGACTGCAACACC 65 FBan0010724 FBgn0036357 CG10724 3 3L actin filament depolymerization; GO:0030042; actin polymerization and/or depolymerization; GO:0008154; cell motility; GO:0006928 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG10724 CG10724 CDMC33595 1 24 12 DAC20-E02 3-CG10724-RA_1 CG10724 AAATCACTCGGTTGGTCTGGCTGGACAATAACACTGTGATCTCCACCGGACAGGACTGCAACACC 65 FBan0010724 FBgn0036357 CG10724 3 3L actin filament depolymerization; GO:0030042; actin polymerization and/or depolymerization; GO:0008154; cell motility; GO:0006928 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG10724 CG10724 CDMC33596 1 25 12 DAC20-E14 1-CG10743-RB_1 CG10743 ATCGTCTCACCCTCGAGGACCTCTCCCAATTGCACGTCAGCTCTTGTTTGCACATAGCCTCCTTG 65 FBan0010743 FBgn0036376 CG10743 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; transport; GO:0006810 receptor signaling protein tyrosine kinase signaling protein activity; GO:0008268; transporter activity; GO:0005215; ; GO:0005215; ; GO:0008268 membrane; GO:0016020 CG10743 CG10743 CDMC33596 1 26 12 DAC20-E14 1-CG10743-RB_1 CG10743 ATCGTCTCACCCTCGAGGACCTCTCCCAATTGCACGTCAGCTCTTGTTTGCACATAGCCTCCTTG 65 FBan0010743 FBgn0036376 CG10743 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; transport; GO:0006810 receptor signaling protein tyrosine kinase signaling protein activity; GO:0008268; transporter activity; GO:0005215; ; GO:0005215; ; GO:0008268 membrane; GO:0016020 CG10743 CG10743 CDMC33597 1 1 13 DAC20-I02 6-CG10888-RA_2 CG10888 GGGCACGCTCTACATCTTCTTCACCCTGATGTCGATGCTGGGCAATGGACTGGTGATTTGGGTCT 65 FBan0010888 FBgn0003249 Rh3 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; absorption of UV light; GO:0016039; detection of UV; GO:0009589; phototransduction; GO:0007602; phototransduction, UV; GO:0007604; visual perception; GO:0007601" G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 integral to membrane; GO:0016021 Rh3 Rhodopsin 3 "CG10888, RH3, rh3, Dm Rh3, Rh, rhodopsin, DMELRH3, Rhodopsin, FBgn0003249" CDMC33597 1 2 13 DAC20-I02 6-CG10888-RA_2 CG10888 GGGCACGCTCTACATCTTCTTCACCCTGATGTCGATGCTGGGCAATGGACTGGTGATTTGGGTCT 65 FBan0010888 FBgn0003249 Rh3 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; absorption of UV light; GO:0016039; detection of UV; GO:0009589; phototransduction; GO:0007602; phototransduction, UV; GO:0007604; visual perception; GO:0007601" G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 integral to membrane; GO:0016021 Rh3 Rhodopsin 3 "CG10888, RH3, rh3, Dm Rh3, Rh, rhodopsin, DMELRH3, Rhodopsin, FBgn0003249" CDMC33598 1 3 13 DAC20-I14 2-CG10912-RA_1 CG10912 CGAGTCCTACGAAGATCTTCAGAAGTGCCTGAGCGGTGAGAATCCTGTGCCGGAAAGAAGCACCA 65 FBan0010912 FBgn0034296 CG10912 2 2R CG10912 CG10912 CDMC33598 1 4 13 DAC20-I14 2-CG10912-RA_1 CG10912 CGAGTCCTACGAAGATCTTCAGAAGTGCCTGAGCGGTGAGAATCCTGTGCCGGAAAGAAGCACCA 65 FBan0010912 FBgn0034296 CG10912 2 2R CG10912 CG10912 CDMC33599 1 5 13 DAC20-M02 1-CG11042-RA_1 CG11042 TTAAAGATCACGGATTACCTGGAAACCGAAGCCCGCCAGCTGGACAGTTGTTGGAGTGGTTGGTG 65 FBan0011042 FBgn0030094 CG11042 X X CG11042 CG11042 CDMC33599 1 6 13 DAC20-M02 1-CG11042-RA_1 CG11042 TTAAAGATCACGGATTACCTGGAAACCGAAGCCCGCCAGCTGGACAGTTGTTGGAGTGGTTGGTG 65 FBan0011042 FBgn0030094 CG11042 X X CG11042 CG11042 CDMC33600 1 7 13 DAC20-M14 5-CG1107-RA_2 CG1107 ACGCTAAGTGGAAAGTCTCCCGTCAACACTAGTCCGCAGCCTACTCAGTTCTCAAGCCCCACTCA 65 FBan0001107 FBgn0037218 auxillin 3 3R intracellular protein transport; GO:0006886; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; synaptic vesicle uncoating; GO:0016191 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 auxillin auxillin "CG1107, CG1107, CG1107, CG1107, Auxilin, GAK, auxilin, anon-WO0118547.393" CDMC33600 1 8 13 DAC20-M14 5-CG1107-RA_2 CG1107 ACGCTAAGTGGAAAGTCTCCCGTCAACACTAGTCCGCAGCCTACTCAGTTCTCAAGCCCCACTCA 65 FBan0001107 FBgn0037218 auxillin 3 3R intracellular protein transport; GO:0006886; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; synaptic vesicle uncoating; GO:0016191 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 auxillin auxillin "CG1107, CG1107, CG1107, CG1107, Auxilin, GAK, auxilin, anon-WO0118547.393" CDMC33601 1 9 13 DAC21-A02 6-CG11154-RB_1 CG11154 AAAATACCGTGCGCACTATCGCCATGGATGGTACCGAAGGCTTGGTTCGCGGACAGAAGGTTCTC 65 FBan0011154 FBgn0010217 ATPsyn-beta 4 4 ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-beta ATP synthase-beta "CG11154, CG11154, beta-ATPase, ATPsyn-beta, ATPB, ATP synthase beta subunit, H+-ATPase beta subunit, ATPsyn b, ATPsyn-b, ATP, ATP synthase beta, F1ATP synthase" CDMC33601 1 10 13 DAC21-A02 6-CG11154-RB_1 CG11154 AAAATACCGTGCGCACTATCGCCATGGATGGTACCGAAGGCTTGGTTCGCGGACAGAAGGTTCTC 65 FBan0011154 FBgn0010217 ATPsyn-beta 4 4 ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" ATPsyn-beta ATP synthase-beta "CG11154, CG11154, beta-ATPase, ATPsyn-beta, ATPB, ATP synthase beta subunit, H+-ATPase beta subunit, ATPsyn b, ATPsyn-b, ATP, ATP synthase beta, F1ATP synthase" CDMC33602 1 11 13 DAC21-A14 3-CG11188-RA_1 CG11188 ATACGTGGTGCACAACAAGCTCATCAACTTCATGGCGCCCAATGAGAGTAGCGACTGGACGGATG 65 FBan0011188 FBgn0031851 CG11188 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 CG11188 CG11188 anon-WO0118547.190 CDMC33602 1 12 13 DAC21-A14 3-CG11188-RA_1 CG11188 ATACGTGGTGCACAACAAGCTCATCAACTTCATGGCGCCCAATGAGAGTAGCGACTGGACGGATG 65 FBan0011188 FBgn0031851 CG11188 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 nucleus; GO:0005634 CG11188 CG11188 anon-WO0118547.190 CDMC33603 1 13 13 DAC21-E02 24-CG11300-RA_1 CG11300 CATGTTGGCTACGAATTTGAAATAAAATTCCAGACAGAAATGCAATAAATCTAAAAAAAACATAA 65 FBan0011300 FBgn0034901 CG11300 2 2R CG11300 CG11300 BcDNA:LP08443 CDMC33603 1 14 13 DAC21-E02 24-CG11300-RA_1 CG11300 CATGTTGGCTACGAATTTGAAATAAAATTCCAGACAGAAATGCAATAAATCTAAAAAAAACATAA 65 FBan0011300 FBgn0034901 CG11300 2 2R CG11300 CG11300 BcDNA:LP08443 CDMC33604 1 15 13 DAC21-E14 4-CG11350-RB_1 CG11350 CTTCCGCTCCAGCTGTCTCCTACTCTGCTCCCTCTCAGAGCTACTCTGCTCCCGAGTACTACAGC 65 FBan0011350 FBgn0035552 CG11350 3 3L CG11350 CG11350 CDMC33604 1 16 13 DAC21-E14 4-CG11350-RB_1 CG11350 CTTCCGCTCCAGCTGTCTCCTACTCTGCTCCCTCTCAGAGCTACTCTGCTCCCGAGTACTACAGC 65 FBan0011350 FBgn0035552 CG11350 3 3L CG11350 CG11350 CDMC33605 1 17 13 DAC21-I02 24-CG11505-RC_1 CG11505 ATCCGACTGTAAATATATGAAATTCCATGTGTAAATATGAGCAAACCTTTTTGTTAAACCTATAA 65 FBan0011505 FBgn0035424 CG11505 3 3L CG11505 CG11505 CDMC33605 1 18 13 DAC21-I02 24-CG11505-RC_1 CG11505 ATCCGACTGTAAATATATGAAATTCCATGTGTAAATATGAGCAAACCTTTTTGTTAAACCTATAA 65 FBan0011505 FBgn0035424 CG11505 3 3L CG11505 CG11505 CDMC33606 1 19 13 DAC21-I14 12-CG11529-RA_1 CG11529 CCGTGGGACAATCGAAGTACGGCAGGATCGAGAAGTTCCCCTACCAGGTGATGCTCATCGGCAAG 65 FBan0011529 FBgn0036264 CG11529 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- CG11529 CG11529 SP84 CDMC33606 1 20 13 DAC21-I14 12-CG11529-RA_1 CG11529 CCGTGGGACAATCGAAGTACGGCAGGATCGAGAAGTTCCCCTACCAGGTGATGCTCATCGGCAAG 65 FBan0011529 FBgn0036264 CG11529 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- CG11529 CG11529 SP84 CDMC33607 1 21 13 DAC21-M02 3-CG11611-RA_2 CG11611 GCTGCCAACATGGAGAAGGGTGAGCTGATGAACCAGGTGAAACAACAGATCGCATTGGCCAATGC 65 FBan0011611 FBgn0036204 Tim13 3 3L protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim13 Tim13 CG11611 CDMC33607 1 22 13 DAC21-M02 3-CG11611-RA_2 CG11611 GCTGCCAACATGGAGAAGGGTGAGCTGATGAACCAGGTGAAACAACAGATCGCATTGGCCAATGC 65 FBan0011611 FBgn0036204 Tim13 3 3L protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 protein translocase activity; GO:0015450; ; GO:0015450; ; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744; mitochondrial inner membrane protein insertion complex; GO:0042721 Tim13 Tim13 CG11611 CDMC33608 1 23 13 DAC21-M14 1-CG1165-RA_2 CG1165 CAACTCCGATGGCTCCAACGACTACGGAATCTTCCAGATCAACGATCTGTACTGGTGCCAGGCCG 65 FBan0001165 FBgn0004430 LysS 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysS Lysozyme S "CG1165, lysS, BcDNA:LP06719" CDMC33608 1 24 13 DAC21-M14 1-CG1165-RA_2 CG1165 CAACTCCGATGGCTCCAACGACTACGGAATCTTCCAGATCAACGATCTGTACTGGTGCCAGGCCG 65 FBan0001165 FBgn0004430 LysS 3 3L antimicrobial humoral response (sensu Protostomia); GO:0006960; cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 LysS Lysozyme S "CG1165, lysS, BcDNA:LP06719" CDMC33609 1 25 13 DAC22-A02 1-CG31606-RB_2 CG31606 ACTTGGAGCGAGTAGTGCGATTCCCGGATAACTCTGCTAGGGGGGAACTTTTTGGGCTTCTCGAG 65 FBan0031606 FBgn0051606 CG31606 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31606 CG31606 CDMC33609 1 26 13 DAC22-A02 1-CG31606-RB_2 CG31606 ACTTGGAGCGAGTAGTGCGATTCCCGGATAACTCTGCTAGGGGGGAACTTTTTGGGCTTCTCGAG 65 FBan0031606 FBgn0051606 CG31606 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31606 CG31606 CDMC33610 1 1 14 DAC22-A14 24-CG31629-RA_1 CG31629 AGTGTAGTGGGCAATTAATAAAGAAAGAGAGAAGTGTCTAAACAAAATGCAGTTAAATACCCTGC 65 FBan0031629 FBgn0031889 Pvf3 2 2L cellular physiological process; GO:0050875; hemocyte migration (sensu Arthropoda); GO:0035099 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf3 PDGF- and VEGF-related factor 3 "CG13782, CG13781, CG4492, CG31629, CG13782, CG13781, CG13782, CG4492, DmVEGF-3, Vegf27Ca, VEGF27Ca, PVF, PVFs, VEGF" CDMC33610 1 2 14 DAC22-A14 24-CG31629-RA_1 CG31629 AGTGTAGTGGGCAATTAATAAAGAAAGAGAGAAGTGTCTAAACAAAATGCAGTTAAATACCCTGC 65 FBan0031629 FBgn0031889 Pvf3 2 2L cellular physiological process; GO:0050875; hemocyte migration (sensu Arthropoda); GO:0035099 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf3 PDGF- and VEGF-related factor 3 "CG13782, CG13781, CG4492, CG31629, CG13782, CG13781, CG13782, CG4492, DmVEGF-3, Vegf27Ca, VEGF27Ca, PVF, PVFs, VEGF" CDMC33611 1 3 14 DAC22-E02 47-CG31711-RA_1 CG31711 TTGAGTACATGAAGGAAAACCTCTATCAGATGATAAAAGACCGAGATACCCATTTACCCGAACCG 65 FBan0031711 FBgn0051711 CG31711 2 2L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG31711 CG31711 "CG4588, MAK" CDMC33611 1 4 14 DAC22-E02 47-CG31711-RA_1 CG31711 TTGAGTACATGAAGGAAAACCTCTATCAGATGATAAAAGACCGAGATACCCATTTACCCGAACCG 65 FBan0031711 FBgn0051711 CG31711 2 2L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; spermatogenesis; GO:0007283 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG31711 CG31711 "CG4588, MAK" CDMC33612 1 5 14 DAC22-E14 18-CG31740-RA_1 CG31740 CCAAACTTTCAAGATGGTTCTGATGCTTTGCTGCAGCTTCGATCCCTTCTACGTTGGACCCTGCC 65 FBan0031740 FBgn0051740 CG31740 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31740 CG31740 "BcDNA:AT23551, BEST:GH22513" CDMC33612 1 6 14 DAC22-E14 18-CG31740-RA_1 CG31740 CCAAACTTTCAAGATGGTTCTGATGCTTTGCTGCAGCTTCGATCCCTTCTACGTTGGACCCTGCC 65 FBan0031740 FBgn0051740 CG31740 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31740 CG31740 "BcDNA:AT23551, BEST:GH22513" CDMC33613 1 7 14 DAC22-I02 16-CG31876-RA_2 CG31876 AGTACACGCTGGTCGATGCCGATGGCTATCTGCGCACCGTGGACTACACTTCGGATGCCCACAAC 65 FBan0031876 FBgn0051876 CG31876 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 CG31876 CG31876 CG5879 CDMC33613 1 8 14 DAC22-I02 16-CG31876-RA_2 CG31876 AGTACACGCTGGTCGATGCCGATGGCTATCTGCGCACCGTGGACTACACTTCGGATGCCCACAAC 65 FBan0031876 FBgn0051876 CG31876 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 CG31876 CG31876 CG5879 CDMC33614 1 9 14 DAC22-I14 2-CG31915-RA_1 CG31915 CCTTGGACCACGACGTACAACAGCTGGTGAACCTCAAGAGCATTATGGTCAATGAACTCGGCGCA 65 FBan0031915 FBgn0051915 CG31915 2 2L carbohydrate metabolism; GO:0005975; lipopolysaccharide biosynthesis; GO:0009103 procollagen-lysine 5-dioxygenase activity; GO:0008475 ; EC:1.14.11.4; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0008475 ; EC:1.14.11.4 CG31915 CG31915 CG6922 CDMC33614 1 10 14 DAC22-I14 2-CG31915-RA_1 CG31915 CCTTGGACCACGACGTACAACAGCTGGTGAACCTCAAGAGCATTATGGTCAATGAACTCGGCGCA 65 FBan0031915 FBgn0051915 CG31915 2 2L carbohydrate metabolism; GO:0005975; lipopolysaccharide biosynthesis; GO:0009103 procollagen-lysine 5-dioxygenase activity; GO:0008475 ; EC:1.14.11.4; enzyme regulator activity; GO:0030234; ; GO:0030234; ; GO:0008475 ; EC:1.14.11.4 CG31915 CG31915 CG6922 CDMC33615 1 11 14 DAC22-M02 3-CG32057-RC_2 CG32057 AATTGCTGCGAGTTCATTGCTCTCCGAGTCCAGGGAAATTTAGAGCCACCCAGTTCGGCATGTCC 65 FBan0032057 FBgn0052057 dpr10 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr10 dpr10 "CG14158, CG14159, CG32057, CG14158, CG14159, CG32057, CT33762, Dpr-10, BcDNA:RE37920" CDMC33615 1 12 14 DAC22-M02 3-CG32057-RC_2 CG32057 AATTGCTGCGAGTTCATTGCTCTCCGAGTCCAGGGAAATTTAGAGCCACCCAGTTCGGCATGTCC 65 FBan0032057 FBgn0052057 dpr10 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 dpr10 dpr10 "CG14158, CG14159, CG32057, CG14158, CG14159, CG32057, CT33762, Dpr-10, BcDNA:RE37920" CDMC33616 1 13 14 DAC22-M14 3-CG32089-RA_1 CG32089 GGGCTGCAGTTGCGATTATATTCACGACCTTGGGAGCGTCTTACGGAACAGCAGTTTCCGGTGTC 65 FBgn0052089 CDMC33616 1 14 14 DAC22-M14 3-CG32089-RA_1 CG32089 GGGCTGCAGTTGCGATTATATTCACGACCTTGGGAGCGTCTTACGGAACAGCAGTTTCCGGTGTC 65 FBgn0052089 CDMC33617 1 15 14 DAC23-A02 4-CG10730-RA_2 CG10730 TGCTCCAGTTGGATAGCAAGTCCGTGGATGAGTTCCCGGATAATCTAAGGGCAAGGCAGTGTAAGAGCT 69 FBan0010730 FBgn0032843 CG10730 2 2L CG10730 CG10730 38B.7 CDMC33617 1 16 14 DAC23-A02 4-CG10730-RA_2 CG10730 TGCTCCAGTTGGATAGCAAGTCCGTGGATGAGTTCCCGGATAATCTAAGGGCAAGGCAGTGTAAGAGCT 69 FBan0010730 FBgn0032843 CG10730 2 2L CG10730 CG10730 38B.7 CDMC33618 1 17 14 DAC23-A14 23-CG10741-RA_5 CG10741 CCAACCCAAAAGCAACCCCTGATCCTCAACGATTCAACTCAAGAGCTGTTTTTATTATAAATATTTCAA 69 FBan0010741 FBgn0036373 CG10741 3 3L CG10741 CG10741 NEST:bs23g10 CDMC33618 1 18 14 DAC23-A14 23-CG10741-RA_5 CG10741 CCAACCCAAAAGCAACCCCTGATCCTCAACGATTCAACTCAAGAGCTGTTTTTATTATAAATATTTCAA 69 FBan0010741 FBgn0036373 CG10741 3 3L CG10741 CG10741 NEST:bs23g10 CDMC33619 1 19 14 DAC23-E02 1-CG1077-RA_1 CG1077 TCGCTTCAGGAAACCAGTACGTAGGTTCACAACCACAAGGACTCCAACCACACCATACAAGCCACGTCA 69 FBan0001077 FBgn0037405 CG1077 3 3R CG1077 CG1077 anon-f CDMC33619 1 20 14 DAC23-E02 1-CG1077-RA_1 CG1077 TCGCTTCAGGAAACCAGTACGTAGGTTCACAACCACAAGGACTCCAACCACACCATACAAGCCACGTCA 69 FBan0001077 FBgn0037405 CG1077 3 3R CG1077 CG1077 anon-f CDMC33620 1 21 14 DAC23-E14 3-CG10794-RA_2 CG10794 GGCTTATCCCTATCCTGATCCCCGAGAGATTGTGAATCTGCAGCCTGAACCACTGGCATATGCTCCCAA 69 FBan0010794 FBgn0034407 DptB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 DptB Diptericin B "CG10794, dptlp, diptericin-like protein, Diptericin, BcDNA:RH29451, Diptericin B" CDMC33620 1 22 14 DAC23-E14 3-CG10794-RA_2 CG10794 GGCTTATCCCTATCCTGATCCCCGAGAGATTGTGAATCTGCAGCCTGAACCACTGGCATATGCTCCCAA 69 FBan0010794 FBgn0034407 DptB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 DptB Diptericin B "CG10794, dptlp, diptericin-like protein, Diptericin, BcDNA:RH29451, Diptericin B" CDMC33621 1 23 14 DAC23-I02 3-CG10825-RA_9 CG10825 TGCCCACCGAAATGTTTCTCAGCCTAAGAGAATCGCCAAACAGCAAGCACAAGTGCATGGAGTTCCAGT 69 FBan0010825 FBgn0038860 CG10825 3 3R CG10825 CG10825 CDMC33621 1 24 14 DAC23-I02 3-CG10825-RA_9 CG10825 TGCCCACCGAAATGTTTCTCAGCCTAAGAGAATCGCCAAACAGCAAGCACAAGTGCATGGAGTTCCAGT 69 FBan0010825 FBgn0038860 CG10825 3 3R CG10825 CG10825 CDMC33622 1 25 14 DAC23-I14 2-CG10837-RA_2 CG10837 GGGTCTGCAAAACCGGTAGATACAGCAGCAAGGGAGTTGGAGATTGAGCAAAGATTGGCTCTCGCTCGA 69 CDMC33622 1 26 14 DAC23-I14 2-CG10837-RA_2 CG10837 GGGTCTGCAAAACCGGTAGATACAGCAGCAAGGGAGTTGGAGATTGAGCAAAGATTGGCTCTCGCTCGA 69 CDMC33623 1 1 15 DAC23-M02 18-CG10866-RA_4 CG10866 TGGATATTGATTTTCACCTGCTTCGTTGTGTCATCGTTCATTGACTTGGACCACTTTGTGGAGGCTCGT 69 FBan0010866 FBgn0035475 CG10866 3 3L CG10866 CG10866 CDMC33623 1 2 15 DAC23-M02 18-CG10866-RA_4 CG10866 TGGATATTGATTTTCACCTGCTTCGTTGTGTCATCGTTCATTGACTTGGACCACTTTGTGGAGGCTCGT 69 FBan0010866 FBgn0035475 CG10866 3 3L CG10866 CG10866 CDMC33624 1 3 15 DAC23-M14 6-CG10895-RC_7 CG10895 GCGCGACCCAGTACCAATTTCAGTGATCCCGACCGGGTGCTGAACGAAGCCAAGATTATGAAGAATCTT 69 FBan0010895 FBgn0019686 lok 2 2L "DNA damage checkpoint; GO:0000077; DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; cell cycle checkpoint; GO:0000075; germ cell development; GO:0007281; intracellular signaling cascade; GO:0007242; meiosis; GO:0007126; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; response to DNA damage stimulus; GO:0006974" ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 cytoplasm; GO:0005737; nucleus; GO:0005634 lok loki "CG10895, CG10895, localized ovarian kinase, Dmnk, Drosophila maternal nuclear kinase, Dmnk-L, Dmnk-S, maternal nuclear kinase, LOKI/CHK2, 38B.4, Dmchk2, DmChk2, mnk, Chk2, chk2, DmCHk2, MNK, chk, chk2/lok, CHK2, loki" CDMC33624 1 4 15 DAC23-M14 6-CG10895-RC_7 CG10895 GCGCGACCCAGTACCAATTTCAGTGATCCCGACCGGGTGCTGAACGAAGCCAAGATTATGAAGAATCTT 69 FBan0010895 FBgn0019686 lok 2 2L "DNA damage checkpoint; GO:0000077; DNA damage response, signal transduction resulting in induction of apoptosis; GO:0008630; cell cycle checkpoint; GO:0000075; germ cell development; GO:0007281; intracellular signaling cascade; GO:0007242; meiosis; GO:0007126; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; response to DNA damage stimulus; GO:0006974" ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 cytoplasm; GO:0005737; nucleus; GO:0005634 lok loki "CG10895, CG10895, localized ovarian kinase, Dmnk, Drosophila maternal nuclear kinase, Dmnk-L, Dmnk-S, maternal nuclear kinase, LOKI/CHK2, 38B.4, Dmchk2, DmChk2, mnk, Chk2, chk2, DmCHk2, MNK, chk, chk2/lok, CHK2, loki" CDMC33625 1 5 15 DAC24-A02 9-CG14916-RA_2 CG14916 ACCGCATGCACAACAAACTGCTGCGTATCTACAAGGGCATCAACGATTGCTGCAACTTGATTCTGGTCT 69 FBan0014916 FBgn0041246 Gr32a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr32a Gustatory receptor 32a "CG14916, CG14916, CG14916, 32D.1, Gustatory receptor 32D.1, Gr32D1, 32D1, GR32D1, Gr32d, GR32D.1, Gustatory receptor 32a" CDMC33625 1 6 15 DAC24-A02 9-CG14916-RA_2 CG14916 ACCGCATGCACAACAAACTGCTGCGTATCTACAAGGGCATCAACGATTGCTGCAACTTGATTCTGGTCT 69 FBan0014916 FBgn0041246 Gr32a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr32a Gustatory receptor 32a "CG14916, CG14916, CG14916, 32D.1, Gustatory receptor 32D.1, Gr32D1, 32D1, GR32D1, Gr32d, GR32D.1, Gustatory receptor 32a" CDMC33626 1 7 15 DAC24-A14 1-CG1492-RA_1 CG1492 GGGCGGAATTCTCAAGAGCCGGAACTATGAGCCCACGTCAAATCCATTTGATGGTCGAGGCAATGAAGT 69 FBan0001492 FBgn0030361 CG1492 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG1492 CG1492 CDMC33626 1 8 15 DAC24-A14 1-CG1492-RA_1 CG1492 GGGCGGAATTCTCAAGAGCCGGAACTATGAGCCCACGTCAAATCCATTTGATGGTCGAGGCAATGAAGT 69 FBan0001492 FBgn0030361 CG1492 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG1492 CG1492 CDMC33627 1 9 15 DAC24-E02 22-CG14959-RC_1 CG14959 TGCGCCAATGAGACGAGCTTTAACCAGGAGTACAGAATCTGTGATTGGGACTACAACTTTAACTGCACA 69 FBan0014959 FBgn0035427 CG14959 3 3L CG14959 CG14959 "EP(3)0714, EP(2)3139, BcDNA:RH52423, EP3139, EP714" CDMC33627 1 10 15 DAC24-E02 22-CG14959-RC_1 CG14959 TGCGCCAATGAGACGAGCTTTAACCAGGAGTACAGAATCTGTGATTGGGACTACAACTTTAACTGCACA 69 FBan0014959 FBgn0035427 CG14959 3 3L CG14959 CG14959 "EP(3)0714, EP(2)3139, BcDNA:RH52423, EP3139, EP714" CDMC33628 1 11 15 DAC24-E14 16-CG14965-RA_2 CG14965 CCAAAGCAGCAACACCTAATACCACCTAAAGATTTCGAGTGTCCTCTGGGATTCGTGGATGGTGAGACA 69 FBan0014965 FBgn0035414 CG14965 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG14965 CG14965 "63BC-T3, ORF1, dmLD47616p, anon-63BC-T3" CDMC33628 1 12 15 DAC24-E14 16-CG14965-RA_2 CG14965 CCAAAGCAGCAACACCTAATACCACCTAAAGATTTCGAGTGTCCTCTGGGATTCGTGGATGGTGAGACA 69 FBan0014965 FBgn0035414 CG14965 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG14965 CG14965 "63BC-T3, ORF1, dmLD47616p, anon-63BC-T3" CDMC33629 1 13 15 DAC24-I02 17-CG14996-RB_2 CG14996 GCCGCTTTTGGGTTCCACACACTTTTCACGTTTTGAGCTAGATTTGGGTAGAGCCCCTGAATGATATGA 69 FBan0014996 FBgn0035499 Chd64 3 3L muscle contraction; GO:0006936; smooth muscle contraction; GO:0006939 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 striated muscle thin filament; GO:0005865 Chd64 Chd64 "CG14996, CG14996, CG14996, clone 1.80, CT34849, anon-EST:Liang-1.80" CDMC33629 1 14 15 DAC24-I02 17-CG14996-RB_2 CG14996 GCCGCTTTTGGGTTCCACACACTTTTCACGTTTTGAGCTAGATTTGGGTAGAGCCCCTGAATGATATGA 69 FBan0014996 FBgn0035499 Chd64 3 3L muscle contraction; GO:0006936; smooth muscle contraction; GO:0006939 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 striated muscle thin filament; GO:0005865 Chd64 Chd64 "CG14996, CG14996, CG14996, clone 1.80, CT34849, anon-EST:Liang-1.80" CDMC33630 1 15 15 DAC24-I14 2-CG15003-RA_1 CG15003 GGTTGCACGCTACGATTTGGACAAGGTTTACAGGGAGCTTCTAGTCTCGCTGATTGTGCCCATTGTGCT 69 FBan0015003 FBgn0035504 CG15003 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG15003 CG15003 anon-WO0172774.111 CDMC33630 1 16 15 DAC24-I14 2-CG15003-RA_1 CG15003 GGTTGCACGCTACGATTTGGACAAGGTTTACAGGGAGCTTCTAGTCTCGCTGATTGTGCCCATTGTGCT 69 FBan0015003 FBgn0035504 CG15003 3 3L calcium ion binding; GO:0005509; ; GO:0005509 CG15003 CG15003 anon-WO0172774.111 CDMC33631 1 17 15 DAC24-M02 18-CG15033-RA_4 CG15033 GGACGACACCATCGAAAATCAGGAAAATTGGGTAGACTGGGGAACGCTGAGTATGAAAAAGGTCTCACG 69 FBan0015033 FBgn0029948 CheA7a X X CheA7a CheA7a CG15033 CDMC33631 1 18 15 DAC24-M02 18-CG15033-RA_4 CG15033 GGACGACACCATCGAAAATCAGGAAAATTGGGTAGACTGGGGAACGCTGAGTATGAAAAAGGTCTCACG 69 FBan0015033 FBgn0029948 CheA7a X X CheA7a CheA7a CG15033 CDMC33632 1 19 15 DAC24-M14 18-CG15046-RA_1 CG15046 ATAGTGCGCCTGGTTCAATTTCAAAAGGATCTATCACTTATACGATTGCAGGACCCACTGCGTCTGGGC 69 FBan0015046 FBgn0030927 CG15046 X X CG15046 CG15046 CDMC33632 1 20 15 DAC24-M14 18-CG15046-RA_1 CG15046 ATAGTGCGCCTGGTTCAATTTCAAAAGGATCTATCACTTATACGATTGCAGGACCCACTGCGTCTGGGC 69 FBan0015046 FBgn0030927 CG15046 X X CG15046 CG15046 CDMC33633 1 21 15 DAC25-A02 2-CG14302-RA_1 CG14302 CCGCAGGCTGAGACCACAAATGCCACGCCAGAAACGTCGACCATCTATCCCATTTACGGATAGTCATCA 69 FBan0014302 FBgn0038647 CG14302 3 3R CG14302 CG14302 BcDNA:LP02994 CDMC33633 1 22 15 DAC25-A02 2-CG14302-RA_1 CG14302 CCGCAGGCTGAGACCACAAATGCCACGCCAGAAACGTCGACCATCTATCCCATTTACGGATAGTCATCA 69 FBan0014302 FBgn0038647 CG14302 3 3R CG14302 CG14302 BcDNA:LP02994 CDMC33634 1 23 15 DAC25-A14 23-CG14307-RD_2 CG14307 CCGCTCAGGATTAGCCATAGGCATTAGCATTAAGTTTTCGTTATCAATTAAATGTCCGAAAAGTAAAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC33634 1 24 15 DAC25-A14 23-CG14307-RD_2 CG14307 CCGCTCAGGATTAGCCATAGGCATTAGCATTAAGTTTTCGTTATCAATTAAATGTCCGAAAAGTAAAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC33635 1 25 15 DAC25-E02 12-CG1434-RA_2 CG1434 CAACGGTGGTTCGAAAAACATGCACTGCTACGATGATCTGCGCAAATTTCAAATGGAATGCGGCGCCGA 69 FBan0001434 FBgn0030554 CG1434 X X tRNA processing; GO:0008033 double-stranded RNA binding; GO:0003725; tRNA dihydrouridine synthase activity; GO:0017150; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017150; FAD binding; GO:0050660; ; GO:0050660; ; GO:0003725 intracellular; GO:0005622 CG1434 CG1434 CDMC33635 1 26 15 DAC25-E02 12-CG1434-RA_2 CG1434 CAACGGTGGTTCGAAAAACATGCACTGCTACGATGATCTGCGCAAATTTCAAATGGAATGCGGCGCCGA 69 FBan0001434 FBgn0030554 CG1434 X X tRNA processing; GO:0008033 double-stranded RNA binding; GO:0003725; tRNA dihydrouridine synthase activity; GO:0017150; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017150; FAD binding; GO:0050660; ; GO:0050660; ; GO:0003725 intracellular; GO:0005622 CG1434 CG1434 CDMC33636 1 1 16 DAC25-E14 3-CG14359-RA_1 CG14359 TGCCTGGACGGTAGCCAGGGCAATGAGGAGGAAGGCACACAGAGCAAAGAACTTCATCGTTTCAAAATT 69 FBan0014359 FBgn0040559 CG14359 3 3R CG14359 CG14359 CDMC33636 1 2 16 DAC25-E14 3-CG14359-RA_1 CG14359 TGCCTGGACGGTAGCCAGGGCAATGAGGAGGAAGGCACACAGAGCAAAGAACTTCATCGTTTCAAAATT 69 FBan0014359 FBgn0040559 CG14359 3 3R CG14359 CG14359 CDMC33637 1 3 16 DAC25-I02 23-CG14408-RA_7 CG14408 AGCCAAAAGAGTTACTGTCCGATGAGCAGGTTGAGAATTTACTATTAAATCACTTGGTGGATGAGAATG 69 FBan0014408 FBgn0030581 CG14408 X X SH3 domain binding; GO:0017124; ; GO:0017124 CG14408 CG14408 CDMC33637 1 4 16 DAC25-I02 23-CG14408-RA_7 CG14408 AGCCAAAAGAGTTACTGTCCGATGAGCAGGTTGAGAATTTACTATTAAATCACTTGGTGGATGAGAATG 69 FBan0014408 FBgn0030581 CG14408 X X SH3 domain binding; GO:0017124; ; GO:0017124 CG14408 CG14408 CDMC33638 1 5 16 DAC25-I14 1-CG14424-RA_1 CG14424 CCCACCGATCAGATTCCCGAGAACGTTCAGTTCATCCCGACACCCAATGGAATTTCCGGTCACAAGGAT 69 FBan0014424 FBgn0025644 CG14424 X X CG14424 CG14424 EG:100G7.5 CDMC33638 1 6 16 DAC25-I14 1-CG14424-RA_1 CG14424 CCCACCGATCAGATTCCCGAGAACGTTCAGTTCATCCCGACACCCAATGGAATTTCCGGTCACAAGGAT 69 FBan0014424 FBgn0025644 CG14424 X X CG14424 CG14424 EG:100G7.5 CDMC33639 1 7 16 DAC25-M02 23-CG14464-RA_3 CG14464 ACTTTAGTATAACAAATTCTCGCCAAGATATGAAGCCGTATTTAGATTCAGATTATTCCATCAGTCGCA 69 FBgn0033000 CG14464 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14464 CG14464 "CG40285, CG40285, CG40285, CG40285, CG40285, BcDNA:LD29015" CDMC33639 1 8 16 DAC25-M02 23-CG14464-RA_3 CG14464 ACTTTAGTATAACAAATTCTCGCCAAGATATGAAGCCGTATTTAGATTCAGATTATTCCATCAGTCGCA 69 FBgn0033000 CG14464 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14464 CG14464 "CG40285, CG40285, CG40285, CG40285, CG40285, BcDNA:LD29015" CDMC33640 1 9 16 DAC25-M14 3-CG14485-RA_3 CG14485 GCGGGACAATCCCCACTACCGCCACGTTGTGGATATGCAGCTGGAGAACAATCAGATATCCAATGTGGA 69 FBan0014485 FBgn0034262 swi2 2 2R intracellular signaling cascade; GO:0007242; pupariation; GO:0035073; response to ecdysone; GO:0035075 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 swi2 swi2 "CG14485, CG14485" CDMC33640 1 10 16 DAC25-M14 3-CG14485-RA_3 CG14485 GCGGGACAATCCCCACTACCGCCACGTTGTGGATATGCAGCTGGAGAACAATCAGATATCCAATGTGGA 69 FBan0014485 FBgn0034262 swi2 2 2R intracellular signaling cascade; GO:0007242; pupariation; GO:0035073; response to ecdysone; GO:0035075 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 swi2 swi2 "CG14485, CG14485" CDMC33641 1 11 16 DAC26-A02 3-CG4704-RA_1 CG4704 GCGGCACATTGCGTATGTAGTGACCGGCGTAAAACTCTCGCAGCATCTCACGGATGTGATTTTCTGCAT 69 FBan0004704 FBgn0039029 CG4704 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4704 CG4704 CDMC33641 1 12 16 DAC26-A02 3-CG4704-RA_1 CG4704 GCGGCACATTGCGTATGTAGTGACCGGCGTAAAACTCTCGCAGCATCTCACGGATGTGATTTTCTGCAT 69 FBan0004704 FBgn0039029 CG4704 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4704 CG4704 CDMC33642 1 13 16 DAC26-A14 12-CG4715-RA_8 CG4715 TGGACTAATTGACTTGGAGAAAGCGTTGGACTTTAGGGCCGGACGACTTTCTTTGGGAGATGACGACGT 69 FBan0004715 FBgn0031305 Iris 2 2L oogenesis (sensu Insecta); GO:0009993 Iris Iris "CG4715, Iris" CDMC33642 1 14 16 DAC26-A14 12-CG4715-RA_8 CG4715 TGGACTAATTGACTTGGAGAAAGCGTTGGACTTTAGGGCCGGACGACTTTCTTTGGGAGATGACGACGT 69 FBan0004715 FBgn0031305 Iris 2 2L oogenesis (sensu Insecta); GO:0009993 Iris Iris "CG4715, Iris" CDMC33643 1 15 16 DAC26-E02 3-CG4746-RA_1 CG4746 GGCTGCCAAATCGTGAGAATTGCATTTGGAATGCCACCAACTGAAGTCGATTGGATTCGGGCTCTTGGT 69 FBan0004746 FBgn0029003 mab-2 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mab-2 mab-2 "CG4746, CG4746" CDMC33643 1 16 16 DAC26-E02 3-CG4746-RA_1 CG4746 GGCTGCCAAATCGTGAGAATTGCATTTGGAATGCCACCAACTGAAGTCGATTGGATTCGGGCTCTTGGT 69 FBan0004746 FBgn0029003 mab-2 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 mab-2 mab-2 "CG4746, CG4746" CDMC33644 1 17 16 DAC26-E14 23-CG4753-RB_1 CG4753 AATATTTGTGTTTATCAGCATTCTTCCTACACGTTCGTTTCTTTATCAGTTGTAACGATCAGAAGCAGC 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC33644 1 18 16 DAC26-E14 23-CG4753-RB_1 CG4753 AATATTTGTGTTTATCAGCATTCTTCCTACACGTTCGTTTCTTTATCAGTTGTAACGATCAGAAGCAGC 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC33645 1 19 16 DAC26-I02 2-CG4780-RA_1 CG4780 CCACCTTCGCAGCGACAAAGCTCCAAACTTCGTGTGGATCAGCTGAAATATGACCTGAGACACCTGCAG 69 FBan0004780 FBgn0035602 CG4780 3 3L exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 SNAP receptor activity; GO:0005484; ; GO:0005484 Golgi apparatus; GO:0005794; integral to membrane; GO:0016021 CG4780 CG4780 BcDNA:SD22572 CDMC33645 1 20 16 DAC26-I02 2-CG4780-RA_1 CG4780 CCACCTTCGCAGCGACAAAGCTCCAAACTTCGTGTGGATCAGCTGAAATATGACCTGAGACACCTGCAG 69 FBan0004780 FBgn0035602 CG4780 3 3L exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 SNAP receptor activity; GO:0005484; ; GO:0005484 Golgi apparatus; GO:0005794; integral to membrane; GO:0016021 CG4780 CG4780 BcDNA:SD22572 CDMC33646 1 21 16 DAC26-I14 17-CG4788-RA_1 CG4788 TCCCTTTGCGGAGGAATACTTTAGTTAAGCCAAAAACGCTTGGGTCAACTACTACAGCGACCTACCCTA 69 FBan0004788 FBgn0032354 CG4788 2 2L CG4788 CG4788 CDMC33646 1 22 16 DAC26-I14 17-CG4788-RA_1 CG4788 TCCCTTTGCGGAGGAATACTTTAGTTAAGCCAAAAACGCTTGGGTCAACTACTACAGCGACCTACCCTA 69 FBan0004788 FBgn0032354 CG4788 2 2L CG4788 CG4788 CDMC33647 1 23 16 DAC26-M02 15-CG4820-RA_7 CG4820 TTCCGTATCCAACCAGCGATTGTTTCCCATCTTACAGCTGCAGAATGTCCAGGATTTGCCCAATCACAT 69 FBan0004820 FBgn0037876 CG4820 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4820 CG4820 CDMC33647 1 24 16 DAC26-M02 15-CG4820-RA_7 CG4820 TTCCGTATCCAACCAGCGATTGTTTCCCATCTTACAGCTGCAGAATGTCCAGGATTTGCCCAATCACAT 69 FBan0004820 FBgn0037876 CG4820 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4820 CG4820 CDMC33648 1 25 16 DAC26-M14 23-CG4838-RA_6 CG4838 CAAATGGCTCTCAGTGAAGAGAACATTAAGAGATGCGGAAAGTCAAACCAAAAATGCACAGTTGCCTGG 69 FBan0004838 FBgn0028644 beat-Ic 2 2L axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ic beaten path Ic "CG4838, BG:DS00913.1, beat-C, CT15531, beat Ic, beaten path Ic" CDMC33648 1 26 16 DAC26-M14 23-CG4838-RA_6 CG4838 CAAATGGCTCTCAGTGAAGAGAACATTAAGAGATGCGGAAAGTCAAACCAAAAATGCACAGTTGCCTGG 69 FBan0004838 FBgn0028644 beat-Ic 2 2L axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ic beaten path Ic "CG4838, BG:DS00913.1, beat-C, CT15531, beat Ic, beaten path Ic" CDMC33649 1 1 17 DAC27-A02 16-CG3448-RB_1 CG3448 TGTCGAAAAACCAGCGTTCAAAGTGTACAAATGCGAAGGATACGAAACGCTGTACTTGGATGTTCCGCT 69 FBan0003448 FBgn0035996 CG3448 3 3L CG3448 CG3448 CDMC33649 1 2 17 DAC27-A02 16-CG3448-RB_1 CG3448 TGTCGAAAAACCAGCGTTCAAAGTGTACAAATGCGAAGGATACGAAACGCTGTACTTGGATGTTCCGCT 69 FBan0003448 FBgn0035996 CG3448 3 3L CG3448 CG3448 CDMC33650 1 3 17 DAC27-A14 15-CG3469-RA_3 CG3469 TGTCAACAAGGAGACCATGTTTCAGTTCATCACTCGGAGCCTGCGATACGATTACGGTTTCAGCCAAGA 69 FBan0003469 FBgn0015000 betaggt-I 2 2L Ras protein signal transduction; GO:0007265; protein lipidation; GO:0006497 protein geranylgeranyltransferase activity; GO:0004661 ; EC:2.5.1.-; ; GO:0004661 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0004661 ; EC:2.5.1.-; ; GO:0004661 ; EC:2.5.1.-; CAAX-protein geranylgeranyltransferase activity; GO:0004662 ; EC:2.5.1.59; ; GO:0004662 ; EC:2.5.1.59 betaggt-I beta subunit of type I geranylgeranyl transferase "CG3469, SR2-2: Suppressor of Ras1 2-2, ggt1, betaGGT-I, type I Geranylgeranyl Transferase, beta-GGT, beta GGT-I, betaggt-I, GGT1, ggt-1, Suppressor of Ras1 2-2, SR2-2" CDMC33650 1 4 17 DAC27-A14 15-CG3469-RA_3 CG3469 TGTCAACAAGGAGACCATGTTTCAGTTCATCACTCGGAGCCTGCGATACGATTACGGTTTCAGCCAAGA 69 FBan0003469 FBgn0015000 betaggt-I 2 2L Ras protein signal transduction; GO:0007265; protein lipidation; GO:0006497 protein geranylgeranyltransferase activity; GO:0004661 ; EC:2.5.1.-; ; GO:0004661 ; EC:2.5.1.-; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0004661 ; EC:2.5.1.-; ; GO:0004661 ; EC:2.5.1.-; CAAX-protein geranylgeranyltransferase activity; GO:0004662 ; EC:2.5.1.59; ; GO:0004662 ; EC:2.5.1.59 betaggt-I beta subunit of type I geranylgeranyl transferase "CG3469, SR2-2: Suppressor of Ras1 2-2, ggt1, betaGGT-I, type I Geranylgeranyl Transferase, beta-GGT, beta GGT-I, betaggt-I, GGT1, ggt-1, Suppressor of Ras1 2-2, SR2-2" CDMC33651 1 5 17 DAC27-E02 2-CG3511-RA_1 CG3511 TGCTCCACACCACGAAAGGCGATATCCACATGAGGCTGTTCTTCAAGGAGGTTCCAAAGACGGTTGAGA 69 FBan0003511 FBgn0035027 CG3511 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG3511 CG3511 CDMC33651 1 6 17 DAC27-E02 2-CG3511-RA_1 CG3511 TGCTCCACACCACGAAAGGCGATATCCACATGAGGCTGTTCTTCAAGGAGGTTCCAAAGACGGTTGAGA 69 FBan0003511 FBgn0035027 CG3511 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG3511 CG3511 CDMC33652 1 7 17 DAC27-E14 23-CG3527-RA_1 CG3527 ACTGAACTTGTGCATTTCGAAAAACGTGCGGATTTCTTAAGAATAATTTCGGAATTGTTTTTAACCATA 69 FBan0003527 FBgn0029714 CG3527 X X rRNA processing; GO:0006364; ribosomal small subunit biogenesis; GO:0042274 nucleolus; GO:0005730 CG3527 CG3527 CDMC33652 1 8 17 DAC27-E14 23-CG3527-RA_1 CG3527 ACTGAACTTGTGCATTTCGAAAAACGTGCGGATTTCTTAAGAATAATTTCGGAATTGTTTTTAACCATA 69 FBan0003527 FBgn0029714 CG3527 X X rRNA processing; GO:0006364; ribosomal small subunit biogenesis; GO:0042274 nucleolus; GO:0005730 CG3527 CG3527 CDMC33653 1 9 17 DAC27-I02 2-CG3569-RA_3 CG3569 ACTGCGTGCTGGACCACAAGACTATACTGAAATGCTGTGACATGATTCGCCCCATGATATCCCGCACCA 69 FBan0003569 FBgn0034865 Or59b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59b Odorant receptor 59b "CG3569, 59E.1, DOR119, 59b" CDMC33653 1 10 17 DAC27-I02 2-CG3569-RA_3 CG3569 ACTGCGTGCTGGACCACAAGACTATACTGAAATGCTGTGACATGATTCGCCCCATGATATCCCGCACCA 69 FBan0003569 FBgn0034865 Or59b 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or59b Odorant receptor 59b "CG3569, 59E.1, DOR119, 59b" CDMC33654 1 11 17 DAC27-I14 24-CG3584-RA_1 CG3584 TCTGGACCATTTCAACAGATAATAAGTCAAATAATTCCTATTATGTTTAAATTATGATTTCCCGAGTTC 69 FBan0003584 FBgn0022984 qkr58E-3 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" RNA binding; GO:0003723; ; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 qkr58E-3 quaking related 58E-3 "CG3584, KEP1, KH domain encompassing protein 1, kep1, qrk58E-3" CDMC33654 1 12 17 DAC27-I14 24-CG3584-RA_1 CG3584 TCTGGACCATTTCAACAGATAATAAGTCAAATAATTCCTATTATGTTTAAATTATGATTTCCCGAGTTC 69 FBan0003584 FBgn0022984 qkr58E-3 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" RNA binding; GO:0003723; ; GO:0003723; mRNA binding; GO:0003729; ; GO:0003729 nucleus; GO:0005634 qkr58E-3 quaking related 58E-3 "CG3584, KEP1, KH domain encompassing protein 1, kep1, qrk58E-3" CDMC33655 1 13 17 DAC27-M02 23-CG3619-RA_2 CG3619 AGCTCTCTCATCCAATTTTGTACATAAAGTTCTCCGATATAAGCTTTTACAGCCTATAGCCACACACAC 69 FBan0003619 FBgn0000463 Dl 3 3R "Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R8 cell differentiation; GO:0045465; antennal morphogenesis; GO:0007469; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; cell adhesion; GO:0007155; cell fate specification; GO:0001708; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; lateral inhibition; GO:0046331; leg joint morphogenesis; GO:0035111; leg morphogenesis (sensu Endopterygota); GO:0007480; leg segmentation; GO:0035286; mesoderm development; GO:0007498; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005112; ; GO:0004871; ; GO:0005509 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Dl Delta "CG3619, CG3619, C1, Complementation group 1, D, 0495/20, 0926/11, 1053/14, 1119/09, 1304/03, 1423/11, 1440/11, 1485/04, dmDelta, delta D1, delta, Overflow, CT12133, Delta, anon-WO0118547.269, l(3)05151, l(3)92Ab, l(3)j8C3" CDMC33655 1 14 17 DAC27-M02 23-CG3619-RA_2 CG3619 AGCTCTCTCATCCAATTTTGTACATAAAGTTCTCCGATATAAGCTTTTACAGCCTATAGCCACACACAC 69 FBan0003619 FBgn0000463 Dl 3 3R "Notch signaling pathway; GO:0007219; R3/R4 cell fate commitment; GO:0007464; R8 cell differentiation; GO:0045465; antennal morphogenesis; GO:0007469; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; cell adhesion; GO:0007155; cell fate specification; GO:0001708; cell proliferation; GO:0008283; cell-cell adhesion; GO:0016337; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; eye development (sensu Endopterygota); GO:0007456; lateral inhibition; GO:0046331; leg joint morphogenesis; GO:0035111; leg morphogenesis (sensu Endopterygota); GO:0007480; leg segmentation; GO:0035286; mesoderm development; GO:0007498; negative regulation of fusion cell fate specification; GO:0035157; negative regulation of terminal cell fate specification; GO:0035155; nervous system development; GO:0007399; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination; GO:0007314; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; regulation of R8 spacing; GO:0045468; restriction of R8 fate; GO:0007461; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; ventral cord development; GO:0007419; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" receptor binding; GO:0005102; Notch binding; GO:0005112; ; GO:0005112; ; GO:0005112; signal transducer activity; GO:0004871; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005112; ; GO:0004871; ; GO:0005509 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Dl Delta "CG3619, CG3619, C1, Complementation group 1, D, 0495/20, 0926/11, 1053/14, 1119/09, 1304/03, 1423/11, 1440/11, 1485/04, dmDelta, delta D1, delta, Overflow, CT12133, Delta, anon-WO0118547.269, l(3)05151, l(3)92Ab, l(3)j8C3" CDMC33656 1 15 17 DAC27-M14 1-CG3632-RC_1 CG3632 TGGGTGCCAGACCATGCAGTTTCGCGTTGCTCTAGTTGTCAAACTGAGTTCTGGCTTGGACGAAGAAAA 69 FBan0003632 FBgn0030735 CG3632 X X protein amino acid dephosphorylation; GO:0006470; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; zinc ion binding; GO:0008270; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008270 CG3632 CG3632 MYOTUBULARIN-like CDMC33656 1 16 17 DAC27-M14 1-CG3632-RC_1 CG3632 TGGGTGCCAGACCATGCAGTTTCGCGTTGCTCTAGTTGTCAAACTGAGTTCTGGCTTGGACGAAGAAAA 69 FBan0003632 FBgn0030735 CG3632 X X protein amino acid dephosphorylation; GO:0006470; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; zinc ion binding; GO:0008270; ; GO:0008138 ; EC:3.1.3.-; ; GO:0008270 CG3632 CG3632 MYOTUBULARIN-like CDMC33657 1 17 17 DAC28-A02 4-CG14716-RA_1 CG14716 GCTGCGCAAAAGAAACATGTCAGCGAGCGAAGAAACAATAGCGGACAGTCAGGTCTCCGAGAATGTGGA 69 FBan0014716 FBgn0037933 Ho 3 3R heme oxidation; GO:0006788 heme oxygenase (decyclizing) activity; GO:0004392 ; EC:1.14.99.3; ; GO:0004392 ; EC:1.14.99.3; ; GO:0004392 ; EC:1.14.99.3 Ho Heme oxygenase "CG14716, CG14716, HO, CT34507, DmHO, Heme oxygenase" CDMC33657 1 18 17 DAC28-A02 4-CG14716-RA_1 CG14716 GCTGCGCAAAAGAAACATGTCAGCGAGCGAAGAAACAATAGCGGACAGTCAGGTCTCCGAGAATGTGGA 69 FBan0014716 FBgn0037933 Ho 3 3R heme oxidation; GO:0006788 heme oxygenase (decyclizing) activity; GO:0004392 ; EC:1.14.99.3; ; GO:0004392 ; EC:1.14.99.3; ; GO:0004392 ; EC:1.14.99.3 Ho Heme oxygenase "CG14716, CG14716, HO, CT34507, DmHO, Heme oxygenase" CDMC33658 1 19 17 DAC28-A14 23-CG14734-RA_8 CG14734 CTTGATGGAAGTTCCTCTTAGAGCTACAAAACTAGGAAATGCGAAAGTAGATGGACACAGGGGACCGGG 69 FBan0014734 FBgn0037976 Tk 3 3R neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ; GO:0005102; ; GO:0005184 Tk Tachykinin "CG14734, CG14734, Dtk, Drm-TK, Drm-TK-1, Drm-TK-2, Drm-TK-3, Drm-TK-4, Drm-TK-5, Drm-TK-6, neurokinin, tachykinin-3, DTK1, Tachykinin" CDMC33658 1 20 17 DAC28-A14 23-CG14734-RA_8 CG14734 CTTGATGGAAGTTCCTCTTAGAGCTACAAAACTAGGAAATGCGAAAGTAGATGGACACAGGGGACCGGG 69 FBan0014734 FBgn0037976 Tk 3 3R neuropeptide signaling pathway; GO:0007218 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ; GO:0005102; ; GO:0005184 Tk Tachykinin "CG14734, CG14734, Dtk, Drm-TK, Drm-TK-1, Drm-TK-2, Drm-TK-3, Drm-TK-4, Drm-TK-5, Drm-TK-6, neurokinin, tachykinin-3, DTK1, Tachykinin" CDMC33659 1 21 17 DAC28-E02 2-CG14791-RC_1 CG14791 CGGAAGCTCCGTCCAAAGCCGTTCCATTCTTAAAGTTGCCCGAGGGATTATGTCTCGAGAGTGCTTCGA 69 FBan0014791 FBgn0025382 Rab27 X X "SRP-dependent cotranslational protein targeting to membrane; GO:0006614; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; mRNA binding; GO:0003729; ; GO:0003729; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677 signal recognition particle (sensu Eukaryota); GO:0005786 Rab27 Rab27 "CG14791, CG14791, EG:80H7.4, DmRab27, AAF45634, AAF45635, dm-Rab27" CDMC33659 1 22 17 DAC28-E02 2-CG14791-RC_1 CG14791 CGGAAGCTCCGTCCAAAGCCGTTCCATTCTTAAAGTTGCCCGAGGGATTATGTCTCGAGAGTGCTTCGA 69 FBan0014791 FBgn0025382 Rab27 X X "SRP-dependent cotranslational protein targeting to membrane; GO:0006614; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; regulation of exocytosis; GO:0017157; regulation of transcription, DNA-dependent; GO:0006355; small GTPase mediated signal transduction; GO:0007264; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; ; GO:0005525; mRNA binding; GO:0003729; ; GO:0003729; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677 signal recognition particle (sensu Eukaryota); GO:0005786 Rab27 Rab27 "CG14791, CG14791, EG:80H7.4, DmRab27, AAF45634, AAF45635, dm-Rab27" CDMC33660 1 23 17 DAC28-E14 23-CG14802-RB_1 CG14802 AACTACTGCTCAGTTAATTTAATACCATAGTACACCCAAACTTACAAAATTAGCCAATGGCGATTGTGT 69 FBan0014802 FBgn0026873 MED18 X X RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED18 Mediator complex subunit 18 "CG14802, CG14802, p28, EG:63B12.13, dp28b, Srb5/Med28b, p28/CG14802, Med18, Mediator complex subunit 18" CDMC33660 1 24 17 DAC28-E14 23-CG14802-RB_1 CG14802 AACTACTGCTCAGTTAATTTAATACCATAGTACACCCAAACTTACAAAATTAGCCAATGGCGATTGTGT 69 FBan0014802 FBgn0026873 MED18 X X RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED18 Mediator complex subunit 18 "CG14802, CG14802, p28, EG:63B12.13, dp28b, Srb5/Med28b, p28/CG14802, Med18, Mediator complex subunit 18" CDMC33661 1 25 17 DAC28-I02 14-CG14837-RB_1 CG14837 TGGAGTCTCTGGAAACTCCACAGGCCACTCATAAAACCCTCGAACGCTGCGATATTTGCTACAATGAGT 69 FBan0014837 FBgn0035797 CG14837 3 3L CG14837 CG14837 CDMC33661 1 26 17 DAC28-I02 14-CG14837-RB_1 CG14837 TGGAGTCTCTGGAAACTCCACAGGCCACTCATAAAACCCTCGAACGCTGCGATATTTGCTACAATGAGT 69 FBan0014837 FBgn0035797 CG14837 3 3L CG14837 CG14837 CDMC33662 1 1 18 DAC28-I14 23-CG1484-RA_5 CG1484 TGAGCTGAGAGGATTACTCCCCTGTGCTAGTCCTTTTAAAATGTTAACCTACTTAAAGCTAGCCTGTAA 69 FBan0001484 FBgn0000709 fliI X X embryonic development; GO:0009790; flight behavior; GO:0007629; gastrulation (sensu Insecta); GO:0010004 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 fliI flightless I "CG1484, CG1484, CG1484, CG1484, 15, section 15, lDCB2-19, lgluful-2, W2, fltO, sdby: standby, l(1)W-2, w-2, fltI, fli, flightless, EN3, DCA3-19, gluful-2, FLI-I, CT3691, fli-I, BcDNA:LD21753, l(1)18-80, l(1)19Fd, l(1)ESHS53, standby, sdby" CDMC33662 1 2 18 DAC28-I14 23-CG1484-RA_5 CG1484 TGAGCTGAGAGGATTACTCCCCTGTGCTAGTCCTTTTAAAATGTTAACCTACTTAAAGCTAGCCTGTAA 69 FBan0001484 FBgn0000709 fliI X X embryonic development; GO:0009790; flight behavior; GO:0007629; gastrulation (sensu Insecta); GO:0010004 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005509; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005509 fliI flightless I "CG1484, CG1484, CG1484, CG1484, 15, section 15, lDCB2-19, lgluful-2, W2, fltO, sdby: standby, l(1)W-2, w-2, fltI, fli, flightless, EN3, DCA3-19, gluful-2, FLI-I, CT3691, fli-I, BcDNA:LD21753, l(1)18-80, l(1)19Fd, l(1)ESHS53, standby, sdby" CDMC33663 1 3 18 DAC28-M02 12-CG14885-RA_3 CG14885 GCCACTGGGGAACGTCGATCTTCCCAGGGCTTGAGGTCCATCCTTTTGAAGGGACAGATGTTCTACATC 69 FBan0014885 FBgn0038435 Gyc-89Da 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gyc-89Da Guanylyl cyclase at 89Da "CG14885, CG14885, GYCb, Guanylyl cyclase at 89Da" CDMC33663 1 4 18 DAC28-M02 12-CG14885-RA_3 CG14885 GCCACTGGGGAACGTCGATCTTCCCAGGGCTTGAGGTCCATCCTTTTGAAGGGACAGATGTTCTACATC 69 FBan0014885 FBgn0038435 Gyc-89Da 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 "guanylate cyclase complex, soluble; GO:0008074" Gyc-89Da Guanylyl cyclase at 89Da "CG14885, CG14885, GYCb, Guanylyl cyclase at 89Da" CDMC33664 1 5 18 DAC28-M14 16-CG14894-RA_1 CG14894 TGGGCAACATGATACTCAAACCGTTCGGACTGTCTACACAGAATTTCCAAATGCAACAGGATCCCAACA 69 FBan0014894 FBgn0038428 CG14894 3 3R protein complex assembly; GO:0006461; protein folding; GO:0006457; protein metabolism; GO:0019538 CG14894 CG14894 CDMC33664 1 6 18 DAC28-M14 16-CG14894-RA_1 CG14894 TGGGCAACATGATACTCAAACCGTTCGGACTGTCTACACAGAATTTCCAAATGCAACAGGATCCCAACA 69 FBan0014894 FBgn0038428 CG14894 3 3R protein complex assembly; GO:0006461; protein folding; GO:0006457; protein metabolism; GO:0019538 CG14894 CG14894 CDMC33665 1 7 18 DAC29-A02 15-CG6370-RA_10 CG6370 AGCTCATGTGCTAATCGAGGCGCTGAAGACTATTAGTGGAGCCGATAAAATTGCTCCCGTTTGTGTGCA 69 FBan0006370 FBgn0034277 CG6370 2 2R protein amino acid N-linked glycosylation via asparagine; GO:0018279; protein modification; GO:0006464 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789; oligosaccharyl transferase complex; GO:0008250 CG6370 CG6370 CDMC33665 1 8 18 DAC29-A02 15-CG6370-RA_10 CG6370 AGCTCATGTGCTAATCGAGGCGCTGAAGACTATTAGTGGAGCCGATAAAATTGCTCCCGTTTGTGTGCA 69 FBan0006370 FBgn0034277 CG6370 2 2R protein amino acid N-linked glycosylation via asparagine; GO:0018279; protein modification; GO:0006464 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789; oligosaccharyl transferase complex; GO:0008250 CG6370 CG6370 CDMC33666 1 9 18 DAC29-A14 1-CG6385-RA_1 CG6385 ACGAGCTGAATATGCCTATACCCTTGGAAAGTCCCTCGGTCAGACATACGTGTCCCGACCAGATGGCAA 69 FBan0006385 FBgn0034276 CG6385 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 sarcosine dehydrogenase activity; GO:0008480 ; EC:1.5.99.1; aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0008480 ; EC:1.5.99.1; ; GO:0004047 ; EC:2.1.2.10 CG6385 CG6385 CDMC33666 1 10 18 DAC29-A14 1-CG6385-RA_1 CG6385 ACGAGCTGAATATGCCTATACCCTTGGAAAGTCCCTCGGTCAGACATACGTGTCCCGACCAGATGGCAA 69 FBan0006385 FBgn0034276 CG6385 2 2R amino acid metabolism; GO:0006520; electron transport; GO:0006118 sarcosine dehydrogenase activity; GO:0008480 ; EC:1.5.99.1; aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0008480 ; EC:1.5.99.1; ; GO:0004047 ; EC:2.1.2.10 CG6385 CG6385 CDMC33667 1 11 18 DAC29-E02 22-CG6416-RJ_2 CG6416 GCTATAAGAAAACTGTCCAGTACGATCCCAGGAACAGCGAAACCTACAGAGCCATTCAAGAAGAGGGCG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC33667 1 12 18 DAC29-E02 22-CG6416-RJ_2 CG6416 GCTATAAGAAAACTGTCCAGTACGATCCCAGGAACAGCGAAACCTACAGAGCCATTCAAGAAGAGGGCG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC33668 1 13 18 DAC29-E14 2-CG6429-RA_2 CG6429 GGCATTTGGGTTCAAGCCGAGGTCCAAAAACCCATCACGGAACAATGCCTGATCTGTATGTGTGAGGCT 69 FBgn0034164 CDMC33668 1 14 18 DAC29-E14 2-CG6429-RA_2 CG6429 GGCATTTGGGTTCAAGCCGAGGTCCAAAAACCCATCACGGAACAATGCCTGATCTGTATGTGTGAGGCT 69 FBgn0034164 CDMC33669 1 15 18 DAC29-I02 23-CG6463-RA_1 CG6463 AGCCCAAGGTTTAGATTCACACTTAGTACTAATTAATCTACAGCAAATCGAAATGAGAAGAGAGCAATA 69 FBgn0036100 CDMC33669 1 16 18 DAC29-I02 23-CG6463-RA_1 CG6463 AGCCCAAGGTTTAGATTCACACTTAGTACTAATTAATCTACAGCAAATCGAAATGAGAAGAGAGCAATA 69 FBgn0036100 CDMC33670 1 17 18 DAC29-I14 3-CG6479-RA_2 CG6479 CCCGAGCCGTGATGAAACCACGCAGCTACGAACCGGATAGCGATATAGAGGACGACATACCCATCATCA 69 FBan0006479 FBgn0036710 CG6479 3 3L CG6479 CG6479 CDMC33670 1 18 18 DAC29-I14 3-CG6479-RA_2 CG6479 CCCGAGCCGTGATGAAACCACGCAGCTACGAACCGGATAGCGATATAGAGGACGACATACCCATCATCA 69 FBan0006479 FBgn0036710 CG6479 3 3L CG6479 CG6479 CDMC33671 1 19 18 DAC29-M02 10-CG6515-RA_1 CG6515 ACTGACCTACGGCATTCCCATGATTGTGATGCTCATATGCTACTCTCTCATGGGTCGTGTCCTGTGGGG 69 FBan0006515 FBgn0004841 Takr86C 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0004995; ; GO:0004983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Takr86C Tachykinin-like receptor at 86C "CG6515, CG6515, CG6515, NKD, NKD12, TAKR86C, NKr, Nkd, Neuropeptide receptor" CDMC33671 1 20 18 DAC29-M02 10-CG6515-RA_1 CG6515 ACTGACCTACGGCATTCCCATGATTGTGATGCTCATATGCTACTCTCTCATGGGTCGTGTCCTGTGGGG 69 FBan0006515 FBgn0004841 Takr86C 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; tachykinin signaling pathway; GO:0007217; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; tachykinin receptor activity; GO:0004995; ; GO:0008188; ; GO:0004995; neuropeptide Y receptor activity; GO:0004983; ; GO:0004995; ; GO:0004983 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Takr86C Tachykinin-like receptor at 86C "CG6515, CG6515, CG6515, NKD, NKD12, TAKR86C, NKr, Nkd, Neuropeptide receptor" CDMC33672 1 21 18 DAC29-M14 23-CG6530-RA_4 CG6530 GAAAGTGAAGAAGGAAGCACAAAACTTTACTCAACAGCAAAAAACAACCAATAGGCTCAATTCGGACAA 69 FBan0006530 FBgn0028956 mthl3 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl3 methuselah-like 3 "CG6530, CG6530, CG6530, CG6530, l(2)k10408, 104/8, GENE 1, gene 1, mth-like 3, Mth-like 3, BEST:GM02553, anon-WO0170980.52, anon-WO0170980.53" CDMC33672 1 22 18 DAC29-M14 23-CG6530-RA_4 CG6530 GAAAGTGAAGAAGGAAGCACAAAACTTTACTCAACAGCAAAAAACAACCAATAGGCTCAATTCGGACAA 69 FBan0006530 FBgn0028956 mthl3 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl3 methuselah-like 3 "CG6530, CG6530, CG6530, CG6530, l(2)k10408, 104/8, GENE 1, gene 1, mth-like 3, Mth-like 3, BEST:GM02553, anon-WO0170980.52, anon-WO0170980.53" CDMC33673 1 23 18 DAC30-A02 2-CG3655-RA_1 CG3655 GGACTCCGATCCCAAAATGGAGAACCCAGAACCCGTCCTCTAATCCCTGAGTCTCTGTTGCGCAGAG 67 FBan0003655 FBgn0040397 CG3655 X X CG3655 CG3655 "EG:103E12.3, RE126B2" CDMC33673 1 24 18 DAC30-A02 2-CG3655-RA_1 CG3655 GGACTCCGATCCCAAAATGGAGAACCCAGAACCCGTCCTCTAATCCCTGAGTCTCTGTTGCGCAGAG 67 FBan0003655 FBgn0040397 CG3655 X X CG3655 CG3655 "EG:103E12.3, RE126B2" CDMC33674 1 25 18 DAC30-A14 3-CG3790-RA_6 CG3790 GTTTGGCAGTGTCCATGCCTTTGCTGATGCTTTTCTCCTGCTTCTTCGTGCTTCCGGAATCACCACG 67 FBan0003790 FBgn0033778 CG3790 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0008324; ; GO:0015226 integral to membrane; GO:0016021 CG3790 CG3790 CDMC33674 1 26 18 DAC30-A14 3-CG3790-RA_6 CG3790 GTTTGGCAGTGTCCATGCCTTTGCTGATGCTTTTCTCCTGCTTCTTCGTGCTTCCGGAATCACCACG 67 FBan0003790 FBgn0033778 CG3790 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0008324; ; GO:0015226 integral to membrane; GO:0016021 CG3790 CG3790 CDMC33675 1 1 19 DAC30-E02 1-CG40381-RA_1 CG40381 GACCCAGTCATGCCCAAGTACTTATCTATCCTACTGCTGTCTGCGGCACTTGTTGGAGCTGCCAAGC 67 FBgn0058381 CG40381 CG40381 CG40381 CDMC33675 1 2 19 DAC30-E02 1-CG40381-RA_1 CG40381 GACCCAGTCATGCCCAAGTACTTATCTATCCTACTGCTGTCTGCGGCACTTGTTGGAGCTGCCAAGC 67 FBgn0058381 CG40381 CG40381 CG40381 CDMC33676 1 3 19 DAC30-E14 3-CG41121-RA_1 CG41121 TGGAAGAACGAGCAGTCCAAGTGAAGAGTAATCCTGGGAGTGGAGGAGAAGGAAGGAAGGACCTGGC 67 FBgn0069930 CG41121 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41121 CG41121 CDMC33676 1 4 19 DAC30-E14 3-CG41121-RA_1 CG41121 TGGAAGAACGAGCAGTCCAAGTGAAGAGTAATCCTGGGAGTGGAGGAGAAGGAAGGAAGGACCTGGC 67 FBgn0069930 CG41121 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41121 CG41121 CDMC33677 1 5 19 DAC30-I02 2-CG4563-RA_1 CG4563 GCCATCGTACAGGGTCTCTACTCGGTGACCAAACCCAAGATCATGTTCATCGACGGTCCGGACTACG 67 FBan0004563 FBgn0035006 CG4563 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0016207 ; EC:6.2.1.12 CG4563 CG4563 CDMC33677 1 6 19 DAC30-I02 2-CG4563-RA_1 CG4563 GCCATCGTACAGGGTCTCTACTCGGTGACCAAACCCAAGATCATGTTCATCGACGGTCCGGACTACG 67 FBan0004563 FBgn0035006 CG4563 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0016207 ; EC:6.2.1.12 CG4563 CG4563 CDMC33678 1 7 19 DAC30-I14 3-CG4684-RA_1 CG4684 CCAAATGGACCGGATCTGGACACCAAGATCGAGGAGTTCCGTGATCAAATCCGTCGATCCGAGACGG 67 FBan0004684 FBgn0035966 nwk 3 3L negative regulation of synaptic growth at neuromuscular junction; GO:0045886; neuromuscular synaptic transmission; GO:0007274 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 nwk nervous wreck "CG4684, CG4684, CG4684, CG4684, nervous wreck" CDMC33678 1 8 19 DAC30-I14 3-CG4684-RA_1 CG4684 CCAAATGGACCGGATCTGGACACCAAGATCGAGGAGTTCCGTGATCAAATCCGTCGATCCGAGACGG 67 FBan0004684 FBgn0035966 nwk 3 3L negative regulation of synaptic growth at neuromuscular junction; GO:0045886; neuromuscular synaptic transmission; GO:0007274 SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070 nwk nervous wreck "CG4684, CG4684, CG4684, CG4684, nervous wreck" CDMC33679 1 9 19 DAC30-M02 3-CG5185-RA_2 CG5185 GGGAAAAACTCCAATTGGCAGCTTTAAGTGCAAGTGTCTCCGTCCATTGGTCGTCGGATGGATGCGG 67 FBan0005185 FBgn0026320 Tom 3 3L Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; establishment of planar polarity; GO:0001736; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 cytoplasm; GO:0005737 Tom Twin of m4 "CG5185, CG5185, barbu, Bbu, Barbu, bbu/tom, anon-EST:fe1F6, anon-fast-evolving-1F6" CDMC33679 1 10 19 DAC30-M02 3-CG5185-RA_2 CG5185 GGGAAAAACTCCAATTGGCAGCTTTAAGTGCAAGTGTCTCCGTCCATTGGTCGTCGGATGGATGCGG 67 FBan0005185 FBgn0026320 Tom 3 3L Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; establishment of planar polarity; GO:0001736; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 cytoplasm; GO:0005737 Tom Twin of m4 "CG5185, CG5185, barbu, Bbu, Barbu, bbu/tom, anon-EST:fe1F6, anon-fast-evolving-1F6" CDMC33680 1 11 19 DAC30-M14 9-CG5258-RA_1 CG5258 AAGAAGGCCATGAAGCACAAGACTTTCCTGCGAAATGGACTTAAGGATGTACAGACTCGCCTGCGCA 67 FBan0005258 FBgn0029148 NHP2 3 3L 35S primary transcript processing; GO:0006365; protein biosynthesis; GO:0006412; rRNA pseudouridine synthesis; GO:0031118 structural constituent of ribosome; GO:0003735; ; GO:0003735; rRNA pseudouridylation guide activity; GO:0030559; snoRNA binding; GO:0030515; ; GO:0030559; ; GO:0030515 nucleolus; GO:0005730; ribosome; GO:0005840; small nucleolar ribonucleoprotein complex; GO:0005732 NHP2 NHP2 "CG5258, CG5258, FBgn0029148" CDMC33680 1 12 19 DAC30-M14 9-CG5258-RA_1 CG5258 AAGAAGGCCATGAAGCACAAGACTTTCCTGCGAAATGGACTTAAGGATGTACAGACTCGCCTGCGCA 67 FBan0005258 FBgn0029148 NHP2 3 3L 35S primary transcript processing; GO:0006365; protein biosynthesis; GO:0006412; rRNA pseudouridine synthesis; GO:0031118 structural constituent of ribosome; GO:0003735; ; GO:0003735; rRNA pseudouridylation guide activity; GO:0030559; snoRNA binding; GO:0030515; ; GO:0030559; ; GO:0030515 nucleolus; GO:0005730; ribosome; GO:0005840; small nucleolar ribonucleoprotein complex; GO:0005732 NHP2 NHP2 "CG5258, CG5258, FBgn0029148" CDMC33681 1 13 19 DAC31-A02 18-CG7459-RA_3 CG7459 AATTCGTTATGAAATGCGAACATTACCAGGTCTGAGTCCTGACAGCCCACAACTCACATTTGAAGGCCT 69 FBgn0037575 CDMC33681 1 14 19 DAC31-A02 18-CG7459-RA_3 CG7459 AATTCGTTATGAAATGCGAACATTACCAGGTCTGAGTCCTGACAGCCCACAACTCACATTTGAAGGCCT 69 FBgn0037575 CDMC33682 1 15 19 DAC31-A14 22-CG7467-RB_1 CG7467 ACCCACACCCAAAATGCTTGGCGTTAGGAAACCAATAAACAATTAATGCAAAACCATACATGGGTGGGT 69 FBan0007467 FBgn0003013 osa 3 3R "Wnt receptor signaling pathway; GO:0016055; photoreceptor cell differentiation; GO:0046530; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nucleus; GO:0005634 osa osa "CG7467, CG7467, eld, eyelid, eye lid, l(3)00090, l(3)04539, E(E2F)3C, p300, en(lz)4F/4H, Osa, OSA, anon-WO0118547.314, anon-WO0172774.126, l(3)j9C3" CDMC33682 1 16 19 DAC31-A14 22-CG7467-RB_1 CG7467 ACCCACACCCAAAATGCTTGGCGTTAGGAAACCAATAAACAATTAATGCAAAACCATACATGGGTGGGT 69 FBan0007467 FBgn0003013 osa 3 3R "Wnt receptor signaling pathway; GO:0016055; photoreceptor cell differentiation; GO:0046530; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nucleus; GO:0005634 osa osa "CG7467, CG7467, eld, eyelid, eye lid, l(3)00090, l(3)04539, E(E2F)3C, p300, en(lz)4F/4H, Osa, OSA, anon-WO0118547.314, anon-WO0172774.126, l(3)j9C3" CDMC33683 1 17 19 DAC31-E02 3-CG7516-RA_4 CG7516 CCGATGGTGCTCGTTCTTGGATAACCTCACCGAGGAGATCGAATCGGAGGTCGTGGAGAATGTGTACGA 69 FBan0007516 FBgn0028529 CG7516 2 2L CG7516 CG7516 BG:DS01068.6 CDMC33683 1 18 19 DAC31-E02 3-CG7516-RA_4 CG7516 CCGATGGTGCTCGTTCTTGGATAACCTCACCGAGGAGATCGAATCGGAGGTCGTGGAGAATGTGTACGA 69 FBan0007516 FBgn0028529 CG7516 2 2L CG7516 CG7516 BG:DS01068.6 CDMC33684 1 19 19 DAC31-E14 2-CG7526-RA_1 CG7526 GCCCGTTGGTTGCACTCTGAAGAATATACGTCCAAAATCGAGATCCCCGAAAGAGCTGAAACGCGGCAA 69 FBan0007526 FBgn0035798 CG7526 3 3L cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; ; GO:0019199 ; EC:2.7.1.- CG7526 CG7526 CT16044 CDMC33684 1 20 19 DAC31-E14 2-CG7526-RA_1 CG7526 GCCCGTTGGTTGCACTCTGAAGAATATACGTCCAAAATCGAGATCCCCGAAAGAGCTGAAACGCGGCAA 69 FBan0007526 FBgn0035798 CG7526 3 3L cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509; ; GO:0019199 ; EC:2.7.1.- CG7526 CG7526 CT16044 CDMC33685 1 21 19 DAC31-I02 3-CG7558-RA_2 CG7558 CGGAACAGAGCCTCGAGACTGCTAAAGCGATCAAGGAGAAGCACTGCTACATCTGTCCCGATATCGCCA 69 FBan0007558 FBgn0011744 Arp66B 3 3L "actin filament reorganization during cell cycle; GO:0030037; axonal fasciculation; GO:0007413; cytoplasmic transport, nurse cell to oocyte; GO:0007303; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; pseudocleavage (sensu Insecta); GO:0030589; regulation of actin polymerization and/or depolymerization; GO:0008064" actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 Arp2/3 protein complex; GO:0005885; actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp66B Actin-related protein 66B "CG7558, CG7558, Actr66B, Actin-related protein, arp3, arp66B, ARP3, Arp3, AcTr66B, anon-WO0172774.138, Actin-related protein 66B" CDMC33685 1 22 19 DAC31-I02 3-CG7558-RA_2 CG7558 CGGAACAGAGCCTCGAGACTGCTAAAGCGATCAAGGAGAAGCACTGCTACATCTGTCCCGATATCGCCA 69 FBan0007558 FBgn0011744 Arp66B 3 3L "actin filament reorganization during cell cycle; GO:0030037; axonal fasciculation; GO:0007413; cytoplasmic transport, nurse cell to oocyte; GO:0007303; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; pseudocleavage (sensu Insecta); GO:0030589; regulation of actin polymerization and/or depolymerization; GO:0008064" actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 Arp2/3 protein complex; GO:0005885; actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp66B Actin-related protein 66B "CG7558, CG7558, Actr66B, Actin-related protein, arp3, arp66B, ARP3, Arp3, AcTr66B, anon-WO0172774.138, Actin-related protein 66B" CDMC33686 1 23 19 DAC31-I14 1-CG7573-RA_1 CG7573 CGGGAAATCAGATCGGCATGAGTGTGGTTCCCCGGAAACTTAGTTTCTCGGATCCGATTCTTTTGCGGC 69 FBan0007573 FBgn0036153 CG7573 3 3L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 CG7573 CG7573 CDMC33686 1 24 19 DAC31-I14 1-CG7573-RA_1 CG7573 CGGGAAATCAGATCGGCATGAGTGTGGTTCCCCGGAAACTTAGTTTCTCGGATCCGATTCTTTTGCGGC 69 FBan0007573 FBgn0036153 CG7573 3 3L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 prenyl-dependent CAAX protease activity; GO:0008487; ; GO:0008487 CG7573 CG7573 CDMC33687 1 25 19 DAC31-M02 3-CG7602-RA_2 CG7602 AGCCACCGTGAGACCAAACAGGCCAACATTCTACCCTCCCTTTTTAAGACCTCCATGTGTCCAGGAGAA 69 FBan0007602 FBgn0037554 DNApol-iota 3 3R bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; iota DNA polymerase activity; GO:0016000; ; GO:0016000; ; GO:0016000; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016000 DNApol-iota DNApol-iota "CG7602, drad30B, AAF54198, DNApol-iota" CDMC33687 1 26 19 DAC31-M02 3-CG7602-RA_2 CG7602 AGCCACCGTGAGACCAAACAGGCCAACATTCTACCCTCCCTTTTTAAGACCTCCATGTGTCCAGGAGAA 69 FBan0007602 FBgn0037554 DNApol-iota 3 3R bypass DNA synthesis; GO:0019985 nucleic acid binding; GO:0003676; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; iota DNA polymerase activity; GO:0016000; ; GO:0016000; ; GO:0016000; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016000 DNApol-iota DNApol-iota "CG7602, drad30B, AAF54198, DNApol-iota" CDMC33688 1 1 20 DAC31-M14 23-CG7615-RA_1 CG7615 ACTTAGTTTTTTTCAAATTCCAGTGCCTAAGAGCGAAGAGAAATGATCACCTGTTTGAGAAACTGGCCG 69 FBan0007615 FBgn0039694 fig 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fig fos intronic gene "CG7615, CG7615, CG7615, fos intronic gene" CDMC33688 1 2 20 DAC31-M14 23-CG7615-RA_1 CG7615 ACTTAGTTTTTTTCAAATTCCAGTGCCTAAGAGCGAAGAGAAATGATCACCTGTTTGAGAAACTGGCCG 69 FBan0007615 FBgn0039694 fig 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fig fos intronic gene "CG7615, CG7615, CG7615, fos intronic gene" CDMC33689 1 3 20 DAC32-A02 1-CG14598-RA_2 CG14598 GGCCAGTGGTTAATACTACGCCAAAACCCGTGGTTAGGATCTCTCAGCCGTCTGTGCTCAAGGTCACT 68 FBan0014598 FBgn0037503 CG14598 3 3R CG14598 CG14598 CDMC33689 1 4 20 DAC32-A02 1-CG14598-RA_2 CG14598 GGCCAGTGGTTAATACTACGCCAAAACCCGTGGTTAGGATCTCTCAGCCGTCTGTGCTCAAGGTCACT 68 FBan0014598 FBgn0037503 CG14598 3 3R CG14598 CG14598 CDMC33690 1 5 20 DAC32-A14 12-CG1474-RA_5 CG1474 CGCTTTGGCCGAAAGGGTCAGCGAAAGGATGCGAAATCAAAAACAAATGGCTCTGGATACGGCGCGTC 68 FBan0001474 FBgn0023506 Es2 X X nervous system development; GO:0007399 sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 nucleus; GO:0005634 Es2 Es2 "CG1474, es" CDMC33690 1 6 20 DAC32-A14 12-CG1474-RA_5 CG1474 CGCTTTGGCCGAAAGGGTCAGCGAAAGGATGCGAAATCAAAAACAAATGGCTCTGGATACGGCGCGTC 68 FBan0001474 FBgn0023506 Es2 X X nervous system development; GO:0007399 sepiapterin reductase activity; GO:0004757 ; EC:1.1.1.153; ; GO:0004757 ; EC:1.1.1.153 nucleus; GO:0005634 Es2 Es2 "CG1474, es" CDMC33691 1 7 20 DAC32-E02 3-CG15179-RA_2 CG15179 CCACCAGCCAGCTGTACAATCTATTCCTCGTCAGCTTTGGGATCTTCGACGTGACCATCATCGACCGG 68 FBan0015179 FBgn0037462 CG15179 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15179 CG15179 BcDNA:AT31060 CDMC33691 1 8 20 DAC32-E02 3-CG15179-RA_2 CG15179 CCACCAGCCAGCTGTACAATCTATTCCTCGTCAGCTTTGGGATCTTCGACGTGACCATCATCGACCGG 68 FBan0015179 FBgn0037462 CG15179 3 3R intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG15179 CG15179 BcDNA:AT31060 CDMC33692 1 9 20 DAC32-E14 6-CG15316-RA_1 CG15316 GCCTCTGGTCGTAGTCCTGGCCTTTAACTCGGTTAGAGCCTGGTTAGAAGCTTGGCCATCCCGTTTAG 68 FBan0015316 FBgn0030133 CG15316 X X CG15316 CG15316 CDMC33692 1 10 20 DAC32-E14 6-CG15316-RA_1 CG15316 GCCTCTGGTCGTAGTCCTGGCCTTTAACTCGGTTAGAGCCTGGTTAGAAGCTTGGCCATCCCGTTTAG 68 FBan0015316 FBgn0030133 CG15316 X X CG15316 CG15316 CDMC33693 1 11 20 DAC32-I02 8-CG15657-RA_1 CG15657 TGATGTCCACATTTCTGTTTGTGCTTGGGATAGCGTGTCACCCGGTAATGGTGATTCCCCTGATGCTG 68 FBan0015657 FBgn0034595 CG15657 2 2R CG15657 CG15657 BcDNA:AT24036 CDMC33693 1 12 20 DAC32-I02 8-CG15657-RA_1 CG15657 TGATGTCCACATTTCTGTTTGTGCTTGGGATAGCGTGTCACCCGGTAATGGTGATTCCCCTGATGCTG 68 FBan0015657 FBgn0034595 CG15657 2 2R CG15657 CG15657 BcDNA:AT24036 CDMC33694 1 13 20 DAC32-I14 3-CG15811-RA_3 CG15811 ATCGCTGTGGTCTCCACCCAGGTGACTCAGAACCTTAAGAAATTCACCGACTCTAAGCGCATGGGCTC 68 FBan0015811 FBgn0004574 Rop 3 3L cytokinesis; GO:0000910; exocytosis; GO:0006887; neurotransmitter secretion; GO:0007269; regulation of pole plasm oskar mRNA localization; GO:0007317; response to light stimulus; GO:0009416; secretory pathway; GO:0045045; synaptic transmission; GO:0007268; synaptic vesicle priming; GO:0016082; synaptic vesicle transport; GO:0048489; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149; syntaxin binding; GO:0019905; ; GO:0019905 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; vesicle membrane; GO:0012506 Rop Ras opposite "CG15811, CG15811, cs1, rop, l(3)64Ah, l(3)SH16, ROP, DRas2, ras2, rop(Sec1)" CDMC33694 1 14 20 DAC32-I14 3-CG15811-RA_3 CG15811 ATCGCTGTGGTCTCCACCCAGGTGACTCAGAACCTTAAGAAATTCACCGACTCTAAGCGCATGGGCTC 68 FBan0015811 FBgn0004574 Rop 3 3L cytokinesis; GO:0000910; exocytosis; GO:0006887; neurotransmitter secretion; GO:0007269; regulation of pole plasm oskar mRNA localization; GO:0007317; response to light stimulus; GO:0009416; secretory pathway; GO:0045045; synaptic transmission; GO:0007268; synaptic vesicle priming; GO:0016082; synaptic vesicle transport; GO:0048489; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149; syntaxin binding; GO:0019905; ; GO:0019905 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; vesicle membrane; GO:0012506 Rop Ras opposite "CG15811, CG15811, cs1, rop, l(3)64Ah, l(3)SH16, ROP, DRas2, ras2, rop(Sec1)" CDMC33695 1 15 20 DAC32-M02 3-CG17009-RA_1 CG17009 CCGTGAAACCGCACAAGATCAACACCGTGAAGCGGGAAGTACTGATGCAGCTGGATGAGAACACACTC 68 FBan0017009 FBgn0032104 CG17009 2 2L CG17009 CG17009 CDMC33695 1 16 20 DAC32-M02 3-CG17009-RA_1 CG17009 CCGTGAAACCGCACAAGATCAACACCGTGAAGCGGGAAGTACTGATGCAGCTGGATGAGAACACACTC 68 FBan0017009 FBgn0032104 CG17009 2 2L CG17009 CG17009 CDMC33696 1 17 20 DAC32-M14 18-CG17109-RA_3 CG17109 GCTCACAGCCTGGATCTTCCCGTGGATGTTATATATCCAGTGGAGAAGAAGCCTGTGGTGATCATCAA 68 FBan0017109 FBgn0039051 CG17109 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG17109 CG17109 CDMC33696 1 18 20 DAC32-M14 18-CG17109-RA_3 CG17109 GCTCACAGCCTGGATCTTCCCGTGGATGTTATATATCCAGTGGAGAAGAAGCCTGTGGTGATCATCAA 68 FBan0017109 FBgn0039051 CG17109 3 3R proteolysis; GO:0006508 NOT aminoacylase activity; GO:0004046 ; EC:3.5.1.14; metallopeptidase activity; GO:0008237; ; GO:0004046 ; EC:3.5.1.14; ; GO:0008237 CG17109 CG17109 CDMC33697 1 19 20 DAC33-A02 9-CG31298-RA_2 CG31298 GCAATTGCAAAAACTGATCCAGCAAAAGCGGACAATTTCACCAGCAAGACTTGGGCTCGAGCTGCG 66 FBan0031298 FBgn0038092 beat-Vb 3 3R extracellular region; GO:0005576 beat-Vb beat-Vb "CG31298, CG14385, CG14386, beat Vb" CDMC33697 1 20 20 DAC33-A02 9-CG31298-RA_2 CG31298 GCAATTGCAAAAACTGATCCAGCAAAAGCGGACAATTTCACCAGCAAGACTTGGGCTCGAGCTGCG 66 FBan0031298 FBgn0038092 beat-Vb 3 3R extracellular region; GO:0005576 beat-Vb beat-Vb "CG31298, CG14385, CG14386, beat Vb" CDMC33698 1 21 20 DAC33-A14 3-CG31445-RA_4 CG31445 CCTTCGCAGCACAGTGTACTGCACCGCAATAAGTCAAGGCACAGAGGAGGATTGGAACTTCCTGTG 66 FBan0031445 FBgn0051445 CG31445 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 integral to membrane; GO:0016021 CG31445 CG31445 "CG11955, CG11955" CDMC33698 1 22 20 DAC33-A14 3-CG31445-RA_4 CG31445 CCTTCGCAGCACAGTGTACTGCACCGCAATAAGTCAAGGCACAGAGGAGGATTGGAACTTCCTGTG 66 FBan0031445 FBgn0051445 CG31445 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0004179 ; EC:3.4.11.2; ; GO:0008270 integral to membrane; GO:0016021 CG31445 CG31445 "CG11955, CG11955" CDMC33699 1 23 20 DAC33-E02 2-CG31829-RA_1 CG31829 TGCTCCAGCTGTCGTTAAAACTGAAACTAGTGCAACCACCTCTGGGCCATCAACCTCAGCTTCAGC 66 FBan0031829 FBgn0051829 CG31829 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31829 CG31829 CDMC33699 1 24 20 DAC33-E02 2-CG31829-RA_1 CG31829 TGCTCCAGCTGTCGTTAAAACTGAAACTAGTGCAACCACCTCTGGGCCATCAACCTCAGCTTCAGC 66 FBan0031829 FBgn0051829 CG31829 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31829 CG31829 CDMC33700 1 25 20 DAC33-E14 3-CG32177-RA_1 CG32177 TCTCACCCTAATTGATCCCTCTACACCCCCACAAAATCTCCCTAGGCCTTTTAGTGGCGCCCATGC 66 FBan0032177 FBgn0052177 CG32177 3 3L CG32177 CG32177 "CG8056, clone 2.19, anon-EST:Liang-2.19" CDMC33700 1 26 20 DAC33-E14 3-CG32177-RA_1 CG32177 TCTCACCCTAATTGATCCCTCTACACCCCCACAAAATCTCCCTAGGCCTTTTAGTGGCGCCCATGC 66 FBan0032177 FBgn0052177 CG32177 3 3L CG32177 CG32177 "CG8056, clone 2.19, anon-EST:Liang-2.19" CDMC33701 1 1 21 DAC33-I02 1-CG32570-RA_1 CG32570 CCTGGCGCCCATCATCAACAAGAAATTCTATCTGGTTTCCGCACCCGAGGATCACAGCAACGATGG 66 FBan0032570 FBgn0052570 CG32570 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32570 CG32570 CDMC33701 1 2 21 DAC33-I02 1-CG32570-RA_1 CG32570 CCTGGCGCCCATCATCAACAAGAAATTCTATCTGGTTTCCGCACCCGAGGATCACAGCAACGATGG 66 FBan0032570 FBgn0052570 CG32570 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32570 CG32570 CDMC33702 1 3 21 DAC33-I14 9-CG32685-RC_4 CG32685 GCCCTACATAGTGGACCTACACTGCGATCTAGAGACGTGCCTTGGTAGAAACTCTCACCAGCGCAG 66 FBan0032685 FBgn0052685 CG32685 X X CG32685 CG32685 "CG12646, CG12647, CG2971" CDMC33702 1 4 21 DAC33-I14 9-CG32685-RC_4 CG32685 GCCCTACATAGTGGACCTACACTGCGATCTAGAGACGTGCCTTGGTAGAAACTCTCACCAGCGCAG 66 FBan0032685 FBgn0052685 CG32685 X X CG32685 CG32685 "CG12646, CG12647, CG2971" CDMC33703 1 5 21 DAC33-M02 17-CG3323-RA_1 CG3323 TCAATAGTCTGGCCTATGCGGATTCAAAAATCATGGATGCTAACACCGTCGAACAGCTTGAGGTGG 66 FBan0003323 FBgn0029750 CG3323 X X CG3323 CG3323 CDMC33703 1 6 21 DAC33-M02 17-CG3323-RA_1 CG3323 TCAATAGTCTGGCCTATGCGGATTCAAAAATCATGGATGCTAACACCGTCGAACAGCTTGAGGTGG 66 FBan0003323 FBgn0029750 CG3323 X X CG3323 CG3323 CDMC33704 1 7 21 DAC33-M14 22-CG33284-RA_2 CG33284 AGTCTAGATTGCCAGTTGGGGAAAAACTTGTTCATCTTTGGCTCTAACGAGCTAACGGAGCGACAA 66 FBan0033284 FBgn0053284 CG33284 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33284 CG33284 NEST:bs10b10 CDMC33704 1 8 21 DAC33-M14 22-CG33284-RA_2 CG33284 AGTCTAGATTGCCAGTTGGGGAAAAACTTGTTCATCTTTGGCTCTAACGAGCTAACGGAGCGACAA 66 FBan0033284 FBgn0053284 CG33284 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33284 CG33284 NEST:bs10b10 CDMC33705 1 9 21 DAC34-A02 3-CG13422-RA_4 CG13422 GTTCACGCAATGGACGCTGGACTTATCGCAACCGGAACCATCAGCTTAGACCCGGAGATGTTCTGTACT 69 FBan0013422 FBgn0034511 CG13422 2 2R defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; polysaccharide metabolism; GO:0005976 glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0015926 ; EC:3.2.1.- CG13422 CG13422 GNBP-like CDMC33705 1 10 21 DAC34-A02 3-CG13422-RA_4 CG13422 GTTCACGCAATGGACGCTGGACTTATCGCAACCGGAACCATCAGCTTAGACCCGGAGATGTTCTGTACT 69 FBan0013422 FBgn0034511 CG13422 2 2R defense response; GO:0006952; defense response to Gram-negative bacteria; GO:0050829; polysaccharide metabolism; GO:0005976 glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0015926 ; EC:3.2.1.- CG13422 CG13422 GNBP-like CDMC33706 1 11 21 DAC34-A14 2-CG13438-RA_2 CG13438 CGGTGAGGTGATTAACGGCAGGAGTAATGGCTTCAATGACATGGATGATGGAGCAGATCTCGACGGCGA 69 FBan0013438 FBgn0034545 CG13438 2 2R CG13438 CG13438 CDMC33706 1 12 21 DAC34-A14 2-CG13438-RA_2 CG13438 CGGTGAGGTGATTAACGGCAGGAGTAATGGCTTCAATGACATGGATGATGGAGCAGATCTCGACGGCGA 69 FBan0013438 FBgn0034545 CG13438 2 2R CG13438 CG13438 CDMC33707 1 13 21 DAC34-E02 7-CG13478-RA_1 CG13478 AGATCCCGGTGCTATGCCACGAATCCTAAGTGAATTCTGCGAGTATCGGGACACGAATATCCTGCAGGA 69 FBgn0036432 CDMC33707 1 14 21 DAC34-E02 7-CG13478-RA_1 CG13478 AGATCCCGGTGCTATGCCACGAATCCTAAGTGAATTCTGCGAGTATCGGGACACGAATATCCTGCAGGA 69 FBgn0036432 CDMC33708 1 15 21 DAC34-E14 23-CG13499-RB_3 CG13499 GGTGGCTTTTGTTCGGATTGTCACATATACATTGATGTATGTAAGTTCATCGGATTTCGCCAAAGCAGC 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC33708 1 16 21 DAC34-E14 23-CG13499-RB_3 CG13499 GGTGGCTTTTGTTCGGATTGTCACATATACATTGATGTATGTAAGTTCATCGGATTTCGCCAAAGCAGC 69 FBan0013499 FBgn0034680 CG13499 2 2R CG13499 CG13499 CDMC33709 1 17 21 DAC34-I02 16-CG13551-RC_1 CG13551 AGCGGCTCTTTTATTGCGACTTGGTTTTCGAAAAAGTTCAATGCACTCCGTTTTGTTAAGGAGACGGCT 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC33709 1 18 21 DAC34-I02 16-CG13551-RC_1 CG13551 AGCGGCTCTTTTATTGCGACTTGGTTTTCGAAAAAGTTCAATGCACTCCGTTTTGTTAAGGAGACGGCT 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC33710 1 19 21 DAC34-I14 1-CG13566-RA_2 CG13566 CCGTCCAAACAGACCAGTCGAAGGAAACAGTGGCCCTCAAGGTGTACAATCTTTCGCAGGAACCGAAGA 69 FBan0013566 FBgn0034942 CG13566 2 2R CG13566 CG13566 CDMC33710 1 20 21 DAC34-I14 1-CG13566-RA_2 CG13566 CCGTCCAAACAGACCAGTCGAAGGAAACAGTGGCCCTCAAGGTGTACAATCTTTCGCAGGAACCGAAGA 69 FBan0013566 FBgn0034942 CG13566 2 2R CG13566 CG13566 CDMC33711 1 21 21 DAC34-M02 6-CG13602-RA_5 CG13602 TGTGGGCGTCTTTCCACTGGCGAAACTAGCTTTACTTGCCATTAAGCACATTAGCAAGCCCATTGGCAA 69 FBan0013602 FBgn0039127 CG13602 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13602 CG13602 BcDNA:AT03227 CDMC33711 1 22 21 DAC34-M02 6-CG13602-RA_5 CG13602 TGTGGGCGTCTTTCCACTGGCGAAACTAGCTTTACTTGCCATTAAGCACATTAGCAAGCCCATTGGCAA 69 FBan0013602 FBgn0039127 CG13602 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13602 CG13602 BcDNA:AT03227 CDMC33712 1 23 21 DAC34-M14 9-CG13609-RA_4 CG13609 TGCATCCACTTCCCCTCCAATCCCAACTGCAACATCAAGGCTCTAATTCTCATCTACTCGCGCGATCAT 69 FBan0013609 FBgn0039170 CG13609 3 3R CG13609 CG13609 CDMC33712 1 24 21 DAC34-M14 9-CG13609-RA_4 CG13609 TGCATCCACTTCCCCTCCAATCCCAACTGCAACATCAAGGCTCTAATTCTCATCTACTCGCGCGATCAT 69 FBan0013609 FBgn0039170 CG13609 3 3R CG13609 CG13609 CDMC33713 1 25 21 DAC35-A02 2-CG17249-RA_1 CG17249 CTCCCGCTAAGGATCTGGAAAATGAGGATGTGGACAACCAGGTTACTTCCGCCTTTGCCAACCTGC 66 FBan0017249 FBgn0035249 CG17249 3 3L CG17249 CG17249 CDMC33713 1 26 21 DAC35-A02 2-CG17249-RA_1 CG17249 CTCCCGCTAAGGATCTGGAAAATGAGGATGTGGACAACCAGGTTACTTCCGCCTTTGCCAACCTGC 66 FBan0017249 FBgn0035249 CG17249 3 3L CG17249 CG17249 CDMC33714 1 1 22 DAC35-A14 1-CG17475-RA_1 CG17475 GGGACCATGTAGCAACTGTCACTGCTATGCCAGTAACTATCCCAGCCTGTGATCCAAGGGGACGAC 66 FBan0017475 FBgn0038481 CG17475 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG17475 CG17475 SP131 CDMC33714 1 2 22 DAC35-A14 1-CG17475-RA_1 CG17475 GGGACCATGTAGCAACTGTCACTGCTATGCCAGTAACTATCCCAGCCTGTGATCCAAGGGGACGAC 66 FBan0017475 FBgn0038481 CG17475 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG17475 CG17475 SP131 CDMC33715 1 3 22 DAC35-E02 15-CG18410-RA_2 CG18410 TCCAAGCGTGTCCTGTCAGGCACCAAGAACGAGGACAAGATCACGGCCATAAAGGAGGGAGTCCAG 66 FBan0018410 FBgn0039226 CG18410 3 3R CG18410 CG18410 CDMC33715 1 4 22 DAC35-E02 15-CG18410-RA_2 CG18410 TCCAAGCGTGTCCTGTCAGGCACCAAGAACGAGGACAAGATCACGGCCATAAAGGAGGGAGTCCAG 66 FBan0018410 FBgn0039226 CG18410 3 3R CG18410 CG18410 CDMC33716 1 5 22 DAC35-E14 2-CG18608-RA_2 CG18608 CCGCAAGAAACGCACCTCATCGGAGCAGTACCAAATGTACATCGACATGATGGAGAGCGACCCCAT 66 FBan0018608 FBgn0014269 prod 2 2R lymph gland development (sensu Arthropoda); GO:0048542 chromatin binding; GO:0003682; ; GO:0003682 "chromosome; GO:0005694; chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792" prod proliferation disrupter "CG18608, CG18608, l(2)88/10, Prod, PROD, l(2)k08810" CDMC33716 1 6 22 DAC35-E14 2-CG18608-RA_2 CG18608 CCGCAAGAAACGCACCTCATCGGAGCAGTACCAAATGTACATCGACATGATGGAGAGCGACCCCAT 66 FBan0018608 FBgn0014269 prod 2 2R lymph gland development (sensu Arthropoda); GO:0048542 chromatin binding; GO:0003682; ; GO:0003682 "chromosome; GO:0005694; chromosome, pericentric region; GO:0000775; heterochromatin; GO:0000792" prod proliferation disrupter "CG18608, CG18608, l(2)88/10, Prod, PROD, l(2)k08810" CDMC33717 1 7 22 DAC35-I02 1-CG2875-RA_1 CG2875 ACAAGGCACGCCTGTTTTACTTGGCCGATATCTTTCTGACCTCCACCCATTTGCCCGAGAATCTGG 66 FBan0002875 FBgn0029672 CG2875 X X CG2875 CG2875 CDMC33717 1 8 22 DAC35-I02 1-CG2875-RA_1 CG2875 ACAAGGCACGCCTGTTTTACTTGGCCGATATCTTTCTGACCTCCACCCATTTGCCCGAGAATCTGG 66 FBan0002875 FBgn0029672 CG2875 X X CG2875 CG2875 CDMC33718 1 9 22 DAC35-I14 11-CG30026-RA_1 CG30026 ACCACCACAGCTTCCACAACACAAGGCGATCCAATATATCCGACTTACAGACCTCCCTACATGCGG 66 FBan0030026 FBgn0050026 CG30026 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30026 CG30026 CDMC33718 1 10 22 DAC35-I14 11-CG30026-RA_1 CG30026 ACCACCACAGCTTCCACAACACAAGGCGATCCAATATATCCGACTTACAGACCTCCCTACATGCGG 66 FBan0030026 FBgn0050026 CG30026 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30026 CG30026 CDMC33719 1 11 22 DAC35-M02 3-CG3054-RA_1 CG3054 ACACCCAATTAAATCCCGCTGAACCAGCCACTGAGGAACCCGTGTTGGAAATCGACGATGATGACG 66 FBan0003054 FBgn0022153 l(2)k05819 2 2L l(2)k05819 lethal (2) k05819 "CG3054, anon-WO0140519.156" CDMC33719 1 12 22 DAC35-M02 3-CG3054-RA_1 CG3054 ACACCCAATTAAATCCCGCTGAACCAGCCACTGAGGAACCCGTGTTGGAAATCGACGATGATGACG 66 FBan0003054 FBgn0022153 l(2)k05819 2 2L l(2)k05819 lethal (2) k05819 "CG3054, anon-WO0140519.156" CDMC33720 1 13 22 DAC35-M14 3-CG31118-RA_2 CG31118 TGACCAACTTGGAGAGCTACAACAACCTGTCCTACTGGTTACGCAACATCCAGGAGAACGCCTCGC 66 FBan0031118 FBgn0051118 RabX4 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 RabX4 RabX4 "CG31118, CG13638, DmRabX4, AAF56345" CDMC33720 1 14 22 DAC35-M14 3-CG31118-RA_2 CG31118 TGACCAACTTGGAGAGCTACAACAACCTGTCCTACTGGTTACGCAACATCCAGGAGAACGCCTCGC 66 FBan0031118 FBgn0051118 RabX4 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 RabX4 RabX4 "CG31118, CG13638, DmRabX4, AAF56345" CDMC33721 1 15 22 DAC36-A02 23-CG17280-RA_3 CG17280 TTCGTTGTTTGGTAGTGATAGACGTTAATGTAAACTGAACTTTACGCGGAAATACACAGAAAACACA 67 FBan0017280 FBgn0034877 CG17280 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG17280 CG17280 "VIa, BcDNA:RH03295" CDMC33721 1 16 22 DAC36-A02 23-CG17280-RA_3 CG17280 TTCGTTGTTTGGTAGTGATAGACGTTAATGTAAACTGAACTTTACGCGGAAATACACAGAAAACACA 67 FBan0017280 FBgn0034877 CG17280 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG17280 CG17280 "VIa, BcDNA:RH03295" CDMC33722 1 17 22 DAC36-A14 1-CG17549-RA_1 CG17549 ACCACGGTCAACGACAACGGAAAGATCACCTCGTATTCGGTGCACTCCTAGAAAGATCGGCGGAGAC 67 FBan0017549 FBgn0032774 CG17549 2 2L CG17549 CG17549 CDMC33722 1 18 22 DAC36-A14 1-CG17549-RA_1 CG17549 ACCACGGTCAACGACAACGGAAAGATCACCTCGTATTCGGTGCACTCCTAGAAAGATCGGCGGAGAC 67 FBan0017549 FBgn0032774 CG17549 2 2L CG17549 CG17549 CDMC33723 1 19 22 DAC36-E02 3-CG18416-RA_2 CG18416 GGATGGCCAAGACATCCTCAAGGATATGCGGGAATCAAGGGGAGATAGGGTAGGGATCTGTGCTGGA 67 FBan0018416 FBgn0034482 CG18416 2 2R CG18416 CG18416 CDMC33723 1 20 22 DAC36-E02 3-CG18416-RA_2 CG18416 GGATGGCCAAGACATCCTCAAGGATATGCGGGAATCAAGGGGAGATAGGGTAGGGATCTGTGCTGGA 67 FBan0018416 FBgn0034482 CG18416 2 2R CG18416 CG18416 CDMC33724 1 21 22 DAC36-E14 2-CG18568-RA_1 CG18568 AGTCCATGGACGATTTCTTCAGCCGGGTCCAAAACTCTATGCCCAAATCAGAGTCCGTGTCCACCAT 67 FBan0018568 FBgn0033888 CG18568 2 2R CG18568 CG18568 anon-WO0140519.113 CDMC33724 1 22 22 DAC36-E14 2-CG18568-RA_1 CG18568 AGTCCATGGACGATTTCTTCAGCCGGGTCCAAAACTCTATGCCCAAATCAGAGTCCGTGTCCACCAT 67 FBan0018568 FBgn0033888 CG18568 2 2R CG18568 CG18568 anon-WO0140519.113 CDMC33725 1 23 22 DAC36-I02 3-CG2262-RA_2 CG2262 GGTGATGTACCACGAGCCGGCCTTTTGGTGTTCCATCTCCTACTATGAGCTAAATACGCGTGTCGGC 67 FBan0002262 FBgn0025800 Smox X X cell-cell signaling; GO:0007267; dendrite morphogenesis; GO:0016358; intracellular signaling cascade; GO:0007242; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; wing morphogenesis; GO:0007476 "transcription regulator activity; GO:0030528; transforming growth factor beta receptor, cytoplasmic mediator activity; GO:0005072; ; GO:0030528; ; GO:0005072" intracellular; GO:0005622 Smox Smad on X "CG2262, sad, sisters against dpp, ted, temporarily deranged, Sad, dSmad2, Smad2, smad2, l(1)G0348, DSMAD2, dSMAD2, smox, SMAD2, tmp, Sisters against dpp, Smad on X" CDMC33725 1 24 22 DAC36-I02 3-CG2262-RA_2 CG2262 GGTGATGTACCACGAGCCGGCCTTTTGGTGTTCCATCTCCTACTATGAGCTAAATACGCGTGTCGGC 67 FBan0002262 FBgn0025800 Smox X X cell-cell signaling; GO:0007267; dendrite morphogenesis; GO:0016358; intracellular signaling cascade; GO:0007242; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; wing morphogenesis; GO:0007476 "transcription regulator activity; GO:0030528; transforming growth factor beta receptor, cytoplasmic mediator activity; GO:0005072; ; GO:0030528; ; GO:0005072" intracellular; GO:0005622 Smox Smad on X "CG2262, sad, sisters against dpp, ted, temporarily deranged, Sad, dSmad2, Smad2, smad2, l(1)G0348, DSMAD2, dSMAD2, smox, SMAD2, tmp, Sisters against dpp, Smad on X" CDMC33726 1 25 22 DAC36-I14 2-CG2767-RA_1 CG2767 GCAGCAGCGAGATCTGGTCGACTTCTGCAAGTCCGAAAACATTACCGTAACTGCCTACTCCCCGTTG 67 FBan0002767 FBgn0037537 CG2767 3 3R alcohol dehydrogenase (NADP+) activity; GO:0008106 ; EC:1.1.1.2; ; GO:0008106 ; EC:1.1.1.2 CG2767 CG2767 CDMC33726 1 26 22 DAC36-I14 2-CG2767-RA_1 CG2767 GCAGCAGCGAGATCTGGTCGACTTCTGCAAGTCCGAAAACATTACCGTAACTGCCTACTCCCCGTTG 67 FBan0002767 FBgn0037537 CG2767 3 3R alcohol dehydrogenase (NADP+) activity; GO:0008106 ; EC:1.1.1.2; ; GO:0008106 ; EC:1.1.1.2 CG2767 CG2767 CDMC33727 1 1 23 DAC36-M02 2-CG3019-RA_2 CG3019 GGCGATCTGGAGAAGTACAACTTGCTCAACGACGATAGCACGAACACCTTCACCAGCAAACCCGTGC 67 FBan0003019 FBgn0003638 su(w[a]) X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleus; GO:0005634; spliceosome complex; GO:0005681 su(w[a]) suppressor of white-apricot "CG3019, CG3019, su(w), su[wa], su(wa), DmSWAP, su(w[a])-1, su(w[a])-2, SWAP, EG:BACR7A4.10" CDMC33727 1 2 23 DAC36-M02 2-CG3019-RA_2 CG3019 GGCGATCTGGAGAAGTACAACTTGCTCAACGACGATAGCACGAACACCTTCACCAGCAAACCCGTGC 67 FBan0003019 FBgn0003638 su(w[a]) X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleus; GO:0005634; spliceosome complex; GO:0005681 su(w[a]) suppressor of white-apricot "CG3019, CG3019, su(w), su[wa], su(wa), DmSWAP, su(w[a])-1, su(w[a])-2, SWAP, EG:BACR7A4.10" CDMC33728 1 3 23 DAC36-M14 14-CG30364-RA_1 CG30364 TCGATGTGGAAGAGATACAAGGATGATGGTAGTAATCGGCCAGAAGCTATGTGGCACTACCCGGAGG 67 FBan0030364 FBgn0050364 CG30364 2 2R CG30364 CG30364 "CG2149, CG2149, anon-WO0140519.168" CDMC33728 1 4 23 DAC36-M14 14-CG30364-RA_1 CG30364 TCGATGTGGAAGAGATACAAGGATGATGGTAGTAATCGGCCAGAAGCTATGTGGCACTACCCGGAGG 67 FBan0030364 FBgn0050364 CG30364 2 2R CG30364 CG30364 "CG2149, CG2149, anon-WO0140519.168" CDMC33729 1 5 23 DAC37-A02 3-CG7539-RA_1 CG7539 TCATCCAAGAAGCGCTCGTTATCGCAATGGCTCTGGTTCGCGTGAGTTGTATGCTGGCCCTTTTG 65 FBan0007539 FBgn0004554 Edg91 3 3R structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 Edg91 Ecdysone-dependent gene 91 "CG7539, EDG91, EDG-91" CDMC33729 1 6 23 DAC37-A02 3-CG7539-RA_1 CG7539 TCATCCAAGAAGCGCTCGTTATCGCAATGGCTCTGGTTCGCGTGAGTTGTATGCTGGCCCTTTTG 65 FBan0007539 FBgn0004554 Edg91 3 3R structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011 Edg91 Ecdysone-dependent gene 91 "CG7539, EDG91, EDG-91" CDMC33730 1 7 23 DAC37-A14 15-CG7570-RA_3 CG7570 CCACCCAGTTCCCATGGTGGCTTAAATCAGCCCGTTTACTTGTGCAGCCTGATTCCAGTTCCGCC 65 FBan0007570 FBgn0036924 hale 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hale hale-bopp "CG7570, hale-bopp" CDMC33730 1 8 23 DAC37-A14 15-CG7570-RA_3 CG7570 CCACCCAGTTCCCATGGTGGCTTAAATCAGCCCGTTTACTTGTGCAGCCTGATTCCAGTTCCGCC 65 FBan0007570 FBgn0036924 hale 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hale hale-bopp "CG7570, hale-bopp" CDMC33731 1 9 23 DAC37-E02 2-CG7691-RA_3 CG7691 AAGGTTGGCATCATTACGGTCACGGCTGAGTCCAAGCAAACTCGCACGAAACTCAAGCGGAAAGG 65 FBan0007691 FBgn0038626 CG7691 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7691 CG7691 CDMC33731 1 10 23 DAC37-E02 2-CG7691-RA_3 CG7691 AAGGTTGGCATCATTACGGTCACGGCTGAGTCCAAGCAAACTCGCACGAAACTCAAGCGGAAAGG 65 FBan0007691 FBgn0038626 CG7691 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7691 CG7691 CDMC33732 1 11 23 DAC37-E14 3-CG7718-RA_2 CG7718 AAATTCAGGTCATCCACGAGCCAAAGCACTTCTACGAAACGCTGGTGCAACGAATCGGTCAGGCC 65 FBan0007718 FBgn0038649 CG7718 3 3R phospholipid metabolism; GO:0006644 CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity; GO:0008444 ; EC:2.7.8.5; ; GO:0008444 ; EC:2.7.8.5 CG7718 CG7718 CDMC33732 1 12 23 DAC37-E14 3-CG7718-RA_2 CG7718 AAATTCAGGTCATCCACGAGCCAAAGCACTTCTACGAAACGCTGGTGCAACGAATCGGTCAGGCC 65 FBan0007718 FBgn0038649 CG7718 3 3R phospholipid metabolism; GO:0006644 CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity; GO:0008444 ; EC:2.7.8.5; ; GO:0008444 ; EC:2.7.8.5 CG7718 CG7718 CDMC33733 1 13 23 DAC37-I02 3-CG7889-RA_1 CG7889 GTGAACCCTGCGTCCAGCTAATGCGCGAGAATATCAGCCTGAATTTTCCAGACACGCCCAAGGAG 65 FBan0007889 FBgn0031003 CG7889 X X CG7889 CG7889 CDMC33733 1 14 23 DAC37-I02 3-CG7889-RA_1 CG7889 GTGAACCCTGCGTCCAGCTAATGCGCGAGAATATCAGCCTGAATTTTCCAGACACGCCCAAGGAG 65 FBan0007889 FBgn0031003 CG7889 X X CG7889 CG7889 CDMC33734 1 15 23 DAC37-I14 1-CG7916-RA_1 CG7916 TTGGCCCCAATATGGAATTCCACCACTGGATCCCTACACCAATGCTGATCTCCGCATCCACTTGG 65 FBan0007916 FBgn0028534 CG7916 2 2L CG7916 CG7916 "BG:DS00941.13, CT23894" CDMC33734 1 16 23 DAC37-I14 1-CG7916-RA_1 CG7916 TTGGCCCCAATATGGAATTCCACCACTGGATCCCTACACCAATGCTGATCTCCGCATCCACTTGG 65 FBan0007916 FBgn0028534 CG7916 2 2L CG7916 CG7916 "BG:DS00941.13, CT23894" CDMC33735 1 17 23 DAC37-M02 6-CG8003-RA_1 CG8003 CGAATGTGCCAGGGAGTTTCCCGTGAGAGAGTGCACCATCTTCCGGCAAATCGCAACGCAATTTG 65 FBan0008003 FBgn0036096 CG8003 3 3L CG8003 CG8003 CDMC33735 1 18 23 DAC37-M02 6-CG8003-RA_1 CG8003 CGAATGTGCCAGGGAGTTTCCCGTGAGAGAGTGCACCATCTTCCGGCAAATCGCAACGCAATTTG 65 FBan0008003 FBgn0036096 CG8003 3 3L CG8003 CG8003 CDMC33736 1 19 23 DAC37-M14 3-CG8021-RA_1 CG8021 TTCGTCGGCAACCTGCCATGGACGATAGGTAGCAAGGAACTGCGGACCTACTTCTCAAAGTACGG 65 FBan0008021 FBgn0037602 CG8021 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG8021 CG8021 cg8021 CDMC33736 1 20 23 DAC37-M14 3-CG8021-RA_1 CG8021 TTCGTCGGCAACCTGCCATGGACGATAGGTAGCAAGGAACTGCGGACCTACTTCTCAAAGTACGG 65 FBan0008021 FBgn0037602 CG8021 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG8021 CG8021 cg8021 CDMC33737 1 21 23 DAC38-A02 23-CG4136-RA_1 CG4136 CCAGATGAAACATGTACATCGATGTGTTGTTCTAAGGACAACGATAAACCTACAGGATTCGAAACACAT 69 FBan0004136 FBgn0029775 CG4136 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0004879 nucleus; GO:0005634 CG4136 CG4136 CDMC33737 1 22 23 DAC38-A02 23-CG4136-RA_1 CG4136 CCAGATGAAACATGTACATCGATGTGTTGTTCTAAGGACAACGATAAACCTACAGGATTCGAAACACAT 69 FBan0004136 FBgn0029775 CG4136 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0030528; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0003700; ; GO:0003677; ; GO:0004879 nucleus; GO:0005634 CG4136 CG4136 CDMC33738 1 23 23 DAC38-A14 24-CG4151-RA_1 CG4151 GTCCAACTTCTTTAAATTTTTTTGCCTATGTTAGTCCCGTACAAATATAAATAATTCAATCACATTTAA 69 FBan0004151 FBgn0029770 CG4151 X X CG4151 CG4151 CDMC33738 1 24 23 DAC38-A14 24-CG4151-RA_1 CG4151 GTCCAACTTCTTTAAATTTTTTTGCCTATGTTAGTCCCGTACAAATATAAATAATTCAATCACATTTAA 69 FBan0004151 FBgn0029770 CG4151 X X CG4151 CG4151 CDMC33739 1 25 23 DAC38-E02 18-CG4194-RA_2 CG4194 AGGCTGGCCATCAATCTAACGGCTGACTTTGAACACCTGCAGCATAAATTGGATGATTTGAAACGACAA 69 FBan0004194 FBgn0025627 CG4194 X X CG4194 CG4194 EG:22E5.6 CDMC33739 1 26 23 DAC38-E02 18-CG4194-RA_2 CG4194 AGGCTGGCCATCAATCTAACGGCTGACTTTGAACACCTGCAGCATAAATTGGATGATTTGAAACGACAA 69 FBan0004194 FBgn0025627 CG4194 X X CG4194 CG4194 EG:22E5.6 CDMC33740 1 1 24 DAC38-E14 23-CG4202-RA_3 CG4202 TTGAAACACCCATTTCATCCAAAGACTCACCGGGGATTAGTCAACTAGCTGTCATATGCGAAACAAACA 69 FBan0004202 FBgn0029755 Sas10 X X Sas10 Sas10 "CG4202, CG4202, l(1)G0106, dSAS10, sas-10" CDMC33740 1 2 24 DAC38-E14 23-CG4202-RA_3 CG4202 TTGAAACACCCATTTCATCCAAAGACTCACCGGGGATTAGTCAACTAGCTGTCATATGCGAAACAAACA 69 FBan0004202 FBgn0029755 Sas10 X X Sas10 Sas10 "CG4202, CG4202, l(1)G0106, dSAS10, sas-10" CDMC33741 1 3 24 DAC38-I02 3-CG4226-RA_4 CG4226 ACGCTCTACGCCGGAATCCTGATTGCCTTTCTCATCGGCATTACGGAGTTTTTGGTCTACGTGCAGCAA 69 FBgn0031293 CDMC33741 1 4 24 DAC38-I02 3-CG4226-RA_4 CG4226 ACGCTCTACGCCGGAATCCTGATTGCCTTTCTCATCGGCATTACGGAGTTTTTGGTCTACGTGCAGCAA 69 FBgn0031293 CDMC33742 1 5 24 DAC38-I14 23-CG4239-RA_9 CG4239 CAGAAACCAACCACAGACTTATTAAGATGCCATACTTAAGTGCTTTAAACATGGCCCATACAGCTTATC 69 FBan0004239 FBgn0030745 CG4239 X X CG4239 CG4239 CDMC33742 1 6 24 DAC38-I14 23-CG4239-RA_9 CG4239 CAGAAACCAACCACAGACTTATTAAGATGCCATACTTAAGTGCTTTAAACATGGCCCATACAGCTTATC 69 FBan0004239 FBgn0030745 CG4239 X X CG4239 CG4239 CDMC33743 1 7 24 DAC38-M02 16-CG4271-RA_1 CG4271 GCGAAAAACTACTCGAGTCCTACGTCGTGACTAGAAAACTGCAAAATGGCGTTACCAAAATCCGTCCCC 69 FBan0004271 FBgn0031409 CG4271 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4271 CG4271 SPH164 CDMC33743 1 8 24 DAC38-M02 16-CG4271-RA_1 CG4271 GCGAAAAACTACTCGAGTCCTACGTCGTGACTAGAAAACTGCAAAATGGCGTTACCAAAATCCGTCCCC 69 FBan0004271 FBgn0031409 CG4271 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4271 CG4271 SPH164 CDMC33744 1 9 24 DAC38-M14 5-CG4294-RA_1 CG4294 GCGCAGGAAAAAACTGTAGAAGTTGCCGTCCCAACTACAGCCCCCTATACGGTTAGCATAATGCGGGAA 69 FBan0004294 FBgn0034742 CG4294 2 2R metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 CG4294 CG4294 FBgn0034742 CDMC33744 1 10 24 DAC38-M14 5-CG4294-RA_1 CG4294 GCGCAGGAAAAAACTGTAGAAGTTGCCGTCCCAACTACAGCCCCCTATACGGTTAGCATAATGCGGGAA 69 FBan0004294 FBgn0034742 CG4294 2 2R metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 CG4294 CG4294 FBgn0034742 CDMC33745 1 11 24 DAC39-A02 23-CG6913-RA_3 CG6913 CGCTTCGCCCTATAATCATAGTTTGTCCTAGTGACATTTCTCAGGAAATCCAATATTCAAATAAATGCT 69 FBan0006913 FBgn0037937 Fer3 3 3R negative regulation of transcription; GO:0016481; regulation of transcription; GO:0045449 protein binding; GO:0005515; transcription factor activity; GO:0003700; transcription corepressor activity; GO:0003714; ; GO:0003700; ; GO:0005515; ; GO:0003714 nucleus; GO:0005634 Fer3 48 related 3 "CG6913, CG6913, CG6913, CG6913, CG6913, Dnato3, nephew of atonal 3, nato3, N-twist, ntwist, BcDNA:LD04689, 48 related 3" CDMC33745 1 12 24 DAC39-A02 23-CG6913-RA_3 CG6913 CGCTTCGCCCTATAATCATAGTTTGTCCTAGTGACATTTCTCAGGAAATCCAATATTCAAATAAATGCT 69 FBan0006913 FBgn0037937 Fer3 3 3R negative regulation of transcription; GO:0016481; regulation of transcription; GO:0045449 protein binding; GO:0005515; transcription factor activity; GO:0003700; transcription corepressor activity; GO:0003714; ; GO:0003700; ; GO:0005515; ; GO:0003714 nucleus; GO:0005634 Fer3 48 related 3 "CG6913, CG6913, CG6913, CG6913, CG6913, Dnato3, nephew of atonal 3, nato3, N-twist, ntwist, BcDNA:LD04689, 48 related 3" CDMC33746 1 13 24 DAC39-A14 23-CG6923-RA_5 CG6923 CATCTTTATGTAAATCCCTCAGACTGAGTTTGTTCTCGGCATGCATCGATACAAGAACAAAGAATGAAA 69 FBan0006923 FBgn0037944 CG6923 3 3R development; GO:0007275; mesoderm development; GO:0007498; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6923 CG6923 CDMC33746 1 14 24 DAC39-A14 23-CG6923-RA_5 CG6923 CATCTTTATGTAAATCCCTCAGACTGAGTTTGTTCTCGGCATGCATCGATACAAGAACAAAGAATGAAA 69 FBan0006923 FBgn0037944 CG6923 3 3R development; GO:0007275; mesoderm development; GO:0007498; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6923 CG6923 CDMC33747 1 15 24 DAC39-E02 17-CG6959-RA_1 CG6959 CGAAACCGGGCCAATATCCTCAGATTAGTTTTTGCCATTAGCGTTTCGCAAAACGTGTGCCATTCACAA 69 FBan0006959 FBgn0037956 CG6959 3 3R CG6959 CG6959 "CT21563, connectin-like" CDMC33747 1 16 24 DAC39-E02 17-CG6959-RA_1 CG6959 CGAAACCGGGCCAATATCCTCAGATTAGTTTTTGCCATTAGCGTTTCGCAAAACGTGTGCCATTCACAA 69 FBan0006959 FBgn0037956 CG6959 3 3R CG6959 CG6959 "CT21563, connectin-like" CDMC33748 1 17 24 DAC39-E14 11-CG6971-RA_1 CG6971 GCAGGCGCATGAGGAAAAGGAAATGCTTCGTGATCGGGTCAAGACTCTTGAACTAGACAAAGAGGCACT 69 FBan0006971 FBgn0037962 CG6971 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG6971 CG6971 anon-WO0140519.67 CDMC33748 1 18 24 DAC39-E14 11-CG6971-RA_1 CG6971 GCAGGCGCATGAGGAAAAGGAAATGCTTCGTGATCGGGTCAAGACTCTTGAACTAGACAAAGAGGCACT 69 FBan0006971 FBgn0037962 CG6971 3 3R cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG6971 CG6971 anon-WO0140519.67 CDMC33749 1 19 24 DAC39-I02 12-CG6999-RA_1 CG6999 AGCCGGAAACGCTGTCAAGTTTCAAGACAAAGAAGAACATGCGTAAGGGCTGGGTGGAGTTCATTTCGA 69 FBan0006999 FBgn0030085 CG6999 X X "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634 CG6999 CG6999 CDMC33749 1 20 24 DAC39-I02 12-CG6999-RA_1 CG6999 AGCCGGAAACGCTGTCAAGTTTCAAGACAAAGAAGAACATGCGTAAGGGCTGGGTGGAGTTCATTTCGA 69 FBan0006999 FBgn0030085 CG6999 X X "regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634 CG6999 CG6999 CDMC33750 1 21 24 DAC39-I14 15-CG7007-RA_9 CG7007 TGTGATTGTGGATTCTTTTTTCGCACGGAGCAGTCACCTGTCGGCCAAGAAAATACAATTACGCCTGCA 69 FBan0007007 FBgn0028662 VhaPPA1-1 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 VhaPPA1-1 VhaPPA1-1 "CG7007, CG7007, vhaPPA1-1, V-ATPase" CDMC33750 1 22 24 DAC39-I14 15-CG7007-RA_9 CG7007 TGTGATTGTGGATTCTTTTTTCGCACGGAGCAGTCACCTGTCGGCCAAGAAAATACAATTACGCCTGCA 69 FBan0007007 FBgn0028662 VhaPPA1-1 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; proton-transporting two-sector ATPase complex; GO:0016469 VhaPPA1-1 VhaPPA1-1 "CG7007, CG7007, vhaPPA1-1, V-ATPase" CDMC33751 1 23 24 DAC39-M02 18-CG7038-RA_1 CG7038 AGATCTGGGACTAGACGGAAAGCAGAGCGATTTTACTGTCGTCAAGAACATACCGGAGAACAATGCCCG 69 FBan0007038 FBgn0029718 mRpL30 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL30 mitochondrial ribosomal protein L30 "CG7038, CG7038, L30: L30 ribosomal gene, mitochondrial ribosomal protein L30, L30" CDMC33751 1 24 24 DAC39-M02 18-CG7038-RA_1 CG7038 AGATCTGGGACTAGACGGAAAGCAGAGCGATTTTACTGTCGTCAAGAACATACCGGAGAACAATGCCCG 69 FBan0007038 FBgn0029718 mRpL30 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL30 mitochondrial ribosomal protein L30 "CG7038, CG7038, L30: L30 ribosomal gene, mitochondrial ribosomal protein L30, L30" CDMC33752 1 25 24 DAC39-M14 22-CG7046-RA_1 CG7046 CGGAGTCGTTTCCCCATATCTATGAAGCTCCGTTGTCCTCTCGATTCTCAAAAACTAACCAAAGGCCAA 69 FBan0007046 FBgn0038979 CG7046 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7046 CG7046 BcDNA:AT28425 CDMC33752 1 26 24 DAC39-M14 22-CG7046-RA_1 CG7046 CGGAGTCGTTTCCCCATATCTATGAAGCTCCGTTGTCCTCTCGATTCTCAAAAACTAACCAAAGGCCAA 69 FBan0007046 FBgn0038979 CG7046 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7046 CG7046 BcDNA:AT28425 CDMC33753 1 1 25 DAC40-A02 2-CG33277-RA_1 CG33277 CAAGACGGTCCTCAGCCAGACATTAGATGTCAACATGGTGGCCGAACCGAAAGCGCATCAGATCG 65 FBan0033277 FBgn0053277 CG33277 3 3L mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG33277 CG33277 "CG18656, CG18656, cg18656" CDMC33753 1 2 25 DAC40-A02 2-CG33277-RA_1 CG33277 CAAGACGGTCCTCAGCCAGACATTAGATGTCAACATGGTGGCCGAACCGAAAGCGCATCAGATCG 65 FBan0033277 FBgn0053277 CG33277 3 3L mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 heterogeneous nuclear ribonucleoprotein complex; GO:0030530 CG33277 CG33277 "CG18656, CG18656, cg18656" CDMC33754 1 3 25 DAC40-A14 17-CG33302-RA_1 CG33302 CGACGTCTCTGCCAGAGTCGGACGGATATATACAGTCGTCAGTCTGAAAGTCATCGCAACCTGTG 65 FBan0033302 FBgn0053302 CG33302 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG33302 CG33302 "CG4791, CG4791" CDMC33754 1 4 25 DAC40-A14 17-CG33302-RA_1 CG33302 CGACGTCTCTGCCAGAGTCGGACGGATATATACAGTCGTCAGTCTGAAAGTCATCGCAACCTGTG 65 FBan0033302 FBgn0053302 CG33302 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG33302 CG33302 "CG4791, CG4791" CDMC33755 1 5 25 DAC40-E02 3-CG33486-RA_3 CG33486 TTATCTGGAGCTTTCGGCTGAGATTGCGAAAAAGCGTGGCTCCTACAACCCCATGAGCGATTGCC 65 FBgn0053486 CDMC33755 1 6 25 DAC40-E02 3-CG33486-RA_3 CG33486 TTATCTGGAGCTTTCGGCTGAGATTGCGAAAAAGCGTGGCTCCTACAACCCCATGAGCGATTGCC 65 FBgn0053486 CDMC33756 1 7 25 DAC40-E14 3-CG3388-RA_1 CG3388 CTGGCCATCATCCGGAGCCTATGAAAATCATGCTGCCTATGGTGGATCGGTTGCATCCATGTCCC 65 FBan0003388 FBgn0001148 gsb 2 2R ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; ventral cord development; GO:0007419 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634; transcription factor complex; GO:0005667 gsb gooseberry "CG3388, gsb-d: gooseberry distal, l(2)gsb, BSH9, BSH-9, gsbBSH9, gsb-distal, gsb-2, l(2)01155, GSB-D, gsbd, Gsb-d, BSH9c2, gooseberry distal, gsb-d, gooseberry" CDMC33756 1 8 25 DAC40-E14 3-CG3388-RA_1 CG3388 CTGGCCATCATCCGGAGCCTATGAAAATCATGCTGCCTATGGTGGATCGGTTGCATCCATGTCCC 65 FBan0003388 FBgn0001148 gsb 2 2R ectoderm development; GO:0007398; endoderm development; GO:0007492; mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment polarity determination; GO:0007367; ventral cord development; GO:0007419 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634; transcription factor complex; GO:0005667 gsb gooseberry "CG3388, gsb-d: gooseberry distal, l(2)gsb, BSH9, BSH-9, gsbBSH9, gsb-distal, gsb-2, l(2)01155, GSB-D, gsbd, Gsb-d, BSH9c2, gooseberry distal, gsb-d, gooseberry" CDMC33757 1 9 25 DAC40-I02 2-CG3526-RA_1 CG3526 GCGGTCCCATTGTCGCAACCGAGTCACATTGCTCACATTGCCAATCACTTGATGTTCTCGCCATC 65 FBan0003526 FBgn0040355 CG3526 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3526 CG3526 EG:BACR43E12.4 CDMC33757 1 10 25 DAC40-I02 2-CG3526-RA_1 CG3526 GCGGTCCCATTGTCGCAACCGAGTCACATTGCTCACATTGCCAATCACTTGATGTTCTCGCCATC 65 FBan0003526 FBgn0040355 CG3526 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3526 CG3526 EG:BACR43E12.4 CDMC33758 1 11 25 DAC40-I14 2-CG3567-RA_1 CG3567 AATGGCCTTTGGACTAGTAGGGCAGGATAACGTGGAGTTCGCTAAGTGGACGCGCAACTACTGGG 65 FBan0003567 FBgn0033121 Cyp6u1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6u1 Cyp6u1 "CG3567, 6u1" CDMC33758 1 12 25 DAC40-I14 2-CG3567-RA_1 CG3567 AATGGCCTTTGGACTAGTAGGGCAGGATAACGTGGAGTTCGCTAAGTGGACGCGCAACTACTGGG 65 FBan0003567 FBgn0033121 Cyp6u1 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6u1 Cyp6u1 "CG3567, 6u1" CDMC33759 1 13 25 DAC40-M02 18-CG3656-RB_1 CG3656 GCCTTCCACTTTCGCATCCTGGAGCCATACGTGGAGATCTTCGACAGGCAGTCACTGCGGCTCGT 65 FBan0003656 FBgn0005670 Cyp4d1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d1 Cytochrome P450-4d1 "CG3656, CG3656, CG3656, CYP4D1, P450, P-450, EG:87B1.1, 4d1, Cyp4D1, Cyt-P450-4D1: Cytochrome P450 4D1, Cytochrome P450 4D1" CDMC33759 1 14 25 DAC40-M02 18-CG3656-RB_1 CG3656 GCCTTCCACTTTCGCATCCTGGAGCCATACGTGGAGATCTTCGACAGGCAGTCACTGCGGCTCGT 65 FBan0003656 FBgn0005670 Cyp4d1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d1 Cytochrome P450-4d1 "CG3656, CG3656, CG3656, CYP4D1, P450, P-450, EG:87B1.1, 4d1, Cyp4D1, Cyt-P450-4D1: Cytochrome P450 4D1, Cytochrome P450 4D1" CDMC33760 1 15 25 DAC40-M14 1-CG3699-RA_1 CG3699 TCGTGGTGACCAACATCCATCGGAACATTGGCATCGTCGACGAGGAGTACAACGGAATGCTCCAG 65 FBan0003699 FBgn0040349 CG3699 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3699 CG3699 "EG:BACR7A4.14, CT12411" CDMC33760 1 16 25 DAC40-M14 1-CG3699-RA_1 CG3699 TCGTGGTGACCAACATCCATCGGAACATTGGCATCGTCGACGAGGAGTACAACGGAATGCTCCAG 65 FBan0003699 FBgn0040349 CG3699 X X metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG3699 CG3699 "EG:BACR7A4.14, CT12411" CDMC33761 1 17 25 DAC41-A02 AutoBlank AutoBlank CDMC33761 1 18 25 DAC41-A02 AutoBlank AutoBlank CDMC33762 1 19 25 DAC41-A14 AutoBlank AutoBlank CDMC33762 1 20 25 DAC41-A14 AutoBlank AutoBlank CDMC33763 1 21 25 DAC41-E02 AutoBlank AutoBlank CDMC33763 1 22 25 DAC41-E02 AutoBlank AutoBlank CDMC33764 1 23 25 DAC41-E14 AutoBlank AutoBlank CDMC33764 1 24 25 DAC41-E14 AutoBlank AutoBlank CDMC33765 1 25 25 DAC41-I02 AutoBlank AutoBlank CDMC33765 1 26 25 DAC41-I02 AutoBlank AutoBlank CDMC33766 1 1 26 DAC41-I14 AutoBlank AutoBlank CDMC33766 1 2 26 DAC41-I14 AutoBlank AutoBlank CDMC33767 1 3 26 DAC41-M02 AutoBlank AutoBlank CDMC33767 1 4 26 DAC41-M02 AutoBlank AutoBlank CDMC33768 1 5 26 DAC41-M14 AutoBlank AutoBlank CDMC33768 1 6 26 DAC41-M14 AutoBlank AutoBlank CDMC33769 1 7 26 DAC42-A02 150mM NaPO4 Blank CDMC33769 1 8 26 DAC42-A02 150mM NaPO4 Blank CDMC33770 1 9 26 DAC42-A14 150mM NaPO4 Blank CDMC33770 1 10 26 DAC42-A14 150mM NaPO4 Blank CDMC33771 1 11 26 DAC42-E02 150mM NaPO4 Blank CDMC33771 1 12 26 DAC42-E02 150mM NaPO4 Blank CDMC33772 1 13 26 DAC42-E14 150mM NaPO4 Blank CDMC33772 1 14 26 DAC42-E14 150mM NaPO4 Blank CDMC33773 1 15 26 DAC42-I02 150mM NaPO4 Blank CDMC33773 1 16 26 DAC42-I02 150mM NaPO4 Blank CDMC33774 1 17 26 DAC42-I14 5uM MSP 5uM MSP CDMC33774 1 18 26 DAC42-I14 5uM MSP 5uM MSP CDMC33775 1 19 26 DAC42-M02 10uM MSP 10uM MSP CDMC33775 1 20 26 DAC42-M02 10uM MSP 10uM MSP CDMC33776 1 21 26 DAC42-M14 20uM MSP 20uM MSP CDMC33776 1 22 26 DAC42-M14 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC33777 2 1 1 DAC01-B02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33777 2 2 1 DAC01-B02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC33778 2 3 1 DAC01-B14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33778 2 4 1 DAC01-B14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC33779 2 5 1 DAC01-F02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33779 2 6 1 DAC01-F02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC33780 2 7 1 DAC01-F14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33780 2 8 1 DAC01-F14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC33781 2 9 1 DAC01-J02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33781 2 10 1 DAC01-J02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC33782 2 11 1 DAC01-J14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33782 2 12 1 DAC01-J14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC33783 2 13 1 DAC01-N02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33783 2 14 1 DAC01-N02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC33784 2 15 1 DAC01-N14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33784 2 16 1 DAC01-N14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC33785 2 17 1 DAC02-B02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33785 2 18 1 DAC02-B02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC33786 2 19 1 DAC02-B14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33786 2 20 1 DAC02-B14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC33787 2 21 1 DAC02-F02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33787 2 22 1 DAC02-F02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC33788 2 23 1 DAC02-F14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33788 2 24 1 DAC02-F14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC33789 2 25 1 DAC02-J02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33789 2 26 1 DAC02-J02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC33790 2 1 2 DAC02-J14 N/A CG9075 (00001-00239) CDMC33790 2 2 2 DAC02-J14 N/A CG9075 (00001-00239) CDMC33791 2 3 2 DAC02-N02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33791 2 4 2 DAC02-N02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC33792 2 5 2 DAC02-N14 AutoBlank AutoBlank CDMC33792 2 6 2 DAC02-N14 AutoBlank AutoBlank CDMC33793 2 7 2 DAC03-B02 12-CG5427-RA_10 CG5427 TCCATCTTGGGACAGATCTCATACGCTTTTCTCTACTGCCCGAATACCTTTTCCATGACGCAAGCGGGA 69 FBan0005427 FBgn0032433 Oatp33Ea 2 2L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; transporter activity; GO:0005215; ; GO:0008514; ; GO:0005215 membrane; GO:0016020 Oatp33Ea Organic anion transporting polypeptide 33Ea "CG5427, oatp 33Ea, Organic anion transporting polypeptide 33Ea" CDMC33793 2 8 2 DAC03-B02 12-CG5427-RA_10 CG5427 TCCATCTTGGGACAGATCTCATACGCTTTTCTCTACTGCCCGAATACCTTTTCCATGACGCAAGCGGGA 69 FBan0005427 FBgn0032433 Oatp33Ea 2 2L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; transporter activity; GO:0005215; ; GO:0008514; ; GO:0005215 membrane; GO:0016020 Oatp33Ea Organic anion transporting polypeptide 33Ea "CG5427, oatp 33Ea, Organic anion transporting polypeptide 33Ea" CDMC33794 2 9 2 DAC03-B14 24-CG5436-RA_1 CG5436 AGTCCCCCTATATTGATCTCATAACCAAAAATACTCAAATATCTAAAAATATAGTTCCAATATGCTATT 69 FBan0005436 FBgn0001230 Hsp68 3 3R defense response; GO:0006952; determination of adult life span; GO:0008340; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739 Hsp68 Heat shock protein 68 "CG5436, 68, hsp68, HSP68, Hsp-68" CDMC33794 2 10 2 DAC03-B14 24-CG5436-RA_1 CG5436 AGTCCCCCTATATTGATCTCATAACCAAAAATACTCAAATATCTAAAAATATAGTTCCAATATGCTATT 69 FBan0005436 FBgn0001230 Hsp68 3 3R defense response; GO:0006952; determination of adult life span; GO:0008340; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 mitochondrion; GO:0005739 Hsp68 Heat shock protein 68 "CG5436, 68, hsp68, HSP68, Hsp-68" CDMC33795 2 11 2 DAC03-F02 9-CG5467-RA_1 CG5467 ACCGAGGTGGTCAAGAAGCAGAAGAAAAAGAAGAGCGAAACTGGGGAGGAGCTTTTCAATCGCCTGCTA 69 FBan0005467 FBgn0039433 CG5467 3 3R CG5467 CG5467 CDMC33795 2 12 2 DAC03-F02 9-CG5467-RA_1 CG5467 ACCGAGGTGGTCAAGAAGCAGAAGAAAAAGAAGAGCGAAACTGGGGAGGAGCTTTTCAATCGCCTGCTA 69 FBan0005467 FBgn0039433 CG5467 3 3R CG5467 CG5467 CDMC33796 2 13 2 DAC03-F14 23-CG5472-RC_2 CG5472 TGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAACAAAAAC 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC33796 2 14 2 DAC03-F14 23-CG5472-RC_2 CG5472 TGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAACAAAAAC 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC33797 2 15 2 DAC03-J02 14-CG5494-RA_1 CG5494 CCCGCTGGGTTTTGACCGATTTGGATTTTCGATCCAGTCACAGCACACACATCTCTACCTACCTACCTA 69 FBan0005494 FBgn0038819 CG5494 3 3R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG5494 CG5494 CDMC33797 2 16 2 DAC03-J02 14-CG5494-RA_1 CG5494 CCCGCTGGGTTTTGACCGATTTGGATTTTCGATCCAGTCACAGCACACACATCTCTACCTACCTACCTA 69 FBan0005494 FBgn0038819 CG5494 3 3R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG5494 CG5494 CDMC33798 2 17 2 DAC03-J14 23-CG5502-RA_1 CG5502 GCCAAGAAGTAAACTTACTTTCCCCCGAGTAGAGCTGACACACTTTTATATTATAATAAACCACAAAAG 69 FBan0005502 FBgn0003279 RpL4 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL4 Ribosomal protein L4 "CG5502, CG5502, RpL1: Ribosomal protein L1, anon-WO0172774.76, rpL1, Ribosomal protein L1, RpL1, Ribosomal protein L4" CDMC33798 2 18 2 DAC03-J14 23-CG5502-RA_1 CG5502 GCCAAGAAGTAAACTTACTTTCCCCCGAGTAGAGCTGACACACTTTTATATTATAATAAACCACAAAAG 69 FBan0005502 FBgn0003279 RpL4 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL4 Ribosomal protein L4 "CG5502, CG5502, RpL1: Ribosomal protein L1, anon-WO0172774.76, rpL1, Ribosomal protein L1, RpL1, Ribosomal protein L4" CDMC33799 2 19 2 DAC03-N02 11-CG5547-RA_1 CG5547 TGGGTCACCTGGACTTTCTGGAAAAGGCTAAGAAACTGGGTGACTATCTGATTGTTGGCCTGCACACAG 69 FBan0005547 FBgn0032482 Pect 2 2L biosynthesis; GO:0009058; ethanolamine and derivative metabolism; GO:0042439; phospholipid metabolism; GO:0006644 ethanolamine-phosphate cytidylyltransferase activity; GO:0004306 ; EC:2.7.7.14; ; GO:0004306 ; EC:2.7.7.14 Pect Phosphoethanolamine cytidylyltransferase "CG5547, CG5547, CG5547, PECT, Phosphoethanolamine cytidylyltransferase" CDMC33799 2 20 2 DAC03-N02 11-CG5547-RA_1 CG5547 TGGGTCACCTGGACTTTCTGGAAAAGGCTAAGAAACTGGGTGACTATCTGATTGTTGGCCTGCACACAG 69 FBan0005547 FBgn0032482 Pect 2 2L biosynthesis; GO:0009058; ethanolamine and derivative metabolism; GO:0042439; phospholipid metabolism; GO:0006644 ethanolamine-phosphate cytidylyltransferase activity; GO:0004306 ; EC:2.7.7.14; ; GO:0004306 ; EC:2.7.7.14 Pect Phosphoethanolamine cytidylyltransferase "CG5547, CG5547, CG5547, PECT, Phosphoethanolamine cytidylyltransferase" CDMC33800 2 21 2 DAC03-N14 9-CG5558-RA_6 CG5558 AGGACTGCTCAGGGACAATCCCAGTTTTGATCCCAGTTTGGCCAAGATTCTAGTCACCGAACTGCTGTT 69 FBan0005558 FBgn0038684 CG5558 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG5558 CG5558 CDMC33800 2 22 2 DAC03-N14 9-CG5558-RA_6 CG5558 AGGACTGCTCAGGGACAATCCCAGTTTTGATCCCAGTTTGGCCAAGATTCTAGTCACCGAACTGCTGTT 69 FBan0005558 FBgn0038684 CG5558 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; rRNA metabolism; GO:0016072" nucleic acid binding; GO:0003676; ; GO:0003676 CG5558 CG5558 CDMC33801 2 23 2 DAC04-B02 2-CG12355-RA_1 CG12355 CGCGCAGGCCTTGAACTTTTCCCTGGTTGCACCCCGATTCCGTGTCATCTATATGGGTATTTGTGGATT 69 FBan0012355 FBgn0040805 CG12355 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG12355 CG12355 CDMC33801 2 24 2 DAC04-B02 2-CG12355-RA_1 CG12355 CGCGCAGGCCTTGAACTTTTCCCTGGTTGCACCCCGATTCCGTGTCATCTATATGGGTATTTGTGGATT 69 FBan0012355 FBgn0040805 CG12355 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG12355 CG12355 CDMC33802 2 25 2 DAC04-B14 15-CG12367-RA_1 CG12367 TCGGAATGGTCTGATCCTTACAAGTTTTCTGATCGTTCCTCCCAGGATGATGCTTTGGTCGACCAGGAA 69 FBan0012367 FBgn0033686 CG12367 2 2R CG12367 CG12367 CDMC33802 2 26 2 DAC04-B14 15-CG12367-RA_1 CG12367 TCGGAATGGTCTGATCCTTACAAGTTTTCTGATCGTTCCTCCCAGGATGATGCTTTGGTCGACCAGGAA 69 FBan0012367 FBgn0033686 CG12367 2 2R CG12367 CG12367 CDMC33803 2 1 3 DAC04-F02 2-CG12396-RA_2 CG12396 AGCCAGCTTAAGCCGAAGAATGACCAGTCCAAGCCCAAGATAGAGGATCAACCGACCTTGAAGGCAGAA 69 FBan0012396 FBgn0022069 Nnp-1 2 2L rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleus; GO:0005634 Nnp-1 Nnp-1 "CG12396, l(2)k07826" CDMC33803 2 2 3 DAC04-F02 2-CG12396-RA_2 CG12396 AGCCAGCTTAAGCCGAAGAATGACCAGTCCAAGCCCAAGATAGAGGATCAACCGACCTTGAAGGCAGAA 69 FBan0012396 FBgn0022069 Nnp-1 2 2L rRNA metabolism; GO:0016072; rRNA processing; GO:0006364 nucleus; GO:0005634 Nnp-1 Nnp-1 "CG12396, l(2)k07826" CDMC33804 2 3 3 DAC04-F14 23-CG12410-RA_3 CG12410 GCGATCAGGATGCCATTCAAGGATTCAAGAAACAGAACAAAACAGAAGCCCACATCTAACAAATTTAGC 69 FBan0012410 FBgn0000394 cv X X embryonic development; GO:0009790 protein binding; GO:0005515; ; GO:0005515 cv crossveinless "CG12410, CG12410, tsg2, twisted gastrulation 2, Tsg2, cv-1" CDMC33804 2 4 3 DAC04-F14 23-CG12410-RA_3 CG12410 GCGATCAGGATGCCATTCAAGGATTCAAGAAACAGAACAAAACAGAAGCCCACATCTAACAAATTTAGC 69 FBan0012410 FBgn0000394 cv X X embryonic development; GO:0009790 protein binding; GO:0005515; ; GO:0005515 cv crossveinless "CG12410, CG12410, tsg2, twisted gastrulation 2, Tsg2, cv-1" CDMC33805 2 5 3 DAC04-J02 14-CG12448-RA_1 CG12448 CCCTCCTGGATTACAAACAGTTCAACGCTGCAAGGACTATTCAGTGTCATGTGAGGGGATTTTTGGCCA 69 FBan0012448 FBgn0028857 CG12448 2 2L CG12448 CG12448 BG:DS07486.4 CDMC33805 2 6 3 DAC04-J02 14-CG12448-RA_1 CG12448 CCCTCCTGGATTACAAACAGTTCAACGCTGCAAGGACTATTCAGTGTCATGTGAGGGGATTTTTGGCCA 69 FBan0012448 FBgn0028857 CG12448 2 2L CG12448 CG12448 BG:DS07486.4 CDMC33806 2 7 3 DAC04-J14 13-CG12464-RA_2 CG12464 GAAGGATGTACGCCCCAAACTTTGAACACAACTGCCTTCACTACTCCCGATTTCATACACCCATCCACC 69 FBan0012464 FBgn0033861 CG12464 2 2R CG12464 CG12464 CDMC33806 2 8 3 DAC04-J14 13-CG12464-RA_2 CG12464 GAAGGATGTACGCCCCAAACTTTGAACACAACTGCCTTCACTACTCCCGATTTCATACACCCATCCACC 69 FBan0012464 FBgn0033861 CG12464 2 2R CG12464 CG12464 CDMC33807 2 9 3 DAC04-N02 23-CG12507-RA_2 CG12507 CGCCTTACAAGCTGAACAAGAAGAAAATCAAAAATATTCAGCGGCCTTTAGCGAATAATTCTACCACGT 69 FBan0012507 FBgn0030729 CG12507 X X CG12507 CG12507 CDMC33807 2 10 3 DAC04-N02 23-CG12507-RA_2 CG12507 CGCCTTACAAGCTGAACAAGAAGAAAATCAAAAATATTCAGCGGCCTTTAGCGAATAATTCTACCACGT 69 FBan0012507 FBgn0030729 CG12507 X X CG12507 CG12507 CDMC33808 2 11 3 DAC04-N14 1-CG12526-RA_1 CG12526 TCTCGAGAGCTGCATCTTACTGAGCTACGTGTCCTTTGTGGTCATGGGCCTCTCCAAGATAGGTGCTGT 69 FBan0012526 FBgn0036009 Or67a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; nucleic acid binding; GO:0003676; olfactory receptor activity; GO:0004984; ; GO:0003676; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67a Odorant receptor 67a "CG12526, 67B.1, DOR84, 67a" CDMC33808 2 12 3 DAC04-N14 1-CG12526-RA_1 CG12526 TCTCGAGAGCTGCATCTTACTGAGCTACGTGTCCTTTGTGGTCATGGGCCTCTCCAAGATAGGTGCTGT 69 FBan0012526 FBgn0036009 Or67a 3 3L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; nucleic acid binding; GO:0003676; olfactory receptor activity; GO:0004984; ; GO:0003676; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67a Odorant receptor 67a "CG12526, 67B.1, DOR84, 67a" CDMC33809 2 13 3 DAC05-B02 8-CG5033-RA_3 CG5033 CCTGCTGCAAAACCCTTTGATTGTGCCTCTCAAGAAGCTGCAAACACACGAGAAACGCGATGAGTTTGG 69 FBan0005033 FBgn0028744 CG5033 2 2R ribosome biogenesis; GO:0007046 ribonucleoprotein binding; GO:0043021; ; GO:0043021 nucleolus; GO:0005730 CG5033 CG5033 EG:52C10.1 CDMC33809 2 14 3 DAC05-B02 8-CG5033-RA_3 CG5033 CCTGCTGCAAAACCCTTTGATTGTGCCTCTCAAGAAGCTGCAAACACACGAGAAACGCGATGAGTTTGG 69 FBan0005033 FBgn0028744 CG5033 2 2R ribosome biogenesis; GO:0007046 ribonucleoprotein binding; GO:0043021; ; GO:0043021 nucleolus; GO:0005730 CG5033 CG5033 EG:52C10.1 CDMC33810 2 15 3 DAC05-B14 9-CG5044-RB_3 CG5044 AGAGCTTCTTCCGGGAGGAGTACAGCACGAATGCCCTGATCGGAAACTATAAGATTCCCTACATCGCCA 69 FBan0005044 FBgn0038326 CG5044 3 3R fatty acid beta-oxidation; GO:0006635 3-hydroxyisobutyryl-CoA hydrolase activity; GO:0003860 ; EC:3.1.2.4; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0003860 ; EC:3.1.2.4 CG5044 CG5044 CT16187 CDMC33810 2 16 3 DAC05-B14 9-CG5044-RB_3 CG5044 AGAGCTTCTTCCGGGAGGAGTACAGCACGAATGCCCTGATCGGAAACTATAAGATTCCCTACATCGCCA 69 FBan0005044 FBgn0038326 CG5044 3 3R fatty acid beta-oxidation; GO:0006635 3-hydroxyisobutyryl-CoA hydrolase activity; GO:0003860 ; EC:3.1.2.4; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016836 ; EC:4.2.1.-; ; GO:0003860 ; EC:3.1.2.4 CG5044 CG5044 CT16187 CDMC33811 2 17 3 DAC05-F02 6-CG5075-RA_1 CG5075 GGGCGAAGCGACTGTCCTGGAGAGCATGAACAAGCTGCATGACAATATCCTTTCAACTTTCCGGGAGAT 69 FBan0005075 FBgn0032464 CG5075 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG5075 CG5075 CDMC33811 2 18 3 DAC05-F02 6-CG5075-RA_1 CG5075 GGGCGAAGCGACTGTCCTGGAGAGCATGAACAAGCTGCATGACAATATCCTTTCAACTTTCCGGGAGAT 69 FBan0005075 FBgn0032464 CG5075 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 CG5075 CG5075 CDMC33812 2 19 3 DAC05-F14 17-CG5085-RA_3 CG5085 TGGCGAAAACTTGCCAAAGAGATTTTACTCCAGTCCTGAAGAGGATTTCCAGGATTGCGATCTGCTGAT 69 FBan0005085 FBgn0038788 Sirt2 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; NAD-dependent histone deacetylase activity; GO:0017136; ; GO:0003682; ; GO:0017136 chromatin silencing complex; GO:0005677 Sirt2 Sirt2 "CG5085, CG5085, CG5085, D.mel2, dSIRT2" CDMC33812 2 20 3 DAC05-F14 17-CG5085-RA_3 CG5085 TGGCGAAAACTTGCCAAAGAGATTTTACTCCAGTCCTGAAGAGGATTTCCAGGATTGCGATCTGCTGAT 69 FBan0005085 FBgn0038788 Sirt2 3 3R "chromatin assembly or disassembly; GO:0006333; chromatin silencing; GO:0006342; regulation of transcription, DNA-dependent; GO:0006355" chromatin binding; GO:0003682; NAD-dependent histone deacetylase activity; GO:0017136; ; GO:0003682; ; GO:0017136 chromatin silencing complex; GO:0005677 Sirt2 Sirt2 "CG5085, CG5085, CG5085, D.mel2, dSIRT2" CDMC33813 2 21 3 DAC05-J02 14-CG5123-RA_1 CG5123 AGCCTAAGTGACAGTCCCAATCAAATCCAATCCAATATCACCCAGTCCCGGACATTTCCCAGCAAAACA 69 FBan0005123 FBgn0003997 W 3 3L NOT nurse cell apoptosis; GO:0045476; antennal morphogenesis; GO:0007469; apoptosis; GO:0006915; apoptotic program; GO:0008632; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic development (sensu Insecta); GO:0001700; head involution; GO:0008258; induction of apoptosis; GO:0006917; larval midgut cell programmed cell death; GO:0035096; larval or pupal development (sensu Insecta); GO:0002165; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of organ size; GO:0046620; regulation of proteolysis; GO:0030162; regulation of retinal programmed cell death; GO:0046668; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; salivary gland cell autophagic cell death; GO:0035071 W Wrinkled "CG5123, CG5123, hid: head involution defective, Hid, l(3)05014, HID, head involution defective, wrinkler, Hid1, head involution defect, Head involution defective, hid" CDMC33813 2 22 3 DAC05-J02 14-CG5123-RA_1 CG5123 AGCCTAAGTGACAGTCCCAATCAAATCCAATCCAATATCACCCAGTCCCGGACATTTCCCAGCAAAACA 69 FBan0005123 FBgn0003997 W 3 3L NOT nurse cell apoptosis; GO:0045476; antennal morphogenesis; GO:0007469; apoptosis; GO:0006915; apoptotic program; GO:0008632; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; embryonic development (sensu Insecta); GO:0001700; head involution; GO:0008258; induction of apoptosis; GO:0006917; larval midgut cell programmed cell death; GO:0035096; larval or pupal development (sensu Insecta); GO:0002165; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of organ size; GO:0046620; regulation of proteolysis; GO:0030162; regulation of retinal programmed cell death; GO:0046668; retinal cell programmed cell death (sensu Endopterygota); GO:0046667; salivary gland cell autophagic cell death; GO:0035071 W Wrinkled "CG5123, CG5123, hid: head involution defective, Hid, l(3)05014, HID, head involution defective, wrinkler, Hid1, head involution defect, Head involution defective, hid" CDMC33814 2 23 3 DAC05-J14 2-CG5133-RA_2 CG5133 GCGCCAGGATTTTGAGCAGGACTCAACGGGTAGTGTTTCGCCAGCTTACTATGGAGCAACTCATCCAGT 69 FBan0005133 FBgn0028789 Doc1 3 3L "embryonic development (sensu Insecta); GO:0001700; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc1 Dorsocross1 "CG5133, CG5133, CG5133, Doc, Tb66F2, Dorsocross, Ect2, dorsocross, Dm-DOC1, Dorsocross1" CDMC33814 2 24 3 DAC05-J14 2-CG5133-RA_2 CG5133 GCGCCAGGATTTTGAGCAGGACTCAACGGGTAGTGTTTCGCCAGCTTACTATGGAGCAACTCATCCAGT 69 FBan0005133 FBgn0028789 Doc1 3 3L "embryonic development (sensu Insecta); GO:0001700; heart development; GO:0007507; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc1 Dorsocross1 "CG5133, CG5133, CG5133, Doc, Tb66F2, Dorsocross, Ect2, dorsocross, Dm-DOC1, Dorsocross1" CDMC33815 2 25 3 DAC05-N02 18-CG5170-RE_1 CG5170 TGCTCCTACTCCTACTCCCTAATCCTCTAGCGTTCTACCATACACACAGCCATGATACAGAACCCGAAA 69 FBan0005170 FBgn0027835 Dp1 2 2R chromosome condensation; GO:0030261; chromosome segregation; GO:0007059 single-stranded DNA binding; GO:0003697; satellite DNA binding; GO:0003696; ; GO:0003697; ; GO:0003696; ; GO:0003697 heterochromatin; GO:0000792; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701 Dp1 Dodeca-satellite-binding protein 1 "CG5170, CG5170, DDP1, Drosophila dodeca-satellite-binding protein 1, ddp1, anon-WO0118547.516, anon-WO0172774.168, BcDNA:LD21383, BcDNA:LD21677, Dodeca-satellite-binding protein 1" CDMC33815 2 26 3 DAC05-N02 18-CG5170-RE_1 CG5170 TGCTCCTACTCCTACTCCCTAATCCTCTAGCGTTCTACCATACACACAGCCATGATACAGAACCCGAAA 69 FBan0005170 FBgn0027835 Dp1 2 2R chromosome condensation; GO:0030261; chromosome segregation; GO:0007059 single-stranded DNA binding; GO:0003697; satellite DNA binding; GO:0003696; ; GO:0003697; ; GO:0003696; ; GO:0003697 heterochromatin; GO:0000792; nucleus; GO:0005634; polytene chromosome chromocenter; GO:0005701 Dp1 Dodeca-satellite-binding protein 1 "CG5170, CG5170, DDP1, Drosophila dodeca-satellite-binding protein 1, ddp1, anon-WO0118547.516, anon-WO0172774.168, BcDNA:LD21383, BcDNA:LD21677, Dodeca-satellite-binding protein 1" CDMC33816 2 1 4 DAC05-N14 9-CG5177-RA_2 CG5177 CCATGGTCTGGAGGTTGAGTATCCTTCCGGCAAGAAATTCAAGATCGAGATGCCCGAGGAATTGCTCGA 69 FBan0005177 FBgn0031908 CG5177 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12 CG5177 CG5177 CDMC33816 2 2 4 DAC05-N14 9-CG5177-RA_2 CG5177 CCATGGTCTGGAGGTTGAGTATCCTTCCGGCAAGAAATTCAAGATCGAGATGCCCGAGGAATTGCTCGA 69 FBan0005177 FBgn0031908 CG5177 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12 CG5177 CG5177 CDMC33817 2 3 4 DAC06-B02 12-CG9362-RA_7 CG9362 AATGGGCACAACACTGGATTTCTCGAGGATTTCAGGGTCTCGAAAAGGTTCTTTCCCATTCGGCGGGCA 69 FBan0009362 FBgn0037696 CG9362 3 3R L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 maleylacetoacetate isomerase activity; GO:0016034 ; EC:5.2.1.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2; ; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2 cytoplasm; GO:0005737 CG9362 CG9362 CDMC33817 2 4 4 DAC06-B02 12-CG9362-RA_7 CG9362 AATGGGCACAACACTGGATTTCTCGAGGATTTCAGGGTCTCGAAAAGGTTCTTTCCCATTCGGCGGGCA 69 FBan0009362 FBgn0037696 CG9362 3 3R L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 maleylacetoacetate isomerase activity; GO:0016034 ; EC:5.2.1.2; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2; ; GO:0004364 ; EC:2.5.1.18; ; GO:0016034 ; EC:5.2.1.2 cytoplasm; GO:0005737 CG9362 CG9362 CDMC33818 2 5 4 DAC06-B14 17-CG9375-RA_1 CG9375 ACAAGCAAAAGCCGATAAGCTCACAGCAACTTTCGCACAAACGAGTAAATTCGCTAGCCCCAAACTAGA 69 FBan0009375 FBgn0003205 Ras85D 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; G1/S transition of mitotic cell cycle; GO:0000082; NOT dorsal closure, amnioserosa morphology change; GO:0046664; anti-apoptosis; GO:0006916; border follicle cell migration (sensu Insecta); GO:0007298; cell fate specification; GO:0001708; cell growth; GO:0016049; cytoskeleton organization and biogenesis; GO:0007010; determination of anterior/posterior axis, embryo; GO:0008595; dorsal closure; GO:0007391; eggshell pattern formation (sensu Insecta); GO:0030381; eye development (sensu Endopterygota); GO:0007456; gastrulation; GO:0007369; heart development; GO:0007507; intracellular protein transport; GO:0006886; muscle contraction; GO:0006936; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; ovarian follicle cell development (sensu Insecta); GO:0030707; perineurial glial growth; GO:0042066; peripheral nervous system development; GO:0007422; positive regulation of cell growth; GO:0030307; primary tracheal branching (sensu Insecta); GO:0007428; receptor mediated endocytosis; GO:0006898; regulation of cell growth; GO:0001558; regulation of exocytosis; GO:0017157; regulation of growth; GO:0040008; regulation of hemocyte differentiation; GO:0045610; sevenless signaling pathway; GO:0045500; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; torso signaling pathway; GO:0008293; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" GTP binding; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0019003; ; GO:0003924; ; GO:0005525 Ras85D Ras oncogene at 85D "CG9375, Dmras85D, D-ras-1, Dras1, E(sev)3C, Ras1, p21[Ras1], Su(tor)3-2, ras1, Ras, Ras-1, l(3)06677, ras, D-Ras, RAS1, E(faf), Enhancer of faf, D-Ras1, DRas, Dras85D, RAS, D-ras1, RTK, RasI, Dras, ras85B, dRAS1, ras85D, dRas1, EK3-4, ras 1, DRAS1, DRas85D/Ras, Ras GTPase, dras1, S35097, Dm Ras1, C-ras1, fs(3)05703, l(3)s1747" CDMC33818 2 6 4 DAC06-B14 17-CG9375-RA_1 CG9375 ACAAGCAAAAGCCGATAAGCTCACAGCAACTTTCGCACAAACGAGTAAATTCGCTAGCCCCAAACTAGA 69 FBan0009375 FBgn0003205 Ras85D 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; G1/S transition of mitotic cell cycle; GO:0000082; NOT dorsal closure, amnioserosa morphology change; GO:0046664; anti-apoptosis; GO:0006916; border follicle cell migration (sensu Insecta); GO:0007298; cell fate specification; GO:0001708; cell growth; GO:0016049; cytoskeleton organization and biogenesis; GO:0007010; determination of anterior/posterior axis, embryo; GO:0008595; dorsal closure; GO:0007391; eggshell pattern formation (sensu Insecta); GO:0030381; eye development (sensu Endopterygota); GO:0007456; gastrulation; GO:0007369; heart development; GO:0007507; intracellular protein transport; GO:0006886; muscle contraction; GO:0006936; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; ovarian follicle cell development (sensu Insecta); GO:0030707; perineurial glial growth; GO:0042066; peripheral nervous system development; GO:0007422; positive regulation of cell growth; GO:0030307; primary tracheal branching (sensu Insecta); GO:0007428; receptor mediated endocytosis; GO:0006898; regulation of cell growth; GO:0001558; regulation of exocytosis; GO:0017157; regulation of growth; GO:0040008; regulation of hemocyte differentiation; GO:0045610; sevenless signaling pathway; GO:0045500; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; torso signaling pathway; GO:0008293; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476" GTP binding; GO:0005525; GDP binding; GO:0019003; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0019003; ; GO:0003924; ; GO:0005525 Ras85D Ras oncogene at 85D "CG9375, Dmras85D, D-ras-1, Dras1, E(sev)3C, Ras1, p21[Ras1], Su(tor)3-2, ras1, Ras, Ras-1, l(3)06677, ras, D-Ras, RAS1, E(faf), Enhancer of faf, D-Ras1, DRas, Dras85D, RAS, D-ras1, RTK, RasI, Dras, ras85B, dRAS1, ras85D, dRas1, EK3-4, ras 1, DRAS1, DRas85D/Ras, Ras GTPase, dras1, S35097, Dm Ras1, C-ras1, fs(3)05703, l(3)s1747" CDMC33819 2 7 4 DAC06-F02 1-CG9415-RA_1 CG9415 CCCGCAGATGAGGACGATTTCCCCTGGGAGAGCAACTTTGACGAGCTGTTTCCCAGTTTGATCTGAGTT 69 FBan0009415 FBgn0021872 Xbp1 2 2R "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; protein homodimerization activity; GO:0042803; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 Xbp1 X box binding protein-1 "CG9415, CG9415, l(2)k13803, 138/3, clone 1.41, xbp1, anon-EST:Liang-1.41, X box binding protein-1" CDMC33819 2 8 4 DAC06-F02 1-CG9415-RA_1 CG9415 CCCGCAGATGAGGACGATTTCCCCTGGGAGAGCAACTTTGACGAGCTGTTTCCCAGTTTGATCTGAGTT 69 FBan0009415 FBgn0021872 Xbp1 2 2R "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; protein homodimerization activity; GO:0042803; ; GO:0003700; ; GO:0042803 nucleus; GO:0005634 Xbp1 X box binding protein-1 "CG9415, CG9415, l(2)k13803, 138/3, clone 1.41, xbp1, anon-EST:Liang-1.41, X box binding protein-1" CDMC33820 2 9 4 DAC06-F14 23-CG9428-RA_4 CG9428 AGCCTAACCTGTTCCTAGCCAGTGTGACGCCACTTCAGTATTATCAAGTTATAGAGGAAGCAACAAAAT 69 FBan0009428 FBgn0033096 ZIP1 2 2R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 ZIP1 Zinc/iron regulated transporter-related protein 1 "CG9428, CG9428, dZIP1, Zinc/iron regulated transporter-related protein 1" CDMC33820 2 10 4 DAC06-F14 23-CG9428-RA_4 CG9428 AGCCTAACCTGTTCCTAGCCAGTGTGACGCCACTTCAGTATTATCAAGTTATAGAGGAAGCAACAAAAT 69 FBan0009428 FBgn0033096 ZIP1 2 2R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 ZIP1 Zinc/iron regulated transporter-related protein 1 "CG9428, CG9428, dZIP1, Zinc/iron regulated transporter-related protein 1" CDMC33821 2 11 4 DAC06-J02 11-CG9454-RA_3 CG9454 TGGAGTCACAGACCAACAACCTGATCAAGGACATAATCGGTCCAAGAGTTCTTACCAAGGACTCGCGGC 69 FBan0009454 FBgn0033112 CG9454 2 2R mesoderm development; GO:0007498; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9454 CG9454 CDMC33821 2 12 4 DAC06-J02 11-CG9454-RA_3 CG9454 TGGAGTCACAGACCAACAACCTGATCAAGGACATAATCGGTCCAAGAGTTCTTACCAAGGACTCGCGGC 69 FBan0009454 FBgn0033112 CG9454 2 2R mesoderm development; GO:0007498; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9454 CG9454 CDMC33822 2 13 4 DAC06-J14 12-CG9468-RA_3 CG9468 ACCTATGACTCCGGTGCATACGTCTTCCGTCAATATCACCAGGCTGACTTCATCGTCCAGTACGAAGGT 69 FBan0009468 FBgn0032069 CG9468 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9468 CG9468 CDMC33822 2 14 4 DAC06-J14 12-CG9468-RA_3 CG9468 ACCTATGACTCCGGTGCATACGTCTTCCGTCAATATCACCAGGCTGACTTCATCGTCCAGTACGAAGGT 69 FBan0009468 FBgn0032069 CG9468 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9468 CG9468 CDMC33823 2 15 4 DAC06-N02 2-CG9501-RA_2 CG9501 CCCATGCCTCAATCCATCACATCGCCTTTCCAGTGGTCATCATCTGCAACAAGAACCGACTGAACTGGT 69 FBan0009501 FBgn0031803 ppk14 2 2L sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk14 pickpocket 14 "CG9501, CG9501, CG9501, PPK14" CDMC33823 2 16 4 DAC06-N02 2-CG9501-RA_2 CG9501 CCCATGCCTCAATCCATCACATCGCCTTTCCAGTGGTCATCATCTGCAACAAGAACCGACTGAACTGGT 69 FBan0009501 FBgn0031803 ppk14 2 2L sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk14 pickpocket 14 "CG9501, CG9501, CG9501, PPK14" CDMC33824 2 17 4 DAC06-N14 2-CG9512-RA_1 CG9512 TTAGGGCCTTGAACATCTACAAGAACTTGCCGAATACCAAAGCCTTCAGTGAGAGGGAGGCCGCACTCC 69 FBan0009512 FBgn0030593 CG9512 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9512 CG9512 CT26924 CDMC33824 2 18 4 DAC06-N14 2-CG9512-RA_1 CG9512 TTAGGGCCTTGAACATCTACAAGAACTTGCCGAATACCAAAGCCTTCAGTGAGAGGGAGGCCGCACTCC 69 FBan0009512 FBgn0030593 CG9512 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9512 CG9512 CT26924 CDMC33825 2 19 4 DAC07-B02 23-CG6562-RA_5 CG6562 TTCCACATTGTTAAACTATCGTTGTATTCCGTCAATTTGAGGCTACATCCGGATTTCTGTTTCAGTTGA 69 FBan0006562 FBgn0034691 synj 2 2R calcium-mediated signaling; GO:0019722; dephosphorylation; GO:0016311; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle endocytosis; GO:0048488 inositol trisphosphate phosphatase activity; GO:0046030; inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0046030; ; GO:0004445 ; EC:3.1.3.56 synj synaptojanin "CG6562, CG6562, CG6562, IPP, Synj" CDMC33825 2 20 4 DAC07-B02 23-CG6562-RA_5 CG6562 TTCCACATTGTTAAACTATCGTTGTATTCCGTCAATTTGAGGCTACATCCGGATTTCTGTTTCAGTTGA 69 FBan0006562 FBgn0034691 synj 2 2R calcium-mediated signaling; GO:0019722; dephosphorylation; GO:0016311; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle endocytosis; GO:0048488 inositol trisphosphate phosphatase activity; GO:0046030; inositol-polyphosphate 5-phosphatase activity; GO:0004445 ; EC:3.1.3.56; ; GO:0046030; ; GO:0004445 ; EC:3.1.3.56 synj synaptojanin "CG6562, CG6562, CG6562, IPP, Synj" CDMC33826 2 21 4 DAC07-B14 2-CG6574-RA_2 CG6574 TTGGACTGGCTGGTTACCTGCAGGTCACTTACTACGTTCAGGTTCTGTGGAAAGTGATCGAACCGGAGC 69 FBan0006574 FBgn0037846 CG6574 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 membrane; GO:0016020 CG6574 CG6574 CDMC33826 2 22 4 DAC07-B14 2-CG6574-RA_2 CG6574 TTGGACTGGCTGGTTACCTGCAGGTCACTTACTACGTTCAGGTTCTGTGGAAAGTGATCGAACCGGAGC 69 FBan0006574 FBgn0037846 CG6574 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 membrane; GO:0016020 CG6574 CG6574 CDMC33827 2 23 4 DAC07-F02 2-CG6602-RA_4 CG6602 CCGCAGACGTACCTCATCTGCAGTAACGCTCGAGATCCAAAGAAGGCTGCGTATTTCATCCAACGTGGT 69 FBan0006602 FBgn0035673 CG6602 3 3L CG6602 CG6602 CDMC33827 2 24 4 DAC07-F02 2-CG6602-RA_4 CG6602 CCGCAGACGTACCTCATCTGCAGTAACGCTCGAGATCCAAAGAAGGCTGCGTATTTCATCCAACGTGGT 69 FBan0006602 FBgn0035673 CG6602 3 3L CG6602 CG6602 CDMC33828 2 25 4 DAC07-F14 22-CG6610-RA_1 CG6610 AGGAGATGGTGGGAACTCTCTTAGGATTCGATGACTTTGTGAATATGCTCTTGGACGACGTAACGGAGT 69 FBan0006610 FBgn0035675 CG6610 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG6610 CG6610 BcDNA:RE60135 CDMC33828 2 26 4 DAC07-F14 22-CG6610-RA_1 CG6610 AGGAGATGGTGGGAACTCTCTTAGGATTCGATGACTTTGTGAATATGCTCTTGGACGACGTAACGGAGT 69 FBan0006610 FBgn0035675 CG6610 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; snRNP U6; GO:0005688; spliceosome complex; GO:0005681 CG6610 CG6610 BcDNA:RE60135 CDMC33829 2 1 5 DAC07-J02 6-CG6644-RA_6 CG6644 AGCCAAACACTTGAGATGTGCTTCGCGTGATCTGGATTTTATTCAGTTCCACGGACTGGACACCTGGGG 69 FBan0006644 FBgn0026315 Ugt35a 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 UDP-glycosyltransferase activity; GO:0008194; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0008194; ; GO:0015020 ; EC:2.4.1.17 Ugt35a UDP-glycosyltransferase 35a "CG6644, DmeUgt35a, AC 006491F, UDPGT1, Ugt86Df, UDP-glycosyltransferase 35a" CDMC33829 2 2 5 DAC07-J02 6-CG6644-RA_6 CG6644 AGCCAAACACTTGAGATGTGCTTCGCGTGATCTGGATTTTATTCAGTTCCACGGACTGGACACCTGGGG 69 FBan0006644 FBgn0026315 Ugt35a 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 UDP-glycosyltransferase activity; GO:0008194; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0008194; ; GO:0015020 ; EC:2.4.1.17 Ugt35a UDP-glycosyltransferase 35a "CG6644, DmeUgt35a, AC 006491F, UDPGT1, Ugt86Df, UDP-glycosyltransferase 35a" CDMC33830 2 3 5 DAC07-J14 2-CG6657-RB_1 CG6657 CGCCTGTTTACTGTGCCGCTCAAATGGATTAATCACCTTGGGATACCCGCTCTACTTCTTCGGACGCCA 69 FBan0006657 FBgn0015562 veg 2 2R peripheral nervous system development; GO:0007422 integral to membrane; GO:0016021 veg vegetable "CG6657, CG6657" CDMC33830 2 4 5 DAC07-J14 2-CG6657-RB_1 CG6657 CGCCTGTTTACTGTGCCGCTCAAATGGATTAATCACCTTGGGATACCCGCTCTACTTCTTCGGACGCCA 69 FBan0006657 FBgn0015562 veg 2 2R peripheral nervous system development; GO:0007422 integral to membrane; GO:0016021 veg vegetable "CG6657, CG6657" CDMC33831 2 5 5 DAC07-N02 18-CG6685-RA_1 CG6685 AGCGGCAAAAGTGCAGTTTGGATCCACTATTCCTGGACGAGAAGCTAACGTAGAGGCTGTTATTGAGTA 69 FBan0006685 FBgn0036062 CG6685 3 3L CG6685 CG6685 CDMC33831 2 6 5 DAC07-N02 18-CG6685-RA_1 CG6685 AGCGGCAAAAGTGCAGTTTGGATCCACTATTCCTGGACGAGAAGCTAACGTAGAGGCTGTTATTGAGTA 69 FBan0006685 FBgn0036062 CG6685 3 3L CG6685 CG6685 CDMC33832 2 7 5 DAC07-N14 23-CG6693-RA_6 CG6693 AATTGCTGTAAACAGGAAAATCAAAGATTTTTTCGCACCATTAAACAAAGGAATTTTTGTCTGCCCCAC 69 FBan0006693 FBgn0037878 CG6693 3 3R CG6693 CG6693 CDMC33832 2 8 5 DAC07-N14 23-CG6693-RA_6 CG6693 AATTGCTGTAAACAGGAAAATCAAAGATTTTTTCGCACCATTAAACAAAGGAATTTTTGTCTGCCCCAC 69 FBan0006693 FBgn0037878 CG6693 3 3R CG6693 CG6693 CDMC33833 2 9 5 DAC08-B02 13-CG31855-RA_1 CG31855 GGGTCTGCCCATACACGATTCGAGCAATTTTACCCATTTGAGCAACGAACATGGAATTCGAACGTCGCA 69 FBan0031855 FBgn0051855 CG31855 2 2L CG31855 CG31855 CG6537 CDMC33833 2 10 5 DAC08-B02 13-CG31855-RA_1 CG31855 GGGTCTGCCCATACACGATTCGAGCAATTTTACCCATTTGAGCAACGAACATGGAATTCGAACGTCGCA 69 FBan0031855 FBgn0051855 CG31855 2 2L CG31855 CG31855 CG6537 CDMC33834 2 11 5 DAC08-B14 18-CG31862-RA_1 CG31862 ACTCCTTAGGAGGCTTGGCATTTACGATAGCTTCACTGTTCGCGTATTCAAGGCAATCTTCAGCGATGA 69 FBan0031862 FBgn0051862 CG31862 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31862 CG31862 CDMC33834 2 12 5 DAC08-B14 18-CG31862-RA_1 CG31862 ACTCCTTAGGAGGCTTGGCATTTACGATAGCTTCACTGTTCGCGTATTCAAGGCAATCTTCAGCGATGA 69 FBan0031862 FBgn0051862 CG31862 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31862 CG31862 CDMC33835 2 13 5 DAC08-F02 15-CG31887-RA_1 CG31887 CCGGCACATGGCAAAGCATTTTCTGGCTTTTCACTCGCAAATCCTCGGGTTTTATTTTTGGTCTCTGGT 69 FBan0031887 FBgn0051887 CG31887 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31887 CG31887 CDMC33835 2 14 5 DAC08-F02 15-CG31887-RA_1 CG31887 CCGGCACATGGCAAAGCATTTTCTGGCTTTTCACTCGCAAATCCTCGGGTTTTATTTTTGGTCTCTGGT 69 FBan0031887 FBgn0051887 CG31887 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31887 CG31887 CDMC33836 2 15 5 DAC08-F14 12-CG31902-RA_1 CG31902 GATCAACGCAGCTTTCTTCAAGGGCTACTGGAAGACGCGATTCGATAAGATGAACACCAAGCCCAAGGT 69 FBan0031902 FBgn0051902 CG31902 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31902 CG31902 CG12318 CDMC33836 2 16 5 DAC08-F14 12-CG31902-RA_1 CG31902 GATCAACGCAGCTTTCTTCAAGGGCTACTGGAAGACGCGATTCGATAAGATGAACACCAAGCCCAAGGT 69 FBan0031902 FBgn0051902 CG31902 2 2L proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG31902 CG31902 CG12318 CDMC33837 2 17 5 DAC08-J02 3-CG31929-RA_1 CG31929 TGTTCGGTGGACTCCTCGAGGATTCGGAAATACCTTTCATTGTACCGCCGTCTTTTGGAGCTCAAGGGA 69 FBan0031929 FBgn0045499 Gr22c 2 2L Gr22c Gustatory receptor 22c "CG31929, CG31929, Gr2940.3, Gustatory receptor 2940.3, Gustatory receptor 22c" CDMC33837 2 18 5 DAC08-J02 3-CG31929-RA_1 CG31929 TGTTCGGTGGACTCCTCGAGGATTCGGAAATACCTTTCATTGTACCGCCGTCTTTTGGAGCTCAAGGGA 69 FBan0031929 FBgn0045499 Gr22c 2 2L Gr22c Gustatory receptor 22c "CG31929, CG31929, Gr2940.3, Gustatory receptor 2940.3, Gustatory receptor 22c" CDMC33838 2 19 5 DAC08-J14 5-CG31949-RA_1 CG31949 TGTTTCCAGATCAGCGATATGCAGAAGTTCTTTGGCTGCAAGGAAGACTGCGTCACACCCAGTGTCCTT 69 FBan0031949 FBgn0051949 CG31949 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31949 CG31949 CDMC33838 2 20 5 DAC08-J14 5-CG31949-RA_1 CG31949 TGTTTCCAGATCAGCGATATGCAGAAGTTCTTTGGCTGCAAGGAAGACTGCGTCACACCCAGTGTCCTT 69 FBan0031949 FBgn0051949 CG31949 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31949 CG31949 CDMC33839 2 21 5 DAC08-N02 11-CG31999-RA_1 CG31999 TCCTGCCCGATAGGTCATGAGCTCAAACGATCCATTGGTGGTGCTAGTACATGTGTTGACACGAACGAA 69 FBan0031999 FBgn0051999 CG31999 4 4 cell adhesion; GO:0007155; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 CG31999 CG31999 "CG10323, CG11288, CG10323, CT31491, CT7856, fibrillin-like" CDMC33839 2 22 5 DAC08-N02 11-CG31999-RA_1 CG31999 TCCTGCCCGATAGGTCATGAGCTCAAACGATCCATTGGTGGTGCTAGTACATGTGTTGACACGAACGAA 69 FBan0031999 FBgn0051999 CG31999 4 4 cell adhesion; GO:0007155; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0005198; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 CG31999 CG31999 "CG10323, CG11288, CG10323, CT31491, CT7856, fibrillin-like" CDMC33840 2 23 5 DAC08-N14 22-CG32015-RA_1 CG32015 TGCCACCAATGCAAGAAACCCGTGTACAAAATGGAGGAAGTCATTCTTAGTTTGAAGACAGCAACGACT 69 FBgn0052015 CDMC33840 2 24 5 DAC08-N14 22-CG32015-RA_1 CG32015 TGCCACCAATGCAAGAAACCCGTGTACAAAATGGAGGAAGTCATTCTTAGTTTGAAGACAGCAACGACT 69 FBgn0052015 CDMC33841 2 25 5 DAC09-B03 15-CG5374-RA_7 CG5374 AATCGGTGCTGATTCCCGGCTATGCCTTGAACTGCACAATTGCCTCCCAGCAGATGCCCAAGAAG 65 FBan0005374 FBgn0003676 T-cp1 3 3R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0008553 ; EC:3.6.3.6; ; GO:0051082" chaperonin-containing T-complex; GO:0005832; proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 T-cp1 Tcp1-like "CG5374, T-cpl, gh05123, Tcp-1, BEST:GH05123" CDMC33841 2 26 5 DAC09-B03 15-CG5374-RA_7 CG5374 AATCGGTGCTGATTCCCGGCTATGCCTTGAACTGCACAATTGCCTCCCAGCAGATGCCCAAGAAG 65 FBan0005374 FBgn0003676 T-cp1 3 3R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0008553 ; EC:3.6.3.6; ; GO:0051082" chaperonin-containing T-complex; GO:0005832; proton-transporting ATP synthase complex (sensu Eukaryota); GO:0005753 T-cp1 Tcp1-like "CG5374, T-cpl, gh05123, Tcp-1, BEST:GH05123" CDMC33842 2 1 6 DAC09-B15 1-CG5391-RA_1 CG5391 ATGAGTCCCGACTCTGATCTCGGAATGGAGGAATCGCAGTTTTTGAGCCACACTCCAGTGAGGGC 65 FBan0005391 FBgn0038943 CG5391 3 3R CG5391 CG5391 CDMC33842 2 2 6 DAC09-B15 1-CG5391-RA_1 CG5391 ATGAGTCCCGACTCTGATCTCGGAATGGAGGAATCGCAGTTTTTGAGCCACACTCCAGTGAGGGC 65 FBan0005391 FBgn0038943 CG5391 3 3R CG5391 CG5391 CDMC33843 2 3 6 DAC09-F03 5-CG5519-RA_1 CG5519 CTACTTGCTGTCCACATCATCCGACAAACACTGGGCATTCTCCGATATCCGCACAGGACGCCTGC 65 FBan0005519 FBgn0013969 Gbp 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein ubiquitination; GO:0016567" GTP binding; GO:0005525; ; GO:0005525; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 Gbp GTP-binding-protein "CG5519, GPB, BcDNA:LD02793" CDMC33843 2 4 6 DAC09-F03 5-CG5519-RA_1 CG5519 CTACTTGCTGTCCACATCATCCGACAAACACTGGGCATTCTCCGATATCCGCACAGGACGCCTGC 65 FBan0005519 FBgn0013969 Gbp 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein ubiquitination; GO:0016567" GTP binding; GO:0005525; ; GO:0005525; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 ubiquitin ligase complex; GO:0000151 Gbp GTP-binding-protein "CG5519, GPB, BcDNA:LD02793" CDMC33844 2 5 6 DAC09-F15 2-CG5571-RA_1 CG5571 TAGTGGCACCTATTTCGAACGACCATACTTCCACCATGCCCAGATGTTCCCCACCAAACTGTGCC 65 FBgn0036982 CDMC33844 2 6 6 DAC09-F15 2-CG5571-RA_1 CG5571 TAGTGGCACCTATTTCGAACGACCATACTTCCACCATGCCCAGATGTTCCCCACCAAACTGTGCC 65 FBgn0036982 CDMC33845 2 7 6 DAC09-J03 3-CG5692-RA_2 CG5692 ATATTAGGGGTGTATAGGGCCTCGTCTACACGAGCAGAGGGAGGAACCTCCAACGGATGCACACA 65 FBan0005692 FBgn0040080 raps 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; establishment of mitotic spindle localization; GO:0040001; establishment of mitotic spindle orientation; GO:0000132; maintenance of protein localization; GO:0045185; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; protein targeting; GO:0006605 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; GTPase activator activity; GO:0005096; ; GO:0005096 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938 raps rapsynoid "CG5692, CG5692, CG5692, Rad, Rapsynoid, pins, partner of inscuteable, rad, rapsyn, Pins, Partner of Inscuteable, Partner of Inscutable, PINS, rapsynoid" CDMC33845 2 8 6 DAC09-J03 3-CG5692-RA_2 CG5692 ATATTAGGGGTGTATAGGGCCTCGTCTACACGAGCAGAGGGAGGAACCTCCAACGGATGCACACA 65 FBan0005692 FBgn0040080 raps 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; establishment of mitotic spindle localization; GO:0040001; establishment of mitotic spindle orientation; GO:0000132; maintenance of protein localization; GO:0045185; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; protein targeting; GO:0006605 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; GTPase activator activity; GO:0005096; ; GO:0005096 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938 raps rapsynoid "CG5692, CG5692, CG5692, Rad, Rapsynoid, pins, partner of inscuteable, rad, rapsyn, Pins, Partner of Inscuteable, Partner of Inscutable, PINS, rapsynoid" CDMC33846 2 9 6 DAC09-J15 3-CG5728-RA_2 CG5728 GGTGTGTCTAGTTTCTGGGAGGATGATGTGAACCAGTCCAAGGAAGGGTCCAGCGACGAAGACGA 65 FBan0005728 FBgn0039182 CG5728 3 3R "rRNA processing; GO:0006364; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; nucleus; GO:0005634 CG5728 CG5728 CDMC33846 2 10 6 DAC09-J15 3-CG5728-RA_2 CG5728 GGTGTGTCTAGTTTCTGGGAGGATGATGTGAACCAGTCCAAGGAAGGGTCCAGCGACGAAGACGA 65 FBan0005728 FBgn0039182 CG5728 3 3R "rRNA processing; GO:0006364; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; nucleus; GO:0005634 CG5728 CG5728 CDMC33847 2 11 6 DAC09-N03 1-CG5841-RA_1 CG5841 GTCCCTGCACGAGGATCCTCCGAAATCGTCAGCCAGTCTTGATGAGTGTTTGGTTTGCTCGGATG 65 FBan0005841 FBgn0036558 mib1 3 3L "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; cell proliferation; GO:0008283; endocytosis; GO:0006897; eye development (sensu Endopterygota); GO:0007456; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; positive regulation of Notch signaling pathway; GO:0045747; positive regulation of endocytosis; GO:0045807; protein amino acid ADP-ribosylation; GO:0006471; protein localization; GO:0008104; protein metabolism; GO:0019538; protein modification; GO:0006464; protein ubiquitination; GO:0016567; regulation of Notch signaling pathway; GO:0008593; transcription, RNA-dependent; GO:0006410; wing margin morphogenesis; GO:0008587" ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0004842 ; EC:6.3.2.19; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0008270; ; GO:0005515; ; GO:0005515 apical cortex; GO:0045179; cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 mib1 mind bomb 1 "CG5841, CG5841, l(3)72CDa, lethal (3) 72CDa, mind-bomb, D-mib, Mib1, Mindbomb1, Mind Bomb, mind bomb 1" CDMC33847 2 12 6 DAC09-N03 1-CG5841-RA_1 CG5841 GTCCCTGCACGAGGATCCTCCGAAATCGTCAGCCAGTCTTGATGAGTGTTTGGTTTGCTCGGATG 65 FBan0005841 FBgn0036558 mib1 3 3L "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; cell proliferation; GO:0008283; endocytosis; GO:0006897; eye development (sensu Endopterygota); GO:0007456; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; positive regulation of Notch signaling pathway; GO:0045747; positive regulation of endocytosis; GO:0045807; protein amino acid ADP-ribosylation; GO:0006471; protein localization; GO:0008104; protein metabolism; GO:0019538; protein modification; GO:0006464; protein ubiquitination; GO:0016567; regulation of Notch signaling pathway; GO:0008593; transcription, RNA-dependent; GO:0006410; wing margin morphogenesis; GO:0008587" ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0004842 ; EC:6.3.2.19; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0005102; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0008270; ; GO:0005515; ; GO:0005515 apical cortex; GO:0045179; cytoplasm; GO:0005737; ubiquitin ligase complex; GO:0000151 mib1 mind bomb 1 "CG5841, CG5841, l(3)72CDa, lethal (3) 72CDa, mind-bomb, D-mib, Mib1, Mindbomb1, Mind Bomb, mind bomb 1" CDMC33848 2 13 6 DAC09-N15 3-CG5907-RC_1 CG5907 AGCGATAGTGACGATGATGGGATGGAACGACGAATCAAGGATCAAAGGTCGCCCCACAAGCACGT 65 FBgn0004120 CDMC33848 2 14 6 DAC09-N15 3-CG5907-RC_1 CG5907 AGCGATAGTGACGATGATGGGATGGAACGACGAATCAAGGATCAAAGGTCGCCCCACAAGCACGT 65 FBgn0004120 CDMC33849 2 15 6 DAC10-B02 15-CG6477-RB_4 CG6477 CGCGACCGTTTTCAAAGGTTTTCTATCCGAACTTCCAGAACCGCTGCTTACGGATGCCCACTATC 65 FBan0006477 FBgn0034249 RhoGAP54D 2 2R RhoGAP54D RhoGAP54D "CG6477, CG6477, CG6477, CG6477" CDMC33849 2 16 6 DAC10-B02 15-CG6477-RB_4 CG6477 CGCGACCGTTTTCAAAGGTTTTCTATCCGAACTTCCAGAACCGCTGCTTACGGATGCCCACTATC 65 FBan0006477 FBgn0034249 RhoGAP54D 2 2R RhoGAP54D RhoGAP54D "CG6477, CG6477, CG6477, CG6477" CDMC33850 2 17 6 DAC10-B14 5-CG6506-RA_1 CG6506 CAAAAGTTTCAGAAGCCCATTTGGTTCACACCAACCGTGGACACAGCCTACTCTCGCGGGGATCC 65 FBan0006506 FBgn0030874 CG6506 X X CG6506 CG6506 CDMC33850 2 18 6 DAC10-B14 5-CG6506-RA_1 CG6506 CAAAAGTTTCAGAAGCCCATTTGGTTCACACCAACCGTGGACACAGCCTACTCTCGCGGGGATCC 65 FBan0006506 FBgn0030874 CG6506 X X CG6506 CG6506 CDMC33851 2 19 6 DAC10-F02 16-CG6632-RA_1 CG6632 CGGCGTAGGCACCTGGTCGCGTCGCTAGCGGCTCTTATACTTGTAAAGTGACAAATAAACAAATT 65 FBan0006632 FBgn0030945 Ing3 X X "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003677; ; GO:0004197 ; EC:3.4.22.- Ing3 Ing3 "CG6632, CG6632, CG6632, CG6632, dIng3" CDMC33851 2 20 6 DAC10-F02 16-CG6632-RA_1 CG6632 CGGCGTAGGCACCTGGTCGCGTCGCTAGCGGCTCTTATACTTGTAAAGTGACAAATAAACAAATT 65 FBan0006632 FBgn0030945 Ing3 X X "apoptosis; GO:0006915; cell cycle; GO:0007049; induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016407 ; EC:2.3.1.-; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0003677; ; GO:0004197 ; EC:3.4.22.- Ing3 Ing3 "CG6632, CG6632, CG6632, CG6632, dIng3" CDMC33852 2 21 6 DAC10-F14 7-CG6669-RA_1 CG6669 GGCCGCGGCCTACAACTCGAACTCGTACACAACTCCCTGTACTTAGCATGTCGATCGAACGAGGC 65 FBan0006669 FBgn0017590 klg 3 3R R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; homophilic cell adhesion; GO:0007156; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; signal transduction; GO:0007165 extrinsic to plasma membrane; GO:0019897 klg klingon "CG6669, CG6669, l(3)rN712, CT20712, h214, klingon" CDMC33852 2 22 6 DAC10-F14 7-CG6669-RA_1 CG6669 GGCCGCGGCCTACAACTCGAACTCGTACACAACTCCCTGTACTTAGCATGTCGATCGAACGAGGC 65 FBan0006669 FBgn0017590 klg 3 3R R7 cell differentiation; GO:0045466; R7 cell fate commitment; GO:0007465; homophilic cell adhesion; GO:0007156; learning and/or memory; GO:0007611; olfactory learning; GO:0008355; signal transduction; GO:0007165 extrinsic to plasma membrane; GO:0019897 klg klingon "CG6669, CG6669, l(3)rN712, CT20712, h214, klingon" CDMC33853 2 23 6 DAC10-J02 18-CG6762-RA_4 CG6762 ACGCCGTGCGGTGTCAAAAATCGTGCAATTGTCCGCCATGGAGTTCATTAGCCATTTCTTGCGAG 65 FBan0006762 FBgn0030876 CG6762 X X biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG6762 CG6762 CDMC33853 2 24 6 DAC10-J02 18-CG6762-RA_4 CG6762 ACGCCGTGCGGTGTCAAAAATCGTGCAATTGTCCGCCATGGAGTTCATTAGCCATTTCTTGCGAG 65 FBan0006762 FBgn0030876 CG6762 X X biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 cellular component unknown; GO:0008372 CG6762 CG6762 CDMC33854 2 25 6 DAC10-J14 6-CG6791-RA_1 CG6791 GCCTCAACTTTCGGCAGATCGACAACCATCACTACCTGTGCCTGGAGTGCTACAAACGGGTGACC 65 FBan0006791 FBgn0037918 CG6791 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6791 CG6791 CDMC33854 2 26 6 DAC10-J14 6-CG6791-RA_1 CG6791 GCCTCAACTTTCGGCAGATCGACAACCATCACTACCTGTGCCTGGAGTGCTACAAACGGGTGACC 65 FBan0006791 FBgn0037918 CG6791 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6791 CG6791 CDMC33855 2 1 7 DAC10-N02 6-CG6900-RA_1 CG6900 GTCGTTGTTCTGGAGAGCCGTGGTCAGGTCCGAAGACCGATTAGGGGATCCAGCTGGCTACATAC 65 FBan0006900 FBgn0030958 CG6900 X X CG6900 CG6900 CDMC33855 2 2 7 DAC10-N02 6-CG6900-RA_1 CG6900 GTCGTTGTTCTGGAGAGCCGTGGTCAGGTCCGAAGACCGATTAGGGGATCCAGCTGGCTACATAC 65 FBan0006900 FBgn0030958 CG6900 X X CG6900 CG6900 CDMC33856 2 3 7 DAC10-N14 3-CG6917-RA_4 CG6917 CCTTTGAACTGGGACGCAACGTGGGATGTGAATCGGCTGAAGACTCGACCAGCCTGAAGAAATGC 65 FBan0006917 FBgn0000592 Est-6 3 3L "NOT sperm competition; GO:0046692; cell-cell signaling; GO:0007267; courtship behavior; GO:0007619; mating; GO:0007618; ovulation; GO:0030728; pheromone biosynthesis; GO:0042811; regulation of female receptivity, post-mating; GO:0046008; regulation of oviposition; GO:0046662; sexual reproduction; GO:0019953; signal transduction; GO:0007165; sperm storage; GO:0046693" carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1 Est-6 Esterase 6 "CG6917, CG6917, Est-D, EST6, Carboxyl ester hydrolase, est-6, Est6, Est, EST-6, Esterase-6, est6, Est-5, EST-5" CDMC33856 2 4 7 DAC10-N14 3-CG6917-RA_4 CG6917 CCTTTGAACTGGGACGCAACGTGGGATGTGAATCGGCTGAAGACTCGACCAGCCTGAAGAAATGC 65 FBan0006917 FBgn0000592 Est-6 3 3L "NOT sperm competition; GO:0046692; cell-cell signaling; GO:0007267; courtship behavior; GO:0007619; mating; GO:0007618; ovulation; GO:0030728; pheromone biosynthesis; GO:0042811; regulation of female receptivity, post-mating; GO:0046008; regulation of oviposition; GO:0046662; sexual reproduction; GO:0019953; signal transduction; GO:0007165; sperm storage; GO:0046693" carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1 Est-6 Esterase 6 "CG6917, CG6917, Est-D, EST6, Carboxyl ester hydrolase, est-6, Est6, Est, EST-6, Esterase-6, est6, Est-5, EST-5" CDMC33857 2 5 7 DAC11-B02 11-FLPase_1 FLPase_1 AGTGGCAGCATATAGAACAGCTAAAGGGTAGTGCTGAAGGAAGCATACGATACCCCGCATGGAATGGGA 69 CDMC33857 2 6 7 DAC11-B02 11-FLPase_1 FLPase_1 AGTGGCAGCATATAGAACAGCTAAAGGGTAGTGCTGAAGGAAGCATACGATACCCCGCATGGAATGGGA 69 CDMC33858 2 7 7 DAC11-B14 18-CG10005-RA_1 CG10005 GCAGTAATATGTCGGGATTAATGAATGGCTTTCTGCTTTTGTTCGCCTGCAATTTGCTGTTGGCTGTGC 69 FBan0010005 FBgn0037972 CG10005 3 3R CG10005 CG10005 BcDNA:RE59626 CDMC33858 2 8 7 DAC11-B14 18-CG10005-RA_1 CG10005 GCAGTAATATGTCGGGATTAATGAATGGCTTTCTGCTTTTGTTCGCCTGCAATTTGCTGTTGGCTGTGC 69 FBan0010005 FBgn0037972 CG10005 3 3R CG10005 CG10005 BcDNA:RE59626 CDMC33859 2 9 7 DAC11-F02 3-CG10042-RB_1 CG10042 GGAGGAGTGCCAGTACCGTTTGATCGAGCATATCAAGGTGCAGCAATCCTTGGTTCTCGATCGGCTGAA 69 FBan0010042 FBgn0038016 MBD-R2 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 MBD-R2 MBD-R2 "CG10042, CG17393, CG10042, CG10042, dMBD-R2, Dm Tam3, TAM3, MBD" CDMC33859 2 10 7 DAC11-F02 3-CG10042-RB_1 CG10042 GGAGGAGTGCCAGTACCGTTTGATCGAGCATATCAAGGTGCAGCAATCCTTGGTTCTCGATCGGCTGAA 69 FBan0010042 FBgn0038016 MBD-R2 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 MBD-R2 MBD-R2 "CG10042, CG17393, CG10042, CG10042, dMBD-R2, Dm Tam3, TAM3, MBD" CDMC33860 2 11 7 DAC11-F14 1-CG10051-RA_1 CG10051 GGTGGCCGTTTTTATGCAAGGTGTGGGTCTAGCCGAATCCTGGTACTACGGAAAATGGATGGCCTTTGG 69 FBan0010051 FBgn0034437 CG10051 2 2R CG10051 CG10051 CDMC33860 2 12 7 DAC11-F14 1-CG10051-RA_1 CG10051 GGTGGCCGTTTTTATGCAAGGTGTGGGTCTAGCCGAATCCTGGTACTACGGAAAATGGATGGCCTTTGG 69 FBan0010051 FBgn0034437 CG10051 2 2R CG10051 CG10051 CDMC33861 2 13 7 DAC11-J02 18-CG1007-RA_1 CG1007 CTCGCAACCTTCGTGTGAAGATCTCCGCATAAGATAACGTGTGAAACTCTCAAGAAAACCACAGCCCAG 69 FBan0001007 FBgn0000575 emc 3 3L "bristle morphogenesis; GO:0008407; cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; restriction of R8 fate; GO:0007461; sensory organ development; GO:0007423; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; spermatid development; GO:0007286; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; ; GO:0003714; ; GO:0003714 nucleus; GO:0005634 emc extra macrochaetae "CG1007, CG1007, Ach: Achetous, ms(3)61CD, gov, 0094/26, 0203/10, 0587/01, 0977/09, l(3)05592, Dm0688, Emc, extramacrochaetae, l(3)04322, l(3)j4E11, Achetous, golovan, male sterile(3)61CD, Ach" CDMC33861 2 14 7 DAC11-J02 18-CG1007-RA_1 CG1007 CTCGCAACCTTCGTGTGAAGATCTCCGCATAAGATAACGTGTGAAACTCTCAAGAAAACCACAGCCCAG 69 FBan0001007 FBgn0000575 emc 3 3L "bristle morphogenesis; GO:0008407; cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; restriction of R8 fate; GO:0007461; sensory organ development; GO:0007423; sex determination; GO:0007530; sex determination, primary response to X:A ratio; GO:0007541; spermatid development; GO:0007286; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586" protein binding; GO:0005515; transcription corepressor activity; GO:0003714; ; GO:0005515; ; GO:0003714; ; GO:0003714 nucleus; GO:0005634 emc extra macrochaetae "CG1007, CG1007, Ach: Achetous, ms(3)61CD, gov, 0094/26, 0203/10, 0587/01, 0977/09, l(3)05592, Dm0688, Emc, extramacrochaetae, l(3)04322, l(3)j4E11, Achetous, golovan, male sterile(3)61CD, Ach" CDMC33862 2 15 7 DAC11-J14 14-CG10091-RA_1 CG10091 TCCCCAGTTGTTCGAGGATGTGAAGAAGCCAGCTGATCCCGATAACCTCAAGAAGATCGATGATGCTTT 69 FBan0010091 FBgn0038020 GstD9 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD9 Glutathione S transferase D9 "CG10091, CG10091, CG10091, CG10091, DmGSTD9, Glutathione S transferase D9" CDMC33862 2 16 7 DAC11-J14 14-CG10091-RA_1 CG10091 TCCCCAGTTGTTCGAGGATGTGAAGAAGCCAGCTGATCCCGATAACCTCAAGAAGATCGATGATGCTTT 69 FBan0010091 FBgn0038020 GstD9 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD9 Glutathione S transferase D9 "CG10091, CG10091, CG10091, CG10091, DmGSTD9, Glutathione S transferase D9" CDMC33863 2 17 7 DAC11-N02 11-CG10124-RA_1 CG10124 AACGCTTTCGGATATGGATATTCGCAAGCCCGTAACGGAGATTGTTGATTTGCGCCTTAAGCATCCGCT 69 FBan0010124 FBgn0035709 CG10124 3 3L translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 CG10124 CG10124 "eIF4E, CT28485, NEST:bs04e06, BEST:GH01027" CDMC33863 2 18 7 DAC11-N02 11-CG10124-RA_1 CG10124 AACGCTTTCGGATATGGATATTCGCAAGCCCGTAACGGAGATTGTTGATTTGCGCCTTAAGCATCCGCT 69 FBan0010124 FBgn0035709 CG10124 3 3L translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 CG10124 CG10124 "eIF4E, CT28485, NEST:bs04e06, BEST:GH01027" CDMC33864 2 19 7 DAC11-N14 7-CG10131-RA_1 CG10131 GGCGGTGCACATACAGGAGTGTGTTCCCGAAGTTTTGCATCTGAAGAAGAGTCTGTACTCGCAGTTGGA 69 FBan0010131 FBgn0033949 CG10131 2 2R cytoskeleton organization and biogenesis; GO:0007010; fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG10131 CG10131 CDMC33864 2 20 7 DAC11-N14 7-CG10131-RA_1 CG10131 GGCGGTGCACATACAGGAGTGTGTTCCCGAAGTTTTGCATCTGAAGAAGAGTCTGTACTCGCAGTTGGA 69 FBan0010131 FBgn0033949 CG10131 2 2R cytoskeleton organization and biogenesis; GO:0007010; fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; ; GO:0016491 ; EC:1.-.-.- CG10131 CG10131 CDMC33865 2 21 7 DAC12-B02 18-CG3008-RA_5 CG3008 TGCTGCTGTACAAGCTGATCAATAACCAAATACTGGAGCAGATCAACGGCATTATATCCACGGGCAAGG 69 FBan0003008 FBgn0031643 CG3008 2 2L protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG3008 CG3008 CDMC33865 2 22 7 DAC12-B02 18-CG3008-RA_5 CG3008 TGCTGCTGTACAAGCTGATCAATAACCAAATACTGGAGCAGATCAACGGCATTATATCCACGGGCAAGG 69 FBan0003008 FBgn0031643 CG3008 2 2L protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG3008 CG3008 CDMC33866 2 23 7 DAC12-B14 8-CG30097-RD_1 CG30097 CCACGAGCTCGCTGAATTTCCAACCAATGAGGAGATGCAAAGCGGACGTATCTATCCTCTGGTGAAGCA 69 FBgn0050097 CDMC33866 2 24 7 DAC12-B14 8-CG30097-RD_1 CG30097 CCACGAGCTCGCTGAATTTCCAACCAATGAGGAGATGCAAAGCGGACGTATCTATCCTCTGGTGAAGCA 69 FBgn0050097 CDMC33867 2 25 7 DAC12-F02 16-CG30128-RB_1 CG30128 GCGTAGGACCGAGATCTCAATGTCGCAACTGAAACTCTTTCACATGAGCCTGATGAACAGCGACTACAA 69 FBan0030128 FBgn0046879 Obp56c 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56c Odorant-binding protein 56c "CG15129, CG30128, CG15129, CG15129, CG15129, CG15129, OBP56c, 56c, Odorant-binding protein 56c" CDMC33867 2 26 7 DAC12-F02 16-CG30128-RB_1 CG30128 GCGTAGGACCGAGATCTCAATGTCGCAACTGAAACTCTTTCACATGAGCCTGATGAACAGCGACTACAA 69 FBan0030128 FBgn0046879 Obp56c 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56c Odorant-binding protein 56c "CG15129, CG30128, CG15129, CG15129, CG15129, CG15129, OBP56c, 56c, Odorant-binding protein 56c" CDMC33868 2 1 8 DAC12-F14 18-CG30148-RA_1 CG30148 AGCTCGTCTTGAACCATTGTTTATGGAGCGTACTTTCCATGCTAATCCGCTCTTTTGGCTCACAGCTAA 69 FBan0030148 FBgn0050148 CG30148 2 2R carbohydrate metabolism; GO:0005975; defense response; GO:0006952; polysaccharide metabolism; GO:0005976 hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0015926 ; EC:3.2.1.- CG30148 CG30148 "CG13429, CG13429, CG13429, BcDNA:AT18611" CDMC33868 2 2 8 DAC12-F14 18-CG30148-RA_1 CG30148 AGCTCGTCTTGAACCATTGTTTATGGAGCGTACTTTCCATGCTAATCCGCTCTTTTGGCTCACAGCTAA 69 FBan0030148 FBgn0050148 CG30148 2 2R carbohydrate metabolism; GO:0005975; defense response; GO:0006952; polysaccharide metabolism; GO:0005976 hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0015926 ; EC:3.2.1.- CG30148 CG30148 "CG13429, CG13429, CG13429, BcDNA:AT18611" CDMC33869 2 3 8 DAC12-J02 15-CG30176-RA_1 CG30176 AGTCCACTCAGATACTGCTACGAGTATATCCTCTCACCTCGTGAACAAATCACCGACCAGAAGTCGCGC 69 FBan0030176 FBgn0034918 wibg 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 wibg within bgcn "CG30176, CG10330, UD3, undefined 3, BEST:HL05757, within bgcn" CDMC33869 2 4 8 DAC12-J02 15-CG30176-RA_1 CG30176 AGTCCACTCAGATACTGCTACGAGTATATCCTCTCACCTCGTGAACAAATCACCGACCAGAAGTCGCGC 69 FBan0030176 FBgn0034918 wibg 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 wibg within bgcn "CG30176, CG10330, UD3, undefined 3, BEST:HL05757, within bgcn" CDMC33870 2 5 8 DAC12-J14 14-CG30186-RA_2 CG30186 TGCGGTTCGAATCTCGGCAGTTCTGCTCTCACTGATAACCAGATGGTATCAGCGTTCCAGATTCATTCG 69 FBan0030186 FBgn0041235 Gr59c 2 2R protein amino acid prenylation; GO:0018346; sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- Gr59c Gustatory receptor 59c "CG13543, CG30186, CG13543, 59D.2, Gustatory receptor 59D.2, Gr59D2, 59D2, GR59D.2, Gustatory receptor 59c" CDMC33870 2 6 8 DAC12-J14 14-CG30186-RA_2 CG30186 TGCGGTTCGAATCTCGGCAGTTCTGCTCTCACTGATAACCAGATGGTATCAGCGTTCCAGATTCATTCG 69 FBan0030186 FBgn0041235 Gr59c 2 2R protein amino acid prenylation; GO:0018346; sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; protein prenyltransferase activity; GO:0008318 ; EC:2.5.1.-; ; GO:0008318 ; EC:2.5.1.- Gr59c Gustatory receptor 59c "CG13543, CG30186, CG13543, 59D.2, Gustatory receptor 59D.2, Gr59D2, 59D2, GR59D.2, Gustatory receptor 59c" CDMC33871 2 7 8 DAC12-N02 13-CG30271-RC_1 CG30271 GGACGTGGGAAAACCCGAGGAGTCTGCTACTGAGAGTGAGCTTGAAGGAAACAAAAAGACTGAAGTGGA 69 FBan0030271 FBgn0050271 CG30271 2 2R CG30271 CG30271 "CG13528, CG13528, BcDNA:AT17081" CDMC33871 2 8 8 DAC12-N02 13-CG30271-RC_1 CG30271 GGACGTGGGAAAACCCGAGGAGTCTGCTACTGAGAGTGAGCTTGAAGGAAACAAAAAGACTGAAGTGGA 69 FBan0030271 FBgn0050271 CG30271 2 2R CG30271 CG30271 "CG13528, CG13528, BcDNA:AT17081" CDMC33872 2 9 8 DAC12-N14 3-CG30282-RA_1 CG30282 CCAGCCATGTGGGTGACTCCTCCTGGTTGGTTAATCATTTGTTTCCTTTTCCCCAGCCTCGAGTGCAAT 69 FBan0030282 FBgn0050282 CG30282 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30282 CG30282 BcDNA:LD42239 CDMC33872 2 10 8 DAC12-N14 3-CG30282-RA_1 CG30282 CCAGCCATGTGGGTGACTCCTCCTGGTTGGTTAATCATTTGTTTCCTTTTCCCCAGCCTCGAGTGCAAT 69 FBan0030282 FBgn0050282 CG30282 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30282 CG30282 BcDNA:LD42239 CDMC33873 2 11 8 DAC13-B02 1-CG13216-RA_1 CG13216 CGGTGGAGCCAATCCAGGATTGTATCCAGCACCTCAGGTCAACATGCAGGGATTGTATCCACCAT 65 FBan0013216 FBgn0033591 CG13216 2 2R CG13216 CG13216 CDMC33873 2 12 8 DAC13-B02 1-CG13216-RA_1 CG13216 CGGTGGAGCCAATCCAGGATTGTATCCAGCACCTCAGGTCAACATGCAGGGATTGTATCCACCAT 65 FBan0013216 FBgn0033591 CG13216 2 2R CG13216 CG13216 CDMC33874 2 13 8 DAC13-B14 14-CG13231-RA_1 CG13231 CCCACCATCCGGTGTCTTCGGTGTCCTATCACCTGCCCACCTACCACTCCATCCACCACTTCTAA 65 FBan0013231 FBgn0033580 CG13231 2 2R CG13231 CG13231 CDMC33874 2 14 8 DAC13-B14 14-CG13231-RA_1 CG13231 CCCACCATCCGGTGTCTTCGGTGTCCTATCACCTGCCCACCTACCACTCCATCCACCACTTCTAA 65 FBan0013231 FBgn0033580 CG13231 2 2R CG13231 CG13231 CDMC33875 2 15 8 DAC13-F02 14-CG13379-RA_1 CG13379 ACTAGCACTACGATTGTAAACCACTTCCGGGAGTTGATCAAGGAACCGAAGAACCTCGACGAGGC 65 FBan0013379 FBgn0036804 CG13379 3 3L CG13379 CG13379 CDMC33875 2 16 8 DAC13-F02 14-CG13379-RA_1 CG13379 ACTAGCACTACGATTGTAAACCACTTCCGGGAGTTGATCAAGGAACCGAAGAACCTCGACGAGGC 65 FBan0013379 FBgn0036804 CG13379 3 3L CG13379 CG13379 CDMC33876 2 17 8 DAC13-F14 23-CG13426-RA_4 CG13426 AGTCTGTGGAACGCATTAAATGCCAGATTAAGGATCTGCTGATCTTAATGGTTCCGTCCAAGGAT 65 FBan0013426 FBgn0034510 CG13426 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0015450 translocon complex; GO:0005784 CG13426 CG13426 CDMC33876 2 18 8 DAC13-F14 23-CG13426-RA_4 CG13426 AGTCTGTGGAACGCATTAAATGCCAGATTAAGGATCTGCTGATCTTAATGGTTCCGTCCAAGGAT 65 FBan0013426 FBgn0034510 CG13426 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0015450 translocon complex; GO:0005784 CG13426 CG13426 CDMC33877 2 19 8 DAC13-J02 1-CG13521-RB_1 CG13521 AGAGGCCCAGACACTTTTCCACTAAACCCCGGATCGTGAGTTGAATTGGGAAAAAAGGGGGCTCG 65 FBan0013521 FBgn0005631 robo 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell adhesion; GO:0007155; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; neuron recognition; GO:0008038; tracheal epithelial cell migration (sensu Insecta); GO:0007427 receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004872 endosome; GO:0005768; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 robo roundabout "CG13521, CG13521, CG13521, D-Robo1, Robo1, dRobo1, robo1, dRobo, Robo, CT32892, Robo-1, Roundabout 1, BEST:GM07780" CDMC33877 2 20 8 DAC13-J02 1-CG13521-RB_1 CG13521 AGAGGCCCAGACACTTTTCCACTAAACCCCGGATCGTGAGTTGAATTGGGAAAAAAGGGGGCTCG 65 FBan0013521 FBgn0005631 robo 2 2R axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; cell adhesion; GO:0007155; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; neuron recognition; GO:0008038; tracheal epithelial cell migration (sensu Insecta); GO:0007427 receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004872 endosome; GO:0005768; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 robo roundabout "CG13521, CG13521, CG13521, D-Robo1, Robo1, dRobo1, robo1, dRobo, Robo, CT32892, Robo-1, Roundabout 1, BEST:GM07780" CDMC33878 2 21 8 DAC13-J14 23-CG13548-RA_1 CG13548 AACCCGCTTTATCATCAAAGGGAAATCAAGCTGTCAGTCAATTTATAGTTATACCCACATCCACG 65 FBan0013548 FBgn0034832 CG13548 2 2R CG13548 CG13548 CDMC33878 2 22 8 DAC13-J14 23-CG13548-RA_1 CG13548 AACCCGCTTTATCATCAAAGGGAAATCAAGCTGTCAGTCAATTTATAGTTATACCCACATCCACG 65 FBan0013548 FBgn0034832 CG13548 2 2R CG13548 CG13548 CDMC33879 2 23 8 DAC13-N02 1-CG13647-RA_1 CG13647 GGATGGCATCGGATGGGGCAGACTATGCTTGGCATGCATTCAACACACGATACTTGGCATTCCAG 65 FBan0013647 FBgn0039256 CG13647 3 3R CG13647 CG13647 CDMC33879 2 24 8 DAC13-N02 1-CG13647-RA_1 CG13647 GGATGGCATCGGATGGGGCAGACTATGCTTGGCATGCATTCAACACACGATACTTGGCATTCCAG 65 FBan0013647 FBgn0039256 CG13647 3 3R CG13647 CG13647 CDMC33880 2 25 8 DAC13-N14 19-CG13674-RA_2 CG13674 CTGCCTACACCGCCCCCATTGCCCGTTATGCCGCCACCCCCTTCGCAGCACCCATCGCCGCTCCC 65 FBan0013674 FBgn0035858 CG13674 3 3L CG13674 CG13674 CDMC33880 2 26 8 DAC13-N14 19-CG13674-RA_2 CG13674 CTGCCTACACCGCCCCCATTGCCCGTTATGCCGCCACCCCCTTCGCAGCACCCATCGCCGCTCCC 65 FBan0013674 FBgn0035858 CG13674 3 3L CG13674 CG13674 CDMC33881 2 1 9 DAC14-B02 2-CG1647-RA_3 CG1647 CCCCAGCACTACAAATGAACCTCATTCCCACACAGTGGAAAATGTCCAGTCTCCTGCAAACGACCTCCA 69 FBan0001647 FBgn0039602 CG1647 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1647 CG1647 CDMC33881 2 2 9 DAC14-B02 2-CG1647-RA_3 CG1647 CCCCAGCACTACAAATGAACCTCATTCCCACACAGTGGAAAATGTCCAGTCTCCTGCAAACGACCTCCA 69 FBan0001647 FBgn0039602 CG1647 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1647 CG1647 CDMC33882 2 3 9 DAC14-B14 23-CG1657-RA_9 CG1657 GCTTAGGCGGATGTATCTGTAGATTTCTTTATCGCTTTGTTGTAGGCATTACACCAATCTCCCATCCCA 69 FBan0001657 FBgn0030286 CG1657 X X phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; transport; GO:0006810 Rab guanyl-nucleotide exchange factor activity; GO:0017112; sugar porter activity; GO:0005351; ; GO:0017112; ; GO:0005351 CG1657 CG1657 CDMC33882 2 4 9 DAC14-B14 23-CG1657-RA_9 CG1657 GCTTAGGCGGATGTATCTGTAGATTTCTTTATCGCTTTGTTGTAGGCATTACACCAATCTCCCATCCCA 69 FBan0001657 FBgn0030286 CG1657 X X phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; transport; GO:0006810 Rab guanyl-nucleotide exchange factor activity; GO:0017112; sugar porter activity; GO:0005351; ; GO:0017112; ; GO:0005351 CG1657 CG1657 CDMC33883 2 5 9 DAC14-F02 23-CG16720-RB_16 CG16720 ATAACCGTGTTAGGCGCTAGACTCTATCTCTCTTCTCTGCTTCAGAAAAATTGGAAAATGGAAAATGGA 69 FBan0016720 FBgn0004168 5-HT1A 2 2R "serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase inhibiting pathway; GO:0007198; serotonin receptor, phospholipase C activating pathway; GO:0007208; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT1 receptor activity; GO:0001586; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001586 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 5-HT1A Serotonin receptor 1A "CG16720, CG16720, 5HT-dro2A, 5HT-drp[[2A]], 5HT1A, serotonin-receptor-2A, 5-HT1ADro, 5htdro2a, DRO2A, 5-HT-dro2A, 5-HT[[1ADro]], Dm5HTdro2A, 5HT[[1ADro]], 5HT-R2A: Serotonin receptor 2A, Serotonin receptor 2A" CDMC33883 2 6 9 DAC14-F02 23-CG16720-RB_16 CG16720 ATAACCGTGTTAGGCGCTAGACTCTATCTCTCTTCTCTGCTTCAGAAAAATTGGAAAATGGAAAATGGA 69 FBan0016720 FBgn0004168 5-HT1A 2 2R "serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase inhibiting pathway; GO:0007198; serotonin receptor, phospholipase C activating pathway; GO:0007208; transmission of nerve impulse; GO:0019226" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT1 receptor activity; GO:0001586; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001586 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 5-HT1A Serotonin receptor 1A "CG16720, CG16720, 5HT-dro2A, 5HT-drp[[2A]], 5HT1A, serotonin-receptor-2A, 5-HT1ADro, 5htdro2a, DRO2A, 5-HT-dro2A, 5-HT[[1ADro]], Dm5HTdro2A, 5HT[[1ADro]], 5HT-R2A: Serotonin receptor 2A, Serotonin receptor 2A" CDMC33884 2 7 9 DAC14-F14 2-CG16733-RA_2 CG16733 GCCAGATTCCTGGGCGTTCAAAGTCTCCTCGATGTGAGCACTTTGCAGAAATTGTGCGATCACCTCACA 69 FBan0016733 FBgn0037665 CG16733 3 3R aryl sulfotransferase activity; GO:0004062 ; EC:2.8.2.1; retinol dehydratase activity; GO:0017051; ; GO:0017051; ; GO:0004062 ; EC:2.8.2.1 CG16733 CG16733 CDMC33884 2 8 9 DAC14-F14 2-CG16733-RA_2 CG16733 GCCAGATTCCTGGGCGTTCAAAGTCTCCTCGATGTGAGCACTTTGCAGAAATTGTGCGATCACCTCACA 69 FBan0016733 FBgn0037665 CG16733 3 3R aryl sulfotransferase activity; GO:0004062 ; EC:2.8.2.1; retinol dehydratase activity; GO:0017051; ; GO:0017051; ; GO:0004062 ; EC:2.8.2.1 CG16733 CG16733 CDMC33885 2 9 9 DAC14-J02 2-CG16757-RA_1 CG16757 GCCACAAGCAGCAATCGTGATCTCAACAGCTCGTACGACTCTATCCTGGGCTCCAACGATAAGCTAGCG 69 FBan0016757 FBgn0010905 Spn 3 3L protein phosphatase 1 binding; GO:0008157; ; GO:0008157 Spn Spinophilin "CG16757, l(3)06911, EL62, d-spinophilin, c62E-5, BcDNA:GM16129, E62, Spinophilin" CDMC33885 2 10 9 DAC14-J02 2-CG16757-RA_1 CG16757 GCCACAAGCAGCAATCGTGATCTCAACAGCTCGTACGACTCTATCCTGGGCTCCAACGATAAGCTAGCG 69 FBan0016757 FBgn0010905 Spn 3 3L protein phosphatase 1 binding; GO:0008157; ; GO:0008157 Spn Spinophilin "CG16757, l(3)06911, EL62, d-spinophilin, c62E-5, BcDNA:GM16129, E62, Spinophilin" CDMC33886 2 11 9 DAC14-J14 9-CG16782-RA_2 CG16782 CCCAGTGAACATCCTTACGCCTTTACAGCCTGTGTTTTCGGTTTCTGTCATGGACTCTTCGGTTTGGCC 69 FBan0016782 FBgn0029659 CG16782 X X CG16782 CG16782 CDMC33886 2 12 9 DAC14-J14 9-CG16782-RA_2 CG16782 CCCAGTGAACATCCTTACGCCTTTACAGCCTGTGTTTTCGGTTTCTGTCATGGACTCTTCGGTTTGGCC 69 FBan0016782 FBgn0029659 CG16782 X X CG16782 CG16782 CDMC33887 2 13 9 DAC14-N02 3-CG16826-RA_3 CG16826 AGCCACGTTTGAGCAAAATGTCCAAGAGGCCATCGAAAAGTACCACAATGCCACCAACGAACTGACGGA 69 FBan0016826 FBgn0032505 CG16826 2 2L CG16826 CG16826 CDMC33887 2 14 9 DAC14-N02 3-CG16826-RA_3 CG16826 AGCCACGTTTGAGCAAAATGTCCAAGAGGCCATCGAAAAGTACCACAATGCCACCAACGAACTGACGGA 69 FBan0016826 FBgn0032505 CG16826 2 2L CG16826 CG16826 CDMC33888 2 15 9 DAC14-N14 2-CG16838-RC_1 CG16838 TCCCGTTGACTTCAGCCTCTTGCGTTTGAATCTCCCCGATCTTATGGCTAGTTCGGCGATGCTAAAGGA 69 FBan0016838 FBgn0036574 CG16838 3 3L nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG16838 CG16838 CDMC33888 2 16 9 DAC14-N14 2-CG16838-RC_1 CG16838 TCCCGTTGACTTCAGCCTCTTGCGTTTGAATCTCCCCGATCTTATGGCTAGTTCGGCGATGCTAAAGGA 69 FBan0016838 FBgn0036574 CG16838 3 3L nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG16838 CG16838 CDMC33889 2 17 9 DAC15-B02 17-CG18607-RA_1 CG18607 CCCGATAATGTGAATGCAGGAACATTGAATTTGAAGCTCGAGAATGTGGAGGATAACGCTTGGGGTCGA 69 FBan0018607 FBgn0034429 CG18607 2 2R CG18607 CG18607 CDMC33889 2 18 9 DAC15-B02 17-CG18607-RA_1 CG18607 CCCGATAATGTGAATGCAGGAACATTGAATTTGAAGCTCGAGAATGTGGAGGATAACGCTTGGGGTCGA 69 FBan0018607 FBgn0034429 CG18607 2 2R CG18607 CG18607 CDMC33890 2 19 9 DAC15-B14 9-CG1862-RA_1 CG1862 ACGGTGCAGCGATATAGTCCTGGAATGGTTGAAATCACCGCGACCTCTATGAACGGGATGTTTGACCAG 69 FBan0001862 FBgn0040324 Ephrin 4 4 axon guidance; GO:0007411 ephrin receptor binding; GO:0046875; ; GO:0046875; ; GO:0046875 integral to plasma membrane; GO:0005887; membrane; GO:0016020 Ephrin Ephrin "CG1862, CG1862, CG1862, CG1862, ephrin, Dephrin" CDMC33890 2 20 9 DAC15-B14 9-CG1862-RA_1 CG1862 ACGGTGCAGCGATATAGTCCTGGAATGGTTGAAATCACCGCGACCTCTATGAACGGGATGTTTGACCAG 69 FBan0001862 FBgn0040324 Ephrin 4 4 axon guidance; GO:0007411 ephrin receptor binding; GO:0046875; ; GO:0046875; ; GO:0046875 integral to plasma membrane; GO:0005887; membrane; GO:0016020 Ephrin Ephrin "CG1862, CG1862, CG1862, CG1862, ephrin, Dephrin" CDMC33891 2 21 9 DAC15-F02 16-CG18682-RA_4 CG18682 CGTATGTGTACAGCGAATGATCTGTCAGTATCTGCAGCAAAACCTATCATCCGGATATGCCAGGGCTCT 69 FBan0018682 FBgn0040625 CG18682 3 3R CG18682 CG18682 CDMC33891 2 22 9 DAC15-F02 16-CG18682-RA_4 CG18682 CGTATGTGTACAGCGAATGATCTGTCAGTATCTGCAGCAAAACCTATCATCCGGATATGCCAGGGCTCT 69 FBan0018682 FBgn0040625 CG18682 3 3R CG18682 CG18682 CDMC33892 2 23 9 DAC15-F14 9-CG18744-RA_3 CG18744 GCGAGGCGGTGTATTCCCTCGTTCAGATCAGCACTTACGTTGCCCATCTAAAGAATAAGCCCAAACGCT 69 FBan0018744 FBgn0042101 CG18744 3 3R CG18744 CG18744 CDMC33892 2 24 9 DAC15-F14 9-CG18744-RA_3 CG18744 GCGAGGCGGTGTATTCCCTCGTTCAGATCAGCACTTACGTTGCCCATCTAAAGAATAAGCCCAAACGCT 69 FBan0018744 FBgn0042101 CG18744 3 3R CG18744 CG18744 CDMC33893 2 25 9 DAC15-J02 11-CG18806-RA_1 CG18806 ACACCCTGGACTTCGATGATTCATTCGAGCTGAACAGACTGGAGGATGCTCTTGAGGAACTGGAAAGCA 69 FBan0018806 FBgn0042129 CG18806 2 2L CG18806 CG18806 CDMC33893 2 26 9 DAC15-J02 11-CG18806-RA_1 CG18806 ACACCCTGGACTTCGATGATTCATTCGAGCTGAACAGACTGGAGGATGCTCTTGAGGAACTGGAAAGCA 69 FBan0018806 FBgn0042129 CG18806 2 2L CG18806 CG18806 CDMC33894 2 1 10 DAC15-J14 16-CG18815-RA_1 CG18815 AGCCCGTTGCATTCCAACTATTCACGCAATATGGAGCGCAGTAAGAGAGTCACACTGAGAGTTATACGA 69 FBan0018815 FBgn0042138 CG18815 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-" CG18815 CG18815 anon-EST:Posey232 CDMC33894 2 2 10 DAC15-J14 16-CG18815-RA_1 CG18815 AGCCCGTTGCATTCCAACTATTCACGCAATATGGAGCGCAGTAAGAGAGTCACACTGAGAGTTATACGA 69 FBan0018815 FBgn0042138 CG18815 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.-" CG18815 CG18815 anon-EST:Posey232 CDMC33895 2 3 10 DAC15-N02 17-CG1901-RA_2 CG1901 GGCGACGCGGATATTCACCAAATCATGCTGACCAATAATAGAAGCGATCAATACGTGCATCACCGTTCA 69 FBan0001901 FBgn0039914 mav 4 4 cellular physiological process; GO:0050875; growth; GO:0040007; transforming growth factor beta receptor signaling pathway; GO:0007179 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160; ; GO:0005160 mav maverick "CG1901, TGF-b, Mav, maverick" CDMC33895 2 4 10 DAC15-N02 17-CG1901-RA_2 CG1901 GGCGACGCGGATATTCACCAAATCATGCTGACCAATAATAGAAGCGATCAATACGTGCATCACCGTTCA 69 FBan0001901 FBgn0039914 mav 4 4 cellular physiological process; GO:0050875; growth; GO:0040007; transforming growth factor beta receptor signaling pathway; GO:0007179 transforming growth factor beta receptor binding; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160; ; GO:0005160 mav maverick "CG1901, TGF-b, Mav, maverick" CDMC33896 2 5 10 DAC15-N14 2-CG1908-RA_1 CG1908 CCCTTGGCGCCTATAACCCAAACCGTAGTGGCTGAGTTGTCACAAGTACCTCCATCACCACAAGCAGAA 69 FBan0001908 FBgn0030274 CG1908 X X CG1908 CG1908 CDMC33896 2 6 10 DAC15-N14 2-CG1908-RA_1 CG1908 CCCTTGGCGCCTATAACCCAAACCGTAGTGGCTGAGTTGTCACAAGTACCTCCATCACCACAAGCAGAA 69 FBan0001908 FBgn0030274 CG1908 X X CG1908 CG1908 CDMC33897 2 7 10 DAC16-B02 22-CG32734-RA_2 CG32734 CGCCAGGTGAGCTGTAACCAATCCGTCAATGCACTCAGAGAAAAGTAGAGAGATCAAAAGGGCTAAACA 69 FBgn0052734 CG32734 CG32734 CG32734 CDMC33897 2 8 10 DAC16-B02 22-CG32734-RA_2 CG32734 CGCCAGGTGAGCTGTAACCAATCCGTCAATGCACTCAGAGAAAAGTAGAGAGATCAAAAGGGCTAAACA 69 FBgn0052734 CG32734 CG32734 CG32734 CDMC33898 2 9 10 DAC16-B14 24-CG32744-RA_2 CG32744 GCATAACTCAAGAATTCATACTAAGTTTTAGTAAATTGGTTTATTCAAAGGCACAAAATAATCAATCAC 69 FBan0032744 FBgn0052744 CG32744 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 CG32744 CG32744 "CG18282, CG18282, CG18282" CDMC33898 2 10 10 DAC16-B14 24-CG32744-RA_2 CG32744 GCATAACTCAAGAATTCATACTAAGTTTTAGTAAATTGGTTTATTCAAAGGCACAAAATAATCAATCAC 69 FBan0032744 FBgn0052744 CG32744 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 CG32744 CG32744 "CG18282, CG18282, CG18282" CDMC33899 2 11 10 DAC16-F02 1-CG32786-RA_14 CG32786 TGTGGTATTGGCAGGACGAATGCCGCCAGAGGATCTTGAACCAAGTGAACAGTTTAAAGCACAAGGGCT 69 FBan0032786 FBgn0052786 CG32786 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32786 CG32786 CDMC33899 2 12 10 DAC16-F02 1-CG32786-RA_14 CG32786 TGTGGTATTGGCAGGACGAATGCCGCCAGAGGATCTTGAACCAAGTGAACAGTTTAAAGCACAAGGGCT 69 FBan0032786 FBgn0052786 CG32786 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32786 CG32786 CDMC33900 2 13 10 DAC16-F14 23-CG32796-RB_13 CG32796 GGCACCCGGTACTGTTTAGTTTTCCAAAAAACCAATTAATTTGGCCAATCATTAAGCTTAGAACTAGGG 69 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC33900 2 14 10 DAC16-F14 23-CG32796-RB_13 CG32796 GGCACCCGGTACTGTTTAGTTTTCCAAAAAACCAATTAATTTGGCCAATCATTAAGCTTAGAACTAGGG 69 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC33901 2 15 10 DAC16-J02 46-CG32820-RA_1 CG32820 ACCCAAAGTAAAGGGATCTCCGAGGAAGAGAAGTGGTAATATATCGAGTCCGTCGACAAATGCTCTGCT 69 FBan0032820 FBgn0052820 CG32820 X X microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG32820 CG32820 CDMC33901 2 16 10 DAC16-J02 46-CG32820-RA_1 CG32820 ACCCAAAGTAAAGGGATCTCCGAGGAAGAGAAGTGGTAATATATCGAGTCCGTCGACAAATGCTCTGCT 69 FBan0032820 FBgn0052820 CG32820 X X microtubule cytoskeleton organization and biogenesis; GO:0000226 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 microtubule; GO:0005874 CG32820 CG32820 CDMC33902 2 17 10 DAC16-J14 23-CG32835-RA_7 CG32835 TGAGACCACTTCGCTGCATCTCTTGATTAACAAACCGTGGTGCATATGTGCTTTTGATCAGAGATTAAT 69 FBan0032835 FBgn0052835 CG32835 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32835 CG32835 NEST:bs16h07 CDMC33902 2 18 10 DAC16-J14 23-CG32835-RA_7 CG32835 TGAGACCACTTCGCTGCATCTCTTGATTAACAAACCGTGGTGCATATGTGCTTTTGATCAGAGATTAAT 69 FBan0032835 FBgn0052835 CG32835 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32835 CG32835 NEST:bs16h07 CDMC33903 2 19 10 DAC16-N02 23-CG32912-RB_2 CG32912 GGACTGCGGTCACTACAAAGAATGATAAGAAGTCCACGGATTAGTCGGGTTTTTTCTCAAATCCACATT 69 FBgn0052912 CDMC33903 2 20 10 DAC16-N02 23-CG32912-RB_2 CG32912 GGACTGCGGTCACTACAAAGAATGATAAGAAGTCCACGGATTAGTCGGGTTTTTTCTCAAATCCACATT 69 FBgn0052912 CDMC33904 2 21 10 DAC16-N14 3-CG3292-RA_1 CG3292 AGGCTCTGGATATAACCGATCCCGAAGAGACCCTGATTGTAGTCACCTCCGATCACGCCCATCCATTGA 69 FBan0003292 FBgn0034710 CG3292 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3292 CG3292 CDMC33904 2 22 10 DAC16-N14 3-CG3292-RA_1 CG3292 AGGCTCTGGATATAACCGATCCCGAAGAGACCCTGATTGTAGTCACCTCCGATCACGCCCATCCATTGA 69 FBan0003292 FBgn0034710 CG3292 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3292 CG3292 CDMC33905 2 23 10 DAC17-B02 3-CG12265-RA_3 CG12265 GAAAAGCTGGAGGTCTTTCGCAAGCTGAACCTCCTGGAACAGCATCGCGTGGAGAGCTACAAGAG 65 FBan0012265 FBgn0038489 CG12265 3 3R anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066 intracellular; GO:0005622 CG12265 CG12265 CDMC33905 2 24 10 DAC17-B02 3-CG12265-RA_3 CG12265 GAAAAGCTGGAGGTCTTTCGCAAGCTGAACCTCCTGGAACAGCATCGCGTGGAGAGCTACAAGAG 65 FBan0012265 FBgn0038489 CG12265 3 3R anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066 intracellular; GO:0005622 CG12265 CG12265 CDMC33906 2 25 10 DAC17-B14 2-CG12298-RA_2 CG12298 AGATCGTGGGCAACAAAGGCCATGTGTTCATCAAGGGTCTGACCAGTGTTTTCGTGACGAGCAGC 65 FBan0012298 FBgn0003545 sub 2 2R cell cycle; GO:0007049; female meiosis chromosome segregation; GO:0016321; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; mitosis; GO:0007067; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871; plus-end kinesin complex; GO:0005873 sub subito "CG12298, CG12298, CG12298, CG12298, Dub, Double or nothing, double-or-nothing, mei-1794, KIF20A" CDMC33906 2 26 10 DAC17-B14 2-CG12298-RA_2 CG12298 AGATCGTGGGCAACAAAGGCCATGTGTTCATCAAGGGTCTGACCAGTGTTTTCGTGACGAGCAGC 65 FBan0012298 FBgn0003545 sub 2 2R cell cycle; GO:0007049; female meiosis chromosome segregation; GO:0016321; meiotic spindle organization and biogenesis; GO:0000212; microtubule-based movement; GO:0007018; mitosis; GO:0007067; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 kinesin complex; GO:0005871; plus-end kinesin complex; GO:0005873 sub subito "CG12298, CG12298, CG12298, CG12298, Dub, Double or nothing, double-or-nothing, mei-1794, KIF20A" CDMC33907 2 1 11 DAC17-F02 1-CG12462-RA_1 CG12462 ATTGCTGTTGTTGCTGTTGTTGCGTCGTCTCGTGGTTGTCGTTGTCGGCCACTTCATCATCGACA 65 FBan0012462 FBgn0029675 CG12462 X X CG12462 CG12462 CDMC33907 2 2 11 DAC17-F02 1-CG12462-RA_1 CG12462 ATTGCTGTTGTTGCTGTTGTTGCGTCGTCTCGTGGTTGTCGTTGTCGGCCACTTCATCATCGACA 65 FBan0012462 FBgn0029675 CG12462 X X CG12462 CG12462 CDMC33908 2 3 11 DAC17-F14 6-CG12492-RA_7 CG12492 GATACCCACTGATCGCGAGGTGTCGGTCATTGCAGCAATCGGACCACTTAATGCCCGAAAGGAGG 65 FBan0012492 FBgn0039123 CG12492 3 3R CG12492 CG12492 CDMC33908 2 4 11 DAC17-F14 6-CG12492-RA_7 CG12492 GATACCCACTGATCGCGAGGTGTCGGTCATTGCAGCAATCGGACCACTTAATGCCCGAAAGGAGG 65 FBan0012492 FBgn0039123 CG12492 3 3R CG12492 CG12492 CDMC33909 2 5 11 DAC17-J02 2-CG12589-RA_1 CG12589 ATGGATGAGCACGGAGAATTGGAGAAAGTGGGTCAGCCTGAGAATTTGGTAGCGATGGTGCTGCG 65 FBan0012589 FBgn0040684 CG12589 3 3R CG12589 CG12589 CDMC33909 2 6 11 DAC17-J02 2-CG12589-RA_1 CG12589 ATGGATGAGCACGGAGAATTGGAGAAAGTGGGTCAGCCTGAGAATTTGGTAGCGATGGTGCTGCG 65 FBan0012589 FBgn0040684 CG12589 3 3R CG12589 CG12589 CDMC33910 2 7 11 DAC17-J14 2-CG12637-RA_1 CG12637 TTCGGTGGTGACTTTGCACACTTTTCGCAATGCAACCGAATTACCCCGTCTTTTGGCCACCGAAC 65 FBan0012637 FBgn0030224 CG12637 X X CG12637 CG12637 CDMC33910 2 8 11 DAC17-J14 2-CG12637-RA_1 CG12637 TTCGGTGGTGACTTTGCACACTTTTCGCAATGCAACCGAATTACCCCGTCTTTTGGCCACCGAAC 65 FBan0012637 FBgn0030224 CG12637 X X CG12637 CG12637 CDMC33911 2 9 11 DAC17-N02 23-CG12728-RA_1 CG12728 GAACGCTTTCAATTTCGTCATAAAGAAGGTTGAATCTTTAAAAGAGTTTTACGATGCCCCAAGGG 65 FBan0012728 FBgn0029825 CG12728 X X CG12728 CG12728 CDMC33911 2 10 11 DAC17-N02 23-CG12728-RA_1 CG12728 GAACGCTTTCAATTTCGTCATAAAGAAGGTTGAATCTTTAAAAGAGTTTTACGATGCCCCAAGGG 65 FBan0012728 FBgn0029825 CG12728 X X CG12728 CG12728 CDMC33912 2 11 11 DAC17-N14 9-CG12769-RA_2 CG12769 GAGTCCAATGGCGATAAGGTGAAAGATCGAGCCCTCATCATGCAATCCCCGGTGGAGTTGCCAAT 65 FBan0012769 FBgn0033252 CG12769 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12769 CG12769 CDMC33912 2 12 11 DAC17-N14 9-CG12769-RA_2 CG12769 GAGTCCAATGGCGATAAGGTGAAAGATCGAGCCCTCATCATGCAATCCCCGGTGGAGTTGCCAAT 65 FBan0012769 FBgn0033252 CG12769 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12769 CG12769 CDMC33913 2 13 11 DAC18-B02 2-CG5682-RA_1 CG5682 GCCAGAACCAAACAGCGTCGGTAGCACAGAAACCGGAAAAAGAATTGTAGTGGACTGCTACGGCTGC 67 FBan0005682 FBgn0032480 CG5682 2 2L protein amino acid N-linked glycosylation; GO:0006487; proteolysis; GO:0006508 "calcium ion binding; GO:0005509; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0005509; ; GO:0008233 ; EC:3.4.-.-; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG5682 CG5682 CDMC33913 2 14 11 DAC18-B02 2-CG5682-RA_1 CG5682 GCCAGAACCAAACAGCGTCGGTAGCACAGAAACCGGAAAAAGAATTGTAGTGGACTGCTACGGCTGC 67 FBan0005682 FBgn0032480 CG5682 2 2L protein amino acid N-linked glycosylation; GO:0006487; proteolysis; GO:0006508 "calcium ion binding; GO:0005509; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0005509; ; GO:0008233 ; EC:3.4.-.-; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; GO:0004571 ; EC:3.2.1.113; ; GO:0004571 ; EC:3.2.1.113" membrane; GO:0016020 CG5682 CG5682 CDMC33914 2 15 11 DAC18-B14 2-CG5741-RA_1 CG5741 TTTGCGCAGCCTTTCAGAGGTAAATTCGGAGAACGTCATCTATGACAGTGATGCGGAGAGCTCGGGC 67 FBan0005741 FBgn0035937 CG5741 3 3L CG5741 CG5741 CDMC33914 2 16 11 DAC18-B14 2-CG5741-RA_1 CG5741 TTTGCGCAGCCTTTCAGAGGTAAATTCGGAGAACGTCATCTATGACAGTGATGCGGAGAGCTCGGGC 67 FBan0005741 FBgn0035937 CG5741 3 3L CG5741 CG5741 CDMC33915 2 17 11 DAC18-F02 2-CG6384-RB_1 CG6384 ACTGCAGAAAAGCCGACACTAGAAAGTGCAAAAGCAGGTGATGAAGCAACGTCAGGTGAAGCAGCCA 67 FBan0006384 FBgn0000283 Cp190 3 3R microtubule-based process; GO:0007017 nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 centrosome; GO:0005813; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Cp190 Centrosomal protein 190kD "CG6384, CG6384, Cen185, Rb188, DMAP190, DMAP-190, Bx63, Cen190, Dmap190, CP190, CP-190, dmap190, CP-60, AbS1-4, Map190" CDMC33915 2 18 11 DAC18-F02 2-CG6384-RB_1 CG6384 ACTGCAGAAAAGCCGACACTAGAAAGTGCAAAAGCAGGTGATGAAGCAACGTCAGGTGAAGCAGCCA 67 FBan0006384 FBgn0000283 Cp190 3 3R microtubule-based process; GO:0007017 nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; ; GO:0008017; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 centrosome; GO:0005813; microtubule associated complex; GO:0005875; nucleus; GO:0005634 Cp190 Centrosomal protein 190kD "CG6384, CG6384, Cen185, Rb188, DMAP190, DMAP-190, Bx63, Cen190, Dmap190, CP190, CP-190, dmap190, CP-60, AbS1-4, Map190" CDMC33916 2 19 11 DAC18-F14 3-CG6540-RA_1 CG6540 GCAAAAGAGCTCCGGTCTGATGGACAAGGCCATGGACCTGATATTCGGCTGGTAAGAAGGGCTGATG 67 FBan0006540 FBgn0030943 CG6540 X X CG6540 CG6540 CDMC33916 2 20 11 DAC18-F14 3-CG6540-RA_1 CG6540 GCAAAAGAGCTCCGGTCTGATGGACAAGGCCATGGACCTGATATTCGGCTGGTAAGAAGGGCTGATG 67 FBan0006540 FBgn0030943 CG6540 X X CG6540 CG6540 CDMC33917 2 21 11 DAC18-J02 15-CG7094-RA_8 CG7094 GCCATTAAGGTGGAGAAGAACGATGCCAAGTACCCGCAGCTGATATACGAGGCGAAAGTGTACGAAC 67 FBan0007094 FBgn0032650 CG7094 2 2L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG7094 CG7094 CKIa-like CDMC33917 2 22 11 DAC18-J02 15-CG7094-RA_8 CG7094 GCCATTAAGGTGGAGAAGAACGATGCCAAGTACCCGCAGCTGATATACGAGGCGAAAGTGTACGAAC 67 FBan0007094 FBgn0032650 CG7094 2 2L intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase I activity; GO:0004681 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004681 ; EC:2.7.1.- CG7094 CG7094 CKIa-like CDMC33918 2 23 11 DAC18-J14 2-CG7183-RA_1 CG7183 ACGGAGCTACAGTGCGAATAACGAAGACGAAGCTGATGAACAACCGAGCACATCCAGTCGTGGCATG 67 FBan0007183 FBgn0038583 CG7183 3 3R CG7183 CG7183 CDMC33918 2 24 11 DAC18-J14 2-CG7183-RA_1 CG7183 ACGGAGCTACAGTGCGAATAACGAAGACGAAGCTGATGAACAACCGAGCACATCCAGTCGTGGCATG 67 FBan0007183 FBgn0038583 CG7183 3 3R CG7183 CG7183 CDMC33919 2 25 11 DAC18-N02 3-CG7769-RA_1 CG7769 ACGTTGGTGAGCGAACTACGCCGATCAATGGATGTGTTCTGTACGGAACATGCAACGGAGCCATTGG 67 FBan0007769 FBgn0027049 DDB1 3 3R "glycolysis; GO:0006096; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide-excision repair; GO:0006289" damaged DNA binding; GO:0003684; ; GO:0003684; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nucleus; GO:0005634 DDB1 DDB1 "CG7769, d-ddb1, Drosophila damage-specific DNA-binding protein 1, D-DDB1" CDMC33919 2 26 11 DAC18-N02 3-CG7769-RA_1 CG7769 ACGTTGGTGAGCGAACTACGCCGATCAATGGATGTGTTCTGTACGGAACATGCAACGGAGCCATTGG 67 FBan0007769 FBgn0027049 DDB1 3 3R "glycolysis; GO:0006096; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide-excision repair; GO:0006289" damaged DNA binding; GO:0003684; ; GO:0003684; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nucleus; GO:0005634 DDB1 DDB1 "CG7769, d-ddb1, Drosophila damage-specific DNA-binding protein 1, D-DDB1" CDMC33920 2 1 12 DAC18-N14 3-CG7907-RA_1 CG7907 TCTCCGCCACCTGAAGCGTGTCCAACAAAAGATCGAAGTCGTGGATGTCGATGATCCAAGTGCATGC 67 FBan0007907 FBgn0038887 CG7907 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 mRNA cap complex; GO:0005845; nucleus; GO:0005634; spliceosome complex; GO:0005681 CG7907 CG7907 CDMC33920 2 2 12 DAC18-N14 3-CG7907-RA_1 CG7907 TCTCCGCCACCTGAAGCGTGTCCAACAAAAGATCGAAGTCGTGGATGTCGATGATCCAAGTGCATGC 67 FBan0007907 FBgn0038887 CG7907 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; protein biosynthesis; GO:0006412" RNA cap binding; GO:0000339; ; GO:0000339; ; GO:0000339 mRNA cap complex; GO:0005845; nucleus; GO:0005634; spliceosome complex; GO:0005681 CG7907 CG7907 CDMC33921 2 3 12 DAC19-B02 9-CG7786-RA_1 CG7786 GCGGAACTGGAGTCCAAGAACAATCCGTCCTACTCCATTTCCATTCCCCAGAATCTTCGGCTAACCGG 68 FBan0007786 FBgn0034096 CG7786 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 CG7786 CG7786 CDMC33921 2 4 12 DAC19-B02 9-CG7786-RA_1 CG7786 GCGGAACTGGAGTCCAAGAACAATCCGTCCTACTCCATTTCCATTCCCCAGAATCTTCGGCTAACCGG 68 FBan0007786 FBgn0034096 CG7786 2 2R "regulation of transcription, DNA-dependent; GO:0006355; transcription; GO:0006350" protein homodimerization activity; GO:0042803; transcription factor activity; GO:0003700; ; GO:0042803; ; GO:0003700 nucleus; GO:0005634 CG7786 CG7786 CDMC33922 2 5 12 DAC19-B14 10-CG7918-RA_1 CG7918 TTGGGGGGGAAAACAAGCAATCCGATTTGGGATGCATACATAGGTCTAGAGTGGCACTAAGCGGGGCG 68 FBan0007918 FBgn0037546 CG7918 3 3R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981 integral to membrane; GO:0016021 CG7918 CG7918 "anon-WO0170980.92, anon-WO0170980.91" CDMC33922 2 6 12 DAC19-B14 10-CG7918-RA_1 CG7918 TTGGGGGGGAAAACAAGCAATCCGATTTGGGATGCATACATAGGTCTAGAGTGGCACTAAGCGGGGCG 68 FBan0007918 FBgn0037546 CG7918 3 3R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981 integral to membrane; GO:0016021 CG7918 CG7918 "anon-WO0170980.92, anon-WO0170980.91" CDMC33923 2 7 12 DAC19-F02 23-CG8493-RA_5 CG8493 CCCACAGCCGAGTAGTTTTTAAGTGACCAAATTACGAATGTAACTCGTTGCCGAAGAATGAGAGGAGC 68 FBan0008493 FBgn0033716 CG8493 2 2R CG8493 CG8493 CDMC33923 2 8 12 DAC19-F02 23-CG8493-RA_5 CG8493 CCCACAGCCGAGTAGTTTTTAAGTGACCAAATTACGAATGTAACTCGTTGCCGAAGAATGAGAGGAGC 68 FBan0008493 FBgn0033716 CG8493 2 2R CG8493 CG8493 CDMC33924 2 9 12 DAC19-F14 2-CG8616-RA_2 CG8616 CGCACAGCGACTCACCTACAACAGTTCCACACTGCCAATGATAGAGAGCATCGACGATCCCGATCTGG 68 FBan0008616 FBgn0035752 CG8616 3 3L CG8616 CG8616 CDMC33924 2 10 12 DAC19-F14 2-CG8616-RA_2 CG8616 CGCACAGCGACTCACCTACAACAGTTCCACACTGCCAATGATAGAGAGCATCGACGATCCCGATCTGG 68 FBan0008616 FBgn0035752 CG8616 3 3L CG8616 CG8616 CDMC33925 2 11 12 DAC19-J02 27-CG9059-RA_3 CG9059 GGGAAAGATGGTCCAGAATGCGGAGGAAATCCAAGCGGAGAGTCAGAATGTGAATGTGACGGATGGCC 68 FBan0009059 FBgn0030810 CG9059 X X cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG9059 CG9059 BcDNA:GH06235 CDMC33925 2 12 12 DAC19-J02 27-CG9059-RA_3 CG9059 GGGAAAGATGGTCCAGAATGCGGAGGAAATCCAAGCGGAGAGTCAGAATGTGAATGTGACGGATGGCC 68 FBan0009059 FBgn0030810 CG9059 X X cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG9059 CG9059 BcDNA:GH06235 CDMC33926 2 13 12 DAC19-J14 3-CG9227-RA_2 CG9227 CCGTTCAGGCAGTCTACGACGAAATGAGACAGAGCCTGAGCTGTCGGAATATCTTCCTCAGCGTTGGC 68 FBan0009227 FBgn0031783 CG9227 2 2L CG9227 CG9227 CDMC33926 2 14 12 DAC19-J14 3-CG9227-RA_2 CG9227 CCGTTCAGGCAGTCTACGACGAAATGAGACAGAGCCTGAGCTGTCGGAATATCTTCCTCAGCGTTGGC 68 FBan0009227 FBgn0031783 CG9227 2 2L CG9227 CG9227 CDMC33927 2 15 12 DAC19-N02 6-CG9635-RF_1 CG9635 ACGAACGCGATATGGAAAGGGAGCGATTGCGTAAAGAGAATCAACACCTTCGCGAGCTCTTGAGTGCG 68 FBan0009635 FBgn0023172 RhoGEF2 2 2R DNA methylation; GO:0006306; actin filament organization; GO:0007015; anterior midgut invagination; GO:0007375; apoptosis; GO:0006915; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellularization (sensu Metazoa); GO:0009796; cytoskeleton organization and biogenesis; GO:0007010; gastrulation; GO:0007369; germ-band extension; GO:0007377; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phagocytosis; GO:0006909; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360; shape changes of embryonic cells; GO:0016476; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 DNA binding; GO:0003677; diacylglycerol binding; GO:0019992; Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0019992; protein binding; GO:0005515; ; GO:0005089; ; GO:0003677; ; GO:0005515 RhoGEF2 RhoGEF2 "CG9635, CG9635, shar, shar pei, DRhoGEF2, Su(Rho1)2B, T2, l(2)04291, Transcription unit 2, DRhoGEF, dRhoGEF, Shar pei, rhoGEF2, DrhoGEF2, RhoGef2, dRhoGEF2, RhoGEF, akkordion" CDMC33927 2 16 12 DAC19-N02 6-CG9635-RF_1 CG9635 ACGAACGCGATATGGAAAGGGAGCGATTGCGTAAAGAGAATCAACACCTTCGCGAGCTCTTGAGTGCG 68 FBan0009635 FBgn0023172 RhoGEF2 2 2R DNA methylation; GO:0006306; actin filament organization; GO:0007015; anterior midgut invagination; GO:0007375; apoptosis; GO:0006915; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellularization (sensu Metazoa); GO:0009796; cytoskeleton organization and biogenesis; GO:0007010; gastrulation; GO:0007369; germ-band extension; GO:0007377; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; phagocytosis; GO:0006909; posterior midgut invagination; GO:0007374; regulation of axonogenesis; GO:0050770; regulation of cell shape; GO:0008360; shape changes of embryonic cells; GO:0016476; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 DNA binding; GO:0003677; diacylglycerol binding; GO:0019992; Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0019992; protein binding; GO:0005515; ; GO:0005089; ; GO:0003677; ; GO:0005515 RhoGEF2 RhoGEF2 "CG9635, CG9635, shar, shar pei, DRhoGEF2, Su(Rho1)2B, T2, l(2)04291, Transcription unit 2, DRhoGEF, dRhoGEF, Shar pei, rhoGEF2, DrhoGEF2, RhoGef2, dRhoGEF2, RhoGEF, akkordion" CDMC33928 2 17 12 DAC19-N14 1-CG9895-RA_3 CG9895 GCCTCTTGGACACTCGTCTCCATCTCCATCTCCGTCTCCAACTTCGACTTCGACTCTTGGAGTCTCCG 68 FBan0009895 FBgn0034810 CG9895 2 2R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 CG9895 CG9895 CDMC33928 2 18 12 DAC19-N14 1-CG9895-RA_3 CG9895 GCCTCTTGGACACTCGTCTCCATCTCCATCTCCGTCTCCAACTTCGACTTCGACTCTTGGAGTCTCCG 68 FBan0009895 FBgn0034810 CG9895 2 2R regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 CG9895 CG9895 CDMC33929 2 19 12 DAC20-B02 23-CG18024-RA_3 CG18024 TCCACTCACCTTTTGCTGTACAAAACATTCTCAGACATTAAATGTGCGTTCAATTGAAGGGAGCAACGG 69 FBan0018024 FBgn0029123 SoxN 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 SoxN SoxNeuro "CG18024, CG18024, SOX29F, SOXB1, Sox B1, soxneuro, soxN, SoxNeuro" CDMC33929 2 20 12 DAC20-B02 23-CG18024-RA_3 CG18024 TCCACTCACCTTTTGCTGTACAAAACATTCTCAGACATTAAATGTGCGTTCAATTGAAGGGAGCAACGG 69 FBan0018024 FBgn0029123 SoxN 2 2L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0005515 nucleus; GO:0005634 SoxN SoxNeuro "CG18024, CG18024, SOX29F, SOXB1, Sox B1, soxneuro, soxN, SoxNeuro" CDMC33930 2 21 12 DAC20-B14 23-CG18042-RA_17 CG18042 CGGAAAGGGTCAATTAGACGACATTTCTTCAAGAGTCAATTCAAATTCAAGTGCAGAAAGATCCCACAC 69 FBan0018042 FBgn0029004 lmg 2 2L mitotic anaphase; GO:0000090; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 anaphase-promoting complex; GO:0005680 lmg lemming "CG18042, CG18042, CG18042, CG18042, l(2)03424, lemming" CDMC33930 2 22 12 DAC20-B14 23-CG18042-RA_17 CG18042 CGGAAAGGGTCAATTAGACGACATTTCTTCAAGAGTCAATTCAAATTCAAGTGCAGAAAGATCCCACAC 69 FBan0018042 FBgn0029004 lmg 2 2L mitotic anaphase; GO:0000090; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 anaphase-promoting complex; GO:0005680 lmg lemming "CG18042, CG18042, CG18042, CG18042, l(2)03424, lemming" CDMC33931 2 23 12 DAC20-F02 3-CG18103-RB_1 CG18103 TGCCTTGTCTACTCTCCTGACCGAGGGATTTTTGGAACCGAAAAGGATCTCGTTGGGATTGGCTCCTCC 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC33931 2 24 12 DAC20-F02 3-CG18103-RB_1 CG18103 TGCCTTGTCTACTCTCCTGACCGAGGGATTTTTGGAACCGAAAAGGATCTCGTTGGGATTGGCTCCTCC 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC33932 2 25 12 DAC20-F14 23-CG18125-RA_2 CG18125 AGGAGTAAACCTTTACATTCAATGGCCGTACTATTGTGGATTAACTGAACCGTCAAGAATATGCGCCGG 69 FBan0018125 FBgn0028917 CG18125 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18125 CG18125 "BG:DS01068.10, DS01068.10, SPH190" CDMC33932 2 26 12 DAC20-F14 23-CG18125-RA_2 CG18125 AGGAGTAAACCTTTACATTCAATGGCCGTACTATTGTGGATTAACTGAACCGTCAAGAATATGCGCCGG 69 FBan0018125 FBgn0028917 CG18125 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18125 CG18125 "BG:DS01068.10, DS01068.10, SPH190" CDMC33933 2 1 13 DAC20-J02 22-CG18186-RA_1 CG18186 GCTTGGGTGTCCGAAACGTCAAGGAGAAATCTTCGGAATACATAGTGGAGAAGTTTCTAGGAAAGCGCT 69 FBan0018186 FBgn0034255 CG18186 2 2R CG18186 CG18186 CDMC33933 2 2 13 DAC20-J02 22-CG18186-RA_1 CG18186 GCTTGGGTGTCCGAAACGTCAAGGAGAAATCTTCGGAATACATAGTGGAGAAGTTTCTAGGAAAGCGCT 69 FBan0018186 FBgn0034255 CG18186 2 2R CG18186 CG18186 CDMC33934 2 3 13 DAC20-J14 3-CG18210-RA_1 CG18210 CGCATCAAGAGGAACGTTGCCACCCACAAGTCCCACTTTCAGTGTTCCGTAATTGCGTATCCGCGTTTT 69 FBan0018210 FBgn0030636 CG18210 X X CG18210 CG18210 CDMC33934 2 4 13 DAC20-J14 3-CG18210-RA_1 CG18210 CGCATCAAGAGGAACGTTGCCACCCACAAGTCCCACTTTCAGTGTTCCGTAATTGCGTATCCGCGTTTT 69 FBan0018210 FBgn0030636 CG18210 X X CG18210 CG18210 CDMC33935 2 5 13 DAC20-N02 23-CG18255-RA_1 CG18255 CCTCCGTTCAGAGGGAACTGTACTTAGGCTAGAGGAAGCTAAGTGTTTAAATTATTGTATCGATTTATA 69 CDMC33935 2 6 13 DAC20-N02 23-CG18255-RA_1 CG18255 CCTCCGTTCAGAGGGAACTGTACTTAGGCTAGAGGAAGCTAAGTGTTTAAATTATTGTATCGATTTATA 69 CDMC33936 2 7 13 DAC20-N14 12-CG18266-RA_5 CG18266 GAGGAGGCCAACGATGCATTGCTAAATGGCAGAATGAGCTTCACAGACGAGAAGGCGAAAGTTGAGGAT 69 FBan0018266 FBgn0031724 CG18266 2 2L CG18266 CG18266 anon-WO0140519.54 CDMC33936 2 8 13 DAC20-N14 12-CG18266-RA_5 CG18266 GAGGAGGCCAACGATGCATTGCTAAATGGCAGAATGAGCTTCACAGACGAGAAGGCGAAAGTTGAGGAT 69 FBan0018266 FBgn0031724 CG18266 2 2L CG18266 CG18266 anon-WO0140519.54 CDMC33937 2 9 13 DAC21-B02 12-CG3883-RA_7 CG3883 GGACAGCTGGCATCTCAAAGTGGTTACCTACATGCAGAGTGCCTGTTTTTGATCAAGAGACGCCTAGCG 69 FBan0003883 FBgn0031281 CG3883 2 2L CG3883 CG3883 CDMC33937 2 10 13 DAC21-B02 12-CG3883-RA_7 CG3883 GGACAGCTGGCATCTCAAAGTGGTTACCTACATGCAGAGTGCCTGTTTTTGATCAAGAGACGCCTAGCG 69 FBan0003883 FBgn0031281 CG3883 2 2L CG3883 CG3883 CDMC33938 2 11 13 DAC21-B14 22-CG3905-RA_1 CG3905 GGCAATCAAACAAATTGAAGGCCTCGGATCGACCTCCAGCTATTCCAATAATAACTTTGGCTCCGACTC 69 FBan0003905 FBgn0008654 Su(z)2 2 2R protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intercalary heterochromatin; GO:0005725; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Su(z)2 Suppressor of zeste 2 "CG3905, Arp, Aristopedoid, l(2)k06344, su(z)2, Su(z)[[2]], SUZ2" CDMC33938 2 12 13 DAC21-B14 22-CG3905-RA_1 CG3905 GGCAATCAAACAAATTGAAGGCCTCGGATCGACCTCCAGCTATTCCAATAATAACTTTGGCTCCGACTC 69 FBan0003905 FBgn0008654 Su(z)2 2 2R protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 intercalary heterochromatin; GO:0005725; nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Su(z)2 Suppressor of zeste 2 "CG3905, Arp, Aristopedoid, l(2)k06344, su(z)2, Su(z)[[2]], SUZ2" CDMC33939 2 13 13 DAC21-F02 9-CG3940-RA_3 CG3940 AGGTAGCATCATCAAGAGTTTGGGAGCCGTTAAGAGCTACGATAGCATGAACAAGCCCGTTCTGGTGGC 69 FBan0003940 FBgn0037788 CG3940 3 3R one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG3940 CG3940 CDMC33939 2 14 13 DAC21-F02 9-CG3940-RA_3 CG3940 AGGTAGCATCATCAAGAGTTTGGGAGCCGTTAAGAGCTACGATAGCATGAACAAGCCCGTTCTGGTGGC 69 FBan0003940 FBgn0037788 CG3940 3 3R one-carbon compound metabolism; GO:0006730 carbonate dehydratase activity; GO:0004089 ; EC:4.2.1.1; zinc ion binding; GO:0008270; ; GO:0004089 ; EC:4.2.1.1; ; GO:0008270 CG3940 CG3940 CDMC33940 2 15 13 DAC21-F14 23-CG3949-RA_1 CG3949 GCGACTGCTAGTCTAGTAACCCTTTAGATTTAAGTGAACATTCGTACAAAGTGGTAATTTCAAATTGAA 69 FBan0003949 FBgn0015393 hoip 2 2L "nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; protein biosynthesis; GO:0006412" mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729 nucleus; GO:0005634; ribosome; GO:0005840; small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 hoip hoi-polloi "CG3949, CG3949" CDMC33940 2 16 13 DAC21-F14 23-CG3949-RA_1 CG3949 GCGACTGCTAGTCTAGTAACCCTTTAGATTTAAGTGAACATTCGTACAAAGTGGTAATTTCAAATTGAA 69 FBan0003949 FBgn0015393 hoip 2 2L "nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; protein biosynthesis; GO:0006412" mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729 nucleus; GO:0005634; ribosome; GO:0005840; small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 hoip hoi-polloi "CG3949, CG3949" CDMC33941 2 17 13 DAC21-J02 23-CG3985-RC_7 CG3985 ATCTAGTCTGAACCAACTGGACAACAATAACAAACCAAAAATATATTCGAAAATGTAGCGATCCCATGC 69 FBan0003985 FBgn0004575 Syn 3 3R neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079 synapse; GO:0045202; synaptic vesicle; GO:0008021; terminal button; GO:0043195 Syn Synapsin "CG3985, CG3985, synapsin, Dsyn-1, SYN1, SYN2, syn" CDMC33941 2 18 13 DAC21-J02 23-CG3985-RC_7 CG3985 ATCTAGTCTGAACCAACTGGACAACAATAACAAACCAAAAATATATTCGAAAATGTAGCGATCCCATGC 69 FBan0003985 FBgn0004575 Syn 3 3R neurotransmitter secretion; GO:0007269; synaptic vesicle exocytosis; GO:0016079 synapse; GO:0045202; synaptic vesicle; GO:0008021; terminal button; GO:0043195 Syn Synapsin "CG3985, CG3985, synapsin, Dsyn-1, SYN1, SYN2, syn" CDMC33942 2 19 13 DAC21-J14 9-CG3997-RA_3 CG3997 GGCTAAGAAGCTGAAGCAGAACAGATCCGTTCCCCAATGGGTTCGCCTACGTACTGGCAACACTATTCG 69 FBan0003997 FBgn0023170 RpL39 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL39 Ribosomal protein L39 "CG3997, rp46, Rp46, L39, RPl46, RpL46: Ribosomal protein L46, BcDNA:RH27094, anon-EST:Posey16, Ribosomal protein L46, RpL46, Ribosomal protein L39" CDMC33942 2 20 13 DAC21-J14 9-CG3997-RA_3 CG3997 GGCTAAGAAGCTGAAGCAGAACAGATCCGTTCCCCAATGGGTTCGCCTACGTACTGGCAACACTATTCG 69 FBan0003997 FBgn0023170 RpL39 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL39 Ribosomal protein L39 "CG3997, rp46, Rp46, L39, RPl46, RpL46: Ribosomal protein L46, BcDNA:RH27094, anon-EST:Posey16, Ribosomal protein L46, RpL46, Ribosomal protein L39" CDMC33943 2 21 13 DAC21-N02 23-CG40084-RD_1 CG40084 TTCCCCAACAAATATGAATAGGTCTCCCGATTTTGTGTATAACAGTGTCGACGAAGCCATCCAAGACGA 69 FBgn0058084 CG40084 CG40084 CG40084 CDMC33943 2 22 13 DAC21-N02 23-CG40084-RD_1 CG40084 TTCCCCAACAAATATGAATAGGTCTCCCGATTTTGTGTATAACAGTGTCGACGAAGCCATCCAAGACGA 69 FBgn0058084 CG40084 CG40084 CG40084 CDMC33944 2 23 13 DAC21-N14 1-CG40100-RA_2 CG40100 ACTTCCGCATATATCCGGCGCACGACTATAAAGGTCAAATGGAAAGCAGTGTGTGGGAGGAGAAGCGGT 69 FBgn0058100 CG40100 CG40100 CG40100 CDMC33944 2 24 13 DAC21-N14 1-CG40100-RA_2 CG40100 ACTTCCGCATATATCCGGCGCACGACTATAAAGGTCAAATGGAAAGCAGTGTGTGGGAGGAGAAGCGGT 69 FBgn0058100 CG40100 CG40100 CG40100 CDMC33945 2 25 13 DAC22-B02 1-CG13727-RA_1 CG13727 CCAGCAGTGGATTACTCCTACAGCTCCTACCCCATCGACTCCCACGAGATAGTCTCCCACAAGGG 65 FBan0013727 FBgn0036711 CG13727 3 3L CG13727 CG13727 CDMC33945 2 26 13 DAC22-B02 1-CG13727-RA_1 CG13727 CCAGCAGTGGATTACTCCTACAGCTCCTACCCCATCGACTCCCACGAGATAGTCTCCCACAAGGG 65 FBan0013727 FBgn0036711 CG13727 3 3L CG13727 CG13727 CDMC33946 2 1 14 DAC22-B14 18-CG13749-RA_3 CG13749 TCCCTCAGCTGCCGATCTCCAGCGGACATACGACGGACATGATGGGCCTCACGTTTTCGGAACAC 65 FBan0013749 FBgn0033353 CG13749 2 2R CG13749 CG13749 CDMC33946 2 2 14 DAC22-B14 18-CG13749-RA_3 CG13749 TCCCTCAGCTGCCGATCTCCAGCGGACATACGACGGACATGATGGGCCTCACGTTTTCGGAACAC 65 FBan0013749 FBgn0033353 CG13749 2 2R CG13749 CG13749 CDMC33947 2 3 14 DAC22-F02 19-CG13814-RA_1 CG13814 CAGCATGCAGACACTGGGCCCAAATGGACAGCCGCAGTCATCCGCCGCGCAGACGAGCACCAGGG 65 FBan0013814 FBgn0036960 CG13814 3 3L CG13814 CG13814 CDMC33947 2 4 14 DAC22-F02 19-CG13814-RA_1 CG13814 CAGCATGCAGACACTGGGCCCAAATGGACAGCCGCAGTCATCCGCCGCGCAGACGAGCACCAGGG 65 FBan0013814 FBgn0036960 CG13814 3 3L CG13814 CG13814 CDMC33948 2 5 14 DAC22-F14 15-CG13849-RA_1 CG13849 ACTAGCGTGTTTGGCGAAACTCTTAAGCAACAGGTCGAAGATCGCCTCAAGTTCTACGAGTCCGG 65 FBan0013849 FBgn0038964 Nop56 3 3R rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; small nuclear ribonucleoprotein complex; GO:0030532 Nop56 Nop56 "CG13849, CG13849, FBgn0038964" CDMC33948 2 6 14 DAC22-F14 15-CG13849-RA_1 CG13849 ACTAGCGTGTTTGGCGAAACTCTTAAGCAACAGGTCGAAGATCGCCTCAAGTTCTACGAGTCCGG 65 FBan0013849 FBgn0038964 Nop56 3 3R rRNA metabolism; GO:0016072 mRNA binding; GO:0003729; ; GO:0003729 nucleolus; GO:0005730; small nuclear ribonucleoprotein complex; GO:0030532 Nop56 Nop56 "CG13849, CG13849, FBgn0038964" CDMC33949 2 7 14 DAC22-J02 6-CG13929-RB_2 CG13929 CAAATCCTCCGGAGATTGGCCAGCAAAAGTTGGGAACACACTCGCCAGCGTAAAAAACCGTCGGG 65 FBan0013929 FBgn0035247 metl 3 3L biological process unknown; GO:0000004 S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 cellular component unknown; GO:0008372 metl methyltransferase-like "CG13929, anon-EST:Posey109, methyltransferase-like" CDMC33949 2 8 14 DAC22-J02 6-CG13929-RB_2 CG13929 CAAATCCTCCGGAGATTGGCCAGCAAAAGTTGGGAACACACTCGCCAGCGTAAAAAACCGTCGGG 65 FBan0013929 FBgn0035247 metl 3 3L biological process unknown; GO:0000004 S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 cellular component unknown; GO:0008372 metl methyltransferase-like "CG13929, anon-EST:Posey109, methyltransferase-like" CDMC33950 2 9 14 DAC22-J14 19-CG13947-RA_1 CG13947 CAACGACCACCGAATCCAGCACCAGCACAACCACGGAAGCCAGCACCGAGTCATCCCCTGCTTAA 65 FBan0013947 FBgn0031277 CG13947 2 2L CG13947 CG13947 CDMC33950 2 10 14 DAC22-J14 19-CG13947-RA_1 CG13947 CAACGACCACCGAATCCAGCACCAGCACAACCACGGAAGCCAGCACCGAGTCATCCCCTGCTTAA 65 FBan0013947 FBgn0031277 CG13947 2 2L CG13947 CG13947 CDMC33951 2 11 14 DAC22-N02 23-CG14007-RA_2 CG14007 GCAGATTAACTTGGGCCTTCTTATCATTCTCACTCTATTGGGCTGTTTCTATATATTGTTTGTGG 65 FBan0014007 FBgn0031731 CG14007 2 2L CG14007 CG14007 CDMC33951 2 12 14 DAC22-N02 23-CG14007-RA_2 CG14007 GCAGATTAACTTGGGCCTTCTTATCATTCTCACTCTATTGGGCTGTTTCTATATATTGTTTGTGG 65 FBan0014007 FBgn0031731 CG14007 2 2L CG14007 CG14007 CDMC33952 2 13 14 DAC22-N14 3-CG14053-RA_4 CG14053 TGAACCGGAACCACGTGGGAACTCCGAGCATCAACCAAGTCGCTTTTCGTTTTTTGGCATGTTGC 65 FBan0014053 FBgn0029603 CG14053 X X CG14053 CG14053 BcDNA:AT10359 CDMC33952 2 14 14 DAC22-N14 3-CG14053-RA_4 CG14053 TGAACCGGAACCACGTGGGAACTCCGAGCATCAACCAAGTCGCTTTTCGTTTTTTGGCATGTTGC 65 FBan0014053 FBgn0029603 CG14053 X X CG14053 CG14053 BcDNA:AT10359 CDMC33953 2 15 14 DAC23-B02 18-CG4605-RA_4 CG4605 GCTGCGACGGATAACCCCAATGACGACCACGCTACATCTGCTGATAATAGTTTGGCTACCGATGG 65 FBan0004605 FBgn0023415 Acp32CD 2 2L "negative regulation of female receptivity, post-mating; GO:0045434" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp32CD Accessory gland-specific peptide 32CD "CG4605, Accessory gland protein 32CD" CDMC33953 2 16 14 DAC23-B02 18-CG4605-RA_4 CG4605 GCTGCGACGGATAACCCCAATGACGACCACGCTACATCTGCTGATAATAGTTTGGCTACCGATGG 65 FBan0004605 FBgn0023415 Acp32CD 2 2L "negative regulation of female receptivity, post-mating; GO:0045434" hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 Acp32CD Accessory gland-specific peptide 32CD "CG4605, Accessory gland protein 32CD" CDMC33954 2 17 14 DAC23-B14 6-CG4659-RA_8 CG4659 CCCAGGACGGTGTGGATATGTTCAAACGCGAGGGTTTCGAGATGATCATTGTGGACACCTCGGGT 65 FBan0004659 FBgn0010747 Srp54k 3 3L "SRP-dependent cotranslational protein targeting to membrane; GO:0006614; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; GO:0006617; protein targeting; GO:0006605" GTP binding; GO:0005525; mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; signal sequence binding; GO:0005048; ; GO:0003729; ; GO:0005048; nucleotide binding; GO:0000166; ; GO:0008312; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0005525; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 signal recognition particle (sensu Eukaryota); GO:0005786 Srp54k Signal recognition particle protein 54k "CG4659, l(3)01418, Srp54, BcDNA.GM09489, BcDNA:GM09489, Signal recognition particle protein 54k" CDMC33954 2 18 14 DAC23-B14 6-CG4659-RA_8 CG4659 CCCAGGACGGTGTGGATATGTTCAAACGCGAGGGTTTCGAGATGATCATTGTGGACACCTCGGGT 65 FBan0004659 FBgn0010747 Srp54k 3 3L "SRP-dependent cotranslational protein targeting to membrane; GO:0006614; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; GO:0006617; protein targeting; GO:0006605" GTP binding; GO:0005525; mRNA binding; GO:0003729; 7S RNA binding; GO:0008312; signal sequence binding; GO:0005048; ; GO:0003729; ; GO:0005048; nucleotide binding; GO:0000166; ; GO:0008312; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0005525; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 signal recognition particle (sensu Eukaryota); GO:0005786 Srp54k Signal recognition particle protein 54k "CG4659, l(3)01418, Srp54, BcDNA.GM09489, BcDNA:GM09489, Signal recognition particle protein 54k" CDMC33955 2 19 14 DAC23-F02 2-CG4830-RA_1 CG4830 GACTCAGGCCACGGTTGAGAGGGTCAAGAAGCTTGCTCCTAATGGAGTGCTGAACTCGTCCTACG 65 FBan0004830 FBgn0037996 CG4830 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG4830 CG4830 CDMC33955 2 20 14 DAC23-F02 2-CG4830-RA_1 CG4830 GACTCAGGCCACGGTTGAGAGGGTCAAGAAGCTTGCTCCTAATGGAGTGCTGAACTCGTCCTACG 65 FBan0004830 FBgn0037996 CG4830 3 3R metabolism; GO:0008152 long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG4830 CG4830 CDMC33956 2 21 14 DAC23-F14 1-CG4884-RA_1 CG4884 GCGCCCACACAAAATGCTCCGGACTTTTCGTCAAATAGCCCGACTAGGAAGATCCCTAAGGACGC 65 FBan0004884 FBgn0039565 CG4884 3 3R CG4884 CG4884 CDMC33956 2 22 14 DAC23-F14 1-CG4884-RA_1 CG4884 GCGCCCACACAAAATGCTCCGGACTTTTCGTCAAATAGCCCGACTAGGAAGATCCCTAAGGACGC 65 FBan0004884 FBgn0039565 CG4884 3 3R CG4884 CG4884 CDMC33957 2 23 14 DAC23-J02 15-CG5072-RA_3 CG5072 TCGAACATGTGGAGCAGGATCTTTCGGATCTTATAGACAGACTTCCCAAATCGGGCATGTCGCCG 65 FBan0005072 FBgn0016131 Cdk4 2 2R JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; cell cycle; GO:0007049; cell growth; GO:0016049; cell proliferation; GO:0008283; mitochondrion organization and biogenesis; GO:0007005; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell growth; GO:0001558; regulation of progression through cell cycle; GO:0000074; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; cyclin binding; GO:0030332; ; GO:0030332 Cdk4 Cyclin-dependent kinase 4 "CG5072, CG5072, 8-6, cdk4/6, l(2)05428, DmCdk4, cdk4, l(2)k06503, l(2)s4639, CDK4, CDK4/6, Cdk4/6: Cyclin-dependent kinase 4/6, l(2)sh0671, l(2)0671, Pk53C, Pk?7, Cyclin-dependent kinase 4/6, Protein kinase-like 53C, Cdk4/6" CDMC33957 2 24 14 DAC23-J02 15-CG5072-RA_3 CG5072 TCGAACATGTGGAGCAGGATCTTTCGGATCTTATAGACAGACTTCCCAAATCGGGCATGTCGCCG 65 FBan0005072 FBgn0016131 Cdk4 2 2R JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; cell cycle; GO:0007049; cell growth; GO:0016049; cell proliferation; GO:0008283; mitochondrion organization and biogenesis; GO:0007005; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of cell growth; GO:0001558; regulation of progression through cell cycle; GO:0000074; tracheal system development (sensu Insecta); GO:0007424 ATP binding; GO:0005524; ; GO:0005524; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; cyclin binding; GO:0030332; ; GO:0030332 Cdk4 Cyclin-dependent kinase 4 "CG5072, CG5072, 8-6, cdk4/6, l(2)05428, DmCdk4, cdk4, l(2)k06503, l(2)s4639, CDK4, CDK4/6, Cdk4/6: Cyclin-dependent kinase 4/6, l(2)sh0671, l(2)0671, Pk53C, Pk?7, Cyclin-dependent kinase 4/6, Protein kinase-like 53C, Cdk4/6" CDMC33958 2 25 14 DAC23-J14 5-CG5131-RA_1 CG5131 CGAGCACCGAAGAAACCACCACTGCTCAAAAGGATTGGGGCTACGACCTTTATCCGGAGCGAAGG 65 FBan0005131 FBgn0032644 CG5131 2 2L proteolysis; GO:0006508 KU70 binding; GO:0017170; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0017170; ; GO:0008270 CG5131 CG5131 CDMC33958 2 26 14 DAC23-J14 5-CG5131-RA_1 CG5131 CGAGCACCGAAGAAACCACCACTGCTCAAAAGGATTGGGGCTACGACCTTTATCCGGAGCGAAGG 65 FBan0005131 FBgn0032644 CG5131 2 2L proteolysis; GO:0006508 KU70 binding; GO:0017170; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0017170; ; GO:0008270 CG5131 CG5131 CDMC33959 2 1 15 DAC23-N02 5-CG5224-RA_2 CG5224 GTACTATGTCGGCCAAACCCATCCTCTATTACGCTCCCCGTAGTCCCCCCTGTCGTGCTGTTCTG 65 FBan0005224 FBgn0034354 CG5224 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG5224 CG5224 CDMC33959 2 2 15 DAC23-N02 5-CG5224-RA_2 CG5224 GTACTATGTCGGCCAAACCCATCCTCTATTACGCTCCCCGTAGTCCCCCCTGTCGTGCTGTTCTG 65 FBan0005224 FBgn0034354 CG5224 2 2R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 CG5224 CG5224 CDMC33960 2 3 15 DAC23-N14 23-CG5273-RB_1 CG5273 CATTTATGTAGTCTTGTCTCCACTCGTCTAAGGGTGAAGCACTAATCCGGATCACATGATGGCCT 65 FBan0005273 FBgn0040382 CG5273 X X CG5273 CG5273 EG:BACR19J1.3 CDMC33960 2 4 15 DAC23-N14 23-CG5273-RB_1 CG5273 CATTTATGTAGTCTTGTCTCCACTCGTCTAAGGGTGAAGCACTAATCCGGATCACATGATGGCCT 65 FBan0005273 FBgn0040382 CG5273 X X CG5273 CG5273 EG:BACR19J1.3 CDMC33961 2 5 15 DAC24-B02 23-CG9175-RA_2 CG9175 GTTATTCGATTTGCATTATTAGTTTGTAAACAGGGTTTAGTTTTCTGCAATAAGCCACAACTCCTCCCC 69 FBan0009175 FBgn0031779 CG9175 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG9175 CG9175 CDMC33961 2 6 15 DAC24-B02 23-CG9175-RA_2 CG9175 GTTATTCGATTTGCATTATTAGTTTGTAAACAGGGTTTAGTTTTCTGCAATAAGCCACAACTCCTCCCC 69 FBan0009175 FBgn0031779 CG9175 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG9175 CG9175 CDMC33962 2 7 15 DAC24-B14 18-CG9191-RA_8 CG9191 GGCGTTGCCAACTGTTCGATGCTTCAGGTGCACATGAAGAATCTCAACCAGAAATACGAAAAGGAAACA 69 FBan0009191 FBgn0004378 Klp61F 3 3L cell cycle; GO:0007049; centrosome separation; GO:0051299; microtubule-based movement; GO:0007018; mitotic centrosome separation; GO:0007100; mitotic spindle organization and biogenesis; GO:0007052; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; plus-end kinesin complex; GO:0005873; spindle; GO:0005819 Klp61F Kinesin-like protein at 61F "CG9191, CG9191, urchin, KLP2, KLP61F, urcn, KRP[[130]], KRP[[(130)]], Kinesin-related protein-130kD, DmKRP130, DmKlp61F, KRP130, DmKLP61F, 6345, KLP61, Klp61F/KRP130, kinesin-like protein, KIP8, klp61f, Klp2, Krp130, l(3)07012, urc" CDMC33962 2 8 15 DAC24-B14 18-CG9191-RA_8 CG9191 GGCGTTGCCAACTGTTCGATGCTTCAGGTGCACATGAAGAATCTCAACCAGAAATACGAAAAGGAAACA 69 FBan0009191 FBgn0004378 Klp61F 3 3L cell cycle; GO:0007049; centrosome separation; GO:0051299; microtubule-based movement; GO:0007018; mitotic centrosome separation; GO:0007100; mitotic spindle organization and biogenesis; GO:0007052; protein targeting; GO:0006605 ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003774; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 cytoplasm; GO:0005737; kinesin complex; GO:0005871; microtubule associated complex; GO:0005875; plus-end kinesin complex; GO:0005873; spindle; GO:0005819 Klp61F Kinesin-like protein at 61F "CG9191, CG9191, urchin, KLP2, KLP61F, urcn, KRP[[130]], KRP[[(130)]], Kinesin-related protein-130kD, DmKRP130, DmKlp61F, KRP130, DmKLP61F, 6345, KLP61, Klp61F/KRP130, kinesin-like protein, KIP8, klp61f, Klp2, Krp130, l(3)07012, urc" CDMC33963 2 9 15 DAC24-F02 9-CG9232-RA_5 CG9232 AGGTTGACATTGGGCTTGTCCCGTGAATCTGAAGTAGTCATAATCCGATCGGAGTGATACGGAGCGCCA 69 FBan0009232 FBgn0031845 CG9232 2 2L galactose metabolism; GO:0006012 UDP-glucose:hexose-1-phosphate uridylyltransferase activity; GO:0008108 ; EC:2.7.7.12; UTP:hexose-1-phosphate uridylyltransferase activity; GO:0003982 ; EC:2.7.7.10; ; GO:0008108 ; EC:2.7.7.12; ; GO:0008108 ; EC:2.7.7.12; ; GO:0003982 ; EC:2.7.7.10 cellular component unknown; GO:0008372 CG9232 CG9232 CDMC33963 2 10 15 DAC24-F02 9-CG9232-RA_5 CG9232 AGGTTGACATTGGGCTTGTCCCGTGAATCTGAAGTAGTCATAATCCGATCGGAGTGATACGGAGCGCCA 69 FBan0009232 FBgn0031845 CG9232 2 2L galactose metabolism; GO:0006012 UDP-glucose:hexose-1-phosphate uridylyltransferase activity; GO:0008108 ; EC:2.7.7.12; UTP:hexose-1-phosphate uridylyltransferase activity; GO:0003982 ; EC:2.7.7.10; ; GO:0008108 ; EC:2.7.7.12; ; GO:0008108 ; EC:2.7.7.12; ; GO:0003982 ; EC:2.7.7.10 cellular component unknown; GO:0008372 CG9232 CG9232 CDMC33964 2 11 15 DAC24-F14 2-CG9244-RB_1 CG9244 TGGCCCAGTAAATGGTCCTGGACCTACTTAAGACACCCAGTCAAGAAGCCTGATCCCAACCTTCTTCCT 69 FBan0009244 FBgn0010100 Acon 2 2L amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3 mitochondrion; GO:0005739 Acon Aconitase "CG9244, CG9244, CG9244, ACON-1, AconM, mAc, mitochondrial aconitase, aconitase, m-Aconitase, i59, i204, FBgn0010100, m-acon, l(2)07054, BEST:GH10550" CDMC33964 2 12 15 DAC24-F14 2-CG9244-RB_1 CG9244 TGGCCCAGTAAATGGTCCTGGACCTACTTAAGACACCCAGTCAAGAAGCCTGATCCCAACCTTCTTCCT 69 FBan0009244 FBgn0010100 Acon 2 2L amino acid biosynthesis; GO:0008652; tricarboxylic acid cycle; GO:0006099 aconitate hydratase activity; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3; ; GO:0003994 ; EC:4.2.1.3 mitochondrion; GO:0005739 Acon Aconitase "CG9244, CG9244, CG9244, ACON-1, AconM, mAc, mitochondrial aconitase, aconitase, m-Aconitase, i59, i204, FBgn0010100, m-acon, l(2)07054, BEST:GH10550" CDMC33965 2 13 15 DAC24-J02 10-CG9280-RC_1 CG9280 TGGACGGCTACCATATCCCTCATACGAACAATATGGTCCTGAAGGCAACGAAAATCTCCCCGAAACCGA 69 FBan0009280 FBgn0001114 Glt 2 2L calcium ion binding; GO:0005509; catalytic activity; GO:0003824; ; GO:0005509; ; GO:0003824 basement membrane; GO:0005604 Glt Glutactin "CG9280, glutactin, CT26441" CDMC33965 2 14 15 DAC24-J02 10-CG9280-RC_1 CG9280 TGGACGGCTACCATATCCCTCATACGAACAATATGGTCCTGAAGGCAACGAAAATCTCCCCGAAACCGA 69 FBan0009280 FBgn0001114 Glt 2 2L calcium ion binding; GO:0005509; catalytic activity; GO:0003824; ; GO:0005509; ; GO:0003824 basement membrane; GO:0005604 Glt Glutactin "CG9280, glutactin, CT26441" CDMC33966 2 15 15 DAC24-J14 23-CG9291-RA_2 CG9291 GGCCAGACTGCGTAAAGCTTAATTTGCCCATGTTAATTTGGTAATAAAACGAGAAGATTGTCCCTGCGA 69 FBan0009291 FBgn0023211 Elongin-C 2 2R transcription from RNA polymerase II promoter; GO:0006366 transcriptional elongation regulator activity; GO:0003711; ; GO:0003711 transcription elongation factor complex; GO:0008023 Elongin-C Elongin C "CG9291, CG9291, d-elongin C, l(2)SH1299, BcDNA:RH71704, Elongin C" CDMC33966 2 16 15 DAC24-J14 23-CG9291-RA_2 CG9291 GGCCAGACTGCGTAAAGCTTAATTTGCCCATGTTAATTTGGTAATAAAACGAGAAGATTGTCCCTGCGA 69 FBan0009291 FBgn0023211 Elongin-C 2 2R transcription from RNA polymerase II promoter; GO:0006366 transcriptional elongation regulator activity; GO:0003711; ; GO:0003711 transcription elongation factor complex; GO:0008023 Elongin-C Elongin C "CG9291, CG9291, d-elongin C, l(2)SH1299, BcDNA:RH71704, Elongin C" CDMC33967 2 17 15 DAC24-N02 23-CG9325-RA_3 CG9325 GCCGATGGAATTGTCAGCTCGTAGATACATATTATGATTTTGATGGAAAATTTACATCTTCGCTTTTGT 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC33967 2 18 15 DAC24-N02 23-CG9325-RA_3 CG9325 GCCGATGGAATTGTCAGCTCGTAGATACATATTATGATTTTGATGGAAAATTTACATCTTCGCTTTTGT 69 FBan0009325 FBgn0004873 hts 2 2R "cystoblast division; GO:0007282; female germ-line cyst formation; GO:0048135; fusome organization and biogenesis; GO:0045478; germ-line cyst formation; GO:0048134; oocyte fate determination (sensu Insecta); GO:0007294; ovarian fusome organization and biogenesis; GO:0030723; protein complex assembly; GO:0006461; ring canal formation, actin assembly; GO:0008302; spectrosome organization and biogenesis; GO:0030721" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 fusome; GO:0045169; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183; spectrosome; GO:0045170 hts hu li tai shao "CG9325, CG9325, CG9325, CG9325, CG9325, Add, Adducin-like-56D, l(2)00634, l(2)k06121, l(2)k14523, Adducin-like 56D, hu-li tai shao, Adducin-like, Add-hts, ADD-87, HTS-RC, EST D, htsRC, Adducin, Hts, HtsRC, HtsF, HTS, Ovhts, 1B1, adducin, l(2)01103, anon-EST:Posey9" CDMC33968 2 19 15 DAC24-N14 16-CG9331-RC_1 CG9331 GCCCGCCTACTAGTAAATTCAAATGGGAAATATGGCTTTCTACCGCTAACCAGTTTGGAATGTCCGCCA 69 FBan0009331 FBgn0032889 CG9331 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016614 ; EC:1.1.-.-; ; GO:0016616 ; EC:1.1.1.-" CG9331 CG9331 CDMC33968 2 20 15 DAC24-N14 16-CG9331-RC_1 CG9331 GCCCGCCTACTAGTAAATTCAAATGGGAAATATGGCTTTCTACCGCTAACCAGTTTGGAATGTCCGCCA 69 FBan0009331 FBgn0032889 CG9331 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016614 ; EC:1.1.-.-; ; GO:0016616 ; EC:1.1.1.-" CG9331 CG9331 CDMC33969 2 21 15 DAC25-B02 9-CG10562-RA_2 CG10562 GGCTACACGGTCGCTACTGGTGTAATGTCTGCTGTTCTTTTGGATCCCACGGACAGTGCTAGTTTGGAA 69 FBan0010562 FBgn0039326 CG10562 3 3R CG10562 CG10562 CDMC33969 2 22 15 DAC25-B02 9-CG10562-RA_2 CG10562 GGCTACACGGTCGCTACTGGTGTAATGTCTGCTGTTCTTTTGGATCCCACGGACAGTGCTAGTTTGGAA 69 FBan0010562 FBgn0039326 CG10562 3 3R CG10562 CG10562 CDMC33970 2 23 15 DAC25-B14 12-CG10573-RA_5 CG10573 GCTGTTGAACCGGAGACCCCTGTTTATGATGGAGGAAAGTACGCCAAGAACACCAATAACGATGCCACC 69 FBan0010573 FBgn0020294 ko 3 3L motor axon guidance; GO:0008045 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ko knockout CG10573 CDMC33970 2 24 15 DAC25-B14 12-CG10573-RA_5 CG10573 GCTGTTGAACCGGAGACCCCTGTTTATGATGGAGGAAAGTACGCCAAGAACACCAATAACGATGCCACC 69 FBan0010573 FBgn0020294 ko 3 3L motor axon guidance; GO:0008045 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ko knockout CG10573 CDMC33971 2 25 15 DAC25-F02 23-CG10601-RB_1 CG10601 GCCCGGGCTTGAAAGGTATAATTACACTTTCGGACAATAATTTACAATGTGATTATTCGGTATTTTGAT 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC33971 2 26 15 DAC25-F02 23-CG10601-RB_1 CG10601 GCCCGGGCTTGAAAGGTATAATTACACTTTCGGACAATAATTTACAATGTGATTATTCGGTATTTTGAT 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC33972 2 1 16 DAC25-F14 22-CG10617-RA_1 CG10617 AGAACGCACTCGAATACACGAATAGTACTTTCCTAGTCGCACCTGCATTTTGACCAACCAACCAATCGA 69 FBan0010617 FBgn0030476 CG10617 X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG10617 CG10617 CDMC33972 2 2 16 DAC25-F14 22-CG10617-RA_1 CG10617 AGAACGCACTCGAATACACGAATAGTACTTTCCTAGTCGCACCTGCATTTTGACCAACCAACCAATCGA 69 FBan0010617 FBgn0030476 CG10617 X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269 calcium-dependent phospholipid binding; GO:0005544; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005544 membrane; GO:0016020; synaptic vesicle; GO:0008021 CG10617 CG10617 CDMC33973 2 3 16 DAC25-J02 23-CG10640-RA_10 CG10640 ACTGGAAACGCGTTAGCACACTTTTACGGTATTTTAGCACTTAGCATTAACCACAATGGCGAATACATC 69 FBan0010640 FBgn0035601 Uev1A 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Uev1A Uev1A "CG10640, dUev1A, UEV, DmUEV, dUEV1a" CDMC33973 2 4 16 DAC25-J02 23-CG10640-RA_10 CG10640 ACTGGAAACGCGTTAGCACACTTTTACGGTATTTTAGCACTTAGCATTAACCACAATGGCGAATACATC 69 FBan0010640 FBgn0035601 Uev1A 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 Uev1A Uev1A "CG10640, dUev1A, UEV, DmUEV, dUEV1a" CDMC33974 2 5 16 DAC25-J14 23-CG10652-RB_1 CG10652 GGAGACGGCCTAAACATTTATTTTTAATCGAACAAGACGACACAATAAAGTTTTGTATGAGCAGAGATA 69 FBan0010652 FBgn0015745 RpL30 2 2L peripheral nervous system development; GO:0007422; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL30 Ribosomal protein L30 "CG10652, BcDNA:RH09938, BcDNA:RE25263, L30: L30 ribosomal gene, anon-EST:fe1D4, l(2)k09918, L30 ribosomal gene, anon-fast-evolving-1D4" CDMC33974 2 6 16 DAC25-J14 23-CG10652-RB_1 CG10652 GGAGACGGCCTAAACATTTATTTTTAATCGAACAAGACGACACAATAAAGTTTTGTATGAGCAGAGATA 69 FBan0010652 FBgn0015745 RpL30 2 2L peripheral nervous system development; GO:0007422; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL30 Ribosomal protein L30 "CG10652, BcDNA:RH09938, BcDNA:RE25263, L30: L30 ribosomal gene, anon-EST:fe1D4, l(2)k09918, L30 ribosomal gene, anon-fast-evolving-1D4" CDMC33975 2 7 16 DAC25-N02 12-CG10682-RA_1 CG10682 AGTGCAAGCAACTCCACTCATCCGAAGACCTACTGCCAACCAACAAACCAATCATCAATCACCACCGTA 69 FBan0010682 FBgn0027936 vih 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004840 vih vihar "CG10682, CG10682, anon-WO0172774.54, anon-WO0172774.55, anon-WO0172774.56, vihar" CDMC33975 2 8 16 DAC25-N02 12-CG10682-RA_1 CG10682 AGTGCAAGCAACTCCACTCATCCGAAGACCTACTGCCAACCAACAAACCAATCATCAATCACCACCGTA 69 FBan0010682 FBgn0027936 vih 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004840 vih vihar "CG10682, CG10682, anon-WO0172774.54, anon-WO0172774.55, anon-WO0172774.56, vihar" CDMC33976 2 9 16 DAC25-N14 2-CG10692-RB_2 CG10692 TTCCATTTGCCGGTGGAAAGATCTGGGAAGAAATGCCGGGTGCTATAGCCCAGAATCAGGGTCTTTCAC 69 FBan0010692 FBgn0028707 Dnmt2 2 2L DNA methylation; GO:0006306; DNA methylation during embryonic development; GO:0043045; chromatin assembly or disassembly; GO:0006333; determination of adult life span; GO:0008340 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA (cytosine-5-)-methyltransferase activity; GO:0003886 ; EC:2.1.1.37; ; GO:0003886 ; EC:2.1.1.37; site-specific DNA-methyltransferase (cytosine-specific) activity; GO:0008326 ; EC:2.1.1.-; ; GO:0003676; ; GO:0003886 ; EC:2.1.1.37; ; GO:0003886 ; EC:2.1.1.37; ; GO:0008326 ; EC:2.1.1.-; ; GO:0003677 colocalizes_with nuclear chromatin; GO:0000790 Dnmt2 DNA methyltransferase 2 "CG10692, Mt2: Methyltransferase 2, DmMT2, dnmt2, dDNMT, dDnmt2, DNMT, Dnmt, nmt2: DNA(5-cytosine) methyltransferase, Methyltransferase 2, DNA(5-cytosine) methyltransferase" CDMC33976 2 10 16 DAC25-N14 2-CG10692-RB_2 CG10692 TTCCATTTGCCGGTGGAAAGATCTGGGAAGAAATGCCGGGTGCTATAGCCCAGAATCAGGGTCTTTCAC 69 FBan0010692 FBgn0028707 Dnmt2 2 2L DNA methylation; GO:0006306; DNA methylation during embryonic development; GO:0043045; chromatin assembly or disassembly; GO:0006333; determination of adult life span; GO:0008340 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA (cytosine-5-)-methyltransferase activity; GO:0003886 ; EC:2.1.1.37; ; GO:0003886 ; EC:2.1.1.37; site-specific DNA-methyltransferase (cytosine-specific) activity; GO:0008326 ; EC:2.1.1.-; ; GO:0003676; ; GO:0003886 ; EC:2.1.1.37; ; GO:0003886 ; EC:2.1.1.37; ; GO:0008326 ; EC:2.1.1.-; ; GO:0003677 colocalizes_with nuclear chromatin; GO:0000790 Dnmt2 DNA methyltransferase 2 "CG10692, Mt2: Methyltransferase 2, DmMT2, dnmt2, dDNMT, dDnmt2, DNMT, Dnmt, nmt2: DNA(5-cytosine) methyltransferase, Methyltransferase 2, DNA(5-cytosine) methyltransferase" CDMC33977 2 11 16 DAC26-B02 8-CG8014-RA_6 CG8014 CCGTGCAGCTCTTTGAGTCTATACACGAGCATCCGGAACTGATTTGGAACGATACCACGCGGTCGAATG 69 FBgn0033390 CDMC33977 2 12 16 DAC26-B02 8-CG8014-RA_6 CG8014 CCGTGCAGCTCTTTGAGTCTATACACGAGCATCCGGAACTGATTTGGAACGATACCACGCGGTCGAATG 69 FBgn0033390 CDMC33978 2 13 16 DAC26-B14 2-CG8029-RA_1 CG8029 CCGGTGGCATCATGTGGAAGTCGACCAATCAGTTTCAGATCTTCTACACTGCCCTGCTCTACAACGGCA 69 FBan0008029 FBgn0033393 CG8029 2 2R ATP synthesis coupled proton transport; GO:0015986 "hydrogen:potassium-exchanging ATPase activity; GO:0008900 ; EC:3.6.3.10; ; GO:0008900 ; EC:3.6.3.10; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen:potassium-exchanging ATPase complex; GO:0005889; proton-transporting two-sector ATPase complex; GO:0016469 CG8029 CG8029 anon-WO0118547.117 CDMC33978 2 14 16 DAC26-B14 2-CG8029-RA_1 CG8029 CCGGTGGCATCATGTGGAAGTCGACCAATCAGTTTCAGATCTTCTACACTGCCCTGCTCTACAACGGCA 69 FBan0008029 FBgn0033393 CG8029 2 2R ATP synthesis coupled proton transport; GO:0015986 "hydrogen:potassium-exchanging ATPase activity; GO:0008900 ; EC:3.6.3.10; ; GO:0008900 ; EC:3.6.3.10; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen:potassium-exchanging ATPase complex; GO:0005889; proton-transporting two-sector ATPase complex; GO:0016469 CG8029 CG8029 anon-WO0118547.117 CDMC33979 2 15 16 DAC26-F02 3-CG8068-RC_5 CG8068 TCTGGCCGTATACCTGGTAAAGAAGCTCACCTCAACACAGCTTTTGCAGCGAATGAAGACGAAGGGCGT 69 FBan0008068 FBgn0003612 Su(var)2-10 2 2R chromosome condensation; GO:0030261; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; imaginal disc growth; GO:0007446; negative regulation of JAK-STAT cascade; GO:0046426; protein modification; GO:0006464; regulation of JAK-STAT cascade; GO:0046425; regulation of protein catabolism; GO:0042176; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; DEAD/H-box RNA helicase binding; GO:0017151; zinc ion binding; GO:0008270; ; GO:0017151; ; GO:0008270 "cytoplasm; GO:0005737; nuclear lamina; GO:0005652; nucleoplasm; GO:0005654; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome, telomeric region; GO:0035012" Su(var)2-10 Suppressor of variegation 2-10 "CG8068, CG8068, Su-var(2)10, zimp, Suvar(2)10, CLOT2057, zinc finger-containing Miz1 PIAS3-like, l(2)03697, dpias, dPIAS, Dpias, ZimpA, ZimpB, Su(Var)2-10, i184, PIAS, DPIAS" CDMC33979 2 16 16 DAC26-F02 3-CG8068-RC_5 CG8068 TCTGGCCGTATACCTGGTAAAGAAGCTCACCTCAACACAGCTTTTGCAGCGAATGAAGACGAAGGGCGT 69 FBan0008068 FBgn0003612 Su(var)2-10 2 2R chromosome condensation; GO:0030261; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; eye development (sensu Endopterygota); GO:0007456; hemopoiesis; GO:0030097; imaginal disc growth; GO:0007446; negative regulation of JAK-STAT cascade; GO:0046426; protein modification; GO:0006464; regulation of JAK-STAT cascade; GO:0046425; regulation of protein catabolism; GO:0042176; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; DEAD/H-box RNA helicase binding; GO:0017151; zinc ion binding; GO:0008270; ; GO:0017151; ; GO:0008270 "cytoplasm; GO:0005737; nuclear lamina; GO:0005652; nucleoplasm; GO:0005654; nucleus; GO:0005634; polytene chromosome; GO:0005700; polytene chromosome, telomeric region; GO:0035012" Su(var)2-10 Suppressor of variegation 2-10 "CG8068, CG8068, Su-var(2)10, zimp, Suvar(2)10, CLOT2057, zinc finger-containing Miz1 PIAS3-like, l(2)03697, dpias, dPIAS, Dpias, ZimpA, ZimpB, Su(Var)2-10, i184, PIAS, DPIAS" CDMC33980 2 17 16 DAC26-F14 17-CG8084-RA_3 CG8084 GACATTGCTGTCCCATGGAGCGTTTACCGAACAGAACCGTTTAAGTCTCATCTGGCGAGTTGGACATTG 69 FBan0008084 FBgn0011746 ana 2 2R negative regulation of neuroblast proliferation; GO:0007406 extracellular region; GO:0005576 ana anachronism "CG8084, med: medusa, medullaless, med" CDMC33980 2 18 16 DAC26-F14 17-CG8084-RA_3 CG8084 GACATTGCTGTCCCATGGAGCGTTTACCGAACAGAACCGTTTAAGTCTCATCTGGCGAGTTGGACATTG 69 FBan0008084 FBgn0011746 ana 2 2R negative regulation of neuroblast proliferation; GO:0007406 extracellular region; GO:0005576 ana anachronism "CG8084, med: medusa, medullaless, med" CDMC33981 2 19 16 DAC26-J02 9-CG8117-RA_1 CG8117 CGCAACTGCAGCCAATTGCATATCCGTGATGGTGACGAGCCCATTATCACCTTTGTGATATGCGACGAG 69 FBan0008117 FBgn0030663 CG8117 X X "RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcriptional elongation regulator activity; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003711; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG8117 CG8117 CDMC33981 2 20 16 DAC26-J02 9-CG8117-RA_1 CG8117 CGCAACTGCAGCCAATTGCATATCCGTGATGGTGACGAGCCCATTATCACCTTTGTGATATGCGACGAG 69 FBan0008117 FBgn0030663 CG8117 X X "RNA elongation from RNA polymerase II promoter; GO:0006368; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcriptional elongation regulator activity; GO:0003711; general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003711; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 CG8117 CG8117 CDMC33982 2 21 16 DAC26-J14 3-CG8128-RA_1 CG8128 TCGTCTGGAGGAACTGGACGGATTGGCTCAGTGACACCATTAGCCATTGACTTTTCTACATGCCCAGGA 69 FBan0008128 FBgn0030668 CG8128 X X "cell proliferation; GO:0008283; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8128 CG8128 CDMC33982 2 22 16 DAC26-J14 3-CG8128-RA_1 CG8128 TCGTCTGGAGGAACTGGACGGATTGGCTCAGTGACACCATTAGCCATTGACTTTTCTACATGCCCAGGA 69 FBan0008128 FBgn0030668 CG8128 X X "cell proliferation; GO:0008283; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8128 CG8128 CDMC33983 2 23 16 DAC26-N02 5-CG8169-RA_1 CG8169 TGGCATTAGACAAACAGGAATCACCGGCAGAACTCAATTCCCAACCGCCTAGTTTCACTCAGCTGTCGG 69 FBan0008169 FBgn0011660 Pms2 2 2R mismatch repair; GO:0006298; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; sugar porter activity; GO:0005351; ; GO:0005351 Pms2 Pms2 "CG8169, dmlh-2, dmlh2, pms2, Mlh2, dpms2" CDMC33983 2 24 16 DAC26-N02 5-CG8169-RA_1 CG8169 TGGCATTAGACAAACAGGAATCACCGGCAGAACTCAATTCCCAACCGCCTAGTTTCACTCAGCTGTCGG 69 FBan0008169 FBgn0011660 Pms2 2 2R mismatch repair; GO:0006298; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; sugar porter activity; GO:0005351; ; GO:0005351 Pms2 Pms2 "CG8169, dmlh-2, dmlh2, pms2, Mlh2, dpms2" CDMC33984 2 25 16 DAC26-N14 15-CG8179-RA_2 CG8179 AGCACTTCAGACAACATCAACAGATCTACCAACAGCCACATGTCAGATGGAGGTCGCAGTGCAAGTACT 69 FBan0008179 FBgn0034020 CG8179 2 2R protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG8179 CG8179 SRPK2 CDMC33984 2 26 16 DAC26-N14 15-CG8179-RA_2 CG8179 AGCACTTCAGACAACATCAACAGATCTACCAACAGCCACATGTCAGATGGAGGTCGCAGTGCAAGTACT 69 FBan0008179 FBgn0034020 CG8179 2 2R protein amino acid phosphorylation; GO:0006468 protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG8179 CG8179 SRPK2 CDMC33985 2 1 17 DAC27-B02 23-CG8415-RA_8 CG8415 TTGGCCCTCTACAAGGAGAAGAAGGAACGCCCAAGATCTTAGATGAACATGCATCTAATCTTTTTCCAG 69 FBan0008415 FBgn0033912 RpS23 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS23 Ribosomal protein S23 "CG8415, CT24703, anon-EST:Posey158, anon-EST:Posey63, Ribosomal protein S23" CDMC33985 2 2 17 DAC27-B02 23-CG8415-RA_8 CG8415 TTGGCCCTCTACAAGGAGAAGAAGGAACGCCCAAGATCTTAGATGAACATGCATCTAATCTTTTTCCAG 69 FBan0008415 FBgn0033912 RpS23 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS23 Ribosomal protein S23 "CG8415, CT24703, anon-EST:Posey158, anon-EST:Posey63, Ribosomal protein S23" CDMC33986 2 3 17 DAC27-B14 3-CG8421-RE_1 CG8421 ACCCCAGCTGGACACGTAATTACTAAACGCACAAATCACCACGTCTGTCGATGACCACCCGACTCCATT 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC33986 2 4 17 DAC27-B14 3-CG8421-RE_1 CG8421 ACCCCAGCTGGACACGTAATTACTAAACGCACAAATCACCACGTCTGTCGATGACCACCCGACTCCATT 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC33987 2 5 17 DAC27-F02 23-CG8462-RA_1 CG8462 GTTTCTTTGATTACCAGTTATTCTCAATAAAAATTAGATCAGGCTTCCCAAATAGGCGTGCAATCAATT 69 FBan0008462 FBgn0034471 Obp56e 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56e Odorant-binding protein 56e "CG8462, CG8462, CG8462, CG8462, CG8462, 56e, Odorant-binding protein 56e" CDMC33987 2 6 17 DAC27-F02 23-CG8462-RA_1 CG8462 GTTTCTTTGATTACCAGTTATTCTCAATAAAAATTAGATCAGGCTTCCCAAATAGGCGTGCAATCAATT 69 FBan0008462 FBgn0034471 Obp56e 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56e Odorant-binding protein 56e "CG8462, CG8462, CG8462, CG8462, CG8462, 56e, Odorant-binding protein 56e" CDMC33988 2 7 17 DAC27-F14 17-CG8479-RA_1 CG8479 AGGAGTTCATCAATTCACTTAATCAGGAAAAGTAGTGTGCCATGACCAAAGACACAACACCCGAGGCGT 69 FBan0008479 FBgn0033914 CG8479 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0016818 ; EC:3.6.1.-" CG8479 CG8479 CDMC33988 2 8 17 DAC27-F14 17-CG8479-RA_1 CG8479 AGGAGTTCATCAATTCACTTAATCAGGAAAAGTAGTGTGCCATGACCAAAGACACAACACCCGAGGCGT 69 FBan0008479 FBgn0033914 CG8479 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0016818 ; EC:3.6.1.-" CG8479 CG8479 CDMC33989 2 9 17 DAC27-J02 18-CG8517-RA_5 CG8517 AAAGCGCCTAATGAATTTGATGAAGGCTAATCGCGGAATGACCAGTACTGGCAAGCAACCGATTTTCGA 69 FBan0008517 FBgn0034472 CG8517 2 2R electron transport; GO:0006118; sulfur metabolism; GO:0006790 electron transporter activity; GO:0005489; thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG8517 CG8517 "mtr, thioredoxin" CDMC33989 2 10 17 DAC27-J02 18-CG8517-RA_5 CG8517 AAAGCGCCTAATGAATTTGATGAAGGCTAATCGCGGAATGACCAGTACTGGCAAGCAACCGATTTTCGA 69 FBan0008517 FBgn0034472 CG8517 2 2R electron transport; GO:0006118; sulfur metabolism; GO:0006790 electron transporter activity; GO:0005489; thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG8517 CG8517 "mtr, thioredoxin" CDMC33990 2 11 17 DAC27-J14 22-CG8532-RB_1 CG8532 TGTGCATTCGCTTTTGGTCCACCTTCAAGTCACCAATGCATACGCGAGTTTGCTGTTGAACATTTTTAT 69 FBan0008532 FBgn0028582 lqf 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; negative regulation of cardioblast cell fate specification; GO:0009997; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488; visual perception; GO:0007601 lqf liquid facets "CG8532, CG32386, CG8532, CG32386, E(faf)bE25, Enhancer of faf bE25, 0110/27, l(3)S011027, LqF, epsin, Epsin, Lqf, anon-WO0118547.239" CDMC33990 2 12 17 DAC27-J14 22-CG8532-RB_1 CG8532 TGTGCATTCGCTTTTGGTCCACCTTCAAGTCACCAATGCATACGCGAGTTTGCTGTTGAACATTTTTAT 69 FBan0008532 FBgn0028582 lqf 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; negative regulation of cardioblast cell fate specification; GO:0009997; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488; visual perception; GO:0007601 lqf liquid facets "CG8532, CG32386, CG8532, CG32386, E(faf)bE25, Enhancer of faf bE25, 0110/27, l(3)S011027, LqF, epsin, Epsin, Lqf, anon-WO0118547.239" CDMC33991 2 13 17 DAC27-N02 3-CG8562-RA_1 CG8562 GCTGGCTCCATTGGATTCAATCCTCCAGTCACCCGAATCGATGAGTTTGTCACCGAAACCTGGATTGGC 69 FBan0008562 FBgn0035779 CG8562 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8562 CG8562 CT15463 CDMC33991 2 14 17 DAC27-N02 3-CG8562-RA_1 CG8562 GCTGGCTCCATTGGATTCAATCCTCCAGTCACCCGAATCGATGAGTTTGTCACCGAAACCTGGATTGGC 69 FBan0008562 FBgn0035779 CG8562 3 3L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8562 CG8562 CT15463 CDMC33992 2 15 17 DAC27-N14 48-CG8578-RA_3 CG8578 CTTGCGATTAATATATAAAATATAGTTAAATTGAGCACAGATTCAATGGAAAGTATCAGCACCACAGGT 69 FBan0008578 FBgn0030699 CG8578 X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 CG8578 CG8578 CDMC33992 2 16 17 DAC27-N14 48-CG8578-RA_3 CG8578 CTTGCGATTAATATATAAAATATAGTTAAATTGAGCACAGATTCAATGGAAAGTATCAGCACCACAGGT 69 FBan0008578 FBgn0030699 CG8578 X X "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 CG8578 CG8578 CDMC33993 2 17 17 DAC28-B02 17-CG30334-RA_1 CG30334 TGCTGCTGAGCATGTACGTCTCGTGGACTCTGGACTTCACTGTTTGCGGTTAATTGGTTTCTTGAGTTA 69 FBan0030334 FBgn0050334 CG30334 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30334 CG30334 NEST:bs09a11 CDMC33993 2 18 17 DAC28-B02 17-CG30334-RA_1 CG30334 TGCTGCTGAGCATGTACGTCTCGTGGACTCTGGACTTCACTGTTTGCGGTTAATTGGTTTCTTGAGTTA 69 FBan0030334 FBgn0050334 CG30334 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30334 CG30334 NEST:bs09a11 CDMC33994 2 19 17 DAC28-B14 11-CG30343-RA_1 CG30343 GTATTCGCTTGACTTCCAGCTGGAACTCAATGACTTCACAACTGTAAGCCCCGATGATTTGACCGCCGC 69 FBan0030343 FBgn0050343 CG30343 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30343 CG30343 BcDNA:GM04716 CDMC33994 2 20 17 DAC28-B14 11-CG30343-RA_1 CG30343 GTATTCGCTTGACTTCCAGCTGGAACTCAATGACTTCACAACTGTAAGCCCCGATGATTTGACCGCCGC 69 FBan0030343 FBgn0050343 CG30343 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30343 CG30343 BcDNA:GM04716 CDMC33995 2 21 17 DAC28-F02 23-CG30376-RA_1 CG30376 CCCAATTTCGGCCGAAGAATTTGAGTCTTATCATAAATTAGCCGGTTAAATCAGAGAATTTAGGGGAAC 69 FBan0030376 FBgn0050376 CG30376 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30376 CG30376 BcDNA:AT30260 CDMC33995 2 22 17 DAC28-F02 23-CG30376-RA_1 CG30376 CCCAATTTCGGCCGAAGAATTTGAGTCTTATCATAAATTAGCCGGTTAAATCAGAGAATTTAGGGGAAC 69 FBan0030376 FBgn0050376 CG30376 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30376 CG30376 BcDNA:AT30260 CDMC33996 2 23 17 DAC28-F14 18-CG30389-RA_2 CG30389 GATGAGCAGGCCGTAACCTGGTGCCGGTTCCAAGAAGATGTTTGCATACAATATCTGAATGTCCGTAAT 69 FBan0030389 FBgn0050389 CG30389 2 2R CG30389 CG30389 "CG10518, CG4126, BcDNA:AT02070" CDMC33996 2 24 17 DAC28-F14 18-CG30389-RA_2 CG30389 GATGAGCAGGCCGTAACCTGGTGCCGGTTCCAAGAAGATGTTTGCATACAATATCTGAATGTCCGTAAT 69 FBan0030389 FBgn0050389 CG30389 2 2R CG30389 CG30389 "CG10518, CG4126, BcDNA:AT02070" CDMC33997 2 25 17 DAC28-J02 23-CG30430-RA_1 CG30430 TGGCCTATTCGTCTTGAAAACAAGATCAAGTCGTAATAAAGGTGTTTGACTTTCCAAGTCTTTTTTATT 69 FBan0030430 FBgn0050430 CG30430 2 2R CG30430 CG30430 "NEST:bs17g03, NEST:bs15a10, NEST:bs14e02, NEST:bs12g08, NEST:bs01g11, NEST:bs02g04, NEST:bs04a11, NEST:bs15d07, NEST:bs29b02, NEST:bs27g03, NEST:bs13e09" CDMC33997 2 26 17 DAC28-J02 23-CG30430-RA_1 CG30430 TGGCCTATTCGTCTTGAAAACAAGATCAAGTCGTAATAAAGGTGTTTGACTTTCCAAGTCTTTTTTATT 69 FBan0030430 FBgn0050430 CG30430 2 2R CG30430 CG30430 "NEST:bs17g03, NEST:bs15a10, NEST:bs14e02, NEST:bs12g08, NEST:bs01g11, NEST:bs02g04, NEST:bs04a11, NEST:bs15d07, NEST:bs29b02, NEST:bs27g03, NEST:bs13e09" CDMC33998 2 1 18 DAC28-J14 23-CG30441-RA_2 CG30441 TGTAATATTTCTGAAACGTTTGCCAAAGATGTCGATAAGGAAAAACTACGCGCTATTGGTACTCAAAAT 69 FBan0030441 FBgn0050441 CG30441 2 2R CG30441 CG30441 CDMC33998 2 2 18 DAC28-J14 23-CG30441-RA_2 CG30441 TGTAATATTTCTGAAACGTTTGCCAAAGATGTCGATAAGGAAAAACTACGCGCTATTGGTACTCAAAAT 69 FBan0030441 FBgn0050441 CG30441 2 2R CG30441 CG30441 CDMC33999 2 3 18 DAC28-N02 4-CG30480-RA_3 CG30480 TCGACGATCCTCCATTCGTAGAAGTGGTGGAAAGGGAAGTGGTTGTTGAGTCCGCAAACAATGGCCAAG 69 FBan0030480 FBgn0050480 CG30480 2 2R CG30480 CG30480 CG18373 CDMC33999 2 4 18 DAC28-N02 4-CG30480-RA_3 CG30480 TCGACGATCCTCCATTCGTAGAAGTGGTGGAAAGGGAAGTGGTTGTTGAGTCCGCAAACAATGGCCAAG 69 FBan0030480 FBgn0050480 CG30480 2 2R CG30480 CG30480 CG18373 CDMC34000 2 5 18 DAC28-N14 3-CG30488-RA_4 CG30488 GCGCCAATACCGACAAGTATCACTATGTGGCAACCACCGAAATCCGTAGCAAGATGGGACGGACCAAGA 69 FBan0030488 FBgn0050488 CG30488 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG30488 CG30488 CDMC34000 2 6 18 DAC28-N14 3-CG30488-RA_4 CG30488 GCGCCAATACCGACAAGTATCACTATGTGGCAACCACCGAAATCCGTAGCAAGATGGGACGGACCAAGA 69 FBan0030488 FBgn0050488 CG30488 2 2R defense response; GO:0006952 extracellular region; GO:0005576 CG30488 CG30488 CDMC34001 2 7 18 DAC29-B02 3-CG9961-RA_1 CG9961 TGGAGATTGGAAAGTCCCTCTTCGACGAGAAGGGATCCGAGTTGGTCAACGACATAGTCTGCAAGGCGA 69 FBan0009961 FBgn0031451 CG9961 2 2L glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; phosphoglycerate kinase activity; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3 CG9961 CG9961 CDMC34001 2 8 18 DAC29-B02 3-CG9961-RA_1 CG9961 TGGAGATTGGAAAGTCCCTCTTCGACGAGAAGGGATCCGAGTTGGTCAACGACATAGTCTGCAAGGCGA 69 FBan0009961 FBgn0031451 CG9961 2 2L glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; phosphoglycerate kinase activity; GO:0004618 ; EC:2.7.2.3; ; GO:0004618 ; EC:2.7.2.3 CG9961 CG9961 CDMC34002 2 9 18 DAC29-B14 12-CG9977-RA_4 CG9977 CCACGCACTTGATGCTAAAAAAGTACCCGACCATGTTCAAGTTGGTCAAGGGAATCGTCGAGGAGAGCG 69 FBan0009977 FBgn0035371 CG9977 3 3L one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 CG9977 CG9977 CDMC34002 2 10 18 DAC29-B14 12-CG9977-RA_4 CG9977 CCACGCACTTGATGCTAAAAAAGTACCCGACCATGTTCAAGTTGGTCAAGGGAATCGTCGAGGAGAGCG 69 FBan0009977 FBgn0035371 CG9977 3 3L one-carbon compound metabolism; GO:0006730; purine base metabolism; GO:0006144 adenosylhomocysteinase activity; GO:0004013 ; EC:3.3.1.1; ; GO:0004013 ; EC:3.3.1.1 CG9977 CG9977 CDMC34003 2 11 18 DAC29-F02 14-CR15821-RA_1 CR15821 ACATGGTCATTTGCATAGACTGTGTGCTGATGCCGAAGTTCGACAGTGACATTGCTCTCGAAAGCTTCC 69 FBan0015821 FBgn0035311 CR15821 3 3L CR15821 CR15821 CG15821 CDMC34003 2 12 18 DAC29-F02 14-CR15821-RA_1 CR15821 ACATGGTCATTTGCATAGACTGTGTGCTGATGCCGAAGTTCGACAGTGACATTGCTCTCGAAAGCTTCC 69 FBan0015821 FBgn0035311 CR15821 3 3L CR15821 CR15821 CG15821 CDMC34004 2 13 18 DAC29-F14 23-CR30370-RA_10 CR30370 AGAATCAGATTTTTCGCTTTCCCATATGTCGATTGTGTAGCCTTAATTAAACACTGGGAAATACGGTGA 69 FBan0030370 FBgn0063356 CR30370 2 2R CR30370 CR30370 BcDNA:AT05157 CDMC34004 2 14 18 DAC29-F14 23-CR30370-RA_10 CR30370 AGAATCAGATTTTTCGCTTTCCCATATGTCGATTGTGTAGCCTTAATTAAACACTGGGAAATACGGTGA 69 FBan0030370 FBgn0063356 CR30370 2 2R CR30370 CR30370 BcDNA:AT05157 CDMC34005 2 15 18 DAC29-J02 17-CR31927-RA_1 CR31927 CGGGTATCATCCTTCTCACCGGACGGTTGGATCTTCTGGTGTTTGCATGATTTGCATTAATTTGGCAAA 69 FBan0031927 FBgn0003926 snRNA:U3:22A 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNA:U3:22A small nuclear RNA U3 at 22A "K7, snRNA[[2]], dU3, snRNA:U3, U3snRNA, CR31927, U3snRNA22A, snRNA2, snRNA3, small nuclear RNA U3" CDMC34005 2 16 18 DAC29-J02 17-CR31927-RA_1 CR31927 CGGGTATCATCCTTCTCACCGGACGGTTGGATCTTCTGGTGTTTGCATGATTTGCATTAATTTGGCAAA 69 FBan0031927 FBgn0003926 snRNA:U3:22A 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" snRNA:U3:22A small nuclear RNA U3 at 22A "K7, snRNA[[2]], dU3, snRNA:U3, U3snRNA, CR31927, U3snRNA22A, snRNA2, snRNA3, small nuclear RNA U3" CDMC34006 2 17 18 DAC29-J14 22-CR32078-RA_2 CR32078 ACTGGTCTACAAGTGGAGTTAGTTTGGAGTGTGGAATACCTGTGAATACTTCCCGACACTGAGCATCGA 69 FBan0032078 FBgn0052078 CR32078 3 3L CR32078 CR32078 CDMC34006 2 18 18 DAC29-J14 22-CR32078-RA_2 CR32078 ACTGGTCTACAAGTGGAGTTAGTTTGGAGTGTGGAATACCTGTGAATACTTCCCGACACTGAGCATCGA 69 FBan0032078 FBgn0052078 CR32078 3 3L CR32078 CR32078 CDMC34007 2 19 18 DAC29-N02 22-CR32885-RA_1 CR32885 ACAAGAAGACCCGAAAATGTGCGACTACCAGATGGAGTACTCCTTTATTTTTGAAGACAGCTCCTGCGA 69 FBan0032885 FBgn0016053 pgc 2 2R germ cell migration; GO:0008354; pole cell development; GO:0007277 polar granule; GO:0018994; pole plasm; GO:0045495 pgc polar granule component "CG11296, 58D gene, Pgc, Pgc1, Polar granule component, pgc-1, pgr, CR32885, polar granule component" CDMC34007 2 20 18 DAC29-N02 22-CR32885-RA_1 CR32885 ACAAGAAGACCCGAAAATGTGCGACTACCAGATGGAGTACTCCTTTATTTTTGAAGACAGCTCCTGCGA 69 FBan0032885 FBgn0016053 pgc 2 2R germ cell migration; GO:0008354; pole cell development; GO:0007277 polar granule; GO:0018994; pole plasm; GO:0045495 pgc polar granule component "CG11296, 58D gene, Pgc, Pgc1, Polar granule component, pgc-1, pgr, CR32885, polar granule component" CDMC34008 2 21 18 DAC29-N14 5-CR32989-RA_1 CR32989 GGAAGGAGAGCAAGTTAGCACTCCCCTAGACAAGGATGGAACACATAAACGGTCGGCTAGGCACAGACA 69 FBan0032989 FBgn0041717 snRNA:U6atac:29B 2 2L "nuclear mRNA splicing via U12-type spliceosome; GO:0006375; nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U6atac; GO:0005691 snRNA:U6atac:29B U6atac snRNA at 29B "l(2)k01105, U6atac-29B, U6atac, CR32989, U6atac snRNA at 29B" CDMC34008 2 22 18 DAC29-N14 5-CR32989-RA_1 CR32989 GGAAGGAGAGCAAGTTAGCACTCCCCTAGACAAGGATGGAACACATAAACGGTCGGCTAGGCACAGACA 69 FBan0032989 FBgn0041717 snRNA:U6atac:29B 2 2L "nuclear mRNA splicing via U12-type spliceosome; GO:0006375; nuclear mRNA splicing, via spliceosome; GO:0000398" snRNP U6atac; GO:0005691 snRNA:U6atac:29B U6atac snRNA at 29B "l(2)k01105, U6atac-29B, U6atac, CR32989, U6atac snRNA at 29B" CDMC34009 2 23 18 DAC30-B02 2-CG11977-RA_1 CG11977 TGGCGATGCGGGTCTCTAATCAATGCTTGCAGCACACTTTCTCACCCTGCGTGAATACGTTCCTCTACA 69 FBan0011977 FBgn0037650 CG11977 3 3R CG11977 CG11977 CDMC34009 2 24 18 DAC30-B02 2-CG11977-RA_1 CG11977 TGGCGATGCGGGTCTCTAATCAATGCTTGCAGCACACTTTCTCACCCTGCGTGAATACGTTCCTCTACA 69 FBan0011977 FBgn0037650 CG11977 3 3R CG11977 CG11977 CDMC34010 2 25 18 DAC30-B14 23-CG11988-RA_10 CG11988 GGACTTCATCCAACAAAGACACCACAAAAAAGACGTATTAAGCACGCTAAGCTATTTTAATGAAGCCGC 69 FBan0011988 FBgn0002932 neur 3 3R asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesoderm development; GO:0007498; nervous system development; GO:0007399; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of Notch signaling pathway; GO:0045747; protein ubiquitination; GO:0016567; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 DNA binding; GO:0003677; ; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634; perinuclear region; GO:0048471; plasma membrane; GO:0005886; ubiquitin ligase complex; GO:0000151 neur neuralized "CG11988, CG11988, neu, 0328/12, 0971/15, 1293/09, 1315/05, neuralized, Neur, Neuralized, Neuralised, l(3)j6B12, l(3)j9B8, l(3)j9B9, l(3)j9C8, l(3)neo37, BEST:LD21494, neuralized" CDMC34010 2 26 18 DAC30-B14 23-CG11988-RA_10 CG11988 GGACTTCATCCAACAAAGACACCACAAAAAAGACGTATTAAGCACGCTAAGCTATTTTAATGAAGCCGC 69 FBan0011988 FBgn0002932 neur 3 3R asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesoderm development; GO:0007498; nervous system development; GO:0007399; ovarian follicle cell development (sensu Insecta); GO:0030707; peripheral nervous system development; GO:0007422; positive regulation of Notch signaling pathway; GO:0045747; protein ubiquitination; GO:0016567; sensory organ development; GO:0007423; sensory organ precursor cell fate determination; GO:0016360 DNA binding; GO:0003677; ; GO:0003677; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634; perinuclear region; GO:0048471; plasma membrane; GO:0005886; ubiquitin ligase complex; GO:0000151 neur neuralized "CG11988, CG11988, neu, 0328/12, 0971/15, 1293/09, 1315/05, neuralized, Neur, Neuralized, Neuralised, l(3)j6B12, l(3)j9B8, l(3)j9B9, l(3)j9C8, l(3)neo37, BEST:LD21494, neuralized" CDMC34011 2 1 19 DAC30-F02 23-CG12019-RA_5 CG12019 TGCAGCATTTACATTCAAATATAAATCCGAAGCAAAGAAACAGCAAAATGGTGGACTACAGCAAGTGGA 69 FBan0012019 FBgn0011573 Cdc37 3 3L protein folding; GO:0006457; protein kinase cascade; GO:0007243; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 protein tyrosine kinase activator activity; GO:0030296; unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0030296; ; GO:0051087; ; GO:0051082 cytoplasm; GO:0005737 Cdc37 Cdc37 "CG12019, E(sev)3B, cdc37, CPDR-1, CPDR-2, DROCPDR, cdc37 protein" CDMC34011 2 2 19 DAC30-F02 23-CG12019-RA_5 CG12019 TGCAGCATTTACATTCAAATATAAATCCGAAGCAAAGAAACAGCAAAATGGTGGACTACAGCAAGTGGA 69 FBan0012019 FBgn0011573 Cdc37 3 3L protein folding; GO:0006457; protein kinase cascade; GO:0007243; regulation of progression through cell cycle; GO:0000074; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 protein tyrosine kinase activator activity; GO:0030296; unfolded protein binding; GO:0051082; chaperone binding; GO:0051087; ; GO:0030296; ; GO:0051087; ; GO:0051082 cytoplasm; GO:0005737 Cdc37 Cdc37 "CG12019, E(sev)3B, cdc37, CPDR-1, CPDR-2, DROCPDR, cdc37 protein" CDMC34012 2 3 19 DAC30-F14 10-CG12025-RA_1 CG12025 GGGCAACGGAAACAGGGAAAGAAAAACGCAGAGAATCCAAGCCAGAAAATATGTACAACAACGGGGCCA 69 FBan0012025 FBgn0035285 CG12025 3 3L CG12025 CG12025 CDMC34012 2 4 19 DAC30-F14 10-CG12025-RA_1 CG12025 GGGCAACGGAAACAGGGAAAGAAAAACGCAGAGAATCCAAGCCAGAAAATATGTACAACAACGGGGCCA 69 FBan0012025 FBgn0035285 CG12025 3 3L CG12025 CG12025 CDMC34013 2 5 19 DAC30-J02 16-CG12052-RS_1 CG12052 AGCGAATGATGCCAGAATTACCATAACGTTTGGAGACCAACAACACCAGACCTCAAGTACAACCCCTTT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34013 2 6 19 DAC30-J02 16-CG12052-RS_1 CG12052 AGCGAATGATGCCAGAATTACCATAACGTTTGGAGACCAACAACACCAGACCTCAAGTACAACCCCTTT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34014 2 7 19 DAC30-J14 12-CG12066-RB_1 CG12066 GCGCCGAAGATCTGTCGAACTTCGAGAACTTCGAGTTCAAGGATCGGTACAAGTCCCGAATAAACCGCC 69 FBan0012066 FBgn0000274 Pka-C2 3 3R anti-apoptosis; GO:0006916; cell homeostasis; GO:0019725; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; ; GO:0004691; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952 Pka-C2 cAMP-dependent protein kinase 2 "CG12066, CG12066, DC1, PKA C2, PKA, cAMP-dependent protein kinase type II, CdkB, DC1a" CDMC34014 2 8 19 DAC30-J14 12-CG12066-RB_1 CG12066 GCGCCGAAGATCTGTCGAACTTCGAGAACTTCGAGTTCAAGGATCGGTACAAGTCCCGAATAAACCGCC 69 FBan0012066 FBgn0000274 Pka-C2 3 3R anti-apoptosis; GO:0006916; cell homeostasis; GO:0019725; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; cAMP-dependent protein kinase activity; GO:0004691; ; GO:0004691; ; GO:0004691; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004691 cAMP-dependent protein kinase complex; GO:0005952 Pka-C2 cAMP-dependent protein kinase 2 "CG12066, CG12066, DC1, PKA C2, PKA, cAMP-dependent protein kinase type II, CdkB, DC1a" CDMC34015 2 9 19 DAC30-N02 9-CG12108-RA_1 CG12108 GGCAGAGCGGCTTCTTCATACATCCCAACGAACAGGTGGATTACGTTTGCAAGCAACTACTGCAGGATG 69 FBan0012108 FBgn0030057 Ppt1 X X protein lipidation; GO:0006497 palmitoyl-(protein) hydrolase activity; GO:0008474 ; EC:3.1.2.22; ; GO:0008474 ; EC:3.1.2.22 lysosome; GO:0005764 Ppt1 Palmitoyl-protein thioesterase 1 "CG12108, CG12108, CG12108, CG12108, CG12108, PPT1, DmPpt1, Palmitoyl-protein thioesterase 1" CDMC34015 2 10 19 DAC30-N02 9-CG12108-RA_1 CG12108 GGCAGAGCGGCTTCTTCATACATCCCAACGAACAGGTGGATTACGTTTGCAAGCAACTACTGCAGGATG 69 FBan0012108 FBgn0030057 Ppt1 X X protein lipidation; GO:0006497 palmitoyl-(protein) hydrolase activity; GO:0008474 ; EC:3.1.2.22; ; GO:0008474 ; EC:3.1.2.22 lysosome; GO:0005764 Ppt1 Palmitoyl-protein thioesterase 1 "CG12108, CG12108, CG12108, CG12108, CG12108, PPT1, DmPpt1, Palmitoyl-protein thioesterase 1" CDMC34016 2 11 19 DAC30-N14 2-CG12114-RA_1 CG12114 CGCCAAAAGATGCTCTCCGACGGCATTAAGGATCTCAGTCTGGAGGAAATAGCCCTGGATGACTTCGGT 69 FBan0012114 FBgn0039837 CG12114 3 3R CG12114 CG12114 CDMC34016 2 12 19 DAC30-N14 2-CG12114-RA_1 CG12114 CGCCAAAAGATGCTCTCCGACGGCATTAAGGATCTCAGTCTGGAGGAAATAGCCCTGGATGACTTCGGT 69 FBan0012114 FBgn0039837 CG12114 3 3R CG12114 CG12114 CDMC34017 2 13 19 DAC31-B02 1-CG3579-RA_1 CG3579 CCTGCTGATGATTCCCTCCATCTACGCCACTGGAGACTACCACGACAAGTACGAAGAGCTAGCCCG 66 FBan0003579 FBgn0035037 CG3579 2 2R CG3579 CG3579 CDMC34017 2 14 19 DAC31-B02 1-CG3579-RA_1 CG3579 CCTGCTGATGATTCCCTCCATCTACGCCACTGGAGACTACCACGACAAGTACGAAGAGCTAGCCCG 66 FBan0003579 FBgn0035037 CG3579 2 2R CG3579 CG3579 CDMC34018 2 15 19 DAC31-B14 9-CG3697-RA_3 CG3697 TGTGGATATGCGTGAGTTTCGCTCAGATCTGCCCTGTTTGATTCACAAGCGTGGTCTGGAAGTGCT 66 FBan0003697 FBgn0002707 mei-9 X X DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome segregation; GO:0007059; double-strand break repair; GO:0006302; meiosis; GO:0007126; meiotic chromosome segregation; GO:0045132; meiotic recombination; GO:0007131; mismatch repair; GO:0006298; nucleotide-excision repair; GO:0006289; resolution of meiotic joint molecules as recombinants; GO:0000712 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0004520; ; GO:0004520 nucleus; GO:0005634 mei-9 meiotic 9 "CG3697, mus(1)110, mei9, DmXPF, DhR1, MEI-9, xpf/mei-9, mus110" CDMC34018 2 16 19 DAC31-B14 9-CG3697-RA_3 CG3697 TGTGGATATGCGTGAGTTTCGCTCAGATCTGCCCTGTTTGATTCACAAGCGTGGTCTGGAAGTGCT 66 FBan0003697 FBgn0002707 mei-9 X X DNA recombination; GO:0006310; DNA repair; GO:0006281; chromosome segregation; GO:0007059; double-strand break repair; GO:0006302; meiosis; GO:0007126; meiotic chromosome segregation; GO:0045132; meiotic recombination; GO:0007131; mismatch repair; GO:0006298; nucleotide-excision repair; GO:0006289; resolution of meiotic joint molecules as recombinants; GO:0000712 nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0004520; ; GO:0004520 nucleus; GO:0005634 mei-9 meiotic 9 "CG3697, mus(1)110, mei9, DmXPF, DhR1, MEI-9, xpf/mei-9, mus110" CDMC34019 2 17 19 DAC31-F02 1-CG40441-RB_1 CG40441 GGAGAAGGAGCAGGTTCAGCGGGATCTCAACAGTGTGCTGATATGGGACAAGTTGGAGGAGGTGTG 66 FBgn0058441 CG40441 CG40441 CG40441 CDMC34019 2 18 19 DAC31-F02 1-CG40441-RB_1 CG40441 GGAGAAGGAGCAGGTTCAGCGGGATCTCAACAGTGTGCTGATATGGGACAAGTTGGAGGAGGTGTG 66 FBgn0058441 CG40441 CG40441 CG40441 CDMC34020 2 19 19 DAC31-F14 3-CG4105-RA_3 CG4105 CCTGCTGGGCTACAACGATCGCATCTTCAAGGATCCCCATCATTTTCGTCCGGAGCGATTTGAGGA 66 FBan0004105 FBgn0015035 Cyp4e3 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e3 Cytochrome P450-4e3 "CG4105, P450, P-450, 4e3, cyp4e3" CDMC34020 2 20 19 DAC31-F14 3-CG4105-RA_3 CG4105 CCTGCTGGGCTACAACGATCGCATCTTCAAGGATCCCCATCATTTTCGTCCGGAGCGATTTGAGGA 66 FBan0004105 FBgn0015035 Cyp4e3 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e3 Cytochrome P450-4e3 "CG4105, P450, P-450, 4e3, cyp4e3" CDMC34021 2 21 19 DAC31-J02 1-CG4685-RA_1 CG4685 GCGCAACTCTACTCGGAGGAGGTCTTTGGTCCAGTGGTCTCCATCATACGGTTCCGAGACGAAGAA 66 FBan0004685 FBgn0039349 CG4685 3 3R amino acid catabolism; GO:0009063; gamma-aminobutyric acid catabolism; GO:0009450 succinate-semialdehyde dehydrogenase activity; GO:0004777 ; EC:1.2.1.24; ; GO:0004777 ; EC:1.2.1.24; ; GO:0004777 ; EC:1.2.1.24 mitochondrion; GO:0005739 CG4685 CG4685 anon-WO0118547.428 CDMC34021 2 22 19 DAC31-J02 1-CG4685-RA_1 CG4685 GCGCAACTCTACTCGGAGGAGGTCTTTGGTCCAGTGGTCTCCATCATACGGTTCCGAGACGAAGAA 66 FBan0004685 FBgn0039349 CG4685 3 3R amino acid catabolism; GO:0009063; gamma-aminobutyric acid catabolism; GO:0009450 succinate-semialdehyde dehydrogenase activity; GO:0004777 ; EC:1.2.1.24; ; GO:0004777 ; EC:1.2.1.24; ; GO:0004777 ; EC:1.2.1.24 mitochondrion; GO:0005739 CG4685 CG4685 anon-WO0118547.428 CDMC34022 2 23 19 DAC31-J14 1-CG4821-RA_1 CG4821 CTGTGTCACACTTCCAAGGAATGCATACCACCAGCCTTTGTGTGCGACAATACCCCAGACTGTGCG 66 FBan0004821 FBgn0023479 Tequila 3 3L ATP synthesis coupled proton transport; GO:0015986; chitin metabolism; GO:0006030; proteolysis; GO:0006508 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0008132 ; EC:3.4.21.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044; ; GO:0008061" extracellular region; GO:0005576; membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 Tequila Tequila "CG18153, CG4948, CG18403, CG4821, CG18153, CG4948, CG4948, CG18403, CK00198, graal, SP72, BEST:CK00198, BEST:GH18038, anon-EST:ParkEST161" CDMC34022 2 24 19 DAC31-J14 1-CG4821-RA_1 CG4821 CTGTGTCACACTTCCAAGGAATGCATACCACCAGCCTTTGTGTGCGACAATACCCCAGACTGTGCG 66 FBan0004821 FBgn0023479 Tequila 3 3L ATP synthesis coupled proton transport; GO:0015986; chitin metabolism; GO:0006030; proteolysis; GO:0006508 "chitin binding; GO:0008061; ATP binding; GO:0005524; ; GO:0005524; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; pancreatic elastase activity; GO:0008132 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; scavenger receptor activity; GO:0005044; ; GO:0008132 ; EC:3.4.21.-; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0004263 ; EC:3.4.21.1; ; GO:0005044; ; GO:0008061" extracellular region; GO:0005576; membrane; GO:0016020; proton-transporting two-sector ATPase complex; GO:0016469 Tequila Tequila "CG18153, CG4948, CG18403, CG4821, CG18153, CG4948, CG4948, CG18403, CK00198, graal, SP72, BEST:CK00198, BEST:GH18038, anon-EST:ParkEST161" CDMC34023 2 25 19 DAC31-N02 2-CG5069-RA_1 CG5069 TGAATGTGTACAACCCGCGGATCCATCACAGCGCCTATCCCTACCACTTGAACGAGGACAACTTGG 66 FBan0005069 FBgn0014143 croc 3 3L "regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 croc crocodile "CG5069, FD1, FD1 transcription unit, Dmfd1, fd1, fd78E: forkhead domain 78E, forkhead domain 78E" CDMC34023 2 26 19 DAC31-N02 2-CG5069-RA_1 CG5069 TGAATGTGTACAACCCGCGGATCCATCACAGCGCCTATCCCTACCACTTGAACGAGGACAACTTGG 66 FBan0005069 FBgn0014143 croc 3 3L "regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, head; GO:0007380" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 croc crocodile "CG5069, FD1, FD1 transcription unit, Dmfd1, fd1, fd78E: forkhead domain 78E, forkhead domain 78E" CDMC34024 2 1 20 DAC31-N14 2-CG5215-RA_1 CG5215 GTGAGCCTAGAGTCTTGAGTGTGTCGTTCAGTTAGCCATCTGTAGCGGTAGCTCAGCCCTCCCAGG 66 FBan0005215 FBgn0017453 Zn72D 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368 mRNA binding; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003729 nucleus; GO:0005634 Zn72D Zn72D "CG5215, CG5215" CDMC34024 2 2 20 DAC31-N14 2-CG5215-RA_1 CG5215 GTGAGCCTAGAGTCTTGAGTGTGTCGTTCAGTTAGCCATCTGTAGCGGTAGCTCAGCCCTCCCAGG 66 FBan0005215 FBgn0017453 Zn72D 3 3L RNA elongation from RNA polymerase II promoter; GO:0006368 mRNA binding; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003729 nucleus; GO:0005634 Zn72D Zn72D "CG5215, CG5215" CDMC34025 2 3 20 DAC32-B02 17-CG11129-RA_3 CG11129 AGCGTTTGGCCTGATCTGATTCAATTCCGGATTTGCACCAAAATGATGAGTCTAAGGATTTGCCTGCTG 69 FBan0011129 FBgn0004047 Yp3 X X phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 ATP binding; GO:0005524; ; GO:0005524; structural molecule activity; GO:0005198; catalytic activity; GO:0003824; ; GO:0005198; ; GO:0003824 Yp3 Yolk protein 3 "CG11129, YP3, yp3, YP, VG3, vitellogenin, YP[[3]], YP-3, fs(1)1526, yolk protein, yp, fs(1)A1526" CDMC34025 2 4 20 DAC32-B02 17-CG11129-RA_3 CG11129 AGCGTTTGGCCTGATCTGATTCAATTCCGGATTTGCACCAAAATGATGAGTCTAAGGATTTGCCTGCTG 69 FBan0011129 FBgn0004047 Yp3 X X phospholipid metabolism; GO:0006644; sex differentiation; GO:0007548; vitellogenesis; GO:0007296 ATP binding; GO:0005524; ; GO:0005524; structural molecule activity; GO:0005198; catalytic activity; GO:0003824; ; GO:0005198; ; GO:0003824 Yp3 Yolk protein 3 "CG11129, YP3, yp3, YP, VG3, vitellogenin, YP[[3]], YP-3, fs(1)1526, yolk protein, yp, fs(1)A1526" CDMC34026 2 5 20 DAC32-B14 2-CG11141-RA_2 CG11141 CGCGAGGATTGCGGAAGATCCTTGATTTCTGCGTCTGTGGCAAAGAGATCTTCGTGTTGGAGGGCAATC 69 FBan0011141 FBgn0033177 CG11141 2 2R CG11141 CG11141 CDMC34026 2 6 20 DAC32-B14 2-CG11141-RA_2 CG11141 CGCGAGGATTGCGGAAGATCCTTGATTTCTGCGTCTGTGGCAAAGAGATCTTCGTGTTGGAGGGCAATC 69 FBan0011141 FBgn0033177 CG11141 2 2R CG11141 CG11141 CDMC34027 2 7 20 DAC32-F02 9-CG11170-RB_1 CG11170 CCAGCTCTCCCTCAAGCTGACTTTTGGATTCGCGGACTTTCGCATTATCTTAACCGATTTCACGGCCGA 69 FBan0011170 FBgn0034705 CG11170 2 2R CG11170 CG11170 CDMC34027 2 8 20 DAC32-F02 9-CG11170-RB_1 CG11170 CCAGCTCTCCCTCAAGCTGACTTTTGGATTCGCGGACTTTCGCATTATCTTAACCGATTTCACGGCCGA 69 FBan0011170 FBgn0034705 CG11170 2 2R CG11170 CG11170 CDMC34028 2 9 20 DAC32-F14 21-CG11190-RA_3 CG11190 GGGCATCTCTTTGAGCATTCGTTCAATGCCACACGTCCGAGTTATGTTCTCAGTTTGCACACGGAAGCG 69 FBan0011190 FBgn0030035 CG11190 X X attachment of GPI anchor to protein; GO:0016255 GPI-anchor transamidase complex; GO:0042765; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG11190 CG11190 Dm*AAF46367/27-522 CDMC34028 2 10 20 DAC32-F14 21-CG11190-RA_3 CG11190 GGGCATCTCTTTGAGCATTCGTTCAATGCCACACGTCCGAGTTATGTTCTCAGTTTGCACACGGAAGCG 69 FBan0011190 FBgn0030035 CG11190 X X attachment of GPI anchor to protein; GO:0016255 GPI-anchor transamidase complex; GO:0042765; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG11190 CG11190 Dm*AAF46367/27-522 CDMC34029 2 11 20 DAC32-J02 18-CG11247-RB_1 CG11247 GATCTGCCACCAGACCTTTGCCCATTCAAGCGTACTAAAACTGCACATCCGAAAGCATACGGGGGAAAA 69 FBan0011247 FBgn0037120 CG11247 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11247 CG11247 CDMC34029 2 12 20 DAC32-J02 18-CG11247-RB_1 CG11247 GATCTGCCACCAGACCTTTGCCCATTCAAGCGTACTAAAACTGCACATCCGAAAGCATACGGGGGAAAA 69 FBan0011247 FBgn0037120 CG11247 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG11247 CG11247 CDMC34030 2 13 20 DAC32-J14 10-CG11258-RA_1 CG11258 TCGACCGATATTCTGTTAATATCAAGCCATGGTCTTCCTGAACCTTCCCTTGCTGGTACGGTCCCGTGG 69 FBan0011258 FBgn0036335 mRpL20 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL20 mitochondrial ribosomal protein L20 "CG11258, CG11258, CG11258, L20, anon-WO0118547.265, mitochondrial ribosomal protein L20" CDMC34030 2 14 20 DAC32-J14 10-CG11258-RA_1 CG11258 TCGACCGATATTCTGTTAATATCAAGCCATGGTCTTCCTGAACCTTCCCTTGCTGGTACGGTCCCGTGG 69 FBan0011258 FBgn0036335 mRpL20 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL20 mitochondrial ribosomal protein L20 "CG11258, CG11258, CG11258, L20, anon-WO0118547.265, mitochondrial ribosomal protein L20" CDMC34031 2 15 20 DAC32-N02 2-CG1128-RA_1 CG1128 AGGGGCTTCTCTTGTACTCAGAGACCAAGACGAATCCGAAGTGTCTAAACGAGTTGGACGACTGCCGGT 69 FBan0001128 FBgn0015577 alpha-Est9 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0004104 ; EC:3.1.1.8 alpha-Est9 alpha-Esterase-9 "CG1128, alphaE9, J, fragment J, aE9, alpha-Est9" CDMC34031 2 16 20 DAC32-N02 2-CG1128-RA_1 CG1128 AGGGGCTTCTCTTGTACTCAGAGACCAAGACGAATCCGAAGTGTCTAAACGAGTTGGACGACTGCCGGT 69 FBan0001128 FBgn0015577 alpha-Est9 3 3R carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1; cholinesterase activity; GO:0004104 ; EC:3.1.1.8; ; GO:0004104 ; EC:3.1.1.8 alpha-Est9 alpha-Esterase-9 "CG1128, alphaE9, J, fragment J, aE9, alpha-Est9" CDMC34032 2 17 20 DAC32-N14 8-CG11303-RA_1 CG11303 CCACCTGACCATTCTGTTCGGCAAGAACGACAACACCCATCCCATGAACATGAACCGGAAAAAGAAGCA 69 FBan0011303 FBgn0020372 TM4SF 2 2R integral to membrane; GO:0016021; plasma membrane; GO:0005886 TM4SF Transmembrane 4 superfamily "CG11303, CG11303, CG11303, CG11303, Dm.Tsp60A" CDMC34032 2 18 20 DAC32-N14 8-CG11303-RA_1 CG11303 CCACCTGACCATTCTGTTCGGCAAGAACGACAACACCCATCCCATGAACATGAACCGGAAAAAGAAGCA 69 FBan0011303 FBgn0020372 TM4SF 2 2R integral to membrane; GO:0016021; plasma membrane; GO:0005886 TM4SF Transmembrane 4 superfamily "CG11303, CG11303, CG11303, CG11303, Dm.Tsp60A" CDMC34033 2 19 20 DAC33-B02 11-CG12567-RA_1 CG12567 GCCTGGAAAGTGGGACAATATGGTAGGCGGTGGACTTTCAGTCGGCTTTGGTATTAAGGAAACAGCCAT 69 FBgn0039958 CG12567 thiamin diphosphokinase activity; GO:0004788 ; EC:2.7.6.2; ; GO:0004788 ; EC:2.7.6.2 CG12567 CG12567 CDMC34033 2 20 20 DAC33-B02 11-CG12567-RA_1 CG12567 GCCTGGAAAGTGGGACAATATGGTAGGCGGTGGACTTTCAGTCGGCTTTGGTATTAAGGAAACAGCCAT 69 FBgn0039958 CG12567 thiamin diphosphokinase activity; GO:0004788 ; EC:2.7.6.2; ; GO:0004788 ; EC:2.7.6.2 CG12567 CG12567 CDMC34034 2 21 20 DAC33-B14 5-CG12586-RA_1 CG12586 GGGATGTGAAAAGGCGAGAAGGACATCTCGGAAGCGAAAATGTTGCTCAAAAGCTAAGCATTGGGCCCC 69 FBan0012586 FBgn0037260 CG12586 3 3R CG12586 CG12586 CDMC34034 2 22 20 DAC33-B14 5-CG12586-RA_1 CG12586 GGGATGTGAAAAGGCGAGAAGGACATCTCGGAAGCGAAAATGTTGCTCAAAAGCTAAGCATTGGGCCCC 69 FBan0012586 FBgn0037260 CG12586 3 3R CG12586 CG12586 CDMC34035 2 23 20 DAC33-F02 1-CG12630-RA_1 CG12630 GGCAGCAGATCCAAGTGAAAAAGGAGTTCAGCATGGAAGCATGTCGGGAGAGTCCTCGGTCTGTAAGCA 69 FBan0012630 FBgn0028979 tio 2 2L "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; transcription factor activity; GO:0003700; ; GO:0008270; ; GO:0003700 nucleus; GO:0005634 tio tiptop "CG12630, CG12630, CG12630, CG12630, tiptop" CDMC34035 2 24 20 DAC33-F02 1-CG12630-RA_1 CG12630 GGCAGCAGATCCAAGTGAAAAAGGAGTTCAGCATGGAAGCATGTCGGGAGAGTCCTCGGTCTGTAAGCA 69 FBan0012630 FBgn0028979 tio 2 2L "regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; transcription factor activity; GO:0003700; ; GO:0008270; ; GO:0003700 nucleus; GO:0005634 tio tiptop "CG12630, CG12630, CG12630, CG12630, tiptop" CDMC34036 2 25 20 DAC33-F14 22-CG1264-RA_1 CG1264 TCCGTAATCAAACGCTAGCAACTAGTGGAATCTAGGAGTCTAGGTGCCATATTCATTCACGTAGGGGCT 69 FBan0001264 FBgn0002522 lab 3 3R anterior/posterior axis specification; GO:0009948; brain development; GO:0007420; cell differentiation; GO:0030154; cell fate determination; GO:0001709; embryonic development; GO:0009790; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704; ; GO:0003704 nucleus; GO:0005634 lab labial "CG1264, EfR9, F90-2, F24, lb, F121, Labial, Lab, BG:DS00004.9, F90, l(3)01241, l(3)84Ac, labial" CDMC34036 2 26 20 DAC33-F14 22-CG1264-RA_1 CG1264 TCCGTAATCAAACGCTAGCAACTAGTGGAATCTAGGAGTCTAGGTGCCATATTCATTCACGTAGGGGCT 69 FBan0001264 FBgn0002522 lab 3 3R anterior/posterior axis specification; GO:0009948; brain development; GO:0007420; cell differentiation; GO:0030154; cell fate determination; GO:0001709; embryonic development; GO:0009790; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704; ; GO:0003704 nucleus; GO:0005634 lab labial "CG1264, EfR9, F90-2, F24, lb, F121, Labial, Lab, BG:DS00004.9, F90, l(3)01241, l(3)84Ac, labial" CDMC34037 2 1 21 DAC33-J02 23-CG1268-RA_1 CG1268 GCTGGTTAGGAAAATAGAGTGACTGCTAACTAAATTATTCTGCAATAATCGTCACATTAGCTGTTTGTT 69 FBan0001268 FBgn0035521 CG1268 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-translocating V-type ATPase complex; GO:0016471; hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 CG1268 CG1268 CDMC34037 2 2 21 DAC33-J02 23-CG1268-RA_1 CG1268 GCTGGTTAGGAAAATAGAGTGACTGCTAACTAAATTATTCTGCAATAATCGTCACATTAGCTGTTTGTT 69 FBan0001268 FBgn0035521 CG1268 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-translocating V-type ATPase complex; GO:0016471; hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 CG1268 CG1268 CDMC34038 2 3 21 DAC33-J14 23-CG12699-RA_1 CG12699 CCACATTGGGGGACACAAATTGTTAGTTTTAAAACATTAACCAAATTTCTTGTACCACATTGCGATATT 69 FBan0012699 FBgn0046294 CG12699 2 2R CG12699 CG12699 "bs24f01.y1, BEST:GH14656, anon-WO0140519.144, NEST:bs24f01" CDMC34038 2 4 21 DAC33-J14 23-CG12699-RA_1 CG12699 CCACATTGGGGGACACAAATTGTTAGTTTTAAAACATTAACCAAATTTCTTGTACCACATTGCGATATT 69 FBan0012699 FBgn0046294 CG12699 2 2R CG12699 CG12699 "bs24f01.y1, BEST:GH14656, anon-WO0140519.144, NEST:bs24f01" CDMC34039 2 5 21 DAC33-N02 4-CG12752-RA_1 CG12752 CCGCCGAGAATGATAAATGGAAGGTCGTCTCCGATTGCTACCGAATGCAGGAGGTCTGAGATCCACACA 69 FBan0012752 FBgn0028411 Nxt1 2 2R mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein export from nucleus; GO:0006611; protein import into nucleus; GO:0006606; snRNA export from nucleus; GO:0006408; tRNA export from nucleus; GO:0006409 protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nucleoplasm; GO:0005654; nucleus; GO:0005634 Nxt1 NTF2-related export protein 1 "CG12752, nxt1, dmNXT1, DmNXT1, p15, dNxt, dmP15, Nxt, NTF2-related export protein 1" CDMC34039 2 6 21 DAC33-N02 4-CG12752-RA_1 CG12752 CCGCCGAGAATGATAAATGGAAGGTCGTCTCCGATTGCTACCGAATGCAGGAGGTCTGAGATCCACACA 69 FBan0012752 FBgn0028411 Nxt1 2 2R mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein export from nucleus; GO:0006611; protein import into nucleus; GO:0006606; snRNA export from nucleus; GO:0006408; tRNA export from nucleus; GO:0006409 protein transporter activity; GO:0008565; ; GO:0008565 cytoplasm; GO:0005737; nuclear membrane; GO:0005635; nucleoplasm; GO:0005654; nucleus; GO:0005634 Nxt1 NTF2-related export protein 1 "CG12752, nxt1, dmNXT1, DmNXT1, p15, dNxt, dmP15, Nxt, NTF2-related export protein 1" CDMC34040 2 7 21 DAC33-N14 22-CG12765-RA_1 CG12765 TCCTGTTTTCAGACGCATTACCAGTGTCTATGGATCATGTGCTACAAGTTTTGGAACCGACAGTCCCAT 69 FBan0012765 FBgn0033813 CG12765 2 2R CG12765 CG12765 CDMC34040 2 8 21 DAC33-N14 22-CG12765-RA_1 CG12765 TCCTGTTTTCAGACGCATTACCAGTGTCTATGGATCATGTGCTACAAGTTTTGGAACCGACAGTCCCAT 69 FBan0012765 FBgn0033813 CG12765 2 2R CG12765 CG12765 CDMC34041 2 9 21 DAC34-B02 2-CG4335-RA_2 CG4335 CGCCGGTATCCCGCCGCTTATGATGTACTGTGCAGTGTCCAAGTTCCTGGAGAGTACATCGAAAAAGGG 69 FBan0004335 FBgn0038795 CG4335 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG4335 CG4335 CDMC34041 2 10 21 DAC34-B02 2-CG4335-RA_2 CG4335 CGCCGGTATCCCGCCGCTTATGATGTACTGTGCAGTGTCCAAGTTCCTGGAGAGTACATCGAAAAAGGG 69 FBan0004335 FBgn0038795 CG4335 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; vitamin biosynthesis; GO:0009110 gamma-butyrobetaine dioxygenase activity; GO:0008336 ; EC:1.14.11.1; ; GO:0008336 ; EC:1.14.11.1 CG4335 CG4335 CDMC34042 2 11 21 DAC34-B14 15-CG4349-RA_4 CG4349 GCATGCTGGTGCGTCAGAACTTCGCCAAAAGTTGCGAGAAGAAGCTAAACGATCAGATCAACATGGAGT 69 FBan0004349 FBgn0030449 CG4349 X X iron ion homeostasis; GO:0006879 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 CG4349 CG4349 CDMC34042 2 12 21 DAC34-B14 15-CG4349-RA_4 CG4349 GCATGCTGGTGCGTCAGAACTTCGCCAAAAGTTGCGAGAAGAAGCTAAACGATCAGATCAACATGGAGT 69 FBan0004349 FBgn0030449 CG4349 X X iron ion homeostasis; GO:0006879 ferric iron binding; GO:0008199; ferrous iron binding; GO:0008198; ; GO:0008198; ; GO:0008199 ferritin complex; GO:0008043 CG4349 CG4349 CDMC34043 2 13 21 DAC34-F02 15-CG4381-RA_1 CG4381 TCGCCAATGTCTCCAATTTCGATGTTGTGGGATTCGACATTAGCAAATATCCGAATGTGGCCCGATGGT 69 FBan0004381 FBgn0010039 GstD3 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cellular component unknown; GO:0008372 GstD3 Glutathione S transferase D3 "CG4381, CG4381, DmGST22, gstD22, Gst, DmGSTD3, BcDNA:LP11313, GstD22: Glutathione S transferase D22, Glutathione S transferase D22, Glutathione S transferase D3" CDMC34043 2 14 21 DAC34-F02 15-CG4381-RA_1 CG4381 TCGCCAATGTCTCCAATTTCGATGTTGTGGGATTCGACATTAGCAAATATCCGAATGTGGCCCGATGGT 69 FBan0004381 FBgn0010039 GstD3 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cellular component unknown; GO:0008372 GstD3 Glutathione S transferase D3 "CG4381, CG4381, DmGST22, gstD22, Gst, DmGSTD3, BcDNA:LP11313, GstD22: Glutathione S transferase D22, Glutathione S transferase D22, Glutathione S transferase D3" CDMC34044 2 15 21 DAC34-F14 8-CG4394-RB_1 CG4394 GGCGCATCAAGGATTACTCGAAAAAACTGGAAGAGTCCAAGCAGTACGACACCATCCTCCATAGCGCCA 69 FBan0004394 FBgn0030748 Traf3 X X defense response; GO:0006952; signal transduction; GO:0007165 Traf3 Traf3 "CG4394, dTRAF3, TRAF3, TRAF6" CDMC34044 2 16 21 DAC34-F14 8-CG4394-RB_1 CG4394 GGCGCATCAAGGATTACTCGAAAAAACTGGAAGAGTCCAAGCAGTACGACACCATCCTCCATAGCGCCA 69 FBan0004394 FBgn0030748 Traf3 X X defense response; GO:0006952; signal transduction; GO:0007165 Traf3 Traf3 "CG4394, dTRAF3, TRAF3, TRAF6" CDMC34045 2 17 21 DAC34-J02 2-CG4434-RA_1 CG4434 CGCCCGATGTGAACACTGGTCCGCGTGAGATGAGCTGGATTGTTGATCAGTACCAGAAGACATTTGGCT 69 FBan0004434 FBgn0039071 CG4434 3 3R glutamate catabolism to 2-oxoglutarate; GO:0019551 glutamate dehydrogenase [NAD(P)+] activity; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3 mitochondrial matrix; GO:0005759 CG4434 CG4434 CDMC34045 2 18 21 DAC34-J02 2-CG4434-RA_1 CG4434 CGCCCGATGTGAACACTGGTCCGCGTGAGATGAGCTGGATTGTTGATCAGTACCAGAAGACATTTGGCT 69 FBan0004434 FBgn0039071 CG4434 3 3R glutamate catabolism to 2-oxoglutarate; GO:0019551 glutamate dehydrogenase [NAD(P)+] activity; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3; ; GO:0004353 ; EC:1.4.1.3 mitochondrial matrix; GO:0005759 CG4434 CG4434 CDMC34046 2 19 21 DAC34-J14 9-CG4443-RA_2 CG4443 AGCACACTGACTGCCTCACCGGACTTAACTGGAGGGCCTATTACCTGAAGTACATCACTGGTAGTTGGA 69 FBan0004443 FBgn0015374 crl X X courtship behavior; GO:0007619; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior; GO:0008049; male meiosis; GO:0007140; spermatogenesis; GO:0007283; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004840 crl courtless "CG4443, col, courtless, Ubc7" CDMC34046 2 20 21 DAC34-J14 9-CG4443-RA_2 CG4443 AGCACACTGACTGCCTCACCGGACTTAACTGGAGGGCCTATTACCTGAAGTACATCACTGGTAGTTGGA 69 FBan0004443 FBgn0015374 crl X X courtship behavior; GO:0007619; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior; GO:0008049; male meiosis; GO:0007140; spermatogenesis; GO:0007283; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840; ; GO:0004840 crl courtless "CG4443, col, courtless, Ubc7" CDMC34047 2 21 21 DAC34-N02 15-CG4482-RA_1 CG4482 CCCCCAGTGGAGCGTATTCGTGACATGGATCACTGGTGATTGCCATTGGACAAACCATAAAAATCGACT 69 FBan0004482 FBgn0028528 mol 2 2L asymmetric protein localization; GO:0008105; learning and/or memory; GO:0007611; olfactory learning; GO:0008355 protein binding; GO:0005515; ; GO:0005515 basal part of cell; GO:0045178; plasma membrane; GO:0005886 mol moladietz "CG4482, CG15268, CG4482, BG:DS01219.1, nip, numb-interacting protein, moladietz" CDMC34047 2 22 21 DAC34-N02 15-CG4482-RA_1 CG4482 CCCCCAGTGGAGCGTATTCGTGACATGGATCACTGGTGATTGCCATTGGACAAACCATAAAAATCGACT 69 FBan0004482 FBgn0028528 mol 2 2L asymmetric protein localization; GO:0008105; learning and/or memory; GO:0007611; olfactory learning; GO:0008355 protein binding; GO:0005515; ; GO:0005515 basal part of cell; GO:0045178; plasma membrane; GO:0005886 mol moladietz "CG4482, CG15268, CG4482, BG:DS01219.1, nip, numb-interacting protein, moladietz" CDMC34048 2 23 21 DAC34-N14 23-CG4491-RA_20 CG4491 GCGCTAGTTACACTTAAGTTTCGCAAACAGAAAATAATCAACCACCTAAAGAACAGTAGTAGCCGCAAA 69 FBan0004491 FBgn0005771 noc 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 noc no ocelli "CG4491, Sco: Scutoid, l(2)br22, l(2)br29, br22, br29, l(2)35Ba, l(2)35Ba/nocA, l35Ba, nocA, Scutoid, BG:DS04641.1, Sco" CDMC34048 2 24 21 DAC34-N14 23-CG4491-RA_20 CG4491 GCGCTAGTTACACTTAAGTTTCGCAAACAGAAAATAATCAACCACCTAAAGAACAGTAGTAGCCGCAAA 69 FBan0004491 FBgn0005771 noc 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal system development (sensu Insecta); GO:0007424 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 noc no ocelli "CG4491, Sco: Scutoid, l(2)br22, l(2)br29, br22, br29, l(2)35Ba, l(2)35Ba/nocA, l35Ba, nocA, Scutoid, BG:DS04641.1, Sco" CDMC34049 2 25 21 DAC35-B02 3-CG8799-RA_4 CG8799 GGTCCTTCCCGTGGTTCTGGTGGATGTGATGCAGATTGCGCTTTGGCTAGCCGGAATAATCATCGTTAT 69 FBan0008799 FBgn0010549 l(2)03659 2 2R defense response; GO:0006952; development; GO:0007275; extracellular transport; GO:0006858; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; ; GO:0042626" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 l(2)03659 lethal (2) 03659 "CG8799, CG11803, CG8799, A, hspr, Hsp related" CDMC34049 2 26 21 DAC35-B02 3-CG8799-RA_4 CG8799 GGTCCTTCCCGTGGTTCTGGTGGATGTGATGCAGATTGCGCTTTGGCTAGCCGGAATAATCATCGTTAT 69 FBan0008799 FBgn0010549 l(2)03659 2 2R defense response; GO:0006952; development; GO:0007275; extracellular transport; GO:0006858; response to toxin; GO:0009636; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215; ; GO:0042626" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 l(2)03659 lethal (2) 03659 "CG8799, CG11803, CG8799, A, hspr, Hsp related" CDMC34050 2 1 22 DAC35-B14 8-CG8808-RA_1 CG8808 AGGTGGATGCGCCTACAGAGAGTTCCATTCAGTACTTTCTCGACAGGCTCTACATGTCTCGCATCAGCA 69 FBan0008808 FBgn0017558 Pdk 2 2R protein amino acid phosphorylation; GO:0006468; pyruvate metabolism; GO:0006090; regulation of phosphate metabolism; GO:0019220; tricarboxylic acid cycle; GO:0006099 ATP binding; GO:0005524; ; GO:0005524; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; [pyruvate dehydrogenase (lipoamide)] kinase activity; GO:0004740 ; EC:2.7.1.99; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004740 ; EC:2.7.1.99; ; GO:0004740 ; EC:2.7.1.99; ; GO:0004740 ; EC:2.7.1.99 mitochondrial matrix; GO:0005759 Pdk Pyruvate dehydrogenase kinase "CG8808, CG8808, DmPDK, DmPdk, pyruvate dehydrogenase kinase, BcDNA:LD09837" CDMC34050 2 2 22 DAC35-B14 8-CG8808-RA_1 CG8808 AGGTGGATGCGCCTACAGAGAGTTCCATTCAGTACTTTCTCGACAGGCTCTACATGTCTCGCATCAGCA 69 FBan0008808 FBgn0017558 Pdk 2 2R protein amino acid phosphorylation; GO:0006468; pyruvate metabolism; GO:0006090; regulation of phosphate metabolism; GO:0019220; tricarboxylic acid cycle; GO:0006099 ATP binding; GO:0005524; ; GO:0005524; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; [pyruvate dehydrogenase (lipoamide)] kinase activity; GO:0004740 ; EC:2.7.1.99; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004740 ; EC:2.7.1.99; ; GO:0004740 ; EC:2.7.1.99; ; GO:0004740 ; EC:2.7.1.99 mitochondrial matrix; GO:0005759 Pdk Pyruvate dehydrogenase kinase "CG8808, CG8808, DmPDK, DmPdk, pyruvate dehydrogenase kinase, BcDNA:LD09837" CDMC34051 2 3 22 DAC35-F02 12-CG8834-RA_3 CG8834 CCATCCGGATTGCGCAGTACCTTAAGAAGAGGGGTCTTAACCACAAGGATGTCATTGGAATTGCAGCCA 69 FBan0008834 FBgn0033733 CG8834 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0016207 ; EC:6.2.1.12 CG8834 CG8834 CDMC34051 2 4 22 DAC35-F02 12-CG8834-RA_3 CG8834 CCATCCGGATTGCGCAGTACCTTAAGAAGAGGGGTCTTAACCACAAGGATGTCATTGGAATTGCAGCCA 69 FBan0008834 FBgn0033733 CG8834 2 2R metabolism; GO:0008152 ligase activity; GO:0016874 ; EC:6.-.-.-; 4-coumarate-CoA ligase activity; GO:0016207 ; EC:6.2.1.12; ; GO:0016874 ; EC:6.-.-.-; ; GO:0016207 ; EC:6.2.1.12 CG8834 CG8834 CDMC34052 2 5 22 DAC35-F14 2-CG8851-RA_1 CG8851 GGAGCCAAAACTCGACGTCCAGTTTGATCCAGGAACGGGATAGTCTGATAGCTGAGCTCCAGACGCAAC 69 FBan0008851 FBgn0031546 CG8851 2 2L CG8851 CG8851 CDMC34052 2 6 22 DAC35-F14 2-CG8851-RA_1 CG8851 GGAGCCAAAACTCGACGTCCAGTTTGATCCAGGAACGGGATAGTCTGATAGCTGAGCTCCAGACGCAAC 69 FBan0008851 FBgn0031546 CG8851 2 2L CG8851 CG8851 CDMC34053 2 7 22 DAC35-J02 2-CG8891-RA_1 CG8891 CCCGCGCACCATTGTGTCAAAGAAGATTGATCTTCCGGAATTGCAAGGCGACATCGACGAGATTGCCAT 69 FBan0008891 FBgn0031663 CG8891 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0019219" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8891 CG8891 CDMC34053 2 8 22 DAC35-J02 2-CG8891-RA_1 CG8891 CCCGCGCACCATTGTGTCAAAGAAGATTGATCTTCCGGAATTGCAAGGCGACATCGACGAGATTGCCAT 69 FBan0008891 FBgn0031663 CG8891 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0019219" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG8891 CG8891 CDMC34054 2 9 22 DAC35-J14 16-CG8908-RB_1 CG8908 CGGAATGTATGAGGCGATACGTATGAGTACCTTCAGCTTGAAGCAGCTACCTTACCTGATCTTCAGCGG 69 FBan0008908 FBgn0034493 CG8908 2 2R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG8908 CG8908 CDMC34054 2 10 22 DAC35-J14 16-CG8908-RB_1 CG8908 CGGAATGTATGAGGCGATACGTATGAGTACCTTCAGCTTGAAGCAGCTACCTTACCTGATCTTCAGCGG 69 FBan0008908 FBgn0034493 CG8908 2 2R transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG8908 CG8908 CDMC34055 2 11 22 DAC35-N02 3-CG8945-RC_1 CG8945 TCCTGAATCCGGACGGATATGCGTACAGCCACGAGTACGATCGTTTCTGGAAGAAGTCGCGATCTCAGC 69 FBan0008945 FBgn0030815 CG8945 X X proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8945 CG8945 CDMC34055 2 12 22 DAC35-N02 3-CG8945-RC_1 CG8945 TCCTGAATCCGGACGGATATGCGTACAGCCACGAGTACGATCGTTTCTGGAAGAAGTCGCGATCTCAGC 69 FBan0008945 FBgn0030815 CG8945 X X proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG8945 CG8945 CDMC34056 2 13 22 DAC35-N14 14-CG8957-RA_2 CG8957 TGTGGACGGATGTCATTCAGGGCACCGTAATGATCGGATCCATGCTCATAGTCATCATAAAGGGCACTT 69 FBan0008957 FBgn0039393 CG8957 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8957 CG8957 CDMC34056 2 14 22 DAC35-N14 14-CG8957-RA_2 CG8957 TGTGGACGGATGTCATTCAGGGCACCGTAATGATCGGATCCATGCTCATAGTCATCATAAAGGGCACTT 69 FBan0008957 FBgn0039393 CG8957 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8957 CG8957 CDMC34057 2 15 22 DAC36-B02 18-CG7026-RA_1 CG7026 CGACAGCACGGTCATGGCGACCAATATGTTTACGGGATTCGCTACTTTTGGGGCAGGTCTCTGCG 65 FBan0007026 FBgn0038276 CG7026 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen:potassium-exchanging ATPase activity; GO:0008900 ; EC:3.6.3.10; ; GO:0008900 ; EC:3.6.3.10; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen:potassium-exchanging ATPase complex; GO:0005889; proton-transporting two-sector ATPase complex; GO:0016469 CG7026 CG7026 CDMC34057 2 16 22 DAC36-B02 18-CG7026-RA_1 CG7026 CGACAGCACGGTCATGGCGACCAATATGTTTACGGGATTCGCTACTTTTGGGGCAGGTCTCTGCG 65 FBan0007026 FBgn0038276 CG7026 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen:potassium-exchanging ATPase activity; GO:0008900 ; EC:3.6.3.10; ; GO:0008900 ; EC:3.6.3.10; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen:potassium-exchanging ATPase complex; GO:0005889; proton-transporting two-sector ATPase complex; GO:0016469 CG7026 CG7026 CDMC34058 2 17 22 DAC36-B14 3-CG7059-RA_1 CG7059 ACTTCTACACCATTTGCAGCAATCCCATATTCGATGATGTTCCTCGCGGTGAGTTCCCCCTCGCG 65 FBan0007059 FBgn0038957 CG7059 3 3R glycolysis; GO:0006096; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 microtubule; GO:0005874 CG7059 CG7059 CDMC34058 2 18 22 DAC36-B14 3-CG7059-RA_1 CG7059 ACTTCTACACCATTTGCAGCAATCCCATATTCGATGATGTTCCTCGCGGTGAGTTCCCCCTCGCG 65 FBan0007059 FBgn0038957 CG7059 3 3R glycolysis; GO:0006096; microtubule-based movement; GO:0007018 structural molecule activity; GO:0005198; ; GO:0005198; phosphoglycerate mutase activity; GO:0004619 ; EC:5.4.2.1; ; GO:0004619 ; EC:5.4.2.1 microtubule; GO:0005874 CG7059 CG7059 CDMC34059 2 19 22 DAC36-F02 6-CG7197-RA_1 CG7197 TAGCTGTTACGCGGGAAGAGCTCTACCGGATGCTGCAACATGAGGATCTGAGCAAGGCCAGTTTG 65 FBan0007197 FBgn0035866 CG7197 3 3L cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7197 CG7197 CDMC34059 2 20 22 DAC36-F02 6-CG7197-RA_1 CG7197 TAGCTGTTACGCGGGAAGAGCTCTACCGGATGCTGCAACATGAGGATCTGAGCAAGGCCAGTTTG 65 FBan0007197 FBgn0035866 CG7197 3 3L cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG7197 CG7197 CDMC34060 2 21 22 DAC36-F14 6-CG7223-RB_1 CG7223 AAGCTGCTCCAGACGAAGGAGGACTACCTCGATGTGGATATCGCCAATCTGGATACACCGCCCTC 65 FBan0007223 FBgn0010389 htl 3 3R cardioblast differentiation; GO:0010002; cell migration; GO:0016477; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm development; GO:0007398; endoderm development; GO:0007492; endodermal cell fate determination; GO:0007493; fibroblast growth factor receptor signaling pathway; GO:0008543; gastrulation; GO:0007369; germ cell migration; GO:0008354; glial cell migration; GO:0008347; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; larval visceral muscle development; GO:0007523; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell migration; GO:0008078; muscle development; GO:0007517; pericardial cell differentiation; GO:0007513; pole cell migration; GO:0007280; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; salivary gland development; GO:0007431; somatic muscle development; GO:0007525; ventral cord development; GO:0007419; visceral muscle development; GO:0007522 ATP binding; GO:0005524; ; GO:0005524; fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007; ; GO:0005007; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0005007; ; GO:0005007; ; GO:0004713 ; EC:2.7.1.112 integral to membrane; GO:0016021; plasma membrane; GO:0005886 htl heartless "CG7223, CG7223, CG7223, CG7223, dtk1, DFR1, DPR3, DFGF-R2, DFR-1, FGFR2, DFR1/DFGF-R2, FR1: Fragment 1, DFGF-R1, FGF-R2, DTRK(FR1), Dfr-1, DmHD-38, FGFR, Htl, FGF receptor, fibroblast growth factor receptor, HTL/FGFR1, CT22273, CT39172, EMS2, j372, i150, i79, i100, Dfr1, Dtk1, Fr1: Fibroblast growth factor receptor 1, HD-38, Tk1, Fibroblast growth factor receptor 1, FR1, heartless" CDMC34060 2 22 22 DAC36-F14 6-CG7223-RB_1 CG7223 AAGCTGCTCCAGACGAAGGAGGACTACCTCGATGTGGATATCGCCAATCTGGATACACCGCCCTC 65 FBan0007223 FBgn0010389 htl 3 3R cardioblast differentiation; GO:0010002; cell migration; GO:0016477; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm development; GO:0007398; endoderm development; GO:0007492; endodermal cell fate determination; GO:0007493; fibroblast growth factor receptor signaling pathway; GO:0008543; gastrulation; GO:0007369; germ cell migration; GO:0008354; glial cell migration; GO:0008347; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; larval visceral muscle development; GO:0007523; lymph gland development (sensu Arthropoda); GO:0048542; mesoderm development; GO:0007498; mesoderm migration; GO:0007509; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell migration; GO:0008078; muscle development; GO:0007517; pericardial cell differentiation; GO:0007513; pole cell migration; GO:0007280; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; salivary gland development; GO:0007431; somatic muscle development; GO:0007525; ventral cord development; GO:0007419; visceral muscle development; GO:0007522 ATP binding; GO:0005524; ; GO:0005524; fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007; ; GO:0005007; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0005007; ; GO:0005007; ; GO:0004713 ; EC:2.7.1.112 integral to membrane; GO:0016021; plasma membrane; GO:0005886 htl heartless "CG7223, CG7223, CG7223, CG7223, dtk1, DFR1, DPR3, DFGF-R2, DFR-1, FGFR2, DFR1/DFGF-R2, FR1: Fragment 1, DFGF-R1, FGF-R2, DTRK(FR1), Dfr-1, DmHD-38, FGFR, Htl, FGF receptor, fibroblast growth factor receptor, HTL/FGFR1, CT22273, CT39172, EMS2, j372, i150, i79, i100, Dfr1, Dtk1, Fr1: Fibroblast growth factor receptor 1, HD-38, Tk1, Fibroblast growth factor receptor 1, FR1, heartless" CDMC34061 2 23 22 DAC36-J02 2-CG7301-RA_1 CG7301 AGCAGAATGAGATCATGCGGCGCAAACAGGACGAGGTGGTGACGCTGGAAATGCAAATCAGACAG 65 FBgn0038559 CDMC34061 2 24 22 DAC36-J02 2-CG7301-RA_1 CG7301 AGCAGAATGAGATCATGCGGCGCAAACAGGACGAGGTGGTGACGCTGGAAATGCAAATCAGACAG 65 FBgn0038559 CDMC34062 2 25 22 DAC36-J14 3-CG7348-RA_1 CG7348 TGTGGACTTACGAATAGTGTGGAGCGAGTCCAAAGCGATTGCACGCGATACCGACAATGCCTGGA 65 FBan0007348 FBgn0036940 CG7348 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7348 CG7348 anon-EST:ParkEST360 CDMC34062 2 26 22 DAC36-J14 3-CG7348-RA_1 CG7348 TGTGGACTTACGAATAGTGTGGAGCGAGTCCAAAGCGATTGCACGCGATACCGACAATGCCTGGA 65 FBan0007348 FBgn0036940 CG7348 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7348 CG7348 anon-EST:ParkEST360 CDMC34063 2 1 23 DAC36-N02 18-CG7424-RA_2 CG7424 CAGGCGTCGTTACGACAGGAAACAGCAGGGTTTCGGAGGTCAGACCAAGCCCATCTTCAGGAAGA 65 FBan0007424 FBgn0031980 RpL36A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL36A Ribosomal protein L36A "CG7424, anon-EST:fe1B2, anon-fast-evolving-1B2, Ribosomal protein L36A" CDMC34063 2 2 23 DAC36-N02 18-CG7424-RA_2 CG7424 CAGGCGTCGTTACGACAGGAAACAGCAGGGTTTCGGAGGTCAGACCAAGCCCATCTTCAGGAAGA 65 FBan0007424 FBgn0031980 RpL36A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL36A Ribosomal protein L36A "CG7424, anon-EST:fe1B2, anon-fast-evolving-1B2, Ribosomal protein L36A" CDMC34064 2 3 23 DAC36-N14 3-CG7442-RA_1 CG7442 CATGACCAGCAGTACGTTGTACTCCACCTGTTTCGTGATCGGGATCGAGCTAGTGGGACCCAAGC 65 FBan0007442 FBgn0037140 CG7442 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7442 CG7442 CDMC34064 2 4 23 DAC36-N14 3-CG7442-RA_1 CG7442 CATGACCAGCAGTACGTTGTACTCCACCTGTTTCGTGATCGGGATCGAGCTAGTGGGACCCAAGC 65 FBan0007442 FBgn0037140 CG7442 3 3L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7442 CG7442 CDMC34065 2 5 23 DAC37-B02 12-CG12869-RA_12 CG12869 CAGGAGCTCCAGGGCTAGATAGAAGCTTATCGCGTAGCAACCGCCACGATACCTATCGAGCAGCA 65 FBan0012869 FBgn0033943 CG12869 2 2R cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399 receptor binding; GO:0005102; ; GO:0005102; carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG12869 CG12869 CDMC34065 2 6 23 DAC37-B02 12-CG12869-RA_12 CG12869 CAGGAGCTCCAGGGCTAGATAGAAGCTTATCGCGTAGCAACCGCCACGATACCTATCGAGCAGCA 65 FBan0012869 FBgn0033943 CG12869 2 2R cell adhesion; GO:0007155; ectoderm development; GO:0007398; nervous system development; GO:0007399 receptor binding; GO:0005102; ; GO:0005102; carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG12869 CG12869 CDMC34066 2 7 23 DAC37-B14 24-CG12895-RA_1 CG12895 TATAAGCATACAAAACAATGTATTAAATGAATGTGTTATTCTACTCCTGATCCTTAAAAGACCAA 65 FBan0012895 FBgn0033523 CG12895 2 2R CG12895 CG12895 BcDNA:RE29446 CDMC34066 2 8 23 DAC37-B14 24-CG12895-RA_1 CG12895 TATAAGCATACAAAACAATGTATTAAATGAATGTGTTATTCTACTCCTGATCCTTAAAAGACCAA 65 FBan0012895 FBgn0033523 CG12895 2 2R CG12895 CG12895 BcDNA:RE29446 CDMC34067 2 9 23 DAC37-F02 3-CG12972-RA_2 CG12972 AGAGGGGGATAATGAAGTGGAGCTGGTAACATGTGAGCCCACCATGATGTCCTCACCATCCAGCA 65 FBan0012972 FBgn0037076 CG12972 3 3L CG12972 CG12972 CDMC34067 2 10 23 DAC37-F02 3-CG12972-RA_2 CG12972 AGAGGGGGATAATGAAGTGGAGCTGGTAACATGTGAGCCCACCATGATGTCCTCACCATCCAGCA 65 FBan0012972 FBgn0037076 CG12972 3 3L CG12972 CG12972 CDMC34068 2 11 23 DAC37-F14 1-CG13010-RA_1 CG13010 GCCGCTCCTGGTGGGGATACTTTGGCATGAGCAAGAACAAGAAGTCCAGCATTGAGTCGCTCTAG 65 FBan0013010 FBgn0030770 CG13010 X X CG13010 CG13010 CDMC34068 2 12 23 DAC37-F14 1-CG13010-RA_1 CG13010 GCCGCTCCTGGTGGGGATACTTTGGCATGAGCAAGAACAAGAAGTCCAGCATTGAGTCGCTCTAG 65 FBan0013010 FBgn0030770 CG13010 X X CG13010 CG13010 CDMC34069 2 13 23 DAC37-J02 2-CG13056-RA_2 CG13056 TTCGCACCAGAGTTCCACCATCGTTCATCGCAGTGTTCCGAGGACTACATCACTGTTGACACCCG 65 FBan0013056 FBgn0040794 CG13056 3 3L CG13056 CG13056 CDMC34069 2 14 23 DAC37-J02 2-CG13056-RA_2 CG13056 TTCGCACCAGAGTTCCACCATCGTTCATCGCAGTGTTCCGAGGACTACATCACTGTTGACACCCG 65 FBan0013056 FBgn0040794 CG13056 3 3L CG13056 CG13056 CDMC34070 2 15 23 DAC37-J14 1-CG13064-RA_1 CG13064 GTTCAAGCTCGTCGTGCTATTCGGCCTTTTGAGTGGTGCCTTTGCCGCCACGGTTATCTACCATC 65 FBan0013064 FBgn0040796 CG13064 3 3L CG13064 CG13064 CDMC34070 2 16 23 DAC37-J14 1-CG13064-RA_1 CG13064 GTTCAAGCTCGTCGTGCTATTCGGCCTTTTGAGTGGTGCCTTTGCCGCCACGGTTATCTACCATC 65 FBan0013064 FBgn0040796 CG13064 3 3L CG13064 CG13064 CDMC34071 2 17 23 DAC37-N02 6-CG13136-RA_1 CG13136 GTCACGCAGGTGACATGGGTGAAGTTCCATAGCCAGTACCTGGAGATCCGTTTCACCATGGCCAC 65 FBan0013136 FBgn0032186 CG13136 2 2L CG13136 CG13136 CDMC34071 2 18 23 DAC37-N02 6-CG13136-RA_1 CG13136 GTCACGCAGGTGACATGGGTGAAGTTCCATAGCCAGTACCTGGAGATCCGTTTCACCATGGCCAC 65 FBan0013136 FBgn0032186 CG13136 2 2L CG13136 CG13136 CDMC34072 2 19 23 DAC37-N14 3-CG13163-RA_1 CG13163 CATTGGTGCGCGCATCACAGAGCACGATCTCTCCTCCAGACTCAAGAACATTGTGAAGTGGCTGG 65 FBan0013163 FBgn0033712 CG13163 2 2R CG13163 CG13163 CDMC34072 2 20 23 DAC37-N14 3-CG13163-RA_1 CG13163 CATTGGTGCGCGCATCACAGAGCACGATCTCTCCTCCAGACTCAAGAACATTGTGAAGTGGCTGG 65 FBan0013163 FBgn0033712 CG13163 2 2R CG13163 CG13163 CDMC34073 2 21 23 DAC38-B02 23-CG32555-RC_6 CG32555 TGTATCTTGTGTCTGAAACGGACCTCAAACTCAAAGCAAGAAAATAACGCGAGATCTGTTGCCAAACAA 69 FBan0032555 FBgn0026375 RhoGAPp190 X X ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; mushroom body development; GO:0016319; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho GTPase activator activity; GO:0005100; ; GO:0005100; ; GO:0005100 RhoGAPp190 RhoGAPp190 "CG8240, CG8267, CG32555, CG8240, CG8267, CG8240, CG8267, DRhoGAP, D-p190, RhoGAP-16B12, p190 RhoGAP, p190RhoGAP, Rp190RhoGAP, BcDNA:GH17919, BcDNA:GM05133, RhoGAP" CDMC34073 2 22 23 DAC38-B02 23-CG32555-RC_6 CG32555 TGTATCTTGTGTCTGAAACGGACCTCAAACTCAAAGCAAGAAAATAACGCGAGATCTGTTGCCAAACAA 69 FBan0032555 FBgn0026375 RhoGAPp190 X X ectoderm development; GO:0007398; intracellular signaling cascade; GO:0007242; mushroom body development; GO:0016319; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho GTPase activator activity; GO:0005100; ; GO:0005100; ; GO:0005100 RhoGAPp190 RhoGAPp190 "CG8240, CG8267, CG32555, CG8240, CG8267, CG8240, CG8267, DRhoGAP, D-p190, RhoGAP-16B12, p190 RhoGAP, p190RhoGAP, Rp190RhoGAP, BcDNA:GH17919, BcDNA:GM05133, RhoGAP" CDMC34074 2 23 23 DAC38-B14 23-CG32574-RA_1 CG32574 TGTTGTTCATCAGAATAGTGATAAATAGCCACCAATTTTACTGTACAGTCATGCAATAGTCAAAGGTTT 69 FBan0032574 FBgn0052574 CG32574 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32574 CG32574 "CG4724, CG4724" CDMC34074 2 24 23 DAC38-B14 23-CG32574-RA_1 CG32574 TGTTGTTCATCAGAATAGTGATAAATAGCCACCAATTTTACTGTACAGTCATGCAATAGTCAAAGGTTT 69 FBan0032574 FBgn0052574 CG32574 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32574 CG32574 "CG4724, CG4724" CDMC34075 2 25 23 DAC38-F02 17-CG3259-RA_3 CG3259 CCAGCCAAACGATCAGATCAAAATGTCGGGCATAAATGTAAAGCTTGAAACCTTTGGCGACTTGGACGA 69 FBan0003259 FBgn0038221 CG3259 3 3R CG3259 CG3259 CDMC34075 2 26 23 DAC38-F02 17-CG3259-RA_3 CG3259 CCAGCCAAACGATCAGATCAAAATGTCGGGCATAAATGTAAAGCTTGAAACCTTTGGCGACTTGGACGA 69 FBan0003259 FBgn0038221 CG3259 3 3R CG3259 CG3259 CDMC34076 2 1 24 DAC38-F14 22-CG32613-RA_1 CG32613 AGCTCTTCTAAACAACATCCAAGACGTCAAAATCTGTGGTTCTTCTGGAAGATTTGGATTTGCGCGGGT 69 FBan0032613 FBgn0052613 CG32613 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32613 CG32613 BcDNA:GM13088 CDMC34076 2 2 24 DAC38-F14 22-CG32613-RA_1 CG32613 AGCTCTTCTAAACAACATCCAAGACGTCAAAATCTGTGGTTCTTCTGGAAGATTTGGATTTGCGCGGGT 69 FBan0032613 FBgn0052613 CG32613 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32613 CG32613 BcDNA:GM13088 CDMC34077 2 3 24 DAC38-J02 8-CG3264-RA_1 CG3264 CGTGTCAGCAGTGTCCAGTGTCATTGGTCTCTTCCAGTCCAAGCTAATGAACTTCCACTTGGAGGCTGA 69 FBan0003264 FBgn0034712 CG3264 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3264 CG3264 CDMC34077 2 4 24 DAC38-J02 8-CG3264-RA_1 CG3264 CGTGTCAGCAGTGTCCAGTGTCATTGGTCTCTTCCAGTCCAAGCTAATGAACTTCCACTTGGAGGCTGA 69 FBan0003264 FBgn0034712 CG3264 2 2R mesoderm development; GO:0007498; metabolism; GO:0008152; skeletal development; GO:0001501 nucleotide phosphatase activity; GO:0019204; ; GO:0019204; alkaline phosphatase activity; GO:0004035 ; EC:3.1.3.1; ; GO:0004035 ; EC:3.1.3.1 CG3264 CG3264 CDMC34078 2 5 24 DAC38-J14 7-CG32655-RA_1 CG32655 AGCTACCAGTGCTAGTTCCGTCGTGAAAAAGAGTTCGGAGAAACCTTCTGGCTCTAGGACCTCTCCCAT 69 FBan0032655 FBgn0052655 CG32655 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32655 CG32655 CDMC34078 2 6 24 DAC38-J14 7-CG32655-RA_1 CG32655 AGCTACCAGTGCTAGTTCCGTCGTGAAAAAGAGTTCGGAGAAACCTTCTGGCTCTAGGACCTCTCCCAT 69 FBan0032655 FBgn0052655 CG32655 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32655 CG32655 CDMC34079 2 7 24 DAC38-N02 13-CG32696-RB_1 CG32696 GCTCTGGCAAGACCATTATTCGGTCACATTTTCGGGAAATTTCAGCGGGTGTGATATGATGGTTCGGGT 69 FBan0032696 FBgn0052696 CG32696 X X CG32696 CG32696 CG15246 CDMC34079 2 8 24 DAC38-N02 13-CG32696-RB_1 CG32696 GCTCTGGCAAGACCATTATTCGGTCACATTTTCGGGAAATTTCAGCGGGTGTGATATGATGGTTCGGGT 69 FBan0032696 FBgn0052696 CG32696 X X CG32696 CG32696 CG15246 CDMC34080 2 9 24 DAC38-N14 8-CG32701-RA_2 CG32701 GCCGCGCATTCGATTGCATTTGGAGCCCCGACGACATTATAAAACAGCCAACAAGATGAGGCATCTGAT 69 FBgn0052701 CDMC34080 2 10 24 DAC38-N14 8-CG32701-RA_2 CG32701 GCCGCGCATTCGATTGCATTTGGAGCCCCGACGACATTATAAAACAGCCAACAAGATGAGGCATCTGAT 69 FBgn0052701 CDMC34081 2 11 24 DAC39-B02 23-CG13645-RB_8 CG13645 CGTGAGTGAGCAGAGCAGATCCGAGTTCAAGTTCCTATTTAGCAGTGATTCCTTTAATGCATGTTTATT 69 FBan0013645 FBgn0039254 CG13645 3 3R NAD biosynthesis; GO:0009435; biosynthesis; GO:0009058; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG13645 CG13645 AAL90149 CDMC34081 2 12 24 DAC39-B02 23-CG13645-RB_8 CG13645 CGTGAGTGAGCAGAGCAGATCCGAGTTCAAGTTCCTATTTAGCAGTGATTCCTTTAATGCATGTTTATT 69 FBan0013645 FBgn0039254 CG13645 3 3R NAD biosynthesis; GO:0009435; biosynthesis; GO:0009058; coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189 transferase activity; GO:0016740 ; EC:2.-.-.-; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016779 ; EC:2.7.7.- CG13645 CG13645 AAL90149 CDMC34082 2 13 24 DAC39-B14 2-CG13662-RA_1 CG13662 CCGAAACAGTCGAGGAGTTCGAAAACAGTCCCCAGTGCTATCCTCCATCGTACTATACCCTCTCGCCCA 69 FBan0013662 FBgn0039287 CG13662 3 3R CG13662 CG13662 CDMC34082 2 14 24 DAC39-B14 2-CG13662-RA_1 CG13662 CCGAAACAGTCGAGGAGTTCGAAAACAGTCCCCAGTGCTATCCTCCATCGTACTATACCCTCTCGCCCA 69 FBan0013662 FBgn0039287 CG13662 3 3R CG13662 CG13662 CDMC34083 2 15 24 DAC39-F02 23-CG13705-RA_1 CG13705 TGAAACTAACAATAAGTCGAGCGTATTAGTCAATTTGAATCCACTATGAACAACCCGAGTACAAACCCG 69 FBan0013705 FBgn0035582 CG13705 3 3L CG13705 CG13705 CDMC34083 2 16 24 DAC39-F02 23-CG13705-RA_1 CG13705 TGAAACTAACAATAAGTCGAGCGTATTAGTCAATTTGAATCCACTATGAACAACCCGAGTACAAACCCG 69 FBan0013705 FBgn0035582 CG13705 3 3L CG13705 CG13705 CDMC34084 2 17 24 DAC39-F14 3-CG13725-RA_1 CG13725 CCGCTTGGGTTACGGCGATAAATTGGCACAGTTGCGAGAGCTGGACGTCTACAAGATGATCTACAGCGA 69 FBan0013725 FBgn0036708 CG13725 3 3L CG13725 CG13725 CDMC34084 2 18 24 DAC39-F14 3-CG13725-RA_1 CG13725 CCGCTTGGGTTACGGCGATAAATTGGCACAGTTGCGAGAGCTGGACGTCTACAAGATGATCTACAGCGA 69 FBan0013725 FBgn0036708 CG13725 3 3L CG13725 CG13725 CDMC34085 2 19 24 DAC39-J02 1-CG13773-RA_1 CG13773 CGCCGTCATTTACCGGGTCTTCAACACCTCCATACGTTTCACAAACCAGAGTGCAAGTCGCGAGGACAT 69 FBan0013773 FBgn0042092 CG13773 2 2L transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 nucleus; GO:0005634 CG13773 CG13773 BEST:GH23590 CDMC34085 2 20 24 DAC39-J02 1-CG13773-RA_1 CG13773 CGCCGTCATTTACCGGGTCTTCAACACCTCCATACGTTTCACAAACCAGAGTGCAAGTCGCGAGGACAT 69 FBan0013773 FBgn0042092 CG13773 2 2L transcription; GO:0006350 DNA binding; GO:0003677; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 nucleus; GO:0005634 CG13773 CG13773 BEST:GH23590 CDMC34086 2 21 24 DAC39-J14 23-CG13780-RA_11 CG13780 TTGCAGTCAAAACGTCAGAATGGCAAAAGCTAAACCAAATTCCCATTGAAAGAATGAAAACGCCAGAAC 69 FBan0013780 FBgn0031888 Pvf2 2 2L hemocyte migration (sensu Arthropoda); GO:0035099; hemocyte proliferation (sensu Arthropoda); GO:0035172 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf2 PDGF- and VEGF-related factor 2 "CG13780, CG13780, CG13780, CG13780, DmVEGF-2, Vegf27Cb, VEGF, VEGF27Cb, VEGF-related factor 2, PVF, pvf2, PVFs, VEGF-2, PVF2" CDMC34086 2 22 24 DAC39-J14 23-CG13780-RA_11 CG13780 TTGCAGTCAAAACGTCAGAATGGCAAAAGCTAAACCAAATTCCCATTGAAAGAATGAAAACGCCAGAAC 69 FBan0013780 FBgn0031888 Pvf2 2 2L hemocyte migration (sensu Arthropoda); GO:0035099; hemocyte proliferation (sensu Arthropoda); GO:0035172 vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005172 membrane; GO:0016020 Pvf2 PDGF- and VEGF-related factor 2 "CG13780, CG13780, CG13780, CG13780, DmVEGF-2, Vegf27Cb, VEGF, VEGF27Cb, VEGF-related factor 2, PVF, pvf2, PVFs, VEGF-2, PVF2" CDMC34087 2 23 24 DAC39-N02 2-CG1381-RA_2 CG1381 CCTGCCCACCAAATTGGAGAAGGGAATCGTTACGCTGTACAGTGACTACACGGTTTGTGAGGAGGGCAA 69 FBan0001381 FBgn0033485 CG1381 2 2R protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG1381 CG1381 FBgn0033485 CDMC34087 2 24 24 DAC39-N02 2-CG1381-RA_2 CG1381 CCTGCCCACCAAATTGGAGAAGGGAATCGTTACGCTGTACAGTGACTACACGGTTTGTGAGGAGGGCAA 69 FBan0001381 FBgn0033485 CG1381 2 2R protein biosynthesis; GO:0006412; protein metabolism; GO:0019538 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 intracellular; GO:0005622; ribosome; GO:0005840 CG1381 CG1381 FBgn0033485 CDMC34088 2 25 24 DAC39-N14 23-CG13838-RA_2 CG13838 AACACCGAAAATCATGATTTAGGGTGAAAAAAATTTAAATTTAAATCGAAAGTTGTTTTCCCAGCCCTT 69 FBan0013838 FBgn0039041 CG13838 3 3R CG13838 CG13838 CDMC34088 2 26 24 DAC39-N14 23-CG13838-RA_2 CG13838 AACACCGAAAATCATGATTTAGGGTGAAAAAAATTTAAATTTAAATCGAAAGTTGTTTTCCCAGCCCTT 69 FBan0013838 FBgn0039041 CG13838 3 3R CG13838 CG13838 CDMC34089 2 1 25 DAC40-B02 2-CG14106-RA_1 CG14106 CTCGCAAGAGTCCTGTGCAGAGCTACCAGTTGTAGAGGTCCAGCGGAATGAAGCGGAAGTCCAAC 65 FBan0014106 FBgn0036358 CG14106 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14106 CG14106 CDMC34089 2 2 25 DAC40-B02 2-CG14106-RA_1 CG14106 CTCGCAAGAGTCCTGTGCAGAGCTACCAGTTGTAGAGGTCCAGCGGAATGAAGCGGAAGTCCAAC 65 FBan0014106 FBgn0036358 CG14106 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG14106 CG14106 CDMC34090 2 3 25 DAC40-B14 2-CG14135-RA_3 CG14135 CAGTGGTCGTTTTGAAATCGACCTGCACTGCAAGCGATGTTCTCCGACCGACAACATCCATCGCG 65 FBan0014135 FBgn0036193 CG14135 3 3L CG14135 CG14135 CDMC34090 2 4 25 DAC40-B14 2-CG14135-RA_3 CG14135 CAGTGGTCGTTTTGAAATCGACCTGCACTGCAAGCGATGTTCTCCGACCGACAACATCCATCGCG 65 FBan0014135 FBgn0036193 CG14135 3 3L CG14135 CG14135 CDMC34091 2 5 25 DAC40-F02 33-CG14200-RA_1 CG14200 AGAAGAAGTATCTGACGACAGGAGGTTCCAGATGGCAATGGACATGGACATCGCACTGGATGCCG 65 FBan0014200 FBgn0031023 CG14200 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14200 CG14200 CDMC34091 2 6 25 DAC40-F02 33-CG14200-RA_1 CG14200 AGAAGAAGTATCTGACGACAGGAGGTTCCAGATGGCAATGGACATGGACATCGCACTGGATGCCG 65 FBan0014200 FBgn0031023 CG14200 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14200 CG14200 CDMC34092 2 7 25 DAC40-F14 2-CG14230-RA_1 CG14230 AAGACGTCTGCCAATAAGCTCGGACTGGCCACTCTCAATCCGTTCTCCTACGACTCGTCCGACAG 65 FBan0014230 FBgn0031062 CG14230 X X mRNA binding; GO:0003729; ; GO:0003729 CG14230 CG14230 "clone 9.42, cg14230, anon-18DEe" CDMC34092 2 8 25 DAC40-F14 2-CG14230-RA_1 CG14230 AAGACGTCTGCCAATAAGCTCGGACTGGCCACTCTCAATCCGTTCTCCTACGACTCGTCCGACAG 65 FBan0014230 FBgn0031062 CG14230 X X mRNA binding; GO:0003729; ; GO:0003729 CG14230 CG14230 "clone 9.42, cg14230, anon-18DEe" CDMC34093 2 9 25 DAC40-J02 6-CG14294-RA_1 CG14294 GTCACCCGTCTGCACATGGAAAGGCTGAGGTCACTCCTCCAAATTACCACTAAGCGACAGGCGAG 65 FBan0014294 FBgn0038656 CG14294 3 3R CG14294 CG14294 BcDNA:AT18358 CDMC34093 2 10 25 DAC40-J02 6-CG14294-RA_1 CG14294 GTCACCCGTCTGCACATGGAAAGGCTGAGGTCACTCCTCCAAATTACCACTAAGCGACAGGCGAG 65 FBan0014294 FBgn0038656 CG14294 3 3R CG14294 CG14294 BcDNA:AT18358 CDMC34094 2 11 25 DAC40-J14 23-CG14327-RA_1 CG14327 CCTTATTAACCTGGATGAAACGTCTGCTGGAAAAGTTAAGTTACTAGCCTTTAAGGGACCCCATG 65 FBan0014327 FBgn0038526 CG14327 3 3R CG14327 CG14327 BcDNA:RE25364 CDMC34094 2 12 25 DAC40-J14 23-CG14327-RA_1 CG14327 CCTTATTAACCTGGATGAAACGTCTGCTGGAAAAGTTAAGTTACTAGCCTTTAAGGGACCCCATG 65 FBan0014327 FBgn0038526 CG14327 3 3R CG14327 CG14327 BcDNA:RE25364 CDMC34095 2 13 25 DAC40-N02 17-CG14416-RA_1 CG14416 GCACAAGCATCCCCAGAAAAAGAAGCGACATCAGAAGAGGAAGCTCAACAAAAAACAGTCGGCGG 65 FBan0014416 FBgn0040352 CG14416 X X CG14416 CG14416 EG:BACR43E12.7 CDMC34095 2 14 25 DAC40-N02 17-CG14416-RA_1 CG14416 GCACAAGCATCCCCAGAAAAAGAAGCGACATCAGAAGAGGAAGCTCAACAAAAAACAGTCGGCGG 65 FBan0014416 FBgn0040352 CG14416 X X CG14416 CG14416 EG:BACR43E12.7 CDMC34096 2 15 25 DAC40-N14 3-CG14445-RA_2 CG14445 CAGCAGTCACTCTCCGTTCTCCCTTCGTTCTCCCTTCTGTGACCCACAGATTGCCATACCGTGTC 65 FBan0014445 FBgn0029851 CG14445 X X CG14445 CG14445 CDMC34096 2 16 25 DAC40-N14 3-CG14445-RA_2 CG14445 CAGCAGTCACTCTCCGTTCTCCCTTCGTTCTCCCTTCTGTGACCCACAGATTGCCATACCGTGTC 65 FBan0014445 FBgn0029851 CG14445 X X CG14445 CG14445 CDMC34097 2 17 25 DAC41-B02 AutoBlank AutoBlank CDMC34097 2 18 25 DAC41-B02 AutoBlank AutoBlank CDMC34098 2 19 25 DAC41-B14 AutoBlank AutoBlank CDMC34098 2 20 25 DAC41-B14 AutoBlank AutoBlank CDMC34099 2 21 25 DAC41-F02 AutoBlank AutoBlank CDMC34099 2 22 25 DAC41-F02 AutoBlank AutoBlank CDMC34100 2 23 25 DAC41-F14 AutoBlank AutoBlank CDMC34100 2 24 25 DAC41-F14 AutoBlank AutoBlank CDMC34101 2 25 25 DAC41-J02 AutoBlank AutoBlank CDMC34101 2 26 25 DAC41-J02 AutoBlank AutoBlank CDMC34102 2 1 26 DAC41-J14 AutoBlank AutoBlank CDMC34102 2 2 26 DAC41-J14 AutoBlank AutoBlank CDMC34103 2 3 26 DAC41-N02 AutoBlank AutoBlank CDMC34103 2 4 26 DAC41-N02 AutoBlank AutoBlank CDMC34104 2 5 26 DAC41-N14 AutoBlank AutoBlank CDMC34104 2 6 26 DAC41-N14 AutoBlank AutoBlank CDMC34105 2 7 26 DAC42-B02 150mM NaPO4 Blank CDMC34105 2 8 26 DAC42-B02 150mM NaPO4 Blank CDMC34106 2 9 26 DAC42-B14 150mM NaPO4 Blank CDMC34106 2 10 26 DAC42-B14 150mM NaPO4 Blank CDMC34107 2 11 26 DAC42-F02 150mM NaPO4 Blank CDMC34107 2 12 26 DAC42-F02 150mM NaPO4 Blank CDMC34108 2 13 26 DAC42-F14 150mM NaPO4 Blank CDMC34108 2 14 26 DAC42-F14 150mM NaPO4 Blank CDMC34109 2 15 26 DAC42-J02 150mM NaPO4 Blank CDMC34109 2 16 26 DAC42-J02 150mM NaPO4 Blank CDMC34110 2 17 26 DAC42-J14 5uM MSP 5uM MSP CDMC34110 2 18 26 DAC42-J14 5uM MSP 5uM MSP CDMC34111 2 19 26 DAC42-N02 10uM MSP 10uM MSP CDMC34111 2 20 26 DAC42-N02 10uM MSP 10uM MSP CDMC34112 2 21 26 DAC42-N14 20uM MSP 20uM MSP CDMC34112 2 22 26 DAC42-N14 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC34113 3 1 1 DAC01-C02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34113 3 2 1 DAC01-C02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34114 3 3 1 DAC01-C14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34114 3 4 1 DAC01-C14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34115 3 5 1 DAC01-G02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34115 3 6 1 DAC01-G02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34116 3 7 1 DAC01-G14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34116 3 8 1 DAC01-G14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34117 3 9 1 DAC01-K02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34117 3 10 1 DAC01-K02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34118 3 11 1 DAC01-K14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34118 3 12 1 DAC01-K14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34119 3 13 1 DAC01-O02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34119 3 14 1 DAC01-O02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34120 3 15 1 DAC01-O14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34120 3 16 1 DAC01-O14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34121 3 17 1 DAC02-C02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34121 3 18 1 DAC02-C02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34122 3 19 1 DAC02-C14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34122 3 20 1 DAC02-C14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34123 3 21 1 DAC02-G02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34123 3 22 1 DAC02-G02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34124 3 23 1 DAC02-G14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34124 3 24 1 DAC02-G14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34125 3 25 1 DAC02-K02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34125 3 26 1 DAC02-K02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34126 3 1 2 DAC02-K14 N/A CG9075 (00957-01195) CDMC34126 3 2 2 DAC02-K14 N/A CG9075 (00957-01195) CDMC34127 3 3 2 DAC02-O02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34127 3 4 2 DAC02-O02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34128 3 5 2 DAC02-O14 AutoBlank AutoBlank CDMC34128 3 6 2 DAC02-O14 AutoBlank AutoBlank CDMC34129 3 7 2 DAC03-C02 23-CG32220-RA_13 CG32220 GACCATCAAAAATTCGACTTGCTTTCGACATATTTGGGTTTCCACAGATGACAAACGAATTGCCATTGA 69 FBan0032220 FBgn0052220 CG32220 3 3L CMP-N-acetylneuraminate biosynthesis; GO:0006055 N-acylneuraminate cytidylyltransferase activity; GO:0008781 ; EC:2.7.7.43; ; GO:0008781 ; EC:2.7.7.43 CG32220 CG32220 CDMC34129 3 8 2 DAC03-C02 23-CG32220-RA_13 CG32220 GACCATCAAAAATTCGACTTGCTTTCGACATATTTGGGTTTCCACAGATGACAAACGAATTGCCATTGA 69 FBan0032220 FBgn0052220 CG32220 3 3L CMP-N-acetylneuraminate biosynthesis; GO:0006055 N-acylneuraminate cytidylyltransferase activity; GO:0008781 ; EC:2.7.7.43; ; GO:0008781 ; EC:2.7.7.43 CG32220 CG32220 CDMC34130 3 9 2 DAC03-C14 3-CG32232-RA_3 CG32232 CAGCCTGCCCGAGATCCTTACACTGAGCAAAGTGTTTTGCCTTCGATGGGAAACAACCAGAGCTCTTGT 69 FBan0032232 FBgn0052232 CG32232 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32232 CG32232 CDMC34130 3 10 2 DAC03-C14 3-CG32232-RA_3 CG32232 CAGCCTGCCCGAGATCCTTACACTGAGCAAAGTGTTTTGCCTTCGATGGGAAACAACCAGAGCTCTTGT 69 FBan0032232 FBgn0052232 CG32232 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32232 CG32232 CDMC34131 3 11 2 DAC03-G02 2-CG32257-RA_3 CG32257 GGAGCAGCTCTTTCTGCGGGTTCCCTATCGGTTCTACGGCGAGTACAGGATAAAGAGGCGCATCTACAT 69 FBan0032257 FBgn0045478 Gr64b 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64b Gustatory receptor 64b "CG14986, CG32257, CG14986, anon-WO0118547.604, Gustatory receptor 64b" CDMC34131 3 12 2 DAC03-G02 2-CG32257-RA_3 CG32257 GGAGCAGCTCTTTCTGCGGGTTCCCTATCGGTTCTACGGCGAGTACAGGATAAAGAGGCGCATCTACAT 69 FBan0032257 FBgn0045478 Gr64b 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr64b Gustatory receptor 64b "CG14986, CG32257, CG14986, anon-WO0118547.604, Gustatory receptor 64b" CDMC34132 3 13 2 DAC03-G14 15-CG32265-RA_6 CG32265 TCCATCAAGATCGCTTCAGTTCGGATGGCTTCTAAGCAGAGACAACCGGAATTGGACTGTTTACGAGCT 69 FBan0032265 FBgn0004911 Eip63F-2 3 3L Eip63F-2 Ecdysone-induced protein 63F 2 "CG32265, E63F, E63-2, Eip63Fb" CDMC34132 3 14 2 DAC03-G14 15-CG32265-RA_6 CG32265 TCCATCAAGATCGCTTCAGTTCGGATGGCTTCTAAGCAGAGACAACCGGAATTGGACTGTTTACGAGCT 69 FBan0032265 FBgn0004911 Eip63F-2 3 3L Eip63F-2 Ecdysone-induced protein 63F 2 "CG32265, E63F, E63-2, Eip63Fb" CDMC34133 3 15 2 DAC03-K02 10-CG32307-RA_1 CG32307 ACCATCAACACATTCCAGAAGTGGGAGACTACGATCGAGTCCATCAGCTATGTGAGCACCAAGACCGTG 69 FBan0032307 FBgn0052307 CG32307 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32307 CG32307 CDMC34133 3 16 2 DAC03-K02 10-CG32307-RA_1 CG32307 ACCATCAACACATTCCAGAAGTGGGAGACTACGATCGAGTCCATCAGCTATGTGAGCACCAAGACCGTG 69 FBan0032307 FBgn0052307 CG32307 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32307 CG32307 CDMC34134 3 17 2 DAC03-K14 12-CG32319-RA_1 CG32319 AGCCAAGTCAGAAGGAATACATTTTTGTGTCTTCCACGACGAATCACAGCTCAAGGTGCTCATGGGCCT 69 FBan0032319 FBgn0052319 CG32319 3 3L protein amino acid acetylation; GO:0006473 N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG32319 CG32319 CG12083 CDMC34134 3 18 2 DAC03-K14 12-CG32319-RA_1 CG32319 AGCCAAGTCAGAAGGAATACATTTTTGTGTCTTCCACGACGAATCACAGCTCAAGGTGCTCATGGGCCT 69 FBan0032319 FBgn0052319 CG32319 3 3L protein amino acid acetylation; GO:0006473 N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG32319 CG32319 CG12083 CDMC34135 3 19 2 DAC03-O02 23-CG32368-RA_3 CG32368 TCAGTCAATACACATCGTGCAAAGACAACTTGATATCAATCGCTGCATACAAAAATGGATGGTGCCATT 69 FBan0032368 FBgn0052368 CG32368 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32368 CG32368 BcDNA:RH61042 CDMC34135 3 20 2 DAC03-O02 23-CG32368-RA_3 CG32368 TCAGTCAATACACATCGTGCAAAGACAACTTGATATCAATCGCTGCATACAAAAATGGATGGTGCCATT 69 FBan0032368 FBgn0052368 CG32368 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32368 CG32368 BcDNA:RH61042 CDMC34136 3 21 2 DAC03-O14 8-CG32384-RA_1 CG32384 CGCCACATAAGCTCCATCAATCAGGAGGATGTAAGGGAGGCCATTCGGAATCTTAAATCACCCACGGGA 69 FBgn0052384 CDMC34136 3 22 2 DAC03-O14 8-CG32384-RA_1 CG32384 CGCCACATAAGCTCCATCAATCAGGAGGATGTAAGGGAGGCCATTCGGAATCTTAAATCACCCACGGGA 69 FBgn0052384 CDMC34137 3 23 2 DAC04-C02 15-CG2944-RB_1 CG2944 CCACACTATCCCCGAGAGTTGTTTTGTCCAGATTGGAGCCGAGGGAGTTTGAACGTCTTCGACTATCCT 69 FBgn0033008 CDMC34137 3 24 2 DAC04-C02 15-CG2944-RB_1 CG2944 CCACACTATCCCCGAGAGTTGTTTTGTCCAGATTGGAGCCGAGGGAGTTTGAACGTCTTCGACTATCCT 69 FBgn0033008 CDMC34138 3 25 2 DAC04-C14 17-CG2958-RA_1 CG2958 AACCCAATCACGGCAATGAAGATGAGAACTGTGTGGAGCTGATTAGGAGCAAAATGAACGATGATCCGT 69 FBan0002958 FBgn0040102 lectin-24Db 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; fucose binding; GO:0042806; mannose binding; GO:0005537; ; GO:0005534; ; GO:0042806; ; GO:0005537 lectin-24Db lectin-24Db "CG2958, CG2958, AC 004371A, AC004371a, lectin, Lectin24Db" CDMC34138 3 26 2 DAC04-C14 17-CG2958-RA_1 CG2958 AACCCAATCACGGCAATGAAGATGAGAACTGTGTGGAGCTGATTAGGAGCAAAATGAACGATGATCCGT 69 FBan0002958 FBgn0040102 lectin-24Db 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; fucose binding; GO:0042806; mannose binding; GO:0005537; ; GO:0005534; ; GO:0042806; ; GO:0005537 lectin-24Db lectin-24Db "CG2958, CG2958, AC 004371A, AC004371a, lectin, Lectin24Db" CDMC34139 3 1 3 DAC04-G02 8-CG2993-RA_1 CG2993 ACGCCATGGCTCTAAGTGAGAAGTTCAGCGATGACACTGAGTTCTTGACCAACGTTAGCATGAGCAGCA 69 FBan0002993 FBgn0037521 CG2993 3 3R CG2993 CG2993 CDMC34139 3 2 3 DAC04-G02 8-CG2993-RA_1 CG2993 ACGCCATGGCTCTAAGTGAGAAGTTCAGCGATGACACTGAGTTCTTGACCAACGTTAGCATGAGCAGCA 69 FBan0002993 FBgn0037521 CG2993 3 3R CG2993 CG2993 CDMC34140 3 3 3 DAC04-G14 23-CG30002-RA_10 CG30002 TGTCAGATCTAGTAGCTCACGTTTTTGTGTTGTTCAGATCGGTAGTCGCATCAAGAAATATGTATAGCG 69 FBan0030002 FBgn0050002 CG30002 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30002 CG30002 CDMC34140 3 4 3 DAC04-G14 23-CG30002-RA_10 CG30002 TGTCAGATCTAGTAGCTCACGTTTTTGTGTTGTTCAGATCGGTAGTCGCATCAAGAAATATGTATAGCG 69 FBan0030002 FBgn0050002 CG30002 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30002 CG30002 CDMC34141 3 5 3 DAC04-K02 17-CG3002-RB_2 CG3002 CCGGATCCCATCAAGGAATCGATTGTGGCCAAAGGCATTGACTATGTGGACTAAAATACCCCGACATAT 69 FBan0003002 FBgn0030141 Gga X X intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; post-Golgi transport; GO:0006892; protein complex assembly; GO:0006461 protein binding; GO:0005515; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0005515 Golgi stack; GO:0005795; clathrin coat of trans-Golgi network vesicle; GO:0030130; cytoplasm; GO:0005737 Gga Gga "CG3002, CG3002, CG3002, CG3002, GGA, dmGGA" CDMC34141 3 6 3 DAC04-K02 17-CG3002-RB_2 CG3002 CCGGATCCCATCAAGGAATCGATTGTGGCCAAAGGCATTGACTATGTGGACTAAAATACCCCGACATAT 69 FBan0003002 FBgn0030141 Gga X X intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; post-Golgi transport; GO:0006892; protein complex assembly; GO:0006461 protein binding; GO:0005515; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0005515 Golgi stack; GO:0005795; clathrin coat of trans-Golgi network vesicle; GO:0030130; cytoplasm; GO:0005737 Gga Gga "CG3002, CG3002, CG3002, CG3002, GGA, dmGGA" CDMC34142 3 7 3 DAC04-K14 18-CG30040-RA_1 CG30040 TCCCCCTCCATACCACAGTTTTTGATTTCGTTCATGAGTGACAACAGTTCTCACGGAAATGGCAGCTAT 69 FBan0030040 FBgn0033681 jeb 2 2R mesoderm migration; GO:0007509; visceral muscle development; GO:0007522 extracellular region; GO:0005576 jeb jelly belly "CG30040, CG13180, CG13182, l(2)k05644, jellybelly, jelly-belly, jelly belly" CDMC34142 3 8 3 DAC04-K14 18-CG30040-RA_1 CG30040 TCCCCCTCCATACCACAGTTTTTGATTTCGTTCATGAGTGACAACAGTTCTCACGGAAATGGCAGCTAT 69 FBan0030040 FBgn0033681 jeb 2 2R mesoderm migration; GO:0007509; visceral muscle development; GO:0007522 extracellular region; GO:0005576 jeb jelly belly "CG30040, CG13180, CG13182, l(2)k05644, jellybelly, jelly-belly, jelly belly" CDMC34143 3 9 3 DAC04-O02 2-CG30073-RA_1 CG30073 TGGCTTCCTCAACCTGTCTGCCATATGCCATGCTTCATGCACAGTGTACCATGGTATACCTAACCGCCA 69 FBan0030073 FBgn0050073 Obp50b 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50b Odorant-binding protein 50b "CG13940, CG30073, CG13940, CG30073, Odorant-binding protein 50b" CDMC34143 3 10 3 DAC04-O02 2-CG30073-RA_1 CG30073 TGGCTTCCTCAACCTGTCTGCCATATGCCATGCTTCATGCACAGTGTACCATGGTATACCTAACCGCCA 69 FBan0030073 FBgn0050073 Obp50b 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp50b Odorant-binding protein 50b "CG13940, CG30073, CG13940, CG30073, Odorant-binding protein 50b" CDMC34144 3 11 3 DAC04-O14 2-CG30080-RA_1 CG30080 ACTCCGGATCCCACTACATCCATCCAAGACACGCCATGCAGTAGCTCCATCGTGGTCTACTAAGATCGA 69 FBan0030080 FBgn0050080 CG30080 2 2R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 cellular component unknown; GO:0008372 CG30080 CG30080 "CG12965, CG12965, BcDNA:RE42467, BcDNA:RE70859" CDMC34144 3 12 3 DAC04-O14 2-CG30080-RA_1 CG30080 ACTCCGGATCCCACTACATCCATCCAAGACACGCCATGCAGTAGCTCCATCGTGGTCTACTAAGATCGA 69 FBan0030080 FBgn0050080 CG30080 2 2R "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700 cellular component unknown; GO:0008372 CG30080 CG30080 "CG12965, CG12965, BcDNA:RE42467, BcDNA:RE70859" CDMC34145 3 13 3 DAC05-C02 3-CG18176-RA_5 CG18176 AGGCTTAACTGCTGGACGCTGTATAGGATTGCACGCACTGCTAGTCGCTATGGTCACCACTATGTGGC 68 FBan0018176 FBgn0036038 defl 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 defl deflated "CG18176, deflated" CDMC34145 3 14 3 DAC05-C02 3-CG18176-RA_5 CG18176 AGGCTTAACTGCTGGACGCTGTATAGGATTGCACGCACTGCTAGTCGCTATGGTCACCACTATGTGGC 68 FBan0018176 FBgn0036038 defl 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 defl deflated "CG18176, deflated" CDMC34146 3 15 3 DAC05-C14 3-CG1859-RA_1 CG1859 TCGAAGCTTGGTATTTCCCAAAACATGATCCACTGGAGACTTCTTTCCGCCCTACTTGTGGGCCTGGC 68 FBgn0033147 CDMC34146 3 16 3 DAC05-C14 3-CG1859-RA_1 CG1859 TCGAAGCTTGGTATTTCCCAAAACATGATCCACTGGAGACTTCTTTCCGCCCTACTTGTGGGCCTGGC 68 FBgn0033147 CDMC34147 3 17 3 DAC05-G02 3-CG2297-RA_2 CG2297 CCCTGATCGCCAAGTACAAGACCTTCGACTATCCCGACGATGACATCACCCGCAACTACATCCAGTGC 68 FBan0002297 FBgn0033268 Obp44a 2 2R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp44a Obp44a "CG2297, CG2297, CG2297, CG2297, bs11e05.y1, Odorant-binding protein 44a, 44a, anon-EST:ParkEST107" CDMC34147 3 18 3 DAC05-G02 3-CG2297-RA_2 CG2297 CCCTGATCGCCAAGTACAAGACCTTCGACTATCCCGACGATGACATCACCCGCAACTACATCCAGTGC 68 FBan0002297 FBgn0033268 Obp44a 2 2R transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp44a Obp44a "CG2297, CG2297, CG2297, CG2297, bs11e05.y1, Odorant-binding protein 44a, 44a, anon-EST:ParkEST107" CDMC34148 3 19 3 DAC05-G14 3-CG2890-RA_1 CG2890 GCGGTTCGGTGTTTCATGCTCTGTGGCCTCCCCTTTTGTTTTGTATTTATGTTGTGCTGTCCACCCCC 68 FBan0002890 FBgn0030208 PPP4R2r X X regulation of protein amino acid dephosphorylation; GO:0035304 protein phosphatase regulator activity; GO:0019888; phosphatase activator activity; GO:0019211; ; GO:0019211; ; GO:0019888 protein phosphatase 4 complex; GO:0030289 PPP4R2r Protein phosphatase 4 regulatory subunit 2-related protein "CG2890, CG2890, PPP4R2, BcDNA:LD29930" CDMC34148 3 20 3 DAC05-G14 3-CG2890-RA_1 CG2890 GCGGTTCGGTGTTTCATGCTCTGTGGCCTCCCCTTTTGTTTTGTATTTATGTTGTGCTGTCCACCCCC 68 FBan0002890 FBgn0030208 PPP4R2r X X regulation of protein amino acid dephosphorylation; GO:0035304 protein phosphatase regulator activity; GO:0019888; phosphatase activator activity; GO:0019211; ; GO:0019211; ; GO:0019888 protein phosphatase 4 complex; GO:0030289 PPP4R2r Protein phosphatase 4 regulatory subunit 2-related protein "CG2890, CG2890, PPP4R2, BcDNA:LD29930" CDMC34149 3 21 3 DAC05-K02 1-CG30415-RB_1 CG30415 GCCCCATGCGCTACCCATACACTTTCTCCGCGAAGATAGCCCAATTCCCCATCAAGCACTACATCAAG 68 FBan0030415 FBgn0050415 CG30415 2 2R CG30415 CG30415 "CG3487, CG3487, CG3487" CDMC34149 3 22 3 DAC05-K02 1-CG30415-RB_1 CG30415 GCCCCATGCGCTACCCATACACTTTCTCCGCGAAGATAGCCCAATTCCCCATCAAGCACTACATCAAG 68 FBan0030415 FBgn0050415 CG30415 2 2R CG30415 CG30415 "CG3487, CG3487, CG3487" CDMC34150 3 23 3 DAC05-K14 3-CG3099-RB_2 CG3099 GCGTCTTCGTCTGCTTCAGTTCGTGACTGGCACGTCGAGCATACCGTACGAAGGATTCTCGGCATTAC 68 FBan0003099 FBgn0030145 CG3099 X X protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG3099 CG3099 CDMC34150 3 24 3 DAC05-K14 3-CG3099-RB_2 CG3099 GCGTCTTCGTCTGCTTCAGTTCGTGACTGGCACGTCGAGCATACCGTACGAAGGATTCTCGGCATTAC 68 FBan0003099 FBgn0030145 CG3099 X X protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG3099 CG3099 CDMC34151 3 25 3 DAC05-O02 2-CG31368-RA_2 CG31368 TGCGGGATGTACGACGTTTAGTGGTGGCCATGAGTCGAGCGCGTCTGGGATTATATGTATTTGGCAGG 68 FBan0031368 FBgn0051368 CG31368 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; DNA restriction-modification system; GO:0009307; RNA catabolism; GO:0006401; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA metabolism; GO:0006399" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 CG31368 CG31368 "CG14729, CG14730, CG14729" CDMC34151 3 26 3 DAC05-O02 2-CG31368-RA_2 CG31368 TGCGGGATGTACGACGTTTAGTGGTGGCCATGAGTCGAGCGCGTCTGGGATTATATGTATTTGGCAGG 68 FBan0031368 FBgn0051368 CG31368 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; DNA restriction-modification system; GO:0009307; RNA catabolism; GO:0006401; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; tRNA metabolism; GO:0006399" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 CG31368 CG31368 "CG14729, CG14730, CG14729" CDMC34152 3 1 4 DAC05-O14 1-CG3156-RA_1 CG3156 GCCTCGGAGCGTATTTGGGAGATCCTGGACAGGGAGTGTTCTATACCCATTGACAAAGGTGTCGTGCC 68 FBan0003156 FBgn0023536 CG3156 X X defense response; GO:0006952; extracellular transport; GO:0006858; heme biosynthesis; GO:0006783; mitochondrial transport; GO:0006839; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG3156 CG3156 EG:171D11.2 CDMC34152 3 2 4 DAC05-O14 1-CG3156-RA_1 CG3156 GCCTCGGAGCGTATTTGGGAGATCCTGGACAGGGAGTGTTCTATACCCATTGACAAAGGTGTCGTGCC 68 FBan0003156 FBgn0023536 CG3156 X X defense response; GO:0006952; extracellular transport; GO:0006858; heme biosynthesis; GO:0006783; mitochondrial transport; GO:0006839; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; ; GO:0008559 ; EC:3.6.3.44; ; GO:0042626; ; GO:0005215; ; GO:0000166" integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743 CG3156 CG3156 EG:171D11.2 CDMC34153 3 3 4 DAC06-C02 8-CG5246-RA_1 CG5246 TAGCGTTGATCCACACGGCTAAGCCCATTGTTTACGACGACCTGACTCAACCTATTAAACTGGCCAGCA 69 FBan0005246 FBgn0038484 CG5246 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG5246 CG5246 "SP96, BcDNA:LP06628" CDMC34153 3 4 4 DAC06-C02 8-CG5246-RA_1 CG5246 TAGCGTTGATCCACACGGCTAAGCCCATTGTTTACGACGACCTGACTCAACCTATTAAACTGGCCAGCA 69 FBan0005246 FBgn0038484 CG5246 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- CG5246 CG5246 "SP96, BcDNA:LP06628" CDMC34154 3 5 4 DAC06-C14 14-CG5264-RA_1 CG5264 TGGTGCAACGAAGCGAACGATCAATGGTTACAAAATGAGGCACCTACTGGTCAAGAACTTCCAAGCCAA 69 FBan0005264 FBgn0014949 btn 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 btn buttonless "CG5264, CG5264, 1261/13, btn/MEOX, buttonless" CDMC34154 3 6 4 DAC06-C14 14-CG5264-RA_1 CG5264 TGGTGCAACGAAGCGAACGATCAATGGTTACAAAATGAGGCACCTACTGGTCAAGAACTTCCAAGCCAA 69 FBan0005264 FBgn0014949 btn 3 3R "regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003677; ; GO:0003677 nucleus; GO:0005634 btn buttonless "CG5264, CG5264, 1261/13, btn/MEOX, buttonless" CDMC34155 3 7 4 DAC06-G02 15-CG5304-RA_1 CG5304 GGGATCCGAGTGGTTCCCAAAAGCAGTGTCATGCTGTATACGCAGTGGCTGTTGTTCAAATTGCTAGTT 69 FBan0005304 FBgn0010497 l(2)01810 2 2L carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 l(2)01810 lethal (2) 01810 "CG5304, anon-WO0118547.88" CDMC34155 3 8 4 DAC06-G02 15-CG5304-RA_1 CG5304 GGGATCCGAGTGGTTCCCAAAAGCAGTGTCATGCTGTATACGCAGTGGCTGTTGTTCAAATTGCTAGTT 69 FBan0005304 FBgn0010497 l(2)01810 2 2L carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 l(2)01810 lethal (2) 01810 "CG5304, anon-WO0118547.88" CDMC34156 3 9 4 DAC06-G14 1-CG5319-RA_1 CG5319 CGCTCTATGCAGCCAAGAAGTACATTGTCCCGCACTTAGCCAGAGCATGCGTCAACTATCTGGAGGTGA 69 FBan0005319 FBgn0038501 CG5319 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG5319 CG5319 anon-WO0118547.289 CDMC34156 3 10 4 DAC06-G14 1-CG5319-RA_1 CG5319 CGCTCTATGCAGCCAAGAAGTACATTGTCCCGCACTTAGCCAGAGCATGCGTCAACTATCTGGAGGTGA 69 FBan0005319 FBgn0038501 CG5319 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 CG5319 CG5319 anon-WO0118547.289 CDMC34157 3 11 4 DAC06-K02 18-CG5355-RA_6 CG5355 TCAAGACACCTGACAAGTCGCCATCAGTATTCCGCGAAATCAAACTGAATTTGGAAGGATTCCGTCGCG 69 FBan0005355 FBgn0032242 CG5355 2 2L proteolysis; GO:0006508 prolyl oligopeptidase activity; GO:0004287 ; EC:3.4.21.26; ; GO:0004287 ; EC:3.4.21.26 CG5355 CG5355 CDMC34157 3 12 4 DAC06-K02 18-CG5355-RA_6 CG5355 TCAAGACACCTGACAAGTCGCCATCAGTATTCCGCGAAATCAAACTGAATTTGGAAGGATTCCGTCGCG 69 FBan0005355 FBgn0032242 CG5355 2 2L proteolysis; GO:0006508 prolyl oligopeptidase activity; GO:0004287 ; EC:3.4.21.26; ; GO:0004287 ; EC:3.4.21.26 CG5355 CG5355 CDMC34158 3 13 4 DAC06-K14 2-CG5372-RA_1 CG5372 GGTGCCCATAAAGCTCTACGACCAGACTAACACTCTGGCTAAGGAGTACCCCTTGGAGGACTCCAGTCG 69 FBan0005372 FBgn0034880 alphaPS5 2 2R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157 cell adhesion molecule binding; GO:0050839; ; GO:0050839; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 alphaPS5 alphaPS5 "CG5372, CT17068, alphaPS5" CDMC34158 3 14 4 DAC06-K14 2-CG5372-RA_1 CG5372 GGTGCCCATAAAGCTCTACGACCAGACTAACACTCTGGCTAAGGAGTACCCCTTGGAGGACTCCAGTCG 69 FBan0005372 FBgn0034880 alphaPS5 2 2R cell adhesion; GO:0007155; cell-matrix adhesion; GO:0007160; heterophilic cell adhesion; GO:0007157 cell adhesion molecule binding; GO:0050839; ; GO:0050839; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004872; ; GO:0050839 integrin complex; GO:0008305 alphaPS5 alphaPS5 "CG5372, CT17068, alphaPS5" CDMC34159 3 15 4 DAC06-O02 12-CG5402-RA_1 CG5402 GCGCCTGTCACAACAGAGTCTAGTTTGCCATCGCAAGAAACCACAACGACTAGAACAACGCCGTTTACA 69 FBan0005402 FBgn0039521 CG5402 3 3R CG5402 CG5402 anon-WO0140519.87 CDMC34159 3 16 4 DAC06-O02 12-CG5402-RA_1 CG5402 GCGCCTGTCACAACAGAGTCTAGTTTGCCATCGCAAGAAACCACAACGACTAGAACAACGCCGTTTACA 69 FBan0005402 FBgn0039521 CG5402 3 3R CG5402 CG5402 anon-WO0140519.87 CDMC34160 3 17 4 DAC06-O14 15-CG5410-RE_1 CG5410 CCAAAGGGATCAGGAAAGACTGGAATGTGCAGGGGATTCCTGGTGGAGGATATGCACAAACTAATCGGA 69 FBan0005410 FBgn0039140 Miro 3 3R cytoplasmic microtubule organization and biogenesis; GO:0031122; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005525 Miro Mitochondrial Rho "CG5410, DmMiro, dMiro, Mitochondrial Rho" CDMC34160 3 18 4 DAC06-O14 15-CG5410-RE_1 CG5410 CCAAAGGGATCAGGAAAGACTGGAATGTGCAGGGGATTCCTGGTGGAGGATATGCACAAACTAATCGGA 69 FBan0005410 FBgn0039140 Miro 3 3R cytoplasmic microtubule organization and biogenesis; GO:0031122; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268 GTP binding; GO:0005525; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005525 Miro Mitochondrial Rho "CG5410, DmMiro, dMiro, Mitochondrial Rho" CDMC34161 3 19 4 DAC07-C02 2-CG9804-RA_1 CG9804 ATTCAGCAGGATTACAGCTACAGCAACGTCTTGCAAGGTCCAACCAGATCCTGAATCCGCCAGCG 65 FBan0009804 FBgn0037251 CG9804 3 3R lipoate biosynthesis; GO:0009107; protein modification; GO:0006464 lipoate-protein ligase activity; GO:0016979 ; EC:6.3.4.-; ; GO:0016979 ; EC:6.3.4.- CG9804 CG9804 CDMC34161 3 20 4 DAC07-C02 2-CG9804-RA_1 CG9804 ATTCAGCAGGATTACAGCTACAGCAACGTCTTGCAAGGTCCAACCAGATCCTGAATCCGCCAGCG 65 FBan0009804 FBgn0037251 CG9804 3 3R lipoate biosynthesis; GO:0009107; protein modification; GO:0006464 lipoate-protein ligase activity; GO:0016979 ; EC:6.3.4.-; ; GO:0016979 ; EC:6.3.4.- CG9804 CG9804 CDMC34162 3 21 4 DAC07-C14 6-CG9828-RA_2 CG9828 ATTCTCTGATGCCTCCGAATTCTTCGCCCAGTGGTTCCCCTTCGATCGAGTCTCGTCCGAAGGTC 65 FBan0009828 FBgn0032474 DnaJ-H 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-H DnaJ homolog "CG9828, CG9828, dDnaJ-H, NEST:bs08d07, DnaJ homolog" CDMC34162 3 22 4 DAC07-C14 6-CG9828-RA_2 CG9828 ATTCTCTGATGCCTCCGAATTCTTCGCCCAGTGGTTCCCCTTCGATCGAGTCTCGTCCGAAGGTC 65 FBan0009828 FBgn0032474 DnaJ-H 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 DnaJ-H DnaJ homolog "CG9828, CG9828, dDnaJ-H, NEST:bs08d07, DnaJ homolog" CDMC34163 3 23 4 DAC07-G02 23-CG9965-RA_1 CG9965 GGCAGCGATTACTCACCGAATAAATTACCTCATTCAGTTTTAGCTAAGTCTATATCCCCACCACC 65 FBan0009965 FBgn0035381 CG9965 3 3L CG9965 CG9965 CDMC34163 3 24 4 DAC07-G02 23-CG9965-RA_1 CG9965 GGCAGCGATTACTCACCGAATAAATTACCTCATTCAGTTTTAGCTAAGTCTATATCCCCACCACC 65 FBan0009965 FBgn0035381 CG9965 3 3L CG9965 CG9965 CDMC34164 3 25 4 DAC07-G14 3-CG9985-RA_1 CG9985 ATCGCGCTTACCGCCATTGAGTACACCAACAAATGCAGTTCGTCAGCCGATCATGACGATGTCGG 65 FBan0009985 FBgn0016984 sktl 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; autophagic cell death; GO:0048102; peripheral nervous system development; GO:0007422; phosphorylation; GO:0016310; salivary gland cell autophagic cell death; GO:0035071 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 nucleus; GO:0005634 sktl skittles "CG9985, CG9985, fam, ski, 25/17, l(2)05475, l(2)k12405, PIP5K 57B6, PIP5-kinase, Skittles, fata morgana, skittles" CDMC34164 3 26 4 DAC07-G14 3-CG9985-RA_1 CG9985 ATCGCGCTTACCGCCATTGAGTACACCAACAAATGCAGTTCGTCAGCCGATCATGACGATGTCGG 65 FBan0009985 FBgn0016984 sktl 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; autophagic cell death; GO:0048102; peripheral nervous system development; GO:0007422; phosphorylation; GO:0016310; salivary gland cell autophagic cell death; GO:0035071 1-phosphatidylinositol-4-phosphate 5-kinase activity; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68; ; GO:0016308 ; EC:2.7.1.68 nucleus; GO:0005634 sktl skittles "CG9985, CG9985, fam, ski, 25/17, l(2)05475, l(2)k12405, PIP5K 57B6, PIP5-kinase, Skittles, fata morgana, skittles" CDMC34165 3 1 5 DAC07-K02 1-CR31614-RA_1 CR31614 AGGGGAAGGGTGCATCTGGATCTTTCAAACTGTCGGCCTCTGCCAAGAAGGAAAAGGATCCGAAG 65 FBan0031614 FBgn0051614 His-Psi:CR31614 2 2L His-Psi:CR31614 His-Psi:CR31614 CR31614 CDMC34165 3 2 5 DAC07-K02 1-CR31614-RA_1 CR31614 AGGGGAAGGGTGCATCTGGATCTTTCAAACTGTCGGCCTCTGCCAAGAAGGAAAAGGATCCGAAG 65 FBan0031614 FBgn0051614 His-Psi:CR31614 2 2L His-Psi:CR31614 His-Psi:CR31614 CR31614 CDMC34166 3 3 5 DAC07-K14 23-CR32661-RA_15 CR32661 TCCCATATGTTGATTGCCTGACCTTGGTAAGGGTCAACTGACACATTCAATTCGAATTTGACAAA 65 FBan0032661 FBgn0030356 CR32661 X X CR32661 CR32661 "CG18184, bs05a04.y1, bs07b04.y1, bs26d09.y1" CDMC34166 3 4 5 DAC07-K14 23-CR32661-RA_15 CR32661 TCCCATATGTTGATTGCCTGACCTTGGTAAGGGTCAACTGACACATTCAATTCGAATTTGACAAA 65 FBan0032661 FBgn0030356 CR32661 X X CR32661 CR32661 "CG18184, bs05a04.y1, bs07b04.y1, bs26d09.y1" CDMC34167 3 5 5 DAC07-O02 24-CR32907-RA_1 CR32907 TTAACAGCTTGTAATGATTATGCATTGTGATTATTCAAGTTTATTTTGTTTCAAGACGGGACTGA 65 FBan0032907 FBgn0020518 snoRNA:U21 3 3L nucleolus; GO:0005730 snoRNA:U21 snoRNA:U21 "SnoRNA U21, U21, snoRNA:21, CR32907" CDMC34167 3 6 5 DAC07-O02 24-CR32907-RA_1 CR32907 TTAACAGCTTGTAATGATTATGCATTGTGATTATTCAAGTTTATTTTGTTTCAAGACGGGACTGA 65 FBan0032907 FBgn0020518 snoRNA:U21 3 3L nucleolus; GO:0005730 snoRNA:U21 snoRNA:U21 "SnoRNA U21, U21, snoRNA:21, CR32907" CDMC34168 3 7 5 DAC07-O14 1-CR33318-RA_2 CR33318 TGCTAATTGCCGAGGCTGTGGACCGTGTCTATGGCACTGGACGTATTCCCGGCAAGGAGTTATAC 65 FBan0033318 FBgn0053318 CR33318 2 2L CR33318 CR33318 "CG18078, CG18078, CG18078, CG18078" CDMC34168 3 8 5 DAC07-O14 1-CR33318-RA_2 CR33318 TGCTAATTGCCGAGGCTGTGGACCGTGTCTATGGCACTGGACGTATTCCCGGCAAGGAGTTATAC 65 FBan0033318 FBgn0053318 CR33318 2 2L CR33318 CR33318 "CG18078, CG18078, CG18078, CG18078" CDMC34169 3 9 5 DAC08-C02 21-CG5613-RA_4 CG5613 AGCACCGTGGAGGCTCTAACCCGTCTCTGTGAGCACTTCGGCTTCGAGGGATGGCTGGTCAACGTGGAG 69 FBan0005613 FBgn0030839 CG5613 X X CG5613 CG5613 CDMC34169 3 10 5 DAC08-C02 21-CG5613-RA_4 CG5613 AGCACCGTGGAGGCTCTAACCCGTCTCTGTGAGCACTTCGGCTTCGAGGGATGGCTGGTCAACGTGGAG 69 FBan0005613 FBgn0030839 CG5613 X X CG5613 CG5613 CDMC34170 3 11 5 DAC08-C14 16-CG5627-RA_1 CG5627 GCCGCCTCTCACTAATCCCATAGACAAATTGTTTCCTGCTAAGCTTTAAGGCAGAAAGCGCCAAACAAA 69 FBan0005627 FBgn0030613 rab3-GEF X X neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 Rab guanyl-nucleotide exchange factor activity; GO:0017112; receptor binding; GO:0005102; ; GO:0005102; ; GO:0017112 synaptic vesicle; GO:0008021 rab3-GEF rab3-GEF "CG5627, CG5627, CG5627, CG5627, anon-EST:Posey246, BEST:GH21304" CDMC34170 3 12 5 DAC08-C14 16-CG5627-RA_1 CG5627 GCCGCCTCTCACTAATCCCATAGACAAATTGTTTCCTGCTAAGCTTTAAGGCAGAAAGCGCCAAACAAA 69 FBan0005627 FBgn0030613 rab3-GEF X X neurotransmitter secretion; GO:0007269; vesicle-mediated transport; GO:0016192 Rab guanyl-nucleotide exchange factor activity; GO:0017112; receptor binding; GO:0005102; ; GO:0005102; ; GO:0017112 synaptic vesicle; GO:0008021 rab3-GEF rab3-GEF "CG5627, CG5627, CG5627, CG5627, anon-EST:Posey246, BEST:GH21304" CDMC34171 3 13 5 DAC08-G02 11-CG5664-RA_8 CG5664 AAGAGGAGGATGCGAATATGTCCCAGGAAACGGTCTTTCTGCGACATGTACAGCAGTATGACTGGCAGA 69 FBan0005664 FBgn0037082 CG5664 3 3L CG5664 CG5664 CDMC34171 3 14 5 DAC08-G02 11-CG5664-RA_8 CG5664 AAGAGGAGGATGCGAATATGTCCCAGGAAACGGTCTTTCTGCGACATGTACAGCAGTATGACTGGCAGA 69 FBan0005664 FBgn0037082 CG5664 3 3L CG5664 CG5664 CDMC34172 3 15 5 DAC08-G14 8-CG5671-RC_4 CG5671 ATGTGGCTCAAGGAAGATTCGTCCAATGTTGTAGCCGTGCACTGTAAAGCTGGAAAGGGCAGAACCGGT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC34172 3 16 5 DAC08-G14 8-CG5671-RC_4 CG5671 ATGTGGCTCAAGGAAGATTCGTCCAATGTTGTAGCCGTGCACTGTAAAGCTGGAAAGGGCAGAACCGGT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC34173 3 17 5 DAC08-K02 23-CG5707-RA_1 CG5707 GCCGACGTGATGCTTTCTTCAAGCCTTAACGCTTTAGAGTAATAATATAGACAATTTTATACGATGTTC 69 FBan0005707 FBgn0026593 CG5707 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5707 CG5707 "HL03644, BEST:HL03644" CDMC34173 3 18 5 DAC08-K02 23-CG5707-RA_1 CG5707 GCCGACGTGATGCTTTCTTCAAGCCTTAACGCTTTAGAGTAATAATATAGACAATTTTATACGATGTTC 69 FBan0005707 FBgn0026593 CG5707 3 3L hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG5707 CG5707 "HL03644, BEST:HL03644" CDMC34174 3 19 5 DAC08-K14 2-CG5715-RA_1 CG5715 GCGCGTGATGAAGGACAACATCAAGCCCGAGATGATGGTCAACTTCGAGAAGTCCAGTTCCAGGACACA 69 FBan0005715 FBgn0039180 CG5715 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG5715 CG5715 CDMC34174 3 20 5 DAC08-K14 2-CG5715-RA_1 CG5715 GCGCGTGATGAAGGACAACATCAAGCCCGAGATGATGGTCAACTTCGAGAAGTCCAGTTCCAGGACACA 69 FBan0005715 FBgn0039180 CG5715 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; meprin A activity; GO:0004238 ; EC:3.4.24.18; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004238 ; EC:3.4.24.18 meprin A complex; GO:0017090 CG5715 CG5715 CDMC34175 3 21 5 DAC08-O02 3-CG5748-RA_2 CG5748 AATACAGTGGCGCTGAGAACGGAAACAACCGCGATACCAACAACAGTCAACTCCTCAGGATGGCCTCAG 69 FBan0005748 FBgn0001222 Hsf 2 2R defense response; GO:0006952; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to heat; GO:0009408 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0016563; ; GO:0003700 nucleus; GO:0005634; polytene chromosome; GO:0005700 Hsf Heat shock factor "CG5748, CG5748, HSF, D-HSF, l(2)03091, dHSF, hsf, DmHSF, Dm-Hsf" CDMC34175 3 22 5 DAC08-O02 3-CG5748-RA_2 CG5748 AATACAGTGGCGCTGAGAACGGAAACAACCGCGATACCAACAACAGTCAACTCCTCAGGATGGCCTCAG 69 FBan0005748 FBgn0001222 Hsf 2 2R defense response; GO:0006952; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to heat; GO:0009408 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0016563; ; GO:0003700 nucleus; GO:0005634; polytene chromosome; GO:0005700 Hsf Heat shock factor "CG5748, CG5748, HSF, D-HSF, l(2)03091, dHSF, hsf, DmHSF, Dm-Hsf" CDMC34176 3 23 5 DAC08-O14 11-CG5760-RA_1 CG5760 TTGGAGCCCTGTTCGCCATATTCTCCGATAAAAGTGGAAGTACTTGGTTTGTGTTGCCCTCTCTGCTGG 69 FBan0005760 FBgn0028468 rtet 3 3R oogenesis (sensu Insecta); GO:0009993; transport; GO:0006810 sugar transporter activity; GO:0051119; ; GO:0051119 integral to membrane; GO:0016021; membrane; GO:0016020 rtet tetracycline resistance "CG5760, CG5760, l(3)07086, Drtet, anon-WO0119857.1, BcDNA:LD28419, tetracycline resistance" CDMC34176 3 24 5 DAC08-O14 11-CG5760-RA_1 CG5760 TTGGAGCCCTGTTCGCCATATTCTCCGATAAAAGTGGAAGTACTTGGTTTGTGTTGCCCTCTCTGCTGG 69 FBan0005760 FBgn0028468 rtet 3 3R oogenesis (sensu Insecta); GO:0009993; transport; GO:0006810 sugar transporter activity; GO:0051119; ; GO:0051119 integral to membrane; GO:0016021; membrane; GO:0016020 rtet tetracycline resistance "CG5760, CG5760, l(3)07086, Drtet, anon-WO0119857.1, BcDNA:LD28419, tetracycline resistance" CDMC34177 3 25 5 DAC09-C03 2-CG31481-RA_1 CG31481 GCACATGCATCACCTGGGAAATGGGGAGACATACAGTGCTCTAGGCCTACAGATGGAGAACTGCGAG 67 FBan0031481 FBgn0051481 pb 3 3R "anterior/posterior axis specification; GO:0009948; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, labial segment; GO:0007381; specification of segmental identity, maxillary segment; GO:0007382" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 pb proboscipedia "CG31481, CG17880, l(3)04498, pd, PB, proposcipedia, BG:DS01719.1, proboscipedia" CDMC34177 3 26 5 DAC09-C03 2-CG31481-RA_1 CG31481 GCACATGCATCACCTGGGAAATGGGGAGACATACAGTGCTCTAGGCCTACAGATGGAGAACTGCGAG 67 FBan0031481 FBgn0051481 pb 3 3R "anterior/posterior axis specification; GO:0009948; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of segmental identity, labial segment; GO:0007381; specification of segmental identity, maxillary segment; GO:0007382" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677; ; GO:0003704 nucleus; GO:0005634 pb proboscipedia "CG31481, CG17880, l(3)04498, pd, PB, proposcipedia, BG:DS01719.1, proboscipedia" CDMC34178 3 1 6 DAC09-C15 1-CG31687-RA_6 CG31687 AGCATCAACAAGTACCGCCCGGAGACGTGTTGTGTAATAGGTGGCCATTTCCTACTTTCAACGCGCC 67 FBan0031687 FBgn0051687 CG31687 2 2L cell cycle; GO:0007049; mitosis; GO:0007067; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 anaphase-promoting complex; GO:0005680 CG31687 CG31687 CDMC34178 3 2 6 DAC09-C15 1-CG31687-RA_6 CG31687 AGCATCAACAAGTACCGCCCGGAGACGTGTTGTGTAATAGGTGGCCATTTCCTACTTTCAACGCGCC 67 FBan0031687 FBgn0051687 CG31687 2 2L cell cycle; GO:0007049; mitosis; GO:0007067; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 anaphase-promoting complex; GO:0005680 CG31687 CG31687 CDMC34179 3 3 6 DAC09-G03 1-CG32132-RA_1 CG32132 CAGTATGGTAGCAGTGCGGCTCTCAGCAATCATCAACCTCATCAGCATACGCATCCACATCCCCAGC 67 FBan0032132 FBgn0052132 CG32132 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32132 CG32132 CDMC34179 3 4 6 DAC09-G03 1-CG32132-RA_1 CG32132 CAGTATGGTAGCAGTGCGGCTCTCAGCAATCATCAACCTCATCAGCATACGCATCCACATCCCCAGC 67 FBan0032132 FBgn0052132 CG32132 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32132 CG32132 CDMC34180 3 5 6 DAC09-G15 16-CG32371-RA_1 CG32371 AATGCTATCCTGGGTGAATAACACGTTGAAATCGCAGTTTTTCAAGGTCGAGGAATTGTGCACCGGA 67 FBan0032371 FBgn0052371 CG32371 3 3L cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; receptor binding; GO:0005102; ; GO:0008017; ; GO:0005102 microtubule cytoskeleton; GO:0015630 CG32371 CG32371 "EB1, BEST:GH23475" CDMC34180 3 6 6 DAC09-G15 16-CG32371-RA_1 CG32371 AATGCTATCCTGGGTGAATAACACGTTGAAATCGCAGTTTTTCAAGGTCGAGGAATTGTGCACCGGA 67 FBan0032371 FBgn0052371 CG32371 3 3L cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 microtubule binding; GO:0008017; receptor binding; GO:0005102; ; GO:0008017; ; GO:0005102 microtubule cytoskeleton; GO:0015630 CG32371 CG32371 "EB1, BEST:GH23475" CDMC34181 3 7 6 DAC09-K03 1-CG32713-RA_1 CG32713 GCTATCCAATCAGAGCGTACTGGAGGATTTGGGGCCCAATAAGTCCACCCTGGATCTCACCTGGAAG 67 FBan0032713 FBgn0052713 CG32713 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32713 CG32713 CDMC34181 3 8 6 DAC09-K03 1-CG32713-RA_1 CG32713 GCTATCCAATCAGAGCGTACTGGAGGATTTGGGGCCCAATAAGTCCACCCTGGATCTCACCTGGAAG 67 FBan0032713 FBgn0052713 CG32713 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32713 CG32713 CDMC34182 3 9 6 DAC09-K15 9-CG33109-RA_2 CG33109 AATCCAACGGAGCACTTGATCGATGTCACTGAAGGCTGTTCCAGCGTTAAGCCAAAAAAGTGCCGGC 67 FBan0033109 FBgn0053109 CG33109 3 3R CG33109 CG33109 "CG9645, CG9645, CG9645, CG9645, CG9645, CG9645" CDMC34182 3 10 6 DAC09-K15 9-CG33109-RA_2 CG33109 AATCCAACGGAGCACTTGATCGATGTCACTGAAGGCTGTTCCAGCGTTAAGCCAAAAAAGTGCCGGC 67 FBan0033109 FBgn0053109 CG33109 3 3R CG33109 CG33109 "CG9645, CG9645, CG9645, CG9645, CG9645, CG9645" CDMC34183 3 11 6 DAC09-O03 2-CG3431-RA_3 CG3431 GGAGGATGAACCCGCTGGAAAAGTGGTCCTGGATCGGGAGAACATCTTCTTTGCCAAGCAGGTGATC 67 FBan0003431 FBgn0011327 Uch-L3 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004175; ; GO:0004221 ; EC:3.1.2.15 cytoplasm; GO:0005737; proteasome regulatory particle (sensu Eukaryota); GO:0005838 Uch-L3 Ubiquitin C-terminal hydrolase "CG3431, l(3)j2B8, Ubiquitin C-terminal hydrolase related, UCH, ubiquitin C-terminal hydrolase, BcDNA.LD24440, p37A, dUCH37, uch-L3, BcDNA:LD24440" CDMC34183 3 12 6 DAC09-O03 2-CG3431-RA_3 CG3431 GGAGGATGAACCCGCTGGAAAAGTGGTCCTGGATCGGGAGAACATCTTCTTTGCCAAGCAGGTGATC 67 FBan0003431 FBgn0011327 Uch-L3 3 3L protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15; ; GO:0004175; ; GO:0004221 ; EC:3.1.2.15 cytoplasm; GO:0005737; proteasome regulatory particle (sensu Eukaryota); GO:0005838 Uch-L3 Ubiquitin C-terminal hydrolase "CG3431, l(3)j2B8, Ubiquitin C-terminal hydrolase related, UCH, ubiquitin C-terminal hydrolase, BcDNA.LD24440, p37A, dUCH37, uch-L3, BcDNA:LD24440" CDMC34184 3 13 6 DAC09-O15 1-CG3608-RA_1 CG3608 AGGTGGACCGTCAGATGCTGCTCATTCTGAAGACAAATGACTTGATCCGCGGAATTGAGTCCACGCT 67 FBan0003608 FBgn0035039 CG3608 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transporter activity; GO:0005215; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005215 CG3608 CG3608 CDMC34184 3 14 6 DAC09-O15 1-CG3608-RA_1 CG3608 AGGTGGACCGTCAGATGCTGCTCATTCTGAAGACAAATGACTTGATCCGCGGAATTGAGTCCACGCT 67 FBan0003608 FBgn0035039 CG3608 2 2R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transporter activity; GO:0005215; ; GO:0004672 ; EC:2.7.1.37; ; GO:0005215 CG3608 CG3608 CDMC34185 3 15 6 DAC10-C02 23-CG18336-RA_10 CG18336 GCTTCTCCTGTCAGGCCAGCTATTAATAGTTAAATTCAGTTTCCAGTTACCCAGTTAAGCAGCAACACT 69 FBan0018336 FBgn0040763 CG18336 2 2R CG18336 CG18336 CG13212 CDMC34185 3 16 6 DAC10-C02 23-CG18336-RA_10 CG18336 GCTTCTCCTGTCAGGCCAGCTATTAATAGTTAAATTCAGTTTCCAGTTACCCAGTTAAGCAGCAACACT 69 FBan0018336 FBgn0040763 CG18336 2 2R CG18336 CG18336 CG13212 CDMC34186 3 17 6 DAC10-C14 2-CG18363-RA_1 CG18363 TTGCCCTTGCACTTTCTCACTTCGCTGGGTACATCGATCATTTCGTCTGCGATCACTCATCCCCTGGAC 69 FBan0018363 FBgn0036808 CG18363 3 3L cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18363 CG18363 CDMC34186 3 18 6 DAC10-C14 2-CG18363-RA_1 CG18363 TTGCCCTTGCACTTTCTCACTTCGCTGGGTACATCGATCATTTCGTCTGCGATCACTCATCCCCTGGAC 69 FBan0018363 FBgn0036808 CG18363 3 3L cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18363 CG18363 CDMC34187 3 19 6 DAC10-G02 3-CG18418-RA_1 CG18418 AGTGCCGGACTATTGAGACAGGCCACGTACACATCAGCCAAGATGGGTGTTTACCAGATGGAGTTGGAT 69 FBan0018418 FBgn0035568 CG18418 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18418 CG18418 anon-WO0140519.190 CDMC34187 3 20 6 DAC10-G02 3-CG18418-RA_1 CG18418 AGTGCCGGACTATTGAGACAGGCCACGTACACATCAGCCAAGATGGGTGTTTACCAGATGGAGTTGGAT 69 FBan0018418 FBgn0035568 CG18418 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18418 CG18418 anon-WO0140519.190 CDMC34188 3 21 6 DAC10-G14 2-CG18446-RA_1 CG18446 CGCAAGCGATTTATTCTGTAGCCTCAGCACTTTGGATCTGGATCTCGACGTCGAAGTCCCAAAGCCCCA 69 FBan0018446 FBgn0033458 CG18446 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18446 CG18446 CDMC34188 3 22 6 DAC10-G14 2-CG18446-RA_1 CG18446 CGCAAGCGATTTATTCTGTAGCCTCAGCACTTTGGATCTGGATCTCGACGTCGAAGTCCCAAAGCCCCA 69 FBan0018446 FBgn0033458 CG18446 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18446 CG18446 CDMC34189 3 23 6 DAC10-K02 2-CG18497-RA_1 CG18497 ATGAGTCCGGACTGTCACCCACGCTGTTAAGCACAATTAGGTTTAAAGTTGCGCCCAGAGGCTTTTCCT 69 FBan0018497 FBgn0016977 spen 2 2L Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; glial cell fate determination; GO:0007403; glial cell migration; GO:0008347; mesoderm development; GO:0007498; neuroblast fate determination; GO:0007400; regulation of transcription; GO:0045449; segment specification; GO:0007379 mRNA binding; GO:0003729; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0003729; ; GO:0030528; ; GO:0003712 nucleus; GO:0005634 spen split ends "CG18497, CG18497, l(2)03350, l(2)k06805, l(2)k07612, l(2)k08102, poc, polycephalon, 136/24, rno, rhinoceros, E(E2F)2A, spe: spectacled, EY2-7, E(Sev-CycE)2A, EK2-9, BcDNA:GM01870, E(Raf)2A, En(yan[ACT])2-7, yip1, yippee interacting protein 1, spe, split ends" CDMC34189 3 24 6 DAC10-K02 2-CG18497-RA_1 CG18497 ATGAGTCCGGACTGTCACCCACGCTGTTAAGCACAATTAGGTTTAAAGTTGCGCCCAGAGGCTTTTCCT 69 FBan0018497 FBgn0016977 spen 2 2L Wnt receptor signaling pathway; GO:0016055; axon guidance; GO:0007411; ectoderm development; GO:0007398; epidermal growth factor receptor signaling pathway; GO:0007173; glial cell fate determination; GO:0007403; glial cell migration; GO:0008347; mesoderm development; GO:0007498; neuroblast fate determination; GO:0007400; regulation of transcription; GO:0045449; segment specification; GO:0007379 mRNA binding; GO:0003729; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0003729; ; GO:0030528; ; GO:0003712 nucleus; GO:0005634 spen split ends "CG18497, CG18497, l(2)03350, l(2)k06805, l(2)k07612, l(2)k08102, poc, polycephalon, 136/24, rno, rhinoceros, E(E2F)2A, spe: spectacled, EY2-7, E(Sev-CycE)2A, EK2-9, BcDNA:GM01870, E(Raf)2A, En(yan[ACT])2-7, yip1, yippee interacting protein 1, spe, split ends" CDMC34190 3 25 6 DAC10-K14 17-CG18518-RA_3 CG18518 CGGCAGAGGCTTTTATCTCTCCAGATGGATTCTGCATTGTCATTGTCATTGGTGGATCGAGTTCCACAA 69 FBan0018518 FBgn0028900 CG18518 2 2L CG18518 CG18518 "BG:DS02252.4, DS02252.4" CDMC34190 3 26 6 DAC10-K14 17-CG18518-RA_3 CG18518 CGGCAGAGGCTTTTATCTCTCCAGATGGATTCTGCATTGTCATTGTCATTGGTGGATCGAGTTCCACAA 69 FBan0018518 FBgn0028900 CG18518 2 2L CG18518 CG18518 "BG:DS02252.4, DS02252.4" CDMC34191 3 1 7 DAC10-O02 16-CG18582-RA_1 CG18582 AGCGAAACAACGAAGGTGTGAATCGAAGGGAGACAGAAAACGAAAGAGAAAGAGATAGCGTTAGGCGGA 69 FBan0018582 FBgn0025743 mbt X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of MAPK activity; GO:0000187; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; mushroom body development; GO:0016319; positive regulation of eye photoreceptor development (sensu Endopterygota); GO:0045315; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0005524; ; GO:0005515 adherens junction; GO:0005912 mbt mushroom bodies tiny "CG18582, CG18582, CG18582, Ste20, STE20, Mbt, dPAK2, DmMBT, DmPAK2, Pak2, anon-EST:fe1G7, anon-fast-evolving-1G7, mushroom bodies tiny" CDMC34191 3 2 7 DAC10-O02 16-CG18582-RA_1 CG18582 AGCGAAACAACGAAGGTGTGAATCGAAGGGAGACAGAAAACGAAAGAGAAAGAGATAGCGTTAGGCGGA 69 FBan0018582 FBgn0025743 mbt X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; activation of MAPK activity; GO:0000187; cell proliferation; GO:0008283; cytoskeleton organization and biogenesis; GO:0007010; eye photoreceptor cell differentiation (sensu Endopterygota); GO:0001751; mushroom body development; GO:0016319; positive regulation of eye photoreceptor development (sensu Endopterygota); GO:0045315; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0005524; ; GO:0005515 adherens junction; GO:0005912 mbt mushroom bodies tiny "CG18582, CG18582, CG18582, Ste20, STE20, Mbt, dPAK2, DmMBT, DmPAK2, Pak2, anon-EST:fe1G7, anon-fast-evolving-1G7, mushroom bodies tiny" CDMC34192 3 3 7 DAC10-O14 1-CG18596-RA_1 CG18596 CGCGCCCTTGAAACGTTTAAACGGAAACAATCGGTTTTGATACCTGAGCTTGCAACGTCCTTGGCTGCA 69 FBan0018596 FBgn0038953 CG18596 3 3R CG18596 CG18596 CDMC34192 3 4 7 DAC10-O14 1-CG18596-RA_1 CG18596 CGCGCCCTTGAAACGTTTAAACGGAAACAATCGGTTTTGATACCTGAGCTTGCAACGTCCTTGGCTGCA 69 FBan0018596 FBgn0038953 CG18596 3 3R CG18596 CG18596 CDMC34193 3 5 7 DAC11-C02 11-CG10352-RA_3 CG10352 TGGTCATATGTGGGTCTTGTACCGCCAGGTGTTGTTTGGTATCCACTGAGGGATTTCATACCCGGTT 67 FBan0010352 FBgn0030348 CG10352 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG10352 CG10352 CDMC34193 3 6 7 DAC11-C02 11-CG10352-RA_3 CG10352 TGGTCATATGTGGGTCTTGTACCGCCAGGTGTTGTTTGGTATCCACTGAGGGATTTCATACCCGGTT 67 FBan0010352 FBgn0030348 CG10352 X X metabolism; GO:0008152 4-nitrophenylphosphatase activity; GO:0003869 ; EC:3.1.3.41; ; GO:0003869 ; EC:3.1.3.41 CG10352 CG10352 CDMC34194 3 7 7 DAC11-C14 3-CG10555-RA_1 CG10555 TCGCTGGTTGAAGGTGGAGAGGAGATTGGGATCTACAGGCCGATCATCGATGGAGAAGGAGGTGATG 67 FBan0010555 FBgn0030034 CG10555 X X CG10555 CG10555 CDMC34194 3 8 7 DAC11-C14 3-CG10555-RA_1 CG10555 TCGCTGGTTGAAGGTGGAGAGGAGATTGGGATCTACAGGCCGATCATCGATGGAGAAGGAGGTGATG 67 FBan0010555 FBgn0030034 CG10555 X X CG10555 CG10555 CDMC34195 3 9 7 DAC11-G02 3-CG10903-RA_1 CG10903 TGATTTTGGACATCGGCTGTGGTTCTGGACTCTCAGGTAGCGTTCTTGAGGACAGCGAGCACATGTG 67 FBan0010903 FBgn0037543 CG10903 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG10903 CG10903 CDMC34195 3 10 7 DAC11-G02 3-CG10903-RA_1 CG10903 TGATTTTGGACATCGGCTGTGGTTCTGGACTCTCAGGTAGCGTTCTTGAGGACAGCGAGCACATGTG 67 FBan0010903 FBgn0037543 CG10903 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG10903 CG10903 CDMC34196 3 11 7 DAC11-G14 3-CG10977-RA_2 CG10977 CAGAGGCAATCGTCAGCCGTGTTACTACTCGTAGTGAAGCCAAAACCCTCAACTGTGCATGCCAGGG 67 FBgn0035651 CDMC34196 3 12 7 DAC11-G14 3-CG10977-RA_2 CG10977 CAGAGGCAATCGTCAGCCGTGTTACTACTCGTAGTGAAGCCAAAACCCTCAACTGTGCATGCCAGGG 67 FBgn0035651 CDMC34197 3 13 7 DAC11-K02 2-CG11318-RA_2 CG11318 AGCAGTTCGGACCTCTTGAAGGATGCCATCATCGAGTGCCACACTAACCACCTCACACAGTTTGCAT 67 FBan0011318 FBgn0039818 CG11318 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG11318 CG11318 "anon-WO0170980.121, anon-WO0170980.122" CDMC34197 3 14 7 DAC11-K02 2-CG11318-RA_2 CG11318 AGCAGTTCGGACCTCTTGAAGGATGCCATCATCGAGTGCCACACTAACCACCTCACACAGTTTGCAT 67 FBan0011318 FBgn0039818 CG11318 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; neuropeptide signaling pathway; GO:0007218 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG11318 CG11318 "anon-WO0170980.121, anon-WO0170980.122" CDMC34198 3 15 7 DAC11-K14 3-CG11416-RA_1 CG11416 GGAGGGCGACGCTACTGACCCTGAATCAGCGACCAAATCGATCCTACGAAACAAATCTGCTGTGGAC 67 FBan0011416 FBgn0035025 CG11416 2 2R CG11416 CG11416 CDMC34198 3 16 7 DAC11-K14 3-CG11416-RA_1 CG11416 GGAGGGCGACGCTACTGACCCTGAATCAGCGACCAAATCGATCCTACGAAACAAATCTGCTGTGGAC 67 FBan0011416 FBgn0035025 CG11416 2 2R CG11416 CG11416 CDMC34199 3 17 7 DAC11-O02 3-CG12084-RA_4 CG12084 GCACGGCGTTTCTAAGACGGAGCAAGAGGGATTTGTCCAGCGCATAGCAATCTACCTGCTGAACACA 67 FBan0012084 FBgn0043458 CG12084 3 3L CG12084 CG12084 "BEST:LD02105, LD02105" CDMC34199 3 18 7 DAC11-O02 3-CG12084-RA_4 CG12084 GCACGGCGTTTCTAAGACGGAGCAAGAGGGATTTGTCCAGCGCATAGCAATCTACCTGCTGAACACA 67 FBan0012084 FBgn0043458 CG12084 3 3L CG12084 CG12084 "BEST:LD02105, LD02105" CDMC34200 3 19 7 DAC11-O14 7-CG12238-RA_1 CG12238 GCCTGAGTGGGGGTCATACGTTATTGTGCCAAGCGTACTCTAACGGACTTATAGTAAGCGCCGGACG 67 FBgn0031046 CDMC34200 3 20 7 DAC11-O14 7-CG12238-RA_1 CG12238 GCCTGAGTGGGGGTCATACGTTATTGTGCCAAGCGTACTCTAACGGACTTATAGTAAGCGCCGGACG 67 FBgn0031046 CDMC34201 3 21 7 DAC12-C02 3-CG10212-RA_7 CG10212 CAGCCACCAACGAGATCAAGGTGACCAAGCAAAGGGCGGAGAAATCTCGTGCGAACTGGAAAAAGC 66 FBan0010212 FBgn0027783 SMC2 2 2R chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 DNA binding; GO:0003677; chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; condensin complex; GO:0000796; nucleus; GO:0005634 SMC2 SMC2 "CG10212, DmSMC2" CDMC34201 3 22 7 DAC12-C02 3-CG10212-RA_7 CG10212 CAGCCACCAACGAGATCAAGGTGACCAAGCAAAGGGCGGAGAAATCTCGTGCGAACTGGAAAAAGC 66 FBan0010212 FBgn0027783 SMC2 2 2R chromosome segregation; GO:0007059; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 DNA binding; GO:0003677; chromatin binding; GO:0003682; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003677; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0016887 cohesin complex; GO:0008278; condensin complex; GO:0000796; nucleus; GO:0005634 SMC2 SMC2 "CG10212, DmSMC2" CDMC34202 3 23 7 DAC12-C14 2-CG10337-RA_1 CG10337 GCGAAGCATTGCTGGTCCGGAATAGCGCATATTTGGAGTCCTCGTTGGGTCCATTGAACCTCAACC 66 FBan0010337 FBgn0032805 CG10337 2 2L CG10337 CG10337 CDMC34202 3 24 7 DAC12-C14 2-CG10337-RA_1 CG10337 GCGAAGCATTGCTGGTCCGGAATAGCGCATATTTGGAGTCCTCGTTGGGTCCATTGAACCTCAACC 66 FBan0010337 FBgn0032805 CG10337 2 2L CG10337 CG10337 CDMC34203 3 25 7 DAC12-G02 2-CG10850-RA_1 CG10850 TCCCTGCTGCAGAACTACACCTTAGCCCTACACTTCGCTGTAAAACTAGGAACGGTGGCTGGCTAC 66 FBan0010850 FBgn0041147 ida 3 3L imaginal disc development; GO:0007444; mitotic anaphase; GO:0000090; mitotic cell cycle; GO:0000278; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- anaphase-promoting complex; GO:0005680 ida imaginal discs arrested "CG10850, CG10850, l(3)SH7, l(3)63Fb, APC5, imaginal discs arrested" CDMC34203 3 26 7 DAC12-G02 2-CG10850-RA_1 CG10850 TCCCTGCTGCAGAACTACACCTTAGCCCTACACTTCGCTGTAAAACTAGGAACGGTGGCTGGCTAC 66 FBan0010850 FBgn0041147 ida 3 3L imaginal disc development; GO:0007444; mitotic anaphase; GO:0000090; mitotic cell cycle; GO:0000278; regulation of progression through cell cycle; GO:0000074; regulation of proteolysis; GO:0030162 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- anaphase-promoting complex; GO:0005680 ida imaginal discs arrested "CG10850, CG10850, l(3)SH7, l(3)63Fb, APC5, imaginal discs arrested" CDMC34204 3 1 8 DAC12-G14 2-CG1099-RA_3 CG1099 CGAGGAAGGCGATTTGAGCTTCAGTGCCGGTGAGATGGTCATGGTCATCAAGAAGGAGGGTGAGTG 66 FBan0001099 FBgn0023388 Dap160 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; receptor mediated endocytosis; GO:0006898; synaptic growth at neuromuscular junction; GO:0051124; synaptic vesicle endocytosis; GO:0048488 protein binding; GO:0005515; calcium ion binding; GO:0005509; ; GO:0005515; ; GO:0005509 colocalizes_with presynaptic membrane; GO:0042734 Dap160 Dynamin associated protein 160 "CG1099, CG1099, CG1099, p160, DAP-160, DAP160, Dap160/intersectin, dap160, Dynamin associated protein 160" CDMC34204 3 2 8 DAC12-G14 2-CG1099-RA_3 CG1099 CGAGGAAGGCGATTTGAGCTTCAGTGCCGGTGAGATGGTCATGGTCATCAAGAAGGAGGGTGAGTG 66 FBan0001099 FBgn0023388 Dap160 2 2L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein localization; GO:0008104; receptor mediated endocytosis; GO:0006898; synaptic growth at neuromuscular junction; GO:0051124; synaptic vesicle endocytosis; GO:0048488 protein binding; GO:0005515; calcium ion binding; GO:0005509; ; GO:0005515; ; GO:0005509 colocalizes_with presynaptic membrane; GO:0042734 Dap160 Dynamin associated protein 160 "CG1099, CG1099, CG1099, p160, DAP-160, DAP160, Dap160/intersectin, dap160, Dynamin associated protein 160" CDMC34205 3 3 8 DAC12-K02 3-CG11184-RB_8 CG11184 ACAAGGGCGTCGAGTACATGGCCATCGTGGAGTATGCTCCCTTCCAGTGCTTCCTTAAGAACAAGG 66 FBan0011184 FBgn0034923 Upf3 2 2R "RNA catabolism; GO:0006401; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" Upf3 Upf3 "CG11184, CG11184, CG11184, CG11184, UPF3" CDMC34205 3 4 8 DAC12-K02 3-CG11184-RB_8 CG11184 ACAAGGGCGTCGAGTACATGGCCATCGTGGAGTATGCTCCCTTCCAGTGCTTCCTTAAGAACAAGG 66 FBan0011184 FBgn0034923 Upf3 2 2R "RNA catabolism; GO:0006401; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" Upf3 Upf3 "CG11184, CG11184, CG11184, CG11184, UPF3" CDMC34206 3 5 8 DAC12-K14 3-CG1129-RB_2 CG1129 ACCGTGCTAGGCGAGGATGTAATCGTGAAGGATGAGCTCTACATTAATGGAGGCCAGGTCTTGCCC 66 FBan0001129 FBgn0037279 CG1129 3 3R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mannose-1-phosphate guanylyltransferase activity; GO:0004475 ; EC:2.7.7.13; ; GO:0004475 ; EC:2.7.7.13 CG1129 CG1129 CDMC34206 3 6 8 DAC12-K14 3-CG1129-RB_2 CG1129 ACCGTGCTAGGCGAGGATGTAATCGTGAAGGATGAGCTCTACATTAATGGAGGCCAGGTCTTGCCC 66 FBan0001129 FBgn0037279 CG1129 3 3R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mannose-1-phosphate guanylyltransferase activity; GO:0004475 ; EC:2.7.7.13; ; GO:0004475 ; EC:2.7.7.13 CG1129 CG1129 CDMC34207 3 7 8 DAC12-O02 2-CG12052-RA_1 CG12052 CCTCCACCACTGAACTGCTTAACGGGGAGGGATTGTAGGAGGGATAGCAATTTGAACTGAGGGGCG 66 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34207 3 8 8 DAC12-O02 2-CG12052-RA_1 CG12052 CCTCCACCACTGAACTGCTTAACGGGGAGGGATTGTAGGAGGGATAGCAATTTGAACTGAGGGGCG 66 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34208 3 9 8 DAC12-O14 AutoBlank AutoBlank CDMC34208 3 10 8 DAC12-O14 AutoBlank AutoBlank CDMC34209 3 11 8 DAC13-C02 12-CG14544-RA_1 CG14544 ATAGAAAAGGGCGATGTGGTCATCCTTTATTTGAGTGTCAGTTCCATGCATGCCATCGAAGCGGTGCCC 69 FBan0014544 FBgn0039407 CG14544 3 3R anti-apoptosis; GO:0006916; apoptosis; GO:0006915; protein metabolism; GO:0019538; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG14544 CG14544 CDMC34209 3 12 8 DAC13-C02 12-CG14544-RA_1 CG14544 ATAGAAAAGGGCGATGTGGTCATCCTTTATTTGAGTGTCAGTTCCATGCATGCCATCGAAGCGGTGCCC 69 FBan0014544 FBgn0039407 CG14544 3 3R anti-apoptosis; GO:0006916; apoptosis; GO:0006915; protein metabolism; GO:0019538; protein modification; GO:0006464 transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757 CG14544 CG14544 CDMC34210 3 13 8 DAC13-C14 14-CG14559-RA_1 CG14559 GCAGATCGTAGTTTCTTGCAAGCGTTGTGAATGAGCCAATTTTAGCGGCGATTATTGTGCAGTGCAGCT 69 FBgn0040604 CDMC34210 3 14 8 DAC13-C14 14-CG14559-RA_1 CG14559 GCAGATCGTAGTTTCTTGCAAGCGTTGTGAATGAGCCAATTTTAGCGGCGATTATTGTGCAGTGCAGCT 69 FBgn0040604 CDMC34211 3 15 8 DAC13-G02 1-CG14597-RA_1 CG14597 ACCCACTAGCAATAACAGCAACTCGAACTCGAACTACAGCCCGAACCATGATCAATTACCCGCCCAGCT 69 FBan0014597 FBgn0037509 CG14597 3 3R CG14597 CG14597 CDMC34211 3 16 8 DAC13-G02 1-CG14597-RA_1 CG14597 ACCCACTAGCAATAACAGCAACTCGAACTCGAACTACAGCCCGAACCATGATCAATTACCCGCCCAGCT 69 FBan0014597 FBgn0037509 CG14597 3 3R CG14597 CG14597 CDMC34212 3 17 8 DAC13-G14 23-CG14613-RA_6 CG14613 CGGCACGTTGCATATTGGTTAATTCCTGTAGAGTATTGGCCAATACAGGTTCAATTATGGCAACAGTGG 69 FBan0014613 FBgn0031188 CG14613 X X CG14613 CG14613 "ADP/ATP translocase, CT34370" CDMC34212 3 18 8 DAC13-G14 23-CG14613-RA_6 CG14613 CGGCACGTTGCATATTGGTTAATTCCTGTAGAGTATTGGCCAATACAGGTTCAATTATGGCAACAGTGG 69 FBan0014613 FBgn0031188 CG14613 X X CG14613 CG14613 "ADP/ATP translocase, CT34370" CDMC34213 3 19 8 DAC13-K02 2-CG14651-RA_1 CG14651 GCCGAGCGTCCGATTAGCATTGAACACCTGTACGAGATTCGCGACTTTGCGCAGACTGTTCCGGATTTA 69 FBan0014651 FBgn0037254 CG14651 3 3R CG14651 CG14651 CDMC34213 3 20 8 DAC13-K02 2-CG14651-RA_1 CG14651 GCCGAGCGTCCGATTAGCATTGAACACCTGTACGAGATTCGCGACTTTGCGCAGACTGTTCCGGATTTA 69 FBan0014651 FBgn0037254 CG14651 3 3R CG14651 CG14651 CDMC34214 3 21 8 DAC13-K14 15-CG14661-RA_5 CG14661 TCCAACTCATCGTAGCCTCCCTGTTGATCTGTTTTGTAGCATGCATCTCAGCTGGCAATATGCCTGACT 69 FBan0014661 FBgn0037288 CG14661 3 3R CG14661 CG14661 CT34439 CDMC34214 3 22 8 DAC13-K14 15-CG14661-RA_5 CG14661 TCCAACTCATCGTAGCCTCCCTGTTGATCTGTTTTGTAGCATGCATCTCAGCTGGCAATATGCCTGACT 69 FBan0014661 FBgn0037288 CG14661 3 3R CG14661 CG14661 CT34439 CDMC34215 3 23 8 DAC13-O02 2-CG14692-RA_2 CG14692 CCAAGTCATCCACTTTGGACACCAAGGCATCCTTTGGCAACGATGCGATCAGTGAGTCCTTGGAACGAT 69 FBan0014692 FBgn0037836 CG14692 3 3R CG14692 CG14692 CDMC34215 3 24 8 DAC13-O02 2-CG14692-RA_2 CG14692 CCAAGTCATCCACTTTGGACACCAAGGCATCCTTTGGCAACGATGCGATCAGTGAGTCCTTGGAACGAT 69 FBan0014692 FBgn0037836 CG14692 3 3R CG14692 CG14692 CDMC34216 3 25 8 DAC13-O14 1-CG14710-RA_1 CG14710 GCTTGGGCGATTTCGAAGAGAGCCAAATGATCTGCCTGTTTGGGGATAAAGGCGAAAGTGACCTCAGGA 69 FBan0014710 FBgn0037920 CG14710 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003676 nucleus; GO:0005634 CG14710 CG14710 CDMC34216 3 26 8 DAC13-O14 1-CG14710-RA_1 CG14710 GCTTGGGCGATTTCGAAGAGAGCCAAATGATCTGCCTGTTTGGGGATAAAGGCGAAAGTGACCTCAGGA 69 FBan0014710 FBgn0037920 CG14710 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003676 nucleus; GO:0005634 CG14710 CG14710 CDMC34217 3 1 9 DAC14-C02 18-CG17275-RA_1 CG17275 AAGAACACTCAGGAAACTTCAATTCTACTGATCGCCATTACGGATTCCGACTGTCCCAGGCTGCC 65 FBan0017275 FBgn0038836 CG17275 3 3R CG17275 CG17275 CDMC34217 3 2 9 DAC14-C02 18-CG17275-RA_1 CG17275 AAGAACACTCAGGAAACTTCAATTCTACTGATCGCCATTACGGATTCCGACTGTCCCAGGCTGCC 65 FBan0017275 FBgn0038836 CG17275 3 3R CG17275 CG17275 CDMC34218 3 3 9 DAC14-C14 6-CG17336-RA_2 CG17336 TTCGACTTAGGCCCAATTTCGGAGGAGAGCCACTACATGTCGGCATGGATTTGACCATCGCCAGC 65 FBan0017336 FBgn0010240 Lcch3 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Lcch3 Ligand-gated chloride channel homolog 3 "CG17336, LCCH3, beta subunit, GABA receptor beta subunit, DmGABAbeta, DmGA_b" CDMC34218 3 4 9 DAC14-C14 6-CG17336-RA_2 CG17336 TTCGACTTAGGCCCAATTTCGGAGGAGAGCCACTACATGTCGGCATGGATTTGACCATCGCCAGC 65 FBan0017336 FBgn0010240 Lcch3 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211 Lcch3 Ligand-gated chloride channel homolog 3 "CG17336, LCCH3, beta subunit, GABA receptor beta subunit, DmGABAbeta, DmGA_b" CDMC34219 3 5 9 DAC14-G02 3-CG17528-RD_2 CG17528 TGGTCTGATATAGGGGACGGAGTGCGCGATCTTATTGCCAATATGCTTCAGGCGGATCCAGACGT 65 FBgn0032999 CG17528 calcium-mediated signaling; GO:0019722; microtubule-based process; GO:0007017; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- microtubule associated complex; GO:0005875 CG17528 CG17528 "CG40283, CG40283, CAMK-like" CDMC34219 3 6 9 DAC14-G02 3-CG17528-RD_2 CG17528 TGGTCTGATATAGGGGACGGAGTGCGCGATCTTATTGCCAATATGCTTCAGGCGGATCCAGACGT 65 FBgn0032999 CG17528 calcium-mediated signaling; GO:0019722; microtubule-based process; GO:0007017; muscle contraction; GO:0006936; protein amino acid phosphorylation; GO:0006468 microtubule binding; GO:0008017; ; GO:0008017; ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- microtubule associated complex; GO:0005875 CG17528 CG17528 "CG40283, CG40283, CAMK-like" CDMC34220 3 7 9 DAC14-G14 1-CG17571-RA_1 CG17571 GATGATCAACGATGTGGCCATCATCAAGCTGAGCTCTCCCGTTCGCCAGACCTCTAAGATCCGGG 65 FBan0017571 FBgn0032947 CG17571 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG17571 CG17571 SP83 CDMC34220 3 8 9 DAC14-G14 1-CG17571-RA_1 CG17571 GATGATCAACGATGTGGCCATCATCAAGCTGAGCTCTCCCGTTCGCCAGACCTCTAAGATCCGGG 65 FBan0017571 FBgn0032947 CG17571 2 2L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG17571 CG17571 SP83 CDMC34221 3 9 9 DAC14-K02 18-CG1768-RA_2 CG1768 AGCAAATACACAATGGAGGAGTTCTTTGCGGACATCAAGACTTTCAAGGATGCCTTCCAAGCGGC 65 FBan0001768 FBgn0011202 dia 2 2L "actin filament organization; GO:0007015; actin filament-based process; GO:0030029; cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring formation; GO:0000915; meiotic spindle assembly; GO:0051226; mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; pole cell formation; GO:0007279; protein localization; GO:0008104; spermatogenesis; GO:0007283" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; Rho GTPase binding; GO:0017048; ; GO:0017048 contractile ring; GO:0005826 dia diaphanous "CG1768, CG1768, l(2)k07135, 38E.16, Dia, ms(2)04138" CDMC34221 3 10 9 DAC14-K02 18-CG1768-RA_2 CG1768 AGCAAATACACAATGGAGGAGTTCTTTGCGGACATCAAGACTTTCAAGGATGCCTTCCAAGCGGC 65 FBan0001768 FBgn0011202 dia 2 2L "actin filament organization; GO:0007015; actin filament-based process; GO:0030029; cellularization (sensu Metazoa); GO:0009796; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring formation; GO:0000915; meiotic spindle assembly; GO:0051226; mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; pole cell formation; GO:0007279; protein localization; GO:0008104; spermatogenesis; GO:0007283" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; Rho GTPase binding; GO:0017048; ; GO:0017048 contractile ring; GO:0005826 dia diaphanous "CG1768, CG1768, l(2)k07135, 38E.16, Dia, ms(2)04138" CDMC34222 3 11 9 DAC14-K14 6-CG17739-RA_1 CG17739 GTACTCCGAAGTATGGAGGCAAGCCATGTCCCAAGCACCTGGTACGTTTGGATCGCTGCTACCAG 65 FBan0017739 FBgn0033710 CG17739 2 2R cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 CG17739 CG17739 "CT39321, anon-WO0153538.35" CDMC34222 3 12 9 DAC14-K14 6-CG17739-RA_1 CG17739 GTACTCCGAAGTATGGAGGCAAGCCATGTCCCAAGCACCTGGTACGTTTGGATCGCTGCTACCAG 65 FBan0017739 FBgn0033710 CG17739 2 2R cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 CG17739 CG17739 "CT39321, anon-WO0153538.35" CDMC34223 3 13 9 DAC14-O02 2-CG17917-RA_1 CG17917 GCCCCGATGTCCCATCCCTTATCAAAGCCATCTCGCACAATGCCCGTCAAGTAGCACACTTTTGA 65 FBan0017917 FBgn0037431 CG17917 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG17917 CG17917 CDMC34223 3 14 9 DAC14-O02 2-CG17917-RA_1 CG17917 GCCCCGATGTCCCATCCCTTATCAAAGCCATCTCGCACAATGCCCGTCAAGTAGCACACTTTTGA 65 FBan0017917 FBgn0037431 CG17917 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG17917 CG17917 CDMC34224 3 15 9 DAC14-O14 2-CG17962-RA_3 CG17962 AAGGAGCAGCATGAGTTCGGAAAACGCGAGTGCTACTCCCTGGACAGCAAGAAGTATTCCCTGGT 65 FBan0017962 FBgn0004052 Z600 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; ventral furrow formation; GO:0007370 cytoplasm; GO:0005737 Z600 Z600 "CG17962, z600, DMZ60MEX, 3.2, frs, fruhstart, frustart" CDMC34224 3 16 9 DAC14-O14 2-CG17962-RA_3 CG17962 AAGGAGCAGCATGAGTTCGGAAAACGCGAGTGCTACTCCCTGGACAGCAAGAAGTATTCCCTGGT 65 FBan0017962 FBgn0004052 Z600 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; ventral furrow formation; GO:0007370 cytoplasm; GO:0005737 Z600 Z600 "CG17962, z600, DMZ60MEX, 3.2, frs, fruhstart, frustart" CDMC34225 3 17 9 DAC15-C02 3-CG12826-RA_2 CG12826 ACGACTTGGATAGCTACGAAAACTACGACACAGATCGCTATGACAGCTACGGCGGGTCCTCGTACGCC 68 FBan0012826 FBgn0033207 CG12826 2 2R CG12826 CG12826 CDMC34225 3 18 9 DAC15-C02 3-CG12826-RA_2 CG12826 ACGACTTGGATAGCTACGAAAACTACGACACAGATCGCTATGACAGCTACGGCGGGTCCTCGTACGCC 68 FBan0012826 FBgn0033207 CG12826 2 2R CG12826 CG12826 CDMC34226 3 19 9 DAC15-C14 1-CG12976-RA_1 CG12976 AGCGACAGTAGTCAGAGCACGCCCGTTTACAGTGGAGAATATCCGGTTAACATGTCTGTGGAGTCCGC 68 FBan0012976 FBgn0037053 CG12976 3 3L CG12976 CG12976 CDMC34226 3 20 9 DAC15-C14 1-CG12976-RA_1 CG12976 AGCGACAGTAGTCAGAGCACGCCCGTTTACAGTGGAGAATATCCGGTTAACATGTCTGTGGAGTCCGC 68 FBan0012976 FBgn0037053 CG12976 3 3L CG12976 CG12976 CDMC34227 3 21 9 DAC15-G02 18-CG13445-RA_1 CG13445 CGGCAGTGCATCCGAAGAAATTTTGATCATCGAGTATCCTGAAGGCTACGAAAGCGGCTCCAATGAAA 68 FBan0013445 FBgn0036532 CG13445 3 3L CG13445 CG13445 CDMC34227 3 22 9 DAC15-G02 18-CG13445-RA_1 CG13445 CGGCAGTGCATCCGAAGAAATTTTGATCATCGAGTATCCTGAAGGCTACGAAAGCGGCTCCAATGAAA 68 FBan0013445 FBgn0036532 CG13445 3 3L CG13445 CG13445 CDMC34228 3 23 9 DAC15-G14 3-CG13582-RA_2 CG13582 GCGAGCTCATCTCTTCGTCAAGCTGGGCCTAGAGAGACTGCTACCCATCATAGTTGTTGTGGGTGCTG 68 FBan0013582 FBgn0035015 CG13582 2 2R CG13582 CG13582 CDMC34228 3 24 9 DAC15-G14 3-CG13582-RA_2 CG13582 GCGAGCTCATCTCTTCGTCAAGCTGGGCCTAGAGAGACTGCTACCCATCATAGTTGTTGTGGGTGCTG 68 FBan0013582 FBgn0035015 CG13582 2 2R CG13582 CG13582 CDMC34229 3 25 9 DAC15-K02 2-CG13886-RA_2 CG13886 GCGAAGGTCGGAGCGATTTATACGCAATCACCGCTATGAGGAGGCCATTAAAGCGCTGGAAACATCCC 68 FBan0013886 FBgn0035163 CG13886 3 3L CG13886 CG13886 CT33419 CDMC34229 3 26 9 DAC15-K02 2-CG13886-RA_2 CG13886 GCGAAGGTCGGAGCGATTTATACGCAATCACCGCTATGAGGAGGCCATTAAAGCGCTGGAAACATCCC 68 FBan0013886 FBgn0035163 CG13886 3 3L CG13886 CG13886 CT33419 CDMC34230 3 1 10 DAC15-K14 3-CG13956-RA_4 CG13956 CGTCAACAAAAGAAAACCACCAGCTTCCCAAAGCCTGATTACGAAATCCAGTGTCCTGGGGAGTGGCC 68 FBan0013956 FBgn0040207 kat80 X X microtubule severing; GO:0051013; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017 katanin; GO:0008352 kat80 katanin 80 "CG9910, CG13956, CG9910, CG9910, CG9910, katanin-80, katanin 80" CDMC34230 3 2 10 DAC15-K14 3-CG13956-RA_4 CG13956 CGTCAACAAAAGAAAACCACCAGCTTCCCAAAGCCTGATTACGAAATCCAGTGTCCTGGGGAGTGGCC 68 FBan0013956 FBgn0040207 kat80 X X microtubule severing; GO:0051013; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017 katanin; GO:0008352 kat80 katanin 80 "CG9910, CG13956, CG9910, CG9910, CG9910, katanin-80, katanin 80" CDMC34231 3 3 10 DAC15-O02 22-CG14436-RA_1 CG14436 CAGTGCCGATGATGCGATGGATTTGGGATCGGGAGTGGGAGTGGGCACTGGCATCGCGAATGGAGCCG 68 FBan0014436 FBgn0029902 CG14436 X X CG14436 CG14436 CDMC34231 3 4 10 DAC15-O02 22-CG14436-RA_1 CG14436 CAGTGCCGATGATGCGATGGATTTGGGATCGGGAGTGGGAGTGGGCACTGGCATCGCGAATGGAGCCG 68 FBan0014436 FBgn0029902 CG14436 X X CG14436 CG14436 CDMC34232 3 5 10 DAC15-O14 2-CG14534-RA_1 CG14534 GCACCATCCCACTAGGCGATCCAGTCCAACCCGAATACCGATTTGCTTATCTCAACCCAACTCATGGC 68 FBan0014534 FBgn0031957 CG14534 2 2L CG14534 CG14534 CDMC34232 3 6 10 DAC15-O14 2-CG14534-RA_1 CG14534 GCACCATCCCACTAGGCGATCCAGTCCAACCCGAATACCGATTTGCTTATCTCAACCCAACTCATGGC 68 FBan0014534 FBgn0031957 CG14534 2 2L CG14534 CG14534 CDMC34233 3 7 10 DAC16-C02 3-CG31080-RA_1 CG31080 CGCCAATAAGCAGTGACTGACCTCAGACTGACCCATGACCCATCAACGATTCCTACGCACTCGCT 65 FBan0031080 FBgn0051080 CG31080 3 3R CG31080 CG31080 "CG14241, CG14241" CDMC34233 3 8 10 DAC16-C02 3-CG31080-RA_1 CG31080 CGCCAATAAGCAGTGACTGACCTCAGACTGACCCATGACCCATCAACGATTCCTACGCACTCGCT 65 FBan0031080 FBgn0051080 CG31080 3 3R CG31080 CG31080 "CG14241, CG14241" CDMC34234 3 9 10 DAC16-C14 17-CG31115-RA_1 CG31115 AGAAGTGCAGAGCGAACTTGAGAAGGACACCATCCCCATCAAAATTGGCATAATTGGAGAGGCCA 65 FBan0031115 FBgn0051115 CG31115 3 3R amino acid metabolism; GO:0006520; purine base metabolism; GO:0006144 S-methyl-5-thioadenosine phosphorylase activity; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28 CG31115 CG31115 CDMC34234 3 10 10 DAC16-C14 17-CG31115-RA_1 CG31115 AGAAGTGCAGAGCGAACTTGAGAAGGACACCATCCCCATCAAAATTGGCATAATTGGAGAGGCCA 65 FBan0031115 FBgn0051115 CG31115 3 3R amino acid metabolism; GO:0006520; purine base metabolism; GO:0006144 S-methyl-5-thioadenosine phosphorylase activity; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28; ; GO:0017061 ; EC:2.4.2.28 CG31115 CG31115 CDMC34235 3 11 10 DAC16-G02 3-CG31235-RA_4 CG31235 AAAAACCCTCGAAAGCGTTACCAAGCTAACCGTCGACAGGGAGGAGTACGGCTTGGATTTGCAGC 65 FBan0031235 FBgn0051235 CG31235 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG31235 CG31235 "CG7117, CG14311, CG7117" CDMC34235 3 12 10 DAC16-G02 3-CG31235-RA_4 CG31235 AAAAACCCTCGAAAGCGTTACCAAGCTAACCGTCGACAGGGAGGAGTACGGCTTGGATTTGCAGC 65 FBan0031235 FBgn0051235 CG31235 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG31235 CG31235 "CG7117, CG14311, CG7117" CDMC34236 3 13 10 DAC16-G14 1-CG31263-RA_2 CG31263 TGTTTAATGTGTTCGGCGCCATCATTAAAAAACCAGTCACTGTCGGGACGTCGTCCATCCGCCGG 65 FBan0031263 FBgn0051263 CG31263 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31263 CG31263 CDMC34236 3 14 10 DAC16-G14 1-CG31263-RA_2 CG31263 TGTTTAATGTGTTCGGCGCCATCATTAAAAAACCAGTCACTGTCGGGACGTCGTCCATCCGCCGG 65 FBan0031263 FBgn0051263 CG31263 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31263 CG31263 CDMC34237 3 15 10 DAC16-K02 3-CG3134-RA_9 CG3134 GTACATCACGGCCCAGGAGTACACAGTGTGGTTTCTGGTACCTTGCCTTGGTGACAAAGACCAGC 65 FBan0003134 FBgn0003009 ord 2 2R chromosome segregation; GO:0007059; female meiosis sister chromatid cohesion; GO:0007066; gametogenesis; GO:0007276; male meiosis chromosome segregation; GO:0007060; male meiosis sister chromatid cohesion; GO:0007065; meiosis; GO:0007126; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 protein binding; GO:0005515; ; GO:0005515 cohesin complex; GO:0008278; female germ cell nucleus; GO:0001674; male germ cell nucleus; GO:0001673 ord orientation disrupter "CG3134, ORD, orientation disruptor" CDMC34237 3 16 10 DAC16-K02 3-CG3134-RA_9 CG3134 GTACATCACGGCCCAGGAGTACACAGTGTGGTTTCTGGTACCTTGCCTTGGTGACAAAGACCAGC 65 FBan0003134 FBgn0003009 ord 2 2R chromosome segregation; GO:0007059; female meiosis sister chromatid cohesion; GO:0007066; gametogenesis; GO:0007276; male meiosis chromosome segregation; GO:0007060; male meiosis sister chromatid cohesion; GO:0007065; meiosis; GO:0007126; mitosis; GO:0007067; sister chromatid cohesion; GO:0007062 protein binding; GO:0005515; ; GO:0005515 cohesin complex; GO:0008278; female germ cell nucleus; GO:0001674; male germ cell nucleus; GO:0001673 ord orientation disrupter "CG3134, ORD, orientation disruptor" CDMC34238 3 17 10 DAC16-K14 24-CG31404-RA_1 CG31404 TTAAAATGAATAGTGAAGCTTTTGGAACACACTTGGGCAAAATAAAGACTTCTGAGCCATCGATA 65 FBan0031404 FBgn0051404 CG31404 3 3R CG31404 CG31404 "CG3575, CG3575" CDMC34238 3 18 10 DAC16-K14 24-CG31404-RA_1 CG31404 TTAAAATGAATAGTGAAGCTTTTGGAACACACTTGGGCAAAATAAAGACTTCTGAGCCATCGATA 65 FBan0031404 FBgn0051404 CG31404 3 3R CG31404 CG31404 "CG3575, CG3575" CDMC34239 3 19 10 DAC16-O02 1-CG3152-RA_1 CG3152 ACAGCAGCCTGATTCGCAAACTGTCCAGTGTGATTTCCACCCGCGTTATCCGTTTCCTGCAAGAG 65 FBan0003152 FBgn0026761 Trap1 2 2R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 Trap1 Trap1 "CG3152, TRAP1dr, dtrap-1, TRAP1, Hsp90-related protein" CDMC34239 3 20 10 DAC16-O02 1-CG3152-RA_1 CG3152 ACAGCAGCCTGATTCGCAAACTGTCCAGTGTGATTTCCACCCGCGTTATCCGTTTCCTGCAAGAG 65 FBan0003152 FBgn0026761 Trap1 2 2R defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 Trap1 Trap1 "CG3152, TRAP1dr, dtrap-1, TRAP1, Hsp90-related protein" CDMC34240 3 21 10 DAC16-O14 2-CG31554-RA_1 CG31554 CGCCACAATAGACGAGCAAACACACCGAAACCTGTGCACTTAATGACTCCACTCGGGGGAAGTGG 65 FBan0031554 FBgn0051554 CG31554 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31554 CG31554 CDMC34240 3 22 10 DAC16-O14 2-CG31554-RA_1 CG31554 CGCCACAATAGACGAGCAAACACACCGAAACCTGTGCACTTAATGACTCCACTCGGGGGAAGTGG 65 FBan0031554 FBgn0051554 CG31554 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31554 CG31554 CDMC34241 3 23 10 DAC17-C02 1-CG32694-RA_1 CG32694 ACGCCCCGAAAGTCTGTCTCTATCTCCCTCTGTCTCACCCCAGAAATAACCCCCTTTCCAATGCC 65 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC34241 3 24 10 DAC17-C02 1-CG32694-RA_1 CG32694 ACGCCCCGAAAGTCTGTCTCTATCTCCCTCTGTCTCACCCCAGAAATAACCCCCTTTCCAATGCC 65 FBan0032694 FBgn0052694 CG32694 X X CG32694 CG32694 "CG12634, CG12649, CG18512, BcDNA:RE02049" CDMC34242 3 25 10 DAC17-C14 16-CG32755-RA_4 CG32755 TGCGTTCGTTTTTGTGAGATTAGAAAGTATAGACGCTTGTGTGGAACCTCACGGCACCCCATGGA 65 FBan0032755 FBgn0052755 CG32755 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32755 CG32755 CDMC34242 3 26 10 DAC17-C14 16-CG32755-RA_4 CG32755 TGCGTTCGTTTTTGTGAGATTAGAAAGTATAGACGCTTGTGTGGAACCTCACGGCACCCCATGGA 65 FBan0032755 FBgn0052755 CG32755 X X protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32755 CG32755 CDMC34243 3 1 11 DAC17-G02 23-CG32838-RA_2 CG32838 TCCAATACCACATTGTAATAGGCATGAATTTGGTGTTTCAAATAGGTACTCCCAATGACTTGCCT 65 FBan0032838 FBgn0052838 CG32838 2 2R copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507; ; GO:0008471 ; EC:1.10.3.2 CG32838 CG32838 CDMC34243 3 2 11 DAC17-G02 23-CG32838-RA_2 CG32838 TCCAATACCACATTGTAATAGGCATGAATTTGGTGTTTCAAATAGGTACTCCCAATGACTTGCCT 65 FBan0032838 FBgn0052838 CG32838 2 2R copper ion binding; GO:0005507; laccase activity; GO:0008471 ; EC:1.10.3.2; ; GO:0008471 ; EC:1.10.3.2; ; GO:0005507; ; GO:0008471 ; EC:1.10.3.2 CG32838 CG32838 CDMC34244 3 3 11 DAC17-G14 3-CG32955-RB_1 CG32955 TAAAGTGCGGACCAGACGTGTCCATGACCCTCAATCGCATCAATGTCCAGGAGAACGAGGTGGAC 65 FBgn0052955 CDMC34244 3 4 11 DAC17-G14 3-CG32955-RB_1 CG32955 TAAAGTGCGGACCAGACGTGTCCATGACCCTCAATCGCATCAATGTCCAGGAGAACGAGGTGGAC 65 FBgn0052955 CDMC34245 3 5 11 DAC17-K02 23-CG33124-RA_1 CG33124 CTTCCATTGCCTTTTTTGTCCTCGGATCGATCATCTTTTACTCGGTTCTCAGCTTCTTGGGACTG 65 FBan0033124 FBgn0053124 CG33124 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 cation transporter activity; GO:0008324; transporter activity; GO:0005215; ; GO:0008324; ; GO:0005215 membrane; GO:0016020 CG33124 CG33124 CG10879 CDMC34245 3 6 11 DAC17-K02 23-CG33124-RA_1 CG33124 CTTCCATTGCCTTTTTTGTCCTCGGATCGATCATCTTTTACTCGGTTCTCAGCTTCTTGGGACTG 65 FBan0033124 FBgn0053124 CG33124 2 2L cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; transport; GO:0006810 cation transporter activity; GO:0008324; transporter activity; GO:0005215; ; GO:0008324; ; GO:0005215 membrane; GO:0016020 CG33124 CG33124 CG10879 CDMC34246 3 7 11 DAC17-K14 11-CG33152-RA_2 CG33152 GGGCTAAATGGCGCAAACGTGAGAAGTTTATGAATCAGGACAAGGCCGGTTACCTTCTGCCCGAA 65 FBan0033152 FBgn0008636 hbn 2 2R "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hbn homeobrain "CG10614, CG33152, CG15647, CG15648, CG10614, CG10614, 57San, homeobrain" CDMC34246 3 8 11 DAC17-K14 11-CG33152-RA_2 CG33152 GGGCTAAATGGCGCAAACGTGAGAAGTTTATGAATCAGGACAAGGCCGGTTACCTTCTGCCCGAA 65 FBan0033152 FBgn0008636 hbn 2 2R "ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; visual perception; GO:0007601" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 hbn homeobrain "CG10614, CG33152, CG15647, CG15648, CG10614, CG10614, 57San, homeobrain" CDMC34247 3 9 11 DAC17-O02 3-CG33254-RA_1 CG33254 CTCGTCACTCGTCCCGATTTCCCGCAAGAGAGCAAGCAACAGCATGTGGTCGAAAATTGCCATCG 65 FBgn0053254 CDMC34247 3 10 11 DAC17-O02 3-CG33254-RA_1 CG33254 CTCGTCACTCGTCCCGATTTCCCGCAAGAGAGCAAGCAACAGCATGTGGTCGAAAATTGCCATCG 65 FBgn0053254 CDMC34248 3 11 11 DAC17-O14 3-CG3326-RA_2 CG3326 GAGCTTACCGATGGCTATTCTGGAGCTGATGTGGATACGCTTTGCCGCTATGCATCCATGGCTCC 65 FBan0003326 FBgn0031519 CG3326 2 2L intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 CG3326 CG3326 "DmCG3326, fidgetin_DROME" CDMC34248 3 12 11 DAC17-O14 3-CG3326-RA_2 CG3326 GAGCTTACCGATGGCTATTCTGGAGCTGATGTGGATACGCTTTGCCGCTATGCATCCATGGCTCC 65 FBan0003326 FBgn0031519 CG3326 2 2L intracellular protein transport; GO:0006886 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; ; GO:0016887; nucleotide binding; GO:0000166; ; GO:0000166 CG3326 CG3326 "DmCG3326, fidgetin_DROME" CDMC34249 3 13 11 DAC18-C02 2-CG5952-RA_1 CG5952 GCTAAGGGTCCATGTACCCACCTTTCCGTACGAGAAACGTCTGAGCAAGATCGACACTCTGCGGCTTG 68 FBan0005952 FBgn0038402 Fer2 3 3R regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Fer2 48 related 2 "CG5952, CG5952, CG5952, CG5952, 48 related 2" CDMC34249 3 14 11 DAC18-C02 2-CG5952-RA_1 CG5952 GCTAAGGGTCCATGTACCCACCTTTCCGTACGAGAAACGTCTGAGCAAGATCGACACTCTGCGGCTTG 68 FBan0005952 FBgn0038402 Fer2 3 3R regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Fer2 48 related 2 "CG5952, CG5952, CG5952, CG5952, 48 related 2" CDMC34250 3 15 11 DAC18-C14 2-CG6014-RA_1 CG6014 GGCAAAGGAACTGAAGAGGATACAGCAAGCCATGCGATTGGATGACAACGAGTAGAAGTCCAGGCGGC 68 FBan0006014 FBgn0027542 CG6014 3 3L CG6014 CG6014 BcDNA:GH11973 CDMC34250 3 16 11 DAC18-C14 2-CG6014-RA_1 CG6014 GGCAAAGGAACTGAAGAGGATACAGCAAGCCATGCGATTGGATGACAACGAGTAGAAGTCCAGGCGGC 68 FBan0006014 FBgn0027542 CG6014 3 3L CG6014 CG6014 BcDNA:GH11973 CDMC34251 3 17 11 DAC18-G02 2-CG6424-RA_3 CG6424 GACCAACTCTGGGAGCAGCTAGATCGAGCACGCGATGAGAAATCCCTGCTAAAATCCACCATTCGGGA 68 FBan0006424 FBgn0028494 CG6424 2 2R CG6424 CG6424 "GH05095, BcDNA:GH05095, anon-WO0118547.96, anon-WO0153538.32, anon-WO0153538.33, anon-WO0153538.34" CDMC34251 3 18 11 DAC18-G02 2-CG6424-RA_3 CG6424 GACCAACTCTGGGAGCAGCTAGATCGAGCACGCGATGAGAAATCCCTGCTAAAATCCACCATTCGGGA 68 FBan0006424 FBgn0028494 CG6424 2 2R CG6424 CG6424 "GH05095, BcDNA:GH05095, anon-WO0118547.96, anon-WO0153538.32, anon-WO0153538.33, anon-WO0153538.34" CDMC34252 3 19 11 DAC18-G14 2-CG6614-RA_1 CG6614 GCGACTGGTCAGCAACACTGGTCAACGAGACTTGGCCATTCACATGTACGATGAGATTGACCACAGCA 68 FBan0006614 FBgn0032369 CG6614 2 2L CG6614 CG6614 CDMC34252 3 20 11 DAC18-G14 2-CG6614-RA_1 CG6614 GCGACTGGTCAGCAACACTGGTCAACGAGACTTGGCCATTCACATGTACGATGAGATTGACCACAGCA 68 FBan0006614 FBgn0032369 CG6614 2 2L CG6614 CG6614 CDMC34253 3 21 11 DAC18-K02 1-CG6984-RA_1 CG6984 GCCCAAGGAAAGATCTGGTCGGCAGGTCACAATCTCAAGGAGTTGCACAATGACCCCAAGATACAGGC 68 FBan0006984 FBgn0034191 CG6984 2 2R fatty acid beta-oxidation; GO:0006635 enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17 CG6984 CG6984 CDMC34253 3 22 11 DAC18-K02 1-CG6984-RA_1 CG6984 GCCCAAGGAAAGATCTGGTCGGCAGGTCACAATCTCAAGGAGTTGCACAATGACCCCAAGATACAGGC 68 FBan0006984 FBgn0034191 CG6984 2 2R fatty acid beta-oxidation; GO:0006635 enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; ; GO:0004300 ; EC:4.2.1.17 CG6984 CG6984 CDMC34254 3 23 11 DAC18-K14 18-CG7139-RA_2 CG7139 CGTTATACTACTCGGAGATAGCCAAGTTACACAAGCAGAAGATCGACGTATTCAACCAGAGGGCGGCC 68 FBan0007139 FBgn0027532 CG7139 3 3L mismatch repair; GO:0006298 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7139 CG7139 "BcDNA:LD21293, anon-WO0118547.415" CDMC34254 3 24 11 DAC18-K14 18-CG7139-RA_2 CG7139 CGTTATACTACTCGGAGATAGCCAAGTTACACAAGCAGAAGATCGACGTATTCAACCAGAGGGCGGCC 68 FBan0007139 FBgn0027532 CG7139 3 3L mismatch repair; GO:0006298 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7139 CG7139 "BcDNA:LD21293, anon-WO0118547.415" CDMC34255 3 25 11 DAC18-O02 1-CG7471-RA_1 CG7471 GGCGTTCTATACCACCGATCGTGTGATGACTGTCAGCTTCCACAAGTACGGAGAGTATTTCCCGGGCA 68 FBan0007471 FBgn0015805 Rpd3 3 3L blastoderm segmentation; GO:0007350; chromatin silencing; GO:0006342; determination of adult life span; GO:0008340; gene silencing; GO:0016458; histone deacetylation; GO:0016575; histone methylation; GO:0016571; negative regulation of transcription; GO:0016481; oogenesis (sensu Insecta); GO:0009993; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; transcription corepressor activity; GO:0003714; protein binding; GO:0005515; ; GO:0003714; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0005515; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0005515 ESC/E(Z) complex; GO:0035098; Myb complex; GO:0031523; NuRD complex; GO:0016581; Sin3 complex; GO:0016580; chromatin; GO:0000785; nucleus; GO:0005634 Rpd3 Rpd3 "CG7471, CG7471, Su(var)326, Su(var)328, l(3)64Cc, RPD3, dRPD3, E(var)3-64BC, dHDAC1, l(3)04556, DmHDAC1, dHDAC-1, HDAC-1, HDAC1, rpd3, HDAC, Rpd3/HDAC, Hdac1, dRpd3, dmHDA401, rpd[3], Suppressor of variegation 326" CDMC34255 3 26 11 DAC18-O02 1-CG7471-RA_1 CG7471 GGCGTTCTATACCACCGATCGTGTGATGACTGTCAGCTTCCACAAGTACGGAGAGTATTTCCCGGGCA 68 FBan0007471 FBgn0015805 Rpd3 3 3L blastoderm segmentation; GO:0007350; chromatin silencing; GO:0006342; determination of adult life span; GO:0008340; gene silencing; GO:0016458; histone deacetylation; GO:0016575; histone methylation; GO:0016571; negative regulation of transcription; GO:0016481; oogenesis (sensu Insecta); GO:0009993; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; transcription corepressor activity; GO:0003714; protein binding; GO:0005515; ; GO:0003714; contributes_to histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; contributes_to histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; ; GO:0046976; ; GO:0046974; ; GO:0005515; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0005515 ESC/E(Z) complex; GO:0035098; Myb complex; GO:0031523; NuRD complex; GO:0016581; Sin3 complex; GO:0016580; chromatin; GO:0000785; nucleus; GO:0005634 Rpd3 Rpd3 "CG7471, CG7471, Su(var)326, Su(var)328, l(3)64Cc, RPD3, dRPD3, E(var)3-64BC, dHDAC1, l(3)04556, DmHDAC1, dHDAC-1, HDAC-1, HDAC1, rpd3, HDAC, Rpd3/HDAC, Hdac1, dRpd3, dmHDA401, rpd[3], Suppressor of variegation 326" CDMC34256 3 1 12 DAC18-O14 2-CG7549-RB_4 CG7549 GCCCGGAGAACACACTCTTCGACCAGACGATCTTAAAGTGCAACTGGTGGTTCTACGTCGACTGCAGC 68 FBan0007549 FBgn0037559 CG7549 3 3R CG7549 CG7549 CDMC34256 3 2 12 DAC18-O14 2-CG7549-RB_4 CG7549 GCCCGGAGAACACACTCTTCGACCAGACGATCTTAAAGTGCAACTGGTGGTTCTACGTCGACTGCAGC 68 FBan0007549 FBgn0037559 CG7549 3 3R CG7549 CG7549 CDMC34257 3 3 12 DAC19-C02 23-CG17799-RA_12 CG17799 AGAAATGCGATTGCAGTCCTTTCAAAACCAGATGGAAACTAAACTTCGGGCTCTAAAGCAACAAATTGA 69 FBan0017799 FBgn0040098 lectin-29Ca 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-29Ca lectin-29Ca "CG17799, AC 004423A, AC004423a, Acp29AB-I, Lectin29Ca" CDMC34257 3 4 12 DAC19-C02 23-CG17799-RA_12 CG17799 AGAAATGCGATTGCAGTCCTTTCAAAACCAGATGGAAACTAAACTTCGGGCTCTAAAGCAACAAATTGA 69 FBan0017799 FBgn0040098 lectin-29Ca 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-29Ca lectin-29Ca "CG17799, AC 004423A, AC004423a, Acp29AB-I, Lectin29Ca" CDMC34258 3 5 12 DAC19-C14 23-CG17814-RA_1 CG17814 GCGAATGGTCTTGGACTGCTTACTGTTGATTGCATTTTTAATAACAACAAAAATGAAAATATATGGCAA 69 FBan0017814 FBgn0040959 Peritrophin-15a 2 2L biological process unknown; GO:0000004 chitin binding; GO:0008061; ; GO:0008061 extracellular space; GO:0005615 Peritrophin-15a Peritrophin-15a "CG17814, CG17814, CG17814, CG17814, Dm15a, Dm-peritrophin-15a, CT39472, Peritrophin-15a" CDMC34258 3 6 12 DAC19-C14 23-CG17814-RA_1 CG17814 GCGAATGGTCTTGGACTGCTTACTGTTGATTGCATTTTTAATAACAACAAAAATGAAAATATATGGCAA 69 FBan0017814 FBgn0040959 Peritrophin-15a 2 2L biological process unknown; GO:0000004 chitin binding; GO:0008061; ; GO:0008061 extracellular space; GO:0005615 Peritrophin-15a Peritrophin-15a "CG17814, CG17814, CG17814, CG17814, Dm15a, Dm-peritrophin-15a, CT39472, Peritrophin-15a" CDMC34259 3 7 12 DAC19-G02 9-CG1786-RA_11 CG1786 GGCCAGTTTCTTCGATGTCTTCAATTCGGTGGGCAATCAGATGGTGGAACAGTTCCAAACGCAGACGAA 69 FBan0001786 FBgn0030369 Cyp318a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp318a1 Cyp318a1 "CG1786, CG11364, CG1786, 318a1" CDMC34259 3 8 12 DAC19-G02 9-CG1786-RA_11 CG1786 GGCCAGTTTCTTCGATGTCTTCAATTCGGTGGGCAATCAGATGGTGGAACAGTTCCAAACGCAGACGAA 69 FBan0001786 FBgn0030369 Cyp318a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp318a1 Cyp318a1 "CG1786, CG11364, CG1786, 318a1" CDMC34260 3 9 12 DAC19-G14 12-CG17885-RA_4 CG17885 GGCCCTGATGCACGGACTACAGATGGTCTCCTCGCTACTGAAGATGGCTATATTCTTGGCCAAATCTCA 69 FBan0017885 FBgn0029521 Or1a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or1a Odorant receptor 1a "CG17885, 1A.1, DOR68, 1a" CDMC34260 3 10 12 DAC19-G14 12-CG17885-RA_4 CG17885 GGCCCTGATGCACGGACTACAGATGGTCTCCTCGCTACTGAAGATGGCTATATTCTTGGCCAAATCTCA 69 FBan0017885 FBgn0029521 Or1a X X sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or1a Odorant receptor 1a "CG17885, 1A.1, DOR68, 1a" CDMC34261 3 11 12 DAC19-K02 3-CG17930-RA_4 CG17930 TGGCATTGGGAGTGGCCATTCAAGTAATCTACGACTCACAGTGGTCTCAGGGATTGGGCATGACCATCA 69 FBan0017930 FBgn0038416 CG17930 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG17930 CG17930 CDMC34261 3 12 12 DAC19-K02 3-CG17930-RA_4 CG17930 TGGCATTGGGAGTGGCCATTCAAGTAATCTACGACTCACAGTGGTCTCAGGGATTGGGCATGACCATCA 69 FBan0017930 FBgn0038416 CG17930 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG17930 CG17930 CDMC34262 3 13 12 DAC19-K14 16-CG17943-RA_1 CG17943 CGGGAGTAGCAGCCCAATTGCTTAGTCACTTGTAAATAGTTGCATCGTCTGCTAATGTTGTTTGCCCCA 69 FBan0017943 FBgn0010105 comm 3 3L axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; dendrite morphogenesis; GO:0016358; endocytosis; GO:0006897; nervous system development; GO:0007399; neuron recognition; GO:0008038; synaptogenesis; GO:0007416 protein binding; GO:0005515; ; GO:0005515 Golgi apparatus; GO:0005794; cytoplasmic membrane-bound vesicle; GO:0016023; endosome; GO:0005768; integral to membrane; GO:0016021; plasma membrane; GO:0005886 comm commissureless CG17943 CDMC34262 3 14 12 DAC19-K14 16-CG17943-RA_1 CG17943 CGGGAGTAGCAGCCCAATTGCTTAGTCACTTGTAAATAGTTGCATCGTCTGCTAATGTTGTTTGCCCCA 69 FBan0017943 FBgn0010105 comm 3 3L axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; dendrite morphogenesis; GO:0016358; endocytosis; GO:0006897; nervous system development; GO:0007399; neuron recognition; GO:0008038; synaptogenesis; GO:0007416 protein binding; GO:0005515; ; GO:0005515 Golgi apparatus; GO:0005794; cytoplasmic membrane-bound vesicle; GO:0016023; endosome; GO:0005768; integral to membrane; GO:0016021; plasma membrane; GO:0005886 comm commissureless CG17943 CDMC34263 3 15 12 DAC19-O02 3-CG17994-RA_3 CG17994 AGCGTCAAGGAGTTGTTGCAACTGGAAAACGACATTCAGACCCTGGAGAAATTGCAGCGACGGGAAAGT 69 FBan0017994 FBgn0033072 CG17994 2 2R CG17994 CG17994 CDMC34263 3 16 12 DAC19-O02 3-CG17994-RA_3 CG17994 AGCGTCAAGGAGTTGTTGCAACTGGAAAACGACATTCAGACCCTGGAGAAATTGCAGCGACGGGAAAGT 69 FBan0017994 FBgn0033072 CG17994 2 2R CG17994 CG17994 CDMC34264 3 17 12 DAC19-O14 23-CG18009-RD_1 CG18009 GAACTCCAATTCAGTTCTGGCCAAGCAAACTACAATTCTCAAGTAAAAATCCGTGGAGAGGAGGTGGGG 69 FBan0018009 FBgn0026758 Trf2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003704; ; GO:0016251; ; GO:0003677; ; GO:0003704 transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf2 TATA box binding protein-related factor 2 "CG18009, CG11195, CG18009, CG18009, CG11195, CG18009, dTRF2, TLF, p79/TRF2, TRF2, trf2, TBP-like factor" CDMC34264 3 18 12 DAC19-O14 23-CG18009-RD_1 CG18009 GAACTCCAATTCAGTTCTGGCCAAGCAAACTACAATTCTCAAGTAAAAATCCGTGGAGAGGAGGTGGGG 69 FBan0018009 FBgn0026758 Trf2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0003704; ; GO:0016251; ; GO:0003677; ; GO:0003704 transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf2 TATA box binding protein-related factor 2 "CG18009, CG11195, CG18009, CG18009, CG11195, CG18009, dTRF2, TLF, p79/TRF2, TRF2, trf2, TBP-like factor" CDMC34265 3 19 12 DAC20-C02 6-CG10662-RA_1 CG10662 GCTGCCATTGCCAATGGAGTCTCCGAGCTTCCCTCTGTGATTATTTTGGACAACCTGCACCACGC 65 FBan0010662 FBgn0032832 CG10662 2 2L cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG10662 CG10662 CDMC34265 3 20 12 DAC20-C02 6-CG10662-RA_1 CG10662 GCTGCCATTGCCAATGGAGTCTCCGAGCTTCCCTCTGTGATTATTTTGGACAACCTGCACCACGC 65 FBan0010662 FBgn0032832 CG10662 2 2L cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; ; GO:0005102; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 CG10662 CG10662 CDMC34266 3 21 12 DAC20-C14 3-CG10703-RA_2 CG10703 TCCAGGACAAGGTGACATCTCAGCAGGAAATGCACGAGAAGATCGAGTGCCTCAAGGAGCAGGTG 65 FBan0010703 FBgn0037881 CG10703 3 3R CG10703 CG10703 CDMC34266 3 22 12 DAC20-C14 3-CG10703-RA_2 CG10703 TCCAGGACAAGGTGACATCTCAGCAGGAAATGCACGAGAAGATCGAGTGCCTCAAGGAGCAGGTG 65 FBan0010703 FBgn0037881 CG10703 3 3R CG10703 CG10703 CDMC34267 3 23 12 DAC20-G02 3-CG10800-RA_3 CG10800 AACCTATTGTCGCAAACTCTGCCTATTGGACGTACAACCAGCACATTCCCCTGCATGACGGGTCC 65 FBan0010800 FBgn0017551 Rca1 2 2L G1/S transition of mitotic cell cycle; GO:0000082; G2 phase of mitotic cell cycle; GO:0000085; compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye-antennal disc morphogenesis; GO:0007455; negative regulation of protein catabolism; GO:0042177; regulation of mitosis; GO:0007088 nucleus; GO:0005634 Rca1 Regulator of cyclin A1 "CG10800, CG10800, S(rux)2A, rca1, Suppressor of rux 2A, regulator of cyclin A, P3300, l(2)03300" CDMC34267 3 24 12 DAC20-G02 3-CG10800-RA_3 CG10800 AACCTATTGTCGCAAACTCTGCCTATTGGACGTACAACCAGCACATTCCCCTGCATGACGGGTCC 65 FBan0010800 FBgn0017551 Rca1 2 2L G1/S transition of mitotic cell cycle; GO:0000082; G2 phase of mitotic cell cycle; GO:0000085; compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye-antennal disc morphogenesis; GO:0007455; negative regulation of protein catabolism; GO:0042177; regulation of mitosis; GO:0007088 nucleus; GO:0005634 Rca1 Regulator of cyclin A1 "CG10800, CG10800, S(rux)2A, rca1, Suppressor of rux 2A, regulator of cyclin A, P3300, l(2)03300" CDMC34268 3 25 12 DAC20-G14 1-CG10853-RA_1 CG10853 ATAAAGAAGGTGCCAGTGCCTGTTCCGGTGCCAGTTCCTGTGCCAGTTCCTGTTCCTGTTTATCC 65 FBan0010853 FBgn0035478 CG10853 3 3L CG10853 CG10853 BcDNA:LP09837 CDMC34268 3 26 12 DAC20-G14 1-CG10853-RA_1 CG10853 ATAAAGAAGGTGCCAGTGCCTGTTCCGGTGCCAGTTCCTGTGCCAGTTCCTGTTCCTGTTTATCC 65 FBan0010853 FBgn0035478 CG10853 3 3L CG10853 CG10853 BcDNA:LP09837 CDMC34269 3 1 13 DAC20-K02 3-CG10938-RB_1 CG10938 TTCGCCGCTAATGGTACCCAGTACTGTGGAGAAGATTGTGGAGGTGGACAAGCACATTGGTTGCG 65 FBan0010938 FBgn0016697 ProsMA5 2 2R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 ProsMA5 Proteasome alpha subunit "CG10938, alpha5_dm, PSMA5, PRCZ, 20S proteasome, prosMA5, 20s proteasome" CDMC34269 3 2 13 DAC20-K02 3-CG10938-RB_1 CG10938 TTCGCCGCTAATGGTACCCAGTACTGTGGAGAAGATTGTGGAGGTGGACAAGCACATTGGTTGCG 65 FBan0010938 FBgn0016697 ProsMA5 2 2R ATP-dependent proteolysis; GO:0006510; cellular physiological process; GO:0050875; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 ProsMA5 Proteasome alpha subunit "CG10938, alpha5_dm, PSMA5, PRCZ, 20S proteasome, prosMA5, 20s proteasome" CDMC34270 3 3 13 DAC20-K14 16-CG10971-RA_1 CG10971 TTGCGAGCAAAGTCAAGGCTGAACGTAATAGTCAAAAGCTAACCGACCTCACAAAAGCCTCGCGA 65 FBan0010971 FBgn0036309 CG10971 3 3L apoptotic program; GO:0008632; cytoskeleton organization and biogenesis; GO:0007010; endocytosis; GO:0006897; intracellular protein transport; GO:0006886 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; phospholipid binding; GO:0005543; ; GO:0005543 CG10971 CG10971 CDMC34270 3 4 13 DAC20-K14 16-CG10971-RA_1 CG10971 TTGCGAGCAAAGTCAAGGCTGAACGTAATAGTCAAAAGCTAACCGACCTCACAAAAGCCTCGCGA 65 FBan0010971 FBgn0036309 CG10971 3 3L apoptotic program; GO:0008632; cytoskeleton organization and biogenesis; GO:0007010; endocytosis; GO:0006897; intracellular protein transport; GO:0006886 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; phospholipid binding; GO:0005543; ; GO:0005543 CG10971 CG10971 CDMC34271 3 5 13 DAC20-O02 3-CG11106-RA_2 CG11106 ATCATGGTGTGGAATACGCTTTCCTTCTGGGACGGTCAACCAGTCACTTCCCCGGTATATCCCCG 65 FBan0011106 FBgn0030280 CG11106 X X CG11106 CG11106 BcDNA:AT24116 CDMC34271 3 6 13 DAC20-O02 3-CG11106-RA_2 CG11106 ATCATGGTGTGGAATACGCTTTCCTTCTGGGACGGTCAACCAGTCACTTCCCCGGTATATCCCCG 65 FBan0011106 FBgn0030280 CG11106 X X CG11106 CG11106 BcDNA:AT24116 CDMC34272 3 7 13 DAC20-O14 23-CG11139-RA_1 CG11139 CGATGGGGGGCAAAAACCTATGAAATAAAACTGGATTTGGTGAAGTCGGGAAACCTATTCGGGCC 65 FBan0011139 FBgn0033179 p47 2 2R nuclear envelope reassembly; GO:0031468; rhabdomere development; GO:0042052 p47 p47 "CG11139, CG11139, CG11139, CG11139, dp47, anon-WO0118547.216" CDMC34272 3 8 13 DAC20-O14 23-CG11139-RA_1 CG11139 CGATGGGGGGCAAAAACCTATGAAATAAAACTGGATTTGGTGAAGTCGGGAAACCTATTCGGGCC 65 FBan0011139 FBgn0033179 p47 2 2R nuclear envelope reassembly; GO:0031468; rhabdomere development; GO:0042052 p47 p47 "CG11139, CG11139, CG11139, CG11139, dp47, anon-WO0118547.216" CDMC34273 3 9 13 DAC21-C02 3-CG11228-RA_3 CG11228 AAGTTCGGTGAATACCAACAGAGCTCAGCCTCAGATGCCACCATGATAGCGCATGCAGAGCAAGG 65 FBan0011228 FBgn0034453 hpo 2 2R apoptosis; GO:0006915; cell proliferation; GO:0008283; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; negative regulation of growth; GO:0045926; negative regulation of organ size; GO:0046621; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; positive regulation of apoptosis; GO:0043065; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127 ATP binding; GO:0005524; protein binding; GO:0005515; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- cellular component unknown; GO:0008372 hpo hippo "CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, MST2, dMST, hippo" CDMC34273 3 10 13 DAC21-C02 3-CG11228-RA_3 CG11228 AAGTTCGGTGAATACCAACAGAGCTCAGCCTCAGATGCCACCATGATAGCGCATGCAGAGCAAGG 65 FBan0011228 FBgn0034453 hpo 2 2R apoptosis; GO:0006915; cell proliferation; GO:0008283; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; negative regulation of growth; GO:0045926; negative regulation of organ size; GO:0046621; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; positive regulation of apoptosis; GO:0043065; protein amino acid phosphorylation; GO:0006468; regulation of cell proliferation; GO:0042127 ATP binding; GO:0005524; protein binding; GO:0005515; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.- cellular component unknown; GO:0008372 hpo hippo "CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, CG11228, MST2, dMST, hippo" CDMC34274 3 11 13 DAC21-C14 12-CG11275-RA_3 CG11275 TCCGTGGAGCCAAGTACACAGATTGCGTGTTCCACGTGTGCGAGGAGCAAGTGAAATGCCACAAG 65 FBan0011275 FBgn0034706 CG11275 2 2R protein binding; GO:0005515; ; GO:0005515 CG11275 CG11275 i188 CDMC34274 3 12 13 DAC21-C14 12-CG11275-RA_3 CG11275 TCCGTGGAGCCAAGTACACAGATTGCGTGTTCCACGTGTGCGAGGAGCAAGTGAAATGCCACAAG 65 FBan0011275 FBgn0034706 CG11275 2 2R protein binding; GO:0005515; ; GO:0005515 CG11275 CG11275 i188 CDMC34275 3 13 13 DAC21-G02 6-CG11406-RA_1 CG11406 CAGCTTATGCCTAACAAAATGGCCTGCCTTCTCTTCCGTTGCCAGAGCATCTTGCCACGCATCCT 65 FBan0011406 FBgn0034990 CG11406 2 2R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11406 CG11406 CDMC34275 3 14 13 DAC21-G02 6-CG11406-RA_1 CG11406 CAGCTTATGCCTAACAAAATGGCCTGCCTTCTCTTCCGTTGCCAGAGCATCTTGCCACGCATCCT 65 FBan0011406 FBgn0034990 CG11406 2 2R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11406 CG11406 CDMC34276 3 15 13 DAC21-G14 3-CG11449-RA_3 CG11449 AGATCCTCGAGGAAAAGGAGTCCGTGTTAAGTCGCGCCTTTCTTGCCCGTCAAGAGCAGGAACAG 65 FBan0011449 FBgn0037162 CG11449 3 3L CG11449 CG11449 CDMC34276 3 16 13 DAC21-G14 3-CG11449-RA_3 CG11449 AGATCCTCGAGGAAAAGGAGTCCGTGTTAAGTCGCGCCTTTCTTGCCCGTCAAGAGCAGGAACAG 65 FBan0011449 FBgn0037162 CG11449 3 3L CG11449 CG11449 CDMC34277 3 17 13 DAC21-K02 6-CG11573-RA_1 CG11573 GCAAACTATTGCACTTTATGTGCCGGACATTGTGTGCCAGGACTATGCGGTGCCTCACATGCAGC 65 FBgn0031795 CDMC34277 3 18 13 DAC21-K02 6-CG11573-RA_1 CG11573 GCAAACTATTGCACTTTATGTGCCGGACATTGTGTGCCAGGACTATGCGGTGCCTCACATGCAGC 65 FBgn0031795 CDMC34278 3 19 13 DAC21-K14 23-CG11591-RA_4 CG11591 CGACGAACTGTTGCCGATTTTAGGTTTCGCACACCAAAAATTACTCTTGTACACAACTTATCGCT 65 FBan0011591 FBgn0035491 CG11591 3 3L CG11591 CG11591 CDMC34278 3 20 13 DAC21-K14 23-CG11591-RA_4 CG11591 CGACGAACTGTTGCCGATTTTAGGTTTCGCACACCAAAAATTACTCTTGTACACAACTTATCGCT 65 FBan0011591 FBgn0035491 CG11591 3 3L CG11591 CG11591 CDMC34279 3 21 13 DAC21-O02 6-CG11693-RA_1 CG11693 CATGTCAGTGTCCTAACTGCCGCACTTAACAATGCCCAATCCGCCTCGGAGTTGGCACAAAAGGC 65 FBan0011693 FBgn0037570 CG11693 3 3R CG11693 CG11693 CDMC34279 3 22 13 DAC21-O02 6-CG11693-RA_1 CG11693 CATGTCAGTGTCCTAACTGCCGCACTTAACAATGCCCAATCCGCCTCGGAGTTGGCACAAAAGGC 65 FBan0011693 FBgn0037570 CG11693 3 3R CG11693 CG11693 CDMC34280 3 23 13 DAC21-O14 2-CG11703-RA_2 CG11703 TTGAACGACAATGCCATTGACTTCTTCGCCGATTTCAACCAGGACACTACGTGGGGCTACGCCAC 65 FBan0011703 FBgn0038690 CG11703 3 3R potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 CG11703 CG11703 "JYbeta2, anon-WO0140519.49" CDMC34280 3 24 13 DAC21-O14 2-CG11703-RA_2 CG11703 TTGAACGACAATGCCATTGACTTCTTCGCCGATTTCAACCAGGACACTACGTGGGGCTACGCCAC 65 FBan0011703 FBgn0038690 CG11703 3 3R potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 CG11703 CG11703 "JYbeta2, anon-WO0140519.49" CDMC34281 3 25 13 DAC22-C02 1-CG31661-RA_1 CG31661 TGCGGGAGAACTATGTGGAGTTCGATTGGGCTAGGAGAAGAATGGGCATAGCACCGGCTGTATGA 65 FBan0031661 FBgn0051661 CG31661 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31661 CG31661 CG10872 CDMC34281 3 26 13 DAC22-C02 1-CG31661-RA_1 CG31661 TGCGGGAGAACTATGTGGAGTTCGATTGGGCTAGGAGAAGAATGGGCATAGCACCGGCTGTATGA 65 FBan0031661 FBgn0051661 CG31661 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31661 CG31661 CG10872 CDMC34282 3 1 14 DAC22-C14 5-CG31690-RB_1 CG31690 CCAGCTATCGCTCTGCGTCAGCAATCTACTCCACCTCCTCCAAATCGAAAAGCGCCTCATGGACA 65 FBan0031690 FBgn0051690 CG31690 2 2L UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- CG31690 CG31690 "CG11542, CG15397" CDMC34282 3 2 14 DAC22-C14 5-CG31690-RB_1 CG31690 CCAGCTATCGCTCTGCGTCAGCAATCTACTCCACCTCCTCCAAATCGAAAAGCGCCTCATGGACA 65 FBan0031690 FBgn0051690 CG31690 2 2L UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase activity; GO:0016253 ; EC:2.4.1.-; ; GO:0016253 ; EC:2.4.1.- CG31690 CG31690 "CG11542, CG15397" CDMC34283 3 3 14 DAC22-G02 15-CG31774-RA_2 CG31774 GAGGAGGCAACGCTAACGCCACGGCTAATCCAGGATCTACCGGTGCCAAAGAGTACGACCTCGAC 65 FBan0031774 FBgn0051774 fred 2 2L adult cuticle pattern formation (sensu Insecta); GO:0035018; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; sensory organ development; GO:0007423 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fred friend of echinoid "CG31774, CG12675, CG3390, CG3393, CT11413, friend of echinoid" CDMC34283 3 4 14 DAC22-G02 15-CG31774-RA_2 CG31774 GAGGAGGCAACGCTAACGCCACGGCTAATCCAGGATCTACCGGTGCCAAAGAGTACGACCTCGAC 65 FBan0031774 FBgn0051774 fred 2 2L adult cuticle pattern formation (sensu Insecta); GO:0035018; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; sensory organ development; GO:0007423 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fred friend of echinoid "CG31774, CG12675, CG3390, CG3393, CT11413, friend of echinoid" CDMC34284 3 5 14 DAC22-G14 12-CG31812-RA_1 CG31812 CGAACAGGCTAAATCCCTGCACGATAATGGTTGTTTTGGCAAGGGAAGCAAATCTCGCGGAGGAC 65 FBan0031812 FBgn0051812 CG31812 2 2L tRNA splicing; GO:0006388 tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG31812 CG31812 CDMC34284 3 6 14 DAC22-G14 12-CG31812-RA_1 CG31812 CGAACAGGCTAAATCCCTGCACGATAATGGTTGTTTTGGCAAGGGAAGCAAATCTCGCGGAGGAC 65 FBan0031812 FBgn0051812 CG31812 2 2L tRNA splicing; GO:0006388 tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG31812 CG31812 CDMC34285 3 7 14 DAC22-K02 23-CG31941-RA_3 CG31941 CCAAGGAGAACAATGTTCATAGGAAGAAGGCACTGGACCTTTTAATGAGCTATCGTTTGAAGAAG 65 FBan0031941 FBgn0043539 Obp22a 2 2L sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp22a Odorant-binding protein 22a "CG31941, 22a, anon-AE003584.1, Obp-b, Odorant-binding protein 22a" CDMC34285 3 8 14 DAC22-K02 23-CG31941-RA_3 CG31941 CCAAGGAGAACAATGTTCATAGGAAGAAGGCACTGGACCTTTTAATGAGCTATCGTTTGAAGAAG 65 FBan0031941 FBgn0043539 Obp22a 2 2L sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp22a Odorant-binding protein 22a "CG31941, 22a, anon-AE003584.1, Obp-b, Odorant-binding protein 22a" CDMC34286 3 9 14 DAC22-K14 3-CG31974-RA_5 CG31974 TACTGGCAGATCTTCCAACCCGAGCGGACTTGCATTACGGAGAACGCGGTGTACCAGTATCTGTC 65 FBan0031974 FBgn0051974 CG31974 2 2L CG31974 CG31974 CG18501 CDMC34286 3 10 14 DAC22-K14 3-CG31974-RA_5 CG31974 TACTGGCAGATCTTCCAACCCGAGCGGACTTGCATTACGGAGAACGCGGTGTACCAGTATCTGTC 65 FBan0031974 FBgn0051974 CG31974 2 2L CG31974 CG31974 CG18501 CDMC34287 3 11 14 DAC22-O02 2-CG32119-RA_3 CG32119 AAATGGAGCTTCGTTGCCCACGTATTGCGGCAAGGGACAGTCCTGTGTGGATTTGAGACCACTTC 65 FBan0032119 FBgn0052119 CG32119 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32119 CG32119 "BcDNA:AT05691, NEST:bs34d09" CDMC34287 3 12 14 DAC22-O02 2-CG32119-RA_3 CG32119 AAATGGAGCTTCGTTGCCCACGTATTGCGGCAAGGGACAGTCCTGTGTGGATTTGAGACCACTTC 65 FBan0032119 FBgn0052119 CG32119 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32119 CG32119 "BcDNA:AT05691, NEST:bs34d09" CDMC34288 3 13 14 DAC22-O14 12-CG32149-RA_3 CG32149 CGATATGCGGAGAGCACCAAGAGCCTCTCGTATCTGCCACAGGTGAGGGACGATTTCTTGCTGGG 65 FBan0032149 FBgn0036518 RhoGAP71E 3 3L metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 RhoGAP71E RhoGAP71E "CG7396, CG16980, CG32149, CG7396, CG16980, l(3)j6B9, RhoGAP-71E1, BcDNA:LD07615" CDMC34288 3 14 14 DAC22-O14 12-CG32149-RA_3 CG32149 CGATATGCGGAGAGCACCAAGAGCCTCTCGTATCTGCCACAGGTGAGGGACGATTTCTTGCTGGG 65 FBan0032149 FBgn0036518 RhoGAP71E 3 3L metabolism; GO:0008152 magnesium ion binding; GO:0000287; pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.-; ; GO:0000287 RhoGAP71E RhoGAP71E "CG7396, CG16980, CG32149, CG7396, CG16980, l(3)j6B9, RhoGAP-71E1, BcDNA:LD07615" CDMC34289 3 15 14 DAC23-C02 23-CG10751-RA_1 CG10751 TGCATCGCGACTATTGCTGAATTATCTGCACATTTATATCTGTATTCTAATCATCAGCGTATAAATGGA 69 FBan0010751 FBgn0024196 robl 2 2R cell motility; GO:0006928; dendrite morphogenesis; GO:0016358; microtubule-based movement; GO:0007018; mushroom body development; GO:0016319 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 robl roadblock "CG10751, CG10751, l(2)k10408, DLC, roadblock" CDMC34289 3 16 14 DAC23-C02 23-CG10751-RA_1 CG10751 TGCATCGCGACTATTGCTGAATTATCTGCACATTTATATCTGTATTCTAATCATCAGCGTATAAATGGA 69 FBan0010751 FBgn0024196 robl 2 2R cell motility; GO:0006928; dendrite morphogenesis; GO:0016358; microtubule-based movement; GO:0007018; mushroom body development; GO:0016319 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" axonemal dynein complex; GO:0005858; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 robl roadblock "CG10751, CG10751, l(2)k10408, DLC, roadblock" CDMC34290 3 17 14 DAC23-C14 12-CG10759-RA_2 CG10759 TGCCTGCACCAAGCTAGCGATGATGTGTACGCCGTTATCTATCTGTATGTGGTCCGGATTCAAGTGCAA 69 FBan0010759 FBgn0030016 Or7a X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or7a Odorant receptor 7a "CG10759, 7D.1, DOR30, 7a" CDMC34290 3 18 14 DAC23-C14 12-CG10759-RA_2 CG10759 TGCCTGCACCAAGCTAGCGATGATGTGTACGCCGTTATCTATCTGTATGTGGTCCGGATTCAAGTGCAA 69 FBan0010759 FBgn0030016 Or7a X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or7a Odorant receptor 7a "CG10759, 7D.1, DOR30, 7a" CDMC34291 3 19 14 DAC23-G02 15-CG10804-RA_1 CG10804 CGAAAGAGACGCGATATATGGGCGACCTTCTATTACCCGCAAAGAATACGCAGATGGAACACACGCAGT 69 FBan0010804 FBgn0029663 CG10804 X X extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG10804 CG10804 CDMC34291 3 20 14 DAC23-G02 15-CG10804-RA_1 CG10804 CGAAAGAGACGCGATATATGGGCGACCTTCTATTACCCGCAAAGAATACGCAGATGGAACACACGCAGT 69 FBan0010804 FBgn0029663 CG10804 X X extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG10804 CG10804 CDMC34292 3 21 14 DAC23-G14 1-CG10812-RA_2 CG10812 TGGTGCGAGGGATGCTAGGCCATCCTTCAAGGCGCGTTGCTCTAAATTGCCGGAAAACTACTAAATGTT 69 FBan0010812 FBgn0035434 dro5 3 3L defense response; GO:0006952; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 dro5 drosomycin-5 "CG10812, CG10812, CG10812, Drosomycin B, Dro-G, drosomycin-G, BcDNA:GH09576" CDMC34292 3 22 14 DAC23-G14 1-CG10812-RA_2 CG10812 TGGTGCGAGGGATGCTAGGCCATCCTTCAAGGCGCGTTGCTCTAAATTGCCGGAAAACTACTAAATGTT 69 FBan0010812 FBgn0035434 dro5 3 3L defense response; GO:0006952; pathogenesis; GO:0009405 ion channel inhibitor activity; GO:0008200; ; GO:0008200 extracellular region; GO:0005576 dro5 drosomycin-5 "CG10812, CG10812, CG10812, Drosomycin B, Dro-G, drosomycin-G, BcDNA:GH09576" CDMC34293 3 23 14 DAC23-K02 3-CG10844-RA_1 CG10844 CGCGTCTGATTTCTGGGCACAATCACACTGGCACTAGACGGTCCAAGGACTCTCGGGATCCAATTTTGT 69 FBan0010844 FBgn0011286 Rya-r44F 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; muscle contraction; GO:0006936 ryanodine-sensitive calcium-release channel activity; GO:0005219; ; GO:0005219; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005219; ; GO:0004872; ; GO:0005509; ; GO:0005219 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 Rya-r44F Ryanodine receptor 44F "CG10844, CG10844, CG10844, dry, DRR, l(2)k04913, DRY, ryanodine receptor, RyR, Ryr, l(2)k00424, ryr, RYR, Rya-r76CD, dya" CDMC34293 3 24 14 DAC23-K02 3-CG10844-RA_1 CG10844 CGCGTCTGATTTCTGGGCACAATCACACTGGCACTAGACGGTCCAAGGACTCTCGGGATCCAATTTTGT 69 FBan0010844 FBgn0011286 Rya-r44F 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; muscle contraction; GO:0006936 ryanodine-sensitive calcium-release channel activity; GO:0005219; ; GO:0005219; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005219; ; GO:0004872; ; GO:0005509; ; GO:0005219 endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021 Rya-r44F Ryanodine receptor 44F "CG10844, CG10844, CG10844, dry, DRR, l(2)k04913, DRY, ryanodine receptor, RyR, Ryr, l(2)k00424, ryr, RYR, Rya-r76CD, dya" CDMC34294 3 25 14 DAC23-K14 3-CG10851-RF_6 CG10851 GGCGGTCGTTACAACGAAAAATCATCCTCTCGTTATGGCCCACCGTTGCGCACTGAGTACCGACTGATT 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC34294 3 26 14 DAC23-K14 3-CG10851-RF_6 CG10851 GGCGGTCGTTACAACGAAAAATCATCCTCTCGTTATGGCCCACCGTTGCGCACTGAGTACCGACTGATT 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC34295 3 1 15 DAC23-O02 14-CG10907-RA_3 CG10907 CGGAAGTCCTCTCGAACCCATTCGATGATATCGTTCCTCGTATTCTCTCCCAACCTTCCACGAAGAGCA 69 FBan0010907 FBgn0036207 CG10907 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG10907 CG10907 CDMC34295 3 2 15 DAC23-O02 14-CG10907-RA_3 CG10907 CGGAAGTCCTCTCGAACCCATTCGATGATATCGTTCCTCGTATTCTCTCCCAACCTTCCACGAAGAGCA 69 FBan0010907 FBgn0036207 CG10907 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG10907 CG10907 CDMC34296 3 3 15 DAC23-O14 22-CG10916-RA_4 CG10916 ACCCACAAATGACTCATCACCTTCACTGAACATTTTATGTGCAATTTGCAACGAGTTTTTCCGGGCCAA 69 FBan0010916 FBgn0034312 CG10916 2 2R CG10916 CG10916 CDMC34296 3 4 15 DAC23-O14 22-CG10916-RA_4 CG10916 ACCCACAAATGACTCATCACCTTCACTGAACATTTTATGTGCAATTTGCAACGAGTTTTTCCGGGCCAA 69 FBan0010916 FBgn0034312 CG10916 2 2R CG10916 CG10916 CDMC34297 3 5 15 DAC24-C02 3-CG14936-RA_1 CG14936 GCGGTGTGGAACTGCTTTTACATCCTGATGGCGTTATGGGTCCTGGCCCTTAAGTTTCTGATCGTGCTT 69 FBan0014936 FBgn0032376 Tsp33B 2 2L integral to membrane; GO:0016021 Tsp33B Tetraspanin 33B "CG14936, CG14936, CG14936, Dm.Tsp33B, Tetraspanin 33B" CDMC34297 3 6 15 DAC24-C02 3-CG14936-RA_1 CG14936 GCGGTGTGGAACTGCTTTTACATCCTGATGGCGTTATGGGTCCTGGCCCTTAAGTTTCTGATCGTGCTT 69 FBan0014936 FBgn0032376 Tsp33B 2 2L integral to membrane; GO:0016021 Tsp33B Tetraspanin 33B "CG14936, CG14936, CG14936, Dm.Tsp33B, Tetraspanin 33B" CDMC34298 3 7 15 DAC24-C14 3-CG14948-RA_1 CG14948 CCCCCTGAGGATAATCGATGAGCACGAGAGGGACGTGGGGGATCGTTATTATAAGTCTGGAAGCACCGT 69 FBan0014948 FBgn0030723 dpr18 X X dpr18 dpr18 "CG14948, CG14948, CT34788, Dpr-18" CDMC34298 3 8 15 DAC24-C14 3-CG14948-RA_1 CG14948 CCCCCTGAGGATAATCGATGAGCACGAGAGGGACGTGGGGGATCGTTATTATAAGTCTGGAAGCACCGT 69 FBan0014948 FBgn0030723 dpr18 X X dpr18 dpr18 "CG14948, CG14948, CT34788, Dpr-18" CDMC34299 3 9 15 DAC24-G02 17-CG14977-RA_1 CG14977 AGCGCAGTGCAAATGTGATAATGGGATTACTAAATCTCACAGAGACCATCGACGAGTCCTTCATGCCGA 69 FBan0014977 FBgn0035469 CG14977 3 3L CG14977 CG14977 BcDNA:RH34338 CDMC34299 3 10 15 DAC24-G02 17-CG14977-RA_1 CG14977 AGCGCAGTGCAAATGTGATAATGGGATTACTAAATCTCACAGAGACCATCGACGAGTCCTTCATGCCGA 69 FBan0014977 FBgn0035469 CG14977 3 3L CG14977 CG14977 BcDNA:RH34338 CDMC34300 3 11 15 DAC24-G14 9-CG14985-RA_3 CG14985 AGGTGGTTTCCCACGTTTCCATCGACGAGAATGATACGGGCTTCGACTACGATCAGCTCTTCGGGAAAT 69 FBan0014985 FBgn0035482 CG14985 3 3L CG14985 CG14985 CDMC34300 3 12 15 DAC24-G14 9-CG14985-RA_3 CG14985 AGGTGGTTTCCCACGTTTCCATCGACGAGAATGATACGGGCTTCGACTACGATCAGCTCTTCGGGAAAT 69 FBan0014985 FBgn0035482 CG14985 3 3L CG14985 CG14985 CDMC34301 3 13 15 DAC24-K02 3-CG15012-RB_1 CG15012 TCGTCGAGTCTGTACGGATTTCCCTCACTATTTCCGACATTCTGCCGCTTTGAATCGGAAAAGGGCGCA 69 FBan0015012 FBgn0035528 CG15012 3 3L beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0004563 ; EC:3.2.1.52 CG15012 CG15012 CDMC34301 3 14 15 DAC24-K02 3-CG15012-RB_1 CG15012 TCGTCGAGTCTGTACGGATTTCCCTCACTATTTCCGACATTCTGCCGCTTTGAATCGGAAAAGGGCGCA 69 FBan0015012 FBgn0035528 CG15012 3 3L beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; ; GO:0004563 ; EC:3.2.1.52 CG15012 CG15012 CDMC34302 3 15 15 DAC24-K14 9-CG15019-RA_1 CG15019 GGGCGTGGAGCACATTTTCAACAGCAAGACCCTCAAAGATCAGTACGGCAATTATCCTGCGTGGTTCAA 69 FBan0015019 FBgn0035541 CG15019 3 3L CG15019 CG15019 CDMC34302 3 16 15 DAC24-K14 9-CG15019-RA_1 CG15019 GGGCGTGGAGCACATTTTCAACAGCAAGACCCTCAAAGATCAGTACGGCAATTATCCTGCGTGGTTCAA 69 FBan0015019 FBgn0035541 CG15019 3 3L CG15019 CG15019 CDMC34303 3 17 15 DAC24-O02 2-CG15065-RA_2 CG15065 GGTCTGCTCGCCATGGCAGTGGCTTCTCCGTTAAATCCGGGTAATGTCATTATCAATGGAGATTGCCGT 69 FBan0015065 FBgn0040734 CG15065 2 2R CG15065 CG15065 "IM2-like, CT34936" CDMC34303 3 18 15 DAC24-O02 2-CG15065-RA_2 CG15065 GGTCTGCTCGCCATGGCAGTGGCTTCTCCGTTAAATCCGGGTAATGTCATTATCAATGGAGATTGCCGT 69 FBan0015065 FBgn0040734 CG15065 2 2R CG15065 CG15065 "IM2-like, CT34936" CDMC34304 3 19 15 DAC24-O14 2-CG15073-RA_1 CG15073 GGAGTGCCATGCTGAGTCACCAGCGATATGTGCATCTCACGGATAGGAAGCACGAATGTAGTGTGTGCA 69 FBan0015073 FBgn0034379 CG15073 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15073 CG15073 CDMC34304 3 20 15 DAC24-O14 2-CG15073-RA_1 CG15073 GGAGTGCCATGCTGAGTCACCAGCGATATGTGCATCTCACGGATAGGAAGCACGAATGTAGTGTGTGCA 69 FBan0015073 FBgn0034379 CG15073 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15073 CG15073 CDMC34305 3 21 15 DAC25-C02 9-CG14322-RA_1 CG14322 TGCGGCCTACGGTGAGCGTTATTTGCTAGTCGGCTGCTACGACGGCTATATTTACGTCCTGAACAAGAT 69 FBan0014322 FBgn0038532 CG14322 3 3R CG14322 CG14322 CDMC34305 3 22 15 DAC25-C02 9-CG14322-RA_1 CG14322 TGCGGCCTACGGTGAGCGTTATTTGCTAGTCGGCTGCTACGACGGCTATATTTACGTCCTGAACAAGAT 69 FBan0014322 FBgn0038532 CG14322 3 3R CG14322 CG14322 CDMC34306 3 23 15 DAC25-C14 23-CG14331-RA_4 CG14331 TTGCAAAGGATTTCTATTCAGCGAAAAATGGGTTAAGTGGATCAAAATTGTTTTGCTCGGAACTCTTAT 69 FBan0014331 FBgn0038510 CG14331 3 3R CG14331 CG14331 CDMC34306 3 24 15 DAC25-C14 23-CG14331-RA_4 CG14331 TTGCAAAGGATTTCTATTCAGCGAAAAATGGGTTAAGTGGATCAAAATTGTTTTGCTCGGAACTCTTAT 69 FBan0014331 FBgn0038510 CG14331 3 3R CG14331 CG14331 CDMC34307 3 25 15 DAC25-G02 16-CG14379-RA_2 CG14379 TCAAGATCCCCGGATAGCGATGGAGACTACGAGAAGGTTTTGACATTCGAAATGCAGCTTTGCGACTTT 69 FBan0014379 FBgn0038142 CheA87a 3 3R CheA87a CheA87a "CG14379, CG14379" CDMC34307 3 26 15 DAC25-G02 16-CG14379-RA_2 CG14379 TCAAGATCCCCGGATAGCGATGGAGACTACGAGAAGGTTTTGACATTCGAAATGCAGCTTTGCGACTTT 69 FBan0014379 FBgn0038142 CheA87a 3 3R CheA87a CheA87a "CG14379, CG14379" CDMC34308 3 1 16 DAC25-G14 17-CG14396-RD_1 CG14396 AGCATCTGTCCAAGACCATCTCGTTCCGTTTCTCTAGTTTGCTGAATCTCAGTGAAACGAAGGAGGTGA 69 FBan0014396 FBgn0011829 Ret 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 plasma membrane; GO:0005886 Ret Ret oncogene "CG14396, CG1061, CG14396, CG1061, CG1061, CG14396, Dret, DRET, DmHD-59, D-ret, ret, RET, dRet, HD-59, Reto" CDMC34308 3 2 16 DAC25-G14 17-CG14396-RD_1 CG14396 AGCATCTGTCCAAGACCATCTCGTTCCGTTTCTCTAGTTTGCTGAATCTCAGTGAAACGAAGGAGGTGA 69 FBan0014396 FBgn0011829 Ret 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 plasma membrane; GO:0005886 Ret Ret oncogene "CG14396, CG1061, CG14396, CG1061, CG1061, CG14396, Dret, DRET, DmHD-59, D-ret, ret, RET, dRet, HD-59, Reto" CDMC34309 3 3 16 DAC25-K02 4-CG14435-RA_2 CG14435 AACCAGAGCAACTGAACACCTGAGCATCTGAAACATCTGAAACATCTGAGTCCCCGGAATCAGCAGGCG 69 FBan0014435 FBgn0029911 CG14435 X X CG14435 CG14435 CDMC34309 3 4 16 DAC25-K02 4-CG14435-RA_2 CG14435 AACCAGAGCAACTGAACACCTGAGCATCTGAAACATCTGAAACATCTGAGTCCCCGGAATCAGCAGGCG 69 FBan0014435 FBgn0029911 CG14435 X X CG14435 CG14435 CDMC34310 3 5 16 DAC25-K14 8-CG14447-RA_4 CG14447 GCCCCGGGTGTTTCATGTCACCCTGTACAAGGACAAGGTGTACGATGACTATGGATTCTCGGTATCCGA 69 FBgn0040917 CDMC34310 3 6 16 DAC25-K14 8-CG14447-RA_4 CG14447 GCCCCGGGTGTTTCATGTCACCCTGTACAAGGACAAGGTGTACGATGACTATGGATTCTCGGTATCCGA 69 FBgn0040917 CDMC34311 3 7 16 DAC25-O02 22-CG1449-RA_1 CG1449 TTGTGACAAACGCGACAAGCCACGCTATTCATACAGCTAGACAAGATTCTGATGTTATTGCCGAAGGGA 69 FBan0001449 FBgn0004607 zfh2 4 4 central nervous system development; GO:0007417; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh2 Zn finger homeodomain 2 "CG1449, zfh-2, ZFH-2, Zfh-2, Zfh2" CDMC34311 3 8 16 DAC25-O02 22-CG1449-RA_1 CG1449 TTGTGACAAACGCGACAAGCCACGCTATTCATACAGCTAGACAAGATTCTGATGTTATTGCCGAAGGGA 69 FBan0001449 FBgn0004607 zfh2 4 4 central nervous system development; GO:0007417; ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing morphogenesis; GO:0007476 DNA binding; GO:0003677; mRNA binding; GO:0003729; ; GO:0003677; ; GO:0003677; ; GO:0003729; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh2 Zn finger homeodomain 2 "CG1449, zfh-2, ZFH-2, Zfh-2, Zfh2" CDMC34312 3 9 16 DAC25-O14 23-CG14509-RA_2 CG14509 TTGATTTTGCATTGGAAAGATTAACTGGCTAACTCTCTGACACACGACAACAGGATACGAAATGCAGCA 69 FBan0014509 FBgn0039647 CG14509 3 3R CG14509 CG14509 CG14510 CDMC34312 3 10 16 DAC25-O14 23-CG14509-RA_2 CG14509 TTGATTTTGCATTGGAAAGATTAACTGGCTAACTCTCTGACACACGACAACAGGATACGAAATGCAGCA 69 FBan0014509 FBgn0039647 CG14509 3 3R CG14509 CG14509 CG14510 CDMC34313 3 11 16 DAC26-C02 22-CG4726-RA_1 CG4726 AGCCAGTTCAAAGTGGAATGGTCAATGCTGGACTGTAAATACCAATTACAAGTGTACAATGCCCACCCT 69 FBan0004726 FBgn0031307 CG4726 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4726 CG4726 CDMC34313 3 12 16 DAC26-C02 22-CG4726-RA_1 CG4726 AGCCAGTTCAAAGTGGAATGGTCAATGCTGGACTGTAAATACCAATTACAAGTGTACAATGCCCACCCT 69 FBan0004726 FBgn0031307 CG4726 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG4726 CG4726 CDMC34314 3 13 16 DAC26-C14 8-CG4738-RA_3 CG4738 GCCTAAACTGTTTGCACCTAGTTGACAGCCGCTACAGATGGATTGCCAAGCCTGTTCTTGGTGATGAGC 69 FBan0004738 FBgn0032347 CG4738 2 2L CG4738 CG4738 CDMC34314 3 14 16 DAC26-C14 8-CG4738-RA_3 CG4738 GCCTAAACTGTTTGCACCTAGTTGACAGCCGCTACAGATGGATTGCCAAGCCTGTTCTTGGTGATGAGC 69 FBan0004738 FBgn0032347 CG4738 2 2L CG4738 CG4738 CDMC34315 3 15 16 DAC26-G02 23-CG4760-RA_1 CG4760 TTCGATTTCTTTTGATTGGACTCATTTTATTTTCGGTTTTGCTTGCTGTAAATAGCAGAGAATGAATGT 69 FBan0004760 FBgn0011206 bol 3 3L male meiosis; GO:0007140; meiotic G2/MI transition; GO:0008315; positive regulation of meiosis; GO:0045836; regulation of translation; GO:0006445; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 bol boule "CG4760, CG4727, CG4760, CG4727, CG4760, CG4727, CG4727, Boule, ms(3)07272, BcDNA:AT13332" CDMC34315 3 16 16 DAC26-G02 23-CG4760-RA_1 CG4760 TTCGATTTCTTTTGATTGGACTCATTTTATTTTCGGTTTTGCTTGCTGTAAATAGCAGAGAATGAATGT 69 FBan0004760 FBgn0011206 bol 3 3L male meiosis; GO:0007140; meiotic G2/MI transition; GO:0008315; positive regulation of meiosis; GO:0045836; regulation of translation; GO:0006445; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleus; GO:0005634 bol boule "CG4760, CG4727, CG4760, CG4727, CG4760, CG4727, CG4727, Boule, ms(3)07272, BcDNA:AT13332" CDMC34316 3 17 16 DAC26-G14 8-CG4770-RA_1 CG4770 TCTGGAGGAGATGGACTATGACGAGTATGTGCGGCGTCACATGATTGGGATCAACAAGTACCTGCACCG 69 FBan0004770 FBgn0038751 CG4770 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG4770 CG4770 CDMC34316 3 18 16 DAC26-G14 8-CG4770-RA_1 CG4770 TCTGGAGGAGATGGACTATGACGAGTATGTGCGGCGTCACATGATTGGGATCAACAAGTACCTGCACCG 69 FBan0004770 FBgn0038751 CG4770 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG4770 CG4770 CDMC34317 3 19 16 DAC26-K02 3-CG4798-RA_3 CG4798 GGGCCTGCACACGTTCATCCGTTGCCGAAATACGTCCCGCGATGAGTTTATTTTTTACTCAAAGCGCCT 69 FBgn0034213 CDMC34317 3 20 16 DAC26-K02 3-CG4798-RA_3 CG4798 GGGCCTGCACACGTTCATCCGTTGCCGAAATACGTCCCGCGATGAGTTTATTTTTTACTCAAAGCGCCT 69 FBgn0034213 CDMC34318 3 21 16 DAC26-K14 23-CG4810-RA_7 CG4810 ACTCCAACGATAACTAACGCCCTCACGAATTTATTCAACTAATAGTTCTCCGAACAAGGGGATCCGTCG 69 FBan0004810 FBgn0037994 CG4810 3 3R mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074; translational initiation; GO:0006413 microtubule binding; GO:0008017; translation initiation factor activity; GO:0003743; ; GO:0003743; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG4810 CG4810 eIF3-S7 CDMC34318 3 22 16 DAC26-K14 23-CG4810-RA_7 CG4810 ACTCCAACGATAACTAACGCCCTCACGAATTTATTCAACTAATAGTTCTCCGAACAAGGGGATCCGTCG 69 FBan0004810 FBgn0037994 CG4810 3 3R mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074; translational initiation; GO:0006413 microtubule binding; GO:0008017; translation initiation factor activity; GO:0003743; ; GO:0003743; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG4810 CG4810 eIF3-S7 CDMC34319 3 23 16 DAC26-O02 3-CG4848-RA_3 CG4848 GGAGCAGAGTGTTCAGTCAACCATTCGAATCCCCAGTCAGCCGCGACTCTCTCTGCAGACGTATCTTCA 69 FBan0004848 FBgn0037998 CG4848 3 3R CG4848 CG4848 CDMC34319 3 24 16 DAC26-O02 3-CG4848-RA_3 CG4848 GGAGCAGAGTGTTCAGTCAACCATTCGAATCCCCAGTCAGCCGCGACTCTCTCTGCAGACGTATCTTCA 69 FBan0004848 FBgn0037998 CG4848 3 3R CG4848 CG4848 CDMC34320 3 25 16 DAC26-O14 8-CG4858-RA_1 CG4858 GGTTGGTCTGCTCGATATAGATCTGTGTGGACCGAGTGTGCCATATCTATTGGGTCTGGAAGGACGGGA 69 FBan0004858 FBgn0037011 CG4858 3 3L ATP binding; GO:0005524; nucleotide binding; GO:0000166; ; GO:0005524; ; GO:0000166 CG4858 CG4858 CDMC34320 3 26 16 DAC26-O14 8-CG4858-RA_1 CG4858 GGTTGGTCTGCTCGATATAGATCTGTGTGGACCGAGTGTGCCATATCTATTGGGTCTGGAAGGACGGGA 69 FBan0004858 FBgn0037011 CG4858 3 3L ATP binding; GO:0005524; nucleotide binding; GO:0000166; ; GO:0005524; ; GO:0000166 CG4858 CG4858 CDMC34321 3 1 17 DAC27-C02 3-CG3491-RA_3 CG3491 CCCTTGAGAATGTGATGCAACAGCTGACCAGCAATAAACCACTGGACCGGTCTCAAGTGCCTCAATCGT 69 FBan0003491 FBgn0028887 CG3491 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transport; GO:0006810" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; transporter activity; GO:0005215; helicase activity; GO:0004386; ; GO:0004386; ; GO:0005215; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG3491 CG3491 BG:DS03323.1 CDMC34321 3 2 17 DAC27-C02 3-CG3491-RA_3 CG3491 CCCTTGAGAATGTGATGCAACAGCTGACCAGCAATAAACCACTGGACCGGTCTCAAGTGCCTCAATCGT 69 FBan0003491 FBgn0028887 CG3491 2 2L "regulation of transcription, DNA-dependent; GO:0006355; transport; GO:0006810" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; transporter activity; GO:0005215; helicase activity; GO:0004386; ; GO:0004386; ; GO:0005215; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG3491 CG3491 BG:DS03323.1 CDMC34322 3 3 17 DAC27-C14 23-CG3500-RA_1 CG3500 ATCCTAAATTCCTCATGTTTCCCACAAAAAATATTTGAAAAAGCGTTGGAACGAGAATATCTGGCAGCT 69 FBan0003500 FBgn0034849 CG3500 2 2R CG3500 CG3500 BcDNA:AT03803 CDMC34322 3 4 17 DAC27-C14 23-CG3500-RA_1 CG3500 ATCCTAAATTCCTCATGTTTCCCACAAAAAATATTTGAAAAAGCGTTGGAACGAGAATATCTGGCAGCT 69 FBan0003500 FBgn0034849 CG3500 2 2R CG3500 CG3500 BcDNA:AT03803 CDMC34323 3 5 17 DAC27-G02 23-CG3539-RD_3 CG3539 GGTCAAGCGACATGTGAGTTTCTCTTTCCAAATTCAAATTCAAGTTCTATATCAAAATTGTTTGCAGAA 69 FBan0003539 FBgn0015816 Slh 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein targeting; GO:0006605; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149 cytoplasm; GO:0005737; membrane; GO:0016020 Slh SLY-1 homologous "CG3539, CG3539, CG3539, d-sly, slh, Sly1, Sly1p, SLY-1 homologous" CDMC34323 3 6 17 DAC27-G02 23-CG3539-RD_3 CG3539 GGTCAAGCGACATGTGAGTTTCTCTTTCCAAATTCAAATTCAAGTTCTATATCAAAATTGTTTGCAGAA 69 FBan0003539 FBgn0015816 Slh 2 2L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein targeting; GO:0006605; vesicle docking during exocytosis; GO:0006904; vesicle-mediated transport; GO:0016192 SNARE binding; GO:0000149; ; GO:0000149 cytoplasm; GO:0005737; membrane; GO:0016020 Slh SLY-1 homologous "CG3539, CG3539, CG3539, d-sly, slh, Sly1, Sly1p, SLY-1 homologous" CDMC34324 3 7 17 DAC27-G14 23-CG3558-RA_3 CG3558 TGGAACGGAAAGCTTGTGTATACATATTTTACGGATTTGTTAGCCCTTGTTTGTTTTAACCAGCTACTC 69 FBan0003558 FBgn0025681 CG3558 2 2L CG3558 CG3558 "c4.3, FBgn0025681, BEST:LD23852" CDMC34324 3 8 17 DAC27-G14 23-CG3558-RA_3 CG3558 TGGAACGGAAAGCTTGTGTATACATATTTTACGGATTTGTTAGCCCTTGTTTGTTTTAACCAGCTACTC 69 FBan0003558 FBgn0025681 CG3558 2 2L CG3558 CG3558 "c4.3, FBgn0025681, BEST:LD23852" CDMC34325 3 9 17 DAC27-K02 10-CG3593-RA_2 CG3593 GCAGCCTACCAGGATCGAGTTGCCAAGTAGAAAACCCAAACAGCATTCCCCCTTAACGAATATTCCCCA 69 FBan0003593 FBgn0003257 r-l 3 3R 'de novo' pyrimidine base biosynthesis; GO:0006207; nucleoside metabolism; GO:0009116; pyrimidine nucleotide biosynthesis; GO:0006221 orotate phosphoribosyltransferase activity; GO:0004588 ; EC:2.4.2.10; orotidine-5'-phosphate decarboxylase activity; GO:0004590 ; EC:4.1.1.23; ; GO:0004588 ; EC:2.4.2.10; ; GO:0004590 ; EC:4.1.1.23 r-l rudimentary-like "CG3593, orotidine phosphate decarboxylase, UMP synthase, OMPDC, OPRT, UMPS, ral" CDMC34325 3 10 17 DAC27-K02 10-CG3593-RA_2 CG3593 GCAGCCTACCAGGATCGAGTTGCCAAGTAGAAAACCCAAACAGCATTCCCCCTTAACGAATATTCCCCA 69 FBan0003593 FBgn0003257 r-l 3 3R 'de novo' pyrimidine base biosynthesis; GO:0006207; nucleoside metabolism; GO:0009116; pyrimidine nucleotide biosynthesis; GO:0006221 orotate phosphoribosyltransferase activity; GO:0004588 ; EC:2.4.2.10; orotidine-5'-phosphate decarboxylase activity; GO:0004590 ; EC:4.1.1.23; ; GO:0004588 ; EC:2.4.2.10; ; GO:0004590 ; EC:4.1.1.23 r-l rudimentary-like "CG3593, orotidine phosphate decarboxylase, UMP synthase, OMPDC, OPRT, UMPS, ral" CDMC34326 3 11 17 DAC27-K14 9-CG3610-RA_1 CG3610 GCCGAGGGTCGTCAAGAGCTAAAGGAATGCAAGGAGATAGTGGAGCAGGGAATCCTAAAGGATGCAGTT 69 FBan0003610 FBgn0038266 CG3610 3 3R CG3610 CG3610 CDMC34326 3 12 17 DAC27-K14 9-CG3610-RA_1 CG3610 GCCGAGGGTCGTCAAGAGCTAAAGGAATGCAAGGAGATAGTGGAGCAGGGAATCCTAAAGGATGCAGTT 69 FBan0003610 FBgn0038266 CG3610 3 3R CG3610 CG3610 CDMC34327 3 13 17 DAC27-O02 5-CG3647-RB_1 CG3647 AGCAAAAGTGTCTAACCAAGTACTCGGAGTTTGTTCGTGGCTTCGCAAAGAAGAACCCAGCGCTGACCA 69 FBan0003647 FBgn0001978 stc 2 2L electron transport; GO:0006118; nervous system development; GO:0007399; protein biosynthesis; GO:0006412; protein ubiquitination; GO:0016567; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; ; GO:0003697; RNA polymerase II transcription factor activity; GO:0003702; structural constituent of ribosome; GO:0003735; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003735; ; GO:0004842 ; EC:6.3.2.19; electron transporter activity; GO:0005489; ; GO:0003700; ; GO:0008270; ; GO:0005489 nucleus; GO:0005634; ribosome; GO:0005840; ubiquitin ligase complex; GO:0000151 stc shuttle craft "CG3647, CG3647, l(2)br33, br33, l(2)35Cb, l35Cb, BG:DS04929.4, BcDNA.LD22726, l(2)SH2 1565, BcDNA:LD22726, Cf4: Chorion-factor-4, l(2)SH1565, Chorion-factor-4" CDMC34327 3 14 17 DAC27-O02 5-CG3647-RB_1 CG3647 AGCAAAAGTGTCTAACCAAGTACTCGGAGTTTGTTCGTGGCTTCGCAAAGAAGAACCCAGCGCTGACCA 69 FBan0003647 FBgn0001978 stc 2 2L electron transport; GO:0006118; nervous system development; GO:0007399; protein biosynthesis; GO:0006412; protein ubiquitination; GO:0016567; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; ; GO:0003697; RNA polymerase II transcription factor activity; GO:0003702; structural constituent of ribosome; GO:0003735; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003735; ; GO:0004842 ; EC:6.3.2.19; electron transporter activity; GO:0005489; ; GO:0003700; ; GO:0008270; ; GO:0005489 nucleus; GO:0005634; ribosome; GO:0005840; ubiquitin ligase complex; GO:0000151 stc shuttle craft "CG3647, CG3647, l(2)br33, br33, l(2)35Cb, l35Cb, BG:DS04929.4, BcDNA.LD22726, l(2)SH2 1565, BcDNA:LD22726, Cf4: Chorion-factor-4, l(2)SH1565, Chorion-factor-4" CDMC34328 3 15 17 DAC27-O14 23-CG3665-RA_5 CG3665 GGGGAAGAGCACTTGAATATCGATCGATTGGCACACTAAGTTGGTTTTAATTTACTTTCGTACACAGCG 69 FBan0003665 FBgn0000635 Fas2 X X Bolwig's organ morphogenesis; GO:0001746; axonal fasciculation; GO:0007413; behavioral response to ethanol; GO:0048149; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; learning; GO:0007612; learning and/or memory; GO:0007611; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; mushroom body development; GO:0016319; neuromuscular junction development; GO:0007528; neuron recognition; GO:0008038; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; regulation of synapse structure and function; GO:0050803; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; short-term memory; GO:0007614; signal transduction; GO:0007165 axon; GO:0030424; cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211; presynaptic membrane; GO:0042734 Fas2 Fasciclin 2 "CG3665, CG3665, CG3665, fasciclin II, fasII, FASII, FasII, fas II, Fasciclin II, fas-II, fasciclinII, fasciclin 2, Fas II, FascII, clone 1.60, l(1)G0081, l(1)G0293, l(1)G0336, mAB1D4, l(1)G0048, l(1)G0032, 1D4, FAS II, mAb1D4, CT12301, FASCICLIN II, Ab 1D4, mAb 1D4, fas2, fasciclin-II, FasciclinII, Fascilin II, EG:EG0007.3, anon-EST:Liang-1.60" CDMC34328 3 16 17 DAC27-O14 23-CG3665-RA_5 CG3665 GGGGAAGAGCACTTGAATATCGATCGATTGGCACACTAAGTTGGTTTTAATTTACTTTCGTACACAGCG 69 FBan0003665 FBgn0000635 Fas2 X X Bolwig's organ morphogenesis; GO:0001746; axonal fasciculation; GO:0007413; behavioral response to ethanol; GO:0048149; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; learning; GO:0007612; learning and/or memory; GO:0007611; male genitalia morphogenesis (sensu Endopterygota); GO:0007485; mushroom body development; GO:0016319; neuromuscular junction development; GO:0007528; neuron recognition; GO:0008038; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; regulation of synapse structure and function; GO:0050803; regulation of synaptic growth at neuromuscular junction; GO:0008582; regulation of tracheal tube architecture; GO:0035152; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; short-term memory; GO:0007614; signal transduction; GO:0007165 axon; GO:0030424; cytoplasm; GO:0005737; integral to membrane; GO:0016021; plasma membrane; GO:0005886; postsynaptic membrane; GO:0045211; presynaptic membrane; GO:0042734 Fas2 Fasciclin 2 "CG3665, CG3665, CG3665, fasciclin II, fasII, FASII, FasII, fas II, Fasciclin II, fas-II, fasciclinII, fasciclin 2, Fas II, FascII, clone 1.60, l(1)G0081, l(1)G0293, l(1)G0336, mAB1D4, l(1)G0048, l(1)G0032, 1D4, FAS II, mAb1D4, CT12301, FASCICLIN II, Ab 1D4, mAb 1D4, fas2, fasciclin-II, FasciclinII, Fascilin II, EG:EG0007.3, anon-EST:Liang-1.60" CDMC34329 3 17 17 DAC28-C02 22-CG14750-RA_1 CG14750 AGCAGCTGAAGGTCTGGACAGATCTCTTTCTCAAATACCTCAGGCACACGAATAGGTTTACTCTCAGCA 69 FBgn0033314 CDMC34329 3 18 17 DAC28-C02 22-CG14750-RA_1 CG14750 AGCAGCTGAAGGTCTGGACAGATCTCTTTCTCAAATACCTCAGGCACACGAATAGGTTTACTCTCAGCA 69 FBgn0033314 CDMC34330 3 19 17 DAC28-C14 22-CG14764-RA_1 CG14764 CGTGGCCAAAGCATTTGATATAACTTTTTCTACCGACAACCACACAAGCGGATACACTCAGGCGGTGAC 69 FBan0014764 FBgn0033236 CG14764 2 2R CG14764 CG14764 CG2923 CDMC34330 3 20 17 DAC28-C14 22-CG14764-RA_1 CG14764 CGTGGCCAAAGCATTTGATATAACTTTTTCTACCGACAACCACACAAGCGGATACACTCAGGCGGTGAC 69 FBan0014764 FBgn0033236 CG14764 2 2R CG14764 CG14764 CG2923 CDMC34331 3 21 17 DAC28-G02 23-CG14813-RA_2 CG14813 CGCTGCATATAACGGTATCAAATAAATTAATTGCAATTAGTTGTAACTGGCGATTGCAGTGTTTTGTTT 69 FBan0014813 FBgn0028969 deltaCOP X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 deltaCOP delta-coatomer protein "CG14813, CG14813, CG14813, EG:63B12.10, 63B12S, l(1)G0051, l(1)G0301, coatomer complex COPI delta-COP subunit, l(1)G0450, DM63B12S, ARCN1, delta-Cop, DeltaCop, deltaCOP, anon-WO03040301.246, ESTS:63B12S, Arch, Archain, delta-coatomer protein" CDMC34331 3 22 17 DAC28-G02 23-CG14813-RA_2 CG14813 CGCTGCATATAACGGTATCAAATAAATTAATTGCAATTAGTTGTAACTGGCGATTGCAGTGTTTTGTTT 69 FBan0014813 FBgn0028969 deltaCOP X X "exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 deltaCOP delta-coatomer protein "CG14813, CG14813, CG14813, EG:63B12.10, 63B12S, l(1)G0051, l(1)G0301, coatomer complex COPI delta-COP subunit, l(1)G0450, DM63B12S, ARCN1, delta-Cop, DeltaCop, deltaCOP, anon-WO03040301.246, ESTS:63B12S, Arch, Archain, delta-coatomer protein" CDMC34332 3 23 17 DAC28-G14 3-CG14824-RA_1 CG14824 GCGGCCACTCTACAGGAGCGGATTCGCATTCGCAACGAATTTATAGGTGAGAAGAGCGATCGAATCCCA 69 FBgn0035738 CDMC34332 3 24 17 DAC28-G14 3-CG14824-RA_1 CG14824 GCGGCCACTCTACAGGAGCGGATTCGCATTCGCAACGAATTTATAGGTGAGAAGAGCGATCGAATCCCA 69 FBgn0035738 CDMC34333 3 25 17 DAC28-K02 1-CG14868-RA_1 CG14868 GCGTCGCCATTACAGCGGATCATGAAGATTCAAAGAAGCACAAGTCCGTTGAGGCTCTGCATTCCGACG 69 FBan0014868 FBgn0038330 CG14868 3 3R CG14868 CG14868 CDMC34333 3 26 17 DAC28-K02 1-CG14868-RA_1 CG14868 GCGTCGCCATTACAGCGGATCATGAAGATTCAAAGAAGCACAAGTCCGTTGAGGCTCTGCATTCCGACG 69 FBan0014868 FBgn0038330 CG14868 3 3R CG14868 CG14868 CDMC34334 3 1 18 DAC28-K14 3-CG14877-RA_3 CG14877 TTCTGCCCGATGATAATATGTACCAGGCATCCCTACCGCGTGTCCTACCAATCCTTAAAGTGGCCGAGC 69 FBan0014877 FBgn0038380 CG14877 3 3R guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2 CG14877 CG14877 CDMC34334 3 2 18 DAC28-K14 3-CG14877-RA_3 CG14877 TTCTGCCCGATGATAATATGTACCAGGCATCCCTACCGCGTGTCCTACCAATCCTTAAAGTGGCCGAGC 69 FBan0014877 FBgn0038380 CG14877 3 3R guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2 CG14877 CG14877 CDMC34335 3 3 18 DAC28-O02 30-CG14900-RA_1 CG14900 CGAGTGTCGAATTTTGGTCCACATTGCGGATGAAAACGATAATGCACCCAAGTTCCGAGGCAATGGGCA 69 FBan0014900 FBgn0038439 Cad89D 3 3R calcium-dependent cell-cell adhesion; GO:0016339; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 mRNA binding; GO:0003729; calcium ion binding; GO:0005509; ; GO:0003729; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad89D Cad89D "CG14900, CG14900, CT34724, DCad89D" CDMC34335 3 4 18 DAC28-O02 30-CG14900-RA_1 CG14900 CGAGTGTCGAATTTTGGTCCACATTGCGGATGAAAACGATAATGCACCCAAGTTCCGAGGCAATGGGCA 69 FBan0014900 FBgn0038439 Cad89D 3 3R calcium-dependent cell-cell adhesion; GO:0016339; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 mRNA binding; GO:0003729; calcium ion binding; GO:0005509; ; GO:0003729; ; GO:0005509 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 Cad89D Cad89D "CG14900, CG14900, CT34724, DCad89D" CDMC34336 3 5 18 DAC28-O14 11-CG14906-RA_1 CG14906 TGCCCGATATCTGCATCCCCACTTCACTTCAATTGGCTTAGAAGTGCTCAAACTGATGGACGAAAGGCT 69 FBan0014906 FBgn0015351 CG14906 3 3R CG14906 CG14906 "ORF2, open reading frame 2, anon-89Eb" CDMC34336 3 6 18 DAC28-O14 11-CG14906-RA_1 CG14906 TGCCCGATATCTGCATCCCCACTTCACTTCAATTGGCTTAGAAGTGCTCAAACTGATGGACGAAAGGCT 69 FBan0014906 FBgn0015351 CG14906 3 3R CG14906 CG14906 "ORF2, open reading frame 2, anon-89Eb" CDMC34337 3 7 18 DAC29-C02 16-CG6393-RD_1 CG6393 TGAGCAGACAACAAAAGGAATTCGGCTCGCTCAACTTCTTCCTAGTTTACCGTTACTTGCACTGCCAAA 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC34337 3 8 18 DAC29-C02 16-CG6393-RD_1 CG6393 TGAGCAGACAACAAAAGGAATTCGGCTCGCTCAACTTCTTCCTAGTTTACCGTTACTTGCACTGCCAAA 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC34338 3 9 18 DAC29-C14 10-CG6406-RB_1 CG6406 ACGGAACCCTCGGTAGAGATCGTTTGCAAATGCTTCAGTCAGAGGGAGACTATGTTCCATTTTCGGGGA 69 FBan0006406 FBgn0034269 CG6406 2 2R CG6406 CG6406 CDMC34338 3 10 18 DAC29-C14 10-CG6406-RB_1 CG6406 ACGGAACCCTCGGTAGAGATCGTTTGCAAATGCTTCAGTCAGAGGGAGACTATGTTCCATTTTCGGGGA 69 FBan0006406 FBgn0034269 CG6406 2 2R CG6406 CG6406 CDMC34339 3 11 18 DAC29-G02 23-CG6446-RA_12 CG6446 AATCGTGTCGAATCTAGGCCTTAACGCTAAACTTGTAAGCTTTGGATGGAAATAATGAGCTTGGTTGGC 69 FBan0006446 FBgn0016059 Sema-1b 2 2R axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 receptor binding; GO:0005102; receptor activity; GO:0004872; ; GO:0005102; ; GO:0004872 plasma membrane; GO:0005886 Sema-1b Sema-1b "CG6446, D-semaIII, sema-III, semaphorin-III, Sema1b, Sema III, semaphorin, Sema 1b, semaphorin-like, semaphorin-I, semiphorin, BcDNA:GH03186" CDMC34339 3 12 18 DAC29-G02 23-CG6446-RA_12 CG6446 AATCGTGTCGAATCTAGGCCTTAACGCTAAACTTGTAAGCTTTGGATGGAAATAATGAGCTTGGTTGGC 69 FBan0006446 FBgn0016059 Sema-1b 2 2R axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 receptor binding; GO:0005102; receptor activity; GO:0004872; ; GO:0005102; ; GO:0004872 plasma membrane; GO:0005886 Sema-1b Sema-1b "CG6446, D-semaIII, sema-III, semaphorin-III, Sema1b, Sema III, semaphorin, Sema 1b, semaphorin-like, semaphorin-I, semiphorin, BcDNA:GH03186" CDMC34340 3 13 18 DAC29-G14 5-CG6453-RA_1 CG6453 GGTCGCTGGGACAAATGGAGTGGAGAGCCAAAGCAATATTCCCAACAAAAGTACACCAATGGTGCTGCC 69 FBan0006453 FBgn0032643 CG6453 2 2L signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509; alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG6453 CG6453 CDMC34340 3 14 18 DAC29-G14 5-CG6453-RA_1 CG6453 GGTCGCTGGGACAAATGGAGTGGAGAGCCAAAGCAATATTCCCAACAAAAGTACACCAATGGTGCTGCC 69 FBan0006453 FBgn0032643 CG6453 2 2L signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509; alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG6453 CG6453 CDMC34341 3 15 18 DAC29-K02 16-CG6490-RA_1 CG6490 ACTCAACCAGAAGCAATGTTCAAAGTAGACTCACCTCGAACCCAGTTAGTTGCGACTTAGACCATCCGT 69 FBan0006490 FBgn0039431 CG6490 3 3R CG6490 CG6490 CT20213 CDMC34341 3 16 18 DAC29-K02 16-CG6490-RA_1 CG6490 ACTCAACCAGAAGCAATGTTCAAAGTAGACTCACCTCGAACCCAGTTAGTTGCGACTTAGACCATCCGT 69 FBan0006490 FBgn0039431 CG6490 3 3R CG6490 CG6490 CT20213 CDMC34342 3 17 18 DAC29-K14 23-CG6503-RA_2 CG6503 GGATTTTCTTTCAAGTGCAGAACTCGATAAGGATTTTATAAACATGCTTTTGAAATGCACTTGGCTATT 69 FBan0006503 FBgn0040606 CG6503 3 3R CG6503 CG6503 "CT20261, pncr007:3R, putative noncoding RNA 007:3R, BcDNA:RH63361" CDMC34342 3 18 18 DAC29-K14 23-CG6503-RA_2 CG6503 GGATTTTCTTTCAAGTGCAGAACTCGATAAGGATTTTATAAACATGCTTTTGAAATGCACTTGGCTATT 69 FBan0006503 FBgn0040606 CG6503 3 3R CG6503 CG6503 "CT20261, pncr007:3R, putative noncoding RNA 007:3R, BcDNA:RH63361" CDMC34343 3 19 18 DAC29-O02 1-CG6541-RA_1 CG6541 AGCCAATCCCGGTCTGATGATTGTGGAAAAGGCCTCATTATGGCGTAAAATGACTCCTGCCGAAAGGGA 69 FBan0006541 FBgn0028412 Mst33A 2 2L Mst33A Mst33A CG6541 CDMC34343 3 20 18 DAC29-O02 1-CG6541-RA_1 CG6541 AGCCAATCCCGGTCTGATGATTGTGGAAAAGGCCTCATTATGGCGTAAAATGACTCCTGCCGAAAGGGA 69 FBan0006541 FBgn0028412 Mst33A 2 2L Mst33A Mst33A CG6541 CDMC34344 3 21 18 DAC29-O14 2-CG6550-RA_1 CG6550 ACCGTCTTGGTCACAGAAGTTTCACACGACAAGCTCCATTACGTGGGCCACAACAAGAGCTACGAGCAA 69 FBan0006550 FBgn0034214 CG6550 2 2R CG6550 CG6550 CDMC34344 3 22 18 DAC29-O14 2-CG6550-RA_1 CG6550 ACCGTCTTGGTCACAGAAGTTTCACACGACAAGCTCCATTACGTGGGCCACAACAAGAGCTACGAGCAA 69 FBan0006550 FBgn0034214 CG6550 2 2R CG6550 CG6550 CDMC34345 3 23 18 DAC30-C02 23-CG3943-RA_1 CG3943 TGTATATAGTTAGTGTATTTCATCCCACTTGTGATGTACAGTGATCAAAGGTATGTGCCCGATTTGC 67 FBan0003943 FBgn0020545 kraken 2 2L aromatic compound metabolism; GO:0006725; digestion; GO:0007586; response to toxin; GO:0009636 serine hydrolase activity; GO:0017171; ; GO:0017171 cellular component unknown; GO:0008372 kraken kraken "CG3943, CG3943, CG3943" CDMC34345 3 24 18 DAC30-C02 23-CG3943-RA_1 CG3943 TGTATATAGTTAGTGTATTTCATCCCACTTGTGATGTACAGTGATCAAAGGTATGTGCCCGATTTGC 67 FBan0003943 FBgn0020545 kraken 2 2L aromatic compound metabolism; GO:0006725; digestion; GO:0007586; response to toxin; GO:0009636 serine hydrolase activity; GO:0017171; ; GO:0017171 cellular component unknown; GO:0008372 kraken kraken "CG3943, CG3943, CG3943" CDMC34346 3 25 18 DAC30-C14 23-CG40182-RA_4 CG40182 ATTGCTAAACTTTTTAAAAGGATTGTGTTACGTCGACGTATTAGTGCCCTGTTACTGGACCAATGGA 67 FBgn0058182 CG40182 CG40182 CG40182 CDMC34346 3 26 18 DAC30-C14 23-CG40182-RA_4 CG40182 ATTGCTAAACTTTTTAAAAGGATTGTGTTACGTCGACGTATTAGTGCCCTGTTACTGGACCAATGGA 67 FBgn0058182 CG40182 CG40182 CG40182 CDMC34347 3 1 19 DAC30-G02 2-CG4190-RA_1 CG4190 ATCTGGATGTGGGACTCTTTCAGCCAGGTGAACTGACCGTCAAACTGGTCAACGAGTGCATTGTGGT 67 FBan0004190 FBgn0001229 Hsp67Bc 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 Hsp67Bc Heat shock gene 67Bc "CG4190, CG4190, gene5, gene 3, Gene 3, gene3, Hspg3, hsp67B, Hsp-G3, gene-3" CDMC34347 3 2 19 DAC30-G02 2-CG4190-RA_1 CG4190 ATCTGGATGTGGGACTCTTTCAGCCAGGTGAACTGACCGTCAAACTGGTCAACGAGTGCATTGTGGT 67 FBan0004190 FBgn0001229 Hsp67Bc 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 Hsp67Bc Heat shock gene 67Bc "CG4190, CG4190, gene5, gene 3, Gene 3, gene3, Hspg3, hsp67B, Hsp-G3, gene-3" CDMC34348 3 3 19 DAC30-G14 3-CG4345-RA_1 CG4345 TCTACAGCTACAGTTCGAGCCAGCGTCAACCGACGGTCATTCAGATATCCTTCGAGATCAGCAGCGG 67 FBan0004345 FBgn0015946 grim 3 3L NOT nurse cell apoptosis; GO:0045476; apoptosis; GO:0006915; apoptotic program; GO:0008632; central nervous system remodeling (sensu Insecta); GO:0035193; embryonic development (sensu Insecta); GO:0001700; induction of apoptosis; GO:0006917; induction of apoptosis by ionic changes; GO:0008627; negative regulation of protein biosynthesis; GO:0017148; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of proteolysis; GO:0030162 cytoplasm; GO:0005737; mitochondrion; GO:0005739 grim grim "CG4345, Grim, BcDNA:RE28551, grim" CDMC34348 3 4 19 DAC30-G14 3-CG4345-RA_1 CG4345 TCTACAGCTACAGTTCGAGCCAGCGTCAACCGACGGTCATTCAGATATCCTTCGAGATCAGCAGCGG 67 FBan0004345 FBgn0015946 grim 3 3L NOT nurse cell apoptosis; GO:0045476; apoptosis; GO:0006915; apoptotic program; GO:0008632; central nervous system remodeling (sensu Insecta); GO:0035193; embryonic development (sensu Insecta); GO:0001700; induction of apoptosis; GO:0006917; induction of apoptosis by ionic changes; GO:0008627; negative regulation of protein biosynthesis; GO:0017148; programmed cell death; GO:0012501; protein ubiquitination; GO:0016567; regulation of proteolysis; GO:0030162 cytoplasm; GO:0005737; mitochondrion; GO:0005739 grim grim "CG4345, Grim, BcDNA:RE28551, grim" CDMC34349 3 5 19 DAC30-K02 3-CG4887-RA_2 CG4887 CCCGACTGTGGGTCCAATGAACAAGCTTGTCAATGCCTATGGCGGAACATCGGACTCTGAAGAGGAC 67 FBan0004887 FBgn0031318 CG4887 2 2L apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634 CG4887 CG4887 cg4887 CDMC34349 3 6 19 DAC30-K02 3-CG4887-RA_2 CG4887 CCCGACTGTGGGTCCAATGAACAAGCTTGTCAATGCCTATGGCGGAACATCGGACTCTGAAGAGGAC 67 FBan0004887 FBgn0031318 CG4887 2 2L apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634 CG4887 CG4887 cg4887 CDMC34350 3 7 19 DAC30-K14 12-CG5080-RA_1 CG5080 CGCGTGGAGGAGACCAAGAAACACATGATCGACATGGACGAGAACCTCAACTATCTGCTGGGCAAGC 67 FBan0005080 FBgn0031313 CG5080 2 2L CG5080 CG5080 CT16297 CDMC34350 3 8 19 DAC30-K14 12-CG5080-RA_1 CG5080 CGCGTGGAGGAGACCAAGAAACACATGATCGACATGGACGAGAACCTCAACTATCTGCTGGGCAAGC 67 FBan0005080 FBgn0031313 CG5080 2 2L CG5080 CG5080 CT16297 CDMC34351 3 9 19 DAC30-O02 2-CG5409-RA_1 CG5409 GGCCTCACTCACGAGCTTCCAAAACATGTGGATCGACAGCTTGGAGTACGAAGAAGTTGGTTCCGCC 67 FBan0005409 FBgn0011743 Arp53D 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp53D Actin-related protein 53D "CG5409, CG5409, CG5409, arp5, ARP53D, arp53D, Actr53D, Actin-related protein 53D" CDMC34351 3 10 19 DAC30-O02 2-CG5409-RA_1 CG5409 GGCCTCACTCACGAGCTTCCAAAACATGTGGATCGACAGCTTGGAGTACGAAGAAGTTGGTTCCGCC 67 FBan0005409 FBgn0011743 Arp53D 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 actin cytoskeleton; GO:0015629; actin filament; GO:0005884 Arp53D Actin-related protein 53D "CG5409, CG5409, CG5409, arp5, ARP53D, arp53D, Actr53D, Actin-related protein 53D" CDMC34352 3 11 19 DAC30-O14 3-CG5640-RA_5 CG5640 AGCTACAAAAACTGCCAGCTTTTGCGCGAGTTATATCCGCTGCCAATATGCTATCACACGTGGGCCA 67 FBan0005640 FBgn0032207 CG5640 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; ; GO:0016564 CG5640 CG5640 CDMC34352 3 12 19 DAC30-O14 3-CG5640-RA_5 CG5640 AGCTACAAAAACTGCCAGCTTTTGCGCGAGTTATATCCGCTGCCAATATGCTATCACACGTGGGCCA 67 FBan0005640 FBgn0032207 CG5640 2 2L regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; ; GO:0016564 CG5640 CG5640 CDMC34353 3 13 19 DAC31-C02 1-CG7487-RA_1 CG7487 CGGCGGAGAACATATCTACTTTGCTCTGCTACATGGAGCTTGATCCCCGATGGTGCATCAGTGTGCTCA 69 FBan0007487 FBgn0040290 RecQ4 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003 RecQ4 RecQ4 "CG7487, DmRECQ4, cg7487" CDMC34353 3 14 19 DAC31-C02 1-CG7487-RA_1 CG7487 CGGCGGAGAACATATCTACTTTGCTCTGCTACATGGAGCTTGATCCCCGATGGTGCATCAGTGTGCTCA 69 FBan0007487 FBgn0040290 RecQ4 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0004003 RecQ4 RecQ4 "CG7487, DmRECQ4, cg7487" CDMC34354 3 15 19 DAC31-C14 9-CG7502-RA_1 CG7502 CCAACCCATTTGGCAGTTCAAGACAATCGAACCCGTAGATCAGGAGATAATCGAAGCCCTTCCCGTCGA 69 FBan0007502 FBgn0030987 CG7502 X X CG7502 CG7502 CDMC34354 3 16 19 DAC31-C14 9-CG7502-RA_1 CG7502 CCAACCCATTTGGCAGTTCAAGACAATCGAACCCGTAGATCAGGAGATAATCGAAGCCCTTCCCGTCGA 69 FBan0007502 FBgn0030987 CG7502 X X CG7502 CG7502 CDMC34355 3 17 19 DAC31-G02 10-CG7536-RA_1 CG7536 GGGCGCTGTCTTTCTACCTCACCGAGATGAAAATCGTTAGCTCAGACATAATGACCTCCGTCACAGGCA 69 FBan0007536 FBgn0030890 CG7536 X X G-protein coupled receptor protein signaling pathway; GO:0007186; RNA processing; GO:0006396; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 mRNA binding; GO:0003729; receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0003729; ; GO:0004872; ; GO:0004930; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- integral to membrane; GO:0016021 CG7536 CG7536 CDMC34355 3 18 19 DAC31-G02 10-CG7536-RA_1 CG7536 GGGCGCTGTCTTTCTACCTCACCGAGATGAAAATCGTTAGCTCAGACATAATGACCTCCGTCACAGGCA 69 FBan0007536 FBgn0030890 CG7536 X X G-protein coupled receptor protein signaling pathway; GO:0007186; RNA processing; GO:0006396; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 mRNA binding; GO:0003729; receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0003729; ; GO:0004872; ; GO:0004930; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- integral to membrane; GO:0016021 CG7536 CG7536 CDMC34356 3 19 19 DAC31-G14 12-CG7550-RA_2 CG7550 TCGCAGTCGTTTCTTGCCTGTTTTGCTTTTTACTGTATCCGACCGGAGTTCAGTACACCTGGCCGAAAA 69 FBan0007550 FBgn0035839 CG7550 3 3L CG7550 CG7550 CDMC34356 3 20 19 DAC31-G14 12-CG7550-RA_2 CG7550 TCGCAGTCGTTTCTTGCCTGTTTTGCTTTTTACTGTATCCGACCGGAGTTCAGTACACCTGGCCGAAAA 69 FBan0007550 FBgn0035839 CG7550 3 3L CG7550 CG7550 CDMC34357 3 21 19 DAC31-K02 23-CG7580-RA_2 CG7580 GCGAACGACGAATAAGCGTCCCAACTAGCAGATAGTTATGTTAAACTAATTAATAAAACTAAACCCACA 69 FBan0007580 FBgn0036728 CG7580 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ubiquinone binding; GO:0048039; ; GO:0008121 ; EC:1.10.2.2; ; GO:0048039; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG7580 CG7580 "ubiquinone binding protein, BcDNA:AT13736" CDMC34357 3 22 19 DAC31-K02 23-CG7580-RA_2 CG7580 GCGAACGACGAATAAGCGTCCCAACTAGCAGATAGTTATGTTAAACTAATTAATAAAACTAAACCCACA 69 FBan0007580 FBgn0036728 CG7580 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ubiquinone binding; GO:0048039; ; GO:0008121 ; EC:1.10.2.2; ; GO:0048039; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG7580 CG7580 "ubiquinone binding protein, BcDNA:AT13736" CDMC34358 3 23 19 DAC31-K14 18-CG7590-RA_1 CG7590 GATGAGGGCCTCGAACTGTGAAAGAGGTAGATGATCACACGCTCCAATTTTAGTTAGACGCAGCTTGCT 69 FBan0007590 FBgn0041094 scyl 3 3L negative regulation of growth; GO:0045926 scyl scylla "CG7590, CG7590, CG7590, scy, anon-WO0118547.215, scylla" CDMC34358 3 24 19 DAC31-K14 18-CG7590-RA_1 CG7590 GATGAGGGCCTCGAACTGTGAAAGAGGTAGATGATCACACGCTCCAATTTTAGTTAGACGCAGCTTGCT 69 FBan0007590 FBgn0041094 scyl 3 3L negative regulation of growth; GO:0045926 scyl scylla "CG7590, CG7590, CG7590, scy, anon-WO0118547.215, scylla" CDMC34359 3 25 19 DAC31-O02 8-CG7623-RA_1 CG7623 AGTCGCAGAACTCGGACTACGCATGGTTCCTTAAGCTGCTGGTCAATTGCTTTGGTTATAGCTGCGTCT 69 FBan0007623 FBgn0038524 sll 3 3R 3'-phosphoadenosine 5'-phosphosulfate transport; GO:0046963; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123 3'-phosphoadenosine 5'-phosphosulfate transporter activity; GO:0046964; ; GO:0046964; ; GO:0046964; UDP-galactose transporter activity; GO:0005459; ; GO:0005459 Golgi apparatus; GO:0005794 sll slalom "CG7623, CG7623, 1422/14, anon-WO0118547.555, anon-WO0172774.85, l(3)S142214, slalom" CDMC34359 3 26 19 DAC31-O02 8-CG7623-RA_1 CG7623 AGTCGCAGAACTCGGACTACGCATGGTTCCTTAAGCTGCTGGTCAATTGCTTTGGTTATAGCTGCGTCT 69 FBan0007623 FBgn0038524 sll 3 3R 3'-phosphoadenosine 5'-phosphosulfate transport; GO:0046963; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123 3'-phosphoadenosine 5'-phosphosulfate transporter activity; GO:0046964; ; GO:0046964; ; GO:0046964; UDP-galactose transporter activity; GO:0005459; ; GO:0005459 Golgi apparatus; GO:0005794 sll slalom "CG7623, CG7623, 1422/14, anon-WO0118547.555, anon-WO0172774.85, l(3)S142214, slalom" CDMC34360 3 1 20 DAC31-O14 2-CG7634-RA_1 CG7634 GGCGCTTGCCTACGTAGATCAGTACACGCTTCCGAAGAACTTTCGCTTTTCGGAGAAGAACGCACTGCT 69 FBan0007634 FBgn0037101 CG7634 3 3L CG7634 CG7634 CDMC34360 3 2 20 DAC31-O14 2-CG7634-RA_1 CG7634 GGCGCTTGCCTACGTAGATCAGTACACGCTTCCGAAGAACTTTCGCTTTTCGGAGAAGAACGCACTGCT 69 FBan0007634 FBgn0037101 CG7634 3 3L CG7634 CG7634 CDMC34361 3 3 20 DAC32-C02 2-CG14909-RA_1 CG14909 AGCACGTGGCATTCATGGTCATCACCGTTTTCTGGCTACTATTCGCCATCATTGGGTTCCTGGTGTCC 68 FBan0014909 FBgn0038458 CG14909 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 "transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; hydrogen ion transporter activity; GO:0015078; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0015078; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 CG14909 CG14909 CDMC34361 3 4 20 DAC32-C02 2-CG14909-RA_1 CG14909 AGCACGTGGCATTCATGGTCATCACCGTTTTCTGGCTACTATTCGCCATCATTGGGTTCCTGGTGTCC 68 FBan0014909 FBgn0038458 CG14909 3 3R ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 "transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; cation transporter activity; GO:0008324; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; hydrogen ion transporter activity; GO:0015078; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0008324; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0015078; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 CG14909 CG14909 CDMC34362 3 5 20 DAC32-C14 2-CG15042-RA_2 CG15042 TGGCCTTGAACTGTTGGTGGCCCTGATCAGGAATAGGACCAACATTCGGAAGATTCCATCCGCACAAC 68 FBan0015042 FBgn0030937 CG15042 X X CG15042 CG15042 CDMC34362 3 6 20 DAC32-C14 2-CG15042-RA_2 CG15042 TGGCCTTGAACTGTTGGTGGCCCTGATCAGGAATAGGACCAACATTCGGAAGATTCCATCCGCACAAC 68 FBan0015042 FBgn0030937 CG15042 X X CG15042 CG15042 CDMC34363 3 7 20 DAC32-G02 3-CG15396-RA_2 CG15396 GCTATGGATGGGGAATGCTGGGACTCCATTTGCTGACCAGCTTTCAGTTCGTGACCAATGCCTACTGG 68 FBan0015396 FBgn0041248 Gr23a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr23a Gustatory receptor 23a "CG15396, 23A.1a, 23A1.b, GR23A.1, Gustatory receptor 23A.1, 23A1a, 23A1b, Gr23a.a, Gr23a.b, Gr23A1a, Gr23A1b, Gustatory receptor 23a" CDMC34363 3 8 20 DAC32-G02 3-CG15396-RA_2 CG15396 GCTATGGATGGGGAATGCTGGGACTCCATTTGCTGACCAGCTTTCAGTTCGTGACCAATGCCTACTGG 68 FBan0015396 FBgn0041248 Gr23a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr23a Gustatory receptor 23a "CG15396, 23A.1a, 23A1.b, GR23A.1, Gustatory receptor 23A.1, 23A1a, 23A1b, Gr23a.a, Gr23a.b, Gr23A1a, Gr23A1b, Gustatory receptor 23a" CDMC34364 3 9 20 DAC32-G14 1-CG15547-RA_1 CG15547 AATGCTGCTCTCATCGTCTTCCTGTGTCACCTGTGGAGGCTTCGAAAGATCTCAGCCCGGTATTTCGG 68 FBan0015547 FBgn0039809 CG15547 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228 ATP binding; GO:0005524; ; GO:0005524; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 CG15547 CG15547 CDMC34364 3 10 20 DAC32-G14 1-CG15547-RA_1 CG15547 AATGCTGCTCTCATCGTCTTCCTGTGTCACCTGTGGAGGCTTCGAAAGATCTCAGCCCGGTATTTCGG 68 FBan0015547 FBgn0039809 CG15547 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228 ATP binding; GO:0005524; ; GO:0005524; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 CG15547 CG15547 CDMC34365 3 11 20 DAC32-K02 2-CG16717-RA_3 CG16717 CCCATCCTTTCCAGAAGAGCAAAAGTCATGCTTCGAGCAGCAAACACACCGGCATGTCCATCCTCGAT 68 FBan0016717 FBgn0036028 CG16717 3 3L CG16717 CG16717 CDMC34365 3 12 20 DAC32-K02 2-CG16717-RA_3 CG16717 CCCATCCTTTCCAGAAGAGCAAAAGTCATGCTTCGAGCAGCAAACACACCGGCATGTCCATCCTCGAT 68 FBan0016717 FBgn0036028 CG16717 3 3L CG16717 CG16717 CDMC34366 3 13 20 DAC32-K14 23-CG16901-RD_2 CG16901 GCATCATACGCAGCTAAAAAACATCATTTATACAATACAAGGCAAACCACAAAGCAAAACAAGAAAAA 68 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC34366 3 14 20 DAC32-K14 23-CG16901-RD_2 CG16901 GCATCATACGCAGCTAAAAAACATCATTTATACAATACAAGGCAAACCACAAAGCAAAACAAGAAAAA 68 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC34367 3 15 20 DAC32-O02 10-CG17248-RB_1 CG17248 ACGAGTGACTCCAACCACTACCCTGTACTACCACCCTATACGGAACTAGCATCTCTACGCTGCACTGG 68 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC34367 3 16 20 DAC32-O02 10-CG17248-RB_1 CG17248 ACGAGTGACTCCAACCACTACCCTGTACTACCACCCTATACGGAACTAGCATCTCTACGCTGCACTGG 68 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC34368 3 17 20 DAC32-O14 3-CG1737-RA_5 CG1737 CATCGACGATGCCAACAGTCCCAAATATTTTCCGCCCGAGACCACAACGTTTCACGAGGAGGATGGTC 68 FBan0001737 FBgn0030293 CG1737 X X CG1737 CG1737 CDMC34368 3 18 20 DAC32-O14 3-CG1737-RA_5 CG1737 CATCGACGATGCCAACAGTCCCAAATATTTTCCGCCCGAGACCACAACGTTTCACGAGGAGGATGGTC 68 FBan0001737 FBgn0030293 CG1737 X X CG1737 CG1737 CDMC34369 3 19 20 DAC33-C02 2-CG31605-RG_1 CG31605 CCGCGTTGTTGTACGAGTGCCTTCAAATACAGCCGTTGTGGAGGGTGAAAAGATGTCGGTGACCTG 66 FBgn0051605 CDMC34369 3 20 20 DAC33-C02 2-CG31605-RG_1 CG31605 CCGCGTTGTTGTACGAGTGCCTTCAAATACAGCCGTTGTGGAGGGTGAAAAGATGTCGGTGACCTG 66 FBgn0051605 CDMC34370 3 21 20 DAC33-C14 3-CG31746-RA_3 CG31746 ACTCTGGAGCAGATCGATGTAATAAAGCGCCTGACGGATCGGTATTCGCCGCAGCTTACCACTTGC 66 FBan0031746 FBgn0051746 CG31746 2 2L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0008239 CG31746 CG31746 "CG7167, CG7198" CDMC34370 3 22 20 DAC33-C14 3-CG31746-RA_3 CG31746 ACTCTGGAGCAGATCGATGTAATAAAGCGCCTGACGGATCGGTATTCGCCGCAGCTTACCACTTGC 66 FBan0031746 FBgn0051746 CG31746 2 2L proteolysis; GO:0006508 dipeptidyl-peptidase activity; GO:0008239; membrane dipeptidase activity; GO:0004237 ; EC:3.4.13.19; ; GO:0004237 ; EC:3.4.13.19; ; GO:0008239 CG31746 CG31746 "CG7167, CG7198" CDMC34371 3 23 20 DAC33-G02 3-CG3224-RA_2 CG3224 GGTATCGAAACGCAAGAAGATGCACTATGGCGATACCCATCTGCAGAGGAGATGGCGTGTGCGGAA 66 FBan0003224 FBgn0029885 CG3224 X X CG3224 CG3224 CDMC34371 3 24 20 DAC33-G02 3-CG3224-RA_2 CG3224 GGTATCGAAACGCAAGAAGATGCACTATGGCGATACCCATCTGCAGAGGAGATGGCGTGTGCGGAA 66 FBan0003224 FBgn0029885 CG3224 X X CG3224 CG3224 CDMC34372 3 25 20 DAC33-G14 6-CG32464-RA_2 CG32464 GGATACTCCTGGTCCCTGATCTTCAGCACCTCACAACATGGTTTCGCACTGAACTCCCTGTACCGC 66 FBan0032464 FBgn0013576 l(3)82Fd 3 3R cell wall catabolism; GO:0016998 l(3)82Fd l(3)82Fd "CG10199, CG32464, CG10196, CG10199, L82, late puff gene at 82F, anon-EST:Posey263" CDMC34372 3 26 20 DAC33-G14 6-CG32464-RA_2 CG32464 GGATACTCCTGGTCCCTGATCTTCAGCACCTCACAACATGGTTTCGCACTGAACTCCCTGTACCGC 66 FBan0032464 FBgn0013576 l(3)82Fd 3 3R cell wall catabolism; GO:0016998 l(3)82Fd l(3)82Fd "CG10199, CG32464, CG10196, CG10199, L82, late puff gene at 82F, anon-EST:Posey263" CDMC34373 3 1 21 DAC33-K02 9-CG32801-RA_1 CG32801 ACCTTTGTTCCAGTGAGCCAAGTTCATCCGCTAACACGGAAGTTCTACGCCCAGTATGAGCAACGC 66 FBan0032801 FBgn0052801 CG32801 X X CG32801 CG32801 "CG14819, CG14819" CDMC34373 3 2 21 DAC33-K02 9-CG32801-RA_1 CG32801 ACCTTTGTTCCAGTGAGCCAAGTTCATCCGCTAACACGGAAGTTCTACGCCCAGTATGAGCAACGC 66 FBan0032801 FBgn0052801 CG32801 X X CG32801 CG32801 "CG14819, CG14819" CDMC34374 3 3 21 DAC33-K14 3-CG3303-RA_1 CG3303 CCTGGGCTTGCATAACTGGCTGTACTTTGCAGATCAGGAGCAACGTGGCAATGTGGACTACAAGGG 66 FBan0003303 FBgn0038381 CG3303 3 3R serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG3303 CG3303 CDMC34374 3 4 21 DAC33-K14 3-CG3303-RA_1 CG3303 CCTGGGCTTGCATAACTGGCTGTACTTTGCAGATCAGGAGCAACGTGGCAATGTGGACTACAAGGG 66 FBan0003303 FBgn0038381 CG3303 3 3R serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- CG3303 CG3303 CDMC34375 3 5 21 DAC33-O02 3-CG3440-RA_3 CG3440 GCTCCCTGGAGTACATTAGGACGCATCCCTACCAGATCAAGGACTACTACACCGGGGAGCTGAAGA 66 FBan0003440 FBgn0003046 Pcp 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011; ; GO:0008011 Pcp Pupal cuticle protein "CG3440, Gart, Pcpgart: Gart intronic gene, Gart intron gene, DMCPGART, Gart intronic gene, Pcpgart" CDMC34375 3 6 21 DAC33-O02 3-CG3440-RA_3 CG3440 GCTCCCTGGAGTACATTAGGACGCATCCCTACCAGATCAAGGACTACTACACCGGGGAGCTGAAGA 66 FBan0003440 FBgn0003046 Pcp 2 2L structural constituent of pupal cuticle (sensu Insecta); GO:0008011; ; GO:0008011; ; GO:0008011; ; GO:0008011 Pcp Pupal cuticle protein "CG3440, Gart, Pcpgart: Gart intronic gene, Gart intron gene, DMCPGART, Gart intronic gene, Pcpgart" CDMC34376 3 7 21 DAC33-O14 AutoBlank AutoBlank CDMC34376 3 8 21 DAC33-O14 AutoBlank AutoBlank CDMC34377 3 9 21 DAC34-C02 2-CG13454-RA_1 CG13454 CGAGAAGAGGGATCCTGGAAACGAGGATTTCTCCGAAACACCTAAACGTTGCGTACGATTGCGCCAGCA 69 FBan0013454 FBgn0036503 CG13454 3 3L CG13454 CG13454 CDMC34377 3 10 21 DAC34-C02 2-CG13454-RA_1 CG13454 CGAGAAGAGGGATCCTGGAAACGAGGATTTCTCCGAAACACCTAAACGTTGCGTACGATTGCGCCAGCA 69 FBan0013454 FBgn0036503 CG13454 3 3L CG13454 CG13454 CDMC34378 3 11 21 DAC34-C14 18-CG13467-RA_3 CG13467 GGTGCTCGATATGTGTTCTCCATGGACGGAGATCGAAAATATCATCTCGATGAACTGGAGGATGGAGCC 69 FBan0013467 FBgn0036455 CG13467 3 3L CG13467 CG13467 CDMC34378 3 12 21 DAC34-C14 18-CG13467-RA_3 CG13467 GGTGCTCGATATGTGTTCTCCATGGACGGAGATCGAAAATATCATCTCGATGAACTGGAGGATGGAGCC 69 FBan0013467 FBgn0036455 CG13467 3 3L CG13467 CG13467 CDMC34379 3 13 21 DAC34-G02 17-CG13506-RA_1 CG13506 TCACCATTCGCCATTGAAACGAAACATTAGTGCCAAGCAAGAAAGTAACTGGAAGATCGGCGAGGACTA 69 FBan0013506 FBgn0034723 CG13506 2 2R CG13506 CG13506 CT32874 CDMC34379 3 14 21 DAC34-G02 17-CG13506-RA_1 CG13506 TCACCATTCGCCATTGAAACGAAACATTAGTGCCAAGCAAGAAAGTAACTGGAAGATCGGCGAGGACTA 69 FBan0013506 FBgn0034723 CG13506 2 2R CG13506 CG13506 CT32874 CDMC34380 3 15 21 DAC34-G14 5-CG13532-RA_1 CG13532 AGCCGAAAACAGACAGCACCGCGATAAGTAGAAACGTCCAACCACCACAGAAGTATTCATTGCCACGCA 69 FBan0013532 FBgn0034788 CG13532 2 2R CG13532 CG13532 CT32907 CDMC34380 3 16 21 DAC34-G14 5-CG13532-RA_1 CG13532 AGCCGAAAACAGACAGCACCGCGATAAGTAGAAACGTCCAACCACCACAGAAGTATTCATTGCCACGCA 69 FBan0013532 FBgn0034788 CG13532 2 2R CG13532 CG13532 CT32907 CDMC34381 3 17 21 DAC34-K02 18-CG13580-RA_1 CG13580 GGGATCCGGATCCCTACAGCCAGATTCAAAGAAAAAAGCCAAGTAACCAGGAATCATCGCATCCACTTT 69 FBan0013580 FBgn0029501 Crtp 2 2R Crtp Caldesmon-related protein "CG13580, Caldesmon-related protein" CDMC34381 3 18 21 DAC34-K02 18-CG13580-RA_1 CG13580 GGGATCCGGATCCCTACAGCCAGATTCAAAGAAAAAAGCCAAGTAACCAGGAATCATCGCATCCACTTT 69 FBan0013580 FBgn0029501 Crtp 2 2R Crtp Caldesmon-related protein "CG13580, Caldesmon-related protein" CDMC34382 3 19 21 DAC34-K14 18-CG13591-RA_3 CG13591 CCCTCCTGGCTAAGGAATGTCCCGAATTTTTAACTCCACACGAACAAAGCACACAAATGTTGGTTTGGT 69 FBan0013591 FBgn0015300 Ssl 2 2R protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 activity; GO:0004682; protein kinase CK2 regulator activity; GO:0008605; ; GO:0004682; ; GO:0004682; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682 protein kinase CK2 complex; GO:0005956 Ssl Suppressor of Stellate-like "CG13591, CG13591, SSL, Su(Ste)-like, betaCK2tes, CKIIb1, CK2betates, Su(Ste)l, NEST:bs30a09" CDMC34382 3 20 21 DAC34-K14 18-CG13591-RA_3 CG13591 CCCTCCTGGCTAAGGAATGTCCCGAATTTTTAACTCCACACGAACAAAGCACACAAATGTTGGTTTGGT 69 FBan0013591 FBgn0015300 Ssl 2 2R protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 activity; GO:0004682; protein kinase CK2 regulator activity; GO:0008605; ; GO:0004682; ; GO:0004682; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008605; ; GO:0004682 protein kinase CK2 complex; GO:0005956 Ssl Suppressor of Stellate-like "CG13591, CG13591, SSL, Su(Ste)-like, betaCK2tes, CKIIb1, CK2betates, Su(Ste)l, NEST:bs30a09" CDMC34383 3 21 21 DAC34-O02 23-CG13620-RA_5 CG13620 CCATATTGCACTAAAAACAAAAGAACACCTAGCGACTAAGCCAAGGATACACTCCCTCAGACACAAATC 69 FBan0013620 FBgn0039211 CG13620 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13620 CG13620 CDMC34383 3 22 21 DAC34-O02 23-CG13620-RA_5 CG13620 CCATATTGCACTAAAAACAAAAGAACACCTAGCGACTAAGCCAAGGATACACTCCCTCAGACACAAATC 69 FBan0013620 FBgn0039211 CG13620 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13620 CG13620 CDMC34384 3 23 21 DAC34-O14 17-CG13631-RA_1 CG13631 TCGCGCCACTTCAAGGACCTAAAGAATTCAAGTTCGCGTAGTTCCCAAGATTCCAATGGGTAATCCAAA 69 FBan0013631 FBgn0040600 CG13631 3 3R CG13631 CG13631 BcDNA:GH19356 CDMC34384 3 24 21 DAC34-O14 17-CG13631-RA_1 CG13631 TCGCGCCACTTCAAGGACCTAAAGAATTCAAGTTCGCGTAGTTCCCAAGATTCCAATGGGTAATCCAAA 69 FBan0013631 FBgn0040600 CG13631 3 3R CG13631 CG13631 BcDNA:GH19356 CDMC34385 3 25 21 DAC35-C02 18-CG17856-RA_1 CG17856 GTCTGCCCCGCAAACTGTACGATGAACGCAACTATCGCATTCTTCGAGCACTGCACCTTTCCATGA 66 FBan0017856 FBgn0039576 CG17856 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG17856 CG17856 CDMC34385 3 26 21 DAC35-C02 18-CG17856-RA_1 CG17856 GTCTGCCCCGCAAACTGTACGATGAACGCAACTATCGCATTCTTCGAGCACTGCACCTTTCCATGA 66 FBan0017856 FBgn0039576 CG17856 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG17856 CG17856 CDMC34386 3 1 22 DAC35-C14 3-CG18124-RA_1 CG18124 TTGGGAGAGTTCTCCTCCGTGGTGGAATACTTAGCGCATCGTCTTGGTTTCAGCACCAGTGAAGCC 66 FBan0018124 FBgn0028530 mTTF 2 2L RNA transcription termination from mitochondrial promoter; GO:0006393 DNA binding; GO:0003677; ; GO:0003677; transcription termination factor activity; GO:0003715; ; GO:0003715 mitochondrion; GO:0005739 mTTF mitochondrial transcription termination factor "CG18124, CG18124, BG:DS01068.4, DS01068.4, DmTTF, mitochondrial transcription termination factor" CDMC34386 3 2 22 DAC35-C14 3-CG18124-RA_1 CG18124 TTGGGAGAGTTCTCCTCCGTGGTGGAATACTTAGCGCATCGTCTTGGTTTCAGCACCAGTGAAGCC 66 FBan0018124 FBgn0028530 mTTF 2 2L RNA transcription termination from mitochondrial promoter; GO:0006393 DNA binding; GO:0003677; ; GO:0003677; transcription termination factor activity; GO:0003715; ; GO:0003715 mitochondrion; GO:0005739 mTTF mitochondrial transcription termination factor "CG18124, CG18124, BG:DS01068.4, DS01068.4, DmTTF, mitochondrial transcription termination factor" CDMC34387 3 3 22 DAC35-G02 3-CG2139-RD_3 CG2139 GAGAGTCCTGCGGACCGATCTGCCTTTATTCAGGTCCTGGAGAGCTCTTACCGTTTCACTCTCGGT 66 FBan0002139 FBgn0028646 aralar1 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839; transport; GO:0006810 calcium ion binding; GO:0005509; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005386; ; GO:0005509; ; GO:0005509; ; GO:0005509; ; GO:0005386; ; GO:0005386 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 aralar1 aralar1 "CG2139, CG2139, DmAralar, BcDNA:GH07418" CDMC34387 3 4 22 DAC35-G02 3-CG2139-RD_3 CG2139 GAGAGTCCTGCGGACCGATCTGCCTTTATTCAGGTCCTGGAGAGCTCTTACCGTTTCACTCTCGGT 66 FBan0002139 FBgn0028646 aralar1 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869; mitochondrial transport; GO:0006839; transport; GO:0006810 calcium ion binding; GO:0005509; carrier activity; GO:0005386; ; GO:0005386; ; GO:0005386; ; GO:0005509; ; GO:0005509; ; GO:0005509; ; GO:0005386; ; GO:0005386 integral to membrane; GO:0016021; mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 aralar1 aralar1 "CG2139, CG2139, DmAralar, BcDNA:GH07418" CDMC34388 3 5 22 DAC35-G14 3-CG2698-RA_4 CG2698 CAGAGCAATACGCAGACGATCCTCGAGGTTGCAGAGTCGTTGTGGCACATCATCCGGACCAACATG 66 FBan0002698 FBgn0037536 CG2698 3 3R CG2698 CG2698 CDMC34388 3 6 22 DAC35-G14 3-CG2698-RA_4 CG2698 CAGAGCAATACGCAGACGATCCTCGAGGTTGCAGAGTCGTTGTGGCACATCATCCGGACCAACATG 66 FBan0002698 FBgn0037536 CG2698 3 3R CG2698 CG2698 CDMC34389 3 7 22 DAC35-K02 1-CG30178-RA_1 CG30178 GCGAGCTTCTTTGAAGTCAACGGATACCTGTTCTGCAAGGCGCACTTCCGGGAACTGTTTTCGTCC 66 FBan0030178 FBgn0050178 CG30178 2 2R zinc ion binding; GO:0008270; ; GO:0008270 CG30178 CG30178 "CG17263, CG17263, CG17263, CG17263" CDMC34389 3 8 22 DAC35-K02 1-CG30178-RA_1 CG30178 GCGAGCTTCTTTGAAGTCAACGGATACCTGTTCTGCAAGGCGCACTTCCGGGAACTGTTTTCGTCC 66 FBan0030178 FBgn0050178 CG30178 2 2R zinc ion binding; GO:0008270; ; GO:0008270 CG30178 CG30178 "CG17263, CG17263, CG17263, CG17263" CDMC34390 3 9 22 DAC35-K14 2-CG30371-RA_1 CG30371 TCCAGGCAGTTCTTGGTCGGAATCATCAGCTACGGAAAGAGCTGTGCTGAATCGCAGTACCCGATG 66 FBan0030371 FBgn0050371 CG30371 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30371 CG30371 "CG2280, SP80" CDMC34390 3 10 22 DAC35-K14 2-CG30371-RA_1 CG30371 TCCAGGCAGTTCTTGGTCGGAATCATCAGCTACGGAAAGAGCTGTGCTGAATCGCAGTACCCGATG 66 FBan0030371 FBgn0050371 CG30371 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30371 CG30371 "CG2280, SP80" CDMC34391 3 11 22 DAC35-O02 10-CG31195-RA_1 CG31195 CGAGGCCGAGTACCAAAATATTGTGGCTGATGTCGAGACCCGCTACGATATGTTCAAGTGCCGACT 66 FBan0031195 FBgn0051195 CG31195 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31195 CG31195 l(3)03806 CDMC34391 3 12 22 DAC35-O02 10-CG31195-RA_1 CG31195 CGAGGCCGAGTACCAAAATATTGTGGCTGATGTCGAGACCCGCTACGATATGTTCAAGTGCCGACT 66 FBan0031195 FBgn0051195 CG31195 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31195 CG31195 l(3)03806 CDMC34392 3 13 22 DAC35-O14 AutoBlank AutoBlank CDMC34392 3 14 22 DAC35-O14 AutoBlank AutoBlank CDMC34393 3 15 22 DAC36-C02 2-CG17914-RA_1 CG17914 GCGTGTGCAGCATCACTTCTTCCACCCAGATCCAATGGCCGGTAACTTCAGCATCAATGGCATTGAG 67 FBan0017914 FBgn0032601 yellow-b 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-b yellow-b "CG17914, yellow-b" CDMC34393 3 16 22 DAC36-C02 2-CG17914-RA_1 CG17914 GCGTGTGCAGCATCACTTCTTCCACCCAGATCCAATGGCCGGTAACTTCAGCATCAATGGCATTGAG 67 FBan0017914 FBgn0032601 yellow-b 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 yellow-b yellow-b "CG17914, yellow-b" CDMC34394 3 17 22 DAC36-C14 2-CG18109-RA_1 CG18109 ATCCAGGTGTTGGTCAAAGCTAATACTTCGTTGGAAGATGCCGACCCATTGGAGAGCGCTACTCGGC 67 FBan0018109 FBgn0028901 CG18109 2 2L CG18109 CG18109 "BG:DS02252.3, DS02252.3" CDMC34394 3 18 22 DAC36-C14 2-CG18109-RA_1 CG18109 ATCCAGGTGTTGGTCAAAGCTAATACTTCGTTGGAAGATGCCGACCCATTGGAGAGCGCTACTCGGC 67 FBan0018109 FBgn0028901 CG18109 2 2L CG18109 CG18109 "BG:DS02252.3, DS02252.3" CDMC34395 3 19 22 DAC36-G02 2-CG1939-RA_1 CG1939 TATCGCCACGGGAAAAAGTACCATCAGCAAAGTGTTCGAACGCCAGGGTATTCCAGTCATCGACGCC 67 FBan0001939 FBgn0037469 CG1939 3 3R ATP binding; GO:0005524; ; GO:0005524 CG1939 CG1939 CDMC34395 3 20 22 DAC36-G02 2-CG1939-RA_1 CG1939 TATCGCCACGGGAAAAAGTACCATCAGCAAAGTGTTCGAACGCCAGGGTATTCCAGTCATCGACGCC 67 FBan0001939 FBgn0037469 CG1939 3 3R ATP binding; GO:0005524; ; GO:0005524 CG1939 CG1939 CDMC34396 3 21 22 DAC36-G14 12-CG2063-RA_1 CG2063 AGCTTTTGCGACATCAACGAGTTCGGTACCAACTATCCGCCCGAGATCTATGATCCTTTGCAGTGGG 67 FBan0002063 FBgn0033400 CG2063 2 2R CG2063 CG2063 CDMC34396 3 22 22 DAC36-G14 12-CG2063-RA_1 CG2063 AGCTTTTGCGACATCAACGAGTTCGGTACCAACTATCCGCCCGAGATCTATGATCCTTTGCAGTGGG 67 FBan0002063 FBgn0033400 CG2063 2 2R CG2063 CG2063 CDMC34397 3 23 22 DAC36-K02 8-CG2956-RA_1 CG2956 TGCCCTCGGAGTACGCCGCCTATGGTATTACCGAACTGGAGGACACAGACTACAACATACCCAGCAA 67 FBan0002956 FBgn0003900 twi 2 2R Malpighian tubule morphogenesis; GO:0007443; anterior midgut invagination; GO:0007375; cell proliferation; GO:0008283; dorsal/ventral axis specification; GO:0009950; ectoderm and mesoderm interaction; GO:0007499; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; heart development; GO:0007507; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell fate specification; GO:0007501; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral furrow formation; GO:0007370 DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0003704 nucleus; GO:0005634 twi twist "CG2956, CG2956, EC9, dip5, DTwist" CDMC34397 3 24 22 DAC36-K02 8-CG2956-RA_1 CG2956 TGCCCTCGGAGTACGCCGCCTATGGTATTACCGAACTGGAGGACACAGACTACAACATACCCAGCAA 67 FBan0002956 FBgn0003900 twi 2 2R Malpighian tubule morphogenesis; GO:0007443; anterior midgut invagination; GO:0007375; cell proliferation; GO:0008283; dorsal/ventral axis specification; GO:0009950; ectoderm and mesoderm interaction; GO:0007499; gastrulation (sensu Insecta); GO:0010004; gastrulation; GO:0007369; heart development; GO:0007507; mesoderm development; GO:0007498; mesodermal cell fate commitment; GO:0001710; mesodermal cell fate determination; GO:0007500; mesodermal cell fate specification; GO:0007501; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral furrow formation; GO:0007370 DNA binding; GO:0003677; ; GO:0003677; transcriptional activator activity; GO:0016563; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016563; ; GO:0003704 nucleus; GO:0005634 twi twist "CG2956, CG2956, EC9, dip5, DTwist" CDMC34398 3 25 22 DAC36-K14 23-CG30062-RA_2 CG30062 GGTCAAAGATTGTTAGAGATAGTCTGCCCATTAGGTCATCACTGCCGAAATATGAGAATTTATGTAT 67 FBan0030062 FBgn0050062 CG30062 2 2R cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG30062 CG30062 CDMC34398 3 26 22 DAC36-K14 23-CG30062-RA_2 CG30062 GGTCAAAGATTGTTAGAGATAGTCTGCCCATTAGGTCATCACTGCCGAAATATGAGAATTTATGTAT 67 FBan0030062 FBgn0050062 CG30062 2 2R cell wall catabolism; GO:0016998 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG30062 CG30062 CDMC34399 3 1 23 DAC36-O02 21-CG30417-RA_1 CG30417 TGATTTTCTACAACACCTATCTGTACACGAATCCCGATCACCTGTGCTACCACATGGCCAAACAGCT 67 FBan0030417 FBgn0050417 CG30417 2 2R MAPKKK cascade; GO:0000165; development; GO:0007275; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 single-stranded DNA binding; GO:0003697; nucleic acid binding; GO:0003676; ; GO:0003676; kinase activity; GO:0016301; ; GO:0003697; ; GO:0016301 CG30417 CG30417 CG17692 CDMC34399 3 2 23 DAC36-O02 21-CG30417-RA_1 CG30417 TGATTTTCTACAACACCTATCTGTACACGAATCCCGATCACCTGTGCTACCACATGGCCAAACAGCT 67 FBan0030417 FBgn0050417 CG30417 2 2R MAPKKK cascade; GO:0000165; development; GO:0007275; intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 single-stranded DNA binding; GO:0003697; nucleic acid binding; GO:0003676; ; GO:0003676; kinase activity; GO:0016301; ; GO:0003697; ; GO:0016301 CG30417 CG30417 CG17692 CDMC34400 3 3 23 DAC36-O14 3-CG31063-RA_4 CG31063 CCAAGGGAGAAGCTGATCTGGAGCAGTTTCCTCCCGAAGTAGGAGTCACTTTGGAACTTTGCGGTGG 67 FBan0031063 FBgn0051063 CG31063 3 3R "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; metal ion binding; GO:0046872; ; GO:0016818 ; EC:3.6.1.-; ; GO:0046872" CG31063 CG31063 CG6001 CDMC34400 3 4 23 DAC36-O14 3-CG31063-RA_4 CG31063 CCAAGGGAGAAGCTGATCTGGAGCAGTTTCCTCCCGAAGTAGGAGTCACTTTGGAACTTTGCGGTGG 67 FBan0031063 FBgn0051063 CG31063 3 3R "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; metal ion binding; GO:0046872; ; GO:0016818 ; EC:3.6.1.-; ; GO:0046872" CG31063 CG31063 CG6001 CDMC34401 3 5 23 DAC37-C02 4-CG7601-RA_1 CG7601 CTGGCCGTGTACAACCAAGTGGACATACTCATCAACAACGGAGGGATCAGTGTGCGAGCCGATGT 65 FBan0007601 FBgn0027583 CG7601 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7601 CG7601 BcDNA:GH06026 CDMC34401 3 6 23 DAC37-C02 4-CG7601-RA_1 CG7601 CTGGCCGTGTACAACCAAGTGGACATACTCATCAACAACGGAGGGATCAGTGTGCGAGCCGATGT 65 FBan0007601 FBgn0027583 CG7601 3 3R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG7601 CG7601 BcDNA:GH06026 CDMC34402 3 7 23 DAC37-C14 23-CG7631-RA_3 CG7631 AGCCGTATGACTATGGAAGCATTCTACACTACAGTTCCTTGGCATTTTCTATAAATGGGGAAGCG 65 FBan0007631 FBgn0028945 CG7631 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG7631 CG7631 BG:BACR44L22.6 CDMC34402 3 8 23 DAC37-C14 23-CG7631-RA_3 CG7631 AGCCGTATGACTATGGAAGCATTCTACACTACAGTTCCTTGGCATTTTCTATAAATGGGGAAGCG 65 FBan0007631 FBgn0028945 CG7631 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG7631 CG7631 BG:BACR44L22.6 CDMC34403 3 9 23 DAC37-G02 3-CG7789-RA_2 CG7789 GGTGGATCCGATCTGAATGTCTGCGACGACTGGCTGGTGAACGAGTTGGATGAGGAATTCCTGCA 65 FBan0007789 FBgn0039698 CG7789 3 3R phospholipid metabolism; GO:0006644 "3'(2'),5'-bisphosphate nucleotidase activity; GO:0008441 ; EC:3.1.3.7; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0008441 ; EC:3.1.3.7; ; GO:0004437" CG7789 CG7789 CDMC34403 3 10 23 DAC37-G02 3-CG7789-RA_2 CG7789 GGTGGATCCGATCTGAATGTCTGCGACGACTGGCTGGTGAACGAGTTGGATGAGGAATTCCTGCA 65 FBan0007789 FBgn0039698 CG7789 3 3R phospholipid metabolism; GO:0006644 "3'(2'),5'-bisphosphate nucleotidase activity; GO:0008441 ; EC:3.1.3.7; inositol or phosphatidylinositol phosphatase activity; GO:0004437; ; GO:0008441 ; EC:3.1.3.7; ; GO:0004437" CG7789 CG7789 CDMC34404 3 11 23 DAC37-G14 3-CG7846-RA_1 CG7846 ATCGCAACCGTAGGCTAAAATGCCGACCAAAGCATTACCCTGGAGGAAGGAAACACTCCGGATGG 65 FBan0007846 FBgn0030877 CG7846 X X ATP synthesis coupled proton transport; GO:0015986; cytoskeleton organization and biogenesis; GO:0007010 "ATP binding; GO:0005524; structural constituent of cytoskeleton; GO:0005200; ; GO:0005524; ; GO:0005200; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" actin filament; GO:0005884; proton-transporting two-sector ATPase complex; GO:0016469 CG7846 CG7846 CDMC34404 3 12 23 DAC37-G14 3-CG7846-RA_1 CG7846 ATCGCAACCGTAGGCTAAAATGCCGACCAAAGCATTACCCTGGAGGAAGGAAACACTCCGGATGG 65 FBan0007846 FBgn0030877 CG7846 X X ATP synthesis coupled proton transport; GO:0015986; cytoskeleton organization and biogenesis; GO:0007010 "ATP binding; GO:0005524; structural constituent of cytoskeleton; GO:0005200; ; GO:0005524; ; GO:0005200; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" actin filament; GO:0005884; proton-transporting two-sector ATPase complex; GO:0016469 CG7846 CG7846 CDMC34405 3 13 23 DAC37-K02 23-CG7939-RB_2 CG7939 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC34405 3 14 23 DAC37-K02 23-CG7939-RB_2 CG7939 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC34406 3 15 23 DAC37-K14 2-CG7968-RA_2 CG7968 TAAACTAAATCTCCTGGCTCGTCTATTTGGTGCCGATTTCTCCCTGTGGGGTGACGGTGCCCTCA 65 FBan0007968 FBgn0028532 CG7968 2 2L CG7968 CG7968 "BG:DS00941.15, DS00941.15" CDMC34406 3 16 23 DAC37-K14 2-CG7968-RA_2 CG7968 TAAACTAAATCTCCTGGCTCGTCTATTTGGTGCCGATTTCTCCCTGTGGGGTGACGGTGCCCTCA 65 FBan0007968 FBgn0028532 CG7968 2 2L CG7968 CG7968 "BG:DS00941.15, DS00941.15" CDMC34407 3 17 23 DAC37-O02 17-CG8055-RA_1 CG8055 TTCGCTAAATTCGGGTGAAAAAACAGATCAGCCAGGATGAGTTTCTTCGGGAAGATGTTCGGCGG 65 FBan0008055 FBgn0033385 CG8055 2 2R intracellular protein transport; GO:0006886 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 CG8055 CG8055 anon-WO0118547.180 CDMC34407 3 18 23 DAC37-O02 17-CG8055-RA_1 CG8055 TTCGCTAAATTCGGGTGAAAAAACAGATCAGCCAGGATGAGTTTCTTCGGGAAGATGTTCGGCGG 65 FBan0008055 FBgn0033385 CG8055 2 2R intracellular protein transport; GO:0006886 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 CG8055 CG8055 anon-WO0118547.180 CDMC34408 3 19 23 DAC37-O14 1-CG8091-RA_1 CG8091 CAATGTGCCAAGTCTTGCCGACACTCTGGTCTGCTATGCTAATACGCCGGGCTATGTTACCCACC 65 FBan0008091 FBgn0026404 Nc 3 3L apoptosis; GO:0006915; apoptotic program; GO:0008632; autophagic cell death; GO:0048102; embryonic development (sensu Insecta); GO:0001700; induction of programmed cell death by hormones; GO:0035081; metamorphosis (sensu Insecta); GO:0046698; proteolysis; GO:0006508; regulation of apoptosis; GO:0042981; regulation of retinal programmed cell death; GO:0046668; salivary gland cell autophagic cell death; GO:0035071; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0005515; ; GO:0030693 NOT mitochondrion; GO:0005739; cytoplasm; GO:0005737 Nc Nedd2-like caspase "CG8091, CG8091, DRONC, Dronc, dronc, anon-WO0118547.313, anon-EST:GressD6, anon-EST:GreesD6" CDMC34408 3 20 23 DAC37-O14 1-CG8091-RA_1 CG8091 CAATGTGCCAAGTCTTGCCGACACTCTGGTCTGCTATGCTAATACGCCGGGCTATGTTACCCACC 65 FBan0008091 FBgn0026404 Nc 3 3L apoptosis; GO:0006915; apoptotic program; GO:0008632; autophagic cell death; GO:0048102; embryonic development (sensu Insecta); GO:0001700; induction of programmed cell death by hormones; GO:0035081; metamorphosis (sensu Insecta); GO:0046698; proteolysis; GO:0006508; regulation of apoptosis; GO:0042981; regulation of retinal programmed cell death; GO:0046668; salivary gland cell autophagic cell death; GO:0035071; sperm individualization; GO:0007291 protein binding; GO:0005515; caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0005515; ; GO:0030693 NOT mitochondrion; GO:0005739; cytoplasm; GO:0005737 Nc Nedd2-like caspase "CG8091, CG8091, DRONC, Dronc, dronc, anon-WO0118547.313, anon-EST:GressD6, anon-EST:GreesD6" CDMC34409 3 21 23 DAC38-C02 17-CG4162-RA_1 CG4162 CCTCCCCGATTGGTAAACCAAAACTACAACACAGTCCAGATAGTGCTAAATCAATCACGAACGGTGGCT 69 FBan0004162 FBgn0002524 lace 2 2L biosynthesis; GO:0009058; lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50; transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0004758 ; EC:2.3.1.50; ; GO:0008483 ; EC:2.6.1.- lace lace "CG4162, CG4162, l(2)br36, br36, l35Dc, l(2)35Dc, BG:DS01845.3, SPT-II, Serine palmitoyltransferase subunit II, anon-EST:Posey289" CDMC34409 3 22 23 DAC38-C02 17-CG4162-RA_1 CG4162 CCTCCCCGATTGGTAAACCAAAACTACAACACAGTCCAGATAGTGCTAAATCAATCACGAACGGTGGCT 69 FBan0004162 FBgn0002524 lace 2 2L biosynthesis; GO:0009058; lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50; transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0004758 ; EC:2.3.1.50; ; GO:0008483 ; EC:2.6.1.- lace lace "CG4162, CG4162, l(2)br36, br36, l35Dc, l(2)35Dc, BG:DS01845.3, SPT-II, Serine palmitoyltransferase subunit II, anon-EST:Posey289" CDMC34410 3 23 23 DAC38-C14 24-CG4180-RA_6 CG4180 TATTGATTAATTCGATCAGTTTGGAATTTAAATAATACGCCTATGCATACTCACAATATTCGCAAAGAA 69 FBan0004180 FBgn0001977 l(2)35Bg 2 2L l(2)35Bg lethal (2) 35Bg "CG4180, D1, lethal group D1, l(2)br26, lethal 26 in the black-reduced region, br26, B, transcription unit B, BG:DS00929.9, anon-35Ba" CDMC34410 3 24 23 DAC38-C14 24-CG4180-RA_6 CG4180 TATTGATTAATTCGATCAGTTTGGAATTTAAATAATACGCCTATGCATACTCACAATATTCGCAAAGAA 69 FBan0004180 FBgn0001977 l(2)35Bg 2 2L l(2)35Bg lethal (2) 35Bg "CG4180, D1, lethal group D1, l(2)br26, lethal 26 in the black-reduced region, br26, B, transcription unit B, BG:DS00929.9, anon-35Ba" CDMC34411 3 25 23 DAC38-G02 15-CG4208-RA_1 CG4208 CCCGCCAAAAAGCAAAAGATCGTGGACACAGCGATTCAATACCGTCCCCTTAATCAGTTACTCAAGGGT 69 FBan0004208 FBgn0026751 XRCC1 X X nucleotide-excision repair; GO:0006289; single strand break repair; GO:0000012 nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 intracellular; GO:0005622; nucleus; GO:0005634 XRCC1 XRCC1 "CG4208, CG4208, Xrcc1" CDMC34411 3 26 23 DAC38-G02 15-CG4208-RA_1 CG4208 CCCGCCAAAAAGCAAAAGATCGTGGACACAGCGATTCAATACCGTCCCCTTAATCAGTTACTCAAGGGT 69 FBan0004208 FBgn0026751 XRCC1 X X nucleotide-excision repair; GO:0006289; single strand break repair; GO:0000012 nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 intracellular; GO:0005622; nucleus; GO:0005634 XRCC1 XRCC1 "CG4208, CG4208, Xrcc1" CDMC34412 3 1 24 DAC38-G14 3-CG4214-RA_2 CG4214 AGCAGGTTCAGAGCTACTCGGAGTTCATGATGGTCGCCAGGTTTATTGGCAAGAACATAGCCAGCACCT 69 FBan0004214 FBgn0011708 Syx5 2 2L cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; protein homodimerization activity; GO:0042803; ; GO:0005486; ; GO:0042803; ; GO:0005486 Golgi apparatus; GO:0005794; Golgi cis-face; GO:0005801; Golgi membrane; GO:0000139; endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 Syx5 Syntaxin 5 "CG4214, CG4214, CG4214, l(2)35Ff, dSed5, II, Sed5, BG:DS02740.12, SED5, DmSyx5, sed5, dsed5, dSyx5, syntaxin, dSed5p, syx5, anon-35Fb, anon-35Fd, lethal(2)35Ff, Syntaxin 5" CDMC34412 3 2 24 DAC38-G14 3-CG4214-RA_2 CG4214 AGCAGGTTCAGAGCTACTCGGAGTTCATGATGGTCGCCAGGTTTATTGGCAAGAACATAGCCAGCACCT 69 FBan0004214 FBgn0011708 Syx5 2 2L cytokinesis; GO:0000910; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; protein homodimerization activity; GO:0042803; ; GO:0005486; ; GO:0042803; ; GO:0005486 Golgi apparatus; GO:0005794; Golgi cis-face; GO:0005801; Golgi membrane; GO:0000139; endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 Syx5 Syntaxin 5 "CG4214, CG4214, CG4214, l(2)35Ff, dSed5, II, Sed5, BG:DS02740.12, SED5, DmSyx5, sed5, dsed5, dSyx5, syntaxin, dSed5p, syx5, anon-35Fb, anon-35Fd, lethal(2)35Ff, Syntaxin 5" CDMC34413 3 3 24 DAC38-K02 9-CG4252-RA_1 CG4252 TGGATCTCACCAACAAGGAGGTGACACTGGATCGCACGTATAAGTTGAGTGATCTGGACACTCGCCTCT 69 FBan0004252 FBgn0004367 mei-41 X X DNA damage checkpoint; GO:0000077; DNA repair; GO:0006281; actin filament organization; GO:0007015; cell cycle checkpoint; GO:0000075; cellularization (sensu Metazoa); GO:0009796; embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444; meiosis; GO:0007126; meiotic anaphase I; GO:0007133; meiotic recombination; GO:0007131; mitotic checkpoint; GO:0007093; oogenesis (sensu Insecta); GO:0009993; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of mitosis; GO:0007088; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; response to radiation; GO:0009314 kinase activity; GO:0016301; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301 mei-41 meiotic 41 "CG4252, CG4252, CG4252, CG4252, fs(1)M37, mus-103, mus-104, mus(1)103, mus(1)104, Mei-41, mus103, mus104, mei41, MEI41, MEI41/FRP1, meiP41, ATR, mei-195" CDMC34413 3 4 24 DAC38-K02 9-CG4252-RA_1 CG4252 TGGATCTCACCAACAAGGAGGTGACACTGGATCGCACGTATAAGTTGAGTGATCTGGACACTCGCCTCT 69 FBan0004252 FBgn0004367 mei-41 X X DNA damage checkpoint; GO:0000077; DNA repair; GO:0006281; actin filament organization; GO:0007015; cell cycle checkpoint; GO:0000075; cellularization (sensu Metazoa); GO:0009796; embryonic development (sensu Insecta); GO:0001700; imaginal disc development; GO:0007444; meiosis; GO:0007126; meiotic anaphase I; GO:0007133; meiotic recombination; GO:0007131; mitotic checkpoint; GO:0007093; oogenesis (sensu Insecta); GO:0009993; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360; regulation of mitosis; GO:0007088; regulation of progression through syncytial blastoderm mitotic cell cycle; GO:0007348; response to radiation; GO:0009314 kinase activity; GO:0016301; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301 mei-41 meiotic 41 "CG4252, CG4252, CG4252, CG4252, fs(1)M37, mus-103, mus-104, mus(1)103, mus(1)104, Mei-41, mus103, mus104, mei41, MEI41, MEI41/FRP1, meiP41, ATR, mei-195" CDMC34414 3 5 24 DAC38-K14 15-CG4262-RA_1 CG4262 GGTCCATTTGGAGCTGTGCAATCGGTAAAGATTGTCAAGGATCCCACAACGAATCAGTGCAAGGGCTAC 69 FBan0004262 FBgn0000570 elav X X "RNA metabolism; GO:0016070; cell proliferation; GO:0008283; ectoderm development; GO:0007398; histone mRNA 3'-end processing; GO:0006398; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Cajal body; GO:0015030; nucleus; GO:0005634 elav "embryonic lethal, abnormal vision" "CG4262, CG4262, CG4262, EC7, l(1)EC7, ELAV, elav-1, elav-2, elav-3, l(1)1Be, l(1)G0031, l(1)G0319, Elav, EG:65F1.2, Elav-9F8A9, 9F8A9, ElaV, 44C11, fliJ" CDMC34414 3 6 24 DAC38-K14 15-CG4262-RA_1 CG4262 GGTCCATTTGGAGCTGTGCAATCGGTAAAGATTGTCAAGGATCCCACAACGAATCAGTGCAAGGGCTAC 69 FBan0004262 FBgn0000570 elav X X "RNA metabolism; GO:0016070; cell proliferation; GO:0008283; ectoderm development; GO:0007398; histone mRNA 3'-end processing; GO:0006398; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 Cajal body; GO:0015030; nucleus; GO:0005634 elav "embryonic lethal, abnormal vision" "CG4262, CG4262, CG4262, EC7, l(1)EC7, ELAV, elav-1, elav-2, elav-3, l(1)1Be, l(1)G0031, l(1)G0319, Elav, EG:65F1.2, Elav-9F8A9, 9F8A9, ElaV, 44C11, fliJ" CDMC34415 3 7 24 DAC38-O02 23-CG4316-RA_6 CG4316 GTCAACGCCCACTAATTTAGTCTAGCGAAATGTTAGCACCGTAAGTTGTCTAACAAGGAAATCGGTCGG 69 FBan0004316 FBgn0003319 Sb 3 3R actin filament bundle formation; GO:0051017; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; morphogenesis of larval imaginal disc epithelium; GO:0016335; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- membrane; GO:0016020; plasma membrane; GO:0005886 Sb Stubble "CG4316, sbd: stubbloid, Sb-sbd, st-sb, stubbloid, c-SP56, SP56, sbd, Stubble" CDMC34415 3 8 24 DAC38-O02 23-CG4316-RA_6 CG4316 GTCAACGCCCACTAATTTAGTCTAGCGAAATGTTAGCACCGTAAGTTGTCTAACAAGGAAATCGGTCGG 69 FBan0004316 FBgn0003319 Sb 3 3R actin filament bundle formation; GO:0051017; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; morphogenesis of larval imaginal disc epithelium; GO:0016335; proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.- membrane; GO:0016020; plasma membrane; GO:0005886 Sb Stubble "CG4316, sbd: stubbloid, Sb-sbd, st-sb, stubbloid, c-SP56, SP56, sbd, Stubble" CDMC34416 3 9 24 DAC38-O14 17-CG4322-RA_1 CG4322 ACAGCCCGAAGAGAAACCAATACTACATGGATCGTAATACAAATGCCGTAGCACCGGAAAGTGACTCCG 69 FBan0004322 FBgn0025631 CG4322 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0004930; ; GO:0016526; melatonin receptor activity; GO:0008502; ; GO:0008502" integral to membrane; GO:0016021 CG4322 CG4322 "EP1631, EG:22E5.11, 1631" CDMC34416 3 10 24 DAC38-O14 17-CG4322-RA_1 CG4322 ACAGCCCGAAGAGAAACCAATACTACATGGATCGTAATACAAATGCCGTAGCACCGGAAAGTGACTCCG 69 FBan0004322 FBgn0025631 CG4322 X X G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0004930; ; GO:0016526; melatonin receptor activity; GO:0008502; ; GO:0008502" integral to membrane; GO:0016021 CG4322 CG4322 "EP1631, EG:22E5.11, 1631" CDMC34417 3 11 24 DAC39-C02 17-CG6944-RA_1 CG6944 GCCTACGGAAGTGACAACCAGCCAGCAATATATATTTTTAGCCATGGCCATAGGGTTTACGATCCACCA 69 FBan0006944 FBgn0002525 Lam 2 2L "cytoskeleton organization and biogenesis; GO:0007010; mitotic nuclear envelope reassembly; GO:0007084; nuclear migration; GO:0007097; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 lamin filament; GO:0005638 Lam Lamin "CG6944, l(2)gdh-7, 74/76, jf27, Dm[[1]], Dm[[2]], Dm[[mit]], lamin, l(2)04643, Dm[[o]], misrouted, lam, misguided, lamin Dm[[0]], Dm[[0]], DM[[O]], nlam, Dm, DmO, Dmo, n-lamin, 2459, Dm0, Dm1, Dm2, D5, lamin A, lamin Dm0, Lamin Dm[[0]], alpha-Lamin, DmLamin, misg, lamDm0, nuclear lamin, intermediate filament-like lamina, Lamin Dm0, Lam Dm[[0]], Dm(0), l(2)25Ec, l(2)gdh7, l(2)jf27, lethal(2)25Ec" CDMC34417 3 12 24 DAC39-C02 17-CG6944-RA_1 CG6944 GCCTACGGAAGTGACAACCAGCCAGCAATATATATTTTTAGCCATGGCCATAGGGTTTACGATCCACCA 69 FBan0006944 FBgn0002525 Lam 2 2L "cytoskeleton organization and biogenesis; GO:0007010; mitotic nuclear envelope reassembly; GO:0007084; nuclear migration; GO:0007097; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 lamin filament; GO:0005638 Lam Lamin "CG6944, l(2)gdh-7, 74/76, jf27, Dm[[1]], Dm[[2]], Dm[[mit]], lamin, l(2)04643, Dm[[o]], misrouted, lam, misguided, lamin Dm[[0]], Dm[[0]], DM[[O]], nlam, Dm, DmO, Dmo, n-lamin, 2459, Dm0, Dm1, Dm2, D5, lamin A, lamin Dm0, Lamin Dm[[0]], alpha-Lamin, DmLamin, misg, lamDm0, nuclear lamin, intermediate filament-like lamina, Lamin Dm0, Lam Dm[[0]], Dm(0), l(2)25Ec, l(2)gdh7, l(2)jf27, lethal(2)25Ec" CDMC34418 3 13 24 DAC39-C14 1-CG6953-RA_1 CG6953 GGAGAACGACTGCCTGAATACGTGCAATGTGCTTAGGTCGCCGTATTCCTCAAGAGTGGATCAGCCCAG 69 FBan0006953 FBgn0026721 fat-spondin 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 extracellular region; GO:0005576 fat-spondin fat-spondin "CG6953, CG6953, CG6953, CT21501" CDMC34418 3 14 24 DAC39-C14 1-CG6953-RA_1 CG6953 GGAGAACGACTGCCTGAATACGTGCAATGTGCTTAGGTCGCCGTATTCCTCAAGAGTGGATCAGCCCAG 69 FBan0006953 FBgn0026721 fat-spondin 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005198; ; GO:0004867 extracellular region; GO:0005576 fat-spondin fat-spondin "CG6953, CG6953, CG6953, CT21501" CDMC34419 3 15 24 DAC39-G02 3-CG6980-RA_2 CG6980 TGCTGAGTTCGAGGCAACCCTTGCGAAGATCGATTGTATACTGCAGAACAAGGCACCCTGTGACGATGA 69 FBan0006980 FBgn0039228 CG6980 3 3R CG6980 CG6980 anon-WO0140519.171 CDMC34419 3 16 24 DAC39-G02 3-CG6980-RA_2 CG6980 TGCTGAGTTCGAGGCAACCCTTGCGAAGATCGATTGTATACTGCAGAACAAGGCACCCTGTGACGATGA 69 FBan0006980 FBgn0039228 CG6980 3 3R CG6980 CG6980 anon-WO0140519.171 CDMC34420 3 17 24 DAC39-G14 23-CG6988-RA_5 CG6988 ATGAACAGAAACAAAAAGCCACAACTAGCAACGTACATTCTGTAGTTTACTTCTTAAGTTTCGGCGCAT 69 FBan0006988 FBgn0014002 Pdi 3 3L electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 Pdi Protein disulfide isomerase "CG6988, CG6988, CG6988, dpdi, pdi, PDI, protein disulfide isomerase, EP(3)1022, Dpdi" CDMC34420 3 18 24 DAC39-G14 23-CG6988-RA_5 CG6988 ATGAACAGAAACAAAAAGCCACAACTAGCAACGTACATTCTGTAGTTTACTTCTTAAGTTTCGGCGCAT 69 FBan0006988 FBgn0014002 Pdi 3 3L electron transport; GO:0006118; protein folding; GO:0006457; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489; ; GO:0003756 ; EC:5.3.4.1 endoplasmic reticulum; GO:0005783; endoplasmic reticulum lumen; GO:0005788 Pdi Protein disulfide isomerase "CG6988, CG6988, CG6988, dpdi, pdi, PDI, protein disulfide isomerase, EP(3)1022, Dpdi" CDMC34421 3 19 24 DAC39-K02 14-CG7016-RA_1 CG7016 ACCCGGAGGTTCCCTCAATTCCCATTGATGTGAGACGAAGATGAATCTTCTAAGAGGGAGTTCCCCGAT 69 FBan0007016 FBgn0039238 CG7016 3 3R CG7016 CG7016 CDMC34421 3 20 24 DAC39-K02 14-CG7016-RA_1 CG7016 ACCCGGAGGTTCCCTCAATTCCCATTGATGTGAGACGAAGATGAATCTTCTAAGAGGGAGTTCCCCGAT 69 FBan0007016 FBgn0039238 CG7016 3 3R CG7016 CG7016 CDMC34422 3 21 24 DAC39-K14 13-CG7028-RA_2 CG7028 CCCAACACAATCGTCCAAAATAAGCATCAACACGAAAATCCCGCTCTCACAGACAATTGGGACGACGCT 69 FBan0007028 FBgn0027587 CG7028 3 3L cell adhesion; GO:0007155; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG7028 CG7028 "PRP4, BcDNA:GH04978, FBgn0027587" CDMC34422 3 22 24 DAC39-K14 13-CG7028-RA_2 CG7028 CCCAACACAATCGTCCAAAATAAGCATCAACACGAAAATCCCGCTCTCACAGACAATTGGGACGACGCT 69 FBan0007028 FBgn0027587 CG7028 3 3L cell adhesion; GO:0007155; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 CG7028 CG7028 "PRP4, BcDNA:GH04978, FBgn0027587" CDMC34423 3 23 24 DAC39-O02 23-CG7057-RB_5 CG7057 TTAACGAGATGAATGGAGAAAGTGTTACCGCATCTATTGGTATTTCCTCAATCAAATTGAACCAGCAGC 69 FBan0007057 FBgn0024832 AP-50 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-50 AP-50 "CG7057, CG7057, CG7057, AP50, mu2, Dmu2, cg7057, anon-WO0172774.104, anon-EST:Posey50" CDMC34423 3 24 24 DAC39-O02 23-CG7057-RB_5 CG7057 TTAACGAGATGAATGGAGAAAGTGTTACCGCATCTATTGGTATTTCCTCAATCAAATTGAACCAGCAGC 69 FBan0007057 FBgn0024832 AP-50 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-50 AP-50 "CG7057, CG7057, CG7057, AP50, mu2, Dmu2, cg7057, anon-WO0172774.104, anon-EST:Posey50" CDMC34424 3 25 24 DAC39-O14 5-CG7069-RA_1 CG7069 TCGCGGCATCTACCCACTCCTCGTTGAGGAAATGGTTATTGGCAGCTTTAACTTTCGACGCATCATGCA 69 FBan0007069 FBgn0038952 CG7069 3 3R glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG7069 CG7069 CDMC34424 3 26 24 DAC39-O14 5-CG7069-RA_1 CG7069 TCGCGGCATCTACCCACTCCTCGTTGAGGAAATGGTTATTGGCAGCTTTAACTTTCGACGCATCATGCA 69 FBan0007069 FBgn0038952 CG7069 3 3R glycolysis; GO:0006096 carbohydrate kinase activity; GO:0019200; ; GO:0019200; pyruvate kinase activity; GO:0004743 ; EC:2.7.1.40; ; GO:0004743 ; EC:2.7.1.40 CG7069 CG7069 CDMC34425 3 1 25 DAC40-C02 4-CG33322-RA_1 CG33322 GGCCACCATTTTAGCCAGGACCAGTGTCAAGTCAATCCTTAGTCCCGAGCAACGAGATTCGGCAG 65 FBan0033322 FBgn0053322 CG33322 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33322 CG33322 "CG9329, CG9329, 38E.23, BcDNA:AT04844" CDMC34425 3 2 25 DAC40-C02 4-CG33322-RA_1 CG33322 GGCCACCATTTTAGCCAGGACCAGTGTCAAGTCAATCCTTAGTCCCGAGCAACGAGATTCGGCAG 65 FBan0033322 FBgn0053322 CG33322 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33322 CG33322 "CG9329, CG9329, 38E.23, BcDNA:AT04844" CDMC34426 3 3 25 DAC40-C14 2-CG33350-RA_1 CG33350 GTCTAACGGACATTCGTGGTGCAACTCTCAGGGGTCGTTACAAAGCTGTGGTCACCTTTGAGGCG 65 CDMC34426 3 4 25 DAC40-C14 2-CG33350-RA_1 CG33350 GTCTAACGGACATTCGTGGTGCAACTCTCAGGGGTCGTTACAAAGCTGTGGTCACCTTTGAGGCG 65 CDMC34427 3 5 25 DAC40-G02 3-CG3424-RA_1 CG3424 TCATCTGGGATGGCATTAAGGAGAAGTGCAAGAAGCGCCCGACATTGGTCAACTATGTGCTGCGC 65 FBan0003424 FBgn0036007 path 3 3L amino acid transport; GO:0006865; regulation of growth; GO:0040008 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 path pathetic "CG3424, anon-WO0118547.271, anon-WO0118547.370, pathetic" CDMC34427 3 6 25 DAC40-G02 3-CG3424-RA_1 CG3424 TCATCTGGGATGGCATTAAGGAGAAGTGCAAGAAGCGCCCGACATTGGTCAACTATGTGCTGCGC 65 FBan0003424 FBgn0036007 path 3 3L amino acid transport; GO:0006865; regulation of growth; GO:0040008 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 path pathetic "CG3424, anon-WO0118547.271, anon-WO0118547.370, pathetic" CDMC34428 3 7 25 DAC40-G14 14-CG3457-RA_2 CG3457 GCGGCCGTAGTGGATGACACGGATACCATTGACGAAATCAGCGATGACAACTGGGTGGACCTGAA 65 FBan0003457 FBgn0024984 CG3457 X X CG3457 CG3457 EG:17E2.1 CDMC34428 3 8 25 DAC40-G14 14-CG3457-RA_2 CG3457 GCGGCCGTAGTGGATGACACGGATACCATTGACGAAATCAGCGATGACAACTGGGTGGACCTGAA 65 FBan0003457 FBgn0024984 CG3457 X X CG3457 CG3457 EG:17E2.1 CDMC34429 3 9 25 DAC40-K02 3-CG3611-RA_4 CG3611 GTCTGTCAAGTGGCTGCTAATGCGATTAGGGAGCACACAGAAAACGGGATTGGCACTCGGGACTG 65 FBan0003611 FBgn0035069 CG3611 2 2R CG3611 CG3611 BcDNA:AT12780 CDMC34429 3 10 25 DAC40-K02 3-CG3611-RA_4 CG3611 GTCTGTCAAGTGGCTGCTAATGCGATTAGGGAGCACACAGAAAACGGGATTGGCACTCGGGACTG 65 FBan0003611 FBgn0035069 CG3611 2 2R CG3611 CG3611 BcDNA:AT12780 CDMC34430 3 11 25 DAC40-K14 3-CG3637-RA_2 CG3637 CTCAGACAATTTGGCCGACTATCTGGAGGACACCGGAATCCACGCCATTGCCCTGTACGACTACC 65 FBan0003637 FBgn0025865 Cortactin 3 3R border follicle cell migration (sensu Insecta); GO:0007298; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal formation; GO:0007301; regulation of cell shape; GO:0008360 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 cytoskeleton; GO:0005856 Cortactin Cortactin "CG3637, DCortactin, cortactin" CDMC34430 3 12 25 DAC40-K14 3-CG3637-RA_2 CG3637 CTCAGACAATTTGGCCGACTATCTGGAGGACACCGGAATCCACGCCATTGCCCTGTACGACTACC 65 FBan0003637 FBgn0025865 Cortactin 3 3R border follicle cell migration (sensu Insecta); GO:0007298; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal formation; GO:0007301; regulation of cell shape; GO:0008360 actin binding; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0003779; ; GO:0005200 cytoskeleton; GO:0005856 Cortactin Cortactin "CG3637, DCortactin, cortactin" CDMC34431 3 13 25 DAC40-O02 3-CG3719-RA_4 CG3719 CAACCAGTTGGACATCCGAGACCCTGCCAGATATCTAATCGCTGCGAGAGTGCCTGTGTTACGCA 65 FBan0003719 FBgn0024986 CG3719 X X electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG3719 CG3719 "EG:132E8.3, thioredoxin, BcDNA:LD03613" CDMC34431 3 14 25 DAC40-O02 3-CG3719-RA_4 CG3719 CAACCAGTTGGACATCCGAGACCCTGCCAGATATCTAATCGCTGCGAGAGTGCCTGTGTTACGCA 65 FBan0003719 FBgn0024986 CG3719 X X electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; ; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0030508; ; GO:0005489 mitochondrion; GO:0005739 CG3719 CG3719 "EG:132E8.3, thioredoxin, BcDNA:LD03613" CDMC34432 3 15 25 DAC40-O14 1-CG3756-RA_1 CG3756 CACGCTACGACACGTGCAGCCGAAATGTGTATCGCTATCCCCAGCTAAACGACGCTGTGACTTTG 65 FBan0003756 FBgn0031657 CG3756 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase I promoter; GO:0006360; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983 DNA-directed RNA polymerase I complex; GO:0005736; DNA-directed RNA polymerase III complex; GO:0005666 CG3756 CG3756 CDMC34432 3 16 25 DAC40-O14 1-CG3756-RA_1 CG3756 CACGCTACGACACGTGCAGCCGAAATGTGTATCGCTATCCCCAGCTAAACGACGCTGTGACTTTG 65 FBan0003756 FBgn0031657 CG3756 2 2L mRNA transcription; GO:0009299; transcription from RNA polymerase I promoter; GO:0006360; transcription from RNA polymerase II promoter; GO:0006366; transcription from RNA polymerase III promoter; GO:0006383 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; protein dimerization activity; GO:0046983; ; GO:0003677; ; GO:0046983 DNA-directed RNA polymerase I complex; GO:0005736; DNA-directed RNA polymerase III complex; GO:0005666 CG3756 CG3756 CDMC34433 3 17 25 DAC41-C02 AutoBlank AutoBlank CDMC34433 3 18 25 DAC41-C02 AutoBlank AutoBlank CDMC34434 3 19 25 DAC41-C14 AutoBlank AutoBlank CDMC34434 3 20 25 DAC41-C14 AutoBlank AutoBlank CDMC34435 3 21 25 DAC41-G02 AutoBlank AutoBlank CDMC34435 3 22 25 DAC41-G02 AutoBlank AutoBlank CDMC34436 3 23 25 DAC41-G14 AutoBlank AutoBlank CDMC34436 3 24 25 DAC41-G14 AutoBlank AutoBlank CDMC34437 3 25 25 DAC41-K02 AutoBlank AutoBlank CDMC34437 3 26 25 DAC41-K02 AutoBlank AutoBlank CDMC34438 3 1 26 DAC41-K14 AutoBlank AutoBlank CDMC34438 3 2 26 DAC41-K14 AutoBlank AutoBlank CDMC34439 3 3 26 DAC41-O02 AutoBlank AutoBlank CDMC34439 3 4 26 DAC41-O02 AutoBlank AutoBlank CDMC34440 3 5 26 DAC41-O14 AutoBlank AutoBlank CDMC34440 3 6 26 DAC41-O14 AutoBlank AutoBlank CDMC34441 3 7 26 DAC42-C02 150mM NaPO4 Blank CDMC34441 3 8 26 DAC42-C02 150mM NaPO4 Blank CDMC34442 3 9 26 DAC42-C14 150mM NaPO4 Blank CDMC34442 3 10 26 DAC42-C14 150mM NaPO4 Blank CDMC34443 3 11 26 DAC42-G02 150mM NaPO4 Blank CDMC34443 3 12 26 DAC42-G02 150mM NaPO4 Blank CDMC34444 3 13 26 DAC42-G14 150mM NaPO4 Blank CDMC34444 3 14 26 DAC42-G14 150mM NaPO4 Blank CDMC34445 3 15 26 DAC42-K02 150mM NaPO4 Blank CDMC34445 3 16 26 DAC42-K02 150mM NaPO4 Blank CDMC34446 3 17 26 DAC42-K14 5uM MSP 5uM MSP CDMC34446 3 18 26 DAC42-K14 5uM MSP 5uM MSP CDMC34447 3 19 26 DAC42-O02 10uM MSP 10uM MSP CDMC34447 3 20 26 DAC42-O02 10uM MSP 10uM MSP CDMC34448 3 21 26 DAC42-O14 20uM MSP 20uM MSP CDMC34448 3 22 26 DAC42-O14 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC34449 4 1 1 DAC01-D02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34449 4 2 1 DAC01-D02 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34450 4 3 1 DAC01-D14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34450 4 4 1 DAC01-D14 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34451 4 5 1 DAC01-H02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34451 4 6 1 DAC01-H02 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34452 4 7 1 DAC01-H14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34452 4 8 1 DAC01-H14 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34453 4 9 1 DAC01-L02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34453 4 10 1 DAC01-L02 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34454 4 11 1 DAC01-L14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34454 4 12 1 DAC01-L14 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34455 4 13 1 DAC01-P02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34455 4 14 1 DAC01-P02 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34456 4 15 1 DAC01-P14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34456 4 16 1 DAC01-P14 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34457 4 17 1 DAC02-D02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34457 4 18 1 DAC02-D02 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34458 4 19 1 DAC02-D14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34458 4 20 1 DAC02-D14 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34459 4 21 1 DAC02-H02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34459 4 22 1 DAC02-H02 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34460 4 23 1 DAC02-H14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34460 4 24 1 DAC02-H14 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34461 4 25 1 DAC02-L02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34461 4 26 1 DAC02-L02 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34462 4 1 2 DAC02-L14 N/A CG9075 (01196-01434) CDMC34462 4 2 2 DAC02-L14 N/A CG9075 (01196-01434) CDMC34463 4 3 2 DAC02-P02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34463 4 4 2 DAC02-P02 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34464 4 5 2 DAC02-P14 AutoBlank AutoBlank CDMC34464 4 6 2 DAC02-P14 AutoBlank AutoBlank CDMC34465 4 7 2 DAC03-D02 14-CG5446-RA_1 CG5446 TCTGTTGCAGAACGTTCAGGACAAGTTCCAGACGATGTCGGACCAGATAATAACGCGCATCGATGACAT 69 FBan0005446 FBgn0032429 CG5446 2 2L CG5446 CG5446 BcDNA:RE36920 CDMC34465 4 8 2 DAC03-D02 14-CG5446-RA_1 CG5446 TCTGTTGCAGAACGTTCAGGACAAGTTCCAGACGATGTCGGACCAGATAATAACGCGCATCGATGACAT 69 FBan0005446 FBgn0032429 CG5446 2 2L CG5446 CG5446 BcDNA:RE36920 CDMC34466 4 9 2 DAC03-D14 23-CG5460-RC_9 CG5460 GGCCTGAAACTTGCTTAAAACTTAATGCACTGAACAAAATCCGAACTAAACACATCTGTTCCAGGCAGA 69 FBan0005460 FBgn0001169 H 3 3R Notch signaling pathway; GO:0007219; negative regulation of Notch signaling pathway; GO:0045746; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 H Hairless "CG5460, hairless" CDMC34466 4 10 2 DAC03-D14 23-CG5460-RC_9 CG5460 GGCCTGAAACTTGCTTAAAACTTAATGCACTGAACAAAATCCGAACTAAACACATCTGTTCCAGGCAGA 69 FBan0005460 FBgn0001169 H 3 3R Notch signaling pathway; GO:0007219; negative regulation of Notch signaling pathway; GO:0045746; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360 transcription corepressor activity; GO:0003714; ; GO:0003714 nucleus; GO:0005634 H Hairless "CG5460, hairless" CDMC34467 4 11 2 DAC03-H02 23-CG5476-RA_1 CG5476 AGTGCCATAGCTTTCAGCTGCCCTATTTGTTGACTTTTTGTGTTATCTATTGATTTGTCGAACGAACCG 69 FBan0005476 FBgn0039441 CG5476 3 3R CG5476 CG5476 "BcDNA:RE20092, BcDNA:RE59605" CDMC34467 4 12 2 DAC03-H02 23-CG5476-RA_1 CG5476 AGTGCCATAGCTTTCAGCTGCCCTATTTGTTGACTTTTTGTGTTATCTATTGATTTGTCGAACGAACCG 69 FBan0005476 FBgn0039441 CG5476 3 3R CG5476 CG5476 "BcDNA:RE20092, BcDNA:RE59605" CDMC34468 4 13 2 DAC03-H14 12-CG5488-RA_1 CG5488 TGGCCCTGGAGGTCTGAGAATCTCCGAGAGAATTCAACCCTCCTCATGGTTCGATCTCACAACAATGTC 69 FBan0005488 FBgn0004854 B-H2 X X "bristle morphogenesis; GO:0008407; eye pigment granule organization and biogenesis; GO:0008057; eye-antennal disc morphogenesis; GO:0007455; leg disc proximal/distal pattern formation; GO:0007479; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 B-H2 BarH2 "CG5488, Bar-H2, Bar, B, BH2, BarH2" CDMC34468 4 14 2 DAC03-H14 12-CG5488-RA_1 CG5488 TGGCCCTGGAGGTCTGAGAATCTCCGAGAGAATTCAACCCTCCTCATGGTTCGATCTCACAACAATGTC 69 FBan0005488 FBgn0004854 B-H2 X X "bristle morphogenesis; GO:0008407; eye pigment granule organization and biogenesis; GO:0008057; eye-antennal disc morphogenesis; GO:0007455; leg disc proximal/distal pattern formation; GO:0007479; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 B-H2 BarH2 "CG5488, Bar-H2, Bar, B, BH2, BarH2" CDMC34469 4 15 2 DAC03-L02 4-CG5517-RA_2 CG5517 GCGCCACAAACCAATCAGCGATATTGTGACCTTTAAGTCGTGCAAGGAGCTTTACCCCATTGCTCTGCC 69 FBan0005517 FBgn0001247 Ide 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; proteolysis; GO:0006508 zinc ion binding; GO:0008270; insulysin activity; GO:0004231 ; EC:3.4.24.56; ; GO:0008270; ; GO:0004231 ; EC:3.4.24.56; ; GO:0004231 ; EC:3.4.24.56; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 Ide Insulin degrading metalloproteinase "CG5517, CG5517, CG5517, dIDE, IDE" CDMC34469 4 16 2 DAC03-L02 4-CG5517-RA_2 CG5517 GCGCCACAAACCAATCAGCGATATTGTGACCTTTAAGTCGTGCAAGGAGCTTTACCCCATTGCTCTGCC 69 FBan0005517 FBgn0001247 Ide 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; proteolysis; GO:0006508 zinc ion binding; GO:0008270; insulysin activity; GO:0004231 ; EC:3.4.24.56; ; GO:0008270; ; GO:0004231 ; EC:3.4.24.56; ; GO:0004231 ; EC:3.4.24.56; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 Ide Insulin degrading metalloproteinase "CG5517, CG5517, CG5517, dIDE, IDE" CDMC34470 4 17 2 DAC03-L14 23-CG5529-RA_7 CG5529 AGTTTACATGGCATTTAGGTTATTTAGATGAATCAGCAGTTGCATTATTCGTGCACCATATCACAACAT 69 FBan0005529 FBgn0011758 B-H1 X X "bristle morphogenesis; GO:0008407; eye pigment granule organization and biogenesis; GO:0008057; eye-antennal disc morphogenesis; GO:0007455; leg disc proximal/distal pattern formation; GO:0007479; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 B-H1 BarH1 "CG5529, CG5529, Bar-H1, barh1, Bar, barH1, BarHI, Bar H1, BH1, BarH1" CDMC34470 4 18 2 DAC03-L14 23-CG5529-RA_7 CG5529 AGTTTACATGGCATTTAGGTTATTTAGATGAATCAGCAGTTGCATTATTCGTGCACCATATCACAACAT 69 FBan0005529 FBgn0011758 B-H1 X X "bristle morphogenesis; GO:0008407; eye pigment granule organization and biogenesis; GO:0008057; eye-antennal disc morphogenesis; GO:0007455; leg disc proximal/distal pattern formation; GO:0007479; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; regulation of transcription, DNA-dependent; GO:0006355; sensory organ determination; GO:0008052" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 B-H1 BarH1 "CG5529, CG5529, Bar-H1, barh1, Bar, barH1, BarHI, Bar H1, BH1, BarH1" CDMC34471 4 19 2 DAC03-P02 3-CG5566-RA_1 CG5566 AGCTTCCCAGCTCCATATCCAACTGATTCCCAGCTTCCCATCTCCATATTCCTCCACTTGCTCCGTCAT 69 FBan0005566 FBgn0039550 CG5566 3 3R CG5566 CG5566 CDMC34471 4 20 2 DAC03-P02 3-CG5566-RA_1 CG5566 AGCTTCCCAGCTCCATATCCAACTGATTCCCAGCTTCCCATCTCCATATTCCTCCACTTGCTCCGTCAT 69 FBan0005566 FBgn0039550 CG5566 3 3R CG5566 CG5566 CDMC34472 4 21 2 DAC03-P14 2-CG5582-RA_1 CG5582 TCAACGTGGTATACTTCCTCACCGAGGTTATCTGGTGGTACACGCCTAGCATCTGGATCGTGTTCGCCA 69 FBan0005582 FBgn0036756 cln3 3 3L transmission of nerve impulse; GO:0019226 membrane; GO:0016020 cln3 cln3 CG5582 CDMC34472 4 22 2 DAC03-P14 2-CG5582-RA_1 CG5582 TCAACGTGGTATACTTCCTCACCGAGGTTATCTGGTGGTACACGCCTAGCATCTGGATCGTGTTCGCCA 69 FBan0005582 FBgn0036756 cln3 3 3L transmission of nerve impulse; GO:0019226 membrane; GO:0016020 cln3 cln3 CG5582 CDMC34473 4 23 2 DAC04-D02 3-CG12374-RA_6 CG12374 AGATGGAATGGGAGACCTACCACACTCTGGACACCATTTACGATTGGATCGATCAGGAGTGTGCTGCCC 69 FBan0012374 FBgn0033774 CG12374 2 2R proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG12374 CG12374 anon-WO0140519.63 CDMC34473 4 24 2 DAC04-D02 3-CG12374-RA_6 CG12374 AGATGGAATGGGAGACCTACCACACTCTGGACACCATTTACGATTGGATCGATCAGGAGTGTGCTGCCC 69 FBan0012374 FBgn0033774 CG12374 2 2R proteolysis; GO:0006508 carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG12374 CG12374 anon-WO0140519.63 CDMC34474 4 25 2 DAC04-D14 3-CG12387-RA_1 CG12387 GCTCCGATGGCGTTATCACCAATGTCAAGGAGATCGTTATGCACGAAGGGTATTACTCGGGAGCTGCCT 69 FBan0012387 FBgn0011556 zetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 zetaTry zetaTrypsin "CG12387, DmZetaTry, SP110, zetaTry" CDMC34474 4 26 2 DAC04-D14 3-CG12387-RA_1 CG12387 GCTCCGATGGCGTTATCACCAATGTCAAGGAGATCGTTATGCACGAAGGGTATTACTCGGGAGCTGCCT 69 FBan0012387 FBgn0011556 zetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 zetaTry zetaTrypsin "CG12387, DmZetaTry, SP110, zetaTry" CDMC34475 4 1 3 DAC04-H02 6-CG12423-RA_1 CG12423 GCCATGTTGCCCATCTAATGACTGGGGTACGACTGGGCCTAATGACTCCAAAGGTGGGTACACACATTT 69 FBgn0040038 CG12423 CG12423 CG12423 anon-WO0140519.152 CDMC34475 4 2 3 DAC04-H02 6-CG12423-RA_1 CG12423 GCCATGTTGCCCATCTAATGACTGGGGTACGACTGGGCCTAATGACTCCAAAGGTGGGTACACACATTT 69 FBgn0040038 CG12423 CG12423 CG12423 anon-WO0140519.152 CDMC34476 4 3 3 DAC04-H14 23-CG12437-RA_12 CG12437 ATGTGGAGTCGATCGAGACAACGGAAATAATCACCACTAAAACCATAGAGACCAAGCCAAATCCGGTGA 69 FBan0012437 FBgn0003209 raw 2 2L "Malpighian tubule morphogenesis; GO:0007443; autophagic cell death; GO:0048102; central nervous system development; GO:0007417; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectodermal gut morphogenesis; GO:0048567; germ-band shortening; GO:0007390; hindgut morphogenesis; GO:0007442; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; regulation of JNK cascade; GO:0046328; regulation of Malpighian tubule diameter; GO:0035297; regulation of cell shape; GO:0008360; salivary gland cell autophagic cell death; GO:0035071; salivary gland morphogenesis; GO:0007435" raw raw "CG9321, CG12437, CG9321, l(2)06825, cyr, cyrano, l(2)k03514" CDMC34476 4 4 3 DAC04-H14 23-CG12437-RA_12 CG12437 ATGTGGAGTCGATCGAGACAACGGAAATAATCACCACTAAAACCATAGAGACCAAGCCAAATCCGGTGA 69 FBan0012437 FBgn0003209 raw 2 2L "Malpighian tubule morphogenesis; GO:0007443; autophagic cell death; GO:0048102; central nervous system development; GO:0007417; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectodermal gut morphogenesis; GO:0048567; germ-band shortening; GO:0007390; hindgut morphogenesis; GO:0007442; morphogenesis of an epithelium; GO:0002009; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; regulation of JNK cascade; GO:0046328; regulation of Malpighian tubule diameter; GO:0035297; regulation of cell shape; GO:0008360; salivary gland cell autophagic cell death; GO:0035071; salivary gland morphogenesis; GO:0007435" raw raw "CG9321, CG12437, CG9321, l(2)06825, cyr, cyrano, l(2)k03514" CDMC34477 4 5 3 DAC04-L02 12-CG12487-RA_1 CG12487 GGCAATCCATCTTCACTGAGTTCTTCTGGGACATCCCCCTCCATCGAGTATCTGTGATGTGACCCGATC 69 FBgn0040808 CDMC34477 4 6 3 DAC04-L02 12-CG12487-RA_1 CG12487 GGCAATCCATCTTCACTGAGTTCTTCTGGGACATCCCCCTCCATCGAGTATCTGTGATGTGACCCGATC 69 FBgn0040808 CDMC34478 4 7 3 DAC04-L14 18-CG12497-RA_3 CG12497 ACGAATACAGAGATCGAGAAAGCGTACAGTTCCAGAACCTGCAAAAACTTCTGGACGATGATCTGCGCA 69 FBgn0040379 CDMC34478 4 8 3 DAC04-L14 18-CG12497-RA_3 CG12497 ACGAATACAGAGATCGAGAAAGCGTACAGTTCCAGAACCTGCAAAAACTTCTGGACGATGATCTGCGCA 69 FBgn0040379 CDMC34479 4 9 3 DAC04-P02 23-CG12537-RA_10 CG12537 TGTGCAAATGAAAAATTTTTAAGCACCAAAAAAGTTGAGCAATTTTTTACGCAAGCCAGGAGGAATCCG 69 FBgn0038193 CG12537 CG12537 CG12537 CDMC34479 4 10 3 DAC04-P02 23-CG12537-RA_10 CG12537 TGTGCAAATGAAAAATTTTTAAGCACCAAAAAAGTTGAGCAATTTTTTACGCAAGCCAGGAGGAATCCG 69 FBgn0038193 CG12537 CG12537 CG12537 CDMC34480 4 11 3 DAC04-P14 16-CG12557-RA_1 CG12557 AGAGGCCTCGGAGTATATCTTCTGGTATCACGATAACCGCATGATTAACTACGACATCGATCGGGGCAT 69 FBan0033996 FBgn0034286 dpr13 2 2R dpr13 dpr13 "CG12557, CG33996, CG14493, CG12557, CG33996, CT34204, Dpr-13" CDMC34480 4 12 3 DAC04-P14 16-CG12557-RA_1 CG12557 AGAGGCCTCGGAGTATATCTTCTGGTATCACGATAACCGCATGATTAACTACGACATCGATCGGGGCAT 69 FBan0033996 FBgn0034286 dpr13 2 2R dpr13 dpr13 "CG12557, CG33996, CG14493, CG12557, CG33996, CT34204, Dpr-13" CDMC34481 4 13 3 DAC05-D02 23-CG5055-RA_5 CG5055 TGGTTTCATTGGATTTCCAACCTATTGACCCACCCTGACACACGTCTATATTAAGTTCACAATTCACAA 69 FBan0005055 FBgn0000163 baz X X apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; basal protein localization; GO:0045175; border follicle cell migration (sensu Insecta); GO:0007298; cytokinesis; GO:0000910; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment of apical/basal cell polarity; GO:0035089; establishment of mitotic spindle localization; GO:0040001; follicle cell adhesion (sensu Insecta); GO:0007299; germ-band extension; GO:0007377; intercellular junction assembly; GO:0007043; maintenance of oocyte identity (sensu Insecta); GO:0016350; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; neuroblast division; GO:0045034; oocyte axis determination; GO:0007309; oocyte fate determination (sensu Insecta); GO:0007294; protein localization; GO:0008104; protein targeting; GO:0006605; synaptogenesis; GO:0007416; zonula adherens assembly; GO:0045186 protein kinase C binding; GO:0005080; protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515; ; GO:0005080 apical cortex; GO:0045179; apical part of cell; GO:0045177; apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell cortex; GO:0005938; cell-cell adherens junction; GO:0005913; cytoplasm; GO:0005737; subapical complex; GO:0035003 baz bazooka "CG5055, l(1)G0484, Par-3, dPar-3, Bazooka, Par3, PAR3, par-3, Baz, bazooka" CDMC34481 4 14 3 DAC05-D02 23-CG5055-RA_5 CG5055 TGGTTTCATTGGATTTCCAACCTATTGACCCACCCTGACACACGTCTATATTAAGTTCACAATTCACAA 69 FBan0005055 FBgn0000163 baz X X apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; basal protein localization; GO:0045175; border follicle cell migration (sensu Insecta); GO:0007298; cytokinesis; GO:0000910; establishment and/or maintenance of cell polarity; GO:0007163; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment of apical/basal cell polarity; GO:0035089; establishment of mitotic spindle localization; GO:0040001; follicle cell adhesion (sensu Insecta); GO:0007299; germ-band extension; GO:0007377; intercellular junction assembly; GO:0007043; maintenance of oocyte identity (sensu Insecta); GO:0016350; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; neuroblast division; GO:0045034; oocyte axis determination; GO:0007309; oocyte fate determination (sensu Insecta); GO:0007294; protein localization; GO:0008104; protein targeting; GO:0006605; synaptogenesis; GO:0007416; zonula adherens assembly; GO:0045186 protein kinase C binding; GO:0005080; protein binding; GO:0005515; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0005515; ; GO:0005080 apical cortex; GO:0045179; apical part of cell; GO:0045177; apical plasma membrane; GO:0016324; apicolateral plasma membrane; GO:0016327; cell cortex; GO:0005938; cell-cell adherens junction; GO:0005913; cytoplasm; GO:0005737; subapical complex; GO:0035003 baz bazooka "CG5055, l(1)G0484, Par-3, dPar-3, Bazooka, Par3, PAR3, par-3, Baz, bazooka" CDMC34482 4 15 3 DAC05-D14 11-CG5062-RA_1 CG5062 TGCCATGTGGACGGCTCAGATACAGGAAAGGAAGCTACTCAATCGCATTCAACTCGATCATGACGAGGA 69 FBan0005062 FBgn0029747 CG5062 X X CG5062 CG5062 BcDNA:AT13663 CDMC34482 4 16 3 DAC05-D14 11-CG5062-RA_1 CG5062 TGCCATGTGGACGGCTCAGATACAGGAAAGGAAGCTACTCAATCGCATTCAACTCGATCATGACGAGGA 69 FBan0005062 FBgn0029747 CG5062 X X CG5062 CG5062 BcDNA:AT13663 CDMC34483 4 17 3 DAC05-H02 2-CG5098-RA_4 CG5098 CGCAAACAGACGCACGATAGCTCGATATCCTACAGCGACGATCCAAATGAGTCCCGCTCACAATGCTCA 69 FBan0005098 FBgn0034300 CG5098 2 2R CG5098 CG5098 CDMC34483 4 18 3 DAC05-H02 2-CG5098-RA_4 CG5098 CGCAAACAGACGCACGATAGCTCGATATCCTACAGCGACGATCCAAATGAGTCCCGCTCACAATGCTCA 69 FBan0005098 FBgn0034300 CG5098 2 2R CG5098 CG5098 CDMC34484 4 19 3 DAC05-H14 3-CG5109-RA_4 CG5109 AGCGCAAGGCTTTCCGATTGTCCAAACGCTATGACAACAGCCGCAATCACTGTGATCTATCATCCGACG 69 FBan0005109 FBgn0003044 Pcl 2 2R "chromatin modification; GO:0016568; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 Pcl Polycomblike "CG5109, l(2)s1859, pcl, PCL" CDMC34484 4 20 3 DAC05-H14 3-CG5109-RA_4 CG5109 AGCGCAAGGCTTTCCGATTGTCCAAACGCTATGACAACAGCCGCAATCACTGTGATCTATCATCCGACG 69 FBan0005109 FBgn0003044 Pcl 2 2R "chromatin modification; GO:0016568; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515; ; GO:0005515 nucleus; GO:0005634 Pcl Polycomblike "CG5109, l(2)s1859, pcl, PCL" CDMC34485 4 21 3 DAC05-L02 6-CG5146-RA_3 CG5146 ACCTGCGCATGTCGATGCTGTCACGAGAGGAGCAATGCTCAAGGAATTCTTTAGCAAACATCCTCCACC 69 FBan0005146 FBgn0035617 CG5146 3 3L CG5146 CG5146 "clone 1.47, anon-EST:Liang-1.47" CDMC34485 4 22 3 DAC05-L02 6-CG5146-RA_3 CG5146 ACCTGCGCATGTCGATGCTGTCACGAGAGGAGCAATGCTCAAGGAATTCTTTAGCAAACATCCTCCACC 69 FBan0005146 FBgn0035617 CG5146 3 3L CG5146 CG5146 "clone 1.47, anon-EST:Liang-1.47" CDMC34486 4 23 3 DAC05-L14 23-CG5161-RA_6 CG5161 CACATACTACTTTGTTATTGTGGGTCAAAATGATAATCCCATTTACGAGAAGGAATTCAGCACCGTGAA 69 FBan0005161 FBgn0036573 CG5161 3 3L ER to Golgi transport; GO:0006888; cell proliferation; GO:0008283; transport; GO:0006810 transcription regulator activity; GO:0030528; ; GO:0030528; intracellular transporter activity; GO:0005478; ; GO:0005478 intracellular; GO:0005622 CG5161 CG5161 BcDNA:RE62842 CDMC34486 4 24 3 DAC05-L14 23-CG5161-RA_6 CG5161 CACATACTACTTTGTTATTGTGGGTCAAAATGATAATCCCATTTACGAGAAGGAATTCAGCACCGTGAA 69 FBan0005161 FBgn0036573 CG5161 3 3L ER to Golgi transport; GO:0006888; cell proliferation; GO:0008283; transport; GO:0006810 transcription regulator activity; GO:0030528; ; GO:0030528; intracellular transporter activity; GO:0005478; ; GO:0005478 intracellular; GO:0005622 CG5161 CG5161 BcDNA:RE62842 CDMC34487 4 25 3 DAC05-P02 16-CG5191-RC_1 CG5191 CCACCAAATGTTCGTTCGGGACCTTCGAAATTAGTAATCCCTCAATCGCGAGTCATTACCACCCATTGT 69 FBan0005191 FBgn0038803 CG5191 3 3R nitrogen compound metabolism; GO:0006807; tRNA aminoacylation for protein translation; GO:0006418 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0017068 ; EC:6.3.5.-; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG5191 CG5191 CDMC34487 4 26 3 DAC05-P02 16-CG5191-RC_1 CG5191 CCACCAAATGTTCGTTCGGGACCTTCGAAATTAGTAATCCCTCAATCGCGAGTCATTACCACCCATTGT 69 FBan0005191 FBgn0038803 CG5191 3 3R nitrogen compound metabolism; GO:0006807; tRNA aminoacylation for protein translation; GO:0006418 glutamyl-tRNA(Gln) amidotransferase activity; GO:0017068 ; EC:6.3.5.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0017068 ; EC:6.3.5.-; amidase activity; GO:0004040 ; EC:3.5.1.4; ; GO:0004040 ; EC:3.5.1.4 CG5191 CG5191 CDMC34488 4 1 4 DAC05-P14 10-CG5201-RA_1 CG5201 CCGTGCGCTAGATGATCTTTAACCCCTTACCAAACCAAACTGCATGTAGGCCATCCTAGAATCCCAGCC 69 FBan0005201 FBgn0020493 Dad 3 3R germ-line stem cell maintenance; GO:0030718; intracellular signaling cascade; GO:0007242; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015 "transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity; GO:0030617; ; GO:0030617; ; GO:0030617; ; GO:0030617" intracellular; GO:0005622 Dad Daughters against dpp "CG5201, 1883, dad, Dad1, DAD, daughters against dpp, EP(3)3196, l(3)j1E4, Daughters against dpp, EP3196, anon-EST:fe1F5, anon-fast-evolving-1F5" CDMC34488 4 2 4 DAC05-P14 10-CG5201-RA_1 CG5201 CCGTGCGCTAGATGATCTTTAACCCCTTACCAAACCAAACTGCATGTAGGCCATCCTAGAATCCCAGCC 69 FBan0005201 FBgn0020493 Dad 3 3R germ-line stem cell maintenance; GO:0030718; intracellular signaling cascade; GO:0007242; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015 "transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity; GO:0030617; ; GO:0030617; ; GO:0030617; ; GO:0030617" intracellular; GO:0005622 Dad Daughters against dpp "CG5201, 1883, dad, Dad1, DAD, daughters against dpp, EP(3)3196, l(3)j1E4, Daughters against dpp, EP3196, anon-EST:fe1F5, anon-fast-evolving-1F5" CDMC34489 4 3 4 DAC06-D02 2-CG9386-RA_1 CG9386 CTTCCGCTTGGATTTTCCGGGTGTGGATTGGTTGATTGGTAACCATTCGGACGAGTTGTCTCCTTGGCT 69 FBan0009386 FBgn0037708 CG9386 3 3R CG9386 CG9386 CDMC34489 4 4 4 DAC06-D02 2-CG9386-RA_1 CG9386 CTTCCGCTTGGATTTTCCGGGTGTGGATTGGTTGATTGGTAACCATTCGGACGAGTTGTCTCCTTGGCT 69 FBan0009386 FBgn0037708 CG9386 3 3R CG9386 CG9386 CDMC34490 4 5 4 DAC06-D14 12-CG9400-RA_2 CG9400 TGGCTTGCGAAAAGGGATTAGCCGGAGCTCAGACCTTAATCGAAACTATAACCACCACTACTCCAGCGT 69 FBan0009400 FBgn0030562 CG9400 X X defense response; GO:0006952; metabolism; GO:0008152 extracellular region; GO:0005576 CG9400 CG9400 anon-WO0140519.10 CDMC34490 4 6 4 DAC06-D14 12-CG9400-RA_2 CG9400 TGGCTTGCGAAAAGGGATTAGCCGGAGCTCAGACCTTAATCGAAACTATAACCACCACTACTCCAGCGT 69 FBan0009400 FBgn0030562 CG9400 X X defense response; GO:0006952; metabolism; GO:0008152 extracellular region; GO:0005576 CG9400 CG9400 anon-WO0140519.10 CDMC34491 4 7 4 DAC06-H02 9-CG9433-RB_6 CG9433 GCCATGGCTCCGGTATTTTCGAGATTTCAAACCGTGGTCATCACTTCTGGCACATTGTCACCCATGGAC 69 FBan0009433 FBgn0015844 Xpd 2 2R chromosome segregation; GO:0007059; nucleotide-excision repair; GO:0006289; regulation of mitosis; GO:0007088; transcription initiation from RNA polymerase II promoter; GO:0006367 "DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0016251; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0016818 ; EC:3.6.1.-; ; GO:0003677; ; GO:0008026; ; GO:0004003" cytoplasm; GO:0005737; nucleus; GO:0005634; polytene chromosome interband; GO:0005705; polytene chromosome puff; GO:0005703; transcription factor TFIIH complex; GO:0005675 Xpd Xeroderma pigmentosum D "CG9433, CG9433, DmXPD, DhR3, DhXPD, XPD/ERCC2, XPD, Xeroderma pigmentosum D" CDMC34491 4 8 4 DAC06-H02 9-CG9433-RB_6 CG9433 GCCATGGCTCCGGTATTTTCGAGATTTCAAACCGTGGTCATCACTTCTGGCACATTGTCACCCATGGAC 69 FBan0009433 FBgn0015844 Xpd 2 2R chromosome segregation; GO:0007059; nucleotide-excision repair; GO:0006289; regulation of mitosis; GO:0007088; transcription initiation from RNA polymerase II promoter; GO:0006367 "DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0003676; DNA helicase activity; GO:0003678; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0016251; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0016818 ; EC:3.6.1.-; ; GO:0003677; ; GO:0008026; ; GO:0004003" cytoplasm; GO:0005737; nucleus; GO:0005634; polytene chromosome interband; GO:0005705; polytene chromosome puff; GO:0005703; transcription factor TFIIH complex; GO:0005675 Xpd Xeroderma pigmentosum D "CG9433, CG9433, DmXPD, DhR3, DhXPD, XPD/ERCC2, XPD, Xeroderma pigmentosum D" CDMC34492 4 9 4 DAC06-H14 11-CG9444-RA_1 CG9444 CGCACGATATCCGGCTTCAGTTTTATCTACGCCTTTGGATGGTTACTCCTCACACTGACATCCCTGCCT 69 FBan0009444 FBgn0037730 CG9444 3 3R oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG9444 CG9444 CDMC34492 4 10 4 DAC06-H14 11-CG9444-RA_1 CG9444 CGCACGATATCCGGCTTCAGTTTTATCTACGCCTTTGGATGGTTACTCCTCACACTGACATCCCTGCCT 69 FBan0009444 FBgn0037730 CG9444 3 3R oligopeptide transport; GO:0006857; transport; GO:0006810 proton-dependent oligopeptide transporter activity; GO:0005427; ; GO:0005427 membrane; GO:0016020 CG9444 CG9444 CDMC34493 4 11 4 DAC06-L02 23-CG9476-RA_1 CG9476 ACAGCCATTACAACTTTATAAACATCACTTTCTTTCTACCAAATACCAATGCATAAAACAGTTTCGCAA 69 FBan0009476 FBgn0003886 alphaTub85E 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub85E alpha-Tubulin at 85E "CG9476, CG9476, alpha2tubulin, DTA3, alpha85E, alpha2, alpha2-tubulin, 2t, alpha-tubulin, T, a2t, alphaTub2, alphaTub84E, aTub85E, alpha tubulin, alphatubulin, ALPHA 85E, alpha-Tubulin, alpha85E-tubulin, alpha-Tub85E, alpha2t" CDMC34493 4 12 4 DAC06-L02 23-CG9476-RA_1 CG9476 ACAGCCATTACAACTTTATAAACATCACTTTCTTTCTACCAAATACCAATGCATAAAACAGTTTCGCAA 69 FBan0009476 FBgn0003886 alphaTub85E 3 3R cell motility; GO:0006928; cellular physiological process; GO:0050875; chromosome segregation; GO:0007059; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; mitosis; GO:0007067; mitotic spindle checkpoint; GO:0007094 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631 microtubule; GO:0005874; tubulin; GO:0045298 alphaTub85E alpha-Tubulin at 85E "CG9476, CG9476, alpha2tubulin, DTA3, alpha85E, alpha2, alpha2-tubulin, 2t, alpha-tubulin, T, a2t, alphaTub2, alphaTub84E, aTub85E, alpha tubulin, alphatubulin, ALPHA 85E, alpha-Tubulin, alpha85E-tubulin, alpha-Tub85E, alpha2t" CDMC34494 4 13 4 DAC06-L14 2-CG9493-RA_1 CG9493 GCCAAAGAACCACGACCCCAACTTTTTACCCTATGACGACAACAGAGTGCGACTGACTCCATGCCGAGA 69 FBan0009493 FBgn0031799 Pez 2 2L protein amino acid dephosphorylation; GO:0006470 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004725 ; EC:3.1.3.48 cytoskeleton; GO:0005856 Pez Pez "CG9493, CG9493, CG9493, CG9493, PTPD1" CDMC34494 4 14 4 DAC06-L14 2-CG9493-RA_1 CG9493 GCCAAAGAACCACGACCCCAACTTTTTACCCTATGACGACAACAGAGTGCGACTGACTCCATGCCGAGA 69 FBan0009493 FBgn0031799 Pez 2 2L protein amino acid dephosphorylation; GO:0006470 cytoskeletal protein binding; GO:0008092; ; GO:0008092; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0004725 ; EC:3.1.3.48 cytoskeleton; GO:0005856 Pez Pez "CG9493, CG9493, CG9493, CG9493, PTPD1" CDMC34495 4 15 4 DAC06-P02 14-CG9522-RA_1 CG9522 GGCGTCATAATCTGCACATTCTAACACTGGCTAGAGTCACCCGAGTTCTGATAGATGCAGCCACCAAGT 69 FBan0009522 FBgn0030587 CG9522 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9522 CG9522 CDMC34495 4 16 4 DAC06-P02 14-CG9522-RA_1 CG9522 GGCGTCATAATCTGCACATTCTAACACTGGCTAGAGTCACCCGAGTTCTGATAGATGCAGCCACCAAGT 69 FBan0009522 FBgn0030587 CG9522 X X electron transport; GO:0006118 choline dehydrogenase activity; GO:0008812 ; EC:1.1.99.1; ; GO:0008812 ; EC:1.1.99.1; FAD binding; GO:0050660; ; GO:0050660 CG9522 CG9522 CDMC34496 4 17 4 DAC06-P14 23-CG9535-RA_3 CG9535 AATCTTTCGTATACCGTTGATGAACTTTATGATTCCCCAAACTGTAGTTAGTGCACGGAAATTCCATTG 69 FBan0009535 FBgn0027501 CG9535 2 2L protein amino acid glycosylation; GO:0006486 UDP-N-acetylglucosamine diphosphorylase activity; GO:0003977 ; EC:2.7.7.23; ; GO:0003977 ; EC:2.7.7.23 CG9535 CG9535 "LD44264, BcDNA:LD24639, anon-WO0140519.242" CDMC34496 4 18 4 DAC06-P14 23-CG9535-RA_3 CG9535 AATCTTTCGTATACCGTTGATGAACTTTATGATTCCCCAAACTGTAGTTAGTGCACGGAAATTCCATTG 69 FBan0009535 FBgn0027501 CG9535 2 2L protein amino acid glycosylation; GO:0006486 UDP-N-acetylglucosamine diphosphorylase activity; GO:0003977 ; EC:2.7.7.23; ; GO:0003977 ; EC:2.7.7.23 CG9535 CG9535 "LD44264, BcDNA:LD24639, anon-WO0140519.242" CDMC34497 4 19 4 DAC07-D02 23-CG6583-RA_4 CG6583 TTTCGCCACTCCACATGATATCTAAGCTAGGATTGACTTTTGATATCAAAAACACATTCCGTCCACCTT 69 FBan0006583 FBgn0032420 CG6583 2 2L CG6583 CG6583 CDMC34497 4 20 4 DAC07-D02 23-CG6583-RA_4 CG6583 TTTCGCCACTCCACATGATATCTAAGCTAGGATTGACTTTTGATATCAAAAACACATTCCGTCCACCTT 69 FBan0006583 FBgn0032420 CG6583 2 2L CG6583 CG6583 CDMC34498 4 21 4 DAC07-D14 10-CG6592-RA_1 CG6592 GGCACTCGAAGAAGAGAGTCCTGGTGGGAATTACATCCTTTGGCAGCATATACGGTTGTGATCGAGGCT 69 FBan0006592 FBgn0035669 CG6592 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- CG6592 CG6592 SP105 CDMC34498 4 22 4 DAC07-D14 10-CG6592-RA_1 CG6592 GGCACTCGAAGAAGAGAGTCCTGGTGGGAATTACATCCTTTGGCAGCATATACGGTTGTGATCGAGGCT 69 FBan0006592 FBgn0035669 CG6592 3 3L proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.- CG6592 CG6592 SP105 CDMC34499 4 23 4 DAC07-H02 22-CG6622-RA_1 CG6622 CACGGACAAGGTGTTTATGATGAATCTGGATCAGTCGGAATTCGTTGGCTTCTCCTACATGAATCCCGA 69 FBan0006622 FBgn0003091 Pkc53E 2 2R MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- Pkc53E Protein C kinase 53E "CG6622, CG6622, dPKC, dPKC53E(br), DPKC, PKC1, PKC, protein kinase C, Dpkc1, PKC 53E, PKC 53B, Pkc1" CDMC34499 4 24 4 DAC07-H02 22-CG6622-RA_1 CG6622 CACGGACAAGGTGTTTATGATGAATCTGGATCAGTCGGAATTCGTTGGCTTCTCCTACATGAATCCCGA 69 FBan0006622 FBgn0003091 Pkc53E 2 2R MAPKKK cascade; GO:0000165; calcium-mediated signaling; GO:0019722; cell cycle; GO:0007049; protein amino acid phosphorylation; GO:0006468; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein kinase C activity; GO:0004697 ; EC:2.7.1.-; ; GO:0019992; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium-dependent protein kinase C activity; GO:0004698 ; EC:2.7.1.-; diacylglycerol-activated phospholipid-dependent protein kinase C activity; GO:0004701 ; EC:2.7.1.-; ; GO:0004697 ; EC:2.7.1.-; ; GO:0004698 ; EC:2.7.1.-; ; GO:0004701 ; EC:2.7.1.- Pkc53E Protein C kinase 53E "CG6622, CG6622, dPKC, dPKC53E(br), DPKC, PKC1, PKC, protein kinase C, Dpkc1, PKC 53E, PKC 53B, Pkc1" CDMC34500 4 25 4 DAC07-H14 7-CG6631-RA_1 CG6631 ACGTTGCCAGTGAGAGTTCAGATGAGTCCTTAAGGGGGCACTTTCTGAAGTCGGTCCTACATTCGCTCT 69 FBan0006631 FBgn0039206 CG6631 3 3R CG6631 CG6631 CDMC34500 4 26 4 DAC07-H14 7-CG6631-RA_1 CG6631 ACGTTGCCAGTGAGAGTTCAGATGAGTCCTTAAGGGGGCACTTTCTGAAGTCGGTCCTACATTCGCTCT 69 FBan0006631 FBgn0039206 CG6631 3 3R CG6631 CG6631 CDMC34501 4 1 5 DAC07-L02 14-CG6665-RA_1 CG6665 CGCCGAGCTAGCCACAAATCCTCTTCATCTTCAAGCACCCTCCGACAGAGATCTCATCATACGCAATAG 69 FBan0006665 FBgn0034172 CG6665 2 2R CG6665 CG6665 CDMC34501 4 2 5 DAC07-L02 14-CG6665-RA_1 CG6665 CGCCGAGCTAGCCACAAATCCTCTTCATCTTCAAGCACCCTCCGACAGAGATCTCATCATACGCAATAG 69 FBan0006665 FBgn0034172 CG6665 2 2R CG6665 CG6665 CDMC34502 4 3 5 DAC07-L14 2-CG6673-RB_1 CG6673 CCATGCGAAGTTCATGAAGACCCGCCATGAGAACAAACCGGACTACGATGTAGCCTTCCAGCCCTTGTA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC34502 4 4 5 DAC07-L14 2-CG6673-RB_1 CG6673 CCATGCGAAGTTCATGAAGACCCGCCATGAGAACAAACCGGACTACGATGTAGCCTTCCAGCCCTTGTA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC34503 4 5 5 DAC07-P02 11-CG6702-RA_1 CG6702 GCACTCGTCCTTGTATTTTTTTCACCCGAGGGGAGATTACGAGGTGCAGATTGACGCCGTTTTAAGGCT 69 FBan0006702 FBgn0004580 Cbp53E 2 2R calcium ion homeostasis; GO:0006874; calcium-mediated signaling; GO:0019722; transmission of nerve impulse; GO:0019226 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Cbp53E Calbindin 53E "CG6702, DCBP, cbn, Calbindin 32, Dcp, cbp53E, calbindin-32, calbindin, Dcbp" CDMC34503 4 6 5 DAC07-P02 11-CG6702-RA_1 CG6702 GCACTCGTCCTTGTATTTTTTTCACCCGAGGGGAGATTACGAGGTGCAGATTGACGCCGTTTTAAGGCT 69 FBan0006702 FBgn0004580 Cbp53E 2 2R calcium ion homeostasis; GO:0006874; calcium-mediated signaling; GO:0019722; transmission of nerve impulse; GO:0019226 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Cbp53E Calbindin 53E "CG6702, DCBP, cbn, Calbindin 32, Dcp, cbp53E, calbindin-32, calbindin, Dcbp" CDMC34504 4 7 5 DAC07-P14 16-CG6715-RA_2 CG6715 GCAAGTACCGTGTGCCCTACTACATCTCAATGGACTGCGAAAACCTAATGAGAAAGTTCCTGGTCCTGA 69 FBan0006715 FBgn0026064 KP78a 3 3R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 KP78a KP78a "CG6715, CG6715, KP78A, Kp78A" CDMC34504 4 8 5 DAC07-P14 16-CG6715-RA_2 CG6715 GCAAGTACCGTGTGCCCTACTACATCTCAATGGACTGCGAAAACCTAATGAGAAAGTTCCTGGTCCTGA 69 FBan0006715 FBgn0026064 KP78a 3 3R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 KP78a KP78a "CG6715, CG6715, KP78A, Kp78A" CDMC34505 4 9 5 DAC08-D02 12-CG31870-RC_1 CG31870 CGGAAACGCGGAGGGTCCACAGTTTTCCATGTATGTTAGGAACTCCAAGATGAAACCCCTTCCCATTCG 69 FBan0031870 FBgn0051870 CG31870 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31870 CG31870 "bs19e04.y1, bs28a02.y1, BcDNA:AT11120, NEST:bs28a02, NEST:bs19e04" CDMC34505 4 10 5 DAC08-D02 12-CG31870-RC_1 CG31870 CGGAAACGCGGAGGGTCCACAGTTTTCCATGTATGTTAGGAACTCCAAGATGAAACCCCTTCCCATTCG 69 FBan0031870 FBgn0051870 CG31870 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31870 CG31870 "bs19e04.y1, bs28a02.y1, BcDNA:AT11120, NEST:bs28a02, NEST:bs19e04" CDMC34506 4 11 5 DAC08-D14 14-CG31878-RA_1 CG31878 GCGGTCTTAGCCAAGCACTTACTCATCAGTCGTCTGCACTCCATCGCTTCAGTTACAACTCCAACTTGT 69 FBan0031878 FBgn0051878 CG31878 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG31878 CG31878 CG4588 CDMC34506 4 12 5 DAC08-D14 14-CG31878-RA_1 CG31878 GCGGTCTTAGCCAAGCACTTACTCATCAGTCGTCTGCACTCCATCGCTTCAGTTACAACTCCAACTTGT 69 FBan0031878 FBgn0051878 CG31878 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG31878 CG31878 CG4588 CDMC34507 4 13 5 DAC08-H02 23-CG31909-RA_6 CG31909 CCCTCGTTTTCCAATACTAACAAATCGGAACTTCAGAACCAACTACGAGTAGAGAGAGCTCTGCAAGAT 69 FBan0031909 FBgn0051909 CG31909 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31909 CG31909 NEST:bs19e08 CDMC34507 4 14 5 DAC08-H02 23-CG31909-RA_6 CG31909 CCCTCGTTTTCCAATACTAACAAATCGGAACTTCAGAACCAACTACGAGTAGAGAGAGCTCTGCAAGAT 69 FBan0031909 FBgn0051909 CG31909 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31909 CG31909 NEST:bs19e08 CDMC34508 4 15 5 DAC08-H14 1-CG31920-RB_1 CG31920 ACCGTGTGGAACTACAGTCCCCAAAAGGAATCCTTGGTGTGGTATGGCGTTAAATCGCAGTACCCGTCT 69 FBan0031920 FBgn0051920 CG31920 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31920 CG31920 "anon-WO0140519.62, BcDNA:GH10778, NEST:bs21f09" CDMC34508 4 16 5 DAC08-H14 1-CG31920-RB_1 CG31920 ACCGTGTGGAACTACAGTCCCCAAAAGGAATCCTTGGTGTGGTATGGCGTTAAATCGCAGTACCCGTCT 69 FBan0031920 FBgn0051920 CG31920 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31920 CG31920 "anon-WO0140519.62, BcDNA:GH10778, NEST:bs21f09" CDMC34509 4 17 5 DAC08-L02 15-CG31961-RA_3 CG31961 GCATCCACCATGTTTCTGCCCGACTTCAAGATCAAATCCTGTCAGAATATCCTTAACACCCTGACCGCC 69 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC34509 4 18 5 DAC08-L02 15-CG31961-RA_3 CG31961 GCATCCACCATGTTTCTGCCCGACTTCAAGATCAAATCCTGTCAGAATATCCTTAACACCCTGACCGCC 69 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC34510 4 19 5 DAC08-L14 23-CG31989-RA_1 CG31989 CATTACAGGGTATATGAGTGCCGTAGGGTATATTTATGCTTATAGAAATGAAATCATACCAACGCATCG 69 FBan0031989 FBgn0051989 CG31989 2 2L CG31989 CG31989 "CG14019, CG6922, BcDNA:RE74832" CDMC34510 4 20 5 DAC08-L14 23-CG31989-RA_1 CG31989 CATTACAGGGTATATGAGTGCCGTAGGGTATATTTATGCTTATAGAAATGAAATCATACCAACGCATCG 69 FBan0031989 FBgn0051989 CG31989 2 2L CG31989 CG31989 "CG14019, CG6922, BcDNA:RE74832" CDMC34511 4 21 5 DAC08-P02 3-CG32022-RA_4 CG32022 CCGGGGAATGGAGAACTTCATGCGGATAAGCATCGATACGGCCATGTTCTACGGATCTAAGGTGCTGCT 69 FBan0032022 FBgn0052022 CG32022 3 3L CG32022 CG32022 "CG5950, CG5950, BcDNA:AT11343" CDMC34511 4 22 5 DAC08-P02 3-CG32022-RA_4 CG32022 CCGGGGAATGGAGAACTTCATGCGGATAAGCATCGATACGGCCATGTTCTACGGATCTAAGGTGCTGCT 69 FBan0032022 FBgn0052022 CG32022 3 3L CG32022 CG32022 "CG5950, CG5950, BcDNA:AT11343" CDMC34512 4 23 5 DAC08-P14 14-CG32032-RA_2 CG32032 CCACCACTCAATCCTCCTATCCGGATAGCGATGAGTACCCGTTGAGATCGATTCAAAGCCAGCAGAAGT 69 FBan0032032 FBgn0043806 CG32032 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32032 CG32032 "BEST:GH25183, BcDNA:RH42907" CDMC34512 4 24 5 DAC08-P14 14-CG32032-RA_2 CG32032 CCACCACTCAATCCTCCTATCCGGATAGCGATGAGTACCCGTTGAGATCGATTCAAAGCCAGCAGAAGT 69 FBan0032032 FBgn0043806 CG32032 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32032 CG32032 "BEST:GH25183, BcDNA:RH42907" CDMC34513 4 25 5 DAC09-D03 6-CG5428-RA_1 CG5428 CAGGGCACCAAGTCGGACTTTATGCACTCCTTCATCGACGGCTATGTGAACTTCACGCCCTGCTG 65 FBan0005428 FBgn0034887 CG5428 2 2R sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG5428 CG5428 CDMC34513 4 26 5 DAC09-D03 6-CG5428-RA_1 CG5428 CAGGGCACCAAGTCGGACTTTATGCACTCCTTCATCGACGGCTATGTGAACTTCACGCCCTGCTG 65 FBan0005428 FBgn0034887 CG5428 2 2R sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.- CG5428 CG5428 CDMC34514 4 1 6 DAC09-D15 3-CG5466-RA_5 CG5466 GAGCTGATGCGAAACATGTCGCGGATGAAAACCTACATACGTCCCTCGATGTGCAAGCCCTACGG 65 FBan0005466 FBgn0038815 CG5466 3 3R cellular physiological process; GO:0050875 CG5466 CG5466 CDMC34514 4 2 6 DAC09-D15 3-CG5466-RA_5 CG5466 GAGCTGATGCGAAACATGTCGCGGATGAAAACCTACATACGTCCCTCGATGTGCAAGCCCTACGG 65 FBan0005466 FBgn0038815 CG5466 3 3R cellular physiological process; GO:0050875 CG5466 CG5466 CDMC34515 4 3 6 DAC09-H03 1-CG5602-RA_1 CG5602 AACTGGCTTCACTGATGAGGACCTGCAAACGCATTCCGAGTTTTTGGGCAAACATGTGACCAGCG 65 FBan0005602 FBgn0034922 CG5602 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 CG5602 CG5602 CDMC34515 4 4 6 DAC09-H03 1-CG5602-RA_1 CG5602 AACTGGCTTCACTGATGAGGACCTGCAAACGCATTCCGAGTTTTTGGGCAAACATGTGACCAGCG 65 FBan0005602 FBgn0034922 CG5602 2 2R DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003910 ; EC:6.5.1.1 CG5602 CG5602 CDMC34516 4 5 6 DAC09-H15 9-CG5648-RA_1 CG5648 TTCACACTTTTGGCCATGTTCCGGAATCAGTATGACAACGACACAACCACTTGGAGTCCGCAGGG 65 FBan0005648 FBgn0032492 Prosalpha6T 2 2L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha6T Prosalpha6T "CG5648, Prosalpha6T" CDMC34516 4 6 6 DAC09-H15 9-CG5648-RA_1 CG5648 TTCACACTTTTGGCCATGTTCCGGAATCAGTATGACAACGACACAACCACTTGGAGTCCGCAGGG 65 FBan0005648 FBgn0032492 Prosalpha6T 2 2L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosalpha6T Prosalpha6T "CG5648, Prosalpha6T" CDMC34517 4 7 6 DAC09-L03 8-CG5762-RA_1 CG5762 GTGTGGCGACCAAACGAAATCGTAGACGGGACTTTCTGGAGTCGATGGAAACTGAGGCTCCTCGA 65 FBan0005762 FBgn0039190 CG5762 3 3R CG5762 CG5762 "anon-WO0140519.76, BEST:GH05452" CDMC34517 4 8 6 DAC09-L03 8-CG5762-RA_1 CG5762 GTGTGGCGACCAAACGAAATCGTAGACGGGACTTTCTGGAGTCGATGGAAACTGAGGCTCCTCGA 65 FBan0005762 FBgn0039190 CG5762 3 3R CG5762 CG5762 "anon-WO0140519.76, BEST:GH05452" CDMC34518 4 9 6 DAC09-L15 6-CG5823-RA_1 CG5823 AACCTGCGCAACACCAACTTCTGTGAGCTGTTTCCGGAGATAGTCGAAGAGATCAAGCAGCGGCT 65 FBan0005823 FBgn0038515 CG5823 3 3R protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; carrier activity; GO:0005386; binding; GO:0005488; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005488; ; GO:0004840; ; GO:0005386; ; GO:0004842 ; EC:6.3.2.19 CG5823 CG5823 CDMC34518 4 10 6 DAC09-L15 6-CG5823-RA_1 CG5823 AACCTGCGCAACACCAACTTCTGTGAGCTGTTTCCGGAGATAGTCGAAGAGATCAAGCAGCGGCT 65 FBan0005823 FBgn0038515 CG5823 3 3R protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; carrier activity; GO:0005386; binding; GO:0005488; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005488; ; GO:0004840; ; GO:0005386; ; GO:0004842 ; EC:6.3.2.19 CG5823 CG5823 CDMC34519 4 11 6 DAC09-P03 3-CG5928-RA_3 CG5928 GACTCCATCAGTGAGCACGAGAAGTACGGCAACAACGGTGACATGTTCGACGGCATCTCGCGATC 65 FBan0005928 FBgn0029836 CG5928 X X CG5928 CG5928 CDMC34519 4 12 6 DAC09-P03 3-CG5928-RA_3 CG5928 GACTCCATCAGTGAGCACGAGAAGTACGGCAACAACGGTGACATGTTCGACGGCATCTCGCGATC 65 FBan0005928 FBgn0029836 CG5928 X X CG5928 CG5928 CDMC34520 4 13 6 DAC09-P15 18-CG5971-RA_9 CG5971 TGCACCAGCATAGCAAGTGTAGGAGCAGTTTACAAGAAACTATGCACCGAACTGCAGCTCAAAGT 65 FBan0005971 FBgn0035918 CG5971 3 3L pre-replicative complex formation and maintenance; GO:0006267; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; DNA clamp loader activity; GO:0003689; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; ; GO:0003689; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 CG5971 CG5971 CDMC34520 4 14 6 DAC09-P15 18-CG5971-RA_9 CG5971 TGCACCAGCATAGCAAGTGTAGGAGCAGTTTACAAGAAACTATGCACCGAACTGCAGCTCAAAGT 65 FBan0005971 FBgn0035918 CG5971 3 3L pre-replicative complex formation and maintenance; GO:0006267; regulation of progression through cell cycle; GO:0000074 ATP binding; GO:0005524; ; GO:0005524; DNA clamp loader activity; GO:0003689; DNA replication origin binding; GO:0003688; ; GO:0003688; nucleotide binding; GO:0000166; ; GO:0003689; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 pre-replicative complex; GO:0005656 CG5971 CG5971 CDMC34521 4 15 6 DAC10-D02 3-CG6524-RA_1 CG6524 GTGGCCAAGCTTTTCGTCCCAGAGAACCAGTATGGCAACCAGTACGTTAGCCAGTACTCTGCACC 65 FBan0006524 FBgn0000358 Cp19 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp19 Chorion protein 19 "CG6524, CG6524, s19-1, s19, C.s19, cp19, Dms19, CP19, S19: Shell-19, Shell-19" CDMC34521 4 16 6 DAC10-D02 3-CG6524-RA_1 CG6524 GTGGCCAAGCTTTTCGTCCCAGAGAACCAGTATGGCAACCAGTACGTTAGCCAGTACTCTGCACC 65 FBan0006524 FBgn0000358 Cp19 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp19 Chorion protein 19 "CG6524, CG6524, s19-1, s19, C.s19, cp19, Dms19, CP19, S19: Shell-19, Shell-19" CDMC34522 4 17 6 DAC10-D14 1-CG6565-RA_2 CG6565 GCGTTGTCTGGAAAAGTTCGCGTCACTGACTATTGGAGCCTGATGGTCATCAAGCCCTTTCGCGG 65 FBan0006565 FBgn0032513 CG6565 2 2L phosphatidylcholine transporter activity; GO:0008525; ; GO:0008525 CG6565 CG6565 CDMC34522 4 18 6 DAC10-D14 1-CG6565-RA_2 CG6565 GCGTTGTCTGGAAAAGTTCGCGTCACTGACTATTGGAGCCTGATGGTCATCAAGCCCTTTCGCGG 65 FBan0006565 FBgn0032513 CG6565 2 2L phosphatidylcholine transporter activity; GO:0008525; ; GO:0008525 CG6565 CG6565 CDMC34523 4 19 6 DAC10-H02 3-CG6699-RA_3 CG6699 TTTGGGTGGGAGACTGCTTCATCTATACCAACTCGGTGAACCGCATCAACTACTACGTGGGCGGC 65 FBan0006699 FBgn0025724 beta'Cop 2 2L "ER to Golgi transport; GO:0006888; Golgi vesicle budding; GO:0048194; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 beta'Cop beta'-coatomer protein "CG6699, CG6699, beta'-COP, dbeta'COP, beta'Cop" CDMC34523 4 20 6 DAC10-H02 3-CG6699-RA_3 CG6699 TTTGGGTGGGAGACTGCTTCATCTATACCAACTCGGTGAACCGCATCAACTACTACGTGGGCGGC 65 FBan0006699 FBgn0025724 beta'Cop 2 2L "ER to Golgi transport; GO:0006888; Golgi vesicle budding; GO:0048194; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 beta'Cop beta'-coatomer protein "CG6699, CG6699, beta'-COP, dbeta'COP, beta'Cop" CDMC34524 4 21 6 DAC10-H14 2-CG6742-RB_3 CG6742 TAAAGCTGCATACGACCTCTCCTCCAGTGACGGAAAGAAGGCTCTGGACATTGCAGTGGACCAGG 65 FBan0006742 FBgn0039056 cenB1A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; carbohydrate metabolism; GO:0005975; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 "ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" cenB1A centaurin beta 1A "CG6742, CenB1A, centaurin beta 1A" CDMC34524 4 22 6 DAC10-H14 2-CG6742-RB_3 CG6742 TAAAGCTGCATACGACCTCTCCTCCAGTGACGGAAAGAAGGCTCTGGACATTGCAGTGGACCAGG 65 FBan0006742 FBgn0039056 cenB1A 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; carbohydrate metabolism; GO:0005975; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; regulation of GTPase activity; GO:0043087 "ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0008060; hydrolase activity, hydrolyzing O-glycosyl compounds; GO:0004553 ; EC:3.2.1.-; ; GO:0004553 ; EC:3.2.1.-" cenB1A centaurin beta 1A "CG6742, CenB1A, centaurin beta 1A" CDMC34525 4 23 6 DAC10-L02 3-CG6838-RA_1 CG6838 ACCTCGTGGCAAGACAAGTACGGTTACTGATATCAGCGAAACACCCATGGTGACCCGCAAAGCAG 65 FBan0006838 FBgn0037182 CG6838 3 3L intracellular protein transport; GO:0006886; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG6838 CG6838 CDMC34525 4 24 6 DAC10-L02 3-CG6838-RA_1 CG6838 ACCTCGTGGCAAGACAAGTACGGTTACTGATATCAGCGAAACACCCATGGTGACCCGCAAAGCAG 65 FBan0006838 FBgn0037182 CG6838 3 3L intracellular protein transport; GO:0006886; regulation of GTPase activity; GO:0043087; vesicle-mediated transport; GO:0016192 ARF GTPase activator activity; GO:0008060; ; GO:0008060 CG6838 CG6838 CDMC34526 4 25 6 DAC10-L14 1-CG6863-RA_1 CG6863 ATCGTGGCCGATATAGTCTGCCCAAACGGTACTACTCCGGAAAGGCATAGGGCTATGGTGGAACC 65 FBan0006863 FBgn0004885 tok 3 3R dorsal/ventral axis specification; GO:0009950; proteolysis; GO:0006508 calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0017026 ; EC:3.4.24.19; ; GO:0005509; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 tok tolkin "CG6863, tldr-1, tolloid-related 1, tlr-1, tld-related-1, CT21251, tlr, tolloid-related, Tok, Tolkin, tldr1: tolloid-related 1, tolkin" CDMC34526 4 26 6 DAC10-L14 1-CG6863-RA_1 CG6863 ATCGTGGCCGATATAGTCTGCCCAAACGGTACTACTCCGGAAAGGCATAGGGCTATGGTGGAACC 65 FBan0006863 FBgn0004885 tok 3 3R dorsal/ventral axis specification; GO:0009950; proteolysis; GO:0006508 calcium ion binding; GO:0005509; zinc ion binding; GO:0008270; procollagen C-endopeptidase activity; GO:0017026 ; EC:3.4.24.19; ; GO:0017026 ; EC:3.4.24.19; ; GO:0005509; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21 tok tolkin "CG6863, tldr-1, tolloid-related 1, tlr-1, tld-related-1, CT21251, tlr, tolloid-related, Tok, Tolkin, tldr1: tolloid-related 1, tolkin" CDMC34527 4 1 7 DAC10-P02 3-CG6962-RA_2 CG6962 GACACTTTGGACACCTCAAAGCTGAACCCGCACCAAATGTCGCTCAATGCTTCTAGCCTGCATGC 65 FBan0006962 FBgn0037958 CG6962 3 3R CG6962 CG6962 CDMC34527 4 2 7 DAC10-P02 3-CG6962-RA_2 CG6962 GACACTTTGGACACCTCAAAGCTGAACCCGCACCAAATGTCGCTCAATGCTTCTAGCCTGCATGC 65 FBan0006962 FBgn0037958 CG6962 3 3R CG6962 CG6962 CDMC34528 4 3 7 DAC10-P14 1-CG7005-RA_1 CG7005 ATTAGGCAAAATGTCCCAGTGGTCATAGATGCGTCGCATGTCTACGGGGCTGACTTCACAACGGC 65 FBan0007005 FBgn0013953 Esp 3 3R extracellular transport; GO:0006858; sulfate transport; GO:0008272; sulfur metabolism; GO:0006790 sulfate porter activity; GO:0008271; ; GO:0008271; ; GO:0008271 Esp Epidermal stripes and patches "CG7005, Epidermal stripes and patches" CDMC34528 4 4 7 DAC10-P14 1-CG7005-RA_1 CG7005 ATTAGGCAAAATGTCCCAGTGGTCATAGATGCGTCGCATGTCTACGGGGCTGACTTCACAACGGC 65 FBan0007005 FBgn0013953 Esp 3 3R extracellular transport; GO:0006858; sulfate transport; GO:0008272; sulfur metabolism; GO:0006790 sulfate porter activity; GO:0008271; ; GO:0008271; ; GO:0008271 Esp Epidermal stripes and patches "CG7005, Epidermal stripes and patches" CDMC34529 4 5 7 DAC11-D02 18-CG10016-RA_1 CG10016 ACCACTAGATGCAATCTACAGCCACGACAAGCGATTATAGTGAACGGAATGCTACGTTCAGGTGTTGGT 69 FBan0010016 FBgn0024244 drm 2 2L foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; leg joint morphogenesis (sensu Endopterygota); GO:0016348 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 drm drumstick "CG10016, CG10016, CG10016, drum, drumstick" CDMC34529 4 6 7 DAC11-D02 18-CG10016-RA_1 CG10016 ACCACTAGATGCAATCTACAGCCACGACAAGCGATTATAGTGAACGGAATGCTACGTTCAGGTGTTGGT 69 FBan0010016 FBgn0024244 drm 2 2L foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; leg joint morphogenesis (sensu Endopterygota); GO:0016348 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 drm drumstick "CG10016, CG10016, CG10016, drum, drumstick" CDMC34530 4 7 7 DAC11-D14 2-CG10032-RA_1 CG10032 GCAAGGGGTCTGAACTGTCTGAACTTTAGTCAGGTGTGCGATGGATTAGCGGATTGCAAGGACTGCAGC 69 FBan0010032 FBgn0037493 CG10032 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10032 CG10032 CDMC34530 4 8 7 DAC11-D14 2-CG10032-RA_1 CG10032 GCAAGGGGTCTGAACTGTCTGAACTTTAGTCAGGTGTGCGATGGATTAGCGGATTGCAAGGACTGCAGC 69 FBan0010032 FBgn0037493 CG10032 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG10032 CG10032 CDMC34531 4 9 7 DAC11-H02 23-CG10063-RA_1 CG10063 TGAAATTGTCAATTGCTTCAGTGAAGAATTTTTAATCTGCTTAAACTTGGAAAATGATTCGCGCCATGG 69 FBan0010063 FBgn0035727 CG10063 3 3L CG10063 CG10063 BcDNA:AT30027 CDMC34531 4 10 7 DAC11-H02 23-CG10063-RA_1 CG10063 TGAAATTGTCAATTGCTTCAGTGAAGAATTTTTAATCTGCTTAAACTTGGAAAATGATTCGCGCCATGG 69 FBan0010063 FBgn0035727 CG10063 3 3L CG10063 CG10063 BcDNA:AT30027 CDMC34532 4 11 7 DAC11-H14 18-CG10075-RA_1 CG10075 CGCCGACAAGATCAACTATGTGACCTTTTTCCGCGACTTCAATCTGCCCAATACCTTTAACTCCTGGTT 69 FBan0010075 FBgn0035722 CG10075 3 3L CG10075 CG10075 CDMC34532 4 12 7 DAC11-H14 18-CG10075-RA_1 CG10075 CGCCGACAAGATCAACTATGTGACCTTTTTCCGCGACTTCAATCTGCCCAATACCTTTAACTCCTGGTT 69 FBan0010075 FBgn0035722 CG10075 3 3L CG10075 CG10075 CDMC34533 4 13 7 DAC11-L02 1-CG10101-RA_2 CG10101 CCCGAATACCTCTCCCCGTTCACTTACCACTTACCTTCAAATCCCCCAGTTGACAGAGAAGCCTCCTGG 69 FBan0010101 FBgn0037501 CG10101 3 3R ionotropic glutamate receptor signaling pathway; GO:0035235 glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; glutamate binding; GO:0016595; ; GO:0016595; ; GO:0004970 ionotropic glutamate receptor complex; GO:0008328 CG10101 CG10101 CT28433 CDMC34533 4 14 7 DAC11-L02 1-CG10101-RA_2 CG10101 CCCGAATACCTCTCCCCGTTCACTTACCACTTACCTTCAAATCCCCCAGTTGACAGAGAAGCCTCCTGG 69 FBan0010101 FBgn0037501 CG10101 3 3R ionotropic glutamate receptor signaling pathway; GO:0035235 glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; glutamate binding; GO:0016595; ; GO:0016595; ; GO:0004970 ionotropic glutamate receptor complex; GO:0008328 CG10101 CG10101 CT28433 CDMC34534 4 15 7 DAC11-L14 2-CG10113-RA_2 CG10113 GCCACCAGTAACCAATCCCAATGTCAGTCTGGAAGTCTGCGATGCTCTGTACGAGTCCAATCGCTTGGA 69 FBan0010113 FBgn0037502 CG10113 3 3R CG10113 CG10113 CDMC34534 4 16 7 DAC11-L14 2-CG10113-RA_2 CG10113 GCCACCAGTAACCAATCCCAATGTCAGTCTGGAAGTCTGCGATGCTCTGTACGAGTCCAATCGCTTGGA 69 FBan0010113 FBgn0037502 CG10113 3 3R CG10113 CG10113 CDMC34535 4 17 7 DAC11-P02 1-CG10140-RA_1 CG10140 ACTCCAATGCGTATCATTTGCGCTATGTTCCCAGCAAGGTTTCCTGCCAGAAGTACTTCATCTGCGGCA 69 FBan0010140 FBgn0036363 CG10140 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG10140 CG10140 CDMC34535 4 18 7 DAC11-P02 1-CG10140-RA_1 CG10140 ACTCCAATGCGTATCATTTGCGCTATGTTCCCAGCAAGGTTTCCTGCCAGAAGTACTTCATCTGCGGCA 69 FBan0010140 FBgn0036363 CG10140 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG10140 CG10140 CDMC34536 4 19 7 DAC11-P14 3-CG10155-RA_1 CG10155 GGCACCGCAGAACGATTACGGACGCTTGCTGTTCTAGGCTTTATCCATGATGACAGCCTGAGGACTCAT 69 FBgn0033964 CDMC34536 4 20 7 DAC11-P14 3-CG10155-RA_1 CG10155 GGCACCGCAGAACGATTACGGACGCTTGCTGTTCTAGGCTTTATCCATGATGACAGCCTGAGGACTCAT 69 FBgn0033964 CDMC34537 4 21 7 DAC12-D02 17-CG30105-RA_1 CG30105 AGCCCATCAGCGATACCTCCGACCGAAAGTTGCGGCTAACTGGAGTATTTCAAGATTTTACTTACTGGA 69 FBan0030105 FBgn0050105 CG30105 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30105 CG30105 BcDNA:RE11282 CDMC34537 4 22 7 DAC12-D02 17-CG30105-RA_1 CG30105 AGCCCATCAGCGATACCTCCGACCGAAAGTTGCGGCTAACTGGAGTATTTCAAGATTTTACTTACTGGA 69 FBan0030105 FBgn0050105 CG30105 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30105 CG30105 BcDNA:RE11282 CDMC34538 4 23 7 DAC12-D14 24-CG30119-RA_3 CG30119 ATGTGACACTTGTAACTAGTCTTGCTCTTGTTTCATAACTAAGACTTTTAATATTTTTCAAAATCCTAA 69 FBan0030119 FBgn0050119 CG30119 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30119 CG30119 CDMC34538 4 24 7 DAC12-D14 24-CG30119-RA_3 CG30119 ATGTGACACTTGTAACTAGTCTTGCTCTTGTTTCATAACTAAGACTTTTAATATTTTTCAAAATCCTAA 69 FBan0030119 FBgn0050119 CG30119 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30119 CG30119 CDMC34539 4 25 7 DAC12-H02 23-CG30154-RA_3 CG30154 ACTTTGCTTCGCAATTGATTTTCGTCGAACAGTACTCGATTTGTATGCTAATACTTCATTCATGGTCAC 69 FBan0030154 FBgn0050154 CG30154 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30154 CG30154 CDMC34539 4 26 7 DAC12-H02 23-CG30154-RA_3 CG30154 ACTTTGCTTCGCAATTGATTTTCGTCGAACAGTACTCGATTTGTATGCTAATACTTCATTCATGGTCAC 69 FBan0030154 FBgn0050154 CG30154 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30154 CG30154 CDMC34540 4 1 8 DAC12-H14 22-CG30169-RA_1 CG30169 TGCAAGCACTGACTCGAACCAACCAACTGTGATCTCTGAGGAATCGAGAAATATTGATGCCAAGTTCGT 69 FBan0030169 FBgn0050169 CG30169 2 2R CG30169 CG30169 "CG13583, CG13584, BcDNA:SD25109" CDMC34540 4 2 8 DAC12-H14 22-CG30169-RA_1 CG30169 TGCAAGCACTGACTCGAACCAACCAACTGTGATCTCTGAGGAATCGAGAAATATTGATGCCAAGTTCGT 69 FBan0030169 FBgn0050169 CG30169 2 2R CG30169 CG30169 "CG13583, CG13584, BcDNA:SD25109" CDMC34541 4 3 8 DAC12-L02 23-CG30195-RA_2 CG30195 GCAGCCAAGGATATGGACAAATCTCAGACGCAAATAGCAGTACACCAATAAATAAAAGCATATTTTTTT 69 FBan0030195 FBgn0050195 CG30195 2 2R CG30195 CG30195 "CG13513, CG13513, CG13513, CG13513" CDMC34541 4 4 8 DAC12-L02 23-CG30195-RA_2 CG30195 GCAGCCAAGGATATGGACAAATCTCAGACGCAAATAGCAGTACACCAATAAATAAAAGCATATTTTTTT 69 FBan0030195 FBgn0050195 CG30195 2 2R CG30195 CG30195 "CG13513, CG13513, CG13513, CG13513" CDMC34542 4 5 8 DAC12-L14 7-CG3025-RA_1 CG3025 GCAGTTTGGCAACTACGAGATCGACACCTGGTACTTTAGTCCCTTCCCCGAAGAATATGGCAAGGCACG 69 FBan0003025 FBgn0014340 mof X X "dosage compensation; GO:0007549; dosage compensation, by hyperactivation of X chromosome; GO:0009047; histone acetylation; GO:0016573; peptidyl-lysine acetylation; GO:0018394; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; protein binding; GO:0005515; ; GO:0003729; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; H3/H4 histone acetyltransferase activity; GO:0004406 ; EC:2.3.1.-; ; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; lysine N-acetyltransferase activity; GO:0004468 ; EC:2.3.1.32; ; GO:0030528; ; GO:0005515; ; GO:0004406 ; EC:2.3.1.-; histone acetyltransferase activity (H4-K16 specific); GO:0046972; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004468 ; EC:2.3.1.32; ; GO:0046972 X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 mof males absent on the first "CG3025, CG3025, max: males-absent on the X, males-absent on the X, MOF, Mof, dmMOF, dMOF, max" CDMC34542 4 6 8 DAC12-L14 7-CG3025-RA_1 CG3025 GCAGTTTGGCAACTACGAGATCGACACCTGGTACTTTAGTCCCTTCCCCGAAGAATATGGCAAGGCACG 69 FBan0003025 FBgn0014340 mof X X "dosage compensation; GO:0007549; dosage compensation, by hyperactivation of X chromosome; GO:0009047; histone acetylation; GO:0016573; peptidyl-lysine acetylation; GO:0018394; regulation of transcription from RNA polymerase II promoter; GO:0006357" chromatin binding; GO:0003682; mRNA binding; GO:0003729; ; GO:0003682; protein binding; GO:0005515; ; GO:0003729; histone acetyltransferase activity; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004402 ; EC:2.3.1.48; H3/H4 histone acetyltransferase activity; GO:0004406 ; EC:2.3.1.-; ; GO:0004402 ; EC:2.3.1.48; transcription regulator activity; GO:0030528; lysine N-acetyltransferase activity; GO:0004468 ; EC:2.3.1.32; ; GO:0030528; ; GO:0005515; ; GO:0004406 ; EC:2.3.1.-; histone acetyltransferase activity (H4-K16 specific); GO:0046972; ; GO:0004402 ; EC:2.3.1.48; ; GO:0004468 ; EC:2.3.1.32; ; GO:0046972 X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 mof males absent on the first "CG3025, CG3025, max: males-absent on the X, males-absent on the X, MOF, Mof, dmMOF, dMOF, max" CDMC34543 4 7 8 DAC12-P02 23-CG3028-RA_3 CG3028 AAGGAATAAAATTAGAAGAAACCATAAAAGTGCGGAAATGAAAATGGAGCTCAAATAGGCGACAGACGG 69 FBan0003028 FBgn0016672 Ipp 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; inositol phosphate dephosphorylation; GO:0046855; synaptic transmission; GO:0007268 "inositol-1,4-bisphosphate 1-phosphatase activity; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57" Ipp Inositol polyphosphate 1-phosphatase "CG3028, ipp, inositol polyphosphate 1-phosphatase, anon-WO02059370.48, Inositol polyphosphate 1-phosphatase" CDMC34543 4 8 8 DAC12-P02 23-CG3028-RA_3 CG3028 AAGGAATAAAATTAGAAGAAACCATAAAAGTGCGGAAATGAAAATGGAGCTCAAATAGGCGACAGACGG 69 FBan0003028 FBgn0016672 Ipp 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; inositol phosphate dephosphorylation; GO:0046855; synaptic transmission; GO:0007268 "inositol-1,4-bisphosphate 1-phosphatase activity; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57; ; GO:0004441 ; EC:3.1.3.57" Ipp Inositol polyphosphate 1-phosphatase "CG3028, ipp, inositol polyphosphate 1-phosphatase, anon-WO02059370.48, Inositol polyphosphate 1-phosphatase" CDMC34544 4 9 8 DAC12-P14 16-CG30323-RA_1 CG30323 TCAAGCGAGCTTATTCAAATCAGAGCTCAAAAGATTTCGGAGTATGAGTGCAAGCCTGACTGCAGCAGA 69 FBan0030323 FBgn0050323 CG30323 2 2R CG30323 CG30323 CDMC34544 4 10 8 DAC12-P14 16-CG30323-RA_1 CG30323 TCAAGCGAGCTTATTCAAATCAGAGCTCAAAAGATTTCGGAGTATGAGTGCAAGCCTGACTGCAGCAGA 69 FBan0030323 FBgn0050323 CG30323 2 2R CG30323 CG30323 CDMC34545 4 11 8 DAC13-D02 3-CG13247-RA_7 CG13247 AATCGGGCAGTGGACTGTTCAACGTCACCGGGAATCCCTTGGATACAGAAGCTGCTCCAAAACTG 65 FBan0013247 FBgn0036979 CG13247 3 3L CG13247 CG13247 CDMC34545 4 12 8 DAC13-D02 3-CG13247-RA_7 CG13247 AATCGGGCAGTGGACTGTTCAACGTCACCGGGAATCCCTTGGATACAGAAGCTGCTCCAAAACTG 65 FBan0013247 FBgn0036979 CG13247 3 3L CG13247 CG13247 CDMC34546 4 13 8 DAC13-D14 2-CG1331-RA_2 CG1331 GTGGTCCATGGCGAGTACTCCCTGATCGATTCCGATGGCTACAAGCGCATTGTCCAGTACACCTC 65 FBan0001331 FBgn0004778 Ccp84Af 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Af Ccp84Af "CG1331, BG:DS00004.6, cc3: cuticle cluster 3, cuticle cluster 3" CDMC34546 4 14 8 DAC13-D14 2-CG1331-RA_2 CG1331 GTGGTCCATGGCGAGTACTCCCTGATCGATTCCGATGGCTACAAGCGCATTGTCCAGTACACCTC 65 FBan0001331 FBgn0004778 Ccp84Af 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Af Ccp84Af "CG1331, BG:DS00004.6, cc3: cuticle cluster 3, cuticle cluster 3" CDMC34547 4 15 8 DAC13-H02 23-CG13461-RA_3 CG13461 AAGAACCTGCTGTTGAAGAAAGTCAAGATTCTGGAAATGTGGATAACCAGGATGATGAAAATAGC 65 FBan0013461 FBgn0036468 CG13461 3 3L CG13461 CG13461 CDMC34547 4 16 8 DAC13-H02 23-CG13461-RA_3 CG13461 AAGAACCTGCTGTTGAAGAAAGTCAAGATTCTGGAAATGTGGATAACCAGGATGATGAAAATAGC 65 FBan0013461 FBgn0036468 CG13461 3 3L CG13461 CG13461 CDMC34548 4 17 8 DAC13-H14 3-CG13500-RA_3 CG13500 ATCTGGCGCAGTTCTATTACCTGGGATTGATGCGACTCCGCTACGATGAGTCCTGCAACGAGCTG 65 FBan0013500 FBgn0034683 CG13500 2 2R CG13500 CG13500 CDMC34548 4 18 8 DAC13-H14 3-CG13500-RA_3 CG13500 ATCTGGCGCAGTTCTATTACCTGGGATTGATGCGACTCCGCTACGATGAGTCCTGCAACGAGCTG 65 FBan0013500 FBgn0034683 CG13500 2 2R CG13500 CG13500 CDMC34549 4 19 8 DAC13-L02 23-CG13589-RA_1 CG13589 GTTCCACTTCCGTCTGGAGACTACTTACTTCTACTTGATTGGATCTTCGACTTCAAGCCACAGTT 65 FBan0013589 FBgn0035011 CG13589 2 2R CG13589 CG13589 CDMC34549 4 20 8 DAC13-L02 23-CG13589-RA_1 CG13589 GTTCCACTTCCGTCTGGAGACTACTTACTTCTACTTGATTGGATCTTCGACTTCAAGCCACAGTT 65 FBan0013589 FBgn0035011 CG13589 2 2R CG13589 CG13589 CDMC34550 4 21 8 DAC13-L14 23-CG1361-RA_1 CG1361 GGTCCTTCGGATGCAGTATTTATTGATATTCTTGACAAAGTGGAAAACGCAATACACAATGCTGC 65 FBan0001361 FBgn0000094 Anp 3 3R anti-Gram-positive bacterial polypeptide induction; GO:0006965; defense response to Gram-positive bacteria; GO:0050830; male-specific antibacterial humoral response; GO:0006962; response to bacteria; GO:0009617 extracellular region; GO:0005576 Anp Andropin "CG1361, CG1361, Cec, And, andropin, CEC, k-9" CDMC34550 4 22 8 DAC13-L14 23-CG1361-RA_1 CG1361 GGTCCTTCGGATGCAGTATTTATTGATATTCTTGACAAAGTGGAAAACGCAATACACAATGCTGC 65 FBan0001361 FBgn0000094 Anp 3 3R anti-Gram-positive bacterial polypeptide induction; GO:0006965; defense response to Gram-positive bacteria; GO:0050830; male-specific antibacterial humoral response; GO:0006962; response to bacteria; GO:0009617 extracellular region; GO:0005576 Anp Andropin "CG1361, CG1361, Cec, And, andropin, CEC, k-9" CDMC34551 4 23 8 DAC13-P02 18-CG1368-RA_4 CG1368 AGCACAGTCGCTTGAAAACGCAGAAACCTCAACTCAAGATGAAATTCCTTATTGCCTTCGCCCTG 65 FBan0001368 FBgn0030539 CG1368 X X structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 CG1368 CG1368 CDMC34551 4 24 8 DAC13-P02 18-CG1368-RA_4 CG1368 AGCACAGTCGCTTGAAAACGCAGAAACCTCAACTCAAGATGAAATTCCTTATTGCCTTCGCCCTG 65 FBan0001368 FBgn0030539 CG1368 X X structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 CG1368 CG1368 CDMC34552 4 25 8 DAC13-P14 18-CG13719-RA_1 CG13719 AATCAGCACCACCAGCACCAGAACCAGTGGGCACTGCACCACCAGAACCACTTGAACCAAACACC 65 FBan0013719 FBgn0040700 CG13719 3 3L CG13719 CG13719 CDMC34552 4 26 8 DAC13-P14 18-CG13719-RA_1 CG13719 AATCAGCACCACCAGCACCAGAACCAGTGGGCACTGCACCACCAGAACCACTTGAACCAAACACC 65 FBan0013719 FBgn0040700 CG13719 3 3L CG13719 CG13719 CDMC34553 4 1 9 DAC14-D02 11-CG1666-RA_1 CG1666 TCAGTGCGTGAACAACGTAATCAACTTCGACTTCCCCAGGGATGTCACGTCTTATATCCATCGGGCTGG 69 FBan0001666 FBgn0001565 Hlc X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Hlc Helicase "CG1666, 7, section 7, 14, section 14, l11P1, lA112, A112, l(1)11P1, 11P1, l(1)A112, HM-44, helicase, hlc, DmRH10, HLC, RNA helicase gene, l(1)19Ff: lethal(1)19Ff, l(1)8-1, l(1)S-19F6, lethal(1)19Ff" CDMC34553 4 2 9 DAC14-D02 11-CG1666-RA_1 CG1666 TCAGTGCGTGAACAACGTAATCAACTTCGACTTCCCCAGGGATGTCACGTCTTATATCCATCGGGCTGG 69 FBan0001666 FBgn0001565 Hlc X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Hlc Helicase "CG1666, 7, section 7, 14, section 14, l11P1, lA112, A112, l(1)11P1, 11P1, l(1)A112, HM-44, helicase, hlc, DmRH10, HLC, RNA helicase gene, l(1)19Ff: lethal(1)19Ff, l(1)8-1, l(1)S-19F6, lethal(1)19Ff" CDMC34554 4 3 9 DAC14-D14 21-CG1670-RA_1 CG1670 GCTGATGCCCGAGGATCAGTTGCAGTATAACGAGGACAAGACGGTCGATATGATCAACATGATGTTCCC 69 FBan0001670 FBgn0031110 Obp19b X X sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp19b Odorant-binding protein 19b "CG1670, CG1670, CG1670, CG1670, 19b, anon-WO0140519.23, Odorant-binding protein 19b" CDMC34554 4 4 9 DAC14-D14 21-CG1670-RA_1 CG1670 GCTGATGCCCGAGGATCAGTTGCAGTATAACGAGGACAAGACGGTCGATATGATCAACATGATGTTCCC 69 FBan0001670 FBgn0031110 Obp19b X X sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp19b Odorant-binding protein 19b "CG1670, CG1670, CG1670, CG1670, 19b, anon-WO0140519.23, Odorant-binding protein 19b" CDMC34555 4 5 9 DAC14-H02 7-CG1673-RA_1 CG1673 ACCTTACCGCATCCCTTTCCCGTACCGTGTATTAGTAGGATTTAGTGCCAAGTGTTTTGTGGGTCGCCA 69 FBan0001673 FBgn0030482 CG1673 X X branched chain family amino acid biosynthesis; GO:0009082 branched-chain-amino-acid transaminase activity; GO:0004084 ; EC:2.6.1.42; ; GO:0004084 ; EC:2.6.1.42; ; GO:0004084 ; EC:2.6.1.42 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG1673 CG1673 CDMC34555 4 6 9 DAC14-H02 7-CG1673-RA_1 CG1673 ACCTTACCGCATCCCTTTCCCGTACCGTGTATTAGTAGGATTTAGTGCCAAGTGTTTTGTGGGTCGCCA 69 FBan0001673 FBgn0030482 CG1673 X X branched chain family amino acid biosynthesis; GO:0009082 branched-chain-amino-acid transaminase activity; GO:0004084 ; EC:2.6.1.42; ; GO:0004084 ; EC:2.6.1.42; ; GO:0004084 ; EC:2.6.1.42 cytoplasm; GO:0005737; mitochondrion; GO:0005739 CG1673 CG1673 CDMC34556 4 7 9 DAC14-H14 23-CG16749-RA_1 CG16749 AGTCATCGCATTATCTGAGTGAATAGTGTATGGGCTATGCGTGCAATAAATAAAATTGATATTGAATGA 69 FBan0016749 FBgn0037678 CG16749 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG16749 CG16749 SP91 CDMC34556 4 8 9 DAC14-H14 23-CG16749-RA_1 CG16749 AGTCATCGCATTATCTGAGTGAATAGTGTATGGGCTATGCGTGCAATAAATAAAATTGATATTGAATGA 69 FBan0016749 FBgn0037678 CG16749 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG16749 CG16749 SP91 CDMC34557 4 9 9 DAC14-L02 15-CG16789-RA_6 CG16789 TGGCAAGTATCCTGGCAAATCGGGACTGATAATGCTAATCCATCTGGTACTGAAAGTGTCGCGACTGCT 69 FBan0016789 FBgn0037712 CG16789 3 3R CG16789 CG16789 CDMC34557 4 10 9 DAC14-L02 15-CG16789-RA_6 CG16789 TGGCAAGTATCCTGGCAAATCGGGACTGATAATGCTAATCCATCTGGTACTGAAAGTGTCGCGACTGCT 69 FBan0016789 FBgn0037712 CG16789 3 3R CG16789 CG16789 CDMC34558 4 11 9 DAC14-L14 9-CG16801-RB_1 CG16801 GGCGATGACTGGGCTAAAAATGGTTGCATGGATTTCGATGGATTTCGAGTGGGAGGGATGGCACTCAGC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC34558 4 12 9 DAC14-L14 9-CG16801-RB_1 CG16801 GGCGATGACTGGGCTAAAAATGGTTGCATGGATTTCGATGGATTTCGAGTGGGAGGGATGGCACTCAGC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC34559 4 13 9 DAC14-P02 23-CG16858-RA_3 CG16858 TACGTCTTAAGTAATTTGCTATCCTATCCAGGAAACGAGATAACGATCCAAACCCCAACTCGAGTACCA 69 FBan0016858 FBgn0016075 vkg 2 2L cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817 extracellular matrix structural constituent; GO:0005201; ; GO:0005201 collagen; GO:0005581; collagen type IV; GO:0005587; cytoplasm; GO:0005737 vkg viking "CG16858, l(2)01209, 1209, 6072, Type IV collagen, DmColA2, alpha(IV)2/vkg, CT25584, collagen IV, collagenIV a2, type IV collagen, alpha-chain, viking" CDMC34559 4 14 9 DAC14-P02 23-CG16858-RA_3 CG16858 TACGTCTTAAGTAATTTGCTATCCTATCCAGGAAACGAGATAACGATCCAAACCCCAACTCGAGTACCA 69 FBan0016858 FBgn0016075 vkg 2 2L cytoskeleton organization and biogenesis; GO:0007010; phosphate transport; GO:0006817 extracellular matrix structural constituent; GO:0005201; ; GO:0005201 collagen; GO:0005581; collagen type IV; GO:0005587; cytoplasm; GO:0005737 vkg viking "CG16858, l(2)01209, 1209, 6072, Type IV collagen, DmColA2, alpha(IV)2/vkg, CT25584, collagen IV, collagenIV a2, type IV collagen, alpha-chain, viking" CDMC34560 4 15 9 DAC14-P14 23-CG16880-RA_3 CG16880 GAGTAAATGCATCATTTTCTAACCAATCTGAATCTCCAGTGGTAATCAATCAGCCATGTAACTGTTTGA 69 FBan0016880 FBgn0001967 l(2)34Fa 2 2L l(2)34Fa lethal (2) 34Fa "CG16880, l(2)br30, br30, l34Fa, l(2)k00811, BG:DS05899.2" CDMC34560 4 16 9 DAC14-P14 23-CG16880-RA_3 CG16880 GAGTAAATGCATCATTTTCTAACCAATCTGAATCTCCAGTGGTAATCAATCAGCCATGTAACTGTTTGA 69 FBan0016880 FBgn0001967 l(2)34Fa 2 2L l(2)34Fa lethal (2) 34Fa "CG16880, l(2)br30, br30, l34Fa, l(2)k00811, BG:DS05899.2" CDMC34561 4 17 9 DAC15-D02 23-CG18647-RA_4 CG18647 TCAAAGGACACAATAATCACGTTTAATTAGGCTCTAAGTAGTGGCACAGTAAAAGTAGTTGCATAGCGC 69 FBan0018647 FBgn0045759 bin 3 3L mesodermal cell fate commitment; GO:0001710; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; sugar porter activity; GO:0005351; ; GO:0003700; ; GO:0005351 nucleus; GO:0005634 bin biniou "CG18647, CG18647, XIV, Distal W5.4 Group XIV, Biniou, FoxF, Dmbin, l(3)65CEe" CDMC34561 4 18 9 DAC15-D02 23-CG18647-RA_4 CG18647 TCAAAGGACACAATAATCACGTTTAATTAGGCTCTAAGTAGTGGCACAGTAAAAGTAGTTGCATAGCGC 69 FBan0018647 FBgn0045759 bin 3 3L mesodermal cell fate commitment; GO:0001710; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; sugar porter activity; GO:0005351; ; GO:0003700; ; GO:0005351 nucleus; GO:0005634 bin biniou "CG18647, CG18647, XIV, Distal W5.4 Group XIV, Biniou, FoxF, Dmbin, l(3)65CEe" CDMC34562 4 19 9 DAC15-D14 6-CG18661-RA_1 CG18661 GGCGCTACTCTCTCAAGTGGACAAAACCACCGAGAATTTGCAATTGCTGGAAATTGCTTCAGGCTCGGG 69 FBan0018661 FBgn0040964 CG18661 2 2L CG18661 CG18661 BcDNA:SD17344 CDMC34562 4 20 9 DAC15-D14 6-CG18661-RA_1 CG18661 GGCGCTACTCTCTCAAGTGGACAAAACCACCGAGAATTTGCAATTGCTGGAAATTGCTTCAGGCTCGGG 69 FBan0018661 FBgn0040964 CG18661 2 2L CG18661 CG18661 BcDNA:SD17344 CDMC34563 4 21 9 DAC15-H02 24-CG18767-RA_1 CG18767 AGCGCGGCTATTAGACCTAATTAGGCATTAATAAAAGCATTTCTTTAAATATGTTCATAAATAAATAAA 69 FBan0018767 FBgn0042112 mRpL36 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL36 mitochondrial ribosomal protein L36 "CG18767, BcDNA:GM01757, mitochondrial ribosomal protein L36" CDMC34563 4 22 9 DAC15-H02 24-CG18767-RA_1 CG18767 AGCGCGGCTATTAGACCTAATTAGGCATTAATAAAAGCATTTCTTTAAATATGTTCATAAATAAATAAA 69 FBan0018767 FBgn0042112 mRpL36 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL36 mitochondrial ribosomal protein L36 "CG18767, BcDNA:GM01757, mitochondrial ribosomal protein L36" CDMC34564 4 23 9 DAC15-H14 13-CG1877-RC_1 CG1877 CATGAAGATGCGCAAACGACTCAACCACACCAATCTCATATCGGAGGTGCTTAATCAGCTGTCAACGCG 69 FBan0001877 FBgn0015509 lin19 2 2R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 lin19 lin-19-like "CG1877, CG1877, l(2)k01207, cul-1, dCul-1, lin19-like, dCul1, Cullin1, l(2)02074, Cul1, dCullin1, cullin1, cul1, Cul-1, CUL1" CDMC34564 4 24 9 DAC15-H14 13-CG1877-RC_1 CG1877 CATGAAGATGCGCAAACGACTCAACCACACCAATCTCATATCGGAGGTGCTTAATCAGCTGTCAACGCG 69 FBan0001877 FBgn0015509 lin19 2 2R proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 SCF ubiquitin ligase complex; GO:0019005; nuclear ubiquitin ligase complex; GO:0000152 lin19 lin-19-like "CG1877, CG1877, l(2)k01207, cul-1, dCul-1, lin19-like, dCul1, Cullin1, l(2)02074, Cul1, dCullin1, cullin1, cul1, Cul-1, CUL1" CDMC34565 4 25 9 DAC15-L02 14-CG1884-RA_1 CG1884 GCGCCCACATGGATATCTTCCAGAATCTTGCTGTTGACTTGGATACGGAGGGTCGCTATCTGTTCTTGA 69 FBan0001884 FBgn0033424 CG1884 2 2R carbohydrate metabolism; GO:0005975 negative regulator of basal transcription activity; GO:0017163; ; GO:0017163 CG1884 CG1884 "clone 1.29, NOT1, anon-EST:Liang-1.29, anon-WO0118547.221" CDMC34565 4 26 9 DAC15-L02 14-CG1884-RA_1 CG1884 GCGCCCACATGGATATCTTCCAGAATCTTGCTGTTGACTTGGATACGGAGGGTCGCTATCTGTTCTTGA 69 FBan0001884 FBgn0033424 CG1884 2 2R carbohydrate metabolism; GO:0005975 negative regulator of basal transcription activity; GO:0017163; ; GO:0017163 CG1884 CG1884 "clone 1.29, NOT1, anon-EST:Liang-1.29, anon-WO0118547.221" CDMC34566 4 1 10 DAC15-L14 14-CG1890-RA_1 CG1890 TCGTATAAGAAGGCAGCAGAGATCCTCAAAGATGCCAAAGCTGAACTGGAGACCTAGAACCACCCCAAA 69 FBan0001890 FBgn0039869 CG1890 3 3R chaperonin-mediated tubulin folding; GO:0007022; tubulin folding; GO:0007021 unfolded protein binding; GO:0051082; ; GO:0051082 CG1890 CG1890 CDMC34566 4 2 10 DAC15-L14 14-CG1890-RA_1 CG1890 TCGTATAAGAAGGCAGCAGAGATCCTCAAAGATGCCAAAGCTGAACTGGAGACCTAGAACCACCCCAAA 69 FBan0001890 FBgn0039869 CG1890 3 3R chaperonin-mediated tubulin folding; GO:0007022; tubulin folding; GO:0007021 unfolded protein binding; GO:0051082; ; GO:0051082 CG1890 CG1890 CDMC34567 4 3 10 DAC15-P02 2-CG1921-RB_1 CG1921 GGGTCCATTCCATGTGTCCGGTTTTTTACCCGAGCAAAAAGCCTAAGGCACAAATGGGATGCTGGATCG 69 FBan0001921 FBgn0014388 sty 3 3L "MAPKKK cascade; GO:0000165; branching morphogenesis; GO:0001763; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of fibroblast growth factor receptor signaling pathway; GO:0040037; negative regulation of signal transduction; GO:0009968; negative regulation of terminal cell fate specification; GO:0035155; ovarian follicle cell development (sensu Insecta); GO:0030707; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" receptor binding; GO:0005102; ; GO:0005102 intracellular; GO:0005622; plasma membrane; GO:0005886 sty sprouty "CG1921, spry, Sprouty, sprouty, Sry, dSPRY, Sty, dSprouty, CS3-3, Calcineurin suppressor, chromosome 3, group 3, Spry" CDMC34567 4 4 10 DAC15-P02 2-CG1921-RB_1 CG1921 GGGTCCATTCCATGTGTCCGGTTTTTTACCCGAGCAAAAAGCCTAAGGCACAAATGGGATGCTGGATCG 69 FBan0001921 FBgn0014388 sty 3 3L "MAPKKK cascade; GO:0000165; branching morphogenesis; GO:0001763; determination of anterior/posterior axis, embryo; GO:0008595; epidermal growth factor receptor signaling pathway; GO:0007173; mesoderm development; GO:0007498; negative regulation of Ras protein signal transduction; GO:0046580; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of fibroblast growth factor receptor signaling pathway; GO:0040037; negative regulation of signal transduction; GO:0009968; negative regulation of terminal cell fate specification; GO:0035155; ovarian follicle cell development (sensu Insecta); GO:0030707; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169" receptor binding; GO:0005102; ; GO:0005102 intracellular; GO:0005622; plasma membrane; GO:0005886 sty sprouty "CG1921, spry, Sprouty, sprouty, Sry, dSPRY, Sty, dSprouty, CS3-3, Calcineurin suppressor, chromosome 3, group 3, Spry" CDMC34568 4 5 10 DAC15-P14 5-CG1934-RA_3 CG1934 ACAAAATCGATCCTGCCAATGATGAGGTGGGTGAATTCGTTCCGGAATCCGATAATGAGCTGCGTGCGA 69 FBan0001934 FBgn0001254 ImpE2 3 3L imaginal disc eversion; GO:0007561 cytoplasm; GO:0005737; extracellular region; GO:0005576; extrinsic to membrane; GO:0019898 ImpE2 Ecdysone-inducible gene E2 "CG1934, IMP-E2, Imp-E2" CDMC34568 4 6 10 DAC15-P14 5-CG1934-RA_3 CG1934 ACAAAATCGATCCTGCCAATGATGAGGTGGGTGAATTCGTTCCGGAATCCGATAATGAGCTGCGTGCGA 69 FBan0001934 FBgn0001254 ImpE2 3 3L imaginal disc eversion; GO:0007561 cytoplasm; GO:0005737; extracellular region; GO:0005576; extrinsic to membrane; GO:0019898 ImpE2 Ecdysone-inducible gene E2 "CG1934, IMP-E2, Imp-E2" CDMC34569 4 7 10 DAC16-D02 23-CG32756-RA_7 CG32756 CATCGAACGCTTTGGATTCTATTAATGATTTTTACGATTACCCCCCGGCATTCACTCAAGAACCCGAAG 69 FBan0032756 FBgn0052756 CG32756 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32756 CG32756 BcDNA:LD29716 CDMC34569 4 8 10 DAC16-D02 23-CG32756-RA_7 CG32756 CATCGAACGCTTTGGATTCTATTAATGATTTTTACGATTACCCCCCGGCATTCACTCAAGAACCCGAAG 69 FBan0032756 FBgn0052756 CG32756 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32756 CG32756 BcDNA:LD29716 CDMC34570 4 9 10 DAC16-D14 13-CG32772-RA_1 CG32772 GCCCCGAACGATCAGCTGCTAAAGTCCCTGATTAGCATAGCCATAGCCAAAGTAGCATCACATTCAGCA 69 FBan0032772 FBgn0052772 CG32772 X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG32772 CG32772 "CG15469, CG6911, CG15469" CDMC34570 4 10 10 DAC16-D14 13-CG32772-RA_1 CG32772 GCCCCGAACGATCAGCTGCTAAAGTCCCTGATTAGCATAGCCATAGCCAAAGTAGCATCACATTCAGCA 69 FBan0032772 FBgn0052772 CG32772 X X cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0003676; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 CG32772 CG32772 "CG15469, CG6911, CG15469" CDMC34571 4 11 10 DAC16-H02 3-CG32803-RA_1 CG32803 CCCGGAATCCGCACGTTGCTATCTGCCTGCTAGCTGGTGGTCTTGTATTCATGCTGCCCTTCCTTATAA 69 FBan0032803 FBgn0052803 CG32803 X X CG32803 CG32803 "CG14819, CG14819, CG14819" CDMC34571 4 12 10 DAC16-H02 3-CG32803-RA_1 CG32803 CCCGGAATCCGCACGTTGCTATCTGCCTGCTAGCTGGTGGTCTTGTATTCATGCTGCCCTTCCTTATAA 69 FBan0032803 FBgn0052803 CG32803 X X CG32803 CG32803 "CG14819, CG14819, CG14819" CDMC34572 4 13 10 DAC16-H14 3-CG32812-RA_1 CG32812 GCTTCTGCTGCGACCATATCTCATATGGGGAGTTCGAGAAGCGCCTGTTTAGTGTGGACGTCGACAGAC 69 FBan0032812 FBgn0025642 CG32812 X X protein amino acid dephosphorylation; GO:0006470 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955 CG32812 CG32812 "CG11408, CG11408, EG:114D9.1" CDMC34572 4 14 10 DAC16-H14 3-CG32812-RA_1 CG32812 GCTTCTGCTGCGACCATATCTCATATGGGGAGTTCGAGAAGCGCCTGTTTAGTGTGGACGTCGACAGAC 69 FBan0032812 FBgn0025642 CG32812 X X protein amino acid dephosphorylation; GO:0006470 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; calcium-dependent protein serine/threonine phosphatase regulator activity; GO:0008597; ; GO:0005509; ; GO:0004723; ; GO:0008597 calcineurin complex; GO:0005955 CG32812 CG32812 "CG11408, CG11408, EG:114D9.1" CDMC34573 4 15 10 DAC16-L02 23-CG32848-RA_6 CG32848 CTCGCACACATGACTCTATAAACGTATTTGAACTGCATCGAAGAAAGAGAATTCCAAATGGCAGTTGCC 69 FBan0032848 FBgn0015323 VAChT 3 3R drug transport; GO:0015893; neurotransmitter transport; GO:0006836; transmission of nerve impulse; GO:0019226 acetylcholine transporter activity; GO:0005277; acetylcholine:hydrogen antiporter activity; GO:0005278; ; GO:0005277; ; GO:0005278; drug transporter activity; GO:0015238; ; GO:0015238 integral to membrane; GO:0016021 VAChT VAChT "CG32848, CG12345, VACHT, Vacht, CT41182, vacht" CDMC34573 4 16 10 DAC16-L02 23-CG32848-RA_6 CG32848 CTCGCACACATGACTCTATAAACGTATTTGAACTGCATCGAAGAAAGAGAATTCCAAATGGCAGTTGCC 69 FBan0032848 FBgn0015323 VAChT 3 3R drug transport; GO:0015893; neurotransmitter transport; GO:0006836; transmission of nerve impulse; GO:0019226 acetylcholine transporter activity; GO:0005277; acetylcholine:hydrogen antiporter activity; GO:0005278; ; GO:0005277; ; GO:0005278; drug transporter activity; GO:0015238; ; GO:0015238 integral to membrane; GO:0016021 VAChT VAChT "CG32848, CG12345, VACHT, Vacht, CT41182, vacht" CDMC34574 4 17 10 DAC16-L14 22-CG32854-RA_1 CG32854 TCAACTTCGAGAAATGCAAGGCCATTTACAACGAGGACATGAACCGAAAAATTCAGTTCGTACTGCGCA 69 FBgn0052854 CDMC34574 4 18 10 DAC16-L14 22-CG32854-RA_1 CG32854 TCAACTTCGAGAAATGCAAGGCCATTTACAACGAGGACATGAACCGAAAAATTCAGTTCGTACTGCGCA 69 FBgn0052854 CDMC34575 4 19 10 DAC16-P02 7-CG32945-RA_1 CG32945 TCGAGGAAGAGCTGGTTCACTGCTATCAACGGTTTCCAAACGAACCCCTTCAGTGCTCTAATTTGGCCA 69 FBan0032945 FBgn0052945 CG32945 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32945 CG32945 CDMC34575 4 20 10 DAC16-P02 7-CG32945-RA_1 CG32945 TCGAGGAAGAGCTGGTTCACTGCTATCAACGGTTTCCAAACGAACCCCTTCAGTGCTCTAATTTGGCCA 69 FBan0032945 FBgn0052945 CG32945 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32945 CG32945 CDMC34576 4 21 10 DAC16-P14 18-CG32954-RF_5 CG32954 ACGGAGCCCTCTTCCAATTGAAACAGATCGAAAGAGCCTGCTAAAGCAAAAAAGAAGTCACCATGTCGT 69 FBgn0052954 CDMC34576 4 22 10 DAC16-P14 18-CG32954-RF_5 CG32954 ACGGAGCCCTCTTCCAATTGAAACAGATCGAAAGAGCCTGCTAAAGCAAAAAAGAAGTCACCATGTCGT 69 FBgn0052954 CDMC34577 4 23 10 DAC17-D02 2-CG12375-RA_1 CG12375 GAGATACCGACGGATATCAAACTCCATCCGCTAGCACACAACCAAGAGTTCACCACGGAGGGGGC 65 FBan0012375 FBgn0031987 CG12375 2 2L defense response; GO:0006952 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12375 CG12375 CDMC34577 4 24 10 DAC17-D02 2-CG12375-RA_1 CG12375 GAGATACCGACGGATATCAAACTCCATCCGCTAGCACACAACCAAGAGTTCACCACGGAGGGGGC 65 FBan0012375 FBgn0031987 CG12375 2 2L defense response; GO:0006952 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG12375 CG12375 CDMC34578 4 25 10 DAC17-D14 18-CG12427-RA_1 CG12427 TTTGAATCACGGTCTGTCAGATAACGAGATGAGAGATCTGAGCGTCACCTTCTACGGCAGCAGCG 65 FBan0012427 FBgn0040615 CG12427 3 3R CG12427 CG12427 CDMC34578 4 26 10 DAC17-D14 18-CG12427-RA_1 CG12427 TTTGAATCACGGTCTGTCAGATAACGAGATGAGAGATCTGAGCGTCACCTTCTACGGCAGCAGCG 65 FBan0012427 FBgn0040615 CG12427 3 3R CG12427 CG12427 CDMC34579 4 1 11 DAC17-H02 2-CG12512-RA_1 CG12512 GTGGAAGCGGTGCATAGTGTCTATGGCCTGACGGAAACCACAGCTGTGATCTTCCAATCCTTGCC 65 FBan0012512 FBgn0031703 CG12512 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG12512 CG12512 CDMC34579 4 2 11 DAC17-H02 2-CG12512-RA_1 CG12512 GTGGAAGCGGTGCATAGTGTCTATGGCCTGACGGAAACCACAGCTGTGATCTTCCAATCCTTGCC 65 FBan0012512 FBgn0031703 CG12512 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 CG12512 CG12512 CDMC34580 4 3 11 DAC17-H14 9-CG12540-RA_1 CG12540 CGCTGTGCGATTCGTCGGTTTACTCGTACTGCTCGCACAAGATGGTACACGATGCCTGTTGCTGC 65 FBan0012540 FBgn0030570 CG12540 X X CG12540 CG12540 BcDNA:RE49992 CDMC34580 4 4 11 DAC17-H14 9-CG12540-RA_1 CG12540 CGCTGTGCGATTCGTCGGTTTACTCGTACTGCTCGCACAAGATGGTACACGATGCCTGTTGCTGC 65 FBan0012540 FBgn0030570 CG12540 X X CG12540 CG12540 BcDNA:RE49992 CDMC34581 4 5 11 DAC17-L02 24-CG12665-RA_1 CG12665 GCTATTGTGACATAGCTAAATATATAGACAAATGAATAAAAGTTGCAAGAAAACACGGATTGAAA 65 FBan0012665 FBgn0030103 Obp8a X X transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp8a Odorant-binding protein 8a "CG12665, CG12665, CG12665, CG12665, 8a, Odorant-binding protein 8a" CDMC34581 4 6 11 DAC17-L02 24-CG12665-RA_1 CG12665 GCTATTGTGACATAGCTAAATATATAGACAAATGAATAAAAGTTGCAAGAAAACACGGATTGAAA 65 FBan0012665 FBgn0030103 Obp8a X X transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp8a Odorant-binding protein 8a "CG12665, CG12665, CG12665, CG12665, 8a, Odorant-binding protein 8a" CDMC34582 4 7 11 DAC17-L14 3-CG12713-RA_1 CG12713 ACTGGATCGAGAGCAAGGCCAATTTTGGGGACACCAAGGGACACAAGTCGAACATCCAACAGCAG 65 FBan0012713 FBgn0036536 CG12713 3 3L CG12713 CG12713 CDMC34582 4 8 11 DAC17-L14 3-CG12713-RA_1 CG12713 ACTGGATCGAGAGCAAGGCCAATTTTGGGGACACCAAGGGACACAAGTCGAACATCCAACAGCAG 65 FBan0012713 FBgn0036536 CG12713 3 3L CG12713 CG12713 CDMC34583 4 9 11 DAC17-P02 3-CG12819-RB_1 CG12819 ATTCACCGCGATCCGAGGAAAGACCGACAGAAATTGTGACTTCAAAACCGAAGGGTATGGCGCCG 65 FBan0012819 FBgn0037810 sle 3 3R brain development; GO:0007420 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sle slender lobes "CG12819, CG12819, CG12819, CG12819, slender lobes" CDMC34583 4 10 11 DAC17-P02 3-CG12819-RB_1 CG12819 ATTCACCGCGATCCGAGGAAAGACCGACAGAAATTGTGACTTCAAAACCGAAGGGTATGGCGCCG 65 FBan0012819 FBgn0037810 sle 3 3R brain development; GO:0007420 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 sle slender lobes "CG12819, CG12819, CG12819, CG12819, slender lobes" CDMC34584 4 11 11 DAC17-P14 3-CG12847-RA_1 CG12847 TTGTGCTCTTTATCCTGCAACTGGTGCTTACGTGCTGGGTGTTCGTGAACCGATCTGCCTTCCTG 65 FBan0012847 FBgn0033124 Tsp42Ec 2 2R integral to membrane; GO:0016021 Tsp42Ec Tetraspanin 42Ec "CG12847, CG12847, CG12847, Dm.Tsp42Ec, tetraspanin 42E, Tetraspanin 42Ec" CDMC34584 4 12 11 DAC17-P14 3-CG12847-RA_1 CG12847 TTGTGCTCTTTATCCTGCAACTGGTGCTTACGTGCTGGGTGTTCGTGAACCGATCTGCCTTCCTG 65 FBan0012847 FBgn0033124 Tsp42Ec 2 2R integral to membrane; GO:0016021 Tsp42Ec Tetraspanin 42Ec "CG12847, CG12847, CG12847, Dm.Tsp42Ec, tetraspanin 42E, Tetraspanin 42Ec" CDMC34585 4 13 11 DAC18-D02 2-CG5961-RA_1 CG5961 TCCAGGATCAGTTCTACCGTCCTGTGCAACTGGTGGAGTACTATCGCTACATTCGCTTTCTGCCCGA 67 FBan0005961 FBgn0038056 CG5961 3 3R CG5961 CG5961 CDMC34585 4 14 11 DAC18-D02 2-CG5961-RA_1 CG5961 TCCAGGATCAGTTCTACCGTCCTGTGCAACTGGTGGAGTACTATCGCTACATTCGCTTTCTGCCCGA 67 FBan0005961 FBgn0038056 CG5961 3 3R CG5961 CG5961 CDMC34586 4 15 11 DAC18-D14 12-CG6147-RA_1 CG6147 GGCGCGCCACAAGGAGATGAACTATGAACTGGAGTCTCTGCGAGGTCAGGTCTTCAGTTTGGGAACC 67 FBan0006147 FBgn0026317 Tsc1 3 3R ATP synthesis coupled proton transport; GO:0015986; determination of adult life span; GO:0008340; insulin receptor signaling pathway; GO:0008286; negative regulation of cell growth; GO:0030308; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; regulation of timing of cell differentiation; GO:0048505; response to nutrient; GO:0007584; signal transduction; GO:0007165 "ATP binding; GO:0005524; ; GO:0005524; kinase binding; GO:0019900; ; GO:0019900; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 Tsc1 Tsc1 "CG6147, TSC1, rocky, dTSC1, dTsc1, hamartin, dTSC, tsc1" CDMC34586 4 16 11 DAC18-D14 12-CG6147-RA_1 CG6147 GGCGCGCCACAAGGAGATGAACTATGAACTGGAGTCTCTGCGAGGTCAGGTCTTCAGTTTGGGAACC 67 FBan0006147 FBgn0026317 Tsc1 3 3R ATP synthesis coupled proton transport; GO:0015986; determination of adult life span; GO:0008340; insulin receptor signaling pathway; GO:0008286; negative regulation of cell growth; GO:0030308; negative regulation of cell proliferation; GO:0008285; negative regulation of cell size; GO:0045792; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; regulation of cell growth; GO:0001558; regulation of organ size; GO:0046620; regulation of progression through cell cycle; GO:0000074; regulation of timing of cell differentiation; GO:0048505; response to nutrient; GO:0007584; signal transduction; GO:0007165 "ATP binding; GO:0005524; ; GO:0005524; kinase binding; GO:0019900; ; GO:0019900; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 Tsc1 Tsc1 "CG6147, TSC1, rocky, dTSC1, dTsc1, hamartin, dTSC, tsc1" CDMC34587 4 17 11 DAC18-H02 12-CG6678-RA_3 CG6678 ATGCTTTTCAGGCCCTGGAAGGTATCACGATGAACCCTACTGTGGATGATGTTCTCTGTGGGCCATG 67 FBan0006678 FBgn0038917 CG6678 3 3R CG6678 CG6678 CDMC34587 4 18 11 DAC18-H02 12-CG6678-RA_3 CG6678 ATGCTTTTCAGGCCCTGGAAGGTATCACGATGAACCCTACTGTGGATGATGTTCTCTGTGGGCCATG 67 FBan0006678 FBgn0038917 CG6678 3 3R CG6678 CG6678 CDMC34588 4 19 11 DAC18-H14 3-CG6812-RA_2 CG6812 CCTTCAATGCGGTTGTTAACTACACGAATCGCAATGCCAACTCGCCAACTAGCGTTACGCAGCTGGG 67 FBan0006812 FBgn0036843 CG6812 3 3L cation transport; GO:0006812 DNA binding; GO:0003677; carrier activity; GO:0005386; transporter activity; GO:0005215; cation transporter activity; GO:0008324; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005215; ; GO:0008324; ; GO:0003677 intracellular; GO:0005622; membrane; GO:0016020 CG6812 CG6812 CDMC34588 4 20 11 DAC18-H14 3-CG6812-RA_2 CG6812 CCTTCAATGCGGTTGTTAACTACACGAATCGCAATGCCAACTCGCCAACTAGCGTTACGCAGCTGGG 67 FBan0006812 FBgn0036843 CG6812 3 3L cation transport; GO:0006812 DNA binding; GO:0003677; carrier activity; GO:0005386; transporter activity; GO:0005215; cation transporter activity; GO:0008324; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0005215; ; GO:0008324; ; GO:0003677 intracellular; GO:0005622; membrane; GO:0016020 CG6812 CG6812 CDMC34589 4 21 11 DAC18-L02 6-CG7276-RB_1 CG7276 CGCAAAAATGTCGACACAAAGACCCAAAACCTTGTCGACTGCAAAGGAGTCCTTTCGAGCGTCCGCG 67 FBan0007276 FBgn0036499 CG7276 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG7276 CG7276 CDMC34589 4 22 11 DAC18-L02 6-CG7276-RB_1 CG7276 CGCAAAAATGTCGACACAAAGACCCAAAACCTTGTCGACTGCAAAGGAGTCCTTTCGAGCGTCCGCG 67 FBan0007276 FBgn0036499 CG7276 3 3L microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG7276 CG7276 CDMC34590 4 23 11 DAC18-L14 17-CG7609-RA_2 CG7609 ACGGAGTTATTCATCCGGTTTTCTTCCTTTTCAGGAGCACTGGTTTTACACCTACGTGGACCAGCTG 67 FBan0007609 FBgn0027518 CG7609 3 3R peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 CG7609 CG7609 BcDNA:LD21720 CDMC34590 4 24 11 DAC18-L14 17-CG7609-RA_2 CG7609 ACGGAGTTATTCATCCGGTTTTCTTCCTTTTCAGGAGCACTGGTTTTACACCTACGTGGACCAGCTG 67 FBan0007609 FBgn0027518 CG7609 3 3R peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 CG7609 CG7609 BcDNA:LD21720 CDMC34591 4 25 11 DAC18-P02 3-CG7995-RC_1 CG7995 TCAATCTCTGCCAGTTCGAGCCTGAGAAGCGATACTACGAGAACGTGCACTACGACACCTTCCTGGC 67 FBan0007995 FBgn0035266 CG7995 3 3L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629; transport; GO:0006810 carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30 CG7995 CG7995 CDMC34591 4 26 11 DAC18-P02 3-CG7995-RC_1 CG7995 TCAATCTCTGCCAGTTCGAGCCTGAGAAGCGATACTACGAGAACGTGCACTACGACACCTTCCTGGC 67 FBan0007995 FBgn0035266 CG7995 3 3L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; lipid metabolism; GO:0006629; transport; GO:0006810 carbohydrate kinase activity; GO:0019200; ; GO:0019200; glycerol kinase activity; GO:0004370 ; EC:2.7.1.30; ; GO:0004370 ; EC:2.7.1.30 CG7995 CG7995 CDMC34592 4 1 12 DAC18-P14 2-CG8110-RA_2 CG8110 CCATACTGGAGACCAAGGATCGTGATGAACCGGCAATGAGCTCTGTAGGTCCAACAATGTGGCTGGG 67 FBan0008110 FBgn0024187 syd 3 3L axon cargo transport; GO:0008088; intracellular signaling cascade; GO:0007242 kinesin binding; GO:0019894; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019894 integral to membrane; GO:0016021; membrane; GO:0016020; microtubule associated complex; GO:0005875; trans-Golgi network transport vesicle; GO:0030140 syd sunday driver "CG8110, CG8110, CG8110, JIP-3, sunday driver" CDMC34592 4 2 12 DAC18-P14 2-CG8110-RA_2 CG8110 CCATACTGGAGACCAAGGATCGTGATGAACCGGCAATGAGCTCTGTAGGTCCAACAATGTGGCTGGG 67 FBan0008110 FBgn0024187 syd 3 3L axon cargo transport; GO:0008088; intracellular signaling cascade; GO:0007242 kinesin binding; GO:0019894; kinase regulator activity; GO:0019207; ; GO:0019207; ; GO:0019894 integral to membrane; GO:0016021; membrane; GO:0016020; microtubule associated complex; GO:0005875; trans-Golgi network transport vesicle; GO:0030140 syd sunday driver "CG8110, CG8110, CG8110, JIP-3, sunday driver" CDMC34593 4 3 12 DAC19-D02 5-CG8072-RA_1 CG8072 CCTGGTGAACATGGCCTATTTCCGTGAGTATTTGCTGGGTCTCCACAACGGATATCGCCAAGAGGTGG 68 FBan0008072 FBgn0036070 CG8072 3 3L defense response; GO:0006952 extracellular region; GO:0005576 CG8072 CG8072 CDMC34593 4 4 12 DAC19-D02 5-CG8072-RA_1 CG8072 CCTGGTGAACATGGCCTATTTCCGTGAGTATTTGCTGGGTCTCCACAACGGATATCGCCAAGAGGTGG 68 FBan0008072 FBgn0036070 CG8072 3 3L defense response; GO:0006952 extracellular region; GO:0005576 CG8072 CG8072 CDMC34594 4 5 12 DAC19-D14 11-CG8195-RA_7 CG8195 AGCGATGATTCAAGTGTAAGAAGTGTGCGCTTCAGCAAGATGGCCGAAGTCAGAGAGATGTCTGCCCA 68 FBan0008195 FBgn0034032 CG8195 2 2R CG8195 CG8195 CDMC34594 4 6 12 DAC19-D14 11-CG8195-RA_7 CG8195 AGCGATGATTCAAGTGTAAGAAGTGTGCGCTTCAGCAAGATGGCCGAAGTCAGAGAGATGTCTGCCCA 68 FBan0008195 FBgn0034032 CG8195 2 2R CG8195 CG8195 CDMC34595 4 7 12 DAC19-H02 3-CG8789-RA_9 CG8789 GCGCAATGTGGTAATCGTATCAGACGAGGAGGAAAACACCTCCGAGTACAGTCACTCACCCTCCAGCC 68 FBan0008789 FBgn0036896 CG8789 3 3L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8789 CG8789 DLK/ZPK CDMC34595 4 8 12 DAC19-H02 3-CG8789-RA_9 CG8789 GCGCAATGTGGTAATCGTATCAGACGAGGAGGAAAACACCTCCGAGTACAGTCACTCACCCTCCAGCC 68 FBan0008789 FBgn0036896 CG8789 3 3L JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674 CG8789 CG8789 DLK/ZPK CDMC34596 4 9 12 DAC19-H14 2-CG8934-RA_1 CG8934 CCCAGTGCTCGTTCCTCTTCATTTCCGGATTGGTTCTTCTGATGGCCATCTGCATGTACAACGGCCTC 68 FBan0008934 FBgn0039391 CG8934 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8934 CG8934 CDMC34596 4 10 12 DAC19-H14 2-CG8934-RA_1 CG8934 CCCAGTGCTCGTTCCTCTTCATTTCCGGATTGGTTCTTCTGATGGCCATCTGCATGTACAACGGCCTC 68 FBan0008934 FBgn0039391 CG8934 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8934 CG8934 CDMC34597 4 11 12 DAC19-L02 3-CG9345-RA_2 CG9345 CGCATTGGTCATGGTTATGCTCTGGCTAAGCATCCGATTCTCCTGAATGCAGTCAAGTCACGCCGGAT 68 FBan0009345 FBgn0038173 Adgf-C 3 3R purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; ; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular region; GO:0005576 Adgf-C Adenosine deaminase-related growth factor C "CG9345, CG9345, CG9345, ADGF-C, adgfc" CDMC34597 4 12 12 DAC19-L02 3-CG9345-RA_2 CG9345 CGCATTGGTCATGGTTATGCTCTGGCTAAGCATCCGATTCTCCTGAATGCAGTCAAGTCACGCCGGAT 68 FBan0009345 FBgn0038173 Adgf-C 3 3R purine ribonucleoside monophosphate biosynthesis; GO:0009168 growth factor activity; GO:0008083; ; GO:0008083; adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular region; GO:0005576 Adgf-C Adenosine deaminase-related growth factor C "CG9345, CG9345, CG9345, ADGF-C, adgfc" CDMC34598 4 13 12 DAC19-L14 3-CG9461-RA_7 CG9461 GGCATGGAAAGCTAGAGGACAATGACATATTCAACCACCTGTACTCGGGAGTGCAAATCCGCACGGGC 68 FBan0009461 FBgn0037760 CG9461 3 3R ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 CG9461 CG9461 CDMC34598 4 14 12 DAC19-L14 3-CG9461-RA_7 CG9461 GGCATGGAAAGCTAGAGGACAATGACATATTCAACCACCTGTACTCGGGAGTGCAAATCCGCACGGGC 68 FBan0009461 FBgn0037760 CG9461 3 3R ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 CG9461 CG9461 CDMC34599 4 15 12 DAC19-P02 2-CG9932-RA_1 CG9932 GGCGCTGCATTTCAATGCTGGTGAGAAGCTCAAGTCCGTGGAGTTCTTTACCTGCTACGATCAGCTGG 68 FBan0009932 FBgn0032469 CG9932 2 2L proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG9932 CG9932 CDMC34599 4 16 12 DAC19-P02 2-CG9932-RA_1 CG9932 GGCGCTGCATTTCAATGCTGGTGAGAAGCTCAAGTCCGTGGAGTTCTTTACCTGCTACGATCAGCTGG 68 FBan0009932 FBgn0032469 CG9932 2 2L proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG9932 CG9932 CDMC34600 4 17 12 DAC19-P14 2-CR32011-RA_1 CR32011 GCATTCGCTGAGCTCCAAACGGACATGACCGACCTAACAGCAGATTTGGAGAGCACAGGCATACCAAC 68 FBan0032011 FBgn0052011 CR32011 4 4 CR32011 CR32011 "CG32011, CG32011" CDMC34600 4 18 12 DAC19-P14 2-CR32011-RA_1 CR32011 GCATTCGCTGAGCTCCAAACGGACATGACCGACCTAACAGCAGATTTGGAGAGCACAGGCATACCAAC 68 FBan0032011 FBgn0052011 CR32011 4 4 CR32011 CR32011 "CG32011, CG32011" CDMC34601 4 19 12 DAC20-D02 23-CG18069-RA_7 CG18069 CACAAATATTTGTTGTAAGTGTCGTGGTACCAATTGTAAGCTTAAACGTTCTCAACGGAAGAATCAAGT 69 FBan0018069 FBgn0004624 CaMKII 4 4 calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning and/or memory; GO:0007611; muscle contraction; GO:0006936; neuromuscular junction development; GO:0007528; protein amino acid phosphorylation; GO:0006468; regulation of filopodium formation; GO:0051489; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123 calcium- and calmodulin-dependent protein kinase complex; GO:0005954 CaMKII Calcium/calmodulin-dependent protein kinase II "CG18069, CG18069, CaM, CaM kinase, CaM kinase II, CamKII, CaMK II, CaM KII, DCK, calcium/calmodulin-dependent protein kinase II, Ca2+/calmodulin-dependent protein kinase II, CDPK1, dCaMKII, camKII, CAMKIId, CaM II, calmodulin-dependent kinase, Calcium/calmodulin-dependent protein kinase, CAMKII, CaMK-II, Cam, CamKIIalpha" CDMC34601 4 20 12 DAC20-D02 23-CG18069-RA_7 CG18069 CACAAATATTTGTTGTAAGTGTCGTGGTACCAATTGTAAGCTTAAACGTTCTCAACGGAAGAATCAAGT 69 FBan0018069 FBgn0004624 CaMKII 4 4 calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning and/or memory; GO:0007611; muscle contraction; GO:0006936; neuromuscular junction development; GO:0007528; protein amino acid phosphorylation; GO:0006468; regulation of filopodium formation; GO:0051489; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; ATP binding; GO:0005524; ; GO:0005524; ; GO:0005516; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123 calcium- and calmodulin-dependent protein kinase complex; GO:0005954 CaMKII Calcium/calmodulin-dependent protein kinase II "CG18069, CG18069, CaM, CaM kinase, CaM kinase II, CamKII, CaMK II, CaM KII, DCK, calcium/calmodulin-dependent protein kinase II, Ca2+/calmodulin-dependent protein kinase II, CDPK1, dCaMKII, camKII, CAMKIId, CaM II, calmodulin-dependent kinase, Calcium/calmodulin-dependent protein kinase, CAMKII, CaMK-II, Cam, CamKIIalpha" CDMC34602 4 21 12 DAC20-D14 2-CG18090-RA_1 CG18090 CGCCAACTTAGATGTTCACCAGTCTGCCAAGGGCACAGTAAAGCATGGGACCTAGAAGCTGTACGCACT 69 FBan0018090 FBgn0000500 Dsk 3 3R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Dsk Drosulfakinin "CG18090, DrmSK-I, DrmSK-II, drosulfakinin, CCK, cholecystokinin-like, DSK-I, DSK, sulfakinin, Drm-SK-0, Drm-SK-1, Drm-SK-2, dsk, BcDNA:RH46857" CDMC34602 4 22 12 DAC20-D14 2-CG18090-RA_1 CG18090 CGCCAACTTAGATGTTCACCAGTCTGCCAAGGGCACAGTAAAGCATGGGACCTAGAAGCTGTACGCACT 69 FBan0018090 FBgn0000500 Dsk 3 3R neuropeptide signaling pathway; GO:0007218 neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0005184 extracellular region; GO:0005576 Dsk Drosulfakinin "CG18090, DrmSK-I, DrmSK-II, drosulfakinin, CCK, cholecystokinin-like, DSK-I, DSK, sulfakinin, Drm-SK-0, Drm-SK-1, Drm-SK-2, dsk, BcDNA:RH46857" CDMC34603 4 23 12 DAC20-H02 10-CG18143-RA_1 CG18143 GCTGTCCCTCGATCACTTGACCGGAAACTTTGCTCTAGGGAAGGATTTCGATGCTTTGTTGGTGGATGT 69 FBan0018143 FBgn0037219 CG18143 3 3R purine base metabolism; GO:0006144 guanine deaminase activity; GO:0008892 ; EC:3.5.4.3; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0008892 ; EC:3.5.4.3 CG18143 CG18143 CDMC34603 4 24 12 DAC20-H02 10-CG18143-RA_1 CG18143 GCTGTCCCTCGATCACTTGACCGGAAACTTTGCTCTAGGGAAGGATTTCGATGCTTTGTTGGTGGATGT 69 FBan0018143 FBgn0037219 CG18143 3 3R purine base metabolism; GO:0006144 guanine deaminase activity; GO:0008892 ; EC:3.5.4.3; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0008892 ; EC:3.5.4.3 CG18143 CG18143 CDMC34604 4 25 12 DAC20-H14 1-CG18160-RA_1 CG18160 GCGGTCCAGTTTTTTGGCACTTCAAACCTGCACGGCCTGTTAACTTTGCAAGTTCTTACGACAGCAGCT 69 FBgn0039980 CG18160 CG18160 CG18160 CDMC34604 4 26 12 DAC20-H14 1-CG18160-RA_1 CG18160 GCGGTCCAGTTTTTTGGCACTTCAAACCTGCACGGCCTGTTAACTTTGCAAGTTCTTACGACAGCAGCT 69 FBgn0039980 CG18160 CG18160 CG18160 CDMC34605 4 1 13 DAC20-L02 1-CG18217-RA_2 CG18217 CGTCGAGCTCCGAGATCCTAAGTCTCTCCGCGATCGACATGGCGCTAAGGGACATAGATCTCAATTCGG 69 FBan0018217 FBgn0036646 CG18217 3 3L CG18217 CG18217 CDMC34605 4 2 13 DAC20-L02 1-CG18217-RA_2 CG18217 CGTCGAGCTCCGAGATCCTAAGTCTCTCCGCGATCGACATGGCGCTAAGGGACATAGATCTCAATTCGG 69 FBan0018217 FBgn0036646 CG18217 3 3L CG18217 CG18217 CDMC34606 4 3 13 DAC20-L14 9-CG18241-RA_3 CG18241 CGCCCGACGGGAACTCGACGAGGATAAGAAATACGATGCATTCCTATCATTCACCCACAAGGACGAGGA 69 FBan0018241 FBgn0032095 Toll-4 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; cytokinesis; GO:0000910; defense response; GO:0006952; defense response to bacteria; GO:0042742; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-4 Toll-4 "CG18241, CG18241, Tl-4, CT29238, Toll-like, TL4, dTLR4, toll, dToll4, Toll-4" CDMC34606 4 4 13 DAC20-L14 9-CG18241-RA_3 CG18241 CGCCCGACGGGAACTCGACGAGGATAAGAAATACGATGCATTCCTATCATTCACCCACAAGGACGAGGA 69 FBan0018241 FBgn0032095 Toll-4 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; cytokinesis; GO:0000910; defense response; GO:0006952; defense response to bacteria; GO:0042742; dorsal/ventral axis specification; GO:0009950; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-4 Toll-4 "CG18241, CG18241, Tl-4, CT29238, Toll-like, TL4, dTLR4, toll, dToll4, Toll-4" CDMC34607 4 5 13 DAC20-P02 17-CG18279-RB_1 CG18279 GGGACGTCCCGCTCAGCACGTAAGCAATCTCACGCATTTAACCAGCGCAATCAACTAACTTATTTATGT 69 FBan0018279 FBgn0033835 IM10 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM10 Immune induced molecule 10 "CG18279, CG18279, CG18279, DIM 10, DIM 12, DIM 13, DIM 24, Immune induced molecule 10" CDMC34607 4 6 13 DAC20-P02 17-CG18279-RB_1 CG18279 GGGACGTCCCGCTCAGCACGTAAGCAATCTCACGCATTTAACCAGCGCAATCAACTAACTTATTTATGT 69 FBan0018279 FBgn0033835 IM10 2 2R Toll signaling pathway; GO:0008063; antibacterial humoral response; GO:0019731; defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 extracellular region; GO:0005576 IM10 Immune induced molecule 10 "CG18279, CG18279, CG18279, DIM 10, DIM 12, DIM 13, DIM 24, Immune induced molecule 10" CDMC34608 4 7 13 DAC20-P14 23-CG18292-RA_4 CG18292 TAAAGAATGTTTAGACTAGCTCAGGTTACAATCGGTTAAATCGACAATGCTACAAGTATAGCTGCAGCC 69 FBan0018292 FBgn0030269 CG18292 X X cell proliferation; GO:0008283 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18292 CG18292 anon-WO03040301.144 CDMC34608 4 8 13 DAC20-P14 23-CG18292-RA_4 CG18292 TAAAGAATGTTTAGACTAGCTCAGGTTACAATCGGTTAAATCGACAATGCTACAAGTATAGCTGCAGCC 69 FBan0018292 FBgn0030269 CG18292 X X cell proliferation; GO:0008283 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18292 CG18292 anon-WO03040301.144 CDMC34609 4 9 13 DAC21-D02 8-CG3920-RA_1 CG3920 GCAGGACGCTGAAACTGAAACAGCATTCGGAGGATAACCAGAGTGTCTAGGGGCAGCTAGTAAAACCCC 69 FBan0003920 FBgn0021800 l(2)k16918 2 2L l(2)k16918 lethal (2) k16918 CG3920 CDMC34609 4 10 13 DAC21-D02 8-CG3920-RA_1 CG3920 GCAGGACGCTGAAACTGAAACAGCATTCGGAGGATAACCAGAGTGTCTAGGGGCAGCTAGTAAAACCCC 69 FBan0003920 FBgn0021800 l(2)k16918 2 2L l(2)k16918 lethal (2) k16918 CG3920 CDMC34610 4 11 13 DAC21-D14 17-CG3929-RA_1 CG3929 TGCTCGAACCCTAAAACAACAGCAAACCACAATTGCAATTGTAGCTTCCTTTCCGCTCTTCCAATTCGT 69 FBan0003929 FBgn0000524 dx X X Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; ectoderm development; GO:0007398; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; positive regulation of Notch signaling pathway; GO:0045747; protein ubiquitination; GO:0016567; regulation of Notch signaling pathway; GO:0008593; transport; GO:0006810 protein binding; GO:0005515; Notch binding; GO:0005112; ; GO:0005515; transporter activity; GO:0005215; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; ; GO:0005112; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005215; SH3 domain binding; GO:0017124; ; GO:0017124; ; GO:0008270 cytoplasm; GO:0005737; membrane; GO:0016020; ubiquitin ligase complex; GO:0000151 dx deltex "CG3929, DMDELTEX, Dx, deltex" CDMC34610 4 12 13 DAC21-D14 17-CG3929-RA_1 CG3929 TGCTCGAACCCTAAAACAACAGCAAACCACAATTGCAATTGTAGCTTCCTTTCCGCTCTTCCAATTCGT 69 FBan0003929 FBgn0000524 dx X X Notch signaling pathway; GO:0007219; Wnt receptor signaling pathway; GO:0016055; ectoderm development; GO:0007398; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; positive regulation of Notch signaling pathway; GO:0045747; protein ubiquitination; GO:0016567; regulation of Notch signaling pathway; GO:0008593; transport; GO:0006810 protein binding; GO:0005515; Notch binding; GO:0005112; ; GO:0005515; transporter activity; GO:0005215; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; ; GO:0005112; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005215; SH3 domain binding; GO:0017124; ; GO:0017124; ; GO:0008270 cytoplasm; GO:0005737; membrane; GO:0016020; ubiquitin ligase complex; GO:0000151 dx deltex "CG3929, DMDELTEX, Dx, deltex" CDMC34611 4 13 13 DAC21-H02 18-CG3960-RD_3 CG3960 CCTTTTGTGCGCTGATACACCATTTCTTGCCAGATGCATTTGATTACACCACACTAACCAAGCAGACGC 69 FBan0003960 FBgn0029876 CG3960 X X mesoderm development; GO:0007498 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 CG3960 CG3960 BcDNA:GH23906 CDMC34611 4 14 13 DAC21-H02 18-CG3960-RD_3 CG3960 CCTTTTGTGCGCTGATACACCATTTCTTGCCAGATGCATTTGATTACACCACACTAACCAAGCAGACGC 69 FBan0003960 FBgn0029876 CG3960 X X mesoderm development; GO:0007498 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 CG3960 CG3960 BcDNA:GH23906 CDMC34612 4 15 13 DAC21-H14 23-CG3975-RA_4 CG3975 AAGAGAGAGATCAAAAGAGATAGTTTACCAGGATCTAGGAGAAGAGGACTAGCAGAAAATATATGGGGT 69 FBan0003975 FBgn0027559 CG3975 2 2L CG3975 CG3975 "BG:DS07295.3, BcDNA:GH08865" CDMC34612 4 16 13 DAC21-H14 23-CG3975-RA_4 CG3975 AAGAGAGAGATCAAAAGAGATAGTTTACCAGGATCTAGGAGAAGAGGACTAGCAGAAAATATATGGGGT 69 FBan0003975 FBgn0027559 CG3975 2 2L CG3975 CG3975 "BG:DS07295.3, BcDNA:GH08865" CDMC34613 4 17 13 DAC21-L02 24-CG40045-RA_6 CG40045 GTGCGTTAAACTGAACCAATTCATTTATCATACAACTTAGAATGTCTGAACTTCAGTCATCTTTACTGT 69 FBgn0058045 CG40045 protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG40045 CG40045 BcDNA:RE63412 CDMC34613 4 18 13 DAC21-L02 24-CG40045-RA_6 CG40045 GTGCGTTAAACTGAACCAATTCATTTATCATACAACTTAGAATGTCTGAACTTCAGTCATCTTTACTGT 69 FBgn0058045 CG40045 protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG40045 CG40045 BcDNA:RE63412 CDMC34614 4 19 13 DAC21-L14 24-CG4005-RA_2 CG4005 CGCTAAGATAATTCTATGTAGTTTTCGTTTGTATACAATAAGTGCCTTTTATATGTTAACGACGATGTC 69 FBan0004005 FBgn0034970 CG4005 2 2R ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 CG4005 CG4005 CDMC34614 4 20 13 DAC21-L14 24-CG4005-RA_2 CG4005 CGCTAAGATAATTCTATGTAGTTTTCGTTTGTATACAATAAGTGCCTTTTATATGTTAACGACGATGTC 69 FBan0004005 FBgn0034970 CG4005 2 2R ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 CG4005 CG4005 CDMC34615 4 21 13 DAC21-P02 14-CG40115-RB_1 CG40115 GGCCGCCAAATCCTAGCTTCGACTGGGTCAAATTGCAGGTTAGTGAGTTTCGAAATATTGGTGAACCGT 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC34615 4 22 13 DAC21-P02 14-CG40115-RB_1 CG40115 GGCCGCCAAATCCTAGCTTCGACTGGGTCAAATTGCAGGTTAGTGAGTTTCGAAATATTGGTGAACCGT 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC34616 4 23 13 DAC21-P14 18-CG40129-RA_7 CG40129 AGGTGATTTTGGGATTGGAACACATGCATAAACGTTGCATTGTGTACCGAGACTTAAAACCCGCCAACA 69 CDMC34616 4 24 13 DAC21-P14 18-CG40129-RA_7 CG40129 AGGTGATTTTGGGATTGGAACACATGCATAAACGTTGCATTGTGTACCGAGACTTAAAACCCGCCAACA 69 CDMC34617 4 25 13 DAC22-D02 1-CG13785-RA_1 CG13785 CATCCACAAGCCCCACTCTACTGATTCATCACAACCCGAACTCACTCAGCTCTGCCACTTTCCCC 65 FBan0013785 FBgn0031901 CG13785 2 2L CG13785 CG13785 CDMC34617 4 26 13 DAC22-D02 1-CG13785-RA_1 CG13785 CATCCACAAGCCCCACTCTACTGATTCATCACAACCCGAACTCACTCAGCTCTGCCACTTTCCCC 65 FBan0013785 FBgn0031901 CG13785 2 2L CG13785 CG13785 CDMC34618 4 1 14 DAC22-D14 3-CG13803-RA_2 CG13803 ACCATAGCCACGGCCTATGTTGTCTGTGTCCTGGTAGTGTCACCTTGGCTGTACCTAGTCACAGC 65 FBan0013803 FBgn0035329 DmsR-2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; negative regulation of muscle contraction; GO:0045932 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0004930; myosuppressin receptor activity; GO:0035013; ; GO:0008188; ; GO:0004930; ; GO:0035013; ; GO:0035013 integral to membrane; GO:0016021 DmsR-2 Dromyosuppressin receptor 2 "CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, DMSR-2, anon-WO0170980.160, anon-WO0170980.161, Dromyosuppressin receptor 2" CDMC34618 4 2 14 DAC22-D14 3-CG13803-RA_2 CG13803 ACCATAGCCACGGCCTATGTTGTCTGTGTCCTGGTAGTGTCACCTTGGCTGTACCTAGTCACAGC 65 FBan0013803 FBgn0035329 DmsR-2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; negative regulation of muscle contraction; GO:0045932 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; ; GO:0008188; ; GO:0004930; myosuppressin receptor activity; GO:0035013; ; GO:0008188; ; GO:0004930; ; GO:0035013; ; GO:0035013 integral to membrane; GO:0016021 DmsR-2 Dromyosuppressin receptor 2 "CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, CG13803, DMSR-2, anon-WO0170980.160, anon-WO0170980.161, Dromyosuppressin receptor 2" CDMC34619 4 3 14 DAC22-H02 23-CG13873-RB_1 CG13873 ATTAAGTCTTACTATGCGAACTCGAACTTTAAGGATGTCATCGAAAAGGATTTGGACAGGTGCAG 65 FBan0013873 FBgn0034474 Obp56g 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56g Odorant-binding protein 56g "CG13873, CG13873, CG13873, CG13873, OBP56g, 56g, Odorant-binding protein 56g" CDMC34619 4 4 14 DAC22-H02 23-CG13873-RB_1 CG13873 ATTAAGTCTTACTATGCGAACTCGAACTTTAAGGATGTCATCGAAAAGGATTTGGACAGGTGCAG 65 FBan0013873 FBgn0034474 Obp56g 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56g Odorant-binding protein 56g "CG13873, CG13873, CG13873, CG13873, OBP56g, 56g, Odorant-binding protein 56g" CDMC34620 4 5 14 DAC22-H14 3-CG13912-RA_1 CG13912 CAGCTTCAACCTCTGGACCATTCCCAACTTCTTGGTGCAGTGCCTCACCAGCTACATGAGCAAGA 65 FBan0013912 FBgn0035186 CG13912 3 3L CG13912 CG13912 CDMC34620 4 6 14 DAC22-H14 3-CG13912-RA_1 CG13912 CAGCTTCAACCTCTGGACCATTCCCAACTTCTTGGTGCAGTGCCTCACCAGCTACATGAGCAAGA 65 FBan0013912 FBgn0035186 CG13912 3 3L CG13912 CG13912 CDMC34621 4 7 14 DAC22-L02 2-CG13954-RA_1 CG13954 CTGGACGATGCCGATAAAATCGACGACCTTGAGCAGATGGTCCCCAGTGGTCATCAGAGGCATCG 65 FBan0013954 FBgn0033405 CG13954 2 2R CG13954 CG13954 CDMC34621 4 8 14 DAC22-L02 2-CG13954-RA_1 CG13954 CTGGACGATGCCGATAAAATCGACGACCTTGAGCAGATGGTCCCCAGTGGTCATCAGAGGCATCG 65 FBan0013954 FBgn0033405 CG13954 2 2R CG13954 CG13954 CDMC34622 4 9 14 DAC22-L14 2-CG13989-RA_1 CG13989 TTTGGTTACTTGCCATGTACCATTCTTCAGGCCCATGTCGTGCCCACTTCAGGCGATCCAGTCAG 65 FBan0013989 FBgn0031786 CG13989 2 2L CG13989 CG13989 BcDNA:AT09383 CDMC34622 4 10 14 DAC22-L14 2-CG13989-RA_1 CG13989 TTTGGTTACTTGCCATGTACCATTCTTCAGGCCCATGTCGTGCCCACTTCAGGCGATCCAGTCAG 65 FBan0013989 FBgn0031786 CG13989 2 2L CG13989 CG13989 BcDNA:AT09383 CDMC34623 4 11 14 DAC22-P02 3-CG1406-RA_1 CG1406 TCTGCCTGCTTATCAACCCGGTATCCACGAAGCCCAACTACCGCGAGTACATGGCCTACAAGTTC 65 FBan0001406 FBgn0033210 U2A 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "mRNA binding; GO:0003729; ; GO:0003729; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 U2A U2A "CG1406, l(2)43Ee, U2A', dU2A', BcDNA:RE56869, lethal(2)43Ee" CDMC34623 4 12 14 DAC22-P02 3-CG1406-RA_1 CG1406 TCTGCCTGCTTATCAACCCGGTATCCACGAAGCCCAACTACCGCGAGTACATGGCCTACAAGTTC 65 FBan0001406 FBgn0033210 U2A 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398" "mRNA binding; GO:0003729; ; GO:0003729; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" small nuclear ribonucleoprotein complex; GO:0030532; snRNP U2; GO:0005686 U2A U2A "CG1406, l(2)43Ee, U2A', dU2A', BcDNA:RE56869, lethal(2)43Ee" CDMC34624 4 13 14 DAC22-P14 17-CG14101-RA_3 CG14101 GTGCTGTTGACGGGTTCGATCACTAGATCCCCACATAAACCACCAACTCTATACCCACACGTGCG 65 FBan0014101 FBgn0036905 CG14101 3 3L CG14101 CG14101 anon-WO0140519.34 CDMC34624 4 14 14 DAC22-P14 17-CG14101-RA_3 CG14101 GTGCTGTTGACGGGTTCGATCACTAGATCCCCACATAAACCACCAACTCTATACCCACACGTGCG 65 FBan0014101 FBgn0036905 CG14101 3 3L CG14101 CG14101 anon-WO0140519.34 CDMC34625 4 15 14 DAC23-D02 3-CG4712-RB_1 CG4712 CATCGTTCTCAGCACGGAGCATCATCTCGAGCAGACGTTAAAACGCATCCTGGTTCGTCCGGACG 65 FBan0004712 FBgn0033818 CG4712 2 2R CG4712 CG4712 CDMC34625 4 16 14 DAC23-D02 3-CG4712-RB_1 CG4712 CATCGTTCTCAGCACGGAGCATCATCTCGAGCAGACGTTAAAACGCATCCTGGTTCGTCCGGACG 65 FBan0004712 FBgn0033818 CG4712 2 2R CG4712 CG4712 CDMC34626 4 17 14 DAC23-D14 3-CG4761-RA_2 CG4761 GAAACTGGACGAACTCATAGAGGCCAGCAGTGAGAATGGAAAACGTCTGAGGTTGGAAGCCCCCG 65 FBan0004761 FBgn0001323 knrl 3 3L branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; regulation of mitosis; GO:0007088; regulation of tracheal tube size; GO:0035151; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700 nucleus; GO:0005634 knrl knirps-like "CG4761, knirps-related, NR0A2, Knirps-related, knirps related, Knrl" CDMC34626 4 18 14 DAC23-D14 3-CG4761-RA_2 CG4761 GAAACTGGACGAACTCATAGAGGCCAGCAGTGAGAATGGAAAACGTCTGAGGTTGGAAGCCCCCG 65 FBan0004761 FBgn0001323 knrl 3 3L branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; regulation of mitosis; GO:0007088; regulation of tracheal tube size; GO:0035151; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal system development (sensu Insecta); GO:0007424 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700 nucleus; GO:0005634 knrl knirps-like "CG4761, knirps-related, NR0A2, Knirps-related, knirps related, Knrl" CDMC34627 4 19 14 DAC23-H02 3-CG4918-RB_2 CG4918 CGTGTCAAGAACCCAAGACTTAAACATGCGTTACGTGGCTGCTTACCTTCTGGCCGTCCTCGGTG 65 FBan0004918 FBgn0003274 RpLP2 2 2R protein biosynthesis; GO:0006412; translational elongation; GO:0006414 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpLP2 Ribosomal protein LP2 "CG4918, rpA1, RpA1: Ribosomal protein A1, rpA1 gene., bs34h02.y1, RpP1: Ribosomal protein P1, BcDNA:SD22208, T1, Tp1: Temporal-protein-1, Ribosomal protein P1, Ribosomal protein A1, Temporal-protein-1, RpA1, RpP1" CDMC34627 4 20 14 DAC23-H02 3-CG4918-RB_2 CG4918 CGTGTCAAGAACCCAAGACTTAAACATGCGTTACGTGGCTGCTTACCTTCTGGCCGTCCTCGGTG 65 FBan0004918 FBgn0003274 RpLP2 2 2R protein biosynthesis; GO:0006412; translational elongation; GO:0006414 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpLP2 Ribosomal protein LP2 "CG4918, rpA1, RpA1: Ribosomal protein A1, rpA1 gene., bs34h02.y1, RpP1: Ribosomal protein P1, BcDNA:SD22208, T1, Tp1: Temporal-protein-1, Ribosomal protein P1, Ribosomal protein A1, Temporal-protein-1, RpA1, RpP1" CDMC34628 4 21 14 DAC23-H14 23-CG5012-RA_2 CG5012 TGCCTTCGTTTATCCACTTTGCGTTTAGCTGCTAGTTACTGTTTTAATAAAAAGCCAGGCAACAT 65 FBan0005012 FBgn0011787 mRpL12 3 3L cell growth; GO:0016049; mitochondrion organization and biogenesis; GO:0007005; protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial small ribosomal subunit; GO:0005763 mRpL12 mitochondrial ribosomal protein L12 "CG5012, l(3)10534, Mrp17, Mitochondrial ribosomal protein L5/L17, L7/12A, mitochondrial ribosomal protein L7/L12, L7/L12, mRpL7-L12, BcDNA:RE53508, l(3)j4B2, l(3)rL424, mitochondrial ribosomal protein L12" CDMC34628 4 22 14 DAC23-H14 23-CG5012-RA_2 CG5012 TGCCTTCGTTTATCCACTTTGCGTTTAGCTGCTAGTTACTGTTTTAATAAAAAGCCAGGCAACAT 65 FBan0005012 FBgn0011787 mRpL12 3 3L cell growth; GO:0016049; mitochondrion organization and biogenesis; GO:0007005; protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003729; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial small ribosomal subunit; GO:0005763 mRpL12 mitochondrial ribosomal protein L12 "CG5012, l(3)10534, Mrp17, Mitochondrial ribosomal protein L5/L17, L7/12A, mitochondrial ribosomal protein L7/L12, L7/L12, mRpL7-L12, BcDNA:RE53508, l(3)j4B2, l(3)rL424, mitochondrial ribosomal protein L12" CDMC34629 4 23 14 DAC23-L02 17-CG5172-RA_1 CG5172 AGTGACTAAAGAGTTCTAAGGATGCGTCACGCTGTGATCCTTGTTTTCGTGTGTTGCCTGCTGAT 65 FBan0005172 FBgn0030830 CG5172 X X CG5172 CG5172 "CT16557, BcDNA:RH06401" CDMC34629 4 24 14 DAC23-L02 17-CG5172-RA_1 CG5172 AGTGACTAAAGAGTTCTAAGGATGCGTCACGCTGTGATCCTTGTTTTCGTGTGTTGCCTGCTGAT 65 FBan0005172 FBgn0030830 CG5172 X X CG5172 CG5172 "CT16557, BcDNA:RH06401" CDMC34630 4 25 14 DAC23-L14 16-CG5196-RA_1 CG5196 AGACGGGCATAGAGATCTGGATAGTGGAGAAGGCCATTTACCGCCGATATAGGAATGCCGACTGC 65 FBan0005196 FBgn0038039 CG5196 3 3R electron transport; GO:0006118 metal ion binding; GO:0046872; ; GO:0046872 CG5196 CG5196 CDMC34630 4 26 14 DAC23-L14 16-CG5196-RA_1 CG5196 AGACGGGCATAGAGATCTGGATAGTGGAGAAGGCCATTTACCGCCGATATAGGAATGCCGACTGC 65 FBan0005196 FBgn0038039 CG5196 3 3R electron transport; GO:0006118 metal ion binding; GO:0046872; ; GO:0046872 CG5196 CG5196 CDMC34631 4 1 15 DAC23-P02 18-CG5308-RA_1 CG5308 CTCCGCGGACAACTCGAATTCTGACAGCGTCTTTGTGCATATCATTAAAAGTGAGCAGCACGCGG 65 FBan0005308 FBgn0037908 dpr5 3 3R dpr5 dpr5 "CG5308, CG5308, CG5308, CG5308, CT16895, Dpr-5" CDMC34631 4 2 15 DAC23-P02 18-CG5308-RA_1 CG5308 CTCCGCGGACAACTCGAATTCTGACAGCGTCTTTGTGCATATCATTAAAAGTGAGCAGCACGCGG 65 FBan0005308 FBgn0037908 dpr5 3 3R dpr5 dpr5 "CG5308, CG5308, CG5308, CG5308, CT16895, Dpr-5" CDMC34632 4 3 15 DAC23-P14 1-CG5345-RA_1 CG5345 GGCGCTGATCTGGTCTGCTACTCCCTGACCAAGTACATGAACGGTCATACGGATGTGGTCATGGG 65 FBan0005345 FBgn0000566 Eip55E 2 2R sulfur amino acid metabolism; GO:0000096 cystathionine gamma-lyase activity; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1 Eip55E Eip55E "CG5345, Eip40: Ecdysone-induced polypeptide 40kD, EIP40, Eip55BD, Ecdysone-induced polypeptide 40kD, Ecdysone-induced protein 40kD, Eip40" CDMC34632 4 4 15 DAC23-P14 1-CG5345-RA_1 CG5345 GGCGCTGATCTGGTCTGCTACTCCCTGACCAAGTACATGAACGGTCATACGGATGTGGTCATGGG 65 FBan0005345 FBgn0000566 Eip55E 2 2R sulfur amino acid metabolism; GO:0000096 cystathionine gamma-lyase activity; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1; ; GO:0004123 ; EC:4.4.1.1 Eip55E Eip55E "CG5345, Eip40: Ecdysone-induced polypeptide 40kD, EIP40, Eip55BD, Ecdysone-induced polypeptide 40kD, Ecdysone-induced protein 40kD, Eip40" CDMC34633 4 5 15 DAC24-D02 3-CG9204-RC_1 CG9204 TGGCCAGGAAGCCAATTGTTGCCGTGAAATCAAGTCGTTTACAGCAGTGGAACAAGTCGGATGTGTCCA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC34633 4 6 15 DAC24-D02 3-CG9204-RC_1 CG9204 TGGCCAGGAAGCCAATTGTTGCCGTGAAATCAAGTCGTTTACAGCAGTGGAACAAGTCGGATGTGTCCA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC34634 4 7 15 DAC24-D14 2-CG9211-RA_3 CG9211 TGGGCGACCGCGATACAACAACTCCCAGTCATAACGAGACATTCAATATGAGTCCCATGCTGACGGGAA 69 FBan0009211 FBgn0031872 iHog 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; positive regulation of smoothened signaling pathway; GO:0045880; signal transduction; GO:0007165 hedgehog receptor activity; GO:0008158; ; GO:0008158 integral to membrane; GO:0016021 iHog interference Hedgehog "CG9211, CG9211, CG9211, CT26314, interference Hedgehog" CDMC34634 4 8 15 DAC24-D14 2-CG9211-RA_3 CG9211 TGGGCGACCGCGATACAACAACTCCCAGTCATAACGAGACATTCAATATGAGTCCCATGCTGACGGGAA 69 FBan0009211 FBgn0031872 iHog 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; positive regulation of smoothened signaling pathway; GO:0045880; signal transduction; GO:0007165 hedgehog receptor activity; GO:0008158; ; GO:0008158 integral to membrane; GO:0016021 iHog interference Hedgehog "CG9211, CG9211, CG9211, CT26314, interference Hedgehog" CDMC34635 4 9 15 DAC24-H02 23-CG9250-RA_1 CG9250 ACTATATTAGATTCAAAAATAAATAAGGAAAATGCCATCCAAATCAAAGCCGAGACTTTCGCGTGGTGT 69 FBan0009250 FBgn0032921 Mpp6 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mpp6 M-phase phosphoprotein 6 "CG9250, dMPP6, MPP6, BcDNA:RE45276, l(2)k16403, M-phase phosphoprotein 6" CDMC34635 4 10 15 DAC24-H02 23-CG9250-RA_1 CG9250 ACTATATTAGATTCAAAAATAAATAAGGAAAATGCCATCCAAATCAAAGCCGAGACTTTCGCGTGGTGT 69 FBan0009250 FBgn0032921 Mpp6 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mpp6 M-phase phosphoprotein 6 "CG9250, dMPP6, MPP6, BcDNA:RE45276, l(2)k16403, M-phase phosphoprotein 6" CDMC34636 4 11 15 DAC24-H14 3-CG9263-RA_1 CG9263 GGCACCCTGCGAATCGACACGTCACACGATATTCATCGATGCCGTTTCCATGCAGATTCCAAATGCACT 69 FBan0009263 FBgn0032530 CG9263 2 2L CG9263 CG9263 CDMC34636 4 12 15 DAC24-H14 3-CG9263-RA_1 CG9263 GGCACCCTGCGAATCGACACGTCACACGATATTCATCGATGCCGTTTCCATGCAGATTCCAAATGCACT 69 FBan0009263 FBgn0032530 CG9263 2 2L CG9263 CG9263 CDMC34637 4 13 15 DAC24-L02 14-CG9304-RA_1 CG9304 CCAAAGGATGGGCAGTTACCAGACAGCAAATCAGCAGAACGGGATGGATAATTCTGATGTCCATCTGGG 69 FBan0009304 FBgn0034674 CG9304 2 2R CG9304 CG9304 CDMC34637 4 14 15 DAC24-L02 14-CG9304-RA_1 CG9304 CCAAAGGATGGGCAGTTACCAGACAGCAAATCAGCAGAACGGGATGGATAATTCTGATGTCCATCTGGG 69 FBan0009304 FBgn0034674 CG9304 2 2R CG9304 CG9304 CDMC34638 4 15 15 DAC24-L14 13-CG9311-RA_1 CG9311 ACCACCATTGCGAAATTGTTCCCGGAGAAAAATCGATCCCTTGATTGTCTGCCATACGATCATGCCAGA 69 FBan0009311 FBgn0036448 CG9311 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG9311 CG9311 CDMC34638 4 16 15 DAC24-L14 13-CG9311-RA_1 CG9311 ACCACCATTGCGAAATTGTTCCCGGAGAAAAATCGATCCCTTGATTGTCTGCCATACGATCATGCCAGA 69 FBan0009311 FBgn0036448 CG9311 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG9311 CG9311 CDMC34639 4 17 15 DAC24-P02 16-CG9339-RB_1 CG9339 ACAACGAATTGAGGGGAAGGGACAGGAGTGATCACAGATTGCAGAATGTAATGGGTAACACTCCACAAC 69 FBan0009339 FBgn0032901 CG9339 2 2L CG9339 CG9339 "CG14399, CG9340, anon-WO0118547.455" CDMC34639 4 18 15 DAC24-P02 16-CG9339-RB_1 CG9339 ACAACGAATTGAGGGGAAGGGACAGGAGTGATCACAGATTGCAGAATGTAATGGGTAACACTCCACAAC 69 FBan0009339 FBgn0032901 CG9339 2 2L CG9339 CG9339 "CG14399, CG9340, anon-WO0118547.455" CDMC34640 4 19 15 DAC24-P14 15-CG9355-RA_2 CG9355 AGCGCTTTAAGCCGTAGACTAAGCCGAATACTTCTGCGTCCCACTGTCAGAGATTTTCCCAGACCCCCG 69 FBan0009355 FBgn0004511 dy X X NOT circadian rhythm; GO:0007623; NOT rhythmic behavior; GO:0007622; cellular morphogenesis; GO:0000902; wing morphogenesis; GO:0007476 structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 integral to membrane; GO:0016021; plasma membrane; GO:0005886 dy dusky "CG9355, ala, alae parvae, And, Andante, dusky" CDMC34640 4 20 15 DAC24-P14 15-CG9355-RA_2 CG9355 AGCGCTTTAAGCCGTAGACTAAGCCGAATACTTCTGCGTCCCACTGTCAGAGATTTTCCCAGACCCCCG 69 FBan0009355 FBgn0004511 dy X X NOT circadian rhythm; GO:0007623; NOT rhythmic behavior; GO:0007622; cellular morphogenesis; GO:0000902; wing morphogenesis; GO:0007476 structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 integral to membrane; GO:0016021; plasma membrane; GO:0005886 dy dusky "CG9355, ala, alae parvae, And, Andante, dusky" CDMC34641 4 21 15 DAC25-D02 15-CG10584-RA_1 CG10584 CCGCGCTACGATATCAGTTCTGGAGTTTGATTTTCTCGCCTCAAAAGAGGATCACTCGCAGGATCTGCT 69 FBan0010584 FBgn0037045 CG10584 3 3L CG10584 CG10584 anon-WO0118547.713 CDMC34641 4 22 15 DAC25-D02 15-CG10584-RA_1 CG10584 CCGCGCTACGATATCAGTTCTGGAGTTTGATTTTCTCGCCTCAAAAGAGGATCACTCGCAGGATCTGCT 69 FBan0010584 FBgn0037045 CG10584 3 3L CG10584 CG10584 anon-WO0118547.713 CDMC34642 4 23 15 DAC25-D14 23-CG10596-RA_3 CG10596 AGAAGAAGGAGTCATCATGTACCCAACTAAACCCGAAGAATCTAAGATTGTAACCGAATCGTCTCGATT 69 FBan0010596 FBgn0015766 Msr-110 3 3L Msr-110 Msr-110 "CG10596, Engrailed nuclear homeoprotein-regulated gene" CDMC34642 4 24 15 DAC25-D14 23-CG10596-RA_3 CG10596 AGAAGAAGGAGTCATCATGTACCCAACTAAACCCGAAGAATCTAAGATTGTAACCGAATCGTCTCGATT 69 FBan0010596 FBgn0015766 Msr-110 3 3L Msr-110 Msr-110 "CG10596, Engrailed nuclear homeoprotein-regulated gene" CDMC34643 4 25 15 DAC25-H02 22-CG10624-RA_1 CG10624 TGCATAAACTTCAGCTAAGCTAGTGCCTTAATTAAGTGACCCAGAGAAAGGTAAGCGAAACTCCGCCCA 69 FBan0010624 FBgn0010894 sinu 3 3L regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; tracheal system development (sensu Insecta); GO:0007424 septate junction; GO:0005918 sinu sinuous "CG10624, CG10624, CG10624, l(3)06524, 6524, i8, sinuous" CDMC34643 4 26 15 DAC25-H02 22-CG10624-RA_1 CG10624 TGCATAAACTTCAGCTAAGCTAGTGCCTTAATTAAGTGACCCAGAGAAAGGTAAGCGAAACTCCGCCCA 69 FBan0010624 FBgn0010894 sinu 3 3L regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; tracheal system development (sensu Insecta); GO:0007424 septate junction; GO:0005918 sinu sinuous "CG10624, CG10624, CG10624, l(3)06524, 6524, i8, sinuous" CDMC34644 4 1 16 DAC25-H14 18-CG10630-RA_4 CG10630 GGCTGAAAGTTGTGCAAAGGTGGACATCTTAGAGATGAAGAAGGCATTGATCCCAAATCCTTCTGCCGA 69 FBan0010630 FBgn0035608 CG10630 3 3L double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG10630 CG10630 CDMC34644 4 2 16 DAC25-H14 18-CG10630-RA_4 CG10630 GGCTGAAAGTTGTGCAAAGGTGGACATCTTAGAGATGAAGAAGGCATTGATCCCAAATCCTTCTGCCGA 69 FBan0010630 FBgn0035608 CG10630 3 3L double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 CG10630 CG10630 CDMC34645 4 3 16 DAC25-L02 23-CG1065-RA_16 CG1065 ACTATCGCAGTGGTTAACTCAGCACTATTCGGCCGATTTCGCACTGCATTAATTAAACGCGTTTTAATT 69 FBan0001065 FBgn0004888 Scsalpha 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Scsalpha Succinyl coenzyme A synthetase alpha subunit "CG1065, succinyl-CoA synthetase alpha-subunit, scsalpha, Scsalpha" CDMC34645 4 4 16 DAC25-L02 23-CG1065-RA_16 CG1065 ACTATCGCAGTGGTTAACTCAGCACTATTCGGCCGATTTCGCACTGCATTAATTAAACGCGTTTTAATT 69 FBan0001065 FBgn0004888 Scsalpha 3 3L tricarboxylic acid cycle; GO:0006099 succinate-CoA ligase (GDP-forming) activity; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4; ; GO:0004776 ; EC:6.2.1.4 succinate-CoA ligase complex (GDP-forming); GO:0045244 Scsalpha Succinyl coenzyme A synthetase alpha subunit "CG1065, succinyl-CoA synthetase alpha-subunit, scsalpha, Scsalpha" CDMC34646 4 5 16 DAC25-L14 12-CG10671-RB_1 CG10671 AGCTGAGAGCTGAACCCTGGTCAAGTCAACAGAGGGGAGAGCAGCCATCAAGCATAGAAGGAATTGATA 69 FBan0010671 FBgn0035586 CG10671 3 3L CG10671 CG10671 i136 CDMC34646 4 6 16 DAC25-L14 12-CG10671-RB_1 CG10671 AGCTGAGAGCTGAACCCTGGTCAAGTCAACAGAGGGGAGAGCAGCCATCAAGCATAGAAGGAATTGATA 69 FBan0010671 FBgn0035586 CG10671 3 3L CG10671 CG10671 i136 CDMC34647 4 7 16 DAC25-P02 3-CG10700-RA_1 CG10700 CGCAGGGAAAAGAATTGTGTCGGTGTCAGATCGTCGATCCCAAGGGGCGAAATTACTGGCTCACGAAGT 69 FBan0010700 FBgn0032754 CG10700 2 2L defense response; GO:0006952; ferredoxin metabolism; GO:0006124; oxygen and reactive oxygen species metabolism; GO:0006800 ferredoxin reductase activity; GO:0008937 ; EC:1.18.1.-; ; GO:0008937 ; EC:1.18.1.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG10700 CG10700 CDMC34647 4 8 16 DAC25-P02 3-CG10700-RA_1 CG10700 CGCAGGGAAAAGAATTGTGTCGGTGTCAGATCGTCGATCCCAAGGGGCGAAATTACTGGCTCACGAAGT 69 FBan0010700 FBgn0032754 CG10700 2 2L defense response; GO:0006952; ferredoxin metabolism; GO:0006124; oxygen and reactive oxygen species metabolism; GO:0006800 ferredoxin reductase activity; GO:0008937 ; EC:1.18.1.-; ; GO:0008937 ; EC:1.18.1.-; disulfide oxidoreductase activity; GO:0015036; ; GO:0015036 CG10700 CG10700 CDMC34648 4 9 16 DAC25-P14 17-CG10719-RA_1 CG10719 GCCGCCTCTCTATATCTTTGCACACTTCTCACTTCAAACCCTCGTATCTCTATCTCGCGTGCAAGTCGT 69 FBan0010719 FBgn0010300 brat 2 2L cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; proteolysis; GO:0006508; rRNA metabolism; GO:0016072; rRNA transcription; GO:0009303; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of translation; GO:0006445; transport; GO:0006810 nucleic acid binding; GO:0003676; translation regulator activity; GO:0045182; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; translation repressor activity; GO:0030371; ; GO:0045182; ; GO:0005515; ; GO:0030371; ; GO:0008237; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 brat brain tumor "CG10719, l(2)E60, l(2)37Cf, Cf, Brain Tumor, E60, anon-37CDa, fs(2)ltoPM43, l(2)brat" CDMC34648 4 10 16 DAC25-P14 17-CG10719-RA_1 CG10719 GCCGCCTCTCTATATCTTTGCACACTTCTCACTTCAAACCCTCGTATCTCTATCTCGCGTGCAAGTCGT 69 FBan0010719 FBgn0010300 brat 2 2L cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; proteolysis; GO:0006508; rRNA metabolism; GO:0016072; rRNA transcription; GO:0009303; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of translation; GO:0006445; transport; GO:0006810 nucleic acid binding; GO:0003676; translation regulator activity; GO:0045182; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; translation repressor activity; GO:0030371; ; GO:0045182; ; GO:0005515; ; GO:0030371; ; GO:0008237; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 brat brain tumor "CG10719, l(2)E60, l(2)37Cf, Cf, Brain Tumor, E60, anon-37CDa, fs(2)ltoPM43, l(2)brat" CDMC34649 4 11 16 DAC26-D02 16-CG8048-RA_1 CG8048 GCCCGAAAATGGTGTCGCAAATCGCAAACTGAAACGTTCACGGAGCTAATTGTGCTAACAAATTTCCGA 69 FBan0008048 FBgn0020611 Vha44 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; regulation of juvenile hormone biosynthesis; GO:0007557 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha44 Vacuolar H[+] ATPase 44kD C subunit "CG8048, C subunit, 6072, V-ATPase C subunit, vha44, l(2)6072, V-ATPase, vacuolar ATPase C-subunit" CDMC34649 4 12 16 DAC26-D02 16-CG8048-RA_1 CG8048 GCCCGAAAATGGTGTCGCAAATCGCAAACTGAAACGTTCACGGAGCTAATTGTGCTAACAAATTTCCGA 69 FBan0008048 FBgn0020611 Vha44 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; regulation of juvenile hormone biosynthesis; GO:0007557 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha44 Vacuolar H[+] ATPase 44kD C subunit "CG8048, C subunit, 6072, V-ATPase C subunit, vha44, l(2)6072, V-ATPase, vacuolar ATPase C-subunit" CDMC34650 4 13 16 DAC26-D14 3-CG8062-RA_4 CG8062 AGGACAAGGCACTGTTGCAAAAGACAGCCGAATCGCTTCAGGTGAACCTGTTCAATAATTCGGCCGACA 69 FBan0008062 FBgn0028469 CG8062 X X transport; GO:0006810 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG8062 CG8062 BcDNA:LD28120 CDMC34650 4 14 16 DAC26-D14 3-CG8062-RA_4 CG8062 AGGACAAGGCACTGTTGCAAAAGACAGCCGAATCGCTTCAGGTGAACCTGTTCAATAATTCGGCCGACA 69 FBan0008062 FBgn0028469 CG8062 X X transport; GO:0006810 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 integral to membrane; GO:0016021 CG8062 CG8062 BcDNA:LD28120 CDMC34651 4 15 16 DAC26-H02 18-CG8090-RA_1 CG8090 AGCCGAGTATCGTGTGATCATCACCGAGGTTCTAGGAAATCTGCACTTCAACTTCTACCATCGTTGGTT 69 FBan0008090 FBgn0033995 CG8090 2 2R CG8090 CG8090 CDMC34651 4 16 16 DAC26-H02 18-CG8090-RA_1 CG8090 AGCCGAGTATCGTGTGATCATCACCGAGGTTCTAGGAAATCTGCACTTCAACTTCTACCATCGTTGGTT 69 FBan0008090 FBgn0033995 CG8090 2 2R CG8090 CG8090 CDMC34652 4 17 16 DAC26-H14 22-CG8103-RA_1 CG8103 AGCCCAAGACCGAAGAGAAGGAAAAAGAAAAGGTGGATGACAAGAAACCAATACCACCGACGACAGTAA 69 FBan0008103 FBgn0013591 Mi-2 3 3L chromatin assembly or disassembly; GO:0006333; nucleosome mobilization; GO:0042766; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ATPase activity; GO:0016887; DNA helicase activity; GO:0003678; ; GO:0016887; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; transcriptional repressor activity; GO:0016564; ; GO:0004386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016887; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0016564; ; GO:0003682; ; GO:0004386; ; GO:0008270 NuRD complex; GO:0016581; chromatin; GO:0000785; nucleus; GO:0005634; polytene chromosome; GO:0005700; ubiquitin ligase complex; GO:0000151 Mi-2 Mi-2 "CG8103, CG8103, Pha: PHD-containing ATPase, pha, PHD-containing ATPase, 0006/06, 0854/01, l(3)A154.3M3, dMi-2, hip76, hb-interacting protein 76, l(3)S000606, l(3)S085401, Dm-Mi-2, Mi 2, MI2, dMI-2, dMi, Mi2, l(3)01058, l(3)j3D4, Pha" CDMC34652 4 18 16 DAC26-H14 22-CG8103-RA_1 CG8103 AGCCCAAGACCGAAGAGAAGGAAAAAGAAAAGGTGGATGACAAGAAACCAATACCACCGACGACAGTAA 69 FBan0008103 FBgn0013591 Mi-2 3 3L chromatin assembly or disassembly; GO:0006333; nucleosome mobilization; GO:0042766; protein ubiquitination; GO:0016567; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ATPase activity; GO:0016887; DNA helicase activity; GO:0003678; ; GO:0016887; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; transcriptional repressor activity; GO:0016564; ; GO:0004386; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016887; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0016564; ; GO:0003682; ; GO:0004386; ; GO:0008270 NuRD complex; GO:0016581; chromatin; GO:0000785; nucleus; GO:0005634; polytene chromosome; GO:0005700; ubiquitin ligase complex; GO:0000151 Mi-2 Mi-2 "CG8103, CG8103, Pha: PHD-containing ATPase, pha, PHD-containing ATPase, 0006/06, 0854/01, l(3)A154.3M3, dMi-2, hip76, hb-interacting protein 76, l(3)S000606, l(3)S085401, Dm-Mi-2, Mi 2, MI2, dMI-2, dMi, Mi2, l(3)01058, l(3)j3D4, Pha" CDMC34653 4 19 16 DAC26-L02 23-CG8137-RA_1 CG8137 GCTTTACTTTTCGTGCGCTATAGTATGCCTATGCCGTCATCTCAAATGGTTTTTAATGCCGATCATCCT 69 FBan0008137 FBgn0028987 Spn2 2 2L negative regulation of proteolysis; GO:0045861; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; hormone binding; GO:0042562; ; GO:0004867; ; GO:0042562 Spn2 Serine protease inhibitor 2 "CG8137, CG8137, CG8137, CG8137, CG8137, sp2: serpin 2, serpin 2, Sp2" CDMC34653 4 20 16 DAC26-L02 23-CG8137-RA_1 CG8137 GCTTTACTTTTCGTGCGCTATAGTATGCCTATGCCGTCATCTCAAATGGTTTTTAATGCCGATCATCCT 69 FBan0008137 FBgn0028987 Spn2 2 2L negative regulation of proteolysis; GO:0045861; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; hormone binding; GO:0042562; ; GO:0004867; ; GO:0042562 Spn2 Serine protease inhibitor 2 "CG8137, CG8137, CG8137, CG8137, CG8137, sp2: serpin 2, serpin 2, Sp2" CDMC34654 4 21 16 DAC26-L14 23-CG8155-RA_7 CG8155 TGCAGCTCTTGATGTAACCATAAACTCAGTCGATTGCTCAGATTTGTCTTGCTAGAGGTGAATGGCAGA 69 FBan0008155 FBgn0034009 CG8155 2 2R intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG8155 CG8155 CDMC34654 4 22 16 DAC26-L14 23-CG8155-RA_7 CG8155 TGCAGCTCTTGATGTAACCATAAACTCAGTCGATTGCTCAGATTTGTCTTGCTAGAGGTGAATGGCAGA 69 FBan0008155 FBgn0034009 CG8155 2 2R intracellular protein transport; GO:0006886 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG8155 CG8155 CDMC34655 4 23 16 DAC26-P02 18-CG8189-RA_2 CG8189 TTTCGGGTGAATTTAGTAGCATAAATTCGTCGCAACTGCCTGGAAAATGTTCTCGAGAGCCGCTCTTCT 69 FBan0008189 FBgn0019644 ATPsyn-b 3 3L ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-b "ATP synthase, subunit b" "CG8189, Fo-ATP synthase subunit b" CDMC34655 4 24 16 DAC26-P02 18-CG8189-RA_2 CG8189 TTTCGGGTGAATTTAGTAGCATAAATTCGTCGCAACTGCCTGGAAAATGTTCTCGAGAGCCGCTCTTCT 69 FBan0008189 FBgn0019644 ATPsyn-b 3 3L ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-b "ATP synthase, subunit b" "CG8189, Fo-ATP synthase subunit b" CDMC34656 4 25 16 DAC26-P14 2-CG8199-RA_1 CG8199 TGGAGCACCCAATATCCAAGCTTAAGCGCTACATGGTGCACAAAGGCTGGTTTGACGAGACTGTCGAAA 69 FBan0008199 FBgn0037709 CG8199 3 3R acyl-CoA biosynthesis; GO:0046949; amino acid catabolism; GO:0009063 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4 3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex; GO:0017086 CG8199 CG8199 CDMC34656 4 26 16 DAC26-P14 2-CG8199-RA_1 CG8199 TGGAGCACCCAATATCCAAGCTTAAGCGCTACATGGTGCACAAAGGCTGGTTTGACGAGACTGTCGAAA 69 FBan0008199 FBgn0037709 CG8199 3 3R acyl-CoA biosynthesis; GO:0046949; amino acid catabolism; GO:0009063 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4; ; GO:0003863 ; EC:1.2.4.4 3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex; GO:0017086 CG8199 CG8199 CDMC34657 4 1 17 DAC27-D02 3-CG8435-RA_2 CG8435 GCCAAAAACCGGCAGTACACCGTGAGATTGATGGCTCCATTTAATATGCGCTGCAAAACGTGTGGGGAA 69 FBan0008435 FBgn0034084 CG8435 2 2R CG8435 CG8435 CDMC34657 4 2 17 DAC27-D02 3-CG8435-RA_2 CG8435 GCCAAAAACCGGCAGTACACCGTGAGATTGATGGCTCCATTTAATATGCGCTGCAAAACGTGTGGGGAA 69 FBan0008435 FBgn0034084 CG8435 2 2R CG8435 CG8435 CDMC34658 4 3 17 DAC27-D14 11-CG8446-RA_1 CG8446 GCTCGTCAGCGCATCGAATGTGAAGCAGGCAATAAACGGATCAGCTTGATTACTGTTGTGCTAGCTCGA 69 FBan0008446 FBgn0034089 CG8446 2 2R coenzyme metabolism; GO:0006732; protein modification; GO:0006464 lipoyltransferase activity; GO:0017118; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0017118 CG8446 CG8446 CDMC34658 4 4 17 DAC27-D14 11-CG8446-RA_1 CG8446 GCTCGTCAGCGCATCGAATGTGAAGCAGGCAATAAACGGATCAGCTTGATTACTGTTGTGCTAGCTCGA 69 FBan0008446 FBgn0034089 CG8446 2 2R coenzyme metabolism; GO:0006732; protein modification; GO:0006464 lipoyltransferase activity; GO:0017118; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0017118 CG8446 CG8446 CDMC34659 4 5 17 DAC27-H02 23-CG8489-RA_17 CG8489 TGGGGTCAGTTCTGATTCGCCATAGTTCTCCCATAGATTGTAAATTAGAAGAACCTCTCTTGGACCTCG 69 FBan0008489 FBgn0038225 CG8489 3 3R CG8489 CG8489 CDMC34659 4 6 17 DAC27-H02 23-CG8489-RA_17 CG8489 TGGGGTCAGTTCTGATTCGCCATAGTTCTCCCATAGATTGTAAATTAGAAGAACCTCTCTTGGACCTCG 69 FBan0008489 FBgn0038225 CG8489 3 3R CG8489 CG8489 CDMC34660 4 7 17 DAC27-H14 17-CG8502-RA_3 CG8502 CTATGACGGAGGCTATGGACCCTACGCTGGTTCGAATATTCCCTATGTCCATGACGACAGGCCTTACAA 69 FBan0008502 FBgn0033725 CG8502 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8502 CG8502 CDMC34660 4 8 17 DAC27-H14 17-CG8502-RA_3 CG8502 CTATGACGGAGGCTATGGACCCTACGCTGGTTCGAATATTCCCTATGTCCATGACGACAGGCCTTACAA 69 FBan0008502 FBgn0033725 CG8502 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG8502 CG8502 CDMC34661 4 9 17 DAC27-L02 23-CG8542-RA_6 CG8542 AAACTATCCGATGCGATTAGGTCAAATCAGACGATGAGACTTCCAAGTAAACAGACGAAGACCAAGCCG 69 FBan0008542 FBgn0001220 Hsc70-5 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-5 Heat shock protein cognate 5 "CG8542, Hsc5, hsc70, HSC5, l(2)k04907, Hsc70, dhsc70, HSC70, HSC-70" CDMC34661 4 10 17 DAC27-L02 23-CG8542-RA_6 CG8542 AAACTATCCGATGCGATTAGGTCAAATCAGACGATGAGACTTCCAAGTAAACAGACGAAGACCAAGCCG 69 FBan0008542 FBgn0001220 Hsc70-5 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting to mitochondrion; GO:0006626; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; unfolded protein binding; GO:0051082; ; GO:0016887; ; GO:0051082 mitochondrion; GO:0005739 Hsc70-5 Heat shock protein cognate 5 "CG8542, Hsc5, hsc70, HSC5, l(2)k04907, Hsc70, dhsc70, HSC70, HSC-70" CDMC34662 4 11 17 DAC27-L14 16-CG8549-RA_1 CG8549 CCACCTTGCACTTAACCTTGCTCATAGATCCTGGCCAATATCGTGTCATTGATGAGCTGGTAAGGAACG 69 FBan0008549 FBgn0035714 CG8549 3 3L CG8549 CG8549 CDMC34662 4 12 17 DAC27-L14 16-CG8549-RA_1 CG8549 CCACCTTGCACTTAACCTTGCTCATAGATCCTGGCCAATATCGTGTCATTGATGAGCTGGTAAGGAACG 69 FBan0008549 FBgn0035714 CG8549 3 3L CG8549 CG8549 CDMC34663 4 13 17 DAC27-P02 15-CG8586-RA_8 CG8586 GCTGGACAGCTATGACAGATGGCTGGTTGAGAGAACCACAACAGTGCCTTCAACAATTCGAAACAAGGT 69 FBan0008586 FBgn0033320 CG8586 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8586 CG8586 "c-SPH58, SPH58" CDMC34663 4 14 17 DAC27-P02 15-CG8586-RA_8 CG8586 GCTGGACAGCTATGACAGATGGCTGGTTGAGAGAACCACAACAGTGCCTTCAACAATTCGAAACAAGGT 69 FBan0008586 FBgn0033320 CG8586 2 2R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8586 CG8586 "c-SPH58, SPH58" CDMC34664 4 15 17 DAC27-P14 13-CG8598-RA_1 CG8598 CGCCAGTTCACCGGGTTGGATAACTTCCTCACCTACGACCAGTGATCGGGGAAATCTATTGAAGCTATT 69 FBan0008598 FBgn0035766 eco 3 3L mitotic sister chromatid cohesion; GO:0007064; proteolysis; GO:0006508 protein binding; GO:0005515; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0008080 ; EC:2.3.1.-; ; GO:0004190 ; EC:3.4.23.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0005515 nuclear chromatin; GO:0000790 eco eco "CG8598, CG8598, deco, Drosophila eco1" CDMC34664 4 16 17 DAC27-P14 13-CG8598-RA_1 CG8598 CGCCAGTTCACCGGGTTGGATAACTTCCTCACCTACGACCAGTGATCGGGGAAATCTATTGAAGCTATT 69 FBan0008598 FBgn0035766 eco 3 3L mitotic sister chromatid cohesion; GO:0007064; proteolysis; GO:0006508 protein binding; GO:0005515; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0008080 ; EC:2.3.1.-; ; GO:0004190 ; EC:3.4.23.-; ; GO:0016407 ; EC:2.3.1.-; ; GO:0005515 nuclear chromatin; GO:0000790 eco eco "CG8598, CG8598, deco, Drosophila eco1" CDMC34665 4 17 17 DAC28-D02 18-CG30356-RA_1 CG30356 GGCACAGTGGATGTTGATGAACTTTTTAAAGTCTTGGCAGGAATCTGTGGTGAGGAACCTTCTCGACCT 69 FBan0030356 FBgn0050356 CG30356 2 2R CG30356 CG30356 CDMC34665 4 18 17 DAC28-D02 18-CG30356-RA_1 CG30356 GGCACAGTGGATGTTGATGAACTTTTTAAAGTCTTGGCAGGAATCTGTGGTGAGGAACCTTCTCGACCT 69 FBan0030356 FBgn0050356 CG30356 2 2R CG30356 CG30356 CDMC34666 4 19 17 DAC28-D14 14-CG30365-RA_3 CG30365 GGACTATCGAAGTTCCTGCCAAGAAGCCTACTAGTAGCCTTAGCACCGAGTCAATTGAAGAGCAGCCGT 69 FBan0030365 FBgn0050365 CG30365 2 2R CG30365 CG30365 "CG2149, CG2149, CG2149, BcDNA:AT04457" CDMC34666 4 20 17 DAC28-D14 14-CG30365-RA_3 CG30365 GGACTATCGAAGTTCCTGCCAAGAAGCCTACTAGTAGCCTTAGCACCGAGTCAATTGAAGAGCAGCCGT 69 FBan0030365 FBgn0050365 CG30365 2 2R CG30365 CG30365 "CG2149, CG2149, CG2149, BcDNA:AT04457" CDMC34667 4 21 17 DAC28-H02 2-CG30396-RA_1 CG30396 GCGGAGAAGTGACCTGAAAATGGGAGACCTCCTGCGAGAATTCAGTCATCTGGAGCTGGTCAAAAGGGA 69 FBan0030396 FBgn0041239 Gr58a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58a Gustatory receptor 58a "CG30396, CG30396, 58A.1, Gustatory receptor 58A.1, Gr58A1, 58A1, GR58A.1" CDMC34667 4 22 17 DAC28-H02 2-CG30396-RA_1 CG30396 GCGGAGAAGTGACCTGAAAATGGGAGACCTCCTGCGAGAATTCAGTCATCTGGAGCTGGTCAAAAGGGA 69 FBan0030396 FBgn0041239 Gr58a 2 2R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr58a Gustatory receptor 58a "CG30396, CG30396, 58A.1, Gustatory receptor 58A.1, Gr58A1, 58A1, GR58A.1" CDMC34668 4 23 17 DAC28-H14 7-CG30420-RA_1 CG30420 GGCGGGAGTGAATATTCCCCAGAGCAAAGAACAACCACCCCATGAACTTAACGCACTGATCAACAAGCT 69 FBan0030420 FBgn0050420 Atf-2 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 Atf-2 Activating transcription factor-2 "CG30420, CG12850, CG3749, CG30420, CG12850, CG12850, dATF-2, Activating transcription factor-2" CDMC34668 4 24 17 DAC28-H14 7-CG30420-RA_1 CG30420 GGCGGGAGTGAATATTCCCCAGAGCAAAGAACAACCACCCCATGAACTTAACGCACTGATCAACAAGCT 69 FBan0030420 FBgn0050420 Atf-2 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; protein homodimerization activity; GO:0042803; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0042803; ; GO:0003677 nucleus; GO:0005634 Atf-2 Activating transcription factor-2 "CG30420, CG12850, CG3749, CG30420, CG12850, CG12850, dATF-2, Activating transcription factor-2" CDMC34669 4 25 17 DAC28-L02 1-CG30456-RA_1 CG30456 CGGCCACGTAAGGAATGGAACAAACATCAGGCATGGAGAGGATCCTTGTCCGGCTAATGAAAATCGGCA 69 FBan0030456 FBgn0050456 CG30456 2 2R CG30456 CG30456 "CG15612, CG15613, CG15612" CDMC34669 4 26 17 DAC28-L02 1-CG30456-RA_1 CG30456 CGGCCACGTAAGGAATGGAACAAACATCAGGCATGGAGAGGATCCTTGTCCGGCTAATGAAAATCGGCA 69 FBan0030456 FBgn0050456 CG30456 2 2R CG30456 CG30456 "CG15612, CG15613, CG15612" CDMC34670 4 1 18 DAC28-L14 16-CG30466-RA_1 CG30466 GCACCTTCGGATTTAAGGAGTTCACATTCGATGCGAAGAAACTGGGAGAAAACCGTACCACAGCACTTA 69 FBan0030466 FBgn0050466 CG30466 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30466 CG30466 CDMC34670 4 2 18 DAC28-L14 16-CG30466-RA_1 CG30466 GCACCTTCGGATTTAAGGAGTTCACATTCGATGCGAAGAAACTGGGAGAAAACCGTACCACAGCACTTA 69 FBan0030466 FBgn0050466 CG30466 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30466 CG30466 CDMC34671 4 3 18 DAC28-P02 3-CG30494-RA_3 CG30494 TGGCCAGCCAAACCTCCTGCGATATGGCCGATGAACTAGAAGTAGAAGCTGACTCCACCATTGCCTTTA 69 FBan0030494 FBgn0027604 CG30494 2 2R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 kinase regulator activity; GO:0019207; ; GO:0019207 CG30494 CG30494 "CG2088, CG2088, CT6764, BcDNA:GH02712" CDMC34671 4 4 18 DAC28-P02 3-CG30494-RA_3 CG30494 TGGCCAGCCAAACCTCCTGCGATATGGCCGATGAACTAGAAGTAGAAGCTGACTCCACCATTGCCTTTA 69 FBan0030494 FBgn0027604 CG30494 2 2R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 kinase regulator activity; GO:0019207; ; GO:0019207 CG30494 CG30494 "CG2088, CG2088, CT6764, BcDNA:GH02712" CDMC34672 4 5 18 DAC28-P14 3-CG30502-RA_2 CG30502 GCCGGCTATCTGTGCTACGATATGATGCACTACTACCTGCACTATGGGAACCCTTCGCTATGGGCCTTT 69 FBan0030502 FBgn0050502 CG30502 2 2R metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG30502 CG30502 "CG1642, CG1645" CDMC34672 4 6 18 DAC28-P14 3-CG30502-RA_2 CG30502 GCCGGCTATCTGTGCTACGATATGATGCACTACTACCTGCACTATGGGAACCCTTCGCTATGGGCCTTT 69 FBan0030502 FBgn0050502 CG30502 2 2R metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG30502 CG30502 "CG1642, CG1645" CDMC34673 4 7 18 DAC29-D02 2-CG9989-RA_2 CG9989 GCTGTGCAATGGAGGACTTCATCGCACCACATTCCTGTGTCGATATGACAGTGTTTTCAGTCCAGCGCT 69 FBan0009989 FBgn0039593 CG9989 3 3R CG9989 CG9989 CDMC34673 4 8 18 DAC29-D02 2-CG9989-RA_2 CG9989 GCTGTGCAATGGAGGACTTCATCGCACCACATTCCTGTGTCGATATGACAGTGTTTTCAGTCCAGCGCT 69 FBan0009989 FBgn0039593 CG9989 3 3R CG9989 CG9989 CDMC34674 4 9 18 DAC29-D14 15-CG9996-RA_6 CG9996 GCGGTCAGAGGGTGCAGGAGACTCTGGTTATGATTAAGTCAGCCATTCTGTTCAACTACGACGAGGAGT 69 FBan0009996 FBgn0039273 CG9996 3 3R CG9996 CG9996 CDMC34674 4 10 18 DAC29-D14 15-CG9996-RA_6 CG9996 GCGGTCAGAGGGTGCAGGAGACTCTGGTTATGATTAAGTCAGCCATTCTGTTCAACTACGACGAGGAGT 69 FBan0009996 FBgn0039273 CG9996 3 3R CG9996 CG9996 CDMC34675 4 11 18 DAC29-H02 17-CR31273-RC_2 CR31273 GCCGAAGGTGATCCTAATAATTGCACCAATATGCTTCGGTAATCGTTTTGAGGCCAGACTCTCCCAGGA 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC34675 4 12 18 DAC29-H02 17-CR31273-RC_2 CR31273 GCCGAAGGTGATCCTAATAATTGCACCAATATGCTTCGGTAATCGTTTTGAGGCCAGACTCTCCCAGGA 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC34676 4 13 18 DAC29-H14 1-CR31615-RA_4 CR31615 CGACGAGGAGTTAAACAAGCTGCTCTCCGGCGTCACAATTGCACAAGGTCGTCAATCAAACCGTCCTTT 69 FBan0031615 FBgn0051615 His-Psi:CR31615 2 2L His-Psi:CR31615 His-Psi:CR31615 "bs28b08.y1, CR31615" CDMC34676 4 14 18 DAC29-H14 1-CR31615-RA_4 CR31615 CGACGAGGAGTTAAACAAGCTGCTCTCCGGCGTCACAATTGCACAAGGTCGTCAATCAAACCGTCCTTT 69 FBan0031615 FBgn0051615 His-Psi:CR31615 2 2L His-Psi:CR31615 His-Psi:CR31615 "bs28b08.y1, CR31615" CDMC34677 4 15 18 DAC29-L02 23-CR32646-RB_9 CR32646 GGGAAAAGCAAACAGACGAGTCGAAAGGAAATACGAAGGAAAAGTCAACAAAAAACCAAACACCACCAA 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC34677 4 16 18 DAC29-L02 23-CR32646-RB_9 CR32646 GGGAAAAGCAAACAGACGAGTCGAAAGGAAATACGAAGGAAAAGTCAACAAAAAACCAAACACCACCAA 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC34678 4 17 18 DAC29-L14 7-CR32730-RA_1 CR32730 CGCCTAGCGCCCACATCACCTACGAGGGGAGAAGCTTGAGCACTTTTTTATTTACAAAAGCGAATGGCA 69 FBan0032730 FBgn0047092 CR32730 X X CR32730 CR32730 BcDNA:RE54930 CDMC34678 4 18 18 DAC29-L14 7-CR32730-RA_1 CR32730 CGCCTAGCGCCCACATCACCTACGAGGGGAGAAGCTTGAGCACTTTTTTATTTACAAAAGCGAATGGCA 69 FBan0032730 FBgn0047092 CR32730 X X CR32730 CR32730 BcDNA:RE54930 CDMC34679 4 19 18 DAC29-P02 16-CR33371-RA_1 CR33371 ACGACCATACCACACTGAATACATCGTTTATCGTCCAATGACCAAAATTAAACATCTTCCGGCGCCCCT 69 FBan0033371 FBgn0053371 5SrRNA-Psi:CR33371 2 2R 5SrRNA-Psi:CR33371 5SrRNA-Psi:CR33371 CR33371 CDMC34679 4 20 18 DAC29-P02 16-CR33371-RA_1 CR33371 ACGACCATACCACACTGAATACATCGTTTATCGTCCAATGACCAAAATTAAACATCTTCCGGCGCCCCT 69 FBan0033371 FBgn0053371 5SrRNA-Psi:CR33371 2 2R 5SrRNA-Psi:CR33371 5SrRNA-Psi:CR33371 CR33371 CDMC34680 4 21 18 DAC29-P14 15-CR40465-RA_1 CR40465 TCGCTGACGTCCTGCATGGATTTCCGATACACCGACACTTACCGTCTATGTGTGCGCTTCAATTTCAAA 69 FBan0040465 FBgn0058465 CR40465 2 2L CR40465 CR40465 CDMC34680 4 22 18 DAC29-P14 15-CR40465-RA_1 CR40465 TCGCTGACGTCCTGCATGGATTTCCGATACACCGACACTTACCGTCTATGTGTGCGCTTCAATTTCAAA 69 FBan0040465 FBgn0058465 CR40465 2 2L CR40465 CR40465 CDMC34681 4 23 18 DAC30-D02 16-CG11999-RA_1 CG11999 CCGGTACAGATTGACTGACTTAGGTCCACGGACTAGGATACGATAACTAGAACAGGACACGATGCAGCA 69 FBan0011999 FBgn0037312 CG11999 3 3R membrane; GO:0016020 CG11999 CG11999 BEST:LD29996 CDMC34681 4 24 18 DAC30-D02 16-CG11999-RA_1 CG11999 CCGGTACAGATTGACTGACTTAGGTCCACGGACTAGGATACGATAACTAGAACAGGACACGATGCAGCA 69 FBan0011999 FBgn0037312 CG11999 3 3R membrane; GO:0016020 CG11999 CG11999 BEST:LD29996 CDMC34682 4 25 18 DAC30-D14 3-CG12007-RA_1 CG12007 ACTGGAGTTCTGGCTACCAGTGGACAAGCGTGGAACCAGTTGGAAGTGTCAGCAGAACTTCGATTACCA 69 FBan0012007 FBgn0037293 CG12007 3 3R cell adhesion; GO:0007155; protein amino acid prenylation; GO:0018346; protein modification; GO:0006464; regulation of cell shape; GO:0008360 Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60 Rab-protein geranylgeranyltransferase complex; GO:0005968 CG12007 CG12007 CDMC34682 4 26 18 DAC30-D14 3-CG12007-RA_1 CG12007 ACTGGAGTTCTGGCTACCAGTGGACAAGCGTGGAACCAGTTGGAAGTGTCAGCAGAACTTCGATTACCA 69 FBan0012007 FBgn0037293 CG12007 3 3R cell adhesion; GO:0007155; protein amino acid prenylation; GO:0018346; protein modification; GO:0006464; regulation of cell shape; GO:0008360 Rab-protein geranylgeranyltransferase activity; GO:0004663 ; EC:2.5.1.60; ; GO:0004663 ; EC:2.5.1.60 Rab-protein geranylgeranyltransferase complex; GO:0005968 CG12007 CG12007 CDMC34683 4 1 19 DAC30-H02 1-CG12031-RA_1 CG12031 CGTGGTTATGGGTCGCATGAAGATACTGTTCTTCCTGCAAATCACGAGGATACCCTACGGCGCGGTCAT 69 FBan0012031 FBgn0035145 MED14 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED14 Mediator complex subunit 14 "CG12031, CG12031, CG12031, CG12031, Trap170, dTRAP170, p160, Med14, Mediator complex subunit 14" CDMC34683 4 2 19 DAC30-H02 1-CG12031-RA_1 CG12031 CGTGGTTATGGGTCGCATGAAGATACTGTTCTTCCTGCAAATCACGAGGATACCCTACGGCGCGGTCAT 69 FBan0012031 FBgn0035145 MED14 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED14 Mediator complex subunit 14 "CG12031, CG12031, CG12031, CG12031, Trap170, dTRAP170, p160, Med14, Mediator complex subunit 14" CDMC34684 4 3 19 DAC30-H14 13-CG12052-RF_1 CG12052 TGGTACGAGCTCAAGTTCTCCGACCTATTCAAGTTCATAAATCCGGATGGACGTTACCAGTGCCCCAGA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34684 4 4 19 DAC30-H14 13-CG12052-RF_1 CG12052 TGGTACGAGCTCAAGTTCTCCGACCTATTCAAGTTCATAAATCCGGATGGACGTTACCAGTGCCCCAGA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC34685 4 5 19 DAC30-L02 18-CG12076-RA_3 CG12076 CGAGGATGAACAAATCGAACTCACTCCCATACTCAAGAAATCCAAGGAGACGGCTCGAGTTATGCGAGA 69 FBan0012076 FBgn0027616 YT521-B 3 3L YT521-B YT521-B "CG12076, dYT521-B, BcDNA:GH01918" CDMC34685 4 6 19 DAC30-L02 18-CG12076-RA_3 CG12076 CGAGGATGAACAAATCGAACTCACTCCCATACTCAAGAAATCCAAGGAGACGGCTCGAGTTATGCGAGA 69 FBan0012076 FBgn0027616 YT521-B 3 3L YT521-B YT521-B "CG12076, dYT521-B, BcDNA:GH01918" CDMC34686 4 7 19 DAC30-L14 18-CG12091-RA_2 CG12091 CGATCTGGCGATCTCTGTCGTCAGTGGCGTTCTAATCACCACAAACAATAAACAAACAACCGATTGCGA 69 FBan0012091 FBgn0035228 CG12091 3 3L CG12091 CG12091 CDMC34686 4 8 19 DAC30-L14 18-CG12091-RA_2 CG12091 CGATCTGGCGATCTCTGTCGTCAGTGGCGTTCTAATCACCACAAACAATAAACAAACAACCGATTGCGA 69 FBan0012091 FBgn0035228 CG12091 3 3L CG12091 CG12091 CDMC34687 4 9 19 DAC30-P02 4-CG12128-RA_1 CG12128 AGCGAAAAACACCCCAGCACAAGACGATTTTGAAGTGGTTTCATCCACCACCGTTTCTGGAACAAGCCA 69 FBan0012128 FBgn0033473 CG12128 2 2R CG12128 CG12128 CDMC34687 4 10 19 DAC30-P02 4-CG12128-RA_1 CG12128 AGCGAAAAACACCCCAGCACAAGACGATTTTGAAGTGGTTTCATCCACCACCGTTTCTGGAACAAGCCA 69 FBan0012128 FBgn0033473 CG12128 2 2R CG12128 CG12128 CDMC34688 4 11 19 DAC30-P14 23-CG12134-RA_1 CG12134 AACAAGCAGATCGTCAGAGATAGTCTTTTCGATTCAAAGAGAAGTTTACTTTTTACAGGCGGAGAATCC 69 FBan0012134 FBgn0033471 CG12134 2 2R CG12134 CG12134 CDMC34688 4 12 19 DAC30-P14 23-CG12134-RA_1 CG12134 AACAAGCAGATCGTCAGAGATAGTCTTTTCGATTCAAAGAGAAGTTTACTTTTTACAGGCGGAGAATCC 69 FBan0012134 FBgn0033471 CG12134 2 2R CG12134 CG12134 CDMC34689 4 13 19 DAC31-D02 3-CG3880-RA_1 CG3880 GCTCCGCCAGAACAAGAATACCAGTACCAGTCTGCTGAACCTAAGCATAGGCGATGTGGGAGGCAG 66 FBan0003880 FBgn0035057 CG3880 2 2R CG3880 CG3880 CDMC34689 4 14 19 DAC31-D02 3-CG3880-RA_1 CG3880 GCTCCGCCAGAACAAGAATACCAGTACCAGTCTGCTGAACCTAAGCATAGGCGATGTGGGAGGCAG 66 FBan0003880 FBgn0035057 CG3880 2 2R CG3880 CG3880 CDMC34690 4 15 19 DAC31-D14 3-CG4008-RA_1 CG4008 GTTGTGCGACATTAAGGGCTGCTACACGGCTCAGTACGAACACACAATTATGCTGCGACCCACCTG 66 FBan0004008 FBgn0025117 und 2 2L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 und uninitiated "CG4008, DMAP2, MAP2" CDMC34690 4 16 19 DAC31-D14 3-CG4008-RA_1 CG4008 GTTGTGCGACATTAAGGGCTGCTACACGGCTCAGTACGAACACACAATTATGCTGCGACCCACCTG 66 FBan0004008 FBgn0025117 und 2 2L protein biosynthesis; GO:0006412; protein modification; GO:0006464; proteolysis; GO:0006508 methionyl aminopeptidase activity; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18; ; GO:0004239 ; EC:3.4.11.18 und uninitiated "CG4008, DMAP2, MAP2" CDMC34691 4 17 19 DAC31-H02 3-CG4329-RB_3 CG4329 AGGAGCTCATCCGTGACCTGATGAAGGAGATGCAGGACAAGAAGGCCGAGTTCATTGAGTACTGCC 66 FBan0004329 FBgn0034745 CG4329 2 2R CG4329 CG4329 anon-WO0140519.244 CDMC34691 4 18 19 DAC31-H02 3-CG4329-RB_3 CG4329 AGGAGCTCATCCGTGACCTGATGAAGGAGATGCAGGACAAGAAGGCCGAGTTCATTGAGTACTGCC 66 FBan0004329 FBgn0034745 CG4329 2 2R CG4329 CG4329 anon-WO0140519.244 CDMC34692 4 19 19 DAC31-H14 3-CG4567-RA_2 CG4567 GGGTGAACTGCATTTGGAGATCTATGCCCAGAGAATGGAGAGGGAATACGGTTGCCCAGTGACGCT 66 FBan0004567 FBgn0031898 CG4567 2 2L translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG4567 CG4567 CDMC34692 4 20 19 DAC31-H14 3-CG4567-RA_2 CG4567 GGGTGAACTGCATTTGGAGATCTATGCCCAGAGAATGGAGAGGGAATACGGTTGCCCAGTGACGCT 66 FBan0004567 FBgn0031898 CG4567 2 2L translational elongation; GO:0006414 GTP binding; GO:0005525; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG4567 CG4567 CDMC34693 4 21 19 DAC31-L02 3-CG4893-RA_3 CG4893 ATGAGCCCAAGGTTAGCTTTTCGGATCAGTTCAAGGCCTTCTCCAAGTTCGGGGACTCCAAGTCCG 66 FBan0004893 FBgn0036616 CG4893 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4893 CG4893 CDMC34693 4 22 19 DAC31-L02 3-CG4893-RA_3 CG4893 ATGAGCCCAAGGTTAGCTTTTCGGATCAGTTCAAGGCCTTCTCCAAGTTCGGGGACTCCAAGTCCG 66 FBan0004893 FBgn0036616 CG4893 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG4893 CG4893 CDMC34694 4 23 19 DAC31-L14 2-CG5006-RA_2 CG5006 TGCGATTGCTGGTACCGACTTTCTTCAAGGATTCCTCACGTCCTGTCCAGCTGTACGTGGTGTTGC 66 FBan0005006 FBgn0026390 Or33c 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33c Odorant receptor 33c "CG5006, CG5006, DOR33B.3, Olfactory receptor 33B.3, dor71, AN2, 33B.3, DOR71, 33c, or71a, Or33B.3, Or71" CDMC34694 4 24 19 DAC31-L14 2-CG5006-RA_2 CG5006 TGCGATTGCTGGTACCGACTTTCTTCAAGGATTCCTCACGTCCTGTCCAGCTGTACGTGGTGTTGC 66 FBan0005006 FBgn0026390 Or33c 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cell-cell signaling; GO:0007267; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or33c Odorant receptor 33c "CG5006, CG5006, DOR33B.3, Olfactory receptor 33B.3, dor71, AN2, 33B.3, DOR71, 33c, or71a, Or33B.3, Or71" CDMC34695 4 25 19 DAC31-P02 3-CG5370-RA_9 CG5370 GCAAGATGACCGACGAGTGCGTAACCAGAAACTACGGAGTAGGCATTCGCAGCCCAAATGGATCGG 66 FBan0005370 FBgn0010501 Dcp-1 2 2R "actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; apoptosis; GO:0006915; apoptotic program; GO:0008632; autophagic cell death; GO:0048102; cleavage of lamin; GO:0006922; cytoplasmic transport, nurse cell to oocyte; GO:0007303; development; GO:0007275; embryonic development; GO:0009790; nurse cell apoptosis; GO:0045476; nurse cell to oocyte transport (sensu Insecta); GO:0007300; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071" caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 caspase complex; GO:0008303 Dcp-1 Death caspase-1 "CG5370, dcp-1, DCP-1, caspase, caspase-1, DCP1, dcp1, Dcp1, l(2)01862, l(2)02132" CDMC34695 4 26 19 DAC31-P02 3-CG5370-RA_9 CG5370 GCAAGATGACCGACGAGTGCGTAACCAGAAACTACGGAGTAGGCATTCGCAGCCCAAATGGATCGG 66 FBan0005370 FBgn0010501 Dcp-1 2 2R "actin cytoskeleton organization and biogenesis; GO:0030036; actin filament organization; GO:0007015; apoptosis; GO:0006915; apoptotic program; GO:0008632; autophagic cell death; GO:0048102; cleavage of lamin; GO:0006922; cytoplasmic transport, nurse cell to oocyte; GO:0007303; development; GO:0007275; embryonic development; GO:0009790; nurse cell apoptosis; GO:0045476; nurse cell to oocyte transport (sensu Insecta); GO:0007300; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071" caspase activity; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693; ; GO:0030693 caspase complex; GO:0008303 Dcp-1 Death caspase-1 "CG5370, dcp-1, DCP-1, caspase, caspase-1, DCP1, dcp1, Dcp1, l(2)01862, l(2)02132" CDMC34696 4 1 20 DAC31-P14 AutoBlank AutoBlank CDMC34696 4 2 20 DAC31-P14 AutoBlank AutoBlank CDMC34697 4 3 20 DAC32-D02 3-CG11149-RA_2 CG11149 AGTCCCGCATTTCTAGTGCACAGTCCTGGGATCAAGCAATCCAGCAAAGCTGACTCCACTCGTCTTCAA 69 FBan0011149 FBgn0031732 CG11149 2 2L "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG11149 CG11149 CDMC34697 4 4 20 DAC32-D02 3-CG11149-RA_2 CG11149 AGTCCCGCATTTCTAGTGCACAGTCCTGGGATCAAGCAATCCAGCAAAGCTGACTCCACTCGTCTTCAA 69 FBan0011149 FBgn0031732 CG11149 2 2L "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG11149 CG11149 CDMC34698 4 5 20 DAC32-D14 12-CG11160-RB_3 CG11160 ATGTCCACGATATTCCAGGACTGGAGAACTTTCTCCTTAGGTGCGTCTGCATTCACGGGTCATAGGCAT 69 FBan0011160 FBgn0030257 CG11160 X X CG11160 CG11160 CDMC34698 4 6 20 DAC32-D14 12-CG11160-RB_3 CG11160 ATGTCCACGATATTCCAGGACTGGAGAACTTTCTCCTTAGGTGCGTCTGCATTCACGGGTCATAGGCAT 69 FBan0011160 FBgn0030257 CG11160 X X CG11160 CG11160 CDMC34699 4 7 20 DAC32-H02 15-CG11209-RA_2 CG11209 TCTCCGGAATTGCTTAACAACGACAGTTTTGTGCTCCGGGTCTATTTGGCCAAACAAGTGGTTCCAGTT 69 FBan0011209 FBgn0034489 ppk6 2 2R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk6 pickpocket 6 "CG11209, CG11209, PPK6" CDMC34699 4 8 20 DAC32-H02 15-CG11209-RA_2 CG11209 TCTCCGGAATTGCTTAACAACGACAGTTTTGTGCTCCGGGTCTATTTGGCCAAACAAGTGGTTCCAGTT 69 FBan0011209 FBgn0034489 ppk6 2 2R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk6 pickpocket 6 "CG11209, CG11209, PPK6" CDMC34700 4 9 20 DAC32-H14 9-CG11229-RA_3 CG11229 AGGCGGCTTCTTTTTGGACCACAAGCAGGCTATTGAGTCGTGTATCTTGGCAGCATCTCACTTAGTCCT 69 FBan0011229 FBgn0031138 CG11229 X X CG11229 CG11229 CDMC34700 4 10 20 DAC32-H14 9-CG11229-RA_3 CG11229 AGGCGGCTTCTTTTTGGACCACAAGCAGGCTATTGAGTCGTGTATCTTGGCAGCATCTCACTTAGTCCT 69 FBan0011229 FBgn0031138 CG11229 X X CG11229 CG11229 CDMC34701 4 11 20 DAC32-L02 23-CG11267-RA_2 CG11267 AGAATAGTTACGCCGGCACGTGTAGTTGAGTAAAAAGTTCACTCATTAACTTTTATCAACCGCTCCAGT 69 FBan0011267 FBgn0036334 CG11267 3 3L 'de novo' protein folding; GO:0006458 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG11267 CG11267 anon-WO0118547.175 CDMC34701 4 12 20 DAC32-L02 23-CG11267-RA_2 CG11267 AGAATAGTTACGCCGGCACGTGTAGTTGAGTAAAAAGTTCACTCATTAACTTTTATCAACCGCTCCAGT 69 FBan0011267 FBgn0036334 CG11267 3 3L 'de novo' protein folding; GO:0006458 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG11267 CG11267 anon-WO0118547.175 CDMC34702 4 13 20 DAC32-L14 23-CG11278-RA_4 CG11278 ATCGTTGAGAACTCTGTTTAATCACCAAGTGAGCAAAGACAACAAGAATGTAGAGGAAAAGCTAAAGCA 69 FBan0011278 FBgn0036341 Syx13 3 3L cytokinesis after meiosis I; GO:0007110; cytokinesis after mitosis; GO:0000281; female meiosis; GO:0007143; male meiosis; GO:0007140; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx13 Syntaxin 13 "CG11278 (69D1-70A2), l(3)01470, Dm Syx13, DmSyx13, ff16, ff16 (69D1-70A2), Syntaxin (69D1-70A2), syntaxin (69D1-70A2), l(3)01470 (69D1-70A2), Syntaxin 13, syntaxin, Syntaxin" CDMC34702 4 14 20 DAC32-L14 23-CG11278-RA_4 CG11278 ATCGTTGAGAACTCTGTTTAATCACCAAGTGAGCAAAGACAACAAGAATGTAGAGGAAAAGCTAAAGCA 69 FBan0011278 FBgn0036341 Syx13 3 3L cytokinesis after meiosis I; GO:0007110; cytokinesis after mitosis; GO:0000281; female meiosis; GO:0007143; male meiosis; GO:0007140; mitosis; GO:0007067; neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx13 Syntaxin 13 "CG11278 (69D1-70A2), l(3)01470, Dm Syx13, DmSyx13, ff16, ff16 (69D1-70A2), Syntaxin (69D1-70A2), syntaxin (69D1-70A2), l(3)01470 (69D1-70A2), Syntaxin 13, syntaxin, Syntaxin" CDMC34703 4 15 20 DAC32-P02 3-CG11313-RA_7 CG11313 TGGGGGCGATATAGCGTACAACCAGATCACGAAAGGCAACGAAACCGTTCTCACTGAATTCGCCTGGAT 69 FBan0011313 FBgn0039798 CG11313 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG11313 CG11313 "c-SP11, SP11" CDMC34703 4 16 20 DAC32-P02 3-CG11313-RA_7 CG11313 TGGGGGCGATATAGCGTACAACCAGATCACGAAAGGCAACGAAACCGTTCTCACTGAATTCGCCTGGAT 69 FBan0011313 FBgn0039798 CG11313 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0004263 ; EC:3.4.21.1 CG11313 CG11313 "c-SP11, SP11" CDMC34704 4 17 20 DAC32-P14 3-CG11322-RA_2 CG11322 GAGCTCTGGTCCATTGCATTCTCCTTTGATCAGTGCACCCCGGACTTGCATAAGGAGCCCATTGATCTT 69 FBan0011322 FBgn0031856 CG11322 2 2L CG11322 CG11322 CDMC34704 4 18 20 DAC32-P14 3-CG11322-RA_2 CG11322 GAGCTCTGGTCCATTGCATTCTCCTTTGATCAGTGCACCCCGGACTTGCATAAGGAGCCCATTGATCTT 69 FBan0011322 FBgn0031856 CG11322 2 2L CG11322 CG11322 CDMC34705 4 19 20 DAC33-D02 11-CG12598-RA_2 CG12598 AGCGGTGAGCATATGAGTGTGAACGGAGCTGTCCTAAATGATTCCCATGCTGAAATAGTCTCCAGGCGT 69 FBan0012598 FBgn0026086 Adar X X RNA editing; GO:0016547; adenosine to inosine editing; GO:0006382; adult behavior; GO:0030534; adult locomotory behavior; GO:0008344; mRNA editing; GO:0006381; mRNA processing; GO:0006397; regulation of membrane potential; GO:0042391; response to heat; GO:0009408; response to hypoxia; GO:0001666 double-stranded RNA binding; GO:0003725; ; GO:0003725; double-stranded RNA adenosine deaminase activity; GO:0003726; ; GO:0003726 intracellular; GO:0005622 Adar Adenosine deaminase acting on RNA "CG12598, CG12598, CG12598, CG12598, hypnos-2, hypoxia, anoxia, sensitive 2, EG:BACN35H14.1, dADAR, cg12598, ADAR, dAdar, Adenosine deaminase acting on RNA" CDMC34705 4 20 20 DAC33-D02 11-CG12598-RA_2 CG12598 AGCGGTGAGCATATGAGTGTGAACGGAGCTGTCCTAAATGATTCCCATGCTGAAATAGTCTCCAGGCGT 69 FBan0012598 FBgn0026086 Adar X X RNA editing; GO:0016547; adenosine to inosine editing; GO:0006382; adult behavior; GO:0030534; adult locomotory behavior; GO:0008344; mRNA editing; GO:0006381; mRNA processing; GO:0006397; regulation of membrane potential; GO:0042391; response to heat; GO:0009408; response to hypoxia; GO:0001666 double-stranded RNA binding; GO:0003725; ; GO:0003725; double-stranded RNA adenosine deaminase activity; GO:0003726; ; GO:0003726 intracellular; GO:0005622 Adar Adenosine deaminase acting on RNA "CG12598, CG12598, CG12598, CG12598, hypnos-2, hypoxia, anoxia, sensitive 2, EG:BACN35H14.1, dADAR, cg12598, ADAR, dAdar, Adenosine deaminase acting on RNA" CDMC34706 4 21 20 DAC33-D14 3-CG12611-RA_1 CG12611 GAATGGCGGGTGTCCTTGGACTTCCTGCTAATCGGCTATTTCCCAAAAACTTCACTCTGGAGGCAGTCG 69 FBan0012611 FBgn0030898 Andorra X X Andorra Andorra CG12611 CDMC34706 4 22 20 DAC33-D14 3-CG12611-RA_1 CG12611 GAATGGCGGGTGTCCTTGGACTTCCTGCTAATCGGCTATTTCCCAAAAACTTCACTCTGGAGGCAGTCG 69 FBan0012611 FBgn0030898 Andorra X X Andorra Andorra CG12611 CDMC34707 4 23 20 DAC33-H02 22-CG12662-RA_1 CG12662 GGAGGGCACTGTTTACTCTCTGAATCCCAAAGACAAGGTCACCAGAAAGGCTTTATGCTATTACGAGGT 69 FBan0012662 FBgn0030074 CG12662 X X CG12662 CG12662 CDMC34707 4 24 20 DAC33-H02 22-CG12662-RA_1 CG12662 GGAGGGCACTGTTTACTCTCTGAATCCCAAAGACAAGGTCACCAGAAAGGCTTTATGCTATTACGAGGT 69 FBan0012662 FBgn0030074 CG12662 X X CG12662 CG12662 CDMC34708 4 25 20 DAC33-H14 23-CG12676-RA_4 CG12676 AACCCTTATCATGTGTTTTGCAACTTTTTGACAATGGCACAGACACAAAGTGAGAAGATCGAGAGAACA 69 FBan0012676 FBgn0000547 ed 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; epidermal growth factor receptor signaling pathway; GO:0007173; homophilic cell adhesion; GO:0007156; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of neurogenesis; GO:0050768; sensory organ development; GO:0007423 integral to membrane; GO:0016021; plasma membrane; GO:0005886 ed echinoid "CG16842, CG12676, CG15424, CG16842, l(2)k01102, 1X5, CT35484, CT13476, E(Elp)[24D], E(Elp)24D" CDMC34708 4 26 20 DAC33-H14 23-CG12676-RA_4 CG12676 AACCCTTATCATGTGTTTTGCAACTTTTTGACAATGGCACAGACACAAAGTGAGAAGATCGAGAGAACA 69 FBan0012676 FBgn0000547 ed 2 2L cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; epidermal growth factor receptor signaling pathway; GO:0007173; homophilic cell adhesion; GO:0007156; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; negative regulation of neurogenesis; GO:0050768; sensory organ development; GO:0007423 integral to membrane; GO:0016021; plasma membrane; GO:0005886 ed echinoid "CG16842, CG12676, CG15424, CG16842, l(2)k01102, 1X5, CT35484, CT13476, E(Elp)[24D], E(Elp)24D" CDMC34709 4 1 21 DAC33-L02 6-CG12726-RA_1 CG12726 TGGGCCAATTGTCGACGGAAATGAAGAACAGCCCGATATAGACAATCCAGTTGCTATTGCCCAGGTGCT 69 FBan0012726 FBgn0030487 CG12726 X X CG12726 CG12726 CDMC34709 4 2 21 DAC33-L02 6-CG12726-RA_1 CG12726 TGGGCCAATTGTCGACGGAAATGAAGAACAGCCCGATATAGACAATCCAGTTGCTATTGCCCAGGTGCT 69 FBan0012726 FBgn0030487 CG12726 X X CG12726 CG12726 CDMC34710 4 3 21 DAC33-L14 23-CG12740-RC_5 CG12740 GGCTCCAAGCCTAGAAACAACTGTTTGGGTTCTTGTCATGATGATCTTTTTTTTAATGCTACACAACCA 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC34710 4 4 21 DAC33-L14 23-CG12740-RC_5 CG12740 GGCTCCAAGCCTAGAAACAACTGTTTGGGTTCTTGTCATGATGATCTTTTTTTTAATGCTACACAACCA 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC34711 4 5 21 DAC33-P02 2-CG12775-RA_1 CG12775 CCGTCCCTTCCGAAAGCATGGAGTTATTCCGTTGTCCACATACATGCGGGTTTTCAAGATCGGCGACAT 69 FBan0012775 FBgn0032987 RpL21 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL21 Ribosomal protein L21 "CG12775, BcDNA:RH06526, anon-EST:Posey18, anon-EST:Posey30, Ribosomal protein L21" CDMC34711 4 6 21 DAC33-P02 2-CG12775-RA_1 CG12775 CCGTCCCTTCCGAAAGCATGGAGTTATTCCGTTGTCCACATACATGCGGGTTTTCAAGATCGGCGACAT 69 FBan0012775 FBgn0032987 RpL21 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL21 Ribosomal protein L21 "CG12775, BcDNA:RH06526, anon-EST:Posey18, anon-EST:Posey30, Ribosomal protein L21" CDMC34712 4 7 21 DAC33-P14 12-CG12789-RA_12 CG12789 GCGCTCCCTTGTCGATGTGGGACTAAAGATGTACGGTGCCGAGATGTCTGTCCAAAAATCGATCGATGA 69 FBan0012789 FBgn0025697 CG12789 2 2L apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; lipid metabolism; GO:0006629; lipid transport; GO:0006869; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG12789 CG12789 "CK01577, BEST:CK01577" CDMC34712 4 8 21 DAC33-P14 12-CG12789-RA_12 CG12789 GCGCTCCCTTGTCGATGTGGGACTAAAGATGTACGGTGCCGAGATGTCTGTCCAAAAATCGATCGATGA 69 FBan0012789 FBgn0025697 CG12789 2 2L apoptosis; GO:0006915; autophagic cell death; GO:0048102; cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; defense response; GO:0006952; lipid metabolism; GO:0006629; lipid transport; GO:0006869; macrophage activation; GO:0042116; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165 scavenger receptor activity; GO:0005044; ; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG12789 CG12789 "CK01577, BEST:CK01577" CDMC34713 4 9 21 DAC34-D02 23-CG4360-RA_9 CG4360 GGCCTAAACTCTATACTATCCCATGATGGTTCGATTTGAGTCGGTGTGTTAAAGGTATCTTAAGGCACT 69 FBan0004360 FBgn0038787 CG4360 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4360 CG4360 CDMC34713 4 10 21 DAC34-D02 23-CG4360-RA_9 CG4360 GGCCTAAACTCTATACTATCCCATGATGGTTCGATTTGAGTCGGTGTGTTAAAGGTATCTTAAGGCACT 69 FBan0004360 FBgn0038787 CG4360 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4360 CG4360 CDMC34714 4 11 21 DAC34-D14 17-CG4372-RA_3 CG4372 TGGCCGGGATGAATGGAGTTCGGAATGCCATTCTAGTAGCCGATGCAGTTCTGAAATACACAAAACATT 69 FBan0004372 FBgn0034665 CG4372 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG4372 CG4372 CDMC34714 4 12 21 DAC34-D14 17-CG4372-RA_3 CG4372 TGGCCGGGATGAATGGAGTTCGGAATGCCATTCTAGTAGCCGATGCAGTTCTGAAATACACAAAACATT 69 FBan0004372 FBgn0034665 CG4372 2 2R amino acid catabolism; GO:0009063; glycoprotein catabolism; GO:0006516 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; GO:0003948 ; EC:3.5.1.26; ; GO:0003948 ; EC:3.5.1.26 CG4372 CG4372 CDMC34715 4 13 21 DAC34-H02 6-CG4414-RA_2 CG4414 AGCCGCTTGTTCACCCATCGATTTTGAGCGGGATCAACCTGAAATGAGCTTCTCCGTACGATTGGGAAA 69 FBan0004414 FBgn0040091 Ugt58Fa 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt58Fa Ugt58Fa "CG4414, CG4414, AC 004377A, lectin-58Fg" CDMC34715 4 14 21 DAC34-H02 6-CG4414-RA_2 CG4414 AGCCGCTTGTTCACCCATCGATTTTGAGCGGGATCAACCTGAAATGAGCTTCTCCGTACGATTGGGAAA 69 FBan0004414 FBgn0040091 Ugt58Fa 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt58Fa Ugt58Fa "CG4414, CG4414, AC 004377A, lectin-58Fg" CDMC34716 4 15 21 DAC34-H14 9-CG4426-RA_3 CG4426 TCGCTCGGAGCACTGTGATTTGCTGCATCTTCACTCGCTGATCCTTAGTTTGGTTGTCCTACGAACCAT 69 FBan0004426 FBgn0015905 ast 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; epidermal growth factor receptor signaling pathway; GO:0007173; larval somatic muscle development; GO:0007526; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; wing vein morphogenesis; GO:0008586 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ast asteroid "CG4426, Star/asteroid, S[r]: Star-recessive, Star-recessive, S[r]" CDMC34716 4 16 21 DAC34-H14 9-CG4426-RA_3 CG4426 TCGCTCGGAGCACTGTGATTTGCTGCATCTTCACTCGCTGATCCTTAGTTTGGTTGTCCTACGAACCAT 69 FBan0004426 FBgn0015905 ast 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; epidermal growth factor receptor signaling pathway; GO:0007173; larval somatic muscle development; GO:0007526; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; wing vein morphogenesis; GO:0008586 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ast asteroid "CG4426, Star/asteroid, S[r]: Star-recessive, Star-recessive, S[r]" CDMC34717 4 17 21 DAC34-L02 14-CG4453-RA_3 CG4453 AGGATCATCGAGGATAAACATGCAGTCACCAAAGTCGCCATGTGTGAACAAATACCGCTTCGTACGCCG 69 FBgn0030762 CDMC34717 4 18 21 DAC34-L02 14-CG4453-RA_3 CG4453 AGGATCATCGAGGATAAACATGCAGTCACCAAAGTCGCCATGTGTGAACAAATACCGCTTCGTACGCCG 69 FBgn0030762 CDMC34718 4 19 21 DAC34-L14 9-CG4468-RA_2 CG4468 GGGCAGAGACACCCATCAATGTGGACAACTTTATGGATTATGTTAGGGAGCTGGACACTCCGGACGAGG 69 FBan0004468 FBgn0038749 CG4468 3 3R CG4468 CG4468 CDMC34718 4 20 21 DAC34-L14 9-CG4468-RA_2 CG4468 GGGCAGAGACACCCATCAATGTGGACAACTTTATGGATTATGTTAGGGAGCTGGACACTCCGGACGAGG 69 FBan0004468 FBgn0038749 CG4468 3 3R CG4468 CG4468 CDMC34719 4 21 21 DAC34-P02 13-CG4520-RA_3 CG4520 GCGCAAGATCAATACCAACTTTCACATAACACTGGTTGCCGTTCCTACCACTTCACTCCAGCAGAAGCC 69 FBan0004520 FBgn0038355 CG4520 3 3R CG4520 CG4520 CDMC34719 4 22 21 DAC34-P02 13-CG4520-RA_3 CG4520 GCGCAAGATCAATACCAACTTTCACATAACACTGGTTGCCGTTCCTACCACTTCACTCCAGCAGAAGCC 69 FBan0004520 FBgn0038355 CG4520 3 3R CG4520 CG4520 CDMC34720 4 23 21 DAC34-P14 1-CG4532-RB_1 CG4532 CCCGGCCCGTCAAAAAGTGTTCCACAGCACGAGTAGAATTGATCTGGGATCGATTGGGATCTCGGGATC 69 FBan0004532 FBgn0029903 pod1 X X actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 pod1 pod1 "CG4532, POD-1/coronin, Dpod1, BcDNA:LD08951, BEST:LD37601" CDMC34720 4 24 21 DAC34-P14 1-CG4532-RB_1 CG4532 CCCGGCCCGTCAAAAAGTGTTCCACAGCACGAGTAGAATTGATCTGGGATCGATTGGGATCTCGGGATC 69 FBan0004532 FBgn0029903 pod1 X X actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 pod1 pod1 "CG4532, POD-1/coronin, Dpod1, BcDNA:LD08951, BEST:LD37601" CDMC34721 4 25 21 DAC35-D02 3-CG8817-RB_2 CG8817 TCTGAGCTATCTAAATAGCGCTCACGAGTTGTGGGATCAAGCCGATCGATTGGTGCGCACAGGCAATCA 69 FBan0008817 FBgn0041111 lilli 2 2L "cytokinesis, contractile ring formation; GO:0000915; eye photoreceptor development (sensu Endopterygota); GO:0042051; periodic partitioning; GO:0007365; regulation of cell size; GO:0008361; regulation of transcription, DNA-dependent; GO:0006355; segment specification; GO:0007379" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lilli lilliputian "CG8817, l(2)00632, Su(Raf)2A, SS2-1, Suppressor of GMR-sina 2-1, l(2)K00632, l(2)K07920, Su(Raf)2a, l(2)23Cc, SY2-1, BcDNA:GM02019, l(2)k07920, l(2)k16124, BEST:GH09955, lilliputian" CDMC34721 4 26 21 DAC35-D02 3-CG8817-RB_2 CG8817 TCTGAGCTATCTAAATAGCGCTCACGAGTTGTGGGATCAAGCCGATCGATTGGTGCGCACAGGCAATCA 69 FBan0008817 FBgn0041111 lilli 2 2L "cytokinesis, contractile ring formation; GO:0000915; eye photoreceptor development (sensu Endopterygota); GO:0042051; periodic partitioning; GO:0007365; regulation of cell size; GO:0008361; regulation of transcription, DNA-dependent; GO:0006355; segment specification; GO:0007379" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 lilli lilliputian "CG8817, l(2)00632, Su(Raf)2A, SS2-1, Suppressor of GMR-sina 2-1, l(2)K00632, l(2)K07920, Su(Raf)2a, l(2)23Cc, SY2-1, BcDNA:GM02019, l(2)k07920, l(2)k16124, BEST:GH09955, lilliputian" CDMC34722 4 1 22 DAC35-D14 3-CG8824-RB_2 CG8824 GGCGGAGCGCTTGTGGACTGATCCTAGCGATGATCACGATATGGACATAGTACCGCCAGATGTTTTCCG 69 FBan0008824 FBgn0045063 fdl 2 2R brain development; GO:0007420; polysaccharide metabolism; GO:0005976 "beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" cellular component unknown; GO:0008372 fdl fused lobes "CG8824, CG8824, l(2)k17040, fused lobes" CDMC34722 4 2 22 DAC35-D14 3-CG8824-RB_2 CG8824 GGCGGAGCGCTTGTGGACTGATCCTAGCGATGATCACGATATGGACATAGTACCGCCAGATGTTTTCCG 69 FBan0008824 FBgn0045063 fdl 2 2R brain development; GO:0007420; polysaccharide metabolism; GO:0005976 "beta-N-acetylhexosaminidase activity; GO:0004563 ; EC:3.2.1.52; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004563 ; EC:3.2.1.52" cellular component unknown; GO:0008372 fdl fused lobes "CG8824, CG8824, l(2)k17040, fused lobes" CDMC34723 4 3 22 DAC35-H02 23-CG8861-RA_2 CG8861 GGCCAACATGTTTGCTGTTATTACTTTGAGGCTTTGTATTTCTGTCTGTCTTCCCAAAAAAACACAAAA 69 FBan0008861 FBgn0037676 CG8861 3 3R CG8861 CG8861 CDMC34723 4 4 22 DAC35-H02 23-CG8861-RA_2 CG8861 GGCCAACATGTTTGCTGTTATTACTTTGAGGCTTTGTATTTCTGTCTGTCTTCCCAAAAAAACACAAAA 69 FBan0008861 FBgn0037676 CG8861 3 3R CG8861 CG8861 CDMC34724 4 5 22 DAC35-H14 7-CG8871-RA_1 CG8871 TGGATTCCAGCGCGTCACCTACCACTTGGACTGGATCCGTGACCACACTGGCATCTCTTACTAATTTTT 69 FBan0008871 FBgn0031653 Jon25Biii 2 2L proteolysis; GO:0006508 elastase activity; GO:0042708; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon25Biii Jonah 25Biii "CG8871, CG8871, CG8871, CG8871, CG8871, 25B, Jon25B, SP177, Jonah 25B" CDMC34724 4 6 22 DAC35-H14 7-CG8871-RA_1 CG8871 TGGATTCCAGCGCGTCACCTACCACTTGGACTGGATCCGTGACCACACTGGCATCTCTTACTAATTTTT 69 FBan0008871 FBgn0031653 Jon25Biii 2 2L proteolysis; GO:0006508 elastase activity; GO:0042708; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 Jon25Biii Jonah 25Biii "CG8871, CG8871, CG8871, CG8871, CG8871, 25B, Jon25B, SP177, Jonah 25B" CDMC34725 4 7 22 DAC35-L02 2-CG8918-RA_1 CG8918 GCGGTACCCGTTACAAGCACCTGGACATCATACCCATGACCTTTGTCCTCCCCTCCGATTACCAAATGT 69 FBan0008918 FBgn0030823 CG8918 X X protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG8918 CG8918 CDMC34725 4 8 22 DAC35-L02 2-CG8918-RA_1 CG8918 GCGGTACCCGTTACAAGCACCTGGACATCATACCCATGACCTTTGTCCTCCCCTCCGATTACCAAATGT 69 FBan0008918 FBgn0030823 CG8918 X X protein metabolism; GO:0019538; protein modification; GO:0006464 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG8918 CG8918 CDMC34726 4 9 22 DAC35-L14 18-CG8930-RA_2 CG8930 GGTGGGGCCAACCAGGAGACCTTTCTATAAAAGTAATGGGGAACAGGACAAAAGCTGACTGTGTTCATA 69 FBan0008930 FBgn0003255 rk 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of cuticle tanning; GO:0007564 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rk rickets "CG8930, BG:DS00180.13, glycoprotein hormone receptor II, DLGR-2, CT25644, LGR2, leucine-rich repeat-containing G protein-coupled receptor 2, rk/CG8930, DLGR2, glycoprotein-hormone-receptor-II" CDMC34726 4 10 22 DAC35-L14 18-CG8930-RA_2 CG8930 GGTGGGGCCAACCAGGAGACCTTTCTATAAAAGTAATGGGGAACAGGACAAAAGCTGACTGTGTTCATA 69 FBan0008930 FBgn0003255 rk 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; regulation of cuticle tanning; GO:0007564 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0004930; ; GO:0016500 integral to membrane; GO:0016021; plasma membrane; GO:0005886 rk rickets "CG8930, BG:DS00180.13, glycoprotein hormone receptor II, DLGR-2, CT25644, LGR2, leucine-rich repeat-containing G protein-coupled receptor 2, rk/CG8930, DLGR2, glycoprotein-hormone-receptor-II" CDMC34727 4 11 22 DAC35-P02 9-CG8966-RA_6 CG8966 TGTCCTTGCCATCCCTGAAAGCCATCAAACAGACCCTCTTCACATTCTCCATTGGACTGGTACTGCTCT 69 FBan0008966 FBgn0039394 CG8966 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8966 CG8966 CDMC34727 4 12 22 DAC35-P02 9-CG8966-RA_6 CG8966 TGTCCTTGCCATCCCTGAAAGCCATCAAACAGACCCTCTTCACATTCTCCATTGGACTGGTACTGCTCT 69 FBan0008966 FBgn0039394 CG8966 3 3R cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189 sodium:iodide symporter activity; GO:0008507; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0008507 membrane; GO:0016020 CG8966 CG8966 CDMC34728 4 13 22 DAC35-P14 9-CG8977-RA_1 CG8977 CGGGAGCTGGACTGTTCGAAGTCAAAAAGATCGGCGATGAGTACTTCACTTTCGTGACGGAGTGCAAGG 69 FBan0008977 FBgn0015019 Cctgamma 3 3R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" chaperonin-containing T-complex; GO:0005832; cytoplasm; GO:0005737 Cctgamma Cctgamma "CG8977, CG8977, Y, CCTgamma-like, chaperonin-containing t-complex protein-1 gamma subunit like, predicted gene Y, Cctg, geneY, Cctgamma" CDMC34728 4 14 22 DAC35-P14 9-CG8977-RA_1 CG8977 CGGGAGCTGGACTGTTCGAAGTCAAAAAGATCGGCGATGAGTACTTCACTTTCGTGACGGAGTGCAAGG 69 FBan0008977 FBgn0015019 Cctgamma 3 3R protein folding; GO:0006457 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" chaperonin-containing T-complex; GO:0005832; cytoplasm; GO:0005737 Cctgamma Cctgamma "CG8977, CG8977, Y, CCTgamma-like, chaperonin-containing t-complex protein-1 gamma subunit like, predicted gene Y, Cctg, geneY, Cctgamma" CDMC34729 4 15 22 DAC36-D02 18-CG7077-RA_1 CG7077 AGTGCTTTTAACTGGATTCGTGAAAAATTCCAGGCCATTCATGTGCTCATCTGCAACGCTGGCAT 65 FBan0007077 FBgn0038946 CG7077 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG7077 CG7077 CDMC34729 4 16 22 DAC36-D02 18-CG7077-RA_1 CG7077 AGTGCTTTTAACTGGATTCGTGAAAAATTCCAGGCCATTCATGTGCTCATCTGCAACGCTGGCAT 65 FBan0007077 FBgn0038946 CG7077 3 3R metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG7077 CG7077 CDMC34730 4 17 22 DAC36-D14 3-CG7130-RA_1 CG7130 TTCGCCGCCTACAAGACATTCCAGTTCTTCAACCGGAAAAAAGAGGCTACCCACGGCGATGGATC 65 FBan0007130 FBgn0037151 CG7130 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 "ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" CG7130 CG7130 CDMC34730 4 18 22 DAC36-D14 3-CG7130-RA_1 CG7130 TTCGCCGCCTACAAGACATTCCAGTTCTTCAACCGGAAAAAAGAGGCTACCCACGGCGATGGATC 65 FBan0007130 FBgn0037151 CG7130 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 "ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" CG7130 CG7130 CDMC34731 4 19 22 DAC36-H02 12-CG7245-RA_2 CG7245 TACTCGGAGACCTGCAAGCTCATTCCGTGCAAAAACAATGGAAGATGCCTGAGAAGTGGACGCTG 65 FBgn0031416 CDMC34731 4 20 22 DAC36-H02 12-CG7245-RA_2 CG7245 TACTCGGAGACCTGCAAGCTCATTCCGTGCAAAAACAATGGAAGATGCCTGAGAAGTGGACGCTG 65 FBgn0031416 CDMC34732 4 21 22 DAC36-H14 14-CG7267-RB_1 CG7267 AGCGAAATCTCAACCGAGCGTCATGGAGTTCAACAATCGCCTCTTGCTGAAGATCATCGAGCTGG 65 FBan0007267 FBgn0030079 CG7267 X X CG7267 CG7267 CDMC34732 4 22 22 DAC36-H14 14-CG7267-RB_1 CG7267 AGCGAAATCTCAACCGAGCGTCATGGAGTTCAACAATCGCCTCTTGCTGAAGATCATCGAGCTGG 65 FBan0007267 FBgn0030079 CG7267 X X CG7267 CG7267 CDMC34733 4 23 22 DAC36-L02 6-CG7378-RA_1 CG7378 TTTTGTGGGACTTGACGGGGAGCCTAAGAGACAACCAAAGATCCAGGGAGAGTGTAAACGGGGGG 65 FBan0007378 FBgn0030976 CG7378 X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG7378 CG7378 "MKP-like, BcDNA:RH25447" CDMC34733 4 24 22 DAC36-L02 6-CG7378-RA_1 CG7378 TTTTGTGGGACTTGACGGGGAGCCTAAGAGACAACCAAAGATCCAGGGAGAGTGTAAACGGGGGG 65 FBan0007378 FBgn0030976 CG7378 X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- CG7378 CG7378 "MKP-like, BcDNA:RH25447" CDMC34734 4 25 22 DAC36-L14 3-CG7409-RA_1 CG7409 ATGTGCACCTGTTCAAGCCCTATGAGATTAGCGTGAAGACCTCAGGCGACACTGTGGTCGTGGAG 65 FBan0007409 FBgn0035817 CG7409 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG7409 CG7409 CT16169 CDMC34734 4 26 22 DAC36-L14 3-CG7409-RA_1 CG7409 ATGTGCACCTGTTCAAGCCCTATGAGATTAGCGTGAAGACCTCAGGCGACACTGTGGTCGTGGAG 65 FBan0007409 FBgn0035817 CG7409 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG7409 CG7409 CT16169 CDMC34735 4 1 23 DAC36-P02 24-CG7478-RA_1 CG7478 ACATTTAGTTGATGAAGAAGTTTTAACATAGATAGAGAAAACAAGAGAAAGAGACGAGAAAAGAC 65 FBan0007478 FBgn0000045 Act79B 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act79B Actin 79B "CG7478, CG7478, actin, Actin, act79B, act 79B, 79B Actin, mus79B, D" CDMC34735 4 2 23 DAC36-P02 24-CG7478-RA_1 CG7478 ACATTTAGTTGATGAAGAAGTTTTAACATAGATAGAGAAAACAAGAGAAAGAGACGAGAAAAGAC 65 FBan0007478 FBgn0000045 Act79B 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; motor activity; GO:0003774; ; GO:0003774 actin filament; GO:0005884 Act79B Actin 79B "CG7478, CG7478, actin, Actin, act79B, act 79B, 79B Actin, mus79B, D" CDMC34736 4 3 23 DAC36-P14 23-CG7535-RA_1 CG7535 GTGAGCATATAGTTGATGAACCAGATGAAGGTCGGGAAAATCGAACAAAATTGATGGCAGTCGGA 65 FBan0007535 FBgn0024963 GluClalpha 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glutamate-gated chloride channel activity; GO:0008068; ; GO:0008068; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; ; GO:0008068; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 GluClalpha GluClalpha "CG7535, CG7535, DrosGluCl, GLUCL, GluCl, DrosGluCl-alpha, indefinite, glc, dGluCl-alpha, DmGluClalpha, DmGlu, GluCla, DrosGlu-Cl-alpha, GluClalpha, DrosGluCl-alpha1, BcDNA:HL07853" CDMC34736 4 4 23 DAC36-P14 23-CG7535-RA_1 CG7535 GTGAGCATATAGTTGATGAACCAGATGAAGGTCGGGAAAATCGAACAAAATTGATGGCAGTCGGA 65 FBan0007535 FBgn0024963 GluClalpha 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glutamate-gated chloride channel activity; GO:0008068; ; GO:0008068; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; ; GO:0008068; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 GluClalpha GluClalpha "CG7535, CG7535, DrosGluCl, GLUCL, GluCl, DrosGluCl-alpha, indefinite, glc, dGluCl-alpha, DmGluClalpha, DmGlu, GluCla, DrosGlu-Cl-alpha, GluClalpha, DrosGluCl-alpha1, BcDNA:HL07853" CDMC34737 4 5 23 DAC37-D02 11-CG12927-RA_2 CG12927 CTGGTCAGCAAGGCAGAAAACCGTCCCAATCTTCACGTGGAAAGCCAACTGATCTTCACCCAGCC 65 FBan0012927 FBgn0033433 CG12927 2 2R CG12927 CG12927 CDMC34737 4 6 23 DAC37-D02 11-CG12927-RA_2 CG12927 CTGGTCAGCAAGGCAGAAAACCGTCCCAATCTTCACGTGGAAAGCCAACTGATCTTCACCCAGCC 65 FBan0012927 FBgn0033433 CG12927 2 2R CG12927 CG12927 CDMC34738 4 7 23 DAC37-D14 17-CG12947-RA_3 CG12947 GTGGCCAAGACCACTAGGAAACCGATGGATCAGAGAACGAGTACAACTAGTCGAAGCGCAACAAC 65 FBan0012947 FBgn0037753 CG12947 3 3R CG12947 CG12947 CDMC34738 4 8 23 DAC37-D14 17-CG12947-RA_3 CG12947 GTGGCCAAGACCACTAGGAAACCGATGGATCAGAGAACGAGTACAACTAGTCGAAGCGCAACAAC 65 FBan0012947 FBgn0037753 CG12947 3 3R CG12947 CG12947 CDMC34739 4 9 23 DAC37-H02 9-CG13035-RB_3 CG13035 CAGGTTGGAGCACTCCGACTGTCACAACTGCTGCCTATCCATCTCCAAAACGAAAAGGTGGCCAT 65 FBan0013035 FBgn0036628 CG13035 3 3L CG13035 CG13035 CDMC34739 4 10 23 DAC37-H02 9-CG13035-RB_3 CG13035 CAGGTTGGAGCACTCCGACTGTCACAACTGCTGCCTATCCATCTCCAAAACGAAAAGGTGGCCAT 65 FBan0013035 FBgn0036628 CG13035 3 3L CG13035 CG13035 CDMC34740 4 11 23 DAC37-H14 1-CG13045-RA_1 CG13045 GTCATATGGCAGGTACAAGCTCCACTTTGGGTCACCACCTCATCATTCTCCGGCCGCCGTTTATG 65 FBan0013045 FBgn0036596 CG13045 3 3L CG13045 CG13045 CDMC34740 4 12 23 DAC37-H14 1-CG13045-RA_1 CG13045 GTCATATGGCAGGTACAAGCTCCACTTTGGGTCACCACCTCATCATTCTCCGGCCGCCGTTTATG 65 FBan0013045 FBgn0036596 CG13045 3 3L CG13045 CG13045 CDMC34741 4 13 23 DAC37-L02 2-CG13088-RA_3 CG13088 CTGTTCCCGCTCTTGACACGGCTGTCACTCAATAGCAGCACAACAGGTCGTTACTTGTGGCACTG 65 FBan0013088 FBgn0032047 CG13088 2 2L CG13088 CG13088 CDMC34741 4 14 23 DAC37-L02 2-CG13088-RA_3 CG13088 CTGTTCCCGCTCTTGACACGGCTGTCACTCAATAGCAGCACAACAGGTCGTTACTTGTGGCACTG 65 FBan0013088 FBgn0032047 CG13088 2 2L CG13088 CG13088 CDMC34742 4 15 23 DAC37-L14 3-CG1311-RA_1 CG1311 TGATGCCCATCAACAAGCAGCCATTTAGTATTACCCGACTCCCTCAGTCCGATCCCGAGGTAGCT 65 FBan0001311 FBgn0035523 CG1311 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG1311 CG1311 CDMC34742 4 16 23 DAC37-L14 3-CG1311-RA_1 CG1311 TGATGCCCATCAACAAGCAGCCATTTAGTATTACCCGACTCCCTCAGTCCGATCCCGAGGTAGCT 65 FBan0001311 FBgn0035523 CG1311 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 CG1311 CG1311 CDMC34743 4 17 23 DAC37-P02 3-CG13183-RA_2 CG13183 AACAGCAGCGAGGATCCATACTCCACCATCGAAAGCCAAGTGGGATTGATCTATCCTACGCCCGC 65 FBan0013183 FBgn0033667 CG13183 2 2R "regulation of transcription, DNA-dependent; GO:0006355" intracellular; GO:0005622 CG13183 CG13183 CDMC34743 4 18 23 DAC37-P02 3-CG13183-RA_2 CG13183 AACAGCAGCGAGGATCCATACTCCACCATCGAAAGCCAAGTGGGATTGATCTATCCTACGCCCGC 65 FBan0013183 FBgn0033667 CG13183 2 2R "regulation of transcription, DNA-dependent; GO:0006355" intracellular; GO:0005622 CG13183 CG13183 CDMC34744 4 19 23 DAC37-P14 12-CG13204-RA_1 CG13204 CTGCCGTGCTACAGGCCAACAGAGAACTTGACGCAAACACTCTTTTCTTCTTGAGTCTGGCGCGG 65 FBan0013204 FBgn0033627 CG13204 2 2R DNA binding; GO:0003677; ; GO:0003677 CG13204 CG13204 CDMC34744 4 20 23 DAC37-P14 12-CG13204-RA_1 CG13204 CTGCCGTGCTACAGGCCAACAGAGAACTTGACGCAAACACTCTTTTCTTCTTGAGTCTGGCGCGG 65 FBan0013204 FBgn0033627 CG13204 2 2R DNA binding; GO:0003677; ; GO:0003677 CG13204 CG13204 CDMC34745 4 21 23 DAC38-D02 23-CG32582-RA_7 CG32582 CACAAAAATTTGGAAATTCTTTTATTAAAAGCAAAAGCGATGTCACTCTCTACCATGAGCAATCCCTTG 69 FBan0032582 FBgn0052582 CG32582 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32582 CG32582 BcDNA:SD27303 CDMC34745 4 22 23 DAC38-D02 23-CG32582-RA_7 CG32582 CACAAAAATTTGGAAATTCTTTTATTAAAAGCAAAAGCGATGTCACTCTCTACCATGAGCAATCCCTTG 69 FBan0032582 FBgn0052582 CG32582 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32582 CG32582 BcDNA:SD27303 CDMC34746 4 23 23 DAC38-D14 3-CG32592-RA_5 CG32592 CCTTGGCTGATTCTAAGACGCTGAAGGCTATGGTGGAGTTCCGGGATGGCAGTCACACGATAATCTCGG 69 FBan0032592 FBgn0030600 hiw X X BMP signaling pathway; GO:0030509; adult walking behavior; GO:0007628; locomotion; GO:0040011; negative regulation of BMP signaling pathway; GO:0030514; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; protein ubiquitination; GO:0016567; regulation of synaptic growth at neuromuscular junction; GO:0008582 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515; ; GO:0004842 ; EC:6.3.2.19 cytoplasmic membrane-bound vesicle; GO:0016023; plasma membrane; GO:0005886; ubiquitin ligase complex; GO:0000151 hiw highwire "CG32592, CG9041, CG9049, highwire" CDMC34746 4 24 23 DAC38-D14 3-CG32592-RA_5 CG32592 CCTTGGCTGATTCTAAGACGCTGAAGGCTATGGTGGAGTTCCGGGATGGCAGTCACACGATAATCTCGG 69 FBan0032592 FBgn0030600 hiw X X BMP signaling pathway; GO:0030509; adult walking behavior; GO:0007628; locomotion; GO:0040011; negative regulation of BMP signaling pathway; GO:0030514; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; protein ubiquitination; GO:0016567; regulation of synaptic growth at neuromuscular junction; GO:0008582 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; ; GO:0005515; ; GO:0004842 ; EC:6.3.2.19 cytoplasmic membrane-bound vesicle; GO:0016023; plasma membrane; GO:0005886; ubiquitin ligase complex; GO:0000151 hiw highwire "CG32592, CG9041, CG9049, highwire" CDMC34747 4 25 23 DAC38-H02 17-CG32633-RA_1 CG32633 AGGTGCGTCTGGAGAATTACGAGGTTCTGGTGAGGATCTAGACGGACAGCTTTGCCTTTATTCCATTTT 69 FBan0032633 FBgn0052633 CG32633 X X CG32633 CG32633 "CG1733, CG1733, CG1733, anon-WO0140519.164" CDMC34747 4 26 23 DAC38-H02 17-CG32633-RA_1 CG32633 AGGTGCGTCTGGAGAATTACGAGGTTCTGGTGAGGATCTAGACGGACAGCTTTGCCTTTATTCCATTTT 69 FBan0032633 FBgn0052633 CG32633 X X CG32633 CG32633 "CG1733, CG1733, CG1733, anon-WO0140519.164" CDMC34748 4 1 24 DAC38-H14 8-CG32642-RC_1 CG32642 GCCACTACAGGCACCACAAAATCAAACAGATATCCTGGATACCCCACCAAATACGCGACAACCACAGCG 69 FBan0032642 FBgn0052642 CG32642 X X CG32642 CG32642 CDMC34748 4 2 24 DAC38-H14 8-CG32642-RC_1 CG32642 GCCACTACAGGCACCACAAAATCAAACAGATATCCTGGATACCCCACCAAATACGCGACAACCACAGCG 69 FBan0032642 FBgn0052642 CG32642 X X CG32642 CG32642 CDMC34749 4 3 24 DAC38-L02 18-CG32676-RA_1 CG32676 ACCAAGAATGTGTTTCGAAACGCGCCGGTAAAGACGAGCGACGAATTGAATTTTGTTCACCTACACCTA 69 FBan0032676 FBgn0052676 CG32676 X X cellular physiological process; GO:0050875 CG32676 CG32676 "CG9725, CG9732, CG9725, CG9725, CG9725" CDMC34749 4 4 24 DAC38-L02 18-CG32676-RA_1 CG32676 ACCAAGAATGTGTTTCGAAACGCGCCGGTAAAGACGAGCGACGAATTGAATTTTGTTCACCTACACCTA 69 FBan0032676 FBgn0052676 CG32676 X X cellular physiological process; GO:0050875 CG32676 CG32676 "CG9725, CG9732, CG9725, CG9725, CG9725" CDMC34750 4 5 24 DAC38-L14 8-CG32686-RB_1 CG32686 TGGCGGACTCGGACCACTTTATTCTGCCAGATGAGCCAATGATTCAGGCCATAACCTATGACGACATCG 69 FBan0032686 FBgn0052686 CG32686 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32686 CG32686 "anon-WO02059370.11, BcDNA:AT25933" CDMC34750 4 6 24 DAC38-L14 8-CG32686-RB_1 CG32686 TGGCGGACTCGGACCACTTTATTCTGCCAGATGAGCCAATGATTCAGGCCATAACCTATGACGACATCG 69 FBan0032686 FBgn0052686 CG32686 X X ATP synthesis coupled proton transport; GO:0015986 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" proton-transporting two-sector ATPase complex; GO:0016469 CG32686 CG32686 "anon-WO02059370.11, BcDNA:AT25933" CDMC34751 4 7 24 DAC38-P02 23-CG32709-RA_8 CG32709 CCGAACTCCTTAACTTTAAACCCTTGTGACACAAAGCAACAATGGAACAATTAAACACGAGCACTTGTG 69 FBan0032709 FBgn0052709 CG32709 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32709 CG32709 BcDNA:HL05735 CDMC34751 4 8 24 DAC38-P02 23-CG32709-RA_8 CG32709 CCGAACTCCTTAACTTTAAACCCTTGTGACACAAAGCAACAATGGAACAATTAAACACGAGCACTTGTG 69 FBan0032709 FBgn0052709 CG32709 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32709 CG32709 BcDNA:HL05735 CDMC34752 4 9 24 DAC38-P14 10-CG32719-RA_2 CG32719 CCTCCCTGGTTATGCGTACCCCAAATTTGGAGTGCTTCAAGGAGTTTTACACTCGTCAGGTATTGCCCA 69 FBan0032719 FBgn0052719 CG32719 X X biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32719 CG32719 CDMC34752 4 10 24 DAC38-P14 10-CG32719-RA_2 CG32719 CCTCCCTGGTTATGCGTACCCCAAATTTGGAGTGCTTCAAGGAGTTTTACACTCGTCAGGTATTGCCCA 69 FBan0032719 FBgn0052719 CG32719 X X biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG32719 CG32719 CDMC34753 4 11 24 DAC39-D02 23-CG13679-RA_1 CG13679 GCTGCTGAAGAAGTAATTCAACGGACTGTGAATCCTACGCCTCAATAACAAATTTTTAAATACATGATT 69 FBan0013679 FBgn0035856 CG13679 3 3L CG13679 CG13679 BcDNA:RE17113 CDMC34753 4 12 24 DAC39-D02 23-CG13679-RA_1 CG13679 GCTGCTGAAGAAGTAATTCAACGGACTGTGAATCCTACGCCTCAATAACAAATTTTTAAATACATGATT 69 FBan0013679 FBgn0035856 CG13679 3 3L CG13679 CG13679 BcDNA:RE17113 CDMC34754 4 13 24 DAC39-D14 17-CG13694-RA_1 CG13694 TGCCAACGATCTAAGAAGACAAGGTCATGGCTATGTGGTCCCCATCTTTCAATACCAACATGATGGTGG 69 FBan0013694 FBgn0031219 CG13694 2 2L CG13694 CG13694 CDMC34754 4 14 24 DAC39-D14 17-CG13694-RA_1 CG13694 TGCCAACGATCTAAGAAGACAAGGTCATGGCTATGTGGTCCCCATCTTTCAATACCAACATGATGGTGG 69 FBan0013694 FBgn0031219 CG13694 2 2L CG13694 CG13694 CDMC34755 4 15 24 DAC39-H02 3-CG13740-RA_1 CG13740 CCAGCAGGACCCACAATTAAAGCGATAAAGGCGCAGGGAAAAAGCTCTGATGTCGCATCTCACAAGCGT 69 FBan0013740 FBgn0033394 CG13740 2 2R CG13740 CG13740 CDMC34755 4 16 24 DAC39-H02 3-CG13740-RA_1 CG13740 CCAGCAGGACCCACAATTAAAGCGATAAAGGCGCAGGGAAAAAGCTCTGATGTCGCATCTCACAAGCGT 69 FBan0013740 FBgn0033394 CG13740 2 2R CG13740 CG13740 CDMC34756 4 17 24 DAC39-H14 13-CG13747-RA_1 CG13747 CCTTGGCTGATCTATCATGGCGTTATTTTTGGCTTTGGTCTTTACTTGGGGGTTTTCTACGCGACCGCA 69 FBan0013747 FBgn0033364 CG13747 2 2R CG13747 CG13747 CDMC34756 4 18 24 DAC39-H14 13-CG13747-RA_1 CG13747 CCTTGGCTGATCTATCATGGCGTTATTTTTGGCTTTGGTCTTTACTTGGGGGTTTTCTACGCGACCGCA 69 FBan0013747 FBgn0033364 CG13747 2 2R CG13747 CG13747 CDMC34757 4 19 24 DAC39-L02 11-CG13788-RB_1 CG13788 TCTGCAACATTCGGTTGTCTCCATAGCGATTTGTTTGTTCTGCGTGATTGCCTTCAGTTTCGAGCGGCG 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC34757 4 20 24 DAC39-L02 11-CG13788-RB_1 CG13788 TCTGCAACATTCGGTTGTCTCCATAGCGATTTGTTTGTTCTGCGTGATTGCCTTCAGTTTCGAGCGGCG 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC34758 4 21 24 DAC39-L14 15-CG13795-RA_5 CG13795 GCTCGCGGGAATTGCTCTGTCCATATCGGAGCACTCTTATTCCACAACAGTGGTCTTCGTGATGTCAAT 69 FBan0013795 FBgn0031937 CG13795 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836; transport; GO:0006810 transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG13795 CG13795 CT33284 CDMC34758 4 22 24 DAC39-L14 15-CG13795-RA_5 CG13795 GCTCGCGGGAATTGCTCTGTCCATATCGGAGCACTCTTATTCCACAACAGTGGTCTTCGTGATGTCAAT 69 FBan0013795 FBgn0031937 CG13795 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836; transport; GO:0006810 transporter activity; GO:0005215; amino acid transporter activity; GO:0015171; ; GO:0005215; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0005328 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG13795 CG13795 CT33284 CDMC34759 4 23 24 DAC39-P02 17-CG13855-RA_4 CG13855 GCTCACCGAGGAGACTTGCTTCCCACATTTTCCCGAACTCTTTGATCTCTTTGATCGCGAAAAGAATCT 69 FBan0013855 FBgn0038960 CG13855 3 3R CG13855 CG13855 CDMC34759 4 24 24 DAC39-P02 17-CG13855-RA_4 CG13855 GCTCACCGAGGAGACTTGCTTCCCACATTTTCCCGAACTCTTTGATCTCTTTGATCGCGAAAAGAATCT 69 FBan0013855 FBgn0038960 CG13855 3 3R CG13855 CG13855 CDMC34760 4 25 24 DAC39-P14 23-CG1386-RA_2 CG1386 TGCCGTGACAGAAAATATGAAGCACCATATTCACACAATTTTCGTAGACAGTTTAATATTCACAGTTAA 69 FBan0001386 FBgn0026268 antdh X X metabolism; GO:0008152 carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 antdh antdh "CG1386, AntDH" CDMC34760 4 26 24 DAC39-P14 23-CG1386-RA_2 CG1386 TGCCGTGACAGAAAATATGAAGCACCATATTCACACAATTTTCGTAGACAGTTTAATATTCACAGTTAA 69 FBan0001386 FBgn0026268 antdh X X metabolism; GO:0008152 carbonyl reductase (NADPH) activity; GO:0004090 ; EC:1.1.1.184; ; GO:0004090 ; EC:1.1.1.184 antdh antdh "CG1386, AntDH" CDMC34761 4 1 25 DAC40-D02 2-CG14160-RA_1 CG14160 TGCTGCATCAGGAACGAGATATGGCTGTGGGTGAGACCCTGAAAGCTCTACACGGACAATCCACC 65 FBan0014160 FBgn0036066 CG14160 3 3L CG14160 CG14160 CDMC34761 4 2 25 DAC40-D02 2-CG14160-RA_1 CG14160 TGCTGCATCAGGAACGAGATATGGCTGTGGGTGAGACCCTGAAAGCTCTACACGGACAATCCACC 65 FBan0014160 FBgn0036066 CG14160 3 3L CG14160 CG14160 CDMC34762 4 3 25 DAC40-D14 23-CG14179-RA_1 CG14179 GGATAATGAATTTTCGATTGTTCAACCTTGCACCTGTCTCAAAAATGAGCTTTCCGTCAGCGGTC 65 FBgn0035994 CG14179 CG14179 CG14179 CDMC34762 4 4 25 DAC40-D14 23-CG14179-RA_1 CG14179 GGATAATGAATTTTCGATTGTTCAACCTTGCACCTGTCTCAAAAATGAGCTTTCCGTCAGCGGTC 65 FBgn0035994 CG14179 CG14179 CG14179 CDMC34763 4 5 25 DAC40-H02 2-CG1424-RA_1 CG1424 CAAACAGTTGGGTGGACTTCCTTTACGCCAGGTATCACCCGAGAACCTTGAATGTCTTGCCGGGG 65 FBan0001424 FBgn0020272 mst X X cytoskeleton; GO:0005856 mst misato "CG1424, CG1424, lLB14, l(1)LB14, LB20, LB-20, l(1)LB20, l(1)19Fg, lethal(1)19Fg" CDMC34763 4 6 25 DAC40-H02 2-CG1424-RA_1 CG1424 CAAACAGTTGGGTGGACTTCCTTTACGCCAGGTATCACCCGAGAACCTTGAATGTCTTGCCGGGG 65 FBan0001424 FBgn0020272 mst X X cytoskeleton; GO:0005856 mst misato "CG1424, CG1424, lLB14, l(1)LB14, LB20, LB-20, l(1)LB20, l(1)19Fg, lethal(1)19Fg" CDMC34764 4 7 25 DAC40-H14 24-CG14273-RA_1 CG14273 TTGGAGCGGTGAAAAAATAAATAAATTTATAGAAAATATATCCATAGAAGGCTGCTCAATCTGGG 65 FBan0014273 FBgn0032024 CG14273 2 2L CG14273 CG14273 CDMC34764 4 8 25 DAC40-H14 24-CG14273-RA_1 CG14273 TTGGAGCGGTGAAAAAATAAATAAATTTATAGAAAATATATCCATAGAAGGCTGCTCAATCTGGG 65 FBan0014273 FBgn0032024 CG14273 2 2L CG14273 CG14273 CDMC34765 4 9 25 DAC40-L02 6-CG14367-RA_1 CG14367 CTTCATGGAGGAGATGCAGATATCACCGGAGCAGTTCGAAATGGCCTGTCTGGAGGGTAGGCAGC 65 FBan0014367 FBgn0038170 CG14367 3 3R CG14367 CG14367 CDMC34765 4 10 25 DAC40-L02 6-CG14367-RA_1 CG14367 CTTCATGGAGGAGATGCAGATATCACCGGAGCAGTTCGAAATGGCCTGTCTGGAGGGTAGGCAGC 65 FBan0014367 FBgn0038170 CG14367 3 3R CG14367 CG14367 CDMC34766 4 11 25 DAC40-L14 5-CG14395-RA_1 CG14395 GTCCTGGATCGAGGATTGGCAATGGTAGCTGTCGGTCGTACGCCTCTTCCAGAAGGTCCTCGTAC 65 FBan0014395 FBgn0038073 CG14395 3 3R CG14395 CG14395 CDMC34766 4 12 25 DAC40-L14 5-CG14395-RA_1 CG14395 GTCCTGGATCGAGGATTGGCAATGGTAGCTGTCGGTCGTACGCCTCTTCCAGAAGGTCCTCGTAC 65 FBan0014395 FBgn0038073 CG14395 3 3R CG14395 CG14395 CDMC34767 4 13 25 DAC40-P02 18-CG14463-RA_1 CG14463 CACGTGCTGCATAAATATTGGCTGAACAGCACCAAAGACCGGTCAGAAGAGTCCTACAGCAAGGA 65 FBan0014463 FBgn0037535 CG14463 3 3R CG14463 CG14463 CDMC34767 4 14 25 DAC40-P02 18-CG14463-RA_1 CG14463 CACGTGCTGCATAAATATTGGCTGAACAGCACCAAAGACCGGTCAGAAGAGTCCTACAGCAAGGA 65 FBan0014463 FBgn0037535 CG14463 3 3R CG14463 CG14463 CDMC34768 4 15 25 DAC40-P14 5-CG14490-RA_1 CG14490 GGTTTGGGGTAAAGCAAACGAGCAGTGGACTTGTCTACGAGGGTCACTGGCAGAAGGGTCAACGG 65 FBan0014490 FBgn0034281 CG14490 2 2R CG14490 CG14490 CDMC34768 4 16 25 DAC40-P14 5-CG14490-RA_1 CG14490 GGTTTGGGGTAAAGCAAACGAGCAGTGGACTTGTCTACGAGGGTCACTGGCAGAAGGGTCAACGG 65 FBan0014490 FBgn0034281 CG14490 2 2R CG14490 CG14490 CDMC34769 4 17 25 DAC41-D02 AutoBlank AutoBlank CDMC34769 4 18 25 DAC41-D02 AutoBlank AutoBlank CDMC34770 4 19 25 DAC41-D14 AutoBlank AutoBlank CDMC34770 4 20 25 DAC41-D14 AutoBlank AutoBlank CDMC34771 4 21 25 DAC41-H02 AutoBlank AutoBlank CDMC34771 4 22 25 DAC41-H02 AutoBlank AutoBlank CDMC34772 4 23 25 DAC41-H14 AutoBlank AutoBlank CDMC34772 4 24 25 DAC41-H14 AutoBlank AutoBlank CDMC34773 4 25 25 DAC41-L02 AutoBlank AutoBlank CDMC34773 4 26 25 DAC41-L02 AutoBlank AutoBlank CDMC34774 4 1 26 DAC41-L14 AutoBlank AutoBlank CDMC34774 4 2 26 DAC41-L14 AutoBlank AutoBlank CDMC34775 4 3 26 DAC41-P02 AutoBlank AutoBlank CDMC34775 4 4 26 DAC41-P02 AutoBlank AutoBlank CDMC34776 4 5 26 DAC41-P14 AutoBlank AutoBlank CDMC34776 4 6 26 DAC41-P14 AutoBlank AutoBlank CDMC34777 4 7 26 DAC42-D02 150mM NaPO4 Blank CDMC34777 4 8 26 DAC42-D02 150mM NaPO4 Blank CDMC34778 4 9 26 DAC42-D14 150mM NaPO4 Blank CDMC34778 4 10 26 DAC42-D14 150mM NaPO4 Blank CDMC34779 4 11 26 DAC42-H02 150mM NaPO4 Blank CDMC34779 4 12 26 DAC42-H02 150mM NaPO4 Blank CDMC34780 4 13 26 DAC42-H14 150mM NaPO4 Blank CDMC34780 4 14 26 DAC42-H14 150mM NaPO4 Blank CDMC34781 4 15 26 DAC42-L02 150mM NaPO4 Blank CDMC34781 4 16 26 DAC42-L02 150mM NaPO4 Blank CDMC34782 4 17 26 DAC42-L14 5uM MSP 5uM MSP CDMC34782 4 18 26 DAC42-L14 5uM MSP 5uM MSP CDMC34783 4 19 26 DAC42-P02 10uM MSP 10uM MSP CDMC34783 4 20 26 DAC42-P02 10uM MSP 10uM MSP CDMC34784 4 21 26 DAC42-P14 20uM MSP 20uM MSP CDMC34784 4 22 26 DAC42-P14 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC34785 1 1 1 DAC01-A01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34785 1 2 1 DAC01-A01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC34786 1 3 1 DAC01-A13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34786 1 4 1 DAC01-A13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC34787 1 5 1 DAC01-E01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34787 1 6 1 DAC01-E01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC34788 1 7 1 DAC01-E13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34788 1 8 1 DAC01-E13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC34789 1 9 1 DAC01-I01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34789 1 10 1 DAC01-I01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC34790 1 11 1 DAC01-I13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34790 1 12 1 DAC01-I13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC34791 1 13 1 DAC01-M01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34791 1 14 1 DAC01-M01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC34792 1 15 1 DAC01-M13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34792 1 16 1 DAC01-M13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC34793 1 17 1 DAC02-A01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34793 1 18 1 DAC02-A01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC34794 1 19 1 DAC02-A13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34794 1 20 1 DAC02-A13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC34795 1 21 1 DAC02-E01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34795 1 22 1 DAC02-E01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC34796 1 23 1 DAC02-E13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34796 1 24 1 DAC02-E13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC34797 1 25 1 DAC02-I01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34797 1 26 1 DAC02-I01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC34798 1 1 2 DAC02-I13 N/A CG9075 (01435-01673) CDMC34798 1 2 2 DAC02-I13 N/A CG9075 (01435-01673) CDMC34799 1 3 2 DAC02-M01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34799 1 4 2 DAC02-M01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC34800 1 5 2 DAC02-M13 AutoBlank AutoBlank CDMC34800 1 6 2 DAC02-M13 AutoBlank AutoBlank CDMC34801 1 7 2 DAC03-A01 2-CG17077-RB_1 CG17077 CGCGGGCAGGAATCGATTCCACGATGGTTATCCACCGGAATTTACGCCCTATGATGCTCAATCCTTCCA 69 FBan0017077 FBgn0003118 pnt 3 3R MAPKKK cascade; GO:0000165; R7 development; GO:0045467; Ras protein signal transduction; GO:0007265; anti-apoptosis; GO:0006916; epidermal growth factor receptor signaling pathway; GO:0007173; heart development; GO:0007507; hemopoiesis; GO:0030097; heterophilic cell adhesion; GO:0007157; mesoderm development; GO:0007498; negative regulation of cardioblast cell fate specification; GO:0009997; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; peripheral nervous system development; GO:0007422; regulation of hemocyte differentiation; GO:0045610; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; secondary tracheal branching (sensu Insecta); GO:0007429; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634 pnt pointed "CG17077, CG17077, CG17077, D-ets-2, D-Ets-2, ETS2, 0123/09, 0608/07, 0998/12, 3520, DMPOINT1A, POINT, E(E2F)3D, pointed-P1, pointed-P2, EY3-1, ptd, EK3-2, Ets protein Pointed P2, pointedP2, PNTP1, PNTP2, pointed-RC, Ets2, Ets58AB, Ets94F, ets94F, l(3)07825, l(3)j1B7, Ets at 58AB" CDMC34801 1 8 2 DAC03-A01 2-CG17077-RB_1 CG17077 CGCGGGCAGGAATCGATTCCACGATGGTTATCCACCGGAATTTACGCCCTATGATGCTCAATCCTTCCA 69 FBan0017077 FBgn0003118 pnt 3 3R MAPKKK cascade; GO:0000165; R7 development; GO:0045467; Ras protein signal transduction; GO:0007265; anti-apoptosis; GO:0006916; epidermal growth factor receptor signaling pathway; GO:0007173; heart development; GO:0007507; hemopoiesis; GO:0030097; heterophilic cell adhesion; GO:0007157; mesoderm development; GO:0007498; negative regulation of cardioblast cell fate specification; GO:0009997; ovarian follicle cell development (sensu Insecta); GO:0030707; pericardial cell differentiation; GO:0007513; peripheral nervous system development; GO:0007422; regulation of hemocyte differentiation; GO:0045610; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; secondary tracheal branching (sensu Insecta); GO:0007429; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0003700; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634 pnt pointed "CG17077, CG17077, CG17077, D-ets-2, D-Ets-2, ETS2, 0123/09, 0608/07, 0998/12, 3520, DMPOINT1A, POINT, E(E2F)3D, pointed-P1, pointed-P2, EY3-1, ptd, EK3-2, Ets protein Pointed P2, pointedP2, PNTP1, PNTP2, pointed-RC, Ets2, Ets58AB, Ets94F, ets94F, l(3)07825, l(3)j1B7, Ets at 58AB" CDMC34802 1 9 2 DAC03-A13 3-CG17086-RA_1 CG17086 GGCGCTGAAACAGCTCACACTGAGCGTCGAGGGACTGGGAAGCGAACTCGATTGATTGACTTATGCATA 69 FBan0017086 FBgn0032310 CG17086 2 2L CG17086 CG17086 CDMC34802 1 10 2 DAC03-A13 3-CG17086-RA_1 CG17086 GGCGCTGAAACAGCTCACACTGAGCGTCGAGGGACTGGGAAGCGAACTCGATTGATTGACTTATGCATA 69 FBan0017086 FBgn0032310 CG17086 2 2L CG17086 CG17086 CDMC34803 1 11 2 DAC03-E01 15-CG17136-RD_1 CG17136 GGGTTCGTCCGCTTTCTCAAGTACTTGACTCTGATGTCGAGAAAACTGGCCTTGAACGCGTTTAACGCT 69 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC34803 1 12 2 DAC03-E01 15-CG17136-RD_1 CG17136 GGGTTCGTCCGCTTTCTCAAGTACTTGACTCTGATGTCGAGAAAACTGGCCTTGAACGCGTTTAACGCT 69 FBan0017136 FBgn0010252 Rbp1 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 Rbp1 RNA-binding protein 1 "CG17136, CG17136, rrm1, RBP1, rbp1, Rbp-1, RRM1" CDMC34804 1 13 2 DAC03-E13 16-CG17149-RA_5 CG17149 GGCACCAAAGGTGTGGAAGTAGTGGCTGAAAACTTGAAGACATCCAATTCGCAGATGACATACAAGGCA 69 FBan0017149 FBgn0036955 CG17149 3 3L amino acid metabolism; GO:0006520; apoptosis; GO:0006915; electron transport; GO:0006118; induction of apoptosis; GO:0006917 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17149 CG17149 CDMC34804 1 14 2 DAC03-E13 16-CG17149-RA_5 CG17149 GGCACCAAAGGTGTGGAAGTAGTGGCTGAAAACTTGAAGACATCCAATTCGCAGATGACATACAAGGCA 69 FBan0017149 FBgn0036955 CG17149 3 3L amino acid metabolism; GO:0006520; apoptosis; GO:0006915; electron transport; GO:0006118; induction of apoptosis; GO:0006917 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG17149 CG17149 CDMC34805 1 15 2 DAC03-I01 3-CG17184-RA_2 CG17184 GGTGAACACACTGTGCAACAAGACGATCGACGATACGCTGCTGACGATACGACAGTACGAAACGGCCAG 69 FBan0017184 FBgn0037884 CG17184 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG17184 CG17184 CDMC34805 1 16 2 DAC03-I01 3-CG17184-RA_2 CG17184 GGTGAACACACTGTGCAACAAGACGATCGACGATACGCTGCTGACGATACGACAGTACGAAACGGCCAG 69 FBan0017184 FBgn0037884 CG17184 3 3R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 small GTPase regulator activity; GO:0005083; ; GO:0005083 CG17184 CG17184 CDMC34806 1 17 2 DAC03-I13 18-CG17197-RA_4 CG17197 CCTGCAAATGTTTTACGTGGTACCCCAATTGTTTGATGTTCAAGGATTCATGTACAAGCTCGGCTGGCT 69 FBan0017197 FBgn0039367 CG17197 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17197 CG17197 CDMC34806 1 18 2 DAC03-I13 18-CG17197-RA_4 CG17197 CCTGCAAATGTTTTACGTGGTACCCCAATTGTTTGATGTTCAAGGATTCATGTACAAGCTCGGCTGGCT 69 FBan0017197 FBgn0039367 CG17197 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17197 CG17197 CDMC34807 1 19 2 DAC03-M01 23-CG17228-RA_17 CG17228 GTATCCACACACAGGGCAGAAACTTAGACATAGCTGAGAGATTTGCAATAGCACACGAGTCGAAAACGC 69 FBan0017228 FBgn0004595 pros 3 3R "R7 cell fate commitment; GO:0007465; asymmetric cell division; GO:0008356; axonogenesis; GO:0007409; cell fate specification; GO:0001708; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; courtship behavior; GO:0007619; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; eye photoreceptor cell differentiation; GO:0001754; ganglion mother cell fate determination; GO:0007402; glial cell differentiation; GO:0010001; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of neuron differentiation; GO:0045664; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423; sensory perception of taste; GO:0050909; synaptogenesis; GO:0007416; ventral cord development; GO:0007419" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0030528 apical cortex; GO:0045179; basal cortex; GO:0045180; basal part of cell; GO:0045178; cell cortex; GO:0005938; nucleus; GO:0005634 pros prospero "CG17228, pro, DMPROSPER, 0244/09, 0320/10, 0441/16, 0451/09, 0563/18, 0585/13, 0664/07, 0671/02, 0763/13, 0989/01, 1135/07, 1135/09, 1167/13, 1316/02, 671/2, Pros, l(3)10419, Voila, a la voile et a la vapeur, DROPROSA, PROS-1, PROS-2, Prosp, anon-WO0140519.15, BcDNA:HL08040, l(3)j12C8, l(3)j6E2, l(3)rH013, l(3)rI160, l(3)rJ806, l(3)rK137, l(3)rK204, l(3)rL433, l(3)rO534, prospero" CDMC34807 1 20 2 DAC03-M01 23-CG17228-RA_17 CG17228 GTATCCACACACAGGGCAGAAACTTAGACATAGCTGAGAGATTTGCAATAGCACACGAGTCGAAAACGC 69 FBan0017228 FBgn0004595 pros 3 3R "R7 cell fate commitment; GO:0007465; asymmetric cell division; GO:0008356; axonogenesis; GO:0007409; cell fate specification; GO:0001708; central nervous system development; GO:0007417; cone cell fate commitment (sensu Endopterygota); GO:0007466; courtship behavior; GO:0007619; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; eye photoreceptor cell differentiation; GO:0001754; ganglion mother cell fate determination; GO:0007402; glial cell differentiation; GO:0010001; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; regulation of neuron differentiation; GO:0045664; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; sensory organ development; GO:0007423; sensory perception of taste; GO:0050909; synaptogenesis; GO:0007416; ventral cord development; GO:0007419" transcription regulator activity; GO:0030528; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0030528 apical cortex; GO:0045179; basal cortex; GO:0045180; basal part of cell; GO:0045178; cell cortex; GO:0005938; nucleus; GO:0005634 pros prospero "CG17228, pro, DMPROSPER, 0244/09, 0320/10, 0441/16, 0451/09, 0563/18, 0585/13, 0664/07, 0671/02, 0763/13, 0989/01, 1135/07, 1135/09, 1167/13, 1316/02, 671/2, Pros, l(3)10419, Voila, a la voile et a la vapeur, DROPROSA, PROS-1, PROS-2, Prosp, anon-WO0140519.15, BcDNA:HL08040, l(3)j12C8, l(3)j6E2, l(3)rH013, l(3)rI160, l(3)rJ806, l(3)rK137, l(3)rK204, l(3)rL433, l(3)rO534, prospero" CDMC34808 1 21 2 DAC03-M13 24-CG17245-RA_1 CG17245 GCTTTGTATTATAAGAACTATGCCCTATCGATCTTATTACGAAGAAAAATATACAACATTTTTGTCAAA 69 FBan0017245 FBgn0025740 plexB 4 4 axon guidance; GO:0007411; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; negative regulation of Rac protein signal transduction; GO:0035021; positive regulation of Rho protein signal transduction; GO:0035025; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; semaphorin receptor activity; GO:0017154; ; GO:0017154 membrane; GO:0016020 plexB plexin B "CG17245, plex, plexin and met-hepatocyte growth factor receptor-like, PlexB, plexin, plexin-B, Plexin-B" CDMC34808 1 22 2 DAC03-M13 24-CG17245-RA_1 CG17245 GCTTTGTATTATAAGAACTATGCCCTATCGATCTTATTACGAAGAAAAATATACAACATTTTTGTCAAA 69 FBan0017245 FBgn0025740 plexB 4 4 axon guidance; GO:0007411; ectoderm development; GO:0007398; motor axon guidance; GO:0008045; negative regulation of Rac protein signal transduction; GO:0035021; positive regulation of Rho protein signal transduction; GO:0035025; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; ; GO:0004714 ; EC:2.7.1.-; semaphorin receptor activity; GO:0017154; ; GO:0017154 membrane; GO:0016020 plexB plexin B "CG17245, plex, plexin and met-hepatocyte growth factor receptor-like, PlexB, plexin, plexin-B, Plexin-B" CDMC34809 1 23 2 DAC04-A01 2-CG15861-RA_1 CG15861 CTACGGCTACTGGGAGATCAACGAGCCTTCACAGCTTTGCTCCGACTACGAAATGCTGGTGGTCA 65 FBan0015861 FBgn0035084 CG15861 2 2R CG15861 CG15861 CDMC34809 1 24 2 DAC04-A01 2-CG15861-RA_1 CG15861 CTACGGCTACTGGGAGATCAACGAGCCTTCACAGCTTTGCTCCGACTACGAAATGCTGGTGGTCA 65 FBan0015861 FBgn0035084 CG15861 2 2R CG15861 CG15861 CDMC34810 1 25 2 DAC04-A13 2-CG15876-RA_1 CG15876 CATGCACTCCACCGAAACCTCGATCCTCCACAGGAGAGTTCTCCAAGATGGACATCTTCGGACCG 65 FBan0015876 FBgn0035569 CG15876 3 3L CG15876 CG15876 HL3 CDMC34810 1 26 2 DAC04-A13 2-CG15876-RA_1 CG15876 CATGCACTCCACCGAAACCTCGATCCTCCACAGGAGAGTTCTCCAAGATGGACATCTTCGGACCG 65 FBan0015876 FBgn0035569 CG15876 3 3L CG15876 CG15876 HL3 CDMC34811 1 1 3 DAC04-E01 8-CG1669-RA_1 CG1669 CTGCCACGCCACTACCTTCAGTTTCCAGATGCATTCGTTCTGGTCTACGATCCCATGGATCCGCG 65 FBan0001669 FBgn0040513 kappaB-Ras 2 2R negative regulation of I-kappaB kinase/NF-kappaB cascade; GO:0043124 GTP binding; GO:0005525; ; GO:0005525; protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 kappaB-Ras kappaB-Ras "CG1669, dkappaB-Ras, kappaB-Ras, BcDNA:RH38596" CDMC34811 1 2 3 DAC04-E01 8-CG1669-RA_1 CG1669 CTGCCACGCCACTACCTTCAGTTTCCAGATGCATTCGTTCTGGTCTACGATCCCATGGATCCGCG 65 FBan0001669 FBgn0040513 kappaB-Ras 2 2R negative regulation of I-kappaB kinase/NF-kappaB cascade; GO:0043124 GTP binding; GO:0005525; ; GO:0005525; protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 kappaB-Ras kappaB-Ras "CG1669, dkappaB-Ras, kappaB-Ras, BcDNA:RH38596" CDMC34812 1 3 3 DAC04-E13 3-CG16761-RA_3 CG16761 TTACCTGGTTCTCTACTACGCCCATCGGGATGCGAACTACTTTCCAGATCCCCTCAGCTTCAGGC 65 FBan0016761 FBgn0035344 Cyp4d20 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d20 Cyp4d20 "CG16761, 4d20" CDMC34812 1 4 3 DAC04-E13 3-CG16761-RA_3 CG16761 TTACCTGGTTCTCTACTACGCCCATCGGGATGCGAACTACTTTCCAGATCCCCTCAGCTTCAGGC 65 FBan0016761 FBgn0035344 Cyp4d20 3 3L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d20 Cyp4d20 "CG16761, 4d20" CDMC34813 1 5 3 DAC04-I01 13-CG16870-RA_1 CG16870 ACCGTGAAGGGTTACATCGAAGGTCGTCCGGCCGAGATGGATGTGATGAAGGAGTGGCTCAGGAC 65 FBan0016870 FBgn0025115 Acyp 2 2L acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 Acyp Acylphosphatase "CG16870, CG16870, AcPDro, BG:DS00180.1, acylphosphatase, ACPDro" CDMC34813 1 6 3 DAC04-I01 13-CG16870-RA_1 CG16870 ACCGTGAAGGGTTACATCGAAGGTCGTCCGGCCGAGATGGATGTGATGAAGGAGTGGCTCAGGAC 65 FBan0016870 FBgn0025115 Acyp 2 2L acylphosphatase activity; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7; ; GO:0003998 ; EC:3.6.1.7 Acyp Acylphosphatase "CG16870, CG16870, AcPDro, BG:DS00180.1, acylphosphatase, ACPDro" CDMC34814 1 7 3 DAC04-I13 23-CG1690-RA_2 CG1690 GGTTTATCTTGCATGCCTAAAAATCGCAAGGAGCATCACACGAAGAACAGGAACCCAGGACACTG 65 FBan0001690 FBgn0033442 CG1690 2 2R CG1690 CG1690 CDMC34814 1 8 3 DAC04-I13 23-CG1690-RA_2 CG1690 GGTTTATCTTGCATGCCTAAAAATCGCAAGGAGCATCACACGAAGAACAGGAACCCAGGACACTG 65 FBan0001690 FBgn0033442 CG1690 2 2R CG1690 CG1690 CDMC34815 1 9 3 DAC04-M01 3-CG17084-RA_3 CG17084 TCTGTTGTCCGGAGAACCTCGTCTTTGATGCCAAGCACTGGAACTGCACAATGCCACACCAAGTC 65 FBan0017084 FBgn0035131 mthl9 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl9 methuselah-like 9 "CG17084, CG17084, mth-like 9, Mth-like 9, anon-WO0170980.163, anon-WO0170980.164" CDMC34815 1 10 3 DAC04-M01 3-CG17084-RA_3 CG17084 TCTGTTGTCCGGAGAACCTCGTCTTTGATGCCAAGCACTGGAACTGCACAATGCCACACCAAGTC 65 FBan0017084 FBgn0035131 mthl9 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl9 methuselah-like 9 "CG17084, CG17084, mth-like 9, Mth-like 9, anon-WO0170980.163, anon-WO0170980.164" CDMC34816 1 11 3 DAC04-M13 11-CG17131-RA_1 CG17131 AGCTACGGCGTGATCTTCCAATGCAATGTCAAGTACTGCTTGGGTCCATGTGAGCCGGCTGTGTG 65 CDMC34816 1 12 3 DAC04-M13 11-CG17131-RA_1 CG17131 AGCTACGGCGTGATCTTCCAATGCAATGTCAAGTACTGCTTGGGTCCATGTGAGCCGGCTGTGTG 65 CDMC34817 1 13 3 DAC05-A01 23-CG10035-RA_1 CG10035 GGGTGTAGGTTTAGTGCTGGCTCGTAAATTAGGTGGAATGCAAAATATACTTTTAATGATGCTATAAA 68 FBan0010035 FBgn0038028 CG10035 3 3R CG10035 CG10035 "clone 20, anon-EST:Liang-20" CDMC34817 1 14 3 DAC05-A01 23-CG10035-RA_1 CG10035 GGGTGTAGGTTTAGTGCTGGCTCGTAAATTAGGTGGAATGCAAAATATACTTTTAATGATGCTATAAA 68 FBan0010035 FBgn0038028 CG10035 3 3R CG10035 CG10035 "clone 20, anon-EST:Liang-20" CDMC34818 1 15 3 DAC05-A13 2-CG10252-RA_2 CG10252 ACCACTATTCCGGGCGAGAATGTCGGACCTGGACCCAACTACTACGACCTCATGTACTATCGTCCTGG 68 FBan0010252 FBgn0039104 CG10252 3 3R CG10252 CG10252 "bs30h03.y1, anon-WO0140519.133, BEST:GH13953" CDMC34818 1 16 3 DAC05-A13 2-CG10252-RA_2 CG10252 ACCACTATTCCGGGCGAGAATGTCGGACCTGGACCCAACTACTACGACCTCATGTACTATCGTCCTGG 68 FBan0010252 FBgn0039104 CG10252 3 3R CG10252 CG10252 "bs30h03.y1, anon-WO0140519.133, BEST:GH13953" CDMC34819 1 17 3 DAC05-E01 24-CG10697-RA_4 CG10697 TATCATTGATGTTGTTCATGATTTTTATTGTTAACGTTATGCGCCTAATTAAAACAAATGTATTCTGC 68 FBan0010697 FBgn0000422 Ddc 2 2L catecholamine metabolism; GO:0006584; courtship behavior; GO:0007619; cuticle biosynthesis; GO:0042335; dopamine biosynthesis from tyrosine; GO:0006585; eclosion rhythm; GO:0008062; learning and/or memory; GO:0007611; melanin biosynthesis; GO:0042438; pigmentation during development; GO:0048066; serotonin biosynthesis from tryptophan; GO:0006587 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Ddc Dopa decarboxylase "CG10697, CG10697, DDC, transcription unit No. 3, DdcDm, fDDC, 5-HT, AADC, dopa decarboxylase, ddc, l(2)37Bl, l(2)37Ch, l(2)k02104" CDMC34819 1 18 3 DAC05-E01 24-CG10697-RA_4 CG10697 TATCATTGATGTTGTTCATGATTTTTATTGTTAACGTTATGCGCCTAATTAAAACAAATGTATTCTGC 68 FBan0010697 FBgn0000422 Ddc 2 2L catecholamine metabolism; GO:0006584; courtship behavior; GO:0007619; cuticle biosynthesis; GO:0042335; dopamine biosynthesis from tyrosine; GO:0006585; eclosion rhythm; GO:0008062; learning and/or memory; GO:0007611; melanin biosynthesis; GO:0042438; pigmentation during development; GO:0048066; serotonin biosynthesis from tryptophan; GO:0006587 aromatic-L-amino-acid decarboxylase activity; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28; ; GO:0004058 ; EC:4.1.1.28 Ddc Dopa decarboxylase "CG10697, CG10697, DDC, transcription unit No. 3, DdcDm, fDDC, 5-HT, AADC, dopa decarboxylase, ddc, l(2)37Bl, l(2)37Ch, l(2)k02104" CDMC34820 1 19 3 DAC05-E13 2-CG10947-RB_1 CG10947 GCTTCGAGGATCACGTGAGTCTGAAGTGCTTGGGCAAGACGGAGAACTGGTACAAATACCGCATGCAG 68 FBan0010947 FBgn0032857 CG10947 2 2L CG10947 CG10947 38C.42 CDMC34820 1 20 3 DAC05-E13 2-CG10947-RB_1 CG10947 GCTTCGAGGATCACGTGAGTCTGAAGTGCTTGGGCAAGACGGAGAACTGGTACAAATACCGCATGCAG 68 FBan0010947 FBgn0032857 CG10947 2 2L CG10947 CG10947 38C.42 CDMC34821 1 21 3 DAC05-I01 2-CG11210-RA_1 CG11210 GCGTTGCCTGTCCGCTGATTATGCCGTTCGCCATGATCTACATCTGCCTAAAACACTTCGTGGATCGC 68 FBan0011210 FBgn0033259 CG11210 2 2R CG11210 CG11210 CT31310 CDMC34821 1 22 3 DAC05-I01 2-CG11210-RA_1 CG11210 GCGTTGCCTGTCCGCTGATTATGCCGTTCGCCATGATCTACATCTGCCTAAAACACTTCGTGGATCGC 68 FBan0011210 FBgn0033259 CG11210 2 2R CG11210 CG11210 CT31310 CDMC34822 1 23 3 DAC05-I13 2-CG11329-RA_1 CG11329 TGGATCCAAATGGGCTACTTCATGGAGGTGACCGACAGAATCTACCTAGGTCCACGTAGCCTCGTCGA 68 FBan0011329 FBgn0031848 CG11329 2 2L CG11329 CG11329 "GM14348, EST2, anon-WO0118547.82" CDMC34822 1 24 3 DAC05-I13 2-CG11329-RA_1 CG11329 TGGATCCAAATGGGCTACTTCATGGAGGTGACCGACAGAATCTACCTAGGTCCACGTAGCCTCGTCGA 68 FBan0011329 FBgn0031848 CG11329 2 2L CG11329 CG11329 "GM14348, EST2, anon-WO0118547.82" CDMC34823 1 25 3 DAC05-M01 15-CG11811-RA_2 CG11811 GCTGTTCTGTGCGAATAAAAGGCCACGCGATGATAAGCTTTCTGTTCATTGTAAATCGGGCGCTCAGC 68 FBan0011811 FBgn0036099 CG11811 3 3L purine base metabolism; GO:0006144 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8 CG11811 CG11811 CDMC34823 1 26 3 DAC05-M01 15-CG11811-RA_2 CG11811 GCTGTTCTGTGCGAATAAAAGGCCACGCGATGATAAGCTTTCTGTTCATTGTAAATCGGGCGCTCAGC 68 FBan0011811 FBgn0036099 CG11811 3 3L purine base metabolism; GO:0006144 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8 CG11811 CG11811 CDMC34824 1 1 4 DAC05-M13 2-CG11992-RA_4 CG11992 AGCTTCCTTAATGGAGTGCCAACCGTACAATTGGACCTCTCGCTAACGAACGACGATGGTCTGACGCC 68 FBan0011992 FBgn0014018 Rel 3 3R I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to bacteria; GO:0009617; signal transduction; GO:0007165 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0003704; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Rel Relish "CG11992, CG11992, CG11992, CG11992, CG11992, l(3)neo36, ird4, immune response deficient 4, relish, ird, rel, REL, Relish" CDMC34824 1 2 4 DAC05-M13 2-CG11992-RA_4 CG11992 AGCTTCCTTAATGGAGTGCCAACCGTACAATTGGACCTCTCGCTAACGAACGACGATGGTCTGACGCC 68 FBan0011992 FBgn0014018 Rel 3 3R I-kappaB kinase/NF-kappaB cascade; GO:0007249; Toll signaling pathway; GO:0008063; antibacterial polypeptide induction; GO:0006963; antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; defense response to Gram-negative bacteria; GO:0050829; immune response; GO:0006955; innate immune response; GO:0045087; positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; response to bacteria; GO:0009617; signal transduction; GO:0007165 transcription factor activity; GO:0003700; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003700; transcription regulator activity; GO:0030528; ; GO:0003700; ; GO:0003704; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; nucleus; GO:0005634 Rel Relish "CG11992, CG11992, CG11992, CG11992, CG11992, l(3)neo36, ird4, immune response deficient 4, relish, ird, rel, REL, Relish" CDMC34825 1 3 4 DAC06-A01 13-CG32972-RA_1 CG32972 TCCCACAACCACATCTTTAGCTCCAACAACTACTGAGGACAACTCAAACACCGCGTCTACAACCACTGA 69 FBan0032972 FBgn0028905 CG32972 2 2L cell adhesion; GO:0007155 CG32972 CG32972 "CG15291, BG:DS01523.2" CDMC34825 1 4 4 DAC06-A01 13-CG32972-RA_1 CG32972 TCCCACAACCACATCTTTAGCTCCAACAACTACTGAGGACAACTCAAACACCGCGTCTACAACCACTGA 69 FBan0032972 FBgn0028905 CG32972 2 2L cell adhesion; GO:0007155 CG32972 CG32972 "CG15291, BG:DS01523.2" CDMC34826 1 5 4 DAC06-A13 22-CG32987-RA_1 CG32987 TGCATTGTATCCCGAGAATATCCTACTACTCTCCCTGTAAGTGGTTCATGACAGGTCTGGTGGTTGTGT 69 FBan0032987 FBgn0052987 CG32987 2 2L CG32987 CG32987 CG15866 CDMC34826 1 6 4 DAC06-A13 22-CG32987-RA_1 CG32987 TGCATTGTATCCCGAGAATATCCTACTACTCTCCCTGTAAGTGGTTCATGACAGGTCTGGTGGTTGTGT 69 FBan0032987 FBgn0052987 CG32987 2 2L CG32987 CG32987 CG15866 CDMC34827 1 7 4 DAC06-E01 2-CG33048-RA_1 CG33048 GCAGTTCCGGGATTTAAGGGTCAGGTCGGTTTCATCACCTCCATGACGGAACACTTTTGTGGTACCTGC 69 FBan0033048 FBgn0036122 Mocs1 3 3L Mo-molybdopterin cofactor biosynthesis; GO:0006777 catalytic activity; GO:0003824; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0005506 molybdopterin synthase complex; GO:0019008 Mocs1 Mocs1 "CG7858, CG33048, CG7858, CG7858, CG33048, mocsI, Mosc1A+Mosc1B, Mocs1A, Mocs1A-B, Mocs1B" CDMC34827 1 8 4 DAC06-E01 2-CG33048-RA_1 CG33048 GCAGTTCCGGGATTTAAGGGTCAGGTCGGTTTCATCACCTCCATGACGGAACACTTTTGTGGTACCTGC 69 FBan0033048 FBgn0036122 Mocs1 3 3L Mo-molybdopterin cofactor biosynthesis; GO:0006777 catalytic activity; GO:0003824; ; GO:0003824; iron ion binding; GO:0005506; ; GO:0005506 molybdopterin synthase complex; GO:0019008 Mocs1 Mocs1 "CG7858, CG33048, CG7858, CG7858, CG33048, mocsI, Mosc1A+Mosc1B, Mocs1A, Mocs1A-B, Mocs1B" CDMC34828 1 9 4 DAC06-E13 23-CG33057-RA_7 CG33057 GTTGACTAAACGATTTCTTGGCAAAAGTCTCTTGGAGCAGGGAGAAATTATTTACAAGGGCGACAACAA 69 FBan0033057 FBgn0053057 CG33057 3 3L tRNA splicing; GO:0006388 2'-phosphotransferase activity; GO:0008665; ; GO:0008665; ; GO:0008665 CG33057 CG33057 CDMC34828 1 10 4 DAC06-E13 23-CG33057-RA_7 CG33057 GTTGACTAAACGATTTCTTGGCAAAAGTCTCTTGGAGCAGGGAGAAATTATTTACAAGGGCGACAACAA 69 FBan0033057 FBgn0053057 CG33057 3 3L tRNA splicing; GO:0006388 2'-phosphotransferase activity; GO:0008665; ; GO:0008665; ; GO:0008665 CG33057 CG33057 CDMC34829 1 11 4 DAC06-I01 9-CG33095-RA_1 CG33095 GCCGCAGTGCAGAGTACAAGCCACCTTGAAGACTTTATATCCCTACAACGAGGCCCCAAAGATTCCACA 69 FBan0033095 FBgn0053095 CG33095 3 3R CG33095 CG33095 "CG11935, CG11938, FBgn0039275" CDMC34829 1 12 4 DAC06-I01 9-CG33095-RA_1 CG33095 GCCGCAGTGCAGAGTACAAGCCACCTTGAAGACTTTATATCCCTACAACGAGGCCCCAAAGATTCCACA 69 FBan0033095 FBgn0053095 CG33095 3 3R CG33095 CG33095 "CG11935, CG11938, FBgn0039275" CDMC34830 1 13 4 DAC06-I13 14-CG33100-RA_1 CG33100 AGGAGAGCACCAGTATCAGCTACCAGTCAGCATCATAATTGCCAGGATGAGCATGGAGAAAGTAGCCAA 69 FBan0033100 FBgn0053100 4EHP 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 4EHP 4EHP "CG10716, CG33100, CG10716, CG33100, CT30033, d4EHP, 4EHP" CDMC34830 1 14 4 DAC06-I13 14-CG33100-RA_1 CG33100 AGGAGAGCACCAGTATCAGCTACCAGTCAGCATCATAATTGCCAGGATGAGCATGGAGAAAGTAGCCAA 69 FBan0033100 FBgn0053100 4EHP 3 3R translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 eukaryotic translation initiation factor 4F complex; GO:0016281 4EHP 4EHP "CG10716, CG33100, CG10716, CG33100, CT30033, d4EHP, 4EHP" CDMC34831 1 15 4 DAC06-M01 1-CG33123-RA_1 CG33123 CGCTTTTCCAGGTCAACACTGTCATATCCGAGGGAGACACGGTCCAATCTCTGCGAGAGAAGCTCTCCA 69 FBan0033123 FBgn0053123 CG33123 2 2L response to oxidative stress; GO:0006979; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; leucine-tRNA ligase activity; GO:0004823 ; EC:6.1.1.4; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0003729; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004823 ; EC:6.1.1.4 cytoplasm; GO:0005737 CG33123 CG33123 "CG3229, CG3229, anon-EST:Posey266" CDMC34831 1 16 4 DAC06-M01 1-CG33123-RA_1 CG33123 CGCTTTTCCAGGTCAACACTGTCATATCCGAGGGAGACACGGTCCAATCTCTGCGAGAGAAGCTCTCCA 69 FBan0033123 FBgn0053123 CG33123 2 2L response to oxidative stress; GO:0006979; tRNA aminoacylation for protein translation; GO:0006418 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; leucine-tRNA ligase activity; GO:0004823 ; EC:6.1.1.4; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0003729; ; GO:0004601 ; EC:1.11.1.7; ; GO:0004823 ; EC:6.1.1.4 cytoplasm; GO:0005737 CG33123 CG33123 "CG3229, CG3229, anon-EST:Posey266" CDMC34832 1 17 4 DAC06-M13 3-CG33130-RC_1 CG33130 AGCCCGAAACGGACCAGGTAACCAAGCTGTATGGTACTGGGCCTAGTCAAGTCGAAGAAGTCATGTTCG 69 FBgn0053130 CDMC34832 1 18 4 DAC06-M13 3-CG33130-RC_1 CG33130 AGCCCGAAACGGACCAGGTAACCAAGCTGTATGGTACTGGGCCTAGTCAAGTCGAAGAAGTCATGTTCG 69 FBgn0053130 CDMC34833 1 19 4 DAC07-A01 18-CG5773-RA_2 CG5773 GTGGCTTGTGCTCAGTCGAATTTTGTTCTCGGACCATTAAACATTACCCATTCAGCCAGCATTCACCAT 69 FBan0005773 FBgn0034290 CG5773 2 2R CG5773 CG5773 BcDNA:RH46075 CDMC34833 1 20 4 DAC07-A01 18-CG5773-RA_2 CG5773 GTGGCTTGTGCTCAGTCGAATTTTGTTCTCGGACCATTAAACATTACCCATTCAGCCAGCATTCACCAT 69 FBan0005773 FBgn0034290 CG5773 2 2R CG5773 CG5773 BcDNA:RH46075 CDMC34834 1 21 4 DAC07-A13 3-CG5787-RA_3 CG5787 ACTGGTGGAAGGACTACAAGAATGTTGGCGAGGAGATCGACCAGCAACTGTTGGAGTGTGGGAACTTGA 69 FBan0005787 FBgn0032454 CG5787 2 2L CG5787 CG5787 CDMC34834 1 22 4 DAC07-A13 3-CG5787-RA_3 CG5787 ACTGGTGGAAGGACTACAAGAATGTTGGCGAGGAGATCGACCAGCAACTGTTGGAGTGTGGGAACTTGA 69 FBan0005787 FBgn0032454 CG5787 2 2L CG5787 CG5787 CDMC34835 1 23 4 DAC07-E01 3-CG5813-RA_2 CG5813 GGGCAAGTTCAACAGCATCAGAGAAGAACTCCCCAGCTGAACGGAAGTCTAGGCAGCTGTATTTCGCCA 69 FBan0005813 FBgn0000307 chif 2 2L "chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306; regulation of DNA replication; GO:0006275; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 chif chiffon "CG5817, CG5813, CG5817, fs(2)chiffon, BG:DS09218.2, BG:DS09218.1, DS09218.1, Dbf4, chf, chiffon" CDMC34835 1 24 4 DAC07-E01 3-CG5813-RA_2 CG5813 GGGCAAGTTCAACAGCATCAGAGAAGAACTCCCCAGCTGAACGGAAGTCTAGGCAGCTGTATTTCGCCA 69 FBan0005813 FBgn0000307 chif 2 2L "chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304; insect chorion formation; GO:0007306; regulation of DNA replication; GO:0006275; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleus; GO:0005634 chif chiffon "CG5817, CG5813, CG5817, fs(2)chiffon, BG:DS09218.2, BG:DS09218.1, DS09218.1, Dbf4, chf, chiffon" CDMC34836 1 25 4 DAC07-E13 3-CG5830-RA_2 CG5830 ATGGCTTCATCGTATCACATTCTGGTTTCCTGAAATGTCTCTCAGTCGTGAGTGGGATTGGGCCGCGCT 69 FBan0005830 FBgn0036556 CG5830 3 3L development; GO:0007275; mesoderm development; GO:0007498 CG5830 CG5830 CDMC34836 1 26 4 DAC07-E13 3-CG5830-RA_2 CG5830 ATGGCTTCATCGTATCACATTCTGGTTTCCTGAAATGTCTCTCAGTCGTGAGTGGGATTGGGCCGCGCT 69 FBan0005830 FBgn0036556 CG5830 3 3L development; GO:0007275; mesoderm development; GO:0007498 CG5830 CG5830 CDMC34837 1 1 5 DAC07-I01 7-CG5862-RA_1 CG5862 CGTGGGGATTGCCGTAGCTCTTTTAGTTGTGATCGTCACACTGTACCTGCTGCAAAAGAAAAACGCCGC 69 FBan0005862 FBgn0038868 CG5862 3 3R CG5862 CG5862 CDMC34837 1 2 5 DAC07-I01 7-CG5862-RA_1 CG5862 CGTGGGGATTGCCGTAGCTCTTTTAGTTGTGATCGTCACACTGTACCTGCTGCAAAAGAAAAACGCCGC 69 FBan0005862 FBgn0038868 CG5862 3 3R CG5862 CG5862 CDMC34838 1 3 5 DAC07-I13 2-CG5873-RA_1 CG5873 TGCCTCGAAACGTCTGTCGGATTTGATCAGGAGACCCTATGATCTGTACCGTGCAGGAGTGCTGGATGA 69 FBan0005873 FBgn0038511 CG5873 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG5873 CG5873 CDMC34838 1 4 5 DAC07-I13 2-CG5873-RA_1 CG5873 TGCCTCGAAACGTCTGTCGGATTTGATCAGGAGACCCTATGATCTGTACCGTGCAGGAGTGCTGGATGA 69 FBan0005873 FBgn0038511 CG5873 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG5873 CG5873 CDMC34839 1 5 5 DAC07-M01 15-CG5915-RA_6 CG5915 CCAACGCCACAAACTGCATCGAAATGTCCGGACGTAAGAAATCCCTACTGAAAGTCATCATTCTGGGCG 69 FBan0005915 FBgn0015795 Rab7 3 3R autophagic cell death; GO:0048102; endosome to lysosome transport; GO:0008333; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 late endosome; GO:0005770 Rab7 Rab-protein 7 "CG5915, CG5915, CG5915, DRAB7, Drab7, RAB7, rab7, DRab7, DmRab7, Rab-7, AAF56218, Dm Rab7, Rab-r7" CDMC34839 1 6 5 DAC07-M01 15-CG5915-RA_6 CG5915 CCAACGCCACAAACTGCATCGAAATGTCCGGACGTAAGAAATCCCTACTGAAAGTCATCATTCTGGGCG 69 FBan0005915 FBgn0015795 Rab7 3 3R autophagic cell death; GO:0048102; endosome to lysosome transport; GO:0008333; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; salivary gland cell autophagic cell death; GO:0035071; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 late endosome; GO:0005770 Rab7 Rab-protein 7 "CG5915, CG5915, CG5915, DRAB7, Drab7, RAB7, rab7, DRab7, DmRab7, Rab-7, AAF56218, Dm Rab7, Rab-r7" CDMC34840 1 7 5 DAC07-M13 23-CG5923-RA_1 CG5923 CTTCGATACATTCTTCGAGAAGATGATTGGGGGAATAATGGAGTCGATTGGTAGTCACACAGCAGTGCT 69 FBan0005923 FBgn0005696 DNApol-alpha73 3 3R DNA-dependent DNA replication; GO:0006261 nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; ; GO:0003889 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha73 DNA polymerase alpha 73kD "CG5923, CG5923, CG5923, pol alpha, DNApol-alpha, DNA polymerase alpha, DNApolalpha, DNApol-alpha72, POLA, DNA-polymerase alpha, Polalpha, B subunit, polalpha, DNA polymerase alpha primase 73 kda subunit, DNA polymerase 73K, DNA polalpha, DNApol-alpha73" CDMC34840 1 8 5 DAC07-M13 23-CG5923-RA_1 CG5923 CTTCGATACATTCTTCGAGAAGATGATTGGGGGAATAATGGAGTCGATTGGTAGTCACACAGCAGTGCT 69 FBan0005923 FBgn0005696 DNApol-alpha73 3 3R DNA-dependent DNA replication; GO:0006261 nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; ; GO:0003889 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha73 DNA polymerase alpha 73kD "CG5923, CG5923, CG5923, pol alpha, DNApol-alpha, DNA polymerase alpha, DNApolalpha, DNApol-alpha72, POLA, DNA-polymerase alpha, Polalpha, B subunit, polalpha, DNA polymerase alpha primase 73 kda subunit, DNA polymerase 73K, DNA polalpha, DNApol-alpha73" CDMC34841 1 9 5 DAC08-A01 23-CG8209-RA_2 CG8209 CGCATAAATCTTTCCTACAAACTGGATATATTTGAATCCGGGTAATCTCTCCCATAAACTAGAACCTAA 69 FBan0008209 FBgn0035830 CG8209 3 3L CG8209 CG8209 anon-WO0172774.138 CDMC34841 1 10 5 DAC08-A01 23-CG8209-RA_2 CG8209 CGCATAAATCTTTCCTACAAACTGGATATATTTGAATCCGGGTAATCTCTCCCATAAACTAGAACCTAA 69 FBan0008209 FBgn0035830 CG8209 3 3L CG8209 CG8209 anon-WO0172774.138 CDMC34842 1 11 5 DAC08-A13 22-CG8224-RB_3 CG8224 GCTGCAACATGGGCATGATATACGATGAGTATCAATTGCCGTATTACGATGTCGTGCAACCTGATCCCA 69 FBan0008224 FBgn0011300 babo 2 2R cytokine and chemokine mediated signaling pathway; GO:0019221; dendrite morphogenesis; GO:0016358; eye-antennal disc morphogenesis; GO:0007455; mesoderm development; GO:0007498; mushroom body development; GO:0016319; positive regulation of body size; GO:0040018; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179 "ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; activin binding; GO:0048185; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; ; GO:0048185; ; GO:0004703 ; EC:2.7.1.-; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025; activin receptor activity, type I; GO:0016361; ; GO:0016361; ; GO:0005025" activin receptor complex; GO:0048179; plasma membrane; GO:0005886 babo baboon "CG8224, CG8224, Gprk-3, Atr-I, atr-I, STK-E, Atr45A: Activin A receptor 45A, Activin A receptor 45A, AtrI, Atr-1, ATR-1, l(2)k16912, ATR-I, Bab, Atf1, Gprk3, l(2)44Fd, G protein-coupled receptor kinase 3, Atr45A, baboon" CDMC34842 1 12 5 DAC08-A13 22-CG8224-RB_3 CG8224 GCTGCAACATGGGCATGATATACGATGAGTATCAATTGCCGTATTACGATGTCGTGCAACCTGATCCCA 69 FBan0008224 FBgn0011300 babo 2 2R cytokine and chemokine mediated signaling pathway; GO:0019221; dendrite morphogenesis; GO:0016358; eye-antennal disc morphogenesis; GO:0007455; mesoderm development; GO:0007498; mushroom body development; GO:0016319; positive regulation of body size; GO:0040018; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179 "ATP binding; GO:0005524; ; GO:0005524; G-protein coupled receptor kinase activity; GO:0004703 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; activin binding; GO:0048185; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; ; GO:0048185; ; GO:0004703 ; EC:2.7.1.-; transforming growth factor beta receptor activity, type I; GO:0005025; ; GO:0005025; ; GO:0005025; activin receptor activity, type I; GO:0016361; ; GO:0016361; ; GO:0005025" activin receptor complex; GO:0048179; plasma membrane; GO:0005886 babo baboon "CG8224, CG8224, Gprk-3, Atr-I, atr-I, STK-E, Atr45A: Activin A receptor 45A, Activin A receptor 45A, AtrI, Atr-1, ATR-1, l(2)k16912, ATR-I, Bab, Atf1, Gprk3, l(2)44Fd, G protein-coupled receptor kinase 3, Atr45A, baboon" CDMC34843 1 13 5 DAC08-E01 17-CG8261-RD_2 CG8261 CGCAAACGTGTGTGGAGTACTACCCCAGTACCAGTATCAACGCCACCTGGAACAATATATAGTTGTGCA 69 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC34843 1 14 5 DAC08-E01 17-CG8261-RD_2 CG8261 CGCAAACGTGTGTGGAGTACTACCCCAGTACCAGTATCAACGCCACCTGGAACAATATATAGTTGTGCA 69 FBan0008261 FBgn0004921 Ggamma1 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; actin filament organization; GO:0007015; apical protein localization; GO:0045176; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Ggamma1 G protein gamma 1 "CG8261, D-G[[gamma]]1, dg1alpha, l(2)k08017, Ggamma-1, Ggamma1, Gbetagamma, G[[gamma]], Ggamma" CDMC34844 1 15 5 DAC08-E13 23-CG8279-RA_20 CG8279 AGCTACCCTAACCAAAATCGTGCTAGTCAAACAAACGTATGAGATACTATTATGTGTACGAAACCCCTA 69 FBan0008279 FBgn0038237 Pde6 3 3R cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004114 ; EC:3.1.4.17; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35" Pde6 Phosphodiesterase 6 "CG8279, CG8279, PDE6, Phosphodiesterase 6" CDMC34844 1 16 5 DAC08-E13 23-CG8279-RA_20 CG8279 AGCTACCCTAACCAAAATCGTGCTAGTCAAACAAACGTATGAGATACTATTATGTGTACGAAACCCCTA 69 FBan0008279 FBgn0038237 Pde6 3 3R cyclic nucleotide metabolism; GO:0009187; signal transduction; GO:0007165 "3',5'-cyclic-nucleotide phosphodiesterase activity; GO:0004114 ; EC:3.1.4.17; cGMP-specific phosphodiesterase activity; GO:0004116 ; EC:3.1.4.-; ; GO:0004114 ; EC:3.1.4.17; ; GO:0004116 ; EC:3.1.4.-; 3',5'-cyclic-GMP phosphodiesterase activity; GO:0047555 ; EC:3.1.4.35; ; GO:0047555 ; EC:3.1.4.35" Pde6 Phosphodiesterase 6 "CG8279, CG8279, PDE6, Phosphodiesterase 6" CDMC34845 1 17 5 DAC08-I01 23-CG8312-RA_4 CG8312 GTGCCCCTTGATCCAAAAATAATGAATTTATATTGTACGCATTTGTAAATAAATTAGTCGCCCTACGCA 69 FBan0008312 FBgn0037720 CG8312 3 3R CG8312 CG8312 CDMC34845 1 18 5 DAC08-I01 23-CG8312-RA_4 CG8312 GTGCCCCTTGATCCAAAAATAATGAATTTATATTGTACGCATTTGTAAATAAATTAGTCGCCCTACGCA 69 FBan0008312 FBgn0037720 CG8312 3 3R CG8312 CG8312 CDMC34846 1 19 5 DAC08-I13 18-CG8321-RA_1 CG8321 GCCCTGTTCTGCGGATTTCTGGTCACGGTCTTCATGTACTTCGACTTGTACTCGTAGAACTGAATACCC 69 FBan0008321 FBgn0033677 CG8321 2 2R CG8321 CG8321 CDMC34846 1 20 5 DAC08-I13 18-CG8321-RA_1 CG8321 GCCCTGTTCTGCGGATTTCTGGTCACGGTCTTCATGTACTTCGACTTGTACTCGTAGAACTGAATACCC 69 FBan0008321 FBgn0033677 CG8321 2 2R CG8321 CG8321 CDMC34847 1 21 5 DAC08-M01 9-CG8359-RA_1 CG8359 CCGCCACTCCGGAAATCGCATATATTCCACAGTTACCATCAGATCCACCCTGCAGTACAAATACCGCCT 69 FBan0008359 FBgn0037634 CG8359 3 3R DNA binding; GO:0003677; ; GO:0003677 CG8359 CG8359 CDMC34847 1 22 5 DAC08-M01 9-CG8359-RA_1 CG8359 CCGCCACTCCGGAAATCGCATATATTCCACAGTTACCATCAGATCCACCCTGCAGTACAAATACCGCCT 69 FBan0008359 FBgn0037634 CG8359 3 3R DNA binding; GO:0003677; ; GO:0003677 CG8359 CG8359 CDMC34848 1 23 5 DAC08-M13 2-CG8372-RB_1 CG8372 CGGATAGACTGCCTCCGATCAACGTAAAGGACCAACGCTTCCCCTACTGCATCGTTTGGACTCCCATTC 69 FBan0008372 FBgn0032000 CG8372 2 2L CG8372 CG8372 CDMC34848 1 24 5 DAC08-M13 2-CG8372-RB_1 CG8372 CGGATAGACTGCCTCCGATCAACGTAAAGGACCAACGCTTCCCCTACTGCATCGTTTGGACTCCCATTC 69 FBan0008372 FBgn0032000 CG8372 2 2L CG8372 CG8372 CDMC34849 1 25 5 DAC09-A02 12-CG1279-RA_1 CG1279 CCTCCTGCTGGATGTGATGGTCCACTCGGTGATCAGTGTGATAAGCATGGTAGGGATCACAGTTCTCAT 69 FBan0001279 FBgn0015831 Rtnl2 3 3R endoplasmic reticulum; GO:0005783 Rtnl2 Rtnl2 "CG1279, trop, tropomyosin-like, anon-WO0170980.134, Tml84D: Tropomyosin-like-84D, Tropomyosin-like-84D" CDMC34849 1 26 5 DAC09-A02 12-CG1279-RA_1 CG1279 CCTCCTGCTGGATGTGATGGTCCACTCGGTGATCAGTGTGATAAGCATGGTAGGGATCACAGTTCTCAT 69 FBan0001279 FBgn0015831 Rtnl2 3 3R endoplasmic reticulum; GO:0005783 Rtnl2 Rtnl2 "CG1279, trop, tropomyosin-like, anon-WO0170980.134, Tml84D: Tropomyosin-like-84D, Tropomyosin-like-84D" CDMC34850 1 1 6 DAC09-A14 8-CG12813-RA_3 CG12813 GCGTGTGCACAATTGCGTTACTCCACCCTGTCAGATTGTGAAGGGAACGACACAGAAGTTCGAGATCGA 69 FBan0012813 FBgn0037782 CG12813 3 3R CG12813 CG12813 CDMC34850 1 2 6 DAC09-A14 8-CG12813-RA_3 CG12813 GCGTGTGCACAATTGCGTTACTCCACCCTGTCAGATTGTGAAGGGAACGACACAGAAGTTCGAGATCGA 69 FBan0012813 FBgn0037782 CG12813 3 3R CG12813 CG12813 CDMC34851 1 3 6 DAC09-E02 1-CG12849-RA_1 CG12849 TGCAGCATCTGAACAAGCTGGTCCAGTCGATCATCCCCGATGGCAGATACATGATGAACAGCACATGGA 69 FBan0012849 FBgn0035068 CG12849 2 2R CG12849 CG12849 CDMC34851 1 4 6 DAC09-E02 1-CG12849-RA_1 CG12849 TGCAGCATCTGAACAAGCTGGTCCAGTCGATCATCCCCGATGGCAGATACATGATGAACAGCACATGGA 69 FBan0012849 FBgn0035068 CG12849 2 2R CG12849 CG12849 CDMC34852 1 5 6 DAC09-E14 2-CG12858-RA_2 CG12858 GTGGCACTCCCACCCTGTTCGGTGTGGCCTCTGTCATCAATCATGTTTCCGAGATTTTTGCCTACTTCT 69 FBan0012858 FBgn0033958 CG12858 2 2R CG12858 CG12858 CDMC34852 1 6 6 DAC09-E14 2-CG12858-RA_2 CG12858 GTGGCACTCCCACCCTGTTCGGTGTGGCCTCTGTCATCAATCATGTTTCCGAGATTTTTGCCTACTTCT 69 FBan0012858 FBgn0033958 CG12858 2 2R CG12858 CG12858 CDMC34853 1 7 6 DAC09-I02 23-CG12898-RA_3 CG12898 TTGAGTATTTCCGCAAAGTTCCAAACACGAAACTGCTTTATACCTTTCGAGTGGTTAAACTGGCACCTG 69 FBan0012898 FBgn0033516 CG12898 2 2R CG12898 CG12898 CDMC34853 1 8 6 DAC09-I02 23-CG12898-RA_3 CG12898 TTGAGTATTTCCGCAAAGTTCCAAACACGAAACTGCTTTATACCTTTCGAGTGGTTAAACTGGCACCTG 69 FBan0012898 FBgn0033516 CG12898 2 2R CG12898 CG12898 CDMC34854 1 9 6 DAC09-I14 3-CG12910-RA_9 CG12910 ACGGTGGGCCTACTGTTCCACTACCGCGACAAGTGCATCAATTGCAAGATGGTGCTGATCGTTGACTAT 69 FBan0012910 FBgn0033502 CG12910 2 2R CG12910 CG12910 CDMC34854 1 10 6 DAC09-I14 3-CG12910-RA_9 CG12910 ACGGTGGGCCTACTGTTCCACTACCGCGACAAGTGCATCAATTGCAAGATGGTGCTGATCGTTGACTAT 69 FBan0012910 FBgn0033502 CG12910 2 2R CG12910 CG12910 CDMC34855 1 11 6 DAC09-M02 23-CG12952-RA_1 CG12952 CGCAATTTGCCAAAGTCATTCCATGAACCTATAAAAGTTAAGGTCCATACTTTACGATTTTGAGAAGAA 69 FBan0012952 FBgn0037672 sage 3 3R regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 sage salivary gland-expressed bHLH "CG12952, CG12952, CG12952, CG12952, Sage, salivary gland-expressed bHLH" CDMC34855 1 12 6 DAC09-M02 23-CG12952-RA_1 CG12952 CGCAATTTGCCAAAGTCATTCCATGAACCTATAAAAGTTAAGGTCCATACTTTACGATTTTGAGAAGAA 69 FBan0012952 FBgn0037672 sage 3 3R regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 sage salivary gland-expressed bHLH "CG12952, CG12952, CG12952, CG12952, Sage, salivary gland-expressed bHLH" CDMC34856 1 13 6 DAC09-M14 15-CG12974-RA_2 CG12974 TGGTCATCTCCTTCAAGGGATTCGTTCTGTGGTTCATTAACTTTGGACTGCTCGCATACCTTGTCGCGA 69 FBan0012974 FBgn0037065 CG12974 3 3L CG12974 CG12974 CDMC34856 1 14 6 DAC09-M14 15-CG12974-RA_2 CG12974 TGGTCATCTCCTTCAAGGGATTCGTTCTGTGGTTCATTAACTTTGGACTGCTCGCATACCTTGTCGCGA 69 FBan0012974 FBgn0037065 CG12974 3 3L CG12974 CG12974 CDMC34857 1 15 6 DAC10-A01 17-CG10924-RA_2 CG10924 TCCTGGTCGACAGCACAAATCCGGGTCTGATCTATATTTAGACGAACTCAGAGGCTCGTCCACTGATAA 69 FBan0010924 FBgn0034356 CG10924 2 2R gluconeogenesis; GO:0006094; transport; GO:0006810 GTP binding; GO:0005525; phosphoenolpyruvate carboxykinase (GTP) activity; GO:0004613 ; EC:4.1.1.32; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0005525 mitochondrion; GO:0005739 CG10924 CG10924 CDMC34857 1 16 6 DAC10-A01 17-CG10924-RA_2 CG10924 TCCTGGTCGACAGCACAAATCCGGGTCTGATCTATATTTAGACGAACTCAGAGGCTCGTCCACTGATAA 69 FBan0010924 FBgn0034356 CG10924 2 2R gluconeogenesis; GO:0006094; transport; GO:0006810 GTP binding; GO:0005525; phosphoenolpyruvate carboxykinase (GTP) activity; GO:0004613 ; EC:4.1.1.32; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004613 ; EC:4.1.1.32; ; GO:0004613 ; EC:4.1.1.32; ; GO:0005525 mitochondrion; GO:0005739 CG10924 CG10924 CDMC34858 1 17 6 DAC10-A13 17-CG1093-RA_1 CG1093 GGGCAGCTTTCAAACCCAACGCTACTCATAACCTCTTCTGTTGCGGCTTAGATACGATTAACCCAACCT 69 FBan0001093 FBgn0004879 plx 3 3R cell adhesion; GO:0007155 small GTPase regulator activity; GO:0005083; ; GO:0005083 plx pollux "CG1093, pollux" CDMC34858 1 18 6 DAC10-A13 17-CG1093-RA_1 CG1093 GGGCAGCTTTCAAACCCAACGCTACTCATAACCTCTTCTGTTGCGGCTTAGATACGATTAACCCAACCT 69 FBan0001093 FBgn0004879 plx 3 3R cell adhesion; GO:0007155 small GTPase regulator activity; GO:0005083; ; GO:0005083 plx pollux "CG1093, pollux" CDMC34859 1 19 6 DAC10-E01 8-CG10973-RA_1 CG10973 ACGCTGGTGAAGCTAGGAGGAACTGCAACTCTACTCCGCTACATAACACATTCGGATAGCGAAGTGCGA 69 FBan0010973 FBgn0036306 CG10973 3 3L CG10973 CG10973 CDMC34859 1 20 6 DAC10-E01 8-CG10973-RA_1 CG10973 ACGCTGGTGAAGCTAGGAGGAACTGCAACTCTACTCCGCTACATAACACATTCGGATAGCGAAGTGCGA 69 FBan0010973 FBgn0036306 CG10973 3 3L CG10973 CG10973 CDMC34860 1 21 6 DAC10-E13 2-CG10988-RA_1 CG10988 CGTGAACAGTCGCTTCGTGATATGTACGCCGTCCACTCAGGAATAGCGACCAATGTCCATGCAATCGGT 69 FBan0010988 FBgn0001612 l(1)dd4 X X amino acid metabolism; GO:0006520; anaphase; GO:0051322; cell cycle; GO:0007049; meiosis; GO:0007126; meiosis I; GO:0007127; microtubule nucleation; GO:0007020; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin small complex; GO:0008275; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 l(1)dd4 lethal (1) discs degenerate 4 "CG10988, CG10988, l(1)d.deg.4, l(1)d deg-4, l(1)d.deg.-4, Dgrip91, GCP3, l(1)G0122, GRIP91, dd4, Dgrips91, dGRIP91, anon-WO03040301.197, Grip91, gamma-tubulin ring protein 91" CDMC34860 1 22 6 DAC10-E13 2-CG10988-RA_1 CG10988 CGTGAACAGTCGCTTCGTGATATGTACGCCGTCCACTCAGGAATAGCGACCAATGTCCATGCAATCGGT 69 FBan0010988 FBgn0001612 l(1)dd4 X X amino acid metabolism; GO:0006520; anaphase; GO:0051322; cell cycle; GO:0007049; meiosis; GO:0007126; meiosis I; GO:0007127; microtubule nucleation; GO:0007020; microtubule-based process; GO:0007017 microtubule binding; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; gamma-tubulin binding; GO:0043015; ; GO:0043015 gamma-tubulin small complex; GO:0008275; microtubule associated complex; GO:0005875; spindle pole; GO:0000922 l(1)dd4 lethal (1) discs degenerate 4 "CG10988, CG10988, l(1)d.deg.4, l(1)d deg-4, l(1)d.deg.-4, Dgrip91, GCP3, l(1)G0122, GRIP91, dd4, Dgrips91, dGRIP91, anon-WO03040301.197, Grip91, gamma-tubulin ring protein 91" CDMC34861 1 23 6 DAC10-I01 2-CG11034-RA_4 CG11034 GCCGATGGAAGTATTGGTTACGCCAAGCTAGCCCTTCCTCCCAATTTCGTGGAGACGAAGAAGTACCCA 69 FBan0011034 FBgn0031741 CG11034 2 2L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG11034 CG11034 CDMC34861 1 24 6 DAC10-I01 2-CG11034-RA_4 CG11034 GCCGATGGAAGTATTGGTTACGCCAAGCTAGCCCTTCCTCCCAATTTCGTGGAGACGAAGAAGTACCCA 69 FBan0011034 FBgn0031741 CG11034 2 2L cell surface receptor linked signal transduction; GO:0007166; proteolysis; GO:0006508 dipeptidyl-peptidase IV activity; GO:0004274 ; EC:3.4.14.5; ; GO:0004274 ; EC:3.4.14.5 membrane; GO:0016020 CG11034 CG11034 CDMC34862 1 25 6 DAC10-I13 13-CG11048-RA_3 CG11048 CCCGTTGAACACTGGTCAAAAAGAGGTTCAACATTACACCGATCAGGATCTGCAAATAGGCGCAGTGCT 69 FBan0011048 FBgn0034487 CG11048 2 2R CG11048 CG11048 CDMC34862 1 26 6 DAC10-I13 13-CG11048-RA_3 CG11048 CCCGTTGAACACTGGTCAAAAAGAGGTTCAACATTACACCGATCAGGATCTGCAAATAGGCGCAGTGCT 69 FBan0011048 FBgn0034487 CG11048 2 2R CG11048 CG11048 CDMC34863 1 1 7 DAC10-M01 14-CG11077-RA_1 CG11077 TCATCGCCCTCGTATGGAACTGCTACCTCTCCATGATACTTAATAGCTAGGGCACTAAGTTCCCCGCAT 69 FBan0011077 FBgn0039930 CG11077 4 4 development; GO:0007275 integral to membrane; GO:0016021 CG11077 CG11077 CDMC34863 1 2 7 DAC10-M01 14-CG11077-RA_1 CG11077 TCATCGCCCTCGTATGGAACTGCTACCTCTCCATGATACTTAATAGCTAGGGCACTAAGTTCCCCGCAT 69 FBan0011077 FBgn0039930 CG11077 4 4 development; GO:0007275 integral to membrane; GO:0016021 CG11077 CG11077 CDMC34864 1 3 7 DAC10-M13 17-CG11093-RA_2 CG11093 ACAGCGACTCTAGCCTAGACTTCGATTCCTGGGTTAAACCAGACTCAAACAATCCAATACCGAATGCGA 69 FBan0011093 FBgn0039932 CG11093 4 4 cellular physiological process; GO:0050875 nucleus; GO:0005634 CG11093 CG11093 CDMC34864 1 4 7 DAC10-M13 17-CG11093-RA_2 CG11093 ACAGCGACTCTAGCCTAGACTTCGATTCCTGGGTTAAACCAGACTCAAACAATCCAATACCGAATGCGA 69 FBan0011093 FBgn0039932 CG11093 4 4 cellular physiological process; GO:0050875 nucleus; GO:0005634 CG11093 CG11093 CDMC34865 1 5 7 DAC11-A01 9-CG12154-RA_1 CG12154 CCCCGACACTCCGCTGCATTCTCAGAACAAATTCGAAGACACACCGACCGTAGATACACTTCCTTTGCG 69 FBan0012154 FBgn0004102 oc X X "adult walking behavior; GO:0007628; anterior head segmentation; GO:0035288; anterior region determination; GO:0007355; brain development; GO:0007420; brain segmentation; GO:0035284; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; eye photoreceptor development (sensu Endopterygota); GO:0042051; nervous system development; GO:0007399; ocellus morphogenesis; GO:0008056; pattern specification; GO:0007389; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355; rhabdomere development; GO:0042052" transcription factor activity; GO:0003700; ; GO:0003700; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 oc ocelliless "CG12154, otd: orthodenticle, orthodenticle, ort, uvi, uvi-insensitive, Otd, Orthodenticle, Otx, l(1)7Ff, l(1)8Ac, otd" CDMC34865 1 6 7 DAC11-A01 9-CG12154-RA_1 CG12154 CCCCGACACTCCGCTGCATTCTCAGAACAAATTCGAAGACACACCGACCGTAGATACACTTCCTTTGCG 69 FBan0012154 FBgn0004102 oc X X "adult walking behavior; GO:0007628; anterior head segmentation; GO:0035288; anterior region determination; GO:0007355; brain development; GO:0007420; brain segmentation; GO:0035284; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; eye photoreceptor development (sensu Endopterygota); GO:0042051; nervous system development; GO:0007399; ocellus morphogenesis; GO:0008056; pattern specification; GO:0007389; proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355; rhabdomere development; GO:0042052" transcription factor activity; GO:0003700; ; GO:0003700; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- nucleus; GO:0005634 oc ocelliless "CG12154, otd: orthodenticle, orthodenticle, ort, uvi, uvi-insensitive, Otd, Orthodenticle, Otx, l(1)7Ff, l(1)8Ac, otd" CDMC34866 1 7 7 DAC11-A13 18-CG12175-RB_1 CG12175 CGCCCATCTGCGCAACTATCGGAAGTATCTGTAACCGCTCTATCAGCAACTAACTGGACGTGTAATCAA 69 FBan0012175 FBgn0030502 tth X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 tth toothrin "CG12175, toothreen, anon-EST:fe2G7, anon-fast-evolving-2G7, toothrin" CDMC34866 1 8 7 DAC11-A13 18-CG12175-RB_1 CG12175 CGCCCATCTGCGCAACTATCGGAAGTATCTGTAACCGCTCTATCAGCAACTAACTGGACGTGTAATCAA 69 FBan0012175 FBgn0030502 tth X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 tth toothrin "CG12175, toothreen, anon-EST:fe2G7, anon-fast-evolving-2G7, toothrin" CDMC34867 1 9 7 DAC11-E01 23-CG12214-RB_2 CG12214 GTGATCTTGTACACGAATCATTTACATTTACTTTACTCTACTGTTAGTGCCGTTCTGTTCTCCGCAGCG 69 FBan0012214 FBgn0033495 CG12214 2 2R CG12214 CG12214 CDMC34867 1 10 7 DAC11-E01 23-CG12214-RB_2 CG12214 GTGATCTTGTACACGAATCATTTACATTTACTTTACTCTACTGTTAGTGCCGTTCTGTTCTCCGCAGCG 69 FBan0012214 FBgn0033495 CG12214 2 2R CG12214 CG12214 CDMC34868 1 11 7 DAC11-E13 23-CG12223-RD_13 CG12223 TTGTCGCGATGGAGGAAAGAAACATGATAACGTTGGTTGATCTATTATCAGGTTGGCCAATGTGTGTTG 69 FBan0012223 FBgn0011764 Dsp1 X X DNA unwinding during replication; GO:0006268; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003697; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 chromatin; GO:0000785; nucleus; GO:0005634 Dsp1 Dorsal switch protein 1 "CG12223, CG12223, CG12223, CG12223, DSP1, ssrp2, dsp1, Hmg14D, Ssrp2, Structure specific recognition protein 2, Dorsal switch protein 1" CDMC34868 1 12 7 DAC11-E13 23-CG12223-RD_13 CG12223 TTGTCGCGATGGAGGAAAGAAACATGATAACGTTGGTTGATCTATTATCAGGTTGGCCAATGTGTGTTG 69 FBan0012223 FBgn0011764 Dsp1 X X DNA unwinding during replication; GO:0006268; chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; chromatin binding; GO:0003682; ; GO:0003697; ; GO:0003682; transcription corepressor activity; GO:0003714; ; GO:0003714 chromatin; GO:0000785; nucleus; GO:0005634 Dsp1 Dorsal switch protein 1 "CG12223, CG12223, CG12223, CG12223, DSP1, ssrp2, dsp1, Hmg14D, Ssrp2, Structure specific recognition protein 2, Dorsal switch protein 1" CDMC34869 1 13 7 DAC11-I01 18-CG12261-RA_8 CG12261 TGGAAAACACCGTGCTGCCCTCACTAATTTCTACACCCGTCTCGTGTATTTTTGTGCCTGATTTACTGA 69 FBan0012261 FBgn0039555 mRpS22 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS22 mitochondrial ribosomal protein S22 "CG12261, CG12261, CG12261, AAF56757, MRP-S22, Mitochondrial ribosomal protein S22, MrpS22, mitochondrial ribosomal protein S22" CDMC34869 1 14 7 DAC11-I01 18-CG12261-RA_8 CG12261 TGGAAAACACCGTGCTGCCCTCACTAATTTCTACACCCGTCTCGTGTATTTTTGTGCCTGATTTACTGA 69 FBan0012261 FBgn0039555 mRpS22 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS22 mitochondrial ribosomal protein S22 "CG12261, CG12261, CG12261, AAF56757, MRP-S22, Mitochondrial ribosomal protein S22, MrpS22, mitochondrial ribosomal protein S22" CDMC34870 1 15 7 DAC11-I13 23-CG12275-RA_1 CG12275 GGTTTCGGTCGTGCTTCTCGCTACGACAATTAAAATAATGGAAAAATATAGTTGTTGCATAAAAACGAT 69 FBan0012275 FBgn0027494 RpS10a 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS10a Ribosomal protein S10a "CG12275, S10, RpS10, BcDNA:LD32148, Ribosomal protein S10a" CDMC34870 1 16 7 DAC11-I13 23-CG12275-RA_1 CG12275 GGTTTCGGTCGTGCTTCTCGCTACGACAATTAAAATAATGGAAAAATATAGTTGTTGCATAAAAACGAT 69 FBan0012275 FBgn0027494 RpS10a 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS10a Ribosomal protein S10a "CG12275, S10, RpS10, BcDNA:LD32148, Ribosomal protein S10a" CDMC34871 1 17 7 DAC11-M01 2-CG12316-RA_2 CG12316 ACAGGAAGCGGATCAACAGCTGTCTATAGAGCAGCCTCAGGAGCACGAAGAGAATCAGTCACTCAGCCA 69 FBan0012316 FBgn0036483 CG12316 3 3L CG12316 CG12316 CDMC34871 1 18 7 DAC11-M01 2-CG12316-RA_2 CG12316 ACAGGAAGCGGATCAACAGCTGTCTATAGAGCAGCCTCAGGAGCACGAAGAGAATCAGTCACTCAGCCA 69 FBan0012316 FBgn0036483 CG12316 3 3L CG12316 CG12316 CDMC34872 1 19 7 DAC11-M13 18-CG12330-RA_1 CG12330 GGTCAACACCGATGGTTCTTATATGTACGAGTACGAGACTGGAAACGGAATTAAGGCGGAGGAGATGGG 69 FBan0012330 FBgn0035686 CG12330 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG12330 CG12330 CDMC34872 1 20 7 DAC11-M13 18-CG12330-RA_1 CG12330 GGTCAACACCGATGGTTCTTATATGTACGAGTACGAGACTGGAAACGGAATTAAGGCGGAGGAGATGGG 69 FBan0012330 FBgn0035686 CG12330 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG12330 CG12330 CDMC34873 1 21 7 DAC12-A01 23-CG7834-RA_2 CG7834 TGAGCGCATATTCTACGTTTTTAATTAGTCGAAAGTTATCAGAAACGTGCATTTATCTAGCCGGAGAGT 69 FBan0007834 FBgn0039697 CG7834 3 3R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 electron carrier activity; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; ; GO:0009055 electron transfer flavoprotein complex (sensu Eukaryota); GO:0017133 CG7834 CG7834 CDMC34873 1 22 7 DAC12-A01 23-CG7834-RA_2 CG7834 TGAGCGCATATTCTACGTTTTTAATTAGTCGAAAGTTATCAGAAACGTGCATTTATCTAGCCGGAGAGT 69 FBan0007834 FBgn0039697 CG7834 3 3R electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 electron carrier activity; GO:0009055; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0009055; ; GO:0016491 ; EC:1.-.-.-; ; GO:0009055 electron transfer flavoprotein complex (sensu Eukaryota); GO:0017133 CG7834 CG7834 CDMC34874 1 23 7 DAC12-A13 2-CG7848-RA_2 CG7848 GGAGGAAGGATATACCCGAAGAGCTTCTGGAATTTGCCAACCAAAGGGATCCGATCCTCGACCTGGTCG 69 FBan0007848 FBgn0034127 CG7848 2 2R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40 CG7848 CG7848 CDMC34874 1 24 7 DAC12-A13 2-CG7848-RA_2 CG7848 GGAGGAAGGATATACCCGAAGAGCTTCTGGAATTTGCCAACCAAAGGGATCCGATCCTCGACCTGGTCG 69 FBan0007848 FBgn0034127 CG7848 2 2R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40 CG7848 CG7848 CDMC34875 1 25 7 DAC12-E01 6-CG7881-RA_6 CG7881 TGGCAATAGTGAATGGCATTGGCAACATCTTTCCGCTCCTAACGCCGCTCTTAGTGGGAGTCATTGTCA 69 FBan0007881 FBgn0033048 CG7881 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG7881 CG7881 CDMC34875 1 26 7 DAC12-E01 6-CG7881-RA_6 CG7881 TGGCAATAGTGAATGGCATTGGCAACATCTTTCCGCTCCTAACGCCGCTCTTAGTGGGAGTCATTGTCA 69 FBan0007881 FBgn0033048 CG7881 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG7881 CG7881 CDMC34876 1 1 8 DAC12-E13 3-CG7891-RA_2 CG7891 CGGCCAATTCGCTGAGGACATGATACCCACAGTTGGATTCAACATGCGCAAGATCACCAGAGGCAATGT 69 FBan0007891 FBgn0037551 CG7891 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525 CG7891 CG7891 BcDNA:LD29185 CDMC34876 1 2 8 DAC12-E13 3-CG7891-RA_2 CG7891 CGGCCAATTCGCTGAGGACATGATACCCACAGTTGGATTCAACATGCGCAAGATCACCAGAGGCAATGT 69 FBan0007891 FBgn0037551 CG7891 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525 CG7891 CG7891 BcDNA:LD29185 CDMC34877 1 3 8 DAC12-I01 10-CG7922-RA_2 CG7922 GGGCGATATTGAAGAGGAGTATCATTCCGGGATGGAAGCTAGTGAATTGGGGGACAACTTAGGTCGCCT 69 FBan0007922 FBgn0038889 CG7922 3 3R DNA restriction-modification system; GO:0009307 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 CG7922 CG7922 cg7922 CDMC34877 1 4 8 DAC12-I01 10-CG7922-RA_2 CG7922 GGGCGATATTGAAGAGGAGTATCATTCCGGGATGGAAGCTAGTGAATTGGGGGACAACTTAGGTCGCCT 69 FBan0007922 FBgn0038889 CG7922 3 3R DNA restriction-modification system; GO:0009307 nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; type III site-specific deoxyribonuclease activity; GO:0015668 ; EC:3.1.21.5; ; GO:0015668 ; EC:3.1.21.5 CG7922 CG7922 cg7922 CDMC34878 1 5 8 DAC12-I13 16-CG7931-RA_1 CG7931 GCGTTCCCCGGGTCAAGATAACCAAGGGTCAGAATCGTTATTTGTTGGTGAATATTCATACGCATGGCT 69 FBan0007931 FBgn0001281 janB 3 3R sex differentiation; GO:0007548 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 janB janus B "CG7931, CG31024, Jan, jan B, jan, bs30f02.y1, janus" CDMC34878 1 6 8 DAC12-I13 16-CG7931-RA_1 CG7931 GCGTTCCCCGGGTCAAGATAACCAAGGGTCAGAATCGTTATTTGTTGGTGAATATTCATACGCATGGCT 69 FBan0007931 FBgn0001281 janB 3 3R sex differentiation; GO:0007548 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 janB janus B "CG7931, CG31024, Jan, jan B, jan, bs30f02.y1, janus" CDMC34879 1 7 8 DAC12-M01 3-CG7966-RA_1 CG7966 CGGATGGCATAACGCCCCTGGAGATTCGATTTCTGCACAATCCTAAGAAGGCAGAGGGATTCGTGGGAT 69 FBan0007966 FBgn0038115 CG7966 3 3R defense response; GO:0006952 selenium binding; GO:0008430; ; GO:0008430 CG7966 CG7966 CDMC34879 1 8 8 DAC12-M01 3-CG7966-RA_1 CG7966 CGGATGGCATAACGCCCCTGGAGATTCGATTTCTGCACAATCCTAAGAAGGCAGAGGGATTCGTGGGAT 69 FBan0007966 FBgn0038115 CG7966 3 3R defense response; GO:0006952 selenium binding; GO:0008430; ; GO:0008430 CG7966 CG7966 CDMC34880 1 9 8 DAC12-M13 2-CG7975-RA_1 CG7975 ACCGACGTGAAGCGGCTATACGAACAGGGCATACTGCAGAAGTATTTTCAGTGAAAAGTGGGCCGACCT 69 FBan0007975 FBgn0034658 Grx-1 2 2R electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Grx-1 Grx-1 CG7975 CDMC34880 1 10 8 DAC12-M13 2-CG7975-RA_1 CG7975 ACCGACGTGAAGCGGCTATACGAACAGGGCATACTGCAGAAGTATTTTCAGTGAAAAGTGGGCCGACCT 69 FBan0007975 FBgn0034658 Grx-1 2 2R electron transport; GO:0006118; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 Grx-1 Grx-1 CG7975 CDMC34881 1 11 8 DAC13-A01 3-CG13223-RA_11 CG13223 AGGAGATGCCACTGAAGCGGCAAGAAATCGATCGACCCTCCATTGGACACGGAAGTCGAAATAAGCGAA 69 FBan0013223 FBgn0033599 CG13223 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 integral to membrane; GO:0016021 CG13223 CG13223 CDMC34881 1 12 8 DAC13-A01 3-CG13223-RA_11 CG13223 AGGAGATGCCACTGAAGCGGCAAGAAATCGATCGACCCTCCATTGGACACGGAAGTCGAAATAAGCGAA 69 FBan0013223 FBgn0033599 CG13223 2 2R cation transport; GO:0006812; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 integral to membrane; GO:0016021 CG13223 CG13223 CDMC34882 1 13 8 DAC13-A13 8-CG13250-RA_3 CG13250 TGCTCGGTCATTGACCCCACTACGGCGGAAATCTTTAAGTGCGACATTGTGGAAATGCCAAAGAAGCAG 69 FBan0013250 FBgn0037013 CG13250 3 3L CG13250 CG13250 CDMC34882 1 14 8 DAC13-A13 8-CG13250-RA_3 CG13250 TGCTCGGTCATTGACCCCACTACGGCGGAAATCTTTAAGTGCGACATTGTGGAAATGCCAAAGAAGCAG 69 FBan0013250 FBgn0037013 CG13250 3 3L CG13250 CG13250 CDMC34883 1 15 8 DAC13-E01 9-CG13288-RA_1 CG13288 CCCGCCGCGTCAAGTTCGATCCGATTGTCGGTTTCATCTTTACCATGGATTTCTTCCTACTGTGCCTCA 69 FBan0013288 FBgn0035648 CG13288 3 3L CG13288 CG13288 CDMC34883 1 16 8 DAC13-E01 9-CG13288-RA_1 CG13288 CCCGCCGCGTCAAGTTCGATCCGATTGTCGGTTTCATCTTTACCATGGATTTCTTCCTACTGTGCCTCA 69 FBan0013288 FBgn0035648 CG13288 3 3L CG13288 CG13288 CDMC34884 1 17 8 DAC13-E13 12-CG13305-RA_3 CG13305 AATGCTGCCACAAATTTGACGAGAGTGCAACGCGATGGATCTGCCAATTGGAAAGTTAAACGGACTGCT 69 FBan0013305 FBgn0035921 CG13305 3 3L CG13305 CG13305 "CT32600, BcDNA:RE33542" CDMC34884 1 18 8 DAC13-E13 12-CG13305-RA_3 CG13305 AATGCTGCCACAAATTTGACGAGAGTGCAACGCGATGGATCTGCCAATTGGAAAGTTAAACGGACTGCT 69 FBan0013305 FBgn0035921 CG13305 3 3L CG13305 CG13305 "CT32600, BcDNA:RE33542" CDMC34885 1 19 8 DAC13-I01 23-CG13324-RA_2 CG13324 GGGGTCGTTAAGTGATCTTTGGGAGCATGTTGTAAACGAATTGAAGTCGAATATGAAATGGCAAACATG 69 FBan0013324 FBgn0033789 CG13324 2 2R CG13324 CG13324 CDMC34885 1 20 8 DAC13-I01 23-CG13324-RA_2 CG13324 GGGGTCGTTAAGTGATCTTTGGGAGCATGTTGTAAACGAATTGAAGTCGAATATGAAATGGCAAACATG 69 FBan0013324 FBgn0033789 CG13324 2 2R CG13324 CG13324 CDMC34886 1 21 8 DAC13-I13 2-CG13335-RB_1 CG13335 GGCTTCCCAATCGTTCGGCACACAGTCAAGATGCAGAGCTTTCTGGGAGTAGCAATCATTCTGGCTCTT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC34886 1 22 8 DAC13-I13 2-CG13335-RB_1 CG13335 GGCTTCCCAATCGTTCGGCACACAGTCAAGATGCAGAGCTTTCTGGGAGTAGCAATCATTCTGGCTCTT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC34887 1 23 8 DAC13-M01 3-CG13384-RD_1 CG13384 CCTGTGAACATCGTGGAGCCCTTTGTGCGAAGTCATTTCGATACAACGAGGGCCAAGGATTTGTCAGCA 69 FBan0013384 FBgn0032036 CG13384 2 2L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG13384 CG13384 CDMC34887 1 24 8 DAC13-M01 3-CG13384-RD_1 CG13384 CCTGTGAACATCGTGGAGCCCTTTGTGCGAAGTCATTTCGATACAACGAGGGCCAAGGATTTGTCAGCA 69 FBan0013384 FBgn0032036 CG13384 2 2L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG13384 CG13384 CDMC34888 1 25 8 DAC13-M13 14-CG13393-RA_1 CG13393 GCTGTCGAGCGTCATTTCCAAGTTCTACAACGACTACGTGCAGAATACGCCCAAGAAACTGAAGCTGGT 69 FBan0013393 FBgn0032035 CG13393 2 2L anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066; protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- oligosaccharyl transferase complex; GO:0008250; plasma membrane; GO:0005886 CG13393 CG13393 BcDNA:RE23864 CDMC34888 1 26 8 DAC13-M13 14-CG13393-RA_1 CG13393 GCTGTCGAGCGTCATTTCCAAGTTCTACAACGACTACGTGCAGAATACGCCCAAGAAACTGAAGCTGGT 69 FBan0013393 FBgn0032035 CG13393 2 2L anti-apoptosis; GO:0006916; negative regulation of apoptosis; GO:0043066; protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- oligosaccharyl transferase complex; GO:0008250; plasma membrane; GO:0005886 CG13393 CG13393 BcDNA:RE23864 CDMC34889 1 1 9 DAC14-A01 2-CG8585-RA_1 CG8585 GGTTGCCACCTCACTTTCGGATGGGTCTTATTTCGGTGAGATCTGTCTGCTGACCAATGCGCGTC 65 FBan0008585 FBgn0028428 Ih 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; receptor activity; GO:0004872; voltage-gated potassium channel activity; GO:0005249; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0004872; ; GO:0005249; ; GO:0005244; ; GO:0005221 plasma membrane; GO:0005886 Ih I[[h]] channel "CG8585, DMIH, putative Ih-channel, Drosophila melanogaster I[[h]]-channel, putative-voltage-and-cyclic-nucleotide-gated-ion-channel, I[[h]] channel" CDMC34889 1 2 9 DAC14-A01 2-CG8585-RA_1 CG8585 GGTTGCCACCTCACTTTCGGATGGGTCTTATTTCGGTGAGATCTGTCTGCTGACCAATGCGCGTC 65 FBan0008585 FBgn0028428 Ih 2 2R cation transport; GO:0006812; potassium ion transport; GO:0006813; sensory perception; GO:0007600 intracellular cyclic nucleotide activated cation channel activity; GO:0005221; ; GO:0005221; receptor activity; GO:0004872; voltage-gated potassium channel activity; GO:0005249; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0004872; ; GO:0005249; ; GO:0005244; ; GO:0005221 plasma membrane; GO:0005886 Ih I[[h]] channel "CG8585, DMIH, putative Ih-channel, Drosophila melanogaster I[[h]]-channel, putative-voltage-and-cyclic-nucleotide-gated-ion-channel, I[[h]] channel" CDMC34890 1 3 9 DAC14-A13 23-CG8615-RA_1 CG8615 GTTGATTAATACATTCAACAGAAGAAATGGGTATTGATATCAACCACAAGTACGATCGCAAGGTT 65 FBan0008615 FBgn0035753 RpL18 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL18 Ribosomal protein L18 "CG8615, CG8615, Ribosomal protein L18" CDMC34890 1 4 9 DAC14-A13 23-CG8615-RA_1 CG8615 GTTGATTAATACATTCAACAGAAGAAATGGGTATTGATATCAACCACAAGTACGATCGCAAGGTT 65 FBan0008615 FBgn0035753 RpL18 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL18 Ribosomal protein L18 "CG8615, CG8615, Ribosomal protein L18" CDMC34891 1 5 9 DAC14-E01 2-CG8749-RA_1 CG8749 CTACGGGCCCATCAAGAAGATCGTCCTGATCCACGACCAGGAATCAGGTAAACCCAAGGGCTACG 65 FBan0008749 FBgn0016978 snRNP70K 2 2L "negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; U1 snRNA binding; GO:0030619; ; GO:0030619 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U1; GO:0005685; snRNP U11; GO:0005692 snRNP70K small nuclear ribonucleoprotein 70K "CG8749, CG8749, U1 70K, U1snRNP-70K, 70K, U1-70K, snRNP, Dm70K, U1 70K snRNP, snRNP27D, U1 snRNP, dU1-70K, U1 snRNP-specific 70K protein, U170K, l(2)02107" CDMC34891 1 6 9 DAC14-E01 2-CG8749-RA_1 CG8749 CTACGGGCCCATCAAGAAGATCGTCCTGATCCACGACCAGGAATCAGGTAAACCCAAGGGCTACG 65 FBan0008749 FBgn0016978 snRNP70K 2 2L "negative regulation of nuclear mRNA splicing, via spliceosome; GO:0048025; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; U1 snRNA binding; GO:0030619; ; GO:0030619 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U1; GO:0005685; snRNP U11; GO:0005692 snRNP70K small nuclear ribonucleoprotein 70K "CG8749, CG8749, U1 70K, U1snRNP-70K, 70K, U1-70K, snRNP, Dm70K, U1 70K snRNP, snRNP27D, U1 snRNP, dU1-70K, U1 snRNP-specific 70K protein, U170K, l(2)02107" CDMC34892 1 7 9 DAC14-E13 13-CG8783-RA_1 CG8783 CTCCTGCAGCAACCATCTAAGGGATGCCATTAGCGATGAAGAAGGAGACCAAGAACCAGATGCGG 65 FBan0008783 FBgn0036397 CG8783 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8783 CG8783 CDMC34892 1 8 9 DAC14-E13 13-CG8783-RA_1 CG8783 CTCCTGCAGCAACCATCTAAGGGATGCCATTAGCGATGAAGAAGGAGACCAAGAACCAGATGCGG 65 FBan0008783 FBgn0036397 CG8783 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG8783 CG8783 CDMC34893 1 9 9 DAC14-I01 15-CG8888-RA_3 CG8888 GTCGCACGAGATTCCCTGGGACATATTCGAGCGACTATTCATGCCCTTCCTGTTCTGCCAGGCGG 65 FBan0008888 FBgn0033679 CG8888 2 2R metabolism; GO:0008152; visual perception; GO:0007601 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG8888 CG8888 CDMC34893 1 10 9 DAC14-I01 15-CG8888-RA_3 CG8888 GTCGCACGAGATTCCCTGGGACATATTCGAGCGACTATTCATGCCCTTCCTGTTCTGCCAGGCGG 65 FBan0008888 FBgn0033679 CG8888 2 2R metabolism; GO:0008152; visual perception; GO:0007601 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG8888 CG8888 CDMC34894 1 11 9 DAC14-I13 3-CG8925-RA_2 CG8925 AAGACCCTGGTGCAGGAATTTGATCTGGTTTGCGGACGCGATATCCTCAGCTTGGTGGAAACCTG 65 FBan0008925 FBgn0038404 CG8925 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015226 integral to membrane; GO:0016021; membrane; GO:0016020 CG8925 CG8925 CDMC34894 1 12 9 DAC14-I13 3-CG8925-RA_2 CG8925 AAGACCCTGGTGCAGGAATTTGATCTGGTTTGCGGACGCGATATCCTCAGCTTGGTGGAAACCTG 65 FBan0008925 FBgn0038404 CG8925 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; ; GO:0008324; ; GO:0015226 integral to membrane; GO:0016021; membrane; GO:0016020 CG8925 CG8925 CDMC34895 1 13 9 DAC14-M01 3-CG9016-RA_2 CG9016 GAAAGTCGCGCTTCAATCCAGACTGGCAGTATGGTGGACGCTAGCACCAAAGAGTTAGCGCTTCC 65 FBan0009016 FBgn0031751 CG9016 2 2L CG9016 CG9016 "bs03c03.y1, bs05g03.y1, bs07e11.y1, bs09c06.y1, bs10d11.y1, bs10f09.y1, bs13h06.y1, bs14b11.y1, bs16c10.y1, bs16d01.y1, bs18b05.y1, bs19d06.y1, bs21a02.y1, bs22a02.y1, bs25d03.y1, bs27b06.y1, bs28b03.y1, bs29e04.y1, bs29f11.y1, bs36f07.y1, bs20d08.y1, bs24f02.y1, NEST:bs36a03, NEST:bs09a09, BcDNA:AT19175, NEST:bs20d08, NEST:bs24f02" CDMC34895 1 14 9 DAC14-M01 3-CG9016-RA_2 CG9016 GAAAGTCGCGCTTCAATCCAGACTGGCAGTATGGTGGACGCTAGCACCAAAGAGTTAGCGCTTCC 65 FBan0009016 FBgn0031751 CG9016 2 2L CG9016 CG9016 "bs03c03.y1, bs05g03.y1, bs07e11.y1, bs09c06.y1, bs10d11.y1, bs10f09.y1, bs13h06.y1, bs14b11.y1, bs16c10.y1, bs16d01.y1, bs18b05.y1, bs19d06.y1, bs21a02.y1, bs22a02.y1, bs25d03.y1, bs27b06.y1, bs28b03.y1, bs29e04.y1, bs29f11.y1, bs36f07.y1, bs20d08.y1, bs24f02.y1, NEST:bs36a03, NEST:bs09a09, BcDNA:AT19175, NEST:bs20d08, NEST:bs24f02" CDMC34896 1 15 9 DAC14-M13 3-CG9053-RA_1 CG9053 GACCCCATTGGCCTGGTGATAGTCAGTGACTTTAAGAAACCGGAGAACGTCCATCGCCACGAGGT 65 FBan0009053 FBgn0030606 CG9053 X X intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; protein carrier activity; GO:0008320; ; GO:0008320 membrane; GO:0016020 CG9053 CG9053 CDMC34896 1 16 9 DAC14-M13 3-CG9053-RA_1 CG9053 GACCCCATTGGCCTGGTGATAGTCAGTGACTTTAAGAAACCGGAGAACGTCCATCGCCACGAGGT 65 FBan0009053 FBgn0030606 CG9053 X X intracellular protein transport; GO:0006886 receptor binding; GO:0005102; ; GO:0005102; protein carrier activity; GO:0008320; ; GO:0008320 membrane; GO:0016020 CG9053 CG9053 CDMC34897 1 17 9 DAC15-A01 16-CG8118-RC_1 CG8118 CGGCTCTGAGAATCTAACCAAATTCTCGGTGGAAATTGTTCAGCAACTGGAGTTTACCACATCGGCG 67 FBan0008118 FBgn0002643 mam 2 2R Notch signaling pathway; GO:0007219; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesodermal cell fate determination; GO:0007500; nervous system development; GO:0007399 nucleus; GO:0005634 mam mastermind "CG8118, CG8118, CG8118, CG8118, N-2G, SR2-4, mam(CAG)[[7]], Dm0064, dMam, Mam, l(2)03505, l(2)04615" CDMC34897 1 18 9 DAC15-A01 16-CG8118-RC_1 CG8118 CGGCTCTGAGAATCTAACCAAATTCTCGGTGGAAATTGTTCAGCAACTGGAGTTTACCACATCGGCG 67 FBan0008118 FBgn0002643 mam 2 2R Notch signaling pathway; GO:0007219; apposition of dorsal and ventral wing surfaces; GO:0007475; asymmetric cell division; GO:0008356; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; mesodermal cell fate determination; GO:0007500; nervous system development; GO:0007399 nucleus; GO:0005634 mam mastermind "CG8118, CG8118, CG8118, CG8118, N-2G, SR2-4, mam(CAG)[[7]], Dm0064, dMam, Mam, l(2)03505, l(2)04615" CDMC34898 1 19 9 DAC15-A13 3-CG8213-RA_1 CG8213 GCGCAGCATAACGGGCGTGAAATAGGTAGTCGCCTCCACAGTTTTCAAGTTTCTCCCCATCCCAGAG 67 FBan0008213 FBgn0033359 CG8213 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG8213 CG8213 "c-SP44, SP44" CDMC34898 1 20 9 DAC15-A13 3-CG8213-RA_1 CG8213 GCGCAGCATAACGGGCGTGAAATAGGTAGTCGCCTCCACAGTTTTCAAGTTTCTCCCCATCCCAGAG 67 FBan0008213 FBgn0033359 CG8213 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG8213 CG8213 "c-SP44, SP44" CDMC34899 1 21 9 DAC15-E01 2-CG8561-RA_1 CG8561 CGAGGCGCTGAGATATGTATAGTATCCCGGGATAGCGATGGAAATACGCGCAAGTGGTTCTCCGGGC 67 FBan0008561 FBgn0033920 CG8561 2 2R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG8561 CG8561 "CT24963, tartan/capricious-like" CDMC34899 1 22 9 DAC15-E01 2-CG8561-RA_1 CG8561 CGAGGCGCTGAGATATGTATAGTATCCCGGGATAGCGATGGAAATACGCGCAAGTGGTTCTCCGGGC 67 FBan0008561 FBgn0033920 CG8561 2 2R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG8561 CG8561 "CT24963, tartan/capricious-like" CDMC34900 1 23 9 DAC15-E13 16-CG8668-RA_1 CG8668 CGAAAGGCGGAGAGTTTATTAAGCTCCTGGTTCTTATTAGCTCAGCGATGTCTCACGATGCAGCCCG 67 FBan0008668 FBgn0031988 CG8668 2 2L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG8668 CG8668 CDMC34900 1 24 9 DAC15-E13 16-CG8668-RA_1 CG8668 CGAAAGGCGGAGAGTTTATTAAGCTCCTGGTTCTTATTAGCTCAGCGATGTCTCACGATGCAGCCCG 67 FBan0008668 FBgn0031988 CG8668 2 2L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG8668 CG8668 CDMC34901 1 25 9 DAC15-I01 2-CG9143-RA_1 CG9143 CCCAGGGCAATCGACATTTGGGCAAGATCGAGGATGTCAGTTTCCTGGTCATCGACGAAACGGATCG 67 FBan0009143 FBgn0034496 CG9143 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0003729 CG9143 CG9143 cg9143 CDMC34901 1 26 9 DAC15-I01 2-CG9143-RA_1 CG9143 CCCAGGGCAATCGACATTTGGGCAAGATCGAGGATGTCAGTTTCCTGGTCATCGACGAAACGGATCG 67 FBan0009143 FBgn0034496 CG9143 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0003729 CG9143 CG9143 cg9143 CDMC34902 1 1 10 DAC15-I13 2-CG9240-RA_3 CG9240 GGAGGAGCTCTTTTTTCGAGAGAATACCAGGTCGTTGGACACGGGAGATGCTCTGATTAGGGGCGCA 67 FBan0009240 FBgn0030669 CG9240 X X mitochondrial protein processing; GO:0006627; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- mitochondrial membrane; GO:0005740 CG9240 CG9240 anon-EST:Posey267 CDMC34902 1 2 10 DAC15-I13 2-CG9240-RA_3 CG9240 GGAGGAGCTCTTTTTTCGAGAGAATACCAGGTCGTTGGACACGGGAGATGCTCTGATTAGGGGCGCA 67 FBan0009240 FBgn0030669 CG9240 X X mitochondrial protein processing; GO:0006627; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; serine-type peptidase activity; GO:0008236; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.- mitochondrial membrane; GO:0005740 CG9240 CG9240 anon-EST:Posey267 CDMC34903 1 3 10 DAC15-M01 3-CG9632-RA_1 CG9632 CTGGCACCGCAATTAAATTCGCCTACAGACGTCGTCTAGTGCCAGATGCCAAAGTTGCATTCTGCGG 67 FBan0009632 FBgn0038377 CG9632 3 3R CG9632 CG9632 "bs19g07.y1, BcDNA:AT06908, NEST:bs19g07" CDMC34903 1 4 10 DAC15-M01 3-CG9632-RA_1 CG9632 CTGGCACCGCAATTAAATTCGCCTACAGACGTCGTCTAGTGCCAGATGCCAAAGTTGCATTCTGCGG 67 FBan0009632 FBgn0038377 CG9632 3 3R CG9632 CG9632 "bs19g07.y1, BcDNA:AT06908, NEST:bs19g07" CDMC34904 1 5 10 DAC15-M13 18-CG9797-RA_2 CG9797 ACAACGTGCTGGATGATGAGTACGAGCATGAAAACATTGTCGTCAAGAAGTGTAGTCTGCCGCCAAA 67 FBan0009797 FBgn0037621 CG9797 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9797 CG9797 CDMC34904 1 6 10 DAC15-M13 18-CG9797-RA_2 CG9797 ACAACGTGCTGGATGATGAGTACGAGCATGAAAACATTGTCGTCAAGAAGTGTAGTCTGCCGCCAAA 67 FBan0009797 FBgn0037621 CG9797 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9797 CG9797 CDMC34905 1 7 10 DAC16-A01 23-CG4863-RD_2 CG4863 CTGGATGATGAAACGATGGTATCTGAATGAGCAAATTATTGTTGAGAAGCCTTTTACCATCTGCTGCCT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC34905 1 8 10 DAC16-A01 23-CG4863-RD_2 CG4863 CTGGATGATGAAACGATGGTATCTGAATGAGCAAATTATTGTTGAGAAGCCTTTTACCATCTGCTGCCT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC34906 1 9 10 DAC16-A13 17-CG4880-RA_1 CG4880 CAATGGTGCACCTGGAAGACGAGCACGTAGAAGAGATAATCAAAAGTATCGATGCTAGCGCTTCTGGCT 69 FBan0004880 FBgn0030803 CG4880 X X CG4880 CG4880 CDMC34906 1 10 10 DAC16-A13 17-CG4880-RA_1 CG4880 CAATGGTGCACCTGGAAGACGAGCACGTAGAAGAGATAATCAAAAGTATCGATGCTAGCGCTTCTGGCT 69 FBan0004880 FBgn0030803 CG4880 X X CG4880 CG4880 CDMC34907 1 11 10 DAC16-E01 2-CG4907-RA_4 CG4907 CCCTGTCAGGATAGGGATTTAATGTGCCAGTTCCCAGTCCTTCACCTGGTTGGAATCGTTATGCCCGGT 69 FBan0004907 FBgn0039010 CG4907 3 3R CG4907 CG4907 CDMC34907 1 12 10 DAC16-E01 2-CG4907-RA_4 CG4907 CCCTGTCAGGATAGGGATTTAATGTGCCAGTTCCCAGTCCTTCACCTGGTTGGAATCGTTATGCCCGGT 69 FBan0004907 FBgn0039010 CG4907 3 3R CG4907 CG4907 CDMC34908 1 13 10 DAC16-E13 17-CG4922-RA_1 CG4922 CCAGTTGAGTCCGGTCATTTTCACGAAAATCCTCATGAATATCCGGAACATCATGGCGATCATCACCGT 69 FBan0004922 FBgn0003313 sala 2 2L sala spalt-adjacent "CG4922, CG4922, spalt, sal adjacent, sal: spalt, BcDNA:RE40068, nsal: not-spalt, not-spalt, spalt accessory, sal" CDMC34908 1 14 10 DAC16-E13 17-CG4922-RA_1 CG4922 CCAGTTGAGTCCGGTCATTTTCACGAAAATCCTCATGAATATCCGGAACATCATGGCGATCATCACCGT 69 FBan0004922 FBgn0003313 sala 2 2L sala spalt-adjacent "CG4922, CG4922, spalt, sal adjacent, sal: spalt, BcDNA:RE40068, nsal: not-spalt, not-spalt, spalt accessory, sal" CDMC34909 1 15 10 DAC16-I01 2-CG4950-RA_1 CG4950 GACACCAATCTGGATGAGACCCCACACATTCGTGACGTATCCTGCATCAGTCAATCCCAGGAGGTCGTT 69 FBan0004950 FBgn0036587 CG4950 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG4950 CG4950 CT15890 CDMC34909 1 16 10 DAC16-I01 2-CG4950-RA_1 CG4950 GACACCAATCTGGATGAGACCCCACACATTCGTGACGTATCCTGCATCAGTCAATCCCAGGAGGTCGTT 69 FBan0004950 FBgn0036587 CG4950 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG4950 CG4950 CT15890 CDMC34910 1 17 10 DAC16-I13 23-CG4957-RA_13 CG4957 ACTGCGAAACTTCAAAATGAATCCAGTTTGGAGGATAAAGCCACCAATGATGCTATAGAGTTGGGCGCC 69 FBan0004957 FBgn0032205 CG4957 2 2L CG4957 CG4957 CDMC34910 1 18 10 DAC16-I13 23-CG4957-RA_13 CG4957 ACTGCGAAACTTCAAAATGAATCCAGTTTGGAGGATAAAGCCACCAATGATGCTATAGAGTTGGGCGCC 69 FBan0004957 FBgn0032205 CG4957 2 2L CG4957 CG4957 CDMC34911 1 19 10 DAC16-M01 23-CG4993-RB_10 CG4993 GAAAAGCGCATACACAAATATGAATTGATAGGCAGCAATCCGTAAAATTGAACTAACCACAGAGAGCCC 69 FBan0004993 FBgn0024734 PRL-1 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; prenylated protein tyrosine phosphatase activity; GO:0004727; ; GO:0004727; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004727 PRL-1 PRL-1 "CG4993, CG4993, BG:DS07473.3, PRL, BcDNA:RE40268" CDMC34911 1 20 10 DAC16-M01 23-CG4993-RB_10 CG4993 GAAAAGCGCATACACAAATATGAATTGATAGGCAGCAATCCGTAAAATTGAACTAACCACAGAGAGCCC 69 FBan0004993 FBgn0024734 PRL-1 2 2L protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; prenylated protein tyrosine phosphatase activity; GO:0004727; ; GO:0004727; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004727 PRL-1 PRL-1 "CG4993, CG4993, BG:DS07473.3, PRL, BcDNA:RE40268" CDMC34912 1 21 10 DAC16-M13 8-CG5002-RA_2 CG5002 ACCTTTTTGGCCTACATCCTCAGTCGAGATGGGAATCAACCCTTCCGTGTCACTGGAAACATTACGGCC 69 FBan0005002 FBgn0034275 CG5002 2 2R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 membrane; GO:0016020 CG5002 CG5002 CDMC34912 1 22 10 DAC16-M13 8-CG5002-RA_2 CG5002 ACCTTTTTGGCCTACATCCTCAGTCGAGATGGGAATCAACCCTTCCGTGTCACTGGAAACATTACGGCC 69 FBan0005002 FBgn0034275 CG5002 2 2R anion transport; GO:0006820; extracellular transport; GO:0006858; sulfur metabolism; GO:0006790 transporter activity; GO:0005215; high affinity sulfate permease activity; GO:0015381; ; GO:0005215; ; GO:0015381 membrane; GO:0016020 CG5002 CG5002 CDMC34913 1 23 10 DAC17-A01 3-CG7080-RA_3 CG7080 GCTGCCAGGACTATCATTACCACCGTCCACAGACTCCTTTCGTTGCGGAATCTTACCATCAGCACCAGC 69 FBan0007080 FBgn0038941 CG7080 3 3R CG7080 CG7080 CDMC34913 1 24 10 DAC17-A01 3-CG7080-RA_3 CG7080 GCTGCCAGGACTATCATTACCACCGTCCACAGACTCCTTTCGTTGCGGAATCTTACCATCAGCACCAGC 69 FBan0007080 FBgn0038941 CG7080 3 3R CG7080 CG7080 CDMC34914 1 25 10 DAC17-A13 2-CG7093-RA_1 CG7093 GAAGCCAGATGAGCCTGAAAGCAAGAGAATAAAGCTGCAGGTTGGGGAGAAAGCTGAGGACAAGCAGGT 69 FBan0007093 FBgn0031965 CG7093 2 2L CG7093 CG7093 CDMC34914 1 26 10 DAC17-A13 2-CG7093-RA_1 CG7093 GAAGCCAGATGAGCCTGAAAGCAAGAGAATAAAGCTGCAGGTTGGGGAGAAAGCTGAGGACAAGCAGGT 69 FBan0007093 FBgn0031965 CG7093 2 2L CG7093 CG7093 CDMC34915 1 1 11 DAC17-E01 1-CG7126-RA_1 CG7126 GCGGGAGAGATTCGGTATGAGCAGTAATCCTTTCTTGTTTGGGTCCACCAAGGCACCAACAGTCCCAAA 69 FBan0007126 FBgn0038602 CG7126 3 3R CG7126 CG7126 CDMC34915 1 2 11 DAC17-E01 1-CG7126-RA_1 CG7126 GCGGGAGAGATTCGGTATGAGCAGTAATCCTTTCTTGTTTGGGTCCACCAAGGCACCAACAGTCCCAAA 69 FBan0007126 FBgn0038602 CG7126 3 3R CG7126 CG7126 CDMC34916 1 3 11 DAC17-E13 1-CG7140-RA_1 CG7140 GACTGCGACACCTTCCACAGCGACAGTACTGACATTCGTAACGAGCTAGTCCTGAGATCCTTCCCCACG 69 FBan0007140 FBgn0037147 CG7140 3 3L glucose metabolism; GO:0006006; monosaccharide metabolism; GO:0005996 glucose-6-phosphate 1-dehydrogenase activity; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49 CG7140 CG7140 CDMC34916 1 4 11 DAC17-E13 1-CG7140-RA_1 CG7140 GACTGCGACACCTTCCACAGCGACAGTACTGACATTCGTAACGAGCTAGTCCTGAGATCCTTCCCCACG 69 FBan0007140 FBgn0037147 CG7140 3 3L glucose metabolism; GO:0006006; monosaccharide metabolism; GO:0005996 glucose-6-phosphate 1-dehydrogenase activity; GO:0004345 ; EC:1.1.1.49; ; GO:0004345 ; EC:1.1.1.49 CG7140 CG7140 CDMC34917 1 5 11 DAC17-I01 3-CG7176-RB_3 CG7176 CCAAGGATCTGGCCATCTGCATTAAAGGCAACATCAACGCCGTTACTCGCAGGGACTACCAGGAGACTT 69 FBan0007176 FBgn0001248 Idh 3 3L glyoxylate cycle; GO:0006097; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NADP+) activity; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42 mitochondrion; GO:0005739 Idh Isocitrate dehydrogenase "CG7176, CG7176, CG7176, IDH-NADP, NADP-IDH, Idh-NADP, IDH, idh, l(3)L3852, CT22171" CDMC34917 1 6 11 DAC17-I01 3-CG7176-RB_3 CG7176 CCAAGGATCTGGCCATCTGCATTAAAGGCAACATCAACGCCGTTACTCGCAGGGACTACCAGGAGACTT 69 FBan0007176 FBgn0001248 Idh 3 3L glyoxylate cycle; GO:0006097; tricarboxylic acid cycle; GO:0006099 isocitrate dehydrogenase (NADP+) activity; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42; ; GO:0004450 ; EC:1.1.1.42 mitochondrion; GO:0005739 Idh Isocitrate dehydrogenase "CG7176, CG7176, CG7176, IDH-NADP, NADP-IDH, Idh-NADP, IDH, idh, l(3)L3852, CT22171" CDMC34918 1 7 11 DAC17-I13 6-CG7185-RA_1 CG7185 CATCGAGACACTGGTCACAGCCATTTCACTGATCAAACAGTCCAAGGTAGCGCACGATGAGCGATGCAA 69 FBan0007185 FBgn0035872 CG7185 3 3L "mRNA cleavage; GO:0006379; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 mRNA cleavage factor complex; GO:0005849; nucleus; GO:0005634 CG7185 CG7185 "cg7185, CFlm-68k" CDMC34918 1 8 11 DAC17-I13 6-CG7185-RA_1 CG7185 CATCGAGACACTGGTCACAGCCATTTCACTGATCAAACAGTCCAAGGTAGCGCACGATGAGCGATGCAA 69 FBan0007185 FBgn0035872 CG7185 3 3L "mRNA cleavage; GO:0006379; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729 mRNA cleavage factor complex; GO:0005849; nucleus; GO:0005634 CG7185 CG7185 "cg7185, CFlm-68k" CDMC34919 1 9 11 DAC17-M01 2-CG7224-RA_1 CG7224 CCTCGCAGATTGCAATTCAGACGCGAAGCAACAAGCAAGTGACATTGACTCCCAGCCGAAAGTGAGACT 69 FBan0007224 FBgn0031971 CG7224 2 2L CG7224 CG7224 "BcDNA:GH18422, anon-EST:Posey12" CDMC34919 1 10 11 DAC17-M01 2-CG7224-RA_1 CG7224 CCTCGCAGATTGCAATTCAGACGCGAAGCAACAAGCAAGTGACATTGACTCCCAGCCGAAAGTGAGACT 69 FBan0007224 FBgn0031971 CG7224 2 2L CG7224 CG7224 "BcDNA:GH18422, anon-EST:Posey12" CDMC34920 1 11 11 DAC17-M13 23-CG7235-RA_1 CG7235 TCCTTACCACGTAATATCCTTACCTAAATTCAAAACAAGGAAACGCTCATGGTTTGCCACATTCTAGCC 69 FBan0007235 FBgn0031728 CG7235 2 2L 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to stress; GO:0006950 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG7235 CG7235 bs36d10.y1 CDMC34920 1 12 11 DAC17-M13 23-CG7235-RA_1 CG7235 TCCTTACCACGTAATATCCTTACCTAAATTCAAAACAAGGAAACGCTCATGGTTTGCCACATTCTAGCC 69 FBan0007235 FBgn0031728 CG7235 2 2L 'de novo' protein folding; GO:0006458; protein folding; GO:0006457; protein refolding; GO:0042026; protein targeting to mitochondrion; GO:0006626; response to stress; GO:0006950 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; unfolded protein binding; GO:0051082; ; GO:0051082" mitochondrial matrix; GO:0005759; mitochondrion; GO:0005739 CG7235 CG7235 bs36d10.y1 CDMC34921 1 13 11 DAC18-A01 16-CG32391-RA_1 CG32391 GCAACTGGCACTTACTCACTGAGCATATACTCCCTGGTATTGTATGTGGTTCTCGACGTGATCTGGGGA 69 FBan0032391 FBgn0052391 CG32391 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32391 CG32391 CDMC34921 1 14 11 DAC18-A01 16-CG32391-RA_1 CG32391 GCAACTGGCACTTACTCACTGAGCATATACTCCCTGGTATTGTATGTGGTTCTCGACGTGATCTGGGGA 69 FBan0032391 FBgn0052391 CG32391 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32391 CG32391 CDMC34922 1 15 11 DAC18-A13 22-CG32399-RA_2 CG32399 TGGCTGGTACCAGAAGTCATACAAACGCAAGACAAAACGAGGCGACAGACAATACAAGACTTCGAACTT 69 FBan0032399 FBgn0052399 CG32399 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32399 CG32399 BcDNA:RH33996 CDMC34922 1 16 11 DAC18-A13 22-CG32399-RA_2 CG32399 TGGCTGGTACCAGAAGTCATACAAACGCAAGACAAAACGAGGCGACAGACAATACAAGACTTCGAACTT 69 FBan0032399 FBgn0052399 CG32399 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32399 CG32399 BcDNA:RH33996 CDMC34923 1 17 11 DAC18-E01 2-CG32433-RA_1 CG32433 CACACTCGGAAGCTGAAGGATTCCATGGATTGTCTGGCCACTAAGGGACACCTGCTAGAAGTGGTGGTG 69 FBan0032433 FBgn0045474 Gr77a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr77a Gustatory receptor 77a "CG32433, 77E.1, Gustatory receptor 77E.1, Gr77E1, GR77E.1, Gustatory receptor 77a" CDMC34923 1 18 11 DAC18-E01 2-CG32433-RA_1 CG32433 CACACTCGGAAGCTGAAGGATTCCATGGATTGTCTGGCCACTAAGGGACACCTGCTAGAAGTGGTGGTG 69 FBan0032433 FBgn0045474 Gr77a 3 3L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr77a Gustatory receptor 77a "CG32433, 77E.1, Gustatory receptor 77E.1, Gr77E1, GR77E.1, Gustatory receptor 77a" CDMC34924 1 19 11 DAC18-E13 23-CG32442-RB_12 CG32442 TGCGTTAATTGTGGACACAGAGTAAAAGAACTGTTCAAGAAATACAGCAATACTATGAAAACCACGCAA 69 FBan0032442 FBgn0052442 CG32442 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32442 CG32442 "BcDNA:RE62711, BcDNA:RH17480" CDMC34924 1 20 11 DAC18-E13 23-CG32442-RB_12 CG32442 TGCGTTAATTGTGGACACAGAGTAAAAGAACTGTTCAAGAAATACAGCAATACTATGAAAACCACGCAA 69 FBan0032442 FBgn0052442 CG32442 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32442 CG32442 "BcDNA:RE62711, BcDNA:RH17480" CDMC34925 1 21 11 DAC18-I01 3-CG32473-RA_4 CG32473 TGGGTCAGAGTCTTGTGTGGGATTACGTGCGTGAAAACTGGGAGAAGTTGGTGGATCGTTTCGGCATCA 69 FBan0032473 FBgn0052473 CG32473 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; endonuclease activity; GO:0004519; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004519 CG32473 CG32473 "CG8775, CG11688, CG8775, GM08240p" CDMC34925 1 22 11 DAC18-I01 3-CG32473-RA_4 CG32473 TGGGTCAGAGTCTTGTGTGGGATTACGTGCGTGAAAACTGGGAGAAGTTGGTGGATCGTTTCGGCATCA 69 FBan0032473 FBgn0052473 CG32473 3 3R proteolysis; GO:0006508 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; endonuclease activity; GO:0004519; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2; ; GO:0004519 CG32473 CG32473 "CG8775, CG11688, CG8775, GM08240p" CDMC34926 1 23 11 DAC18-I13 16-CG32485-RA_1 CG32485 GGCTTCTGCTAGGCGTAGACATATCTCCAAAGAGAACCGAAACCAGTACCTAAGTTTGCAAGGAGGCTT 69 FBan0032485 FBgn0052485 CG32485 3 3L CG32485 CG32485 "CG2159, CG2159" CDMC34926 1 24 11 DAC18-I13 16-CG32485-RA_1 CG32485 GGCTTCTGCTAGGCGTAGACATATCTCCAAAGAGAACCGAAACCAGTACCTAAGTTTGCAAGGAGGCTT 69 FBan0032485 FBgn0052485 CG32485 3 3L CG32485 CG32485 "CG2159, CG2159" CDMC34927 1 25 11 DAC18-M01 23-CG32494-RA_1 CG32494 TGACTGCCGAAAAATATAAAAAGCAAAAGCTAGCAAAACCAACAAGTACAAAAGGGCAGACTCATTTCA 69 FBan0032494 FBgn0052494 CG32494 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32494 CG32494 CDMC34927 1 26 11 DAC18-M01 23-CG32494-RA_1 CG32494 TGACTGCCGAAAAATATAAAAAGCAAAAGCTAGCAAAACCAACAAGTACAAAAGGGCAGACTCATTTCA 69 FBan0032494 FBgn0052494 CG32494 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32494 CG32494 CDMC34928 1 1 12 DAC18-M13 23-CG32512-RA_3 CG32512 TTCCACGTTCGATAAATGTCTCAAATTCAAATATGGCTTATTGAACACTTGAGTTTTTGAACTGGTCCT 69 FBan0032512 FBgn0052512 CG32512 X X CG32512 CG32512 "CG15447, CG1739, CG15447" CDMC34928 1 2 12 DAC18-M13 23-CG32512-RA_3 CG32512 TTCCACGTTCGATAAATGTCTCAAATTCAAATATGGCTTATTGAACACTTGAGTTTTTGAACTGGTCCT 69 FBan0032512 FBgn0052512 CG32512 X X CG32512 CG32512 "CG15447, CG1739, CG15447" CDMC34929 1 3 12 DAC19-A01 17-CG8104-RA_1 CG8104 ATCTCAAACAAGAGCTGAACGTCAAGTCACGCTTTACCCCAGTGGTCAATGGAACGAGCGTTCCC 65 FBan0008104 FBgn0036059 nudE 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 nudE nudE "CG8104, DnudE" CDMC34929 1 4 12 DAC19-A01 17-CG8104-RA_1 CG8104 ATCTCAAACAAGAGCTGAACGTCAAGTCACGCTTTACCCCAGTGGTCAATGGAACGAGCGTTCCC 65 FBan0008104 FBgn0036059 nudE 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 nudE nudE "CG8104, DnudE" CDMC34930 1 5 12 DAC19-A13 23-CG8144-RB_5 CG8144 GCCCCTATTTTTTAATTTGGCCCTAGAGCCCATTAGACATAGAAACAAAAGCCAAGCAGACACAG 65 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC34930 1 6 12 DAC19-A13 23-CG8144-RB_5 CG8144 GCCCCTATTTTTTAATTTGGCCCTAGAGCCCATTAGACATAGAAACAAAAGCCAAGCAGACACAG 65 FBan0008144 FBgn0026188 ps 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729 nucleus; GO:0005634 ps pasilla "CG16776, CG8144, CG18509, CG16776, cg8144, PS, pasilla" CDMC34931 1 7 12 DAC19-E01 18-CG8235-RA_1 CG8235 GGCGTCACCTCGGAGGCTATGGTCATGTGCGCATCTACACCGGAAAAAGTGGAAGTGCTCAGTCC 65 FBan0008235 FBgn0033351 CG8235 2 2R tRNA aminoacylation for protein translation; GO:0006418 nucleic acid binding; GO:0003676; aminoacyl-tRNA synthetase auxiliary protein activity; GO:0017100; ; GO:0003676; tRNA binding; GO:0000049; ; GO:0017100; ; GO:0000049 aminoacyl-tRNA synthetase multienzyme complex; GO:0017101 CG8235 CG8235 CDMC34931 1 8 12 DAC19-E01 18-CG8235-RA_1 CG8235 GGCGTCACCTCGGAGGCTATGGTCATGTGCGCATCTACACCGGAAAAAGTGGAAGTGCTCAGTCC 65 FBan0008235 FBgn0033351 CG8235 2 2R tRNA aminoacylation for protein translation; GO:0006418 nucleic acid binding; GO:0003676; aminoacyl-tRNA synthetase auxiliary protein activity; GO:0017100; ; GO:0003676; tRNA binding; GO:0000049; ; GO:0017100; ; GO:0000049 aminoacyl-tRNA synthetase multienzyme complex; GO:0017101 CG8235 CG8235 CDMC34932 1 9 12 DAC19-E13 2-CG8252-RA_2 CG8252 CGGTGCCCTACCCATTGCCATAATACCCAGCATATCCAGCTTAGTCAACCAGTGCAACAAGCCGG 65 FBan0008252 FBgn0033344 CG8252 2 2R CG8252 CG8252 CDMC34932 1 10 12 DAC19-E13 2-CG8252-RA_2 CG8252 CGGTGCCCTACCCATTGCCATAATACCCAGCATATCCAGCTTAGTCAACCAGTGCAACAAGCCGG 65 FBan0008252 FBgn0033344 CG8252 2 2R CG8252 CG8252 CDMC34933 1 11 12 DAC19-I01 14-CG8335-RA_1 CG8335 CTAGTGGATGCAGCCCTGAAGAACCAGCGACTCTCGACCCGACTGTACTGTGCTGTGGAGATGGG 65 FBan0008335 FBgn0033069 CG8335 2 2R translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8335 CG8335 eIF3-S5 CDMC34933 1 12 12 DAC19-I01 14-CG8335-RA_1 CG8335 CTAGTGGATGCAGCCCTGAAGAACCAGCGACTCTCGACCCGACTGTACTGTGCTGTGGAGATGGG 65 FBan0008335 FBgn0033069 CG8335 2 2R translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8335 CG8335 eIF3-S5 CDMC34934 1 13 12 DAC19-I13 23-CG8361-RA_4 CG8361 TAACCTCCTCCGAAAGATCGAAGAAGTTCTTCAACAAGTCGTTCTTCCATTTACCTAAACGCAAC 65 FBan0008361 FBgn0002633 HLHm7 3 3R cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 HLHm7 E(spl) region transcript m7 "CG8361, CG8361, CG8361, CG8361, CG8361, m7, E(spl)m7, HLH-m7, E(SPL)m7, E(spl)-M7, E(spl)M7, E(spl)-m7, E(spl) m7, M7, ESPL" CDMC34934 1 14 12 DAC19-I13 23-CG8361-RA_4 CG8361 TAACCTCCTCCGAAAGATCGAAGAAGTTCTTCAACAAGTCGTTCTTCCATTTACCTAAACGCAAC 65 FBan0008361 FBgn0002633 HLHm7 3 3R cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003704 nucleus; GO:0005634 HLHm7 E(spl) region transcript m7 "CG8361, CG8361, CG8361, CG8361, CG8361, m7, E(spl)m7, HLH-m7, E(SPL)m7, E(spl)-M7, E(spl)M7, E(spl)-m7, E(spl) m7, M7, ESPL" CDMC34935 1 15 12 DAC19-M01 6-CG8442-RA_1 CG8442 CAACCACCGGGAATTATTGGAGGTGCCACTTTGAGTGAACCACAAGCGCATGTGCCTCCAGTTCC 65 FBan0008442 FBgn0004619 Glu-RI 3 3L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate-gated ion channel activity; GO:0005234; potassium channel activity; GO:0005267; ; GO:0004971; ; GO:0005234; ; GO:0005267 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Glu-RI Glutamate receptor I "CG8442, DGluR-I, glutamate receptor kainate-selective subunit, DGluR-IA, dglur-IA, dGluRI, kainate receptor, glutamate receptor, DGluRI" CDMC34935 1 16 12 DAC19-M01 6-CG8442-RA_1 CG8442 CAACCACCGGGAATTATTGGAGGTGCCACTTTGAGTGAACCACAAGCGCATGTGCCTCCAGTTCC 65 FBan0008442 FBgn0004619 Glu-RI 3 3L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate-gated ion channel activity; GO:0005234; potassium channel activity; GO:0005267; ; GO:0004971; ; GO:0005234; ; GO:0005267 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Glu-RI Glutamate receptor I "CG8442, DGluR-I, glutamate receptor kainate-selective subunit, DGluR-IA, dglur-IA, dGluRI, kainate receptor, glutamate receptor, DGluRI" CDMC34936 1 17 12 DAC19-M13 2-CG8470-RA_4 CG8470 CCGCTATTACGGCTTCAAGGTGGTCGACTTCAACGACTCGAAAATCCCCTACAATGCACTGCCGC 65 FBan0008470 FBgn0030692 mRpS30 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS30 mitochondrial ribosomal protein S30 "CG8470, MRP-S30, mRSp30, mitochondrial ribosomal protein S30" CDMC34936 1 18 12 DAC19-M13 2-CG8470-RA_4 CG8470 CCGCTATTACGGCTTCAAGGTGGTCGACTTCAACGACTCGAAAATCCCCTACAATGCACTGCCGC 65 FBan0008470 FBgn0030692 mRpS30 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS30 mitochondrial ribosomal protein S30 "CG8470, MRP-S30, mRSp30, mitochondrial ribosomal protein S30" CDMC34937 1 19 12 DAC20-A01 3-CG7644-RA_2 CG7644 CGGCTGCGAATCTCACCTGGTGGATCAATGACATACAGGTGCCACCCAATTATCTCCGCATCTACGACA 69 FBan0007644 FBgn0028645 beat-Ib 2 2L axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ib beaten path Ib "CG7644, BG:DS00365.4, beat-B, CT23325, beat Ib, BcDNA:RE51929, beaten path Ib" CDMC34937 1 20 12 DAC20-A01 3-CG7644-RA_2 CG7644 CGGCTGCGAATCTCACCTGGTGGATCAATGACATACAGGTGCCACCCAATTATCTCCGCATCTACGACA 69 FBan0007644 FBgn0028645 beat-Ib 2 2L axon choice point recognition; GO:0016198; cell adhesion; GO:0007155; defasciculation of motor neuron; GO:0007415 extracellular region; GO:0005576 beat-Ib beaten path Ib "CG7644, BG:DS00365.4, beat-B, CT23325, beat Ib, BcDNA:RE51929, beaten path Ib" CDMC34938 1 21 12 DAC20-A13 11-CG7658-RA_1 CG7658 ACCCTCCACAGCCCTAAATCCCCGATTGGATACCCCATTCAAAGCCTAGTCAGTGCTTTTGCTAAACAT 69 FBan0007658 FBgn0037069 CG7658 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7658 CG7658 "BcDNA:RE32113, anon-EST:ParkEST167" CDMC34938 1 22 12 DAC20-A13 11-CG7658-RA_1 CG7658 ACCCTCCACAGCCCTAAATCCCCGATTGGATACCCCATTCAAAGCCTAGTCAGTGCTTTTGCTAAACAT 69 FBan0007658 FBgn0037069 CG7658 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7658 CG7658 "BcDNA:RE32113, anon-EST:ParkEST167" CDMC34939 1 23 12 DAC20-E01 3-CG7705-RA_4 CG7705 TGATGCTGGTCTACAACAAGTTCTTGCACAGTCAGCTGGATTTGGAAGGAGAGTTGCCGAAGCCCAAGC 69 FBan0007705 FBgn0038639 CG7705 3 3R CG7705 CG7705 CDMC34939 1 24 12 DAC20-E01 3-CG7705-RA_4 CG7705 TGATGCTGGTCTACAACAAGTTCTTGCACAGTCAGCTGGATTTGGAAGGAGAGTTGCCGAAGCCCAAGC 69 FBan0007705 FBgn0038639 CG7705 3 3R CG7705 CG7705 CDMC34940 1 25 12 DAC20-E13 23-CG7713-RA_2 CG7713 AACCTCCATACAGAAGCTCGAATAATCTATTAGAATACTTTTTGACTTGACACGCAACAAGAACTCCGT 69 FBan0007713 FBgn0038545 CG7713 3 3R CG7713 CG7713 CDMC34940 1 26 12 DAC20-E13 23-CG7713-RA_2 CG7713 AACCTCCATACAGAAGCTCGAATAATCTATTAGAATACTTTTTGACTTGACACGCAACAAGAACTCCGT 69 FBan0007713 FBgn0038545 CG7713 3 3R CG7713 CG7713 CDMC34941 1 1 13 DAC20-I01 3-CG7752-RA_10 CG7752 GCAGTGGCCAGATGGTACTTGTCCATGGTGACAACAATGAACAGCAGCTTATCGATGCCTCCCTGTTGA 69 FBan0007752 FBgn0037066 Z4 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634; polytene chromosome interband; GO:0005705 Z4 Z4 "CG7752, CG7752, p160" CDMC34941 1 2 13 DAC20-I01 3-CG7752-RA_10 CG7752 GCAGTGGCCAGATGGTACTTGTCCATGGTGACAACAATGAACAGCAGCTTATCGATGCCTCCCTGTTGA 69 FBan0007752 FBgn0037066 Z4 3 3L establishment and/or maintenance of chromatin architecture; GO:0006325 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634; polytene chromosome interband; GO:0005705 Z4 Z4 "CG7752, CG7752, p160" CDMC34942 1 3 13 DAC20-I13 3-CG7762-RA_2 CG7762 GCGTGGAGATATTGGGTATTACGGCTCTGTCGCTGGGTCTCATCAGTGTTGGTTCGTGCAATTCGGAGA 69 FBan0007762 FBgn0028695 Rpn1 3 3L proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpn1 Rpn1 "CG7762, p97, BcDNA:LD21723" CDMC34942 1 4 13 DAC20-I13 3-CG7762-RA_2 CG7762 GCGTGGAGATATTGGGTATTACGGCTCTGTCGCTGGGTCTCATCAGTGTTGGTTCGTGCAATTCGGAGA 69 FBan0007762 FBgn0028695 Rpn1 3 3L proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 endopeptidase activity; GO:0004175; enzyme regulator activity; GO:0030234; ; GO:0004175; ; GO:0030234 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpn1 Rpn1 "CG7762, p97, BcDNA:LD21723" CDMC34943 1 5 13 DAC20-M01 18-CG7793-RA_1 CG7793 TGCCTGGCGATGTGATAAGGACGAAAACTACGAGTATGATCCGTAAGATTCAAAGTTGCGAGCACTGCT 69 FBan0007793 FBgn0001965 Sos 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; Ras protein signal transduction; GO:0007265; actin filament organization; GO:0007015; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; determination of anterior/posterior axis, embryo; GO:0008595; nervous system development; GO:0007399; nucleosome assembly; GO:0006334; regulation of cell shape; GO:0008360; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" DNA binding; GO:0003677; Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; protein binding; GO:0005515; ; GO:0005088; ; GO:0005088; ; GO:0003677; ; GO:0005515 nucleosome; GO:0000786; nucleus; GO:0005634 Sos Son of sevenless "CG7793, l(2)br24, l(2)br25, lethal 24 in the black-reduced region, lethal 25 in the black-reduced region, br24, l(2)34Ea, E(sev)2A, sos, Su(tor)2-2, dSos, SOS, dme-SOS, l(2)k05224, l(2)k06321, EY2-3, 2.3, BG:DS00941.4, Sos1, br25, 34Ea, EK2-8, E(var)189, l(2)Sos" CDMC34943 1 6 13 DAC20-M01 18-CG7793-RA_1 CG7793 TGCCTGGCGATGTGATAAGGACGAAAACTACGAGTATGATCCGTAAGATTCAAAGTTGCGAGCACTGCT 69 FBan0007793 FBgn0001965 Sos 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; Ras protein signal transduction; GO:0007265; actin filament organization; GO:0007015; chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; determination of anterior/posterior axis, embryo; GO:0008595; nervous system development; GO:0007399; nucleosome assembly; GO:0006334; regulation of cell shape; GO:0008360; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" DNA binding; GO:0003677; Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; protein binding; GO:0005515; ; GO:0005088; ; GO:0005088; ; GO:0003677; ; GO:0005515 nucleosome; GO:0000786; nucleus; GO:0005634 Sos Son of sevenless "CG7793, l(2)br24, l(2)br25, lethal 24 in the black-reduced region, lethal 25 in the black-reduced region, br24, l(2)34Ea, E(sev)2A, sos, Su(tor)2-2, dSos, SOS, dme-SOS, l(2)k05224, l(2)k06321, EY2-3, 2.3, BG:DS00941.4, Sos1, br25, 34Ea, EK2-8, E(var)189, l(2)Sos" CDMC34944 1 7 13 DAC20-M13 9-CG7806-RA_6 CG7806 CGCGCTCTCCATAACTGGTCAATTGGGAGATCTACTTCATGCTGTGGCTGAAACAGAGCAGGAACTGGT 69 FBan0007806 FBgn0032018 CG7806 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166 integral to membrane; GO:0016021 CG7806 CG7806 CDMC34944 1 8 13 DAC20-M13 9-CG7806-RA_6 CG7806 CGCGCTCTCCATAACTGGTCAATTGGGAGATCTACTTCATGCTGTGGCTGAAACAGAGCAGGAACTGGT 69 FBan0007806 FBgn0032018 CG7806 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; response to toxin; GO:0009636 ATP binding; GO:0005524; ; GO:0005524; xenobiotic-transporting ATPase activity; GO:0008559 ; EC:3.6.3.44; nucleotide binding; GO:0000166; ; GO:0008559 ; EC:3.6.3.44; ; GO:0000166 integral to membrane; GO:0016021 CG7806 CG7806 CDMC34945 1 9 13 DAC21-A01 11-CG2528-RA_2 CG2528 AGCCCGCGATCTTAGCACAGGAAAGCTCATCCGTCAATTTGGCCTGGATATTGGCTCAATAAATGGGAT 69 FBan0002528 FBgn0032969 CG2528 2 2L proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; prolyl oligopeptidase activity; GO:0004287 ; EC:3.4.21.26; prolyl aminopeptidase activity; GO:0016804 ; EC:3.4.11.5; ; GO:0016804 ; EC:3.4.11.5; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004287 ; EC:3.4.21.26 CG2528 CG2528 CDMC34945 1 10 13 DAC21-A01 11-CG2528-RA_2 CG2528 AGCCCGCGATCTTAGCACAGGAAAGCTCATCCGTCAATTTGGCCTGGATATTGGCTCAATAAATGGGAT 69 FBan0002528 FBgn0032969 CG2528 2 2L proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; prolyl oligopeptidase activity; GO:0004287 ; EC:3.4.21.26; prolyl aminopeptidase activity; GO:0016804 ; EC:3.4.11.5; ; GO:0016804 ; EC:3.4.11.5; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004287 ; EC:3.4.21.26 CG2528 CG2528 CDMC34946 1 11 13 DAC21-A13 11-CG2560-RA_1 CG2560 GGGCAGTGGACAGAGTGGCGATGACTATAGCTACACGTCTCCCTATGGAAATGGCAATGCTTACGGTAA 69 FBan0002560 FBgn0030394 CG2560 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG2560 CG2560 CDMC34946 1 12 13 DAC21-A13 11-CG2560-RA_1 CG2560 GGGCAGTGGACAGAGTGGCGATGACTATAGCTACACGTCTCCCTATGGAAATGGCAATGCTTACGGTAA 69 FBan0002560 FBgn0030394 CG2560 X X structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG2560 CG2560 CDMC34947 1 13 13 DAC21-E01 23-CG2663-RB_7 CG2663 GGAGACAATAACTTCACTTGAAATTGTGCGAATAACTCAATTTGAATGGCAGCAAACAATGAAGAAGGC 69 FBan0002663 FBgn0037323 CG2663 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG2663 CG2663 alpha tocopherol transfer protein CDMC34947 1 14 13 DAC21-E01 23-CG2663-RB_7 CG2663 GGAGACAATAACTTCACTTGAAATTGTGCGAATAACTCAATTTGAATGGCAGCAAACAATGAAGAAGGC 69 FBan0002663 FBgn0037323 CG2663 3 3R coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; vitamin E binding; GO:0008431; ; GO:0008431 intracellular; GO:0005622 CG2663 CG2663 alpha tocopherol transfer protein CDMC34948 1 15 13 DAC21-E13 1-CG2674-RH_1 CG2674 TGCCTTGTCCAAGTGTCCTACGCCATAGGTCTTGCTGAGCCTCTCTCCATAACTGTGTTCGACTACGGA 69 FBan0002674 FBgn0005278 M(2)21AB 2 2L S-adenosylmethionine biosynthesis; GO:0006556; one-carbon compound metabolism; GO:0006730 ATP binding; GO:0005524; ; GO:0005524; methionine adenosyltransferase activity; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6 M(2)21AB Minute (2) 21AB "CG2674, CG2674, Su(z)5, S-adenosylmethionine synthetase, SamS: S-adenosylmethionine synthetase, Sam-S, METK, Methionine adenosyl transferase, S-Adenosylmethionine synthetase, M(2)21A-B, SamS" CDMC34948 1 16 13 DAC21-E13 1-CG2674-RH_1 CG2674 TGCCTTGTCCAAGTGTCCTACGCCATAGGTCTTGCTGAGCCTCTCTCCATAACTGTGTTCGACTACGGA 69 FBan0002674 FBgn0005278 M(2)21AB 2 2L S-adenosylmethionine biosynthesis; GO:0006556; one-carbon compound metabolism; GO:0006730 ATP binding; GO:0005524; ; GO:0005524; methionine adenosyltransferase activity; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0004478 ; EC:2.5.1.6; ; GO:0004478 ; EC:2.5.1.6 M(2)21AB Minute (2) 21AB "CG2674, CG2674, Su(z)5, S-adenosylmethionine synthetase, SamS: S-adenosylmethionine synthetase, Sam-S, METK, Methionine adenosyl transferase, S-Adenosylmethionine synthetase, M(2)21A-B, SamS" CDMC34949 1 17 13 DAC21-I01 18-CG2715-RA_2 CG2715 GCTTGGAGGCAAGGATGAAAAGAACCCTTTTCTATGGACTCCACCAGACTTTCATCAATCTGTGGCACA 69 FBan0002715 FBgn0024980 Syx4 X X neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; regulation of exocytosis; GO:0017157; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx4 Syntaxin 4 "CG2715, CG2715, EG:95B7.11, EG:95B7.1, DmSyx4, syx4, syntaxin, Syx-4, Dm Syx4, Syntaxin 4" CDMC34949 1 18 13 DAC21-I01 18-CG2715-RA_2 CG2715 GCTTGGAGGCAAGGATGAAAAGAACCCTTTTCTATGGACTCCACCAGACTTTCATCAATCTGTGGCACA 69 FBan0002715 FBgn0024980 Syx4 X X neurotransmitter secretion; GO:0007269; protein targeting; GO:0006605; regulation of exocytosis; GO:0017157; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx4 Syntaxin 4 "CG2715, CG2715, EG:95B7.11, EG:95B7.1, DmSyx4, syx4, syntaxin, Syx-4, Dm Syx4, Syntaxin 4" CDMC34950 1 19 13 DAC21-I13 13-CG2765-RA_1 CG2765 ACTCAAGGCCTTCTCGACCCTCTATTTCCTATGCCTCCTACACTATCACTTTCTTTCGAGCTGGTCGGG 69 FBan0002765 FBgn0035087 CG2765 2 2R CG2765 CG2765 CDMC34950 1 20 13 DAC21-I13 13-CG2765-RA_1 CG2765 ACTCAAGGCCTTCTCGACCCTCTATTTCCTATGCCTCCTACACTATCACTTTCTTTCGAGCTGGTCGGG 69 FBan0002765 FBgn0035087 CG2765 2 2R CG2765 CG2765 CDMC34951 1 21 13 DAC21-M01 23-CG2839-RA_6 CG2839 GAAGAAAGAGACAGAGGAAAAGGAAAAGAATATGCAGGAAAAGTGTTGGGTTACTAAAAAAGGCACAAA 69 FBan0002839 FBgn0031273 CG2839 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG2839 CG2839 CDMC34951 1 22 13 DAC21-M01 23-CG2839-RA_6 CG2839 GAAGAAAGAGACAGAGGAAAAGGAAAAGAATATGCAGGAAAAGTGTTGGGTTACTAAAAAAGGCACAAA 69 FBan0002839 FBgn0031273 CG2839 2 2L development; GO:0007275; gametogenesis; GO:0007276; spermatogenesis; GO:0007283 sugar binding; GO:0005529; ; GO:0005529 CG2839 CG2839 CDMC34952 1 23 13 DAC21-M13 3-CG2855-RA_1 CG2855 TCAGCCACCTGTTCGTCTCCCTGATAACTCTGCTCAATGCCAATGAGCTTTACACGACCACTCTGCTGA 69 FBan0002855 FBgn0031458 aph-1 2 2L Notch signaling pathway; GO:0007219; positive regulation of enzyme activity; GO:0043085; protein processing; GO:0016485 endopeptidase activity; GO:0004175; protein binding; GO:0005515; ; GO:0004175; ; GO:0005515 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 aph-1 anterior pharynx defective 1 "CG2855, l(2)23AB6, l(2)23Ag, pen-1, presenilin enhancer-1, Dm APH-1, Aph-1, Pen-1, presenilin stabilization factor" CDMC34952 1 24 13 DAC21-M13 3-CG2855-RA_1 CG2855 TCAGCCACCTGTTCGTCTCCCTGATAACTCTGCTCAATGCCAATGAGCTTTACACGACCACTCTGCTGA 69 FBan0002855 FBgn0031458 aph-1 2 2L Notch signaling pathway; GO:0007219; positive regulation of enzyme activity; GO:0043085; protein processing; GO:0016485 endopeptidase activity; GO:0004175; protein binding; GO:0005515; ; GO:0004175; ; GO:0005515 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 aph-1 anterior pharynx defective 1 "CG2855, l(2)23AB6, l(2)23Ag, pen-1, presenilin enhancer-1, Dm APH-1, Aph-1, Pen-1, presenilin stabilization factor" CDMC34953 1 25 13 DAC22-A01 3-CG14495-RA_6 CG14495 TTCACTCCCGAACCGGATCTCACGATAGACGAATGCCACGATGAGTTCACCATTGCCTGTGCCAA 65 FBan0014495 FBgn0034293 CG14495 2 2R CG14495 CG14495 CDMC34953 1 26 13 DAC22-A01 3-CG14495-RA_6 CG14495 TTCACTCCCGAACCGGATCTCACGATAGACGAATGCCACGATGAGTTCACCATTGCCTGTGCCAA 65 FBan0014495 FBgn0034293 CG14495 2 2R CG14495 CG14495 CDMC34954 1 1 14 DAC22-A13 17-CG14520-RA_1 CG14520 CACTGCTCCGTCATCTCCTACCCTTCGCCCCGCGCACTCCTTTGACGCATTTATGGAGCTTGGTG 65 FBan0014520 FBgn0039618 CG14520 3 3R CG14520 CG14520 CDMC34954 1 2 14 DAC22-A13 17-CG14520-RA_1 CG14520 CACTGCTCCGTCATCTCCTACCCTTCGCCCCGCGCACTCCTTTGACGCATTTATGGAGCTTGGTG 65 FBan0014520 FBgn0039618 CG14520 3 3R CG14520 CG14520 CDMC34955 1 3 14 DAC22-E01 1-CG14621-RA_1 CG14621 CACCGTCGTCCTGACACGCGTTTTTTTTGGTGAGAAACAACCGACACTCGTGTACCTGAGCCTGC 65 FBan0014621 FBgn0031183 CG14621 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose 6-phosphate:phosphate antiporter activity; GO:0008524; ; GO:0008524 CG14621 CG14621 CDMC34955 1 4 14 DAC22-E01 1-CG14621-RA_1 CG14621 CACCGTCGTCCTGACACGCGTTTTTTTTGGTGAGAAACAACCGACACTCGTGTACCTGAGCCTGC 65 FBan0014621 FBgn0031183 CG14621 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose 6-phosphate:phosphate antiporter activity; GO:0008524; ; GO:0008524 CG14621 CG14621 CDMC34956 1 5 14 DAC22-E13 3-CG14635-RA_1 CG14635 CACGGGTCTCCTACGAAGCCTTGGAGCGCTACGATCGAATTTTTGGCAGATCTTTCCAAGACGCC 65 FBan0014635 FBgn0029535 CG14635 X X CG14635 CG14635 CDMC34956 1 6 14 DAC22-E13 3-CG14635-RA_1 CG14635 CACGGGTCTCCTACGAAGCCTTGGAGCGCTACGATCGAATTTTTGGCAGATCTTTCCAAGACGCC 65 FBan0014635 FBgn0029535 CG14635 X X CG14635 CG14635 CDMC34957 1 7 14 DAC22-I01 12-CG14736-RA_1 CG14736 GCCTGGCGTTTATGGACCTGCAATCTTATCGGGACTTCCTACGAACTCGTTGGTAATCAGCCGGC 65 FBan0014736 FBgn0037986 CG14736 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG14736 CG14736 CDMC34957 1 8 14 DAC22-I01 12-CG14736-RA_1 CG14736 GCCTGGCGTTTATGGACCTGCAATCTTATCGGGACTTCCTACGAACTCGTTGGTAATCAGCCGGC 65 FBan0014736 FBgn0037986 CG14736 3 3R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG14736 CG14736 CDMC34958 1 9 14 DAC22-I13 15-CG14759-RA_1 CG14759 ACATGGACGCCGACTACGGGAAGGACATGACACGAGTTACGGACGAGCTAAGTTTCCAGCCCCAC 65 FBan0014759 FBgn0033278 CG14759 2 2R CG14759 CG14759 CDMC34958 1 10 14 DAC22-I13 15-CG14759-RA_1 CG14759 ACATGGACGCCGACTACGGGAAGGACATGACACGAGTTACGGACGAGCTAAGTTTCCAGCCCCAC 65 FBan0014759 FBgn0033278 CG14759 2 2R CG14759 CG14759 CDMC34959 1 11 14 DAC22-M01 1-CG14826-RA_1 CG14826 CAGGCTCTTGGTCTACACTGCACTGGAGGAGTATATGGGCAGGAGGAACAATGACCGCTCCATGG 65 FBan0014826 FBgn0035750 CG14826 3 3L CG14826 CG14826 CDMC34959 1 12 14 DAC22-M01 1-CG14826-RA_1 CG14826 CAGGCTCTTGGTCTACACTGCACTGGAGGAGTATATGGGCAGGAGGAACAATGACCGCTCCATGG 65 FBan0014826 FBgn0035750 CG14826 3 3L CG14826 CG14826 CDMC34960 1 13 14 DAC22-M13 21-CG14851-RA_1 CG14851 GTCCGCGTTAGCAACCTGCGCTACTCCGTCAACCGTCGCATTCGGATCAACACCACCGCTCGATC 65 FBan0014851 FBgn0038240 CG14851 3 3R CG14851 CG14851 CDMC34960 1 14 14 DAC22-M13 21-CG14851-RA_1 CG14851 GTCCGCGTTAGCAACCTGCGCTACTCCGTCAACCGTCGCATTCGGATCAACACCACCGCTCGATC 65 FBan0014851 FBgn0038240 CG14851 3 3R CG14851 CG14851 CDMC34961 1 15 14 DAC23-A01 17-CG6730-RA_5 CG6730 TCTGCGTGATTTTCTTGGCGATGGACTTCTTTTAAGCACGGGAAATAAGTGGACTTCTCGCAGAAAGGT 69 FBan0006730 FBgn0031925 Cyp4d21 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d21 Cyp4d21 "CG6730, CG6730, 4d21, sxe1" CDMC34961 1 16 14 DAC23-A01 17-CG6730-RA_5 CG6730 TCTGCGTGATTTTCTTGGCGATGGACTTCTTTTAAGCACGGGAAATAAGTGGACTTCTCGCAGAAAGGT 69 FBan0006730 FBgn0031925 Cyp4d21 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d21 Cyp4d21 "CG6730, CG6730, 4d21, sxe1" CDMC34962 1 17 14 DAC23-A13 1-CG6739-RA_2 CG6739 ATCCCACAAGGCGACGTGACTATTGCTACGGAAATGAGTTCCAATGCCATGATGGGAGTTGCATTCCCC 69 FBan0006739 FBgn0031926 CG6739 2 2L development; GO:0007275 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 CG6739 CG6739 CDMC34962 1 18 14 DAC23-A13 1-CG6739-RA_2 CG6739 ATCCCACAAGGCGACGTGACTATTGCTACGGAAATGAGTTCCAATGCCATGATGGGAGTTGCATTCCCC 69 FBan0006739 FBgn0031926 CG6739 2 2L development; GO:0007275 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 CG6739 CG6739 CDMC34963 1 19 14 DAC23-E01 23-CG6773-RA_2 CG6773 TTTAATGTGCCCCTTTAAACGCTGTTTAGTGTATGTTTATTTGGACTTCATATGGGATCCCTATTTGAA 69 FBan0006773 FBgn0024509 sec13 3 3R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle budding; GO:0006900 sec13 sec13 "CG6773, l(3)01031, CK00043, Dsec13, BEST:CK00043, BcDNA:LD03471" CDMC34963 1 20 14 DAC23-E01 23-CG6773-RA_2 CG6773 TTTAATGTGCCCCTTTAAACGCTGTTTAGTGTATGTTTATTTGGACTTCATATGGGATCCCTATTTGAA 69 FBan0006773 FBgn0024509 sec13 3 3R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886; vesicle budding; GO:0006900 sec13 sec13 "CG6773, l(3)01031, CK00043, Dsec13, BEST:CK00043, BcDNA:LD03471" CDMC34964 1 21 14 DAC23-E13 12-CG6785-RA_1 CG6785 GCTGCCATTTACTACTCCAAGGTGAATCCGCTGACCAGTGATTACGACTACACGGATTACCTGGGTGGA 69 FBan0006785 FBgn0032399 CG6785 2 2L CG6785 CG6785 CDMC34964 1 22 14 DAC23-E13 12-CG6785-RA_1 CG6785 GCTGCCATTTACTACTCCAAGGTGAATCCGCTGACCAGTGATTACGACTACACGGATTACCTGGGTGGA 69 FBan0006785 FBgn0032399 CG6785 2 2L CG6785 CG6785 CDMC34965 1 23 14 DAC23-I01 1-CG6827-RB_1 CG6827 GCTGACGATCCAGACGATGCTGTCCTGCACTCAACTACTGGCCATCAAGTCAGGAAGCGAACAGAGATC 69 FBan0006827 FBgn0013997 Nrx-IV 3 3L cell-cell adhesion; GO:0016337; dorsal closure; GO:0007391; establishment and/or maintenance of cell polarity; GO:0007163; establishment of blood-nerve barrier; GO:0008065; intercellular junction assembly and/or maintenance; GO:0045216; protein localization; GO:0008104; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; signal transduction; GO:0007165; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 transmembrane receptor activity; GO:0004888; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004888; phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; sugar binding; GO:0005529; ; GO:0005529; ; GO:0016303 ; EC:2.7.1.137 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; phosphoinositide 3-kinase complex; GO:0005942; plasma membrane; GO:0005886; pleated septate junction; GO:0005919; septate junction; GO:0005918 Nrx-IV Neurexin IV "CG6827, CG6827, CG6827, rsg23, rose-gespleten region interval 23, Nrx: Neurexin, nrx: neurexin, Dnrx, neurexin, Neurexin, NrxIV, Neurexin IV, NRX IV, Nx IV, Nrx IV, neurexin IV, nrx IV, CT21123, nrxIV, Neurexin-4, NRX, l(3)68Ff, l(3)rsg23, Nrx, nrx" CDMC34965 1 24 14 DAC23-I01 1-CG6827-RB_1 CG6827 GCTGACGATCCAGACGATGCTGTCCTGCACTCAACTACTGGCCATCAAGTCAGGAAGCGAACAGAGATC 69 FBan0006827 FBgn0013997 Nrx-IV 3 3L cell-cell adhesion; GO:0016337; dorsal closure; GO:0007391; establishment and/or maintenance of cell polarity; GO:0007163; establishment of blood-nerve barrier; GO:0008065; intercellular junction assembly and/or maintenance; GO:0045216; protein localization; GO:0008104; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; signal transduction; GO:0007165; synaptic vesicle docking during exocytosis; GO:0016081; synaptic vesicle targeting; GO:0016080 transmembrane receptor activity; GO:0004888; structural molecule activity; GO:0005198; ; GO:0005198; ; GO:0004888; phosphatidylinositol 3-kinase activity; GO:0016303 ; EC:2.7.1.137; sugar binding; GO:0005529; ; GO:0005529; ; GO:0016303 ; EC:2.7.1.137 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; phosphoinositide 3-kinase complex; GO:0005942; plasma membrane; GO:0005886; pleated septate junction; GO:0005919; septate junction; GO:0005918 Nrx-IV Neurexin IV "CG6827, CG6827, CG6827, rsg23, rose-gespleten region interval 23, Nrx: Neurexin, nrx: neurexin, Dnrx, neurexin, Neurexin, NrxIV, Neurexin IV, NRX IV, Nx IV, Nrx IV, neurexin IV, nrx IV, CT21123, nrxIV, Neurexin-4, NRX, l(3)68Ff, l(3)rsg23, Nrx, nrx" CDMC34966 1 25 14 DAC23-I13 17-CG6834-RA_7 CG6834 CCTTCTGTACACCAACAAACGCTATCACGGCTACATTGAAAAATTGCTTCCATGGCTGGACAACAAGGG 69 FBan0006834 FBgn0037935 CG6834 3 3R CG6834 CG6834 CDMC34966 1 26 14 DAC23-I13 17-CG6834-RA_7 CG6834 CCTTCTGTACACCAACAAACGCTATCACGGCTACATTGAAAAATTGCTTCCATGGCTGGACAACAAGGG 69 FBan0006834 FBgn0037935 CG6834 3 3R CG6834 CG6834 CDMC34967 1 1 15 DAC23-M01 2-CG6870-RA_3 CG6870 CGCGTTGACGAACCTCTTGCAATCGCTGAGAATTGTGCCCTTGGGACATGGAAAGTCCAGTAATCAGGT 69 FBan0006870 FBgn0032652 CG6870 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 microsome; GO:0005792 CG6870 CG6870 cytochrome B5 CDMC34967 1 2 15 DAC23-M01 2-CG6870-RA_3 CG6870 CGCGTTGACGAACCTCTTGCAATCGCTGAGAATTGTGCCCTTGGGACATGGAAAGTCCAGTAATCAGGT 69 FBan0006870 FBgn0032652 CG6870 2 2L electron transport; GO:0006118; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 microsome; GO:0005792 CG6870 CG6870 cytochrome B5 CDMC34968 1 3 15 DAC23-M13 3-CG6884-RA_3 CG6884 CGCTAGGTCCAGAGTGCGTGAACTTGAGGAAACTAAGGCCAAACACTCACATGCAGCTCGTCAGCAGTT 69 FBan0006884 FBgn0036811 MED11 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED11 Mediator complex subunit 11 "CG6884, CG6884, Med21, dMED21, Med11, anon-WO0153538.71, BcDNA:GH01072, Mediator complex subunit 11" CDMC34968 1 4 15 DAC23-M13 3-CG6884-RA_3 CG6884 CGCTAGGTCCAGAGTGCGTGAACTTGAGGAAACTAAGGCCAAACACTCACATGCAGCTCGTCAGCAGTT 69 FBan0006884 FBgn0036811 MED11 3 3L regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED11 Mediator complex subunit 11 "CG6884, CG6884, Med21, dMED21, Med11, anon-WO0153538.71, BcDNA:GH01072, Mediator complex subunit 11" CDMC34969 1 5 15 DAC24-A01 3-CG2145-RA_1 CG2145 TGAAGGACGGCACCATTATCGGATTCCACAACTGGGTCTATATTGGCGATGAGGAAAAGGACGGTCGCT 69 FBan0002145 FBgn0030251 CG2145 X X serine-type peptidase activity; GO:0008236; ; GO:0008236 CG2145 CG2145 CDMC34969 1 6 15 DAC24-A01 3-CG2145-RA_1 CG2145 TGAAGGACGGCACCATTATCGGATTCCACAACTGGGTCTATATTGGCGATGAGGAAAAGGACGGTCGCT 69 FBan0002145 FBgn0030251 CG2145 X X serine-type peptidase activity; GO:0008236; ; GO:0008236 CG2145 CG2145 CDMC34970 1 7 15 DAC24-A13 11-CG2160-RA_1 CG2160 GGCAATATGTTGTTGATGCATTTCTACGCCCCAGTAACTAAGCGCACAGTCTCTCTTCACGTGCACGCC 69 FBan0002160 FBgn0033266 Socs44A 2 2R intracellular signaling cascade; GO:0007242 Socs44A Suppressor of Cytokine Signaling at 44A "CG2160, CG2160, SOCS, Socs44E, Suppressor of Cytokine Signaling at 44E, socs44A, SOCS44A, dmSocs44A" CDMC34970 1 8 15 DAC24-A13 11-CG2160-RA_1 CG2160 GGCAATATGTTGTTGATGCATTTCTACGCCCCAGTAACTAAGCGCACAGTCTCTCTTCACGTGCACGCC 69 FBan0002160 FBgn0033266 Socs44A 2 2R intracellular signaling cascade; GO:0007242 Socs44A Suppressor of Cytokine Signaling at 44A "CG2160, CG2160, SOCS, Socs44E, Suppressor of Cytokine Signaling at 44E, socs44A, SOCS44A, dmSocs44A" CDMC34971 1 9 15 DAC24-E01 3-CG2198-RA_2 CG2198 TGCCCTCCTTGTCGTAATAAGCCCTCAACGTCTGATTTCCATTCCCACGCAACAAGACTGGAACCCTCA 69 FBan0002198 FBgn0000071 Ama 3 3R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 antigen binding; GO:0003823; ; GO:0003823 plasma membrane; GO:0005886 Ama Amalgam "CG2198, ama, AMA, CT7244, amalgam, BG:DS00276.6, M109" CDMC34971 1 10 15 DAC24-E01 3-CG2198-RA_2 CG2198 TGCCCTCCTTGTCGTAATAAGCCCTCAACGTCTGATTTCCATTCCCACGCAACAAGACTGGAACCCTCA 69 FBan0002198 FBgn0000071 Ama 3 3R cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 antigen binding; GO:0003823; ; GO:0003823 plasma membrane; GO:0005886 Ama Amalgam "CG2198, ama, AMA, CT7244, amalgam, BG:DS00276.6, M109" CDMC34972 1 11 15 DAC24-E13 14-CG2204-RC_1 CG2204 ACCGCATGCAAGAGTCGCTGAAACTGTTTGACTCGATCTGTAACAACAAATGGTTCACGGACACCTCGA 69 FBan0002204 FBgn0001122 G-oalpha47A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; establishment of wing hair orientation; GO:0001737; heart development; GO:0007507 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 G-oalpha47A G protein oalpha 47A "CG2204, DGalpha[[o]], dgo, Goalpha, DG[[o]], G[[oalpha]], dgoalpha, alpha(o), G[[o]]alpha, Go-alpha, Go, DROGPAD, Goa, bkh, brokenheart, Galpha47A, Galpha[[047A]], Drogpad, Galphao, Bkh, brokenhearted, Galpha[[o]], Galpha[[0]], Galphao47A, G-oalpha47A, Galpha47A, DGalpha0, G-alpha-47A" CDMC34972 1 12 15 DAC24-E13 14-CG2204-RC_1 CG2204 ACCGCATGCAAGAGTCGCTGAAACTGTTTGACTCGATCTGTAACAACAAATGGTTCACGGACACCTCGA 69 FBan0002204 FBgn0001122 G-oalpha47A 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; Wnt receptor signaling pathway; GO:0016055; establishment of wing hair orientation; GO:0001737; heart development; GO:0007507 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 G-oalpha47A G protein oalpha 47A "CG2204, DGalpha[[o]], dgo, Goalpha, DG[[o]], G[[oalpha]], dgoalpha, alpha(o), G[[o]]alpha, Go-alpha, Go, DROGPAD, Goa, bkh, brokenheart, Galpha47A, Galpha[[047A]], Drogpad, Galphao, Bkh, brokenhearted, Galpha[[o]], Galpha[[0]], Galphao47A, G-oalpha47A, Galpha47A, DGalpha0, G-alpha-47A" CDMC34973 1 13 15 DAC24-I01 3-CG2254-RA_1 CG2254 GGGCGCCACCATTCTCTGCTGGGATGTCAATGAGCAGACCAATAACCAGACCGTCAAGGAGATCAAGAA 69 FBan0002254 FBgn0029994 CG2254 X X metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2254 CG2254 CDMC34973 1 14 15 DAC24-I01 3-CG2254-RA_1 CG2254 GGGCGCCACCATTCTCTGCTGGGATGTCAATGAGCAGACCAATAACCAGACCGTCAAGGAGATCAAGAA 69 FBan0002254 FBgn0029994 CG2254 X X metabolism; GO:0008152; visual perception; GO:0007601 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2254 CG2254 CDMC34974 1 15 15 DAC24-I13 15-CG2269-RB_1 CG2269 CGCTTGACATTCTAAGCAAAATGAAAGGCAGAGCTCACATTGGCAGCTAGTCCTCCAAAGTCACCGTCA 69 FBan0002269 FBgn0033484 CG2269 2 2R CG2269 CG2269 anon-WO0118547.141 CDMC34974 1 16 15 DAC24-I13 15-CG2269-RB_1 CG2269 CGCTTGACATTCTAAGCAAAATGAAAGGCAGAGCTCACATTGGCAGCTAGTCCTCCAAAGTCACCGTCA 69 FBan0002269 FBgn0033484 CG2269 2 2R CG2269 CG2269 anon-WO0118547.141 CDMC34975 1 17 15 DAC24-M01 17-CG2360-RA_1 CG2360 AGCCATCAGCACCGTTTCCGCAAAGAACTAACCCACGAATCCAAAAACCCTATAAAATGGCATTCAAGT 69 FBan0002360 FBgn0004783 Ccp84Aa 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Aa Ccp84Aa "CG2360, BG:DS00004.1, cc8: cuticle cluster 8, cuticle cluster 8" CDMC34975 1 18 15 DAC24-M01 17-CG2360-RA_1 CG2360 AGCCATCAGCACCGTTTCCGCAAAGAACTAACCCACGAATCCAAAAACCCTATAAAATGGCATTCAAGT 69 FBan0002360 FBgn0004783 Ccp84Aa 3 3R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Ccp84Aa Ccp84Aa "CG2360, BG:DS00004.1, cc8: cuticle cluster 8, cuticle cluster 8" CDMC34976 1 19 15 DAC24-M13 15-CG2397-RA_3 CG2397 AGGCGACGGGAGAATATTCATCGCAACGACCTGATCCAACTACTAATGGAATTGGGTGAGGAGGGAGTA 69 FBan0002397 FBgn0033304 Cyp6a13 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a13 Cyp6a13 "CG2397, 6a13" CDMC34976 1 20 15 DAC24-M13 15-CG2397-RA_3 CG2397 AGGCGACGGGAGAATATTCATCGCAACGACCTGATCCAACTACTAATGGAATTGGGTGAGGAGGGAGTA 69 FBan0002397 FBgn0033304 Cyp6a13 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a13 Cyp6a13 "CG2397, 6a13" CDMC34977 1 21 15 DAC25-A01 2-LacZ_3 LacZ_3 CGGGCAAACCATCGAAGTGACCAGCGAATACCTGTTCCGTCATAGCGATAACGAGCTCCTGCACT 65 CDMC34977 1 22 15 DAC25-A01 2-LacZ_3 LacZ_3 CGGGCAAACCATCGAAGTGACCAGCGAATACCTGTTCCGTCATAGCGATAACGAGCTCCTGCACT 65 CDMC34978 1 23 15 DAC25-A13 3-CG10039-RA_1 CG10039 TGTACCATGCGAATGCTACCATCGTCGTGGCCTTCTCTACTACGCGAATCCATTGGCTTGGGGTC 65 FBan0010039 FBgn0031581 CG10039 2 2L CG10039 CG10039 CDMC34978 1 24 15 DAC25-A13 3-CG10039-RA_1 CG10039 TGTACCATGCGAATGCTACCATCGTCGTGGCCTTCTCTACTACGCGAATCCATTGGCTTGGGGTC 65 FBan0010039 FBgn0031581 CG10039 2 2L CG10039 CG10039 CDMC34979 1 25 15 DAC25-E01 2-CG10157-RA_2 CG10157 CTGACCGACTGGCGATCACCCTGTACTACGAAGCATTGTGTCCCTACTGCATGGAGTTCGTGACC 65 FBan0010157 FBgn0039099 CG10157 3 3R CG10157 CG10157 anon-EST:Posey120 CDMC34979 1 26 15 DAC25-E01 2-CG10157-RA_2 CG10157 CTGACCGACTGGCGATCACCCTGTACTACGAAGCATTGTGTCCCTACTGCATGGAGTTCGTGACC 65 FBan0010157 FBgn0039099 CG10157 3 3R CG10157 CG10157 anon-EST:Posey120 CDMC34980 1 1 16 DAC25-E13 2-CG10184-RA_1 CG10184 TGGCCGGAGTCCAATTAGCCACTCTGAAGAACGAGCAGGATGGCACCTTTAGTCTGCAGGATCTG 65 FBan0010184 FBgn0039094 CG10184 3 3R amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 threonine aldolase activity; GO:0004793 ; EC:4.1.2.5; ; GO:0004793 ; EC:4.1.2.5 CG10184 CG10184 CDMC34980 1 2 16 DAC25-E13 2-CG10184-RA_1 CG10184 TGGCCGGAGTCCAATTAGCCACTCTGAAGAACGAGCAGGATGGCACCTTTAGTCTGCAGGATCTG 65 FBan0010184 FBgn0039094 CG10184 3 3R amino acid catabolism; GO:0009063; aromatic amino acid family metabolism; GO:0009072 threonine aldolase activity; GO:0004793 ; EC:4.1.2.5; ; GO:0004793 ; EC:4.1.2.5 CG10184 CG10184 CDMC34981 1 3 16 DAC25-I01 3-CG10306-RA_1 CG10306 CAACCCGCACATGCTGAACTTCGACATCACGTACACCATTCTGCTGAAGTCACTGACCAGCCTGC 65 FBan0010306 FBgn0034654 CG10306 2 2R translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852; nucleus; GO:0005634 CG10306 CG10306 CDMC34981 1 4 16 DAC25-I01 3-CG10306-RA_1 CG10306 CAACCCGCACATGCTGAACTTCGACATCACGTACACCATTCTGCTGAAGTCACTGACCAGCCTGC 65 FBan0010306 FBgn0034654 CG10306 2 2R translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852; nucleus; GO:0005634 CG10306 CG10306 CDMC34982 1 5 16 DAC25-I13 3-CG10333-RA_1 CG10333 CAAGGGTCAGGAGCAGAGAGAGTATGCTTTGGCTGCTTTGAAGTCAGGCGCAAAGGACATCCTGG 65 FBan0010333 FBgn0032690 CG10333 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG10333 CG10333 "cg10333, DmRH19" CDMC34982 1 6 16 DAC25-I13 3-CG10333-RA_1 CG10333 CAAGGGTCAGGAGCAGAGAGAGTATGCTTTGGCTGCTTTGAAGTCAGGCGCAAAGGACATCCTGG 65 FBan0010333 FBgn0032690 CG10333 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" ATP binding; GO:0005524; ; GO:0005524; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682; spliceosome complex; GO:0005681 CG10333 CG10333 "cg10333, DmRH19" CDMC34983 1 7 16 DAC25-M01 3-CG10446-RA_2 CG10446 TACAGCAGCCAGGATTCGAATCCAGTGGACTACAGCAAGGGTCTGAAAATGGTAGCCGCTGAGCA 65 FBan0010446 FBgn0032741 Side 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 Side similar to Deadpan "CG10446, CG10446, CG10446, CG10446, similar to Deadpan" CDMC34983 1 8 16 DAC25-M01 3-CG10446-RA_2 CG10446 TACAGCAGCCAGGATTCGAATCCAGTGGACTACAGCAAGGGTCTGAAAATGGTAGCCGCTGAGCA 65 FBan0010446 FBgn0032741 Side 2 2L cell proliferation; GO:0008283; ectoderm development; GO:0007398; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcriptional repressor activity; GO:0016564; ; GO:0016564; ; GO:0003677 nucleus; GO:0005634 Side similar to Deadpan "CG10446, CG10446, CG10446, CG10446, similar to Deadpan" CDMC34984 1 9 16 DAC25-M13 1-CG10483-RA_1 CG10483 GTGTGGAGTACGTGTCTCTGTTGCATCCCATTGTTGCCATAATGCCTGCCTACTTCCGGTTCGCC 65 FBan0010483 FBgn0035649 CG10483 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG10483 CG10483 CDMC34984 1 10 16 DAC25-M13 1-CG10483-RA_1 CG10483 GTGTGGAGTACGTGTCTCTGTTGCATCCCATTGTTGCCATAATGCCTGCCTACTTCCGGTTCGCC 65 FBan0010483 FBgn0035649 CG10483 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930 integral to membrane; GO:0016021 CG10483 CG10483 CDMC34985 1 11 16 DAC26-A01 13-CG6164-RA_1 CG6164 AGGTAGCATGTTGTGGGAATCCAAGGATGCGAACGATCAGAACCTAATCTGTTTCCAGGTTCCCGTTGT 69 FBan0006164 FBgn0039154 CG6164 3 3R CG6164 CG6164 BcDNA:LP08842 CDMC34985 1 12 16 DAC26-A01 13-CG6164-RA_1 CG6164 AGGTAGCATGTTGTGGGAATCCAAGGATGCGAACGATCAGAACCTAATCTGTTTCCAGGTTCCCGTTGT 69 FBan0006164 FBgn0039154 CG6164 3 3R CG6164 CG6164 BcDNA:LP08842 CDMC34986 1 13 16 DAC26-A13 16-CG6175-RB_2 CG6175 TTCGGGGAATACGTGGCCATAACCATACGCAAACTAAAGACGTCCAAGTCGAAAATAGTGGTCAAGCAC 69 FBan0006175 FBgn0036152 CG6175 3 3L CG6175 CG6175 anon-WO0257455.23 CDMC34986 1 14 16 DAC26-A13 16-CG6175-RB_2 CG6175 TTCGGGGAATACGTGGCCATAACCATACGCAAACTAAAGACGTCCAAGTCGAAAATAGTGGTCAAGCAC 69 FBan0006175 FBgn0036152 CG6175 3 3L CG6175 CG6175 anon-WO0257455.23 CDMC34987 1 15 16 DAC26-E01 13-CG6204-RA_1 CG6204 GGCACCGGAAAAACACACCTTTCAGTGCAGTTGGTTAACAGTTTGATACAGAATGCTAAAGCCCTGGGC 69 FBan0006204 FBgn0039165 CG6204 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; RNA catabolism; GO:0006401; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678 CG6204 CG6204 CDMC34987 1 16 16 DAC26-E01 13-CG6204-RA_1 CG6204 GGCACCGGAAAAACACACCTTTCAGTGCAGTTGGTTAACAGTTTGATACAGAATGCTAAAGCCCTGGGC 69 FBan0006204 FBgn0039165 CG6204 3 3R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; RNA catabolism; GO:0006401; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386; ; GO:0003678 CG6204 CG6204 CDMC34988 1 17 16 DAC26-E13 16-CG6213-RA_1 CG6213 TGGCCCCCCAAACTGTGCGCTGTAAATTCAATGTCCACGTTCAACTCTAATCCATAATTTAGACCCGTA 69 FBan0006213 FBgn0026753 Vha13 3 3R embryonic development (sensu Insecta); GO:0001700; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V1 domain; GO:0000221 Vha13 Vacuolar H[+] ATPase G-subunit "CG6213, l(3)05113, VhaG, vha13, V-ATPase, BcDNA:AT14009" CDMC34988 1 18 16 DAC26-E13 16-CG6213-RA_1 CG6213 TGGCCCCCCAAACTGTGCGCTGTAAATTCAATGTCCACGTTCAACTCTAATCCATAATTTAGACCCGTA 69 FBan0006213 FBgn0026753 Vha13 3 3R embryonic development (sensu Insecta); GO:0001700; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V1 domain; GO:0000221 Vha13 Vacuolar H[+] ATPase G-subunit "CG6213, l(3)05113, VhaG, vha13, V-ATPase, BcDNA:AT14009" CDMC34989 1 19 16 DAC26-I01 12-CG6246-RA_3 CG6246 ACTGCAAGGGAGGTCACGTTTAGGGACAAAGACAGTGCAATGTGCGGGATAAATCGAAGGAAGCTTAGC 69 FBan0006246 FBgn0002970 nub 2 2L ectoderm development; GO:0007398; ganglion mother cell fate determination; GO:0007402; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 nub nubbin "CG6246, CG6246, pdm-1, dPOU-19, dPOU19, POU33F1, dOct1, pdm1: POU domain protein 1, dPOU-19/pdm-1, Oct-1, pdm, Pdm, Pdm-1, Pdm1, nb, POU domain protein 1, PDM1, twn: twain, twain, pdm1" CDMC34989 1 20 16 DAC26-I01 12-CG6246-RA_3 CG6246 ACTGCAAGGGAGGTCACGTTTAGGGACAAAGACAGTGCAATGTGCGGGATAAATCGAAGGAAGCTTAGC 69 FBan0006246 FBgn0002970 nub 2 2L ectoderm development; GO:0007398; ganglion mother cell fate determination; GO:0007402; neuroblast fate determination; GO:0007400; pattern specification; GO:0007389; regulation of transcription from RNA polymerase II promoter; GO:0006357; ventral cord development; GO:0007419 transcription factor activity; GO:0003700; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 nub nubbin "CG6246, CG6246, pdm-1, dPOU-19, dPOU19, POU33F1, dOct1, pdm1: POU domain protein 1, dPOU-19/pdm-1, Oct-1, pdm, Pdm, Pdm-1, Pdm1, nb, POU domain protein 1, PDM1, twn: twain, twain, pdm1" CDMC34990 1 21 16 DAC26-I13 9-CG6265-RA_2 CG6265 CGCCTGGTAAAGTCCACCTCTTGGATGGATGCAGCTACCAAGCGGAAAACCATTCAAAAGTCAGCTGAG 69 FBan0006265 FBgn0039478 Nep5 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep5 Neprilysin 5 "CG6265, Neprilysin 5" CDMC34990 1 22 16 DAC26-I13 9-CG6265-RA_2 CG6265 CGCCTGGTAAAGTCCACCTCTTGGATGGATGCAGCTACCAAGCGGAAAACCATTCAAAAGTCAGCTGAG 69 FBan0006265 FBgn0039478 Nep5 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep5 Neprilysin 5 "CG6265, Neprilysin 5" CDMC34991 1 23 16 DAC26-M01 18-CG6310-RA_5 CG6310 GAGGGCATTATCAAGCAGAGTCAACCGGAAAAGGTCTGGGAGTATGTGGCGGATTTTAATAAGATGCGT 69 FBan0006310 FBgn0036121 CG6310 3 3L CG6310 CG6310 BcDNA:AT03632 CDMC34991 1 24 16 DAC26-M01 18-CG6310-RA_5 CG6310 GAGGGCATTATCAAGCAGAGTCAACCGGAAAAGGTCTGGGAGTATGTGGCGGATTTTAATAAGATGCGT 69 FBan0006310 FBgn0036121 CG6310 3 3L CG6310 CG6310 BcDNA:AT03632 CDMC34992 1 25 16 DAC26-M13 1-CG6324-RA_1 CG6324 GCCGCCAAACAAGACTATTTGGAGTTTTGAGCGCCATGATCCCAAGCCAAGACATGTGACACCCAATCC 69 FBan0006324 FBgn0030647 CG6324 X X CG6324 CG6324 CDMC34992 1 26 16 DAC26-M13 1-CG6324-RA_1 CG6324 GCCGCCAAACAAGACTATTTGGAGTTTTGAGCGCCATGATCCCAAGCCAAGACATGTGACACCCAATCC 69 FBan0006324 FBgn0030647 CG6324 X X CG6324 CG6324 CDMC34993 1 1 17 DAC27-A01 1-CG3672-RA_1 CG3672 GGTCAGGATGGTTTGGGTCAATTTGCCTATGGCTATAGGGATTGGAACCAGGGCAAGAACGAGAAGCGC 69 FBan0003672 FBgn0035985 CG3672 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG3672 CG3672 CDMC34993 1 2 17 DAC27-A01 1-CG3672-RA_1 CG3672 GGTCAGGATGGTTTGGGTCAATTTGCCTATGGCTATAGGGATTGGAACCAGGGCAAGAACGAGAAGCGC 69 FBan0003672 FBgn0035985 CG3672 3 3L structural constituent of cuticle; GO:0042302; ; GO:0042302 CG3672 CG3672 CDMC34994 1 3 17 DAC27-A13 3-CG3690-RA_10 CG3690 CGTCCCCTTTTCACCAAACCCTACTTGGGCCTATCCCTTTGGGTGTATCTCCTCAACTTTTGCGTGCTC 69 FBan0003690 FBgn0040350 CG3690 X X neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG3690 CG3690 "EG:BACR7A4.13, anon-WO0140519.250" CDMC34994 1 4 17 DAC27-A13 3-CG3690-RA_10 CG3690 CGTCCCCTTTTCACCAAACCCTACTTGGGCCTATCCCTTTGGGTGTATCTCCTCAACTTTTGCGTGCTC 69 FBan0003690 FBgn0040350 CG3690 X X neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG3690 CG3690 "EG:BACR7A4.13, anon-WO0140519.250" CDMC34995 1 5 17 DAC27-E01 17-CG3727-RA_1 CG3727 GGGCGGCGACTTATACGCGTATAAGCCATACTGTACAGTTGATGCAATGCTAACCTAGGCACTCTTTCA 69 FBan0003727 FBgn0010583 dock 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; axon guidance; GO:0007411; axonogenesis; GO:0007409; insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242 insulin receptor binding; GO:0005158; ; GO:0005158; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070 cytoplasm; GO:0005737 dock dreadlocks "CG3727, Dock, dck, doc, Dm0447, Nck, l(2)04723" CDMC34995 1 6 17 DAC27-E01 17-CG3727-RA_1 CG3727 GGGCGGCGACTTATACGCGTATAAGCCATACTGTACAGTTGATGCAATGCTAACCTAGGCACTCTTTCA 69 FBan0003727 FBgn0010583 dock 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; axon guidance; GO:0007411; axonogenesis; GO:0007409; insulin receptor signaling pathway; GO:0008286; intracellular signaling cascade; GO:0007242 insulin receptor binding; GO:0005158; ; GO:0005158; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070 cytoplasm; GO:0005737 dock dreadlocks "CG3727, Dock, dck, doc, Dm0447, Nck, l(2)04723" CDMC34996 1 7 17 DAC27-E13 2-CG3739-RA_1 CG3739 TGGTCGGCGAGTCGTACGCTACCCTTGGAGGACAATATTGCTATGATCTGATCGATAACGCCACCTCGT 69 FBan0003739 FBgn0038702 CG3739 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 CG3739 CG3739 CDMC34996 1 8 17 DAC27-E13 2-CG3739-RA_1 CG3739 TGGTCGGCGAGTCGTACGCTACCCTTGGAGGACAATATTGCTATGATCTGATCGATAACGCCACCTCGT 69 FBan0003739 FBgn0038702 CG3739 3 3R proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; ; GO:0008236 CG3739 CG3739 CDMC34997 1 9 17 DAC27-I01 23-CG3777-RC_2 CG3777 AATACCCGAAAAATATAACTGATATGATTGCCAACTACCCTGCGACTATGTAAACCCAACCTTCCCCCC 69 FBan0003777 FBgn0024989 CG3777 X X CG3777 CG3777 "CK01670, EG:125H10.1, BEST:CK01670" CDMC34997 1 10 17 DAC27-I01 23-CG3777-RC_2 CG3777 AATACCCGAAAAATATAACTGATATGATTGCCAACTACCCTGCGACTATGTAAACCCAACCTTCCCCCC 69 FBan0003777 FBgn0024989 CG3777 X X CG3777 CG3777 "CK01670, EG:125H10.1, BEST:CK01670" CDMC34998 1 11 17 DAC27-I13 15-CG3793-RA_1 CG3793 GGATAGAGAGCCAACCTACTTGGATGCACTATTTATTGACTCTGCTCGGTTTGGAGGAAGGCCATGCCA 69 FBan0003793 FBgn0028507 CG3793 2 2L CG3793 CG3793 BG:DS09217.4 CDMC34998 1 12 17 DAC27-I13 15-CG3793-RA_1 CG3793 GGATAGAGAGCCAACCTACTTGGATGCACTATTTATTGACTCTGCTCGGTTTGGAGGAAGGCCATGCCA 69 FBan0003793 FBgn0028507 CG3793 2 2L CG3793 CG3793 BG:DS09217.4 CDMC34999 1 13 17 DAC27-M01 2-CG3832-RA_4 CG3832 AGCAACACAGACCCCATAATCGAGGGAGATAAGATCGCCGTGAGGTGTACTATGCAGAGCACTCGCCAT 69 FBan0003832 FBgn0019948 Phm 2 2R peptide amidation; GO:0001519; protein modification; GO:0006464 peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; copper ion binding; GO:0005507; ; GO:0005507 membrane; GO:0016020 Phm Peptidylglycine-alpha-hydroxylating monooxygenase "CG3832, CG3832, dPHM, PHM, Peptidyl gycine alpha hydroxylating monooxygenase, Peptidylglycine-alpha-hydroxylating monooxygenase" CDMC34999 1 14 17 DAC27-M01 2-CG3832-RA_4 CG3832 AGCAACACAGACCCCATAATCGAGGGAGATAAGATCGCCGTGAGGTGTACTATGCAGAGCACTCGCCAT 69 FBan0003832 FBgn0019948 Phm 2 2R peptide amidation; GO:0001519; protein modification; GO:0006464 peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; ; GO:0004504 ; EC:1.14.17.3; copper ion binding; GO:0005507; ; GO:0005507 membrane; GO:0016020 Phm Peptidylglycine-alpha-hydroxylating monooxygenase "CG3832, CG3832, dPHM, PHM, Peptidyl gycine alpha hydroxylating monooxygenase, Peptidylglycine-alpha-hydroxylating monooxygenase" CDMC35000 1 15 17 DAC27-M13 9-CG3843-RA_1 CG3843 CGTCTTCGGGGATCAGGAGCACTGTTATAAGGCCAAAGCCATAGGAGTTGATTGCCTAGATGTGGAGGC 69 FBan0003843 FBgn0038281 RpL10Aa 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Aa Ribosomal protein L10Aa "CG3843, CG3843, BcDNA:AT11516, Ribosomal protein L10Aa" CDMC35000 1 16 17 DAC27-M13 9-CG3843-RA_1 CG3843 CGTCTTCGGGGATCAGGAGCACTGTTATAAGGCCAAAGCCATAGGAGTTGATTGCCTAGATGTGGAGGC 69 FBan0003843 FBgn0038281 RpL10Aa 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL10Aa Ribosomal protein L10Aa "CG3843, CG3843, BcDNA:AT11516, Ribosomal protein L10Aa" CDMC35001 1 17 17 DAC28-A01 13-CG10168-RA_1 CG10168 TGGCGGGAAATCTGGCTCCGAGTGTATATGAACCCATATCCCCTAACGGTTTTGCTCTTGATAACACGT 69 FBan0010168 FBgn0039087 CG10168 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG10168 CG10168 CDMC35001 1 18 17 DAC28-A01 13-CG10168-RA_1 CG10168 TGGCGGGAAATCTGGCTCCGAGTGTATATGAACCCATATCCCCTAACGGTTTTGCTCTTGATAACACGT 69 FBan0010168 FBgn0039087 CG10168 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG10168 CG10168 CDMC35002 1 19 17 DAC28-A13 6-CG10178-RA_2 CG10178 GGCCAGCGAGCTTATAATGCCTACTTATCTCTGTACGATGCGGTCATGAGACGATGGGTGTACCTGCCC 69 FBan0010178 FBgn0032684 CG10178 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG10178 CG10178 CDMC35002 1 20 17 DAC28-A13 6-CG10178-RA_2 CG10178 GGCCAGCGAGCTTATAATGCCTACTTATCTCTGTACGATGCGGTCATGAGACGATGGGTGTACCTGCCC 69 FBan0010178 FBgn0032684 CG10178 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG10178 CG10178 CDMC35003 1 21 17 DAC28-E01 2-CG10214-RA_1 CG10214 GGCATCCCGCAATTCTGGATTCCGCTCCCAAAAAATCTTTCACGCATCGTAGTCTGGACGACATCCGAG 69 FBan0010214 FBgn0039115 CG10214 3 3R RNA catabolism; GO:0006401 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; oligonucleotidase activity; GO:0008946 ; EC:3.1.13.3; ; GO:0000175 ; EC:3.1.13.-; ; GO:0008946 ; EC:3.1.13.3 mitochondrion; GO:0005739; nucleus; GO:0005634 CG10214 CG10214 CDMC35003 1 22 17 DAC28-E01 2-CG10214-RA_1 CG10214 GGCATCCCGCAATTCTGGATTCCGCTCCCAAAAAATCTTTCACGCATCGTAGTCTGGACGACATCCGAG 69 FBan0010214 FBgn0039115 CG10214 3 3R RNA catabolism; GO:0006401 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; oligonucleotidase activity; GO:0008946 ; EC:3.1.13.3; ; GO:0000175 ; EC:3.1.13.-; ; GO:0008946 ; EC:3.1.13.3 mitochondrion; GO:0005739; nucleus; GO:0005634 CG10214 CG10214 CDMC35004 1 23 17 DAC28-E13 17-CG10223-RA_1 CG10223 TGGATGTTGACAGAGGAGAAGAAAAACGAGCTACTCAAACAGCGCGACACTAAACTGTCCGAGTTGGAA 69 FBan0010223 FBgn0003732 Top2 2 2L DNA replication; GO:0006260; DNA topological change; GO:0006265; mRNA transcription; GO:0009299; meiosis; GO:0007126; mitosis; GO:0007067; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; ; GO:0003677; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; ATPase activity; GO:0016887; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3; ; GO:0016887; ; GO:0003918 ; EC:5.99.1.3 NOT ACF complex; GO:0016590; NOT chromatin accessibility complex; GO:0008623; chromatin accessibility complex; GO:0008623; chromosome; GO:0005694; insoluble fraction; GO:0005626; nucleus; GO:0005634; soluble fraction; GO:0005625 Top2 Topoisomerase 2 "CG10223, CG10223, CG10223, topoisomerase II, type II topoisomerase, Topoisomerase II, topo II, TopII, topoII, CHRAC, TopoII, top2, TOP2, Topo II, type II DNA topoisomerase, dCHRAC, TOPOII, dTopoII" CDMC35004 1 24 17 DAC28-E13 17-CG10223-RA_1 CG10223 TGGATGTTGACAGAGGAGAAGAAAAACGAGCTACTCAAACAGCGCGACACTAAACTGTCCGAGTTGGAA 69 FBan0010223 FBgn0003732 Top2 2 2L DNA replication; GO:0006260; DNA topological change; GO:0006265; mRNA transcription; GO:0009299; meiosis; GO:0007126; mitosis; GO:0007067; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; ; GO:0003677; mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; ATPase activity; GO:0016887; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0003918 ; EC:5.99.1.3; ; GO:0016887; ; GO:0003918 ; EC:5.99.1.3 NOT ACF complex; GO:0016590; NOT chromatin accessibility complex; GO:0008623; chromatin accessibility complex; GO:0008623; chromosome; GO:0005694; insoluble fraction; GO:0005626; nucleus; GO:0005634; soluble fraction; GO:0005625 Top2 Topoisomerase 2 "CG10223, CG10223, CG10223, topoisomerase II, type II topoisomerase, Topoisomerase II, topo II, TopII, topoII, CHRAC, TopoII, top2, TOP2, Topo II, type II DNA topoisomerase, dCHRAC, TOPOII, dTopoII" CDMC35005 1 25 17 DAC28-I01 1-CG10250-RA_2 CG10250 AAACCATCAAGCAGGAGTACCACAATGGCTATGGTCAGCCGACACATCCTGGATACGGATTTAGCGCCT 69 FBan0010250 FBgn0002922 nau 3 3R "cell proliferation; GO:0008283; mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of striated muscle development; GO:0016202; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 nau nautilus "CG10250, Dmyd, myogenic determination, MyoD, MYOD, Mdrf" CDMC35005 1 26 17 DAC28-I01 1-CG10250-RA_2 CG10250 AAACCATCAAGCAGGAGTACCACAATGGCTATGGTCAGCCGACACATCCTGGATACGGATTTAGCGCCT 69 FBan0010250 FBgn0002922 nau 3 3R "cell proliferation; GO:0008283; mesoderm development; GO:0007498; muscle development; GO:0007517; regulation of striated muscle development; GO:0016202; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 nau nautilus "CG10250, Dmyd, myogenic determination, MyoD, MYOD, Mdrf" CDMC35006 1 1 18 DAC28-I13 12-CG10265-RA_7 CG10265 AGACGCCCGAGAAACCAGTTCCTACCATAACAAGCAAATCAACTCCTCCATTGGATGGCACCCAGAAAA 69 FBan0010265 FBgn0033990 CG10265 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10265 CG10265 "CG30474, CG30474" CDMC35006 1 2 18 DAC28-I13 12-CG10265-RA_7 CG10265 AGACGCCCGAGAAACCAGTTCCTACCATAACAAGCAAATCAACTCCTCCATTGGATGGCACCCAGAAAA 69 FBan0010265 FBgn0033990 CG10265 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG10265 CG10265 "CG30474, CG30474" CDMC35007 1 3 18 DAC28-M01 14-CG10301-RA_2 CG10301 CCCGTTTCGGTCATTTCGATCCCAATTTGTACATGCTGCGGGAGATCTATCATTTTTCGTCGATGGCCA 69 FBan0010301 FBgn0039106 CG10301 3 3R CG10301 CG10301 CDMC35007 1 4 18 DAC28-M01 14-CG10301-RA_2 CG10301 CCCGTTTCGGTCATTTCGATCCCAATTTGTACATGCTGCGGGAGATCTATCATTTTTCGTCGATGGCCA 69 FBan0010301 FBgn0039106 CG10301 3 3R CG10301 CG10301 CDMC35008 1 5 18 DAC28-M13 23-CG10315-RA_1 CG10315 GGCTACTAATCAGACTTCATCGATCGCTCAGTAGAACTCGCAGTTGTTGAATAAATAAGTTTTATTACA 69 FBan0010315 FBgn0034858 eIF2B-delta 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-delta eIF2B-delta "CG10315, CG10315, CG10315, CG10315, eIF2Bdelta, eIF2B-delta" CDMC35008 1 6 18 DAC28-M13 23-CG10315-RA_1 CG10315 GGCTACTAATCAGACTTCATCGATCGCTCAGTAGAACTCGCAGTTGTTGAATAAATAAGTTTTATTACA 69 FBan0010315 FBgn0034858 eIF2B-delta 2 2R regulation of translation; GO:0006445; translational initiation; GO:0006413 GTP binding; GO:0005525; translation initiation factor activity; GO:0003743; ; GO:0003743; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0003743; ; GO:0003743; ; GO:0005525 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-delta eIF2B-delta "CG10315, CG10315, CG10315, CG10315, eIF2Bdelta, eIF2B-delta" CDMC35009 1 7 18 DAC29-A01 1-CG13877-RA_1 CG13877 GGGTGCACCATGGGAAGGGTCGCATCCTAAGTCTCAGGTGGAATACATCAGCAACGACAAGAGAGTTGA 69 FBan0013877 FBgn0035112 CG13877 3 3L CG13877 CG13877 CDMC35009 1 8 18 DAC29-A01 1-CG13877-RA_1 CG13877 GGGTGCACCATGGGAAGGGTCGCATCCTAAGTCTCAGGTGGAATACATCAGCAACGACAAGAGAGTTGA 69 FBan0013877 FBgn0035112 CG13877 3 3L CG13877 CG13877 CDMC35010 1 9 18 DAC29-A13 23-CG13892-RA_2 CG13892 CCAAGGAGGTGGATTTTTTGGAGGAACTGCTAGAATAAGTACGATTTAAACAAGCGAAAGGTATCTTTC 69 FBan0013892 FBgn0035141 Cypl 3 3L "defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605; regulation of oviposition, post-mating; GO:0048042" peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 Cypl Cyclophilin-like "CG13892, Cyclophilin-like" CDMC35010 1 10 18 DAC29-A13 23-CG13892-RA_2 CG13892 CCAAGGAGGTGGATTTTTTGGAGGAACTGCTAGAATAAGTACGATTTAAACAAGCGAAAGGTATCTTTC 69 FBan0013892 FBgn0035141 Cypl 3 3L "defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605; regulation of oviposition, post-mating; GO:0048042" peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 Cypl Cyclophilin-like "CG13892, Cyclophilin-like" CDMC35011 1 11 18 DAC29-E01 14-CG13937-RA_1 CG13937 GCCGCAGGGGAGAGTCCGCACCAGTTCCTATGCAGCTATATTCGAGTTTAAATGAAATTGAGCAAGAGC 69 FBan0013937 FBgn0035287 CG13937 3 3L HNK-1 sulfotransferase activity; GO:0016232 ; EC:2.8.2.-; ; GO:0016232 ; EC:2.8.2.- CG13937 CG13937 CDMC35011 1 12 18 DAC29-E01 14-CG13937-RA_1 CG13937 GCCGCAGGGGAGAGTCCGCACCAGTTCCTATGCAGCTATATTCGAGTTTAAATGAAATTGAGCAAGAGC 69 FBan0013937 FBgn0035287 CG13937 3 3L HNK-1 sulfotransferase activity; GO:0016232 ; EC:2.8.2.-; ; GO:0016232 ; EC:2.8.2.- CG13937 CG13937 CDMC35012 1 13 18 DAC29-E13 2-CG13962-RA_1 CG13962 TGTCACTCACCATCAAATTCGTGCAACAAGTTGTGGACACAGTTCCGCTTGAACAACGTGGACCGGGAA 69 FBan0013962 FBgn0032824 CG13962 2 2L CG13962 CG13962 CDMC35012 1 14 18 DAC29-E13 2-CG13962-RA_1 CG13962 TGTCACTCACCATCAAATTCGTGCAACAAGTTGTGGACACAGTTCCGCTTGAACAACGTGGACCGGGAA 69 FBan0013962 FBgn0032824 CG13962 2 2L CG13962 CG13962 CDMC35013 1 15 18 DAC29-I01 5-CG14000-RA_3 CG14000 ACGCGGCTCATCCTACTGGCCAGAGCGTACTCCTCATGTGATCCTATATTGTGCCACATTTTCGTCCTT 69 FBan0014000 FBgn0031749 CG14000 2 2L CG14000 CG14000 CDMC35013 1 16 18 DAC29-I01 5-CG14000-RA_3 CG14000 ACGCGGCTCATCCTACTGGCCAGAGCGTACTCCTCATGTGATCCTATATTGTGCCACATTTTCGTCCTT 69 FBan0014000 FBgn0031749 CG14000 2 2L CG14000 CG14000 CDMC35014 1 17 18 DAC29-I13 8-CG14017-RB_1 CG14017 TCTCCGGCTACATCGATTTGGAGCACAGTTTGCGTAGATACAAGACCGCTGGATCGAAGTCTCATCCGT 69 FBan0014017 FBgn0031721 CG14017 2 2L CG14017 CG14017 CDMC35014 1 18 18 DAC29-I13 8-CG14017-RB_1 CG14017 TCTCCGGCTACATCGATTTGGAGCACAGTTTGCGTAGATACAAGACCGCTGGATCGAAGTCTCATCCGT 69 FBan0014017 FBgn0031721 CG14017 2 2L CG14017 CG14017 CDMC35015 1 19 18 DAC29-M01 3-CG1403-RB_1 CG1403 TGCCATCGACAACTCCAACAGCTTTGGTGCCATACTCGAGTACATCGATGAGCAATACGAGCGCTTCCT 69 FBan0001403 FBgn0011710 1-Sep X X cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 1-Sep Septin-1 "CG1403, CG1403, tu1, sep1, septin, iby, septin 1, Diff6, anon-19Fa, innocent bystander" CDMC35015 1 20 18 DAC29-M01 3-CG1403-RB_1 CG1403 TGCCATCGACAACTCCAACAGCTTTGGTGCCATACTCGAGTACATCGATGAGCAATACGAGCGCTTCCT 69 FBan0001403 FBgn0011710 1-Sep X X cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 1-Sep Septin-1 "CG1403, CG1403, tu1, sep1, septin, iby, septin 1, Diff6, anon-19Fa, innocent bystander" CDMC35016 1 21 18 DAC29-M13 14-CG14047-RB_1 CG14047 GGCGATCTGGAAATCTTAGCGAGACGCGAGAAGATATACTCCATGTCTCAATCGAGGAGTGGCTGTCGA 69 FBan0014047 FBgn0040390 CG14047 X X CG14047 CG14047 EG:BACH48C10.4 CDMC35016 1 22 18 DAC29-M13 14-CG14047-RB_1 CG14047 GGCGATCTGGAAATCTTAGCGAGACGCGAGAAGATATACTCCATGTCTCAATCGAGGAGTGGCTGTCGA 69 FBan0014047 FBgn0040390 CG14047 X X CG14047 CG14047 EG:BACH48C10.4 CDMC35017 1 23 18 DAC30-A01 16-CG15086-RB_3 CG15086 AGAATCCCCAGACACCAACAATCAAACTGATCAGCCTTGGAACCAGTCATACGATTATGGCCAATCCAA 69 FBan0015086 FBgn0034374 CG15086 2 2R CG15086 CG15086 CDMC35017 1 24 18 DAC30-A01 16-CG15086-RB_3 CG15086 AGAATCCCCAGACACCAACAATCAAACTGATCAGCCTTGGAACCAGTCATACGATTATGGCCAATCCAA 69 FBan0015086 FBgn0034374 CG15086 2 2R CG15086 CG15086 CDMC35018 1 25 18 DAC30-A13 17-CG15101-RA_1 CG15101 GCCGAATTTTGGCCCAGTTTGTTTGTGCCCTCTGGCTTTGAAGATTTCTTCTTTCCCAAGTCTAACGAG 69 FBan0015101 FBgn0010053 Jheh1 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; ; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- Jheh1 Juvenile hormone epoxide hydrolase 1 "CG15101, JH, Jheh: Juvenile hormone epoxide hydrolase, microsomal apoxide hydrolase, JHEH, JH-epoxide hydrolase, BEST:GH06241, Juvenile hormone epoxide hydrolase, Jheh" CDMC35018 1 26 18 DAC30-A13 17-CG15101-RA_1 CG15101 GCCGAATTTTGGCCCAGTTTGTTTGTGCCCTCTGGCTTTGAAGATTTCTTCTTTCCCAAGTCTAACGAG 69 FBan0015101 FBgn0010053 Jheh1 2 2R defense response; GO:0006952; juvenile hormone catabolism; GO:0006719; response to toxin; GO:0009636 juvenile hormone epoxide hydrolase activity; GO:0008096 ; EC:3.3.2.-; ; GO:0008096 ; EC:3.3.2.-; epoxide hydrolase activity; GO:0004301 ; EC:3.3.2.3; ; GO:0004301 ; EC:3.3.2.3; ; GO:0008096 ; EC:3.3.2.- Jheh1 Juvenile hormone epoxide hydrolase 1 "CG15101, JH, Jheh: Juvenile hormone epoxide hydrolase, microsomal apoxide hydrolase, JHEH, JH-epoxide hydrolase, BEST:GH06241, Juvenile hormone epoxide hydrolase, Jheh" CDMC35019 1 1 19 DAC30-E01 10-CG15128-RA_1 CG15128 TGCTGTGCAAGAATCCAAACCTTTTGCTACCCCAGTGCAAGGAGTCCTCATACTTCCTTCAGCAGCTTT 69 FBan0015128 FBgn0034467 CG15128 2 2R CG15128 CG15128 CDMC35019 1 2 19 DAC30-E01 10-CG15128-RA_1 CG15128 TGCTGTGCAAGAATCCAAACCTTTTGCTACCCCAGTGCAAGGAGTCCTCATACTTCCTTCAGCAGCTTT 69 FBan0015128 FBgn0034467 CG15128 2 2R CG15128 CG15128 CDMC35020 1 3 19 DAC30-E13 3-CG15144-RA_3 CG15144 GGTGGCTGGAGTCCTTCAAACTGATCCAGAATCCACTCAATTTCACCCCACTTCGTCTCATGCTGCAGG 69 FBan0015144 FBgn0032648 CG15144 2 2L CG15144 CG15144 CDMC35020 1 4 19 DAC30-E13 3-CG15144-RA_3 CG15144 GGTGGCTGGAGTCCTTCAAACTGATCCAGAATCCACTCAATTTCACCCCACTTCGTCTCATGCTGCAGG 69 FBan0015144 FBgn0032648 CG15144 2 2L CG15144 CG15144 CDMC35021 1 5 19 DAC30-I01 3-CG1517-RB_6 CG1517 TGGGCAACAACTACTGGGAGACGGATTGTGGCAACTTCACTGCCAGCCTGATATACTTCTGCACCTTCT 69 FBan0001517 FBgn0002917 na X X adult locomotory behavior; GO:0008344; cation transport; GO:0006812; circadian rhythm; GO:0007623; protein biosynthesis; GO:0006412 cation channel activity; GO:0005261; structural constituent of ribosome; GO:0003735; ; GO:0005261; ; GO:0003735; voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 intracellular; GO:0005622; membrane; GO:0016020; ribosome; GO:0005840 na narrow abdomen "CG1517, CG1517, CG1517, har, har38, har85, harA, alpha1U, Dma1U, Dmalpha1U, halothane-resistant" CDMC35021 1 6 19 DAC30-I01 3-CG1517-RB_6 CG1517 TGGGCAACAACTACTGGGAGACGGATTGTGGCAACTTCACTGCCAGCCTGATATACTTCTGCACCTTCT 69 FBan0001517 FBgn0002917 na X X adult locomotory behavior; GO:0008344; cation transport; GO:0006812; circadian rhythm; GO:0007623; protein biosynthesis; GO:0006412 cation channel activity; GO:0005261; structural constituent of ribosome; GO:0003735; ; GO:0005261; ; GO:0003735; voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 intracellular; GO:0005622; membrane; GO:0016020; ribosome; GO:0005840 na narrow abdomen "CG1517, CG1517, CG1517, har, har38, har85, harA, alpha1U, Dma1U, Dmalpha1U, halothane-resistant" CDMC35022 1 7 19 DAC30-I13 15-CG1518-RA_1 CG1518 AGCACCAATTGCTGCATTCTCCTGCTTTGCCCATCATGCATTTAGTTCTACACTGGCACAAAACCACAA 69 FBan0001518 FBgn0031149 CG1518 X X protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- membrane; GO:0016020 CG1518 CG1518 CDMC35022 1 8 19 DAC30-I13 15-CG1518-RA_1 CG1518 AGCACCAATTGCTGCATTCTCCTGCTTTGCCCATCATGCATTTAGTTCTACACTGGCACAAAACCACAA 69 FBan0001518 FBgn0031149 CG1518 X X protein amino acid glycosylation; GO:0006486 oligosaccharyl transferase activity; GO:0004576 ; EC:2.4.1.-; ; GO:0004576 ; EC:2.4.1.- membrane; GO:0016020 CG1518 CG1518 CDMC35023 1 9 19 DAC30-M01 1-CG15225-RA_1 CG15225 CCTGGAGGAGAATCTTGAGCAGAACTCGGAGGTGGAGAACAGCCAGGAGTTGAATAGCGTCGAGGAGAA 69 FBan0015225 FBgn0034551 CG15225 2 2R CG15225 CG15225 CDMC35023 1 10 19 DAC30-M01 1-CG15225-RA_1 CG15225 CCTGGAGGAGAATCTTGAGCAGAACTCGGAGGTGGAGAACAGCCAGGAGTTGAATAGCGTCGAGGAGAA 69 FBan0015225 FBgn0034551 CG15225 2 2R CG15225 CG15225 CDMC35024 1 11 19 DAC30-M13 12-CG15235-RA_1 CG15235 GCCGATGGCAAGGTAAGTCCTTACTTACACCAGTCAGGAGATGAGACATCCTGGAACACTATTCCGCCG 69 FBan0015235 FBgn0033103 CG15235 2 2R Rap guanyl-nucleotide exchange factor activity; GO:0017034; ; GO:0017034 CG15235 CG15235 CDMC35024 1 12 19 DAC30-M13 12-CG15235-RA_1 CG15235 GCCGATGGCAAGGTAAGTCCTTACTTACACCAGTCAGGAGATGAGACATCCTGGAACACTATTCCGCCG 69 FBan0015235 FBgn0033103 CG15235 2 2R Rap guanyl-nucleotide exchange factor activity; GO:0017034; ; GO:0017034 CG15235 CG15235 CDMC35025 1 13 19 DAC31-A01 3-CG12245-RA_1 CG12245 GGGAGTGGACAACTCGTGGAACATTCAAATGGACGCGACATATCACCCAGTCAACAGCACGGATCCC 67 FBan0012245 FBgn0014179 gcm 2 2L "NOT crystal cell differentiation; GO:0042688; cell proliferation; GO:0008283; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; embryonic plasmatocyte differentiation; GO:0035164; glial cell differentiation; GO:0010001; glial cell fate determination; GO:0007403; gliogenesis; GO:0042063; hemocyte development; GO:0007516; hemopoiesis; GO:0030097; lymph gland plasmatocyte differentiation; GO:0035169; plasmatocyte differentiation; GO:0042387; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 gcm glial cells missing "CG12245, glide, glial cell deficient, glide/gcm, Gcm, N7-4, glide glide2, GCM, GCM1, l(2)N7-4, ucc: upper class chordotonals, upper class chordotonals, glial cells missing" CDMC35025 1 14 19 DAC31-A01 3-CG12245-RA_1 CG12245 GGGAGTGGACAACTCGTGGAACATTCAAATGGACGCGACATATCACCCAGTCAACAGCACGGATCCC 67 FBan0012245 FBgn0014179 gcm 2 2L "NOT crystal cell differentiation; GO:0042688; cell proliferation; GO:0008283; defense response; GO:0006952; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; embryonic plasmatocyte differentiation; GO:0035164; glial cell differentiation; GO:0010001; glial cell fate determination; GO:0007403; gliogenesis; GO:0042063; hemocyte development; GO:0007516; hemopoiesis; GO:0030097; lymph gland plasmatocyte differentiation; GO:0035169; plasmatocyte differentiation; GO:0042387; regulation of transcription; GO:0045449; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 gcm glial cells missing "CG12245, glide, glial cell deficient, glide/gcm, Gcm, N7-4, glide glide2, GCM, GCM1, l(2)N7-4, ucc: upper class chordotonals, upper class chordotonals, glial cells missing" CDMC35026 1 15 19 DAC31-A13 3-CG12612-RA_2 CG12612 GCGTGCACATGGAATCCGCATCATATTCCTGTTCCTGCACCATGTTGCATGTTGCATGGACTGACCT 67 FBan0012612 FBgn0030896 CG12612 X X CG12612 CG12612 CDMC35026 1 16 19 DAC31-A13 3-CG12612-RA_2 CG12612 GCGTGCACATGGAATCCGCATCATATTCCTGTTCCTGCACCATGTTGCATGTTGCATGGACTGACCT 67 FBan0012612 FBgn0030896 CG12612 X X CG12612 CG12612 CDMC35027 1 17 19 DAC31-E01 1-CG13067-RB_1 CG13067 TTGGCTGGCTTCAAAATGGACTTGGAACCGATCTGGGAATGGATGTGCATACCAATGGCCACGCATC 67 FBan0013067 FBgn0036589 CG13067 3 3L CG13067 CG13067 "anon-WO0153538.39, anon-WO0153538.46" CDMC35027 1 18 19 DAC31-E01 1-CG13067-RB_1 CG13067 TTGGCTGGCTTCAAAATGGACTTGGAACCGATCTGGGAATGGATGTGCATACCAATGGCCACGCATC 67 FBan0013067 FBgn0036589 CG13067 3 3L CG13067 CG13067 "anon-WO0153538.39, anon-WO0153538.46" CDMC35028 1 19 19 DAC31-E13 1-CG13206-RA_1 CG13206 GCATCGCTTGGATCTGCATCCCTACACGTTCTGGTTCCTCTACATCTGGCAGAGTCTGACCTCGCAG 67 FBan0013206 FBgn0026385 Or47b 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or47b Odorant receptor 47b "CG13206, CG13206, CG13206, DOR47E.2, Olfactory receptor 47E.2, 47E.2, DOR25, Or47E.2, 47b" CDMC35028 1 20 19 DAC31-E13 1-CG13206-RA_1 CG13206 GCATCGCTTGGATCTGCATCCCTACACGTTCTGGTTCCTCTACATCTGGCAGAGTCTGACCTCGCAG 67 FBan0013206 FBgn0026385 Or47b 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or47b Odorant receptor 47b "CG13206, CG13206, CG13206, DOR47E.2, Olfactory receptor 47E.2, 47E.2, DOR25, Or47E.2, 47b" CDMC35029 1 21 19 DAC31-I01 1-CG13558-RA_1 CG13558 CCTCTCACCATTCTGGAGCAACCGATGATCTTCGAGTTCGGCGGCTTTCTCTTCAAGCAGCACTTCT 67 FBan0013558 FBgn0034869 CG13558 2 2R CG13558 CG13558 CDMC35029 1 22 19 DAC31-I01 1-CG13558-RA_1 CG13558 CCTCTCACCATTCTGGAGCAACCGATGATCTTCGAGTTCGGCGGCTTTCTCTTCAAGCAGCACTTCT 67 FBan0013558 FBgn0034869 CG13558 2 2R CG13558 CG13558 CDMC35030 1 23 19 DAC31-I13 2-CG13625-RA_6 CG13625 GCCCAGAAGGAGGAAAGATTCCGATCAAAGCCCACCTCGAAGGCGTAAAGCAGACGATCAATCTCCG 67 FBan0013625 FBgn0039210 CG13625 3 3R CG13625 CG13625 anon-WO0118547.376 CDMC35030 1 24 19 DAC31-I13 2-CG13625-RA_6 CG13625 GCCCAGAAGGAGGAAAGATTCCGATCAAAGCCCACCTCGAAGGCGTAAAGCAGACGATCAATCTCCG 67 FBan0013625 FBgn0039210 CG13625 3 3R CG13625 CG13625 anon-WO0118547.376 CDMC35031 1 25 19 DAC31-M01 15-CG13930-RA_6 CG13930 ACGGAGGTGTGGAGGTTAGGGATATTTCTGGACAGGATCTGCCACCACTAGCTGTATCGCAGCGTTT 67 FBan0013930 FBgn0035256 CG13930 3 3L microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG13930 CG13930 CDMC35031 1 26 19 DAC31-M01 15-CG13930-RA_6 CG13930 ACGGAGGTGTGGAGGTTAGGGATATTTCTGGACAGGATCTGCCACCACTAGCTGTATCGCAGCGTTT 67 FBan0013930 FBgn0035256 CG13930 3 3L microtubule-based movement; GO:0007018 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG13930 CG13930 CDMC35032 1 1 20 DAC31-M13 3-CG14109-RA_2 CG14109 GCCGAGCTCCTGAATTCCATGCTTAACATGTTCACGGACTTCACCAGTGATCTACGCGGTCAAGCGG 67 FBan0014109 FBgn0036364 CG14109 3 3L CG14109 CG14109 CDMC35032 1 2 20 DAC31-M13 3-CG14109-RA_2 CG14109 GCCGAGCTCCTGAATTCCATGCTTAACATGTTCACGGACTTCACCAGTGATCTACGCGGTCAAGCGG 67 FBan0014109 FBgn0036364 CG14109 3 3L CG14109 CG14109 CDMC35033 1 3 20 DAC32-A01 3-CG31695-RA_4 CG31695 AGCGTCCTTTGAGCGAGCAAATGGAGATGATTGATATCCTGGATTTGGGTGACCGTCCGAGACGACAGG 69 FBan0031695 FBgn0005590 scw 2 2L "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; cell fate specification; GO:0001708; cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; dorsal/ventral pattern formation; GO:0009953; growth; GO:0040007; mesoderm development; GO:0007498; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179; zygotic determination of anterior/posterior axis, embryo; GO:0007354" transforming growth factor beta receptor binding; GO:0005160; ; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160 extracellular region; GO:0005576 scw screw "CG31695, l(2)37Ff, Scw, BcDNA:LD30945, l(2)IG76, screw" CDMC35033 1 4 20 DAC32-A01 3-CG31695-RA_4 CG31695 AGCGTCCTTTGAGCGAGCAAATGGAGATGATTGATATCCTGGATTTGGGTGACCGTCCGAGACGACAGG 69 FBan0031695 FBgn0005590 scw 2 2L "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; cell fate specification; GO:0001708; cell-cell signaling; GO:0007267; cellular physiological process; GO:0050875; dorsal/ventral pattern formation; GO:0009953; growth; GO:0040007; mesoderm development; GO:0007498; skeletal development; GO:0001501; transforming growth factor beta receptor signaling pathway; GO:0007179; zygotic determination of anterior/posterior axis, embryo; GO:0007354" transforming growth factor beta receptor binding; GO:0005160; ; GO:0005160; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0005160 extracellular region; GO:0005576 scw screw "CG31695, l(2)37Ff, Scw, BcDNA:LD30945, l(2)IG76, screw" CDMC35034 1 5 20 DAC32-A13 23-CG31708-RB_3 CG31708 AAAGCAAGAAAGCATGTTGAATGTTGAGAAATATAATTGAATTGAACGCAGAGCTATGGACACAATGGA 69 FBan0031708 FBgn0051708 CG31708 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31708 CG31708 "CG13103, CG13104, CG13105, CT32337, CT32338" CDMC35034 1 6 20 DAC32-A13 23-CG31708-RB_3 CG31708 AAAGCAAGAAAGCATGTTGAATGTTGAGAAATATAATTGAATTGAACGCAGAGCTATGGACACAATGGA 69 FBan0031708 FBgn0051708 CG31708 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31708 CG31708 "CG13103, CG13104, CG13105, CT32337, CT32338" CDMC35035 1 7 20 DAC32-E01 2-CG31739-RA_4 CG31739 CCTAGGCAAGGAGTTCAAGGGTACGTTGTTCGTGCGCAAATTTGGCCCAACAAAGGATGTGCAGGAGAA 69 FBan0031739 FBgn0051739 CG31739 2 2L aspartyl-tRNA aminoacylation; GO:0006422; lysyl-tRNA aminoacylation; GO:0006430 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0003729; ; GO:0004815 ; EC:6.1.1.12; lysine-tRNA ligase activity; GO:0004824 ; EC:6.1.1.6; ; GO:0004824 ; EC:6.1.1.6 cytoplasm; GO:0005737 CG31739 CG31739 CG17938 CDMC35035 1 8 20 DAC32-E01 2-CG31739-RA_4 CG31739 CCTAGGCAAGGAGTTCAAGGGTACGTTGTTCGTGCGCAAATTTGGCCCAACAAAGGATGTGCAGGAGAA 69 FBan0031739 FBgn0051739 CG31739 2 2L aspartyl-tRNA aminoacylation; GO:0006422; lysyl-tRNA aminoacylation; GO:0006430 mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0005524; aspartate-tRNA ligase activity; GO:0004815 ; EC:6.1.1.12; ; GO:0003729; ; GO:0004815 ; EC:6.1.1.12; lysine-tRNA ligase activity; GO:0004824 ; EC:6.1.1.6; ; GO:0004824 ; EC:6.1.1.6 cytoplasm; GO:0005737 CG31739 CG31739 CG17938 CDMC35036 1 9 20 DAC32-E13 3-CG31747-RA_1 CG31747 GGAATCATTGGATCGCTTGGGGTTCAACGAATTCGTGGGAATGGCTTCGGATTTCTGGATGTCGGCCAT 69 FBan0031747 FBgn0045487 Gr36a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36a Gustatory receptor 36a "CG31747, CG31747, LU.1, Gustatory receptor LU.1, Gr36B1, GrLU1, GRLU.1, Gustatory receptor 36a" CDMC35036 1 10 20 DAC32-E13 3-CG31747-RA_1 CG31747 GGAATCATTGGATCGCTTGGGGTTCAACGAATTCGTGGGAATGGCTTCGGATTTCTGGATGTCGGCCAT 69 FBan0031747 FBgn0045487 Gr36a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr36a Gustatory receptor 36a "CG31747, CG31747, LU.1, Gustatory receptor LU.1, Gr36B1, GrLU1, GRLU.1, Gustatory receptor 36a" CDMC35037 1 11 20 DAC32-I01 22-CG31770-RB_1 CG31770 ACTGCATTCGACGCCATTATGGTTCATATTCTGTGAAAGAGCAATGCAAGCCCATTGAAAGTACCGCAT 69 FBgn0044869 CDMC35037 1 12 20 DAC32-I01 22-CG31770-RB_1 CG31770 ACTGCATTCGACGCCATTATGGTTCATATTCTGTGAAAGAGCAATGCAAGCCCATTGAAAGTACCGCAT 69 FBgn0044869 CDMC35038 1 13 20 DAC32-I13 23-CG31779-RA_6 CG31779 TGCTTGGCATATTTCAAGCTCTGGACCTATGATTCCAAAAAGAACAAATGCGTTATCTTTATCTACGGA 69 FBan0031779 FBgn0051779 Acp24A4 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Acp24A4 Acp24A4 CG31779 CDMC35038 1 14 20 DAC32-I13 23-CG31779-RA_6 CG31779 TGCTTGGCATATTTCAAGCTCTGGACCTATGATTCCAAAAAGAACAAATGCGTTATCTTTATCTACGGA 69 FBan0031779 FBgn0051779 Acp24A4 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867 Acp24A4 Acp24A4 CG31779 CDMC35039 1 15 20 DAC32-M01 24-CG31810-RA_5 CG31810 TATTAAGTGAAACATGGCTCTTATTTTGCAAGTGATTTCTACAGGAATCTACATAGTGGGTTCTCTTAG 69 FBan0031810 FBgn0051810 CG31810 2 2L lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016229 ; EC:1.1.1.- CG31810 CG31810 BcDNA:RE06583 CDMC35039 1 16 20 DAC32-M01 24-CG31810-RA_5 CG31810 TATTAAGTGAAACATGGCTCTTATTTTGCAAGTGATTTCTACAGGAATCTACATAGTGGGTTCTCTTAG 69 FBan0031810 FBgn0051810 CG31810 2 2L lipid metabolism; GO:0006629; steroid metabolism; GO:0008202 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; steroid dehydrogenase activity; GO:0016229 ; EC:1.1.1.-; ; GO:0016229 ; EC:1.1.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016229 ; EC:1.1.1.- CG31810 CG31810 BcDNA:RE06583 CDMC35040 1 17 20 DAC32-M13 2-CG31819-RA_1 CG31819 ACCGTCGAATCCATCAGGTCGCCCAAATTGGAGACGGTTTGACTACCCCTTTGGAAAGTCCATCGAACA 69 FBan0031819 FBgn0028893 CG31819 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31819 CG31819 "BG:DS02795.3, BcDNA:AT12868" CDMC35040 1 18 20 DAC32-M13 2-CG31819-RA_1 CG31819 ACCGTCGAATCCATCAGGTCGCCCAAATTGGAGACGGTTTGACTACCCCTTTGGAAAGTCCATCGAACA 69 FBan0031819 FBgn0028893 CG31819 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31819 CG31819 "BG:DS02795.3, BcDNA:AT12868" CDMC35041 1 19 20 DAC33-A01 2-CG15505-RA_1 CG15505 CGCGCAGATGGTCTACGAGGATCTAGAGAAGTGTCGCCAAGAAAGCCAAGAAGAGGATGCTGCTACCCT 69 FBan0015505 FBgn0039684 Obp99d 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp99d Odorant-binding protein 99d "CG15505, CG155505, CG15505, CG155505, CG15505, CG15505, CG15505, 99d, Obp99c, Odorant-binding protein 99d" CDMC35041 1 20 20 DAC33-A01 2-CG15505-RA_1 CG15505 CGCGCAGATGGTCTACGAGGATCTAGAGAAGTGTCGCCAAGAAAGCCAAGAAGAGGATGCTGCTACCCT 69 FBan0015505 FBgn0039684 Obp99d 3 3R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549 Obp99d Odorant-binding protein 99d "CG15505, CG155505, CG15505, CG155505, CG15505, CG15505, CG15505, 99d, Obp99c, Odorant-binding protein 99d" CDMC35042 1 21 20 DAC33-A13 23-CG15520-RA_3 CG15520 ACACACTGACTCCCCCTTTTGACACTCTGAATGTCGTAGATACTTTTGTATATCAAAGAGAACGCTTCT 69 FBan0015520 FBgn0039722 capa 3 3R cation transport; GO:0006812; epithelial fluid transport; GO:0042045; neuropeptide signaling pathway; GO:0007218; regulation of heart contraction rate; GO:0008016 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ; GO:0005184; diuretic hormone activity; GO:0008613; myostimulatory hormone activity; GO:0016084; ; GO:0008613; ; GO:0005102; ; GO:0005184; ; GO:0008613; ; GO:0016084 extracellular region; GO:0005576 capa capability "CG15520, CG15520, CG15520, CG15520, CG15520, CG15520, CG15520, CAP[[2b]], Cap-2b, CAP2b, CAP-2b, myotropin-CAP2b-like, Drm-CAP-1, Drm-CAP-2, Drm-CAP2b/MT, Drm-MT, CAP2B/pyrokinin, pyrokinin/PBAN-like, capa-1, capa-2, capa-3, CAP2b-1, CAP2b-2, CAP2b-3, cap2b-like, Drm-PVK-1, Drm-PVK-2, pyrokinin-like, myotropin, pyrokinin, CAP2B-1, CAP2B-2, CAP2B-3, Drm-PK-1, TGPSASSGLWFGPRLamide, Drm-myotropin, Cardioacceleratory peptide-2b, capability" CDMC35042 1 22 20 DAC33-A13 23-CG15520-RA_3 CG15520 ACACACTGACTCCCCCTTTTGACACTCTGAATGTCGTAGATACTTTTGTATATCAAAGAGAACGCTTCT 69 FBan0015520 FBgn0039722 capa 3 3R cation transport; GO:0006812; epithelial fluid transport; GO:0042045; neuropeptide signaling pathway; GO:0007218; regulation of heart contraction rate; GO:0008016 receptor binding; GO:0005102; neuropeptide hormone activity; GO:0005184; ; GO:0005184; diuretic hormone activity; GO:0008613; myostimulatory hormone activity; GO:0016084; ; GO:0008613; ; GO:0005102; ; GO:0005184; ; GO:0008613; ; GO:0016084 extracellular region; GO:0005576 capa capability "CG15520, CG15520, CG15520, CG15520, CG15520, CG15520, CG15520, CAP[[2b]], Cap-2b, CAP2b, CAP-2b, myotropin-CAP2b-like, Drm-CAP-1, Drm-CAP-2, Drm-CAP2b/MT, Drm-MT, CAP2B/pyrokinin, pyrokinin/PBAN-like, capa-1, capa-2, capa-3, CAP2b-1, CAP2b-2, CAP2b-3, cap2b-like, Drm-PVK-1, Drm-PVK-2, pyrokinin-like, myotropin, pyrokinin, CAP2B-1, CAP2B-2, CAP2B-3, Drm-PK-1, TGPSASSGLWFGPRLamide, Drm-myotropin, Cardioacceleratory peptide-2b, capability" CDMC35043 1 23 20 DAC33-E01 5-CG15556-RA_1 CG15556 CTGCAGCCGTGTTTAAGAGCTTCCGGACATTAGCCTCCACGAAGATATTGCTGAATCTGTGTGCTGCCC 69 FBan0015556 FBgn0039821 CG15556 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG15556 CG15556 "anon-WO0170980.178, anon-WO0170980.179" CDMC35043 1 24 20 DAC33-E01 5-CG15556-RA_1 CG15556 CTGCAGCCGTGTTTAAGAGCTTCCGGACATTAGCCTCCACGAAGATATTGCTGAATCTGTGTGCTGCCC 69 FBan0015556 FBgn0039821 CG15556 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 CG15556 CG15556 "anon-WO0170980.178, anon-WO0170980.179" CDMC35044 1 25 20 DAC33-E13 3-CG15576-RB_3 CG15576 TGCGGGGACTGCCACCAAACCCCTAGGATCTGTACCTTCTCTTACCACACTTGCCATCACTGTCTTTTG 69 FBan0015576 FBgn0029700 CG15576 X X CG15576 CG15576 CDMC35044 1 26 20 DAC33-E13 3-CG15576-RB_3 CG15576 TGCGGGGACTGCCACCAAACCCCTAGGATCTGTACCTTCTCTTACCACACTTGCCATCACTGTCTTTTG 69 FBan0015576 FBgn0029700 CG15576 X X CG15576 CG15576 CDMC35045 1 1 21 DAC33-I01 14-CG15616-RA_1 CG15616 AGTTGGCTGCCACAATCAAACCATTTGCCGAGCAGATATCGGGATTAGGTTGCTTGGACGAAGAAGATT 69 FBan0015616 FBgn0034153 Acp53C14b 2 2R Acp53C14b Acp53C14b "CG15616, CG15616" CDMC35045 1 2 21 DAC33-I01 14-CG15616-RA_1 CG15616 AGTTGGCTGCCACAATCAAACCATTTGCCGAGCAGATATCGGGATTAGGTTGCTTGGACGAAGAAGATT 69 FBan0015616 FBgn0034153 Acp53C14b 2 2R Acp53C14b Acp53C14b "CG15616, CG15616" CDMC35046 1 3 21 DAC33-I13 1-CG15631-RA_1 CG15631 TGTACGGTGTCCCATGATTCCAGCCTGTCCTCCATCAACGTTTGCTATAGCCAAGAGCAACAGAGGGAT 69 FBan0015631 FBgn0031626 CG15631 2 2L CG15631 CG15631 CDMC35046 1 4 21 DAC33-I13 1-CG15631-RA_1 CG15631 TGTACGGTGTCCCATGATTCCAGCCTGTCCTCCATCAACGTTTGCTATAGCCAAGAGCAACAGAGGGAT 69 FBan0015631 FBgn0031626 CG15631 2 2L CG15631 CG15631 CDMC35047 1 5 21 DAC33-M01 12-CG15690-RA_1 CG15690 TCGGAGACTTCGTTCTTTAATCTCGGATTTCGGAGGAAGTCCACTGTGGTCTACTACGCTCCAGCGGAT 69 FBan0015690 FBgn0038825 CG15690 3 3R CG15690 CG15690 CDMC35047 1 6 21 DAC33-M01 12-CG15690-RA_1 CG15690 TCGGAGACTTCGTTCTTTAATCTCGGATTTCGGAGGAAGTCCACTGTGGTCTACTACGCTCCAGCGGAT 69 FBan0015690 FBgn0038825 CG15690 3 3R CG15690 CG15690 CDMC35048 1 7 21 DAC33-M13 23-CG15705-RA_3 CG15705 TCGATGAGGTAGCGGATCAGTCGGTTGAATACGATTACATGAAGTATCCCAGCAATAAAGAGAAGGCAA 69 FBan0015705 FBgn0034104 CG15705 2 2R CG15705 CG15705 CDMC35048 1 8 21 DAC33-M13 23-CG15705-RA_3 CG15705 TCGATGAGGTAGCGGATCAGTCGGTTGAATACGATTACATGAAGTATCCCAGCAATAAAGAGAAGGCAA 69 FBan0015705 FBgn0034104 CG15705 2 2R CG15705 CG15705 CDMC35049 1 9 21 DAC34-A01 9-CG31116-RA_1 CG31116 GCTGGTGGAACGCACCTCCATACTCAAGGTTCACTCGTTGTTTTCCATGGTGGGTATTAACCACGCCTA 69 FBan0031116 FBgn0051116 CG31116 3 3R chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG31116 CG31116 "CG6942, CG14726, CG6942, FBgn0037951" CDMC35049 1 10 21 DAC34-A01 9-CG31116-RA_1 CG31116 GCTGGTGGAACGCACCTCCATACTCAAGGTTCACTCGTTGTTTTCCATGGTGGGTATTAACCACGCCTA 69 FBan0031116 FBgn0051116 CG31116 3 3R chloride transport; GO:0006821 chloride channel activity; GO:0005254; ; GO:0005254; voltage-gated chloride channel activity; GO:0005247; ; GO:0005247 membrane; GO:0016020 CG31116 CG31116 "CG6942, CG14726, CG6942, FBgn0037951" CDMC35050 1 11 21 DAC34-A13 6-CG31137-RD_1 CG31137 ACTGGGACCCTGAGTTCTGCGACGTCAAGCTCATCCAGACGATGATGCTTAGCAATGAGTTGAAGACGA 69 FBgn0039168 CDMC35050 1 12 21 DAC34-A13 6-CG31137-RD_1 CG31137 ACTGGGACCCTGAGTTCTGCGACGTCAAGCTCATCCAGACGATGATGCTTAGCAATGAGTTGAAGACGA 69 FBgn0039168 CDMC35051 1 13 21 DAC34-E01 14-CG31164-RA_1 CG31164 ACCAACCCATTGATCAATCTTCGTGCAGTTCGAGCTATTTTGGGCCAAACTTCTCCCATCTCCAATCGA 69 FBan0031164 FBgn0051164 CG31164 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31164 CG31164 CDMC35051 1 14 21 DAC34-E01 14-CG31164-RA_1 CG31164 ACCAACCCATTGATCAATCTTCGTGCAGTTCGAGCTATTTTGGGCCAAACTTCTCCCATCTCCAATCGA 69 FBan0031164 FBgn0051164 CG31164 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31164 CG31164 CDMC35052 1 15 21 DAC34-E13 10-CG31178-RA_1 CG31178 CCAGGATCAGGGTTAACTAGACGTCCATTTGTTCAGGAGCAAACTGGCCAAAATGTCTGGATCGAGGCG 69 FBgn0051178 CDMC35052 1 16 21 DAC34-E13 10-CG31178-RA_1 CG31178 CCAGGATCAGGGTTAACTAGACGTCCATTTGTTCAGGAGCAAACTGGCCAAAATGTCTGGATCGAGGCG 69 FBgn0051178 CDMC35053 1 17 21 DAC34-I01 2-CG31203-RA_1 CG31203 GCCACCCACTGCATTAAGTACATGTACAAGTACCGTGCTCCGTACGACGACTTGCTGAACGACGACCAG 69 FBan0031203 FBgn0051203 CG31203 3 3R CG31203 CG31203 "CG15688, CG15689" CDMC35053 1 18 21 DAC34-I01 2-CG31203-RA_1 CG31203 GCCACCCACTGCATTAAGTACATGTACAAGTACCGTGCTCCGTACGACGACTTGCTGAACGACGACCAG 69 FBan0031203 FBgn0051203 CG31203 3 3R CG31203 CG31203 "CG15688, CG15689" CDMC35054 1 19 21 DAC34-I13 1-CG31210-RA_1 CG31210 TGCCAGGCGCATCCAATTCCACCTTTGTGTGCATACAGATCATGGGATCCTGTGGAGTTACTGCATTCT 69 FBan0031210 FBgn0051210 CG31210 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31210 CG31210 CDMC35054 1 20 21 DAC34-I13 1-CG31210-RA_1 CG31210 TGCCAGGCGCATCCAATTCCACCTTTGTGTGCATACAGATCATGGGATCCTGTGGAGTTACTGCATTCT 69 FBan0031210 FBgn0051210 CG31210 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31210 CG31210 CDMC35055 1 21 21 DAC34-M01 6-CG31245-RA_1 CG31245 TGCAGCGACTAGAGTTCCTAGCAAAACCAAATCCTCGGGTTTTGGCCGATTTACTGTGCTGCTGTCACT 69 FBan0031245 FBgn0051245 CG31245 3 3R CG31245 CG31245 "CG3575, CG3575, BcDNA:AT17586" CDMC35055 1 22 21 DAC34-M01 6-CG31245-RA_1 CG31245 TGCAGCGACTAGAGTTCCTAGCAAAACCAAATCCTCGGGTTTTGGCCGATTTACTGTGCTGCTGTCACT 69 FBan0031245 FBgn0051245 CG31245 3 3R CG31245 CG31245 "CG3575, CG3575, BcDNA:AT17586" CDMC35056 1 23 21 DAC34-M13 14-CG3125-RA_4 CG3125 CTGTAAATAATTGCCAGGACAGGTAGCCCACAGGATCTGGATGGGGATCAACGCATACCAAACAAGCAA 69 FBgn0029797 CDMC35056 1 24 21 DAC34-M13 14-CG3125-RA_4 CG3125 CTGTAAATAATTGCCAGGACAGGTAGCCCACAGGATCTGGATGGGGATCAACGCATACCAAACAAGCAA 69 FBgn0029797 CDMC35057 1 25 21 DAC35-A01 23-CG7770-RA_2 CG7770 GGTGAAGCAACTGTTTCATTAAACACCCTATTCCGAACAAACACCTGCTGTATCTAAACCAAAATG 66 FBan0007770 FBgn0036918 CG7770 3 3L 'de novo' protein folding; GO:0006458 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG7770 CG7770 BcDNA:GH28557 CDMC35057 1 26 21 DAC35-A01 23-CG7770-RA_2 CG7770 GGTGAAGCAACTGTTTCATTAAACACCCTATTCCGAACAAACACCTGCTGTATCTAAACCAAAATG 66 FBan0007770 FBgn0036918 CG7770 3 3L 'de novo' protein folding; GO:0006458 chaperone binding; GO:0051087; ; GO:0051087 prefoldin complex; GO:0016272 CG7770 CG7770 BcDNA:GH28557 CDMC35058 1 1 22 DAC35-A13 1-CG7861-RA_3 CG7861 CGTCATCCCAAATCACTGAGCTTGAGCCCTCATTTCGGCAGCTCAAACGCATCAACCTTCGCAGTT 66 FBan0007861 FBgn0033055 CG7861 2 2R protein folding; GO:0006457; tubulin folding; GO:0007021 CG7861 CG7861 CDMC35058 1 2 22 DAC35-A13 1-CG7861-RA_3 CG7861 CGTCATCCCAAATCACTGAGCTTGAGCCCTCATTTCGGCAGCTCAAACGCATCAACCTTCGCAGTT 66 FBan0007861 FBgn0033055 CG7861 2 2R protein folding; GO:0006457; tubulin folding; GO:0007021 CG7861 CG7861 CDMC35059 1 3 22 DAC35-E01 1-CG8281-RA_1 CG8281 AACTCGGAGAAGTTTCTAGCCGTCAATCCCGCCTTTAAGAACGAGCCCAACTTCGCCTTCGGTGAG 66 FBan0008281 FBgn0035824 CG8281 3 3L CG8281 CG8281 CDMC35059 1 4 22 DAC35-E01 1-CG8281-RA_1 CG8281 AACTCGGAGAAGTTTCTAGCCGTCAATCCCGCCTTTAAGAACGAGCCCAACTTCGCCTTCGGTGAG 66 FBan0008281 FBgn0035824 CG8281 3 3L CG8281 CG8281 CDMC35060 1 5 22 DAC35-E13 3-CG8362-RA_3 CG8362 GGCTTTCGGTTGACAGCCATGCGCATGATTCTAATGGCCCGAATCAACTGCGAGGAGTTCTACGAA 66 FBan0008362 FBgn0028997 nmdyn-D7 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228 ATP binding; GO:0005524; ; GO:0005524; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 nmdyn-D7 nmdyn-D7 CG8362 CDMC35060 1 6 22 DAC35-E13 3-CG8362-RA_3 CG8362 GGCTTTCGGTTGACAGCCATGCGCATGATTCTAATGGCCCGAATCAACTGCGAGGAGTTCTACGAA 66 FBan0008362 FBgn0028997 nmdyn-D7 3 3R CTP biosynthesis; GO:0006241; GTP biosynthesis; GO:0006183; UTP biosynthesis; GO:0006228 ATP binding; GO:0005524; ; GO:0005524; nucleoside diphosphate kinase activity; GO:0004550 ; EC:2.7.4.6; ; GO:0004550 ; EC:2.7.4.6 nmdyn-D7 nmdyn-D7 CG8362 CDMC35061 1 7 22 DAC35-I01 3-CG9020-RA_1 CG9020 AACGGGGGGAATCGTTCTACCAATCACGTATGCTGTCCGTTGTGGAATACTTGCGAGGCAAGGGTC 66 FBgn0030698 CDMC35061 1 8 22 DAC35-I01 3-CG9020-RA_1 CG9020 AACGGGGGGAATCGTTCTACCAATCACGTATGCTGTCCGTTGTGGAATACTTGCGAGGCAAGGGTC 66 FBgn0030698 CDMC35062 1 9 22 DAC35-I13 3-CG9173-RA_2 CG9173 CCCTGCATCATCTGTGGCTTGCAAGTTCCGCAAATGGATAAGGAGGTCAGGATGAAGAAGCCACCG 66 FBan0009173 FBgn0035218 CG9173 3 3L CG9173 CG9173 CDMC35062 1 10 22 DAC35-I13 3-CG9173-RA_2 CG9173 CCCTGCATCATCTGTGGCTTGCAAGTTCCGCAAATGGATAAGGAGGTCAGGATGAAGAAGCCACCG 66 FBan0009173 FBgn0035218 CG9173 3 3L CG9173 CG9173 CDMC35063 1 11 22 DAC35-M01 3-CG9667-RA_1 CG9667 CTACGGCTATCGAGATGACGAAGATGGTGTTCTGATCCCTCTGGAGGAACGCATCGAACGAGCGGC 66 FBan0009667 FBgn0037550 CG9667 3 3R CG9667 CG9667 CDMC35063 1 12 22 DAC35-M01 3-CG9667-RA_1 CG9667 CTACGGCTATCGAGATGACGAAGATGGTGTTCTGATCCCTCTGGAGGAACGCATCGAACGAGCGGC 66 FBan0009667 FBgn0037550 CG9667 3 3R CG9667 CG9667 CDMC35064 1 13 22 DAC35-M13 2-CG9809-RA_1 CG9809 GCACCATCAGCTTCCGGTACTGTACTTCAGGGCCACAGTCAGATGTGACATTTTGGCAGAAACCGG 66 FBan0009809 FBgn0037248 CG9809 3 3R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 mRNA binding; GO:0003729; ; GO:0003729; sugar porter activity; GO:0005351; ; GO:0005351 CG9809 CG9809 cg9809 CDMC35064 1 14 22 DAC35-M13 2-CG9809-RA_1 CG9809 GCACCATCAGCTTCCGGTACTGTACTTCAGGGCCACAGTCAGATGTGACATTTTGGCAGAAACCGG 66 FBan0009809 FBgn0037248 CG9809 3 3R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 mRNA binding; GO:0003729; ; GO:0003729; sugar porter activity; GO:0005351; ; GO:0005351 CG9809 CG9809 cg9809 CDMC35065 1 15 22 DAC36-A01 5-CG1801-RA_1 CG1801 GTCTGTTGTGCATGATCCGTGGTGTTCCCGAGGCTAAGATCGGCGAGAAGATGCATGACCTGTGC 65 FBan0001801 FBgn0031171 CG1801 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1801 CG1801 CDMC35065 1 16 22 DAC36-A01 5-CG1801-RA_1 CG1801 GTCTGTTGTGCATGATCCGTGGTGTTCCCGAGGCTAAGATCGGCGAGAAGATGCATGACCTGTGC 65 FBan0001801 FBgn0031171 CG1801 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG1801 CG1801 CDMC35066 1 17 22 DAC36-A13 23-CG18111-RA_1 CG18111 AAGTAATTGATTTCCCATACAAGTTCGAGCATTCCTTCTCGATTCAGTGGGGAAAAACAGAATGT 65 FBan0018111 FBgn0039678 Obp99a 3 3R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp99a Odorant-binding protein 99a "CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, OBP99a, 99a, BcDNA:RH70762, Odorant-binding protein 99a" CDMC35066 1 18 22 DAC36-A13 23-CG18111-RA_1 CG18111 AAGTAATTGATTTCCCATACAAGTTCGAGCATTCCTTCTCGATTCAGTGGGGAAAAACAGAATGT 65 FBan0018111 FBgn0039678 Obp99a 3 3R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp99a Odorant-binding protein 99a "CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, CG18111, OBP99a, 99a, BcDNA:RH70762, Odorant-binding protein 99a" CDMC35067 1 19 22 DAC36-E01 1-CG18294-RA_1 CG18294 CATAATGTTCAAATCCGCCGTTGTTATTCTGGCTATCGTTGCCTGCGCTGCTGCCAAGCCTGGAC 65 FBan0018294 FBgn0036873 CG18294 3 3L CG18294 CG18294 BcDNA:RE51966 CDMC35067 1 20 22 DAC36-E01 1-CG18294-RA_1 CG18294 CATAATGTTCAAATCCGCCGTTGTTATTCTGGCTATCGTTGCCTGCGCTGCTGCCAAGCCTGGAC 65 FBan0018294 FBgn0036873 CG18294 3 3L CG18294 CG18294 BcDNA:RE51966 CDMC35068 1 21 22 DAC36-E13 1-CG18362-RA_1 CG18362 ATCGACGTTCCACGAGTCACAGGATTCCCCACTGTCTCCTACAACCAGCCTAAAATTCCAGCCGC 65 FBan0018362 FBgn0032940 Mio 2 2L regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Mio Mlx interactor "CG18362, CG18362, CG18362, CG18362, dmondo, anon-39Da" CDMC35068 1 22 22 DAC36-E13 1-CG18362-RA_1 CG18362 ATCGACGTTCCACGAGTCACAGGATTCCCCACTGTCTCCTACAACCAGCCTAAAATTCCAGCCGC 65 FBan0018362 FBgn0032940 Mio 2 2L regulation of transcription; GO:0045449 transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Mio Mlx interactor "CG18362, CG18362, CG18362, CG18362, dmondo, anon-39Da" CDMC35069 1 23 22 DAC36-I01 15-CG18553-RA_3 CG18553 GCCCGGCGGGATAGTTAGCAACCCAATTAGTTATGGCCAAAGTCTGACAACATTGGCGCGGGTCA 65 FBgn0038064 CDMC35069 1 24 22 DAC36-I01 15-CG18553-RA_3 CG18553 GCCCGGCGGGATAGTTAGCAACCCAATTAGTTATGGCCAAAGTCTGACAACATTGGCGCGGGTCA 65 FBgn0038064 CDMC35070 1 25 22 DAC36-I13 2-CG18616-RA_1 CG18616 GAGGCGTTTCAGTGCTTTCTGGTTCCCGTTAAGCAATTCCACAGCAATCCACGTCTTTGGCTGCG 65 FBan0018616 FBgn0028495 CG18616 3 3R CG18616 CG18616 CDMC35070 1 26 22 DAC36-I13 2-CG18616-RA_1 CG18616 GAGGCGTTTCAGTGCTTTCTGGTTCCCGTTAAGCAATTCCACAGCAATCCACGTCTTTGGCTGCG 65 FBan0018616 FBgn0028495 CG18616 3 3R CG18616 CG18616 CDMC35071 1 1 23 DAC36-M01 18-CG18735-RA_3 CG18735 ACAATCTAGCTCAACTAAGGCAGAGTAGCTTTCTGGACTGGATTCAATCGATCCTGGGACCCGAG 65 FBan0018735 FBgn0042098 CG18735 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18735 CG18735 SP22 CDMC35071 1 2 23 DAC36-M01 18-CG18735-RA_3 CG18735 ACAATCTAGCTCAACTAAGGCAGAGTAGCTTTCTGGACTGGATTCAATCGATCCTGGGACCCGAG 65 FBan0018735 FBgn0042098 CG18735 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18735 CG18735 SP22 CDMC35072 1 3 23 DAC36-M13 14-CG18802-RA_3 CG18802 CCCATACCTTCTGGTATGTTCATTGAGGATGCCAATACGCGACTCACTCTCCTCACGGGTCAACC 65 FBan0018802 FBgn0011740 alpha-Man-II 3 3R carbohydrate metabolism; GO:0005975; protein amino acid N-linked glycosylation; GO:0006487; protein amino acid glycosylation; GO:0006486 "mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; GO:0004572 ; EC:3.2.1.114; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004572 ; EC:3.2.1.114; ; GO:0004572 ; EC:3.2.1.114; ; GO:0004559 ; EC:3.2.1.24" Golgi membrane; GO:0000139; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 alpha-Man-II alpha Mannosidase II "CG18802, CG18474, CG8139, MAN-2, GmII, Golgi Man II, GMII, Golgi mannosidase II, dGMII, alpha-mannosidase II, DM-GII.1, mannosidase II, alpha-mannosidase 2, alpha-Man-II" CDMC35072 1 4 23 DAC36-M13 14-CG18802-RA_3 CG18802 CCCATACCTTCTGGTATGTTCATTGAGGATGCCAATACGCGACTCACTCTCCTCACGGGTCAACC 65 FBan0018802 FBgn0011740 alpha-Man-II 3 3R carbohydrate metabolism; GO:0005975; protein amino acid N-linked glycosylation; GO:0006487; protein amino acid glycosylation; GO:0006486 "mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; GO:0004572 ; EC:3.2.1.114; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004572 ; EC:3.2.1.114; ; GO:0004572 ; EC:3.2.1.114; ; GO:0004559 ; EC:3.2.1.24" Golgi membrane; GO:0000139; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783 alpha-Man-II alpha Mannosidase II "CG18802, CG18474, CG8139, MAN-2, GmII, Golgi Man II, GMII, Golgi mannosidase II, dGMII, alpha-mannosidase II, DM-GII.1, mannosidase II, alpha-mannosidase 2, alpha-Man-II" CDMC35073 1 5 23 DAC37-A01 23-CG16888-RA_1 CG16888 GCCAAAACGACAGCATAGAAGGTCAAACTATTTGCGTATGCTATAACTAGATAAATTGCAATTTTTCTT 69 FBan0016888 FBgn0032533 CG16888 2 2L CG16888 CG16888 CDMC35073 1 6 23 DAC37-A01 23-CG16888-RA_1 CG16888 GCCAAAACGACAGCATAGAAGGTCAAACTATTTGCGTATGCTATAACTAGATAAATTGCAATTTTTCTT 69 FBan0016888 FBgn0032533 CG16888 2 2L CG16888 CG16888 CDMC35074 1 7 23 DAC37-A13 23-CG16901-RA_4 CG16901 AACAAACAAAGAAACATGAAACACAAGAGAGGAGCATGTGCCAATTATGTGAAACTGTGTGAAACGCCA 69 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC35074 1 8 23 DAC37-A13 23-CG16901-RA_4 CG16901 AACAAACAAAGAAACATGAAACACAAGAGAGGAGCATGTGCCAATTATGTGAAACTGTGTGAAACGCCA 69 FBan0016901 FBgn0003498 sqd 3 3R "RNA export from nucleus; GO:0006405; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral pattern formation; GO:0009953; follicle cell migration (sensu Insecta); GO:0007297; intracellular mRNA localization; GO:0008298; mRNA catabolism, nonsense-mediated decay; GO:0000184; mRNA export from nucleus; GO:0006406; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; pole plasm mRNA localization; GO:0019094; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730 NOT nucleolus; GO:0005730; chromatin; GO:0000785; cytoplasm; GO:0005737; nucleus; GO:0005634; omega speckle; GO:0035062; polytene chromosome puff; GO:0005703; ribonucleoprotein complex; GO:0030529 sqd squid "CG16901, CG17791, CG16901, CG17791, hrp40, Hrb87, rrm3, HRP40, l(3)EP3631, RRM3, Squid, hnRNP 1, Hrp40, Hrb87Fb: heterogeneous-nuclear-ribonucleoprotein-87Fb, Rbp3, fs(3)00048, l(3)j6E3, heterogeneous-nuclear-ribonucleoprotein-87Fb, RNA-binding protein 3" CDMC35075 1 9 23 DAC37-E01 10-CG16941-RA_2 CG16941 AGCCGCCTTCTAAAAAGATTCGAAGCGAGGACAACCTGATTCCAGAAGCAGACTTTATTGCCACCCACA 69 FBan0016941 FBgn0038464 CG16941 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG16941 CG16941 SF3a120 CDMC35075 1 10 23 DAC37-E01 10-CG16941-RA_2 CG16941 AGCCGCCTTCTAAAAAGATTCGAAGCGAGGACAACCTGATTCCAGAAGCAGACTTTATTGCCACCCACA 69 FBan0016941 FBgn0038464 CG16941 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG16941 CG16941 SF3a120 CDMC35076 1 11 23 DAC37-E13 12-CG16957-RA_2 CG16957 GGACGGTCGCATCCTAGTGGCCATCCTTTTCAACATCTACGATGTCTCGCGATCCGTTCACTATTACGG 69 FBan0016957 FBgn0032519 CG16957 2 2L CG16957 CG16957 CDMC35076 1 12 23 DAC37-E13 12-CG16957-RA_2 CG16957 GGACGGTCGCATCCTAGTGGCCATCCTTTTCAACATCTACGATGTCTCGCGATCCGTTCACTATTACGG 69 FBan0016957 FBgn0032519 CG16957 2 2L CG16957 CG16957 CDMC35077 1 13 23 DAC37-I01 23-CG16983-RA_2 CG16983 ATTTCCGTTTACTGTGCAATTCGGTGTGAAAGTGTTCAGATTTATCAATGCGTATTCTGCTTTCGACTT 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC35077 1 14 23 DAC37-I01 23-CG16983-RA_2 CG16983 ATTTCCGTTTACTGTGCAATTCGGTGTGAAAGTGTTCAGATTTATCAATGCGTATTCTGCTTTCGACTT 69 FBan0016983 FBgn0025637 skpA X X DNA endoreduplication; GO:0042023; centrosome duplication; GO:0051298; chromosome condensation; GO:0030261; chromosome segregation; GO:0007059; mitosis; GO:0007067; positive regulation of mitotic cell cycle; GO:0045931; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 centromeric DNA binding; GO:0019237; ; GO:0019237 SCF ubiquitin ligase complex; GO:0019005 skpA skpA "CG16983, CG16983, CG16983, CG16983, dskpA, l(1)G0058, l(1)G0037, l(1)G0109, l(1)G0389, Skp1, EG:115C2.4, dSkp-1, dSkpA, spkA, SkpA, anon-WO03040301.234, anon-WO03040301.236, anon-WO03040301.238" CDMC35078 1 15 23 DAC37-I13 1-CG16988-RA_1 CG16988 CCGCTGGACAACAAGGAGTGGGTCTACCAGAAGTACGGCCGCTAGCGAGGAATATGGATCGGGATATTA 69 FBan0016988 FBgn0040291 Roc1b 3 3L protein ubiquitination; GO:0016567; sperm motility; GO:0030317 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 SCF ubiquitin ligase complex; GO:0019005 Roc1b Roc1b "CG16988, CG16988, CG16988, CG16988, dRoc1b, ROC1B, ROC2, ROC1b, BcDNA:AT21612" CDMC35078 1 16 23 DAC37-I13 1-CG16988-RA_1 CG16988 CCGCTGGACAACAAGGAGTGGGTCTACCAGAAGTACGGCCGCTAGCGAGGAATATGGATCGGGATATTA 69 FBan0016988 FBgn0040291 Roc1b 3 3L protein ubiquitination; GO:0016567; sperm motility; GO:0030317 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 SCF ubiquitin ligase complex; GO:0019005 Roc1b Roc1b "CG16988, CG16988, CG16988, CG16988, dRoc1b, ROC1B, ROC2, ROC1b, BcDNA:AT21612" CDMC35079 1 17 23 DAC37-M01 23-CG1702-RA_3 CG1702 CCACAGGCCAAGCTATAAACTCCAACGTTCACAAAGCCATTCTGTACATAGATCATTATCATTGCTGGG 69 FBan0001702 FBgn0031117 CG1702 X X defense response; GO:0006952; response to toxin; GO:0009636 transferase activity; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004364 ; EC:2.5.1.18 CG1702 CG1702 CDMC35079 1 18 23 DAC37-M01 23-CG1702-RA_3 CG1702 CCACAGGCCAAGCTATAAACTCCAACGTTCACAAAGCCATTCTGTACATAGATCATTATCATTGCTGGG 69 FBan0001702 FBgn0031117 CG1702 X X defense response; GO:0006952; response to toxin; GO:0009636 transferase activity; GO:0016740 ; EC:2.-.-.-; glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0016740 ; EC:2.-.-.-; ; GO:0004364 ; EC:2.5.1.18 CG1702 CG1702 CDMC35080 1 19 23 DAC37-M13 9-CG17036-RA_1 CG17036 GCCCAGCTGGTAATTGTGTTCCTCATCACAGATCTGGTGAGGTACAAACCGGTTATCGTGCTATCGGCA 69 FBan0017036 FBgn0032449 CG17036 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 plasma membrane; GO:0005886 CG17036 CG17036 CDMC35080 1 20 23 DAC37-M13 9-CG17036-RA_1 CG17036 GCCCAGCTGGTAATTGTGTTCCTCATCACAGATCTGGTGAGGTACAAACCGGTTATCGTGCTATCGGCA 69 FBan0017036 FBgn0032449 CG17036 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 reduced folate carrier activity; GO:0008518; ; GO:0008518; folic acid binding; GO:0005542; ; GO:0005542 plasma membrane; GO:0005886 CG17036 CG17036 CDMC35081 1 21 23 DAC38-A01 23-CG17530-RA_1 CG17530 CGCGCTGTTAAGCTTACTTTGGCCGCTCTAAACCTAACCTACGAATATGTAAACGTTGACATTGTGGCT 69 FBgn0034340 CDMC35081 1 22 23 DAC38-A01 23-CG17530-RA_1 CG17530 CGCGCTGTTAAGCTTACTTTGGCCGCTCTAAACCTAACCTACGAATATGTAAACGTTGACATTGTGGCT 69 FBgn0034340 CDMC35082 1 23 23 DAC38-A13 9-CG17566-RA_5 CG17566 ACCGCGGGCCGTTCTCATAGACTTAGAGCCCAGAGTCATTAACAACATCATGACCTCTCCGTACTCCAA 69 FBan0017566 FBgn0010097 gammaTub37C 2 2L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 gamma-tubulin small complex; GO:0008275; microtubule; GO:0005874; microtubule organizing center; GO:0005815; tubulin; GO:0045298 gammaTub37C gamma-Tubulin at 37C "CG17566, CG17566, fs(2)TWI, fs(2)TW1, gamma[mat], gamma-tubulin, fsTW1, gamma-tubulin-2, TW1, PL10, gammatubulin, gammaTUB37C, gamma tubulin, gammaTub37CD, gamma-tubulin, gamma Tub37CD, gamma tubulin, D.m.GAMMA-37C, gama-tubulin, gamma-Tub, gamma-Tubulin, maternal gamma-tubulin, gammaTUB, g-Tubulin, Rb1011, gammaTub37C, &g-Tub37C, gammaTub2: gamma Tubulin2, gamma Tubulin2, female sterile(2)Ted Wright 1" CDMC35082 1 24 23 DAC38-A13 9-CG17566-RA_5 CG17566 ACCGCGGGCCGTTCTCATAGACTTAGAGCCCAGAGTCATTAACAACATCATGACCTCTCCGTACTCCAA 69 FBan0017566 FBgn0010097 gammaTub37C 2 2L cell motility; GO:0006928; chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; microtubule polymerization; GO:0046785; microtubule-based movement; GO:0007018; microtubule-based process; GO:0007017; mitosis; GO:0007067 GTP binding; GO:0005525; ; GO:0005525; structural constituent of cytoskeleton; GO:0005200; tubulin binding; GO:0015631; ; GO:0005200; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0015631; ; GO:0005525 gamma-tubulin small complex; GO:0008275; microtubule; GO:0005874; microtubule organizing center; GO:0005815; tubulin; GO:0045298 gammaTub37C gamma-Tubulin at 37C "CG17566, CG17566, fs(2)TWI, fs(2)TW1, gamma[mat], gamma-tubulin, fsTW1, gamma-tubulin-2, TW1, PL10, gammatubulin, gammaTUB37C, gamma tubulin, gammaTub37CD, gamma-tubulin, gamma Tub37CD, gamma tubulin, D.m.GAMMA-37C, gama-tubulin, gamma-Tub, gamma-Tubulin, maternal gamma-tubulin, gammaTUB, g-Tubulin, Rb1011, gammaTub37C, &g-Tub37C, gammaTub2: gamma Tubulin2, gamma Tubulin2, female sterile(2)Ted Wright 1" CDMC35083 1 25 23 DAC38-E01 16-CG17604-RA_3 CG17604 GGGCCAACCAGAACTGAGAGCATTCCTACTAAGGTGCAACCGGAAAATACAGACGAATTTTCAAGCACT 69 FBan0017604 FBgn0000246 c(3)G 3 3R cytoskeleton organization and biogenesis; GO:0007010; meiotic recombination; GO:0007131; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 synaptonemal complex; GO:0000795 c(3)G crossover suppressor on 3 of Gowan "CG17604, CG17604, CG17604, c3G, C(3)G, c(3)g, cx" CDMC35083 1 26 23 DAC38-E01 16-CG17604-RA_3 CG17604 GGGCCAACCAGAACTGAGAGCATTCCTACTAAGGTGCAACCGGAAAATACAGACGAATTTTCAAGCACT 69 FBan0017604 FBgn0000246 c(3)G 3 3R cytoskeleton organization and biogenesis; GO:0007010; meiotic recombination; GO:0007131; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0008017; ; GO:0005200 synaptonemal complex; GO:0000795 c(3)G crossover suppressor on 3 of Gowan "CG17604, CG17604, CG17604, c3G, C(3)G, c(3)g, cx" CDMC35084 1 1 24 DAC38-E13 11-CG17625-RA_1 CG17625 GGAGCCGTGTGAGCTGCATGAGGAGATTGAACTGAAATTAGACCCGGATGTTGAGTTGTTTGCTTCGCT 69 FBan0017625 FBgn0039002 CG17625 3 3R CG17625 CG17625 CDMC35084 1 2 24 DAC38-E13 11-CG17625-RA_1 CG17625 GGAGCCGTGTGAGCTGCATGAGGAGATTGAACTGAAATTAGACCCGGATGTTGAGTTGTTTGCTTCGCT 69 FBan0017625 FBgn0039002 CG17625 3 3R CG17625 CG17625 CDMC35085 1 3 24 DAC38-I01 9-CG17666-RA_1 CG17666 GCTGGCTGTGTGGATAGTCATCGGAACTATCAACGGAATAACCAAGGTCCTCCTTTCAACATCGGCCGC 69 FBan0017666 FBgn0036311 CG17666 3 3L CG17666 CG17666 bs31g10.y1 CDMC35085 1 4 24 DAC38-I01 9-CG17666-RA_1 CG17666 GCTGGCTGTGTGGATAGTCATCGGAACTATCAACGGAATAACCAAGGTCCTCCTTTCAACATCGGCCGC 69 FBan0017666 FBgn0036311 CG17666 3 3L CG17666 CG17666 bs31g10.y1 CDMC35086 1 5 24 DAC38-I13 11-CG17684-RE_1 CG17684 AGAAAGGCTACAAAAGCTAGCTTTACCGACCCAGCGATCTTTTGAAGTGCCATTACCGCATGGAGGTCG 69 CDMC35086 1 6 24 DAC38-I13 11-CG17684-RE_1 CG17684 AGAAAGGCTACAAAAGCTAGCTTTACCGACCCAGCGATCTTTTGAAGTGCCATTACCGCATGGAGGTCG 69 CDMC35087 1 7 24 DAC38-M01 23-CG17724-RA_9 CG17724 TTTTATTTGCAATCTTGTTATGCCATTCGTACACAAATAGGAATTCAAGCATAGCACCGACCCATACTT 69 FBan0017724 FBgn0033802 CG17724 2 2R CG17724 CG17724 "CG17724a, CG4037" CDMC35087 1 8 24 DAC38-M01 23-CG17724-RA_9 CG17724 TTTTATTTGCAATCTTGTTATGCCATTCGTACACAAATAGGAATTCAAGCATAGCACCGACCCATACTT 69 FBan0017724 FBgn0033802 CG17724 2 2R CG17724 CG17724 "CG17724a, CG4037" CDMC35088 1 9 24 DAC38-M13 9-CG17736-RA_4 CG17736 CCTGCTGTCCTTTGTCGAGCATGGAATCACATCCTTCTATGGGATTAGGTGGTCAGATCAGCCAGCACA 69 FBan0017736 FBgn0036925 schuy 3 3L schuy schumacher-levy "CG17736, schumacher-levy" CDMC35088 1 10 24 DAC38-M13 9-CG17736-RA_4 CG17736 CCTGCTGTCCTTTGTCGAGCATGGAATCACATCCTTCTATGGGATTAGGTGGTCAGATCAGCCAGCACA 69 FBan0017736 FBgn0036925 schuy 3 3L schuy schumacher-levy "CG17736, schumacher-levy" CDMC35089 1 11 24 DAC39-A01 23-CG32158-RB_1 CG32158 CCATTGAGAATTTGGAGATTCTGCTGAAGAACAACATCAGTCTTTCCGACCTGAGCAACAAGCAG 65 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC35089 1 12 24 DAC39-A01 23-CG32158-RB_1 CG32158 CCATTGAGAATTTGGAGATTCTGCTGAAGAACAACATCAGTCTTTCCGACCTGAGCAACAAGCAG 65 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC35090 1 13 24 DAC39-A13 23-CG32175-RA_4 CG32175 TCCCATCGTGTTAGTATGTATTCCTGCCCCCTAAAATATTCATGGTAGCCATTAAAAATTCCCAC 65 FBan0032175 FBgn0052175 CG32175 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32175 CG32175 CDMC35090 1 14 24 DAC39-A13 23-CG32175-RA_4 CG32175 TCCCATCGTGTTAGTATGTATTCCTGCCCCCTAAAATATTCATGGTAGCCATTAAAAATTCCCAC 65 FBan0032175 FBgn0052175 CG32175 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32175 CG32175 CDMC35091 1 15 24 DAC39-E01 1-CG32260-RA_1 CG32260 CATTCGCGCTACGTAATCACCTCGGCACATTGCATCAATCCGATGTTGACCTTGGTCCGACTGGG 65 FBan0032260 FBgn0052260 CG32260 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32260 CG32260 BcDNA:GH24648 CDMC35091 1 16 24 DAC39-E01 1-CG32260-RA_1 CG32260 CATTCGCGCTACGTAATCACCTCGGCACATTGCATCAATCCGATGTTGACCTTGGTCCGACTGGG 65 FBan0032260 FBgn0052260 CG32260 3 3L amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32260 CG32260 BcDNA:GH24648 CDMC35092 1 17 24 DAC39-E13 11-CG32284-RA_2 CG32284 CTTTGCCAGCTCCAGAGTTTGACGACCACAACTCGAAGACTTGGAGTGCGGAAGAAGCCTGCAGC 65 FBan0032284 FBgn0052284 CG32284 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32284 CG32284 BcDNA:LP03531 CDMC35092 1 18 24 DAC39-E13 11-CG32284-RA_2 CG32284 CTTTGCCAGCTCCAGAGTTTGACGACCACAACTCGAAGACTTGGAGTGCGGAAGAAGCCTGCAGC 65 FBan0032284 FBgn0052284 CG32284 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG32284 CG32284 BcDNA:LP03531 CDMC35093 1 19 24 DAC39-I01 1-CG32432-RA_1 CG32432 AATTGGGTGCCTGTGTAAATGCCAGTGTTTGGTGTGATGGTGTAGTCCACTGTCCTTCCGGGGAC 65 FBan0032432 FBgn0052432 CG32432 3 3L hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 CG32432 CG32432 "CG13256, CG13257, CG3116, CG13256, CG13257, FBgn0037032" CDMC35093 1 20 24 DAC39-I01 1-CG32432-RA_1 CG32432 AATTGGGTGCCTGTGTAAATGCCAGTGTTTGGTGTGATGGTGTAGTCCACTGTCCTTCCGGGGAC 65 FBan0032432 FBgn0052432 CG32432 3 3L hormone activity; GO:0005179; ; GO:0005179 extracellular region; GO:0005576 CG32432 CG32432 "CG13256, CG13257, CG3116, CG13256, CG13257, FBgn0037032" CDMC35094 1 21 24 DAC39-I13 15-CG32484-RA_1 CG32484 GCGCAGCTTTTACTATTCCATATCGGAGAGCATCTACCACAGTCTGGCGGATGAGAGCGAGTTCG 65 FBan0032484 FBgn0052484 Sk2 3 3L anti-apoptosis; GO:0006916; flight behavior; GO:0007629; oviposition; GO:0018991; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165; sphingolipid metabolism; GO:0006665; sphingosine metabolism; GO:0006670 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0017050; carbohydrate kinase activity; GO:0019200; ; GO:0004143 ; EC:2.7.1.107; ; GO:0017050; ; GO:0019200; ; GO:0017050; ; GO:0017050 Sk2 Sphingosine kinase 2 "CG2159, CG32484, CG2159, CG2159, CG2159, CG32484, CG32484, CG32484, SK2, Sphk2, sphingosine kinase, Sphingosine kinase II, Sphingosine kinase 2" CDMC35094 1 22 24 DAC39-I13 15-CG32484-RA_1 CG32484 GCGCAGCTTTTACTATTCCATATCGGAGAGCATCTACCACAGTCTGGCGGATGAGAGCGAGTTCG 65 FBan0032484 FBgn0052484 Sk2 3 3L anti-apoptosis; GO:0006916; flight behavior; GO:0007629; oviposition; GO:0018991; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205; signal transduction; GO:0007165; sphingolipid metabolism; GO:0006665; sphingosine metabolism; GO:0006670 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0017050; carbohydrate kinase activity; GO:0019200; ; GO:0004143 ; EC:2.7.1.107; ; GO:0017050; ; GO:0019200; ; GO:0017050; ; GO:0017050 Sk2 Sphingosine kinase 2 "CG2159, CG32484, CG2159, CG2159, CG2159, CG32484, CG32484, CG32484, SK2, Sphk2, sphingosine kinase, Sphingosine kinase II, Sphingosine kinase 2" CDMC35095 1 23 24 DAC39-M01 24-CG32533-RA_1 CG32533 CGCCACAAAAAGCAGTGTCGAAATAACAAGTAATCGTCTGAATAAACGTATTTAATTATAAAAAA 65 FBan0032533 FBgn0052533 CG32533 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 nucleus; GO:0005634 CG32533 CG32533 "CG12211, CG14198, CG12211, CG12211, CG12211, CG12211, CG12211, cg12211" CDMC35095 1 24 24 DAC39-M01 24-CG32533-RA_1 CG32533 CGCCACAAAAAGCAGTGTCGAAATAACAAGTAATCGTCTGAATAAACGTATTTAATTATAAAAAA 65 FBan0032533 FBgn0052533 CG32533 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 nucleus; GO:0005634 CG32533 CG32533 "CG12211, CG14198, CG12211, CG12211, CG12211, CG12211, CG12211, cg12211" CDMC35096 1 25 24 DAC39-M13 3-CG32548-RB_2 CG32548 ACCACTACTATCCCGATGTATCCGGCGGCCTAACATCACCGGCTCATCAGATTCAACCCCAAACC 65 FBan0032548 FBgn0052548 CG32548 X X CG32548 CG32548 "CG6306, CG15051, CG6306, anon-WO0140519.88" CDMC35096 1 26 24 DAC39-M13 3-CG32548-RB_2 CG32548 ACCACTACTATCCCGATGTATCCGGCGGCCTAACATCACCGGCTCATCAGATTCAACCCCAAACC 65 FBan0032548 FBgn0052548 CG32548 X X CG32548 CG32548 "CG6306, CG15051, CG6306, anon-WO0140519.88" CDMC35097 1 1 25 DAC40-A01 5-CG4087-RA_1 CG4087 CAACCGGACATCCGTTGTGTTTGTGCTGTAATCCTCGAGAGGTGGACGTGTACCCGTTTCCCGAC 65 FBan0004087 FBgn0002593 RpLP1 2 2L protein biosynthesis; GO:0006412; translational elongation; GO:0006414 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpLP1 Ribosomal protein LP1 "CG4087, CG4087, M(2)21C1-2, rp21C, M(2)21C: Minute(2)21C, rpP2, RpP2: Ribosomal protein P2, RpA2: Ribosomal protein A2, rpA2: Ribosomal-protein-A2, Ribosomal protein P2, Minute(2)21C, Ribosomal protein A2, Ribosomal-protein-A2, RpP2, M(2)21C" CDMC35097 1 2 25 DAC40-A01 5-CG4087-RA_1 CG4087 CAACCGGACATCCGTTGTGTTTGTGCTGTAATCCTCGAGAGGTGGACGTGTACCCGTTTCCCGAC 65 FBan0004087 FBgn0002593 RpLP1 2 2L protein biosynthesis; GO:0006412; translational elongation; GO:0006414 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpLP1 Ribosomal protein LP1 "CG4087, CG4087, M(2)21C1-2, rp21C, M(2)21C: Minute(2)21C, rpP2, RpP2: Ribosomal protein P2, RpA2: Ribosomal protein A2, rpA2: Ribosomal-protein-A2, Ribosomal protein P2, Minute(2)21C, Ribosomal protein A2, Ribosomal-protein-A2, RpP2, M(2)21C" CDMC35098 1 3 25 DAC40-A13 3-CG41072-RA_1 CG41072 AGAGAAGACAAGTACAGGACCCAGAAATCGGAAGGGATGGGGAACTGGTGGTACAAAGCCAGGGG 65 FBan0041072 FBgn0069951 CG41072 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41072 CG41072 CDMC35098 1 4 25 DAC40-A13 3-CG41072-RA_1 CG41072 AGAGAAGACAAGTACAGGACCCAGAAATCGGAAGGGATGGGGAACTGGTGGTACAAAGCCAGGGG 65 FBan0041072 FBgn0069951 CG41072 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41072 CG41072 CDMC35099 1 5 25 DAC40-E01 3-CG4145-RA_3 CG4145 GCTTGGTTGGACAGAAGGGAGATACCGGCTACCCTGGCTTAAATGGAAACGATGGACCTGTCGGA 65 FBan0004145 FBgn0000299 Cg25C 2 2L cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; phosphate transport; GO:0006817 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 basement membrane; GO:0005604; collagen type IV; GO:0005587; cytoplasm; GO:0005737 Cg25C Collagen type IV "CG25C alpha1(IV), CG4145 alpha1(IV), DCg1, collagen IV, gp125, Dcg1, Collagen IV, alpha1, type IV collagen, preprocollagen alpha alpha1(IV), Dcg alpha1(IV), DCg1 alpha1(IV), Type IV collagen alpha1(IV), collagen alpha1(IV), collagen type IV alpha1(IV), Cgc25C alpha1(IV), Laminin alpha3,5 alpha1(IV), collagen IV alpha1(IV), alpha(IV)1/Cg25C alpha1(IV), CT12803 alpha1(IV), collagenIV a1 alpha1(IV), Dcg1 alpha1(IV), type IV collagen, alpha-chain alpha1(IV), Cgc25 alpha1(IV), type IV collagen, alpha-chain, Type IV collagen, Collagen type IV, Laminin alpha3,5" CDMC35099 1 6 25 DAC40-E01 3-CG4145-RA_3 CG4145 GCTTGGTTGGACAGAAGGGAGATACCGGCTACCCTGGCTTAAATGGAAACGATGGACCTGTCGGA 65 FBan0004145 FBgn0000299 Cg25C 2 2L cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; phosphate transport; GO:0006817 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 basement membrane; GO:0005604; collagen type IV; GO:0005587; cytoplasm; GO:0005737 Cg25C Collagen type IV "CG25C alpha1(IV), CG4145 alpha1(IV), DCg1, collagen IV, gp125, Dcg1, Collagen IV, alpha1, type IV collagen, preprocollagen alpha alpha1(IV), Dcg alpha1(IV), DCg1 alpha1(IV), Type IV collagen alpha1(IV), collagen alpha1(IV), collagen type IV alpha1(IV), Cgc25C alpha1(IV), Laminin alpha3,5 alpha1(IV), collagen IV alpha1(IV), alpha(IV)1/Cg25C alpha1(IV), CT12803 alpha1(IV), collagenIV a1 alpha1(IV), Dcg1 alpha1(IV), type IV collagen, alpha-chain alpha1(IV), Cgc25 alpha1(IV), type IV collagen, alpha-chain, Type IV collagen, Collagen type IV, Laminin alpha3,5" CDMC35100 1 7 25 DAC40-E13 23-CG4169-RA_2 CG4169 CATCTGTTAACCGTAATGTAACGACTAAATAAACCTGATCAAGGGGATCGATCCGCGAACGTAAA 65 FBan0004169 FBgn0036642 CG4169 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4169 CG4169 "ubiquinol-cytochrome c reductase, anon-EST:Posey245" CDMC35100 1 8 25 DAC40-E13 23-CG4169-RA_2 CG4169 CATCTGTTAACCGTAATGTAACGACTAAATAAACCTGATCAAGGGGATCGATCCGCGAACGTAAA 65 FBan0004169 FBgn0036642 CG4169 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4169 CG4169 "ubiquinol-cytochrome c reductase, anon-EST:Posey245" CDMC35101 1 9 25 DAC40-I01 23-CG4307-RA_2 CG4307 TGAAAGTTTGGTATTGGAATTCAAGCGGTAATAGCGAATAAAACACTCTTCACCCTTTGAAAACC 65 FBan0004307 FBgn0016691 Oscp 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" Oscp Oligomycin sensitivity-conferring protein "CG4307, OSCP" CDMC35101 1 10 25 DAC40-I01 23-CG4307-RA_2 CG4307 TGAAAGTTTGGTATTGGAATTCAAGCGGTAATAGCGAATAAAACACTCTTCACCCTTTGAAAACC 65 FBan0004307 FBgn0016691 Oscp 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" Oscp Oligomycin sensitivity-conferring protein "CG4307, OSCP" CDMC35102 1 11 25 DAC40-I13 2-CG4357-RB_1 CG4357 TCTGTGGTCACGTTCTGAAAGGTTCCAGCTCGCAGAAGTACCGGACATATCTGCAGGAAAGGGCG 65 FBan0004357 FBgn0036279 Ncc69 3 3L amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814 cation transporter activity; GO:0008324; ; GO:0008324; sodium:chloride symporter activity; GO:0015378; ; GO:0015378; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 Ncc69 sodium chloride cotransporter 69 "CG43567, CG4357, CG43567, CG4357, CG4357, CK01027, NCC69, BEST:CK01027, sodium chloride cotransporter 69" CDMC35102 1 12 25 DAC40-I13 2-CG4357-RB_1 CG4357 TCTGTGGTCACGTTCTGAAAGGTTCCAGCTCGCAGAAGTACCGGACATATCTGCAGGAAAGGGCG 65 FBan0004357 FBgn0036279 Ncc69 3 3L amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814 cation transporter activity; GO:0008324; ; GO:0008324; sodium:chloride symporter activity; GO:0015378; ; GO:0015378; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 Ncc69 sodium chloride cotransporter 69 "CG43567, CG4357, CG43567, CG4357, CG4357, CK01027, NCC69, BEST:CK01027, sodium chloride cotransporter 69" CDMC35103 1 13 25 DAC40-M01 3-CG4465-RA_1 CG4465 AAGCAGCCCGTACCAATGGTAGAATGCACAAAGTGTCCAAGGAGTTACCCCAGCAGTTGGAGGAG 65 FBan0004465 FBgn0038750 CG4465 3 3R organic cation porter activity; GO:0008513; ; GO:0008513 CG4465 CG4465 CDMC35103 1 14 25 DAC40-M01 3-CG4465-RA_1 CG4465 AAGCAGCCCGTACCAATGGTAGAATGCACAAAGTGTCCAAGGAGTTACCCCAGCAGTTGGAGGAG 65 FBan0004465 FBgn0038750 CG4465 3 3R organic cation porter activity; GO:0008513; ; GO:0008513 CG4465 CG4465 CDMC35104 1 15 25 DAC40-M13 23-CG4528-RA_1 CG4528 ACGACAGGATGGAGATGCTACCCAACCAAACGATTTACATCAACAATCTGAACGAGAAGATCAAG 65 FBan0004528 FBgn0003449 snf X X "RNA splicing; GO:0008380; female germ-line sex determination; GO:0019099; nuclear mRNA splicing, via spliceosome; GO:0000398; oogenesis (sensu Insecta); GO:0009993; primary sex determination, soma; GO:0007539; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; U1 snRNA binding; GO:0030619; ; GO:0030619 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U1; GO:0005685; snRNP U11; GO:0005692; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 snf sans fille "CG4528, CG4528, fs(1)1621, liz, fs(1)A1621, snRNP B'', fs(1)A16121, snf1621, splicing necessary factor, U2 snRNP B'' protein, SNF/D25, SNF, Snf, U2 snRNP, D25, simply not fertile" CDMC35104 1 16 25 DAC40-M13 23-CG4528-RA_1 CG4528 ACGACAGGATGGAGATGCTACCCAACCAAACGATTTACATCAACAATCTGAACGAGAAGATCAAG 65 FBan0004528 FBgn0003449 snf X X "RNA splicing; GO:0008380; female germ-line sex determination; GO:0019099; nuclear mRNA splicing, via spliceosome; GO:0000398; oogenesis (sensu Insecta); GO:0009993; primary sex determination, soma; GO:0007539; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; U1 snRNA binding; GO:0030619; ; GO:0030619 nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; snRNP U1; GO:0005685; snRNP U11; GO:0005692; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 snf sans fille "CG4528, CG4528, fs(1)1621, liz, fs(1)A1621, snRNP B'', fs(1)A16121, snf1621, splicing necessary factor, U2 snRNP B'' protein, SNF/D25, SNF, Snf, U2 snRNP, D25, simply not fertile" CDMC35105 1 17 25 DAC41-A01 23-CG4539-RA_4 CG4539 ACAAGAAAACGCAGAAGGTTAAGAAACAACGTAATGCACAGCTTAAACGCATCATAAAACCCACAGACG 69 FBan0004539 FBgn0010520 Bka 2 2L chromatin-mediated maintenance of transcription; GO:0048096 transcriptional activator activity; GO:0016563; ; GO:0016563 nucleus; GO:0005634 Bka Bekka "CG4539, CG4539, CG4539, l(2)02695, mip: more inner photoreceptors, missing imaginal precursors, BcDNA:RE14949, mip, Bekka" CDMC35105 1 18 25 DAC41-A01 23-CG4539-RA_4 CG4539 ACAAGAAAACGCAGAAGGTTAAGAAACAACGTAATGCACAGCTTAAACGCATCATAAAACCCACAGACG 69 FBan0004539 FBgn0010520 Bka 2 2L chromatin-mediated maintenance of transcription; GO:0048096 transcriptional activator activity; GO:0016563; ; GO:0016563 nucleus; GO:0005634 Bka Bekka "CG4539, CG4539, CG4539, l(2)02695, mip: more inner photoreceptors, missing imaginal precursors, BcDNA:RE14949, mip, Bekka" CDMC35106 1 19 25 DAC41-A13 9-CG4560-RB_1 CG4560 AGTGGATACTTGCGCATCAAAGGCAAACGAGTTGGCGTTGAGATATTCCCAATCAAGGAAGTGCGCCAG 69 FBan0004560 FBgn0038369 Arpc3A 3 3R cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arpc3A Arpc3A "CG4560, CG4560, ARC-P21" CDMC35106 1 20 25 DAC41-A13 9-CG4560-RB_1 CG4560 AGTGGATACTTGCGCATCAAAGGCAAACGAGTTGGCGTTGAGATATTCCCAATCAAGGAAGTGCGCCAG 69 FBan0004560 FBgn0038369 Arpc3A 3 3R cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament polymerization; GO:0030833 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoskeleton; GO:0005856 Arpc3A Arpc3A "CG4560, CG4560, ARC-P21" CDMC35107 1 21 25 DAC41-E01 23-CG4598-RA_1 CG4598 ACTCATTTTGACTTCGTCTAGCTCCACAATATTCTCAGCTGGTTTGGATATTCTGGAGATGTACAAGCC 69 FBan0004598 FBgn0032160 CG4598 2 2L fatty acid beta-oxidation; GO:0006635 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4598 CG4598 CDMC35107 1 22 25 DAC41-E01 23-CG4598-RA_1 CG4598 ACTCATTTTGACTTCGTCTAGCTCCACAATATTCTCAGCTGGTTTGGATATTCTGGAGATGTACAAGCC 69 FBan0004598 FBgn0032160 CG4598 2 2L fatty acid beta-oxidation; GO:0006635 hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 mitochondrion; GO:0005739 CG4598 CG4598 CDMC35108 1 23 25 DAC41-E13 18-CG4607-RA_2 CG4607 AGTGCCTCCGGGATAGCCATCTTCTTTGGCATGATTCTGGCCTTCATAATGCTGAAGATATACCCGAAT 69 FBan0004607 FBgn0029932 CG4607 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; sugar porter activity; GO:0005351; ; GO:0005215; ; GO:0015144; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG4607 CG4607 CDMC35108 1 24 25 DAC41-E13 18-CG4607-RA_2 CG4607 AGTGCCTCCGGGATAGCCATCTTCTTTGGCATGATTCTGGCCTTCATAATGCTGAAGATATACCCGAAT 69 FBan0004607 FBgn0029932 CG4607 X X carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; sugar porter activity; GO:0005351; ; GO:0005215; ; GO:0015144; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG4607 CG4607 CDMC35109 1 25 25 DAC41-I01 48-CG4630-RA_2 CG4630 GTGCCCACCTTCTATATATGTATACACCTTCGAAAACACGTGATAAACATTAGAATGCCTTATAATTAC 69 FBan0004630 FBgn0033809 CG4630 2 2R anion transport; GO:0006820; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; carbohydrate transporter activity; GO:0015144; ; GO:0008324; ; GO:0015226; ; GO:0015144 integral to membrane; GO:0016021 CG4630 CG4630 CDMC35109 1 26 25 DAC41-I01 48-CG4630-RA_2 CG4630 GTGCCCACCTTCTATATATGTATACACCTTCGAAAACACGTGATAAACATTAGAATGCCTTATAATTAC 69 FBan0004630 FBgn0033809 CG4630 2 2R anion transport; GO:0006820; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 carnitine transporter activity; GO:0015226; cation transporter activity; GO:0008324; carbohydrate transporter activity; GO:0015144; ; GO:0008324; ; GO:0015226; ; GO:0015144 integral to membrane; GO:0016021 CG4630 CG4630 CDMC35110 1 1 26 DAC41-I13 2-CG4644-RA_1 CG4644 CCGCAAGGTGATCAAACAAACAGTGATGACAACGGTCTACGGAGTGACTCGTTACGGAGCCAGACTGCA 69 FBan0004644 FBgn0031300 CG4644 2 2L mRNA transcription; GO:0009299; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 mitochondrion; GO:0005739 CG4644 CG4644 mt RNA pol CDMC35110 1 2 26 DAC41-I13 2-CG4644-RA_1 CG4644 CCGCAAGGTGATCAAACAAACAGTGATGACAACGGTCTACGGAGTGACTCGTTACGGAGCCAGACTGCA 69 FBan0004644 FBgn0031300 CG4644 2 2L mRNA transcription; GO:0009299; transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003677 mitochondrion; GO:0005739 CG4644 CG4644 mt RNA pol CDMC35111 1 3 26 DAC41-M01 8-CG4672-RA_1 CG4672 CGCTGTCTCGGGAGGATCTCTGCAAGTCGACTGCGAGTATGCACTTGGTTACATGGCAGTATATAGGGT 69 FBan0004672 FBgn0028399 TMS1 3 3L electron transport; GO:0006118 receptor signaling protein activity; GO:0005057; ; GO:0005057; electron transporter activity; GO:0005489; ; GO:0005489 plasma membrane; GO:0005886 TMS1 TMS1 "CG4672, TMS1d" CDMC35111 1 4 26 DAC41-M01 8-CG4672-RA_1 CG4672 CGCTGTCTCGGGAGGATCTCTGCAAGTCGACTGCGAGTATGCACTTGGTTACATGGCAGTATATAGGGT 69 FBan0004672 FBgn0028399 TMS1 3 3L electron transport; GO:0006118 receptor signaling protein activity; GO:0005057; ; GO:0005057; electron transporter activity; GO:0005489; ; GO:0005489 plasma membrane; GO:0005886 TMS1 TMS1 "CG4672, TMS1d" CDMC35112 1 5 26 DAC41-M13 23-CG4678-RB_17 CG4678 CGCAACTAACCCACTAAAACACCATTGAAGTAATCTGTTTTGGTTTTTGCTTTAGTTCCCATTGCGATT 69 FBan0004678 FBgn0030778 CG4678 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; ; GO:0008237; carboxypeptidase D activity; GO:0004187 ; EC:3.4.16.6; ; GO:0004187 ; EC:3.4.16.6; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG4678 CG4678 CDMC35112 1 6 26 DAC41-M13 23-CG4678-RB_17 CG4678 CGCAACTAACCCACTAAAACACCATTGAAGTAATCTGTTTTGGTTTTTGCTTTAGTTCCCATTGCGATT 69 FBan0004678 FBgn0030778 CG4678 X X proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; ; GO:0008237; carboxypeptidase D activity; GO:0004187 ; EC:3.4.16.6; ; GO:0004187 ; EC:3.4.16.6; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG4678 CG4678 CDMC35113 1 7 26 DAC42-A01 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC35113 1 8 26 DAC42-A01 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC35114 1 9 26 DAC42-A13 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC35114 1 10 26 DAC42-A13 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC35115 1 11 26 DAC42-E01 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC35115 1 12 26 DAC42-E01 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC35116 1 13 26 DAC42-E13 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC35116 1 14 26 DAC42-E13 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC35117 1 15 26 DAC42-I01 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC35117 1 16 26 DAC42-I01 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC35118 1 17 26 DAC42-I13 5uM MSP 5uM MSP CDMC35118 1 18 26 DAC42-I13 5uM MSP 5uM MSP CDMC35119 1 19 26 DAC42-M01 10uM MSP 10uM MSP CDMC35119 1 20 26 DAC42-M01 10uM MSP 10uM MSP CDMC35120 1 21 26 DAC42-M13 20uM MSP 20uM MSP CDMC35120 1 22 26 DAC42-M13 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC35121 2 1 1 DAC01-B01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35121 2 2 1 DAC01-B01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35122 2 3 1 DAC01-B13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35122 2 4 1 DAC01-B13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35123 2 5 1 DAC01-F01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35123 2 6 1 DAC01-F01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35124 2 7 1 DAC01-F13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35124 2 8 1 DAC01-F13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35125 2 9 1 DAC01-J01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35125 2 10 1 DAC01-J01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35126 2 11 1 DAC01-J13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35126 2 12 1 DAC01-J13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35127 2 13 1 DAC01-N01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35127 2 14 1 DAC01-N01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35128 2 15 1 DAC01-N13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35128 2 16 1 DAC01-N13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35129 2 17 1 DAC02-B01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35129 2 18 1 DAC02-B01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35130 2 19 1 DAC02-B13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35130 2 20 1 DAC02-B13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35131 2 21 1 DAC02-F01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35131 2 22 1 DAC02-F01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35132 2 23 1 DAC02-F13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35132 2 24 1 DAC02-F13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35133 2 25 1 DAC02-J01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35133 2 26 1 DAC02-J01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35134 2 1 2 DAC02-J13 N/A CG9075 (00718-00956) CDMC35134 2 2 2 DAC02-J13 N/A CG9075 (00718-00956) CDMC35135 2 3 2 DAC02-N01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35135 2 4 2 DAC02-N01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35136 2 5 2 DAC02-N13 AutoBlank AutoBlank CDMC35136 2 6 2 DAC02-N13 AutoBlank AutoBlank CDMC35137 2 7 2 DAC03-B01 14-CG3773-RA_1 CG3773 TCCTAGGGAAAAGTTTATGCCATTCCGAACCACCAAGTCCAATGTCCACAATCCCGACAAGGAGC 65 FBan0003773 FBgn0038692 CG3773 3 3R CG3773 CG3773 "anon-EST:fe2D10, anon-EST:fe2D12, anon-fast-evolving-2D10, anon-fast-evolving-2D12" CDMC35137 2 8 2 DAC03-B01 14-CG3773-RA_1 CG3773 TCCTAGGGAAAAGTTTATGCCATTCCGAACCACCAAGTCCAATGTCCACAATCCCGACAAGGAGC 65 FBan0003773 FBgn0038692 CG3773 3 3R CG3773 CG3773 "anon-EST:fe2D10, anon-EST:fe2D12, anon-fast-evolving-2D10, anon-fast-evolving-2D12" CDMC35138 2 9 2 DAC03-B13 1-CG3809-RA_1 CG3809 TCGATGCGGATCTTCCAGTGGATCGTGCAGACACCATTTCGAGCTGTGTTCATAGGGTCAGTGGG 65 FBan0003809 FBgn0037995 CG3809 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine ribonucleoside salvage; GO:0006166" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004001 ; EC:2.7.1.20 CG3809 CG3809 anon-WO0140519.193 CDMC35138 2 10 2 DAC03-B13 1-CG3809-RA_1 CG3809 TCGATGCGGATCTTCCAGTGGATCGTGCAGACACCATTTCGAGCTGTGTTCATAGGGTCAGTGGG 65 FBan0003809 FBgn0037995 CG3809 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine ribonucleoside salvage; GO:0006166" adenosine kinase activity; GO:0004001 ; EC:2.7.1.20; nucleotide kinase activity; GO:0019201; ; GO:0019201; ; GO:0004001 ; EC:2.7.1.20 CG3809 CG3809 anon-WO0140519.193 CDMC35139 2 11 2 DAC03-F01 23-CG3922-RB_1 CG3922 ATTAATTATGCGTATTCGATTGAAAAATATCCAAAGTGAACATCGTTTCCAAAGTGGCTCACCAG 65 FBan0003922 FBgn0005533 RpS17 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS17 Ribosomal protein S17 "CG3922, CG3922, M(3)i, M(3L)i, M(3)i[55], RPS17, M(3L)i[55], M(3)67, D9, M(3)67C: Minute(3)67C, ribosomal protein S17, M(3)RpS17, M(3)i(55), BcDNA:RE44119, M(3)S33, M(3)q, anon-EST:Posey48, l(3)67BDo, l(3)dtOA4, rpS17, Minute(3)67C, M(3)67C" CDMC35139 2 12 2 DAC03-F01 23-CG3922-RB_1 CG3922 ATTAATTATGCGTATTCGATTGAAAAATATCCAAAGTGAACATCGTTTCCAAAGTGGCTCACCAG 65 FBan0003922 FBgn0005533 RpS17 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS17 Ribosomal protein S17 "CG3922, CG3922, M(3)i, M(3L)i, M(3)i[55], RPS17, M(3L)i[55], M(3)67, D9, M(3)67C: Minute(3)67C, ribosomal protein S17, M(3)RpS17, M(3)i(55), BcDNA:RE44119, M(3)S33, M(3)q, anon-EST:Posey48, l(3)67BDo, l(3)dtOA4, rpS17, Minute(3)67C, M(3)67C" CDMC35140 2 13 2 DAC03-F13 9-CG3967-RB_3 CG3967 CAGCGCCTGAGGATGTCCGACAATCAGACCATCTATCTGCTGGCAGATAATGAGGCGGGTCACAA 65 FBan0003967 FBgn0035989 CG3967 3 3L CG3967 CG3967 CDMC35140 2 14 2 DAC03-F13 9-CG3967-RB_3 CG3967 CAGCGCCTGAGGATGTCCGACAATCAGACCATCTATCTGCTGGCAGATAATGAGGCGGGTCACAA 65 FBan0003967 FBgn0035989 CG3967 3 3L CG3967 CG3967 CDMC35141 2 15 2 DAC03-J01 9-CG40122-RA_1 CG40122 TCACTGTTTGTTATTTCCGACTTGACCGCGTGTGTTCACTCCCGAACTCCTTCTGGTACCGCTCC 65 FBgn0058122 CG40122 CG40122 CG40122 CDMC35141 2 16 2 DAC03-J01 9-CG40122-RA_1 CG40122 TCACTGTTTGTTATTTCCGACTTGACCGCGTGTGTTCACTCCCGAACTCCTTCTGGTACCGCTCC 65 FBgn0058122 CG40122 CG40122 CG40122 CDMC35142 2 17 2 DAC03-J13 23-CG40170-RA_1 CG40170 TAGAAAATACTACAAAACACTTATCTGGGTGACAAATAGAAAAAGAGCTGAATGAACAGGGGGGG 65 FBgn0058170 CG40170 CG40170 CG40170 CDMC35142 2 18 2 DAC03-J13 23-CG40170-RA_1 CG40170 TAGAAAATACTACAAAACACTTATCTGGGTGACAAATAGAAAAAGAGCTGAATGAACAGGGGGGG 65 FBgn0058170 CG40170 CG40170 CG40170 CDMC35143 2 19 2 DAC03-N01 23-CG40346-RA_3 CG40346 ATCTAAAGACGAGATAAACTTAGCGTCACTTAGCCTAGCTAGCTGATCAGAAATAAGTGGCAACG 65 FBgn0058346 CG40346 CG40346 CG40346 CDMC35143 2 20 2 DAC03-N01 23-CG40346-RA_3 CG40346 ATCTAAAGACGAGATAAACTTAGCGTCACTTAGCCTAGCTAGCTGATCAGAAATAAGTGGCAACG 65 FBgn0058346 CG40346 CG40346 CG40346 CDMC35144 2 21 2 DAC03-N13 23-CG40385-RA_6 CG40385 AGCACCAAATTAGTTCACATGAACGTGCAACAAAATCAGTGTCCTAAGATTTTACCAGCAAGACT 65 FBgn0058385 CG40385 CG40385 CG40385 CDMC35144 2 22 2 DAC03-N13 23-CG40385-RA_6 CG40385 AGCACCAAATTAGTTCACATGAACGTGCAACAAAATCAGTGTCCTAAGATTTTACCAGCAAGACT 65 FBgn0058385 CG40385 CG40385 CG40385 CDMC35145 2 23 2 DAC04-B01 23-CG31508-RA_2 CG31508 AGGCTCTTTACTGGATAATCACCATTCAGGACTAAGGGATTTTGAGAAACATTAGATAAACATGTTGTA 69 FBan0031508 FBgn0044812 TotC 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotC Turandot C "CG31508, totC, tot" CDMC35145 2 24 2 DAC04-B01 23-CG31508-RA_2 CG31508 AGGCTCTTTACTGGATAATCACCATTCAGGACTAAGGGATTTTGAGAAACATTAGATAAACATGTTGTA 69 FBan0031508 FBgn0044812 TotC 3 3R humoral defense mechanism (sensu Protostomia); GO:0016065 TotC Turandot C "CG31508, totC, tot" CDMC35146 2 25 2 DAC04-B13 9-CG31519-RA_6 CG31519 ACCGCACTCAGCTTGAAGCACATTAGCTCCCTGATCTTCGTAATATCGGCGCAGTATCCCCTGATCTCT 69 FBgn0051519 CDMC35146 2 26 2 DAC04-B13 9-CG31519-RA_6 CG31519 ACCGCACTCAGCTTGAAGCACATTAGCTCCCTGATCTTCGTAATATCGGCGCAGTATCCCCTGATCTCT 69 FBgn0051519 CDMC35147 2 1 3 DAC04-F01 14-CG31545-RA_1 CG31545 GTGGTGGTCGCACTTAGGTGGATGCGTGTATAGGTGTATGTGTGCGCTTACCTGTGACGTATTAATGGA 69 FBan0031545 FBgn0051545 CG31545 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31545 CG31545 CDMC35147 2 2 3 DAC04-F01 14-CG31545-RA_1 CG31545 GTGGTGGTCGCACTTAGGTGGATGCGTGTATAGGTGTATGTGTGCGCTTACCTGTGACGTATTAATGGA 69 FBan0031545 FBgn0051545 CG31545 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31545 CG31545 CDMC35148 2 3 3 DAC04-F13 2-CG31556-RA_2 CG31556 GGGACCCTGTTGATGCTGGATCTGAGGTTACAGTTGTTGGGAGCCTTGTAGACGTTCTCCTTCTCCTCC 69 FBan0031556 FBgn0051556 CG31556 3 3R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; proteolysis; GO:0006508 sugar porter activity; GO:0005351; ; GO:0005351; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- cellular component unknown; GO:0008372 CG31556 CG31556 CDMC35148 2 4 3 DAC04-F13 2-CG31556-RA_2 CG31556 GGGACCCTGTTGATGCTGGATCTGAGGTTACAGTTGTTGGGAGCCTTGTAGACGTTCTCCTTCTCCTCC 69 FBan0031556 FBgn0051556 CG31556 3 3R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; proteolysis; GO:0006508 sugar porter activity; GO:0005351; ; GO:0005351; subtilase activity; GO:0004289 ; EC:3.4.21.-; ; GO:0004289 ; EC:3.4.21.- cellular component unknown; GO:0008372 CG31556 CG31556 CDMC35149 2 5 3 DAC04-J01 9-CG31622-RD_1 CG31622 CGCAACGCATTTGAAGAGTTGAGGGTTCAGTTGCGAACCTTAAAATGGCTTGGAGTCCTGCGGTTCACT 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC35149 2 6 3 DAC04-J01 9-CG31622-RD_1 CG31622 CGCAACGCATTTGAAGAGTTGAGGGTTCAGTTGCGAACCTTAAAATGGCTTGGAGTCCTGCGGTTCACT 69 FBan0031622 FBgn0041244 Gr39a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr39a Gustatory receptor 39a "CG31622, 39D.2, 39D.2a, 39D.2b, 39D.2c, 39D.2d, Gustatory receptor 39D.2, Gr39D2A, Gr39D2b, 39D2a, 39D2b, 39D2c, 39D2d, Gr39a.a, Gr39a.b, Gr39a.c, Gr39a.d, Gr39D2a, Gr39D2c, Gr39D2d, Gr39aA, GR39D.2, Gustatory receptor 39a" CDMC35150 2 7 3 DAC04-J13 22-CG31634-RA_1 CG31634 GCACCTTTCTCGGTGGCTACTTGGTCAAGAAATGGAATCTTGCCTGTAGAGGAATCATCAAAATGTGCC 69 FBan0031634 FBgn0051634 Oatp26F 2 2L organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; ; GO:0008514 integral to membrane; GO:0016021; membrane; GO:0016020 Oatp26F Organic anion transporting polypeptide 26F "CG31634, CG11332, CG13767, CG18784, CG31634, oatp 26F, Organic anion transporting polypeptide 26F" CDMC35150 2 8 3 DAC04-J13 22-CG31634-RA_1 CG31634 GCACCTTTCTCGGTGGCTACTTGGTCAAGAAATGGAATCTTGCCTGTAGAGGAATCATCAAAATGTGCC 69 FBan0031634 FBgn0051634 Oatp26F 2 2L organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; ; GO:0008514 integral to membrane; GO:0016021; membrane; GO:0016020 Oatp26F Organic anion transporting polypeptide 26F "CG31634, CG11332, CG13767, CG18784, CG31634, oatp 26F, Organic anion transporting polypeptide 26F" CDMC35151 2 9 3 DAC04-N01 23-CG31653-RA_5 CG31653 GCATGTGAATCCAATTCAGGTACATTTCGATCTTAGCTCAATACTATGGCTCAACTCCTTCGGCCTCAA 69 FBan0031653 FBgn0051653 CG31653 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31653 CG31653 CDMC35151 2 10 3 DAC04-N01 23-CG31653-RA_5 CG31653 GCATGTGAATCCAATTCAGGTACATTTCGATCTTAGCTCAATACTATGGCTCAACTCCTTCGGCCTCAA 69 FBan0031653 FBgn0051653 CG31653 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31653 CG31653 CDMC35152 2 11 3 DAC04-N13 23-CG31665-RA_3 CG31665 CACGCCTTAGCCTAAGGGGAAAATCACAGACACAAAGAGAGCAAAGCCAATGAAAGTAATGTAATGAAA 69 FBan0031665 FBgn0051665 CG31665 2 2L cell communication; GO:0007154; cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0004872; ; GO:0005509 CG31665 CG31665 "CG12704, CG15621, CT35769, fibropellin" CDMC35152 2 12 3 DAC04-N13 23-CG31665-RA_3 CG31665 CACGCCTTAGCCTAAGGGGAAAATCACAGACACAAAGAGAGCAAAGCCAATGAAAGTAATGTAATGAAA 69 FBan0031665 FBgn0051665 CG31665 2 2L cell communication; GO:0007154; cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor binding; GO:0005102; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0004872; ; GO:0005509 CG31665 CG31665 "CG12704, CG15621, CT35769, fibropellin" CDMC35153 2 13 3 DAC05-B01 2-CG5959-RA_1 CG5959 GGCTTCCGGCCTATCGTCCTCTGGAGATGGTTGTAGCCAATTATTTGGACAGCACACATCCCTTCCACA 69 FBan0005959 FBgn0039387 CG5959 3 3R defense response; GO:0006952; response to toxin; GO:0009636 L-ascorbate oxidase activity; GO:0008447 ; EC:1.10.3.3; ferroxidase activity; GO:0004322 ; EC:1.16.3.1; iron ion transporter activity; GO:0005381; ; GO:0005381; copper ion binding; GO:0005507; ; GO:0008447 ; EC:1.10.3.3; ; GO:0004322 ; EC:1.16.3.1; ; GO:0005507 CG5959 CG5959 CDMC35153 2 14 3 DAC05-B01 2-CG5959-RA_1 CG5959 GGCTTCCGGCCTATCGTCCTCTGGAGATGGTTGTAGCCAATTATTTGGACAGCACACATCCCTTCCACA 69 FBan0005959 FBgn0039387 CG5959 3 3R defense response; GO:0006952; response to toxin; GO:0009636 L-ascorbate oxidase activity; GO:0008447 ; EC:1.10.3.3; ferroxidase activity; GO:0004322 ; EC:1.16.3.1; iron ion transporter activity; GO:0005381; ; GO:0005381; copper ion binding; GO:0005507; ; GO:0008447 ; EC:1.10.3.3; ; GO:0004322 ; EC:1.16.3.1; ; GO:0005507 CG5959 CG5959 CDMC35154 2 15 3 DAC05-B13 23-CG5974-RA_2 CG5974 TTCGAACCGTTTGTTACCGACTAGATGGGCCTTATTATGTTACCATTTTATTGACGAACTTGAAAAGCT 69 FBan0005974 FBgn0010441 pll 3 3R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; protein amino acid phosphorylation; GO:0006468; protein import into nucleus; GO:0006606; regulation of proteolysis; GO:0030162; response to fungi; GO:0009620; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; zygotic determination of dorsal/ventral axis; GO:0007352 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 pll pelle "CG5974, CG5974, CG5974, CG5974, p11, PELLE/IL-1, pelle" CDMC35154 2 16 3 DAC05-B13 23-CG5974-RA_2 CG5974 TTCGAACCGTTTGTTACCGACTAGATGGGCCTTATTATGTTACCATTTTATTGACGAACTTGAAAAGCT 69 FBan0005974 FBgn0010441 pll 3 3R Toll signaling pathway; GO:0008063; antifungal humoral response (sensu Protostomia); GO:0006966; defense response; GO:0006952; dorsal/ventral axis specification; GO:0009950; hemocyte proliferation (sensu Arthropoda); GO:0035172; hemopoiesis; GO:0030097; protein amino acid phosphorylation; GO:0006468; protein import into nucleus; GO:0006606; regulation of proteolysis; GO:0030162; response to fungi; GO:0009620; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; zygotic determination of dorsal/ventral axis; GO:0007352 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004675 ; EC:2.7.1.-; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 pll pelle "CG5974, CG5974, CG5974, CG5974, p11, PELLE/IL-1, pelle" CDMC35155 2 17 3 DAC05-F01 15-CG6019-RA_1 CG6019 TGGCATTGGGTGACAATTCAGTTGACCTGGTAATGCACCTACATGACGAACTCATTTTCGAGGTGCCAA 69 FBan0006019 FBgn0002905 mus308 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; theta DNA polymerase activity; GO:0016452; ; GO:0016452; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016452; ; GO:0003677; ; GO:0008026 intracellular; GO:0005622 mus308 mutagen-sensitive 308 "CG6019, mus-308, 0443/09, AAF54858, Pol theta, Nuc3, Nuclease-3" CDMC35155 2 18 3 DAC05-F01 15-CG6019-RA_1 CG6019 TGGCATTGGGTGACAATTCAGTTGACCTGGTAATGCACCTACATGACGAACTCATTTTCGAGGTGCCAA 69 FBan0006019 FBgn0002905 mus308 3 3R DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA-directed DNA polymerase activity; GO:0003887 ; EC:2.7.7.7; ; GO:0003676; theta DNA polymerase activity; GO:0016452; ; GO:0016452; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ; GO:0003887 ; EC:2.7.7.7; ; GO:0016452; ; GO:0003677; ; GO:0008026 intracellular; GO:0005622 mus308 mutagen-sensitive 308 "CG6019, mus-308, 0443/09, AAF54858, Pol theta, Nuc3, Nuclease-3" CDMC35156 2 19 3 DAC05-F13 18-CG6033-RA_2 CG6033 GCAATCCTTCCGCACAGAGGACGAAACTCACTTGCTACAATCTTGACCGCAACTATAGGCATATGCAAG 69 FBan0006033 FBgn0004638 drk 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; Ras protein signal transduction; GO:0007265; actin filament organization; GO:0007015; cytoskeleton organization and biogenesis; GO:0007010; determination of anterior/posterior axis, embryo; GO:0008595; embryonic development (sensu Insecta); GO:0001700; memory; GO:0007613; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" sevenless binding; GO:0005118; receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005118; ; GO:0005515; ; GO:0005515; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070 plasma membrane; GO:0005886 drk downstream of receptor kinase "CG6033, CG6033, CG6033, E(sev)2B: Enhancer of sevenless-2B, crkl, 24/1, Drk, l(2)10626, l(2)k13809, DRK, P1112, Su(sev)R1, Grb2/drk, Drk/Grb2, Enhancer of sevenless-2B, E(sev)2B" CDMC35156 2 20 3 DAC05-F13 18-CG6033-RA_2 CG6033 GCAATCCTTCCGCACAGAGGACGAAACTCACTTGCTACAATCTTGACCGCAACTATAGGCATATGCAAG 69 FBan0006033 FBgn0004638 drk 2 2R "G-protein coupled receptor protein signaling pathway; GO:0007186; Ras protein signal transduction; GO:0007265; actin filament organization; GO:0007015; cytoskeleton organization and biogenesis; GO:0007010; determination of anterior/posterior axis, embryo; GO:0008595; embryonic development (sensu Insecta); GO:0001700; memory; GO:0007613; olfactory learning; GO:0008355; regulation of cell shape; GO:0008360; sevenless signaling pathway; GO:0045500; torso signaling pathway; GO:0008293" sevenless binding; GO:0005118; receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005118; ; GO:0005515; ; GO:0005515; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070 plasma membrane; GO:0005886 drk downstream of receptor kinase "CG6033, CG6033, CG6033, E(sev)2B: Enhancer of sevenless-2B, crkl, 24/1, Drk, l(2)10626, l(2)k13809, DRK, P1112, Su(sev)R1, Grb2/drk, Drk/Grb2, Enhancer of sevenless-2B, E(sev)2B" CDMC35157 2 21 3 DAC05-J01 14-CG6061-RA_3 CG6061 TCGGACAGCGAATGTACAGCGTGTGGTGTCTAGCAGTACAAGTCCCAGTTCCAACTCCACAAAGAAAAT 69 FBan0006061 FBgn0033846 mip120 2 2R "chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 Myb complex; GO:0031523; chromatin; GO:0000785 mip120 Myb-interacting protein 120 "CG6061, CG6061, l(3)L4569, p120, Mip120, Myb-interacting protein 120" CDMC35157 2 22 3 DAC05-J01 14-CG6061-RA_3 CG6061 TCGGACAGCGAATGTACAGCGTGTGGTGTCTAGCAGTACAAGTCCCAGTTCCAACTCCACAAAGAAAAT 69 FBan0006061 FBgn0033846 mip120 2 2R "chorion gene amplification; GO:0007307; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; ; GO:0005515 Myb complex; GO:0031523; chromatin; GO:0000785 mip120 Myb-interacting protein 120 "CG6061, CG6061, l(3)L4569, p120, Mip120, Myb-interacting protein 120" CDMC35158 2 23 3 DAC05-J13 13-CG6072-RA_1 CG6072 GGTGGTGACGAAACTAAAGCTGAAAACCTGAGTTGTAAAACCAAACGATCGGGACAACGGGTTGGGACT 69 FBan0006072 FBgn0020250 sra 3 3R "calcium-mediated signaling; GO:0019722; long-term memory; GO:0007616; meiosis I; GO:0007127; olfactory learning; GO:0008355; regulation of female receptivity; GO:0045924; regulation of female receptivity, post-mating; GO:0046008" receptor binding; GO:0005102; ; GO:0005102 sra sarah "CG6072, CG6072, 89B11, 89B, nla, nebula, sara, anon-WO0118547.92, anon-WO0172774.10, sarah" CDMC35158 2 24 3 DAC05-J13 13-CG6072-RA_1 CG6072 GGTGGTGACGAAACTAAAGCTGAAAACCTGAGTTGTAAAACCAAACGATCGGGACAACGGGTTGGGACT 69 FBan0006072 FBgn0020250 sra 3 3R "calcium-mediated signaling; GO:0019722; long-term memory; GO:0007616; meiosis I; GO:0007127; olfactory learning; GO:0008355; regulation of female receptivity; GO:0045924; regulation of female receptivity, post-mating; GO:0046008" receptor binding; GO:0005102; ; GO:0005102 sra sarah "CG6072, CG6072, 89B11, 89B, nla, nebula, sara, anon-WO0118547.92, anon-WO0172774.10, sarah" CDMC35159 2 25 3 DAC05-N01 23-CG6120-RA_9 CG6120 TGCTGTGAGTTCGAAACCTTTAAAATCACCCACACTTGAAACGAATTTTGTCGAATCCAACTTACCTGC 69 FBan0006120 FBgn0027865 Tsp96F 3 3R B cell mediated immunity; GO:0019724; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp96F Tetraspanin 96F "CG6120, CG6120, CG6120, Dm.Tsp96F, LD19727, BcDNA:LD19727, Tetraspanin 96F" CDMC35159 2 26 3 DAC05-N01 23-CG6120-RA_9 CG6120 TGCTGTGAGTTCGAAACCTTTAAAATCACCCACACTTGAAACGAATTTTGTCGAATCCAACTTACCTGC 69 FBan0006120 FBgn0027865 Tsp96F 3 3R B cell mediated immunity; GO:0019724; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp96F Tetraspanin 96F "CG6120, CG6120, CG6120, Dm.Tsp96F, LD19727, BcDNA:LD19727, Tetraspanin 96F" CDMC35160 2 1 4 DAC05-N13 9-CG6133-RA_1 CG6133 GGCGAGAATGATCCTGACTACCAGGCGATCAAGGAGTTCTACCAGCTGGACGAATCCCTTAGTCAACGA 69 FBan0006133 FBgn0026079 CG6133 X X rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; DNA (cytosine-5-)-methyltransferase activity; GO:0003886 ; EC:2.1.1.37; ; GO:0003676; ; GO:0003886 ; EC:2.1.1.37 CG6133 CG6133 EG:EG0007.9 CDMC35160 2 2 4 DAC05-N13 9-CG6133-RA_1 CG6133 GGCGAGAATGATCCTGACTACCAGGCGATCAAGGAGTTCTACCAGCTGGACGAATCCCTTAGTCAACGA 69 FBan0006133 FBgn0026079 CG6133 X X rRNA metabolism; GO:0016072 nucleic acid binding; GO:0003676; DNA (cytosine-5-)-methyltransferase activity; GO:0003886 ; EC:2.1.1.37; ; GO:0003676; ; GO:0003886 ; EC:2.1.1.37 CG6133 CG6133 EG:EG0007.9 CDMC35161 2 3 4 DAC06-B01 13-CG11512-RA_1 CG11512 AGCTCTTGGACTGGAACTGAACAAAAAGCAACTGCGTATCACAGAAGGGGAACACCTCAAGCCAGAATT 69 FBan0011512 FBgn0010040 GstD4 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD4 Glutathione S transferase D4 "CG11512, DmGST23, gstD23, GST, Gst, DmGSTD4, GstD23: Glutathione S transferase D23, Glutathione S transferase D23, Glutathione S transferase D4" CDMC35161 2 4 4 DAC06-B01 13-CG11512-RA_1 CG11512 AGCTCTTGGACTGGAACTGAACAAAAAGCAACTGCGTATCACAGAAGGGGAACACCTCAAGCCAGAATT 69 FBan0011512 FBgn0010040 GstD4 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD4 Glutathione S transferase D4 "CG11512, DmGST23, gstD23, GST, Gst, DmGSTD4, GstD23: Glutathione S transferase D23, Glutathione S transferase D23, Glutathione S transferase D4" CDMC35162 2 5 4 DAC06-B13 3-CG11526-RA_5 CG11526 ACGTGAACACCAAGAACTCCATTCCTCTGCTCGATTTCCCGTCGTGTGTGATTGGTGAGCAACCGGATT 69 FBan0011526 FBgn0035437 CG11526 3 3L CG11526 CG11526 CDMC35162 2 6 4 DAC06-B13 3-CG11526-RA_5 CG11526 ACGTGAACACCAAGAACTCCATTCCTCTGCTCGATTTCCCGTCGTGTGTGATTGGTGAGCAACCGGATT 69 FBan0011526 FBgn0035437 CG11526 3 3L CG11526 CG11526 CDMC35163 2 7 4 DAC06-F01 9-CG11579-RA_2 CG11579 TGGCTGCCTGGTACGATACCGATTGTTAGACAAGCCGAGCTAAGGGTAAGGGTCGAGTATCCATTCGAC 69 FBan0011579 FBgn0000117 arm X X Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoskeletal anchoring; GO:0007016; dorsal closure; GO:0007391; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; germ-line stem cell division; GO:0042078; heart development; GO:0007507; neuroblast fate determination; GO:0007400; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of JNK cascade; GO:0046330; protein localization; GO:0008104; regulation of cell shape; GO:0008360; somatic stem cell maintenance; GO:0035019; tracheal branch fusion; GO:0035147; zonula adherens assembly; GO:0045186 cytoskeletal protein binding; GO:0008092; ; GO:0008092; alpha-catenin binding; GO:0045294; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; protein binding; GO:0005515; ; GO:0045294; ; GO:0005515; ; GO:0005515 adherens junction; GO:0005912; apicolateral plasma membrane; GO:0016327; catenin complex; GO:0016342; cytoplasm; GO:0005737; membrane; GO:0016020; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 arm armadillo "CG11579, CG11579, CG11579, CG11579, CG11579, CG11579, CG11579, l(1)arm, beta-catenin, l(1)G0234, l(1)G0192, Armadillo, beta-catenin, Arm, beta-Catenin, EG:86E4.6, l(1)G0410, Beta-catenin, b-catenin, ARM, t12687 ALR Dm, catenin, Beta-catenin, beta-cat, l(1)2Bv" CDMC35163 2 8 4 DAC06-F01 9-CG11579-RA_2 CG11579 TGGCTGCCTGGTACGATACCGATTGTTAGACAAGCCGAGCTAAGGGTAAGGGTCGAGTATCCATTCGAC 69 FBan0011579 FBgn0000117 arm X X Wnt receptor signaling pathway; GO:0016055; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoskeletal anchoring; GO:0007016; dorsal closure; GO:0007391; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; germ-line stem cell division; GO:0042078; heart development; GO:0007507; neuroblast fate determination; GO:0007400; oocyte localization during oogenesis; GO:0030720; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; positive regulation of JNK cascade; GO:0046330; protein localization; GO:0008104; regulation of cell shape; GO:0008360; somatic stem cell maintenance; GO:0035019; tracheal branch fusion; GO:0035147; zonula adherens assembly; GO:0045186 cytoskeletal protein binding; GO:0008092; ; GO:0008092; alpha-catenin binding; GO:0045294; structural constituent of cytoskeleton; GO:0005200; receptor binding; GO:0005102; ; GO:0005200; ; GO:0005102; protein binding; GO:0005515; ; GO:0045294; ; GO:0005515; ; GO:0005515 adherens junction; GO:0005912; apicolateral plasma membrane; GO:0016327; catenin complex; GO:0016342; cytoplasm; GO:0005737; membrane; GO:0016020; spot adherens junction; GO:0005914; zonula adherens; GO:0005915 arm armadillo "CG11579, CG11579, CG11579, CG11579, CG11579, CG11579, CG11579, l(1)arm, beta-catenin, l(1)G0234, l(1)G0192, Armadillo, beta-catenin, Arm, beta-Catenin, EG:86E4.6, l(1)G0410, Beta-catenin, b-catenin, ARM, t12687 ALR Dm, catenin, Beta-catenin, beta-cat, l(1)2Bv" CDMC35164 2 9 4 DAC06-F13 5-CG11590-RA_1 CG11590 CCGCATGCGTGAACATTGTGTCCCAAGTCGAGTCTATCTACAAGTGGGAAGGCGAGATTAGCGAGGACT 69 FBan0011590 FBgn0030545 CG11590 X X cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 CG11590 CG11590 BcDNA:GM24986 CDMC35164 2 10 4 DAC06-F13 5-CG11590-RA_1 CG11590 CCGCATGCGTGAACATTGTGTCCCAAGTCGAGTCTATCTACAAGTGGGAAGGCGAGATTAGCGAGGACT 69 FBan0011590 FBgn0030545 CG11590 X X cation transport; GO:0006812; cell homeostasis; GO:0019725; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0008324 CG11590 CG11590 BcDNA:GM24986 CDMC35165 2 11 4 DAC06-J01 15-CG11635-RA_1 CG11635 CGACAGGACCCTCTTCCGATTTTCTCCAATTTTCAACCAGCTCTTTTTCGTCCAGTAGGCCTCGATCGA 69 FBan0011635 FBgn0033283 CG11635 2 2R CG11635 CG11635 CDMC35165 2 12 4 DAC06-J01 15-CG11635-RA_1 CG11635 CGACAGGACCCTCTTCCGATTTTCTCCAATTTTCAACCAGCTCTTTTTCGTCCAGTAGGCCTCGATCGA 69 FBan0011635 FBgn0033283 CG11635 2 2R CG11635 CG11635 CDMC35166 2 13 4 DAC06-J13 16-CG11642-RA_1 CG11642 TGGCTACTTGGCTCCCTGTTTGATGTAATCTCGTTAGCTCAAAACTACCACTGCAACATTTCTGCTGCA 69 FBan0011642 FBgn0040340 CG11642 X X SRP-dependent cotranslational protein targeting to membrane; GO:0006614 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG11642 CG11642 "CG18830, CG18830, EG:BACR7A4.5, BACR7A4.5" CDMC35166 2 14 4 DAC06-J13 16-CG11642-RA_1 CG11642 TGGCTACTTGGCTCCCTGTTTGATGTAATCTCGTTAGCTCAAAACTACCACTGCAACATTTCTGCTGCA 69 FBan0011642 FBgn0040340 CG11642 X X SRP-dependent cotranslational protein targeting to membrane; GO:0006614 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG11642 CG11642 "CG18830, CG18830, EG:BACR7A4.5, BACR7A4.5" CDMC35167 2 15 4 DAC06-N01 24-CG11686-RA_1 CG11686 CCCAATATCAATTAACTAAGTGCCTTACTGATAACTCTTGTTTTCAATCATTTTTTACAATTTTACAAA 69 FBan0011686 FBgn0040551 CG11686 3 3R CG11686 CG11686 BcDNA:RH19248 CDMC35167 2 16 4 DAC06-N01 24-CG11686-RA_1 CG11686 CCCAATATCAATTAACTAAGTGCCTTACTGATAACTCTTGTTTTCAATCATTTTTTACAATTTTACAAA 69 FBan0011686 FBgn0040551 CG11686 3 3R CG11686 CG11686 BcDNA:RH19248 CDMC35168 2 17 4 DAC06-N13 11-CG11711-RA_1 CG11711 GGCGCCTACCGGTATGCACCAAATATGTCACAACTTACGTACCACACACTTCACACACCAACACAACCA 69 FBan0011711 FBgn0036172 Mob1 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mob1 Mob1 "CG11711, CG11712, CG11711, CG11711, CG11711, gh06341, Dmob1, Dmob2, dmob1, DMob1, BcDNA:GH13236, BEST:GH06341" CDMC35168 2 18 4 DAC06-N13 11-CG11711-RA_1 CG11711 GGCGCCTACCGGTATGCACCAAATATGTCACAACTTACGTACCACACACTTCACACACCAACACAACCA 69 FBan0011711 FBgn0036172 Mob1 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Mob1 Mob1 "CG11711, CG11712, CG11711, CG11711, CG11711, gh06341, Dmob1, Dmob2, dmob1, DMob1, BcDNA:GH13236, BEST:GH06341" CDMC35169 2 19 4 DAC07-B01 2-CG14958-RA_1 CG14958 TATGCCAGTCAAATGGAGCCTCCTGCATCAACCAGACCGCATACAATTTGTGCTTCGGCTCCACT 65 FBan0014958 FBgn0035413 CG14958 3 3L CG14958 CG14958 CDMC35169 2 20 4 DAC07-B01 2-CG14958-RA_1 CG14958 TATGCCAGTCAAATGGAGCCTCCTGCATCAACCAGACCGCATACAATTTGTGCTTCGGCTCCACT 65 FBan0014958 FBgn0035413 CG14958 3 3L CG14958 CG14958 CDMC35170 2 21 4 DAC07-B13 3-CG15008-RA_1 CG15008 GTTCGTTTTGGGACTGATCCTGTCCGCCGTTGTGGCCATTCCCATTGATCCCTATGGACTTTCGG 65 FBan0015008 FBgn0035512 CG15008 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15008 CG15008 CDMC35170 2 22 4 DAC07-B13 3-CG15008-RA_1 CG15008 GTTCGTTTTGGGACTGATCCTGTCCGCCGTTGTGGCCATTCCCATTGATCCCTATGGACTTTCGG 65 FBan0015008 FBgn0035512 CG15008 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG15008 CG15008 CDMC35171 2 23 4 DAC07-F01 5-CG15077-RA_1 CG15077 ACGCCGGGAAATTTTCGCATAACACCCAAGGATCTAGTGCTATCGGGCTATCAGGTGCCACGTGG 65 FBan0015077 FBgn0034387 Cyp12b2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12b2 Cyp12b2 "CG15077, 12b2" CDMC35171 2 24 4 DAC07-F01 5-CG15077-RA_1 CG15077 ACGCCGGGAAATTTTCGCATAACACCCAAGGATCTAGTGCTATCGGGCTATCAGGTGCCACGTGG 65 FBan0015077 FBgn0034387 Cyp12b2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 mitochondrion; GO:0005739 Cyp12b2 Cyp12b2 "CG15077, 12b2" CDMC35172 2 25 4 DAC07-F13 1-CG15111-RA_1 CG15111 TGTATAGGATCGCATTGGATGGCAGAAGTCGAACCTCGGGACCTGTGGAGTTCCATCGCTTTGGG 65 FBan0015111 FBgn0034419 CG15111 2 2R CG15111 CG15111 CDMC35172 2 26 4 DAC07-F13 1-CG15111-RA_1 CG15111 TGTATAGGATCGCATTGGATGGCAGAAGTCGAACCTCGGGACCTGTGGAGTTCCATCGCTTTGGG 65 FBan0015111 FBgn0034419 CG15111 2 2R CG15111 CG15111 CDMC35173 2 1 5 DAC07-J01 6-CG15191-RA_1 CG15191 CATCCTGATGGAGAAGGGCACCAACAACAGCTTCACCGTAGAGCAGCTGATCGCCGAGGTAACAC 65 FBan0015191 FBgn0000618 e(y)2 X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 e(y)2 enhancer of yellow 2 "CG15191, CG15191, e(y)[2], d" CDMC35173 2 2 5 DAC07-J01 6-CG15191-RA_1 CG15191 CATCCTGATGGAGAAGGGCACCAACAACAGCTTCACCGTAGAGCAGCTGATCGCCGAGGTAACAC 65 FBan0015191 FBgn0000618 e(y)2 X X transcription; GO:0006350 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 e(y)2 enhancer of yellow 2 "CG15191, CG15191, e(y)[2], d" CDMC35174 2 3 5 DAC07-J13 5-CG15213-RA_1 CG15213 GTGAGTCCGTCAACCCATCCGACGACCAATCCTTCCTGCTCAAGCTGAAGCTGCTCAAGAAGCTG 65 FBan0015213 FBgn0040843 CG15213 3 3L CG15213 CG15213 CDMC35174 2 4 5 DAC07-J13 5-CG15213-RA_1 CG15213 GTGAGTCCGTCAACCCATCCGACGACCAATCCTTCCTGCTCAAGCTGAAGCTGCTCAAGAAGCTG 65 FBan0015213 FBgn0040843 CG15213 3 3L CG15213 CG15213 CDMC35175 2 5 5 DAC07-N01 1-CG15314-RA_1 CG15314 AATTCCATGTACCGCGAACGAACCACTTTTGACTACCGACTGGCAGCTGCGACAACCAACGACTG 65 FBan0015314 FBgn0030172 CG15314 X X CG15314 CG15314 CDMC35175 2 6 5 DAC07-N01 1-CG15314-RA_1 CG15314 AATTCCATGTACCGCGAACGAACCACTTTTGACTACCGACTGGCAGCTGCGACAACCAACGACTG 65 FBan0015314 FBgn0030172 CG15314 X X CG15314 CG15314 CDMC35176 2 7 5 DAC07-N13 2-CG15350-RA_1 CG15350 TCGGGAGGACTACAAGTTCGTGGATGATTCGCAGCTTAGGAGCCTGTTGTCCACCACTTCTGTGC 65 FBgn0030044 CDMC35176 2 8 5 DAC07-N13 2-CG15350-RA_1 CG15350 TCGGGAGGACTACAAGTTCGTGGATGATTCGCAGCTTAGGAGCCTGTTGTCCACCACTTCTGTGC 65 FBgn0030044 CDMC35177 2 9 5 DAC08-B01 18-CG14372-RA_1 CG14372 AACCGATTGCCGTGCATATACTTACCAAGGATCGATTCGTGTCTGCAGATCGCACCTATGACGTGG 66 FBan0014372 FBgn0038156 CG14372 3 3R CG14372 CG14372 "CT34011, BP1073" CDMC35177 2 10 5 DAC08-B01 18-CG14372-RA_1 CG14372 AACCGATTGCCGTGCATATACTTACCAAGGATCGATTCGTGTCTGCAGATCGCACCTATGACGTGG 66 FBan0014372 FBgn0038156 CG14372 3 3R CG14372 CG14372 "CT34011, BP1073" CDMC35178 2 11 5 DAC08-B13 2-CG14471-RA_1 CG14471 CCGCGACTTCGAGACGATCAACGATCCAGCTACATGGCAGCTGAAACTTGATCCTGTCAGCAGCAT 66 FBan0014471 FBgn0033049 CG14471 2 2R CG14471 CG14471 CDMC35178 2 12 5 DAC08-B13 2-CG14471-RA_1 CG14471 CCGCGACTTCGAGACGATCAACGATCCAGCTACATGGCAGCTGAAACTTGATCCTGTCAGCAGCAT 66 FBan0014471 FBgn0033049 CG14471 2 2R CG14471 CG14471 CDMC35179 2 13 5 DAC08-F01 8-CG14714-RA_2 CG14714 CGTCGGCGACTCTGGACAATCATAGCAGCTATGGCGATTACCAGGTGACCCTCAAGCATCGCGAAG 66 FBan0014714 FBgn0037929 CG14714 3 3R protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 CG14714 CG14714 CDMC35179 2 14 5 DAC08-F01 8-CG14714-RA_2 CG14714 CGTCGGCGACTCTGGACAATCATAGCAGCTATGGCGATTACCAGGTGACCCTCAAGCATCGCGAAG 66 FBan0014714 FBgn0037929 CG14714 3 3R protein amino acid dephosphorylation; GO:0006470; signal transduction; GO:0007165 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004725 ; EC:3.1.3.48 CG14714 CG14714 CDMC35180 2 15 5 DAC08-F13 3-CG14779-RA_1 CG14779 CGCCAGCTTTTTCGTGCTGATGATGTCCTTTTGCTCGCCGTACTGGATCGAGTCCTACGAGGAGAC 66 FBgn0025384 CDMC35180 2 16 5 DAC08-F13 3-CG14779-RA_1 CG14779 CGCCAGCTTTTTCGTGCTGATGATGTCCTTTTGCTCGCCGTACTGGATCGAGTCCTACGAGGAGAC 66 FBgn0025384 CDMC35181 2 17 5 DAC08-J01 1-CG1513-RA_1 CG1513 GCGCACGGATCGATGATTACGCACTTGCTGTCCCAGGTTAAAATCGGCATGGACCTCACGAAAGTG 66 FBan0001513 FBgn0033463 CG1513 2 2R cholesterol metabolism; GO:0008203 oxysterol binding; GO:0008142; ; GO:0008142 CG1513 CG1513 CDMC35181 2 18 5 DAC08-J01 1-CG1513-RA_1 CG1513 GCGCACGGATCGATGATTACGCACTTGCTGTCCCAGGTTAAAATCGGCATGGACCTCACGAAAGTG 66 FBan0001513 FBgn0033463 CG1513 2 2R cholesterol metabolism; GO:0008203 oxysterol binding; GO:0008142; ; GO:0008142 CG1513 CG1513 CDMC35182 2 19 5 DAC08-J13 2-CG15288-RB_2 CG15288 GGGCTACCACAGTCTCCAGTCAAGGTCTCCTCCGATCTCTATGTCCGTCTGGAACCATTCAAGGGT 66 FBan0015288 FBgn0004002 wb 2 2L cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; cell-matrix adhesion; GO:0007160; regulation of cell adhesion; GO:0030155; regulation of cell migration; GO:0030334; regulation of embryonic development; GO:0045995; signal transduction; GO:0007165 actin binding; GO:0003779; binding; GO:0005488; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0003779; ; GO:0005102; ; GO:0005198; ; GO:0005488 basal lamina; GO:0005605; basement membrane; GO:0005604; laminin-1; GO:0005606 wb wing blister "CG15288, CG15288, A1, lethal group A1, l(2)br1, lethal 1 in the black-reduced region, l34Fb, l(2)34Fb, DLAM, D-laminin alpha2, CK02229, laminin alpha1,2, BG:DS03792.1, wing blistered, laminin, Laminin alpha1,2, LM-A/alpha2, CT35236, BEST:CK02229, l(2)09437, wing blister" CDMC35182 2 20 5 DAC08-J13 2-CG15288-RB_2 CG15288 GGGCTACCACAGTCTCCAGTCAAGGTCTCCTCCGATCTCTATGTCCGTCTGGAACCATTCAAGGGT 66 FBan0015288 FBgn0004002 wb 2 2L cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; cell-matrix adhesion; GO:0007160; regulation of cell adhesion; GO:0030155; regulation of cell migration; GO:0030334; regulation of embryonic development; GO:0045995; signal transduction; GO:0007165 actin binding; GO:0003779; binding; GO:0005488; receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0003779; ; GO:0005102; ; GO:0005198; ; GO:0005488 basal lamina; GO:0005605; basement membrane; GO:0005604; laminin-1; GO:0005606 wb wing blister "CG15288, CG15288, A1, lethal group A1, l(2)br1, lethal 1 in the black-reduced region, l34Fb, l(2)34Fb, DLAM, D-laminin alpha2, CK02229, laminin alpha1,2, BG:DS03792.1, wing blistered, laminin, Laminin alpha1,2, LM-A/alpha2, CT35236, BEST:CK02229, l(2)09437, wing blister" CDMC35183 2 21 5 DAC08-N01 3-CG15783-RA_1 CG15783 CCATTCCACCCGCCCACTCGACTGTCAATACGCAAGTCAATGTGAAAATGGAGCTGACCGCCAATG 66 FBgn0029772 CDMC35183 2 22 5 DAC08-N01 3-CG15783-RA_1 CG15783 CCATTCCACCCGCCCACTCGACTGTCAATACGCAAGTCAATGTGAAAATGGAGCTGACCGCCAATG 66 FBgn0029772 CDMC35184 2 23 5 DAC08-N13 1-CG1630-RB_1 CG1630 GGAGTGCTTCCAGATTCTCATGCACGATCTGCTTAGGCCCTATGTGCCCGTTTACAAGGGTCAGGT 66 FBan0001630 FBgn0030471 IP3K2 X X inositol and derivative phosphorylation; GO:0046853 inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 IP3K2 "Inositol 1,4,5-triphosphate kinase 2" "CG1630, CG1630, CG1630, D-IP3K2, DIP3K2, dmIP3K2, dmIP3Kbeta, Inositol 1,4,5-triphosphate kinase 2" CDMC35184 2 24 5 DAC08-N13 1-CG1630-RB_1 CG1630 GGAGTGCTTCCAGATTCTCATGCACGATCTGCTTAGGCCCTATGTGCCCGTTTACAAGGGTCAGGT 66 FBan0001630 FBgn0030471 IP3K2 X X inositol and derivative phosphorylation; GO:0046853 inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127 IP3K2 "Inositol 1,4,5-triphosphate kinase 2" "CG1630, CG1630, CG1630, D-IP3K2, DIP3K2, dmIP3K2, dmIP3Kbeta, Inositol 1,4,5-triphosphate kinase 2" CDMC35185 2 25 5 DAC09-B02 2-CG1407-RB_1 CG1407 CGACGATCATCGACGGCGGAAGACACCCTGCGGATTTTGTATGGCAGTCTTCAAATGGATACCAGTGCT 69 FBan0001407 FBgn0033474 CG1407 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG1407 CG1407 CDMC35185 2 26 5 DAC09-B02 2-CG1407-RB_1 CG1407 CGACGATCATCGACGGCGGAAGACACCCTGCGGATTTTGTATGGCAGTCTTCAAATGGATACCAGTGCT 69 FBan0001407 FBgn0033474 CG1407 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG1407 CG1407 CDMC35186 2 1 6 DAC09-B14 12-CG14089-RA_1 CG14089 CCGCCACAGGAAGTGATCATAGAGGAGGATCACGATCATCAACATTATCATCCGCCACACTATCCGCCA 69 FBan0014089 FBgn0036861 CG14089 3 3L CG14089 CG14089 CDMC35186 2 2 6 DAC09-B14 12-CG14089-RA_1 CG14089 CCGCCACAGGAAGTGATCATAGAGGAGGATCACGATCATCAACATTATCATCCGCCACACTATCCGCCA 69 FBan0014089 FBgn0036861 CG14089 3 3L CG14089 CG14089 CDMC35187 2 3 6 DAC09-F02 16-CG1412-RA_1 CG1412 CGGTGGCAATTTCACATGGTGAAACACACATGAAACACTCTGGGCGAACTCACATTCTTAGCAAACAGT 69 FBan0001412 FBgn0031118 RhoGAP19D X X intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP19D RhoGAP19D "CG1412, CG1412, CG1412, CG1412, CG1412" CDMC35187 2 4 6 DAC09-F02 16-CG1412-RA_1 CG1412 CGGTGGCAATTTCACATGGTGAAACACACATGAAACACTCTGGGCGAACTCACATTCTTAGCAAACAGT 69 FBan0001412 FBgn0031118 RhoGAP19D X X intracellular signaling cascade; GO:0007242; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515; small GTPase regulator activity; GO:0005083; ; GO:0005083 RhoGAP19D RhoGAP19D "CG1412, CG1412, CG1412, CG1412, CG1412" CDMC35188 2 5 6 DAC09-F14 17-CG14151-RA_1 CG14151 CCTCCCGATGAGAAGTATAGAGAAAGGAGTGGCTGTGATGTGAAATACGCTGAGGAAGAGGAAAAGCCA 69 FBan0014151 FBgn0036089 CG14151 3 3L CG14151 CG14151 CDMC35188 2 6 6 DAC09-F14 17-CG14151-RA_1 CG14151 CCTCCCGATGAGAAGTATAGAGAAAGGAGTGGCTGTGATGTGAAATACGCTGAGGAAGAGGAAAAGCCA 69 FBan0014151 FBgn0036089 CG14151 3 3L CG14151 CG14151 CDMC35189 2 7 6 DAC09-J02 3-CG14194-RA_4 CG14194 GCCGCTAAAGCTGGATCGCTTTGTCTACTGGAACTGGGACGTAGTGTTTGTGCCCATGTGGATCGTCAT 69 FBan0014194 FBgn0030996 CG14194 X X CG14194 CG14194 CDMC35189 2 8 6 DAC09-J02 3-CG14194-RA_4 CG14194 GCCGCTAAAGCTGGATCGCTTTGTCTACTGGAACTGGGACGTAGTGTTTGTGCCCATGTGGATCGTCAT 69 FBan0014194 FBgn0030996 CG14194 X X CG14194 CG14194 CDMC35190 2 9 6 DAC09-J14 3-CG14211-RB_1 CG14211 CCCCCCAGCTTCCATGGGACTTCGTGCACCTTCGGATATTGGCGCTACCTTATCGATATTGATGTGCTT 69 FBan0014211 FBgn0031044 CG14211 X X MAPKKK cascade; GO:0000165; glycolysis; GO:0006096; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; sugar porter activity; GO:0005351; ; GO:0019210; ; GO:0005351 CG14211 CG14211 MKP-like CDMC35190 2 10 6 DAC09-J14 3-CG14211-RB_1 CG14211 CCCCCCAGCTTCCATGGGACTTCGTGCACCTTCGGATATTGGCGCTACCTTATCGATATTGATGTGCTT 69 FBan0014211 FBgn0031044 CG14211 X X MAPKKK cascade; GO:0000165; glycolysis; GO:0006096; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; kinase inhibitor activity; GO:0019210; ; GO:0008138 ; EC:3.1.3.-; sugar porter activity; GO:0005351; ; GO:0019210; ; GO:0005351 CG14211 CG14211 MKP-like CDMC35191 2 11 6 DAC09-N02 17-CG14242-RA_1 CG14242 CCGATGTTGTGCAACTAAAACCACAAACGACTGAGACCCCAGTGATCTTCAAGATTAGGCCAAAGGACA 69 FBan0014242 FBgn0039443 CG14242 3 3R CG14242 CG14242 CDMC35191 2 12 6 DAC09-N02 17-CG14242-RA_1 CG14242 CCGATGTTGTGCAACTAAAACCACAAACGACTGAGACCCCAGTGATCTTCAAGATTAGGCCAAAGGACA 69 FBan0014242 FBgn0039443 CG14242 3 3R CG14242 CG14242 CDMC35192 2 13 6 DAC09-N14 2-CG14259-RA_5 CG14259 GGCCATTTTGTGCCTGAATGAAATCGCCATGGATAGGTCGTTGGTTTCAGCCGTTGCCTACTACTCCGA 69 FBan0014259 FBgn0039483 CG14259 3 3R CG14259 CG14259 CDMC35192 2 14 6 DAC09-N14 2-CG14259-RA_5 CG14259 GGCCATTTTGTGCCTGAATGAAATCGCCATGGATAGGTCGTTGGTTTCAGCCGTTGCCTACTACTCCGA 69 FBan0014259 FBgn0039483 CG14259 3 3R CG14259 CG14259 CDMC35193 2 15 6 DAC10-B01 23-CG1943-RA_5 CG1943 CTCCAAGTCGTTCTTCCTTTCGCCCTTTCATTTTCATGTCCCACATTTGTTCTATTGTCTAAGTAACAG 69 FBan0001943 FBgn0037468 CG1943 3 3R CG1943 CG1943 CDMC35193 2 16 6 DAC10-B01 23-CG1943-RA_5 CG1943 CTCCAAGTCGTTCTTCCTTTCGCCCTTTCATTTTCATGTCCCACATTTGTTCTATTGTCTAAGTAACAG 69 FBan0001943 FBgn0037468 CG1943 3 3R CG1943 CG1943 CDMC35194 2 17 6 DAC10-B13 1-CG1960-RA_1 CG1960 ACATAAAGGCAGACCATCTGTTCAGCGACCCAACGTTCGAGGAGACCTACAAGTTCAAACCCTCCTCCG 69 FBan0001960 FBgn0002872 mu2 3 3L intracellular; GO:0005622 mu2 mutator 2 "CG1960, CG1960, mutator[2], cDNA D, mu-2" CDMC35194 2 18 6 DAC10-B13 1-CG1960-RA_1 CG1960 ACATAAAGGCAGACCATCTGTTCAGCGACCCAACGTTCGAGGAGACCTACAAGTTCAAACCCTCCTCCG 69 FBan0001960 FBgn0002872 mu2 3 3L intracellular; GO:0005622 mu2 mutator 2 "CG1960, CG1960, mutator[2], cDNA D, mu-2" CDMC35195 2 19 6 DAC10-F01 17-CG1988-RB_1 CG1988 GCGAAAAGCAGGCGAAAATAGAAGCCATCAAACGAGCGTGTCGAGAAGAAAAAGAAAGGCAAGAGTGCG 69 FBan0001988 FBgn0037464 CG1988 3 3R CG1988 CG1988 CDMC35195 2 20 6 DAC10-F01 17-CG1988-RB_1 CG1988 GCGAAAAGCAGGCGAAAATAGAAGCCATCAAACGAGCGTGTCGAGAAGAAAAAGAAAGGCAAGAGTGCG 69 FBan0001988 FBgn0037464 CG1988 3 3R CG1988 CG1988 CDMC35196 2 21 6 DAC10-F13 4-CG2013-RA_1 CG2013 AGGCGTCCGAGTTCCAAATCCAACACAACACGAGTGGTAGTATCGCTGTGAAAAATGTCAACACCCGCA 69 FBan0002013 FBgn0004436 UbcD6 3 3R DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 nucleus; GO:0005634 UbcD6 Ubiquitin conjugating enzyme "CG2013, Dhr6, Rad6, RAD6, BcDNA:RE56673" CDMC35196 2 22 6 DAC10-F13 4-CG2013-RA_1 CG2013 AGGCGTCCGAGTTCCAAATCCAACACAACACGAGTGGTAGTATCGCTGTGAAAAATGTCAACACCCGCA 69 FBan0002013 FBgn0004436 UbcD6 3 3R DNA repair; GO:0006281; regulation of progression through cell cycle; GO:0000074; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840; ; GO:0004840; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004840 nucleus; GO:0005634 UbcD6 Ubiquitin conjugating enzyme "CG2013, Dhr6, Rad6, RAD6, BcDNA:RE56673" CDMC35197 2 23 6 DAC10-J01 9-CG2050-RA_4 CG2050 GCCCAGAGCTTTTGTACGTTTGGCGTCGGTCGATGACATACCGAAGGCTCTTAAACTGCATAGCACTGA 69 FBan0002050 FBgn0002780 mod 3 3R cell proliferation; GO:0008283; spermatid development; GO:0007286 DNA binding; GO:0003677; ; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 mod modulo "CG2050, ms(3)100EF, 0952/14, male sterile(3)100EF, modulo" CDMC35197 2 24 6 DAC10-J01 9-CG2050-RA_4 CG2050 GCCCAGAGCTTTTGTACGTTTGGCGTCGGTCGATGACATACCGAAGGCTCTTAAACTGCATAGCACTGA 69 FBan0002050 FBgn0002780 mod 3 3R cell proliferation; GO:0008283; spermatid development; GO:0007286 DNA binding; GO:0003677; ; GO:0003677; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003677; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 mod modulo "CG2050, ms(3)100EF, 0952/14, male sterile(3)100EF, modulo" CDMC35198 2 25 6 DAC10-J13 8-CG2062-RA_1 CG2062 TGGTGACATTGTGCCGAAGGGGACTACCTTGAACTTGGGCCTTCTTATGTTGGGATACAATGACCGTGT 69 FBan0002062 FBgn0015034 Cyp4e1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e1 Cytochrome P450-4e1 "CG2062, P450, P-450, CYP4E1, 4e1" CDMC35198 2 26 6 DAC10-J13 8-CG2062-RA_1 CG2062 TGGTGACATTGTGCCGAAGGGGACTACCTTGAACTTGGGCCTTCTTATGTTGGGATACAATGACCGTGT 69 FBan0002062 FBgn0015034 Cyp4e1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4e1 Cytochrome P450-4e1 "CG2062, P450, P-450, CYP4E1, 4e1" CDMC35199 2 1 7 DAC10-N01 23-CG2096-RA_1 CG2096 GCCCATAGTTAAGTCGATTCCTGCATTTGATGATTATCTGTTGAATGGAAATTGTGACAACGTCCCCGT 69 FBan0002096 FBgn0000711 flw X X cell adhesion; GO:0007155; larval development (sensu Insecta); GO:0002168; mesoderm development; GO:0007498; muscle attachment; GO:0016203; nurse cell to oocyte transport (sensu Insecta); GO:0007300; ovarian ring canal formation; GO:0007301; protein amino acid dephosphorylation; GO:0006470; wing morphogenesis; GO:0007476 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 protein phosphatase type 1 complex; GO:0000164 flw flap wing "CG2096, CG15305, CG2096, CG2096, CG2096, PP-1, PP1beta9C, PP1beta, PP1 9C, Pp1beta-9C, PP1, l(1)G0172, Pp1beta-9C, FLW/PP1B, PP19C, PP1c, PP1 b9C, anon-WO03040301.120, Protein phosphatase 1beta at 9C" CDMC35199 2 2 7 DAC10-N01 23-CG2096-RA_1 CG2096 GCCCATAGTTAAGTCGATTCCTGCATTTGATGATTATCTGTTGAATGGAAATTGTGACAACGTCCCCGT 69 FBan0002096 FBgn0000711 flw X X cell adhesion; GO:0007155; larval development (sensu Insecta); GO:0002168; mesoderm development; GO:0007498; muscle attachment; GO:0016203; nurse cell to oocyte transport (sensu Insecta); GO:0007300; ovarian ring canal formation; GO:0007301; protein amino acid dephosphorylation; GO:0006470; wing morphogenesis; GO:0007476 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 protein phosphatase type 1 complex; GO:0000164 flw flap wing "CG2096, CG15305, CG2096, CG2096, CG2096, PP-1, PP1beta9C, PP1beta, PP1 9C, Pp1beta-9C, PP1, l(1)G0172, Pp1beta-9C, FLW/PP1B, PP19C, PP1c, PP1 b9C, anon-WO03040301.120, Protein phosphatase 1beta at 9C" CDMC35200 2 3 7 DAC10-N13 3-CG2108-RA_3 CG2108 GGAGGCAGCAAATTGGATCTTCTGGATCCCCACGAAGATGAGATACCCTTGCGGTCGAACTGAGGAACT 69 FBan0002108 FBgn0037364 Rab23 3 3R intracellular protein transport; GO:0006886; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab23 Rab23 "CG2108, CG2108, DmRab23" CDMC35200 2 4 7 DAC10-N13 3-CG2108-RA_3 CG2108 GGAGGCAGCAAATTGGATCTTCTGGATCCCCACGAAGATGAGATACCCTTGCGGTCGAACTGAGGAACT 69 FBan0002108 FBgn0037364 Rab23 3 3R intracellular protein transport; GO:0006886; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 Rab23 Rab23 "CG2108, CG2108, DmRab23" CDMC35201 2 5 7 DAC11-B01 5-CG9171-RA_2 CG9171 AACTCATGCCGATCCCCATTACGATGAACGGCTCAGCTGGGAGGGTAAAAGCGACAAGATGCCTC 65 FBan0009171 FBgn0031738 CG9171 2 2L "N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; GO:0008109 ; EC:2.4.1.150; ; GO:0008109 ; EC:2.4.1.150" CG9171 CG9171 CDMC35201 2 6 7 DAC11-B01 5-CG9171-RA_2 CG9171 AACTCATGCCGATCCCCATTACGATGAACGGCTCAGCTGGGAGGGTAAAAGCGACAAGATGCCTC 65 FBan0009171 FBgn0031738 CG9171 2 2L "N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; GO:0008109 ; EC:2.4.1.150; ; GO:0008109 ; EC:2.4.1.150" CG9171 CG9171 CDMC35202 2 7 7 DAC11-B13 14-CG9195-RB_1 CG9195 TGCGAGTCAGTGCGTTTTTCTGGTCATTGAACAGCCGTATCCAAAGTAGAATTCCCATGTCCGGC 65 FBan0009195 FBgn0040285 Scamp X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; synaptic vesicle exocytosis; GO:0016079 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Scamp Scamp "CG9195, CG9195, dmSCAMP, SCAMP, dmSC, BcDNA:GM04934, anon-EST:fe1F7, anon-fast-evolving-1F7" CDMC35202 2 8 7 DAC11-B13 14-CG9195-RB_1 CG9195 TGCGAGTCAGTGCGTTTTTCTGGTCATTGAACAGCCGTATCCAAAGTAGAATTCCCATGTCCGGC 65 FBan0009195 FBgn0040285 Scamp X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; synaptic vesicle exocytosis; GO:0016079 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 Scamp Scamp "CG9195, CG9195, dmSCAMP, SCAMP, dmSC, BcDNA:GM04934, anon-EST:fe1F7, anon-fast-evolving-1F7" CDMC35203 2 9 7 DAC11-F01 12-CG9313-RA_1 CG9313 TGCCCAAGCGAAAGAACAAGCTCACCAGGTTATCCTTCAACGAGAAGCTCGCCTTCATTGTGGTG 65 FBan0009313 FBgn0034566 CG9313 2 2R microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG9313 CG9313 CDMC35203 2 10 7 DAC11-F01 12-CG9313-RA_1 CG9313 TGCCCAAGCGAAAGAACAAGCTCACCAGGTTATCCTTCAACGAGAAGCTCGCCTTCATTGTGGTG 65 FBan0009313 FBgn0034566 CG9313 2 2R microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" cytoplasmic dynein complex; GO:0005868; dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG9313 CG9313 CDMC35204 2 11 7 DAC11-F13 17-CG9353-RA_1 CG9353 AGTTCTAGAACCCATAGCCCTAGGTGTTATCGTTGATTTTGGAGACACAGCCGACCGTCACAGCG 65 FBan0009353 FBgn0034579 mRpL54 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL54 mitochondrial ribosomal protein L54 "CG9353, MRP-L54, BcDNA:SD09147, mitochondrial ribosomal protein L54" CDMC35204 2 12 7 DAC11-F13 17-CG9353-RA_1 CG9353 AGTTCTAGAACCCATAGCCCTAGGTGTTATCGTTGATTTTGGAGACACAGCCGACCGTCACAGCG 65 FBan0009353 FBgn0034579 mRpL54 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL54 mitochondrial ribosomal protein L54 "CG9353, MRP-L54, BcDNA:SD09147, mitochondrial ribosomal protein L54" CDMC35205 2 13 7 DAC11-J01 3-CG9466-RA_2 CG9466 AAGCGAGAGGACTTCACCCCCGAGCTTGCTGTCCAGCCTACTTCCGGAAACTATTATCCCATCAC 65 FBan0009466 FBgn0032068 CG9466 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9466 CG9466 CDMC35205 2 14 7 DAC11-J01 3-CG9466-RA_2 CG9466 AAGCGAGAGGACTTCACCCCCGAGCTTGCTGTCCAGCCTACTTCCGGAAACTATTATCCCATCAC 65 FBan0009466 FBgn0032068 CG9466 2 2L carbohydrate metabolism; GO:0005975 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9466 CG9466 CDMC35206 2 15 7 DAC11-J13 3-CG9505-RA_2 CG9505 CACCAGCTACAGGAGCAGTTCAGAAGTTTGGAGCAGAACTTGGTGCGACTGGCTAAGCCCCATTC 65 FBan0009505 FBgn0031805 CG9505 2 2L proteolysis; GO:0006508 zinc ion binding; GO:0008270; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG9505 CG9505 CDMC35206 2 16 7 DAC11-J13 3-CG9505-RA_2 CG9505 CACCAGCTACAGGAGCAGTTCAGAAGTTTGGAGCAGAACTTGGTGCGACTGGCTAAGCCCCATTC 65 FBan0009505 FBgn0031805 CG9505 2 2L proteolysis; GO:0006508 zinc ion binding; GO:0008270; endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG9505 CG9505 CDMC35207 2 17 7 DAC11-N01 18-CG9597-RA_5 CG9597 GCTCGACTATTGCCAGGGGTTGGACAATCTGGTGGACTACGACCGTGTGGAGACCGTAGCGGGTG 65 FBan0009597 FBgn0038371 CG9597 3 3R CG9597 CG9597 CDMC35207 2 18 7 DAC11-N01 18-CG9597-RA_5 CG9597 GCTCGACTATTGCCAGGGGTTGGACAATCTGGTGGACTACGACCGTGTGGAGACCGTAGCGGGTG 65 FBan0009597 FBgn0038371 CG9597 3 3R CG9597 CG9597 CDMC35208 2 19 7 DAC11-N13 23-CG9614-RH_2 CG9614 TTCTGCAAACAGCGTCTTTATATGCAGTATATAGCCCTTAAGCGAACTGAATTGGAACGACTGAA 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC35208 2 20 7 DAC11-N13 23-CG9614-RH_2 CG9614 TTCTGCAAACAGCGTCTTTATATGCAGTATATAGCCCTTAAGCGAACTGAATTGGAACGACTGAA 65 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC35209 2 21 7 DAC12-B01 16-CG15388-RA_1 CG15388 CAGCCAGTGGAAATAACTACGGGACATCCTTTGCAAACAGAGGACCTTATTGGAGTGCAGGAACC 65 FBan0033955 FBgn0031414 eys 2 2L cell adhesion; GO:0007155; cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; nervous system development; GO:0007399 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 plasma membrane; GO:0005886 eys eyes shut "CG7245, CG15388, CG15389, CG33955, CG7245, CG15388, CG15389, CG7245, CT35437, fibropellin, agrin-like, eyes shut" CDMC35209 2 22 7 DAC12-B01 16-CG15388-RA_1 CG15388 CAGCCAGTGGAAATAACTACGGGACATCCTTTGCAAACAGAGGACCTTATTGGAGTGCAGGAACC 65 FBan0033955 FBgn0031414 eys 2 2L cell adhesion; GO:0007155; cell proliferation; GO:0008283; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; nervous system development; GO:0007399 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 plasma membrane; GO:0005886 eys eyes shut "CG7245, CG15388, CG15389, CG33955, CG7245, CG15388, CG15389, CG7245, CT35437, fibropellin, agrin-like, eyes shut" CDMC35210 2 23 7 DAC12-B13 3-CG15433-RA_1 CG15433 GTTAATGCTAGGGATCCCACCAAGTTTCAGCACCAGGGCTTCGGTATGTTGCTGATGGAGGAGGC 65 FBan0015433 FBgn0031604 CG15433 2 2L "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; chromatin assembly or disassembly; GO:0006333; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; iron ion binding; GO:0005506; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0005506; ; GO:0008080 ; EC:2.3.1.-" proton-transporting two-sector ATPase complex; GO:0016469 CG15433 CG15433 dmHAG408 CDMC35210 2 24 7 DAC12-B13 3-CG15433-RA_1 CG15433 GTTAATGCTAGGGATCCCACCAAGTTTCAGCACCAGGGCTTCGGTATGTTGCTGATGGAGGAGGC 65 FBan0015433 FBgn0031604 CG15433 2 2L "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; chromatin assembly or disassembly; GO:0006333; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" "acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0016407 ; EC:2.3.1.-; iron ion binding; GO:0005506; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961; ; GO:0005506; ; GO:0008080 ; EC:2.3.1.-" proton-transporting two-sector ATPase complex; GO:0016469 CG15433 CG15433 dmHAG408 CDMC35211 2 25 7 DAC12-F01 2-CG15499-RA_1 CG15499 AAATACGAGCACTCCCCCATTGAAGGACCCCCAAGGAAATCGCCCCACACATTGATGAAGGTGTG 65 FBan0015499 FBgn0038891 CG15499 3 3R CG15499 CG15499 CDMC35211 2 26 7 DAC12-F01 2-CG15499-RA_1 CG15499 AAATACGAGCACTCCCCCATTGAAGGACCCCCAAGGAAATCGCCCCACACATTGATGAAGGTGTG 65 FBan0015499 FBgn0038891 CG15499 3 3R CG15499 CG15499 CDMC35212 2 1 8 DAC12-F13 14-CG15524-RA_1 CG15524 CGGCTTTCAGGCCCAATTGGACAAGGCTTCGTTGGAGAAAGCAGAACTAAAGTCGGCCCAAGAGC 65 FBan0015524 FBgn0039731 CG15524 3 3R centrosome duplication; GO:0051298 molecular function unknown; GO:0005554; ; GO:0005554 centrosome; GO:0005813 CG15524 CG15524 CDMC35212 2 2 8 DAC12-F13 14-CG15524-RA_1 CG15524 CGGCTTTCAGGCCCAATTGGACAAGGCTTCGTTGGAGAAAGCAGAACTAAAGTCGGCCCAAGAGC 65 FBan0015524 FBgn0039731 CG15524 3 3R centrosome duplication; GO:0051298 molecular function unknown; GO:0005554; ; GO:0005554 centrosome; GO:0005813 CG15524 CG15524 CDMC35213 2 3 8 DAC12-J01 3-CG15614-RA_3 CG15614 GAACCTCCGATGTGTGCTTCGGTTTGTGTTGTTTCCGGGCTGTAAGAAGGACATGGAGACGCTGC 65 FBan0015614 FBgn0034168 CG15614 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG15614 CG15614 CDMC35213 2 4 8 DAC12-J01 3-CG15614-RA_3 CG15614 GAACCTCCGATGTGTGCTTCGGTTTGTGTTGTTTCCGGGCTGTAAGAAGGACATGGAGACGCTGC 65 FBan0015614 FBgn0034168 CG15614 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG15614 CG15614 CDMC35214 2 5 8 DAC12-J13 19-CG15641-RA_1 CG15641 ACGCGACTGATAGGCCAGGCCAACTGCTCGCCATGCGCCGATCTGTACGTCTTCAATCGCCAATC 65 FBan0015641 FBgn0030643 CG15641 X X CG15641 CG15641 CDMC35214 2 6 8 DAC12-J13 19-CG15641-RA_1 CG15641 ACGCGACTGATAGGCCAGGCCAACTGCTCGCCATGCGCCGATCTGTACGTCTTCAATCGCCAATC 65 FBan0015641 FBgn0030643 CG15641 X X CG15641 CG15641 CDMC35215 2 7 8 DAC12-N01 16-CG15733-RA_1 CG15733 CAGCAGCGAGGATGAGTACCAGAATACCGGACAGGCGACGGCATTCGATACCCAACTGCTCGCCC 65 FBan0015733 FBgn0030378 CG15733 X X CG15733 CG15733 CDMC35215 2 8 8 DAC12-N01 16-CG15733-RA_1 CG15733 CAGCAGCGAGGATGAGTACCAGAATACCGGACAGGCGACGGCATTCGATACCCAACTGCTCGCCC 65 FBan0015733 FBgn0030378 CG15733 X X CG15733 CG15733 CDMC35216 2 9 8 DAC12-N13 15-CG15766-RA_1 CG15766 GGCAGAGATTTGGGGCATCAGCTCGTATCCGTCGACTGTACCAGTGTCTACTCCGCCCGATTGGT 65 FBan0015766 FBgn0029813 CG15766 X X N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG15766 CG15766 CDMC35216 2 10 8 DAC12-N13 15-CG15766-RA_1 CG15766 GGCAGAGATTTGGGGCATCAGCTCGTATCCGTCGACTGTACCAGTGTCTACTCCGCCCGATTGGT 65 FBan0015766 FBgn0029813 CG15766 X X N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG15766 CG15766 CDMC35217 2 11 8 DAC13-B01 9-CG13011-RA_1 CG13011 GCCTTCTCCGACAAATCCTACAGTCTCATTCGGCAGTCACTATTCGAGACCTTGTTCAATGGCCTCGCC 69 FBan0013011 FBgn0030771 CG13011 X X CG13011 CG13011 CDMC35217 2 12 8 DAC13-B01 9-CG13011-RA_1 CG13011 GCCTTCTCCGACAAATCCTACAGTCTCATTCGGCAGTCACTATTCGAGACCTTGTTCAATGGCCTCGCC 69 FBan0013011 FBgn0030771 CG13011 X X CG13011 CG13011 CDMC35218 2 13 8 DAC13-B13 6-CG13027-RA_3 CG13027 CCGAGGCACCTTCCCTTGATCATTCCCCCAACATCAGCCAGTACGAGTACATAGTCTACGATGAACCCG 69 FBan0013027 FBgn0036681 CG13027 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13027 CG13027 CDMC35218 2 14 8 DAC13-B13 6-CG13027-RA_3 CG13027 CCGAGGCACCTTCCCTTGATCATTCCCCCAACATCAGCCAGTACGAGTACATAGTCTACGATGAACCCG 69 FBan0013027 FBgn0036681 CG13027 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13027 CG13027 CDMC35219 2 15 8 DAC13-F01 17-CG13071-RA_1 CG13071 AGCCATCAAACCATCTTTTGGCAGCTTCTCAACGAGTTCCACTTTGAGTTTTGCGTTCCAGAAGTTCTT 69 FBan0013071 FBgn0036585 CG13071 3 3L CG13071 CG13071 CDMC35219 2 16 8 DAC13-F01 17-CG13071-RA_1 CG13071 AGCCATCAAACCATCTTTTGGCAGCTTCTCAACGAGTTCCACTTTGAGTTTTGCGTTCCAGAAGTTCTT 69 FBan0013071 FBgn0036585 CG13071 3 3L CG13071 CG13071 CDMC35220 2 17 8 DAC13-F13 1-CG13077-RA_1 CG13077 GCCGAAGTGAGACGGATTTCCAAATCCTGATGAAGTGCCTCACCCTCATATCGTTGGTCCTGTCGAGCT 69 FBan0013077 FBgn0032810 CG13077 2 2L CG13077 CG13077 CDMC35220 2 18 8 DAC13-F13 1-CG13077-RA_1 CG13077 GCCGAAGTGAGACGGATTTCCAAATCCTGATGAAGTGCCTCACCCTCATATCGTTGGTCCTGTCGAGCT 69 FBan0013077 FBgn0032810 CG13077 2 2L CG13077 CG13077 CDMC35221 2 19 8 DAC13-J01 8-CG13116-RA_2 CG13116 AGTCACGAAGCCTTAACCAAGCCGCATCGAAACGCGAATAGATCGAAGCCTAGCCACCATGTTTCAGAA 69 FBan0013116 FBgn0032139 CG13116 2 2L CG13116 CG13116 CDMC35221 2 20 8 DAC13-J01 8-CG13116-RA_2 CG13116 AGTCACGAAGCCTTAACCAAGCCGCATCGAAACGCGAATAGATCGAAGCCTAGCCACCATGTTTCAGAA 69 FBan0013116 FBgn0032139 CG13116 2 2L CG13116 CG13116 CDMC35222 2 21 8 DAC13-J13 6-CG13127-RA_1 CG13127 AGCGGAATATGTTGGAACTGAAGAGATCTGTGACGGGTCTGGGTAGTTCCATCAGCTATGCCAGCCACA 69 FBan0013127 FBgn0032176 CG13127 2 2L CG13127 CG13127 CDMC35222 2 22 8 DAC13-J13 6-CG13127-RA_1 CG13127 AGCGGAATATGTTGGAACTGAAGAGATCTGTGACGGGTCTGGGTAGTTCCATCAGCTATGCCAGCCACA 69 FBan0013127 FBgn0032176 CG13127 2 2L CG13127 CG13127 CDMC35223 2 23 8 DAC13-N01 16-CG13188-RA_1 CG13188 AGCAACAACCAGCACAAAAGACAGCTAACGAACGCCAAGCAAGACAATGAGGACATGTTGAAAAGCAAA 69 FBan0013188 FBgn0033668 CG13188 2 2R CG13188 CG13188 CDMC35223 2 24 8 DAC13-N01 16-CG13188-RA_1 CG13188 AGCAACAACCAGCACAAAAGACAGCTAACGAACGCCAAGCAAGACAATGAGGACATGTTGAAAAGCAAA 69 FBan0013188 FBgn0033668 CG13188 2 2R CG13188 CG13188 CDMC35224 2 25 8 DAC13-N13 12-CG13193-RA_3 CG13193 CCAAGCCCACCAAGATCTGATCCAGATCCAGATCAGTGCTCTGCGATTCGGACCAACTCTTCGAAGTAA 69 FBan0013193 FBgn0033650 CG13193 2 2R CG13193 CG13193 CDMC35224 2 26 8 DAC13-N13 12-CG13193-RA_3 CG13193 CCAAGCCCACCAAGATCTGATCCAGATCCAGATCAGTGCTCTGCGATTCGGACCAACTCTTCGAAGTAA 69 FBan0013193 FBgn0033650 CG13193 2 2R CG13193 CG13193 CDMC35225 2 1 9 DAC14-B01 3-CG40153-RA_1 CG40153 AGCAATGTTCTGAGAGGCAGATGGTGAACGCCAGCAACAATGAGTCCAACAAATGTTTCGCGATCCCGA 69 FBgn0058153 CG40153 CG40153 CG40153 CDMC35225 2 2 9 DAC14-B01 3-CG40153-RA_1 CG40153 AGCAATGTTCTGAGAGGCAGATGGTGAACGCCAGCAACAATGAGTCCAACAAATGTTTCGCGATCCCGA 69 FBgn0058153 CG40153 CG40153 CG40153 CDMC35226 2 3 9 DAC14-B13 3-CG40159-RA_1 CG40159 CGCAATCCCAAATGATTCAGGACGTCCAGGTTCAAGGACAGGAAGTCAGTGGCGAGCAAATATCGCAGG 69 FBgn0058159 CG40159 CG40159 CG40159 CDMC35226 2 4 9 DAC14-B13 3-CG40159-RA_1 CG40159 CGCAATCCCAAATGATTCAGGACGTCCAGGTTCAAGGACAGGAAGTCAGTGGCGAGCAAATATCGCAGG 69 FBgn0058159 CG40159 CG40159 CG40159 CDMC35227 2 5 9 DAC14-F01 17-CG4019-RC_1 CG4019 TGCATTCGTTGTACGCTAATGTTAGCAGTGTCTTCACAAAGTGGCTCGAACGTTTCAAAAGGCGAACCA 69 FBan0004019 FBgn0034885 CG4019 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; water channel activity; GO:0015250; ; GO:0015250 membrane; GO:0016020 CG4019 CG4019 CDMC35227 2 6 9 DAC14-F01 17-CG4019-RC_1 CG4019 TGCATTCGTTGTACGCTAATGTTAGCAGTGTCTTCACAAAGTGGCTCGAACGTTTCAAAAGGCGAACCA 69 FBan0004019 FBgn0034885 CG4019 2 2R cell homeostasis; GO:0019725; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386; water channel activity; GO:0015250; ; GO:0015250 membrane; GO:0016020 CG4019 CG4019 CDMC35228 2 7 9 DAC14-F13 23-CG40214-RA_15 CG40214 ATTAAATGGGCGAAATTAGAGCGCTCTGTAAAAGGTGAAATCGGTCTTATGAAAACTGAAATACACCGC 69 FBgn0058214 CG40214 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 CG40214 CG40214 CDMC35228 2 8 9 DAC14-F13 23-CG40214-RA_15 CG40214 ATTAAATGGGCGAAATTAGAGCGCTCTGTAAAAGGTGAAATCGGTCTTATGAAAACTGAAATACACCGC 69 FBgn0058214 CG40214 "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; damaged DNA binding; GO:0003684; ; GO:0003676; ; GO:0003684 CG40214 CG40214 CDMC35229 2 9 9 DAC14-J01 10-CG40274-RA_1 CG40274 TCCACTGCATTGTGAAATTCAATTATGCTGATCGATGCATTGGCCGTGGTTTGGTCTCCAAGCGGAAGC 69 FBgn0058274 CG40274 CG40274 CG40274 CDMC35229 2 10 9 DAC14-J01 10-CG40274-RA_1 CG40274 TCCACTGCATTGTGAAATTCAATTATGCTGATCGATGCATTGGCCGTGGTTTGGTCTCCAAGCGGAAGC 69 FBgn0058274 CG40274 CG40274 CG40274 CDMC35230 2 11 9 DAC14-J13 23-CG40298-RA_3 CG40298 TGGAACCGAACCAGAACTACTGCCTTCCAATTGGCTTTCCAAATACTCAAATGTCAACAGATCTAAAAG 69 FBgn0058298 CG40298 CG40298 CG40298 CDMC35230 2 12 9 DAC14-J13 23-CG40298-RA_3 CG40298 TGGAACCGAACCAGAACTACTGCCTTCCAATTGGCTTTCCAAATACTCAAATGTCAACAGATCTAAAAG 69 FBgn0058298 CG40298 CG40298 CG40298 CDMC35231 2 13 9 DAC14-N01 1-CG40354-RB_1 CG40354 CCACCAATGTGACGTCAGAAAATCTTTCGCGCCACGACATGCTAGCTTGGGTTAACGATTGCCTCCAGT 69 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC35231 2 14 9 DAC14-N01 1-CG40354-RB_1 CG40354 CCACCAATGTGACGTCAGAAAATCTTTCGCGCCACGACATGCTAGCTTGGGTTAACGATTGCCTCCAGT 69 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC35232 2 15 9 DAC14-N13 6-CG40368-RB_1 CG40368 AGCCCGGAACAGTCGCAATTTTAGAGGCATTATTCAAGGAGTACGGAGGGAGACATGCCGTAGAGGTCA 69 FBgn0040035 CG40368 CG40368 CG40368 CG12458 CDMC35232 2 16 9 DAC14-N13 6-CG40368-RB_1 CG40368 AGCCCGGAACAGTCGCAATTTTAGAGGCATTATTCAAGGAGTACGGAGGGAGACATGCCGTAGAGGTCA 69 FBgn0040035 CG40368 CG40368 CG40368 CG12458 CDMC35233 2 17 9 DAC15-B01 22-CG7282-RA_1 CG7282 TCTTGTGCAAATACAAACGTCTTTAGACCGACAGGAGAGCACGTTGCAAGTGTCGTTTATAGGCGGATT 69 FBan0007282 FBgn0030967 CG7282 X X CG7282 CG7282 CDMC35233 2 18 9 DAC15-B01 22-CG7282-RA_1 CG7282 TCTTGTGCAAATACAAACGTCTTTAGACCGACAGGAGAGCACGTTGCAAGTGTCGTTTATAGGCGGATT 69 FBan0007282 FBgn0030967 CG7282 X X CG7282 CG7282 CDMC35234 2 19 9 DAC15-B13 6-CG7290-RA_2 CG7290 CCACTGCGACCTTTGTAAACGCCTACTCGGCAACCAATTGCTCTGATTACCTATACTGCGTGAACGGCG 69 FBan0007290 FBgn0036949 CG7290 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7290 CG7290 CDMC35234 2 20 9 DAC15-B13 6-CG7290-RA_2 CG7290 CCACTGCGACCTTTGTAAACGCCTACTCGGCAACCAATTGCTCTGATTACCTATACTGCGTGAACGGCG 69 FBan0007290 FBgn0036949 CG7290 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7290 CG7290 CDMC35235 2 21 9 DAC15-F01 23-CG7325-RA_15 CG7325 TTGTATCCTGCAATTGTGCCACATTGATGCTCAATGGAGTCGAGTGTACTGTGAGAATATCTATAACGA 69 FBan0007325 FBgn0014851 Eig71Ek 3 3L Eig71Ek Eig71Ek "CG7325, CG7325, L71-11, L71" CDMC35235 2 22 9 DAC15-F01 23-CG7325-RA_15 CG7325 TTGTATCCTGCAATTGTGCCACATTGATGCTCAATGGAGTCGAGTGTACTGTGAGAATATCTATAACGA 69 FBan0007325 FBgn0014851 Eig71Ek 3 3L Eig71Ek Eig71Ek "CG7325, CG7325, L71-11, L71" CDMC35236 2 23 9 DAC15-F13 10-CG7333-RA_1 CG7333 ACGAGGACACTTTCTTAGCCATGTTTTTGACCCCTCGGTTGCGTCGATTCACTTTGACATTGCTCGTGA 69 FBan0007333 FBgn0038715 CG7333 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7333 CG7333 CDMC35236 2 24 9 DAC15-F13 10-CG7333-RA_1 CG7333 ACGAGGACACTTTCTTAGCCATGTTTTTGACCCCTCGGTTGCGTCGATTCACTTTGACATTGCTCGTGA 69 FBan0007333 FBgn0038715 CG7333 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG7333 CG7333 CDMC35237 2 25 9 DAC15-J01 8-CG7361-RA_1 CG7361 CGTGGAGTGGGTCGATTCGCTAATGCTGTTACCCATTTCCTCTTTAGCAACGTGTGATCAAGCCCGAGT 69 FBan0007361 FBgn0021906 RFeSP 2 2L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 RFeSP Rieske iron-sulfur protein "CG7361, CG7361, l(2)k11704, H, RfeSP, anon-EST:Posey219, Rieske iron-sulfur protein" CDMC35237 2 26 9 DAC15-J01 8-CG7361-RA_1 CG7361 CGTGGAGTGGGTCGATTCGCTAATGCTGTTACCCATTTCCTCTTTAGCAACGTGTGATCAAGCCCGAGT 69 FBan0007361 FBgn0021906 RFeSP 2 2L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 RFeSP Rieske iron-sulfur protein "CG7361, CG7361, l(2)k11704, H, RfeSP, anon-EST:Posey219, Rieske iron-sulfur protein" CDMC35238 2 1 10 DAC15-J13 23-CG7370-RA_3 CG7370 TATGTCTGCGTTAGCTATTCATAGGGGGCTATAAAGCTAGGACTCTTGCGTTTTAAAAGCGATTAGGGT 69 FBan0007370 FBgn0037133 CG7370 3 3L CG7370 CG7370 BcDNA:GM07065 CDMC35238 2 2 10 DAC15-J13 23-CG7370-RA_3 CG7370 TATGTCTGCGTTAGCTATTCATAGGGGGCTATAAAGCTAGGACTCTTGCGTTTTAAAAGCGATTAGGGT 69 FBan0007370 FBgn0037133 CG7370 3 3L CG7370 CG7370 BcDNA:GM07065 CDMC35239 2 3 10 DAC15-N01 2-CG7400-RB_1 CG7400 CGGTGAGATGGCTCGCTACATTCTAGCTACGAAACCCTCGGAATACGACCAGAAACACCGAGTGCGTCT 69 FBan0007400 FBgn0021953 Fatp 2 2L fatty acid metabolism; GO:0006631; long-chain fatty acid transport; GO:0015909 long-chain fatty acid transporter activity; GO:0005324; catalytic activity; GO:0003824; ; GO:0003824; ; GO:0005324; ; GO:0005324 plasma membrane; GO:0005886 Fatp Fatty acid (long chain) transport protein "CG7400, CG7400, l(2)k10307, anon-WO0121795.74, Fatty acid (long chain) transport protein" CDMC35239 2 4 10 DAC15-N01 2-CG7400-RB_1 CG7400 CGGTGAGATGGCTCGCTACATTCTAGCTACGAAACCCTCGGAATACGACCAGAAACACCGAGTGCGTCT 69 FBan0007400 FBgn0021953 Fatp 2 2L fatty acid metabolism; GO:0006631; long-chain fatty acid transport; GO:0015909 long-chain fatty acid transporter activity; GO:0005324; catalytic activity; GO:0003824; ; GO:0003824; ; GO:0005324; ; GO:0005324 plasma membrane; GO:0005886 Fatp Fatty acid (long chain) transport protein "CG7400, CG7400, l(2)k10307, anon-WO0121795.74, Fatty acid (long chain) transport protein" CDMC35240 2 5 10 DAC15-N13 23-CG7421-RA_1 CG7421 AACCCGAATGCGTTTCGTGGATTTTTTATAAGCCTTTAAGAGTTAAACCCCTATACATTTCTATTGTAT 69 FBan0007421 FBgn0037137 Nopp140 3 3L nucleologenesis; GO:0017126 nucleolus; GO:0005730 Nopp140 Nopp140 "CG7421, CG7421, CG7421, DmNopp140" CDMC35240 2 6 10 DAC15-N13 23-CG7421-RA_1 CG7421 AACCCGAATGCGTTTCGTGGATTTTTTATAAGCCTTTAAGAGTTAAACCCCTATACATTTCTATTGTAT 69 FBan0007421 FBgn0037137 Nopp140 3 3L nucleologenesis; GO:0017126 nucleolus; GO:0005730 Nopp140 Nopp140 "CG7421, CG7421, CG7421, DmNopp140" CDMC35241 2 7 10 DAC16-B01 2-CG12212-RA_1 CG12212 GCCAAACTTCTGGGTGTGGACAACAAGTGAACGCAACTCGAGTGACAATCGAGCGACACCAAGAGC 66 FBan0012212 FBgn0003053 peb X X "amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; germ-band shortening; GO:0007390; head involution; GO:0008258; maintenance of tracheal epithelial integrity; GO:0035160; negative regulation of JNK cascade; GO:0046329; ommatidial rotation; GO:0016318; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; regulation of tracheal tube architecture; GO:0035152; regulation of transcription; GO:0045449; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; wing disc dorsal/ventral pattern formation; GO:0048190" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 peb pebbled "CG12212, CG12212, hnt, hindsight, PEB, HNT, hnd, EP55, Hindsight, Hnt, Hind, EG:66A1.1, anon-4Cg" CDMC35241 2 8 10 DAC16-B01 2-CG12212-RA_1 CG12212 GCCAAACTTCTGGGTGTGGACAACAAGTGAACGCAACTCGAGTGACAATCGAGCGACACCAAGAGC 66 FBan0012212 FBgn0003053 peb X X "amnioserosa maintenance; GO:0046665; dorsal closure; GO:0007391; dorsal closure, leading edge cell fate determination; GO:0007393; ectoderm development; GO:0007398; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development (sensu Endopterygota); GO:0007456; germ-band shortening; GO:0007390; head involution; GO:0008258; maintenance of tracheal epithelial integrity; GO:0035160; negative regulation of JNK cascade; GO:0046329; ommatidial rotation; GO:0016318; photoreceptor cell morphogenesis (sensu Endopterygota); GO:0008594; regulation of tracheal tube architecture; GO:0035152; regulation of transcription; GO:0045449; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; tracheal system development (sensu Insecta); GO:0007424; wing disc dorsal/ventral pattern formation; GO:0048190" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 peb pebbled "CG12212, CG12212, hnt, hindsight, PEB, HNT, hnd, EP55, Hindsight, Hnt, Hind, EG:66A1.1, anon-4Cg" CDMC35242 2 9 10 DAC16-B13 3-CG12272-RA_1 CG12272 GGAACGGTTACAGCGTAACCTGACCTCGGATCGTATGTGGGTGGATACGTTAGCGGCACTGACTCG 66 FBan0012272 FBgn0036571 CG12272 3 3L CG12272 CG12272 p118 CDMC35242 2 10 10 DAC16-B13 3-CG12272-RA_1 CG12272 GGAACGGTTACAGCGTAACCTGACCTCGGATCGTATGTGGGTGGATACGTTAGCGGCACTGACTCG 66 FBan0012272 FBgn0036571 CG12272 3 3L CG12272 CG12272 p118 CDMC35243 2 11 10 DAC16-F01 3-CG12833-RA_1 CG12833 CCTGCACAACGCACAAACGCAGGTGGGAACGACTCCCCTCAATCTGCTAAACAATCTGGACAACTG 66 FBan0012833 FBgn0028642 esn 2 2R cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; gametogenesis; GO:0007276 nucleic acid binding; GO:0003676; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 esn espinas "CG12833, espinas" CDMC35243 2 12 10 DAC16-F01 3-CG12833-RA_1 CG12833 CCTGCACAACGCACAAACGCAGGTGGGAACGACTCCCCTCAATCTGCTAAACAATCTGGACAACTG 66 FBan0012833 FBgn0028642 esn 2 2R cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; gametogenesis; GO:0007276 nucleic acid binding; GO:0003676; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 esn espinas "CG12833, espinas" CDMC35244 2 13 10 DAC16-F13 3-CG13032-RA_1 CG13032 GGAGACGGAGAGAGCCAAGAACGAAGCAGCTCAGGAGCAGATTGGCAAGTTAAAGGCCCGTATCAG 66 FBan0013032 FBgn0036652 CG13032 3 3L CG13032 CG13032 CDMC35244 2 14 10 DAC16-F13 3-CG13032-RA_1 CG13032 GGAGACGGAGAGAGCCAAGAACGAAGCAGCTCAGGAGCAGATTGGCAAGTTAAAGGCCCGTATCAG 66 FBan0013032 FBgn0036652 CG13032 3 3L CG13032 CG13032 CDMC35245 2 15 10 DAC16-J01 8-CG13442-RA_1 CG13442 CGCTTTTTGCGGTCATTTCAATTGGAGACGGTATCGACGACAGCCTCCATGTACACCCACCACGAT 66 FBan0013442 FBgn0034546 CG13442 2 2R CG13442 CG13442 CDMC35245 2 16 10 DAC16-J01 8-CG13442-RA_1 CG13442 CGCTTTTTGCGGTCATTTCAATTGGAGACGGTATCGACGACAGCCTCCATGTACACCCACCACGAT 66 FBan0013442 FBgn0034546 CG13442 2 2R CG13442 CG13442 CDMC35246 2 17 10 DAC16-J13 3-CG13526-RA_1 CG13526 TGGTCGCATAAGCTTGCGCGATTTCGTAGGCTTTATGCACAGCCCCATTTGAGCTGAGACAGCAAG 66 FBan0013526 FBgn0034774 CG13526 2 2R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG13526 CG13526 BcDNA:AT13807 CDMC35246 2 18 10 DAC16-J13 3-CG13526-RA_1 CG13526 TGGTCGCATAAGCTTGCGCGATTTCGTAGGCTTTATGCACAGCCCCATTTGAGCTGAGACAGCAAG 66 FBan0013526 FBgn0034774 CG13526 2 2R calcium-mediated signaling; GO:0019722 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG13526 CG13526 BcDNA:AT13807 CDMC35247 2 19 10 DAC16-N01 1-CG14075-RA_1 CG14075 GGCAGCGCTTGCGTCTCGGATGACTACATGGACCTCTACACCGATGCCAACTGCTCATCTCAATAG 66 FBan0014075 FBgn0036835 CG14075 3 3L CG14075 CG14075 CDMC35247 2 20 10 DAC16-N01 1-CG14075-RA_1 CG14075 GGCAGCGCTTGCGTCTCGGATGACTACATGGACCTCTACACCGATGCCAACTGCTCATCTCAATAG 66 FBan0014075 FBgn0036835 CG14075 3 3L CG14075 CG14075 CDMC35248 2 21 10 DAC16-N13 12-CG14130-RA_1 CG14130 ACACGGCTCGCTACAAATTCACACACGAGATACTAGCTAAGGAGCACTCCCAGTTTCAGGGTGCGC 66 FBan0014130 FBgn0036210 CG14130 3 3L CG14130 CG14130 CDMC35248 2 22 10 DAC16-N13 12-CG14130-RA_1 CG14130 ACACGGCTCGCTACAAATTCACACACGAGATACTAGCTAAGGAGCACTCCCAGTTTCAGGGTGCGC 66 FBan0014130 FBgn0036210 CG14130 3 3L CG14130 CG14130 CDMC35249 2 23 10 DAC17-B01 1-CG17274-RA_1 CG17274 CCACCGTTGAGGATCCCGACCAAAAGCCCTTCAATTATACCCAGCCCATCAGTGTGCAGAAGTACTCCT 69 FBan0017274 FBgn0038835 CG17274 3 3R glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 plasma membrane; GO:0005886 CG17274 CG17274 CT35907 CDMC35249 2 24 10 DAC17-B01 1-CG17274-RA_1 CG17274 CCACCGTTGAGGATCCCGACCAAAAGCCCTTCAATTATACCCAGCCCATCAGTGTGCAGAAGTACTCCT 69 FBan0017274 FBgn0038835 CG17274 3 3R glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 plasma membrane; GO:0005886 CG17274 CG17274 CT35907 CDMC35250 2 25 10 DAC17-B13 16-CG17287-RA_1 CG17287 GGCCCACGATCGACTAAAGGAAGTCCGTACCGGTAACCAGAAAAAAGATAATCAACCCACCAGAACTCA 69 FBan0017287 FBgn0034202 CG17287 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG17287 CG17287 CDMC35250 2 26 10 DAC17-B13 16-CG17287-RA_1 CG17287 GGCCCACGATCGACTAAAGGAAGTCCGTACCGGTAACCAGAAAAAAGATAATCAACCCACCAGAACTCA 69 FBan0017287 FBgn0034202 CG17287 2 2R metal ion binding; GO:0046872; ; GO:0046872 CG17287 CG17287 CDMC35251 2 1 11 DAC17-F01 2-CG1732-RA_1 CG1732 GGCCTTGCATTTCTTGTCTATCCATCGGCAGTTCTGCAGTTACCAGGGTCTCCAATGTGGTCTTGCCTC 69 FBan0001732 FBgn0039915 CG1732 4 4 amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 gamma-aminobutyric acid:sodium symporter activity; GO:0005332; ; GO:0005332 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG1732 CG1732 anon-WO0149848.11 CDMC35251 2 2 11 DAC17-F01 2-CG1732-RA_1 CG1732 GGCCTTGCATTTCTTGTCTATCCATCGGCAGTTCTGCAGTTACCAGGGTCTCCAATGTGGTCTTGCCTC 69 FBan0001732 FBgn0039915 CG1732 4 4 amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 gamma-aminobutyric acid:sodium symporter activity; GO:0005332; ; GO:0005332 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG1732 CG1732 anon-WO0149848.11 CDMC35252 2 3 11 DAC17-F13 16-CG17341-RA_1 CG17341 AGCCTTCAATATGTTTGTGCGGCTGTTTGTTGATGAGAATCTCGATCGCATCATTCCCATCTCGAAGCA 69 FBan0017341 FBgn0028906 CG17341 2 2L CG17341 CG17341 BG:DS01523.1 CDMC35252 2 4 11 DAC17-F13 16-CG17341-RA_1 CG17341 AGCCTTCAATATGTTTGTGCGGCTGTTTGTTGATGAGAATCTCGATCGCATCATTCCCATCTCGAAGCA 69 FBan0017341 FBgn0028906 CG17341 2 2L CG17341 CG17341 BG:DS01523.1 CDMC35253 2 5 11 DAC17-J01 3-CG17383-RA_1 CG17383 GGCAAGGGCTACAATCACTTTGCGGAAAGCTATCACCGACGACACCAAAACCAGCCGGAGTACATCATC 69 FBan0017383 FBgn0039350 CG17383 3 3R CG17383 CG17383 bs29f05.y1 CDMC35253 2 6 11 DAC17-J01 3-CG17383-RA_1 CG17383 GGCAAGGGCTACAATCACTTTGCGGAAAGCTATCACCGACGACACCAAAACCAGCCGGAGTACATCATC 69 FBan0017383 FBgn0039350 CG17383 3 3R CG17383 CG17383 bs29f05.y1 CDMC35254 2 7 11 DAC17-J13 15-CG1740-RA_1 CG1740 CCGGTACTCTCGCTTTACGATCCACGGAACCCTAGAATTATATGTTCTGCGAACACCTGGATCTCGCGA 69 FBan0001740 FBgn0031145 Ntf-2 X X intracellular protein transport; GO:0006886; protein import into nucleus; GO:0006606; protein targeting; GO:0006605 protein carrier activity; GO:0008320; ; GO:0008320 intracellular; GO:0005622; nucleus; GO:0005634 Ntf-2 Nuclear transport factor-2 "CG1740, CG1740, l(1)G0428, l(1)G0125, l(1)G0086, l(1)G0337, DNTF-2, NTF-2, dmNTF2, ntf2, Dntf2, Dntf-2, BcDNA:GM08921, Nuclear transport factor-2" CDMC35254 2 8 11 DAC17-J13 15-CG1740-RA_1 CG1740 CCGGTACTCTCGCTTTACGATCCACGGAACCCTAGAATTATATGTTCTGCGAACACCTGGATCTCGCGA 69 FBan0001740 FBgn0031145 Ntf-2 X X intracellular protein transport; GO:0006886; protein import into nucleus; GO:0006606; protein targeting; GO:0006605 protein carrier activity; GO:0008320; ; GO:0008320 intracellular; GO:0005622; nucleus; GO:0005634 Ntf-2 Nuclear transport factor-2 "CG1740, CG1740, l(1)G0428, l(1)G0125, l(1)G0086, l(1)G0337, DNTF-2, NTF-2, dmNTF2, ntf2, Dntf2, Dntf-2, BcDNA:GM08921, Nuclear transport factor-2" CDMC35255 2 9 11 DAC17-N01 11-CG17484-RA_1 CG17484 ACCGATGGCTTCACAGGGACGTACTCGCTATGAGGACAGAACCATTCAACGCGGAACAAGCACATTATA 69 CDMC35255 2 10 11 DAC17-N01 11-CG17484-RA_1 CG17484 ACCGATGGCTTCACAGGGACGTACTCGCTATGAGGACAGAACCATTCAACGCGGAACAAGCACATTATA 69 CDMC35256 2 11 11 DAC17-N13 16-CG17492-RA_1 CG17492 AGGAGGCTCCTGAGATTCACAAGTTTTACCTGAGTCTAGTACACTCGAGCATTCGTCCTGAGGATCGTT 69 FBan0017492 FBgn0032742 mib2 2 2L protein ubiquitination; GO:0016567 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0008270 ubiquitin ligase complex; GO:0000151 mib2 mind bomb 2 "CG17492, CG17492, CG17492, i115, mind bomb 2" CDMC35256 2 12 11 DAC17-N13 16-CG17492-RA_1 CG17492 AGGAGGCTCCTGAGATTCACAAGTTTTACCTGAGTCTAGTACACTCGAGCATTCGTCCTGAGGATCGTT 69 FBan0017492 FBgn0032742 mib2 2 2L protein ubiquitination; GO:0016567 receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005057; ; GO:0008270 ubiquitin ligase complex; GO:0000151 mib2 mind bomb 2 "CG17492, CG17492, CG17492, i115, mind bomb 2" CDMC35257 2 13 11 DAC18-B01 23-CG31291-RB_2 CG31291 AGTAATGAGGAGCATATGAGTAAATTAGATAGCTCACCACACGATTATACTAGCTTAGTACCCGGAAAA 69 FBan0031291 FBgn0051291 CG31291 3 3R CG31291 CG31291 "CG14878, CG5552" CDMC35257 2 14 11 DAC18-B01 23-CG31291-RB_2 CG31291 AGTAATGAGGAGCATATGAGTAAATTAGATAGCTCACCACACGATTATACTAGCTTAGTACCCGGAAAA 69 FBan0031291 FBgn0051291 CG31291 3 3R CG31291 CG31291 "CG14878, CG5552" CDMC35258 2 15 11 DAC18-B13 17-CG31300-RA_1 CG31300 AATTCTGAGCGCGTACGAAGATTCCCCGGAACTAAAAGTTGTCGATCTTAAAATCACACCCGCAAGTGC 69 FBan0031300 FBgn0051300 CG31300 3 3R CG31300 CG31300 CG13657 CDMC35258 2 16 11 DAC18-B13 17-CG31300-RA_1 CG31300 AATTCTGAGCGCGTACGAAGATTCCCCGGAACTAAAAGTTGTCGATCTTAAAATCACACCCGCAAGTGC 69 FBan0031300 FBgn0051300 CG31300 3 3R CG31300 CG31300 CG13657 CDMC35259 2 17 11 DAC18-F01 16-CG31336-RA_2 CG31336 CGCAGTTTCCAGCAACTTTTCGATCTACCACTTTTTCTCAGCCTTGCACAAAGTCTTTTGGCCATGTCT 69 FBan0031336 FBgn0045470 Gr93b 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr93b Gustatory receptor 93b "CG13411, CG31336, CG13411, 93F.2, Gustatory receptor 93F.2, Gr93F2, GR93F.2, Gustatory receptor 93b" CDMC35259 2 18 11 DAC18-F01 16-CG31336-RA_2 CG31336 CGCAGTTTCCAGCAACTTTTCGATCTACCACTTTTTCTCAGCCTTGCACAAAGTCTTTTGGCCATGTCT 69 FBan0031336 FBgn0045470 Gr93b 3 3R sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr93b Gustatory receptor 93b "CG13411, CG31336, CG13411, 93F.2, Gustatory receptor 93F.2, Gr93F2, GR93F.2, Gustatory receptor 93b" CDMC35260 2 19 11 DAC18-F13 2-CG31349-RE_1 CG31349 TGCAGTGGATCGTCTCAATTACGCGCAGTTCTATCCGGTGGTGATCTTCCTGAAGACAGACAGCAAGCA 69 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC35260 2 20 11 DAC18-F13 2-CG31349-RE_1 CG31349 TGCAGTGGATCGTCTCAATTACGCGCAGTTCTATCCGGTGGTGATCTTCCTGAAGACAGACAGCAAGCA 69 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC35261 2 21 11 DAC18-J01 23-CG31374-RA_1 CG31374 CGCCGTCTGTATTCTACATGTAACGGAATTTTTACAAAGTAATGTAAAATGTTGTGTCGCTGTAGATTT 69 FBan0031374 FBgn0051374 CG31374 3 3R CG31374 CG31374 "CG6771, CG14703, CG6771" CDMC35261 2 22 11 DAC18-J01 23-CG31374-RA_1 CG31374 CGCCGTCTGTATTCTACATGTAACGGAATTTTTACAAAGTAATGTAAAATGTTGTGTCGCTGTAGATTT 69 FBan0031374 FBgn0051374 CG31374 3 3R CG31374 CG31374 "CG6771, CG14703, CG6771" CDMC35262 2 23 11 DAC18-J13 16-CG31394-RA_2 CG31394 ACAGCGGCTGAATAAATGCGAATTTTTTGCTCACCCTCACTTTGAGTTTTTGCACTTTGCTTCCCGTTT 69 FBan0031394 FBgn0051394 CG31394 3 3R CG31394 CG31394 BcDNA:RE47391 CDMC35262 2 24 11 DAC18-J13 16-CG31394-RA_2 CG31394 ACAGCGGCTGAATAAATGCGAATTTTTTGCTCACCCTCACTTTGAGTTTTTGCACTTTGCTTCCCGTTT 69 FBan0031394 FBgn0051394 CG31394 3 3R CG31394 CG31394 BcDNA:RE47391 CDMC35263 2 25 11 DAC18-N01 8-CG31436-RA_1 CG31436 GCCCGAGTTCGAGAGGATCCTTCGACAGGTCGGCGATGACACCCAGCTATATGTGAATTGCATATACCA 69 FBan0031436 FBgn0051436 CG31436 3 3R CG31436 CG31436 CG13660 CDMC35263 2 26 11 DAC18-N01 8-CG31436-RA_1 CG31436 GCCCGAGTTCGAGAGGATCCTTCGACAGGTCGGCGATGACACCCAGCTATATGTGAATTGCATATACCA 69 FBan0031436 FBgn0051436 CG31436 3 3R CG31436 CG31436 CG13660 CDMC35264 2 1 12 DAC18-N13 1-CG31449-RA_1 CG31449 CCATCGAGATCGACGCATTGTTTGAGGGCCAAGACTTCTACACCAAAGTAAGCCGTGCCAGGTTTGAGG 69 FBan0031449 FBgn0013277 Hsp70Ba 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ba Heat-shock-protein-70Ba "CG31449, hsp70 87C, hsp70, 87C locus, hsp-70, Protein 70, Hsp70, Hsp70(87C), HSP70, dhsp70, Hsp70B, Hsp 70, hsp70Ba, heat shock 70, hsp70B" CDMC35264 2 2 12 DAC18-N13 1-CG31449-RA_1 CG31449 CCATCGAGATCGACGCATTGTTTGAGGGCCAAGACTTCTACACCAAAGTAAGCCGTGCCAGGTTTGAGG 69 FBan0031449 FBgn0013277 Hsp70Ba 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ba Heat-shock-protein-70Ba "CG31449, hsp70 87C, hsp70, 87C locus, hsp-70, Protein 70, Hsp70, Hsp70(87C), HSP70, dhsp70, Hsp70B, Hsp 70, hsp70Ba, heat shock 70, hsp70B" CDMC35265 2 3 12 DAC19-B01 13-CG5984-RA_1 CG5984 ATCAAGTGCAATTCCGTGACCCTGCCTCGCTCTCCTTTCATCATCGTGGCCATCGCAGGAGCTAC 65 FBan0005984 FBgn0039500 CG5984 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG5984 CG5984 Filamin-like CDMC35265 2 4 12 DAC19-B01 13-CG5984-RA_1 CG5984 ATCAAGTGCAATTCCGTGACCCTGCCTCGCTCTCCTTTCATCATCGTGGCCATCGCAGGAGCTAC 65 FBan0005984 FBgn0039500 CG5984 3 3R cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG5984 CG5984 Filamin-like CDMC35266 2 5 12 DAC19-B13 3-CG6015-RA_1 CG6015 GCCCTCAATCGCTTCAAGATGAACCGCAAAAAGACCTTCACCGGTCACATGGTCTCTGGCTACGC 65 FBan0006015 FBgn0038927 CG6015 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6015 CG6015 CDMC35266 2 6 12 DAC19-B13 3-CG6015-RA_1 CG6015 GCCCTCAATCGCTTCAAGATGAACCGCAAAAAGACCTTCACCGGTCACATGGTCTCTGGCTACGC 65 FBan0006015 FBgn0038927 CG6015 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" "RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" spliceosome complex; GO:0005681 CG6015 CG6015 CDMC35267 2 7 12 DAC19-F01 3-CG6122-RA_7 CG6122 ACCCTTGTCCGGACTGATGACAATTGGCTTTGACATTGCGAAGAGCACACGAGATCGGAAGAGGG 65 FBan0006122 FBgn0004872 piwi 2 2L RNA interference; GO:0016246; cell fate determination; GO:0001709; chromatin silencing; GO:0006342; female gamete generation; GO:0007292; female germ-line stem cell division; GO:0048132; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; male germ-line stem cell division; GO:0048133; posttranscriptional gene silencing; GO:0016441; stem cell division; GO:0017145 mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleoplasm; GO:0005654; nucleus; GO:0005634 piwi piwi "CG6122, P-element induced wimpy testis, PIWI" CDMC35267 2 8 12 DAC19-F01 3-CG6122-RA_7 CG6122 ACCCTTGTCCGGACTGATGACAATTGGCTTTGACATTGCGAAGAGCACACGAGATCGGAAGAGGG 65 FBan0006122 FBgn0004872 piwi 2 2L RNA interference; GO:0016246; cell fate determination; GO:0001709; chromatin silencing; GO:0006342; female gamete generation; GO:0007292; female germ-line stem cell division; GO:0048132; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; male germ-line stem cell division; GO:0048133; posttranscriptional gene silencing; GO:0016441; stem cell division; GO:0017145 mRNA binding; GO:0003729; ; GO:0003729 cytoplasm; GO:0005737; nucleoplasm; GO:0005654; nucleus; GO:0005634 piwi piwi "CG6122, P-element induced wimpy testis, PIWI" CDMC35268 2 9 12 DAC19-F13 2-CG6153-RA_2 CG6153 CAACTACGAATCCCGTGCCAATGCAGCGGATCACAAGGAAAAGGCTTTCGATGGAGTCGGCAGAG 65 FBan0006153 FBgn0032445 CG6153 2 2L CG6153 CG6153 CDMC35268 2 10 12 DAC19-F13 2-CG6153-RA_2 CG6153 CAACTACGAATCCCGTGCCAATGCAGCGGATCACAAGGAAAAGGCTTTCGATGGAGTCGGCAGAG 65 FBan0006153 FBgn0032445 CG6153 2 2L CG6153 CG6153 CDMC35269 2 11 12 DAC19-J01 1-CG6277-RA_3 CG6277 CTCCACCAAGTCCATTGATGCCTCCAGCTTTAACTCCGCCCATCCAACTCGCTTTGTGATCCACG 65 FBan0006277 FBgn0039475 CG6277 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6277 CG6277 CDMC35269 2 12 12 DAC19-J01 1-CG6277-RA_3 CG6277 CTCCACCAAGTCCATTGATGCCTCCAGCTTTAACTCCGCCCATCCAACTCGCTTTGTGATCCACG 65 FBan0006277 FBgn0039475 CG6277 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6277 CG6277 CDMC35270 2 13 12 DAC19-J13 3-CG6318-RA_1 CG6318 ATCGTCTGCGGCATGTACACGGTGGAGTCTGCCTTTCTGGAGAATCGTTTTGGCGAAAACTTGCC 65 FBan0006318 FBgn0030931 Rad51D X X DNA recombination; GO:0006310; DNA repair; GO:0006281 recombinase activity; GO:0000150; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 Rad51D Rad51D "CG6318, CG6318, Dm CG6318" CDMC35270 2 14 12 DAC19-J13 3-CG6318-RA_1 CG6318 ATCGTCTGCGGCATGTACACGGTGGAGTCTGCCTTTCTGGAGAATCGTTTTGGCGAAAACTTGCC 65 FBan0006318 FBgn0030931 Rad51D X X DNA recombination; GO:0006310; DNA repair; GO:0006281 recombinase activity; GO:0000150; ; GO:0000150; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094 Rad51D Rad51D "CG6318, CG6318, Dm CG6318" CDMC35271 2 15 12 DAC19-N01 3-CG6394-RA_1 CG6394 ATTGGGTCACTGCGATGTTAACGATAGCTACCAGCAGTGGTGGTTCAAGGAGATACGCCCACGCT 65 FBan0006394 FBgn0030930 GalNAc-T2 X X oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 GalNAc-T2 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 "CG6394, CG6394, CG6394, CG6394, dGalNAc-T2, pgant7, polypeptide GalNAc transferase 7, anon-WO02059370.15, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2" CDMC35271 2 16 12 DAC19-N01 3-CG6394-RA_1 CG6394 ATTGGGTCACTGCGATGTTAACGATAGCTACCAGCAGTGGTGGTTCAAGGAGATACGCCCACGCT 65 FBan0006394 FBgn0030930 GalNAc-T2 X X oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 GalNAc-T2 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 "CG6394, CG6394, CG6394, CG6394, dGalNAc-T2, pgant7, polypeptide GalNAc transferase 7, anon-WO02059370.15, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2" CDMC35272 2 17 12 DAC19-N13 3-CG6435-RA_4 CG6435 ATGGAGACGAGCACATCGATTGCCTGGATTTCGGAGCACTCCACAAACTGGGCAATCTGAAGTGC 65 FBan0006435 FBgn0034165 CG6435 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 CG6435 CG6435 CDMC35272 2 18 12 DAC19-N13 3-CG6435-RA_4 CG6435 ATGGAGACGAGCACATCGATTGCCTGGATTTCGGAGCACTCCACAAACTGGGCAATCTGAAGTGC 65 FBan0006435 FBgn0034165 CG6435 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 CG6435 CG6435 CDMC35273 2 19 12 DAC20-B01 23-CG2986-RC_1 CG2986 CGTGGCGTACCCATAGCTAGATTTTGATTTGGTAATAAAGCGATTTCCCTTTGTAATTTAACGTA 65 FBan0002986 FBgn0015521 oho23B 2 2L lymph gland development (sensu Arthropoda); GO:0048542; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 oho23B overgrown hematopoietic organs at 23B "CG2986, l(2)168/14, l(2)k16814, oho23, overgrown hematopoietic organs-23, RpS21: Ribosomal protein S21, rpS21, Ribosomal protein S21, l(2)03575, RpS21" CDMC35273 2 20 12 DAC20-B01 23-CG2986-RC_1 CG2986 CGTGGCGTACCCATAGCTAGATTTTGATTTGGTAATAAAGCGATTTCCCTTTGTAATTTAACGTA 65 FBan0002986 FBgn0015521 oho23B 2 2L lymph gland development (sensu Arthropoda); GO:0048542; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 oho23B overgrown hematopoietic organs at 23B "CG2986, l(2)168/14, l(2)k16814, oho23, overgrown hematopoietic organs-23, RpS21: Ribosomal protein S21, rpS21, Ribosomal protein S21, l(2)03575, RpS21" CDMC35274 2 21 12 DAC20-B13 3-CG30046-RB_10 CG30046 CTCCTTTCTACGACATATCCGGAACTCCCATGAAACCCATGGCCATTCTGACGGTGAAGCGCCAG 65 FBan0030046 FBgn0050046 CG30046 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 CG30046 CG30046 "CG17740, CG17740, CT39323" CDMC35274 2 22 12 DAC20-B13 3-CG30046-RB_10 CG30046 CTCCTTTCTACGACATATCCGGAACTCCCATGAAACCCATGGCCATTCTGACGGTGAAGCGCCAG 65 FBan0030046 FBgn0050046 CG30046 2 2R cell adhesion; GO:0007155; cytoskeleton organization and biogenesis; GO:0007010; development; GO:0007275; ectoderm development; GO:0007398 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 CG30046 CG30046 "CG17740, CG17740, CT39323" CDMC35275 2 23 12 DAC20-F01 23-CG30159-RB_6 CG30159 CCTCGAGCACAAGTACACAAGTCAGTCTCAAAAGCTTATTAGTAAGGGGAATAGCTAGCGCGACT 65 FBan0030159 FBgn0050159 CG30159 2 2R CG30159 CG30159 "CG3364, CG3364, CG3364, CG3364" CDMC35275 2 24 12 DAC20-F01 23-CG30159-RB_6 CG30159 CCTCGAGCACAAGTACACAAGTCAGTCTCAAAAGCTTATTAGTAAGGGGAATAGCTAGCGCGACT 65 FBan0030159 FBgn0050159 CG30159 2 2R CG30159 CG30159 "CG3364, CG3364, CG3364, CG3364" CDMC35276 2 25 12 DAC20-F13 2-CG30191-RA_4 CG30191 AACGGTGTAATCCAGGCCTATTGGGGTGCTGTGTTCACCTTTGACCTCTCCACGCCCTTCTTTTG 65 FBan0030191 FBgn0045482 Gr59b 2 2R Gr59b Gustatory receptor 59b "CG13537, CG30191, CG13537, GR59C.2, Gr59D3, Gustatory receptor 59D3, Gr59C1, Gustatory receptor 59C1, Gustatory receptor 59b" CDMC35276 2 26 12 DAC20-F13 2-CG30191-RA_4 CG30191 AACGGTGTAATCCAGGCCTATTGGGGTGCTGTGTTCACCTTTGACCTCTCCACGCCCTTCTTTTG 65 FBan0030191 FBgn0045482 Gr59b 2 2R Gr59b Gustatory receptor 59b "CG13537, CG30191, CG13537, GR59C.2, Gr59D3, Gustatory receptor 59D3, Gr59C1, Gustatory receptor 59C1, Gustatory receptor 59b" CDMC35277 2 1 13 DAC20-J01 23-CG30349-RA_2 CG30349 CAGACACAGACTCTGACGTATCCATGGATTAGACAGTCTACCCGTAATTTAAGCTTAAATGCAAT 65 FBan0030349 FBgn0050349 CG30349 2 2R CG30349 CG30349 "CG13750, CG2396" CDMC35277 2 2 13 DAC20-J01 23-CG30349-RA_2 CG30349 CAGACACAGACTCTGACGTATCCATGGATTAGACAGTCTACCCGTAATTTAAGCTTAAATGCAAT 65 FBan0030349 FBgn0050349 CG30349 2 2R CG30349 CG30349 "CG13750, CG2396" CDMC35278 2 3 13 DAC20-J13 15-CG30377-RA_1 CG30377 CCGCCAAAGATGTCGCTTCATCACCACGTTCCTCAGCCTGGTCTTTTTCCTGCTGACTGTGATGG 65 FBan0030377 FBgn0050377 CG30377 2 2R CG30377 CG30377 "CG14595, CG1918" CDMC35278 2 4 13 DAC20-J13 15-CG30377-RA_1 CG30377 CCGCCAAAGATGTCGCTTCATCACCACGTTCCTCAGCCTGGTCTTTTTCCTGCTGACTGTGATGG 65 FBan0030377 FBgn0050377 CG30377 2 2R CG30377 CG30377 "CG14595, CG1918" CDMC35279 2 5 13 DAC20-N01 23-CG30450-RA_4 CG30450 GGAAAAGGCTGAAGAAAAGTGTCATTCCATCAAGGCTTCAGGAAAATGTGAATTGGGCTACGAAA 65 FBan0030450 FBgn0043533 Obp56f 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56f Odorant-binding protein 56f "CG30450, 56f, anon-AE003794.1, Obp-d, Odorant-binding protein 56f" CDMC35279 2 6 13 DAC20-N01 23-CG30450-RA_4 CG30450 GGAAAAGGCTGAAGAAAAGTGTCATTCCATCAAGGCTTCAGGAAAATGTGAATTGGGCTACGAAA 65 FBan0030450 FBgn0043533 Obp56f 2 2R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp56f Odorant-binding protein 56f "CG30450, 56f, anon-AE003794.1, Obp-d, Odorant-binding protein 56f" CDMC35280 2 7 13 DAC20-N13 3-CG30482-RA_5 CG30482 GTTACGTTCTCCCGAAGCGGATCGTACCGACACCAAAAACGGTGGGTCTTGATTCCAAATGGCCC 65 FBan0030482 FBgn0050482 CG30482 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30482 CG30482 CDMC35280 2 8 13 DAC20-N13 3-CG30482-RA_5 CG30482 GTTACGTTCTCCCGAAGCGGATCGTACCGACACCAAAAACGGTGGGTCTTGATTCCAAATGGCCC 65 FBan0030482 FBgn0050482 CG30482 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30482 CG30482 CDMC35281 2 9 13 DAC21-B01 2-CG3797-RA_2 CG3797 AGTGGACAAAAGCCAGTACTTGCCATACCCATTCTAGCCGAACAAGAGGTGATGGCTAAGCGCTTGCA 68 FBan0003797 FBgn0036842 CG3797 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG3797 CG3797 CDMC35281 2 10 13 DAC21-B01 2-CG3797-RA_2 CG3797 AGTGGACAAAAGCCAGTACTTGCCATACCCATTCTAGCCGAACAAGAGGTGATGGCTAAGCGCTTGCA 68 FBan0003797 FBgn0036842 CG3797 3 3L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG3797 CG3797 CDMC35282 2 11 13 DAC21-B13 2-CG3909-RA_5 CG3909 CGGACTGGATGACTTGGTAAAGGTGTGGGACTTGCAGGAGGACAACACCCTAAAGTTGCGCCACAAAC 68 FBan0003909 FBgn0027524 CG3909 3 3R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3909 CG3909 BcDNA:LD21537 CDMC35282 2 12 13 DAC21-B13 2-CG3909-RA_5 CG3909 CGGACTGGATGACTTGGTAAAGGTGTGGGACTTGCAGGAGGACAACACCCTAAAGTTGCGCCACAAAC 68 FBan0003909 FBgn0027524 CG3909 3 3R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG3909 CG3909 BcDNA:LD21537 CDMC35283 2 13 13 DAC21-F01 3-CG4173-RA_1 CG4173 GGCGAAGATCATTCAGGAGCTAAACGCCAATGGAGTGCACATCTACCAGTTCCCCACCGACGATGAGA 68 FBan0004173 FBgn0014029 2-Sep 3 3R cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 2-Sep Septin-2 "CG4173, CG4173, sep2, septin, septin 2, septin-2, Septin-2" CDMC35283 2 14 13 DAC21-F01 3-CG4173-RA_1 CG4173 GGCGAAGATCATTCAGGAGCTAAACGCCAATGGAGTGCACATCTACCAGTTCCCCACCGACGATGAGA 68 FBan0004173 FBgn0014029 2-Sep 3 3R cellularization; GO:0007349; cytokinesis; GO:0000910; mitosis; GO:0007067 GTP binding; GO:0005525; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; protein binding; GO:0005515; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0005515 ring canal (sensu Insecta); GO:0045172; septin ring; GO:0005940 2-Sep Septin-2 "CG4173, CG4173, sep2, septin, septin 2, septin-2, Septin-2" CDMC35284 2 15 13 DAC21-F13 2-CG4302-RA_1 CG4302 GCGAATGGTCAATGTGATGGGTATCCACACCACGGATTTCGCACTGGAACAACCGGAGATTCAGGCAG 68 FBan0004302 FBgn0027073 CG4302 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG4302 CG4302 "GH09393, BEST:GH09393" CDMC35284 2 16 13 DAC21-F13 2-CG4302-RA_1 CG4302 GCGAATGGTCAATGTGATGGGTATCCACACCACGGATTTCGCACTGGAACAACCGGAGATTCAGGCAG 68 FBan0004302 FBgn0027073 CG4302 2 2R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 CG4302 CG4302 "GH09393, BEST:GH09393" CDMC35285 2 17 13 DAC21-J01 9-CG4805-RA_4 CG4805 TGCCTCTTCTCCGATGAGAATGACCTGGCCTACTATCGGACATATTCGCGTAAGAACTGCGAGCTGGA 68 FBan0004805 FBgn0030795 ppk28 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk28 pickpocket 28 "CG4805, CG4805, CG4805, PPK28" CDMC35285 2 18 13 DAC21-J01 9-CG4805-RA_4 CG4805 TGCCTCTTCTCCGATGAGAATGACCTGGCCTACTATCGGACATATTCGCGTAAGAACTGCGAGCTGGA 68 FBan0004805 FBgn0030795 ppk28 X X cation transport; GO:0006812; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk28 pickpocket 28 "CG4805, CG4805, CG4805, PPK28" CDMC35286 2 19 13 DAC21-J13 3-CG4984-RA_2 CG4984 GCGCTGTAAGTACATCGACATGTTCCCCAACTCCAATGCTCTGCGAAATGAGCCCGGTTTCGATGACG 68 FBan0004984 FBgn0034267 CG4984 2 2R CG4984 CG4984 CDMC35286 2 20 13 DAC21-J13 3-CG4984-RA_2 CG4984 GCGCTGTAAGTACATCGACATGTTCCCCAACTCCAATGCTCTGCGAAATGAGCCCGGTTTCGATGACG 68 FBan0004984 FBgn0034267 CG4984 2 2R CG4984 CG4984 CDMC35287 2 21 13 DAC21-N01 12-CG5303-RA_1 CG5303 AGTCGGGGAAAAGAGACTGGGAAGGGATCATGGTTGGCTATTTCCGTAGCTGTGGAAGATTCTCCACA 68 FBan0005303 FBgn0002715 mei-S332 2 2R female meiosis; GO:0007143; male meiosis; GO:0007140; meiotic metaphase I; GO:0007132; sister chromatid cohesion; GO:0007062 molecular function unknown; GO:0005554; ; GO:0005554 "chromosome; GO:0005694; chromosome, pericentric region; GO:0000775" mei-S332 meiotic from via Salaria 332 "CG5303, meiS322, MEI-S332, meiS332, MeiS332, mei-s332, mei-S322, BEST:LD13774, meiotic from via Salaria 332" CDMC35287 2 22 13 DAC21-N01 12-CG5303-RA_1 CG5303 AGTCGGGGAAAAGAGACTGGGAAGGGATCATGGTTGGCTATTTCCGTAGCTGTGGAAGATTCTCCACA 68 FBan0005303 FBgn0002715 mei-S332 2 2R female meiosis; GO:0007143; male meiosis; GO:0007140; meiotic metaphase I; GO:0007132; sister chromatid cohesion; GO:0007062 molecular function unknown; GO:0005554; ; GO:0005554 "chromosome; GO:0005694; chromosome, pericentric region; GO:0000775" mei-S332 meiotic from via Salaria 332 "CG5303, meiS322, MEI-S332, meiS332, MeiS332, mei-s332, mei-S322, BEST:LD13774, meiotic from via Salaria 332" CDMC35288 2 23 13 DAC21-N13 2-CG5479-RA_1 CG5479 GCAGGAACAGCACCCAAGAGGAGATCTCCAAGTGGATTGACCTGCTAAAGACTCAAAACGGCAGCTCC 68 FBan0005479 FBgn0034893 mRpL43 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL43 mitochondrial ribosomal protein L43 "CG5479, CI-B8, mitochondrial ribosomal protein L-CI-B8, mRpL-CI-B8, BcDNA:RE35686, mitochondrial ribosomal protein L43" CDMC35288 2 24 13 DAC21-N13 2-CG5479-RA_1 CG5479 GCAGGAACAGCACCCAAGAGGAGATCTCCAAGTGGATTGACCTGCTAAAGACTCAAAACGGCAGCTCC 68 FBan0005479 FBgn0034893 mRpL43 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL43 mitochondrial ribosomal protein L43 "CG5479, CI-B8, mitochondrial ribosomal protein L-CI-B8, mRpL-CI-B8, BcDNA:RE35686, mitochondrial ribosomal protein L43" CDMC35289 2 25 13 DAC22-B01 9-CG4043-RA_1 CG4043 CGAGGTGAAGACCCAAAACCTGAGCATAGATGGCAGCTACTTGGAGTGTAACTACCGACCAAAAGCGGG 69 FBan0004043 FBgn0037815 Rrp46 3 3R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp46 Rrp46 "CG4043, CG4043, dRrp46" CDMC35289 2 26 13 DAC22-B01 9-CG4043-RA_1 CG4043 CGAGGTGAAGACCCAAAACCTGAGCATAGATGGCAGCTACTTGGAGTGTAACTACCGACCAAAAGCGGG 69 FBan0004043 FBgn0037815 Rrp46 3 3R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; nucleotidyltransferase activity; GO:0016779 ; EC:2.7.7.-; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0016779 ; EC:2.7.7.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp46 Rrp46 "CG4043, CG4043, dRrp46" CDMC35290 2 1 14 DAC22-B13 11-CG40449-RA_4 CG40449 GCATTCCCCTTGGTGTATCTACCTTCTTCGTAGCCGAGAGCCATAACATTGTGGTAACAGGAGGGCCGG 69 FBgn0058449 CG40449 CG40449 CG40449 CDMC35290 2 2 14 DAC22-B13 11-CG40449-RA_4 CG40449 GCATTCCCCTTGGTGTATCTACCTTCTTCGTAGCCGAGAGCCATAACATTGTGGTAACAGGAGGGCCGG 69 FBgn0058449 CG40449 CG40449 CG40449 CDMC35291 2 3 14 DAC22-F01 16-CG4051-RA_1 CG4051 TCGTGGCAATGCAATCTTACCGAATCCCTCTTCTCAGAAAATGTCTACGGACCTGAGATTCTGAGTGGA 69 FBan0004051 FBgn0000562 egl 2 2R intracellular mRNA localization; GO:0008298; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 egl egalitarian "CG4051, CG4051, CG4051, egal, Egl" CDMC35291 2 4 14 DAC22-F01 16-CG4051-RA_1 CG4051 TCGTGGCAATGCAATCTTACCGAATCCCTCTTCTCAGAAAATGTCTACGGACCTGAGATTCTGAGTGGA 69 FBan0004051 FBgn0000562 egl 2 2R intracellular mRNA localization; GO:0008298; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oocyte fate determination (sensu Insecta); GO:0007294; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte nucleus migration during oocyte axis determination (sensu Insecta); GO:0048128; oogenesis (sensu Insecta); GO:0009993 nucleic acid binding; GO:0003676; ; GO:0003676; 3'-5' exonuclease activity; GO:0008408; ; GO:0008408 intracellular; GO:0005622 egl egalitarian "CG4051, CG4051, CG4051, egal, Egl" CDMC35292 2 5 14 DAC22-F13 8-CG4061-RA_1 CG4061 CGCTTGCCGGTAAATATTGCTATTGACATGCAACAGACGGCTCAACGCGAGATACATCGTTTGTGGCCG 69 FBan0004061 FBgn0025630 CG4061 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; RNA-3'-phosphate cyclase activity; GO:0003963 ; EC:6.5.1.4; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0003729; ; GO:0003963 ; EC:6.5.1.4; ; GO:0003963 ; EC:6.5.1.4; ; GO:0016849 ; EC:4.6.-.- nucleus; GO:0005634 CG4061 CG4061 EG:22E5.3 CDMC35292 2 6 14 DAC22-F13 8-CG4061-RA_1 CG4061 CGCTTGCCGGTAAATATTGCTATTGACATGCAACAGACGGCTCAACGCGAGATACATCGTTTGTGGCCG 69 FBan0004061 FBgn0025630 CG4061 X X "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; RNA-3'-phosphate cyclase activity; GO:0003963 ; EC:6.5.1.4; phosphorus-oxygen lyase activity; GO:0016849 ; EC:4.6.-.-; ; GO:0003729; ; GO:0003963 ; EC:6.5.1.4; ; GO:0003963 ; EC:6.5.1.4; ; GO:0016849 ; EC:4.6.-.- nucleus; GO:0005634 CG4061 CG4061 EG:22E5.3 CDMC35293 2 7 14 DAC22-J01 23-CG4097-RA_2 CG4097 AATCATTTCGTTGGTTTTTTACTTGGCGAGTTAATTGGTGAATTTCAGCACAAAACATGAGCAGATTGG 69 FBan0004097 FBgn0002284 Pros26 3 3L ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros26 Proteasome 26kD subunit "CG4097, DTS-5, l(3)DTS-5, DTS5, l(3)73Ai, beta6_dm, Pros26-DTS, 20S proteasome, pros26, Proteasome subunit 20S, l(3)DTS5" CDMC35293 2 8 14 DAC22-J01 23-CG4097-RA_2 CG4097 AATCATTTCGTTGGTTTTTTACTTGGCGAGTTAATTGGTGAATTTCAGCACAAAACATGAGCAGATTGG 69 FBan0004097 FBgn0002284 Pros26 3 3L ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros26 Proteasome 26kD subunit "CG4097, DTS-5, l(3)DTS-5, DTS5, l(3)73Ai, beta6_dm, Pros26-DTS, 20S proteasome, pros26, Proteasome subunit 20S, l(3)DTS5" CDMC35294 2 9 14 DAC22-J13 3-CG4104-RA_3 CG4104 TCGGCGTGGACTGGAACGAACGCATCAAGATTATCTATGTGGGTGACGATCTAACAGACGAGGACGCCA 69 FBan0004104 FBgn0027560 Tps1 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 "alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity; GO:0003825 ; EC:2.4.1.15; ; GO:0003825 ; EC:2.4.1.15; ; GO:0003825 ; EC:2.4.1.15; trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12" Tps1 Trehalose-6-phosphate synthase 1 "CG4104, CG4104, jf5, l(2)k08903, BcDNA:GH08860, tps1, trehalose-6-phosphate synthase, dtps1, TPS, Trehalos-6-phosphate synthase, TreS, l(2)24Ea, l(2)jf4, l(2)jf5, lethal(2)24Ea, Trehalose-6-phosphate synthase 1" CDMC35294 2 10 14 DAC22-J13 3-CG4104-RA_3 CG4104 TCGGCGTGGACTGGAACGAACGCATCAAGATTATCTATGTGGGTGACGATCTAACAGACGAGGACGCCA 69 FBan0004104 FBgn0027560 Tps1 2 2L disaccharide metabolism; GO:0005984; trehalose biosynthesis; GO:0005992 "alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity; GO:0003825 ; EC:2.4.1.15; ; GO:0003825 ; EC:2.4.1.15; ; GO:0003825 ; EC:2.4.1.15; trehalose-phosphatase activity; GO:0004805 ; EC:3.1.3.12; ; GO:0004805 ; EC:3.1.3.12" Tps1 Trehalose-6-phosphate synthase 1 "CG4104, CG4104, jf5, l(2)k08903, BcDNA:GH08860, tps1, trehalose-6-phosphate synthase, dtps1, TPS, Trehalos-6-phosphate synthase, TreS, l(2)24Ea, l(2)jf4, l(2)jf5, lethal(2)24Ea, Trehalose-6-phosphate synthase 1" CDMC35295 2 11 14 DAC22-N01 1-CG41107-RA_1 CG41107 GCGCTTAGTGGCTGGCTCGCCATCGTCTTTTGCCTTCGTCCCTGATACCTTGGTCATTTTCACAAGATT 69 FBgn0069937 CG41107 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41107 CG41107 CDMC35295 2 12 14 DAC22-N01 1-CG41107-RA_1 CG41107 GCGCTTAGTGGCTGGCTCGCCATCGTCTTTTGCCTTCGTCCCTGATACCTTGGTCATTTTCACAAGATT 69 FBgn0069937 CG41107 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41107 CG41107 CDMC35296 2 13 14 DAC22-N13 23-CG41122-RA_8 CG41122 CTCTGGAATTACTTACCCCCTGCTTCGGGAATTGGATTTTATAGGAGAGCATTCAATAAACCTAGTCCA 69 FBgn0069929 CG41122 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41122 CG41122 CDMC35296 2 14 14 DAC22-N13 23-CG41122-RA_8 CG41122 CTCTGGAATTACTTACCCCCTGCTTCGGGAATTGGATTTTATAGGAGAGCATTCAATAAACCTAGTCCA 69 FBgn0069929 CG41122 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41122 CG41122 CDMC35297 2 15 14 DAC23-B01 3-CG3332-RA_3 CG3332 ATATGCGCCGTAATCCTCTTCGAGATGTGGAAGACGGTCAAATCGATTCCGGACATCGACAAGACGCGC 69 FBan0003332 FBgn0031514 CG3332 2 2L CG3332 CG3332 CDMC35297 2 16 14 DAC23-B01 3-CG3332-RA_3 CG3332 ATATGCGCCGTAATCCTCTTCGAGATGTGGAAGACGGTCAAATCGATTCCGGACATCGACAAGACGCGC 69 FBan0003332 FBgn0031514 CG3332 2 2L CG3332 CG3332 CDMC35298 2 17 14 DAC23-B13 3-CG33341-RA_3 CG33341 CCGCCGGGATCGTTTGTAAAGTTCACTTGCTCCTTTGCTACTGGACTTCTAGCGGCCTATCCCAAAGGT 69 FBan0033341 FBgn0053341 CG33341 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33341 CG33341 CDMC35298 2 18 14 DAC23-B13 3-CG33341-RA_3 CG33341 CCGCCGGGATCGTTTGTAAAGTTCACTTGCTCCTTTGCTACTGGACTTCTAGCGGCCTATCCCAAAGGT 69 FBan0033341 FBgn0053341 CG33341 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33341 CG33341 CDMC35299 2 19 14 DAC23-F01 23-CG33463-RA_7 CG33463 CCTTTCTGTACAATATAACAGTGGATTGTTGCAAGCTCGTCAAGAATCCGAAGTACAGTCCCGTTGCTA 69 FBan0033463 FBgn0053463 CG33463 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33463 CG33463 CDMC35299 2 20 14 DAC23-F01 23-CG33463-RA_7 CG33463 CCTTTCTGTACAATATAACAGTGGATTGTTGCAAGCTCGTCAAGAATCCGAAGTACAGTCCCGTTGCTA 69 FBan0033463 FBgn0053463 CG33463 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33463 CG33463 CDMC35300 2 21 14 DAC23-F13 16-CG33472-RA_1 CG33472 AACGAACCGAATGAGAAGCCAAAGAACTAAGGATACGAAAGCAGCTGAAATAACGTTGGAGGATCGGCG 69 FBan0033472 FBgn0053472 CG33472 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33472 CG33472 "CG30032, CG30032, anon-WO02059370.1, BcDNA:GH06755" CDMC35300 2 22 14 DAC23-F13 16-CG33472-RA_1 CG33472 AACGAACCGAATGAGAAGCCAAAGAACTAAGGATACGAAAGCAGCTGAAATAACGTTGGAGGATCGGCG 69 FBan0033472 FBgn0053472 CG33472 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33472 CG33472 "CG30032, CG30032, anon-WO02059370.1, BcDNA:GH06755" CDMC35301 2 23 14 DAC23-J01 8-CG33490-RA_3 CG33490 TGCCCTTGATTGGATCCATTACACCCATGCCAAAGGTGACGTACAACCAGGATACAGCCTATCGTCAGT 69 FBan0033490 FBgn0053490 CG33490 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33490 CG33490 CG6110 CDMC35301 2 24 14 DAC23-J01 8-CG33490-RA_3 CG33490 TGCCCTTGATTGGATCCATTACACCCATGCCAAAGGTGACGTACAACCAGGATACAGCCTATCGTCAGT 69 FBan0033490 FBgn0053490 CG33490 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33490 CG33490 CG6110 CDMC35302 2 25 14 DAC23-J13 23-CG33502-RA_2 CG33502 GGGACTCATTTTAATTTCCCTGCTTACGTTGCTAATTCGCTAGTGAAACCAATAGTTAGTTGTATACAT 69 FBgn0042218 CDMC35302 2 26 14 DAC23-J13 23-CG33502-RA_2 CG33502 GGGACTCATTTTAATTTCCCTGCTTACGTTGCTAATTCGCTAGTGAAACCAATAGTTAGTTGTATACAT 69 FBgn0042218 CDMC35303 2 1 15 DAC23-N01 3-CG3394-RA_3 CG3394 TGCCAGGAGCTGTGGACTTGGTTACTGCTCTAAAGACCCAAAAGAAACTGGAGCTACCGAGTGCTGTCT 69 FBan0003394 FBgn0034999 CG3394 2 2R fatty acid metabolism; GO:0006631 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain fatty acid transporter activity; GO:0005324; ; GO:0005324 CG3394 CG3394 CDMC35303 2 2 15 DAC23-N01 3-CG3394-RA_3 CG3394 TGCCAGGAGCTGTGGACTTGGTTACTGCTCTAAAGACCCAAAAGAAACTGGAGCTACCGAGTGCTGTCT 69 FBan0003394 FBgn0034999 CG3394 2 2R fatty acid metabolism; GO:0006631 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; long-chain fatty acid transporter activity; GO:0005324; ; GO:0005324 CG3394 CG3394 CDMC35304 2 3 15 DAC23-N13 18-CG3408-RA_1 CG3408 GCGCGTGTGTGGAGGCAAAATTCAAAATGAGATACGTGTTGACCACCTGAACGAGTTATACGACTGCTA 69 FBan0003408 FBgn0036008 CG3408 3 3L muscle maintenance; GO:0046716 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3408 CG3408 CT11439 CDMC35304 2 4 15 DAC23-N13 18-CG3408-RA_1 CG3408 GCGCGTGTGTGGAGGCAAAATTCAAAATGAGATACGTGTTGACCACCTGAACGAGTTATACGACTGCTA 69 FBan0003408 FBgn0036008 CG3408 3 3L muscle maintenance; GO:0046716 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG3408 CG3408 CT11439 CDMC35305 2 5 15 DAC24-B01 23-CG3314-RD_1 CG3314 TGAATTTTGTGCTAAAAACCAATATTTTATTTACTTTCAGCGAGTATTTCGATACGTTCGTGGTCGTGC 69 FBan0003314 FBgn0014026 RpL7A X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7A Ribosomal protein L7A "CG3314, Surf-3/rpL7a, Surf3/rpL7a, L7A, L7a" CDMC35305 2 6 15 DAC24-B01 23-CG3314-RD_1 CG3314 TGAATTTTGTGCTAAAAACCAATATTTTATTTACTTTCAGCGAGTATTTCGATACGTTCGTGGTCGTGC 69 FBan0003314 FBgn0014026 RpL7A X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL7A Ribosomal protein L7A "CG3314, Surf-3/rpL7a, Surf3/rpL7a, L7A, L7a" CDMC35306 2 7 15 DAC24-B13 13-CG33169-RA_1 CG33169 TTTGGGGACAAAATGTATCCGAATTACGGTCGTTGGTGGTAGTGTTGAAAACCGTCTAGCGCTTTGGCG 69 FBan0033169 FBgn0053169 CG33169 3 3L CG33169 CG33169 "CG8244, BcDNA:RH56317, EP3524" CDMC35306 2 8 15 DAC24-B13 13-CG33169-RA_1 CG33169 TTTGGGGACAAAATGTATCCGAATTACGGTCGTTGGTGGTAGTGTTGAAAACCGTCTAGCGCTTTGGCG 69 FBan0033169 FBgn0053169 CG33169 3 3L CG33169 CG33169 "CG8244, BcDNA:RH56317, EP3524" CDMC35307 2 9 15 DAC24-F01 13-CG33192-RA_1 CG33192 GCTGCTCCACCAAAAACTAGATACAGGACCCATCTCGAGCTCATCTGTGTGATGAAAGACCCTTTGGCA 69 FBan0033192 FBgn0053192 MtnD 3 3R MtnD Metallothionein D CG33192 CDMC35307 2 10 15 DAC24-F01 13-CG33192-RA_1 CG33192 GCTGCTCCACCAAAAACTAGATACAGGACCCATCTCGAGCTCATCTGTGTGATGAAAGACCCTTTGGCA 69 FBan0033192 FBgn0053192 MtnD 3 3R MtnD Metallothionein D CG33192 CDMC35308 2 11 15 DAC24-F13 10-CG33197-RC_1 CG33197 GTGTGACAGGTGCCAAGACAAAACCACCCCTCTTCCAACCCCTCAGCCTTGAAGCAATTTTTATATGCA 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC35308 2 12 15 DAC24-F13 10-CG33197-RC_1 CG33197 GTGTGACAGGTGCCAAGACAAAACCACCCCTCTTCCAACCCCTCAGCCTTGAAGCAATTTTTATATGCA 69 FBan0033197 FBgn0053197 mbl 2 2R embryonic development; GO:0009790; mesoderm development; GO:0007498; muscle development; GO:0007517; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; somatic muscle development; GO:0007525 DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003677; ; GO:0003676; ; GO:0003729 nucleus; GO:0005634 mbl muscleblind "CG14477, CG33197, CG10941, CG14477, l(2)k01212, mm, l(2)01038, l(2)k05507, Muscleblind, n(2)k07110, mindmelt" CDMC35309 2 13 15 DAC24-J01 6-CG33223-RA_2 CG33223 GGCACTGGGCGACCTAAATTGCGATTCCACCTGTCATCAGCCGAGCTCTTCTTTGCCTTACCTATCATT 69 FBan0033223 FBgn0053223 CG33223 X X CG33223 CG33223 CDMC35309 2 14 15 DAC24-J01 6-CG33223-RA_2 CG33223 GGCACTGGGCGACCTAAATTGCGATTCCACCTGTCATCAGCCGAGCTCTTCTTTGCCTTACCTATCATT 69 FBan0033223 FBgn0053223 CG33223 X X CG33223 CG33223 CDMC35310 2 15 15 DAC24-J13 14-CG33229-RA_1 CG33229 AGCTTAATGAGTGTGGCGAAATAAGACGTCGCTTACAGGCATCCCAAACGTCACGAAATCGGTCAGACA 69 FBan0033229 FBgn0053229 CG33229 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33229 CG33229 "CG16971, CG32492" CDMC35310 2 16 15 DAC24-J13 14-CG33229-RA_1 CG33229 AGCTTAATGAGTGTGGCGAAATAAGACGTCGCTTACAGGCATCCCAAACGTCACGAAATCGGTCAGACA 69 FBan0033229 FBgn0053229 CG33229 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33229 CG33229 "CG16971, CG32492" CDMC35311 2 17 15 DAC24-N01 3-CG33282-RA_2 CG33282 TCGAGTTTCCAGCATTCGAGGGGCTCTGACTTCGATGGTGATGCTATCCGTCGATTTGGGAATACTGGC 69 FBan0033282 FBgn0053282 CG33282 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33282 CG33282 "CG15407, CG15407" CDMC35311 2 18 15 DAC24-N01 3-CG33282-RA_2 CG33282 TCGAGTTTCCAGCATTCGAGGGGCTCTGACTTCGATGGTGATGCTATCCGTCGATTTGGGAATACTGGC 69 FBan0033282 FBgn0053282 CG33282 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33282 CG33282 "CG15407, CG15407" CDMC35312 2 19 15 DAC24-N13 22-CG33292-RA_1 CG33292 GGCAGCGAAACGGTACAGCGAACTCTTCGAATCTCGAGCTATTACTTATTTTCTCGTTCCCAATCCCAA 69 FBan0033292 FBgn0053292 CG33292 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33292 CG33292 "CG11250, CG11250" CDMC35312 2 20 15 DAC24-N13 22-CG33292-RA_1 CG33292 GGCAGCGAAACGGTACAGCGAACTCTTCGAATCTCGAGCTATTACTTATTTTCTCGTTCCCAATCCCAA 69 FBan0033292 FBgn0053292 CG33292 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33292 CG33292 "CG11250, CG11250" CDMC35313 2 21 15 DAC25-B01 2-CG10347-RA_1 CG10347 GCGGAGATTCAGAACTGGCCACGTTTGTTCGCGCAGAAGAAAGATGACGTAGCGGAGGAAGTACATCCA 69 FBan0010347 FBgn0030342 CG10347 X X CG10347 CG10347 Q9VYT5 CDMC35313 2 22 15 DAC25-B01 2-CG10347-RA_1 CG10347 GCGGAGATTCAGAACTGGCCACGTTTGTTCGCGCAGAAGAAAGATGACGTAGCGGAGGAAGTACATCCA 69 FBan0010347 FBgn0030342 CG10347 X X CG10347 CG10347 Q9VYT5 CDMC35314 2 23 15 DAC25-B13 1-CG10357-RA_1 CG10357 GCCGCTCAATTCGTGGATGTGATTCACACGGACTATCCCTTGTTTGGCGACATTCGACCTCGAGGAACT 69 FBan0010357 FBgn0035453 CG10357 3 3L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG10357 CG10357 CDMC35314 2 24 15 DAC25-B13 1-CG10357-RA_1 CG10357 GCCGCTCAATTCGTGGATGTGATTCACACGGACTATCCCTTGTTTGGCGACATTCGACCTCGAGGAACT 69 FBan0010357 FBgn0035453 CG10357 3 3L lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG10357 CG10357 CDMC35315 2 25 15 DAC25-F01 23-CG10392-RC_2 CG10392 GAACTTCCGGACCACATTTCAGCAGTATAAAAAACGTTTATAATGTCAATTGCGATTTGGACATGGGAA 69 FBan0010392 FBgn0040295 Ogt 2 2R protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-" Ogt O-glycosyltransferase "CG10392, CG10392, BcDNA:GH04245, O-glycosyltransferase" CDMC35315 2 26 15 DAC25-F01 23-CG10392-RC_2 CG10392 GAACTTCCGGACCACATTTCAGCAGTATAAAAAACGTTTATAATGTCAATTGCGATTTGGACATGGGAA 69 FBan0010392 FBgn0040295 Ogt 2 2R protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-" Ogt O-glycosyltransferase "CG10392, CG10392, BcDNA:GH04245, O-glycosyltransferase" CDMC35316 2 1 16 DAC25-F13 22-CG10413-RA_1 CG10413 CCTCCACAACGCTCTAGACTTCGAATTGGAGATATTCGCGTTTCCATGAGTGATAAAATCCGGAGTGCA 69 FBan0010413 FBgn0032689 CG10413 2 2L amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; ; GO:0008511 membrane; GO:0016020 CG10413 CG10413 CDMC35316 2 2 16 DAC25-F13 22-CG10413-RA_1 CG10413 CCTCCACAACGCTCTAGACTTCGAATTGGAGATATTCGCGTTTCCATGAGTGATAAAATCCGGAGTGCA 69 FBan0010413 FBgn0032689 CG10413 2 2L amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279; ; GO:0008511 membrane; GO:0016020 CG10413 CG10413 CDMC35317 2 3 16 DAC25-J01 11-CG10460-RA_1 CG10460 GGGCGAAGTGACTTGGAAAATGGGAATTAATCATTTGGCTGATCTCACGCCTGAGGAATTTGCCCAGCG 69 FBan0010460 FBgn0034443 cer 2 2R long-term memory; GO:0007616 cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 cer crammer "CG10460, CG10460, crammer" CDMC35317 2 4 16 DAC25-J01 11-CG10460-RA_1 CG10460 GGGCGAAGTGACTTGGAAAATGGGAATTAATCATTTGGCTGATCTCACGCCTGAGGAATTTGCCCAGCG 69 FBan0010460 FBgn0034443 cer 2 2R long-term memory; GO:0007616 cysteine protease inhibitor activity; GO:0004869; ; GO:0004869 cer crammer "CG10460, CG10460, crammer" CDMC35318 2 5 16 DAC25-J13 18-CG10473-RB_3 CG10473 GCGCGGACGGGAAAGATCGTTGAGGAAGATGGTTTCTGGATAGATCGGATCAAGTCTAAGTGCTATGTT 69 FBan0010473 FBgn0032745 CG10473 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 nucleus; GO:0005634 CG10473 CG10473 "CG10437, CG10437" CDMC35318 2 6 16 DAC25-J13 18-CG10473-RB_3 CG10473 GCGCGGACGGGAAAGATCGTTGAGGAAGATGGTTTCTGGATAGATCGGATCAAGTCTAAGTGCTATGTT 69 FBan0010473 FBgn0032745 CG10473 2 2L apoptosis; GO:0006915; induction of apoptosis; GO:0006917 nucleus; GO:0005634 CG10473 CG10473 "CG10437, CG10437" CDMC35319 2 7 16 DAC25-N01 22-CG10516-RA_1 CG10516 ACACGGCTGACACAATTCATTACAAAGCAATCGAAGGTAAACCAGTGAAGAGGAACAAGTGCCAGCATG 69 FBan0010516 FBgn0036549 CG10516 3 3L CG10516 CG10516 CDMC35319 2 8 16 DAC25-N01 22-CG10516-RA_1 CG10516 ACACGGCTGACACAATTCATTACAAAGCAATCGAAGGTAAACCAGTGAAGAGGAACAAGTGCCAGCATG 69 FBan0010516 FBgn0036549 CG10516 3 3L CG10516 CG10516 CDMC35320 2 9 16 DAC25-N13 3-CG10528-RA_1 CG10528 TGCACACGATCGACACTGAGGAAGACTCGTTTGTGGACGACGTGGACTTTTACAATGTCGACCGGGAGA 69 FBan0010528 FBgn0004811 fs(2)ltoPP43 2 2L eggshell formation (sensu Insecta); GO:0007304 fs(2)ltoPP43 female sterile (2) ltoPP43 "CG10528, CG10528, CG10528, LD12957, l(2)38Ac, BEST:LD12957" CDMC35320 2 10 16 DAC25-N13 3-CG10528-RA_1 CG10528 TGCACACGATCGACACTGAGGAAGACTCGTTTGTGGACGACGTGGACTTTTACAATGTCGACCGGGAGA 69 FBan0010528 FBgn0004811 fs(2)ltoPP43 2 2L eggshell formation (sensu Insecta); GO:0007304 fs(2)ltoPP43 female sterile (2) ltoPP43 "CG10528, CG10528, CG10528, LD12957, l(2)38Ac, BEST:LD12957" CDMC35321 2 11 16 DAC26-B01 2-CG15275-RA_1 CG15275 GCTTGTCGACAATCAAAACGAGCACAATTCCGGCGATGTTATCGAGAACCGTCTGTTGTGGCCATCGGT 69 FBgn0028914 CDMC35321 2 12 16 DAC26-B01 2-CG15275-RA_1 CG15275 GCTTGTCGACAATCAAAACGAGCACAATTCCGGCGATGTTATCGAGAACCGTCTGTTGTGGCCATCGGT 69 FBgn0028914 CDMC35322 2 13 16 DAC26-B13 24-CG15281-RB_3 CG15281 GCTAAAAAGCCGATGTATTTTCTTCTTTCACGTAAATTCTTGTAAGTTTAGTAAAGCAACAGTTAGAGT 69 FBan0015281 FBgn0028536 CG15281 2 2L CG15281 CG15281 "CG18456, BG:DS00810.3, DS00810.3, BcDNA:RH63170" CDMC35322 2 14 16 DAC26-B13 24-CG15281-RB_3 CG15281 GCTAAAAAGCCGATGTATTTTCTTCTTTCACGTAAATTCTTGTAAGTTTAGTAAAGCAACAGTTAGAGT 69 FBan0015281 FBgn0028536 CG15281 2 2L CG15281 CG15281 "CG18456, BG:DS00810.3, DS00810.3, BcDNA:RH63170" CDMC35323 2 15 16 DAC26-F01 13-CG15329-RA_1 CG15329 ATCGACGTGCGTGTTTCCTACTCGAACTTTCATCGTTCTCTCGTCCTCTCCCATTCCAATTGCACACTT 69 FBan0015329 FBgn0029977 hdm X X meiotic recombination; GO:0007131 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hdm hold'em "CG15329, hold'em" CDMC35323 2 16 16 DAC26-F01 13-CG15329-RA_1 CG15329 ATCGACGTGCGTGTTTCCTACTCGAACTTTCATCGTTCTCTCGTCCTCTCCCATTCCAATTGCACACTT 69 FBan0015329 FBgn0029977 hdm X X meiotic recombination; GO:0007131 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 hdm hold'em "CG15329, hold'em" CDMC35324 2 17 16 DAC26-F13 24-CG15347-RA_4 CG15347 CCCGTCTTATTATTTTCTACATTCTAAAACATCATTATACATACATACATACACTGGGATGTTACATTT 69 FBan0015347 FBgn0030040 CG15347 X X CG15347 CG15347 CDMC35324 2 18 16 DAC26-F13 24-CG15347-RA_4 CG15347 CCCGTCTTATTATTTTCTACATTCTAAAACATCATTATACATACATACATACACTGGGATGTTACATTT 69 FBan0015347 FBgn0030040 CG15347 X X CG15347 CG15347 CDMC35325 2 19 16 DAC26-J01 3-CG15396-RB_1 CG15396 TGGTGTGCTCGAACGCGCCAGAATATGCCTTTCGTATCAGGATCTATCACCTGAAAACGCTGCCCAGTT 69 FBan0015396 FBgn0041248 Gr23a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr23a Gustatory receptor 23a "CG15396, 23A.1a, 23A1.b, GR23A.1, Gustatory receptor 23A.1, 23A1a, 23A1b, Gr23a.a, Gr23a.b, Gr23A1a, Gr23A1b, Gustatory receptor 23a" CDMC35325 2 20 16 DAC26-J01 3-CG15396-RB_1 CG15396 TGGTGTGCTCGAACGCGCCAGAATATGCCTTTCGTATCAGGATCTATCACCTGAAAACGCTGCCCAGTT 69 FBan0015396 FBgn0041248 Gr23a 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr23a Gustatory receptor 23a "CG15396, 23A.1a, 23A1.b, GR23A.1, Gustatory receptor 23A.1, 23A1a, 23A1b, Gr23a.a, Gr23a.b, Gr23A1a, Gr23A1b, Gustatory receptor 23a" CDMC35326 2 21 16 DAC26-J13 40-CG15406-RA_1 CG15406 TCAACGCGGAACAACCAAGGATACAGAGCATGGAAAAAGGACATTTGAGCAGGAAGTTTACACGCAAGT 69 FBan0015406 FBgn0031517 CG15406 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; ; GO:0005353 integral to membrane; GO:0016021; membrane; GO:0016020 CG15406 CG15406 CDMC35326 2 22 16 DAC26-J13 40-CG15406-RA_1 CG15406 TCAACGCGGAACAACCAAGGATACAGAGCATGGAAAAAGGACATTTGAGCAGGAAGTTTACACGCAAGT 69 FBan0015406 FBgn0031517 CG15406 2 2L carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; ; GO:0005353 integral to membrane; GO:0016021; membrane; GO:0016020 CG15406 CG15406 CDMC35327 2 23 16 DAC26-N01 8-CG15453-RA_1 CG15453 AGGAGGAAGAGGAGTGTCCTGTGGTTCGTTCGTTTATTGCGTGCTTTTTTGCGACCCACTTTAGGAGCT 69 FBan0015453 FBgn0031123 CG15453 X X CG15453 CG15453 CDMC35327 2 24 16 DAC26-N01 8-CG15453-RA_1 CG15453 AGGAGGAAGAGGAGTGTCCTGTGGTTCGTTCGTTTATTGCGTGCTTTTTTGCGACCCACTTTAGGAGCT 69 FBan0015453 FBgn0031123 CG15453 X X CG15453 CG15453 CDMC35328 2 25 16 DAC26-N13 17-CG15464-RA_1 CG15464 CCATGGAGGGCATCATACAGTGTTTGGTATTTCTCAAAGCATTCTCGATGAGGGGAGAACCTTTGACCT 69 FBan0015464 FBgn0029748 CG15464 X X CG15464 CG15464 CDMC35328 2 26 16 DAC26-N13 17-CG15464-RA_1 CG15464 CCATGGAGGGCATCATACAGTGTTTGGTATTTCTCAAAGCATTCTCGATGAGGGGAGAACCTTTGACCT 69 FBan0015464 FBgn0029748 CG15464 X X CG15464 CG15464 CDMC35329 2 1 17 DAC27-B01 14-CG9740-RA_1 CG9740 GGATGATAGCAGTGCACGCAATCAGGAATCCAACTTGGTGAGCTACTTGACCGATCTGGATCAACTGGT 69 FBan0009740 FBgn0037669 CG9740 3 3R CG9740 CG9740 CDMC35329 2 2 17 DAC27-B01 14-CG9740-RA_1 CG9740 GGATGATAGCAGTGCACGCAATCAGGAATCCAACTTGGTGAGCTACTTGACCGATCTGGATCAACTGGT 69 FBan0009740 FBgn0037669 CG9740 3 3R CG9740 CG9740 CDMC35330 2 3 17 DAC27-B13 3-CG9750-RA_3 CG9750 CCGGATGCCCTGACCATTCTTACACGCATCGCCACAGATACCAGTTTACGCTACGCCATCCAACTGATT 69 FBan0009750 FBgn0040075 rept 3 3L DNA recombination; GO:0006310; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0003678; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 rept reptin "CG9750, CG9750, l(3)06945, drep, rep, Tip48/Reptin, Tip48, dRep, dReptin, anon-WO0142479.1, reptin" CDMC35330 2 4 17 DAC27-B13 3-CG9750-RA_3 CG9750 CCGGATGCCCTGACCATTCTTACACGCATCGCCACAGATACCAGTTTACGCTACGCCATCCAACTGATT 69 FBan0009750 FBgn0040075 rept 3 3L DNA recombination; GO:0006310; DNA repair; GO:0006281 nucleic acid binding; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0003676; ; GO:0003678; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 rept reptin "CG9750, CG9750, l(3)06945, drep, rep, Tip48/Reptin, Tip48, dRep, dReptin, anon-WO0142479.1, reptin" CDMC35331 2 5 17 DAC27-F01 23-CG9790-RA_2 CG9790 GCCTGATGTAAAATAAGAAACCATAGCTTTAGGGTTCAGCTGGGAAGTTCAAAGACACGAAACGAACTG 69 FBan0009790 FBgn0037613 Cks85A 3 3R mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- Cks85A Cyclin-dependent kinase subunit 85A "CG9790, CG9790, CG9790, cks85A, BcDNA:GM01344, Cyclin-dependent kinase subunit 85A" CDMC35331 2 6 17 DAC27-F01 23-CG9790-RA_2 CG9790 GCCTGATGTAAAATAAGAAACCATAGCTTTAGGGTTCAGCTGGGAAGTTCAAAGACACGAAACGAACTG 69 FBan0009790 FBgn0037613 Cks85A 3 3R mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- Cks85A Cyclin-dependent kinase subunit 85A "CG9790, CG9790, CG9790, cks85A, BcDNA:GM01344, Cyclin-dependent kinase subunit 85A" CDMC35332 2 7 17 DAC27-F13 14-CG9801-RA_1 CG9801 CGCCTGTACTGCAATCCAAGGAGTTCAAGGAGACGAATTTCTGAATTGGAGGAAACGCTAGACTGCCGA 69 FBan0009801 FBgn0037623 CG9801 3 3R CG9801 CG9801 CDMC35332 2 8 17 DAC27-F13 14-CG9801-RA_1 CG9801 CGCCTGTACTGCAATCCAAGGAGTTCAAGGAGACGAATTTCTGAATTGGAGGAAACGCTAGACTGCCGA 69 FBan0009801 FBgn0037623 CG9801 3 3R CG9801 CG9801 CDMC35333 2 9 17 DAC27-J01 9-CG9850-RA_3 CG9850 CGGGCACAGCTCGGTTAGGACATTCGCATTCACACATCCTACGCAGATCTCATAAAGCATGCTTGCAGA 69 FBan0009850 FBgn0034903 CG9850 2 2R cell proliferation; GO:0008283 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG9850 CG9850 "CG11169, Dimp, Dlg-interacting metalloprotease, dimp" CDMC35333 2 10 17 DAC27-J01 9-CG9850-RA_3 CG9850 CGGGCACAGCTCGGTTAGGACATTCGCATTCACACATCCTACGCAGATCTCATAAAGCATGCTTGCAGA 69 FBan0009850 FBgn0034903 CG9850 2 2R cell proliferation; GO:0008283 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG9850 CG9850 "CG11169, Dimp, Dlg-interacting metalloprotease, dimp" CDMC35334 2 11 17 DAC27-J13 23-CG9864-RA_3 CG9864 ACCTGTGATTATGTACTTTAAGTATTATGCCATAACGACGATGTGTACTTCTTTATGGAGAGAGTCCTA 69 FBan0009864 FBgn0034490 CG9864 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9864 CG9864 CT27832 CDMC35334 2 12 17 DAC27-J13 23-CG9864-RA_3 CG9864 ACCTGTGATTATGTACTTTAAGTATTATGCCATAACGACGATGTGTACTTCTTTATGGAGAGAGTCCTA 69 FBan0009864 FBgn0034490 CG9864 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9864 CG9864 CT27832 CDMC35335 2 13 17 DAC27-N01 1-CG9900-RB_1 CG9900 TGCGCCTTTTTTGCGAGCGAGGAATGTTGAACGGCGGATAGACATCACATTTGAGGTGGTAAACGGAGT 69 FBan0009900 FBgn0004643 mit(1)15 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; meiotic anaphase I; GO:0007133; mitotic sister chromatid segregation; GO:0000070; mitotic spindle checkpoint; GO:0007094; regulation of meiosis; GO:0040020 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737; kinetochore; GO:0000776; kinetochore microtubule; GO:0005828; nucleus; GO:0005634; outer kinetochore of condensed chromosome; GO:0000940 mit(1)15 mitotic 15 "CG9900, CG9900, CG9900, zw10, l(1)zw10, zw-10, ZW-10, abe: abnmormal eye, abnormal-eye, ZW10, dZW10, mit(l)15, EG:BACR7C10.3, Zeste-White 10, Zw10, l(1)3Af, l(1)6-99, abe" CDMC35335 2 14 17 DAC27-N01 1-CG9900-RB_1 CG9900 TGCGCCTTTTTTGCGAGCGAGGAATGTTGAACGGCGGATAGACATCACATTTGAGGTGGTAAACGGAGT 69 FBan0009900 FBgn0004643 mit(1)15 X X cell cycle; GO:0007049; chromosome segregation; GO:0007059; meiotic anaphase I; GO:0007133; mitotic sister chromatid segregation; GO:0000070; mitotic spindle checkpoint; GO:0007094; regulation of meiosis; GO:0040020 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 cytoplasm; GO:0005737; kinetochore; GO:0000776; kinetochore microtubule; GO:0005828; nucleus; GO:0005634; outer kinetochore of condensed chromosome; GO:0000940 mit(1)15 mitotic 15 "CG9900, CG9900, CG9900, zw10, l(1)zw10, zw-10, ZW-10, abe: abnmormal eye, abnormal-eye, ZW10, dZW10, mit(l)15, EG:BACR7C10.3, Zeste-White 10, Zw10, l(1)3Af, l(1)6-99, abe" CDMC35336 2 15 17 DAC27-N13 3-CG9917-RA_3 CG9917 CGTCGAGTCCATGTTCAACTTCATTCGGAACCAAACGATGTGCCGTGACAATCAGAAATCGCCGCTCGT 69 FBan0009917 FBgn0030740 CG9917 X X CG9917 CG9917 anon-WO0140519.229 CDMC35336 2 16 17 DAC27-N13 3-CG9917-RA_3 CG9917 CGTCGAGTCCATGTTCAACTTCATTCGGAACCAAACGATGTGCCGTGACAATCAGAAATCGCCGCTCGT 69 FBan0009917 FBgn0030740 CG9917 X X CG9917 CG9917 anon-WO0140519.229 CDMC35337 2 17 17 DAC28-B01 1-CG11738-RA_1 CG11738 AGTAAAAGCACAACAGATTGCACCATGGAGGCAGAGAACATCAGAGCAGACGCATTCGAGCCGGC 65 FBgn0031105 CDMC35337 2 18 17 DAC28-B01 1-CG11738-RA_1 CG11738 AGTAAAAGCACAACAGATTGCACCATGGAGGCAGAGAACATCAGAGCAGACGCATTCGAGCCGGC 65 FBgn0031105 CDMC35338 2 19 17 DAC28-B13 23-CG11801-RA_3 CG11801 CTATATGGTGCCATTTCTCTTTATGTTCGGTAGGTTCTATGCTCAAAAATACTGTGTTTCGGCAG 65 FBan0011801 FBgn0036128 CG11801 3 3L fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG11801 CG11801 CDMC35338 2 20 17 DAC28-B13 23-CG11801-RA_3 CG11801 CTATATGGTGCCATTTCTCTTTATGTTCGGTAGGTTCTATGCTCAAAAATACTGTGTTTCGGCAG 65 FBan0011801 FBgn0036128 CG11801 3 3L fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG11801 CG11801 CDMC35339 2 21 17 DAC28-F01 2-CG11905-RD_1 CG11905 CTCAGGAAAGCACCCAAAAGCAGGCATTGCGCGAAGGAGGAATCATCATTCAGCGGCTAAAGGTT 65 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC35339 2 22 17 DAC28-F01 2-CG11905-RD_1 CG11905 CTCAGGAAAGCACCCAAAAGCAGGCATTGCGCGAAGGAGGAATCATCATTCAGCGGCTAAAGGTT 65 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC35340 2 23 17 DAC28-F13 27-CG11940-RA_1 CG11940 GTACACTGGATTGGGATGGCGCAAGAAGTGGAAGTCGCCGACTGACTACACCTTTGGCTTCAAGG 65 FBan0011940 FBgn0031079 CG11940 X X cell surface receptor linked signal transduction; GO:0007166; development; GO:0007275; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 receptor signaling protein activity; GO:0005057; ; GO:0005057 CG11940 CG11940 BcDNA:LP01106 CDMC35340 2 24 17 DAC28-F13 27-CG11940-RA_1 CG11940 GTACACTGGATTGGGATGGCGCAAGAAGTGGAAGTCGCCGACTGACTACACCTTTGGCTTCAAGG 65 FBan0011940 FBgn0031079 CG11940 X X cell surface receptor linked signal transduction; GO:0007166; development; GO:0007275; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 receptor signaling protein activity; GO:0005057; ; GO:0005057 CG11940 CG11940 BcDNA:LP01106 CDMC35341 2 25 17 DAC28-J01 12-CG12052-RP_2 CG12052 CATACCAGCCACCATTACGACGATTTCGGCACCCAAGCAGATGATGTCAGGTGCGGGAACCAGTG 65 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC35341 2 26 17 DAC28-J01 12-CG12052-RP_2 CG12052 CATACCAGCCACCATTACGACGATTTCGGCACCCAAGCAGATGATGTCAGGTGCGGGAACCAGTG 65 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC35342 2 1 18 DAC28-J13 2-CG12092-RA_2 CG12092 TCCATGCCGAAAAACTCCCATGTGGTCAAGTATTTCCGCTACATGGTCGACCTGCTAGCGATGGG 65 FBan0012092 FBgn0031140 NPC1b X X lipid metabolism; GO:0006629; lipid transport; GO:0006869; proteolysis; GO:0006508 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0008158 plasma membrane; GO:0005886 NPC1b NPC1b "CG12092, CG12092, CG12092" CDMC35342 2 2 18 DAC28-J13 2-CG12092-RA_2 CG12092 TCCATGCCGAAAAACTCCCATGTGGTCAAGTATTTCCGCTACATGGTCGACCTGCTAGCGATGGG 65 FBan0012092 FBgn0031140 NPC1b X X lipid metabolism; GO:0006629; lipid transport; GO:0006869; proteolysis; GO:0006508 receptor activity; GO:0004872; ; GO:0004872; hedgehog receptor activity; GO:0008158; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0008158 plasma membrane; GO:0005886 NPC1b NPC1b "CG12092, CG12092, CG12092" CDMC35343 2 3 18 DAC28-N01 2-CG12157-RB_1 CG12157 TTGCCATTCACACTAGCCCTGAGCGGACGCATGAACCACGTGAAGAACAACTTTAGACTCGGCTG 65 FBan0012157 FBgn0016041 Tom40 X X anion transport; GO:0006820; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308 mitochondrial outer membrane translocase complex; GO:0005742 Tom40 Translocase of outer membrane 40 "CG12157, CG12157, CG12157, ms15, l(1)G0216, mit, membrane import protein, dtom40, ms(1)15, Translocase of outer membrane 40" CDMC35343 2 4 18 DAC28-N01 2-CG12157-RB_1 CG12157 TTGCCATTCACACTAGCCCTGAGCGGACGCATGAACCACGTGAAGAACAACTTTAGACTCGGCTG 65 FBan0012157 FBgn0016041 Tom40 X X anion transport; GO:0006820; protein targeting to mitochondrion; GO:0006626 carrier activity; GO:0005386; ; GO:0005386; protein translocase activity; GO:0015450; ; GO:0015450; voltage-gated ion-selective channel activity; GO:0008308; ; GO:0008308 mitochondrial outer membrane translocase complex; GO:0005742 Tom40 Translocase of outer membrane 40 "CG12157, CG12157, CG12157, ms15, l(1)G0216, mit, membrane import protein, dtom40, ms(1)15, Translocase of outer membrane 40" CDMC35344 2 5 18 DAC28-N13 2-CG12173-RA_1 CG12173 GTCCAGGATCTACAGCAAGTGCCCCAGTATGCGGACTACAAGGCCCTGTTAAGTGGTCCACCTAC 65 FBan0012173 FBgn0037305 CG12173 3 3R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520 hydrolase activity; GO:0016787 ; EC:3.-.-.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016791 ; EC:3.1.3.- CG12173 CG12173 CDMC35344 2 6 18 DAC28-N13 2-CG12173-RA_1 CG12173 GTCCAGGATCTACAGCAAGTGCCCCAGTATGCGGACTACAAGGCCCTGTTAAGTGGTCCACCTAC 65 FBan0012173 FBgn0037305 CG12173 3 3R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520 hydrolase activity; GO:0016787 ; EC:3.-.-.-; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016791 ; EC:3.1.3.- CG12173 CG12173 CDMC35345 2 7 18 DAC29-B01 23-CG3065-RA_9 CG3065 GCAGACGCATTTGAAGATACGATAGTTTCATAGTTACTCCTTACTCCTTAAGTCGCTAGCCATTGGCAT 69 FBan0003065 FBgn0034946 CG3065 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3065 CG3065 CDMC35345 2 8 18 DAC29-B01 23-CG3065-RA_9 CG3065 GCAGACGCATTTGAAGATACGATAGTTTCATAGTTACTCCTTACTCCTTAAGTCGCTAGCCATTGGCAT 69 FBan0003065 FBgn0034946 CG3065 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3065 CG3065 CDMC35346 2 9 18 DAC29-B13 10-CG3077-RA_1 CG3077 TGAGGTAGAGCCCATATGTACCCCCTTTGTCCTCCAAAGTAGTCCGTTCGTGCGAACAATGTGTCACAA 69 FBan0003077 FBgn0031457 CG3077 2 2L intracellular signaling cascade; GO:0007242 CG3077 CG3077 CDMC35346 2 10 18 DAC29-B13 10-CG3077-RA_1 CG3077 TGAGGTAGAGCCCATATGTACCCCCTTTGTCCTCCAAAGTAGTCCGTTCGTGCGAACAATGTGTCACAA 69 FBan0003077 FBgn0031457 CG3077 2 2L intracellular signaling cascade; GO:0007242 CG3077 CG3077 CDMC35347 2 11 18 DAC29-F01 23-CG31010-RA_15 CG31010 GGATGCCAAAGCTGTACATCCCTAGTGACACATCCTAGTTATACAATTAGGCAACATTATCCAGGTCCT 69 FBan0031010 FBgn0051010 CG31010 3 3R CG31010 CG31010 "BcDNA:AT12704, NEST:bs21b05" CDMC35347 2 12 18 DAC29-F01 23-CG31010-RA_15 CG31010 GGATGCCAAAGCTGTACATCCCTAGTGACACATCCTAGTTATACAATTAGGCAACATTATCCAGGTCCT 69 FBan0031010 FBgn0051010 CG31010 3 3R CG31010 CG31010 "BcDNA:AT12704, NEST:bs21b05" CDMC35348 2 13 18 DAC29-F13 2-CG31016-RA_1 CG31016 CCATCGCAACCGACATGCTGATGCGGGATTTCATGTTTGGTGAAGCTGGTAGTGCACTCACTGTACACT 69 FBan0031016 FBgn0051016 CG31016 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401; protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG31016 CG31016 CG9708 CDMC35348 2 14 18 DAC29-F13 2-CG31016-RA_1 CG31016 CCATCGCAACCGACATGCTGATGCGGGATTTCATGTTTGGTGAAGCTGGTAGTGCACTCACTGTACACT 69 FBan0031016 FBgn0051016 CG31016 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401; protein modification; GO:0006464 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG31016 CG31016 CG9708 CDMC35349 2 15 18 DAC29-J01 2-CG31048-RA_1 CG31048 GCCCGTTGTATCATCTTCCTCAAAGCAGTCAGGATGCACATGCTCAGACGGATTTTTCCTACGCGCAGC 69 FBan0031048 FBgn0051048 CG31048 3 3R development; GO:0007275; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; muscle development; GO:0007517; phagocytosis; GO:0006909; signal transduction; GO:0007165 GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG31048 CG31048 "CG11754, CG14530" CDMC35349 2 16 18 DAC29-J01 2-CG31048-RA_1 CG31048 GCCCGTTGTATCATCTTCCTCAAAGCAGTCAGGATGCACATGCTCAGACGGATTTTTCCTACGCGCAGC 69 FBan0031048 FBgn0051048 CG31048 3 3R development; GO:0007275; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; intracellular signaling cascade; GO:0007242; mesoderm development; GO:0007498; muscle development; GO:0007517; phagocytosis; GO:0006909; signal transduction; GO:0007165 GTP binding; GO:0005525; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005525; GTPase binding; GO:0051020; ; GO:0051020; small GTPase regulator activity; GO:0005083; ; GO:0005083 CG31048 CG31048 "CG11754, CG14530" CDMC35350 2 17 18 DAC29-J13 11-CG31057-RA_1 CG31057 AGAGGTGCAAGCACGCAATGAGATGCAGATACTCGTACATCTACACAACCACCCCACATAGAAGCGGTA 69 FBan0031057 FBgn0051057 tau 3 3R microtubule-based process; GO:0007017; negative regulation of microtubule depolymerization; GO:0007026 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule associated complex; GO:0005875 tau tau "CG5606, CG12881, CG31057, CG5606, CG5606, CG12881, BcDNA:RE16764" CDMC35350 2 18 18 DAC29-J13 11-CG31057-RA_1 CG31057 AGAGGTGCAAGCACGCAATGAGATGCAGATACTCGTACATCTACACAACCACCCCACATAGAAGCGGTA 69 FBan0031057 FBgn0051057 tau 3 3R microtubule-based process; GO:0007017; negative regulation of microtubule depolymerization; GO:0007026 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 microtubule associated complex; GO:0005875 tau tau "CG5606, CG12881, CG31057, CG5606, CG5606, CG12881, BcDNA:RE16764" CDMC35351 2 19 18 DAC29-N01 24-CG31084-RA_1 CG31084 GCTGCCGTTATTACACGATGAGAAATAATGGTGAAACAATTTAATAAAAACTCATAGATTTTAATAGTT 69 FBan0031084 FBgn0051084 CG31084 3 3R CG31084 CG31084 BcDNA:RH74240 CDMC35351 2 20 18 DAC29-N01 24-CG31084-RA_1 CG31084 GCTGCCGTTATTACACGATGAGAAATAATGGTGAAACAATTTAATAAAAACTCATAGATTTTAATAGTT 69 FBan0031084 FBgn0051084 CG31084 3 3R CG31084 CG31084 BcDNA:RH74240 CDMC35352 2 21 18 DAC29-N13 2-CG31090-RA_1 CG31090 GCGCAGTTGGCTCAAATGCATGGAGAGATTCGTTATCCCAAACTTCCCGTATCGGTGGATGGCTGTGAC 69 FBan0031090 FBgn0051090 CG31090 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; vitamin transport; GO:0051180 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 integral to membrane; GO:0016021 CG31090 CG31090 "CG14539, CG8951, CG14539" CDMC35352 2 22 18 DAC29-N13 2-CG31090-RA_1 CG31090 GCGCAGTTGGCTCAAATGCATGGAGAGATTCGTTATCCCAAACTTCCCGTATCGGTGGATGGCTGTGAC 69 FBan0031090 FBgn0051090 CG31090 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; coenzyme metabolism; GO:0006732; extracellular transport; GO:0006858; prosthetic group metabolism; GO:0051189; vitamin transport; GO:0051180 cation transporter activity; GO:0008324; ; GO:0008324; sodium-dependent multivitamin transporter activity; GO:0008523; ; GO:0008523 integral to membrane; GO:0016021 CG31090 CG31090 "CG14539, CG8951, CG14539" CDMC35353 2 23 18 DAC30-B01 2-CG1945-RA_3 CG1945 TGGCTACATGCTAGAGCGATCGCAGTCTGCTAAAAACACGTGGTCCATGGCCTTCGAGCTCTGTC 65 FBan0001945 FBgn0005632 faf 3 3R cellularization; GO:0007349; embryonic development; GO:0009790; endocytosis; GO:0006897; eye development (sensu Endopterygota); GO:0007456; germ cell migration; GO:0008354; mystery cell fate differentiation (sensu Endopterygota); GO:0008583; negative regulation of proteolysis; GO:0045861; nuclear migration; GO:0007097; protein deubiquitination; GO:0016579; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 cytoplasm; GO:0005737 faf fat facets "CG1945, CG1945, CG1945, BcDNA.LD22582, BcDNA:LD22582, fat facets" CDMC35353 2 24 18 DAC30-B01 2-CG1945-RA_3 CG1945 TGGCTACATGCTAGAGCGATCGCAGTCTGCTAAAAACACGTGGTCCATGGCCTTCGAGCTCTGTC 65 FBan0001945 FBgn0005632 faf 3 3R cellularization; GO:0007349; embryonic development; GO:0009790; endocytosis; GO:0006897; eye development (sensu Endopterygota); GO:0007456; germ cell migration; GO:0008354; mystery cell fate differentiation (sensu Endopterygota); GO:0008583; negative regulation of proteolysis; GO:0045861; nuclear migration; GO:0007097; protein deubiquitination; GO:0016579; ubiquitin cycle; GO:0006512; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 cytoplasm; GO:0005737 faf fat facets "CG1945, CG1945, CG1945, BcDNA.LD22582, BcDNA:LD22582, fat facets" CDMC35354 2 25 18 DAC30-B13 3-CG1970-RA_3 CG1970 ATGATGGAATTCTATGAGCGAGTTTCTGGTGCCCGAATGCATGCTGCCTACATACGTCCTGGCGG 65 FBan0001970 FBgn0039909 CG1970 4 4 "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG1970 CG1970 CDMC35354 2 26 18 DAC30-B13 3-CG1970-RA_3 CG1970 ATGATGGAATTCTATGAGCGAGTTTCTGGTGCCCGAATGCATGCTGCCTACATACGTCCTGGCGG 65 FBan0001970 FBgn0039909 CG1970 4 4 "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG1970 CG1970 CDMC35355 2 1 19 DAC30-F01 17-CG2121-RA_3 CG2121 CCGCACTATGTGCCGTGGTCAACCTCTGTCTGCTCACCTACATGTACACCTGGGAAGCGCGAGAG 65 FBan0002121 FBgn0033289 CG2121 2 2R muscle contraction; GO:0006936 CG2121 CG2121 CG8698 CDMC35355 2 2 19 DAC30-F01 17-CG2121-RA_3 CG2121 CCGCACTATGTGCCGTGGTCAACCTCTGTCTGCTCACCTACATGTACACCTGGGAAGCGCGAGAG 65 FBan0002121 FBgn0033289 CG2121 2 2R muscle contraction; GO:0006936 CG2121 CG2121 CG8698 CDMC35356 2 3 19 DAC30-F13 16-CG2179-RA_1 CG2179 GGCATCGGCATAAGAGGGAGTCGTTCCGGATATGACACGTATTACAACACGAAGCACGATCGCTA 65 FBgn0037362 CDMC35356 2 4 19 DAC30-F13 16-CG2179-RA_1 CG2179 GGCATCGGCATAAGAGGGAGTCGTTCCGGATATGACACGTATTACAACACGAAGCACGATCGCTA 65 FBgn0037362 CDMC35357 2 5 19 DAC30-J01 18-CG2304-RC_2 CG2304 CTCGTGGTGTTGTCAGTGTCTCTGCTCTACCACCTCTGGTCGCAGCAATCCATCTCCACCTGGCT 65 FBan0002304 FBgn0039668 Trc8 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Trc8 Trc8 "CG2304, CG2304, CG2304, Dtrc8, TRC8" CDMC35357 2 6 19 DAC30-J01 18-CG2304-RC_2 CG2304 CTCGTGGTGTTGTCAGTGTCTCTGCTCTACCACCTCTGGTCGCAGCAATCCATCTCCACCTGGCT 65 FBan0002304 FBgn0039668 Trc8 3 3R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 Trc8 Trc8 "CG2304, CG2304, CG2304, Dtrc8, TRC8" CDMC35358 2 7 19 DAC30-J13 2-CG2507-RB_1 CG2507 GATACGGGCTACGAGATTGGGCTGTACTACATCCCATTGGCTGGACATGGAGCTGAATTGCGTGC 65 FBan0002507 FBgn0002306 sas 3 3R larval development (sensu Insecta); GO:0002168 receptor activity; GO:0004872; ; GO:0004872 apical plasma membrane; GO:0016324; integral to plasma membrane; GO:0005887 sas stranded at second "CG2507, l(3)84Cd, rfd, Sas" CDMC35358 2 8 19 DAC30-J13 2-CG2507-RB_1 CG2507 GATACGGGCTACGAGATTGGGCTGTACTACATCCCATTGGCTGGACATGGAGCTGAATTGCGTGC 65 FBan0002507 FBgn0002306 sas 3 3R larval development (sensu Insecta); GO:0002168 receptor activity; GO:0004872; ; GO:0004872 apical plasma membrane; GO:0016324; integral to plasma membrane; GO:0005887 sas stranded at second "CG2507, l(3)84Cd, rfd, Sas" CDMC35359 2 9 19 DAC30-N01 8-CG2854-RA_3 CG2854 AGGGAACTCTTTAAGGATGCCAAAAGGGAGCACTCTTTGGAAATATGGATGCGTCAGGCCCTGGC 65 FBan0002854 FBgn0040391 CG2854 X X CG2854 CG2854 EG:BACH48C10.2 CDMC35359 2 10 19 DAC30-N01 8-CG2854-RA_3 CG2854 AGGGAACTCTTTAAGGATGCCAAAAGGGAGCACTCTTTGGAAATATGGATGCGTCAGGCCCTGGC 65 FBan0002854 FBgn0040391 CG2854 X X CG2854 CG2854 EG:BACH48C10.2 CDMC35360 2 11 19 DAC30-N13 2-CG2898-RA_2 CG2898 CCGGGTTAGCAAGTTCCAGATCCTGACCACCCTCTTTCTACTGGCCTATCATGAGAGCAGACCGC 65 FBan0002898 FBgn0030195 CG2898 X X CG2898 CG2898 CDMC35360 2 12 19 DAC30-N13 2-CG2898-RA_2 CG2898 CCGGGTTAGCAAGTTCCAGATCCTGACCACCCTCTTTCTACTGGCCTATCATGAGAGCAGACCGC 65 FBan0002898 FBgn0030195 CG2898 X X CG2898 CG2898 CDMC35361 2 13 19 DAC31-B01 9-CG31691-RA_1 CG31691 GGAGTTGGTGTGGTGTTCGCGCTACTTCTTCCTTTCGCTGTGTCAATTGTGGAAGGAATCGCCAAGGC 68 FBan0031691 FBgn0044811 TotF 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 TotF Turandot F "CG31691, CG13963, tot" CDMC35361 2 14 19 DAC31-B01 9-CG31691-RA_1 CG31691 GGAGTTGGTGTGGTGTTCGCGCTACTTCTTCCTTTCGCTGTGTCAATTGTGGAAGGAATCGCCAAGGC 68 FBan0031691 FBgn0044811 TotF 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 TotF Turandot F "CG31691, CG13963, tot" CDMC35362 2 15 19 DAC31-B13 3-CG31753-RA_3 CG31753 GCATTCGAAGGCGAAGAGGACGAGAGCCGGAGTTCCCTGGACATTAAGGGTAAATTGGAGGACACCAG 68 FBgn0051753 CDMC35362 2 16 19 DAC31-B13 3-CG31753-RA_3 CG31753 GCATTCGAAGGCGAAGAGGACGAGAGCCGGAGTTCCCTGGACATTAAGGGTAAATTGGAGGACACCAG 68 FBgn0051753 CDMC35363 2 17 19 DAC31-F01 1-CG32114-RA_1 CG32114 GCAAAGTCGTTTCGAAGCCAAAAGCGGTTGTTACCTCTTCGTTGCTCGTTTCGACGTCTTGCAGCACG 68 FBan0032114 FBgn0052114 CG32114 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32114 CG32114 CDMC35363 2 18 19 DAC31-F01 1-CG32114-RA_1 CG32114 GCAAAGTCGTTTCGAAGCCAAAAGCGGTTGTTACCTCTTCGTTGCTCGTTTCGACGTCTTGCAGCACG 68 FBan0032114 FBgn0052114 CG32114 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32114 CG32114 CDMC35364 2 19 19 DAC31-F13 2-CG32298-RA_1 CG32298 GCCGGACTCTGATCGAACTGCACCTGATACCACTGAACCCCTAACCTCTGGTGATATTCCAACCCCAG 68 FBan0032298 FBgn0052298 CG32298 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32298 CG32298 NEST:bs10a03 CDMC35364 2 20 19 DAC31-F13 2-CG32298-RA_1 CG32298 GCCGGACTCTGATCGAACTGCACCTGATACCACTGAACCCCTAACCTCTGGTGATATTCCAACCCCAG 68 FBan0032298 FBgn0052298 CG32298 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32298 CG32298 NEST:bs10a03 CDMC35365 2 21 19 DAC31-J01 13-CG32614-RA_1 CG32614 AGGAAAAACAATTTGACGATCGCCTAGACTGCCACAAAACTGAACTGAACAGCAAGACTTTGGCCCGG 68 FBan0032614 FBgn0052614 CG32614 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32614 CG32614 CDMC35365 2 22 19 DAC31-J01 13-CG32614-RA_1 CG32614 AGGAAAAACAATTTGACGATCGCCTAGACTGCCACAAAACTGAACTGAACAGCAAGACTTTGGCCCGG 68 FBan0032614 FBgn0052614 CG32614 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32614 CG32614 CDMC35366 2 23 19 DAC31-J13 3-CG32986-RA_3 CG32986 GCCATGACTGTGATATGCTATTTCGCTGGCGCATGGATACCCAAGATCATCCTCCCCGGAGAGAGGAC 68 FBan0032986 FBgn0052986 CG32986 2 2L CG32986 CG32986 CG15866 CDMC35366 2 24 19 DAC31-J13 3-CG32986-RA_3 CG32986 GCCATGACTGTGATATGCTATTTCGCTGGCGCATGGATACCCAAGATCATCCTCCCCGGAGAGAGGAC 68 FBan0032986 FBgn0052986 CG32986 2 2L CG32986 CG32986 CG15866 CDMC35367 2 25 19 DAC31-N01 1-CG3363-RA_1 CG3363 CCGAGTGGAAGTTCCATCCCTTGGAGCAGTTCAATAAACAGGTGCCATCTAGGAGTCAGCAGTCCCCT 68 FBan0003363 FBgn0034987 CG3363 2 2R CG3363 CG3363 CDMC35367 2 26 19 DAC31-N01 1-CG3363-RA_1 CG3363 CCGAGTGGAAGTTCCATCCCTTGGAGCAGTTCAATAAACAGGTGCCATCTAGGAGTCAGCAGTCCCCT 68 FBan0003363 FBgn0034987 CG3363 2 2R CG3363 CG3363 CDMC35368 2 1 20 DAC31-N13 9-CG3494-RA_1 CG3494 TCGCAGTACTCGAAGTTGACTAACCTGAGCCTCTCCAACAATCTTCTGTGCGACTTGCCCATGGAGTT 68 FBan0003494 FBgn0035008 CG3494 2 2R receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG3494 CG3494 CT11751 CDMC35368 2 2 20 DAC31-N13 9-CG3494-RA_1 CG3494 TCGCAGTACTCGAAGTTGACTAACCTGAGCCTCTCCAACAATCTTCTGTGCGACTTGCCCATGGAGTT 68 FBan0003494 FBgn0035008 CG3494 2 2R receptor binding; GO:0005102; structural molecule activity; GO:0005198; ; GO:0005102; ; GO:0005198 CG3494 CG3494 CT11751 CDMC35369 2 3 20 DAC32-B01 23-CG15736-RA_3 CG15736 TCGGAGTCTGATGAATAGACGGTCATGCAGATGTTTATCTACACCGAAATTGAGTGGATGATCTCCATT 69 FBan0015736 FBgn0043001 Chrac-16 X X DNA binding; GO:0003677; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003677 chromatin accessibility complex; GO:0008623 Chrac-16 Chrac-16 "CG15736, joey, CHRAC-16, CHRAC16, CHRAC, BcDNA:RE59557" CDMC35369 2 4 20 DAC32-B01 23-CG15736-RA_3 CG15736 TCGGAGTCTGATGAATAGACGGTCATGCAGATGTTTATCTACACCGAAATTGAGTGGATGATCTCCATT 69 FBan0015736 FBgn0043001 Chrac-16 X X DNA binding; GO:0003677; protein heterodimerization activity; GO:0046982; ; GO:0046982; ; GO:0003677 chromatin accessibility complex; GO:0008623 Chrac-16 Chrac-16 "CG15736, joey, CHRAC-16, CHRAC16, CHRAC, BcDNA:RE59557" CDMC35370 2 5 20 DAC32-B13 11-CG15745-RA_1 CG15745 AATGAGGGCAGGTCTGAATGGCAGCGAAAGAGATAAGCAAGTTGGTGCATATACACAGGGAGAAACGGG 69 FBan0015745 FBgn0030469 CG15745 X X CG15745 CG15745 CDMC35370 2 6 20 DAC32-B13 11-CG15745-RA_1 CG15745 AATGAGGGCAGGTCTGAATGGCAGCGAAAGAGATAAGCAAGTTGGTGCATATACACAGGGAGAAACGGG 69 FBan0015745 FBgn0030469 CG15745 X X CG15745 CG15745 CDMC35371 2 7 20 DAC32-F01 18-CG15822-RC_3 CG15822 GGGATTTCTCTGAGAGATCTGGACAAGCTGTCCCAGTTGAAAGATGAACACAAAACGATTTCCCGCCCA 69 FBan0015822 FBgn0035308 CG15822 3 3L CG15822 CG15822 CDMC35371 2 8 20 DAC32-F01 18-CG15822-RC_3 CG15822 GGGATTTCTCTGAGAGATCTGGACAAGCTGTCCCAGTTGAAAGATGAACACAAAACGATTTCCCGCCCA 69 FBan0015822 FBgn0035308 CG15822 3 3L CG15822 CG15822 CDMC35372 2 9 20 DAC32-F13 11-CG1583-RA_1 CG1583 ATCGATGGCATGTCCAATCGCTATGATCTCTTCAACTATCGACCGTACACGCTGTCACACTGCAGCTGT 69 FBan0001583 FBgn0030013 CG1583 X X lipid catabolism; GO:0016042; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 CG1583 CG1583 BEST:HL07869 CDMC35372 2 10 20 DAC32-F13 11-CG1583-RA_1 CG1583 ATCGATGGCATGTCCAATCGCTATGATCTCTTCAACTATCGACCGTACACGCTGTCACACTGCAGCTGT 69 FBan0001583 FBgn0030013 CG1583 X X lipid catabolism; GO:0016042; lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 extracellular region; GO:0005576 CG1583 CG1583 BEST:HL07869 CDMC35373 2 11 20 DAC32-J01 18-CG15893-RA_1 CG15893 CCCCCCGGGAAAAAGGAAAGTGAGTTGGCGTACAGAGTTGTTGGTGCAAATTAGATTGGGCATAATCTA 69 FBan0015893 FBgn0029865 CG15893 X X CG15893 CG15893 BEST:LD05774 CDMC35373 2 12 20 DAC32-J01 18-CG15893-RA_1 CG15893 CCCCCCGGGAAAAAGGAAAGTGAGTTGGCGTACAGAGTTGTTGGTGCAAATTAGATTGGGCATAATCTA 69 FBan0015893 FBgn0029865 CG15893 X X CG15893 CG15893 BEST:LD05774 CDMC35374 2 13 20 DAC32-J13 1-CG15909-RA_1 CG15909 GCGCGCCCACCTATCTGAATTGGGACATGAAAAACGGTCGACTGGATCATTACTCAAGCGTGGACAAGG 69 FBan0015909 FBgn0033090 CG15909 2 2R CG15909 CG15909 CDMC35374 2 14 20 DAC32-J13 1-CG15909-RA_1 CG15909 GCGCGCCCACCTATCTGAATTGGGACATGAAAAACGGTCGACTGGATCATTACTCAAGCGTGGACAAGG 69 FBan0015909 FBgn0033090 CG15909 2 2R CG15909 CG15909 CDMC35375 2 15 20 DAC32-N01 23-CG1607-RA_11 CG1607 AACCATGCTCTAGGCTTGGCTTGATCTAGAAAGCTAGAAGAACGCTTGAACATACTCATCGGAAGGATC 69 FBan0001607 FBgn0039844 CG1607 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG1607 CG1607 CDMC35375 2 16 20 DAC32-N01 23-CG1607-RA_11 CG1607 AACCATGCTCTAGGCTTGGCTTGATCTAGAAAGCTAGAAGAACGCTTGAACATACTCATCGGAAGGATC 69 FBan0001607 FBgn0039844 CG1607 3 3R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 amino acid transporter activity; GO:0015171; ; GO:0015171; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG1607 CG1607 CDMC35376 2 17 20 DAC32-N13 23-CG1624-RB_15 CG1624 CCGATCATCCAGTCACGAATCATCATGGGCATAGCTGAAACCGAGTTTAACTGACATTCATCGACATAT 69 FBan0001624 FBgn0015930 dpld 2 2R larval development (sensu Insecta); GO:0002168; regulation of progression through cell cycle; GO:0000074; transcription from RNA polymerase II promoter; GO:0006366; transport; GO:0006810 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622 dpld dappled "CG1624, CG1624, CG1624, lin-41, l(2)k08815-3, dappled" CDMC35376 2 18 20 DAC32-N13 23-CG1624-RB_15 CG1624 CCGATCATCCAGTCACGAATCATCATGGGCATAGCTGAAACCGAGTTTAACTGACATTCATCGACATAT 69 FBan0001624 FBgn0015930 dpld 2 2R larval development (sensu Insecta); GO:0002168; regulation of progression through cell cycle; GO:0000074; transcription from RNA polymerase II promoter; GO:0006366; transport; GO:0006810 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622 dpld dappled "CG1624, CG1624, CG1624, lin-41, l(2)k08815-3, dappled" CDMC35377 2 19 20 DAC33-B01 3-CG11326-RE_1 CG11326 CGCCCGAAAATACTCGGTCGTTACGAACTAATCCGCGGAGGAAGGGACTATTGCAACGTTTTCGGCTGA 69 FBan0011326 FBgn0031850 Tsp 2 2L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 Tsp Thrombospondin "CG11326, CG11326, CG11326, CG11326, CG11326, CT31613, DTSP, D-TSP, SP295, tsp, thrombospondin, Thrombospondin" CDMC35377 2 20 20 DAC33-B01 3-CG11326-RE_1 CG11326 CGCCCGAAAATACTCGGTCGTTACGAACTAATCCGCGGAGGAAGGGACTATTGCAACGTTTTCGGCTGA 69 FBan0011326 FBgn0031850 Tsp 2 2L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 extracellular matrix (sensu Metazoa); GO:0005578 Tsp Thrombospondin "CG11326, CG11326, CG11326, CG11326, CG11326, CT31613, DTSP, D-TSP, SP295, tsp, thrombospondin, Thrombospondin" CDMC35378 2 21 20 DAC33-B13 7-CG11334-RA_1 CG11334 GCGAAAGTGCACACATTAATCGGTAACCCTTTCCAGTTTCAGCACAATCCCCTGGAGAGATGAGCCTGC 69 FBan0011334 FBgn0039849 CG11334 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 GTP binding; GO:0005525; translation regulator activity; GO:0045182; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0045182; ; GO:0005525 eukaryotic translation initiation factor 2B complex; GO:0005851 CG11334 CG11334 CDMC35378 2 22 20 DAC33-B13 7-CG11334-RA_1 CG11334 GCGAAAGTGCACACATTAATCGGTAACCCTTTCCAGTTTCAGCACAATCCCCTGGAGAGATGAGCCTGC 69 FBan0011334 FBgn0039849 CG11334 3 3R protein biosynthesis; GO:0006412; translational initiation; GO:0006413 GTP binding; GO:0005525; translation regulator activity; GO:0045182; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0045182; ; GO:0005525 eukaryotic translation initiation factor 2B complex; GO:0005851 CG11334 CG11334 CDMC35379 2 23 20 DAC33-F01 23-CG11370-RA_1 CG11370 CCCGAATCAAATCAGTCTAAAACGATTCTCCTGTAATTATTAGCAAATTTGTCAATCTTTGAGCGCAAT 69 FBan0011370 FBgn0037181 CG11370 3 3L CG11370 CG11370 CDMC35379 2 24 20 DAC33-F01 23-CG11370-RA_1 CG11370 CCCGAATCAAATCAGTCTAAAACGATTCTCCTGTAATTATTAGCAAATTTGTCAATCTTTGAGCGCAAT 69 FBan0011370 FBgn0037181 CG11370 3 3L CG11370 CG11370 CDMC35380 2 25 20 DAC33-F13 7-CG11377-RA_4 CG11377 GCGTTCGTACAAGAACAGCGAGGTACGGCTAGTGGAGATCCAGGAGAAGCTATGTTCGGAAGGAGAAGT 69 FBan0011377 FBgn0031217 CG11377 2 2L structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 CG11377 CG11377 CT31762 CDMC35380 2 26 20 DAC33-F13 7-CG11377-RA_4 CG11377 GCGTTCGTACAAGAACAGCGAGGTACGGCTAGTGGAGATCCAGGAGAAGCTATGTTCGGAAGGAGAAGT 69 FBan0011377 FBgn0031217 CG11377 2 2L structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; ; GO:0005198; ; GO:0005509 CG11377 CG11377 CT31762 CDMC35381 2 1 21 DAC33-J01 15-CG11412-RC_2 CG11412 GCCGGAACCTGCCATTTCAGCCGACGAGATCGTATATAAGGAATACGAGGCTGAACACCAAATGCATGT 69 FBan0011412 FBgn0024362 CG11412 X X protein amino acid acetylation; GO:0006473 N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG11412 CG11412 "EG:8D8.6, DmAAF45606" CDMC35381 2 2 21 DAC33-J01 15-CG11412-RC_2 CG11412 GCCGGAACCTGCCATTTCAGCCGACGAGATCGTATATAAGGAATACGAGGCTGAACACCAAATGCATGT 69 FBan0011412 FBgn0024362 CG11412 X X protein amino acid acetylation; GO:0006473 N-acetyltransferase activity; GO:0008080 ; EC:2.3.1.-; ; GO:0008080 ; EC:2.3.1.- CG11412 CG11412 "EG:8D8.6, DmAAF45606" CDMC35382 2 3 21 DAC33-J13 2-CG11420-RA_1 CG11420 ACGCCGGCATGACTGTGACCCTCTACAAGCATTACTTCAGCTACAGCTACTAACGGAAGCCAATGGTCA 69 FBan0011420 FBgn0000826 png X X egg activation; GO:0007343; mitotic cell cycle; GO:0000278; protein amino acid phosphorylation; GO:0006468; regulation of progression through mitotic cell cycle; GO:0007346 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112 png pan gu "CG11420, CG11420, CG11420, fs(1)M2, EG:8D8.5, PNG, Png, pan-gnu" CDMC35382 2 4 21 DAC33-J13 2-CG11420-RA_1 CG11420 ACGCCGGCATGACTGTGACCCTCTACAAGCATTACTTCAGCTACAGCTACTAACGGAAGCCAATGGTCA 69 FBan0011420 FBgn0000826 png X X egg activation; GO:0007343; mitotic cell cycle; GO:0000278; protein amino acid phosphorylation; GO:0006468; regulation of progression through mitotic cell cycle; GO:0007346 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004713 ; EC:2.7.1.112 png pan gu "CG11420, CG11420, CG11420, fs(1)M2, EG:8D8.5, PNG, Png, pan-gnu" CDMC35383 2 5 21 DAC33-N01 41-CG11466-RA_1 CG11466 CGCTCCCGATTGTTTGTGGCGTAGTTAGTTATATTCTGGACGCTTAGATCGCCAAGCTAGGGTCAACAT 69 FBan0011466 FBgn0038037 Cyp9f2 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9f2 Cyp9f2 "CG11466, 9f2, anon-EST:Posey150" CDMC35383 2 6 21 DAC33-N01 41-CG11466-RA_1 CG11466 CGCTCCCGATTGTTTGTGGCGTAGTTAGTTATATTCTGGACGCTTAGATCGCCAAGCTAGGGTCAACAT 69 FBan0011466 FBgn0038037 Cyp9f2 3 3R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9f2 Cyp9f2 "CG11466, 9f2, anon-EST:Posey150" CDMC35384 2 7 21 DAC33-N13 3-CG11486-RG_2 CG11486 GCAACGCGACAATGTCCAGTCCAGCATCGATATGGTCACGCGAAACTACTCCACCGATCTGCGAAACTT 69 FBan0011486 FBgn0035397 CG11486 3 3L "RNA elongation from RNA polymerase II promoter; GO:0006368; histone mRNA 3'-end processing; GO:0006398; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein amino acid phosphorylation; GO:0006468; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; protein kinase activity; GO:0004672 ; EC:2.7.1.37; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 CG11486 CG11486 polyA-nuclease related CDMC35384 2 8 21 DAC33-N13 3-CG11486-RG_2 CG11486 GCAACGCGACAATGTCCAGTCCAGCATCGATATGGTCACGCGAAACTACTCCACCGATCTGCGAAACTT 69 FBan0011486 FBgn0035397 CG11486 3 3L "RNA elongation from RNA polymerase II promoter; GO:0006368; histone mRNA 3'-end processing; GO:0006398; mRNA processing; GO:0006397; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein amino acid phosphorylation; GO:0006468; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; protein kinase activity; GO:0004672 ; EC:2.7.1.37; nuclease activity; GO:0004518 ; EC:3.1.-.-; exoribonuclease activity; GO:0004532; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004518 ; EC:3.1.-.-; ; GO:0004532 CG11486 CG11486 polyA-nuclease related CDMC35385 2 9 21 DAC34-B01 22-CG14441-RA_1 CG14441 TCACACGTGAAATACTCGAGCTGATTAAGGAGGATAGCAACATTCAGTACTGGAAGGTATCGGCCCG 67 FBan0014441 FBgn0029895 CG14441 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14441 CG14441 CDMC35385 2 10 21 DAC34-B01 22-CG14441-RA_1 CG14441 TCACACGTGAAATACTCGAGCTGATTAAGGAGGATAGCAACATTCAGTACTGGAAGGTATCGGCCCG 67 FBan0014441 FBgn0029895 CG14441 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG14441 CG14441 CDMC35386 2 11 21 DAC34-B13 3-CG14584-RA_3 CG14584 CTTGCCGATGGACTCCAGAGCTGCAATTCAACTAGAGATCCTAGCCAATAGCCTAAGCCACCTGCGG 67 FBan0014584 FBgn0031181 CG14584 X X CG14584 CG14584 CDMC35386 2 12 21 DAC34-B13 3-CG14584-RA_3 CG14584 CTTGCCGATGGACTCCAGAGCTGCAATTCAACTAGAGATCCTAGCCAATAGCCTAAGCCACCTGCGG 67 FBan0014584 FBgn0031181 CG14584 X X CG14584 CG14584 CDMC35387 2 13 21 DAC34-F01 2-CG1490-RB_1 CG1490 GCCGAACAATCCTGACCAGAGTATCAGCTTTCGCATCGAGTCCAGTACCTCGAACTCCCGTTGACGC 67 FBan0001490 FBgn0030366 CG1490 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG1490 CG1490 CDMC35387 2 14 21 DAC34-F01 2-CG1490-RB_1 CG1490 GCCGAACAATCCTGACCAGAGTATCAGCTTTCGCATCGAGTCCAGTACCTCGAACTCCCGTTGACGC 67 FBan0001490 FBgn0030366 CG1490 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG1490 CG1490 CDMC35388 2 15 21 DAC34-F13 3-CG1501-RA_6 CG1501 TGGCTATCGGAACTGGAGGAGGGTCACGAACAGGACAGCTATCCCTTTACGAATGCCATCACCGAAG 67 FBgn0031160 CDMC35388 2 16 21 DAC34-F13 3-CG1501-RA_6 CG1501 TGGCTATCGGAACTGGAGGAGGGTCACGAACAGGACAGCTATCCCTTTACGAATGCCATCACCGAAG 67 FBgn0031160 CDMC35389 2 17 21 DAC34-J01 2-CG15534-RA_1 CG15534 GGATGAGTACAATCTCACCTTGTCCATCCAGGGAGACTTGCCCCAGGAATCGAACTCCAACTTGCCC 67 FBan0015534 FBgn0039769 CG15534 3 3R sphingomyelin catabolism; GO:0006685; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG15534 CG15534 aSMase CDMC35389 2 18 21 DAC34-J01 2-CG15534-RA_1 CG15534 GGATGAGTACAATCTCACCTTGTCCATCCAGGGAGACTTGCCCCAGGAATCGAACTCCAACTTGCCC 67 FBan0015534 FBgn0039769 CG15534 3 3R sphingomyelin catabolism; GO:0006685; sphingomyelin metabolism; GO:0006684 sphingomyelin phosphodiesterase activity; GO:0004767 ; EC:3.1.4.12; ; GO:0004767 ; EC:3.1.4.12 CG15534 CG15534 aSMase CDMC35390 2 19 21 DAC34-J13 12-CG15627-RA_4 CG15627 AGTCATTGACTTCACCGTTCCGTACTACGATCTGGTCGGGATTACGATCATGATGCAGCGACCCAGT 67 FBan0015627 FBgn0031634 CG15627 2 2L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 glutamate-gated ion channel activity; GO:0005234; glutamate receptor activity; GO:0008066; potassium channel activity; GO:0005267; ionotropic glutamate receptor activity; GO:0004970; ; GO:0008066; ; GO:0005234; ; GO:0005267; ; GO:0004970 membrane; GO:0016020 CG15627 CG15627 CT35778 CDMC35390 2 20 21 DAC34-J13 12-CG15627-RA_4 CG15627 AGTCATTGACTTCACCGTTCCGTACTACGATCTGGTCGGGATTACGATCATGATGCAGCGACCCAGT 67 FBan0015627 FBgn0031634 CG15627 2 2L cation transport; GO:0006812; nerve-nerve synaptic transmission; GO:0007270; potassium ion transport; GO:0006813 glutamate-gated ion channel activity; GO:0005234; glutamate receptor activity; GO:0008066; potassium channel activity; GO:0005267; ionotropic glutamate receptor activity; GO:0004970; ; GO:0008066; ; GO:0005234; ; GO:0005267; ; GO:0004970 membrane; GO:0016020 CG15627 CG15627 CT35778 CDMC35391 2 21 21 DAC34-N01 3-CG16708-RA_1 CG16708 CCTGGACCTGATTCTCGTGAAAAAGACCTCACTGCTCAACAACGTGCGTTTTCTGCTCAACACGGCG 67 FBan0016708 FBgn0037315 CG16708 3 3R autophagic cell death; GO:0048102; protein kinase C activation; GO:0007205; salivary gland cell autophagic cell death; GO:0035071 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0004143 ; EC:2.7.1.107 CG16708 CG16708 CDMC35391 2 22 21 DAC34-N01 3-CG16708-RA_1 CG16708 CCTGGACCTGATTCTCGTGAAAAAGACCTCACTGCTCAACAACGTGCGTTTTCTGCTCAACACGGCG 67 FBan0016708 FBgn0037315 CG16708 3 3R autophagic cell death; GO:0048102; protein kinase C activation; GO:0007205; salivary gland cell autophagic cell death; GO:0035071 diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; D-erythro-sphingosine kinase activity; GO:0017050; ; GO:0017050; ; GO:0004143 ; EC:2.7.1.107 CG16708 CG16708 CDMC35392 2 23 21 DAC34-N13 3-CG16899-RA_1 CG16899 GGCACGGGTTCAAATGCAAGTTGTCTCCCAGCTGGAATCCCACCTGCAAAAAGAACGAGATCGCTTG 67 FBan0016899 FBgn0037735 CG16899 3 3R "cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG16899 CG16899 Dmcg16899 CDMC35392 2 24 21 DAC34-N13 3-CG16899-RA_1 CG16899 GGCACGGGTTCAAATGCAAGTTGTCTCCCAGCTGGAATCCCACCTGCAAAAAGAACGAGATCGCTTG 67 FBan0016899 FBgn0037735 CG16899 3 3R "cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG16899 CG16899 Dmcg16899 CDMC35393 2 25 21 DAC35-B01 23-CG11752-RA_1 CG11752 GCCCTCAAGTAGATGTAGCCCAATTGTTGATGTTAAATAAAATAAATGCCATTTAAAGAGGACAGTTGA 69 FBan0011752 FBgn0030292 CG11752 X X CG11752 CG11752 "BcDNA:RH44935, anon-EST:Posey214" CDMC35393 2 26 21 DAC35-B01 23-CG11752-RA_1 CG11752 GCCCTCAAGTAGATGTAGCCCAATTGTTGATGTTAAATAAAATAAATGCCATTTAAAGAGGACAGTTGA 69 FBan0011752 FBgn0030292 CG11752 X X CG11752 CG11752 "BcDNA:RH44935, anon-EST:Posey214" CDMC35394 2 1 22 DAC35-B13 9-CG11760-RA_1 CG11760 AGCCTATTGGCAACTCGAAACGCCCTTTAAATCACGCTCAATTATCCCCGCCTGATAGGATCCGAGGAT 69 FBan0011760 FBgn0037615 CG11760 3 3R CG11760 CG11760 BcDNA:LD16427 CDMC35394 2 2 22 DAC35-B13 9-CG11760-RA_1 CG11760 AGCCTATTGGCAACTCGAAACGCCCTTTAAATCACGCTCAATTATCCCCGCCTGATAGGATCCGAGGAT 69 FBan0011760 FBgn0037615 CG11760 3 3R CG11760 CG11760 BcDNA:LD16427 CDMC35395 2 3 22 DAC35-F01 23-CG11797-RA_1 CG11797 GGCCTAAAGAAGTTAGGGATTTAATGCTTGGCAAATTGTGATTCGGGAAAAAATGTAACAAAATTTAAA 69 FBan0011797 FBgn0034468 Obp56a 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56a Odorant-binding protein 56a "CG11797, CG11797, CG11797, 56a, BcDNA:RE46170, Odorant-binding protein 56a" CDMC35395 2 4 22 DAC35-F01 23-CG11797-RA_1 CG11797 GGCCTAAAGAAGTTAGGGATTTAATGCTTGGCAAATTGTGATTCGGGAAAAAATGTAACAAAATTTAAA 69 FBan0011797 FBgn0034468 Obp56a 2 2R olfactory behavior; GO:0042048; response to pheromone; GO:0019236; sensory perception of chemical stimulus; GO:0007606; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 extracellular region; GO:0005576 Obp56a Odorant-binding protein 56a "CG11797, CG11797, CG11797, 56a, BcDNA:RE46170, Odorant-binding protein 56a" CDMC35396 2 5 22 DAC35-F13 2-CG11814-RA_2 CG11814 ACGCCGTTTTTCTGGACTCCGAGATCAGCGATCCCATCGAAAGGGAAGCAGTCAAGACAATGGTGAAGA 69 FBan0011814 FBgn0035296 CG11814 3 3L defense response; GO:0006952; lysosomal transport; GO:0007041; protein targeting; GO:0006605 CG11814 CG11814 CDMC35396 2 6 22 DAC35-F13 2-CG11814-RA_2 CG11814 ACGCCGTTTTTCTGGACTCCGAGATCAGCGATCCCATCGAAAGGGAAGCAGTCAAGACAATGGTGAAGA 69 FBan0011814 FBgn0035296 CG11814 3 3L defense response; GO:0006952; lysosomal transport; GO:0007041; protein targeting; GO:0006605 CG11814 CG11814 CDMC35397 2 7 22 DAC35-J01 1-CG11858-RA_1 CG11858 TGCCCATCTCCACTGTCAACAATCCCGTGTACACAGATCCCCCGATTAAGACCAAGTTTGGCTACCACA 69 FBan0011858 FBgn0039305 CG11858 3 3R peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG11858 CG11858 BcDNA:RH66629 CDMC35397 2 8 22 DAC35-J01 1-CG11858-RA_1 CG11858 TGCCCATCTCCACTGTCAACAATCCCGTGTACACAGATCCCCCGATTAAGACCAAGTTTGGCTACCACA 69 FBan0011858 FBgn0039305 CG11858 3 3R peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG11858 CG11858 BcDNA:RH66629 CDMC35398 2 9 22 DAC35-J13 36-CG11873-RA_7 CG11873 AGCAAGTCACAGCCACAGCAGACTACTACAGTAAAGCAAGAGGAGAGCAACGAATCTGGGGAACCTTCT 69 FBan0011873 FBgn0039633 CG11873 3 3R CG11873 CG11873 anon-WO0140519.162 CDMC35398 2 10 22 DAC35-J13 36-CG11873-RA_7 CG11873 AGCAAGTCACAGCCACAGCAGACTACTACAGTAAAGCAAGAGGAGAGCAACGAATCTGGGGAACCTTCT 69 FBan0011873 FBgn0039633 CG11873 3 3R CG11873 CG11873 anon-WO0140519.162 CDMC35399 2 11 22 DAC35-N01 11-CG11905-RE_2 CG11905 CCATTTCCAAGGCGTATCTGAAGAAGGGTGTACCCACCAACGTTTACTTCAATCCGGAATCTGTGGCCA 69 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC35399 2 12 22 DAC35-N01 11-CG11905-RE_2 CG11905 CCATTTCCAAGGCGTATCTGAAGAAGGGTGTACCCACCAACGTTTACTTCAATCCGGAATCTGTGGCCA 69 FBan0011905 FBgn0036678 CG11905 3 3L CG11905 CG11905 CDMC35400 2 13 22 DAC35-N13 3-CG11912-RA_2 CG11912 GGCGCCCTATATTGTGTCCTTACAGACCACATCCAACTCGCACTTCTGTGCAGGAAGCTTGCTCGATGA 69 FBan0011912 FBgn0031248 CG11912 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11912 CG11912 "SP140, anon-WO0140519.112" CDMC35400 2 14 22 DAC35-N13 3-CG11912-RA_2 CG11912 GGCGCCCTATATTGTGTCCTTACAGACCACATCCAACTCGCACTTCTGTGCAGGAAGCTTGCTCGATGA 69 FBan0011912 FBgn0031248 CG11912 2 2L proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG11912 CG11912 "SP140, anon-WO0140519.112" CDMC35401 2 15 22 DAC36-B01 2-CG8606-RA_3 CG8606 ACGGGTAATCAAGGAGGGTGTACTGCAGAAGATCACTCACAAGGGCACGGAAATCAAGCGCTACTGTGT 69 FBan0008606 FBgn0035761 RhoGEF4 3 3L regulation of cell shape; GO:0008360 Rho guanyl-nucleotide exchange factor activity; GO:0005089; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005089 RhoGEF4 RhoGEF4 CG8606 CDMC35401 2 16 22 DAC36-B01 2-CG8606-RA_3 CG8606 ACGGGTAATCAAGGAGGGTGTACTGCAGAAGATCACTCACAAGGGCACGGAAATCAAGCGCTACTGTGT 69 FBan0008606 FBgn0035761 RhoGEF4 3 3L regulation of cell shape; GO:0008360 Rho guanyl-nucleotide exchange factor activity; GO:0005089; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005089 RhoGEF4 RhoGEF4 CG8606 CDMC35402 2 17 22 DAC36-B13 15-CG8617-RA_1 CG8617 AGTTCGCCCGATTTGAGCATCATGAGCGCATGGAAACCATCGTGGATAGTTTCGATGCAGCAATGAGCT 69 FBan0008617 FBgn0033925 CG8617 2 2R CG8617 CG8617 CDMC35402 2 18 22 DAC36-B13 15-CG8617-RA_1 CG8617 AGTTCGCCCGATTTGAGCATCATGAGCGCATGGAAACCATCGTGGATAGTTTCGATGCAGCAATGAGCT 69 FBan0008617 FBgn0033925 CG8617 2 2R CG8617 CG8617 CDMC35403 2 19 22 DAC36-F01 12-CG8648-RA_1 CG8648 TGCCCTCACATTCGGATCTACAAAACTGTTGAGATACCTTACCTACAGCGAGGCACGAAAGATGCCCGT 69 FBan0008648 FBgn0025832 Fen1 2 2R DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; ; GO:0003676; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004519; ; GO:0048256; ; GO:0003677 nucleus; GO:0005634 Fen1 Flap endonuclease 1 "CG8648, CG8648, FEN1, EG:EG0003.3, DmFEN-1, Flap endonuclease 1" CDMC35403 2 20 22 DAC36-F01 12-CG8648-RA_1 CG8648 TGCCCTCACATTCGGATCTACAAAACTGTTGAGATACCTTACCTACAGCGAGGCACGAAAGATGCCCGT 69 FBan0008648 FBgn0025832 Fen1 2 2R DNA repair; GO:0006281; DNA replication; GO:0006260 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; ; GO:0003676; exodeoxyribonuclease activity; GO:0004529; ; GO:0004529; ; GO:0004519; ; GO:0048256; ; GO:0003677 nucleus; GO:0005634 Fen1 Flap endonuclease 1 "CG8648, CG8648, FEN1, EG:EG0003.3, DmFEN-1, Flap endonuclease 1" CDMC35404 2 21 22 DAC36-F13 18-CG8664-RA_2 CG8664 GGCCATGCTGAACAATGTCAAGCAAATGATCATCACCAGCAACAAGATCATCAACATGAAGTCCGAGCT 69 FBan0008664 FBgn0030836 CG8664 X X CG8664 CG8664 CDMC35404 2 22 22 DAC36-F13 18-CG8664-RA_2 CG8664 GGCCATGCTGAACAATGTCAAGCAAATGATCATCACCAGCAACAAGATCATCAACATGAAGTCCGAGCT 69 FBan0008664 FBgn0030836 CG8664 X X CG8664 CG8664 CDMC35405 2 23 22 DAC36-J01 16-CG8697-RA_1 CG8697 ACCACTCCACGGACTGTTCTCCCGAAACAAATCGCCCAAGTTGTTTAGCTGTACTTCTTGACTTTCAAA 69 FBan0008697 FBgn0002533 Lcp2 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp2 Larval cuticle protein 2 "CG8697, Gene II, LCP2, CP2, II, LCP-2, 2, cuticle p. II-, L[[3]]CP2" CDMC35405 2 24 22 DAC36-J01 16-CG8697-RA_1 CG8697 ACCACTCCACGGACTGTTCTCCCGAAACAAATCGCCCAAGTTGTTTAGCTGTACTTCTTGACTTTCAAA 69 FBan0008697 FBgn0002533 Lcp2 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp2 Larval cuticle protein 2 "CG8697, Gene II, LCP2, CP2, II, LCP-2, 2, cuticle p. II-, L[[3]]CP2" CDMC35406 2 25 22 DAC36-J13 9-CG8711-RA_1 CG8711 CCACAACTTGGACTTGTGCGTCAGCATTCTTACCATGGGCTACTGGCCTACATATGCACCTACAGAGGT 69 FBan0008711 FBgn0033260 cul-4 2 2R induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 nuclear ubiquitin ligase complex; GO:0000152 cul-4 cul-4 "CG8711, CG8711, DMcul-4, Cul4, CUL4" CDMC35406 2 26 22 DAC36-J13 9-CG8711-RA_1 CG8711 CCACAACTTGGACTTGTGCGTCAGCATTCTTACCATGGGCTACTGGCCTACATATGCACCTACAGAGGT 69 FBan0008711 FBgn0033260 cul-4 2 2R induction of apoptosis; GO:0006917; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 nuclear ubiquitin ligase complex; GO:0000152 cul-4 cul-4 "CG8711, CG8711, DMcul-4, Cul4, CUL4" CDMC35407 2 1 23 DAC36-N01 17-CG8742-RC_1 CG8742 GCAGGATGACCAGGATGAGCTAAATAGCCGGATGAGAGAGATGGAAAAGTTACTCAGGAACCGAGTCGA 69 CDMC35407 2 2 23 DAC36-N01 17-CG8742-RC_1 CG8742 GCAGGATGACCAGGATGAGCTAAATAGCCGGATGAGAGAGATGGAAAAGTTACTCAGGAACCGAGTCGA 69 CDMC35408 2 3 23 DAC36-N13 12-CG8759-RB_5 CG8759 AGCGACAGTCACACTCCCCTCCGCCATATTTCTTTTCTTCGTTTCCGATTAAAATGCCCGAACTGACCG 69 FBan0008759 FBgn0017565 Nacalpha 2 2R protein binding; GO:0005515; ; GO:0005515 nascent polypeptide-associated complex; GO:0005854 Nacalpha Nascent polypeptide associated complex protein alpha subunit "CG8759, NAC, alpha-NAC, NAC protein alpha subunit, alphaNAC, Nacalpha, Alpha NAC" CDMC35408 2 4 23 DAC36-N13 12-CG8759-RB_5 CG8759 AGCGACAGTCACACTCCCCTCCGCCATATTTCTTTTCTTCGTTTCCGATTAAAATGCCCGAACTGACCG 69 FBan0008759 FBgn0017565 Nacalpha 2 2R protein binding; GO:0005515; ; GO:0005515 nascent polypeptide-associated complex; GO:0005854 Nacalpha Nascent polypeptide associated complex protein alpha subunit "CG8759, NAC, alpha-NAC, NAC protein alpha subunit, alphaNAC, Nacalpha, Alpha NAC" CDMC35409 2 5 23 DAC37-B01 3-CG8991-RA_4 CG8991 TGCCTGTGATAGATTTTTACAAGGCACACCTAACTCCCGAGGAGAGGAAGCGTTTCGATGAGCAGCGGG 69 FBan0008991 FBgn0033654 CG8991 2 2R CG8991 CG8991 CDMC35409 2 6 23 DAC37-B01 3-CG8991-RA_4 CG8991 TGCCTGTGATAGATTTTTACAAGGCACACCTAACTCCCGAGGAGAGGAAGCGTTTCGATGAGCAGCGGG 69 FBan0008991 FBgn0033654 CG8991 2 2R CG8991 CG8991 CDMC35410 2 7 23 DAC37-B13 16-CG8998-RA_1 CG8998 TGGATTGGTCAGTTTCCCAGACTTTTTTGACATGGCTGATGATCCAGAAAACTCAGTGGATAGGCCCAC 69 FBgn0033641 CDMC35410 2 8 23 DAC37-B13 16-CG8998-RA_1 CG8998 TGGATTGGTCAGTTTCCCAGACTTTTTTGACATGGCTGATGATCCAGAAAACTCAGTGGATAGGCCCAC 69 FBgn0033641 CDMC35411 2 9 23 DAC37-F01 1-CG9031-RA_1 CG9031 CGCCACCCAAAGCTGACAAAAGCAAGAAGGCCTCTCGAATTCGCGCATAGTGATTCTCCACCAGAAGAT 69 FBan0009031 FBgn0028546 Rsu-1 2 2L MAPKKK cascade; GO:0000165; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 kinase regulator activity; GO:0019207; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0019207; ; GO:0004675 ; EC:2.7.1.-; small GTPase regulator activity; GO:0005083; ; GO:0005083 Rsu-1 Ras suppressor-1 "CG9031, BG:BACR48E02.4, CT25926, RSU-1, Ras suppressor-1" CDMC35411 2 10 23 DAC37-F01 1-CG9031-RA_1 CG9031 CGCCACCCAAAGCTGACAAAAGCAAGAAGGCCTCTCGAATTCGCGCATAGTGATTCTCCACCAGAAGAT 69 FBan0009031 FBgn0028546 Rsu-1 2 2L MAPKKK cascade; GO:0000165; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 kinase regulator activity; GO:0019207; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0019207; ; GO:0004675 ; EC:2.7.1.-; small GTPase regulator activity; GO:0005083; ; GO:0005083 Rsu-1 Ras suppressor-1 "CG9031, BG:BACR48E02.4, CT25926, RSU-1, Ras suppressor-1" CDMC35412 2 11 23 DAC37-F13 23-CG9042-RB_6 CG9042 TTCCACGTCAACTGCATTACTTTTTCCTCTAATTCTCGCAAGTGTTTTTCAATGTGTACAGTGCTTAAG 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC35412 2 12 23 DAC37-F13 23-CG9042-RB_6 CG9042 TTCCACGTCAACTGCATTACTTTTTCCTCTAATTCTCGCAAGTGTTTTTCAATGTGTACAGTGCTTAAG 69 FBan0009042 FBgn0001128 Gpdh 2 2L carbohydrate metabolism; GO:0005975; glycerol-3-phosphate metabolism; GO:0006072; glycerophosphate shuttle; GO:0006127; lipid metabolism; GO:0006629 glycerol-3-phosphate dehydrogenase (NAD+) activity; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8; ; GO:0004367 ; EC:1.1.1.8 cytoplasm; GO:0005737; glycerol-3-phosphate dehydrogenase complex; GO:0009331 Gpdh Glycerol 3 phosphate dehydrogenase "CG9042, CG9042, Gdh, alpha-Gpdh, alphaGpdh-1, GAPDH, alpha-GPDH, alphaGpdh, GPDH, 5' gene, GPD, alpha-Gpdh, alpha-GPDH, alphaGpd, alpha-GPD, alphaGPDH, sn-Gpdh, Gpd, alpha-GPDH-1, GPDA, DROGPDHA, gpdh" CDMC35413 2 13 23 DAC37-J01 1-CG9080-RA_1 CG9080 GGCGGCAGTGCATCAGCATCGGCGTCAGCTTCAGCCAGTTCCAGTTGGGGACGTAAATAAAAATAGTTA 69 FBan0009080 FBgn0033593 CG9080 2 2R CG9080 CG9080 BcDNA:RH62530 CDMC35413 2 14 23 DAC37-J01 1-CG9080-RA_1 CG9080 GGCGGCAGTGCATCAGCATCGGCGTCAGCTTCAGCCAGTTCCAGTTGGGGACGTAAATAAAAATAGTTA 69 FBan0009080 FBgn0033593 CG9080 2 2R CG9080 CG9080 BcDNA:RH62530 CDMC35414 2 15 23 DAC37-J13 23-CG9090-RA_2 CG9090 CAACAACGACTCTATACTTCAACTATATCTAATCCCTATCTGCACTTCACCTCCTTCGATACCCCGCAC 69 FBan0009090 FBgn0034497 CG9090 2 2R phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; phosphate transporter activity; GO:0015114; ; GO:0015114 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG9090 CG9090 CDMC35414 2 16 23 DAC37-J13 23-CG9090-RA_2 CG9090 CAACAACGACTCTATACTTCAACTATATCTAATCCCTATCTGCACTTCACCTCCTTCGATACCCCGCAC 69 FBan0009090 FBgn0034497 CG9090 2 2R phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; phosphate transporter activity; GO:0015114; ; GO:0015114 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG9090 CG9090 CDMC35415 2 17 23 DAC37-N01 17-CG9126-RB_1 CG9126 GGCTTGTGCGCTCGGTCTGTGAGGACAATAAAACCCAGCTCTTCAGAAAAGCATACTACTTGACGAACT 69 FBan0009126 FBgn0045073 Stim X X cell adhesion; GO:0007155 plasma membrane; GO:0005886 Stim Stromal interaction molecule "CG9126, CG9126, CG9126, D-Stim, D-STIM, Drosophila Stromal interaction molecule, Stromal interaction molecule" CDMC35415 2 18 23 DAC37-N01 17-CG9126-RB_1 CG9126 GGCTTGTGCGCTCGGTCTGTGAGGACAATAAAACCCAGCTCTTCAGAAAAGCATACTACTTGACGAACT 69 FBan0009126 FBgn0045073 Stim X X cell adhesion; GO:0007155 plasma membrane; GO:0005886 Stim Stromal interaction molecule "CG9126, CG9126, CG9126, D-Stim, D-STIM, Drosophila Stromal interaction molecule, Stromal interaction molecule" CDMC35416 2 19 23 DAC37-N13 9-CG9139-RA_1 CG9139 CGGCGCGGATGCTCCCAAATAAACGTTTGTTCACTGGGTCACTGAATCCTGCAGCTGTGTGAATGTAAA 69 FBan0009139 FBgn0035202 CG9139 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886 DNA binding; GO:0003677; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9139 CG9139 CDMC35416 2 20 23 DAC37-N13 9-CG9139-RA_1 CG9139 CGGCGCGGATGCTCCCAAATAAACGTTTGTTCACTGGGTCACTGAATCCTGCAGCTGTGTGAATGTAAA 69 FBan0009139 FBgn0035202 CG9139 3 3L endocytosis; GO:0006897; intracellular protein transport; GO:0006886 DNA binding; GO:0003677; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9139 CG9139 CDMC35417 2 21 23 DAC38-B01 6-CG5520-RA_1 CG5520 CCGACGATCCTCAGCGCACCTACTACCTCAACCAGAAGAAAACGCTCGAGATCAATCCCAGGCATC 66 FBan0005520 FBgn0039562 Gp93 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 Gp93 Glycoprotein 93 "CG5520, CG5520, CG5520, CG5520, p93, CT17486, gp93, Glycoprotein 93" CDMC35417 2 22 23 DAC38-B01 6-CG5520-RA_1 CG5520 CCGACGATCCTCAGCGCACCTACTACCTCAACCAGAAGAAAACGCTCGAGATCAATCCCAGGCATC 66 FBan0005520 FBgn0039562 Gp93 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; unfolded protein binding; GO:0051082; ; GO:0051082 Gp93 Glycoprotein 93 "CG5520, CG5520, CG5520, CG5520, p93, CT17486, gp93, Glycoprotein 93" CDMC35418 2 23 23 DAC38-B13 17-CG5677-RA_1 CG5677 CGACTTGGGCTTCGTGACCTTCGATCTGCAAACGAATCTCACAGGCATCTTCAACTGGAACGTGAA 66 FBan0005677 FBgn0039172 CG5677 3 3R proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; signal peptidase complex; GO:0005787 CG5677 CG5677 CDMC35418 2 24 23 DAC38-B13 17-CG5677-RA_1 CG5677 CGACTTGGGCTTCGTGACCTTCGATCTGCAAACGAATCTCACAGGCATCTTCAACTGGAACGTGAA 66 FBan0005677 FBgn0039172 CG5677 3 3R proteolysis; GO:0006508; signal peptide processing; GO:0006465 signal peptidase activity; GO:0009003; ; GO:0009003; ; GO:0009003 integral to membrane; GO:0016021; signal peptidase complex; GO:0005787 CG5677 CG5677 CDMC35419 2 25 23 DAC38-F01 3-CG6170-RA_1 CG6170 CAGCGGCCGGATAATCGTTTGCCTGGAAGGTGGCTACAATGTGAACTCCATTTCGTACGCGATGAC 66 FBan0006170 FBgn0026428 HDAC6 X X chromatin assembly or disassembly; GO:0006333; histone deacetylation; GO:0016575; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0004407 ; EC:3.5.1.- HDAC6 HDAC6 "CG6170, histone deacetylase HDA2, dHDAC2, DmHDAC2, HDAC, dHDAC6, dmHDA404, HDAC2" CDMC35419 2 26 23 DAC38-F01 3-CG6170-RA_1 CG6170 CAGCGGCCGGATAATCGTTTGCCTGGAAGGTGGCTACAATGTGAACTCCATTTCGTACGCGATGAC 66 FBan0006170 FBgn0026428 HDAC6 X X chromatin assembly or disassembly; GO:0006333; histone deacetylation; GO:0016575; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 chromatin binding; GO:0003682; histone deacetylase activity; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0004407 ; EC:3.5.1.-; ; GO:0003682; ; GO:0004407 ; EC:3.5.1.- HDAC6 HDAC6 "CG6170, histone deacetylase HDA2, dHDAC2, DmHDAC2, HDAC, dHDAC6, dmHDA404, HDAC2" CDMC35420 2 1 24 DAC38-F13 2-CG6296-RA_1 CG6296 CTGTGCCCACTAAGCTACCTTCGACAACGGGTGTTCCTCCTGAAGTTCCCATTACCACTCTGGCTC 66 FBan0006296 FBgn0039470 CG6296 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6296 CG6296 CDMC35420 2 2 24 DAC38-F13 2-CG6296-RA_1 CG6296 CTGTGCCCACTAAGCTACCTTCGACAACGGGTGTTCCTCCTGAAGTTCCCATTACCACTCTGGCTC 66 FBan0006296 FBgn0039470 CG6296 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6296 CG6296 CDMC35421 2 3 24 DAC38-J01 3-CG6686-RA_2 CG6686 TGGCCGCATATTGAACCTCAAAGAGGCTTTCCGCTACTTGTCACATAAGTTCCATGGCAAGGGGCC 66 FBan0006686 FBgn0032388 CG6686 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG6686 CG6686 CDMC35421 2 4 24 DAC38-J01 3-CG6686-RA_2 CG6686 TGGCCGCATATTGAACCTCAAAGAGGCTTTCCGCTACTTGTCACATAAGTTCCATGGCAAGGGGCC 66 FBan0006686 FBgn0032388 CG6686 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ; GO:0030528 CG6686 CG6686 CDMC35422 2 5 24 DAC38-J13 12-CG6844-RA_1 CG6844 GCACAAGATGCGACCCTGGATTAGGTCCTTCTTCATCAAGAGATTGCCGAAACTCCTGCTGATGCG 66 FBan0006844 FBgn0000039 nAcRalpha-96Ab 3 3R cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-96Ab nicotinic Acetylcholine Receptor alpha 96Ab "CG6844, CG6844, sad, Dalpha2, Da2, SAD: Second alpha-like subunit of Drosophila, Drosophila alpha-like subunit 2, Second alpha-like subunit of Drosophila, alpha[[2]], alpha2, da2, Acr96Ab, Dalpha2 nicotimic acetylcholine receptor, nicotinic acetylcholine receptor alpha-2, Dalpha2/SAD, nAcRs, nAcr96Ab, nAChR, nAcRalpha-96Ab, AcrE, D[a2]: Drosophila alpha-like subunit 2, SAD" CDMC35422 2 6 24 DAC38-J13 12-CG6844-RA_1 CG6844 GCACAAGATGCGACCCTGGATTAGGTCCTTCTTCATCAAGAGATTGCCGAAACTCCTGCTGATGCG 66 FBan0006844 FBgn0000039 nAcRalpha-96Ab 3 3R cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 integral to plasma membrane; GO:0005887; nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-96Ab nicotinic Acetylcholine Receptor alpha 96Ab "CG6844, CG6844, sad, Dalpha2, Da2, SAD: Second alpha-like subunit of Drosophila, Drosophila alpha-like subunit 2, Second alpha-like subunit of Drosophila, alpha[[2]], alpha2, da2, Acr96Ab, Dalpha2 nicotimic acetylcholine receptor, nicotinic acetylcholine receptor alpha-2, Dalpha2/SAD, nAcRs, nAcr96Ab, nAChR, nAcRalpha-96Ab, AcrE, D[a2]: Drosophila alpha-like subunit 2, SAD" CDMC35423 2 7 24 DAC38-N01 2-CG7343-RA_1 CG7343 AGAACATGTTGGATCGTCCGAACTTCTGGGTTGAGGGCAGCTTGGTTCTGCGTTCCAGTTTGGATG 66 FBgn0038263 CDMC35423 2 8 24 DAC38-N01 2-CG7343-RA_1 CG7343 AGAACATGTTGGATCGTCCGAACTTCTGGGTTGAGGGCAGCTTGGTTCTGCGTTCCAGTTTGGATG 66 FBgn0038263 CDMC35424 2 9 24 DAC38-N13 2-CG7535-RB_1 CG7535 GGCCTGCCCAATGAACCTAAAGCTGTATCCGCTGGATAGACAGATCTGCTCACTACGGATGGCCAG 66 FBan0007535 FBgn0024963 GluClalpha 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glutamate-gated chloride channel activity; GO:0008068; ; GO:0008068; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; ; GO:0008068; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 GluClalpha GluClalpha "CG7535, CG7535, DrosGluCl, GLUCL, GluCl, DrosGluCl-alpha, indefinite, glc, dGluCl-alpha, DmGluClalpha, DmGlu, GluCla, DrosGlu-Cl-alpha, GluClalpha, DrosGluCl-alpha1, BcDNA:HL07853" CDMC35424 2 10 24 DAC38-N13 2-CG7535-RB_1 CG7535 GGCCTGCCCAATGAACCTAAAGCTGTATCCGCTGGATAGACAGATCTGCTCACTACGGATGGCCAG 66 FBan0007535 FBgn0024963 GluClalpha 3 3R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glutamate-gated chloride channel activity; GO:0008068; ; GO:0008068; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; ; GO:0008068; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 GluClalpha GluClalpha "CG7535, CG7535, DrosGluCl, GLUCL, GluCl, DrosGluCl-alpha, indefinite, glc, dGluCl-alpha, DmGluClalpha, DmGlu, GluCla, DrosGlu-Cl-alpha, GluClalpha, DrosGluCl-alpha1, BcDNA:HL07853" CDMC35425 2 11 24 DAC39-B01 23-CG3203-RD_3 CG3203 AGTGCATGTGCCTAGAAAGTTATTTTCCGAAAATTGCCACTTAAATCGTATTCAAACTCATTTATTTGT 69 FBan0003203 FBgn0029897 RpL17 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL17 Ribosomal protein L17 "CG3203, anon-EST:Posey276, Ribosomal protein L17" CDMC35425 2 12 24 DAC39-B01 23-CG3203-RD_3 CG3203 AGTGCATGTGCCTAGAAAGTTATTTTCCGAAAATTGCCACTTAAATCGTATTCAAACTCATTTATTTGT 69 FBan0003203 FBgn0029897 RpL17 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL17 Ribosomal protein L17 "CG3203, anon-EST:Posey276, Ribosomal protein L17" CDMC35426 2 13 24 DAC39-B13 1-CG32044-RA_1 CG32044 CGACCAACCACATCCTGAATCAGTCTCGAATCAGGCCAGAACCTCAATTACCCGTCGAGAACAACGGCT 69 FBan0032044 FBgn0052044 CG32044 3 3L CG32044 CG32044 CG6740 CDMC35426 2 14 24 DAC39-B13 1-CG32044-RA_1 CG32044 CGACCAACCACATCCTGAATCAGTCTCGAATCAGGCCAGAACCTCAATTACCCGTCGAGAACAACGGCT 69 FBan0032044 FBgn0052044 CG32044 3 3L CG32044 CG32044 CG6740 CDMC35427 2 15 24 DAC39-F01 17-CG32072-RA_1 CG32072 ACGGCACCTGGATAACCCTATCGATGGCCATATATTCCCTGCCTTTCCTCTTTATGTTCGGGAAATTCT 69 FBan0032072 FBgn0052072 CG32072 3 3L "fatty acid biosynthesis; GO:0006633; fatty acid elongation, unsaturated fatty acid; GO:0019368; pheromone biosynthesis; GO:0042811; very-long-chain fatty acid metabolism; GO:0000038" acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; fatty acid elongase activity; GO:0009922; ; GO:0009922 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG32072 CG32072 "CG6261, elo68alpha" CDMC35427 2 16 24 DAC39-F01 17-CG32072-RA_1 CG32072 ACGGCACCTGGATAACCCTATCGATGGCCATATATTCCCTGCCTTTCCTCTTTATGTTCGGGAAATTCT 69 FBan0032072 FBgn0052072 CG32072 3 3L "fatty acid biosynthesis; GO:0006633; fatty acid elongation, unsaturated fatty acid; GO:0019368; pheromone biosynthesis; GO:0042811; very-long-chain fatty acid metabolism; GO:0000038" acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; fatty acid elongase activity; GO:0009922; ; GO:0009922 endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 CG32072 CG32072 "CG6261, elo68alpha" CDMC35428 2 17 24 DAC39-F13 11-CG32083-RA_1 CG32083 AGACACAGTGGGCTCAGAAAGTCTGTCAAGTGTCATAAGCGCAAGTTGATGCCTCCTGTGCTGTTTGAA 69 FBan0032083 FBgn0052083 CG32083 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32083 CG32083 CDMC35428 2 18 24 DAC39-F13 11-CG32083-RA_1 CG32083 AGACACAGTGGGCTCAGAAAGTCTGTCAAGTGTCATAAGCGCAAGTTGATGCCTCCTGTGCTGTTTGAA 69 FBan0032083 FBgn0052083 CG32083 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32083 CG32083 CDMC35429 2 19 24 DAC39-J01 2-CG32113-RA_2 CG32113 TGCCGTTCGTGAAACAAGCCGAGATAGTCACAGAAACGCTCCGGAAAGGAAAAGGCTACCCAGATGTGT 69 FBan0032113 FBgn0052113 CG32113 3 3L vesicle-mediated transport; GO:0016192 CG32113 CG32113 "CG11003, CG11002, CG11003, CG11003, CG11003, CG11003" CDMC35429 2 20 24 DAC39-J01 2-CG32113-RA_2 CG32113 TGCCGTTCGTGAAACAAGCCGAGATAGTCACAGAAACGCTCCGGAAAGGAAAAGGCTACCCAGATGTGT 69 FBan0032113 FBgn0052113 CG32113 3 3L vesicle-mediated transport; GO:0016192 CG32113 CG32113 "CG11003, CG11002, CG11003, CG11003, CG11003, CG11003" CDMC35430 2 21 24 DAC39-J13 1-CG32134-RA_1 CG32134 GGCCTCAAGTGGTCTGGGAAGGAGTAACTCCAGTGTGTACCTTAGGGTAGTGAGTCCTCTGCCACCTTT 69 FBan0032134 FBgn0005592 btl 3 3L "branching morphogenesis; GO:0001763; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm development; GO:0007398; endoderm development; GO:0007492; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; salivary gland morphogenesis; GO:0007435; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" ATP binding; GO:0005524; ; GO:0005524; fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007; ; GO:0005007; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0005007 plasma membrane; GO:0005886 btl breathless "CG6714, CG32134, CG6714, dev, dtk2, fgf-r, Fgf-r: Fibroblast-growth-factor-receptor, DFGF-R1, FGFR, DFR2, FGFR1, Btl, 0844/01, Dfr-2, DmHD-311, FGF receptor, BTL/FGFR2, CT20816, D-FGFR, Dtk2, HD-311, Tk2, l(3)00208, Fibroblast-growth-factor-receptor, devenir, Fgf-r, breathless" CDMC35430 2 22 24 DAC39-J13 1-CG32134-RA_1 CG32134 GGCCTCAAGTGGTCTGGGAAGGAGTAACTCCAGTGTGTACCTTAGGGTAGTGAGTCCTCTGCCACCTTT 69 FBan0032134 FBgn0005592 btl 3 3L "branching morphogenesis; GO:0001763; cell proliferation; GO:0008283; central nervous system development; GO:0007417; ectoderm development; GO:0007398; endoderm development; GO:0007492; fibroblast growth factor receptor signaling pathway; GO:0008543; filopodium formation; GO:0046847; genital disc development; GO:0035215; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; salivary gland morphogenesis; GO:0007435; secondary tracheal branching (sensu Insecta); GO:0007429; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430; tracheal epithelial cell migration (sensu Insecta); GO:0007427; tracheal outgrowth (sensu Insecta); GO:0007426; tracheal system development (sensu Insecta); GO:0007424" ATP binding; GO:0005524; ; GO:0005524; fibroblast growth factor receptor activity; GO:0005007; ; GO:0005007; ; GO:0005007; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0005007 plasma membrane; GO:0005886 btl breathless "CG6714, CG32134, CG6714, dev, dtk2, fgf-r, Fgf-r: Fibroblast-growth-factor-receptor, DFGF-R1, FGFR, DFR2, FGFR1, Btl, 0844/01, Dfr-2, DmHD-311, FGF receptor, BTL/FGFR2, CT20816, D-FGFR, Dtk2, HD-311, Tk2, l(3)00208, Fibroblast-growth-factor-receptor, devenir, Fgf-r, breathless" CDMC35431 2 23 24 DAC39-N01 3-CG32163-RA_2 CG32163 GCAAGGTGGCCGAAGAACGTATTCCTTGTGCTCGAGAGATTACACCATCCCCACAAGTAACCACACCCT 69 FBan0032163 FBgn0052163 CG32163 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32163 CG32163 CDMC35431 2 24 24 DAC39-N01 3-CG32163-RA_2 CG32163 GCAAGGTGGCCGAAGAACGTATTCCTTGTGCTCGAGAGATTACACCATCCCCACAAGTAACCACACCCT 69 FBan0032163 FBgn0052163 CG32163 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32163 CG32163 CDMC35432 2 25 24 DAC39-N13 23-CG32171-RE_3 CG32171 TGTGCCGCGGATACAAAAGAATTTGCTTAGATATCAATTCCCTATAGACAGTGTGTTTGTTTTGTTTGG 69 FBan0032171 FBgn0036672 Lmpt 3 3L heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Lmpt Limpet "CG11914, CG32171, CG11916, CG9959, CG11914, CG11914, CG11914, BcDNA:RE37250" CDMC35432 2 26 24 DAC39-N13 23-CG32171-RE_3 CG32171 TGTGCCGCGGATACAAAAGAATTTGCTTAGATATCAATTCCCTATAGACAGTGTGTTTGTTTTGTTTGG 69 FBan0032171 FBgn0036672 Lmpt 3 3L heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Lmpt Limpet "CG11914, CG32171, CG11916, CG9959, CG11914, CG11914, CG11914, BcDNA:RE37250" CDMC35433 2 1 25 DAC40-B01 23-CG9548-RA_1 CG9548 AGCAACTGTTTTTATATTTGCTGACTGAAAACTAATATTAAATCATGGCCAAACATCATCCGGATTTGA 69 FBan0009548 FBgn0031822 CG9548 2 2L CG9548 CG9548 BcDNA:RH02789 CDMC35433 2 2 25 DAC40-B01 23-CG9548-RA_1 CG9548 AGCAACTGTTTTTATATTTGCTGACTGAAAACTAATATTAAATCATGGCCAAACATCATCCGGATTTGA 69 FBan0009548 FBgn0031822 CG9548 2 2L CG9548 CG9548 BcDNA:RH02789 CDMC35434 2 3 25 DAC40-B13 18-CG9568-RA_1 CG9568 TTTTCGTGTGCCAATCTCACTTACTATCATGCAGCAAACTACACTCACACCTTTGAGTTCCTGGGCTGC 69 FBan0009568 FBgn0032087 CG9568 2 2L CG9568 CG9568 anon-WO0140519.183 CDMC35434 2 4 25 DAC40-B13 18-CG9568-RA_1 CG9568 TTTTCGTGTGCCAATCTCACTTACTATCATGCAGCAAACTACACTCACACCTTTGAGTTCCTGGGCTGC 69 FBan0009568 FBgn0032087 CG9568 2 2L CG9568 CG9568 anon-WO0140519.183 CDMC35435 2 5 25 DAC40-F01 1-CG9609-RA_1 CG9609 GGAGCAGGAGTAGAGCAAAAGGCCATTCAAAGGGACGGGAGTGAGAAGGTCTGGTCAAGAGGCTAACAA 69 FBan0009609 FBgn0030787 CG9609 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0003709; ; GO:0008270 nucleus; GO:0005634 CG9609 CG9609 CDMC35435 2 6 25 DAC40-F01 1-CG9609-RA_1 CG9609 GGAGCAGGAGTAGAGCAAAAGGCCATTCAAAGGGACGGGAGTGAGAAGGTCTGGTCAAGAGGCTAACAA 69 FBan0009609 FBgn0030787 CG9609 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0003709; ; GO:0008270 nucleus; GO:0005634 CG9609 CG9609 CDMC35436 2 7 25 DAC40-F13 12-CG9614-RF_7 CG9614 TCGTCTTGGATTTGACACCTACAGAAATATCGTGCGTCCCTCGAGGTCGATTACCGAATCCGAGGAGGA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC35436 2 8 25 DAC40-F13 12-CG9614-RF_7 CG9614 TCGTCTTGGATTTGACACCTACAGAAATATCGTGCGTCCCTCGAGGTCGATTACCGAATCCGAGGAGGA 69 FBan0009614 FBgn0003089 pip 3 3L "Toll signaling pathway; GO:0008063; dorsal/ventral axis specification; GO:0009950; maternal determination of dorsal/ventral axis, oocyte, soma encoded; GO:0007313; meiosis; GO:0007126; oogenesis (sensu Insecta); GO:0009993; protein processing; GO:0016485" sulfotransferase activity; GO:0008146 ; EC:2.8.2.-; ; GO:0008146 ; EC:2.8.2.-; heparan sulfate 2-O-sulfotransferase activity; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.-; ; GO:0004394 ; EC:2.8.2.- Golgi apparatus; GO:0005794; chromosome; GO:0005694; nucleus; GO:0005634 pip pipe "CG9614, pipe-ST2, pipe" CDMC35437 2 9 25 DAC40-J01 23-CG9648-RA_14 CG9648 TCCGGCTTCCGTTTTCACCGACATTCTGAATTCTTACGTGGATTTAGTTCAACTTTGAGTTGTGTTATA 69 FBan0009648 FBgn0017578 Max 3 3L "regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Max Max "CG9648, dmax, dMax, max: males-absent on the X, max" CDMC35437 2 10 25 DAC40-J01 23-CG9648-RA_14 CG9648 TCCGGCTTCCGTTTTCACCGACATTCTGAATTCTTACGTGGATTTAGTTCAACTTTGAGTTGTGTTATA 69 FBan0009648 FBgn0017578 Max 3 3L "regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Max Max "CG9648, dmax, dMax, max: males-absent on the X, max" CDMC35438 2 11 25 DAC40-J13 15-CG9659-RB_1 CG9659 GCGCGTACTGGAGACTGTCTAGACTATTTTGTGGAACTGGATGAGGGAGGAAAGGAGTCATCGAGTGCA 69 FBan0009659 FBgn0001404 egh X X border follicle cell migration (sensu Insecta); GO:0007298; cell fate commitment; GO:0045165; egg chamber formation (sensu Insecta); GO:0007293; follicle cell adhesion (sensu Insecta); GO:0007299; germ cell development; GO:0007281; maintenance of polarity of follicular epithelium; GO:0042248; morphogenesis of follicular epithelium; GO:0016333; oocyte localization during oogenesis; GO:0030720; oocyte microtubule cytoskeleton organization; GO:0016325; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707 "beta-1,4-mannosyltransferase activity; GO:0019187 ; EC:2.4.1.-; ; GO:0019187 ; EC:2.4.1.-" integral to plasma membrane; GO:0005887 egh egghead "CG9659, CG9659, CG9659, zw4, l(1)zw4, zw-4, ZW-4, zeste-white 4, EG:BACR25B3.8, l(1)3Ae" CDMC35438 2 12 25 DAC40-J13 15-CG9659-RB_1 CG9659 GCGCGTACTGGAGACTGTCTAGACTATTTTGTGGAACTGGATGAGGGAGGAAAGGAGTCATCGAGTGCA 69 FBan0009659 FBgn0001404 egh X X border follicle cell migration (sensu Insecta); GO:0007298; cell fate commitment; GO:0045165; egg chamber formation (sensu Insecta); GO:0007293; follicle cell adhesion (sensu Insecta); GO:0007299; germ cell development; GO:0007281; maintenance of polarity of follicular epithelium; GO:0042248; morphogenesis of follicular epithelium; GO:0016333; oocyte localization during oogenesis; GO:0030720; oocyte microtubule cytoskeleton organization; GO:0016325; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707 "beta-1,4-mannosyltransferase activity; GO:0019187 ; EC:2.4.1.-; ; GO:0019187 ; EC:2.4.1.-" integral to plasma membrane; GO:0005887 egh egghead "CG9659, CG9659, CG9659, zw4, l(1)zw4, zw-4, ZW-4, zeste-white 4, EG:BACR25B3.8, l(1)3Ae" CDMC35439 2 13 25 DAC40-N01 16-CG9696-RE_1 CG9696 GCGTATCCATTCCTGTCGCTTCGGGAAAGATTAGGATGAACTCAACATTCAGGGAACAAAAACGGACGA 69 FBan0009696 FBgn0020306 dom 2 2R "DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260; DNA topological change; GO:0006265; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; hemopoiesis; GO:0030097; larval or pupal development (sensu Insecta); GO:0002165; negative regulation of hemocyte proliferation (sensu Arthropoda); GO:0035207; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0016251; ; GO:0003678; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003918 ; EC:5.99.1.3 chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dom domino "CG9696, CG9696, CG9696, CG9696, CG9696, l(2)81/8, 27/4, DomA, anon-WO0172774.190, l(2)k02704, l(2)k08108, domino" CDMC35439 2 14 25 DAC40-N01 16-CG9696-RE_1 CG9696 GCGTATCCATTCCTGTCGCTTCGGGAAAGATTAGGATGAACTCAACATTCAGGGAACAAAAACGGACGA 69 FBan0009696 FBgn0020306 dom 2 2R "DNA recombination; GO:0006310; DNA repair; GO:0006281; DNA replication; GO:0006260; DNA topological change; GO:0006265; border follicle cell migration (sensu Insecta); GO:0007298; cell proliferation; GO:0008283; establishment and/or maintenance of chromatin architecture; GO:0006325; gene silencing; GO:0016458; hemopoiesis; GO:0030097; larval or pupal development (sensu Insecta); GO:0002165; negative regulation of hemocyte proliferation (sensu Arthropoda); GO:0035207; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of transcription from RNA polymerase II promoter; GO:0006357" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; general RNA polymerase II transcription factor activity; GO:0016251; helicase activity; GO:0004386; ; GO:0003676; DNA helicase activity; GO:0003678; ; GO:0004386; ; GO:0016251; ; GO:0003678; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; DNA ligase (ATP) activity; GO:0003910 ; EC:6.5.1.1; DNA-dependent ATPase activity; GO:0008094; ; GO:0008094; ; GO:0008094; ; GO:0003677; ; GO:0003910 ; EC:6.5.1.1; ; GO:0003918 ; EC:5.99.1.3 chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dom domino "CG9696, CG9696, CG9696, CG9696, CG9696, l(2)81/8, 27/4, DomA, anon-WO0172774.190, l(2)k02704, l(2)k08108, domino" CDMC35440 2 15 25 DAC40-N13 17-CG9705-RA_2 CG9705 GCCACCCGAGATGAACGAAACGGAAAACCGGAACAGAACAATAACCATGAAAGTAAACGAAAGCACAGC 69 FBan0009705 FBgn0036661 CG9705 3 3L "calcium-mediated signaling; GO:0019722; intracellular signaling cascade; GO:0007242; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ; GO:0003677 CG9705 CG9705 CDMC35440 2 16 25 DAC40-N13 17-CG9705-RA_2 CG9705 GCCACCCGAGATGAACGAAACGGAAAACCGGAACAGAACAATAACCATGAAAGTAAACGAAAGCACAGC 69 FBan0009705 FBgn0036661 CG9705 3 3L "calcium-mediated signaling; GO:0019722; intracellular signaling cascade; GO:0007242; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; ; GO:0003677 CG9705 CG9705 CDMC35441 2 17 25 DAC41-B01 AutoBlank AutoBlank CDMC35441 2 18 25 DAC41-B01 AutoBlank AutoBlank CDMC35442 2 19 25 DAC41-B13 AutoBlank AutoBlank CDMC35442 2 20 25 DAC41-B13 AutoBlank AutoBlank CDMC35443 2 21 25 DAC41-F01 AutoBlank AutoBlank CDMC35443 2 22 25 DAC41-F01 AutoBlank AutoBlank CDMC35444 2 23 25 DAC41-F13 AutoBlank AutoBlank CDMC35444 2 24 25 DAC41-F13 AutoBlank AutoBlank CDMC35445 2 25 25 DAC41-J01 AutoBlank AutoBlank CDMC35445 2 26 25 DAC41-J01 AutoBlank AutoBlank CDMC35446 2 1 26 DAC41-J13 AutoBlank AutoBlank CDMC35446 2 2 26 DAC41-J13 AutoBlank AutoBlank CDMC35447 2 3 26 DAC41-N01 AutoBlank AutoBlank CDMC35447 2 4 26 DAC41-N01 AutoBlank AutoBlank CDMC35448 2 5 26 DAC41-N13 AutoBlank AutoBlank CDMC35448 2 6 26 DAC41-N13 AutoBlank AutoBlank CDMC35449 2 7 26 DAC42-B01 Oligo GFP control GFP (A. victoria) CDMC35449 2 8 26 DAC42-B01 Oligo GFP control GFP (A. victoria) CDMC35450 2 9 26 DAC42-B13 Oligo lacZ control lacZ (E.coli) CDMC35450 2 10 26 DAC42-B13 Oligo lacZ control lacZ (E.coli) CDMC35451 2 11 26 DAC42-F01 pBS vector pBS vector CDMC35451 2 12 26 DAC42-F01 pBS vector pBS vector CDMC35452 2 13 26 DAC42F13 pOT2A vector pOT2A vector CDMC35452 2 14 26 DAC42F13 pOT2A vector pOT2A vector CDMC35453 2 15 26 DAC42-J01 Oligo Tet control Tet CDMC35453 2 16 26 DAC42-J01 Oligo Tet control Tet CDMC35454 2 17 26 DAC42-J13 5uM MSP 5uM MSP CDMC35454 2 18 26 DAC42-J13 5uM MSP 5uM MSP CDMC35455 2 19 26 DAC42-N01 10uM MSP 10uM MSP CDMC35455 2 20 26 DAC42-N01 10uM MSP 10uM MSP CDMC35456 2 21 26 DAC42-N13 20uM MSP 20uM MSP CDMC35456 2 22 26 DAC42-N13 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC35457 3 1 1 DAC01-C01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35457 3 2 1 DAC01-C01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35458 3 3 1 DAC01-C13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35458 3 4 1 DAC01-C13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35459 3 5 1 DAC01-G01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35459 3 6 1 DAC01-G01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35460 3 7 1 DAC01-G13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35460 3 8 1 DAC01-G13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35461 3 9 1 DAC01-K01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35461 3 10 1 DAC01-K01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35462 3 11 1 DAC01-K13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35462 3 12 1 DAC01-K13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35463 3 13 1 DAC01-O01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35463 3 14 1 DAC01-O01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35464 3 15 1 DAC01-O13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35464 3 16 1 DAC01-O13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35465 3 17 1 DAC02-C01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35465 3 18 1 DAC02-C01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35466 3 19 1 DAC02-C13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35466 3 20 1 DAC02-C13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35467 3 21 1 DAC02-G01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35467 3 22 1 DAC02-G01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35468 3 23 1 DAC02-G13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35468 3 24 1 DAC02-G13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35469 3 25 1 DAC02-K01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35469 3 26 1 DAC02-K01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35470 3 1 2 DAC02-K13 N/A CG9075 (00240-00478) CDMC35470 3 2 2 DAC02-K13 N/A CG9075 (00240-00478) CDMC35471 3 3 2 DAC02-O01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35471 3 4 2 DAC02-O01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35472 3 5 2 DAC02-O13 AutoBlank AutoBlank CDMC35472 3 6 2 DAC02-O13 AutoBlank AutoBlank CDMC35473 3 7 2 DAC03-C01 17-CG17107-RA_1 CG17107 GAGGTGGACATGGCAGACATGGATAGGCTCGAAACGGATTCATAACTGTACTCTCGAAAAGTGGGCACG 69 FBan0017107 FBgn0032281 CG17107 2 2L CG17107 CG17107 CDMC35473 3 8 2 DAC03-C01 17-CG17107-RA_1 CG17107 GAGGTGGACATGGCAGACATGGATAGGCTCGAAACGGATTCATAACTGTACTCTCGAAAAGTGGGCACG 69 FBan0017107 FBgn0032281 CG17107 2 2L CG17107 CG17107 CDMC35474 3 9 2 DAC03-C13 13-CG17118-RA_1 CG17118 ATCCGGCGCATCTACTTCGCAGATAAGCTATACACAGAGGCTGAATTGCCCAATGACTACCGTCTGATG 69 FBan0017118 FBgn0032291 CG17118 2 2L transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG17118 CG17118 CDMC35474 3 10 2 DAC03-C13 13-CG17118-RA_1 CG17118 ATCCGGCGCATCTACTTCGCAGATAAGCTATACACAGAGGCTGAATTGCCCAATGACTACCGTCTGATG 69 FBan0017118 FBgn0032291 CG17118 2 2L transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG17118 CG17118 CDMC35475 3 11 2 DAC03-G01 11-CG17163-RA_1 CG17163 ACGGTCACCATTGCTGCACCTAATAATGGGCATTTCGACTAGCGGATTGAAAATGTCCTGAGCTGGACA 69 FBgn0039942 CG17163 CG17163 CG17163 CDMC35475 3 12 2 DAC03-G01 11-CG17163-RA_1 CG17163 ACGGTCACCATTGCTGCACCTAATAATGGGCATTTCGACTAGCGGATTGAAAATGTCCTGAGCTGGACA 69 FBgn0039942 CG17163 CG17163 CG17163 CDMC35476 3 13 2 DAC03-G13 17-CG17174-RA_4 CG17174 AGGTGGCCTTTATAATGACCACGTTTGCCTTGGATCTAATGAGAGTGCTTTCCGTCTGCAATAAGGCAT 69 FBan0017174 FBgn0040509 ACXB 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXB ACXB "CG17174, CG17174, adenylyl cyclase, Ac34A, AC34A, DACXB, AC, Adenylyl cyclase 34A" CDMC35476 3 14 2 DAC03-G13 17-CG17174-RA_4 CG17174 AGGTGGCCTTTATAATGACCACGTTTGCCTTGGATCTAATGAGAGTGCTTTCCGTCTGCAATAAGGCAT 69 FBan0017174 FBgn0040509 ACXB 2 2L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004383 ; EC:4.6.1.2 ACXB ACXB "CG17174, CG17174, adenylyl cyclase, Ac34A, AC34A, DACXB, AC, Adenylyl cyclase 34A" CDMC35477 3 15 2 DAC03-K01 7-CG17207-RA_1 CG17207 CGGAACCAAGTCTCGTACCGGAGCTGAAATATGAGCCAACCATCACTGCCGATTTTTTTTGCCTGCACA 69 FBan0017207 FBgn0038051 CG17207 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17207 CG17207 BcDNA:AT11646 CDMC35477 3 16 2 DAC03-K01 7-CG17207-RA_1 CG17207 CGGAACCAAGTCTCGTACCGGAGCTGAAATATGAGCCAACCATCACTGCCGATTTTTTTTGCCTGCACA 69 FBan0017207 FBgn0038051 CG17207 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17207 CG17207 BcDNA:AT11646 CDMC35478 3 17 2 DAC03-K13 14-CG17217-RA_1 CG17217 TGAAAACATTTGAAGATGGCTCCACAGTTGTTTACTCAGCGGTGGTTAAGGATGCGAGAGCTGGTTGGT 69 FBan0017217 FBgn0032419 CG17217 2 2L CG17217 CG17217 CDMC35478 3 18 2 DAC03-K13 14-CG17217-RA_1 CG17217 TGAAAACATTTGAAGATGGCTCCACAGTTGTTTACTCAGCGGTGGTTAAGGATGCGAGAGCTGGTTGGT 69 FBan0017217 FBgn0032419 CG17217 2 2L CG17217 CG17217 CDMC35479 3 19 2 DAC03-O01 23-CG1725-RB_12 CG1725 ATTGCATGGTGGTTAACTATAAGTACGACAATGTTTAGTAGCTGACTACGAATAATGACGACGATGACG 69 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC35479 3 20 2 DAC03-O01 23-CG1725-RB_12 CG1725 ATTGCATGGTGGTTAACTATAAGTACGACAATGTTTAGTAGCTGACTACGAATAATGACGACGATGACG 69 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC35480 3 21 2 DAC03-O13 3-CG17269-RA_3 CG17269 GGGAAGATCCCGAAAGGCTAACAAGGTTTTTGCACGAGCTCCAGAAGGTGACACGCTTTCTGCACCAAC 69 FBan0017269 FBgn0038827 Fancd2 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Fancd2 Fancd2 "CG17269, CG31194, CG31192, CG17269, CG31194, dmFANCD2" CDMC35480 3 22 2 DAC03-O13 3-CG17269-RA_3 CG17269 GGGAAGATCCCGAAAGGCTAACAAGGTTTTTGCACGAGCTCCAGAAGGTGACACGCTTTCTGCACCAAC 69 FBan0017269 FBgn0038827 Fancd2 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Fancd2 Fancd2 "CG17269, CG31194, CG31192, CG17269, CG31194, dmFANCD2" CDMC35481 3 23 2 DAC04-C01 3-CG15905-RA_1 CG15905 CTAACGAAGCCCTTGCACCACCCACTTCATGCTCGATCCAAGGATATACCCAGTATGGCTGCAGC 65 FBan0015905 FBgn0034462 CG15905 2 2R CG15905 CG15905 CDMC35481 3 24 2 DAC04-C01 3-CG15905-RA_1 CG15905 CTAACGAAGCCCTTGCACCACCCACTTCATGCTCGATCCAAGGATATACCCAGTATGGCTGCAGC 65 FBan0015905 FBgn0034462 CG15905 2 2R CG15905 CG15905 CDMC35482 3 25 2 DAC04-C13 3-CG1605-RA_3 CG1605 AGGCGACCGTCAATCTTCACCTAACGGCCTATAAGCTGAAGAAGTGCATCACCAGCCTACACGCG 65 FBan0001605 FBgn0025185 az2 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004867; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 az2 az2 "CG1605, zf43C, Zinc finger protein 43C" CDMC35482 3 26 2 DAC04-C13 3-CG1605-RA_3 CG1605 AGGCGACCGTCAATCTTCACCTAACGGCCTATAAGCTGAAGAAGTGCATCACCAGCCTACACGCG 65 FBan0001605 FBgn0025185 az2 2 2R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004867; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634 az2 az2 "CG1605, zf43C, Zinc finger protein 43C" CDMC35483 3 1 3 DAC04-G01 3-CG16790-RA_3 CG16790 GAGTCGAACAGTGGTGCTGCAGTACCATCAGATCGATGAATTCTCCCGATCCTTGCAAAGCGCCC 65 FBan0016790 FBgn0037713 CG16790 3 3R CG16790 CG16790 CDMC35483 3 2 3 DAC04-G01 3-CG16790-RA_3 CG16790 GAGTCGAACAGTGGTGCTGCAGTACCATCAGATCGATGAATTCTCCCGATCCTTGCAAAGCGCCC 65 FBan0016790 FBgn0037713 CG16790 3 3R CG16790 CG16790 CDMC35484 3 3 3 DAC04-G13 3-CG16850-RA_1 CG16850 CTTGCCGATGAACCGCAGCTGATCTTCAAAGGATTGGGGGTCAATGGGCGCAAGATGCAGATATG 65 FBan0016850 FBgn0032527 CG16850 2 2L CG16850 CG16850 CDMC35484 3 4 3 DAC04-G13 3-CG16850-RA_1 CG16850 CTTGCCGATGAACCGCAGCTGATCTTCAAAGGATTGGGGGTCAATGGGCGCAAGATGCAGATATG 65 FBan0016850 FBgn0032527 CG16850 2 2L CG16850 CG16850 CDMC35485 3 5 3 DAC04-K01 1-CG16959-RA_1 CG16959 CATCTCCTACAATGGAATGTGCGGTTGTTCCGGTGTCCTCACCAATCTGGATCAGCAGTGCACGG 65 FBan0016959 FBgn0036481 CG16959 3 3L CG16959 CG16959 CT21630 CDMC35485 3 6 3 DAC04-K01 1-CG16959-RA_1 CG16959 CATCTCCTACAATGGAATGTGCGGTTGTTCCGGTGTCCTCACCAATCTGGATCAGCAGTGCACGG 65 FBan0016959 FBgn0036481 CG16959 3 3L CG16959 CG16959 CT21630 CDMC35486 3 7 3 DAC04-K13 3-CG17011-RA_3 CG17011 ATTGATGGCCATGCAAAGCAAGTTGGCATACGCACTGAACGAGCTGCAGACCATAATGGGCAACC 65 FBan0017011 FBgn0040097 lectin-30A 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-30A lectin-30A "CG17011, CG17011, CG17011, AC 005889A, AC005889a, Lectin30A" CDMC35486 3 8 3 DAC04-K13 3-CG17011-RA_3 CG17011 ATTGATGGCCATGCAAAGCAAGTTGGCATACGCACTGAACGAGCTGCAGACCATAATGGGCAACC 65 FBan0017011 FBgn0040097 lectin-30A 2 2L spermatogenesis; GO:0007283 galactose binding; GO:0005534; ; GO:0005534 lectin-30A lectin-30A "CG17011, CG17011, CG17011, AC 005889A, AC005889a, Lectin30A" CDMC35487 3 9 3 DAC04-O01 15-CG17154-RA_2 CG17154 AATGCTAATGGAGGAGAGCTCGATCCCGAACATTCCCAACGAGGTGATCAACTACGTTGAGGAGC 65 FBan0017154 FBgn0036246 CG17154 3 3L CG17154 CG17154 CDMC35487 3 10 3 DAC04-O01 15-CG17154-RA_2 CG17154 AATGCTAATGGAGGAGAGCTCGATCCCGAACATTCCCAACGAGGTGATCAACTACGTTGAGGAGC 65 FBan0017154 FBgn0036246 CG17154 3 3L CG17154 CG17154 CDMC35488 3 11 3 DAC04-O13 24-CG17202-RA_1 CG17202 TAGAAGAAATGTTAAGTATTTTCCGGAATTTACATGTAAATAAAGCGAAATAAAGCATGAGCGCA 65 FBan0017202 FBgn0038043 CG17202 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG17202 CG17202 BcDNA:RH21090 CDMC35488 3 12 3 DAC04-O13 24-CG17202-RA_1 CG17202 TAGAAGAAATGTTAAGTATTTTCCGGAATTTACATGTAAATAAAGCGAAATAAAGCATGAGCGCA 65 FBan0017202 FBgn0038043 CG17202 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 CG17202 CG17202 BcDNA:RH21090 CDMC35489 3 13 3 DAC05-C01 3-CG10435-RA_1 CG10435 GCTGGAGGCGAGACAGAAGGAGATGCTTGGAGCAGTTGATTATCCTAGTGCGGACGACTTGTCATCGG 68 FBan0010435 FBgn0037539 CG10435 3 3R CG10435 CG10435 CDMC35489 3 14 3 DAC05-C01 3-CG10435-RA_1 CG10435 GCTGGAGGCGAGACAGAAGGAGATGCTTGGAGCAGTTGATTATCCTAGTGCGGACGACTTGTCATCGG 68 FBan0010435 FBgn0037539 CG10435 3 3R CG10435 CG10435 CDMC35490 3 15 3 DAC05-C13 6-CG10514-RA_2 CG10514 GCGAGCGTATGGCCATTATCTTCGAAGATCTTTCTGTGGTGGGCTACGTAATGGCCGATCGAGTGCGT 68 FBan0010514 FBgn0039312 CG10514 3 3R CG10514 CG10514 CT29508 CDMC35490 3 16 3 DAC05-C13 6-CG10514-RA_2 CG10514 GCGAGCGTATGGCCATTATCTTCGAAGATCTTTCTGTGGTGGGCTACGTAATGGCCGATCGAGTGCGT 68 FBan0010514 FBgn0039312 CG10514 3 3R CG10514 CG10514 CT29508 CDMC35491 3 17 3 DAC05-G01 3-CG11030-RA_2 CG11030 GCAAGCAAGTAGTGAGCCAGATGCGGTTCGAAACGGTGCAGTCAACTGAAGCTCGCGTAGTGCAATAC 68 FBan0011030 FBgn0031736 CG11030 2 2L CG11030 CG11030 CDMC35491 3 18 3 DAC05-G01 3-CG11030-RA_2 CG11030 GCAAGCAAGTAGTGAGCCAGATGCGGTTCGAAACGGTGCAGTCAACTGAAGCTCGCGTAGTGCAATAC 68 FBan0011030 FBgn0031736 CG11030 2 2L CG11030 CG11030 CDMC35492 3 19 3 DAC05-G13 2-CG11186-RA_2 CG11186 TTCCTCCGTCGCAACGTCAAACAACTCGACTCCAGGGATTGTGAACTCAGCAATCAACGTTGCGGAAC 68 FBan0011186 FBgn0019650 toy 4 4 cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc development; GO:0035214; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 toy twin of eyeless "CG11186, l(4)102CDg, l(4)8, lethal(4)102CDg, twin of eyeless" CDMC35492 3 20 3 DAC05-G13 2-CG11186-RA_2 CG11186 TTCCTCCGTCGCAACGTCAAACAACTCGACTCCAGGGATTGTGAACTCAGCAATCAACGTTGCGGAAC 68 FBan0011186 FBgn0019650 toy 4 4 cell proliferation; GO:0008283; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc development; GO:0035214; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 toy twin of eyeless "CG11186, l(4)102CDg, l(4)8, lethal(4)102CDg, twin of eyeless" CDMC35493 3 21 3 DAC05-K01 1-CG11397-RA_1 CG11397 GTGGGTGGAACAATTGAGGGGGATAACACGATAGCTGCCGAGAACCAAGACGATACCCCCACGAAGAA 68 FBan0011397 FBgn0015391 glu 2 2L chromatin assembly or disassembly; GO:0006333; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; peripheral nervous system development; GO:0007422 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0000166; ; GO:0016887 chromatin; GO:0000785; chromosome; GO:0005694; condensin complex; GO:0000796; cytoplasm; GO:0005737; nucleus; GO:0005634 glu gluon "CG11397, l(2)k08819, SMC4, BcDNA.LD20207, DmSMC4/gluon, Gluon, anon-WO0118547.156, BcDNA:LD20207" CDMC35493 3 22 3 DAC05-K01 1-CG11397-RA_1 CG11397 GTGGGTGGAACAATTGAGGGGGATAACACGATAGCTGCCGAGAACCAAGACGATACCCCCACGAAGAA 68 FBan0011397 FBgn0015391 glu 2 2L chromatin assembly or disassembly; GO:0006333; mitosis; GO:0007067; mitotic chromosome condensation; GO:0007076; mitotic sister chromatid segregation; GO:0000070; peripheral nervous system development; GO:0007422 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; nucleotide binding; GO:0000166; ; GO:0003682; ATPase activity; GO:0016887; ; GO:0000166; ; GO:0016887 chromatin; GO:0000785; chromosome; GO:0005694; condensin complex; GO:0000796; cytoplasm; GO:0005737; nucleus; GO:0005634 glu gluon "CG11397, l(2)k08819, SMC4, BcDNA.LD20207, DmSMC4/gluon, Gluon, anon-WO0118547.156, BcDNA:LD20207" CDMC35494 3 23 3 DAC05-K13 18-CG11648-RA_4 CG11648 CCAGAGATCTCTAGCATGCGGGATAGGAATATGTGACCACAATGAGGAGCAAGGATGTGGATGAGCAA 68 FBan0011648 FBgn0000015 Abd-B 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; male gonad development; GO:0008584; midgut development; GO:0007494; negative regulation of cardioblast cell fate specification; GO:0009997; negative regulation of salivary gland determination; GO:0045705; negative regulation of striated muscle development; GO:0045843; pigmentation during development; GO:0048066; pole cell migration; GO:0007280; positive regulation of pigmentation; GO:0048087; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; specification of segmental identity, abdomen; GO:0007385; spiracle morphogenesis; GO:0035277" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Abd-B Abdominal B "CG11648, CG10291, tuh-3, Mcp: Miscadastral pigmentation, iab-5, iab-8, iab-7, AbdB, twig, Sab: Superabdominal, Tab: Transabdominal, iab5: infra-abdominal 5, iab6: infra-abdominal 6, iab7: infra-abdominal 7, iab8: infra-abdominal 8, iab9: infra-abdominal 9, Male chauvinist pigmentation, Miscadastral pigmentation, Superabdominal, Transabdominal, infra-abdominal 5, infra-abdominal 6, infra-abdominal 7, infra-abdominal 8, infra-abdominal 9, Mc: Microcephalus, FAB, MCP, Fab7, DROABDB, Fab-7, Abd B, abdB, AbdB(CA)[[26]], ABDB, pH189, abd-B, AbdB-I, AbdB-II, iab-6, Abd-b, Abdominal-B, AdbB, Uab-5[Sab], iab8.9: infraabdominal-8.9, iab: infraabdominal, l(3)89Ed, Microcephalus, infraabdominal-8.9, infraabdominal, Mcp, iab6, iab7, iab8, iab9, Mc, iab5, Sab, Tab" CDMC35494 3 24 3 DAC05-K13 18-CG11648-RA_4 CG11648 CCAGAGATCTCTAGCATGCGGGATAGGAATATGTGACCACAATGAGGAGCAAGGATGTGGATGAGCAA 68 FBan0011648 FBgn0000015 Abd-B 3 3R "determination of anterior/posterior axis, embryo; GO:0008595; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; germ cell migration; GO:0008354; gonad development; GO:0008406; gonadal mesoderm development; GO:0007506; heart development; GO:0007507; male gonad development; GO:0008584; midgut development; GO:0007494; negative regulation of cardioblast cell fate specification; GO:0009997; negative regulation of salivary gland determination; GO:0045705; negative regulation of striated muscle development; GO:0045843; pigmentation during development; GO:0048066; pole cell migration; GO:0007280; positive regulation of pigmentation; GO:0048087; regulation of transcription from RNA polymerase II promoter; GO:0006357; salivary gland development; GO:0007431; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; specification of segmental identity, abdomen; GO:0007385; spiracle morphogenesis; GO:0035277" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Abd-B Abdominal B "CG11648, CG10291, tuh-3, Mcp: Miscadastral pigmentation, iab-5, iab-8, iab-7, AbdB, twig, Sab: Superabdominal, Tab: Transabdominal, iab5: infra-abdominal 5, iab6: infra-abdominal 6, iab7: infra-abdominal 7, iab8: infra-abdominal 8, iab9: infra-abdominal 9, Male chauvinist pigmentation, Miscadastral pigmentation, Superabdominal, Transabdominal, infra-abdominal 5, infra-abdominal 6, infra-abdominal 7, infra-abdominal 8, infra-abdominal 9, Mc: Microcephalus, FAB, MCP, Fab7, DROABDB, Fab-7, Abd B, abdB, AbdB(CA)[[26]], ABDB, pH189, abd-B, AbdB-I, AbdB-II, iab-6, Abd-b, Abdominal-B, AdbB, Uab-5[Sab], iab8.9: infraabdominal-8.9, iab: infraabdominal, l(3)89Ed, Microcephalus, infraabdominal-8.9, infraabdominal, Mcp, iab6, iab7, iab8, iab9, Mc, iab5, Sab, Tab" CDMC35495 3 25 3 DAC05-O01 18-CG12142-RA_16 CG12142 TGATTGTCTTGGTCATACTGGAAGTTCTAGCAGTTGGGTTCCTGTGGGTTTTCCAAACCTCGCTGCTG 68 FBan0012142 FBgn0033128 Tsp42Eg 2 2R integral to membrane; GO:0016021 Tsp42Eg Tetraspanin 42Eg "CG12142, CG12142, CG12142, Dm.Tsp42Eg, tetraspanin 42E, BcDNA:GM06962, Tetraspanin 42Eg" CDMC35495 3 26 3 DAC05-O01 18-CG12142-RA_16 CG12142 TGATTGTCTTGGTCATACTGGAAGTTCTAGCAGTTGGGTTCCTGTGGGTTTTCCAAACCTCGCTGCTG 68 FBan0012142 FBgn0033128 Tsp42Eg 2 2R integral to membrane; GO:0016021 Tsp42Eg Tetraspanin 42Eg "CG12142, CG12142, CG12142, Dm.Tsp42Eg, tetraspanin 42E, BcDNA:GM06962, Tetraspanin 42Eg" CDMC35496 3 1 4 DAC05-O13 2-CG12253-RA_1 CG12253 GGTCACCTACGCATCGGCTAGAAAGTGTCTCAATCTGCTGATGAGTCGCTTCGGTATCCTTGCCACCG 68 FBan0012253 FBgn0026148 CG12253 2 2L CG12253 CG12253 "LD08487, BEST:LD08487" CDMC35496 3 2 4 DAC05-O13 2-CG12253-RA_1 CG12253 GGTCACCTACGCATCGGCTAGAAAGTGTCTCAATCTGCTGATGAGTCGCTTCGGTATCCTTGCCACCG 68 FBan0012253 FBgn0026148 CG12253 2 2L CG12253 CG12253 "LD08487, BEST:LD08487" CDMC35497 3 3 4 DAC06-C01 15-CG33005-RB_1 CG33005 GGCTCTCAAGCCGACACTCAGCCTCATGGAGGAGTTCGGCATTCGGGAGCTAAAAATGATGTAGTATAA 69 FBgn0053005 CDMC35497 3 4 4 DAC06-C01 15-CG33005-RB_1 CG33005 GGCTCTCAAGCCGACACTCAGCCTCATGGAGGAGTTCGGCATTCGGGAGCTAAAAATGATGTAGTATAA 69 FBgn0053005 CDMC35498 3 5 4 DAC06-C13 10-CG33038-RA_1 CG33038 GCTCTCCGCTGATCTGAATCACATGCGTGAACGTTCGGCTTGCATTGATCGCTTCTCCAAAATCTACGG 69 FBgn0053038 CDMC35498 3 6 4 DAC06-C13 10-CG33038-RA_1 CG33038 GCTCTCCGCTGATCTGAATCACATGCGTGAACGTTCGGCTTGCATTGATCGCTTCTCCAAAATCTACGG 69 FBgn0053038 CDMC35499 3 7 4 DAC06-G01 23-CG33070-RA_7 CG33070 GTTGCCGAGCATTAACCTGTAACCCTTTTAGATCCACTTACCTCTTCAGCATCTTCAGATCGCATCAAT 69 FBgn0053070 CDMC35499 3 8 4 DAC06-G01 23-CG33070-RA_7 CG33070 GTTGCCGAGCATTAACCTGTAACCCTTTTAGATCCACTTACCTCTTCAGCATCTTCAGATCGCATCAAT 69 FBgn0053070 CDMC35500 3 9 4 DAC06-G13 3-CG33084-RA_3 CG33084 GGCTGAGGATCTCAATCCCAACGACTATCAAGCCATCGATATCCGCACGAGCTACGGTGATGCAGGAGA 69 FBgn0053084 CDMC35500 3 10 4 DAC06-G13 3-CG33084-RA_3 CG33084 GGCTGAGGATCTCAATCCCAACGACTATCAAGCCATCGATATCCGCACGAGCTACGGTGATGCAGGAGA 69 FBgn0053084 CDMC35501 3 11 4 DAC06-K01 14-CG33108-RA_1 CG33108 GGCAGTCCCACGGCAGATGATCTCCTCAAGGATGCAATCGACCAGGAGTATACCCTTAATGGTGAACTA 69 FBan0033108 FBgn0053108 CG33108 3 3R CG33108 CG33108 "CG5926, CG5926, CG5926, BcDNA:RE26840" CDMC35501 3 12 4 DAC06-K01 14-CG33108-RA_1 CG33108 GGCAGTCCCACGGCAGATGATCTCCTCAAGGATGCAATCGACCAGGAGTATACCCTTAATGGTGAACTA 69 FBan0033108 FBgn0053108 CG33108 3 3R CG33108 CG33108 "CG5926, CG5926, CG5926, BcDNA:RE26840" CDMC35502 3 13 4 DAC06-K13 23-CG33116-RA_17 CG33116 GCATCGGATTGCGCTATTTTGGATTAGTTGCGAGTTATTTTGCAAGTTTTTCTGTATATCAAGGAGGCT 69 FBan0033116 FBgn0053116 CG33116 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-alcohol phosphotransferase activity; GO:0008414; ; GO:0008414 CG33116 CG33116 "CG10355, CG10355" CDMC35502 3 14 4 DAC06-K13 23-CG33116-RA_17 CG33116 GCATCGGATTGCGCTATTTTGGATTAGTTGCGAGTTATTTTGCAAGTTTTTCTGTATATCAAGGAGGCT 69 FBan0033116 FBgn0053116 CG33116 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 CDP-alcohol phosphotransferase activity; GO:0008414; ; GO:0008414 CG33116 CG33116 "CG10355, CG10355" CDMC35503 3 15 4 DAC06-O01 2-CG33139-RA_1 CG33139 CCACAGGCAGTTGGTGCTCAAAGATCCCGTTTACAAGATCCCCCTTACCGAGTATCTCAAGTGGCAGCT 69 FBan0033139 FBgn0053139 Ranbp11 2 2R "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp11 Ranbp11 "CG8212, CG33139, CG8212, SP49" CDMC35503 3 16 4 DAC06-O01 2-CG33139-RA_1 CG33139 CCACAGGCAGTTGGTGCTCAAAGATCCCGTTTACAAGATCCCCCTTACCGAGTATCTCAAGTGGCAGCT 69 FBan0033139 FBgn0053139 Ranbp11 2 2R "protein import into nucleus, docking; GO:0000059" protein transporter activity; GO:0008565; ; GO:0008565; Ran GTPase binding; GO:0008536; ; GO:0008536 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Ranbp11 Ranbp11 "CG8212, CG33139, CG8212, SP49" CDMC35504 3 17 4 DAC06-O13 23-CG33144-RA_9 CG33144 GACAAGACGCCTTCGATTCTTTTTAGGTTCTGTCTCTACATATATTCTTTCCTCCCCCTAACCACACCT 69 FBan0033144 FBgn0053144 CG33144 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG33144 CG33144 "CG7621, CG12339" CDMC35504 3 18 4 DAC06-O13 23-CG33144-RA_9 CG33144 GACAAGACGCCTTCGATTCTTTTTAGGTTCTGTCTCTACATATATTCTTTCCTCCCCCTAACCACACCT 69 FBan0033144 FBgn0053144 CG33144 2 2R protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG33144 CG33144 "CG7621, CG12339" CDMC35505 3 19 4 DAC07-C01 3-CG5796-RA_4 CG5796 GGCGGTCTGGAGAACCTACCCAAAACTATGCGAAAGTACTTAGGTGAGCGGGATGTGAACGTGCAGCTA 69 FBan0005796 FBgn0020018 Ppox 3 3R electron transport; GO:0006118; heme biosynthesis; GO:0006783 protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4 mitochondrial inner membrane; GO:0005743 Ppox Protoporphyrinogen oxidase "CG5796, CG5796, Protoporphyrinogen-oxidase, protoporphyrinogen-oxidase, BcDNA:LD41392, ESTS:9F2T" CDMC35505 3 20 4 DAC07-C01 3-CG5796-RA_4 CG5796 GGCGGTCTGGAGAACCTACCCAAAACTATGCGAAAGTACTTAGGTGAGCGGGATGTGAACGTGCAGCTA 69 FBan0005796 FBgn0020018 Ppox 3 3R electron transport; GO:0006118; heme biosynthesis; GO:0006783 protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4 mitochondrial inner membrane; GO:0005743 Ppox Protoporphyrinogen oxidase "CG5796, CG5796, Protoporphyrinogen-oxidase, protoporphyrinogen-oxidase, BcDNA:LD41392, ESTS:9F2T" CDMC35506 3 21 4 DAC07-C13 15-CG5805-RA_4 CG5805 GCCAAACGGAAACCAACTCAAAACTGCATTTACGCGACGTACTGAGAACCACCAGAACTGGAGGAGATT 69 FBan0005805 FBgn0039223 CG5805 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5805 CG5805 CDMC35506 3 22 4 DAC07-C13 15-CG5805-RA_4 CG5805 GCCAAACGGAAACCAACTCAAAACTGCATTTACGCGACGTACTGAGAACCACCAGAACTGGAGGAGATT 69 FBan0005805 FBgn0039223 CG5805 3 3R transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5805 CG5805 CDMC35507 3 23 4 DAC07-G01 23-CG5844-RA_2 CG5844 AGTAAAGATCCCAAGGATAAGCCAAACGAAAAGTAGTTGTGCCATATCCAAACAAAATTATCTGTTCCA 69 FBan0005844 FBgn0038049 CG5844 3 3R fatty acid beta-oxidation; GO:0006635 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 CG5844 CG5844 Enoyl-CoA hydratase CDMC35507 3 24 4 DAC07-G01 23-CG5844-RA_2 CG5844 AGTAAAGATCCCAAGGATAAGCCAAACGAAAAGTAGTTGTGCCATATCCAAACAAAATTATCTGTTCCA 69 FBan0005844 FBgn0038049 CG5844 3 3R fatty acid beta-oxidation; GO:0006635 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; hydro-lyase activity; GO:0016836 ; EC:4.2.1.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016836 ; EC:4.2.1.-; dodecenoyl-CoA delta-isomerase activity; GO:0004165 ; EC:5.3.3.8; ; GO:0004165 ; EC:5.3.3.8 CG5844 CG5844 Enoyl-CoA hydratase CDMC35508 3 25 4 DAC07-G13 22-CG5850-RA_1 CG5850 TCCCCATCCCATATCTTGATTTGTGCTAGGCTTAGAATACTCATGAAACGAACACTTTCTAGCGGCCCA 69 FBan0005850 FBgn0032172 CG5850 2 2L CG5850 CG5850 CDMC35508 3 26 4 DAC07-G13 22-CG5850-RA_1 CG5850 TCCCCATCCCATATCTTGATTTGTGCTAGGCTTAGAATACTCATGAAACGAACACTTTCTAGCGGCCCA 69 FBan0005850 FBgn0032172 CG5850 2 2L CG5850 CG5850 CDMC35509 3 1 5 DAC07-K01 2-CG5882-RA_4 CG5882 GCGCACGTCGAGAAACTAAAGGCCAAGATCGGTTACAGGGATGGCGAGATCTCCAGACTTCAGTTGCAG 69 FBan0005882 FBgn0039490 CG5882 3 3R cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003682; ; GO:0008017; ; GO:0005200 CG5882 CG5882 CDMC35509 3 2 5 DAC07-K01 2-CG5882-RA_4 CG5882 GCGCACGTCGAGAAACTAAAGGCCAAGATCGGTTACAGGGATGGCGAGATCTCCAGACTTCAGTTGCAG 69 FBan0005882 FBgn0039490 CG5882 3 3R cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 chromatin binding; GO:0003682; nucleic acid binding; GO:0003676; microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0003676; ; GO:0003682; ; GO:0008017; ; GO:0005200 CG5882 CG5882 CDMC35510 3 3 5 DAC07-K13 23-CG5896-RA_2 CG5896 ATGGCCTGTGAGGAGAATCATCATTCGTTGGCAGTTCTTAGAGCGTTCCTTAGTATTAAGTCAAACCCA 69 FBan0005896 FBgn0039494 CG5896 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5896 CG5896 "SP2: Serine Protease 2, c-SP1, SP1, SP2" CDMC35510 3 4 5 DAC07-K13 23-CG5896-RA_2 CG5896 ATGGCCTGTGAGGAGAATCATCATTCGTTGGCAGTTCTTAGAGCGTTCCTTAGTATTAAGTCAAACCCA 69 FBan0005896 FBgn0039494 CG5896 3 3R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5896 CG5896 "SP2: Serine Protease 2, c-SP1, SP1, SP2" CDMC35511 3 5 5 DAC07-O01 16-CG5934-RA_1 CG5934 CGACCCACCGGTACTGGAAACCAAAAACCTTCTCAAATATGCCTTCTCGTTCACGCTAGAGCTACATGT 69 FBan0005934 FBgn0039505 CG5934 3 3R CG5934 CG5934 CDMC35511 3 6 5 DAC07-O01 16-CG5934-RA_1 CG5934 CGACCCACCGGTACTGGAAACCAAAAACCTTCTCAAATATGCCTTCTCGTTCACGCTAGAGCTACATGT 69 FBan0005934 FBgn0039505 CG5934 3 3R CG5934 CG5934 CDMC35512 3 7 5 DAC07-O13 8-CG5940-RA_4 CG5940 TGAGCAAGGACGACTTCGATCAGCTCTGTGAGGCTTACAATTGCAAGCAGAAAGAGGATGAGCACCAGC 69 FBan0005940 FBgn0000404 CycA 3 3L G2/M transition of mitotic cell cycle; GO:0000086; cellular physiological process; GO:0050875; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; negative regulation of mitotic metaphase/anaphase transition; GO:0045841; peripheral nervous system development; GO:0007422; regulation of mitosis; GO:0007088; regulation of progression through embryonic mitotic cell cycle; GO:0009794 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- cytoplasm; GO:0005737; fusome; GO:0045169; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; nucleus; GO:0005634; spectrosome; GO:0045170 CycA Cyclin A "CG5940, rsg11, rose-gespleten region interval 11, cycA, cyclin A, l(3)183, S(rux)3B, Suppressor of rux 3B, 0033/02, 0040/24, 0046/23, 0104/07, 0245/34, 0521/06, 0545/13, 1329/16, 1449/05, CyclinA, DmcycA, anon-WO0140519.128, hari, l(3)03946, l(3)68Ea, l(3)j3C8, l(3)neo114, l(3)rsg11" CDMC35512 3 8 5 DAC07-O13 8-CG5940-RA_4 CG5940 TGAGCAAGGACGACTTCGATCAGCTCTGTGAGGCTTACAATTGCAAGCAGAAAGAGGATGAGCACCAGC 69 FBan0005940 FBgn0000404 CycA 3 3L G2/M transition of mitotic cell cycle; GO:0000086; cellular physiological process; GO:0050875; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; negative regulation of mitotic metaphase/anaphase transition; GO:0045841; peripheral nervous system development; GO:0007422; regulation of mitosis; GO:0007088; regulation of progression through embryonic mitotic cell cycle; GO:0009794 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- cytoplasm; GO:0005737; fusome; GO:0045169; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; nucleus; GO:0005634; spectrosome; GO:0045170 CycA Cyclin A "CG5940, rsg11, rose-gespleten region interval 11, cycA, cyclin A, l(3)183, S(rux)3B, Suppressor of rux 3B, 0033/02, 0040/24, 0046/23, 0104/07, 0245/34, 0521/06, 0545/13, 1329/16, 1449/05, CyclinA, DmcycA, anon-WO0140519.128, hari, l(3)03946, l(3)68Ea, l(3)j3C8, l(3)neo114, l(3)rsg11" CDMC35513 3 9 5 DAC08-C01 1-CG8234-RA_3 CG8234 CGATGCCGATCGTCAGGCCACTCAGAACACCTGTTTGGAGCTGTTTAAGCGAAACAATCTGAAGCCACT 69 FBan0008234 FBgn0033644 CG8234 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005353; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG8234 CG8234 CDMC35513 3 10 5 DAC08-C01 1-CG8234-RA_3 CG8234 CGATGCCGATCGTCAGGCCACTCAGAACACCTGTTTGGAGCTGTTTAAGCGAAACAATCTGAAGCCACT 69 FBan0008234 FBgn0033644 CG8234 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 fructose transporter activity; GO:0005353; glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005353; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG8234 CG8234 CDMC35514 3 11 5 DAC08-C13 11-CG8247-RA_2 CG8247 GCAGCGATTGGAGGACTTGGTTCAAATCTCTTTGCTGCTAGTCGAGCACTTTCAGCTGGAAGTCAACCG 69 FBan0008247 FBgn0033348 CG8247 2 2R cellularization; GO:0007349; cytoskeleton organization and biogenesis; GO:0007010 cytoplasm; GO:0005737; membrane; GO:0016020 CG8247 CG8247 CDMC35514 3 12 5 DAC08-C13 11-CG8247-RA_2 CG8247 GCAGCGATTGGAGGACTTGGTTCAAATCTCTTTGCTGCTAGTCGAGCACTTTCAGCTGGAAGTCAACCG 69 FBan0008247 FBgn0033348 CG8247 2 2R cellularization; GO:0007349; cytoskeleton organization and biogenesis; GO:0007010 cytoplasm; GO:0005737; membrane; GO:0016020 CG8247 CG8247 CDMC35515 3 13 5 DAC08-G01 15-CG8288-RA_8 CG8288 CGCGATAAGGGCCATTTGAGCAGACCTCGACTGCGGAATCCCCAATGGTTTCTGCGCAAGGAAATTACA 69 FBan0008288 FBgn0030686 mRpL3 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial small ribosomal subunit; GO:0005763 mRpL3 mitochondrial ribosomal protein L3 "CG8288, CG8288, CG8288, L3, mitochondrial ribosomal protein L3" CDMC35515 3 14 5 DAC08-G01 15-CG8288-RA_8 CG8288 CGCGATAAGGGCCATTTGAGCAGACCTCGACTGCGGAATCCCCAATGGTTTCTGCGCAAGGAAATTACA 69 FBan0008288 FBgn0030686 mRpL3 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762; mitochondrial small ribosomal subunit; GO:0005763 mRpL3 mitochondrial ribosomal protein L3 "CG8288, CG8288, CG8288, L3, mitochondrial ribosomal protein L3" CDMC35516 3 15 5 DAC08-G13 17-CG8299-RA_1 CG8299 CCCCCATGCCGGCTACAATAAGAAAACGTATGTGAATGATATCGGTTTGATCATCACTCGCGAGCCATT 69 FBan0008299 FBgn0034052 CG8299 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8299 CG8299 SP65 CDMC35516 3 16 5 DAC08-G13 17-CG8299-RA_1 CG8299 CCCCCATGCCGGCTACAATAAGAAAACGTATGTGAATGATATCGGTTTGATCATCACTCGCGAGCCATT 69 FBan0008299 FBgn0034052 CG8299 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG8299 CG8299 SP65 CDMC35517 3 17 5 DAC08-K01 23-CG8328-RA_1 CG8328 TGATGTTCCTGTGATAGTTCTTAAGTTCGTATTTTGTATTTGATCTCCCATAGGCTTACTGATTCATGT 69 FBan0008328 FBgn0002734 HLHmdelta 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0003677; ; GO:0016564 nucleus; GO:0005634 HLHmdelta E(spl) region transcript mdelta "CG8328, mC, HLH-mdelta, mdelta, E(spl)mdelta, E(spl)delta, E(spl) mdelta, E(spl)Mdelta, split locus enhancer protein mC, E(spl)-mdelta, E(Spl) HLH-m delta, E(spl)mdelta, HLHMD, E(spl)mC, E(spl)mbeta, mdelta0.5, E(Spl)-HLH-mdelta, HLHmdelta, HLHmC: Enhancer of split region transcript HLHmC, Enhancer of split region transcript HLHmC" CDMC35517 3 18 5 DAC08-K01 23-CG8328-RA_1 CG8328 TGATGTTCCTGTGATAGTTCTTAAGTTCGTATTTTGTATTTGATCTCCCATAGGCTTACTGATTCATGT 69 FBan0008328 FBgn0002734 HLHmdelta 3 3R Notch signaling pathway; GO:0007219; cell proliferation; GO:0008283; ectoderm development; GO:0007398; eye development (sensu Endopterygota); GO:0007456; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; specific transcriptional repressor activity; GO:0016566; ; GO:0003700; transcriptional repressor activity; GO:0016564; ; GO:0016566; ; GO:0003677; ; GO:0016564 nucleus; GO:0005634 HLHmdelta E(spl) region transcript mdelta "CG8328, mC, HLH-mdelta, mdelta, E(spl)mdelta, E(spl)delta, E(spl) mdelta, E(spl)Mdelta, split locus enhancer protein mC, E(spl)-mdelta, E(Spl) HLH-m delta, E(spl)mdelta, HLHMD, E(spl)mC, E(spl)mbeta, mdelta0.5, E(Spl)-HLH-mdelta, HLHmdelta, HLHmC: Enhancer of split region transcript HLHmC, Enhancer of split region transcript HLHmC" CDMC35518 3 19 5 DAC08-K13 2-CG8342-RA_1 CG8342 AGCCAGTATGCGGAACTGATGGCCAGAACTTCAAGGAGTTTGCTAGCACCTGCAATCTTTTGTCCCACA 69 FBan0008342 FBgn0002578 m1 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 m1 E(spl) region transcript m1 "CG8342, CG8342, E(spl)m1, E(spl)-m1, BcDNA:RE44854" CDMC35518 3 20 5 DAC08-K13 2-CG8342-RA_1 CG8342 AGCCAGTATGCGGAACTGATGGCCAGAACTTCAAGGAGTTTGCTAGCACCTGCAATCTTTTGTCCCACA 69 FBan0008342 FBgn0002578 m1 3 3R serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 m1 E(spl) region transcript m1 "CG8342, CG8342, E(spl)m1, E(spl)-m1, BcDNA:RE44854" CDMC35519 3 21 5 DAC08-O01 18-CG8385-RB_4 CG8385 GCGAACTTATTCAAAGGCCTATTCGGCAAAAAGGAAATGAGGATATTGATGGTCGGTTTGGATGCCGCT 69 FBan0008385 FBgn0010348 Arf79F 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; regulation of cell shape; GO:0008360; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 Arf79F ADP ribosylation factor 79F "CG8385, ARF1, dARFI, ARF-1, Arf1, ADP-ribosylation factor 1, Dm Arf79F, Darf1" CDMC35519 3 22 5 DAC08-O01 18-CG8385-RB_4 CG8385 GCGAACTTATTCAAAGGCCTATTCGGCAAAAAGGAAATGAGGATATTGATGGTCGGTTTGGATGCCGCT 69 FBan0008385 FBgn0010348 Arf79F 3 3L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; endosome transport; GO:0016197; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein amino acid ADP-ribosylation; GO:0006471; protein transport; GO:0015031; regulation of cell shape; GO:0008360; synaptic vesicle endocytosis; GO:0048488 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 Arf79F ADP ribosylation factor 79F "CG8385, ARF1, dARFI, ARF-1, Arf1, ADP-ribosylation factor 1, Dm Arf79F, Darf1" CDMC35520 3 23 5 DAC08-O13 5-CG8402-RA_1 CG8402 CCGCGAGCTGCTTCACTACTTAAGTACGAGTATGGCGAGTCCATAAGGCGTAGGACGAGTGGAGGACGG 69 FBan0008402 FBgn0005777 PpD3 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737; nucleus; GO:0005634 PpD3 Protein phosphatase D3 "CG8402, CG8402, CG8402, D3, PP5 85E, PP5, protein phosphatase from PCR fragment D3, DmPP5, Pp5-85E" CDMC35520 3 24 5 DAC08-O13 5-CG8402-RA_1 CG8402 CCGCGAGCTGCTTCACTACTTAAGTACGAGTATGGCGAGTCCATAAGGCGTAGGACGAGTGGAGGACGG 69 FBan0008402 FBgn0005777 PpD3 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 cytoplasm; GO:0005737; nucleus; GO:0005634 PpD3 Protein phosphatase D3 "CG8402, CG8402, CG8402, D3, PP5 85E, PP5, protein phosphatase from PCR fragment D3, DmPP5, Pp5-85E" CDMC35521 3 25 5 DAC09-C02 1-CG12822-RA_1 CG12822 ACACCCGTGTTGGACATTAAGCCCTACATTCCACACTACGATGCACCATCCTTGAGCGTTGACTCAGGT 69 FBan0012822 FBgn0033229 CG12822 2 2R CG12822 CG12822 CDMC35521 3 26 5 DAC09-C02 1-CG12822-RA_1 CG12822 ACACCCGTGTTGGACATTAAGCCCTACATTCCACACTACGATGCACCATCCTTGAGCGTTGACTCAGGT 69 FBan0012822 FBgn0033229 CG12822 2 2R CG12822 CG12822 CDMC35522 3 1 6 DAC09-C14 23-CG12839-RA_1 CG12839 TGTTGGCAACGCATAATCCGATATCTATGGATTTTTATAGCAGTTTAAGATGATCTGGAGGCAACAGAA 69 FBan0012839 FBgn0033135 Tsp42En 2 2R integral to membrane; GO:0016021 Tsp42En Tetraspanin 42En "CG12839, CG12839, CG12839, Dm.Tsp42En, tetraspanin 42E, BcDNA:RH02160, Tetraspanin 42En" CDMC35522 3 2 6 DAC09-C14 23-CG12839-RA_1 CG12839 TGTTGGCAACGCATAATCCGATATCTATGGATTTTTATAGCAGTTTAAGATGATCTGGAGGCAACAGAA 69 FBan0012839 FBgn0033135 Tsp42En 2 2R integral to membrane; GO:0016021 Tsp42En Tetraspanin 42En "CG12839, CG12839, CG12839, Dm.Tsp42En, tetraspanin 42E, BcDNA:RH02160, Tetraspanin 42En" CDMC35523 3 3 6 DAC09-G02 1-CG12866-RA_1 CG12866 GGCATCCTCGCTTACAAAAGGCGTAGTTGGACCCTCGGACTTTGTGGTTGTGGTCTAATTTTCGGTGGT 69 FBan0012866 FBgn0033955 CG12866 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG12866 CG12866 CDMC35523 3 4 6 DAC09-G02 1-CG12866-RA_1 CG12866 GGCATCCTCGCTTACAAAAGGCGTAGTTGGACCCTCGGACTTTGTGGTTGTGGTCTAATTTTCGGTGGT 69 FBan0012866 FBgn0033955 CG12866 2 2R cation transport; GO:0006812 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG12866 CG12866 CDMC35524 3 5 6 DAC09-G14 3-CG1287-RA_1 CG1287 TCATTGGTTACCCTGGGACTGGTAATGCTCAGTGGATCCATTGCACAAGGCCTAGAATATCAGCCGGGA 69 FBan0001287 FBgn0037506 CG1287 3 3R CG1287 CG1287 BEST:GH03396 CDMC35524 3 6 6 DAC09-G14 3-CG1287-RA_1 CG1287 TCATTGGTTACCCTGGGACTGGTAATGCTCAGTGGATCCATTGCACAAGGCCTAGAATATCAGCCGGGA 69 FBan0001287 FBgn0037506 CG1287 3 3R CG1287 CG1287 BEST:GH03396 CDMC35525 3 7 6 DAC09-K02 11-CG1291-RA_1 CG1291 TGTGCTGTATCCTTCACTGCACACCCAGTACTTTGACCAGATGCAGAAAAAGCTAGAACAGCGGTCTGC 69 FBan0001291 FBgn0035401 CG1291 3 3L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 glycolipid mannosyltransferase activity; GO:0004376 ; EC:2.4.1.-; ; GO:0004376 ; EC:2.4.1.- CG1291 CG1291 CDMC35525 3 8 6 DAC09-K02 11-CG1291-RA_1 CG1291 TGTGCTGTATCCTTCACTGCACACCCAGTACTTTGACCAGATGCAGAAAAAGCTAGAACAGCGGTCTGC 69 FBan0001291 FBgn0035401 CG1291 3 3L polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 glycolipid mannosyltransferase activity; GO:0004376 ; EC:2.4.1.-; ; GO:0004376 ; EC:2.4.1.- CG1291 CG1291 CDMC35526 3 9 6 DAC09-K14 1-CG12942-RA_1 CG12942 AGTGCACTACGAACGGGCTCATGTCAATGAGGAACCAGTTAGCTGCCTTACCTGTGGCAATCAGTTCCA 69 FBan0012942 FBgn0033569 CG12942 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12942 CG12942 CDMC35526 3 10 6 DAC09-K14 1-CG12942-RA_1 CG12942 AGTGCACTACGAACGGGCTCATGTCAATGAGGAACCAGTTAGCTGCCTTACCTGTGGCAATCAGTTCCA 69 FBan0012942 FBgn0033569 CG12942 2 2R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG12942 CG12942 CDMC35527 3 11 6 DAC09-O02 15-CG12991-RA_2 CG12991 GTGCCGAAAGCGAGCATAGATCGCGAAAATCGAAGGTTCTATCCGCGGAGTATAAGCACATCAATCGCT 69 FBan0012991 FBgn0030847 CG12991 X X CG12991 CG12991 CDMC35527 3 12 6 DAC09-O02 15-CG12991-RA_2 CG12991 GTGCCGAAAGCGAGCATAGATCGCGAAAATCGAAGGTTCTATCCGCGGAGTATAAGCACATCAATCGCT 69 FBan0012991 FBgn0030847 CG12991 X X CG12991 CG12991 CDMC35528 3 13 6 DAC09-O14 24-CG13001-RA_3 CG13001 GCATTAATATTTTATACATTACTAGTGTATTTGAAAATCGATGAAGAAATTATTCATGACACGCCGGCC 69 FBan0013001 FBgn0030806 CG13001 X X CG13001 CG13001 CDMC35528 3 14 6 DAC09-O14 24-CG13001-RA_3 CG13001 GCATTAATATTTTATACATTACTAGTGTATTTGAAAATCGATGAAGAAATTATTCATGACACGCCGGCC 69 FBan0013001 FBgn0030806 CG13001 X X CG13001 CG13001 CDMC35529 3 15 6 DAC10-C01 3-CG10951-RA_4 CG10951 GGCGACCTACCGCCTCGGAGGTATTGGTCTACTGGATTCCACTGATATTCCGTAGCCTGGGAAAGAACA 69 FBgn0039230 CDMC35529 3 16 6 DAC10-C01 3-CG10951-RA_4 CG10951 GGCGACCTACCGCCTCGGAGGTATTGGTCTACTGGATTCCACTGATATTCCGTAGCCTGGGAAAGAACA 69 FBgn0039230 CDMC35530 3 17 6 DAC10-C13 18-CG10962-RA_1 CG10962 GGCGCTGGCTGTGAAAATGAATTCCGCGAATGGCAAACCAACATGAACAACCATAAAGAAATGCAAAGT 69 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC35530 3 18 6 DAC10-C13 18-CG10962-RA_1 CG10962 GGCGCTGGCTGTGAAAATGAATTCCGCGAATGGCAAACCAACATGAACAACCATAAAGAAATGCAAAGT 69 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC35531 3 19 6 DAC10-G01 2-CG10996-RA_1 CG10996 AGGTTGTGGAGGACATCTTTGGTATTGCGACCAATCCGTTTACCAAACAGGCCCAAGTGATTCGTCGCT 69 FBan0010996 FBgn0030525 CG10996 X X galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG10996 CG10996 CDMC35531 3 20 6 DAC10-G01 2-CG10996-RA_1 CG10996 AGGTTGTGGAGGACATCTTTGGTATTGCGACCAATCCGTTTACCAAACAGGCCCAAGTGATTCGTCGCT 69 FBan0010996 FBgn0030525 CG10996 X X galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG10996 CG10996 CDMC35532 3 21 6 DAC10-G13 23-CG11019-RA_6 CG11019 TGTGCGGAGTACATATGTAATAGGGCCATGAAGTTTTATTGAAAAACGAGGCAGAGACAAGGCGAAAGG 69 FBan0011019 FBgn0040998 CG11019 2 2L CG11019 CG11019 38C.49 CDMC35532 3 22 6 DAC10-G13 23-CG11019-RA_6 CG11019 TGTGCGGAGTACATATGTAATAGGGCCATGAAGTTTTATTGAAAAACGAGGCAGAGACAAGGCGAAAGG 69 FBan0011019 FBgn0040998 CG11019 2 2L CG11019 CG11019 38C.49 CDMC35533 3 23 6 DAC10-K01 12-CG11055-RC_1 CG11055 AGCTGCGGAGGCTAACAAACTTCAATGTCGGAGATATGCCAAGGTTTTTTGTCTATCCCACGCCAAGGT 69 FBan0011055 FBgn0034491 CG11055 2 2R fatty acid metabolism; GO:0006631; steroid metabolism; GO:0008202 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11055 CG11055 CDMC35533 3 24 6 DAC10-K01 12-CG11055-RC_1 CG11055 AGCTGCGGAGGCTAACAAACTTCAATGTCGGAGATATGCCAAGGTTTTTTGTCTATCCCACGCCAAGGT 69 FBan0011055 FBgn0034491 CG11055 2 2R fatty acid metabolism; GO:0006631; steroid metabolism; GO:0008202 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11055 CG11055 CDMC35534 3 25 6 DAC10-K13 24-CG11063-RB_2 CG11063 GCACAAAACCAGAACAAACTATCGCAATCAACTTATTCCAATTAACAATATTATCTTAAATAGACAGAA 69 FBan0011063 FBgn0030530 CG11063 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 actin binding; GO:0003779; ; GO:0003779; thyroid hormone receptor binding; GO:0046966; ; GO:0046966; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0046966; ; GO:0008270; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 CG11063 CG11063 CDMC35534 3 26 6 DAC10-K13 24-CG11063-RB_2 CG11063 GCACAAAACCAGAACAAACTATCGCAATCAACTTATTCCAATTAACAATATTATCTTAAATAGACAGAA 69 FBan0011063 FBgn0030530 CG11063 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 actin binding; GO:0003779; ; GO:0003779; thyroid hormone receptor binding; GO:0046966; ; GO:0046966; transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0046966; ; GO:0008270; ligand-dependent nuclear receptor binding; GO:0016922; ; GO:0016922 CG11063 CG11063 CDMC35535 3 1 7 DAC10-O01 23-CG1109-RA_2 CG1109 CGCTATCCCACCAACACTGTTTTCTGCCAATCTCCTTTGCATCTTTTGCTTTGTAATGCTGAAATCAAT 69 FBan0001109 FBgn0046222 CG1109 3 3R CG1109 CG1109 BcDNA:LD24014 CDMC35535 3 2 7 DAC10-O01 23-CG1109-RA_2 CG1109 CGCTATCCCACCAACACTGTTTTCTGCCAATCTCCTTTGCATCTTTTGCTTTGTAATGCTGAAATCAAT 69 FBan0001109 FBgn0046222 CG1109 3 3R CG1109 CG1109 BcDNA:LD24014 CDMC35536 3 3 7 DAC10-O13 2-CG11120-RA_1 CG11120 GCGGCGCATTGACATGTTCAAGGGTAGAACAACCAAGGACCAGAAGGAGAAAGGAGAGTTTATCCGCGG 69 FBan0011120 FBgn0039250 CG11120 3 3R CG11120 CG11120 CDMC35536 3 4 7 DAC10-O13 2-CG11120-RA_1 CG11120 GCGGCGCATTGACATGTTCAAGGGTAGAACAACCAAGGACCAGAAGGAGAAAGGAGAGTTTATCCGCGG 69 FBan0011120 FBgn0039250 CG11120 3 3R CG11120 CG11120 CDMC35537 3 5 7 DAC11-C01 14-CG1218-RA_6 CG1218 TCCAATACGAGTGCTTCAAGTACGGAGATGGTGAACAAGGATACAGCCAAGGGCAGTTATGAAGCCGAA 69 FBan0001218 FBgn0037377 CG1218 3 3R CG1218 CG1218 CDMC35537 3 6 7 DAC11-C01 14-CG1218-RA_6 CG1218 TCCAATACGAGTGCTTCAAGTACGGAGATGGTGAACAAGGATACAGCCAAGGGCAGTTATGAAGCCGAA 69 FBan0001218 FBgn0037377 CG1218 3 3R CG1218 CG1218 CDMC35538 3 7 7 DAC11-C13 2-CG12205-RA_2 CG12205 AGCGTTTGGAATTCGCCCTGACCCTATTGCCCTATGATCCCGAGACAGTTCAGTTGTCTGAAACGCAGA 69 FBan0012205 FBgn0000227 Bsg25A 2 2L Bsg25A Blastoderm-specific gene 25A "CG12205, bsg25A, blastoderm-specific gene 25A, clone 1.70, anon-EST:Liang-1.70" CDMC35538 3 8 7 DAC11-C13 2-CG12205-RA_2 CG12205 AGCGTTTGGAATTCGCCCTGACCCTATTGCCCTATGATCCCGAGACAGTTCAGTTGTCTGAAACGCAGA 69 FBan0012205 FBgn0000227 Bsg25A 2 2L Bsg25A Blastoderm-specific gene 25A "CG12205, bsg25A, blastoderm-specific gene 25A, clone 1.70, anon-EST:Liang-1.70" CDMC35539 3 9 7 DAC11-G01 2-CG12232-RA_3 CG12232 TGGAACGATGTGGGTATTCGCGCCTGCTATGATCGCTCAAATGAGTTTCCCCTGCTGGATAGTGCGAAA 69 FBan0012232 FBgn0010223 Galpha73B 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; mesoderm development; GO:0007498 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Galpha73B G protein alpha 73B "CG12232, Gfalpha, Gfalpha, GTP-binding protein alpha-subunit, Galpha73B" CDMC35539 3 10 7 DAC11-G01 2-CG12232-RA_3 CG12232 TGGAACGATGTGGGTATTCGCGCCTGCTATGATCGCTCAAATGAGTTTCCCCTGCTGGATAGTGCGAAA 69 FBan0012232 FBgn0010223 Galpha73B 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; mesoderm development; GO:0007498 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 Galpha73B G protein alpha 73B "CG12232, Gfalpha, Gfalpha, GTP-binding protein alpha-subunit, Galpha73B" CDMC35540 3 11 7 DAC11-G13 23-CG12249-RA_7 CG12249 ACAGCCAGAGGTGTTTCTGAAATCTCTTTCGAGCACTCTCCGACTAAATTCCAAATCTGATTGTTTTCT 69 FBan0012249 FBgn0021776 mira 3 3R asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; cytoskeleton organization and biogenesis; GO:0007010; ganglion mother cell fate determination; GO:0007402; intracellular mRNA localization; GO:0008298; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 apical part of cell; GO:0045177; basal cortex; GO:0045180; basal part of cell; GO:0045178; cell cortex; GO:0005938; cytoplasm; GO:0005737 mira miranda "CG12249, CG12249, mir, Miranda, MIR, Mir, miranda" CDMC35540 3 12 7 DAC11-G13 23-CG12249-RA_7 CG12249 ACAGCCAGAGGTGTTTCTGAAATCTCTTTCGAGCACTCTCCGACTAAATTCCAAATCTGATTGTTTTCT 69 FBan0012249 FBgn0021776 mira 3 3R asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; cytoskeleton organization and biogenesis; GO:0007010; ganglion mother cell fate determination; GO:0007402; intracellular mRNA localization; GO:0008298; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 apical part of cell; GO:0045177; basal cortex; GO:0045180; basal part of cell; GO:0045178; cell cortex; GO:0005938; cytoplasm; GO:0005737 mira miranda "CG12249, CG12249, mir, Miranda, MIR, Mir, miranda" CDMC35541 3 13 7 DAC11-K01 17-CG12295-RB_5 CG12295 ACTGAAAATTCCAACAACGGCCTTAAACGACTTGCAACCTTCAAGTAAGCTGAATGCAAAGCGCTGTCA 69 FBan0012295 FBgn0033870 CG12295 2 2R cation transport; GO:0006812; muscle contraction; GO:0006936 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 voltage-gated calcium channel complex; GO:0005891 CG12295 CG12295 alpha[[2]]delta CDMC35541 3 14 7 DAC11-K01 17-CG12295-RB_5 CG12295 ACTGAAAATTCCAACAACGGCCTTAAACGACTTGCAACCTTCAAGTAAGCTGAATGCAAAGCGCTGTCA 69 FBan0012295 FBgn0033870 CG12295 2 2R cation transport; GO:0006812; muscle contraction; GO:0006936 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245 voltage-gated calcium channel complex; GO:0005891 CG12295 CG12295 alpha[[2]]delta CDMC35542 3 15 7 DAC11-K13 17-CG12304-RA_2 CG12304 ACGGCAAGCACATTTTGGAATTGATAATTTGCGCAGGTTATTGTGTTTATCCAACGATTCTCGCCGCGA 69 FBan0012304 FBgn0036515 CG12304 3 3L aminoacyl-tRNA synthetase multienzyme complex; GO:0017101 CG12304 CG12304 CDMC35542 3 16 7 DAC11-K13 17-CG12304-RA_2 CG12304 ACGGCAAGCACATTTTGGAATTGATAATTTGCGCAGGTTATTGTGTTTATCCAACGATTCTCGCCGCGA 69 FBan0012304 FBgn0036515 CG12304 3 3L aminoacyl-tRNA synthetase multienzyme complex; GO:0017101 CG12304 CG12304 CDMC35543 3 17 7 DAC11-O01 14-CG12344-RA_1 CG12344 ACTTCAAGTGCAATGCCAGTGACGCTAGGTCTTTGGATGGGAATATCTGGAAACCGAGAGCTCTATGCT 69 FBan0012344 FBgn0033558 CG12344 2 2R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0004890; ; GO:0016934 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG12344 CG12344 CDMC35543 3 18 7 DAC11-O01 14-CG12344-RA_1 CG12344 ACTTCAAGTGCAATGCCAGTGACGCTAGGTCTTTGGATGGGAATATCTGGAAACCGAGAGCTCTATGCT 69 FBan0012344 FBgn0033558 CG12344 2 2R anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016917; glycine-gated chloride channel activity; GO:0016934; ; GO:0004890; ; GO:0016934 glycine-gated chloride channel complex; GO:0016935; postsynaptic membrane; GO:0045211 CG12344 CG12344 CDMC35544 3 19 7 DAC11-O13 23-CG12348-RB_16 CG12348 GGCATTCGAAGGGTTTACAAATATTAGGACGAACTCTGAAAGCCTCAATGCGGGAATTAGGTTTACTTA 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC35544 3 20 7 DAC11-O13 23-CG12348-RB_16 CG12348 GGCATTCGAAGGGTTTACAAATATTAGGACGAACTCTGAAAGCCTCAATGCGGGAATTAGGTTTACTTA 69 FBan0012348 FBgn0003380 Sh X X behavioral response to ether; GO:0048150; courtship behavior; GO:0007619; flight behavior; GO:0007629; learning and/or memory; GO:0007611; potassium ion transport; GO:0006813; sensory perception of taste; GO:0050909; sleep; GO:0030431 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515; ; GO:0005249 integral to membrane; GO:0016021; voltage-gated potassium channel complex; GO:0008076 Sh Shaker "CG12348, CG7640, CG17860, CG12348, CG12348, CG7640, Shw: Shaker downheld, Shaker-downheld, Sha, SH, V-I, sh, EKO, BcDNA:GH03046, F-c: F-c transcription unit, minisleep, F-c transcription unit, Shw, Shaker" CDMC35545 3 21 7 DAC12-C01 11-CG7857-RA_1 CG7857 GCGTGCTCACAAGGACTCGCTTATCTCATACATGATCCACCCGGAAACAGGAGACATTCTGAACGACCA 69 FBan0007857 FBgn0026738 CG7857 3 3L CG7857 CG7857 anon-Becker1 CDMC35545 3 22 7 DAC12-C01 11-CG7857-RA_1 CG7857 GCGTGCTCACAAGGACTCGCTTATCTCATACATGATCCACCCGGAAACAGGAGACATTCTGAACGACCA 69 FBan0007857 FBgn0026738 CG7857 3 3L CG7857 CG7857 anon-Becker1 CDMC35546 3 23 7 DAC12-C13 9-CG7872-RA_1 CG7872 TCGCGACGAGATCCAGGAAAAGATCCAGAAGAAGGGCAAGAATCGTATGTCCAAGAACGATCAGCGCGA 69 FBan0007872 FBgn0030658 CG7872 X X CG7872 CG7872 CDMC35546 3 24 7 DAC12-C13 9-CG7872-RA_1 CG7872 TCGCGACGAGATCCAGGAAAAGATCCAGAAGAAGGGCAAGAATCGTATGTCCAAGAACGATCAGCGCGA 69 FBan0007872 FBgn0030658 CG7872 X X CG7872 CG7872 CDMC35547 3 25 7 DAC12-G01 12-CG7904-RA_1 CG7904 TGCGCAGCTAAACAAGTATCCCTCAACCCAGTTGCTAATCAAGAACCACACCAACATTGACGACGCCAA 69 FBan0007904 FBgn0003169 put 3 3R Malpighian tubule morphogenesis; GO:0007443; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytokine and chemokine mediated signaling pathway; GO:0019221; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal/ventral pattern formation; GO:0009953; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; head involution; GO:0008258; mesoderm development; GO:0007498; negative regulation of salivary gland determination; GO:0045705; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; skeletal development; GO:0001501; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; activin binding; GO:0048185; transforming growth factor beta receptor activity; GO:0005024; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; ; GO:0048185; activin receptor activity; GO:0017002; ; GO:0005024; ; GO:0017002; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; activin receptor activity, type II; GO:0016362; ; GO:0016362; ; GO:0016362" activin receptor complex; GO:0048179; plasma membrane; GO:0005886 put punt "CG7904, CG7904, CG7904, TGF-beta, Atr-II, activin receptor type II, pun, STK-C, l(3)10460, activin receptor, TGF-B, Punt, atrII, Act-r, Atr88CD, Atr: Activin-A-receptor-88CD, AtrII, Tgf-r: TGF-beta-type-receptor-like, dlhC: dorsal holes C, l(3)j5A5, Activin-A-receptor-88CD, TGF-beta-type-receptor-like, dorsal holes C, punt" CDMC35547 3 26 7 DAC12-G01 12-CG7904-RA_1 CG7904 TGCGCAGCTAAACAAGTATCCCTCAACCCAGTTGCTAATCAAGAACCACACCAACATTGACGACGCCAA 69 FBan0007904 FBgn0003169 put 3 3R Malpighian tubule morphogenesis; GO:0007443; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytokine and chemokine mediated signaling pathway; GO:0019221; dendrite morphogenesis; GO:0016358; dorsal closure; GO:0007391; dorsal/ventral pattern formation; GO:0009953; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; head involution; GO:0008258; mesoderm development; GO:0007498; negative regulation of salivary gland determination; GO:0045705; primary tracheal branching (sensu Insecta); GO:0007428; protein amino acid phosphorylation; GO:0006468; skeletal development; GO:0001501; tracheal system development (sensu Insecta); GO:0007424; transforming growth factor beta receptor signaling pathway; GO:0007179 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; activin binding; GO:0048185; transforming growth factor beta receptor activity; GO:0005024; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004896; ; GO:0048185; activin receptor activity; GO:0017002; ; GO:0005024; ; GO:0017002; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; activin receptor activity, type II; GO:0016362; ; GO:0016362; ; GO:0016362" activin receptor complex; GO:0048179; plasma membrane; GO:0005886 put punt "CG7904, CG7904, CG7904, TGF-beta, Atr-II, activin receptor type II, pun, STK-C, l(3)10460, activin receptor, TGF-B, Punt, atrII, Act-r, Atr88CD, Atr: Activin-A-receptor-88CD, AtrII, Tgf-r: TGF-beta-type-receptor-like, dlhC: dorsal holes C, l(3)j5A5, Activin-A-receptor-88CD, TGF-beta-type-receptor-like, dorsal holes C, punt" CDMC35548 3 1 8 DAC12-G13 2-CG7913-RA_2 CG7913 CGGCGGTGATATTACCCATTATGTTCCCAGCGCTCAATCGCAACTCAAAGACGCACTGGAACAAGACCA 69 FBan0007913 FBgn0042693 PP2A-B' 3 3R anti-apoptosis; GO:0006916; intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 PP2A-B' PP2A-B' "CG7901, CG7913, CG7901, CG7913, CG7913, CG7901, CG7913, CG7901, CG7913, dPP2A,B', B'/PR61, PP2A B', PP2A B' subunit, PP2A, i234, B56-1, anon-WO0118547.420, BcDNA:GM05554" CDMC35548 3 2 8 DAC12-G13 2-CG7913-RA_2 CG7913 CGGCGGTGATATTACCCATTATGTTCCCAGCGCTCAATCGCAACTCAAAGACGCACTGGAACAAGACCA 69 FBan0007913 FBgn0042693 PP2A-B' 3 3R anti-apoptosis; GO:0006916; intracellular signaling cascade; GO:0007242; protein amino acid dephosphorylation; GO:0006470 protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 PP2A-B' PP2A-B' "CG7901, CG7913, CG7901, CG7913, CG7913, CG7901, CG7913, CG7901, CG7913, dPP2A,B', B'/PR61, PP2A B', PP2A B' subunit, PP2A, i234, B56-1, anon-WO0118547.420, BcDNA:GM05554" CDMC35549 3 3 8 DAC12-K01 5-CG7942-RA_1 CG7942 TGCGGCAGCTAGAAGTCTTTCGGCTGAAACAAATTTCCGGGCGAGTTGATATTTTCCTGTCCCACGACT 69 FBan0007942 FBgn0035838 CG7942 3 3L "RNA processing; GO:0006396; nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; RNA lariat debranching enzyme activity; GO:0008419; ; GO:0008419; ; GO:0003676; ; GO:0008419 spliceosome complex; GO:0005681 CG7942 CG7942 CDMC35549 3 4 8 DAC12-K01 5-CG7942-RA_1 CG7942 TGCGGCAGCTAGAAGTCTTTCGGCTGAAACAAATTTCCGGGCGAGTTGATATTTTCCTGTCCCACGACT 69 FBan0007942 FBgn0035838 CG7942 3 3L "RNA processing; GO:0006396; nuclear mRNA splicing, via spliceosome; GO:0000398" nucleic acid binding; GO:0003676; RNA lariat debranching enzyme activity; GO:0008419; ; GO:0008419; ; GO:0003676; ; GO:0008419 spliceosome complex; GO:0005681 CG7942 CG7942 CDMC35550 3 5 8 DAC12-K13 16-CG7949-RA_4 CG7949 CCACGGAAATCGAGAACATCAACCCCAATGTCTACGACAGAATCAAGGAAAGGGTATTAACCGCCAACG 69 FBan0007949 FBgn0036107 CG7949 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7949 CG7949 CDMC35550 3 6 8 DAC12-K13 16-CG7949-RA_4 CG7949 CCACGGAAATCGAGAACATCAACCCCAATGTCTACGACAGAATCAAGGAAAGGGTATTAACCGCCAACG 69 FBan0007949 FBgn0036107 CG7949 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7949 CG7949 CDMC35551 3 7 8 DAC12-O01 2-CG7988-RA_1 CG7988 CGACGAAGCGTTCTGGACACGATGTGCTCCCTTGAAGGTAAACGAGGATGAACTGATCACGGAAACGGA 69 FBan0007988 FBgn0038582 CG7988 3 3R circadian rhythm; GO:0007623 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7988 CG7988 CDMC35551 3 8 8 DAC12-O01 2-CG7988-RA_1 CG7988 CGACGAAGCGTTCTGGACACGATGTGCTCCCTTGAAGGTAAACGAGGATGAACTGATCACGGAAACGGA 69 FBan0007988 FBgn0038582 CG7988 3 3R circadian rhythm; GO:0007623 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7988 CG7988 CDMC35552 3 9 8 DAC12-O13 13-CG7999-RA_1 CG7999 TCACCGACGACATAAAAGTGGGTCTCATCAGCAGACTATACGATCTGCGAATCCAGGCAGGAAGACTGT 69 FBan0007999 FBgn0035851 MED24 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED24 Mediator complex subunit 24 "CG7999, Trap100, dTRAP100, Mediator, Med24, Mediator complex subunit 24" CDMC35552 3 10 8 DAC12-O13 13-CG7999-RA_1 CG7999 TCACCGACGACATAAAAGTGGGTCTCATCAGCAGACTATACGATCTGCGAATCCAGGCAGGAAGACTGT 69 FBan0007999 FBgn0035851 MED24 3 3L transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED24 Mediator complex subunit 24 "CG7999, Trap100, dTRAP100, Mediator, Med24, Mediator complex subunit 24" CDMC35553 3 11 8 DAC13-C01 3-CG13270-RA_1 CG13270 TGGCCACGCAACCAATGGGCTTCCTCAAACGAACTGAAAACGCTCTCAAATCCCTGCTCTTCGAATTCA 69 FBan0013270 FBgn0040262 Ugt36Ba 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Ba Ugt36Ba "CG13270, CG13270, AC 005121A" CDMC35553 3 12 8 DAC13-C01 3-CG13270-RA_1 CG13270 TGGCCACGCAACCAATGGGCTTCCTCAAACGAACTGAAAACGCTCTCAAATCCCTGCTCTTCGAATTCA 69 FBan0013270 FBgn0040262 Ugt36Ba 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17 Ugt36Ba Ugt36Ba "CG13270, CG13270, AC 005121A" CDMC35554 3 13 8 DAC13-C13 3-CG13281-RA_2 CG13281 GCCCAACCAGCAGGATCACCTGGCTGAGATTAAGGATGCTCGCCAGTTTCTAGCAACTTCGCTCTCTAA 69 FBan0013281 FBgn0022213 Cas 2 2L "apoptosis; GO:0006915; cell proliferation; GO:0008283; induction of apoptosis; GO:0006917; protein export from nucleus; GO:0006611; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" importin-alpha export receptor activity; GO:0008262; protein transporter activity; GO:0008565; ; GO:0008262; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Cas CAS/CSE1 segregation protein "CG13281, l(2)k03902, cas, Dcas, dcas, BcDNA:LD14270, CAS, CAS/CSE1 segregation protein" CDMC35554 3 14 8 DAC13-C13 3-CG13281-RA_2 CG13281 GCCCAACCAGCAGGATCACCTGGCTGAGATTAAGGATGCTCGCCAGTTTCTAGCAACTTCGCTCTCTAA 69 FBan0013281 FBgn0022213 Cas 2 2L "apoptosis; GO:0006915; cell proliferation; GO:0008283; induction of apoptosis; GO:0006917; protein export from nucleus; GO:0006611; protein import into nucleus; GO:0006606; protein import into nucleus, docking; GO:0000059" importin-alpha export receptor activity; GO:0008262; protein transporter activity; GO:0008565; ; GO:0008262; ; GO:0008565 cytoplasm; GO:0005737; nuclear pore; GO:0005643; nucleus; GO:0005634 Cas CAS/CSE1 segregation protein "CG13281, l(2)k03902, cas, Dcas, dcas, BcDNA:LD14270, CAS, CAS/CSE1 segregation protein" CDMC35555 3 15 8 DAC13-G01 2-CG13311-RA_1 CG13311 GCGATGGCACCAACCTAACTGGCCAGGTCACCAAGTGCAAGGACAACAAGATCTGCTCGATTAAATCGG 69 FBan0013311 FBgn0035929 CG13311 3 3L metabolism; GO:0008152 structural molecule activity; GO:0005198; ; GO:0005198 CG13311 CG13311 BcDNA:RE29808 CDMC35555 3 16 8 DAC13-G01 2-CG13311-RA_1 CG13311 GCGATGGCACCAACCTAACTGGCCAGGTCACCAAGTGCAAGGACAACAAGATCTGCTCGATTAAATCGG 69 FBan0013311 FBgn0035929 CG13311 3 3L metabolism; GO:0008152 structural molecule activity; GO:0005198; ; GO:0005198 CG13311 CG13311 BcDNA:RE29808 CDMC35556 3 17 8 DAC13-G13 12-CG13318-RA_1 CG13318 TCCCGCCCAGGATGTGTACATCTCGAATGTGTACGTCAATCCGTCCTTCAATCCCAACAATCTGCAGAA 69 FBan0013318 FBgn0037627 CG13318 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG13318 CG13318 "c-SPH101, SPH101" CDMC35556 3 18 8 DAC13-G13 12-CG13318-RA_1 CG13318 TCCCGCCCAGGATGTGTACATCTCGAATGTGTACGTCAATCCGTCCTTCAATCCCAACAATCTGCAGAA 69 FBan0013318 FBgn0037627 CG13318 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG13318 CG13318 "c-SPH101, SPH101" CDMC35557 3 19 8 DAC13-K01 3-CG13343-RA_1 CG13343 GCGGACTTTGTACATGTCCGGGGTAAAGAGCATTGAAGAGGCCACCCGAAAGAACCTTACTCAGAGCCT 69 FBan0013343 FBgn0033882 CG13343 2 2R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin activating enzyme activity; GO:0004839; NEDD8 conjugating enzyme activity; GO:0016976; ; GO:0016976; ; GO:0004839 CG13343 CG13343 CDMC35557 3 20 8 DAC13-K01 3-CG13343-RA_1 CG13343 GCGGACTTTGTACATGTCCGGGGTAAAGAGCATTGAAGAGGCCACCCGAAAGAACCTTACTCAGAGCCT 69 FBan0013343 FBgn0033882 CG13343 2 2R protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin activating enzyme activity; GO:0004839; NEDD8 conjugating enzyme activity; GO:0016976; ; GO:0016976; ; GO:0004839 CG13343 CG13343 CDMC35558 3 21 8 DAC13-K13 11-CG13363-RA_3 CG13363 CCCAGGAGCCACTGTGAATCAGAATGGGAGGATTTAGGACGCAATTAGCAGAGGTTTTAGACGCCTTGC 69 FBan0013363 FBgn0025639 Suv4-20 X X histone methylation; GO:0016571 histone lysine N-methyltransferase activity (H4-K20 specific); GO:0042799; ; GO:0042799 nucleus; GO:0005634 Suv4-20 Suv4-20 "CG13363, CG13363, CG13363, CG13363, EG:115C2.10, BcDNA:LD36415" CDMC35558 3 22 8 DAC13-K13 11-CG13363-RA_3 CG13363 CCCAGGAGCCACTGTGAATCAGAATGGGAGGATTTAGGACGCAATTAGCAGAGGTTTTAGACGCCTTGC 69 FBan0013363 FBgn0025639 Suv4-20 X X histone methylation; GO:0016571 histone lysine N-methyltransferase activity (H4-K20 specific); GO:0042799; ; GO:0042799 nucleus; GO:0005634 Suv4-20 Suv4-20 "CG13363, CG13363, CG13363, CG13363, EG:115C2.10, BcDNA:LD36415" CDMC35559 3 23 8 DAC13-O01 2-CG13401-RB_2 CG13401 GCCGGTCCTCAAGCTTCAGATCTACTGGAAGGTCAACTTCGAGAAGTGCATAGACTCCCCAGTGACCGA 69 FBan0013401 FBgn0027780 U26 2 2L electron transport; GO:0006118; metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 U26 U26 CG13401 CDMC35559 3 24 8 DAC13-O01 2-CG13401-RB_2 CG13401 GCCGGTCCTCAAGCTTCAGATCTACTGGAAGGTCAACTTCGAGAAGTGCATAGACTCCCCAGTGACCGA 69 FBan0013401 FBgn0027780 U26 2 2L electron transport; GO:0006118; metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 U26 U26 CG13401 CDMC35560 3 25 8 DAC13-O13 22-CG13416-RA_1 CG13416 GGGTCATTATTCTGAGCCCAGTTCCACTACCGAGATAATAGTGCTCATCTCATCTTGGGTCTCTGCTCT 69 FBan0013416 FBgn0038906 CG13416 3 3R CG13416 CG13416 CDMC35560 3 26 8 DAC13-O13 22-CG13416-RA_1 CG13416 GGGTCATTATTCTGAGCCCAGTTCCACTACCGAGATAATAGTGCTCATCTCATCTTGGGTCTCTGCTCT 69 FBan0013416 FBgn0038906 CG13416 3 3R CG13416 CG13416 CDMC35561 3 1 9 DAC14-C01 18-CG8649-RA_2 CG8649 ATGATGGCCCTCGACTACGTGCCCAACATGGACAGTGTGGACCAGAACAACCACAACAGCTCCGC 65 FBan0008649 FBgn0024238 Fim X X cytoskeleton organization and biogenesis; GO:0007010; female meiosis chromosome segregation; GO:0016321 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0005509 Fim Fimbrin "CG8649, CG8649, fimbrin, Fimbrin" CDMC35561 3 2 9 DAC14-C01 18-CG8649-RA_2 CG8649 ATGATGGCCCTCGACTACGTGCCCAACATGGACAGTGTGGACCAGAACAACCACAACAGCTCCGC 65 FBan0008649 FBgn0024238 Fim X X cytoskeleton organization and biogenesis; GO:0007010; female meiosis chromosome segregation; GO:0016321 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0005509 Fim Fimbrin "CG8649, CG8649, fimbrin, Fimbrin" CDMC35562 3 3 9 DAC14-C13 12-CG8693-RA_1 CG8693 GTGTGGGCTCTCGATTCGGAGCCGATCGAGTTGACCTCTTCAACATCCTGCTTCTCACTCTGCCC 65 FBan0008693 FBgn0033294 CG8693 2 2R carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG8693 CG8693 CDMC35562 3 4 9 DAC14-C13 12-CG8693-RA_1 CG8693 GTGTGGGCTCTCGATTCGGAGCCGATCGAGTTGACCTCTTCAACATCCTGCTTCTCACTCTGCCC 65 FBan0008693 FBgn0033294 CG8693 2 2R carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG8693 CG8693 CDMC35563 3 5 9 DAC14-G01 3-CG8823-RA_1 CG8823 TGCCATCGTGGAGGTCTGCGGATCCATGGAGTTCATGCCCAGCAATAAGTTCAAGCAGGATTTGG 65 FBan0008823 FBgn0023495 Lip3 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3 Lip3 Lip3 "CG8823, Dmlip3, lip3, LIP3" CDMC35563 3 6 9 DAC14-G01 3-CG8823-RA_1 CG8823 TGCCATCGTGGAGGTCTGCGGATCCATGGAGTTCATGCCCAGCAATAAGTTCAAGCAGGATTTGG 65 FBan0008823 FBgn0023495 Lip3 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3; lipase activity; GO:0016298 ; EC:3.1.1.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004806 ; EC:3.1.1.3 Lip3 Lip3 "CG8823, Dmlip3, lip3, LIP3" CDMC35564 3 7 9 DAC14-G13 12-CG8857-RA_4 CG8857 TACCTGCACTTTGTGCGCAAATACAGCCGTTTCGAGAAGCGTCACCGCAACATGAGCGTCCACTG 65 FBan0008857 FBgn0033699 RpS11 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS11 Ribosomal protein S11 "CG8857, clone 23, S11, anon-MMS23, anon-EST:fe1D2, anon-fast-evolving-1D2, Ribosomal protein S11" CDMC35564 3 8 9 DAC14-G13 12-CG8857-RA_4 CG8857 TACCTGCACTTTGTGCGCAAATACAGCCGTTTCGAGAAGCGTCACCGCAACATGAGCGTCCACTG 65 FBan0008857 FBgn0033699 RpS11 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS11 Ribosomal protein S11 "CG8857, clone 23, S11, anon-MMS23, anon-EST:fe1D2, anon-fast-evolving-1D2, Ribosomal protein S11" CDMC35565 3 9 9 DAC14-K01 9-CG8978-RA_2 CG8978 AACCGAACCGAAGAAACTACGCGTGTGGTTGGATTTGGACGAGCGAACACTGCACATTCCGAGCG 65 FBan0008978 FBgn0001961 Sop2 2 2L "actin filament polymerization; GO:0030041; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoplasmic transport, nurse cell to oocyte; GO:0007303; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; pseudocleavage (sensu Insecta); GO:0030589" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Arp2/3 protein complex; GO:0005885 Sop2 Suppressor of profilin 2 "CG8978, CG8978, l(2)br32, br32, l(2)34Dd: lethal(2)34Dd, 34Dd, p42, BG:DS00941.7, arc41, Dsop2, l(2)Sop2, sop2/arc41, ARC-P41, Spo2, ARPC1/p41, Arpc1, ARPC1, DSop2, lethal(2)34Dd, l(2)34Dd, Suppressor of profilin 2" CDMC35565 3 10 9 DAC14-K01 9-CG8978-RA_2 CG8978 AACCGAACCGAAGAAACTACGCGTGTGGTTGGATTTGGACGAGCGAACACTGCACATTCCGAGCG 65 FBan0008978 FBgn0001961 Sop2 2 2L "actin filament polymerization; GO:0030041; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cytoplasmic transport, nurse cell to oocyte; GO:0007303; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; pseudocleavage (sensu Insecta); GO:0030589" actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 Arp2/3 protein complex; GO:0005885 Sop2 Suppressor of profilin 2 "CG8978, CG8978, l(2)br32, br32, l(2)34Dd: lethal(2)34Dd, 34Dd, p42, BG:DS00941.7, arc41, Dsop2, l(2)Sop2, sop2/arc41, ARC-P41, Spo2, ARPC1/p41, Arpc1, ARPC1, DSop2, lethal(2)34Dd, l(2)34Dd, Suppressor of profilin 2" CDMC35566 3 11 9 DAC14-K13 3-CG8994-RA_5 CG8994 TTCATTCCCTACATGATCCTGGAGTCGTTGAAGAAGTACGGCCTGTTGGAGCGCTTCACCGCGTC 65 FBan0008994 FBgn0000615 exu 2 2R bicoid mRNA localization; GO:0045450; embryonic development (sensu Insecta); GO:0001700; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; spermatogenesis; GO:0007283 cytoplasm; GO:0005737 exu exuperantia "CG8994, CG8994, Exu, bs30h09.y1" CDMC35566 3 12 9 DAC14-K13 3-CG8994-RA_5 CG8994 TTCATTCCCTACATGATCCTGGAGTCGTTGAAGAAGTACGGCCTGTTGGAGCGCTTCACCGCGTC 65 FBan0008994 FBgn0000615 exu 2 2R bicoid mRNA localization; GO:0045450; embryonic development (sensu Insecta); GO:0001700; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; regulation of bicoid mRNA localization; GO:0008359; spermatogenesis; GO:0007283 cytoplasm; GO:0005737 exu exuperantia "CG8994, CG8994, Exu, bs30h09.y1" CDMC35567 3 13 9 DAC14-O01 23-CG9075-RC_1 CG9075 TCTGTATCCATTTAGTTCTCTGTGTATCATCAATTTTAAAACTGCGTTGTCAACCAGCAACAACA 65 FBan0009075 FBgn0001942 eIF-4a 2 2L "DNA unwinding during replication; GO:0006268; imaginal disc growth; GO:0007446; larval development (sensu Insecta); GO:0002168; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; translational initiation; GO:0006413" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0000339; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281; nucleus; GO:0005634 eIF-4a Eukaryotic initiation factor 4a "CG9075, CG9075, CG9075, CG9075, CG9075, l(2)gdh-4, l(2L)162, l(2)k01501, eIF4A, 2439, eif-4a, eif4A, EiF4A, eIF-4A, DmRH2, EIF-4A, Eif-4a, Dm-eIF4A, Eif4a, anon-26Aa, anon26A, l(2)02439, l(2)162, l(2)26Ac" CDMC35567 3 14 9 DAC14-O01 23-CG9075-RC_1 CG9075 TCTGTATCCATTTAGTTCTCTGTGTATCATCAATTTTAAAACTGCGTTGTCAACCAGCAACAACA 65 FBan0009075 FBgn0001942 eIF-4a 2 2L "DNA unwinding during replication; GO:0006268; imaginal disc growth; GO:0007446; larval development (sensu Insecta); GO:0002168; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; translational initiation; GO:0006413" mRNA binding; GO:0003729; ATP binding; GO:0005524; ; GO:0003729; ; GO:0005524; RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0003743; ; GO:0000339; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281; nucleus; GO:0005634 eIF-4a Eukaryotic initiation factor 4a "CG9075, CG9075, CG9075, CG9075, CG9075, l(2)gdh-4, l(2L)162, l(2)k01501, eIF4A, 2439, eif-4a, eif4A, EiF4A, eIF-4A, DmRH2, EIF-4A, Eif-4a, Dm-eIF4A, Eif4a, anon-26Aa, anon26A, l(2)02439, l(2)162, l(2)26Ac" CDMC35568 3 15 9 DAC14-O13 23-CG9113-RC_1 CG9113 GCGATTGTATTAAAGCGAAACCAGATTAGCCTAATATCGGAAATAATTCAATACACGGAGCAGCA 65 FBan0009113 FBgn0030089 AP-1gamma X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1gamma AP-1gamma "CG9113, CG9113, AP-1[gamma], gamma, cg9113, AP-1gamma" CDMC35568 3 16 9 DAC14-O13 23-CG9113-RC_1 CG9113 GCGATTGTATTAAAGCGAAACCAGATTAGCCTAATATCGGAAATAATTCAATACACGGAGCAGCA 65 FBan0009113 FBgn0030089 AP-1gamma X X intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1gamma AP-1gamma "CG9113, CG9113, AP-1[gamma], gamma, cg9113, AP-1gamma" CDMC35569 3 17 9 DAC15-C01 23-CG8343-RA_1 CG8343 AGTCGAAAAAGAGTCCGGTTGTTAAATAAAATATCAGCCGAATATGTGCAATTAAAAATGCGAATGA 67 FBan0008343 FBgn0040502 CG8343 2 2R mannose binding; GO:0005537; ; GO:0005537 CG8343 CG8343 "GH10831-Inc, GH10831, Incilarin-like, BEST:GH10831" CDMC35569 3 18 9 DAC15-C01 23-CG8343-RA_1 CG8343 AGTCGAAAAAGAGTCCGGTTGTTAAATAAAATATCAGCCGAATATGTGCAATTAAAAATGCGAATGA 67 FBan0008343 FBgn0040502 CG8343 2 2R mannose binding; GO:0005537; ; GO:0005537 CG8343 CG8343 "GH10831-Inc, GH10831, Incilarin-like, BEST:GH10831" CDMC35570 3 19 9 DAC15-C13 2-CG8465-RB_1 CG8465 ACAGAAACAGCGACTGATTGATGAAAGGCCGACTGCATACTTACCCCCCTGAATAGCCGGTGTCGTC 67 FBgn0030845 CDMC35570 3 20 9 DAC15-C13 2-CG8465-RB_1 CG8465 ACAGAAACAGCGACTGATTGATGAAAGGCCGACTGCATACTTACCCCCCTGAATAGCCGGTGTCGTC 67 FBgn0030845 CDMC35571 3 21 9 DAC15-G01 15-CG8878-RB_2 CG8878 GGAATCCCGTCTTCCAAGGCGCTATGAAGGTAAACCCACTTACGCGATACTAGACATGGAGCAGAGG 67 FBan0008878 FBgn0027504 CG8878 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 CG8878 CG8878 "VRK, BcDNA:LD23371" CDMC35571 3 22 9 DAC15-G01 15-CG8878-RB_2 CG8878 GGAATCCCGTCTTCCAAGGCGCTATGAAGGTAAACCCACTTACGCGATACTAGACATGGAGCAGAGG 67 FBan0008878 FBgn0027504 CG8878 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37 CG8878 CG8878 "VRK, BcDNA:LD23371" CDMC35572 3 23 9 DAC15-G13 2-CG9066-RA_3 CG9066 CGTTGCAAAGCCATCCGAACCTGAGTTACCCAAAATCCGACGCGATTTTACCGTGAAGGAGCTTCGC 67 FBan0009066 FBgn0030703 CG9066 X X cell communication; GO:0007154; hormone secretion; GO:0046879; signal transduction; GO:0007165 receptor activity; GO:0004872; ; GO:0004872 CG9066 CG9066 CDMC35572 3 24 9 DAC15-G13 2-CG9066-RA_3 CG9066 CGTTGCAAAGCCATCCGAACCTGAGTTACCCAAAATCCGACGCGATTTTACCGTGAAGGAGCTTCGC 67 FBan0009066 FBgn0030703 CG9066 X X cell communication; GO:0007154; hormone secretion; GO:0046879; signal transduction; GO:0007165 receptor activity; GO:0004872; ; GO:0004872 CG9066 CG9066 CDMC35573 3 25 9 DAC15-K01 2-CG9393-RA_4 CG9393 CCTACTACCACTACTTCCTGTTTGGAGAGCCTCACAATTTTGACACAACCACGCGGGGCCTCTACGC 67 FBan0009393 FBgn0037710 CG9393 3 3R embryonic development; GO:0009790; mitochondrial transport; GO:0006839; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 P-P-bond-hydrolysis-driven transporter activity; GO:0015405; ; GO:0015405 mitochondrial outer membrane; GO:0005741 CG9393 CG9393 CDMC35573 3 26 9 DAC15-K01 2-CG9393-RA_4 CG9393 CCTACTACCACTACTTCCTGTTTGGAGAGCCTCACAATTTTGACACAACCACGCGGGGCCTCTACGC 67 FBan0009393 FBgn0037710 CG9393 3 3R embryonic development; GO:0009790; mitochondrial transport; GO:0006839; protein targeting to mitochondrion; GO:0006626; protein transport; GO:0015031 P-P-bond-hydrolysis-driven transporter activity; GO:0015405; ; GO:0015405 mitochondrial outer membrane; GO:0005741 CG9393 CG9393 CDMC35574 3 1 10 DAC15-K13 2-CG9467-RA_1 CG9467 CGAGACCTTCTTTGTGCACCAAAGCCCCGTAACGAAGGTGATGCTGTCGGAGAAATACCTCGTCTCC 67 FBan0009467 FBgn0037758 CG9467 3 3R glycolysis; GO:0006096; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0005515; ; GO:0004365 ; EC:1.2.1.12 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG9467 CG9467 CDMC35574 3 2 10 DAC15-K13 2-CG9467-RA_1 CG9467 CGAGACCTTCTTTGTGCACCAAAGCCCCGTAACGAAGGTGATGCTGTCGGAGAAATACCTCGTCTCC 67 FBan0009467 FBgn0037758 CG9467 3 3R glycolysis; GO:0006096; potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0005515; ; GO:0004365 ; EC:1.2.1.12 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG9467 CG9467 CDMC35575 3 3 10 DAC15-O01 3-CG9899-RA_3 CG9899 AGACCTACGAACGATGCCTGAAGGACCATCTTCCCAAAAACCGTGTGGACGTTATGCACTGCTTGGC 67 FBan0009899 FBgn0034829 CG9899 2 2R CG9899 CG9899 CDMC35575 3 4 10 DAC15-O01 3-CG9899-RA_3 CG9899 AGACCTACGAACGATGCCTGAAGGACCATCTTCCCAAAAACCGTGTGGACGTTATGCACTGCTTGGC 67 FBan0009899 FBgn0034829 CG9899 2 2R CG9899 CG9899 CDMC35576 3 5 10 DAC15-O13 23-CR32880-RA_1 CR32880 GGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACTC 67 FBan0032880 FBgn0043021 snRNA:U5:38ABb 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABb snRNA:U5:38ABb "dU5, K2, U5, U5 small nuclear RNA, U5-38ABb, snRNA:U5, U5snRNA, CR32880, small nuclear RNA U5" CDMC35576 3 6 10 DAC15-O13 23-CR32880-RA_1 CR32880 GGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACTC 67 FBan0032880 FBgn0043021 snRNA:U5:38ABb 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABb snRNA:U5:38ABb "dU5, K2, U5, U5 small nuclear RNA, U5-38ABb, snRNA:U5, U5snRNA, CR32880, small nuclear RNA U5" CDMC35577 3 7 10 DAC16-C01 16-CG4896-RB_2 CG4896 GCCAATCAGAAAGCACTTGAAGCTAGCGTTGGGACTAAACGAGCCATTAGCGATGAATCTGACTACGTG 69 FBan0004896 FBgn0031319 CG4896 2 2L apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634 CG4896 CG4896 cg4896 CDMC35577 3 8 10 DAC16-C01 16-CG4896-RB_2 CG4896 GCCAATCAGAAAGCACTTGAAGCTAGCGTTGGGACTAAACGAGCCATTAGCGATGAATCTGACTACGTG 69 FBan0004896 FBgn0031319 CG4896 2 2L apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 intracellular; GO:0005622; nucleus; GO:0005634 CG4896 CG4896 cg4896 CDMC35578 3 9 10 DAC16-C13 2-CG4898-RF_1 CG4898 TTCCTTGCTGAGGAGGCTGACAAGAAATACGATGAGGTTGCCCGTAAATTGGCCATGGTTGAAGCCGAT 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC35578 3 10 10 DAC16-C13 2-CG4898-RF_1 CG4898 TTCCTTGCTGAGGAGGCTGACAAGAAATACGATGAGGTTGCCCGTAAATTGGCCATGGTTGAAGCCGAT 69 FBan0004898 FBgn0003721 Tm1 3 3R dendrite morphogenesis; GO:0016358; muscle contraction; GO:0006936; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 muscle thin filament tropomyosin; GO:0005862 Tm1 Tropomyosin 1 "CG4898, CG4898, mTmII, region 3, Tmr33, Tmr34, cTm, TmII, Tropomyosin-1, tropomyosin, TnH-34, cTmII, tropomyosin II, 1305/10, cTM, TnH, Tropomyosin, 2299, Tropomyosin II, tropomysin II, l(3)S130510, cytoplasmic tropomyosin, TMII, tropomyosinII, cytoskeletal Tropomyosin, tmII, Troponin H, Tm, BcDNA:GH09289, BcDNA:SD21996, BcDNA:LD37158, PmI, l(3)02299, l(3)s2958" CDMC35579 3 11 10 DAC16-G01 6-CG4931-RA_4 CG4931 TCCGGACGCGAAGACAGAGCTATTTCAGTCTTTCCGGGAGTTTGGCAACAGCATTATCTTTTGCCTGCT 69 FBan0004931 FBgn0038320 Sra-1 3 3R axon guidance; GO:0007411; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; regulation of cell shape; GO:0008360; regulation of synapse structure; GO:0050807; signal transduction; GO:0007165 Rho GTPase binding; GO:0017048; ; GO:0017048 Sra-1 specifically Rac1-associated protein 1 "CG4931, DSra-1, CYFIP, Sra1, Sra, sra1, PIR121/Sra-1, CYFIP1/2, specifically Rac1-associated protein 1" CDMC35579 3 12 10 DAC16-G01 6-CG4931-RA_4 CG4931 TCCGGACGCGAAGACAGAGCTATTTCAGTCTTTCCGGGAGTTTGGCAACAGCATTATCTTTTGCCTGCT 69 FBan0004931 FBgn0038320 Sra-1 3 3R axon guidance; GO:0007411; cell projection biogenesis; GO:0030031; cortical actin cytoskeleton organization and biogenesis; GO:0030866; regulation of cell shape; GO:0008360; regulation of synapse structure; GO:0050807; signal transduction; GO:0007165 Rho GTPase binding; GO:0017048; ; GO:0017048 Sra-1 specifically Rac1-associated protein 1 "CG4931, DSra-1, CYFIP, Sra1, Sra, sra1, PIR121/Sra-1, CYFIP1/2, specifically Rac1-associated protein 1" CDMC35580 3 13 10 DAC16-G13 2-CG4943-RA_1 CG4943 CCTGTGGATTTGCCGTGGAGTAAGATCCAGAAGAGACACTGTGACCCTCACCTGATCCACGCATATGCA 69 FBan0004943 FBgn0029006 lack 2 2R proteolysis; GO:0006508; transforming growth factor beta receptor signaling pathway; GO:0007179; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 lack lethal with a checkpoint kinase "CG4943, dSmurf1, Smurf1, Dsmurf, Smurf, DSmurf, dSmurf, lethal with a checkpoint kinase" CDMC35580 3 14 10 DAC16-G13 2-CG4943-RA_1 CG4943 CCTGTGGATTTGCCGTGGAGTAAGATCCAGAAGAGACACTGTGACCCTCACCTGATCCACGCATATGCA 69 FBan0004943 FBgn0029006 lack 2 2R proteolysis; GO:0006508; transforming growth factor beta receptor signaling pathway; GO:0007179; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 lack lethal with a checkpoint kinase "CG4943, dSmurf1, Smurf1, Dsmurf, Smurf, DSmurf, dSmurf, lethal with a checkpoint kinase" CDMC35581 3 15 10 DAC16-K01 6-CG4973-RA_1 CG4973 GCCCAGTGGACCCCAAGATCAGGGAGCTACATCGATTAACGAAATGGACACAGAATTGGATCGCGATGC 69 FBan0004973 FBgn0038772 CG4973 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG4973 CG4973 CDMC35581 3 16 10 DAC16-K01 6-CG4973-RA_1 CG4973 GCCCAGTGGACCCCAAGATCAGGGAGCTACATCGATTAACGAAATGGACACAGAATTGGATCGCGATGC 69 FBan0004973 FBgn0038772 CG4973 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG4973 CG4973 CDMC35582 3 17 10 DAC16-K13 22-CG4980-RA_1 CG4980 GGACAAATCCGAGGCACAGGAGGAATCTTCCAATGGATCAACGTAGATTTAGTACACTGAGCGAAAGCA 69 FBan0004980 FBgn0039558 CG4980 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG4980 CG4980 CDMC35582 3 18 10 DAC16-K13 22-CG4980-RA_1 CG4980 GGACAAATCCGAGGCACAGGAGGAATCTTCCAATGGATCAACGTAGATTTAGTACACTGAGCGAAAGCA 69 FBan0004980 FBgn0039558 CG4980 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG4980 CG4980 CDMC35583 3 19 10 DAC16-O01 23-CG5013-RA_2 CG5013 TAGTTTAGTGAAAATAGTAATACTCCTGCATGCTTGAGCTAAGATGCGTTTCCACATGAAGAGCGGCAG 69 FBan0005013 FBgn0038396 CG5013 3 3R CG5013 CG5013 CDMC35583 3 20 10 DAC16-O01 23-CG5013-RA_2 CG5013 TAGTTTAGTGAAAATAGTAATACTCCTGCATGCTTGAGCTAAGATGCGTTTCCACATGAAGAGCGGCAG 69 FBan0005013 FBgn0038396 CG5013 3 3R CG5013 CG5013 CDMC35584 3 21 10 DAC16-O13 2-CG5025-RA_1 CG5025 GGTGGGCCAAAGCACAAAGTTTCGTTCTGGCAGATCGGTGGAAACCTCTGGAGGCCTTTTAATATGCCT 69 FBan0005025 FBgn0032224 Sps2 2 2L selenocysteine biosynthesis; GO:0016260 "ATP binding; GO:0005524; ; GO:0005524; selenide, water dikinase activity; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3; purine nucleotide binding; GO:0017076; ; GO:0017076; ; GO:0004756 ; EC:2.7.9.3" Sps2 Selenophosphate synthetase 2 "CG5025, Dsps2, dsps2, SPS2" CDMC35584 3 22 10 DAC16-O13 2-CG5025-RA_1 CG5025 GGTGGGCCAAAGCACAAAGTTTCGTTCTGGCAGATCGGTGGAAACCTCTGGAGGCCTTTTAATATGCCT 69 FBan0005025 FBgn0032224 Sps2 2 2L selenocysteine biosynthesis; GO:0016260 "ATP binding; GO:0005524; ; GO:0005524; selenide, water dikinase activity; GO:0004756 ; EC:2.7.9.3; ; GO:0004756 ; EC:2.7.9.3; purine nucleotide binding; GO:0017076; ; GO:0017076; ; GO:0004756 ; EC:2.7.9.3" Sps2 Selenophosphate synthetase 2 "CG5025, Dsps2, dsps2, SPS2" CDMC35585 3 23 10 DAC17-C01 23-CG7103-RA_8 CG7103 TAAATGTAGGCTAAAACTTCAATATCCCTAAACTTAACACACAGTATTTACCCCACTCTGCATCTGCGG 69 FBan0007103 FBgn0030964 Pvf1 X X border follicle cell migration (sensu Insecta); GO:0007298; cell projection biogenesis; GO:0030031; hemocyte migration (sensu Arthropoda); GO:0035099 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; ; GO:0005102; ; GO:0005102; vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0005102; heparin binding; GO:0008201; ; GO:0008083; ; GO:0005172; ; GO:0008201 cytoplasm; GO:0005737; extracellular region; GO:0005576; membrane; GO:0016020 Pvf1 PDGF- and VEGF-related factor 1 "CG7103, CG7103, CG7103, l(1)G0146, DmVEGF-1, PVF1, Vegf17E, VEGF, Vegf17e-a, VEGF2-B, Vegf17e-b, pvf1, PVF, vegf1, PVFs, EP1624" CDMC35585 3 24 10 DAC17-C01 23-CG7103-RA_8 CG7103 TAAATGTAGGCTAAAACTTCAATATCCCTAAACTTAACACACAGTATTTACCCCACTCTGCATCTGCGG 69 FBan0007103 FBgn0030964 Pvf1 X X border follicle cell migration (sensu Insecta); GO:0007298; cell projection biogenesis; GO:0030031; hemocyte migration (sensu Arthropoda); GO:0035099 receptor binding; GO:0005102; ; GO:0005102; ; GO:0005102; ; GO:0005102; ; GO:0005102; vascular endothelial growth factor receptor binding; GO:0005172; growth factor activity; GO:0008083; ; GO:0005102; heparin binding; GO:0008201; ; GO:0008083; ; GO:0005172; ; GO:0008201 cytoplasm; GO:0005737; extracellular region; GO:0005576; membrane; GO:0016020 Pvf1 PDGF- and VEGF-related factor 1 "CG7103, CG7103, CG7103, l(1)G0146, DmVEGF-1, PVF1, Vegf17E, VEGF, Vegf17e-a, VEGF2-B, Vegf17e-b, pvf1, PVF, vegf1, PVFs, EP1624" CDMC35586 3 25 10 DAC17-C13 5-CG7110-RB_1 CG7110 CCAGCCAAGGACTCTACGTCGAGTAATCTGACCGATGTGTCGCCACCATATTCCGTTAACATAGCGCGG 69 FBan0007110 FBgn0032521 CG7110 2 2L CG7110 CG7110 CDMC35586 3 26 10 DAC17-C13 5-CG7110-RB_1 CG7110 CCAGCCAAGGACTCTACGTCGAGTAATCTGACCGATGTGTCGCCACCATATTCCGTTAACATAGCGCGG 69 FBan0007110 FBgn0032521 CG7110 2 2L CG7110 CG7110 CDMC35587 3 1 11 DAC17-G01 18-CG7149-RA_1 CG7149 AGGCTATGTTCACTGTACCGCCCATCGTATTGTAATTTTCTGTAGATCACGAAACAGACTGTCGCCGCT 69 FBan0007149 FBgn0031948 CG7149 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 diacylglycerol cholinephosphotransferase activity; GO:0004142 ; EC:2.7.8.2; ; GO:0004142 ; EC:2.7.8.2 CG7149 CG7149 CDMC35587 3 2 11 DAC17-G01 18-CG7149-RA_1 CG7149 AGGCTATGTTCACTGTACCGCCCATCGTATTGTAATTTTCTGTAGATCACGAAACAGACTGTCGCCGCT 69 FBan0007149 FBgn0031948 CG7149 2 2L phospholipid biosynthesis; GO:0008654; phospholipid metabolism; GO:0006644 diacylglycerol cholinephosphotransferase activity; GO:0004142 ; EC:2.7.8.2; ; GO:0004142 ; EC:2.7.8.2 CG7149 CG7149 CDMC35588 3 3 11 DAC17-G13 2-CG7164-RA_1 CG7164 TGCCAGGACGTTACCTGTTGCCCGACACCAGAAAGACCTACGACAATATGGTGGCCAATATTCACTCGA 69 FBan0007164 FBgn0031946 CG7164 2 2L CG7164 CG7164 CDMC35588 3 4 11 DAC17-G13 2-CG7164-RA_1 CG7164 TGCCAGGACGTTACCTGTTGCCCGACACCAGAAAGACCTACGACAATATGGTGGCCAATATTCACTCGA 69 FBan0007164 FBgn0031946 CG7164 2 2L CG7164 CG7164 CDMC35589 3 5 11 DAC17-K01 16-CG7194-RA_1 CG7194 GGAGCGCGAAATTATGAAGGGCAAGGATAATTTGAAGAACGTTCTACGGCTGATGAAAGGATTGCGGGA 69 FBan0007194 FBgn0035868 CG7194 3 3L gonad development; GO:0008406 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7194 CG7194 "CK01174, ck00048, BEST:CK01174, BEST:CK00048" CDMC35589 3 6 11 DAC17-K01 16-CG7194-RA_1 CG7194 GGAGCGCGAAATTATGAAGGGCAAGGATAATTTGAAGAACGTTCTACGGCTGATGAAAGGATTGCGGGA 69 FBan0007194 FBgn0035868 CG7194 3 3L gonad development; GO:0008406 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG7194 CG7194 "CK01174, ck00048, BEST:CK01174, BEST:CK00048" CDMC35590 3 7 11 DAC17-K13 23-CG7210-RA_19 CG7210 TGTGTCATGTCGAGTTATAGGTAACCTAAGAGCCACATCATATCACTCTCCGTAACCACTTTAAGCAAT 69 FBan0007210 FBgn0001301 kel 2 2L "apoptosis; GO:0006915; cytoplasmic transport, nurse cell to oocyte; GO:0007303; follicle cell migration (sensu Insecta); GO:0007297; oogenesis (sensu Insecta); GO:0009993; ovarian ring canal formation; GO:0007301" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779 cell cortex; GO:0005938; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183 kel kelch "CG7210, CG7210, Kelch, Dm.Ring_canal/KELC_DROME, kelch" CDMC35590 3 8 11 DAC17-K13 23-CG7210-RA_19 CG7210 TGTGTCATGTCGAGTTATAGGTAACCTAAGAGCCACATCATATCACTCTCCGTAACCACTTTAAGCAAT 69 FBan0007210 FBgn0001301 kel 2 2L "apoptosis; GO:0006915; cytoplasmic transport, nurse cell to oocyte; GO:0007303; follicle cell migration (sensu Insecta); GO:0007297; oogenesis (sensu Insecta); GO:0009993; ovarian ring canal formation; GO:0007301" actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; ; GO:0003779 cell cortex; GO:0005938; ring canal (sensu Insecta); GO:0045172; ring canal inner rim; GO:0035183 kel kelch "CG7210, CG7210, Kelch, Dm.Ring_canal/KELC_DROME, kelch" CDMC35591 3 9 11 DAC17-O01 2-CG7252-RA_1 CG7252 GGTGACCTCGTCTACAACGCCACCTTAGACCAGTGCGACTATCCTGAAAACTATGTGCCCAAGGTGGAG 69 FBan0007252 FBgn0036226 CG7252 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7252 CG7252 BcDNA:LP01340 CDMC35591 3 10 11 DAC17-O01 2-CG7252-RA_1 CG7252 GGTGACCTCGTCTACAACGCCACCTTAGACCAGTGCGACTATCCTGAAAACTATGTGCCCAAGGTGGAG 69 FBan0007252 FBgn0036226 CG7252 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7252 CG7252 BcDNA:LP01340 CDMC35592 3 11 11 DAC17-O13 3-CG7266-RA_1 CG7266 GGGCGATCATACGGAGGTGCTGGAAATCGACTATGATCCCACGGTCATTAGCTTTAAGGAGCTGCTGGA 69 FBan0007266 FBgn0000565 Eip71CD 3 3L autophagic cell death; GO:0048102; defense response; GO:0006952; protein modification; GO:0006464; response to stress; GO:0006950; salivary gland cell autophagic cell death; GO:0035071; sulfur amino acid metabolism; GO:0000096 protein-methionine-S-oxide reductase activity; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6 Eip71CD Ecdysone-induced protein 28/29kD "CG7266, Eip28/29, Eip28, DROZ60MEX, Eip28 /29, eip28/29, MsrA, methionine-S-sulfoxide reductase, Eip71C" CDMC35592 3 12 11 DAC17-O13 3-CG7266-RA_1 CG7266 GGGCGATCATACGGAGGTGCTGGAAATCGACTATGATCCCACGGTCATTAGCTTTAAGGAGCTGCTGGA 69 FBan0007266 FBgn0000565 Eip71CD 3 3L autophagic cell death; GO:0048102; defense response; GO:0006952; protein modification; GO:0006464; response to stress; GO:0006950; salivary gland cell autophagic cell death; GO:0035071; sulfur amino acid metabolism; GO:0000096 protein-methionine-S-oxide reductase activity; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6; ; GO:0008113 ; EC:1.8.4.6 Eip71CD Ecdysone-induced protein 28/29kD "CG7266, Eip28/29, Eip28, DROZ60MEX, Eip28 /29, eip28/29, MsrA, methionine-S-sulfoxide reductase, Eip71C" CDMC35593 3 13 11 DAC18-C01 23-CG32406-RA_5 CG32406 ACCGATACCAAGAAAATGTGATACTCTATGAAAAAGAAAAACACAGACACTGCAAATGAAACGCCTAGC 69 FBan0032406 FBgn0052406 CG32406 3 3L intracellular signaling cascade; GO:0007242 CG32406 CG32406 "CG6062, CG13292, CG6062" CDMC35593 3 14 11 DAC18-C01 23-CG32406-RA_5 CG32406 ACCGATACCAAGAAAATGTGATACTCTATGAAAAAGAAAAACACAGACACTGCAAATGAAACGCCTAGC 69 FBan0032406 FBgn0052406 CG32406 3 3L intracellular signaling cascade; GO:0007242 CG32406 CG32406 "CG6062, CG13292, CG6062" CDMC35594 3 15 11 DAC18-C13 15-CG32413-RA_1 CG32413 TGCACAACCTGATTGCTGACATCGAACAGGATCTCAGAAAATCCGGAGAACTCGACGACTGTCATGTGT 69 FBan0032413 FBgn0052413 CG32413 3 3L CG32413 CG32413 "CG10487, CG10487" CDMC35594 3 16 11 DAC18-C13 15-CG32413-RA_1 CG32413 TGCACAACCTGATTGCTGACATCGAACAGGATCTCAGAAAATCCGGAGAACTCGACGACTGTCATGTGT 69 FBan0032413 FBgn0052413 CG32413 3 3L CG32413 CG32413 "CG10487, CG10487" CDMC35595 3 17 11 DAC18-G01 2-CG32450-RA_1 CG32450 GCCGGACTCGCACTGGTCGTTGAGGTTTGTGGACATCGTGAAGCCTTTTCCAAAACATACTTTGGCCAA 69 FBan0032450 FBgn0052450 CG32450 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32450 CG32450 "anon-WO0140519.221, BcDNA:GH25462, BEST:GH25462" CDMC35595 3 18 11 DAC18-G01 2-CG32450-RA_1 CG32450 GCCGGACTCGCACTGGTCGTTGAGGTTTGTGGACATCGTGAAGCCTTTTCCAAAACATACTTTGGCCAA 69 FBan0032450 FBgn0052450 CG32450 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32450 CG32450 "anon-WO0140519.221, BcDNA:GH25462, BEST:GH25462" CDMC35596 3 19 11 DAC18-G13 2-CG32459-RA_1 CG32459 CCATGGGGTGATGTGAGATCGTCAGATAGCCAGCTTACCCTGAAGCAGAGTGAGAGCCAGGAGACGATA 69 FBan0032459 FBgn0052459 CG32459 3 3L CG32459 CG32459 "CG8220, CG8220, anon-WO0140519.31" CDMC35596 3 20 11 DAC18-G13 2-CG32459-RA_1 CG32459 CCATGGGGTGATGTGAGATCGTCAGATAGCCAGCTTACCCTGAAGCAGAGTGAGAGCCAGGAGACGATA 69 FBan0032459 FBgn0052459 CG32459 3 3L CG32459 CG32459 "CG8220, CG8220, anon-WO0140519.31" CDMC35597 3 21 11 DAC18-K01 3-CG32491-RC_4 CG32491 CGGAGCATCCAAGGAAACCAGTAACTGATAGCGTGCAGAAGTCCCCTAGAGATGCTGACGCTATCCCCT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35597 3 22 11 DAC18-K01 3-CG32491-RC_4 CG32491 CGGAGCATCCAAGGAAACCAGTAACTGATAGCGTGCAGAAGTCCCCTAGAGATGCTGACGCTATCCCCT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35598 3 23 11 DAC18-K13 23-CG32491-RR_1 CG32491 CGAAGCACTCGCACCTGTGACCTAAGAAAACATACAAATACCTGTTGAATAAATCTTAAAGCATTTTTA 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35598 3 24 11 DAC18-K13 23-CG32491-RR_1 CG32491 CGAAGCACTCGCACCTGTGACCTAAGAAAACATACAAATACCTGTTGAATAAATCTTAAAGCATTTTTA 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35599 3 25 11 DAC18-O01 23-CG32528-RA_3 CG32528 CGAGATTGTGCCTTTAGATCACACAGAGCTTTTGCAAATTATGTCACAGATCAGATTTTAACGCTGTAA 69 FBan0032528 FBgn0052528 CG32528 X X cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG32528 CG32528 "CG12533, CG12533" CDMC35599 3 26 11 DAC18-O01 23-CG32528-RA_3 CG32528 CGAGATTGTGCCTTTAGATCACACAGAGCTTTTGCAAATTATGTCACAGATCAGATTTTAACGCTGTAA 69 FBan0032528 FBgn0052528 CG32528 X X cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 CG32528 CG32528 "CG12533, CG12533" CDMC35600 3 1 12 DAC18-O13 6-CG32540-RA_1 CG32540 CGCAGTCTATAATGGTTGGCGGAGGATCAACCAATATGGCAACGACCACCTTGACAACGAGACCAACGG 69 FBan0032540 FBgn0030954 CCKLR-17D3 X X G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; cholecystokinin receptor activity; GO:0004951; ; GO:0008188; ; GO:0004930; ; GO:0004951 integral to membrane; GO:0016021 CCKLR-17D3 CCK-like receptor at 17D3 "CG6881, CG6894, CG6861, CG32540, CG6881, CG6894, CG6881, CG6861, CG6894, CG6881, CG6894, DSK-R1, anon-WO0131005.21, anon-WO0170980.64, anon-WO0170980.65, CCK-like receptor at 17D3" CDMC35600 3 2 12 DAC18-O13 6-CG32540-RA_1 CG32540 CGCAGTCTATAATGGTTGGCGGAGGATCAACCAATATGGCAACGACCACCTTGACAACGAGACCAACGG 69 FBan0032540 FBgn0030954 CCKLR-17D3 X X G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936; transmission of nerve impulse; GO:0019226 G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; cholecystokinin receptor activity; GO:0004951; ; GO:0008188; ; GO:0004930; ; GO:0004951 integral to membrane; GO:0016021 CCKLR-17D3 CCK-like receptor at 17D3 "CG6881, CG6894, CG6861, CG32540, CG6881, CG6894, CG6881, CG6861, CG6894, CG6881, CG6894, DSK-R1, anon-WO0131005.21, anon-WO0170980.64, anon-WO0170980.65, CCK-like receptor at 17D3" CDMC35601 3 3 12 DAC19-C01 24-CG8175-RA_2 CG8175 GTGGGAAATTCACACTGCTGATGTCGTTAACACATTGATAAAATTAATACAATTAAACCAAAACT 65 FBan0008175 FBgn0014865 Mtk 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal humoral response; GO:0019732; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; defense response to fungi; GO:0050832 extracellular region; GO:0005576 Mtk Metchnikowin "CG8175, CG8175, CG8175, Metch, DIM 17, metchnikowin, Drosophila Immune induced molecule 17, metchnikowin-1, metchnikowin-2, Metchnikowin A, Metchnikowin B, mtk, METCH, metk, metch, Metc, BcDNA:RH07954" CDMC35601 3 4 12 DAC19-C01 24-CG8175-RA_2 CG8175 GTGGGAAATTCACACTGCTGATGTCGTTAACACATTGATAAAATTAATACAATTAAACCAAAACT 65 FBan0008175 FBgn0014865 Mtk 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; antifungal humoral response (sensu Protostomia); GO:0006966; antifungal humoral response; GO:0019732; defense response; GO:0006952; defense response to Gram-positive bacteria; GO:0050830; defense response to fungi; GO:0050832 extracellular region; GO:0005576 Mtk Metchnikowin "CG8175, CG8175, CG8175, Metch, DIM 17, metchnikowin, Drosophila Immune induced molecule 17, metchnikowin-1, metchnikowin-2, Metchnikowin A, Metchnikowin B, mtk, METCH, metk, metch, Metc, BcDNA:RH07954" CDMC35602 3 5 12 DAC19-C13 5-CG8205-RA_1 CG8205 ACATCCACAGGAGCAAAGGACACATCGACGCCTCAAGAGACCTCTGCATCACAAACGCTGCTCAG 65 FBan0008205 FBgn0023441 fus 2 2R epidermal growth factor receptor signaling pathway; GO:0007173 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fus fusilli "CG8205, CG8205, E(cact[E10])7, Enhancer of cactus[E10], number 7, cg8205, fusilli" CDMC35602 3 6 12 DAC19-C13 5-CG8205-RA_1 CG8205 ACATCCACAGGAGCAAAGGACACATCGACGCCTCAAGAGACCTCTGCATCACAAACGCTGCTCAG 65 FBan0008205 FBgn0023441 fus 2 2R epidermal growth factor receptor signaling pathway; GO:0007173 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 fus fusilli "CG8205, CG8205, E(cact[E10])7, Enhancer of cactus[E10], number 7, cg8205, fusilli" CDMC35603 3 7 12 DAC19-G01 2-CG8271-RA_1 CG8271 GAGACCTTTCCGGAGACTACGAGATATGCTTCTACTGCATGGGATCCTGCATGGTGCTCGGGACC 65 FBan0008271 FBgn0033657 CG8271 2 2R cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8271 CG8271 CDMC35603 3 8 12 DAC19-G01 2-CG8271-RA_1 CG8271 GAGACCTTTCCGGAGACTACGAGATATGCTTCTACTGCATGGGATCCTGCATGGTGCTCGGGACC 65 FBan0008271 FBgn0033657 CG8271 2 2R cation transport; GO:0006812 monocarboxylate porter activity; GO:0015355; ; GO:0015355 integral to membrane; GO:0016021 CG8271 CG8271 CDMC35604 3 9 12 DAC19-G13 3-CG8302-RA_1 CG8302 GAGAGCAATCGGGACTTCACCGAGGAGGATATCGTCAACGAGGCCTGTACCTTTATGCTGGCTGG 65 FBan0008302 FBgn0034053 Cyp4aa1 2 2R electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4aa1 Cyp4aa1 "CG8302, 4aa1" CDMC35604 3 10 12 DAC19-G13 3-CG8302-RA_1 CG8302 GAGAGCAATCGGGACTTCACCGAGGAGGATATCGTCAACGAGGCCTGTACCTTTATGCTGGCTGG 65 FBan0008302 FBgn0034053 Cyp4aa1 2 2R electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4aa1 Cyp4aa1 "CG8302, 4aa1" CDMC35605 3 11 12 DAC19-K01 15-CG8392-RA_2 CG8392 ATTGTGGCCTACTCGCTGAACTATCACGAGAATCAGACCAACAAGGATGCTCTGGTGTTCGAGGC 65 FBan0008392 FBgn0010590 l(2)05070 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 l(2)05070 lethal (2) 05070 "CG8392, CG8392, CG8392" CDMC35605 3 12 12 DAC19-K01 15-CG8392-RA_2 CG8392 ATTGTGGCCTACTCGCTGAACTATCACGAGAATCAGACCAACAAGGATGCTCTGGTGTTCGAGGC 65 FBan0008392 FBgn0010590 l(2)05070 2 2R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 l(2)05070 lethal (2) 05070 "CG8392, CG8392, CG8392" CDMC35606 3 13 12 DAC19-K13 2-CG8408-RA_1 CG8408 ATTCGCCATTCCCGGATCGCTGTTCCTCTCGATTCTGCTGGGATTCCTGTACAAGTTCCCGATCG 65 FBan0008408 FBgn0030850 CG8408 X X CG8408 CG8408 CDMC35606 3 14 12 DAC19-K13 2-CG8408-RA_1 CG8408 ATTCGCCATTCCCGGATCGCTGTTCCTCTCGATTCTGCTGGGATTCCTGTACAAGTTCCCGATCG 65 FBan0008408 FBgn0030850 CG8408 X X CG8408 CG8408 CDMC35607 3 15 12 DAC19-O01 6-CG8509-RA_2 CG8509 GATTGGAGCGCAACTACATCGACCATGTGCTCTCCTCGTTCGGAACCGTGGAGCAAGCCATCTTC 65 FBan0008509 FBgn0030696 CG8509 X X protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160 CG8509 CG8509 CDMC35607 3 16 12 DAC19-O01 6-CG8509-RA_2 CG8509 GATTGGAGCGCAACTACATCGACCATGTGCTCTCCTCGTTCGGAACCGTGGAGCAAGCCATCTTC 65 FBan0008509 FBgn0030696 CG8509 X X protein tyrosine phosphatase activator activity; GO:0008160; ; GO:0008160 CG8509 CG8509 CDMC35608 3 17 12 DAC19-O13 9-CG8543-RA_1 CG8543 CACTGTGTCCACCTACTCCAAGAACGTGGTTACCCCGTACTCCAGTGTCAGCAAGGTGGACTCCC 65 FBan0008543 FBgn0035787 CG8543 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8543 CG8543 CDMC35608 3 18 12 DAC19-O13 9-CG8543-RA_1 CG8543 CACTGTGTCCACCTACTCCAAGAACGTGGTTACCCCGTACTCCAGTGTCAGCAAGGTGGACTCCC 65 FBan0008543 FBgn0035787 CG8543 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8543 CG8543 CDMC35609 3 19 12 DAC20-C01 3-CG7671-RA_7 CG7671 AGAGGGTTCCATAACCGTCTGGGATATGCGAAACCTCAGTTATCCCGCCTCCTATCTCAGCGCTCACAA 69 FBan0007671 FBgn0038609 CG7671 3 3R CG7671 CG7671 CDMC35609 3 20 12 DAC20-C01 3-CG7671-RA_7 CG7671 AGAGGGTTCCATAACCGTCTGGGATATGCGAAACCTCAGTTATCCCGCCTCCTATCTCAGCGCTCACAA 69 FBan0007671 FBgn0038609 CG7671 3 3R CG7671 CG7671 CDMC35610 3 21 12 DAC20-C13 1-CG7692-RA_1 CG7692 TGCCTGACGCGTTCTTCCCAGGTGTGCTTAACCAGATTGACACCACGAGACATAGAAAAACTCAGGGGA 69 FBan0007692 FBgn0036714 CG7692 3 3L CG7692 CG7692 CDMC35610 3 22 12 DAC20-C13 1-CG7692-RA_1 CG7692 TGCCTGACGCGTTCTTCCCAGGTGTGCTTAACCAGATTGACACCACGAGACATAGAAAAACTCAGGGGA 69 FBan0007692 FBgn0036714 CG7692 3 3L CG7692 CG7692 CDMC35611 3 23 12 DAC20-G01 16-CG7725-RA_1 CG7725 CCAAGTCAGCAGTCAATCGGTACTTAAAGTCGGTACTTACAACGTTTATACCCCCTAACACAGCCCCCT 69 FBan0007725 FBgn0036697 rogdi 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 rogdi rogdi "CG7725, CG7725, CG7725" CDMC35611 3 24 12 DAC20-G01 16-CG7725-RA_1 CG7725 CCAAGTCAGCAGTCAATCGGTACTTAAAGTCGGTACTTACAACGTTTATACCCCCTAACACAGCCCCCT 69 FBan0007725 FBgn0036697 rogdi 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 rogdi rogdi "CG7725, CG7725, CG7725" CDMC35612 3 25 12 DAC20-G13 10-CG7740-RA_1 CG7740 GCGGCAAGGACTATATCAACGCCCTAGGAGGCAATCTGACGAATTCCATTGACCAGATGATCGACGACT 69 FBan0007740 FBgn0026189 prominin-like 3 3L intracellular protein transport; GO:0006886 integral to membrane; GO:0016021; plasma membrane; GO:0005886 prominin-like prominin-like "CG7740, CG7740, prominin-like protein, bs29e02.y1" CDMC35612 3 26 12 DAC20-G13 10-CG7740-RA_1 CG7740 GCGGCAAGGACTATATCAACGCCCTAGGAGGCAATCTGACGAATTCCATTGACCAGATGATCGACGACT 69 FBan0007740 FBgn0026189 prominin-like 3 3L intracellular protein transport; GO:0006886 integral to membrane; GO:0016021; plasma membrane; GO:0005886 prominin-like prominin-like "CG7740, CG7740, prominin-like protein, bs29e02.y1" CDMC35613 3 1 13 DAC20-K01 3-CG7771-RA_1 CG7771 CGCCCTCACAGACGACCTACAGCGATCTGAGTCACAACTTCGAGCTGAGCTACTTCTCCGACAACAGTT 69 FBan0007771 FBgn0004666 sim 3 3R adult walking behavior; GO:0007628; brain development; GO:0007420; central nervous system development; GO:0007417; ectoderm development; GO:0007398; locomotion; GO:0040011; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 sim single-minded "CG7771, l(3)s8, l(3)S8, S8, shm, 0483/09, 0716/08, 0899/14, 0953/08, 1002/10, 1034/02, 1050/13, 1110/04, 1111/10, 1330/08, 1479/04, SIM, singleminded, l(3)87Ea, l(3)E320, l(3)RD, schm, schmal" CDMC35613 3 2 13 DAC20-K01 3-CG7771-RA_1 CG7771 CGCCCTCACAGACGACCTACAGCGATCTGAGTCACAACTTCGAGCTGAGCTACTTCTCCGACAACAGTT 69 FBan0007771 FBgn0004666 sim 3 3R adult walking behavior; GO:0007628; brain development; GO:0007420; central nervous system development; GO:0007417; ectoderm development; GO:0007398; locomotion; GO:0040011; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 sim single-minded "CG7771, l(3)s8, l(3)S8, S8, shm, 0483/09, 0716/08, 0899/14, 0953/08, 1002/10, 1034/02, 1050/13, 1110/04, 1111/10, 1330/08, 1479/04, SIM, singleminded, l(3)87Ea, l(3)E320, l(3)RD, schm, schmal" CDMC35614 3 3 13 DAC20-K13 17-CG7780-RA_1 CG7780 CCGGCAACTTACCGAATAGCTGCGATAAGTCCGATAAGGTTCTCAATGTGGAATCCATTTCCAATCCGG 69 FBan0007780 FBgn0000477 DNaseII 3 3R DNA catabolism; GO:0006308; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; deoxyribonuclease II activity; GO:0004531 ; EC:3.1.22.1; ; GO:0004531 ; EC:3.1.22.1; ; GO:0003676; ; GO:0004531 ; EC:3.1.22.1; ; GO:0004531 ; EC:3.1.22.1 DNaseII Deoxyribonuclease II "CG7780, CG7780, CG7780, CG7780, CG7780, DNase1: Deoxyribonuclease 1, acid DNase, DNase 1, dDNase II, DNase-1, DNase, Deoxyribonuclease 1, DNase1" CDMC35614 3 4 13 DAC20-K13 17-CG7780-RA_1 CG7780 CCGGCAACTTACCGAATAGCTGCGATAAGTCCGATAAGGTTCTCAATGTGGAATCCATTTCCAATCCGG 69 FBan0007780 FBgn0000477 DNaseII 3 3R DNA catabolism; GO:0006308; apoptotic program; GO:0008632 nucleic acid binding; GO:0003676; deoxyribonuclease II activity; GO:0004531 ; EC:3.1.22.1; ; GO:0004531 ; EC:3.1.22.1; ; GO:0003676; ; GO:0004531 ; EC:3.1.22.1; ; GO:0004531 ; EC:3.1.22.1 DNaseII Deoxyribonuclease II "CG7780, CG7780, CG7780, CG7780, CG7780, DNase1: Deoxyribonuclease 1, acid DNase, DNase 1, dDNase II, DNase-1, DNase, Deoxyribonuclease 1, DNase1" CDMC35615 3 5 13 DAC20-O01 6-CG7816-RF_3 CG7816 GGGATCGGTGGTAATTGGACTGAGTGGCATATTCCCGCTGATCATCATTCCCACGGAGGAGAAAATGGC 69 FBan0007816 FBgn0039714 CG7816 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to membrane; GO:0016021 CG7816 CG7816 CDMC35615 3 6 13 DAC20-O01 6-CG7816-RF_3 CG7816 GGGATCGGTGGTAATTGGACTGAGTGGCATATTCCCGCTGATCATCATTCCCACGGAGGAGAAAATGGC 69 FBan0007816 FBgn0039714 CG7816 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 integral to membrane; GO:0016021 CG7816 CG7816 CDMC35616 3 7 13 DAC20-O13 23-CG7826-RC_12 CG7826 GTACGATACTCAAGTTTGTGATGAGTAGCAAGCAAGAATGCAAGCAATGATGATTGGTGGTCCCTCATA 69 FBan0007826 FBgn0002777 mnb X X brain development; GO:0007420; cell proliferation; GO:0008283; circadian rhythm; GO:0007623; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; learning and/or memory; GO:0007611; nervous system development; GO:0007399; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; visual behavior; GO:0007632 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004712 ; EC:2.7.1.- mnb minibrain "CG7826, CG7826, Mnb, ME-IV, Dyrk1, Minibrain, min" CDMC35616 3 8 13 DAC20-O13 23-CG7826-RC_12 CG7826 GTACGATACTCAAGTTTGTGATGAGTAGCAAGCAAGAATGCAAGCAATGATGATTGGTGGTCCCTCATA 69 FBan0007826 FBgn0002777 mnb X X brain development; GO:0007420; cell proliferation; GO:0008283; circadian rhythm; GO:0007623; ectoderm development; GO:0007398; induction of apoptosis; GO:0006917; learning and/or memory; GO:0007611; nervous system development; GO:0007399; olfactory learning; GO:0008355; protein amino acid phosphorylation; GO:0006468; visual behavior; GO:0007632 ATP binding; GO:0005524; ; GO:0005524; protein threonine/tyrosine kinase activity; GO:0004712 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004712 ; EC:2.7.1.- mnb minibrain "CG7826, CG7826, Mnb, ME-IV, Dyrk1, Minibrain, min" CDMC35617 3 9 13 DAC21-C01 12-CG2615-RB_1 CG2615 CGCGCACACTGACCTACAACGACGAACAGTTTCATGCCCTGGAGAAGATTAAAGTGGATCACAATGGCA 69 FBan0002615 FBgn0028633 ik2 2 2L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; sugar porter activity; GO:0005351; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0004674; ; GO:0008965 ; EC:2.7.3.9 IkappaB kinase complex; GO:0008385 ik2 ik2 "CG2615, CG2615, dik2, DmIKKepsilon, Ik2, DIK2, Dmik2, 38D.31, DmIKKepsilon/dIK2, dIKK, IK2, Dik2, IKKepsilon" CDMC35617 3 10 13 DAC21-C01 12-CG2615-RB_1 CG2615 CGCGCACACTGACCTACAACGACGAACAGTTTCATGCCCTGGAGAAGATTAAAGTGGATCACAATGGCA 69 FBan0002615 FBgn0028633 ik2 2 2L cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein serine/threonine kinase activity; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; sugar porter activity; GO:0005351; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005351; phosphoenolpyruvate-protein phosphotransferase activity; GO:0008965 ; EC:2.7.3.9; ; GO:0004674; ; GO:0008965 ; EC:2.7.3.9 IkappaB kinase complex; GO:0008385 ik2 ik2 "CG2615, CG2615, dik2, DmIKKepsilon, Ik2, DIK2, Dmik2, 38D.31, DmIKKepsilon/dIK2, dIKK, IK2, Dik2, IKKepsilon" CDMC35618 3 11 13 DAC21-C13 18-CG2652-RA_1 CG2652 GGGCTCTATGAAAGGAACAACTGAGAATGTTTGTTGTCCTGGCATGTGCAGTTACTGGATTGGCATTGG 69 FBan0002652 FBgn0025838 CG2652 X X CG2652 CG2652 EG:155E2.5 CDMC35618 3 12 13 DAC21-C13 18-CG2652-RA_1 CG2652 GGGCTCTATGAAAGGAACAACTGAGAATGTTTGTTGTCCTGGCATGTGCAGTTACTGGATTGGCATTGG 69 FBan0002652 FBgn0025838 CG2652 X X CG2652 CG2652 EG:155E2.5 CDMC35619 3 13 13 DAC21-G01 23-CG2681-RA_1 CG2681 TGTGCCTTTTCTAATTCGTCAACAGTCGCAAGAGTTGAAAGCATGTAAATATAGCAAATGTTTTAATCT 69 FBan0002681 FBgn0024997 CG2681 X X development; GO:0007275; protein ubiquitination; GO:0016567; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG2681 CG2681 "EG:100G10.2, 100G10.2" CDMC35619 3 14 13 DAC21-G01 23-CG2681-RA_1 CG2681 TGTGCCTTTTCTAATTCGTCAACAGTCGCAAGAGTTGAAAGCATGTAAATATAGCAAATGTTTTAATCT 69 FBan0002681 FBgn0024997 CG2681 X X development; GO:0007275; protein ubiquitination; GO:0016567; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG2681 CG2681 "EG:100G10.2, 100G10.2" CDMC35620 3 15 13 DAC21-G13 22-CG2706-RA_1 CG2706 TGCGATGGTGATGAGCTCCAAGGACTGTCCATATATGTAGCTTCTAGTTTCATCACTGTCCACTGACCA 69 FBan0002706 FBgn0000928 fs(1)Yb X X germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; oogenesis (sensu Insecta); GO:0009993; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713 cytoplasm; GO:0005737 fs(1)Yb female sterile (1) Yb "CG2706, CG2706, CG2706, fs(1)Y[b], Yb, EG:95B7.8, fs(1)M104: female sterile(1)M104, nov, female sterile(1)M104, no ovaries" CDMC35620 3 16 13 DAC21-G13 22-CG2706-RA_1 CG2706 TGCGATGGTGATGAGCTCCAAGGACTGTCCATATATGTAGCTTCTAGTTTCATCACTGTCCACTGACCA 69 FBan0002706 FBgn0000928 fs(1)Yb X X germ cell development; GO:0007281; germ-line stem cell division; GO:0042078; germ-line stem cell maintenance; GO:0030718; oogenesis (sensu Insecta); GO:0009993; somatic stem cell division; GO:0048103; stalk formation (sensu Insecta); GO:0030713 cytoplasm; GO:0005737 fs(1)Yb female sterile (1) Yb "CG2706, CG2706, CG2706, fs(1)Y[b], Yb, EG:95B7.8, fs(1)M104: female sterile(1)M104, nov, female sterile(1)M104, no ovaries" CDMC35621 3 17 13 DAC21-K01 2-CG2791-RA_4 CG2791 GCTTTCTTCTCGGTTGCCGAAGATGTCATGGAACCACAGGTGTACCAGTTGAGCGGAGATTCTGGAGCA 69 FBan0002791 FBgn0037533 CG2791 3 3R CG2791 CG2791 CDMC35621 3 18 13 DAC21-K01 2-CG2791-RA_4 CG2791 GCTTTCTTCTCGGTTGCCGAAGATGTCATGGAACCACAGGTGTACCAGTTGAGCGGAGATTCTGGAGCA 69 FBan0002791 FBgn0037533 CG2791 3 3R CG2791 CG2791 CDMC35622 3 19 13 DAC21-K13 23-CG2822-RB_4 CG2822 CCTACTCGTATCACTTGAGATCGTCTTTGTTTTCCTCATATCATCACACACTGTGTTTCGCAAAGCCTC 69 FBan0002822 FBgn0003386 Shaw 2 2L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shaw Shaker cognate w "CG2822, CG15419, dShaw2, dShaw, Shaw2" CDMC35622 3 20 13 DAC21-K13 23-CG2822-RB_4 CG2822 CCTACTCGTATCACTTGAGATCGTCTTTGTTTTCCTCATATCATCACACACTGTGTTTCGCAAAGCCTC 69 FBan0002822 FBgn0003386 Shaw 2 2L potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; ; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 integral to membrane; GO:0016021; plasma membrane; GO:0005886; voltage-gated potassium channel complex; GO:0008076 Shaw Shaker cognate w "CG2822, CG15419, dShaw2, dShaw, Shaw2" CDMC35623 3 21 13 DAC21-O01 20-CG2871-RA_1 CG2871 ATTCTGGACCACACTCAAAGATGTTTTCGAAGTAGCCAGCTGGAATGTTATGCCTGGAGTGCATCTCGG 69 FBan0002871 FBgn0029725 CG2871 X X CG2871 CG2871 CDMC35623 3 22 13 DAC21-O01 20-CG2871-RA_1 CG2871 ATTCTGGACCACACTCAAAGATGTTTTCGAAGTAGCCAGCTGGAATGTTATGCCTGGAGTGCATCTCGG 69 FBan0002871 FBgn0029725 CG2871 X X CG2871 CG2871 CDMC35624 3 23 13 DAC21-O13 10-CG2905-RA_1 CG2905 AAATGTTCCGGGATCAGTAACCTCCTCAATTTCTAATTCAGCAGCCTCGGAGTCTCTTGCTCGACGCGC 69 FBgn0033013 CDMC35624 3 24 13 DAC21-O13 10-CG2905-RA_1 CG2905 AAATGTTCCGGGATCAGTAACCTCCTCAATTTCTAATTCAGCAGCCTCGGAGTCTCTTGCTCGACGCGC 69 FBgn0033013 CDMC35625 3 25 13 DAC22-C01 9-CG14551-RA_1 CG14551 AATTTTCTTAACCGCGAGAAGCTTTTTGCCACCCGTCCGTACTCCAGCCTCCCGGAAGTGGTCAC 65 FBan0014551 FBgn0039408 CG14551 3 3R CG14551 CG14551 CDMC35625 3 26 13 DAC22-C01 9-CG14551-RA_1 CG14551 AATTTTCTTAACCGCGAGAAGCTTTTTGCCACCCGTCCGTACTCCAGCCTCCCGGAAGTGGTCAC 65 FBan0014551 FBgn0039408 CG14551 3 3R CG14551 CG14551 CDMC35626 3 1 14 DAC22-C13 3-CG14572-RA_1 CG14572 ATTCGGGCCGAGATCGAAAGTCCAACATGCAGTCCATTCTACCCGTTATCCTTTGCCTTTGGGCC 65 FBan0014572 FBgn0037128 CG14572 3 3L CG14572 CG14572 CDMC35626 3 2 14 DAC22-C13 3-CG14572-RA_1 CG14572 ATTCGGGCCGAGATCGAAAGTCCAACATGCAGTCCATTCTACCCGTTATCCTTTGCCTTTGGGCC 65 FBan0014572 FBgn0037128 CG14572 3 3L CG14572 CG14572 CDMC35627 3 3 14 DAC22-G01 6-CG14647-RA_3 CG14647 CTGGGGGACAGACCATTGACGCGCAACGACGTCATCAAGGCCATCATTCAGACCTCCGTGATAAC 65 FBan0014647 FBgn0037244 CG14647 3 3R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG14647 CG14647 CDMC35627 3 4 14 DAC22-G01 6-CG14647-RA_3 CG14647 CTGGGGGACAGACCATTGACGCGCAACGACGTCATCAAGGCCATCATTCAGACCTCCGTGATAAC 65 FBan0014647 FBgn0037244 CG14647 3 3R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG14647 CG14647 CDMC35628 3 5 14 DAC22-G13 2-CG14683-RA_1 CG14683 TTGGTTGAGACGAAGCTCTATAGATGTGACGACTGCTCCCCATGTTCCTGTGCTCTGCGACACCG 65 FBan0014683 FBgn0037822 CG14683 3 3R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG14683 CG14683 CDMC35628 3 6 14 DAC22-G13 2-CG14683-RA_1 CG14683 TTGGTTGAGACGAAGCTCTATAGATGTGACGACTGCTCCCCATGTTCCTGTGCTCTGCGACACCG 65 FBan0014683 FBgn0037822 CG14683 3 3R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG14683 CG14683 CDMC35629 3 7 14 DAC22-K01 24-CG14786-RA_1 CG14786 GTTATACACTTGGTATGTATGTACACACATAAATTAGTGCAGTAAATACGAGACGGTATACCTGC 65 FBan0014786 FBgn0027794 CG14786 X X CG14786 CG14786 EG:BACN32G11.3 CDMC35629 3 8 14 DAC22-K01 24-CG14786-RA_1 CG14786 GTTATACACTTGGTATGTATGTACACACATAAATTAGTGCAGTAAATACGAGACGGTATACCTGC 65 FBan0014786 FBgn0027794 CG14786 X X CG14786 CG14786 EG:BACN32G11.3 CDMC35630 3 9 14 DAC22-K13 18-CG14798-RA_4 CG14798 GATTTTGCGGCAACACCACTGCGGGCATTAGCATGCTCAGCGACTGAAGCGCGTGACCAAGGATC 65 FBan0014798 FBgn0029588 CG14798 X X CG14798 CG14798 BcDNA:RE57135 CDMC35630 3 10 14 DAC22-K13 18-CG14798-RA_4 CG14798 GATTTTGCGGCAACACCACTGCGGGCATTAGCATGCTCAGCGACTGAAGCGCGTGACCAAGGATC 65 FBan0014798 FBgn0029588 CG14798 X X CG14798 CG14798 BcDNA:RE57135 CDMC35631 3 11 14 DAC22-O01 6-CG14884-RA_2 CG14884 CTCGGGTCTGCTCACCAACACAGAGTACACCACCGGTCAGATCATGGATCTCTCCGAGAAGCTGG 65 FBan0014884 FBgn0027053 CSN5 3 3R axonogenesis; GO:0007409; glial cell migration; GO:0008347; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein deneddylation; GO:0000338; transcription from RNA polymerase II promoter; GO:0006366 transcription regulator activity; GO:0030528; ; GO:0030528; NEDD8 activating enzyme activity; GO:0019781; ; GO:0019781 cytoplasm; GO:0005737; signalosome complex; GO:0008180 CSN5 COP9 complex homolog subunit 5 "CG14884, l(3)L4032, l(3)89Cf, l(3)M203, DCH5, JadBp, Jun activation domain binding protein, Dch5, dch5, Drosophila COP9 signalosome homolog 5, COP9 complex homolog subunit 5, BcDNA.LD14392, Jab1, JUN activation domain-binding protein-1, Csn5, JAB1/CSN5, quo: quo vadis, csn5, jab1/csn5, BcDNA:LD14392, CH5, quo" CDMC35631 3 12 14 DAC22-O01 6-CG14884-RA_2 CG14884 CTCGGGTCTGCTCACCAACACAGAGTACACCACCGGTCAGATCATGGATCTCTCCGAGAAGCTGG 65 FBan0014884 FBgn0027053 CSN5 3 3R axonogenesis; GO:0007409; glial cell migration; GO:0008347; oocyte anterior/posterior axis determination; GO:0007314; oocyte axis determination; GO:0007309; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; protein deneddylation; GO:0000338; transcription from RNA polymerase II promoter; GO:0006366 transcription regulator activity; GO:0030528; ; GO:0030528; NEDD8 activating enzyme activity; GO:0019781; ; GO:0019781 cytoplasm; GO:0005737; signalosome complex; GO:0008180 CSN5 COP9 complex homolog subunit 5 "CG14884, l(3)L4032, l(3)89Cf, l(3)M203, DCH5, JadBp, Jun activation domain binding protein, Dch5, dch5, Drosophila COP9 signalosome homolog 5, COP9 complex homolog subunit 5, BcDNA.LD14392, Jab1, JUN activation domain-binding protein-1, Csn5, JAB1/CSN5, quo: quo vadis, csn5, jab1/csn5, BcDNA:LD14392, CH5, quo" CDMC35632 3 13 14 DAC22-O13 23-CG14935-RA_7 CG14935 ACTAAGCACATCTACTCGAGAGATCTGCCAGAAGTCTTGGAAATGATTCATCACTGGAGGCAACT 65 FBan0014935 FBgn0032382 CG14935 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG14935 CG14935 FBgn0032382 CDMC35632 3 14 14 DAC22-O13 23-CG14935-RA_7 CG14935 ACTAAGCACATCTACTCGAGAGATCTGCCAGAAGTCTTGGAAATGATTCATCACTGGAGGCAACT 65 FBan0014935 FBgn0032382 CG14935 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG14935 CG14935 FBgn0032382 CDMC35633 3 15 14 DAC23-C01 23-CG6755-RA_11 CG6755 ACGGTGGGATTACCTTCCAACTTTATTGGCAAAGACTTTCAGGTCTGAATAAAGTGACATTGTGATACT 69 FBan0006755 FBgn0039066 EloA 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368 positive transcription elongation factor activity; GO:0008159; transcription cofactor activity; GO:0003712; ; GO:0003712; transcriptional elongation regulator activity; GO:0003711; ; GO:0008159; ; GO:0003711; RNA polymerase II transcription elongation factor activity; GO:0016944; ; GO:0016944; ; GO:0016944 transcription elongation factor complex; GO:0008023 EloA Elongin A "CG6755, CG6755, CG6755, CG6755, dEloA, Elongin A" CDMC35633 3 16 14 DAC23-C01 23-CG6755-RA_11 CG6755 ACGGTGGGATTACCTTCCAACTTTATTGGCAAAGACTTTCAGGTCTGAATAAAGTGACATTGTGATACT 69 FBan0006755 FBgn0039066 EloA 3 3R RNA elongation from RNA polymerase II promoter; GO:0006368 positive transcription elongation factor activity; GO:0008159; transcription cofactor activity; GO:0003712; ; GO:0003712; transcriptional elongation regulator activity; GO:0003711; ; GO:0008159; ; GO:0003711; RNA polymerase II transcription elongation factor activity; GO:0016944; ; GO:0016944; ; GO:0016944 transcription elongation factor complex; GO:0008023 EloA Elongin A "CG6755, CG6755, CG6755, CG6755, dEloA, Elongin A" CDMC35634 3 17 14 DAC23-C13 23-CG6765-RA_17 CG6765 TCGTCAGGCAACGATGCAAAACAAGACAAAGCAAGAAATTCAGAAACGAAAGCAAAGCAACATTTAACT 69 FBan0006765 FBgn0035903 CG6765 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG6765 CG6765 CDMC35634 3 18 14 DAC23-C13 23-CG6765-RA_17 CG6765 TCGTCAGGCAACGATGCAAAACAAGACAAAGCAAGAAATTCAGAAACGAAAGCAAAGCAACATTTAACT 69 FBan0006765 FBgn0035903 CG6765 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 CG6765 CG6765 CDMC35635 3 19 14 DAC23-G01 14-CG6801-RA_2 CG6801 AGTGATATGGTTGCTAGCAAAGCCATGAAAAGAACGCGAACTCCCTCTCCCAGTATTCCGGAAATCCCG 69 FBgn0036247 CDMC35635 3 20 14 DAC23-G01 14-CG6801-RA_2 CG6801 AGTGATATGGTTGCTAGCAAAGCCATGAAAAGAACGCGAACTCCCTCTCCCAGTATTCCGGAAATCCCG 69 FBgn0036247 CDMC35636 3 21 14 DAC23-G13 8-CG6813-RA_1 CG6813 ACGTGCAAAAAGAGTTTTGTAAGCTCCGGATGTCTCAGGAAGCACAAGATGATCCATGTGGATGCGCGG 69 FBan0006813 FBgn0037923 CG6813 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6813 CG6813 CG31372 CDMC35636 3 22 14 DAC23-G13 8-CG6813-RA_1 CG6813 ACGTGCAAAAAGAGTTTTGTAAGCTCCGGATGTCTCAGGAAGCACAAGATGATCCATGTGGATGCGCGG 69 FBan0006813 FBgn0037923 CG6813 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG6813 CG6813 CG31372 CDMC35637 3 23 14 DAC23-K01 22-CG6851-RA_1 CG6851 TCATCGTGGTCCGTTAGTCTTGCGCGATGTTTTCTTTTCTTTCAGCAACTACGAGCACTGAAATCGTGA 69 FBan0006851 FBgn0027786 Mtch 3 3L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 Mtch Mitochondrial carrier homolog 1 CG6851 CDMC35637 3 24 14 DAC23-K01 22-CG6851-RA_1 CG6851 TCATCGTGGTCCGTTAGTCTTGCGCGATGTTTTCTTTTCTTTCAGCAACTACGAGCACTGAAATCGTGA 69 FBan0006851 FBgn0027786 Mtch 3 3L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 Mtch Mitochondrial carrier homolog 1 CG6851 CDMC35638 3 25 14 DAC23-K13 3-CG6860-RB_1 CG6860 GCCATCAGCAAGCGGATCGAGTTCTTCGAACAGCAGAAGAGTGGAAAACCAAAGCTGGAGGTCTTCAGC 69 FBan0006860 FBgn0032633 CG6860 2 2L Ras protein signal transduction; GO:0007265; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.- CG6860 CG6860 CT21229 CDMC35638 3 26 14 DAC23-K13 3-CG6860-RB_1 CG6860 GCCATCAGCAAGCGGATCGAGTTCTTCGAACAGCAGAAGAGTGGAAAACCAAAGCTGGAGGTCTTCAGC 69 FBan0006860 FBgn0032633 CG6860 2 2L Ras protein signal transduction; GO:0007265; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; ; GO:0004675 ; EC:2.7.1.- CG6860 CG6860 CT21229 CDMC35639 3 1 15 DAC23-O01 3-CG6891-RA_1 CG6891 TGGCGCTGTGTATTTTTGTTTTCGTTGTCATTGTGCCACTCTGCCACTCTGCCACTTTGTCACCTTGCA 69 FBan0006891 FBgn0030955 CG6891 X X actin binding; GO:0003779; ; GO:0003779 intracellular; GO:0005622 CG6891 CG6891 CDMC35639 3 2 15 DAC23-O01 3-CG6891-RA_1 CG6891 TGGCGCTGTGTATTTTTGTTTTCGTTGTCATTGTGCCACTCTGCCACTCTGCCACTTTGTCACCTTGCA 69 FBan0006891 FBgn0030955 CG6891 X X actin binding; GO:0003779; ; GO:0003779 intracellular; GO:0005622 CG6891 CG6891 CDMC35640 3 3 15 DAC23-O13 3-CG6899-RA_1 CG6899 CCGGCACACAGTCCCATGCAGATACCGAATCTGACAACACAGACTCAGATGACGATGATGAGGATGGGG 69 FBan0006899 FBgn0004368 Ptp4E X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001 plasma membrane; GO:0005886 Ptp4E Protein tyrosine phosphatase 4E "CG6899, CG6899, CG6899, DPTP4E, PTP4E, R-PTP 4E, CT21187" CDMC35640 3 4 15 DAC23-O13 3-CG6899-RA_1 CG6899 CCGGCACACAGTCCCATGCAGATACCGAATCTGACAACACAGACTCAGATGACGATGATGAGGATGGGG 69 FBan0006899 FBgn0004368 Ptp4E X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001 plasma membrane; GO:0005886 Ptp4E Protein tyrosine phosphatase 4E "CG6899, CG6899, CG6899, DPTP4E, PTP4E, R-PTP 4E, CT21187" CDMC35641 3 5 15 DAC24-C01 17-CG2171-RC_1 CG2171 GGCGAGCCTCCAGTCATCGAGTTACCCACTTGAAATTATCAGTTCCAAACACTCTAATAGCAGTCCCCT 69 FBan0002171 FBgn0003738 Tpi 3 3R gluconeogenesis; GO:0006094; glycolysis; GO:0006096; pentose-phosphate shunt; GO:0006098 triose-phosphate isomerase activity; GO:0004807 ; EC:5.3.1.1; intramolecular transferase activity; GO:0016866 ; EC:5.4.-.-; ; GO:0016866 ; EC:5.4.-.-; ; GO:0004807 ; EC:5.3.1.1; ; GO:0004807 ; EC:5.3.1.1 Tpi Triose phosphate isomerase "CG2171, TPI, TPIS" CDMC35641 3 6 15 DAC24-C01 17-CG2171-RC_1 CG2171 GGCGAGCCTCCAGTCATCGAGTTACCCACTTGAAATTATCAGTTCCAAACACTCTAATAGCAGTCCCCT 69 FBan0002171 FBgn0003738 Tpi 3 3R gluconeogenesis; GO:0006094; glycolysis; GO:0006096; pentose-phosphate shunt; GO:0006098 triose-phosphate isomerase activity; GO:0004807 ; EC:5.3.1.1; intramolecular transferase activity; GO:0016866 ; EC:5.4.-.-; ; GO:0016866 ; EC:5.4.-.-; ; GO:0004807 ; EC:5.3.1.1; ; GO:0004807 ; EC:5.3.1.1 Tpi Triose phosphate isomerase "CG2171, TPI, TPIS" CDMC35642 3 7 15 DAC24-C13 9-CG2183-RA_2 CG2183 CCGACGCACTTCCTGGGCTACAACACGCTAAGGGATCACATTCCACGCATCTTCCTTAAGAGCGATTGC 69 FBan0002183 FBgn0033273 CG2183 2 2R mismatch repair; GO:0006298 CG2183 CG2183 BEST:LD05795 CDMC35642 3 8 15 DAC24-C13 9-CG2183-RA_2 CG2183 CCGACGCACTTCCTGGGCTACAACACGCTAAGGGATCACATTCCACGCATCTTCCTTAAGAGCGATTGC 69 FBan0002183 FBgn0033273 CG2183 2 2R mismatch repair; GO:0006298 CG2183 CG2183 BEST:LD05795 CDMC35643 3 9 15 DAC24-G01 22-CG2219-RA_4 CG2219 ACCCTTGGCAAAGCAAAAGGAGTTCATTTTTTGGTTTGGGATGTCGGAGGACAAGAAAAATTGAGACCA 69 FBan0002219 FBgn0039889 CG2219 4 4 cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG2219 CG2219 BcDNA:AT26185 CDMC35643 3 10 15 DAC24-G01 22-CG2219-RA_4 CG2219 ACCCTTGGCAAAGCAAAAGGAGTTCATTTTTTGGTTTGGGATGTCGGAGGACAAGAAAAATTGAGACCA 69 FBan0002219 FBgn0039889 CG2219 4 4 cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; small GTPase mediated signal transduction; GO:0007264; vesicle-mediated transport; GO:0016192 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG2219 CG2219 BcDNA:AT26185 CDMC35644 3 11 15 DAC24-G13 2-CG2245-RA_1 CG2245 CCGACGGCCTAGCCAAACTAGACGCGACCAAGTGATTTTCGCCGAACATTTGCATCTACCAGCTGTGTA 69 FBgn0039871 CDMC35644 3 12 15 DAC24-G13 2-CG2245-RA_1 CG2245 CCGACGGCCTAGCCAAACTAGACGCGACCAAGTGATTTTCGCCGAACATTTGCATCTACCAGCTGTGTA 69 FBgn0039871 CDMC35645 3 13 15 DAC24-K01 27-CG2302-RA_1 CG2302 GGGCGTGGATCTGTCCGAGTTCTATACGTCCGTCGAATGGGATATCCTCGAAGTTCCTGCAGTGCGAAA 69 FBan0002302 FBgn0015519 nAcRalpha-7E X X cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-7E nicotinic Acetylcholine Receptor alpha 7E "CG2302, Dalpha3, Drosophila alpha-like subunit 3, nAcRalpha-7E, Da3, nACRalpha-7E, nAcRe, nAChR, Acr7E, D[a3]: Drosophila alpha-like subunit 3" CDMC35645 3 14 15 DAC24-K01 27-CG2302-RA_1 CG2302 GGGCGTGGATCTGTCCGAGTTCTATACGTCCGTCGAATGGGATATCCTCGAAGTTCCTGCAGTGCGAAA 69 FBan0002302 FBgn0015519 nAcRalpha-7E X X cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 nicotinic acetylcholine-activated cation-selective channel activity; GO:0004889; ; GO:0004889; acetylcholine receptor activity; GO:0015464; ; GO:0004889; ; GO:0015464 nicotinic acetylcholine-gated receptor-channel complex; GO:0005892; postsynaptic membrane; GO:0045211 nAcRalpha-7E nicotinic Acetylcholine Receptor alpha 7E "CG2302, Dalpha3, Drosophila alpha-like subunit 3, nAcRalpha-7E, Da3, nACRalpha-7E, nAcRe, nAChR, Acr7E, D[a3]: Drosophila alpha-like subunit 3" CDMC35646 3 15 15 DAC24-K13 12-CG2330-RA_1 CG2330 CCTGCTGCTTCTCCATTCTGGAGCATTGCATTGAGTATATGGCTACGGATCAGCTGGATCTAGAGCCCA 69 FBan0002330 FBgn0037447 CG2330 3 3R development; GO:0007275; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; skeletal development; GO:0001501 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 CG2330 CG2330 CDMC35646 3 16 15 DAC24-K13 12-CG2330-RA_1 CG2330 CCTGCTGCTTCTCCATTCTGGAGCATTGCATTGAGTATATGGCTACGGATCAGCTGGATCTAGAGCCCA 69 FBan0002330 FBgn0037447 CG2330 3 3R development; GO:0007275; ectoderm development; GO:0007398; mesoderm development; GO:0007498; nervous system development; GO:0007399; skeletal development; GO:0001501 structural molecule activity; GO:0005198; extracellular matrix structural constituent; GO:0005201; ; GO:0005198; ; GO:0005201 CG2330 CG2330 CDMC35647 3 17 15 DAC24-O01 18-CG2467-RA_1 CG2467 ACGCTGCCGTTTGATGGGAAATTTGTATGAGCAGGTCACAAAATCCTGTCCAACTGATCGGATCTTACT 69 FBan0002467 FBgn0030355 CG2467 X X CG2467 CG2467 CDMC35647 3 18 15 DAC24-O01 18-CG2467-RA_1 CG2467 ACGCTGCCGTTTGATGGGAAATTTGTATGAGCAGGTCACAAAATCCTGTCCAACTGATCGGATCTTACT 69 FBan0002467 FBgn0030355 CG2467 X X CG2467 CG2467 CDMC35648 3 19 15 DAC24-O13 3-CG2508-RA_3 CG2508 GCCTGGACCTTGATGGGACACGAGTTCATGGAGCTGAAAAACACAAATGCAGCCATACAGAGCTACCGA 69 FBan0002508 FBgn0032863 cdc23 2 2L mitotic anaphase; GO:0000090; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 anaphase-promoting complex; GO:0005680 cdc23 cdc23 "CG2508, CG2508, 38C.54, cdc23" CDMC35648 3 20 15 DAC24-O13 3-CG2508-RA_3 CG2508 GCCTGGACCTTGATGGGACACGAGTTCATGGAGCTGAAAAACACAAATGCAGCCATACAGAGCTACCGA 69 FBan0002508 FBgn0032863 cdc23 2 2L mitotic anaphase; GO:0000090; regulation of mitotic metaphase/anaphase transition; GO:0030071; regulation of progression through cell cycle; GO:0000074 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 anaphase-promoting complex; GO:0005680 cdc23 cdc23 "CG2508, CG2508, 38C.54, cdc23" CDMC35649 3 21 15 DAC25-C01 5-CG10086-RA_3 CG10086 CTCGTCCTTCGAGGGTGCCTATGGACACATCCGGTATCTGGCCAAGGTCACCTTTTTGAAGCCAG 65 FBan0010086 FBgn0037517 CG10086 3 3R CG10086 CG10086 CDMC35649 3 22 15 DAC25-C01 5-CG10086-RA_3 CG10086 CTCGTCCTTCGAGGGTGCCTATGGACACATCCGGTATCTGGCCAAGGTCACCTTTTTGAAGCCAG 65 FBan0010086 FBgn0037517 CG10086 3 3R CG10086 CG10086 CDMC35650 3 23 15 DAC25-C13 1-CG10146-RA_2 CG10146 ATGGAGCTGGTCTGGATTACTCCCACATCAACGGACATGGTGCTTCCTTGACGCACAGCAACTTC 65 FBan0010146 FBgn0012042 AttA 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttA Attacin-A "CG10146, CG10146, CG10146, Att, Attacin, att, attacin, ATT, att A, Attacin A, attA, Att A, Attackin, attacin A, anon-WO0140519.5, BcDNA:LP05763" CDMC35650 3 24 15 DAC25-C13 1-CG10146-RA_2 CG10146 ATGGAGCTGGTCTGGATTACTCCCACATCAACGGACATGGTGCTTCCTTGACGCACAGCAACTTC 65 FBan0010146 FBgn0012042 AttA 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttA Attacin-A "CG10146, CG10146, CG10146, Att, Attacin, att, attacin, ATT, att A, Attacin A, attA, Att A, Attackin, attacin A, anon-WO0140519.5, BcDNA:LP05763" CDMC35651 3 25 15 DAC25-G01 3-CG10245-RA_1 CG10245 GAGGAAGCGTCCTGTCGTCGGTCACTTAATCCGCGTTGCAACTCAACACTACCAGCACACCAATC 65 FBan0010245 FBgn0033980 Cyp6a20 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a20 Cyp6a20 "CG10245, 6a20" CDMC35651 3 26 15 DAC25-G01 3-CG10245-RA_1 CG10245 GAGGAAGCGTCCTGTCGTCGGTCACTTAATCCGCGTTGCAACTCAACACTACCAGCACACCAATC 65 FBan0010245 FBgn0033980 Cyp6a20 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a20 Cyp6a20 "CG10245, 6a20" CDMC35652 3 1 16 DAC25-G13 2-CG10270-RA_1 CG10270 CTGAAGTTGGATCATGTTTGAGCGGCAGAATCAAACGGAAATGCTTGCGAGCAAACCCGGCCTCC 65 FBan0010270 FBgn0022699 D19B 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 D19B D19B CG10270 CDMC35652 3 2 16 DAC25-G13 2-CG10270-RA_1 CG10270 CTGAAGTTGGATCATGTTTGAGCGGCAGAATCAAACGGAAATGCTTGCGAGCAAACCCGGCCTCC 65 FBan0010270 FBgn0022699 D19B 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 D19B D19B CG10270 CDMC35653 3 3 16 DAC25-K01 2-CG10371-RA_1 CG10371 CGCACAGCGAATCACTCTTCGAGCTCAGCCGTTAGTGCTGGTGAAAGTTACAGCTGTTGCGTTCG 65 FBan0010371 FBgn0039111 Plip 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- Plip PTEN-like phosphatase "CG10371, CG10371, MKP-like, PLIP, PTEN-like phosphatase" CDMC35653 3 4 16 DAC25-K01 2-CG10371-RA_1 CG10371 CGCACAGCGAATCACTCTTCGAGCTCAGCCGTTAGTGCTGGTGAAAGTTACAGCTGTTGCGTTCG 65 FBan0010371 FBgn0039111 Plip 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.- Plip PTEN-like phosphatase "CG10371, CG10371, MKP-like, PLIP, PTEN-like phosphatase" CDMC35654 3 5 16 DAC25-K13 9-CG10399-RA_4 CG10399 ACTGGTATAAGCTATCCAGTCCTCACGCCTAATCTGAAGGGATTCGAGAGTGCTCTGGAGGCGGG 65 FBan0010399 FBgn0031877 CG10399 2 2L acyl-CoA metabolism; GO:0006637; leucine metabolism; GO:0006551 hydroxymethylglutaryl-CoA lyase activity; GO:0004419 ; EC:4.1.3.4; ; GO:0004419 ; EC:4.1.3.4 mitochondrial matrix; GO:0005759 CG10399 CG10399 CDMC35654 3 6 16 DAC25-K13 9-CG10399-RA_4 CG10399 ACTGGTATAAGCTATCCAGTCCTCACGCCTAATCTGAAGGGATTCGAGAGTGCTCTGGAGGCGGG 65 FBan0010399 FBgn0031877 CG10399 2 2L acyl-CoA metabolism; GO:0006637; leucine metabolism; GO:0006551 hydroxymethylglutaryl-CoA lyase activity; GO:0004419 ; EC:4.1.3.4; ; GO:0004419 ; EC:4.1.3.4 mitochondrial matrix; GO:0005759 CG10399 CG10399 CDMC35655 3 7 16 DAC25-O01 2-CG10535-RA_2 CG10535 GAAAGAGGTGGACCTACTGTCGGACACCACCAGTCTCCACTCCTCGCAATACAGTGGCACATCAC 65 FBan0010535 FBgn0037926 CG10535 3 3R asymmetric protein localization; GO:0008105; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; protein targeting; GO:0006605; signal transduction; GO:0007165 kinase activator activity; GO:0019209; ; GO:0019209 CG10535 CG10535 CDMC35655 3 8 16 DAC25-O01 2-CG10535-RA_2 CG10535 GAAAGAGGTGGACCTACTGTCGGACACCACCAGTCTCCACTCCTCGCAATACAGTGGCACATCAC 65 FBan0010535 FBgn0037926 CG10535 3 3R asymmetric protein localization; GO:0008105; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; protein targeting; GO:0006605; signal transduction; GO:0007165 kinase activator activity; GO:0019209; ; GO:0019209 CG10535 CG10535 CDMC35656 3 9 16 DAC25-O13 5-CG1056-RB_1 CG1056 GCCACAATTGGGTTACCCGACCAATGTAGGTGGAAATGGAGGTAGAACTGTTGGAGCGACGGAGG 65 FBan0001056 FBgn0013743 5-HT2 3 3R germ-band extension; GO:0007377; serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT2 receptor activity; GO:0001587; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001587 integral to membrane; GO:0016021; plasma membrane; GO:0005886 5-HT2 Serotonin receptor 2 "CG1056, 5HT-dro[[1]], 5-HT2Dro, 5-HT[[2]], 5HT2Dro, 5-ht2Dro, 5HT[[2Dro]], 5-HT[[2Dro]], 5HT2-Dro, Dm5HT2, 5HT-R82A" CDMC35656 3 10 16 DAC25-O13 5-CG1056-RB_1 CG1056 GCCACAATTGGGTTACCCGACCAATGTAGGTGGAAATGGAGGTAGAACTGTTGGAGCGACGGAGG 65 FBan0001056 FBgn0013743 5-HT2 3 3R germ-band extension; GO:0007377; serotonin receptor signaling pathway; GO:0007210; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0004993; 5-HT2 receptor activity; GO:0001587; ; GO:0008227; ; GO:0016609; ; GO:0004993; ; GO:0001587 integral to membrane; GO:0016021; plasma membrane; GO:0005886 5-HT2 Serotonin receptor 2 "CG1056, 5HT-dro[[1]], 5-HT2Dro, 5-HT[[2]], 5HT2Dro, 5-ht2Dro, 5HT[[2Dro]], 5-HT[[2Dro]], 5HT2-Dro, Dm5HT2, 5HT-R82A" CDMC35657 3 11 16 DAC26-C01 3-CG6185-RA_6 CG6185 GCCGCATAATTTCGAATGCCTGACCTTTCTCACACCGGAATCGTCGACGGATAACTCCTGGCAGACCTT 69 FBan0006185 FBgn0036150 CG6185 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG6185 CG6185 CT19410 CDMC35657 3 12 16 DAC26-C01 3-CG6185-RA_6 CG6185 GCCGCATAATTTCGAATGCCTGACCTTTCTCACACCGGAATCGTCGACGGATAACTCCTGGCAGACCTT 69 FBan0006185 FBgn0036150 CG6185 3 3L glutamate-gated ion channel activity; GO:0005234; ionotropic glutamate receptor activity; GO:0004970; ; GO:0005234; ; GO:0004970 membrane; GO:0016020 CG6185 CG6185 CT19410 CDMC35658 3 13 16 DAC26-C13 9-CG6194-RA_1 CG6194 CCGGGAGCCATCATACGACGCCTCAGTCATCCCATCAAACCGAGCAAACAGAGATGAACTATCCATTGT 69 FBan0006194 FBgn0038325 CG6194 3 3R autophagic cell death; GO:0048102; autophagy; GO:0006914; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG6194 CG6194 CDMC35658 3 14 16 DAC26-C13 9-CG6194-RA_1 CG6194 CCGGGAGCCATCATACGACGCCTCAGTCATCCCATCAAACCGAGCAAACAGAGATGAACTATCCATTGT 69 FBan0006194 FBgn0038325 CG6194 3 3R autophagic cell death; GO:0048102; autophagy; GO:0006914; proteolysis; GO:0006508; salivary gland cell autophagic cell death; GO:0035071 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG6194 CG6194 CDMC35659 3 15 16 DAC26-G01 2-CG6222-RA_1 CG6222 GCCCCAATGATCTTAAAGCGATGCTATGCCACATGACCCTTTCCCCCAACCATACCATACGTCGTGGAA 69 FBan0006222 FBgn0003575 su(s) X X mRNA binding; GO:0003729; ; GO:0003729; transcriptional repressor activity; GO:0016564; ; GO:0016564 nucleus; GO:0005634 su(s) suppressor of sable "CG6222, CG6222, su-v, su-s, EG:115C2.3, suppressor of sable" CDMC35659 3 16 16 DAC26-G01 2-CG6222-RA_1 CG6222 GCCCCAATGATCTTAAAGCGATGCTATGCCACATGACCCTTTCCCCCAACCATACCATACGTCGTGGAA 69 FBan0006222 FBgn0003575 su(s) X X mRNA binding; GO:0003729; ; GO:0003729; transcriptional repressor activity; GO:0016564; ; GO:0016564 nucleus; GO:0005634 su(s) suppressor of sable "CG6222, CG6222, su-v, su-s, EG:115C2.3, suppressor of sable" CDMC35660 3 17 16 DAC26-G13 3-CG6233-RA_2 CG6233 CGGAGGGACGCAATTTTCATGCCAACTACAAGTGCTTCTCCGTATCCATGTTGCCAGGAAACGAGCGAA 69 FBan0006233 FBgn0036136 Ufd1-like 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 proteasome complex (sensu Eukaryota); GO:0000502 Ufd1-like Ubiquitin fusion-degradation 1-like "CG6233, UfD1-like, Udf1, anon-WO0118547.405, Ubiquitin fusion-degradation 1-like" CDMC35660 3 18 16 DAC26-G13 3-CG6233-RA_2 CG6233 CGGAGGGACGCAATTTTCATGCCAACTACAAGTGCTTCTCCGTATCCATGTTGCCAGGAAACGAGCGAA 69 FBan0006233 FBgn0036136 Ufd1-like 3 3L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 proteasome complex (sensu Eukaryota); GO:0000502 Ufd1-like Ubiquitin fusion-degradation 1-like "CG6233, UfD1-like, Udf1, anon-WO0118547.405, Ubiquitin fusion-degradation 1-like" CDMC35661 3 19 16 DAC26-K01 23-CG6287-RA_4 CG6287 AAATTAACGCAATCTACCGGTTGTCCAGATTTTTCAGTGTATTCATTACCCACCCAAATATGCCCCTCA 69 FBan0006287 FBgn0032350 CG6287 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 phosphoglycerate dehydrogenase activity; GO:0004617 ; EC:1.1.1.95; ; GO:0004617 ; EC:1.1.1.95 CG6287 CG6287 CDMC35661 3 20 16 DAC26-K01 23-CG6287-RA_4 CG6287 AAATTAACGCAATCTACCGGTTGTCCAGATTTTTCAGTGTATTCATTACCCACCCAAATATGCCCCTCA 69 FBan0006287 FBgn0032350 CG6287 2 2L L-serine biosynthesis; GO:0006564; amino acid biosynthesis; GO:0008652; carbohydrate metabolism; GO:0005975 phosphoglycerate dehydrogenase activity; GO:0004617 ; EC:1.1.1.95; ; GO:0004617 ; EC:1.1.1.95 CG6287 CG6287 CDMC35662 3 21 16 DAC26-K13 6-CG6299-RA_3 CG6299 CACACCCGTGATCAGCGACATGAACGGAAACATAAACAAACTGACGAAAGCCTACGGAGCGGATGTGGT 69 FBan0006299 FBgn0030641 CG6299 X X glycolipid transport; GO:0046836 CG6299 CG6299 CDMC35662 3 22 16 DAC26-K13 6-CG6299-RA_3 CG6299 CACACCCGTGATCAGCGACATGAACGGAAACATAAACAAACTGACGAAAGCCTACGGAGCGGATGTGGT 69 FBan0006299 FBgn0030641 CG6299 X X glycolipid transport; GO:0046836 CG6299 CG6299 CDMC35663 3 23 16 DAC26-O01 23-CG6340-RA_5 CG6340 GCCTAGTTTTCAGTGCCTCCATTCCTTTACGCCAGCAAAAGTAATAATTCTATACATAGGCAAGGTCAT 69 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC35663 3 24 16 DAC26-O01 23-CG6340-RA_5 CG6340 GCCTAGTTTTCAGTGCCTCCATTCCTTTACGCCAGCAAAAGTAATAATTCTATACATAGGCAAGGTCAT 69 FBan0006340 FBgn0030648 CG6340 X X CG6340 CG6340 CDMC35664 3 25 16 DAC26-O13 2-CG6353-RA_1 CG6353 GCTGTTCCTGTTCTCTGCCGAACCGTATCTGGTGTGCAAGAAGCTGGAGATCACCAAGTTCGATGTGGA 69 FBan0006353 FBgn0038893 CG6353 3 3R CG6353 CG6353 BcDNA:SD28072 CDMC35664 3 26 16 DAC26-O13 2-CG6353-RA_1 CG6353 GCTGTTCCTGTTCTCTGCCGAACCGTATCTGGTGTGCAAGAAGCTGGAGATCACCAAGTTCGATGTGGA 69 FBan0006353 FBgn0038893 CG6353 3 3R CG6353 CG6353 BcDNA:SD28072 CDMC35665 3 1 17 DAC27-C01 22-CG3705-RA_1 CG3705 CAAGATGCTGTTCGATTATTTGGGCGAATACGATAGCTTTGATATCAACCAGCCCACTTCGCGTTCCGG 69 FBan0003705 FBgn0023129 aay 3 3L L-serine biosynthesis; GO:0006564; L-serine metabolism; GO:0006563; axon guidance; GO:0007411; peripheral nervous system development; GO:0007422 phosphoserine phosphatase activity; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3 cellular component unknown; GO:0008372 aay astray "CG3705, 0423/14, anon-WO0172774.117, astray" CDMC35665 3 2 17 DAC27-C01 22-CG3705-RA_1 CG3705 CAAGATGCTGTTCGATTATTTGGGCGAATACGATAGCTTTGATATCAACCAGCCCACTTCGCGTTCCGG 69 FBan0003705 FBgn0023129 aay 3 3L L-serine biosynthesis; GO:0006564; L-serine metabolism; GO:0006563; axon guidance; GO:0007411; peripheral nervous system development; GO:0007422 phosphoserine phosphatase activity; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3; ; GO:0004647 ; EC:3.1.3.3 cellular component unknown; GO:0008372 aay astray "CG3705, 0423/14, anon-WO0172774.117, astray" CDMC35666 3 3 17 DAC27-C13 23-CG3712-RA_3 CG3712 TGCATTTTCCCCATTTACCGAATCAAAATGCGTCTAACTAACGTTTTGTTCAAAAAGGTGAAGAGCAAG 69 FBan0003712 FBgn0040907 mRpL33 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL33 mitochondrial ribosomal protein L33 "CG3712, CG3712, L33, BcDNA:GH15938, mitochondrial ribosomal protein L33" CDMC35666 3 4 17 DAC27-C13 23-CG3712-RA_3 CG3712 TGCATTTTCCCCATTTACCGAATCAAAATGCGTCTAACTAACGTTTTGTTCAAAAAGGTGAAGAGCAAG 69 FBan0003712 FBgn0040907 mRpL33 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL33 mitochondrial ribosomal protein L33 "CG3712, CG3712, L33, BcDNA:GH15938, mitochondrial ribosomal protein L33" CDMC35667 3 5 17 DAC27-G01 3-CG3752-RA_1 CG3752 ACGGAGAGTATGCTCTGTCCAACTACACGGAGGTCAAGAGCGTCATCGTCAAGGTTGCCCAGAAGAACT 69 FBgn0032114 CDMC35667 3 6 17 DAC27-G01 3-CG3752-RA_1 CG3752 ACGGAGAGTATGCTCTGTCCAACTACACGGAGGTCAAGAGCGTCATCGTCAAGGTTGCCCAGAAGAACT 69 FBgn0032114 CDMC35668 3 7 17 DAC27-G13 3-CG3762-RA_1 CG3762 CGTGGAGTCTACGGCTCAGTCTGAGAACAAGATCACCTGGAACGTGATTCGTGAGGCAATGGGCAACAT 69 FBan0003762 FBgn0020367 Vha68-2 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha68-2 Vha68-2 "CG3762, vha68-2, vha67-3, V-ATPase, ATPalpha, l(2)01510, l(2)s4214" CDMC35668 3 8 17 DAC27-G13 3-CG3762-RA_1 CG3762 CGTGGAGTCTACGGCTCAGTCTGAGAACAAGATCACCTGGAACGTGATTCGTGAGGCAATGGGCAACAT 69 FBan0003762 FBgn0020367 Vha68-2 2 2L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha68-2 Vha68-2 "CG3762, vha68-2, vha67-3, V-ATPase, ATPalpha, l(2)01510, l(2)s4214" CDMC35669 3 9 17 DAC27-K01 15-CG3806-RB_1 CG3806 CTGGGCCCTGTGGTATCCAACTACATTAAGAGCGAGGATTCCATGATGGATTGTCTCAAGGCGCTGGAG 69 FBan0003806 FBgn0023512 eIF2B-epsilon X X regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 guanyl-nucleotide exchange factor activity; GO:0005085; translation initiation factor activity; GO:0003743; ; GO:0005085; ; GO:0003743; ; GO:0005085; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-epsilon eIF2B-epsilon "CG3806, CG3806, CG3806, eIF2Bepsilon, EG:86E4.1, eIF2B-epsilon, eIF-2bepsilon" CDMC35669 3 10 17 DAC27-K01 15-CG3806-RB_1 CG3806 CTGGGCCCTGTGGTATCCAACTACATTAAGAGCGAGGATTCCATGATGGATTGTCTCAAGGCGCTGGAG 69 FBan0003806 FBgn0023512 eIF2B-epsilon X X regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 guanyl-nucleotide exchange factor activity; GO:0005085; translation initiation factor activity; GO:0003743; ; GO:0005085; ; GO:0003743; ; GO:0005085; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 2B complex; GO:0005851 eIF2B-epsilon eIF2B-epsilon "CG3806, CG3806, CG3806, eIF2Bepsilon, EG:86E4.1, eIF2B-epsilon, eIF-2bepsilon" CDMC35670 3 11 17 DAC27-K13 3-CG3819-RA_1 CG3819 TTTCGCGGGTAAGAATGTGGACAAGCTATACACGCAGGCTGTTCAGAAGGAGACCATCGACAAGGAGCT 69 FBan0003819 FBgn0036833 CG3819 3 3L CG3819 CG3819 CT12789 CDMC35670 3 12 17 DAC27-K13 3-CG3819-RA_1 CG3819 TTTCGCGGGTAAGAATGTGGACAAGCTATACACGCAGGCTGTTCAGAAGGAGACCATCGACAAGGAGCT 69 FBan0003819 FBgn0036833 CG3819 3 3L CG3819 CG3819 CT12789 CDMC35671 3 13 17 DAC27-O01 23-CG3856-RB_6 CG3856 CCCACTTCTCAAAACTGTCAGTATTCGCATTGAACGACGTTGTAACTGTATGGCAATAATTTTCATGTA 69 FBan0003856 FBgn0024944 Oamb 3 3R "NOT G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; octopamine/tyramine signaling pathway; GO:0007211; ovulation; GO:0030728" amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0008227; ; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Oamb Octopamine receptor in mushroom bodies "CG3856, CG15698, OAMB, octopamine receptor, octopamine receptor OAMB, OAMB-1a, DmOCT1B, Oamb a, Oamb b, DmOAMB, oamb, Dmoa1, Dm-OAMB, Octopamine receptor in mushroom bodies" CDMC35671 3 14 17 DAC27-O01 23-CG3856-RB_6 CG3856 CCCACTTCTCAAAACTGTCAGTATTCGCATTGAACGACGTTGTAACTGTATGGCAATAATTTTCATGTA 69 FBan0003856 FBgn0024944 Oamb 3 3R "NOT G-protein signaling, coupled to cAMP nucleotide second messenger; GO:0007188; elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); GO:0051482; octopamine/tyramine signaling pathway; GO:0007211; ovulation; GO:0030728" amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; ; GO:0008227; ; GO:0004989; ; GO:0004989 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Oamb Octopamine receptor in mushroom bodies "CG3856, CG15698, OAMB, octopamine receptor, octopamine receptor OAMB, OAMB-1a, DmOCT1B, Oamb a, Oamb b, DmOAMB, oamb, Dmoa1, Dm-OAMB, Octopamine receptor in mushroom bodies" CDMC35672 3 15 17 DAC27-O13 18-CG3870-RA_1 CG3870 AGGGAGCAGCACTCACGAAACACTCACAAAACACTCACGAAACACTCACCCACAAGACATTAACACAAA 69 FBan0003870 FBgn0015372 chrw 2 2R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; peripheral nervous system development; GO:0007422; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 plasma membrane; GO:0005886 chrw chrowded "CG3870, chr, chrowded, l(2)k06908, DmRabX1, AAF47018" CDMC35672 3 16 17 DAC27-O13 18-CG3870-RA_1 CG3870 AGGGAGCAGCACTCACGAAACACTCACAAAACACTCACGAAACACTCACCCACAAGACATTAACACAAA 69 FBan0003870 FBgn0015372 chrw 2 2R intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; peripheral nervous system development; GO:0007422; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924 plasma membrane; GO:0005886 chrw chrowded "CG3870, chr, chrowded, l(2)k06908, DmRabX1, AAF47018" CDMC35673 3 17 17 DAC28-C01 3-CG10195-RA_1 CG10195 GCAGCGGATTGGGAACGACCATGTTCTTGCCGATTGGTTATAACTGCCAGGGCTCTATGGTTTTCGTCT 69 FBan0010195 FBgn0032787 CG10195 2 2L CG10195 CG10195 CDMC35673 3 18 17 DAC28-C01 3-CG10195-RA_1 CG10195 GCAGCGGATTGGGAACGACCATGTTCTTGCCGATTGGTTATAACTGCCAGGGCTCTATGGTTTTCGTCT 69 FBan0010195 FBgn0032787 CG10195 2 2L CG10195 CG10195 CDMC35674 3 19 17 DAC28-C13 22-CG10203-RA_2 CG10203 TCCACGCACTGGACTCTAATCCTCATTCCCAAAAGAAACAACCTCACGTGTAACAAGACAGATTCCCAA 69 FBan0010203 FBgn0028554 xl6 2 2L "mRNA splice site selection; GO:0006376; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 xl6 xl6 "CG10203, CG10203, CG10203, l(2)k00230, 2/30, Dxl6, RBP1-like, 9G8, Xl6, X16/9G8, d9G8, TN166, anon-WO0118547.78" CDMC35674 3 20 17 DAC28-C13 22-CG10203-RA_2 CG10203 TCCACGCACTGGACTCTAATCCTCATTCCCAAAAGAAACAACCTCACGTGTAACAAGACAGATTCCCAA 69 FBan0010203 FBgn0028554 xl6 2 2L "mRNA splice site selection; GO:0006376; nervous system development; GO:0007399; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 xl6 xl6 "CG10203, CG10203, CG10203, l(2)k00230, 2/30, Dxl6, RBP1-like, 9G8, Xl6, X16/9G8, d9G8, TN166, anon-WO0118547.78" CDMC35675 3 21 17 DAC28-G01 23-CG10233-RB_3 CG10233 AAACGAAATATTGTAGCACTTGAAAACTATTCTTGTAGCCACTACTCGGGGAGTAAGAGGAAATGCTAG 69 FBan0010233 FBgn0037302 CG10233 3 3R CG10233 CG10233 "9C4, anon-83ABa" CDMC35675 3 22 17 DAC28-G01 23-CG10233-RB_3 CG10233 AAACGAAATATTGTAGCACTTGAAAACTATTCTTGTAGCCACTACTCGGGGAGTAAGAGGAAATGCTAG 69 FBan0010233 FBgn0037302 CG10233 3 3R CG10233 CG10233 "9C4, anon-83ABa" CDMC35676 3 23 17 DAC28-G13 9-CG10244-RA_1 CG10244 GCTGCACGGACAAGGATCCCACATTTGTGATTCTGGAGTACGTGAATCGGGGAAAACTGCAAACGTACC 69 FBan0010244 FBgn0022800 Cad96Ca 3 3R calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad96Ca Cad96Ca "CG10239, CG10244, CG10239, CG10244, CG10239, DmHD-14, HD-14, FGFR1-like, CT28779, DCad96Ca" CDMC35676 3 24 17 DAC28-G13 9-CG10244-RA_1 CG10244 GCTGCACGGACAAGGATCCCACATTTGTGATTCTGGAGTACGTGAATCGGGGAAAACTGCAAACGTACC 69 FBan0010244 FBgn0022800 Cad96Ca 3 3R calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; ectoderm development; GO:0007398; homophilic cell adhesion; GO:0007156; nervous system development; GO:0007399; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; calcium ion binding; GO:0005509; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004714 ; EC:2.7.1.-; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad96Ca Cad96Ca "CG10239, CG10244, CG10239, CG10244, CG10239, DmHD-14, HD-14, FGFR1-like, CT28779, DCad96Ca" CDMC35677 3 25 17 DAC28-K01 13-CG10275-RA_1 CG10275 GGCCACAGGAAATTCAACACCGTTACCGGGTTTCAGCAATATTCCCCATTGCAAGATAATACCCGTGGA 69 FBan0010275 FBgn0032683 CG10275 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; development; GO:0007275; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 CG10275 CG10275 "CT28869, NG2-like" CDMC35677 3 26 17 DAC28-K01 13-CG10275-RA_1 CG10275 GGCCACAGGAAATTCAACACCGTTACCGGGTTTCAGCAATATTCCCCATTGCAAGATAATACCCGTGGA 69 FBan0010275 FBgn0032683 CG10275 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; development; GO:0007275; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 structural molecule activity; GO:0005198; ; GO:0005198 CG10275 CG10275 "CT28869, NG2-like" CDMC35678 3 1 18 DAC28-K13 23-CG1028-RL_18 CG1028 CATCTGTGGAAATCCATATACCAAAGTCAAAGGAACGAAGGAGAAAGAAAAAGGAGGACGGAATGGCAA 69 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC35678 3 2 18 DAC28-K13 23-CG1028-RL_18 CG1028 CATCTGTGGAAATCCATATACCAAAGTCAAAGGAACGAAGGAGAAAGAAAAAGGAGGACGGAATGGCAA 69 FBan0001028 FBgn0000095 Antp 3 3R heart development; GO:0007507; midgut development; GO:0007494; regulation of transcription from RNA polymerase II promoter; GO:0006357; segment specification; GO:0007379 DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Antp Antennapedia "CG1028, CG1028, CG1028, Hu: Humeral, Scx: Sex combs extra, Humeral, Sex combs extra, l(3)84Ba, antp, Sex comb extra, DMANTPE1, DRO15DC96Z, AntP, Ant, 3.4, ANT-P, DmAntp, Antp1, ANT-C, ANTC, BG:DS07700.1, Ns: Nasobemia, Nasobemia, Scx, Antennapedia, Hu" CDMC35679 3 3 18 DAC28-O01 23-CG10327-RA_4 CG10327 TGGGATCAGAAATCTATATCTACTTGCCATACGCAGTCAGAAATTACAGCAACCAACTAATCCCTGTCA 69 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC35679 3 4 18 DAC28-O01 23-CG10327-RA_4 CG10327 TGGGATCAGAAATCTATATCTACTTGCCATACGCAGTCAGAAATTACAGCAACCAACTAATCCCTGTCA 69 FBan0010327 FBgn0025790 TBPH 2 2R "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of transcription from RNA polymerase II promoter; GO:0006357" mRNA binding; GO:0003729; ; GO:0003729; transcription regulator activity; GO:0030528; ; GO:0030528 TBPH TBPH "CG10327, CG10327, dtar" CDMC35680 3 5 18 DAC28-O13 6-CG10338-RA_1 CG10338 TGGGCCTGTATCTCCTCTCGCTGATCAAGAGTCAGGCGGTCCTGTATACCATATTCTACGTGGTGGTCA 69 FBan0010338 FBgn0032700 CG10338 2 2L CG10338 CG10338 CDMC35680 3 6 18 DAC28-O13 6-CG10338-RA_1 CG10338 TGGGCCTGTATCTCCTCTCGCTGATCAAGAGTCAGGCGGTCCTGTATACCATATTCTACGTGGTGGTCA 69 FBan0010338 FBgn0032700 CG10338 2 2L CG10338 CG10338 CDMC35681 3 7 18 DAC29-C01 5-CG13902-RA_3 CG13902 GCTCTTCGCCCAGATACCAGCCCTCAAAGAGGATATATCCATTCCCGACTACTGCACCATCAGCAACGA 69 FBan0013902 FBgn0035166 CG13902 3 3L CG13902 CG13902 CDMC35681 3 8 18 DAC29-C01 5-CG13902-RA_3 CG13902 GCTCTTCGCCCAGATACCAGCCCTCAAAGAGGATATATCCATTCCCGACTACTGCACCATCAGCAACGA 69 FBan0013902 FBgn0035166 CG13902 3 3L CG13902 CG13902 CDMC35682 3 9 18 DAC29-C13 23-CG13923-RA_2 CG13923 TACATCCGTCGTAGCTCTAACATTTCAAATCTTCTTTGTCCTCTTTTCAATGGTTTCTATCGTGTTAGT 69 FBan0013923 FBgn0035277 CG13923 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13923 CG13923 "CG32317, CG32317, CG32317" CDMC35682 3 10 18 DAC29-C13 23-CG13923-RA_2 CG13923 TACATCCGTCGTAGCTCTAACATTTCAAATCTTCTTTGTCCTCTTTTCAATGGTTTCTATCGTGTTAGT 69 FBan0013923 FBgn0035277 CG13923 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG13923 CG13923 "CG32317, CG32317, CG32317" CDMC35683 3 11 18 DAC29-G01 12-CG13976-RA_4 CG13976 TGTGGCAGGCTATCCGTTGTCTGGAGTGCTACTTTCAACTGAGCCTGATCACACTGCTCATGAAGTTCT 69 FBan0013976 FBgn0039520 Gr98a 3 3R sensory perception of taste; GO:0050909 mRNA binding; GO:0003729; taste receptor activity; GO:0008527; ; GO:0003729; ; GO:0008527 integral to membrane; GO:0016021 Gr98a Gustatory receptor 98a "CG13976, 98B.4, Gustatory receptor 98B.4, Gr98B4, GR98B.4, Gustatory receptor 98a" CDMC35683 3 12 18 DAC29-G01 12-CG13976-RA_4 CG13976 TGTGGCAGGCTATCCGTTGTCTGGAGTGCTACTTTCAACTGAGCCTGATCACACTGCTCATGAAGTTCT 69 FBan0013976 FBgn0039520 Gr98a 3 3R sensory perception of taste; GO:0050909 mRNA binding; GO:0003729; taste receptor activity; GO:0008527; ; GO:0003729; ; GO:0008527 integral to membrane; GO:0016021 Gr98a Gustatory receptor 98a "CG13976, 98B.4, Gustatory receptor 98B.4, Gr98B4, GR98B.4, Gustatory receptor 98a" CDMC35684 3 13 18 DAC29-G13 12-CG13982-RA_1 CG13982 GCGTCAGCTTCGTCTGGAGGATGACAATCTGGATGATAGAACGCTCAAGTTGCTGCATCAGATCGAGCA 69 FBan0013982 FBgn0031811 CG13982 2 2L CG13982 CG13982 CDMC35684 3 14 18 DAC29-G13 12-CG13982-RA_1 CG13982 GCGTCAGCTTCGTCTGGAGGATGACAATCTGGATGATAGAACGCTCAAGTTGCTGCATCAGATCGAGCA 69 FBan0013982 FBgn0031811 CG13982 2 2L CG13982 CG13982 CDMC35685 3 15 18 DAC29-K01 14-CG14027-RA_3 CG14027 TTAGTGTGTATGGTGATTCTTCGGTTGATGAGGCCACCAAATACCGGAACATCGACAGCCTGGTCACTT 69 FBan0014027 FBgn0031701 TotM 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 TotM Turandot M "CG14027, CG14027, CG14027, totM, tot" CDMC35685 3 16 18 DAC29-K01 14-CG14027-RA_3 CG14027 TTAGTGTGTATGGTGATTCTTCGGTTGATGAGGCCACCAAATACCGGAACATCGACAGCCTGGTCACTT 69 FBan0014027 FBgn0031701 TotM 2 2L humoral defense mechanism (sensu Protostomia); GO:0016065 TotM Turandot M "CG14027, CG14027, CG14027, totM, tot" CDMC35686 3 17 18 DAC29-K13 2-CG14033-RA_1 CG14033 CGACCAGGGGAACTGATTTCGTATGGGCAGAACATGGCGACAATAAGCAAAACCCAGGCACAAAGTGGA 69 FBgn0040946 CDMC35686 3 18 18 DAC29-K13 2-CG14033-RA_1 CG14033 CGACCAGGGGAACTGATTTCGTATGGGCAGAACATGGCGACAATAAGCAAAACCCAGGCACAAAGTGGA 69 FBgn0040946 CDMC35687 3 19 18 DAC29-O01 9-CG14057-RA_2 CG14057 ACGGGCCAAGTTTAGGACGCTGTACATTGGTGCCACCATCATCCAATGCAACAAGTTCATAGTCAAGCA 69 FBan0014057 FBgn0036696 CG14057 3 3L CG14057 CG14057 CDMC35687 3 20 18 DAC29-O01 9-CG14057-RA_2 CG14057 ACGGGCCAAGTTTAGGACGCTGTACATTGGTGCCACCATCATCCAATGCAACAAGTTCATAGTCAAGCA 69 FBan0014057 FBgn0036696 CG14057 3 3L CG14057 CG14057 CDMC35688 3 21 18 DAC29-O13 23-CG14066-RB_8 CG14066 CGGCTGTTGTGTAATTATACATATGTAGTTCTGCCACAACTATTTTGTTTTTCACATGAAGTGTTGACT 69 FBan0014066 FBgn0040108 larp 3 3R autophagic cell death; GO:0048102; centrosome separation; GO:0051299; mitotic chromosome condensation; GO:0007076; mitotic spindle assembly; GO:0051227; salivary gland cell autophagic cell death; GO:0035071 cytosol; GO:0005829 larp La related protein "CG14066, CG14066, CG14066, Larp, meteor, BcDNA:LD02611, La related protein" CDMC35688 3 22 18 DAC29-O13 23-CG14066-RB_8 CG14066 CGGCTGTTGTGTAATTATACATATGTAGTTCTGCCACAACTATTTTGTTTTTCACATGAAGTGTTGACT 69 FBan0014066 FBgn0040108 larp 3 3R autophagic cell death; GO:0048102; centrosome separation; GO:0051299; mitotic chromosome condensation; GO:0007076; mitotic spindle assembly; GO:0051227; salivary gland cell autophagic cell death; GO:0035071 cytosol; GO:0005829 larp La related protein "CG14066, CG14066, CG14066, Larp, meteor, BcDNA:LD02611, La related protein" CDMC35689 3 23 18 DAC30-C01 23-CG15109-RC_1 CG15109 AAGGCGATACTGCAAGTGATTATAATGAAACCACTACAATGGACAATACTGCTTCACTGAGCGGAAAAG 69 FBan0015109 FBgn0034416 CG15109 2 2R CG15109 CG15109 CDMC35689 3 24 18 DAC30-C01 23-CG15109-RC_1 CG15109 AAGGCGATACTGCAAGTGATTATAATGAAACCACTACAATGGACAATACTGCTTCACTGAGCGGAAAAG 69 FBan0015109 FBgn0034416 CG15109 2 2R CG15109 CG15109 CDMC35690 3 25 18 DAC30-C13 9-CG15118-RA_1 CG15118 GTGTGGCGACCGTGAGATATGTCTTATATGCGATCGAACCGGGTTAGCCACATGCTTGCGTGTCCTTAA 69 FBan0015118 FBgn0034418 CG15118 2 2R CG15118 CG15118 "anon-EST:fe1H12, anon-fast-evolving-1H12" CDMC35690 3 26 18 DAC30-C13 9-CG15118-RA_1 CG15118 GTGTGGCGACCGTGAGATATGTCTTATATGCGATCGAACCGGGTTAGCCACATGCTTGCGTGTCCTTAA 69 FBan0015118 FBgn0034418 CG15118 2 2R CG15118 CG15118 "anon-EST:fe1H12, anon-fast-evolving-1H12" CDMC35691 3 1 19 DAC30-G01 18-CG15151-RA_1 CG15151 ACCCAAAACCAGCAGAAGTTGGCAATCATTTGAATGAAACCCAACTAGGAGCCCAAACGATTTTCGGTT 69 FBan0015151 FBgn0032661 PFE 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- PFE Pray For Elves "CG15151, CG15151, CT35050, Pray For Elves" CDMC35691 3 2 19 DAC30-G01 18-CG15151-RA_1 CG15151 ACCCAAAACCAGCAGAAGTTGGCAATCATTTGAATGAAACCCAACTAGGAGCCCAAACGATTTTCGGTT 69 FBan0015151 FBgn0032661 PFE 2 2L cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; transmembrane receptor protein serine/threonine kinase activity; GO:0004675 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0016301; ; GO:0004872; ; GO:0004675 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- PFE Pray For Elves "CG15151, CG15151, CT35050, Pray For Elves" CDMC35692 3 3 19 DAC30-G13 1-CG15166-RA_1 CG15166 CGCAGATGTTGCATTAGCTGCCATGGATGCGTTTTTGGGGAGTCAGCCGATGATGACGATGGCGATAAT 69 FBan0015166 FBgn0032708 CG15166 2 2L CG15166 CG15166 CDMC35692 3 4 19 DAC30-G13 1-CG15166-RA_1 CG15166 CGCAGATGTTGCATTAGCTGCCATGGATGCGTTTTTGGGGAGTCAGCCGATGATGACGATGGCGATAAT 69 FBan0015166 FBgn0032708 CG15166 2 2L CG15166 CG15166 CDMC35693 3 5 19 DAC30-K01 3-CG15208-RA_7 CG15208 GCGGCCTGAATGACATAAGTCTCTGCCTCAAGATGCCGTACCTGGAGGTCCTTTCGCTTAGCATGAACA 69 FBan0015208 FBgn0030247 CG15208 X X CG15208 CG15208 anon-WO0140519.64 CDMC35693 3 6 19 DAC30-K01 3-CG15208-RA_7 CG15208 GCGGCCTGAATGACATAAGTCTCTGCCTCAAGATGCCGTACCTGGAGGTCCTTTCGCTTAGCATGAACA 69 FBan0015208 FBgn0030247 CG15208 X X CG15208 CG15208 anon-WO0140519.64 CDMC35694 3 7 19 DAC30-K13 6-CG15216-RA_1 CG15216 CCAAGTGCGACCAGAGTACCTCTCCCAGCGATGCAAAGAAACTCTACAAGTCGTGCCACAATTGTTCCC 69 FBan0015216 FBgn0032978 CG15216 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15216 CG15216 CDMC35694 3 8 19 DAC30-K13 6-CG15216-RA_1 CG15216 CCAAGTGCGACCAGAGTACCTCTCCCAGCGATGCAAAGAAACTCTACAAGTCGTGCCACAATTGTTCCC 69 FBan0015216 FBgn0032978 CG15216 2 2L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG15216 CG15216 CDMC35695 3 9 19 DAC30-O01 8-CG15255-RA_1 CG15255 ACACGGAAAAGAGATGGCCTGGAAATGTGGTGGTCTACAGGATATCAGATGACTTTGACACGGCGCACA 69 FBan0015255 FBgn0028950 CG15255 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15255 CG15255 BG:BACR44L22.1 CDMC35695 3 10 19 DAC30-O01 8-CG15255-RA_1 CG15255 ACACGGAAAAGAGATGGCCTGGAAATGTGGTGGTCTACAGGATATCAGATGACTTTGACACGGCGCACA 69 FBan0015255 FBgn0028950 CG15255 2 2L proteolysis; GO:0006508 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; astacin activity; GO:0008533 ; EC:3.4.24.21; ; GO:0008533 ; EC:3.4.24.21; ; GO:0004222 ; EC:3.4.24.- CG15255 CG15255 BG:BACR44L22.1 CDMC35696 3 11 19 DAC30-O13 9-CG15266-RA_1 CG15266 AGGCGCGAATCACCCAAATTGAGGAGTTCATCAACGAGGTGCTGAAAGAGGATCTCAGAGAGCTGGAAA 69 FBan0015266 FBgn0028860 CG15266 2 2L CG15266 CG15266 BG:DS07295.5 CDMC35696 3 12 19 DAC30-O13 9-CG15266-RA_1 CG15266 AGGCGCGAATCACCCAAATTGAGGAGTTCATCAACGAGGTGCTGAAAGAGGATCTCAGAGAGCTGGAAA 69 FBan0015266 FBgn0028860 CG15266 2 2L CG15266 CG15266 BG:DS07295.5 CDMC35697 3 13 19 DAC31-C01 3-CG12759-RA_1 CG12759 GTCGAGCTGGTTATGAATCACATGCTTCCCCGGACACCAAAGGAGTACATCCATCGCGTAGGCAGAA 67 FBan0012759 FBgn0010220 Dbp45A 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634 Dbp45A DEAD box protein 45A "CG12759, Dbp45, ATP-dependent RNA helicase, dbp45A, DmRH18, DBP45A" CDMC35697 3 14 19 DAC31-C01 3-CG12759-RA_1 CG12759 GTCGAGCTGGTTATGAATCACATGCTTCCCCGGACACCAAAGGAGTACATCCATCGCGTAGGCAGAA 67 FBan0012759 FBgn0010220 Dbp45A 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0004004 nucleus; GO:0005634 Dbp45A DEAD box protein 45A "CG12759, Dbp45, ATP-dependent RNA helicase, dbp45A, DmRH18, DBP45A" CDMC35698 3 15 19 DAC31-C13 18-CG12905-RA_4 CG12905 CAACGAGATGATCCTGCACTGTCCCACCAAGCGCTTCCGTCAAACAGCCCAGTGCGAAGAGACACGC 67 FBan0012905 FBgn0033508 Obp46a 2 2R odorant binding; GO:0005549; ; GO:0005549 Obp46a Odorant-binding protein 46a "CG12905, CG12905, Odorant-binding protein 46a" CDMC35698 3 16 19 DAC31-C13 18-CG12905-RA_4 CG12905 CAACGAGATGATCCTGCACTGTCCCACCAAGCGCTTCCGTCAAACAGCCCAGTGCGAAGAGACACGC 67 FBan0012905 FBgn0033508 Obp46a 2 2R odorant binding; GO:0005549; ; GO:0005549 Obp46a Odorant-binding protein 46a "CG12905, CG12905, Odorant-binding protein 46a" CDMC35699 3 17 19 DAC31-G01 3-CG13349-RA_1 CG13349 GACGGGCCGTGTCTATGTGCTTAAGTTCAAGTCATCGACACGCCGCATGTTCTTCTGGATGCAGGAG 67 FBan0013349 FBgn0033886 CG13349 2 2R CG13349 CG13349 "p42E, GC13349" CDMC35699 3 18 19 DAC31-G01 3-CG13349-RA_1 CG13349 GACGGGCCGTGTCTATGTGCTTAAGTTCAAGTCATCGACACGCCGCATGTTCTTCTGGATGCAGGAG 67 FBan0013349 FBgn0033886 CG13349 2 2R CG13349 CG13349 "p42E, GC13349" CDMC35700 3 19 19 DAC31-G13 1-CG13423-RA_1 CG13423 TGGTAGGCTGTACGGTGAATCTAGACGCCTTTGTCTGTCTGGGTCACGATCCGCGAATCTCATCCAG 67 FBan0013423 FBgn0034513 CG13423 2 2R proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG13423 CG13423 CDMC35700 3 20 19 DAC31-G13 1-CG13423-RA_1 CG13423 TGGTAGGCTGTACGGTGAATCTAGACGCCTTTGTCTGTCTGGGTCACGATCCGCGAATCTCATCCAG 67 FBan0013423 FBgn0034513 CG13423 2 2R proteolysis; GO:0006508 cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.- CG13423 CG13423 CDMC35701 3 21 19 DAC31-K01 3-CG13688-RA_9 CG13688 TGCGTCATGGACGTGAAGATGGGTAAACGAACTTGGGATCCAGAGTCCTCGCCCAACAAACGAAAGG 67 FBan0013688 FBgn0031267 Ipk2 2 2L inositol and derivative phosphorylation; GO:0046853 inositol polyphosphate multikinase activity; GO:0050516 ; EC:2.7.1.151; inositol tetrakisphosphate 5-kinase activity; GO:0047326 ; EC:2.7.1.140; inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0050516 ; EC:2.7.1.151; ; GO:0047326 ; EC:2.7.1.140 nucleoplasm; GO:0005654 Ipk2 Ipk2 "CG13688, CG13688, dmIpk2" CDMC35701 3 22 19 DAC31-K01 3-CG13688-RA_9 CG13688 TGCGTCATGGACGTGAAGATGGGTAAACGAACTTGGGATCCAGAGTCCTCGCCCAACAAACGAAAGG 67 FBan0013688 FBgn0031267 Ipk2 2 2L inositol and derivative phosphorylation; GO:0046853 inositol polyphosphate multikinase activity; GO:0050516 ; EC:2.7.1.151; inositol tetrakisphosphate 5-kinase activity; GO:0047326 ; EC:2.7.1.140; inositol trisphosphate 3-kinase activity; GO:0008440 ; EC:2.7.1.127; ; GO:0008440 ; EC:2.7.1.127; ; GO:0050516 ; EC:2.7.1.151; ; GO:0047326 ; EC:2.7.1.140 nucleoplasm; GO:0005654 Ipk2 Ipk2 "CG13688, CG13688, dmIpk2" CDMC35702 3 23 19 DAC31-K13 1-CG13857-RA_1 CG13857 GGTCGTCCCGAGGACATATACATCCTGCCAAACAACTTGGGTCCGCTCTACAACGAGCAGAGCTACT 67 FBan0013857 FBgn0038958 CG13857 3 3R CG13857 CG13857 CDMC35702 3 24 19 DAC31-K13 1-CG13857-RA_1 CG13857 GGTCGTCCCGAGGACATATACATCCTGCCAAACAACTTGGGTCCGCTCTACAACGAGCAGAGCTACT 67 FBan0013857 FBgn0038958 CG13857 3 3R CG13857 CG13857 CDMC35703 3 25 19 DAC31-O01 3-CG14301-RA_1 CG14301 AGTATCCTGGATTCTTTGCCGACATGGAGACAAGGTGTCAGGGCTGGCATTACTGCGACATCGATGG 67 FBan0014301 FBgn0038632 CG14301 3 3R CG14301 CG14301 CDMC35703 3 26 19 DAC31-O01 3-CG14301-RA_1 CG14301 AGTATCCTGGATTCTTTGCCGACATGGAGACAAGGTGTCAGGGCTGGCATTACTGCGACATCGATGG 67 FBan0014301 FBgn0038632 CG14301 3 3R CG14301 CG14301 CDMC35704 3 1 20 DAC31-O13 1-CG14440-RA_1 CG14440 CGCGATCCGTTCTTCATCAAGCCGGAGTATCTCAGCTATGAGAGTCCCATGCACCATGCCCTCTACT 67 FBan0014440 FBgn0029894 CG14440 X X CG14440 CG14440 CDMC35704 3 2 20 DAC31-O13 1-CG14440-RA_1 CG14440 CGCGATCCGTTCTTCATCAAGCCGGAGTATCTCAGCTATGAGAGTCCCATGCACCATGCCCTCTACT 67 FBan0014440 FBgn0029894 CG14440 X X CG14440 CG14440 CDMC35705 3 3 20 DAC32-C01 9-CG3171-RA_2 CG3171 GCCGCTACTCGCAGATATATAAGCCTAAGTTCATAACCCTGCAGCTGTTGTTCGTTTGGGCCGTCTCCT 69 FBan0003171 FBgn0046687 Tre1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; germ cell development; GO:0007281; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; pole cell migration; GO:0007280; sensory perception of sweet taste; GO:0050916; sensory perception of taste; GO:0050909 "taste receptor activity; GO:0008527; ; GO:0008527; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; ; GO:0008527" integral to membrane; GO:0016021 Tre1 trapped in endoderm-1 "CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, LD12308, G protein coupled receptor, tre1, sctt, scattershot, Tre-1, tre-1, anon-WO0170980.16, anon-WO0170980.17, anon-WO0170981.1, BEST:LD12308, trapped in endoderm-1" CDMC35705 3 4 20 DAC32-C01 9-CG3171-RA_2 CG3171 GCCGCTACTCGCAGATATATAAGCCTAAGTTCATAACCCTGCAGCTGTTGTTCGTTTGGGCCGTCTCCT 69 FBan0003171 FBgn0046687 Tre1 X X G-protein coupled receptor protein signaling pathway; GO:0007186; germ cell development; GO:0007281; germ cell migration; GO:0008354; germ cell programmed cell death; GO:0035234; pole cell migration; GO:0007280; sensory perception of sweet taste; GO:0050916; sensory perception of taste; GO:0050909 "taste receptor activity; GO:0008527; ; GO:0008527; G-protein coupled receptor activity, unknown ligand; GO:0016526; ; GO:0016526; ; GO:0008527" integral to membrane; GO:0016021 Tre1 trapped in endoderm-1 "CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, CG3171, LD12308, G protein coupled receptor, tre1, sctt, scattershot, Tre-1, tre-1, anon-WO0170980.16, anon-WO0170980.17, anon-WO0170981.1, BEST:LD12308, trapped in endoderm-1" CDMC35706 3 5 20 DAC32-C13 2-CG31731-RA_1 CG31731 GGCGCAGACATTCGCGAGCATGAGTTGAAATACCGGGAATACTTTGGCTACTGCCCTCAGTACGATGCA 69 FBan0031731 FBgn0028539 CG31731 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG31731 CG31731 "CG7491, CG7559, CG7491, BG:DS00797.5, D00797.5, DS00797.5" CDMC35706 3 6 20 DAC32-C13 2-CG31731-RA_1 CG31731 GGCGCAGACATTCGCGAGCATGAGTTGAAATACCGGGAATACTTTGGCTACTGCCCTCAGTACGATGCA 69 FBan0031731 FBgn0028539 CG31731 2 2L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0042626; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG31731 CG31731 "CG7491, CG7559, CG7491, BG:DS00797.5, D00797.5, DS00797.5" CDMC35707 3 7 20 DAC32-G01 3-CG31755-RA_6 CG31755 TGGCTATGGATATTCGTTTGTCGGGATTGGCTGGATCAGGACAAGGTGGGATGTGGTCAACGGATTCCA 69 FBan0031755 FBgn0051755 CG31755 2 2L ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG31755 CG31755 CG5831 CDMC35707 3 8 20 DAC32-G01 3-CG31755-RA_6 CG31755 TGGCTATGGATATTCGTTTGTCGGGATTGGCTGGATCAGGACAAGGTGGGATGTGGTCAACGGATTCCA 69 FBan0031755 FBgn0051755 CG31755 2 2L ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 CG31755 CG31755 CG5831 CDMC35708 3 9 20 DAC32-G13 23-CG31762-RD_5 CG31762 AAGAAACGAATAACACAACACTTAGACCGTAGTTTAGTTAACTTTCTGTTGAAGTTCCCTTCGAACCCA 69 FBan0031762 FBgn0000114 aret 2 2L "female germ-line cyst formation (sensu Insecta); GO:0030727; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of oskar mRNA translation; GO:0046011; spermatid development; GO:0007286" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730; ; GO:0005515; ; GO:0003729 nucleus; GO:0005634 aret arrest "CG6319, CG31762, CG6319, CG6319, bruno, bru, Bruno, Bru, Dm Bru, arrest/Bruno, BcDNA:GM15173, ms(2)01284, NEST:bs01g04, NEST:bs34h11" CDMC35708 3 10 20 DAC32-G13 23-CG31762-RD_5 CG31762 AAGAAACGAATAACACAACACTTAGACCGTAGTTTAGTTAACTTTCTGTTGAAGTTCCCTTCGAACCCA 69 FBan0031762 FBgn0000114 aret 2 2L "female germ-line cyst formation (sensu Insecta); GO:0030727; germ-line stem cell division; GO:0042078; mRNA polyadenylylation; GO:0006378; negative regulation of oskar mRNA translation; GO:0007319; negative regulation of translation; GO:0016478; oogenesis (sensu Insecta); GO:0009993; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; regulation of oskar mRNA translation; GO:0046011; spermatid development; GO:0007286" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0003730; ; GO:0005515; ; GO:0003729 nucleus; GO:0005634 aret arrest "CG6319, CG31762, CG6319, CG6319, bruno, bru, Bruno, Bru, Dm Bru, arrest/Bruno, BcDNA:GM15173, ms(2)01284, NEST:bs01g04, NEST:bs34h11" CDMC35709 3 11 20 DAC32-K01 14-CG31789-RA_1 CG31789 GTCCGGTGGACCAGGATTCATCAATGCCCAGGTCAATGTCACAAGCCAGTTTTCTCAAGGAATCAATGT 69 FBan0031789 FBgn0051789 CG31789 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31789 CG31789 CDMC35709 3 12 20 DAC32-K01 14-CG31789-RA_1 CG31789 GTCCGGTGGACCAGGATTCATCAATGCCCAGGTCAATGTCACAAGCCAGTTTTCTCAAGGAATCAATGT 69 FBan0031789 FBgn0051789 CG31789 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31789 CG31789 CDMC35710 3 13 20 DAC32-K13 14-CG31803-RA_1 CG31803 ACGCGGAGCCTTTTACAAGATGACCGATGGTCGTGTTATACCCAACCAGATGTTTCGTGGACTGAATGA 69 FBan0031803 FBgn0051803 CG31803 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31803 CG31803 BcDNA:AT29119 CDMC35710 3 14 20 DAC32-K13 14-CG31803-RA_1 CG31803 ACGCGGAGCCTTTTACAAGATGACCGATGGTCGTGTTATACCCAACCAGATGTTTCGTGGACTGAATGA 69 FBan0031803 FBgn0051803 CG31803 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31803 CG31803 BcDNA:AT29119 CDMC35711 3 15 20 DAC32-O01 1-CG31828-RA_1 CG31828 GGATGCCAAATAGAACTCGGCTCACACAATGGACATGTTGCCACTTTTGTGCCGATTGTGTCTGGCGTG 69 FBan0031828 FBgn0051828 CG31828 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31828 CG31828 CDMC35711 3 16 20 DAC32-O01 1-CG31828-RA_1 CG31828 GGATGCCAAATAGAACTCGGCTCACACAATGGACATGTTGCCACTTTTGTGCCGATTGTGTCTGGCGTG 69 FBan0031828 FBgn0051828 CG31828 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31828 CG31828 CDMC35712 3 17 20 DAC32-O13 3-CG3183-RA_1 CG3183 GGAGGACGACACTACGGGTGACGAGGACAAGGTCAACGCCTAGGCTACACACCAATCACACGTTTTTTT 69 FBan0003183 FBgn0033081 geminin 2 2R chorion gene amplification; GO:0007307; negative regulation of DNA replication; GO:0008156; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 geminin geminin "CG3183, CG3183, CG3183, CG3183, CG3183, l(2)k14019, v(2)k09107, Dm geminin, Dm Geminin, Gem, anon-WO0257455.1" CDMC35712 3 18 20 DAC32-O13 3-CG3183-RA_1 CG3183 GGAGGACGACACTACGGGTGACGAGGACAAGGTCAACGCCTAGGCTACACACCAATCACACGTTTTTTT 69 FBan0003183 FBgn0033081 geminin 2 2R chorion gene amplification; GO:0007307; negative regulation of DNA replication; GO:0008156; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 geminin geminin "CG3183, CG3183, CG3183, CG3183, CG3183, l(2)k14019, v(2)k09107, Dm geminin, Dm Geminin, Gem, anon-WO0257455.1" CDMC35713 3 19 20 DAC33-C01 17-CG15535-RA_1 CG15535 CGCAGGACCTCTATGCTACACTAGGAACACTTCCCCAGCCTCACAATCAGTTGTTCATCTACACATACA 69 FBan0015535 FBgn0039764 CG15535 3 3R CG15535 CG15535 CDMC35713 3 20 20 DAC33-C01 17-CG15535-RA_1 CG15535 CGCAGGACCTCTATGCTACACTAGGAACACTTCCCCAGCCTCACAATCAGTTGTTCATCTACACATACA 69 FBan0015535 FBgn0039764 CG15535 3 3R CG15535 CG15535 CDMC35714 3 21 20 DAC33-C13 9-CG15548-RA_2 CG15548 GCCGATTGGAGACAACTTTACTGACATGACCAAGCTGAGGGAGTTGACCAAGAAGTTCAGGGAACGCCA 69 FBan0015548 FBgn0039812 CG15548 3 3R CG15548 CG15548 CDMC35714 3 22 20 DAC33-C13 9-CG15548-RA_2 CG15548 GCCGATTGGAGACAACTTTACTGACATGACCAAGCTGAGGGAGTTGACCAAGAAGTTCAGGGAACGCCA 69 FBan0015548 FBgn0039812 CG15548 3 3R CG15548 CG15548 CDMC35715 3 23 20 DAC33-G01 23-CG15592-RA_7 CG15592 GTTCATGCCAGGCTTACACACTTAAGGCGCCATCAAGAGAAATAGAAGGAAAGGTAAATCCCGAACCCA 69 FBan0015592 FBgn0037416 Osi9 3 3R Osi9 Osiris 9 "CG15592, CG15592, CG15592, CG15592, Osiris, Osiris 9" CDMC35715 3 24 20 DAC33-G01 23-CG15592-RA_7 CG15592 GTTCATGCCAGGCTTACACACTTAAGGCGCCATCAAGAGAAATAGAAGGAAAGGTAAATCCCGAACCCA 69 FBan0015592 FBgn0037416 Osi9 3 3R Osi9 Osiris 9 "CG15592, CG15592, CG15592, CG15592, Osiris, Osiris 9" CDMC35716 3 25 20 DAC33-G13 3-CG1559-RA_7 CG1559 GCCGGAACTTTCACAGGACTTTGGGCAAATATCGCAGATGGACGGTTTGCTATCCCAGGATGTTGCCTT 69 FBan0001559 FBgn0030354 Upf1 X X "mRNA catabolism, nonsense-mediated decay; GO:0000184" nucleic acid binding; GO:0003676; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386 cytoplasm; GO:0005737 Upf1 Upf1 "CG1559, CG1559, CG1559, CG1559, UPF1, Dm-Upf1, DmUpf1" CDMC35716 3 26 20 DAC33-G13 3-CG1559-RA_7 CG1559 GCCGGAACTTTCACAGGACTTTGGGCAAATATCGCAGATGGACGGTTTGCTATCCCAGGATGTTGCCTT 69 FBan0001559 FBgn0030354 Upf1 X X "mRNA catabolism, nonsense-mediated decay; GO:0000184" nucleic acid binding; GO:0003676; helicase activity; GO:0004386; ; GO:0003676; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003724 ; EC:2.7.7.-; ; GO:0004386 cytoplasm; GO:0005737 Upf1 Upf1 "CG1559, CG1559, CG1559, CG1559, UPF1, Dm-Upf1, DmUpf1" CDMC35717 3 1 21 DAC33-K01 12-CG15643-RA_4 CG15643 CACCGACACTGCAACTGGATGTAATCACGATCAGCAGAAGTAGCTGAAGTCATCCGAGGAGTGACAGCA 69 FBan0015643 FBgn0030654 CG15643 X X CG15643 CG15643 CG32583 CDMC35717 3 2 21 DAC33-K01 12-CG15643-RA_4 CG15643 CACCGACACTGCAACTGGATGTAATCACGATCAGCAGAAGTAGCTGAAGTCATCCGAGGAGTGACAGCA 69 FBan0015643 FBgn0030654 CG15643 X X CG15643 CG15643 CG32583 CDMC35718 3 3 21 DAC33-K13 9-CG15667-RA_4 CG15667 GGTCAACCCAGGAAAATCACTGGAGCTAGCTTCTTTGTGCTAAATGAAGCCCTCAAGAGCAGCAGTGGC 69 FBan0015667 FBgn0026369 Sara 2 2R intracellular signaling cascade; GO:0007242; protein localization; GO:0008104; transforming growth factor beta receptor signaling pathway; GO:0007179 transforming growth factor beta receptor binding; GO:0005160; kinase activator activity; GO:0019209; zinc ion binding; GO:0008270; ; GO:0005160; ; GO:0019209; ; GO:0008270 Sara Smad anchor for receptor activation "CG15667, CG15667, dSARA, sara, SARA, Smad anchor for receptor activation" CDMC35718 3 4 21 DAC33-K13 9-CG15667-RA_4 CG15667 GGTCAACCCAGGAAAATCACTGGAGCTAGCTTCTTTGTGCTAAATGAAGCCCTCAAGAGCAGCAGTGGC 69 FBan0015667 FBgn0026369 Sara 2 2R intracellular signaling cascade; GO:0007242; protein localization; GO:0008104; transforming growth factor beta receptor signaling pathway; GO:0007179 transforming growth factor beta receptor binding; GO:0005160; kinase activator activity; GO:0019209; zinc ion binding; GO:0008270; ; GO:0005160; ; GO:0019209; ; GO:0008270 Sara Smad anchor for receptor activation "CG15667, CG15667, dSARA, sara, SARA, Smad anchor for receptor activation" CDMC35719 3 5 21 DAC33-O01 23-CG15717-RA_6 CG15717 TACATCCAGGTGCTTTTTAAGCCATACTTTAAAATACCTCTCTAAGCATTTTACATGTAGCTTGGGGCA 69 FBan0015717 FBgn0030451 CG15717 X X CG15717 CG15717 CDMC35719 3 6 21 DAC33-O01 23-CG15717-RA_6 CG15717 TACATCCAGGTGCTTTTTAAGCCATACTTTAAAATACCTCTCTAAGCATTTTACATGTAGCTTGGGGCA 69 FBan0015717 FBgn0030451 CG15717 X X CG15717 CG15717 CDMC35720 3 7 21 DAC33-O13 2-CG15730-RA_2 CG15730 TCGAGCGGAATAACGATTGCCGACAGTTGTATGCCTTTGGCTTTGAGAATGTCACACCGCTAGAGGCCT 69 FBan0015730 FBgn0030395 CG15730 X X CG15730 CG15730 CDMC35720 3 8 21 DAC33-O13 2-CG15730-RA_2 CG15730 TCGAGCGGAATAACGATTGCCGACAGTTGTATGCCTTTGGCTTTGAGAATGTCACACCGCTAGAGGCCT 69 FBan0015730 FBgn0030395 CG15730 X X CG15730 CG15730 CDMC35721 3 9 21 DAC34-C01 10-CG31147-RA_1 CG31147 TCCATTCCAGTCAAGTTCAGCTCCGTCTTCTTTATGGTCATTACAATTGCGGCGTACCTTTGGCTGCCA 69 FBan0031147 FBgn0045443 mthl11 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl11 methuselah-like 11 "CG31147, Mth-like 11, Mth-like-11" CDMC35721 3 10 21 DAC34-C01 10-CG31147-RA_1 CG31147 TCCATTCCAGTCAAGTTCAGCTCCGTCTTCTTTATGGTCATTACAATTGCGGCGTACCTTTGGCTGCCA 69 FBan0031147 FBgn0045443 mthl11 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl11 methuselah-like 11 "CG31147, Mth-like 11, Mth-like-11" CDMC35722 3 11 21 DAC34-C13 12-CG31155-RA_2 CG31155 GGATGTGGTTATCTCCGGAGAGGATAAGATTCGGCTGAAGATTGTGGGCACACGAGTAGATGCCACTGG 69 FBan0031155 FBgn0051155 Rpb7 3 3R transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; ; GO:0016251; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb7 Rpb7 "CG6572, CG31155, CG6572, RPB7, dRpb7" CDMC35722 3 12 21 DAC34-C13 12-CG31155-RA_2 CG31155 GGATGTGGTTATCTCCGGAGAGGATAAGATTCGGCTGAAGATTGTGGGCACACGAGTAGATGCCACTGG 69 FBan0031155 FBgn0051155 Rpb7 3 3R transcription from RNA polymerase II promoter; GO:0006366 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003729; ; GO:0016251; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665" Rpb7 Rpb7 "CG6572, CG31155, CG6572, RPB7, dRpb7" CDMC35723 3 13 21 DAC34-G01 47-CG31188-RA_13 CG31188 ATGTGTTAGACAAAAATCCACTATCGCATAACAATCATGAGCTGGCAGTGATAAAGCATTGCTAATTTA 69 FBgn0051188 CDMC35723 3 14 21 DAC34-G01 47-CG31188-RA_13 CG31188 ATGTGTTAGACAAAAATCCACTATCGCATAACAATCATGAGCTGGCAGTGATAAAGCATTGCTAATTTA 69 FBgn0051188 CDMC35724 3 15 21 DAC34-G13 9-CG31198-RA_2 CG31198 AGACCCTGCTGCAGAACTCATTCGGTTGCGTCAAGACCCAGTCTCTAATCGAGAAGGTGTTCGATCTGA 69 FBan0031198 FBgn0051198 CG31198 3 3R proteolysis; GO:0006508 NOT membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004179 ; EC:3.4.11.2 CG31198 CG31198 "CG5845, CG5845, anon-WO0140519.24, anon-WO0140519.12" CDMC35724 3 16 21 DAC34-G13 9-CG31198-RA_2 CG31198 AGACCCTGCTGCAGAACTCATTCGGTTGCGTCAAGACCCAGTCTCTAATCGAGAAGGTGTTCGATCTGA 69 FBan0031198 FBgn0051198 CG31198 3 3R proteolysis; GO:0006508 NOT membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; receptor activity; GO:0004872; ; GO:0004872; ; GO:0004179 ; EC:3.4.11.2 CG31198 CG31198 "CG5845, CG5845, anon-WO0140519.24, anon-WO0140519.12" CDMC35725 3 17 21 DAC34-K01 2-CG31218-RA_2 CG31218 CGCACGGCCAAAGGATTTCGTGGAAAGTACAAGTTCGTGTCGAATGATCTGGGAGTACCGAACGCCTCT 69 FBan0031218 FBgn0051218 CG31218 3 3R CG31218 CG31218 "CG17756, CT39356" CDMC35725 3 18 21 DAC34-K01 2-CG31218-RA_2 CG31218 CGCACGGCCAAAGGATTTCGTGGAAAGTACAAGTTCGTGTCGAATGATCTGGGAGTACCGAACGCCTCT 69 FBan0031218 FBgn0051218 CG31218 3 3R CG31218 CG31218 "CG17756, CT39356" CDMC35726 3 19 21 DAC34-K13 2-CG31232-RA_2 CG31232 GCCCTTGGTCAAGGACTTCACCCGAGAGAACCAGTGGGAGATCATCGAGAACGTGATCGAGGTCTACAA 69 FBan0031232 FBgn0051232 CG31232 3 3R cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- CG31232 CG31232 "CG7682, CG7683, CG7682, CG7682, CG7682, CG7682, CG7683, EP(3)1037" CDMC35726 3 20 21 DAC34-K13 2-CG31232-RA_2 CG31232 GCCCTTGGTCAAGGACTTCACCCGAGAGAACCAGTGGGAGATCATCGAGAACGTGATCGAGGTCTACAA 69 FBan0031232 FBgn0051232 CG31232 3 3R cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- CG31232 CG31232 "CG7682, CG7683, CG7682, CG7682, CG7682, CG7682, CG7683, EP(3)1037" CDMC35727 3 21 21 DAC34-O01 9-CG3126-RA_1 CG3126 TTGGGTCGATGGACCTAACCTCAGCTAACTCCCCACCAATATTCGAATCCGAATCCCTGTCTGCGAGTC 69 FBan0003126 FBgn0026145 C3G X X Ras protein signal transduction; GO:0007265; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; ; GO:0005088 cellular component unknown; GO:0008372 C3G C3G "CG3126, DC3G, C(3)G" CDMC35727 3 22 21 DAC34-O01 9-CG3126-RA_1 CG3126 TTGGGTCGATGGACCTAACCTCAGCTAACTCCCCACCAATATTCGAATCCGAATCCCTGTCTGCGAGTC 69 FBan0003126 FBgn0026145 C3G X X Ras protein signal transduction; GO:0007265; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ras guanyl-nucleotide exchange factor activity; GO:0005088; ; GO:0005088; ; GO:0005088 cellular component unknown; GO:0008372 C3G C3G "CG3126, DC3G, C(3)G" CDMC35728 3 23 21 DAC34-O13 18-CG31283-RA_2 CG31283 TCCCACAACCCTTCTGTTGCATGTCATTCGAAACTGAGCCCTTAACATGTGTTTAACACAAGTGGACGA 69 FBan0031283 FBgn0051283 CG31283 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31283 CG31283 CDMC35728 3 24 21 DAC34-O13 18-CG31283-RA_2 CG31283 TCCCACAACCCTTCTGTTGCATGTCATTCGAAACTGAGCCCTTAACATGTGTTTAACACAAGTGGACGA 69 FBan0031283 FBgn0051283 CG31283 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31283 CG31283 CDMC35729 3 25 21 DAC35-C01 17-CG7989-RA_1 CG7989 TCGATCGTAAAGCCCGGAACAGTGATCTGCCCCAGAAGACTCTGAATTTTAAACGGGTCAAAGACC 66 FBgn0034119 CDMC35729 3 26 21 DAC35-C01 17-CG7989-RA_1 CG7989 TCGATCGTAAAGCCCGGAACAGTGATCTGCCCCAGAAGACTCTGAATTTTAAACGGGTCAAAGACC 66 FBgn0034119 CDMC35730 3 1 22 DAC35-C13 6-CG8189-RB_2 CG8189 AGGTAAATCTGCAAACCATGCTAATAGCTGCCCAGCTAATCGGTGTACGCTAATCGTGCGGTGGGC 66 FBan0008189 FBgn0019644 ATPsyn-b 3 3L ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-b "ATP synthase, subunit b" "CG8189, Fo-ATP synthase subunit b" CDMC35730 3 2 22 DAC35-C13 6-CG8189-RB_2 CG8189 AGGTAAATCTGCAAACCATGCTAATAGCTGCCCAGCTAATCGGTGTACGCTAATCGTGCGGTGGGC 66 FBan0008189 FBgn0019644 ATPsyn-b 3 3L ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" ATPsyn-b "ATP synthase, subunit b" "CG8189, Fo-ATP synthase subunit b" CDMC35731 3 3 22 DAC35-G01 3-CG8526-RA_1 CG8526 ACTGGACGAACGGCTCTGCACTACGCCTGCCAGTTAGGTAATCACGAGGTGGTAGACTATCTGCTG 66 FBan0008526 FBgn0037759 CG8526 3 3R amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG8526 CG8526 CDMC35731 3 4 22 DAC35-G01 3-CG8526-RA_1 CG8526 ACTGGACGAACGGCTCTGCACTACGCCTGCCAGTTAGGTAATCACGAGGTGGTAGACTATCTGCTG 66 FBan0008526 FBgn0037759 CG8526 3 3R amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG8526 CG8526 CDMC35732 3 5 22 DAC35-G13 23-CG8860-RA_1 CG8860 CATTGGTAATTCTTAGTTAAATACTCACAAATCAAAAATGGACAAGGTTGTCAAATTCGCCGAACC 66 FBan0008860 FBgn0033691 CG8860 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; protein transport; GO:0015031; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0015450 integral to endoplasmic reticulum membrane; GO:0030176; translocon complex; GO:0005784 CG8860 CG8860 BcDNA:GM14157 CDMC35732 3 6 22 DAC35-G13 23-CG8860-RA_1 CG8860 CATTGGTAATTCTTAGTTAAATACTCACAAATCAAAAATGGACAAGGTTGTCAAATTCGCCGAACC 66 FBan0008860 FBgn0033691 CG8860 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616; protein transport; GO:0015031; vesicle-mediated transport; GO:0016192" protein translocase activity; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565; ; GO:0008565; ; GO:0015450 integral to endoplasmic reticulum membrane; GO:0030176; translocon complex; GO:0005784 CG8860 CG8860 BcDNA:GM14157 CDMC35733 3 7 22 DAC35-K01 2-CG9286-RA_1 CG9286 GGCTAAGTTCTCCTTCGAGTATTCCATGGCCTCTGAAACCGATTCGGGCATGTCTGGCGATTGGCT 66 FBan0009286 FBgn0038183 CG9286 3 3R cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 CG9286 CG9286 CDMC35733 3 8 22 DAC35-K01 2-CG9286-RA_1 CG9286 GGCTAAGTTCTCCTTCGAGTATTCCATGGCCTCTGAAACCGATTCGGGCATGTCTGGCGATTGGCT 66 FBan0009286 FBgn0038183 CG9286 3 3R cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 CG9286 CG9286 CDMC35734 3 9 22 DAC35-K13 1-CG9455-RA_1 CG9455 GTGGACCGGGACACTCACGTGCAGGTGAATATGATGTACCAAGAGGACAAGTTCCGGTTCGCAGAA 66 FBan0009455 FBgn0033113 CG9455 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9455 CG9455 CDMC35734 3 10 22 DAC35-K13 1-CG9455-RA_1 CG9455 GTGGACCGGGACACTCACGTGCAGGTGAATATGATGTACCAAGAGGACAAGTTCCGGTTCGCAGAA 66 FBan0009455 FBgn0033113 CG9455 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9455 CG9455 CDMC35735 3 11 22 DAC35-O01 2-CG9941-RA_1 CG9941 AGTCCAGCCTAAAGAAGGGTTCGTCGATAAAGCGCACCAAACCGAGACCAGAACTTAGCGGAAGCG 66 FBan0009941 FBgn0030514 CG9941 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG9941 CG9941 "A, x93" CDMC35735 3 12 22 DAC35-O01 2-CG9941-RA_1 CG9941 AGTCCAGCCTAAAGAAGGGTTCGTCGATAAAGCGCACCAAACCGAGACCAGAACTTAGCGGAAGCG 66 FBan0009941 FBgn0030514 CG9941 X X protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG9941 CG9941 "A, x93" CDMC35736 3 13 22 DAC35-O13 AutoBlank AutoBlank CDMC35736 3 14 22 DAC35-O13 AutoBlank AutoBlank CDMC35737 3 15 22 DAC36-C01 30-CG18166-RA_2 CG18166 CGGCGCTTCCTCTCCGATCTACCACCCGCTCCATTACAGGAAGACCCTCTTCATCTTTCGTGGTC 65 FBan0018166 FBgn0029526 CG18166 X X CG18166 CG18166 "CG13372, CG13372, BEST:GH02584" CDMC35737 3 16 22 DAC36-C01 30-CG18166-RA_2 CG18166 CGGCGCTTCCTCTCCGATCTACCACCCGCTCCATTACAGGAAGACCCTCTTCATCTTTCGTGGTC 65 FBan0018166 FBgn0029526 CG18166 X X CG18166 CG18166 "CG13372, CG13372, BEST:GH02584" CDMC35738 3 17 22 DAC36-C13 3-CG18234-RB_2 CG18234 GCGAGGATCACCAGAGCCCTCTAAGCCTGCGAATTAAGGACATGACAGGAGAGGACGTGCAAGAG 65 FBan0018234 FBgn0036794 CG18234 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18234 CG18234 CDMC35738 3 18 22 DAC36-C13 3-CG18234-RB_2 CG18234 GCGAGGATCACCAGAGCCCTCTAAGCCTGCGAATTAAGGACATGACAGGAGAGGACGTGCAAGAG 65 FBan0018234 FBgn0036794 CG18234 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18234 CG18234 CDMC35739 3 19 22 DAC36-G01 23-CG18444-RA_1 CG18444 ACCCAGTAGGTTGGATGTGTCAAAAGCCTTCAATAAATATTTGCCATTCAGAACATAGATGATTT 65 FBan0018444 FBgn0003863 alphaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 alphaTry alphaTrypsin "CG18444, alpha, alpha, DmAlphaTry, Try, SP102, alphaTry" CDMC35739 3 20 22 DAC36-G01 23-CG18444-RA_1 CG18444 ACCCAGTAGGTTGGATGTGTCAAAAGCCTTCAATAAATATTTGCCATTCAGAACATAGATGATTT 65 FBan0018444 FBgn0003863 alphaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 alphaTry alphaTrypsin "CG18444, alpha, alpha, DmAlphaTry, Try, SP102, alphaTry" CDMC35740 3 21 22 DAC36-G13 47-CG18510-RA_3 CG18510 TACTATTATGCAAGTAACGGAAAATTAAAACGCTAAGCGGAGTGTGTTCGAACCCAAAATCGCGG 65 FBgn0035053 CDMC35740 3 22 22 DAC36-G13 47-CG18510-RA_3 CG18510 TACTATTATGCAAGTAACGGAAAATTAAAACGCTAAGCGGAGTGTGTTCGAACCCAAAATCGCGG 65 FBgn0035053 CDMC35741 3 23 22 DAC36-K01 1-CG18648-RA_2 CG18648 CAATCATCGGCCAGTTTTCTTGCCCTCCAAGAGAGAGCGCGTCATTTGCTTTCATCCTCTCCGGT 65 FBgn0036473 CDMC35741 3 24 22 DAC36-K01 1-CG18648-RA_2 CG18648 CAATCATCGGCCAGTTTTCTTGCCCTCCAAGAGAGAGCGCGTCATTTGCTTTCATCCTCTCCGGT 65 FBgn0036473 CDMC35742 3 25 22 DAC36-K13 2-CG18676-RA_1 CG18676 TAGTGCCATCGGTTCTGTTCGTGGTCTCGTGTTCCATCCTGATCATGTGCCAGACCACCGTCTAC 65 FBan0018676 FBgn0040697 CG18676 3 3L CG18676 CG18676 CDMC35742 3 26 22 DAC36-K13 2-CG18676-RA_1 CG18676 TAGTGCCATCGGTTCTGTTCGTGGTCTCGTGTTCCATCCTGATCATGTGCCAGACCACCGTCTAC 65 FBan0018676 FBgn0040697 CG18676 3 3L CG18676 CG18676 CDMC35743 3 1 23 DAC36-O01 18-CG1887-RA_8 CG1887 CGGGCATGGACAGCATGGACCAGTTCGGCTACATAGACCAGCTGAATGGACTGGATCACCTGCCG 65 FBan0001887 FBgn0035290 CG1887 3 3L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG1887 CG1887 CDMC35743 3 2 23 DAC36-O01 18-CG1887-RA_8 CG1887 CGGGCATGGACAGCATGGACCAGTTCGGCTACATAGACCAGCTGAATGGACTGGATCACCTGCCG 65 FBan0001887 FBgn0035290 CG1887 3 3L apoptosis; GO:0006915; cell adhesion; GO:0007155; defense response; GO:0006952 scavenger receptor activity; GO:0005044; ; GO:0005044 integral to plasma membrane; GO:0005887 CG1887 CG1887 CDMC35744 3 3 23 DAC36-O13 15-CG1912-RA_1 CG1912 GACAGATGGTGCACTGTCCCGAGTCCAATTCGTTGCTCTTCATTGGATCCCCCTTCCTGGACGGC 65 FBan0001912 FBgn0013972 Gycalpha99B 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; positive phototactic behavior; GO:0046954; rhodopsin mediated phototransduction; GO:0009586" guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "cytoplasm; GO:0005737; guanylate cyclase complex, soluble; GO:0008074" Gycalpha99B Guanylyl cyclase alpha-subunit at 99B "CG1912, CG1912, dgc1, dgcalpha1, Dgc1, gycalpha, SGCalpha, Soluble Guanylyl Cyclase alpha, dgca1, GYCa 99B, Gcalpha1, guanylate cyclase 99B, Gycalpha-99B, Gycalpha63A, Guanyl cyclase alpha-subunit at 63A" CDMC35744 3 4 23 DAC36-O13 15-CG1912-RA_1 CG1912 GACAGATGGTGCACTGTCCCGAGTCCAATTCGTTGCTCTTCATTGGATCCCCCTTCCTGGACGGC 65 FBan0001912 FBgn0013972 Gycalpha99B 3 3R "G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; nitric oxide mediated signal transduction; GO:0007263; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; positive phototactic behavior; GO:0046954; rhodopsin mediated phototransduction; GO:0009586" guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 "cytoplasm; GO:0005737; guanylate cyclase complex, soluble; GO:0008074" Gycalpha99B Guanylyl cyclase alpha-subunit at 99B "CG1912, CG1912, dgc1, dgcalpha1, Dgc1, gycalpha, SGCalpha, Soluble Guanylyl Cyclase alpha, dgca1, GYCa 99B, Gcalpha1, guanylate cyclase 99B, Gycalpha-99B, Gycalpha63A, Guanyl cyclase alpha-subunit at 63A" CDMC35745 3 5 23 DAC37-C01 16-CG16918-RA_1 CG16918 ACATCAGCCAAGTCAAGTGCGAAAATGCCTTCAAATTGTATCCGCAGAATTCGCATATCTGTGCTGGCT 69 FBan0016918 FBgn0039574 CG16918 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16918 CG16918 SPH201 CDMC35745 3 6 23 DAC37-C01 16-CG16918-RA_1 CG16918 ACATCAGCCAAGTCAAGTGCGAAAATGCCTTCAAATTGTATCCGCAGAATTCGCATATCTGTGCTGGCT 69 FBan0016918 FBgn0039574 CG16918 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG16918 CG16918 SPH201 CDMC35746 3 7 23 DAC37-C13 14-CG16932-RA_1 CG16932 AGGGCCAACCGACTTCAAGGATGACCCCTTCAAGGATTACCGTTACGAAGATCCATTTAGCATCAAGGA 69 FBan0016932 FBgn0035060 Eps-15 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488; vesicle-mediated transport; GO:0016192 calcium ion binding; GO:0005509; ; GO:0005509 Eps-15 Eps-15 "CG16932, CG16932, EPS-15, Eps15, eps-15, eps15, i31, anon-WO0118547.85" CDMC35746 3 8 23 DAC37-C13 14-CG16932-RA_1 CG16932 AGGGCCAACCGACTTCAAGGATGACCCCTTCAAGGATTACCGTTACGAAGATCCATTTAGCATCAAGGA 69 FBan0016932 FBgn0035060 Eps-15 2 2R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; receptor mediated endocytosis; GO:0006898; synaptic vesicle endocytosis; GO:0048488; vesicle-mediated transport; GO:0016192 calcium ion binding; GO:0005509; ; GO:0005509 Eps-15 Eps-15 "CG16932, CG16932, EPS-15, Eps15, eps-15, eps15, i31, anon-WO0118547.85" CDMC35747 3 9 23 DAC37-G01 2-CG16965-RA_3 CG16965 AACCCGTGAATCTGGTCCAGCAATGACGTGGTCCATGTTCGCAGCCAACTATCTACGAAACCTTCAGCT 69 FBan0016965 FBgn0032387 CG16965 2 2L monosaccharide metabolism; GO:0005996 "alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; phosphorylase activity; GO:0004645 ; EC:2.4.1.1; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004645 ; EC:2.4.1.1" CG16965 CG16965 CDMC35747 3 10 23 DAC37-G01 2-CG16965-RA_3 CG16965 AACCCGTGAATCTGGTCCAGCAATGACGTGGTCCATGTTCGCAGCCAACTATCTACGAAACCTTCAGCT 69 FBan0016965 FBgn0032387 CG16965 2 2L monosaccharide metabolism; GO:0005996 "alpha,alpha-trehalase activity; GO:0004555 ; EC:3.2.1.28; phosphorylase activity; GO:0004645 ; EC:2.4.1.1; ; GO:0004555 ; EC:3.2.1.28; ; GO:0004645 ; EC:2.4.1.1" CG16965 CG16965 CDMC35748 3 11 23 DAC37-G13 2-CG16974-RA_2 CG16974 CGCTTTACTATACCCCACCAGACGATGACTTGCTGCATAGCTCGCAACTTAACCTGCAGAACTCCCCCA 69 FBan0016974 FBgn0032479 CG16974 2 2L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG16974 CG16974 "CT35580, kekkon-like" CDMC35748 3 12 23 DAC37-G13 2-CG16974-RA_2 CG16974 CGCTTTACTATACCCCACCAGACGATGACTTGCTGCATAGCTCGCAACTTAACCTGCAGAACTCCCCCA 69 FBan0016974 FBgn0032479 CG16974 2 2L cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG16974 CG16974 "CT35580, kekkon-like" CDMC35749 3 13 23 DAC37-K01 23-CG17004-RB_2 CG17004 TAGGGTCCCCGGAGATCTCTCTACCAATAAAGCATATATACGAGTTTGTAAGATAACTGGGGTGTAAGC 69 FBgn0031083 CDMC35749 3 14 23 DAC37-K01 23-CG17004-RB_2 CG17004 TAGGGTCCCCGGAGATCTCTCTACCAATAAAGCATATATACGAGTTTGTAAGATAACTGGGGTGTAAGC 69 FBgn0031083 CDMC35750 3 15 23 DAC37-K13 9-CG17023-RB_1 CG17023 AACAGCGTTGCCAACTCTTCTCGCAGATCCACCGCAAAATATGATAGCACAAAGCCAGTCTGGGACAGG 69 CDMC35750 3 16 23 DAC37-K13 9-CG17023-RB_1 CG17023 AACAGCGTTGCCAACTCTTCTCGCAGATCCACCGCAAAATATGATAGCACAAAGCCAGTCTGGGACAGG 69 CDMC35751 3 17 23 DAC37-O01 16-CG17049-RA_1 CG17049 GGCAGTTAGGAAGTGGCAAAAGAAACCGGATTACTACGAACACGTCAAGGATCAGGACAAGATCTGGGA 69 FBan0017049 FBgn0033832 CG17049 2 2R CG17049 CG17049 CDMC35751 3 18 23 DAC37-O01 16-CG17049-RA_1 CG17049 GGCAGTTAGGAAGTGGCAAAAGAAACCGGATTACTACGAACACGTCAAGGATCAGGACAAGATCTGGGA 69 FBan0017049 FBgn0033832 CG17049 2 2R CG17049 CG17049 CDMC35752 3 19 23 DAC37-O13 2-CG1705-RA_1 CG1705 TGAGGAGACGGAGGGTACAGTGGGCTTGACCATTTACAGACAGCCAGAACCCTATCAGTTGGAGTACCA 69 FBan0001705 FBgn0002723 Rst(1)JH X X regulation of development; GO:0050793; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 juvenile hormone binding; GO:0005500; ; GO:0005500; transcription factor activity; GO:0003700; ; GO:0005500; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 Rst(1)JH Resistance to Juvenile Hormone "CG1705, Met, methoprene tolerant, Methoprene-tolerant, juvenile hormone resistance, met, Mett: Methoprene-tolerant" CDMC35752 3 20 23 DAC37-O13 2-CG1705-RA_1 CG1705 TGAGGAGACGGAGGGTACAGTGGGCTTGACCATTTACAGACAGCCAGAACCCTATCAGTTGGAGTACCA 69 FBan0001705 FBgn0002723 Rst(1)JH X X regulation of development; GO:0050793; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 juvenile hormone binding; GO:0005500; ; GO:0005500; transcription factor activity; GO:0003700; ; GO:0005500; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0004871 nucleus; GO:0005634 Rst(1)JH Resistance to Juvenile Hormone "CG1705, Met, methoprene tolerant, Methoprene-tolerant, juvenile hormone resistance, met, Mett: Methoprene-tolerant" CDMC35753 3 21 23 DAC38-C01 2-CG17577-RA_2 CG17577 GGGGTGTGTCACATGAGAAGCCATGGCCTCTAATTGGCAATATTCCGCTGAAAGCCATGATCGGTGGAA 69 FBan0017577 FBgn0033775 Cyp9h1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9h1 Cyp9h1 "CG17577, 9h1" CDMC35753 3 22 23 DAC38-C01 2-CG17577-RA_2 CG17577 GGGGTGTGTCACATGAGAAGCCATGGCCTCTAATTGGCAATATTCCGCTGAAAGCCATGATCGGTGGAA 69 FBan0017577 FBgn0033775 Cyp9h1 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp9h1 Cyp9h1 "CG17577, 9h1" CDMC35754 3 23 23 DAC38-C13 14-CG17596-RA_1 CG17596 CGCCAGCACTCCAAATGATTCACCGGACGTAATACTGAAGCGCATCGGATCAGGACAAATTGACTTCAC 69 FBan0017596 FBgn0011285 S6kII X X MAPKKK cascade; GO:0000165; associative learning; GO:0008306; cell cycle; GO:0007049; operant conditioning; GO:0035106; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; ribosomal protein S6 kinase activity; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.- ribosome; GO:0005840 S6kII RPS6-protein kinase-II "CG17596, CG17596, S6KII, RSK, dRSK, ign, ignorant, p90 ribosomal S6 kinase, Rsk: Ribosomal-S6-kinase, Ribosomal-S6-kinase" CDMC35754 3 24 23 DAC38-C13 14-CG17596-RA_1 CG17596 CGCCAGCACTCCAAATGATTCACCGGACGTAATACTGAAGCGCATCGGATCAGGACAAATTGACTTCAC 69 FBan0017596 FBgn0011285 S6kII X X MAPKKK cascade; GO:0000165; associative learning; GO:0008306; cell cycle; GO:0007049; operant conditioning; GO:0035106; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; ribosomal protein S6 kinase activity; GO:0004711 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004711 ; EC:2.7.1.- ribosome; GO:0005840 S6kII RPS6-protein kinase-II "CG17596, CG17596, S6KII, RSK, dRSK, ign, ignorant, p90 ribosomal S6 kinase, Rsk: Ribosomal-S6-kinase, Ribosomal-S6-kinase" CDMC35755 3 25 23 DAC38-G01 8-CG17636-RA_3 CG17636 TTGGGCGACATCCACTATGAACCAGATGTGCAGGAGATGTACGAAAACCTTATCGATCCGGCCTTTGCC 69 FBgn0025837 CG17636 amino acid metabolism; GO:0006520; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG17636 CG17636 EG:23E12.1 CDMC35755 3 26 23 DAC38-G01 8-CG17636-RA_3 CG17636 TTGGGCGACATCCACTATGAACCAGATGTGCAGGAGATGTACGAAAACCTTATCGATCCGGCCTTTGCC 69 FBgn0025837 CG17636 amino acid metabolism; GO:0006520; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG17636 CG17636 EG:23E12.1 CDMC35756 3 1 24 DAC38-G13 15-CG17650-RA_3 CG17650 GATATTCGGAGCATCTTTGGGAGATGACATGGACTTCGAGGACTTTCCCGACCTCAACCAACCACTGCC 69 FBan0017650 FBgn0031365 CG17650 2 2L CG17650 CG17650 CDMC35756 3 2 24 DAC38-G13 15-CG17650-RA_3 CG17650 GATATTCGGAGCATCTTTGGGAGATGACATGGACTTCGAGGACTTTCCCGACCTCAACCAACCACTGCC 69 FBan0017650 FBgn0031365 CG17650 2 2L CG17650 CG17650 CDMC35757 3 3 24 DAC38-K01 18-CG17698-RB_5 CG17698 GGGCTGCTCGAGGATTGAAAGGTTCATACGCGCAGGTCGATCTAATTCAGCACCTGGTTCATATCATAT 69 FBgn0040056 CG17698 protein amino acid phosphorylation; GO:0006468 protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123 CG17698 CG17698 "CG40297, CG40297, CAMKIIb" CDMC35757 3 4 24 DAC38-K01 18-CG17698-RB_5 CG17698 GGGCTGCTCGAGGATTGAAAGGTTCATACGCGCAGGTCGATCTAATTCAGCACCTGGTTCATATCATAT 69 FBgn0040056 CG17698 protein amino acid phosphorylation; GO:0006468 protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; calcium- and calmodulin-dependent protein kinase activity; GO:0004685 ; EC:2.7.1.123; ; GO:0004685 ; EC:2.7.1.123 CG17698 CG17698 "CG40297, CG40297, CAMKIIb" CDMC35758 3 5 24 DAC38-K13 6-CG17715-RE_3 CG17715 GGCCCCGAGGCAGAGAGCTATTGAGGACGCAACTGATTATCCCGCCATCTTCTACATCTAGCCCATTTA 69 FBgn0041004 CG17715 CG17715 CG17715 "CG18603, BcDNA:RE07178, BcDNA:RE63764" CDMC35758 3 6 24 DAC38-K13 6-CG17715-RE_3 CG17715 GGCCCCGAGGCAGAGAGCTATTGAGGACGCAACTGATTATCCCGCCATCTTCTACATCTAGCCCATTTA 69 FBgn0041004 CG17715 CG17715 CG17715 "CG18603, BcDNA:RE07178, BcDNA:RE63764" CDMC35759 3 7 24 DAC38-O01 17-CG17751-RA_2 CG17751 CCTTCGGGCTAAACATCATCCTCGGCGTATTCTATTGCGTTGGGCTAATGATATCTCCGTGGATAGCTA 69 FBan0017751 FBgn0038717 CG17751 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG17751 CG17751 CDMC35759 3 8 24 DAC38-O01 17-CG17751-RA_2 CG17751 CCTTCGGGCTAAACATCATCCTCGGCGTATTCTATTGCGTTGGGCTAATGATATCTCCGTGGATAGCTA 69 FBan0017751 FBgn0038717 CG17751 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG17751 CG17751 CDMC35760 3 9 24 DAC38-O13 1-CG17760-RA_1 CG17760 GCTGCCTATCGGACCAGGCTTGTGAGGAAAGGCGTATCAGCAGGGAAATTGATAAGTTCCTGAAAGCGG 69 FBan0017760 FBgn0033756 CG17760 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; protein amino acid ADP-ribosylation; GO:0006471; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 CG17760 CG17760 BcDNA:SD21019 CDMC35760 3 10 24 DAC38-O13 1-CG17760-RA_1 CG17760 GCTGCCTATCGGACCAGGCTTGTGAGGAAAGGCGTATCAGCAGGGAAATTGATAAGTTCCTGAAAGCGG 69 FBan0017760 FBgn0033756 CG17760 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; hemopoiesis; GO:0030097; mesoderm development; GO:0007498; protein amino acid ADP-ribosylation; GO:0006471; sensory perception of taste; GO:0050909 GTP binding; GO:0005525; signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525; ; GO:0004871 heterotrimeric G-protein complex; GO:0005834 CG17760 CG17760 BcDNA:SD21019 CDMC35761 3 11 24 DAC39-C01 2-CG32199-RA_2 CG32199 CTATCAGGGGACGAGAAGATCTTCCAAGAGGTAGCAGCCCGACTGAAGCGCAAACCAACCAAGCT 65 FBan0032199 FBgn0052199 CG32199 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG32199 CG32199 CG13382 CDMC35761 3 12 24 DAC39-C01 2-CG32199-RA_2 CG32199 CTATCAGGGGACGAGAAGATCTTCCAAGAGGTAGCAGCCCGACTGAAGCGCAAACCAACCAAGCT 65 FBan0032199 FBgn0052199 CG32199 3 3L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG32199 CG32199 CG13382 CDMC35762 3 13 24 DAC39-C13 1-CG32239-RA_1 CG32239 CGCGTTACGAAGTATCCCCTTTTACTGGCCCGTCTTTACAAGGTCACACCCTCCCACCTCGAAGG 65 FBan0032239 FBgn0035574 Gef64C 3 3L axon guidance; GO:0007411 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 Gef64C Guanine nucleotide exchange factor GEF64C "CG32239, CG13709, CG13710, CG32239, GEF64C, EP(3)3035, EP3035" CDMC35762 3 14 24 DAC39-C13 1-CG32239-RA_1 CG32239 CGCGTTACGAAGTATCCCCTTTTACTGGCCCGTCTTTACAAGGTCACACCCTCCCACCTCGAAGG 65 FBan0032239 FBgn0035574 Gef64C 3 3L axon guidance; GO:0007411 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 Gef64C Guanine nucleotide exchange factor GEF64C "CG32239, CG13709, CG13710, CG32239, GEF64C, EP(3)3035, EP3035" CDMC35763 3 15 24 DAC39-G01 15-CG32365-RA_9 CG32365 GGCCTTTCGTTTGGCCAGAACCATAAGGAATCTTTTGCACACCTCGGAACAGCAACCAGATCTCA 65 FBan0032365 FBgn0052365 CG32365 3 3L cellular physiological process; GO:0050875 CG32365 CG32365 "CG8294, CG13683, CG13682, CG8294, CG13683, CG13683, CG8294" CDMC35763 3 16 24 DAC39-G01 15-CG32365-RA_9 CG32365 GGCCTTTCGTTTGGCCAGAACCATAAGGAATCTTTTGCACACCTCGGAACAGCAACCAGATCTCA 65 FBan0032365 FBgn0052365 CG32365 3 3L cellular physiological process; GO:0050875 CG32365 CG32365 "CG8294, CG13683, CG13682, CG8294, CG13683, CG13683, CG8294" CDMC35764 3 17 24 DAC39-G13 3-CG32414-RA_1 CG32414 CCACGGCGAGTCGGATCACAACTTGGATGTACCACATGGCAGTCGTAAGAGGAGTATGTCTGCCC 65 FBan0032414 FBgn0052414 CG32414 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32414 CG32414 CDMC35764 3 18 24 DAC39-G13 3-CG32414-RA_1 CG32414 CCACGGCGAGTCGGATCACAACTTGGATGTACCACATGGCAGTCGTAAGAGGAGTATGTCTGCCC 65 FBan0032414 FBgn0052414 CG32414 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32414 CG32414 CDMC35765 3 19 24 DAC39-K01 23-CG32491-RO_3 CG32491 AGTTCGCATATGCTTTGCAAATCCAATTGTTCCATTCCCTTGACGGCTATGTGATCATGTGAAAT 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35765 3 20 24 DAC39-K01 23-CG32491-RO_3 CG32491 AGTTCGCATATGCTTTGCAAATCCAATTGTTCCATTCCCTTGACGGCTATGTGATCATGTGAAAT 65 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC35766 3 21 24 DAC39-K13 6-CG32509-RA_7 CG32509 GGGGCCATCGTGCATTCATTAGCGTGTCGTTGGGATCTGCTCTCCACTTTTCTCCTGCTCCTCTG 65 FBan0032509 FBgn0052509 CG32509 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32509 CG32509 BcDNA:GH23462 CDMC35766 3 22 24 DAC39-K13 6-CG32509-RA_7 CG32509 GGGGCCATCGTGCATTCATTAGCGTGTCGTTGGGATCTGCTCTCCACTTTTCTCCTGCTCCTCTG 65 FBan0032509 FBgn0052509 CG32509 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32509 CG32509 BcDNA:GH23462 CDMC35767 3 23 24 DAC39-O01 23-CG32569-RA_1 CG32569 TCGTGAAATGTTGAACATATTTGTGTGGTTATCACTTTCGTTGATTAGTCTGTCCTGGGCACAAG 65 FBan0032569 FBgn0052569 CG32569 X X CG32569 CG32569 CDMC35767 3 24 24 DAC39-O01 23-CG32569-RA_1 CG32569 TCGTGAAATGTTGAACATATTTGTGTGGTTATCACTTTCGTTGATTAGTCTGTCCTGGGCACAAG 65 FBan0032569 FBgn0052569 CG32569 X X CG32569 CG32569 CDMC35768 3 25 24 DAC39-O13 13-CG32599-RA_1 CG32599 AATGGACGTCTGGTGGCTGTGATCGTCTGTTTTCTGGTGCTCTTCCTGGCCGTCTACCATGCCTG 65 FBan0032599 FBgn0052599 CG32599 X X CG32599 CG32599 "CG12047, CG12047, unknown protein, GM07807" CDMC35768 3 26 24 DAC39-O13 13-CG32599-RA_1 CG32599 AATGGACGTCTGGTGGCTGTGATCGTCTGTTTTCTGGTGCTCTTCCTGGCCGTCTACCATGCCTG 65 FBan0032599 FBgn0052599 CG32599 X X CG32599 CG32599 "CG12047, CG12047, unknown protein, GM07807" CDMC35769 3 1 25 DAC40-C01 19-CG41114-RB_1 CG41114 AAGAAGCGTTTCGGGCACCAACAACGGAGCAGCCAGAGCCAACACAGCCGCCGGCAAAACAGCCA 65 FBgn0069935 CG41114 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41114 CG41114 CDMC35769 3 2 25 DAC40-C01 19-CG41114-RB_1 CG41114 AAGAAGCGTTTCGGGCACCAACAACGGAGCAGCCAGAGCCAACACAGCCGCCGGCAAAACAGCCA 65 FBgn0069935 CG41114 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41114 CG41114 CDMC35770 3 3 25 DAC40-C13 3-CG4116-RA_1 CG4116 GGCCTGGTCACCACGACTTCCAATGGAGCTATCTATGTGAACCTGGGCAGTTCGGGATCCTCATC 65 FBan0004116 FBgn0029649 CG4116 X X CG4116 CG4116 CDMC35770 3 4 25 DAC40-C13 3-CG4116-RA_1 CG4116 GGCCTGGTCACCACGACTTCCAATGGAGCTATCTATGTGAACCTGGGCAGTTCGGGATCCTCATC 65 FBan0004116 FBgn0029649 CG4116 X X CG4116 CG4116 CDMC35771 3 5 25 DAC40-G01 1-CG4218-RA_1 CG4218 CATGTTCTCCAGCAATCCTGGTTTCTGCTCAAGAAGTCCACGGAGAGTTGTGCTCGGTTCGCCAG 65 FBan0004218 FBgn0028881 CG4218 2 2L CG4218 CG4218 BG:DS04641.8 CDMC35771 3 6 25 DAC40-G01 1-CG4218-RA_1 CG4218 CATGTTCTCCAGCAATCCTGGTTTCTGCTCAAGAAGTCCACGGAGAGTTGTGCTCGGTTCGCCAG 65 FBan0004218 FBgn0028881 CG4218 2 2L CG4218 CG4218 BG:DS04641.8 CDMC35772 3 7 25 DAC40-G13 15-CG4279-RA_1 CG4279 GACCGTGAAAAGGAGCAGAAACTGCCACTCAAAGAGATATCCGTCGATGAAATCCTGGACGCCCA 65 FBan0004279 FBgn0034600 CG4279 2 2R "RNA processing; GO:0006396; nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG4279 CG4279 CDMC35772 3 8 25 DAC40-G13 15-CG4279-RA_1 CG4279 GACCGTGAAAAGGAGCAGAAACTGCCACTCAAAGAGATATCCGTCGATGAAATCCTGGACGCCCA 65 FBan0004279 FBgn0034600 CG4279 2 2R "RNA processing; GO:0006396; nuclear mRNA splicing, via spliceosome; GO:0000398" small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 CG4279 CG4279 CDMC35773 3 9 25 DAC40-K01 3-CG4395-RA_1 CG4395 TGCCTGCACAAGTCTGCATTCTTTATGGGCGACTTCTGTGCATGGCAGATGTGATTTCCTGCAGC 65 FBan0004395 FBgn0030437 CG4395 X X G-protein coupled receptor protein signaling pathway; GO:0007186; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008188; ; GO:0001633; ; GO:0004948 integral to membrane; GO:0016021 CG4395 CG4395 "anon-WO0170980.1, anon-WO0170980.2" CDMC35773 3 10 25 DAC40-K01 3-CG4395-RA_1 CG4395 TGCCTGCACAAGTCTGCATTCTTTATGGGCGACTTCTGTGCATGGCAGATGTGATTTCCTGCAGC 65 FBan0004395 FBgn0030437 CG4395 X X G-protein coupled receptor protein signaling pathway; GO:0007186; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 neuropeptide receptor activity; GO:0008188; calcitonin receptor activity; GO:0004948; secretin-like receptor activity; GO:0001633; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0008188; ; GO:0001633; ; GO:0004948 integral to membrane; GO:0016021 CG4395 CG4395 "anon-WO0170980.1, anon-WO0170980.2" CDMC35774 3 11 25 DAC40-K13 23-CG4412-RA_3 CG4412 CAACTGCCATTGTGAACTGACAATTGTAACTTTTCCGCACGAAAGTTAGCATTTGCAAAGGAAAA 65 FBan0004412 FBgn0016119 ATPsyn-Cf6 3 3R ATP synthesis coupled proton transport; GO:0015986; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" ATPsyn-Cf6 ATPase coupling factor 6 "CG4412, BcDNA:RH08870, ATPase coupling factor 6" CDMC35774 3 12 25 DAC40-K13 23-CG4412-RA_3 CG4412 CAACTGCCATTGTGAACTGACAATTGTAACTTTTCCGCACGAAAGTTAGCATTTGCAAAGGAAAA 65 FBan0004412 FBgn0016119 ATPsyn-Cf6 3 3R ATP synthesis coupled proton transport; GO:0015986; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase, central stalk (sensu Eukaryota); GO:0005756" ATPsyn-Cf6 ATPase coupling factor 6 "CG4412, BcDNA:RH08870, ATPase coupling factor 6" CDMC35775 3 13 25 DAC40-O01 3-CG4559-RA_1 CG4559 TCTGTTTGATCTGACCCAAGACGATTTCCGTGGTCAGTGCACAAACGATCGCTTCCCCATGCTGC 65 FBan0004559 FBgn0020414 Idgf3 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Idgf3 Imaginal disc growth factor 3 "CG4559, CG4559, CG4559, CG4559, IDGF, BG:DS02780.2, IDGF3, idgf3, IDGF-3, Imaginal disc growth factor 3" CDMC35775 3 14 25 DAC40-O01 3-CG4559-RA_1 CG4559 TCTGTTTGATCTGACCCAAGACGATTTCCGTGGTCAGTGCACAAACGATCGCTTCCCCATGCTGC 65 FBan0004559 FBgn0020414 Idgf3 2 2L cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 "imaginal disc growth factor activity; GO:0008084; NOT chitinase activity; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0008084; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Idgf3 Imaginal disc growth factor 3 "CG4559, CG4559, CG4559, CG4559, IDGF, BG:DS02780.2, IDGF3, idgf3, IDGF-3, Imaginal disc growth factor 3" CDMC35776 3 15 25 DAC40-O13 23-CG4591-RA_2 CG4591 GGGCAAAAATACCAGGAAAAGTAATACTCATCGAAATACTCGGCTGAAAACACGACTTGCACATT 65 FBan0004591 FBgn0037848 Tsp86D 3 3R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp86D Tetraspanin 86D "CG4591, CG4591, CG4591, CG4591, Dm.Tsp86D, Tetraspanin 86D" CDMC35776 3 16 25 DAC40-O13 23-CG4591-RA_2 CG4591 GGGCAAAAATACCAGGAAAAGTAATACTCATCGAAATACTCGGCTGAAAACACGACTTGCACATT 65 FBan0004591 FBgn0037848 Tsp86D 3 3R cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp86D Tetraspanin 86D "CG4591, CG4591, CG4591, CG4591, Dm.Tsp86D, Tetraspanin 86D" CDMC35777 3 17 25 DAC41-C01 1-CG4573-RA_1 CG4573 GCGTAGCGGAAATGATGGAGATCCTAGGCAAATCCGTCACTCTCGAACGACTCAAAGAAGCTCTGCCCA 69 FBan0004573 FBgn0036629 CG4573 3 3L glutamyl-tRNA aminoacylation; GO:0006424; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004818 ; EC:6.1.1.17 cytoplasm; GO:0005737 CG4573 CG4573 CDMC35777 3 18 25 DAC41-C01 1-CG4573-RA_1 CG4573 GCGTAGCGGAAATGATGGAGATCCTAGGCAAATCCGTCACTCTCGAACGACTCAAAGAAGCTCTGCCCA 69 FBan0004573 FBgn0036629 CG4573 3 3L glutamyl-tRNA aminoacylation; GO:0006424; tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; glutamate-tRNA ligase activity; GO:0004818 ; EC:6.1.1.17; ; GO:0004818 ; EC:6.1.1.17 cytoplasm; GO:0005737 CG4573 CG4573 CDMC35778 3 19 25 DAC41-C13 23-CG4584-RB_1 CG4584 GCCGCATTCTTAATCCCTTCATGGTCACTATCAAAGAGTTTCATTCTGTATCCTTAAGTGAAATATGTT 69 FBgn0027890 CDMC35778 3 20 25 DAC41-C13 23-CG4584-RB_1 CG4584 GCCGCATTCTTAATCCCTTCATGGTCACTATCAAAGAGTTTCATTCTGTATCCTTAAGTGAAATATGTT 69 FBgn0027890 CDMC35779 3 21 25 DAC41-G01 17-CG4613-RA_2 CG4613 CGCCGGGAATATGAAACTCAATCCGCCAGCTTTTCTACTCCTTCTTGCTCTTATTTCGATCTGCGATCG 69 FBan0004613 FBgn0036427 CG4613 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4613 CG4613 SP40 CDMC35779 3 22 25 DAC41-G01 17-CG4613-RA_2 CG4613 CGCCGGGAATATGAAACTCAATCCGCCAGCTTTTCTACTCCTTCTTGCTCTTATTTCGATCTGCGATCG 69 FBan0004613 FBgn0036427 CG4613 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG4613 CG4613 SP40 CDMC35780 3 23 25 DAC41-G13 24-CG4621-RA_1 CG4621 CAGCAAAAACGGAGATAACTAATAATGCTATCAATTTTATAGTTCATTAAGCTATACGTATTTTTCGAA 69 FBan0004621 FBgn0032321 YL-1 2 2L YL-1 YL-1 "CG4621, CG4621, CG4621, dYL-1" CDMC35780 3 24 25 DAC41-G13 24-CG4621-RA_1 CG4621 CAGCAAAAACGGAGATAACTAATAATGCTATCAATTTTATAGTTCATTAAGCTATACGTATTTTTCGAA 69 FBan0004621 FBgn0032321 YL-1 2 2L YL-1 YL-1 "CG4621, CG4621, CG4621, dYL-1" CDMC35781 3 25 25 DAC41-K01 23-CG4651-RA_1 CG4651 GCCAAGAAGTAAACCACATCTTAACCTGATCGTTCTGTCTACAACATCAACCAGAATAAAATCTTAGTT 69 FBan0004651 FBgn0011272 RpL13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL13 Ribosomal protein L13 "CG4651, Dmbbc1, rpL13, r-protein L13, bbc1, Rpl13, Bbc1, anon-EST:fe1D1, anon-fast-evolving-1D1" CDMC35781 3 26 25 DAC41-K01 23-CG4651-RA_1 CG4651 GCCAAGAAGTAAACCACATCTTAACCTGATCGTTCTGTCTACAACATCAACCAGAATAAAATCTTAGTT 69 FBan0004651 FBgn0011272 RpL13 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL13 Ribosomal protein L13 "CG4651, Dmbbc1, rpL13, r-protein L13, bbc1, Rpl13, Bbc1, anon-EST:fe1D1, anon-fast-evolving-1D1" CDMC35782 3 1 26 DAC41-K13 9-CG4662-RA_3 CG4662 GCCGAAATCAGGATTCCGAATCGCATTCAACATGTTCGACACGGATGGAAATCAGCGCGTTGACAAGGA 69 FBan0004662 FBgn0038735 CG4662 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4662 CG4662 CDMC35782 3 2 26 DAC41-K13 9-CG4662-RA_3 CG4662 GCCGAAATCAGGATTCCGAATCGCATTCAACATGTTCGACACGGATGGAAATCAGCGCGTTGACAAGGA 69 FBan0004662 FBgn0038735 CG4662 3 3R calcium ion binding; GO:0005509; ; GO:0005509 CG4662 CG4662 CDMC35783 3 3 26 DAC41-O01 23-CG4690-RA_2 CG4690 TTTGTTTGTAATCTGTAGGCGGAGACAAGTCGAAACAAAATTGAACTGGCAGCAAAATGACAAATTCGC 69 FBan0004690 FBgn0029837 Tsp5D X X cell adhesion; GO:0007155; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386 extracellular space; GO:0005615; integral to membrane; GO:0016021 Tsp5D Tetraspanin 5D "CG4690, CG4690, CG4690, Dm.Tsp5D, Tetraspanin 5D" CDMC35783 3 4 26 DAC41-O01 23-CG4690-RA_2 CG4690 TTTGTTTGTAATCTGTAGGCGGAGACAAGTCGAAACAAAATTGAACTGGCAGCAAAATGACAAATTCGC 69 FBan0004690 FBgn0029837 Tsp5D X X cell adhesion; GO:0007155; transport; GO:0006810 carrier activity; GO:0005386; ; GO:0005386 extracellular space; GO:0005615; integral to membrane; GO:0016021 Tsp5D Tetraspanin 5D "CG4690, CG4690, CG4690, Dm.Tsp5D, Tetraspanin 5D" CDMC35784 3 5 26 DAC41-O13 23-CG4698-RA_1 CG4698 GTCTCCGTCACTTTCTATCCCTCTACTGTGCTCTTTGAAAATGTAATTTGTAAAGTTTTTTTCTACCTT 69 FBan0004698 FBgn0010453 Wnt4 2 2L Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; cell migration; GO:0016477; cell motility; GO:0006928; female gonad development; GO:0008585; focal adhesion formation; GO:0048041; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt4 Wnt oncogene analog 4 "CG4698, DWnt-4, DWnt4, wnt4, Wnt-4, clone 2.4, wnt-4, Wnt, Dwnt4, anon-EST:Liang-2.4" CDMC35784 3 6 26 DAC41-O13 23-CG4698-RA_1 CG4698 GTCTCCGTCACTTTCTATCCCTCTACTGTGCTCTTTGAAAATGTAATTTGTAAAGTTTTTTTCTACCTT 69 FBan0004698 FBgn0010453 Wnt4 2 2L Wnt receptor signaling pathway; GO:0016055; blastoderm segmentation; GO:0007350; cell migration; GO:0016477; cell motility; GO:0006928; female gonad development; GO:0008585; focal adhesion formation; GO:0048041; frizzled-2 signaling pathway; GO:0007223 receptor binding; GO:0005102; ; GO:0005102; signal transducer activity; GO:0004871; ; GO:0004871; ; GO:0005102; ; GO:0004871 extracellular region; GO:0005576 Wnt4 Wnt oncogene analog 4 "CG4698, DWnt-4, DWnt4, wnt4, Wnt-4, clone 2.4, wnt-4, Wnt, Dwnt4, anon-EST:Liang-2.4" CDMC35785 3 7 26 DAC42-C01 15-CG6779-RA_3 Rp s3 TCAGCGTGCCAAGTCGATGAAATTCGTCGATGGCCTGATGATCCATTCGGGAGATCCGTGCAACG 65 FBan0006779 FBgn0002622 RpS3 3 3R DNA repair; GO:0006281; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS3 Ribosomal protein S3 "CG6779, M[[w]], Mw, M(3)w, M(3R)w, M(3)95A: Minute(3)95A, rpS3, S3, RS3, rps3 gene, ribosomal protein S3, dS3, DmRpS3, X72921, Rps3, M(3)124, M(3)B, M(3)B2, M(3)Fla, Minute(3)95A, M(3)95A" CDMC35785 3 8 26 DAC42-C01 15-CG6779-RA_3 Rp s3 TCAGCGTGCCAAGTCGATGAAATTCGTCGATGGCCTGATGATCCATTCGGGAGATCCGTGCAACG 65 FBan0006779 FBgn0002622 RpS3 3 3R DNA repair; GO:0006281; protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003735; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003735 cytoplasm; GO:0005737; cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; nucleus; GO:0005634; ribosome; GO:0005840 RpS3 Ribosomal protein S3 "CG6779, M[[w]], Mw, M(3)w, M(3R)w, M(3)95A: Minute(3)95A, rpS3, S3, RS3, rps3 gene, ribosomal protein S3, dS3, DmRpS3, X72921, Rps3, M(3)124, M(3)B, M(3)B2, M(3)Fla, Minute(3)95A, M(3)95A" CDMC35786 3 9 26 DAC42-C13 5-CG11981-RA_1 prosB3 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC35786 3 10 26 DAC42-C13 5-CG11981-RA_1 prosB3 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC35787 3 11 26 DAC42-G01 12-CG3644-RB_1 bicaudal TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC35787 3 12 26 DAC42-G01 12-CG3644-RB_1 bicaudal TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC35788 3 13 26 DAC42-G13 3-CG3725-RA_2 ca-p60A TGCTGGCTGACGACAACTTCTCCTCCATCGTGTCTGCCGTTGAAGAAGGTCGCGCTATCTACAACAAC 68 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC35788 3 14 26 DAC42-G13 3-CG3725-RA_2 ca-p60A TGCTGGCTGACGACAACTTCTCCTCCATCGTGTCTGCCGTTGAAGAAGGTCGCGCTATCTACAACAAC 68 FBan0003725 FBgn0004551 Ca-P60A 2 2R calcium ion homeostasis; GO:0006874; calcium ion transport; GO:0006816; metabolism; GO:0008152; neuromuscular synaptic transmission; GO:0007274; regulation of sequestering of calcium ion; GO:0051282 "ATP binding; GO:0005524; ; GO:0005524; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; calcium-transporting ATPase activity; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0005388 ; EC:3.6.3.8; ; GO:0016820 ; EC:3.6.3.-" endoplasmic reticulum; GO:0005783; endoplasmic reticulum membrane; GO:0005789; integral to membrane; GO:0016021; nuclear membrane; GO:0005635; sarcoplasmic reticulum; GO:0016529 Ca-P60A Calcium ATPase at 60A "CG3725, CG3725, l(2)k08308ab, l(2)k09025, Ca[2+]ATPase, CA-P60A, SERCA, Kum, Kumbhakarna, sarco/endoplasmic reticulum-type Ca-2+-ATPase., Ca-ATPase, organellar-type Ca-ATPase, calcium ATPase, dSERCA, CaP60A, Ca-p" CDMC35789 3 15 26 DAC42-K01 2-CG7929-RA_1 ocn GGCACCTGTTTCACAATTGTTGAAGCCCCTTCGAAGGCAAAGTTCTTCGCGCGTAAACGCCCTTTTGAT 69 FBan0007929 FBgn0041102 ocn 3 3R ocn ocnus "CG7929, CG7929, BcDNA:GH02250, bs29e10.y1, ocnus" CDMC35789 3 16 26 DAC42-K01 2-CG7929-RA_1 ocn GGCACCTGTTTCACAATTGTTGAAGCCCCTTCGAAGGCAAAGTTCTTCGCGCGTAAACGCCCTTTTGAT 69 FBan0007929 FBgn0041102 ocn 3 3R ocn ocnus "CG7929, CG7929, BcDNA:GH02250, bs29e10.y1, ocnus" CDMC35790 3 17 26 DAC42-K13 5uM MSP 5uM MSP CDMC35790 3 18 26 DAC42-K13 5uM MSP 5uM MSP CDMC35791 3 19 26 DAC42-O01 10uM MSP 10uM MSP CDMC35791 3 20 26 DAC42-O01 10uM MSP 10uM MSP CDMC35792 3 21 26 DAC42-O13 20uM MSP 20uM MSP CDMC35792 3 22 26 DAC42-O13 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC35793 4 1 1 DAC01-D01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35793 4 2 1 DAC01-D01 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC35794 4 3 1 DAC01-D13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35794 4 4 1 DAC01-D13 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC35795 4 5 1 DAC01-H01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35795 4 6 1 DAC01-H01 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC35796 4 7 1 DAC01-H13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35796 4 8 1 DAC01-H13 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC35797 4 9 1 DAC01-L01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35797 4 10 1 DAC01-L01 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC35798 4 11 1 DAC01-L13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35798 4 12 1 DAC01-L13 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC35799 4 13 1 DAC01-P01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35799 4 14 1 DAC01-P01 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC35800 4 15 1 DAC01-P13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35800 4 16 1 DAC01-P13 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC35801 4 17 1 DAC02-D01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35801 4 18 1 DAC02-D01 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC35802 4 19 1 DAC02-D13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35802 4 20 1 DAC02-D13 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC35803 4 21 1 DAC02-H01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35803 4 22 1 DAC02-H01 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC35804 4 23 1 DAC02-H13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35804 4 24 1 DAC02-H13 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC35805 4 25 1 DAC02-L01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35805 4 26 1 DAC02-L01 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC35806 4 1 2 DAC02-L13 N/A CG9075 (00718-00956) CDMC35806 4 2 2 DAC02-L13 N/A CG9075 (00718-00956) CDMC35807 4 3 2 DAC02-P01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35807 4 4 2 DAC02-P01 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC35808 4 5 2 DAC02-P13 AutoBlank AutoBlank CDMC35808 4 6 2 DAC02-P13 AutoBlank AutoBlank CDMC35809 4 7 2 DAC03-D01 2-CG3841-RA_2 CG3841 GTTCGCCAATCCAGTTCCGGAAACTAGTTGGGGTGACGAGGTGTTCAACGCAACATCGGATTCCC 65 FBan0003841 FBgn0032131 CG3841 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG3841 CG3841 CDMC35809 4 8 2 DAC03-D01 2-CG3841-RA_2 CG3841 GTTCGCCAATCCAGTTCCGGAAACTAGTTGGGGTGACGAGGTGTTCAACGCAACATCGGATTCCC 65 FBan0003841 FBgn0032131 CG3841 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG3841 CG3841 CDMC35810 4 9 2 DAC03-D13 18-CG3894-RB_5 CG3894 GAGGGAAAAAAGGCGCCTCAGGAGAATCTGGTTTTTCTCGCGCAACCCAAGGGACAAGGCAGCAC 65 FBan0003894 FBgn0035059 CG3894 2 2R intracellular signaling cascade; GO:0007242 CG3894 CG3894 "CG9197, dmNeural-like" CDMC35810 4 10 2 DAC03-D13 18-CG3894-RB_5 CG3894 GAGGGAAAAAAGGCGCCTCAGGAGAATCTGGTTTTTCTCGCGCAACCCAAGGGACAAGGCAGCAC 65 FBan0003894 FBgn0035059 CG3894 2 2R intracellular signaling cascade; GO:0007242 CG3894 CG3894 "CG9197, dmNeural-like" CDMC35811 4 11 2 DAC03-H01 15-CG3995-RA_4 CG3995 TTCCAAAACAACTTAGTCGAAATGAAGCGGAAAACGAGCGAGATCTGGTGCTTTTTCCGGGCGGT 65 FBan0003995 FBgn0038472 CG3995 3 3R CG3995 CG3995 CDMC35811 4 12 2 DAC03-H01 15-CG3995-RA_4 CG3995 TTCCAAAACAACTTAGTCGAAATGAAGCGGAAAACGAGCGAGATCTGGTGCTTTTTCCGGGCGGT 65 FBan0003995 FBgn0038472 CG3995 3 3R CG3995 CG3995 CDMC35812 4 13 2 DAC03-H13 9-CG40068-RA_1 CG40068 CAAAACACGGGTGGTGGCCACACCTGAAGAAACAAACGCAGATGAGCAGAAGGAACGCGATGTGG 65 FBgn0058068 CG40068 protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of translation; GO:0006445 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0008135" CG40068 CG40068 CDMC35812 4 14 2 DAC03-H13 9-CG40068-RA_1 CG40068 CAAAACACGGGTGGTGGCCACACCTGAAGAAACAAACGCAGATGAGCAGAAGGAACGCGATGTGG 65 FBgn0058068 CG40068 protein biosynthesis; GO:0006412; protein metabolism; GO:0019538; regulation of translation; GO:0006445 "nucleic acid binding; GO:0003676; ; GO:0003676; translation factor activity, nucleic acid binding; GO:0008135; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0008135" CG40068 CG40068 CDMC35813 4 15 2 DAC03-L01 12-CG40216-RA_2 CG40216 TACAAATCTGGAACGATTTGACGCCGTGACCGCTACTATACAACAGGTTTGGCGAAGGGTCAGCC 65 FBgn0058216 CG40216 CG40216 CG40216 CDMC35813 4 16 2 DAC03-L01 12-CG40216-RA_2 CG40216 TACAAATCTGGAACGATTTGACGCCGTGACCGCTACTATACAACAGGTTTGGCGAAGGGTCAGCC 65 FBgn0058216 CG40216 CG40216 CG40216 CDMC35814 4 17 2 DAC03-L13 1-CG40271-RA_2 CG40271 GAAAGAGGCGAGGACAACGAAGAGGCGCAAACGACGCGGCAAAATGGATCGGGTTGAAATTCTTG 65 FBgn0058271 CG40271 CG40271 CG40271 CDMC35814 4 18 2 DAC03-L13 1-CG40271-RA_2 CG40271 GAAAGAGGCGAGGACAACGAAGAGGCGCAAACGACGCGGCAAAATGGATCGGGTTGAAATTCTTG 65 FBgn0058271 CG40271 CG40271 CG40271 CDMC35815 4 19 2 DAC03-P01 3-CG40485-RB_1 CG40485 GAGCATTAGTCCGGGATTGGTGGACACTGAGTTAGTGCCGTTGGACTACAAAGGGCTGCCTATGC 65 FBgn0069973 CG40485 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40485 CG40485 CDMC35815 4 20 2 DAC03-P01 3-CG40485-RB_1 CG40485 GAGCATTAGTCCGGGATTGGTGGACACTGAGTTAGTGCCGTTGGACTACAAAGGGCTGCCTATGC 65 FBgn0069973 CG40485 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG40485 CG40485 CDMC35816 4 21 2 DAC03-P13 3-CG4068-RA_1 CG4068 TATCCTGCTGAAGCCAGCCAAATTTGTGGGACCAGCATCGGCAAACGAGGTAAACACAGCGACTC 65 FBan0004068 FBgn0029738 CG4068 X X CG4068 CG4068 CDMC35816 4 22 2 DAC03-P13 3-CG4068-RA_1 CG4068 TATCCTGCTGAAGCCAGCCAAATTTGTGGGACCAGCATCGGCAAACGAGGTAAACACAGCGACTC 65 FBan0004068 FBgn0029738 CG4068 X X CG4068 CG4068 CDMC35817 4 23 2 DAC04-D01 10-CG31525-RA_2 CG31525 GCCGACACGAAACCTACTCTGTTCAAAATCCCCAATTCCGATGGAAAAGGAACCTGATCACGGTGCAGA 69 FBan0031525 FBgn0051525 CG31525 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31525 CG31525 CDMC35817 4 24 2 DAC04-D01 10-CG31525-RA_2 CG31525 GCCGACACGAAACCTACTCTGTTCAAAATCCCCAATTCCGATGGAAAAGGAACCTGATCACGGTGCAGA 69 FBan0031525 FBgn0051525 CG31525 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31525 CG31525 CDMC35818 4 25 2 DAC04-D13 23-CG31534-RB_13 CG31534 CGCTTTTAAATTAGTTAGTTTCTAACTTTTTGTACCCGCTACAGCCCACTTAAAATACCTAACGACGCA 69 FBan0031534 FBgn0051534 CG31534 3 3R zinc ion binding; GO:0008270; ; GO:0008270 CG31534 CG31534 "CG18253, CG1055, CG18253, anon-WO0140519.95" CDMC35818 4 26 2 DAC04-D13 23-CG31534-RB_13 CG31534 CGCTTTTAAATTAGTTAGTTTCTAACTTTTTGTACCCGCTACAGCCCACTTAAAATACCTAACGACGCA 69 FBan0031534 FBgn0051534 CG31534 3 3R zinc ion binding; GO:0008270; ; GO:0008270 CG31534 CG31534 "CG18253, CG1055, CG18253, anon-WO0140519.95" CDMC35819 4 1 3 DAC04-H01 23-CG31600-RA_11 CG31600 AAGTACCGTTTCCATTACCATTTGCCTGAATTTGGTCAGCCTATACTTAGCCAATTTGCGTGATGATTG 69 FBan0031600 FBgn0051600 CG31600 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG31600 CG31600 CDMC35819 4 2 3 DAC04-H01 23-CG31600-RA_11 CG31600 AAGTACCGTTTCCATTACCATTTGCCTGAATTTGGTCAGCCTATACTTAGCCAATTTGCGTGATGATTG 69 FBan0031600 FBgn0051600 CG31600 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 CG31600 CG31600 CDMC35820 4 3 3 DAC04-H13 23-CG31619-RA_6 CG31619 CAAACGCCTACAGACCGAAGCAAAACTAAACACTATCGCAGCTCAAAAAATTGCATAGCTCAGCAAGGA 69 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC35820 4 4 3 DAC04-H13 23-CG31619-RA_6 CG31619 CAAACGCCTACAGACCGAAGCAAAACTAAACACTATCGCAGCTCAAAAAATTGCATAGCTCAGCAAGGA 69 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC35821 4 5 3 DAC04-L01 41-CG31640-RA_3 CG31640 ACTGCTGGGAAAACCGGTTGAAATAGTCTTTGAGTTTGATACGGTTCGCAATTTCAGTGCCATCGTCCT 69 FBan0031640 FBgn0051640 CG31640 2 2L cell adhesion; GO:0007155; signal transduction; GO:0007165 receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.- CG31640 CG31640 "CG15813, CG13986, CG13987, CG15813, anon-WO0073329.6" CDMC35821 4 6 3 DAC04-L01 41-CG31640-RA_3 CG31640 ACTGCTGGGAAAACCGGTTGAAATAGTCTTTGAGTTTGATACGGTTCGCAATTTCAGTGCCATCGTCCT 69 FBan0031640 FBgn0051640 CG31640 2 2L cell adhesion; GO:0007155; signal transduction; GO:0007165 receptor signaling protein tyrosine kinase activity; GO:0004716 ; EC:2.7.1.-; ; GO:0004716 ; EC:2.7.1.- CG31640 CG31640 "CG15813, CG13986, CG13987, CG15813, anon-WO0073329.6" CDMC35822 4 7 3 DAC04-L13 3-CG31648-RA_2 CG31648 GGCGGGCGCGTATTTCAACAAAATCCAATGCTTTTGCTTCGAGGAACAGCAACTGAATCCACACGAGGA 69 FBan0031648 FBgn0051648 CG31648 2 2L cytochrome c oxidase complex assembly; GO:0008535; protein complex assembly; GO:0006461; protein metabolism; GO:0019538 copper ion binding; GO:0005507; ; GO:0005507 mitochondrial inner membrane; GO:0005743 CG31648 CG31648 CG6922 CDMC35822 4 8 3 DAC04-L13 3-CG31648-RA_2 CG31648 GGCGGGCGCGTATTTCAACAAAATCCAATGCTTTTGCTTCGAGGAACAGCAACTGAATCCACACGAGGA 69 FBan0031648 FBgn0051648 CG31648 2 2L cytochrome c oxidase complex assembly; GO:0008535; protein complex assembly; GO:0006461; protein metabolism; GO:0019538 copper ion binding; GO:0005507; ; GO:0005507 mitochondrial inner membrane; GO:0005743 CG31648 CG31648 CG6922 CDMC35823 4 9 3 DAC04-P01 3-CG31675-RA_1 CG31675 GGCGGTGCAGAACTCAAGTTGTCATGTGTGCGACAGCGAGAACTACTGCAACGGATCGGAAAATCATCC 69 FBan0031675 FBgn0051675 CG31675 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31675 CG31675 BcDNA:RE19849 CDMC35823 4 10 3 DAC04-P01 3-CG31675-RA_1 CG31675 GGCGGTGCAGAACTCAAGTTGTCATGTGTGCGACAGCGAGAACTACTGCAACGGATCGGAAAATCATCC 69 FBan0031675 FBgn0051675 CG31675 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31675 CG31675 BcDNA:RE19849 CDMC35824 4 11 3 DAC04-P13 10-CG31682-RA_1 CG31682 TACGTCCATGAGATGAGTCAACGACATGGAACCGTGTATGCCTACACCGGATCAATTTACTTGCCCCGG 69 FBan0031682 FBgn0051682 CG31682 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG31682 CG31682 "CG17006, BcDNA:AT02809" CDMC35824 4 12 3 DAC04-P13 10-CG31682-RA_1 CG31682 TACGTCCATGAGATGAGTCAACGACATGGAACCGTGTATGCCTACACCGGATCAATTTACTTGCCCCGG 69 FBan0031682 FBgn0051682 CG31682 2 2L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; endodeoxyribonuclease activity; GO:0004520; ; GO:0004520 mitochondrion; GO:0005739 CG31682 CG31682 "CG17006, BcDNA:AT02809" CDMC35825 4 13 3 DAC05-D01 16-CG5993-RA_1 CG5993 GCAGCGCACGTGAAATAGCATACACAACATTCCCATATCTTTCCATTTCCCCTTACCTCAGGACTCGCC 69 FBan0005993 FBgn0004956 os X X "JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; foregut morphogenesis; GO:0007440; germ-line stem cell division; GO:0042078; hindgut morphogenesis; GO:0007442; ovarian follicle cell development (sensu Insecta); GO:0030707; primary sex determination; GO:0007538; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; somatic stem cell division; GO:0048103; stem cell division; GO:0017145" receptor binding; GO:0005102; ; GO:0005102; morphogen activity; GO:0016015; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0016015; ; GO:0005125 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 os outstretched "CG5993, sy: small eye, small-eye, upd: unpaired, unpaired, upa, sisC, sisterless c, od: outstretched, outstretched, sis-c, sis-C, Upd, Unpaired, UPD, unp, bdw: bending-wings, l(1)YC43, l(1)YM55, odsy: outstretched-smalleye, bending-wings, outstretched-smalleye, upd, od, sy" CDMC35825 4 14 3 DAC05-D01 16-CG5993-RA_1 CG5993 GCAGCGCACGTGAAATAGCATACACAACATTCCCATATCTTTCCATTTCCCCTTACCTCAGGACTCGCC 69 FBan0005993 FBgn0004956 os X X "JAK-STAT cascade; GO:0007259; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; defense response; GO:0006952; embryonic development (sensu Insecta); GO:0001700; foregut morphogenesis; GO:0007440; germ-line stem cell division; GO:0042078; hindgut morphogenesis; GO:0007442; ovarian follicle cell development (sensu Insecta); GO:0030707; primary sex determination; GO:0007538; sex determination; GO:0007530; sex determination, establishment of X:A ratio; GO:0007540; somatic stem cell division; GO:0048103; stem cell division; GO:0017145" receptor binding; GO:0005102; ; GO:0005102; morphogen activity; GO:0016015; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0016015; ; GO:0005125 extracellular matrix (sensu Metazoa); GO:0005578; extracellular region; GO:0005576 os outstretched "CG5993, sy: small eye, small-eye, upd: unpaired, unpaired, upa, sisC, sisterless c, od: outstretched, outstretched, sis-c, sis-C, Upd, Unpaired, UPD, unp, bdw: bending-wings, l(1)YC43, l(1)YM55, odsy: outstretched-smalleye, bending-wings, outstretched-smalleye, upd, od, sy" CDMC35826 4 15 3 DAC05-D13 3-CG6005-RA_1 CG6005 GCAGAGCCTGAGCGACATTCTGCCTTTCGACATCAGTCCTCCCGGACACATAGTCGATGATTTCTGCAT 69 FBan0006005 FBgn0038672 CG6005 3 3R CG6005 CG6005 CDMC35826 4 16 3 DAC05-D13 3-CG6005-RA_1 CG6005 GCAGAGCCTGAGCGACATTCTGCCTTTCGACATCAGTCCTCCCGGACACATAGTCGATGATTTCTGCAT 69 FBan0006005 FBgn0038672 CG6005 3 3R CG6005 CG6005 CDMC35827 4 17 3 DAC05-H01 23-CG6043-RC_20 CG6043 CAGGTCACATAATACGCTCAGCTAATCAATTTGTCGATCAAGGTTACCAGAATTACCCACCACAAGCCC 69 FBan0006043 FBgn0032497 CG6043 2 2L CG6043 CG6043 CDMC35827 4 18 3 DAC05-H01 23-CG6043-RC_20 CG6043 CAGGTCACATAATACGCTCAGCTAATCAATTTGTCGATCAAGGTTACCAGAATTACCCACCACAAGCCC 69 FBan0006043 FBgn0032497 CG6043 2 2L CG6043 CG6043 CDMC35828 4 19 3 DAC05-H13 23-CG6051-RA_10 CG6051 CCGTAAGCTTTAACTTTGCAAGATCCTTTGTCACTAGCCAAGGCCTTACTAAATGGCAGTTAGAGGTGT 69 FBan0006051 FBgn0039492 CG6051 3 3R CG6051 CG6051 CDMC35828 4 20 3 DAC05-H13 23-CG6051-RA_10 CG6051 CCGTAAGCTTTAACTTTGCAAGATCCTTTGTCACTAGCCAAGGCCTTACTAAATGGCAGTTAGAGGTGT 69 FBan0006051 FBgn0039492 CG6051 3 3R CG6051 CG6051 CDMC35829 4 21 3 DAC05-L01 2-CG6091-RA_2 CG6091 GGCTCGTGATGCTCATGGCAACCACATTGAGATCCAAGCTATTTCCGAGATCTACAGCCGTACCGTCGA 69 FBan0006091 FBgn0036180 CG6091 3 3L CG6091 CG6091 CDMC35829 4 22 3 DAC05-L01 2-CG6091-RA_2 CG6091 GGCTCGTGATGCTCATGGCAACCACATTGAGATCCAAGCTATTTCCGAGATCTACAGCCGTACCGTCGA 69 FBan0006091 FBgn0036180 CG6091 3 3L CG6091 CG6091 CDMC35830 4 23 3 DAC05-L13 17-CG6105-RA_1 CG6105 GTAGGCTACAATGTCTAAGCTTACTATAGTCTCCGCTTGGCAGTCACTGGAATGGGCAACGTAATCCCT 69 FBan0006105 FBgn0010612 l(2)06225 2 2L ATP synthesis coupled proton transport; GO:0015986; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" l(2)06225 lethal (2) 06225 "CG6105, I(2)06225, BcDNA:RE20862, BcDNA:RH28372, anon-EST:Posey10" CDMC35830 4 24 3 DAC05-L13 17-CG6105-RA_1 CG6105 GTAGGCTACAATGTCTAAGCTTACTATAGTCTCCGCTTGGCAGTCACTGGAATGGGCAACGTAATCCCT 69 FBan0006105 FBgn0010612 l(2)06225 2 2L ATP synthesis coupled proton transport; GO:0015986; electron transport; GO:0006118; oxidative phosphorylation; GO:0006119; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" l(2)06225 lethal (2) 06225 "CG6105, I(2)06225, BcDNA:RE20862, BcDNA:RH28372, anon-EST:Posey10" CDMC35831 4 25 3 DAC05-P01 2-CG6142-RA_2 CG6142 TGCTTAAGAAGATATGGCTCCAGCTTGCAGCATCAATCAGGCACCTGCAAAATGGGTCCTGCAACGGAT 69 FBan0006142 FBgn0039415 CG6142 3 3R electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" CG6142 CG6142 CDMC35831 4 26 3 DAC05-P01 2-CG6142-RA_2 CG6142 TGCTTAAGAAGATATGGCTCCAGCTTGCAGCATCAATCAGGCACCTGCAAAATGGGTCCTGCAACGGAT 69 FBan0006142 FBgn0039415 CG6142 3 3R electron transport; GO:0006118 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; FAD binding; GO:0050660; ; GO:0050660; ; GO:0016614 ; EC:1.1.-.-" CG6142 CG6142 CDMC35832 4 1 4 DAC05-P13 23-CG6151-RA_11 CG6151 AGGGCAAACCTAACCAAGAGAACATCGGCAGGCAATCATAAACATAATCATGTGCAATTTCTGATTGTT 69 FBan0006151 FBgn0036533 CG6151 3 3L CG6151 CG6151 anon-WO0118547.242 CDMC35832 4 2 4 DAC05-P13 23-CG6151-RA_11 CG6151 AGGGCAAACCTAACCAAGAGAACATCGGCAGGCAATCATAAACATAATCATGTGCAATTTCTGATTGTT 69 FBan0006151 FBgn0036533 CG6151 3 3L CG6151 CG6151 anon-WO0118547.242 CDMC35833 4 3 4 DAC06-D01 12-CG11550-RA_1 CG11550 AGGAATTCTACAAGTTTGTGCCCCAGGAAATGCTTCCCAAGGAATATGGTGGTCAACTGGAGGAGGCAA 69 FBan0011550 FBgn0039864 CG11550 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 intracellular; GO:0005622 CG11550 CG11550 CDMC35833 4 4 4 DAC06-D01 12-CG11550-RA_1 CG11550 AGGAATTCTACAAGTTTGTGCCCCAGGAAATGCTTCCCAAGGAATATGGTGGTCAACTGGAGGAGGCAA 69 FBan0011550 FBgn0039864 CG11550 3 3R transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 intracellular; GO:0005622 CG11550 CG11550 CDMC35834 4 5 4 DAC06-D13 23-CG11562-RA_5 CG11562 CCCCTAAATATGCACCTATTAAAATCTAAGACTAAGTCGGGGAAAACAAGAATTTCGTTGTTCAAATGT 69 FBan0011562 FBgn0031247 CG11562 2 2L CG11562 CG11562 BcDNA:RE44650 CDMC35834 4 6 4 DAC06-D13 23-CG11562-RA_5 CG11562 CCCCTAAATATGCACCTATTAAAATCTAAGACTAAGTCGGGGAAAACAAGAATTTCGTTGTTCAAATGT 69 FBan0011562 FBgn0031247 CG11562 2 2L CG11562 CG11562 BcDNA:RE44650 CDMC35835 4 7 4 DAC06-H01 3-CG11604-RA_2 CG11604 GGCAAAGAGTAAAAAGATGGAAAAGAACACCGAGGAGGATGTTGTCTGCATGGGCTCTCAGGAGCGCCA 69 FBan0011604 FBgn0031242 CG11604 2 2L CG11604 CG11604 CDMC35835 4 8 4 DAC06-H01 3-CG11604-RA_2 CG11604 GGCAAAGAGTAAAAAGATGGAAAAGAACACCGAGGAGGATGTTGTCTGCATGGGCTCTCAGGAGCGCCA 69 FBan0011604 FBgn0031242 CG11604 2 2L CG11604 CG11604 CDMC35836 4 9 4 DAC06-H13 17-CG11622-RA_1 CG11622 GCGGCTCCAAATTGAATATGACGAGCTAATGGAATGGCAGAACGAACTAAAAGCACGTATCGTCGCCGA 69 FBan0011622 FBgn0026056 Rlip 3 3R transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ral GTPase activator activity; GO:0017123; ; GO:0017123 Rlip Rlip "CG11622, CG11622, dRlip, dRLIP, D-RLIP, RhoGAP-93B3, dRalBP" CDMC35836 4 10 4 DAC06-H13 17-CG11622-RA_1 CG11622 GCGGCTCCAAATTGAATATGACGAGCTAATGGAATGGCAGAACGAACTAAAAGCACGTATCGTCGCCGA 69 FBan0011622 FBgn0026056 Rlip 3 3R transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 Ral GTPase activator activity; GO:0017123; ; GO:0017123 Rlip Rlip "CG11622, CG11622, dRlip, dRLIP, D-RLIP, RhoGAP-93B3, dRalBP" CDMC35837 4 11 4 DAC06-L01 1-CG11660-RA_1 CG11660 GGCGCGAGAGTTGTACAGGGATTGCGTAGTCATCATGTGGCGCATTTACAATCAATGCCGTCTTGTGCA 69 FBan0011660 FBgn0036187 CG11660 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG11660 CG11660 CDMC35837 4 12 4 DAC06-L01 1-CG11660-RA_1 CG11660 GGCGCGAGAGTTGTACAGGGATTGCGTAGTCATCATGTGGCGCATTTACAATCAATGCCGTCTTGTGCA 69 FBan0011660 FBgn0036187 CG11660 3 3L protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004713 ; EC:2.7.1.112 CG11660 CG11660 CDMC35838 4 13 4 DAC06-L13 3-CG11669-RA_1 CG11669 GGCACATCTGCCCTTTAACTTCAATCTGATTACGGTTCTGGCAAGCGATGGTGTCTCTGCCGGATCCAT 69 FBan0011669 FBgn0033296 CG11669 2 2R carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG11669 CG11669 CT36683 CDMC35838 4 14 4 DAC06-L13 3-CG11669-RA_1 CG11669 GGCACATCTGCCCTTTAACTTCAATCTGATTACGGTTCTGGCAAGCGATGGTGTCTCTGCCGGATCCAT 69 FBan0011669 FBgn0033296 CG11669 2 2R carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG11669 CG11669 CT36683 CDMC35839 4 15 4 DAC06-P01 16-CG11723-RA_3 CG11723 GCTACCAAATCAGTAGCCGAAAAACACCAACTTCGTTTGACTATGTCGACAGCTCCATGGTTGAGTGCG 69 FBan0011723 FBgn0031391 CG11723 2 2L DNA binding; GO:0003677; ; GO:0003677 CG11723 CG11723 CDMC35839 4 16 4 DAC06-P01 16-CG11723-RA_3 CG11723 GCTACCAAATCAGTAGCCGAAAAACACCAACTTCGTTTGACTATGTCGACAGCTCCATGGTTGAGTGCG 69 FBan0011723 FBgn0031391 CG11723 2 2L DNA binding; GO:0003677; ; GO:0003677 CG11723 CG11723 CDMC35840 4 17 4 DAC06-P13 16-CG11735-RA_1 CG11735 CGCCACGAATTGAGTGGAGATTGGAAGAAGGACTCCCGATTTCTGGTGGACATTGTTAGGTATCACGAA 69 FBan0011735 FBgn0037590 Or85b 3 3R sensory perception of smell; GO:0007608 actin binding; GO:0003779; odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0003779; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85b Odorant receptor 85b "CG11735, 85A.1, DOR115, 85b" CDMC35840 4 18 4 DAC06-P13 16-CG11735-RA_1 CG11735 CGCCACGAATTGAGTGGAGATTGGAAGAAGGACTCCCGATTTCTGGTGGACATTGTTAGGTATCACGAA 69 FBan0011735 FBgn0037590 Or85b 3 3R sensory perception of smell; GO:0007608 actin binding; GO:0003779; odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0003779; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or85b Odorant receptor 85b "CG11735, 85A.1, DOR115, 85b" CDMC35841 4 19 4 DAC07-D01 2-CG1502-RA_1 CG1502 GTCTGCAGGTGTCACCCTATGCACCGTGATCTATGTGAACTCGTGCATTCGGGCAAACAAGTGCC 65 FBan0001502 FBgn0003865 tsg X X "cell fate commitment; GO:0045165; regulation of BMP signaling pathway; GO:0030510; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of anterior/posterior axis, embryo; GO:0007354" heparin binding; GO:0008201; protein binding; GO:0005515; ; GO:0008201; ; GO:0005515 extracellular region; GO:0005576 tsg twisted gastrulation "CG1502, RF32, l(1)tsg, dTsg, l(1)11Ab, l(1)RF32, l(1)11Ac, lethal(1)11Ac" CDMC35841 4 20 4 DAC07-D01 2-CG1502-RA_1 CG1502 GTCTGCAGGTGTCACCCTATGCACCGTGATCTATGTGAACTCGTGCATTCGGGCAAACAAGTGCC 65 FBan0001502 FBgn0003865 tsg X X "cell fate commitment; GO:0045165; regulation of BMP signaling pathway; GO:0030510; regulation of transforming growth factor beta receptor signaling pathway; GO:0017015; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; zygotic determination of anterior/posterior axis, embryo; GO:0007354" heparin binding; GO:0008201; protein binding; GO:0005515; ; GO:0008201; ; GO:0005515 extracellular region; GO:0005576 tsg twisted gastrulation "CG1502, RF32, l(1)tsg, dTsg, l(1)11Ab, l(1)RF32, l(1)11Ac, lethal(1)11Ac" CDMC35842 4 21 4 DAC07-D13 16-CG15057-RA_1 CG15057 GGTGGATACTGGTGCTGGATGGTGGTCGACGATCGGCGGTCAGAGGGGATGCAACTGCTAATCCG 65 FBan0015057 FBgn0030908 CG15057 X X CG15057 CG15057 CDMC35842 4 22 4 DAC07-D13 16-CG15057-RA_1 CG15057 GGTGGATACTGGTGCTGGATGGTGGTCGACGATCGGCGGTCAGAGGGGATGCAACTGCTAATCCG 65 FBan0015057 FBgn0030908 CG15057 X X CG15057 CG15057 CDMC35843 4 23 4 DAC07-H01 1-CG15147-RA_3 CG15147 TTGCTATTGCTCCGCAACCAACCGATGATTCCACGGCCCGTCAAAGTGTATGGACTGGACTAAGG 65 FBan0015147 FBgn0032654 CG15147 2 2L CG15147 CG15147 CDMC35843 4 24 4 DAC07-H01 1-CG15147-RA_3 CG15147 TTGCTATTGCTCCGCAACCAACCGATGATTCCACGGCCCGTCAAAGTGTATGGACTGGACTAAGG 65 FBan0015147 FBgn0032654 CG15147 2 2L CG15147 CG15147 CDMC35844 4 25 4 DAC07-H13 2-CG15167-RA_1 CG15167 GAGAAGATCAAAAGCCAGATGAAGGAGCCACGATTCTCGAAGTGGAAGCTGCAATCAGGGGCCCC 65 FBan0015167 FBgn0032709 CG15167 2 2L CG15167 CG15167 CDMC35844 4 26 4 DAC07-H13 2-CG15167-RA_1 CG15167 GAGAAGATCAAAAGCCAGATGAAGGAGCCACGATTCTCGAAGTGGAAGCTGCAATCAGGGGCCCC 65 FBan0015167 FBgn0032709 CG15167 2 2L CG15167 CG15167 CDMC35845 4 1 5 DAC07-L01 23-CG1524-RA_8 CG1524 TCGTCGTCTGTAGATGGCAGTATCTGGAAAGCAGTAGTCTATGTTTGCGGTCGAAATACAATACT 65 FBan0001524 FBgn0004403 RpS14a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS14a Ribosomal protein S14a "CG1524, RPS14A, RpS14, RpS14A, S14, anon-WO03040301.136, anon-WO03040301.138, anon-EST:Posey115, anon-EST:Posey131, anon-EST:Posey154, anon-EST:Posey77, rpS14A" CDMC35845 4 2 5 DAC07-L01 23-CG1524-RA_8 CG1524 TCGTCGTCTGTAGATGGCAGTATCTGGAAAGCAGTAGTCTATGTTTGCGGTCGAAATACAATACT 65 FBan0001524 FBgn0004403 RpS14a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS14a Ribosomal protein S14a "CG1524, RPS14A, RpS14, RpS14A, S14, anon-WO03040301.136, anon-WO03040301.138, anon-EST:Posey115, anon-EST:Posey131, anon-EST:Posey154, anon-EST:Posey77, rpS14A" CDMC35846 4 3 5 DAC07-L13 17-CG15276-RA_1 CG15276 TCAGAGGATTTGGTTGAGGACGAACGTGATCCGGATGTAATACCATCGCAATACGTCGGTGGGAG 65 FBgn0028890 CDMC35846 4 4 5 DAC07-L13 17-CG15276-RA_1 CG15276 TCAGAGGATTTGGTTGAGGACGAACGTGATCCGGATGTAATACCATCGCAATACGTCGGTGGGAG 65 FBgn0028890 CDMC35847 4 5 5 DAC07-P01 18-CG15368-RA_1 CG15368 TTCCGGCCAGGATCAAGATGGTAATCAGGCACAGGATTCCACAAAAAAACGATGCGACAAGTGCG 65 FBan0015368 FBgn0030104 CG15368 X X CG15368 CG15368 CDMC35847 4 6 5 DAC07-P01 18-CG15368-RA_1 CG15368 TTCCGGCCAGGATCAAGATGGTAATCAGGCACAGGATTCCACAAAAAAACGATGCGACAAGTGCG 65 FBan0015368 FBgn0030104 CG15368 X X CG15368 CG15368 CDMC35848 4 7 5 DAC07-P13 18-CG15379-RA_1 CG15379 CCCGAGGACACGTCCCCGAATGACATAATGAGCGAGGTGGACCTGCAGATGGAGTTCGCCACACG 65 FBgn0031386 CDMC35848 4 8 5 DAC07-P13 18-CG15379-RA_1 CG15379 CCCGAGGACACGTCCCCGAATGACATAATGAGCGAGGTGGACCTGCAGATGGAGTTCGCCACACG 65 FBgn0031386 CDMC35849 4 9 5 DAC08-D01 2-CG14569-RA_1 CG14569 ATCACCCCGAGTGTTCCCTTCGATTTACCCAGTTCGACTGTCAAGCCGGAGAACACTTATCTGCCG 66 FBan0014569 FBgn0037123 CG14569 3 3L CG14569 CG14569 CDMC35849 4 10 5 DAC08-D01 2-CG14569-RA_1 CG14569 ATCACCCCGAGTGTTCCCTTCGATTTACCCAGTTCGACTGTCAAGCCGGAGAACACTTATCTGCCG 66 FBan0014569 FBgn0037123 CG14569 3 3L CG14569 CG14569 CDMC35850 4 11 5 DAC08-D13 2-CG14674-RA_1 CG14674 AGTCGTACAACTCGGACTTTGAGCTGCAGTTCAGTCATCCCCTGAAGCATATCGTCGGCATGTGCC 66 FBan0014674 FBgn0037366 CG14674 3 3R CG14674 CG14674 CDMC35850 4 12 5 DAC08-D13 2-CG14674-RA_1 CG14674 AGTCGTACAACTCGGACTTTGAGCTGCAGTTCAGTCATCCCCTGAAGCATATCGTCGGCATGTGCC 66 FBan0014674 FBgn0037366 CG14674 3 3R CG14674 CG14674 CDMC35851 4 13 5 DAC08-H01 3-CG14853-RA_4 CG14853 CGATATCGTGCCCGTAAGCCTTAACTTTGGCCTAAAGGAGAACACCGCAGCTGACCTGGACGTGAG 66 FBan0014853 FBgn0038246 CG14853 3 3R CG14853 CG14853 CDMC35851 4 14 5 DAC08-H01 3-CG14853-RA_4 CG14853 CGATATCGTGCCCGTAAGCCTTAACTTTGGCCTAAAGGAGAACACCGCAGCTGACCTGGACGTGAG 66 FBan0014853 FBgn0038246 CG14853 3 3R CG14853 CG14853 CDMC35852 4 15 5 DAC08-H13 2-CG14990-RA_1 CG14990 ATTGCCCCAGAAGTAGTCCTTACAGCGGCTAGCATTGTGGTGGGCAAGACTGATGCGGAAATTGTG 66 FBan0014990 FBgn0035496 CG14990 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14990 CG14990 SPH97 CDMC35852 4 16 5 DAC08-H13 2-CG14990-RA_1 CG14990 ATTGCCCCAGAAGTAGTCCTTACAGCGGCTAGCATTGTGGTGGGCAAGACTGATGCGGAAATTGTG 66 FBan0014990 FBgn0035496 CG14990 3 3L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG14990 CG14990 SPH97 CDMC35853 4 17 5 DAC08-L01 3-CG15395-RA_1 CG15395 GGAGAGCTTTGCATCCGCAATAAGTGAGGAGTTTCCCAGACTCCAACAGCATCGTGAGCAGGTGGA 66 FBan0015395 FBgn0031440 CG15395 2 2L CG15395 CG15395 CDMC35853 4 18 5 DAC08-L01 3-CG15395-RA_1 CG15395 GGAGAGCTTTGCATCCGCAATAAGTGAGGAGTTTCCCAGACTCCAACAGCATCGTGAGCAGGTGGA 66 FBan0015395 FBgn0031440 CG15395 2 2L CG15395 CG15395 CDMC35854 4 19 5 DAC08-L13 3-CG15591-RA_2 CG15591 GGAATGGGGTCTACGGGCTTGTGGAAGGACATGTCAATGGTCTACCGCATATACCAGCAGTGCTCG 66 FBan0015591 FBgn0037415 Osi8 3 3R Osi8 Osiris 8 "CG15591, CG15591, CG15591, Osiris, Osiris 8" CDMC35854 4 20 5 DAC08-L13 3-CG15591-RA_2 CG15591 GGAATGGGGTCTACGGGCTTGTGGAAGGACATGTCAATGGTCTACCGCATATACCAGCAGTGCTCG 66 FBan0015591 FBgn0037415 Osi8 3 3R Osi8 Osiris 8 "CG15591, CG15591, CG15591, Osiris, Osiris 8" CDMC35855 4 21 5 DAC08-P01 3-CG17111-RA_2 CG17111 GCTGACCAACCAGATCGTAGACCGGAAGACCTACGAGTTCAGAACCCCGTGTACATCTCCACGGTG 66 FBan0017111 FBgn0039048 CG17111 3 3R CG17111 CG17111 CDMC35855 4 22 5 DAC08-P01 3-CG17111-RA_2 CG17111 GCTGACCAACCAGATCGTAGACCGGAAGACCTACGAGTTCAGAACCCCGTGTACATCTCCACGGTG 66 FBan0017111 FBgn0039048 CG17111 3 3R CG17111 CG17111 CDMC35856 4 23 5 DAC08-P13 AutoBlank AutoBlank CDMC35856 4 24 5 DAC08-P13 AutoBlank AutoBlank CDMC35857 4 25 5 DAC09-D02 2-CG14110-RA_2 CG14110 GCCAAGCGAACCTGCAGAAGTCCTAGAGGATGTGCAGAATACGCCGCTCTACGAGATCCTTCAAAAGCA 69 FBan0014110 FBgn0036352 CG14110 3 3L CG14110 CG14110 CDMC35857 4 26 5 DAC09-D02 2-CG14110-RA_2 CG14110 GCCAAGCGAACCTGCAGAAGTCCTAGAGGATGTGCAGAATACGCCGCTCTACGAGATCCTTCAAAAGCA 69 FBan0014110 FBgn0036352 CG14110 3 3L CG14110 CG14110 CDMC35858 4 1 6 DAC09-D14 1-CG14119-RA_1 CG14119 GGGGCGTGCGTATTATCCCTCGTATATGGGACAACCTTATATGGGACAACCGTACATGCCAGGTGCCAT 69 FBan0014119 FBgn0036322 CG14119 3 3L CG14119 CG14119 CDMC35858 4 2 6 DAC09-D14 1-CG14119-RA_1 CG14119 GGGGCGTGCGTATTATCCCTCGTATATGGGACAACCTTATATGGGACAACCGTACATGCCAGGTGCCAT 69 FBan0014119 FBgn0036322 CG14119 3 3L CG14119 CG14119 CDMC35859 4 3 6 DAC09-H02 3-CG14168-RA_2 CG14168 CCGCAGGCGAAACAGAGGATGCAGGTGCAAAAAACTATGCCCAGGTCGACAGCAAGGACATATCCATAT 69 FBan0014168 FBgn0036044 CG14168 3 3L protein binding; GO:0005515; ; GO:0005515 CG14168 CG14168 CDMC35859 4 4 6 DAC09-H02 3-CG14168-RA_2 CG14168 CCGCAGGCGAAACAGAGGATGCAGGTGCAAAAAACTATGCCCAGGTCGACAGCAAGGACATATCCATAT 69 FBan0014168 FBgn0036044 CG14168 3 3L protein binding; GO:0005515; ; GO:0005515 CG14168 CG14168 CDMC35860 4 5 6 DAC09-H14 9-CG14184-RA_1 CG14184 ACGCCCTCTCCAGACTGGTGCAGAATACTGCGATAAACATGATAAACGTTGGAGCCATGGACTGTCACA 69 FBan0014184 FBgn0036932 CG14184 3 3L CG14184 CG14184 anon-WO0118547.633 CDMC35860 4 6 6 DAC09-H14 9-CG14184-RA_1 CG14184 ACGCCCTCTCCAGACTGGTGCAGAATACTGCGATAAACATGATAAACGTTGGAGCCATGGACTGTCACA 69 FBan0014184 FBgn0036932 CG14184 3 3L CG14184 CG14184 anon-WO0118547.633 CDMC35861 4 7 6 DAC09-L02 3-CG14217-RB_2 CG14217 ACGCTACAAGGCCCAAGTACTGCAGACGACACCAAAGGAGCAACAGAAGGAGGTCATTAAGCAGCTGAA 69 FBan0014217 FBgn0031030 Tao-1 X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Tao-1 Tao-1 "CG14217, CG14217, CG14217, CG14217, CG14217, TAO1, AAF48973, dTao-1" CDMC35861 4 8 6 DAC09-L02 3-CG14217-RB_2 CG14217 ACGCTACAAGGCCCAAGTACTGCAGACGACACCAAAGGAGCAACAGAAGGAGGTCATTAAGCAGCTGAA 69 FBan0014217 FBgn0031030 Tao-1 X X JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; induction of apoptosis; GO:0006917; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.- Tao-1 Tao-1 "CG14217, CG14217, CG14217, CG14217, CG14217, TAO1, AAF48973, dTao-1" CDMC35862 4 9 6 DAC09-L14 13-CG14229-RA_1 CG14229 TCCGTGTCTGGAGTCACTTGCGTTTGTGTGATAAGCATTGTTTACTTGCATGGCATTAGCATCACCCCT 69 FBan0014229 FBgn0031059 CG14229 X X CG14229 CG14229 BcDNA:RE31307 CDMC35862 4 10 6 DAC09-L14 13-CG14229-RA_1 CG14229 TCCGTGTCTGGAGTCACTTGCGTTTGTGTGATAAGCATTGTTTACTTGCATGGCATTAGCATCACCCCT 69 FBan0014229 FBgn0031059 CG14229 X X CG14229 CG14229 BcDNA:RE31307 CDMC35863 4 11 6 DAC09-P02 9-CG14277-RA_1 CG14277 GGGCAAGTCCTGCATTCATGCCGAAATCGAGATCACCAAGAACTAGTGACGGAATCCGATCGTTGGTCT 69 FBan0014277 FBgn0032008 CG14277 2 2L CG14277 CG14277 CDMC35863 4 12 6 DAC09-P02 9-CG14277-RA_1 CG14277 GGGCAAGTCCTGCATTCATGCCGAAATCGAGATCACCAAGAACTAGTGACGGAATCCGATCGTTGGTCT 69 FBan0014277 FBgn0032008 CG14277 2 2L CG14277 CG14277 CDMC35864 4 13 6 DAC09-P14 15-CG14297-RA_1 CG14297 CGGCCAAGGCGAATCACTTGACGGAAACAAGCCATAACAACAGTGGCATATATCTGCTAAACACGGAGA 69 FBan0014297 FBgn0038655 CG14297 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737 CG14297 CG14297 LMW-PTP CDMC35864 4 14 6 DAC09-P14 15-CG14297-RA_1 CG14297 CGGCCAAGGCGAATCACTTGACGGAAACAAGCCATAACAACAGTGGCATATATCTGCTAAACACGGAGA 69 FBan0014297 FBgn0038655 CG14297 3 3R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 cytoplasm; GO:0005737 CG14297 CG14297 LMW-PTP CDMC35865 4 15 6 DAC10-D01 2-CG1972-RA_2 CG1972 AGACGTACTGGGAGCGCATGAACCTCAAGTACCCCATATACTTTGCTCTGGGTCTTACCGAGAAGGCCA 69 FBan0001972 FBgn0039691 CG1972 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG1972 CG1972 CDMC35865 4 16 6 DAC10-D01 2-CG1972-RA_2 CG1972 AGACGTACTGGGAGCGCATGAACCTCAAGTACCCCATATACTTTGCTCTGGGTCTTACCGAGAAGGCCA 69 FBan0001972 FBgn0039691 CG1972 3 3R histone mRNA 3'-end processing; GO:0006398; mRNA cleavage; GO:0006379; mRNA polyadenylylation; GO:0006378 poly(A) binding; GO:0008143; ; GO:0008143; endoribonuclease activity; GO:0004521; ; GO:0004521 mRNA cleavage and polyadenylation specificity factor complex; GO:0005847 CG1972 CG1972 CDMC35866 4 17 6 DAC10-D13 2-CG1979-RA_1 CG1979 TGCCGGTGAAACCACCAGTTGAAAAGAGCCTCATCCAACACCTTTTTGACAAGATCTTGGGCCGAGGAA 69 FBan0001979 FBgn0026563 CG1979 3 3R CG1979 CG1979 "BG:DS00464.1, BcDNA:GH19145" CDMC35866 4 18 6 DAC10-D13 2-CG1979-RA_1 CG1979 TGCCGGTGAAACCACCAGTTGAAAAGAGCCTCATCCAACACCTTTTTGACAAGATCTTGGGCCGAGGAA 69 FBan0001979 FBgn0026563 CG1979 3 3R CG1979 CG1979 "BG:DS00464.1, BcDNA:GH19145" CDMC35867 4 19 6 DAC10-H01 12-CG2031-RA_1 CG2031 GCCCCTTATAGGCGAGCCATGGATGAAGGTGGGAAAGAAGATTGGCTTCACCAACGATGAACTTCTCTT 69 FBan0002031 FBgn0037382 Hpr1 3 3R mRNA export from nucleus; GO:0006406; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 nucleoplasm; GO:0005654 Hpr1 Hpr1 "CG2031, CG2031" CDMC35867 4 20 6 DAC10-H01 12-CG2031-RA_1 CG2031 GCCCCTTATAGGCGAGCCATGGATGAAGGTGGGAAAGAAGATTGGCTTCACCAACGATGAACTTCTCTT 69 FBan0002031 FBgn0037382 Hpr1 3 3R mRNA export from nucleus; GO:0006406; signal transduction; GO:0007165 protein binding; GO:0005515; ; GO:0005515 nucleoplasm; GO:0005654 Hpr1 Hpr1 "CG2031, CG2031" CDMC35868 4 21 6 DAC10-H13 23-CG2043-RA_1 CG2043 ACTAGGAACATGAAAGATTGGAGACAGCTAGGTTGAGTTTGGATAATTTCTTACCAGTTGTTTTAAATT 69 FBan0002043 FBgn0002534 Lcp3 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp3 Larval cuticle protein 3 "CG2043, Gene III, LCP3, CP3, III, LCP-3, 3, cuticle p. III, L[[3]]CP3, LcpIII, DMLCP3" CDMC35868 4 22 6 DAC10-H13 23-CG2043-RA_1 CG2043 ACTAGGAACATGAAAGATTGGAGACAGCTAGGTTGAGTTTGGATAATTTCTTACCAGTTGTTTTAAATT 69 FBan0002043 FBgn0002534 Lcp3 2 2R structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 Lcp3 Larval cuticle protein 3 "CG2043, Gene III, LCP3, CP3, III, LCP-3, 3, cuticle p. III, L[[3]]CP3, LcpIII, DMLCP3" CDMC35869 4 23 6 DAC10-L01 14-CG2076-RA_3 CG2076 AGCCGCAGTGAGCAATTAAAATCAGTTGGAAGAAACGCTAGTGCCCCACATAGGAATCCGAATCAAGCA 69 FBan0002076 FBgn0030263 CG2076 X X CG2076 CG2076 CDMC35869 4 24 6 DAC10-L01 14-CG2076-RA_3 CG2076 AGCCGCAGTGAGCAATTAAAATCAGTTGGAAGAAACGCTAGTGCCCCACATAGGAATCCGAATCAAGCA 69 FBan0002076 FBgn0030263 CG2076 X X CG2076 CG2076 CDMC35870 4 25 6 DAC10-L13 22-CG2082-RD_1 CG2082 CGCTACTGAATTTACGCCTCATGCAAATGTTCTGCTTTCCTAAACACTGCTTCCAAAACTACTGCCGGT 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC35870 4 26 6 DAC10-L13 22-CG2082-RD_1 CG2082 CGCTACTGAATTTACGCCTCATGCAAATGTTCTGCTTTCCTAAACACTGCTTCCAAAACTACTGCCGGT 69 FBan0002082 FBgn0027608 CG2082 3 3R cell differentiation; GO:0030154; signal transduction; GO:0007165 CG2082 CG2082 BcDNA:GH02439 CDMC35871 4 1 7 DAC10-P01 3-CG2124-RA_1 CG2124 CCGGCTGGAACAACGTAATCCGCGATAAGGATCGTTTCACCGGCCAAATGGATATGAAGCTAAGGCAGC 69 FBan0002124 FBgn0030217 CG2124 X X CG2124 CG2124 CDMC35871 4 2 7 DAC10-P01 3-CG2124-RA_1 CG2124 CCGGCTGGAACAACGTAATCCGCGATAAGGATCGTTTCACCGGCCAAATGGATATGAAGCTAAGGCAGC 69 FBan0002124 FBgn0030217 CG2124 X X CG2124 CG2124 CDMC35872 4 3 7 DAC10-P13 4-CG2135-RA_1 CG2135 GCGGCAACAAAAAGGGAGTCTTTACAAGGAACCGACAACCCAAAGAAGTGGCTCACATTCTTAGGCGGC 69 FBan0002135 FBgn0039874 CG2135 3 3R carbohydrate metabolism; GO:0005975 beta-glucuronidase activity; GO:0004566 ; EC:3.2.1.31; ; GO:0004566 ; EC:3.2.1.31 CG2135 CG2135 CDMC35872 4 4 7 DAC10-P13 4-CG2135-RA_1 CG2135 GCGGCAACAAAAAGGGAGTCTTTACAAGGAACCGACAACCCAAAGAAGTGGCTCACATTCTTAGGCGGC 69 FBan0002135 FBgn0039874 CG2135 3 3R carbohydrate metabolism; GO:0005975 beta-glucuronidase activity; GO:0004566 ; EC:3.2.1.31; ; GO:0004566 ; EC:3.2.1.31 CG2135 CG2135 CDMC35873 4 5 7 DAC11-D01 9-CG9256-RA_1 CG9256 AGGACGAGGACTTCGATTCCTACGATGACGAGAACATTGTGGTCACCACCTTTACAACACCGGCC 65 FBan0009256 FBgn0040297 Nhe2 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe2 Nhe2 "CG9256, CG9255, DmNHE2, NHE2" CDMC35873 4 6 7 DAC11-D01 9-CG9256-RA_1 CG9256 AGGACGAGGACTTCGATTCCTACGATGACGAGAACATTGTGGTCACCACCTTTACAACACCGGCC 65 FBan0009256 FBgn0040297 Nhe2 2 2L cation transport; GO:0006812; regulation of pH; GO:0006885; sodium ion transport; GO:0006814 sodium:hydrogen antiporter activity; GO:0015385; ; GO:0015385; solute:hydrogen antiporter activity; GO:0015299; ; GO:0015299 integral to membrane; GO:0016021 Nhe2 Nhe2 "CG9256, CG9255, DmNHE2, NHE2" CDMC35874 4 7 7 DAC11-D13 8-CG9281-RB_1 CG9281 CCCCATCTTCTGCTACTTGACGAACCCACCAATCACTTGGACATGGAGACAATCGATGCGCTCGC 65 FBan0009281 FBgn0030672 CG9281 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9281 CG9281 BEST:LD38280 CDMC35874 4 8 7 DAC11-D13 8-CG9281-RB_1 CG9281 CCCCATCTTCTGCTACTTGACGAACCCACCAATCACTTGGACATGGAGACAATCGATGCGCTCGC 65 FBan0009281 FBgn0030672 CG9281 X X transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; nucleotide binding; GO:0000166; ; GO:0042626; ; GO:0005215; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190 CG9281 CG9281 BEST:LD38280 CDMC35875 4 9 7 DAC11-H01 2-CG9377-RA_2 CG9377 GATTGTGGTCATCTGTCTTCTAGGCTCCCTAGTGCCCTCCATAGCGGCATCCAAAGTCTGCGGAC 65 FBan0009377 FBgn0032507 CG9377 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG9377 CG9377 "SPH166, c-SPH166" CDMC35875 4 10 7 DAC11-H01 2-CG9377-RA_2 CG9377 GATTGTGGTCATCTGTCTTCTAGGCTCCCTAGTGCCCTCCATAGCGGCATCCAAAGTCTGCGGAC 65 FBan0009377 FBgn0032507 CG9377 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4 CG9377 CG9377 "SPH166, c-SPH166" CDMC35876 4 11 7 DAC11-H13 15-CG9401-RA_5 CG9401 GAAGCAATCATGTCCACGGAGGACTTTTACCTACGCTACTACGTCGGACACAAGGGCAAGTTCGG 65 FBan0009401 FBgn0002736 mago 2 2R cell-cell signaling; GO:0007267; mRNA export from nucleus; GO:0006406; maintenance of pole plasm mRNA localization; GO:0046594; microtubule cytoskeleton organization and biogenesis; GO:0000226; oocyte axis determination; GO:0007309; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317; sex determination; GO:0007530 cytoplasm; GO:0005737; nucleus; GO:0005634; pole plasm; GO:0045495 mago mago nashi "CG9401, mgn, l(2)57Ca, Dm MGN, MGN, DmMago, mago-nashi, Mago nashi, Magoh" CDMC35876 4 12 7 DAC11-H13 15-CG9401-RA_5 CG9401 GAAGCAATCATGTCCACGGAGGACTTTTACCTACGCTACTACGTCGGACACAAGGGCAAGTTCGG 65 FBan0009401 FBgn0002736 mago 2 2R cell-cell signaling; GO:0007267; mRNA export from nucleus; GO:0006406; maintenance of pole plasm mRNA localization; GO:0046594; microtubule cytoskeleton organization and biogenesis; GO:0000226; oocyte axis determination; GO:0007309; oocyte microtubule cytoskeleton organization; GO:0016325; oocyte microtubule cytoskeleton polarization; GO:0008103; oogenesis (sensu Insecta); GO:0009993; pole plasm assembly (sensu Insecta); GO:0048113; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; pole plasm protein localization; GO:0007318; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317; sex determination; GO:0007530 cytoplasm; GO:0005737; nucleus; GO:0005634; pole plasm; GO:0045495 mago mago nashi "CG9401, mgn, l(2)57Ca, Dm MGN, MGN, DmMago, mago-nashi, Mago nashi, Magoh" CDMC35877 4 13 7 DAC11-L01 17-CG9543-RA_1 CG9543 CTGAGGCAGTTCTATCCCAAGAGCGACTTTGTCACCGATCTAGACAAGAAGTCAGCGGAGTTCGA 65 FBan0009543 FBgn0027496 CG9543 2 2L "intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 CG9543 CG9543 BcDNA:LD29885 CDMC35877 4 14 7 DAC11-L01 17-CG9543-RA_1 CG9543 CTGAGGCAGTTCTATCCCAAGAGCGACTTTGTCACCGATCTAGACAAGAAGTCAGCGGAGTTCGA 65 FBan0009543 FBgn0027496 CG9543 2 2L "intracellular protein transport; GO:0006886; retrograde transport, Golgi to ER; GO:0006890" protein transporter activity; GO:0008565; ; GO:0008565 COPI vesicle coat; GO:0030126 CG9543 CG9543 BcDNA:LD29885 CDMC35878 4 15 7 DAC11-L13 24-CG9572-RA_2 CG9572 GTTTTGTTTTTTATTTTACGTTCTTTATCTGCTGTAGTGCTAGTGTTTTCTAAGAACTGAACCCC 65 FBan0009572 FBgn0031089 CG9572 X X CG9572 CG9572 CT17356 CDMC35878 4 16 7 DAC11-L13 24-CG9572-RA_2 CG9572 GTTTTGTTTTTTATTTTACGTTCTTTATCTGCTGTAGTGCTAGTGTTTTCTAAGAACTGAACCCC 65 FBan0009572 FBgn0031089 CG9572 X X CG9572 CG9572 CT17356 CDMC35879 4 17 7 DAC11-P01 3-CG9649-RA_4 CG9649 CAACCCGTGCCTCAATTGCCACAAGAACCAGAGTTCCAGACGTCAGCCAGACCTTCAGTTCATCC 65 FBan0009649 FBgn0038211 CG9649 3 3R defense response; GO:0006952; proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; enteropeptidase activity; GO:0004275 ; EC:3.4.21.9; ; GO:0004275 ; EC:3.4.21.9; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9649 CG9649 SP55 CDMC35879 4 18 7 DAC11-P01 3-CG9649-RA_4 CG9649 CAACCCGTGCCTCAATTGCCACAAGAACCAGAGTTCCAGACGTCAGCCAGACCTTCAGTTCATCC 65 FBan0009649 FBgn0038211 CG9649 3 3R defense response; GO:0006952; proteolysis; GO:0006508 elastase activity; GO:0042708; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0042708; enteropeptidase activity; GO:0004275 ; EC:3.4.21.9; ; GO:0004275 ; EC:3.4.21.9; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9649 CG9649 SP55 CDMC35880 4 19 7 DAC11-P13 23-CG9686-RA_5 CG9686 CCAGGTCAGTCCAGTATCAGTGGAGTCAACGTTCAGTCTGGTTTTTGTGGATAAAGCCAAAGGAA 65 FBan0009686 FBgn0030158 CG9686 X X CG9686 CG9686 "CT6802, BcDNA:RH74092, anon-EST:Posey3" CDMC35880 4 20 7 DAC11-P13 23-CG9686-RA_5 CG9686 CCAGGTCAGTCCAGTATCAGTGGAGTCAACGTTCAGTCTGGTTTTTGTGGATAAAGCCAAAGGAA 65 FBan0009686 FBgn0030158 CG9686 X X CG9686 CG9686 "CT6802, BcDNA:RH74092, anon-EST:Posey3" CDMC35881 4 21 7 DAC12-D01 3-CG15442-RA_1 CG15442 CCGCCCCGTCATCGTGAAGGCCAAGTACTTCTCTAAGAAGGCTGAGGACAAGATCAAGAAGGCCG 65 FBan0015442 FBgn0010410 RpL27A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL27A Ribosomal protein L27A "CG15442, CG15442, RpL27a, rpL27a, ribosomal protein L27a, RpL27Aa, RpL27Ab, RpL27a2, anon-EST:Posey257" CDMC35881 4 22 7 DAC12-D01 3-CG15442-RA_1 CG15442 CCGCCCCGTCATCGTGAAGGCCAAGTACTTCTCTAAGAAGGCTGAGGACAAGATCAAGAAGGCCG 65 FBan0015442 FBgn0010410 RpL27A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL27A Ribosomal protein L27A "CG15442, CG15442, RpL27a, rpL27a, ribosomal protein L27a, RpL27Aa, RpL27Ab, RpL27a2, anon-EST:Posey257" CDMC35882 4 23 7 DAC12-D13 6-CG15459-RA_3 CG15459 CTTGTCATTAGGTTCTCGCTCGGAGCTATAGGCAGAACACACTCAGCTCTCACCCGGACCCGACC 65 FBan0015459 FBgn0031108 CG15459 X X CG15459 CG15459 CDMC35882 4 24 7 DAC12-D13 6-CG15459-RA_3 CG15459 CTTGTCATTAGGTTCTCGCTCGGAGCTATAGGCAGAACACACTCAGCTCTCACCCGGACCCGACC 65 FBan0015459 FBgn0031108 CG15459 X X CG15459 CG15459 CDMC35883 4 25 7 DAC12-H01 15-CG1553-RC_1 CG1553 GCAAGAAGAAAATCCGTCAAGGAACTGCAACGATAGCGGATTGGATCTCACTGGAGCAGCAGGTG 65 FBan0001553 FBgn0033224 CG1553 2 2R CG1553 CG1553 CDMC35883 4 26 7 DAC12-H01 15-CG1553-RC_1 CG1553 GCAAGAAGAAAATCCGTCAAGGAACTGCAACGATAGCGGATTGGATCTCACTGGAGCAGCAGGTG 65 FBan0001553 FBgn0033224 CG1553 2 2R CG1553 CG1553 CDMC35884 4 1 8 DAC12-H13 2-CG15582-RA_2 CG15582 CCAGGACGAGTGGAAGAGCTTCGATGCCTTCGCCTACTATCCTGTCAATGAACCGATTCCGTGCT 65 FBan0015582 FBgn0046878 Obp83cd 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83cd Odorant-binding protein 83cd "CG15582, CG15582, CG15582, CG15582, CG15582, 83c, 83d, Odorant-binding protein 83c, Odorant-binding protein 83d, 83c-1, 83c-2, Obp83c, Obp83d" CDMC35884 4 2 8 DAC12-H13 2-CG15582-RA_2 CG15582 CCAGGACGAGTGGAAGAGCTTCGATGCCTTCGCCTACTATCCTGTCAATGAACCGATTCCGTGCT 65 FBan0015582 FBgn0046878 Obp83cd 3 3R sensory perception of chemical stimulus; GO:0007606; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp83cd Odorant-binding protein 83cd "CG15582, CG15582, CG15582, CG15582, CG15582, 83c, 83d, Odorant-binding protein 83c, Odorant-binding protein 83d, 83c-1, 83c-2, Obp83c, Obp83d" CDMC35885 4 3 8 DAC12-L01 17-CG15664-RA_1 CG15664 ACGCTCACCCAGATTCGCCTCAAGAAGGACCAAGTTCAGTTGCAGGGACCAAGGGACGCCAATTC 65 FBgn0034610 CDMC35885 4 4 8 DAC12-L01 17-CG15664-RA_1 CG15664 ACGCTCACCCAGATTCGCCTCAAGAAGGACCAAGTTCAGTTGCAGGGACCAAGGGACGCCAATTC 65 FBgn0034610 CDMC35886 4 5 8 DAC12-L13 2-CG15693-RA_1 CG15693 TAAGACTCCTTGTGGTGAGGGTTCCAAGACCTGGGATCGCTTCCAGATGAGAATCCACAAGCGCA 65 FBan0015693 FBgn0019936 RpS20 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS20 Ribosomal protein S20 "CG15693, ribosomal protein S20, anon-EST:Posey111, anon-EST:Posey122, anon-EST:Posey147" CDMC35886 4 6 8 DAC12-L13 2-CG15693-RA_1 CG15693 TAAGACTCCTTGTGGTGAGGGTTCCAAGACCTGGGATCGCTTCCAGATGAGAATCCACAAGCGCA 65 FBan0015693 FBgn0019936 RpS20 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS20 Ribosomal protein S20 "CG15693, ribosomal protein S20, anon-EST:Posey111, anon-EST:Posey122, anon-EST:Posey147" CDMC35887 4 7 8 DAC12-P01 15-CG15780-RA_1 CG15780 GCGCTGCGGACATTAATGGCAATGTCCTCTACGAGCACCTAGTACACCAGCTGTTCGCCACGGAT 65 FBan0015780 FBgn0029776 CG15780 X X "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG15780 CG15780 CDMC35887 4 8 8 DAC12-P01 15-CG15780-RA_1 CG15780 GCGCTGCGGACATTAATGGCAATGTCCTCTACGAGCACCTAGTACACCAGCTGTTCGCCACGGAT 65 FBan0015780 FBgn0029776 CG15780 X X "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG15780 CG15780 CDMC35888 4 9 8 DAC12-P13 18-CG15812-RA_7 CG15812 AGGAGTTCGCGCAAGCCGATCCTCTTATGGAACTAGAAGCTGGTACTGAAATGGACGACGATGAC 65 FBan0015812 FBgn0035405 pfk 3 3L chromatin remodeling; GO:0006338 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 pfk piefke "CG15812, CG15812, CG15812, piefke" CDMC35888 4 10 8 DAC12-P13 18-CG15812-RA_7 CG15812 AGGAGTTCGCGCAAGCCGATCCTCTTATGGAACTAGAAGCTGGTACTGAAATGGACGACGATGAC 65 FBan0015812 FBgn0035405 pfk 3 3L chromatin remodeling; GO:0006338 DNA binding; GO:0003677; ; GO:0003677; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 pfk piefke "CG15812, CG15812, CG15812, piefke" CDMC35889 4 11 8 DAC13-D01 11-CG13039-RA_1 CG13039 AGCAGCACCCAGGATGACGATACAGAGAACCACGTGATTGGTAATTCATCTTCCAGCACCACCTATCGA 69 FBan0013039 FBgn0036609 CG13039 3 3L CG13039 CG13039 BcDNA:AT27312 CDMC35889 4 12 8 DAC13-D01 11-CG13039-RA_1 CG13039 AGCAGCACCCAGGATGACGATACAGAGAACCACGTGATTGGTAATTCATCTTCCAGCACCACCTATCGA 69 FBan0013039 FBgn0036609 CG13039 3 3L CG13039 CG13039 BcDNA:AT27312 CDMC35890 4 13 8 DAC13-D13 15-CG13053-RA_3 CG13053 ACTGGACGGCGTAGTTTGCAGTTTGAACAGAAAATGCGCAATTATCTCTGGTTAGCAGTGCTCCTGGTG 69 FBan0013053 FBgn0040801 CG13053 3 3L CG13053 CG13053 CDMC35890 4 14 8 DAC13-D13 15-CG13053-RA_3 CG13053 ACTGGACGGCGTAGTTTGCAGTTTGAACAGAAAATGCGCAATTATCTCTGGTTAGCAGTGCTCCTGGTG 69 FBan0013053 FBgn0040801 CG13053 3 3L CG13053 CG13053 CDMC35891 4 15 8 DAC13-H01 20-CG13091-RA_1 CG13091 GGATCCTTCGCCTCTTGTATGTCAATCCTAAGGCCGATGCTATAATAGTTCCTGGCGACTATTGTGCCA 69 FBan0013091 FBgn0032055 CG13091 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG13091 CG13091 CT32316 CDMC35891 4 16 8 DAC13-H01 20-CG13091-RA_1 CG13091 GGATCCTTCGCCTCTTGTATGTCAATCCTAAGGCCGATGCTATAATAGTTCCTGGCGACTATTGTGCCA 69 FBan0013091 FBgn0032055 CG13091 2 2L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG13091 CG13091 CT32316 CDMC35892 4 17 8 DAC13-H13 3-CG13102-RA_1 CG13102 GCAGCACTATTGCCATCGCGTCTAGCGTTCTGGGTCTCTTGCTGGTCAAGATGTATGCCTAGTGTGACT 69 FBan0013102 FBgn0032088 CG13102 2 2L CG13102 CG13102 BcDNA:RE57454 CDMC35892 4 18 8 DAC13-H13 3-CG13102-RA_1 CG13102 GCAGCACTATTGCCATCGCGTCTAGCGTTCTGGGTCTCTTGCTGGTCAAGATGTATGCCTAGTGTGACT 69 FBan0013102 FBgn0032088 CG13102 2 2L CG13102 CG13102 BcDNA:RE57454 CDMC35893 4 19 8 DAC13-L01 3-CG13148-RA_4 CG13148 ACCCAAGATGGAGTACGATGGCGATCAAGTTGCGGAGGCTGAACGTACAAACGATAGCAGCCAACATCT 69 FBan0013148 FBgn0033767 CG13148 2 2R CG13148 CG13148 CDMC35893 4 20 8 DAC13-L01 3-CG13148-RA_4 CG13148 ACCCAAGATGGAGTACGATGGCGATCAAGTTGCGGAGGCTGAACGTACAAACGATAGCAGCCAACATCT 69 FBan0013148 FBgn0033767 CG13148 2 2R CG13148 CG13148 CDMC35894 4 21 8 DAC13-L13 24-CG13168-RC_4 CG13168 GCATAGAAGTTAAGAATATTCAAACAAGTGAAATACGCTCAAGAACATTTAATGGAAAAAAAAGCTTCA 69 FBan0013168 FBgn0033705 CG13168 2 2R CG13168 CG13168 CDMC35894 4 22 8 DAC13-L13 24-CG13168-RC_4 CG13168 GCATAGAAGTTAAGAATATTCAAACAAGTGAAATACGCTCAAGAACATTTAATGGAAAAAAAAGCTTCA 69 FBan0013168 FBgn0033705 CG13168 2 2R CG13168 CG13168 CDMC35895 4 23 8 DAC13-P01 13-CG13200-RA_1 CG13200 TGTTGGCCATCGTAGTGATCTGCATACCTACTTACACACTAACCACACAACCATGAGTCGCACACCACT 69 FBan0013200 FBgn0033630 CG13200 2 2R CG13200 CG13200 CDMC35895 4 24 8 DAC13-P01 13-CG13200-RA_1 CG13200 TGTTGGCCATCGTAGTGATCTGCATACCTACTTACACACTAACCACACAACCATGAGTCGCACACCACT 69 FBan0013200 FBgn0033630 CG13200 2 2R CG13200 CG13200 CDMC35896 4 25 8 DAC13-P13 1-CG13214-RA_1 CG13214 TCCGTGATGGGCTCATACTCCTACACAAATCCCGAAGGTGAACTCGTCGAGATCATGTACACGGCGGAT 69 FBan0013214 FBgn0033603 CG13214 2 2R phosphate transport; GO:0006817 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 cytoplasm; GO:0005737 CG13214 CG13214 CDMC35896 4 26 8 DAC13-P13 1-CG13214-RA_1 CG13214 TCCGTGATGGGCTCATACTCCTACACAAATCCCGAAGGTGAACTCGTCGAGATCATGTACACGGCGGAT 69 FBan0013214 FBgn0033603 CG13214 2 2R phosphate transport; GO:0006817 structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 cytoplasm; GO:0005737 CG13214 CG13214 CDMC35897 4 1 9 DAC14-D01 1-CG40174-RA_1 CG40174 CCCCCCAATCCAACCCACTCTACTCGTAACCACTTCAGCCATTCCACCCTCGATGTCCTTCGAAAGTTA 69 FBan0040174 FBgn0058174 CG40174 2 2L CG40174 CG40174 CDMC35897 4 2 9 DAC14-D01 1-CG40174-RA_1 CG40174 CCCCCCAATCCAACCCACTCTACTCGTAACCACTTCAGCCATTCCACCCTCGATGTCCTTCGAAAGTTA 69 FBan0040174 FBgn0058174 CG40174 2 2L CG40174 CG40174 CDMC35898 4 3 9 DAC14-D13 23-CG40188-RB_9 CG40188 GCAAAGTTGGGTCACGTTTATTTTGAAAACCCTACGCACGATTTTTGTACTTACGTACGTAACTATGCG 69 FBgn0058188 CG40188 CG40188 CG40188 CDMC35898 4 4 9 DAC14-D13 23-CG40188-RB_9 CG40188 GCAAAGTTGGGTCACGTTTATTTTGAAAACCCTACGCACGATTTTTGTACTTACGTACGTAACTATGCG 69 FBgn0058188 CG40188 CG40188 CG40188 CDMC35899 4 5 9 DAC14-H01 3-CG40236-RA_2 CG40236 ACCGCTCGTAGGATTAGGTGTTTGGCAGTTTTGACACCTACCTCCCATAGTTCACTCGCTCCGACGGAT 69 FBgn0058236 CG40236 CG40236 CG40236 CDMC35899 4 6 9 DAC14-H01 3-CG40236-RA_2 CG40236 ACCGCTCGTAGGATTAGGTGTTTGGCAGTTTTGACACCTACCTCCCATAGTTCACTCGCTCCGACGGAT 69 FBgn0058236 CG40236 CG40236 CG40236 CDMC35900 4 7 9 DAC14-H13 18-CG40260-RA_1 CG40260 ACACCAATGTCGGAATGATGACGTACCCGTGGTTATCGTCTGGAGCTTTATTCTCTGGAAGTGGGATAT 69 FBgn0058260 CG40260 CG40260 CG40260 CDMC35900 4 8 9 DAC14-H13 18-CG40260-RA_1 CG40260 ACACCAATGTCGGAATGATGACGTACCCGTGGTTATCGTCTGGAGCTTTATTCTCTGGAAGTGGGATAT 69 FBgn0058260 CG40260 CG40260 CG40260 CDMC35901 4 9 9 DAC14-L01 23-CG4030-RA_4 CG4030 TTGGTATCTCCTTGAACTCTATTGCTCTATTTCTGTGCTCCGATACTACGATTACGATCCGAGGTCAAA 69 FBan0004030 FBgn0034585 CG4030 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; Rab GTPase binding; GO:0017137; ; GO:0017137 ubiquitin ligase complex; GO:0000151 CG4030 CG4030 CDMC35901 4 10 9 DAC14-L01 23-CG4030-RA_4 CG4030 TTGGTATCTCCTTGAACTCTATTGCTCTATTTCTGTGCTCCGATACTACGATTACGATCCGAGGTCAAA 69 FBan0004030 FBgn0034585 CG4030 2 2R cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270; Rab GTPase binding; GO:0017137; ; GO:0017137 ubiquitin ligase complex; GO:0000151 CG4030 CG4030 CDMC35902 4 11 9 DAC14-L13 17-CG40338-RA_1 CG40338 TCGTAGAAGCATTCCGAAAGTTCCGAGTACAAATGGGAAATCTGCACAACCCAGATAGACACGGCTAGT 69 FBgn0058338 CG40338 CG40338 CG40338 CDMC35902 4 12 9 DAC14-L13 17-CG40338-RA_1 CG40338 TCGTAGAAGCATTCCGAAAGTTCCGAGTACAAATGGGAAATCTGCACAACCCAGATAGACACGGCTAGT 69 FBgn0058338 CG40338 CG40338 CG40338 CDMC35903 4 13 9 DAC14-P01 10-CG40388-RA_1 CG40388 CAGGGACGAGAATGACCAGATTGACAGAGCTTCCAAGGATTCAGTTGATGAGAGTGCAGAGGGAGTGGT 69 FBgn0058388 CG40388 CG40388 CG40388 CDMC35903 4 14 9 DAC14-P01 10-CG40388-RA_1 CG40388 CAGGGACGAGAATGACCAGATTGACAGAGCTTCCAAGGATTCAGTTGATGAGAGTGCAGAGGGAGTGGT 69 FBgn0058388 CG40388 CG40388 CG40388 CDMC35904 4 15 9 DAC14-P13 15-CG40409-RA_2 CG40409 TGCCCGCCACAGTTCTCATAAACAGAGTGGAGATTAAAGCCACGGTGGATACTGGAGCTTTATTAGCGA 69 FBgn0058409 CG40409 CG40409 CG40409 CDMC35904 4 16 9 DAC14-P13 15-CG40409-RA_2 CG40409 TGCCCGCCACAGTTCTCATAAACAGAGTGGAGATTAAAGCCACGGTGGATACTGGAGCTTTATTAGCGA 69 FBgn0058409 CG40409 CG40409 CG40409 CDMC35905 4 17 9 DAC15-D01 8-CG7298-RA_1 CG7298 GCCCAATTATCGTGAAGGGCTTTCAGGTTGGAACTCAACGGAACAGGAGTAACTGACAACGCGACCCTA 69 FBan0007298 FBgn0036948 CG7298 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7298 CG7298 anon-EST:ParkEST398 CDMC35905 4 18 9 DAC15-D01 8-CG7298-RA_1 CG7298 GCCCAATTATCGTGAAGGGCTTTCAGGTTGGAACTCAACGGAACAGGAGTAACTGACAACGCGACCCTA 69 FBan0007298 FBgn0036948 CG7298 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; structural constituent of peritrophic membrane (sensu Insecta); GO:0016490; ; GO:0016490; ; GO:0008061 extracellular region; GO:0005576 CG7298 CG7298 anon-EST:ParkEST398 CDMC35906 4 19 9 DAC15-D13 4-CG7313-RA_1 CG7313 TGTGCAACCCTCTCTGAAGACTGGAGAAACCACAAATTTCCCCGTTGTCGACGATGACTTTTGCCCAGT 69 FBan0007313 FBgn0036783 CheA75a 3 3L CheA75a CheA75a "CG7313, CG7313, CG7313, CG7313, BcDNA:HL02449" CDMC35906 4 20 9 DAC15-D13 4-CG7313-RA_1 CG7313 TGTGCAACCCTCTCTGAAGACTGGAGAAACCACAAATTTCCCCGTTGTCGACGATGACTTTTGCCCAGT 69 FBan0007313 FBgn0036783 CheA75a 3 3L CheA75a CheA75a "CG7313, CG7313, CG7313, CG7313, BcDNA:HL02449" CDMC35907 4 21 9 DAC15-H01 3-CG7340-RA_6 CG7340 CCACACGGGCAATTCGAATGACTGCTCGCATTGTAGATATGCCCTGCAACGAAATGAACGTGGACCACT 69 FBan0007340 FBgn0040493 granny-smith 3 3R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737 granny-smith granny smith "CG7340, CG7340, CG7340, aminopeptidase, BcDNA:LD41548, l(3)c00064, lethal (3) c00064, granny smith" CDMC35907 4 22 9 DAC15-H01 3-CG7340-RA_6 CG7340 CCACACGGGCAATTCGAATGACTGCTCGCATTGTAGATATGCCCTGCAACGAAATGAACGTGGACCACT 69 FBan0007340 FBgn0040493 granny-smith 3 3R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; aminopeptidase activity; GO:0004177 ; EC:3.4.11.-; ; GO:0004177 ; EC:3.4.11.-; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737 granny-smith granny smith "CG7340, CG7340, CG7340, aminopeptidase, BcDNA:LD41548, l(3)c00064, lethal (3) c00064, granny smith" CDMC35908 4 23 9 DAC15-H13 3-CG7350-RA_2 CG7350 GTGGCTGGACAAAATCGGAACTGCGACGAGTTGACCCGGAGATGTGAACGCTGTGTGGAAACATTGAAT 69 FBan0007350 FBgn0004591 Eig71Ed 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ed Ecdysone-induced gene 71Ed "CG7350, gene IV, IV: transcript group IV, Gene IV, 71E-Gene-IV, L71-4, L71, BcDNA:LP04160, gene-IV, IV" CDMC35908 4 24 9 DAC15-H13 3-CG7350-RA_2 CG7350 GTGGCTGGACAAAATCGGAACTGCGACGAGTTGACCCGGAGATGTGAACGCTGTGTGGAAACATTGAAT 69 FBan0007350 FBgn0004591 Eig71Ed 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ed Ecdysone-induced gene 71Ed "CG7350, gene IV, IV: transcript group IV, Gene IV, 71E-Gene-IV, L71-4, L71, BcDNA:LP04160, gene-IV, IV" CDMC35909 4 25 9 DAC15-L01 17-CG7380-RA_1 CG7380 GGTGCGAGGAGTTCTTGTAAGAGGTGGACACACAAGCCATCCGAGTAATTCGATCAAAAGGAATCTGCT 69 FBan0007380 FBgn0031977 CG7380 2 2L biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG7380 CG7380 anon-WO0172774.178 CDMC35909 4 26 9 DAC15-L01 17-CG7380-RA_1 CG7380 GGTGCGAGGAGTTCTTGTAAGAGGTGGACACACAAGCCATCCGAGTAATTCGATCAAAAGGAATCTGCT 69 FBan0007380 FBgn0031977 CG7380 2 2L biological process unknown; GO:0000004 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG7380 CG7380 anon-WO0172774.178 CDMC35910 4 1 10 DAC15-L13 17-CG7387-RA_5 CG7387 GGATCTGTATGCGGATGATCAGTCAATATCAGTTCAGGACCACGAAACCAGCCTACTATCCAGATCGCC 69 FBan0007387 FBgn0035852 CG7387 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG7387 CG7387 anon-WO0140519.72 CDMC35910 4 2 10 DAC15-L13 17-CG7387-RA_5 CG7387 GGATCTGTATGCGGATGATCAGTCAATATCAGTTCAGGACCACGAAACCAGCCTACTATCCAGATCGCC 69 FBan0007387 FBgn0035852 CG7387 3 3L defense response; GO:0006952; protein folding; GO:0006457; protein metabolism; GO:0019538; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG7387 CG7387 anon-WO0140519.72 CDMC35911 4 3 10 DAC15-P01 2-CG7438-RA_1 CG7438 CCGGACGTAAGGTGGAGGCTAAACTGCATCGTATGTTCGATTTCTGGCGAGCCAACATGATCCTGCACA 69 FBan0007438 FBgn0011673 Myo31DF 2 2L intracellular protein transport; GO:0006886; mesoderm development; GO:0007498; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasm; GO:0005737; myosin; GO:0016459 Myo31DF Myosin 31DF "CG7438, CG7438, CG7438, myosin I, DroMIA, myosin-IA, myosin 1a, IA, Myo1A, myosin IA, MYOIA, DmIA, Dm IA, Myo-IA, Myosin-IA" CDMC35911 4 4 10 DAC15-P01 2-CG7438-RA_1 CG7438 CCGGACGTAAGGTGGAGGCTAAACTGCATCGTATGTTCGATTTCTGGCGAGCCAACATGATCCTGCACA 69 FBan0007438 FBgn0011673 Myo31DF 2 2L intracellular protein transport; GO:0006886; mesoderm development; GO:0007498; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; ; GO:0005524; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" cytoplasm; GO:0005737; myosin; GO:0016459 Myo31DF Myosin 31DF "CG7438, CG7438, CG7438, myosin I, DroMIA, myosin-IA, myosin 1a, IA, Myo1A, myosin IA, MYOIA, DmIA, Dm IA, Myo-IA, Myosin-IA" CDMC35912 4 5 10 DAC15-P13 14-CG7448-RA_1 CG7448 GGGTTAGACTCCAGGTATGAAGAACCATTCCTAAATTTCACCACTCCACAACGTCACGGCAACTGGGCT 69 FBan0007448 FBgn0037143 CG7448 3 3L organic cation porter activity; GO:0008513; ; GO:0008513 CG7448 CG7448 CDMC35912 4 6 10 DAC15-P13 14-CG7448-RA_1 CG7448 GGGTTAGACTCCAGGTATGAAGAACCATTCCTAAATTTCACCACTCCACAACGTCACGGCAACTGGGCT 69 FBan0007448 FBgn0037143 CG7448 3 3L organic cation porter activity; GO:0008513; ; GO:0008513 CG7448 CG7448 CDMC35913 4 7 10 DAC16-D01 3-CG12398-RA_3 CG12398 GCCATGCCAGTGAGTGAGGTGATGGGCTTTTTCAGCACTCGTTATCAGGATCCCCGATTGGATTGG 66 FBan0012398 FBgn0030596 CG12398 X X electron transport; GO:0006118 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 CG12398 CG12398 CDMC35913 4 8 10 DAC16-D01 3-CG12398-RA_3 CG12398 GCCATGCCAGTGAGTGAGGTGATGGGCTTTTTCAGCACTCGTTATCAGGATCCCCGATTGGATTGG 66 FBan0012398 FBgn0030596 CG12398 X X electron transport; GO:0006118 glucose dehydrogenase (acceptor) activity; GO:0004344 ; EC:1.1.99.10; ; GO:0004344 ; EC:1.1.99.10; FAD binding; GO:0050660; ; GO:0050660 CG12398 CG12398 CDMC35914 4 9 10 DAC16-D13 9-CG12609-RB_4 CG12609 GCTGTACAAAATGCATTGGAAGGTTCGCACGGGTCAAAGGTCATTACGTCCTGGACACGATCGCTG 66 FBan0012609 FBgn0030952 CG12609 X X CG12609 CG12609 CDMC35914 4 10 10 DAC16-D13 9-CG12609-RB_4 CG12609 GCTGTACAAAATGCATTGGAAGGTTCGCACGGGTCAAAGGTCATTACGTCCTGGACACGATCGCTG 66 FBan0012609 FBgn0030952 CG12609 X X CG12609 CG12609 CDMC35915 4 11 10 DAC16-H01 3-CG13213-RA_1 CG13213 CTGGACGTACGCAACTGTACACGACTGACGCACGAGAGCCTAATCCGCTTACCTGCCTGGGATATC 66 FBan0013213 FBgn0033609 CG13213 2 2R carbohydrate metabolism; GO:0005975 CG13213 CG13213 CDMC35915 4 12 10 DAC16-H01 3-CG13213-RA_1 CG13213 CTGGACGTACGCAACTGTACACGACTGACGCACGAGAGCCTAATCCGCTTACCTGCCTGGGATATC 66 FBan0013213 FBgn0033609 CG13213 2 2R carbohydrate metabolism; GO:0005975 CG13213 CG13213 CDMC35916 4 13 10 DAC16-H13 2-CG13334-RA_1 CG13334 CCCAAATCTCAAGTGGAAAATGAAAACCCGGAGAAGACCAGCTGTGGGAGTGAGTAGGCAAGCCCT 66 FBan0013334 FBgn0033856 CG13334 2 2R glycolysis; GO:0006096; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-lactate dehydrogenase activity; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27 CG13334 CG13334 NEST:bs27e02 CDMC35916 4 14 10 DAC16-H13 2-CG13334-RA_1 CG13334 CCCAAATCTCAAGTGGAAAATGAAAACCCGGAGAAGACCAGCTGTGGGAGTGAGTAGGCAAGCCCT 66 FBan0013334 FBgn0033856 CG13334 2 2R glycolysis; GO:0006096; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-lactate dehydrogenase activity; GO:0004459 ; EC:1.1.1.27; ; GO:0004459 ; EC:1.1.1.27 CG13334 CG13334 NEST:bs27e02 CDMC35917 4 15 10 DAC16-L01 1-CG13717-RA_1 CG13717 GCAGTCCTTTGATGTAGCCACAAATGCCAATGGGTCCTCTCTGCCAGCGAGTCGGGTGAAAAATCC 66 FBan0013717 FBgn0035562 CG13717 3 3L CG13717 CG13717 CDMC35917 4 16 10 DAC16-L01 1-CG13717-RA_1 CG13717 GCAGTCCTTTGATGTAGCCACAAATGCCAATGGGTCCTCTCTGCCAGCGAGTCGGGTGAAAAATCC 66 FBan0013717 FBgn0035562 CG13717 3 3L CG13717 CG13717 CDMC35918 4 17 10 DAC16-L13 3-CG13894-RA_2 CG13894 AGTTGAAGCCACTAGGATCCTCCCTGTGGATCCCGGACATCGTACAGGACCTAGCCCATCTCTTTC 66 FBan0013894 FBgn0035157 CG13894 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG13894 CG13894 dmCG13894 CDMC35918 4 18 10 DAC16-L13 3-CG13894-RA_2 CG13894 AGTTGAAGCCACTAGGATCCTCCCTGTGGATCCCGGACATCGTACAGGACCTAGCCCATCTCTTTC 66 FBan0013894 FBgn0035157 CG13894 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG13894 CG13894 dmCG13894 CDMC35919 4 19 10 DAC16-P01 8-CG14232-RA_1 CG14232 AGGCACCCATTTCCATTATCGTACCGATCTATCGACGGGAGTGCTACAACGAGGTCTACGTGGGCT 66 FBan0014232 FBgn0031061 CG14232 X X CG14232 CG14232 anon-18DEc CDMC35919 4 20 10 DAC16-P01 8-CG14232-RA_1 CG14232 AGGCACCCATTTCCATTATCGTACCGATCTATCGACGGGAGTGCTACAACGAGGTCTACGTGGGCT 66 FBan0014232 FBgn0031061 CG14232 X X CG14232 CG14232 anon-18DEc CDMC35920 4 21 10 DAC16-P13 AutoBlank AutoBlank CDMC35920 4 22 10 DAC16-P13 AutoBlank AutoBlank CDMC35921 4 23 10 DAC17-D01 5-CG17298-RA_1 CG17298 CCCCACCAGACCCAGACCAATCCCTTCCTGAGCACCATAACCACGATCCCACAATAAAAGTTCATAGCC 69 FBan0017298 FBgn0038879 CG17298 3 3R CG17298 CG17298 "CT35916, BcDNA:RH37844" CDMC35921 4 24 10 DAC17-D01 5-CG17298-RA_1 CG17298 CCCCACCAGACCCAGACCAATCCCTTCCTGAGCACCATAACCACGATCCCACAATAAAAGTTCATAGCC 69 FBan0017298 FBgn0038879 CG17298 3 3R CG17298 CG17298 "CT35916, BcDNA:RH37844" CDMC35922 4 25 10 DAC17-D13 9-CG17319-RA_2 CG17319 GCGAAAGGCCACAAAAAGAAACCATCGCTGAGCATCAAGAAGATGACCTACAGTACCAAACACGCGGCA 69 FBan0017319 FBgn0038119 CG17319 3 3R CG17319 CG17319 CT38314 CDMC35922 4 26 10 DAC17-D13 9-CG17319-RA_2 CG17319 GCGAAAGGCCACAAAAAGAAACCATCGCTGAGCATCAAGAAGATGACCTACAGTACCAAACACGCGGCA 69 FBan0017319 FBgn0038119 CG17319 3 3R CG17319 CG17319 CT38314 CDMC35923 4 1 11 DAC17-H01 3-CG17361-RA_3 CG17361 CCTGCTAGACATCTACGACAACAAGAGCTTGGGGGACAGACTGAGCGACGATCTACAGCGAACCAAGGA 69 FBan0017361 FBgn0036395 CG17361 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17361 CG17361 CDMC35923 4 2 11 DAC17-H01 3-CG17361-RA_3 CG17361 CCTGCTAGACATCTACGACAACAAGAGCTTGGGGGACAGACTGAGCGACGATCTACAGCGAACCAAGGA 69 FBan0017361 FBgn0036395 CG17361 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17361 CG17361 CDMC35924 4 3 11 DAC17-H13 23-CG17377-RA_3 CG17377 GAACCCATGTGCAATTCGTCAGACGGTCTTGATTTAAACACAAAATCATATGTTGGTATCTGGAATCTA 69 FBan0017377 FBgn0031859 CG17377 2 2L CG17377 CG17377 "anon-WO0140519.32, BEST:LP06279" CDMC35924 4 4 11 DAC17-H13 23-CG17377-RA_3 CG17377 GAACCCATGTGCAATTCGTCAGACGGTCTTGATTTAAACACAAAATCATATGTTGGTATCTGGAATCTA 69 FBan0017377 FBgn0031859 CG17377 2 2L CG17377 CG17377 "anon-WO0140519.32, BEST:LP06279" CDMC35925 4 5 11 DAC17-L01 3-CG1743-RB_1 CG1743 ACCACCTTTTGATCCACTGATCCAATGACCCACGAACAACCCGATCAACTGAACACCGAACGCGAAGTT 69 FBan0001743 FBgn0001145 Gs2 X X glutamate catabolism; GO:0006538; glutamine biosynthesis; GO:0006542; neurotransmitter receptor metabolism; GO:0045213; nitrogen fixation; GO:0009399; synaptogenesis; GO:0007416 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2 cytoplasm; GO:0005737 Gs2 Glutamine synthetase 2 "CG1743, CG1743, GsII, GS2, gs-c, cytoplasmic glutamine synthetase, Glutamate-ammonia ligase, gs2" CDMC35925 4 6 11 DAC17-L01 3-CG1743-RB_1 CG1743 ACCACCTTTTGATCCACTGATCCAATGACCCACGAACAACCCGATCAACTGAACACCGAACGCGAAGTT 69 FBan0001743 FBgn0001145 Gs2 X X glutamate catabolism; GO:0006538; glutamine biosynthesis; GO:0006542; neurotransmitter receptor metabolism; GO:0045213; nitrogen fixation; GO:0009399; synaptogenesis; GO:0007416 glutamate-ammonia ligase activity; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2; ; GO:0004356 ; EC:6.3.1.2 cytoplasm; GO:0005737 Gs2 Glutamine synthetase 2 "CG1743, CG1743, GsII, GS2, gs-c, cytoplasmic glutamine synthetase, Glutamate-ammonia ligase, gs2" CDMC35926 4 7 11 DAC17-L13 17-CG1746-RA_2 CG1746 AGATGCGGTGGATCGTTGAGCTCAGCAACTTTTCGATTTTATTGTGGCGCGTACTGAAAGTCTACGTTT 69 FBan0001746 FBgn0039830 CG1746 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG1746 CG1746 anon-EST:Posey224 CDMC35926 4 8 11 DAC17-L13 17-CG1746-RA_2 CG1746 AGATGCGGTGGATCGTTGAGCTCAGCAACTTTTCGATTTTATTGTGGCGCGTACTGAAAGTCTACGTTT 69 FBan0001746 FBgn0039830 CG1746 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, coupling factor F(o) (sensu Eukaryota); GO:0000276" CG1746 CG1746 anon-EST:Posey224 CDMC35927 4 9 11 DAC17-P01 9-CG1750-RA_1 CG1750 TCGAGATCCCTCATAATCGGATGTGCTCAGCAGAGTCAGTTGGAAGTGCTTCAGTTACGCGTGGAAGGT 69 FBan0001750 FBgn0039836 CG1750 3 3R biosynthesis; GO:0009058; protein biosynthesis; GO:0006412; tRNA metabolism; GO:0006399 nucleic acid binding; GO:0003676; ; GO:0003676; methionyl-tRNA formyltransferase activity; GO:0004479 ; EC:2.1.2.9; ; GO:0004479 ; EC:2.1.2.9 CG1750 CG1750 CDMC35927 4 10 11 DAC17-P01 9-CG1750-RA_1 CG1750 TCGAGATCCCTCATAATCGGATGTGCTCAGCAGAGTCAGTTGGAAGTGCTTCAGTTACGCGTGGAAGGT 69 FBan0001750 FBgn0039836 CG1750 3 3R biosynthesis; GO:0009058; protein biosynthesis; GO:0006412; tRNA metabolism; GO:0006399 nucleic acid binding; GO:0003676; ; GO:0003676; methionyl-tRNA formyltransferase activity; GO:0004479 ; EC:2.1.2.9; ; GO:0004479 ; EC:2.1.2.9 CG1750 CG1750 CDMC35928 4 11 11 DAC17-P13 14-CG17520-RB_1 CG17520 AGCCGTTGTCAAGGACCCAGTTTCTCGAACACCAGCGTTGATTTTTGAGCACGTCAACAACACAGATTT 69 FBan0017520 FBgn0000258 CkIIalpha 3 3L cell proliferation; GO:0008283; circadian rhythm; GO:0007623; eye development (sensu Endopterygota); GO:0007456; frizzled signaling pathway; GO:0007222; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 activity; GO:0004682; ; GO:0004682; ; GO:0004682; ; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004682; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIalpha Casein kinase II alpha subunit "CG17520, CG17520, CK-2, Casein kinase II, CKII, CK-II alpha, CK2, CkII, CKIIalpha, CK2 alpha, NAP1-kinase, CK II, CKIIa, DmCKIIalpha, CK2alpha, Tik, Timekeeper, CKII-alpha, CK-II, CKIIalpha, CK2a, dCKII, casein kinase 2, CK2alpha, CkIIalpha, CKIIalfa, DmCK2alpha, anon-WO02059370.53, Cask-II-a" CDMC35928 4 12 11 DAC17-P13 14-CG17520-RB_1 CG17520 AGCCGTTGTCAAGGACCCAGTTTCTCGAACACCAGCGTTGATTTTTGAGCACGTCAACAACACAGATTT 69 FBan0017520 FBgn0000258 CkIIalpha 3 3L cell proliferation; GO:0008283; circadian rhythm; GO:0007623; eye development (sensu Endopterygota); GO:0007456; frizzled signaling pathway; GO:0007222; intracellular signaling cascade; GO:0007242; locomotor rhythm; GO:0045475; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; casein kinase activity; GO:0004680 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein kinase CK2 activity; GO:0004682; ; GO:0004682; ; GO:0004682; ; GO:0004682; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004682; ; GO:0004680 ; EC:2.7.1.- cytosol; GO:0005829; nucleus; GO:0005634; protein kinase CK2 complex; GO:0005956 CkIIalpha Casein kinase II alpha subunit "CG17520, CG17520, CK-2, Casein kinase II, CKII, CK-II alpha, CK2, CkII, CKIIalpha, CK2 alpha, NAP1-kinase, CK II, CKIIa, DmCKIIalpha, CK2alpha, Tik, Timekeeper, CKII-alpha, CK-II, CKIIalpha, CK2a, dCKII, casein kinase 2, CK2alpha, CkIIalpha, CKIIalfa, DmCK2alpha, anon-WO02059370.53, Cask-II-a" CDMC35929 4 13 11 DAC18-D01 23-CG31312-RA_3 CG31312 CGACGTTTATCTTGAACTAATCTTTCAATTGTGTGGCTTTTCTGGGTTATTTGTCCACTTTGGATTACT 69 FBan0031312 FBgn0051312 CG31312 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31312 CG31312 CDMC35929 4 14 11 DAC18-D01 23-CG31312-RA_3 CG31312 CGACGTTTATCTTGAACTAATCTTTCAATTGTGTGGCTTTTCTGGGTTATTTGTCCACTTTGGATTACT 69 FBan0031312 FBgn0051312 CG31312 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31312 CG31312 CDMC35930 4 15 11 DAC18-D13 8-CG31320-RA_2 CG31320 GCTCAGGGAGCCGAGTCGGAATCTGTGGAAGTACTACCCTCTCTGGCCAAATATATGCCTAGCCTGCTC 69 FBan0031320 FBgn0051320 CG31320 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31320 CG31320 NEST:bs27f03 CDMC35930 4 16 11 DAC18-D13 8-CG31320-RA_2 CG31320 GCTCAGGGAGCCGAGTCGGAATCTGTGGAAGTACTACCCTCTCTGGCCAAATATATGCCTAGCCTGCTC 69 FBan0031320 FBgn0051320 CG31320 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31320 CG31320 NEST:bs27f03 CDMC35931 4 17 11 DAC18-H01 2-CG3135-RA_1 CG3135 CCGGGTGACCAATGATCTGAGGGACACGACGCTGTACAACTTCCTGGTAATCCCATCGGAGGTCAACTA 69 FBgn0029901 CDMC35931 4 18 11 DAC18-H01 2-CG3135-RA_1 CG3135 CCGGGTGACCAATGATCTGAGGGACACGACGCTGTACAACTTCCTGGTAATCCCATCGGAGGTCAACTA 69 FBgn0029901 CDMC35932 4 19 11 DAC18-H13 12-CG31367-RA_5 CG31367 GCCGCAACAATTCGAGACCCCTCTAATTCGATCTGTTTGTCGCATTTCTCTTCTCTTCCGCATGGCTGT 69 FBan0031367 FBgn0051367 CG31367 3 3R "regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 CG31367 CG31367 CG15187 CDMC35932 4 20 11 DAC18-H13 12-CG31367-RA_5 CG31367 GCCGCAACAATTCGAGACCCCTCTAATTCGATCTGTTTGTCGCATTTCTCTTCTCTTCCGCATGGCTGT 69 FBan0031367 FBgn0051367 CG31367 3 3R "regulation of transcription, DNA-dependent; GO:0006355; transcription from RNA polymerase II promoter; GO:0006366" general RNA polymerase II transcription factor activity; GO:0016251; transcription factor activity; GO:0003700; ; GO:0016251; ; GO:0003700 nucleus; GO:0005634 CG31367 CG31367 CG15187 CDMC35933 4 21 11 DAC18-L01 3-CG31407-RA_4 CG31407 GGGACGGGATATAGACCAGTATGCAGCCGATATACTGGCGGGATATAGTTGCGAGGGTTCTCTGCCCAA 69 FBan0031407 FBgn0051407 CG31407 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31407 CG31407 "NEST:bs35f01, NEST:bs33d08" CDMC35933 4 22 11 DAC18-L01 3-CG31407-RA_4 CG31407 GGGACGGGATATAGACCAGTATGCAGCCGATATACTGGCGGGATATAGTTGCGAGGGTTCTCTGCCCAA 69 FBan0031407 FBgn0051407 CG31407 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31407 CG31407 "NEST:bs35f01, NEST:bs33d08" CDMC35934 4 23 11 DAC18-L13 15-CG31419-RA_1 CG31419 TGGGCAATGCCATCCAAAGAAGGGTAAAACGGGAAATTACAAGCACACAAACCACGTCTATGGACTCCA 69 FBan0031419 FBgn0051419 CG31419 3 3R CG31419 CG31419 CG5329 CDMC35934 4 24 11 DAC18-L13 15-CG31419-RA_1 CG31419 TGGGCAATGCCATCCAAAGAAGGGTAAAACGGGAAATTACAAGCACACAAACCACGTCTATGGACTCCA 69 FBan0031419 FBgn0051419 CG31419 3 3R CG31419 CG31419 CG5329 CDMC35935 4 25 11 DAC18-P01 2-CG31463-RA_1 CG31463 TGTGGAGTGGTGTTCGTCAACAGCATACCCCAAATGTTGGAAACGGCCCAGAATCTGACCACTTGCATT 69 FBan0031463 FBgn0051463 CG31463 3 3R CG31463 CG31463 CG11673 CDMC35935 4 26 11 DAC18-P01 2-CG31463-RA_1 CG31463 TGTGGAGTGGTGTTCGTCAACAGCATACCCCAAATGTTGGAAACGGCCCAGAATCTGACCACTTGCATT 69 FBan0031463 FBgn0051463 CG31463 3 3R CG31463 CG31463 CG11673 CDMC35936 4 1 12 DAC18-P13 23-CG31483-RA_7 CG31483 TTGGTCATCCCCAACTTATGCCAGTTAGTGCTGTGTAAAGTTTTTGGCCTCTTCCAAAAATTAATTAAA 69 FBan0031483 FBgn0046873 Pif2 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Pif2 PFTAIRE-interacting factor 2 "CG31483, bs20e01.y1, PIF-2, BcDNA:AT26658, NEST:bs18a02, NEST:bs20e01, NEST:bs35g11, NEST:bs25a03, NEST:bs19e11" CDMC35936 4 2 12 DAC18-P13 23-CG31483-RA_7 CG31483 TTGGTCATCCCCAACTTATGCCAGTTAGTGCTGTGTAAAGTTTTTGGCCTCTTCCAAAAATTAATTAAA 69 FBan0031483 FBgn0046873 Pif2 3 3R biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 Pif2 PFTAIRE-interacting factor 2 "CG31483, bs20e01.y1, PIF-2, BcDNA:AT26658, NEST:bs18a02, NEST:bs20e01, NEST:bs35g11, NEST:bs25a03, NEST:bs19e11" CDMC35937 4 3 12 DAC19-D01 2-CG6048-RA_4 CG6048 GTACTGTACCCACTGGACATCCGACCATTCGTCCAATTGCCCTCAATCGGTTTGCCATACCGGAG 65 FBan0006048 FBgn0029827 CG6048 X X defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6048 CG6048 SP108 CDMC35937 4 4 12 DAC19-D01 2-CG6048-RA_4 CG6048 GTACTGTACCCACTGGACATCCGACCATTCGTCCAATTGCCCTCAATCGGTTTGCCATACCGGAG 65 FBan0006048 FBgn0029827 CG6048 X X defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6048 CG6048 SP108 CDMC35938 4 5 12 DAC19-D13 5-CG6094-RA_1 CG6094 CTTCTGGGTCGTCAGCTCTCCTACAAGAGCGATTTATCCCTGGACAAGATCTATCCCGGCGCCCG 65 FBan0006094 FBgn0032261 CG6094 2 2L CG6094 CG6094 CDMC35938 4 6 12 DAC19-D13 5-CG6094-RA_1 CG6094 CTTCTGGGTCGTCAGCTCTCCTACAAGAGCGATTTATCCCTGGACAAGATCTATCCCGGCGCCCG 65 FBan0006094 FBgn0032261 CG6094 2 2L CG6094 CG6094 CDMC35939 4 7 12 DAC19-H01 3-CG6196-RA_1 CG6196 GACGAACAACCACGGAATGTACGTTGTGCAGGACAAGGCTTTCCGCTTTCTGACTCGCATCTCGC 65 FBan0006196 FBgn0038323 CG6196 3 3R CG6196 CG6196 BcDNA:RH37427 CDMC35939 4 8 12 DAC19-H01 3-CG6196-RA_1 CG6196 GACGAACAACCACGGAATGTACGTTGTGCAGGACAAGGCTTTCCGCTTTCTGACTCGCATCTCGC 65 FBan0006196 FBgn0038323 CG6196 3 3R CG6196 CG6196 BcDNA:RH37427 CDMC35940 4 9 12 DAC19-H13 2-CG6216-RA_1 CG6216 TTGCGGCGACTTCAATTACGATCTGTACATTCGGGTTGAGGCCAGGGTGATTAAGCCGAAACCGG 65 FBan0006216 FBgn0036139 CG6216 3 3L CG6216 CG6216 CDMC35940 4 10 12 DAC19-H13 2-CG6216-RA_1 CG6216 TTGCGGCGACTTCAATTACGATCTGTACATTCGGGTTGAGGCCAGGGTGATTAAGCCGAAACCGG 65 FBan0006216 FBgn0036139 CG6216 3 3L CG6216 CG6216 CDMC35941 4 11 12 DAC19-L01 1-CG6335-RA_1 CG6335 ATGAACAAGATCTCGAGCATCAAGCGCTACCACATCGCCAAGGTCTATCGACGCGACAATCCGGC 65 FBgn0030934 CDMC35941 4 12 12 DAC19-L01 1-CG6335-RA_1 CG6335 ATGAACAAGATCTCGAGCATCAAGCGCTACCACATCGCCAAGGTCTATCGACGCGACAATCCGGC 65 FBgn0030934 CDMC35942 4 13 12 DAC19-L13 23-CG6361-RA_2 CG6361 ACGCACTCAATAAACGACATCGATACGTAGACGTACTACTCCCTTATCAGAGACCGAAAAAAGGT 65 FBan0006361 FBgn0030925 CG6361 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6361 CG6361 "c-SP31, SP31" CDMC35942 4 14 12 DAC19-L13 23-CG6361-RA_2 CG6361 ACGCACTCAATAAACGACATCGATACGTAGACGTACTACTCCCTTATCAGAGACCGAAAAAAGGT 65 FBan0006361 FBgn0030925 CG6361 X X proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG6361 CG6361 "c-SP31, SP31" CDMC35943 4 15 12 DAC19-P01 15-CG6452-RA_1 CG6452 AGCCCGGACTACTCGGTCTCCAGCGAACTGAACAAGGAGTACTACACCTTCGAGGCTGACGAGAG 65 FBan0006452 FBgn0039438 CG6452 3 3R CG6452 CG6452 CDMC35943 4 16 12 DAC19-P01 15-CG6452-RA_1 CG6452 AGCCCGGACTACTCGGTCTCCAGCGAACTGAACAAGGAGTACTACACCTTCGAGGCTGACGAGAG 65 FBan0006452 FBgn0039438 CG6452 3 3R CG6452 CG6452 CDMC35944 4 17 12 DAC19-P13 12-CG6474-RA_1 CG6474 GTGGTGACCATTCCCAAGCCCGTCATCAAGTTTACCACCACTACGACAACGAAAACGGTGGGCAG 65 FBan0006474 FBgn0000617 e(y)1 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0016251; ; GO:0016563; ; GO:0003677 SAGA complex; GO:0000124; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 e(y)1 enhancer of yellow 1 "CG6474, CG6474, e(y)[1], TAFII40, TAF42, dTAF[[II]]40, p42, Taf[[II]]40, Taf42, TAF[[II]]40, dme-TAFII40, dTAF[[II]]42, dTAF42, TAF40, TAF[[II]]40/42, dTAF[[40]], TAF[[II]]42, Taf40, TAF40/42, TAFII40(42), TFIID 42, TAF40/42/e(y)1, d40, TFIID, dTAFII42, TAF9, TAF[II]40, TAF[[II]], taf40/e(y)1, dmTAF9, dmTaf9, dTAF9, TFIID-p42, e(y)4, TBP-associated factor 40kD, enhancer of yellow 4" CDMC35944 4 18 12 DAC19-P13 12-CG6474-RA_1 CG6474 GTGGTGACCATTCCCAAGCCCGTCATCAAGTTTACCACCACTACGACAACGAAAACGGTGGGCAG 65 FBan0006474 FBgn0000617 e(y)1 X X regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003702; transcriptional activator activity; GO:0016563; ; GO:0016251; ; GO:0016563; ; GO:0003677 SAGA complex; GO:0000124; nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 e(y)1 enhancer of yellow 1 "CG6474, CG6474, e(y)[1], TAFII40, TAF42, dTAF[[II]]40, p42, Taf[[II]]40, Taf42, TAF[[II]]40, dme-TAFII40, dTAF[[II]]42, dTAF42, TAF40, TAF[[II]]40/42, dTAF[[40]], TAF[[II]]42, Taf40, TAF40/42, TAFII40(42), TFIID 42, TAF40/42/e(y)1, d40, TFIID, dTAFII42, TAF9, TAF[II]40, TAF[[II]], taf40/e(y)1, dmTAF9, dmTaf9, dTAF9, TFIID-p42, e(y)4, TBP-associated factor 40kD, enhancer of yellow 4" CDMC35945 4 19 12 DAC20-D01 3-CG30085-RA_1 CG30085 TAAGACCAACGTGCTAGAGACTCTGTCGGAGAACCACTCCAAGGATTTCCTGGACCACGCTGTGC 65 FBan0030085 FBgn0050085 CG30085 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30085 CG30085 BcDNA:LD22218 CDMC35945 4 20 12 DAC20-D01 3-CG30085-RA_1 CG30085 TAAGACCAACGTGCTAGAGACTCTGTCGGAGAACCACTCCAAGGATTTCCTGGACCACGCTGTGC 65 FBan0030085 FBgn0050085 CG30085 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30085 CG30085 BcDNA:LD22218 CDMC35946 4 21 12 DAC20-D13 3-CG30120-RA_5 CG30120 CCCAAGTCTACATACGCGGACGAACAGGACACGACTCTTGCCAAGGTGGAGAAAATCCAGGGCTA 65 FBan0030120 FBgn0050120 CG30120 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30120 CG30120 CDMC35946 4 22 12 DAC20-D13 3-CG30120-RA_5 CG30120 CCCAAGTCTACATACGCGGACGAACAGGACACGACTCTTGCCAAGGTGGAGAAAATCCAGGGCTA 65 FBan0030120 FBgn0050120 CG30120 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30120 CG30120 CDMC35947 4 23 12 DAC20-H01 8-CG30266-RA_1 CG30266 CGCACGCCGCTTCATTACGCAGCCACAATTAAGGACAACGGCCATTTCTACAACATGCTCCTGCA 65 FBan0030266 FBgn0050266 CG30266 2 2R CG30266 CG30266 CG13528 CDMC35947 4 24 12 DAC20-H01 8-CG30266-RA_1 CG30266 CGCACGCCGCTTCATTACGCAGCCACAATTAAGGACAACGGCCATTTCTACAACATGCTCCTGCA 65 FBan0030266 FBgn0050266 CG30266 2 2R CG30266 CG30266 CG13528 CDMC35948 4 25 12 DAC20-H13 24-CG30291-RA_1 CG30291 ATGGGGGGTGTTAACTAATGTAACTTTTTTATGGCTGTTTGTTAAAAATAAACTGGTAAATGGAC 65 FBan0030291 FBgn0050291 CG30291 2 2R regulation of cyclin dependent protein kinase activity; GO:0000079 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30291 CG30291 "CG3282, CG3282" CDMC35948 4 26 12 DAC20-H13 24-CG30291-RA_1 CG30291 ATGGGGGGTGTTAACTAATGTAACTTTTTTATGGCTGTTTGTTAAAAATAAACTGGTAAATGGAC 65 FBan0030291 FBgn0050291 CG30291 2 2R regulation of cyclin dependent protein kinase activity; GO:0000079 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30291 CG30291 "CG3282, CG3282" CDMC35949 4 1 13 DAC20-L01 2-CG30390-RA_1 CG30390 CATGTGCTGAGCAAGCGAAAGGTCATCCCACTGCCTCTAATGCGTGCAAATCCTGAGACCGATGG 65 FBan0030390 FBgn0050390 CG30390 2 2R CG30390 CG30390 CG10509 CDMC35949 4 2 13 DAC20-L01 2-CG30390-RA_1 CG30390 CATGTGCTGAGCAAGCGAAAGGTCATCCCACTGCCTCTAATGCGTGCAAATCCTGAGACCGATGG 65 FBan0030390 FBgn0050390 CG30390 2 2R CG30390 CG30390 CG10509 CDMC35950 4 3 13 DAC20-L13 23-CG30419-RA_1 CG30419 GAAACCGCAATCAAAAATTGTAAACAAACACTGGAAATCGAGCGAAATCAACAAAGGAAGTCGAC 65 FBan0030419 FBgn0050419 CG30419 2 2R CG30419 CG30419 "CG13572, CG13573" CDMC35950 4 4 13 DAC20-L13 23-CG30419-RA_1 CG30419 GAAACCGCAATCAAAAATTGTAAACAAACACTGGAAATCGAGCGAAATCAACAAAGGAAGTCGAC 65 FBan0030419 FBgn0050419 CG30419 2 2R CG30419 CG30419 "CG13572, CG13573" CDMC35951 4 5 13 DAC20-P01 3-CG3060-RA_1 CG3060 CTCACGAATCTTGACTCCATGCCAATTGACCGAATCCACCAGATGCTGAAGCTGTTCGCCTCCCA 65 FBan0003060 FBgn0002791 mr 2 2R cell cycle; GO:0007049; mitosis; GO:0007067; mitotic anaphase; GO:0000090; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; regulation of progression through cell cycle; GO:0000074; regulation of synaptic transmission; GO:0050804 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- anaphase-promoting complex; GO:0005680 mr morula "CG3060, CG3060, APC2/mr" CDMC35951 4 6 13 DAC20-P01 3-CG3060-RA_1 CG3060 CTCACGAATCTTGACTCCATGCCAATTGACCGAATCCACCAGATGCTGAAGCTGTTCGCCTCCCA 65 FBan0003060 FBgn0002791 mr 2 2R cell cycle; GO:0007049; mitosis; GO:0007067; mitotic anaphase; GO:0000090; negative regulation of synaptic growth at neuromuscular junction; GO:0045886; regulation of progression through cell cycle; GO:0000074; regulation of synaptic transmission; GO:0050804 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- anaphase-promoting complex; GO:0005680 mr morula "CG3060, CG3060, APC2/mr" CDMC35952 4 7 13 DAC20-P13 1-CG31007-RA_1 CG31007 GCACCGAGGACAACAGCAGTGATCTCTCCGTTTGCAAGGAGTTTAACGAGGCAATGCAGCAGTGT 65 FBan0031007 FBgn0051007 CG31007 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31007 CG31007 CDMC35952 4 8 13 DAC20-P13 1-CG31007-RA_1 CG31007 GCACCGAGGACAACAGCAGTGATCTCTCCGTTTGCAAGGAGTTTAACGAGGCAATGCAGCAGTGT 65 FBan0031007 FBgn0051007 CG31007 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31007 CG31007 CDMC35953 4 9 13 DAC21-D01 3-CG40001-RA_6 CG40001 GGCCAAGATATGAGGCAGTGAGTCGTAGATCATCAGAGCGTCTGCATGAGTTCCGGCCAGTAACGGTG 68 FBgn0058001 CG40001 CG40001 CG40001 CDMC35953 4 10 13 DAC21-D01 3-CG40001-RA_6 CG40001 GGCCAAGATATGAGGCAGTGAGTCGTAGATCATCAGAGCGTCTGCATGAGTTCCGGCCAGTAACGGTG 68 FBgn0058001 CG40001 CG40001 CG40001 CDMC35954 4 11 13 DAC21-D13 1-CG40269-RA_1 CG40269 AGGACTTGACGTGTTCGAAAGGGTCAGTGGAGTCAGTGGTCTTCAAAGATGGTCCTATGCCGAGCGTT 68 FBgn0058269 CG40269 CG40269 CG40269 CDMC35954 4 12 13 DAC21-D13 1-CG40269-RA_1 CG40269 AGGACTTGACGTGTTCGAAAGGGTCAGTGGAGTCAGTGGTCTTCAAAGATGGTCCTATGCCGAGCGTT 68 FBgn0058269 CG40269 CG40269 CG40269 CDMC35955 4 13 13 DAC21-H01 2-CG4445-RA_1 CG4445 ACAACGTCTGCCTGACCTATCGACAGCAAAAGCTGGGTGTGATCAAGATGCTAAAGAACCGCAACGCC 68 FBan0004445 FBgn0027558 pgant3 2 2R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant3 polypeptide GalNAc transferase 3 "CG4445, CG4445, CG4445, CG4445, BcDNA:GH09147, anon-WO0118547.119, polypeptide GalNAc transferase 3" CDMC35955 4 14 13 DAC21-H01 2-CG4445-RA_1 CG4445 ACAACGTCTGCCTGACCTATCGACAGCAAAAGCTGGGTGTGATCAAGATGCTAAAGAACCGCAACGCC 68 FBan0004445 FBgn0027558 pgant3 2 2R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 pgant3 polypeptide GalNAc transferase 3 "CG4445, CG4445, CG4445, CG4445, BcDNA:GH09147, anon-WO0118547.119, polypeptide GalNAc transferase 3" CDMC35956 4 15 13 DAC21-H13 1-CG4558-RA_1 CG4558 CCTTGTCTCTGCGACTTACCCAGTCCTTTGTGCGTGAGTATCGTTTCGATTGCTTTTGTTCCGGGGCC 68 FBan0004558 FBgn0029914 CG4558 X X CG4558 CG4558 CDMC35956 4 16 13 DAC21-H13 1-CG4558-RA_1 CG4558 CCTTGTCTCTGCGACTTACCCAGTCCTTTGTGCGTGAGTATCGTTTCGATTGCTTTTGTTCCGGGGCC 68 FBan0004558 FBgn0029914 CG4558 X X CG4558 CG4558 CDMC35957 4 17 13 DAC21-L01 1-CG5079-RA_2 CG5079 GCATCTCATCAGGAAGTGCAACCGAATAGGGAGGAAAGACGGGTGGTGGGGCAAAAGACCAAACTTCA 68 FBan0005079 FBgn0039346 CG5079 3 3R CG5079 CG5079 CDMC35957 4 18 13 DAC21-L01 1-CG5079-RA_2 CG5079 GCATCTCATCAGGAAGTGCAACCGAATAGGGAGGAAAGACGGGTGGTGGGGCAAAAGACCAAACTTCA 68 FBan0005079 FBgn0039346 CG5079 3 3R CG5079 CG5079 CDMC35958 4 19 13 DAC21-L13 2-CG5182-RA_2 CG5182 GGCTCATCATGCACTCGTCCGTGAGTTTGGGCTTTCCGTCAGTGGACTACGTTTTGCTGGTTATGGAG 68 FBan0005182 FBgn0028410 Pk34A 2 2L intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Pk34A Pk34A "CG5182, CG5182, GSK3a" CDMC35958 4 20 13 DAC21-L13 2-CG5182-RA_2 CG5182 GGCTCATCATGCACTCGTCCGTGAGTTTGGGCTTTCCGTCAGTGGACTACGTTTTGCTGGTTATGGAG 68 FBan0005182 FBgn0028410 Pk34A 2 2L intracellular signaling cascade; GO:0007242; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Pk34A Pk34A "CG5182, CG5182, GSK3a" CDMC35959 4 21 13 DAC21-P01 1-CG5548-RA_1 CG5548 CCGCGGATTCACTGCCACTGCCCCATGTTGCAAGCTAGTTTCCAGCGGAAATGTCAATAAACAACTCC 68 FBan0005548 FBgn0030605 CG5548 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG5548 CG5548 CDMC35959 4 22 13 DAC21-P01 1-CG5548-RA_1 CG5548 CCGCGGATTCACTGCCACTGCCCCATGTTGCAAGCTAGTTTCCAGCGGAAATGTCAATAAACAACTCC 68 FBan0005548 FBgn0030605 CG5548 X X "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG5548 CG5548 CDMC35960 4 23 13 DAC21-P13 13-CG5720-RA_3 CG5720 CGGCCAATGGTCACAAGGACAATAAGGATAAGGGTAAAATCGAGGAAGGCTCAACAACTCCACCGCTG 68 FBan0005720 FBgn0028471 CG5720 3 3R CG5720 CG5720 "clone 1.43, BEST:GH27517, RE28534, BcDNA:LD27873, anon-EST:Liang-1.43" CDMC35960 4 24 13 DAC21-P13 13-CG5720-RA_3 CG5720 CGGCCAATGGTCACAAGGACAATAAGGATAAGGGTAAAATCGAGGAAGGCTCAACAACTCCACCGCTG 68 FBan0005720 FBgn0028471 CG5720 3 3R CG5720 CG5720 "clone 1.43, BEST:GH27517, RE28534, BcDNA:LD27873, anon-EST:Liang-1.43" CDMC35961 4 25 13 DAC22-D01 1-CG40463-RA_1 CG40463 ACACACTCCGAGTGCGTACCATGCAAATGCTTTTGGTGCCGTACATTAGCTTGTCCAGACAGCAGTCAG 69 FBan0040463 FBgn0058463 CG40463 2 2L CG40463 CG40463 CDMC35961 4 26 13 DAC22-D01 1-CG40463-RA_1 CG40463 ACACACTCCGAGTGCGTACCATGCAAATGCTTTTGGTGCCGTACATTAGCTTGTCCAGACAGCAGTCAG 69 FBan0040463 FBgn0058463 CG40463 2 2L CG40463 CG40463 CDMC35962 4 1 14 DAC22-D13 1-CG40484-RA_1 CG40484 ACCAGCTAGAGCAGCATTGGACAGCCAACAAACTTGTCCGCGTTCTAAGAGGTAACCTTCGTCCTGAGA 69 FBgn0069974 CG40484 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40484 CG40484 CDMC35962 4 2 14 DAC22-D13 1-CG40484-RA_1 CG40484 ACCAGCTAGAGCAGCATTGGACAGCCAACAAACTTGTCCGCGTTCTAAGAGGTAACCTTCGTCCTGAGA 69 FBgn0069974 CG40484 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG40484 CG40484 CDMC35963 4 3 14 DAC22-H01 9-CG4071-RB_1 CG4071 AGGCGGTTCTGGTAAGTTGGTGCAATTGAAGCAACAGAGGGATCGTCTGAAGCAGTACCAAAAACGCAT 69 FBan0004071 FBgn0034744 CG4071 2 2R intracellular protein transport; GO:0006886 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 CG4071 CG4071 anon-EST:Posey40 CDMC35963 4 4 14 DAC22-H01 9-CG4071-RB_1 CG4071 AGGCGGTTCTGGTAAGTTGGTGCAATTGAAGCAACAGAGGGATCGTCTGAAGCAGTACCAAAAACGCAT 69 FBan0004071 FBgn0034744 CG4071 2 2R intracellular protein transport; GO:0006886 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 CG4071 CG4071 anon-EST:Posey40 CDMC35964 4 5 14 DAC22-H13 1-CG4084-RA_2 CG4084 GCCGTATGTGCTAGTGCTCAGTGCCTTCACGTCGTATCGGATCCACTCGATATACGTGCTGCGACTGTT 69 FBan0004084 FBgn0011297 l(2)not 2 2R mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0000030 ; EC:2.4.1.- integral to endoplasmic reticulum membrane; GO:0030176 l(2)not lethal (2) neighbor of tid "CG4084, CG4084, cDNA 10F, 1(2) not, lethal(2) neighbor of 1(2)tid, ntid" CDMC35964 4 6 14 DAC22-H13 1-CG4084-RA_2 CG4084 GCCGTATGTGCTAGTGCTCAGTGCCTTCACGTCGTATCGGATCCACTCGATATACGTGCTGCGACTGTT 69 FBan0004084 FBgn0011297 l(2)not 2 2R mannosyltransferase activity; GO:0000030 ; EC:2.4.1.-; ; GO:0000030 ; EC:2.4.1.- integral to endoplasmic reticulum membrane; GO:0030176 l(2)not lethal (2) neighbor of tid "CG4084, CG4084, cDNA 10F, 1(2) not, lethal(2) neighbor of 1(2)tid, ntid" CDMC35965 4 7 14 DAC22-L01 2-CG41073-RA_1 CG41073 CGCCGAAATGGGGACTCGAACAAACAACATCATCGTGGACGTACCCCCATTTTGCACCGGAAACTTCAT 69 FBan0041073 FBgn0069950 CG41073 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41073 CG41073 CG40171 CDMC35965 4 8 14 DAC22-L01 2-CG41073-RA_1 CG41073 CGCCGAAATGGGGACTCGAACAAACAACATCATCGTGGACGTACCCCCATTTTGCACCGGAAACTTCAT 69 FBan0041073 FBgn0069950 CG41073 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41073 CG41073 CG40171 CDMC35966 4 9 14 DAC22-L13 1-CG41090-RA_1 CG41090 ACCCATCGGTACCACGCCTACACTCCCTACCGAAACCCCCTCGATCGTTCCAAGTTCACTATCAATGTT 69 FBgn0069945 CG41090 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41090 CG41090 CDMC35966 4 10 14 DAC22-L13 1-CG41090-RA_1 CG41090 ACCCATCGGTACCACGCCTACACTCCCTACCGAAACCCCCTCGATCGTTCCAAGTTCACTATCAATGTT 69 FBgn0069945 CG41090 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41090 CG41090 CDMC35967 4 11 14 DAC22-P01 12-CG4114-RA_2 CG4114 TTGCTTGCTCCGATCGCTGGACGAAGGGAACTAAAGAATTTCAAGAGTGCCTAGACTTGCCCTCCATCC 69 FBan0004114 FBgn0004583 ex 2 2L imaginal disc development; GO:0007444; negative regulation of imaginal disc growth; GO:0045571; regulation of cell proliferation; GO:0042127; signal transduction; GO:0007165 apical plasma membrane; GO:0016324; cytoskeleton; GO:0005856; zonula adherens; GO:0005915 ex expanded "CG4114, l(2)ey, l(2)k12913, 1270, l(2)01270, brl: braille, braille, expanded" CDMC35967 4 12 14 DAC22-P01 12-CG4114-RA_2 CG4114 TTGCTTGCTCCGATCGCTGGACGAAGGGAACTAAAGAATTTCAAGAGTGCCTAGACTTGCCCTCCATCC 69 FBan0004114 FBgn0004583 ex 2 2L imaginal disc development; GO:0007444; negative regulation of imaginal disc growth; GO:0045571; regulation of cell proliferation; GO:0042127; signal transduction; GO:0007165 apical plasma membrane; GO:0016324; cytoskeleton; GO:0005856; zonula adherens; GO:0005915 ex expanded "CG4114, l(2)ey, l(2)k12913, 1270, l(2)01270, brl: braille, braille, expanded" CDMC35968 4 13 14 DAC22-P13 22-CG4122-RE_1 CG4122 AGGCCTTATATGTAGCCTAACGGTGGAGTCATGGTTAGGGACGTTCAAGAAACTCCCAGTCACATCTAA 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC35968 4 14 14 DAC22-P13 22-CG4122-RE_1 CG4122 AGGCCTTATATGTAGCCTAACGGTGGAGTCATGGTTAGGGACGTTCAAGAAACTCCCAGTCACATCTAA 69 FBan0004122 FBgn0004648 svr X X cuticle biosynthesis (sensu Insecta); GO:0040003; proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; metallocarboxypeptidase D activity; GO:0008472 ; EC:3.4.17.22; carboxypeptidase E activity; GO:0004183 ; EC:3.4.17.10; lysine carboxypeptidase activity; GO:0004184 ; EC:3.4.17.3; ; GO:0004183 ; EC:3.4.17.10; ; GO:0004184 ; EC:3.4.17.3; ; GO:0008472 ; EC:3.4.17.22; ; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 svr silver "CG18503, CG4122, CG32818, CG18503, CG18503, CG4122, CG4122, CG4122, slv, CP, carboxypeptidase, EG:171D11.3, EP(X)0356, CPD, carboxypeptidase D, CpepE, cc: chlorotic, dwp: dwarp, l(1)1Bd, poi: pointed, Carboxypeptidase E, chlorotic, dwarp, pointed" CDMC35969 4 15 14 DAC23-D01 17-CG3337-RA_1 CG3337 TGCGTCACAGCGTTTCCAAACGGACGAGATTTTTTCGGCGAGATCTCTGGAAGTTCGATATAAAGGACT 69 FBan0003337 FBgn0038871 CG3337 3 3R CG3337 CG3337 CDMC35969 4 16 14 DAC23-D01 17-CG3337-RA_1 CG3337 TGCGTCACAGCGTTTCCAAACGGACGAGATTTTTTCGGCGAGATCTCTGGAAGTTCGATATAAAGGACT 69 FBan0003337 FBgn0038871 CG3337 3 3R CG3337 CG3337 CDMC35970 4 17 14 DAC23-D13 15-CG33454-RA_1 CG33454 TGCCCGTATGGTACGGTGGTACTTAACGATTTTCATCGCATTTCACTACCCCTTCCATTTCCCTCTGGA 69 FBan0033454 FBgn0053454 CG33454 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33454 CG33454 CDMC35970 4 18 14 DAC23-D13 15-CG33454-RA_1 CG33454 TGCCCGTATGGTACGGTGGTACTTAACGATTTTCATCGCATTTCACTACCCCTTCCATTTCCCTCTGGA 69 FBan0033454 FBgn0053454 CG33454 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33454 CG33454 CDMC35971 4 19 14 DAC23-H01 3-CG33478-RB_4 CG33478 GGCCATGTTGGAGGTATGCAGCATCGAGGGATGGATCTGCTATTGGTCGCAGTACCTTTTCCACTCGAT 69 FBgn0026387 CDMC35971 4 20 14 DAC23-H01 3-CG33478-RB_4 CG33478 GGCCATGTTGGAGGTATGCAGCATCGAGGGATGGATCTGCTATTGGTCGCAGTACCTTTTCCACTCGAT 69 FBgn0026387 CDMC35972 4 21 14 DAC23-H13 15-CG33482-RA_1 CG33482 GGCGGGCCTACTTCTCATCCGTGGAGAAGTGCTGAAGCTGGGAAAATCTCTTTTTCAGAACGTACTAGA 69 FBan0033482 FBgn0053482 CG33482 2 2L CG33482 CG33482 "CG12636, BG:DS07721.6, DS07721.6-like protein, DS07721.6" CDMC35972 4 22 14 DAC23-H13 15-CG33482-RA_1 CG33482 GGCGGGCCTACTTCTCATCCGTGGAGAAGTGCTGAAGCTGGGAAAATCTCTTTTTCAGAACGTACTAGA 69 FBan0033482 FBgn0053482 CG33482 2 2L CG33482 CG33482 "CG12636, BG:DS07721.6, DS07721.6-like protein, DS07721.6" CDMC35973 4 23 14 DAC23-L01 2-CG3356-RA_3 CG3356 CCCATTGACCTGGAGGATCTAAAGAAGCACTGTGAATACGGCGGTGAATTCTCTCCAGAGCACCCCTCG 69 FBan0003356 FBgn0034989 CG3356 2 2R protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG3356 CG3356 CDMC35973 4 24 14 DAC23-L01 2-CG3356-RA_3 CG3356 CCCATTGACCTGGAGGATCTAAAGAAGCACTGTGAATACGGCGGTGAATTCTCTCCAGAGCACCCCTCG 69 FBan0003356 FBgn0034989 CG3356 2 2R protein metabolism; GO:0019538; protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG3356 CG3356 CDMC35974 4 25 14 DAC23-L13 3-CG3373-RA_2 CG3373 GCCCTTCCGCTACTTGAACAGCGTATATCCGAACAAGTTCTCGCAGCGATTCGTTCACTTCGTGGGACA 69 FBan0003373 FBgn0015737 Hmu 3 3R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mRNA binding; GO:0003729; ; GO:0003729; receptor activity; GO:0004872; NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0004872; ; GO:0004252 ; EC:3.4.21.-; ; GO:0016829 ; EC:4.-.-.-; strictosidine synthase activity; GO:0016844 ; EC:4.3.3.2; ; GO:0016844 ; EC:4.3.3.2 cell surface; GO:0009986 Hmu Hemomucin "CG3373, rrm5, RRM5, hemomucin, SPH210, Rbp5, RNA-binding protein 5" CDMC35974 4 26 14 DAC23-L13 3-CG3373-RA_2 CG3373 GCCCTTCCGCTACTTGAACAGCGTATATCCGAACAAGTTCTCGCAGCGATTCGTTCACTTCGTGGGACA 69 FBan0003373 FBgn0015737 Hmu 3 3R biosynthesis; GO:0009058; carbohydrate metabolism; GO:0005975 mRNA binding; GO:0003729; ; GO:0003729; receptor activity; GO:0004872; NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0004872; ; GO:0004252 ; EC:3.4.21.-; ; GO:0016829 ; EC:4.-.-.-; strictosidine synthase activity; GO:0016844 ; EC:4.3.3.2; ; GO:0016844 ; EC:4.3.3.2 cell surface; GO:0009986 Hmu Hemomucin "CG3373, rrm5, RRM5, hemomucin, SPH210, Rbp5, RNA-binding protein 5" CDMC35975 4 1 15 DAC23-P01 23-CG3419-RB_6 CG3419 TCACAACTTTCGCGATACAAAATACTCTTGTTAAGCTTGACTTCTGTAAACATTCCCAATATGTGCACA 69 FBan0003419 FBgn0035002 CG3419 2 2R CG3419 CG3419 CDMC35975 4 2 15 DAC23-P01 23-CG3419-RB_6 CG3419 TCACAACTTTCGCGATACAAAATACTCTTGTTAAGCTTGACTTCTGTAAACATTCCCAATATGTGCACA 69 FBan0003419 FBgn0035002 CG3419 2 2R CG3419 CG3419 CDMC35976 4 3 15 DAC23-P13 1-CG3434-RA_1 CG3434 TGCAGTGGAGCATGTGCCTTTCTTGGACATAACCGACGAAGCTATCAAGGAGGATTTTACTCCGCCGCT 69 FBan0003434 FBgn0036000 CG3434 3 3L queuosine biosynthesis; GO:0008616; tRNA metabolism; GO:0006399; tRNA modification; GO:0006400 queuine tRNA-ribosyltransferase activity; GO:0008479 ; EC:2.4.2.29; ; GO:0008479 ; EC:2.4.2.29 CG3434 CG3434 CDMC35976 4 4 15 DAC23-P13 1-CG3434-RA_1 CG3434 TGCAGTGGAGCATGTGCCTTTCTTGGACATAACCGACGAAGCTATCAAGGAGGATTTTACTCCGCCGCT 69 FBan0003434 FBgn0036000 CG3434 3 3L queuosine biosynthesis; GO:0008616; tRNA metabolism; GO:0006399; tRNA modification; GO:0006400 queuine tRNA-ribosyltransferase activity; GO:0008479 ; EC:2.4.2.29; ; GO:0008479 ; EC:2.4.2.29 CG3434 CG3434 CDMC35977 4 5 15 DAC24-D01 23-CG33174-RD_3 CG33174 GAACTCACAAGGAATCTAACATTTTGCATACCGATTACCTAAGGAACAACATTTAGCATTAACACACAA 69 FBan0033174 FBgn0053174 CG33174 X X lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG33174 CG33174 "CG11102, CG32630, CG11104, CG15761, CG11096, CG11102, EP(X)1101" CDMC35977 4 6 15 DAC24-D01 23-CG33174-RD_3 CG33174 GAACTCACAAGGAATCTAACATTTTGCATACCGATTACCTAAGGAACAACATTTAGCATTAACACACAA 69 FBan0033174 FBgn0053174 CG33174 X X lipid metabolism; GO:0006629 catalytic activity; GO:0003824; ; GO:0003824; triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG33174 CG33174 "CG11102, CG32630, CG11104, CG15761, CG11096, CG11102, EP(X)1101" CDMC35978 4 7 15 DAC24-D13 23-CG33183-RB_1 CG33183 ACTTAAAATCCTTTCCCTGAATCCAAGCAAAAATATTTACACTAGCTTACATAGAACTGGGACGAGGAC 69 FBan0033183 FBgn0000448 Hr46 2 2R "intracellular signaling cascade; GO:0007242; metamorphosis (sensu Insecta); GO:0046698; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357" ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0005515; ; GO:0003707 nucleus; GO:0005634 Hr46 Hormone receptor-like in 46 "CG11823, CG12208, CG33183, CG11823, CG12208, Dhr3, Hr3, Hormone receptor 3, DHR3, 12.6, dHR3, D, Complementation group D, l(2)k09242, 2.4, HR3, NR1F4, l(2)46CFi" CDMC35978 4 8 15 DAC24-D13 23-CG33183-RB_1 CG33183 ACTTAAAATCCTTTCCCTGAATCCAAGCAAAAATATTTACACTAGCTTACATAGAACTGGGACGAGGAC 69 FBan0033183 FBgn0000448 Hr46 2 2R "intracellular signaling cascade; GO:0007242; metamorphosis (sensu Insecta); GO:0046698; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357" ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0005515; ; GO:0003707 nucleus; GO:0005634 Hr46 Hormone receptor-like in 46 "CG11823, CG12208, CG33183, CG11823, CG12208, Dhr3, Hr3, Hormone receptor 3, DHR3, 12.6, dHR3, D, Complementation group D, l(2)k09242, 2.4, HR3, NR1F4, l(2)46CFi" CDMC35979 4 9 15 DAC24-H01 8-CG33204-RA_1 CG33204 TCCACAAGAGCGTATGGAAGAACCAAAACCGTTGAAAGTCTACTGGCTGCTGAGATCCAAGACAGCGGT 69 FBan0033204 FBgn0053204 CG33204 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33204 CG33204 CDMC35979 4 10 15 DAC24-H01 8-CG33204-RA_1 CG33204 TCCACAAGAGCGTATGGAAGAACCAAAACCGTTGAAAGTCTACTGGCTGCTGAGATCCAAGACAGCGGT 69 FBan0033204 FBgn0053204 CG33204 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33204 CG33204 CDMC35980 4 11 15 DAC24-H13 24-CG33213-RA_2 CG33213 CCAGTAAAATTCGCGTCTTTTTATAAAAAGCAAGCGTAATTAATAACAAAAATAAAATAAGTTCCAAGT 69 FBan0033213 FBgn0053213 CG33213 3 3R biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG33213 CG33213 "CG12260, CG12260, CG12260" CDMC35980 4 12 15 DAC24-H13 24-CG33213-RA_2 CG33213 CCAGTAAAATTCGCGTCTTTTTATAAAAAGCAAGCGTAATTAATAACAAAAATAAAATAAGTTCCAAGT 69 FBan0033213 FBgn0053213 CG33213 3 3R biological process unknown; GO:0000004 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG33213 CG33213 "CG12260, CG12260, CG12260" CDMC35981 4 13 15 DAC24-L01 3-CG33249-RA_3 CG33249 ACGCGCATGGACAACGTGCTCAAGAACATCGGGAAGCGAAAGTATGCCTTCAATCGAACTCAGGTCTCT 69 FBan0033249 FBgn0053249 CG33249 X X phosphoinositide dephosphorylation; GO:0046856 "phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; GO:0016316 ; EC:3.1.3.66; ; GO:0016316 ; EC:3.1.3.66; ; GO:0016316 ; EC:3.1.3.66" CG33249 CG33249 "CG1846, CG1846" CDMC35981 4 14 15 DAC24-L01 3-CG33249-RA_3 CG33249 ACGCGCATGGACAACGTGCTCAAGAACATCGGGAAGCGAAAGTATGCCTTCAATCGAACTCAGGTCTCT 69 FBan0033249 FBgn0053249 CG33249 X X phosphoinositide dephosphorylation; GO:0046856 "phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; GO:0016316 ; EC:3.1.3.66; ; GO:0016316 ; EC:3.1.3.66; ; GO:0016316 ; EC:3.1.3.66" CG33249 CG33249 "CG1846, CG1846" CDMC35982 4 15 15 DAC24-L13 3-CG33261-RC_3 CG33261 CCACGCACTCGATACAACTGCAGCACATGATTCCACAACATCACGACCAAGACCAACTGATTGCCACGA 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC35982 4 16 15 DAC24-L13 3-CG33261-RC_3 CG33261 CCACGCACTCGATACAACTGCAGCACATGATTCCACAACATCACGACCAAGACCAACTGATTGCCACGA 69 FBan0033261 FBgn0013263 Trl 3 3L "cellular physiological process; GO:0050875; dosage compensation; GO:0007549; establishment and/or maintenance of chromatin architecture; GO:0006325; nuclear division; GO:0000280; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; syncytial blastoderm mitotic cell cycle; GO:0035186" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003702; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 centric heterochromatin; GO:0005721; chromatin; GO:0000785; nucleus; GO:0005634 Trl Trithorax-like "CG33261, CG9343, CG13470, CG33261, GAGA factor, GAGA, NC70F, Nc70F, GAGA element, Adf2, transcription-factor-Adh2, Adf-2, GAGA transcription factor, GAF, Gaf, Gaga, E(var)62, trl, TfGAGA/Adf-2, Adf-2-519, E(var)3-trl, Trl-GAGA, anon-EST:fe2E12, l(3)s2325, Adh transcription factor 2, Neural conserved at 70F, anon-fast-evolving-2E12" CDMC35983 4 17 15 DAC24-P01 3-CG3329-RA_2 CG3329 TCTGGTGCTTGGTGGAGTGGATAAGACTGGACCCCACATCTATTCCATTCACCCACATGGAAGTTCGGA 69 FBan0003329 FBgn0023174 Prosbeta2 3 3L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta2 Proteasome beta2 subunit "CG3329, DTS-7, l(3)DTS7, beta2, DTS7, beta2_dm, 20S proteasome, Prosbeta2, 20s proteasome, beta2_dm, anon-EST:fe1E6, anon-EST:fe1G6, anon-fast-evolving-1E6, anon-fast-evolving-1G6" CDMC35983 4 18 15 DAC24-P01 3-CG3329-RA_2 CG3329 TCTGGTGCTTGGTGGAGTGGATAAGACTGGACCCCACATCTATTCCATTCACCCACATGGAAGTTCGGA 69 FBan0003329 FBgn0023174 Prosbeta2 3 3L proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta2 Proteasome beta2 subunit "CG3329, DTS-7, l(3)DTS7, beta2, DTS7, beta2_dm, 20S proteasome, Prosbeta2, 20s proteasome, beta2_dm, anon-EST:fe1E6, anon-EST:fe1G6, anon-fast-evolving-1E6, anon-fast-evolving-1G6" CDMC35984 4 19 15 DAC24-P13 3-CG33311-RA_4 CG33311 CCCAACAGATTTGGCCAGGACAGACAGACCGAAGCAGAACAGAGTCGACTTGAAGAGGACAGGTAGCAG 69 FBan0033311 FBgn0053311 CG33311 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33311 CG33311 CDMC35984 4 20 15 DAC24-P13 3-CG33311-RA_4 CG33311 CCCAACAGATTTGGCCAGGACAGACAGACCGAAGCAGAACAGAGTCGACTTGAAGAGGACAGGTAGCAG 69 FBan0033311 FBgn0053311 CG33311 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33311 CG33311 CDMC35985 4 21 15 DAC25-D01 14-CG10370-RA_2 CG10370 CCTGATGGACAACGAGATCAAGATCATGAAGAGCGAAGTGATACGCATAACGCACGAGATTCAGGCGCA 69 FBan0010370 FBgn0028684 Tbp-1 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ; GO:0004175; ATPase activity; GO:0016887; ; GO:0004175; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Tbp-1 Tat-binding protein-1 "CG10370, l(3)04210, Pros26S, Proteasome 26S regulatory subunit 6A, p50, BcDNA.GH12068, Pros26S-RS6A, DmTBP-1, Dm_Rpt5a, Dm_Rpt5b, dRpt5, Tbp1, Rpt5, tbp-1, anon-WO0153538.8, anon-WO0153538.9, anon-WO0153538.10, BcDNA:GH12068" CDMC35985 4 22 15 DAC25-D01 14-CG10370-RA_2 CG10370 CCTGATGGACAACGAGATCAAGATCATGAAGAGCGAAGTGATACGCATAACGCACGAGATTCAGGCGCA 69 FBan0010370 FBgn0028684 Tbp-1 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ; GO:0004175; ATPase activity; GO:0016887; ; GO:0004175; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Tbp-1 Tat-binding protein-1 "CG10370, l(3)04210, Pros26S, Proteasome 26S regulatory subunit 6A, p50, BcDNA.GH12068, Pros26S-RS6A, DmTBP-1, Dm_Rpt5a, Dm_Rpt5b, dRpt5, Tbp1, Rpt5, tbp-1, anon-WO0153538.8, anon-WO0153538.9, anon-WO0153538.10, BcDNA:GH12068" CDMC35986 4 23 15 DAC25-D13 2-CG10383-RA_3 CG10383 GCCATGTAAAGGTGGTCAGTGTAGCTGAAGGATCCCCTACCATGTTGACCTCGTTCAAGTTCCCCCTGC 69 FBan0010383 FBgn0032699 CG10383 2 2L CG10383 CG10383 CDMC35986 4 24 15 DAC25-D13 2-CG10383-RA_3 CG10383 GCCATGTAAAGGTGGTCAGTGTAGCTGAAGGATCCCCTACCATGTTGACCTCGTTCAAGTTCCCCCTGC 69 FBan0010383 FBgn0032699 CG10383 2 2L CG10383 CG10383 CDMC35987 4 25 15 DAC25-H01 8-CG10420-RA_1 CG10420 AGGCCCAGATCAAGGTGTTCGAAAAGAATTTCGGGTCTCATCTGGCTCAGATTCTGACCAGTTCCGGAA 69 FBan0010420 FBgn0039296 CG10420 3 3R CG10420 CG10420 CDMC35987 4 26 15 DAC25-H01 8-CG10420-RA_1 CG10420 AGGCCCAGATCAAGGTGTTCGAAAAGAATTTCGGGTCTCATCTGGCTCAGATTCTGACCAGTTCCGGAA 69 FBan0010420 FBgn0039296 CG10420 3 3R CG10420 CG10420 CDMC35988 4 1 16 DAC25-H13 23-CG10440-RA_13 CG10440 CGCAGGTGGGGAGAGTGGTCTATGAACAATTCCAAGTGATACAATGTACTGAGAAGGGCAAATGAAAAA 69 FBan0010440 FBgn0034636 CG10440 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10440 CG10440 CDMC35988 4 2 16 DAC25-H13 23-CG10440-RA_13 CG10440 CGCAGGTGGGGAGAGTGGTCTATGAACAATTCCAAGTGATACAATGTACTGAGAAGGGCAAATGAAAAA 69 FBan0010440 FBgn0034636 CG10440 2 2R potassium ion transport; GO:0006813 voltage-gated potassium channel activity; GO:0005249; protein binding; GO:0005515; ; GO:0005249; ; GO:0005515 membrane; GO:0016020; voltage-gated potassium channel complex; GO:0008076 CG10440 CG10440 CDMC35989 4 3 16 DAC25-L01 2-CG10489-RA_1 CG10489 AGGCAGTTGTTTTGGGGCTACTTACCCAGCTTAAAGAGGGCAAGTTCTATGTCGAGGATCCCACGGGTT 69 FBan0010489 FBgn0035644 Pole2 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; epsilon DNA polymerase activity; GO:0003893; ; GO:0003893; ; GO:0003677 epsilon DNA polymerase complex; GO:0008622 Pole2 Pole2 "CG10489, CG10489, CG10489, POLE2" CDMC35989 4 4 16 DAC25-L01 2-CG10489-RA_1 CG10489 AGGCAGTTGTTTTGGGGCTACTTACCCAGCTTAAAGAGGGCAAGTTCTATGTCGAGGATCCCACGGGTT 69 FBan0010489 FBgn0035644 Pole2 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260; DNA-dependent DNA replication; GO:0006261 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; epsilon DNA polymerase activity; GO:0003893; ; GO:0003893; ; GO:0003677 epsilon DNA polymerase complex; GO:0008622 Pole2 Pole2 "CG10489, CG10489, CG10489, POLE2" CDMC35990 4 5 16 DAC25-L13 23-CG1049-RA_3 CG1049 CTTTAATGCTATTGTAAATGGACTTGCTTGCAACTAGTTCGACGGCACACTATAGATGCCCCAGGATCG 69 FBan0001049 FBgn0041342 Cct1 3 3L biosynthesis; GO:0009058; determination of adult life span; GO:0008340; endocytosis; GO:0006897; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development; GO:0001654; oogenesis (sensu Insecta); GO:0009993; phospholipid metabolism; GO:0006644; wing morphogenesis; GO:0007476 choline-phosphate cytidylyltransferase activity; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15 Cct1 CTP:phosphocholine cytidylyltransferase 1 "CG1049, CG1049, CG1049, Cct, CTP:phosphocholine cytidylyltransferase, cct1, Phosphocholine cytidylyltransferase, CT41283, CCT1, CTP:phosphocholine cytidylyltransferase 1" CDMC35990 4 6 16 DAC25-L13 23-CG1049-RA_3 CG1049 CTTTAATGCTATTGTAAATGGACTTGCTTGCAACTAGTTCGACGGCACACTATAGATGCCCCAGGATCG 69 FBan0001049 FBgn0041342 Cct1 3 3L biosynthesis; GO:0009058; determination of adult life span; GO:0008340; endocytosis; GO:0006897; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; eye development; GO:0001654; oogenesis (sensu Insecta); GO:0009993; phospholipid metabolism; GO:0006644; wing morphogenesis; GO:0007476 choline-phosphate cytidylyltransferase activity; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15; ; GO:0004105 ; EC:2.7.7.15 Cct1 CTP:phosphocholine cytidylyltransferase 1 "CG1049, CG1049, CG1049, Cct, CTP:phosphocholine cytidylyltransferase, cct1, Phosphocholine cytidylyltransferase, CT41283, CCT1, CTP:phosphocholine cytidylyltransferase 1" CDMC35991 4 7 16 DAC25-P01 12-CG10536-RA_3 CG10536 GCCGACAGGGCTTGTATGCGGAAAGTGTTTTTCGATTCACAATTTTGCTCCCAGATCGTTTTCCCGACG 69 FBan0010536 FBgn0011241 cbx 2 2R protein modification; GO:0006464; sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 cbx crossbronx "CG10536, ms(2)46C: male sterile(2)46C, Ft1, ms(2)05704, male sterile(2)46C, ms(2)46C" CDMC35991 4 8 16 DAC25-P01 12-CG10536-RA_3 CG10536 GCCGACAGGGCTTGTATGCGGAAAGTGTTTTTCGATTCACAATTTTGCTCCCAGATCGTTTTCCCGACG 69 FBan0010536 FBgn0011241 cbx 2 2R protein modification; GO:0006464; sperm individualization; GO:0007291; spermatid development; GO:0007286; ubiquitin cycle; GO:0006512 ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 cbx crossbronx "CG10536, ms(2)46C: male sterile(2)46C, Ft1, ms(2)05704, male sterile(2)46C, ms(2)46C" CDMC35992 4 9 16 DAC25-P13 17-CG10542-RA_3 CG10542 ACTGAACGACCAGAAAGAAATGAAACTCCTGCTGGATATGTACAAAGGCGTATCGAAGGATCAGCGCGA 69 FBan0010542 FBgn0035637 CG10542 3 3L cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG10542 CG10542 CDMC35992 4 10 16 DAC25-P13 17-CG10542-RA_3 CG10542 ACTGAACGACCAGAAAGAAATGAAACTCCTGCTGGATATGTACAAAGGCGTATCGAAGGATCAGCGCGA 69 FBan0010542 FBgn0035637 CG10542 3 3L cytoskeleton organization and biogenesis; GO:0007010; protein ubiquitination; GO:0016567 structural constituent of cytoskeleton; GO:0005200; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG10542 CG10542 CDMC35993 4 11 16 DAC26-D01 22-CG15296-RA_1 CG15296 TGGCGATGGATCTTTCGAGGATTTAGTCCCATTTGAGAAACCAAAGACCGTAGATAATTTTGCGGGGGA 69 FBan0015296 FBgn0030215 CG15296 X X CG15296 CG15296 BcDNA:AT26906 CDMC35993 4 12 16 DAC26-D01 22-CG15296-RA_1 CG15296 TGGCGATGGATCTTTCGAGGATTTAGTCCCATTTGAGAAACCAAAGACCGTAGATAATTTTGCGGGGGA 69 FBan0015296 FBgn0030215 CG15296 X X CG15296 CG15296 BcDNA:AT26906 CDMC35994 4 13 16 DAC26-D13 15-CG15317-RA_1 CG15317 CTGCAGAAGCACGCATTACCCTTGGATTGGCCAAAATAGAGAGACTGTCCAGTTTTCCGCTGACTTTGT 69 FBan0015317 FBgn0030137 CG15317 X X CG15317 CG15317 CDMC35994 4 14 16 DAC26-D13 15-CG15317-RA_1 CG15317 CTGCAGAAGCACGCATTACCCTTGGATTGGCCAAAATAGAGAGACTGTCCAGTTTTCCGCTGACTTTGT 69 FBan0015317 FBgn0030137 CG15317 X X CG15317 CG15317 CDMC35995 4 15 16 DAC26-H01 23-CG15367-RA_1 CG15367 GTTCTCGCACAAGGATCTTTAGAGAACTGTCTGTTTTTTCCCTTACTTGTAATTTGGTTTTAAGTGTAT 69 FBan0015367 FBgn0040467 Dip1 X X double-stranded DNA binding; GO:0003690; zinc ion binding; GO:0008270; ; GO:0003690; ; GO:0008270 nucleus; GO:0005634 Dip1 Dorsal interacting protein 1 "CG15367, dip1, Dorsal interacting protein 1" CDMC35995 4 16 16 DAC26-H01 23-CG15367-RA_1 CG15367 GTTCTCGCACAAGGATCTTTAGAGAACTGTCTGTTTTTTCCCTTACTTGTAATTTGGTTTTAAGTGTAT 69 FBan0015367 FBgn0040467 Dip1 X X double-stranded DNA binding; GO:0003690; zinc ion binding; GO:0008270; ; GO:0003690; ; GO:0008270 nucleus; GO:0005634 Dip1 Dorsal interacting protein 1 "CG15367, dip1, Dorsal interacting protein 1" CDMC35996 4 17 16 DAC26-H13 3-CG15381-RA_2 CG15381 TCGCTACTCTGGCCATTCTGTAACGGTAAGTGCTCTAGCCCTCTCAGCAGATCTGCCACTTTTTTGGCC 69 FBgn0040716 CDMC35996 4 18 16 DAC26-H13 3-CG15381-RA_2 CG15381 TCGCTACTCTGGCCATTCTGTAACGGTAAGTGCTCTAGCCCTCTCAGCAGATCTGCCACTTTTTTGGCC 69 FBgn0040716 CDMC35997 4 19 16 DAC26-L01 15-CG1542-RA_2 CG1542 AGCCGCGTGAAGGTCACACTGCAACATCGATAGCCGATAGACTTAGGCCAGCAACAATCGATAATTCTT 69 FBan0001542 FBgn0039828 CG1542 3 3R processing of 27S pre-rRNA; GO:0030489 molecular function unknown; GO:0005554; ; GO:0005554 nucleolus; GO:0005730 CG1542 CG1542 CDMC35997 4 20 16 DAC26-L01 15-CG1542-RA_2 CG1542 AGCCGCGTGAAGGTCACACTGCAACATCGATAGCCGATAGACTTAGGCCAGCAACAATCGATAATTCTT 69 FBan0001542 FBgn0039828 CG1542 3 3R processing of 27S pre-rRNA; GO:0030489 molecular function unknown; GO:0005554; ; GO:0005554 nucleolus; GO:0005730 CG1542 CG1542 CDMC35998 4 21 16 DAC26-L13 2-CG15443-RA_2 CG15443 GGGGAGGGAAGTTTTCTGCGAAACAAGATTCGTGCATATGCCAAGGATCACCGTGTTGAGTGCCGCATA 69 FBan0015443 FBgn0031609 CG15443 2 2L CG15443 CG15443 CDMC35998 4 22 16 DAC26-L13 2-CG15443-RA_2 CG15443 GGGGAGGGAAGTTTTCTGCGAAACAAGATTCGTGCATATGCCAAGGATCACCGTGTTGAGTGCCGCATA 69 FBan0015443 FBgn0031609 CG15443 2 2L CG15443 CG15443 CDMC35999 4 23 16 DAC26-P01 12-CG15473-RA_4 CG15473 CCGACTGCGCTGAAATTTGGAAATCATCCGGAATTGGAAAGATTCCCATCACACAGCGGTGATTTGGGT 69 FBan0015473 FBgn0029719 CG15473 X X CG15473 CG15473 CDMC35999 4 24 16 DAC26-P01 12-CG15473-RA_4 CG15473 CCGACTGCGCTGAAATTTGGAAATCATCCGGAATTGGAAAGATTCCCATCACACAGCGGTGATTTGGGT 69 FBan0015473 FBgn0029719 CG15473 X X CG15473 CG15473 CDMC36000 4 25 16 DAC26-P13 15-CG15488-RA_4 CG15488 AGGATGCGGGACAAGAAGCTAACGCTCGAATTGAAGTTGCAATCGTGTGATGAATATGTTGAGCAGCCA 69 FBan0015488 FBgn0032440 CG15488 2 2L CG15488 CG15488 CDMC36000 4 26 16 DAC26-P13 15-CG15488-RA_4 CG15488 AGGATGCGGGACAAGAAGCTAACGCTCGAATTGAAGTTGCAATCGTGTGATGAATATGTTGAGCAGCCA 69 FBan0015488 FBgn0032440 CG15488 2 2L CG15488 CG15488 CDMC36001 4 1 17 DAC27-D01 7-CG9765-RC_1 CG9765 TCGCACTCACCCTCATCACAACACTCATTTGGCATATGGAGCCTTTCCAGAAAGCAGCATGTCCGTAGA 69 FBan0009765 FBgn0026620 tacc 3 3R female meiosis; GO:0007143; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; negative regulation of microtubule depolymerization; GO:0007026; nuclear migration; GO:0007097; pronuclear fusion; GO:0007344; pronuclear migration; GO:0035046; protein localization; GO:0008104 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 astral microtubule; GO:0000235; centrosome; GO:0005813; pericentriolar material; GO:0000242; spindle microtubule; GO:0005876 tacc transforming acidic coiled-coil protein "CG9765, D-TACC, acc, DTACC, TACC, d-tacc, dTACC, dtacc, D-tacc, transforming acidic coiled-coil protein" CDMC36001 4 2 17 DAC27-D01 7-CG9765-RC_1 CG9765 TCGCACTCACCCTCATCACAACACTCATTTGGCATATGGAGCCTTTCCAGAAAGCAGCATGTCCGTAGA 69 FBan0009765 FBgn0026620 tacc 3 3R female meiosis; GO:0007143; microtubule cytoskeleton organization and biogenesis; GO:0000226; mitosis; GO:0007067; mitotic spindle organization and biogenesis; GO:0007052; negative regulation of microtubule depolymerization; GO:0007026; nuclear migration; GO:0007097; pronuclear fusion; GO:0007344; pronuclear migration; GO:0035046; protein localization; GO:0008104 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515 astral microtubule; GO:0000235; centrosome; GO:0005813; pericentriolar material; GO:0000242; spindle microtubule; GO:0005876 tacc transforming acidic coiled-coil protein "CG9765, D-TACC, acc, DTACC, TACC, d-tacc, dTACC, dtacc, D-tacc, transforming acidic coiled-coil protein" CDMC36002 4 3 17 DAC27-D13 18-CG9774-RA_1 CG9774 AGCCACATGCCAGCTAACAACAAACGAATCGAGCAATCAGCAAACCCAGAACTAAGTTAAAGCCACTTT 69 FBan0009774 FBgn0026181 rok X X Rho protein signal transduction; GO:0007266; cell adhesion; GO:0007155; cell cycle; GO:0007049; cell motility; GO:0006928; cytokinesis; GO:0000910; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515 rok Rho-kinase "CG9774, CG9774, Drok, DRhk, DRho-kinase, ROCK1, RhoK, ROCK, ROKalpha/beta, RHO kinase, dRok, DROK, dROK, ROK, drok, Rock, Rok, Rhk, Rho-kinase" CDMC36002 4 4 17 DAC27-D13 18-CG9774-RA_1 CG9774 AGCCACATGCCAGCTAACAACAAACGAATCGAGCAATCAGCAAACCCAGAACTAAGTTAAAGCCACTTT 69 FBan0009774 FBgn0026181 rok X X Rho protein signal transduction; GO:0007266; cell adhesion; GO:0007155; cell cycle; GO:0007049; cell motility; GO:0006928; cytokinesis; GO:0000910; dorsal closure; GO:0007391; establishment of planar polarity; GO:0001736; ommatidial rotation; GO:0016318; protein amino acid phosphorylation; GO:0006468; regulation of axonogenesis; GO:0050770 ATP binding; GO:0005524; diacylglycerol binding; GO:0019992; ; GO:0005524; ; GO:0019992; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674; ; GO:0004674; protein binding; GO:0005515; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0005515 rok Rho-kinase "CG9774, CG9774, Drok, DRhk, DRho-kinase, ROCK1, RhoK, ROCK, ROKalpha/beta, RHO kinase, dRok, DROK, dROK, ROK, drok, Rock, Rok, Rhk, Rho-kinase" CDMC36003 4 5 17 DAC27-H01 23-CG9819-RB_8 CG9819 GGTGGGAGGGAGTCAGCACATACAGTTCGGAACATAGGAATAGTCTCAAGTTCGGCTCAAAGAAGATAA 69 FBan0009819 FBgn0030758 CanA-14F X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 CanA-14F Calcineurin A at 14F "CG9819, CG9819, CG9819, D27, protein phosphatase from PCR fragment D27, CnnA14D, CnnA14D(I), PP2B, canA-14F, PpD27, Protein phosphatase D27, Calcineurin A at 14F" CDMC36003 4 6 17 DAC27-H01 23-CG9819-RB_8 CG9819 GGTGGGAGGGAGTCAGCACATACAGTTCGGAACATAGGAATAGTCTCAAGTTCGGCTCAAAGAAGATAA 69 FBan0009819 FBgn0030758 CanA-14F X X protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0004722 CanA-14F Calcineurin A at 14F "CG9819, CG9819, CG9819, D27, protein phosphatase from PCR fragment D27, CnnA14D, CnnA14D(I), PP2B, canA-14F, PpD27, Protein phosphatase D27, Calcineurin A at 14F" CDMC36004 4 7 17 DAC27-H13 9-CG9837-RA_1 CG9837 AGGCTCCGATGACCCAGTGGACAGATCAGGATCAGTATAATCAGGACGCATTGCTGAAGGTGACCGATA 69 FBan0009837 FBgn0037635 CG9837 3 3R CG9837 CG9837 CDMC36004 4 8 17 DAC27-H13 9-CG9837-RA_1 CG9837 AGGCTCCGATGACCCAGTGGACAGATCAGGATCAGTATAATCAGGACGCATTGCTGAAGGTGACCGATA 69 FBan0009837 FBgn0037635 CG9837 3 3R CG9837 CG9837 CDMC36005 4 9 17 DAC27-L01 23-CG9877-RA_1 CG9877 GCTTCTACGGATAGAAAGTCGAGAAGATGATTAACCCTAAGCCTGTTCAATTCAAATAAACCAAATAAA 69 FBan0009877 FBgn0034819 CG9877 2 2R CG9877 CG9877 BcDNA:RE26296 CDMC36005 4 10 17 DAC27-L01 23-CG9877-RA_1 CG9877 GCTTCTACGGATAGAAAGTCGAGAAGATGATTAACCCTAAGCCTGTTCAATTCAAATAAACCAAATAAA 69 FBan0009877 FBgn0034819 CG9877 2 2R CG9877 CG9877 BcDNA:RE26296 CDMC36006 4 11 17 DAC27-L13 16-CG9886-RA_1 CG9886 GAGACGGTCTTCAGTGACAGCATAAAACGGCAATTAGCTTTCGTCTCCGGTTATGAAATCAGCCTGGAA 69 FBan0009886 FBgn0031428 CG9886 2 2L carbohydrate metabolism; GO:0005975 kinase activity; GO:0016301; carbohydrate kinase activity; GO:0019200; ; GO:0016301; ; GO:0019200 CG9886 CG9886 CDMC36006 4 12 17 DAC27-L13 16-CG9886-RA_1 CG9886 GAGACGGTCTTCAGTGACAGCATAAAACGGCAATTAGCTTTCGTCTCCGGTTATGAAATCAGCCTGGAA 69 FBan0009886 FBgn0031428 CG9886 2 2L carbohydrate metabolism; GO:0005975 kinase activity; GO:0016301; carbohydrate kinase activity; GO:0019200; ; GO:0016301; ; GO:0019200 CG9886 CG9886 CDMC36007 4 13 17 DAC27-P01 14-CG9924-RA_2 CG9924 GCTGTGCGTCAATCTCTCTGTAGAAACAGCAGCCGAAACCCTAATATTAGCTGATCTCCACAGTGCGGA 69 FBan0009924 FBgn0038192 CG9924 3 3R protein binding; GO:0005515; ; GO:0005515 CG9924 CG9924 "CG12537, anon-WO0118547.577, BEST:GM07940" CDMC36007 4 14 17 DAC27-P01 14-CG9924-RA_2 CG9924 GCTGTGCGTCAATCTCTCTGTAGAAACAGCAGCCGAAACCCTAATATTAGCTGATCTCCACAGTGCGGA 69 FBan0009924 FBgn0038192 CG9924 3 3R protein binding; GO:0005515; ; GO:0005515 CG9924 CG9924 "CG12537, anon-WO0118547.577, BEST:GM07940" CDMC36008 4 15 17 DAC27-P13 24-CG9943-RA_1 CG9943 GCAAAACGGTCTTACTATCAACTTCCAGTTGGAAATGTAAATAAATAAATAAATAGAAAATTTAGAGCA 69 FBan0009943 FBgn0029117 Surf1 3 3L cytochrome c oxidase complex assembly; GO:0008535 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; heme transporter activity; GO:0015232; ; GO:0015232 mitochondrial inner membrane; GO:0005743 Surf1 Surfeit 1 "CG9943, CG9943, CG9943, BcDNA:GH23574, Surfeit 1" CDMC36008 4 16 17 DAC27-P13 24-CG9943-RA_1 CG9943 GCAAAACGGTCTTACTATCAACTTCCAGTTGGAAATGTAAATAAATAAATAAATAGAAAATTTAGAGCA 69 FBan0009943 FBgn0029117 Surf1 3 3L cytochrome c oxidase complex assembly; GO:0008535 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; heme transporter activity; GO:0015232; ; GO:0015232 mitochondrial inner membrane; GO:0005743 Surf1 Surfeit 1 "CG9943, CG9943, CG9943, BcDNA:GH23574, Surfeit 1" CDMC36009 4 17 17 DAC28-D01 2-CG11838-RB_2 CG11838 TGCGGCAGCTTACTTTGAAGAGTGCGGAAACTTTAAACACGCCGTTGAACTCTACCATCGGGCCG 65 FBan0011838 FBgn0031262 Oseg3 2 2L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg3 Oseg3 "CG11838, OSEG3" CDMC36009 4 18 17 DAC28-D01 2-CG11838-RB_2 CG11838 TGCGGCAGCTTACTTTGAAGAGTGCGGAAACTTTAAACACGCCGTTGAACTCTACCATCGGGCCG 65 FBan0011838 FBgn0031262 Oseg3 2 2L sensory cilium biogenesis; GO:0035058 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Oseg3 Oseg3 "CG11838, OSEG3" CDMC36010 4 19 17 DAC28-D13 23-CG11875-RA_5 CG11875 GCATCCAGCTTAATGAAGCCATCTACTGCTACGATATATGCACCAATGACTTTGCCTACAACCTA 65 FBan0011875 FBgn0039301 CG11875 3 3R CG11875 CG11875 CDMC36010 4 20 17 DAC28-D13 23-CG11875-RA_5 CG11875 GCATCCAGCTTAATGAAGCCATCTACTGCTACGATATATGCACCAATGACTTTGCCTACAACCTA 65 FBan0011875 FBgn0039301 CG11875 3 3R CG11875 CG11875 CDMC36011 4 21 17 DAC28-H01 3-CG12001-RA_1 CG12001 GCAGGGATTTGGCTTTACCCCCTGGTTCCCTCGATCACAAACTGCTACCAAACAGAGTACGGAGC 65 FBan0012001 FBgn0037265 CG12001 3 3R CG12001 CG12001 CDMC36011 4 22 17 DAC28-H01 3-CG12001-RA_1 CG12001 GCAGGGATTTGGCTTTACCCCCTGGTTCCCTCGATCACAAACTGCTACCAAACAGAGTACGGAGC 65 FBan0012001 FBgn0037265 CG12001 3 3R CG12001 CG12001 CDMC36012 4 23 17 DAC28-H13 15-CG12018-RA_3 CG12018 ACTGCACCGGACACTCTAGCGTGCTACCCGTACATCGAAAGTGATCCCTTCATCCTGCGCGAGTG 65 FBan0012018 FBgn0027903 CG12018 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ; GO:0003676; delta DNA polymerase activity; GO:0003891; ; GO:0003891; ; GO:0003891 delta DNA polymerase complex; GO:0005659; nucleus; GO:0005634 CG12018 CG12018 BcDNA:HL03874 CDMC36012 4 24 17 DAC28-H13 15-CG12018-RA_3 CG12018 ACTGCACCGGACACTCTAGCGTGCTACCCGTACATCGAAAGTGATCCCTTCATCCTGCGCGAGTG 65 FBan0012018 FBgn0027903 CG12018 3 3L DNA repair; GO:0006281; DNA replication; GO:0006260 nucleic acid binding; GO:0003676; ; GO:0003676; delta DNA polymerase activity; GO:0003891; ; GO:0003891; ; GO:0003891 delta DNA polymerase complex; GO:0005659; nucleus; GO:0005634 CG12018 CG12018 BcDNA:HL03874 CDMC36013 4 25 17 DAC28-L01 3-CG12118-RA_1 CG12118 AATTCACCTGCTGTAAGTGTCCCCTGCTTATCCGTGTGCCACTCTTGGAGATCTTCCCGGTACCC 65 FBan0012118 FBgn0030101 CG12118 X X CG12118 CG12118 CDMC36013 4 26 17 DAC28-L01 3-CG12118-RA_1 CG12118 AATTCACCTGCTGTAAGTGTCCCCTGCTTATCCGTGTGCCACTCTTGGAGATCTTCCCGGTACCC 65 FBan0012118 FBgn0030101 CG12118 X X CG12118 CG12118 CDMC36014 4 1 18 DAC28-L13 2-CG12131-RA_2 CG12131 TGGAAACAAGTCGATCCCAGCACCATCCCATCCAGAAGCACAAATCCCGCAAGCAAATAGGCAAC 65 FBan0012131 FBgn0027619 Adam 2 2R ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; ; GO:0003743; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" eukaryotic translation initiation factor 3 complex; GO:0005852; proton-transporting two-sector ATPase complex; GO:0016469 Adam Adam "CG12131, CG12131, CG12131, 5.3, E, Complementation group E, l(2)k13906, l(2)46Cf, l(2)46CFd, eIF3-S1" CDMC36014 4 2 18 DAC28-L13 2-CG12131-RA_2 CG12131 TGGAAACAAGTCGATCCCAGCACCATCCCATCCAGAAGCACAAATCCCGCAAGCAAATAGGCAAC 65 FBan0012131 FBgn0027619 Adam 2 2R ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; translational initiation; GO:0006413 "translation initiation factor activity; GO:0003743; ; GO:0003743; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" eukaryotic translation initiation factor 3 complex; GO:0005852; proton-transporting two-sector ATPase complex; GO:0016469 Adam Adam "CG12131, CG12131, CG12131, 5.3, E, Complementation group E, l(2)k13906, l(2)46Cf, l(2)46CFd, eIF3-S1" CDMC36015 4 3 18 DAC28-P01 14-CG12200-RA_1 CG12200 GTCACTATGTTTCGAGTGCATTGCAACAAGTGTTTCCGTCATCGCAAAACTGATCCAGCCGTGCC 65 FBan0012200 FBgn0031018 CG12200 X X CG12200 CG12200 CDMC36015 4 4 18 DAC28-P01 14-CG12200-RA_1 CG12200 GTCACTATGTTTCGAGTGCATTGCAACAAGTGTTTCCGTCATCGCAAAACTGATCCAGCCGTGCC 65 FBan0012200 FBgn0031018 CG12200 X X CG12200 CG12200 CDMC36016 4 5 18 DAC28-P13 23-CG12250-RB_1 CG12250 ACTTACACCCTGGTTACTTGATATGCGAATACATAGGGGCTCAAATCGACTTTCATACTTGCTGG 65 FBan0012250 FBgn0039345 CG12250 3 3R CG12250 CG12250 BcDNA:AT03213 CDMC36016 4 6 18 DAC28-P13 23-CG12250-RB_1 CG12250 ACTTACACCCTGGTTACTTGATATGCGAATACATAGGGGCTCAAATCGACTTTCATACTTGCTGG 65 FBan0012250 FBgn0039345 CG12250 3 3R CG12250 CG12250 BcDNA:AT03213 CDMC36017 4 7 18 DAC29-D01 12-CG3093-RA_2 CG3093 GCGGGAACAGACCCAACGATACCTTGAGTTCGCCATTTACAAACTAAACACGACCAATGACGCCATCCA 69 FBan0003093 FBgn0000482 dor X X endocytosis; GO:0006897; endosome organization and biogenesis; GO:0007032; endosome to lysosome transport; GO:0008333; eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular protein transport; GO:0006886; ommochrome biosynthesis; GO:0006727; protein targeting to lysosome; GO:0006622; protein ubiquitination; GO:0016567; pteridine biosynthesis; GO:0006728 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; ; GO:0008270 lysosome; GO:0005764; synapse; GO:0045202; ubiquitin ligase complex; GO:0000151 dor deep orange "CG3093, CG3093, dor1, l(1)7, EG:171E4.1, Dor, Deep-orange, l(1)2Be, l(1)2Bw, l(1)76" CDMC36017 4 8 18 DAC29-D01 12-CG3093-RA_2 CG3093 GCGGGAACAGACCCAACGATACCTTGAGTTCGCCATTTACAAACTAAACACGACCAATGACGCCATCCA 69 FBan0003093 FBgn0000482 dor X X endocytosis; GO:0006897; endosome organization and biogenesis; GO:0007032; endosome to lysosome transport; GO:0008333; eye pigment biosynthesis; GO:0006726; eye pigment granule organization and biogenesis; GO:0008057; intracellular protein transport; GO:0006886; ommochrome biosynthesis; GO:0006727; protein targeting to lysosome; GO:0006622; protein ubiquitination; GO:0016567; pteridine biosynthesis; GO:0006728 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005515; ; GO:0008270 lysosome; GO:0005764; synapse; GO:0045202; ubiquitin ligase complex; GO:0000151 dor deep orange "CG3093, CG3093, dor1, l(1)7, EG:171E4.1, Dor, Deep-orange, l(1)2Be, l(1)2Bw, l(1)76" CDMC36018 4 9 18 DAC29-D13 1-CG31004-RA_1 CG31004 CGAGGGCTTTATCCTGATTGGAGATCAACGTCGTGAGTGCTTGTCGAACGGTCTGTGGAACATTCCGGA 69 FBan0031004 FBgn0051004 CG31004 3 3R cell-matrix adhesion; GO:0007160 CG31004 CG31004 "CG15560, CG12074, CG15560, CT5150, anon-WO0140519.233" CDMC36018 4 10 18 DAC29-D13 1-CG31004-RA_1 CG31004 CGAGGGCTTTATCCTGATTGGAGATCAACGTCGTGAGTGCTTGTCGAACGGTCTGTGGAACATTCCGGA 69 FBan0031004 FBgn0051004 CG31004 3 3R cell-matrix adhesion; GO:0007160 CG31004 CG31004 "CG15560, CG12074, CG15560, CT5150, anon-WO0140519.233" CDMC36019 4 11 18 DAC29-H01 2-CG31022-RA_1 CG31022 TGACAGAACGAAGGGCTTACGAGATGTTGTGCAGAGGCGAACTAAAGCCATCACCATCGGATCTGCGAT 69 FBan0031022 FBgn0039776 PH4alphaEFB 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaEFB prolyl-4-hydroxylase-alpha EFB "CG12088, CG1473, CG31022, CG12088, CG1473, BcDNA:SD05564, PH4alphaEFB, prolyl-4-hydroxylase-alpha EFB" CDMC36019 4 12 18 DAC29-H01 2-CG31022-RA_1 CG31022 TGACAGAACGAAGGGCTTACGAGATGTTGTGCAGAGGCGAACTAAAGCCATCACCATCGGATCTGCGAT 69 FBan0031022 FBgn0039776 PH4alphaEFB 3 3R peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" PH4alphaEFB prolyl-4-hydroxylase-alpha EFB "CG12088, CG1473, CG31022, CG12088, CG1473, BcDNA:SD05564, PH4alphaEFB, prolyl-4-hydroxylase-alpha EFB" CDMC36020 4 13 18 DAC29-H13 23-CG31036-RA_2 CG31036 TCATGGCAATGGCGTATCATTCATGTCCGAACCAAAACTGTTTGCAATTCATTTAGAATAAACTTTTCT 69 FBan0031036 FBgn0051036 CG31036 3 3R CG31036 CG31036 "CG15518, CG15516, CG15518" CDMC36020 4 14 18 DAC29-H13 23-CG31036-RA_2 CG31036 TCATGGCAATGGCGTATCATTCATGTCCGAACCAAAACTGTTTGCAATTCATTTAGAATAAACTTTTCT 69 FBan0031036 FBgn0051036 CG31036 3 3R CG31036 CG31036 "CG15518, CG15516, CG15518" CDMC36021 4 15 18 DAC29-L01 23-CG31064-RA_8 CG31064 AGACCACAACTAAATGAACACCATAGACAGTGTGTACCATATATAGGATGCCTTTACTCCGTAGACCAG 69 FBan0031064 FBgn0051064 CG31064 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 zinc ion binding; GO:0008270; ; GO:0008270 CG31064 CG31064 "CG6001, CG14261, CG6001" CDMC36021 4 16 18 DAC29-L01 23-CG31064-RA_8 CG31064 AGACCACAACTAAATGAACACCATAGACAGTGTGTACCATATATAGGATGCCTTTACTCCGTAGACCAG 69 FBan0031064 FBgn0051064 CG31064 3 3R endocytosis; GO:0006897; intracellular protein transport; GO:0006886 zinc ion binding; GO:0008270; ; GO:0008270 CG31064 CG31064 "CG6001, CG14261, CG6001" CDMC36022 4 17 18 DAC29-L13 3-CG3106-RA_1 CG3106 GCGGTCTGGTCAATGACTTCTTGTCCTGGGGATTCTTCACGGGCTTCAGCCGACTGTGTTACTGTATGT 69 FBan0003106 FBgn0030148 CG3106 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG3106 CG3106 CDMC36022 4 18 18 DAC29-L13 3-CG3106-RA_1 CG3106 GCGGTCTGGTCAATGACTTCTTGTCCTGGGGATTCTTCACGGGCTTCAGCCGACTGTGTTACTGTATGT 69 FBan0003106 FBgn0030148 CG3106 X X "transferase activity, transferring groups other than amino-acyl groups; GO:0016747 ; EC:2.3.1.-; ; GO:0016747 ; EC:2.3.1.-" CG3106 CG3106 CDMC36023 4 19 18 DAC29-P01 1-CG31099-RA_1 CG31099 GTGCAGATTACGTCCGTCATCCCAAGCGTTCATCTTATCCAGTTTCGCAACTGCACTGTGCTTCTGCCA 69 FBan0031099 FBgn0051099 CG31099 3 3R CG31099 CG31099 "CG10551, CG10551" CDMC36023 4 20 18 DAC29-P01 1-CG31099-RA_1 CG31099 GTGCAGATTACGTCCGTCATCCCAAGCGTTCATCTTATCCAGTTTCGCAACTGCACTGTGCTTCTGCCA 69 FBan0031099 FBgn0051099 CG31099 3 3R CG31099 CG31099 "CG10551, CG10551" CDMC36024 4 21 18 DAC29-P13 3-CG31106-RA_1 CG31106 GGGAATTCTTCACTCCCCGTCATCGACCAATCGCCATTAATTACGCCAGTCTCTTCGTGGGTGTGTCCA 69 FBan0031106 FBgn0051106 CG31106 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144 integral to membrane; GO:0016021 CG31106 CG31106 CG13655 CDMC36024 4 22 18 DAC29-P13 3-CG31106-RA_1 CG31106 GGGAATTCTTCACTCCCCGTCATCGACCAATCGCCATTAATTACGCCAGTCTCTTCGTGGGTGTGTCCA 69 FBan0031106 FBgn0051106 CG31106 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; ; GO:0015144 integral to membrane; GO:0016021 CG31106 CG31106 CG13655 CDMC36025 4 23 18 DAC30-D01 23-CG2022-RA_2 CG2022 GAAACTATCACTGACATTCGACGAGATCATCACAAGAGACCGTTGAAAATGTTTCGTAGCTTGGT 65 FBan0002022 FBgn0037292 CG2022 3 3R receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG2022 CG2022 CDMC36025 4 24 18 DAC30-D01 23-CG2022-RA_2 CG2022 GAAACTATCACTGACATTCGACGAGATCATCACAAGAGACCGTTGAAAATGTTTCGTAGCTTGGT 65 FBan0002022 FBgn0037292 CG2022 3 3R receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021; peroxisomal membrane; GO:0005778 CG2022 CG2022 CDMC36026 4 25 18 DAC30-D13 18-CG2070-RA_1 CG2070 CCCCAAAATGCTGACGGAGGACGGATTTGAAATGCAAATCGGAGTGAATCACATGGGCCACTTCC 65 FBan0002070 FBgn0033203 CG2070 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2070 CG2070 CDMC36026 4 26 18 DAC30-D13 18-CG2070-RA_1 CG2070 CCCCAAAATGCTGACGGAGGACGGATTTGAAATGCAAATCGGAGTGAATCACATGGGCCACTTCC 65 FBan0002070 FBgn0033203 CG2070 2 2R metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG2070 CG2070 CDMC36027 4 1 19 DAC30-H01 5-CG2222-RA_1 CG2222 CTGCACCCGTACTTCTACGAGTTCGGTCGCTATCTGACGCCCTACGATCGCAACCATGTCATCGG 65 FBan0002222 FBgn0030196 CG2222 X X CG2222 CG2222 CDMC36027 4 2 19 DAC30-H01 5-CG2222-RA_1 CG2222 CTGCACCCGTACTTCTACGAGTTCGGTCGCTATCTGACGCCCTACGATCGCAACCATGTCATCGG 65 FBan0002222 FBgn0030196 CG2222 X X CG2222 CG2222 CDMC36028 4 3 19 DAC30-H13 1-CG2256-RB_1 CG2256 CAAGGTCTCCCTGGAGGATTTTATGGGCACGGTCACCGCGGAACCATTGCTAATCGAGGCATTTG 65 FBan0002256 FBgn0029995 CG2256 X X intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG2256 CG2256 CDMC36028 4 4 19 DAC30-H13 1-CG2256-RB_1 CG2256 CAAGGTCTCCCTGGAGGATTTTATGGGCACGGTCACCGCGGAACCATTGCTAATCGAGGCATTTG 65 FBan0002256 FBgn0029995 CG2256 X X intracellular signaling cascade; GO:0007242 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG2256 CG2256 CDMC36029 4 5 19 DAC30-L01 23-CG2685-RA_2 CG2685 GACGATGGGAAAGATATAGATAAGATAGAGGAACGAACATCTGACTCCGATAAGAGAACCGCCAG 65 FBan0002685 FBgn0024998 CG2685 X X CG2685 CG2685 EG:100G10.1 CDMC36029 4 6 19 DAC30-L01 23-CG2685-RA_2 CG2685 GACGATGGGAAAGATATAGATAAGATAGAGGAACGAACATCTGACTCCGATAAGAGAACCGCCAG 65 FBan0002685 FBgn0024998 CG2685 X X CG2685 CG2685 EG:100G10.1 CDMC36030 4 7 19 DAC30-L13 17-CG2803-RA_4 CG2803 GCAGAAGTACCCGGAGAACCTACTTAGTCTGCGCTACTTGTCCAGCTACGAGAACTCAACCACCC 65 FBan0002803 FBgn0035083 Tina-1 2 2R heart development; GO:0007507 structural constituent of muscle; GO:0008307; ; GO:0008307 cellular component unknown; GO:0008372 Tina-1 Troponin C-akin-1 "CG2803, CG2803, CG2803, BEST:GM14784, Troponin C-akin-1" CDMC36030 4 8 19 DAC30-L13 17-CG2803-RA_4 CG2803 GCAGAAGTACCCGGAGAACCTACTTAGTCTGCGCTACTTGTCCAGCTACGAGAACTCAACCACCC 65 FBan0002803 FBgn0035083 Tina-1 2 2R heart development; GO:0007507 structural constituent of muscle; GO:0008307; ; GO:0008307 cellular component unknown; GO:0008372 Tina-1 Troponin C-akin-1 "CG2803, CG2803, CG2803, BEST:GM14784, Troponin C-akin-1" CDMC36031 4 9 19 DAC30-P01 3-CG2925-RA_6 CG2925 ATGATTCGGGTGTACAACAATCCGGACGACATGAGTGCCCTAGTGGAGTTCACTGACGAGGAGGG 65 FBan0002925 FBgn0014366 noi 3 3R "fertilization; GO:0009566; nuclear mRNA splicing, via spliceosome; GO:0000398" zinc ion binding; GO:0008270; ; GO:0008270 snRNP U2; GO:0005686; spliceosome complex; GO:0005681 noi noisette "CG2925, CG2925, l(3)j3E7, ms3225, SF3a[60], U2, noisette" CDMC36031 4 10 19 DAC30-P01 3-CG2925-RA_6 CG2925 ATGATTCGGGTGTACAACAATCCGGACGACATGAGTGCCCTAGTGGAGTTCACTGACGAGGAGGG 65 FBan0002925 FBgn0014366 noi 3 3R "fertilization; GO:0009566; nuclear mRNA splicing, via spliceosome; GO:0000398" zinc ion binding; GO:0008270; ; GO:0008270 snRNP U2; GO:0005686; spliceosome complex; GO:0005681 noi noisette "CG2925, CG2925, l(3)j3E7, ms3225, SF3a[60], U2, noisette" CDMC36032 4 11 19 DAC30-P13 3-CG2970-RA_5 CG2970 ATTCCGTCGCAATCTCGGAGGGGAAAGGCCTCCACCCCGATAAACATGTGTGTTATGTTTGTGCC 65 FBan0002970 FBgn0034936 CG2970 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG2970 CG2970 CDMC36032 4 12 19 DAC30-P13 3-CG2970-RA_5 CG2970 ATTCCGTCGCAATCTCGGAGGGGAAAGGCCTCCACCCCGATAAACATGTGTGTTATGTTTGTGCC 65 FBan0002970 FBgn0034936 CG2970 2 2R cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200 membrane; GO:0016020 CG2970 CG2970 CDMC36033 4 13 19 DAC31-D01 2-CG31851-RA_1 CG31851 CCTTGGCGGAAGTGTACTCCTTGCCATTCTTGCTTCCCAAGATTCTGGAGCATCCCGAACTGGTTCTT 68 FBan0031851 FBgn0051851 CG31851 2 2L CG31851 CG31851 "CG16821, CG16821, CG16821" CDMC36033 4 14 19 DAC31-D01 2-CG31851-RA_1 CG31851 CCTTGGCGGAAGTGTACTCCTTGCCATTCTTGCTTCCCAAGATTCTGGAGCATCCCGAACTGGTTCTT 68 FBan0031851 FBgn0051851 CG31851 2 2L CG31851 CG31851 "CG16821, CG16821, CG16821" CDMC36034 4 15 19 DAC31-D13 3-CG32060-RA_3 CG32060 GGCGTCGGTTTTCCACATTTGCGTTCGTGAGTGTATTTGTGCGAAGATGTTGGCATGTGGGAGAGCAC 68 FBan0032060 FBgn0052060 CG32060 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32060 CG32060 CDMC36034 4 16 19 DAC31-D13 3-CG32060-RA_3 CG32060 GGCGTCGGTTTTCCACATTTGCGTTCGTGAGTGTATTTGTGCGAAGATGTTGGCATGTGGGAGAGCAC 68 FBan0032060 FBgn0052060 CG32060 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32060 CG32060 CDMC36035 4 17 19 DAC31-H01 3-CG32380-RA_4 CG32380 CCAAGAGGACGCGTGTTTGGTTTCCCATGTTTAGCTACTTCGAGAGCAGTGTCGATGGAATGGTGCCC 68 FBan0032380 FBgn0052380 SMSr 3 3L sphingomyelin biosynthesis; GO:0006686 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 SMSr SMSr "CG8576, CG32380, CG8572, CG8576, Css3beta" CDMC36035 4 18 19 DAC31-H01 3-CG32380-RA_4 CG32380 CCAAGAGGACGCGTGTTTGGTTTCCCATGTTTAGCTACTTCGAGAGCAGTGTCGATGGAATGGTGCCC 68 FBan0032380 FBgn0052380 SMSr 3 3L sphingomyelin biosynthesis; GO:0006686 molecular function unknown; GO:0005554; ; GO:0005554 integral to membrane; GO:0016021 SMSr SMSr "CG8576, CG32380, CG8572, CG8576, Css3beta" CDMC36036 4 19 19 DAC31-H13 3-CG32437-RA_1 CG32437 GGAGCTCCATGATCCTGCCCATGAGCATGATCTCGCAAATGACCGATAATGGGAGCAGATTACTGCCC 68 FBan0032437 FBgn0052437 CG32437 3 3L CG32437 CG32437 "CG5051, CG5051" CDMC36036 4 20 19 DAC31-H13 3-CG32437-RA_1 CG32437 GGAGCTCCATGATCCTGCCCATGAGCATGATCTCGCAAATGACCGATAATGGGAGCAGATTACTGCCC 68 FBan0032437 FBgn0052437 CG32437 3 3L CG32437 CG32437 "CG5051, CG5051" CDMC36037 4 21 19 DAC31-L01 9-CG33154-RA_1 CG33154 ACCAAGGAGCTGCCTAATGTAACGCTCTACTATCGAGCTCTCTTGGAGATTCTGGTTTGCCGCCATGC 68 FBgn0053154 CDMC36037 4 22 19 DAC31-L01 9-CG33154-RA_1 CG33154 ACCAAGGAGCTGCCTAATGTAACGCTCTACTATCGAGCTCTCTTGGAGATTCTGGTTTGCCGCCATGC 68 FBgn0053154 CDMC36038 4 23 19 DAC31-L13 3-CG33307-RA_1 CG33307 GCCCACAAATCCACAACTCCTAAACTCCGATGATCCAGTGCAAAGGGAGTTGGAGAGACAGGCCAAGG 68 FBan0033307 FBgn0053307 CG33307 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33307 CG33307 "CG16887, CG16887, CG16887, BG:DS00941.11, DS00941.11, BcDNA:GH07914" CDMC36038 4 24 19 DAC31-L13 3-CG33307-RA_1 CG33307 GCCCACAAATCCACAACTCCTAAACTCCGATGATCCAGTGCAAAGGGAGTTGGAGAGACAGGCCAAGG 68 FBan0033307 FBgn0053307 CG33307 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33307 CG33307 "CG16887, CG16887, CG16887, BG:DS00941.11, DS00941.11, BcDNA:GH07914" CDMC36039 4 25 19 DAC31-P01 2-CG3581-RA_4 CG3581 GGCTCATCAAGGAGAGGCGCTATCTAACCAGATGGCAAATTCCCGGACCGATGAAAAAGGCACAGTGG 68 FBan0003581 FBgn0038697 CG3581 3 3R CG3581 CG3581 CDMC36039 4 26 19 DAC31-P01 2-CG3581-RA_4 CG3581 GGCTCATCAAGGAGAGGCGCTATCTAACCAGATGGCAAATTCCCGGACCGATGAAAAAGGCACAGTGG 68 FBan0003581 FBgn0038697 CG3581 3 3R CG3581 CG3581 CDMC36040 4 1 20 DAC31-P13 1-CG3692-RA_1 CG3692 CCGGTGGTTGTCGCAATCACGAGTCGTTCCATATCAACCCCCAGCTACTGATATCCGTGCAGGATGAG 68 FBan0003692 FBgn0030741 CalpC X X proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; NOT calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622 CalpC Calpain C "CG3692, CG3692, CG3692, Calpain C" CDMC36040 4 2 20 DAC31-P13 1-CG3692-RA_1 CG3692 CCGGTGGTTGTCGCAATCACGAGTCGTTCCATATCAACCCCCAGCTACTGATATCCGTGCAGGATGAG 68 FBan0003692 FBgn0030741 CalpC X X proteolysis; GO:0006508 calmodulin binding; GO:0005516; calpain activity; GO:0004198 ; EC:3.4.22.17; NOT calpain activity; GO:0004198 ; EC:3.4.22.17; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0004198 ; EC:3.4.22.17; ; GO:0004198 ; EC:3.4.22.17 cytoplasm; GO:0005737; intracellular; GO:0005622 CalpC Calpain C "CG3692, CG3692, CG3692, Calpain C" CDMC36041 4 3 20 DAC32-D01 3-CG15773-RA_1 CG15773 GCACGTCTGCCTTAAGTGCAATTATAATGGTTGCAATGCGGAGAAGACCGTCACGGAATTGCGCTGCCT 69 FBan0015773 FBgn0029795 CG15773 X X CG15773 CG15773 CDMC36041 4 4 20 DAC32-D01 3-CG15773-RA_1 CG15773 GCACGTCTGCCTTAAGTGCAATTATAATGGTTGCAATGCGGAGAAGACCGTCACGGAATTGCGCTGCCT 69 FBan0015773 FBgn0029795 CG15773 X X CG15773 CG15773 CDMC36042 4 5 20 DAC32-D13 16-CG15797-RA_1 CG15797 AGAAGCGGAAAACCTAAGCCACAAATGTATTGCGGGATCTGCTATGGCACAACTTCCAAATAGCTACCA 69 FBgn0030115 CDMC36042 4 6 20 DAC32-D13 16-CG15797-RA_1 CG15797 AGAAGCGGAAAACCTAAGCCACAAATGTATTGCGGGATCTGCTATGGCACAACTTCCAAATAGCTACCA 69 FBgn0030115 CDMC36043 4 7 20 DAC32-H01 9-CG15860-RA_6 CG15860 TCCTCAAGTTCCACGAAAGCGATCAAAGGGCTCTTACTGCATTTTTCGGATTGCTTTCCTGGCTGGGAA 69 FBgn0035080 CDMC36043 4 8 20 DAC32-H01 9-CG15860-RA_6 CG15860 TCCTCAAGTTCCACGAAAGCGATCAAAGGGCTCTTACTGCATTTTTCGGATTGCTTTCCTGGCTGGGAA 69 FBgn0035080 CDMC36044 4 9 20 DAC32-H13 23-CG1587-RA_14 CG1587 CGCCCGCGTAAAACAGTCAAGGGTCCCTAACGCATACGATAAGACTGCATTAAAATTGGAAATAGGTGA 69 FBan0001587 FBgn0024811 Crk 4 4 "G-protein coupled receptor protein signaling pathway; GO:0007186; imaginal disc fusion, thorax closure; GO:0046529; intracellular signaling cascade; GO:0007242; myoblast fusion; GO:0007520; positive regulation of JNK cascade; GO:0046330; signal transduction; GO:0007165" protein binding; GO:0005515; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005515 Crk Crk "CG1587, CG1587, CG1587, D-CRK, dCRK, Dcrk, D-Crk, CRK, DCrk" CDMC36044 4 10 20 DAC32-H13 23-CG1587-RA_14 CG1587 CGCCCGCGTAAAACAGTCAAGGGTCCCTAACGCATACGATAAGACTGCATTAAAATTGGAAATAGGTGA 69 FBan0001587 FBgn0024811 Crk 4 4 "G-protein coupled receptor protein signaling pathway; GO:0007186; imaginal disc fusion, thorax closure; GO:0046529; intracellular signaling cascade; GO:0007242; myoblast fusion; GO:0007520; positive regulation of JNK cascade; GO:0046330; signal transduction; GO:0007165" protein binding; GO:0005515; SH3/SH2 adaptor activity; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005070; ; GO:0005515 Crk Crk "CG1587, CG1587, CG1587, D-CRK, dCRK, Dcrk, D-Crk, CRK, DCrk" CDMC36045 4 11 20 DAC32-L01 22-CG15920-RA_2 CG15920 TGGCAGCGGTTATCGGTACTAGGAACGACTCACAGACACATTTAGCTAGATTCCCCGAACATATAGCAA 69 FBan0015920 FBgn0034157 CG15920 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15920 CG15920 CDMC36045 4 12 20 DAC32-L01 22-CG15920-RA_2 CG15920 TGGCAGCGGTTATCGGTACTAGGAACGACTCACAGACACATTTAGCTAGATTCCCCGAACATATAGCAA 69 FBan0015920 FBgn0034157 CG15920 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG15920 CG15920 CDMC36046 4 13 20 DAC32-L13 12-CG15927-RA_1 CG15927 AGTGAGGCCAAAGGTTAAGCAACAAATCAGATTGGAGAGAGCCAATCCTTTGAGGGAGGCCAAAGGTGT 69 FBan0015927 FBgn0030389 CG15927 X X CG15927 CG15927 CDMC36046 4 14 20 DAC32-L13 12-CG15927-RA_1 CG15927 AGTGAGGCCAAAGGTTAAGCAACAAATCAGATTGGAGAGAGCCAATCCTTTGAGGGAGGCCAAAGGTGT 69 FBan0015927 FBgn0030389 CG15927 X X CG15927 CG15927 CDMC36047 4 15 20 DAC32-P01 23-CG1633-RA_1 CG1633 CCCCCCGTTCAACTAAAACCAATACATATACTACATTATATATCCTACACATTAACCCTAGAGCGTAGA 69 FBan0001633 FBgn0040309 Jafrac1 X X cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; NOT glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0004602 ; EC:1.11.1.9; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.- cytosol; GO:0005829 Jafrac1 thioredoxin peroxidase 1 "CG1633, CG1633, CG1633, CG1633, CG1633, CG1633, SSP5111, DPx4783, Peroxiredoxin 4783, DPx-4783, DmTPx-1, Thioredoxin peroxidase 1, T20, thioredoxin peroxidase, Prx4783, thioredoxin peroxidase 1" CDMC36047 4 16 20 DAC32-P01 23-CG1633-RA_1 CG1633 CCCCCCGTTCAACTAAAACCAATACATATACTACATTATATATCCTACACATTAACCCTAGAGCGTAGA 69 FBan0001633 FBgn0040309 Jafrac1 X X cell redox homeostasis; GO:0045454; defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; antioxidant activity; GO:0016209; thioredoxin peroxidase activity; GO:0008379 ; EC:1.11.1.-; NOT glutathione peroxidase activity; GO:0004602 ; EC:1.11.1.9; ; GO:0008379 ; EC:1.11.1.-; ; GO:0004601 ; EC:1.11.1.7; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.-; ; GO:0004602 ; EC:1.11.1.9; ; GO:0016209; ; GO:0008379 ; EC:1.11.1.- cytosol; GO:0005829 Jafrac1 thioredoxin peroxidase 1 "CG1633, CG1633, CG1633, CG1633, CG1633, CG1633, SSP5111, DPx4783, Peroxiredoxin 4783, DPx-4783, DmTPx-1, Thioredoxin peroxidase 1, T20, thioredoxin peroxidase, Prx4783, thioredoxin peroxidase 1" CDMC36048 4 17 20 DAC32-P13 18-CG1640-RD_2 CG1640 ACCCGCGCAGGTTTTATCGCCACGATAACGTTTCCAGTTAGCAATTAACCCACTTAACCATGTAGTCTT 69 FBan0001640 FBgn0030478 CG1640 X X amino acid biosynthesis; GO:0008652; nitrogen compound metabolism; GO:0006807 alanine transaminase activity; GO:0004021 ; EC:2.6.1.2; ; GO:0004021 ; EC:2.6.1.2 CG1640 CG1640 CDMC36048 4 18 20 DAC32-P13 18-CG1640-RD_2 CG1640 ACCCGCGCAGGTTTTATCGCCACGATAACGTTTCCAGTTAGCAATTAACCCACTTAACCATGTAGTCTT 69 FBan0001640 FBgn0030478 CG1640 X X amino acid biosynthesis; GO:0008652; nitrogen compound metabolism; GO:0006807 alanine transaminase activity; GO:0004021 ; EC:2.6.1.2; ; GO:0004021 ; EC:2.6.1.2 CG1640 CG1640 CDMC36049 4 19 20 DAC33-D01 23-CG11347-RA_3 CG11347 TAACCTTACCCCCAGATGAAACGAGAGAAAATTCGCAAAAAAAGGAAAAATGCCACAAAAATATCAAAA 69 FBan0011347 FBgn0035542 CG11347 3 3L CG11347 CG11347 CDMC36049 4 20 20 DAC33-D01 23-CG11347-RA_3 CG11347 TAACCTTACCCCCAGATGAAACGAGAGAAAATTCGCAAAAAAAGGAAAAATGCCACAAAAATATCAAAA 69 FBan0011347 FBgn0035542 CG11347 3 3L CG11347 CG11347 CDMC36050 4 21 20 DAC33-D13 1-CG11357-RA_1 CG11357 AGGATCCCCCGTTCCTCTTCACAAATCACGCCATTAAGCCAGACGAAAGCATGACCATTTGGCAGATGG 69 FBan0011357 FBgn0035558 CG11357 3 3L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG11357 CG11357 BcDNA:GM04393 CDMC36050 4 22 20 DAC33-D13 1-CG11357-RA_1 CG11357 AGGATCCCCCGTTCCTCTTCACAAATCACGCCATTAAGCCAGACGAAAGCATGACCATTTGGCAGATGG 69 FBan0011357 FBgn0035558 CG11357 3 3L protein amino acid glycosylation; GO:0006486 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; GO:0008499; ; GO:0008499" membrane; GO:0016020 CG11357 CG11357 BcDNA:GM04393 CDMC36051 4 23 20 DAC33-H01 13-CG11387-RB_1 CG11387 GCCGTCCCCTCAAACCAGTACGCACAATTGAGAAAACACTTGCACAAATAAACAAAACCCCCCATCACT 69 FBan0011387 FBgn0004198 ct X X Malpighian tubule morphogenesis; GO:0007443; antennal morphogenesis; GO:0007469; cell fate commitment; GO:0045165; central nervous system development; GO:0007417; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; female gonad development; GO:0008585; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360; spiracle morphogenesis; GO:0035277; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; catalytic activity; GO:0003824; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003824; ; GO:0003700 nucleus; GO:0005634 ct cut "CG11387, CG11387, kf: kinked-femur, kinked-femur, Cut, Ct, BcDNA:GH10590, l(1)7Ba, l(1)7Bb, l(1)VE614, kf, cut" CDMC36051 4 24 20 DAC33-H01 13-CG11387-RB_1 CG11387 GCCGTCCCCTCAAACCAGTACGCACAATTGAGAAAACACTTGCACAAATAAACAAAACCCCCCATCACT 69 FBan0011387 FBgn0004198 ct X X Malpighian tubule morphogenesis; GO:0007443; antennal morphogenesis; GO:0007469; cell fate commitment; GO:0045165; central nervous system development; GO:0007417; dendrite morphogenesis; GO:0016358; ectoderm development; GO:0007398; female gonad development; GO:0008585; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sensory organ determination; GO:0008052; sensory organ precursor cell fate determination; GO:0016360; spiracle morphogenesis; GO:0035277; stalk formation (sensu Insecta); GO:0030713; tracheal system development (sensu Insecta); GO:0007424; wing margin morphogenesis; GO:0008587 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; catalytic activity; GO:0003824; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003824; ; GO:0003700 nucleus; GO:0005634 ct cut "CG11387, CG11387, kf: kinked-femur, kinked-femur, Cut, Ct, BcDNA:GH10590, l(1)7Ba, l(1)7Bb, l(1)VE614, kf, cut" CDMC36052 4 25 20 DAC33-H13 15-CG11399-RB_1 CG11399 CGCATCCACGCAAGCGGTCATCAACTCAGCCGTCTAGATTTGATTCTTTTTGGGATCTTGCTATCCACA 69 FBan0011399 FBgn0037021 CG11399 3 3L CG11399 CG11399 CDMC36052 4 26 20 DAC33-H13 15-CG11399-RB_1 CG11399 CGCATCCACGCAAGCGGTCATCAACTCAGCCGTCTAGATTTGATTCTTTTTGGGATCTTGCTATCCACA 69 FBan0011399 FBgn0037021 CG11399 3 3L CG11399 CG11399 CDMC36053 4 1 21 DAC33-L01 12-CG11430-RC_1 CG11430 TCCGCGACTGTTTTCCGTTTCAGTTCCTAGCTTTTCGTGCTTTCCTCTCAGCTAGCAGTCGTTAGGGTA 69 FBan0011430 FBgn0041585 olf186-F 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- olf186-F olf186-F "CG11430, CG11430, l(2)k11505[k11505], SPH206, BcDNA:LD03241, l(2)k11505, lethal (2) k11505" CDMC36053 4 2 21 DAC33-L01 12-CG11430-RC_1 CG11430 TCCGCGACTGTTTTCCGTTTCAGTTCCTAGCTTTTCGTGCTTTCCTCTCAGCTAGCAGTCGTTAGGGTA 69 FBan0011430 FBgn0041585 olf186-F 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- olf186-F olf186-F "CG11430, CG11430, l(2)k11505[k11505], SPH206, BcDNA:LD03241, l(2)k11505, lethal (2) k11505" CDMC36054 4 3 21 DAC33-L13 9-CG11448-RA_2 CG11448 GCTCCCCTTCCACTCACAAGCACAAAGCGAGGAAACTCCGTTTACATATCAGCTCCATCGCTATCGTCG 69 FBan0011448 FBgn0024985 CG11448 X X CG11448 CG11448 EG:132E8.4 CDMC36054 4 4 21 DAC33-L13 9-CG11448-RA_2 CG11448 GCTCCCCTTCCACTCACAAGCACAAAGCGAGGAAACTCCGTTTACATATCAGCTCCATCGCTATCGTCG 69 FBan0011448 FBgn0024985 CG11448 X X CG11448 CG11448 EG:132E8.4 CDMC36055 4 5 21 DAC33-P01 23-CG11491-RE_5 CG11491 AGCTAGTTGTAGGCGAAGAAACACATGTTTGGAAGCTTAGGAGTTTACAAGAAAAATGAACCGACGAGC 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC36055 4 6 21 DAC33-P01 23-CG11491-RE_5 CG11491 AGCTAGTTGTAGGCGAAGAAACACATGTTTGGAAGCTTAGGAGTTTACAAGAAAAATGAACCGACGAGC 69 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC36056 4 7 21 DAC33-P13 23-CG11502-RA_6 CG11502 GATAGCGTTAGGTAGACCTAAACCCTCTGTAAATGTACTTACTTTAGTGCCTATGGCTAGTTTCTATCT 69 FBan0011502 FBgn0003651 svp 3 3R R1/R6 cell fate commitment; GO:0007462; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; cardioblast cell fate determination; GO:0007510; central nervous system development; GO:0007417; embryonic development (sensu Insecta); GO:0001700; eye development (sensu Endopterygota); GO:0007456; fat body development; GO:0007503; heart development; GO:0007507; nerve-nerve synaptic transmission; GO:0007270; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; phototactic behavior; GO:0046953; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 ligand-dependent nuclear receptor activity; GO:0004879; receptor activity; GO:0004872; ; GO:0004872; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0004872; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0005515; ; GO:0003707 cytoplasm; GO:0005737; nucleus; GO:0005634 svp seven up "CG18158, CG11502, CG18158, CG18158, CG18158, l(3)ck16, Svp, ck16, SVP, 0005/12, 0042/01, 0106/18, 0114/20, 0351/01, 0598/01, 0861/07, NR2F3, seven-up, don, down-and-out, SEVEN-UP, complementation group 7, BcDNA:GH08189, l(3)07842, l(3)87Bd, l(3)j2E2, l(3)rA028, l(3)rL069" CDMC36056 4 8 21 DAC33-P13 23-CG11502-RA_6 CG11502 GATAGCGTTAGGTAGACCTAAACCCTCTGTAAATGTACTTACTTTAGTGCCTATGGCTAGTTTCTATCT 69 FBan0011502 FBgn0003651 svp 3 3R R1/R6 cell fate commitment; GO:0007462; R3/R4 cell fate commitment; GO:0007464; R7 cell fate commitment; GO:0007465; cardioblast cell fate determination; GO:0007510; central nervous system development; GO:0007417; embryonic development (sensu Insecta); GO:0001700; eye development (sensu Endopterygota); GO:0007456; fat body development; GO:0007503; heart development; GO:0007507; nerve-nerve synaptic transmission; GO:0007270; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; phototactic behavior; GO:0046953; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; ventral cord development; GO:0007419 ligand-dependent nuclear receptor activity; GO:0004879; receptor activity; GO:0004872; ; GO:0004872; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004879; ; GO:0004872; ; GO:0004879; ; GO:0003700; steroid hormone receptor activity; GO:0003707; ; GO:0005515; ; GO:0003707 cytoplasm; GO:0005737; nucleus; GO:0005634 svp seven up "CG18158, CG11502, CG18158, CG18158, CG18158, l(3)ck16, Svp, ck16, SVP, 0005/12, 0042/01, 0106/18, 0114/20, 0351/01, 0598/01, 0861/07, NR2F3, seven-up, don, down-and-out, SEVEN-UP, complementation group 7, BcDNA:GH08189, l(3)07842, l(3)87Bd, l(3)j2E2, l(3)rA028, l(3)rL069" CDMC36057 4 9 21 DAC34-D01 13-CG14688-RA_1 CG14688 GCCTACACTTTCCACGTCATCGAGACTGAGAACAACGTCAAGTATTCGGAGGACAATTGGCTGCAGG 67 FBan0014688 FBgn0037819 CG14688 3 3R CG14688 CG14688 CDMC36057 4 10 21 DAC34-D01 13-CG14688-RA_1 CG14688 GCCTACACTTTCCACGTCATCGAGACTGAGAACAACGTCAAGTATTCGGAGGACAATTGGCTGCAGG 67 FBan0014688 FBgn0037819 CG14688 3 3R CG14688 CG14688 CDMC36058 4 11 21 DAC34-D13 3-CG14854-RA_1 CG14854 GGAGGAGCAGCACTTGGTGTTCCAGTACATGGACAATACGCTGCATGACATCATCCAGACGTGTGCG 67 FBan0014854 FBgn0038238 CG14854 3 3R CG14854 CG14854 CDMC36058 4 12 21 DAC34-D13 3-CG14854-RA_1 CG14854 GGAGGAGCAGCACTTGGTGTTCCAGTACATGGACAATACGCTGCATGACATCATCCAGACGTGTGCG 67 FBan0014854 FBgn0038238 CG14854 3 3R CG14854 CG14854 CDMC36059 4 13 21 DAC34-H01 3-CG15087-RA_1 CG15087 ACCCACGAAACTGAGATATGTGCTGAAATGCGGGAGACGGCACAGTCACTATTGGACGCCTATGTGC 67 FBan0015087 FBgn0034380 CG15087 2 2R CG15087 CG15087 CDMC36059 4 14 21 DAC34-H01 3-CG15087-RA_1 CG15087 ACCCACGAAACTGAGATATGTGCTGAAATGCGGGAGACGGCACAGTCACTATTGGACGCCTATGTGC 67 FBan0015087 FBgn0034380 CG15087 2 2R CG15087 CG15087 CDMC36060 4 15 21 DAC34-H13 1-CG15380-RA_1 CG15380 ACAAACGGAAGCCACGAATCACACTTTCAAGAGTTTAGCCTTCCTGGACGCGTCCTTTGGCTCCGAT 67 FBgn0031387 CDMC36060 4 16 21 DAC34-H13 1-CG15380-RA_1 CG15380 ACAAACGGAAGCCACGAATCACACTTTCAAGAGTTTAGCCTTCCTGGACGCGTCCTTTGGCTCCGAT 67 FBgn0031387 CDMC36061 4 17 21 DAC34-L01 3-CG15737-RA_3 CG15737 GCCGGTTTCCACATGTCGAATGGCGAAGAGCCCCAAGAACGATGTCTACCAGTGGAAGGAGCTAAAC 67 FBan0015737 FBgn0030353 CG15737 X X nucleic acid binding; GO:0003676; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0003676; ; GO:0004652 ; EC:2.7.7.19 CG15737 CG15737 DmCG15737 CDMC36061 4 18 21 DAC34-L01 3-CG15737-RA_3 CG15737 GCCGGTTTCCACATGTCGAATGGCGAAGAGCCCCAAGAACGATGTCTACCAGTGGAAGGAGCTAAAC 67 FBan0015737 FBgn0030353 CG15737 X X nucleic acid binding; GO:0003676; polynucleotide adenylyltransferase activity; GO:0004652 ; EC:2.7.7.19; ; GO:0003676; ; GO:0004652 ; EC:2.7.7.19 CG15737 CG15737 DmCG15737 CDMC36062 4 19 21 DAC34-L13 18-CG15816-RA_1 CG15816 TCTACCAGCCCTACGATGTGTGTCCCTTGAGTCTGGACGAGCTCAATTGCTATTTCCAGGCGGATCA 67 FBan0015816 FBgn0030866 CG15816 X X CG15816 CG15816 CDMC36062 4 20 21 DAC34-L13 18-CG15816-RA_1 CG15816 TCTACCAGCCCTACGATGTGTGTCCCTTGAGTCTGGACGAGCTCAATTGCTATTTCCAGGCGGATCA 67 FBan0015816 FBgn0030866 CG15816 X X CG15816 CG15816 CDMC36063 4 21 21 DAC34-P01 3-CG17061-RA_5 CG17061 GCAACCAGCACGGAAAGAGCTTGGTCTGCTATTTAATAGGGCTCTCCGTGGGTTACTCCTCGCTGTG 67 FBan0017061 FBgn0035132 mthl10 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl10 methuselah-like 10 "CG17061, mth-like 10, Mth-like 10, mth2, anon-WO0170980.166, anon-WO0170980.167" CDMC36063 4 22 21 DAC34-P01 3-CG17061-RA_5 CG17061 GCAACCAGCACGGAAAGAGCTTGGTCTGCTATTTAATAGGGCTCTCCGTGGGTTACTCCTCGCTGTG 67 FBan0017061 FBgn0035132 mthl10 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl10 methuselah-like 10 "CG17061, mth-like 10, Mth-like 10, mth2, anon-WO0170980.166, anon-WO0170980.167" CDMC36064 4 23 21 DAC34-P13 15-CG1725-RF_1 CG1725 TCCAATCAAACCAACCAATCAGCACTCAATCAGAATCCGATCGCGAATAATGTGAGTGCCCAAGCGC 67 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC36064 4 24 21 DAC34-P13 15-CG1725-RF_1 CG1725 TCCAATCAAACCAACCAATCAGCACTCAATCAGAATCCGATCGCGAATAATGTGAGTGCCCAAGCGC 67 FBan0001725 FBgn0001624 dlg1 X X asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cell proliferation; GO:0008283; central nervous system development; GO:0007417; cytoskeleton organization and biogenesis; GO:0007010; dorsal closure; GO:0007391; establishment and/or maintenance of epithelial cell polarity; GO:0045197; establishment and/or maintenance of neuroblast polarity; GO:0045196; establishment and/or maintenance of polarity of embryonic epithelium; GO:0016332; establishment and/or maintenance of polarity of follicular epithelium; GO:0016334; establishment and/or maintenance of polarity of larval imaginal disc epithelium; GO:0016336; morphogenesis of a polarized epithelium; GO:0001738; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; morphogenesis of larval imaginal disc epithelium; GO:0016335; negative regulation of cell proliferation; GO:0008285; nervous system development; GO:0007399; neuron differentiation; GO:0030182; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; protein targeting; GO:0006605; regulation of border follicle cell delamination; GO:0030710; regulation of cell proliferation; GO:0042127; regulation of progression through cell cycle; GO:0000074; septate junction assembly; GO:0019991; synaptic transmission; GO:0007268; zonula adherens assembly; GO:0045186 protein binding; GO:0005515; guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; epidermal growth factor receptor binding; GO:0005154; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005198; ; GO:0005515; ; GO:0005154; ; GO:0004385 ; EC:2.7.4.8 apical cortex; GO:0045179; apicolateral plasma membrane; GO:0016327; basolateral plasma membrane; GO:0016323; cell cortex; GO:0005938; cytoplasm; GO:0005737; cytoskeleton; GO:0005856; membrane; GO:0016020; plasma membrane; GO:0005886; septate junction; GO:0005918; synapse; GO:0045202 dlg1 discs large 1 "CG1725, CG1730, CG1725, l(1)bwn: lethal(1)benign wing imaginal disc neoplasm, l(1)d.lg.-1, l(1)lpr-2, 11, l(1)L11, l(1)d.lg-1, l(1)dlg-1, d. lg.-1, dlg, dlg-A, l(1)dlg, lethal(1)benign wing imaginal disc neoplasm, l(1)discs large, Dlg, lethal(1)discs large, l(1)10Bf, l(1)dlg1, dlg-1, DlgA, discs large, DLG, discslarge, Drodlg, dlgA, lethal(2)discs large, misb, l(1)G0276, l(1)G0342, Discs large, l(1)G0456, lethal(1)discs-large, Discs-Large, discs-large, Discs-large, DLG-A, Dlg-A, Dlg1, Discslarge, anon-EST:Posey93, disc-large, Discs Large, Disc Large, anon-WO03040301.260, anon-WO03040301.268, anon-WO03040301.258, l(1)G19, l(1)l.pr.-2, l(1)bwn" CDMC36065 4 25 21 DAC35-D01 23-CG11770-RA_6 CG11770 GTCTTTCAACCCAGATACATACCCAGCTGTATGTAATTGTCATTGTAATTGTAATGAGCATCACAAGTT 69 FBan0011770 FBgn0002552 lin 2 2R epidermis development; GO:0008544; foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 cytoplasm; GO:0005737; nucleus; GO:0005634 lin lines "CG11770, CG11770, Lin" CDMC36065 4 26 21 DAC35-D01 23-CG11770-RA_6 CG11770 GTCTTTCAACCCAGATACATACCCAGCTGTATGTAATTGTCATTGTAATTGTAATGAGCATCACAAGTT 69 FBan0011770 FBgn0002552 lin 2 2R epidermis development; GO:0008544; foregut morphogenesis; GO:0007440; hindgut morphogenesis; GO:0007442; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293 cytoplasm; GO:0005737; nucleus; GO:0005634 lin lines "CG11770, CG11770, Lin" CDMC36066 4 1 22 DAC35-D13 23-CG11781-RA_1 CG11781 GCATGGTGCACGTGTATTAGCGCATTTATACAATACAACACACTATAATAGCGAAATAAACATAGGATC 69 FBan0011781 FBgn0039259 CG11781 3 3R CG11781 CG11781 BcDNA:RE35789 CDMC36066 4 2 22 DAC35-D13 23-CG11781-RA_1 CG11781 GCATGGTGCACGTGTATTAGCGCATTTATACAATACAACACACTATAATAGCGAAATAAACATAGGATC 69 FBan0011781 FBgn0039259 CG11781 3 3R CG11781 CG11781 BcDNA:RE35789 CDMC36067 4 3 22 DAC35-H01 8-CG11833-RA_1 CG11833 TCCCTGCATGGGTTTGACAGATCAGCTTCGGGCATATCCCACGTGCTGGAAGTTAAGGGTCACTTATAT 69 FBgn0039624 CDMC36067 4 4 22 DAC35-H01 8-CG11833-RA_1 CG11833 TCCCTGCATGGGTTTGACAGATCAGCTTCGGGCATATCCCACGTGCTGGAAGTTAAGGGTCACTTATAT 69 FBgn0039624 CDMC36068 4 5 22 DAC35-H13 23-CG11848-RA_18 CG11848 AGCAAGCTGCCATGATAGACGCACTTATATCACACTTTACAGATCAAATCAGAAACAAAAAACAGGAGG 69 FBan0011848 FBgn0039282 CG11848 3 3R CG11848 CG11848 CDMC36068 4 6 22 DAC35-H13 23-CG11848-RA_18 CG11848 AGCAAGCTGCCATGATAGACGCACTTATATCACACTTTACAGATCAAATCAGAAACAAAAAACAGGAGG 69 FBan0011848 FBgn0039282 CG11848 3 3R CG11848 CG11848 CDMC36069 4 7 22 DAC35-L01 3-CG11883-RB_3 CG11883 ACCATGGGCGATCTGGTGAACGTTATTCCCATGCGTGACCCACTAATCCTGCTCGAAGTGAAGGGTAAA 69 FBan0011883 FBgn0033538 CG11883 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166; proteolysis; GO:0006508" nucleotide phosphatase activity; GO:0019204; serine-type peptidase activity; GO:0008236; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0008236; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008081 ; EC:3.1.4.-; ; GO:0008253 ; EC:3.1.3.5 membrane; GO:0016020 CG11883 CG11883 CDMC36069 4 8 22 DAC35-L01 3-CG11883-RB_3 CG11883 ACCATGGGCGATCTGGTGAACGTTATTCCCATGCGTGACCCACTAATCCTGCTCGAAGTGAAGGGTAAA 69 FBan0011883 FBgn0033538 CG11883 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166; proteolysis; GO:0006508" nucleotide phosphatase activity; GO:0019204; serine-type peptidase activity; GO:0008236; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0008236; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008081 ; EC:3.1.4.-; ; GO:0008253 ; EC:3.1.3.5 membrane; GO:0016020 CG11883 CG11883 CDMC36070 4 9 22 DAC35-L13 9-CG11896-RA_4 CG11896 ATGCCCTTCGAACTGCATGCCTTAAGGGAGCACATCACATCTTCGACTTCTTGAAAAAGCAGCTGCACT 69 FBan0011896 FBgn0038488 CG11896 3 3R CG11896 CG11896 CDMC36070 4 10 22 DAC35-L13 9-CG11896-RA_4 CG11896 ATGCCCTTCGAACTGCATGCCTTAAGGGAGCACATCACATCTTCGACTTCTTGAAAAAGCAGCTGCACT 69 FBan0011896 FBgn0038488 CG11896 3 3R CG11896 CG11896 CDMC36071 4 11 22 DAC35-P01 16-CG11927-RA_1 CG11927 AGGGAGCACAAAACAATCGCAGCAATCCAAACCAGAATAACAAGAAATTCAAGGTAAACCATCGCGGCA 69 FBan0011927 FBgn0031638 CG11927 2 2L CG11927 CG11927 CDMC36071 4 12 22 DAC35-P01 16-CG11927-RA_1 CG11927 AGGGAGCACAAAACAATCGCAGCAATCCAAACCAGAATAACAAGAAATTCAAGGTAAACCATCGCGGCA 69 FBan0011927 FBgn0031638 CG11927 2 2L CG11927 CG11927 CDMC36072 4 13 22 DAC35-P13 17-CG11958-RB_1 CG11958 CTGTCGTGTTCGACCCTCTGTCGTCCCCATATCTCCTATACATATATAGCACCCTTACACAGAGCCAGC 69 FBan0011958 FBgn0015622 Cnx99A 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 calcium ion binding; GO:0005509; unfolded protein binding; GO:0051082; ; GO:0005509; ; GO:0051082 endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 Cnx99A Calnexin 99A "CG11958, CG11958, Cnx: Calnexin, calnexin, Calnexin, Cnx" CDMC36072 4 14 22 DAC35-P13 17-CG11958-RB_1 CG11958 CTGTCGTGTTCGACCCTCTGTCGTCCCCATATCTCCTATACATATATAGCACCCTTACACAGAGCCAGC 69 FBan0011958 FBgn0015622 Cnx99A 3 3R exocytosis; GO:0006887; intracellular protein transport; GO:0006886; protein folding; GO:0006457 calcium ion binding; GO:0005509; unfolded protein binding; GO:0051082; ; GO:0005509; ; GO:0051082 endoplasmic reticulum; GO:0005783; plasma membrane; GO:0005886 Cnx99A Calnexin 99A "CG11958, CG11958, Cnx: Calnexin, calnexin, Calnexin, Cnx" CDMC36073 4 15 22 DAC36-D01 23-CG8627-RA_1 CG8627 AGCAATTAGCGATCTTAAACCAGCTAGAGACTATTGTAATGTTACCTTTAATGCGGAATAAACTTCGTA 69 FBan0008627 FBgn0010387 Dbi 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; ; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857; ; GO:0000062 Dbi Diazepam-binding inhibitor "CG8627, CG8627, DBI, diazepam binding inhibitor, ACBP, acyl-CoA binding protein, diazepam-binding protein, endozepine, anon-WO0172774.131, BcDNA:RH39533" CDMC36073 4 16 22 DAC36-D01 23-CG8627-RA_1 CG8627 AGCAATTAGCGATCTTAAACCAGCTAGAGACTATTGTAATGTTACCTTTAATGCGGAATAAACTTCGTA 69 FBan0008627 FBgn0010387 Dbi 3 3L cell acyl-CoA homeostasis; GO:0042049; lipid transport; GO:0006869 acyl-CoA binding; GO:0000062; ; GO:0000062; ; GO:0000062; ; GO:0000062; carrier activity; GO:0005386; ; GO:0005386; diazepam binding; GO:0050809; enzyme inhibitor activity; GO:0004857; ; GO:0050809; ; GO:0004857; ; GO:0000062 Dbi Diazepam-binding inhibitor "CG8627, CG8627, DBI, diazepam binding inhibitor, ACBP, acyl-CoA binding protein, diazepam-binding protein, endozepine, anon-WO0172774.131, BcDNA:RH39533" CDMC36074 4 17 22 DAC36-D13 1-CG8636-RA_1 CG8636 TCCCGTTCCCACTACCCGCGTTTACTGCTCATAGGAGTCCGTTCGAGTCGATCACACAATTTGTCCCTA 69 FBan0008636 FBgn0029629 CG8636 X X translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8636 CG8636 "cg8636, eIF3-S4" CDMC36074 4 18 22 DAC36-D13 1-CG8636-RA_1 CG8636 TCCCGTTCCCACTACCCGCGTTTACTGCTCATAGGAGTCCGTTCGAGTCGATCACACAATTTGTCCCTA 69 FBan0008636 FBgn0029629 CG8636 X X translational initiation; GO:0006413 mRNA binding; GO:0003729; ; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003743 eukaryotic translation initiation factor 3 complex; GO:0005852 CG8636 CG8636 "cg8636, eIF3-S4" CDMC36075 4 19 22 DAC36-H01 15-CG8676-RA_1 CG8676 CCAAAGCCACGATAGCAGTCACATCAGGCCCACTGGTCGAGATTAAATCCAAGAGCAAGATTGCCAAAT 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC36075 4 20 22 DAC36-H01 15-CG8676-RA_1 CG8676 CCAAAGCCACGATAGCAGTCACATCAGGCCCACTGGTCGAGATTAAATCCAAGAGCAAGATTGCCAAAT 69 FBan0008676 FBgn0010229 Hr39 2 2L "female meiosis chromosome segregation; GO:0016321; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; ; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; transcription cofactor activity; GO:0003712; ; GO:0004879; transcription factor activity; GO:0003700; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0003712; steroid hormone receptor activity; GO:0003707; ; GO:0003707 nucleus; GO:0005634 Hr39 Hormone receptor-like in 39 "CG8676, CG8676, CG8676, CG8676, FTZ-F1beta, FTZ-F1, ftz-f1beta, DHR39, ftz-F1beta, dFTZ-F1beta, ftz-F1, betaFTZ-F1, NR5B1, DHR39/Ftz-F1beta, FTZ-F1B, DHR30, EP(2)2490, i70" CDMC36076 4 21 22 DAC36-H13 23-CG8680-RA_4 CG8680 ATCATTGAGGAAACCATAGTGGCCAATAGATTTTAGCTAAAACACCTTTCTATCCTGTTGCGCTAGCTT 69 FBan0008680 FBgn0031684 CG8680 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8680 CG8680 CDMC36076 4 22 22 DAC36-H13 23-CG8680-RA_4 CG8680 ATCATTGAGGAAACCATAGTGGCCAATAGATTTTAGCTAAAACACCTTTCTATCCTGTTGCGCTAGCTT 69 FBan0008680 FBgn0031684 CG8680 2 2L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8680 CG8680 CDMC36077 4 23 22 DAC36-L01 9-CG8722-RC_1 CG8722 CGAGATTAGCAACAAATTGCCGCTGAGCTGTTTGTCCTGGAACACTTCCACTTACATGGTCACCCAGCT 69 FBan0008722 FBgn0033247 Nup44A 2 2R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup44A Nup44A "CG8722, nup44A, nucleoporin-44A" CDMC36077 4 24 22 DAC36-L01 9-CG8722-RC_1 CG8722 CGAGATTAGCAACAAATTGCCGCTGAGCTGTTTGTCCTGGAACACTTCCACTTACATGGTCACCCAGCT 69 FBan0008722 FBgn0033247 Nup44A 2 2R RNA localization; GO:0006403; exocytosis; GO:0006887; intracellular protein transport; GO:0006886 structural constituent of nuclear pore; GO:0017056; ; GO:0017056 nuclear pore; GO:0005643 Nup44A Nup44A "CG8722, nup44A, nucleoporin-44A" CDMC36078 4 25 22 DAC36-L13 2-CG8734-RA_1 CG8734 CCGCCACCATGACACATACAAGAATCTTACCGCGAAGCTCATGCAGTCCCTGTATATCCTGAGACGCCA 69 FBan0008734 FBgn0033315 CG8734 2 2R chondroitin sulfate biosynthesis; GO:0030206; heparan sulfate proteoglycan biosynthesis; GO:0015012; protein amino acid glycosylation; GO:0006486 "galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008378 ; EC:2.4.1.-" membrane; GO:0016020 CG8734 CG8734 CDMC36078 4 26 22 DAC36-L13 2-CG8734-RA_1 CG8734 CCGCCACCATGACACATACAAGAATCTTACCGCGAAGCTCATGCAGTCCCTGTATATCCTGAGACGCCA 69 FBan0008734 FBgn0033315 CG8734 2 2R chondroitin sulfate biosynthesis; GO:0030206; heparan sulfate proteoglycan biosynthesis; GO:0015012; protein amino acid glycosylation; GO:0006486 "galactosyltransferase activity; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; ; GO:0008378 ; EC:2.4.1.-; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008378 ; EC:2.4.1.-" membrane; GO:0016020 CG8734 CG8734 CDMC36079 4 1 23 DAC36-P01 3-CG8770-RA_1 CG8770 TGCCTCTGATCTGGGTTCAGTGTCGTCCAAAGGCGAAGACAACGTTTATGCGTGCAGTTTGCTTGCAAA 69 FBan0008770 FBgn0004623 Gbeta76C 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; deactivation of rhodopsin mediated signaling; GO:0016059; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 cytoplasm; GO:0005737; heterotrimeric G-protein complex; GO:0005834; rhabdomere; GO:0016028 Gbeta76C G protein beta-subunit 76C "CG8770, Gbe, G[[beta]] eye, gbe, Gbetae, guanine nucleotide regulatory protein beta subunit, Gqbeta, Gbeta[[e]], Gbeta, G[[beta]]e, DGqbeta, G[[beta]], Gbeta76C, G[q]" CDMC36079 4 2 23 DAC36-P01 3-CG8770-RA_1 CG8770 TGCCTCTGATCTGGGTTCAGTGTCGTCCAAAGGCGAAGACAACGTTTATGCGTGCAGTTTGCTTGCAAA 69 FBan0008770 FBgn0004623 Gbeta76C 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; deactivation of rhodopsin mediated signaling; GO:0016059; phospholipase C activation; GO:0007202; phototransduction; GO:0007602; rhodopsin mediated signaling; GO:0016056 signal transducer activity; GO:0004871; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0004871 cytoplasm; GO:0005737; heterotrimeric G-protein complex; GO:0005834; rhabdomere; GO:0016028 Gbeta76C G protein beta-subunit 76C "CG8770, Gbe, G[[beta]] eye, gbe, Gbetae, guanine nucleotide regulatory protein beta subunit, Gqbeta, Gbeta[[e]], Gbeta, G[[beta]]e, DGqbeta, G[[beta]], Gbeta76C, G[q]" CDMC36080 4 3 23 DAC36-P13 16-CG8782-RA_1 CG8782 CGAGTACAAGTGCCATACCCCATCGACTCGCGAGATACATACATACATACTATCGCCAACATGTTCGCC 69 FBgn0036898 CDMC36080 4 4 23 DAC36-P13 16-CG8782-RA_1 CG8782 CGAGTACAAGTGCCATACCCCATCGACTCGCGAGATACATACATACATACTATCGCCAACATGTTCGCC 69 FBgn0036898 CDMC36081 4 5 23 DAC37-D01 17-CG9008-RA_1 CG9008 GGCGGAGAATCAGGATGAACAGAAGGAGGGTTGTTCCCGCACGGTCTCTAGACTCTAATCTATCTCTTA 69 FBan0009008 FBgn0028540 CG9008 2 2L carbohydrate metabolism; GO:0005975; galactose metabolism; GO:0006012 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG9008 CG9008 BG:DS00797.2 CDMC36081 4 6 23 DAC37-D01 17-CG9008-RA_1 CG9008 GGCGGAGAATCAGGATGAACAGAAGGAGGGTTGTTCCCGCACGGTCTCTAGACTCTAATCTATCTCTTA 69 FBan0009008 FBgn0028540 CG9008 2 2L carbohydrate metabolism; GO:0005975; galactose metabolism; GO:0006012 isomerase activity; GO:0016853 ; EC:5.-.-.-; racemase and epimerase activity; GO:0016854 ; EC:5.1.-.-; ; GO:0016853 ; EC:5.-.-.-; ; GO:0016854 ; EC:5.1.-.-; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG9008 CG9008 BG:DS00797.2 CDMC36082 4 7 23 DAC37-D13 2-CG9023-RA_1 CG9023 TGCTGATCGAAGCGCTGATCACCTTTATTTTGGTTTTCGTGGTCAAGGCTGTTTCGGATCCTGGACGCC 69 FBan0009023 FBgn0015872 Drip 2 2R cell homeostasis; GO:0019725; water homeostasis; GO:0030104; water transport; GO:0006833 water transporter activity; GO:0005372; carrier activity; GO:0005386; ; GO:0005386; water channel activity; GO:0015250; ; GO:0005372; ; GO:0015250; ; GO:0005372 integral to membrane; GO:0016021 Drip Drip "CG9023, I: Intensifier of Bar, transcript group I, aquaporin, drip, DRIP, anon-48Aa, I" CDMC36082 4 8 23 DAC37-D13 2-CG9023-RA_1 CG9023 TGCTGATCGAAGCGCTGATCACCTTTATTTTGGTTTTCGTGGTCAAGGCTGTTTCGGATCCTGGACGCC 69 FBan0009023 FBgn0015872 Drip 2 2R cell homeostasis; GO:0019725; water homeostasis; GO:0030104; water transport; GO:0006833 water transporter activity; GO:0005372; carrier activity; GO:0005386; ; GO:0005386; water channel activity; GO:0015250; ; GO:0005372; ; GO:0015250; ; GO:0005372 integral to membrane; GO:0016021 Drip Drip "CG9023, I: Intensifier of Bar, transcript group I, aquaporin, drip, DRIP, anon-48Aa, I" CDMC36083 4 9 23 DAC37-H01 16-CG9050-RA_1 CG9050 GCAGGATCTGGATCCCTTCAAGCAGATGAAACTCTTCAAGAAACTTCCCGAACTATTTCCCACAGCCAG 69 FBan0009050 FBgn0031755 CG9050 2 2L CG9050 CG9050 BcDNA:GM32356 CDMC36083 4 10 23 DAC37-H01 16-CG9050-RA_1 CG9050 GCAGGATCTGGATCCCTTCAAGCAGATGAAACTCTTCAAGAAACTTCCCGAACTATTTCCCACAGCCAG 69 FBan0009050 FBgn0031755 CG9050 2 2L CG9050 CG9050 BcDNA:GM32356 CDMC36084 4 11 23 DAC37-H13 1-CG9068-RA_1 CG9068 GCCAGTGAAGCAGTCCGCATTTACTCCGATGCTGGAACTCTTCGTTCTGCTGCACAAATACCAGGTGAA 69 FBan0009068 FBgn0034106 CG9068 2 2R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 microtubule associated complex; GO:0005875 CG9068 CG9068 CDMC36084 4 12 23 DAC37-H13 1-CG9068-RA_1 CG9068 GCCAGTGAAGCAGTCCGCATTTACTCCGATGCTGGAACTCTTCGTTCTGCTGCACAAATACCAGGTGAA 69 FBan0009068 FBgn0034106 CG9068 2 2R cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; motor activity; GO:0003774; ; GO:0003777; ; GO:0003774 microtubule associated complex; GO:0005875 CG9068 CG9068 CDMC36085 4 13 23 DAC37-L01 7-CG9097-RB_1 CG9097 TCCCCGAATTGATCCCGCATCAACCCAAATCCCCACTAGATCCCCTTCTAAAGTGCCTTTTCTAGCCTT 69 FBan0009097 FBgn0004870 bab1 3 3L behavior; GO:0007610; chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; female sex differentiation; GO:0046660; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of male pigmentation; GO:0048092; negative regulation of pigmentation; GO:0048086; regulation of developmental pigmentation; GO:0048070; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bab1 bric a brac 1 "CG9097, CG13910, bab, bric-a-brac, bab-I, bric a brac I, BAB1, bric a brac, anon-WO0118547.639, bric a brac 1" CDMC36085 4 14 23 DAC37-L01 7-CG9097-RB_1 CG9097 TCCCCGAATTGATCCCGCATCAACCCAAATCCCCACTAGATCCCCTTCTAAAGTGCCTTTTCTAGCCTT 69 FBan0009097 FBgn0004870 bab1 3 3L behavior; GO:0007610; chromatin assembly or disassembly; GO:0006333; eye-antennal disc morphogenesis; GO:0007455; female gonad development; GO:0008585; female sex differentiation; GO:0046660; leg morphogenesis (sensu Endopterygota); GO:0007480; negative regulation of male pigmentation; GO:0048092; negative regulation of pigmentation; GO:0048086; regulation of developmental pigmentation; GO:0048070; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; sex differentiation; GO:0007548; sex-specific pigmentation; GO:0048071; transcription; GO:0006350; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; ; GO:0003677; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700; ; GO:0003700; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634 bab1 bric a brac 1 "CG9097, CG13910, bab, bric-a-brac, bab-I, bric a brac I, BAB1, bric a brac, anon-WO0118547.639, bric a brac 1" CDMC36086 4 15 23 DAC37-L13 17-CG9117-RA_2 CG9117 GCACAACTGTGCGAGTTTATAATCCCAGGACATGGTCCGATGTTTTCTGTCACACAATCAATGCGCTGT 69 FBan0009117 FBgn0031766 CG9117 2 2L CG9117 CG9117 CDMC36086 4 16 23 DAC37-L13 17-CG9117-RA_2 CG9117 GCACAACTGTGCGAGTTTATAATCCCAGGACATGGTCCGATGTTTTCTGTCACACAATCAATGCGCTGT 69 FBan0009117 FBgn0031766 CG9117 2 2L CG9117 CG9117 CDMC36087 4 17 23 DAC37-P01 3-CG9150-RA_1 CG9150 GAGACGGAACTGGTCACCCCGAGCAATACGCAGAAGCTTAAGGAGGTCATAGACACCAACGTAATGGGC 69 FBan0009150 FBgn0031775 CG9150 2 2L metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG9150 CG9150 CDMC36087 4 18 23 DAC37-P01 3-CG9150-RA_1 CG9150 GAGACGGAACTGGTCACCCCGAGCAATACGCAGAAGCTTAAGGAGGTCATAGACACCAACGTAATGGGC 69 FBan0009150 FBgn0031775 CG9150 2 2L metabolism; GO:0008152 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG9150 CG9150 CDMC36088 4 19 23 DAC37-P13 23-CG9162-RA_8 CG9162 GGAGCTACATTGTATGCTGCACTGAATATGGTTAACAAACTGCATGCCTAATGGAACCGACAATTCCCC 69 FBan0009162 FBgn0031778 CG9162 2 2L CG9162 CG9162 CDMC36088 4 20 23 DAC37-P13 23-CG9162-RA_8 CG9162 GGAGCTACATTGTATGCTGCACTGAATATGGTTAACAAACTGCATGCCTAATGGAACCGACAATTCCCC 69 FBan0009162 FBgn0031778 CG9162 2 2L CG9162 CG9162 CDMC36089 4 21 23 DAC38-D01 3-CG5819-RB_5 CG5819 CCTGCGCATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGC 66 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC36089 4 22 23 DAC38-D01 3-CG5819-RB_5 CG5819 CCTGCGCATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGC 66 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC36090 4 23 23 DAC38-D13 17-CG6092-RA_2 CG6092 AGGCGGCATACACATAAACCACGCATTCAATTTGCCTTCAGTTTGGTTCAGTCGTCAATGTGGCGG 66 FBan0006092 FBgn0028833 Dak1 3 3R pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; cytidylate kinase activity; GO:0004127 ; EC:2.7.4.14; ; GO:0004127 ; EC:2.7.4.14; uridylate kinase activity; GO:0009041 ; EC:2.7.4.-; ; GO:0004127 ; EC:2.7.4.14; ; GO:0004127 ; EC:2.7.4.14; ; GO:0009041 ; EC:2.7.4.- Dak1 Dak1 "CG6092, Dak1L, dak1, Dm.UMP-CMP kinase, anon-WO0118547.320" CDMC36090 4 24 23 DAC38-D13 17-CG6092-RA_2 CG6092 AGGCGGCATACACATAAACCACGCATTCAATTTGCCTTCAGTTTGGTTCAGTCGTCAATGTGGCGG 66 FBan0006092 FBgn0028833 Dak1 3 3R pyrimidine base metabolism; GO:0006206 ATP binding; GO:0005524; ; GO:0005524; cytidylate kinase activity; GO:0004127 ; EC:2.7.4.14; ; GO:0004127 ; EC:2.7.4.14; uridylate kinase activity; GO:0009041 ; EC:2.7.4.-; ; GO:0004127 ; EC:2.7.4.14; ; GO:0004127 ; EC:2.7.4.14; ; GO:0009041 ; EC:2.7.4.- Dak1 Dak1 "CG6092, Dak1L, dak1, Dm.UMP-CMP kinase, anon-WO0118547.320" CDMC36091 4 25 23 DAC38-H01 6-CG6379-RA_1 CG6379 CGCTCGATCTTCTTCGGCCAGATTGTGTACGAGTTCTACGGAGAGGGCAGGACCATTCAGCGAATG 66 FBan0006379 FBgn0029693 CG6379 X X CG6379 CG6379 CDMC36091 4 26 23 DAC38-H01 6-CG6379-RA_1 CG6379 CGCTCGATCTTCTTCGGCCAGATTGTGTACGAGTTCTACGGAGAGGGCAGGACCATTCAGCGAATG 66 FBan0006379 FBgn0029693 CG6379 X X CG6379 CG6379 CDMC36092 4 1 24 DAC38-H13 3-CG6542-RA_1 CG6542 TACAAGCCTACGGCAAGACGATTGGACTGAAATTCAAGGAGGGCTCATCCATGAACCTGGCCACGT 66 FBan0006542 FBgn0027506 EDTP 2 2R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 EDTP Egg-derived tyrosine phosphatase "CG6542, D-EDTP, anon-WO0118547.124, BcDNA:LD23181, Egg-derived tyrosine phosphatase" CDMC36092 4 2 24 DAC38-H13 3-CG6542-RA_1 CG6542 TACAAGCCTACGGCAAGACGATTGGACTGAAATTCAAGGAGGGCTCATCCATGAACCTGGCCACGT 66 FBan0006542 FBgn0027506 EDTP 2 2R protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48 EDTP Egg-derived tyrosine phosphatase "CG6542, D-EDTP, anon-WO0118547.124, BcDNA:LD23181, Egg-derived tyrosine phosphatase" CDMC36093 4 3 24 DAC38-L01 12-CG7054-RA_2 CG7054 GATCCCGATGCACCGACTCGTCAAGATCCCAAGTACCGTGAGATTCTGCACTGGTCTGTGGTCAAC 66 FBan0007054 FBgn0038972 CG7054 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG7054 CG7054 CDMC36093 4 4 24 DAC38-L01 12-CG7054-RA_2 CG7054 GATCCCGATGCACCGACTCGTCAAGATCCCAAGTACCGTGAGATTCTGCACTGGTCTGTGGTCAAC 66 FBan0007054 FBgn0038972 CG7054 3 3R signal transduction; GO:0007165 kinase inhibitor activity; GO:0019210; ; GO:0019210; phosphatidylethanolamine binding; GO:0008429; ; GO:0008429 CG7054 CG7054 CDMC36094 4 5 24 DAC38-L13 9-CG7166-RA_3 CG7166 TGTGTTTTCCGGGCCAACACACCTGTCGGATAGCTCTACACTCATATTGGAAAACGTGGACAGGCA 66 FBan0007166 FBgn0037107 CG7166 3 3L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 extracellular region; GO:0005576 CG7166 CG7166 CT22143 CDMC36094 4 6 24 DAC38-L13 9-CG7166-RA_3 CG7166 TGTGTTTTCCGGGCCAACACACCTGTCGGATAGCTCTACACTCATATTGGAAAACGTGGACAGGCA 66 FBan0007166 FBgn0037107 CG7166 3 3L cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 extracellular region; GO:0005576 CG7166 CG7166 CT22143 CDMC36095 4 7 24 DAC38-P01 15-CG7728-RA_7 CG7728 GGCGAGGAGGATAATGGTCGGATAACTGGCGATCACTCCTTCTACGAGGACCTTAAAGCAGAGGCT 66 FBan0007728 FBgn0036686 CG7728 3 3L CG7728 CG7728 CDMC36095 4 8 24 DAC38-P01 15-CG7728-RA_7 CG7728 GGCGAGGAGGATAATGGTCGGATAACTGGCGATCACTCCTTCTACGAGGACCTTAAAGCAGAGGCT 66 FBan0007728 FBgn0036686 CG7728 3 3L CG7728 CG7728 CDMC36096 4 9 24 DAC38-P13 AutoBlank AutoBlank CDMC36096 4 10 24 DAC38-P13 AutoBlank AutoBlank CDMC36097 4 11 24 DAC39-D01 1-CG32053-RA_1 CG32053 TGCTGAGACCTACGACCAAGTGAGGGATCATCGCACCTATGTCGAACATCACAGATCAATGGGTTGGCG 69 FBan0032053 FBgn0052053 CG32053 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG32053 CG32053 "CG6645, CG6645, CG6645" CDMC36097 4 12 24 DAC39-D01 1-CG32053-RA_1 CG32053 TGCTGAGACCTACGACCAAGTGAGGGATCATCGCACCTATGTCGAACATCACAGATCAATGGGTTGGCG 69 FBan0032053 FBgn0052053 CG32053 3 3L transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; membrane; GO:0016020 CG32053 CG32053 "CG6645, CG6645, CG6645" CDMC36098 4 13 24 DAC39-D13 14-CG32063-RB_1 CG32063 GCAGCTGCTCTATCTTTGCCCATCAATATAACTGCTGTGATACCACTGTGCGAGAATCTGCCGTCTGGA 69 FBgn0052063 CDMC36098 4 14 24 DAC39-D13 14-CG32063-RB_1 CG32063 GCAGCTGCTCTATCTTTGCCCATCAATATAACTGCTGTGATACCACTGTGCGAGAATCTGCCGTCTGGA 69 FBgn0052063 CDMC36099 4 15 24 DAC39-H01 12-CG3209-RA_4 CG3209 TGGAACATGCTGACACGCACCAATAGGCACTACGAGTTCATTTCCTGGAAAATCACCTCCATCTGGGTG 69 FBan0003209 FBgn0034971 CG3209 2 2R metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG3209 CG3209 CDMC36099 4 16 24 DAC39-H01 12-CG3209-RA_4 CG3209 TGGAACATGCTGACACGCACCAATAGGCACTACGAGTTCATTTCCTGGAAAATCACCTCCATCTGGGTG 69 FBan0003209 FBgn0034971 CG3209 2 2R metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG3209 CG3209 CDMC36100 4 17 24 DAC39-H13 16-CG32107-RA_1 CG32107 AGCCACGAATCTGTGACGCTCGTACTGGAATTCTTTGTACAGTGCATCCTGAGTTATGGGAGTATCCTT 69 FBan0032107 FBgn0052107 CG32107 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32107 CG32107 CDMC36100 4 18 24 DAC39-H13 16-CG32107-RA_1 CG32107 AGCCACGAATCTGTGACGCTCGTACTGGAATTCTTTGTACAGTGCATCCTGAGTTATGGGAGTATCCTT 69 FBan0032107 FBgn0052107 CG32107 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32107 CG32107 CDMC36101 4 19 24 DAC39-L01 16-CG32140-RA_2 CG32140 CGGATAGTCTGGAGGATCTGAATTTGAGTTTTAACACAAGTGCCTCGCAAAATCCGCTAAGCAACGCCT 69 FBgn0052140 CDMC36101 4 20 24 DAC39-L01 16-CG32140-RA_2 CG32140 CGGATAGTCTGGAGGATCTGAATTTGAGTTTTAACACAAGTGCCTCGCAAAATCCGCTAAGCAACGCCT 69 FBgn0052140 CDMC36102 4 21 24 DAC39-L13 23-CG32151-RA_6 CG32151 GTTGGGCATTTAGCAAGCAATATACCTAATTTAATTGTGTTTTTTGTTAAAACAAATTCACCCGCTCGT 69 FBan0032151 FBgn0052151 CG32151 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32151 CG32151 CDMC36102 4 22 24 DAC39-L13 23-CG32151-RA_6 CG32151 GTTGGGCATTTAGCAAGCAATATACCTAATTTAATTGTGTTTTTTGTTAAAACAAATTCACCCGCTCGT 69 FBan0032151 FBgn0052151 CG32151 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32151 CG32151 CDMC36103 4 23 24 DAC39-P01 13-CG32181-RA_1 CG32181 GCCAGTCTCGATGGAAGTGAGAATTTCAACGAGTACTCCAGGGAGATTGCTTTTGCAGGACCCATTCCG 69 FBan0032181 FBgn0052181 CG32181 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32181 CG32181 BcDNA:AT19257 CDMC36103 4 24 24 DAC39-P01 13-CG32181-RA_1 CG32181 GCCAGTCTCGATGGAAGTGAGAATTTCAACGAGTACTCCAGGGAGATTGCTTTTGCAGGACCCATTCCG 69 FBan0032181 FBgn0052181 CG32181 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32181 CG32181 BcDNA:AT19257 CDMC36104 4 25 24 DAC39-P13 3-CG3218-RA_4 CG3218 TGGGCGCGACATAATTGAAACAGAGTGGCCGGATCCTAAGCACTCTGGCATAAATCACACTGTAGGCCT 69 FBan0003218 FBgn0000810 fs(1)K10 X X dorsal/ventral pattern formation; GO:0009953; intracellular mRNA localization; GO:0008298; negative regulation of translation; GO:0016478; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; pole plasm mRNA localization; GO:0019094; protein localization; GO:0008104 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 fs(1)K10 female sterile (1) K10 "CG3218, CG3218, CG3218, fs(1)M9, fs(1)k10, K10, K-10, EG:30B8.5" CDMC36104 4 26 24 DAC39-P13 3-CG3218-RA_4 CG3218 TGGGCGCGACATAATTGAAACAGAGTGGCCGGATCCTAAGCACTCTGGCATAAATCACACTGTAGGCCT 69 FBan0003218 FBgn0000810 fs(1)K10 X X dorsal/ventral pattern formation; GO:0009953; intracellular mRNA localization; GO:0008298; negative regulation of translation; GO:0016478; oocyte dorsal/ventral axis determination (sensu Insecta); GO:0048123; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; pole plasm mRNA localization; GO:0019094; protein localization; GO:0008104 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 fs(1)K10 female sterile (1) K10 "CG3218, CG3218, CG3218, fs(1)M9, fs(1)k10, K10, K-10, EG:30B8.5" CDMC36105 4 1 25 DAC40-D01 3-CG9582-RA_3 CG9582 AGCATGATGGCTATGGCATCAAAGGGTTGTATCGGGGTATCACTGCACTAGTGGCTCGAAATGCCGTCT 69 FBan0009582 FBgn0032090 CG9582 2 2L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG9582 CG9582 CDMC36105 4 2 25 DAC40-D01 3-CG9582-RA_3 CG9582 AGCATGATGGCTATGGCATCAAAGGGTTGTATCGGGGTATCACTGCACTAGTGGCTCGAAATGCCGTCT 69 FBan0009582 FBgn0032090 CG9582 2 2L transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG9582 CG9582 CDMC36106 4 3 25 DAC40-D13 16-CG9592-RA_1 CG9592 CGCGAATCGGCATTGGGATAACTGTCTGGATCTGGTAGTTGAGTGTGCCAATGTCCAAAGAAAACTTCA 69 FBan0009592 FBgn0036426 CG9592 3 3L CG9592 CG9592 CDMC36106 4 4 25 DAC40-D13 16-CG9592-RA_1 CG9592 CGCGAATCGGCATTGGGATAACTGTCTGGATCTGGTAGTTGAGTGTGCCAATGTCCAAAGAAAACTTCA 69 FBan0009592 FBgn0036426 CG9592 3 3L CG9592 CG9592 CDMC36107 4 5 25 DAC40-H01 2-CG9621-RA_1 CG9621 CCAGCTTCCTGATAGCCGAGAACTTTCCCATCGTTATATCATCCGATGATCCGGGTGTTTGGGGAGCCA 69 FBan0009621 FBgn0038172 Adgf-D 3 3R cell proliferation; GO:0008283; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular space; GO:0005615 Adgf-D Adenosine deaminase-related growth factor D "CG9621, CG9621, CG9621, CG9621, ADGF-D, adgfd, Adenosine deaminase-related growth factor D" CDMC36107 4 6 25 DAC40-H01 2-CG9621-RA_1 CG9621 CCAGCTTCCTGATAGCCGAGAACTTTCCCATCGTTATATCATCCGATGATCCGGGTGTTTGGGGAGCCA 69 FBan0009621 FBgn0038172 Adgf-D 3 3R cell proliferation; GO:0008283; purine ribonucleoside monophosphate biosynthesis; GO:0009168 adenosine deaminase activity; GO:0004000 ; EC:3.5.4.4; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0004000 ; EC:3.5.4.4 extracellular space; GO:0005615 Adgf-D Adenosine deaminase-related growth factor D "CG9621, CG9621, CG9621, CG9621, ADGF-D, adgfd, Adenosine deaminase-related growth factor D" CDMC36108 4 7 25 DAC40-H13 17-CG9636-RB_1 CG9636 CCGCCCACTGAGATATCTGGAACCCATAACAATTCGGCTACTGCTCGGTGTAAGACAGCAATACTAACA 69 FBan0009636 FBgn0037556 CG9636 3 3R CG9636 CG9636 CDMC36108 4 8 25 DAC40-H13 17-CG9636-RB_1 CG9636 CCGCCCACTGAGATATCTGGAACCCATAACAATTCGGCTACTGCTCGGTGTAAGACAGCAATACTAACA 69 FBan0009636 FBgn0037556 CG9636 3 3R CG9636 CG9636 CDMC36109 4 9 25 DAC40-L01 23-CG9668-RA_5 CG9668 CCGCTGCATAGAACCAAGGACAACTCTACTCTAAGACAACTGACCATGTAACATGAAAGCCAAGGAAAA 69 FBan0009668 FBgn0003250 Rh4 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; detection of UV; GO:0009589; phototransduction; GO:0007602; phototransduction, UV; GO:0007604; visual perception; GO:0007601" G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 integral to membrane; GO:0016021 Rh4 Rhodopsin 4 "CG9668, CG9668, RH4, rh4, Dm Rh4, rhodopsin, Rh, DMELRH4, Rhodopsin, FBgn0003250" CDMC36109 4 10 25 DAC40-L01 23-CG9668-RA_5 CG9668 CCGCTGCATAGAACCAAGGACAACTCTACTCTAAGACAACTGACCATGTAACATGAAAGCCAAGGAAAA 69 FBan0009668 FBgn0003250 Rh4 3 3L "G-protein coupled receptor protein signaling pathway; GO:0007186; detection of UV; GO:0009589; phototransduction; GO:0007602; phototransduction, UV; GO:0007604; visual perception; GO:0007601" G-protein coupled receptor activity; GO:0004930; G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0004930; ; GO:0008020 integral to membrane; GO:0016021 Rh4 Rhodopsin 4 "CG9668, CG9668, RH4, rh4, Dm Rh4, rhodopsin, Rh, DMELRH4, Rhodopsin, FBgn0003250" CDMC36110 4 11 25 DAC40-L13 1-CG9682-RA_1 CG9682 CCTCCGGTTGGGAACTTGGAATGGATGGCAGCATTTTTGGTCACGAATTGGGAGATGAGGGCAATTTGT 69 FBan0009682 FBgn0039760 CG9682 3 3R CG9682 CG9682 anon-WO0140519.240 CDMC36110 4 12 25 DAC40-L13 1-CG9682-RA_1 CG9682 CCTCCGGTTGGGAACTTGGAATGGATGGCAGCATTTTTGGTCACGAATTGGGAGATGAGGGCAATTTGT 69 FBan0009682 FBgn0039760 CG9682 3 3R CG9682 CG9682 anon-WO0140519.240 CDMC36111 4 13 25 DAC40-P01 1-CG9715-RA_1 CG9715 TGCGCCATACTCTCAATCCGGAGTGTGACCGTCTGTTGAGTGAAATGGATCACAATCAACCTGGCAGCA 69 FBan0009715 FBgn0036668 CG9715 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG9715 CG9715 CDMC36111 4 14 25 DAC40-P01 1-CG9715-RA_1 CG9715 TGCGCCATACTCTCAATCCGGAGTGTGACCGTCTGTTGAGTGAAATGGATCACAATCAACCTGGCAGCA 69 FBan0009715 FBgn0036668 CG9715 3 3L nucleic acid binding; GO:0003676; ; GO:0003676 CG9715 CG9715 CDMC36112 4 15 25 DAC40-P13 2-CG9727-RA_6 CG9727 GGATGAAGCAAAGACCCAACTTGTTGAGCAAGCAGCAATCACTTGACTGCGACAACCGGGATCCCATGA 69 FBan0009727 FBgn0037445 CG9727 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG9727 CG9727 CDMC36112 4 16 25 DAC40-P13 2-CG9727-RA_6 CG9727 GGATGAAGCAAAGACCCAACTTGTTGAGCAAGCAGCAATCACTTGACTGCGACAACCGGGATCCCATGA 69 FBan0009727 FBgn0037445 CG9727 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 CG9727 CG9727 CDMC36113 4 17 25 DAC41-D01 AutoBlank AutoBlank CDMC36113 4 18 25 DAC41-D01 AutoBlank AutoBlank CDMC36114 4 19 25 DAC41-D13 AutoBlank AutoBlank CDMC36114 4 20 25 DAC41-D13 AutoBlank AutoBlank CDMC36115 4 21 25 DAC41-H01 AutoBlank AutoBlank CDMC36115 4 22 25 DAC41-H01 AutoBlank AutoBlank CDMC36116 4 23 25 DAC41-H13 AutoBlank AutoBlank CDMC36116 4 24 25 DAC41-H13 AutoBlank AutoBlank CDMC36117 4 25 25 DAC41-L01 AutoBlank AutoBlank CDMC36117 4 26 25 DAC41-L01 AutoBlank AutoBlank CDMC36118 4 1 26 DAC41-L13 AutoBlank AutoBlank CDMC36118 4 2 26 DAC41-L13 AutoBlank AutoBlank CDMC36119 4 3 26 DAC41-P01 AutoBlank AutoBlank CDMC36119 4 4 26 DAC41-P01 AutoBlank AutoBlank CDMC36120 4 5 26 DAC41-P13 AutoBlank AutoBlank CDMC36120 4 6 26 DAC41-P13 AutoBlank AutoBlank CDMC36121 4 7 26 DAC42-D01 1-CG8922-RA_6 Rp s5a TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC36121 4 8 26 DAC42-D01 1-CG8922-RA_6 Rp s5a TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC36122 4 9 26 DAC42-D13 22-CG9553-RA_1 chic GCCGTGCGGTAAAGCAACAGCGATCCATATCCAGATCCATATATATCAGTTCAACTTAATCCGCACCCA 69 FBan0009553 FBgn0000308 chic 2 2L "actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; actin polymerization and/or depolymerization; GO:0008154; brain development; GO:0007420; cellular morphogenesis; GO:0000902; central nervous system remodeling (sensu Insecta); GO:0035193; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; dorsal closure; GO:0007391; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; spermatogenesis; GO:0007283" "actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; phosphatidylinositol-4,5-bisphosphate binding; GO:0005546; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005546" actin cytoskeleton; GO:0015629 chic chickadee "CG9553, CG9553, sand, stranded, D88, l(2)27/7, profilin, Profilin, chi, Chic, Chi, chickadee" CDMC36122 4 10 26 DAC42-D13 22-CG9553-RA_1 chic GCCGTGCGGTAAAGCAACAGCGATCCATATCCAGATCCATATATATCAGTTCAACTTAATCCGCACCCA 69 FBan0009553 FBgn0000308 chic 2 2L "actin filament organization; GO:0007015; actin filament polymerization; GO:0030041; actin polymerization and/or depolymerization; GO:0008154; brain development; GO:0007420; cellular morphogenesis; GO:0000902; central nervous system remodeling (sensu Insecta); GO:0035193; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; dorsal closure; GO:0007391; nurse cell to oocyte transport (sensu Insecta); GO:0007300; pole plasm oskar mRNA localization; GO:0045451; spermatogenesis; GO:0007283" "actin binding; GO:0003779; ; GO:0003779; ; GO:0003779; phosphatidylinositol-4,5-bisphosphate binding; GO:0005546; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005546" actin cytoskeleton; GO:0015629 chic chickadee "CG9553, CG9553, sand, stranded, D88, l(2)27/7, profilin, Profilin, chi, Chic, Chi, chickadee" CDMC36123 4 11 26 DAC42-H01 23-CG17835-RB_2 invected TATGGAGTAGTGTGTAAGCTAGCTTTAGAAATTCTGAGCGATTAAGTTGTACAATATTCTAGTCCGCCG 69 FBan0017835 FBgn0001269 inv 2 2R compartment specification; GO:0007386; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 inv invected "CG17835, CG17835, er, engrailed-related, in, Engrailed/Invected, IV: transcript group IV, transcript group IV, engrailed-invected, invected" CDMC36123 4 12 26 DAC42-H01 23-CG17835-RB_2 invected TATGGAGTAGTGTGTAAGCTAGCTTTAGAAATTCTGAGCGATTAAGTTGTACAATATTCTAGTCCGCCG 69 FBan0017835 FBgn0001269 inv 2 2R compartment specification; GO:0007386; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuroblast fate determination; GO:0007400; regulation of transcription from RNA polymerase II promoter; GO:0006357; wing disc anterior/posterior pattern formation; GO:0048100 DNA binding; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 inv invected "CG17835, CG17835, er, engrailed-related, in, Engrailed/Invected, IV: transcript group IV, transcript group IV, engrailed-invected, invected" CDMC36124 4 13 26 DAC42-H13 23-CG15323-RA_1 CG15323 AAGGACCTGAAAGATCTGATTGCCCTGAATGAGAAGGAATGTAATAGGCTGTTATTCGATCGCCT 65 FBan0015323 FBgn0040784 CG15323 X X CG15323 CG15323 CDMC36124 4 14 26 DAC42-H13 23-CG15323-RA_1 CG15323 AAGGACCTGAAAGATCTGATTGCCCTGAATGAGAAGGAATGTAATAGGCTGTTATTCGATCGCCT 65 FBan0015323 FBgn0040784 CG15323 X X CG15323 CG15323 CDMC36125 4 15 26 DAC42-L01 150mM NaPO4 Blank CDMC36125 4 16 26 DAC42-L01 150mM NaPO4 Blank CDMC36126 4 17 26 DAC42-L13 5uM MSP 5uM MSP CDMC36126 4 18 26 DAC42-L13 5uM MSP 5uM MSP CDMC36127 4 19 26 DAC42-P01 10uM MSP 10uM MSP CDMC36127 4 20 26 DAC42-P01 10uM MSP 10uM MSP CDMC36128 4 21 26 DAC42-P13 20uM MSP 20uM MSP CDMC36128 4 22 26 DAC42-P13 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY